PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Iglesias-Guimarais, V; Gil-Guinon, E; Sanchez-Osuna, M; Casanelles, E; Garcia-Belinchon, M; Comella, JX; Yuste, VJ				Iglesias-Guimarais, Victoria; Gil-Guinon, Estel; Sanchez-Osuna, Maria; Casanelles, Elisenda; Garcia-Belinchon, Merce; Comella, Joan X.; Yuste, Victor J.			Chromatin Collapse during Caspase-dependent Apoptotic Cell Death Requires DNA Fragmentation Factor, 40-kDa Subunit-/Caspase-activated Deoxyribonuclease-mediated 3 '-OH Single-strand DNA Breaks	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADP-RIBOSYL TRANSFERASE; ENDONUCLEASE DFF40/CAD; MORPHOLOGICAL CHANGE; NEUROBLASTOMA-CELLS; INHIBITOR; CLEAVAGE; CAD; NUCLEASE; DIFFERENTIATION; CONDENSATION	Apoptotic nuclear morphology and oligonucleosomal double-strand DNA fragments (also known as DNA ladder) are considered the hallmarks of apoptotic cell death. From a classic point of view, these two processes occur concomitantly. Once activated, DNA fragmentation factor, 40-kDa subunit (DFF40)/caspase-activated DNase (CAD) endonuclease hydrolyzes the DNA into oligonucleosomal-size pieces, facilitating the chromatin package. However, the dogma that the apoptotic nuclear morphology depends on DNA fragmentation has been questioned. Here, we use different cellular models, including MEF CAD(-/-) cells, to unravel the mechanism by which DFF40/CAD influences chromatin condensation and nuclear collapse during apoptosis. Upon apoptotic insult, SK-N-AS cells display caspase-dependent apoptotic nuclear alterations in the absence of internucleosomal DNA degradation. The overexpression of a wild-type form of DFF40/CAD endonuclease, but not of different catalytic-null mutants, restores the cellular ability to degrade the chromatin into oligonucleosomal-length fragments. We show that apoptotic nuclear collapse requires a 3'-OH endonucleolytic activity even though the internucleosomal DNA degradation is impaired. Moreover, alkaline unwinding electrophoresis and In Situ End-Labeling (ISEL)/In Situ Nick Translation (ISNT) assays reveal that the apoptotic DNA damage observed in the DNA ladder-deficient SK-N-AS cells is characterized by the presence of single-strand nicks/breaks. Apoptotic single-strand breaks can be impaired by DFF40/CAD knockdown, abrogating nuclear collapse and disassembly. In conclusion, the highest order of chromatin compaction observed in the later steps of caspase-dependent apoptosis relies on DFF40/CAD-mediated DNA damage by generating 3'-OH ends in single-strand rather than double-strand DNA nicks/breaks.	[Iglesias-Guimarais, Victoria; Gil-Guinon, Estel; Sanchez-Osuna, Maria; Casanelles, Elisenda; Garcia-Belinchon, Merce; Yuste, Victor J.] Univ Autonoma Barcelona, Fac Med, Dept Bioquim & Biol Mol, Cell Death Senescence & Survival Grp, E-08193 Barcelona, Spain; [Iglesias-Guimarais, Victoria; Gil-Guinon, Estel; Sanchez-Osuna, Maria; Casanelles, Elisenda; Garcia-Belinchon, Merce; Yuste, Victor J.] Univ Autonoma Barcelona, Fac Med, Inst Neurociencies, E-08193 Barcelona, Spain; [Iglesias-Guimarais, Victoria; Casanelles, Elisenda; Comella, Joan X.] Vall dHebron Inst Recerca, Cell Signalling & Apoptosis Grp, Barcelona 08035, Spain; [Iglesias-Guimarais, Victoria; Casanelles, Elisenda; Comella, Joan X.; Yuste, Victor J.] Ctr Invest Biomed Red Enfermedades Neurodegenerat, Barcelona 08035, Spain	Autonomous University of Barcelona; Autonomous University of Barcelona; University of Barcelona; Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR); CIBERNED	Yuste, VJ (corresponding author), Univ Autonoma Barcelona, Fac Med, Dept Bioquim & Biol Mol, Campus Bellaterra, E-08193 Barcelona, Spain.	victor.yuste@uab.cat	Gil, Estel/B-9786-2015; Yuste, Victor J./C-7071-2008; Comella, Joan/GQA-4279-2022; Comella, Joan X/D-7333-2012	Yuste, Victor J./0000-0001-5322-9261; Comella, Joan X/0000-0002-6218-0786; Gil, Estel/0000-0003-4502-4623	Ministerio de Ciencia e Innovacion/Fondo Europeo de Desarrollo Regional (FEDER) [SAF2011-24081, SAF2012-31485, SAF2010-19953]; Centro de Investigacion Biomedica en Red sobre Enfermedades Neurodegenerativas (CIBERNED) Grant [CB06/05/0042]; Generalitat de Catalunya Grant [SGR2009-346]; Agencia de Gestio d'Ajuts Universitaris i de Recerca (AGAUR, Generalitat de Catalunya); Ministerio de Ciencia e Innovacion [TRA2009-0185, BES-2099-028572]; Ramon y Cajal Program (Spanish Ministerio de Educacion y Ciencia)	Ministerio de Ciencia e Innovacion/Fondo Europeo de Desarrollo Regional (FEDER); Centro de Investigacion Biomedica en Red sobre Enfermedades Neurodegenerativas (CIBERNED) Grant; Generalitat de Catalunya Grant(Generalitat de Catalunya); Agencia de Gestio d'Ajuts Universitaris i de Recerca (AGAUR, Generalitat de Catalunya)(Agencia de Gestio D'Ajuts Universitaris de Recerca Agaur (AGAUR)Generalitat de Catalunya); Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Ramon y Cajal Program (Spanish Ministerio de Educacion y Ciencia)(German Research Foundation (DFG))	This work was supported by Ministerio de Ciencia e Innovacion/Fondo Europeo de Desarrollo Regional (FEDER) Grants SAF2011-24081 and SAF2012-31485 (to V. J. Y.) and SAF2010-19953 (to J. X. C.), by Centro de Investigacion Biomedica en Red sobre Enfermedades Neurodegenerativas (CIBERNED) Grant CB06/05/0042, and by Generalitat de Catalunya Grant SGR2009-346. This work was also supported by a fellowship from Agencia de Gestio d'Ajuts Universitaris i de Recerca (AGAUR, Generalitat de Catalunya) (to V. I. G.), by Postdoctoral Contract TRA2009-0185 from the Ministerio de Ciencia e Innovacion (to E. G. G.), by Formacion de Personal Investigador (FPI) Fellowship BES-2099-028572 from the Ministerio de Ciencia e Innovacion (to M. G. B.), and by the Ramon y Cajal Program (Spanish Ministerio de Educacion y Ciencia) (to V. J. Y.).	Ageichik AV, 2007, J BIOL CHEM, V282, P27374, DOI 10.1074/jbc.M704307200; Ahn JY, 2006, EMBO J, V25, P2083, DOI 10.1038/sj.emboj.7601111; Ahn JY, 2005, MOL CELL, V18, P435, DOI 10.1016/j.molcel.2005.04.010; Bayascas JR, 2002, CELL DEATH DIFFER, V9, P1078, DOI 10.1038/sj.cdd.4401075; Bayascas JR, 2004, FEBS LETT, V566, P234, DOI 10.1016/S0014-5793(04)00519-8; Boix J, 1997, NEUROPHARMACOLOGY, V36, P811, DOI 10.1016/S0028-3908(97)00030-0; BORTNER CD, 1995, TRENDS CELL BIOL, V5, P21, DOI 10.1016/S0962-8924(00)88932-1; Boulares AH, 2001, J BIOL CHEM, V276, P38185; Chalmers Claire R., 2006, Angiogenesis, V9, P193, DOI 10.1007/s10456-006-9050-0; Cho SG, 2003, J CELL BIOL, V163, P71, DOI 10.1083/jcb.200303003; COULTON GR, 1992, J CELL SCI, V102, P653; DAWSON BA, 1988, DEV BIOL, V127, P362, DOI 10.1016/0012-1606(88)90322-3; Dieker J, 2012, TRAFFIC, V13, P257, DOI 10.1111/j.1600-0854.2011.01307.x; Dix MM, 2008, CELL, V134, P679, DOI 10.1016/j.cell.2008.06.038; Enari M, 1998, NATURE, V391, P43, DOI 10.1038/34112; FARZANEH F, 1982, NATURE, V300, P362, DOI 10.1038/300362a0; Fischer U, 2003, CELL DEATH DIFFER, V10, P76, DOI 10.1038/sj.cdd.4401160; FORNACE AJ, 1986, CARCINOGENESIS, V7, P927, DOI 10.1093/carcin/7.6.927; FOURNEL S, 1995, FEBS LETT, V367, P188, DOI 10.1016/0014-5793(95)00532-E; FRANKFURT OS, 1987, EXP CELL RES, V170, P369, DOI 10.1016/0014-4827(87)90314-4; Halenbeck R, 1998, CURR BIOL, V8, P537, DOI 10.1016/S0960-9822(98)79298-X; Hipfner DR, 2004, NAT REV MOL CELL BIO, V5, P805, DOI 10.1038/nrm1491; Iglesias-Guimarais V, 2012, J BIOL CHEM, V287, P7766, DOI 10.1074/jbc.M111.290718; Jacobson MD, 1997, CELL, V88, P347, DOI 10.1016/S0092-8674(00)81873-5; Kawane K, 2003, NAT IMMUNOL, V4, P138, DOI 10.1038/ni881; Korn C, 2002, NUCLEIC ACIDS RES, V30, P1325, DOI 10.1093/nar/30.6.1325; Kothakota S, 1997, SCIENCE, V278, P294, DOI 10.1126/science.278.5336.294; Larsen BD, 2010, CELL CYCLE, V9, P2940, DOI 10.4161/cc.9.15.12335; Larsen BD, 2010, P NATL ACAD SCI USA, V107, P4230, DOI 10.1073/pnas.0913089107; Lechardeur D, 2004, J CELL BIOL, V167, P851, DOI 10.1083/jcb.200404105; Li XL, 2005, GENE DEV, V19, P2705, DOI 10.1101/gad.1359305; Liu XS, 1999, J BIOL CHEM, V274, P13836, DOI 10.1074/jbc.274.20.13836; Liu XS, 1998, P NATL ACAD SCI USA, V95, P8461, DOI 10.1073/pnas.95.15.8461; Liu XS, 1997, CELL, V89, P175, DOI 10.1016/S0092-8674(00)80197-X; Lu CR, 2006, MOL CELL, V23, P121, DOI 10.1016/j.molcel.2006.05.023; MODAK SP, 1972, EXP CELL RES, V75, P307, DOI 10.1016/0014-4827(72)90434-X; Nagase H, 2003, CELL DEATH DIFFER, V10, P142, DOI 10.1038/sj.cdd.4401139; OBERHAMMER F, 1993, EMBO J, V12, P3679, DOI 10.1002/j.1460-2075.1993.tb06042.x; PEITSCH MC, 1993, NUCLEIC ACIDS RES, V21, P4206, DOI 10.1093/nar/21.18.4206; Perez-Alvarez S, 2011, PHARMACOL RES, V63, P352, DOI 10.1016/j.phrs.2010.12.001; Ribas J, 2008, BIOCHEM PHARMACOL, V76, P39, DOI 10.1016/j.bcp.2008.03.023; Sahara S, 1999, NATURE, V401, P168, DOI 10.1038/43678; Sakahira H, 2001, ARCH BIOCHEM BIOPHYS, V388, P91, DOI 10.1006/abbi.2000.2266; Sakahira H, 1998, NATURE, V391, P96, DOI 10.1038/34214; Sakahira H, 1999, CURR BIOL, V9, P543, DOI 10.1016/S0960-9822(99)80240-1; Samejima K, 2001, J BIOL CHEM, V276, P45427, DOI 10.1074/jbc.M108844200; Sancho P, 2010, J BIOL CHEM, V285, P24815, DOI 10.1074/jbc.M110.114280; SCHULZEOSTHOFF K, 1994, J CELL BIOL, V127, P15, DOI 10.1083/jcb.127.1.15; SEN S, 1992, BIOL REV, V67, P287, DOI 10.1111/j.1469-185X.1992.tb00727.x; Sherman MH, 2011, TRENDS CELL BIOL, V21, P312, DOI 10.1016/j.tcb.2011.01.004; Sjakste N, 2007, EUR J HISTOCHEM, V51, P81; Susin SA, 2000, J EXP MED, V192, P571, DOI 10.1084/jem.192.4.571; Takahashi M, 2007, ONCOGENE, V26, P5669, DOI 10.1038/sj.onc.1210352; THOMPSON CB, 1995, SCIENCE, V267, P1456, DOI 10.1126/science.7878464; Timmer JC, 2007, CELL DEATH DIFFER, V14, P66, DOI 10.1038/sj.cdd.4402059; Widlak P, 2000, J BIOL CHEM, V275, P8226, DOI 10.1074/jbc.275.11.8226; Widlak P, 2002, J BIOL CHEM, V277, P21683, DOI 10.1074/jbc.M201027200; Widlak P, 2009, CELL MOL LIFE SCI, V66, P263, DOI 10.1007/s00018-008-8472-9; Widlak P, 2001, MOL CELL BIOCHEM, V218, P125, DOI 10.1023/A:1007231822086; Widlak P, 2006, APOPTOSIS, V11, P1331, DOI 10.1007/s10495-006-6983-0; WILLIAMS GT, 1983, BIOSCIENCE REP, V3, P815, DOI 10.1007/BF01133780; Wlodkowic D, 2011, METHOD CELL BIOL, V103, P55, DOI 10.1016/B978-0-12-385493-3.00004-8; Woo EJ, 2004, MOL CELL, V14, P531, DOI 10.1016/S1097-2765(04)00258-8; WYLLIE AH, 1984, J PATHOL, V142, P67, DOI 10.1002/path.1711420112; Yamaguchi K, 2004, BIOCHEM BIOPH RES CO, V318, P710, DOI 10.1016/j.bbrc.2004.04.086; Yuste VJ, 2005, J BIOL CHEM, V280, P35670, DOI 10.1074/jbc.M504015200; Yuste VJ, 2001, J BIOL CHEM, V276, P22323, DOI 10.1074/jbc.M100072200; Zamzami N, 1999, NATURE, V401, P127, DOI 10.1038/43591	68	29	30	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 29	2013	288	13					9200	9215		10.1074/jbc.M112.411371	http://dx.doi.org/10.1074/jbc.M112.411371			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	116DG	23430749	hybrid, Green Published			2022-12-25	WOS:000316862200039
J	Zhao, X; Yang, B; Solakylidirim, K; Joo, EJ; Toida, T; Higashi, K; Linhardt, RJ; Li, LY				Zhao, Xue; Yang, Bo; Solakylidirim, Kemal; Joo, Eun Ji; Toida, Toshihiko; Higashi, Kyohei; Linhardt, Robert J.; Li, Lingyun			Sequence Analysis and Domain Motifs in the Porcine Skin Decorin Glycosaminoglycan Chain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DERMATAN SULFATE; IDURONIC ACID; COLLAGEN FIBRILS; BIOSYNTHESIS; LYASES; OLIGOSACCHARIDES; PROTEOGLYCANS; BIKUNIN	Decorin proteoglycan is comprised of a core protein containing a single O-linked dermatan sulfate/chondroitin sulfate glycosaminoglycan (GAG) chain. Although the sequence of the decorin core protein is determined by the gene encoding its structure, the structure of its GAG chain is determined in the Golgi. The recent application of modern MS to bikunin, a far simpler chondroitin sulfate proteoglycans, suggests that it has a single or small number of defined sequences. On this basis, a similar approach to sequence the decorin of porcine skin much larger and more structurally complex dermatan sulfate/chondroitin sulfate GAG chain was undertaken. This approach resulted in information on the consistency/variability of its linkage region at the reducing end of the GAG chain, its iduronic acid-rich domain, glucuronic acid-rich domain, and non-reducing end. A general motif for the porcine skin decorin GAG chain was established. A single small decorin GAG chain was sequenced using MS/MS analysis. The data obtained in the study suggest that the decorin GAG chain has a small or a limited number of sequences.	[Zhao, Xue] Ocean Univ China, Coll Food Sci & Technol, Qingdao 266003, Peoples R China; [Zhao, Xue; Yang, Bo; Solakylidirim, Kemal; Joo, Eun Ji; Linhardt, Robert J.; Li, Lingyun] Rensselaer Polytech Inst, Dept Chem & Chem Biol, Ctr Biotechnol & Interdisciplinary Studies, Troy, NY 12180 USA; [Linhardt, Robert J.] Rensselaer Polytech Inst, Dept Chem & Biol Engn, Ctr Biotechnol & Interdisciplinary Studies, Troy, NY 12180 USA; [Linhardt, Robert J.] Rensselaer Polytech Inst, Dept Biol, Ctr Biotechnol & Interdisciplinary Studies, Troy, NY 12180 USA; [Linhardt, Robert J.] Rensselaer Polytech Inst, Dept Biomed Engn, Ctr Biotechnol & Interdisciplinary Studies, Troy, NY 12180 USA; [Toida, Toshihiko; Higashi, Kyohei] Chiba Univ, Grad Sch Pharmaceut Sci, Chuo Ku, Chiba 2608675, Japan	Ocean University of China; Rensselaer Polytechnic Institute; Rensselaer Polytechnic Institute; Rensselaer Polytechnic Institute; Rensselaer Polytechnic Institute; Chiba University	Li, LY (corresponding author), Rensselaer Polytech Inst, Dept Chem & Chem Biol, Ctr Biotechnol & Interdisciplinary Studies, Biotechnol Bldg 4211, Troy, NY 12180 USA.	lil12@rpi.edu		Higashi, Kyohei/0000-0002-2622-4825	National Institutes of Heath [GM38060, HL096972, ES 020903]; China Scholarship Council; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL096972] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES020903] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM038060] Funding Source: NIH RePORTER	National Institutes of Heath(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); China Scholarship Council(China Scholarship Council); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Heath Grants GM38060, HL096972, and ES 020903 (to R.J.L.) and by a grant from the China Scholarship Council (to X.Z.).	Buraschi S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045559; Chi LL, 2008, J AM CHEM SOC, V130, P2617, DOI 10.1021/ja0778500; Fansson LA, 2000, MATRIX BIOL, V19, P367, DOI 10.1016/S0945-053X(00)00083-4; FERRO DR, 1990, CARBOHYD RES, V195, P157, DOI 10.1016/0008-6215(90)84164-P; Goldoni S, 2004, J BIOL CHEM, V279, P6606, DOI 10.1074/jbc.M310342200; GU KN, 1995, BIOCHEM J, V312, P569, DOI 10.1042/bj3120569; GU KN, 1993, CARBOHYD RES, V244, P369, DOI 10.1016/0008-6215(83)85014-9; Guidetti GF, 2004, FEBS LETT, V574, P95, DOI 10.1016/j.febslet.2004.08.011; Heinegard D, 2009, INT J EXP PATHOL, V90, P575, DOI 10.1111/j.1365-2613.2009.00695.x; Hocking AM, 1998, MATRIX BIOL, V17, P1; Iozzo RV, 2009, MOL CELLS, V27, P503, DOI 10.1007/s10059-009-0069-0; JANDIK KA, 1994, GLYCOBIOLOGY, V4, P289, DOI 10.1093/glycob/4.3.289; Kitagawa H, 1997, GLYCOBIOLOGY, V7, P1175, DOI 10.1093/glycob/7.8.1175; Laremore TN, 2010, BIOCHEM J, V431, P199, DOI 10.1042/BJ20100788; Laremore TN, 2010, ANAL BIOCHEM, V401, P236, DOI 10.1016/j.ab.2010.03.004; Li LY, 2012, ANAL CHEM, V84, P8822, DOI 10.1021/ac302232c; Li LY, 2012, MOL BIOSYST, V8, P1613, DOI 10.1039/c2mb25021g; LINHARDT RJ, 1995, GEN PHARMACOL-VASC S, V26, P443, DOI 10.1016/0306-3623(94)00231-B; Ly M, 2011, NAT CHEM BIOL, V7, P827, DOI 10.1038/nchembio.673; Ly M, 2011, ANAL BIOANAL CHEM, V399, P737, DOI 10.1007/s00216-010-3679-7; Maccarana M, 2006, J BIOL CHEM, V281, P11560, DOI 10.1074/jbc.M513373200; Maccarana M, 2009, MOL CELL BIOL, V29, P5517, DOI 10.1128/MCB.00430-09; Malavaki C, 2008, CONNECT TISSUE RES, V49, P133, DOI 10.1080/03008200802148546; Malmstrom A., 2012, J HISTOCHEM CYTOCHEM; Malmstrom A, 2012, J HISTOCHEM CYTOCHEM, V60, P916, DOI 10.1369/0022155412459857; Matsuda N, 2006, J NUTR SCI VITAMINOL, V52, P211, DOI 10.3177/jnsv.52.211; Neill T, 2012, AM J PATHOL, V181, P380, DOI 10.1016/j.ajpath.2012.04.029; Nomura Y, 2006, CONNECT TISSUE RES, V47, P249, DOI 10.1080/03008200600846606; Pacheco B, 2009, GLYCOBIOLOGY, V19, P1197, DOI 10.1093/glycob/cwp110; Prabhakar V, 2006, ADV PHARMACOL, V53, P69, DOI 10.1016/S1054-3589(06)53005-9; Redaelli A, 2003, J BIOMECH, V36, P1555, DOI 10.1016/S0021-9290(03)00133-7; Reed CC, 2002, GLYCOCONJUGATE J, V19, P249, DOI 10.1023/A:1025383913444; RUOSLAHTI E, 1988, ANNU REV CELL BIOL, V4, P229, DOI 10.1146/annurev.cb.04.110188.001305; Seidler DG, 2008, IUBMB LIFE, V60, P729, DOI 10.1002/iub.115; Seidler DG, 2007, THESCIENTIFICWORLDJO, V7, P233, DOI 10.1100/tsw.2007.63; Seidler DG, 2006, J MOL MED, V84, P583, DOI 10.1007/s00109-006-0046-4; Seidler DG, 2012, CURR OPIN STRUC BIOL, V22, P578, DOI 10.1016/j.sbi.2012.07.012; Seo NS, 2005, J BIOL CHEM, V280, P42774, DOI 10.1074/jbc.M511531200; Silbert JE, 2002, IUBMB LIFE, V54, P177, DOI 10.1080/15216540214923; Solakyildirim K, 2010, ANAL BIOCHEM, V397, P24, DOI 10.1016/j.ab.2009.09.031; Tollefsen DM, 2010, PROG MOL BIOL TRANSL, V93, P351, DOI 10.1016/S1877-1173(10)93015-9; Watanabe T, 2012, J ANAT, V220, P156, DOI 10.1111/j.1469-7580.2011.01456.x; Wheatley DN, 2004, J BIOMED BIOTECHNOL, P211; Zamfir A, 2003, GLYCOBIOLOGY, V13, P733, DOI 10.1093/glycob/cwg086; Zamfir AD, 2009, PROTEOMICS, V9, P3435, DOI 10.1002/pmic.200800440; Zhang YT, 2011, J BIOL CHEM, V286, P13011, DOI 10.1074/jbc.M110.169813	46	20	21	0	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 29	2013	288	13					9226	9237		10.1074/jbc.M112.437236	http://dx.doi.org/10.1074/jbc.M112.437236			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	116DG	23423381	Green Published, hybrid			2022-12-25	WOS:000316862200041
J	Haglund, S; Almer, S; Peterson, C; Soderman, J				Haglund, Sofie; Almer, Sven; Peterson, Curt; Soederman, Jan			Gene Expression and Thiopurine Metabolite Profiling in Inflammatory Bowel Disease - Novel Clues to Drug Targets and Disease Mechanisms?	PLOS ONE			English	Article							METHYLTRANSFERASE ACTIVITY; 6-THIOGUANINE NUCLEOTIDE; S-METHYLTRANSFERASE; T-LYMPHOCYTES; AZATHIOPRINE; 6-MERCAPTOPURINE; THERAPY; ALLOPURINOL; INHIBITION; PHARMACOGENETICS	Background and Aims: Thiopurines are effective to induce and maintain remission in inflammatory bowel disease (IBD). The methyl thioinosine monophosphate (meTIMP)/6-thioguanine nucleotide (6-TGN) concentration ratio has been associated with drug efficacy. Here we explored the molecular basis of differences in metabolite profiles and in relation to disease activity. Methods: Transcriptional profiles in blood samples from an exploratory IBD-patient cohort (n = 21) with a normal thiopurine S- methyltransferase phenotype and meTIMP/6-TGN ratios >20, 10.0-14.0 and <= 4, respectively, were assessed by hybridization to microarrays. Results were further evaluated with RT qPCR in an expanded patient cohort (n = 54). Additionally, 30 purine/thiopurine related genes were analysed separately. Results: Among 17 genes identified by microarray-screening, there were none with a known relationship to pathways of purines/thiopurines. For nine of them a correlation between expression level and the concentration of meTIMP, 6-TGN and/or the meTIMP/6-TGN ratio was confirmed in the expanded cohort. Nine of the purine/thiopurine related genes were identified in the expanded cohort to correlate with meTIMP, 6-TGN and/or the meTIMP/6-TGN ratio. However, only small differences in gene expression levels were noticed over the three different metabolite profiles. The expression levels of four genes identified by microarray screening (PLCB2, HVCN1, CTSS, and DEF8) and one purine/thiopurine related gene (NME6) correlated significantly with the clinical activity of Crohn's disease. Additionally, 16 of the genes from the expanded patient cohort interacted in networks with candidate IBD susceptibility genes. Conclusions: Seventeen of the 18 genes which correlated with thiopurine metabolite levels also correlated with disease activity or participated in networks with candidate IBD susceptibility genes involved in processes such as purine metabolism, cytokine signaling, and functioning of invariant natural killer T cells, T cells and B cells. Therefore, we conclude that the identified genes to a large extent are related to drug targets and disease mechanisms of IBD.	[Haglund, Sofie; Soederman, Jan] Ryhov Cty Hosp, Div Med Diagnost, Jonkoping, Sweden; [Haglund, Sofie; Almer, Sven] Linkoping Univ, Fac Hlth Sci, Dept Clin & Expt Med, Div Gastroenterol & Hepatol, Linkoping, Sweden; [Almer, Sven] Cty Council Ostergotland UHL, Dept Gastroenterol, Linkoping, Sweden; [Peterson, Curt] Linkoping Univ, Fac Hlth Sci, Dept Med & Hlth, Div Drug Res, Linkoping, Sweden	Linkoping University; City Council Ostergotland; Linkoping University	Haglund, S (corresponding author), Ryhov Cty Hosp, Div Med Diagnost, Jonkoping, Sweden.	sofie.haglund@lj.se		Soderman, Jan/0000-0001-7505-7210; Almer, Sven/0000-0001-9334-1821	Futurum - the Academy for Healthcare; County Council Jonkoping; Medical Research Council of Southeast Sweden (FORSS); Swedish Society of Medicine; County Council of Ostergotland; Swedish Cancer Society; Swedish Childhood Cancer Foundation; Rut and Richard Juhlin's Foundation; Swedish Research Council	Futurum - the Academy for Healthcare; County Council Jonkoping; Medical Research Council of Southeast Sweden (FORSS); Swedish Society of Medicine; County Council of Ostergotland; Swedish Cancer Society(Swedish Cancer Society); Swedish Childhood Cancer Foundation(European Commission); Rut and Richard Juhlin's Foundation; Swedish Research Council(Swedish Research CouncilEuropean Commission)	This study was funded by Futurum - the Academy for Healthcare, County Council Jonkoping, the Medical Research Council of Southeast Sweden (FORSS), the Swedish Society of Medicine, the County Council of Ostergotland, the Swedish Cancer Society, the Swedish Childhood Cancer Foundation, Rut and Richard Juhlin's Foundation and the Swedish Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldinucci A, 2010, J NEUROIMMUNOL, V218, P28, DOI 10.1016/j.jneuroim.2009.11.001; Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Ansari A, 2010, ALIMENT PHARM THER, V31, P640, DOI 10.1111/j.1365-2036.2009.04221.x; Baldwin SA, 1999, MOL MED TODAY, V5, P216, DOI 10.1016/S1357-4310(99)01459-8; Bierau J, 2007, PHARMACOGENOMICS, V8, P1221, DOI 10.2217/14622416.8.9.1221; BOKKERINK JPM, 1993, BIOCHEM PHARMACOL, V45, P1455, DOI 10.1016/0006-2952(93)90045-X; Colombel JF, 2000, GASTROENTEROLOGY, V118, P1025, DOI 10.1016/S0016-5085(00)70354-4; Daperno M, 2009, ALIMENT PHARM THER, V30, P843, DOI 10.1111/j.1365-2036.2009.04106.x; de Boer NKH, 2007, AM J GASTROENTEROL, V102, P2747, DOI 10.1111/j.1572-0241.2007.01511.x; Dubinsky MC, 2000, GASTROENTEROLOGY, V118, P705, DOI 10.1016/S0016-5085(00)70140-5; Dubinsky MC, 2002, GASTROENTEROLOGY, V122, P904, DOI 10.1053/gast.2002.32420; Egmond Rv, 2011, GUT, V60, pA187; ELION GB, 1967, FED PROC, V26, P898; Gardiner SJ, 2008, EUR J GASTROEN HEPAT, V20, P1238, DOI 10.1097/MEG.0b013e3282ffda37; Haglund S, 2008, BRIT J CLIN PHARMACO, V65, P69, DOI 10.1111/j.1365-2125.2007.02985.x; Haglund S, 2011, THER DRUG MONIT, V33, P200, DOI 10.1097/FTD.0b013e31820b42bb; Hande S, 2006, INFLAMM BOWEL DIS, V12, P251, DOI 10.1097/01.MIB.0000206544.05661.9f; Hindorf U, 2006, GUT, V55, P1423, DOI 10.1136/gut.2005.074930; Hoentjen F, 2012, DIGEST DIS SCI, V57, P250, DOI 10.1007/s10620-011-1999-x; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Jostins L, 2012, NATURE, V491, P119, DOI 10.1038/nature11582; KLEMETSDAL B, 1992, CLIN PHARMACOL THER, V51, P24, DOI 10.1038/clpt.1992.4; Kruhoffer M, 2007, J MOL DIAGN, V9, P452, DOI 10.2353/jmoldx.2007.060175; LENNARD L, 1987, CLIN PHARMACOL THER, V41, P18, DOI 10.1038/clpt.1987.4; LENNARD L, 1992, J CHROMATOGR-BIOMED, V583, P83, DOI 10.1016/0378-4347(92)80347-S; Leung Y, 2009, J CROHNS COLITIS, V3, P162, DOI 10.1016/j.crohns.2009.02.003; Lewis LD, 1997, CLIN PHARMACOL THER, V62, P464, DOI 10.1016/S0009-9236(97)90125-9; Li F, 2010, DRUG METAB DISPOS, V38, P2329, DOI 10.1124/dmd.110.035220; Lowry PW, 2001, GUT, V49, P656, DOI 10.1136/gut.49.5.656; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Osterman MT, 2006, GASTROENTEROLOGY, V130, P1047, DOI 10.1053/j.gastro.2006.01.046; Poppe D, 2006, J IMMUNOL, V176, P640, DOI 10.4049/jimmunol.176.1.640; Prefontaine E, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000067.pub2; Roberts RL, 2007, PHARMACOGENOMICS J, V7, P312, DOI 10.1038/sj.tpj.6500421; Rutgeerts P, 2004, GASTROENTEROLOGY, V126, P1593, DOI 10.1053/j.gastro.2004.02.070; Sandborn WJ, 1996, AM J GASTROENTEROL, V91, P423; Sparrow MP, 2007, CLIN GASTROENTEROL H, V5, P209, DOI 10.1016/j.cgh.2006.11.020; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; SZUMLANSKI CL, 1995, BRIT J CLIN PHARMACO, V39, P456, DOI 10.1111/j.1365-2125.1995.tb04478.x; Thomas CW, 2005, J PHARMACOL EXP THER, V312, P537, DOI 10.1124/jpet.104.074815; Tiede I, 2003, J CLIN INVEST, V111, P1133, DOI 10.1172/JCI200316432; Timmer A, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000478.pub2; Travis SPL, 2006, GUT, V55, DOI 10.1136/gut.2005.081950b; Vikingsson S, 2009, THER DRUG MONIT, V31, P345, DOI 10.1097/FTD.0b013e3181a1ea58; von Mering C, 2005, NUCLEIC ACIDS RES, V33, pD433, DOI 10.1093/nar/gki005; Xin H, 2005, ALIMENT PHARM THER, V21, P1105, DOI 10.1111/j.1365-2036.2005.02460.x	46	14	15	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2013	8	2							e56989	10.1371/journal.pone.0056989	http://dx.doi.org/10.1371/journal.pone.0056989			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IT	23437289	Green Published, Green Submitted, gold			2022-12-25	WOS:000315186000065
J	Matsuoka, F; Takeuchi, I; Agata, H; Kagami, H; Shiono, H; Kiyota, Y; Honda, H; Kato, R				Matsuoka, Fumiko; Takeuchi, Ichiro; Agata, Hideki; Kagami, Hideaki; Shiono, Hirofumi; Kiyota, Yasujiro; Honda, Hiroyuki; Kato, Ryuji			Morphology-Based Prediction of Osteogenic Differentiation Potential of Human Mesenchymal Stem Cells	PLOS ONE			English	Article							BONE-MARROW; PERIOSTEUM; REGENERATION; TISSUE	Human bone marrow mesenchymal stem cells (hBMSCs) are widely used cell source for clinical bone regeneration. Achieving the greatest therapeutic effect is dependent on the osteogenic differentiation potential of the stem cells to be implanted. However, there are still no practical methods to characterize such potential non-invasively or previously. Monitoring cellular morphology is a practical and non-invasive approach for evaluating osteogenic potential. Unfortunately, such image-based approaches had been historically qualitative and requiring experienced interpretation. By combining the non-invasive attributes of microscopy with the latest technology allowing higher throughput and quantitative imaging metrics, we studied the applicability of morphometric features to quantitatively predict cellular osteogenic potential. We applied computational machine learning, combining cell morphology features with their corresponding biochemical osteogenic assay results, to develop prediction model of osteogenic differentiation. Using a dataset of 9,990 images automatically acquired by BioStation CT during osteogenic differentiation culture of hBMSCs, 666 morphometric features were extracted as parameters. Two commonly used osteogenic markers, alkaline phosphatase (ALP) activity and calcium deposition were measured experimentally, and used as the true biological differentiation status to validate the prediction accuracy. Using time-course morphological features throughout differentiation culture, the prediction results highly correlated with the experimentally defined differentiation marker values (R>0.89 for both marker predictions). The clinical applicability of our morphology-based prediction was further examined with two scenarios: one using only historical cell images and the other using both historical images together with the patient's own cell images to predict a new patient's cellular potential. The prediction accuracy was found to be greatly enhanced by incorporation of patients' own cell features in the modeling, indicating the practical strategy for clinical usage. Consequently, our results provide strong evidence for the feasibility of using a quantitative time series of phase-contrast cellular morphology for non-invasive cell quality prediction in regenerative medicine.	[Matsuoka, Fumiko; Honda, Hiroyuki; Kato, Ryuji] Nagoya Univ, Grad Sch Engn, Dept Biotechnol, Nagoya, Aichi 4648601, Japan; [Takeuchi, Ichiro] Nagoya Inst Technol, Dept Engn, Nagoya, Aichi, Japan; [Agata, Hideki; Kagami, Hideaki] Univ Tokyo, Inst Med Sci, Tissue Engn Res Grp, Div Mol Therapy, Tokyo, Japan; [Kagami, Hideaki] Matsumoto Dent Univ, Dept Oral & Maxillofacial Surg, Sch Dent, Nagano, Japan; [Shiono, Hirofumi; Kiyota, Yasujiro] Nikon Inc, Tokyo, Japan; [Kato, Ryuji] Nagoya Univ, Grad Sch Pharmaceut Sci, Dept Basic Med Sci, Nagoya, Aichi 4648601, Japan	Nagoya University; Nagoya Institute of Technology; University of Tokyo; Matsumoto Dental University; Nikon Corporation; Nagoya University	Kato, R (corresponding author), Nagoya Univ, Grad Sch Engn, Dept Biotechnol, Nagoya, Aichi 4648601, Japan.	kato-r@ps.nagoya-u.ac.jp	Kato, Ryuji/I-6952-2014	Kagami, Hideaki/0000-0003-2285-2602	New Energy and Industrial Technology Development Organization (NEDO) for the Grant for Industrial Technology Research [09C46036a]; Nikon Corporation	New Energy and Industrial Technology Development Organization (NEDO) for the Grant for Industrial Technology Research; Nikon Corporation	We are grateful to the New Energy and Industrial Technology Development Organization (NEDO) for the Grant for Industrial Technology Research (Financial Support to Young Researchers, 09C46036a) for the support. The research was also supported in part by a grant-in-aid from Nikon Corporation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We have the following interests. This study was supported in part by a grant-in-aid from Nikon Corporation. Hirofumi Shiono and Yasujiro Kiyota are employed by Nikon Instruments. Ryuji Kato is one of the main investigators of 12 patents (pending) related to basic technologies of "algorithms of cellular image processing. Hirofumi Shiono, is one of the inventors of the hardware we used in our research, "BioStaion CT" which is the automatic cell culture system, and a member of this collaborative project with Nagoya Univ. The BioStation CT and relating software are marketed products of Nikon Corporation. Although the system and the software were used in this study, the result of this research does not depend on the system and the software. He is one of the inventors of related 12 patents. Yasujiro Kiyota, is one of the inventors of the hardware we used in our research work. There are no further patents, products in development or marketed products to declare. This does not alter our adherence to all the PLoS ONE policies on sharing data and materials, as detailed online in the guide for authors.	Agata H, 2007, J DENT RES, V86, P79, DOI 10.1177/154405910708600113; Barry FP, 2004, INT J BIOCHEM CELL B, V36, P568, DOI 10.1016/j.biocel.2003.11.001; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; Chen LW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001886; Dennis JE, 2007, STEM CELLS, V25, P2575, DOI 10.1634/stemcells.2007-0204; Harder N, 2009, GENOME RES, V19, P2113, DOI 10.1101/gr.092494.109; Hastie T, 2009, ELEMENTS STAT LEARNI, P43; Hayashi O, 2008, CALCIFIED TISSUE INT, V82, P238, DOI 10.1007/s00223-008-9112-y; HOERL AE, 1970, TECHNOMETRICS, V12, P55, DOI 10.1080/00401706.1970.10488634; Jones TR, 2009, P NATL ACAD SCI USA, V106, P1826, DOI 10.1073/pnas.0808843106; Kagami H, 2011, INT J BIOCHEM CELL B, V43, P286, DOI 10.1016/j.biocel.2010.12.006; Kelly DJ, 2010, BIRTH DEFECTS RES C, V90, P75, DOI 10.1002/bdrc.20173; Kino-oka M, 2009, J BIOSCI BIOENG, V107, P544, DOI 10.1016/j.jbiosc.2008.12.018; Misselwitz B, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-30; Mizuno D, 2008, CLIN ORAL IMPLAN RES, V19, P289, DOI 10.1111/j.1600-0501.2007.01452.x; Olivo C, 2008, J ORTHOP RES, V26, P901, DOI 10.1002/jor.20582; Platt MO, 2009, STEM CELLS, V27, P2804, DOI 10.1002/stem.215; Wu YJ, 2007, STEM CELLS, V25, P2648, DOI 10.1634/stemcells.2007-0226	18	94	97	23	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2013	8	2							e55082	10.1371/journal.pone.0055082	http://dx.doi.org/10.1371/journal.pone.0055082			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IT	23437049	Green Submitted, Green Published, gold			2022-12-25	WOS:000315186000006
J	Arora, A; Gera, S; Maheshwari, T; Raghav, D; Alam, MJ; Singh, RKB; Agarwal, SM				Arora, Akshit; Gera, Saurav; Maheshwari, Tanuj; Raghav, Dhwani; Alam, Md. Jahoor; Singh, R. K. Brojen; Agarwal, Subhash M.			The Dynamics of Stress p53-Mdm2 Network Regulated by p300 and HDAC1	PLOS ONE			English	Article							STOCHASTIC SIMULATION; P53 ACETYLATION; FEEDBACK LOOP; DNA-BINDING; IN-VITRO; OSCILLATIONS; PHOSPHORYLATION; DEACETYLATION; RESONANCE; GROWTH	We construct a stress p53-Mdm2-p300-HDAC1 regulatory network that is activated and stabilised by two regulatory proteins, p300 and HDAC1. Different activation levels of p53 observed due to these regulators during stress condition have been investigated using a deterministic as well as a stochastic approach to understand how the cell responds during stress conditions. We found that these regulators help in adjusting p53 to different conditions as identified by various oscillatory states, namely fixed point oscillations, damped oscillations and sustain oscillations. On assessing the impact of p300 on p53-Mdm2 network we identified three states: first stabilised or normal condition where the impact of p300 is negligible, second an interim region where p53 is activated due to interaction between p53 and p300, and finally the third regime where excess of p300 leads to cell stress condition. Similarly evaluation of HDAC1 on our model led to identification of the above three distinct states. Also we observe that noise in stochastic cellular system helps to reach each oscillatory state quicker than those in deterministic case. The constructed model validated different experimental findings qualitatively.	[Arora, Akshit; Gera, Saurav; Maheshwari, Tanuj; Raghav, Dhwani; Agarwal, Subhash M.] Inst Cytol & Prevent Oncol, Bioinformat Div, Noida, India; [Alam, Md. Jahoor; Singh, R. K. Brojen] Jamia Millia Islamia, Ctr Interdisciplinary Res Basic Sci, New Delhi 110025, India	Indian Council of Medical Research (ICMR); ICMR - National Institute of Cancer Prevention & Research (NICPR); Jamia Millia Islamia	Singh, RKB (corresponding author), Jamia Millia Islamia, Ctr Interdisciplinary Res Basic Sci, New Delhi 110025, India.	brojen2k@yahoo.com; smagarwal@yahoo.com	Agarwal, Subhash Mohan/L-3162-2019; Alam, Jahoor/F-5071-2012; Alam, MD JAHOOR/AAR-8528-2021	Alam, MD JAHOOR/0000-0003-0144-6517; Agarwal, Subhash Mohan/0000-0001-6685-789X	University Grants Commission	University Grants Commission(University Grants Commission, India)	Dr. Brojen Singh has received partial financial support for this work from University Grants Commission. However Dr. Subhash Agarwal has worked without any financial support from any funding agency. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai L, 2006, J CANC MOL, V2, P141; Bar-Or RL, 2000, P NATL ACAD SCI USA, V97, P11250, DOI 10.1073/pnas.210171597; Becskei A, 2001, EMBO J, V20, P2528, DOI 10.1093/emboj/20.10.2528; Blake WJ, 2003, NATURE, V422, P633, DOI 10.1038/nature01546; Bratsun D, 2005, P NATL ACAD SCI USA, V102, P14593, DOI 10.1073/pnas.0503858102; Cai XD, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2710253; Carter S, 2008, CELL CYCLE, V7, P2519, DOI 10.4161/cc.7.16.6422; Ciliberto A, 2005, CELL CYCLE, V4, P488, DOI 10.4161/cc.4.3.1548; Dumaz N, 1999, EMBO J, V18, P7002, DOI 10.1093/emboj/18.24.7002; FINLAY CA, 1993, MOL CELL BIOL, V13, P301, DOI 10.1128/MCB.13.1.301; Gillespie DT, 2007, ANNU REV PHYS CHEM, V58, P35, DOI 10.1146/annurev.physchem.58.032806.104637; Gillespie DT, 2001, J CHEM PHYS, V115, P1716, DOI 10.1063/1.1378322; Gillespie DT, 2000, J CHEM PHYS, V113, P297, DOI 10.1063/1.481811; GILLESPIE DT, 1977, J PHYS CHEM-US, V81, P2340, DOI 10.1021/j100540a008; Grossman SR, 1998, MOL CELL, V2, P405, DOI 10.1016/S1097-2765(00)80140-9; Grossman SR, 2003, SCIENCE, V300, P342, DOI 10.1126/science.1080386; Gu W, 1997, CELL, V90, P595, DOI 10.1016/S0092-8674(00)80521-8; Hanggi P, 2002, CHEMPHYSCHEM, V3, P285, DOI 10.1002/1439-7641(20020315)3:3<285::AID-CPHC285>3.0.CO;2-A; Ito A, 2001, EMBO J, V20, P1331, DOI 10.1093/emboj/20.6.1331; Ito A, 2002, EMBO J, V21, P6236, DOI 10.1093/emboj/cdf616; Juan LJ, 2000, J BIOL CHEM, V275, P20436, DOI 10.1074/jbc.M000202200; Knights CD, 2006, J CELL BIOL, V173, P533, DOI 10.1083/jcb.200512059; Kobet E, 2000, P NATL ACAD SCI USA, V97, P12547, DOI 10.1073/pnas.97.23.12547; Kubbutat MHG, 1997, NATURE, V387, P299, DOI 10.1038/387299a0; Kussell E, 2005, SCIENCE, V309, P2075, DOI 10.1126/science.1114383; Lahav G, 2004, NAT GENET, V36, P147, DOI 10.1038/ng1293; Lambert PF, 1998, J BIOL CHEM, V273, P33048, DOI 10.1074/jbc.273.49.33048; LANE DP, 1992, NATURE, V358, P15, DOI 10.1038/358015a0; LESLIE PH, 1958, BIOMETRIKA, V45, P16, DOI 10.1093/biomet/45.1-2.16; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; Li MY, 2002, J BIOL CHEM, V277, P50607, DOI 10.1074/jbc.C200578200; Luo JY, 2000, NATURE, V408, P377, DOI 10.1038/35042612; Luo JY, 2004, P NATL ACAD SCI USA, V101, P2259, DOI 10.1073/pnas.0308762101; MCQUARRI.DA, 1967, J APPL PROBAB, V4, P413, DOI 10.2307/3212214; Meek DW, 2009, COLD SPRING HARB PER, V00; Pavithra L, 2009, J MOL BIOL, V388, P691, DOI 10.1016/j.jmb.2009.03.033; Press W. H., 1992, NUMERICAL RECIPE FOR; Proctor CJ, 2008, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-75; Rodriguez MS, 2000, MOL CELL BIOL, V20, P8458, DOI 10.1128/MCB.20.22.8458-8467.2000; Salis H, 2005, J CHEM PHYS, V122, DOI 10.1063/1.1835951; Toledo F, 2006, NAT REV CANCER, V6, P909, DOI 10.1038/nrc2012; VanKampen NG, 2007, NORTH-HOLL PERS LIBR, P1; Vousden KH, 2000, CELL, V103, P691, DOI 10.1016/S0092-8674(00)00171-9; Wagner J, 2005, IEE P SYST BIOL, V152, P109, DOI 10.1049/ip-syb:20050025; Weinberger LS, 2005, CELL, V122, P169, DOI 10.1016/j.cell.2005.06.006; Zeng XY, 1999, MOL CELL BIOL, V19, P3257; Zhang TL, 2007, CELL CYCLE, V6, P85, DOI 10.4161/cc.6.1.3705	48	12	12	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e52736	10.1371/journal.pone.0052736	http://dx.doi.org/10.1371/journal.pone.0052736			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437037	Green Published, Green Submitted, gold			2022-12-25	WOS:000315184200004
J	Dasgupta, T; Stillwagon, SJ; Ladd, AN				Dasgupta, Twishasri; Stillwagon, Samantha J.; Ladd, Andrea N.			Gene Expression Analyses Implicate an Alternative Splicing Program in Regulating Contractile Gene Expression and Serum Response Factor Activity in Mice	PLOS ONE			English	Article							RNA-BINDING PROTEINS; CARDIAC-HYPERTROPHY; ANKYRIN-B; TRANSGENIC MICE; HOMEOBOX GENE; CELF; CARDIOMYOCYTES; CARDIOMYOPATHY; HEART; OVEREXPRESSION	Members of the CUG-BP, Elav-like family (CELF) regulate alternative splicing in the heart. In MHC-CELF Delta transgenic mice, CELF splicing activity is inhibited postnatally in heart muscle via expression of a nuclear dominant negative CELF protein under an alpha-myosin heavy chain promoter. MHC-CELF Delta mice develop dilated cardiomyopathy characterized by alternative splicing defects, enlarged hearts, and severe contractile dysfunction. In this study, gene expression profiles in the hearts of wild type, high- and low-expressing lines of MHC-CELF Delta mice were compared using microarrays. Gene ontology and pathway analyses identified contraction and calcium signaling as the most affected processes. Network analysis revealed that the serum response factor (SRF) network is highly affected. Downstream targets of SRF were up-regulated in MHC-CELF Delta mice compared to the wild type, suggesting an increase in SRF activity. Although SRF levels remained unchanged, known inhibitors of SRF activity were down-regulated. Conversely, we found that these inhibitors are up-regulated and downstream SRF targets are down-regulated in the hearts of MCKCUG-BP1 mice, which mildly over-express CELF1 in heart and skeletal muscle. This suggests that changes in SRF activity are a consequence of changes in CELF-mediated regulation rather than a secondary result of compensatory pathways in heart failure. In MHC-CELF Delta males, where the phenotype is only partially penetrant, both alternative splicing changes and down-regulation of inhibitors of SRF correlate with the development of cardiomyopathy. Together, these results strongly support a role for CELF-mediated alternative splicing in the regulation of contractile gene expression, achieved in part through modulating the activity of SRF, a key cardiac transcription factor.	[Dasgupta, Twishasri; Stillwagon, Samantha J.; Ladd, Andrea N.] Cleveland Clin, Lerner Res Inst, Dept Cellular & Mol Med, Cleveland, OH 44106 USA	Cleveland Clinic Foundation	Ladd, AN (corresponding author), Cleveland Clin, Lerner Res Inst, Dept Cellular & Mol Med, Cleveland, OH 44106 USA.	ladda@ccf.org		Ladd, Andrea/0000-0003-4725-5644; Auboeuf, Didier/0000-0002-3757-0002	National Heart, Lung, and Blood Institute of the National Institutes of Health [R01HL089376]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000439] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL089376] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by a grant to ANL from the National Heart, Lung, and Blood Institute of the National Institutes of Health (R01HL089376). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akazawa H, 2003, CIRC RES, V92, P1079, DOI 10.1161/01.RES.0000072977.86706.23; Aronow BJ, 2001, PHYSIOL GENOMICS, V6, P19, DOI 10.1152/physiolgenomics.2001.6.1.19; Balza RO, 2006, J BIOL CHEM, V281, P6498, DOI 10.1074/jbc.M509487200; Bovill E, 2009, J THORAC CARDIOV SUR, V137, P853, DOI 10.1016/j.jtcvs.2008.09.006; Chen F, 2002, CELL, V110, P713, DOI 10.1016/S0092-8674(02)00932-7; Cunha SR, 2007, J BIOL CHEM, V282, P4875, DOI 10.1074/jbc.M607096200; Dasgupta T, 2012, WIRES RNA, V3, P104, DOI 10.1002/wrna.107; Ding JH, 2004, EMBO J, V23, P885, DOI 10.1038/sj.emboj.7600054; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Ho TH, 2005, HUM MOL GENET, V14, P1539, DOI 10.1093/hmg/ddi162; Kalsotra A, 2008, P NATL ACAD SCI USA, V105, P20333, DOI 10.1073/pnas.0809045105; Komamura K, 2004, J HUM GENET, V49, P129, DOI 10.1007/s10038-003-0121-4; Kong SW, 2010, CIRC-CARDIOVASC GENE, V3, P138, DOI 10.1161/CIRCGENETICS.109.904698; Kong YF, 2001, CIRCULATION, V103, P2731; Ladd AN, 2005, MOL CELL BIOL, V25, P6267, DOI 10.1128/MCB.25.14.6267-6278.2005; Ladd AN, 2001, MOL CELL BIOL, V21, P1285, DOI 10.1128/MCB.21.4.1285-1296.2001; Mango R, 2005, CIRC RES, V97, P152, DOI 10.1161/01.RES.0000174563.62625.8e; McGlincy NJ, 2008, TRENDS BIOCHEM SCI, V33, P385, DOI 10.1016/j.tibs.2008.06.001; Miano JM, 2010, LAB INVEST, V90, P1274, DOI 10.1038/labinvest.2010.104; Mohler PJ, 2007, CIRCULATION, V115, P432, DOI 10.1161/CIRCULATIONAHA.106.656512; Mohler PJ, 2004, P NATL ACAD SCI USA, V101, P9137, DOI 10.1073/pnas.0402546101; Mohler PJ, 2003, NATURE, V421, P634, DOI 10.1038/nature01335; Nelson TJ, 2005, J MOL CELL CARDIOL, V39, P479, DOI 10.1016/j.yjmcc.2005.05.004; Pan Q, 2008, NAT GENET, V40, P1413, DOI 10.1038/ng.259; Park JY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022391; Philippar U, 2004, MOL CELL, V16, P867, DOI 10.1016/j.molcel.2004.11.039; Shin CH, 2002, CELL, V110, P725, DOI 10.1016/S0092-8674(02)00933-9; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Song HK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035552; Stamm S, 2005, GENE, V344, P1, DOI 10.1016/j.gene.2004.10.022; Terenzi F, 2009, J MOL CELL CARDIOL, V46, P395, DOI 10.1016/j.yjmcc.2008.10.030; Treisman R, 1992, CURR OPIN GENET DEV, V2, P221, DOI 10.1016/S0959-437X(05)80277-1; Trivedi CM, 2011, J MOL CELL CARDIOL, V50, P1056, DOI 10.1016/j.yjmcc.2011.02.015; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Ward AJ, 2010, J PATHOL, V220, P152, DOI 10.1002/path.2649; Xu XD, 2005, CELL, V120, P59, DOI 10.1016/j.cell.2004.11.036; Yamaguchi S, 2009, INT J CANCER, V124, P2577, DOI 10.1002/ijc.24217; Zhang XM, 2003, AM J PHYSIOL-REG I, V285, pR552, DOI 10.1152/ajpregu.00631.2002; Zhang XM, 2001, AM J PHYSIOL-HEART C, V280, pH1782, DOI 10.1152/ajpheart.2001.280.4.H1782; Zheng Q, 2008, NUCLEIC ACIDS RES, V36, pW358, DOI 10.1093/nar/gkn276	40	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e56590	10.1371/journal.pone.0056590	http://dx.doi.org/10.1371/journal.pone.0056590			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437181	Green Submitted, Green Published, gold			2022-12-25	WOS:000315184200117
J	De Palma, S; Leone, R; Grumati, P; Vasso, M; Polishchuk, R; Capitanio, D; Braghetta, P; Bernardi, P; Bonaldo, P; Gelfi, C				De Palma, Sara; Leone, Roberta; Grumati, Paolo; Vasso, Michele; Polishchuk, Roman; Capitanio, Daniele; Braghetta, Paola; Bernardi, Paolo; Bonaldo, Paolo; Gelfi, Cecilia			Changes in Muscle Cell Metabolism and Mechanotransduction Are Associated with Myopathic Phenotype in a Mouse Model of Collagen VI Deficiency	PLOS ONE			English	Article							FOCAL ADHESION KINASE; TENASCIN-C; SUBCELLULAR-LOCALIZATION; GLUTAMINE-METABOLISM; SKELETAL-MUSCLE; SIRT3; PROTEINS; BETHLEM; COMPLEX; COSTAMERES	This study identifies metabolic and protein phenotypic alterations in gastrocnemius, tibialis anterior and diaphragm muscles of Col6a1(-/-) mice, a model of human collagen VI myopathies. All three muscles of Col6a1(-/-) mice show some common changes in proteins involved in metabolism, resulting in decreased glycolysis and in changes of the TCA cycle fluxes. These changes lead to a different fate of alpha-ketoglutarate, with production of anabolic substrates in gastrocnemius and tibialis anterior, and with lipotoxicity in diaphragm. The metabolic changes are associated with changes of proteins involved in mechanotransduction at the myotendineous junction/costameric/sarcomeric level (TN-C, FAK, ROCK1, troponin I fast) and in energy metabolism (aldolase, enolase 3, triose phosphate isomerase, creatine kinase, adenylate kinase 1, parvalbumin, IDH1 and FASN). Together, these change may explain Ca2+ deregulation, impaired force development, increased muscle-relaxation-time and fiber damage found in the mouse model as well as in patients. The severity of these changes differs in the three muscles (gastrocnemius<tibialis anterior<diaphragm) and correlates to the mass-to-tendon (myotendineous junction) ratio and to muscle morphology.	[De Palma, Sara; Leone, Roberta; Vasso, Michele; Capitanio, Daniele; Gelfi, Cecilia] Univ Milan, Dept Biomed Sci Hlth, Segrate, MI, Italy; [De Palma, Sara; Vasso, Michele; Gelfi, Cecilia] Natl Res Council CNR, Inst Mol Bioimaging & Physiol, Segrate, MI, Italy; [Grumati, Paolo; Braghetta, Paola; Bernardi, Paolo; Bonaldo, Paolo] Univ Padua, Dept Biomed Sci, Padua, Italy; [Polishchuk, Roman] Italian Natl Res Council CNR, Inst Prot Biochem, Telethon Inst Genet & Med, Naples, Italy	University of Milan; Consiglio Nazionale delle Ricerche (CNR); Istituto di Bioimmagini e Fisiologia Molecolare (IBFM-CNR); University of Padua; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biochimica delle Proteine (IBP-CNR); Istituto di Neuroscienze (IN-CNR); Fondazione Telethon; Telethon Institute of Genetics & Medicine (TIGEM)	Gelfi, C (corresponding author), Univ Milan, Dept Biomed Sci Hlth, Segrate, MI, Italy.	cecilia.gelfi@unimi.it	Bernardi, Paolo/C-3656-2008; Gelfi, Cecilia/L-1490-2016; Braghetta, Paola/K-5478-2016; Grumati, Paolo/AAA-5787-2019; CAPITANIO, DANIELE/AAC-4059-2019; Vasso, Michele/AAE-6208-2020; Capitanio, Daniele/J-9976-2018	Bernardi, Paolo/0000-0001-9187-3736; Gelfi, Cecilia/0000-0002-2996-6912; Braghetta, Paola/0000-0003-2547-8679; CAPITANIO, DANIELE/0000-0001-7701-728X; Capitanio, Daniele/0000-0001-7701-728X; Polishchuk, Roman/0000-0002-7698-1955; VASSO, MICHELE/0000-0003-0431-0981; Bonaldo, Paolo/0000-0002-9571-8140; De Palma, Sara/0000-0002-6795-4138	Telethon foundation [GGP08017, GGP08017A, GGP08017D]; FP7 BIO-NMD project [241665]; FIRB RBR [7BMCT]	Telethon foundation(Fondazione Telethon); FP7 BIO-NMD project; FIRB RBR	This work was supported by Telethon foundation (grant number GGP08017 to P. Bernardi, grant number GGP08017A to P. Bonaldo, grant no GGP08017D to C.G.), the FP7 BIO-NMD project (grant number 241665 to P. Bonaldo and C.G.), FIRB RBR (grant number 7BMCT to C.G.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amano M, 2010, CYTOSKELETON, V67, P545, DOI 10.1002/cm.20472; Bernardi P, 2008, ANN NY ACAD SCI, V1147, P303, DOI 10.1196/annals.1427.009; BETHLEM J, 1976, BRAIN, V99, P91, DOI 10.1093/brain/99.1.91; Bishop-Bailey D, 2009, PHARMACOL THERAPEUT, V124, P141, DOI 10.1016/j.pharmthera.2009.06.011; Bloch RJ, 2003, EXERC SPORT SCI REV, V31, P73, DOI 10.1097/00003677-200304000-00004; Bonaldo P, 1998, HUM MOL GENET, V7, P2135, DOI 10.1093/hmg/7.13.2135; Bonnemann CG, 2011, NAT REV NEUROL, V7, P379, DOI 10.1038/nrneurol.2011.81; Brinas L, 2010, ANN NEUROL, V68, P511, DOI 10.1002/ana.22087; Burri L, 2010, PPAR RES, V2010, DOI 10.1155/2010/542359; Canato M, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/981945; Chandrasekharan K, 2010, METHOD ENZYMOL, V479, P291, DOI 10.1016/S0076-6879(10)79017-0; Chen YH, 2011, EMBO REP, V12, P534, DOI 10.1038/embor.2011.65; Chopard A, 2005, FASEB J, V19, P1722, DOI 10.1096/fj.04-3336fje; Collins J, 2010, CURR NEUROL NEUROSCI, V10, P83, DOI 10.1007/s11910-010-0092-8; Deldicque L, 2011, EUR J APPL PHYSIOL, V111, P1553, DOI 10.1007/s00421-010-1783-1; Demir E, 2002, AM J HUM GENET, V70, P1446, DOI 10.1086/340608; Durieux AC, 2007, BIOCHEM SOC T, V35, P1312, DOI 10.1042/BST0351312; Ervasti JM, 2003, J BIOL CHEM, V278, P13591, DOI 10.1074/jbc.R200021200; Fluck M, 2002, J EXP BIOL, V205, P2337; Fluck M, 2008, P NATL ACAD SCI USA, V105, P13662, DOI 10.1073/pnas.0805365105; Gelfi C, 2006, J PROTEOME RES, V5, P1344, DOI 10.1021/pr050414x; Gizak A, 2004, FEBS LETT, V576, P445, DOI 10.1016/j.febslet.2004.09.050; Grossi M, 2005, P NATL ACAD SCI USA, V102, P11313, DOI 10.1073/pnas.0505011102; Grounds MD, 2005, SCAND J MED SCI SPOR, V15, P381, DOI 10.1111/j.1600-0838.2005.00467.x; Grumati P, 2011, AUTOPHAGY, V7, P426, DOI 10.4161/auto.7.4.14392; Grumati P, 2010, NAT MED, V16, P1313, DOI 10.1038/nm.2247; Guo WJ, 2004, NAT REV MOL CELL BIO, V5, P816, DOI 10.1038/nrm1490; Hallows WC, 2006, P NATL ACAD SCI USA, V103, P10230, DOI 10.1073/pnas.0604392103; HAMMARQVIST F, 1989, ANN SURG, V209, P455, DOI 10.1097/00000658-198904000-00011; Haq RU, 1999, NEUROLOGY, V52, P174, DOI 10.1212/WNL.52.1.174; Higdon A. N., 2012, ANTIOXID REDOX SIGNA; Hirschey MD, 2010, NATURE, V464, P121, DOI 10.1038/nature08778; Hoffman BD, 2011, NATURE, V475, P316, DOI 10.1038/nature10316; Huang XW, 2012, AM J RESP CELL MOL, V47, P340, DOI 10.1165/rcmb.2012-0050OC; Irwin WA, 2003, NAT GENET, V35, P367, DOI 10.1038/ng1270; Izu Y, 2012, TISSUE CELL, V44, P1, DOI 10.1016/j.tice.2011.08.002; Izu Y, 2011, MATRIX BIOL, V30, P53, DOI 10.1016/j.matbio.2010.10.001; Jaalouk DE, 2009, NAT REV MOL CELL BIO, V10, P63, DOI 10.1038/nrm2597; Janssen AJM, 2007, CLIN CHEM, V53, P729, DOI 10.1373/clinchem.2006.078873; Jarvinen TAH, 2003, J CELL SCI, V116, P857, DOI 10.1242/jcs.00303; Jobsis GJ, 1999, BRAIN, V122, P649, DOI 10.1093/brain/122.4.649; Kadler KE, 2008, CURR OPIN CELL BIOL, V20, P495, DOI 10.1016/j.ceb.2008.06.008; Kannus P, 1998, HISTOCHEM J, V30, P799, DOI 10.1023/A:1003448106673; Kansanen E, 2012, FREE RADICAL BIO MED, V52, P973, DOI 10.1016/j.freeradbiomed.2011.11.038; Keller A, 2000, BIOL CELL, V92, P527, DOI 10.1016/S0248-4900(00)01103-5; Kim HS, 2010, CANCER CELL, V17, P41, DOI 10.1016/j.ccr.2009.11.023; Knoll R, 2012, J MUSCLE RES CELL M, V33, P31, DOI 10.1007/s10974-011-9281-6; Lampe AK, 2005, J MED GENET, V42, P673, DOI 10.1136/jmg.2002.002311; Le A, 2012, CELL METAB, V15, P110, DOI 10.1016/j.cmet.2011.12.009; Mackey AL, 2011, FASEB J, V25, P1943, DOI 10.1096/fj.10-176487; Mamczur P, 2005, FEBS LETT, V579, P1607, DOI 10.1016/j.febslet.2005.01.071; Maraldi NM, 2009, ADV ENZYME REGUL, V49, P197, DOI 10.1016/j.advenzreg.2008.12.009; Mercuri E, 2002, NEUROLOGY, V58, P1354, DOI 10.1212/WNL.58.9.1354; Merlini L, 2008, NEUROLOGY, V71, P1245, DOI 10.1212/01.wnl.0000327611.01687.5e; Merlini L, 2008, NEUROTHERAPEUTICS, V5, P613, DOI 10.1016/j.nurt.2008.08.004; Metallo CM, 2012, NATURE, V481, P380, DOI 10.1038/nature10602; Metallo CM, 2009, J BIOTECHNOL, V144, P167, DOI 10.1016/j.jbiotec.2009.07.010; Midwood KS, 2009, J CELL COMMUN SIGNAL, V3, P287, DOI 10.1007/s12079-009-0075-1; Moriggi M, 2010, PROTEOMICS, V10, P3756, DOI 10.1002/pmic.200900817; MUNUJOS P, 1993, ANAL BIOCHEM, V212, P506, DOI 10.1006/abio.1993.1360; Murphy-Ullrich JE, 2001, J CLIN INVEST, V107, P785, DOI 10.1172/JCI12609; Nadeau A, 2009, NEUROLOGY, V73, P25, DOI 10.1212/WNL.0b013e3181aae851; NONAKA I, 1981, NEUROPEDIATRICS, V12, P197, DOI 10.1055/s-2008-1059651; Palacios OM, 2009, AGING-US, V1, P771, DOI 10.18632/aging.100075; Quach NL, 2006, DEV BIOL, V293, P38, DOI 10.1016/j.ydbio.2005.12.040; Rennie MJ, 1996, BIOCHEM SOC T, V24, P869, DOI 10.1042/bst0240869; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; ROSIERS CD, 1995, J BIOL CHEM, V270, P10027, DOI 10.1074/jbc.270.17.10027; Rotman N, 2010, PHYSIOLOGY, V25, P176, DOI 10.1152/physiol.00018.2010; Schwaller Beat, 2002, Cerebellum, V1, P241, DOI 10.1080/147342202320883551; Schwer B, 2006, P NATL ACAD SCI USA, V103, P10224, DOI 10.1073/pnas.0603968103; Someya S, 2010, CELL, V143, P802, DOI 10.1016/j.cell.2010.10.002; Terrasa A, 1998, MOL CELL BIOCHEM, V178, P181, DOI 10.1023/A:1006839413757; Ullrich O, 1930, Z GESAMTE NEUROL PSY, V126, P171, DOI 10.1007/BF02864097; Vigano A, 2011, PROTEOMICS, V11, P4202, DOI 10.1002/pmic.201000804; Wagner KD, 2010, PHARMACOL THERAPEUT, V125, P423, DOI 10.1016/j.pharmthera.2009.12.001; Wang RH, 2008, CANCER CELL, V14, P312, DOI 10.1016/j.ccr.2008.09.001; Wiberg C, 2002, J BIOL CHEM, V277, P49120, DOI 10.1074/jbc.M206891200; Wise DR, 2011, P NATL ACAD SCI USA, V108, P19611, DOI 10.1073/pnas.1117773108; Yanez M, 2012, ADV EXP MED BIOL, V740, P461, DOI 10.1007/978-94-007-2888-2_19; Yoo H, 2008, J BIOL CHEM, V283, P20621, DOI 10.1074/jbc.M706494200	81	17	17	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e56716	10.1371/journal.pone.0056716	http://dx.doi.org/10.1371/journal.pone.0056716			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437220	Green Published, Green Submitted, gold			2022-12-25	WOS:000315184200150
J	Yu, L; Chen, C; Wang, LF; Kuang, X; Liu, K; Zhang, H; Du, JR				Yu, Lu; Chen, Chu; Wang, Liang-Fen; Kuang, Xi; Liu, Ke; Zhang, Hao; Du, Jun-Rong			Neuroprotective Effect of Kaempferol Glycosides against Brain Injury and Neuroinflammation by Inhibiting the Activation of NF-kappa B and STAT3 in Transient Focal Stroke	PLOS ONE			English	Article							CEREBRAL-ARTERY OCCLUSION; NITRIC-OXIDE SYNTHASE; ISCHEMIA; INFLAMMATION; DAMAGE; FLAVONOIDS; PROTEIN; PHOSPHORYLATION; NICOTIFLORIN; INFILTRATION	Background: Ischemic brain injury is associated with neuroinflammatory response, which essentially involves glial activation and neutrophil infiltration. Transcription factors nuclear factor-kappa B (NF-kappa B) and signal transducer and activator of transcription 3 (STAT3) contribute to ischemic neuroinflammatory processes and secondary brain injury by releasing proinflammatory mediators. Kaempferol-3-O-rutinoside (KRS) and kaempferol-3-O- glucoside (KGS) are primary flavonoids found in Carthamus tinctorius L. Recent studies demonstrated that KRS protected against ischemic brain injury. However, little is known about the underlying mechanisms. Flavonoids have been reported to have antiinflammatory properties. Herein, we explored the effects of KRS and KGS in a transient focal stroke model. Methodology/Principal Findings: Rats were subjected to middle cerebral artery occlusion for 2 hours followed by 22 h reperfusion. An equimolar dose of KRS or KGS was administered i.v. at the beginning of reperfusion. The results showed that KRS or KGS significantly attenuated the neurological deficits, brain infarct volume, and neuron and axon injury, reflected by the upregulation of neuronal nuclear antigen-positive neurons and downregulation of amyloid precursor protein immunoreactivity in the ipsilateral ischemic hemisphere. Moreover, KRS and KGS inhibited the expression of OX-42, glial fibrillary acidic protein, phosphorylated STAT3 and NF-kappa B p65, and the nuclear content of NF-kappa B p65. Subsequently, these flavonoids inhibited the expression of tumor necrosis factor a, interleukin 1 beta, intercellular adhesion molecule 1, matrix metallopeptidase 9, inducible nitric oxide synthase, and myeloperoxidase. Conclusion/Significance: Our findings suggest that postischemic treatment with KRS or KGS prevents ischemic brain injury and neuroinflammation by inhibition of STAT3 and NF-kappa B activation and has the therapeutic potential for the neuroinflammation-related diseases, such as ischemic stroke.	[Yu, Lu; Wang, Liang-Fen; Kuang, Xi; Liu, Ke; Zhang, Hao; Du, Jun-Rong] Sichuan Univ, Projects Sci & Technol Innovat Platform Novel Dru, Key Lab Drug Targeting & Drug Delivery Syst, Minist Educ,Dept Pharmacol,W China Sch Pharm, Chengdu, Peoples R China; [Chen, Chu] Sichuan Acad Chinese Med Sci, Chengdu, Peoples R China; [Yu, Lu] Luzhou Med Coll, Luzhou, Sichuan, Peoples R China	Sichuan University; Southwest Medical University	Du, JR (corresponding author), Sichuan Univ, Projects Sci & Technol Innovat Platform Novel Dru, Key Lab Drug Targeting & Drug Delivery Syst, Minist Educ,Dept Pharmacol,W China Sch Pharm, Chengdu, Peoples R China.	dujr07@gmail.com			National Science Foundation of China [81072636]; Science Foundation from the Science & Technology Department of Sichuan Province, China [2009SZ0142]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science Foundation from the Science & Technology Department of Sichuan Province, China	This work was mainly supported by the National Science Foundation of China (81072636) and the Science Foundation from the Science & Technology Department of Sichuan Province, China (2009SZ0142). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Autore G, 2001, LIFE SCI, V70, P523, DOI 10.1016/S0024-3205(01)01425-4; Bromberg J, 2000, ONCOGENE, V19, P2468, DOI 10.1038/sj.onc.1203476; Chen YL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040165; Chu K, 2006, BRAIN RES, V1093, P208, DOI 10.1016/j.brainres.2006.03.114; del Zoppo GJ, 2010, J INTERN MED, V267, P156, DOI 10.1111/j.1365-2796.2009.02199.x; DELZOPPO GJ, 1991, STROKE, V22, P1276, DOI 10.1161/01.STR.22.10.1276; DEWAR D, 1995, BRAIN RES, V684, P70, DOI 10.1016/0006-8993(95)00417-O; Durukan A, 2007, PHARMACOL BIOCHEM BE, V87, P179, DOI 10.1016/j.pbb.2007.04.015; Emerich DF, 2002, EXP NEUROL, V173, P168, DOI 10.1006/exnr.2001.7835; Gresle MM, 2006, BRAIN RES, V1110, P13, DOI 10.1016/j.brainres.2006.06.111; Hamann GF, 1996, J CEREBR BLOOD F MET, V16, P1373, DOI 10.1097/00004647-199611000-00036; Huang JL, 2007, PHARMACOL BIOCHEM BE, V86, P741, DOI 10.1016/j.pbb.2007.03.003; Kuang X, 2009, PHARMACOL BIOCHEM BE, V92, P635, DOI 10.1016/j.pbb.2009.03.007; Kunz A, 2008, J NEUROSCI, V28, P1649, DOI 10.1523/JNEUROSCI.5205-07.2008; Lakhan SE, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-97; Li RP, 2006, J ETHNOPHARMACOL, V107, P143, DOI 10.1016/j.jep.2006.04.024; Liu F, 2009, J NEUROSCI METH, V179, P1, DOI 10.1016/j.jneumeth.2008.12.028; LONGA EZ, 1989, STROKE, V20, P84, DOI 10.1161/01.STR.20.1.84; Medana IM, 2003, BRAIN, V126, P515, DOI 10.1093/brain/awg061; Middleton E, 2000, PHARMACOL REV, V52, P673; Molina CA, 2009, CEREBROVASC DIS, V27, P162, DOI 10.1159/000200455; Muir KW, 2007, CURR OPIN NEUROL, V20, P334, DOI 10.1097/WCO.0b013e32813ba151; Oh H, 2004, J ETHNOPHARMACOL, V95, P421, DOI 10.1016/j.jep.2004.08.015; Park SE, 2011, BRIT J PHARMACOL, V164, P1008, DOI 10.1111/j.1476-5381.2011.01389.x; Parveen Z, 2007, YAKUGAKU ZASSHI, V127, P1275, DOI 10.1248/yakushi.127.1275; Peng HY, 2007, BIOL PHARM BULL, V30, P309, DOI 10.1248/bpb.30.309; Sasaki CY, 2005, J BIOL CHEM, V280, P34538, DOI 10.1074/jbc.M504943200; Satriotomo I, 2006, J NEUROCHEM, V98, P1353, DOI 10.1111/j.1471-4159.2006.04051.x; Schilling M, 2003, EXP NEUROL, V183, P25, DOI 10.1016/S0014-4886(03)00082-7; Shi F, 2006, LISHIZHEN MED MAT ME, V17, P1666; Suzuki S, 2001, EXP NEUROL, V170, P63, DOI 10.1006/exnr.2001.7701; Swanson RA, 2004, CURR MOL MED, V4, P193, DOI 10.2174/1566524043479185; Tsuji K, 2005, STROKE, V36, P1954, DOI 10.1161/01.STR.0000177517.01203.eb; Weston RM, 2007, J CEREBR BLOOD F MET, V27, P100, DOI 10.1038/sj.jcbfm.9600324; Yi JH, 2007, NEUROCHEM INT, V50, P1014, DOI 10.1016/j.neuint.2007.04.019; [于丹 Yu Dan], 2010, [华西药学杂志, West China Journal of Pharmaceutical Sciences], V25, P751	36	100	110	2	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e55839	10.1371/journal.pone.0055839	http://dx.doi.org/10.1371/journal.pone.0055839			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437066	Green Submitted, gold, Green Published			2022-12-25	WOS:000315184200025
J	Hashem, AM; Gravel, C; Farnsworth, A; Zou, W; Lemieux, M; Xu, KW; Li, CG; Wang, JZ; Goneau, MF; Merziotis, M; He, RT; Gilbert, M; Li, XG				Hashem, Anwar M.; Gravel, Caroline; Farnsworth, Aaron; Zou, Wei; Lemieux, Michelle; Xu, Kangwei; Li, Changgui; Wang, Junzhi; Goneau, Marie-France; Merziotis, Maria; He, Runtao; Gilbert, Michel; Li, Xuguang			A Novel Synthetic Receptor-Based Immunoassay for Influenza Vaccine Quantification	PLOS ONE			English	Article							PERFORMANCE LIQUID-CHROMATOGRAPHY; SINGLE-RADIAL-IMMUNODIFFUSION; UNIVERSAL ANTIBODIES; VIRUS NEURAMINIDASE; HEMAGGLUTININ; SUBTYPES; IMMUNOGENICITY; ASSAY; REACTOGENICITY; IDENTIFICATION	Vaccination is the most effective prophylactic method for preventing influenza. Quantification of influenza vaccine antigens is critically important before the vaccine is used for human immunization. Currently the vaccine antigen quantification relies on hemagglutinin content quantification, the key antigenic component, by single radial immunodiffusion (SRID) assay. Due to the inherent disadvantages associated with the traditional SRID; i.e. low sensitivity, low throughput and need for annual reagents, several approaches have been proposed and investigated as alternatives. Yet, most alternative methods cannot distinguish native hemagglutinin from denatured form, making them less relevant to antigenic analyses. Here, we developed a quantitative immunoassay based on the sialic acid binding property of influenza vaccine antigens. Specifically, we chemically synthesized human and avian influenza virus receptors analogues, N-acetylneuraminic acid-2,6-lactose and N-acetylneuraminic acid-2,3-lactose derivatives with an azidopropyl aglycon, using alpha-2,6- and alpha-2,3-sialyltransferases, respectively. The azido group of the two sialyllactose-derivatives was reduced and conjugated to mouse serum albumin through a squarate linkage. We showed that the synthetic alpha-2,6- and alpha-2,3-receptors selectively bound to human and avian-derived hemagglutinins, respectively, forming the basis of a new, and robust assay for hemagglutinin quantification. Hemagglutinin treated at high temperature or low pH was measured differentially to untreated samples suggesting native conformation is dependent for optimal binding. Importantly, this receptor-based immunoassay showed excellent specificity and reproducibility, high precision, less turnaround time and significantly higher sensitivity and throughput compared with SRID in analyzing multiple influenza vaccines.	[Hashem, Anwar M.; Gravel, Caroline; Farnsworth, Aaron; Lemieux, Michelle; Li, Xuguang] Hlth Canada, Ctr Vaccine Evaluat, Biol & Genet Therapies Directorate, Ottawa, ON K1A 0L2, Canada; [Hashem, Anwar M.] King Abdulaziz Univ, Fac Med, Dept Microbiol, Jeddah 21413, Saudi Arabia; [Zou, Wei; Goneau, Marie-France; Merziotis, Maria; Gilbert, Michel] Natl Res Council Canada, Inst Biol Sci, Ottawa, ON K1A 0R6, Canada; [Xu, Kangwei; Li, Changgui; Wang, Junzhi] Natl Inst Food & Drug Control, Beijing, Peoples R China; [He, Runtao] Publ Hlth Agcy Canada, Natl Microbiol Lab, Winnipeg, MB, Canada; [Hashem, Anwar M.; Li, Xuguang] Univ Ottawa, Dept Biochem Microbiol & Immunol, Ottawa, ON, Canada	Health Canada; King Abdulaziz University; National Research Council Canada; National Institute of Food & Drug Control - China; Public Health Agency of Canada; University of Ottawa	Gilbert, M (corresponding author), Natl Res Council Canada, Inst Biol Sci, 100 Sussex Dr, Ottawa, ON K1A 0R6, Canada.	michel.gilbert@nrc-cnrc.gc.ca; sean.li@hc-sc.gc.ca	kangwei, xu/B-2185-2018; Hashem, Anwar M/B-2301-2017; Hashem, Anwar/E-9411-2011	kangwei, xu/0000-0002-1375-0586; Hashem, Anwar M/0000-0002-8471-7011; Gilbert, Michel/0000-0002-0204-4408	King Abdulaziz University, through the Saudi Arabian Cultural Bureau in Canada; Canadian Regulatory Strategy for Biotechnology	King Abdulaziz University, through the Saudi Arabian Cultural Bureau in Canada; Canadian Regulatory Strategy for Biotechnology	AMH is supported by a scholarship from King Abdulaziz University, through the Saudi Arabian Cultural Bureau in Canada. This work was supported by the Canadian Regulatory Strategy for Biotechnology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Smith Nicole M., 2006, Morbidity and Mortality Weekly Report, V55, P1; Bliu A, 2012, VACCINE, V30, P5506, DOI 10.1016/j.vaccine.2012.06.051; BUCHER DJ, 1976, P NATL ACAD SCI USA, V73, P238, DOI 10.1073/pnas.73.1.238; CATE TR, 1983, REV INFECT DIS, V5, P737; Chan J, 2010, NAT CHEM BIOL, V6, P405, DOI 10.1038/nchembio.352; Chen J, 1998, CELL, V95, P409, DOI 10.1016/S0092-8674(00)81771-7; Chun S, 2008, VACCINE, V26, P6068, DOI 10.1016/j.vaccine.2008.09.015; CONNOR RJ, 1994, VIROLOGY, V205, P17, DOI 10.1006/viro.1994.1615; Creskey MC, 2010, ANAL BIOCHEM, V406, P193, DOI 10.1016/j.ab.2010.07.016; Du LY, 2010, MICROBES INFECT, V12, P280, DOI 10.1016/j.micinf.2010.01.001; Farnsworth A, 2011, VACCINE, V29, P1529, DOI 10.1016/j.vaccine.2010.12.120; GAMBARYAN AS, 1992, J VIROL METHODS, V39, P111, DOI 10.1016/0166-0934(92)90130-6; Garcia-Canas V, 2007, ANAL CHEM, V79, P3164, DOI 10.1021/ac0621120; Garcia-Canas V, 2006, J CHROMATOGR A, V1123, P225, DOI 10.1016/j.chroma.2006.04.003; Getie-Kebtie M, 2009, PROTEOM CLIN APPL, V3, P979, DOI 10.1002/prca.200800219; Gravel C, 2011, JOVE-J VIS EXP, DOI 10.3791/2784; Gravel C, 2010, VACCINE, V28, P5774, DOI 10.1016/j.vaccine.2010.06.075; Hannoun C, 2004, VIRUS RES, V103, P133, DOI 10.1016/j.virusres.2004.02.025; Hardy Stephanie, 2011, Influenza Other Respir Viruses, V5, P438, DOI 10.1111/j.1750-2659.2011.00250.x; Hashem AM, 2012, HUM VACC IMMUNOTHER, V8, P425, DOI 10.4161/hv.19109; Hashem AM, 2011, CURR BIOINFORM, V6, P415; Hashem AM, 2010, BIOCHEM BIOPH RES CO, V403, P247, DOI 10.1016/j.bbrc.2010.11.030; JOHANSSON BE, 1993, VACCINE, V11, P1037, DOI 10.1016/0264-410X(93)90130-P; Kakuta Y, 2008, GLYCOBIOLOGY, V18, P66, DOI 10.1093/glycob/cwm119; Kamath VP, 1996, GLYCOCONJUGATE J, V13, P315, DOI 10.1007/BF00731506; Kapteyn JC, 2009, VACCINE, V27, P1468, DOI 10.1016/j.vaccine.2008.11.113; Kapteyn JC, 2006, VACCINE, V24, P3137, DOI 10.1016/j.vaccine.2006.01.046; LAMONTAGNE JR, 1983, REV INFECT DIS, V5, P723; Legastelois I, 2011, J VIROL METHODS, V178, P129, DOI 10.1016/j.jviromet.2011.08.027; Li CG, 2010, BIOLOGICALS, V38, P284, DOI 10.1016/j.biologicals.2009.12.004; Li CG, 2010, NAT PROTOC, V5, P14, DOI 10.1038/nprot.2009.200; Lindstrom SE, 1999, J VIROL, V73, P4413, DOI 10.1128/JVI.73.5.4413-4426.1999; Luna LG, 2008, ANAL CHEM, V80, P2688, DOI 10.1021/ac701945h; Luykx DMAM, 2004, EUR J PHARM SCI, V23, P65, DOI 10.1016/j.ejps.2004.05.007; Marcelin G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026335; MATROSOVICH MN, 1993, VIROLOGY, V196, P111, DOI 10.1006/viro.1993.1459; Murphy Trudy V., 2008, Morbidity and Mortality Weekly Report, V57, P1; PHELAN MA, 1983, J CHROMATOGR, V266, P55, DOI 10.1016/S0021-9673(01)90879-9; Plennevaux E, 2011, VACCINE, V29, P1569, DOI 10.1016/j.vaccine.2010.12.116; Poland GA, 2001, VACCINE, V19, P2216, DOI 10.1016/S0264-410X(00)00448-5; Pukin AV, 2008, CARBOHYD RES, V343, P636, DOI 10.1016/j.carres.2008.01.007; Quan FS, 2011, VIROLOGY, V417, P196, DOI 10.1016/j.virol.2011.05.014; ROTT R, 1974, J GEN VIROL, V22, P35, DOI 10.1099/0022-1317-22-1-35; Sandbulte MR, 2007, PLOS MED, V4, P265, DOI 10.1371/journal.pmed.0040059; SCHULMAN JL, 1968, J VIROL, V2, P778, DOI 10.1128/JVI.2.8.778-786.1968; Stevens J, 2006, SCIENCE, V312, P404, DOI 10.1126/science.1124513; Takahashi Y, 2009, J INFECT DIS, V199, P1629, DOI 10.1086/598954; Tsukamoto H, 2008, J BIOCHEM, V143, P187, DOI 10.1093/jb/mvm208; Wang YF, 2012, J MED VIROL, V84, P679, DOI 10.1002/jmv.23219; WEBSTER RG, 1992, MICROBIOL REV, V56, P152, DOI 10.1128/MMBR.56.1.152-179.1992; Weldon WC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012466; WHITE JM, 1987, J CELL BIOL, V105, P2887, DOI 10.1083/jcb.105.6.2887; WILLIAMS MS, 1993, VET MICROBIOL, V37, P253, DOI 10.1016/0378-1135(93)90027-5; Williams TL, 2008, VACCINE, V26, P2510, DOI 10.1016/j.vaccine.2008.03.014; Wood J M, 1986, Dev Biol Stand, V64, P169; Wood J M, 1999, Dev Biol Stand, V98, P183; WOOD JM, 1977, J BIOL STAND, V5, P237, DOI 10.1016/S0092-1157(77)80008-5; WRIGHT PF, 1983, REV INFECT DIS, V5, P758; Zambon MC, 1999, J ANTIMICROB CHEMOTH, V44, P3, DOI 10.1093/jac/44.suppl_2.3; Zou W, 2004, J BIOL CHEM, V279, P25390, DOI 10.1074/jbc.M402787200; Zou W, 1996, J CARBOHYD CHEM, V15, P279, DOI 10.1080/07328309608005653	61	20	21	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2013	8	2							e55428	10.1371/journal.pone.0055428	http://dx.doi.org/10.1371/journal.pone.0055428			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104BU	23424631	Green Published, gold			2022-12-25	WOS:000315965100019
J	Shatnawi, A; Norris, JD; Chaveroux, C; Jasper, JS; Sherk, AB; McDonnell, DP; Giguere, V				Shatnawi, A.; Norris, J. D.; Chaveroux, C.; Jasper, J. S.; Sherk, A. B.; McDonnell, D. P.; Giguere, V.			ELF3 is a repressor of androgen receptor action in prostate cancer cells	ONCOGENE			English	Article						ETS factor; ChIP; nuclear receptor; LNCaP cells; xenograft	ETS TRANSCRIPTION FACTOR; EXPRESSION; GENE; EPITHELIUM; ESE-1; RECURRENCE; MECHANISM; BINDING; FAMILY; DIFFERENTIATION	The androgen receptor (AR) has a critical role in the development and progression of prostate cancer (PC) and is a major therapeutic target in this disease. The transcriptional activity of AR is modulated by the coregulators with which it interacts, and consequently deregulation of cofactor expression and/or activity impacts the expression of genes whose products can have a role in PC pathogenesis. Here we report that E74-like factor 3 (ELF3), a member of the ETS family of transcription factors, is a repressor of AR transcriptional activity. Exogenous expression of ELF3 represses AR transcriptional activity when assessed using reporter-based transfection assays or when evaluated on endogenous AR target genes. Conversely, ELF3 knock down increases the AR transcriptional activity. Biochemical dissection of this activity indicates that it results from the physical interaction between ELF3 and AR and that this interaction inhibits the recruitment of AR to specific androgen response elements within target gene promoters. Significantly, we observed that depletion of ELF3 expression in LNCaP cells promotes cell migration, whereas increased ELF3 expression severely inhibits tumor growth in vitro and in a mouse xenograft model. Taken together, these results suggest that modulation of ELF3 expression and/or AR/ELF3 interaction may have utility in the treatment of PC.	[Shatnawi, A.; Chaveroux, C.; Giguere, V.] McGill Univ, Goodman Canc Res Ctr, Montreal, PQ H3A 1A3, Canada; [Norris, J. D.; Jasper, J. S.; Sherk, A. B.; McDonnell, D. P.] Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC USA; [Giguere, V.] McGill Univ, Dept Biochem, Montreal, PQ, Canada; McGill Univ, Dept Med, Montreal, PQ, Canada; [Giguere, V.] McGill Univ, Dept Oncol, Montreal, PQ, Canada	McGill University; Duke University; McGill University; McGill University; McGill University	Giguere, V (corresponding author), McGill Univ, Goodman Canc Res Ctr, 1160 Pine Ave West, Montreal, PQ H3A 1A3, Canada.	vincent.giguere@mcgill.ca	shatnawi, Aymen/AAF-5661-2020	Chaveroux, Cedric/0000-0002-4116-3354; Norris, John/0000-0001-6553-8053; Giguere, Vincent/0000-0001-9567-3694; Jasper, Jeff/0000-0003-3941-0018	US Department of Defense [W81XWH-09-1-0605]; Canadian Institutes of Health Research [MOP-64275]; Terry Fox Foundation Program Project Grant; NIH [5RO1 CA139818]; NATIONAL CANCER INSTITUTE [R01CA139818] Funding Source: NIH RePORTER	US Department of Defense(United States Department of Defense); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Terry Fox Foundation Program Project Grant; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Dr Angie Rizzino (University of Nebraska Medical Center) for providing the Flag-ELF3 construct and ELF3 mutants and Majid Ghahremani for technical help. This work was financially supported by a postdoctoral award (W81XWH-09-1-0605) from the US Department of Defense PC Research Program (to AS); the Canadian Institutes of Health Research (MOP-64275) and a Terry Fox Foundation Program Project Grant (to VG); and NIH Grant 5RO1 CA139818 (to DPMcD).	Agoulnik IU, 2006, CANCER RES, V66, P10594, DOI 10.1158/0008-5472.CAN-06-1023; Chang CH, 1999, ONCOGENE, V18, P3682, DOI 10.1038/sj.onc.1202674; Chang CH, 1997, ONCOGENE, V14, P1617, DOI 10.1038/sj.onc.1200978; Chang CY, 2005, TRENDS PHARMACOL SCI, V26, P225, DOI 10.1016/j.tips.2005.03.002; Chang J, 2000, ONCOGENE, V19, P151, DOI 10.1038/sj.onc.1203252; Charest-Marcotte A, 2010, GENE DEV, V24, P537, DOI 10.1101/gad.1871610; Clegg NJ, 2012, CANCER RES, V72, P1494, DOI 10.1158/0008-5472.CAN-11-3948; Eckel KL, 2003, DNA CELL BIOL, V22, P79, DOI 10.1089/104454903321515896; Feldman BJ, 2001, NAT REV CANCER, V1, P34, DOI 10.1038/35094009; Frigo DE, 2009, MOL ENDOCRINOL, V23, P1385, DOI 10.1210/me.2009-0010; Gregory CW, 2001, CANCER RES, V61, P4315; HAGMAN J, 1992, P NATL ACAD SCI USA, V89, P8889, DOI 10.1073/pnas.89.19.8889; Halkidou K, 2003, ONCOGENE, V22, P2466, DOI 10.1038/sj.onc.1206342; Heemers HV, 2007, ENDOCR REV, V28, P778, DOI 10.1210/er.2007-0019; Kahl P, 2006, CANCER RES, V66, P11341, DOI 10.1158/0008-5472.CAN-06-1570; Knudsen KE, 2011, EXPERT REV ENDOCRINO, V6, P483, DOI 10.1586/EEM.11.33; Knudsen KE, 2010, TRENDS ENDOCRIN MET, V21, P315, DOI 10.1016/j.tem.2010.01.002; Kopp JL, 2007, J BIOL CHEM, V282, P3027, DOI 10.1074/jbc.M609907200; Lessard L, 2012, CANCER RES, V72, P1529, DOI 10.1158/0008-5472.CAN-11-2602; Maniccia AW, 2009, J CELL PHYSIOL, V219, P634, DOI 10.1002/jcp.21708; Ng AYN, 2002, GASTROENTEROLOGY, V122, P1455, DOI 10.1053/gast.2002.32990; Norris JD, 2009, CHEM BIOL, V16, P452, DOI 10.1016/j.chembiol.2009.01.016; O'Malley BW, 2012, MOL ENDOCRINOL, V26, P1646, DOI 10.1210/me.2012-1114; Oettgen P, 1997, MOL CELL BIOL, V17, P4419, DOI 10.1128/MCB.17.8.4419; Oh S, 2012, BBA-REV CANCER, V1826, P1, DOI 10.1016/j.bbcan.2012.02.002; Oliver JR, 2012, LAB INVEST, V92, P320, DOI 10.1038/labinvest.2011.186; Pienta KJ, 2006, CLIN CANCER RES, V12, P1665, DOI 10.1158/1078-0432.CCR-06-0067; Prescott JD, 2004, MOL CELL BIOL, V24, P5548, DOI 10.1128/MCB.24.12.5548-5564.2004; Reddy SPM, 2003, J BIOL CHEM, V278, P21378, DOI 10.1074/jbc.M212258200; Rudders S, 2001, J BIOL CHEM, V276, P3302, DOI 10.1074/jbc.M006507200; Ryan CJ, 2011, J CLIN ONCOL, V29, P3651, DOI 10.1200/JCO.2011.35.2005; Shatnawi A, 2007, MOL ENDOCRINOL, V21, P635, DOI 10.1210/me.2006-0274; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Taylor BS, 2010, CANCER CELL, V18, P11, DOI 10.1016/j.ccr.2010.05.026; Tomlins SA, 2005, SCIENCE, V310, P644, DOI 10.1126/science.1117679; Tymms MJ, 1997, ONCOGENE, V15, P2449, DOI 10.1038/sj.onc.1201427; Yap TA, 2011, NAT REV CLIN ONCOL, V8, P597, DOI 10.1038/nrclinonc.2011.117; Yu JD, 2010, CANCER CELL, V17, P443, DOI 10.1016/j.ccr.2010.03.018; Zhou HJ, 2005, CANCER RES, V65, P7976, DOI 10.1158/0008-5472.CAN-04-4076; Zong Y, 2009, P NATL ACAD SCI USA, V106, P12465, DOI 10.1073/pnas.0905931106	40	22	22	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 13	2014	33	7					862	871		10.1038/onc.2013.15	http://dx.doi.org/10.1038/onc.2013.15			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AB2MN	23435425	Green Accepted			2022-12-25	WOS:000331626900007
J	Faiss, R; Leger, B; Vesin, JM; Fournier, PE; Eggel, Y; Deriaz, O; Millet, GP				Faiss, Raphael; Leger, Bertrand; Vesin, Jean-Marc; Fournier, Pierre-Etienne; Eggel, Yan; Deriaz, Olivier; Millet, Gregoire P.			Significant Molecular and Systemic Adaptations after Repeated Sprint Training in Hypoxia	PLOS ONE			English	Article							HUMAN SKELETAL-MUSCLE; NEAR-INFRARED SPECTROSCOPY; FIBER-TYPE; TRANSPORTER MCT4; OXYGEN-UPTAKE; BLOOD-FLOW; EXERCISE; INTENSITY; DEOXYGENATION; KINETICS	While intermittent hypoxic training (IHT) has been reported to evoke cellular responses via hypoxia inducible factors (HIFs) but without substantial performance benefits in endurance athletes, we hypothesized that repeated sprint training in hypoxia could enhance repeated sprint ability (RSA) performed in normoxia via improved glycolysis and O-2 utilization. 40 trained subjects completed 8 cycling repeated sprint sessions in hypoxia (RSH, 3000 m) or normoxia (RSN, 485 m). Before (Pre-) and after (Post-) training, muscular levels of selected mRNAs were analyzed from resting muscle biopsies and RSA tested until exhaustion (10-s sprint, work-to-rest ratio 1: 2) with muscle perfusion assessed by near-infrared spectroscopy. From Pre- to Post-, the average power output of all sprints in RSA was increased (p<0.01) to the same extent (6% vs 7%, NS) in RSH and in RSN but the number of sprints to exhaustion was increased in RSH (9.4+/-4.8 vs. 13.0+/-6.2 sprints, p<0.01) but not in RSN (9.3+/-4.2 vs. 8.9+/-3.5). mRNA concentrations of HIF-1 alpha (+55%), carbonic anhydrase III (+35%) and monocarboxylate transporter-4 (+20%) were augmented (p<0.05) whereas mitochondrial transcription factor A (-40%), peroxisome proliferator-activated receptor gamma coactivator 1 alpha (-23%) and monocarboxylate transporter-1 (-36%) were decreased (p<0.01) in RSH only. Besides, the changes in total hemoglobin variations (Delta[tHb]) during sprints throughout RSA test increased to a greater extent (p<0.01) in RSH. Our findings show larger improvement in repeated sprint performance in RSH than in RSN with significant molecular adaptations and larger blood perfusion variations in active muscles.	[Faiss, Raphael; Millet, Gregoire P.] Univ Lausanne, Fac Biol & Med, ISSUL Dept Physiol, CH-1015 Lausanne, Switzerland; [Faiss, Raphael; Leger, Bertrand; Deriaz, Olivier] SuvaCare Rehabil Clin, Inst Res Rehabil, Sion, Switzerland; [Faiss, Raphael; Fournier, Pierre-Etienne; Eggel, Yan] SuvaCare Rehabil Clin, Sport Med Unit, Sion, Switzerland; [Vesin, Jean-Marc] Ecole Polytech Fed Lausanne, Swiss Fed Inst Technol, Appl Signal Proc Grp, CH-1015 Lausanne, Switzerland	University of Lausanne; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Faiss, R (corresponding author), Univ Lausanne, Fac Biol & Med, ISSUL Dept Physiol, CH-1015 Lausanne, Switzerland.	raphael.faiss@unil.ch	Millet, Gregoire P/F-4104-2012; Millet, Grégoire/M-3220-2019; Faiss, Raphaël/AAX-3714-2021; Léger, Bertrand/AAK-4356-2020; Fournier, Pierre-Edouard/AAC-6155-2021	Millet, Gregoire P/0000-0001-8081-4423; Millet, Grégoire/0000-0001-8081-4423; Faiss, Raphaël/0000-0001-6029-9516; Fournier, Pierre-Edouard/0000-0001-8463-8885; Leger, Bertrand/0000-0003-2782-1442	Swiss Federal Research Grant (BASPO) [10-10]	Swiss Federal Research Grant (BASPO)	This research was funded by a Swiss Federal Research Grant (BASPO, Project 10-10). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Billaut F, 2005, NEUROSCI LETT, V380, P265, DOI 10.1016/j.neulet.2005.01.048; Bogdanis GC, 1996, J APPL PHYSIOL, V80, P876, DOI 10.1152/jappl.1996.80.3.876; Boushel R, 2000, ACTA PHYSIOL SCAND, V168, P615, DOI 10.1046/j.1365-201x.2000.00713.x; Buchheit M, 2009, INT J SPORTS MED, V30, P418, DOI 10.1055/s-0028-1105933; Burnley M, 2006, MED SCI SPORT EXER, V38, P1995, DOI 10.1249/01.mss.0000232024.06114.a6; Calbet JAL, 2009, HIGH ALT MED BIOL, V10, P123, DOI 10.1089/ham.2008.1099; Casey DP, 2012, J PHYSL; Cleland SM, 2012, APPL PHYSIOL NUTR ME, V37, P138, DOI [10.1139/H11-143, 10.1139/h11-143]; Delpy DT, 1997, PHILOS T R SOC B, V352, P649, DOI 10.1098/rstb.1997.0046; Dimmer KS, 2000, BIOCHEM J, V350, P219, DOI 10.1042/0264-6021:3500219; DOTAN R, 1983, EUR J APPL PHYSIOL O, V51, P409, DOI 10.1007/BF00429077; Endo M, 2005, EUR J APPL PHYSIOL, V95, P418, DOI 10.1007/s00421-005-0051-2; ESSEN B, 1975, ACTA PHYSIOL SCAND, V95, P153, DOI 10.1111/j.1748-1716.1975.tb10038.x; Ferguson SK, 2012, J PHYSL; Ferreira LF, 2006, EUR J APPL PHYSIOL, V96, P558, DOI 10.1007/s00421-005-0107-3; Foss O, 2004, EUR J APPL PHYSIOL, V92, P443, DOI 10.1007/s00421-004-1175-5; GAITANOS GC, 1993, J APPL PHYSIOL, V75, P712, DOI 10.1152/jappl.1993.75.2.712; Girard O, 2011, SPORTS MED, V41, P673, DOI 10.2165/11590550-000000000-00000; GOLLNICK PD, 1974, J PHYSIOL-LONDON, V241, P45, DOI 10.1113/jphysiol.1974.sp010639; GRANGER HJ, 1973, MICROVASC RES, V5, P49, DOI 10.1016/S0026-2862(73)80006-8; Hanada A, 2003, J PHYSIOL-LONDON, V551, P635, DOI 10.1113/jphysiol.2003.044024; Hautier CA, 1996, EUR J APPL PHYSIOL, V74, P114, DOI 10.1007/BF00376503; He ZH, 2012, MED SCI SPORT EXER, V44, P1013, DOI 10.1249/MSS.0b013e3182442d82; Hoppeler H, 2008, SCAND J MED SCI SPOR, V18, P38, DOI 10.1111/j.1600-0838.2008.00831.x; Hoppeler H, 2001, J EXP BIOL, V204, P3133; Jacobs TL, 2000, J PHYSIOL-LONDON, V524, P929, DOI 10.1111/j.1469-7793.2000.00929.x; Karatzaferi C, 2001, EXP PHYSIOL, V86, P411, DOI 10.1113/eph8602223; Leger B, 2006, J PHYSIOL-LONDON, V576, P923, DOI 10.1113/jphysiol.2006.116715; Leger B, 2011, INT J CARDIOL, V146, P270, DOI 10.1016/j.ijcard.2010.10.078; Leger B, 2009, MUSCLE NERVE, V40, P69, DOI 10.1002/mus.21293; Lundby C, 2012, BR J SPORTS MED; Lundby C, 2009, CELL MOL LIFE SCI, V66, P3615, DOI 10.1007/s00018-009-0146-8; McDonough P, 2005, J PHYSIOL-LONDON, V563, P903, DOI 10.1113/jphysiol.2004.079533; Messonnier L, 2007, J APPL PHYSIOL, V102, P1936, DOI 10.1152/japplphysiol.00691.2006; Mortensen SP, 2008, J PHYSIOL-LONDON, V586, P2621, DOI 10.1113/jphysiol.2007.149401; Racinais S, 2007, MED SCI SPORT EXER, V39, P268, DOI 10.1249/01.mss.0000251775.46460.cb; Roels B, 2007, EUR J APPL PHYSIOL, V101, P359, DOI 10.1007/s00421-007-0506-8; Russell A, 2002, INT J OBESITY, V26, P157, DOI 10.1038/sj.ijo.0801885; Semenza G.L., 2007, SCI STKE, V2007, pcm8; SEMENZA GL, 2006, NOVART FDN SYMP, V272, P8, DOI DOI 10.1002/9780470035009.CH2; Semenza Gregg L, 2006, Novartis Found Symp, V272, P2; Smith KJ, 2010, EUR J APPL PHYSIOL, V109, P989, DOI 10.1007/s00421-010-1444-4; Szubski C, 2006, J APPL PHYSIOL, V101, P1673, DOI 10.1152/japplphysiol.00617.2006; Truijens MJ, 2003, J APPL PHYSIOL, V94, P733, DOI 10.1152/japplphysiol.00079.2002; Ullah MS, 2006, J BIOL CHEM, V281, P9030, DOI 10.1074/jbc.M511397200; Umberger BR, 2006, J BIOMECH, V39, P1472, DOI 10.1016/j.jbiomech.2005.03.025; van Beekvelt MCP, 2001, J APPL PHYSIOL, V90, P511, DOI 10.1152/jappl.2001.90.2.511; Vogt M, 2001, J APPL PHYSIOL, V91, P173, DOI 10.1152/jappl.2001.91.1.173; Westerblad H, 2002, NEWS PHYSIOL SCI, V17, P17; WILSON DF, 1977, AM J PHYSIOL, V233, pC135, DOI 10.1152/ajpcell.1977.233.5.C135; Zoll J, 2006, J APPL PHYSIOL, V100, P1258, DOI 10.1152/japplphysiol.00359.2005	51	178	183	1	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e56522	10.1371/journal.pone.0056522	http://dx.doi.org/10.1371/journal.pone.0056522			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437154	Green Published, gold			2022-12-25	WOS:000315184200092
J	Mino, T; Mori, T; Aoyama, Y; Sera, T				Mino, Takashi; Mori, Tomoaki; Aoyama, Yasuhiro; Sera, Takashi			Gene- and Protein-Delivered Zinc Finger-Staphylococcal Nuclease Hybrid for Inhibition of DNA Replication of Human Papillomavirus	PLOS ONE			English	Article							BINDING DOMAIN; TYPE-16 E1; CLEAVAGE; SELECTION; SPECIFICITY; PREVALENCE; ENHANCER; ORIGIN; CANCER; VIRUS	Previously, we reported that artificial zinc-finger proteins (AZPs) inhibited virus DNA replication in planta and in mammalian cells by blocking binding of a viral replication protein to its replication origin. However, the replication mechanisms of viruses of interest need to be disentangled for the application. To develop more widely applicable methods for antiviral therapy, we explored the feasibility of inhibition of HPV-18 replication as a model system by cleaving its viral genome. To this end, we fused the staphylococcal nuclease cleaving DNA as a monomer to an AZP that binds to the viral genome. The resulting hybrid nuclease (designated AZP-SNase) cleaved its target DNA plasmid efficiently and sequence-specifically in vitro. Then, we confirmed that transfection with a plasmid expressing AZP-SNase inhibited HPV-18 DNA replication in transient replication assays using mammalian cells. Linker-mediated PCR analysis revealed that the AZP-SNase cleaved an HPV-18 ori plasmid around its binding site. Finally, we demonstrated that the protein-delivered AZP-SNase inhibited HPV-18 DNA replication as well and did not show any significant cytotoxicity. Thus, both gene- and protein- delivered hybrid nucleases efficiently inhibited HPV-18 DNA replication, leading to development of a more universal antiviral therapy for human DNA viruses.	[Mino, Takashi; Mori, Tomoaki; Aoyama, Yasuhiro; Sera, Takashi] Kyoto Univ, Dept Synthet Chem & Biol Chem, Grad Sch Engn, Kyoto, Japan; [Mori, Tomoaki; Sera, Takashi] Okayama Univ, Dept Appl Chem & Biotechnol, Grad Sch Nat Sci & Technol, Okayama 7008530, Japan; [Aoyama, Yasuhiro] Doshisha Univ, Dept Mol Chem & Biochem, Fac Sci & Engn, Kyoto 602, Japan; [Mino, Takashi] Kyoto Univ, Inst Virus Res, Lab Infect & Prevent, Kyoto 606, Japan	Kyoto University; Okayama University; Doshisha University; Kyoto University	Sera, T (corresponding author), Kyoto Univ, Dept Synthet Chem & Biol Chem, Grad Sch Engn, Kyoto, Japan.	sera@cc.okayama-u.ac.jp	Mino, Takashi/GRO-0332-2022	Mino, Takashi/0000-0002-9562-008X	Grants-in-Aid for Scientific Research [25860355] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		Andrei G, 1998, ONCOL RES, V10, P523; Bibikova M, 2001, MOL CELL BIOL, V21, P289, DOI 10.1128/MCB.21.1.289-297.2001; Bitinaite J, 1998, P NATL ACAD SCI USA, V95, P10570, DOI 10.1073/pnas.95.18.10570; Boch J, 2009, SCIENCE, V326, P1509, DOI 10.1126/science.1178811; BOSCH FX, 1995, JNCI-J NATL CANCER I, V87, P796, DOI 10.1093/jnci/87.11.796; Cathomen T, 2008, MOL THER, V16, P1200, DOI 10.1038/mt.2008.114; Chao SF, 1999, BIOCHEMISTRY-US, V38, P4586, DOI 10.1021/bi982616v; CHIANG CM, 1992, P NATL ACAD SCI USA, V89, P5799, DOI 10.1073/pnas.89.13.5799; CHOO Y, 1994, P NATL ACAD SCI USA, V91, P11168, DOI 10.1073/pnas.91.23.11168; DELVECCHIO AM, 1992, J VIROL, V66, P5949, DOI 10.1128/JVI.66.10.5949-5958.1992; DIMAIO D, 2001, FIELDS VIROLOGY, P119; DOWTY ME, 1995, P NATL ACAD SCI USA, V92, P4572, DOI 10.1073/pnas.92.10.4572; FRATTINI MG, 1994, P NATL ACAD SCI USA, V91, P12398, DOI 10.1073/pnas.91.26.12398; Gabriel R, 2011, NAT BIOTECHNOL, V29, P816, DOI 10.1038/nbt.1948; Gaj T, 2012, NAT METHODS, V9, P805, DOI [10.1038/nmeth.2030, 10.1038/NMETH.2030]; HIRT B, 1967, J MOL BIOL, V26, P365, DOI 10.1016/0022-2836(67)90307-5; Ho A, 2001, CANCER RES, V61, P474; Horner SM, 2007, J VIROL, V81, P6254, DOI 10.1128/JVI.00232-07; Howley P. M., 2001, FIELDS VIROLOGY, V2, P2197; Ishiyama M, 1997, TALANTA, V44, P1299, DOI 10.1016/S0039-9140(97)00017-9; LabatMoleur F, 1996, GENE THER, V3, P1010; Lee D, 1997, VIRUS RES, V52, P97, DOI 10.1016/S0168-1702(97)00114-7; Lowy DR, 2001, FIELDS VIROLOGY, P2231; Mineta Y, 2008, BIOCHEMISTRY-US, V47, P12257, DOI 10.1021/bi801800k; Mino T, 2008, ARCH VIROL, V153, P1291, DOI 10.1007/s00705-008-0125-7; Mino T, 2006, J VIROL, V80, P5405, DOI 10.1128/JVI.01795-05; Morbitzer R, 2011, NUCLEIC ACIDS RES, V39, P5790, DOI 10.1093/nar/gkr151; MUELLER PR, 1989, SCIENCE, V246, P780, DOI 10.1126/science.2814500; Mussolino C, 2012, CURR OPIN BIOTECH, V23, P644, DOI 10.1016/j.copbio.2012.01.013; Mussolino C, 2011, NUCLEIC ACIDS RES, V39, P9283, DOI 10.1093/nar/gkr597; PEDEN KWC, 1980, SCIENCE, V209, P1392, DOI 10.1126/science.6251547; PEI D, 1990, J AM CHEM SOC, V112, P4579, DOI 10.1021/ja00167a085; Pisani P, 2002, INT J CANCER, V97, P72, DOI 10.1002/ijc.1571; Porteus MH, 2005, NAT BIOTECHNOL, V23, P967, DOI 10.1038/nbt1125; REBAR EJ, 1994, SCIENCE, V263, P671, DOI 10.1126/science.8303274; RUSSELL J, 1995, J VIROL, V69, P651, DOI 10.1128/JVI.69.2.651-660.1995; Sambrook JD, 2001, MOL CLONING LAB MANU, P1261; Schiffer JT, 2012, J VIROL, V86, P8920, DOI 10.1128/JVI.00052-12; Sera T, 2002, BIOCHEMISTRY-US, V41, P7074, DOI 10.1021/bi020095c; Sera T, 2005, J VIROL, V79, P2614, DOI 10.1128/JVI.79.4.2614-2619.2005; Smith J, 2000, NUCLEIC ACIDS RES, V28, P3361, DOI 10.1093/nar/28.17.3361; Tachikawa K, 2004, P NATL ACAD SCI USA, V101, P15225, DOI 10.1073/pnas.0406473101; Titolo S, 1999, J VIROL, V73, P5282, DOI 10.1128/JVI.73.7.5282-5293.1999; TUCKER PW, 1979, MOL CELL BIOCHEM, V23, P67; Walboomers JMM, 1999, J PATHOL, V189, P12, DOI 10.1002/(SICI)1096-9896(199909)189:1&lt;12::AID-PATH431&gt;3.0.CO;2-F; Wayengera M, 2012, THEOR BIOL MED MODEL, V9, P30; Wener PA, 2000, P NATL ACAD SCI USA, V97, P13003; Wilson VG, 2002, VIRUS GENES, V24, P275, DOI 10.1023/A:1015336817836; Wright DA, 2006, NAT PROTOC, V1, P1637, DOI 10.1038/nprot.2006.259; WU H, 1995, P NATL ACAD SCI USA, V92, P344, DOI 10.1073/pnas.92.2.344; Yasugi T, 1997, J VIROL, V71, P891, DOI 10.1128/JVI.71.2.891-899.1997; Zou NX, 1998, J VIROL, V72, P3436, DOI 10.1128/JVI.72.4.3436-3441.1998	52	20	21	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e56633	10.1371/journal.pone.0056633	http://dx.doi.org/10.1371/journal.pone.0056633			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437192	Green Published, Green Submitted, gold			2022-12-25	WOS:000315184200124
J	Morceli, G; Honorio-Franca, AC; Fagundes, DLG; Calderon, IMP; Franca, EL				Morceli, Gliciane; Honorio-Franca, Adenilda C.; Fagundes, Danny L. G.; Calderon, Iracema M. P.; Franca, Eduardo L.			Antioxidant Effect of Melatonin on the Functional Activity of Colostral Phagocytes in Diabetic Women	PLOS ONE			English	Article							BINDING-SITES; MICROBICIDAL ACTIVITY; SIGNAL-TRANSDUCTION; NITRIC-OXIDE; RECEPTORS; MACROPHAGES; NEUTROPHILS; SUPEROXIDE; EXPRESSION; CALCIUM	Melatonin is involved in a number of physiological and oxidative processes, including functional regulation in human milk. The present study investigated the mechanisms of action of melatonin and its effects on the functional activity of colostral phagocytes in diabetic women. Colostrum samples were collected from normoglycemic (N = 38) and diabetic (N = 38) women. We determined melatonin concentration, superoxide release, bactericidal activity and intracellular Ca2+ release by colostral phagocytes treated or not with 8-(Diethylamino) octyl-3,4,5-trimethoxybenzoate hydrochloride (TMB-8) and incubated with melatonin and its precursor (N-acetyl-serotonin-NAS), antagonist (luzindole) and agonist (chloromelatonin-CMLT). Melatonin concentration was higher in colostrum samples from hyperglycemic than normoglycemic mothers. Melatonin stimulated superoxide release by colostral phagocytes from normoglycemic but not hyperglycemic women. NAS increased superoxide, irrespective of glycemic status, whereas CMTL increased superoxide only in cells from the normoglycemic group. Phagocytic activity in colostrum increased significantly in the presence of melatonin, NAS and CMLT, irrespective of glycemic status. The bactericidal activity of colostral phagocytes against enterophatogenic Escherichia coli (EPEC) increased in the presence of melatonin or NAS in the normoglycemic group, but not in the hyperglycemic group. Luzindole blocked melatonin action on colostrum phagocytes. Phagocytes from the normoglycemic group treated with melatonin exhibited an increase in intracellular Ca2+ release. Phagocytes treated with TMB-8 (intracellular Ca2+ inhibitor) decreased superoxide, bactericidal activity and intracellular Ca2+ release in both groups. The results obtained suggest an interactive effect of glucose metabolism and melatonin on colostral phagocytes. In colostral phagocytes from normoglycemic mothers, melatonin likely increases the ability of colostrum to protect against EPEC and other infections. In diabetic mothers, because maternal hyperglycemia modifies the functional activity of colostrum phagocytes, melatonin effects are likely limited to anti-inflammatory processes, with low superoxide release and bactericidal activity.	[Morceli, Gliciane; Fagundes, Danny L. G.; Calderon, Iracema M. P.] Sao Paulo State Univ, UNESP, Botucatu Med Sch, Post Grad Program Gynecol Obstet & Mastol, Sao Paulo, Brazil; [Honorio-Franca, Adenilda C.; Franca, Eduardo L.] Univ Fed Mato Grosso, Inst Biol & Hlth Sci, Barra Do Garcas, Mato Grosso, Brazil	Universidade Estadual Paulista; Universidade Federal de Mato Grosso; Universidade Federal de Mato Grosso do Sul	Honorio-Franca, AC (corresponding author), Univ Fed Mato Grosso, Inst Biol & Hlth Sci, Barra Do Garcas, Mato Grosso, Brazil.	denifran@terra.com.br	Calderon, Iracema/W-4336-2019; França, Eduardo Luzia/W-8727-2019; Calderon, Iracema MP/C-8136-2012; Honorio-França, Adenilda C/C-8012-2012; Morceli, Glilciane/C-7487-2012; Triches, Danny Laura/AAE-2352-2022; França, Eduardo L/C-8053-2012	Calderon, Iracema/0000-0003-4761-4336; França, Eduardo Luzia/0000-0002-1854-5397; Calderon, Iracema MP/0000-0003-4761-4336; Honorio-França, Adenilda C/0000-0002-0452-9804; Morceli, Glilciane/0000-0001-8216-9931; Triches, Danny Laura/0000-0002-9971-1288; 	FAPESP [2008/09187-8, 2009/01188-8, 2011/18045-5]; FAPEMAT [299032/2010]; CNPq [475826/2010-8, 475739/2011-6]	FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); FAPEMAT(Fundacao de Amparo a Pesquisa do Estado de Mato Grosso (FAPEMAT)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	The authors declare non-financial competing interests. This research was supported by FAPESP (2008/09187-8; 2009/01188-8; 2011/18045-5) (http://www.fapesp.br), FAPEMAT (299032/2010) and CNPq (475826/2010-8; 475739/2011-6) (http://www.fapemat.mt.gov.br). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alba-Loureiro TC, 2007, BRAZ J MED BIOL RES, V40, P1037, DOI 10.1590/S0100-879X2006005000143; American Diabetes Association, 2003, Diabetes Care, V26 Suppl 1, pS103; Barjavel MJ, 1998, J IMMUNOL, V160, P1191; BellinatiPires R, 1995, J INVEST ALLERG CLIN, V5, P337; Belyaev O, 2011, J PINEAL RES, V50, P71, DOI 10.1111/j.1600-079X.2010.00811.x; Besedovsky HO, 1996, ENDOCR REV, V17, P64, DOI 10.1210/er.17.1.64; Bromme HJ, 2000, J PINEAL RES, V29, P201, DOI 10.1034/j.1600-0633.2002.290402.x; Bubenik GA, 2002, DIGEST DIS SCI, V47, P2336, DOI 10.1023/A:1020107915919; Ferrari CKB, 2009, J APPL BIOMED, V7, P163, DOI 10.32725/jab.2009.019; Carneiro-Sampaio MMS, 1996, REV MICROBIOL, V26, P151; Carrichon L, 2011, BBA-BIOMEMBRANES, V1808, P78, DOI 10.1016/j.bbamem.2010.08.002; Chertok IRA, 2009, J HUM NUTR DIET, V22, P166, DOI 10.1111/j.1365-277X.2008.00921.x; Cutolo M, 1999, ANN NY ACAD SCI, V876, P246, DOI 10.1111/j.1749-6632.1999.tb07645.x; Davis MK, 2001, PEDIATR CLIN N AM, V48, P125, DOI 10.1016/S0031-3955(05)70289-3; Devi MMS, 2000, J PINEAL RES, V29, P108; Djaldetti M, 2002, MICROSC RES TECHNIQ, V57, P421, DOI 10.1002/jemt.10096; DUBOCOVICH ML, 1998, IUPHAR COMPENDIUM RE, P187; Erren TC, 2008, NEUROENDOCRINOL LETT, V29, P815; Franca EL, 2011, APMIS, V119, P710, DOI 10.1111/j.1600-0463.2011.02789.x; Franca EL, 2011, J MICROBIOL IMMUNOL, V44, P1, DOI 10.1016/j.jmii.2011.01.002; Franca EL, 2010, BIOL RHYTHM RES, V41, P333, DOI 10.1080/09291010903407441; Franca EL, 2009, BRATISL MED J, V7, P163; Franca-Botelho AC, 2006, ACTA PAEDIATR, V95, P438, DOI 10.1080/08035250500421592; Franca-Botelho AC, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-62; Fagundes DLG, 2012, INT J PHARMACOL, V8, P510, DOI 10.3923/ijp.2012.510.518; Hanson LA, 2007, P NUTR SOC, V66, P384, DOI 10.1017/S0029665107005654; Honorio-Franca A. C., 2009, INT J DIABETES METAB, V17, P87; Honorio-Fransa AC, 2001, J LEUKOCYTE BIOL, V69, P289; HonorioFranca AC, 1997, SCAND J IMMUNOL, V46, P59, DOI 10.1046/j.1365-3083.1997.d01-86.x; Hussain SA, 2006, SAUDI MED J, V27, P1483; ILLNEROVA H, 1993, J CLIN ENDOCR METAB, V77, P838, DOI 10.1210/jc.77.3.838; Jockers R, 2008, BRIT J PHARMACOL, V154, P1182, DOI 10.1038/bjp.2008.184; Kadhim HM, 2006, J PINEAL RES, V41, P189, DOI 10.1111/j.1600-079X.2006.00353.x; Kent JC, 2007, J MIDWIFERY WOM HEAL, V52, P564, DOI 10.1016/j.jmwh.2007.04.007; Kireev RA, 2008, J PINEAL RES, V45, P394, DOI 10.1111/j.1600-079X.2008.00606.x; Klepac N, 2006, BIOMED PHARMACOTHER, V60, P32, DOI 10.1016/j.biopha.2005.08.005; KOJIMA I, 1986, BIOCHIM BIOPHYS ACTA, V888, P25, DOI 10.1016/0167-4889(86)90066-2; Konakchieva R, 1999, ADV EXP MED BIOL, V460, P411; Korkmaz A, 2009, REV ENDOCR METAB DIS, V10, P261, DOI 10.1007/s11154-009-9117-5; Lopez-Gonzalez Miguel A., 1993, Biotechnology Therapeutics, V4, P253; Morceli G, 2011, ACTA PAEDIATR, V100, P550, DOI 10.1111/j.1651-2227.2010.02070.x; NOVELLI ELB, 1993, BRAZ J MED BIOL RES, V26, P31; Ogasawara T, 1991, Nihon Sanka Fujinka Gakkai Zasshi, V43, P335; Owen CG, 2006, AM J CLIN NUTR, V84, P1043, DOI 10.1093/ajcn/84.5.1043; Pandi-Perumal SR, 2008, PROG NEUROBIOL, V85, P335, DOI 10.1016/j.pneurobio.2008.04.001; Pawlak J, 2005, MOL CELL BIOCHEM, V275, P207, DOI 10.1007/s11010-005-1995-6; Peschke E, 2012, J PINEAL RES, V52, P389, DOI 10.1111/j.1600-079X.2011.00951.x; Peschke E, 2008, J PINEAL RES, V44, P26, DOI 10.1111/j.1600-079X.2007.00519.x; PICK E, 1981, J IMMUNOL METHODS, V46, P211, DOI 10.1016/0022-1759(81)90138-1; PIOLI C, 1993, INT J IMMUNOPHARMACO, V15, P463, DOI 10.1016/0192-0561(93)90060-C; Ramraeheya RD, 2008, J PINEAL RES, V44, P273, DOI 10.1111/j.1600-079X.2007.00523.x; Reiter RJ, 2008, NEUROENDOCRINOL LETT, V29, P391; Rodriguez C, 2004, J PINEAL RES, V36, P1, DOI 10.1046/j.1600-079X.2003.00092.x; Rudge MVC, 2000, GYNECOL OBSTET INVES, V50, P108, DOI 10.1159/000010293; Silva SO, 2006, MICROBES INFECT, V8, P420, DOI 10.1016/j.micinf.2005.07.004; Skwarlo-Sonta K, 2002, J PHYSIOL-LONDON, V543, p6S; Sudnikovich EJ, 2007, EUR J PHARMACOL, V569, P180, DOI 10.1016/j.ejphar.2007.05.018; Tutuncu NB, 2005, J PINEAL RES, V39, P43, DOI 10.1111/j.1600-079X.2005.00213.x; VACAS MI, 1992, J PINEAL RES, V13, P60, DOI 10.1111/j.1600-079X.1992.tb00055.x; Vidarsson G, 1998, CURR OPIN INFECT DIS, V11, P271, DOI 10.1097/00001432-199806000-00002	60	32	32	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e56915	10.1371/journal.pone.0056915	http://dx.doi.org/10.1371/journal.pone.0056915			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437270	gold, Green Published, Green Submitted			2022-12-25	WOS:000315184200184
J	Rodriguez-Gil, DJ; Hu, W; Greer, CA				Rodriguez-Gil, Diego J.; Hu, Wilbur; Greer, Charles A.			Dishevelled Proteins Are Associated with Olfactory Sensory Neuron Presynaptic Terminals	PLOS ONE			English	Article							ODORANT RECEPTOR GENES; CELL-ADHESION MOLECULE; BETA-CATENIN; COMPARTMENTAL ORGANIZATION; ZONAL SEGREGATION; AXON EXTENSION; FAMILY-MEMBERS; WNT PATHWAY; MOUSE; EXPRESSION	Olfactory sensory neurons (OSNs) project their axons from the olfactory epithelium toward the olfactory bulb (OB) in a heterogeneous and unsorted arrangement. However, as the axons approach the glomerular layer of the OB, axons from OSNs expressing the same odorant receptor (OR) sort and converge to form molecularly homogeneous glomeruli. Axon guidance cues, cell adhesion molecules, and OR induced activity have been implicated in the final targeting of OSN axons to specific glomeruli. Less understood, and often controversial, are the mechanisms used by OSN axons to initially navigate from the OE toward the OB. We previously demonstrated a role for Wnt and Frizzled (Fz) molecules in OSN axon extension and organization within the olfactory nerve. Building on that we now turned our attention to the downstream signaling cascades from Wnt-Fz interactions. Dishevelled (Dvl) is a key molecule downstream of Fz receptors. Three isoforms of Dvl with specific as well as overlapping functions are found in mammals. Here, we show that Dvl-1 expression is restricted to OSNs in the dorsal recess of the nasal cavity, and labels a unique subpopulation of glomeruli. Dvl-2 and Dvl-3 have a widespread distribution in both the OE and OB. Both Dvl-1 and Dvl-2 are associated with intra-glomerular pre-synaptic OSN terminals, suggesting a role in synapse formation/stabilization. Moreover, because Dvl proteins were observed in all OSN axons, we hypothesize that they are important determinants of OSN cell differentiation and axon extension.	[Rodriguez-Gil, Diego J.; Hu, Wilbur; Greer, Charles A.] Yale Univ, Sch Med, Dept Neurosurg, New Haven, CT 06520 USA; [Greer, Charles A.] Yale Univ, Sch Med, Dept Neurobiol, New Haven, CT USA	Yale University; Yale University	Greer, CA (corresponding author), Yale Univ, Sch Med, Dept Neurosurg, New Haven, CT 06520 USA.	charles.greer@yale.edu			United States National Institutes of Health Grant [DC00210, DC010894]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC007880, R01DC000210, R03DC010894, R01DC012441] Funding Source: NIH RePORTER	United States National Institutes of Health Grant; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by United States National Institutes of Health Grant DC00210 to Charles A. Greer and DC010894 to Diego Rodriguez-Gil. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad-Annuar A, 2006, J CELL BIOL, V174, P127, DOI 10.1083/jcb.200511054; Bikkavilli RK, 2008, J CELL SCI, V121, P234, DOI 10.1242/jcs.021964; Booker-Dwyer T, 2008, DEV NEUROBIOL, V68, P859, DOI 10.1002/dneu.20606; Bozza T, 2009, NEURON, V61, P220, DOI 10.1016/j.neuron.2008.11.010; Cho JH, 2007, J NEUROSCI, V27, P9094, DOI 10.1523/JNEUROSCI.2217-07.2007; Christie SB, 2009, J NEUROSCI, V29, P1514, DOI 10.1523/JNEUROSCI.3937-08.2009; Ciani L, 2004, J CELL BIOL, V164, P243, DOI 10.1083/jcb.200309096; Cloutier JF, 2002, NEURON, V33, P877, DOI 10.1016/S0896-6273(02)00635-9; Corbit KC, 2008, NAT CELL BIOL, V10, P70, DOI 10.1038/ncb1670; Cutforth T, 2003, CELL, V114, P311, DOI 10.1016/S0092-8674(03)00568-3; Elbert M, 2006, MOL BIOL CELL, V17, P3345, DOI 10.1091/mbc.E06-03-0193; Etheridge SL, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000259; Feinstein P, 2004, CELL, V117, P817, DOI 10.1016/j.cell.2004.05.011; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Gao C, 2010, CELL SIGNAL, V22, P717, DOI 10.1016/j.cellsig.2009.11.021; Gerdes JM, 2007, NAT GENET, V39, P1350, DOI 10.1038/ng.2007.12; Gerdes JM, 2008, CURR TOP DEV BIOL, V85, P175, DOI 10.1016/S0070-2153(08)00807-7; Gonzalez-Sancho JM, 2004, MOL CELL BIOL, V24, P4757, DOI 10.1128/MCB.24.11.4757-4768.2004; Gussing F, 2004, EUR J NEUROSCI, V19, P2511, DOI 10.1111/j.0953-816X.2004.03331.x; Habas R, 2003, GENE DEV, V17, P295, DOI 10.1101/gad.1022203; HINDS JW, 1976, J COMP NEUROL, V169, P41, DOI 10.1002/cne.901690104; Imai T, 2006, SCIENCE, V314, P657, DOI 10.1126/science.1131794; Imamura F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006729; Ishii T, 2004, J NEUROCYTOL, V33, P657, DOI 10.1007/s11068-005-3334-y; Johnson MA, 2012, P NATL ACAD SCI USA, V109, P13410, DOI 10.1073/pnas.1206724109; Kafitz KW, 1998, J NEUROBIOL, V34, P271, DOI 10.1002/(SICI)1097-4695(19980215)34:3<271::AID-NEU6>3.0.CO;2-#; Kaneko-Goto T, 2008, NEURON, V57, P834, DOI 10.1016/j.neuron.2008.01.023; Kasowski HJ, 1999, J COMP NEUROL, V407, P261, DOI 10.1002/(SICI)1096-9861(19990503)407:2<261::AID-CNE7>3.0.CO;2-G; Krylova O, 2000, J CELL BIOL, V151, P83, DOI 10.1083/jcb.151.1.83; Kulaga HM, 2004, NAT GENET, V36, P994, DOI 10.1038/ng1418; Liberles SD, 2006, NATURE, V442, P645, DOI 10.1038/nature05066; McEwen DP, 2007, P NATL ACAD SCI USA, V104, P15917, DOI 10.1073/pnas.0704140104; Miyamichi K, 2005, J NEUROSCI, V25, P3586, DOI 10.1523/JNEUROSCI.0324-05.2005; Mobley AS, 2010, J NEUROSCI, V30, P16498, DOI 10.1523/JNEUROSCI.4225-10.2010; Nagahata T, 2003, CANCER SCI, V94, P515, DOI 10.1111/j.1349-7006.2003.tb01475.x; Oka Y, 2003, EUR J BIOCHEM, V270, P1995, DOI 10.1046/j.1432-1033.2003.03571.x; Pacifico R, 2012, CELL REP, V2, P76, DOI 10.1016/j.celrep.2012.06.006; Pluznick JL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019694; Potter SM, 2001, J NEUROSCI, V21, P9713, DOI 10.1523/JNEUROSCI.21-24-09713.2001; RESSLER KJ, 1993, CELL, V73, P597, DOI 10.1016/0092-8674(93)90145-G; Rodriguez-Gil DJ, 2008, J COMP NEUROL, V511, P301, DOI 10.1002/cne.21834; Rodriguez-Gil DJ, 2010, J NEUROSCI, V30, P10067, DOI 10.1523/JNEUROSCI.1776-10.2010; Sahores M, 2010, DEVELOPMENT, V137, P2215, DOI 10.1242/dev.046722; Serizawa S, 2006, CELL, V127, P1057, DOI 10.1016/j.cell.2006.10.031; Shay EL, 2008, DEV DYNAM, V237, P1837, DOI 10.1002/dvdy.21595; Shimogori T, 2004, J COMP NEUROL, V473, P496, DOI 10.1002/cne.20135; Simons M, 2005, NAT GENET, V37, P537, DOI 10.1038/ng1552; Sullivan SL, 1996, P NATL ACAD SCI USA, V93, P884, DOI 10.1073/pnas.93.2.884; Tissir F, 2006, EUR J NEUROSCI, V23, P597, DOI 10.1111/j.1460-9568.2006.04596.x; Torban E, 2004, J BIOL CHEM, V279, P52703, DOI 10.1074/jbc.M408675200; Treloar HB, 2009, J NEUROSCI, V29, P9405, DOI 10.1523/JNEUROSCI.2356-09.2009; Uematsu K, 2003, ONCOGENE, V22, P7218, DOI 10.1038/sj.onc.1206817; Uematsu K, 2003, CANCER RES, V63, P4547; van Amerongen R, 2009, DEVELOPMENT, V136, P3205, DOI 10.1242/dev.033910; VASSAR R, 1993, CELL, V74, P309, DOI 10.1016/0092-8674(93)90422-M; von Maltzahn J, 2012, NAT CELL BIOL, V14, P186, DOI 10.1038/ncb2404; Waites CL, 2005, ANNU REV NEUROSCI, V28, P251, DOI 10.1146/annurev.neuro.27.070203.144336; Walz A, 2002, J NEUROSCI, V22, P4025, DOI 10.1523/JNEUROSCI.22-10-04025.2002; Walz A, 2006, MOL CELL NEUROSCI, V32, P1, DOI 10.1016/j.mcn.2006.01.013; Wang F, 1998, CELL, V93, P47, DOI 10.1016/S0092-8674(00)81145-9; Wang YZ, 2008, DEV DYNAM, V237, P3157, DOI 10.1002/dvdy.21712; Wang ZS, 2005, MOL CELL BIOL, V25, P5022, DOI 10.1128/MCB.25.12.5022-5030.2005; Whitman MC, 2007, DEV NEUROBIOL, V67, P1079, DOI 10.1002/dneu.20389; YANAGAWA SI, 1995, GENE DEV, V9, P1087, DOI 10.1101/gad.9.9.1087; Yoshihara Y, 1997, J NEUROSCI, V17, P5830; Zaghetto AA, 2007, J NEUROSCI, V27, P9757, DOI 10.1523/JNEUROSCI.0763-07.2007; Zhang X, 2007, NAT CELL BIOL, V9, P743, DOI 10.1038/ncb1603; Zhang XH, 2009, RESULTS PROBL CELL D, V47, P25, DOI 10.1007/400_2008_28; Zhang XM, 2002, NAT NEUROSCI, V5, P124, DOI 10.1038/nn800; Zou DJ, 2007, J NEUROSCI, V27, P6675, DOI 10.1523/JNEUROSCI.0699-07.2007	70	7	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e56561	10.1371/journal.pone.0056561	http://dx.doi.org/10.1371/journal.pone.0056561			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437169	Green Published, gold, Green Submitted			2022-12-25	WOS:000315184200105
J	Takase, O; Yoshikawa, M; Idei, M; Hirahashi, J; Fujita, T; Takato, T; Isagawa, T; Nagae, G; Suemori, H; Aburatani, H; Hishikawa, K				Takase, Osamu; Yoshikawa, Masahiro; Idei, Mana; Hirahashi, Junichi; Fujita, Toshiro; Takato, Tsuyoshi; Isagawa, Takayuki; Nagae, Genta; Suemori, Hirofumi; Aburatani, Hiroyuki; Hishikawa, Keiichi			The Role of NF-kappa B Signaling in the Maintenance of Pluripotency of Human Induced Pluripotent Stem Cells	PLOS ONE			English	Article							DIFFERENTIATION; INDUCTION; INHIBITION; EXPRESSION; APOPTOSIS; LINES	NF-kappa B signaling plays an essential role in maintaining the undifferentiated state of embryonic stem (ES) cells. However, opposing roles of NF-kappa B have been reported in mouse and human ES cells, and the role of NF-kappa B in human induced pluripotent stem (iPS) cells has not yet been clarified. Here, we report the role of NF-kappa B signaling in maintaining the undifferentiated state of human iPS cells. Compared with differentiated cells, undifferentiated human iPS cells showed an augmentation of NF-kappa B activity. During differentiation induced by the removal of feeder cells and FGF2, we observed a reduction in NF-kappa B activity, the expression of the undifferentiation markers Oct3/4 and Nanog, and the up-regulation of the differentiated markers WT-1 and Pax-2. The specific knockdown of NF-kappa B signaling using p65 siRNA also reduced the expression of Oct3/4 and Nanog and up-regulated WT-1 and Pax-2 but did not change the ES-like colony formation. Our results show that the augmentation of NF-kappa B signaling maintains the undifferentiated state of human iPS and suggest the importance of this signaling pathway in maintenance of human iPS cells.	[Takase, Osamu; Yoshikawa, Masahiro; Idei, Mana; Takato, Tsuyoshi; Hishikawa, Keiichi] Univ Tokyo, Grad Sch Med, Dept Adv Nephrol & Regenerat Med, Tokyo, Japan; [Takase, Osamu; Yoshikawa, Masahiro; Idei, Mana; Hirahashi, Junichi; Fujita, Toshiro; Hishikawa, Keiichi] Univ Tokyo, Grad Sch Med, Dept Nephrol & Endocrinol, Tokyo, Japan; [Takato, Tsuyoshi] Univ Tokyo, Grad Sch Med, Dept Oral & Maxillofacial Surg, Tokyo, Japan; [Isagawa, Takayuki; Nagae, Genta; Aburatani, Hiroyuki] Univ Tokyo, Res Ctr Adv Sci & Technol, Genome Sci Div, Tokyo, Japan; [Suemori, Hirofumi] Kyoto Univ, Inst Frontier Med Sci, Kyoto, Japan	University of Tokyo; University of Tokyo; University of Tokyo; University of Tokyo; Kyoto University	Hishikawa, K (corresponding author), Univ Tokyo, Grad Sch Med, Dept Adv Nephrol & Regenerat Med, Tokyo, Japan.	hishikawa-tky@umin.ac.jp	Nagae, Genta/AAN-1167-2021; Nagae, Genta/H-6579-2019; Hishikawa, Keiichi/A-8661-2011	Nagae, Genta/0000-0002-2929-7990; YOSHIKAWA, Masahiro/0000-0002-3682-9713	Mochida Pharmaceutical Co. Ltd.; Ichiro Kanehara Foundation for Promotion of Medical Sciences and Medical Care; Daiwa Securities Health Foundation; Ministry of Education, Culture, Sports, Science and Technology of Japan; Ministry of Health, Labour and Welfare	Mochida Pharmaceutical Co. Ltd.; Ichiro Kanehara Foundation for Promotion of Medical Sciences and Medical Care; Daiwa Securities Health Foundation; Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labour and Welfare(Ministry of Health, Labour and Welfare, Japan)	This work was supported, in part, by Mochida Pharmaceutical Co. Ltd., the Ichiro Kanehara Foundation for Promotion of Medical Sciences and Medical Care, the Daiwa Securities Health Foundation, a Grant-in-Aid from the Ministry of Education, Culture, Sports, Science and Technology of Japan, and Health Science Research Grants from the Ministry of Health, Labour and Welfare. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong L, 2006, HUM MOL GENET, V15, P1894, DOI 10.1093/hmg/ddl112; Brons IGM, 2007, NATURE, V448, P191, DOI 10.1038/nature05950; Chen YJ, 2000, GENE EXPRESSION, V9, P103; Daheron L, 2004, STEM CELLS, V22, P770, DOI 10.1634/stemcells.22-5-770; Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225; Ginis I, 2004, DEV BIOL, V269, P360, DOI 10.1016/j.ydbio.2003.12.034; Hayashi R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045435; Hong H, 2009, NATURE, V460, P1132, DOI 10.1038/nature08235; Ichikawa H, 2012, CRYOBIOLOGY, V64, P12, DOI 10.1016/j.cryobiol.2011.11.005; Inowa T, 2010, STEM CELLS INT, V2010, DOI 10.4061/2010/782967; Kim YE, 2008, BMB REP, V41, P705, DOI 10.5483/BMBRep.2008.41.10.705; Nakatsuji N, 2005, E SCHERING RES FDN W, V54, P15; Ogawa S, 2011, IN VITRO CELL DEV-AN, V47, P464, DOI 10.1007/s11626-011-9435-2; Okita K, 2011, NAT METHODS, V8, P409, DOI [10.1038/nmeth.1591, 10.1038/NMETH.1591]; Takahashi K, 2007, NAT PROTOC, V2, P3081, DOI 10.1038/nprot.2007.418; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Takase O, 2008, KIDNEY INT, V73, P567, DOI 10.1038/sj.ki.5002563; Takase O, 2011, EUR J PHARMACOL, V669, P128, DOI 10.1016/j.ejphar.2011.07.043; Tesar PJ, 2007, NATURE, V448, P196, DOI 10.1038/nature05972; Torres J, 2008, NAT CELL BIOL, V10, P194, DOI 10.1038/ncb1680; Watabe M, 2004, J BIOL CHEM, V279, P6017, DOI 10.1074/jbc.M306040200; Xu RH, 2002, NAT BIOTECHNOL, V20, P1261, DOI 10.1038/nbt761; Yang CB, 2010, STEM CELLS, V28, P1970, DOI 10.1002/stem.528; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zeng M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047306	26	26	28	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e56399	10.1371/journal.pone.0056399	http://dx.doi.org/10.1371/journal.pone.0056399			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437124	gold, Green Submitted, Green Published			2022-12-25	WOS:000315184200068
J	Zhi, F; Cao, XS; Xie, XB; Wang, B; Dong, WM; Gu, WY; Ling, Y; Wang, R; Yang, YL; Liu, Y				Zhi, Feng; Cao, Xiangshan; Xie, Xiaobao; Wang, Biao; Dong, Weimin; Gu, Weiying; Ling, Yun; Wang, Rong; Yang, Yilin; Liu, Yan			Identification of Circulating MicroRNAs as Potential Biomarkers for Detecting Acute Myeloid Leukemia	PLOS ONE			English	Article							PROGNOSTIC-SIGNIFICANCE; EXPRESSION SIGNATURES; DOWN-REGULATION; CANCER; SERUM; GENE; CELLS; PROLIFERATION; ANGIOGENESIS; MUTATIONS	Acute myeloid leukemia (AML) is the most common acute leukemia in adults. The disease is characterized by various cytogenetic and molecular abnormalities with distinct prognoses and gene expression profiles. Emerging evidence has suggested that circulating microRNAs (miRNAs) could serve as noninvasive biomarkers for cancer detection; however, little is known about circulating miRNA profiles in AML patients. In this study, a genome-wide serum miRNA expression analysis was performed using Solexa sequencing for initial screen, followed by validation with real-time PCR assays. The analysis was conducted on training and verification sets of serum samples from 140 newly diagnosed AML patients and 135 normal adult donors. After a two-phase selection and validation process, 6 miRNAs, miR-10a-5p, miR-93-5p, miR-129-5p, miR-155-5p, miR-181b-5p and miR-320d, were found to have significantly different expression levels in AML compared with control serum samples. Furthermore, unsupervised clustering analysis revealed the remarkable ability of the 6-miRNA profile to differentiate between AML patients and normal controls. The areas under the ROC curve for the selected miRNAs ranged from 0.8129 to 0.9531. More importantly, miR-181b-5p levels in serum were significantly associated with overall survival. These data demonstrated that the expression patterns of circulating miRNAs were systematically altered in AML and miR-181b-5p may serve as a predictor for overall survival in AML patients.	[Zhi, Feng; Wang, Rong; Yang, Yilin] Soochow Univ, Affiliated Hosp 3, Modern Med Res Ctr, Changzhou, Jiangsu, Peoples R China; [Cao, Xiangshan; Xie, Xiaobao; Wang, Biao; Dong, Weimin; Gu, Weiying; Ling, Yun; Liu, Yan] Soochow Univ, Affiliated Hosp 3, Dept Hematol, Changzhou, Jiangsu, Peoples R China; [Yang, Yilin] Soochow Univ, Affiliated Hosp 3, Dept Neurosurg, Changzhou, Jiangsu, Peoples R China	Soochow University - China; Soochow University - China; Soochow University - China	Yang, YL (corresponding author), Soochow Univ, Affiliated Hosp 3, Modern Med Res Ctr, Changzhou, Jiangsu, Peoples R China.	yilinyang.czfph@gmail.com; yanliu.czfph@gmail.com			Changzhou Social Science and Technology Development Project [CS20102004]	Changzhou Social Science and Technology Development Project	This work was supported by a grant from the Changzhou Social Science and Technology Development Project (CS20102004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Blum W, 2010, P NATL ACAD SCI USA, V107, P7473, DOI 10.1073/pnas.1002650107; Bryant A, 2012, MOL CANCER, V11, DOI 10.1186/1476-4598-11-8; Campayo M, 2012, EUR RESP J; Cao P, 2012, HEAD NECK; Chen L, 2012, IUBMB LIFE, V64, P628, DOI 10.1002/iub.1030; Chen X, 2008, CELL RES, V18, P997, DOI 10.1038/cr.2008.282; Chen X, 2012, INT J CANCER, V130, P1620, DOI 10.1002/ijc.26177; Cui Y, 2012, J CELL PHYSIOL, V227, P772, DOI 10.1002/jcp.22789; Dyrskjot L, 2009, CANCER RES, V69, P4851, DOI 10.1158/0008-5472.CAN-08-4043; Eis PS, 2005, P NATL ACAD SCI USA, V102, P3627, DOI 10.1073/pnas.0500613102; Fang L, 2011, ONCOGENE, V30, P806, DOI 10.1038/onc.2010.465; Faraoni I, 2012, J HEMATOL ONCOL, V5, DOI 10.1186/1756-8722-5-26; Fu X, 2012, FEBS LETT, V586, P1279, DOI 10.1016/j.febslet.2012.03.006; Garzon R, 2008, BLOOD, V111, P3183, DOI 10.1182/blood-2007-07-098749; Garzon R, 2008, P NATL ACAD SCI USA, V105, P3945, DOI 10.1073/pnas.0800135105; Gregory TK, 2009, J HEMATOL ONCOL, V2, DOI 10.1186/1756-8722-2-23; Griffiths-Jones S, 2004, NUCLEIC ACIDS RES, V32, pD109, DOI 10.1093/nar/gkh023; Hafner M, 2008, METHODS, V44, P3, DOI 10.1016/j.ymeth.2007.09.009; Hu ZB, 2010, J CLIN ONCOL, V28, P1721, DOI 10.1200/JCO.2009.24.9342; Jongen-Lavrencic M, 2008, BLOOD, V111, P5078, DOI 10.1182/blood-2008-01-133355; Kohavi R., 1995, IJCAI-95. Proceedings of the Fourteenth International Joint Conference on Artificial Intelligence, P1137; Li ZJ, 2012, BLOOD, V119, P2314, DOI 10.1182/blood-2011-10-386235; Liao RX, 2008, J CELL BIOCHEM, V104, P805, DOI 10.1002/jcb.21668; Liu R, 2011, EUR J CANCER, V47, P784, DOI 10.1016/j.ejca.2010.10.025; Liu Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035800; Lowery AJ, 2008, CLIN CANCER RES, V14, P360, DOI 10.1158/1078-0432.CCR-07-0992; Lu YZ, 2011, J BIOL CHEM, V286, P42292, DOI 10.1074/jbc.M111.270926; Marcucci G, 2008, J CLIN ONCOL, V26, P5078, DOI 10.1200/JCO.2008.17.5554; Marcucci G, 2008, NEW ENGL J MED, V358, P1919, DOI 10.1056/NEJMoa074256; Marcucci G, 2011, BLOOD, V117, P1121, DOI 10.1182/blood-2010-09-191312; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; O'Connell RM, 2008, J EXP MED, V205, P585, DOI 10.1084/jem.20072108; Ohshima K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013247; Ovcharenko D, 2011, EXP HEMATOL, V39, P1030, DOI 10.1016/j.exphem.2011.07.008; Schwind S, 2010, J CLIN ONCOL, V28, P5257, DOI 10.1200/JCO.2010.29.2953; Smith ML, 2011, BLOOD REV, V25, P39, DOI 10.1016/j.blre.2010.10.002; Sun SM, 2012, LEUKEMIA; Sun XH, 2012, J CLIN INVEST, V122, P1973, DOI 10.1172/JCI61495; Tefferi A, 2009, CANCER-AM CANCER SOC, V115, P3842, DOI 10.1002/cncr.24440; Visone R, 2011, BLOOD, V118, P3072, DOI 10.1182/blood-2011-01-333484; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Wang B, 2010, ONCOGENE, V29, P1787, DOI 10.1038/onc.2009.468; Wang BC, 2012, BIOCHEM BIOPH RES CO, V421, P4, DOI 10.1016/j.bbrc.2012.03.025; Wang F, 2012, MOL BIOL REP, V39, P2713, DOI 10.1007/s11033-011-1026-5; Whitman SP, 2010, BLOOD, V116, P3622, DOI 10.1182/blood-2010-05-283648; Wu JJ, 2010, CELL CYCLE, V9, P1809, DOI 10.4161/cc.9.9.11535; Xiong Y, 2011, BRIT J HAEMATOL, V153, P753, DOI 10.1111/j.1365-2141.2011.08662.x; Zen K, 2012, MED RES REV, V32, P326, DOI 10.1002/med.20215; Zhang CN, 2010, CLIN CHEM, V56, P1871, DOI 10.1373/clinchem.2010.147553; Zhang HL, 2011, BIOCHEM BIOPH RES CO, V404, P273, DOI 10.1016/j.bbrc.2010.11.106; Zhu DX, 2012, CARCINOGENESIS, V33, P1294, DOI 10.1093/carcin/bgs179; Zhu YD, 2012, MED ONCOL, V29, P2323, DOI 10.1007/s12032-011-0140-5	53	93	101	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e56718	10.1371/journal.pone.0056718	http://dx.doi.org/10.1371/journal.pone.0056718			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437222	gold, Green Published, Green Submitted			2022-12-25	WOS:000315184200152
J	Bourquin, Y; Cooper, JM				Bourquin, Yannyk; Cooper, Jonathan M.			Swimming Using Surface Acoustic Waves	PLOS ONE			English	Article							MOTOR	Microactuation of free standing objects in fluids is currently dominated by the rotary propeller, giving rise to a range of potential applications in the military, aeronautic and biomedical fields. Previously, surface acoustic waves (SAWs) have been shown to be of increasing interest in the field of microfluidics, where the refraction of a SAW into a drop of fluid creates a convective flow, a phenomenon generally known as SAW streaming. We now show how SAWs, generated at microelectronic devices, can be used as an efficient method of propulsion actuated by localised fluid streaming. The direction of the force arising from such streaming is optimal when the devices are maintained at the Rayleigh angle. The technique provides propulsion without any moving parts, and, due to the inherent design of the SAW transducer, enables simple control of the direction of travel.	[Bourquin, Yannyk; Cooper, Jonathan M.] Univ Glasgow, Div Biomed Engn, Glasgow, Lanark, Scotland	University of Glasgow	Cooper, JM (corresponding author), Univ Glasgow, Div Biomed Engn, Glasgow, Lanark, Scotland.	Jon.Cooper@glasgow.ac.uk	Cooper, Jonathan/GLS-9195-2022; Cooper, Jonathan/E-9000-2010; Bourquin, Yannyk/E-5213-2010	Cooper, Jonathan/0000-0002-2358-1050; Cooper, Jonathan/0000-0002-2358-1050; Bourquin, Yannyk/0000-0003-0278-1640	RCUK "Listening to the Microworld" Basic Technology Grant; RCUK School of Engineering Scholarship; Engineering and Physical Sciences Research Council [EP/F040857/1] Funding Source: researchfish; EPSRC [EP/F040857/1] Funding Source: UKRI	RCUK "Listening to the Microworld" Basic Technology Grant; RCUK School of Engineering Scholarship; Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	The authors thank RCUK "Listening to the Microworld" Basic Technology Grant and School of Engineering Scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison EM, 2008, J PROPUL POWER, V24, P547, DOI 10.2514/1.30044; Bourquin Y, 2011, LAB CHIP, V11, P2725, DOI 10.1039/c1lc20320g; Bourquin Y, 2011, ADV MATER, V23, P1458, DOI 10.1002/adma.201004455; Bourquin Y, 2010, LAB CHIP, V10, P1898, DOI 10.1039/c004506c; ECKART C, 1948, PHYS REV, V73, P68, DOI 10.1103/PhysRev.73.68; Ehlers KM, 1996, P NATL ACAD SCI USA, V93, P8340, DOI 10.1073/pnas.93.16.8340; Ehlers KM, 2011, MATH COMPUT MODEL, V53, P1489, DOI 10.1016/j.mcm.2010.03.054; Friend J, 2011, REV MOD PHYS, V83, P647, DOI 10.1103/RevModPhys.83.647; Hori K, 1997, INT J JPN S PREC ENG, V31, P1; Kurosawa M, 1996, IEEE T ULTRASON FERR, V43, P901, DOI 10.1109/58.535493; LIGHTHILL J, 1978, J SOUND VIB, V61, P391, DOI 10.1016/0022-460X(78)90388-7; Nyborg, 1965, PHYS ACOUSTICS, V2; Sankaranarayanan SKRS, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.066308; SHIOKAWA S, 1989, IEEE 1989 ULTRASONICS SYMPOSIUM : PROCEEDINGS, VOLS 1 AND 2, P643, DOI 10.1109/ULTSYM.1989.67063; Sinclair MJ, 2000, ITHERM 2000: SEVENTH INTERSOCIETY CONFERENCE ON THERMAL AND THERMOMECHANICAL PHENOMENA IN ELECTRONIC SYSTEMS, VOL I, PROCEEDINGS, P127, DOI 10.1109/ITHERM.2000.866818; Su YC, 2002, J MICROELECTROMECH S, V11, P736, DOI 10.1109/JMEMS.2002.805045; TAI YC, 1989, SENSOR ACTUATOR, V20, P49, DOI 10.1016/0250-6874(89)87101-X; Tan ACH, 2010, OCEANS 2010, P1; Tan MK, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.024501; Watson B, 2009, J MICROMECH MICROENG, V19, DOI 10.1088/0960-1317/19/2/022001; Wixforth A., 2006, J ASS LAB AUTOM, V11, P399, DOI DOI 10.1016/J.JALA.2006.08.001; Yu HY, 2004, PROC IEEE MICR ELECT, P486, DOI 10.1109/MEMS.2004.1290628	22	14	14	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2013	8	2							e42686	10.1371/journal.pone.0042686	http://dx.doi.org/10.1371/journal.pone.0042686			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093HR	23431358	Green Submitted, Green Published, Green Accepted, gold			2022-12-25	WOS:000315182800001
J	Kitagawa, M; Sugiyama, H; Morinaga, H; Inoue, T; Takiue, K; Ogawa, A; Yamanari, T; Kikumoto, Y; Uchida, HA; Kitamura, S; Maeshima, Y; Nakamura, K; Ito, H; Makino, H				Kitagawa, Masashi; Sugiyama, Hitoshi; Morinaga, Hiroshi; Inoue, Tatsuyuki; Takiue, Keiichi; Ogawa, Ayu; Yamanari, Toshio; Kikumoto, Yoko; Uchida, Haruhito Adam; Kitamura, Shinji; Maeshima, Yohei; Nakamura, Kazufumi; Ito, Hiroshi; Makino, Hirofumi			A Decreased Level of Serum Soluble Klotho Is an Independent Biomarker Associated with Arterial Stiffness in Patients with Chronic Kidney Disease	PLOS ONE			English	Article							IMPROVING GLOBAL OUTCOMES; COMMUNITY-DWELLING ADULTS; FLOW-MEDIATED DILATION; PULSE-WAVE VELOCITY; STAGE RENAL-DISEASE; GROWTH-FACTOR 23; ENDOTHELIAL DYSFUNCTION; AORTIC CALCIFICATION; PLASMA KLOTHO; ALPHA-KLOTHO	Background: Klotho was originally identified in a mutant mouse strain unable to express the gene that consequently showed shortened life spans. In humans, low serum Klotho levels are related to the prevalence of cardiovascular diseases in community-dwelling adults. However, it is unclear whether the serum Klotho levels are associated with signs of vascular dysfunction such as arterial stiffness, a major determinant of prognosis, in human subjects with chronic kidney disease (CKD). Methods: We determined the levels of serum soluble Klotho in 114 patients with CKD using ELISA and investigated the relationship between the level of Klotho and markers of CKD-mineral and bone disorder (CKD-MBD) and various types of vascular dysfunction, including flow-mediated dilatation, a marker of endothelial dysfunction, ankle-brachial pulse wave velocity (baPWV), a marker of arterial stiffness, intima-media thickness (IMT), a marker of atherosclerosis, and the aortic calcification index (ACI), a marker of vascular calcification. Results: The serum Klotho level significantly correlated with the 1,25-dihydroxyvitamin D level and inversely correlated with the parathyroid hormone level and the fractional excretion of phosphate. There were significant decreases in serum Klotho in patients with arterial stiffness defined as baPWV >= 1400 cm/sec, atherosclerosis defined as maximum IMT >= 1.1 mm and vascular calcification scores of ACI>0%. The serum Klotho level was a significant determinant of arterial stiffness, but not endothelial dysfunction, atherosclerosis or vascular calcification, in the multivariate analysis in either metabolic model, the CKD model or the CKD-MBD model. The adjusted odds ratio of serum Klotho for the baPWV was 0.60 (p = 0.0075). Conclusions: Decreases in the serum soluble Klotho levels are independently associated with signs of vascular dysfunction such as arterial stiffness in patients with CKD. Further research exploring whether therapeutic approaches to maintain or elevate the Klotho level could improve arterial stiffness in CKD patients is warranted.	[Kitagawa, Masashi; Sugiyama, Hitoshi; Morinaga, Hiroshi; Inoue, Tatsuyuki; Takiue, Keiichi; Ogawa, Ayu; Yamanari, Toshio; Kikumoto, Yoko; Uchida, Haruhito Adam; Kitamura, Shinji; Maeshima, Yohei; Makino, Hirofumi] Okayama Univ, Dept Med & Clin Sci, Grad Sch Med Dent & Pharmaceut Sci, Okayama 7008530, Japan; [Sugiyama, Hitoshi; Morinaga, Hiroshi] Okayama Univ, Dept Chron Kidney Dis & Peritoneal Dialysis, Grad Sch Med Dent & Pharmaceut Sci, Okayama 7008530, Japan; [Nakamura, Kazufumi; Ito, Hiroshi] Okayama Univ, Dept Cardiovasc Med, Grad Sch Med Dent & Pharmaceut Sci, Okayama 7008530, Japan	Okayama University; Okayama University; Okayama University	Sugiyama, H (corresponding author), Okayama Univ, Dept Med & Clin Sci, Grad Sch Med Dent & Pharmaceut Sci, Okayama 7008530, Japan.	hitoshis@md.okayama-u.ac.jp	Sugiyama, Hitoshi/B-2252-2011	Sugiyama, Hitoshi/0000-0002-4127-6471	Kidney Foundation Japan [JKFB10-20, JKFB12-44]; Chronic Kidney Disease Award; Japan Vascular Disease Research Foundation; Ministry of Health, Labor and Welfare of Japan; Grants-in-Aid for Scientific Research [23591193] Funding Source: KAKEN	Kidney Foundation Japan(Kidney Foundation, Japan); Chronic Kidney Disease Award; Japan Vascular Disease Research Foundation(Japan Vascular Disease Research Foundation); Ministry of Health, Labor and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	A portion of this study was supported by a Research Grant from the Kidney Foundation Japan (JKFB10-20 and JKFB12-44) and a 2011 Chronic Kidney Disease Award to M. K., a Research Grant from the Japan Vascular Disease Research Foundation to H. S. and a Grant-in-Aid for Progressive Renal Diseases Research, Research on Intractable Disease, from the Ministry of Health, Labor and Welfare of Japan. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Akimoto T, 2012, CLIN EXP NEPHROL, V16, P442, DOI 10.1007/s10157-011-0582-2; Asai O, 2012, KIDNEY INT, V81, P539, DOI 10.1038/ki.2011.423; Barreto FC, 2009, CLIN J AM SOC NEPHRO, V4, P1551, DOI 10.2215/CJN.03980609; Briet M, 2006, KIDNEY INT, V69, P350, DOI 10.1038/sj.ki.5000047; Chen CD, 2007, P NATL ACAD SCI USA, V104, P19796, DOI 10.1073/pnas.0709805104; Chue CD, 2012, HEART, V98, P219, DOI 10.1136/heartjnl-2011-300570; Desjardins L, 2012, OSTEOPOROSIS INT, V23, P2017, DOI 10.1007/s00198-011-1838-0; Devaraj S, 2012, AM J CLIN PATHOL, V137, P479, DOI 10.1309/AJCPGPMAF7SFRBO4; Di Marco GS, 2012, KIDNEY INT; Ford ML, 2012, NEPHROL DIAL TRANSPL, V27, P727, DOI 10.1093/ndt/gfr316; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; Guerin AP, 2001, CIRCULATION, V103, P987; Hanada S, 2010, NEPHROL DIAL TRANSPL, V25, P1888, DOI 10.1093/ndt/gfp728; HANDA N, 1990, STROKE, V21, P1567, DOI 10.1161/01.STR.21.11.1567; Hu MC, 2011, J AM SOC NEPHROL, V22, P124, DOI 10.1681/ASN.2009121311; Hu MC, 2010, FASEB J, V24, P3438, DOI 10.1096/fj.10-154765; Hu MC, 2010, KIDNEY INT, V78, P1240, DOI 10.1038/ki.2010.328; Imai Enyu, 2007, Clin Exp Nephrol, V11, P41, DOI 10.1007/s10157-006-0453-4; Imura A, 2004, FEBS LETT, V565, P143, DOI 10.1016/j.febslet.2004.03.090; Imura A, 2007, SCIENCE, V316, P1615, DOI 10.1126/science.1135901; Isakova T, 2011, KIDNEY INT, V79, P1370, DOI 10.1038/ki.2011.47; John GB, 2011, AM J KIDNEY DIS, V58, P127, DOI 10.1053/j.ajkd.2010.12.027; Kestenbaum B, 2005, J AM SOC NEPHROL, V16, P520, DOI 10.1681/ASN.2004070602; Kidney Disease: Improving Global Outcomes, 2009, KIDNEY INT S, pS1, DOI DOI 10.1038/KI.2009.188; Kidney Disease Outcomes Quality Initiative (K/DOQI), 2004, Am J Kidney Dis, V43, pS1; Kitagawa M, 2011, NEPHRON EXTRA, V1, P166, DOI 10.1159/000333801; Koh N, 2001, BIOCHEM BIOPH RES CO, V280, P1015, DOI 10.1006/bbrc.2000.4226; Komaba H, 2012, NEPHROL DIAL TRANSPL, V27, P1967, DOI 10.1093/ndt/gfr645; Kramann R, 2011, ARTERIOSCL THROM VAS, V31, pE45, DOI 10.1161/ATVBAHA.111.228601; Kuro-O M, 2011, KIDNEY INT, V79, pS20, DOI 10.1038/ki.2011.26; Kuro-o M, 2009, BBA-GEN SUBJECTS, V1790, P1049, DOI 10.1016/j.bbagen.2009.02.005; Kuroo M, 1997, NATURE, V390, P45, DOI 10.1038/36285; Kurosu H, 2006, J BIOL CHEM, V281, P6120, DOI 10.1074/jbc.C500457200; Kurosu H, 2005, SCIENCE, V309, P1829, DOI 10.1126/science.1112766; Kusaba T, 2010, P NATL ACAD SCI USA, V107, P19308, DOI 10.1073/pnas.1008544107; Kuwahara N, 2008, INT J CARDIOL, V123, P84, DOI 10.1016/j.ijcard.2007.02.029; Lau WL, 2012, KIDNEY INT, V82, P1261, DOI 10.1038/ki.2012.322; Lim K, 2012, CIRCULATION, V125, P2243, DOI 10.1161/CIRCULATIONAHA.111.053405; London GM, 2007, J AM SOC NEPHROL, V18, P613, DOI 10.1681/ASN.2006060573; Martin A, 2012, PHYSIOL REV, V92, P131, DOI 10.1152/physrev.00002.2011; Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; Moe S, 2006, KIDNEY INT, V69, P1945, DOI 10.1038/sj.ki.5000414; Moe SM, 2008, CLIN J AM SOC NEPHRO, V3, pS127, DOI 10.2215/CJN.04331206; Morimoto S, 2009, AM J NEPHROL, V30, P55, DOI 10.1159/000201416; Morinaga H, 2012, PERITON DIALYSIS INT, V32, P453, DOI 10.3747/pdi.2011.00032; Nagai R, 2000, CELL MOL LIFE SCI, V57, P738, DOI 10.1007/s000180050038; Nakamura A, 2005, DIABETES CARE, V28, P2890, DOI 10.2337/diacare.28.12.2890; Nakano C, 2012, CLIN J AM SOC NEPHRO, V7, P810, DOI 10.2215/CJN.08680811; Ohya M, 2010, INTERNAL MED, V49, P2071, DOI 10.2169/internalmedicine.49.3752; Rosa J, 2011, HYPERTENS RES, V34, P296, DOI 10.1038/hr.2010.232; Saito Y, 2000, BIOCHEM BIOPH RES CO, V276, P767, DOI 10.1006/bbrc.2000.3470; Saito Y, 1998, BIOCHEM BIOPH RES CO, V248, P324, DOI 10.1006/bbrc.1998.8943; Sarnak MJ, 2003, CIRCULATION, V108, P2154, DOI 10.1161/01.CIR.0000095676.90936.80; Schillaci G, 2011, ATHEROSCLEROSIS, V218, P96, DOI 10.1016/j.atherosclerosis.2011.05.010; Seiler S, 2012, KIDNEY INT; Semba RD, 2012, EUR J APPL PHYSIOL, V112, P1215, DOI 10.1007/s00421-011-2072-3; Semba RD, 2011, J AM GERIATR SOC, V59, P1596, DOI 10.1111/j.1532-5415.2011.03558.x; Semba RD, 2011, J GERONTOL A-BIOL, V66, P794, DOI 10.1093/gerona/glr058; Shimamura Y, 2012, CLIN EXP NEPHROL, V16, P722, DOI 10.1007/s10157-012-0621-7; Six I, 2012, CARDIOVASC RES, V96, P130, DOI 10.1093/cvr/cvs240; Sun CY, 2012, KIDNEY INT, V81, P640, DOI 10.1038/ki.2011.445; Teragawa H, 2001, AM J CARDIOL, V88, P1147, DOI 10.1016/S0002-9149(01)02051-3; Townsend RR, 2010, AM J HYPERTENS, V23, P282, DOI 10.1038/ajh.2009.240; Uchida HA, 2006, NEPHROL DIAL TRANSPL, V21, P3475, DOI 10.1093/ndt/gfl423; Urakawa I, 2006, NATURE, V444, P770, DOI 10.1038/nature05315; Wolf M, 2010, J AM SOC NEPHROL, V21, P1427, DOI 10.1681/ASN.2009121293; Yamashina A, 2003, HYPERTENS RES, V26, P615, DOI 10.1291/hypres.26.615; Yamazaki Y, 2010, BIOCHEM BIOPH RES CO, V398, P513, DOI 10.1016/j.bbrc.2010.06.110; Yilmaz MI, 2010, KIDNEY INT, V78, P679, DOI 10.1038/ki.2010.194; Yokoyama K, 2012, CLIN NEPHROL, V77, P347, DOI 10.5414/CN107204; Yoon HE, 2011, NEPHROL DIAL TRANSPL, V26, P800, DOI 10.1093/ndt/gfq537; Yunoki K, 2011, ATHEROSCLEROSIS, V217, P486, DOI 10.1016/j.atherosclerosis.2011.04.019	72	138	144	0	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2013	8	2							e56695	10.1371/journal.pone.0056695	http://dx.doi.org/10.1371/journal.pone.0056695			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093HR	23431388	Green Published, Green Submitted, gold			2022-12-25	WOS:000315182800031
J	Sarnacki, SH; Castaneda, MDA; Llana, MN; Giacomodonato, MN; Valvano, MA; Cerquetti, MC				Hernan Sarnacki, Sebastian; Aya Castaneda, Maria del Rosario; Noto Llana, Mariangeles; Nancy Giacomodonato, Monica; Valvano, Miguel Angel; Cristina Cerquetti, Maria			Dam Methylation Participates in the Regulation of PmrA/PmrB and RcsC/RcsD/RcsB Two Component Regulatory Systems in Salmonella enterica Serovar Enteritidis	PLOS ONE			English	Article							DNA ADENINE METHYLATION; LIPOPOLYSACCHARIDE O-ANTIGEN; POLYACRYLAMIDE-GEL-ELECTROPHORESIS; POLYMYXIN-RESISTANT MUTANTS; ESCHERICHIA-COLI; LIPID-A; GENE-EXPRESSION; OUTER-MEMBRANE; ENVIRONMENTAL STIMULI; SIGNAL-TRANSDUCTION	The absence of Dam in Salmonella enterica serovar Enteritidis causes a defect in lipopolysaccharide (LPS) pattern associated to a reduced expression of wzz gene. Wzz is the chain length regulator of the LPS O-antigen. Here we investigated whether Dam regulates wzz gene expression through its two known regulators, PmrA and RcsB. Thus, the expression of rcsB and pmrA was monitored by quantitative real-time RT-PCR and Western blotting using fusions with 3xFLAG tag in wild type (wt) and dam strains of S. Enteritidis. Dam regulated the expression of both rcsB and pmrA genes; nevertheless, the defect in LPS pattern was only related to a diminished expression of RcsB. Interestingly, regulation of wzz in serovar Enteritidis differed from that reported earlier for serovar Typhimurium; RcsB induces wzz expression in both serovars, whereas PmrA induces wzz in S. Typhimurium but represses it in serovar Enteritidis. Moreover, we found that in S. Enteritidis there is an interaction between both wzz regulators: RcsB stimulates the expression of pmrA and PmrA represses the expression of rcsB. Our results would be an example of differential regulation of orthologous genes expression, providing differences in phenotypic traits between closely related bacterial serovars.	[Hernan Sarnacki, Sebastian; Aya Castaneda, Maria del Rosario; Noto Llana, Mariangeles; Nancy Giacomodonato, Monica; Cristina Cerquetti, Maria] Univ Buenos Aires, CONICET, Inst Invest Microbiol & Parasitol Med, IMPaM, Buenos Aires, DF, Argentina; [Valvano, Miguel Angel] Univ Western Ontario, Dept Microbiol & Immunol, Ctr Human Immunol, London, ON, Canada	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; Western University (University of Western Ontario)	Sarnacki, SH (corresponding author), Univ Buenos Aires, CONICET, Inst Invest Microbiol & Parasitol Med, IMPaM, Buenos Aires, DF, Argentina.	sebasarnacki@yahoo.com.ar; ccerquetti@fmed.uba.ar	Valvano, Miguel A/G-8759-2012	Valvano, Miguel A/0000-0001-8229-3641	Universidad de Buenos Aires, Buenos Aires, Argentina [UBACyT 20020100100541, UBACyT 20020100300040]; Consejo Nacional de Investigaciones Cientificas y Tecnicas, Argentina [PIP 0992]	Universidad de Buenos Aires, Buenos Aires, Argentina(University of Buenos Aires); Consejo Nacional de Investigaciones Cientificas y Tecnicas, Argentina(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET))	This work was supported in part from grants from Universidad de Buenos Aires, Buenos Aires, Argentina (UBACyT 20020100100541) (http://www.uba.ar/secyt/index.php) and Consejo Nacional de Investigaciones Cientificas y Tecnicas, Argentina (PIP 0992) (http://www.conicet.gov.ar) (to M.C.C.) and Universidad de Buenos Aires, Buenos Aires, Argentina (UBACyT 20020100300040) (http://www.uba.ar/secyt/index.php) (to S.H.S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEX LA, 1994, TRENDS GENET, V10, P133, DOI 10.1016/0168-9525(94)90215-1; Balbontin R, 2006, J BACTERIOL, V188, P8160, DOI 10.1128/JB.00847-06; BATCHELOR RA, 1991, J BACTERIOL, V173, P5699, DOI 10.1128/jb.173.18.5699-5704.1991; Bijisma JJE, 2003, TRENDS MICROBIOL, V11, P359, DOI 10.1016/S0966-842X(03)00176-8; Breazeale SD, 2003, J BIOL CHEM, V278, P24731, DOI 10.1074/jbc.M304043200; Brockmann R, 2007, PLOS COMPUT BIOL, V3, P531, DOI 10.1371/journal.pcbi.0030057; Campellone KG, 2007, MOL MICROBIOL, V63, P1468, DOI 10.1111/j.1365-2958.2007.05602.x; Chessa D, 2008, MOL MICROBIOL, V68, P573, DOI 10.1111/j.1365-2958.2008.06185.x; COHEN SN, 1972, P NATL ACAD SCI USA, V69, P2110, DOI 10.1073/pnas.69.8.2110; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Delgado MA, 2006, MOL MICROBIOL, V60, P39, DOI 10.1111/j.1365-2958.2006.05069.x; DOWER WJ, 1988, NUCLEIC ACIDS RES, V16, P6127, DOI 10.1093/nar/16.13.6127; Dueger EL, 2003, VACCINE, V21, P3249, DOI 10.1016/S0264-410X(03)00252-4; Dueger EL, 2003, INT J FOOD MICROBIOL, V80, P153, DOI 10.1016/S0168-1605(02)00152-6; Eguchi Y, 2005, TRENDS BIOCHEM SCI, V30, P70, DOI 10.1016/j.tibs.2004.12.003; Falker S, 2007, INFECT IMMUN, V75, P4990, DOI 10.1128/IAI.00457-07; Goulian M, 2010, CURR OPIN MICROBIOL, V13, P184, DOI 10.1016/j.mib.2010.01.009; GROSSMAN N, 1987, J BACTERIOL, V169, P856, DOI 10.1128/jb.169.2.856-863.1987; Gunn JS, 2008, TRENDS MICROBIOL, V16, P284, DOI 10.1016/j.tim.2008.03.007; Gunn JS, 1998, MOL MICROBIOL, V27, P1171, DOI 10.1046/j.1365-2958.1998.00757.x; Heithoff DM, 1999, SCIENCE, V284, P967, DOI 10.1126/science.284.5416.967; HITCHCOCK PJ, 1983, J BACTERIOL, V154, P269, DOI 10.1128/JB.154.1.269-277.1983; Hoare A, 2006, INFECT IMMUN, V74, P1555, DOI 10.1128/IAI.74.3.1555-1564.2006; Jakomin M, 2008, J BACTERIOL, V190, P7406, DOI 10.1128/JB.01136-08; Kato A, 2004, GENE DEV, V18, P2302, DOI 10.1101/gad.1230804; Kato A, 2008, ADV EXP MED BIOL, V631, P7; Kawasaki K, 2007, J BACTERIOL, V189, P4911, DOI 10.1128/JB.00451-07; KOFOID EC, 1988, P NATL ACAD SCI USA, V85, P4981, DOI 10.1073/pnas.85.14.4981; Kox LFF, 2000, EMBO J, V19, P1861, DOI 10.1093/emboj/19.8.1861; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lee H, 2004, J BACTERIOL, V186, P4124, DOI 10.1128/JB.186.13.4124-4133.2004; LESSE AJ, 1990, J IMMUNOL METHODS, V126, P109, DOI 10.1016/0022-1759(90)90018-Q; Lin HH, 2012, CURR MICROBIOL, V64, P412, DOI 10.1007/s00284-012-0087-6; Liu D, 1996, J BACTERIOL, V178, P2102, DOI 10.1128/jb.178.7.2102-2107.1996; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lobner-Olesen A, 2005, CURR OPIN MICROBIOL, V8, P154, DOI 10.1016/j.mib.2005.02.009; Low DA, 2001, INFECT IMMUN, V69, P7197, DOI 10.1128/IAI.69.12.7197-7204.2001; MARINO PA, 1991, J BACTERIOL, V173, P3128, DOI 10.1128/JB.173.10.3128-3133.1991; Marinus M.G., 1996, E COLI SALMONELLA CE, P782; MAROLDA CL, 1990, J BACTERIOL, V172, P3590, DOI 10.1128/jb.172.7.3590-3599.1990; McGowan CC, 1998, MOL MICROBIOL, V30, P19, DOI 10.1046/j.1365-2958.1998.t01-1-01079.x; MCGRATH BC, 1991, J BACTERIOL, V173, P649, DOI 10.1128/jb.173.2.649-654.1991; Mittal N, 2009, P NATL ACAD SCI USA, V106, P20300, DOI 10.1073/pnas.0906940106; Msadek Tarek, 1993, P729; MULFORD CA, 1983, P NATL ACAD SCI-BIOL, V80, P1159, DOI 10.1073/pnas.80.5.1159; Murata T, 2007, J BACTERIOL, V189, P7213, DOI 10.1128/JB.00973-07; Murray GL, 2006, J BACTERIOL, V188, P2735, DOI 10.1128/JB.188.7.2735-2739.2006; Murray GL, 2005, MICROBES INFECT, V7, P1296, DOI 10.1016/j.micinf.2005.04.015; Murray GL, 2003, MOL MICROBIOL, V47, P1395, DOI 10.1046/j.1365-2958.2003.03383.x; Nishino K, 2006, MOL MICROBIOL, V61, P645, DOI 10.1111/j.1365-2958.2006.05273.x; NIXON BT, 1986, P NATL ACAD SCI USA, V83, P7850, DOI 10.1073/pnas.83.20.7850; OSBORN MJ, 1963, P NATL ACAD SCI USA, V50, P499, DOI 10.1073/pnas.50.3.499; Parkinson J.S., 1995, 2 COMPONENT SIGNAL T, P9; Phalipon A, 2006, J IMMUNOL, V176, P1686, DOI 10.4049/jimmunol.176.3.1686; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; Rick PD, 2003, J BIOL CHEM, V278, P16534, DOI 10.1074/jbc.M301750200; RONSON CW, 1987, CELL, V49, P579, DOI 10.1016/0092-8674(87)90530-7; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Sarnacki SH, 2009, J BACTERIOL, V191, P6694, DOI 10.1128/JB.00839-09; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; SNAVELY MD, 1991, J BIOL CHEM, V266, P824; SWANSON RV, 1994, TRENDS BIOCHEM SCI, V19, P485, DOI 10.1016/0968-0004(94)90135-X; Torreblanca J, 1999, GENETICS, V152, P31; Trent MS, 2001, J BIOL CHEM, V276, P43122, DOI 10.1074/jbc.M106961200; Uzzau S, 2001, P NATL ACAD SCI USA, V98, P15264, DOI 10.1073/pnas.261348198; Valvano MA, 2003, FRONT BIOSCI-LANDMRK, V8, pS452, DOI 10.2741/1079; Wales AD, 2011, AVIAN PATHOL, V40, P429, DOI 10.1080/03079457.2011.606799; Wion D, 2006, NAT REV MICROBIOL, V4, P183, DOI 10.1038/nrmicro1350; Zhou ZM, 2001, J BIOL CHEM, V276, P43111, DOI 10.1074/jbc.M106960200	69	7	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e56474	10.1371/journal.pone.0056474	http://dx.doi.org/10.1371/journal.pone.0056474			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418573	Green Published, Green Submitted, gold			2022-12-25	WOS:000315970300166
J	Jain, D; Chattopadhyay, D				Jain, Deepti; Chattopadhyay, Debasis			Promoter of CaZF, a Chickpea Gene That Positively Regulates Growth and Stress Tolerance, Is Activated by an AP2-Family Transcription Factor CAP2	PLOS ONE			English	Article							ZINC-FINGER PROTEIN; SALT TOLERANCE; DROUGHT TOLERANCE; DEHYDRATION; COLD; DNA; OVEREXPRESSION; TEMPERATURE; EXPRESSION; REPRESSORS	Plants respond to different forms of stresses by inducing transcription of a common and distinct set of genes by concerted actions of a cascade of transcription regulators. We previously reported that a gene, CaZF encoding a C2H2-zinc finger family protein from chickpea (Cicer arietinum) imparted high salinity tolerance when expressed in tobacco plants. We report here that in addition to promoting tolerance against dehydration, salinity and high temperature, the CaZF overexpressing plants exhibited similar phenotype of growth and development like the plants overexpressing CAP2, encoding an AP2-family transcription factor from chickpea. To investigate any relationship between these two genes, we performed gene expression analysis in the overexpressing plants, promoter-reporter analysis and chromatin immunoprecipitation. A number of transcripts that exhibited enhanced accumulation upon expression of CAP2 or CaZF in tobacco plants were found common. Transient expression of CAP2 in chickpea leaves resulted in increased accumulation of CaZF transcript. Gel mobility shift and transient promoter-reporter assays suggested that CAP2 activates CaZF promoter by interacting with Crepeat elements (CRTs) in CaZF promoter. Chromatin immunoprecipitation (ChIP) assay demonstrated an in vivo interaction of CAP2 protein with CaZF promoter.	[Jain, Deepti; Chattopadhyay, Debasis] Natl Inst Plant Genome Res, New Delhi, India	Department of Biotechnology (DBT) India; National Institute of Plant Genome Research (NIPGR)	Chattopadhyay, D (corresponding author), Natl Inst Plant Genome Res, Aruna Asaf Ali Marg, New Delhi, India.	debasis@nipgr.ac.in		Chattopadhyay, Debasis/0000-0002-5754-4987	National Institute of Plant Genome Research, New Delhi, India; Council for Scientific and Industrial Research, India	National Institute of Plant Genome Research, New Delhi, India; Council for Scientific and Industrial Research, India(Council of Scientific & Industrial Research (CSIR) - India)	The project has been funded by National Institute of Plant Genome Research, New Delhi, India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors acknowledge Dr. S. Chakraborty and V. Sharma, School of Life Sciences, Jawaharlal Nehru University, New Delhi, India for experimental help. DJ acknowledges Council for Scientific and Industrial Research, India for fellowship.	Agarwal PK, 2006, PLANT CELL REP, V25, P1263, DOI 10.1007/s00299-006-0204-8; Armengaud P, 2004, PHYSIOL PLANTARUM, V120, P442, DOI 10.1111/j.0031-9317.2004.00251.x; Boominathan P, 2004, PLANT PHYSIOL, V135, P1608, DOI 10.1104/pp.104.043141; Dathan N, 2002, NUCLEIC ACIDS RES, V30, P4945, DOI 10.1093/nar/gkf613; Frugier F, 2000, GENE DEV, V14, P475; Higo K, 1999, NUCLEIC ACIDS RES, V27, P297, DOI 10.1093/nar/27.1.297; Huai JL, 2009, PLANT CELL TISS ORG, V99, P117, DOI 10.1007/s11240-009-9582-2; Huang J, 2005, MOL BIOL REP, V32, P177, DOI 10.1007/s11033-005-2338-0; Huang J, 2007, BBA-GENE STRUCT EXPR, V1769, P220, DOI 10.1016/j.bbaexp.2007.02.006; Jain D, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-24; Jain D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005154; JEFFERSON RA, 1987, EMBO J, V6, P3901; Johnson TA, 2001, BIOTECHNIQUES, V31, P740, DOI 10.2144/01314bm05; Kim JC, 2001, PLANT J, V25, P247, DOI 10.1046/j.1365-313x.2001.00947.x; Kodaira KS, 2011, PLANT PHYSIOL, V157, P742, DOI 10.1104/pp.111.182683; Lescot M, 2002, NUCLEIC ACIDS RES, V30, P325, DOI 10.1093/nar/30.1.325; Lippuner V, 1996, J BIOL CHEM, V271, P12859, DOI 10.1074/jbc.271.22.12859; Liu QL, 2010, MOL BIOL REP, V37, P1137, DOI 10.1007/s11033-009-9886-7; MILLER J, 1985, EMBO J, V4, P1609, DOI 10.1002/j.1460-2075.1985.tb03825.x; Mittler R, 2006, FEBS LETT, V580, P6537, DOI 10.1016/j.febslet.2006.11.002; Mukhopadhyay A, 2004, P NATL ACAD SCI USA, V101, P6309, DOI 10.1073/pnas.0401572101; Ohta M, 2001, PLANT CELL, V13, P1959, DOI 10.1105/tpc.13.8.1959; Pascuzzi P, 1998, J BIOL CHEM, V273, P26631, DOI 10.1074/jbc.273.41.26631; Pauwels L, 2010, NATURE, V464, P788, DOI 10.1038/nature08854; Saibo NJM, 2009, ANN BOT-LONDON, V103, P609, DOI 10.1093/aob/mcn227; Sakamoto A, 1996, PLANT CELL PHYSIOL, V37, P557, DOI 10.1093/oxfordjournals.pcp.a028980; Sakamoto H, 2004, PLANT PHYSIOL, V136, P2734, DOI 10.1104/pp.104.046599; Shinozaki K, 2000, CURR OPIN PLANT BIOL, V3, P217, DOI 10.1016/S1369-5266(00)00067-4; Shukla RK, 2006, PLANT PHYSIOL, V142, P113, DOI 10.1104/pp.106.081752; Shukla RK, 2009, FEBS J, V276, P5252, DOI 10.1111/j.1742-4658.2009.07219.x; Sugano S, 2003, PLANT J, V36, P830, DOI 10.1046/j.1365-313X.2003.01924.x; Sun SJ, 2010, J EXP BOT, V61, P2807, DOI 10.1093/jxb/erq120; Sussman DJ, 2002, BIOTECHNIQUES, V32, P1000, DOI 10.2144/02325bm04; Takatsuji H, 1998, CELL MOL LIFE SCI, V54, P582, DOI 10.1007/s000180050186; Takatsuji H, 1999, PLANT MOL BIOL, V39, P1073, DOI 10.1023/A:1006184519697; Tripathi V, 2009, PLANT J, V58, P778, DOI 10.1111/j.1365-313X.2009.03812.x; TROLL W, 1955, J BIOL CHEM, V215, P655; Umezawa T, 2006, CURR OPIN BIOTECH, V17, P113, DOI 10.1016/j.copbio.2006.02.002; Xiong LM, 2006, PLANT PHYSIOL, V142, P1065, DOI 10.1104/pp.106.084632; Xu DQ, 2008, FEBS LETT, V582, P1037, DOI 10.1016/j.febslet.2008.02.052; Xu SM, 2007, PLANT CELL REP, V26, P497, DOI 10.1007/s00299-006-0248-9; Yamaguchi-Shinozaki K, 2006, ANNU REV PLANT BIOL, V57, P781, DOI 10.1146/annurev.arplant.57.032905.105444; Zhu JK, 2001, TRENDS PLANT SCI, V6, P66, DOI 10.1016/S1360-1385(00)01838-0	43	6	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e56737	10.1371/journal.pone.0056737	http://dx.doi.org/10.1371/journal.pone.0056737			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418595	gold, Green Submitted, Green Published			2022-12-25	WOS:000315970300188
J	Champion, MD; Gray, V; Eberhard, C; Kumar, S				Champion, Mia D.; Gray, Vanessa; Eberhard, Carl; Kumar, Sudhir			The Evolutionary History of Amino Acid Variations Mediating Increased Resistance of S-aureus Identifies Reversion Mutations in Metabolic Regulators	PLOS ONE			English	Article							METHICILLIN-RESISTANT; RIFAMPIN RESISTANCE; FUSIDIC ACID; SUSCEPTIBILITY; BACTEREMIA	The evolution of resistance in Staphylococcus aureus occurs rapidly, and in response to all known antimicrobial treatments. Numerous studies of model species describe compensatory roles of mutations in mediating competitive fitness, and there is growing evidence that these mutation types also drive adaptation of S. aureus strains. However, few studies have tracked amino acid changes during the complete evolutionary trajectory of antibiotic adaptation or been able to predict their functional relevance. Here, we have assessed the efficacy of computational methods to predict biological resistance of a collection of clinically known Resistance Associated Mutations (RAMs). We have found that >90% of known RAMs are incorrectly predicted to be functionally neutral by at least one of the prediction methods used. By tracing the evolutionary histories of all of the false negative RAMs, we have discovered that a significant number are reversion mutations to ancestral alleles also carried in the MSSA476 methicillin-sensitive isolate. These genetic reversions are most prevalent in strains following daptomycin treatment and show a tendency to accumulate in biological pathway reactions that are distinct from those accumulating non-reversion mutations. Our studies therefore show that in addition to non-reversion mutations, reversion mutations arise in isolates exposed to new antibiotic treatments. It is possible that acquisition of reversion mutations in the genome may prevent substantial fitness costs during the progression of resistance. Our findings pose an interesting question to be addressed by further clinical studies regarding whether or not these reversion mutations lead to a renewed vulnerability of a vancomycin or daptomycin resistant strain to antibiotics administered at an earlier stage of infection.	[Champion, Mia D.; Gray, Vanessa; Kumar, Sudhir] Arizona State Univ, Biodesign Inst, Ctr Evolutionary Med & Informat, Tempe, AZ 85287 USA	Arizona State University; Arizona State University-Tempe	Champion, MD (corresponding author), Mayo Clin, Scottsdale, AZ USA.	Mia.Champion@asu.edu	Kumar, Sudhir/F-1411-2011	Kumar, Sudhir/0000-0002-9918-8212; Hasle, Vanessa/0000-0001-8007-4891	National Institutes of Health [R01LM010834]; The National Institute of General Medical Sciences [R25GM071798]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG002096] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM071798] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [R01LM010834] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); The National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	This work was supported by grants from the National Institutes of Health [R01LM010834] (MDC and SK) and The National Institute of General Medical Sciences [R25GM071798] (VG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aubry-Damon H, 1998, ANTIMICROB AGENTS CH, V42, P2590, DOI 10.1128/AAC.42.10.2590; Besier S, 2005, ANTIMICROB AGENTS CH, V49, P1426, DOI 10.1128/AAC.49.4.1426-1431.2005; Billington OJ, 1999, ANTIMICROB AGENTS CH, V43, P1866, DOI 10.1128/AAC.43.8.1866; Brandis G, 2012, MOL MICROBIOL, V85, P142, DOI 10.1111/j.1365-2958.2012.08099.x; Cameron DR, 2012, J INFECT DIS; Campbell RE, 2000, BIOCHEMISTRY-US, V39, P14993, DOI 10.1021/bi001627x; Casali N, 2012, GENOME RES, V22, P735, DOI 10.1101/gr.128678.111; Caspi R, 2010, NUCLEIC ACIDS RES, V38, pD473, DOI 10.1093/nar/gkp875; Charles PGP, 2004, CLIN INFECT DIS, V38, P448, DOI 10.1086/381093; Comas I, 2012, NAT GENET, V44, P106, DOI 10.1038/ng.1038; Cui LZ, 2006, ANTIMICROB AGENTS CH, V50, P1079, DOI 10.1128/AAC.50.3.1079-1082.2006; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Eng J, 2006, ROC ANAL WEB BASED C; GeneDB, STAPH AUR; Golubchik T, 2012, NAT GENET, V44, P352, DOI 10.1038/ng.1072; Highlander SK, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-99; Howden BP, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002359; Karp Peter D, 2002, Bioinformatics, V18 Suppl 1, pS225; Katayama Y, 2000, ANTIMICROB AGENTS CH, V44, P1549, DOI 10.1128/AAC.44.6.1549-1555.2000; Kuhn G, 2006, J BACTERIOL, V188, P169, DOI 10.1128/JB.188.1.169-178.2006; Kumar S, 2011, HEALTH INFORM SER, P1, DOI 10.1007/978-0-85729-529-3_1; Kumar S, 2009, GENOME RES, V19, P1562, DOI 10.1101/gr.091991.109; Lannergard J, 2008, ANTIMICROB AGENTS CH, V52, P4017, DOI 10.1128/AAC.00668-08; Lannergard J, 2009, ANTIMICROB AGENTS CH, V53, P2059, DOI 10.1128/AAC.00871-08; Lieberman TD, 2011, NAT GENET, V43, P1275, DOI 10.1038/ng.997; Lopes MC, 2012, HUM HERED, V73, P47, DOI 10.1159/000334984; Mwangi MM, 2007, P NATL ACAD SCI USA, V104, P9451, DOI 10.1073/pnas.0609839104; Nei M., 2000, MOL EVOLUTION PHYLOG; Ng PC, 2001, GENOME RES, V11, P863, DOI 10.1101/gr.176601; Parsons JB, 2011, P NATL ACAD SCI USA, V108, P15378, DOI 10.1073/pnas.1109208108; Peleg AY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028316; Reynolds MG, 2000, GENETICS, V156, P1471; Sing T, 2005, BIOINFORMATICS, V21, P3940, DOI 10.1093/bioinformatics/bti623; Subramanian S, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-306; Sunyaev SR, 1999, PROTEIN ENG, V12, P387, DOI 10.1093/protein/12.5.387; Tamura K, 2011, MOL BIOL EVOL; The Broad Institute of MIT and Harvard, 2011, STAPH AUR DRUG RES P; Toprak E, 2012, NAT GENET, V44, P101, DOI 10.1038/ng.1034; Zorzet A, 2012, J ANTIMICROB CHEMOTH	39	2	2	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2013	8	2							e56466	10.1371/journal.pone.0056466	http://dx.doi.org/10.1371/journal.pone.0056466			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104BU	23424663	gold, Green Published, Green Submitted			2022-12-25	WOS:000315965100051
J	do Amaral, ASR; Pawlick, RL; Rodrigues, E; Costal, F; Pepper, A; Galvao, FHF; Correa-Giannella, ML; Shapiro, AMJ				Raposo do Amaral, Alexandre S.; Pawlick, Rena L.; Rodrigues, Erika; Costal, Flavia; Pepper, Andrew; Ferreira Galvao, Flavio H.; Correa-Giannella, Maria Lucia; Shapiro, A. M. James			Glutathione Ethyl Ester Supplementation during Pancreatic Islet Isolation Improves Viability and Transplant Outcomes in a Murine Marginal Isleet Mass Model	PLOS ONE			English	Article							MONOETHYL ESTER; UW SOLUTION; RAT-LIVER; HYPOXIA-REOXYGENATION; SUPEROXIDE-DISMUTASE; REPERFUSION INJURY; OXIDATIVE INJURY; PEROXIDASE; MOUSE; ISCHEMIA	Background: The success of pancreatic islet transplantation still faces many challenges, mainly related to cell damage during islet isolation and early post-transplant. The increased generation of reactive oxygen species (ROS) during islet isolation and the consumption of antioxidant defenses appear to be an important pathway related to islet damage. Methodology/Principal Findings: In the present study we evaluated whether supplementation of glutathione-ethyl-ester (GEE) during islet isolation could improve islet viability and transplant outcomes in a murine marginal islet mass model. We also cultured human islets for 24 hours in standard CMRL media with or without GEE supplementation. Supplementation of GEE decreased the content of ROS in isolated islets, leading to a decrease in apoptosis and maintenance of islet viability. A higher percentage of mice transplanted with a marginal mass of GEE treated islets became euglycemic after transplant. The supplementation of 20 mM GEE in cultured human islets significantly reduced the apoptosis rate in comparison to untreated islets. Conclusions/Significance: GEE supplementation was able to decrease the apoptosis rate and intracellular content of ROS in isolated islets and might be considered a potential intervention to improve islet viability during the isolation process and maintenance in culture before islet transplantation.	[Raposo do Amaral, Alexandre S.; Pawlick, Rena L.; Pepper, Andrew; Shapiro, A. M. James] Univ Alberta, Alberta Diabet Inst, Edmonton, AB, Canada; [Raposo do Amaral, Alexandre S.; Rodrigues, Erika; Costal, Flavia; Correa-Giannella, Maria Lucia] Univ Sao Paulo, Fac Med, Hosp Clin, Lab Endocrinol Celular Mol LIM 25, Sao Paulo, Brazil; [Ferreira Galvao, Flavio H.] Univ Sao Paulo, Fac Med, Dept Gastroenterol, Unidade Transplante Cirurgia Figado LIM37, Sao Paulo, Brazil	University of Alberta; Universidade de Sao Paulo; Universidade de Sao Paulo	Shapiro, AMJ (corresponding author), Univ Alberta, Alberta Diabet Inst, Edmonton, AB, Canada.	amjs@islet.ca	de Carvalho Rodrigues, Erika/AAE-9445-2020; Rodrigues, Erika/R-6007-2017; Correa-Giannella, Maria Lúcia/N-3834-2019; Galvao, Flavio Henrique Ferreira/D-3487-2017	de Carvalho Rodrigues, Erika/0000-0001-5464-2963; Rodrigues, Erika/0000-0001-5464-2963; Correa-Giannella, Maria Lúcia/0000-0003-3655-4446; Galvao, Flavio Henrique Ferreira/0000-0003-1924-3208	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP), Brazil; Juvenile Diabetes Research Foundation (JDRF); JDRF, through the Clinical Islet Transplant Consortium (CIT) from the National Institutes of Health (NIH) National Institute of Diabetes, Digestive Diseases and Kidney (NIDDK); National Institute of Allergy, Immunology and Diabetes (NIAID); Alberta Innovates Healthcare Solutions (AIHS); Diabetes Research Institute Foundation of Canada (DRIFCan)	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP), Brazil(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Juvenile Diabetes Research Foundation (JDRF)(Juvenile Diabetes Research Foundation); JDRF, through the Clinical Islet Transplant Consortium (CIT) from the National Institutes of Health (NIH) National Institute of Diabetes, Digestive Diseases and Kidney (NIDDK); National Institute of Allergy, Immunology and Diabetes (NIAID); Alberta Innovates Healthcare Solutions (AIHS); Diabetes Research Institute Foundation of Canada (DRIFCan)	This work was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP), Brazil and by a research centre grant from the Juvenile Diabetes Research Foundation (JDRF). AMJS is supported through the JDRF, through the Clinical Islet Transplant Consortium (CIT) from the National Institutes of Health (NIH) National Institute of Diabetes, Digestive Diseases and Kidney (NIDDK) and the National Institute of Allergy, Immunology and Diabetes (NIAID). AMJS is further supported through Alberta Innovates Healthcare Solutions (AIHS) as a Senior Clinical Scholar. This work was further supported through the Diabetes Research Institute Foundation of Canada (DRIFCan). AMJS and RLP are members of the Alberta Diabetes Institute. the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson MF, 2004, NEUROSCI LETT, V354, P163, DOI 10.1016/j.neulet.2003.09.067; Armann B, 2007, AM J TRANSPLANT, V7, P38, DOI 10.1111/j.1600-6143.2006.01577.x; Avila J, 2005, AM J TRANSPLANT, V5, P2830, DOI 10.1111/j.1600-6143.2005.01109.x; Avila JG, 2003, CELL TRANSPLANT, V12, P877, DOI 10.3727/000000003771000228; Biolo G, 2007, CRIT CARE MED, V35, pS591, DOI 10.1097/01.CCM.0000278913.19123.13; BLAUSTEIN A, 1989, CIRCULATION, V80, P1449, DOI 10.1161/01.CIR.80.5.1449; Bottino R, 2004, DIABETES, V53, P2559, DOI 10.2337/diabetes.53.10.2559; Davalli AM, 1996, DIABETES, V45, P1161, DOI 10.2337/diabetes.45.9.1161; Dickinson DA, 2002, ANN NY ACAD SCI, V973, P488, DOI 10.1111/j.1749-6632.2002.tb04690.x; Emamaullee JA, 2006, DIABETES, V55, P1907, DOI 10.2337/db05-1254; Eriksson O, 2009, AM J TRANSPLANT, V9, P2816, DOI 10.1111/j.1600-6143.2009.02844.x; FUKUZAWA K, 1995, TRANSPLANTATION, V59, P6, DOI 10.1097/00007890-199501150-00002; GRANKVIST K, 1981, BIOCHEM J, V199, P393, DOI 10.1042/bj1990393; GRATTAGLIANO I, 1995, J PHARMACOL EXP THER, V272, P484; Ichii H, 2005, AM J TRANSPLANT, V5, P1635, DOI 10.1111/j.1600-6143.2005.00913.x; Kevelaitis E, 1997, TRANSPLANTATION, V64, P660, DOI 10.1097/00007890-199708270-00022; Kin T, 2011, TRANSPL P, V43, P3195, DOI 10.1016/j.transproceed.2011.10.003; Kin T., 2010, ISLETS LANGERHANS, P791; Lakhani SA, 2006, SCIENCE, V311, P847, DOI 10.1126/science.1115035; Lepore DA, 2004, XENOTRANSPLANTATION, V11, P53, DOI 10.1111/j.1399-3089.2004.00082.x; LEVY EJ, 1993, P NATL ACAD SCI USA, V90, P9171, DOI 10.1073/pnas.90.19.9171; Li CY, 2002, AM J PHYSIOL-CELL PH, V282, pC227, DOI 10.1152/ajpcell.00112.2001; Littman ED, 1995, J SURG RES, V59, P694, DOI 10.1006/jsre.1995.1225; McCall MD, 2011, ISLETS, V3, P144, DOI 10.4161/isl.3.4.15729; Mysore TB, 2005, DIABETES, V54, P2109, DOI 10.2337/diabetes.54.7.2109; NEUSCHWANDERTETRI BA, 1992, J CLIN INVEST, V89, P109, DOI 10.1172/JCI115550; Pileggi A, 2006, ANN NY ACAD SCI, V1079, P383, DOI 10.1196/annals.1375.059; PURI RN, 1983, P NATL ACAD SCI-BIOL, V80, P5258, DOI 10.1073/pnas.80.17.5258; Robertson RP, 2004, DIABETES, V53, pS119, DOI 10.2337/diabetes.53.2007.S119; Ryan EA, 2005, DIABETES, V54, P2060, DOI 10.2337/diabetes.54.7.2060; Schauer RJ, 2004, ANN SURG, V239, P220, DOI 10.1097/01.sla.0000110321.64275.95; Shapiro AMJ, 2000, NEW ENGL J MED, V343, P230, DOI 10.1056/NEJM200007273430401; SOUTHARD JH, 1990, TRANSPLANTATION, V49, P251, DOI 10.1097/00007890-199002000-00004; Sumimoto K, 1996, TRANSPLANTATION, V62, P1391, DOI 10.1097/00007890-199611270-00003; Tonooka N, 2007, CLIN TRANSPLANT, V21, P767, DOI 10.1111/j.1399-0012.2007.00736.x; YU WM, 1990, TRANSPLANTATION, V49, P1060, DOI 10.1097/00007890-199006000-00007; Zeevalk GD, 2007, EXP NEUROL, V203, P512, DOI 10.1016/j.expneurol.2006.09.004	37	20	20	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2013	8	2							e55288	10.1371/journal.pone.0055288	http://dx.doi.org/10.1371/journal.pone.0055288			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104BU	23424628	Green Submitted, gold, Green Published			2022-12-25	WOS:000315965100016
J	Tsushima, H; Malabarba, MG; Confalonieri, S; Senic-Matuglia, F; Verhoef, LGGC; Bartocci, C; D'Ario, G; Cocito, A; Di Fiore, PP; Salcini, AE				Tsushima, Hanako; Malabarba, Maria Grazia; Confalonieri, Stefano; Senic-Matuglia, Francesca; Verhoef, Lisette G. G. C.; Bartocci, Cristina; D'Ario, Giovanni; Cocito, Andrea; Di Fiore, Pier Paolo; Salcini, Anna Elisabetta			A Snapshot of the Physical and Functional Wiring of the Eps15 Homology Domain Network in the Nematode	PLOS ONE			English	Article							AMYLOID PRECURSOR PROTEIN; TYROSINE KINASE SUBSTRATE; EH-DOMAIN; ADAPTER PROTEIN; BINDING DOMAIN; CLATHRIN COAT; ENDOCYTOSIS; INTERACTS; FAMILY; NPF	Protein interaction modules coordinate the connections within and the activity of intracellular signaling networks. The Eps15 Homology (EH) module, a protein-protein interaction domain that is a key feature of the EH-network, was originally identified in a few proteins involved in endocytosis and vesicle trafficking, and has subsequently also been implicated in actin reorganization, nuclear shuttling, and DNA repair. Here we report an extensive characterization of the physical connections and of the functional wirings of the EH-network in the nematode. Our data show that one of the major physiological roles of the EH-network is in neurotransmission. In addition, we found that the proteins of the network intersect, and possibly coordinate, a number of "territories" of cellular activity including endocytosis/recycling/vesicle transport, actin dynamics, general metabolism and signal transduction, ubiquitination/degradation of proteins, DNA replication/repair, and miRNA biogenesis and processing.	[Tsushima, Hanako; Malabarba, Maria Grazia; Confalonieri, Stefano; Senic-Matuglia, Francesca; Verhoef, Lisette G. G. C.; Bartocci, Cristina; D'Ario, Giovanni; Cocito, Andrea; Di Fiore, Pier Paolo; Salcini, Anna Elisabetta] Fdn Ist FIRC Oncol Mol, IFOM, Milan, Italy; [Malabarba, Maria Grazia; Di Fiore, Pier Paolo] Univ Milan, Dipartimento Med Chirurg & Odontoiatria, Milan, Italy; [Di Fiore, Pier Paolo] Ist Europeo Oncol, Milan, Italy; [Salcini, Anna Elisabetta] Univ Copenhagen, BRIC, Copenhagen, Denmark	IFOM - FIRC Institute of Molecular Oncology; University of Milan; IRCCS European Institute of Oncology (IEO); University of Copenhagen	Di Fiore, PP (corresponding author), Fdn Ist FIRC Oncol Mol, IFOM, Milan, Italy.	pierpaolo.difiore@ifom-ieo-campus.it; lisa.salcini@bric.dk	Senic-Matuglia, Francesca/AAQ-3815-2020; Confalonieri, Stefano/AAQ-6786-2020; Malabarba, Maria Grazia/L-4805-2015; Salcini, Anna Elisabetta/G-4472-2017; Di Fiore, Pier Paolo/K-2130-2012	Confalonieri, Stefano/0000-0001-6886-9851; Malabarba, Maria Grazia/0000-0002-9457-2047; Di Fiore, Pier Paolo/0000-0002-2252-0950; Salcini, Anna Elisabetta/0000-0001-5828-2512; Tsushima, Hanako/0000-0003-3179-4301	Associazione Italiana per la Ricerca sul Cancro; Ferrari Foundation; Monzino Foundation to PPDF; Danish National Research Council	Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro); Ferrari Foundation; Monzino Foundation to PPDF; Danish National Research Council(Danmarks Grundforskningsfond)	This work was supported by grants from the Associazione Italiana per la Ricerca sul Cancro, the Ferrari Foundation and the Monzino Foundation to PPDF; and by grants from the Danish National Research Council to AES. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benjamin S, 2011, BIOCH J; Blume JJ, 2007, EXP CELL RES, V313, P219, DOI 10.1016/j.yexcr.2006.10.006; Braun A, 2005, MOL BIOL CELL, V16, P3642, DOI 10.1091/mbc.E05-01-0076; Breitkreutz BJ, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-3-r22; BRENNER S, 1974, GENETICS, V77, P71; Chen H, 1998, NATURE, V394, P793, DOI 10.1038/29555; Chi S, 2008, MOL BIOL CELL, V19, P3564, DOI 10.1091/mbc.E07-10-0997; Coda L, 1998, J BIOL CHEM, V273, P3003, DOI 10.1074/jbc.273.5.3003; Confalonieri S, 2002, FEBS LETT, V513, P24, DOI 10.1016/S0014-5793(01)03241-0; de Beer T, 2000, NAT STRUCT BIOL, V7, P1018, DOI 10.1038/80924; de Beer T, 1998, SCIENCE, V281, P1357, DOI 10.1126/science.281.5381.1357; Deribe YL, 2010, NAT STRUCT MOL BIOL, V17, P666, DOI 10.1038/nsmb.1842; DiFiore PP, 1997, TRENDS BIOCHEM SCI, V22, P411, DOI 10.1016/S0968-0004(97)01127-4; Ding XC, 2009, EMBO J, V28, P213, DOI 10.1038/emboj.2008.275; Doherty KR, 2008, J BIOL CHEM, V283, P20252, DOI 10.1074/jbc.M802306200; Doria M, 1999, J CELL BIOL, V147, P1379, DOI 10.1083/jcb.147.7.1379; Drees BL, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-4-r38; Enmon JL, 2000, BIOCHEMISTRY-US, V39, P4309, DOI 10.1021/bi9927383; Eulalio A, 2008, CELL, V132, P9, DOI 10.1016/j.cell.2007.12.024; Fernandez-Chacon R, 2000, J BIOL CHEM, V275, P12752, DOI 10.1074/jbc.275.17.12752; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Galperin E, 2002, TRAFFIC, V3, P575, DOI 10.1034/j.1600-0854.2002.30807.x; Gibbings DJ, 2009, NAT CELL BIOL, V11, P1143, DOI 10.1038/ncb1929; Glodowski DR, 2007, MOL BIOL CELL, V18, P4387, DOI 10.1091/mbc.E07-05-0486; Grabbe C, 2009, CHEM REV, V109, P1481, DOI 10.1021/cr800413p; Grant B, 2001, NAT CELL BIOL, V3, P573, DOI 10.1038/35078549; Grant BD, 2008, TRAFFIC, V9, P2043, DOI 10.1111/j.1600-0854.2008.00834.x; Gross GG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002495; Guilherme A, 2004, J BIOL CHEM, V279, P10593, DOI 10.1074/jbc.M307702200; Haffner C, 1997, FEBS LETT, V419, P175, DOI 10.1016/S0014-5793(97)01451-8; Henegouwen PMPVE, 2009, CELL COMMUN SIGNAL, V7, DOI 10.1186/1478-811X-7-24; Henry GD, 2010, BIOCHEMISTRY-US, V49, P3381, DOI 10.1021/bi100065r; Hiltunen M, 2006, J BIOL CHEM, V281, P32240, DOI 10.1074/jbc.M603106200; Ho A, 2008, J NEUROSCI, V28, P14392, DOI 10.1523/JNEUROSCI.2481-08.2008; Homayouni R, 1999, J NEUROSCI, V19, P7507, DOI 10.1523/JNEUROSCI.19-17-07507.1999; Hussain NK, 2001, NAT CELL BIOL, V3, P927, DOI 10.1038/ncb1001-927; Hyman J, 2000, J CELL BIOL, V149, P537, DOI 10.1083/jcb.149.3.537; Jovic M, 2009, MOL BIOL CELL, V20, P2731, DOI 10.1091/mbc.E08-11-1102; Kamikura DM, 2003, GENE DEV, V17, P2798, DOI 10.1101/gad.1136103; Kieken F, 2010, J BIOL CHEM, V285, P8687, DOI 10.1074/jbc.M109.045666; Kieken F, 2009, PROTEIN SCI, V18, P2471, DOI 10.1002/pro.258; Kim S, 2001, BIOCHEMISTRY-US, V40, P6776, DOI 10.1021/bi002700m; Kins S, 2006, NEURODEGENER DIS, V3, P218, DOI 10.1159/000095259; Krishnamoorthy K, 2006, STAT TEXTB MONOGR, P1; Lanzetti L, 2008, TRAFFIC, V9, P2011, DOI 10.1111/j.1600-0854.2008.00816.x; Lee DW, 2005, J BIOL CHEM, V280, P17213, DOI 10.1074/jbc.M412751200; Lee YS, 2009, NAT CELL BIOL, V11, P1150, DOI 10.1038/ncb1930; Malacombe M, 2006, EMBO J, V25, P3494, DOI 10.1038/sj.emboj.7601247; Martina JA, 2001, J CELL BIOL, V153, P1111, DOI 10.1083/jcb.153.5.1111; Marzolo MP, 2009, SEMIN CELL DEV BIOL, V20, P191, DOI 10.1016/j.semcdb.2008.10.005; Mayer BJ, 1999, CURR BIOL, V9, pR70, DOI 10.1016/S0960-9822(99)80014-1; Miliaras NB, 2004, CELL BIOCHEM BIOPHYS, V41, P295, DOI 10.1385/CBB:41:2:295; Moldovan GL, 2007, CELL, V129, P665, DOI 10.1016/j.cell.2007.05.003; Montesinos ML, 2005, BRAIN RES REV, V49, P416, DOI 10.1016/j.brainresrev.2005.06.002; Morgan JR, 2003, J BIOL CHEM, V278, P33583, DOI 10.1074/jbc.M304346200; Morinaka K, 1999, ONCOGENE IN PRESS; Musacchio Andrea, 2002, Adv Protein Chem, V61, P211; Naslavsky N, 2006, MOL BIOL CELL, V17, P163, DOI 10.1091/mbc.e05-05-0466; Naslavsky N, 2004, MOL BIOL CELL, V15, P2410, DOI 10.1091/mbc.E03-10-0733; Naslavsky N, 2007, J BIOL CHEM, V282, P16612, DOI 10.1074/jbc.M609493200; Okamoto M, 2001, NEUROSCIENCE, V104, P653, DOI 10.1016/S0306-4522(01)00124-5; Ow MC, 2008, GENE DEV, V22, P2520, DOI 10.1101/gad.1678808; Page LJ, 1999, J CELL BIOL, V146, P993, DOI 10.1083/jcb.146.5.993; Pant S, 2009, NAT CELL BIOL, V11, P1399, DOI 10.1038/ncb1986; Paoluzi S, 1998, EMBO J, V17, P6541, DOI 10.1093/emboj/17.22.6541; Pawson T, 2004, CELL, V116, P191, DOI 10.1016/S0092-8674(03)01077-8; Pawson T, 2009, CURR OPIN CELL BIOL, V21, P147, DOI 10.1016/j.ceb.2009.02.005; Pece S, 2011, BBA-REV CANCER, V1815, P26, DOI 10.1016/j.bbcan.2010.10.001; Polo S, 2004, CURR OPIN CELL BIOL, V16, P156, DOI 10.1016/j.ceb.2004.02.003; Polo Simona, 2003, Sci STKE, V2003, pre17, DOI 10.1126/stke.2132003re17; Poupon V, 2002, J BIOL CHEM, V277, P8941, DOI 10.1074/jbc.M108385200; Pyrzynska B, 2009, MOL ONCOL, V3, P321, DOI 10.1016/j.molonc.2009.06.001; Regan-Klapisz E, 2005, J CELL SCI, V118, P4437, DOI 10.1242/jcs.02571; Rose S, 2007, MOL BIOL CELL, V18, P5091, DOI 10.1091/mbc.E07-05-0460; Rosenthal JA, 1999, J BIOL CHEM, V274, P33959, DOI 10.1074/jbc.274.48.33959; Roxrud I, 2008, J CELL BIOL, V180, P1205, DOI 10.1083/jcb.200708115; Rumpf J, 2008, EMBO J, V27, P558, DOI 10.1038/sj.emboj.7601980; Salcini AE, 1999, INT J BIOCHEM CELL B, V31, P805, DOI 10.1016/S1357-2725(99)00042-4; Salcini AE, 1997, GENE DEV, V11, P2239, DOI 10.1101/gad.11.17.2239; Salcini AE, 2001, NAT CELL BIOL, V3, P755, DOI 10.1038/35087075; Santolini E, 2000, J CELL BIOL, V151, P1345, DOI 10.1083/jcb.151.6.1345; Santolini E, 1999, EXP CELL RES, V253, P186, DOI 10.1006/excr.1999.4694; Santonico Elena, 2007, BMC Biochemistry, V8, P29, DOI 10.1186/1471-2091-8-29; Schlessinger Joseph, 2003, Sci STKE, V2003, pRE12, DOI 10.1126/stke.2003.191.re12; Scita G, 2010, NATURE, V463, P464, DOI 10.1038/nature08910; Serretti A, 2007, J ALZHEIMERS DIS, V12, P73; Shi A, 2007, CURR BIOL, V17, P1913, DOI 10.1016/j.cub.2007.10.045; Sigismund S, 2012, PHYSIOL REV, V92, P273, DOI 10.1152/physrev.00005.2011; Siomi H, 2009, NAT CELL BIOL, V11, P1049, DOI 10.1038/ncb0909-1049; Smith CA, 2004, MOL BIOL CELL, V15, P3698, DOI 10.1091/mbc.E04-01-0026; Timmons L, 2001, GENE, V263, P103, DOI 10.1016/S0378-1119(00)00579-5; Vecchi M, 2001, J CELL BIOL, V153, P1511, DOI 10.1083/jcb.153.7.1511; Wang W, 2008, TRAFFIC, V9, P742, DOI 10.1111/j.1600-0854.2008.00712.x; Wendland B, 1998, J CELL BIOL, V141, P71, DOI 10.1083/jcb.141.1.71; WONG WT, 1995, P NATL ACAD SCI USA, V92, P9530, DOI 10.1073/pnas.92.21.9530; Wu FB, 2009, AGEING RES REV, V8, P147, DOI 10.1016/j.arr.2009.03.002; Yamabhai M, 1998, J BIOL CHEM, V273, P31401, DOI 10.1074/jbc.273.47.31401; Zhang L, 2007, MOL CELL, V28, P598, DOI 10.1016/j.molcel.2007.09.014	98	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2013	8	2							e56383	10.1371/journal.pone.0056383	http://dx.doi.org/10.1371/journal.pone.0056383			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104BU	23424658	Green Published, Green Submitted, gold			2022-12-25	WOS:000315965100046
J	Wasylishen, AR; Kalkat, M; Kim, SS; Pandyra, A; Chan, PK; Oliveri, S; Sedivy, E; Konforte, D; Bros, C; Raught, B; Penn, LZ				Wasylishen, A. R.; Kalkat, M.; Kim, S. S.; Pandyra, A.; Chan, P-K; Oliveri, S.; Sedivy, E.; Konforte, D.; Bros, C.; Raught, B.; Penn, L. Z.			MYC activity is negatively regulated by a C-terminal lysine cluster	ONCOGENE			English	Article						Myc; cellular transformation; apoptosis; lysine; transcription	TRANSACTIVATION DOMAIN; TRANSFORMATION; CELLS; ACETYLATION; FIBROBLASTS; ONCOPROTEIN; REPRESSES; PHENOTYPE; APOPTOSIS; LYMPHOMA	The MYC oncogene is not only deregulated in cancer through abnormally high levels of expression, but also through oncogenic lesions in upstream signalling cascades. Modelling MYC deregulation using signalling mutants is a productive research strategy. For example, the MYC threonine-58 to alanine substitution mutant (T58A) within MYC-homology box 1 is more transforming than wildtype (WT) MYC, because of decreased apoptosis and increased protein stability. Understanding the regulatory mechanisms controlling T58 phosphorylation has led to new approaches for the development of MYC inhibitors. In this manuscript, we have extensively characterized a MYC signalling mutant in which six lysine residues near the highly conserved MYC homology box IV and basic region have been substituted to arginines (6KR). Previous literature suggests these lysines can undergo both ubiquitylation and acetylation. We show MYC 6KR is able to fully rescue the slow growth phenotype of HO15.19 MYC-null fibroblasts, and promote cell cycle entry of serum-starved MCF10A cells. Remarkably, 6KR increased anchorage-independent colony growth compared with WT MYC in both SH-EP and MCF10A cells. Moreover, it was also more potent in promoting xenograft tumour growth of Rat1A and SH-EP cells. Combined, our data identify this region and these six lysines as important residues for the negative regulation of MYC-induced transformation. Mechanistically, we demonstrate that, unlike T58A, the increased transformation is not a result of increased protein stability or a reduced capacity for 6KR to induce apoptosis. Through expression analysis and luciferase reporter assays, we show that 6KR has increased transcriptional activity compared with WT MYC. Combined, through a comprehensive evaluation across multiple cell types, we identify an important regulatory region within MYC. A better understanding of the full scope of signalling through these residues will provide further insights into the mechanisms contributing to MYC-induced tumorigenesis and may unveil novel therapeutic strategies to target Myc in cancer.	[Wasylishen, A. R.; Kalkat, M.; Kim, S. S.; Pandyra, A.; Oliveri, S.; Sedivy, E.; Raught, B.; Penn, L. Z.] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada; [Wasylishen, A. R.; Kalkat, M.; Kim, S. S.; Pandyra, A.; Chan, P-K; Oliveri, S.; Sedivy, E.; Konforte, D.; Bros, C.; Raught, B.; Penn, L. Z.] Princess Margaret Hosp, Campbell Family Inst Canc Res, Ontario Canc Inst, Toronto, ON M5G 2M9, Canada	University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre	Penn, LZ (corresponding author), Princess Margaret Hosp, Campbell Family Inst Canc Res, Ontario Canc Inst, Room 9-628,610 Univ Ave, Toronto, ON M5G 2M9, Canada.	lpenn@uhnres.utoronto.ca		Penn, Linda/0000-0001-8133-5459; Kalkat, Manpreet/0000-0002-4843-9755; Wasylishen, Amanda/0000-0002-1940-5169	Canadian Cancer Society Research Institute; Canadian Institute for Health Research; Canadian Breast Cancer Foundation Ontario Region Doctoral Fellowships; Ontario Graduate Student Fellowship; Ontario Ministry of Health; Ontario Long Term Care	Canadian Cancer Society Research Institute(Canadian Cancer Society (CCS)); Canadian Institute for Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Breast Cancer Foundation Ontario Region Doctoral Fellowships; Ontario Graduate Student Fellowship; Ontario Ministry of Health(Ministry of Health and Long-Term Care, Ontario); Ontario Long Term Care	We thank Dr Martin Eilers for kindly providing the Myc 6KR construct, Dr Garry Nolan for providing retroviral reagents and packaging cell lines. SH-EP Tet21/N-Myc, MCF10A, Rat-1A and HO15.19 cells were kindly provided by Dr Manfred Schwab, Dr Senthil Muthuswamy, Dr Edward Prochownick and Dr John Sedivy, respectively. Additionally we thank Drs Bruno Amati, Chi Dang and Stephen Hann for kindly providing luciferase reporter constructs. We also thank Andrew Rust and Drs Angelina Stojanova and Peter Mullen for technical assistance, and the members of the Penn Lab for helpful discussions and critical review of this manuscript. This research was funded by grants from the Canadian Cancer Society Research Institute and Canadian Institute for Health Research (LZP), Canadian Breast Cancer Foundation Ontario Region Doctoral Fellowships (ARW and AP) and an Ontario Graduate Student Fellowship (MK). BR and LZP hold the Canada Research Chairs in Proteomics & Molecular Medicine and Molecular Oncology, respectively. Additional support was provided by the Ontario Ministry of Health and Long Term Care. The views expressed do not necessarily reflect those of the OMOHLTC.	Adhikary S, 2005, CELL, V123, P409, DOI 10.1016/j.cell.2005.08.016; Berns K, 2000, ONCOGENE, V19, P3330, DOI 10.1038/sj.onc.1203639; BHATIA K, 1993, NAT GENET, V5, P56, DOI 10.1038/ng0993-56; Callus BA, 2008, CELL DEATH DIFFER, V15, P213, DOI 10.1038/sj.cdd.4402245; Chang DW, 2000, MOL CELL BIOL, V20, P4309, DOI 10.1128/MCB.20.12.4309-4319.2000; Conzen SD, 2000, MOL CELL BIOL, V20, P6008, DOI 10.1128/MCB.20.16.6008-6018.2000; Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X; Faiola F, 2005, MOL CELL BIOL, V25, P10220, DOI 10.1128/MCB.25.23.10220-10234.2005; Gartel AL, 2001, P NATL ACAD SCI USA, V98, P4510, DOI 10.1073/pnas.081074898; Graves JA, PLOS ONE, V5; Hann SR, 2006, SEMIN CANCER BIOL, V16, P288, DOI 10.1016/j.semcancer.2006.08.004; Hemann MT, 2005, NATURE, V436, P807, DOI 10.1038/nature03845; Kim W, 2011, MOL CELL, V44, P325, DOI 10.1016/j.molcel.2011.08.025; Lin CY, 2012, CELL, V151, P56, DOI 10.1016/j.cell.2012.08.026; Marhin WW, 1997, ONCOGENE, V14, P2825, DOI 10.1038/sj.onc.1201138; Mateyak MK, 1997, CELL GROWTH DIFFER, V8, P1039; Ngo CV, 2000, CELL GROWTH DIFFER, V11, P201; Nie ZQ, 2012, CELL, V151, P68, DOI 10.1016/j.cell.2012.08.033; Oster SK, 2003, ONCOGENE, V22, P1998, DOI 10.1038/sj.onc.1206228; Patel JH, 2004, MOL CELL BIOL, V24, P10826, DOI 10.1128/MCB.24.24.10826-10834.2004; Popov N, 2007, NAT CELL BIOL, V9, P765, DOI 10.1038/ncb1601; RABBITTS TH, 1983, NATURE, V306, P760, DOI 10.1038/306760a0; Sears RC, 2004, CELL CYCLE, V3, P1133, DOI 10.4161/cc.3.9.1145; STONE J, 1987, MOL CELL BIOL, V7, P1697, DOI 10.1128/MCB.7.5.1697; Thibodeaux CA, 2009, BREAST CANCER RES TR, V116, P281, DOI 10.1007/s10549-008-0127-x; Wang XY, 2011, CANCER RES, V71, P925, DOI 10.1158/0008-5472.CAN-10-1032; Wasylishen AR, 2011, ONCOGENE, V30, P3727, DOI 10.1038/onc.2011.88; Zhang KL, 2005, BIOCHEM BIOPH RES CO, V336, P274, DOI 10.1016/j.bbrc.2005.08.075	28	12	12	1	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 20	2014	33	8					1066	1072		10.1038/onc.2013.36	http://dx.doi.org/10.1038/onc.2013.36			7	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AB6XO	23435422				2022-12-25	WOS:000331933200014
J	Filippova, EV; Weston, LA; Kuhn, ML; Geissler, B; Gehring, AM; Armoush, N; Adkins, CT; Minasov, G; Dubrovska, I; Shuvalova, L; Winsor, JR; Lavis, LD; Satchell, KJF; Becker, DP; Anderson, WF; Johnson, RJ				Filippova, Ekaterina V.; Weston, Leigh A.; Kuhn, Misty L.; Geissler, Brett; Gehring, Alexandra M.; Armoush, Nicola; Adkins, Chinessa T.; Minasov, George; Dubrovska, Ievgeniia; Shuvalova, Ludmilla; Winsor, James R.; Lavis, Luke D.; Satchell, Karla J. F.; Becker, Daniel P.; Anderson, Wayne F.; Johnson, R. Jeremy			Large Scale Structural Rearrangement of a Serine Hydrolase from Francisella tularensis Facilitates Catalysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							X-RAY CRYSTALLOGRAPHY; ALPHA/BETA-HYDROLASE; CRYSTAL-STRUCTURE; PSEUDOMONAS-AERUGINOSA; SUBSTRATE-SPECIFICITY; OPEN CONFORMATION; PROTEIN; MODEL; CARBOXYLESTERASE; ESTERASE	Tularemia is a deadly, febrile disease caused by infection by the Gram-negative bacterium, Francisella tularensis. Members of the ubiquitous serine hydrolase protein family are among current targets to treat diverse bacterial infections. Herein we present a structural and functional study of a novel bacterial carboxylesterase (FTT258) from F. tularensis, a homologue of human acyl protein thioesterase (hAPT1). The structure of FTT258 has been determined in multiple forms, and unexpectedly large conformational changes of a peripheral flexible loop occur in the presence of a mechanistic cyclobutanone ligand. The concomitant changes in this hydrophobic loop and the newly exposed hydrophobic substrate binding pocket suggest that the observed structural changes are essential to the biological function and catalytic activity of FTT258. Using diverse substrate libraries, site-directed mutagenesis, and liposome binding assays, we determined the importance of these structural changes to the catalytic activity and membrane binding activity of FTT258. Residues within the newly exposed hydrophobic binding pocket and within the peripheral flexible loop proved essential to the hydrolytic activity of FTT258, indicating that structural rearrangement is required for catalytic activity. Both FTT258 and hAPT1 also showed significant association with liposomes designed to mimic bacterial or human membranes, respectively, even though similar structural rearrangements for hAPT1 have not been reported. The necessity for acyl protein thioesterases to have maximal catalytic activity near the membrane surface suggests that these conformational changes in the protein may dually regulate catalytic activity and membrane association in bacterial and human homologues.	[Weston, Leigh A.; Gehring, Alexandra M.; Johnson, R. Jeremy] Butler Univ, Dept Chem, Indianapolis, IN 46208 USA; [Filippova, Ekaterina V.; Kuhn, Misty L.; Minasov, George; Dubrovska, Ievgeniia; Shuvalova, Ludmilla; Winsor, James R.; Anderson, Wayne F.] Northwestern Univ, Feinberg Sch Med, Ctr Struct Genom Infect Dis, Chicago, IL 60611 USA; [Filippova, Ekaterina V.; Kuhn, Misty L.; Minasov, George; Dubrovska, Ievgeniia; Shuvalova, Ludmilla; Winsor, James R.; Anderson, Wayne F.] Northwestern Univ, Feinberg Sch Med, Dept Mol Pharmacol & Biol Chem, Chicago, IL 60611 USA; [Geissler, Brett; Satchell, Karla J. F.] Northwestern Univ, Feinberg Sch Med, Dept Microbiol Immunol, Chicago, IL 60611 USA; [Armoush, Nicola; Becker, Daniel P.] Loyola Univ, Dept Chem & Biochem, Chicago, IL 60660 USA; [Adkins, Chinessa T.; Lavis, Luke D.] HHMI Janelia Farm Res Campus, Ashburn, VA 20147 USA	Butler University; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Loyola University Chicago; Howard Hughes Medical Institute	Johnson, RJ (corresponding author), Butler Univ, Dept Chem, 4600 Sunset Ave, Indianapolis, IN 46208 USA.	rjjohns1@butler.edu	Satchell, Karla/GSN-3100-2022	Minasov, George/0000-0001-5460-3462; Lavis, Luke/0000-0002-0789-6343; Winsor, James/0000-0002-9673-4839	Department of Health and Human Services, NIAID, National Institutes of Health (NIH) [HHSN272200700058C]; NIH [AI051490]; Burroughs Wellcome Fund; Butler University; Howard Hughes Medical Institute; Indiana Academy of Sciences; NATIONAL CANCER INSTITUTE [P30CA060553] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI051490] Funding Source: NIH RePORTER	Department of Health and Human Services, NIAID, National Institutes of Health (NIH); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Fund(Burroughs Wellcome Fund); Butler University; Howard Hughes Medical Institute(Howard Hughes Medical Institute); Indiana Academy of Sciences; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by Department of Health and Human Services, NIAID, National Institutes of Health (NIH) Contract HHSN272200700058C (to W. F. A.), NIH Grant AI051490 (to K. J. F. S.), and an Investigator in the Pathogenesis of Infectious Disease award from the Burroughs Wellcome Fund (to K. J. F. S.).; Supported by a Holcomb grant from Butler University.; Supported by the Howard Hughes Medical Institute.; Supported by start-up funds and a Holcomb grant from Butler University and a Senior Research Grant from the Indiana Academy of Sciences. To whom correspondence should be addressed: Dept. of Chemistry, Butler University, 4600 Sunset Ave., Indianapolis, IN 46208. Tel.: 317-940-9062; Fax: 317-940-9519; E-mail: rjjohns1@butler.edu.	Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Armoush N, 2008, SYNTHETIC COMMUN, V38, P1679, DOI 10.1080/00397910801981110; Bachovchin DA, 2012, NAT REV DRUG DISCOV, V11, P52, DOI 10.1038/nrd3620; Beckstrom-Sternberg SM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000947; BHAT TN, 1988, J APPL CRYSTALLOGR, V21, P279, DOI 10.1107/S0021889887012755; Bisel P, 1998, EUR J ORG CHEM, V1998, P729, DOI 10.1002/(SICI)1099-0690(199804)1998:4<729::AID-EJOC729>3.0.CO;2-B; Bornscheuer UT, 2002, FEMS MICROBIOL REV, V26, P73, DOI 10.1016/S0168-6445(01)00075-4; Busto E, 2010, CHEM SOC REV, V39, P4504, DOI 10.1039/c003811c; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Dekker FJ, 2010, NAT CHEM BIOL, V6, P449, DOI 10.1038/nchembio.362; DEREWENDA ZS, 1991, BIOCHEM CELL BIOL, V69, P842, DOI 10.1139/o91-125; Devedjiev Y, 2000, STRUCTURE, V8, P1137, DOI 10.1016/S0969-2126(00)00529-3; Drzewiecki K, 2010, MICROB BIOTECHNOL, V3, P84, DOI 10.1111/j.1751-7915.2009.00150.x; EDELHOCH H, 1967, BIOCHEMISTRY-US, V6, P1948, DOI 10.1021/bi00859a010; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Forestal CA, 2008, MICROB PATHOGENESIS, V44, P512, DOI 10.1016/j.micpath.2008.01.003; Geissler B, 2012, CELL MICROBIOL, V14, P286, DOI 10.1111/j.1462-5822.2011.01718.x; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; Heal WP, 2012, TOP CURR CHEM, V324, P115, DOI 10.1007/128_2011_299; Hedge MK, 2012, BBA-PROTEINS PROTEOM, V1824, P1024, DOI 10.1016/j.bbapap.2012.05.009; Hirano T, 2009, BBA-MOL CELL BIOL L, V1791, P797, DOI 10.1016/j.bbalip.2009.05.001; Holmquist M, 2000, CURR PROTEIN PEPT SC, V1, P209, DOI 10.2174/1389203003381405; Johnson JW, 2010, J AM CHEM SOC, V132, P2558, DOI 10.1021/ja9086374; Kim KK, 1997, STRUCTURE, V5, P1571, DOI 10.1016/S0969-2126(97)00306-7; Kim KK, 1997, STRUCTURE, V5, P173, DOI 10.1016/S0969-2126(97)00177-9; Kim S, 2004, BIOSCI BIOTECH BIOCH, V68, P2289, DOI 10.1271/bbb.68.2289; Kim Y, 2008, ADV PROTEIN CHEM, V75, P85, DOI 10.1016/S0065-3233(07)75003-9; Kourist R, 2010, CHEMBIOCHEM, V11, P1635, DOI 10.1002/cbic.201000213; Kovacs-Simon A, 2011, INFECT IMMUN, V79, P548, DOI 10.1128/IAI.00682-10; Lall MS, 2002, J ORG CHEM, V67, P1536, DOI 10.1021/jo0109016; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lavis LD, 2011, CHEM SCI, V2, P521, DOI 10.1039/c0sc00466a; Long JZ, 2011, CHEM REV, V111, P6022, DOI 10.1021/cr200075y; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Macarron R, 2011, MOL BIOTECHNOL, V47, P270, DOI 10.1007/s12033-010-9335-9; Martin BR, 2012, NAT METHODS, V9, P84, DOI [10.1038/NMETH.1769, 10.1038/nmeth.1769]; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McLendon MK, 2006, ANNU REV MICROBIOL, V60, P167, DOI 10.1146/annurev.micro.60.080805.142126; Minor W, 2006, ACTA CRYSTALLOGR D, V62, P859, DOI 10.1107/S0907444906019949; OLLIS DL, 1992, PROTEIN ENG, V5, P197, DOI 10.1093/protein/5.3.197; Oyston PCF, 2004, NAT REV MICROBIOL, V2, P967, DOI 10.1038/nrmicro1045; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; Parra MC, 2010, MICROBIOL RES, V165, P531, DOI 10.1016/j.micres.2009.11.004; Pechous RD, 2009, MICROBIOL MOL BIOL R, V73, P684, DOI 10.1128/MMBR.00028-09; Pesaresi A, 2005, CURR MICROBIOL, V50, P102, DOI 10.1007/s00284-004-4414-4; Pesaresi A, 2010, BIOCHIMIE, V92, P1787, DOI 10.1016/j.biochi.2010.09.001; Pohanka M, 2009, FOLIA MICROBIOL, V54, P263, DOI 10.1007/s12223-009-0046-1; Qin AP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024611; Rehm S, 2010, PROTEIN SCI, V19, P2122, DOI 10.1002/pro.493; Schrag JD, 1997, STRUCTURE, V5, P187, DOI 10.1016/S0969-2126(97)00178-0; Siegel G, 2009, NAT CELL BIOL, V11, P705, DOI 10.1038/ncb1876; Simon GM, 2010, J BIOL CHEM, V285, P11051, DOI 10.1074/jbc.R109.097600; Singh G, 2010, CRIT REV MICROBIOL, V36, P259, DOI 10.3109/1040841X.2010.482923; Thakran S, 2008, J BIOL CHEM, V283, P3751, DOI 10.1074/jbc.M706854200; Tian L, 2012, P NATL ACAD SCI USA, V109, P4756, DOI 10.1073/pnas.1111943109; Tokuda H, 2009, BIOSCI BIOTECH BIOCH, V73, P465, DOI 10.1271/bbb.80778; Vaguine AA, 1999, ACTA CRYSTALLOGR D, V55, P191, DOI 10.1107/S0907444998006684; VANTILBEURGH H, 1993, NATURE, V362, P814, DOI 10.1038/362814a0; West NP, 2011, CHEM COMMUN, V47, P5166, DOI 10.1039/c0cc05635a; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Yang HW, 2004, ACTA CRYSTALLOGR D, V60, P1833, DOI 10.1107/S0907444904019419; Zeidman R, 2009, MOL MEMBR BIOL, V26, P32, DOI 10.1080/09687680802629329	63	23	23	2	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 12	2013	288	15					10522	10535		10.1074/jbc.M112.446625	http://dx.doi.org/10.1074/jbc.M112.446625			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	125TU	23430251	Green Published, hybrid			2022-12-25	WOS:000317565000032
J	Bhattacharyya, S; Singh, P; Rathore, U; Purwar, M; Wagner, D; Arendt, H; DeStefano, J; LaBranche, CC; Montefiori, DC; Phogat, S; Varadarajan, R				Bhattacharyya, Sanchari; Singh, Pranveer; Rathore, Ujjwal; Purwar, Mansi; Wagner, Denise; Arendt, Heather; DeStefano, Joanne; LaBranche, Celia C.; Montefiori, David C.; Phogat, Sanjay; Varadarajan, Raghavan			Design of an Escherichia coli Expressed HIV-1 gp120 Fragment Immunogen That Binds to b12 and Induces Broad and Potent Neutralizing Antibodies	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; ENVELOPE GLYCOPROTEIN; MONOCLONAL-ANTIBODIES; CD4-BINDING SITE; CD4 BINDING; COMPUTATIONAL DESIGN; STRUCTURAL BASIS; RATIONAL DESIGN; CD4-BOUND STATE; MONOMERIC GP120	b12, one of the few broadly neutralizing antibodies against HIV-1, binds to the CD4 binding site (CD4bs) on the gp120 subunit of HIV-1 Env. Two small fragments of HIV-1 gp120, b121a and b122a, which display about 70% of the b12 epitope and include solubility-enhancing mutations, were designed. Bacterially expressed b121a/b122a were partially folded and could bind b12 but not the CD4bs-directed non-neutralizing antibody b6. Sera from rabbits primed with b121a or b122a protein fragments and boosted with full-length gp120 showed broad neutralizing activity in a TZM-bl assay against a 16-virus panel that included nine Tier 2 and 3 viruses as well as in a five-virus panel previously designed to screen for broad neutralization. Using a mean IC50 cut-off of 50, sera from control rabbits immunized with gp120 alone neutralized only one virus of the 14 non-Tier 1 viruses tested (7%), whereas sera from b121a- and b122a-immunized rabbits neutralized seven (50%) and twelve (86%) viruses, respectively. Serum depletion studies confirmed that neutralization was gp120-directed and that sera from animals immunized with gp120 contained lower amounts of CD4bs-directed antibodies than corresponding sera from animals immunized with b121a/b122a. Competition binding assays with b12 also showed that b121a/2a sera contained significantly higher amounts of antibodies directed toward the CD4 binding site than the gp120 sera. The data demonstrate that it is possible to elicit broadly neutralizing sera against HIV-1 in small animals.	[Bhattacharyya, Sanchari; Singh, Pranveer; Rathore, Ujjwal; Purwar, Mansi; Varadarajan, Raghavan] Indian Inst Sci, Mol Biophys Unit, Bangalore 560012, Karnataka, India; [Varadarajan, Raghavan] Jakkur, Jawaharlal Nehru Ctr Adv Sci Res, Bangalore 560064, Karnataka, India; [Wagner, Denise; Arendt, Heather; DeStefano, Joanne; Phogat, Sanjay; Varadarajan, Raghavan] Int AIDS Vaccine Initiat, AIDS Vaccine Design & Dev Lab, New York, NY 11220 USA; [LaBranche, Celia C.; Montefiori, David C.] Duke Univ, Dept Surg, Durham, NC 27705 USA	Indian Institute of Science (IISC) - Bangalore; Department of Science & Technology (India); Jawaharlal Nehru Center for Advanced Scientific Research (JNCASR); International AIDS Vaccine Initiative; Duke University	Phogat, S (corresponding author), Sanofi Pasteur, 1 Discovery Dr, Swiftwater, PA 18370 USA.	sanjay.phogat@sanofipasteur.com; varadar@mbu.iisc.ernet.in	Bhattacharyya, Sanchari/L-4344-2019; Rathore, Ujjwal/AAD-9974-2021	Bhattacharyya, Sanchari/0000-0003-3421-4755; Rathore, Ujjwal/0000-0002-0329-7431	Council of Scientific and Industrial Research, Government of India; D. S. Kothari fellowship	Council of Scientific and Industrial Research, Government of India(Council of Scientific & Industrial Research (CSIR) - India); D. S. Kothari fellowship	Recipient of a fellowship from the Council of Scientific and Industrial Research, Government of India.; Supported by a D. S. Kothari fellowship.	Azoitei ML, 2012, J MOL BIOL, V415, P175, DOI 10.1016/j.jmb.2011.10.003; Azoitei ML, 2011, SCIENCE, V334, P373, DOI 10.1126/science.1209368; Beddows S, 2005, J VIROL, V79, P8812, DOI 10.1128/JVI.79.14.8812-8827.2005; Bhattacharyya S, 2010, J BIOL CHEM, V285, P27100, DOI 10.1074/jbc.M110.152272; Bommakanti G, 2010, P NATL ACAD SCI USA, V107, P13701, DOI 10.1073/pnas.1007465107; Bonsignori M, 2012, J VIROL, V86, P4688, DOI 10.1128/JVI.07163-11; Bowley DR, 2007, PROTEIN ENG DES SEL, V20, P81, DOI 10.1093/protein/gzl057; Chao G, 2006, NAT PROTOC, V1, P755, DOI 10.1038/nprot.2006.94; Cohen J, 2011, SCIENCE, V333, P1560, DOI 10.1126/science.333.6049.1560; Correia BE, 2010, STRUCTURE, V18, P1116, DOI 10.1016/j.str.2010.06.010; Corti D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008805; Dey B, 2007, J VIROL, V81, P5579, DOI 10.1128/JVI.02500-06; Diskin R, 2011, SCIENCE, V334, P1289, DOI 10.1126/science.1213782; Doria-Rose NA, 2010, J VIROL, V84, P1631, DOI 10.1128/JVI.01482-09; Feng Y, 2012, J BIOL CHEM, V287, P5673, DOI 10.1074/jbc.M111.317776; Gray ES, 2011, J VIROL, V85, P4828, DOI 10.1128/JVI.00198-11; Haynes BF, 2012, NAT BIOTECHNOL, V30, P423, DOI 10.1038/nbt.2197; Hessell AJ, 2009, NAT MED, V15, P951, DOI 10.1038/nm.1974; Hessell AJ, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000433; Kang Y, 2009, VACCINE, V27, P5120, DOI 10.1016/j.vaccine.2009.06.037; Korber B, 2011, EXPERT REV VACCINES, V10, P929, DOI [10.1586/ERV.11.81, 10.1586/erv.11.81]; Kovacs JM, 2012, P NATL ACAD SCI USA, V109, P12111, DOI 10.1073/pnas.1204533109; Kwong PD, 1998, NATURE, V393, P648, DOI 10.1038/31405; LaBranche CC, 2001, ANTIVIR RES, V50, P95, DOI 10.1016/S0166-3542(01)00130-9; Lavinder JJ, 2009, J AM CHEM SOC, V131, P3794, DOI 10.1021/ja8049063; Li YX, 2007, NAT MED, V13, P1032, DOI 10.1038/nm1624; Li YX, 2009, J VIROL, V83, P1045, DOI 10.1128/JVI.01992-08; Mikell I, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001251; MONTEFIORI D, 2004, EVALUATING NEUTRALIZ; Murad W, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-S1-S12; Niesen FH, 2007, NAT PROTOC, V2, P2212, DOI 10.1038/nprot.2007.321; Pantophlet R, 2004, PROTEIN ENG DES SEL, V17, P749, DOI 10.1093/protein/gzh085; Pantophlet R, 2003, J VIROL, V77, P642, DOI 10.1128/JVI.77.1.642-658.2003; Pantophlet R, 2003, J VIROL, V77, P5889, DOI 10.1128/JVI.77.10.5889-5901.2003; Pantophlet R, 2006, ANNU REV IMMUNOL, V24, P739, DOI 10.1146/annurev.immunol.24.021605.090557; Richman DD, 2003, P NATL ACAD SCI USA, V100, P4144, DOI 10.1073/pnas.0630530100; ROBEN P, 1994, J VIROL, V68, P4821, DOI 10.1128/JVI.68.8.4821-4828.1994; Roehr B, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d5880; Saha P, 2012, BIOCHEMISTRY-US, V51, P1836, DOI 10.1021/bi300003v; Saha P, 2011, BIOCHEMISTRY-US, V50, P7891, DOI 10.1021/bi200870r; Sallusto F, 2010, IMMUNITY, V33, P451, DOI 10.1016/j.immuni.2010.10.008; Scheid JF, 2011, SCIENCE, V333, P1633, DOI 10.1126/science.1207227; Scheid JF, 2009, NATURE, V458, P636, DOI 10.1038/nature07930; Seaman MS, 2010, J VIROL, V84, P1439, DOI 10.1128/JVI.02108-09; Selvarajah S, 2005, J VIROL, V79, P12148, DOI 10.1128/JVI.79.19.12148-12163.2005; Sharma D, 2005, BIOCHEMISTRY-US, V44, P16192, DOI 10.1021/bi051120s; Shingai M, 2012, P NATL ACAD SCI USA, V109, P19769, DOI 10.1073/pnas.1217443109; Simek MD, 2009, J VIROL, V83, P7337, DOI 10.1128/JVI.00110-09; Strain MC, 2003, P NATL ACAD SCI USA, V100, P4819, DOI 10.1073/pnas.0736332100; Walker LM, 2011, NATURE, V477, P466, DOI 10.1038/nature10373; Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746; Walker LM, 2009, J MOL BIOL, V389, P365, DOI 10.1016/j.jmb.2009.04.019; Wang SX, 2005, J VIROL, V79, P7933, DOI 10.1128/JVI.79.12.7933-7937.2005; West AP, 2012, P NATL ACAD SCI USA, V109, pE2083, DOI 10.1073/pnas.1208984109; Willey R, 2010, AIDS RES HUM RETROV, V26, P89, DOI 10.1089/aid.2009.0144; Wu XL, 2011, SCIENCE, V333, P1593, DOI 10.1126/science.1207532; Wu XL, 2010, SCIENCE, V329, P856, DOI 10.1126/science.1187659; Wyatt R, 1998, SCIENCE, V280, P1884, DOI 10.1126/science.280.5371.1884; Xiang SH, 2002, J VIROL, V76, P9888, DOI 10.1128/JVI.76.19.9888-9899.2002; Yang XZ, 2004, J VIROL, V78, P12975, DOI 10.1128/JVI.78.23.12975-12986.2004; Zhou TQ, 2007, NATURE, V445, P732, DOI 10.1038/nature05580; Zhou TQ, 2010, SCIENCE, V329, P811, DOI 10.1126/science.1192819	62	22	24	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 5	2013	288	14					9815	9825		10.1074/jbc.M112.425959	http://dx.doi.org/10.1074/jbc.M112.425959			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	119RB	23430741	hybrid, Green Published			2022-12-25	WOS:000317114000022
J	Caravagna, G; Mauri, G; d'Onofrio, A				Caravagna, Giulio; Mauri, Giancarlo; d'Onofrio, Alberto			The Interplay of Intrinsic and Extrinsic Bounded Noises in Biomolecular Networks	PLOS ONE			English	Article							EXACT STOCHASTIC SIMULATION; GENE-EXPRESSION; PERIODIC PERTURBATION; PROTEIN EXPRESSION; POSITIVE-FEEDBACK; SWITCHES; FLUCTUATIONS; MULTISTABILITY; BISTABILITY; SUPPRESSION	After being considered as a nuisance to be filtered out, it became recently clear that biochemical noise plays a complex role, often fully functional, for a biomolecular network. The influence of intrinsic and extrinsic noises on biomolecular networks has intensively been investigated in last ten years, though contributions on the co-presence of both are sparse. Extrinsic noise is usually modeled as an unbounded white or colored gaussian stochastic process, even though realistic stochastic perturbations are clearly bounded. In this paper we consider Gillespie-like stochastic models of nonlinear networks, i.e. the intrinsic noise, where the model jump rates are affected by colored bounded extrinsic noises synthesized by a suitable biochemical state-dependent Langevin system. These systems are described by a master equation, and a simulation algorithm to analyze them is derived. This new modeling paradigm should enlarge the class of systems amenable at modeling. We investigated the influence of both amplitude and autocorrelation time of a extrinsic Sine-Wiener noise on: (i) the Michaelis-Menten approximation of noisy enzymatic reactions, which we show to be applicable also in co-presence of both intrinsic and extrinsic noise, (ii) a model of enzymatic futile cycle and (iii) a genetic toggle switch. In (ii) and (iii) we show that the presence of a bounded extrinsic noise induces qualitative modifications in the probability densities of the involved chemicals, where new modes emerge, thus suggesting the possible functional role of bounded noises.	[Caravagna, Giulio; Mauri, Giancarlo] Univ Milano Bicocca, Dipartimento Informat Sistemist & Comunicaz, Milan, Italy; [d'Onofrio, Alberto] European Inst Oncol, Dept Expt Oncol, Milan, Italy	University of Milano-Bicocca; IRCCS European Institute of Oncology (IEO)	d'Onofrio, A (corresponding author), European Inst Oncol, Dept Expt Oncol, Milan, Italy.	alberto.donofrio@ieo.eu	Caravagna, Giulio/F-5011-2015; Mauri, Giancarlo/M-3258-2013; d'Onofrio, Alberto/R-4683-2016	Caravagna, Giulio/0000-0003-4240-3265; Mauri, Giancarlo/0000-0003-3520-4022; d'Onofrio, Alberto/0000-0002-2190-272X				ALFONSI A, 2005, ESAIM P, V14, P1, DOI DOI 10.1051/PROC:2005001; Alfonsi A., 2004, RR5435 INRIA; Alon U., 2006, INTRO SYSTEMS BIOL D; Anderson DF, 2007, J CHEM PHYS, V127, DOI 10.1063/1.2799998; Angeli D, 2004, P NATL ACAD SCI USA, V101, P1822, DOI 10.1073/pnas.0308265100; Becskei A, 2000, NATURE, V405, P590, DOI 10.1038/35014651; Becskei A, 2005, NAT GENET, V37, P937, DOI 10.1038/ng1616; Bena I, 2006, INT J MOD PHYS B, V20, P2825, DOI 10.1142/S0217979206034881; Bobryk RV, 2005, PHYSICA A, V358, P263, DOI 10.1016/j.physa.2005.03.055; Bouzas PR, 2007, COMPUTATION STAT, V22, P467, DOI 10.1007/s00180-007-0052-1; Cai GQ, 1996, PHYS REV E, V54, P299, DOI 10.1103/PhysRevE.54.299; Cai L, 2006, NATURE, V440, P358, DOI 10.1038/nature04599; Cao Y, 2005, J CHEM PHYS, V122, DOI [10.1063/1.1824902, 10.1063/1.1924598]; Caravagna G, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-S4-S8; Caravagna G, 2010, J THEOR BIOL, V265, P336, DOI 10.1016/j.jtbi.2010.05.013; Chalancon G, 2012, TRENDS GENET, V28, P221, DOI 10.1016/j.tig.2012.01.006; Chang HH, 2006, BMC CELL BIOL, V7, DOI 10.1186/1471-2121-7-11; Chen L, 2009, BIOMOLECULAR NETWORK; Cherry JL, 2000, J THEOR BIOL, V203, P117, DOI 10.1006/jtbi.2000.1068; Cinquin O, 2005, J THEOR BIOL, V233, P391, DOI 10.1016/j.jtbi.2004.10.027; COX DR, 1955, J ROY STAT SOC B, V17, P129; d'Onofrio A, BOUNDED STOCHASTIC P; d'Onofrio A, 2013, ADV EXP MED BIOL, V734, P111, DOI 10.1007/978-1-4614-1445-2_7; d'Onofrio A, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.061901; d'Onofrio A, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.021923; Daley D.J., 2003, INTRO THEORY POINT P, V2nd ed; de Franciscis S, 2012, PHYS REV E, V86, DOI 10.1103/PhysRevE.86.021118; Detwiler PB, 2000, BIOPHYS J, V79, P2801, DOI 10.1016/S0006-3495(00)76519-2; Doob JL, 1942, T AM MATH SOC, V52, P37, DOI 10.2307/1990152; DOOB JL, 1945, T AM MATH SOC, V58, P455, DOI 10.2307/1990339; Eldar A, 2010, NATURE, V467, P167, DOI 10.1038/nature09326; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; Feller W, 1940, T AM MATH SOC, V48, P488, DOI 10.2307/1990095; Ferrell JE, 1998, SCIENCE, V280, P895, DOI 10.1126/science.280.5365.895; Gardiner C. W., 1985, HDB STOCHASTIC METHO; Gardner TS, 2000, NATURE, V403, P339, DOI 10.1038/35002131; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Gibson MA, 2000, J PHYS CHEM A, V104, P1876, DOI 10.1021/jp993732q; Gillespie D., 2006, SYSTEMS MODELLING CE, P331, DOI DOI 10.7551/MITPRESS/9780262195485.003.0016; GILLESPIE DT, 1976, J COMPUT PHYS, V22, P403, DOI 10.1016/0021-9991(76)90041-3; Gillespie DT, 2001, J CHEM PHYS, V115, P1716, DOI 10.1063/1.1378322; Gillespie DT, 2000, J CHEM PHYS, V113, P297, DOI 10.1063/1.481811; GILLESPIE DT, 1977, J PHYS CHEM-US, V81, P2340, DOI 10.1021/j100540a008; GILLESPIE DT, 1980, J CHEM PHYS, V72, P5363, DOI 10.1063/1.439029; GLASS L, 1973, J THEOR BIOL, V39, P103, DOI 10.1016/0022-5193(73)90208-7; GRABERT H, 1983, PHYSICA A, V117, P300, DOI 10.1016/0378-4371(83)90119-X; GRIFFITH JS, 1968, J THEOR BIOL, V20, P209, DOI 10.1016/0022-5193(68)90190-2; Hallen M, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002209; Hasty J, 2000, P NATL ACAD SCI USA, V97, P2075, DOI 10.1073/pnas.040411297; Hilfinger A, 2011, P NATL ACAD SCI USA, V108, P12167, DOI 10.1073/pnas.1018832108; Horsthemke W., 1984, NOISE INDUCED TRANSI; Iglesias PA., 2010, CONTROL THEORY SYSTE; Junker B. H., 2008, WILEY SERIES BIOINFO; Kaern M, 2005, NAT REV GENET, V6, P451, DOI 10.1038/nrg1615; KAUFFMAN SA, 1969, J THEOR BIOL, V22, P437, DOI 10.1016/0022-5193(69)90015-0; Kolmogoroff A, 1931, MATH ANN, V104, P415, DOI 10.1007/BF01457949; Kramer BP, 2005, P NATL ACAD SCI USA, V102, P9517, DOI 10.1073/pnas.0500345102; Lestas I, 2010, NATURE, V467, P174, DOI 10.1038/nature09333; Losick R, 2008, SCIENCE, V320, P65, DOI 10.1126/science.1147888; Lotka A. J., 1925, ELEMENTS PHYS BIOL, DOI 10.1038/116461b0; Markevich NI, 2004, J CELL BIOL, V164, P353, DOI 10.1083/jcb.200308060; Mateescu M, 2010, IET SYST BIOL, V4, P441, DOI 10.1049/iet-syb.2010.0005; Murray J.D., 1993, MATH BIOL, V3rd; Nacher JC, 2011, OPEN BIOINF J, V5, P34; NoisySIM, 2012, NOISYSIM; Paulsson BO, 2011, SYSTEMS BIOL SIMULAT; Rao CV, 2002, NATURE, V420, P231, DOI 10.1038/nature01258; RIGNEY DR, 1977, J THEOR BIOL, V69, P761, DOI 10.1016/0022-5193(77)90381-2; Rigney DR, 1979, KINETIC LOGIC BOOLEA; Ross R, 1911, NATURE, V87, P466, DOI 10.1038/087466a0; Samoilov M, 2005, P NATL ACAD SCI USA, V102, P2310, DOI 10.1073/pnas.0406841102; Sanft KR, 2011, IET SYST BIOL, V5, P58, DOI 10.1049/iet-syb.2009.0057; SEGEL LA, 1989, SIAM REV, V31, P446, DOI 10.1137/1031091; Siegal-Gaskins D, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-96; SIMON Z, 1965, J THEOR BIOL, V8, P258, DOI 10.1016/0022-5193(65)90076-7; Smith DL, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002588; Stratonovich RL, 1963, TOPICS THEORY RANDOM, V1; Sugita M, 1964, J TH BIO, V4, P437; Thattai M, 2001, P NATL ACAD SCI USA, V98, P8614, DOI 10.1073/pnas.151588598; Thattai M, 2002, BIOPHYS J, V82, P2943, DOI 10.1016/S0006-3495(02)75635-X; THOMAS R, 1978, J THEOR BIOL, V73, P631, DOI 10.1016/0022-5193(78)90127-3; Todorovic P, 1992, SPRINGER SERIES STAT; Tomas R, 1990, BIOL FEEDBACKS; Tze-Leung T, 2010, SCIENCE, V327, P1142; Ullah M, 2011, STOCHASTIC APPROACHES FOR SYSTEMS BIOLOGY, P1, DOI 10.1007/978-1-4614-0478-1; Voet D, 1999, FOUNDAMENTALS BIOCH; Volterra V, 1926, NATURE, V118, P558, DOI 10.1038/118558a0; Wang L, 2009, P NATL ACAD SCI USA, V106, P6638, DOI 10.1073/pnas.0806137106; Wilkinson U, 2006, STOCHASTIC MODELLING; Wio HS, 2004, PHYSICA D, V193, P161, DOI 10.1016/j.physd.2004.01.017; Xiong W, 2003, NATURE, V426, P460, DOI 10.1038/nature02089; Yamada T, 2009, NAT REV MOL CELL BIO, V10, P791, DOI 10.1038/nrm2787; Zhdanov VP, 2012, CHAOS SOLITON FRACT, V45, P577, DOI 10.1016/j.chaos.2011.12.008; Zhdanov VP, 2011, PHYSICA A, V390, P57, DOI 10.1016/j.physa.2010.03.036; Zhdanov VP, 2009, J PHYS A-MATH THEOR, V42, DOI 10.1088/1751-8113/42/6/065102	95	30	30	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2013	8	2							e51174	10.1371/journal.pone.0051174	http://dx.doi.org/10.1371/journal.pone.0051174			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IT	23437034	Green Published, gold, Green Submitted			2022-12-25	WOS:000315186000001
J	Rothe, M; Alpert, C; Loh, G; Blaut, M				Rothe, Monique; Alpert, Carl; Loh, Gunnar; Blaut, Michael			Novel Insights into E-coli's Hexuronate Metabolism: KduI Facilitates the Conversion of Galacturonate and Glucuronate under Osmotic Stress Conditions	PLOS ONE			English	Article							ESCHERICHIA-COLI; 5-KETO-4-DEOXYURONATE ISOMERASE; SYSTEM GENES; TRANSPORT; DIFFUSION; PROTEINS; PATHWAY; REGULON; CLONING	Using a gnotobiotic mouse model, we previously observed the upregulation of 2-deoxy-D-gluconate 3-dehydrogenase (KduD) in intestinal E. coli of mice fed a lactose-rich diet and the downregulation of this enzyme and of 5-keto 4-deoxyuronate isomerase (KduI) on a casein-rich diet. The present study aimed to define the role of the so far poorly characterized E. coli proteins KduD and KduI in vitro. Galacturonate and glucuronate induced kduD and kduI gene expression 3-fold and 7 to 11-fold, respectively, under aerobic conditions as well as 9 to 20-fold and 19 to 54-fold, respectively, under anaerobic conditions. KduI facilitated the breakdown of these hexuronates. In E. coli, galacturonate and glucuronate are normally degraded by UxaABC and UxuAB. However, osmotic stress represses the expression of the corresponding genes in an OxyR-dependent manner. When grown in the presence of galacturonate or glucuronate, kduID-deficient E. coli had a 30% to 80% lower maximal cell density and 1.5 to 2-fold longer doubling times under osmotic stress conditions than wild type E. coli. Growth on lactose promoted the intracellular formation of hexuronates, which possibly explain the induction of KduD on a lactose-rich diet. These results indicate a novel function of KduI and KduD in E. coli and demonstrate the crucial influence of osmotic stress on the gene expression of hexuronate degrading enzymes.	[Rothe, Monique; Alpert, Carl; Loh, Gunnar; Blaut, Michael] German Inst Human Nutr Potsdam Rehbrucke, Dept Gastrointestinal Microbiol, Nuthetal, Germany	Deutsches Institut fur Ernahrungsforschung Potsdam-Rehbrucke (DIfE)	Blaut, M (corresponding author), German Inst Human Nutr Potsdam Rehbrucke, Dept Gastrointestinal Microbiol, Nuthetal, Germany.	blaut@dife.de		Blaut, Michael/0000-0002-6628-2907	Deutsche Forschungsgemeinschaft [BL 257/7-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This project was supported by grant BL 257/7-1 from Deutsche Forschungsgemeinschaft. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABENDANO JJ, 1973, BIOCHEM BIOPH RES CO, V54, P1342, DOI 10.1016/0006-291X(73)91134-0; Allen A, 1984, ATTACHMENT ORGANISMS, VII, P3; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; BARTOLOME B, 1991, GENE, V102, P75, DOI 10.1016/0378-1119(91)90541-I; BECKWITH JR, 1967, SCIENCE, V156, P597, DOI 10.1126/science.156.3775.597; COHN M, 1989, BIOCHIM BIOPHYS ACTA, V1000, P109, DOI 10.1016/S0006-3002(89)80012-5; CONDEMINE G, 1991, MOL MICROBIOL, V5, P2191, DOI 10.1111/j.1365-2958.1991.tb02149.x; CONDEMINE G, 1986, J BACTERIOL, V165, P937, DOI 10.1128/jb.165.3.937-941.1986; Crowther RL, 2005, PROTEINS, V61, P680, DOI 10.1002/prot.20598; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Dunten P, 1998, ACTA CRYSTALLOGR D, V54, P678, DOI 10.1107/S090744499701785X; Frey PA, 1996, FASEB J, V10, P461, DOI 10.1096/fasebj.10.4.8647345; Gill SR, 2006, SCIENCE, V312, P1355, DOI 10.1126/science.1124234; Hu WT, 2010, ANAL BIOCHEM, V398, P245, DOI 10.1016/j.ab.2009.11.002; Hugenholtz J, 1999, CURR OPIN BIOTECH, V10, P492, DOI 10.1016/S0958-1669(99)00016-6; Kageyama A, 1999, INT J SYST BACTERIOL, V49, P1725, DOI 10.1099/00207713-49-4-1725; Kamlage B, 1999, J NUTR, V129, P2212, DOI 10.1093/jn/129.12.2212; Kawano M, 2000, J BACTERIOL, V182, P2507, DOI 10.1128/JB.182.9.2507-2512.2000; Kleerebezem M, 1999, ANTON LEEUW INT J G, V76, P357, DOI 10.1023/A:1002084822851; Kornberg HL, 2000, P NATL ACAD SCI USA, V97, P1808, DOI 10.1073/pnas.97.4.1808; Kurokawa K, 2007, DNA RES, V14, P169, DOI 10.1093/dnares/dsm018; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAGARDE AE, 1975, EUR J BIOCHEM, V55, P343, DOI 10.1111/j.1432-1033.1975.tb02168.x; LANCASTER JR, 1977, J BIOL CHEM, V252, P7662; MATAGILSINGER M, 1983, GENETICS, V105, P829; Moon TS, 2009, ANAL BIOCHEM, V392, P183, DOI 10.1016/j.ab.2009.05.032; MUIR M, 1985, J BACTERIOL, V163, P1237, DOI 10.1128/JB.163.3.1237-1242.1985; Patrone V, 2012, MICROBIOL-SGM, V158, P983, DOI 10.1099/mic.0.054247-0; Peekhaus N, 1998, J BACTERIOL, V180, P3495, DOI 10.1128/JB.180.14.3495-3502.1998; PORTALIER R, 1980, J BACTERIOL, V143, P1095, DOI 10.1128/JB.143.3.1095-1107.1980; RICHEY DP, 1972, J BACTERIOL, V112, P784, DOI 10.1128/JB.112.2.784-790.1972; RITZENTHALER P, 1981, J BACTERIOL, V145, P181, DOI 10.1128/JB.145.1.181-190.1981; ROBERTBAUDOUY JM, 1973, BIOCHIM BIOPHYS ACTA, V309, P473, DOI 10.1016/0005-2744(73)90045-4; Rodionov DA, 2004, MICROBIOL-SGM, V150, P3571, DOI 10.1099/mic.0.27041-0; Rodionov DA, 2000, MOL MICROBIOL, V38, P673, DOI 10.1046/j.1365-2958.2000.02115.x; Rothe M, 2012, APPL ENVIRON MICROB, V78, P3580, DOI 10.1128/AEM.00244-12; Smith RAJ, 1999, EUR J BIOCHEM, V263, P709, DOI 10.1046/j.1432-1327.1999.00543.x; Stevenson G, 1996, J BACTERIOL, V178, P4885, DOI 10.1128/jb.178.16.4885-4893.1996; STOCK JB, 1977, J BIOL CHEM, V252, P7850; STORZ G, 1990, SCIENCE, V248, P189, DOI 10.1126/science.2183352; Turnbaugh PJ, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000322; Wu GD, 2011, SCIENCE, V334, P105, DOI 10.1126/science.1208344; Yatsunenko T, 2012, NATURE, V486, P222, DOI 10.1038/nature11053; Zheng M, 2001, J BACTERIOL, V183, P4562, DOI 10.1128/JB.183.15.4562-4570.2001	44	19	21	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2013	8	2							e56906	10.1371/journal.pone.0056906	http://dx.doi.org/10.1371/journal.pone.0056906			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IT	23437267	Green Published, gold, Green Submitted			2022-12-25	WOS:000315186000055
J	Hsu, KC; Hung, HC; Horng, JT; Fang, MY; Chang, CY; Li, LT; Chen, IJ; Chen, YC; Chou, DL; Chang, CW; Hsieh, HP; Yang, JM; Hsu, JTA				Hsu, Kai-Cheng; Hung, Hui-Chen; Horng, Jim-Tong; Fang, Ming-Yu; Chang, Chun-Yu; Li, Ling-Ting; Chen, I-Jung; Chen, Yun-Chu; Chou, Ding-Li; Chang, Chun-Wei; Hsieh, Hsing-Pang; Yang, Jinn-Moon; Hsu, John T. -A.			Parallel Screening of Wild-Type and Drug-Resistant Targets for Anti-Resistance Neuraminidase Inhibitors	PLOS ONE			English	Article							INFLUENZA-VIRUS NEURAMINIDASE; CELL LUNG-CANCER; OSELTAMIVIR RESISTANCE; MOLECULAR DOCKING; CHEMICAL SPACE; H1N1 VIRUS; IN-VITRO; DESIGN; PROTEIN; ACID	Infection with influenza virus is a major public health problem, causing serious illness and death each year. Emergence of drug-resistant influenza virus strains limits the effectiveness of drug treatment. Importantly, a dual H275Y/I223R mutation detected in the pandemic influenza A 2009 virus strain results in multidrug resistance to current neuraminidase (NA) drugs. Therefore, discovery of new agents for treating multiple drug-resistant (MDR) influenza virus infections is important. Here, we propose a parallel screening strategy that simultaneously screens wild-type (WT) and MDR NAs, and identifies inhibitors matching the subsite characteristics of both NA-binding sites. These may maintain their potency when drug-resistant mutations arise. Initially, we analyzed the subsite of the dual H275Y/I223R NA mutant. Analysis of the site-moiety maps of NA protein structures show that the mutant subsite has a relatively small volume and is highly polar compared with the WT subsite. Moreover, the mutant subsite has a high preference for forming hydrogen-bonding interactions with polar moieties. These changes may drive multidrug resistance. Using this strategy, we identified a new inhibitor, Remazol Brilliant Blue R (RB19, an anthraquinone dye), which inhibited WT NA and MDR NA with IC50 values of 3.4 and 4.5 mu M, respectively. RB19 comprises a rigid core scaffold and a flexible chain with a large polar moiety. The former interacts with highly conserved residues, decreasing the probability of resistance. The latter forms van der Waals contacts with the WT subsite and yields hydrogen bonds with the mutant subsite by switching the orientation of its flexible side chain. Both scaffolds of RB19 are good starting points for lead optimization. The results reveal a parallel screening strategy for identifying resistance mechanisms and discovering anti-resistance neuraminidase inhibitors. We believe that this strategy may be applied to other diseases with high mutation rates, such as cancer and human immunodeficiency virus type 1.	[Hsu, Kai-Cheng; Li, Ling-Ting; Yang, Jinn-Moon] Natl Chiao Tung Univ, Inst Bioinformat & Syst Biol, Hsinchu, Taiwan; [Hung, Hui-Chen; Fang, Ming-Yu; Chang, Chun-Yu; Chen, I-Jung; Chang, Chun-Wei; Hsieh, Hsing-Pang; Hsu, John T. -A.] Natl Hlth Res Inst, Inst Biotechnol & Pharmaceut Res, Miaoli, Taiwan; [Horng, Jim-Tong; Chen, Yun-Chu; Chou, Ding-Li] Chang Gung Univ, Dept Biochem, Tao Yuan, Taiwan; [Yang, Jinn-Moon; Hsu, John T. -A.] Natl Chiao Tung Univ, Dept Biol Sci & Technol, Hsinchu, Taiwan; [Yang, Jinn-Moon] Natl Chiao Tung Univ, Ctr Bioinformat Res, Hsinchu, Taiwan	National Yang Ming Chiao Tung University; National Health Research Institutes - Taiwan; Chang Gung University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University	Yang, JM (corresponding author), Natl Chiao Tung Univ, Inst Bioinformat & Syst Biol, Hsinchu, Taiwan.	moon@faculty.nctu.edu.tw; tsuanhsu@nhri.org.tw	Yang, Jinn-Moon/AAU-4400-2021; Hsu, John Tsu-An/C-1199-2010; Hsieh, Hsing-Pang/B-2649-2010; Fang, Ming Yu/K-8577-2013	Hsieh, Hsing-Pang/0000-0002-1332-005X; Fang, Ming Yu/0000-0002-2530-7522; Yang, Jinn-Moon/0000-0002-3205-4391; Horng, Jim-Tong/0000-0001-6294-9981	National Science Council; Ministry of Education and National Health Research Institutes [NHRI-EX100-10009PI]; National Science Council [NSC 98-2323-B-002-010, NSC 100-2325-B-009-002]; National Health Research Institutes of Taiwan, the Republic of China [NHRI-EX100-10009PI]; 'Aim for the Top University Plan' of the National Chiao Tung University and Ministry of Education, Taiwan; National Core Facility Program for Biotechnology	National Science Council(Ministry of Science and Technology, Taiwan); Ministry of Education and National Health Research Institutes; National Science Council(Ministry of Science and Technology, Taiwan); National Health Research Institutes of Taiwan, the Republic of China; 'Aim for the Top University Plan' of the National Chiao Tung University and Ministry of Education, Taiwan; National Core Facility Program for Biotechnology	J.-M. Yang was supported by National Science Council, partial supports of Ministry of Education and National Health Research Institutes (NHRI-EX100-10009PI). J.T.-A H was supported by the National Science Council (NSC 98-2323-B-002-010 and NSC 100-2325-B-009-002) and National Health Research Institutes (NHRI-EX100-10009PI) of Taiwan, the Republic of China. This paper is also particularly supported by 'Aim for the Top University Plan' of the National Chiao Tung University and Ministry of Education, Taiwan. J.-M. Yang also thanks Core Facility for Protein Structural Analysis supported by National Core Facility Program for Biotechnology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2005, MED LETT DRUGS THERA, V47, P93; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Babu YS, 2000, J MED CHEM, V43, P3482, DOI 10.1021/jm0002679; Bharathi A, 1997, GENE, V198, P251, DOI 10.1016/S0378-1119(97)00322-3; BROWNING CH, 1967, BRIT MED J, V2, P111, DOI 10.1136/bmj.2.5544.111-a; Carr J, 2002, ANTIVIR RES, V54, P79, DOI 10.1016/S0166-3542(01)00215-7; Chen LM, 2004, J VIROL, V78, P3722, DOI 10.1128/JVI.78.7.3722-3732.2004; Chen YF, 2010, NUCLEIC ACIDS RES, V38, pW424, DOI 10.1093/nar/gkq480; Chin KH, 2010, J MOL BIOL, V396, P646, DOI 10.1016/j.jmb.2009.11.076; Collins PJ, 2008, NATURE, V453, P1258, DOI 10.1038/nature06956; COLMAN PM, 1994, PROTEIN SCI, V3, P1687, DOI 10.1002/pro.5560031007; CORY AH, 1991, CANCER COMMUN, V3, P207, DOI 10.3727/095535491820873191; Dandapani S, 2010, NAT CHEM BIOL, V6, P861, DOI 10.1038/nchembio.479; de Jong MD, 2005, NEW ENGL J MED, V353, P2667, DOI 10.1056/NEJMoa054512; Duesberg P, 2000, P NATL ACAD SCI USA, V97, P14295, DOI 10.1073/pnas.97.26.14295; Ewing TJA, 2001, J COMPUT AID MOL DES, V15, P411, DOI 10.1023/A:1011115820450; Ferri N, 2009, J MED CHEM, V52, P4087, DOI 10.1021/jm8015987; Fukuoka M, 2003, J CLIN ONCOL, V21, P2237, DOI 10.1200/JCO.2003.10.038; Hsieh HP, 2007, CURR PHARM DESIGN, V13, P3531, DOI 10.2174/138161207782794248; Hsu KC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032142; Hsu KC, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-S1-S33; Hung HC, 2009, ANTIVIR RES, V81, P123, DOI 10.1016/j.antiviral.2008.10.006; Hurt AC, 2009, ANTIMICROB AGENTS CH, V53, P4433, DOI 10.1128/AAC.00334-09; Irwin JJ, 2005, J CHEM INF MODEL, V45, P177, DOI 10.1021/ci049714+; JEDRZEJAS MJ, 1995, BIOCHEMISTRY-US, V34, P3144, DOI 10.1021/bi00010a003; Jones G, 1997, J MOL BIOL, V267, P727, DOI 10.1006/jmbi.1996.0897; Jonges M, 2010, J CLIN MICROBIOL, V48, P928, DOI 10.1128/JCM.02045-09; Kim CU, 1998, J MED CHEM, V41, P2451, DOI 10.1021/jm980162u; Kim CU, 1997, J AM CHEM SOC, V119, P681, DOI 10.1021/ja963036t; Kitchen DB, 2004, NAT REV DRUG DISCOV, V3, P935, DOI 10.1038/nrd1549; Kobayashi S, 2005, NEW ENGL J MED, V352, P786, DOI 10.1056/NEJMoa044238; Kramer B, 1999, PROTEINS, V37, P228, DOI 10.1002/(SICI)1097-0134(19991101)37:2<228::AID-PROT8>3.0.CO;2-8; Li WX, 1998, ANTIMICROB AGENTS CH, V42, P647, DOI 10.1128/AAC.42.3.647; Lipinski C, 2004, NATURE, V432, P855, DOI 10.1038/nature03193; Luo M, 2006, NATURE, V443, P37, DOI 10.1038/nature05003; Lyne PD, 2002, DRUG DISCOV TODAY, V7, P1047, DOI 10.1016/S1359-6446(02)02483-2; Mandi G, 2005, TROP MED INT HEALTH, V10, P32, DOI 10.1111/j.1365-3156.2004.01356.x; Maring CJ, 2005, J MED CHEM, V48, P3980, DOI 10.1021/jm049276y; MEINDL P, 1974, VIROLOGY, V58, P457, DOI 10.1016/0042-6822(74)90080-4; Meissner PE, 2005, MALARIA J, V4, DOI 10.1186/1475-2875-4-45; Morris GM, 1996, J COMPUT AID MOL DES, V10, P293, DOI 10.1007/BF00124499; Moscona A, 2005, NEW ENGL J MED, V353, P2633, DOI 10.1056/NEJMp058291; Neumann G, 2009, NATURE, V459, P931, DOI 10.1038/nature08157; Nguyen HT, 2010, CLIN INFECT DIS, V51, P983, DOI 10.1086/656439; Nunziante M, 2005, J CELL SCI, V118, P4959, DOI 10.1242/jcs.02609; PALESE P, 1982, SCIENCE, V215, P1468, DOI 10.1126/science.7038875; PALESE P, 1974, VIROLOGY, V59, P490, DOI 10.1016/0042-6822(74)90458-9; PENNISI E, 1995, SCIENCE, V270, P1916, DOI 10.1126/science.270.5244.1916; Pizzorno A, 2011, SEMIN RESP CRIT CARE, V32, P409, DOI 10.1055/s-0031-1283281; POTIER M, 1979, ANAL BIOCHEM, V94, P287, DOI 10.1016/0003-2697(79)90362-2; Rambaut A, 2009, PLOS CURR, V1, DOI DOI 10.1371/CURRENTS.RRN1003; Ravindranathan KP, 2010, J MED CHEM, V53, P1662, DOI 10.1021/jm901386e; Russell RJ, 2006, NATURE, V443, P45, DOI 10.1038/nature05114; Sawatdichaikul O, 2012, J MOL MODEL, V18, P1241, DOI 10.1007/s00894-011-1135-z; Service RF, 1997, SCIENCE, V275, P756, DOI 10.1126/science.275.5301.756; SETO JT, 1966, VIROLOGY, V30, P731, DOI 10.1016/0042-6822(66)90178-4; Shih SR, 2010, J ANTIMICROB CHEMOTH, V65, P63, DOI 10.1093/jac/dkp393; Shindyalov IN, 1998, PROTEIN ENG, V11, P739, DOI 10.1093/protein/11.9.739; Smee DF, 2001, ANTIMICROB AGENTS CH, V45, P743, DOI 10.1128/AAC.45.3.743-748.2001; Smith J, 2005, CLIN THER, V27, P1513, DOI 10.1016/j.clinthera.2005.10.014; Steele RM, 2009, BIOORG MED CHEM LETT, V19, P6565, DOI 10.1016/j.bmcl.2009.10.036; Stoll V, 2003, BIOCHEMISTRY-US, V42, P718, DOI 10.1021/bi0205449; Tanrikulu Y, 2008, NAT REV DRUG DISCOV, V7, P667, DOI 10.1038/nrd2615; van der Vries E, 2010, NEW ENGL J MED, V363, P1381, DOI 10.1056/NEJMc1003749; Varghese JN, 1997, P NATL ACAD SCI USA, V94, P11808, DOI 10.1073/pnas.94.22.11808; Venkatramani L, 2006, J MOL BIOL, V356, P651, DOI 10.1016/j.jmb.2005.11.061; VONITZSTEIN M, 1993, NATURE, V363, P418, DOI 10.1038/363418a0; Wang YL, 2009, NUCLEIC ACIDS RES, V37, pW623, DOI 10.1093/nar/gkp456; Wood JM, 2007, INFLUENZA OTHER RESP, V1, P5, DOI 10.1111/j.1750-2659.2006.00003.x; Xu XJ, 2008, J VIROL, V82, P10493, DOI 10.1128/JVI.00959-08; Yang JM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000428; Yang JM, 2005, J CHEM INF MODEL, V45, P1134, DOI 10.1021/ci050034w; Yang JM, 2005, PROTEINS, V59, P205, DOI 10.1002/prot.20387; Yang JM, 2004, PROTEINS, V55, P288, DOI 10.1002/prot.20035; Yang L, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002016; Yang M, 2008, INDIAN J TRADIT KNOW, V7, P3; Yen HL, 2006, J VIROL, V80, P8787, DOI 10.1128/JVI.00477-06	77	8	8	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e56704	10.1371/journal.pone.0056704	http://dx.doi.org/10.1371/journal.pone.0056704			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437217	Green Submitted, gold, Green Published			2022-12-25	WOS:000315184200147
J	Kovess, V; Pilowsky, DJ; Boyd, A; Pez, O; Bitfoi, A; Carta, M; Eke, C; Golitz, D; Kuijpers, R; Lesinskiene, S; Mihova, Z; Otten, R; Susser, E				Kovess, Viviane; Pilowsky, Daniel J.; Boyd, Anders; Pez, Ondine; Bitfoi, Adina; Carta, Mauro; Eke, Ceyda; Golitz, Dietmar; Kuijpers, Rowella; Lesinskiene, Sigita; Mihova, Zlatka; Otten, Roy; Susser, Ezra			Parental Smoking in the Vicinity of Children and Tobacco Control Policies in the European Region	PLOS ONE			English	Article							2ND-HAND SMOKE; EXPOSURE; HEALTH	Objective: To ascertain patterns of parental smoking in the vicinity of children in Eastern and Western Europe and their relation to Tobacco Control Scale (TCS) scores. Methods: Data on parental smoking patterns were obtained from the School Child Mental Health Europe (SCMHE), a 2010 cross-sectional survey of 5141 school children aged 6 to 11 years and their parents in six countries: Germany, Netherlands, Lithuania, Romania, Bulgaria and Turkey ranked by TCS into three level categories toward tobacco control policies. Results: A slightly higher proportion of Eastern compared to Western European mothers (42.4 vs. 35.1%) were currently smoking in but the difference was not statistically significant after adjusting for maternal age and maternal educational attainment. About a fifth (19.3%) and a tenth (10.0%) of Eastern and Western European mothers, respectively, smoked in the vicinity of their children, and the difference was significant even after adjustment for potential confounders (p<0.001). Parents with the highest educational attainment were significantly less likely to smoke in the vicinity of their children than those with the lowest attainment. After control of these covariates lax tobacco control policies, compared to intermediate policies, were associated with a 50% increase in the likelihood of maternal smoking in the vicinity of children adjusted odds ratio (AOR) = 1.52 and 1.64. Among fathers, however, the relationship with paternal smoking and TCS seems more complex since strict policy increases the risk as well AOR = 1,40. Only one country, however belongs to the strict group. Significance: Tobacco control policies seem to have influenced maternal smoking behaviors overall to a limited degree and smoking in the vicinity of children to a much greater degree. Children living in European countries with lax tobacco control policies are more likely to be exposed to second hand smoking from maternal and paternal smoking.	[Kovess, Viviane; Pez, Ondine] Univ Paris 05, EHESP Rennes, EA 4069, Paris, France; [Pilowsky, Daniel J.] Columbia Univ, Dept Epidemiol & Psychiat, New York, NY USA; [Boyd, Anders] EHESP, Inserm Unite Mixte Rech Sante 707, Paris, France; [Bitfoi, Adina] Romanian League Mental Hlth, Bucharest, Romania; [Carta, Mauro] Univ Cagliari, Dept Publ Hlth, Psychiat Unit, Cagliari, Italy; [Eke, Ceyda] Yeniden Hlth & Educ Soc, Istanbul, Turkey; [Golitz, Dietmar] Leuphana Univ Luneburg, Inst Psychol, Luneburg, Germany; [Kuijpers, Rowella] Radboud Univ Nijmegen, Inst Behav Sci, NL-6525 ED Nijmegen, Netherlands; [Lesinskiene, Sigita] Vilnius State Univ, Psychiat Clin, Fac Med, Vilnius, Lithuania; [Mihova, Zlatka] Fdn Human Relat, Sofia, Bulgaria; [Otten, Roy] Radboud Univ Nijmegen, Fac Social Sci, NL-6525 ED Nijmegen, Netherlands; [Susser, Ezra] Columbia Univ, Mailman Sch Publ Hlth, New York, NY USA; [Pilowsky, Daniel J.; Susser, Ezra] New York State Psychiat Inst & Hosp, New York, NY 10032 USA	UDICE-French Research Universities; Universite Paris Cite; Columbia University; Ecole des Hautes Etudes en Sante Publique (EHESP); Institut National de la Sante et de la Recherche Medicale (Inserm); University of Cagliari; Leuphana University Luneburg; Radboud University Nijmegen; Vilnius University; Radboud University Nijmegen; Columbia University; New York State Psychiatry Institute	Kovess, V (corresponding author), Univ Paris 05, EHESP Rennes, EA 4069, Paris, France.	Viviane.kovess@ehesp.fr	Boyd, Anders/GLQ-8906-2022	Boyd, Anders/0000-0001-9512-8928	European Union [2006336]	European Union(European Commission)	This project had been financed by the European Union, grant number 2006336. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen A, 2012, TOB CONTROL, DOI [10.1136/tobaccocontrol-2011-050391, DOI 10.1136/TOBACCOCONTROL-2011-050391]; [Anonymous], FLASH EB 253 SURVEY; [Anonymous], 5 EUR C TOB HLTH AMS; Bogdanovica I, 2011, TOB CONTROL, V20, DOI 10.1136/tc.2010.036103; Flouris AD, 2010, AM J PHYSIOL-LUNG C, V298, pL3, DOI 10.1152/ajplung.00215.2009; Glover M, 2011, ADDICT BEHAV, V36, P1027, DOI 10.1016/j.addbeh.2011.06.003; Gruer L, 2012, PUBLIC HEALTH, V126, P227, DOI 10.1016/j.puhe.2011.12.005; Herrmann M, 2008, CURR OPIN PEDIATR, V20, P184, DOI 10.1097/MOP.0b013e3282f56165; Leonardi-Bee J, 2008, ARCH DIS CHILD-FETAL, V93, pF351, DOI 10.1136/adc.2007.133553; Oberg M, 2011, LANCET, V377, P139, DOI 10.1016/S0140-6736(10)61388-8; Pattenden S, 2006, TOB CONTROL, V15, DOI 10.1136/tc.2005.015065; Peto R, 2000, BRIT MED J, V321, P323, DOI 10.1136/bmj.321.7257.323; Pez O., 2011, SCH CHILDREN MENTAL; Sims M, 2010, ADDICTION, V105, P543, DOI 10.1111/j.1360-0443.2009.02805.x; Special Eurobarometer, 2006, ATTITUDES EUROPEAN T, V239, P641; Statistics Canada, 2007, CAN COMM HLTH SURV C; Wang HD, 2009, P NATL ACAD SCI USA, V106, P393, DOI 10.1073/pnas.0811809106; Winickoff JP, 2003, PEDIATRICS, V112, P1146, DOI 10.1542/peds.112.5.1146; World Health Organization (WHO), 2005, WHO FRAM CONV TOB CO	19	10	10	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e56783	10.1371/journal.pone.0056783	http://dx.doi.org/10.1371/journal.pone.0056783			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	093IE	23437236	Green Published, gold, Green Submitted			2022-12-25	WOS:000315184200160
J	Liu, YY; Fatheree, NY; Dingle, BM; Tran, DQ; Rhoads, JM				Liu, Yuying; Fatheree, Nicole Y.; Dingle, Bridgette M.; Tran, Dat Q.; Rhoads, Jon Marc			Lactobacillus reuteri DSM 17938 Changes the Frequency of Foxp3(+) Regulatory T Cells in the Intestine and Mesenteric Lymph Node in Experimental Necrotizing Enterocolitis	PLOS ONE			English	Article							EPIDERMAL-GROWTH-FACTOR; NEONATAL-RAT MODEL; BACTERIAL-COLONIZATION; GUT DEVELOPMENT; LAMINA PROPRIA; BREAST-MILK; INFANTS; EXPRESSION; BIFIDOBACTERIA; STIMULATION	Necrotizing enterocolitis (NEC) is an inflammatory disease of the intestine in premature infants. Lactobacillus reuteri DSM 17938 improves survival and reduces the incidence and severity of NEC in a rodent model. Foxp3(+) regulatory T cells (Tregs) maintain intestinal homeostasis by controlling inflammation and inducing tolerance. To determine whether there are insufficient numbers of Tregs to control inflammation in NEC and to determine if LR17938 increases the frequency of Tregs, we studied selected groups of newborn Sprague-Dawley rats according to feeding plan: dam +/- LR17938, formula +/- LR17938, and NEC +/- LR17938. NEC was induced by gavage feeding with special formula and exposure to hypoxic conditions. Lymphocytes isolated from ileum, mesenteric lymph nodes (MLN), spleen and thymus were labeled for T cell surface markers (CD3, CD4, CD8) and intracellular Foxp3; and labeled cells were analyzed by flow cytometry. The percentage of CD3(+) T cells and Foxp3(+) Tregs in the ileum significantly decreased in pups with NEC, compared to normal controls. Feeding LR17938 to neonatal rats with NEC increased the % of Foxp3(+) T cells in the ileum while decreasing the percentage of cells in the MLN. Administration of LR17938 to dam-fed rats significantly increased Foxp3(+)Tregs in the ileum as early as day of life (DOL)1 but did not produce an increase in Tregs in formula-fed rats on DOL1. These results suggest that factors in breast milk may enhance the early immunomodulatory effects of LR17938. An anti-inflammatory effect of LR17938 in NEC was associated with the modulation of immune responses and induction and what appears to be migration of Foxp3(+) Tregs to the diseased gut. Probiotic-facilitated development of Tregs might play an important role in the prevention of NEC.	[Rhoads, Jon Marc] Univ Texas Houston, Hlth Sci Ctr, Dept Pediat, Div Gastroenterol,Med Sch, Houston, TX 77225 USA; Univ Texas Houston, Hlth Sci Ctr, Div Allergy Immunol, Dept Pediat,Med Sch, Houston, TX 77225 USA	University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston	Rhoads, JM (corresponding author), Univ Texas Houston, Hlth Sci Ctr, Dept Pediat, Div Gastroenterol,Med Sch, Houston, TX 77225 USA.	j.marc.rhoads@uth.tmc.edu	Liu, Yuying/ABB-8417-2021	Liu, Yuying/0000-0003-3848-9254	public health service grant [DK56338]; Biogaia, Inc, Stockholm, Sweden; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL113304] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056338] Funding Source: NIH RePORTER	public health service grant(United States Department of Health & Human ServicesUnited States Public Health Service); Biogaia, Inc, Stockholm, Sweden; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by public health service grant DK56338, which funds the Texas medical center digestive diseases center and in part by by Biogaia, Inc, Stockholm, Sweden. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boehm F, 2012, BMC GASTROENTEROL, V12, DOI 10.1186/1471-230X-12-97; Bruder MC, 1999, TOXICOL PATHOL, V27, P171, DOI 10.1177/019262339902700204; Caicedo RA, 2005, PEDIATR RES, V58, P625, DOI 10.1203/01.PDR.0000180533.09295.84; Chang CC, 2002, NAT IMMUNOL, V3, P237, DOI 10.1038/ni760; Chen ML, 2009, EUR J IMMUNOL, V39, P3423, DOI 10.1002/eji.200939441; Cilieborg MS, 2012, EARLY HUM DEV, V88, pS41, DOI 10.1016/j.earlhumdev.2011.12.027; Claud EC, 2008, J CLIN GASTROENTEROL, V42, pS46, DOI 10.1097/MCG.0b013e31815a57a8; Dvorak B, 2003, PEDIATR RES, V53, P426, DOI 10.1203/01.PDR.0000050657.56817.E0; Dvorak B, 2002, AM J PHYSIOL-GASTR L, V282, pG156, DOI 10.1152/ajpgi.00196.2001; Dvorak B, 2008, J PEDIATR GASTR NUTR, V47, P11, DOI 10.1097/MPG.0b013e3181788618; Gronlund MM, 2007, CLIN EXP ALLERGY, V37, P1764, DOI 10.1111/j.1365-2222.2007.02849.x; Gueimonde M, 2007, NEONATOLOGY, V92, P64, DOI 10.1159/000100088; Hahn BH, 2005, J IMMUNOL, V175, P7728, DOI 10.4049/jimmunol.175.11.7728; Hunter CJ, 2008, PEDIATR RES, V63, P117, DOI 10.1203/PDR.0b013e31815ed64c; Joosten SA, 2007, P NATL ACAD SCI USA, V104, P8029, DOI 10.1073/pnas.0702257104; Lee Jane S, 2003, Semin Neonatol, V8, P449, DOI 10.1016/S1084-2756(03)00123-4; Lin PW, 2008, SEMIN PERINATOL, V32, P70, DOI 10.1053/j.semperi.2008.01.004; Lin YP, 2008, INFLAMM BOWEL DIS, V14, P1068, DOI 10.1002/ibd.20448; Liu Y, 2011, AM J PHYSL GASTROINT; Liu Y, 2010, AM J PHYSL GASTROINT; Liu YY, 2009, AM J PHYSIOL-GASTR L, V297, pG442, DOI 10.1152/ajpgi.00182.2009; Mack DR, 2003, GUT, V52, P827, DOI 10.1136/gut.52.6.827; Menezes JD, 2003, INT IMMUNOL, V15, P447, DOI 10.1093/intimm/dxg043; Mountzouris KC, 2002, BRIT J NUTR, V87, P405, DOI 10.1079/BJN2002563; Mshvildadze M, 2008, NUTR REV, V66, P658, DOI 10.1111/j.1753-4887.2008.00119.x; Nadler EP, 2000, J SURG RES, V92, P71, DOI 10.1006/jsre.2000.5877; Neu J, 2007, AM J CLIN NUTR, V85, p629S, DOI 10.1093/ajcn/85.2.629S; Neu J, 2011, NEW ENGL J MED, V364, P255, DOI 10.1056/NEJMra1005408; Perez-Cano FJ, 2005, PEDIATR RES, V58, P164, DOI 10.1203/01.PDR.0000156367.60769.36; Reibke R, 2006, P NATL ACAD SCI USA, V103, P15142, DOI 10.1073/pnas.0602622103; Rosander A, 2008, APPL ENVIRON MICROB, V74, P6032, DOI 10.1128/AEM.00991-08; Sangild PT, 2006, GASTROENTEROLOGY, V130, P1776, DOI 10.1053/j.gastro.2006.02.026; Singh RP, 2007, J IMMUNOL, V178, P7649, DOI 10.4049/jimmunol.178.12.7649; SPENCER J, 1989, J PEDIATR GASTR NUTR, V9, P173, DOI 10.1097/00005176-198908000-00007; SPENCER J, 1986, CLIN EXP IMMUNOL, V65, P553; Tran DQ, 2007, BLOOD, V110, P2983, DOI 10.1182/blood-2007-06-094656; Uss E, 2006, J IMMUNOL, V177, P2775, DOI 10.4049/jimmunol.177.5.2775; VAAGE JT, 1990, EUR J IMMUNOL, V20, P1193, DOI 10.1002/eji.1830200538; Wang QZ, 2012, J PEDIATR SURG, V47, P241, DOI 10.1016/j.jpedsurg.2011.09.064; Weitkamp JH, 2009, PEDIATR DEVEL PATHOL, V12, P443, DOI 10.2350/08-09-0533.1; Westerbeek EAM, 2006, CLIN NUTR, V25, P361, DOI 10.1016/j.clnu.2006.03.002; Zelenika D, 1998, J IMMUNOL, V161, P1868; Zhang L, 2009, J IMMUNOL, V183, P6346, DOI 10.4049/jimmunol.0901773	43	50	58	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e56547	10.1371/journal.pone.0056547	http://dx.doi.org/10.1371/journal.pone.0056547			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437165	Green Published, Green Submitted, gold			2022-12-25	WOS:000315184200103
J	Magle, SB; Samuel, MD; Van Deelen, TR; Robinson, SJ; Mathews, NE				Magle, Seth B.; Samuel, Michael D.; Van Deelen, Timothy R.; Robinson, Stacie J.; Mathews, Nancy E.			Evaluating Spatial Overlap and Relatedness of White-tailed Deer in a Chronic Wasting Disease Management Zone	PLOS ONE			English	Article							MAXIMUM-LIKELIHOOD-ESTIMATION; SOCIAL-ORGANIZATION; PRION TRANSMISSION; GENETIC-STRUCTURE; SPACE USE; ELK	Wildlife disease transmission, at a local scale, can occur from interactions between infected and susceptible conspecifics or from a contaminated environment. Thus, the degree of spatial overlap and rate of contact among deer is likely to impact both direct and indirect transmission of infectious diseases such chronic wasting disease (CWD) or bovine tuberculosis. We identified a strong relationship between degree of spatial overlap (volume of intersection) and genetic relatedness for female white-tailed deer in Wisconsin's area of highest CWD prevalence. We used volume of intersection as a surrogate for contact rates between deer and concluded that related deer are more likely to have contact, which may drive disease transmission dynamics. In addition, we found that age of deer influences overlap, with fawns exhibiting the highest degree of overlap with other deer. Our results further support the finding that female social groups have higher contact among related deer which can result in transmission of infectious diseases. We suggest that control of large social groups comprised of closely related deer may be an effective strategy in slowing the transmission of infectious pathogens, and CWD in particular.	[Magle, Seth B.] Urban Wildlife Inst, Chicago, IL 60614 USA; [Samuel, Michael D.] Univ Wisconsin, US Geol Survey, Wisconsin Cooperat Wildlife Res Unit, Madison, WI USA; [Van Deelen, Timothy R.; Robinson, Stacie J.] Univ Wisconsin, Dept Forest & Wildlife Ecol, Madison, WI USA; [Mathews, Nancy E.] Univ Wisconsin, Nelson Inst Environm Studies, Madison, WI USA	United States Department of the Interior; United States Geological Survey; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Magle, SB (corresponding author), Urban Wildlife Inst, Lincoln Pk Zoo, Chicago, IL 60614 USA.	SMagle@lpzoo.org		Magle, Seth/0000-0003-0275-3885	Wisconsin Department of Natural Resources; Whitetails Unlimited; University of Wisconsin; National Beef and Cattleman's Association; North Central Agricultural Experiment Station Hatch Program	Wisconsin Department of Natural Resources; Whitetails Unlimited; University of Wisconsin; National Beef and Cattleman's Association; North Central Agricultural Experiment Station Hatch Program	This project was supported by the Wisconsin Department of Natural Resources, Whitetails Unlimited, the University of Wisconsin, the National Beef and Cattleman's Association, and the North Central Agricultural Experiment Station Hatch Program. Thanks to the University of Wisconsin's Department of Forest & Wildlife Ecology and the Nelson Institute for Environmental Studies for assistance with publication costs. Note that any use of trade, product or firm names is for descriptive purposes, and does not imply endorsement by the United States Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altizer S, 2003, ANNU REV ECOL EVOL S, V34, P517, DOI 10.1146/annurev.ecolsys.34.030102.151725; Atwood TC, 2002, AM MIDL NAT, V148, P289, DOI 10.1674/0003-0031(2002)148[0289:SAASPO]2.0.CO;2; Aycrigg JL, 1997, J MAMMAL, V78, P468, DOI 10.2307/1382899; Blanchong JA, 2008, BIOL LETTERS, V4, P130, DOI 10.1098/rsbl.2007.0523; Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; Comer CE, 2005, J WILDLIFE MANAGE, V69, P332, DOI 10.2193/0022-541X(2005)069&lt;0332:FGSASO&gt;2.0.CO;2; Cross Paul C., 2009, P9, DOI 10.1007/978-4-431-77134-0_2; FORD RG, 1979, J THEOR BIOL, V76, P125, DOI 10.1016/0022-5193(79)90366-7; Grear DA, 2010, J APPL ECOL, V47, P532, DOI 10.1111/j.1365-2664.2010.01813.x; Habib TJ, 2011, ECOL MODEL, V222, P2722, DOI 10.1016/j.ecolmodel.2011.05.007; HAWKINS RE, 1968, J WILDLIFE MANAGE, V32, P191, DOI 10.2307/3798258; HAWKINS RE, 1970, J WILDLIFE MANAGE, V34, P407, DOI 10.2307/3799027; Hirth DH, 1977, WILDLIFE MONOGR, V53, P3, DOI DOI 10.2307/3830446; Joly DO, 2003, EMERG INFECT DIS, V9, P599, DOI 10.3201/eid0905.020721; Kalinowski ST, 2006, MOL ECOL NOTES, V6, P576, DOI 10.1111/j.1471-8286.2006.01256.x; Kie JG, 1999, J MAMMAL, V80, P1004, DOI 10.2307/1383271; Kjaer LJ, 2008, J WILDLIFE MANAGE, V72, P1819, DOI 10.2193/2007-489; LASETER B. R., 2004, THESIS U GEORGIA ATH; LOCATION OF A SIGNAL TM, 2003, LOC SIGN; Mathews N.E., 1989, THESIS STATE U NEW Y; MATHEWS NE, 1993, J MAMMAL, V74, P33, DOI 10.2307/1381903; McCallum H, 2001, TRENDS ECOL EVOL, V16, P295, DOI 10.1016/S0169-5347(01)02144-9; Miller KV, 1997, WILDLIFE SOC B, V25, P279; Miller MW, 2003, NATURE, V425, P35, DOI 10.1038/425035a; Miller MW, 2004, EMERG INFECT DIS, V10, P1003, DOI 10.3201/eid1006.040010; Milligan BG, 2003, GENETICS, V163, P1153; Millspaugh JSJ, 2004, WILDLIFE SOC B, V32, P148, DOI 10.2193/0091-7648(2004)32[148:COTATT]2.0.CO;2; Nelson ME, 1999, CAN J ZOOL, V77, P1128, DOI 10.1139/cjz-77-7-1128; NIXON CM, 1991, WILDLIFE MONOGR, P1; Oyer AM, 2007, J WILDLIFE MANAGE, V71, P1635, DOI 10.2193/2006-381; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Pinheiro J., 2019, NLME LINEAR NONLINEA; Pinheiro J.C., 2000, MIXED EFFECTS MODELS, DOI [10.1007/0-387-22747-4_1, DOI 10.1007/B98882]; PORTER WF, 1991, ENVIRON MANAGE, V15, P809, DOI 10.1007/BF02394818; QUELLER DC, 1989, EVOLUTION, V43, P258, DOI 10.1111/j.1558-5646.1989.tb04226.x; RAMSEY CW, 1968, J WILDLIFE MANAGE, V32, P187, DOI 10.2307/3798257; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Robinson SJ, 2012, MOL ECOL, V21, P4190, DOI 10.1111/j.1365-294X.2012.05681.x; Rosenberry CS, 2009, J WILDLIFE MANAGE, V73, P357, DOI 10.2193/2007-050; Schauber EM, 2007, J WILDLIFE MANAGE, V71, P155, DOI 10.2193/2005-546; SEVERINGHAUS CW, 1949, J WILDLIFE MANAGE, V13, P195, DOI 10.2307/3796089; Silbernagel ER, 2011, J WILDLIFE MANAGE, V75, P1453, DOI 10.1002/jwmg.172; Skuldt L. H., 2005, THESIS U WISCONSIN M; Skuldt LH, 2008, J WILDLIFE MANAGE, V72, P1156, DOI 10.2193/2006-469; Thompson AK, 2008, J WILDLIFE MANAGE, V72, P416, DOI 10.2193/2006-543; VANWINKLE W, 1975, J WILDLIFE MANAGE, V39, P118; VerCauteren KC, 2007, J WILDLIFE DIS, V43, P784, DOI 10.7589/0090-3558-43.4.784; Williams ES, 2002, J WILDLIFE MANAGE, V66, P551, DOI 10.2307/3803123; Williams SC, 2008, CAN J ZOOL, V86, P1358, DOI 10.1139/Z08-126; Wolfe LL, 2002, J WILDLIFE MANAGE, V66, P564, DOI 10.2307/3803124; Zuur Alain F., 2009, P1	51	17	17	1	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e56568	10.1371/journal.pone.0056568	http://dx.doi.org/10.1371/journal.pone.0056568			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437171	Green Published, gold, Green Submitted			2022-12-25	WOS:000315184200107
J	Salinari, S; Debard, C; Bertuzzi, A; Durand, C; Zimmet, P; Vidal, H; Mingrone, G				Salinari, Serenella; Debard, Cyrille; Bertuzzi, Alessandro; Durand, Christine; Zimmet, Paul; Vidal, Hubert; Mingrone, Geltrude			Jejunal Proteins Secreted by db/db Mice or Insulin-Resistant Humans Impair the Insulin Signaling and Determine Insulin Resistance	PLOS ONE			English	Article							GLYCOGEN-SYNTHASE KINASE-3; SKELETAL-MUSCLE CELLS; BARIATRIC SURGERY; RECEPTOR SUBSTRATE-1; GLUCOSE-TRANSPORT; MEDICAL THERAPY; BYPASS-SURGERY; OBESE-PATIENTS; PHOSPHORYLATION; MTOR	Background: Two recent studies demonstrated that bariatric surgery induced remission of type 2 diabetes very soon after surgery and far too early to be attributed to weight loss. In this study, we sought to explore the mechanism/s of this phenomenon by testing the effects of proteins from the duodenum-jejunum conditioned-medium (CM) of db/db or Swiss mice on glucose uptake in vivo in Swiss mice and in vitro in both Swiss mice soleus and L6 cells. We studied the effect of sera and CM proteins from insulin resistant (IR) and insulin-sensitive subjects on insulin signaling in human myoblasts. Methodology/Principal Findings: db/db proteins induced massive IR either in vivo or in vitro, while Swiss proteins did not. In L6 cells, only db/db proteins produced a noticeable increase in basal (473)Ser-Akt phosphorylation, lack of GSK3 beta inhibition and a reduced basal (389)Thr-p70-S6K1 phosphorylation. Human IR serum markedly increased basal (473)Ser-Akt phosphorylation in a dose-dependent manner. Human CM IR proteins increased by about twofold both basal and insulin-stimulated (473)Ser-Akt. Basal (9)Ser-GSK3 beta phosphorylation was increased by IR subjects serum with a smaller potentiating effect of insulin. Conclusions: These findings show that jejunal proteins either from db/db mice or from insulin resistant subjects impair muscle insulin signaling, thus inducing insulin resistance.	[Salinari, Serenella] Univ Roma La Sapienza, Dept Comp & Syst Sci, Rome, Italy; [Debard, Cyrille; Durand, Christine; Vidal, Hubert] Univ Lyon 1, CarMeN Lab, INSERM, U1060, Oullins, France; [Bertuzzi, Alessandro] CNR, Inst Syst Anal & Comp Sci, Rome, Italy; [Zimmet, Paul] Baker IDI Heart & Diabet Inst, Melbourne, Vic, Australia; [Mingrone, Geltrude] Univ Cattolica Sacro Cuore, Dept Internal Med, Sch Med, Rome, Italy	Sapienza University Rome; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Consiglio Nazionale delle Ricerche (CNR); Istituto di Analisi dei Sistemi ed Informatica "Antonio Ruberti" (IASI-CNR); Baker Heart and Diabetes Institute; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli	Mingrone, G (corresponding author), Univ Cattolica Sacro Cuore, Dept Internal Med, Sch Med, Rome, Italy.	gmingrone@rm.unicatt.it	Zimmet, Paul/O-8486-2019; Vidal, Hubert/M-6674-2017; Zimmet, Paul/H-7635-2013; Mingrone, Geltrude/AAB-9681-2019	Zimmet, Paul/0000-0003-0627-0776; Vidal, Hubert/0000-0002-9467-0317; BERTUZZI, ALESSANDRO/0000-0003-4969-7366; Mingrone, Geltrude/0000-0003-2021-528X	Catholic University	Catholic University	Financed by the Catholic University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alessi DR, 1997, CURR BIOL, V7, P261, DOI 10.1016/S0960-9822(06)00122-9; BERGMAN RN, 1979, AM J PHYSIOL, V236, pE667, DOI 10.1152/ajpendo.1979.236.6.E667; Bouzakri K, 2003, DIABETES, V52, P1319, DOI 10.2337/diabetes.52.6.1319; Breen DM, 2012, NAT MED, V18, P950, DOI 10.1038/nm.2745; Brozinick JT, 2001, DIABETES, V50, P593, DOI 10.2337/diabetes.50.3.593; Burcelin M, 2002, AM J PHYSIOL-ENDOC M, V282, pE834, DOI 10.1152/ajpendo.00332.2001; Capristo E, 1998, J INTERN MED, V243, P339; Ciaraldi TP, 2007, ENDOCRINOLOGY, V148, P4393, DOI 10.1210/en.2006-0932; Cozzone D, 2008, DIABETOLOGIA, V51, P512, DOI 10.1007/s00125-007-0913-8; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Cybulski N, 2009, TRENDS BIOCHEM SCI, V34, P620, DOI 10.1016/j.tibs.2009.09.004; DEFRONZO RA, 1979, AM J PHYSIOL, V237, pE214; DeFronzo RA, 2004, MED CLIN N AM, V88, P787, DOI 10.1016/j.mcna.2004.04.013; Dixon JB, 2012, LANCET, V379, P2300, DOI 10.1016/S0140-6736(12)60401-2; Dokken BB, 2005, AM J PHYSIOL-ENDOC M, V288, pE1188, DOI 10.1152/ajpendo.00547.2004; Eldar-Finkelman H, 1999, DIABETES, V48, P1662, DOI 10.2337/diabetes.48.8.1662; EldarFinkelman H, 1997, P NATL ACAD SCI USA, V94, P9660, DOI 10.1073/pnas.94.18.9660; Feldman ME, 2009, PLOS BIOL, V7, P371, DOI 10.1371/journal.pbio.1000038; Fraenkel M, 2008, DIABETES, V57, P945, DOI 10.2337/db07-0922; Frame S, 2001, BIOCHEM J, V359, P1, DOI 10.1042/0264-6021:3590001; Goni-Oliver P, 2007, J BIOL CHEM, V282, P22406, DOI 10.1074/jbc.M702793200; Guidone C, 2006, DIABETES, V55, P2025, DOI 10.2337/db06-0068; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; Huang JX, 2008, MOL CELL BIOL, V28, P4104, DOI 10.1128/MCB.00289-08; Huang JX, 2009, BIOCHEM SOC T, V37, P217, DOI 10.1042/BST0370217; HUMMEL KP, 1966, SCIENCE, V153, P1127, DOI 10.1126/science.153.3740.1127; Kasuga M, 2006, J CLIN INVEST, V116, P1756, DOI 10.1172/JCI29189; KODAMA H, 1994, DIABETOLOGIA, V37, P739, DOI 10.1007/s001250050173; KOIVISTO UM, 1991, J BIOL CHEM, V266, P2615; Li JP, 1999, J BIOL CHEM, V274, P9351, DOI 10.1074/jbc.274.14.9351; Liberman Z, 2005, J BIOL CHEM, V280, P4422, DOI 10.1074/jbc.M410610200; Mari A, 2006, DIABETOLOGIA, V49, P2136, DOI 10.1007/s00125-006-0337-x; McManus EJ, 2005, EMBO J, V24, P1571, DOI 10.1038/sj.emboj.7600633; Mingrone G, 2012, NEW ENGL J MED, V366, P1577, DOI 10.1056/NEJMoa1200111; Montori-Grau M, 2007, BIOCHEM J, V405, P107, DOI 10.1042/BJ20061572; Mora A, 2005, FEBS LETT, V579, P3632, DOI 10.1016/j.febslet.2005.05.040; Pacini G, 2001, AM J PHYSIOL-ENDOC M, V281, pE693, DOI 10.1152/ajpendo.2001.281.4.E693; Prentki M, 2006, J CLIN INVEST, V116, P1802, DOI 10.1172/JCI29103; Ring DB, 2003, DIABETES, V52, P588, DOI 10.2337/diabetes.52.3.588; Rubino FA, 2004, ANN SURG, V239, P1, DOI 10.1097/01.sla.0000102989.54824.fc; Rubino F, 2006, ANN SURG, V244, P741, DOI 10.1097/01.sla.0000224726.61448.1b; Russell M S, 2006, Drugs R D, V7, P111, DOI 10.2165/00126839-200607020-00005; Salinari S, 2009, DIABETES CARE, V32, P375, DOI 10.2337/dc08-1314; Sarbassov DD, 2005, CURR OPIN CELL BIOL, V17, P596, DOI 10.1016/j.ceb.2005.09.009; Schauer PR, 2012, NEW ENGL J MED, V366, P1567, DOI 10.1056/NEJMoa1200225; SHEINER LB, 1980, J PHARMACOKINET BIOP, V8, P553, DOI 10.1007/BF01060053; Stephens L, 1998, SCIENCE, V279, P710, DOI 10.1126/science.279.5351.710; Ueyama A, 1999, AM J PHYSIOL-ENDOC M, V277, pE572, DOI 10.1152/ajpendo.1999.277.3.E572; WANG QM, 1994, J BIOL CHEM, V269, P14566; WENTE SR, 1990, P NATL ACAD SCI USA, V87, P2805, DOI 10.1073/pnas.87.7.2805	50	43	43	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e56258	10.1371/journal.pone.0056258	http://dx.doi.org/10.1371/journal.pone.0056258			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437106	Green Submitted, Green Published, gold			2022-12-25	WOS:000315184200053
J	Turlin, E; Debarbouille, M; Augustyniak, K; Gilles, AM; Wandersman, C				Turlin, Evelyne; Debarbouille, Michel; Augustyniak, Katarzyna; Gilles, Anne-Marie; Wandersman, Cecile			Staphylococcus aureus FepA and FepB Proteins Drive Heme Iron Utilization in Escherichia coli	PLOS ONE			English	Article							BINDING; TRANSPORTER; HEMOGLOBIN; MEMBRANE; PERMEASE; RECEPTOR; ISDB	EfeUOB-like tripartite systems are widespread in bacteria and in many cases they are encoded by genes organized into iron-regulated operons. They consist of: EfeU, a protein similar to the yeast iron permease Ftrp1; EfeO, an extracytoplasmic protein of unknown function and EfeB, also an extracytoplasmic protein with heme peroxidase activity, belonging to the DyP family. Many bacterial EfeUOB systems have been implicated in iron uptake, but a prefential iron source remains undetermined. Nevertheless, in the case of Escherichia coli, the EfeUOB system has been shown to recognize heme and to allow extracytoplasmic heme iron extraction via a deferrochelation reaction. Given the high level of sequence conservations between EfeUOB orthologs, we hypothesized that heme might be the physiological iron substrate for the other orthologous systems. To test this hypothesis, we undertook characterization of the Staphylococcus aureus FepABC system. Results presented here indicate: i) that the S. aureus FepB protein binds both heme and PPIX with high affinity, like EfeB, the E. coli ortholog; ii) that it has low peroxidase activity, comparable to that of EfeB; iii) that both FepA and FepB drive heme iron utilization, and both are required for this activity and iv) that the E. coli FepA ortholog ( EfeO) cannot replace FepA in FepB-driven iron release from heme indicating protein specificity in these activities. Our results show that the function in heme iron extraction is conserved in the two orthologous systems.	[Turlin, Evelyne; Augustyniak, Katarzyna; Gilles, Anne-Marie; Wandersman, Cecile] Inst Pasteur, Unite Membranes Bacteriennes, Dept Microbiol, CNRS,ERL3526, Paris, France; [Debarbouille, Michel] Inst Pasteur, Unite Biol Bacteries Pathogenes Grampositif, Dept Microbiol, CNRS,ERL3526, Paris, France	Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Wandersman, C (corresponding author), Inst Pasteur, Unite Membranes Bacteriennes, Dept Microbiol, CNRS,ERL3526, Paris, France.	cecile.wandersman@pasteur.fr			Institut Pasteur, CNRS ERL3526; Agence nationale de la Recherche (ANR Grabiron)	Institut Pasteur, CNRS ERL3526; Agence nationale de la Recherche (ANR Grabiron)(French National Research Agency (ANR))	Institut Pasteur, CNRS ERL3526, Agence nationale de la Recherche (ANR Grabiron). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrett CML, 2003, BIOCHEM BIOPH RES CO, V304, P279, DOI 10.1016/S0006-291X(03)00583-7; BARTOLOME B, 1991, GENE, V102, P75, DOI 10.1016/0378-1119(91)90541-I; Biswas L, 2009, J BACTERIOL, V191, P5921, DOI 10.1128/JB.00642-09; Cao J, 2007, MOL MICROBIOL, V65, P857, DOI 10.1111/j.1365-2958.2007.05802.x; Dailey HA, 2011, MBIO, V2, DOI 10.1128/mBio.00248-11; Du Plessis DJF, 2011, BBA-BIOMEMBRANES, V1808, P851, DOI 10.1016/j.bbamem.2010.08.016; Gaballa A, 2011, MICROBIOL-SGM, V157, P3221, DOI 10.1099/mic.0.053579-0; Grosse C, 2006, MOL MICROBIOL, V62, P120, DOI 10.1111/j.1365-2958.2006.05326.x; Hammer ND, 2011, ANNU REV MICROBIOL, V65, P129, DOI 10.1146/annurev-micro-090110-102851; Herbert S, 2010, INFECT IMMUN, V78, P2877, DOI 10.1128/IAI.00088-10; Hommais F, 2001, MOL MICROBIOL, V40, P20, DOI 10.1046/j.1365-2958.2001.02358.x; Hurd AF, 2012, FEMS MICROBIOL LETT, V329, P93, DOI 10.1111/j.1574-6968.2012.02502.x; KELLERMANN O, 1974, EUR J BIOCHEM, V47, P139, DOI 10.1111/j.1432-1033.1974.tb03677.x; Letoffe S, 2003, MOL MICROBIOL, V50, P77, DOI 10.1046/j.1365-2958.2003.03686.x; Letoffe S, 2006, P NATL ACAD SCI USA, V103, P12891, DOI 10.1073/pnas.0605440103; Letoffe S, 2009, P NATL ACAD SCI USA, V106, P11719, DOI 10.1073/pnas.0903842106; Liu XH, 2011, J BIOL CHEM, V286, P14922, DOI 10.1074/jbc.M110.197780; Maruyama Y, 2011, BIOCHEM BIOPH RES CO, V405, P411, DOI 10.1016/j.bbrc.2011.01.043; Mechold U, 2006, NUCLEIC ACIDS RES, V34, P2364, DOI 10.1093/nar/gkl247; Osborn M J, 1974, Methods Enzymol, V31, P642; Perrotte-Piquemal M, 1999, BIOCHIMIE, V81, P245, DOI 10.1016/S0300-9084(99)80058-3; Peschel A, 1996, J BACTERIOL, V178, P531, DOI 10.1128/jb.178.2.531-536.1996; Pogliano J, 1997, GENE DEV, V11, P1169, DOI 10.1101/gad.11.9.1169; Rajasekaran MB, 2010, BIOCHEM BIOPH RES CO, V398, P366, DOI 10.1016/j.bbrc.2010.06.072; Rajasekaran MB, 2010, BIOMETALS, V23, P1, DOI 10.1007/s10534-009-9262-z; Severance S, 2004, BIOCHEM J, V380, P487, DOI 10.1042/BJ20031921; Sturm A, 2006, J BIOL CHEM, V281, P13972, DOI 10.1074/jbc.M511891200; Sugano Y, 2009, CELL MOL LIFE SCI, V66, P1387, DOI 10.1007/s00018-008-8651-8; Torres VJ, 2006, J BACTERIOL, V188, P8421, DOI 10.1128/JB.01335-06; van der Ploeg R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018140; Xiao QB, 2011, MOL MICROBIOL, V80, P1581, DOI 10.1111/j.1365-2958.2011.07667.x; Xu QP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021875; Zubieta C, 2007, PROTEINS, V69, P234, DOI 10.1002/prot.21673	33	28	29	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e56529	10.1371/journal.pone.0056529	http://dx.doi.org/10.1371/journal.pone.0056529			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437157	Green Submitted, gold, Green Published			2022-12-25	WOS:000315184200095
J	Wan, Q; Kozhaya, L; Imberg, K; Mercer, F; Zhong, S; Krogsgaard, M; Unutmaz, D				Wan, Qi; Kozhaya, Lina; Imberg, Keren; Mercer, Frances; Zhong, Shi; Krogsgaard, Michelle; Unutmaz, Derya			Probing the Effector and Suppressive Functions of Human T Cell Subsets Using Antigen-Specific Engineered T Cell Receptors	PLOS ONE			English	Article							CLASS-I MOLECULES; HIV-INFECTION; LYMPHOCYTES; EXPRESSION; NAIVE; TCR; ACTIVATION; SIGNALS; GENES; IDENTIFICATION	Activation of T cells through the engagement of the T cell receptors (TCRs) with specific peptide-MHC complexes on antigen presenting cells (APCs) is the major determinant for their proliferation, differentiation and display of effector functions. To assess the role of quantity and quality of peptide-MHC presentation in eliciting T cell activation and suppression functions, we genetically engineered human T cells with two TCRs that recognize HLA-A*0201-restricted peptides derived from either HIV or melanoma antigens. The engineered-TCRs are highly functional in both CD8(+) and CD4(+) T cells as assessed by the upregulation of activation markers, induction of cytokine secretion and cytotoxicity. We further demonstrated that engineered-TCRs can also be expressed on naive human T cells, which are stimulated through APCs presenting specific peptides to induce T cell proliferation and acquire effector functions. Furthermore, regulatory T cells (Tregs) ectopically expressing the engineered-TCRs are activated in an antigen-specific fashion and suppress T cell proliferation. In this system, the inhibitory activity of peptide-stimulated Tregs require the presence of dendritic cells (DCs) in the culture, either as presenters or as bystander cells, pointing to a critical role for DCs in suppression by Tregs. In conclusion, the engineered-TCR system reported here advances our ability to understand the differentiation pathways of naive T cells into antigen-specific effector cells and the role of antigen-specific signaling in Treg-mediated immune suppression.	[Wan, Qi; Kozhaya, Lina; Mercer, Frances; Unutmaz, Derya] NYU, Sch Med, Dept Microbiol, New York, NY 10016 USA; [Imberg, Keren; Krogsgaard, Michelle; Unutmaz, Derya] NYU, Sch Med, Dept Pathol, New York, NY USA; [Unutmaz, Derya] NYU, Sch Med, Dept Med, New York, NY USA; [Zhong, Shi; Krogsgaard, Michelle] NYU, Sch Med, Inst Canc, New York, NY USA	New York University; New York University; New York University; New York University	Unutmaz, D (corresponding author), NYU, Sch Med, Dept Microbiol, New York, NY 10016 USA.	Derya@mac.com	Wan, Qi/F-1694-2013	Wan, Qi/0000-0003-3726-5187	National Institute of Health (NIH) [R21AI087973, R01AI065303]; NIH/National Cancer Institute [U01CA137070]; National Institute of General Medical Sciences/NIH [R01GM085586]; American Cancer Society [RSG-09-070-01-LIB]; NATIONAL CANCER INSTITUTE [U01CA137070] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI087973, T32AI007180, R01AI065303] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM085586] Funding Source: NIH RePORTER	National Institute of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH/National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of General Medical Sciences/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); American Cancer Society(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institute of Health (NIH) grants R21AI087973 and R01AI065303 to DU's laboratory. MK was supported by NIH/National Cancer Institute grants U01CA137070, National Institute of General Medical Sciences/NIH, R01GM085586 and American Cancer Society grant RSG-09-070-01-LIB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER J, 1989, IMMUNOGENETICS, V29, P380, DOI 10.1007/BF00375866; Antons AK, 2008, J IMMUNOL, V180, P764, DOI 10.4049/jimmunol.180.2.764; Antons AK, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002952; Brunkow ME, 2001, NAT GENET, V27, P68, DOI 10.1038/83784; Brusko TM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011726; Cohen CJ, 2006, CANCER RES, V66, P8878, DOI 10.1158/0008-5472.CAN-06-1450; Cooper LJN, 2000, J VIROL, V74, P8207, DOI 10.1128/JVI.74.17.8207-8212.2000; DAY PM, 1995, IMMUNITY, V2, P137, DOI 10.1016/S1074-7613(95)80014-X; DEMARS R, 1984, HUM IMMUNOL, V11, P77, DOI 10.1016/0198-8859(84)90047-8; Frankel TL, 2010, J IMMUNOL, V184, P5988, DOI 10.4049/jimmunol.1000189; Hinrichs CS, 2011, BLOOD, V117, P808, DOI 10.1182/blood-2010-05-286286; Hughes MS, 2005, HUM GENE THER, V16, P457, DOI 10.1089/hum.2005.16.457; Joseph A, 2008, J VIROL, V82, P3078, DOI 10.1128/JVI.01812-07; Kitchen SG, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002649; Kitchen SG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008208; Kobayashi H, 2001, IMMUNOGENETICS, V53, P626, DOI 10.1007/s00251-001-0379-7; LEVY F, 1991, CELL, V67, P265, DOI 10.1016/0092-8674(91)90178-2; LJUNGGREN HG, 1990, NATURE, V346, P476, DOI 10.1038/346476a0; Morgan RA, 2006, SCIENCE, V314, P126, DOI 10.1126/science.1129003; Oswald-Richter K, 2004, PLOS BIOL, V2, P955, DOI 10.1371/journal.pbio.0020198; Oswald-Richter K, 2004, EUR J IMMUNOL, V34, P1705, DOI 10.1002/eji.200424892; Oswald-Richter K, 2007, PLOS PATHOG, V3, P553, DOI 10.1371/journal.ppat.0030058; Piccirillo CA, 2004, SEMIN IMMUNOL, V16, P81, DOI 10.1016/j.smim.2003.12.003; Plesa G, 2012, BLOOD; Porter DL, 2011, NEW ENGL J MED, V365, P725, DOI 10.1056/NEJMoa1103849; SALTER RD, 1985, IMMUNOGENETICS, V21, P235, DOI 10.1007/BF00375376; Seddiki N, 2006, BLOOD, V107, P2830, DOI 10.1182/blood-2005-06-2403; Thornton AM, 2010, J IMMUNOL, V184, P3433, DOI 10.4049/jimmunol.0904028; Tsang JYS, 2008, J CLIN INVEST, V118, P3619, DOI 10.1172/JCI33185; UNUTMAZ D, 1994, J EXP MED, V180, P1159, DOI 10.1084/jem.180.3.1159; Unutmaz D, 1999, J EXP MED, V189, P1735, DOI 10.1084/jem.189.11.1735; Varela-Rohena A, 2008, NAT MED, V14, P1390, DOI 10.1038/nm.1779; Wang R, 2009, P NATL ACAD SCI USA, V106, P13439, DOI 10.1073/pnas.0901965106; Wang R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002705; Wildin RS, 2001, NAT GENET, V27, P18, DOI 10.1038/83707; Wright GP, 2009, P NATL ACAD SCI USA, V106, P19078, DOI 10.1073/pnas.0907396106; Zhao Y, 2007, J IMMUNOL, V179, P5845, DOI 10.4049/jimmunol.179.9.5845	37	8	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e56302	10.1371/journal.pone.0056302	http://dx.doi.org/10.1371/journal.pone.0056302			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437112	Green Published, gold, Green Submitted			2022-12-25	WOS:000315184200058
J	Xu, J; Wu, X; Zhou, WH; Liu, AW; Wu, JB; Deng, JY; Yue, CF; Yang, SB; Wang, J; Yuan, ZY; Liu, QT				Xu, Jie; Wu, Xing; Zhou, Wei-hua; Liu, An-wen; Wu, Jian-bing; Deng, Jin-yun; Yue, Cai-feng; Yang, Shao-bing; Wang, Jing; Yuan, Zhong-yu; Liu, Quentin			Aurora-A Identifies Early Recurrence and Poor Prognosis and Promises a Potential Therapeutic Target in Triple Negative Breast Cancer	PLOS ONE			English	Article							SMALL-MOLECULE INHIBITOR; EXPRESSION; KINASE; OVEREXPRESSION; CLASSIFICATION; SURVIVAL; GROWTH; KI-67; AMPLIFICATION; ASSOCIATION	Triple negative breast cancer (TNBC) acquires an unfavorable prognosis, emerging as a major challenge for the treatment of breast cancer. In the present study, 122 TNBC patients were subjected to analysis of Aurora-A (Aur-A) expression and survival prognosis. We found that Aur-A high expression was positively associated with initial clinical stage (P = 0.025), the proliferation marker Ki-67 (P = 0.001), and the recurrence rate of TNBC patients (P<0.001). In TNBC patients with Aur-A high expression, the risk of distant recurrence peaked at the first 3 years and declined rapidly thereafter, whereas patients with Aur-A low expression showed a relatively constant risk of recurrence during the entire follow-up period. Univariate and multivariate analysis showed that overexpression of Aur-A predicted poor overall survival (P = 0.002) and progression-free survival (P = 0.012) in TNBC. Furthermore, overexpression of Aur-A, associated with high Ki-67, predicted an inferior prognosis compared with low expression of both Aur-A and Ki-67. Importantly, we further found that Aur-A was overexpressed in TNBC cells, and inhibition of this kinase inhibited cell proliferation and prevented cell migration in TNBC. Our findings demonstrated that Aur-A was a potential therapeutic target for TNBC and inhibition of Aur-A kinase was a promising regimen for TNBC cancer therapy.	[Xu, Jie; Wu, Xing; Zhou, Wei-hua; Yue, Cai-feng; Wang, Jing; Yuan, Zhong-yu; Liu, Quentin] Sun Yat Sen Univ, Ctr Canc, State Key Lab Oncol S China, Guangzhou, Guangdong, Peoples R China; [Xu, Jie; Zhou, Wei-hua; Liu, An-wen; Wu, Jian-bing] Nanchang Univ, Affiliated Hosp 2, Dept Oncol, Nanchang, Peoples R China; [Wu, Xing; Liu, Quentin] Sun Yat Sen Univ, Affiliated Hosp 3, Dept Hematol, Guangzhou 510275, Guangdong, Peoples R China; [Deng, Jin-yun] Jiangxi Prov Canc Hosp, Dept Internal Med 3, Nanchang, Peoples R China; [Yang, Shao-bing] Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Dept Anesthesiol, Wuhan 430074, Peoples R China; [Yuan, Zhong-yu] Sun Yat Sen Univ, Ctr Canc, Dept Med Oncol, Guangzhou 510275, Guangdong, Peoples R China; [Liu, Quentin] Dalian Med Univ, Inst Canc Stem Cell, Dalian, Peoples R China	Sun Yat Sen University; Nanchang University; Sun Yat Sen University; Huazhong University of Science & Technology; Sun Yat Sen University; Dalian Medical University	Yuan, ZY (corresponding author), Sun Yat Sen Univ, Ctr Canc, State Key Lab Oncol S China, Guangzhou, Guangdong, Peoples R China.	yuanzhy@sysucc.org.cn; liuq9@mail.sysu.edu.cn	CF, Yue/AAT-9821-2021		National Nature Science Foundation of China [81101521, 81160305, 81160306]; National Science Fund for Distinguished Young Scholars [30888003]; State Key Program of National Natural Science of China [81130040]; 973 Project from the Ministry of Science and Technology of China [2012CB967000]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science Fund for Distinguished Young Scholars(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); State Key Program of National Natural Science of China(National Natural Science Foundation of China (NSFC)); 973 Project from the Ministry of Science and Technology of China(National Basic Research Program of China)	The work was supported by a National Nature Science Foundation of China (Grant No. 81101521 to J. Wang, Grant No. 81160305 to A.W. Liu and Grant No. 81160306 to J.B. Wu), the National Science Fund for Distinguished Young Scholars (Grant No. 30888003 to Q. Liu), the State Key Program of National Natural Science of China (Grant No. 81130040 to Q. Liu), and 973 Project from the Ministry of Science and Technology of China (Grants No. 2012CB967000 to Q. Liu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bauer KR, 2007, CANCER, V109, P1721, DOI 10.1002/cncr.22618; Brenton JD, 2005, J CLIN ONCOL, V23, P7350, DOI 10.1200/JCO.2005.03.3845; Carey LA, 2007, CLIN CANCER RES, V13, P2329, DOI 10.1158/1078-0432.CCR-06-1109; Cheang MCU, 2008, CLIN CANCER RES, V14, P1368, DOI 10.1158/1078-0432.CCR-07-1658; Dent R, 2007, CLIN CANCER RES, V13, P4429, DOI 10.1158/1078-0432.CCR-06-3045; Edge SB, 2010, ANN SURG ONCOL, V17, P1471, DOI 10.1245/s10434-010-0985-4; Giles FJ, 2007, BLOOD, V109, P500, DOI 10.1182/blood-2006-05-025049; Gluz O, 2009, ANN ONCOL, V20, P1913, DOI 10.1093/annonc/mdp492; Guan Z, 2007, CANCER RES, V67, P10436, DOI 10.1158/0008-5472.CAN-07-1379; Haffty BG, 2006, J CLIN ONCOL, V24, P5652, DOI 10.1200/JCO.2006.06.5664; Harrington EA, 2004, NAT MED, V10, P262, DOI 10.1038/nm1003; Huang XF, 2008, BLOOD, V111, P2854, DOI 10.1182/blood-2007-07-099325; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Jeng YM, 2004, CLIN CANCER RES, V10, P2065, DOI 10.1158/1078-0432.CCR-1057-03; Keam B, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2834; Landen CN, 2007, CLIN CANCER RES, V13, P4098, DOI 10.1158/1078-0432.CCR-07-0431; Liedtke C, 2008, J CLIN ONCOL, V26, P1275, DOI 10.1200/JCO.2007.14.4147; Linderholm BK, 2009, ANN ONCOL, V20, P1639, DOI 10.1093/annonc/mdp062; Liu Q, 2006, P NATL ACAD SCI USA, V103, P5811, DOI 10.1073/pnas.0601425103; Marumoto T, 2005, NAT REV CANCER, V5, P42, DOI 10.1038/nrc1526; Millar EKA, 2011, BRIT J CANCER, V105, P272, DOI 10.1038/bjc.2011.228; Millar EKA, 2009, J CLIN ONCOL, V27, P4701, DOI 10.1200/JCO.2008.21.7075; Miyoshi Y, 2001, INT J CANCER, V92, P370, DOI 10.1002/ijc.1200; Nadler Y, 2008, CLIN CANCER RES, V14, P4455, DOI 10.1158/1078-0432.CCR-07-5268; Pan CB, 2008, ORAL ONCOL, V44, P639, DOI 10.1016/j.oraloncology.2007.08.010; Perez EA, 2002, MAYO CLIN PROC, V77, P148; Prat A, 2008, NAT CLIN PRACT ONCOL, V5, P531, DOI 10.1038/ncponc1179; Rakha EA, 2006, EUR J CANCER, V42, P3149, DOI 10.1016/j.ejca.2006.08.015; Rakha EA, 2007, CANCER-AM CANCER SOC, V109, P25, DOI 10.1002/cncr.22381; Romond EH, 2005, NEW ENGL J MED, V353, P1673, DOI 10.1056/NEJMoa052122; Schneider BP, 2008, CLIN CANCER RES, V14, P8010, DOI 10.1158/1078-0432.CCR-08-1208; Shang XY, 2009, MOL CANCER THER, V8, P2461, DOI 10.1158/1535-7163.MCT-08-0857; Sotiriou C, 2003, P NATL ACAD SCI USA, V100, P10393, DOI 10.1073/pnas.1732912100; Subik K, 2010, BREAST CANCER-BASIC, V4, P35; Tanaka E, 2005, CLIN CANCER RES, V11, P1827, DOI 10.1158/1078-0432.CCR-04-1627; Tanaka T, 1999, CANCER RES, V59, P2041; Traynor AM, 2011, CANCER CHEMOTH PHARM, V67, P305, DOI 10.1007/s00280-010-1318-9; Wan XB, 2008, CARCINOGENESIS, V29, P1930, DOI 10.1093/carcin/bgn176; Wang LH, 2010, CANCER RES, V70, P9118, DOI 10.1158/0008-5472.CAN-10-1246; Wang X, 2006, ONCOGENE, V25, P7148, DOI 10.1038/sj.onc.1209707; Xie D, 2003, INT J CANCER, V107, P896, DOI 10.1002/ijc.11514; Yamamoto Y, 2009, BREAST CANCER-TOKYO, V16, P260, DOI 10.1007/s12282-009-0150-8; Zhou WH, 2012, AUTOPHAGY, V8, P389, DOI 10.4161/auto.18641; Zhou WH, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-397	44	49	51	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e56919	10.1371/journal.pone.0056919	http://dx.doi.org/10.1371/journal.pone.0056919			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437271	gold, Green Published, Green Submitted			2022-12-25	WOS:000315184200185
J	Weber, AAT; Pawlowski, J				Weber, Alexandra A-T; Pawlowski, Jan			Can Abundance of Protists Be Inferred from Sequence Data: A Case Study of Foraminifera	PLOS ONE			English	Article							COPY NUMBER; MICROBIAL COMMUNITIES; BENTHIC FORAMINIFERA; GENOME SIZE; DIVERSITY; PCR; SAMPLES; RDNA; QUANTIFICATION; INDICATORS	Protists are key players in microbial communities, yet our understanding of their role in ecosystem functioning is seriously impeded by difficulties in identification of protistan species and their quantification. Current microscopy-based methods used for determining the abundance of protists are tedious and often show a low taxonomic resolution. Recent development of next-generation sequencing technologies offered a very powerful tool for studying the richness of protistan communities. Still, the relationship between abundance of species and number of sequences remains subjected to various technical and biological biases. Here, we test the impact of some of these biological biases on sequence abundance of SSU rRNA gene in foraminifera. First, we quantified the rDNA copy number and rRNA expression level of three species of foraminifera by qPCR. Then, we prepared five mock communities with these species, two in equal proportions and three with one species ten times more abundant. The libraries of rDNA and cDNA of the mock communities were constructed, Sanger sequenced and the sequence abundance was calculated. The initial species proportions were compared to the raw sequence proportions as well as to the sequence abundance normalized by rDNA copy number and rRNA expression level per species. Our results showed that without normalization, all sequence data differed significantly from the initial proportions. After normalization, the congruence between the number of sequences and number of specimens was much better. We conclude that without normalization, species abundance determination based on sequence data was not possible because of the effect of biological biases. Nevertheless, by taking into account the variation of rDNA copy number and rRNA expression level we were able to infer species abundance, suggesting that our approach can be successful in controlled conditions.	[Weber, Alexandra A-T; Pawlowski, Jan] Univ Geneva, Dept Genet & Evolut, Geneva, Switzerland; [Weber, Alexandra A-T] Aix Marseille Univ, Inst Mediterraneen Biodiversite & Ecol Marine & C, Marine Endoume Stn, CNRS,IMBE,UMR 7263, Marseille, France	University of Geneva; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Aix-Marseille Universite; Institut de Recherche pour le Developpement (IRD)	Pawlowski, J (corresponding author), Univ Geneva, Dept Genet & Evolut, Geneva, Switzerland.	Jan.Pawlowski@unige.ch	Pawlowski, Jan/AAO-3306-2021	Pawlowski, Jan/0000-0003-2421-388X; Weber, Alexandra/0000-0002-7980-388X	Swiss National Foundation [31003A-140766]; G & L Claraz Donation	Swiss National Foundation(Swiss National Science Foundation (SNSF)); G & L Claraz Donation	The study was supported by the Swiss National Foundation grant 31003A-140766 (JP) and G & L Claraz Donation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acinas SG, 2005, APPL ENVIRON MICROB, V71, P8966, DOI 10.1128/AEM.71.12.8966-8969.2005; Amend AS, 2010, MOL ECOL, V19, P5555, DOI 10.1111/j.1365-294X.2010.04898.x; Barriuso J, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-473; Bartram AK, 2011, APPL ENVIRON MICROB, V77, P3846, DOI 10.1128/AEM.02772-10; Candela M, 2004, LETT APPL MICROBIOL, V38, P229, DOI 10.1111/j.1472-765X.2003.01475.x; Chernoff H, 1954, ANN MATH STAT, V25, P59; Crosby LD, 2003, BIOTECHNIQUES, V34, P790, DOI 10.2144/03344rr01; Denoyelle M, 2010, MAR POLLUT BULL, V60, P2007, DOI 10.1016/j.marpolbul.2010.07.024; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; FARRELLY V, 1995, APPL ENVIRON MICROB, V61, P2798, DOI 10.1128/AEM.61.7.2798-2801.1995; FOYN BJORN, 1934, ARCH PROTISTENK, V83, P1; Godhe A, 2008, APPL ENVIRON MICROB, V74, P7174, DOI 10.1128/AEM.01298-08; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Heyse G, 2010, P NATL ACAD SCI USA, V107, P22134, DOI 10.1073/pnas.1009284107; Jorissen FJ, 2009, DEEP-SEA RES PT II, V56, P2270, DOI 10.1016/j.dsr2.2009.04.009; Lee J.J., 1991, BIOL FORAMINIFERA; Legendre L, 2001, CYTOMETRY, V44, P164, DOI 10.1002/1097-0320(20010701)44:3<164::AID-CYTO1108>3.0.CO;2-6; Lindner MS, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks803; Liu XH, 2012, MICROBES ENVIRON, V27, P497, DOI 10.1264/jsme2.ME12056; Madoni P, 2006, ENVIRON POLLUT, V141, P1, DOI 10.1016/j.envpol.2005.08.025; Manter DK, 2007, J MICROBIOL METH, V71, P7, DOI 10.1016/j.mimet.2007.06.016; Martin-Laurent F, 2001, APPL ENVIRON MICROB, V67, P2354, DOI 10.1128/AEM.67.5.2354-2359.2001; Mojtahid M, 2008, MAR POLLUT BULL, V56, P42, DOI 10.1016/j.marpolbul.2007.08.018; Mojtahid M, 2006, MAR MICROPALEONTOL, V61, P58, DOI 10.1016/j.marmicro.2006.05.004; Nigam R, 2006, ENVIRON INT, V32, P273, DOI 10.1016/j.envint.2005.08.024; Nolte V, 2010, MOL ECOL, V19, P2908, DOI 10.1111/j.1365-294X.2010.04669.x; Parfrey LW, 2008, MOL BIOL EVOL, V25, P787, DOI 10.1093/molbev/msn032; Parfrey LW, 2010, GENOME BIOL EVOL, V2, P678, DOI 10.1093/gbe/evq051; Pawlowski J, 2010, J EUKARYOT MICROBIOL, V57, P197, DOI 10.1111/j.1550-7408.2009.00468.x; PORTER KG, 1980, LIMNOL OCEANOGR, V25, P943, DOI 10.4319/lo.1980.25.5.0943; Prokopowich CD, 2003, GENOME, V46, P48, DOI [10.1139/g02-103, 10.1139/G02-103]; Rimet F, 2011, ECOL INDIC, V11, P489, DOI 10.1016/j.ecolind.2010.07.004; Rodriguez-Martinez R, 2009, ENVIRON MICROBIOL, V11, P397, DOI 10.1111/j.1462-2920.2008.01779.x; ROTTGER R, 1989, EUR J PROTISTOL, V25, P60, DOI 10.1016/S0932-4739(89)80078-1; Shi XL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018979; Taniguchi A, 2011, FISHERIES SCI, V77, P607, DOI 10.1007/s12562-011-0362-7; von Wintzingerode F, 1997, FEMS MICROBIOL REV, V21, P213; Warner JR, 1999, TRENDS BIOCHEM SCI, V24, P437, DOI 10.1016/S0968-0004(99)01460-7; Zhang T, 2006, APPL MICROBIOL BIOT, V70, P281, DOI 10.1007/s00253-006-0333-6; Zhu F, 2005, FEMS MICROBIOL ECOL, V52, P79, DOI 10.1016/j.femsec.2004.10.006	40	91	95	1	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2013	8	2							e56739	10.1371/journal.pone.0056739	http://dx.doi.org/10.1371/journal.pone.0056739			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093HR	23431390	Green Published, Green Submitted, gold			2022-12-25	WOS:000315182800033
J	Engelen, E; Janssens, RC; Yagita, K; Smits, VAJ; van der Horst, GTJ; Tamanini, F				Engelen, Erik; Janssens, Roel C.; Yagita, Kazuhiro; Smits, Veronique A. J.; van der Horst, Gijsbertus T. J.; Tamanini, Filippo			Mammalian TIMELESS Is Involved in Period Determination and DNA Damage-Dependent Phase Advancing of the Circadian Clock	PLOS ONE			English	Article							CELL-CYCLES; IN-VIVO; PROTEIN; GENE; CRY1; CRYPTOCHROME; RHYTHMICITY; INHIBITION; MECHANISMS; NETWORK	The transcription/translation feedback loop-based molecular oscillator underlying the generation of circadian gene expression is preserved in almost all organisms. Interestingly, the animal circadian clock proteins CRYPTOCHROME (CRY), PERIOD (PER) and TIMELESS (TIM) are strongly conserved at the amino acid level through evolution. Within this evolutionary frame, TIM represents a fascinating puzzle. While Drosophila contains two paralogs, dTIM and dTIM2, acting in clock/photoreception and chromosome integrity/photoreception respectively, mammals contain only one TIM homolog. Whereas TIM has been shown to regulate replication termination and cell cycle progression, its functional link to the circadian clock is under debate. Here we show that RNAi-mediated knockdown of TIM in NIH3T3 and U2OS cells shortens the period by 1 hour and diminishes DNA damage-dependent phase advancing. Furthermore, we reveal that the N-terminus of TIM is sufficient for interaction with CRY1 and CHK1 as well for homodimerization, and the C-terminus is necessary for nuclear localization. Interestingly, the long TIM isoform (l-TIM), but not the short (s-TIM), interacts with CRY1 and both proteins can reciprocally regulate their nuclear translocation in transiently transfected COS7 cells. Finally, we demonstrate that co-expression of PER2 abolishes the formation of the TIM/CRY1 complex through affinity binding competition to the C-terminal tail of CRY1. Notably, the presence of the latter protein region evolutionarily and structurally distinguishes mammalian from insect CRYs. We propose that the dynamic interaction between these three proteins could represent a post-translational aspect of the mammalian circadian clock that is important for its pace and adaption to external stimuli, such as DNA damage and/or light.	[Engelen, Erik; Janssens, Roel C.; van der Horst, Gijsbertus T. J.; Tamanini, Filippo] Erasmus Univ, Med Ctr, Dept Genet, Ctr Biomed Genet, Rotterdam, Netherlands; [Engelen, Erik] Erasmus Univ, Med Ctr, Dept Cell Biol, Ctr Biomed Genet, Rotterdam, Netherlands; [Yagita, Kazuhiro] Kyoto Prefectural Univ Med, Dept Neurosci & Cell Biol, Kyoto, Japan; [Smits, Veronique A. J.] Hosp Univ Canarias, Inst Tecnol Biomed, Unidad Invest, Tenerife, Spain	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Kyoto Prefectural University of Medicine; Universidad de la Laguna	van der Horst, GTJ (corresponding author), Erasmus Univ, Med Ctr, Dept Genet, Ctr Biomed Genet, Rotterdam, Netherlands.	g.vanderhorst@erasmusmc.nl; f.tamanini@erasmusmc.nl	van der Horst, Gijsbertus TJ/E-3661-2015; Smits, Veronique A.J./R-2302-2019	van der Horst, Gijsbertus TJ/0000-0002-7773-6396; Smits, Veronique A.J./0000-0002-9160-4525	Netherlands Organization for Scientific Research (ZonMW) [918.36.619, 90.201.127]	Netherlands Organization for Scientific Research (ZonMW)(Netherlands Organization for Scientific Research (NWO)Netherlands Organization for Health Research and Development)	This work was supported by grants from the Netherlands Organization for Scientific Research (ZonMW Vici grant nr. 918.36.619; ZonMW/ErasSysBio+ grant nr. 90.201.127) to GTJvdH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baggs JE, 2009, PLOS BIOL, V7, P563, DOI 10.1371/journal.pbio.1000052; Balakrishnan A, 2010, EXP CELL RES, V316, P3512, DOI 10.1016/j.yexcr.2010.07.007; Barnes JW, 2003, SCIENCE, V302, P439, DOI 10.1126/science.1086593; Benna C, 2000, CURR BIOL, V10, pR512, DOI 10.1016/S0960-9822(00)00594-7; Benna C, 2010, CURR BIOL, V20, P346, DOI 10.1016/j.cub.2009.12.048; Bunger MK, 2000, CELL, V103, P1009, DOI 10.1016/S0092-8674(00)00205-1; Ceriani MF, 1999, SCIENCE, V285, P553, DOI 10.1126/science.285.5427.553; Chaves I, 2006, MOL CELL BIOL, V26, P1743, DOI 10.1128/MCB.26.5.1743-1753.2006; Dekker S, 2003, J VIROL, V77, P12132, DOI 10.1128/JVI.77.22.12132-12139.2003; Fu LN, 2002, CELL, V111, P41, DOI 10.1016/S0092-8674(02)00961-3; Gery S, 2006, MOL CELL, V22, P375, DOI 10.1016/j.molcel.2006.03.038; Gotter AL, 2003, J MOL BIOL, V331, P167, DOI 10.1016/S0022-2836(03)00633-8; Gotter AL, 2000, NAT NEUROSCI, V3, P755, DOI 10.1038/77653; Griffin EA, 1999, SCIENCE, V286, P768, DOI 10.1126/science.286.5440.768; Kume K, 1999, CELL, V98, P193, DOI 10.1016/S0092-8674(00)81014-4; Lee C, 2001, CELL, V107, P855, DOI 10.1016/S0092-8674(01)00610-9; Liu AC, 2007, CELL, V129, P605, DOI 10.1016/j.cell.2007.02.047; Matsuo T, 2003, SCIENCE, V302, P255, DOI 10.1126/science.1086271; Oklejewicz M, 2008, CURR BIOL, V18, P286, DOI 10.1016/j.cub.2008.01.047; Pregueiro AM, 2006, SCIENCE, V313, P644, DOI 10.1126/science.1121716; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; RUSAK B, 1989, BRAIN RES, V493, P283, DOI 10.1016/0006-8993(89)91163-3; Sasaki M, 2009, J BIOL CHEM, V284, P25149, DOI 10.1074/jbc.M109.040758; Sato TK, 2006, NAT GENET, V38, P312, DOI 10.1038/ng1745; Smith KD, 2009, J CELL BIOL, V187, P15, DOI 10.1083/jcb.200905006; Takumi T, 1999, GENES CELLS, V4, P67, DOI 10.1046/j.1365-2443.1999.00238.x; Unsal-Kacmaz K, 2005, MOL CELL BIOL, V25, P3109, DOI 10.1128/MCB.25.8.3109-3116.2005; Unsal-Kacmaz K, 2007, MOL CELL BIOL, V27, P3131, DOI 10.1128/MCB.02190-06; van der Horst GTJ, 1999, NATURE, V398, P627, DOI 10.1038/19323; Wood LD, 2007, SCIENCE, V318, P1108, DOI 10.1126/science.1145720; Xiao J, 2003, DEV DYNAM, V228, P82, DOI 10.1002/dvdy.10346; Yagita K, 2000, GENE DEV, V14, P1353; Yagita K, 2002, EMBO J, V21, P1301, DOI 10.1093/emboj/21.6.1301; Yagita K, 2001, SCIENCE, V292, P278, DOI 10.1126/science.1059542; Yang XM, 2010, J BIOL CHEM, V285, DOI 10.1074/jbc.M109.050237; Zhang EE, 2010, NAT MED, V16, P1152, DOI 10.1038/nm.2214; Zylka MJ, 1998, NEURON, V21, P1115, DOI 10.1016/S0896-6273(00)80628-5	37	51	58	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e56623	10.1371/journal.pone.0056623	http://dx.doi.org/10.1371/journal.pone.0056623			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418588	Green Published, gold, Green Submitted			2022-12-25	WOS:000315970300181
J	Hong, IS; Kang, KS				Hong, In-Sun; Kang, Kyung-Sun			The Effects of Hedgehog on the RNA-Binding Protein Msi1 in the Proliferation and Apoptosis of Mesenchymal Stem Cells	PLOS ONE			English	Article							HAIR FOLLICLE DEVELOPMENT; UMBILICAL-CORD BLOOD; C-MYC; SONIC HEDGEHOG; PROGENITOR CELLS; SELF-RENEWAL; EXPRESSION; CANCER; MUSASHI; MARKER	Human umbilical cord blood (UCB)-derived mesenchymal stem cells (MSCs) are essential tools for regenerative medicine due to their capacity for self-renewal and multi-lineage differentiation. As MSCs are found in very small numbers in various tissues, in vitro cell expansion is an essential step that is needed before these cells can be used in clinical applications. Therefore, it is important to identify and characterize factors that are involved in MSC proliferation and apoptosis. In the present study, we focused on Hedgehog (Hh) signaling because several studies have proposed that Hh signaling plays a critical role in controlling the proliferation of stem and progenitor cells. However, the molecular mechanisms underlying the effects on the proliferation and apoptosis of MSCs remain unclear. In this study, we evaluated the direct effects of Hh signaling on the proliferation and apoptosis of hUCB-MSCs as well as investigated potential downstream regulatory mechanisms that may be responsible for Hh signaling. We observed that the Hedgehog agonist purmorphamine enhanced cell proliferation and suppressed apoptosis through the RNA-binding protein Msi1 by regulating the expression of an oncoprotein (i.e., c-Myc), a cell cycle regulatory molecule (i.e., p21(CIP1,WAF1)) and two microRNAs (i.e., miRNA-148a and miRNA-148b). This study provides novel insights into the molecular mechanisms regulating the self-renewal capability of MSCs with relevance to clinical applications.	[Hong, In-Sun; Kang, Kyung-Sun] Seoul Natl Univ, Adult Stem Cell Res Ctr, Seoul, South Korea; [Hong, In-Sun; Kang, Kyung-Sun] Seoul Natl Univ, Dept Vet Publ Hlth, Lab Stem Cell & Tumor Biol, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU)	Kang, KS (corresponding author), Seoul Natl Univ, Adult Stem Cell Res Ctr, Seoul, South Korea.	kangpub@snu.ac.kr	Kang, Kyung-Sun/G-6205-2013					Abbas T, 2009, NAT REV CANCER, V9, P400, DOI 10.1038/nrc2657; Akasaka Y, 2005, HISTOPATHOLOGY, V47, P348, DOI 10.1111/j.1365-2559.2005.02223.x; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Beachy PA, 2004, NATURE, V432, P324, DOI 10.1038/nature03100; Bhandari DR, 2011, DIFFERENTIATION, V82, P144, DOI 10.1016/j.diff.2011.06.003; Bhandari DR, 2011, J CELL MOL MED, V15, P1603, DOI 10.1111/j.1582-4934.2010.01144.x; Boland GM, 2004, J CELL BIOCHEM, V93, P1210, DOI 10.1002/jcb.20284; Clarke RB, 2005, DEV BIOL, V277, P443, DOI 10.1016/j.ydbio.2004.07.044; Copeland N, 2009, CLIN MED, V9, P342, DOI 10.7861/clinmedicine.9-4-342; Dang CV, 1999, EXP CELL RES, V253, P63, DOI 10.1006/excr.1999.4686; George RJ, 2009, AM J PHYSIOL-GASTR L, V296, pG245, DOI 10.1152/ajpgi.00021.2008; James A.W., 2012, STEM CELLS DEV; Jung CJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027740; Kanai R, 2006, J GENE MED, V8, P1329, DOI 10.1002/jgm.965; Kaneko Y, 2000, DEV NEUROSCI-BASEL, V22, P139, DOI 10.1159/000017435; Kang KS, 2005, CYTOTHERAPY, V7, P368, DOI 10.1080/14653240500238160; Kern S, 2006, STEM CELLS, V24, P1294, DOI 10.1634/stemcells.2005-0342; Kippin TE, 2005, GENE DEV, V19, P756, DOI 10.1101/gad.1272305; Kondo M, 2003, ANNU REV IMMUNOL, V21, P759, DOI 10.1146/annurev.immunol.21.120601.141007; Li N, 2008, STEM CELLS, V26, P1253, DOI 10.1634/stemcells.2007-0691; Machold R, 2003, NEURON, V39, P937, DOI 10.1016/S0896-6273(03)00561-0; Mallick B, 2011, RNA BIOL, V8, P415, DOI 10.4161/rna.8.3.14497; Mill P, 2003, GENE DEV, V17, P282, DOI 10.1101/gad.1038103; Muto J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033431; Obaya AJ, 1999, ONCOGENE, V18, P2934, DOI 10.1038/sj.onc.1202749; Okano H, 2002, J CELL SCI, V115, P1355; Osterlund T, 2006, TRENDS CELL BIOL, V16, P176, DOI 10.1016/j.tcb.2006.02.004; Park SB, 2012, CELL DEATH DIFFER, V19, P534, DOI 10.1038/cdd.2011.137; Plasilova M, 2009, PLAST RECONSTR SURG, V123, p149S, DOI 10.1097/PRS.0b013e318191c82b; Potten CS, 2003, DIFFERENTIATION, V71, P28, DOI 10.1046/j.1432-0436.2003.700603.x; Raji B, 2007, MOL VIS, V13, P1412; Sakakibara S, 2002, P NATL ACAD SCI USA, V99, P15194, DOI 10.1073/pnas.232087499; Sakakibara S, 2001, J NEUROSCI, V21, P8091, DOI 10.1523/JNEUROSCI.21-20-08091.2001; Sakakibara S, 1997, J NEUROSCI, V17, P8300; Sarugaser R, 2005, STEM CELLS, V23, P220, DOI 10.1634/stemcells.2004-0166; Satoh Y, 2004, J BIOL CHEM, V279, P24986, DOI 10.1074/jbc.M400407200; Saze Z, 2012, DIGEST SURG, V29, P115, DOI 10.1159/000336949; SHERR CJ, 1995, GENE DEV, V9, P1149, DOI 10.1101/gad.9.10.1149; Shin KK, 2012, MOL CELL BIOCH; Shu HJ, 2002, BIOCHEM BIOPH RES CO, V293, P150, DOI 10.1016/S0006-291X(02)00175-4; Siddall NA, 2006, P NATL ACAD SCI USA, V103, P8402, DOI 10.1073/pnas.0600906103; Song Z, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017687; Soucek L, 2008, NATURE, V455, P679, DOI 10.1038/nature07260; Sugiyama-Nakagiri Y, 2006, AM J PATHOL, V168, P80, DOI 10.2353/ajpath.2006.050469; Teglund S, 2010, BBA-REV CANCER, V1805, P181, DOI 10.1016/j.bbcan.2010.01.003; Waikel RL, 2001, NAT GENET, V28, P165, DOI 10.1038/88889; Wang YM, 2011, RESULTS PROBL CELL D, V53, P459, DOI 10.1007/978-3-642-19065-0_19; Yaddanapudi K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026766; Yang Ling, 2012, Int J Biochem Mol Biol, V3, P46; Yokota N, 2004, ONCOGENE, V23, P3444, DOI 10.1038/sj.onc.1207475; Zaragosi LE, 2006, STEM CELLS, V24, P2412, DOI 10.1634/stemcells.2006-0006; Zaragosi LE, 2010, DIABETES, V59, P2513, DOI 10.2337/db10-0013; Zhao C, 2009, NATURE, V458, P776, DOI 10.1038/nature07737	53	16	17	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e56496	10.1371/journal.pone.0056496	http://dx.doi.org/10.1371/journal.pone.0056496			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418578	gold, Green Submitted, Green Published			2022-12-25	WOS:000315970300171
J	Ino, Y; Yamazaki-Itoh, R; Oguro, S; Shimada, K; Kosuge, T; Zavada, J; Kanai, Y; Hiraoka, N				Ino, Yoshinori; Yamazaki-Itoh, Rie; Oguro, Seiji; Shimada, Kazuaki; Kosuge, Tomoo; Zavada, Jan; Kanai, Yae; Hiraoka, Nobuyoshi			Arginase II Expressed in Cancer-Associated Fibroblasts Indicates Tissue Hypoxia and Predicts Poor Outcome in Patients with Pancreatic Cancer	PLOS ONE			English	Article							ARGININE METABOLISM; SUPPRESSOR-CELLS; PROLIFERATION; ANGIOGENESIS; MACROPHAGES; MOLECULES	An adequate level of arginine in the tissue microenvironment is essential for T cell activity and survival. Arginine levels are regulated by the arginine-catabolizing enzyme, arginase (ARG). It has been reported that arginase II (ARG2), one of two ARGs, is aberrantly expressed in prostate cancer cells, which convert arginine into ornithine, resulting in a lack of arginine that weakens tumor-infiltrating lymphocytes and renders them dysfunctional. However, immune suppression mediated by ARG2-expressing cancer cells in lung cancer has not been observed. Here we studied the expression of ARG2 in pancreatic ductal carcinoma (PDC) tissue clinicopathologically by examining over 200 cases of PDC. In contrast to prostate cancer, ARG2 expression was rarely demonstrated in PDC cells by immunohistochemistry, and instead ARG2 was characteristically expressed in alpha-smooth muscle actin-positive cancer-associated fibroblasts (CAFs), especially those located within and around necrotic areas in PDC. The presence of ARG2-expressing CAFs was closely correlated with shorter overall survival (OS; P = 0.003) and disease-free survival (DFS; P = 0.0006). Multivariate Cox regression analysis showed that the presence of ARG2-expressing CAFs in PDC tissue was an independent predictor of poorer OS (hazard ratio [HR] = 1.582, P = 0.007) and DFS (HR = 1.715, P = 0.001) in PDC patients. In addition to the characteristic distribution of ARG2-expressing CAFs, such CAFs co-expressed carbonic anhydrase IX, SLC2A1, or HIF-1 alpha, markers of hypoxia, in PDC tissue. Furthermore, in vitro experiments revealed that cultured fibroblasts extracted from PDC tissue expressed the ARG2 transcript after exposure to hypoxia, which had arginase activity. These results indicate that cancer cell-mediated immune suppression through ARG2 expression is not a general event and that the presence of ARG2-expressing CAFs is an indicator of poor prognosis, as well as hypoxia, in PDC tissue.	[Ino, Yoshinori; Yamazaki-Itoh, Rie; Oguro, Seiji; Kanai, Yae; Hiraoka, Nobuyoshi] Natl Canc Ctr, Res Inst, Div Mol Pathol, Tokyo 104, Japan; [Shimada, Kazuaki; Kosuge, Tomoo] Natl Canc Ctr, Hepatobiliary & Pancreat Surg Div, Tokyo, Japan; [Zavada, Jan] Acad Sci Czech Republ, Inst Organ Chem & Biochem, Prague, Czech Republic	National Cancer Center - Japan; National Cancer Center - Japan; Czech Academy of Sciences; Institute of Organic Chemistry & Biochemistry of the Czech Academy of Sciences	Hiraoka, N (corresponding author), Natl Canc Ctr, Res Inst, Div Mol Pathol, Tokyo 104, Japan.	nhiraoka@ncc.go.jp	Oguro, Seiji/M-2224-2017; Kanai, Yae/AAE-6987-2019	Oguro, Seiji/0000-0002-5562-6727; 	Ministry of Health, Labor and Welfare of Japan; Ministry of Education, Culture, Sports, Science and Technology of Japan; Princess Takamatsu Foundation [10-24216]; Cancer Research and Development Fund	Ministry of Health, Labor and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Princess Takamatsu Foundation; Cancer Research and Development Fund	This work was supported by a Grant-in-Aid for Third Term Comprehensive 10-year Strategy for Cancer Control from the Ministry of Health, Labor and Welfare of Japan (NH), a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan (NH), Princess Takamatsu Foundation (10-24216) (NH), and Cancer Research and Development Fund (NH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBINA JE, 1995, J IMMUNOL, V155, P4391; Bronte V, 2005, J EXP MED, V201, P1257, DOI 10.1084/jem.20042028; Center for Cancer Control and Information Services and National Cancer Center J, 2009, CANC STAT JAP; Chen B, 2009, AM J PHYSIOL-LUNG C, V297, pL1151, DOI 10.1152/ajplung.00183.2009; Clarkson AN, 2005, FASEB J, V19, P1036, DOI 10.1096/fj.04-3367fje; Gabrilovich DI, 2009, NAT REV IMMUNOL, V9, P162, DOI 10.1038/nri2506; Gerner EW, 2004, NAT REV CANCER, V4, P781, DOI 10.1038/nrc1454; Grothey A, 2009, NAT REV CLIN ONCOL, V6, P507, DOI 10.1038/nrclinonc.2009.110; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hasebe T, 1996, JPN J CANCER RES, V87, P385, DOI 10.1111/j.1349-7006.1996.tb00234.x; Hiraoka N, 2010, BRIT J CANCER, V103, P1057, DOI 10.1038/sj.bjc.6605854; Hiraoka N, 2006, CLIN CANCER RES, V12, P5423, DOI 10.1158/1078-0432.CCR-06-0369; Hiraoka N, 2011, GASTROENTEROLOGY, V140, P310, DOI 10.1053/j.gastro.2010.10.009; Hruban RH, 2010, WHO CLASSIFICATION T, P281; Japan Pancreas Society, 2003, CLASS PANCR CANC; Krotova K, 2010, AM J PHYSIOL-CELL PH, V299, pC1541, DOI 10.1152/ajpcell.00068.2010; Li H, 2001, AM J PHYSIOL-ENDOC M, V280, pE75, DOI 10.1152/ajpendo.2001.280.1.E75; Lim JE, 2003, ANN SURG, V237, P74, DOI 10.1097/00000658-200301000-00011; Louis CA, 1998, AM J PHYSIOL-REG I, V274, pR775, DOI 10.1152/ajpregu.1998.274.3.R775; Morris SM, 2009, BRIT J PHARMACOL, V157, P922, DOI 10.1111/j.1476-5381.2009.00278.x; Munder M, 2009, BRIT J PHARMACOL, V158, P638, DOI 10.1111/j.1476-5381.2009.00291.x; Ochoa AC, 2007, CLIN CANCER RES, V13, p721S, DOI 10.1158/1078-0432.CCR-06-2197; Okami J, 2004, CANCER RES, V64, P5338, DOI 10.1158/0008-5472.CAN-04-0089; PASTOREKOVA S, 1992, VIROLOGY, V187, P620, DOI 10.1016/0042-6822(92)90464-Z; Philip PA, 2009, J CLIN ONCOL, V27, P5660, DOI 10.1200/JCO.2009.21.9022; Pitman MB, 2007, TUMORS PANCREAS, P111; Rodriguez PC, 2003, J IMMUNOL, V171, P1232, DOI 10.4049/jimmunol.171.3.1232; Rotondo R, 2008, INT J CANCER, V123, P1108, DOI 10.1002/ijc.23437; Semenza GL, 2009, CURR PHARM DESIGN, V15, P3839, DOI 10.2174/138161209789649402; Semenza GL, 2006, EXPERT OPIN THER TAR, V10, P267, DOI 10.1517/14728222.10.2.267; Sessa C, 2008, NAT CLIN PRACT ONCOL, V5, P378, DOI 10.1038/ncponc1150; Sica A, 2007, J CLIN INVEST, V117, P1155, DOI 10.1172/JCI31422; Sica A, 2011, J MOL MED, V89, P657, DOI 10.1007/s00109-011-0724-8; Siegel R, 2011, CA-CANCER J CLIN, V61, P212, DOI 10.3322/caac.20121; Sobin LH, 2009, UICC TNM ATLAS; Takahashi Y, 2007, CLIN CANCER RES, V13, P187, DOI 10.1158/1078-0432.CCR-06-1408; Toby IT, 2010, AM J PHYSIOL-LUNG C, V298, pL600, DOI 10.1152/ajplung.00122.2009; Wenger Roland H, 2005, Sci STKE, V2005, pre12, DOI 10.1126/stke.3062005re12; Wu GY, 1998, BIOCHEM J, V336, P1, DOI 10.1042/bj3360001; Zavada J, 2000, BRIT J CANCER, V82, P1808, DOI 10.1054/bjoc.2000.1111	40	100	103	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2013	8	2							e55146	10.1371/journal.pone.0055146	http://dx.doi.org/10.1371/journal.pone.0055146			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104BU	23424623	Green Published, gold, Green Submitted			2022-12-25	WOS:000315965100011
J	Lee, JJ; Chen, CH; Chen, YH; Huang, MJ; Huang, J; Hung, JS; Chen, MT; Huang, MC				Lee, Jian-Jr; Chen, Chia-Hua; Chen, Ya-Hsin; Huang, Miao-Juei; Huang, John; Hung, Ji-Shiang; Chen, Ming-Ting; Huang, Min-Chuan			COSMC Is Overexpressed in Proliferating Infantile Hemangioma and Enhances Endothelial Cell Growth via VEGFR2	PLOS ONE			English	Article							PROTEIN O-GLYCOSYLATION; EXPRESSION; CANCER; RECEPTORS; CHAPERONE; VACCINES; SWEET; MICE	Infantile hemangiomas are localized lesions comprised primarily of aberrant endothelial cells. COSMC plays a crucial role in blood vessel formation and is characterized as a molecular chaperone of T-synthase which catalyzes the synthesis of T antigen (Gal beta 1,3GalNAc). T antigen expression is associated with tumor malignancy in many cancers. However, roles of COSMC in infantile hemangioma are still unclear. In this study, immunohistochemistry showed that COSMC was upregulated in proliferating hemangiomas compared with involuted hemangiomas. Higher levels of T antigen expression were also observed in the proliferating hemangioma. Overexpression of COSMC significantly enhanced cell growth and phosphorylation of AKT and ERK in human umbilical vein endothelial cells (HUVECs). Conversely, knockdown of COSMC with siRNA inhibited endothelial cell growth. Mechanistic investigation showed that O-glycans were present on VEGFR2 and these structures were modulated by COSMC. Furthermore, VEGFR2 degradation was delayed by COSMC overexpression and facilitated by COSMC knockdown. We also showed that COSMC was able to regulate VEGF-triggered phosphorylation of VEGFR2. Our results suggest that COSMC is a novel regulator for VEGFR2 signaling in endothelial cells and dysregulation of COSMC expression may contribute to the pathogenesis of hemangioma.	[Lee, Jian-Jr; Chen, Chia-Hua; Chen, Ya-Hsin; Huang, Miao-Juei; Huang, Min-Chuan] Natl Taiwan Univ, Coll Med, Grad Inst Anat & Cell Biol, Taipei 10764, Taiwan; [Huang, Miao-Juei; Huang, Min-Chuan] Natl Taiwan Univ, Res Ctr Dev Biol & Regenerat Med, Taipei 10764, Taiwan; [Huang, John; Hung, Ji-Shiang] Natl Taiwan Univ Hosp, Dept Surg, Taipei, Taiwan; [Lee, Jian-Jr; Chen, Ming-Ting] Cathay Gen Hosp, Dept Surg, Div Plast Surg, Taipei, Taiwan	National Taiwan University; National Taiwan University; National Taiwan University; National Taiwan University Hospital; Cathay General Hospital	Huang, MC (corresponding author), Natl Taiwan Univ, Coll Med, Grad Inst Anat & Cell Biol, Taipei 10764, Taiwan.	mchuang@ntu.edu.tw		Hung, Ji-Shiang/0000-0001-7392-5694; HUANG, MIN-CHUAN/0000-0002-0704-3447; Chen, Chia-Hua/0000-0003-0536-8085	National Taiwan University [10R71808]; National Science Council [NSC 99-2314-B-002-097-MY2, NSC 98-2320-B-002-032-MY3]	National Taiwan University(National Taiwan University); National Science Council(Ministry of Science and Technology, Taiwan)	This study was supported by grants from the National Taiwan University 10R71808, and the National Science Council NSC 99-2314-B-002-097-MY2 and NSC 98-2320-B-002-032-MY3 (to Dr. M. C. Huang). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, HISTOPATHOLOGY VASCU, V38, P31; Astronomo RD, 2010, NAT REV DRUG DISCOV, V9, P308, DOI 10.1038/nrd3012; Berard M, 1997, AM J PATHOL, V150, P1315; Drolet BA, 1999, NEW ENGL J MED, V341, P173, DOI 10.1056/NEJM199907153410307; Fu JX, 2008, J CLIN INVEST, V118, P3725, DOI 10.1172/JCI36077; Fuster MM, 2005, NAT REV CANCER, V5, P526, DOI 10.1038/nrc1649; Heimburg-Molinaro J, 2011, VACCINE, V29, P8802, DOI 10.1016/j.vaccine.2011.09.009; Holmes K, 2007, CELL SIGNAL, V19, P2003, DOI 10.1016/j.cellsig.2007.05.013; Jinnin M, 2008, NAT MED, V14, P1236, DOI 10.1038/nm.1877; Ju TZ, 2008, J CELL BIOL, V182, P531, DOI 10.1083/jcb.200711151; Ju TZ, 2011, ANGEW CHEM INT EDIT, V50, P1770, DOI 10.1002/anie.201002313; Ju TZ, 2002, J BIOL CHEM, V277, P178, DOI 10.1074/jbc.M109060200; Kilcline C, 2008, PEDIATR DERMATOL, V25, P168, DOI 10.1111/j.1525-1470.2008.00626.x; Robinson CJ, 2001, J CELL SCI, V114, P853; Tarp MA, 2008, BBA-GEN SUBJECTS, V1780, P546, DOI 10.1016/j.bbagen.2007.09.010; Tian E, 2009, GLYCOCONJUGATE J, V26, P325, DOI 10.1007/s10719-008-9162-4; Walter JW, 2002, GENE CHROMOSOME CANC, V33, P295, DOI 10.1002/gcc.10028; Wang YC, 2010, P NATL ACAD SCI USA, V107, P9228, DOI 10.1073/pnas.0914004107; Wu YM, 2011, CANCER RES, V71, P7270, DOI 10.1158/0008-5472.CAN-11-1161; Xia LJ, 2006, METHOD ENZYMOL, V416, P314, DOI 10.1016/S0076-6879(06)16021-8; Yu LG, 2007, GLYCOCONJUGATE J, V24, P411, DOI 10.1007/s10719-007-9034-3; Yu Y, 2001, AM J PATHOL, V159, P2271, DOI 10.1016/S0002-9440(10)63077-5	22	12	14	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2013	8	2							e56211	10.1371/journal.pone.0056211	http://dx.doi.org/10.1371/journal.pone.0056211			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104BU	23424651	Green Published, Green Submitted, gold			2022-12-25	WOS:000315965100039
J	Liu, BL; Su, JB; Chen, JW; Cui, GF; Ma, JZ				Liu, Bingliang; Su, Jinbao; Chen, Jianwei; Cui, Guofa; Ma, Jianzhang			Anthropogenic Halo Disturbances Alter Landscape and Plant Richness: A Ripple Effect	PLOS ONE			English	Article							FOREST FRAGMENTATION; HABITAT FRAGMENTATION; MOVEMENT ECOLOGY; TROPICAL FOREST; SEED DISPERSAL; CORRIDORS; POLLINATION; COMMUNITY; SUSTAINABILITY; CONNECTIVITY	Although anthropogenic landscape fragmentation is often considered as the primary threat to biodiversity, other factors such as immediate human disturbances may also simultaneously threaten species persistence in various ways. In this paper, we introduce a conceptual framework applied to recreation landscapes (RLs), with an aim to provide insight into the composite influences of landscape alteration accompanying immediate human disturbances on plant richness dynamics. These impacts largely occur at patch-edges. They can not only alter patch-edge structure and environment, but also permeate into surrounding natural matrices/patches affecting species persistence-here we term these "Halo disturbance effects" (HDEs). We categorized species into groups based on seed or pollen dispersal mode (animal- vs. wind-dispersed) as they can be associated with species richness dynamics. We evaluated the richness of the two groups and total species in our experimental landscapes by considering the distance from patch-edge, the size of RLs and the intensity of human use over a six-year period. Our results show that animal-dispersed species decreased considerably, whereas wind-dispersed species increased while their richness presented diverse dynamics at different distances from patch-edges. Our findings clearly demonstrate that anthropogenic HDEs produce ripple effects on plant, providing an experimental interpretation for the diverse responses of species to anthropogenic disturbances. This study highlights the importance of incorporating these composite threats into conservation and management strategies.	[Liu, Bingliang; Cui, Guofa] Beijing Forestry Univ, Coll Nat Reserve, Beijing, Peoples R China; [Su, Jinbao] Northeast Forestry Univ, Coll Econ & Management, Harbin, Peoples R China; [Chen, Jianwei] Wildlife & Nat Reserve Management Div State Fores, Beijing, Peoples R China; [Ma, Jianzhang] Northeast Forestry Univ, Coll Wildlife Resource, Harbin, Peoples R China	Beijing Forestry University; Northeast Forestry University - China; Northeast Forestry University - China	Su, JB (corresponding author), Northeast Forestry Univ, Coll Econ & Management, 26 Xiangfang Dist, Harbin, Peoples R China.	cites.nature@hotmail.com			postdoctoral scientific foundation of Heilongjiang Province, China [LRB05385]	postdoctoral scientific foundation of Heilongjiang Province, China	This research was partly supported by postdoctoral scientific foundation of Heilongjiang Province, China (LRB05385) from 2006 to 2010. The funders had no role in analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Adler P. B., 2007, Ecology, V88, P2673, DOI 10.1890/0012-9658(2007)88[2673:LMQFKP]2.0.CO;2; AIZEN MA, 1994, ECOLOGY, V75, P330, DOI 10.2307/1939538; Antongiovanni M, 2005, BIOL CONSERV, V122, P441, DOI 10.1016/j.biocon.2004.09.005; Beier P, 1998, CONSERV BIOL, V12, P1241, DOI 10.1046/j.1523-1739.1998.98036.x; Bohrer G, 2008, J ECOL, V96, P569, DOI 10.1111/j.1365-2745.2008.01368.x; Brudvig LA, 2009, P NATL ACAD SCI USA, V106, P9328, DOI 10.1073/pnas.0809658106; Choi HC, 2006, TOURISM MANAGE, V27, P1274, DOI 10.1016/j.tourman.2005.05.018; Cochrane MA, 1999, SCIENCE, V284, P1832, DOI 10.1126/science.284.5421.1832; Cordeiro NJ, 2003, P NATL ACAD SCI USA, V100, P14052, DOI 10.1073/pnas.2331023100; Cordeiro NJ, 2001, CONSERV BIOL, V15, P1733, DOI 10.1046/j.1523-1739.2001.99579.x; Damschen EI, 2008, P NATL ACAD SCI USA, V105, P19078, DOI 10.1073/pnas.0802037105; FAHRIG L, 1988, THEOR POPUL BIOL, V34, P194, DOI 10.1016/0040-5809(88)90042-1; Fall PL, 2011, PAC SCI, V65, P143, DOI 10.2984/65.2.143; Fazey I, 2005, BIOL CONSERV, V124, P63, DOI 10.1016/j.biocon.2005.01.013; Fischer J, 2007, GLOBAL ECOL BIOGEOGR, V16, P265, DOI 10.1111/j.1466-8238.2007.00287.x; Foley JA, 2005, SCIENCE, V309, P570, DOI 10.1126/science.1111772; Francis CD, 2012, P ROY SOC B-BIOL SCI, V279, P2727, DOI 10.1098/rspb.2012.0230; Francis CD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027052; Galetti M, 2003, BIOL CONSERV, V111, P269, DOI 10.1016/S0006-3207(02)00299-9; Gascon C, 1999, BIOL CONSERV, V91, P223, DOI 10.1016/S0006-3207(99)00080-4; Greene DF, 2008, ECOLOGY, V89, P118, DOI 10.1890/06-0781.1; Groom MJ, 1998, AM NAT, V151, P487, DOI 10.1086/286135; Haila Y, 2002, ECOL APPL, V12, P321, DOI 10.1890/1051-0761(2002)012[0321:ACGOFR]2.0.CO;2; [蒋依依 JIANG YiYi], 2008, [生态学报, Acta Ecologica Sinica], V28, P1786; Laurance WF, 1997, SCIENCE, V278, P1117, DOI 10.1126/science.278.5340.1117; Laurance WF, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001017; Laurance WF, 2006, P NATL ACAD SCI USA, V103, P19010, DOI 10.1073/pnas.0609048103; Levey DJ, 2005, SCIENCE, V309, P146, DOI 10.1126/science.1111479; Lindenmayer D, 2006, HABITAT FRAGMENTATIO; Luck GW, 2003, ECOL APPL, V13, P235, DOI 10.1890/1051-0761(2003)013[0235:TCBARC]2.0.CO;2; Malanson George P., 1999, Diversity and Distributions, V5, P27, DOI 10.1046/j.1472-4642.1999.00035.x; Manne LL, 2001, ANIM CONSERV, V4, P221, DOI 10.1017/S1367943001001263; Herrera JM, 2010, CONSERV BIOL, V24, P1089, DOI 10.1111/j.1523-1739.2010.01459.x; McIntyre S, 1999, CONSERV BIOL, V13, P1282, DOI 10.1046/j.1523-1739.1999.97509.x; Nathan R, 2005, DIVERS DISTRIB, V11, P131, DOI 10.1111/j.1366-9516.2005.00146.x; Nathan R, 2006, SCIENCE, V313, P786, DOI 10.1126/science.1124975; Nathan R, 2008, P NATL ACAD SCI USA, V105, P19052, DOI 10.1073/pnas.0800375105; Orrock JL, 2003, ECOLOGY, V84, P2589, DOI 10.1890/02-0439; Ricketts TH, 2004, P NATL ACAD SCI USA, V101, P12579, DOI 10.1073/pnas.0405147101; ROLSTAD J, 1991, BIOL J LINN SOC, V42, P149, DOI 10.1111/j.1095-8312.1991.tb00557.x; Sala OE, 2000, SCIENCE, V287, P1770, DOI 10.1126/science.287.5459.1770; Sieving KE, 1996, AUK, V113, P944, DOI 10.2307/4088877; Slabbekoorn H, 2003, NATURE, V424, P267, DOI 10.1038/424267a; STEARNS SC, 1976, Q REV BIOL, V51, P3, DOI 10.1086/409052; Terborgh J, 2001, SCIENCE, V294, P1923, DOI 10.1126/science.1064397; Tewksbury JJ, 2002, P NATL ACAD SCI USA, V99, P12923, DOI 10.1073/pnas.202242699; Tischendorf L, 2000, OIKOS, V90, P7, DOI 10.1034/j.1600-0706.2000.900102.x; Tsaur SH, 2006, TOURISM MANAGE, V27, P640, DOI 10.1016/j.tourman.2005.02.006; Uezu A, 2005, BIOL CONSERV, V123, P507, DOI 10.1016/j.biocon.2005.01.001; Wang Y.L., 1999, INT J ADV EARTH SCI, V14, P235; Wilcock C, 2002, TRENDS PLANT SCI, V7, P270, DOI 10.1016/S1360-1385(02)02258-6; With KA, 1997, CONSERV BIOL, V11, P1069, DOI 10.1046/j.1523-1739.1997.96210.x; Wu J.G., 2000, CHINESE J ECOL, V19, P42	53	3	5	1	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2013	8	2							e56109	10.1371/journal.pone.0056109	http://dx.doi.org/10.1371/journal.pone.0056109			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104BU	23424648	gold, Green Published, Green Submitted			2022-12-25	WOS:000315965100036
J	Chen, CC; Liou, SW; Chen, CC; Chen, WC; Hu, FR; Wang, IJ; Lin, SJ				Chen, Chun-Chen; Liou, Shiow-Wen; Chen, Chi-Chih; Chen, Wen-Chung; Hu, Fung-Rong; Wang, I-Jong; Lin, Shing-Jong			Coenzyme Q(10) Rescues Ethanol-induced Corneal Fibroblast Apoptosis through the Inhibition of Caspase-2 Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STRESS-INDUCED APOPTOSIS; MITOCHONDRIAL PERMEABILITY TRANSITION; CYTOCHROME-C RELEASE; OXIDATIVE DNA-DAMAGE; CELL-DEATH; CAENORHABDITIS-ELEGANS; IN-VITRO; ALCOHOL; UBIQUINONE; PATHWAYS	Recent studies indicate that caspase-2 is involved in the early stages of apoptosis, particularly before the occurrence of mitochondrial damage. Here we report the important role of the coenzyme Q(10) (CoQ(10)) on the activity of caspase-2 upstream of mitochondria in ethanol (EtOH)-treated corneal fibroblasts. After EtOH exposure, cells produce excessive reactive oxygen species formation, p53 expression, and most importantly, caspase-2 activation. After the activation of the caspase-2, the cells exhibited hallmarks of apoptotic pathway, such as mitochondrial damage and translocation of Bax and cytochrome c, which were then followed by caspase-3 activation. By pretreating the cells with a cell-permeable, biotinylated pan-caspase inhibitor, we identified caspase-2 as an initiator caspase in EtOH-treated corneal fibroblasts. Loss of caspase-2 inhibited EtOH-induced apoptosis. We further found that caspase-2 acts upstream of mitochondria to mediate EtOH-induced apoptosis. The loss of caspase-2 significantly inhibited EtOH-induced mitochondrial dysfunction, Bax translocation, and cytochrome c release from mitochondria. The pretreatment of CoQ(10) prevented EtOH-induced caspase-2 activation and mitochondria-mediated apoptosis. Our data demonstrated that by blocking caspase-2 activity, CoQ(10) can protect the cells from mitochondrial membrane change, apoptotic protein translocation, and apoptosis. Taken together, EtOH-induced mitochondria-mediated apoptosis is initiated by caspase-2 activation, which is regulated by CoQ(10).	[Chen, Chun-Chen; Liou, Shiow-Wen] Taipei City Hosp Renai Branch, Dept Ophthalmol, Taipei 106, Taiwan; [Chen, Chun-Chen; Lin, Shing-Jong] Natl Yang Ming Univ, Inst Clin Med, Taipei 112, Taiwan; [Lin, Shing-Jong] Natl Yang Ming Univ, Cardiovasc Res Ctr, Taipei 112, Taiwan; [Chen, Chi-Chih; Chen, Wen-Chung] Taipei Vet Gen Hosp, Dept Internal Med, Div Cardiol, Taipei 112, Taiwan; [Lin, Shing-Jong] Taipei Vet Gen Hosp, Dept Med Res & Educ, Taipei 112, Taiwan; [Liou, Shiow-Wen; Hu, Fung-Rong; Wang, I-Jong] Natl Taiwan Univ Hosp, Dept Ophthalmol, Taipei 100, Taiwan; [Liou, Shiow-Wen] Taipei Med Univ, Taipei 110, Taiwan; [Wang, I-Jong] China Med Univ, Grad Inst Clin Med Sci, Taichung 404, Taiwan	Taipei City Hospital; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; Taipei Veterans General Hospital; National Taiwan University; National Taiwan University Hospital; Taipei Medical University; China Medical University Taiwan	Wang, IJ (corresponding author), Natl Taiwan Univ Hosp, Dept Ophthalmol, 7 Chung Shan S Rd, Taipei 100, Taiwan.	ijong@ms8.hinet.net; sjlin@vghtpe.gov.tw		Wang, I-Jong/0000-0002-3045-0614; HU, FUNG-RONG/0000-0002-2102-5317	Taiwan National Science Council [NSC95-2314-B002-149-MY3, NSC96-2627-B002-011, NSC97-2627-B002-007, NSC98-2627-B002-004, NSC98-3112-B002-040, NSC99-3112-B002-029, NSC99-2314-B002-039-MY3, NSC99-2314-B002-040-MY3, NSC100-2314-B002-061-MY3]; Department of Health, Executive Yuan, R.O.C. (Taiwan) [DOH100-TD-PB-111-TM005]; National Taiwan University Hospital [NTUH.98-S1105, NTUH.99-MSN 01, NTUH.100-001637, NTUH.VN101-06]	Taiwan National Science Council(Ministry of Science and Technology, Taiwan); Department of Health, Executive Yuan, R.O.C. (Taiwan); National Taiwan University Hospital(National Taiwan University)	This work was supported in part by Taiwan National Science Council Grants NSC95-2314-B002-149-MY3, NSC96-2627-B002-011, NSC97-2627-B002-007, NSC98-2627-B002-004, NSC98-3112-B002-040, NSC99-3112-B002-029, NSC99-2314-B002-039-MY3, NSC99-2314-B002-040-MY3, NSC100-2314-B002-061-MY3, Department of Health, Executive Yuan, R.O.C. (Taiwan), DOH100-TD-PB-111-TM005, and National Taiwan University Hospital NTUH.98-S1105, NTUH.99-MSN 01, NTUH.100-001637, and NTUH.VN101-06.	Abad JC, 1997, OPHTHALMOLOGY, V104, P1566, DOI 10.1016/S0161-6420(97)30095-5; Alleva R, 2001, FEBS LETT, V503, P46, DOI 10.1016/S0014-5793(01)02694-1; Baliga BC, 2004, CELL DEATH DIFFER, V11, P1234, DOI 10.1038/sj.cdd.4401492; Bergeron L, 1998, GENE DEV, V12, P1304, DOI 10.1101/gad.12.9.1304; Boatright KM, 2003, MOL CELL, V11, P529, DOI 10.1016/S1097-2765(03)00051-0; Bonzon C, 2006, MOL BIOL CELL, V17, P2150, DOI 10.1091/mbc.E05-12-1107; Bouchier-Hayes L, 2012, CELL DEATH DIFFER, V19, P51, DOI 10.1038/cdd.2011.157; Bouchier-Hayes L, 2010, J CELL MOL MED, V14, P1212, DOI 10.1111/j.1582-4934.2010.01037.x; Brancato R, 2000, EUR J OPHTHALMOL, V10, P32, DOI 10.1177/112067210001000106; Budihardjo I, 1999, ANNU REV CELL DEV BI, V15, P269, DOI 10.1146/annurev.cellbio.15.1.269; Chan KM, 2010, TOXICOL SCI, V116, P533, DOI 10.1093/toxsci/kfq151; Chang K, 2006, NAT METHODS, V3, P707, DOI 10.1038/NMETH923; Chauvier D, 2005, APOPTOSIS, V10, P1243, DOI 10.1007/s10495-005-1681-x; Chen CC, 2002, INVEST OPHTH VIS SCI, V43, P2593; Chen CC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019111; Chen F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006830; Chen Y, 2008, PHARM RES-DORDR, V25, P72, DOI 10.1007/s11095-007-9504-0; Cryns V, 1998, GENE DEV, V12, P1551, DOI 10.1101/gad.12.11.1551; Dallner G, 2000, FREE RADICAL BIO MED, V29, P285, DOI 10.1016/S0891-5849(00)00307-5; Fewell GD, 2006, DRUG DISCOV TODAY, V11, P975, DOI 10.1016/j.drudis.2006.09.008; Fontaine E, 1998, J BIOL CHEM, V273, P12662, DOI 10.1074/jbc.273.20.12662; Funderburgh JL, 2001, J BIOL CHEM, V276, P44173, DOI 10.1074/jbc.M107596200; Guo Y, 2002, J BIOL CHEM, V277, P13430, DOI 10.1074/jbc.M108029200; Gutierrez-Mariscal FM, 2012, AGE, V34, P389, DOI 10.1007/s11357-011-9229-1; Higuchi H, 2001, HEPATOLOGY, V34, P320, DOI 10.1053/jhep.2001.26380; Hoek JB, 2002, GASTROENTEROLOGY, V122, P2049, DOI 10.1053/gast.2002.33613; Kanno S, 2006, TOXICOL LETT, V166, P131, DOI 10.1016/j.toxlet.2006.06.005; Keating DJ, 2008, J NEUROCHEM, V104, P298, DOI 10.1111/j.1471-4159.2007.04997.x; Kelso GF, 2001, J BIOL CHEM, V276, P4588, DOI 10.1074/jbc.M009093200; Kim TI, 2004, INVEST OPHTH VIS SCI, V45, P86, DOI 10.1167/iovs.03-0520; Kitevska T, 2009, APOPTOSIS, V14, P829, DOI 10.1007/s10495-009-0365-3; Kluck RM, 1997, SCIENCE, V275, P1132, DOI 10.1126/science.275.5303.1132; Kroemer G, 2000, NAT MED, V6, P513, DOI 10.1038/74994; Krumschnabel G, 2009, CELL DEATH DIFFER, V16, P195, DOI 10.1038/cdd.2008.170; KUMAR S, 1994, GENE DEV, V8, P1613, DOI 10.1101/gad.8.14.1613; Kumar S, 2002, SCIENCE, V297, P1290, DOI 10.1126/science.1076118; Kumar S, 2009, NAT REV CANCER, V9, P897, DOI 10.1038/nrc2745; Lamkanfi M, 2002, CELL DEATH DIFFER, V9, P358, DOI 10.1038/sj.cdd.4400989; Lassus P, 2002, SCIENCE, V297, P1352, DOI 10.1126/science.1074721; LENAZ G, 1993, CLIN INVESTIGATOR, V71, pS66; Lopez-Lluch G, 1999, BIOFACTORS, V9, P171, DOI 10.1002/biof.5520090212; Madesh M, 2009, MOL CELL BIOL, V29, P3099, DOI 10.1128/MCB.01845-08; Mancuso M, 2010, CURR DRUG TARGETS, V11, P111, DOI 10.2174/138945010790031018; McStay GP, 2008, CELL DEATH DIFFER, V15, P322, DOI 10.1038/sj.cdd.4402260; Nair VD, 2006, APOPTOSIS, V11, P955, DOI 10.1007/s10495-006-6316-3; Nanji AA, 1998, SEMIN LIVER DIS, V18, P187, DOI 10.1055/s-2007-1007154; Olsson M, 2009, ONCOGENE, V28, P1949, DOI 10.1038/onc.2009.36; Papucci L, 2003, J BIOL CHEM, V278, P28220, DOI 10.1074/jbc.M302297200; Paroni G, 2002, J BIOL CHEM, V277, P15147, DOI 10.1074/jbc.M112338200; Pepper C, 1998, LEUKEMIA RES, V22, P439, DOI 10.1016/S0145-2126(98)00013-7; Petronilli V, 2001, J BIOL CHEM, V276, P12030, DOI 10.1074/jbc.M010604200; Renatus M, 2001, P NATL ACAD SCI USA, V98, P14250, DOI 10.1073/pnas.231465798; Robertson JD, 2002, J BIOL CHEM, V277, P29803, DOI 10.1074/jbc.M204185200; Rutjes SK, 1999, J BIOL CHEM, V274, P24799, DOI 10.1074/jbc.274.35.24799; Schweizer A, 2003, J BIOL CHEM, V278, P42441, DOI 10.1074/jbc.M304895200; Shim HY, 2007, MOL CELLS, V24, P95; Sosne G, 2004, INVEST OPHTH VIS SCI, V45, P1095, DOI 10.1167/iovs.03-1002; Srimathi T, 2008, BIOCHEMISTRY-US, V47, P1319, DOI 10.1021/bi7016602; Stein HA, 1997, J CATARACT REFR SURG, V23, P1160, DOI 10.1016/S0886-3350(97)80309-4; Tamm C, 2008, APOPTOSIS, V13, P354, DOI 10.1007/s10495-007-0172-7; Thornberry NA, 1998, SCIENCE, V281, P1312, DOI 10.1126/science.281.5381.1312; Tinel A, 2004, SCIENCE, V304, P843, DOI 10.1126/science.1095432; Tiwari M, 2011, J BIOL CHEM, V286, P8493, DOI 10.1074/jbc.M110.163824; Tomasetti M, 2001, FASEB J, V15, P1425, DOI 10.1096/fj.00-0694fje; Troy CM, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.138pe42; Troy CM, 2001, J NEUROSCI, V21, P5007, DOI 10.1523/JNEUROSCI.21-14-05007.2001; Tu S, 2006, NAT CELL BIOL, V8, P72, DOI 10.1038/ncb1340; VALLS V, 1994, BIOCHEM MOL BIOL INT, V33, P633; Wang XC, 2002, SCIENCE, V298, P1587, DOI 10.1126/science.1076194; Zhang FX, 1998, J NEUROCHEM, V71, P196, DOI 10.1046/j.1471-4159.1998.71010196.x; Zhivotovsky B, 2005, BIOCHEM BIOPH RES CO, V331, P859, DOI 10.1016/j.bbrc.2005.03.191	71	15	16	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 26	2013	288	17					11689	11704		10.1074/jbc.M112.401844	http://dx.doi.org/10.1074/jbc.M112.401844			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	133RP	23430247	hybrid, Green Published			2022-12-25	WOS:000318157600007
J	Li, Y; Wong, K; Walsh, K; Gao, B; Zang, MW				Li, Yu; Wong, Kimberly; Walsh, Kenneth; Gao, Bin; Zang, Mengwei			Retinoic Acid Receptor beta Stimulates Hepatic Induction of Fibroblast Growth Factor 21 to Promote Fatty Acid Oxidation and Control Whole-body Energy Homeostasis in Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; IMPROVES INSULIN SENSITIVITY; ADAPTIVE THERMOGENESIS; LIPID-METABOLISM; TRANSGENIC MICE; HEPG2 CELLS; PPAR-ALPHA; ALL-TRANS; EXPRESSION; OBESITY	Activation of retinoic acid receptor (RAR) with all-trans-retinoic acid (RA) ameliorates glucose intolerance and insulin resistance in obese mice. The recently discovered fibroblast growth factor 21 (FGF21) is a hepatocyte-derived hormone that restores glucose and lipid homeostasis in obesity-induced diabetes. However, whether hepatic RAR is linked to FGF21 in the control of lipid metabolism and energy homeostasis remains elusive. Here we identify FGF21 as a direct target gene of RAR beta. The gene transcription of Fgf21 is increased by the RAR agonist RA and by overexpression of RAR alpha and RAR beta, but it is unaffected by RAR gamma in HepG2 cells. Promoter deletion analysis characterizes a putative RA-responsive element (RARE) primarily located in the 5'-flanking region of the Fgf21 gene. Disruption of the RARE sequence abolishes RA responsiveness. In vivo adenoviral overexpression of RAR beta in the liver enhances production and secretion of FGF21, which in turn promotes hepatic fatty acid oxidation and ketogenesis and ultimately leads to increased energy expenditure in mice. The metabolic effects of RA or RAR beta are mimicked by FGF21 overexpression and largely abolished by FGF21 knockdown. Moreover, hepatic RAR beta is bound to the putative RAREs of the Fgf21 promoter in a fasting-inducible manner in vivo, which contributes to FGF21 induction and the metabolic adaptation to prolonged fasting. In addition to other nuclear receptors, such as peroxisome proliferator-activated receptor alpha and retinoic acid receptor-related receptor alpha, RAR may act as a novel component to induce hepatic FGF21 in the regulation of lipid metabolism. The hepatic RAR-FGF21 pathway may represent a potential drug target for treating metabolic disorders.	[Li, Yu; Wong, Kimberly; Walsh, Kenneth; Zang, Mengwei] Boston Univ, Sch Med, Whitaker Cardiovasc Inst, Dept Med, Boston, MA 02118 USA; [Gao, Bin] NIAAA, Lab Liver Dis, Bethesda, MD 20892 USA	Boston University; National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)	Li, Y (corresponding author), Boston Univ, Sch Med, Whitaker Cardiovasc Inst, Vasc Biol Sect,Dept Med, X725,650 Albany St, Boston, MA 02118 USA.	leonli@bu.edu; mwzang1@bu.edu		Zang, Mengwei/0000-0002-2502-2586; Li, Yu/0000-0001-6910-5933; Walsh, Kenneth/0000-0001-7580-2276	National Institutes of Health [DK076942]; Robert Dawson Evans Junior Faculty Merit Award; Wing Tat Lee Award; Boston University CTSI subsidy fund [UL1RR025771]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025771] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL081587] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK076942] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Robert Dawson Evans Junior Faculty Merit Award; Wing Tat Lee Award; Boston University CTSI subsidy fund; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK076942. This work was also supported by the Robert Dawson Evans Junior Faculty Merit Award, the Wing Tat Lee Award (to M. Z.), and Boston University CTSI subsidy fund Grant UL1RR025771 (to Y. L.).	Altucci L, 2007, NAT REV DRUG DISCOV, V6, P793, DOI 10.1038/nrd2397; Amengual J, 2010, CELL PHYSIOL BIOCHEM, V25, P657, DOI 10.1159/000315085; Ashla AA, 2010, HEPATOL RES, V40, P594, DOI 10.1111/j.1872-034X.2010.00646.x; Badman MK, 2007, CELL METAB, V5, P426, DOI 10.1016/j.cmet.2007.05.002; Bastien J, 2004, GENE, V328, P1, DOI 10.1016/j.gene.2003.12.005; Bence KK, 2006, NAT MED, V12, P917, DOI 10.1038/nm1435; Berry DC, 2012, DIABETES, V61, P1112, DOI 10.2337/db11-1620; Berry DC, 2009, MOL CELL BIOL, V29, P3286, DOI 10.1128/MCB.01742-08; Bonilla S, 2000, BRIT J NUTR, V83, P665, DOI 10.1017/S0007114500000842; Cai SY, 2010, J LIPID RES, V51, P2265, DOI 10.1194/jlr.M005546; Choi CS, 2007, P NATL ACAD SCI USA, V104, P16480, DOI 10.1073/pnas.0706794104; Coskun T, 2008, ENDOCRINOLOGY, V149, P6018, DOI 10.1210/en.2008-0816; Donmez G, 2010, CELL, V142, P320, DOI 10.1016/j.cell.2010.06.020; DURAND B, 1992, CELL, V71, P73, DOI 10.1016/0092-8674(92)90267-G; Dutchak PA, 2012, CELL, V148, P556, DOI 10.1016/j.cell.2011.11.062; Feige JN, 2008, CELL METAB, V8, P347, DOI 10.1016/j.cmet.2008.08.017; Fisher FM, 2012, GENE DEV, V26, P271, DOI 10.1101/gad.177857.111; Fisher FM, 2011, ENDOCRINOLOGY, V152, P2996, DOI 10.1210/en.2011-0281; Fukao T, 2004, PROSTAG LEUKOTR ESS, V70, P243, DOI 10.1016/j.plefa.2003.11.001; Ge X, 2011, J BIOL CHEM, V286, P34533, DOI 10.1074/jbc.M111.248591; Gerhart-Hines Z, 2011, MOL CELL, V44, P851, DOI 10.1016/j.molcel.2011.12.005; Germain P, 2006, PHARMACOL REV, V58, P712, DOI 10.1124/pr.58.4.4; Hofmann SM, 2007, J CLIN INVEST, V117, P3271, DOI 10.1172/JCI31929; Holzel M, 2010, CELL, V142, P218, DOI 10.1016/j.cell.2010.06.004; Hou XY, 2008, J BIOL CHEM, V283, P20015, DOI 10.1074/jbc.M802187200; Inagaki T, 2007, CELL METAB, V5, P415, DOI 10.1016/j.cmet.2007.05.003; Izumiya Y, 2008, FEBS LETT, V582, P3805, DOI 10.1016/j.febslet.2008.10.021; KAKIZUKA A, 1991, CELL, V66, P663, DOI 10.1016/0092-8674(91)90112-C; Kharitonenkov A, 2005, J CLIN INVEST, V115, P1627, DOI 10.1172/JCI23606; Kharitonenkov A, 2008, J CELL PHYSIOL, V215, P1, DOI 10.1002/jcp.21357; Kharitonenkov A, 2007, ENDOCRINOLOGY, V148, P774, DOI 10.1210/en.2006-1168; Li Y, 2011, CELL METAB, V13, P376, DOI 10.1016/j.cmet.2011.03.009; Li Y, 2011, FASEB J, V25, P1664, DOI 10.1096/fj.10-173492; Lowell BB, 2000, NATURE, V404, P652, DOI 10.1038/35007527; Luo J, 2007, NAT PROTOC, V2, P1236, DOI 10.1038/nprot.2007.135; Maeda K, 2005, CELL METAB, V1, P107, DOI 10.1016/j.cmet.2004.12.008; Mark M, 2006, ANNU REV PHARMACOL, V46, P451, DOI 10.1146/annurev.pharmtox.46.120604.141156; Podvinec M, 2002, MOL ENDOCRINOL, V16, P1269, DOI 10.1210/me.16.6.1269; Potthoff MJ, 2009, P NATL ACAD SCI USA, V106, P10853, DOI 10.1073/pnas.0904187106; ROCHETTEEGLY C, 1995, MOL ENDOCRINOL, V9, P860, DOI 10.1210/me.9.7.860; Tang T, 2010, J BIOL CHEM, V285, P4637, DOI 10.1074/jbc.M109.068007; Tay S, 2010, MOL PHARMACOL, V77, P218, DOI 10.1124/mol.109.059071; Tsuchiya H, 2012, HEPATOLOGY, V56, P1319, DOI 10.1002/hep.25798; VALERA A, 1994, J BIOL CHEM, V269, P6267; Wang YJ, 2010, J BIOL CHEM, V285, P15668, DOI 10.1074/jbc.M110.102160; Xu J, 2009, DIABETES, V58, P250, DOI 10.2337/db08-0392; Zang MW, 2008, J BIOL CHEM, V283, P31429, DOI 10.1074/jbc.M802855200; Zang MW, 2006, DIABETES, V55, P2180, DOI 10.2337/db05-1188; Zang MW, 2004, J BIOL CHEM, V279, P47898, DOI 10.1074/jbc.M408149200; ZELENT A, 1989, NATURE, V339, P714, DOI 10.1038/339714a0	50	72	77	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 12	2013	288	15					10490	10504		10.1074/jbc.M112.429852	http://dx.doi.org/10.1074/jbc.M112.429852			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	125TU	23430257	hybrid, Green Published			2022-12-25	WOS:000317565000029
J	Vandevenne, M; Jacques, DA; Artuz, C; Nguyen, CD; Kwan, AHY; Segal, DJ; Matthews, JM; Crossley, M; Guss, JM; Mackay, JP				Vandevenne, Marylene; Jacques, David A.; Artuz, Crisbel; Cuong Dinh Nguyen; Kwan, Ann H. Y.; Segal, David J.; Matthews, Jacqueline M.; Crossley, Merlin; Guss, J. Mitchell; Mackay, Joel P.			New Insights into DNA Recognition by Zinc Fingers Revealed by Structural Analysis of the Oncoprotein ZNF217	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ARTIFICIAL TRANSCRIPTION FACTORS; SINGLE-STRANDED RNA; CRYSTAL-STRUCTURE; BINDING PROTEINS; NONSPECIFIC DNA; DOMAINS; COMPLEX; SEQUENCES; SITE; PLASTOCYANIN	Classical zinc fingers (ZFs) are one of the most abundant and best characterized DNA-binding domains. Typically, tandem arrays of three or more ZFs bind DNA target sequences with high affinity and specificity, and the mode of DNA recognition is sufficiently well understood that tailor-made ZF-based DNA-binding proteins can be engineered. We have shown previously that a two-zinc finger unit found in the transcriptional coregulator ZNF217 recognizes DNA but with an affinity and specificity that is lower than other ZF arrays. To investigate the basis for these differences, we determined the structure of a ZNF217-DNA complex. We show that although the overall position of the ZFs on the DNA closely resembles that observed for other ZFs, the side-chain interaction pattern differs substantially from the canonical model. The structure also reveals the presence of two methyl-pi interactions, each featuring a tyrosine contacting a thymine methyl group. To our knowledge, interactions of this type have not previously been described in classical ZF-DNA complexes. Finally, we investigated the sequence specificity of this two-ZF unit and discuss how ZNF217 might discriminate its target DNA sites in the cell.	[Vandevenne, Marylene; Jacques, David A.; Cuong Dinh Nguyen; Kwan, Ann H. Y.; Matthews, Jacqueline M.; Guss, J. Mitchell; Mackay, Joel P.] Univ Sydney, Sch Mol Biosci, Sydney, NSW 2006, Australia; [Artuz, Crisbel; Crossley, Merlin] Univ New S Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW 2052, Australia; [Segal, David J.] Univ Calif Davis, Genome Ctr, Davis, CA 95616 USA; [Segal, David J.] Univ Calif Davis, Dept Biochem & Mol Med, Davis, CA 95616 USA	University of Sydney; University of New South Wales Sydney; University of California System; University of California Davis; University of California System; University of California Davis	Mackay, JP (corresponding author), Univ Sydney, Sch Mol Biosci, Butlin Ave & Maze Crescent,Darlington Campus, Sydney, NSW 2006, Australia.	joel.mackay@sydney.edu.au	Crossley, Merlin/D-7888-2011; Segal, David/V-9126-2019; Guss, Jules Mitchell/N-1387-2019; Mackay, Joel/D-6834-2011	Crossley, Merlin/0000-0003-2057-3642; Segal, David/0000-0001-8962-3105; Guss, Jules Mitchell/0000-0003-4259-6079; Matthews, Jacqueline/0000-0001-8518-3472; Vandevenne, Marylene/0000-0002-4492-2635; Mackay, Joel/0000-0001-7508-8033; Jacques, David/0000-0002-6426-4510; Kwan, Ann/0000-0002-1506-2226	National Health and Medical Research Council; Australian Research Council	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council)	This work was supported by grants from the National Health and Medical Research Council and the Australian Research Council (to J. P. M.).	Blackshear PJ, 2002, BIOCHEM SOC T, V30, P945, DOI 10.1042/BST0300945; Bond CS, 1999, ACTA CRYSTALLOGR D, V55, P414, DOI 10.1107/S0907444998012074; Brown RS, 2005, CURR OPIN STRUC BIOL, V15, P94, DOI 10.1016/j.sbi.2005.01.006; Buck-Koehntop BA, 2012, P NATL ACAD SCI USA, V109, P15229, DOI 10.1073/pnas.1213726109; Cai CQ, 2009, PLANT MOL BIOL, V69, P699, DOI 10.1007/s11103-008-9449-7; Choo Y, 1998, NAT STRUCT BIOL, V5, P264, DOI 10.1038/nsb0498-264; Choo Y, 1997, CURR OPIN STRUC BIOL, V7, P117, DOI 10.1016/S0959-440X(97)80015-2; CHOO Y, 1994, P NATL ACAD SCI USA, V91, P11163, DOI 10.1073/pnas.91.23.11163; Cowger JJM, 2007, ONCOGENE, V26, P3378, DOI 10.1038/sj.onc.1210126; Dahlquist FW, 2006, NAT CHEM BIOL, V2, P353, DOI 10.1038/nchembio0706-353; De Guzman RN, 1998, SCIENCE, V279, P384, DOI 10.1126/science.279.5349.384; de la Rosa MAD, 2010, BIOPHYS J, V98, P2943, DOI 10.1016/j.bpj.2010.02.055; Dreier B, 2005, J BIOL CHEM, V280, P35588, DOI 10.1074/jbc.M506654200; Dreier B, 2001, J BIOL CHEM, V276, P29466, DOI 10.1074/jbc.M102604200; Dreyer AK, 2011, METHODS MOL BIOL, V813, P145, DOI 10.1007/978-1-61779-412-4_8; Durai S, 2005, NUCLEIC ACIDS RES, V33, P5978, DOI 10.1093/nar/gki912; Emerson RO, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000325; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FAIRALL L, 1993, NATURE, V366, P483, DOI 10.1038/366483a0; Foster MP, 1997, NAT STRUCT BIOL, V4, P605, DOI 10.1038/nsb0897-605; Gamsjaeger R, 2007, TRENDS BIOCHEM SCI, V32, P63, DOI 10.1016/j.tibs.2006.12.007; Gao M, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000341; Givaty O, 2009, J MOL BIOL, V385, P1087, DOI 10.1016/j.jmb.2008.11.016; Goddard T. D, 2007, SPARKY 3; Halford SE, 2004, NUCLEIC ACIDS RES, V32, P3040, DOI 10.1093/nar/gkh624; HANSEN A, 1991, BIOCHEM BIOPH RES CO, V175, P492, DOI 10.1016/0006-291X(91)91591-Y; Iuchi S, 2001, CELL MOL LIFE SCI, V58, P625, DOI 10.1007/PL00000885; Iwahara J, 2006, NATURE, V440, P1227, DOI 10.1038/nature04673; Iwahara J, 2004, J AM CHEM SOC, V126, P12800, DOI 10.1021/ja046246b; Iwahara J, 2006, P NATL ACAD SCI USA, V103, P15062, DOI 10.1073/pnas.0605868103; JenJacobson L, 1997, BIOPOLYMERS, V44, P153; JOHNSTON M, 1987, NATURE, V328, P353, DOI 10.1038/328353a0; Kalodimos CG, 2004, SCIENCE, V305, P386, DOI 10.1126/science.1097064; Kim CA, 1996, NAT STRUCT BIOL, V3, P940, DOI 10.1038/nsb1196-940; KLUG A, 1995, FASEB J, V9, P597, DOI 10.1096/fasebj.9.8.7768350; Krishna SS, 2003, NUCLEIC ACIDS RES, V31, P532, DOI 10.1093/nar/gkg161; Lee S, 2010, J MOL BIOL, V397, P1055, DOI 10.1016/j.jmb.2010.02.006; Lefrancois P, 2010, METHOD ENZYMOL, V470, P77, DOI 10.1016/S0076-6879(10)70004-5; LIN SY, 1975, CELL, V4, P107, DOI 10.1016/0092-8674(75)90116-6; Liu YW, 2013, TRENDS BIOCHEM SCI, V38, P177, DOI 10.1016/j.tibs.2012.12.005; Liu YW, 2012, GENE DEV, V26, P2374, DOI 10.1101/gad.202200.112; Lowry JA, 2009, J BIOL CHEM, V284, P5827, DOI 10.1074/jbc.M808712200; Mackay JP, 2011, NAT STRUCT MOL BIOL, V18, P256, DOI 10.1038/nsmb.2005; Mackay JP, 1998, TRENDS BIOCHEM SCI, V23, P1, DOI 10.1016/S0968-0004(97)01168-7; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MILLER J, 1985, EMBO J, V4, P1609, DOI 10.1002/j.1460-2075.1985.tb03825.x; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nguyen CD, 2011, J MOL BIOL, V407, P273, DOI 10.1016/j.jmb.2010.12.041; Nonet GH, 2001, CANCER RES, V61, P1250; Nunez N, 2011, J BIOL CHEM, V286, P38190, DOI 10.1074/jbc.M111.301234; Omichinski JG, 1997, NAT STRUCT BIOL, V4, P122, DOI 10.1038/nsb0297-122; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PAVLETICH NP, 1993, SCIENCE, V261, P1701, DOI 10.1126/science.8378770; PAVLETICH NP, 1991, SCIENCE, V252, P809, DOI 10.1126/science.2028256; Peterson SN, 2007, J MOL BIOL, V369, P1307, DOI 10.1016/j.jmb.2007.04.023; Pingoud A, 2007, STRUCTURE, V15, P391, DOI 10.1016/j.str.2007.04.001; Plevin MJ, 2010, NAT CHEM, V2, P466, DOI [10.1038/NCHEM.650, 10.1038/nchem.650]; Riley LG, 1996, PROTEIN ENG, V9, P223, DOI 10.1093/protein/9.2.223; Roberts MAJ, 2012, P NATL ACAD SCI USA, V109, P6698, DOI 10.1073/pnas.1114000109; SANCHEZGARCIA I, 1994, TRENDS GENET, V10, P315, DOI 10.1016/0168-9525(94)90034-5; Schmidt L, 2006, ACTA CRYSTALLOGR D, V62, P1022, DOI 10.1107/S0907444906023638; Schuetz A, 2011, CELL MOL LIFE SCI, V68, P3121, DOI 10.1007/s00018-010-0618-x; SCHWABE JWR, 1993, CELL, V75, P567, DOI 10.1016/0092-8674(93)90390-C; Segal DJ, 2006, J MOL BIOL, V363, P405, DOI 10.1016/j.jmb.2006.08.016; Segal DJ, 1999, P NATL ACAD SCI USA, V96, P2758, DOI 10.1073/pnas.96.6.2758; Shibata N, 1999, J BIOL CHEM, V274, P4225, DOI 10.1074/jbc.274.7.4225; Tadepally HD, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-176; Terwilliger TC, 2009, ACTA CRYSTALLOGR D, V65, P582, DOI 10.1107/S0907444909012098; Umezawa Y, 2002, NUCLEIC ACIDS RES, V30, P2183, DOI 10.1093/nar/30.10.2183; Vendrell JA, 2012, CANCER RES, V72, P3593, DOI 10.1158/0008-5472.CAN-11-3095; VONHIPPE PH, 1972, ANNU REV BIOCHEM, V41, P231, DOI 10.1146/annurev.bi.41.070172.001311; Wu J, 2007, CELL MOL LIFE SCI, V64, P2933, DOI 10.1007/s00018-007-7206-8; Zandarashvili L, 2012, P NATL ACAD SCI USA, V109, pE1724, DOI 10.1073/pnas.1121500109	73	32	32	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 12	2013	288	15					10616	10627		10.1074/jbc.M112.441451	http://dx.doi.org/10.1074/jbc.M112.441451			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	125TU	23436653	hybrid, Green Published			2022-12-25	WOS:000317565000040
J	Liu, H; Lin, H; Zhang, L; Sun, Q; Yuan, GH; Zhang, L; Chen, S; Chen, Z				Liu, Huan; Lin, Heng; Zhang, Li; Sun, Qin; Yuan, Guohua; Zhang, Lu; Chen, Shuo; Chen, Zhi			miR-145 and miR-143 Regulate Odontoblast Differentiation through Targeting Klf4 and Osx Genes in a Feedback Loop	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IN-SITU HYBRIDIZATION; TOOTH MORPHOGENESIS; CELL FATE; DENTIN; MICRORNAS; IDENTIFICATION; DSPP; DENTINOGENESIS; TRANSCRIPTION; EXPRESSION	Dentin tissue is derived from mesenchymal cells induced into the odontoblast lineage. The differentiation of odontoblasts is a complex process regulated by several transcriptional factor signaling transduction pathways. However, post-translational regulation of these factors during dentinogenesis remains unclear. To further explore the mechanisms, we investigated the role of microRNA (miRNA) during odontoblast differentiation. We profiled the miRNA expression pattern during mouse odontoblast differentiation using a microarray assay and identified that miR-145 and miR-143 were down-regulated during this process. In situ hybridization verified that the two miRNAs were gradually decreased during mouse odontoblast differentiation. Loss-of-function and gain-of-function experiments revealed that down-regulation of miR-145 and miR-143 could promote odontoblast differentiation and increased Dspp and Dmp1 expression in mouse primary dental pulp cells and vice versa. We found that miR-145 and miR-143 controlled odontoblast differentiation through several mechanisms. First, KLF4 and OSX bind to their motifs in Dspp and Dmp1 gene promoters and up-regulate their transcription thereby inducing odontoblast differentiation. The miR-145 binds to the 3'-UTRs of Klf4 and Osx genes, inhibiting their expression. Second, KLF4 repressed miR-143 transcription by binding to its motifs in miR-143 regulatory regions as detected by ChIP assay and dual luciferase reporter assay. Third, miR-143 regulates odontoblast differentiation in part through miR-145 pathway. Taken together, we for the first time showed that the miR-143 and miR-145 controlled odontoblast differentiation and dentin formation through KLF4 and OSX transcriptional factor signaling pathways.	[Liu, Huan; Lin, Heng; Zhang, Li; Sun, Qin; Yuan, Guohua; Zhang, Lu; Chen, Zhi] Wuhan Univ, Sch & Hosp Stomatol, State Key Lab Breeding Base Basic Sci Stomatol Hu, Wuhan 430079, Peoples R China; [Liu, Huan; Lin, Heng; Zhang, Li; Sun, Qin; Yuan, Guohua; Zhang, Lu; Chen, Zhi] Wuhan Univ, Sch & Hosp Stomatol, Minist Educ, Key Lab Oral Biomed, Wuhan 430079, Peoples R China; [Chen, Shuo] Univ Texas Hlth Sci Ctr San Antonio, Dept Dev Dent, San Antonio, TX 78229 USA	Wuhan University; Wuhan University; University of Texas System; University of Texas Health San Antonio	Chen, S (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Dev Dent, San Antonio, TX 78229 USA.	chens0@uthscsa.edu; zhichen@whu.edu.cn	Chen, Zhi/V-2214-2017; Liu, Huan/AAJ-1566-2020; Liu, Huan/E-3115-2013	Chen, Zhi/0000-0003-2095-1324; Liu, Huan/0000-0002-9947-6687; 	National Natural Science Foundation of China [81070797, 81271099]; National 973 Project of China Grant [2010CB534915]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE019802] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National 973 Project of China Grant(National Basic Research Program of China); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by National Natural Science Foundation of China Grants 81070797 and 81271099 and National 973 Project of China Grant 2010CB534915.	Andl T, 2006, CURR BIOL, V16, P1041, DOI 10.1016/j.cub.2006.04.005; Arana-Chavez VE, 2004, INT J BIOCHEM CELL B, V36, P1367, DOI 10.1016/j.biocel.2004.01.006; Balic A, 2010, BONE, V47, P948, DOI 10.1016/j.bone.2010.08.009; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Birsoy K, 2008, CELL METAB, V7, P339, DOI 10.1016/j.cmet.2008.02.001; Bushati N, 2007, ANNU REV CELL DEV BI, V23, P175, DOI 10.1146/annurev.cellbio.23.090506.123406; Cao H, 2010, J DENT RES, V89, P779, DOI 10.1177/0022034510369304; Chen S, 2005, J BIOL CHEM, V280, P29717, DOI 10.1074/jbc.M502929200; Chen S, 2009, J DENT RES, V88, P904, DOI 10.1177/0022034509342873; Chen Z, 2009, ARCH ORAL BIOL, V54, P403, DOI 10.1016/j.archoralbio.2009.02.003; Cordes KR, 2009, NATURE, V460, P705, DOI 10.1038/nature08195; Ebert MS, 2007, NAT METHODS, V4, P721, DOI 10.1038/NMETH1079; Feinberg MW, 2007, EMBO J, V26, P4138, DOI 10.1038/sj.emboj.7601824; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; Ivey KN, 2010, CELL STEM CELL, V7, P36, DOI 10.1016/j.stem.2010.06.012; Janebodin K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027526; Jevnaker AM, 2008, ARCH ORAL BIOL, V53, P629, DOI 10.1016/j.archoralbio.2008.01.014; Katz JP, 2002, DEVELOPMENT, V129, P2619; Kim JW, 2007, J DENT RES, V86, P392, DOI 10.1177/154405910708600502; Kim JW, 2004, HUM GENET, V115, P248, DOI 10.1007/s00439-004-1143-5; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Li H, 2009, J CLIN INVEST, V119, P3666, DOI 10.1172/JCI39832; Lin H, 2011, J ENDODONT, V37, P948, DOI 10.1016/j.joen.2011.03.030; Liu F, 2008, DEV BIOL, V313, P210, DOI 10.1016/j.ydbio.2007.10.016; Liu H, 2012, BIOCHEM BIOPH RES CO, V422, P405, DOI 10.1016/j.bbrc.2012.05.002; Michon F, 2011, BIRTH DEFECTS RES A, V91, P763, DOI 10.1002/bdra.20787; Michon F, 2010, DEV BIOL, V340, P355, DOI 10.1016/j.ydbio.2010.01.019; Miranda KC, 2006, CELL, V126, P1203, DOI 10.1016/j.cell.2006.07.031; Narayanan K, 2006, J BIOL CHEM, V281, P19064, DOI 10.1074/jbc.M600714200; Ono K, 2011, CELL RES, V21, P864, DOI 10.1038/cr.2011.78; Park CY, 2010, HUM MOL GENET, V19, pR169, DOI 10.1093/hmg/ddq367; Pena JTG, 2009, NAT METHODS, V6, P139, DOI [10.1038/NMETH.1294, 10.1038/nmeth.1294]; Qin C, 2007, J DENT RES, V86, P1134, DOI 10.1177/154405910708601202; Qin C, 2004, CRIT REV ORAL BIOL M, V15, P126, DOI 10.1177/154411130401500302; Salmon P, 2000, MOL THER, V2, P404, DOI 10.1006/mthe.2000.0141; Silahtaroglu AN, 2007, NAT PROTOC, V2, P2520, DOI 10.1038/nprot.2007.313; Sun Y, 2011, CELLS TISSUES ORGANS, V194, P199, DOI 10.1159/000324672; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Thesleff I, 2003, J CELL SCI, V116, P1647, DOI 10.1242/jcs.00410; Thesleff I, 2001, Adv Dent Res, V15, P14; Tummers M, 2009, J EXP ZOOL PART B, V312B, P309, DOI 10.1002/jez.b.21280; Turan S, 2010, BONE, V46, P402, DOI 10.1016/j.bone.2009.09.016; Wu X, 2007, CELL DEATH DIFFER, V14, P1792, DOI 10.1038/sj.cdd.4402190; Xiao SX, 2001, NAT GENET, V27, P201, DOI 10.1038/84848; Yi C, 2011, FEBS LETT, V585, P3303, DOI 10.1016/j.febslet.2011.09.015; Yi R, 2006, NAT GENET, V38, P356, DOI 10.1038/ng1744; Zhang PL, 2010, J BIOL CHEM, V285, P9180, DOI 10.1074/jbc.M109.077958; Zhang XH, 2001, NAT GENET, V27, P151, DOI 10.1038/84765; Zhang YD, 2005, CELL RES, V15, P301, DOI 10.1038/sj.cr.7290299	49	86	96	0	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 29	2013	288	13					9261	9271		10.1074/jbc.M112.433730	http://dx.doi.org/10.1074/jbc.M112.433730			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	116DG	23430263	Green Published, hybrid			2022-12-25	WOS:000316862200044
J	Jensen, A; Fago-Olsen, H; Sorensen, CH; Kilian, M				Jensen, Anders; Fago-Olsen, Helena; Sorensen, Christian Hjort; Kilian, Mogens			Molecular Mapping to Species Level of the Tonsillar Crypt Microbiota Associated with Health and Recurrent Tonsillitis	PLOS ONE			English	Article							UPPER RESPIRATORY-TRACT; FUSOBACTERIUM-NECROPHORUM; HAEMOPHILUS-INFLUENZAE; NEISSERIA-LACTAMICA; SYMBIOTIC BACTERIA; ANAEROBIC-BACTERIA; LEMIERRES-SYNDROME; DIVERSITY; CHILDREN; IDENTIFICATION	The human palatine tonsils, which belong to the central antigen handling sites of the mucosal immune system, are frequently affected by acute and recurrent infections. This study compared the microbiota of the tonsillar crypts in children and adults affected by recurrent tonsillitis with that of healthy adults and children with tonsillar hyperplasia. An in-depth 16S rRNA gene based pyrosequencing approach combined with a novel strategy that included phylogenetic analysis and detection of species- specific sequence signatures enabled identification of the major part of the microbiota to species level. A complex microbiota consisting of between 42 and 110 taxa was demonstrated in both children and adults. This included a core microbiome of 12 abundant genera found in all samples regardless of age and health status. Yet, Haemophilus influenzae, Neisseria species, and Streptococcus pneumoniae were almost exclusively detected in children. In contrast, Streptococcus pseudopneumoniae was present in all samples. Obligate anaerobes like Porphyromonas, Prevotella, and Fusobacterium were abundantly present in children, but the species diversity of Porphyromonas and Prevotella was larger in adults and included species that are considered putative pathogens in periodontal diseases, i.e. Porphyromonas gingivalis, Porphyromonas endodontalis, and Tannerella forsythia. Unifrac analysis showed that recurrent tonsillitis is associated with a shift in the microbiota of the tonsillar crypts. Fusobacterium necrophorum, Streptococcus intermedius and Prevotella melaninogenica/histicola were associated with recurrent tonsillitis in adults, whereas species traditionally associated with acute tonsillitis like pyogenic streptococci and Staphylococcus aureus were scarce. The findings suggest that recurrent tonsillitis is a polymicrobial infection in which interactions within consortia of taxa play an etiologic role. The study contributes to the human microbiome data, to the understanding of the etiology of infections affecting the tonsils, and forms a basis for further insight into the consequences of the intense microbe-host interactions that take place in the tonsils.	[Jensen, Anders; Kilian, Mogens] Aarhus Univ, Dept Biomed, Fac Hlth Sci, Aarhus, Denmark; [Fago-Olsen, Helena; Sorensen, Christian Hjort] Univ Copenhagen, Gentofte Hosp, Dept Otorhinolaryngol Head & Neck Surg, Copenhagen, Denmark	Aarhus University; University of Copenhagen; Herlev & Gentofte Hospital	Kilian, M (corresponding author), Aarhus Univ, Dept Biomed, Fac Hlth Sci, Aarhus, Denmark.	kilian@microbiology.au.dk	Jensen, Anders/B-1968-2016	Jensen, Anders/0000-0003-1185-3343; Kilian, Mogens/0000-0002-5861-0472	Faculty of Health Sciences, Aarhus University; Danish Medical Research Council [271-08-0808]	Faculty of Health Sciences, Aarhus University; Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This study was supported by a stipend from the Faculty of Health Sciences, Aarhus University, to AJ and by a project grant to MK from the Danish Medical Research Council (271-08-0808). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Batty A, 2005, BRIT J BIOMED SCI, V62, P66, DOI 10.1080/09674845.2005.11732687; Bik EM, 2010, ISME J, V4, P962, DOI 10.1038/ismej.2010.30; Brook I, 2005, INT J PEDIATR OTORHI, V69, P9, DOI 10.1016/j.ijporl.2004.08.007; Brook I, 2002, ANN OTO RHINOL LARYN, V111, P430, DOI 10.1177/000348940211100508; BROOK I, 1993, ANN OTO RHINOL LARYN, V102, P113, DOI 10.1177/000348949310200207; BROOK I, 1984, REV INFECT DIS, V6, P601; BROOK I, 1986, LARYNGOSCOPE, V96, P1385, DOI 10.1288/00005537-198612000-00013; Carapetis JR, 2005, LANCET INFECT DIS, V5, P685, DOI 10.1016/S1473-3099(05)70267-X; Centor RM, 2009, ANN INTERN MED, V151, P812, DOI 10.7326/0003-4819-151-11-200912010-00011; Chole RA, 2003, ARCH OTOLARYNGOL, V129, P634, DOI 10.1001/archotol.129.6.634; Claesson MJ, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq873; Costello EK, 2009, SCIENCE, V326, P1694, DOI 10.1126/science.1177486; Crielaard W, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-22; de Lillo A, 2004, J CLIN MICROBIOL, V42, P5523, DOI 10.1128/JCM.42.12.5523-5527.2004; Dewhirst FE, 2010, J BACTERIOL, V192, P5002, DOI 10.1128/JB.00542-10; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Gaffney RJ, 1998, CLIN OTOLARYNGOL, V23, P181; Gebert A, 1999, SEMIN IMMUNOL, V11, P165, DOI 10.1006/smim.1999.0172; Gill SR, 2006, SCIENCE, V312, P1355, DOI 10.1126/science.1124234; Grice EA, 2011, NAT REV MICROBIOL, V9, P244, DOI 10.1038/nrmicro2537; Gul M, 2007, AM J OTOLARYNG, V28, P173, DOI 10.1016/j.amjoto.2006.08.010; Hagelskjaer LH, 1998, EUR J CLIN MICROBIOL, V17, P561, DOI 10.1007/BF01708619; Harris JK, 2007, P NATL ACAD SCI USA, V104, P20529, DOI 10.1073/pnas.0709804104; Holt SC, 2005, PERIODONTOL 2000, V38, P72, DOI 10.1111/j.1600-0757.2005.00113.x; Huse SM, 2010, ENVIRON MICROBIOL, V12, P1889, DOI 10.1111/j.1462-2920.2010.02193.x; Jensen A, 2007, CLIN MICROBIOL INFEC, V13, P695, DOI 10.1111/j.1469-0691.2007.01719.x; Jeong JH, 2007, LARYNGOSCOPE, V117, P2146, DOI 10.1097/MLG.0b013e31814543c8; Keijser BJF, 2008, J DENT RES, V87, P1016, DOI 10.1177/154405910808701104; Klug TE, 2011, DAN MED BULL, V58; Kononen E, 2000, ANN MED, V32, P107, DOI 10.3109/07853890009011759; Kristensen LH, 2008, EUR J CLIN MICROBIOL, V27, P779, DOI 10.1007/s10096-008-0496-4; KUHN JJ, 1995, ANN OTO RHINOL LARYN, V104, P646, DOI 10.1177/000348949510400810; Larsen N, 2011, FEMS MICROBIOL ECOL, V75, P482, DOI 10.1111/j.1574-6941.2010.01024.x; Larsen N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009085; Liu CM, 2011, ARCH OTOLARYNGOL, V137, P664, DOI 10.1001/archoto.2011.116; Mazmanian SK, 2005, CELL, V122, P107, DOI 10.1016/j.cell.2005.05.007; Murphy TF, 2007, J INFECT DIS, V195, P81, DOI 10.1086/509824; Nasidze I, 2009, GENOME RES, V19, P636, DOI 10.1101/gr.084616.108; NORD CE, 1986, REV INFECT DIS, V8, pS543; Pamer EG, 2007, NAT IMMUNOL, V8, P1173, DOI 10.1038/ni1526; Perry M, 1998, IMMUNOL TODAY, V19, P414, DOI 10.1016/S0167-5699(98)01307-3; Quince C, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-38; Quince C, 2009, NAT METHODS, V6, P639, DOI [10.1038/NMETH.1361, 10.1038/nmeth.1361]; Riordan T, 2007, CLIN MICROBIOL REV, V20, P622, DOI 10.1128/CMR.00011-07; Schloss PD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027310; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Scholz CFP, 2012, J CLIN MICROBIOL, V50, P1968, DOI 10.1128/JCM.00365-12; SINAVE CP, 1989, MEDICINE, V68, P85, DOI 10.1097/00005792-198903000-00002; Sogin ML, 2006, P NATL ACAD SCI USA, V103, P12115, DOI 10.1073/pnas.0605127103; Stjernquist-Desatnik A, 1999, ACTA OTO-LARYNGOL, V119, P102; STJERNQUISTDESATNIK A, 1990, ACTA OTO-LARYNGOL, V109, P314, DOI 10.3109/00016489009107448; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; TUNER K, 1983, SCAND J INFECT DIS, P83; Turnbaugh PJ, 2007, NATURE, V449, P804, DOI 10.1038/nature06244; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Turner JC, 1997, J CLIN MICROBIOL, V35, P1; Van Cauwenberge P, 1976, Acta Otorhinolaryngol Belg, V30, P334; Vaughan AT, 2010, J IMMUNOL, V185, P3652, DOI 10.4049/jimmunol.0902468; Vaughan AT, 2009, J IMMUNOL, V182, P2231, DOI 10.4049/jimmunol.0802531; White JR, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000352; Wu GD, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-206; Xu J, 2007, PLOS BIOL, V5, P1574, DOI 10.1371/journal.pbio.0050156; Zaura E, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-259	63	87	92	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2013	8	2							e56418	10.1371/journal.pone.0056418	http://dx.doi.org/10.1371/journal.pone.0056418			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IT	23437130	gold, Green Published, Green Submitted			2022-12-25	WOS:000315186000027
J	Wang, C; Hu, SR; Han, XJ; Huang, W; Tian, LF				Wang, Chao; Hu, Surong; Han, Xijiang; Huang, Wen; Tian, Lunfu			Controlled Synthesis and Microwave Absorption Property of Chain-Like Co Flower	PLOS ONE			English	Article							ELECTROMAGNETIC PROPERTIES	Chain-like Co flower is synthesized by simply modulating the reaction conditions via a facile liquid-phase reduction method. The morphology evolution process and transformation mechanism from particle to flower and finally to chain-like flower have been systematically investigated. [001] is the preferred growth orientation due to the existence of easy magnetic axis. The microwave loss mechanism can be attributed to the synergistic effect of magnetic loss and dielectric loss, while magnetic loss is the main loss mechanism. In addition, the special microstructure of chain-like Co flower may further enhance microwave attenuation. The architectural design of functional material morphology is critical for improving its property toward future application.	[Wang, Chao; Hu, Surong; Huang, Wen; Tian, Lunfu] China Acad Engn Phys, Inst Mech Mfg Technol, Mianyang, Peoples R China; [Wang, Chao; Han, Xijiang] Harbin Inst Technol, Dept Chem, Harbin 150006, Peoples R China	Chinese Academy of Engineering Physics; Harbin Institute of Technology	Wang, C (corresponding author), China Acad Engn Phys, Inst Mech Mfg Technol, Mianyang, Peoples R China.	wangchaohit@126.com			Natural Science Foundation of China [51202228]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was funded by the Natural Science Foundation of China no. 51202228 (www.nsfc.gov.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An ZG, 2009, J PHYS CHEM C, V113, P2715, DOI 10.1021/jp809199s; Che RC, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2165276; Chen YJ, 2009, J PHYS CHEM C, V113, P10061, DOI 10.1021/jp902296z; Chiu SC, 2010, J PHYS CHEM C, V114, P1947, DOI 10.1021/jp905127t; Deng LJ, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2755875; Guo L, 2007, ADV FUNCT MATER, V17, P425, DOI 10.1002/adfm.200600415; Hong JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040554; Kato Y, 2002, MATER TRANS, V43, P406, DOI 10.2320/matertrans.43.406; Li YL, 2009, COLLOID SURFACE A, V336, P41, DOI 10.1016/j.colsurfa.2008.11.012; Ni SB, 2010, MATER CHEM PHYS, V124, P353, DOI 10.1016/j.matchemphys.2010.06.046; Niu HL, 2003, J MATER CHEM, V13, P1803, DOI 10.1039/b303024e; Shi XL, 2009, APPL PHYS LETT, V95, DOI 10.1063/1.3250170; Wang C, 2011, APPL PHYS LETT, V98, DOI 10.1063/1.3555436; Wang C, 2010, J PHYS CHEM C, V114, P14826, DOI 10.1021/jp1050386; Wang C, 2010, J PHYS CHEM C, V114, P3196, DOI 10.1021/jp908839r; Yu SH, 2012, CRYSTENGCOMM, V14, P7531, DOI 10.1039/c2ce90082c; Zhu LP, 2008, CRYST GROWTH DES, V8, P1113, DOI 10.1021/cg701036k	17	8	11	1	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2013	8	2							e55928	10.1371/journal.pone.0055928	http://dx.doi.org/10.1371/journal.pone.0055928			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IT	23437073	Green Published, gold, Green Submitted			2022-12-25	WOS:000315186000011
J	Fang, HS; Liu, AD; Sun, J; Kitz, A; Dirsch, O; Dahmen, U				Fang, Haoshu; Liu, Anding; Sun, Jian; Kitz, Alexandra; Dirsch, Olaf; Dahmen, Uta			Granulocyte Colony Stimulating Factor Induces Lipopolysaccharide (LPS) Sensitization via Upregulation of LPS Binding Protein in Rat	PLOS ONE			English	Article							INDUCED LIVER-INJURY; HEMORRHAGIC-SHOCK; G-CSF; ENDOTOXIN; MICE; INFECTION; RESPONSES; SEPSIS; LBP; ANTIBODIES	Liver is the main organ for lipopolysaccharide (LPS) clearance. Sensitization to LPS is associated with the upregulation of LPS-binding protein (LBP) in animal models. Therefore, we hypothesized that LBP could induce LPS sensitization through enhancing hepatic uptake of LPS. In this study, we examined the role of LBP in pathogenesis of LPS induced systemic inflammatory response syndrome (SIRS). LBP expression was upregulated after granulocyte colony stimulating (G-CSF) pretreatment. The effect of LBP was further confirmed by blockade of LBP using LBP blocking peptide - LBPK95A. After G-CSF pretreatment, upregulation of LBP was observed in bone marrow cells and liver. The G-CSF induced LBP upregulation caused LPS hypersensitization in rats as indicated by higher mortality and severer liver damage. Of note, LBP blockade increased the survival rate and attenuated the liver injury. The LBP induced LPS hypersensitization was associated with increased hepatic uptake of LPS and augmented hepatic expression of LPS receptors, such as toll-like receptor (TLR)-4. Furthermore, LBP mediated early neutrophil infiltration, which led to increased monocyte recruitment in liver after LPS administration. In conclusion, G-CSF induced LBP expression could serve as a new model for investigation of LPS sensitization. We demonstrated the crucial role of LBP upregulation in pathogenesis of LPS induced SIRS.	[Fang, Haoshu; Liu, Anding; Sun, Jian; Dahmen, Uta] Univ Hosp Jena, Jena, Germany; [Liu, Anding] Huazhong Univ Sci & Technol, Ctr Med Expt, Tongji Hosp, Wuhan 430074, Peoples R China; [Sun, Jian] Sun Yat Sen Univ, Dept Hepatobiliopancreat Surg, Sun Yat Sen Mem Hosp, Guangzhou 510275, Guangdong, Peoples R China; [Kitz, Alexandra] Univ Gottingen, Inst Neuroimmunol, D-37073 Gottingen, Germany; [Dirsch, Olaf] Univ Hosp Jena, Inst Pathol, Jena, Germany	Friedrich Schiller University of Jena; Huazhong University of Science & Technology; Sun Yat Sen University; University of Gottingen; Friedrich Schiller University of Jena	Dahmen, U (corresponding author), Univ Hosp Jena, Jena, Germany.	uta.dahmen@med.uni-jena.de	Liu, Anding/AAU-2477-2020		German Federal Ministry for Education and Research (BMBF) Virtual Liver Network	German Federal Ministry for Education and Research (BMBF) Virtual Liver Network(Federal Ministry of Education & Research (BMBF))	This study was supported by the German Federal Ministry for Education and Research (BMBF) Virtual Liver Network. URL: http://www.virtual-liver.de/ and Center for Sepsis Control and Care. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander C, 2001, J ENDOTOXIN RES, V7, P167, DOI 10.1179/096805101101532675; Amulic B, 2012, ANNU REV IMMUNOL, V30, P459, DOI 10.1146/annurev-immunol-020711-074942; Arana MD, 2003, J ENDOTOXIN RES, V9, P281, DOI 10.1177/09680519030090050301; Bo LL, 2011, CRIT CARE, V15, DOI 10.1186/cc10031; Cornelie S, 2002, INTENS CARE MED, V28, P1340, DOI 10.1007/s00134-002-1418-z; Cotroneo TM, 2012, INNATE IMMUN; FERLUGA J, 1978, LANCET, V2, P610; GALANOS C, 1979, P NATL ACAD SCI USA, V76, P5939, DOI 10.1073/pnas.76.11.5939; GALLAY P, 1994, P NATL ACAD SCI USA, V91, P7922, DOI 10.1073/pnas.91.17.7922; Jack RS, 1997, NATURE, V389, P742, DOI 10.1038/39622; Ji Y, 2009, J INVEST SURG, V22, P167, DOI 10.1080/08941930802713027; Le Roy D, 1999, J IMMUNOL, V162, P7454; LEDER LD, 1970, BLUT, V21, P1, DOI 10.1007/BF01633225; Lehnert M, 2006, AM J PHYSIOL-GASTR L, V291, pG456, DOI 10.1152/ajpgi.00480.2005; Liu AD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035379; Lundblad R, 1996, CRIT CARE MED, V24, P820, DOI 10.1097/00003246-199605000-00016; MILESKI WJ, 1992, J APPL PHYSIOL, V73, P1146, DOI 10.1152/jappl.1992.73.3.1146; Minter RM, 2009, AM J PHYSIOL-GASTR L, V296, pG45, DOI 10.1152/ajpgi.00041.2008; MOORE MAS, 1991, ANNU REV IMMUNOL, V9, P159; Pollmacher T, 1996, BLOOD, V87, P900, DOI 10.1182/blood.V87.3.900.bloodjournal873900; PRINS JM, 1994, ANTIMICROB AGENTS CH, V38, P1211, DOI 10.1128/AAC.38.6.1211; Sakr Y, 2008, CRIT CARE MED, V36, P2014, DOI 10.1097/CCM.0b013e31817b86e3; Schroder NWJ, 2000, J IMMUNOL, V165, P2683, DOI 10.4049/jimmunol.165.5.2683; Schumann RR, 2011, BIOCHEM SOC T, V39, P989, DOI 10.1042/BST0390989; Schumann RR, 1999, CLIN CHEM LAB MED, V37, P271, DOI 10.1515/CCLM.1999.047; SCHUMANN RR, 1990, SCIENCE, V249, P1429, DOI 10.1126/science.2402637; Scott MJ, 2009, HEPATOLOGY, V49, P1695, DOI 10.1002/hep.22839; Su GL, 2005, HEPATOLOGY, V41, P187, DOI 10.1002/hep.20533; SUTER E, 1962, J IMMUNOL, V89, P377; van OOsten M, 2001, J ENDOTOXIN RES, V7, P381, DOI 10.1177/09680519010070050601; Vollmer T, 2009, CLIN CHEM, V55, P295, DOI 10.1373/clinchem.2008.106195; Wurfel MM, 1997, J EXP MED, V186, P2051, DOI 10.1084/jem.186.12.2051; Yang KK, 2002, J IMMUNOL, V169, P4475, DOI 10.4049/jimmunol.169.8.4475; Yano R, 2010, J ANDROL, V31, P201, DOI 10.2164/jandrol.109.007880; Yasui M, 1995, HEPATO-GASTROENTEROL, V42, P683	35	29	31	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e56654	10.1371/journal.pone.0056654	http://dx.doi.org/10.1371/journal.pone.0056654			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437199	gold, Green Published, Green Submitted			2022-12-25	WOS:000315184200129
J	Su, TH; Liu, CJ; Tseng, TC; Liu, CH; Yang, HC; Chen, CL; Chen, PJ; Kao, JH; Chen, DS				Su, Tung-Hung; Liu, Chun-Jen; Tseng, Tai-Chung; Liu, Chen-Hua; Yang, Hung-Chih; Chen, Chi-Ling; Chen, Pei-Jer; Kao, Jia-Horng; Chen, Ding-Shinn			Longitudinal Change of HBsAg in HBeAg-negative Patients with Genotype B or C Infection	PLOS ONE			English	Article							CHRONIC HEPATITIS-B; SURFACE-ANTIGEN LEVELS; VIRUS-INFECTION; NATURAL-HISTORY; ISOLATED ANTIBODY; CORE ANTIGEN; HBV DNA; QUANTIFICATION; CARRIERS; SEROCONVERTERS	Background & Aims: Quantitative HBsAg has been recognized to assist in the management of chronic hepatitis B virus (HBV) infection. However, its role in disease monitoring of HBeAg-negative patients remains unclear. We aimed to investigate the longitudinal HBsAg change in HBeAg-negative carriers with HBV genotype B or C infection. Methods: This is a retrospective cohort study conducted in a university hospital. Treatment-naive HBeAg-negative carriers followed for more than 3 years were recruited. Their hepatitis activities were categorized by longitudinal HBV-DNA levels into high viral-load (HVL: HBV-DNA >/=2000 IU/mL persistently), low viral-load (LVL: HBV-DNA <2000 IU/mL persistently) and fluctuated viral-load (FVL: HBV-DNA between HVL and LVL). The baseline and end-of-follow-up (EOF) HBsAg levels were quantified for analyses. Results: We recruited 187 patients with a median follow-up of 8 years. LVL patients had a significantly lower HBsAg at baseline and EOF and a significantly greater annualized HBsAg decline compared with the FVL and HVL. The longitudinal HBsAg change was independent of genotype B or C. The lower baseline HBsAg level predicted the HBsAg decline and HBsAg loss, whereas the higher baseline HBV-DNA predicted the hepatitis flare. A baseline HBsAg <50 IU/mL predicted subsequent HBsAg loss with a sensitivity of 82% and specificity of 67%. The annualized HBsAg decline appeared non-linear, and accelerated as the HBsAg level lowered (0.054, 0.091, 0.126 log(10) IU/mL in patients with baseline HBsAg >1000, 100-999, <100 IU/mL, respectively, P for trend = .014). Conclusions: In genotype B or C HBeAg-negative carriers, baseline HBsAg levels correlate with future disease activities and help to predict HBsAg decline or loss. Inactive carriers with lower baseline HBsAg levels have a greater and accelerating HBsAg decline over time, regardless of HBV genotypes.	[Su, Tung-Hung; Liu, Chun-Jen; Liu, Chen-Hua; Yang, Hung-Chih; Chen, Pei-Jer; Kao, Jia-Horng; Chen, Ding-Shinn] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan; [Su, Tung-Hung; Liu, Chun-Jen; Tseng, Tai-Chung; Liu, Chen-Hua; Chen, Chi-Ling; Chen, Pei-Jer; Kao, Jia-Horng; Chen, Ding-Shinn] Natl Taiwan Univ, Coll Med, Grad Inst Clin Med, Taipei 10764, Taiwan; [Su, Tung-Hung; Liu, Chun-Jen; Liu, Chen-Hua; Chen, Pei-Jer; Kao, Jia-Horng; Chen, Ding-Shinn] Natl Taiwan Univ Hosp, Hepatitis Res Ctr, Taipei 100, Taiwan; [Tseng, Tai-Chung] Buddhist Tzu Chi Gen Hosp, Taipei Branch, Dept Internal Med, Div Gastroenterol, Taipei, Taiwan; [Yang, Hung-Chih] Natl Taiwan Univ, Coll Med, Dept Microbiol, Taipei 10764, Taiwan	National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University; National Taiwan University Hospital; Buddhist Tzu Chi General Hospital; National Taiwan University	Kao, JH (corresponding author), Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan.	kaojh@ntu.edu.tw	Kao, Jia-Horng/AAB-8947-2019; Liu, Chen-Hua/F-6608-2018; CHEN, DING-SHINN/T-4395-2019	Kao, Jia-Horng/0000-0002-2442-7952; Liu, Chen-Hua/0000-0003-3622-9707; YANG, HUNG-CHIH/0000-0003-3864-9895; LIU, CHUN-JEN/0000-0002-6202-0993; CHEN, DING-SHINN/0000-0001-7791-6154; Chen, Pei-Jer/0000-0001-8316-3785; SU, TUNG-HUNG/0000-0002-6747-7941	National Taiwan University Hospital [NTUH 100-S1914]; Department of Health; National Science Council, Executive Yuan, Taiwan	National Taiwan University Hospital(National Taiwan University); Department of Health; National Science Council, Executive Yuan, Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by grants from the National Taiwan University Hospital (NTUH 100-S1914), the Department of Health, and the National Science Council, Executive Yuan, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bruix J, 2005, HEPATOLOGY, V42, P1208, DOI 10.1002/hep.20933; Brunetto MR, 2010, GASTROENTEROLOGY, V139, P483, DOI 10.1053/j.gastro.2010.04.052; Brunetto MR, 2010, J HEPATOL, V52, P475, DOI 10.1016/j.jhep.2009.12.020; Brunetto MR, 2009, HEPATOLOGY, V49, P1141, DOI 10.1002/hep.22760; Chan HLY, 2010, ALIMENT PHARM THER, V32, P1323, DOI 10.1111/j.1365-2036.2010.04474.x; Chan HLY, 2011, J HEPATOL, V55, P1121, DOI 10.1016/j.jhep.2011.06.006; Chan HLY, 2011, J INFECT DIS, V204, P408, DOI 10.1093/infdis/jir283; Chan HLY, 2010, HEPATOLOGY, V52, P1232, DOI 10.1002/hep.23803; CHEN DS, 1993, SCIENCE, V262, P369, DOI 10.1126/science.8211155; Chen YC, 2012, CLIN GASTROENTEROL H, V10, P297, DOI 10.1016/j.cgh.2011.08.029; Chu CM, 2009, AM J GASTROENTEROL, V104, P1693, DOI 10.1038/ajg.2009.187; Chulanov VP, 2003, J MED VIROL, V69, P313, DOI 10.1002/jmv.10291; Feld JJ, 2007, HEPATOLOGY, V46, P1057, DOI 10.1002/hep.21811; Jaroszewicz J, 2010, J HEPATOL, V52, P514, DOI 10.1016/j.jhep.2010.01.014; Kabir A, 2008, HUM VACCINES, V4, P379, DOI 10.4161/hv.4.5.6010; Kao JH, 2002, J CLIN MICROBIOL, V40, P1207, DOI 10.1128/JCM.40.4.1207-1209.2002; Kao JH, 2000, GASTROENTEROLOGY, V118, P554, DOI 10.1016/S0016-5085(00)70261-7; Kao JH, 2000, J HEPATOL, V33, P998, DOI 10.1016/S0168-8278(00)80135-X; Kao JH, 2004, J MED VIROL, V72, P363, DOI 10.1002/jmv.10534; Liaw YF, 2011, HEPATOLOGY, V53, P2121, DOI 10.1002/hep.24364; Liaw YF, 2009, LANCET, V373, P582, DOI 10.1016/S0140-6736(09)60207-5; Liu CJ, 2005, LIVER INT, V25, P1097, DOI 10.1111/j.1478-3231.2005.01177.x; LOK ASF, 1988, HEPATOLOGY, V8, P766, DOI 10.1002/hep.1840080411; Moucari R, 2009, ANTIVIR THER, V14, P1183, DOI 10.3851/IMP1458; Moucari R, 2009, HEPATOLOGY, V49, P1151, DOI 10.1002/hep.22744; Nguyen T, 2010, J HEPATOL, V52, P508, DOI 10.1016/j.jhep.2010.01.007; Pei SN, 2012, ANN HEMATOL, V91, P1007, DOI 10.1007/s00277-012-1405-6; Reijnders JGP, 2011, J HEPATOL, V54, P449, DOI 10.1016/j.jhep.2010.07.046; Su TH, 2010, ANTIVIR THER, V15, P1133, DOI 10.3851/IMP1696; Sugiyama M, 2006, HEPATOLOGY, V44, P915, DOI 10.1002/hep.21345; Taheri H, 2011, HEPAT MON, V11, P119; Tseng KC, 2003, HEPATO-GASTROENTEROL, V50, P1474; Tseng TC, 2012, HEPATOLOGY, V55, P68, DOI 10.1002/hep.24615; Tseng TC, 2012, J INFECT DIS, V205, P54, DOI 10.1093/infdis/jir687; Tseng TC, 2011, GASTROENTEROLOGY, V141, P517, DOI 10.1053/j.gastro.2011.04.046; Yeh SH, 2004, J HEPATOL, V41, P659, DOI 10.1016/j.jhep.2004.06.031	36	16	17	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e55916	10.1371/journal.pone.0055916	http://dx.doi.org/10.1371/journal.pone.0055916			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437072	Green Published, Green Submitted, gold			2022-12-25	WOS:000315184200030
J	Xue, ZH; Feng, C; Liu, WL; Tan, SM				Xue, Zhi-Hong; Feng, Chen; Liu, Wei-Ling; Tan, Suet-Mien			A Role of Kindlin-3 in Integrin alpha M beta 2 Outside-In Signaling and the Syk-Vav1-Rac1/Cdc42 Signaling Axis	PLOS ONE			English	Article							TRANSCRIPTION FACTOR FOXP1; ADHESION DEFICIENCY-III; LEUKOCYTE ADHESION; DOWN-REGULATION; RHO GTPASES; MONOCYTE DIFFERENTIATION; MONOCLONAL-ANTIBODY; STRUCTURAL BASIS; TYROSINE KINASE; FOCAL ADHESIONS	Integrins mediate cell-cell and cell-extracellular matrix attachments. Integrins are signaling receptors because their cytoplasmic tails are docking sites for cytoskeletal and signaling proteins. Kindlins are a family of band 4.1-ezrin-radixin-moesin-containing intracellular proteins. Apart from regulating integrin ligand-binding affinity, recent evidence suggests that kindlins are involved in integrin outside-in signaling. Kindlin-3 is expressed in platelets, hematopoietic cells and endothelial cells. In humans, loss of kindlin-3 expression accounts for the rare autosomal disease leukocyte adhesion deficiency (LAD) type III that is characterized by bleeding disorders and defective recruitment of leukocytes into sites of infection. Studies have shown that the loss of kindlin-3 expression leads to poor ligand-binding properties of beta 1, beta 2 and beta 3 integrin subfamilies. The leukocyte-restricted beta 2 integrin subfamily comprises four members, namely alpha L beta 2, alpha M beta 2, alpha X beta 2 and alpha D beta 2. Integrin alpha M beta 2 mediates leukocyte adhesion, phagocytosis, degranulation and it is involved in the maintenance of immune tolerance. Here we provide further evidence that kindlin-3 is required for integrin alpha M beta 2-mediated cell adhesion and spreading using transfected K562 cells that expressed endogenous kindlin-3 but not beta 2 integrins. K562 stable cell line expressing si-RNA targeting kindlin-3, but not control-si-RNA, and transfected with constitutively activated integrin alpha M beta 2N329S adhered and spread poorly on iC3b. We also show that kindlin-3 is required for the integrin alpha M beta 2-Syk-Vav1 signaling axis that regulates Rac1 and Cdc42 activities. These findings reinforce a role for kindlin-3 in integrin outside-in signaling.	[Xue, Zhi-Hong; Feng, Chen; Liu, Wei-Ling; Tan, Suet-Mien] Nanyang Technol Univ, Sch Biol Sci, Singapore 639798, Singapore	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Tan, SM (corresponding author), Nanyang Technol Univ, Sch Biol Sci, Singapore 639798, Singapore.	smtan@ntu.edu.sg	Tan, Suet/A-2224-2011; Xue, Zhihong/T-8848-2019	Tan, Suet-Mien/0000-0003-2371-8739	Singapore Ministry of Education grant [2010-T2-2-014]; Singapore Agency for Science, Technology, and Research Biomedical Research Council grant [10/1/22/19/654]	Singapore Ministry of Education grant(Ministry of Education, Singapore); Singapore Agency for Science, Technology, and Research Biomedical Research Council grant	This work was supported by Singapore Ministry of Education grant 2010-T2-2-014 and Singapore Agency for Science, Technology, and Research Biomedical Research Council grant 10/1/22/19/654. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDREW D, 1993, EUR J IMMUNOL, V23, P2217, DOI 10.1002/eji.1830230925; Arnaout MA, 2007, CURR OPIN CELL BIOL, V19, P495, DOI 10.1016/j.ceb.2007.08.002; ARNAOUT MA, 1983, J CLIN INVEST, V72, P171, DOI 10.1172/JCI110955; Beglova N, 2002, NAT STRUCT BIOL, V9, P282, DOI 10.1038/nsb779; BELLER DI, 1982, J EXP MED, V156, P1000, DOI 10.1084/jem.156.4.1000; Bialkowska K, 2010, J BIOL CHEM, V285, P18640, DOI 10.1074/jbc.M109.085746; Bouaouina M, 2012, J BIOL CHEM, V287, P6979, DOI 10.1074/jbc.M111.330845; Bouaouina M, 2011, CURR BIOL, V21, pR99, DOI 10.1016/j.cub.2010.12.002; Bustelo XR, 2000, MOL CELL BIOL, V20, P1461, DOI 10.1128/MCB.20.5.1461-1477.2000; Butler B, 2003, J BIOL CHEM, V278, P5264, DOI 10.1074/jbc.M206997200; Campbell I.D., 2011, COLD SPRING HARB PER, V3; Chavakis T, 2003, J EXP MED, V198, P1507, DOI 10.1084/jem.20030800; Cheng M, 2007, J BIOL CHEM, V282, P18225, DOI 10.1074/jbc.M701386200; Cox EA, 2003, MOL BIOL CELL, V14, P658, DOI 10.1091/mbc.E02-03-0142; Critchley DR, 2008, J CELL SCI, V121, P1345, DOI 10.1242/jcs.018085; DAVIS GE, 1992, EXP CELL RES, V200, P242, DOI 10.1016/0014-4827(92)90170-D; de Hoog CL, 2004, CELL, V117, P649, DOI 10.1016/S0092-8674(04)00456-8; Deckert M, 1996, IMMUNITY, V5, P591, DOI 10.1016/S1074-7613(00)80273-3; Ding ZM, 1999, J IMMUNOL, V163, P5029; Doan AT, 2007, EXP CELL RES, V313, P2667, DOI 10.1016/j.yexcr.2007.05.013; Feng C, 2012, J BIOL CHEM, V287, P10714, DOI 10.1074/jbc.M111.299594; Gakidis MAM, 2004, J CELL BIOL, V166, P273, DOI 10.1083/jcb.200404166; Goult BT, 2009, J MOL BIOL, V394, P944, DOI 10.1016/j.jmb.2009.09.061; Graff JC, 2007, J LEUKOCYTE BIOL, V82, P603, DOI 10.1189/jlb.0207125; Gupton Stephanie L, 2007, Sci STKE, V2007, pre5, DOI 10.1126/stke.4002007re5; Han CF, 2010, NAT IMMUNOL, V11, P734, DOI 10.1038/ni.1908; Harburger DS, 2009, J BIOL CHEM, V284, P11485, DOI 10.1074/jbc.M809233200; Has C, 2009, AM J PATHOL, V175, P1442, DOI 10.2353/ajpath.2009.090203; Huveneers S, 2009, J CELL SCI, V122, P1059, DOI 10.1242/jcs.039446; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; Jung GY, 2011, J CELL BIOCHEM, V112, P2541, DOI 10.1002/jcb.23178; Kjoller L, 1999, EXP CELL RES, V253, P166, DOI 10.1006/excr.1999.4674; LARSON RS, 1990, IMMUNOL REV, V114, P181, DOI 10.1111/j.1600-065X.1990.tb00565.x; Lefort CT, 2012, BLOOD, V119, P4275, DOI 10.1182/blood-2011-08-373118; Lim J, 2007, MOL BIOL CELL, V18, P976, DOI 10.1091/mbc.E06-09-0813; Liu JM, 2011, J BIOL CHEM, V286, P43334, DOI 10.1074/jbc.M111.295352; Luo BH, 2007, ANNU REV IMMUNOL, V25, P619, DOI 10.1146/annurev.immunol.25.022106.141618; Malinin NL, 2010, BLOOD, V115, P4011, DOI 10.1182/blood-2009-10-239269; Malinin NL, 2009, NAT MED, V15, P313, DOI 10.1038/nm.1917; Manevich-Mendelson E, 2009, BLOOD, V114, P2344, DOI 10.1182/blood-2009-04-218636; Mayadas TN, 2005, TRENDS IMMUNOL, V26, P388, DOI 10.1016/j.it.2005.05.002; McDowall A, 2010, BLOOD, V115, P4834, DOI 10.1182/blood-2009-08-238709; McEver RP, 2007, NAT IMMUNOL, V8, P1035, DOI 10.1038/ni1007-1035; Meves A, 2009, TRENDS CELL BIOL, V19, P504, DOI 10.1016/j.tcb.2009.07.006; Miao H, 2002, J CELL SCI, V115, P2199; Miranti CK, 1998, CURR BIOL, V8, P1289, DOI 10.1016/S0960-9822(07)00559-3; Mocsai A, 2002, IMMUNITY, V16, P547, DOI 10.1016/S1074-7613(02)00303-5; Mocsai A, 2006, NAT IMMUNOL, V7, P1326, DOI 10.1038/ni1407; Montanez E, 2008, GENE DEV, V22, P1325, DOI 10.1101/gad.469408; Mory A, 2008, BLOOD, V112, P2591, DOI 10.1182/blood-2008-06-163162; Moser M, 2008, NAT MED, V14, P325, DOI 10.1038/nm1722; Moser M, 2009, SCIENCE, V324, P895, DOI 10.1126/science.1163865; Moser M, 2009, NAT MED, V15, P300, DOI 10.1038/nm.1921; Nimnual AS, 2003, NAT CELL BIOL, V5, P236, DOI 10.1038/ncb938; Ohta Y, 2006, NAT CELL BIOL, V8, P803, DOI 10.1038/ncb1437; Perera HD, 2011, STRUCTURE, V19, P1664, DOI 10.1016/j.str.2011.08.012; Puklin-Faucher E, 2009, J CELL SCI, V122, P179, DOI 10.1242/jcs.042127; Qu H, 2011, J CELL SCI, V124, P879, DOI 10.1242/jcs.076976; RIDLEY AJ, 1992, CELL, V70, P401, DOI 10.1016/0092-8674(92)90164-8; RIDLEY AJ, 1992, CELL, V70, P389, DOI 10.1016/0092-8674(92)90163-7; Schymeinsky J, 2006, BLOOD, V108, P3919, DOI 10.1182/blood-2005-12-030387; Shattil SJ, 2010, NAT REV MOL CELL BIO, V11, P288, DOI 10.1038/nrm2871; Shaw JM, 2001, CLIN EXP IMMUNOL, V126, P311, DOI 10.1046/j.1365-2249.2001.01661.x; Shi C, 2004, J CLIN INVEST, V114, P408, DOI 10.1172/jci200421100; Shi C, 2008, BLOOD, V112, P4699, DOI 10.1182/blood-2008-01-137018; Skoberne M, 2006, BLOOD, V108, P947, DOI 10.1182/blood-2005-12-4812; SPRINGER T, 1979, EUR J IMMUNOL, V9, P301, DOI 10.1002/eji.1830090410; Stephens P, 1995, CELL ADHES COMMUN, V3, P375, DOI 10.3109/15419069509081292; Svensson L, 2009, NAT MED, V15, P306, DOI 10.1038/nm.1931; Tadokoro S, 2003, SCIENCE, V302, P103, DOI 10.1126/science.1086652; Tan SM, 2000, J IMMUNOL, V165, P2574, DOI 10.4049/jimmunol.165.5.2574; Tan SM, 2012, BIOSCIENCE REP, V32, P241, DOI 10.1042/BSR20110101; Tang ML, 2006, BIOCHEM BIOPH RES CO, V348, P1184, DOI 10.1016/j.bbrc.2006.07.179; Tang XY, 2008, J IMMUNOL, V180, P4793, DOI 10.4049/jimmunol.180.7.4793; Tu YZ, 2003, CELL, V113, P37, DOI 10.1016/S0092-8674(03)00163-6; Xiong YM, 2003, J IMMUNOL, V171, P1042, DOI 10.4049/jimmunol.171.2.1042; Xue ZH, 2010, J IMMUNOL, V184, P3697, DOI 10.4049/jimmunol.0903316; Yan SR, 1997, J IMMUNOL, V158, P1902; Yu Y, 2012, EMBO REP, V13, P750, DOI 10.1038/embor.2012.88	80	24	25	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e56911	10.1371/journal.pone.0056911	http://dx.doi.org/10.1371/journal.pone.0056911			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437269	gold, Green Published, Green Submitted			2022-12-25	WOS:000315184200183
J	Zhang, YF; Anderson, SJ; French, SL; Sikes, ML; Viktorovskaya, OV; Huband, J; Holcomb, K; Hartman, JL; Beyer, AL; Schneider, DA				Zhang, Yinfeng; Anderson, Susan J.; French, Sarah L.; Sikes, Martha L.; Viktorovskaya, Olga V.; Huband, Jacalyn; Holcomb, Katherine; Hartman, John L.; Beyer, Ann L.; Schneider, David A.			The SWI/SNF Chromatin Remodeling Complex Influences Transcription by RNA Polymerase I in Saccharomyces cerevisiae	PLOS ONE			English	Article							RIBOSOMAL-RNA; HISTONE ACETYLTRANSFERASE; REPRESSES TRANSCRIPTION; GENE-EXPRESSION; MULTIPLE STEPS; YEAST; ELONGATION; RECRUITMENT; ACTIVATION; DNA	SWI/SNF is a chromatin remodeling complex that affects transcription initiation and elongation by RNA polymerase II. Here we report that SWI/SNF also plays a role in transcription by RNA polymerase I (Pol I) in Saccharomyces cerevisiae. Deletion of the genes encoding the Snf6p or Snf5p subunits of SWI/SNF was lethal in combination with mutations that impair Pol I transcription initiation and elongation. SWI/SNF physically associated with ribosomal DNA ( rDNA) within the coding region, with an apparent peak near the 59 end of the gene. In snf6 Delta cells there was a similar to 2.5-fold reduction in rRNA synthesis rate compared to WT, but there was no change in average polymerase occupancy per gene, the number of rDNA gene repeats, or the percentage of transcriptionally active rDNA genes. However, both ChIP and EM analyses showed a small but reproducible increase in Pol I density in a region near the 59 end of the gene. Based on these data, we conclude that SWI/SNF plays a positive role in Pol I transcription, potentially by modifying chromatin structure in the rDNA repeats. Our findings demonstrate that SWI/SNF influences the most robust transcription machinery in proliferating cells.	[Zhang, Yinfeng; Anderson, Susan J.; Viktorovskaya, Olga V.; Schneider, David A.] Univ Alabama Birmingham, Dept Biochem & Mol Genet, Birmingham, AL 35294 USA; [French, Sarah L.; Sikes, Martha L.; Beyer, Ann L.] Univ Virginia Hlth Syst, Dept Microbiol, Charlottesville, VA USA; [Hartman, John L.] Univ Alabama Birmingham, Dept Genet, Birmingham, AL USA; [Huband, Jacalyn; Holcomb, Katherine] Univ Virginia, Alliance Computat Sci & Engn, Charlottesville, VA USA	University of Alabama System; University of Alabama Birmingham; University of Virginia; University of Alabama System; University of Alabama Birmingham; University of Virginia	Schneider, DA (corresponding author), Univ Alabama Birmingham, Dept Biochem & Mol Genet, Birmingham, AL 35294 USA.	dschneid@uab.edu		Schneider, David/0000-0003-0635-5091; Hartman, John/0000-0003-1176-6469	NIH [GM63952, GM84946]; Howard Hughes Medical Institute [P/S ECA 57005927]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084946, R01GM063952] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH GM63952 to ALB; NIH GM84946 to DAS; Howard Hughes Medical Institute P/S ECA 57005927 to JLH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert B, 2012, GENET RES INT, V2012, DOI 10.1155/2012/276948; Allmang C, 1999, EMBO J, V18, P5399, DOI 10.1093/emboj/18.19.5399; Anderson SJ, 2011, J BIOL CHEM, V286, P18816, DOI 10.1074/jbc.M110.202101; Biggar SR, 1999, EMBO J, V18, P2254, DOI 10.1093/emboj/18.8.2254; BRAND AH, 1985, CELL, V41, P41, DOI 10.1016/0092-8674(85)90059-5; CARLSON M, 1981, GENETICS, V98, P25; Cheng SWG, 1999, NAT GENET, V22, P102, DOI 10.1038/8811; Cioci F, 2003, MOL CELL, V12, P135, DOI 10.1016/S1097-2765(03)00262-4; Claypool JA, 2004, MOL BIOL CELL, V15, P946, DOI 10.1091/mbc.E03-08-0594; Corey LL, 2003, GENE DEV, V17, P1392, DOI 10.1101/gad.1071803; Davie JK, 2000, MOL CELL BIOL, V20, P5960, DOI 10.1128/MCB.20.16.5960-5973.2000; De la Serna IL, 2000, MOL CELL BIOL, V20, P2839, DOI 10.1128/MCB.20.8.2839-2851.2000; Dechassa ML, 2010, MOL CELL, V38, P590, DOI 10.1016/j.molcel.2010.02.040; Dror V, 2004, MOL CELL BIOL, V24, P8227, DOI 10.1128/MCB.24.18.8227-8235.2004; El Hage A, 2010, GENE DEV, V24, P1546, DOI 10.1101/gad.573310; Ferreira ME, 2009, FEBS J, V276, P2557, DOI 10.1111/j.1742-4658.2009.06979.x; Flaus A, 2001, CURR OPIN GENET DEV, V11, P148, DOI 10.1016/S0959-437X(00)00172-6; French SL, 2003, MOL CELL BIOL, V23, P1558, DOI 10.1128/MCB.23.5.1558-1568.2003; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; GOTTSCHLING DE, 1990, CELL, V63, P751, DOI 10.1016/0092-8674(90)90141-Z; Govind CK, 2005, MOL CELL BIOL, V25, P5626, DOI 10.1128/MCB.25.13.5626-5638.2005; Gunawardena RW, 2007, J BIOL CHEM, V282, P20116, DOI 10.1074/jbc.M701406200; Hassan AH, 2001, CELL, V104, P817, DOI 10.1016/S0092-8674(01)00279-3; Holstege FCP, 1998, CELL, V95, P717, DOI 10.1016/S0092-8674(00)81641-4; Jones HS, 2007, NAT STRUCT MOL BIOL, V14, P123, DOI 10.1038/nsmb1199; Kobayashi T, 2005, SCIENCE, V309, P1581, DOI 10.1126/science.1116102; Kuai L, 2004, P NATL ACAD SCI USA, V101, P8581, DOI 10.1073/pnas.0402888101; Kuhn CD, 2007, CELL, V131, P1260, DOI 10.1016/j.cell.2007.10.051; Larson DR, 2011, SCIENCE, V332, P475, DOI 10.1126/science.1202142; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Loo S, 1995, ANNU REV CELL DEV BI, V11, P519, DOI 10.1146/annurev.cellbio.11.1.519; Martens JA, 2005, GENE DEV, V19, P2695, DOI 10.1101/gad.1367605; Martens JA, 2003, CURR OPIN GENET DEV, V13, P136, DOI 10.1016/S0959-437X(03)00022-4; Martens JA, 2002, GENE DEV, V16, P2231, DOI 10.1101/gad.1009902; Mayer C, 2004, GENE DEV, V18, P423, DOI 10.1101/gad.285504; Merz K, 2008, GENE DEV, V22, P1190, DOI 10.1101/gad.466908; Murphy DJ, 1999, MOL CELL BIOL, V19, P2724; Narlikar GJ, 2002, CELL, V108, P475, DOI 10.1016/S0092-8674(02)00654-2; NASMYTH K, 1987, SCIENCE, V237, P1162, DOI 10.1126/science.3306917; NEIGEBORN L, 1984, GENETICS, V108, P845; PETERSON CL, 1992, CELL, V68, P573, DOI 10.1016/0092-8674(92)90192-F; Schneider DA, 2006, P NATL ACAD SCI USA, V103, P12707, DOI 10.1073/pnas.0605686103; Schneider DA, 2007, MOL CELL, V26, P217, DOI 10.1016/j.molcel.2007.04.007; Schneider DA, 2012, GENE, V493, P176, DOI 10.1016/j.gene.2011.08.006; Schwabish MA, 2007, MOL CELL BIOL, V27, P6987, DOI 10.1128/MCB.00717-07; Shivaswamy S, 2008, MOL CELL BIOL, V28, P2221, DOI 10.1128/MCB.01659-07; Singh I, 2009, GENETICS, V181, P289, DOI 10.1534/genetics.108.092981; Smith JS, 1997, GENE DEV, V11, P241, DOI 10.1101/gad.11.2.241; Stefanovsky V, 2006, MOL CELL, V21, P629, DOI 10.1016/j.molcel.2006.01.023; Sudarsanam P, 2000, P NATL ACAD SCI USA, V97, P3364, DOI 10.1073/pnas.050407197; Sudarsanam P, 1999, EMBO J, V18, P3101, DOI 10.1093/emboj/18.11.3101; Thomson E, 2010, MOL CELL BIOL, V30, P976, DOI 10.1128/MCB.01359-09; Tong A, 2005, YEAST PROTOCOLS METH, P171; WARNER JR, 1991, METHOD ENZYMOL, V194, P423; Zhang Y, 2010, J BIOL CHEM, V108, P6079; Zhang YF, 2009, P NATL ACAD SCI USA, V106, P2153, DOI 10.1073/pnas.0812939106; Zofall M, 2006, NAT STRUCT MOL BIOL, V13, P339, DOI 10.1038/nsmb1071	57	12	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e56793	10.1371/journal.pone.0056793	http://dx.doi.org/10.1371/journal.pone.0056793			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437238	Green Published, Green Submitted, gold			2022-12-25	WOS:000315184200162
J	Pancera, M; Yang, YP; Louder, MK; Gorman, J; Lu, G; McLellan, JS; Stuckey, J; Zhu, J; Burton, DR; Koff, WC; Mascola, JR; Kwong, PD				Pancera, Marie; Yang, Yongping; Louder, Mark K.; Gorman, Jason; Lu, Gabriel; McLellan, Jason S.; Stuckey, Jonathan; Zhu, Jiang; Burton, Dennis R.; Koff, Wayne C.; Mascola, John R.; Kwong, Peter D.			N332-Directed Broadly Neutralizing Antibodies Use Diverse Modes of HIV-1 Recognition: Inferences from Heavy-Light Chain Complementation of Function	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; HUMAN MONOCLONAL-ANTIBODIES; CD4 BINDING; POTENT; GP120; SEQUENCE; SITE; GP41; ASSOCIATION; PREDICTION	Dozens of broadly neutralizing HIV-1 antibodies have been isolated in the last few years from the sera of HIV-1-infected individuals. Only a limited number of regions on the HIV-1 spike, however, are recognized by these antibodies. One of these regions (N332) is characterized by an N-linked glycan at residue 332 on HIV-1 gp120 and is recognized by antibody 2G12 and by the recently reported antibodies PGT121-137, the latter isolated from three donors. To investigate the diversity in mode of antibody recognition at the N332 site, we used functional complementation between antibody heavy and light chains as a means of assessing similarity in mode of recognition. We examined a matrix of 12 PGT-heavy chains with each of 12 PGT-light chains. Expression in 96-well format for the 144 antibodies (132 chimeric and 12 wild-type) was generally consistent (58+/-10 mu g/ml). In contrast, recognition of HIV-1 gp120 was bimodal: when the source of heavy and light chains was from the same donor, recognition was good; when sources of heavy and light chains were from different donors, recognition was poor. Moreover, neutralization of HIV-1 strains SF162.LS and TRO.11 generally followed patterns of gp120 recognition. These results are consistent with published sequence, mutational, and structural findings, all of which indicate that N332-directed neutralizing antibodies from different donors utilize different modes of recognition, and provide support for a correlation between functional complementation of antibody heavy and light chains and similarity in antibody mode of recognition. Overall, our results add to the growing body of evidence that the human immune system is capable of recognizing the N332-region of HIV-1 gp120 in diverse ways.	[Pancera, Marie; Yang, Yongping; Louder, Mark K.; Gorman, Jason; Lu, Gabriel; McLellan, Jason S.; Zhu, Jiang; Mascola, John R.; Kwong, Peter D.] NIAID, Vaccine Res Ctr, NIH, Bethesda, MD 20892 USA; [Burton, Dennis R.] Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA; [Burton, Dennis R.] Scripps Res Inst, IAVI Neutralizing Antibody Ctr, La Jolla, CA 92037 USA; [Burton, Dennis R.] MIT, Ragon Inst MGH, Cambridge, MA 02139 USA; [Burton, Dennis R.] Harvard Univ, Cambridge, MA 02138 USA; [Koff, Wayne C.] Int AIDS Vaccine Initiat IAVI, New York, NY USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Scripps Research Institute; International AIDS Vaccine Initiative; Scripps Research Institute; Harvard University; Massachusetts Institute of Technology (MIT); Ragon Institute; Harvard University; International AIDS Vaccine Initiative	Kwong, PD (corresponding author), NIAID, Vaccine Res Ctr, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	pdkwong@nih.gov	Mascola, John/AAI-7193-2021; Gorman, Jason/AGG-9417-2022	McLellan, Jason/0000-0003-3991-542X; Gorman, Jason/0000-0002-3775-6560	National Institutes of Health (NIH); International AIDS Vaccine Initiative's Neutralizing Antibody Consortium; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI005022] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); International AIDS Vaccine Initiative's Neutralizing Antibody Consortium; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Support for this work was provided by the Intramural Research Program of the National Institutes of Health (NIH) and by the International AIDS Vaccine Initiative's Neutralizing Antibody Consortium. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abhinandan KR, 2010, PROTEIN ENG DES SEL, V23, P689, DOI 10.1093/protein/gzq043; Calarese DA, 2003, SCIENCE, V300, P2065, DOI 10.1126/science.1083182; Chailyan A, 2011, FEBS J, V278, P2858, DOI 10.1111/j.1742-4658.2011.08207.x; Chen L, 2009, SCIENCE, V326, P1123, DOI 10.1126/science.1175868; Chen Yunjia, 2008, V426, P209, DOI 10.1007/978-1-60327-058-8_13; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Corti D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008805; Doria-Rose NA, 2010, J VIROL, V84, P1631, DOI 10.1128/JVI.01482-09; Gray ES, 2009, J VIROL, V83, P11265, DOI 10.1128/JVI.01359-09; Jayaram N, 2012, PROTEIN ENG DES SEL, V25, P523, DOI 10.1093/protein/gzs043; Kuroda D, 2012, PROTEIN ENG DES SEL, V25, P507, DOI 10.1093/protein/gzs024; Kwong PD, 2012, IMMUNITY, V37, P412, DOI 10.1016/j.immuni.2012.08.012; Kwong PD, 2009, CELL HOST MICROBE, V6, P292, DOI 10.1016/j.chom.2009.09.008; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Li M, 2005, J VIROL, V79, P10108, DOI 10.1128/JVI.79.16.10108-10125.2005; Li YX, 2007, NAT MED, V13, P1032, DOI 10.1038/nm1624; Moore PL, 2011, AIDS RES HUM RETROV, V27, pA29; Moore PL, 2011, J VIROL, V85, P3128, DOI 10.1128/JVI.02658-10; Mouquet H, 2012, P NATL ACAD SCI US; MUSTER T, 1994, J VIROL, V68, P4031, DOI 10.1128/JVI.68.6.4031-4034.1994; MUSTER T, 1993, J VIROL, V67, P6642, DOI 10.1128/JVI.67.11.6642-6647.1993; Noonan Daniel J, 2004, Methods Mol Biol, V284, P51; Pancera M, 2010, J VIROL, V84, P8098, DOI 10.1128/JVI.00966-10; Pejchal R, 2011, SCIENCE, V334, P1097, DOI 10.1126/science.1213256; Petrey D, 2003, PROTEINS, V53, P430, DOI 10.1002/prot.10550; PURTSCHER M, 1994, AIDS RES HUM RETROV, V10, P1651, DOI 10.1089/aid.1994.10.1651; ROBEN P, 1994, J VIROL, V68, P4821, DOI 10.1128/JVI.68.8.4821-4828.1994; Sather DN, 2009, J VIROL, V83, P757, DOI 10.1128/JVI.02036-08; Scheid JF, 2011, SCIENCE, V333, P1633, DOI 10.1126/science.1207227; Seaman MS, 2010, J VIROL, V84, P1439, DOI 10.1128/JVI.02108-09; Stamatatos L, 2009, NAT MED, V15, P866, DOI 10.1038/nm.1949; TRKOLA A, 1995, J VIROL, V69, P6609, DOI 10.1128/JVI.69.11.6609-6617.1995; Trkola A, 1996, J VIROL, V70, P1100, DOI 10.1128/JVI.70.2.1100-1108.1996; Walker LM, 2011, P NATL ACAD SCI USA, V108, P20125, DOI 10.1073/pnas.1117531108; Walker LM, 2011, NATURE, V477, P466, DOI 10.1038/nature10373; Walker LM, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001028; Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746; Wu XL, 2011, SCIENCE, V333, P1593, DOI 10.1126/science.1207532; Wu XL, 2010, SCIENCE, V329, P856, DOI 10.1126/science.1187659; Wu XL, 2009, J VIROL, V83, P10892, DOI 10.1128/JVI.01142-09; Zhou HY, 2002, PROTEIN SCI, V11, P2714, DOI 10.1110/ps.0217002	41	29	38	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2013	8	2							e55701	10.1371/journal.pone.0055701	http://dx.doi.org/10.1371/journal.pone.0055701			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093HR	23431362	Green Published, Green Submitted, gold			2022-12-25	WOS:000315182800005
J	Seymour, R; Shirley, BJ; HogenEsch, H; Shultz, LD; Sundberg, JP				Seymour, Rosemarie; Shirley, Bobbi-Jo; HogenEsch, Harm; Shultz, Leonard D.; Sundberg, John P.			Loss of Function of the Mouse Sharpin Gene Results in Peyer's Patch Regression	PLOS ONE			English	Article							CHRONIC PROLIFERATIVE DERMATITIS; TUMOR-NECROSIS-FACTOR; LYMPH-NODE GENESIS; NF-KAPPA-B; LYMPHOTOXIN BETA-RECEPTOR; DISTINCT ROLES; DEFICIENT MICE; ORGANOGENESIS; CELLS; INFLAMMATION	Peyer's patches (PP) are an important component in the immune response against intestinal pathogens. Two independent, spontaneous mutations in the mouse Sharpin gene (Sharpin(cpdm) and Sharpin(cpdm-Dem)) result in the absence of PP and disrupted splenic white pulp in adult mice, although a full complement of lymph nodes is present. Here we report that rudimentary PP begin to develop in Sharpin(cpdm) mice during embryogenesis, but lack the organizational patterns that are typical of this tissue. In the present study, small intestines examined at weekly intervals from birth to maturity showed spontaneous regression of PP in mutant mice with concurrent infiltration of granulocytes. At 5 to 6 weeks of age, only indistinct remnants of granulocytic accumulations remain. Transplantation of normal bone marrow into Sharpin(cpdm) mice at 7 days of age did not prevent regression of PP in bone marrow chimeras examined at 7 to 8 weeks of age. These findings indicate that SHARPIN expression is required for the normal development and maintenance, but not initiation, of PP.	[Seymour, Rosemarie; Shirley, Bobbi-Jo; Shultz, Leonard D.; Sundberg, John P.] Jackson Lab, Bar Harbor, ME 04609 USA; [HogenEsch, Harm] Purdue Univ, Dept Comparat Pathobiol, W Lafayette, IN 47907 USA	Jackson Laboratory; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Seymour, R (corresponding author), Amer Vet Med Assoc, Schaumburg, IL USA.	rosemarie.seymour@gmail.com		HogenEsch, Harm/0000-0002-2738-9189	United States National Institutes of Health [AR049288, AI060707, CA34196]; NATIONAL CANCER INSTITUTE [P30CA034196] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K08AI060707] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR049288] Funding Source: NIH RePORTER	United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was funded in part by grants from the United States National Institutes of Health (AR049288, AI060707, and CA34196). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi S, 1997, INT IMMUNOL, V9, P507, DOI 10.1093/intimm/9.4.507; Adachi S, 1998, INT IMMUNOL, V10, P1, DOI 10.1093/intimm/10.1.1; Ansel KM, 2000, NATURE, V406, P309, DOI 10.1038/35018581; BANKS TA, 1995, J IMMUNOL, V155, P1685; CERNY A, 1988, CELL TISSUE RES, V254, P449; Cerutti A, 2008, IMMUNITY, V28, P740, DOI 10.1016/j.immuni.2008.05.001; DETOGNI P, 1994, SCIENCE, V264, P703, DOI 10.1126/science.8171322; Eberl G, 2004, NAT IMMUNOL, V5, P64, DOI 10.1038/ni1022; Forster R, 1996, CELL, V87, P1037, DOI 10.1016/S0092-8674(00)81798-5; Fu YX, 1999, ANNU REV IMMUNOL, V17, P399, DOI 10.1146/annurev.immunol.17.1.399; Fukuyama S, 2002, IMMUNITY, V17, P31, DOI 10.1016/S1074-7613(02)00339-4; Futterer A, 1998, IMMUNITY, V9, P59, DOI 10.1016/S1074-7613(00)80588-9; Gerlach B, 2011, NATURE, V471, P591, DOI 10.1038/nature09816; Gonzalez M, 1998, J EXP MED, V187, P997, DOI 10.1084/jem.187.7.997; Hashi H, 2001, J IMMUNOL, V166, P3702, DOI 10.4049/jimmunol.166.6.3702; HOGENESCH H, 1993, AM J PATHOL, V143, P972; HogenEsch H, 1999, J IMMUNOL, V162, P3890; HogenEsch H, 2001, EUR J IMMUNOL, V31, P734, DOI 10.1002/1521-4141(200103)31:3<734::AID-IMMU734>3.0.CO;2-9; Ikeda F, 2011, NATURE, V471, P637, DOI 10.1038/nature09814; Kim D, 2000, J EXP MED, V192, P1467, DOI 10.1084/jem.192.10.1467; Koni PA, 1997, IMMUNITY, V6, P491, DOI 10.1016/S1074-7613(00)80292-7; Korner H, 1997, EUR J IMMUNOL, V27, P2600, DOI 10.1002/eji.1830271020; McElwee KJ, 1998, J INVEST DERMATOL, V111, P797, DOI 10.1046/j.1523-1747.1998.00380.x; Mebius RE, 2005, NAT REV IMMUNOL, V5, P606, DOI 10.1038/nri1669; Mebius RE, 2003, NAT REV IMMUNOL, V3, P292, DOI 10.1038/nri1054; MIYAWAKI S, 1994, EUR J IMMUNOL, V24, P429, DOI 10.1002/eji.1830240224; National Center for Biotechnology Information U.S. National Library of Medicine, GEN REP SHARPIN SHAN; Neumann B, 1996, J EXP MED, V184, P259, DOI 10.1084/jem.184.1.259; PARK CM, 1987, J MICROSC-OXFORD, V145, P115, DOI 10.1111/j.1365-2818.1987.tb01321.x; Pomerantz JL, 2002, MOL CELL, V10, P693, DOI 10.1016/S1097-2765(02)00697-4; Randall TD, 2008, ANNU REV IMMUNOL, V26, P627, DOI 10.1146/annurev.immunol.26.021607.090257; Rennert PD, 1998, IMMUNITY, V9, P71, DOI 10.1016/S1074-7613(00)80589-0; Ruuls SR, 2001, IMMUNITY, V15, P533, DOI 10.1016/S1074-7613(01)00215-1; Scheu S, 2002, J EXP MED, V195, P1613, DOI 10.1084/jem.20020215; Seymour RE, 2007, GENES IMMUN, V8, P416, DOI 10.1038/sj.gene.6364403; Sundberg JP, 2000, J EXP ANIM SCI, V41, P101, DOI 10.1016/S0939-8600(00)80001-2; Tokunaga F, 2011, NATURE, V471, P633, DOI 10.1038/nature09815; Ueno M, 2005, INVEST OPHTH VIS SCI, V46, P4097, DOI 10.1167/iovs.05-0548; Veiga-Fernandes H, 2007, NATURE, V446, P547, DOI 10.1038/nature05597; Wang JH, 1996, IMMUNITY, V5, P537, DOI 10.1016/S1074-7613(00)80269-1; Webb CM, 2012, VET PATHOL, V49, P727, DOI 10.1177/0300985811414033; Wigle JT, 1999, CELL, V98, P769, DOI 10.1016/S0092-8674(00)81511-1; Yilmaz ZB, 2003, EMBO J, V22, P121, DOI 10.1093/emboj/cdg004; Yoshida H, 1999, INT IMMUNOL, V11, P643, DOI 10.1093/intimm/11.5.643	44	11	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2013	8	2							e55224	10.1371/journal.pone.0055224	http://dx.doi.org/10.1371/journal.pone.0055224			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104BU	23424624	gold, Green Published, Green Submitted			2022-12-25	WOS:000315965100012
J	Hasegawa, K; Wakino, S; Kimoto, M; Minakuchi, H; Fujimura, K; Hosoya, K; Komatsu, M; Kaneko, Y; Kanda, T; Tokuyama, H; Hayashi, K; Itoh, H				Hasegawa, Kazuhiro; Wakino, Shu; Kimoto, Masumi; Minakuchi, Hitoshi; Fujimura, Keiko; Hosoya, Koji; Komatsu, Motoaki; Kaneko, Yuka; Kanda, Takeshi; Tokuyama, Hirobumi; Hayashi, Koichi; Itoh, Hiroshi			The hydrolase DDAH2 enhances pancreatic insulin secretion by transcriptional regulation of secretagogin through a Sirt1-dependent mechanism in mice	FASEB JOURNAL			English	Article						beta cells; glucose-stimulated insulin secretion; glucose tolerance; knockout; overexpression	NITRIC-OXIDE SYNTHASE; HIGH-FAT DIET; BETA-CELLS; ENDOTHELIAL-CELLS; DIMETHYLARGININE DIMETHYLAMINOHYDROLASE; ASYMMETRIC DIMETHYLARGININE; UNCOUPLING PROTEIN-2; FACTOR EXPRESSION; OXIDATIVE STRESS; RAT ISLETS	The role of dimethylarginine dimethylaminohydrolase 2 (DDAH2) in glucose metabolism is unknown. Here, we generated DDAH2 transgenic (Tg) mice. These mice had lower plasma glucose levels (60 min: 298 +/- 32 vs. 418 +/- 35 mg/dl; 120 min: 205 +/- 15 vs. 284 +/- 20 mg/dl) and higher insulin levels (15 min: 2.1 +/- 0.2 vs. 1.5 +/- 0.1 ng/ml; 30 min: 1.8 +/- 0.1 vs. 1.5 +/- 0.1 ng/ml) during intraperitoneal glucose tolerance tests when fed a high-fat diet (HFD) compared with HFD-fed wild-type (WT) mice. Glucose-stimulated insulin secretion (GSIS) was increased in Tg islets by 33%. Pancreatic asymmetrical dimethylarginine, nitric oxide, and oxidative stress levels were not correlated with improvements in insulin secretion in Tg mice. Secretagogin, an insulin vesicle docking protein, was up-regulated by 2.7-fold in Tg mice and in pancreatic MIN-6 cells overexpressing DDAH2. GSIS in MIN-6 cells was dependent on DDAH2-induced secretagogin expression. Pancreatic Sirt1, DDAH2, and secretagogin were down-regulated in HFD-fed WT mice by 70, 75, and 85%, respectively. Overexpression of Sirt1 overexpression by 3.9-fold increased DDAH2 and secretagogin expression in MIN-6 cells by 3.2- and 2.5-fold, respectively. DDAH2 overexpression improved GSIS in pancreas-specific Sirt1-deficient mice. In summary, the Sirt1/DDAH2/secretagogin pathway is a novel regulator of GSIS.-Hasegawa, K, Wakino, S., Kimoto, M, Minakuchi, H., Fujimura, K., Hosoya, K., Komatsu, M., Kaneko, Y., Kanda, T., Tokuyama, H., Hayashi, K., Itoh, H. The hydrolase DDAH2 enhances pancreatic insulin secretion by transcriptional regulation of secretagogin through a Sirt1-dependent mechanism in mice.	[Hasegawa, Kazuhiro; Wakino, Shu; Minakuchi, Hitoshi; Fujimura, Keiko; Hosoya, Koji; Komatsu, Motoaki; Kaneko, Yuka; Kanda, Takeshi; Tokuyama, Hirobumi; Hayashi, Koichi; Itoh, Hiroshi] Keio Univ, Dept Internal Med, Sch Med, Tokyo 1608582, Japan; [Kimoto, Masumi] Okayama Prefectural Univ, Dept Nutr Sci, Okayama, Japan	Keio University; Okayama Prefectural University	Wakino, S (corresponding author), Keio Univ, Dept Internal Med, Sch Med, Shinjuku Ku, 35 Shinanomachi, Tokyo 1608582, Japan.	shuwakino@z8.keio.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [22790800]; Grants-in-Aid for Scientific Research [23590683] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	The authors thank K. Miyashita (Department of Internal Medicine, School of Medicine, Keio University, Tokyo, Japan) for providing the MIN-6 cells. This work was supported by the Scientific Research Fund of the Ministry of Education, Culture, Sports, Science and Technology of Japan (grant 22790800). Author contributions: H.K., S.W., and H.I. designed the experiments and the study; K.H., H.M., and K.F. collected data or performed the experiments; K.H., S.W., M.K., H.M., K.F., K.H., M.K., Y.K., T.K., H.T., K.H., and H.I. analyzed the data and helped write the manuscript; H.I. supervised all experiments and assisted with preparation of the manuscript; S.W. is the guarantor of this work, had full access to all of the data, and takes responsibility for the integrity and accuracy of the data. The authors declare no conflicts of interest.	Arafat HA, 2007, ENDOCRINOLOGY, V148, P575, DOI 10.1210/en.2006-0970; Bauer MC, 2011, MOL BIOSYST, V7, P2196, DOI 10.1039/c0mb00349b; Boger RH, 2000, J AM COLL CARDIOL, V36, P2287, DOI 10.1016/S0735-1097(00)01013-5; Bordone L, 2006, PLOS BIOL, V4, P210, DOI 10.1371/journal.pbio.0040031; Brown JM, 2008, CIRCULATION, V118, P1467, DOI 10.1161/CIRCULATIONAHA.108.793182; Chepurny OG, 2010, AM J PHYSIOL-ENDOC M, V298, pE622, DOI 10.1152/ajpendo.00630.2009; Collins SC, 2010, DIABETES, V59, P1192, DOI 10.2337/db09-0791; Cooke JP, 2004, CIRCULATION, V109, P1813, DOI 10.1161/01.CIR.0000126823.07732.D5; Fukui K, 2005, CELL METAB, V2, P373, DOI 10.1016/j.cmet.2005.11.003; Hals IK, 2012, BIOCHEM BIOPH RES CO, V423, P259, DOI 10.1016/j.bbrc.2012.05.101; Hasegawa K, 2008, BIOCHEM BIOPH RES CO, V372, P51, DOI 10.1016/j.bbrc.2008.04.176; Hasegawa K, 2007, CIRC RES, V101, pE2, DOI 10.1161/CIRCRESAHA.107.156901; Hasegawa K, 2006, ARTERIOSCL THROM VAS, V26, P1488, DOI 10.1161/01.ATV.0000219615.88323.b4; Henningsson R, 2002, AM J PHYSIOL-CELL PH, V283, pC296, DOI 10.1152/ajpcell.00537.2001; ISHIHARA H, 1993, DIABETOLOGIA, V36, P1139, DOI 10.1007/BF00401058; Jeong H, 2012, NAT MED, V18, P159, DOI 10.1038/nm.2559; Joseph JW, 2002, DIABETES, V51, P3211, DOI 10.2337/diabetes.51.11.3211; Kang LJ, 2006, CELL METAB, V3, P463, DOI 10.1016/j.cmet.2006.04.012; Kasai K, 2005, J CLIN INVEST, V115, P388, DOI 10.1172/JCI200522955; Krzyzanowska K, 2008, DIABETES RES CLIN PR, V82, pS122, DOI 10.1016/j.diabres.2008.09.024; Kumar D, 2009, J IMMUNOL, V182, P1011, DOI 10.4049/jimmunol.182.2.1011; Kwon G, 1998, DIABETES, V47, P583, DOI 10.2337/diabetes.47.4.583; Lajoix AD, 2001, DIABETES, V50, P1311, DOI 10.2337/diabetes.50.6.1311; Leibiger IB, 2005, CELL METAB, V2, P80, DOI 10.1016/j.cmet.2005.07.006; Leiper J, 2007, NAT MED, V13, P198, DOI 10.1038/nm1543; Liadis N, 2007, DIABETES, V56, P2302, DOI 10.2337/db06-1771; Liew CW, 2010, J CLIN INVEST, V120, P2876, DOI 10.1172/JCI36849; Moeenrezakhanlou A, 2007, J LEUKOCYTE BIOL, V81, P1311, DOI 10.1189/jlb.1106681; Nagamatsu S, 1999, DIABETES, V48, P2367, DOI 10.2337/diabetes.48.12.2367; Picard F, 2004, NATURE, V429, P771, DOI 10.1038/nature02583; Qader SS, 2007, AM J PHYSIOL-ENDOC M, V292, pE1447, DOI 10.1152/ajpendo.00172.2006; Ramsey KM, 2008, AGING CELL, V7, P78, DOI 10.1111/j.1474-9726.2007.00355.x; Rogstam A, 2007, BIOCHEM J, V401, P353, DOI 10.1042/BJ20060918; Sauter NS, 2008, ENDOCRINOLOGY, V149, P2208, DOI 10.1210/en.2007-1059; Shankar RR, 2000, DIABETES, V49, P684, DOI 10.2337/diabetes.49.5.684; Sorrenti V, 2006, CURR NEUROVASC RES, V3, P49, DOI 10.2174/156720206775541778; Sydow K, 2003, ATHEROSCLEROSIS SUPP, V4, P41, DOI 10.1016/S1567-5688(03)00033-3; Sydow K, 2008, ARTERIOSCL THROM VAS, V28, P692, DOI 10.1161/ATVBAHA.108.162073; Tanaka M, 2006, J HYPERTENS, V24, P489, DOI 10.1097/01.hjh.0000209985.66853.1e; Terauchi Y, 2007, J CLIN INVEST, V117, P246, DOI 10.1172/JCI17645; Wagner L, 2000, J BIOL CHEM, V275, P24740, DOI 10.1074/jbc.M001974200; Wang D, 2007, CIRC RES, V101, P627, DOI 10.1161/CIRCRESAHA.107.158915; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047; Xin HY, 2007, THROMB HAEMOSTASIS, V97, P830, DOI 10.1160/TH06-11-0656; Yoshino J, 2011, CELL METAB, V14, P528, DOI 10.1016/j.cmet.2011.08.014; Yuan Q, 2010, CLIN EXP PHARMACOL P, V37, P630, DOI 10.1111/j.1440-1681.2010.05368.x	46	25	25	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	JUN	2013	27	6					2301	2315		10.1096/fj.12-226092	http://dx.doi.org/10.1096/fj.12-226092			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	154II	23430976				2022-12-25	WOS:000319667600020
J	DeVay, RM; Shelton, DL; Liang, H				DeVay, Rachel M.; Shelton, David L.; Liang, Hong			Characterization of Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Trafficking Reveals a Novel Lysosomal Targeting Mechanism via Amyloid Precursor-like Protein 2 (APLP2)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DENSITY-LIPOPROTEIN RECEPTOR; AUTOSOMAL-DOMINANT HYPERCHOLESTEROLEMIA; C-TERMINAL DOMAIN; SECRETED PCSK9; MEDIATED ENDOCYTOSIS; LDL RECEPTORS; NONHUMAN-PRIMATES; STATISTICAL-MODEL; HEPG2 CELLS; IN-VIVO	Proprotein convertase subtilisin/kexin type 9 (PCSK9) regulates low density lipoprotein receptor protein levels by diverting it to lysosomes. Monoclonal antibody therapeutics aimed to neutralize PCSK9 have been shown to successfully lower serum LDL levels; however, we previously found that such therapeutic antibodies are subject to PCSK9-mediated clearance. In this study, we discovered that PCSK9 interacts via its C-terminal domain directly and in a pH-dependent manner with amyloid precursor protein as well as its closely related family member, amyloid precursor protein-like protein 2. Furthermore, we determined that amyloid precursor protein-like protein-2, but not amyloid precursor protein, is involved in mediating postendocytic delivery of PCSK9 to lysosomes and is therefore important for PCSK9 function. Based on our data, we propose a model for a lysosomal transport complex by which a soluble protein can target another protein for degradation from the luminal side of the membrane by bridging it to a lysosomally targeted transmembrane protein.	[DeVay, Rachel M.; Shelton, David L.; Liang, Hong] Rinat Pfizer Inc, San Francisco, CA 94080 USA	Pfizer	Liang, H (corresponding author), Rinat Pfizer Inc, 230 E Grand Ave, San Francisco, CA 94080 USA.	hong.liang@pfizer.com						Abifadel M, 2003, NAT GENET, V34, P154, DOI 10.1038/ng1161; Abisambra JF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008556; Beglova N, 2004, BIOCHEM SOC T, V32, P721, DOI 10.1042/BST0320721; Bonifacino JS, 2003, ANNU REV BIOCHEM, V72, P395, DOI 10.1146/annurev.biochem.72.121801.161800; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Chan JCY, 2009, P NATL ACAD SCI USA, V106, P9820, DOI 10.1073/pnas.0903849106; Chaparro-Riggers J, 2012, J BIOL CHEM, V287, P11090, DOI 10.1074/jbc.M111.319764; Cunningham D, 2007, NAT STRUCT MOL BIOL, V14, P413, DOI 10.1038/nsmb1235; Fisher TS, 2007, J BIOL CHEM, V282, P20502, DOI 10.1074/jbc.M701634200; GOLDSTEIN JL, 1979, NATURE, V279, P679, DOI 10.1038/279679a0; Grant BD, 2009, NAT REV MOL CELL BIO, V10, P597, DOI 10.1038/nrm2755; Holla OL, 2011, J LIPID RES, V52, P1787, DOI 10.1194/jlr.M018093; Holla OL, 2010, MOL GENET METAB, V99, P149, DOI 10.1016/j.ymgme.2009.09.012; Jaskolski F, 2005, J NEUROSCI METH, V146, P42, DOI 10.1016/j.jneumeth.2005.01.012; Jeon H, 2005, ANNU REV BIOCHEM, V74, P535, DOI 10.1146/annurev.biochem.74.082803.133354; Jonas MC, 2008, EMBO REP, V9, P916, DOI 10.1038/embor.2008.132; Jonathan C, 2005, NAT GENET, V37, P161, DOI 10.1038/ng1509; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Kwon HJ, 2008, P NATL ACAD SCI USA, V105, P1820, DOI 10.1073/pnas.0712064105; Lagace TA, 2006, J CLIN INVEST, V116, P2995, DOI 10.1172/JCI29383; Liang H, 2012, J PHARMACOL EXP THER, V340, P228, DOI 10.1124/jpet.111.187419; Liu ML, 2010, J LIPID RES, V51, P2611, DOI 10.1194/jlr.M006635; Lo Surdo P, 2011, EMBO REP, V12, P1300, DOI 10.1038/embor.2011.205; Marzolo MP, 2009, SEMIN CELL DEV BIOL, V20, P191, DOI 10.1016/j.semcdb.2008.10.005; Maxwell KN, 2005, CURR OPIN LIPIDOL, V16, P167, DOI 10.1097/01.mol.0000162321.31925.a3; McNutt MC, 2007, J BIOL CHEM, V282, P20799, DOI 10.1074/jbc.C700095200; McNutt MC, 2009, J BIOL CHEM, V284, P10561, DOI 10.1074/jbc.M808802200; Mettlen M, 2010, J CELL BIOL, V188, P919, DOI 10.1083/jcb.200908078; Nassoury N, 2007, TRAFFIC, V8, P718, DOI 10.1111/j.1600-0854.2007.00562.x; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; Ni YG, 2011, J LIPID RES, V52, P78, DOI 10.1194/jlr.M011445; Ni YG, 2010, J BIOL CHEM, V285, P12882, DOI 10.1074/jbc.M110.113035; Poirier S, 2008, J BIOL CHEM, V283, P2363, DOI 10.1074/jbc.M708098200; Qian YW, 2007, J LIPID RES, V48, P1488, DOI 10.1194/jlr.M700071-JLR200; Saavedra YGL, 2012, J BIOL CHEM, V287, P43492, DOI 10.1074/jbc.M112.394023; Saftig P, 2009, NAT REV MOL CELL BIO, V10, P623, DOI 10.1038/nrm2745; Shan LX, 2008, BIOCHEM BIOPH RES CO, V375, P69, DOI 10.1016/j.bbrc.2008.07.106; Strom TB, 2010, MOL GENET METAB, V101, P76, DOI 10.1016/j.ymgme.2010.05.003; Tibolla G, 2011, NUTR METAB CARDIOVAS, V21, P835, DOI 10.1016/j.numecd.2011.06.002; Tuli A, 2008, J IMMUNOL, V181, P1978, DOI 10.4049/jimmunol.181.3.1978; Tuli A, 2009, J BIOL CHEM, V284, P34296, DOI 10.1074/jbc.M109.039727; Wang Y, 2012, J LIPID RES, V53, P1932, DOI 10.1194/jlr.M028563; Zhang DW, 2008, P NATL ACAD SCI USA, V105, P13045, DOI 10.1073/pnas.0806312105; Zhang DW, 2007, J BIOL CHEM, V282, P18602, DOI 10.1074/jbc.M702027200	44	40	54	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 12	2013	288	15					10805	10818		10.1074/jbc.M113.453373	http://dx.doi.org/10.1074/jbc.M113.453373			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	125TU	23430252	hybrid, Green Published			2022-12-25	WOS:000317565000058
J	Ozaki, T; Nishiyama, M; Kuzuyama, T				Ozaki, Taro; Nishiyama, Makoto; Kuzuyama, Tomohisa			Novel Tryptophan Metabolism by a Potential Gene Cluster That Is Widely Distributed among Actinomycetes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FLAVIN-CONTAINING MONOOXYGENASE; COMPLETE GENOME SEQUENCE; NATURAL-PRODUCT; STREPTOMYCES; IDENTIFICATION; BIOSYNTHESIS; CONVERSION; DISCOVERY; OXIME	The characterization of potential gene clusters is a promising strategy for the identification of novel natural products and the expansion of structural diversity. However, there are often difficulties in identifying potential metabolites because their biosynthetic genes are either silenced or expressed only at a low level. Here, we report the identification of a novel metabolite that is synthesized by a potential gene cluster containing an indole prenyltransferase gene (SCO7467) and a flavin-dependent monooxygenase (FMO) gene (SCO7468), which were mined from the genome of Streptomyces coelicolor A3(2). We introduced these two genes into the closely related Streptomyces lividans TK23 and analyzed the culture broths of the transformants. This process allowed us to identify a novel metabolite, 5-dimethylallylindole-3-acetonitrile (5-DMAIAN) that was overproduced in the transformant. Biochemical characterization of the recombinant SCO7467 and SCO7468 demonstrated the novel L-tryptophan metabolism leading to 5-DMAIAN. SCO7467 catalyzes the prenylation of L-tryptophan to form 5-dimethylallyl-L-tryptophan (5-DMAT). This enzyme is the first actinomycetes prenyltransferase known to catalyze the addition of a dimethylallyl group to the C-5 of tryptophan. SCO7468 then catalyzes the conversion of 5-DMAT into 5-dimethylallylindole-3-acetaldoxime (5-DMAIAOx). An aldoxime-forming reaction catalyzed by the FMO enzyme was also identified for the first time in this study. Finally, dehydration of 5-DMAIAOx presumably occurs to yield 5-DMAIAN. This study provides insight into the biosynthesis of prenylated indoles that have been purified from actinomycetes.	[Ozaki, Taro; Nishiyama, Makoto; Kuzuyama, Tomohisa] Univ Tokyo, Biotechnol Res Ctr, Bunkyo Ku, Tokyo 1138657, Japan	University of Tokyo	Kuzuyama, T (corresponding author), Univ Tokyo, Biotechnol Res Ctr, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1138657, Japan.	utkuz@mail.ecc.u-tokyo.ac.jp	OZAKI, Taro/F-1614-2016	OZAKI, Taro/0000-0002-4673-4478; Nishiyama, Makoto/0000-0001-8143-8052; Kuzuyama, Tomohisa/0000-0002-7221-5858	Japan Society for the Promotion of Science through the "Funding Program for Next Generation World Leading Researchers (NEXT Program)" [LS028];  [22-3411]	Japan Society for the Promotion of Science through the "Funding Program for Next Generation World Leading Researchers (NEXT Program)"(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); 	This work was supported by the Japan Society for the Promotion of Science through the "Funding Program for Next Generation World Leading Researchers (NEXT Program)" Grant LS028 (to T. K.), which was initiated by the Council for Science and Technology Policy.; Supported by Grant-in-aid 22-3411 for Japan Society for the Promotion of Science Fellows.	AHMAD A, 1974, B CHEM SOC JPN, V47, P1819, DOI 10.1246/bcsj.47.1819; Bentley SD, 2002, NATURE, V417, P141, DOI 10.1038/417141a; Bergmann S, 2007, NAT CHEM BIOL, V3, P213, DOI 10.1038/nchembio869; Clardy J, 2004, NATURE, V432, P829, DOI 10.1038/nature03194; DAIRI T, 1995, BIOSCI BIOTECH BIOCH, V59, P1835, DOI 10.1271/bbb.59.1835; Hull AK, 2000, P NATL ACAD SCI USA, V97, P2379, DOI 10.1073/pnas.040569997; Ikeda H, 2003, NAT BIOTECHNOL, V21, P526, DOI 10.1038/nbt820; Isogai S, 2012, BIOORG MED CHEM LETT, V22, P5823, DOI 10.1016/j.bmcl.2012.07.084; Jez JM, 2000, BIOCHEMISTRY-US, V39, P890, DOI 10.1021/bi991489f; Kawase Y, 2009, HETEROCYCLES, V78, P463, DOI 10.3987/COM-08-11532; Kieser T., 2000, PRACTICAL STREPTOMYC, V4362; Komatsu M, 2003, GENE, V306, P79, DOI 10.1016/S0378-1119(03)00405-0; Komatsu M, 2006, MOL MICROBIOL, V62, P1534, DOI 10.1111/j.1365-2958.2006.05461.x; Komatsua M, 2010, P NATL ACAD SCI USA, V107, P2646, DOI 10.1073/pnas.0914833107; Lautru S, 2005, NAT CHEM BIOL, V1, P265, DOI 10.1038/nchembio731; Lin J, 1997, J PHARMACOL EXP THER, V282, P1269; Lopez JMS, 2003, J NAT PROD, V66, P863, DOI 10.1021/np0204444; Mikkelsen MD, 2000, J BIOL CHEM, V275, P33712, DOI 10.1074/jbc.M001667200; Motohashi K, 2008, J ANTIBIOT, V61, P75, DOI 10.1038/ja.2008.113; Newman DJ, 2007, J NAT PROD, V70, P461, DOI 10.1021/np068054v; Ohnishi Y, 2008, J BACTERIOL, V190, P4050, DOI 10.1128/JB.00204-08; Ortiz-Castro R, 2011, P NATL ACAD SCI USA, V108, P7253, DOI 10.1073/pnas.1006740108; Ozaki T, 2009, J ANTIBIOT, V62, P385, DOI 10.1038/ja.2009.48; POULSEN LL, 1986, MOL PHARMACOL, V30, P680; Sambrook J, 2001, MOL CLONING LAB MANU; Sasaki T, 2002, J ANTIBIOT, V55, P1009, DOI 10.7164/antibiotics.55.1009; SIBBESEN O, 1995, J BIOL CHEM, V270, P3506, DOI 10.1074/jbc.270.8.3506; Takahashi S, 2010, J BACTERIOL, V192, P2839, DOI 10.1128/JB.01557-09; Takano H, 2011, GENE, V477, P12, DOI 10.1016/j.gene.2011.01.005; Wilkinson B, 2007, NAT CHEM BIOL, V3, P379, DOI 10.1038/nchembio.2007.7; Yu X, 2012, J BIOL CHEM, V287, P1371, DOI 10.1074/jbc.M111.317982	31	27	28	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 5	2013	288	14					9946	9956		10.1074/jbc.M112.436451	http://dx.doi.org/10.1074/jbc.M112.436451			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	119RB	23430264	Green Published, hybrid			2022-12-25	WOS:000317114000034
J	Chen, JJ; Rosas, HD; Salat, DH				Chen, J. Jean; Rosas, H. Diana; Salat, David H.			The Relationship between Cortical Blood Flow and Sub-Cortical White-Matter Health across the Adult Age Span	PLOS ONE			English	Article							MILD COGNITIVE IMPAIRMENT; VASCULAR RISK-FACTORS; DIFFUSION TENSOR; ALZHEIMERS-DISEASE; NEUROVASCULAR MECHANISMS; CEREBRAL PERFUSION; CORPUS-CALLOSUM; OLDER-ADULTS; RANDOM-FIELD; INTEGRITY	Degeneration of cerebral white matter is commonly observed in aging, and the associated degradation in neural connectivity contributes to cognitive decline in older adults. Vascular dysfunction has been implicated as a potential mechanism for general age-related neural tissue deterioration; however, no prior study has examined the direct relationship between cortical vascular health and subcortical white-matter integrity. In this work, we aimed to determine whether blood supply to the brain is associated with microstructural integrity of connective tissue, and whether such associations are regionally specific and mainly accounted for by aging. We examined the association between cerebral blood flow (CBF) in the cortical mantle, measured using arterial spin labeling (ASL), and subcortical white-matter integrity, measured using diffusion tensor imaging (DTI), in a group of healthy adults spanning early to late adulthood. We found cortical CBF to be significantly associated with white-matter integrity throughout the brain. In addition, these associations were only partially tied to aging, as they remained even when statistically controlling for age, and when restricting the analyses to a young subset of the sample. Furthermore, vascular risk was not a prominent determinant of these effects. These findings suggest that the overall blood supply to the brain is an important indicator of white-matter health in the normal range of variations amongst adults, and that the decline in CBF with advancing age may potentially exacerbate deterioration of the connective anatomy of the brain.	[Chen, J. Jean] Univ Toronto, Rotman Res Inst, Baycrest Ctr Geriatr Care, Toronto, ON, Canada; [Chen, J. Jean; Rosas, H. Diana; Salat, David H.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Athinoula A Martinos Ctr Biomed Imaging, Boston, MA USA; [Chen, J. Jean; Salat, David H.] Harvard Univ, Sch Med, Dept Radiol, Massachusetts Gen Hosp, Boston, MA 02115 USA; [Rosas, H. Diana] Harvard Univ, Sch Med, Dept Neurol, Massachusetts Gen Hosp, Boston, MA 02115 USA; [Salat, David H.] VA Boston Healthcare Syst, Neuroimaging Res Vet Ctr, Boston, MA USA	University of Toronto; University Toronto Affiliates; Baycrest; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System	Chen, JJ (corresponding author), Univ Toronto, Rotman Res Inst, Baycrest Ctr Geriatr Care, Toronto, ON, Canada.	jchen@rotman-baycrest.on.ca	Chen, Jean/A-2846-2013	Chen, Jean/0000-0001-5469-7542	National Institutes of Health [R01NR010827, NS042861, P41RR14075]; Canadian Institutes of Health Research; Athinoula A. Martinos Center for Biomedical Imaging; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR014075] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS042861] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NURSING RESEARCH [R01NR010827] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Athinoula A. Martinos Center for Biomedical Imaging; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NURSING RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR))	This research was supported by National Institutes of Health grants R01NR010827, NS042861, and P41RR14075, as well as by fellowship funding from the Canadian Institutes of Health Research (to JJC) and the Athinoula A. Martinos Center for Biomedical Imaging. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe O, 2010, NMR BIOMED, V23, P446, DOI 10.1002/nbm.1479; Aslan S, 2011, NEUROIMAGE, V56, P1145, DOI 10.1016/j.neuroimage.2011.02.082; Avants BB, 2010, NEUROIMAGE, V50, P1004, DOI 10.1016/j.neuroimage.2010.01.041; Barodka VM, 2011, ANESTH ANALG, V112, P1048, DOI 10.1213/ANE.0b013e3182147e3c; Bastin ME, 2010, NEUROIMAGE, V51, P1, DOI 10.1016/j.neuroimage.2010.02.036; Bell RD, 2009, ACTA NEUROPATHOL, V118, P103, DOI 10.1007/s00401-009-0522-3; Bosch B, 2012, NEUROBIOL AGING, V33, P61, DOI 10.1016/j.neurobiolaging.2010.02.004; Brown WR, 2007, J NEUROL SCI, V257, P62, DOI 10.1016/j.jns.2007.01.015; Brown WR, 2002, J NEUROL SCI, V203, P159, DOI 10.1016/S0022-510X(02)00283-6; Buckner RL, 2005, J NEUROSCI, V25, P7709, DOI 10.1523/JNEUROSCI.2177-05.2005; Bullmore ET, 1999, IEEE T MED IMAGING, V18, P32, DOI 10.1109/42.750253; Buxton RB, 1998, MAGNET RESON MED, V40, P383, DOI 10.1002/mrm.1910400308; Caroli A, 2007, J NEUROL, V254, P1698, DOI 10.1007/s00415-007-0631-7; Cavusoglu M, 2009, MAGN RESON IMAGING, V27, P1039, DOI 10.1016/j.mri.2009.04.002; Chen JJ, 2012, NEUROIMAGE, V59, P1043, DOI 10.1016/j.neuroimage.2011.08.112; Chen JJ, 2011, NEUROIMAGE, V55, P468, DOI 10.1016/j.neuroimage.2010.12.032; Cohen ER, 2002, J CEREBR BLOOD F MET, V22, P1042, DOI 10.1097/00004647-200209000-00002; D'Esposito M, 2003, NAT REV NEUROSCI, V4, P863, DOI 10.1038/nrn1246; Davis SW, 2009, NEUROIMAGE, V46, P530, DOI 10.1016/j.neuroimage.2009.01.068; de la Torre JC, 2005, ANN NEUROL, V57, P783, DOI 10.1002/ana.20516; de Laat KF, 2011, BRAIN, V134, P73, DOI 10.1093/brain/awq343; Deary IJ, 2006, NEUROLOGY, V66, P505, DOI 10.1212/01.wnl.0000199954.81900.e2; Dickstein DL, 2010, MT SINAI J MED, V77, P82, DOI 10.1002/msj.20155; DUVERNOY HM, 1981, BRAIN RES BULL, V7, P519, DOI 10.1016/0361-9230(81)90007-1; Fischl B, 1999, HUM BRAIN MAPP, V8, P272, DOI 10.1002/(SICI)1097-0193(1999)8:4<272::AID-HBM10>3.0.CO;2-4; Fischl B, 2000, P NATL ACAD SCI USA, V97, P11050, DOI 10.1073/pnas.200033797; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Franc DT, 2011, DIABETES, V60, P315, DOI 10.2337/db10-0598; Gouw AA, 2008, BRAIN, V131, P3286, DOI 10.1093/brain/awn265; Greve DN, 2009, NEUROIMAGE, V48, P63, DOI 10.1016/j.neuroimage.2009.06.060; Hayasaka S, 2003, NEUROIMAGE, V20, P2343, DOI 10.1016/j.neuroimage.2003.08.003; Helzner EP, 2009, ARCH NEUROL-CHICAGO, V66, P343, DOI 10.1001/archneur.66.3.343; Henskens LH, 2009, J HYPERTENS, V27, P846, DOI 10.1097/HJH.0b013e3283232c96; Hofer S, 2006, NEUROIMAGE, V32, P989, DOI 10.1016/j.neuroimage.2006.05.044; HUGHES CCW, 1987, J NEUROL SCI, V79, P101, DOI 10.1016/0022-510X(87)90264-4; Jacobs HIL, 2013, HUM BRAIN MAPP, V34, P77, DOI 10.1002/hbm.21412; Jeerakathil T, 2004, STROKE, V35, P1857, DOI 10.1161/01.STR.0000135226.53499.85; Kakou M, 1998, NEUROCHIRURGIE, V44, P31; Kantarci K, 2003, NEUROIMAG CLIN N AM, V13, P197, DOI 10.1016/S1052-5149(03)00025-X; Kennedy KM, 2009, BRAIN RES, V1297, P41, DOI 10.1016/j.brainres.2009.08.058; KERTESZ A, 1990, ARCH NEUROL-CHICAGO, V47, P387, DOI 10.1001/archneur.1990.00530040029015; Keymel S, 2011, AM J CARDIOVASC DIS, V1, P68; Klawiter EC, 2011, NEUROIMAGE, V55, P1454, DOI 10.1016/j.neuroimage.2011.01.007; KOBARI M, 1990, AM J NEURORADIOL, V11, P273; Korf ESC, 2005, DEMENT GERIATR COGN, V20, P331, DOI 10.1159/000088464; Lebel C, 2012, NEUROIMAGE, V60, P340, DOI 10.1016/j.neuroimage.2011.11.094; Leoni RF, 2011, NEUROIMAGE, V58, P75, DOI 10.1016/j.neuroimage.2011.06.030; Leritz EC, 2011, NEUROIMAGE, V54, P2659, DOI 10.1016/j.neuroimage.2010.10.050; Leritz EC, 2010, NEUROPSYCHOLOGY, V24, P199, DOI 10.1037/a0018108; Lu HZ, 2006, MAGN RESON MED, V56, P546, DOI 10.1002/mrm.20976; Madden DJ, 2012, BBA-MOL BASIS DIS, V1822, P386, DOI 10.1016/j.bbadis.2011.08.003; MATSUSHITA K, 1994, HYPERTENSION, V23, P565, DOI 10.1161/01.HYP.23.5.565; Ni JM, 2010, EUR J RADIOL, V75, P134, DOI 10.1016/j.ejrad.2009.04.028; O'Sullivan M, 2002, NEUROLOGY, V59, P321, DOI 10.1212/WNL.59.3.321; O'Sullivan M, 2001, NEUROLOGY, V57, P632, DOI 10.1212/WNL.57.4.632; Pfefferbaum A, 2005, NEUROIMAGE, V26, P891, DOI 10.1016/j.neuroimage.2005.02.034; Pierpaoli C, 2001, NEUROIMAGE, V13, P1174, DOI 10.1006/nimg.2001.0765; Reese TG, 2003, MAGN RESON MED, V49, P177, DOI 10.1002/mrm.10308; Reshef S, 2011, J GERONTOL A-BIOL, V66, P74, DOI 10.1093/gerona/glq166; Rosso C, 2011, NEURORADIOLOGY, V53, P763, DOI 10.1007/s00234-011-0916-5; Ruitenberg A, 2005, ANN NEUROL, V57, P789, DOI 10.1002/ana.20493; Sachdev PS, 1999, MED J AUSTRALIA, V170, P81, DOI 10.5694/j.1326-5377.1999.tb126889.x; Salat DH, 2010, NEUROBIOL AGING, V31, P244, DOI 10.1016/j.neurobiolaging.2008.03.013; Salat DH, 2006, STROKE, V37, P1759, DOI 10.1161/01.STR.0000227328.86353.a7; Salat DH, 2012, NEUROIMAGE, V59, P181, DOI 10.1016/j.neuroimage.2011.07.033; Salat DH, 2009, NEUROIMAGE, V44, P1247, DOI 10.1016/j.neuroimage.2008.10.030; Salat DH, 2005, ANN NY ACAD SCI, V1064, P37, DOI 10.1196/annals.1340.009; Salat DH, 2005, NEUROBIOL AGING, V26, P1215, DOI 10.1016/j.neurobiolaging.2004.09.017; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Song SK, 2005, NEUROIMAGE, V26, P132, DOI 10.1016/j.neuroimage.2005.01.028; Sullivan EV, 2003, EUR J RADIOL, V45, P244, DOI 10.1016/S0720-048X(02)00313-3; Sydykova D, 2007, CEREB CORTEX, V17, P2276, DOI 10.1093/cercor/bhl136; Tarumi T, 2011, AM J HYPERTENS, V24, P1108, DOI 10.1038/ajh.2011.101; TELL GS, 1994, HYPERTENSION, V23, P59, DOI 10.1161/01.HYP.23.1.59; van Beek AHEA, 2008, J CEREBR BLOOD F MET, V28, P1071, DOI 10.1038/jcbfm.2008.13; van der Kouwe AJW, 2008, NEUROIMAGE, V40, P559, DOI 10.1016/j.neuroimage.2007.12.025; van Elderen SGC, 2011, DIABETES CARE, V34, P459, DOI 10.2337/dc10-1446; van Norden AGW, 2008, NEUROLOGY, V71, P1152, DOI 10.1212/01.wnl.0000327564.44819.49; Wang JJ, 2002, MAGN RESON MED, V48, P242, DOI 10.1002/mrm.10211; Wang L, 2009, AM J NEURORADIOL, V30, P893, DOI 10.3174/ajnr.A1484; Westlye LT, 2010, CEREB CORTEX, V20, P2055, DOI 10.1093/cercor/bhp280; Wong EC, 1998, MAGNET RESON MED, V39, P702, DOI 10.1002/mrm.1910390506; Worsley KJ, 2004, NEUROIMAGE, V23, pS189, DOI 10.1016/j.neuroimage.2004.07.026; Zhuang L, 2010, NEUROIMAGE, V53, P16, DOI 10.1016/j.neuroimage.2010.05.068; Zlokovic BV, 2005, TRENDS NEUROSCI, V28, P202, DOI 10.1016/j.tins.2005.02.001	85	29	31	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2013	8	2							e56733	10.1371/journal.pone.0056733	http://dx.doi.org/10.1371/journal.pone.0056733			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IT	23437228	Green Published, Green Submitted, gold			2022-12-25	WOS:000315186000042
J	Delaney, C; Garg, SK; Fernandes, C; Hoeltzel, M; Allen, RH; Stabler, S; Yung, R				Delaney, Colin; Garg, Sanjay K.; Fernandes, Chris; Hoeltzel, Mark; Allen, Robert H.; Stabler, Sally; Yung, Raymond			Maternal Diet Supplemented with Methyl-Donors Protects against Atherosclerosis in F1 ApoE(-/-) Mice	PLOS ONE			English	Article							DNA METHYLATION; EPIGENETIC MODIFICATION; CARDIOVASCULAR-DISEASE; LIVER; GENE; DEFICIENCY; EXPRESSION; SERUM; INFLAMMATION; CHOLESTEROL	Atherosclerosis is an inflammatory condition of the arterial wall mediated by cells of both innate and adaptive immunity. T lymphocytes play an important role in orchestrating the pathogenic immune response involved in the acceleration of atherosclerosis. Previously, we have shown that a prenatal methyl-donor supplementation diet (MS), when fed to dams during pregnancy and lactation, decreased the T cell-mediated pro-inflammatory cytokine and chemokine response in F1 mice. In the current study, we report feeding Apolipoprotein E (ApoE(-/-)) deficient dams with the MS diet during pregnancy reduces atherosclerotic plaques in F1 mice that were fed high fat diet (HFD) after weaning. F1 mice from dams on the MS diet exhibited increased global T cell DNA methylation. T-cell chemokines and their receptors (in particular CCR2, CCR5, and CXCR3) play important roles in the inflammatory cell recruitment to vascular lesions. MS diet significantly reduced Ccr2 mRNA and protein expression in CD3+ T cells but not in CD11b+ monocytes in MS F1 mice relative to controls. F1 litter size, HFD consumption, body weight, and body fat were similar between control and MS diet groups. Moreover, serum thiol metabolite levels were similar between the two groups. However, MS diet is associated with significantly higher serum HDL and lower LDL+VLDL levels in comparison to F1 mice from dams on the control diet. Inflammatory cytokines (IL-17, TNF-alpha, IL-6) were also lower in MS F1 mice serum and conditioned media from T-cell culture. Altogether, these data suggest that the MS diet ameliorates development of atherosclerosis by inhibiting the T-cell Ccr2 expression, reducing inflammatory cytokines production and increasing serum HDL:LDL ratio.	[Delaney, Colin; Garg, Sanjay K.; Fernandes, Chris; Yung, Raymond] Univ Michigan, Sch Med, Dept Internal Med, Ann Arbor, MI 48109 USA; [Hoeltzel, Mark] Childrens Mercy Hosp & Clin, Dept Pediat, Kansas City, MO USA; [Allen, Robert H.; Stabler, Sally] Univ Colorado, Sch Med, Aurora, CO USA	University of Michigan System; University of Michigan; Children's Mercy Hospital; University of Colorado System; University of Colorado Anschutz Medical Campus	Yung, R (corresponding author), Univ Michigan, Sch Med, Dept Internal Med, Ann Arbor, MI 48109 USA.	ryung@umich.edu		Delaney, Colin E/0000-0001-6880-6973	National Institutes of Health National Institute on Aging [AG020628, AG028268, AG013283, AG024824]; National Institute of Environmental Health Sciences [ES017885]; Michigan Diabetes Research and Training Center; VA Ann Arbor Geriatrics Research, Education and Clinical Care Center (GRECC); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES017885] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG020628, P30AG024824, R56AG020628, R01AG028268, P30AG013283] Funding Source: NIH RePORTER	National Institutes of Health National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Michigan Diabetes Research and Training Center; VA Ann Arbor Geriatrics Research, Education and Clinical Care Center (GRECC); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The work was supported by National Institutes of Health National Institute on Aging (AG020628, AG028268, AG013283, AG024824), National Institute of Environmental Health Sciences (ES017885), Michigan Diabetes Research and Training Center, VA Ann Arbor Geriatrics Research, Education and Clinical Care Center (GRECC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEN RH, 1993, METABOLISM, V42, P1448, DOI 10.1016/0026-0495(93)90198-W; Ballestar E, 2006, J IMMUNOL, V176, P7143, DOI 10.4049/jimmunol.176.12.7143; Boring L, 1998, NATURE, V394, P894, DOI 10.1038/29788; Branen L, 2004, ARTERIOSCL THROM VAS, V24, P2137, DOI 10.1161/01.ATV.0000143933.20616.1b; Brooks WH, 2010, J AUTOIMMUN, V34, pJ207, DOI 10.1016/j.jaut.2009.12.006; Caligiuri G, 2003, MOL MED, V9, P10, DOI 10.1007/BF03402102; Castro R, 2003, CLIN CHEM, V49, P1292, DOI 10.1373/49.8.1292; Cropley JE, 2006, P NATL ACAD SCI USA, V103, P17308, DOI 10.1073/pnas.0607090103; Davenport P, 2003, AM J PATHOL, V163, P1117, DOI 10.1016/S0002-9440(10)63471-2; Delaney C, 2012, J NUTR, V142, P1329, DOI 10.3945/jn.111.155903; Erbel C, 2009, J IMMUNOL, V183, P8167, DOI 10.4049/jimmunol.0901126; Fausto N, 2006, HEPATOLOGY, V43, pS45, DOI 10.1002/hep.20969; Feingold KR, 1998, ATHEROSCLEROSIS, V139, P307, DOI 10.1016/S0021-9150(98)00084-7; Forsen T, 1997, BRIT MED J, V315, P837, DOI 10.1136/bmj.315.7112.837; Fraga MF, 2005, P NATL ACAD SCI USA, V102, P10604, DOI 10.1073/pnas.0500398102; Garg S, 2006, J BIOL CHEM, V281, P38712, DOI 10.1074/jbc.M606235200; HANSSON GK, 1988, CIRC RES, V63, P712, DOI 10.1161/01.RES.63.4.712; Hoekstra M, 2005, J HEPATOL, V42, P400, DOI 10.1016/j.jhep.2004.11.032; Hollingsworth JW, 2008, J CLIN INVEST, V118, P3462, DOI 10.1172/JCI34378; Jones PA, 2007, CELL, V128, P683, DOI 10.1016/j.cell.2007.01.029; Khateeb J, 2010, ATHEROSCLEROSIS, V208, P119, DOI 10.1016/j.atherosclerosis.2009.08.051; Kim J, 2007, BBA-MOL BASIS DIS, V1772, P72, DOI 10.1016/j.bbadis.2006.10.004; Kim M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009692; Kleemann R, 2008, CARDIOVASC RES, V79, P360, DOI 10.1093/cvr/cvn120; Leddy Meaghan A, 2008, Rev Obstet Gynecol, V1, P170; Libby P, 2000, BBA-MOL CELL BIOL L, V1529, P299, DOI 10.1016/S1388-1981(00)00161-X; Lillycrop KA, 2005, J NUTR, V135, P1382, DOI 10.1093/jn/135.6.1382; Ludwig DS, 2007, NEW ENGL J MED, V357, P2325, DOI 10.1056/NEJMp0706538; Lund G, 2004, J BIOL CHEM, V279, P29147, DOI 10.1074/jbc.M403618200; Mercier FE, 2012, NAT REV IMMUNOL, V12, P49, DOI 10.1038/nri3132; Merhi-Soussi F, 2005, CARDIOVASC RES, V66, P583, DOI 10.1016/j.cardiores.2005.01.008; Michalopoulos GK, 2007, J CELL PHYSIOL, V213, P286, DOI 10.1002/jcp.21172; Moghadasian MH, 2001, FASEB J, V15, P2623, DOI 10.1096/fj.01-0463com; Morgan HD, 1999, NAT GENET, V23, P314, DOI 10.1038/15490; Ohta H, 2005, ATHEROSCLEROSIS, V180, P11, DOI 10.1016/j.atherosclerosis.2004.11.016; ONO T, 1989, MUTAT RES, V219, P39, DOI 10.1016/0921-8734(89)90039-8; Portela A, 2010, NAT BIOTECHNOL, V28, P1057, DOI 10.1038/nbt.1685; Richardson BC, 2002, J NUTR, V132, p2401S, DOI 10.1093/jn/132.8.2401S; Ridker PM, 1997, NEW ENGL J MED, V336, P973, DOI 10.1056/NEJM199704033361401; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Schaible TD, 2011, HUM MOL GENET, V20, P1687, DOI 10.1093/hmg/ddr044; STABLER SP, 1993, BLOOD, V81, P3404; Suarez-Alvarez B, 2012, TRENDS GENET; Turunen MP, 2009, BBA-GEN SUBJECTS, V1790, P886, DOI 10.1016/j.bbagen.2009.02.008; van Dam RM, 2006, ANN INTERN MED, V145, P91, DOI 10.7326/0003-4819-145-2-200607180-00006; Waterland RA, 2007, FASEB J, V21, P3380, DOI 10.1096/fj.07-8229com; Zhang DQ, 2009, CIRCULATION, V120, P1893, DOI 10.1161/CIRCULATIONAHA.109.866889	47	20	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2013	8	2							e56253	10.1371/journal.pone.0056253	http://dx.doi.org/10.1371/journal.pone.0056253			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IT	23437105	gold, Green Published, Green Submitted			2022-12-25	WOS:000315186000021
J	Faheem, M; Rehman, MT; Danishuddin, M; Khan, AU				Faheem, Mohammad; Rehman, Md Tabish; Danishuddin, Mohd; Khan, Asad U.			Biochemical Characterization of CTX-M-15 from Enterobacter cloacae and Designing a Novel Non-beta-Lactam-beta-Lactamase Inhibitor	PLOS ONE			English	Article							ESCHERICHIA-COLI; DRUG-RESISTANCE; TEM-1; CLAVULANATE; HYPERPRODUCTION; SUSCEPTIBILITY; IDENTIFICATION; EPIDEMIOLOGY; CEFOTAXIMASE; CEFTAZIDIME	The worldwide dissemination of CTX-M type beta-lactamases is a threat to human health. Previously, we have reported the spread of bla(CTX-M-15) gene in different clinical strains of Enterobacteriaceae from the hospital settings of Aligarh in north India. In view of the varying resistance pattern against cephalosporins and other beta-lactam antibiotics, we intended to understand the correlation between MICs and catalytic activity of CTX-M-15. In this study, steady-state kinetic parameters and MICs were determined on E. coli DH5 alpha transformed with bla(CTX-M-15) gene that was cloned from Enterobacter cloacae (EC-15) strain of clinical background. The effect of conventional beta-lactamase inhibitors (clavulanic acid, sulbactam and tazobactam) on CTX-M-15 was also studied. We have found that tazobactam is the best among these inhibitors against CTX-M-15. The inhibition characteristic of tazobactam is defined by its very low IC50 value (6 nM), high affinity (K-i = 0.017 mu M) and better acylation efficiency (k(+2)/K' = 0.44 mu M-1 s(-1)). It forms an acyl-enzyme covalent complex, which is quite stable (k(+3) = 0.0057 s(-1)). Since increasing resistance has been reported against conventional b-lactam antibiotic-inhibitor combinations, we aspire to design a non-beta-lactam core containing beta-lactamase inhibitor. For this, we screened ZINC database and performed molecular docking to identify a potential non-beta-lactam based inhibitor (ZINC03787097). The MICs of cephalosporin antibiotics in combination with this inhibitor gave promising results. Steady-state kinetics and molecular docking studies showed that ZINC03787097 is a reversible inhibitor which binds non-covalently to the active site of the enzyme through hydrogen bonds and hydrophobic interactions. Though, it's IC50 (180 nM) is much higher than tazobactam, it has good affinity for CTX-M-15 (K-i = 0.388 mu M). This study concludes that ZINC03787097 compound can be used as seed molecule to design more efficient non-b-lactam containing b-lactamase inhibitor that could evade pre-existing bacterial resistance mechanisms.	[Faheem, Mohammad; Rehman, Md Tabish; Danishuddin, Mohd; Khan, Asad U.] Aligarh Muslim Univ, Interdisciplinary Biotechnol Unit, Med Microbiol & Mol Biol Lab, Aligarh, Uttar Pradesh, India	Aligarh Muslim University	Khan, AU (corresponding author), Aligarh Muslim Univ, Interdisciplinary Biotechnol Unit, Med Microbiol & Mol Biol Lab, Aligarh, Uttar Pradesh, India.	asad.k@rediffmail.com	REHMAN, TABISH/H-8471-2012; Rehman, Md Tabish/AAC-8512-2019; Khan, Asad U/K-8157-2013	REHMAN, TABISH/0000-0003-2341-900X; Rehman, Md Tabish/0000-0003-2341-900X; Khan, Asad U/0000-0001-9191-9423	Department of Biotechnology, Government of India [BT/PR12553/BID/07/296/2009]	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India)	This work was funded by Department of Biotechnology, Government of India grant no. BT/PR12553/BID/07/296/2009. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMBLER RP, 1991, BIOCHEM J, V276, P269, DOI 10.1042/bj2760269; BAUERNFEIND A, 1992, INFECTION, V20, P158, DOI 10.1007/BF01704610; BENNETT PM, 1993, ANTIMICROB AGENTS CH, V37, P153, DOI 10.1128/AAC.37.2.153; Bethel CR, 2011, ANTIMICROB AGENTS CH, V55, P3465, DOI 10.1128/AAC.00089-11; Bonnet R, 2003, J ANTIMICROB CHEMOTH, V52, P29, DOI 10.1093/jac/dkg256; Bonnet R, 2000, ANTIMICROB AGENTS CH, V44, P1936, DOI 10.1128/AAC.44.7.1936-1942.2000; Bonnet R, 2001, ANTIMICROB AGENTS CH, V45, P2269, DOI 10.1128/AAC.45.8.2269-2275.2001; Bonnet R, 2004, ANTIMICROB AGENTS CH, V48, P1, DOI 10.1128/AAC.48.1.1-14.2004; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; BUSH K, 1995, ANTIMICROB AGENTS CH, V39, P1211, DOI 10.1128/AAC.39.6.1211; Bush K, 1999, CURR PHARM DESIGN, V5, P839; Bush K, 2010, CURR OPIN MICROBIOL, V13, P558, DOI 10.1016/j.mib.2010.09.006; Bush K, 2010, CRIT CARE, V14, DOI 10.1186/cc8892; Celenza G, 2008, J ANTIMICROB CHEMOTH, V62, P991, DOI 10.1093/jac/dkn339; Chambers HF, 1999, J INFECT DIS, V179, pS353, DOI 10.1086/513854; Clinical and Laboratory Standards Institute, 2011, M100S21 CLSI; Coque TM, 2008, EURO SURVEILL, V13; Cosgrove SE, 2003, CLIN INFECT DIS, V36, P1433, DOI 10.1086/375081; Djamdjian L, 2011, ANTIMICROB AGENTS CH, V55, P1861, DOI 10.1128/AAC.01656-10; Drawz SM, 2010, CLIN MICROBIOL REV, V23, P160, DOI 10.1128/CMR.00037-09; Essack SY, 2001, PHARM RES-DORDR, V18, P1391, DOI 10.1023/A:1012272403776; GALLENI M, 1994, ANTIMICROB AGENTS CH, V38, P1608, DOI 10.1128/AAC.38.7.1608; Gniadkowski M, 1998, ANTIMICROB AGENTS CH, V42, P827, DOI 10.1128/AAC.42.4.827; Hanson ND, 1999, CURR PHARM DESIGN, V5, P881; Hasan S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040319; Hawkey PM, 2009, J ANTIMICROB CHEMOTH, V64, P3, DOI 10.1093/jac/dkp256; Irwin JJ, 2005, J CHEM INF MODEL, V45, P177, DOI 10.1021/ci049714+; ISHII Y, 1995, ANTIMICROB AGENTS CH, V39, P2269, DOI 10.1128/AAC.39.10.2269; JONES G, 1995, J MOL BIOL, V245, P43, DOI 10.1016/S0022-2836(95)80037-9; Perez-Llarena FJ, 2011, ANTIMICROB AGENTS CH, V55, P4361, DOI 10.1128/AAC.00298-11; Karim A, 2001, FEMS MICROBIOL LETT, V201, P237, DOI 10.1016/S0378-1097(01)00276-2; Li XZ, 2004, DRUGS, V64, P159, DOI 10.2165/00003495-200464020-00004; Li XZ, 2004, ANTIMICROB AGENTS CH, V48, P2415, DOI 10.1128/AAC.48.7.2415-2423.2004; MARTINEZ JL, 1989, ANTIMICROB AGENTS CH, V33, P595, DOI 10.1128/AAC.33.4.595-a; MARTINEZ JL, 1987, LANCET, V2, P1473; MATAGNE A, 1993, BIOCHEM J, V295, P705, DOI 10.1042/bj2950705; Meroueh SO, 2002, J AM CHEM SOC, V124, P9422, DOI 10.1021/ja026547q; Naas T, 2007, ANTIMICROB AGENTS CH, V51, P223, DOI 10.1128/AAC.00611-06; Paterson DL, 2005, CLIN MICROBIOL REV, V18, P657, DOI 10.1128/CMR.18.4.657-686.2005; Poirel L, 2002, J ANTIMICROB CHEMOTH, V50, P1031, DOI 10.1093/jac/dkf240; Power RA, 2002, STRUCTURE, V10, P1012; Powers RA, 1999, PROTEIN SCI, V8, P2330; Rehman MT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017159; Rice LB, 2000, DRUG RESIST UPDATE, V3, P178, DOI 10.1054/drup.2000.0144; SANDERS CC, 1988, ANTIMICROB AGENTS CH, V32, P1365, DOI 10.1128/AAC.32.9.1365; Shakil S, 2010, J MED MICROBIOL, V59, P948, DOI 10.1099/jmm.0.020214-0; Shakil S, 2010, ANN CLIN MICROB ANTI, V9, DOI 10.1186/1476-0711-9-2; Stachyra T, 2010, ANTIMICROB AGENTS CH, V54, P5132, DOI 10.1128/AAC.00568-10; STRYNADKA NCJ, 1992, NATURE, V359, P700, DOI 10.1038/359700a0; Sun T, 2004, BIOCHEMISTRY-US, V43, P14111, DOI 10.1021/bi0487903; Thiolas A, 2004, BIOCHEM BIOPH RES CO, V317, P851, DOI 10.1016/j.bbrc.2004.03.130; Tondi D, 2005, J AM CHEM SOC, V127, P4632, DOI 10.1021/ja042984o; Vilar M, 2001, ANTIMICROB AGENTS CH, V45, P2215, DOI 10.1128/AAC.45.8.2215-2223.2001; Waley SG, 1992, CHEM BLACTAMS, P198; WILLIAMS H, 1988, LANCET, V1, P304; WU PJ, 1994, ANTIMICROB AGENTS CH, V38, P494, DOI 10.1128/AAC.38.3.494; Wu PJ, 1995, J ANTIMICROB CHEMOTH, V36, P927, DOI 10.1093/jac/36.6.927	57	48	49	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2013	8	2							e56926	10.1371/journal.pone.0056926	http://dx.doi.org/10.1371/journal.pone.0056926			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IT	23437273	gold, Green Submitted, Green Published			2022-12-25	WOS:000315186000057
J	Hemmatzadeh, F; Sumarningsih, S; Tarigan, S; Indriani, R; Dharmayanti, NLPI; Ebrahimie, E; Igniatovic, J				Hemmatzadeh, Farhid; Sumarningsih, Sumarningsih; Tarigan, Simson; Indriani, Risa; Dharmayanti, N. L. P. Indi; Ebrahimie, Esmaeil; Igniatovic, Jagoda			Recombinant M2e Protein-Based ELISA: A Novel and Inexpensive Approach for Differentiating Avian Influenza Infected Chickens from Vaccinated Ones	PLOS ONE			English	Article							LINKED-IMMUNOSORBENT-ASSAY; CONJUGATE VACCINES; ANIMALS STRATEGY; A VACCINE; VIRUS; DIVA; IMMUNOGENICITY; GENETICS; POULTRY; PEPTIDE	Available avian influenza (AIV) serological diagnostic tests cannot distinguish vaccinated from naturally infected birds. Differentiation of vaccinated from infected animals (DIVA) is currently advocated as a means of achieving the full control of H5N1. In this study, for the first time, recombinant ectodomain of M2 protein (M2e) of avian influenza virus (H5N1 strain) was used for the DIVA serology test. M2e was cloned into pMAL-P4X vector and expressed in E. coli cells. We used Western blot to recognize the expressed M2e-MBP protein by chicken antisera produced against live H5N1 virus. Also, the specificity of M2e-MBP protein was compared to the M2e synthetic peptide via ELISA. In M2e-MBP ELISA, all sera raised against the live avian influenza viruses were positive for M2e antibodies, whereas sera from killed virus vaccination were negative. Furthermore, M2e-MBP ELISA of the field sera obtained from vaccinated and non-vaccinated chickens showed negative results, while challenged vaccinated chickens demonstrated strong positive reactions. H5N1-originated recombinant M2e protein induced broad-spectrum response and successfully reacted with antibodies against other AIV strains such as H5N2, H9N2, H7N7, and H11N6. The application of the recombinant protein instead of synthetic peptide has the advantages of continues access to an inexpensive reagent for performing a large scale screening. Moreover, recombinant proteins provide the possibility of testing the DIVA results with an additional technique such a Western blotting which is not possible in the case of synthetic proteins. All together, the results of the present investigation show that recombinant M2e-MBP can be used as a robust and inexpensive solution for DIVA test.	[Hemmatzadeh, Farhid] Univ Adelaide, Sch Anim & Vet Sci, Adelaide, SA, Australia; [Sumarningsih, Sumarningsih; Igniatovic, Jagoda] Univ Melbourne, Sch Vet Sci, Melbourne, Vic, Australia; [Tarigan, Simson; Indriani, Risa; Dharmayanti, N. L. P. Indi] Indonesian Res Ctr Vet Sci, Bogor, Indonesia; [Ebrahimie, Esmaeil] Univ Adelaide, Res Ctr Infect Dis, Sch Mol & Biomed Sci, Adelaide, SA, Australia	University of Adelaide; University of Melbourne; University of Adelaide	Hemmatzadeh, F (corresponding author), Univ Adelaide, Sch Anim & Vet Sci, Adelaide, SA, Australia.	farhid.hemmatzadeh@adelaide.edu.au	Ebrahimi, Mansour/AAO-9096-2021; Ebrahimie, Esmaeil/AAN-2611-2020	Ebrahimi, Mansour/0000-0001-7011-2567; Ebrahimie, Esmaeil/0000-0002-4431-2861; Hemmatzadeh, Farhid/0000-0002-4572-8869	Australian Centre for International Agricultural Research (ACIAR) fund [AH/2006/050]	Australian Centre for International Agricultural Research (ACIAR) fund(Australian Ctr Intl Agr Res)	This work was supported by Australian Centre for International Agricultural Research (ACIAR) fund (project number AH/2006/050). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander DJ, 2007, VACCINE, V25, P5637, DOI 10.1016/j.vaccine.2006.10.051; Bouma A, 2008, REV SCI TECH OIE, V27, P633, DOI 10.20506/rst.27.3.1823; Bright RA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001501; Capua I, 2004, DEV BIOLOGICALS, V119, P229; Capua I., 2003, VVolume 114, P213; Capua I, 2003, AVIAN PATHOL, V32, P47, DOI 10.1080/0307945021000070714; Capua I, 2007, VACCINE, V25, P5645, DOI 10.1016/j.vaccine.2006.10.053; De Filette M, 2005, VIROLOGY, V337, P149, DOI 10.1016/j.virol.2005.04.004; De Filette M, 2008, VACCINE, V26, P6503, DOI 10.1016/j.vaccine.2008.09.038; Denis J, 2008, VACCINE, V26, P3395, DOI 10.1016/j.vaccine.2008.04.052; Fan JA, 2004, VACCINE, V22, P2993, DOI 10.1016/j.vaccine.2004.02.021; Fu TM, 2009, VACCINE, V27, P1440, DOI 10.1016/j.vaccine.2008.12.034; Greiner M, 1996, J IMMUNOL METHODS, V191, P93, DOI 10.1016/0022-1759(96)00013-0; GREINER M, 1995, J IMMUNOL METHODS, V185, P123, DOI 10.1016/0022-1759(95)00121-P; Huleatt JW, 2008, VACCINE, V26, P201, DOI 10.1016/j.vaccine.2007.10.062; Intharathep P, 2008, J MOL GRAPH MODEL, V27, P342, DOI 10.1016/j.jmgm.2008.06.002; Kim MC, 2010, CLIN VACCINE IMMUNOL, V17, P1977, DOI 10.1128/CVI.00191-10; Kitikoon P, 2009, VACCINE, V28, P523, DOI 10.1016/j.vaccine.2009.09.130; Kollerova E, 2007, Acta Virol, V51, P119; Kolocouris A, 2008, BIOORG MED CHEM LETT, V18, P6156, DOI 10.1016/j.bmcl.2008.10.003; LAMB RA, 1985, CELL, V40, P627, DOI 10.1016/0092-8674(85)90211-9; Lambrecht B, 2007, AVIAN DIS, V51, P221, DOI 10.1637/7589-040206R.1; Layton SL, 2009, POULTRY SCI, V88, P2244, DOI 10.3382/ps.2009-00251; Lee CW, 2004, VACCINE, V22, P3175, DOI 10.1016/j.vaccine.2004.01.055; Marangon S, 2004, DEV BIOLOGICALS, V119, P155; Mettenleiter T, 2009, REV SCI TECH OIE, V28, P15, DOI 10.20506/rst.28.1.1873; Pasick John, 2004, Animal Health Research Reviews, V5, P257, DOI 10.1079/AHR200479; Sambrook J, 2001, MOL CLONING LAB MANU; Steinhauer DA, 2002, ANNU REV GENET, V36, P305, DOI 10.1146/annurev.genet.36.052402.152757; Suarez DL, 2005, BIOLOGICALS, V33, P221, DOI 10.1016/j.biologicals.2005.08.003; Tumpey TM, 2005, J CLIN MICROBIOL, V43, P676, DOI 10.1128/JCM.43.2.676-683.2005; van den Berg T, 2008, COMP IMMUNOL MICROB, V31, P121, DOI 10.1016/j.cimid.2007.07.004	32	28	31	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2013	8	2							e56801	10.1371/journal.pone.0056801	http://dx.doi.org/10.1371/journal.pone.0056801			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IT	23437243	gold, Green Published, Green Submitted			2022-12-25	WOS:000315186000046
J	Poce, G; Bates, RH; Alfonso, S; Cocozza, M; Porretta, GC; Ballell, L; Rullas, J; Ortega, F; De Logu, A; Agus, E; La Rosa, V; Pasca, MR; De Rossi, E; Wae, BJ; Franzblau, SG; Manetti, F; Botta, M; Biava, M				Poce, Giovanna; Bates, Robert H.; Alfonso, Salvatore; Cocozza, Martina; Porretta, Giulio Cesare; Ballell, Lluis; Rullas, Joaquin; Ortega, Fatima; De Logu, Alessandro; Agus, Emanuela; La Rosa, Valentina; Pasca, Maria Rosalia; De Rossi, Edda; Wae, Baojie; Franzblau, Scott G.; Manetti, Fabrizio; Botta, Maurizio; Biava, Mariangela			Improved BM212 MmpL3 Inhibitor Analogue Shows Efficacy in Acute Murine Model of Tuberculosis Infection	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; DRUG DISCOVERY; ANTIMYCOBACTERIAL; IDENTIFICATION; STREPTOMYCIN; DERIVATIVES; ASSAY	1,5-Diphenyl pyrroles were previously identified as a class of compounds endowed with high in vitro efficacy against M. tuberculosis. To improve the physical chemical properties and drug-like parameters of this class of compounds, a medicinal chemistry effort was undertaken. By selecting the optimal substitution patterns for the phenyl rings at N1 and C5 and by replacing the thiomorpholine moiety with a morpholine one, a new series of compounds was produced. The replacement of the sulfur with oxygen gave compounds with lower lipophilicity and improved in vitro microsomal stability. Moreover, since the parent compound of this family has been shown to target MmpL3, mycobacterial mutants resistant to two compounds have been isolated and characterized by sequencing the mmpL3 gene; all the mutants showed point mutations in this gene. The best compound identified to date was progressed to dose-response studies in an acute murine TB infection model. The resulting ED99 of 49 mg/Kg is within the range of commonly employed tuberculosis drugs, demonstrating the potential of this chemical series. The in vitro and in vivo target validation evidence presented here adds further weight to MmpL3 as a druggable target of interest for anti-tubercular drug discovery.	[Poce, Giovanna; Alfonso, Salvatore; Cocozza, Martina; Porretta, Giulio Cesare; Biava, Mariangela] Univ Roma La Sapienza, Ist Pasteur Fdn Cenci Bolognetti, Dipartimento Chim & Tecnol Farmaco, Rome, Italy; [Bates, Robert H.; Ballell, Lluis; Rullas, Joaquin; Ortega, Fatima] GlaxoSmithKline, Dis Dev World, Madrid, Spain; [De Logu, Alessandro; Agus, Emanuela] Univ Cagliari, Dipartimento Sci Vita & Ambiente, Cagliari, Italy; [La Rosa, Valentina; Pasca, Maria Rosalia; De Rossi, Edda] Univ Pavia, Dipartimento Biol & Biotecnol, I-27100 Pavia, Italy; [Wae, Baojie; Franzblau, Scott G.] Univ Illinois, Inst TB Res, Chicago, IL USA; [Manetti, Fabrizio; Botta, Maurizio] Univ Siena, Dipartimento Farmaco Chim Tecnol, I-53100 Siena, Italy	Fondazione Cenci Bolognetti; Sapienza University Rome; GlaxoSmithKline; University of Cagliari; University of Pavia; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Siena	Poce, G (corresponding author), Univ Roma La Sapienza, Ist Pasteur Fdn Cenci Bolognetti, Dipartimento Chim & Tecnol Farmaco, Rome, Italy.	giovanna.poce@uniroma1.it; mariangela.biava@uniroma1.it	Manetti, Fabrizio/Q-9412-2019; Pasca, Maria Rosalia/J-8752-2016	Manetti, Fabrizio/0000-0002-9598-2339; Pasca, Maria Rosalia/0000-0002-8906-4937; Franzblau, Scott/0000-0002-8698-0243; poce, giovanna/0000-0001-7466-8861; biava, mariangela/0000-0002-5409-807X; Ballell, Lluis/0000-0002-3029-1860	Istituto Pasteur Fondazione Cenci-Bolognetti (Italy); MIUR-PRIN (Italy); MIUR (Progetti di Ricerca di Ateneo) (Italy); Tres Cantos Open Lab Foundation; European Union's 7th framework programme (FP7) [261378]	Istituto Pasteur Fondazione Cenci-Bolognetti (Italy)(Istituto Pasteur Italia Fondazione Cenci Bolognetti); MIUR-PRIN (Italy)(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN)); MIUR (Progetti di Ricerca di Ateneo) (Italy)(Ministry of Education, Universities and Research (MIUR)); Tres Cantos Open Lab Foundation; European Union's 7th framework programme (FP7)	This work was supported by Istituto Pasteur Fondazione Cenci-Bolognetti (Italy), MIUR-PRIN 2008 (Italy), MIUR 2011 (Progetti di Ricerca di Ateneo) (Italy) and Tres Cantos Open Lab Foundation. The research leading to these results also received funding from the European Union's 7th framework programme (FP7-2007-2013) under grant agreement no 261378. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Biava M, 1997, MED CHEM RES, V7, P228; Biava M, 2006, J MED CHEM, V49, P4946, DOI 10.1021/jm0602662; Biava M, 2011, CHEMMEDCHEM, V6, P593, DOI 10.1002/cmdc.201000526; Biava M, 2010, BIOORGAN MED CHEM, V18, P8076, DOI 10.1016/j.bmc.2010.09.006; Cho SH, 2007, ANTIMICROB AGENTS CH, V51, P1380, DOI 10.1128/AAC.00055-06; Coates A, 2002, NAT REV DRUG DISCOV, V1, P895, DOI 10.1038/nrd940; Deidda D, 1998, ANTIMICROB AGENTS CH, V42, P3035, DOI 10.1128/AAC.42.11.3035; Domenech P, 2005, INFECT IMMUN, V73, P3492, DOI 10.1128/IAI.73.6.3492-3501.2005; Fioravanti R, 1996, FARMACO, V51, P643; Fioravanti R, 1997, MED CHEM RES, V7, P87; Grzegorzewicz AE, 2012, NAT CHEM BIOL, V8, P334, DOI [10.1038/NCHEMBIO.794, 10.1038/nchembio.794]; La Rosa V, 2012, ANTIMICROB AGENTS CH, V56, P324, DOI 10.1128/AAC.05270-11; Rullas J, 2010, ANTIMICROB AGENTS CH, V54, P2262, DOI 10.1128/AAC.01423-09; Stanley SA, 2012, ACS CHEM BIOL, V7, P1377, DOI 10.1021/cb300151m; Tahlan K, 2012, ANTIMICROB AGENTS CH, V56, P1797, DOI 10.1128/AAC.05708-11; Varela C, 2012, CHEM BIOL, V19, P498, DOI 10.1016/j.chembiol.2012.03.006; World Health Organization, WHOHTMTB201116; World Health Organization, WHOHTMTB2009420, V4th; World Health Organization, 2010, WHOHTMTB20103; Zhang M, 2012, ANTIMICROB AGENTS CH, V56, P5782, DOI 10.1128/AAC.01125-12	20	76	79	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2013	8	2							e56980	10.1371/journal.pone.0056980	http://dx.doi.org/10.1371/journal.pone.0056980			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IT	23437287	Green Submitted, gold, Green Published			2022-12-25	WOS:000315186000063
J	Zhao, Y; Zhang, DH; Wang, S; Tao, L; Wang, AY; Chen, WX; Zhu, ZJ; Zheng, SZ; Gao, X; Lu, Y				Zhao, Yang; Zhang, Daohai; Wang, Sheng; Tao, Li; Wang, Aiyun; Chen, Wenxing; Zhu, Zhijie; Zheng, Shizhong; Gao, Xiang; Lu, Yin			Holothurian Glycosaminoglycan Inhibits Metastasis and Thrombosis via Targeting of Nuclear Factor-kappa B/Tissue Factor/Factor Xa Pathway in Melanoma B16F10 Cells	PLOS ONE			English	Article							TISSUE FACTOR EXPRESSION; BREAST-CANCER; PROCOAGULANT ACTIVITY; GCMA PHOSPHORYLATION; SIGNALING PATHWAYS; MOLECULAR-WEIGHT; TUMOR-GROWTH; COAGULATION; INVASION; INVOLVEMENT	Holothurian glycosaminoglycan (hGAG) is a high-molecular-weight form of fucosylated chondroitin sulfate and has an antithrombotic effect. Our previous studies demonstrated that hGAG efficiently inhibited tumor cell metastasis. The interplays between thrombosis and tumor progression may have a major impact on hematogenous metastasis. In this study, we demonstrated that the mouse melanoma B16F10 cells treated with hGAG displayed a significant reduction of metastasis and coagulation capacity in vitro and in vivo. Mechanistic studies revealed that hGAG treatment in B16F10 cells remarkably inhibited the formation of fibrin through attenuating the generation of activated Factor Xa (FXa), without affecting the expression of urokinase (uPA) and plasminogen activator inhibitor 1 (PAI-1) that involved in fibrinolysis. Moreover, hGAG treatment downregulated the transcription and protein expression of tissue factor (TF). Promoter deletions, site mutations and functional studies identified that the nuclear transcription factor NF-kappa B binding region is responsible for hGAG-induced inhibition of TF expression. While the hGAG treatment of B16F10 cells was unable to inhibit NF-kappa B expression and phosphorylation, hGAG significantly prevented nuclear translocation of NF-kappa B from the cytosol, a potential mechanism underlying the transcriptional suppression of TF. Moreover, hGAG markedly suppressed the activation of p38MAPK and ERK1/2 signaling pathways, the central regulators for the expression of metastasis-related matrix metalloproteinases (MMPs). Consequently, hGAG exerts a dual function in the inhibition of metastasis and coagulation activity in mouse melanoma B16F10 cells. Our studies suggest hGAG to be a promising therapeutic agent for metastatic cancer treatment.	[Zhao, Yang; Wang, Sheng; Tao, Li; Wang, Aiyun; Chen, Wenxing; Zhu, Zhijie; Zheng, Shizhong; Lu, Yin] Nanjing Univ Chinese Med, Coll Pharm, Dept Clin Pharm, Nanjing, Jiangsu, Peoples R China; [Zhang, Daohai] Univ Sydney, Sch Med Sci, Dept Pathol, Sydney, NSW 2006, Australia; [Zheng, Shizhong; Lu, Yin] Nanjing Univ Chinese Med, Jiangsu Key Lab Efficacy & Safety Evaluat Tradit, Coll Pharm, Nanjing, Jiangsu, Peoples R China; [Gao, Xiang] Nanjing Univ, Model Anim Res Ctr, Nanjing 210008, Jiangsu, Peoples R China	Nanjing University of Chinese Medicine; University of Sydney; Nanjing University of Chinese Medicine; Nanjing University	Lu, Y (corresponding author), Nanjing Univ Chinese Med, Coll Pharm, Dept Clin Pharm, Nanjing, Jiangsu, Peoples R China.	profyinlu@163.com	Chen, Wenxing/GSI-9910-2022; Tao, Li/AAF-4654-2021	Chen, Wenxing/0000-0003-4571-7622	National Natural Science Foundation of China [81173174, 30772766]; Natural Science Foundation of Jiangsu Province [BK2010085, 2010562]; Educational Commission of Jiangsu Province [09KJA360002]; Jiangsu College Graduate Research and Innovation Projects [2010-469, 2010-471]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); Supporting Jiangsu Provincial Talents in Six Fields [06-B-023, 08-A-012]; Jiangsu Administration of Traditional Chinese Medicine [LZ09022]; Open Program of Jiangsu Key Laboratory for Pharmacology and Safety Evaluation of Chinese Materia Medica [P09013]; Program of Jiangsu International Cooperation [SBZ200900175]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); Educational Commission of Jiangsu Province; Jiangsu College Graduate Research and Innovation Projects; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); Supporting Jiangsu Provincial Talents in Six Fields; Jiangsu Administration of Traditional Chinese Medicine; Open Program of Jiangsu Key Laboratory for Pharmacology and Safety Evaluation of Chinese Materia Medica; Program of Jiangsu International Cooperation	This work was supported by research funds/projects from National Natural Science Foundation of China (81173174,30772766); Natural Science Foundation of Jiangsu Province (BK2010085, 2010562); Educational Commission of Jiangsu Province (09KJA360002); Jiangsu College Graduate Research and Innovation Projects (2010-469 and 2010-471); Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); Supporting Jiangsu Provincial Talents in Six Fields (06-B-023 and 08-A-012); Jiangsu Administration of Traditional Chinese Medicine (LZ09022); Open Program of Jiangsu Key Laboratory for Pharmacology and Safety Evaluation of Chinese Materia Medica (P09013); and Program of Jiangsu International Cooperation (SBZ200900175). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Saleh S, 2011, INT J ONCOL, V38, P1197, DOI 10.3892/ijo.2011.942; Babykutty S, 2012, MOL CARCINOGEN, V51, P475, DOI 10.1002/mc.20812; Bambang IF, 2009, LAB INVEST, V89, P1229, DOI 10.1038/labinvest.2009.87; Barrowcliffe TW, 2002, THROMB HAEMOSTASIS, V87, P442; Bastarache JA, 2007, THORAX, V62, P608, DOI 10.1136/thx.2006.063305; Blom JW, 2004, J THROMB HAEMOST, V2, P1760, DOI 10.1111/j.1538-7836.2004.00928.x; Buyue Y, 2009, BLOOD, V114, P3092, DOI 10.1182/blood-2009-02-203661; de Vicente JC, 2012, HEAD NECK-J SCI SPEC, V17, P2303; Gil-Bernabe AM, 2012, BLOOD, V119, P3164, DOI 10.1182/blood-2011-08-376426; Gomez K, 2006, FRONT BIOSCI-LANDMRK, V11, P1349, DOI 10.2741/1888; Gomez-Pina V, 2012, J LEUKOCYTE BIOL, V91, P933, DOI 10.1189/jlb.0711340; Gupta SC, 2010, BBA-GENE REGUL MECH, V1799, P775, DOI 10.1016/j.bbagrm.2010.05.004; Higuchi Y, 2006, AM J PHYSIOL-HEART C, V290, pH590, DOI 10.1152/ajpheart.00379.2005; Huang GJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035901; Imanari T, 1999, THROMB RES, V93, P129, DOI 10.1016/S0049-3848(98)00171-6; Ingles-Esteve J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038347; Julien LA, 2010, MOL CELL BIOL, V30, P908, DOI 10.1128/MCB.00601-09; Kim D, 2001, FASEB J, V15, P1953, DOI 10.1096/fj.01-0198com; Ko HS, 2012, J AGR FOOD CHEM, V60, P4083, DOI 10.1021/jf205171g; Lee BJ, 2011, ONCOL REP, V26, P665, DOI 10.3892/or.2011.1314; Lee SO, 2008, BIOCHEM BIOPH RES CO, V366, P1019, DOI 10.1016/j.bbrc.2007.12.068; Li H, 2010, ENDOCRINOLOGY, V151, P63, DOI 10.1210/en.2009-0833; Lim W, 2012, PHOTOCHEM PHOTOBIOL, V14, P1751; Lin KL, 2012, LIFE SCI, V90, P54, DOI 10.1016/j.lfs.2011.10.020; Ludwig RJ, 2004, CANCER RES, V64, P2743, DOI 10.1158/0008-5472.CAN-03-1054; Mandal SK, 2007, BLOOD, V110, P161, DOI 10.1182/blood-2006-10-050476; Matsui F, 2012, J SURG RES, V178, P339, DOI 10.1016/j.jss.2012.06.050; Mousa SA, 2009, THROMB HAEMOSTASIS, V102, P258, DOI 10.1160/TH08-12-0832; Nicolini A, 2009, MED RES REV, V29, P436, DOI 10.1002/med.20143; Otero LL, 2011, BIOMARKERS, V16, P58, DOI 10.3109/1354750X.2010.533282; Palumbo JS, 2005, BLOOD, V105, P178, DOI 10.1182/blood-2004-06-2272; Petersen M, 2010, ONCOGENE, V29, P1351, DOI 10.1038/onc.2009.426; Pickering W, 2004, J THROMB HAEMOST, V2, P459, DOI 10.1111/j.1538-7836.2004.00607.x; Pikarsky E, 2004, NATURE, V431, P461, DOI 10.1038/nature02924; Popescu NI, 2010, BLOOD, V116, P993, DOI 10.1182/blood-2009-10-249607; Reddy KB, 2003, CANCER METAST REV, V22, P395, DOI 10.1023/A:1023781114568; Riddel JP, 2007, J PEDIATR ONCOL NURS, V24, P123, DOI 10.1177/1043454206298693; Rizoli SB, 2011, J TRAUMA, V71, pS427, DOI 10.1097/TA.0b013e318232e5ab; Rong Y, 2005, CANCER RES, V65, P1406, DOI 10.1158/0008-5472.CAN-04-3376; Satou R, 2012, FASEB J, V26, P1821, DOI 10.1096/fj.11-195198; Schoots IG, 2004, THROMB HAEMOSTASIS, V91, P497, DOI 10.1160/TH03-08-0529; Sheehan JP, 2006, BLOOD, V107, P3876, DOI 10.1182/blood-2005-07-3043; Sheng SJ, 2009, J CELL PHYSIOL, V218, P451, DOI 10.1002/jcp.21616; Shum MSY, 2011, FASEB J, V25, P4423, DOI 10.1096/fj.11-185447; Sorensen HT, 2000, NEW ENGL J MED, V343, P1846, DOI 10.1056/NEJM200012213432504; Stenina OI, 2005, NAT MED, V11, P376, DOI 10.1038/nm0405-376; Sudha T, 2012, CLIN EXP METASTAS, V29, P431, DOI 10.1007/s10585-012-9461-9; Switzer CH, 2012, CANCER RES, V72, P2394, DOI 10.1158/0008-5472.CAN-11-3115; Takada H, 2010, CANCER GENET CYTOGEN, V197, P16, DOI 10.1016/j.cancergencyto.2009.11.004; Tan W, 2011, NATURE, V470, P548, DOI 10.1038/nature09707; Tang CH, 2012, BIOCHEM PHARMACOL, V83, P335, DOI 10.1016/j.bcp.2011.11.013; Terasaka N, 2005, FEBS J, V272, P1546, DOI 10.1111/j.1742-4658.2005.04599.x; Tian ML, 2011, CANCER BIOL THER, V12, P896, DOI 10.4161/cbt.12.10.17679; Tormoen GW, 2011, PHYS BIOL, V8, DOI 10.1088/1478-3975/8/6/066005; Vlodavsky I, 2012, CANCER MICROENVIRON, V5, P115, DOI 10.1007/s12307-011-0082-7; Welsh J, 2012, INT J LAB HEMATOL, V34, P396, DOI 10.1111/j.1751-553X.2012.01409.x; Yang J, 2008, J BIOMED MATER RES B, V84B, P131, DOI 10.1002/jbm.b.30853; Yasui Y, 2012, BIOMED RES-TOKYO, V33, P217, DOI 10.2220/biomedres.33.217; Yasui Y, 2012, BIOCHEM BIOPH RES CO, V417, P1127, DOI 10.1016/j.bbrc.2011.12.059; Yates KR, 2011, BLOOD COAGUL FIBRIN, V22, P680, DOI 10.1097/MBC.0b013e32834ad7bc; Ye M, 2008, INVEST OPHTH VIS SCI, V49, P497, DOI 10.1167/iovs.07-0975; Yokota N, 2009, BRIT J CANCER, V101, P2023, DOI 10.1038/sj.bjc.6605406; Zhang WW, 2009, CANCER BIOL THER, V8, P1489, DOI 10.4161/cbt.8.15.8948; Zheng S, 2009, CANCER SCI, V100, P859, DOI 10.1111/j.1349-7006.2009.01115.x; Zubair A, 2012, CURR ALLERGY ASTHM R, V6, P234	65	30	35	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2013	8	2							e56557	10.1371/journal.pone.0056557	http://dx.doi.org/10.1371/journal.pone.0056557			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IT	23437168	Green Published, Green Submitted, gold			2022-12-25	WOS:000315186000032
J	Curlik, DM; Maeng, LY; Agarwal, PR; Shors, TJ				Curlik, Daniel M., II; Maeng, Lisa Y.; Agarwal, Prateek R.; Shors, Tracey J.			Physical Skill Training Increases the Number of Surviving New Cells in the Adult Hippocampus	PLOS ONE			English	Article							LEARNING INCREASES; NEUROGENESIS; MOTOR; CEREBELLAR; ACQUISITION; PERFORMANCE; AMNESIA; NEURONS; LESIONS; TIME	The dentate gyrus is a major site of plasticity in the adult brain, giving rise to thousands of new neurons every day, through the process of adult neurogenesis. Although the majority of these cells die within two weeks of their birth, they can be rescued from death by various forms of learning. Successful acquisition of select types of associative and spatial memories increases the number of these cells that survive. Here, we investigated the possibility that an entirely different form of learning, physical skill learning, could rescue new hippocampal cells from death. To test this possibility, rats were trained with a physically-demanding and technically-difficult version of a rotarod procedure. Acquisition of the physical skill greatly increased the number of new hippocampal cells that survived. The number of surviving cells positively correlated with performance on the task. Only animals that successfully mastered the task retained the cells that would have otherwise died. Animals that failed to learn, and those that did not learn well did not retain any more cells than those that were untrained. Importantly, acute voluntary exercise in activity wheels did not increase the number of surviving cells. These data suggest that acquisition of a physical skill can increase the number of surviving hippocampal cells. Moreover, learning an easier version of the task did not increase cell survival. These results are consistent with previous reports revealing that learning only rescues new neurons from death when acquisition is sufficiently difficult to achieve. Finally, complete hippocampal lesions did not disrupt acquisition of this physical skill. Therefore, physical skill training that does not depend on the hippocampus can effectively increase the number of surviving cells in the adult hippocampus, the vast majority of which become mature neurons.	[Shors, Tracey J.] Rutgers State Univ, Dept Psychol, Piscataway, NJ 08854 USA; Rutgers State Univ, Ctr Collaborat Neurosci, Piscataway, NJ USA	Rutgers State University New Brunswick; Rutgers State University New Brunswick	Shors, TJ (corresponding author), Rutgers State Univ, Dept Psychol, Piscataway, NJ 08854 USA.	shors@rutgers.edu			National Institutes of Health [MH-59970, ARRA-3R01MH059970-10S1]; National Science Foundation [IOB-0444364, IOS-0914386]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH059970] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by the National Institutes of Health (grant nos. MH-59970 and ARRA-3R01MH059970-10S1) and the National Science Foundation (grant nos. IOB-0444364 and IOS-0914386) to TJS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achanta P, 2009, BEHAV NEUROSCI, V123, P1036, DOI 10.1037/a0016870; Albouy G, 2008, NEURON, V58, P261, DOI 10.1016/j.neuron.2008.02.008; Ambrogini P, 2000, NEUROSCI LETT, V286, P21, DOI 10.1016/S0304-3940(00)01074-0; Anagnostaras SG, 1999, J NEUROSCI, V19, P1106; Anderson ML, 2011, EUR J NEUROSCI, V33, P175, DOI 10.1111/j.1460-9568.2010.07486.x; Bangasser DA, 2005, BEHAV NEUROSCI, V119, P1459, DOI 10.1037/0735-7044.119.6.1459; BERGER TW, 1976, SCIENCE, V192, P483, DOI 10.1126/science.1257783; Beylin AV, 2001, NEUROBIOL LEARN MEM, V76, P447, DOI 10.1006/nlme.2001.4039; Bhardwaj RD, 2006, P NATL ACAD SCI USA, V103, P12564, DOI 10.1073/pnas.0605177103; Bizon Jennifer L, 2005, Sci Aging Knowledge Environ, V2005, pre2, DOI 10.1126/sageke.2005.7.re2; Buitrago MM, 2004, NEUROBIOL LEARN MEM, V81, P211, DOI 10.1016/j.nlm.2004.01.001; Cameron HA, 2001, J COMP NEUROL, V435, P406, DOI 10.1002/cne.1040; Christian KM, 2003, LEARN MEMORY, V10, P427, DOI 10.1101/lm.59603; COHEN NJ, 1980, SCIENCE, V210, P207, DOI 10.1126/science.7414331; Curlik DM, 2011, J COGNITIVE NEUROSCI, V23, P2159, DOI 10.1162/jocn.2010.21597; Dalla C, 2007, NEUROBIOL LEARN MEM, V88, P143, DOI 10.1016/j.nlm.2007.02.003; Dobrossy MD, 2003, MOL PSYCHIATR, V8, P974, DOI 10.1038/sj.mp.4001419; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; Gasbarri A, 2003, NEUROSCIENCE, V116, P1131, DOI 10.1016/S0306-4522(02)00780-7; Goddyn H, 2006, BEHAV BRAIN RES, V173, P138, DOI 10.1016/j.bbr.2006.06.016; Gould E, 1999, NAT NEUROSCI, V2, P260, DOI 10.1038/6365; Hastings NB, 1999, J COMP NEUROL, V413, P146, DOI 10.1002/(SICI)1096-9861(19991011)413:1<146::AID-CNE10>3.0.CO;2-B; KARNI A, 1995, NATURE, V377, P155; Leuner B, 2004, J NEUROSCI, V24, P7477, DOI 10.1523/JNEUROSCI.0204-04.2004; Leuner B, 2006, J NEUROSCI, V26, P13437, DOI 10.1523/JNEUROSCI.2781-06.2006; NEWMAN PP, 1979, J PHYSIOL-LONDON, V287, P405, DOI 10.1113/jphysiol.1979.sp012667; Nokia MS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031375; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Shors TJ, 2012, BEHAV BRAIN RES, V227, P450, DOI 10.1016/j.bbr.2011.04.023; Shors TJ, 2002, HIPPOCAMPUS, V12, P578, DOI 10.1002/hipo.10103; Shors TJ, 2001, NATURE, V410, P372, DOI 10.1038/35066584; Sisti HM, 2007, LEARN MEMORY, V14, P368, DOI 10.1101/lm.488707; Snyder JS, 2009, HIPPOCAMPUS, V19, P898, DOI 10.1002/hipo.20552; SOLOMON PR, 1983, SCIENCE, V220, P329, DOI 10.1126/science.6836277; Song YN, 2006, NEUROSCIENCE, V140, P33, DOI 10.1016/j.neuroscience.2006.01.045; SQUIRE LR, 1986, SCIENCE, V232, P1612, DOI 10.1126/science.3086978; TEITELBAUM H, 1963, J COMP PHYSIOL PSYCH, V56, P284, DOI 10.1037/h0047052; van Praag H, 1999, NAT NEUROSCI, V2, P266, DOI 10.1038/6368; van Praag H, 2002, NATURE, V415, P1030, DOI 10.1038/4151030a; Waddell J, 2008, EUR J NEUROSCI, V27, P3020, DOI 10.1111/j.1460-9568.2008.06222.x; Waddell J, 2011, NEUROBIOL LEARN MEM, V95, P159, DOI 10.1016/j.nlm.2010.09.012	41	40	41	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e55850	10.1371/journal.pone.0055850	http://dx.doi.org/10.1371/journal.pone.0055850			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437067	gold, Green Submitted, Green Published			2022-12-25	WOS:000315184200026
J	Fan, CJ; Ma, JM; Guo, QR; Li, XT; Wang, H; Lu, MZ				Fan, Chunjie; Ma, Jinmin; Guo, Qirong; Li, Xiaotie; Wang, Hui; Lu, Mengzhu			Selection of Reference Genes for Quantitative Real-Time PCR in Bamboo (Phyllostachys edulis)	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; INTERNAL CONTROL; RT-PCR; EXPRESSION; NORMALIZATION; ARABIDOPSIS; ORGAN	Background: The Moso bamboo (Phyllostachys edulis) is one of the most important forestry resources and plays essential ecological roles in southern China. A draft nuclear genome sequence is expected to be publicly available in the near future; an explosion of gene expression data related to the unique traits of Moso bamboo will undoubtedly follow. Reverse transcription quantitative real-time PCR ((RT-)qPCR) is a widely used method for gene expression analysis. A necessary prerequisite of exact and reliable data is the accurate choice of reference genes. Result: In this study, 14 candidate reference genes were chosen, and their expression levels were assessed by (RT-)qPCR in a set of six tissue samples (root, stem, mature stem, leaf, flower, and leaf sheath) and at two developmental stages (before and after flowering) in bamboo specimens obtained in three locations. The stability and suitability of the candidate reference genes were validated using the geNorm, NormFinder and BestKeeper programs. The results showed that TIP41 and NTB were suitable reference genes across all the tissues and at the different developmental stages examined in this study. While the expression of the NTB, TIP41 and UBQ were the mostly stable in different plant tissues samples, the expression of the TIP41, NTB and CAC were ranked the most stable in bamboo plants at various developmental stages. AP2-like gene was further assessed by using the reference genes TIP41 and NTB in comparison to ACT. Significant difference of the expression profile of AP2-like demonstrated the importance of choosing adequate reference genes in bamboo. Conclusion: TIP41 and NTB were found to be homogeneously expressed and were adequate for normalization purposes, showing equivalent transcript levels in different samples. They are therefore the recommended reference genes for measuring gene expression in P. edulis.	[Fan, Chunjie; Wang, Hui; Lu, Mengzhu] Chinese Acad Forestry, Res Inst Forestry, State Key Lab Tree Genet & Breeding, Beijing, Peoples R China; [Fan, Chunjie] Chinese Acad Forestry, Res Inst Trop Forestry, Guangzhou, Guangdong, Peoples R China; [Ma, Jinmin; Wang, Hui] Beijing Genom Inst Shenzhen, Shenzhen, Peoples R China; [Guo, Qirong] Int Ctr Bamboo & Rattan, Beijing, Peoples R China; [Li, Xiaotie] Guilin Res Inst Forestry, Guilin, Peoples R China; [Wang, Hui] NERC, Ctr Ecol & Hydrol, Wallingford, Oxon, England	Chinese Academy of Forestry; Research Institute of Forestry, CAF; State Key Laboratory of Tree Genetics & Breeding, CAF; Chinese Academy of Forestry; Research Institute of Tropical Forestry, CAF; Beijing Genomics Institute (BGI); International Centre for Bamboo & Rattan; UK Centre for Ecology & Hydrology (UKCEH); UK Research & Innovation (UKRI); Natural Environment Research Council (NERC)	Wang, H (corresponding author), Chinese Acad Forestry, Res Inst Forestry, State Key Lab Tree Genet & Breeding, Beijing, Peoples R China.	huw@ceh.ac.uk; lumz@caf.ac.cn	Ma, Jinmin/L-8470-2019; Wang, Hui/E-6764-2012; Lu, Meng-Zhu/AAN-9710-2020	Ma, Jinmin/0000-0002-7993-7001; 	National Natural Science Foundation of China (China) [31028004]; Ministry of Science and Technology of the Peoples Republic of China (China) [S2012ZR0137]; Natural Environment Research Council (United Kingdom) [NE/I000593/1]; NERC [NE/I000593/1] Funding Source: UKRI; Natural Environment Research Council [NE/I000593/1, CEH010021] Funding Source: researchfish	National Natural Science Foundation of China (China)(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of the Peoples Republic of China (China); Natural Environment Research Council (United Kingdom)(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	Funding provided by the National Natural Science Foundation of China (China, grant no. 31028004), Ministry of Science and Technology of the Peoples Republic of China (China, grant no. S2012ZR0137) and Natural Environment Research Council (United Kingdom, grant no. NE/I000593/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamczyk BJ, 2007, PLANT J, V50, P1007, DOI 10.1111/j.1365-313X.2007.03105.x; Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Bustin SA, 2005, J MOL ENDOCRINOL, V34, P597, DOI 10.1677/jme.1.01755; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Chang EM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033278; Chen X, 2010, ANAL BIOCHEM, V405, P138, DOI 10.1016/j.ab.2010.05.032; Cruz F, 2009, MOL BREEDING, V23, P607, DOI 10.1007/s11032-009-9259-x; Demidenko NV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019434; Exposito-Rodriguez M, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-131; Ginzinger DG, 2002, EXP HEMATOL, V30, P503, DOI 10.1016/S0301-472X(02)00806-8; Gui YJ, 2007, SCI CHINA SER C, V50, P700, DOI 10.1007/s11427-007-0081-6; Hammond JW, 2008, CURR OPIN CELL BIOL, V20, P71, DOI 10.1016/j.ceb.2007.11.010; Han JG, 2009, MICROB ECOL, V58, P363, DOI 10.1007/s00248-009-9491-2; Han XJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043084; Hong SY, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-112; Hu RB, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-93; Isagiks Y, 2004, MOL ECOL, V13, P5; Janzen DH, 1976, ANN REV ECOLOGY SYST, P7; Jian B, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-59; Jiang Z, 2002, BAMBOO RATTAN WORLD; Krogan NT, 2012, DEVELOPMENT, V139, P4180, DOI 10.1242/dev.085407; Li R, 1997, ACTA PHYTOECOLOGICA, V21, P7; Li XB, 2007, J TROP FOR SCI, V19, P6; Luo HL, 2010, ANAL BIOCHEM, V404, P100, DOI 10.1016/j.ab.2010.05.002; Mafra V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031263; Mathieu J, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000148; Nair SK, 2010, P NATL ACAD SCI USA, V107, P490, DOI 10.1073/pnas.0909097107; Narsai R, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-56; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Pollard TD, 2009, SCIENCE, V326, P1208, DOI 10.1126/science.1175862; Rai V, 2012, GENE, V497, P243, DOI 10.1016/j.gene.2012.01.018; Rai V, 2011, GENE, V478, P19, DOI 10.1016/j.gene.2011.01.004; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; VanGuilder HD, 2008, BIOTECHNIQUES, V44, P619, DOI 10.2144/000112776; Wang JW, 2009, CELL, V138, P738, DOI 10.1016/j.cell.2009.06.014; Wu G, 2009, CELL, V138, P750, DOI 10.1016/j.cell.2009.06.031; Xu H, 2010, BIOTECHNOL LETT, V32, P1961, DOI 10.1007/s10529-010-0362-1; Xu M, 2011, ANAL BIOCHEM, V408, P337, DOI 10.1016/j.ab.2010.08.044; Zhu QH, 2011, J EXP BOT, V62, P487, DOI 10.1093/jxb/erq295	39	203	248	4	88	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e56573	10.1371/journal.pone.0056573	http://dx.doi.org/10.1371/journal.pone.0056573			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437174	Green Published, Green Accepted, gold			2022-12-25	WOS:000315184200110
J	Hardy, R; Cooper, R; Sayer, AA; Ben-Shlomo, Y; Cooper, C; Deary, IJ; Demakakos, P; Gallacher, J; Martin, RM; McNeill, G; Starr, JM; Steptoe, A; Syddall, H; Kuh, D				Hardy, Rebecca; Cooper, Rachel; Sayer, Avan Aihie; Ben-Shlomo, Yoav; Cooper, Cyrus; Deary, Ian J.; Demakakos, Panayotes; Gallacher, John; Martin, Richard M.; McNeill, Geraldine; Starr, John M.; Steptoe, Andrew; Syddall, Holly; Kuh, Diana		HALCyon Study Team	Body Mass Index, Muscle Strength and Physical Performance in Older Adults from Eight Cohort Studies: The HALCyon Programme	PLOS ONE			English	Article							GRIP STRENGTH; FUNCTIONAL DECLINE; BIRTH COHORT; FOLLOW-UP; OBESITY; HEALTH; PROFILE; WOMEN; DISABILITY; PERCENTAGE	Objective: To investigate the associations of body mass index (BMI) and grip strength with objective measures of physical performance (chair rise time, walking speed and balance) including an assessment of sex differences and non-linearity. Methods: Cross-sectional data from eight UK cohort studies (total N = 16 444) participating in the Healthy Ageing across the Life Course (HALCyon) research programme, ranging in age from 50 to 90+ years at the time of physical capability assessment, were used. Regression models were fitted within each study and meta-analysis methods used to pool regression coefficients across studies and to assess the extent of heterogeneity between studies. Results: Higher BMI was associated with poorer performance on chair rise (N = 10 773), walking speed (N = 9 761) and standing balance (N = 13 921) tests. Higher BMI was associated with stronger grip strength in men only. Stronger grip strength was associated with better performance on all tests with a tendency for the associations to be stronger in women than men; for example, walking speed was higher by 0.43 cm/s (0.14, 0.71) more per kg in women than men. Both BMI and grip strength remained independently related with performance after mutual adjustment, but there was no evidence of effect modification. Both BMI and grip strength exhibited non-linear relations with performance; those in the lowest fifth of grip strength and highest fifth of BMI having particularly poor performance. Findings were similar when waist circumference was examined in place of BMI. Conclusion: Older men and women with weak muscle strength and high BMI have considerably poorer performance than others and associations were observed even in the youngest cohort (age 53). Although causality cannot be inferred from observational cross-sectional studies, our findings suggest the likely benefit of early assessment and interventions to reduce fat mass and improve muscle strength in the prevention of future functional limitations.	[Hardy, Rebecca; Cooper, Rachel; Kuh, Diana] UCL, MRC, Unit Lifelong Hlth & Ageing, London, England; [Hardy, Rebecca; Cooper, Rachel; Kuh, Diana] UCL, Inst Epidemiol & Hlth Care, London, England; [Sayer, Avan Aihie; Cooper, Cyrus; Syddall, Holly] Univ Southampton, MRC, Lifecourse Epidemiol Unit, Southampton, Hants, England; [Ben-Shlomo, Yoav; Martin, Richard M.] Univ Bristol, Sch Social & Community Med, Bristol, Avon, England; [Cooper, Cyrus] Univ Oxford, Natl Inst Hlth & Res, Musculoskeletal Biomed Res Unit, Oxford, England; [Deary, Ian J.; Starr, John M.] Univ Edinburgh, Ctr Cognit Ageing & Cognit Epidemiol, Edinburgh, Midlothian, Scotland; [Demakakos, Panayotes; Steptoe, Andrew] UCL, Dept Epidemiol & Publ Hlth, London, England; [Gallacher, John] Cardiff Univ, Dept Primary Care & Publ Hlth, Cardiff CF10 3AX, S Glam, Wales; [McNeill, Geraldine] Univ Aberdeen, Inst Appl Hlth Sci, Aberdeen, Scotland; [Starr, John M.] Western Gen Hosp, Geriatr Med Unit, Edinburgh EH4 2XU, Midlothian, Scotland	University of London; University College London; University of London; University College London; University of Southampton; University of Bristol; University of Oxford; University of Edinburgh; University of London; University College London; Cardiff University; University of Aberdeen; University of Edinburgh	Hardy, R (corresponding author), UCL, MRC, Unit Lifelong Hlth & Ageing, London, England.	r.hardy@nshd.mrc.ac.uk	Ben-Shlomo, Yoav/ABD-2004-2021; Steptoe, Andrew/Y-2440-2019; Kuh, Diana/L-6019-2014; Hardy, Rebecca/AFR-1989-2022; Deary, Ian J/C-6297-2009; Cooper, Rachel/ABE-3768-2021	Ben-Shlomo, Yoav/0000-0001-6648-3007; Kuh, Diana/0000-0001-7386-2857; Deary, Ian J/0000-0002-1733-263X; Cooper, Rachel/0000-0003-3370-5720; Martin-Ruiz, Carmen/0000-0002-3361-6974; Cooper, Cyrus/0000-0003-3510-0709; Steptoe, Andrew/0000-0001-7808-4943; Aihie Sayer, Avan/0000-0003-1283-6457; von Zglinicki, Thomas/0000-0002-5939-0248; Hardy, Rebecca/0000-0001-9949-0799; Martin, Richard/0000-0002-7992-7719; Shiels, Paul/0000-0002-7577-9843; McNeill, Geraldine/0000-0003-0373-650X; Demakakos, Panayotes/0000-0002-7663-2122	New Dynamics of Ageing [RES-353-25-0001]; UK Medical Research Council; Biological Sciences Research Council; Alzheimer Research Trust; Medical Research Council; World Cancer Research Fund; Research into Ageing; United Kingdom Survivors; Economic and Social Research Council; Wellcome Trust; British Heart Foundation; Alzheimer's society; National Institute of Aging in the United States; Arthritis Research UK; University of Southampton; Biotechnology and Biological Sciences Research Council; Royal Society-Wolfson Research Merit Award; Chief Scientist Office of the Scottish Government; Engineering and Physical Sciences Research Council; ESRC [ES/G00773X/1] Funding Source: UKRI; MRC [MC_U147585827, G0601333, G0400491, G0700704, MC_UU_12011/2, MC_U123092720, MC_UP_A620_1015, MC_U123092724, MC_U123092721, MC_U147585819] Funding Source: UKRI; Economic and Social Research Council [ES/G00773X/1] Funding Source: researchfish; Medical Research Council [MC_U123092720, U1475000002, U1475000001, MC_U123092724, G0601333, MC_UU_12011/2, MC_U147585824, MC_UP_A620_1015, MC_UU_12011/1, MC_U147585827, MR/K026992/1, MC_U123092721, G0400491, MC_U147585819, MC_UP_A620_1014, G0700704] Funding Source: researchfish; National Institute for Health Research [NF-SI-0508-10082] Funding Source: researchfish; Chief Scientist Office [ETM/55] Funding Source: researchfish	New Dynamics of Ageing; UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Alzheimer Research Trust; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); World Cancer Research Fund(World Cancer Research Fund International (WCRF)); Research into Ageing; United Kingdom Survivors; Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Wellcome Trust(Wellcome Trust); British Heart Foundation(British Heart Foundation); Alzheimer's society; National Institute of Aging in the United States(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Arthritis Research UK(Versus Arthritis); University of Southampton; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Royal Society-Wolfson Research Merit Award(Royal Society of London); Chief Scientist Office of the Scottish Government; Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); Chief Scientist Office	HALCyon is funded by the New Dynamics of Ageing (RES-353-25-0001) and R. C. received support from this grant. D. K., A. A. S. and R. H. were supported by the UK Medical Research Council. The Aberdeen Birth Cohort 1936 data collection was funded by the Biological Sciences Research Council (wave 1) and the Alzheimer Research Trust. Boyd Orr cohort has received funding from the Medical Research Council, the World Cancer Research Fund, Research into Ageing, United Kingdom Survivors, the Economic and Social Research Council, the Wellcome Trust, and the British Heart Foundation. The Caerphilly Prospective Study was undertaken by the former Medical Research Council Epidemiology Unit (South Wales), and the School of Social and Community Based Medicine, University of Bristol, acts as the data custodian. The phase V follow-up was funded by the Alzheimer's society. The ELSA was developed by a team of researchers based at University College London, the National Centre for Social Research, and the Institute for Fiscal Studies. The funding is provided by the National Institute of Aging in the United States, and a consortium of UK government departments co-ordinated by the Office for National Statistics. The Hertfordshire Ageing Study and the Hertfordshire Cohort Study were funded by the UK Medical Research Council, the Wellcome Trust, Arthritis Research UK and the University of Southampton. The LBC1921 data were collected by grants from the Biotechnology and Biological Sciences Research Council (wave 1), a Royal Society-Wolfson Research Merit Award to IJD (wave 2), and the Chief Scientist Office of the Scottish Government (wave 3). LBC1921 has been undertaken within The University of Edinburgh Centre for Cognitive Ageing and Cognitive Epidemiology, part of the cross council Lifelong Health and Wellbeing Initiative (G0700704/84698). Funding from the Biotechnology and Biological Sciences Research Council, Engineering and Physical Sciences Research Council, Economic and Social Research Council and Medical Research Council is gratefully acknowledged. The NSHD is funded by the UK Medical Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bouchard DR, 2009, OBESITY, V17, P2082, DOI 10.1038/oby.2009.109; Brach JS, 2004, PREV MED, V39, P74, DOI 10.1016/j.ypmed.2004.02.044; Cole TJ, 2000, STAT MED, V19, P3109, DOI 10.1002/1097-0258(20001130)19:22<3109::AID-SIM558>3.0.CO;2-F; COOPER R, 2011, PLOS ONE, V0006; Cooper R, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c4467; Cooper R, 2011, AGE AGEING, V40, P14, DOI 10.1093/ageing/afq117; Davison KK, 2002, J AM GERIATR SOC, V50, P1802, DOI 10.1046/j.1532-5415.2002.50508.x; Deary IJ, 2004, J PERS SOC PSYCHOL, V86, P130, DOI 10.1037/0022-3514.86.1.130; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Ding JZ, 2007, AM J CLIN NUTR, V85, P405; ELWOOD PC, 1984, J EPIDEMIOL COMMUN H, V38, P259, DOI 10.1136/jech.38.3.259; Ferrucci L, 2000, J AM GERIATR SOC, V48, P1102, DOI 10.1111/j.1532-5415.2000.tb04787.x; Forrest KYZ, 2006, J GERONTOL A-BIOL, V61, P1194, DOI 10.1093/gerona/61.11.1194; GURALNIK JM, 1994, J GERONTOL, V49, pM85, DOI 10.1093/geronj/49.2.M85; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Houston DK, 2007, INT J OBESITY, V31, P1680, DOI 10.1038/sj.ijo.0803652; Jensen GL, 2005, CLIN GERIATR MED, V21, P677, DOI 10.1016/j.cger.2005.06.007; Jensen GL, 2002, J AM GERIATR SOC, V50, P918, DOI 10.1046/j.1532-5415.2002.50220.x; Kuh D, 2005, J GERONTOL A-BIOL, V60, P224, DOI 10.1093/gerona/60.2.224; Kuh D, 2006, J GERONTOL A-BIOL, V61, P702, DOI 10.1093/gerona/61.7.702; Kuh D, 2006, AM J EPIDEMIOL, V164, P110, DOI 10.1093/aje/kwj193; Lang IA, 2008, J AM GERIATR SOC, V56, P1474, DOI 10.1111/j.1532-5415.2008.01813.x; Li L, 2008, AM J EPIDEMIOL, V168, P1008, DOI 10.1093/aje/kwn227; Lobstein T., 2007, FORESIGHT TACKLING O; Martin RM, 2005, INT J EPIDEMIOL, V34, P742, DOI 10.1093/ije/dyi124; Rantanen T, 1998, J APPL PHYSIOL, V85, P2047, DOI 10.1152/jappl.1998.85.6.2047; Rossner S, 2002, INT J OBES RELAT S4, V26, pS4; Sergi G, 2007, J AM GERIATR SOC, V55, P2023, DOI 10.1111/j.1532-5415.2007.01460.x; Shin Hyehyung, 2011, J Aging Res, V2011, P191896, DOI 10.4061/2011/191896; Stenholm S, 2009, INT J OBESITY, V33, P634; Stenholm S, 2008, CURR OPIN CLIN NUTR, V11, P693, DOI 10.1097/MCO.0b013e328312c37d; Steptoe A, 2012, INT J EPIDEMIOL; Syddall HE, 2010, INT J EPIDEMIOL, V39, P36, DOI 10.1093/ije/dyn275; Syddall HE, 2005, INT J EPIDEMIOL, V34, P1234, DOI 10.1093/ije/dyi127; Tolea MI, 2010, J GERONTOL B-PSYCHOL, V65, P174, DOI 10.1093/geronb/gbp130; Vincent HK, 2010, OBES REV, V11, P568, DOI 10.1111/j.1467-789X.2009.00703.x; Wadsworth M, 2006, INT J EPIDEMIOL, V35, P49, DOI 10.1093/ije/dyi201; Wells JCK, 2007, BEST PRACT RES CL EN, V21, P415, DOI 10.1016/j.beem.2007.04.007; Woo J, 2007, OBESITY, V15, P1886, DOI 10.1038/oby.2007.223; Zoico E, 2004, INT J OBESITY, V28, P234, DOI 10.1038/sj.ijo.0802552	40	103	106	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e56483	10.1371/journal.pone.0056483	http://dx.doi.org/10.1371/journal.pone.0056483			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	093IE	23437142	Green Accepted, gold, Green Published			2022-12-25	WOS:000315184200081
J	Liu, ME; Huang, CC; Yang, AC; Tu, PC; Yeh, HL; Hong, CJ; Chen, JF; Liou, YJ; Lin, CP; Tsai, SJ				Liu, Mu-En; Huang, Chu-Chung; Yang, Albert C.; Tu, Pei-Chi; Yeh, Heng-Liang; Hong, Chen-Jee; Chen, Jin-Fan; Liou, Ying-Jay; Lin, Ching-Po; Tsai, Shih-Jen			Effect of Bcl-2 rs956572 Polymorphism on Age-Related Gray Matter Volume Changes	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; CELL-DEATH; ALZHEIMERS-DISEASE; BRAIN MORPHOLOGY; TRANSGENIC MICE; PSYCHIATRIC-DISORDERS; VAL66MET POLYMORPHISM; COGNITIVE IMPAIRMENT; PROTEIN EXPRESSION; OXIDATIVE-STRESS	The anti-apoptotic protein B-cell CLL/lymphoma 2 (Bcl-2) gene is a major regulator of neural plasticity and cellular resilience. Recently, the Bcl-2 rs956572 single nucleotide polymorphism was proposed to be a functional allelic variant that modulates cellular vulnerability to apoptosis. Our cross-sectional study investigated the genetic effect of this Bcl-2 polymorphism on age-related decreases in gray matter (GM) volume across the adult lifespan. Our sample comprised 330 healthy volunteers (191 male, 139 female) with a mean age of 56.2 +/- 22.0 years (range: 21-92). Magnetic resonance imaging and genotyping of the Bcl-2 rs956572 were performed for each participant. The differences in regional GM volumes between G homozygotes and A-allele carriers were tested using optimized voxel-based morphometry. The association between the Bcl-2 rs956572 polymorphism and age was a predictor of regional GM volumes in the right cerebellum, bilateral lingual gyrus, right middle temporal gyrus, and right parahippocampal gyrus. We found that the volume of these five regions decreased with increasing age (all P<.001). Moreover, the downward slope was steeper among the Bcl-2 rs956572 A-allele carriers than in the G-homozygous participants. Our data provide convergent evidence for the genetic effect of the Bcl-2 functional allelic variant in brain aging. The rs956572 G-allele, which is associated with significantly higher Bcl-2 protein expression and diminished cellular sensitivity to stress-induced apoptosis, conferred a protective effect against age-related changes in brain GM volume, particularly in the cerebellum.	[Liu, Mu-En] Kaohsiung Vet Gen Hosp, Dept Psychiat, Kaohsiung, Taiwan; [Huang, Chu-Chung; Lin, Ching-Po] Natl Yang Ming Univ, Dept Biomed Imaging & Radiol Sci, Taipei 112, Taiwan; [Yang, Albert C.; Tu, Pei-Chi; Hong, Chen-Jee; Liou, Ying-Jay; Tsai, Shih-Jen] Taipei Vet Gen Hosp, Dept Psychiat, Taipei, Taiwan; [Yang, Albert C.; Hong, Chen-Jee; Liou, Ying-Jay; Tsai, Shih-Jen] Natl Yang Ming Univ, Sch Med, Taipei 112, Taiwan; [Yang, Albert C.] Natl Cent Univ, Ctr Dynam Biomarkers & Translat Med, Chungli 32054, Taiwan; [Tu, Pei-Chi] Taipei Vet Gen Hosp, Dept Med Res & Educ, Taipei, Taiwan; [Yeh, Heng-Liang] Taipei Vet Home, New Taipei City, Taiwan; [Chen, Jin-Fan] Tao Yuan Vet Hosp, Dept Pathol, Tao Yuan, Tao Yuan County, Taiwan; [Lin, Ching-Po] Natl Yang Ming Univ, Inst Neurosci, Taipei 112, Taiwan	Kaohsiung Veterans General Hospital; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; National Central University; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University	Lin, CP (corresponding author), Natl Yang Ming Univ, Dept Biomed Imaging & Radiol Sci, Taipei 112, Taiwan.	chingpolin@gmail.com; tsai610913@gmail.com	Tsai, Shih-Jen/AAK-7944-2020	Tsai, Shih-Jen/0000-0002-9987-022X; Yang, Albert Chih-Chieh/0000-0003-2794-9649; Huang, Chu-Chung/0000-0002-9096-9610	Taipei Veterans General Hospital, Taiwan [V101C-006, VGHUST101-G1-1-1, VGHUST102-G1-2-1]; Center for Dynamical Biomarkers and Translational Medicine, National Central University, Taiwan [NSC 101-2911-I-008-001]; National Science Council Grant, Taiwan [NSC 101-2911-I-008-001, NSC 101-2314-B-075-040]	Taipei Veterans General Hospital, Taiwan(Taipei Veterans General Hospital); Center for Dynamical Biomarkers and Translational Medicine, National Central University, Taiwan; National Science Council Grant, Taiwan	This work was supported by grants V101C-006, VGHUST101-G1-1-1, VGHUST102-G1-2-1 from Taipei Veterans General Hospital, Taiwan, grant NSC 101-2911-I-008-001 (the Center for Dynamical Biomarkers and Translational Medicine, National Central University, Taiwan) and grants NSC 101-2314-B-075-040, NSC 101-2911-I-008-001 from National Science Council Grant, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLSOPP TE, 1993, CELL, V73, P295, DOI 10.1016/0092-8674(93)90230-N; Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007; Baare WFC, 2001, CEREB CORTEX, V11, P816, DOI 10.1093/cercor/11.9.816; Baldacara L, 2008, REV BRAS PSIQUIATR, V30, P281, DOI 10.1590/S1516-44462008000300016; Berridge MJ, 2011, NEUROCHEM RES, V36, P1149, DOI 10.1007/s11064-010-0371-4; Caraci F, 2005, BRAIN RES, V1047, P30, DOI 10.1016/j.brainres.2005.04.004; Cardozo-Pelaez F, 1999, MOVEMENT DISORD, V14, P972, DOI 10.1002/1531-8257(199911)14:6<972::AID-MDS1010>3.0.CO;2-0; Chan WY, 1998, ANAT RECORD, V252, P165; Chen DF, 1997, NATURE, V385, P434, DOI 10.1038/385434a0; Chen G, 2006, CURR OPIN PSYCHIATR, V19, P313, DOI 10.1097/01.yco.0000218604.63463.cd; Crivello F, 2010, NEUROIMAGE, V53, P1064, DOI 10.1016/j.neuroimage.2009.12.116; Cuadra MB, 2005, IEEE T MED IMAGING, V24, P1548, DOI 10.1109/TMI.2005.857652; Drevets WC, 2008, BRAIN STRUCT FUNCT, V213, P93, DOI 10.1007/s00429-008-0189-x; DUBOISDAUPHIN M, 1994, P NATL ACAD SCI USA, V91, P3309, DOI 10.1073/pnas.91.8.3309; Engidawork E, 2001, NEUROSCI LETT, V303, P79, DOI 10.1016/S0304-3940(01)01618-4; GARCIA I, 1992, SCIENCE, V258, P302, DOI 10.1126/science.1411528; Good CD, 2001, NEUROIMAGE, V14, P21, DOI 10.1006/nimg.2001.0786; Hochman A, 1998, J NEUROCHEM, V71, P741; Jarskog LF, 2000, BIOL PSYCHIAT, V48, P641, DOI 10.1016/S0006-3223(00)00988-4; Jernigan TL, 2001, NEUROBIOL AGING, V22, P581, DOI 10.1016/S0197-4580(01)00217-2; Jiao JW, 2005, EMBO J, V24, P1068, DOI 10.1038/sj.emboj.7600589; Jonas E, 2006, MOL INTERV, V6, P208, DOI 10.1124/mi.6.4.7; Kaufmann JA, 2001, J NEUROCHEM, V76, P1099, DOI 10.1046/j.1471-4159.2001.00118.x; Kawamoto EM, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00061; Liang HL, 2006, NEUROSCIENCE, V139, P639, DOI 10.1016/j.neuroscience.2005.12.047; Liu ME, 2011, AGE DORDR; Machado-Vieira R, 2011, BIOL PSYCHIAT, V69, P344, DOI 10.1016/j.biopsych.2010.10.019; Manjon JV, 2010, J MAGN RESON IMAGING, V31, P192, DOI 10.1002/jmri.22003; Marshall KA, 1997, BIOCHEM BIOPH RES CO, V240, P84, DOI 10.1006/bbrc.1997.7604; MARTINOU JC, 1994, NEURON, V13, P1017, DOI 10.1016/0896-6273(94)90266-6; MERRY DE, 1994, DEVELOPMENT, V120, P301; Meyer-Lindenberg A, 2006, NAT REV NEUROSCI, V7, P818, DOI 10.1038/nrn1993; MIDDLETON FA, 1994, SCIENCE, V266, P458, DOI 10.1126/science.7939688; Nemoto K, 2006, NEUROSCI LETT, V397, P25, DOI 10.1016/j.neulet.2005.11.067; Nyberg L, 2010, P NATL ACAD SCI USA, V107, P22682, DOI 10.1073/pnas.1012651108; Passot JB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032560; PFEFFERBAUM A, 1994, ARCH NEUROL-CHICAGO, V51, P874, DOI 10.1001/archneur.1994.00540210046012; Pfefferbaum A, 2004, NEUROBIOL AGING, V25, P175, DOI 10.1016/S0197-4580(03)00045-9; Pollack M, 2002, ANN NY ACAD SCI, V959, P93, DOI 10.1111/j.1749-6632.2002.tb02086.x; Rajapakse JC, 1997, IEEE T MED IMAGING, V16, P176, DOI 10.1109/42.563663; Salvadore G, 2009, BIOL PSYCHIAT, V66, P804, DOI 10.1016/j.biopsych.2009.05.025; SATOU T, 1995, BRAIN RES, V697, P35, DOI 10.1016/0006-8993(95)00748-F; SCHMAHMANN JD, 1992, J COMP NEUROL, V326, P159, DOI 10.1002/cne.903260202; Shacka JJ, 2005, CNS NEUROL DISORD-DR, V4, P25, DOI 10.2174/1568007053005127; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P34, DOI 10.4088/JCP.09m05305whi; Sublette ME, 2008, PROG NEURO-PSYCHOPH, V32, P1652, DOI 10.1016/j.pnpbp.2008.06.009; Sullivan EV, 2007, BRIT J RADIOL, V80, pS99, DOI 10.1259/bjr/22893432; Sultana R, 2010, J NEUROSCI RES, V88, P469, DOI 10.1002/jnr.22227; Talairach J., 1988, COPLANAR STEREOTAXIC; Tanabe H, 1997, EUR J NEUROSCI, V9, P848, DOI 10.1111/j.1460-9568.1997.tb01434.x; Thompson PM, 2001, NAT NEUROSCI, V4, P1253, DOI 10.1038/nn758; Tisserand DJ, 2004, CEREB CORTEX, V14, P966, DOI 10.1093/cercor/bhh057; Tohka J, 2004, NEUROIMAGE, V23, P84, DOI 10.1016/j.neuroimage.2004.05.007; Toman J, 2011, J BIOENERG BIOMEMBR, V43, P3, DOI 10.1007/s10863-011-9337-8; Uemura T, 2011, BIPOLAR DISORD, V13, P41, DOI 10.1111/j.1399-5618.2011.00897.x; van Haren NEM, 2008, BIOL PSYCHIAT, V63, P106, DOI 10.1016/j.biopsych.2007.01.004; Vinet J, 2002, NEUROSCI RES, V42, P269, DOI 10.1016/S0168-0102(02)00004-4; Warsh JJ, 2004, CLIN NEUROSCI RES, V4, P201, DOI 10.1016/j.cnr.2004.09.012; Winstein CJ, 1997, J NEUROPHYSIOL, V77, P1581, DOI 10.1152/jn.1997.77.3.1581	59	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e56663	10.1371/journal.pone.0056663	http://dx.doi.org/10.1371/journal.pone.0056663			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437205	gold, Green Published, Green Submitted			2022-12-25	WOS:000315184200135
J	Reinius, B; Kanduri, C				Reinius, Bjorn; Kanduri, Chandrasekhar			Elevated Expression of H19 and Igf2 in the Female Mouse Eye	PLOS ONE			English	Article							SEX-DIFFERENCES; BLADDER-CARCINOMA; GENE-EXPRESSION; X-CHROMOSOME; METHYLATION; CANCER; BRAIN; CTCF; ASSOCIATION; BINDING	The catalogue of genes expressed at different levels in the two sexes is growing, and the mechanisms underlying sex differences in regulation of the mammalian transcriptomes are being explored. Here we report that the expression of the imprinted non-protein-coding maternally expressed gene H19 was female-biased specifically in the female mouse eye (1.9-fold, p = 3.0E-6) while not being sex-biased in other somatic tissues. The female-to-male expression fold-change of H19 fell in the range expected from an effect of biallelic versus monoallelic expression. Recently, the possibility of sex-specific parent-of-origin allelic expression has been debated. This led us to hypothesize that H19 might express biallelically in the female mouse eye, thus escape its silencing imprint on the paternal allele specifically in this tissue. We therefore performed a sex-specific imprinting assay of H19 in female and male eye derived from a cross between Mus musculus and Mus spretus. However, this analysis demonstrated that H19 was exclusively expressed from the maternal gene copy, disproving the escape hypothesis. Instead, this supports that the female-biased expression of H19 is the result of upregulation of the single maternal. Furthermore, if H19 would have been expressed from both gene copies in the female eye, an associated downregulation of Insulin-like growth factor 2 (Igf2) was expected, since H19 and Igf2 compete for a common enhancer element located in the H19/Igf2 imprinted domain. On the contrary we found that also Igf2 was significantly upregulated in its expression in the female eye (1.2-fold, p = 6.1E-3), in further agreement with the conclusion that H19 is monoallelically elevated in females. The female-biased expression of H19 and Igf2 specifically in the eye may contribute to our understanding of sex differences in normal as well as abnormal eye physiology and processes.	[Reinius, Bjorn; Kanduri, Chandrasekhar] Univ Gothenburg, Inst Biomed, Dept Med & Clin Genet, Sahlgrenska Acad, Gothenburg, Sweden	University of Gothenburg	Reinius, B (corresponding author), Karolinska Inst, Dept Cell & Mol Biol, Stockholm, Sweden.	bjorn.reinius@licr.ki.se		Kanduri, Chandrasekhar/0000-0001-6271-9078; Reinius, Bjorn/0000-0002-7021-5248	Swedish Cancer Research foundation (Cancerfonden) [100422]; Swedish Research Council [VR-M: K2011-66X-20781-04-3, VR-NT: 621-2011-4996]; Barncancerfonden [PROJ11/067]	Swedish Cancer Research foundation (Cancerfonden)(Swedish Cancer Society); Swedish Research Council(Swedish Research CouncilEuropean Commission); Barncancerfonden	This work was supported by the grants from the Swedish Cancer Research foundation (Cancerfonden: Kontrakt no. 100422), Swedish Research Council (VR-M: K2011-66X-20781-04-3; VR-NT: 621-2011-4996), and Barncancerfonden (PROJ11/067) to C.K. The funders had no role in the study design, data collection or analysis, decision to publish, or preparation of the manuscript.	Ariel I, 2000, J CLIN PATHOL-MOL PA, V53, P320, DOI 10.1136/mp.53.6.320; ARIEL I, 1995, UROLOGY, V45, P335, DOI 10.1016/0090-4295(95)80030-1; Arnold AP, 2012, ENDOCRINOLOGY, V153, P2551, DOI 10.1210/en.2011-2134; Aubin-Horth N, 2009, MOL ECOL, V18, P3763, DOI 10.1111/j.1365-294X.2009.04313.x; BARLOW DP, 1991, NATURE, V349, P84, DOI 10.1038/349084a0; Barsyte-Lovejoy D, 2006, CANCER RES, V66, P5330, DOI 10.1158/0008-5472.CAN-06-0037; BARTOLOMEI MS, 1991, NATURE, V351, P153, DOI 10.1038/351153a0; Cook MB, 2009, CANCER EPIDEM BIOMAR, V18, P1174, DOI 10.1158/1055-9965.EPI-08-1118; Dean W, 1998, DEVELOPMENT, V125, P2273; DECHIARA TM, 1991, CELL, V64, P849, DOI 10.1016/0092-8674(91)90513-X; DeVeale B, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002600; Durcova-Hills G, 2004, DEV BIOL, V268, P105, DOI 10.1016/j.ydbio.2003.12.018; Gregg C, 2010, SCIENCE, V329, P682, DOI 10.1126/science.1190831; Hager R, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-303; Hark AT, 2000, NATURE, V405, P486, DOI 10.1038/35013106; Hibi K, 1996, CANCER RES, V56, P480; Hines M, 2011, ANNU REV NEUROSCI, V34, P69, DOI 10.1146/annurev-neuro-061010-113654; Jazin E, 2010, NAT REV NEUROSCI, V11, P9, DOI 10.1038/nrn2754; Kanduri C, 2000, CURR BIOL, V10, P853, DOI 10.1016/S0960-9822(00)00597-2; Lottin S, 2002, CARCINOGENESIS, V23, P1885, DOI 10.1093/carcin/23.11.1885; McCarthy MM, 2011, NAT NEUROSCI, V14, P677, DOI 10.1038/nn.2834; MOORE T, 1991, TRENDS GENET, V7, P45, DOI 10.1016/0168-9525(91)90230-N; Ober C, 2008, NAT REV GENET, V9, P911, DOI 10.1038/nrg2415; Ober C, 2011, TRENDS GENET, V27, P107, DOI 10.1016/j.tig.2010.12.004; Razeghinejad MR, 2005, MED HYPOTHESES, V64, P572, DOI 10.1016/j.mehy.2004.07.035; Reinius B, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000100; Reinius B, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-607; Reinius B, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-614; Sasaki H, 1995, DEVELOPMENT, V121, P4195; Tada T, 1998, DEV GENES EVOL, V207, P551, DOI 10.1007/s004270050146; Talebizadeh Z, 2006, GENOMICS, V88, P675, DOI 10.1016/j.ygeno.2006.07.016; Tanos V, 2004, INT J GYNECOL CANCER, V14, P521, DOI 10.1111/j.1048-891x.2004.014314.x; Wagner Heidi, 2008, Optometry, V79, P636, DOI 10.1016/j.optm.2008.01.024; Weth O, 2011, BIOCHEM CELL BIOL, V89, P459, DOI [10.1139/O11-033, 10.1139/o11-033]; Wijchers PJ, 2010, DEV CELL, V19, P477, DOI 10.1016/j.devcel.2010.08.005; Wu C, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r130; Yang X, 2006, GENOME RES, V16, P995, DOI 10.1101/gr.5217506	37	9	9	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e56611	10.1371/journal.pone.0056611	http://dx.doi.org/10.1371/journal.pone.0056611			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437185	Green Published, Green Submitted, gold			2022-12-25	WOS:000315184200119
J	Saito, A; Suzuki, HI; Horie, M; Ohshima, M; Morishita, Y; Abiko, Y; Nagase, T				Saito, Akira; Suzuki, Hiroshi I.; Horie, Masafumi; Ohshima, Mitsuhiro; Morishita, Yasuyuki; Abiko, Yoshimitsu; Nagase, Takahide			An Integrated Expression Profiling Reveals Target Genes of TGF-beta and TNF-alpha Possibly Mediated by MicroRNAs in Lung Cancer Cells	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; GROWTH-FACTOR-BETA; NF-KAPPA-B; UP-REGULATION; DIFFERENTIAL REGULATION; ADENOCARCINOMA CELLS; CARCINOMA CELLS; E-CADHERIN; PROGRESSION; PROMOTES	EMT (epithelial-mesenchymal transition) is crucial for cancer cells to acquire invasive phenotypes. In A549 lung adenocarcinoma cells, TGF-beta elicited EMT in Smad-dependent manner and TNF-alpha accelerated this process, as confirmed by cell morphology, expression of EMT markers, capacity of gelatin lysis and cell invasion. TNF-alpha stimulated the phosphorylation of Smad2 linker region, and this effect was attenuated by inhibiting MEK or JNK pathway. Comprehensive expression analysis unraveled genes differentially regulated by TGF-beta and TNF-alpha, such as cytokines, chemokines, growth factors and ECM (extracellular matrices), suggesting the drastic change in autocrine/paracrine signals as well as cell-to-ECM interactions. Integrated analysis of microRNA signature enabled us to identify a subset of genes, potentially regulated by microRNAs. Among them, we confirmed TGF-beta-mediated induction of miR-23a in lung epithelial cell lines, target genes of which were further identified by gene expression profiling. Combined with in silico approaches, we determined HMGN2 as a downstream target of miR-23a. These findings provide a line of evidence that the effects of TGF-beta and TNF-alpha were partially mediated by microRNAs, and shed light on the complexity of molecular events elicited by TGF-beta and TNF-alpha.	[Saito, Akira; Horie, Masafumi; Nagase, Takahide] Univ Tokyo, Grad Sch Med, Dept Resp Med, Bunkyo Ku, Tokyo, Japan; [Saito, Akira] Univ Tokyo, Div Hlth Serv Promot, Bunkyo Ku, Tokyo, Japan; [Suzuki, Hiroshi I.; Morishita, Yasuyuki] Univ Tokyo, Grad Sch Med, Dept Mol Pathol, Bunkyo Ku, Tokyo, Japan; [Ohshima, Mitsuhiro] Ohu Univ, Dept Biochem, Sch Pharmaceut Sci, Koriyama, Fukushima, Japan; [Abiko, Yoshimitsu] Nihon Univ, Sch Dent Matsudo, Dept Biochem & Mol Biol, Matsudo, Chiba, Japan	University of Tokyo; University of Tokyo; University of Tokyo; Nihon University	Saito, A (corresponding author), Univ Tokyo, Grad Sch Med, Dept Resp Med, Bunkyo Ku, Tokyo, Japan.	asaitou-tky@umin.ac.jp		Suzuki, Hiroshi/0000-0003-4682-5086	KAKENHI Ministry of Education, Culture, Sports, Science, and Technology; Ministry of Health, Labour and Welfare of Japan	KAKENHI Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan)	This work was supported by KAKENHI (Grants-in-Aid for Scientific Research) from the Ministry of Education, Culture, Sports, Science, and Technology and grants from the Ministry of Health, Labour and Welfare of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asiedu MK, 2011, CANCER RES, V71, P4707, DOI 10.1158/0008-5472.CAN-10-4554; Bhowmick NA, 2003, P NATL ACAD SCI USA, V100, P15548, DOI 10.1073/pnas.2536483100; Bierie B, 2006, NAT REV CANCER, V6, P506, DOI 10.1038/nrc1926; Borthwick LA, 2012, CANCER MICROENVIRON, V5, P45, DOI 10.1007/s12307-011-0080-9; Brabletz S, 2010, EMBO REP, V11, P670, DOI 10.1038/embor.2010.117; Cao MR, 2012, INT J ONCOL, V41, P869, DOI 10.3892/ijo.2012.1535; Chhabra R, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-232; Chua HL, 2007, ONCOGENE, V26, P711, DOI 10.1038/sj.onc.1209808; Cottonham CL, 2010, J BIOL CHEM, V285, P35293, DOI 10.1074/jbc.M110.160069; Deng LX, 2011, FEBS J, V278, P2152, DOI 10.1111/j.1742-4658.2011.08132.x; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Gerlitz G, 2010, BBA-GENE REGUL MECH, V1799, P80, DOI 10.1016/j.bbagrm.2009.10.007; GIARD DJ, 1973, J NATL CANCER I, V51, P1417, DOI 10.1093/jnci/51.5.1417; Heldin CH, 1997, NATURE, V390, P465, DOI 10.1038/37284; Horiguchi K, 2009, J BIOL CHEM, V284, P245, DOI 10.1074/jbc.M804777200; Huang SL, 2008, INT J CANCER, V123, P972, DOI 10.1002/ijc.23580; Ikushima H, 2010, NAT REV CANCER, V10, P415, DOI 10.1038/nrc2853; Jahid S, 2012, CANCER DISCOV, V2, P540, DOI 10.1158/2159-8290.CD-11-0267; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Kamitani S, 2011, INT ARCH ALLERGY IMM, V155, P119, DOI 10.1159/000318854; Karin M, 2006, NATURE, V441, P431, DOI 10.1038/nature04870; Kasai H, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-56; Kawata M, 2012, J BIOCHEM, V151, P205, DOI 10.1093/jb/mvr136; Lehtonen S, 2001, DIFFERENTIATION, V67, P154, DOI 10.1046/j.1432-0436.2001.670407.x; Li CW, 2012, CANCER RES, V72, P1290, DOI 10.1158/0008-5472.CAN-11-3123; Meng XB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018715; Min CY, 2008, J CELL BIOCHEM, V104, P733, DOI 10.1002/jcb.21695; Papadimitriou E, 2012, ONCOGENE, V31, P2862, DOI 10.1038/onc.2011.457; Peinado H, 2007, NAT REV CANCER, V7, P415, DOI 10.1038/nrc2131; Pietras K, 2010, EXP CELL RES, V316, P1324, DOI 10.1016/j.yexcr.2010.02.045; Saito RA, 2010, CANCER RES, V70, P2644, DOI 10.1158/0008-5472.CAN-09-3644; Saito RA, 2009, CANCER RES, V69, P2783, DOI 10.1158/0008-5472.CAN-08-3490; Sartor MA, 2010, BIOINFORMATICS, V26, P456, DOI 10.1093/bioinformatics/btp683; Sekimoto G, 2007, CANCER RES, V67, P5090, DOI 10.1158/0008-5472.CAN-06-4629; Shintani Y, 2008, J CELL BIOL, V180, P1277, DOI 10.1083/jcb.200708137; Shirakihara T, 2007, MOL BIOL CELL, V18, P3533, DOI 10.1091/mbc.E07-03-0249; Suzuki HI, 2011, J BIOCHEM, V149, P15, DOI 10.1093/jb/mvq113; Suzuki HI, 2009, NATURE, V460, P529, DOI 10.1038/nature08199; Takahashi E, 2010, J BIOL CHEM, V285, P4060, DOI 10.1074/jbc.M109.056523; Takahashi H, 2010, CANCER CELL, V17, P89, DOI 10.1016/j.ccr.2009.12.008; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Yamauchi Y, 2010, EXP LUNG RES, V36, P12, DOI 10.3109/01902140903042589; Zhang YZ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020319; Zhu LH, 2010, FEBS J, V277, P3726, DOI 10.1111/j.1742-4658.2010.07773.x	44	53	56	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e56587	10.1371/journal.pone.0056587	http://dx.doi.org/10.1371/journal.pone.0056587			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437179	Green Published, Green Submitted, gold			2022-12-25	WOS:000315184200115
J	Tannetta, DS; Dragovic, RA; Gardiner, C; Redman, CW; Sargent, IL				Tannetta, Dionne S.; Dragovic, Rebecca A.; Gardiner, Chris; Redman, Christopher W.; Sargent, Ian L.			Characterisation of Syncytiotrophoblast Vesicles in Normal Pregnancy and Pre-Eclampsia: Expression of Flt-1 and Endoglin	PLOS ONE			English	Article							PLACENTAL ALKALINE-PHOSPHATASE; MICROVILLOUS MEMBRANES; ENDOTHELIAL-CELLS; SOLUBLE ENDOGLIN; MATERNAL CIRCULATION; FLOW CYTOMETER; GROWTH-FACTOR; IN-VITRO; MICROPARTICLES; EXOSOMES	Background: The placental syncytiotrophoblast releases micro and nanovesicles (STBM), into the maternal circulation in normal pregnancy and in increased amounts in pre-eclampsia (PE), which have proinflammatory and antiangiogenic activity and are implicated in PE pathophysiology. Better characterisation of STBM is essential to understand their role in PE. Methods and Results: STBM prepared by placental lobe dual perfusion (pSTBM) and mechanical disruption (mSTBM) were analysed by four colour flow cytometry (4CFC), nanoparticle tracking analysis (NTA) and Western blotting to determine vesicle size, purity and Flt-1 and endoglin (Eng) expression. Biological activity of STBM associated Flt-1 and endoglin was assessed by the ability of VEGF, PIGF and TGF beta to bind to mSTBM and inhibit mSTBM induced endothelial monolayer disruption. STBM content was consistently high (similar to 87-95%) across the different preparations. However, surface antigen intensities differed, with significantly lower placental alkaline phosphatase (P<0.05) and Eng (P<0.05) expression on mSTBM, and Flt-1 (P<0.05) expression on pSTBM. For PE placenta derived preparations, pSTBM contained lower Eng positive STBM (P<0.05) and mSTBM Eng expression was increased (P<0.05). Western blotting revealed increased Flt-1/sFlt-1 (P<0.02) and decreased placental alkaline phosphatase (P = 0.0002) content of PE placenta pSTBM. Using NTA, perfused PE placentas released significantly larger MV (P<0.001). Finally, VEGF, PlGF and TGFb bound to mSTBM at physiologically relevant concentrations and inhibited mSTBM induced endothelial disruption (P<0.05-P<0.001). Conclusions: This study has found differences in physical and antigenic characteristics of normal and PE placenta STBM preparations produced by placental perfusion or mechanical disruption. We have also demonstrated that large quantities of biologically active STBM associated endoglin and Flt-1/sFlt-1 could contribute to the increased circulating levels measured in PE patients and add to the perturbation of the maternal vascular endothelium, normally attributed to non-membrane bound sFlt-1 and sEndoglin.	[Tannetta, Dionne S.; Dragovic, Rebecca A.; Gardiner, Chris; Redman, Christopher W.; Sargent, Ian L.] Univ Oxford, John Radcliffe Hosp, Nuffield Dept Obstet & Gynaecol, Oxford OX3 9DU, England	University of Oxford	Tannetta, DS (corresponding author), Univ Oxford, John Radcliffe Hosp, Nuffield Dept Obstet & Gynaecol, Oxford OX3 9DU, England.	dionne.tannetta@obs-gyn.ox.ac.uk	Gardiner, Chris/F-1178-2011	Gardiner, Chris/0000-0002-2318-0062; Dragovic, Rebecca/0000-0002-4634-5165	Wellcome Trust Programme Grant [GR079862MA]; Wellcome Trust Technology Development Grant [GR087730]; MRC Programme Grant [MR/J003360/1]; Oxford Partnership Comprehensive Biomedical Research Centre; Department of Health's NIHR Biomedical Research Centres; MRC [MR/J003360/1] Funding Source: UKRI; Medical Research Council [MR/J003360/1] Funding Source: researchfish	Wellcome Trust Programme Grant(Wellcome Trust); Wellcome Trust Technology Development Grant(Wellcome Trust); MRC Programme Grant(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Oxford Partnership Comprehensive Biomedical Research Centre; Department of Health's NIHR Biomedical Research Centres(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by a Wellcome Trust Programme Grant (ref GR079862MA), Wellcome Trust Technology Development Grant (ref GR087730), MRC Programme Grant MR/J003360/1 and by the Oxford Partnership Comprehensive Biomedical Research Centre with funding from the Department of Health's NIHR Biomedical Research Centres funding scheme. The views expressed in this publication are those of the authors and not necessarily those of the Department of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADENIYI FA, 1984, BRIT J OBSTET GYNAEC, V91, P857, DOI 10.1111/j.1471-0528.1984.tb03697.x; Alvarez-Erviti L, 2011, NEUROBIOL DIS, V42, P360, DOI 10.1016/j.nbd.2011.01.029; Aly AS, 2004, AM J OBSTET GYNECOL, V190, P252, DOI 10.1016/j.ajog.2003.07.003; Aras O, 2004, BLOOD, V103, P4545, DOI 10.1182/blood-2003-03-0713; ARKWRIGHT PD, 1994, GLYCOBIOLOGY, V4, P39, DOI 10.1093/glycob/4.1.39; ARKWRIGHT PD, 1991, PLACENTA, V12, P637, DOI 10.1016/0143-4004(91)90498-5; Ayers L, 2011, THROMB RES, V127, P370, DOI 10.1016/j.thromres.2010.12.014; Balaj L, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1180; Bergmann A, 2010, J CELL MOL MED, V14, P1857, DOI 10.1111/j.1582-4934.2009.00820.x; Burton GJ, 2004, J SOC GYNECOL INVEST, V11, P342, DOI 10.1016/j.jsgi.2004.03.003; Chandler WL, 2011, J THROMB HAEMOST, V9, P1216, DOI 10.1111/j.1538-7836.2011.04283.x; Cockell AP, 1997, BRIT J OBSTET GYNAEC, V104, P235, DOI 10.1111/j.1471-0528.1997.tb11052.x; Cocucci E, 2009, TRENDS CELL BIOL, V19, P43, DOI 10.1016/j.tcb.2008.11.003; DAVIES JO, 1985, J ROY SOC MED, V78, P899, DOI 10.1177/014107688507801104; De Jong WH, 2008, BIOMATERIALS, V29, P1912, DOI 10.1016/j.biomaterials.2007.12.037; Dragovic RA, 2011, NANOMED-NANOTECHNOL, V7, P780, DOI 10.1016/j.nano.2011.04.003; Enjeti AK, 2007, SEMIN THROMB HEMOST, V33, P771, DOI 10.1055/s-2007-1000369; Fisher Susan J, 2004, Reprod Biol Endocrinol, V2, P53, DOI 10.1186/1477-7827-2-53; Gardiner C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026313; Germain SJ, 2007, J IMMUNOL, V178, P5949, DOI 10.4049/jimmunol.178.9.5949; Gilbert JS, 2010, HYPERTENSION, V55, P380, DOI 10.1161/HYPERTENSIONAHA.109.141937; Godfrey KM, 2000, AM J CLIN NUTR, V71, p1344S, DOI 10.1093/ajcn/71.5.1344s; Goswami D, 2006, PLACENTA, V27, P56, DOI 10.1016/j.placenta.2004.11.007; Gu Y, 2008, J CLIN ENDOCR METAB, V93, P260, DOI 10.1210/jc.2007-1550; Gupta AK, 2005, HUM IMMUNOL, V66, P1146, DOI 10.1016/j.humimm.2005.11.003; Gupta AK, 2005, PLACENTA, V26, P59, DOI 10.1016/j.placenta.2004.04.004; Hedlund M, 2009, J IMMUNOL, V183, P340, DOI 10.4049/jimmunol.0803477; Holder BS, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.097014; HOLMGREN PA, 1979, OBSTET GYNECOL, V54, P631; Ishihara N, 2002, AM J OBSTET GYNECOL, V186, P158, DOI 10.1067/mob.2002.119176; Kaitu'u-Lino TJ, 2012, AM J PATHOL, V180, P888, DOI 10.1016/j.ajpath.2011.11.014; Knight M, 1998, BRIT J OBSTET GYNAEC, V105, P632, DOI 10.1111/j.1471-0528.1998.tb10178.x; Li ZH, 2007, HYPERTENSION, V50, P686, DOI 10.1161/HYPERTENSIONAHA.107.092098; Messerli M, 2010, PLACENTA, V31, P106, DOI 10.1016/j.placenta.2009.11.011; Perez-Pujol S, 2007, CYTOM PART A, V71A, P38, DOI 10.1002/cyto.a.20354; Powe CE, 2011, CIRCULATION, V123, P2856, DOI 10.1161/CIRCULATIONAHA.109.853127; Rajakumar A, 2012, HYPERTENSION, V59, P256, DOI 10.1161/HYPERTENSIONAHA.111.182170; Sabapatha A, 2006, AM J REPROD IMMUNOL, V56, P345, DOI 10.1111/j.1600-0897.2006.00435.x; Sadallah S, 2011, CLIN EXP IMMUNOL, V163, P26, DOI 10.1111/j.1365-2249.2010.04271.x; Sattar N, 2002, BMJ-BRIT MED J, V325, P157, DOI 10.1136/bmj.325.7356.157; Schneider H, 1985, Contrib Gynecol Obstet, V13, P40; SMARASON AK, 1993, BRIT J OBSTET GYNAEC, V100, P943, DOI 10.1111/j.1471-0528.1993.tb15114.x; SMITH NC, 1974, NATURE, V252, P302, DOI 10.1038/252302b0; Southcombe J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020245; Tannetta DS, 2003, J CLIN ENDOCR METAB, V88, P5995, DOI 10.1210/jc.2002-021924; Taylor DD, 2006, J IMMUNOL, V176, P1534, DOI 10.4049/jimmunol.176.3.1534; Thery C, 2009, NAT REV IMMUNOL, V9, P581, DOI 10.1038/nri2567; Venkatesha S, 2006, NAT MED, V12, P642, DOI 10.1038/nm1429; Yu T, 2012, J CONTROLLE IN PRESS; Zhao S, 2010, PLACENTA, V31, P512, DOI 10.1016/j.placenta.2010.03.014	50	127	133	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e56754	10.1371/journal.pone.0056754	http://dx.doi.org/10.1371/journal.pone.0056754			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437230	Green Published, Green Submitted, gold			2022-12-25	WOS:000315184200156
J	Teferedegne, B; Lewis, AM; Peden, K; Murata, H				Teferedegne, Belete; Lewis, Andrew M., Jr.; Peden, Keith; Murata, Haruhiko			Development of a Neutralization Assay for Influenza Virus Using an Endpoint Assessment Based on Quantitative Reverse-Transcription PCR	PLOS ONE			English	Article							HEMAGGLUTINATION-INHIBITING ANTIBODY; SEROLOGIC ASSAYS; MEDIATED NEUTRALIZATION; PARVOVIRUS B19; INFECTION; SERUM; VACCINATION; PROTECTION; CHALLENGE; DIAGNOSIS	A microneutralization assay using an ELISA-based endpoint assessment (ELISA-MN) is widely used to measure the serological response to influenza virus infection and vaccination. We have developed an alternative microneutralization assay for influenza virus using a quantitative reverse transcription PCR-based endpoint assessment (qPCR-MN) in order to improve upon technical limitations associated with ELISA-MN. For qPCR-MN, infected MDCK-London cells in 96-well cell-culture plates are processed with minimal steps such that resulting samples are amenable to high-throughput analysis by downstream one-step quantitative reverse transcription PCR (qRT-PCR; SYBR Green chemistry with primers targeting a conserved region of the M1 gene of influenza A viruses). The growth curves of three recent vaccine strains demonstrated that the qRT-PCR signal detected at 6 hours post-infection reflected an amplification of at least 100-fold over input. Using ferret antisera, we have established the feasibility of measuring virus neutralization at 6 hours post-infection, a duration likely confined to a single virus-replication cycle. The neutralization titer for qPCR-MN was defined as the highest reciprocal serum dilution necessary to achieve a 90% inhibition of the qRT-PCR signal; this endpoint was found to be in agreement with ELISA-MN using the same critical reagents in each assay. qPCR-MN was robust with respect to assay duration (6 hours vs. 12 hours). In addition, qPCR-MN appeared to be compliant with the Percentage Law (i.e., virus neutralization results appear to be consistent over an input virus dose ranging from 500 to 12,000 TCID50). Compared with ELISA-MN, qPCR-MN might have inherent properties conducive to reducing intra-and inter-laboratory variability while affording suitability for automation and high-throughput uses. Finally, our qRT-PCR-based approach may be broadly applicable to the development of neutralization assays for a wide variety of viruses.	[Teferedegne, Belete; Lewis, Andrew M., Jr.; Peden, Keith; Murata, Haruhiko] US FDA, Lab DNA Viruses, Div Viral Prod, Off Vaccines Res & Review,Ctr Biol Evaluat & Res, Bethesda, MD 20014 USA	US Food & Drug Administration (FDA)	Murata, H (corresponding author), US FDA, Lab DNA Viruses, Div Viral Prod, Off Vaccines Res & Review,Ctr Biol Evaluat & Res, Bethesda, MD 20014 USA.	haruhiko.murata@fda.hhs.gov			Division of Microbiology and Infectious Diseases, NIAID, NIH [YI-AI-4893-02NIAID]	Division of Microbiology and Infectious Diseases, NIAID, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was funded by a contract from the Division of Microbiology and Infectious Diseases, NIAID, NIH (YI-AI-4893-02NIAID; http://www.niaid.nih.gov/about/organization/dmid/Pages/default.aspx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberini I, 2009, VACCINE, V27, P5998, DOI 10.1016/j.vaccine.2009.07.079; Andrewes CH, 1933, BRIT J EXP PATHOL, V14, P367; Barr IG, 2010, VACCINE, V28, P1156, DOI 10.1016/j.vaccine.2009.11.043; Coudeville L, 2010, BMC MED RES METHODOL, V10, DOI 10.1186/1471-2288-10-18; Grund S, 2011, J VIROL METHODS, V171, P369, DOI 10.1016/j.jviromet.2010.11.024; Hale BG, 2008, J GEN VIROL, V89, P2359, DOI 10.1099/vir.0.2008/004606-0; Hancock K, 2009, NEW ENGL J MED, V361, P1945, DOI 10.1056/NEJMoa0906453; HOBSON D, 1972, J HYG-CAMBRIDGE, V70, P767, DOI 10.1017/S0022172400022610; Katz JM, 2011, EXPERT REV ANTI-INFE, V9, P669, DOI [10.1586/ERI.11.51, 10.1586/eri.11.51]; Klasse PJ, 2002, J GEN VIROL, V83, P2091, DOI 10.1099/0022-1317-83-9-2091; Klimov Alexander, 2012, Methods Mol Biol, V865, P25, DOI 10.1007/978-1-61779-621-0_3; Kong WP, 2006, P NATL ACAD SCI USA, V103, P15987, DOI 10.1073/pnas.0607564103; Kramski M, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-139; Lin YP, 2010, J VIROL, V84, P6769, DOI 10.1128/JVI.00458-10; Murata H, 2009, J VIROL METHODS, V162, P236, DOI 10.1016/j.jviromet.2009.08.012; Nefkens I, 2007, J CLIN VIROL, V39, P27, DOI 10.1016/j.jcv.2007.02.005; Pierson TC, 2006, VIROLOGY, V346, P53, DOI 10.1016/j.virol.2005.10.030; REED L. J., 1938, AMER JOUR HYG, V27, P493; Rowe T, 1999, J CLIN MICROBIOL, V37, P937, DOI 10.1128/JCM.37.4.937-943.1999; Saito T, 2003, J VIROL METHODS, V107, P81, DOI 10.1016/S0166-0934(02)00195-7; Seitz C, 2012, APPL MICROBIOL BIOT, V93, P601, DOI 10.1007/s00253-011-3569-8; Seitz C, 2010, J GEN VIROL, V91, P1754, DOI 10.1099/vir.0.020370-0; Stephenson I, 2007, VACCINE, V25, P4056, DOI 10.1016/j.vaccine.2007.02.039; Stephenson I, 2009, EMERG INFECT DIS, V15, P1250, DOI 10.3201/eid1508.081754; Temperton NJ, 2007, INFLUENZA OTHER RESP, V1, P105, DOI 10.1111/j.1750-2659.2007.00016.x; Tsai CJ, 2009, J NANOPART RES, V11, P1, DOI 10.1007/s11051-008-9474-0; van Santen VL, 2004, J VIROL METHODS, V115, P123, DOI 10.1016/j.jviromet.2003.09.022; Veguilla V, 2011, J CLIN MICROBIOL, V49, P2210, DOI 10.1128/JCM.00229-11; Wang W, 2008, J VIROL METHODS, V153, P111, DOI 10.1016/j.jviromet.2008.07.015; Wang W, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002081; Ward CL, 2004, J CLIN VIROL, V29, P179, DOI 10.1016/S1386-6532(03)00122-7; Wong S, 2006, J CLIN VIROL, V35, P407, DOI 10.1016/j.jcv.2005.12.008; Wood JM, 2012, VACCINE, V30, P210, DOI 10.1016/j.vaccine.2011.11.019; World Health Organization, MAN LAB DIAGN VIR SU; Yuan L, 2007, J VIROL METHODS, V146, P96, DOI 10.1016/j.jviromet.2007.06.009	35	18	19	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e56023	10.1371/journal.pone.0056023	http://dx.doi.org/10.1371/journal.pone.0056023			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437084	gold, Green Published, Green Submitted			2022-12-25	WOS:000315184200038
J	Wendel, SK; Mullis, CE; Eshleman, SH; Blankson, JN; Moore, RD; Keruly, JC; Brookmeyer, R; Quinn, TC; Laeyendecker, O				Wendel, Sarah K.; Mullis, Caroline E.; Eshleman, Susan H.; Blankson, Joel N.; Moore, Richard D.; Keruly, Jeanne C.; Brookmeyer, Ron; Quinn, Thomas C.; Laeyendecker, Oliver			Effect of Natural and ARV-Induced Viral Suppression and Viral Breakthrough on Anti-HIV Antibody Proportion and Avidity in Patients with HIV-1 Subtype B Infection	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; ENZYME-IMMUNOASSAY; ASSAYS	Background: Viral suppression and viral breakthrough impact the humoral immune response to HIV infection. We evaluated the impact of viral suppression and viral breakthrough on results obtained with two cross-sectional HIV incidence assays. Methods: All samples were collected from adults in the US who were HIV infected for >2 years. Samples were tested with the BED capture enzyme immunoassay (BED-CEIA) which measures the proportion of IgG that is HIV-specific, and with an antibody avidity assay based on the Genetic Systems 1/2+ O ELISA. We tested 281 samples: (1) 30 samples from 18 patients with natural control of HIV-1 infection known as elite controllers or suppressors (2) 72 samples from 18 adults on antiretroviral therapy (ART), with 1 sample before and 2-6 samples after ART initiation, and (3) 179 samples from 20 virally-suppressed adults who had evidence of viral breakthrough receiving ART (>400 copies/ml HIV RNA) and with subsequent viral suppression. Results: For elite suppressors, 10/18 had BED-CEIA values <0.8 normalized optical density units (OD-n) and these values did not change significantly over time. For patients receiving ART, 14/18 had BED-CEIA values that decreased over time, with a median decrease of 0.42 OD-n (range 0.10 to 0.63)/time point receiving ART. Three patterns of BED-CEIA values were observed during viral breakthrough: (1) values that increased then returned to pre-breakthrough values when viral suppression was re-established, (2) values that increased after viral breakthrough, and (3) values that did not change with viral breakthrough. Conclusions: Viral suppression and viral breakthrough were associated with changes in BED-CEIA values, reflecting changes in the proportion of HIV-specific IgG. These changes can result in misclassification of patients with long-term HIV infection as recently infected using the BED-CEIA, thereby influencing a falsely high value for cross-sectional incidence estimates.	[Wendel, Sarah K.; Quinn, Thomas C.; Laeyendecker, Oliver] NIAID, Div Intramural Res, NIH, Baltimore, MD USA; [Mullis, Caroline E.; Blankson, Joel N.; Moore, Richard D.; Keruly, Jeanne C.; Quinn, Thomas C.; Laeyendecker, Oliver] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; [Eshleman, Susan H.] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA; [Brookmeyer, Ron] Univ Calif Los Angeles, Sch Publ Hlth, Dept Biostat, Los Angeles, CA 90024 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); NIH National Institute on Aging (NIA); Johns Hopkins University; Johns Hopkins University; University of California System; University of California Los Angeles	Laeyendecker, O (corresponding author), NIAID, Div Intramural Res, NIH, Baltimore, MD USA.	olaeyen1@jhmi.edu	Laeyendecker, Oliver B/B-9331-2009	Laeyendecker, Oliver/0000-0002-6429-4760	Division of Intramural Research, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH); HIV Prevention Trials Network; NIAID [R01-AI-80328, R24-AI-067039]; National Institutes of Child Health and Human Development; National Institute on Drug Abuse (NIDA) [R01-DA-11602]; National Institute of Mental Health; Office of AIDS Research, of the NIH, Department of Health and Human Services [UM1-AI068613]; National Institute on Alcohol Abuse and Alcoholism [R01-AA16893]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI068613, UM1AI068613, ZIAAI000361, R01AI095068, R24AI067039, R01AI080328] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA016893] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA011602] Funding Source: NIH RePORTER	Division of Intramural Research, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); HIV Prevention Trials Network; NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institutes of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institute on Drug Abuse (NIDA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Office of AIDS Research, of the NIH, Department of Health and Human Services; National Institute on Alcohol Abuse and Alcoholism(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH). Additional support was provided by the HIV Prevention Trials Network sponsored by NIAID, National Institutes of Child Health and Human Development, National Institute on Drug Abuse (NIDA), National Institute of Mental Health, and Office of AIDS Research, of the NIH, Department of Health and Human Services (UM1-AI068613). The Johns Hopkins HIV Clinical Practice Cohort was supported by NIDA (R01-DA-11602), National Institute on Alcohol Abuse and Alcoholism (R01-AA16893), NIAID (R01-AI-80328) and NIAID (R24-AI-067039). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atun R, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001045; Bailey JR, 2006, J VIROL, V80, P4758, DOI 10.1128/JVI.80.10.4758-4770.2006; Bailey JR, 2009, J VIROL, V83, P88, DOI 10.1128/JVI.01958-08; Blankson JN, 2007, J VIROL, V81, P2508, DOI 10.1128/JVI.02165-06; Brookmeyer R, 2010, EPIDEMIOL REV, V32, P26, DOI 10.1093/epirev/mxq002; Busch MP, 2010, AIDS, V24, P2763, DOI 10.1097/QAD.0b013e32833f1142; Carr JK, 2010, JAIDS-J ACQ IMM DEF, V54, P297, DOI 10.1097/QAI.0b013e3181e0c3b3; Dobbs T, 2004, J CLIN MICROBIOL, V42, P2623, DOI 10.1128/JCM.42.6.2623-2628.2004; Hallett TB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005720; Hatano H, 2010, AIDS, V24, P2528, DOI 10.1097/QAD.0b013e32833dba03; Hayashida T, 2008, AIDS RES HUM RETROV, V24, P495, DOI 10.1089/aid.2007.0150; Janssen RS, 1998, JAMA-J AM MED ASSOC, V280, P42, DOI 10.1001/jama.280.1.42; Kahle E, 2012, 15 18 APR INT MICR C; Kassutto S, 2005, CLIN INFECT DIS, V40, P868, DOI 10.1086/428127; LAEYENDECKER O, 2010, 17 C RETR OPP INF SA; Laeyendecker O, 2011, AIDS RES HUM RETROVI, V27; Laeyendecker O, 2008, JAIDS-J ACQ IMM DEF, V48, P211, DOI 10.1097/QAI.0b013e3181743980; Marinda ET, 2010, JAIDS-J ACQ IMM DEF, V53, P496, DOI 10.1097/QAI.0b013e3181b61938; Masciotra S, 2010, 17 C RETR OPP INF SA; Mastro Timothy D, 2010, J HIV AIDS Surveill Epidemiol, V2, P1; Moore RD, 1998, J ACQ IMMUN DEF SYND, V17, pS38, DOI 10.1097/00042560-199801001-00011; Murphy G, 2008, EURO SURVEILL, V13; Nelson KE, 2002, AM J EPIDEMIOL, V156, P641, DOI 10.1093/aje/kwf086; Orrell C, 2011, AIDS RES TREAT, V2011, DOI 10.1155/2011/469127; Parekh BS, 2002, AIDS RES HUM RETROV, V18, P295, DOI 10.1089/088922202753472874; Taha TE, 2011, AIDS, V25, P1357, DOI 10.1097/QAD.0b013e3283489d45; Truong HHM, 2009, JAIDS-J ACQ IMM DEF, V51, P502, DOI 10.1097/QAI.0b013e3181a25383; van der Straten A, 2012, AIDS, V26, pF13, DOI 10.1097/QAD.0b013e3283522272; Welte A, 2010, EURO SURVEILL, V15, p[pii, 19589]; Zhang C, 2012, THER DRUG MONIT, V34, P481, DOI 10.1097/FTD.0b013e31825c6067	30	36	37	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e55525	10.1371/journal.pone.0055525	http://dx.doi.org/10.1371/journal.pone.0055525			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437058	Green Submitted, Green Published, gold			2022-12-25	WOS:000315184200020
J	Yang, TY; Eissler, CL; Hall, MC; Parker, LL				Yang, Tzu-Yi; Eissler, Christie L.; Hall, Mark C.; Parker, Laurie L.			A Multiple Reaction Monitoring (MRM) Method to Detect Bcr-Abl Kinase Activity in CML Using a Peptide Biosensor	PLOS ONE			English	Article							CHRONIC MYELOID-LEUKEMIA; MASS-SPECTROMETRY; PHOSPHORYLATION; IMATINIB; ASSAY; QUANTIFICATION; STOICHIOMETRY; INHIBITION; ACTIVATION; CELLS	The protein kinase Bcr-Abl plays a major role in the pathogenesis of chronic myelogenous leukemia (CML), and is the target of the breakthrough drug imatinib (Gleevec (TM)). While most patients respond well to imatinib, approximately 30% never achieve remission or develop resistance within 1-5 years of starting imatinib treatment. Evidence from clinical studies suggests that achieving at least 50% inhibition of a patient's Bcr-Abl kinase activity (relative to their level at diagnosis) is associated with improved patient outcomes, including reduced occurrence of resistance and longer maintenance of remission. Accordingly, sensitive assays for detecting Bcr-Abl kinase activity compatible with small amounts of patient material are desirable as potential companion diagnostics for imatinib. Here we report the detection of Bcr-Abl activity and inhibition by imatinib in the human CML cell line K562 using a cell-penetrating peptide biosensor and multiple reaction monitoring (MRM) on a triple quadrupole mass spectrometer. MRM enabled reproducible, selective detection of the peptide biosensor at fmol levels from aliquots of cell lysate equivalent to similar to 15,000 cells. This degree of sensitivity will facilitate the miniaturization of the entire assay procedure down to cell numbers approaching 15,000, making it practical for translational applications in patient cells in which the limited amount of available patient material often presents a major challenge.	[Yang, Tzu-Yi; Parker, Laurie L.] Purdue Univ, Dept Med Chem & Mol Pharmacol, W Lafayette, IN 47907 USA; [Eissler, Christie L.; Hall, Mark C.] Purdue Univ, Dept Biochem, W Lafayette, IN 47907 USA; [Yang, Tzu-Yi; Eissler, Christie L.; Hall, Mark C.; Parker, Laurie L.] Purdue Univ, Ctr Canc Res, W Lafayette, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Parker, LL (corresponding author), Purdue Univ, Dept Med Chem & Mol Pharmacol, W Lafayette, IN 47907 USA.	llparker@purdue.edu	Hall, Mark C./D-1698-2011; Parker, Laurie L/C-1510-2010	Parker, Laurie L/0000-0002-6234-3346; Hall, Mark/0000-0001-6429-2506	National Institutes of Health [R00CA127161, R21CA160129]; Project Development Team within the ICTSI NIH/NCRR Grant [TR000006]; NATIONAL CANCER INSTITUTE [R21CA160129, R00CA127161] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Project Development Team within the ICTSI NIH/NCRR Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The authors acknowledge support and funding for this work from the National Institutes of Health through the following grants to LLP: Howard Temin Pathway to Independence Award R00CA127161, R21CA160129; and by a Project Development Team within the ICTSI NIH/NCRR Grant Number TR000006. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcolea MP, 2012, MOL CELL PROTEOMICS, V11, P453, DOI 10.1074/mcp.M112.017483; [Anonymous], 2012, WORLD MARKET CANC TH; Balasubramaniam D, 2010, PROTEOMICS, V10, P4301, DOI 10.1002/pmic.201000232; Blagosklonny MV, 2003, CANCER BIOL THER, V2, P137, DOI 10.4161/cbt.2.2.286; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; de Lavallade H, 2008, J CLIN ONCOL, V26, P3358, DOI 10.1200/JCO.2007.15.8154; Disis M, 2004, ASSAY VALIDATION VAC; Domanski D, 2010, ANAL CHEM, V82, P5610, DOI 10.1021/ac1005553; Druker BJ, 2006, NEW ENGL J MED, V355, P2408, DOI 10.1056/NEJMoa062867; Eissler CL, 2011, ANAL BIOCHEM, V418, P267, DOI 10.1016/j.ab.2011.07.015; Houseman BT, 2002, NAT BIOTECHNOL, V20, P270, DOI 10.1038/nbt0302-270; Lee AG, 2012, BIOMED MICRODEVICES, V14, P247, DOI 10.1007/s10544-011-9602-y; MacLean B, 2010, BIOINFORMATICS, V26, P966, DOI 10.1093/bioinformatics/btq054; Pisabarro MT, 1996, BIOCHEMISTRY-US, V35, P10634, DOI 10.1021/bi960203t; Placzek EA, 2010, ANAL BIOCHEM, V397, P73, DOI 10.1016/j.ab.2009.09.048; Pratz KW, 2009, BLOOD, V113, P3938, DOI 10.1182/blood-2008-09-177030; Proctor A, 2012, ANAL CHEM, V84, P7195, DOI 10.1021/ac301489d; Proctor A, 2012, ANALYST, V137, P3028, DOI 10.1039/c2an16162a; Schmidt C, 2011, NAT BIOTECHNOL, V29, P955, DOI 10.1038/nbt1111-955; SONGYANG Z, 1995, NATURE, V373, P536, DOI 10.1038/373536a0; Storey S, 2009, NAT REV DRUG DISCOV, V8, P447, DOI [10.1038/nrd2908, 10.1038/nrd2873]; Sylvester JE, 2010, MOL CANCER THER, V9, P1469, DOI 10.1158/1535-7163.MCT-10-0157; Tang JB, 2012, CHEMBIOCHEM, V13, P665, DOI 10.1002/cbic.201100763; White D, 2007, J CLIN ONCOL, V25, P4445, DOI 10.1200/JCO.2006.09.9499; Wolf-Yadlin A, 2007, P NATL ACAD SCI USA, V104, P5860, DOI 10.1073/pnas.0608638104; Wu D, 2005, ANAL BIOCHEM, V347, P67, DOI 10.1016/j.ab.2005.09.001; Wu D, 2008, ANAL BIOCHEM, V375, P18, DOI 10.1016/j.ab.2007.12.023; Zhang Y, 2008, CHINESE J CHEM, V26, P1863, DOI 10.1002/cjoc.200890336; Zhou GC, 2011, ANAL BIOCHEM, V408, P5, DOI 10.1016/j.ab.2010.08.034	29	16	19	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e56627	10.1371/journal.pone.0056627	http://dx.doi.org/10.1371/journal.pone.0056627			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437189	Green Published, Green Submitted, gold			2022-12-25	WOS:000315184200122
J	Yue, XP; Li, R; Xie, WM; Xu, P; Chang, TC; Liu, L; Cheng, F; Zhang, RF; Lan, XY; Chen, H; Lei, CZ				Yue, Xiang-Peng; Li, Ran; Xie, Wen-Mei; Xu, Ping; Chang, Ti-Cheng; Liu, Li; Cheng, Feng; Zhang, Run-Feng; Lan, Xian-Yong; Chen, Hong; Lei, Chu-Zhao			Phylogeography and Domestication of Chinese Swamp Buffalo	PLOS ONE			English	Article							DNA D-LOOP; GENETIC DIVERSITY; WATER-BUFFALO; BUBALUS-BUBALIS; MITOCHONDRIAL-DNA; MATERNAL ORIGIN; RIVER; SEQUENCES; DIFFERENTIATION; POPULATIONS	To further probe into whether swamp buffaloes were domesticated once or multiple times in China, this survey examined the mitochondrial DNA (mtDNA) Control Region (D-loop) diversity of 471 individuals representing 22 populations of 455 Chinese swamp buffaloes and 16 river buffaloes. Phylogenetic analysis revealed that Chinese swamp buffaloes could be divided into two distinct lineages, A and B, which were defined previously. Of the two lineages, lineage A was predominant across all populations. For predominant lineage A, Southwestern buffalo populations possess the highest genetic diversity among the three hypothesized domestication centers (Southeastern, Central, and Southwestern China), suggesting Southwestern China as the most likely location for the domestication of lineage A. However, a complex pattern of diversity is detected for the lineage B, preventing the unambiguous pinpointing of the exact place of domestication center and suggesting the presence of a long-term, strong gene flow among swamp buffalo populations caused by extensive migrations of buffaloes and frequent human movements along the Yangtze River throughout history. Our current study suggests that Southwestern China is the most likely domestication center for lineage A, and may have been a primary center of swamp buffalo domestication. More archaeological and genetic evidence is needed to show the process of domestication.	[Yue, Xiang-Peng; Li, Ran; Xu, Ping; Lan, Xian-Yong; Chen, Hong; Lei, Chu-Zhao] NW A&F Univ, Coll Anim Sci & Technol, Shaanxi Key Lab Mol Biol Agr, Yangling, Shaanxi, Peoples R China; [Xie, Wen-Mei] Pingliang Med Coll, Dept Basic Med, Pingliang, Gansu, Peoples R China; [Chang, Ti-Cheng] Penn State Univ, Dept Dairy & Anim Sci, Ctr Reprod Biol & Hlth, Coll Agr Sci, University Pk, PA 16802 USA; [Liu, Li] Stanford Univ, Dept E Asian Languages & Cultures, Stanford, CA 94305 USA; [Cheng, Feng] Xinyang Agr Coll, Dept Anim Sci, Xinyang, Henan, Peoples R China; [Zhang, Run-Feng] Hubei Normal Univ, Coll Life Sci, Huangshi, Hubei, Peoples R China	Northwest A&F University - China; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Stanford University; Hubei Normal University	Lei, CZ (corresponding author), NW A&F Univ, Coll Anim Sci & Technol, Shaanxi Key Lab Mol Biol Agr, Yangling, Shaanxi, Peoples R China.	leichuzhao1118@126.com	Chang, Ti-Cheng/N-3252-2018; Zhang, RF/GXZ-8547-2022; Chang, Ti-Cheng/HHS-7370-2022		National Natural Science Foundation of China [31272399, 31072001]; Agricultural Science & Technology Project of Shaanxi Province [2012K02-02]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Agricultural Science & Technology Project of Shaanxi Province	This work was supported by the National Natural Science Foundation of China (Grant Nos. 31272399, 31072001) and Agricultural Science & Technology Project of Shaanxi Province (No.2012K02-02). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMANO T, 1994, ANIM GENET, V25, P29, DOI 10.1111/j.1365-2052.1994.tb00400.x; [Anonymous], KAOGU; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Barker JSF, 1997, ANIM GENET, V28, P1, DOI 10.1111/j.1365-2052.1997.00036.x; Barker JSF, 1997, ANIM GENET, V28, P103, DOI 10.1111/j.1365-2052.1997.00085.x; Beja-Pereira A, 2004, SCIENCE, V304, P1781, DOI 10.1126/science.1096008; Chen SY, 2006, GENE, V376, P216, DOI 10.1016/j.gene.2006.03.009; Chen SY, 2010, MOL BIOL EVOL, V27, P1, DOI 10.1093/molbev/msp213; Chen SY, 2005, MOL PHYLOGENET EVOL, V37, P804, DOI 10.1016/j.ympev.2005.06.014; Chen Y.C., 1989, Buffalo Journal, V5, P51; COCKRILL WR, 1981, BRIT VET J, V137, P8, DOI 10.1016/S0007-1935(17)31782-7; DEJONG PED, 1965, J ASIAN STUD, V24, P283, DOI 10.2307/2050566; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Ge J, 1997, MIGRATION HIST CHINA; Groves CP, 1996, Z SAUGETIERKD, V61, P327; Guo SC, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-73; HIGHAM CFW, 1981, J ARCHAEOL SCI, V8, P353, DOI 10.1016/0305-4403(81)90035-2; Higham Ch., 1989, ARCHAEOLOGY MAINLAND; Hu WP, 1997, BIOCHEM GENET, V35, P225, DOI 10.1023/A:1021892915368; Jiang Y, 1995, GUDIA XINAN SICHOU Z; Kierstein G, 2004, MOL PHYLOGENET EVOL, V30, P308, DOI 10.1016/S1055-7903(03)00221-5; Kikkawa Y, 1997, ANIM GENET, V28, P195, DOI 10.1111/j.1365-2052.1997.00101.x; Kumar S, 2007, ANIM GENET, V38, P227, DOI 10.1111/j.1365-2052.2007.01602.x; Kumar S, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-186; Lau CH, 1998, ANIM GENET, V29, P253, DOI 10.1046/j.1365-2052.1998.00309.x; Legendre P, 2002, SYST BIOL, V51, P199, DOI 10.1080/10635150252899725; Lei CZ, 2007, ANIM GENET, V38, P97, DOI 10.1111/j.1365-2052.2007.01567.x; Lei CZ, 2011, ANIM GENET, V42, P432, DOI 10.1111/j.1365-2052.2011.02174.x; Lei CZ, 2007, ASIAN AUSTRAL J ANIM, V20, P645, DOI 10.5713/ajas.2007.645; Lei CZ, 2007, ASIAN AUSTRAL J ANIM, V20, P471, DOI 10.5713/ajas.2007.471; Liu Li, 2006, KAOGU XUEBAO, V2, P141; Liu RY, 2007, ASIAN AUSTRAL J ANIM, V20, P178; Luikart G, 2001, P NATL ACAD SCI USA, V98, P5927, DOI 10.1073/pnas.091591198; Mason I.L., 1974, HUSBANDRY HLTH DOMES, P1; Milne I, 2004, BIOINFORMATICS, V20, P1806, DOI 10.1093/bioinformatics/bth155; Mudar K., 2007, ASIAN PERSPECT, V46, P298, DOI DOI 10.1353/ASI.2007.0013; Nanda Amarjit Singh, 2003, Animal Science Journal, V74, P443, DOI 10.1046/j.1344-3941.2003.00138.x; Navani N, 2002, ANIM GENET, V33, P149, DOI 10.1046/j.1365-2052.2002.00823.x; O'Reilly Dougald J.W., 2006, Asian Perspectives, V45, P188, DOI 10.1353/asi.2006.0024; Patel Ajita, 1998, ARC PUBLICATIES, V18, P180; Patel Ajita, 1998, S ASIAN ARCHAEOLOGY, P101; QIU H, 1986, BOVINE BREEDS CHINA; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Shapiro B, 2004, SCIENCE, V306, P1561, DOI 10.1126/science.1101074; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tanaka K, 1996, BIOCHEM GENET, V34, P443, DOI 10.1007/BF00570125; TANAKA K, 1995, BIOCHEM GENET, V33, P137, DOI 10.1007/BF00554726; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tong E, 1983, WENWU, V9, P73; Troy CS, 2001, NATURE, V410, P1088, DOI 10.1038/35074088; Woese CR, 2002, P NATL ACAD SCI USA, V99, P8742, DOI 10.1073/pnas.132266999; Xiaochen Li, 2000, GUJIZHUI DONGWU XUEB, V38, P218; Yunnan Museum, 1995, KAOGU, V9, P775; Zhang Y, 2007, ANIM GENET, V38, P569, DOI 10.1111/j.1365-2052.2007.01648.x; Zhang Y, 2011, ANIM GENET, V42, P366, DOI 10.1111/j.1365-2052.2010.02166.x; Zhu FY, 2005, JIEMI WASHAN DECODIN; Zong Guanfu, 1985, SHIQIAN YANJIU, V4, P46; [No title captured]	58	24	27	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e56552	10.1371/journal.pone.0056552	http://dx.doi.org/10.1371/journal.pone.0056552			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437167	gold, Green Published, Green Submitted			2022-12-25	WOS:000315184200104
J	Fanning, LB; Buckley, CC; Xing, W; Breslow, RG; Katz, HR				Fanning, Laura B.; Buckley, Carolyn C.; Xing, Wei; Breslow, Rebecca G.; Katz, Howard R.			Downregulation of Key Early Events in the Mobilization of Antigen-bearing Dendritic Cells by Leukocyte Immunoglobulin-like Receptor B4 in a Mouse Model of Allergic Pulmonary Inflammation	PLOS ONE			English	Article							T-CELLS; AIRWAY INFLAMMATION; ENDOTHELIAL-CELLS; INHALED ANTIGEN; LYMPH-NODES; IN-VIVO; DIFFERENTIAL REGULATION; CUTTING EDGE; EXPRESSION; ASTHMA	Leukocyte Immunoglobulin-like Receptor B4 (LILRB4) null mice have an exacerbated T helper cell type 2 (Th2) immune response and pulmonary inflammation compared with Lilrb4(+/+) animals when sensitized intranasally with ovalbumin (OVA) and low-dose lipopolysaccharide (LPS) followed by challenge with OVA. Moreover, OVA-challenged Lilrb4(-/-) mice exhibit greater migration of antigen (Ag)-bearing dendritic cells (DCs) to lymph nodes and accumulation of interleukin 4- and interleukin 5-producing lymph node lymphocytes. The main objective of this study was to determine how the absence of LILRB4 leads to a greater number of DCs in the lymph nodes of Ag-challenged mice and increased lung Th2 inflammation. Mice were sensitized intranasally with PBS alone or containing OVA and LPS; additional cohorts were subsequently challenged with OVA. Expression of chemokine (C-C motif) ligand 21 (CCL21) in the lung was assessed immunohistologically. OVA ingestion and expression of LILRB4 and chemokine (C-C motif) receptor 7 (CCR7) were quantified by flow cytometry. Inhalation of OVA and LPS induced upregulation of LILRB4 selectively on lung Ag-bearing DCs. After sensitization and challenge, the lung lymphatic vessels of Lilrb4(-/-) mice expressed more CCL21, a chemokine that directs the migration of DCs from peripheral tissue to draining lymph nodes, compared with Lilrb4(+/+) mice. In addition, lung DCs of challenged Lilrb4(-/-) mice expressed more CCR7, the CCL21 receptor. The lungs of challenged Lilrb4(-/-) mice also contained significantly greater numbers of CD4+ cells expressing interleukin-4 or interleukin-5, consistent with the greater number of Ag-bearing DCs and Th2 cells in lymph nodes and the attendant exacerbated Th2 lung pathology. Our data establish a new mechanism by which LILRB4 can downregulate the development of pathologic allergic inflammation: reduced upregulation of key molecules needed for DC migration leading to decreases in Th2 cells in lymph nodes and their target tissue.	[Katz, Howard R.] Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA; Brigham & Womens Hosp, Div Rheumatol Immunol & Allergy, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital	Katz, HR (corresponding author), Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA.	hkatz@rics.bwh.harvard.edu			National Institutes of Health [AI07306, AI41144, HL36110]; American Lung Association; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL036110] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007306, R01AI041144] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Lung Association; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by AI07306, AI41144, and HL36110 from the National Institutes of Health; and a Senior Research Training Fellowship from the American Lung Association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexis NE, 2004, J ALLERGY CLIN IMMUN, V114, P1325, DOI 10.1016/j.jaci.2004.09.002; Baluk P, 2005, J CLIN INVEST, V115, P247, DOI 10.1172/JCI200522037; Banchereau J, 2000, ANNU REV IMMUNOL, V18, P767, DOI 10.1146/annurev.immunol.18.1.767; Banerji S, 1999, J CELL BIOL, V144, P789, DOI 10.1083/jcb.144.4.789; Benedict CA, 2006, PLOS PATHOG, V2, P164, DOI 10.1371/journal.ppat.0020016; Besnard AG, 2011, EUR J IMMUNOL, V41, P1675, DOI 10.1002/eji.201041033; Breslow RG, 2010, J IMMUNOL, V184, P1003, DOI 10.4049/jimmunol.0900877; Britschgi MR, 2010, EUR J IMMUNOL, V40, P1266, DOI 10.1002/eji.200939921; Chang CC, 2009, J IMMUNOL, V182, P5208, DOI 10.4049/jimmunol.0804048; Daheshia M, 2001, J EXP MED, V194, P227, DOI 10.1084/jem.194.2.227; Dieu MC, 1998, J EXP MED, V188, P373, DOI 10.1084/jem.188.2.373; Eisenbarth SC, 2002, J EXP MED, V196, P1645, DOI 10.1084/jem.20021340; Feldweg AM, 2003, EUR J IMMUNOL, V33, P2262, DOI 10.1002/eji.200323978; Forster R, 1999, CELL, V99, P23, DOI 10.1016/S0092-8674(00)80059-8; Gunn MD, 1999, J EXP MED, V189, P451, DOI 10.1084/jem.189.3.451; Hintzen G, 2006, J IMMUNOL, V177, P7346, DOI 10.4049/jimmunol.177.10.7346; Huh JC, 2003, J EXP MED, V198, P19, DOI 10.1084/jem.20021328; Itakura M, 2001, J IMMUNOL, V166, P2071, DOI 10.4049/jimmunol.166.3.2071; Itano AA, 2003, NAT IMMUNOL, V4, P733, DOI 10.1038/ni957; Jahnsen FL, 2001, THORAX, V56, P823, DOI 10.1136/thorax.56.11.823; Jang MH, 2006, J IMMUNOL, V176, P803, DOI 10.4049/jimmunol.176.2.803; Koya T, 2006, AM J RESP CRIT CARE, V173, P42, DOI 10.1164/rccm.200505-783OC; Kriehuber E, 2001, J EXP MED, V194, P797, DOI 10.1084/jem.194.6.797; Lambrecht BN, 1998, J IMMUNOL, V160, P4090; Lo JC, 2003, J CLIN INVEST, V112, P1495, DOI 10.1172/JCI200319188; Martin-Fontecha A, 2003, J EXP MED, V198, P615, DOI 10.1084/jem.20030448; Martin-Fontecha Alfonso, 2009, Handb Exp Pharmacol, P31, DOI 10.1007/978-3-540-71029-5_2; Medoff BD, 2008, ANNU REV IMMUNOL, V26, P205, DOI 10.1146/annurev.immunol.26.021607.090312; Miteva DO, 2010, CIRC RES, V106, P920, DOI 10.1161/CIRCRESAHA.109.207274; Morandi F, 2011, BLOOD, V118, P5840, DOI 10.1182/blood-2011-05-352393; Morandi F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011763; Ogata M, 1999, BLOOD, V93, P3225, DOI 10.1182/blood.V93.10.3225.410k25_3225_3232; Ohl L, 2004, IMMUNITY, V21, P279, DOI 10.1016/j.immuni.2004.06.014; Pflicke H, 2009, J EXP MED, V206, P2925, DOI 10.1084/jem.20091739; Ritter U, 2004, J LEUKOCYTE BIOL, V76, P472, DOI 10.1189/jlb.0104037; Saeki H, 1999, J IMMUNOL, V162, P2472; Schacht V, 2003, EMBO J, V22, P3546, DOI 10.1093/emboj/cdg342; Schaumann F, 2008, AM J RESP CRIT CARE, V177, P1307, DOI 10.1164/rccm.200706-870OC; Sozzani S, 1998, J IMMUNOL, V161, P1083; Strickland DH, 2006, J EXP MED, V203, P2649, DOI 10.1084/jem.20060155; Sugaya M, 2006, J IMMUNOL, V177, P7665, DOI 10.4049/jimmunol.177.11.7665; Tal O, 2011, J EXP MED, V208, P2141, DOI 10.1084/jem.20102392; Tomei AA, 2009, J IMMUNOL, V183, P4273, DOI 10.4049/jimmunol.0900835; van Rijt LS, 2005, J EXP MED, V201, P981, DOI 10.1084/jem.20042311; van Rijt LS, 2002, BLOOD, V100, P3663, DOI 10.1182/blood-2002-03-0673; Vermaelen K, 2003, AM J RESP CELL MOL, V29, P405, DOI 10.1165/rcmb.2003-0008OC; Vigl B, 2011, BLOOD, V118, P205, DOI 10.1182/blood-2010-12-326447; von Garnier C, 2007, J IMMUNOL, V179, P5748, DOI 10.4049/jimmunol.179.9.5748; Zhou JS, 2007, J EXP MED, V204, P2797, DOI 10.1084/jem.20071391; Zhou JS, 2005, EUR J IMMUNOL, V35, P1530, DOI 10.1002/eji.200425895; Zhou JS, 2003, J EXP MED, V198, P1243, DOI 10.1084/jem.20030906	51	7	8	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2013	8	2							e57007	10.1371/journal.pone.0057007	http://dx.doi.org/10.1371/journal.pone.0057007			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093HR	23431396	Green Published, gold, Green Submitted			2022-12-25	WOS:000315182800039
J	Moren, J; Shibata, T; Doya, K				Moren, Jan; Shibata, Tomohiro; Doya, Kenji			The Mechanism of Saccade Motor Pattern Generation Investigated by a Large-Scale Spiking Neuron Model of the Superior Colliculus	PLOS ONE			English	Article							MESENCEPHALIC RETICULAR-FORMATION; INTERMEDIATE GRAY LAYER; FRONTAL EYE FIELD; BRAIN-STEM; REVERSIBLE INACTIVATION; IN-VITRO; MONKEY; MOVEMENTS; CONNECTIONS; PRIMATE	The subcortical saccade-generating system consists of the retina, superior colliculus, cerebellum and brainstem motoneuron areas. The superior colliculus is the site of sensory-motor convergence within this basic visuomotor loop preserved throughout the vertebrates. While the system has been extensively studied, there are still several outstanding questions regarding how and where the saccade eye movement profile is generated and the contribution of respective parts within this system. Here we construct a spiking neuron model of the whole intermediate layer of the superior colliculus based on the latest anatomy and physiology data. The model consists of conductance-based spiking neurons with quasi-visual, burst, buildup, local inhibitory, and deep layer inhibitory neurons. The visual input is given from the superficial superior colliculus and the burst neurons send the output to the brainstem oculomotor nuclei. Gating input from the basal ganglia and an integral feedback from the reticular formation are also included. We implement the model in the NEST simulator and show that the activity profile of bursting neurons can be reproduced by a combination of NMDA-type and cholinergic excitatory synaptic inputs and integrative inhibitory feedback. The model shows that the spreading neural activity observed in vivo can keep track of the collicular output over time and reset the system at the end of a saccade through activation of deep layer inhibitory neurons. We identify the model parameters according to neural recording data and show that the resulting model recreates the saccade size-velocity curves known as the saccadic main sequence in behavioral studies. The present model is consistent with theories that the superior colliculus takes a principal role in generating the temporal profiles of saccadic eye movements, rather than just specifying the end points of eye movements.	[Moren, Jan] Kyoto Univ, Grad Sch Informat, Kyoto, Japan; [Shibata, Tomohiro] Nara Inst Sci & Technol, Math Informat Lab, Nara, Japan; [Doya, Kenji] Okinawa Inst Sci & Technol, Neural Computat Unit, Okinawa, Japan	Kyoto University; Nara Institute of Science & Technology; Okinawa Institute of Science & Technology Graduate University	Moren, J (corresponding author), Kyoto Univ, Grad Sch Informat, Kyoto, Japan.	jan.moren@gmail.com	Doya, Kenji/B-5841-2015	Doya, Kenji/0000-0002-2446-6820; Shibata, Tomohiro/0000-0002-8766-4250	Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan [06060246]; Next Generation Supercomputing Project; MEXT (Ministry of of Education, Culture, Sports, Science, and Technology) in Japan	Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Next Generation Supercomputing Project(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); MEXT (Ministry of of Education, Culture, Sports, Science, and Technology) in Japan	This study was funded by the Research and Development of the Next-Generation Integrated Simulation of Living Matter, a part of the Development and Use of the Next-Generation Supercomputer Project of the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan, grant number 06060246 (http://www.csrp.riken.jp/index_e.html and http://www.nsc.riken.jp/index-eng.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are very grateful to the Riken Integrated Cluster of Clusters (RICC) at RIKEN for supplying the computing resources, and to the Next Generation Supercomputing Project and MEXT (Ministry of of Education, Culture, Sports, Science, and Technology) in Japan for the support. We also thank Drs. Yasushi Kobayashi, Tadashi Ogawa and Kae Nakamura for very productive discussions.	Aizawa H, 1998, J NEUROPHYSIOL, V79, P2082, DOI 10.1152/jn.1998.79.4.2082; Aizawa H, 1999, J NEUROPHYSIOL, V82, P1642, DOI 10.1152/jn.1999.82.3.1642; Anderson RW, 1998, J NEUROPHYSIOL, V80, P798, DOI 10.1152/jn.1998.80.2.798; BALOH RW, 1975, NEUROLOGY, V25, P1065, DOI 10.1212/WNL.25.11.1065; Brette R, 2005, J NEUROPHYSIOL, V94, P3637, DOI 10.1152/jn.00686.2005; Choi WY, 2009, J NEUROSCI, V29, P7166, DOI 10.1523/JNEUROSCI.5038-08.2009; Cromer JA, 2007, J NEUROPHYSIOL, V98, P835, DOI 10.1152/jn.00308.2007; Cui H, 2003, J NEUROPHYSIOL, V89, P3128, DOI 10.1152/jn.01067.2002; Everling S, 1998, J NEUROPHYSIOL, V79, P511, DOI 10.1152/jn.1998.79.2.511; FUCHS AF, 1967, J PHYSIOL-LONDON, V191, P609, DOI 10.1113/jphysiol.1967.sp008271; Gandhi NJ, 2008, EXP BRAIN RES, V189, P35, DOI 10.1007/s00221-008-1401-1; Gewaltig MO, 2007, SCHOLARPEDIA, V2, P1430, DOI [DOI 10.4249/SCH0LARPEDIA.1430, 10.4249/scholarpedia.1430, DOI 10.4249/SCHOLARPEDIA.1430]; Girard B, 2005, PROG NEUROBIOL, V77, P215, DOI 10.1016/j.pneurobio.2005.11.001; Gisbergen J, 1985, EXPT BRAIN RES, V57; Goossens HHLM, 2000, J NEUROPHYSIOL, V83, P3430, DOI 10.1152/jn.2000.83.6.3430; Grantyn AA, 2004, METH NE FRO NEUROSCI, P107; Hafed ZM, 2009, SCIENCE, V323, P940, DOI 10.1126/science.1166112; Harris CM, 2006, BIOL CYBERN, V95, P21, DOI 10.1007/s00422-006-0064-x; Helms MC, 2004, J NEUROPHYSIOL, V91, P1706, DOI 10.1152/jn.00705.2003; Hikosaka O, 2000, PHYSIOL REV, V80, P953, DOI 10.1152/physrev.2000.80.3.953; Isa T, 2002, PROG NEUROBIOL, V66, P205, DOI 10.1016/S0301-0082(02)00006-0; Isa T, 2009, J NEUROPHYSIOL, V102, P2581, DOI 10.1152/jn.00498.2009; Isoda M, 2008, J NEUROPHYSIOL, V100, P1332, DOI 10.1152/jn.90275.2008; JAY MF, 1987, J NEUROPHYSIOL, V57, P22, DOI 10.1152/jn.1987.57.1.22; Keller EL, 2004, METH NE FRO NEUROSCI, P277; Krauzlis RJ, 2005, NEUROSCIENTIST, V11, P124, DOI 10.1177/1073858404271196; Lee P, 2006, J NEUROSCI, V26, P4763, DOI 10.1523/JNEUROSCI.0724-06.2006; LEFEVRE P, 1992, NEURAL NETWORKS, V5, P871, DOI 10.1016/S0893-6080(05)80084-X; Marino RA, 2008, J NEUROPHYSIOL, V100, P2564, DOI 10.1152/jn.90688.2008; MEREDITH MA, 1986, J NEUROPHYSIOL, V56, P640, DOI 10.1152/jn.1986.56.3.640; Meredith MA, 1998, J NEUROPHYSIOL, V79, P1597, DOI 10.1152/jn.1998.79.3.1597; Munoz DP, 1998, J NEUROPHYSIOL, V79, P1193, DOI 10.1152/jn.1998.79.3.1193; MUNOZ DP, 1995, J NEUROPHYSIOL, V73, P2334, DOI 10.1152/jn.1995.73.6.2334; MUNOZ DP, 1995, J NEUROPHYSIOL, V73, P2313, DOI 10.1152/jn.1995.73.6.2313; MUNOZ DP, 1991, SCIENCE, V251, P1358, DOI 10.1126/science.2003221; Nakahara H, 2006, J NEUROPHYSIOL, V96, P765, DOI 10.1152/jn.01372.2005; OTTES FP, 1986, VISION RES, V26, P857, DOI 10.1016/0042-6989(86)90144-6; Pettit DL, 1999, J NEUROPHYSIOL, V81, P1424, DOI 10.1152/jn.1999.81.3.1424; Port NL, 2000, J NEUROPHYSIOL, V84, P344, DOI 10.1152/jn.2000.84.1.344; Saito Y, 2005, J NEUROPHYSIOL, V93, P2898, DOI 10.1152/jn.01051.2004; Saito Y, 2003, J NEUROSCI, V23, P5854; Saito Y, 1999, J NEUROPHYSIOL, V82, P754, DOI 10.1152/jn.1999.82.2.754; SCHILLER PH, 1979, SCIENCE, V206, P590, DOI 10.1126/science.115091; SCHILLER PH, 1987, J NEUROPHYSIOL, V57, P1033, DOI 10.1152/jn.1987.57.4.1033; Soetedjo R, 2002, J NEUROPHYSIOL, V87, P679, DOI 10.1152/jn.00886.2000; Soetedjo R, 2002, J NEUROPHYSIOL, V87, P2778, DOI 10.1152/jn.2002.87.6.2778; SPARKS DL, 1978, BRAIN RES, V156, P1, DOI 10.1016/0006-8993(78)90075-6; SPARKS DL, 1980, BRAIN RES, V190, P39, DOI 10.1016/0006-8993(80)91158-0; Tabareau N, 2007, BIOL CYBERN, V97, P279, DOI 10.1007/s00422-007-0172-2; Takagi M, 1998, J NEUROPHYSIOL, V80, P1911, DOI 10.1152/jn.1998.80.4.1911; Takahashi M, 2010, J NEUROPHYSIOL, V104, P3146, DOI 10.1152/jn.00554.2010; van Opstal AJ, 2008, BIOL CYBERN, V98, P561, DOI 10.1007/s00422-008-0219-z; Waitzman DM, 2000, J NEUROPHYSIOL, V83, P2260, DOI 10.1152/jn.2000.83.4.2260; Wallman J, 1998, J NEUROPHYSIOL, V80, P2405, DOI 10.1152/jn.1998.80.5.2405; Zhou L, 2008, EXP BRAIN RES, V189, P485, DOI 10.1007/s00221-008-1444-3; Zhu JJ, 2000, J PHYSIOL-LONDON, V523, P731, DOI 10.1111/j.1469-7793.2000.00731.x	57	9	9	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2013	8	2							e57134	10.1371/journal.pone.0057134	http://dx.doi.org/10.1371/journal.pone.0057134			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093HR	23431402	Green Published, Green Submitted, gold			2022-12-25	WOS:000315182800045
J	Ando, M; Sato, Y; Takata, K; Nomoto, J; Nakamura, S; Ohshima, K; Takeuchi, T; Orita, Y; Kobayashi, Y; Yoshino, T				Ando, Midori; Sato, Yasuharu; Takata, Katsuyoshi; Nomoto, Junko; Nakamura, Shigeo; Ohshima, Koichi; Takeuchi, Tamotsu; Orita, Yorihisa; Kobayashi, Yukio; Yoshino, Tadashi			A20 (TNFAIP3) Deletion in Epstein-Barr Virus-Associated Lymphoproliferative Disorders/Lymphomas	PLOS ONE			English	Article							B-CELL LYMPHOMA; NF-KAPPA-B; TUMOR-SUPPRESSOR GENE; HODGKIN LYMPHOMA; MUTATIONS; EXPRESSION; MULTIPLE	A negative regulator of the nuclear factor (NF)-kappa B pathway, A20 (TNFAIP3), is inactivated in several types of lymphomas; particularly in diffuse large B-cell lymphoma (DLBCL), classical Hodgkin's lymphoma, and extranodal marginal zone lymphoma of the mucosa-associated lymphoid tissue. These findings suggest that the NF-kappa B activation is related to A20 inactivation. Recently, A20 inactivation has also been observed in Epstein-Barr virus (EBV)-related lymphomas; however, this occurrence has not been well investigated. Moreover, NF-kappa B is a key molecule in activated B-cell-like (ABC)-type DLBCL; EBV-associated DLBCL is of the ABC type. Therefore, we focused on A20 deletions in EBV-associated lymphoproliferative disorders/lymphomas. Using fluorescent in situ hybridization analysis, A20 deletions were identified in 4 of 13 samples from patients with pyothorax-associated lymphoma (PAL) (31%), 3 of 20 samples from nasal-type NK/T cell lymphomas (NKTLs) (15%), 1 of 8 samples of EBV-positive DLBCL of the elderly (DLBCL-e) (13%), but not in any of the 11 samples from individuals with methotrexate-related lymphoproliferative disorder (MTX-LPD) (0%). Among the samples with A20 deletions, EBV latent membrane protein 1 (LMP-1) expression was detected in all 4 of the PAL samples with A20 deletions and in the DLBCL-e sample with an A20 deletion, but not in any of the 3 NKTL samples. This finding indicated that A20 deletions were not directly related to the EBV latency pattern of lymphomas, although such deletions might be related to the diagnostic category. Immunohistologically, the A20 protein was absent in 2 (15%) of the13 PAL samples, 1 (9%) of 11 MTX-LPD samples, and in none of the 20 NKTL (0%) or 8 DLBCL-e samples. In conclusion, A20 deletion and/or dysfunctional expression are frequently associated with PALs, and A20 abnormalities may be related to the pathogenesis of PAL.	[Ando, Midori; Sato, Yasuharu; Takata, Katsuyoshi; Yoshino, Tadashi] Okayama Univ, Dept Pathol, Grad Sch Med Dent & Pharmaceut Sci, Okayama 7008530, Japan; [Nomoto, Junko; Kobayashi, Yukio] Natl Canc Ctr, Div Hematol, Tokyo, Japan; [Nakamura, Shigeo] Nagoya Univ Hosp, Dept Pathol & Clin Lab, Nagoya, Aichi, Japan; [Ohshima, Koichi] Kurume Univ, Sch Med, Dept Pathol, Fukuoka, Japan; [Takeuchi, Tamotsu] Gifu Univ, Grad Sch Med, Dept Immunopathol, Gifu, Japan; [Orita, Yorihisa] Okayama Univ, Dept Otolaryngol Head & Neck Surg, Grad Sch Med Dent & Pharmaceut Sci, Okayama 7008530, Japan	Okayama University; National Cancer Center - Japan; Nagoya University; Kurume University; Gifu University; Okayama University	Sato, Y (corresponding author), Okayama Univ, Dept Pathol, Grad Sch Med Dent & Pharmaceut Sci, Okayama 7008530, Japan.	satou-y@cc.okayama-u.ac.jp	Nakamura, Shigeo/I-1571-2012; Kobayahi, Yukio/E-9081-2017	Kobayahi, Yukio/0000-0003-2378-7865				Aozasa K, 2006, J CLIN EXP HEMATOP, V46, P5, DOI 10.3960/jslrt.46.5; Bi Y., 2011, HAEMATOLOGICA, V97, P926; Braun FCM, 2011, LEUKEMIA, V25, P1494, DOI 10.1038/leu.2011.101; Chanudet E, 2009, J PATHOL, V217, P420, DOI 10.1002/path.2466; Chao C, 2012, CLIN CANCER RES, V18, P4702, DOI 10.1158/1078-0432.CCR-11-3169; Chiang AKS, 1996, INT J CANCER, V68, P285, DOI 10.1002/(SICI)1097-0215(19961104)68:3<285::AID-IJC3>3.0.CO;2-Y; Compagno M, 2009, NATURE, V459, P717, DOI 10.1038/nature07968; Davis RE, 2001, J EXP MED, V194, P1861, DOI 10.1084/jem.194.12.1861; Dong GH, 2011, CLIN CANCER RES, V17, P1440, DOI 10.1158/1078-0432.CCR-10-1859; FUKAYAMA M, 1993, AM J PATHOL, V143, P1044; Giulino L, 2011, BLOOD, V117, P4852, DOI 10.1182/blood-2010-10-310995; Honma K, 2009, BLOOD, V114, P2467, DOI 10.1182/blood-2008-12-194852; Iqbal J, 2004, AM J PATHOL, V165, P159, DOI 10.1016/S0002-9440(10)63284-1; Karin M, 2006, NATURE, V441, P431, DOI 10.1038/nature04870; Karube K, 2011, BLOOD, V118, P3195, DOI 10.1182/blood-2011-04-346890; Kato M, 2009, NATURE, V459, P712, DOI 10.1038/nature07969; Kim WS, 2007, GENE CHROMOSOME CANC, V46, P776, DOI 10.1002/gcc.20463; Lenz G, 2008, SCIENCE, V319, P1676, DOI 10.1126/science.1153629; Montes-Moreno S, 2012, MODERN PATHOL, V25, P968, DOI 10.1038/modpathol.2012.52; Nomoto J, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-457; Novak U, 2009, BLOOD, V113, P4918, DOI 10.1182/blood-2008-08-174110; Rossi D, 2011, BLOOD, V118, P4930, DOI 10.1182/blood-2011-06-359166; Schmitz R, 2009, J EXP MED, V206, P981, DOI 10.1084/jem.20090528; Swerdlow E., 2008, WHO CLASSIFICATION T; vanGorp J, 1996, J CLIN PATHOL, V49, P72, DOI 10.1136/jcp.49.1.72; Young LS, 2004, NAT REV CANCER, V4, P757, DOI 10.1038/nrc1452	26	22	26	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e56741	10.1371/journal.pone.0056741	http://dx.doi.org/10.1371/journal.pone.0056741			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418597	Green Published, Green Submitted, gold			2022-12-25	WOS:000315970300190
J	Bailleul, AM; Hall, BK; Horner, JR				Bailleul, Alida M.; Hall, Brian K.; Horner, John R.			Secondary Cartilage Revealed in a Non-Avian Dinosaur Embryo	PLOS ONE			English	Article							GROWTH; REPAIR; TISSUE; BONE; EGG	The skull and jaws of extant birds possess secondary cartilage, a tissue that arises after bone formation during embryonic development at articulations, ligamentous and muscular insertions. Using histological analysis, we discovered secondary cartilage in a non-avian dinosaur embryo, Hypacrosaurus stebingeri (Ornithischia, Lambeosaurinae). This finding extends our previous report of secondary cartilage in post-hatching specimens of the same dinosaur species. It provides the first information on the ontogeny of avian and dinosaurian secondary cartilages, and further stresses their developmental similarities. Secondary cartilage was found in an embryonic dentary within a tooth socket where it is hypothesized to have arisen due to mechanical stresses generated during tooth formation. Two patterns were discerned: secondary cartilage is more restricted in location in this Hypacrosaurus embryo, than it is in Hypacrosaurus post-hatchlings; secondary cartilage occurs at far more sites in bird embryos and nestlings than in Hypacrosaurus. This suggests an increase in the number of sites of secondary cartilage during the evolution of birds. We hypothesize that secondary cartilage provided advantages in the fine manipulation of food and was selected over other types of tissues/articulations during the evolution of the highly specialized avian beak from the jaws of their dinosaurian ancestors.	[Bailleul, Alida M.; Horner, John R.] Montana State Univ, Museum Rockies, Bozeman, MT 59717 USA; [Bailleul, Alida M.; Horner, John R.] Montana State Univ, Dept Earth Sci, Bozeman, MT 59717 USA; [Hall, Brian K.] Dalhousie Univ, Dept Biol, Halifax, NS, Canada	Montana State University System; Montana State University Bozeman; Montana State University System; Montana State University Bozeman; Dalhousie University	Bailleul, AM (corresponding author), Montana State Univ, Museum Rockies, Bozeman, MT 59717 USA.	alida.bailleul@msu.montana.edu			Natural Sciences and Engineering Research Council of Canada [A5056]	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	AMB and JRH are indebted to Gerry Ohrstrom for funding. BKH is supported by Natural Sciences and Engineering Research Council of Canada (Grant A5056). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1981, CHONDROID BONE SECON; Bailleul AM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036112; Behrensmeyer AK, 2000, PALEOBIOLOGY, V26, P103, DOI 10.1666/0094-8373(2000)26[103:TAP]2.0.CO;2; BENJAMIN M, 1989, J ANAT, V164, P145; BOCK WALTER J., 1960, AUK, V77, P19; Gauthier J., 1986, Memoirs of the California Academy of Sciences, P1; Gillis JA, 2006, J FISH BIOL, V68, P1133, DOI 10.1111/j.0022-1112.2006.00998.x; Goret-Nicaise M, 1986, THESIS U LOUVAIN UCL; GORETNICAISE M, 1984, ARCH ANAT MICROSC MO, V73, P291; HALL B. K., 1967, AUST J ZOOL, V15, P685, DOI 10.1071/ZO9670685; HALL B K, 1968, Australian Journal of Zoology, V16, P795, DOI 10.1071/ZO9680795; Hall B.K., 2015, BONES CARTILAGE DEV; HALL BK, 1986, J EMBRYOL EXP MORPH, V93, P133; HALL BK, 1985, J EXP ZOOL, V233, P359, DOI 10.1002/jez.1402330304; Hall BK, 2000, WENN GR INT, V76, P101; HALL BK, 1971, CLIN ORTHOP RELAT R, P182, DOI 10.1097/00003086-197107000-00015; Holliday CM, 2009, ANAT REC, V292, P1246, DOI 10.1002/ar.20982; Homer J. R., 1994, DINOSAUR EGGS BABIES, P312; Horner John R., 1994, P116; Horner JR, 1999, J VERTEBR PALEONTOL, V19, P607, DOI 10.1080/02724634.1999.10011174; Hunt GR, 1996, NATURE, V379, P249, DOI 10.1038/379249a0; IRWIN CR, 1986, J ANAT, V146, P53; Lengele B, 1996, ANAT REC, V246, P377, DOI 10.1002/(SICI)1097-0185(199611)246:3<377::AID-AR9>3.0.CO;2-V; Masquelin MH, 1878, B ACAD ROY BELGE, V45, P430; MURRAY P. D. F., 1963, AUSTRALIAN JOUR ZOOL, V11, P368, DOI 10.1071/ZO9630368; Murray P. D. F., 1965, Australian Journal of Zoology, V13, P351, DOI 10.1071/ZO9650351; Payne SL, 2011, ANAT REC, V294, P399, DOI 10.1002/ar.21329; PRITCHARD JJ, 1956, J ANAT, V90, P73; RAHN H, 1974, CONDOR, V76, P147, DOI 10.2307/1366724; Ricklefs Robert E., 1998, Oxford Ornithology Series, V8, P31; Vickaryous MK, 2008, J MORPHOL, V269, P398, DOI 10.1002/jmor.10575; VINKKAPUHAKKA H, 1993, ARCH ORAL BIOL, V38, P49, DOI 10.1016/0003-9969(93)90154-E; Weishampel DB., 2004, DINOSAURIA; WILLIAMS DLG, 1984, PALAEOGEOGR PALAEOCL, V45, P23, DOI 10.1016/0031-0182(84)90107-X; Zusi Richard L., 1993, P391	35	10	11	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e56937	10.1371/journal.pone.0056937	http://dx.doi.org/10.1371/journal.pone.0056937			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418610	Green Published, gold, Green Submitted			2022-12-25	WOS:000315970300205
J	Fantin, M; van der Kooij, MA; Grosse, J; Krummenacher, C; Sandi, C				Fantin, Martina; van der Kooij, Michael A.; Grosse, Jocelyn; Krummenacher, Claude; Sandi, Carmen			A Key Role for Nectin-1 in the Ventral Hippocampus in Contextual Fear Memory	PLOS ONE			English	Article							CELL-ADHESION MOLECULE; HERPES-SIMPLEX-VIRUS; ENTRY RECEPTOR NECTIN-1; LONG-TERM POTENTIATION; GLYCOPROTEIN-D; DORSAL HIPPOCAMPUS; INTRAVENTRICULAR INFUSIONS; DIFFERENTIAL CONTRIBUTION; SYNAPTIC PLASTICITY; GENE-EXPRESSION	Nectins are cell adhesion molecules that are widely expressed in the brain. Nectin expression shows a dynamic spatiotemporal regulation, playing a role in neural migratory processes during development. Nectin-1 and nectin-3 and their heterophilic trans-interactions are important for the proper formation of synapses. In the hippocampus, nectin-1 and nectin-3 localize at puncta adherentia junctions and may play a role in synaptic plasticity, a mechanism essential for memory and learning. We evaluated the potential involvement of nectin-1 and nectin-3 in memory consolidation using an emotional learning paradigm. Rats trained for contextual fear conditioning showed transient nectin-1- but not nectin-3-protein upregulation in synapse-enriched hippocampal fractions at about 2 h posttraining. The upregulation of nectin-1 was found exclusively in the ventral hippocampus and was apparent in the synaptoneurosomal fraction. This upregulation was induced by contextual fear conditioning but not by exposure to context or shock alone. When an antibody against nectin-1, R165, was infused in the ventral-hippocampus immediately after training, contextual fear memory was impaired. However, treatment with the antibody in the dorsal hippocampus had no effect in contextual fear memory formation. Similarly, treatment with the antibody in the ventral hippocampus did not interfere with acoustic memory formation. Further control experiments indicated that the effects of ventral hippocampal infusion of the nectin-1 antibody in contextual fear memory cannot be ascribed to memory non-specific effects such as changes in anxiety-like behavior or locomotor behavior. Therefore, we conclude that nectin-1 recruitment to the perisynaptic environment in the ventral hippocampus plays an important role in the formation of contextual fear memories. Our results suggest that these mechanisms could be involved in the connection of emotional and contextual information processed in the amygdala and dorsal hippocampus, respectively, thus opening new venues for the development of treatments to psychopathological alterations linked to impaired contextualization of emotions.	[Fantin, Martina; van der Kooij, Michael A.; Grosse, Jocelyn; Sandi, Carmen] Ecole Polytech Fed Lausanne, Sch Life Sci, Brain Mind Inst, Lab Behav Genet, CH-1015 Lausanne, Switzerland; [Krummenacher, Claude] Univ Penn, Sch Vet Med, Dept Pathobiol, Philadelphia, PA 19104 USA	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; University of Pennsylvania	Sandi, C (corresponding author), Ecole Polytech Fed Lausanne, Sch Life Sci, Brain Mind Inst, Lab Behav Genet, CH-1015 Lausanne, Switzerland.	carmen.sandi@epfl.ch		Krummenacher, Claude/0000-0002-3492-4987; van der Kooij, Michael/0000-0001-7415-1379; Sandi, Carmen/0000-0001-7713-8321	European Union integrated project MEMSTICK [FP7-HEALTH-F2M-2007-201600]; Swiss National Science Foundation [310000-120791, 31003AB-135710, CRSIK3-122691]; EPFL; Public Health Service grants from the National Institutes of Health [AI-097171, DE-022137]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI097171] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R21DE022137] Funding Source: NIH RePORTER	European Union integrated project MEMSTICK; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); EPFL; Public Health Service grants from the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by a grant from the European Union integrated project MEMSTICK (FP7-HEALTH-F2M-2007-201600; MemStick), the Swiss National Science Foundation (310000-120791 and 31003AB-135710; Sinergia CRSIK3-122691; and the NCCR "The synaptic basis of mental diseases") as well as the intramural funding from the EPFL. C.K. is supported by Public Health Service grants from the National Institutes of Health AI-097171 and DE-022137. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht A, 2010, INT J NEUROPSYCHOPH, V13, P661, DOI 10.1017/S1461145709991106; Anagnostaras SG, 2001, HIPPOCAMPUS, V11, P8; Bannerman DM, 2004, NEUROSCI BIOBEHAV R, V28, P273, DOI 10.1016/j.neubiorev.2004.03.004; Bannerman DM, 2003, BEHAV BRAIN RES, V139, P197, DOI 10.1016/S0166-4328(02)00268-1; Baringer JR, 2008, NEUROL CLIN, V26, P657, DOI 10.1016/j.ncl.2008.03.005; Bast T, 2001, PSYCHOPHARMACOLOGY, V156, P225, DOI 10.1007/s002130100775; BEERS DR, 1995, J NEUROL SCI, V131, P119, DOI 10.1016/0022-510X(95)00099-N; Bisaz R, 2010, GENES BRAIN BEHAV, V9, P353, DOI 10.1111/j.1601-183X.2010.00563.x; Bisaz R, 2009, NEUROBIOL LEARN MEM, V91, P333, DOI 10.1016/j.nlm.2008.11.003; Bojesen KB, 2012, J BIOL CHEM, V287, P37420, DOI 10.1074/jbc.M112.345215; Cambon K, 2004, J NEUROSCI, V24, P4197, DOI 10.1523/JNEUROSCI.0436-04.2004; Cambon K, 2003, NEUROSCIENCE, V122, P183, DOI 10.1016/S0306-4522(03)00597-9; Chang HP, 2001, NEUROSCIENCE, V102, P289, DOI 10.1016/S0306-4522(00)00478-4; Coltinho AS, 2007, NEUROBIOL DIS, V26, P282, DOI 10.1016/j.nbd.2007.01.005; Conboy L, 2010, NEUROPSYCHOPHARMACOL, V35, P674, DOI 10.1038/npp.2009.172; Corcoran KA, 2001, J NEUROSCI, V21, P1720, DOI 10.1523/JNEUROSCI.21-05-01720.2001; Czerniawski J, 2012, HIPPOCAMPUS, V22, P1528, DOI 10.1002/hipo.20992; Czerniawski J, 2011, J NEUROSCI, V31, P11200, DOI 10.1523/JNEUROSCI.2211-11.2011; Di Giovine P, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002277; Dickerson FB, 2004, BIOL PSYCHIAT, V55, P588, DOI 10.1016/j.biopsych.2003.10.008; Dityatev A, 2008, NEURON GLIA BIOL, V4, P197, DOI 10.1017/S1740925X09990111; DOYLE E, 1992, J NEUROCHEM, V59, P1570, DOI 10.1111/j.1471-4159.1992.tb08477.x; Esclassan F, 2009, HIPPOCAMPUS, V19, P33, DOI 10.1002/hipo.20473; Fabre S, 2002, J BIOL CHEM, V277, P27006, DOI 10.1074/jbc.M203228200; Fanselow MS, 2010, NEURON, V65, P7, DOI 10.1016/j.neuron.2009.11.031; Fanselow MS, 2000, BEHAV BRAIN RES, V110, P73, DOI 10.1016/S0166-4328(99)00186-2; Foley AG, 2003, J NEUROSCI RES, V74, P570, DOI 10.1002/jnr.10758; FOX GB, 1995, J NEUROCHEM, V65, P2796; Frankland PW, 2004, HIPPOCAMPUS, V14, P557, DOI 10.1002/hipo.10208; Gafford GM, 2011, NEUROSCIENCE, V182, P98, DOI 10.1016/j.neuroscience.2011.03.023; Garcia R, 1998, NEUROSCIENCE, V82, P139; GORDON B, 1990, ARCH NEUROL-CHICAGO, V47, P646, DOI 10.1001/archneur.1990.00530060054017; Haarr L, 2001, VIROLOGY, V287, P301, DOI 10.1006/viro.2001.1041; Hall J, 2000, NAT NEUROSCI, V3, P533, DOI 10.1038/75698; Hobin JA, 2006, HIPPOCAMPUS, V16, P174, DOI 10.1002/hipo.20144; HOLLINGSWORTH EB, 1985, J NEUROSCI, V5, P2240; Horvath S, 2006, J NEUROVIROL, V12, P161, DOI 10.1080/13550280600760594; Huff NC, 2006, J NEUROSCI, V26, P1616, DOI 10.1523/JNEUROSCI.4964-05.2006; Huff NC, 2004, BEHAV NEUROSCI, V118, P53, DOI 10.1037/0735-7044.118.1.53; Hunsaker MR, 2008, NEUROBIOL LEARN MEM, V89, P61, DOI 10.1016/j.nlm.2007.08.016; Igaz LM, 2002, J NEUROSCI, V22, P6781; Kenney JW, 2012, HIPPOCAMPUS, V22, P1681, DOI 10.1002/hipo.22003; KIM JJ, 1992, SCIENCE, V256, P675, DOI 10.1126/science.1585183; Kiss JZ, 2001, REV NEUROSCIENCE, V12, P297; Kjelstrup KG, 2002, P NATL ACAD SCI USA, V99, P10825, DOI 10.1073/pnas.152112399; Kopp SJ, 2009, P NATL ACAD SCI USA, V106, P17916, DOI 10.1073/pnas.0908892106; Krummenacher C, 2003, J VIROL, V77, P8985, DOI 10.1128/JVI.77.16.8985-8999.2003; Krummenacher C, 2002, J VIROL, V76, P2424, DOI 10.1128/JVI.76.5.2424-2433.2002; Krummenacher C, 1998, J VIROL, V72, P7064, DOI 10.1128/JVI.72.9.7064-7074.1998; Lim ST, 2012, J NEUROCHEM, V120, P741, DOI 10.1111/j.1471-4159.2011.07592.x; Lopez-Fernandez MA, 2007, J NEUROSCI, V27, P4552, DOI 10.1523/JNEUROSCI.0396-07.2007; Maren S, 2004, BEHAV NEUROSCI, V118, P97, DOI 10.1037/0735-7044.118.1.97; Maren S, 1999, BEHAV NEUROSCI, V113, P283, DOI 10.1037/0735-7044.113.2.283; Martin SJ, 2000, ANNU REV NEUROSCI, V23, P649, DOI 10.1146/annurev.neuro.23.1.649; McNaughton N, 2000, J AFFECT DISORDERS, V61, P161, DOI 10.1016/S0165-0327(00)00344-X; Merino JJ, 2000, EUR J NEUROSCI, V12, P3283, DOI 10.1046/j.1460-9568.2000.00191.x; Mitsushima D, 2011, P NATL ACAD SCI USA, V108, P12503, DOI 10.1073/pnas.1104558108; Mizoguchi A, 2002, J CELL BIOL, V156, P555, DOI 10.1083/jcb.200103113; Moser MB, 1998, HIPPOCAMPUS, V8, P608, DOI 10.1002/(SICI)1098-1063(1998)8:6<608::AID-HIPO3>3.0.CO;2-7; Motanis H, 2010, EUR J NEUROSCI, V32, P840, DOI 10.1111/j.1460-9568.2010.07334.x; Murphy KJ, 1998, NEUROBIOL LEARN MEM, V70, P73, DOI 10.1006/nlme.1998.3839; Niedringhaus M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042631; O'Sullivan NC, 2007, J NEUROCHEM, V101, P1085, DOI 10.1111/j.1471-4159.2006.04418.x; OConnell AW, 1997, J NEUROCHEM, V68, P2538; Okabe N, 2004, DEV BIOL, V273, P244, DOI 10.1016/j.ydbio.2004.05.034; PHILLIPS RG, 1992, BEHAV NEUROSCI, V106, P274, DOI 10.1037/0735-7044.106.2.274; Restivo L, 2009, J NEUROSCI, V29, P8206, DOI 10.1523/JNEUROSCI.0966-09.2009; Richart SM, 2003, J VIROL, V77, P3307, DOI 10.1128/JVI.77.5.3307-3311.2003; Richmond MA, 1999, BEHAV NEUROSCI, V113, P1189, DOI 10.1037/0735-7044.113.6.1189; RONN LCB, 1995, BRAIN RES, V677, P145, DOI 10.1016/0006-8993(95)00147-I; Rudy JW, 2001, COGN AFFECT BEHAV NE, V1, P66, DOI 10.3758/CABN.1.1.66; Sandi C, 2004, NAT REV NEUROSCI, V5, P917, DOI 10.1038/nrn1555; Sandi C, 2003, BIOL PSYCHIAT, V54, P599, DOI 10.1016/S0006-3223(03)00182-3; Seymour CM, 2008, NEUROSCIENCE, V157, P813, DOI 10.1016/j.neuroscience.2008.09.041; Shapiro M, 2001, ARCH NEUROL-CHICAGO, V58, P874, DOI 10.1001/archneur.58.6.874; Shukla D, 2000, J VIROL, V74, P11773, DOI 10.1128/JVI.74.24.11773-11781.2000; Stiles KM, 2008, VIROLOGY, V373, P98, DOI 10.1016/j.virol.2007.11.012; Stork O, 2000, EUR J NEUROSCI, V12, P3291, DOI 10.1046/j.1460-9568.2000.00197.x; Sutherland RJ, 2008, HIPPOCAMPUS, V18, P710, DOI 10.1002/hipo.20431; Takai Y, 2003, CURR OPIN NEUROBIOL, V13, P520, DOI 10.1016/j.conb.2003.09.003; Takai Y, 2008, NAT REV MOL CELL BIO, V9, P603, DOI 10.1038/nrm2457; Togashi H, 2006, J CELL BIOL, V174, P141, DOI 10.1083/jcb.200601089; Trivedi MA, 2004, NEUROBIOL LEARN MEM, V81, P172, DOI 10.1016/j.nlm.2004.02.005; Venero C, 2006, EUR J NEUROSCI, V23, P1585, DOI 10.1111/j.1460-9568.2006.04663.x; Wang XD, 2011, NEUROBIOL DIS, V42, P300, DOI 10.1016/j.nbd.2011.01.020; Zhang WN, 2001, BEHAV BRAIN RES, V126, P159, DOI 10.1016/S0166-4328(01)00256-X	87	15	16	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e56897	10.1371/journal.pone.0056897	http://dx.doi.org/10.1371/journal.pone.0056897			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418609	gold, Green Submitted, Green Published			2022-12-25	WOS:000315970300204
J	Spooner, E; McLaughlin, BM; Lepow, T; Durns, TA; Randall, J; Upchurch, C; Miller, K; Campbell, EM; Fares, H				Spooner, Ellen; McLaughlin, Brooke M.; Lepow, Talya; Durns, Tyler A.; Randall, Justin; Upchurch, Cameron; Miller, Katherine; Campbell, Erin M.; Fares, Hanna			Systematic Screens for Proteins That Interact with the Mucolipidosis Type IV Protein TRPML1	PLOS ONE			English	Article							MEMBRANE-PROTEIN; ABNORMAL TRANSPORT; STATISTICAL-MODEL; CHANNEL ACTIVITY; CATION CHANNEL; IDENTIFICATION; TRAFFICKING; ACTIN; ACCUMULATION; MUTATIONS	Mucolipidosis type IV is a lysosomal storage disorder resulting from mutations in the MCOLN1 gene, which encodes the endosomal/lysosomal Transient Receptor Potential channel protein mucolipin-1/TRPML1. Cells isolated from Mucolipidosis type IV patients and grown in vitro and in in vivo models of this disease both show several lysosome-associated defects. However, it is still unclear how TRPML1 regulates the transport steps implicated by these defects. Identifying proteins that associate with TRPML1 will facilitate the elucidation of its cellular and biochemical functions. We report here two saturation screens for proteins that interact with TRPML1: one that is based on immunoprecipitation/mass spectrometry and the other using a genetic yeast two-hybrid approach. From these screens, we identified largely non-overlapping proteins, which represent potential TRPML1-interactors., Using additional interaction assays on some of the potential interactors from each screen, we validated some proteins as candidate TRPML1 interactors In addition, our analysis indicates that each of the two screens not only identified some false-positive interactors, as expected from any screen, but also failed to uncover potential TRPML1 interactors. Future studies on the true interactors, first identified in these screens, will help elucidate the structure and function of protein complexes containing TRPML1.	[Spooner, Ellen; McLaughlin, Brooke M.; Lepow, Talya; Durns, Tyler A.; Randall, Justin; Upchurch, Cameron; Miller, Katherine; Campbell, Erin M.; Fares, Hanna] Univ Arizona, Dept Mol & Cellular Biol, Tucson, AZ 85721 USA	University of Arizona	Fares, H (corresponding author), Univ Arizona, Dept Mol & Cellular Biol, Tucson, AZ 85721 USA.	fares@email.arizona.edu		Upchurch, Cameron/0000-0002-8003-0749	National Science Foundation [1052166]	National Science Foundation(National Science Foundation (NSF))	This work was supported by a National Science Foundation grant number 1052166 to HF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altarescu G, 2002, NEUROLOGY, V59, P306, DOI 10.1212/WNL.59.3.306; Bach G, 2001, MOL GENET METAB, V73, P197, DOI 10.1006/mgme.2001.3195; Bach Gideon, 2005, Hum Mutat, V26, P591, DOI 10.1002/humu.9385; Bargal R, 2000, NAT GENET, V26, P118, DOI 10.1038/79095; Bargal R, 1997, J INHERIT METAB DIS, V20, P625, DOI 10.1023/A:1005362123443; Bassi MT, 2000, AM J HUM GENET, V67, P1110, DOI 10.1016/S0002-9297(07)62941-3; Blazer-Yost BL, 2005, PFLUG ARCH EUR J PHY, V450, P75, DOI 10.1007/s00424-004-1371-5; Bright NA, 2005, CURR BIOL, V15, P360, DOI 10.1016/j.cub.2005.01.049; Cantiello HF, 2005, PFLUG ARCH EUR J PHY, V451, P304, DOI 10.1007/s00424-005-1448-9; Chen CS, 1998, P NATL ACAD SCI USA, V95, P6373, DOI 10.1073/pnas.95.11.6373; Chen EI, 2006, MOL CELL PROTEOMICS, V5, P53, DOI 10.1074/mcp.T500013-MCP200; Chun DK, 2008, MOL BIOL CELL, V19, P2682, DOI 10.1091/mbc.E07-11-1120; Craig R, 2004, BIOINFORMATICS, V20, P1466, DOI 10.1093/bioinformatics/bth092; Curcio-Morelli C, 2010, J CELL PHYSIOL, V222, P328, DOI 10.1002/jcp.21956; Dang HP, 2011, TRAFFIC, V12, P1417, DOI 10.1111/j.1600-0854.2011.01243.x; Di Paolo G, 2004, NATURE, V431, P415, DOI 10.1038/nature02896; Dong XP, 2008, NATURE, V455, P992, DOI 10.1038/nature07311; Eichelsdoerfer JL, 2010, J BIOL CHEM, V285, P34304, DOI 10.1074/jbc.C110.165480; Hilpela P, 2004, CURR TOP MICROBIOL, V282, P117; Jennings JJ, 2006, J BIOL CHEM, V281, P39041, DOI 10.1074/jbc.M607982200; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Kiselyov K, 2005, J BIOL CHEM, V280, P43218, DOI 10.1074/jbc.M508210200; Kiselyov K, 2007, AUTOPHAGY, V3, P259, DOI 10.4161/auto.3906; LaPlante JM, 2006, MOL GENET METAB, V89, P339, DOI 10.1016/j.ymgme.2006.05.016; LaPlante JM, 2002, FEBS LETT, V532, P183, DOI 10.1016/S0014-5793(02)03670-0; LaPlante JM, 2004, BIOCHEM BIOPH RES CO, V322, P1384, DOI 10.1016/j.bbrc.2004.08.045; Liu HB, 2002, BIOTECHNIQUES, V32, P898, DOI 10.2144/02324pt01; Lorente-Rodriguez A, 2011, COLD SPRING HARB PER, P3; Lu Q, 2008, DEVELOPMENT, V135, P1069, DOI 10.1242/dev.016063; Mairhofer M, 2009, J BIOL CHEM, V284, P29218, DOI 10.1074/jbc.M109.014993; Manzoni M, 2004, FEBS LETT, V567, P219, DOI 10.1016/j.febslet.2004.04.080; Matern H, 2000, EMBO J, V19, P4485, DOI 10.1093/emboj/19.17.4485; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; NISHIDA E, 1985, BIOCHEMISTRY-US, V24, P6624, DOI 10.1021/bi00344a049; Pryor PR, 2006, TRAFFIC, V7, P1388, DOI 10.1111/j.1600-0854.2006.00475.x; Schaheen B, 2009, J CELL SCI, V122, P2228, DOI 10.1242/jcs.048892; Schiffmann R, 1993, GENEREVIEWS; Spiering D, 2011, CELL ADHES MIGR, V5, P170, DOI 10.4161/cam.5.2.14403; Sun M, 2000, HUM MOL GENET, V9, P2471, DOI 10.1093/hmg/9.17.2471; Thaminy Safia, 2004, Methods Mol Biol, V261, P297; Thompson EG, 2007, BMC CELL BIOL, V8, DOI 10.1186/1471-2121-8-54; Treusch S, 2004, P NATL ACAD SCI USA, V101, P4483, DOI 10.1073/pnas.0400709101; Venugopal B, 2007, AM J HUM GENET, V81, P1070, DOI 10.1086/521954; Venugopal B, 2009, J CELL PHYSIOL, V219, P344, DOI 10.1002/jcp.21676; Vergarajauregui S, 2008, AUTOPHAGY, V4, P832, DOI 10.4161/auto.6567; Vergarajauregui S, 2008, BIOCHEM J, V410, P417, DOI 10.1042/BJ20070713; Vergarajauregui S, 2011, J CELL SCI, V124, P459, DOI 10.1242/jcs.076240; Vergarajauregui S, 2009, J BIOL CHEM, V284, P36357, DOI 10.1074/jbc.M109.047241; Waselle L, 2005, MOL ENDOCRINOL, V19, P3097, DOI 10.1210/me.2004-0530; Weernink PAO, 2004, EUR J PHARMACOL, V500, P87, DOI 10.1016/j.ejphar.2004.07.014; Yu M, 2007, MOL BIOL CELL, V18, P688, DOI 10.1091/mbc.E06-10-0914; Zeevi DA, 2010, J CELL SCI, V123, P3112, DOI 10.1242/jcs.067330; ZEIGLER M, 1992, PRENATAL DIAG, V12, P1037, DOI 10.1002/pd.1970121209	53	14	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e56780	10.1371/journal.pone.0056780	http://dx.doi.org/10.1371/journal.pone.0056780			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418601	Green Published, gold, Green Submitted			2022-12-25	WOS:000315970300194
J	Wang, M; Gu, BL; Huang, J; Jiang, S; Chen, YJ; Yin, YL; Pan, YF; Yu, GJ; Li, YM; Wong, BHC; Liang, Y; Sun, H				Wang, Man; Gu, Bianli; Huang, Jie; Jiang, Shuai; Chen, Yijie; Yin, Yalin; Pan, Yongfu; Yu, Guojun; Li, Yamu; Wong, Barry Hon Cheung; Liang, Yi; Sun, Hui			Transcriptome and Proteome Exploration to Provide a Resource for the Study of Agrocybe aegerita	PLOS ONE			English	Article							EDIBLE MUSHROOM; AGARICUS-BISPORUS; GENOME SEQUENCE; FRUITING BODY; CARBOHYDRATE-METABOLISM; COPRINOPSIS-CINEREA; HYDROPHOBIN GENES; MASS-SPECTROMETRY; DEGRADING ENZYMES; GANODERMA-LUCIDUM	Background: Agrocybe aegerita, the black poplar mushroom, has been highly valued as a functional food for its medicinal and nutritional benefits. Several bioactive extracts from A. aegerita have been found to exhibit antitumor and antioxidant activities. However, limited genetic resources for A. aegerita have hindered exploration of this species. Methodology/Principal Findings: To facilitate the research on A. aegerita, we established a deep survey of the transcriptome and proteome of this mushroom. We applied high-throughput sequencing technology (Illumina) to sequence A. aegerita transcriptomes from mycelium and fruiting body. The raw clean reads were de novo assembled into a total of 36,134 expressed sequences tags (ESTs) with an average length of 663 bp. These ESTs were annotated and classified according to Gene Ontology (GO), Clusters of Orthologous Groups (COG), and Kyoto Encyclopedia of Genes and Genomes (KEGG) metabolic pathways. Gene expression profile analysis showed that 18,474 ESTs were differentially expressed, with 10,131 up-regulated in mycelium and 8,343 up-regulated in fruiting body. Putative genes involved in polysaccharide and steroid biosynthesis were identified from A. aegerita transcriptome, and these genes were differentially expressed at the two stages of A. aegerita. Based on one-dimensional gel electrophoresis (1-DGE) coupled with electrospray ionization liquid chromatography tandem MS (LC-ESI-MS/MS), we identified a total of 309 non-redundant proteins. And many metabolic enzymes involved in glycolysis were identified in the protein database. Conclusions/Significance: This is the first study on transcriptome and proteome analyses of A. aegerita. The data in this study serve as a resource of A. aegerita transcripts and proteins, and offer clues to the applications of this mushroom in nutrition, pharmacy and industry.	[Wang, Man; Gu, Bianli; Huang, Jie; Jiang, Shuai; Chen, Yijie; Yin, Yalin; Pan, Yongfu; Yu, Guojun; Li, Yamu; Wong, Barry Hon Cheung; Liang, Yi; Sun, Hui] Wuhan Univ, Coll Life Sci, State Key Lab Virol, Wuhan 430072, Peoples R China; [Liang, Yi] Guangdong Med Coll, Dept Clin Immunol, Dongguan, Peoples R China; [Sun, Hui] Hubei Univ Technol, Minist Educ, Key Lab Fermentat Engn, Wuhan, Peoples R China; [Sun, Hui] Wuhan Univ, Minist Educ, Key Lab Combinatorial Biosynth & Drug Discovey, Wuhan 430072, Peoples R China; [Gu, Bianli] Henan Univ Sci & Technol, Affiliated Hosp 1, Mol Diag Ctr, Luoyang, Peoples R China	Wuhan University; Guangdong Medical University; Hubei University of Technology; Wuhan University; Henan University of Science & Technology	Sun, H (corresponding author), Wuhan Univ, Coll Life Sci, State Key Lab Virol, Wuhan 430072, Peoples R China.	sunhui@whu.edu.cn		Huang, Jie/0000-0003-3842-6181	National Key Technologies RD Program [2009ZX09103-676]; Natural Science Foundation of China (NSFC) program [81102850]; Major State Basic Research Development Program of China, 973 Program [2011CB811302]; National Mega Project on Major Drug Development [2009ZX09301-014-1]; Chinese 111 project [B06018]; Wuhan municipal project [201160923296]; Office of Science of the U.S. Department of Energy	National Key Technologies RD Program(National Key Technology R&D Program); Natural Science Foundation of China (NSFC) program(National Natural Science Foundation of China (NSFC)); Major State Basic Research Development Program of China, 973 Program(National Basic Research Program of China); National Mega Project on Major Drug Development; Chinese 111 project(Ministry of Education, China - 111 Project); Wuhan municipal project; Office of Science of the U.S. Department of Energy(United States Department of Energy (DOE))	This work was funded by the National Key Technologies R&D Program [2009ZX09103-676], the Natural Science Foundation of China (NSFC) program [81102850], the Major State Basic Research Development Program of China, 973 Program [2011CB811302], National Mega Project on Major Drug Development [2009ZX09301-014-1], the Chinese 111 project [B06018] and Wuhan municipal project (No. 201160923296). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank Professor Xiangdong Fu (University of California, San Diego, USA) for his advice and technical assistance. We also thank Professors Igor V. Grigoriev (Joint Genome Institute, California, USA), Han A. B. Wosten (Utrecht University, Utrecht, The Netherlands), Jason E. Stajich (University of California, Riverside, CA 92521) and Francis Martin (INRA-Nancy University, France) for their help and support. Annotation information used in this study was obtained from the U.S. Department of Energy's Joint Genome Institute (JGI), and is supported by the Office of Science of the U.S. Department of Energy (http://www.jgi.doe. gov.).	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Ando A, 2001, CURR GENET, V39, P190, DOI 10.1007/s002940100193; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Barros L, 2007, FOOD CHEM, V105, P140, DOI 10.1016/j.foodchem.2007.03.052; Bayry J, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002700; Berg Miller ME, 2009, PLOS ONE, V4, pe6650, DOI DOI 10.1371/journal.pone.0006650; Berne S, 2002, BBA-GEN SUBJECTS, V1570, P153, DOI 10.1016/S0304-4165(02)00190-3; Boh B, 2007, BIOTECHNOL ANN REV, V13, P265, DOI 10.1016/S1387-2656(07)13010-6; BONNEN AM, 1994, APPL ENVIRON MICROB, V60, P960, DOI 10.1128/AEM.60.3.960-965.1994; Ceccaroli P, 2011, NEW PHYTOL, V189, P751, DOI 10.1111/j.1469-8137.2010.03520.x; Chakraborty TK, 2003, J BASIC MICROB, V43, P462, DOI 10.1002/jobm.200310275; Chen SL, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1923; Chin CY, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-672; Chum WWY, 2011, FUNGAL GENET BIOL, V48, P359, DOI 10.1016/j.fgb.2011.01.009; Chum WWY, 2008, MYCOL RES, V112, P950, DOI 10.1016/j.mycres.2008.01.028; Combet Emilie, 2006, Mycoscience, V47, P317, DOI 10.1007/s10267-006-0318-4; Conesa Ana, 2008, Int J Plant Genomics, V2008, P619832, DOI 10.1155/2008/619832; Cresnar B, 2011, BBA-PROTEINS PROTEOM, V1814, P29, DOI 10.1016/j.bbapap.2010.06.020; Deveau A, 2008, NEW PHYTOL, V180, P379, DOI 10.1111/j.1469-8137.2008.02581.x; Diyabalanage T, 2008, FOOD CHEM, V108, P97, DOI 10.1016/j.foodchem.2007.10.049; Donadio S, 2007, NAT PROD REP, V24, P1073, DOI 10.1039/b514050c; Douglas CM, 2001, MED MYCOL, V39, P55, DOI 10.1080/mmy.39.1.55.66; Elvan H, 2010, FOOD CHEM, V123, P291, DOI 10.1016/j.foodchem.2010.04.034; Espinar MTF, 1997, CURR GENET, V32, P420, DOI 10.1007/s002940050297; Guo ZH, 2009, VACCINE, V27, P660, DOI 10.1016/j.vaccine.2008.11.038; Heneghan MN, 2009, APPL ENVIRON MICROB, V75, P792, DOI 10.1128/AEM.01897-08; Hirosue S, 2011, BIOCHEM BIOPH RES CO, V407, P118, DOI 10.1016/j.bbrc.2011.02.121; Hooff GP, 2010, BBA-MOL CELL BIOL L, V1801, P896, DOI 10.1016/j.bbalip.2010.03.014; Horcajada C, 2006, J BIOL CHEM, V281, P2923, DOI 10.1074/jbc.M507394200; Horie K, 2008, J PROTEOME RES, V7, P1819, DOI 10.1021/pr070369o; Huang BF, 2011, CURR MICROBIOL, V62, P1160, DOI 10.1007/s00284-010-9838-4; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Ide M, 2012, ARCH MICROBIOL, V194, P243, DOI 10.1007/s00203-011-0753-2; Iordachescu M, 2008, J INTEGR PLANT BIOL, V50, P1223, DOI 10.1111/j.1744-7909.2008.00736.x; Jensen KA, 2002, APPL ENVIRON MICROB, V68, P2699, DOI 10.1128/AEM.68.6.2699-2703.2002; Joh JH, 2004, FEMS MICROBIOL LETT, V239, P57, DOI 10.1016/j.femsle.2004.08.020; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; KAWAGISHI H, 1990, BIOCHIM BIOPHYS ACTA, V1034, P247, DOI 10.1016/0304-4165(90)90045-X; Keller NP, 2005, NAT REV MICROBIOL, V3, P937, DOI 10.1038/nrmicro1286; Kelly DJ, 2001, CITRIC ACID CYCLE FA; Kershaw MJ, 1998, FUNGAL GENET BIOL, V23, P18, DOI 10.1006/fgbi.1997.1022; Kim SY, 2011, J BIOL CHEM, V286, P31932, DOI 10.1074/jbc.M111.267633; Kinne M, 2009, J BIOL CHEM, V284, P29343, DOI 10.1074/jbc.M109.040857; Kolbe A, 2005, P NATL ACAD SCI USA, V102, P11118, DOI 10.1073/pnas.0503410102; Kues U, 2000, MICROBIOL MOL BIOL R, V64, P316, DOI 10.1128/MMBR.64.2.316-353.2000; Kumar S, 2001, BIOINFORMATICS, V17, P1244, DOI 10.1093/bioinformatics/17.12.1244; Kurita T, 2012, J BIOL CHEM, V287, P17415, DOI 10.1074/jbc.M111.321018; Larsen PE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009780; Lee IK, 2007, BIOORG MED CHEM LETT, V17, P6678, DOI 10.1016/j.bmcl.2007.10.072; Lee IK, 2006, BIOORG MED CHEM LETT, V16, P5621, DOI 10.1016/j.bmcl.2006.08.016; Li RQ, 2010, GENOME RES, V20, P265, DOI 10.1101/gr.097261.109; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Li YR, 2008, BBA-GEN SUBJECTS, V1780, P51, DOI 10.1016/j.bbagen.2007.09.004; Lin WY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033716; Lin YL, 2011, INT J MED MUSHROOMS, V13, P473, DOI 10.1615/IntJMedMushr.v13.i5.70; Lugones LG, 1998, MICROBIOL-UK, V144, P2345, DOI 10.1099/00221287-144-8-2345; Luk SU, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019804; Martin F, 2008, NATURE, V452, P88, DOI 10.1038/nature06556; Martinez D, 2004, NAT BIOTECHNOL, V22, P695, DOI 10.1038/nbt967; Matis M, 2005, PROTEOMICS, V5, P67, DOI 10.1002/pmic.200400904; Medina ML, 2005, PROTEOMICS, V5, P3153, DOI 10.1002/pmic.200401136; Miyazaki Y, 2005, FUNGAL GENET BIOL, V42, P493, DOI 10.1016/j.fgb.2005.03.003; Moktali V, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-525; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Ng WL, 2000, FEMS MICROBIOL LETT, V185, P139, DOI 10.1111/j.1574-6968.2000.tb09052.x; Oba K, 2007, CANCER IMMUNOL IMMUN, V56, P905, DOI 10.1007/s00262-006-0248-1; Oguri S, 1996, J BACTERIOL, V178, P5692, DOI 10.1128/jb.178.19.5692-5698.1996; Ohm RA, 2010, NAT BIOTECHNOL, V28, P957, DOI 10.1038/nbt.1643; Panagiotou G, 2009, APPL ENVIRON MICROB, V75, P2212, DOI 10.1128/AEM.01461-08; Park J, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-402; Patterson SD, 2000, PHYSIOL GENOMICS, V2, P59, DOI 10.1152/physiolgenomics.2000.2.2.59; Pecyna MJ, 2009, APPL MICROBIOL BIOT, V84, P885, DOI 10.1007/s00253-009-2000-1; Pertea G, 2003, BIOINFORMATICS, V19, P651, DOI 10.1093/bioinformatics/btg034; Piontek K, 2010, ACTA CRYSTALLOGR F, V66, P693, DOI 10.1107/S1744309110013515; Plett JM, 2012, FUNGAL GENET BIOL, V49, P199, DOI 10.1016/j.fgb.2012.01.002; Qin L, 2011, FUNGAL GENET BIOL, V48, P956, DOI 10.1016/j.fgb.2011.06.007; SALVADO JC, 1991, CURR GENET, V20, P205, DOI 10.1007/BF00326234; Sarikaya A, 1997, APPL BIOCHEM BIOTECH, V62, P131, DOI 10.1007/BF02787990; Sarikurkcu C, 2008, BIORESOURCE TECHNOL, V99, P6651, DOI 10.1016/j.biortech.2007.11.062; Schimoler-O'Rourke R, 2003, CURR MICROBIOL, V46, P408, DOI 10.1007/s00284-002-3884-5; Shahinian S, 2000, MOL MICROBIOL, V35, P477, DOI 10.1046/j.1365-2958.2000.01713.x; Sirand-Pugnet P, 2003, CURR GENET, V44, P124, DOI 10.1007/s00294-003-0435-y; Stajich JE, 2010, P NATL ACAD SCI USA, V107, P11889, DOI 10.1073/pnas.1003391107; Sunde M, 2008, MICRON, V39, P773, DOI 10.1016/j.micron.2007.08.003; Sweetlove LJ, 2010, TRENDS PLANT SCI, V15, P462, DOI 10.1016/j.tplants.2010.05.006; Tatusov RL, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-41; Tatusov RL, 2000, NUCLEIC ACIDS RES, V28, P33, DOI 10.1093/nar/28.1.33; Toth EA, 2000, STRUCT FOLD DES, V8, P163, DOI 10.1016/S0969-2126(00)00092-7; Tsai SY, 2006, FOOD CHEM, V98, P670, DOI 10.1016/j.foodchem.2005.07.003; Tsivileva Olga M., 2001, International Microbiology, V4, P41; Ulrich R, 2004, APPL ENVIRON MICROB, V70, P4575, DOI 10.1128/AEM.70.8.4575-4581.2004; van den Brink J, 2011, APPL MICROBIOL BIOT, V91, P1477, DOI 10.1007/s00253-011-3473-2; van Vliet AHM, 2010, FEMS MICROBIOL LETT, V302, P1, DOI 10.1111/j.1574-6968.2009.01767.x; Vanden Wymelenberg A, 2006, APPL ENVIRON MICROB, V72, P4871, DOI 10.1128/AEM.00375-06; Vesper SJ, 2004, ADV APPL MICROBIOL, V55, P191, DOI 10.1016/S0065-2164(04)55007-4; Wan JMF, 2008, INT J ONCOL, V32, P689; Wang LK, 2010, BIOINFORMATICS, V26, P136, DOI 10.1093/bioinformatics/btp612; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Wanke M, 2001, ACTA BIOCHIM POL, V48, P663; Wasser SP, 2011, APPL MICROBIOL BIOT, V89, P1323, DOI 10.1007/s00253-010-3067-4; Wasser SP, 1999, CRIT REV IMMUNOL, V19, P65; Wasser SP, 2002, APPL MICROBIOL BIOT, V60, P258, DOI 10.1007/s00253-002-1076-7; Whitaker JW, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-4-r36; Wu YY, 2011, J MICROBIOL BIOTECHN, V21, P256, DOI 10.4014/jmb.1010.10060; Xu H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030646; Xu ZT, 2011, AM J CHINESE MED, V39, P15, DOI 10.1142/S0192415X11008610; Yamada M, 2006, FEMS MICROBIOL LETT, V254, P165, DOI 10.1111/j.1574-6968.2005.00023.x; Yang F, 2012, J BIOSCI BIOENG, V114, P228, DOI 10.1016/j.jbiosc.2012.03.009; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; YU LG, 1993, CANCER RES, V53, P4627; Yuan JP, 2008, APPL MICROBIOL BIOT, V80, P459, DOI 10.1007/s00253-008-1589-9; Zhang Y, 2003, PHYTOMEDICINE, V10, P386, DOI 10.1078/0944-7113-00272	112	46	48	0	89	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e56686	10.1371/journal.pone.0056686	http://dx.doi.org/10.1371/journal.pone.0056686			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418592	Green Submitted, Green Published, gold			2022-12-25	WOS:000315970300185
J	Hillaire, MLB; Nieuwkoop, NJ; Boon, ACM; de Mutsert, G; Vogelzang-van Trierum, SE; Fouchier, RAM; Osterhaus, ADME; Rimmelzwaan, GF				Hillaire, Marine L. B.; Nieuwkoop, Nella J.; Boon, Adrianus C. M.; de Mutsert, Gerrie; Vogelzang-van Trierum, Stella E.; Fouchier, Ron A. M.; Osterhaus, Albert D. M. E.; Rimmelzwaan, Guus F.			Binding of DC-SIGN to the Hemagglutinin of Influenza A Viruses Supports Virus Replication in DC-SIGN Expressing Cells	PLOS ONE			English	Article							HUMAN DENDRITIC CELLS; RESPIRATORY SYNDROME CORONAVIRUS; N-LINKED GLYCOSYLATION; RECEPTOR-BINDING; IN-VITRO; MANNOSE RECEPTOR; STRUCTURAL BASIS; TRANS-INFECTION; ENTRY; RECOGNITION	Dendritic cells express lectins receptors, like DC-SIGN, which allow these cells to sense glycans that are present on various bacterial and viral pathogens. Interaction of DC-SIGN with carbohydrate moieties induces maturation of dendritic cells and promotes endocytosis of pathogens which is an important property of these professional antigen presenting cells. Uptake of pathogens by dendritic cells may lead to cross-presentation of antigens or infection of these cells, which ultimately results in activation of virus-specific T cells in draining lymph nodes. Little is known about the interaction of DC-SIGN with influenza A viruses. Here we show that a virus with a non-functional receptor binding site in its hemagglutinin, can replicate in cells expressing DC-SIGN. Also in the absence of sialic acids, which is the receptor for influenza A viruses, these viruses replicate in DC-SIGN expressing cells including human dendritic cells. Furthermore, the efficiency of DC-SIGN mediated infection is dependent on the extent of glycosylation of the viral hemagglutinin.	[Hillaire, Marine L. B.; Nieuwkoop, Nella J.; de Mutsert, Gerrie; Vogelzang-van Trierum, Stella E.; Fouchier, Ron A. M.; Osterhaus, Albert D. M. E.; Rimmelzwaan, Guus F.] Erasmus MC, Rotterdam, Netherlands; [Osterhaus, Albert D. M. E.; Rimmelzwaan, Guus F.] Viroclin Biosci BV, Rotterdam, Netherlands; [Boon, Adrianus C. M.] Erasmus MC, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC	Rimmelzwaan, GF (corresponding author), Erasmus MC, Rotterdam, Netherlands.	g.rimmelzwaan@erasmusmc.nl	Fouchier, Ron A/A-1911-2014	Fouchier, Ron A/0000-0001-8095-2869; Boon, Adrianus/0000-0002-4700-8224; Osterhaus, Albert/0000-0002-6074-1172; Hillaire, Marine/0000-0002-3672-3935				Alvarez CP, 2002, J VIROL, V76, P6841, DOI 10.1128/JVI.76.13.6841-6844.2002; CONNOR RJ, 1994, VIROLOGY, V205, P17, DOI 10.1006/viro.1994.1615; de Vries E, 2012, P NATL ACAD SCI USA, V109, P7457, DOI 10.1073/pnas.1200987109; de Wit E, 2004, VIRUS RES, V103, P155, DOI 10.1016/j.virusres.2004.02.028; Feinberg H, 2001, SCIENCE, V294, P2163, DOI 10.1126/science.1066371; Gambaryan AS, 1997, VIROLOGY, V232, P345, DOI 10.1006/viro.1997.8572; Gamblin SJ, 2004, SCIENCE, V303, P1838, DOI 10.1126/science.1093155; Geijtenbeek TBH, 2000, CELL, V100, P587, DOI 10.1016/S0092-8674(00)80694-7; Halary F, 2002, IMMUNITY, V17, P653, DOI 10.1016/S1074-7613(02)00447-8; Hillaire MLB, 2012, VIRUS RES, V169, P301, DOI 10.1016/j.virusres.2012.08.003; Hillaire MLB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025005; Hoffmann E, 2000, P NATL ACAD SCI USA, V97, P6108, DOI 10.1073/pnas.100133697; Londrigan SL, 2012, J LEUKOCYTE BIOL, V92, P97, DOI 10.1189/jlb.1011492; Londrigan SL, 2011, J VIROL, V85, P2990, DOI 10.1128/JVI.01705-10; Martin J, 1998, VIROLOGY, V241, P101, DOI 10.1006/viro.1997.8958; Martina BEE, 2008, VIRUS RES, V135, P64, DOI 10.1016/j.virusres.2008.02.008; Marzi A, 2004, J VIROL, V78, P12090, DOI 10.1128/JVI.78.21.12090-12095.2004; Matrosovich MN, 1997, VIROLOGY, V233, P224, DOI 10.1006/viro.1997.8580; Pohlmann S, 2003, J VIROL, V77, P4070, DOI 10.1128/JVI.77.7.4070-4080.2003; Qi L, 2011, VIROLOGY, V412, P426, DOI 10.1016/j.virol.2011.01.029; Reading PC, 1997, J VIROL, V71, P8204, DOI 10.1128/JVI.71.11.8204-8212.1997; Reading PC, 2000, J VIROL, V74, P5190, DOI 10.1128/JVI.74.11.5190-5197.2000; Rimmelzwaan GF, 1998, J VIROL METHODS, V74, P57, DOI 10.1016/S0166-0934(98)00071-8; Rimmelzwaan GF, 2007, VIRUS RES, V129, P175, DOI 10.1016/j.virusres.2007.07.007; ROGERS GN, 1989, VIROLOGY, V173, P317, DOI 10.1016/0042-6822(89)90249-3; Skehel JJ, 2000, ANNU REV BIOCHEM, V69, P531, DOI 10.1146/annurev.biochem.69.1.531; Soilleux EJ, 2002, J LEUKOCYTE BIOL, V71, P445; Stray SJ, 2000, GLYCOBIOLOGY, V10, P649, DOI 10.1093/glycob/10.7.649; Suzuki Y, 2005, BIOL PHARM BULL, V28, P399, DOI 10.1248/bpb.28.399; Svajger U, 2010, CELL SIGNAL, V22, P1397, DOI 10.1016/j.cellsig.2010.03.018; Tailleux L, 2003, J EXP MED, V197, P121, DOI 10.1084/jem.20021468; Tassaneetrithep B, 2003, J EXP MED, V197, P823, DOI 10.1084/jem.20021840; Tate MD, 2011, J IMMUNOL, V187, P1884, DOI 10.4049/jimmunol.1100295; Thompson CI, 2006, J VIROL, V80, P8060, DOI 10.1128/JVI.00384-06; Upham JP, 2010, J VIROL, V84, P3730, DOI 10.1128/JVI.02148-09; Van Pottelberge GR, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-35; van Riel D, 2007, AM J PATHOL, V171, P1215, DOI 10.2353/ajpath.2007.070248; Wang SF, 2008, BIOCHEM BIOPH RES CO, V373, P561, DOI 10.1016/j.bbrc.2008.06.078; WILEY DC, 1987, ANNU REV BIOCHEM, V56, P365, DOI 10.1146/annurev.bi.56.070187.002053; WILSON IA, 1990, ANNU REV IMMUNOL, V8, P737, DOI 10.1146/annurev.iy.08.040190.003513; Yang ZY, 2004, J VIROL, V78, P5642, DOI 10.1128/JVI.78.11.5642-5650.2004	41	34	35	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2013	8	2							e56164	10.1371/journal.pone.0056164	http://dx.doi.org/10.1371/journal.pone.0056164			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104BU	23424649	Green Published, Green Submitted, gold			2022-12-25	WOS:000315965100037
J	Wang, GD; Cheng, LG; Fan, RX; Irwin, DM; Tang, SS; Peng, JG; Zhang, YP				Wang, Guo-dong; Cheng, Lu-guang; Fan, Ruo-xi; Irwin, David M.; Tang, Shu-sheng; Peng, Jian-guo; Zhang, Ya-ping			Signature of Balancing Selection at the MC1R Gene in Kunming Dog Populations	PLOS ONE			English	Article							MELANOCORTIN 1 RECEPTOR; DNA POLYMORPHISM DATA; DOMESTIC DOGS; COAT COLOR; HAPLOTYPE RECONSTRUCTION; STATISTICAL-METHOD; MUTATION; BLACK; IDENTIFICATION; RECOMBINATION	Coat color in dog breeds is an excellent character for revealing the power of artificial selection, as it is extremely diverse and likely the result of recent domestication. Coat color is generated by melanocytes, which synthesize pheomelanin (a red or yellow pigment) or eumelanin (a black or brown pigment) through the pigment type-switching pathway, and is regulated by three genes in dogs: MC1R (melanocortin receptor 1), CBD103 (beta-defensin 103), and ASIP (agouti-signaling protein precursor). The genotypes of these three gene loci in dog breeds are associated with coat color pattern. Here, we resequenced these three gene loci in two Kunming dog populations and analyzed these sequences using population genetic approaches to identify evolutionary patterns that have occurred at these loci during the recent domestication and breeding of the Kunming dog. The analysis showed that MC1R undergoes balancing selection in both Kunming dog populations, and that the Fst value for MC1R indicates significant genetic differentiation across the two populations. In contrast, similar results were not observed for CBD103 or ASIP. These results suggest that high heterozygosity and allelic differences at the MC1R locus may explain both the mixed color coat, of yellow and black, and the difference in coat colors in both Kunming dog populations.	[Wang, Guo-dong; Irwin, David M.; Zhang, Ya-ping] Chinese Acad Sci, Kunming Inst Zool, State Key Lab Genet Resources & Evolut, Kunming, Peoples R China; [Fan, Ruo-xi; Zhang, Ya-ping] Yunnan Univ, Lab Conservat & Utilizat Bioresources, Kunming, Peoples R China; [Cheng, Lu-guang; Tang, Shu-sheng; Peng, Jian-guo] Minist Publ Secur, Kunming Police Dog Base, Kunming, Peoples R China; [Irwin, David M.] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON M5S 1A1, Canada; [Irwin, David M.] Univ Toronto, Banting & Best Diabet Ctr, Toronto, ON M5G 1L5, Canada	Chinese Academy of Sciences; Kunming Institute of Zoology; Yunnan University; Ministry of Public Security (China); University of Toronto; University of Toronto	Zhang, YP (corresponding author), Chinese Acad Sci, Kunming Inst Zool, State Key Lab Genet Resources & Evolut, Kunming, Peoples R China.	zhangyp1@263.net.cn		Irwin, David/0000-0001-6131-4933	National Basic Research Program of China (973 Program) [2013CB835200]; National Natural Science Foundation of China [91231108]; Chinese Academy of Sciences; Bureau of Science and Technology of Yunnan Province	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences); Bureau of Science and Technology of Yunnan Province	This work was supported by grants from the National Basic Research Program of China (973 Program, 2013CB835200), National Natural Science Foundation of China (91231108), Chinese Academy of Sciences, and Bureau of Science and Technology of Yunnan Province. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison A., 1964, POLYMORPHISM NATURAL, P137; Anderson TM, 2009, SCIENCE, V323, P1339, DOI 10.1126/science.1165448; Andersson L, 2003, ANN NY ACAD SCI, V994, P313, DOI 10.1111/j.1749-6632.2003.tb03195.x; Andersson L, 2001, NAT REV GENET, V2, P130, DOI 10.1038/35052563; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Cagliani R, 2010, HUM GENET; Cagliani R, 2010, MOL BIOL EVOL, V27, P1945, DOI 10.1093/molbev/msq082; Cagliani R, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r143; Candille SI, 2007, SCIENCE; Chhajlani V, 1996, BIOCHEM BIOPH RES CO, V219, P521, DOI 10.1006/bbrc.1996.0266; CHHAJLANI V, 1992, FEBS LETT, V309, P417, DOI 10.1016/0014-5793(92)80820-7; COCKERHAM CC, 1987, P NATL ACAD SCI USA, V84, P8512, DOI 10.1073/pnas.84.23.8512; Cone RD, 2006, ENDOCR REV, V27, P736, DOI 10.1210/er.2006-0034; Dreger DL, 2011, J HERED, V102, pS11, DOI 10.1093/jhered/esr042; Everts RE, 2000, ANIM GENET, V31, P194, DOI 10.1046/j.1365-2052.2000.00639.x; FRANDBERG PA, 1994, BIOCHEM BIOPH RES CO, V202, P1266, DOI 10.1006/bbrc.1994.2067; Frandberg PA, 1997, BIOCHEM BIOPH RES CO, V236, P489, DOI 10.1006/bbrc.1997.6994; Fumagalli M, 2009, GENOME RES, V19, P199, DOI 10.1101/gr.082768.108; Hudson RR, 2002, BIOINFORMATICS, V18, P337, DOI 10.1093/bioinformatics/18.2.337; HUDSON RR, 1985, GENETICS, V111, P147; Hughes A.L., 1999, ADAPTIVE EVOLUTION G; Innan H, 2004, P NATL ACAD SCI USA, V101, P10667, DOI 10.1073/pnas.0401720101; Kerns JA, 2004, MAMM GENOME, V15, P798, DOI 10.1007/s00335-004-2377-1; Kerns JA, 2003, J HERED, V94, P75, DOI 10.1093/jhered/esg016; Kerns JA, 2007, GENETICS, V176, P1679, DOI 10.1534/genetics.107.074237; Klungland H, 2003, ANN NY ACAD SCI, V994, P331, DOI 10.1111/j.1749-6632.2003.tb03197.x; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lindblad-Toh K, 2005, NATURE, V438, P803, DOI 10.1038/nature04338; Marklund L, 1996, MAMM GENOME, V7, P895, DOI 10.1007/s003359900264; NEI M, 1979, P NATL ACAD SCI USA, V76, P5269, DOI 10.1073/pnas.76.10.5269; Newton JM, 2000, MAMM GENOME, V11, P24, DOI 10.1007/s003350010005; Pang JF, 2009, MOL BIOL EVOL, V26, P2849, DOI 10.1093/molbev/msp195; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Savolainen P, 2002, SCIENCE, V298, P1610, DOI 10.1126/science.1073906; Schmutz SM, 2007, ANIM GENET, V38, P539, DOI 10.1111/j.1365-2052.2007.01664.x; Schmutz SM, 2003, J HERED, V94, P69, DOI 10.1093/jhered/esg014; SIMONSEN KL, 1995, GENETICS, V141, P413; Sonnhammer E L, 1998, Proc Int Conf Intell Syst Mol Biol, V6, P175; Stephens M, 2003, AM J HUM GENET, V73, P1162, DOI 10.1086/379378; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Sutter NB, 2007, SCIENCE, V316, P112, DOI 10.1126/science.1137045; TAJIMA F, 1989, GENETICS, V123, P585; Tishkoff SA, 2001, SCIENCE, V293, P455, DOI 10.1126/science.1061573; WATTERSON GA, 1975, THEOR POPUL BIOL, V7, P256, DOI 10.1016/0040-5809(75)90020-9; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI [10.2307/2408641, 10.1111/j.1558-5646.1984.tb05657.x]; Xu XL, 1996, NAT GENET, V14, P384, DOI 10.1038/ng1296-384	47	15	20	2	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2013	8	2							e55469	10.1371/journal.pone.0055469	http://dx.doi.org/10.1371/journal.pone.0055469			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104BU	23424634	Green Published, gold, Green Submitted			2022-12-25	WOS:000315965100022
J	Kjaer-Sorensen, K; Engholm, DH; Kamei, H; Morch, MG; Kristensen, AO; Zhou, JF; Conover, CA; Duan, CM; Oxvig, C				Kjaer-Sorensen, Kasper; Engholm, Ditte H.; Kamei, Hiroyasu; Morch, Maria G.; Kristensen, Anisette O.; Zhou, Jianfeng; Conover, Cheryl A.; Duan, Cunming; Oxvig, Claus			Pregnancy-associated Plasma Protein A (PAPP-A) Modulates the Early Developmental Rate in Zebrafish Independently of Its Proteolytic Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IGF-BINDING PROTEIN-4; MAJOR BASIC-PROTEIN; MESSENGER-RIBONUCLEIC-ACID; TARGETED GENE KNOCKDOWN; SUBSTRATE-SPECIFICITY; EMBRYONIC-DEVELOPMENT; CELL-SURVIVAL; GROWTH; EXPRESSION; DUPLICATION	Pregnancy-associated plasma protein-A (PAPP-A) is a large metalloproteinase specifically cleaving insulin-like growth factor (IGF) binding proteins, causing increased IGF bioavailability and, hence, local regulation of IGF receptor activation. We have identified two highly conserved zebrafish homologs of the human PAPP-A gene. Expression of zebrafish Papp-a, one of the two paralogs, begins during gastrulation and persists throughout the first week of development, and analyses demonstrate highly conserved patterns of expression between adult zebrafish, humans, and mice. We show that the specific knockdown of zebrafish papp-a limits the developmental rate beginning during gastrulation without affecting the normal patterning of the embryo. This phenotype is different from those resulting from deficiency of Igf receptor or ligand in zebrafish, suggesting a function of Papp-a outside of the Igf system. Biochemical analysis of recombinant zebrafish Papp-a demonstrates conservation of proteolytic activity, specificity, and the intrinsic regulatory mechanism. However, in vitro transcribed mRNA, which encodes a proteolytically inactive Papp-a mutant, recues the papp-a knockdown phenotype as efficiently as wildtype Papp-a. Thus, the developmental phenotype of papp-a knockdown is not a consequence of lacking Papp-a proteolytic activity. We conclude that Papp-a possesses biological functions independent of its proteolytic activity. Our data represent the first evidence for a non-proteolytic function of PAPP-A.	[Kjaer-Sorensen, Kasper; Engholm, Ditte H.; Morch, Maria G.; Kristensen, Anisette O.; Oxvig, Claus] Aarhus Univ, Dept Mol Biol & Genet, DK-8000 Aarhus C, Denmark; [Kamei, Hiroyasu; Zhou, Jianfeng; Duan, Cunming] Univ Michigan, Dept Mol Cellular & Dev Biol, Ann Arbor, MI 48105 USA; [Conover, Cheryl A.] Mayo Clin, Endocrine Res Unit, Rochester, MN 55905 USA	Aarhus University; University of Michigan System; University of Michigan; Mayo Clinic	Oxvig, C (corresponding author), Univ Aarhus, Dept Mol Biol & Genet, DK-8000 Aarhus, Denmark.	co@mb.au.dk	Kjaer-Sorensen, Kasper/AAF-1457-2020	KAMEI, HIROYASU/0000-0001-7123-040X; Oxvig, Claus/0000-0002-4715-9719	Danish Council for Independent Research (Medical Sciences, and Technology and Production Sciences); Novo Nordic Foundation; Karen Elise Jensen Foundation; Danish National Research Infrastructure Program; Division Of Integrative Organismal Systems [1051034] Funding Source: National Science Foundation	Danish Council for Independent Research (Medical Sciences, and Technology and Production Sciences); Novo Nordic Foundation(Novo Nordisk Foundation); Karen Elise Jensen Foundation; Danish National Research Infrastructure Program; Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by grants from the Danish Council for Independent Research (Medical Sciences, and Technology and Production Sciences), by the Novo Nordic Foundation, by the Karen Elise Jensen Foundation, and by the Danish National Research Infrastructure Program.	Bale LK, 2005, J ENDOCRINOL, V186, P325, DOI 10.1677/joe.1.06259; Boldt HB, 2004, J BIOL CHEM, V279, P38525, DOI 10.1074/jbc.M405222200; Boldt HB, 2001, BIOCHEM J, V358, P359, DOI 10.1042/0264-6021:3580359; BONNO M, 1994, LAB INVEST, V71, P560; Bradford Y, 2011, NUCLEIC ACIDS RES, V39, pD822, DOI 10.1093/nar/gkq1077; Bunn RC, 2003, TRENDS ENDOCRIN MET, V14, P176, DOI 10.1016/S1043-2760(03)00049-3; Burns JL, 2001, DEVELOPMENT, V128, P3819; Conover CA, 2004, DEVELOPMENT, V131, P1187, DOI 10.1242/dev.00997; CONOVER CA, 1995, J BIOL CHEM, V270, P4395, DOI 10.1074/jbc.270.9.4395; DECHIARA TM, 1990, NATURE, V345, P78, DOI 10.1038/345078a0; Firth SM, 2002, ENDOCR REV, V23, P824, DOI 10.1210/er.2001-0033; Forbes Briony E, 2012, Front Endocrinol (Lausanne), V3, P38, DOI 10.3389/fendo.2012.00038; Fox NS, 2009, PRENATAL DIAG, V29, P1244, DOI 10.1002/pd.2397; Kajimura S, 2005, P NATL ACAD SCI USA, V102, P1240, DOI 10.1073/pnas.0407443102; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kirkegaard I, 2011, ULTRASOUND OBST GYN, V37, P341, DOI 10.1002/uog.8808; Laursen LS, 2007, MOL ENDOCRINOL, V21, P1246, DOI 10.1210/me.2006-0522; Laursen LS, 2002, J BIOL CHEM, V277, P47225, DOI 10.1074/jbc.M209155200; Laursen LS, 2002, BIOCHEM J, V367, P31, DOI 10.1042/BJ20020831; Laursen LS, 2001, FEBS LETT, V504, P36, DOI 10.1016/S0014-5793(01)02760-0; Lawrence JB, 1999, P NATL ACAD SCI USA, V96, P3149, DOI 10.1073/pnas.96.6.3149; LIU JP, 1993, CELL, V75, P59, DOI 10.1016/S0092-8674(05)80084-4; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mikkelsen JH, 2008, J BIOL CHEM, V283, P16772, DOI 10.1074/jbc.M802429200; Nasevicius A, 2000, NAT GENET, V26, P216, DOI 10.1038/79951; Ning Y, 2008, MOL ENDOCRINOL, V22, P1213, DOI 10.1210/me.2007-0536; Overgaard MT, 1999, BIOL REPROD, V61, P1083, DOI 10.1095/biolreprod61.4.1083; Overgaard MT, 2003, J BIOL CHEM, V278, P2106, DOI 10.1074/jbc.M208777200; PEAR WS, 1993, P NATL ACAD SCI USA, V90, P8392, DOI 10.1073/pnas.90.18.8392; Peterson SE, 2008, AM J OBSTET GYNECOL, V198, pE43, DOI 10.1016/j.ajog.2007.12.026; Robu ME, 2007, PLOS GENET, V3, P787, DOI 10.1371/journal.pgen.0030078; Schlueter PJ, 2007, CELL DEATH DIFFER, V14, P1095, DOI 10.1038/sj.cdd.4402109; Schlueter PJ, 2006, FASEB J, V20, P1230, DOI 10.1096/fj.05-3882fje; Smith GCS, 2002, NATURE, V417, P916, DOI 10.1038/417916a; Soe R, 2002, EUR J BIOCHEM, V269, P2247, DOI 10.1046/j.1432-1033.2002.02883.x; Weyer K, 2004, EUR J BIOCHEM, V271, P1525, DOI 10.1111/j.1432-1033.2004.04061.x; Weyer K, 2007, J BIOL CHEM, V282, P10988, DOI 10.1074/jbc.M607903200; White YAR, 2009, ENDOCRINOLOGY, V150, P4366, DOI 10.1210/en.2009-0356; Zhong YB, 2011, J CELL SCI, V124, P1925, DOI 10.1242/jcs.082644; Zou SM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007026	40	18	19	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 5	2013	288	14					9982	9992		10.1074/jbc.M112.426304	http://dx.doi.org/10.1074/jbc.M112.426304			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	119RB	23430244	Green Published, hybrid			2022-12-25	WOS:000317114000037
J	Thompson, CA; Purushothaman, A; Ramani, VC; Vlodavsky, I; Sanderson, RD				Thompson, Camilla A.; Purushothaman, Anurag; Ramani, Vishnu C.; Vlodavsky, Israel; Sanderson, Ralph D.			Heparanase Regulates Secretion, Composition, and Function of Tumor Cell-derived Exosomes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MULTIPLE-MYELOMA; SULFATE PROTEOGLYCANS; METASTASIS; SYNDECAN-1; GROWTH; EXPRESSION; PROMOTES; ACTIVATION; PROLIFERATION; STIMULATION	Emerging evidence indicates that exosomes play a key role in tumor-host cross-talk and that exosome secretion, composition, and functional capacity are altered as tumors progress to an aggressive phenotype. However, little is known regarding the mechanisms that regulate these changes. Heparanase is an enzyme whose expression is up-regulated as tumors become more aggressive and is associated with enhanced tumor growth, angiogenesis, and metastasis. We have discovered that in human cancer cells (myeloma, lymphoblastoid, and breast cancer), when expression of heparanase is enhanced or when tumor cells are exposed to exogenous heparanase, exosome secretion is dramatically increased. Heparanase enzyme activity is required for robust enhancement of exosome secretion because enzymatically inactive forms of heparanase, even when present in high amounts, do not dramatically increase exosome secretion. Heparanase also impacts exosome protein cargo as reflected by higher levels of syndecan-1, VEGF, and hepatocyte growth factor in exosomes secreted by heparanase-high expressing cells as compared with heparanase-low expressing cells. In functional assays, exosomes from heparanase-high cells stimulated spreading of tumor cells on fibronectin and invasion of endothelial cells through extracellular matrix better than did exosomes secreted by heparanase-low cells. These studies reveal that heparanase helps drive exosome secretion, alters exosome composition, and facilitates production of exosomes that impact both tumor and host cell behavior, thereby promoting tumor progression.	[Thompson, Camilla A.; Purushothaman, Anurag; Ramani, Vishnu C.; Sanderson, Ralph D.] Univ Alabama Birmingham, Dept Pathol, Birmingham, AL 35294 USA; [Purushothaman, Anurag; Sanderson, Ralph D.] Univ Alabama Birmingham, Univ Alabama UAB, Ctr Comprehens Canc, Birmingham, AL 35294 USA; [Vlodavsky, Israel] Technion Israel Inst Technol, Bruce Rappaport Fac Med, Canc & Vasc Biol Res Ctr, IL-31096 Haifa, Israel	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; Technion Israel Institute of Technology; Rappaport Faculty of Medicine	Sanderson, RD (corresponding author), Univ Alabama Birmingham, Dept Pathol, 602 WTI,1720 2nd Ave S, Birmingham, AL 35294 USA.	sanderson@uab.edu			National Institutes of Health [CA135075, CA138340]; United States-Israel Binational Science Foundation; NATIONAL CANCER INSTITUTE [R01CA138340, R01CA135075] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States-Israel Binational Science Foundation(US-Israel Binational Science Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA135075 and CA138340 (to R. D. S.). This work was also supported by a grant from the United States-Israel Binational Science Foundation (jointly to R. D. S. and I. V.).	Baietti MF, 2012, NAT CELL BIOL, V14, P677, DOI 10.1038/ncb2502; Barash U, 2010, FEBS J, V277, P3890, DOI 10.1111/j.1742-4658.2010.07799.x; Bobrie A, 2012, CANCER RES, V72, P4920, DOI 10.1158/0008-5472.CAN-12-0925; Borset M, 2000, BLOOD, V96, P2528; Derksen PWB, 2003, LEUKEMIA, V17, P764, DOI 10.1038/sj.leu.2402875; Fux L, 2009, TRENDS BIOCHEM SCI, V34, P511, DOI 10.1016/j.tibs.2009.06.005; Fux L, 2009, CANCER RES, V69, P1758, DOI 10.1158/0008-5472.CAN-08-1837; Gingis-Velitski S, 2004, J BIOL CHEM, V279, P44084, DOI 10.1074/jbc.M402131200; Gingis-Velitski S, 2004, J BIOL CHEM, V279, P23536, DOI 10.1074/jbc.M400554200; Henderson MC, 2012, FRONT ONCOL, V2, DOI 10.3389/fonc.2012.00038; Hood JL, 2011, CANCER RES, V71, P3792, DOI 10.1158/0008-5472.CAN-10-4455; Hov H, 2009, EUR J HAEMATOL, V82, P277, DOI 10.1111/j.1600-0609.2009.01212.x; Ilan N, 2006, INT J BIOCHEM CELL B, V38, P2018, DOI 10.1016/j.biocel.2006.06.004; Kelly T, 2003, CANCER RES, V63, P8749; Lee TH, 2011, SEMIN IMMUNOPATHOL, V33, P455, DOI 10.1007/s00281-011-0250-3; Liu DF, 2002, P NATL ACAD SCI USA, V99, P568, DOI 10.1073/pnas.012578299; McQuade KJ, 2006, J CELL SCI, V119, P2445, DOI 10.1242/jcs.02970; Ostrowski M, 2010, NAT CELL BIOL, V12, P19, DOI 10.1038/ncb2000; Peinado H, 2012, NAT MED, V18, P883, DOI 10.1038/nm.2753; Peinado H, 2011, SEMIN CANCER BIOL, V21, P139, DOI 10.1016/j.semcancer.2011.01.002; Poliakov A, 2009, PROSTATE, V69, P159, DOI 10.1002/pros.20860; Purushothaman A, 2008, J BIOL CHEM, V283, P32628, DOI 10.1074/jbc.M806266200; Purushothaman A, 2010, BLOOD, V115, P2449, DOI 10.1182/blood-2009-07-234757; Ramani VC, 2012, J BIOL CHEM, V287, P9952, DOI 10.1074/jbc.M111.330803; Ramani VC, 2011, J BIOL CHEM, V286, P6490, DOI 10.1074/jbc.M110.183277; Record M, 2011, BIOCHEM PHARMACOL, V81, P1171, DOI 10.1016/j.bcp.2011.02.011; Simons M, 2009, CURR OPIN CELL BIOL, V21, P575, DOI 10.1016/j.ceb.2009.03.007; Thery Clotilde, 2006, Curr Protoc Cell Biol, VChapter 3, DOI 10.1002/0471143030.cb0322s30; Vlodavsky I, 2012, CANCER MICROENVIRON, V5, P115, DOI 10.1007/s12307-011-0082-7; Vreys V, 2005, J BIOL CHEM, V280, P33141, DOI 10.1074/jbc.M503007200; Xiang XY, 2009, INT J CANCER, V124, P2621, DOI 10.1002/ijc.24249; Yang Y, 2005, BLOOD, V105, P1303, DOI 10.1182/blood-200406-2141; Yang Y, 2002, BLOOD, V100, P610, DOI 10.1182/blood.V100.2.610; Yang Y, 2007, J BIOL CHEM, V282, P13326, DOI 10.1074/jbc.M611259200; Yang Y, 2010, CANCER RES, V70, P8329, DOI 10.1158/0008-5472.CAN-10-2179; Zetser A, 2006, CANCER RES, V66, P1455, DOI 10.1158/0008-5472.CAN-05-1811; Zetser A, 2004, J CELL SCI, V117, P2249, DOI 10.1242/jcs.01068; Zhang HG, 2011, CLIN CANCER RES, V17, P959, DOI 10.1158/1078-0432.CCR-10-1489; Zhang LX, 2011, CANCER RES, V71, P645, DOI 10.1158/0008-5472.CAN-10-1910	40	233	240	2	33	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 5	2013	288	14					10093	10099		10.1074/jbc.C112.444562	http://dx.doi.org/10.1074/jbc.C112.444562			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	119RB	23430739	Green Published, hybrid			2022-12-25	WOS:000317114000050
J	Abed, M; Balasaheb, S; Towhid, ST; Daniel, C; Amann, K; Lang, F				Abed, Majed; Balasaheb, Siraskar; Towhid, Syeda Tasneem; Daniel, Christoph; Amann, Kerstin; Lang, Florian			Adhesion of Annexin 7 Deficient Erythrocytes to Endothelial Cells	PLOS ONE			English	Article							RED-BLOOD-CELLS; BERGHEI-INFECTED MICE; ACUTE KIDNEY INJURY; SUICIDAL DEATH; PHOSPHATIDYLSERINE EXPOSURE; CATION CHANNELS; CA2+ ENTRY; IN-VITRO; ERYPTOTIC ERYTHROCYTES; APOPTOTIC DEATH	Annexin 7 deficiency has previously been shown to foster suicidal death of erythrocytes or eryptosis, which is triggered by increase of intracellular Ca2+ concentration ([Ca2+](i)) and characterized by cell shrinkage and cell membrane scrambling with subsequent phosphatidylserine exposure at the cell surface. Eryptosis following increase of [Ca2+](i) by Ca2+ ionophore ionomycin, osmotic shock or energy depletion was more pronounced in erythrocytes from annexinA7-deficient mice (anxA7(-/-)) than in erythrocytes from wild type mice (anxA7(+/+)). As phosphatidylserine exposure is considered to mediate adhesion of erythrocytes to the vascular wall, the present study explored adhesion of erythrocytes from anx7(-/-) and anx7(+/+)-mice following increase of [Ca2+](i) by Ca2+ ionophore ionomycin (1 mu M for 30 min), hyperosmotic shock (addition of 550 mM sucrose for 2 hours) or energy depletion (removal of glucose for 12 hours). Phosphatidylserine exposing erythrocytes were identified by annexin V binding, cell volume estimated from forward scatter in FACS analysis and adhesion to human umbilical vein endothelial cells (HUVEC) utilizing a flow chamber. As a result, ionomycin, sucrose addition and glucose removal all triggered phosphatidylserine-exposure, decreased forward scatter and enhanced adhesion of erythrocytes to human umbilical vein endothelial cells (HUVEC), effects significantly more pronounced in anx7(-/-) than in anx7(+/+)-erythrocytes. Following ischemia, morphological renal injury was significantly higher in anx7(-/-) than in anx7(+/+)-mice. The present observations demonstrate that enhanced eryptosis of annexin7 deficient cells is paralleled by increased adhesion of erythrocytes to the vascular wall, an effect, which may impact on microcirculation during ischemia.	[Abed, Majed; Balasaheb, Siraskar; Towhid, Syeda Tasneem; Lang, Florian] Univ Tubingen, Dept Physiol, Tubingen, Germany; [Abed, Majed] Al Furat Univ, Dept Physiol, Fac Med, Deir Ezzor, Syria; [Daniel, Christoph; Amann, Kerstin] Univ Erlangen Nurnberg, Inst Pathol, Erlangen, Germany	Eberhard Karls University of Tubingen; University of Erlangen Nuremberg	Lang, F (corresponding author), Univ Tubingen, Dept Physiol, Tubingen, Germany.	florian.lang@uni-tuebingen.de	Daniel, Christoph/AAK-2136-2021	Daniel, Christoph/0000-0002-6803-4755	Deutsche Forschungsgemeinschaft	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This study was supported by the Deutsche Forschungsgemeinschaft. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abed M, 2012, TOXICOLOGY, V302, P123, DOI 10.1016/j.tox.2012.10.006; Abed M, 2012, AM J PHYSIOL-CELL PH, V303, pC991, DOI 10.1152/ajpcell.00239.2012; Andrews D A, 1999, Curr Opin Hematol, V6, P76, DOI 10.1097/00062752-199903000-00004; Berg CP, 2001, CELL DEATH DIFFER, V8, P1197, DOI 10.1038/sj.cdd.4400905; Bernhardt I, 2007, CELL PHYSIOL BIOCHEM, V20, P601, DOI 10.1159/000107543; Bhavsar SK, 2011, CELL PHYSIOL BIOCHEM, V27, P547, DOI 10.1159/000329956; Birka C, 2004, PFLUG ARCH EUR J PHY, V448, P471, DOI 10.1007/s00424-004-1289-y; Bobbala D, 2010, CELL PHYSIOL BIOCHEM, V26, P355, DOI 10.1159/000320559; Bottger E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033774; Bookchin R M, 1987, Prog Clin Biol Res, V240, P193; Borst O, 2012, AM J PHYSIOL-CELL PH, V302, pC644, DOI 10.1152/ajpcell.00340.2011; Brand VB, 2003, CELL PHYSIOL BIOCHEM, V13, P347, DOI 10.1159/000075122; Bratosin D, 2001, CELL DEATH DIFFER, V8, P1143, DOI 10.1038/sj.cdd.4400946; BRUGNARA C, 1993, J CLIN INVEST, V92, P520, DOI 10.1172/JCI116597; Clemen CS, 1999, J MUSCLE RES CELL M, V20, P669, DOI 10.1023/A:1005524623337; Clemen CS, 2003, EXP CELL RES, V291, P406, DOI 10.1016/j.yexcr.2003.07.012; Closse C, 1999, BRIT J HAEMATOL, V107, P300, DOI 10.1046/j.1365-2141.1999.01718.x; Duranton C, 2003, CELL PHYSIOL BIOCHEM, V13, P189, DOI 10.1159/000072421; Duranton C, 2002, J PHYSIOL-LONDON, V539, P847, DOI 10.1113/jphysiol.2001.013040; Felder KM, 2011, CELL PHYSIOL BIOCHEM, V27, P557, DOI 10.1159/000329957; Firat U, 2012, EXP DIABETES RES, DOI 10.1155/2012/316384; Foller M, 2008, P NATL ACAD SCI USA, V105, P6771, DOI 10.1073/pnas.0708940105; Foller M, 2008, CELL PHYSIOL BIOCHEM, V21, P183, DOI 10.1159/000113760; Foller M, 2009, CELL PHYSIOL BIOCHEM, V24, P133, DOI 10.1159/000233238; Foller M, 2009, FASEB J, V23, P1072, DOI 10.1096/fj.08-121772; Gallagher PG, 2003, BLOOD, V101, P4625, DOI 10.1182/blood-2001-12-0329; Ganesan S, 2012, TOXICOLOGY, V294, P54, DOI 10.1016/j.tox.2012.01.015; Gao MH, 2012, ARCH TOXICOL, V86, P741, DOI 10.1007/s00204-012-0808-4; Gatidis S, 2011, CELL PHYSIOL BIOCHEM, V28, P1279, DOI 10.1159/000335859; Ghashghaeinia M, 2012, BRIT J HAEMATOL, V157, P606, DOI 10.1111/j.1365-2141.2012.09100.x; Ghashghaeinia M, 2011, CELL PHYSIOL BIOCHEM, V27, P45, DOI 10.1159/000325204; Gough PJ, 2004, J IMMUNOL, V172, P3678, DOI 10.4049/jimmunol.172.6.3678; Grenz A, 2007, AM J PHYSIOL-RENAL, V292, pF475, DOI 10.1152/ajprenal.00275.2006; Havasi A, 2011, KIDNEY INT, V80, P29, DOI 10.1038/ki.2011.120; Herr C, 2001, MOL CELL BIOL, V21, P4119, DOI 10.1128/MCB.21.13.4119-4128.2001; Heyman SN, 2011, CONTRIB NEPHROL, V169, P286, DOI 10.1159/000313957; Hung CH, 1996, P NATL ACAD SCI USA, V93, P10797, DOI 10.1073/pnas.93.20.10797; Jilani K, 2012, KIDNEY BLOOD PRESS R, V36, P107, DOI 10.1159/000341488; Jilani K, 2013, TOXICOL IN VITRO, V27, P52, DOI 10.1016/j.tiv.2012.09.004; Kaestner L, 2000, BIOELECTROCHEMISTRY, V52, P117, DOI 10.1016/S0302-4598(00)00110-0; Kaestner L, 2002, BIOELECTROCHEMISTRY, V55, P71, DOI 10.1016/S1567-5394(01)00164-5; Kempe DS, 2007, J MOL MED-JMM, V85, P269, DOI 10.1007/s00109-006-0123-8; Kempe DS, 2006, FASEB J, V20, P368, DOI 10.1096/fj.05-4872fje; Koka S, 2009, CELL PHYSIOL BIOCHEM, V23, P191, DOI 10.1159/000204107; Kucherenko Y, 2012, CELL PHYSIOL BIOCHEM, V30, P407, DOI 10.1159/000339034; Kucherenko YV, 2012, CELL PHYSIOL BIOCHEM, V30, P863, DOI 10.1159/000341464; KUIJPERS GAJ, 1992, CELL TISSUE RES, V269, P323, DOI 10.1007/BF00319624; Lang E, 2012, BASIC CLIN PHARMACOL, V111, P348, DOI 10.1111/j.1742-7843.2012.00915.x; Lang E, 2012, INT J BIOCHEM CELL B, V44, P1236, DOI 10.1016/j.biocel.2012.04.019; Lang E, 2011, CELL PHYSIOL BIOCHEM, V28, P347, DOI 10.1159/000331751; Lang E, 2010, PFLUG ARCH EUR J PHY, V460, P667, DOI 10.1007/s00424-010-0829-x; Lang F, 2012, BLOOD PURIFICAT, V33, P125, DOI 10.1159/000334163; Lang F, 2008, CELL PHYSIOL BIOCHEM, V22, P373, DOI 10.1159/000185448; Lang KS, 2004, AM J PHYSIOL-RENAL, V286, pF1046, DOI 10.1152/ajprenal.00263.2003; Lang KS, 2003, CELL DEATH DIFFER, V10, P249, DOI 10.1038/sj.cdd.4401144; Lang PA, 2005, CELL DEATH DIFFER, V12, P415, DOI 10.1038/sj.cdd.4401561; Lang PA, 2003, AM J PHYSIOL-CELL PH, V285, pC1553, DOI 10.1152/ajpcell.00186.2003; Lang PA, 2007, NAT MED, V13, P164, DOI 10.1038/nm1539; Lang PA, 2006, J MOL MED, V84, P378, DOI 10.1007/s00109-006-0058-0; Lang PA, 2009, CELL PHYSIOL BIOCHEM, V24, P415, DOI 10.1159/000257529; Lindoso RS, 2011, CELL PHYSIOL BIOCHEM, V28, P267, DOI 10.1159/000331739; Linkermann A, 2012, NEPHROL DIAL TRANSPL, V27, P3412, DOI 10.1093/ndt/gfs373; Liu Y, 2012, KIDNEY BLOOD PRESS R, V35, P373, DOI 10.1159/000336171; Lupescu A, 2012, J NAT PROD; Lupescu A, 2012, CELL PHYSIOL BIOCHEM, V30, P876, DOI 10.1159/000341465; Lupescu A, 2012, CELL PHYSIOL BIOCHEM, V30, P428, DOI 10.1159/000339036; Lupescu A, 2012, BIOMETALS, V25, P309, DOI 10.1007/s10534-011-9507-5; MASON J, 1986, RENAL PHYSIOL BIOCH, V9, P129; Monastyrskaya K, 2009, CELL MOL LIFE SCI, V66, P2623, DOI 10.1007/s00018-009-0027-1; Monastyrskaya K, 2009, J BIOL CHEM, V284, P17227, DOI 10.1074/jbc.M109.004457; Nogueira BV, 2012, CELL PHYSIOL BIOCHEM, V29, P143, DOI 10.1159/000337595; Pandolfi A, 2007, J CELL PHYSIOL, V213, P699, DOI 10.1002/jcp.21138; Polak-Jonkisz D, 2012, BLOOD PURIFICAT, V34, P209, DOI 10.1159/000341627; Qadri SM, 2011, CELL PHYSIOL BIOCHEM, V28, P857, DOI 10.1159/000335800; Qadri SM, 2011, CELL PHYSIOL BIOCHEM, V28, P339, DOI 10.1159/000331750; Qadri SM, 2011, TOXICOLOGY, V283, P24, DOI 10.1016/j.tox.2011.01.023; Qian EW, 2012, J NAT PROD, V75, P531, DOI 10.1021/np200555s; RAYNAL P, 1994, BBA-REV BIOMEMBRANES, V1197, P63, DOI 10.1016/0304-4157(94)90019-1; Rodriguez F, 2012, CURR PHARM DES; Sauvant C, 2009, CELL PHYSIOL BIOCHEM, V24, P567, DOI 10.1159/000257513; Shaik N, 2012, CELL PHYSIOL BIOCHEM, V30, P678, DOI 10.1159/000341448; Shaik N, 2012, CELL PHYSIOL BIOCHEM, V30, P512, DOI 10.1159/000341434; Shimaoka T, 2007, J IMMUNOL, V179, P8172, DOI 10.4049/jimmunol.179.12.8172; Siraskar B, 2010, CELL PHYSIOL BIOCHEM, V26, P347, DOI 10.1159/000320558; Srivastava M, 1999, P NATL ACAD SCI USA, V96, P13783, DOI 10.1073/pnas.96.24.13783; VERMES I, 1995, J IMMUNOL METHODS, V184, P39, DOI 10.1016/0022-1759(95)00072-I; Vota D.M., 2012, CELL BIOCH BIOPHYS; Weiss E, 2012, CELL CALCIUM, V51, P51, DOI 10.1016/j.ceca.2011.10.005; Wood BL, 1996, BLOOD, V88, P1873; Zappulla Donatella, 2008, J Cardiometab Syndr, V3, P30, DOI 10.1111/j.1559-4572.2008.07263.x; Zbidah M., 2012, BASIC CLIN PHARM TOX; Zbidah M, 2012, TOXICOLOGY, V302, P101, DOI 10.1016/j.tox.2012.09.010; Zelenak C, 2012, CELL PHYSIOL BIOCHEM, V30, P282, DOI 10.1159/000339064; Zelenak C, 2012, CELL PHYSIOL BIOCHEM, V29, P171, DOI 10.1159/000337598; Zelenak C, 2011, J PROTEOME RES, V10, P1690, DOI 10.1021/pr101004j	95	10	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e56650	10.1371/journal.pone.0056650	http://dx.doi.org/10.1371/journal.pone.0056650			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437197	gold, Green Published, Green Submitted			2022-12-25	WOS:000315184200128
J	Glorvigen, P; Andreassen, HP; Ims, RA				Glorvigen, Petter; Andreassen, Harry P.; Ims, Rolf A.			Local and Regional Determinants of Colonisation-Extinction Dynamics of a Riparian Mainland-Island Root Vole Metapopulation	PLOS ONE			English	Article							ESTIMATING SITE OCCUPANCY; SPACE-USE RESPONSES; HABITAT FRAGMENTATION; MICROTUS-OECONOMUS; POPULATION-SIZE; PATCH QUALITY; CONNECTIVITY; AREA; PATTERNS; RATES	The role of local habitat geometry (habitat area and isolation) in predicting species distribution has become an increasingly more important issue, because habitat loss and fragmentation cause species range contraction and extinction. However, it has also become clear that other factors, in particular regional factors (environmental stochasticity and regional population dynamics), should be taken into account when predicting colonisation and extinction. In a live trapping study of a mainland-island metapopulation of the root vole (Microtus oeconomus) we found extensive occupancy dynamics across 15 riparian islands, but yet an overall balance between colonisation and extinction over 4 years. The 54 live trapping surveys conducted over 13 seasons revealed imperfect detection and proxies of population density had to be included in robust design, multi-season occupancy models to achieve unbiased rate estimates. Island colonisation probability was parsimoniously predicted by the multi-annual density fluctuations of the regional mainland population and local island habitat quality, while extinction probability was predicted by island population density and the level of the recent flooding events (the latter being the main regionalized disturbance regime in the study system). Island size and isolation had no additional predictive power and thus such local geometric habitat characteristics may be overrated as predictors of vole habitat occupancy relative to measures of local habitat quality. Our results suggest also that dynamic features of the larger region and/or the metapopulation as a whole, owing to spatially correlated environmental stochasticity and/or biotic interactions, may rule the colonisation - extinction dynamics of boreal vole metapopulations. Due to high capacities for dispersal and habitat tracking voles originating from large source populations can rapidly colonise remote and small high quality habitat patches and re-establish populations that have gone extinct due to demographic (small population size) and environmental stochasticity (e.g. extreme climate events).	[Glorvigen, Petter; Andreassen, Harry P.] Hedmark Univ Coll, Fac Appl Ecol & Agr Sci, Koppang, Norway; [Ims, Rolf A.] Univ Tromso, Dept Arctic & Marine Biol, Tromso, Norway	Inland Norway University of Applied Sciences; UiT The Arctic University of Tromso	Glorvigen, P (corresponding author), Hedmark Univ Coll, Fac Appl Ecol & Agr Sci, Koppang, Norway.	petter.glorvigen@hihm.no			Research Council of Norway [182612]	Research Council of Norway(Research Council of Norway)	Funding was provided by the Research Council of Norway (project 182612). (http://www.forskningsradet.no/en/Home_page/1177315753906). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aars J, 2002, ECOLOGY, V83, P3449, DOI 10.1890/0012-9658(2002)083[3449:IACDOP]2.0.CO;2; Aars J, 1999, OIKOS, V85, P204, DOI 10.2307/3546487; Andreassen HP, 1998, ECOLOGY, V79, P1223, DOI 10.1890/0012-9658(1998)079[1223:SURTHF]2.0.CO;2; Baguette M, 2004, BASIC APPL ECOL, V5, P213, DOI 10.1016/j.baae.2004.03.001; Barrett GW, 1999, LANDSCAPE ECOLOGY SM; Buckland ST, 1997, BIOMETRICS, V53, P603, DOI 10.2307/2533961; Crone EE, 2001, ECOLOGY, V82, P831; Fleishman E, 2002, CONSERV BIOL, V16, P706, DOI 10.1046/j.1523-1739.2002.00539.x; Franken RJ, 2004, J ANIM ECOL, V73, P889, DOI 10.1111/j.0021-8790.2004.00865.x; Franzen M, 2010, P ROY SOC B-BIOL SCI, V277, P79, DOI 10.1098/rspb.2009.1584; GILBERT FS, 1980, J BIOGEOGR, V7, P209, DOI 10.2307/2844629; HANSKI I, 1993, ECOGRAPHY, V16, P372, DOI 10.1111/j.1600-0587.1993.tb00227.x; HANSKI I, 1988, OIKOS, V51, P105, DOI 10.2307/3565813; Hanski I., 1999, METAPOPULATION ECOLO; HANSSON L, 1977, OIKOS, V29, P539, DOI 10.2307/3543592; HARRISON S, 1991, BIOL J LINN SOC, V42, P73, DOI 10.1111/j.1095-8312.1991.tb00552.x; Henden JA, 2011, POLAR BIOL, V34, P533, DOI 10.1007/s00300-010-0908-7; Hines JE., 2006, PRESENCESOFTWARE EST; IMS RA, 1993, BIOL CONSERV, V63, P261, DOI 10.1016/0006-3207(93)90722-D; IMS RA, 1989, NATURE, V342, P21; Ims RA, 2008, TRENDS ECOL EVOL, V23, P79, DOI 10.1016/j.tree.2007.10.010; Kausrud KL, 2008, NATURE, V456, P93, DOI 10.1038/nature07442; Korslund L, 2006, J ANIM ECOL, V75, P156, DOI 10.1111/j.1365-2656.2005.01031.x; LOFGREN O, 1995, OIKOS, V72, P29, DOI 10.2307/3546034; MAC ARTHUR ROBERT H., 1967; MacKenzie DI, 2003, ECOLOGY, V84, P2200, DOI 10.1890/02-3090; MacKenzie DI, 2002, ECOLOGY, V83, P2248, DOI 10.1890/0012-9658(2002)083[2248:ESORWD]2.0.CO;2; MARGULES C, 1982, BIOL CONSERV, V24, P115, DOI 10.1016/0006-3207(82)90063-5; Mauritzen M, 1999, J APPL ECOL, V36, P409, DOI 10.1046/j.1365-2664.1999.00414.x; Moilanen A, 2002, ECOLOGY, V83, P1131, DOI 10.1890/0012-9658(2002)083[1131:SCMISE]2.0.CO;2; Moilanen A, 2002, OIKOS, V96, P516, DOI 10.1034/j.1600-0706.2002.960313.x; Pellet J, 2007, BIOL CONSERV, V136, P483, DOI 10.1016/j.biocon.2006.12.020; PELTONEN A, 1991, ECOLOGY, V72, P1698, DOI 10.2307/1940969; POKKI J, 1981, ACTA ZOOL FENN, V164, P1, DOI DOI 10.1007/S00248-004-0240-2; POLLOCK KH, 1982, J WILDLIFE MANAGE, V46, P752, DOI 10.2307/3808568; Prugh LR, 2008, P NATL ACAD SCI USA, V105, P20770, DOI 10.1073/pnas.0806080105; Ricketts TH, 2001, AM NAT, V158, P87, DOI 10.1086/320863; Robles H, 2012, CONSERV BIOL, V26, P284, DOI 10.1111/j.1523-1739.2011.01816.x; Snall T, 2005, ECOLOGY, V86, P106, DOI 10.1890/04-0531; STEEN H, 1995, OIKOS, V73, P65, DOI 10.2307/3545726; Stenseth N.C., 1992, ANIMAL DISPERSAL SMA; Sunarto S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030859; Tanadini LG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028244; TAST JOHAN, 1966, ANN ZOOL FENNICI, V3, P127; THOMAS CD, 1994, CONSERV BIOL, V8, P373, DOI 10.1046/j.1523-1739.1994.08020373.x; Thomas L, 2010, USERS GUIDE DISTANCE; WIENS JA, 1993, OIKOS, V66, P369, DOI 10.2307/3544931	47	12	12	1	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e56462	10.1371/journal.pone.0056462	http://dx.doi.org/10.1371/journal.pone.0056462			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437137	Green Published, gold, Green Submitted			2022-12-25	WOS:000315184200078
J	Madsen, JM; Zimmermann, NG; Timmons, J; Tablante, NL				Madsen, Jennifer M.; Zimmermann, Nickolas G.; Timmons, Jennifer; Tablante, Nathaniel L.			Avian Influenza Seroprevalence and Biosecurity Risk Factors in Maryland Backyard Poultry: A Cross-Sectional Study	PLOS ONE			English	Article							MANAGEMENT-PRACTICES; VIRUS	Major implications on a country's economy, food source, and public health. With recent concern over the highly pathogenic avian influenza outbreaks around the world, government agencies are carefully monitoring and inspecting live bird markets, commercial flocks, and migratory bird populations. However, there remains limited surveillance of non-commercial poultry. Therefore, a cross-sectional study was conducted in backyard poultry flocks using a convenience sampling method across three regions of Maryland from July 2011 to August 2011. The objective of this study was to develop a better understanding of the ecology and epidemiology of avian influenza by investigating the prevalence and seroprevalence in this potentially vulnerable population and by evaluating biosecurity risk factors associated with positive findings. Serum, tracheal, and cloacal swabs were randomly collected from 262 birds among 39 registered premises. Analysis indicated bird and flock seroprevalence as 4.2% (11/262) and 23.1% (9/39), respectively. Based on RT-qPCR analysis, none of the samples were found to be positive for AI RNA and evidence of AI hemagglutinin subtypes H5, H7, or H9 were not detected. Although no statistically significant biosecurity associations were identified (p <= 0.05), AI seroprevalence was positively associated with exposure to waterfowl, pest control, and location. AI seropositive flocks exposed to waterfowl were 3.14 times as likely to be AI seropositive than those not exposed (p = 0.15). AI seropositive flocks that did not use pest control were 2.5 times as likely to be AI seropositive compared to those that did and AI seropositive flocks located in the Northern region of Maryland were 2.8 times as likely to be AI seropositive than those that were located elsewhere.	[Madsen, Jennifer M.; Tablante, Nathaniel L.] Univ Maryland, Virginia Maryland Reg Coll Vet Med, College Pk, MD 20742 USA; [Zimmermann, Nickolas G.] Univ Maryland, Dept Anim & Avian Sci, College Pk, MD 20742 USA; [Timmons, Jennifer] Univ Maryland Extens, Lower Eastern Shore Res & Educ Ctr, Salisbury, MD USA	University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park	Tablante, NL (corresponding author), Univ Maryland, Virginia Maryland Reg Coll Vet Med, College Pk, MD 20742 USA.	nlt@umd.edu			Maryland Agricultural Experiment Station Competitive Grants Program	Maryland Agricultural Experiment Station Competitive Grants Program	This project was funded by the Maryland Agricultural Experiment Station Competitive Grants Program (FY 2011-2012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achenbach JE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017643; Alexander DJ, 2007, VACCINE, V25, P5637, DOI 10.1016/j.vaccine.2006.10.051; Beard CW, 2000, IT IS LIKE TICKING B, P4; Boon ACM, 2007, EMERG INFECT DIS, V13, P1720, DOI 10.3201/eid1311.070114; Brooks J, 2005, P 39 NAT M POULTR HL, P17; Brown VL, 2012, BIOL LETTERS, V8, P1036, DOI 10.1098/rsbl.2012.0635; Cardona C, 2009, POULTRY SCI, V88, P856, DOI 10.3382/ps.2008-00338; CDC, 2005, INFL VIR; CDC, 2006, AV INFL OUTBR; FAO, 2011, ANIMAL PRODUCTION HL, P14; FAOSTAT, 2010, FOOD AGR COMM; Friend M., 1999, FIELD MANUAL WILDLIF, P181; Halvorson DA, 2009, REV SCI TECH OIE, V28, P359, DOI 10.20506/rst.28.1.1866; Hanson BA, 2003, THESIS U GEORGIA GEO; Killian Mary Lea, 2008, V436, P7, DOI 10.1007/978-1-59745-279-3_2; Lee JM, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-8; PALMER DF, 1975, IMMUNOLOGY SERIES, V6, P51; Pascua A, 2006, THESIS U MARYLAND CO; Slemons RD, 2003, AVIAN DIS, V47, P1107, DOI 10.1637/0005-2086-47.s3.1107; Sorrell EM, 2009, P NATL ACAD SCI USA, V106, P7565, DOI 10.1073/pnas.0900877106; Spackman Erica, 2008, V436, P13, DOI 10.1007/978-1-59745-279-3_3; STALLKNECHT DE, 1988, VET RES COMMUN, V12, P125, DOI 10.1007/BF00362792; Swayne D.E., 2008, DIS POULTRY, P153; Swayne DE, 2005, WAG UR FRON, V8, P113; USDA, 2012, POULTR PROD VAL 2011; USDA, 2007, NAT AV INFL SURV PLA; WHO, 2012, CUM NUMB CONF HUM CA; Woolcock Peter R., 2008, V436, P35, DOI 10.1007/978-1-59745-279-3_6; Wunderwald C, 2002, AVIAN PATHOL, V31, P157, DOI 10.1080/03079450120118649; Yendell SJ, 2012, ZOONOSES PUBLIC HLTH, V59, P139, DOI 10.1111/j.1863-2378.2011.01427.x; Zheng T, 2010, NEW ZEAL VET J, V58, P74, DOI 10.1080/00480169.2010.65086	31	21	21	16	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e56851	10.1371/journal.pone.0056851	http://dx.doi.org/10.1371/journal.pone.0056851			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437257	Green Published, Green Submitted, gold			2022-12-25	WOS:000315184200173
J	Wang, HX; Zhou, Y; Tang, CX; He, YH; Wu, JG; Chen, Y; Jiang, QW				Wang, Hexing; Zhou, Ying; Tang, Chuanxi; He, Yanhong; Wu, Jingui; Chen, Yue; Jiang, Qingwu			Urinary Phthalate Metabolites Are Associated with Body Mass Index and Waist Circumference in Chinese School Children	PLOS ONE			English	Article							DI(2-ETHYLHEXYL) PHTHALATE; ENDOCRINE DISRUPTORS; TEMPORAL VARIABILITY; US POPULATION; EXPOSURE; OBESITY; HEALTH; TOXICITY; PHENOLS; ESTERS	Background: Lab studies have suggested that ubiquitous phthalate exposures are related to obesity, but relevant epidemiological studies are scarce, especially for children. Objective: To investigate the association of phthalate exposures with body mass index (BMI) and waist circumference (WC) in Chinese school children. Methods: A cross-sectional study was conducted in three primary and three middle schools randomly selected from Changning District of Shanghai City of China in 2011-2012. According to the physical examination data in October, 2011, 124 normal weight, 53 overweight, and 82 obese students 8-15 years of age were randomly chosen from these schools on the basis of BMI-based age- and sex-specific criterion. First morning urine was collected in January, 2012, and fourteen urine phthalate metabolites (free plus conjugated) were determined by ultra-performance liquid chromatography coupled to tandem mass spectrometry. Multiple linear regression was used to explore the associations between naturally log-transformed urine phthalate metabolites and BMI or WC. Results: The urine specific gravity-corrected concentrations of nine urine phthalate metabolites and five molar sums were positively associated with BMI or WC in Chinese school children after adjustment for age and sex. However, when other urine phthalate metabolites were included in the models together with age and sex as covariables, most of these significant associations disappeared except for mono (2-ethylhexyl) phthalate (MEHP) and monoethyl phthalate (MEP). Additionally, some associations showed sex- or age- specific differences. Conclusions: Some phthalate exposures were associated with BMI or WC in Chinese school children. Given the cross-sectional nature of this study and lack of some important obesity-related covariables, further studies are needed to confirm the associations.	[Wang, Hexing; Zhou, Ying; Jiang, Qingwu] Fudan Univ, Sch Publ Hlth, Minist Educ, Key Lab Publ Hlth Safety, Shanghai 200433, Peoples R China; [Tang, Chuanxi; Wu, Jingui] Ctr Dis Control & Prevent Changning Dist, Shanghai, Peoples R China; [He, Yanhong] Anting Hosp, Dept Lab Med, Shanghai, Peoples R China; [Chen, Yue] Univ Ottawa, Fac Med, Dept Epidemiol & Community Med, Ottawa, ON, Canada	Fudan University; Shanghai Center for Disease Control & Prevention; University of Ottawa	Zhou, Y (corresponding author), Fudan Univ, Sch Publ Hlth, Minist Educ, Key Lab Publ Hlth Safety, Shanghai 200433, Peoples R China.	yingchou@fudan.edu.cn		Jiang, Qingwu/0000-0001-8921-3317; Wang, Hexing/0000-0002-8456-8888	Ministry of Education of China [EZF201001]; National Health Research Program from the State Ministry of Health of China [201202012]	Ministry of Education of China(Ministry of Education, China); National Health Research Program from the State Ministry of Health of China	This study was supported by project of 985 innovation platform for superiority subject of Ministry of Education of China (No. EZF201001) and grants of the National Health Research Program from the State Ministry of Health of China (No. 201202012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aylward LL, 2012, J EXPO SCI ENV EPID, V22, P398, DOI 10.1038/jes.2012.35; Barr DB, 2005, ENVIRON HEALTH PERSP, V113, P192, DOI 10.1289/ehp.7337; Becker K, 2009, INT J HYG ENVIR HEAL, V212, P685, DOI 10.1016/j.ijheh.2009.08.002; Bility MT, 2004, TOXICOL SCI, V82, P170, DOI 10.1093/toxsci/kfh253; Boas M, 2010, ENVIRON HEALTH PERSP, V118, P1458, DOI 10.1289/ehp.0901331; BOENIGER MF, 1993, AM IND HYG ASSOC J, V54, P615, DOI 10.1202/0002-8894(1993)054<0615:IOURUT>2.0.CO;2; Braun JM, 2012, ENVIRON HEALTH PERSP, V120, P739, DOI 10.1289/ehp.1104139; CAMERON N, 1978, HUMAN GROWTH, V2, P35, DOI DOI 10.1007/978-1-4684-2622-9_3; Casals-Casas C, 2011, ANNU REV PHYSIOL, V73, P135, DOI 10.1146/annurev-physiol-012110-142200; Casas L, 2011, ENVIRON INT, V37, P858, DOI 10.1016/j.envint.2011.02.012; Centers for Disease Control and Prevention, 2012, 4 CDCP; Clark K, 2003, HANDB ENVIRON CHEM, V3, P227; Desdoits-Lethimonier C, 2012, HUM REPROD, V27, P1451, DOI 10.1093/humrep/des069; Desvergne B, 2009, MOL CELL ENDOCRINOL, V304, P43, DOI 10.1016/j.mce.2009.02.017; Duty SM, 2005, ENVIRON HEALTH PERSP, V113, P1530, DOI 10.1289/ehp.8083; Feige JN, 2007, J BIOL CHEM, V282, P19152, DOI 10.1074/jbc.M702724200; Grun F, 2009, MOL CELL ENDOCRINOL, V304, P19, DOI 10.1016/j.mce.2009.02.018; Guo Y, 2012, J AGR FOOD CHEM; Guo Y, 2011, ENVIRON INT, V37, P893, DOI 10.1016/j.envint.2011.03.005; Guo Y, 2011, ENVIRON SCI TECHNOL, V45, P3138, DOI 10.1021/es103879m; Hatch EE, 2010, INT J ANDROL, V33, P324, DOI 10.1111/j.1365-2605.2009.01035.x; Hatch EE, 2008, ENVIRON HEALTH-GLOB, V7, DOI 10.1186/1476-069X-7-27; Hauser R, 2004, ENVIRON HEALTH PERSP, V112, P1734, DOI 10.1289/ehp.7212; Hines EP, 2009, ENVIRON HEALTH PERSP, V117, P86, DOI 10.1289/ehp.11610; Holtcamp W, 2012, ENVIRON HEALTH PERSP, V120, pA62, DOI 10.1289/ehp.120-a62; Hornung RW, 1990, APPL OCCUP ENVIRON H, V5, P46, DOI [10.1080/1047322X.1990.10389587, DOI 10.1080/1047322X.1990.10389587]; Ji CY, 2010, BIOMED ENVIRON SCI, V23, P12, DOI 10.1016/S0895-3988(10)60026-8; Ji CY, 2005, BIOMED ENVIRON SCI, V18, P390; Kitahara CM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034979; KORN EL, 1991, AM J PUBLIC HEALTH, V81, P1166, DOI 10.2105/AJPH.81.9.1166; Latini G, 2005, CLIN CHIM ACTA, V361, P20, DOI 10.1016/j.cccn.2005.05.003; Lovekamp TN, 2001, TOXICOL APPL PHARM, V172, P217, DOI 10.1006/taap.2001.9156; Meeker JD, 2007, ENVIRON HEALTH PERSP, V115, P1029, DOI 10.1289/ehp.9852; Meeker JD, 2009, PHILOS T R SOC B, V364, P2097, DOI 10.1098/rstb.2008.0268; Pasquali R, 2006, FERTIL STERIL, V85, P1319, DOI 10.1016/j.fertnstert.2005.10.054; Pietrobelli A, 1998, J PEDIATR-US, V132, P204, DOI 10.1016/S0022-3476(98)70433-0; Preau JL, 2010, ENVIRON HEALTH PERSP, V118, P1748, DOI 10.1289/ehp.1002231; Rajapakse N, 2002, ENVIRON HEALTH PERSP, V110, P917, DOI 10.1289/ehp.02110917; Rider CV, 2008, INT J ANDROL, V31, P249, DOI 10.1111/j.1365-2605.2007.00859.x; Sargis RM, 2010, OBESITY, V18, P1283, DOI 10.1038/oby.2009.419; Shen OX, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019159; Silva MJ, 2004, ENVIRON HEALTH PERSP, V112, P331, DOI 10.1289/ehp.6723; Stahlhut RW, 2007, ENVIRON HEALTH PERSP, V115, P876, DOI 10.1289/ehp.9882; Swan SH, 2008, ENVIRON RES, V108, P177, DOI 10.1016/j.envres.2008.08.007; Takeuchi S, 2005, TOXICOLOGY, V210, P223, DOI 10.1016/j.tox.2005.02.002; Tanaka T, 2005, FOOD CHEM TOXICOL, V43, P581, DOI 10.1016/j.fct.2005.01.001; Teitelbaum SL, 2008, ENVIRON RES, V106, P257, DOI 10.1016/j.envres.2007.09.010; Teitelbaum SL, 2012, ENVIRON RES, V112, P186, DOI 10.1016/j.envres.2011.12.006; Thayer KA, 2012, ENVIRON HEALTH PERSP, V120, P779, DOI 10.1289/ehp.1104597; Trasande L, 2012, JAMA-J AM MED ASSOC, V308, P1113, DOI 10.1001/2012.jama.11461; Tyl RW, 2004, REPROD TOXICOL, V18, P241, DOI 10.1016/j.reprotox.2003.10.006; Wang HX, 2012, ENVIRON HEALTH-GLOB, V11, DOI 10.1186/1476-069X-11-79; WINSHIP C, 1994, SOCIOL METHOD RES, V23, P230, DOI 10.1177/0049124194023002004; Wittassek M, 2011, MOL NUTR FOOD RES, V55, P7, DOI 10.1002/mnfr.201000121; Wormuth M, 2006, RISK ANAL, V26, P803, DOI 10.1111/j.1539-6924.2006.00770.x; Yen TH, 2011, J FORMOS MED ASSOC, V110, P671, DOI 10.1016/j.jfma.2011.09.002; Zhou Y, 2011, LANCET, V378, pE4, DOI 10.1016/S0140-6736(11)61700-5	57	91	91	2	74	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e56800	10.1371/journal.pone.0056800	http://dx.doi.org/10.1371/journal.pone.0056800			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437242	Green Published, gold, Green Submitted			2022-12-25	WOS:000315184200166
J	Chang, YY; Huang, HL; Lai, CH; Hsu, JT; Shieh, TM; Wu, AYJ; Chen, CL				Chang, Yin-Yu; Huang, Heng-Li; Lai, Chih-Ho; Hsu, Jui-Ting; Shieh, Tzong-Ming; Wu, Aaron Yu-Jen; Chen, Chao-Ling			Analyses of Antibacterial Activity and Cell Compatibility of Titanium Coated with a Zr-C-N Film	PLOS ONE			English	Article							DENTAL IMPLANTS; STAPHYLOCOCCUS-AUREUS; COATINGS; ADHESION; BIOFILM	Objective: The purpose of this study was to verify the antibacterial performance and cell proliferation activity of zirconium (Zr)-carbon (C)-nitride (N) coatings on commercially pure titanium (Ti) with different C contents. Materials and Methods: Reactive nitrogen gas (N-2) with and without acetylene (C2H2) was activated by Zr plasma in a cathodic-arc evaporation system to deposit either a zirconium nitride (ZrN) or a Zr-C-N coating onto Ti plates. The bacterial activity of the coatings was evaluated against Staphylococcus aureus with the aid of SYTO9 nucleic acid staining and scanning electron microscopy (SEM). Cell compatibility, mRNA expression, and morphology related to human gingival fibroblasts (HGFs) on the coated samples were also determined by using the MTT assay, reverse transcriptase-polymerase chain reaction, and SEM. Results: The Zr-C-N coating with the highest C content (21.7 at%) exhibited the lowest bacterial preservation (P<0.001). Biological responses including proliferation, gene expression, and attachment of HGF cells to ZrN and Zr-C-N coatings were comparable to those of the uncoated Ti plate. Conclusions: High-C-content Zr-C-N coatings not only provide short-term antibacterial activity against S. aureus but are also biocompatible with HGF cells.	[Chang, Yin-Yu] Natl Formosa Univ, Dept Mech & Comp Aided Engn, Yunlin, Taiwan; [Huang, Heng-Li; Hsu, Jui-Ting] China Med Univ, Sch Dent, Taichung, Taiwan; [Lai, Chih-Ho] China Med Univ, Sch Med, Taichung, Taiwan; [Shieh, Tzong-Ming] China Med Univ, Dept Dent Hyg, Taichung, Taiwan; [Wu, Aaron Yu-Jen] Chang Gung Univ, Chang Gung Mem Hosp, Coll Med, Kaohsiung, Taiwan; [Chen, Chao-Ling] China Med Univ, Sch Pharm, Taichung, Taiwan	National Formosa University; China Medical University Taiwan; China Medical University Taiwan; China Medical University Taiwan; Chang Gung Memorial Hospital; Chang Gung University; China Medical University Taiwan	Huang, HL (corresponding author), China Med Univ, Sch Dent, Taichung, Taiwan.	henleyh@gmail.com	Hsu, Jui-Ting/I-8224-2012; Lai, Chih-Ho/M-2433-2013	Lai, Chih-Ho/0000-0001-9229-818X	Government Organization-National Science Council in Taiwan [NSC 101-2314-B-039-022-MY3]	Government Organization-National Science Council in Taiwan	This research was supported by the Government Organization-National Science Council (NSC 101-2314-B-039-022-MY3) in Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almaguer-Flores A, 2009, DIAM RELAT MATER, V18, P1179, DOI 10.1016/j.diamond.2009.03.003; BARTH E, 1989, BIOMATERIALS, V10, P325, DOI 10.1016/0142-9612(89)90073-2; BECKER W, 1990, International Journal of Oral and Maxillofacial Implants, V5, P31; Chang YY, 2012, CLIN ORAL INVEST, V16, P95, DOI 10.1007/s00784-010-0504-9; Chaudhari A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024186; Costerton JW, 2005, INT J ARTIF ORGANS, V28, P1062, DOI 10.1177/039139880502801103; Esteban-Tejeda L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033135; Grainger DW, 2004, EXPERT OPIN BIOL TH, V4, P1029, DOI 10.1517/14712598.4.7.1029; Groessner-Schreiber B, 2004, EUR J ORAL SCI, V112, P516, DOI 10.1111/j.1600-0722.2004.00171.x; Grossner-Schreiber B, 2006, CLIN ORAL IMPLAN RES, V17, P736, DOI 10.1111/j.1600-0501.2006.01277.x; Grossner-Schreiber B, 2009, CLIN ORAL IMPLAN RES, V20, P817, DOI 10.1111/j.1600-0501.2009.01729.x; Harris LG, 2004, J MATER SCI-MATER M, V15, P311, DOI 10.1023/B:JMSM.0000021093.84680.bb; Harris LG, 2006, INJURY, V37, P3, DOI 10.1016/j.injury.2006.04.003; Hetrick EM, 2007, BIOMATERIALS, V28, P4571, DOI 10.1016/j.biomaterials.2007.06.036; Heydenrijk K, 2002, INT J ORAL MAX IMPL, V17, P829; Hoyle B D, 1991, Prog Drug Res, V37, P91; Huang HL, 2010, SURF COAT TECH, V205, P1636, DOI 10.1016/j.surfcoat.2010.07.096; Isidor F, 2006, CLIN ORAL IMPLAN RES, V17, P8, DOI 10.1111/j.1600-0501.2006.01360.x; Kang S, 2007, LANGMUIR, V23, P8670, DOI 10.1021/la701067r; Kelly PJ, 2010, SURF COAT TECH, V205, P1606, DOI 10.1016/j.surfcoat.2010.07.029; Kertzman Z, 2008, J BIOMED MATER RES A, V84A, P1061, DOI 10.1002/jbm.a.31533; Koerner RJ, 2002, BIOMATERIALS, V23, P2835, DOI 10.1016/S0142-9612(01)00404-5; Kronstrom M, 2001, INT J ORAL MAX IMPL, V16, P201; Leonhardt A, 1999, CLIN ORAL IMPLAN RES, V10, P339, DOI 10.1034/j.1600-0501.1999.100501.x; MEYERSIEGLER K, 1992, CARCINOGENESIS, V13, P2127, DOI 10.1093/carcin/13.11.2127; Narayan RJ, 2005, MAT SCI ENG C-BIO S, V25, P405, DOI 10.1016/j.msec.2005.01.026; Niinomi M, 2008, J ARTIF ORGANS, V11, P105, DOI 10.1007/s10047-008-0422-7; Norowski PA, 2009, J BIOMED MATER RES B, V88B, P530, DOI 10.1002/jbm.b.31152; Pae A, 2009, BIOMED MATER, V4, DOI 10.1088/1748-6041/4/2/025005; Roy RK, 2007, J BIOMED MATER RES B, V83B, P72, DOI 10.1002/jbm.b.30768; Socransky SS, 2002, PERIODONTOL 2000, V28, P12, DOI 10.1034/j.1600-0757.2002.280102.x; Tian XB, 2007, SURF COAT TECH, V201, P8606, DOI 10.1016/j.surfcoat.2006.09.322; Wang GC, 2010, MATERIALS, V3, P3994, DOI 10.3390/ma3073994; Wang J, 2004, SURF COAT TECH, V186, P299, DOI 10.1016/j.surfcoat.2004.02.046; Watzak G, 2005, CLIN ORAL IMPLAN RES, V16, P408, DOI 10.1111/j.1600-0501.2005.01155.x; Zhao LZ, 2009, J BIOMED MATER RES B, V91B, P470, DOI 10.1002/jbm.b.31463; Zhou H, 2008, DIAM RELAT MATER, V17, P1416, DOI 10.1016/j.diamond.2008.01.047	37	9	9	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2013	8	2							e56771	10.1371/journal.pone.0056771	http://dx.doi.org/10.1371/journal.pone.0056771			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093HR	23431391	Green Published, Green Submitted, gold			2022-12-25	WOS:000315182800034
J	Han, XY; Luo, YY; Zhang, XY; Lv, C; Sun, XQ; Zhang, XM; Zhou, XH; Cai, XL; Ren, Q; Ji, LN				Han, Xueyao; Luo, Yingying; Zhang, Xiuying; Lv, Chao; Sun, Xiuqin; Zhang, Xiaomei; Zhou, Xianghai; Cai, Xiaoling; Ren, Qian; Ji, Linong			Rs4074134 Near BDNF Gene Is Associated with Type 2 Diabetes Mellitus in Chinese Han Population Independently of Body Mass Index	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; NEUROTROPHIC FACTOR BDNF; BETA-CELL FUNCTION; COMMON VARIANTS; FTO GENE; FAT MASS; OBESITY; SUSCEPTIBILITY; EXPRESSION; CHILDHOOD	Obesity and family history are the most important predictors for type 2 diabetes mellitus(T2DM) in the Chinese Han population. However, it is not known whether the genetic loci related to obesity are associated with the risk of developing T2DM in this population. The present case-control study evaluated the associations between five genetic loci for obesity and the pathogenesis of T2DM. The study included 1117 Chinese Han patients with T2DM, 1629 patients with pre-diabetes (impaired fasting glucose and impaired glucose tolerance, IFG/IGT) and 1113 control subjects residing in Beijing. Five genetic loci including rs2815752 near NEGR1, rs10938397 near GNPDA2, rs4074134 near BDNF, rs17782313 near MC4R and rs1084753 near KCTD15 were genotyped. The results showed an association between rs4074134-BDNF minor allele and T2DM irrespective of age, gender and body mass index (BMI) (OR = 0.87; 95% CI: 0.77-0.99, P = 0.04). This SNP was also associated with pre-diabetes (OR = 0.87; 95% CI: 0.77-0.97, P = 0.01) independently of age, gender and BMI. No associations were found between diabetes or pre-diabetes and any of the other SNP loci studied. Genotype-phenotype association analysis (adjusting for age and gender) showed rs4074134-BDNF to be associated with BMI, waist circumference, fasting and postprandial plasma glucose, fasting serum insulin, and HOMA-IR in subjects without T2DM. However, fasting and postprandial plasma glucose were the only significant factors after adjusting for BMI. These results suggest that the common variation of BDNF (rs4074134) is associated with T2DM independently of obesity in Chinese Han population. This variant also has an effect on plasma glucose concentration, BMI and insulin sensitivity.	[Han, Xueyao; Luo, Yingying; Zhang, Xiuying; Lv, Chao; Sun, Xiuqin; Zhang, Xiaomei; Zhou, Xianghai; Cai, Xiaoling; Ren, Qian; Ji, Linong] Peking Univ, Dept Endocrinol & Metab, Peoples Hosp, Ctr Diabet, Beijing 100871, Peoples R China	Peking University	Ji, LN (corresponding author), Peking Univ, Dept Endocrinol & Metab, Peoples Hosp, Ctr Diabet, Beijing 100871, Peoples R China.	jiln@bjmu.edu.cn	Linong, Ji/AAB-6543-2020	Cai, Xiaoling/0000-0002-7881-0543	National High Technology Research and Development Program (863 program) [2006AA02A409, 2012AA02A509]; Beijing Science&Technology Committee [D0905003040131, D090507046410012]; National Basic Research Program of China [2011CB504001]; National Natural Science Foundation of China [30771031]	National High Technology Research and Development Program (863 program)(National High Technology Research and Development Program of China); Beijing Science&Technology Committee; National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by funds from the National High Technology Research and Development Program (863 program, 2006AA02A409,2012AA02A509), Beijing Science&Technology Committee(D0905003040131 and D090507046410012), the National Basic Research Program of China (2011CB504001) and the National Natural Science Foundation of China (30771031). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cassiman D, 2001, HEPATOLOGY, V33, P148, DOI 10.1053/jhep.2001.20793; Dina C, 2007, NAT GENET, V39, P724, DOI 10.1038/ng2048; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Gray J, 2006, DANCING TIMES, V96, P55; Han JC, 2008, NEW ENGL J MED, V359, P918, DOI 10.1056/NEJMoa0801119; Han XY, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-81; Hinney A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001361; Horikawa Y, 2008, J CLIN ENDOCR METAB, V93, P3136, DOI 10.1210/jc.2008-0452; Kernie SG, 2000, EMBO J, V19, P1290, DOI 10.1093/emboj/19.6.1290; KLEIN R, 1991, CELL, V66, P395, DOI 10.1016/0092-8674(91)90628-C; Krabbe KS, 2007, DIABETOLOGIA, V50, P431, DOI 10.1007/s00125-006-0537-4; LEIBROCK J, 1989, NATURE, V341, P149, DOI 10.1038/341149a0; Li H, 2012, DIABETOLOGIA, V55, P981, DOI 10.1007/s00125-011-2370-7; Li JKY, 2006, DIABETES-METAB RES, V22, P46, DOI 10.1002/dmrr.577; Liao GY, 2012, NAT MED, V18, P564, DOI 10.1038/nm.2687; Lommatzsch M, 1999, AM J PATHOL, V155, P1183, DOI 10.1016/S0002-9440(10)65221-2; Loos RJF, 2003, J INTERN MED, V254, P401, DOI 10.1046/j.1365-2796.2003.01242.x; Loos RJF, 2008, NAT GENET, V40, P768, DOI 10.1038/ng.140; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Morris AP, 2012, NAT GENET, V44, P981, DOI 10.1038/ng.2383; Mousavi K, 2006, J NEUROSCI, V26, P5739, DOI 10.1523/JNEUROSCI.5398-05.2006; Ng MCY, 2008, DIABETES, V57, P2226, DOI 10.2337/db07-1583; Ng MCY, 2010, J CLIN ENDOCR METAB, V95, P2418, DOI 10.1210/jc.2009-2077; Nonomura T, 2001, Int J Exp Diabetes Res, V2, P201, DOI 10.1155/EDR.2001.201; Ong CJ, 2010, OBESITY, V18, pS61; Perry JRB, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002741; Rios M, 2001, MOL ENDOCRINOL, V15, P1748, DOI 10.1210/me.15.10.1748; Robiou-du-Pont S, 2013, INT J OBESITY, V37, P980, DOI 10.1038/ijo.2012.175; Sandholt CH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023531; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; Scuteri A, 2007, PLOS GENET, V3, P1200, DOI 10.1371/journal.pgen.0030115; Speliotes EK, 2010, NAT GENET, V42, P937, DOI 10.1038/ng.686; Takeuchi F, 2011, DIABETOLOGIA, V54, P1350, DOI 10.1007/s00125-011-2086-8; Thorleifsson G, 2009, NAT GENET, V41, P18, DOI 10.1038/ng.274; Torrens JI, 2004, DIABETES CARE, V27, P354, DOI 10.2337/diacare.27.2.354; Ukropec Jozef, 2008, Archives of Physiology and Biochemistry, V114, P357, DOI 10.1080/13813450802535812 ; Wen WQ, 2012, NAT GENET, V44, P307, DOI 10.1038/ng.1087; Willer CJ, 2009, NAT GENET, V41, P25, DOI 10.1038/ng.287; Yang WY, 2010, NEW ENGL J MED, V362, P1090, DOI 10.1056/NEJMoa0908292; Yoon KH, 2006, LANCET, V368, P1681, DOI 10.1016/S0140-6736(06)69703-1; Zhou BF, 2002, BIOMED ENVIRON SCI, V15, P83	41	15	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2013	8	2							e56898	10.1371/journal.pone.0056898	http://dx.doi.org/10.1371/journal.pone.0056898			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093HR	23431394	Green Published, Green Submitted, gold			2022-12-25	WOS:000315182800037
J	Lodi, A; Tiziani, S; Khanim, FL; Gunther, UL; Viant, MR; Morgan, GJ; Bunce, CM; Drayson, MT				Lodi, Alessia; Tiziani, Stefano; Khanim, Farhat L.; Guenther, Ulrich L.; Viant, Mark R.; Morgan, Gareth J.; Bunce, Christopher M.; Drayson, Mark T.			Proton NMR-Based Metabolite Analyses of Archived Serial Paired Serum and Urine Samples from Myeloma Patients at Different Stages of Disease Activity Identifies Acetylcarnitine as a Novel Marker of Active Disease	PLOS ONE			English	Article							FATTY-ACID SYNTHASE; UNDETERMINED SIGNIFICANCE; MONOCLONAL GAMMOPATHY; L-CARNITINE; IN-VITRO; APOPTOSIS; SPECTROSCOPY; METABOLOMICS; CHEMOTHERAPY; PATHOGENESIS	Background: Biomarker identification is becoming increasingly important for the development of personalized or stratified therapies. Metabolomics yields biomarkers indicative of phenotype that can be used to characterize transitions between health and disease, disease progression and therapeutic responses. The desire to reproducibly detect ever greater numbers of metabolites at ever diminishing levels has naturally nurtured advances in best practice for sample procurement, storage and analysis. Reciprocally, since many of the available extensive clinical archives were established prior to the metabolomics era and were not processed in such an 'ideal' fashion, considerable scepticism has arisen as to their value for metabolomic analysis. Here we have challenged that paradigm. Methods: We performed proton nuclear magnetic resonance spectroscopy-based metabolomics on blood serum and urine samples from 32 patients representative of a total cohort of 1970 multiple myeloma patients entered into the United Kingdom Medical Research Council Myeloma IX trial. Findings: Using serial paired blood and urine samples we detected metabolite profiles that associated with diagnosis, post-treatment remission and disease progression. These studies identified carnitine and acetylcarnitine as novel potential biomarkers of active disease both at diagnosis and relapse and as a mediator of disease associated pathologies. Conclusions: These findings show that samples conventionally processed and archived can provide useful metabolomic information that has important implications for understanding the biology of myeloma, discovering new therapies and identifying biomarkers potentially useful in deciding the choice and application of therapy.	[Lodi, Alessia; Tiziani, Stefano; Guenther, Ulrich L.] Univ Birmingham, Sch Canc Sci, Birmingham, W Midlands, England; [Lodi, Alessia; Tiziani, Stefano] Univ Texas Austin, Dept Nutr Sci, Austin, TX 78712 USA; [Tiziani, Stefano] Univ Texas Austin, Dell Pediat Res Inst, Austin, TX 78712 USA; [Khanim, Farhat L.; Viant, Mark R.; Bunce, Christopher M.] Univ Birmingham, Sch Biosci, Birmingham, W Midlands, England; [Morgan, Gareth J.] Royal Marsden NHS Fdn Trust, Inst Canc Res, London, England; [Drayson, Mark T.] Univ Birmingham, Sch Immun & Infect, Birmingham, W Midlands, England	University of Birmingham; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; University of Birmingham; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; University of Birmingham	Lodi, A (corresponding author), Univ Birmingham, Sch Canc Sci, Birmingham, W Midlands, England.	alessia@austin.utexas.edu; m.t.drayson@bham.ac.uk	Viant, Mark R/B-6339-2009; Bunce, Chris/D-4579-2015	Viant, Mark R/0000-0001-5898-4119; morgan, gareth/0000-0002-4271-6360; Bunce, Chris/0000-0003-4084-8973; Drayson, Mark/0000-0002-1528-7564	EU Marie Currie grants MOTET; EU-NMR EU; Leukaemia & Lymphoma Research Specialist Programme; University of Birmingham's System Science for Health initiative	EU Marie Currie grants MOTET; EU-NMR EU; Leukaemia & Lymphoma Research Specialist Programme; University of Birmingham's System Science for Health initiative	A.L. and S.T. were supported by EU Marie Currie grants MOTET & EU-NMR EU. F. L. K. is supported by a Leukaemia & Lymphoma Research Specialist Programme awarded to CMB and MTD. The Myeloma IX trial was supported by the Medical Research Council UK. This study was in part supported by the University of Birmingham's System Science for Health initiative. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Athanassakis I, 2001, INT IMMUNOPHARMACOL, V1, P1813, DOI 10.1016/S1567-5769(01)00105-9; Bandyopadhyay S, 2006, CANCER RES, V66, P5934, DOI 10.1158/0008-5472.CAN-05-3197; Barton RH, 2008, INT J EPIDEMIOL, V37, P31, DOI 10.1093/ije/dym284; Beckonert O, 2007, NAT PROTOC, V2, P2692, DOI 10.1038/nprot.2007.376; Brindle JT, 2003, ANALYST, V128, P32, DOI 10.1039/b209155k; Bryce AH, 2009, HAEMATOL-HEMATOL J, V94, P380, DOI 10.3324/haematol.13369; Bylesjo M, 2006, J CHEMOMETR, V20, P341, DOI 10.1002/cem.1006; Chapman MA, 2011, NATURE, V471, P467, DOI 10.1038/nature09837; Colucci S, 2005, CALCIFIED TISSUE INT, V76, P458, DOI 10.1007/s00223-004-0147-4; Dieterle F, 2006, ANAL CHEM, V78, P4281, DOI 10.1021/ac051632c; Dimopoulos MA, 2010, J CLIN ONCOL, V28, P4976, DOI 10.1200/JCO.2010.30.8791; Drayson M, 2006, BLOOD, V108, P2013, DOI 10.1182/blood-2006-03-008953; Gall WE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010883; Gao HC, 2008, ANAL CHIM ACTA, V624, P269, DOI 10.1016/j.aca.2008.06.051; Gunther UL, 2000, J MAGN RESON, V145, P201, DOI 10.1006/jmre.2000.2071; Hamed EA, 2010, J PEDIAT HEMATOL ONC, V32, P267, DOI 10.1097/MPH.0b013e3181d419d6; Hersey P, 2009, CLIN CANCER RES, V15, P6490, DOI 10.1158/1078-0432.CCR-09-0251; Holmes E, 2008, CELL, V134, P714, DOI 10.1016/j.cell.2008.08.026; Holmes E, 2007, ANAL CHEM, V79, P2629, DOI 10.1021/ac062305n; HOLUB BJ, 1986, ANNU REV NUTR, V6, P563, DOI 10.1146/annurev.nu.06.070186.003023; Hoppel C, 2003, AM J KIDNEY DIS, V41, pS4, DOI 10.1016/S0272-6386(03)00112-4; HWANG TL, 1995, J MAGN RESON SER A, V112, P275, DOI 10.1006/jmra.1995.1047; Khoo SHG, 2009, METAB ENG, V11, P199, DOI 10.1016/j.ymben.2009.02.001; KULISZKIEWICZJANUS M, 1995, NMR BIOMED, V8, P127, DOI 10.1002/nbm.1940080308; Kyle RA, 2010, LEUKEMIA, V24, P1121, DOI 10.1038/leu.2010.60; Kyle RA, 2010, CURR HEMATOL MALIG R, V5, P62, DOI 10.1007/s11899-010-0047-9; Lazarus HM, 2008, J CLIN ONCOL, V26, P2240, DOI 10.1200/JCO.2007.14.7827; Lemaire M, 2011, ADV CANCER RES, V110, P19, DOI 10.1016/B978-0-12-386469-7.00002-5; Li X, 2009, ANAL CHIM ACTA, V633, P257, DOI 10.1016/j.aca.2008.11.058; Ludwig C, 2009, MAGN RESON CHEM, V47, pS68, DOI 10.1002/mrc.2519; MacIntyre DA, 2010, LEUKEMIA, V24, P788, DOI 10.1038/leu.2009.295; Menendez JA, 2007, NAT REV CANCER, V7, P763, DOI 10.1038/nrc2222; Minter AR, 2011, SEMIN HEMATOL, V48, P55, DOI 10.1053/j.seminhematol.2010.11.001; Mitsiades CS, 2011, J CLIN ONCOL, V29, P1916, DOI 10.1200/JCO.2010.34.0760; Morgan GJ, 2012, BLOOD, V119, P7, DOI 10.1182/blood-2011-06-357038; Morgan GJ, 2011, BLOOD, V118, P1231, DOI 10.1182/blood-2011-02-338665; Odunsi K, 2005, INT J CANCER, V113, P782, DOI 10.1002/ijc.20651; Palumbo A, 2011, NEW ENGL J MED, V364, P1046, DOI 10.1056/NEJMra1011442; Parsons HM, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-234; Portilla D, 2000, AM J PHYSIOL-RENAL, V278, pF667, DOI 10.1152/ajprenal.2000.278.4.F667; Radin NS, 2003, BIOCHEM J, V371, P243, DOI 10.1042/BJ20021878; Rajkumar SV, 2011, NAT REV CLIN ONCOL, V8, P479, DOI 10.1038/nrclinonc.2011.63; Ramsay RR, 2001, BBA-PROTEIN STRUCT M, V1546, P21, DOI 10.1016/S0167-4838(01)00147-9; Roodman GD, 2009, LEUKEMIA, V23, P435, DOI 10.1038/leu.2008.336; SILIPRANDI N, 1989, CLIN CHIM ACTA, V183, P3, DOI 10.1016/0009-8981(89)90267-2; Tiziani S, 2008, ANAL BIOCHEM, V377, P16, DOI 10.1016/j.ab.2008.01.037; Tiziani S, 2009, NEOPLASIA, V11, P269, DOI 10.1593/neo.81396; van de Donk NWCJ, 2011, CANCER TREAT REV, V37, P266, DOI 10.1016/j.ctrv.2010.08.008; Wang J, 2006, APOPTOSIS, V11, P2043, DOI 10.1007/s10495-006-0191-9; Westerhuis JA, 2008, METABOLOMICS, V4, P81, DOI 10.1007/s11306-007-0099-6; Whitehead TL, 2005, PROG NUCL MAG RES SP, V47, P165, DOI 10.1016/j.pnmrs.2005.09.001; Xie H, 2008, AMINO ACIDS, V35, P419, DOI 10.1007/s00726-007-0598-9	52	35	36	0	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2013	8	2							e56422	10.1371/journal.pone.0056422	http://dx.doi.org/10.1371/journal.pone.0056422			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093HR	23431376	Green Published, Green Submitted, gold			2022-12-25	WOS:000315182800018
J	Oishi, M; Iizumi, Y; Taniguchi, T; Goi, W; Miki, T; Sakai, T				Oishi, Masakatsu; Iizumi, Yosuke; Taniguchi, Tomoyuki; Goi, Wakana; Miki, Tsuneharu; Sakai, Toshiyuki			Apigenin Sensitizes Prostate Cancer Cells to Apo2L/TRAIL by Targeting Adenine Nucleotide Translocase-2	PLOS ONE			English	Article							TRAIL-INDUCED APOPTOSIS; UP-REGULATION; DOWN-REGULATION; C-FLIP; TUMOR; RESISTANCE; RECEPTOR; PROTEIN; SUSCEPTIBILITY; MITOXANTRONE	Apo2 ligand (Apo2L)/tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) is a promising cancer therapeutic agent. Recombinant human Apo2L/TRAIL has been under clinical trials, whereas various kinds of malignant tumors have resistance to Apo2L/TRAIL. We and others have shown that several anticancer agents and flavonoids overcome resistance to Apo2L/TRAIL by upregulating death receptor 5 (DR5) in malignant tumor cells. However, the mechanisms by which these compounds induce DR5 expression remain unknown. Here we show that the dietary flavonoid apigenin binds and inhibits adenine nucleotide translocase-2 (ANT2), resulting in enhancement of Apo2L/TRAIL-induced apoptosis by upregulation of DR5. Apigenin and genistein, which are major flavonoids, enhanced Apo2L/TRAIL-induced apoptosis in cancer cells. Apigenin induced DR5 expression, but genistein did not. Using our method identifying the direct targets of flavonoids, we compared the binding proteins of apigenin with those of genistein. We discovered that ANT2 was a target of apigenin, but not genistein. Similarly to apigenin, knockdown of ANT2 enhanced Apo2L/TRAIL-induced apoptosis by upregulating DR5 expression at the post-transcriptional level. Moreover, silencing of ANT2 attenuated the enhancement of Apo2L/TRAIL-induced apoptosis by apigenin. These results suggest that apigenin upregulates DR5 and enhances Apo2L/TRAIL-induced apoptosis by binding and inhibiting ANT2. We propose that ANT2 inhibitors may contribute to Apo2L/TRAIL therapy.	[Oishi, Masakatsu; Iizumi, Yosuke; Taniguchi, Tomoyuki; Goi, Wakana; Sakai, Toshiyuki] Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Mol Targeting Canc Prevent, Kamigyo Ku, Kyoto, Japan; [Oishi, Masakatsu; Miki, Tsuneharu] Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Urol, Kamigyo Ku, Kyoto, Japan	Kyoto Prefectural University of Medicine; Kyoto Prefectural University of Medicine	Sakai, T (corresponding author), Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Mol Targeting Canc Prevent, Kamigyo Ku, Kyoto, Japan.	tsakai@koto.kpu-m.ac.jp			Japan Society for the Promotion of Science (JSPS) [21890223, 20533178]; Grants-in-Aid for Scientific Research [23659335] Funding Source: KAKEN	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a Grant-in-Aid for Young Scientists (Start-up,21890223) and (A,20533178) from Japan Society for the Promotion of Science (JSPS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belzacq AS, 2002, BIOCHIMIE, V84, P167, DOI 10.1016/S0300-9084(02)01366-4; Bracarda S, 2011, BJU INT, V107, P13, DOI 10.1111/j.1464-410X.2010.10036.x; Budhraja A, 2012, MOL CANCER THER, V11, P132, DOI 10.1158/1535-7163.MCT-11-0343; Chan LP, 2012, BBA-GEN SUBJECTS, V1820, P1081, DOI 10.1016/j.bbagen.2012.04.013; Chevrollier A, 2011, BBA-BIOENERGETICS, V1807, P562, DOI 10.1016/j.bbabio.2010.10.008; Ding J, 2012, J BIOL CHEM, V287, P641, DOI 10.1074/jbc.M111.286526; el Dein OS, 2011, CURR DRUG TARGETS, V12, P894, DOI 10.2174/138945011795529047; Hellebrand EE, 2010, DRUG DISCOV THER, V4, P54; Horinaka M, 2006, MOL CANCER THER, V5, P945, DOI 10.1158/1535-7163.MCT-05-0431; Horinaka M, 2005, ONCOGENE, V24, P7180, DOI 10.1038/sj.onc.1208874; Ito T, 2010, SCIENCE, V327, P1345, DOI 10.1126/science.1177319; Jang JY, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1857; Jang JY, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-262; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Jin CY, 2007, CANCER LETT, V257, P56, DOI 10.1016/j.canlet.2007.06.019; Johnstone RW, 2008, NAT REV CANCER, V8, P782, DOI 10.1038/nrc2465; Kantoff PW, 1999, J CLIN ONCOL, V17, P2506, DOI 10.1200/JCO.1999.17.8.2506; Le Bras M, 2006, CANCER RES, V66, P9143, DOI 10.1158/0008-5472.CAN-05-4407; Sakamoto S, 2009, CHEM REC, V9, P66, DOI 10.1002/tcr.20170; Son YG, 2007, CANCER RES, V67, P8274, DOI 10.1158/0008-5472.CAN-07-0407; Srivastava RK, 2001, NEOPLASIA, V3, P535, DOI 10.1038/sj.neo.7900203; Szliszka E, 2008, INT J MOL SCI, V9, P56, DOI 10.3390/ijms9010056; Szliszka E, 2011, EUR J CANCER PREV, V20, P63, DOI 10.1097/CEJ.0b013e32833ecc48; Taniguchi H, 2008, CANCER RES, V68, P8918, DOI 10.1158/0008-5472.CAN-08-1120; Tannock IF, 2004, NEW ENGL J MED, V351, P1502, DOI 10.1056/NEJMoa040720; Torkin R, 2005, MOL CANCER THER, V4, P1; Tsaytler P, 2011, SCIENCE, V332, P91, DOI 10.1126/science.1201396; Urusova DV, 2011, CANCER PREV RES, V4, P1366, DOI 10.1158/1940-6207.CAPR-11-0301; Walczak H, 1999, NAT MED, V5, P157, DOI 10.1038/5517; Xu YM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029169; Yagoda N, 2007, NATURE, V447, P864, DOI 10.1038/nature05859; Zhang LD, 2005, CANCER GENE THER, V12, P228, DOI 10.1038/sj.cgt.7700792	32	47	48	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2013	8	2							e55922	10.1371/journal.pone.0055922	http://dx.doi.org/10.1371/journal.pone.0055922			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093HR	23431365	Green Submitted, Green Published, gold			2022-12-25	WOS:000315182800007
J	Lai, J; Kong, CM; Mahalingam, D; Xie, XJ; Wang, XY				Lai, Jason; Kong, Chiou Mee; Mahalingam, Dashayini; Xie, Xiaojin; Wang, Xueying			Elite Model for the Generation of Induced Pluripotent Cancer Cells (iPCs)	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; LUNG-CANCER; DEFINED FACTORS; TUMOR; HETEROGENEITY; NETWORK; GENE	The inefficiency of generating induced pluripotent somatic cells (iPS) engendered two contending models, namely the Stochastic model and Elite model. Although the former is more favorable to explain the inherent inefficiencies, it may be fallible to extrapolate the same working model to reprogramming of cancer cells. Indeed, tumor cells are known to be inherently heterogeneous with respect to distinctive characteristics thus providing a suitable platform to test whether the reprogramming process of cancer cells is biased. Here, we report our observations that all randomly picked induced pluripotent cancer cells (iPCs) established previously do not possess mutations known in the parental population. This unanticipated observation is most parsimoniously explained by the Elite model, whereby putative early tumor progenies were selected during induction to pluripotency.	[Lai, Jason; Kong, Chiou Mee; Mahalingam, Dashayini; Xie, Xiaojin; Wang, Xueying] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Biochem, Singapore 117595, Singapore	National University of Singapore	Wang, XY (corresponding author), Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Biochem, Singapore 117595, Singapore.	bchwxy@nus.edu.sg		Lai, Jason Kuan Han/0000-0002-3476-4733	Ministry of Education Academic Research Fund Tier 1 [R-183-000-259-112, R-183-000-295-112]; Yong Loo Lin School of Medicine, NUHS, NUS, Singapore	Ministry of Education Academic Research Fund Tier 1; Yong Loo Lin School of Medicine, NUHS, NUS, Singapore	Ministry of Education Academic Research Fund Tier 1 grants, R-183-000-259-112 and R-183-000-295-112. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Chiou Mee Kong is a recipient of research scholarships from Yong Loo Lin School of Medicine, NUHS, NUS, Singapore. We thank Dr. Patrick Tan for insightful comments as well as Dr. Phillip Koeffler for his kind gift of H460 cells.	Banito A, 2010, EMBO REP, V11, P353, DOI 10.1038/embor.2010.47; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Carette JE, 2010, BLOOD, V115, P4039, DOI 10.1182/blood-2009-07-231845; Chang S, 2003, GENE DEV, V17, P88, DOI 10.1101/gad.1029903; Chin MH, 2009, CELL STEM CELL, V5, P111, DOI 10.1016/j.stem.2009.06.008; Du P, 2008, BIOINFORMATICS, V24, P1547, DOI 10.1093/bioinformatics/btn224; Duesberg P, 2011, CELL CYCLE, V10, P2100, DOI 10.4161/cc.10.13.16352; FIDLER IJ, 1977, SCIENCE, V197, P893, DOI 10.1126/science.887927; FITZGERALD PJ, 1986, INT J PANCREATOL, V1, P91; HIRSCH FR, 1983, VIRCHOWS ARCH A, V402, P147, DOI 10.1007/BF00695056; Hochedlinger K, 2004, GENE DEV, V18, P1875, DOI 10.1101/gad.1213504; Ikediobi ON, 2006, MOL CANCER THER, V5, P2606, DOI 10.1158/1535-7163.MCT-06-0433; Jeppesen P, 2000, IMMUNOFLUORESCENCE C; Kim JW, 2008, CELL, V132, P1049, DOI 10.1016/j.cell.2008.02.039; Kruger S, 2003, Int Urol Nephrol, V35, P169, DOI 10.1023/B:UROL.0000020305.70637.c6; Li H, 2009, NATURE, V460, P1136, DOI 10.1038/nature08290; Lin SL, 2008, RNA, V14, P2115, DOI 10.1261/rna.1162708; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; Mahalingam D, 2012, SCI REP-UK, V2, DOI 10.1038/srep00592; Marion RM, 2009, NATURE, V460, P1149, DOI 10.1038/nature08287; Miyoshi N, 2010, P NATL ACAD SCI USA, V107, P40, DOI 10.1073/pnas.0912407107; MULLER HJ, 1964, MUTAT RES, V1, P2, DOI 10.1016/0027-5107(64)90047-8; Navin N, 2011, NATURE, V472, P90, DOI 10.1038/nature09807; Russnes HG, 2011, J CLIN INVEST, V121, P3810, DOI 10.1172/JCI57088; Shan ZH, 2004, ONCOGENE, V23, P6612, DOI 10.1038/sj.onc.1207857; Sheltzer JM, 2011, SCIENCE, V333, P1026, DOI 10.1126/science.1206412; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; TAKAHASHI T, 1989, SCIENCE, V246, P491, DOI 10.1126/science.2554494; Utikal J, 2009, J CELL SCI, V122, P3502, DOI 10.1242/jcs.054783; vanderPoel HG, 1997, UROLOGY, V49, P652, DOI 10.1016/S0090-4295(96)00557-2; Yamanaka S, 2009, NATURE, V460, P49, DOI 10.1038/nature08180; ZHANG X, 2012, ONCOGENE	32	7	7	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e56702	10.1371/journal.pone.0056702	http://dx.doi.org/10.1371/journal.pone.0056702			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418593	gold, Green Published, Green Submitted			2022-12-25	WOS:000315970300186
J	Espina, L; Gelaw, TK; de Lamo-Castellvi, S; Pagan, R; Garcia-Gonzalo, D				Espina, Laura; Gelaw, Tilahun K.; de Lamo-Castellvi, Silvia; Pagan, Rafael; Garcia-Gonzalo, Diego			Mechanism of Bacterial Inactivation by (+)-Limonene and Its Potential Use in Food Preservation Combined Processes	PLOS ONE			English	Article							ALTERNATIVE SIGMA-FACTORS; ESCHERICHIA-COLI O157/H7; ESSENTIAL OILS; OUTER-MEMBRANE; STRESS-RESPONSE; ANTIMICROBIAL ACTIVITY; HEAT-RESISTANCE; FTIR SPECTROSCOPY; GENOME SEQUENCE; RPOS	This work explores the bactericidal effect of (+)-limonene, the major constituent of citrus fruits' essential oils, against E. coli. The degree of E. coli BJ4 inactivation achieved by (+)-limonene was influenced by the pH of the treatment medium, being more bactericidal at pH 4.0 than at pH 7.0. Deletion of rpoS and exposure to a sub-lethal heat or an acid shock did not modify E. coli BJ4 resistance to (+)-limonene. However, exposure to a sub-lethal cold shock decreased its resistance to (+)-limonene. Although no sub-lethal injury was detected in the cell envelopes after exposure to (+)-limonene by the selective-plating technique, the uptake of propidium iodide by inactivated E. coli BJ4 cells pointed out these structures as important targets in the mechanism of action. Attenuated Total Reflectance Infrared Microspectroscopy (ATR-IRMS) allowed identification of altered E. coli BJ4 structures after (+)-limonene treatments as a function of the treatment pH: beta-sheet proteins at pH 4.0 and phosphodiester bonds at pH 7.0. The increased sensitivity to (+)-limonene observed at pH 4.0 in an E. coli MC4100 lptD4213 mutant with an increased outer membrane permeability along with the identification of altered beta-sheet proteins by ATR-IRMS indicated the importance of this structure in the mechanism of action of (+)-limonene. The study of mechanism of inactivation by (+)-limonene led to the design of a synergistic combined process with heat for the inactivation of the pathogen E. coli O157:H7 in fruit juices. These results show the potential of (+)-limonene in food preservation, either acting alone or in combination with lethal heat treatments.	[Espina, Laura; Pagan, Rafael; Garcia-Gonzalo, Diego] Univ Zaragoza, Fac Vet, Dept Prod Anim & Ciencia Alimentos, Zaragoza, Spain; [Gelaw, Tilahun K.; de Lamo-Castellvi, Silvia] Univ Rovira & Virgili, Dept Engn Quim, Tarragona, Spain	University of Zaragoza; Universitat Rovira i Virgili	Garcia-Gonzalo, D (corresponding author), Univ Zaragoza, Fac Vet, Dept Prod Anim & Ciencia Alimentos, Zaragoza, Spain.	Diego.Garcia@unizar.es	Gonzalo, Diego Garcia/AAE-8947-2021; Gonzalo, Diego Garcia/A-2766-2012; Pagan, Rafael/H-4401-2011; de Lamo Castellví, Sílvia/L-8233-2014	Gonzalo, Diego Garcia/0000-0002-7629-8101; Gonzalo, Diego Garcia/0000-0002-7629-8101; Pagan, Rafael/0000-0002-0238-6328; de Lamo Castellví, Sílvia/0000-0002-5261-6806; Espina, Laura/0000-0002-3170-9755	Comison Interministerial de Ciencia y Tecnologia (CICYT) [AGL2009-11660, AGL2012-32165]; Gobierno de Aragon; European Social Fund; Departament Quimica of Universitat Rovira i Virgili; Spanish Ministerio de Ciencia e Innovacion	Comison Interministerial de Ciencia y Tecnologia (CICYT)(Consejo Interinstitucional de Ciencia y Tecnologia (CICYT)); Gobierno de Aragon(Gobierno de Aragon); European Social Fund(European Social Fund (ESF)); Departament Quimica of Universitat Rovira i Virgili; Spanish Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government)	This study was financially supported by the Comison Interministerial de Ciencia y Tecnologia (CICYT) (Projects AGL2009-11660 and AGL2012-32165), Gobierno de Aragon, European Social Fund and Departament Quimica of Universitat Rovira i Virgili. Spanish Ministerio de Ciencia e Innovacion provided LE with a grant to carry out this investigation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abee T, 1999, INT J FOOD MICROBIOL, V50, P65, DOI 10.1016/S0168-1605(99)00078-1; Ait-Ouazzou A, 2012, INT J FOOD MICROBIOL, V153, P358, DOI 10.1016/j.ijfoodmicro.2011.11.027; Ait-Ouazzou A, 2011, INNOV FOOD SCI EMERG, V12, P320, DOI 10.1016/j.ifset.2011.04.004; Alvarez-Ordonez A, 2011, J MICROBIOL METH, V84, P369, DOI 10.1016/j.mimet.2011.01.009; Arroyo C, 2010, LETT APPL MICROBIOL, V51, P525, DOI 10.1111/j.1472-765X.2010.02931.x; Bakkali F, 2008, FOOD CHEM TOXICOL, V46, P446, DOI 10.1016/j.fct.2007.09.106; Barth A, 2007, BBA-BIOENERGETICS, V1767, P1073, DOI 10.1016/j.bbabio.2007.06.004; Belfer S, 2005, DESALINATION, V184, P13, DOI 10.1016/j.desal.2005.04.035; Braun M, 2002, MOL MICROBIOL, V45, P1289, DOI 10.1046/j.1365-2958.2002.03091.x; Burt S, 2004, INT J FOOD MICROBIOL, V94, P223, DOI 10.1016/j.ijfoodmicro.2004.03.022; CHAPMAN PA, 1993, EPIDEMIOL INFECT, V111, P439, DOI 10.1017/S0950268800057162; Chee Hee Youn, 2009, Mycobiology, V37, P243, DOI 10.4489/MYCO.2009.37.3.243; Chung HJ, 2006, COMPR REV FOOD SCI F, V5, P52, DOI 10.1111/j.1541-4337.2006.00002.x; Condon S, 1996, LETT APPL MICROBIOL, V22, P149, DOI 10.1111/j.1472-765X.1996.tb01130.x; Dambolena JS, 2008, TOXICON, V51, P37, DOI 10.1016/j.toxicon.2007.07.005; Dorman HJD, 2000, J APPL MICROBIOL, V88, P308, DOI 10.1046/j.1365-2672.2000.00969.x; Dunn W.J., 1995, CHEMOMETRIC METHODS, P179; Espina L, 2010, J FOOD PROTECT, V73, P2189, DOI 10.4315/0362-028X-73.12.2189; Espina L, 2012, INT J FOOD MICROBIOL, V159, P9, DOI 10.1016/j.ijfoodmicro.2012.07.020; Espina L, 2011, FOOD CONTROL, V22, P896, DOI 10.1016/j.foodcont.2010.11.021; FDA, 2001, FED REGISTER, V66, P6137; Fisher K, 2008, TRENDS FOOD SCI TECH, V19, P156, DOI 10.1016/j.tifs.2007.11.006; FULCO AJ, 1974, ANNU REV BIOCHEM, V43, P215, DOI 10.1146/annurev.bi.43.070174.001243; Garcia D, 2005, INNOV FOOD SCI EMERG, V6, P388, DOI 10.1016/j.ifset.2005.04.003; GIBSON AM, 1988, INT J FOOD MICROBIOL, V6, P155, DOI [10.1016/0168-1605(88)90051-7, 10.1016/S0168-1605(00)00395-0]; GMEINER J, 1980, ARCH MICROBIOL, V127, P81, DOI 10.1007/BF00428010; Gould GW, 1989, MECH ACTION FOOD PRE, P11; Grasso EM, 2009, J AGR FOOD CHEM, V57, P10670, DOI 10.1021/jf902371j; Hayashi T, 2001, DNA RES, V8, P11, DOI 10.1093/dnares/8.1.11; Hengge-Aronis R, 2002, MICROBIOL MOL BIOL R, V66, P373, DOI 10.1128/MMBR.66.3.373-395.2002; Hruschka WR, 2001, NEAR INFRARED TECHNO, P39; Hucl T, 2007, CELL CYCLE, V6, P1336, DOI 10.4161/cc.6.11.4359; Jaroenkit P., 2011, International Journal of Medicinal and Aromatic Plants, V1, P234; JUVEN BJ, 1994, J APPL BACTERIOL, V76, P626, DOI 10.1111/j.1365-2672.1994.tb01661.x; Kazmierczak MJ, 2005, MICROBIOL MOL BIOL R, V69, P527, DOI 10.1128/MMBR.69.4.527-543.2005; Kong J, 2007, ACTA BIOCH BIOPH SIN, V39, P549, DOI 10.1111/j.1745-7270.2007.00320.x; Krogfelt KA, 2000, INFECT IMMUN, V68, P2518, DOI 10.1128/IAI.68.5.2518-2524.2000; LEGAL JM, 1991, J MOL STRUCT, V242, P397, DOI 10.1016/0022-2860(91)87150-G; LEISTNER L, 1995, TRENDS FOOD SCI TECH, V6, P41, DOI 10.1016/S0924-2244(00)88941-4; Mackey B. M., 2000, MICROBIOLOGICAL SAFE, VI, P315; MACKEY BM, 1982, J APPL BACTERIOL, V53, P243, DOI 10.1111/j.1365-2672.1982.tb04683.x; Manas P, 2005, J APPL MICROBIOL, V98, P1387, DOI 10.1111/j.1365-2672.2005.02561.x; Mourey A, 2002, FOOD CONTROL, V13, P289, DOI 10.1016/S0956-7135(02)00026-9; Pagan R, 2000, APPL ENVIRON MICROB, V66, P2829, DOI 10.1128/AEM.66.7.2829-2834.2000; Parikh SJ, 2006, LANGMUIR, V22, P8492, DOI 10.1021/la061359p; Perna NT, 2001, NATURE, V409, P529, DOI 10.1038/35054089; Rangel JM, 2005, EMERG INFECT DIS, V11, P603, DOI 10.3201/eid1104.040739; Rota C, 2004, J FOOD PROTECT, V67, P1252, DOI 10.4315/0362-028X-67.6.1252; Ruiz N, 2006, NAT REV MICROBIOL, V4, P57, DOI 10.1038/nrmicro1322; SAMPSON BA, 1989, GENETICS, V122, P491; Shin JK, 1997, J FOOD SCI, V62, P163, DOI 10.1111/j.1365-2621.1997.tb04391.x; SIKKEMA J, 1994, J BIOL CHEM, V269, P8022; Silhavy TJ, 2010, COLD SPRING HARB PER, P2; Somolinos M, 2008, INT J FOOD MICROBIOL, V124, P260, DOI 10.1016/j.ijfoodmicro.2008.03.021; Somolinos M, 2010, INT J FOOD MICROBIOL, V141, P32, DOI 10.1016/j.ijfoodmicro.2010.04.023; Somolinos M, 2010, J APPL MICROBIOL, V108, P1928, DOI 10.1111/j.1365-2672.2009.04597.x; Tamm LK, 2004, BBA-BIOMEMBRANES, V1666, P250, DOI 10.1016/j.bbamem.2004.06.011; Van Vuuren SF, 2007, FLAVOUR FRAG J, V22, P540, DOI 10.1002/ffj.1843; Weber H, 2005, J BACTERIOL, V187, P1591, DOI 10.1128/JB.187.5.1591-1603.2005; Wu T, 2006, P NATL ACAD SCI USA, V103, P11754, DOI 10.1073/pnas.0604744103; Yamanaka Kunitoshi, 1999, Journal of Molecular Microbiology and Biotechnology, V1, P193; Yu CX, 2005, BIOPOLYMERS, V77, P368, DOI 10.1002/bip.20247; ZUKERMAN I, 1951, NATURE, V168, P517, DOI 10.1038/168517a0	63	87	91	0	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2013	8	2							e56769	10.1371/journal.pone.0056769	http://dx.doi.org/10.1371/journal.pone.0056769			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104BU	23424676	gold, Green Published			2022-12-25	WOS:000315965100064
J	Spencer, KL; Malinowski, J; Carty, CL; Franceschini, N; Fernandez-Rhodes, L; Young, A; Cheng, I; Ritchie, MD; Haiman, CA; Wilkens, L; ChunyuanWu; Matise, TC; Carlson, CS; Brennan, K; Park, A; Rajkovic, A; Hindorff, LA; Buyske, S; Crawford, DC				Spencer, Kylee L.; Malinowski, Jennifer; Carty, Cara L.; Franceschini, Nora; Fernandez-Rhodes, Lindsay; Young, Alicia; Cheng, Iona; Ritchie, Marylyn D.; Haiman, Christopher A.; Wilkens, Lynne; ChunyuanWu; Matise, Tara C.; Carlson, Christopher S.; Brennan, Kathleen; Park, Amy; Rajkovic, Aleksandar; Hindorff, Lucia A.; Buyske, Steven; Crawford, Dana C.			Genetic Variation and Reproductive Timing: African American Women from the Population Architecture Using Genomics and Epidemiology (PAGE) Study	PLOS ONE			English	Article							BODY-MASS INDEX; NATURAL MENOPAUSE; RISK-FACTORS; CARDIOVASCULAR-DISEASE; WIDE ASSOCIATION; BREAST-CANCER; FUNCTIONAL-ANALYSIS; INFLUENCE AGE; RSF-1 HBXAP; MENARCHE	Age at menarche (AM) and age at natural menopause (ANM) define the boundaries of the reproductive lifespan in women. Their timing is associated with various diseases, including cancer and cardiovascular disease. Genome-wide association studies have identified several genetic variants associated with either AM or ANM in populations of largely European or Asian descent women. The extent to which these associations generalize to diverse populations remains unknown. Therefore, we sought to replicate previously reported AM and ANM findings and to identify novel AM and ANM variants using the Metabochip (n = 161,098 SNPs) in 4,159 and 1,860 African American women, respectively, in the Women's Health Initiative (WHI) and Atherosclerosis Risk in Communities (ARIC) studies, as part of the Population Architecture using Genomics and Epidemiology (PAGE) Study. We replicated or generalized one previously identified variant for AM, rs1361108/CENPW, and two variants for ANM, rs897798/BRSK1 and rs769450/APOE, to our African American cohort. Overall, generalization of the majority of previously-identified variants for AM and ANM, including LIN28B and MCM8, was not observed in this African American sample. We identified three novel loci associated with ANM that reached significance after multiple testing correction (LDLR rs189596789, p = 5 x 10(-08); KCNQ1 rs79972789, p = 1.9 x 10(-07); COL4A3BP rs181686584, p = 2.9 x 10(-07)). Our most significant AM association was upstream of RSF1, a gene implicated in ovarian and breast cancers (rs11604207, p = 1.6 x 10(-06)). While most associations were identified in either AM or ANM, we did identify genes suggestively associated with both: PHACTR1 and ARHGAP42. The lack of generalization coupled with the potentially novel associations identified here emphasize the need for additional genetic discovery efforts for AM and ANM in diverse populations.	[Malinowski, Jennifer; Ritchie, Marylyn D.; Crawford, Dana C.] Vanderbilt Univ, Dept Mol Physiol & Biophys, Ctr Human Genet Res, Nashville, TN 37232 USA; [Matise, Tara C.; Buyske, Steven] Rutgers State Univ, Dept Genet, Piscataway, NJ USA; [Buyske, Steven] Rutgers State Univ, Dept Stat, Piscataway, NJ USA; [Franceschini, Nora; Fernandez-Rhodes, Lindsay] Univ N Carolina, Dept Epidemiol, Chapel Hill, NC USA; [Carty, Cara L.; Young, Alicia; ChunyuanWu; Carlson, Christopher S.] Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA; [Haiman, Christopher A.] Univ So Calif, Keck Sch Med, Los Angeles, CA 90033 USA; [Cheng, Iona; Wilkens, Lynne] Univ Hawaii, Ctr Canc, Honolulu, HI 96822 USA; [Brennan, Kathleen] Univ Calif Los Angeles, Dept Obstet & Gynecol, Los Angeles, CA 90024 USA; [Park, Amy] Georgetown Univ, Sch Med, Dept Obstet & Gynecol, Washington, DC 20007 USA; [Rajkovic, Aleksandar] Univ Pittsburgh, Magee Womens Res Inst, Dept Obstet Gynecol & Reprod Sci, Pittsburgh, PA USA; [Hindorff, Lucia A.] NHGRI, Off Populat Genom, NIH, Bethesda, MD 20892 USA; [Spencer, Kylee L.] Heidelberg Univ, Dept Biol & Environm Sci, Tiffin, OH USA; [Ritchie, Marylyn D.] Penn State Univ, University Pk, MD USA	Vanderbilt University; Rutgers State University New Brunswick; Rutgers State University New Brunswick; University of North Carolina; University of North Carolina Chapel Hill; Fred Hutchinson Cancer Center; University of Southern California; Cancer Research Center of Hawaii; University of Hawaii System; University of California System; University of California Los Angeles; Georgetown University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Magee-Womens Research Institute; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Heidelberg University USA	Crawford, DC (corresponding author), Vanderbilt Univ, Dept Mol Physiol & Biophys, Ctr Human Genet Res, Nashville, TN 37232 USA.	dana.c.crawford@vanderbilt.edu	Crawford, Dana/O-5578-2019	Crawford, Dana/0000-0002-6437-6248; Malinowski, Jennifer/0000-0001-7500-2199; Buyske, Steven/0000-0001-8539-5416; Fernandez-Rhodes, Lindsay/0000-0001-6985-423X	National Human Genome Research Institute (NHGRI); Causal Variants Across the Life Course, known as CALiCo [U01HG004803]; Epidemiologic Architecture for Genes Linked to Environment, known as EAGLE [U01HG004798]; Multiethnic Cohort, known as MEC [U01HG004802]; Women's Health Initiative, known as WHI [U01HG004790]; Coordinating Center [U01HG004801]; NHLBI [N01-HC-55015, N01-HC-55016, N01-HC-55018, N01-HC-55019, N01-HC-55020, N01-HC-55021, N01-HC-55022]; National Cancer Institute [R37CA54281, R01 CA63, P01CA33619, U01CA136792, U01CA98758]; National Heart, Lung, and Blood Institute (NHLBI) (NIH); U.S. Department of Health and Human Services [N01WH22110, 24152, 32100-2, 32105-6, 32108-9, 32111-13, 32115, 32118-32119, 32122, 42107-26, 42129-32, 44221]; National Institutes of Mental Health; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC055020, N01HC055022, N01HC055021, N01HC055015, N01HC055018, N01HC055016, N01HC055019] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [U01CA136792, P01CA033619, R37CA054281, U01CA098758] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG004790, U01HG004803, U01HG004798, U01HG004802, U01HG004801] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM080178] Funding Source: NIH RePORTER; WOMEN&apos;S HEALTH INITIATIVE - OFFICE OF THE DIRECTOR NIH [N01WH032122, N01WH032111, N01WH032108, N01WH032105, N01WH032118, N01WH022110, N01WH032100, N01WH042129, N01WH042107, N01WH032115] Funding Source: NIH RePORTER	National Human Genome Research Institute (NHGRI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Causal Variants Across the Life Course, known as CALiCo; Epidemiologic Architecture for Genes Linked to Environment, known as EAGLE; Multiethnic Cohort, known as MEC; Women's Health Initiative, known as WHI; Coordinating Center; NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Heart, Lung, and Blood Institute (NHLBI) (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); U.S. Department of Health and Human Services; National Institutes of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); WOMEN&apos;S HEALTH INITIATIVE - OFFICE OF THE DIRECTOR NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The Population Architecture Using Genomics and Epidemiology (PAGE) program is funded by the National Human Genome Research Institute (NHGRI), supported by U01HG004803 (Causal Variants Across the Life Course, known as CALiCo), U01HG004798 (Epidemiologic Architecture for Genes Linked to Environment, known as EAGLE), U01HG004802 (the Multiethnic Cohort, known as MEC), U01HG004790 (Women's Health Initiative, known as WHI), and U01HG004801 (Coordinating Center). The Atherosclerosis Risk in Communities (ARIC) Study is carried out as a collaborative study supported by NHLBI contracts N01-HC-55015, N01-HC-55016, N01-HC-55018, N01-HC-55019, N01-HC-55020, N01-HC-55021, N01-HC-55022. The Multiethnic Cohort (MEC) study is funded through the National Cancer Institute (R37CA54281, R01 CA63, P01CA33619, U01CA136792, and U01CA98758). The Women's Health Initiative (WHI) program is funded by the National Heart, Lung, and Blood Institute (NHLBI) (NIH) and by U.S. Department of Health and Human Services through contracts N01WH22110, 24152, 32100-2, 32105-6, 32108-9, 32111-13, 32115, 32118-32119, 32122, 42107-26, 42129-32, and 44221. The National Institutes of Mental Health also contributes to the support for the Coordinating Center. NHGRI collaborators (LAH) assisted in the study design, analysis, and preparation of the manuscript.	Adair LS, 2001, AM J PUBLIC HEALTH, V91, P642, DOI 10.2105/AJPH.91.4.642; Adams Hillard Paula J, 2008, Medscape J Med, V10, P295; Anderson CA, 2008, J CLIN ENDOCR METAB, V93, P3965, DOI 10.1210/jc.2007-2568; Anderson G, 1998, CONTROL CLIN TRIALS, V19, P61; Anderson SE, 2005, J PEDIATR-US, V147, P753, DOI 10.1016/j.jpeds.2005.07.016; Atsma F, 2006, MENOPAUSE, V13, P265, DOI 10.1097/01.gme.0000218683.97338.ea; Boyce BF, 2008, ARCH BIOCHEM BIOPHYS, V473, P139, DOI 10.1016/j.abb.2008.03.018; Brown LA, 2008, GENE CHROMOSOME CANC, V47, P481, DOI 10.1002/gcc.20549; Buber J, 2011, CIRCULATION, V123, P2784, DOI 10.1161/CIRCULATIONAHA.110.000620; Buyske S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035651; Carr MC, 2003, J CLIN ENDOCR METAB, V88, P2404, DOI 10.1210/jc.2003-030242; Carter R, 2011, J YOUTH ADOLESCENCE, V40, P1394, DOI 10.1007/s10964-010-9611-9; Casazza K, 2008, J CLIN ENDOCR METAB, V93, P2610, DOI 10.1210/jc.2007-2776; Cerne JZ, 2011, EUR J CONTRACEP REPR, V16, P241, DOI 10.3109/13625187.2011.575481; Chen CTL, 2012, HUM MOL GENET, V21, P1419, DOI 10.1093/hmg/ddr570; Choi JH, 2009, CANCER RES, V69, P1407, DOI 10.1158/0008-5472.CAN-08-3602; Cui B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022353; De Castro-Oros I, 2011, HUM MUTAT, V32, P868, DOI 10.1002/humu.21520; Deardorff J, 2011, J ADOLESCENT HEALTH, V48, P441, DOI 10.1016/j.jadohealth.2010.07.032; Diakou M, 2011, EUR J INTERN MED, V22, pE55, DOI 10.1016/j.ejim.2011.01.003; Dishi M, 2011, DIABETES RES CLIN PR, V93, P437, DOI 10.1016/j.diabres.2011.07.001; Dossus L, 2010, INT J CANCER, V127, P442, DOI 10.1002/ijc.25050; Dvornyk V, 2012, HUM REPROD UPDATE, V18, P198, DOI 10.1093/humupd/dmr050; Ehret GB, 2011, NATURE, V478, P103, DOI 10.1038/nature10405; Elias SG, 2005, HUM REPROD, V20, P2483, DOI 10.1093/humrep/dei090; Elks CE, 2010, NAT GENET, V42, P1077, DOI 10.1038/ng.714; Gauderman WJ, 2002, AM J EPIDEMIOL, V155, P478, DOI 10.1093/aje/155.5.478; Gold EB, 2011, OBSTET GYN CLIN N AM, V38, P425, DOI 10.1016/j.ogc.2011.05.002; Guo Y, 2006, HUM MOL GENET, V15, P2401, DOI 10.1093/hmg/ddl155; Hartge P, 2009, NAT GENET, V41, P637, DOI 10.1038/ng0609-637; He CY, 2010, HUM GENET, V128, P515, DOI 10.1007/s00439-010-0878-4; He CY, 2010, AM J EPIDEMIOL, V171, P334, DOI 10.1093/aje/kwp372; He CY, 2009, NAT GENET, V41, P724, DOI 10.1038/ng.385; He LN, 2007, J GENET, V86, P269, DOI 10.1007/s12041-007-0034-7; He LN, 2009, MATURITAS, V62, P37, DOI 10.1016/j.maturitas.2008.10.011; Hofbauer LC, 2004, JAMA-J AM MED ASSOC, V292, P490, DOI 10.1001/jama.292.4.490; HSIEH CC, 1990, INT J CANCER, V46, P796, DOI 10.1002/ijc.2910460508; Jasen P, 2011, CAN BULL MED HIST, V28, P43, DOI 10.3138/cbmh.28.1.43; Jenkins BWC, 2011, INT J ENV RES PUB HE, V8, P2491, DOI 10.3390/ijerph8062491; Johnson AD, 2008, BIOINFORMATICS, V24, P2938, DOI 10.1093/bioinformatics/btn564; Jurvansuu JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025317; Kallen AN, 2011, CURR OPIN OBSTET GYN, V23, P258, DOI 10.1097/GCO.0b013e3283488a21; Kaplowitz P, 2006, CURR OPIN OBSTET GYN, V18, P487, DOI 10.1097/01.gco.0000242949.02373.09; Kinney A, 2007, HUM REPROD, V22, P1175, DOI 10.1093/humrep/del496; Kok HS, 2005, HUM REPROD UPDATE, V11, P483, DOI 10.1093/humupd/dmi024; Lakshman R, 2009, J CLIN ENDOCR METAB, V94, P4953, DOI 10.1210/jc.2009-1789; Lisabeth LD, 2009, STROKE, V40, P1044, DOI 10.1161/STROKEAHA.108.542993; Liu P, 2010, MENOPAUSE, V17, P185, DOI 10.1097/gme.0b013e3181aa2597; Long JR, 2006, MATURITAS, V55, P238, DOI 10.1016/j.maturitas.2006.03.005; Lu Y, 2010, MENOPAUSE, V17, P1048, DOI 10.1097/gme.0b013e3181d5d523; Lunetta KL, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-S1-S13; Maeda D, 2011, INT J GYNECOL PATHOL, V30, P30, DOI 10.1097/PGP.0b013e3181e9a319; Matise TC, 2011, AM J EPIDEMIOL, V174, P849, DOI 10.1093/aje/kwr160; Meng FT, 2012, AGE, V34, P1023, DOI 10.1007/s11357-011-9287-4; Milne FH, 2011, MED HYPOTHESES, V77, P626, DOI 10.1016/j.mehy.2011.07.001; Mitchell ES, 2008, MENOPAUSE, V15, P105, DOI 10.1097/gme.0b013e31804d2406; Mondul AM, 2005, AM J EPIDEMIOL, V162, P1089, DOI 10.1093/aje/kwi324; Morris DH, 2011, PAEDIATR PERINAT EP, V25, P306, DOI 10.1111/j.1365-3016.2010.01183.x; Murray A, 2011, HUM MOL GENET, V20, P186, DOI 10.1093/hmg/ddq417; Must A, 2002, AM J EPIDEMIOL, V155, P672, DOI 10.1093/aje/155.7.672; Narod SA, 2011, CURR ONCOL, V18, P204; Narod SA, 2011, JAMA-J AM MED ASSOC, V306, P1920, DOI 10.1001/jama.2011.1589; Ogden CL, 2012, JAMA-J AM MED ASSOC, V307, P483, DOI 10.1001/jama.2012.40; Ong KK, 2009, NAT GENET, V41, P729, DOI 10.1038/ng.382; Opdahl S, 2011, BRIT J CANCER, V105, P731, DOI 10.1038/bjc.2011.286; Pan L, 2007, GENET EPIDEMIOL, V31, P338, DOI 10.1002/gepi.20214; Perry JRB, 2009, NAT GENET, V41, P648, DOI 10.1038/ng.386; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Pruim RJeal, 2010, LOCUSZOOM REGIONAL V, P26; R Development Core Team, 2012, R LANG ENV STAT COMP; Rees SD, 2011, DIABETOLOGIA, V54, P1368, DOI 10.1007/s00125-011-2063-2; Remsberg KE, 2005, J CLIN ENDOCR METAB, V90, P2718, DOI 10.1210/jc.2004-1991; Reynolds RF, 2001, ANN HUM BIOL, V28, P21; Reynolds RF, 2003, ANN HUM BIOL, V30, P97, DOI 10.1080/03014460210165908; Ripatti S, 2010, LANCET, V376, P1393, DOI 10.1016/S0140-6736(10)61267-6; Saif-Ali R, 2011, ANN ACAD MED SINGAP, V40, P488; Saif-Ali R, 2011, INT J MOL SCI, V12, P5705, DOI 10.3390/ijms12095705; Salpeter SR, 2006, J GEN INTERN MED, V21, P363, DOI 10.1111/j.1525-1497.2006.00389.x; Salsberry PJ, 2009, NURS RES, V58, P382, DOI 10.1097/NNR.0b013e3181b4b921; Schunkert H, 2011, NAT GENET, V43, P333, DOI [10.1038/ng.784, 10.1161/CIRCGENETICS.111.960443]; Snieder H, 1998, J CLIN ENDOCR METAB, V83, P1875, DOI 10.1210/jc.83.6.1875; Speliotes EK, 2010, NAT GENET, V42, P937, DOI 10.1038/ng.686; Stolk L, 2012, NAT GENET, V44, P260, DOI 10.1038/ng.1051; Stolk L, 2009, NAT GENET, V41, P645, DOI 10.1038/ng.387; Sulem P, 2009, NAT GENET, V41, P734, DOI 10.1038/ng.383; Towne B, 2005, AM J PHYS ANTHROPOL, V128, P210, DOI 10.1002/ajpa.20106; Unoki H, 2008, NAT GENET, V40, P1098, DOI 10.1038/ng.208; van Asselt KM, 2004, FERTIL STERIL, V82, P1348, DOI 10.1016/j.fertnstert.2004.04.047; vanNoord PAH, 1997, FERTIL STERIL, V68, P95, DOI 10.1016/S0015-0282(97)81482-3; Voight BF, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002793; Voorhuis M, 2011, J CLIN ENDOCR METAB, V96, pE473, DOI 10.1210/jc.2010-1799; Willer CJ, 2010, BIOINFORMATICS, V26, P2190, DOI 10.1093/bioinformatics/btq340; WILLIAMS OD, 1989, AM J EPIDEMIOL, V129, P687, DOI 10.1093/oxfordjournals.aje.a115184; Yasuda K, 2008, NAT GENET, V40, P1092, DOI 10.1038/ng.207; Zhao J, 2007, HUM REPROD, V22, P1789, DOI 10.1093/humrep/dem052	95	35	35	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2013	8	2							e55258	10.1371/journal.pone.0055258	http://dx.doi.org/10.1371/journal.pone.0055258			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104BU	23424626	gold, Green Published, Green Accepted			2022-12-25	WOS:000315965100014
J	Hu, HY; Li, SQ; Cui, XY; Lv, XB; Jiao, Y; Yu, FY; Yao, HR; Song, EW; Chen, YS; Wang, MH; Lin, L				Hu, Haiyan; Li, Shuqin; Cui, Xiuying; Lv, Xiaobin; Jiao, Yu; Yu, Fengyan; Yao, Herui; Song, Erwei; Chen, Yongsong; Wang, Minghui; Lin, Ling			The Overexpression of Hypomethylated miR-663 Induces Chemotherapy Resistance in Human Breast Cancer Cells by Targeting Heparin Sulfate Proteoglycan 2 (HSPG2)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MICRORNAS; EXPRESSION; CHEMORESISTANCE; PROMOTES; CARCINOMA; PROTEIN; DRUG	MicroRNAs are involved in regulating the biology of cancer cells, but their involvement in chemoresistance is not fully understood. We found that miR-663 was up-regulated in our induced multidrug-resistant MDA-MB-231/ADM cell line and that this up-regulation was closely related to chemosensitivity. In the present study, we aimed to clarify the role of miR-663 in regulating the chemoresistance of breast cancer. MicroRNA microarray and quantitative RT-PCR assays were used to identify differentially expressed microRNAs. Cell apoptosis was evaluated by annexin V/propidium iodide staining, TUNEL, and reactive oxygen species generation analysis. The expression of miR-663 and HSPG2 in breast cancer tissues was detected by in situ hybridization and immunohistochemistry. The potential targets of miR-663 were defined by a luciferase reporter assay. Bisulfite sequencing PCR was used to analyze the methylation status. We found that miR-663 was significantly elevated in MDA-MB-231/ADM cells, and the down-regulation of miR-663 sensitized MDA-MB-231/ADM cells to both cyclophosphamide and docetaxel. The overexpression of miR-663 in breast tumor tissues was associated with chemoresistance; in MDA-MB-231 cells, this chemoresistance was accompanied by the down-regulation of HSPG2, which was identified as a target of miR-663. MDA-MB-231/ADM contained fewer methylated CpG sites than its parental cell line, and miR-663 expression in MDA-MB-231 cells was reactivated by 5-aza-29-deoxycytidine treatment, indicating that DNA methylation may play a functional role in the expression of miR-663. Our findings suggest that the over-expression of hypomethylated miR-663 induced chemoresistance in breast cancer cells by down-regulating HSPG2, thus providing a potential target for the development of an microRNA-based approach for breast cancer therapy.	[Hu, Haiyan; Li, Shuqin; Jiao, Yu; Yu, Fengyan; Yao, Herui; Song, Erwei] Sun Yat Sen Univ, Breast Tumor Ctr, Sun Yat Sen Mem Hosp, Guangzhou 510120, Peoples R China; [Cui, Xiuying; Lv, Xiaobin] Sun Yat Sen Univ, Key Lab Malignant Tumor Gene Regulat & Target The, Sun Yat Sen Mem Hosp, Guangdong Higher Educ Inst, Guangzhou 510120, Peoples R China; [Wang, Minghui] Sun Yat Sen Univ, Dept Cardiothorac Surg, Sun Yat Sen Mem Hosp, Guangzhou 510120, Peoples R China; [Chen, Yongsong; Lin, Ling] Shantou Univ, Coll Med, Affiliated Hosp 1, Dept Internal Med, Shantou 515041, Guangdong, Peoples R China; [Hu, Haiyan; Song, Erwei] Shanghai Jiao Tong Univ, Dept Oncol, Peoples Hosp 6, Shanghai 200233, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University; Shantou University; Shanghai Jiao Tong University	Chen, YS (corresponding author), Shantou Univ, Coll Med, Affiliated Hosp 1, Dept Internal Med, 57 Changping Rd, Shantou 515041, Guangdong, Peoples R China.	yongsongchen@126.com; wangminghui01@yahoo.com.cn; llinc@163.net	Lv, Xiao-Bin/T-7607-2019	Lin, Ling/0000-0001-5603-0688; Chen, Yongsong/0000-0002-8208-4951	973 Projects from the Ministry of Science and Technology of China [2010CB912800, 2011CB504203]; National Science Foundation of China [81230060, 81261140373, 81072176, 81072177, 30800486]; Foundation of Ministry of Education of the People's Republic of China [20120171110075]; Science Foundation of Guangdong Province [S2012030006287]; China Postdoctoral Science Foundation [201003379, 201104379]; Guangdong Natural Science Foundation [10151503102000019]; Science and Technology Foundation of the Guangdong Province [2008B030301238, 2008B030301243]; National S&T Major Special Project on New Drug Innovation of China [2011ZX09102-010-02]	973 Projects from the Ministry of Science and Technology of China; National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Foundation of Ministry of Education of the People's Republic of China(Ministry of Education, China); Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Guangdong Natural Science Foundation(National Natural Science Foundation of Guangdong Province); Science and Technology Foundation of the Guangdong Province; National S&T Major Special Project on New Drug Innovation of China	This work was supported by 973 Projects from the Ministry of Science and Technology of China Grants 2010CB912800 and 2011CB504203; National Science Foundation of China Grants 81230060, 81261140373, 81072176, 81072177, and 30800486; National S&T Major Special Project on New Drug Innovation of China Grant 2011ZX09102-010-02; Foundation of Ministry of Education of the People's Republic of China Grant 20120171110075; Science Foundation of Guangdong Province Grant S2012030006287; the special financial grant from the China Postdoctoral Science Foundation (Grants 201003379 and 201104379); Guangdong Natural Science Foundation Grant 10151503102000019; and Science and Technology Foundation of the Guangdong Province Grants 2008B030301238 and 2008B030301243.	Amant F, 2010, EUR J CANCER, V46, P3158, DOI 10.1016/j.ejca.2010.09.010; Chen JQ, 2011, CANCER CELL, V19, P541, DOI 10.1016/j.ccr.2011.02.006; Duarte IL, 2012, BREAST, V21, P343, DOI 10.1016/j.breast.2012.02.011; Elhassan MO, 2012, J BIOL CHEM, V287, P5267, DOI 10.1074/jbc.M111.318865; Gogna R, 2012, J BIOL CHEM, V287, P2907, DOI 10.1074/jbc.M111.317354; Hummel R, 2010, EUR J CANCER, V46, P298, DOI 10.1016/j.ejca.2009.10.027; Kitade Y, 2010, J PHARMACOL SCI, V114, P276, DOI 10.1254/jphs.10R12FM; Krell J, 2012, PHARMACOGENOMICS, V13, P709, DOI [10.2217/PGS.12.15, 10.2217/pgs.12.15]; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Ma KL, 2012, J BIOL CHEM, V287, P5639, DOI 10.1074/jbc.M111.291229; Majumder S, 2011, GENE EXPRESSION, V15, P141, DOI 10.3727/105221611X13176664479287; Naci D, 2012, J BIOL CHEM, V287, P17065, DOI 10.1074/jbc.M112.349365; Nair VS, 2012, JNCI-J NATL CANCER I, V104, P528, DOI 10.1093/jnci/djs027; O'Day E, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2484; Oliva CR, 2010, J BIOL CHEM, V285, P39759, DOI 10.1074/jbc.M110.147504; Pan JA, 2010, ONCOL REP, V24, P105, DOI 10.3892/or_00000834; Penault-Llorca F, 2009, J CLIN ONCOL, V27, P2809, DOI 10.1200/JCO.2008.18.2808; Sato F, 2011, FEBS J, V278, P1598, DOI 10.1111/j.1742-4658.2011.08089.x; Stark M, 2011, J BIOL CHEM, V286, P3741, DOI 10.1074/jbc.M110.163444; Xu CX, 2012, J BIOL CHEM, V287, P34970, DOI 10.1074/jbc.M112.374611; Yi C, 2012, ONCOGENE, V31, P4421, DOI 10.1038/onc.2011.629; Zhu YH, 2011, CLIN CANCER RES, V17, P7105, DOI 10.1158/1078-0432.CCR-11-0071	23	93	95	0	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 19	2013	288	16					10973	10985		10.1074/jbc.M112.434340	http://dx.doi.org/10.1074/jbc.M112.434340			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	130KW	23436656	Green Published, hybrid			2022-12-25	WOS:000317915500004
J	Wang, J; Wang, YL; Wang, Y; Ma, Y; Lan, Y; Yang, X				Wang, Jun; Wang, Youliang; Wang, Yu; Ma, Ying; Lan, Yu; Yang, Xiao			Transforming Growth Factor beta-regulated MicroRNA-29a Promotes Angiogenesis through Targeting the Phosphatase and Tensin Homolog in Endothelium	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXPRESSION; PTEN; OVEREXPRESSION; ACTIVATION; REVEALS; MALFORMATIONS; HEMATOPOIESIS; SUPPRESSION; MECHANISMS; INTEGRITY	The TGF-beta pathway plays an important role in physiological and pathological angiogenesis. MicroRNAs (miRNAs) are a class of 18- to 25-nucleotide, small, noncoding RNAs that function by regulating gene expression. A number of miRNAs have been found to be regulated by the TGF-beta pathway. However, the role of endothelial miRNAs in the TGF-beta-mediated control of angiogenesis is still largely unknown. Here we investigated the regulation of endothelial microRNA-29a (miR-29a) by TGF-beta signaling and the potential role of miR-29a in angiogenesis. MiR-29a was directly up-regulated by TGF-beta/Smad4 signaling in human and mice endothelial cells. In a chick chorioallantoic membrane assay, miR-29a overexpression promoted the formation of new blood vessels, and miR-29a suppression completely blocked TGF-beta 1-stimulated angiogenesis. Consistently, miR-29a overexpression increased tube formation and migration in endothelial cultures. Mechanistically, miR-29a directly targeted the phosphatase and tensin homolog (PTEN) in endothelial cells, leading to activation of the AKT pathway. PTEN knockdown recapitulated the role of miR-29a in endothelial migration, whereas AKT inhibition completely attenuated the stimulating role of miR-29a in angiogenesis. Taken together, these results reveal a crucial role of a TGF-beta-regulated miRNA in promoting angiogenesis by targeting PTEN to stimulate AKT activity.	[Wang, Jun; Wang, Youliang; Wang, Yu; Ma, Ying; Lan, Yu; Yang, Xiao] Inst Biotechnol, State Key Lab Prote, Genet Lab Dev & Dis, Beijing 100071, Peoples R China; [Yang, Xiao] Shanghai Jiao Tong Univ, Model Organism Div, E Inst Shanghai Univ, Shanghai 200025, Peoples R China	Shanghai Jiao Tong University	Lan, Y (corresponding author), Inst Biotechnol, State Key Lab Prote, Genet Lab Dev & Dis, Beijing 100071, Peoples R China.	rainyblue_1999@yahoo.com; yangx@bmi.ac.cn	Lan, Yu/AAV-2236-2021	Lan, Yu/0000-0002-4731-5945; Yang, Xiao/0000-0002-0298-9831; Wang, Jun/0000-0001-6498-0675	Chinese National Key Program on Basic Research [2012CB945103, 2011CB964803, 2011CB504202]; National Natural Science Foundation of China [31030040, 31171410]; State Key Laboratory of Proteomics [SKLP-K201102]	Chinese National Key Program on Basic Research; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); State Key Laboratory of Proteomics	This work was supported by Chinese National Key Program on Basic Research Grants 2012CB945103, 2011CB964803, and 2011CB504202; by National Natural Science Foundation of China Grants 31030040 and 31171410; and by State Key Laboratory of Proteomics Grant SKLP-K201102.	Alaiti MA, 2012, J CELL MOL MED, V16, P2413, DOI 10.1111/j.1582-4934.2012.01557.x; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bonauer A, 2009, SCIENCE, V324, P1710, DOI 10.1126/science.1174381; Bourdeau A, 1999, J CLIN INVEST, V104, P1343, DOI 10.1172/JCI8088; Bridge G, 2012, BLOOD, V120, P5063, DOI 10.1182/blood-2012-04-423004; Carmeliet P, 2011, NATURE, V473, P298, DOI 10.1038/nature10144; Chen Y, 2008, BLOOD, V111, P1217, DOI 10.1182/blood-2007-07-104133; Chen Y, 2010, MOL CELL BIOL, V30, P3902, DOI 10.1128/MCB.01237-09; Chow JYC, 2008, CANCER BIOL THER, V7, P1694, DOI 10.4161/cbt.7.10.6665; Chow JYC, 2008, AM J PHYSIOL-GASTR L, V294, pG899, DOI 10.1152/ajpgi.00411.2007; Chow JYC, 2010, AM J PHYSIOL-GASTR L, V298, pG275, DOI 10.1152/ajpgi.00344.2009; Cushing L, 2011, AM J RESP CELL MOL, V45, P287, DOI 10.1165/rcmb.2010-0323OC; Davis BN, 2008, NATURE, V454, P56, DOI 10.1038/nature07086; DICKSON MC, 1995, DEVELOPMENT, V121, P1845; Doebele C, 2010, BLOOD, V115, P4944, DOI 10.1182/blood-2010-01-264812; Du B, 2010, FEBS LETT, V584, P811, DOI 10.1016/j.febslet.2009.12.053; Fasanaro P, 2008, J BIOL CHEM, V283, P15878, DOI 10.1074/jbc.M800731200; Fish JE, 2009, SCI SIGNAL, V1, DOI 10.1126/scisignal.252pe1; Ghosh G, 2010, J CLIN INVEST, V120, P4141, DOI 10.1172/JCI42980; Goumans MJ, 2002, EMBO J, V21, P1743, DOI 10.1093/emboj/21.7.1743; Graupera M, 2008, NATURE, V453, P662, DOI 10.1038/nature06892; Guduric-Fuchs J, 2012, J CELL BIOCHEM, V113, P2098, DOI 10.1002/jcb.24084; Huang JH, 2002, J BIOL CHEM, V277, P10760, DOI 10.1074/jbc.M110219200; Jiang BH, 2009, ADV CANCER RES, V102, P19, DOI 10.1016/S0065-230X(09)02002-8; Kong GY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019518; Kong W, 2008, MOL CELL BIOL, V28, P6773, DOI 10.1128/MCB.00941-08; Kuhnert F, 2008, DEVELOPMENT, V135, P3989, DOI 10.1242/dev.029736; Kumarswamy R, 2012, ARTERIOSCL THROM VAS, V32, P361, DOI 10.1161/ATVBAHA.111.234286; Lan Y, 2007, MOL CELL BIOL, V27, P7683, DOI 10.1128/MCB.00577-07; Lechleider RJ, 2001, DEV BIOL, V240, P157, DOI 10.1006/dbio.2001.0469; Lenato GM, 2006, CURR PHARM DESIGN, V12, P1173, DOI 10.2174/138161206776361291; Li DY, 1999, SCIENCE, V284, P1534, DOI 10.1126/science.284.5419.1534; Li FF, 2011, DEV CELL, V20, P291, DOI 10.1016/j.devcel.2011.01.011; Liu LZ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019139; Ma J, 2007, BLOOD, V109, P987, DOI 10.1182/blood-2006-07-036400; Maurer B, 2010, ARTHRITIS RHEUM-US, V62, P1733, DOI 10.1002/art.27443; McCall MN, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-78; Mott JL, 2010, J CELL BIOCHEM, V110, P1155, DOI 10.1002/jcb.22630; Muramatsu F, 2013, ONCOGENE, V32, P414, DOI 10.1038/onc.2012.68; Nicoli S, 2010, NATURE, V464, P1196, DOI 10.1038/nature08889; Oshima M, 1996, DEV BIOL, V179, P297, DOI 10.1006/dbio.1996.0259; Pardali E, 2010, TRENDS CELL BIOL, V20, P556, DOI 10.1016/j.tcb.2010.06.006; Perry B, 2007, ARCH DERMATOL, V143, P504, DOI 10.1001/archderm.143.4.504; Poliseno L, 2006, BLOOD, V108, P3068, DOI 10.1182/blood-2006-01-012369; Qin W, 2011, J AM SOC NEPHROL, V22, P1462, DOI 10.1681/ASN.2010121308; Roderburg C, 2011, HEPATOLOGY, V53, P209, DOI 10.1002/hep.23922; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Stahlhut C, 2012, DEVELOPMENT, V139, P4356, DOI 10.1242/dev.083774; Sun Q, 2008, NUCLEIC ACIDS RES, V36, P2690, DOI 10.1093/nar/gkn032; Urbich C, 2012, BLOOD, V119, P1607, DOI 10.1182/blood-2011-08-373886; Urness LD, 2000, NAT GENET, V26, P328, DOI 10.1038/81634; van Mil A, 2012, CARDIOVASC RES, V93, P655, DOI 10.1093/cvr/cvs003; Wang F, 2012, MOL BIOL REP, V39, P2713, DOI 10.1007/s11033-011-1026-5; Wang J, 2012, CELL RES, V22, P516, DOI 10.1038/cr.2011.132; Wang SS, 2008, DEV CELL, V15, P261, DOI 10.1016/j.devcel.2008.07.002; Weis SM, 2011, NAT MED, V17, P1359, DOI 10.1038/nm.2537; Winbanks CE, 2011, J BIOL CHEM, V286, P13805, DOI 10.1074/jbc.M110.192625; Wu YH, 2011, BLOOD, V118, P2896, DOI 10.1182/blood-2011-01-330589; Wurdinger T, 2008, CANCER CELL, V14, P382, DOI 10.1016/j.ccr.2008.10.005; Yang X, 1999, DEVELOPMENT, V126, P1571; Yang X, 2011, INT J BIOL SCI, V7, P685, DOI 10.7150/ijbs.7.685; Zhou QB, 2011, P NATL ACAD SCI USA, V108, P8287, DOI 10.1073/pnas.1105254108	62	61	66	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 12	2013	288	15					10418	10426		10.1074/jbc.M112.444463	http://dx.doi.org/10.1074/jbc.M112.444463			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	125TU	23426367	Green Published, hybrid			2022-12-25	WOS:000317565000022
J	Batra, J; Szabo, A; Caulfield, TR; Soares, AS; Sahin-Toth, M; Radisky, ES				Batra, Jyotica; Szabo, Andras; Caulfield, Thomas R.; Soares, Alexei S.; Sahin-Toth, Miklos; Radisky, Evette S.			Long-range Electrostatic Complementarity Governs Substrate Recognition by Human Chymotrypsin C, a Key Regulator of Digestive Enzyme Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN CATIONIC TRYPSINOGEN; PROTEIN INHIBITOR COMPLEXES; CIS-TRANS ISOMERIZATION; EGLIN-C; CHRONIC-PANCREATITIS; MOLECULAR-STRUCTURE; SUBTILISIN CARLSBERG; CRYSTAL-STRUCTURE; SERINE PROTEASES; HEREDITARY PANCREATITIS	Human chymotrypsin C (CTRC) is a pancreatic serine protease that regulates activation and degradation of trypsinogens and procarboxypeptidases by targeting specific cleavage sites within their zymogen precursors. In cleaving these regulatory sites, which are characterized by multiple flanking acidic residues, CTRC shows substrate specificity that is distinct from that of other isoforms of chymotrypsin and elastase. Here, we report the first crystal structure of active CTRC, determined at 1.9-angstrom resolution, revealing the structural basis for binding specificity. The structure shows human CTRC bound to the small protein protease inhibitor eglin c, which binds in a substrate-like manner filling the S-6-S-5' subsites of the substrate binding cleft. Significant binding affinity derives from burial of preferred hydrophobic residues at the P-1, P-4, and P-2' positions of CTRC, although acidic P-2' residues can also be accommodated by formation of an interfacial salt bridge. Acidic residues may also be specifically accommodated in the P-6 position. The most unique structural feature of CTRC is a ring of intense positive electrostatic surface potential surrounding the primarily hydrophobic substrate binding site. Our results indicate that long-range electrostatic attraction toward substrates of concentrated negative charge governs substrate discrimination, which explains CTRC selectivity in regulating active digestive enzyme levels.	[Batra, Jyotica; Caulfield, Thomas R.; Radisky, Evette S.] Mayo Clin, Ctr Canc, Dept Canc Biol, Jacksonville, FL 32224 USA; [Caulfield, Thomas R.] Mayo Clin, Ctr Canc, Dept Neurosci, Jacksonville, FL 32224 USA; [Szabo, Andras; Sahin-Toth, Miklos] Boston Univ, Dept Mol & Cell Biol, Henry M Goldman Sch Dent Med, Boston, MA 02118 USA; [Soares, Alexei S.] Brookhaven Natl Lab, Dept Biol, Upton, NY 11973 USA	Mayo Clinic; Mayo Clinic; Boston University; United States Department of Energy (DOE); Brookhaven National Laboratory	Sahin-Toth, M (corresponding author), 72 East Concord St,Evans 433, Boston, MA 02118 USA.	miklos@bu.edu; radisky.evette@mayo.edu	Radisky, Evette S/C-8526-2012; Soares, Alexei S/F-4800-2014	Radisky, Evette S/0000-0003-3121-109X; Soares, Alexei S/0000-0002-6565-8503; Caulfield, Thomas/0000-0002-1055-3069; Sahin-Toth, Miklos/0000-0003-4513-9922	Offices of Biological and Environmental Research and Basic Energy Sciences of the United States Department of Energy; National Center for Research Resources of the National Institutes of Health; National Institutes of Health [R01 DK082412-S2, R01 DK082412, R01 DK058088, R01 DK095753]; Florida Department of Health Postdoctoral Fellowship [1BD-01]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK095753, R01DK058088, R01DK082412] Funding Source: NIH RePORTER	Offices of Biological and Environmental Research and Basic Energy Sciences of the United States Department of Energy(United States Department of Energy (DOE)); National Center for Research Resources of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Florida Department of Health Postdoctoral Fellowship; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Diffraction data were measured at beamline X29 of the National Synchrotron Light Source, which is supported by the Offices of Biological and Environmental Research and Basic Energy Sciences of the United States Department of Energy, and the National Center for Research Resources of the National Institutes of Health.; This work was supported, in whole or in part, by National Institutes of Health Grants R01 DK082412-S2 (ARRA), R01 DK082412, R01 DK058088, and R01 DK095753 (to M. S.-T.) and Florida Department of Health Postdoctoral Fellowship 1BD-01 (to J. B.).	Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Beer S, 2013, GUT, V62, P1616, DOI 10.1136/gutjnl-2012-303090; Bence M, 2011, FEBS J, V278, P4338, DOI 10.1111/j.1742-4658.2011.08351.x; BIRKTOFT JJ, 1976, BIOCHEMISTRY-US, V15, P4481, DOI 10.1021/bi00665a023; BODE W, 1986, EMBO J, V5, P813, DOI 10.1002/j.1460-2075.1986.tb04286.x; BODE W, 1992, EUR J BIOCHEM, V204, P433, DOI 10.1111/j.1432-1033.1992.tb16654.x; BRANDTS JF, 1975, BIOCHEMISTRY-US, V14, P4953, DOI 10.1021/bi00693a026; Caulfield T, 2012, PROTEINS, V80, P2489, DOI 10.1002/prot.24131; Caulfield T, 2011, J STRUCT BIOL, V176, P185, DOI 10.1016/j.jsb.2011.07.015; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FEHLHAMMER H, 1977, J MOL BIOL, V111, P415, DOI 10.1016/S0022-2836(77)80062-4; FISCHER G, 1994, ANGEW CHEM INT EDIT, V33, P1415, DOI 10.1002/anie.199414151; FRIGERIO F, 1992, J MOL BIOL, V225, P107, DOI 10.1016/0022-2836(92)91029-O; GOMISRUTH FX, 1995, EMBO J, V14, P4387, DOI 10.1002/j.1460-2075.1995.tb00117.x; GRATHWOHL C, 1981, BIOPOLYMERS, V20, P2623, DOI 10.1002/bip.1981.360201209; Grocock CJ, 2010, GUT, V59, P357, DOI 10.1136/gut.2009.186817; Grunberg R, 2004, STRUCTURE, V12, P2125, DOI 10.1016/j.str.2004.09.014; Hedstrom L, 2002, CHEM REV, V102, P4501, DOI 10.1021/cr000033x; HEINZ DW, 1992, BIOCHEMISTRY-US, V31, P8755, DOI 10.1021/bi00152a011; HUANG K, 1994, STRUCTURE, V2, P679, DOI 10.1016/S0969-2126(00)00068-X; HUBBARD SJ, 1991, J MOL BIOL, V220, P507, DOI 10.1016/0022-2836(91)90027-4; Kardos J, 1999, BIOCHEMISTRY-US, V38, P12248, DOI 10.1021/bi990764v; Koch U, 2001, BIOCHEMISTRY-US, V40, P631, DOI 10.1021/bi002160t; Komiyama T, 2000, BIOCHEMISTRY-US, V39, P15156, DOI 10.1021/bi001907c; KOSSIAKOFF AA, 1977, BIOCHEMISTRY-US, V16, P654, DOI 10.1021/bi00623a016; Krowarsch D, 2003, CELL MOL LIFE SCI, V60, P2427, DOI 10.1007/s00018-003-3120-x; Li H, 2005, PROTEINS, V61, P704, DOI 10.1002/prot.20660; Loving K, 2009, J COMPUT AID MOL DES, V23, P541, DOI 10.1007/s10822-009-9268-1; Lu WY, 1999, CHEM BIOL, V6, P419, DOI 10.1016/S1074-5521(99)80060-X; Lu WY, 2000, BIOCHEMISTRY-US, V39, P3575, DOI 10.1021/bi992292q; MACARTHUR MW, 1991, J MOL BIOL, V218, P397, DOI 10.1016/0022-2836(91)90721-H; Masson E, 2008, HUM GENET, V123, P83, DOI 10.1007/s00439-007-0459-3; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; MCPHALEN CA, 1985, P NATL ACAD SCI USA, V82, P7242, DOI 10.1073/pnas.82.21.7242; MCPHALEN CA, 1988, BIOCHEMISTRY-US, V27, P6582, DOI 10.1021/bi00417a058; MCPHALEN CA, 1985, FEBS LETT, V188, P55, DOI 10.1016/0014-5793(85)80873-5; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nemoda Z, 2006, J BIOL CHEM, V281, P11879, DOI 10.1074/jbc.M600124200; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; OTZEN DE, 1995, BIOCHEMISTRY-US, V34, P13051, DOI 10.1021/bi00040a016; Page MJ, 2008, CELL MOL LIFE SCI, V65, P1220, DOI 10.1007/s00018-008-7565-9; Pasternak A, 1999, PROTEIN SCI, V8, P253; PERONA JJ, 1995, PROTEIN SCI, V4, P337; Perrakis A, 2001, ACTA CRYSTALLOGR D, V57, P1445, DOI 10.1107/S0907444901014007; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; POLAK E, 1969, REV FR INFORM RECH O, V3, P35; Radisky ES, 2005, BIOCHEMISTRY-US, V44, P6823, DOI 10.1021/bi047301w; Radisky ES, 2003, BIOCHEMISTRY-US, V42, P6484, DOI 10.1021/bi034275d; Radisky ES, 2002, P NATL ACAD SCI USA, V99, P10316, DOI 10.1073/pnas.112332899; Rajamani D, 2004, P NATL ACAD SCI USA, V101, P11287, DOI 10.1073/pnas.0401942101; RINDERKNECHT H, 1986, DIGEST DIS SCI, V31, P314, DOI 10.1007/BF01318124; Rosendahl J, 2008, NAT GENET, V40, P78, DOI 10.1038/ng.2007.44; Salam NK, 2009, J CHEM INF MODEL, V49, P2356, DOI 10.1021/ci900212v; Salameh MA, 2008, J BIOL CHEM, V283, P4115, DOI 10.1074/jbc.M708268200; SCHECHTER I, 1967, BIOCHEM BIOPH RES CO, V27, P157, DOI 10.1016/S0006-291X(67)80055-X; SCHIMMEL PR, 1968, J MOL BIOL, V34, P105, DOI 10.1016/0022-2836(68)90237-4; Schreiber G, 2009, CHEM REV, V109, P839, DOI 10.1021/cr800373w; SEEMULLER U, 1977, H-S Z PHYSIOL CHEM, V358, P1105, DOI 10.1515/bchm2.1977.358.2.1105; Sondergaard CR, 2011, J CHEM THEORY COMPUT, V7, P2284, DOI 10.1021/ct200133y; Szabo A, 2012, FEBS J, V279, P4283, DOI 10.1111/febs.12018; Szabo A, 2012, J BIOL CHEM, V287, P20701, DOI 10.1074/jbc.M112.360065; Szabo A, 2011, J BIOL CHEM, V286, P22535, DOI 10.1074/jbc.M111.235754; Szmola R, 2007, P NATL ACAD SCI USA, V104, P11227, DOI 10.1073/pnas.0703714104; Szmola R, 2011, J BIOL CHEM, V286, P1819, DOI 10.1074/jbc.M110.187369; Teich N, 2006, HUM MUTAT, V27, P721, DOI 10.1002/humu.20343; Wang HB, 2011, ACTA BIOCH BIOPH SIN, V43, P568, DOI 10.1093/abbs/gmr047; Wedemeyer WJ, 2002, BIOCHEMISTRY-US, V41, P14637, DOI 10.1021/bi020574b; Whitcomb DC, 1996, NAT GENET, V14, P141, DOI 10.1038/ng1096-141; Witt H, 1999, GASTROENTEROLOGY, V117, P7, DOI 10.1016/S0016-5085(99)70543-3; Zhou JY, 2011, J GASTROEN HEPATOL, V26, P1238, DOI 10.1111/j.1440-1746.2011.06791.x	70	26	27	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 5	2013	288	14					9848	9859		10.1074/jbc.M113.457382	http://dx.doi.org/10.1074/jbc.M113.457382			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	119RB	23430245	Green Published, hybrid, Green Submitted			2022-12-25	WOS:000317114000025
J	Eaton, JM; Mullins, GR; Brindley, DN; Harris, TE				Eaton, James M.; Mullins, Garrett R.; Brindley, David N.; Harris, Thurl E.			Phosphorylation of Lipin 1 and Charge on the Phosphatidic Acid Head Group Control Its Phosphatidic Acid Phosphatase Activity and Membrane Association	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM; PLASMA-MEMBRANE; RAT-LIVER; PHOSPHOLIPID-SYNTHESIS; FATTY-ACIDS; PHOSPHOHYDROLASE; YEAST; PROTEINS; LOCALIZATION; METABOLISM	The lipin gene family encodes a class of Mg2+-dependent phosphatidic acid phosphatases involved in the de novo synthesis of phospholipids and triglycerides. Unlike other enzymes in the Kennedy pathway, lipins are not integral membrane proteins, and they need to translocate from the cytosol to intracellular membranes to participate in glycerolipid synthesis. The movement of lipin 1 within the cell is closely associated with its phosphorylation status. Although cellular analyses have demonstrated that highly phosphorylated lipin 1 is enriched in the cytosol and dephosphorylated lipin 1 is found on membranes, the effects of phosphorylation on lipin 1 activity and binding to membranes has not been recapitulated in vitro. Herein we describe a new biochemical assay for lipin 1 using mixtures of phosphatidic acid (PA) and phosphatidylethanolamine that reflects its physiological activity and membrane interaction. This depends on our observation that lipin 1 binding to PA in membranes is highly responsive to the electrostatic charge of PA. The studies presented here demonstrate that phosphorylation regulates the ability of the polybasic domain of lipin 1 to recognize di-anionic PA and identify mTOR as a crucial upstream signaling component regulating lipin 1 phosphorylation. These results demonstrate how phosphorylation of lipin 1 together with pH and membrane phospholipid composition play important roles in the membrane association of lipin 1 and thus the regulation of its enzymatic activity.	[Eaton, James M.; Mullins, Garrett R.; Harris, Thurl E.] Univ Virginia, Dept Pharmacol, Charlottesville, VA 22908 USA; [Brindley, David N.] Univ Alberta, Dept Biochem, Signal Transduct Res Grp, Edmonton, AB T6G 2S2, Canada	University of Virginia; University of Alberta	Harris, TE (corresponding author), Univ Virginia Hlth Syst, Dept Pharmacol, POB 800735,1300 Jefferson Pk Ave,Jordan Hall Rm 5, Charlottesville, VA 22908 USA.	teh3c@virginia.edu			American Diabetes Association [7-11-JF-21]; Canadian Institutes of Health Research; Heart and Stroke Foundation of Alberta; Northwest Territories; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007055] Funding Source: NIH RePORTER	American Diabetes Association(American Diabetes Association); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of Alberta; Northwest Territories; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by American Diabetes Association Junior Faculty Grant 7-11-JF-21 (to T. E. H.) and the Canadian Institutes of Health Research and the Heart and Stroke Foundation of Alberta and the Northwest Territories (to D. N. B.).	BOWLEY M, 1977, BIOCHEM J, V165, P447, DOI 10.1042/bj1650447; CARMAN GM, 1995, J BIOL CHEM, V270, P18711, DOI 10.1074/jbc.270.32.18711; Choi HS, 2012, J BIOL CHEM, V287, P11290, DOI 10.1074/jbc.M112.346023; Choi HS, 2011, J BIOL CHEM, V286, P1486, DOI 10.1074/jbc.M110.155598; Civelek VN, 1996, P NATL ACAD SCI USA, V93, P10139, DOI 10.1073/pnas.93.19.10139; Coleman RA, 2000, ANNU REV NUTR, V20, P77, DOI 10.1146/annurev.nutr.20.1.77; Donkor J, 2007, J BIOL CHEM, V282, P3450, DOI 10.1074/jbc.M610745200; Eastmond PJ, 2010, PLANT CELL, V22, P2796, DOI 10.1105/tpc.109.071423; Fu SN, 2011, NATURE, V473, P528, DOI 10.1038/nature09968; Grimsey N, 2008, J BIOL CHEM, V283, P29166, DOI 10.1074/jbc.M804278200; Han GS, 2010, J BIOL CHEM, V285, P14628, DOI 10.1074/jbc.M110.117747; Han Gil-Soo, 2004, Methods Mol Biol, V284, P209; Han GS, 2006, J BIOL CHEM, V281, P9210, DOI 10.1074/jbc.M600425200; Han S, 2012, J BIOL CHEM, V287, P3123, DOI 10.1074/jbc.M111.324350; Harris TE, 2007, J BIOL CHEM, V282, P277, DOI 10.1074/jbc.M609537200; Harris TE, 2011, TRENDS ENDOCRIN MET, V22, P226, DOI 10.1016/j.tem.2011.02.006; Hofer CT, 2010, METHODS MOL BIOL, V606, P69, DOI 10.1007/978-1-60761-447-0_6; HOPEWELL R, 1985, BIOCHEM J, V232, P485, DOI 10.1042/bj2320485; Huang P, 2005, MOL BIOL CELL, V16, P2614, DOI 10.1091/mbc.E04-12-1124; JAMAL Z, 1991, J BIOL CHEM, V266, P2988; Karanasios E, 2010, P NATL ACAD SCI USA, V107, P17539, DOI 10.1073/pnas.1007974107; Kim YJ, 2007, P NATL ACAD SCI USA, V104, P6596, DOI 10.1073/pnas.0702099104; Kooijman EE, 2007, J BIOL CHEM, V282, P11356, DOI 10.1074/jbc.M609737200; Kooijman EE, 2009, BBA-MOL CELL BIOL L, V1791, P881, DOI 10.1016/j.bbalip.2009.04.001; Kooijman EE, 2005, BIOCHEMISTRY-US, V44, P17007, DOI 10.1021/bi0518794; Liu GH, 2010, BIOCHEM J, V432, P65, DOI 10.1042/BJ20100584; Liu GH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007031; MACDONALD RC, 1991, BIOCHIM BIOPHYS ACTA, V1061, P297, DOI 10.1016/0005-2736(91)90295-J; MARTIN A, 1986, BIOCHIM BIOPHYS ACTA, V876, P581, DOI 10.1016/0005-2760(86)90047-0; MARTINSANZ P, 1984, FEBS LETT, V175, P284, DOI 10.1016/0014-5793(84)80752-8; MOLLER F, 1981, CAN J BIOCHEM CELL B, V59, P9, DOI 10.1139/o81-002; O'Hara L, 2006, J BIOL CHEM, V281, P34537, DOI 10.1074/jbc.M606654200; Peterfy M, 2001, NAT GENET, V27, P121, DOI 10.1038/83685; Peterfy M, 2010, J BIOL CHEM, V285, P3857, DOI 10.1074/jbc.M109.072488; Peterson TR, 2011, CELL, V146, P408, DOI 10.1016/j.cell.2011.06.034; Ren HM, 2010, MOL BIOL CELL, V21, P3171, DOI 10.1091/mbc.E10-01-0073; Santos-Rosa H, 2005, EMBO J, V24, P1931, DOI 10.1038/sj.emboj.7600672; Scott PH, 1998, J BIOL CHEM, V273, P34496, DOI 10.1074/jbc.273.51.34496; Shin JJH, 2011, BMC BIOL, V9, DOI 10.1186/1741-7007-9-85; Stace CL, 2006, BBA-MOL CELL BIOL L, V1761, P913, DOI 10.1016/j.bbalip.2006.03.006; Su WM, 2012, J BIOL CHEM, V287, P33364, DOI 10.1074/jbc.M112.402339; TAYLOR SJ, 1986, BIOCHEM J, V239, P275, DOI 10.1042/bj2390275; Vicogne J, 2006, P NATL ACAD SCI USA, V103, P14761, DOI 10.1073/pnas.0606881103; Wu R, 2011, BIOCHEMISTRY-US, V50, P3045, DOI 10.1021/bi200336b; Xu Z, 2012, J LIPID RES, V53, P522, DOI 10.1194/jlr.M022798	45	63	66	0	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 5	2013	288	14					9933	9945		10.1074/jbc.M112.441493	http://dx.doi.org/10.1074/jbc.M112.441493			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	119RB	23426360	Green Published, hybrid			2022-12-25	WOS:000317114000033
J	Okamoto, Y; Bernstein, JD; Shikano, S				Okamoto, Yukari; Bernstein, Joshua David; Shikano, Sojin			Role of C-terminal Membrane-proximal Basic Residues in Cell Surface Trafficking of HIV Coreceptor GPR15 Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM; COUPLED RECEPTORS; SELECTIVE EXPORT; ER EXPORT; COPII; PALMITOYLATION; MOTIF; RETENTION; SIGNALS; TAIL	Cell surface density of G protein-coupled receptors (GPCRs) is controlled by dynamic molecular interactions that often involve recognition of the distinct sequence signals on the cargo receptors. We reported previously that the RXR-type dibasic motif in the distal C-terminal tail of an HIV coreceptor GPR15 negatively regulates the cell surface expression by mediating the coatomer protein I complex-dependent retrograde transport to the endoplasmic reticulum (ER). Here we demonstrate that another pair of basic residues (Arg(310)-Arg(311)) in the membrane-proximal region of the C-terminal tail plays a pivotal role in mediating the anterograde trafficking of GPR15. The Ala mutation of the C-terminal membrane-proximal basic residues (MPBRs) (R310/311A) abolished the O-glycosylation and cell surface expression of GPR15. The subcellular fractionation and immunocytochemistry assays indicated that the R310/311A mutant was more localized in the ER but much less in the trans-Golgi when compared with the wild-type GPR15, suggesting the positive role of Arg(310)-Arg(311) in the ER-to-Golgi transport of GPR15. Sequence analysis on human GPCRs showed that the basic residues are frequent in the membrane-proximal region of the C-terminal tail. Similar to GPR15, mutation of the C-terminal MPBRs resulted in a marked reduction of the cell surface expression in multiple different GPCRs. Our results suggest that the C-terminal MPBRs are critically involved in mediating the anterograde trafficking of a broad range of membrane proteins, including GPCRs.	[Okamoto, Yukari; Bernstein, Joshua David; Shikano, Sojin] Univ Illinois, Dept Biochem & Mol Genet, Chicago, IL 60607 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Shikano, S (corresponding author), 900 S Ashland Ave,MBRB2006, Chicago, IL 60607 USA.	sshikano@uic.edu			National Institutes of Health Grant [1R01GM099974-01]; LUNGevity Foundation/American Cancer Society Lung Cancer Research Grant [2009-07001-00-00]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM099974] Funding Source: NIH RePORTER	National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); LUNGevity Foundation/American Cancer Society Lung Cancer Research Grant; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported, in whole or in part, by National Institutes of Health Grant 1R01GM099974-01 (to S. S.). this work was also supported by LUNGevity Foundation/American Cancer Society Lung Cancer Research Grant 2009-07001-00-00 (to S. S.).	Almen MS, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-50; Aridor M, 1998, J CELL BIOL, V141, P61, DOI 10.1083/jcb.141.1.61; Barlowe C, 2003, TRENDS CELL BIOL, V13, P295, DOI 10.1016/S0962-8924(03)00082-5; Barlowe C, 1998, BBA-MOL CELL RES, V1404, P67, DOI 10.1016/S0167-4889(98)00047-0; Chini B, 2009, J MOL ENDOCRINOL, V42, P371, DOI 10.1677/JME-08-0114; COSSON P, 1994, SCIENCE, V263, P1629, DOI 10.1126/science.8128252; Dong CM, 2012, TRAFFIC, V13, P857, DOI 10.1111/j.1600-0854.2012.01351.x; Dowhan W, 2009, ANNU REV BIOCHEM, V78, P515, DOI 10.1146/annurev.biochem.77.060806.091251; Drake MT, 2006, CIRC RES, V99, P570, DOI 10.1161/01.RES.0000242563.47507.ce; Dunham JH, 2009, TRENDS BIOTECHNOL, V27, P541, DOI 10.1016/j.tibtech.2009.06.005; Fukushima Y, 2001, BBA-MOL CELL RES, V1539, P181, DOI 10.1016/S0167-4889(01)00104-5; Gassmann M, 2005, MOL PHARMACOL, V68, P137, DOI 10.1124/mol.104.010256; Giraudo CG, 2003, MOL BIOL CELL, V14, P3753, DOI 10.1091/mbc.E03-02-0101; Glick BS, 2001, CURR BIOL, V11, pR361; Gurevich VV, 2008, TRENDS NEUROSCI, V31, P74, DOI 10.1016/j.tins.2007.11.007; Hanyaloglu AC, 2008, ANNU REV PHARMACOL, V48, P537, DOI 10.1146/annurev.pharmtox.48.113006.094830; Higy M, 2004, BIOCHEMISTRY-US, V43, P12716, DOI 10.1021/bi048368m; JACKSON MR, 1990, EMBO J, V9, P3153, DOI 10.1002/j.1460-2075.1990.tb07513.x; KARNIK SS, 1993, P NATL ACAD SCI USA, V90, P40, DOI 10.1073/pnas.90.1.40; Khalil H, 2005, J CELL SCI, V118, P4679, DOI 10.1242/jcs.02592; Ma DH, 2011, CELL, V145, P1102, DOI 10.1016/j.cell.2011.06.007; Michelsen K, 2007, J CELL BIOL, V179, P209, DOI 10.1083/jcb.200704142; Nilsson J, 2005, PROTEINS, V60, P606, DOI 10.1002/prot.20583; Okamoto Y, 2011, J BIOL CHEM, V286, P7171, DOI 10.1074/jbc.M110.199695; Otte S, 2002, EMBO J, V21, P6095, DOI 10.1093/emboj/cdf598; Palmer KJ, 2004, TRENDS CELL BIOL, V14, P57, DOI 10.1016/j.tcb.2003.12.001; Percherancier Y, 2001, J BIOL CHEM, V276, P31936, DOI 10.1074/jbc.M104013200; Sato Ken, 2010, Seikagaku, V82, P1011; Shikano S, 2003, P NATL ACAD SCI USA, V100, P5783, DOI 10.1073/pnas.1031748100; Tetsuka M, 2004, ENDOCRINOLOGY, V145, P3712, DOI 10.1210/en.2003-1638; Venkatesan S, 2001, J BIOL CHEM, V276, P40133, DOI 10.1074/jbc.M105722200; Wendeler MW, 2007, EMBO REP, V8, P258, DOI 10.1038/sj.embor.7400893; Wolfe BL, 2007, TRAFFIC, V8, P462, DOI 10.1111/j.1600-0854.2007.00551.x; Yuan HB, 2003, CURR BIOL, V13, P638, DOI 10.1016/S0960-9822(03)00208-2; Zanetti G, 2012, NAT CELL BIOL, V14, P20, DOI 10.1038/ncb2390; Zerangue N, 1999, NEURON, V22, P537, DOI 10.1016/S0896-6273(00)80708-4; ZHU HY, 1995, MOL ENDOCRINOL, V9, P141, DOI 10.1210/me.9.2.141	37	7	7	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 29	2013	288	13					9189	9199		10.1074/jbc.M112.445817	http://dx.doi.org/10.1074/jbc.M112.445817			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	116DG	23430259	hybrid, Green Published			2022-12-25	WOS:000316862200038
J	Persson, M; Gullberg, M; Tolf, C; Lindberg, AM; Mansson, A; Kocer, A				Persson, Malin; Gullberg, Maria; Tolf, Conny; Lindberg, A. Michael; Mansson, Alf; Kocer, Armagan			Transportation of Nanoscale Cargoes by Myosin Propelled Actin Filaments	PLOS ONE			English	Article							IN-VITRO; F-ACTIN; MOTOR PROTEINS; ACTOMYOSIN FUNCTION; MOLECULAR SHUTTLES; SLIDING MOVEMENT; DNA-MOLECULES; DRIVEN; GELSOLIN; DYNAMICS	Myosin II propelled actin filaments move ten times faster than kinesin driven microtubules and are thus attractive candidates as cargo-transporting shuttles in motor driven lab-on-a-chip devices. In addition, actomyosin-based transportation of nanoparticles is useful in various fundamental studies. However, it is poorly understood how actomyosin function is affected by different number of nanoscale cargoes, by cargo size, and by the mode of cargo-attachment to the actin filament. This is studied here using biotin/fluorophores, streptavidin, streptavidin-coated quantum dots, and liposomes as model cargoes attached to monomers along the actin filaments ("side-attached") or to the trailing filament end via the plus end capping protein CapZ. Long-distance transportation (> 100 mu m) could be seen for all cargoes independently of attachment mode but the fraction of motile filaments decreased with increasing number of side-attached cargoes, a reduction that occurred within a range of 10-50 streptavidin molecules, 1-10 quantum dots or with just 1 liposome. However, as observed by monitoring these motile filaments with the attached cargo, the velocity was little affected. This also applied for end-attached cargoes where the attachment was mediated by CapZ. The results with side-attached cargoes argue against certain models for chemomechanical energy transduction in actomyosin and give important insights of relevance for effective exploitation of actomyosin-based cargo-transportation in molecular diagnostics and other nanotechnological applications. The attachment of quantum dots via CapZ, without appreciable modulation of actomyosin function, is useful in fundamental studies as exemplified here by tracking with nanometer accuracy.	[Persson, Malin; Gullberg, Maria; Tolf, Conny; Lindberg, A. Michael; Mansson, Alf] Linnaeus Univ, Sch Nat Sci, Kalmar, Sweden; [Kocer, Armagan] Univ Groningen, Dept Biochem, Groningen, Netherlands	Linnaeus University; University of Groningen	Mansson, A (corresponding author), Linnaeus Univ, Sch Nat Sci, Kalmar, Sweden.	alf.mansson@lnu.se; a.kocer@rug.nl	Kocer, A/M-6371-2013; Mansson, Alf/ABC-6271-2021; Persson, Malin/K-6133-2017	Mansson, Alf/0000-0002-5889-7792; Persson, Malin/0000-0003-2819-3046; kocer, Armagan/0000-0001-7343-3139	Carl Trygger Foundation; European Union [228971]; Swedish Research Council [621-2007-6137, 621-210-5146]; Faculty of Natural Sciences and Engineering at Linnaeus University; Netherlands Organisation for Scientific Research [700.57.427]	Carl Trygger Foundation; European Union(European Commission); Swedish Research Council(Swedish Research CouncilEuropean Commission); Faculty of Natural Sciences and Engineering at Linnaeus University; Netherlands Organisation for Scientific Research(Netherlands Organization for Scientific Research (NWO))	This work was funded by the Carl Trygger Foundation, the European Union Seventh Framework Programme (FP7/2007-2011) under grant agreement number 228971 (MONAD), the Swedish Research Council (Project #621-2007-6137 and #621-210-5146), the Faculty of Natural Sciences and Engineering at Linnaeus University and the Netherlands Organisation for Scientific Research (NWO-VIDI Grant 700.57.427 to AK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal A, 2010, PROG POLYM SCI, V35, P252, DOI 10.1016/j.progpolymsci.2009.10.007; Albet-Torres N, 2007, LANGMUIR, V23, P11147, DOI 10.1021/la7008682; Albet-Torres N, 2011, LANGMUIR, V27, P7108, DOI 10.1021/la201081w; Albet-Torres N, 2010, SOFT MATTER, V6, P3211, DOI 10.1039/c0sm00019a; Bachand GD, 2004, NANO LETT, V4, P817, DOI 10.1021/nl049811h; Bachand GD, 2006, SMALL, V2, P381, DOI 10.1002/smll.200500262; Bakewell DJG, 2007, AUST J CHEM, V60, P314, DOI 10.1071/CH06456; Balaz M, 2005, ANAL BIOCHEM, V338, P224, DOI 10.1016/j.ab.2004.12.012; Balaz M, 2007, BIOCHEMISTRY-US, V46, P7233, DOI 10.1021/bi700211u; Banos FGD, 1996, BIOPHYS J, V71, P576, DOI 10.1016/S0006-3495(96)79292-5; Beausang JF, 2008, BIOPHYS J, V95, P5820, DOI 10.1529/biophysj.108.140319; Brunner C, 2007, LAB CHIP, V7, P1263, DOI 10.1039/b707301a; CASELLA JF, 1991, METHOD ENZYMOL, V196, P140; Chase PB, 2000, AM J PHYSIOL-CELL PH, V278, pC1088, DOI 10.1152/ajpcell.2000.278.6.C1088; Chen Y, 2011, NANOTECHNOLOGY, V22; Clemmens J, 2004, LAB CHIP, V4, P83, DOI 10.1039/b317059d; DE LA CRUZ EM, 1994, BIOCHEMISTRY-US, V33, P14387, DOI 10.1021/bi00252a003; Diez S, 2003, NANO LETT, V3, P1251, DOI 10.1021/nl034504h; Dinu CZ, 2006, SMALL, V2, P1090, DOI 10.1002/smll.200600112; Esaki S, 2007, BIOSYSTEMS, V88, P293, DOI 10.1016/j.biosystems.2006.03.013; FINER JT, 1994, NATURE, V368, P113, DOI 10.1038/368113a0; Fischer T, 2009, NAT NANOTECHNOL, V4, P162, DOI [10.1038/nnano.2008.393, 10.1038/NNANO.2008.393]; FRASER IDC, 1995, J BIOL CHEM, V270, P7836, DOI 10.1074/jbc.270.14.7836; Goel A, 2008, NAT NANOTECHNOL, V3, P465, DOI 10.1038/nnano.2008.190; Hess H, 2001, NANO LETT, V1, P235, DOI 10.1021/nl015521e; Hess H, 2005, NANO LETT, V5, P629, DOI 10.1021/nl0478427; Hild G, 2010, CYTOSKELETON, V67, P609, DOI 10.1002/cm.20473; Hiratsuka Y, 2001, BIOPHYS J, V81, P1555, DOI 10.1016/S0006-3495(01)75809-2; Hiyama S, 2010, LAB CHIP, V10, P2741, DOI 10.1039/c004615a; Holohan S.-J. P., 2005, IEE Proceedings Nanobiotechnology, V152, P113, DOI 10.1049/ip-nbt:20045003; HOMSHER E, 1992, AM J PHYSIOL, V262, pC714, DOI 10.1152/ajpcell.1992.262.3.C714; Howard J., 2001, MECH MOTOR PROTEINS; Huang YM, 2007, BIOMED MICRODEVICES, V9, P175, DOI 10.1007/s10544-006-9019-1; Hutchins BM, 2007, SMALL, V3, P126, DOI 10.1002/smll.200600410; Ishijima A, 1998, CELL, V92, P161, DOI 10.1016/S0092-8674(00)80911-3; Ishikawa R, 2003, J NEUROCHEM, V87, P676, DOI 10.1046/j.1471-4159.2003.02058.x; Iwabuchi S, 2012, BIOCHEM BIOPH RES CO, V422, P164, DOI 10.1016/j.bbrc.2012.04.130; Jia LL, 2004, BIOMED MICRODEVICES, V6, P67, DOI 10.1023/B:BMMD.0000013368.89455.8d; Kaur H, 2010, J BIOMED NANOTECHNOL, V6, P279, DOI 10.1166/jbn.2010.1124; Kaya M, 2010, SCIENCE, V329, P686, DOI 10.1126/science.1191484; Kim T, 2009, LAB CHIP, V9, P1282, DOI 10.1039/b900753a; Kitamura K, 1999, NATURE, V397, P129, DOI 10.1038/16403; Klinth J, 2003, J MUSCLE RES CELL M, V24, P15, DOI 10.1023/A:1024894130989; Kocer A, 2007, NAT PROTOC, V2, P1426, DOI 10.1038/nprot.2007.196; Korten T, 2008, LAB CHIP, V8, P1441, DOI 10.1039/b803585g; Korten T, 2010, CURR OPIN BIOTECH, V21, P477, DOI 10.1016/j.copbio.2010.05.001; KRON SJ, 1991, METHOD ENZYMOL, V196, P399; Kumar S, 2011, 2 INT C BIOS TECHN A; Kumar S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046298; LORENZ M, 1993, J MOL BIOL, V234, P826, DOI 10.1006/jmbi.1993.1628; Mansson A, 2005, IEEE T ADV PACKAGING, V28, P547, DOI 10.1109/TADVP.2005.858309; Mansson A, 2004, BIOCHEM BIOPH RES CO, V314, P529, DOI 10.1016/j.bbrc.2003.12.133; Mansson A, 2003, ANAL BIOCHEM, V314, P281, DOI 10.1016/S0003-2697(02)00610-3; Mansson A, 2008, FRONT BIOSCI-LANDMRK, V13, P5732; Mansson A, 2012, J MUSCLE RES CELL M, V33, P219, DOI 10.1007/s10974-012-9298-5; MARGOSSIAN SS, 1982, METHOD ENZYMOL, V85, P55; MCLAUGHLIN PJ, 1993, NATURE, V364, P685, DOI 10.1038/364685a0; Nakayama H, 1998, BIOCHEM BIOPH RES CO, V246, P261, DOI 10.1006/bbrc.1998.8594; ORLOVA A, 1995, J MOL BIOL, V245, P598, DOI 10.1006/jmbi.1994.0049; PARDEE JD, 1982, METHOD CELL BIOL, V24, P271; PATERNOSTRE MT, 1988, BIOCHEMISTRY-US, V27, P2668, DOI 10.1021/bi00408a006; Patolsky F, 2004, NAT MATER, V3, P692, DOI 10.1038/nmat1205; Persson M, 2010, LANGMUIR, V26, P9927, DOI 10.1021/la100395a; POPE B, 1991, FEBS LETT, V280, P70, DOI 10.1016/0014-5793(91)80206-I; Prochniewicz E, 1996, J MOL BIOL, V260, P756, DOI 10.1006/jmbi.1996.0435; Ramachandran S, 2006, SMALL, V2, P330, DOI 10.1002/smll.200500265; Rios L, 2009, LAB CHIP, V9, P1005, DOI 10.1039/b816444d; Sase I, 1997, P NATL ACAD SCI USA, V94, P5646, DOI 10.1073/pnas.94.11.5646; Schmidt C, 2012, NANO LETT, V12, P3466, DOI 10.1021/nl300936j; Sheehan PE, 2005, NANO LETT, V5, P803, DOI 10.1021/nl050298x; Soeno Y, 1998, J MUSCLE RES CELL M, V19, P639, DOI 10.1023/A:1005329114263; Soto CM, 2008, ANAL CHEM, V80, P5433, DOI 10.1021/ac800541x; Sundberg M, 2003, ANAL BIOCHEM, V323, P127, DOI 10.1016/j.ab.2003.07.022; Sundberg M, 2006, LANGMUIR, V22, P7302, DOI 10.1021/la060365i; Sundberg M, 2006, LANGMUIR, V22, P7286, DOI 10.1021/la060854i; Suzuki N, 1996, BIOPHYS J, V70, P401, DOI 10.1016/S0006-3495(96)79583-8; Taira S, 2008, BIOTECHNOL BIOENG, V99, P734, DOI 10.1002/bit.21618; Taira S, 2006, BIOTECHNOL BIOENG, V95, P533, DOI 10.1002/bit.21055; Takatsuki H, 2011, NANOTECHNOLOGY, V22, DOI 10.1088/0957-4484/22/24/245101; Takatsuki H, 2010, SMALL, V6, P452, DOI 10.1002/smll.200901369; Thompson RE, 2002, BIOPHYS J, V82, P2775, DOI 10.1016/S0006-3495(02)75618-X; UYEDA TQP, 1990, J MOL BIOL, V214, P699, DOI 10.1016/0022-2836(90)90287-V; Vale RD, 2003, CELL, V112, P467, DOI 10.1016/S0092-8674(03)00111-9; van den Heuvel MGL, 2007, SCIENCE, V317, P333, DOI 10.1126/science.1139570; Vikhorev PG, 2008, LANGMUIR, V24, P13509, DOI 10.1021/la8016112; Vikhoreva NN, 2008, EUR MUSCL C OXF SEPT; Wells AL, 1999, NATURE, V401, P505, DOI 10.1038/46835; Xu JY, 1999, CELL MOTIL CYTOSKEL, V42, P73, DOI 10.1002/(SICI)1097-0169(1999)42:1<73::AID-CM7>3.0.CO;2-Z; Yildiz A, 2003, SCIENCE, V300, P2061, DOI 10.1126/science.1084398; YU FX, 1990, SCIENCE, V250, P1413, DOI 10.1126/science.2255912; YU FX, 1991, J BIOL CHEM, V266, P19269	91	24	24	0	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2013	8	2							e55931	10.1371/journal.pone.0055931	http://dx.doi.org/10.1371/journal.pone.0055931			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IT	23437074	gold, Green Published			2022-12-25	WOS:000315186000012
J	Zhu, T; Wang, DX; Zhang, W; Liao, XQ; Guan, X; Bo, H; Sun, JY; Huang, NW; He, J; Zhang, YK; Tong, J; Li, CY				Zhu, Tao; Wang, Dao-xin; Zhang, Wei; Liao, Xiu-qing; Guan, Xian; Bo, Hong; Sun, Jia-yang; Huang, Ni-wen; He, Jing; Zhang, Yun-kun; Tong, Jing; Li, Chang-yi			Andrographolide Protects against LPS-Induced Acute Lung Injury by Inactivation of NF-kappa B	PLOS ONE			English	Article							RESPIRATORY-DISTRESS-SYNDROME; PI-3K/AKT-NF-KAPPA-B SIGNALING PATHWAY; EPITHELIAL SODIUM-CHANNEL; ALVEOLAR FLUID CLEARANCE; INDUCED MITOGENIC FACTOR; IN-VITRO; EXPRESSION; PANICULATA; INHIBITION; ACTIVATION	Background: Nuclear factor-kappa B (NF-kappa B) is a central transcriptional factor and a pleiotropic regulator of many genes involved in acute lung injury. Andrographolide is found in the plant of Andrographis paniculata and widely used in Traditional Chinese Medicine, exhibiting potently anti-inflammatory property by inhibiting NF-kappa B activity. The purpose of our investigation was designed to reveal the effect of andrographolide on various aspects of LPS induced inflammation in vivo and in vitro. Methods and Results: In vivo, BALB/C mice were subjected to LPS injection with or without andrographolide treatments to induce ALI model. In vitro, MLE-12 cells were stimulated with LPS in the presence and absence of andrographolide. In vivo, pulmonary inflammation, pulmonary edema, ultrastructure changes of type II alveolar epithelial cells, MPO activity, total cells, neutrophils, macrophages, TNF-alpha, IL-6 and IL-1 beta in BALF, along with the expression of VCAM-1 and VEGF were dose-dependently attenuated by andrographolide. Meanwhile, in vitro, the expression of VCAM-1 and VEGF was also reduced by andrographolide. Moreover, our data showed that andrographolide significantly inhibited the ratios of phospho-IKK beta/total IKK beta, phospho-I kappa B alpha/total I kappa B alpha and phospho-NF-kappa B p65/total NF-kappa B p65, and NF-kappa B p65 DNA binding activities, both in vivo and in vitro. Conclusions: These results indicate that andrographolide dose-dependently suppressed the severity of LPS-induced ALI, more likely by virtue of andrographolide-mediated NF-kappa B inhibition at the level of IKK beta activation. These results suggest andrographolide may be considered as an effective and safe drug for the potential treatment of ALI.	[Zhu, Tao; Wang, Dao-xin; Guan, Xian; He, Jing; Zhang, Yun-kun; Tong, Jing; Li, Chang-yi] Chongqing Med Univ, Affiliated Hosp 2, Chongqing, Peoples R China; [Zhang, Wei] Chengdu Med Coll, Affiliated Hosp 1, Chengdu, Peoples R China; [Liao, Xiu-qing] Chongqing Fuling Cent Hosp, Chongqing, Peoples R China; [Bo, Hong] Sichuan Univ, W China Hosp, Chengdu 610064, Peoples R China; [Sun, Jia-yang; Huang, Ni-wen] Guiyang Med Coll, Affiliated Hosp, Guiyang, Peoples R China	Chongqing Medical University; Chengdu Medical College; Sichuan University; Guizhou Medical University	Wang, DX (corresponding author), Chongqing Med Univ, Affiliated Hosp 2, Chongqing, Peoples R China.	wangdaoxin2011@sina.com	Li, Changyi/GVS-6654-2022		National Natural Science Foundation of China [30971303]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Natural Science Foundation of China (Grant No. 30971303). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Ghefreh AA, 2009, INT IMMUNOPHARMACOL, V9, P313, DOI 10.1016/j.intimp.2008.12.002; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Amroyan E, 1999, PHYTOMEDICINE, V6, P27, DOI 10.1016/S0944-7113(99)80031-2; Bao Z, 2009, AM J RESP CRIT CARE, V179, P657, DOI 10.1164/rccm.200809-1516OC; Batkhuu J, 2002, BIOL PHARM BULL, V25, P1169, DOI 10.1248/bpb.25.1169; Burgos RA, 2009, CLIN RHEUMATOL, V28, P931, DOI 10.1007/s10067-009-1180-5; Christofidou-Solomidou M, 2002, AM J PATHOL, V160, P1155, DOI 10.1016/S0002-9440(10)64935-8; Deng J, 2012, RESP PHYSIOL NEUROBI, V181, P53, DOI 10.1016/j.resp.2011.11.009; Deng W, 2012, RESP RES, V13, DOI 10.1186/1465-9921-13-29; Deng W, 2011, CHINESE MED J-PEKING, V124, P1551, DOI 10.3760/cma.j.issn.0366-6999.2011.10.021; Everhart MB, 2006, J IMMUNOL, V176, P4995, DOI 10.4049/jimmunol.176.8.4995; Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225; Hidalgo MA, 2005, BRIT J PHARMACOL, V144, P680, DOI 10.1038/sj.bjp.0706105; Ito K, 2005, INJURY, V36, P387, DOI 10.1016/j.injury.2004.06.018; KAPIL A, 1993, BIOCHEM PHARMACOL, V46, P182, DOI 10.1016/0006-2952(93)90364-3; Lee L, 2012, J SURG RES, V174, P24, DOI 10.1016/j.jss.2011.06.022; Li QT, 2002, NAT REV IMMUNOL, V2, P725, DOI 10.1038/nri910; Liu SF, 2006, AM J PHYSIOL-LUNG C, V290, pL622, DOI 10.1152/ajplung.00477.2005; Liu S, 2008, EUR J PHARMACOL, V584, P159, DOI 10.1016/j.ejphar.2008.02.009; Medford ARL, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-27; MEDURI GU, 1995, CHEST, V108, P1303, DOI 10.1378/chest.108.5.1303; Moine P, 2000, SHOCK, V13, P85, DOI 10.1097/00024382-200013020-00001; Parsey MV, 1998, J IMMUNOL, V160, P1007; PURI A, 1993, J NAT PROD, V56, P995, DOI 10.1021/np50097a002; Shen YC, 2000, PLANTA MED, V66, P314, DOI 10.1055/s-2000-8537; Shen YC, 2002, BRIT J PHARMACOL, V135, P399, DOI 10.1038/sj.bjp.0704493; SHU HB, 1993, MOL CELL BIOL, V13, P6283, DOI 10.1128/MCB.13.10.6283; Tong QS, 2006, AM J RESP CELL MOL, V35, P444, DOI 10.1165/rcmb.2005-0424OC; Tong QS, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-37; Ware LB, 2000, NEW ENGL J MED, V342, P1334, DOI 10.1056/NEJM200005043421806; Ware LB, 2006, SEMIN RESP CRIT CARE, V27, P337, DOI 10.1055/s-2006-948288; WHITLEY MZ, 1994, MOL CELL BIOL, V14, P6464, DOI 10.1128/MCB.14.10.6464; Xia YF, 2004, J IMMUNOL, V173, P4207, DOI 10.4049/jimmunol.173.6.4207; Xu T, 2009, EUR RESPIR J, V33, P852, DOI 10.1183/09031936.00130507; Zhang X, 2005, INJURY, V36, P387; Zhu T, 2012, INJURY, V43, P1277, DOI 10.1016/j.injury.2012.04.004	36	196	215	2	79	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2013	8	2							e56407	10.1371/journal.pone.0056407	http://dx.doi.org/10.1371/journal.pone.0056407			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IT	23437127	gold, Green Published, Green Submitted			2022-12-25	WOS:000315186000026
J	Gale, HB; Rodriguez, MD; Hoffman, HJ; Benator, DA; Gordin, FM; Labriola, AM; Kan, VL				Gale, Howard B.; Rodriguez, Manuel D.; Hoffman, Heather J.; Benator, Debra A.; Gordin, Fred M.; Labriola, Ann M.; Kan, Virginia L.			Progress Realized: Trends in HIV-1 Viral Load and CD4 Cell Count in a Tertiary-Care Center from 1999 through 2011	PLOS ONE			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; HEALTH-CARE; HEPATITIS-C; ALCOHOL-USE; VIRUS; VETERANS; RNA; COMORBIDITIES; PREDICTORS; DISORDERS	Background: HIV-1 RNA and CD4 cell counts are important parameters for HIV care. The objective of this study was to assess the overall trends in HIV-1 viral load and CD4 cell counts within our clinic. Methods: Patients with at least one of each test performed by the Infectious Diseases Laboratory from 1999 through 2011 were included in this analysis. By adapting a novel statistical model, log(10) HIV-1 RNA means were estimated by month, and log(10)-transformed HIV-1 RNA means were estimated by calendar year. Geometric means were calculated for CD4 cell counts by month and calendar year. Log(10) HIV-1 RNA and CD4 cell count monthly means were also examined with polynomial regression. Results: There were 1,814 individuals with approximately 25,000 paired tests over the 13-year observation period. Based on each patient's final value of the year, the percentage of patients with viral loads below the lower limit of quantitation rose from 29% in 1999 to 72% in 2011, while the percentage with CD4 counts <200 cells/mu L fell from 31% to 11%. On average annually, the mean HIV-1 RNA decreased by 86 copies/mL and the mean CD4 counts increased by 16 cells/mu L. For the monthly means, the correlations (R-2) from second-order polynomial regressions were 0.944 for log(10) HIV-1 RNA and 0.840 for CD4 cell counts. Conclusions: Marked improvements in HIV-1 RNA suppression and CD4 cell counts were achieved in a large inner-city population from 1999 through 2011. This success demonstrates that sustained viral control with improved immunologic status can be a realistic goal for most individuals in clinical care.	[Gale, Howard B.; Rodriguez, Manuel D.; Benator, Debra A.; Gordin, Fred M.; Labriola, Ann M.; Kan, Virginia L.] Vet Affairs Med Ctr, Med Serv, Infect Dis Sect, Washington, DC 20422 USA; [Rodriguez, Manuel D.; Benator, Debra A.; Gordin, Fred M.; Labriola, Ann M.; Kan, Virginia L.] George Washington Univ, Div Infect Dis, Washington, DC USA; [Hoffman, Heather J.] George Washington Univ, Dept Epidemiol & Biostat, Washington, DC USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); George Washington University; George Washington University	Gale, HB (corresponding author), Vet Affairs Med Ctr, Med Serv, Infect Dis Sect, 50 Irving St NW, Washington, DC 20422 USA.	howard.gale@va.gov	Hoffman, Heather/AAF-6429-2020		District of Columbia Developmental Center for AIDS Research [P30AI087714/NIAID/NIH]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI087714] Funding Source: NIH RePORTER	District of Columbia Developmental Center for AIDS Research; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The authors thank the staff of the Infectious Diseases Clinic and our volunteer clinicians for their dedication to the HIV care of our patients and Karen Rexroth and Rebecca Shinol for their performance of CD4 counts and HIV-1 RNA viral loads in the Infectious Diseases Laboratory. This work was IRB-exempt and reviewed and approved by the R&D Committee at this VA Medical Center. The views expressed are those of the authors and do not reflect the views or policies of the Department of Veterans Affairs. Statistical support for our work was provided by The District of Columbia Developmental Center for AIDS Research (P30AI087714/NIAID/NIH). Presented in part at the XIX International AIDS Conference, Washington, DC, July 22-27, 2012 (Abstract THPE061).	Althoff KN, 2012, ANN INTERN MED, V157, P325, DOI 10.7326/0003-4819-157-5-201209040-00005; Ammassari A, 2002, JAIDS, V31, pS123, DOI 10.1097/00126334-200212153-00007; Backus LI, 2005, AIDS, V19, pS13, DOI 10.1097/01.aids.0000192065.09281.01; Box G.E.P., 2008, TIMES SERIES ANAL FO; Carr A, 2000, LANCET, V356, P1423, DOI 10.1016/S0140-6736(00)02854-3; Clavel F, 2004, NEW ENGL J MED, V350, P1023, DOI 10.1056/NEJM2ra025195; Cohen Stacy M., 2011, Morbidity and Mortality Weekly Report, V60, P1618; Conigliaro J, 2003, JAIDS-J ACQ IMM DEF, V33, P521, DOI 10.1097/00126334-200308010-00014; Conigliaro J, 2006, MED CARE, V44, pS1, DOI 10.1097/01.mlr.0000223659.36369.cf; Dieffenbach CW, 2011, ANN INTERN MED, V154, P766, DOI 10.7326/0003-4819-154-11-201106070-00345; Folker GK, 2012, JAMA-J AM MED ASSOC, V304, P350; Frick P, 2006, AIDS PATIENT CARE ST, V20, P511, DOI 10.1089/apc.2006.20.511; Fuller BE, 2009, CURR OPIN PSYCHIATR, V22, P401, DOI 10.1097/YCO.0b013e32832cadb9; Gale HB, 2008, J MOL DIAGN, V10, P586; GALE HB, 1992, CYTOMETRY, V13, P175, DOI 10.1002/cyto.990130211; Gill VS, 2010, CLIN INFECT DIS, V50, P98, DOI 10.1086/648729; Gordon AJ, 2006, MED CARE, V44, pS37, DOI 10.1097/01.mlr.0000223705.00175.3d; Goulet JL, 2005, AIDS, V19, pS99, DOI 10.1097/01.aids.0000192077.11067.e5; Goulet JL, 2007, CLIN INFECT DIS, V45, P1593, DOI 10.1086/523577; Napolitano L. M., 2009, Morbidity and Mortality Weekly Report, V58, P749; Hoang T, 2009, MED CARE, V47, P560, DOI 10.1097/MLR.0b013e31819432a0; Justice Amy C, 2006, Top HIV Med, V14, P159; Kilbourne AM, 2002, J GEN INTERN MED, V17, P512, DOI 10.1046/j.1525-1497.2002.10803.x; Lifson AR, 2011, AIDS RES THER, V8, DOI 10.1186/1742-6405-8-2; Lok JJ, 2010, AIDS, V24, P1867, DOI 10.1097/QAD.0b013e32833adbcf; Lubin JH, 2004, ENVIRON HEALTH PERSP, V112, P1691, DOI 10.1289/ehp.7199; Ma A, 2010, AIDS CARE, V22, P1189, DOI 10.1080/09540121003668102; MADDALA GS, 1983, LIMITED DEPENDENT QU; Mavandadi S, 2009, JAIDS-J ACQ IMM DEF, V51, P91, DOI 10.1097/QAI.0b013e318199069b; Moore RD, 2011, CLIN INFECT DIS, V53, P600, DOI 10.1093/cid/cir467; Mrus JM, 2006, J GEN INTERN MED, V21, pS39, DOI 10.1111/j.1525-1497.2006.00644.x; Nurutdinova D, 2012, AIDS, V26, P229, DOI 10.1097/QAD.0b013e32834e1404; Sherer R, 2002, AIDS CARE, V14, pS31, DOI 10.1080/09540120220149975; Sullivan G, 2006, COMMUNITY MENT HLT J, V42, P345, DOI 10.1007/s10597-006-9053-8; Zaragoza-Macias E, 2010, AIDS RES HUM RETROV, V26, P133, DOI 10.1089/aid.2009.0001	35	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e56845	10.1371/journal.pone.0056845	http://dx.doi.org/10.1371/journal.pone.0056845			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437255	Green Published, Green Submitted, gold			2022-12-25	WOS:000315184200171
J	Tashyreva, D; Elster, J; Billi, D				Tashyreva, Daria; Elster, Josef; Billi, Daniela			A Novel Staining Protocol for Multiparameter Assessment of Cell Heterogeneity in Phormidium Populations (Cyanobacteria) Employing Fluorescent Dyes	PLOS ONE			English	Article							5-CYANO-2,3-DITOLYL TETRAZOLIUM CHLORIDE; FLOW-CYTOMETRY; ESCHERICHIA-COLI; CHLOROPHYLL FLUORESCENCE; MICROBIAL-POPULATIONS; RESPIRATORY ACTIVITY; RESPIRING BACTERIA; VIABILITY; PHYCOBILISOMES; MEMBRANE	Bacterial populations display high heterogeneity in viability and physiological activity at the single-cell level, especially under stressful conditions. We demonstrate a novel staining protocol for multiparameter assessment of individual cells in physiologically heterogeneous populations of cyanobacteria. The protocol employs fluorescent probes, i.e., redox dye 5-cyano-2,3-ditolyl tetrazolium chloride, 'dead cell' nucleic acid stain SYTOX Green, and DNA-specific fluorochrome 4',6-diamidino-2-phenylindole, combined with microscopy image analysis. Our method allows simultaneous estimates of cellular respiration activity, membrane and nucleoid integrity, and allows the detection of photosynthetic pigments fluorescence along with morphological observations. The staining protocol has been adjusted for, both, laboratory and natural populations of the genus Phormidium (Oscillatoriales), and tested on 4 field-collected samples and 12 laboratory strains of cyanobacteria. Based on the mentioned cellular functions we suggest classification of cells in cyanobacterial populations into four categories: (i) active and intact; (ii) injured but active; (iii) metabolically inactive but intact; (iv) inactive and injured, or dead.	[Tashyreva, Daria; Elster, Josef] Univ S Bohemia, Fac Sci, Dept Bot, Ceske Budejovice, Czech Republic; [Elster, Josef] Acad Sci Czech Republ, Inst Bot, Ctr Phycol, Trebon, Czech Republic; [Billi, Daniela] Univ Roma Tor Vergata, Dept Biol, I-00173 Rome, Italy	University of South Bohemia Ceske Budejovice; Czech Academy of Sciences; Institute of Botany of the Czech Academy of Sciences; University of Rome Tor Vergata	Tashyreva, D (corresponding author), Univ S Bohemia, Fac Sci, Dept Bot, Ceske Budejovice, Czech Republic.	tashyreva@butbn.cas.cz	Billi, Daniela/AAT-6690-2021; Elster, Josef/B-1031-2008; Tashyreva, Daria/Q-6880-2016; Tashyreva, Daria/AAD-6325-2021	Tashyreva, Daria/0000-0002-1280-4095; BILLI, DANIELA/0000-0002-9363-2415	Ministery of Education of the Czech Republic [Kontakt ME 934, Ingo LA 341]; Czech Polar Project [LM 2010009]; GAJU Grant (Czech Republic) [138/2010/P]	Ministery of Education of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic); Czech Polar Project; GAJU Grant (Czech Republic)	This work was funded by Kontakt ME 934, Ingo LA 341 (Ministery of Education of the Czech Republic); LM 2010009 (Czech Polar Project); GAJU Grant 138/2010/P (Czech Republic); microscopy analyses were partially paid from PNRA, PEA2009 to DB (previously to Patrizia Albertano dagger). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernas T, 2000, ARCH BIOCHEM BIOPHYS, V380, P108, DOI 10.1006/abbi.2000.1907; Billi D, 2009, EXTREMOPHILES, V13, P49, DOI 10.1007/s00792-008-0196-0; Bodemer U, 2004, J PLANKTON RES, V26, P1147, DOI 10.1093/plankt/fbh105; Breeuwer P, 2000, INT J FOOD MICROBIOL, V55, P193, DOI 10.1016/S0168-1605(00)00163-X; BROWN JS, 1969, BIOPHYS J, V9, P1542, DOI 10.1016/S0006-3495(69)86469-6; BRYANT DA, 1982, J GEN MICROBIOL, V128, P835; Campbell D, 1998, MICROBIOL MOL BIOL R, V62, P667, DOI 10.1128/MMBR.62.3.667-683.1998; CARON GNV, 1995, J MICROSC-OXFORD, V179, P55, DOI 10.1111/j.1365-2818.1995.tb03612.x; Davey Hazel M., 2003, Current Issues in Molecular Biology, V5, P9; Davey HM, 1996, MICROBIOL REV, V60, P641, DOI 10.1128/MMBR.60.4.641-696.1996; FRENCH CS, 1956, PLANT PHYSIOL, V31, P369, DOI 10.1104/pp.31.5.369; GANTT E, 1979, PLANT PHYSIOL, V63, P615, DOI 10.1104/pp.63.4.615; Hatzinger PB, 2003, J MICROBIOL METH, V52, P47, DOI 10.1016/S0167-7012(02)00132-X; Hernlem B, 2010, CURR MICROBIOL, V61, P57, DOI 10.1007/s00284-009-9576-7; KAPRELYANTS AS, 1993, J MICROBIOL METH, V17, P115, DOI 10.1016/0167-7012(93)90004-2; Karner M, 1997, APPL ENVIRON MICROB, V63, P1208, DOI 10.1128/AEM.63.4.1208-1213.1997; Kell DB, 2000, CURR OPIN MICROBIOL, V3, P238, DOI 10.1016/S1369-5274(00)00082-5; Kell DB, 1998, ANTON LEEUW INT J G, V73, P169, DOI 10.1023/A:1000664013047; Kirchman D.L., 2008, MICROBIAL ECOLOGY OC, V2, P243, DOI DOI 10.1002/9780470281840.CH8; Lidstrom ME, 2010, NAT CHEM BIOL, V6, P705, DOI [10.1038/NCHEMBIO.436, 10.1038/nchembio.436]; LopezAmoros R, 1997, CYTOMETRY, V29, P298, DOI 10.1002/(SICI)1097-0320(19971201)29:4<298::AID-CYTO6>3.0.CO;2-6; Maxwell K, 2000, J EXP BOT, V51, P659, DOI 10.1093/jexbot/51.345.659; MCFETERS GA, 1995, J MICROBIOL METH, V21, P1, DOI 10.1016/0167-7012(94)00027-5; Mimuro M, 1999, CONCEPTS IN PHOTOBIOLOGY, P104; Muller S, 2010, FEMS MICROBIOL REV, V34, P554, DOI 10.1111/j.1574-6976.2010.00214.x; Nebe-von Caron G, 1998, J APPL MICROBIOL, V84, P988, DOI 10.1046/j.1365-2672.1998.00436.x; PORTER J, 1995, J APPL BACTERIOL, V79, P399, DOI 10.1111/j.1365-2672.1995.tb03154.x; RIGBI M, 1980, P NATL ACAD SCI-BIOL, V77, P1961, DOI 10.1073/pnas.77.4.1961; ROBINOW C, 1994, MICROBIOL REV, V58, P211, DOI 10.1128/MMBR.58.2.211-232.1994; RODRIGUEZ GG, 1992, APPL ENVIRON MICROB, V58, P1801, DOI 10.1128/AEM.58.6.1801-1808.1992; Roth BL, 1997, APPL ENVIRON MICROB, V63, P2421, DOI 10.1128/AEM.63.6.2421-2431.1997; SCHAULE G, 1993, APPL ENVIRON MICROB, V59, P3850, DOI 10.1128/AEM.59.11.3850-3857.1993; Schumann R, 2003, AQUAT MICROB ECOL, V32, P137, DOI 10.3354/ame032137; Schwarz R, 2005, MICROBIOL-SGM, V151, P2503, DOI 10.1099/mic.0.27883-0; SIEGELMAN HW, 1982, PLANT PHYSIOL, V70, P887, DOI 10.1104/pp.70.3.887; Smith JJ, 1997, J MICROBIOL METH, V29, P161, DOI 10.1016/S0167-7012(97)00036-5; Strunecky O, 2012, POLISH POLA IN PRESS; Tachon S, 2009, MICROBIOL-SGM, V155, P2941, DOI 10.1099/mic.0.029678-0; TEALE FWJ, 1970, BIOCHEM J, V116, P161, DOI 10.1042/bj1160161; Veldhuis MJW, 2001, EUR J PHYCOL, V36, P167, DOI 10.1080/09670260110001735318; Ying LM, 1998, J PHYS CHEM B, V102, P10399, DOI 10.1021/jp983227d; YU W, 1995, APPL ENVIRON MICROB, V61, P3367, DOI 10.1128/AEM.61.9.3367-3372.1995; ZIMMERMANN R, 1978, APPL ENVIRON MICROB, V36, P926, DOI 10.1128/AEM.36.6.926-935.1978; ZWEIFEL UL, 1995, APPL ENVIRON MICROB, V61, P2180, DOI 10.1128/AEM.61.6.2180-2185.1995	44	30	31	1	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e55283	10.1371/journal.pone.0055283	http://dx.doi.org/10.1371/journal.pone.0055283			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437052	Green Published, Green Submitted, gold			2022-12-25	WOS:000315184200014
J	Bagci, U; Yao, JH; Miller-Jaster, K; Chen, XJ; Mollura, DJ				Bagci, Ulas; Yao, Jianhua; Miller-Jaster, Kirsten; Chen, Xinjian; Mollura, Daniel J.			Predicting Future Morphological Changes of Lesions from Radiotracer Uptake in 18F-FDG-PET Images	PLOS ONE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; F-18-FDG PET; SEGMENTATION; TEXTURE; HETEROGENEITY; VOLUMES	We introduce a novel computational framework to enable automated identification of texture and shape features of lesions on F-18-FDG-PET images through a graph-based image segmentation method. The proposed framework predicts future morphological changes of lesions with high accuracy. The presented methodology has several benefits over conventional qualitative and semi-quantitative methods, due to its fully quantitative nature and high accuracy in each step of (i) detection, (ii) segmentation, and (iii) feature extraction. To evaluate our proposed computational framework, thirty patients received 2 F-18-FDG-PET scans (60 scans total), at two different time points. Metastatic papillary renal cell carcinoma, cerebellar hemongioblastoma, non-small cell lung cancer, neurofibroma, lymphomatoid granulomatosis, lung neoplasm, neuroendocrine tumor, soft tissue thoracic mass, nonnecrotizing granulomatous inflammation, renal cell carcinoma with papillary and cystic features, diffuse large B-cell lymphoma, metastatic alveolar soft part sarcoma, and small cell lung cancer were included in this analysis. The radiotracer accumulation in patients' scans was automatically detected and segmented by the proposed segmentation algorithm. Delineated regions were used to extract shape and textural features, with the proposed adaptive feature extraction framework, as well as standardized uptake values (SUV) of uptake regions, to conduct a broad quantitative analysis. Evaluation of segmentation results indicates that our proposed segmentation algorithm has a mean dice similarity coefficient of 85.75 +/- 1.75%. We found that 28 of 68 extracted imaging features were correlated well with SUVmax (p<0.05), and some of the textural features (such as entropy and maximum probability) were superior in predicting morphological changes of radiotracer uptake regions longitudinally, compared to single intensity feature such as SUVmax. We also found that integrating textural features with SUV measurements significantly improves the prediction accuracy of morphological changes (Spearman correlation coefficient = 0.8715, p<e-16).	[Bagci, Ulas; Miller-Jaster, Kirsten; Mollura, Daniel J.] NIH, Ctr Infect Dis Imaging, Bethesda, MD 20892 USA; [Bagci, Ulas; Yao, Jianhua; Miller-Jaster, Kirsten; Mollura, Daniel J.] NIH, Ctr Clin, Bethesda, MD 20892 USA; [Chen, Xinjian] Soochow Univ, Sch Elect & Informat Engn, Suzhou, Peoples R China	National Institutes of Health (NIH) - USA; National Institutes of Health (NIH) - USA; NIH Clinical Center (CC); Soochow University - China	Bagci, U (corresponding author), NIH, Ctr Infect Dis Imaging, Bldg 10, Bethesda, MD 20892 USA.	ulas.bagci@nih.gov	Chen, Xinjian/E-8592-2016; Bagci, Ulas/A-4225-2012; Yao, Jianhua/GQZ-6627-2022	Bagci, Ulas/0000-0001-7379-6829; Yao, Jianhua/0000-0001-9157-9596; Chen, Xinjian/0000-0002-0871-293X	Imaging Sciences Training Program (ISTP); Center for Infectious Disease Imaging (CIDI); Intramural Program of the National Institutes of Allergy and Infectious Diseases; Intramural Research Program of the National Institutes of Bio-imaging and Bioengineering at the National Institutes of Health (NIH); CLINICAL CENTER [ZIACL090018, ZIDCL040016] Funding Source: NIH RePORTER	Imaging Sciences Training Program (ISTP); Center for Infectious Disease Imaging (CIDI); Intramural Program of the National Institutes of Allergy and Infectious Diseases; Intramural Research Program of the National Institutes of Bio-imaging and Bioengineering at the National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CLINICAL CENTER	This research is supported by the Imaging Sciences Training Program (ISTP), the Center for Infectious Disease Imaging (CIDI), the Intramural Program of the National Institutes of Allergy and Infectious Diseases, and the Intramural Research Program of the National Institutes of Bio-imaging and Bioengineering at the National Institutes of Health (NIH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Kadi OS, 2010, PATTERN RECOGN, V43, P2043, DOI 10.1016/j.patcog.2010.01.005; Bagci U, 2012, LECT NOTES COMPUT SC, V7512, P459, DOI 10.1007/978-3-642-33454-2_57; Bagci U, 2011, IEEE ENG MED BIO, P8479, DOI 10.1109/IEMBS.2011.6092092; Bagci U, 2012, COMPUT MED IMAG GRAP, V36, P72, DOI 10.1016/j.compmedimag.2011.06.002; BESAG J, 1986, J R STAT SOC B, V48, P259; Botev ZI, 2010, ANN STAT, V38, P2916, DOI 10.1214/10-AOS799; Bouaynaya N, 2008, IEEE T PATTERN ANAL, V30, P823, DOI 10.1109/TPAMI.2007.70754; Catana C, 2008, P NATL ACAD SCI USA, V105, P3705, DOI 10.1073/pnas.0711622105; Chen XJ, 2011, MED PHYS, V38, P4610, DOI 10.1118/1.3602070; Cignoni P, 1998, COMPUT GRAPH FORUM, V17, P167, DOI 10.1111/1467-8659.00236; COGGINS JM, 1985, PATTERN RECOGN LETT, V3, P195, DOI 10.1016/0167-8655(85)90053-4; CROSS GR, 1983, IEEE T PATTERN ANAL, V5, P25, DOI 10.1109/TPAMI.1983.4767341; Day E, 2009, MED PHYS, V36, P4349, DOI 10.1118/1.3213099; DICE LR, 1945, ECOLOGY, V26, P297, DOI 10.2307/1932409; El Naqa I, 2009, PATTERN RECOGN, V42, P1162, DOI 10.1016/j.patcog.2008.08.011; Erdi YE, 1997, CANCER, V80, P2505, DOI 10.1002/(SICI)1097-0142(19971215)80:12+<2505::AID-CNCR24>3.3.CO;2-B; EVERITT B, 1980, QUAL QUANT, V14, P75, DOI 10.1007/BF00154794; Grady L, 2006, IEEE T PATTERN ANAL, V28, P1768, DOI 10.1109/TPAMI.2006.233; HALL P, 1993, BIOMETRIKA, V80, P246, DOI 10.2307/2336774; HARALICK RM, 1973, IEEE T SYST MAN CYB, VSMC3, P610, DOI 10.1109/TSMC.1973.4309314; Hatt M, 2011, J NUCL MED, V52, P1690, DOI 10.2967/jnumed.111.092767; Hatt M, 2009, IEEE T MED IMAGING, V28, P881, DOI 10.1109/TMI.2008.2012036; INGLIS J, 1975, TECHNOMETRICS, V17, P513, DOI 10.2307/1268442; Jentzen W, 2007, J NUCL MED, V48, P108; Komodakis N, 2011, IEEE T PATTERN ANAL, V33, P531, DOI 10.1109/TPAMI.2010.108; MARKOWSKI CA, 1990, AM STAT, V44, P322, DOI 10.2307/2684360; Montgomery DWG, 2007, MED PHYS, V34, P722, DOI 10.1118/1.2432404; O'Sullivan F, 2005, BIOSTATISTICS, V6, P293, DOI 10.1093/biostatistics/kxi010; O'Sullivan F, 2003, BIOSTATISTICS, V4, P433, DOI 10.1093/biostatistics/4.3.433; Reshef DN, 2011, SCIENCE, V334, P1518, DOI 10.1126/science.1205438; Rosenfeld A, 1975, TR361 U MAR COMP SCI; Shankar LK, 2006, J NUCL MED, V47, P1059; SHAPIRO SS, 1965, BIOMETRIKA, V52, P591, DOI 10.1093/biomet/52.3-4.591; SWARTZLA EE, 1974, IEEE T SYST MAN CYB, VMC 4, P238; Tang XO, 1998, IEEE T IMAGE PROCESS, V7, P1602, DOI 10.1109/83.725367; Tixier F, 2011, J NUCL MED, V52, P369, DOI 10.2967/jnumed.110.082404; Zhu SC, 2000, IEEE T PATTERN ANAL, V22, P554, DOI 10.1109/34.862195	37	24	24	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2013	8	2							e57105	10.1371/journal.pone.0057105	http://dx.doi.org/10.1371/journal.pone.0057105			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093HR	23431398	Green Submitted, gold, Green Published			2022-12-25	WOS:000315182800041
J	Costamagna, AC; McCornack, BP; Ragsdale, DW				Costamagna, Alejandro C.; McCornack, Brian P.; Ragsdale, David W.			Within-Plant Bottom-Up Effects Mediate Non-Consumptive Impacts of Top-Down Control of Soybean Aphids	PLOS ONE			English	Article							POPULATION-GROWTH; GLYCINES MATSUMURA; GENERALIST PREDATORS; BIOLOGICAL-CONTROL; TROPHIC CASCADES; NATURAL ENEMIES; SUGAR-BEET; PEA APHIDS; MANAGEMENT; QUALITY	There is increasing evidence that top-down controls have strong non-consumptive effects on herbivore populations. However, little is known about how these non-consumptive effects relate to bottom-up influences. Using a series of field trials, we tested how changes in top-down and bottom-up controls at the within-plant scale interact to increase herbivore suppression. In the first experiment, we manipulated access of natural populations of predators (primarily lady beetles) to controlled numbers of A. glycines on upper (i.e. vigorous-growing) versus lower (i.e. slow-growing) soybean nodes and under contrasting plant ages. In a second experiment, we measured aphid dispersion in response to predation. Bottom-up and top-down controls had additive effects on A. glycines population growth. Plant age and within-plant quality had significant bottom-up effects on aphid size and population growth. However, top-down control was the dominant force suppressing aphid population growth, and completely counteracted bottom-up effects at the plant and within-plant scales. The intensity of predation was higher on upper than lower soybean nodes, and resulted in a non-consumptive reduction in aphid population growth because most of the surviving aphids were located on lower plant nodes, where rates of increase were reduced. No effects of predation on aphid dispersal among plants were detected, suggesting an absence of predator avoidance behavior by A. glycines. Our results revealed significant non-consumptive predator impacts on aphids due to the asymmetric intensity of predation at the within-plant scale, suggesting that low numbers of predators are highly effective at suppressing aphid populations.	[Costamagna, Alejandro C.; McCornack, Brian P.; Ragsdale, David W.] Univ Minnesota, Dept Entomol, St Paul, MN USA	University of Minnesota System; University of Minnesota Twin Cities	Costamagna, AC (corresponding author), Univ Manitoba, Dept Entomol, Winnipeg, MB R3T 2N2, Canada.	Ale_Costamagna@umanitoba.ca	Costamagna, Alejandro/B-1750-2009	Costamagna, Alejandro/0000-0002-7301-2534	North Central Soybean Research Program; Minnesota Soybean Research and Promotion Council; Minnesota Agricultural Experiment Station; College of Food, Agricultural, and Natural Resource Sciences Rapid Agricultural Response Fund	North Central Soybean Research Program; Minnesota Soybean Research and Promotion Council; Minnesota Agricultural Experiment Station; College of Food, Agricultural, and Natural Resource Sciences Rapid Agricultural Response Fund	Funding for this research was provided by the North Central Soybean Research Program; the Minnesota Soybean Research and Promotion Council; the Minnesota Agricultural Experiment Station; and the College of Food, Agricultural, and Natural Resource Sciences Rapid Agricultural Response Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2015, SPRINGERPLUS, DOI DOI 10.1186/s40064-015-1263-5; Awmack CS, 2007, APHIDS AS CROP PESTS, P135, DOI 10.1079/9780851998190.0135; Awmack CS, 2002, ANNU REV ENTOMOL, V47, P817, DOI 10.1146/annurev.ento.47.091201.145300; Berryman AA, 2006, OIKOS, V115, P192, DOI 10.1111/j.0030-1299.2006.15188.x; Blaauw BR, 2012, ECOL ENTOMOL, V37, P386, DOI 10.1111/j.1365-2311.2012.01376.x; Brosius TR, 2007, J ECON ENTOMOL, V100, P1268, DOI 10.1603/0022-0493(2007)100[1268:PDOSAA]2.0.CO;2; Butler CD, 2006, ANN ENTOMOL SOC AM, V99, P317, DOI 10.1603/0013-8746(2006)099[0317:DROSAH]2.0.CO;2; Case T. J, 2000, ILLUSTRATED GUIDE TH; Cornelissen T, 2008, OIKOS, V117, P1121, DOI 10.1111/j.0030-1299.2008.16588.x; Costamagna AC, 2007, AGR FOREST ENTOMOL, V9, P297, DOI 10.1111/j.1461-9563.2007.00348.x; Costamagna AC, 2013, J APPL ENTOMOL, V137, P317, DOI 10.1111/j.1439-0418.2012.01730.x; Costamagna AC, 2008, BIOL CONTROL, V45, P368, DOI 10.1016/j.biocontrol.2008.01.018; Costamagna AC, 2007, BIOL CONTROL, V42, P16, DOI 10.1016/j.biocontrol.2007.04.001; Costamagna AC, 2007, ECOL APPL, V17, P441, DOI 10.1890/06-0284; Costamagna AC, 2006, ECOL APPL, V16, P1619, DOI 10.1890/1051-0761(2006)016[1619:PETCOS]2.0.CO;2; Costamagna AC, 2011, BIOL CONTROL, V57, P184, DOI 10.1016/j.biocontrol.2011.03.006; Denno RF, 2002, ECOLOGY, V83, P1443, DOI 10.1890/0012-9658(2002)083[1443:BUFMNE]2.0.CO;2; Desneux N, 2006, ENVIRON ENTOMOL, V35, P1342, DOI 10.1603/0046-225X(2006)35[1342:SOPGOT]2.0.CO;2; Donaldson JR, 2007, BIOL CONTROL, V43, P111, DOI 10.1016/j.biocontrol.2007.06.004; Dyer LA, 2003, BASIC APPL ECOL, V4, P423, DOI 10.1078/1439-1791-00191; Fox TB, 2004, ENVIRON ENTOMOL, V33, P608, DOI 10.1603/0046-225X-33.3.608; Gardiner MM, 2009, ECOL APPL, V19, P143, DOI 10.1890/07-1265.1; HACKER SD, 1995, AM NAT, V145, P192, DOI 10.1086/285736; Hodek I., 1996, Series Entomologica (Dordrecht), V54, P143; Hodgson EW, 2005, ENVIRON ENTOMOL, V34, P1456, DOI 10.1603/0046-225X-34.6.1456; Kift NB, 1998, ENTOMOL EXP APPL, V88, P155, DOI 10.1023/A:1003445427935; Landis DA, 1997, ENTOMOPHAGA, V42, P499, DOI 10.1007/BF02769810; Lin LA, 2003, ECOL ENTOMOL, V28, P542, DOI 10.1046/j.1365-2311.2003.00536.x; Losey JE, 1998, ECOL ENTOMOL, V23, P53, DOI 10.1046/j.1365-2311.1998.00102.x; McCornack BP, 2008, J ECON ENTOMOL, V101, P1488, DOI 10.1603/0022-0493(2008)101[1488:WDOSAH]2.0.CO;2; McCornack BP, 2004, J ECON ENTOMOL, V97, P854, DOI 10.1603/0022-0493(2004)097[0854:DOSAHA]2.0.CO;2; Meihls LN, 2010, J INSECT SCI, V10, DOI 10.1673/031.010.14104; Moon DC, 2006, ECOL ENTOMOL, V31, P236, DOI 10.1111/j.1365-2311.2006.00785.x; Nelson EH, 2004, ECOLOGY, V85, P1853, DOI 10.1890/03-3109; Polis GA, 2000, TRENDS ECOL EVOL, V15, P473, DOI 10.1016/S0169-5347(00)01971-6; PRICE PW, 1991, OIKOS, V62, P244, DOI 10.2307/3545270; Ragsdale DW, 2011, ANNU REV ENTOMOL, V56, P375, DOI 10.1146/annurev-ento-120709-144755; Rhainds M, 2007, CAN ENTOMOL, V139, P728, DOI 10.4039/N06-095; Ritchie SW, 1994, 53 IOW STAT U IOW ST; ROITBERG BD, 1979, J ANIM ECOL, V48, P111, DOI 10.2307/4104; *SAS I INC, 2001, SAS STAT US MAN VERS; Schmidt NP, 2007, ENVIRON ENTOMOL, V36, P416, DOI 10.1603/0046-225X(2007)36[416:ALMABC]2.0.CO;2; Schmitz OJ, 2004, ECOL LETT, V7, P153, DOI 10.1111/j.1461-0248.2003.00560.x; Thaler JS, 2008, ENTOMOL EXP APPL, V128, P34, DOI 10.1111/j.1570-7458.2008.00737.x; TURCHIN P, 1989, ECOLOGY, V70, P1008, DOI 10.2307/1941369; VandenBerg H, 1997, J APPL ECOL, V34, P971, DOI 10.2307/2405287; Von Ende CN., 2001, DESIGN ANAL ECOLOGIC, P134; Walker M, 2001, OIKOS, V93, P177, DOI 10.1034/j.1600-0706.2001.930201.x; Walter AJ, 2007, ENVIRON ENTOMOL, V36, P26, DOI 10.1603/0046-225X(2007)36[26:SPDASP]2.0.CO;2; Weisser WW, 1999, P ROY SOC B-BIOL SCI, V266, P1175, DOI 10.1098/rspb.1999.0760; Werner EE, 2003, ECOLOGY, V84, P1083, DOI 10.1890/0012-9658(2003)084[1083:AROTII]2.0.CO;2; White TCR, 2009, OIKOS, V118, P807, DOI 10.1111/j.1600-0706.2009.17495.x; Williams CT, 1995, B ENTOMOL RES, V85, P557, DOI 10.1017/S000748530003306X; Woltz JM, 2012, AGR ECOSYST ENVIRON, V152, P40, DOI 10.1016/j.agee.2012.02.008; Xia JY, 2003, ENVIRON ENTOMOL, V32, P151, DOI 10.1603/0046-225X-32.1.151	55	16	16	2	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2013	8	2							e56394	10.1371/journal.pone.0056394	http://dx.doi.org/10.1371/journal.pone.0056394			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093HR	23431373	Green Submitted, Green Published, gold			2022-12-25	WOS:000315182800015
J	Garringer, HJ; Murrell, J; Sammeta, N; Gnezda, A; Ghetti, B; Vidal, R				Garringer, Holly J.; Murrell, Jill; Sammeta, Neeraja; Gnezda, Anita; Ghetti, Bernardino; Vidal, Ruben			Increased Tau Phosphorylation and Tau Truncation, and Decreased Synaptophysin Levels in Mutant BRI2/Tau Transgenic Mice	PLOS ONE			English	Article							FAMILIAL BRITISH DEMENTIA; STRAUSSLER-SCHEINKER DISEASE; NEUROFIBRILLARY TANGLES; AMYLOID DEPOSITION; ALZHEIMERS-DISEASE; DANISH DEMENTIA; SYNAPSE LOSS; A-BETA; PRECURSOR PROTEIN; MICROGLIAL ACTIVATION	Familial Danish dementia (FDD) is an autosomal dominant neurodegenerative disease caused by a 10-nucleotide duplication-insertion in the BRI2 gene. FDD is clinically characterized by loss of vision, hearing impairment, cerebellar ataxia and dementia. The main neuropathologic findings in FDD are the deposition of Danish amyloid (ADan) and the presence of neurofibrillary tangles (NFTs). Here we investigated tau accumulation and truncation in double transgenic (Tg-FDD-Tau) mice generated by crossing transgenic mice expressing human Danish mutant BRI2 (Tg-FDD) with mice expressing human 4-repeat mutant Tau-P301S (Tg-Tau). Compared to Tg-Tau mice, we observed a significant enhancement of tau deposition in Tg-FDD-Tau mice. In addition, a significant increase in tau cleaved at aspartic acid (Asp) 421 was observed in Tg-FDD-Tau mice. Tg-FDD-Tau mice also showed a significant decrease in synaptophysin levels, occurring before widespread deposition of fibrillar ADan and tau can be observed. Thus, the presence of soluble ADan/mutant BRI2 can lead to significant changes in tau metabolism and synaptic dysfunction. Our data provide new in vivo insights into the pathogenesis of FDD and the pathogenic pathway(s) by which amyloidogenic peptides, regardless of their primary amino acid sequence, can cause neurodegeneration.	[Garringer, Holly J.] Indiana Univ Sch Med, Dept Pathol & Lab Med, Indianapolis, IN USA; Indiana Univ Sch Med, Indiana Alzheimer Dis Ctr, Indianapolis, IN USA	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington	Garringer, HJ (corresponding author), Indiana Univ Sch Med, Dept Pathol & Lab Med, Indianapolis, IN USA.	hjgarrin@iupui.edu; rvidal@iupui.edu			National Institute on Neurological Disorders and Stroke [NS050227]; National Institute on Aging [AG037338, AG10133]; American Health Assistance Foundation [A2008-304]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS050227] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R21AG037338, P30AG010133] Funding Source: NIH RePORTER	National Institute on Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); American Health Assistance Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was supported by grants from the National Institute on Neurological Disorders and Stroke NS050227 (RV), by the National Institute on Aging AG037338 (RV) and AG10133 (BG), and by the American Health Assistance Foundation A2008-304 (RV). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama H, 2004, ACTA NEUROPATHOL, V107, P53, DOI 10.1007/s00401-003-0783-1; Allen B, 2002, J NEUROSCI, V22, P9340; Barbeito AG, 2009, J NEUROCHEM, V109, P1067, DOI 10.1111/j.1471-4159.2009.06028.x; Bellucci A, 2011, NEURODEGENER DIS, V8, P221, DOI 10.1159/000322228; Billings LM, 2005, NEURON, V45, P675, DOI 10.1016/j.neuron.2005.01.040; Boutajangout A, 2004, NEUROBIOL DIS, V15, P47, DOI 10.1016/j.nbd.2003.09.007; Brendza RP, 2003, J COMP NEUROL, V456, P375, DOI 10.1002/cne.10536; Choi SI, 2003, FASEB J, V17, P373, DOI 10.1096/fj.03-0730fje; Coomaraswamy J, 2010, P NATL ACAD SCI USA, V107, P7969, DOI 10.1073/pnas.1001056107; de Calignon A, 2010, NATURE, V464, P1201, DOI 10.1038/nature08890; Delobel P, 2008, AM J PATHOL, V172, P123, DOI 10.2353/ajpath.2008.070627; Dong HX, 2007, J COMP NEUROL, V500, P311, DOI 10.1002/cne.21176; Gamblin TC, 2003, P NATL ACAD SCI USA, V100, P10032, DOI 10.1073/pnas.1630428100; Garringer HJ, 2010, BRAIN STRUCT FUNCT, V214, P235, DOI 10.1007/s00429-009-0221-9; GHETTI B, 1989, NEUROLOGY, V39, P1453, DOI 10.1212/WNL.39.11.1453; Giaccone G, 2008, NEUROBIOL AGING, V29, P1864, DOI 10.1016/j.neurobiolaging.2007.04.026; GIACCONE G, 1990, BRAIN RES, V530, P325, DOI 10.1016/0006-8993(90)91304-Y; Giliberto L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007900; Goedert M, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006254; Gotz J, 2001, SCIENCE, V293, P1491, DOI 10.1126/science.1062097; Holton JL, 2002, J NEUROPATH EXP NEUR, V61, P254, DOI 10.1093/jnen/61.3.254; Holton JL, 2001, AM J PATHOL, V158, P515, DOI 10.1016/S0002-9440(10)63993-4; Hurtado DE, 2010, AM J PATHOL, V177, P1977, DOI 10.2353/ajpath.2010.100346; Ikeda M, 2005, AM J PATHOL, V166, P521, DOI 10.1016/S0002-9440(10)62274-2; Kim SH, 2002, J BIOL CHEM, V277, P1872, DOI 10.1074/jbc.M108739200; Kim SH, 1999, NAT NEUROSCI, V2, P984, DOI 10.1038/14783; Knafo S, 2009, CEREB CORTEX, V19, P586, DOI 10.1093/cercor/bhn111; Koffie RM, 2009, P NATL ACAD SCI USA, V106, P4012, DOI 10.1073/pnas.0811698106; Lasagna-Reeves CA, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-39; Lewis J, 2001, SCIENCE, V293, P1487, DOI 10.1126/science.1058189; Martin L, 2008, J BIOL CHEM, V283, P1644, DOI 10.1074/jbc.M706661200; Martin L, 2009, J BIOL CHEM, V284, P5662, DOI 10.1074/jbc.M807485200; Matsuda S, 2005, J BIOL CHEM, V280, P28912, DOI 10.1074/jbc.C500217200; Murrell J, 2006, BRAIN PATHOL, V16, pS44; Oddo S, 2003, NEURON, V39, P409, DOI 10.1016/S0896-6273(03)00434-3; Rissman RA, 2004, J CLIN INVEST, V114, P121, DOI 10.1172/JCI200420640; Sahara N, 2002, J NEUROCHEM, V83, P1498, DOI 10.1046/j.1471-4159.2002.01241.x; Sanchez-Pulido L, 2002, TRENDS BIOCHEM SCI, V27, P329, DOI 10.1016/S0968-0004(02)02134-5; Sasaki A, 2008, BRAIN RES, V1214, P159, DOI 10.1016/j.brainres.2008.02.084; Spires TL, 2005, J NEUROSCI, V25, P7278, DOI 10.1523/JNEUROSCI.1879-05.2005; Spires-Jones TL, 2008, J NEUROSCI, V28, P862, DOI 10.1523/JNEUROSCI.3072-08.2008; STROMGREN E, 1970, ACTA NEUROL SCAND, V46, P261; Sze CI, 1997, J NEUROPATH EXP NEUR, V56, P933, DOI 10.1097/00005072-199708000-00011; Tamayev R, 2011, EMBO J, V30, P2501, DOI 10.1038/emboj.2011.161; Tamayev R, 2010, P NATL ACAD SCI USA, V107, P20822, DOI 10.1073/pnas.1011689107; Tamayev R, 2010, J NEUROSCI, V30, P14915, DOI 10.1523/JNEUROSCI.3917-10.2010; TERRY RD, 1991, ANN NEUROL, V30, P572, DOI 10.1002/ana.410300410; Tsai J, 2004, NAT NEUROSCI, V7, P1181, DOI 10.1038/nn1335; Vidal R, 2000, P NATL ACAD SCI USA, V97, P4920, DOI 10.1073/pnas.080076097; Vidal R, 2004, J NEUROPATH EXP NEUR, V63, P787, DOI 10.1093/jnen/63.8.787; Vidal R, 1999, NATURE, V399, P776; Vidal R, 2001, GENE, V266, P95, DOI 10.1016/S0378-1119(01)00374-2; Vidal R, 2008, J NEUROSCI, V28, P60, DOI 10.1523/JNEUROSCI.3962-07.2008; Vidal R, 2012, FASEB J, V26, P2899, DOI 10.1096/fj.12-205542; Vidal R, 2009, BRAIN PATHOL, V19, P58, DOI 10.1111/j.1750-3639.2008.00164.x; Walsh DM, 2004, NEURON, V44, P181, DOI 10.1016/j.neuron.2004.09.010; Winton MJ, 2011, J NEUROSCI, V31, P7691, DOI 10.1523/JNEUROSCI.6637-10.2011; Worster-Drought C, 1933, J NEUROL PSYCHOPATHO, V14, P27; Yoshiyama Y, 2007, NEURON, V53, P337, DOI 10.1016/j.neuron.2007.01.010; Zhang QP, 2009, ACTA NEUROPATHOL, V117, P687, DOI 10.1007/s00401-009-0491-6; Zilka N, 2009, ACTA NEUROPATHOL, V118, P71, DOI 10.1007/s00401-009-0499-y	61	15	22	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e56426	10.1371/journal.pone.0056426	http://dx.doi.org/10.1371/journal.pone.0056426			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418567	Green Submitted, Green Published, gold			2022-12-25	WOS:000315970300160
J	Chen, AP; Chu, W; Gu, YP; Cunnhingham, CH				Chen, Albert P.; Chu, William; Gu, Yi-Ping; Cunnhingham, Charles H.			Probing Early Tumor Response to Radiation Therapy Using Hyperpolarized [1-C-13]pyruvate in MDA-MB-231 Xenografts	PLOS ONE			English	Article							IN-VIVO; ACCELERATED SENESCENCE; GROWTH-FACTOR; CANCER-CELLS; ANGIOGENESIS; METABOLISM; CARCINOMA; PATHWAYS; SPECTROSCOPY; RADIOTHERAPY	Following radiation therapy (RT), tumor morphology may remain unchanged for days and sometimes weeks, rendering anatomical imaging methods inadequate for early detection of therapeutic response. Changes in the hyperpolarized [1-C-13]lactate signals observed in vivo following injection of pre-polarized [1-C-13]pyruvate has recently been shown to be a marker for tumor progression or early treatment response. In this study, the feasibility of using C-13 metabolic imaging with [1-C-13]pyruvate to detect early radiation treatment response in a breast cancer xenograft model was demonstrated in vivo and in vitro. Significant decreases in hyperpolarized [1-C-13]lactate relative to [1-C-13]pyruvate were observed in MDA-MB-231 tumors 96 hrs following a single dose of ionizing radiation. Histopathologic data from the treated tumors showed higher cellular apoptosis and senescence; and changes in the expression of membrane monocarboxylate transporters and lactate dehydrogenase B were also observed. Hyperpolarized C-13 metabolic imaging may be a promising new tool to develop novel and adaptive therapeutic regimens for patients undergoing RT.	[Chen, Albert P.] GE Healthcare, Toronto, ON, Canada; [Chu, William] Univ Toronto, Dept Radiat Oncol, Toronto, ON, Canada; [Gu, Yi-Ping; Cunnhingham, Charles H.] Sunnybrook Hlth Sci Ctr, Imaging Res, Toronto, ON M4N 3M5, Canada; [Cunnhingham, Charles H.] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada	General Electric; University of Toronto; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto	Chen, AP (corresponding author), GE Healthcare, Toronto, ON, Canada.	Albert.Chen@ge.com	Cunningham, Charles H/ABD-4550-2021	Cunningham, Charles/0000-0001-9636-8130	Ontario Institute for Cancer Research; Canadian Institutes of Health Research; GE Healthcare	Ontario Institute for Cancer Research; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); GE Healthcare(General ElectricGE Healthcare)	Ontario Institute for Cancer Research, the Canadian Institutes of Health Research and GE Healthcare. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albers M, 2007, CANCER RES, V68, P8607; Arbiser JL, 1997, P NATL ACAD SCI USA, V94, P861, DOI 10.1073/pnas.94.3.861; Ardenkjaer-Larsen JH, 2003, P NATL ACAD SCI USA, V100, P10158, DOI 10.1073/pnas.1733835100; Bohndiek SE, 2012, CANCER RES, V72, P854, DOI 10.1158/0008-5472.CAN-11-2795; Bourboulia D, 2011, AM J PATHOL, V179, P2589, DOI 10.1016/j.ajpath.2011.07.035; Bussink J, 2011, NAT REV CLIN ONCOL, V8, P233, DOI 10.1038/nrclinonc.2010.218; Chen AP, 2011, NMR BIOMED, V24, P514, DOI 10.1002/nbm.1618; Cunningham CH, 2008, J MAGN RESON, V193, P139, DOI 10.1016/j.jmr.2008.03.012; Dafni H, 2010, CANCER RES, V70, P7400, DOI 10.1158/0008-5472.CAN-10-0883; Day SE, 2007, NAT MED, V13, P1382, DOI 10.1038/nm1650; Day SE, 2011, MAGN RESON MED, V65, P557, DOI 10.1002/mrm.22698; Dent P, 2003, ONCOGENE, V22, P5885, DOI 10.1038/sj.onc.1206701; Ewald JA, 2010, JNCI-J NATL CANCER I, V102, P1536, DOI 10.1093/jnci/djq364; Fritz V, 2010, ONCOGENE, V29, P4369, DOI 10.1038/onc.2010.182; GAVRIELI Y, 1992, J CELL BIOL, V119, P493, DOI 10.1083/jcb.119.3.493; Gewirtz DA, 2008, BIOCHEM PHARMACOL, V76, P947, DOI 10.1016/j.bcp.2008.06.024; Golman K, 2006, CANCER RES, V66, P10855, DOI 10.1158/0008-5472.CAN-06-2564; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Heimann R, 2000, EUR J CANCER, V36, P1631, DOI 10.1016/S0959-8049(00)00151-9; HOWARD RB, 1991, CANCER RES, V51, P3274; Hurd RE, 2010, J CEREBR BLOOD F MET, V30, P1734, DOI 10.1038/jcbfm.2010.93; Hurkmans CW, 2012, RADIOTHER ONCOL, V103, P183, DOI 10.1016/j.radonc.2011.12.014; Itahana Koji, 2007, Methods Mol Biol, V371, P21; Jones KR, 2005, INT J RADIAT BIOL, V81, P445, DOI 10.1080/09553000500168549; Ko EC, 2011, CANCER RADIOTHER, V15, P221, DOI 10.1016/j.canrad.2010.12.007; Kohler SJ, 2007, MAGN RESON MED, V58, P65, DOI 10.1002/mrm.21253; Kurtz JM, 2006, CLIN ONCOL-UK, V18, P162, DOI 10.1016/j.clon.2005.11.007; Larson PEZ, 2008, J MAGN RESON, V194, P121, DOI 10.1016/j.jmr.2008.06.010; Lau AZ, 2011, NMR BIOMED, V24, P988, DOI 10.1002/nbm.1743; Lund EL, 2000, CLIN CANCER RES, V6, P4287; Maddocks ODK, 2011, J MOL MED, V89, P237, DOI 10.1007/s00109-011-0735-5; Messa C, 2006, Q J NUCL MED MOL IM, V50, P4; NICOLETTI I, 1991, J IMMUNOL METHODS, V139, P271, DOI 10.1016/0022-1759(91)90198-O; Park I, 2011, J MAGN RESON IMAGING, V33, P1284, DOI 10.1002/jmri.22563; Robertson FM, 2007, ANTICANCER RES, V27, P719; Schoder H, 2009, J NUCL MED, V50, p74S, DOI 10.2967/jnumed.108.057208; Sirover MA, 2005, J CELL BIOCHEM, V95, P45, DOI 10.1002/jcb.20399; Sirover MA, 2012, J CELL BIOCH; Tei K, 2002, CANCER RES, V62, P6289; Tinkey P T, 1999, Sarcoma, V3, P129, DOI 10.1080/13577149977767; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Wilson DM, 2010, J MAGN RESON, V205, P141, DOI 10.1016/j.jmr.2010.04.012; Witney TH, 2010, BRIT J CANCER, V103, P1400, DOI 10.1038/sj.bjc.6605945; Woo M, 2006, BIOMEDICAL IMAGING I, V2	44	53	53	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2013	8	2							e56551	10.1371/journal.pone.0056551	http://dx.doi.org/10.1371/journal.pone.0056551			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104BU	23424666	Green Published, Green Submitted, gold			2022-12-25	WOS:000315965100054
J	Li, D; Wang, X; Wu, JL; Quan, WQ; Ma, L; Yang, F; Wu, KY; Wan, HY				Li, Dong; Wang, Xuan; Wu, Jun-Lu; Quan, Wen-Qiang; Ma, Li; Yang, Fan; Wu, Kai-Yin; Wan, Hai-Ying			Tumor-Produced Versican V1 Enhances hCAP18/LL-37 Expression in Macrophages through Activation of TLR2 and Vitamin D3 Signaling to Promote Ovarian Cancer Progression In Vitro	PLOS ONE			English	Article							PUTATIVE GROWTH-FACTOR; MYELOID CELLS; INFLAMMATORY CYTOKINES; BREAST-CANCER; PEPTIDE LL-37; INVASIVENESS; RECEPTOR; PROLIFERATION; INTERLEUKIN-6; TRANSDUCTION	Tumor-associated macrophages have been shown to promote tumor growth. They may have an obligatory function in angiogenesis, invasion, and metastasis through release of inflammatory mediators. Their presence in ovarian cancer has been correlated with poor prognosis in these patients. The human cationic antimicrobial protein-18 (hCAP18)/LL-37 was originally identified as an effector molecule of the innate immune system. It is released by innate immune cells, such as macrophages, to combat microorganisms. Previous studies have characterized the hCAP18/LL-37 as a growth factor that has been shown to promote ovarian tumor progression. However, the role hCAP18/LL-37 has in macrophage-promoted ovarian tumor development and how its expression is controlled in this context remains poorly understood. Here, we demonstrate in co-culture experiments of macrophages and ovarian cancer cells a significant increase in the in vitro proliferation and invasiveness of the tumor cells is observed. These enhanced growth and invasion properties correlated with hCAP18/LL-37 induction. HCAP18/LL-37 expression was diminished by addition of two neutralizing antibodies, TLR2 or TLR6, as well as Cyp27B1 or VDR inhibitors. Furthermore, either the TLR2 or TLR6 antibody reduced vitamin D3 signaling and tumor cell progression in vitro. Addition of Cyp27B1 or VDR inhibitors abrogated TLR2/6 activation-induced expression of hCAP18/LL-37 in macrophages. Knockdown of tumor-produced versican V1 by RNAi in these tumor cells led to a decreased induction of hCAP18/LL-37 in macrophages. Versican V1 knockdown also inhibited TLR2 and vitamin D3 signaling, as well as growth and invasiveness of these tumor cells in the in vitro co-culture. In summary, we have found that versican V1 enhances hCAP18/LL-37 expression in macrophages through activation of TLR2 and subsequent vitamin D-dependent mechanisms which promote ovarian tumor progression in vitro.	[Li, Dong; Wu, Jun-Lu; Quan, Wen-Qiang; Ma, Li; Yang, Fan; Wan, Hai-Ying] Tongji Univ, Tongji Hosp, Dept Clin Lab, Shanghai 200092, Peoples R China; [Wang, Xuan] Putuo Peoples Hosp, Dept Pharm, Shanghai, Peoples R China; [Wu, Kai-Yin] Charite, Inst Pathol, Berlin, Germany	Tongji University; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Wan, HY (corresponding author), Tongji Univ, Tongji Hosp, Dept Clin Lab, Shanghai 200092, Peoples R China.	186ldwx@googlemail.com			National Natural Science Foundation of China Grants [81272603]; Research Program of the Committee of Science and Technology of Putuo District, Shanghai [PTKW09-B02]	National Natural Science Foundation of China Grants(National Natural Science Foundation of China (NSFC)); Research Program of the Committee of Science and Technology of Putuo District, Shanghai	This work was supported by National Natural Science Foundation of China Grants (81272603); Research Program of the Committee of Science and Technology of Putuo District, Shanghai (PTKW09-B02). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beisswenger Christoph, 2005, V86, P55, DOI 10.1159/000086651; Bingle L, 2002, J PATHOL, V196, P254, DOI 10.1002/path.1027; Bucki R, 2010, ARCH IMMUNOL THER EX, V58, P15, DOI 10.1007/s00005-009-0057-2; Chromek M, 2006, NAT MED, V12, P636, DOI 10.1038/nm1407; Coffelt SB, 2008, CANCER RES, V68, P6482, DOI 10.1158/0008-5472.CAN-08-0044; Coffelt SB, 2008, INT J CANCER, V122, P1030, DOI 10.1002/ijc.23186; Coffelt SB, 2009, MOL CANCER RES, V7, P907, DOI 10.1158/1541-7786.MCR-08-0326; Coffelt SB, 2009, P NATL ACAD SCI USA, V106, P3806, DOI 10.1073/pnas.0900244106; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Erdag G, 2002, ANN SURG, V235, P113, DOI 10.1097/00000658-200201000-00015; Gombart AF, 2005, FASEB J, V19, P1067, DOI 10.1096/fj.04-3284com; Grivennikov SI, 2011, ANN RHEUM DIS, V70, pI104, DOI 10.1136/ard.2010.140145; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Grivennikov SI, 2010, CURR OPIN GENET DEV, V20, P65, DOI 10.1016/j.gde.2009.11.004; Hagemann T, 2004, CARCINOGENESIS, V25, P1543, DOI 10.1093/carcin/bgh146; Hagemann T, 2005, J IMMUNOL, V175, P1197, DOI 10.4049/jimmunol.175.2.1197; Hagemann T, 2008, J EXP MED, V205, P1261, DOI 10.1084/jem.20080108; Hagemann T, 2009, BLOOD, V113, P3139, DOI 10.1182/blood-2008-12-172825; Heilborn JD, 2005, INT J CANCER, V114, P713, DOI 10.1002/ijc.20795; Hensel JA, 2011, PROSTATE, V71, P659, DOI 10.1002/pros.21282; Hess C, 2010, EUR RESPIR J, V35, P343, DOI 10.1183/09031936.00196408; Kim JE, 2010, BRIT J DERMATOL, V163, P959, DOI 10.1111/j.1365-2133.2010.09957.x; Kim S, 2009, NATURE, V457, P102, DOI 10.1038/nature07623; Koukourakis MI, 1998, BRIT J CANCER, V77, P1696, DOI 10.1038/bjc.1998.280; Krutzik SR, 2008, J IMMUNOL, V181, P7115, DOI 10.4049/jimmunol.181.10.7115; Liu PT, 2006, SCIENCE, V311, P1770, DOI 10.1126/science.1123933; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Murdoch C, 2008, NAT REV CANCER, V8, P618, DOI 10.1038/nrc2444; Pollard JW, 2004, NAT REV CANCER, V4, P71, DOI 10.1038/nrc1256; Ricciardelli C, 2006, SEMIN REPROD MED, V24, P270, DOI 10.1055/s-2006-948556; Schauber J, 2007, J CLIN INVEST, V117, P803, DOI 10.1172/JCI30142; Shaykhiev R, 2005, AM J PHYSIOL-LUNG C, V289, pL842, DOI 10.1152/ajplung.00286.2004; Sorensen OE, 2003, J IMMUNOL, V170, P5583, DOI 10.4049/jimmunol.170.11.5583; Standiford TJ, 2011, ONCOGENE, V30, P2475, DOI 10.1038/onc.2010.619; Takahashi H, 2010, CANCER CELL, V17, P89, DOI 10.1016/j.ccr.2009.12.008; von Haussen J, 2008, LUNG CANCER, V59, P12, DOI 10.1016/j.lungcan.2007.07.014; Voutilainen K, 2003, INT J CANCER, V107, P359, DOI 10.1002/ijc.11423; Wu WKK, 2010, INT J CANCER, V127, P1741, DOI 10.1002/ijc.25489; Xiao S, 2006, P NATL ACAD SCI USA, V103, P16448, DOI 10.1073/pnas.0607830103; Yoshimura A, 2006, CANCER SCI, V97, P439, DOI 10.1111/j.1349-7006.2006.00197.x	40	47	56	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2013	8	2							e56616	10.1371/journal.pone.0056616	http://dx.doi.org/10.1371/journal.pone.0056616			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104BU	23424670	gold, Green Published, Green Submitted			2022-12-25	WOS:000315965100058
J	Radke, J; Bortolussi, G; Pagenstecher, A				Radke, Josefine; Bortolussi, Ginette; Pagenstecher, Axel			Akt and c-Myc Induce Stem-Cell Markers in Mature Primary p53(-/-) Astrocytes and Render These Cells Gliomagenic in the Brain of Immunocompetent Mice	PLOS ONE			English	Article							IN-VITRO; GLIOBLASTOMA-MULTIFORME; ANAPLASTIC ASTROCYTOMA; PATHWAY ACTIVATION; SELF-RENEWAL; MOUSE MODELS; P53; CANCER; EXPRESSION; DIFFERENTIATION	Astrocytomas and their most malignant variant glioblastoma multiforme (GBM) represent the vast majority of primary brain tumors. Despite the current progress in neurosurgery, radiation therapy and chemotherapy, most astrocytomas remain fatal disorders. Although brain tumor biology is a matter of intense research, the cell-of-origin and the complete astrocytoma-inducing signaling pathway remain unknown. To further identify the mechanisms leading to gliomagenesis, we transduced primary astrocytes on a p53(-/-) background with c-Myc, constitutively active myr-Akt or both, myr-Akt and c-Myc. Transduced astrocytes showed oncogene-specific alterations of morphology, proliferation and differentiation. Following prolonged periods of cultivation, oncogene-transduced astrocytes expressed several stem-cell markers. Furthermore, astrocytes coexpressing c-Myc and Akt were tumorigenic when implanted into the brain of immunocompetent C57BL/6 mice. Our results reveal that the loss of p53 combined with oncogene overexpression in mature astrocytes simulates pivotal features of glioma pathogenesis, providing a good model for assessing the development of secondary glioblastomas.	[Radke, Josefine; Bortolussi, Ginette; Pagenstecher, Axel] Univ Marburg, Dept Neuropathol, Marburg, Germany	Philipps University Marburg	Pagenstecher, A (corresponding author), Univ Marburg, Dept Neuropathol, Marburg, Germany.	pagenste@med.uni-marburg.de	Radke, Josefine/GQH-8274-2022	Radke, Josefine/0000-0001-9860-2007; Pagenstecher, Axel/0000-0001-9627-6439	University Hospital (UKGM); University of Marburg	University Hospital (UKGM); University of Marburg	This study was funded by an in-house grant according to the cooperation agreement between the University Hospital (UKGM) and the University of Marburg. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Althoff GEM, 2010, AM J PATHOL, V177, P840, DOI 10.2353/ajpath.2010.090918; Bello MJ, 2006, CANCER GENET CYTOGEN, V164, P172, DOI 10.1016/j.cancergencyto.2005.07.002; Boehm JS, 2007, CELL, V129, P1065, DOI 10.1016/j.cell.2007.03.052; Bogler O, 1999, CELL GROWTH DIFFER, V10, P73; BOGLER O, 1995, CANCER RES, V55, P2746; Boone DN, 2011, P NATL ACAD SCI USA, V108, P632, DOI 10.1073/pnas.1008848108; Bourseau-Guilmain E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025515; CBTRUS, 2012, STAT REP PRIM BRAIN; Endersby R, 2008, ONCOGENE, V27, P5416, DOI 10.1038/onc.2008.239; Fatoo A, 2011, J NEURO-ONCOL, V103, P397, DOI 10.1007/s11060-010-0406-3; Felsher DW, 2000, P NATL ACAD SCI USA, V97, P10544, DOI 10.1073/pnas.190327097; Fischer U, 2010, INT J CANCER, V126, P2594, DOI 10.1002/ijc.24971; Friedl G, 2004, J VIROL, V78, P1212, DOI 10.1128/JVI.78.3.1212-1218.2004; Ge WP, 2012, NATURE, V484, P376, DOI 10.1038/nature10959; Griend DJV, 2008, CANCER RES, V68, P9703, DOI 10.1158/0008-5472.CAN-08-3084; Hadjipanayis CG, 2009, TRENDS MOL MED, V15, P519, DOI 10.1016/j.molmed.2009.09.003; Hambardzumyan D, 2011, GLIA, V59, P1155, DOI 10.1002/glia.21142; Herold S, 2009, NAT REV CANCER, V9, P441, DOI 10.1038/nrc2640; Hoffman B, 2008, ONCOGENE, V27, P6462, DOI 10.1038/onc.2008.312; Holland EC, 2000, NAT GENET, V25, P55, DOI 10.1038/75596; Huse JT, 2010, NAT REV CANCER, V10, P319, DOI 10.1038/nrc2818; Jao SW, 2012, ANN SURG ONCOL, V19, P3432, DOI 10.1245/s10434-012-2394-3; Jeuken J, 2007, ACTA NEUROPATHOL, V114, P121, DOI 10.1007/s00401-007-0239-0; Ke RH, 2009, NEUROSCI RES, V65, P280, DOI 10.1016/j.neures.2009.08.002; Kim YH, 2011, BRAIN PATHOL, V21, P645, DOI 10.1111/j.1750-3639.2011.00492.x; Kleihues P, 1999, Neuro Oncol, V1, P44, DOI 10.1093/neuonc/1.1.44; Ksendzovsky A, 2009, J NEURO-ONCOL, V93, P107, DOI 10.1007/s11060-009-9884-6; Lassman AB, 2004, NEURON GLIA BIOL, V1, P157, DOI 10.1017/S1740925X04000249; Lee JS, 2008, BIOCHEM BIOPH RES CO, V365, P496, DOI 10.1016/j.bbrc.2007.11.005; Martelli AM, 2006, CELL SIGNAL, V18, P1101, DOI 10.1016/j.cellsig.2006.01.011; Meletis K, 2006, DEVELOPMENT, V133, P363, DOI 10.1242/dev.02208; Moliterno JA, 2012, CANCER J, V18, P20, DOI 10.1097/PPO.0b013e3183243f6e3; Munoz DM, 2011, ONCOTARGET, V2, P590; Murphy DJ, 2008, CANCER CELL, V14, P447, DOI 10.1016/j.ccr.2008.10.018; Nozaki M, 1999, Neuro Oncol, V1, P124, DOI 10.1093/neuonc/1.2.124; Ohgaki H, 2007, AM J PATHOL, V170, P1445, DOI 10.2353/ajpath.2007.070011; Ohgaki H, 2009, CANCER SCI, V100, P2235, DOI 10.1111/j.1349-7006.2009.01308.x; Park DM, 2009, MOL CELLS, V28, P7, DOI 10.1007/s10059-009-0111-2; Purow B, 2009, NAT REV NEUROL, V5, P419, DOI 10.1038/nrneurol.2009.96; Reilly KM, 2000, NAT GENET, V26, P109, DOI 10.1038/79075; Ruano Y, 2008, CANCER-AM CANCER SOC, V112, P1575, DOI 10.1002/cncr.23338; Sachdeva M, 2009, P NATL ACAD SCI USA, V106, P3207, DOI 10.1073/pnas.0808042106; Schmidt KF, 2004, J NEURO-ONCOL, V68, P207, DOI 10.1023/B:NEON.0000033364.43142.bf; Siebzehnrubl FA, 2011, GLIA, V59, P1135, DOI 10.1002/glia.21143; Sonoda Y, 2001, CANCER RES, V61, P4956; Sonoda Y, 2001, CANCER RES, V61, P6674; Spalding KL, 2005, CELL, V122, P133, DOI 10.1016/j.cell.2005.04.028; Stalder A K, 1999, Methods Mol Med, V22, P53, DOI 10.1385/0-89603-612-X:53; Swift S, 2001, Curr Protoc Immunol, VChapter 10, DOI 10.1002/0471142735.im1017cs31; Tabatabai G, 2011, CELL TISSUE RES, V343, P459, DOI 10.1007/s00441-010-1123-0; Varley JM, 1997, BRIT J CANCER, V76, P1, DOI 10.1038/bjc.1997.328; Vetter M, 2009, J NEUROPATH EXP NEUR, V68, P525, DOI 10.1097/NEN.0b013e3181a2afa0; Wang J, 2008, INT J CANCER, V122, P761, DOI 10.1002/ijc.23130; Wang YY, 2012, J NEURO-ONCOL, V106, P217, DOI 10.1007/s11060-011-0679-1; Wang Y, 2009, CANCER CELL, V15, P514, DOI 10.1016/j.ccr.2009.04.001; Weller M, 2012, CANCER J, V18, P40, DOI 10.1097/PPO.0b013e318243f6c9; Wildeboer D, 2006, J NEUROPATH EXP NEUR, V65, P516, DOI 10.1097/01.jnen.0000229240.51490.d3; YAHANDA AM, 1995, MOL CELL BIOL, V15, P4249; Zheng H, 2008, COLD SH Q B, V73, P427, DOI 10.1101/sqb.2008.73.047; Zheng HW, 2008, NATURE, V455, P1129, DOI 10.1038/nature07443	60	28	30	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2013	8	2							e56691	10.1371/journal.pone.0056691	http://dx.doi.org/10.1371/journal.pone.0056691			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104BU	23424671	Green Published, Green Submitted, gold			2022-12-25	WOS:000315965100059
J	Rashed, A; Kwan, J; Baraff, B; Ling, D; Daugherty, MP; Killiny, N; Almeida, RPP				Rashed, Arash; Kwan, Joyce; Baraff, Breanna; Ling, Diane; Daugherty, Matthew P.; Killiny, Nabil; Almeida, Rodrigo P. P.			Relative Susceptibility of Vitis vinifera Cultivars to Vector-Borne Xylella fastidiosa through Time	PLOS ONE			English	Article							SCANNING-ELECTRON-MICROSCOPY; PIERCES DISEASE BACTERIUM; ARABIDOPSIS-THALIANA; GENETIC-VARIATION; RESISTANCE; GRAPEVINE; PLANT; TRANSMISSION; PREFERENCE; TOLERANCE	Understanding the interactions between pathogen, crop and vector are necessary for the development of disease control practices of vector-borne pathogens. For instance, resistant plant genotypes can help constrain disease symptoms due to infections and limit pathogen spread by vectors. On the other hand, genotypes susceptible to infection may increase pathogen spread owing to their greater pathogen quantity, regardless of their symptom status. In this study, we evaluated under greenhouse conditions the relative levels of resistance (i.e. relatively lower pathogen quantity) versus tolerance (i.e. less symptom severity) of 10 commercial grapevine (Vitis vinifera) cultivars to Pierce's disease etiological agent, the bacterium Xylella fastidiosa. Overall, no correlation was detected between pathogen quantity and disease severity, indicating the existence of among-cultivar variation in plant response to infection. Thompson Seedless and Barbera were the two most susceptible among 10 evaluated cultivars. Rubired showed the least severe disease symptoms and was categorized as one of the most resistant genotypes in this study. However, within each cultivar the degree of resistance/tolerance was not consistent across sampling dates. These cultivar and temporal differences in susceptibility to infection may have important consequences for disease epidemiology and the effectiveness of management protocols.	[Rashed, Arash; Kwan, Joyce; Baraff, Breanna; Ling, Diane; Almeida, Rodrigo P. P.] Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA; [Daugherty, Matthew P.] Univ Calif Riverside, Dept Entomol, Riverside, CA 92521 USA; [Killiny, Nabil] Univ Florida, Dept Entomol & Nematol, Citrus Res & Educ Ctr, IFAS, Lake Alfred, FL USA	University of California System; University of California Berkeley; University of California System; University of California Riverside; State University System of Florida; University of Florida	Rashed, A (corresponding author), Texas A&M AgriLife Res & Extens Ctr, Amarillo, TX USA.	arashed@ag.tamu.edu	Almeida, Rodrigo/GZH-0682-2022	Killiny, Nabil/0000-0002-3895-6943; Almeida, Rodrigo/0000-0003-2888-9617	California Department of Food and Agriculture, Pierce's Disease Research Grant Program [CDFA 08-0173, 2010-34442-21101]; United States Department of Agriculture (USDA-CSREES) [2009-05174]	California Department of Food and Agriculture, Pierce's Disease Research Grant Program; United States Department of Agriculture (USDA-CSREES)(United States Department of Agriculture (USDA)National Institute of Food and Agriculture)	This study was funded by California Department of Food and Agriculture, Pierce's Disease Research Grant Program (CDFA 08-0173 to RPPA, and 2010-34442-21101 to MPD), and United States Department of Agriculture (USDA-CSREES #2009-05174 to MPD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alves E, 2004, J PHYTOPATHOL, V152, P291, DOI 10.1111/j.1439-0434.2004.00843.x; ANDERSON TR, 1986, PLANT DIS, V70, P468, DOI 10.1094/PD-70-468; Baccari C, 2011, PHYTOPATHOLOGY, V101, P77, DOI 10.1094/PHYTO-04-10-0104; Blua M. J., 1999, California Agriculture, V53, P22, DOI 10.3733/ca.v053n02p22; BLUA MJ, 1992, ENVIRON ENTOMOL, V21, P578, DOI 10.1093/ee/21.3.578; Chatterjee S, 2008, ANNU REV PHYTOPATHOL, V46, P243, DOI 10.1146/annurev.phyto.45.062806.094342; Crawley M. J., 2009, R BOOK; Daugherty MP, 2009, ANN APPL BIOL, V155, P361, DOI 10.1111/j.1744-7348.2009.00346.x; Daugherty MP, 2011, ECOL ENTOMOL, V36, P654, DOI 10.1111/j.1365-2311.2011.01309.x; Daugherty MP, 2010, ECOL ENTOMOL, V35, P360, DOI 10.1111/j.1365-2311.2010.01189.x; Feil H, 2001, PLANT DIS, V85, P1230, DOI 10.1094/PDIS.2001.85.12.1230; Francis M, 2006, EUR J PLANT PATHOL, V115, P203, DOI 10.1007/s10658-006-9009-4; Fritschi FB, 2008, PLANT DIS, V92, P276, DOI 10.1094/PDIS-92-2-0276; Fritschi FB, 2007, AM J ENOL VITICULT, V58, P326; FRY SM, 1990, PHYTOPATHOLOGY, V80, P61, DOI 10.1094/Phyto-80-61; Goss EM, 2006, EVOLUTION, V60, P1562, DOI 10.1111/j.0014-3820.2006.tb00501.x; Guilhabert MR, 2005, MOL PLANT MICROBE IN, V18, P856, DOI 10.1094/MPMI-18-0856; Hewitt Wm. B., 1942, CALIFORNIA AGRIC EXP STA CIRC, V353, P1; HILL BL, 1995, PHYTOPATHOLOGY, V85, P1368, DOI 10.1094/Phyto-85-1368; Hill BL, 1997, PHYTOPATHOLOGY, V87, P1197, DOI 10.1094/PHYTO.1997.87.12.1197; HOPKINS DL, 1989, ANNU REV PHYTOPATHOL, V27, P271, DOI 10.1146/annurev.py.27.090189.001415; HOPKINS DL, 1981, PHYTOPATHOLOGY, V71, P415, DOI 10.1094/Phyto-71-415; Hopkins DL, 2002, PLANT DIS, V86, P1056, DOI 10.1094/PDIS.2002.86.10.1056; Kolmer JA, 1996, ANNU REV PHYTOPATHOL, V34, P435, DOI 10.1146/annurev.phyto.34.1.435; Kover PX, 2002, P NATL ACAD SCI USA, V99, P11270, DOI 10.1073/pnas.102288999; Krivanek AF, 2005, PHYTOPATHOLOGY, V95, P44, DOI 10.1094/PHYTO-95-0044; Krivanek AF, 2005, PHYTOPATHOLOGY, V95, P36, DOI 10.1094/PHYTO-95-0036; Laine AL, 2007, J EVOLUTION BIOL, V20, P2371, DOI 10.1111/j.1420-9101.2007.01406.x; Laine AL, 2011, J ECOL, V99, P96, DOI 10.1111/j.1365-2745.2010.01738.x; Mauck KE, 2010, P NATL ACAD SCI USA, V107, P3600, DOI 10.1073/pnas.0907191107; MAY RM, 1983, PROC R SOC SER B-BIO, V219, P281, DOI 10.1098/rspb.1983.0075; MCELHANY P, 1995, ECOLOGY, V76, P444, DOI 10.2307/1941203; Meung H, 2003, PLANT DIS, V87, P1156, DOI 10.1094/PDIS.2003.87.10.1156; Newman KL, 2003, APPL ENVIRON MICROB, V101, P1737; Purcell A., 2001, Pesticide Outlook, V12, P199, DOI 10.1039/b108599a; Purcell A. H., 1997, Journal of Plant Pathology, V79, P99; PURCELL AH, 1974, AM J ENOL VITICULT, V25, P162; Raberg L, 2007, SCIENCE, V318, P812, DOI 10.1126/science.1148526; RAJU BC, 1981, AM J ENOL VITICULT, V32, P155; Rashed A, 2011, ENVIRON ENTOMOL, V40, P1192, DOI 10.1603/EN11108; Restif O, 2004, AM NAT, V164, pE90, DOI 10.1086/423713; Sisterson MS, 2008, J ECON ENTOMOL, V101, P1, DOI 10.1603/0022-0493(2008)101[1:EOIPFH]2.0.CO;2; Sorensen JT, 1996, PAN-PAC ENTOMOL, V72, P160; Stenger DC, 2010, VIROLOGY, V407, P53, DOI 10.1016/j.virol.2010.08.002; TYSON GE, 1985, PHYTOPATHOLOGY, V75, P264, DOI 10.1094/Phyto-75-264	45	18	18	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2013	8	2							e55326	10.1371/journal.pone.0055326	http://dx.doi.org/10.1371/journal.pone.0055326			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104BU	23424629	Green Published, gold, Green Submitted			2022-12-25	WOS:000315965100017
J	Pedersen, K; Canals, F; Prat, A; Tabernero, J; Arribas, J				Pedersen, K.; Canals, F.; Prat, A.; Tabernero, J.; Arribas, J.			PELO negatively regulates HER receptor signalling and metastasis	ONCOGENE			English	Article						breast cancer; EGFR; metastasis; p95HER2; PELO; PI3K	GROWTH-FACTOR RECEPTOR; BREAST-CANCER METASTASIS; MOLECULAR CHARACTERIZATION; KINASE INHIBITOR; PROTEIN; NETWORK; PHOSPHORYLATION; PROTEOMICS; CARCINOMA; MIGRATION	The HER family is composed of four receptor tyrosine kinases, which are frequently deregulated in several types of cancer. Activated HER receptors initiate intracellular signalling pathways by attracting to the plasma membrane a plethora of adaptor and signalling molecules. Although there are more than a dozen HER-interacting proteins that regulate signal transduction and have been extensively studied, recent proteomic studies have shown the existence of many novel but largely uncharacterized factors that may bind HER receptors. In this report, we describe a cell-based identification of several new HER2-binding proteins, including HAX1, YWHAZ, PELO and ACP1. Analysis of these factors showed that one of them, PELO, binds to active HER2 and epidermal growth factor receptor and thereby attenuates phosphatidylinositol 3-kinase (PI3K)/AKT signalling, likely through regulation of the recruitment of p85-PI3K to activated receptor. Functional characterization of PELO showed that it negatively regulates cell migration and metastasis in vivo. These results reveal that PELO is a novel regulator of HER-signalling and therefore is likely to have a role in inhibiting tumour progression and invasion.	[Pedersen, K.; Canals, F.; Arribas, J.] Vall Hebron Inst Oncol, Preclin Res Program, Barcelona 08035, Spain; [Prat, A.] VHIO, Translat Genom Res Program, Barcelona 08035, Spain; [Tabernero, J.] VHIO, Clin Res Program, Barcelona 08035, Spain; [Arribas, J.] Univ Autonoma Barcelona, Dept Biochem & Mol Biol, Bellaterra, Spain; [Arribas, J.] ICREA, Barcelona, Spain	Vall d'Hebron Institut d'Oncologia (VHIO); Vall d'Hebron Institut d'Oncologia (VHIO); Autonomous University of Barcelona; ICREA	Pedersen, K (corresponding author), Vall Hebron Inst Oncol, Preclin Res Program, Psg Vall Hebron 119-129, Barcelona 08035, Spain.	kp@kim-pedersen.com; jarribas@vhio.net	Tabernero, Josep/AAG-5026-2019; Prat, Aleix/P-8561-2014; Arribas, Jose R/A-1595-2015; Arribas, Joaquin/M-4482-2014	Tabernero, Josep/0000-0002-2495-8139; Prat, Aleix/0000-0003-2377-540X; Arribas, Joaquin/0000-0002-0504-0664	Instituto de Salud Carlos III [PI081154]; Instituto de Salud Carlos III (network of cooperative cancer research) [RTICC-RD06/0020/0022]; Breast Cancer Research Foundation; Asociacion Espanola Contra el Cancer (AECC); AVON Foundation; AECC; ICREA Funding Source: Custom	Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Instituto de Salud Carlos III (network of cooperative cancer research); Breast Cancer Research Foundation; Asociacion Espanola Contra el Cancer (AECC); AVON Foundation; AECC; ICREA(ICREA)	This work was supported by the Instituto de Salud Carlos III (Intrasalud PI081154 and the network of cooperative cancer research (RTICC-RD06/0020/0022)), the Breast Cancer Research Foundation, the Asociacion Espanola Contra el Cancer (AECC) and AVON Foundation. KP was supported by the postdoctoral program from the AECC.	Adham IM, 2003, MOL CELL BIOL, V23, P1470, DOI 10.1128/MCB.23.4.1470-1476.2003; Baselga J, 2009, NAT REV CANCER, V9, P463, DOI 10.1038/nrc2656; Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; Blagoev B, 2003, NAT BIOTECHNOL, V21, P315, DOI 10.1038/nbt790; Burnicka-Turek O, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-28; Citri A, 2006, NAT REV MOL CELL BIO, V7, P505, DOI 10.1038/nrm1962; Davis L, 1998, GENETICS, V149, P45; EBERHART CG, 1995, DEVELOPMENT, V121, P3477; Engelman JA, 2009, NAT REV CANCER, V9, P550, DOI 10.1038/nrc2664; Garcia-Castillo J, 2009, J BIOL CHEM, V284, P25302, DOI 10.1074/jbc.M109.001982; Hammerman PS, 2012, NATURE, V489, P519, DOI 10.1038/nature11404; Hynes NE, 2009, CURR OPIN CELL BIOL, V21, P177, DOI 10.1016/j.ceb.2008.12.010; Jones RB, 2006, NATURE, V439, P168, DOI 10.1038/nature04177; Kang YB, 2003, CANCER CELL, V3, P537, DOI 10.1016/S1535-6108(03)00132-6; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Minn AJ, 2005, NATURE, V436, P518, DOI 10.1038/nature03799; Moasser MM, 2001, CANCER RES, V61, P7184; Morandell S, 2008, PROTEOMICS, V8, P4383, DOI 10.1002/pmic.200800204; Mukherjee M, 2012, EMBO J, V31, P1308, DOI 10.1038/emboj.2011.496; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Nielsen TO, 2004, CLIN CANCER RES, V10, P5367, DOI 10.1158/1078-0432.CCR-04-0220; Oppel F, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-137; Pedersen K, 2009, MOL CELL BIOL, V29, P3319, DOI 10.1128/MCB.01803-08; Prat A, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2635; Rhodes N, 2008, CANCER RES, V68, P2366, DOI 10.1158/0008-5472.CAN-07-5783; Rodrigues GA, 2000, MOL CELL BIOL, V20, P1448, DOI 10.1128/MCB.20.4.1448-1459.2000; Schulze WX, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100012; Segatto O, 2011, J CELL SCI, V124, P1785, DOI 10.1242/jcs.083303; STOVER DR, 1995, J BIOL CHEM, V270, P15591, DOI 10.1074/jbc.270.26.15591; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Yaffe MB, 2002, NAT REV MOL CELL BIO, V3, P177, DOI 10.1038/nrm759; Yarden Y, 2012, NAT REV CANCER, V12, P553, DOI 10.1038/nrc3309; Zhout PC, 2003, J BIOL CHEM, V278, P13829, DOI 10.1074/jbc.M209640200	33	10	10	1	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 27	2014	33	9					1190	1197		10.1038/onc.2013.35	http://dx.doi.org/10.1038/onc.2013.35			8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AB6XT	23435426				2022-12-25	WOS:000331933800012
J	Newman, JA; Rodrigues, C; Lewis, RJ				Newman, Joseph A.; Rodrigues, Cecilia; Lewis, Richard J.			Molecular Basis of the Activity of SinR Protein, the Master Regulator of Biofilm Formation in Bacillus subtilis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SPORULATION; REPRESSOR; EXPRESSION; COMPLEX; SYSTEM	Bacterial biofilms are complex communities of cells that are attached to a surface by an extracellular matrix. Biofilms are an increasing environmental and healthcare issue, causing problems ranging from the biofouling of ocean-going vessels, to dental plaque, infections of the urinary tract, and contamination of medical instruments such as catheters. A complete understanding of biofilm formation therefore requires knowledge of the regulatory pathways underpinning its formation so that effective intervention strategies can be determined. The master regulator that determines whether the Gram-positive model organism Bacillus subtilis switches from a free-living, planktonic lifestyle to form a biofilm is called SinR. The activity of SinR, a transcriptional regulator, is controlled by its antagonists, SinI, SlrA, and SlrR. The interaction of these four proteins forms a switch, which determines whether or not SinR can inhibit biofilm formation by its repression of a number of extracellular matrix-associated operons. To determine the thermodynamic and kinetic parameters governing the protein-protein and protein-DNA interactions at the heart of this epigenetic switch, we have analyzed the protein-protein and protein-DNA interactions by isothermal titration calorimetry and surface plasmon resonance. We also present the crystal structure of SinR in complex with DNA, revealing the molecular basis of base-specific DNA recognition by SinR and suggesting that the most effective means of transcriptional control occurs by the looping of promoter DNA. The structural analysis also enables predictions about how SinR activity is controlled by its interaction with its antagonists.	[Newman, Joseph A.; Rodrigues, Cecilia; Lewis, Richard J.] Newcastle Univ, Inst Cell & Mol Biosci, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England	Newcastle University - UK	Lewis, RJ (corresponding author), Newcastle Univ, Inst Cell & Mol Biosci, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.	r.lewis@ncl.ac.uk	Rodrigues, Cecilia MP/M-3572-2013	Rodrigues, Cecilia MP/0000-0002-4829-754X; lewis, richard/0000-0003-2641-8643; newman, Joseph/0000-0003-4488-0516; Rodrigues, Cecilia/0000-0002-9643-9733	Biotechnology and Biological Sciences Research Council as part of the BaCell SysMO2 consortium; BBSRC [BB/I004572/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/I004572/1] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council as part of the BaCell SysMO2 consortium(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by a Biotechnology and Biological Sciences Research Council grant (to R. J. L.) as part of the BaCell SysMO2 consortium.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; BAI U, 1993, GENE DEV, V7, P139, DOI 10.1101/gad.7.1.139; Branda SS, 2006, MOL MICROBIOL, V59, P1229, DOI 10.1111/j.1365-2958.2005.05020.x; Branda SS, 2001, P NATL ACAD SCI USA, V98, P11621, DOI 10.1073/pnas.191384198; Chai YR, 2008, MOL MICROBIOL, V67, P254, DOI 10.1111/j.1365-2958.2007.06040.x; Chai YR, 2010, GENE DEV, V24, P754, DOI 10.1101/gad.1915010; Chai YR, 2009, MOL MICROBIOL, V74, P876, DOI 10.1111/j.1365-2958.2009.06900.x; Chai YR, 2009, J BACTERIOL, V191, P2423, DOI 10.1128/JB.01464-08; Chu F, 2006, MOL MICROBIOL, V59, P1216, DOI 10.1111/j.1365-2958.2005.05019.x; Chu F, 2008, MOL MICROBIOL, V68, P1117, DOI 10.1111/j.1365-2958.2008.06201.x; Colledge VL, 2011, J MOL BIOL, V411, P597, DOI 10.1016/j.jmb.2011.06.004; Davey ME, 2000, MICROBIOL MOL BIOL R, V64, P847, DOI 10.1128/MMBR.64.4.847-867.2000; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; GAUR NK, 1988, J BACTERIOL, V170, P1046, DOI 10.1128/jb.170.3.1046-1053.1988; Hamon MA, 2001, MOL MICROBIOL, V42, P1199, DOI 10.1046/j.1365-2958.2001.02709.x; HARRISON SC, 1990, ANNU REV BIOCHEM, V59, P933, DOI 10.1146/annurev.bi.59.070190.004441; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kearns DB, 2005, MOL MICROBIOL, V55, P739, DOI 10.1111/j.1365-2958.2004.04440.x; Kobayashi K, 2008, MOL MICROBIOL, V69, P1399, DOI 10.1111/j.1365-2958.2008.06369.x; Lewis RJ, 1996, FEBS LETT, V378, P98, DOI 10.1016/0014-5793(95)01432-2; Lewis RJ, 1998, J MOL BIOL, V283, P907, DOI 10.1006/jmbi.1998.2163; Lu XJ, 2008, NAT PROTOC, V3, P1213, DOI 10.1038/nprot.2008.104; Margot P, 1996, MICROB DRUG RESIST, V2, P119, DOI 10.1089/mdr.1996.2.119; MONDRAGON A, 1991, J MOL BIOL, V219, P321, DOI 10.1016/0022-2836(91)90568-Q; O'Toole G, 2000, ANNU REV MICROBIOL, V54, P49, DOI 10.1146/annurev.micro.54.1.49; OTWINOWSKI Z, 1988, NATURE, V335, P321, DOI 10.1038/335321a0; Rohs R, 2010, ANNU REV BIOCHEM, V79, P233, DOI 10.1146/annurev-biochem-060408-091030; Rohs R, 2009, NATURE, V461, P1248, DOI 10.1038/nature08473; Scott DJ, 1999, J MOL BIOL, V293, P997, DOI 10.1006/jmbi.1999.3221; Sutherland IW, 2001, TRENDS MICROBIOL, V9, P222, DOI 10.1016/S0966-842X(01)02012-1; Whitchurch CB, 2002, SCIENCE, V295, P1487, DOI 10.1126/science.295.5559.1487	31	68	69	3	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 12	2013	288	15					10766	10778		10.1074/jbc.M113.455592	http://dx.doi.org/10.1074/jbc.M113.455592			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	125TU	23430750	hybrid, Green Published			2022-12-25	WOS:000317565000055
J	Chan, AA; Hertsenberg, AJ; Funderburgh, ML; Mann, MM; Du, YQ; Davoli, KA; Mich-Basso, JD; Yang, L; Funderburgh, JL				Chan, Audrey A.; Hertsenberg, Andrew J.; Funderburgh, Martha L.; Mann, Mary M.; Du, Yiqin; Davoli, Katherine A.; Mich-Basso, Jocelyn Danielle; Yang, Lei; Funderburgh, James L.			Differentiation of Human Embryonic Stem Cells into Cells with Corneal Keratocyte Phenotype	PLOS ONE			English	Article							NEURAL CREST CELLS; IN-VITRO; KERATAN SULFATE; COLLAGEN LAMELLAE; PROGENITOR CELLS; EXPRESSION; TISSUE; STROMA; FIBROBLASTS; GENERATION	Corneal transparency depends on a unique extracellular matrix secreted by stromal keratocytes, mesenchymal cells of neural crest lineage. Derivation of keratocytes from human embryonic stem (hES) cells could elucidate the keratocyte developmental pathway and open a potential for cell-based therapy for corneal blindness. This study seeks to identify conditions inducing differentiation of pluripotent hES cells to the keratocyte lineage. Neural differentiation of hES cell line WA01(H1) was induced by co-culture with mouse PA6 fibroblasts. After 6 days of co-culture, hES cells expressing cell-surface NGFR protein (CD271, p75NTR) were isolated by immunoaffinity adsorption, and cultured as a monolayer for one week. Keratocyte phenotype was induced by substratum-independent pellet culture in serum-free medium containing ascorbate. Gene expression, examined by quantitative RT-PCR, found hES cells co-cultured with PA6 cells for 6 days to upregulate expression of neural crest genes including NGFR, SNAI1, NTRK3, SOX9, and MSX1. Isolated NGFR-expressing cells were free of PA6 feeder cells. After expansion as a monolayer, mRNAs typifying adult stromal stem cells were detected, including BMI1, KIT, NES, NOTCH1, and SIX2. When these cells were cultured as substratum-free pellets keratocyte markers AQP1, B3GNT7, PTDGS, and ALDH3A1 were upregulated. mRNA for keratocan (KERA), a cornea-specific proteoglycan, was upregulated more than 10,000 fold. Culture medium from pellets contained high molecular weight keratocan modified with keratan sulfate, a unique molecular component of corneal stroma. These results show hES cells can be induced to differentiate into keratocytes in vitro. Pluripotent stem cells, therefore, may provide a renewable source of material for development of treatment of corneal stromal opacities.	[Chan, Audrey A.; Hertsenberg, Andrew J.; Funderburgh, Martha L.; Mann, Mary M.; Du, Yiqin; Davoli, Katherine A.; Funderburgh, James L.] Univ Pittsburgh, Sch Med, Dept Ophthalmol, Pittsburgh, PA 15261 USA; [Mich-Basso, Jocelyn Danielle; Yang, Lei] Univ Pittsburgh, Sch Med, Dept Dev Biol, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Funderburgh, JL (corresponding author), Univ Pittsburgh, Sch Med, Dept Ophthalmol, Pittsburgh, PA 15261 USA.	jlfunder@pitt.edu	DU, YIQIN/AAO-1566-2020; Yang, Lei/D-7462-2015; Du, Yiqin/A-7727-2018	DU, YIQIN/0000-0002-4330-0957; Hertsenberg, Andrew/0000-0002-9058-1595; Davoli, Katherine/0000-0001-7681-245X	National Institutes of Health [EY016415, EY009368, P30-EY008098]; Research to Prevent Blindness Inc; Eye and Ear Foundation of Pittsburgh; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000005] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY009368, P30EY008098, R01EY016415] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research to Prevent Blindness Inc(Research to Prevent Blindness (RPB)); Eye and Ear Foundation of Pittsburgh; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	Supported by National Institutes of Health Grants EY016415 (JLF), EY009368 (JLF), P30-EY008098, Research to Prevent Blindness Inc, and the Eye and Ear Foundation of Pittsburgh. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe S, 2012, CELL BIOL INT, V36, P927, DOI 10.1042/CBI20110506; Betters E, 2010, DEV BIOL, V344, P578, DOI 10.1016/j.ydbio.2010.05.012; Cox G, 2012, BONE, V50, P510, DOI 10.1016/j.bone.2011.07.016; Doillon CJ, 2003, INT J ARTIF ORGANS, V26, P764, DOI 10.1177/039139880302600810; Du YD, 2005, STEM CELLS, V23, P1266, DOI 10.1634/stemcells.2004-0256; Du YQ, 2007, INVEST OPHTH VIS SCI, V48, P5038, DOI 10.1167/iovs.07-0587; Du YQ, 2012, INVEST OPHTH VIS SCI, V53, P1566, DOI 10.1167/iovs.11-9134; Du YQ, 2010, MOL VIS, V16, P2680; Du YQ, 2009, STEM CELLS, V27, P1635, DOI 10.1002/stem.91; Funderburgh JL, 2000, GLYCOBIOLOGY, V10, P951, DOI 10.1093/glycob/10.10.951; Funderburgh JL, 2003, J BIOL CHEM, V278, P45629, DOI 10.1074/jbc.M303292200; Funderburgh ML, 2008, MOL VIS, V14, P308; Funderburgh ML, 2005, FASEB J, V19, P1371, DOI 10.1096/fj.04-2770fje; Guo XQ, 2007, INVEST OPHTH VIS SCI, V48, P4050, DOI 10.1167/iovs.06-1216; Jiang XH, 2009, STEM CELLS DEV, V18, P1059, DOI 10.1089/scd.2008.0362; Karamichos D, 2010, INVEST OPHTH VIS SCI, V51, P1382, DOI 10.1167/iovs.09-3860; Kitayama K, 2007, J BIOL CHEM, V282, P30085, DOI 10.1074/jbc.M703695200; Lambiase A, 2005, P NATL ACAD SCI USA, V102, P16795, DOI 10.1073/pnas.0508516102; Lee G, 2007, NAT BIOTECHNOL, V25, P1468, DOI 10.1038/nbt1365; Lee G, 2010, NAT PROTOC, V5, P688, DOI 10.1038/nprot.2010.35; Liu H, 2011, J CELL MOL MED; Long CJ, 2000, J BIOL CHEM, V275, P13918, DOI 10.1074/jbc.275.18.13918; Ludwig TE, 2006, NAT METHODS, V3, P637, DOI 10.1038/NMETH902; Morishige N, 2011, INVEST OPHTH VIS SCI, V52, P911, DOI 10.1167/iovs.10-5657; Pinnamaneni N, 2012, STEM CELLS; Pomp O, 2005, STEM CELLS, V23, P923, DOI 10.1634/stemcells.2005-0038; Qi H, 2008, EXP EYE RES, V86, P34, DOI 10.1016/j.exer.2007.09.003; Qi H, 2007, MOL VIS, V13, P1934; Ren SW, 2010, MOL VIS, V16, P1076; Roh DS, 2011, INVEST OPHTH VIS SCI, V52, P5174, DOI 10.1167/iovs.11-7272; Torbet J, 2007, P ANN INT IEEE EMBS, P6400; Turksen K, 2006, HUMAN EMBRYONIC STEM; Vaculik C, 2012, J INVEST DERMATOL, V132, P563, DOI 10.1038/jid.2011.355; Vrana NE, 2008, INVEST OPHTH VIS SCI, V49, P5325, DOI 10.1167/iovs.07-1599; Wu J, 2012, BIOMATERIALS, V33, P1343, DOI 10.1016/j.biomaterials.2011.10.055	35	66	69	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2013	8	2							e56831	10.1371/journal.pone.0056831	http://dx.doi.org/10.1371/journal.pone.0056831			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IT	23437251	Green Submitted, gold, Green Accepted, Green Published			2022-12-25	WOS:000315186000051
J	Zhang, Y; Lu, TL; Yan, H; Ruan, YY; Wang, LF; Zhang, D; Yue, WH; Lu, L				Zhang, Yang; Lu, Tianlan; Yan, Hao; Ruan, Yanyan; Wang, Lifang; Zhang, Dai; Yue, Weihua; Lu, Lin			Replication of Association between Schizophrenia and Chromosome 6p21-6p22.1 Polymorphisms in Chinese Han Population	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; SUSCEPTIBILITY GENE; JAPANESE PATIENTS; LINKAGE ANALYSES; COMMON VARIANTS; SCAN DOMAIN; LOCUS; 6P; RISK; HLA	Chromosome 6p21-p22.1, spanning the extended major histocompatibility complex (MHC) region, is a highly polymorphic, gene-dense region. It has been identified as a susceptibility locus of schizophrenia in Europeans, Japanese, and Chinese. In our previous two-stage genome-wide association study (GWAS), polymorphisms of zinc finger with KRAB and SCAN domains 4 (ZKSCAN4), nuclear factor-kappa B-activating protein-like (NKAPL), and piggyBac transposable element derived 1 (PGBD1), localized to chromosome 6p21-p22.1, were strongly associated with schizophrenia. To further investigate the association between polymorphisms at this locus and schizophrenia in the Chinese Han population, we selected eight other single-nucleotide polymorphisms (SNPs) distributed in or near these genes for a case-control association study in an independent sample of 902 cases and 1,091 healthy controls in an attempt to replicate the GWAS results. Four of these eight SNPs (rs12214383, rs1150724, rs3800324, and rs1997660) displayed a nominal difference in allele frequencies between the case and control groups. The association between two of these SNPs and schizophrenia were significant even after Bonferroni correction (rs12000: allele A. G, P = 2.50E-04, odds ratio [OR] = 1.27, 95% confidence interval [CI] = 1.12-1.45; rs1150722: allele C. T, P = 4.28E-05, OR = 0.55, 95% CI = 0.41-0.73). Haplotype ATTGACGC, comprising these eight SNPs (rs2235359, rs2185955, rs12214383, rs12000, rs1150724, rs1150722, rs3800324, and rs1997660), was significantly associated with schizophrenia (P = 6.60E-05). We also performed a combined study of this replication sample and the first-stage GWAS sample. The combined study revealed that rs12000 and rs1150722 were still strongly associated with schizophrenia (rs12000: allele G. A, P-combined = 0.0019, OR = 0.81; rs1150722: allele G. A, P-combined = 3.00E-04, OR = 0.61). These results support our findings that locus 6p21-p22.1 is significantly associated with schizophrenia in the Chinese Han population and encourage further studies of the functions of these genetic factors.	[Zhang, Yang; Lu, Lin] Peking Univ, Natl Inst Drug Dependence, Beijing 100871, Peoples R China; [Zhang, Yang; Lu, Tianlan; Yan, Hao; Ruan, Yanyan; Wang, Lifang; Zhang, Dai; Yue, Weihua] Peking Univ, Inst Mental Hlth, Beijing 100871, Peoples R China; [Zhang, Yang; Lu, Tianlan; Yan, Hao; Ruan, Yanyan; Wang, Lifang; Zhang, Dai; Yue, Weihua] Peking Univ, Key Lab Mental Hlth, Minist Hlth, Beijing 100871, Peoples R China	Peking University; Peking University; Peking University	Yue, WH (corresponding author), Peking Univ, Inst Mental Hlth, Beijing 100871, Peoples R China.	dryue@bjmu.edu.cn; linlu@bjmu.edu.cn	Yan, Hao/U-1330-2017	Yan, Hao/0000-0003-0376-9037; Zhang, Yang/0000-0001-6898-346X	National Natural Science Foundation of China [81071087, 81071088]; International Science & Technology Cooperation Program of China [2010DFB30820]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); International Science & Technology Cooperation Program of China	This work was supported by grants from the National Natural Science Foundation of China (81071087 and 81071088; http://www.nsfc.gov.cn/) and International Science & Technology Cooperation Program of China (2010DFB30820; http://www.istcp.org.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agartz I, 2011, BIOL PSYCHIAT, V70, P696, DOI 10.1016/j.biopsych.2011.02.034; Alkelai A, 2012, INT J NEUROPSYCHOPH, V15, P459, DOI 10.1017/S1461145711000903; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Belbin O, 2011, HUM GENET, V129, P273, DOI 10.1007/s00439-010-0924-2; Bertram L, 2009, HUM MOL GENET, V18, pR137, DOI 10.1093/hmg/ddp406; Chen JM, 2009, AM J HUM GENET, V85, P775, DOI 10.1016/j.ajhg.2009.10.016; Czerski PM, 2008, NEUROPSYCHOBIOLOGY, V57, P88, DOI 10.1159/000135642; Daniels JK, 1997, AM J MED GENET, V74, P319, DOI 10.1002/(SICI)1096-8628(19970531)74:3<319::AID-AJMG14>3.0.CO;2-R; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Garner C, 1996, AM J MED GENET, V67, P595, DOI 10.1002/(SICI)1096-8628(19961122)67:6<595::AID-AJMG12>3.3.CO;2-D; Gibson S, 1999, AM J MED GENET, V88, P416, DOI 10.1002/(SICI)1096-8628(19990820)88:4<416::AID-AJMG21>3.0.CO;2-S; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Horton R, 2004, NAT REV GENET, V5, P889, DOI 10.1038/nrg1489; Hsu FC, 2011, J EXP MED, V208, P1291, DOI 10.1084/jem.20101874; Ikeda M, 2013, MOL PSYCHIATR, V18, P636, DOI 10.1038/mp.2012.74; Ikeda M, 2011, BIOL PSYCHIAT, V69, P472, DOI 10.1016/j.biopsych.2010.07.010; Ivanov D, 2005, MOL CELL, V17, P137, DOI 10.1016/j.molcel.2004.12.015; Kim HG, 2011, J BIOL CHEM, V286, P17672, DOI 10.1074/jbc.M111.236612; Kim JJ, 2008, EUR ARCH PSY CLIN N, V258, P239, DOI 10.1007/s00406-007-0791-6; Kitazawa M, 2012, AM J MED GENET B, V159B, P456, DOI 10.1002/ajmg.b.32049; Lewis CM, 2003, AM J HUM GENET, V73, P34, DOI 10.1086/376549; Li T, 2005, MOL PSYCHIATR, V10, P1037, DOI 10.1038/sj.mp.4001718; Li T, 2010, BIOL PSYCHIAT, V68, P671, DOI 10.1016/j.biopsych.2010.06.014; Li W, 2003, NAT GENET, V35, P84, DOI 10.1038/ng1229; Ma L, 2013, MOL PSYCHIATR, V18, P638, DOI 10.1038/mp.2012.63; Marchler-Bauer A, 2011, NUCLEIC ACIDS RES, V39, pD225, DOI 10.1093/nar/gkq1189; Matsumoto S, 2002, AM J MED GENET, V114, P42, DOI 10.1002/ajmg.1629; Morano KA, 2007, ANN NY ACAD SCI, V1113, P1, DOI 10.1196/annals.1391.018; Morar B, 2007, AM J MED GENET B, V144B, P318, DOI 10.1002/ajmg.b.30451; Mowry BJ, 2012, MOL PSYCHIAT; Pae CU, 2009, NEUROPSYCHOBIOLOGY, V59, P135, DOI 10.1159/000218075; Pajerowski AG, 2009, IMMUNITY, V30, P696, DOI 10.1016/j.immuni.2009.02.011; Peterson FC, 2006, J MOL BIOL, V363, P137, DOI 10.1016/j.jmb.2006.07.063; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Purcell SM, 2009, NATURE, V460, P748, DOI 10.1038/nature08185; Riley BP, 1996, PSYCHIATR GENET, V6, P41, DOI 10.1097/00041444-199622000-00003; Rogers DP, 2009, EXPERT REV NEUROTHER, V9, P47, DOI 10.1586/14737175.9.1.47; Roig B, 2007, MOL PSYCHIATR, V12, P833, DOI 10.1038/sj.mp.4001995; Schwab SG, 2000, MOL PSYCHIATR, V5, P638, DOI 10.1038/sj.mp.4000791; SCHWAB SG, 1995, NAT GENET, V11, P325, DOI 10.1038/ng1195-325; Seng KC, 2008, EUR J HUM GENET, V16, P554, DOI 10.1038/ejhg.2008.12; Shao LS, 2011, P NATL ACAD SCI USA, V108, P18831, DOI 10.1073/pnas.1114569108; Shi JX, 2009, NATURE, V460, P753, DOI 10.1038/nature08192; Shirts BH, 2007, SCHIZOPHR RES, V94, P342, DOI 10.1016/j.schres.2007.04.021; Singh B, 2011, PSYCHIAT RES, V189, P215, DOI 10.1016/j.psychres.2011.03.010; Stefansson H, 2009, NATURE, V460, P744, DOI 10.1038/nature08186; STRAUB RE, 1995, NAT GENET, V11, P287, DOI 10.1038/ng1195-287; Tochigi M, 2007, AM J MED GENET B, V144B, P305, DOI 10.1002/ajmg.b.30441; Turecki G, 1997, AM J MED GENET, V74, P195, DOI 10.1002/(SICI)1096-8628(19970418)74:2<195::AID-AJMG16>3.3.CO;2-T; Vuillermot S, 2010, J NEUROSCI, V30, P1270, DOI 10.1523/JNEUROSCI.5408-09.2010; Xu SH, 2009, AM J HUM GENET, V85, P762, DOI 10.1016/j.ajhg.2009.10.015; Yue WH, 2011, NAT GENET, V43, P1228, DOI 10.1038/ng.979	52	82	89	2	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2013	8	2							e56732	10.1371/journal.pone.0056732	http://dx.doi.org/10.1371/journal.pone.0056732			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IT	23437227	Green Published, Green Submitted, gold			2022-12-25	WOS:000315186000041
J	Kenny, LC; Lavender, T; McNamee, R; O'Neill, SM; Mills, T; Khashan, AS				Kenny, Louise C.; Lavender, Tina; McNamee, Roseanne; O'Neill, Sinead M.; Mills, Tracey; Khashan, Ali S.			Advanced Maternal Age and Adverse Pregnancy Outcome: Evidence from a Large Contemporary Cohort	PLOS ONE			English	Article							CESAREAN-SECTION RATES; DELAYED CHILDBEARING; FETAL-DEATH; STILLBIRTH; RISK; POPULATION; WOMEN; IMPACT; OLDER	Background: Recent decades have witnessed an increase in mean maternal age at childbirth in most high-resourced countries. Advanced maternal age has been associated with several adverse maternal and perinatal outcomes. Although there are many studies on this topic, data from large contemporary population-based cohorts that controls for demographic variables known to influence perinatal outcomes is limited. Methods: We performed a population-based cohort study using data on all singleton births in 2004-2008 from the North Western Perinatal Survey based at The University of Manchester, UK. We compared pregnancy outcomes in women aged 30-34, 35-39 and >= 40 years with women aged 20-29 years using log-linear binomial regression. Models were adjusted for parity, ethnicity, social deprivation score and body mass index. Results: The final study cohort consisted of 215,344 births; 122,307 mothers (54.19%) were aged 20-29 years, 62,371(27.63%) were aged 30-34 years, 33,966(15.05%) were aged 35-39 years and 7,066(3.13%) were aged >= 40 years. Women aged 40+ at delivery were at increased risk of stillbirth (RR = 1.83, [95% CI 1.37-2.43]), pre-term (RR = 1.25, [95% CI: 1.14-1.36]) and very pre-term birth (RR = 1.29, [95% CI: 1.08-1.55]), Macrosomia (RR = 1.31, [95% CI: 1.12-1.54]), extremely large for gestational age (RR = 1.40, [95% CI: 1.25-1.58]) and Caesarean delivery (RR = 1.83, [95% CI: 1.77-1.90]). Conclusions: Advanced maternal age is associated with a range of adverse pregnancy outcomes. These risks are independent of parity and remain after adjusting for the ameliorating effects of higher socioeconomic status. The data from this large contemporary cohort will be of interest to healthcare providers and women and will facilitate evidence based counselling of older expectant mothers.	[Kenny, Louise C.; Khashan, Ali S.] Cork Univ, Matern Hosp, Univ Coll Cork, Dept Obstet & Gynaecol,Anu Res Ctr, Cork, Ireland; [Lavender, Tina; Mills, Tracey] Univ Manchester, Sch Nursing Midwifery & Social Work, Manchester, Lancs, England; [McNamee, Roseanne] Univ Manchester, Biostat Grp, Sch Community Based Med, Manchester, Lancs, England; [O'Neill, Sinead M.] Cork Univ, Matern Hosp, Univ Coll Cork, Dept Obstet & Gynaecol,Anu Res Ctr,NPEC, Cork, Ireland; [Khashan, Ali S.] Univ Manchester, Maternal & Fetal Hlth Res Ctr, Manchester, Lancs, England	University College Cork; University of Manchester; University of Manchester; University College Cork; University of Manchester	Khashan, AS (corresponding author), Cork Univ, Matern Hosp, Univ Coll Cork, Dept Obstet & Gynaecol,Anu Res Ctr, Cork, Ireland.	a.khashan@ucc.ie	Mills, Tracey A/F-6748-2014; Kenny, Louise/X-6329-2019; Lavender, Tina/B-1211-2011; Kenny, Louise C/G-1112-2011	Mills, Tracey A/0000-0002-2183-7999; Kenny, Louise/0000-0002-9011-759X; Lavender, Tina/0000-0003-1473-4956; Kenny, Louise C/0000-0002-9011-759X; O Neill, Sinead/0000-0001-9787-4609				ALES KL, 1990, SURG GYNECOL OBSTET, V171, P209; Aliyu MH, 2008, ARCH GYNECOL OBSTET, V278, P39, DOI 10.1007/s00404-007-0529-8; Andersen AMN, 2000, BRIT MED J, V320, P1708, DOI 10.1136/bmj.320.7251.1708; [Anonymous], NATL VITAL STAT REPO; Bahtiyar MO, 2008, AM J PERINAT, V25, P301, DOI 10.1055/s-2008-1076605; Bell JS, 2001, BRIT MED J, V322, P894, DOI 10.1136/bmj.322.7291.894; BERKOWITZ GS, 1990, NEW ENGL J MED, V322, P659, DOI 10.1056/NEJM199003083221004; Carolan M, 2003, JOGNN-J OBST GYN NEO, V32, P19, DOI 10.1177/0884217502239797; Carolan M, 2011, MIDWIFERY, V27, P793, DOI 10.1016/j.midw.2010.07.006; Chan BCP, 2008, INT J GYNECOL OBSTET, V102, P237, DOI 10.1016/j.ijgo.2008.05.004; Cleary-Goldman J, 2005, OBSTET GYNECOL, V105, P983, DOI 10.1097/01.AOG.0000158118.75532.51; CNATTINGIUS S, 1992, Journal of the American Medical Association, V268, P886, DOI 10.1001/jama.268.7.886; Delbaere I, 2007, EUR J OBSTET GYN R B, V135, P41, DOI 10.1016/j.ejogrb.2006.10.030; European Commission, FERT STAT; Flenady V, 2011, LANCET, V377, P1331, DOI 10.1016/S0140-6736(10)62233-7; Fretts RC, 2005, AM J OBSTET GYNECOL, V193, P1923, DOI 10.1016/j.ajog.2005.03.074; Hoffman MC, 2007, AM J OBSTET GYNECOL, V196, DOI 10.1016/j.ajog.2006.10.862; Huang L, 2008, CAN MED ASSOC J, V178, P165, DOI 10.1503/cmaj.070150; Janssens S, 2008, AUST NZ J OBSTET GYN, V48, P564, DOI 10.1111/j.1479-828X.2008.00920.x; Jolly M, 2000, HUM REPROD, V15, P2433, DOI 10.1093/humrep/15.11.2433; Joseph KS, 2005, OBSTET GYNECOL, V105, P1410, DOI 10.1097/01.AOG.0000163256.83313.36; Khashan AS, 2009, EUR J EPIDEMIOL, V24, P697, DOI 10.1007/s10654-009-9375-2; Khashan AS, 2010, BMC PREGNANCY CHILDB, V10, DOI 10.1186/1471-2393-10-36; Martin JA, 2011, NATL VITAL STAT REPO, V60; Mathews T, 2002, NATL VITAL STAT REPO, V50; O'Leary CM, 2007, PAEDIATR PERINAT EP, V21, P541, DOI 10.1111/j.1365-3016.2007.00849.x; Office for National Statistics, 2011, FREQ ASK QUEST BIRTH; Office of the deputy Prime Minsiter, 2004, ENGL IND DEPR; Silver RM, 2007, OBSTET GYNECOL, V109, P153, DOI 10.1097/01.AOG.0000248537.89739.96; Wang Y, 2011, ARCH GYNECOL OBSTET, V284, P31, DOI 10.1007/s00404-010-1587-x; Wildschut HIJ, 1999, HIGH RISK PREGNANCY, P39	31	313	329	2	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e56583	10.1371/journal.pone.0056583	http://dx.doi.org/10.1371/journal.pone.0056583			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437176	Green Submitted, gold, Green Published			2022-12-25	WOS:000315184200112
J	Kim, J; Heindl, JE; Fuqua, C				Kim, Jinwoo; Heindl, Jason E.; Fuqua, Clay			Coordination of Division and Development Influences Complex Multicellular Behavior in Agrobacterium tumefaciens	PLOS ONE			English	Article							BACTERIAL RESPONSE REGULATOR; CELL-CYCLE REGULATION; RHIZOBIUM-MELILOTI; HISTIDINE KINASES; BIOFILM FORMATION; TI PLASMID; PROTEINS; TRANSFORMATION; MUTANTS; LOCALIZATION	The alpha-Proteobacterium Agrobacterium tumefaciens has proteins homologous to known regulators that govern cell division and development in Caulobacter crescentus, many of which are also conserved among diverse alpha-Proteobacteria. In light of recent work demonstrating similarity between the division cycle of C. crescentus and that of A. tumefaciens, the functional conservation for this presumptive control pathway was examined. In C. crescentus the CtrA response regulator serves as the master regulator of cell cycle progression and cell division. CtrA activity is controlled by an integrated pair of multi-component phosphorelays: PleC/DivJ-DivK and CckA-ChpT-CtrA. Although several of the conserved orthologues appear to be essential in A. tumefaciens, deletions in pleC or divK were isolated and resulted in cell division defects, diminished swimming motility, and a decrease in biofilm formation. A. tumefaciens also has two additional pleC/divJ homologue sensor kinases called pdhS1 and pdhS2, absent in C. crescentus. Deletion of pdhS1 phenocopied the Delta pleC and Delta divK mutants. Cells lacking pdhS2 morphologically resembled wild-type bacteria, but were decreased in swimming motility and elevated for biofilm formation, suggesting that pdhS2 may serve to regulate the motile to non-motile switch in A. tumefaciens. Genetic analysis suggests that the PleC/DivJ-DivK and CckA-ChpT-CtrA phosphorelays in A. tumefaciens are vertically-integrated, as in C. crescentus. A gain-of-function mutation in CckA (Y674D) was identified as a spontaneous suppressor of the Delta pleC motility phenotype. Thus, although the core architecture of the A. tumefaciens pathway resembles that of C. crescentus there are specific differences including additional regulators, divergent pathway architecture, and distinct target functions.	[Kim, Jinwoo; Heindl, Jason E.; Fuqua, Clay] Indiana Univ, Dept Biol, Bloomington, IN 47405 USA	Indiana University System; Indiana University Bloomington	Fuqua, C (corresponding author), Indiana Univ, Dept Biol, Bloomington, IN 47405 USA.	cfuqua@indiana.edu	Kim, Jinwoo/AAP-8786-2020	Kim, Jinwoo/0000-0003-1104-8088; Heindl, Jason/0000-0003-3919-8045	United States National Institutes of Health (NIH) grant [GM080546]; National Research Foundation of Korea grant [NRF-2007-357-F00002]; Ruth L. Kirschstein National Research Service Award [1 F32 GM100601-01A1]; Indiana University METACyt program; Lilly Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM100601, R01GM080546] Funding Source: NIH RePORTER	United States National Institutes of Health (NIH) grant; National Research Foundation of Korea grant(National Research Foundation of Korea); Ruth L. Kirschstein National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Indiana University METACyt program; Lilly Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This project was supported by United States National Institutes of Health (NIH) grant GM080546 (CF), National Research Foundation of Korea grant NRF-2007-357-F00002 (JK), Ruth L. Kirschstein National Research Service Award 1 F32 GM100601-01A1 (JEH), and through a grant from the Indiana University METACyt program funded in part by a major endowment from the Lilly Foundation (CF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel S, 2011, MOL CELL, V43, P550, DOI 10.1016/j.molcel.2011.07.018; Aldridge P, 2003, MOL MICROBIOL, V47, P1695, DOI 10.1046/j.1365-2958.2003.03401.x; Alvarez-Martinez CE, 2009, MICROBIOL MOL BIOL R, V73, P775, DOI 10.1128/MMBR.00023-09; AMEMURA A, 1984, AGR BIOL CHEM TOKYO, V48, P1809, DOI 10.1080/00021369.1984.10866397; ANAND VK, 1977, AM J BOT, V64, P153, DOI 10.2307/2442102; Bertani G, 2004, J BACTERIOL, V186, P595, DOI 10.1128/JB.186.3.595-600.2004; Biondi EG, 2006, NATURE, V444, P899, DOI 10.1038/nature05321; Brilli M, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-52; Brown PJB, 2012, P NATL ACAD SCI USA, V109, P1697, DOI 10.1073/pnas.1114476109; Brown PJB, 2009, ADV MICROB PHYSIOL, V54, P1, DOI 10.1016/S0065-2911(08)00001-5; Chen YE, 2009, J BACTERIOL, V191, P7417, DOI 10.1128/JB.00992-09; Chesnokova O, 1997, MOL MICROBIOL, V23, P579, DOI 10.1046/j.1365-2958.1997.d01-1875.x; Chiang SL, 2002, GENE, V296, P179, DOI 10.1016/S0378-1119(02)00856-9; Citovsky V, 2007, CELL MICROBIOL, V9, P9, DOI 10.1111/j.1462-5822.2006.00830.x; Cormack BP, 1996, GENE, V173, P33, DOI 10.1016/0378-1119(95)00685-0; Curtis PD, 2010, MICROBIOL MOL BIOL R, V74, P13, DOI 10.1128/MMBR.00040-09; Danhorn T, 2007, ANNU REV MICROBIOL, V61, P401, DOI 10.1146/annurev.micro.61.080706.093316; DELORENZO V, 1994, METHOD ENZYMOL, V235, P386; DOHERTY D, 1988, J BACTERIOL, V170, P4249, DOI 10.1128/jb.170.9.4249-4256.1988; Downie JA, 2010, FEMS MICROBIOL REV, V34, P150, DOI 10.1111/j.1574-6976.2009.00205.x; Dworkin J, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a003368; Dworkin M, 2007, CURR OPIN MICROBIOL, V10, P588, DOI 10.1016/j.mib.2007.10.007; ELY B, 1984, GENETICS, V108, P523; Escobar MA, 2003, TRENDS PLANT SCI, V8, P380, DOI 10.1016/S1360-1385(03)00162-6; FUKUDA A, 1977, J BACTERIOL, V131, P280, DOI 10.1128/JB.131.1.280-287.1977; Gibson KE, 2007, J BACTERIOL, V189, P3591, DOI 10.1128/JB.01834-06; Gibson KE, 2006, J BACTERIOL, V188, P4508, DOI 10.1128/JB.01923-05; Gibson KE, 2008, ANNU REV GENET, V42, P413, DOI 10.1146/annurev.genet.42.110807.091427; Hallez R, 2004, TRENDS MICROBIOL, V12, P361, DOI 10.1016/j.tim.2004.06.002; Hallez R, 2007, EMBO J, V26, P1444, DOI 10.1038/sj.emboj.7601577; Iniesta AA, 2010, P NATL ACAD SCI USA, V107, P7012, DOI 10.1073/pnas.1001767107; Janakiraman A, 2004, TRENDS MICROBIOL, V12, P518, DOI 10.1016/j.tim.2004.09.003; Kahng LS, 2001, J BACTERIOL, V183, P3065, DOI 10.1128/JB.183.10.3065-3075.2001; Kelly AJ, 1998, GENE DEV, V12, P880, DOI 10.1101/gad.12.6.880; Khan SR, 2008, APPL ENVIRON MICROB, V74, P5053, DOI 10.1128/AEM.01098-08; Kirkpatrick C. L, 2011, COLD SPRING HARB PER, V3; Kunik T, 2001, P NATL ACAD SCI USA, V98, P1871, DOI 10.1073/pnas.041327598; Lacroix B, 2006, TRENDS GENET, V22, P29, DOI 10.1016/j.tig.2005.10.004; Lam H, 2003, DEV CELL, V5, P149, DOI 10.1016/S1534-5807(03)00191-6; Laub MT, 2007, ANNU REV GENET, V41, P121, DOI 10.1146/annurev.genet.41.042007.170548; LEIGH JA, 1985, P NATL ACAD SCI USA, V82, P6231, DOI 10.1073/pnas.82.18.6231; Li GL, 2012, MOL MICROBIOL, V83, P41, DOI 10.1111/j.1365-2958.2011.07909.x; LUKAT GS, 1992, P NATL ACAD SCI USA, V89, P718, DOI 10.1073/pnas.89.2.718; MATTHYSSE AG, 1981, J BACTERIOL, V145, P583, DOI 10.1128/JB.145.1.583-595.1981; MAYFIELD CI, 1977, CAN J MICROBIOL, V23, P1311, DOI 10.1139/m77-198; Merritt PM, 2007, J BACTERIOL, V189, P8005, DOI 10.1128/JB.00566-07; MERSEREAU M, 1990, GENE, V90, P149, DOI 10.1016/0378-1119(90)90452-W; Mignolet J, 2010, J BACTERIOL, V192, P3235, DOI 10.1128/JB.00066-10; Morton E.R., 2012, CURR PROTOC MICROBIO, V24; Morton Elise R, 2012, Curr Protoc Microbiol, VChapter 3, DOI 10.1002/9780471729259.mc03d02s25; Paul R, 2004, GENE DEV, V18, P715, DOI 10.1101/gad.289504; Paul R, 2008, CELL, V133, P452, DOI 10.1016/j.cell.2008.02.045; Pierce DL, 2006, J BACTERIOL, V188, P2473, DOI 10.1128/JB.188.7.2473-2482.2006; Piers KL, 1996, P NATL ACAD SCI USA, V93, P1613, DOI 10.1073/pnas.93.4.1613; Quon KC, 1996, CELL, V84, P83, DOI 10.1016/S0092-8674(00)80995-2; Ramey BE, 2004, MOL MICROBIOL, V52, P1495, DOI 10.1111/j.1365-2958.2004.04079.x; Stock AM, 2000, ANNU REV BIOCHEM, V69, P183, DOI 10.1146/annurev.biochem.69.1.183; TEMPE J, 1977, P NATL ACAD SCI USA, V74, P2848, DOI 10.1073/pnas.74.7.2848; Tomlinson AD, 2010, MICROBIOL-SGM, V156, P2670, DOI 10.1099/mic.0.039032-0; Tomlinson AD, 2009, CURR OPIN MICROBIOL, V12, P708, DOI 10.1016/j.mib.2009.09.014; Tsokos CG, 2011, DEV CELL, V20, P329, DOI 10.1016/j.devcel.2011.01.007; Warrens AN, 1997, GENE, V186, P29, DOI 10.1016/S0378-1119(96)00674-9; WATSON B, 1975, J BACTERIOL, V123, P255, DOI 10.1128/JB.123.1.255-264.1975; Wheeler RT, 1999, MOL CELL, V4, P683, DOI 10.1016/S1097-2765(00)80379-2; White CE, 2007, PHILOS T R SOC B, V362, P1135, DOI 10.1098/rstb.2007.2040; WOOD PJ, 1980, CARBOHYD RES, V85, P271, DOI 10.1016/S0008-6215(00)84676-5; Wu JG, 1999, P NATL ACAD SCI USA, V96, P13068, DOI 10.1073/pnas.96.23.13068; Wu JG, 1998, P NATL ACAD SCI USA, V95, P1443, DOI 10.1073/pnas.95.4.1443; Xu J, 2012, RES MICROBIOL, V163, P674, DOI 10.1016/j.resmic.2012.10.013; ZEVENHUIZEN LPTM, 1986, A VAN LEEUW J MICROB, V52, P381, DOI 10.1007/BF00393465; Zhang HT, 2011, J IND MICROBIOL BIOT, V38, P667, DOI 10.1007/s10295-010-0810-x	71	30	30	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e56682	10.1371/journal.pone.0056682	http://dx.doi.org/10.1371/journal.pone.0056682			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437210	Green Published, Green Submitted, gold			2022-12-25	WOS:000315184200140
J	Spring, KJ; Pham, S; Zufall, RA				Spring, Kevin J.; Pham, Stephanie; Zufall, Rebecca A.			Chromosome Copy Number Variation and Control in the Ciliate Chilodonella uncinata	PLOS ONE			English	Article							STRUCTURAL VARIATION; TUBULIN GENES; EXPRESSION; EVOLUTION; GENOME; DNA; AMPLIFICATION; MICRONUCLEAR; SEGREGATION; PROTEIN	Copy number variations are widespread in eukaryotes. The unusual genome architecture of ciliates, in particular, with its process of amitosis in macronuclear division, provides a valuable model in which to study copy number variation. The current model of amitosis envisions stochastic distribution of macronuclear chromosomes during asexual reproduction. This suggests that amitosis is likely to result in high levels of copy number variation in ciliates, as dividing daughter cells can have variable copy numbers of chromosomes if chromosomal distribution during amitosis is a stochastic process. We examined chromosomal distribution during amitosis in Chilodonella uncinata, a ciliate with gene-size macronuclear chromosomes. We quantified 4 chromosomes in evolving populations of C. uncinata and modeled the amitotic distribution process. We found that macronuclear chromosomes differ in copy number from one another but that copy number does not change as expected under a stochastic process. The chromosome carrying SSU increased in copy number, which is consistent with selection to increase abundance; however, two other studied chromosomes displayed much lower than expected among-line variance. Our models suggest that balancing selection is sufficient to explain the observed maintenance of chromosome copy during asexual reproduction.	[Spring, Kevin J.; Pham, Stephanie; Zufall, Rebecca A.] Univ Houston, Dept Biol & Biochem, Houston, TX 77004 USA	University of Houston System; University of Houston	Spring, KJ (corresponding author), Univ Houston, Dept Biol & Biochem, Houston, TX 77004 USA.	kevinjspring@gmail.com			University of Houston GEAR; Sigma Xi	University of Houston GEAR; Sigma Xi	This work was supported in part by the University of Houston GEAR and Sigma Xi Grant-in-Aid of Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PS, 2006, REAL TIME PCR, P40; Aitman TJ, 2006, NATURE, V439, P851, DOI 10.1038/nature04489; Auer H, 2008, CYTOGENET GENOME RES, V123, P278, DOI 10.1159/000184718; Ausubel F.M., 1993, CURRENT PROTOCOLS MO; Baayen RH, 2008, J MEM LANG, V59, P390, DOI 10.1016/j.jml.2007.12.005; Baayen R. H., 2011, LANGUAGE DATA SETS F; BAIRD SE, 1991, J PROTOZOOL, V38, P136, DOI 10.1111/j.1550-7408.1991.tb06033.x; Bates D., 2011, PACKAGE LME4 LINEAR, V1; Bell G., 1988, SEX DEATH PROTOZOA H; Bellec L, 2012, GENE, V504, P303, DOI 10.1016/j.gene.2012.04.067; BLACKBURN EH, 1986, ANNU REV GENET, V20, P501; Canty A, 2012, BOOT BOOTSTRAP R S P; Davison AC, 1997, BOOTSTRAP METHODS TH; Ding CM, 2004, J BIOCHEM MOL BIOL, V37, P1; DOERDER FP, 1992, DEV GENET, V13, P126, DOI 10.1002/dvg.1020130206; Drummond AJ, 2008, GENEIOUS V4 0 4; Duerr HP, 2004, PROTIST, V155, P45, DOI 10.1078/1434461000163; Eickbush TH, 2007, GENETICS, V175, P477, DOI 10.1534/genetics.107.071399; Eisen JA, 2006, PLOS BIOL, V4, P1620, DOI 10.1371/journal.pbio.0040286; Force A, 1999, GENETICS, V151, P1531; Gonzalez E, 2005, SCIENCE, V307, P1434, DOI 10.1126/science.1101160; Halligan DL, 2009, ANNU REV ECOL EVOL S, V40, P151, DOI 10.1146/annurev.ecolsys.39.110707.173437; Hothorn T, 2008, BIOMETRICAL J, V50, P346, DOI 10.1002/bimj.200810425; Ide S, 2010, SCIENCE, V327, P693, DOI 10.1126/science.1179044; Infante JJ, 2003, GENETICS, V165, P1745; Israel RL, 2002, EVOLUTION, V56, P1110; Katz LA, 2003, GENE, V315, P15, DOI 10.1016/j.gene.2003.08.003; Katz LA, 2001, INT J SYST EVOL MICR, V51, P1587, DOI 10.1099/00207713-51-4-1587; KAUFMANN J, 1992, NUCLEIC ACIDS RES, V20, P4445, DOI 10.1093/nar/20.17.4445; Kidd JM, 2008, NATURE, V453, P56, DOI 10.1038/nature06862; KIMURA M, 1957, ANN MATH STAT, V28, P882, DOI 10.1214/aoms/1177706791; Kobayashi T, 1998, GENE DEV, V12, P3821, DOI 10.1101/gad.12.24.3821; LATERZA A, 1995, DEV GENET, V17, P272, DOI 10.1002/dvg.1020170312; Locke DP, 2006, AM J HUM GENET, V79, P275, DOI 10.1086/505653; LONG EO, 1980, ANNU REV BIOCHEM, V49, P727, DOI 10.1146/annurev.bi.49.070180.003455; Nowacki M, 2010, P NATL ACAD SCI USA, V107, P22140, DOI 10.1073/pnas.1012236107; ORIAS E, 1992, DEV GENET, V13, P87, DOI 10.1002/dvg.1020130114; Peirson SN, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng073; PREER JR, 1976, GENET RES, V27, P227, DOI 10.1017/S0016672300016426; PRESCOTT DM, 1994, MICROBIOL REV, V58, P233, DOI 10.1128/MMBR.58.2.233-267.1994; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Robinson T, 2007, MOL BIOL EVOL, V24, P2495, DOI 10.1093/molbev/msm203; Roff DA, 2010, MODELING EVOLUTION I, P223; Rozen S, 2000, Methods Mol Biol, V132, P365; Schenker N, 2001, AM STAT, V55, P182, DOI 10.1198/000313001317097960; SCHENSTED IV, 1958, AM NAT, V92, P161, DOI 10.1086/282023; Stankiewicz P, 2010, ANNU REV MED, V61, P437, DOI 10.1146/annurev-med-100708-204735; Wagner GP, 1997, EVOLUTION, V51, P329, DOI [10.2307/2411105, 10.1111/j.1558-5646.1997.tb02420.x]; Xu K, 2012, GENE, V505, P75, DOI 10.1016/j.gene.2012.05.045; Zufall RA, 2007, J EUKARYOT MICROBIOL, V54, P275, DOI 10.1111/j.1550-7408.2007.00267.x	50	11	11	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e56413	10.1371/journal.pone.0056413	http://dx.doi.org/10.1371/journal.pone.0056413			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437129	Green Published, Green Submitted, gold			2022-12-25	WOS:000315184200071
J	Teng, GG; Wang, WH; Dai, Y; Wang, SJ; Chu, YX; Li, J				Teng, Gui-gen; Wang, Wei-hong; Dai, Yun; Wang, Shu-jun; Chu, Yun-xiang; Li, Jiang			Let-7b Is Involved in the Inflammation and Immune Responses Associated with Helicobacter pylori Infection by Targeting Toll-Like Receptor 4	PLOS ONE			English	Article							GASTRIC EPITHELIAL-CELLS; NF-KAPPA-B; SIGNALING PATHWAY; GENE-EXPRESSION; MICRORNA FAMILY; CANCER; LIPOPOLYSACCHARIDE; INTERLEUKIN-8; ACTIVATION; INDUCTION	Objectives: Toll-like receptors (TLRs) are important initiators in native immune responses to microbial infections. TLR4 is up-regulated in response to H. pylori infection in gastric epithelial cells. However, the regulatory mechanisms for the expression of TLR4 in H. pylori infection have not been clearly defined. The aims of this study are to present the evidence that microRNA let-7b directly regulates TLR4 expression in human gastric epithelial cells, and subsequently influences the activation of NF-kappa B and the expression of the downstream genes in H. pylori infection. Methods: The expression of let-7b was determined in gastric mucosa specimens and in two gastric epithelial cell lines using quantitative RT-PCR. The expression of TLR4 was determined by immunohistochemistry staining and RT-PCR. The potential target of let-7b was identified by luciferase reporter assay and Western blot. Let-7b mimics and inhibitors were used to examine the effects of let-7b on NF-kappa B activity. The expression of the downstream genes of NF-kappa B was also determined in cells infected with H. pylori 26695. Results: Let-7b was significantly decreased in gastric mucosa specimens and in gastric epithelial cell lines (AGS, GES-1) infected with H. pylori 26695 (cagA+). Let-7b was complementary to the 3'-UTR of TLR4 mRNA and regulated TLR4 expression via post-transcriptional suppression in gastric epithelium. Infection of H. pylori induced the expression of TLR4 and activated NF-kappa B in AGS and GES-1 cells. Overexpression of let-7b by mimics downregulated TLR4, and subsequently attenuated NF-kappa B, MyD88, NF-kappa B1/p50, RelA/p65. The expression of IL-8, COX-2 and CyclinD1 was inhibited in H. pylori infected cells with let-7b overexpression. Both TAK-242 (TLR4 inhibitor) and SN50 (NF-kappa B inhibitor) significantly inhibited the H. pylori induced downregulation of let-7b. Conclusions: Let-7b targets at TLR4 mRNA, and regulates the activation of NF-kappa B and the expression of the downstream genes related to the inflammation and immune responses in H. pylori infection.	[Teng, Gui-gen; Wang, Wei-hong; Dai, Yun; Wang, Shu-jun; Chu, Yun-xiang; Li, Jiang] Peking Univ, Dept Gastroenterol, Hosp 1, Beijing 100871, Peoples R China	Peking University	Wang, WH (corresponding author), Peking Univ, Dept Gastroenterol, Hosp 1, Beijing 100871, Peoples R China.	wangweihong@medmail.com.cn			Beijing Natural Science Foundation [7123232]	Beijing Natural Science Foundation(Beijing Natural Science Foundation)	This work was supported by a grant from the Beijing Natural Science Foundation (No. 7123232). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aihara M, 1997, INFECT IMMUN, V65, P3218, DOI 10.1128/IAI.65.8.3218-3224.1997; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Androulidaki A, 2009, IMMUNITY, V31, P220, DOI 10.1016/j.immuni.2009.06.024; Baeuerle PA, 1996, CELL, V87, P13, DOI 10.1016/S0092-8674(00)81318-5; Baldwin AS, 1996, ANNU REV IMMUNOL, V14, P649, DOI 10.1146/annurev.immunol.14.1.649; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Benakanakere MR, 2009, J BIOL CHEM, V284, P23107, DOI 10.1074/jbc.M109.013862; Blaser MJ, 2001, J CLIN INVEST, V107, P767, DOI 10.1172/JCI12672; Chang TC, 2009, P NATL ACAD SCI USA, V106, P3384, DOI 10.1073/pnas.0808300106; Chen XM, 2007, J BIOL CHEM, V282, P28929, DOI 10.1074/jbc.M702633200; Chow JC, 1999, J BIOL CHEM, V274, P10689, DOI 10.1074/jbc.274.16.10689; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Fukata M, 2008, ONCOGENE, V27, P234, DOI 10.1038/sj.onc.1210908; Heikham R, 2010, J BIOSCIENCES, V35, P105, DOI 10.1007/s12038-010-0013-7; Heo I, 2008, MOL CELL, V32, P276, DOI 10.1016/j.molcel.2008.09.014; Iliopoulos D, 2009, CELL, V139, P693, DOI 10.1016/j.cell.2009.10.014; Ishihara S, 2004, J IMMUNOL, V173, P1406, DOI 10.4049/jimmunol.173.2.1406; Johnson SM, 2005, CELL, V120, P635, DOI 10.1016/j.cell.2005.01.014; Jung HC, 1997, J GASTROEN HEPATOL, V12, P473, DOI 10.1111/j.1440-1746.1997.tb00469.x; Keates S, 1997, GASTROENTEROLOGY, V113, P1099, DOI 10.1053/gast.1997.v113.pm9322504; Liu Z, 2010, MICROBES INFECT, V12, P854, DOI 10.1016/j.micinf.2010.06.002; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maeda S, 2000, GASTROENTEROLOGY, V119, P97, DOI 10.1053/gast.2000.8540; Matsushima K, 2011, INT J CANCER, V128, P361, DOI 10.1002/ijc.25348; Mayr C, 2007, SCIENCE, V315, P1576, DOI 10.1126/science.1137999; Motoyama K, 2008, CLIN CANCER RES, V14, P2334, DOI 10.1158/1078-0432.CCR-07-4667; Muzio M, 1998, J EXP MED, V187, P2097, DOI 10.1084/jem.187.12.2097; O'Neill LA, 2011, NAT REV IMMUNOL, V11, P163, DOI 10.1038/nri2957; Pimentel-Nunes P, 2011, PATHOL ONCOL RES, V17, P677, DOI 10.1007/s12253-011-9368-9; Satoh M, 2012, IMMUNOBIOLOGY, V217, P533, DOI 10.1016/j.imbio.2011.08.005; Schmausser B, 2004, CLIN EXP IMMUNOL, V136, P521, DOI 10.1111/j.1365-2249.2004.02464.x; Sharma SA, 1998, J IMMUNOL, V160, P2401; Sheedy FJ, 2010, NAT IMMUNOL, V11, P141, DOI 10.1038/ni.1828; Sonkoly E, 2008, SEMIN CANCER BIOL, V18, P131, DOI 10.1016/j.semcancer.2008.01.005; Strober W, 2004, NAT MED, V10, P898, DOI 10.1038/nm0904-898; Su B, 2003, INFECT IMMUN, V71, P3496, DOI 10.1128/IAI.71.6.3496-3502.2003; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; Takenaka R, 2004, MICROBIOL-SGM, V150, P3913, DOI 10.1099/mic.0.27527-0; Tang B, 2010, FEBS LETT, V584, P1481, DOI 10.1016/j.febslet.2010.02.063; Tserel L, 2011, J BIOL CHEM, V286, P26487, DOI 10.1074/jbc.M110.213561; Wang BL, 2006, WORLD J GASTROENTERO, V12, P966, DOI 10.3748/wjg.v12.i6.966; Wang DJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031240; Wu WKK, 2010, ONCOGENE, V29, P5761, DOI 10.1038/onc.2010.352; Xiao B, 2009, J INFECT DIS, V200, P916, DOI 10.1086/605443; Zhang HH, 2007, WORLD J GASTROENTERO, V13, P2883, DOI 10.3748/wjg.v13.i20.2883	46	107	114	3	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e56709	10.1371/journal.pone.0056709	http://dx.doi.org/10.1371/journal.pone.0056709			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437218	Green Published, gold, Green Submitted			2022-12-25	WOS:000315184200148
J	Gadan, K; Sandtro, A; Marjara, IS; Santi, N; Munang'andu, HM; Evensen, O				Gadan, Koestan; Sandtro, Ane; Marjara, Inderjit S.; Santi, Nina; Munang'andu, Hetron M.; Evensen, Oystein			Stress-Induced Reversion to Virulence of Infectious Pancreatic Necrosis Virus in Naive Fry of Atlantic Salmon (Salmo salar L.)	PLOS ONE			English	Article							CRYSTAL-STRUCTURE; POLYOMAVIRUS VP1; RAINBOW-TROUT; CARRIER STATE; POST-SMOLTS; CELL-LINE; IN-VITRO; A VIRUS; REPLICATION; IPNV	We have studied stress-induced reversion to virulence of infectious pancreatic necrosis virus (IPNV) in persistently infected Atlantic salmon (Salmo salar L.) fry. Naive fry were persistently infected with a virulent strain (T(217)A(221) of major structural virus protein 2, VP2) or a low virulent (T217T221) variant of IPNV. The fry were infected prior to immunocompetence as documented by lack of recombination activating gene-1, T-cell receptor and B-cell receptor mRNA expression at time of challenge. The fish were followed over 6 months and monitored monthly for presence of virus and viral genome mutations. No mutation was identified in the TA or TT group over the 6 months period post infection. Six months post infection TA and TT infected groups were subject to daily stress for 7 days and then sampled weekly for an additional period of 28 days post stress. Stress-responses were documented by down-regulation of mRNA expression of IFN-alpha 1 and concomitant increase of replication levels of T217T221 infected fish at day 1 post stress. By 28 days post stress a T221A reversion was found in 3 of 6 fish in the T217T221 infected group. Sequencing of reverted isolates showed single nucleotide peaks on chromatograms for residue 221 for all three isolates and no mix of TA and TT strains. Replication fitness of reverted (TA) and non-reverted (TT) variants was studied in vitro under an antiviral state induced by recombinant IFN-alpha 1. The T(217)A(221) reverted variant replicated to levels 23-fold higher than the T217T221 strain in IFN-alpha 1 treated cells. Finally, reverted TA strains were virulent when tested in an in vivo trial in susceptible salmon fry. In conclusion, these results indicate that stress plays a key role in viral replication in vivo and can facilitate conditions that will allow reversion from attenuated virus variants of IPNV.	[Gadan, Koestan; Sandtro, Ane; Marjara, Inderjit S.; Munang'andu, Hetron M.; Evensen, Oystein] Norwegian Sch Vet Sci, Oslo, Norway; [Santi, Nina] Aqua Gen AS, Trondheim, Norway	Norwegian University of Life Sciences	Evensen, O (corresponding author), Norwegian Sch Vet Sci, Oslo, Norway.	oystein.evensen@nvh.no	Munang'andu, Hetron Mweemba/C-5926-2014; Evensen, Øystein/O-3011-2015	Munang'andu, Hetron Mweemba/0000-0002-1021-6396; Evensen, Øystein/0000-0002-4856-3043	Research Council of Norway [172508]; European Union [501984]	Research Council of Norway(Research Council of Norway); European Union(European Commission)	Funding was received from the Research Council of Norway (project number 172508) and the European Union under the 6th Framework program (project number 501984). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Bahir I, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.71; BAUER PH, 1995, J VIROL, V69, P7925, DOI 10.1128/JVI.69.12.7925-7931.1995; Betts M.J., 2007, BIOINFORMATICS GENET, DOI [10.1002/9780470059180.ch13, DOI 10.1002/0470867302.CH14]; BOOTLAND LM, 1991, DIS AQUAT ORGAN, V10, P13, DOI 10.3354/dao010013; Brower-Sinning R, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-2-r18; Collet B, 2007, FISH SHELLFISH IMMUN, V22, P44, DOI 10.1016/j.fsi.2006.03.011; Coulibaly F, 2005, CELL, V120, P761, DOI 10.1016/j.cell.2005.01.009; Coulibaly F, 2010, J VIROL, V84, P1792, DOI 10.1128/JVI.01536-09; Evensen O., 2008, ENCY VIROLOGY, P83, DOI DOI 10.1016/B978-012374410-4.00772-X; Fishman SL, 2009, CLIN CANCER RES, V15, P3205, DOI 10.1158/1078-0432.CCR-08-2418; FREUND R, 1991, J VIROL, V65, P350, DOI 10.1128/JVI.65.1.350-355.1991; Grimm D, 2007, P NATL ACAD SCI USA, V104, P6806, DOI 10.1073/pnas.0701849104; Hanada K, 2004, MOL BIOL EVOL, V21, P1074, DOI 10.1093/molbev/msh109; HEDRICK RP, 1978, J FISH DIS, V1, P297, DOI 10.1111/j.1365-2761.1978.tb00034.x; JARP J, 1995, J FISH DIS, V18, P67, DOI 10.1111/j.1365-2761.1995.tb01267.x; JOHANSEN LH, 1995, J FISH DIS, V18, P147, DOI 10.1111/j.1365-2761.1995.tb00272.x; Karber G, 1931, ARCH EXP PATHOL PH, V162, P761; KNOTT RM, 1986, VET IMMUNOL IMMUNOP, V12, P359, DOI 10.1016/0165-2427(86)90141-8; Kudla G, 2009, SCIENCE, V324, P255, DOI 10.1126/science.1170160; Larsen R, 2004, J VIROL, V78, P7938, DOI 10.1128/JVI.78.15.7938-7944.2004; LIU CG, 1995, J VIROL, V69, P1099, DOI 10.1128/JVI.69.2.1099-1106.1995; Lockhart K, 2004, FISH SHELLFISH IMMUN, V17, P245, DOI 10.1016/j.fsi.2004.03.008; Lodish H, 2000, MOL CELL BIOL; MANGUNWIRYO H, 1988, J FISH DIS, V11, P125, DOI 10.1111/j.1365-2761.1988.tb00532.x; Moreno-Gonzalez E, 2003, TRANSPLANT P, V35, P1863, DOI 10.1016/S0041-1345(03)00595-5; Murray AG, 2003, EMERG INFECT DIS, V9, P455; PALESE P, 1974, VIROLOGY, V61, P397, DOI 10.1016/0042-6822(74)90276-1; Roberts RJ, 2005, J FISH DIS, V28, P383, DOI 10.1111/j.1365-2761.2005.00642.x; Sadasiv Eileen C., 1995, Annual Review of Fish Diseases, V5, P209, DOI 10.1016/0959-8030(95)00001-1; Santi N, 2005, VIROLOGY, V342, P13, DOI 10.1016/j.virol.2005.07.028; Santi N, 2005, J VIROL, V79, P9206, DOI 10.1128/JVI.79.14.9206-9216.2005; Santi N, 2004, VIROLOGY, V322, P31, DOI 10.1016/j.virol.2003.12.016; Schvoerer E, 2006, PATHOL BIOL, V54, P556, DOI 10.1016/j.patbio.2006.07.027; Skjesol A, 2009, VIRUS RES, V143, P53, DOI 10.1016/j.virusres.2009.03.004; Song HC, 2005, J VIROL, V79, P10289, DOI 10.1128/JVI.79.16.10289-10299.2005; Taksdal T, 1998, J FISH DIS, V21, P193, DOI 10.1046/j.1365-2761.1998.00092.x; THUVANDER A, 1990, DEV COMP IMMUNOL, V14, P415, DOI 10.1016/0145-305X(90)90034-C; Verani A, 2005, MOL IMMUNOL, V42, P195, DOI 10.1016/j.molimm.2004.06.020; Wergeland HI, 2001, DIS AQUAT ORGAN, V44, P183, DOI 10.3354/dao044183; Xu C, 2010, J VIROL, V84, P8903, DOI 10.1128/JVI.00851-10; Yao K, 1998, J VIROL, V72, P8913, DOI 10.1128/JVI.72.11.8913-8920.1998	42	32	33	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2013	8	2							e54656	10.1371/journal.pone.0054656	http://dx.doi.org/10.1371/journal.pone.0054656			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093HR	23431359	Green Submitted, gold, Green Published			2022-12-25	WOS:000315182800002
J	Gao, YH; Yechikov, S; Vazquez, AE; Chen, DY; Nie, LP				Gao, Yanhong; Yechikov, Sergey; Vazquez, Ana E.; Chen, Dongyang; Nie, Liping			Distinct Roles of Molecular Chaperones HSP90 alpha and HSP90 beta in the Biogenesis of KCNQ4 Channels	PLOS ONE			English	Article							SENSORINEURAL HEARING-LOSS; OUTER HAIR-CELLS; POTASSIUM CHANNELS; CYSTIC-FIBROSIS; CLIENT PROTEINS; HERG CHANNEL; PORE-REGION; HOT-SPOT; MUTATION; GENE	Loss-of-function mutations in the KCNQ4 channel cause DFNA2, a subtype of autosomal dominant non-syndromic deafness that is characterized by progressive sensorineural hearing loss. Previous studies have demonstrated that the majority of the pathogenic KCNQ4 mutations lead to trafficking deficiency and loss of KCNQ4 currents. Over the last two decades, various strategies have been developed to rescue trafficking deficiency of pathogenic mutants; the most exciting advances have been made by manipulating activities of molecular chaperones involved in the biogenesis and quality control of the target protein. However, such strategies have not been established for KCNQ4 mutants and little is known about the molecular chaperones governing the KCNQ4 biogenesis. To identify KCNQ4-associated molecular chaperones, a proteomic approach was used in this study. As a result, two major molecular chaperones, HSP70 and HSP90, were identified and then confirmed by reciprocal co-immunoprecipitation assays, suggesting that the HSP90 chaperone pathway might be involved in the KCNQ4 biogenesis. Manipulating chaperone expression further revealed that two different isoforms of HSP90, the inducible HSP90 alpha and the constitutive HSP90 beta, had opposite effects on the cellular level of the KCNQ4 channel; that HSP40, HSP70, and HOP, three key components of the HSP90 chaperone pathway, were crucial in facilitating KCNQ4 biogenesis. In contrast, CHIP, a major E3 ubiquitin ligase, had an opposite effect. Collectively, our data suggest that HSP90 alpha and HSP90 beta play key roles in controlling KCNQ4 homeostasis via the HSP40-HSP70-HOP-HSP90 chaperone pathway and the ubiquitin-proteasome pathway. Most importantly, we found that over-expression of HSP90 beta significantly improved cell surface expression of the trafficking-deficient, pathogenic KCNQ4 mutants L274H and W276S. KCNQ4 surface expression was restored by HSP90 beta in cells mimicking heterozygous conditions of the DFNA2 patients, even though it was not sufficient to rescue the function of KCNQ4 channels.	[Gao, Yanhong; Yechikov, Sergey; Vazquez, Ana E.; Chen, Dongyang; Nie, Liping] Univ Calif Davis, Dept Otolaryngol, Davis, CA 95616 USA	University of California System; University of California Davis	Vazquez, AE (corresponding author), Univ Calif Davis, Dept Otolaryngol, Davis, CA 95616 USA.	avazquez@ucdavis.edu; lnie@ucdavis.edu			National Institutes of Health, USA [DC008649]; American Hearing Research Foundation; National Science Foundation, USA [0920802]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC008649] Funding Source: NIH RePORTER; Direct For Biological Sciences [0920802] Funding Source: National Science Foundation	National Institutes of Health, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Hearing Research Foundation; National Science Foundation, USA(National Science Foundation (NSF)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by a grant from the National Institutes of Health, USA (DC008649) and a research award from the American Hearing Research Foundation to L.N., and a grant from the National Science Foundation, USA (0920802 to A.E.V). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akita J, 2001, J HUM GENET, V46, P355, DOI 10.1007/s100380170053; Aridon P, 2011, NEURODEGENER DIS, V8, P155, DOI 10.1159/000321548; Arnett J, 2011, ARCH OTOLARYNGOL, V137, P54, DOI 10.1001/archoto.2010.234; Baek JI, 2011, BBA-MOL BASIS DIS, V1812, P536, DOI 10.1016/j.bbadis.2010.09.001; Cheng CF, 2008, MOL CELL BIOL, V28, P3344, DOI 10.1128/MCB.01287-07; Cortes-Gonzalez C, 2010, CELL PHYSIOL BIOCHEM, V26, P657, DOI 10.1159/000322333; de Heer AMR, 2011, ANN OTO RHINOL LARYN, V120, P243, DOI 10.1177/000348941112000405; Dennis A, 2007, BIOCHEM SOC T, V35, P1060, DOI 10.1042/BST0351060; Deutsch C, 2002, ANNU REV PHYSIOL, V64, P19, DOI 10.1146/annurev.physiol.64.081501.155934; Eustace BK, 2004, NAT CELL BIOL, V6, P507, DOI 10.1038/ncb1131; Ficker E, 2003, CIRC RES, V92, pE87, DOI 10.1161/01.RES.0000079028.31393.15; Guo J, 2012, BIOCHEM BIOPH RES CO, V422, P305, DOI 10.1016/j.bbrc.2012.04.153; Hahn JS, 2009, BMB REP, V42, P623, DOI 10.5483/BMBRep.2009.42.10.623; Hartl FU, 2009, NAT STRUCT MOL BIOL, V16, P574, DOI 10.1038/nsmb.1591; Hildebrand MS, 2008, GENET MED, V10, P297, DOI 10.1097/GIM.0b013e318187e106; Hinzpeter A, 2006, AM J PHYSIOL-CELL PH, V290, pC45, DOI 10.1152/ajpcell.00209.2005; Holt JR, 2007, J NEUROSCI, V27, P8940, DOI 10.1523/JNEUROSCI.2085-07.2007; Johnson JL, 2012, BBA-MOL CELL RES, V1823, P607, DOI 10.1016/j.bbamcr.2011.09.020; Kalia SK, 2010, CNS NEUROL DISORD-DR, V9, P741; Kamada F, 2006, J HUM GENET, V51, P455, DOI 10.1007/s10038-006-0384-7; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Kharkovets T, 2006, EMBO J, V25, P642, DOI 10.1038/sj.emboj.7600951; Kim HJ, 2011, J BIOL CHEM, V286, P1517, DOI 10.1074/jbc.M110.179010; Kubisch C, 1999, CELL, V96, P437, DOI 10.1016/S0092-8674(00)80556-5; Kundrat L, 2010, BIOCHEMISTRY-US, V49, P7428, DOI 10.1021/bi100386w; Li W, 2012, BBA-MOL CELL RES, V1823, P730, DOI 10.1016/j.bbamcr.2011.09.009; Luo WJ, 2010, MOL NEURODEGENER, V5, DOI 10.1186/1750-1326-5-24; Mencia A, 2008, HUM GENET, V123, P41, DOI 10.1007/s00439-007-0447-7; Namba Kazunori, 2012, BMC Res Notes, V5, P145, DOI 10.1186/1756-0500-5-145; Neckers L, 2012, CLIN CANCER RES, V18, P64, DOI 10.1158/1078-0432.CCR-11-1000; Nie LP, 2008, CURR OPIN OTOLARYNGO, V16, P441, DOI 10.1097/MOO.0b013e32830f4aa3; Oliver D, 2003, J NEUROSCI, V23, P2141; Peterson LB, 2012, MOL PHARMACEUT, V9, P1841, DOI 10.1021/mp300138n; Pratt WB, 2003, EXP BIOL MED, V228, P111, DOI 10.1177/153537020322800201; Pratt WB, 2010, EXP BIOL MED, V235, P278, DOI 10.1258/ebm.2009.009250; Robbins J, 2001, PHARMACOL THERAPEUT, V90, P1, DOI 10.1016/S0163-7258(01)00116-4; Smith RJ., 1993, GENEREVIEWS; Su CC, 2007, AUDIOL NEURO-OTOL, V12, P20, DOI 10.1159/000096154; Sun F, 2008, FASEB J, V22, P3255, DOI 10.1096/fj.07-105338; Taipale M, 2010, NAT REV MOL CELL BIO, V11, P515, DOI 10.1038/nrm2918; Talebizadeh Z, 1999, HUM MUTAT, V14, P493, DOI 10.1002/(SICI)1098-1004(199912)14:6<493::AID-HUMU8>3.0.CO;2-P; Theodoraki MA, 2012, BBA-MOL CELL RES, V1823, P683, DOI 10.1016/j.bbamcr.2011.08.006; Topsakal V, 2005, OTOL NEUROTOL, V26, P52, DOI 10.1097/00129492-200501000-00009; Trepel J, 2010, NAT REV CANCER, V10, P537, DOI 10.1038/nrc2887; Tsutsumi S, 2008, ONCOGENE, V27, P2478, DOI 10.1038/sj.onc.1210897; Van Camp G, 2002, HUM MUTAT, V20, P15, DOI 10.1002/humu.10096; Van Hauwe P, 2000, AM J MED GENET, V93, P184, DOI 10.1002/1096-8628(20000731)93:3<184::AID-AJMG4>3.0.CO;2-5; Wang XD, 2006, CELL, V127, P803, DOI 10.1016/j.cell.2006.09.043; Wangemann P, 2006, J PHYSIOL-LONDON, V576, P11, DOI 10.1113/jphysiol.2006.112888; Whitesell L, 2012, CURR MOL MED; Yan FF, 2010, MOL BIOL CELL, V21, P1945, DOI 10.1091/mbc.E10-02-0116; Yang BX, 2009, FASEB J, V23, P503, DOI 10.1096/fj.08-118422; Zuehlke A, 2010, BIOPOLYMERS, V93, P211, DOI 10.1002/bip.21292	53	22	23	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2013	8	2							e57282	10.1371/journal.pone.0057282	http://dx.doi.org/10.1371/journal.pone.0057282			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093HR	23431407	Green Published, Green Submitted, gold			2022-12-25	WOS:000315182800050
J	Du, MM; Prescott, J; Cornelis, MC; Hankinson, SE; Giovannucci, E; Kraft, P; De Vivo, I				Du, Mengmeng; Prescott, Jennifer; Cornelis, Marilyn C.; Hankinson, Susan E.; Giovannucci, Edward; Kraft, Peter; De Vivo, Immaculata			Genetic Predisposition to Higher Body Mass Index or Type 2 Diabetes and Leukocyte Telomere Length in the Nurses' Health Study	PLOS ONE			English	Article							INSULIN-RESISTANCE; PHYSICAL-ACTIVITY; OXIDATIVE STRESS; MENDELIAN RANDOMIZATION; CIGARETTE-SMOKING; RISK; ASSOCIATION; CANCER; OBESITY; ADIPOSITY	Background: Although cross-sectional studies have linked higher body mass index (BMI) and type 2 diabetes (T2D) to shortened telomeres, whether these metabolic conditions play a causal role in telomere biology is unknown. We therefore examined whether genetic predisposition to higher BMI or T2D was associated with shortened leukocyte telomere length (LTL). Methodology: We conducted an analysis of 3,968 women of European ancestry aged 43-70 years from the Nurses' Health Study, who were selected as cases or controls in genome-wide association studies and studies of telomeres and disease. Pre-diagnostic relative telomere length in peripheral blood leukocytes, collected in 1989-1990, was measured by quantitative PCR. We combined information from multiple risk variants by calculating genetic risk scores based on 32 polymorphisms near 32 loci for BMI, and 36 polymorphisms near 35 loci for T2D. Findings: After adjustment for age and case-control status, there was no association between the BMI genetic risk score and LTL (beta per standard deviation increase: -0.01; SE: 0.02; P = 0.52). Similarly, the T2D genetic score was not associated with LTL (b per standard deviation increase: -0.006; SE: 0.02; P = 0.69). Conclusions: In this population of middle-aged and older women of European ancestry, those genetically predisposed to higher BMI or T2D did not possess shortened telomeres. Although we cannot exclude weak or modest effects, our findings do not support a causal relation of strong magnitude between these metabolic conditions and telomere dynamics.	[Du, Mengmeng] Univ Washington, Sch Publ Hlth, Dept Epidemiol, Seattle, WA 98195 USA; [Du, Mengmeng] Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, Seattle, WA 98104 USA; [Du, Mengmeng; Prescott, Jennifer; Hankinson, Susan E.; Giovannucci, Edward; De Vivo, Immaculata] Brigham & Womens Hosp, Dept Med, Channing Lab, Boston, MA USA; [Du, Mengmeng; Prescott, Jennifer; Hankinson, Susan E.; Giovannucci, Edward; De Vivo, Immaculata] Harvard Univ, Sch Med, Boston, MA USA; [Prescott, Jennifer; Kraft, Peter; De Vivo, Immaculata] Harvard Univ, Sch Publ Hlth, Program Mol & Genet Epidemiol, Boston, MA 02115 USA; [Cornelis, Marilyn C.; Giovannucci, Edward] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; [Hankinson, Susan E.] Univ Massachusetts, Sch Publ Hlth & Hlth Sci, Div Biostat & Epidemiol, Amherst, MA 01003 USA; [Giovannucci, Edward; Kraft, Peter; De Vivo, Immaculata] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA	University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; University of Massachusetts System; University of Massachusetts Amherst; Harvard University; Harvard T.H. Chan School of Public Health	Du, MM (corresponding author), Univ Washington, Sch Publ Hlth, Dept Epidemiol, Seattle, WA 98195 USA.	mdu@fhcrc.org		De Vivo, Immaculata/0000-0002-7185-7402	National Institutes of Health (NIH) [R01 CA082838, P01 CA87969, R01 CA49449, R01 HL034594, R01 HL088521, CA065725, CA139586, CA140790, CA132190, CA132175, CA133914, JP: T32 ES01664, T32 CA09001, R25 CA94880]; American Health Association Foundation; Canadian Institutes of Health Research Fellowship; NIH [HL35464, CA55075, HHSN268200782096C]; Merck/Rosetta Research Laboratories, North Wales, PA; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) [5P01DK070756]; NIH Genes, Environment, and Health Initiative (GEI) [U01HG004399, U01HG004738, U01HG004422, U01HG004402, U01HG004729, U01HG004726, 01HG004735, U01HG004415, U01HG004436, U01HG004423, U01HG004728, AHG006033]; NIH Institutes [NIDCR: U01DE018993, U01DE018903, NIAAA: U10AA008401, NIDA: P01CA089392, 01DA013423, NCI: CA63464, CA54281, CA136792, Z01CP010200]; NIH GEI [U01HG04424, U01HG004438]; Johns Hopkins University Center for Inherited Disease Research; Merck/Rosetta Research Laboratories;  [R01CA134958-01A1]; NATIONAL CANCER INSTITUTE [R37CA054281, R03CA132175, R01CA063464, P01CA089392, R01CA049449, R01CA134958, R25CA094880, T32CA009001, U01CA136792, K07CA140790, Z01CP010200, R03CA139586, R03CA133914, R03CA132190, P01CA087969, R01CA054281, R01CA082838, R01CA065725, U01CA063464] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL035464, R01HL088521, R01HL034594] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG004415, U01HG004726, U01HG004446, U01HG004423, U01HG004436, U01HG004438, U01HG004424, U01HG004738, U01HG004735, U01HG004729, U01HG004399, U01HG004402, U01HG004422, U01HG004728] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [U01DE018903, U01DE018993] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK070756] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES001664] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [U10AA008401] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA013423] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Health Association Foundation; Canadian Institutes of Health Research Fellowship(Canadian Institutes of Health Research (CIHR)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Merck/Rosetta Research Laboratories, North Wales, PA; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIH Genes, Environment, and Health Initiative (GEI); NIH Institutes(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH GEI; Johns Hopkins University Center for Inherited Disease Research; Merck/Rosetta Research Laboratories; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	The current study was supported by the National Institutes of Health (NIH) (www.nih.gov) (grants R01 CA082838, P01 CA87969, R01 CA49449, R01 HL034594, R01 HL088521; for telomere data: CA065725, CA139586, CA140790, CA132190, CA132175, CA133914; for MD and JP: T32 ES01664, T32 CA09001, R25 CA94880). Telomere data for women in the cognitive sub-study was funded by the American Health Association Foundation. MCC is a recipient of a Canadian Institutes of Health Research Fellowship. The breast cancer GWAS was performed as part of the Cancer Genetic Markers of Susceptibility initiative of the NCI. The CHD GWAS was supported by HL35464 and CA55075 from the NIH with additional support for genotyping from Merck/Rosetta Research Laboratories, North Wales, PA. The Kidney GWAS was supported by The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK): 5P01DK070756. The endometrial cancer GWAS was supported by R01CA134958-01A1. The type 2 diabetes GWAS (U01HG004399) is a component of a collaborative project that includes 13 other GWAS funded as part of the Gene Environment-Association Studies (GENEVA) under the NIH Genes, Environment, and Health Initiative (GEI) (U01HG004738, U01HG004422, U01HG004402, U01HG004729, U01HG004726, 01HG004735, U01HG004415, U01HG004436, U01HG004423, U01HG004728, AHG006033) with additional support from individual NIH Institutes (NIDCR: U01DE018993, U01DE018903; NIAAA: U10AA008401; NIDA: P01CA089392, 01DA013423; NCI: CA63464, CA54281, CA136792, Z01CP010200). Assistance with genotype cleaning and general study coordination was provided by the GENEVA Coordinating Center (U01HG004446). Assistance with data cleaning was provided by the NCBI. Genotyping was performed at the Broad Institute of MIT and Harvard, with funding support from the NIH GEI (U01HG04424), and Johns Hopkins University Center for Inherited Disease Research, with support from the NIH GEI (U01HG004438) and the NIH contract "High throughput genotyping for studying the genetic contributions to human disease" (HHSN268200782096C). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The contents hereof are solely the responsibility of the authors and do not necessarily represent the official views of the NIH.; The genome-wide association study of cardiovascular disease was supported in part by Merck/Rosetta Research Laboratories. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Adaikalakoteswari A, 2007, ATHEROSCLEROSIS, V195, P83, DOI 10.1016/j.atherosclerosis.2006.12.003; Al-Attas OS, 2010, ACTA PAEDIATR, V99, P896, DOI 10.1111/j.1651-2227.2010.01720.x; Al-Attas OS, 2010, EUR J ENDOCRINOL, V163, P601, DOI 10.1530/EJE-10-0241; Aviv A., 2004, SCI AGING KNOWLEDGE, V2004, pp, DOI [10.1126/sageke.2004.51.pe43, DOI 10.1126/SAGEKE.2004.51.PE43]; Benjamini Y, 2001, BEHAV BRAIN RES, V125, P279, DOI 10.1016/S0166-4328(01)00297-2; Blasco MA, 2005, NAT REV GENET, V6, P611, DOI 10.1038/nrg1656; Buxton JL, 2011, J CLIN ENDOCR METAB, V96, P1500, DOI 10.1210/jc.2010-2924; Calado RT, 2009, NEW ENGL J MED, V361, P2353, DOI 10.1056/NEJMra0903373; Cassidy A, 2010, AM J CLIN NUTR, V91, P1273, DOI 10.3945/ajcn.2009.28947; Cawthon RM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e47; Chiuve SE, 2008, CIRCULATION, V118, P947, DOI 10.1161/CIRCULATIONAHA.108.781062; Cornelis MC, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002033; Cornelis MC, 2009, ANN INTERN MED, V150, P541, DOI 10.7326/0003-4819-150-8-200904210-00008; de Miguel-Yanes JM, 2011, DIABETES CARE, V34, P121, DOI 10.2337/dc10-1265; De Vivo I, 2009, CANCER EPIDEM BIOMAR, V18, P1152, DOI 10.1158/1055-9965.EPI-08-0998; Diaz VA, 2010, INT J OBESITY, V34, P261, DOI 10.1038/ijo.2009.198; Didelez V, 2007, STAT METHODS MED RES, V16, P309, DOI 10.1177/0962280206077743; Du MM, 2012, AM J EPIDEMIOL, V175, P414, DOI 10.1093/aje/kwr330; Farzaneh-Far R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008612; Fitzpatrick AL, 2007, AM J EPIDEMIOL, V165, P14, DOI [10.1093/aje/kw346, 10.1093/aje/kwj346]; Franks PW, 2011, CURR DIABETES REP, V11, P552, DOI 10.1007/s11892-011-0224-9; Furukawa S, 2004, J CLIN INVEST, V114, P1752, DOI [10.1172/JCI20042162S, 10.1172/JCI21625]; Gardner JP, 2005, CIRCULATION, V111, P2171, DOI 10.1161/01.CIR.0000163550.70487.0B; Gavin JR, 1997, DIABETES CARE, V20, P1183; Han JL, 2009, J INVEST DERMATOL, V129, P415, DOI 10.1038/jid.2008.238; HANKINSON SE, 1995, J NATL CANCER I, V87, P1297, DOI 10.1093/jnci/87.17.1297; HARRIS M, 1979, DIABETES, V28, P1039; Hu FB, 1999, JAMA-J AM MED ASSOC, V282, P1433, DOI 10.1001/jama.282.15.1433; Hunt SC, 2008, AGING CELL, V7, P451, DOI 10.1111/j.1474-9726.2008.00397.x; Hunter DJ, 2007, NAT GENET, V39, P870, DOI 10.1038/ng2075; Kejariwal Deepak, 2008, BMC Endocr Disord, V8, P12, DOI 10.1186/1472-6823-8-12; Kim SM, 2009, CANCER EPIDEM BIOMAR, V18, P816, DOI 10.1158/1055-9965.EPI-08-0935; Lee M, 2011, AM J HUM BIOL, V23, P100, DOI 10.1002/ajhb.21109; Li SX, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000332; Li Y, 2006, AM J HUM GENET S, VS79, P2290; MacEneaney OJ, 2010, OBESITY, V18, P1677, DOI 10.1038/oby.2009.494; MANSON JE, 1991, LANCET, V338, P774, DOI 10.1016/0140-6736(91)90664-B; McGrath M, 2007, CANCER EPIDEM BIOMAR, V16, P815, DOI 10.1158/1055-9965.EPI-06-0961; Monickaraj F, 2012, MOL CELL BIOCH; Moreno-Navarrete JM, 2010, INT J OBESITY, V34, P1345, DOI 10.1038/ijo.2010.49; Njajou OT, 2011, INT J OBES LOND; Nordfjall K, 2008, OBESITY, V16, P2682, DOI 10.1038/oby.2008.413; O'Callaghan NJ, 2009, REJUV RES, V12, P169, DOI 10.1089/rej.2008.0819; Olivieri F, 2009, ATHEROSCLEROSIS, V206, P588, DOI 10.1016/j.atherosclerosis.2009.03.034; Peterson RE, 2011, HUM GENET, V129, P221, DOI 10.1007/s00439-010-0917-1; Pierce BL, 2011, INT J EPIDEMIOL, V40, P740, DOI 10.1093/ije/dyq151; Pou KM, 2007, CIRCULATION, V116, P1234, DOI 10.1161/CIRCULATIONAHA.107.710509; Prescott J, 2010, CANCER-AM CANCER SOC, V116, P4275, DOI 10.1002/cncr.25328; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Qi L, 2008, NUTR REV, V66, P684, DOI 10.1111/j.1753-4887.2008.00128.x; Qi L, 2010, HUM MOL GENET, V19, P2706, DOI 10.1093/hmg/ddq156; ROSNER B, 1983, TECHNOMETRICS, V25, P165, DOI 10.2307/1268549; Roux AVD, 2009, AGING CELL, V8, P251, DOI 10.1111/j.1474-9726.2009.00470.x; Salpea KD, 2010, ATHEROSCLEROSIS, V209, P42, DOI 10.1016/j.atherosclerosis.2009.09.070; Salpea KD, 2010, ATHEROSCLEROSIS, V209, P35, DOI 10.1016/j.atherosclerosis.2009.12.021; Sampson MJ, 2006, DIABETES CARE, V29, P283, DOI 10.2337/diacare.29.02.06.dc05-1715; Sheehan NA, 2008, PLOS MED, V5, P1205, DOI 10.1371/journal.pmed.0050177; Shen Q, 2012, J CLIN ENDOCRINOL ME; Speliotes EK, 2010, NAT GENET, V42, P937, DOI 10.1038/ng.686; Sun Q, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038374; Testa R, 2011, DIABETIC MED, V28, P1388, DOI 10.1111/j.1464-5491.2011.03370.x; Valdes AM, 2005, LANCET, V366, P662, DOI 10.1016/S0140-6736(05)66630-5; Voight BF, 2010, NAT GENET, V42, P579, DOI 10.1038/ng.609; Wellen KE, 2005, J CLIN INVEST, V115, P1111, DOI 10.1172/JCI200525102; Wentzensen IM, 2011, CANCER EPIDEM BIOMAR, V20, P1238, DOI 10.1158/1055-9965.EPI-11-0005; Wiggs JL, 2011, HUM MOL GENET, V20, P4707, DOI 10.1093/hmg/ddr382; Willeit P, 2010, JAMA-J AM MED ASSOC, V304, P69, DOI 10.1001/jama.2010.897; WILLETT WC, 1987, J AM DIET ASSOC, V87, P43; Wu XF, 2003, J NATL CANCER I, V95, P1211, DOI 10.1093/jnci/djg011; Xiao F, 2011, DIABETES CARE, V34, P2273, DOI 10.2337/dc10-2431; Zannolli R, 2008, ACTA PAEDIATR, V97, P952, DOI 10.1111/j.1651-2227.2008.00783.x; Zee RYL, 2011, ATHEROSCLEROSIS, V218, P144, DOI 10.1016/j.atherosclerosis.2011.05.013; Zee RYL, 2010, TRANSL RES, V155, P166, DOI 10.1016/j.trsl.2009.09.012; Zhu HD, 2011, J PEDIATR-US, V158, P215, DOI 10.1016/j.jpeds.2010.08.007	74	16	17	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2013	8	2							e52240	10.1371/journal.pone.0052240	http://dx.doi.org/10.1371/journal.pone.0052240			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104BU	23424613	gold, Green Published			2022-12-25	WOS:000315965100001
J	Gatford, KL; Sulaiman, SA; Mohammad, SNB; De Blasio, MJ; Harland, ML; Simmons, RA; Owens, JA				Gatford, Kathryn L.; Sulaiman, Siti A.; Mohammad, Saidatul N. B.; De Blasio, Miles J.; Harland, M. Lyn; Simmons, Rebecca A.; Owens, Julie A.			Neonatal Exendin-4 Reduces Growth, Fat Deposition and Glucose Tolerance during Treatment in the Intrauterine Growth-Restricted Lamb	PLOS ONE			English	Article							GLUCAGON-LIKE PEPTIDE-1; BETA-CELL FUNCTION; CARDIOVASCULAR RISK-FACTORS; MESSENGER-RNA EXPRESSION; FOR-GESTATIONAL-AGE; PLACENTAL RESTRICTION; INSULIN SENSITIVITY; EXENATIDE EXENDIN-4; GLYCEMIC CONTROL; BIRTH-WEIGHT	Background: IUGR increases the risk of type 2 diabetes mellitus (T2DM) in later life, due to reduced insulin sensitivity and impaired adaptation of insulin secretion. In IUGR rats, development of T2DM can be prevented by neonatal administration of the GLP-1 analogue exendin-4. We therefore investigated effects of neonatal exendin-4 administration on insulin action and beta-cell mass and function in the IUGR neonate in the sheep, a species with a more developed pancreas at birth. Methods: Twin IUGR lambs were injected s.c. daily with vehicle (IUGR+Veh, n = 8) or exendin-4 (1 nmol.kg(-1), IUGR+Ex-4, n = 8), and singleton control lambs were injected with vehicle (CON, n = 7), from d 1 to 16 of age. Glucose-stimulated insulin secretion and insulin sensitivity were measured in vivo during treatment (d 12-14). Body composition, beta-cell mass and in vitro insulin secretion of isolated pancreatic islets were measured at d 16. Principal Findings: IUGR+Veh did not alter in vivo insulin secretion or insulin sensitivity or beta-cell mass, but increased glucose-stimulated insulin secretion in vitro. Exendin-4 treatment of the IUGR lamb impaired glucose tolerance in vivo, reflecting reduced insulin sensitivity, and normalised glucose-stimulated insulin secretion in vitro. Exendin-4 also reduced neonatal growth and visceral fat accumulation in IUGR lambs, known risk factors for later T2DM. Conclusions: Neonatal exendin-4 induces changes in IUGR lambs that might improve later insulin action. Whether these effects of exendin-4 lead to improved insulin action in adult life after IUGR in the sheep, as in the PR rat, requires further investigation.	[Gatford, Kathryn L.; Sulaiman, Siti A.; Mohammad, Saidatul N. B.; De Blasio, Miles J.; Harland, M. Lyn; Owens, Julie A.] Univ Adelaide, Robinson Inst, Adelaide, SA, Australia; [Gatford, Kathryn L.; Sulaiman, Siti A.; Mohammad, Saidatul N. B.; De Blasio, Miles J.; Harland, M. Lyn; Owens, Julie A.] Univ Adelaide, Sch Paediat & Reprod Hlth, Adelaide, SA, Australia; [Simmons, Rebecca A.] Univ Penn, Perelman Sch Med, Dept Pediat, Philadelphia, PA 19104 USA	Robinson Research Institute; University of Adelaide; University of Adelaide; University of Pennsylvania; Pennsylvania Medicine	Gatford, KL (corresponding author), Univ Adelaide, Robinson Inst, Adelaide, SA, Australia.	kathy.gatford@adelaide.edu.au	De Blasio, Miles J/GQB-1536-2022; Gatford, Kathryn L/B-8136-2013; Owens, Julie A/C-9744-2009; De Blasio, Miles/AAB-7234-2019; Sulaiman, Siti Aishah/Q-9863-2019; De Blasio, Miles/D-5460-2011; Sulaiman, Siti Aishah/O-9240-2015	De Blasio, Miles J/0000-0002-4797-5193; Gatford, Kathryn L/0000-0002-2823-3004; Owens, Julie A/0000-0002-7498-1353; De Blasio, Miles/0000-0002-4797-5193; Sulaiman, Siti Aishah/0000-0001-7309-3381; Sulaiman, Siti Aishah/0000-0001-7309-3381; Simmons, Rebecca/0000-0002-2901-8904	Diabetes Australia Research Trust; National Health and Medical Research Council of Australia [627123]	Diabetes Australia Research Trust; National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	This study was supported from project funding from the Diabetes Australia Research Trust (http://www.diabetesaustralia.com.au/en/Research/DART/) and National Health and Medical Research Council of Australia (grant 627123, http://www.nhmrc.gov.au/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arakawa M, 2009, BIOCHEM BIOPH RES CO, V390, P809, DOI 10.1016/j.bbrc.2009.10.054; BASSETT JM, 1977, ANN RECH VET, V8, P362; Belfiore F, 1998, MOL GENET METAB, V65, P121, DOI 10.1006/mgme.1998.2727; Blonde L, 2006, DIABETES OBES METAB, V8, P436, DOI 10.1111/j.1463-1326.2006.00602.x; Brissova M, 2005, AM J PHYSIOL-ENDOC M, V288, pE707, DOI 10.1152/ajpendo.00252.2004; Buse JB, 2004, DIABETES CARE, V27, P2628, DOI 10.2337/diacare.27.11.2628; Cabou C, 2008, DIABETES, V57, P2577, DOI 10.2337/db08-0121; Cabou C, 2011, DIABETES, V60, P2245, DOI 10.2337/db11-0464; Cersosimo E, 2011, J CLIN ENDOCR METAB, V96, P1763, DOI 10.1210/jc.2010-2146; De Blasio MJ, 2007, AM J PHYSIOL-REG I, V292, pR875, DOI 10.1152/ajpregu.00430.2006; De Blasio MJ, 2007, ENDOCRINOLOGY, V148, P1350, DOI 10.1210/en.2006-0653; De Blasio MJ, 2006, AM J PHYSIOL-REG I, V291, pR1016, DOI 10.1152/ajpregu.00103.2006; De Blasio MJ, 2012, ENDOCRINOLOGY, V153, P2142, DOI 10.1210/en.2011-1955; DeFronzo RA, 2005, DIABETES CARE, V28, P1092, DOI 10.2337/diacare.28.5.1092; DeFronzo RA, 2008, CURR MED RES OPIN, V24, P2943, DOI 10.1185/03007990802418851 ; Ding XK, 2006, HEPATOLOGY, V43, P173, DOI 10.1002/hep.21006; Doyle ME, 2001, RECENT PROG HORM RES, V56, P377, DOI 10.1210/rp.56.1.377; Duffield JA, 2008, AM J PHYSIOL-REG I, V294, pR1413, DOI 10.1152/ajpregu.00787.2007; Duffield JA, 2009, PEDIATR RES, V66, P59, DOI 10.1203/PDR.0b013e3181a7c121; Edwards CMB, 2001, AM J PHYSIOL-ENDOC M, V281, pE155, DOI 10.1152/ajpendo.2001.281.1.E155; Eriksson M, 2004, J INTERN MED, V255, P236, DOI 10.1046/j.1365-2796.2003.01289.x; Fehse F, 2005, J CLIN ENDOCR METAB, V90, P5991, DOI 10.1210/jc.2005-1093; Forsen T, 2000, ANN INTERN MED, V133, P176, DOI 10.7326/0003-4819-133-3-200008010-00008; FOWDEN AL, 1980, J ENDOCRINOL, V87, P293, DOI 10.1677/joe.0.0870293; Garber AJ, 2011, DIABETES CARE, V34, pS258, DOI 10.2337/dc11-s230; Gatford KL, 2008, ENDOCRINOLOGY, V149, P5118, DOI 10.1210/en.2008-0233; Gatford KL, 2004, AM J PHYSIOL-ENDOC M, V286, pE1050, DOI 10.1152/ajpendo.00340.2003; Gedulin BR, 2005, ENDOCRINOLOGY, V146, P2069, DOI 10.1210/en.2004-1349; HANSEN BC, 1990, AM J PHYSIOL, V259, pR612, DOI 10.1152/ajpregu.1990.259.3.R612; Imeryuz N, 1997, AM J PHYSIOL-GASTR L, V273, pG920, DOI 10.1152/ajpgi.1997.273.4.G920; JAHR H, 1983, METABOLISM, V32, P1101, DOI 10.1016/0026-0495(83)90055-0; Jensen CB, 2002, DIABETES, V51, P1271, DOI 10.2337/diabetes.51.4.1271; Jetton TL, 2005, DIABETES, V54, P2294, DOI 10.2337/diabetes.54.8.2294; Kaijser M, 2009, DIABETES, V58, P523, DOI 10.2337/db08-0558; Kassem SA, 2000, DIABETES, V49, P1325, DOI 10.2337/diabetes.49.8.1325; Kastin AJ, 2003, INT J OBESITY, V27, P313, DOI 10.1038/sj.ijo.0802206; Katsumata M, 1999, FASEB J, V13, P1405, DOI 10.1096/fasebj.13.11.1405; Kelly AS, 2012, OBESITY, V20, P364, DOI 10.1038/oby.2011.337; Kolterman OG, 2003, J CLIN ENDOCR METAB, V88, P3082, DOI 10.1210/jc.2002-021545; Kulkarni RN, 2004, J CLIN INVEST, V114, P828, DOI 10.1172/JCI200421845; Kwon DY, 2009, J PHARMACOL SCI, V111, P361, DOI 10.1254/jphs.09178FP; Li L, 2008, DIABETES OBES METAB, V10, P921, DOI 10.1111/j.1463-1326.2007.00832.x; Limesand SW, 2006, ENDOCRINOLOGY, V147, P1488, DOI 10.1210/en.2005-0900; Limesand SW, 2005, AM J PHYSIOL-REG I, V288, pR1297, DOI 10.1152/ajpregu.00494.2004; Linnebjerg H, 2008, REGUL PEPTIDES, V151, P123, DOI 10.1016/j.regpep.2008.07.003; Mericq V, 2005, DIABETOLOGIA, V48, P2609, DOI 10.1007/s00125-005-0036-z; Muhlhausler BS, 2009, J PHYSIOL-LONDON, V587, P4199, DOI 10.1113/jphysiol.2009.173161; National Health and Medical Research Council, 2004, AUSTR COD PRACT CAR; NAUCK MA, 1993, J CLIN INVEST, V91, P301, DOI 10.1172/JCI116186; Navarro-Tableros V, 2007, AM J PHYSIOL-ENDOC M, V292, pE1018, DOI 10.1152/ajpendo.00457.2006; Newsome CA, 2003, DIABETIC MED, V20, P339, DOI 10.1046/j.1464-5491.2003.00871.x; Ong KKL, 2000, BRIT MED J, V320, P967, DOI 10.1136/bmj.320.7240.967; OTONKOSKI T, 1988, DIABETES, V37, P286, DOI 10.2337/diabetes.37.3.286; Owens JA, 2007, EARLY HUM DEV, V83, pS134, DOI 10.1016/S0378-3782(07)70351-1; Owens JA, 2007, AM J PHYSIOL-ENDOC M, V292, pE1879, DOI 10.1152/ajpendo.00706.2006; Park JH, 2008, J CLIN INVEST, V118, P2316, DOI [10.1172/JC133655, 10.1172/JCI33655]; Petrik J, 1999, ENDOCRINOLOGY, V140, P4861, DOI 10.1210/en.140.10.4861; Petrik J, 1998, ENDOCRINOLOGY, V139, P2994, DOI 10.1210/en.139.6.2994; Pinney SE, 2011, DIABETOLOGIA, V54, P2606, DOI 10.1007/s00125-011-2250-1; Piper K, 2004, J ENDOCRINOL, V181, P11, DOI 10.1677/joe.0.1810011; REDDY S, 1988, EXPERIENTIA, V44, P1, DOI 10.1007/BF01960221; Robinson JS, 1996, PEDIAT PERINATOLOGY, P290; Rozance PJ, 2006, AM J PHYSIOL-ENDOC M, V291, pE404, DOI 10.1152/ajpendo.00643.2005; Sano H, 1999, J ANIM SCI, V77, P2564; Scaglia L, 1997, ENDOCRINOLOGY, V138, P1736, DOI 10.1210/en.138.4.1736; Simmons RA, 2005, J BIOL CHEM, V280, P28785, DOI 10.1074/jbc.M505695200; Simmons RA, 2001, DIABETES, V50, P2279, DOI 10.2337/diabetes.50.10.2279; Stoffers DA, 2003, DIABETES, V52, P734, DOI 10.2337/diabetes.52.3.734; Summermatter S, 2009, DIABETES, V58, P2228, DOI 10.2337/db08-1793; Tan C, 2002, DIABETES, V51, P2989, DOI 10.2337/diabetes.51.10.2989; THOMPSON GE, 1983, BRIT J NUTR, V50, P151, DOI 10.1079/BJN19830082; Veening MA, 2003, DIABETES, V52, P1756, DOI 10.2337/diabetes.52.7.1756; Wang Q, 2002, DIABETOLOGIA, V45, P1263, DOI 10.1007/s00125-002-0828-3; Whincup PH, 2008, JAMA-J AM MED ASSOC, V300, P2886, DOI 10.1001/jama.2008.886; Young AA, 1999, DIABETES, V48, P1026, DOI 10.2337/diabetes.48.5.1026; Zander M, 2002, LANCET, V359, P824, DOI 10.1016/S0140-6736(02)07952-7	76	16	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2013	8	2							e56553	10.1371/journal.pone.0056553	http://dx.doi.org/10.1371/journal.pone.0056553			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104BU	23424667	gold, Green Published, Green Submitted			2022-12-25	WOS:000315965100055
J	Yu, FF; Jarver, P; Nygren, PA				Yu, Feifan; Jarver, Peter; Nygren, Per-Ake			Tailor-Making a Protein A-Derived Domain for Efficient Site-Specific Photocoupling to Fc of Mouse IgG(1)	PLOS ONE			English	Article							ANTIBODY-BINDING; BIOTINYLATION; SUBSTRATE; FRAGMENT	Affinity proteins binding to antibody constant regions have proved to be invaluable tools in biotechnology. Here, protein engineering was used to expand the repertoire of available immunoglobulin binding proteins via improvement of the binding strength between the widely used staphylococcal protein A-derived Z domain and the important immunoglobulin isotype mouse IgG(1) (mIgG(1)). Addressing seven positions in the 58-residue three-helix bundle Z domain by single or double amino acid substitutions, a total of 170 variants were individually constructed, produced in E. coli and tested for binding to a set of mouse IgG(1) monoclonal antibodies (mAbs). The best variant, denoted Z(F5I) corresponding to a Phe to Ile substitution at position 5, showed a typical ten-fold higher affinity than the wild-type as determined by biosensor technology. Eight amino acid positions in the Z(F5I) variant were separately mutated to cysteine for incorporation of a photoactivable maleimide-benzophenone (MBP) group as a probe for site-specific photoconjugation to Fc of mIgG(1), The best photocoupling efficiency to mIgG(1) Fc was seen when the MBP group was coupled to Cys at position 32, resulting in adduct formation to more than 60% of all heavy chains, with no observable non-selective conjugation to the light chains. A similar coupling yield was obtained for a panel of 19 different mIgG(1) mAbs, indicating a general characteristic. To exemplify functionalization of a mIgG(1) antibody via site-specific biotinylation, the Z(F5I-Q32C-MBP) protein was first biotinylated using an amine reactive reagent and subsequently photoconjugated to an anti-human interferon-gamma mIgG(1) mAb. When comparing the specific antigen binding ability of the probe-biotinylated mAb to that of the directly biotinylated mAb, a significantly h`igher bioactivity was observed for the sample biotinylated using the Z(F5I-Q32C-MBP) probe. This result indicates that the use of a site-specific and affinity probe-mediated conjugation strategy can result in antibody reagents with increased assay sensitivity.	[Yu, Feifan; Jarver, Peter; Nygren, Per-Ake] AlbaNova Univ Ctr, Royal Inst Technol KTH, Div Mol Biotechnol, Stockholm, Sweden	Royal Institute of Technology	Nygren, PA (corresponding author), AlbaNova Univ Ctr, Royal Inst Technol KTH, Div Mol Biotechnol, Stockholm, Sweden.	perake@biotech.kth.se	Nygren, Per-Åke/AAM-7888-2020	Nygren, Per-Åke/0000-0003-4214-6991; Jarver, Peter/0000-0001-9643-5874	The ProNova VINN Excellence Centre for Protein Technology	The ProNova VINN Excellence Centre for Protein Technology	The ProNova VINN Excellence Centre for Protein Technology (www.biotech.kth.se/pronova) is acknowledged for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beckett D, 1999, PROTEIN SCI, V8, P921, DOI 10.1110/ps.8.4.921; Chapman-Smith A, 1999, BIOMOL ENG, V16, P119, DOI 10.1016/S1050-3862(99)00046-7; Clausson CM, 2011, NAT METHODS, V8, P892, DOI 10.1038/nmeth.1743; DEISENHOFER J, 1981, BIOCHEMISTRY-US, V20, P2361, DOI 10.1021/bi00512a001; Gallagher S, 2011, CURR PROTOC CELL BIO; Holm L, 2009, J BIOL CHEM, V284, P32906, DOI 10.1074/jbc.M109.034322; Jung YW, 2009, ANAL CHEM, V81, P936, DOI 10.1021/ac8014565; KATO K, 1993, FEBS LETT, V328, P49, DOI 10.1016/0014-5793(93)80963-U; Konrad A, 2011, BIOCONJUGATE CHEM, V22, P2395, DOI 10.1021/bc200052h; Nagaoka M, 2003, PROTEIN ENG, V16, P243, DOI 10.1093/proeng/gzg037; NILSSON B, 1987, PROTEIN ENG, V1, P107, DOI 10.1093/protein/1.2.107; Page M, 1998, METH MOL B, V80, P113; SCHATZ PJ, 1993, BIO-TECHNOL, V11, P1138, DOI 10.1038/nbt1093-1138; Stadler C, 2012, J PROTEOMICS, V75, P2236, DOI 10.1016/j.jprot.2012.01.030; Tavoosidana G, 2011, P NATL ACAD SCI USA, V108, P8809, DOI 10.1073/pnas.1019330108; Vashist SK, 2012, ANAL BIOCHEM, V421, P336, DOI 10.1016/j.ab.2011.10.036	16	36	39	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2013	8	2							e56597	10.1371/journal.pone.0056597	http://dx.doi.org/10.1371/journal.pone.0056597			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104BU	23424669	Green Submitted, Green Published, gold			2022-12-25	WOS:000315965100057
J	Kim, YJ; Greer, CB; Cecchini, KR; Harris, LN; Tuck, DP; Kim, TH				Kim, Y. J.; Greer, C. B.; Cecchini, K. R.; Harris, L. N.; Tuck, D. P.; Kim, T. H.			HDAC inhibitors induce transcriptional repression of high copy number genes in breast cancer through elongation blockade	ONCOGENE			English	Article						GRO-seq; transcription elongation; HDAC inhibition; oncogenes; amplicons	HISTONE DEACETYLASE INHIBITORS; RNA-POLYMERASE-II; P-TEFB; 7SK SNRNA; C-MYC; MECHANISMS; EXPRESSION; COMPLEXES; CHROMATIN; PROTEIN	Treatment with histone deacetylase inhibitors (HDACI) results in potent cytotoxicity of a variety of cancer cell types, and these drugs are used clinically to treat hematological tumors. They are known to repress the transcription of ERBB2 and many other oncogenes, but little is known about this mechanism. Using global run-on sequencing (GRO-seq) to measure nascent transcription, we find that HDACI cause transcriptional repression by blocking RNA polymerase II elongation. Our data show that HDACI preferentially repress the transcription of highly expressed genes as well as high copy number genes in HER2 + breast cancer genomes. In contrast, genes that are activated by HDACI are moderately expressed. We analyzed gene copy number in combination with microarray and GRO-seq analysis of expression level, in normal and breast cancer cells to show that high copy number genes are more likely to be repressed by HDACI than non-amplified genes. The inhibition of transcription of amplified oncogenes, which promote survival and proliferation of cancer cells, might explain the cancer-specific lethality of HDACI, and may represent a general therapeutic strategy for cancer.	[Kim, Y. J.; Cecchini, K. R.; Kim, T. H.] Yale Univ, Dept Genet, Sch Med, New Haven, CT 06520 USA; [Greer, C. B.] Yale Univ, Dept Pharmacol, Sch Med, New Haven, CT 06520 USA; [Harris, L. N.] Yale Univ, Dept Med, Sch Med, New Haven, CT 06520 USA; [Harris, L. N.; Tuck, D. P.; Kim, T. H.] Yale Univ, Yale Comprehens Canc Ctr, Sch Med, New Haven, CT 06520 USA; [Tuck, D. P.] Yale Univ, Dept Pathol, Sch Med, New Haven, CT 06520 USA	Yale University; Yale University; Yale University; Yale University; Yale University	Kim, TH (corresponding author), Yale Univ, Dept Genet, Sch Med, 333 Cedar St, New Haven, CT 06520 USA.	taehoon.kim@yale.edu		Kim, Tae Hoon/0000-0003-3950-7557; Greer, Celeste/0000-0001-6876-1189	Rita Allen Foundation; Sidney Kimmel Foundation for Cancer Research; Yale Comprehensive Cancer Center [CA-16359]; Alexander and Margaret Stewart Trust; National Cancer Institute [R01CA140485]; NATIONAL CANCER INSTITUTE [P30CA016359, R01CA140485] Funding Source: NIH RePORTER	Rita Allen Foundation; Sidney Kimmel Foundation for Cancer Research; Yale Comprehensive Cancer Center; Alexander and Margaret Stewart Trust; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank the members of the laboratory for their comments on the manuscript. Yale Center for Genomic Analysis provided services for microarray labeling, hybridization and scanning. Bing Ren (Ludwig Institute for Cancer Research, La Jolla, CA, USA) provided critical help with sequencing the GRO-seq libraries. CBG is a PhRMA Foundation predoctoral fellow. Grants to THK from the Rita Allen Foundation, Sidney Kimmel Foundation for Cancer Research, Yale Comprehensive Cancer Center (CA-16359), Alexander and Margaret Stewart Trust supported this work. A portion of this work was also made possible by a grant from the National Cancer Institute (R01CA140485 to THK).	Albertson DG, 2006, TRENDS GENET, V22, P447, DOI 10.1016/j.tig.2006.06.007; Berger SL, 2007, NATURE, V447, P407, DOI 10.1038/nature05915; Chao SH, 2000, J BIOL CHEM, V275, P28345, DOI 10.1074/jbc.C000446200; Cheng B, 2007, J BIOL CHEM, V282, P21901, DOI 10.1074/jbc.M702936200; Chou CW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018087; Choudhary C, 2009, SCIENCE, V325, P834, DOI 10.1126/science.1175371; Core LJ, 2008, SCIENCE, V319, P1791, DOI 10.1126/science.1150843; Core LJ, 2008, SCIENCE, V322, P1845, DOI 10.1126/science.1162228; Delmore JE, 2011, CELL, V146, P903, DOI 10.1016/j.cell.2011.08.017; Federico M, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/475641; Gilmour DS, 2009, METHODS, V48, P368, DOI 10.1016/j.ymeth.2009.02.020; Govind CK, 2010, MOL CELL, V39, P234, DOI 10.1016/j.molcel.2010.07.003; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Huang XP, 2009, CANCER RES, V69, P8403, DOI 10.1158/0008-5472.CAN-09-2146; Khan N, 2008, BIOCHEM J, V409, P581, DOI 10.1042/BJ20070779; Khan O, 2012, IMMUNOL CELL BIOL, V90, P85, DOI 10.1038/icb.2011.100; Kim YJ, 2011, P NATL ACAD SCI USA, V108, P7391, DOI 10.1073/pnas.1018279108; Kozikowski AP, 2008, J MED CHEM, V51, P4370, DOI 10.1021/jm8002894; LaBonte MJ, 2011, CANCER RES, V71, P3635, DOI 10.1158/0008-5472.CAN-10-2430; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li B, 2007, SCIENCE, V316, P1050, DOI 10.1126/science.1139004; Liu ZZ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010909; Marchion D, 2007, EXPERT REV ANTICANC, V7, P583, DOI 10.1586/14737140.7.4.583; Michels AA, 2004, EMBO J, V23, P2608, DOI 10.1038/sj.emboj.7600275; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Petrella A, 2011, MINI-REV MED CHEM, V11, P519, DOI 10.2174/138955711795843347; Rahl PB, 2010, CELL, V141, P432, DOI 10.1016/j.cell.2010.03.030; Reid G, 2005, ONCOGENE, V24, P4894, DOI 10.1038/sj.onc.1208662; Rikiishi H, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/830260; Sawarkar R, 2012, CELL, V149, P807, DOI 10.1016/j.cell.2012.02.061; Scott GK, 2008, MOL CANCER RES, V6, P1250, DOI 10.1158/1541-7786.MCR-07-2110; Sollars V, 2003, NAT GENET, V33, P70, DOI 10.1038/ng1067; Wang ZB, 2009, CELL, V138, P1019, DOI 10.1016/j.cell.2009.06.049; Xu WS, 2007, ONCOGENE, V26, P5541, DOI 10.1038/sj.onc.1210620; Yik JHN, 2003, MOL CELL, V12, P971, DOI 10.1016/S1097-2765(03)00388-5; Yokoyama S, 2008, PIGM CELL MELANOMA R, V21, P457, DOI 10.1111/j.1755-148X.2008.00480.x; Zuber J, 2011, NATURE, V478, P524, DOI 10.1038/nature10334	38	66	67	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN 6	2013	32	23					2828	2835		10.1038/onc.2013.32	http://dx.doi.org/10.1038/onc.2013.32			8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	163WR	23435418	Green Accepted			2022-12-25	WOS:000320369100003
J	de Silva, S; Hoy, H; Hake, TS; Wong, HK; Porcu, P; Wu, L				de Silva, Suresh; Hoy, Heather; Hake, Timothy S.; Wong, Henry K.; Porcu, Pierluigi; Wu, Li			Promoter Methylation Regulates SAMHD1 Gene Expression in Human CD4(+) T Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; AICARDI-GOUTIERES SYNDROME; RESTRICTS HIV-1 INFECTION; DNA METHYLATION; CPG ISLANDS; IDENTIFICATION; DEMETHYLATION; TRANSCRIPTION; REPLICATION; MACROPHAGES	The retrovirus restriction factor SAMHD1 is the first identified mammalian dNTP triphosphohydrolase that is highly expressed in human myeloid lineage cells and CD4(+) T lymphocytes. Although SAMHD1 expression is variable in human cell lines and tissue types, mechanisms underlying SAMHD1 gene regulation have not been defined. Recent studies showed that SAMHD1 is highly expressed in human primary CD4(+) T lymphocytes, but not in some CD4(+) T cell lines. Here, we report that SAMHD1 expression varies among four CD4(+) T cell lines and is transcriptionally regulated. Cloning and sequence analysis of the human SAMHD1 promoter revealed a CpG island that is methylated in CD4(+) T cell lines (such as Jurkat and Sup-T1), resulting in transcriptional repression of SAMHD1. We also found that the SAMHD1 promoter is unmethylated in primary CD4(+) T lymphocytes, which express high levels of SAMHD1, indicating a direct correlation between the methylation of the SAMHD1 promoter and transcriptional repression. SAMHD1 expression was induced in CD4(+) T cell lines by blocking DNA methyltransferase activity, suggesting that promoter methylation is one of the key epigenetic mechanisms by which SAMHD1 expression is regulated.	[de Silva, Suresh; Hoy, Heather; Wu, Li] Ohio State Univ, Dept Vet Biosci, Ctr Retrovirus Res, Columbus, OH 43210 USA; [Wu, Li] Ohio State Univ, Dept Microbial Infect & Immun, Columbus, OH 43210 USA; [Wong, Henry K.; Porcu, Pierluigi] Ohio State Univ, Dept Internal Med, Columbus, OH 43210 USA; [Hake, Timothy S.; Wong, Henry K.; Porcu, Pierluigi; Wu, Li] Ohio State Univ, Ctr Comprehens Canc, Columbus, OH 43210 USA; [Wong, Henry K.] Ohio State Univ, Div Dermatol, Columbus, OH 43210 USA; [Porcu, Pierluigi] Ohio State Univ, Div Hematol, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Wu, L (corresponding author), Ohio State Univ, Dept Vet Biosci, Ctr Retrovirus Res, 1900 Coffey Rd, Columbus, OH 43210 USA.	wu.840@osu.edu	Wu, Li/ABB-2813-2020; Wu, Li/E-4330-2011; Wong, Henry K/AAU-8810-2021	Wu, Li/0000-0002-5468-2487; Wu, Li/0000-0002-5468-2487; Wong, Henry/0000-0001-9181-7195; Porcu, Pierluigi/0000-0002-8056-023X	National Institutes of Health [AI098524, AI102822]; Public Health Preparedness for Infectious Diseases Program (PHPID) of The Ohio State University; NATIONAL CANCER INSTITUTE [R21CA164911] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI098524, R21AI102822] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Public Health Preparedness for Infectious Diseases Program (PHPID) of The Ohio State University; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants AI098524 and AI102822 (to L. W.).; Supported in part by the Public Health Preparedness for Infectious Diseases Program (PHPID) of The Ohio State University. To whom correspondence should be addressed: Center for Retrovirus Research, Department of Veterinary Biosciences, The Ohio State University, 1900 Coffey Rd., Columbus, OH43210. Tel.:614-292-5408; Fax:614-292-6473; E-mail: wu.840@osu.edu.	Ayinde D, 2012, NAT REV MICROBIOL, V10, P675, DOI 10.1038/nrmicro2862; Baldauf HM, 2012, NAT MED, V18, P1682, DOI 10.1038/nm.2964; Ballestar E, 2001, EUR J BIOCHEM, V268, P1, DOI 10.1046/j.1432-1327.2001.01869.x; Baylin SB, 1998, ADV CANCER RES, V72, P141; Berger A, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002425; Cameron EE, 1999, NAT GENET, V21, P103, DOI 10.1038/5047; Chan MF, 2000, CURR TOP MICROBIOL, V249, P75; Chiurazzi P, 1999, HUM MOL GENET, V8, P2317, DOI 10.1093/hmg/8.12.2317; Christman JK, 2002, ONCOGENE, V21, P5483, DOI 10.1038/sj.onc.1205699; Coon S, 2012, AIDS RES HUM RETROV, V28, P1565, DOI [10.1089/AID.2012.0039, 10.1089/aid.2012.0039]; Crow YJ, 2009, HUM MOL GENET, V18, pR130, DOI 10.1093/hmg/ddp293; de Silva S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035385; Descours B, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-87; Dong CS, 2007, J VIROL, V81, P11352, DOI 10.1128/JVI.01081-07; DUBRIDGE RB, 1987, MOL CELL BIOL, V7, P379, DOI 10.1128/MCB.7.1.379; ERCOLANI L, 1988, J BIOL CHEM, V263, P15335; GARDINERGARDEN M, 1987, J MOL BIOL, V196, P261, DOI 10.1016/0022-2836(87)90689-9; Goldstone DC, 2011, NATURE, V480, P379, DOI 10.1038/nature10623; Herman JG, 1996, P NATL ACAD SCI USA, V93, P9821, DOI 10.1073/pnas.93.18.9821; Hermankova M, 2003, J VIROL, V77, P7383, DOI 10.1128/JVI.77.13.7383-7392.2003; Hrecka K, 2011, NATURE, V474, P658, DOI 10.1038/nature10195; Jaenisch R, 2003, NAT GENET, V33, P245, DOI 10.1038/ng1089; Jamburuthugoda VK, 2006, J BIOL CHEM, V281, P13388, DOI 10.1074/jbc.M600291200; KALTOFT K, 1992, IN VITRO CELL DEV-AN, V28A, P161; LAFUSE WP, 1995, J LEUKOCYTE BIOL, V57, P477, DOI 10.1002/jlb.57.3.477; Laguette N, 2011, NATURE, V474, P654, DOI 10.1038/nature10117; Lahouassa H, 2012, NAT IMMUNOL, V13, P223, DOI 10.1038/ni.2236; LARSEN F, 1992, GENOMICS, V13, P1095, DOI 10.1016/0888-7543(92)90024-M; Li N, 2000, IMMUNOL LETT, V74, P221, DOI 10.1016/S0165-2478(00)00276-5; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Powell RD, 2011, J BIOL CHEM, V286, P43596, DOI 10.1074/jbc.C111.317628; Raghavendra NK, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-66; Rice GI, 2009, NAT GENET, V41, P829, DOI 10.1038/ng.373; St Gelais C, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-105; St Gelais C, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-55; Welbourn S, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-86; White TE, 2013, VIROLOGY, V436, P81, DOI 10.1016/j.virol.2012.10.029; Wu L, 2004, VIROLOGY, V318, P17, DOI 10.1016/j.virol.2003.09.028; Wu L, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-88	39	47	48	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 29	2013	288	13					9284	9292		10.1074/jbc.M112.447201	http://dx.doi.org/10.1074/jbc.M112.447201			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	116DG	23426363	hybrid, Green Published			2022-12-25	WOS:000316862200046
J	Carey, AL; Siebel, AL; Reddy-Luthmoodoo, M; Natoli, AK; D'Souza, W; Meikle, PJ; Sviridov, D; Drew, BG; Kingwell, BA				Carey, Andrew L.; Siebel, Andrew L.; Reddy-Luthmoodoo, Medini; Natoli, Alaina K.; D'Souza, Wilissa; Meikle, Peter J.; Sviridov, Dmitri; Drew, Brian G.; Kingwell, Bronwyn A.			Skeletal Muscle Insulin Resistance Associated with Cholesterol-Induced Activation of Macrophages Is Prevented by High Density Lipoprotein	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; FATTY-ACID OXIDATION; GLUCOSE-UPTAKE; AMP-KINASE; ABCA1; INFLAMMATION; EFFLUX; ACCUMULATION; MECHANISMS; SALSALATE	Background: Emerging evidence suggests that high density lipoprotein (HDL) may modulate glucose metabolism through multiple mechanisms including pancreatic insulin secretion as well as insulin-independent glucose uptake into muscle. We hypothesized that HDL may also increase skeletal muscle insulin sensitivity via cholesterol removal and anti-inflammatory actions in macrophages associated with excess adiposity and ectopic lipid deposition. Methods: Human primary and THP-1 macrophages were treated with vehicle (PBS) or acetylated low density lipoprotein (acLDL) with or without HDL for 18 hours. Treatments were then removed, and macrophages were incubated with fresh media for 4 hours. This conditioned media was then applied to primary human skeletal myotubes derived from vastus lateralis biopsies taken from patients with type 2 diabetes to examine insulin-stimulated glucose uptake. Results: Conditioned media from acLDL-treated primary and THP-1 macrophages reduced insulin-stimulated glucose uptake in primary human skeletal myotubes compared with vehicle (primary macrophages, 168 +/- 21% of basal uptake to 104 +/- 19%; THP-1 macrophages, 142 +/- 8% of basal uptake to 108 +/- 6%; P<0.05). This was restored by co-treatment of macrophages with HDL. While acLDL increased total intracellular cholesterol content, phosphorylation of c-jun N-terminal kinase and secretion of pro- and anti-inflammatory cytokines from macrophages, none were altered by co-incubation with HDL. Insulin-stimulated Akt phosphorylation in human skeletal myotubes exposed to conditioned media was unaltered by either treatment condition. Conclusion: Inhibition of insulin-stimulated glucose uptake in primary human skeletal myotubes by conditioned media from macrophages pre-incubated with acLDL was restored by co-treatment with HDL. However, these actions were not linked to modulation of common pro- or anti-inflammatory mediators or insulin signaling via Akt.	[Carey, Andrew L.; Siebel, Andrew L.; Reddy-Luthmoodoo, Medini; Natoli, Alaina K.; Kingwell, Bronwyn A.] Baker IDI Heart & Diabet Res Inst, Metab & Vasc Physiol Lab, Melbourne, Vic, Australia; [D'Souza, Wilissa; Sviridov, Dmitri] Baker IDI Heart & Diabet Res Inst, Lipoprot & Atherosclerosis Lab, Melbourne, Vic, Australia; [Meikle, Peter J.] Baker IDI Heart & Diabet Res Inst, Metabol Lab, Melbourne, Vic, Australia; [Drew, Brian G.] Univ Calif Los Angeles, Div Endocrinol Diabet & Hypertens, Los Angeles, CA USA	University of California System; University of California Los Angeles	Kingwell, BA (corresponding author), Baker IDI Heart & Diabet Res Inst, Metab & Vasc Physiol Lab, Melbourne, Vic, Australia.	bronwyn.kingwell@bakeridi.edu.au	Sviridov, Dmitri/E-7943-2010; Kingwell, Bronwyn A/B-1183-2009; Meikle, Peter J/B-4023-2009; Siebel, Andrew L/B-3203-2013	Siebel, Andrew L/0000-0002-9230-9042; Carey, Andrew/0000-0003-3452-1501; Meikle, Peter/0000-0002-2593-4665	National Health and Medical Research Council of Australia; Operational Infrastructure Support (OIS) Scheme of the Victorian State Government	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Operational Infrastructure Support (OIS) Scheme of the Victorian State Government	This study was supported by the National Health and Medical Research Council of Australia and the Operational Infrastructure Support (OIS) Scheme of the Victorian State Government. BAK and DS are fellows of the National Health and Medical Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barter PJ, 2011, CIRCULATION, V124, P555, DOI 10.1161/CIRCULATIONAHA.111.018259; Brunham LR, 2007, NAT MED, V13, P340, DOI 10.1038/nm1546; Cao HM, 2008, CELL, V134, P933, DOI 10.1016/j.cell.2008.07.048; Carey AL, 2006, DIABETES, V55, P2688, DOI 10.2337/db05-1404; Chen MB, 2005, J CLIN ENDOCR METAB, V90, P3665, DOI 10.1210/jc.2004-1980; DeVries-Seimon T, 2005, J CELL BIOL, V171, P61, DOI 10.1083/jcb.200502078; Drew BG, 2012, NAT REV ENDOCRINOL, V8, P237, DOI 10.1038/nrendo.2011.235; Drew BG, 2009, CIRCULATION, V119, P2103, DOI 10.1161/CIRCULATIONAHA.108.843219; Elmendorf JS, 2004, MOL BIOTECHNOL, V27, P127, DOI 10.1385/MB:27:2:127; Ford ES, 2002, JAMA-J AM MED ASSOC, V287, P356, DOI 10.1001/jama.287.3.356; Fryirs MA, 2010, ARTERIOSCL THROM VAS, V30, P1642, DOI 10.1161/ATVBAHA.110.207373; Goldfine AB, 2010, ANN INTERN MED, V152, P346, DOI 10.7326/0003-4819-152-6-201003160-00004; Goldfine AB, 2008, CTS-CLIN TRANSL SCI, V1, P36, DOI 10.1111/j.1752-8062.2008.00026.x; Gregor MF, 2011, ANNU REV IMMUNOL, V29, P415, DOI 10.1146/annurev-immunol-031210-101322; Hevener AL, 2007, J CLIN INVEST, V117, P1658, DOI 10.1172/JCI31561; Hoang A, 2012, EUR HEART J, V33, P657, DOI 10.1093/eurheartj/ehr103; Hoffman NJ, 2011, TRENDS ENDOCRIN MET, V22, P110, DOI 10.1016/j.tem.2010.12.001; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183; HOTAMISLIGIL GS, 1994, P NATL ACAD SCI USA, V91, P4854, DOI 10.1073/pnas.91.11.4854; Huang R, 2011, NAT STRUCT MOL BIOL, V18, P416, DOI 10.1038/nsmb.2028; Kruit JK, 2010, DIABETOLOGIA, V53, P1110, DOI 10.1007/s00125-010-1691-2; Kruit JK, 2011, DIABETES, V60, P3186, DOI 10.2337/db11-0081; Meikle PJ, 2011, ARTERIOSCL THROM VAS, V31, P2723, DOI 10.1161/ATVBAHA.111.234096; Murphy AJ, 2008, ARTERIOSCL THROM VAS, V28, P2071, DOI 10.1161/ATVBAHA.108.168690; Patel S, 2009, J AM COLL CARDIOL, V53, P962, DOI 10.1016/j.jacc.2008.12.008; Quehenberger O, 2011, NEW ENGL J MED, V365, P1812, DOI 10.1056/NEJMra1104901; Singh I, 2008, EUR J NUTR, V47, P387, DOI 10.1007/s00394-008-0739-2; Solinas G, 2007, CELL METAB, V6, P386, DOI 10.1016/j.cmet.2007.09.011; Steinberg GR, 2006, CELL METAB, V4, P465, DOI 10.1016/j.cmet.2006.11.005; Terasaka N, 2007, P NATL ACAD SCI USA, V104, P15093, DOI 10.1073/pnas.0704602104; THIEBAUD D, 1982, DIABETES, V31, P957, DOI 10.2337/diacare.31.11.957; Varma V, 2009, AM J PHYSIOL-ENDOC M, V296, pE1300, DOI 10.1152/ajpendo.90885.2008; Vergeer M, 2010, DIABETES CARE, V33, P869, DOI 10.2337/dc09-1562; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Yvan-Charvet L, 2010, SCIENCE, V328, P1689, DOI 10.1126/science.1189731	36	10	10	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2013	8	2							e56601	10.1371/journal.pone.0056601	http://dx.doi.org/10.1371/journal.pone.0056601			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IT	23437184	gold, Green Published			2022-12-25	WOS:000315186000034
J	Green-Mitchell, SM; Tersey, SA; Cole, BK; Ma, KW; Kuhn, NS; Cunningham, TD; Maybee, NA; Chakrabarti, SK; McDuffie, M; Taylor-Fishwick, DA; Mirmira, RG; Nadler, JL; Morris, MA				Green-Mitchell, Shamina M.; Tersey, Sarah A.; Cole, Banumathi K.; Ma, Kaiwen; Kuhn, Norine S.; Cunningham, Tina Duong; Maybee, Nelly A.; Chakrabarti, Swarup K.; McDuffie, Marcia; Taylor-Fishwick, David A.; Mirmira, Raghavendra G.; Nadler, Jerry L.; Morris, Margaret A.			Deletion of 12/15-Lipoxygenase Alters Macrophage and Islet Function in NOD-Alox15(null) Mice, Leading to Protection against Type 1 Diabetes Development	PLOS ONE			English	Article							NOD MICE; INSULIN-SECRETION; IL-12 PRODUCTION; MOUSE MODEL; T-CELLS; BETA; INFLAMMATION; 12-LIPOXYGENASE; ACTIVATION; TRANSCRIPTION	Aims: Type 1 diabetes (T1D) is characterized by autoimmune depletion of insulin-producing pancreatic beta cells. We showed previously that deletion of the 12/15-lipoxygenase enzyme (12/15-LO, Alox15 gene) in NOD mice leads to nearly 100 percent protection from T1D. In this study, we test the hypothesis that cytokines involved in the IL-12/12/15-LO axis affect both macrophage and islet function, which contributes to the development of T1D. Methods: 12/15-LO expression was clarified in immune cells by qRT-PCR, and timing of expression was tested in islets using qRT-PCR and Western blotting. Expression of key proinflammatory cytokines and pancreatic transcription factors was studied in NOD and NOD-Alox15(null) macrophages and islets using qRT-PCR. The two mouse strains were also assessed for the ability of splenocytes to transfer diabetes in an adoptive transfer model, and beta cell mass. Results: 12/15-LO is expressed in macrophages, but not B and T cells of NOD mice. In macrophages, 12/15-LO deletion leads to decreased proinflammatory cytokine mRNA and protein levels. Furthermore, splenocytes from NOD-Alox15(null) mice are unable to transfer diabetes in an adoptive transfer model. In islets, expression of 12/15-LO in NOD mice peaks at a crucial time during insulitis development. The absence of 12/15-LO results in maintenance of islet health with respect to measurements of islet-specific transcription factors, markers of islet health, proinflammatory cytokines, and beta cell mass. Conclusions: These results suggest that 12/15-LO affects islet and macrophage function, causing inflammation, and leading to autoimmunity and reduced beta cell mass.	[Green-Mitchell, Shamina M.; Cole, Banumathi K.; Ma, Kaiwen; Kuhn, Norine S.; Chakrabarti, Swarup K.; Taylor-Fishwick, David A.; Nadler, Jerry L.; Morris, Margaret A.] Eastern Virginia Med Sch, Dept Internal Med, Norfolk, VA 23501 USA; [Tersey, Sarah A.; Mirmira, Raghavendra G.] Indiana Univ Sch Med, Dept Pediat, Indianapolis, IN USA; [Tersey, Sarah A.; Mirmira, Raghavendra G.] Indiana Univ Sch Med, Herman B Wells Ctr Pediat Res, Indianapolis, IN USA; [Cunningham, Tina Duong] Eastern Virginia Med Sch, Grad Program Publ Hlth, Norfolk, VA 23501 USA; [McDuffie, Marcia] Univ Virginia, Dept Microbiol, Charlottesville, VA 22908 USA; [Maybee, Nelly A.; McDuffie, Marcia; Nadler, Jerry L.] Univ Virginia, Dept Med, Charlottesville, VA USA; [Taylor-Fishwick, David A.; Morris, Margaret A.] Eastern Virginia Med Sch, Dept Microbiol & Mol Cell Biol, Norfolk, VA 23501 USA	Eastern Virginia Medical School; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Eastern Virginia Medical School; University of Virginia; University of Virginia; Eastern Virginia Medical School	Morris, MA (corresponding author), Eastern Virginia Med Sch, Dept Internal Med, Norfolk, VA 23501 USA.	morrisma@evms.edu	Taylor, David/S-5508-2019; Mirmira, Raghavendra G/AAD-7592-2020	Taylor, David/0000-0002-6720-7482; Mirmira, Raghavendra G/0000-0002-5013-6075; Tersey, Sarah/0000-0003-0667-2361	Juvenile Diabetes Research Foundation [40-2009-711]; American Diabetes Association [7-11-JF-33]	Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); American Diabetes Association(American Diabetes Association)	This work was funded by grants from the Juvenile Diabetes Research Foundation (www.jdrf.org, 40-2009-711), and the American Diabetes Association (www.diabetes.org, 7-11-JF-33). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson MS, 2005, ANNU REV IMMUNOL, V23, P447, DOI 10.1146/annurev.immunol.23.021704.115643; BENDELAC A, 1987, J EXP MED, V166, P823, DOI 10.1084/jem.166.4.823; Berardi MJ, 2011, NATURE, V476, P109, DOI 10.1038/nature10257; Bleich D, 1998, INT J MOL MED, V1, P265; Boyton RJ, 2005, INT IMMUNOL, V17, P1157, DOI 10.1093/intimm/dxh293; Carrington EM, 2011, EUR J IMMUNOL, V41, P2238, DOI 10.1002/eji.201141476; Cetkovic-Cvrlje M, 2005, CLIN IMMUNOL, V114, P299, DOI 10.1016/j.clim.2004.11.001; Chakrabarti SK, 2011, AM J PHYSIOL-ENDOC M, V300, pE175, DOI 10.1152/ajpendo.00203.2010; Chakrabarti SK, 2009, OBESITY, V17, P1657, DOI 10.1038/oby.2009.192; Chen M, 2005, DIABETOLOGIA, V48, P486, DOI 10.1007/s00125-005-1673-y; Cole BK, 2012, AM J PHYSIOL-ENDOC M, V302, pE654, DOI 10.1152/ajpendo.00373.2011; Dioszeghy V, 2008, J IMMUNOL, V181, P6514, DOI 10.4049/jimmunol.181.9.6514; Dobrian AD, 2011, PROG LIPID RES, V50, P115, DOI 10.1016/j.plipres.2010.10.005; Estil les E, 2009, J ENDOCRINOL, V203, P55, DOI [10.1677/JOE-09-0047, DOI 10.1677/JOE-09-0047]; Francis J, 2005, J BIOL CHEM, V280, P36244, DOI 10.1074/jbc.M505741200; GUEST PC, 1989, BIOCHEM J, V257, P431, DOI 10.1042/bj2570431; Hagman DK, 2008, DIABETES, V57, P424, DOI 10.2337/db07-1285; ISHIHARA H, 1993, DIABETOLOGIA, V36, P1139, DOI 10.1007/BF00401058; Ize-Ludlow D, 2011, DIABETES, V60, P2086, DOI 10.2337/db11-0373; Kim HS, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar4048; Kuhn H, 2006, PROG LIPID RES, V45, P334, DOI 10.1016/j.plipres.2006.02.003; Kulkarni RN, 2004, J CLIN INVEST, V114, P828, DOI 10.1172/JCI200421845; Li L, 2009, J IMMUNOL, V183, P7585, DOI 10.4049/jimmunol.0901587; Ma K, 2010, J CLIN ENDOCR METAB, V95, P887, DOI 10.1210/jc.2009-1102; Maier B, 2010, J CLIN INVEST, V120, P2156, DOI 10.1172/JCI38924; McDuffie M, 2008, DIABETES, V57, P199, DOI 10.2337/db07-0830; Middleton MK, 2006, J IMMUNOL, V176, P265, DOI 10.4049/jimmunol.176.1.265; Morris MA, 2011, AUTOIMMUNITY, V44, P115, DOI 10.3109/08916934.2010.499885; SOBERMAN RJ, 1985, J BIOL CHEM, V260, P4508; Taylor-Fishwick D.A., 2012, DIABETOLOGIA; Tersey SA, 2011, DIAB 71 SCI SESS, P117; Tersey SA, DIABETES IN PRESS; Todd JA, 2010, IMMUNITY, V32, P457, DOI 10.1016/j.immuni.2010.04.001; Weaver JR, 2012, MOL CELL ENDOCRINOL, V358, P88, DOI 10.1016/j.mce.2012.03.004; Wen YH, 2008, AM J PHYSIOL-HEART C, V294, pH1933, DOI 10.1152/ajpheart.00260.2007; Wolk K, 2006, CYTOKINE GROWTH F R, V17, P367, DOI 10.1016/j.cytogfr.2006.09.001; Yang ZD, 2003, ANN NY ACAD SCI, V1005, P409, DOI 10.1196/annals.1288.069; Yang ZD, 2004, J AUTOIMMUN, V22, P191, DOI 10.1016/j.jaut.2003.08.006; Zhao L, 2002, J BIOL CHEM, V277, P35350, DOI 10.1074/jbc.M205738200; Zhu JF, 2012, IMMUNITY, V37, P660, DOI 10.1016/j.immuni.2012.09.007; Ziegler AG, 2010, IMMUNITY, V32, P468, DOI 10.1016/j.immuni.2010.03.018	41	29	29	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2013	8	2							e56763	10.1371/journal.pone.0056763	http://dx.doi.org/10.1371/journal.pone.0056763			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IT	23437231	Green Submitted, gold, Green Published			2022-12-25	WOS:000315186000043
J	Smitz, N; Berthouly, C; Cornelis, D; Heller, R; Van Hooft, P; Chardonnet, P; Caron, A; Prins, H; van Vuuren, BJ; De Iongh, H; Michaux, J				Smitz, Nathalie; Berthouly, Cecile; Cornelis, Daniel; Heller, Rasmus; Van Hooft, Pim; Chardonnet, Philippe; Caron, Alexandre; Prins, Herbert; van Vuuren, Bettine Jansen; De Iongh, Hans; Michaux, Johan			Pan-African Genetic Structure in the African Buffalo (Syncerus caffer): Investigating Intraspecific Divergence	PLOS ONE			English	Article							MITOCHONDRIAL CONTROL REGION; POPULATION-STRUCTURE; FOREST BUFFALO; NATIONAL-PARK; CAPE BUFFALO; MICROSATELLITE ANALYSIS; EVOLUTIONARY HISTORY; SABLE ANTELOPE; DNA VARIATION; D-LOOP	The African buffalo (Syncerus caffer) exhibits extreme morphological variability, which has led to controversies about the validity and taxonomic status of the various recognized subspecies. The present study aims to clarify these by inferring the pan-African spatial distribution of genetic diversity, using a comprehensive set of mitochondrial D-loop sequences from across the entire range of the species. All analyses converged on the existence of two distinct lineages, corresponding to a group encompassing West and Central African populations and a group encompassing East and Southern African populations. The former is currently assigned to two to three subspecies (S. c. nanus, S. c. brachyceros, S. c. aequinoctialis) and the latter to a separate subspecies (S. c. caffer). Forty-two per cent of the total amount of genetic diversity is explained by the between-lineage component, with one to seventeen female migrants per generation inferred as consistent with the isolation-with-migration model. The two lineages diverged between 145 000 to 449 000 years ago, with strong indications for a population expansion in both lineages, as revealed by coalescent-based analyses, summary statistics and a star-like topology of the haplotype network for the S. c. caffer lineage. A Bayesian analysis identified the most probable historical migration routes, with the Cape buffalo undertaking successive colonization events from Eastern toward Southern Africa. Furthermore, our analyses indicate that, in the West- Central African lineage, the forest ecophenotype may be a derived form of the savanna ecophenotype and not vice versa, as has previously been proposed. The African buffalo most likely expanded and diverged in the late to middle Pleistocene from an ancestral population located around the current-day Central African Republic, adapting morphologically to colonize new habitats, hence developing the variety of ecophenotypes observed today.	[Smitz, Nathalie; Michaux, Johan] Univ Liege, Dept Life Sci Conservat Genet, Liege, Belgium; [Berthouly, Cecile; Cornelis, Daniel; Caron, Alexandre] Ctr Cooperat Int Rech Agron Dev CIRAD, Montferrier Le Lez, France; [Heller, Rasmus] Univ Copenhagen, Dept Biol Bioinformat, Copenhagen, Denmark; [Van Hooft, Pim] Wageningen Univ, Resource Ecol Grp, NL-6700 AP Wageningen, Netherlands; [Chardonnet, Philippe] Int Fdn Conservat Wildlife IGF, Paris, France; [Caron, Alexandre] Univ Zimbabwe, Dept Environm & Soc, Ctr Cooperat Int Rech Agron Dev CIRAD, Harare, Zimbabwe; [Caron, Alexandre] Univ Pretoria, Mammal Res Inst, Dept Zool & Entomol, ZA-0002 Pretoria, South Africa; [Prins, Herbert] Wageningen Univ, Trop Nat Conservat & Vertebrate Ecol Grp, NL-6700 AP Wageningen, Netherlands; [van Vuuren, Bettine Jansen] Univ Johannesburg, Dept Zool, Ctr Invas Biol, Johannesburg, South Africa; [De Iongh, Hans] Leiden Univ, Inst Environm Sci, Leiden, Netherlands; [Michaux, Johan] Ctr Biol & Gest Populat CBGP, Montferrier Le Lez, France	University of Liege; CIRAD; University of Copenhagen; Wageningen University & Research; CIRAD; University of Zimbabwe; University of Pretoria; Wageningen University & Research; University of Johannesburg; Leiden University; Leiden University - Excl LUMC	Smitz, N (corresponding author), Univ Liege, Dept Life Sci Conservat Genet, Liege, Belgium.	nsmitz@student.ulg.ac.be	Berthouly-Salazar, Cecile/J-3204-2016; Jansen van Vuuren, Bettine/E-6227-2013; Caron, Alexandre/F-8969-2010; de Iongh, Hendrik/K-6694-2013; Heller, Rasmus/M-2580-2014	Berthouly-Salazar, Cecile/0000-0002-0685-6745; Jansen van Vuuren, Bettine/0000-0002-5334-5358; Caron, Alexandre/0000-0002-5213-3273; Heller, Rasmus/0000-0001-6583-6923; Smitz, Nathalie/0000-0001-5155-0801; Prins, Herbert/0000-0003-1131-5107	FRS-FNRS of Belgium (Fond National pour la Recherche Scientifique) [A5/5-MCF/BIC-11561, F3/5/5-MCF/ROI/BC-20.003]; French National Research Agency (ANR Mobility program)	FRS-FNRS of Belgium (Fond National pour la Recherche Scientifique)(Fonds de la Recherche Scientifique - FNRS); French National Research Agency (ANR Mobility program)(French National Research Agency (ANR))	This study is supported by research grants from the FRS-FNRS of Belgium (Fond National pour la Recherche Scientifique) provided to J.R. Michaux (A5/5-MCF/BIC-11561) and N.M.R. Smitz (F3/5/5- MCF/ROI/BC-20.003) (http://www1.frs-fnrs.be/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; West African buffalo tissue samples came from a study funded by the French National Research Agency (ANR Mobility program). Special thanks go to M. Pellerin from the IGF of Paris (Fondation Internationale pour la Gestion de la Faune), K.L. Kanapeckas for the samples from the Hluhluwe-Imfolozi National Park, P. Bouche, M. de Garine-Wichatitsky (Centre de Cooperation Internationale en Recherche Agronomique pour le Developpement), F. Jori (Centre de Cooperation Internationale en Recherche Agronomique pour le Developpement), R. Godinho, D. Mathieu, R. Barrat, E. Turquin, P. Dumesnil, Y. Penet, R. Michael, R. Paolucci, D. Stromberg, M. Pariente, E. Jan, Y. Forestier, J.F. Herrera, R. Garza, P. Leveau, P. Augais, Basson, R. Buij, B. Croes and Jayet for all other samples of tissue, dung or blood of the African buffalo. We also thank the CIRAD RP-PCP platform of Harare for providing samples from Southern Africa. Further thanks to M. Melletti and E.S. Vrba for personal comments and investigation into the interpretation of the results.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; ALDEN P, 1995, NATL AUDUBON SOC FIE; Alpers DL, 2004, MOL ECOL, V13, P1771, DOI 10.1111/j.1365-294X.2004.02204.x; [Anonymous], CHROM; AQUADRO CF, 1983, GENETICS, V103, P287; Arctander P, 1999, MOL BIOL EVOL, V16, P1724, DOI 10.1093/oxfordjournals.molbev.a026085; Arctander P, 1996, HEREDITY, V76, P465, DOI 10.1038/hdy.1996.69; Arctander P, 1996, MOL GENETICS CONSERV; Bekhuis PDBM, 2008, AFR J ECOL, V46, P668, DOI 10.1111/j.1365-2028.2008.00956.x; Bertola LD, 2011, J BIOGEOGR, V38, P1356, DOI 10.1111/j.1365-2699.2011.02500.x; Birungi J, 2000, MOL ECOL, V9, P1997, DOI 10.1046/j.1365-294X.2000.01107.x; Brown DM, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-57; Buchholtz C, 1990, GRZIMEKS ENCY MAMMAL, V5, P360; Cohen AS, 2007, P NATL ACAD SCI USA, V104, P16422, DOI 10.1073/pnas.0703873104; Corson PJ, 2002, BUFFLE AFRIQUE BIOL; CRANDALL KA, 1993, GENETICS, V134, P959; CRIBIU EP, 1980, ANN GENET SEL ANIM, V12, P291, DOI 10.1186/1297-9686-12-3-291; DEMENOCAL PB, 1995, SCIENCE, V270, P53, DOI 10.1126/science.270.5233.53; DeMenocal PB, 2004, EARTH PLANET SC LETT, V220, P3, DOI 10.1016/S0012-821X(04)00003-2; Dettman JR, 2007, NATURE, V447, P585, DOI 10.1038/nature05856; Douzery E, 1997, MOL BIOL EVOL, V14, P1154, DOI 10.1093/oxfordjournals.molbev.a025725; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Dupont LM, 2000, PALAEOGEOGR PALAEOCL, V155, P95, DOI 10.1016/S0031-0182(99)00095-4; DUPONT LM, 1992, VEG HIST ARCHAEOBOT, V1, P163; East R., 1999, AFRICAN ANTELOPE DAT, V21; Endler J.A., 1977, Monographs in Population Biology, pi; Eriksson J, 2004, MOL ECOL, V13, P3425, DOI 10.1111/j.1365-294X.2004.02332.x; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Fang M, 2006, ANIM GENET, V37, P459, DOI 10.1111/j.1365-2052.2006.01498.x; Finlay EK, 2007, BIOLOGY LETT, V3, P449, DOI 10.1098/rsbl.2007.0146; Flagstad O, 2001, P ROY SOC B-BIOL SCI, V268, P667, DOI 10.1098/rspb.2000.1416; Fritz H, 1997, ECOGRAPHY, V20, P417, DOI 10.1111/j.1600-0587.1997.tb00387.x; Fu YX, 1997, GENETICS, V147, P915; Gentry A.W., 1978, P540; GIRMAN DJ, 1993, J HERED, V84, P450, DOI 10.1093/oxfordjournals.jhered.a111371; Greyling BJ, 2008, AFR J BIOTECHNOL, V7, P655; Groves C., 2011, UNGULATE TAXONOMY; Groves Colin P., 1992, Archaeology in Oceania, V27, P153; GRUBB P, 1972, Zeitschrift fuer Saeugetierkunde, V37, P121; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [DOI 10.1021/BK-1999-0734.CH008, citeulike-article-id:691774, 10.12691/ajmr-6-4-3]; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; Heller R, 2008, MOL ECOL, V17, P4845, DOI 10.1111/j.1365-294X.2008.03961.x; Heller R, 2010, MOL ECOL, V19, P1324, DOI 10.1111/j.1365-294X.2010.04589.x; Heller R, 2012, MOL ECOL, V21, P3947, DOI 10.1111/j.1365-294X.2012.05671.x; Hewitt Godfrey M., 2004, Frontiers in Zoology, V1, P1, DOI 10.1186/1742-9994-1-4; Hey J, 2005, PLOS BIOL, V3, P965, DOI 10.1371/journal.pbio.0030193; Hey J, 2004, GENETICS, V167, P747, DOI 10.1534/genetics.103.024182; Hsu T. C., 1970, ATLAS MAMMALIAN CHRO, V4; Joly S, 2007, SYST BIOL, V56, P857, DOI 10.1080/10635150701633153; Kingdon J, 1997, KINGDON FIELD GUIDE; Kingdon J., 1982, E AFRICAN MAMMALS AT, V3; Klein R. G., 1988, AFR ARCHAEOL REV, V6, P3, DOI [10.1007/BF01117110., DOI 10.1007/BF01117110]; Klein R. G., 1995, QUATERNARY EXTINCTIO, P553; Korte LM, 2008, J ZOOL, V275, P229, DOI 10.1111/j.1469-7998.2008.00430.x; Korte LM, 2008, J MAMMAL, V89, P115, DOI 10.1644/06-MAMM-A-423.1; Kraus RH, 2011, JOVE-J VIS EXP, V54; Kraus Robert H. S., 2009, Wildfowl, P215; Lemey P, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000520; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lorenzen ED, 2012, MOL ECOL, V21, P3656, DOI 10.1111/j.1365-294X.2012.05650.x; Lorenzen ED, 2006, J HERED, V97, P119, DOI 10.1093/jhered/esj012; Lorenzen ED, 2004, MOL ECOL, V13, P3007, DOI 10.1111/j.1365-294X.2004.02308.x; Lorenzen ED, 2007, MOL ECOL, V16, P3241, DOI 10.1111/j.1365-294X.2007.03382.x; Lorenzen ED, 2006, MOL ECOL, V15, P3787, DOI 10.1111/j.1365-294X.2006.03059.x; Marsden CD, 2012, MOL ECOL, V21, P1379, DOI 10.1111/j.1365-294X.2012.05477.x; Melletti M, 2007, J MAMMAL, V88, P1312, DOI 10.1644/06-MAMM-A-240R1.1; Moodley Y, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000454; MORITZ C, 1994, TRENDS ECOL EVOL, V9, P373, DOI 10.1016/0169-5347(94)90057-4; Muwanika VB, 2003, HEREDITY, V91, P361, DOI 10.1038/sj.hdy.6800341; Nei M., 1987, MOL EVOLUTIONARY GEN; Nersting LG, 2001, MOL ECOL, V10, P711, DOI 10.1046/j.1365-294x.2001.01205.x; Nowak RM, 1991, WALKERS MAMMALS WORL; Nyakaana S, 1999, MOL ECOL, V8, P1105, DOI 10.1046/j.1365-294x.1999.00661.x; Nyakaana S, 2002, HEREDITY, V89, P90, DOI 10.1038/sj.hdy.6800110; O'Ryan C, 1998, ANIM CONSERV, V1, P85, DOI 10.1111/j.1469-1795.1998.tb00015.x; Okello JBA, 2005, HEREDITY, V95, P206, DOI 10.1038/sj.hdy.6800711; Pitra C, 2002, MOL ECOL, V11, P1197, DOI 10.1046/j.1365-294X.2002.01516.x; Pitra C, 2006, EUR J WILDLIFE RES, V52, P145, DOI 10.1007/s10344-005-0026-y; Porat N, 2010, J ARCHAEOL SCI, V37, P269, DOI 10.1016/j.jas.2009.09.038; Prins HHT, 1996, WILDLIFE ECOLOGY BEH, V1; ROGERS AR, 1995, EVOLUTION, V49, P608, DOI 10.1111/j.1558-5646.1995.tb02297.x; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; Sbisa E, 1997, GENE, V205, P125, DOI 10.1016/S0378-1119(97)00404-6; Schneider S., 2000, ARLEQUIN SOFTWARE PO, V2, P2496; Shapiro B, 2004, SCIENCE, V306, P1561, DOI 10.1126/science.1101074; Simonsen B. T., 1997, THESIS U COPENHAGEN; Simonsen BT, 1998, MOL ECOL, V7, P225, DOI 10.1046/j.1365-294x.1998.00343.x; Sinclair A.R.E., 1977, AFRICAN BUFFALO STUD; STARK MA, 1986, AFR J ECOL, V24, P255, DOI 10.1111/j.1365-2028.1986.tb00369.x; Templeton A. R., 1996, CONSERVATION GENETIC; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; van Hooft P, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-106; van Hooft P, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001086; van Hooft WF, 2003, CONSERV GENET, V4, P467, DOI 10.1023/A:1024719231545; Van Hooft WF, 2002, MOL ECOL, V11, P267, DOI 10.1046/j.1365-294X.2002.01429.x; van Hooft WF, 2000, MOL ECOL, V9, P2017, DOI 10.1046/j.1365-294X.2000.01101.x; van Vuuren BJ, 2010, S AFR J WILDL RES, V40, P35, DOI 10.3957/056.040.0114; Villagomez DAF, 2008, CYTOGENET GENOME RES, V120, P69, DOI 10.1159/000118742; VRBA ES, 1992, J MAMMAL, V73, P1, DOI 10.2307/1381862; Wenink PW, 1998, MOL ECOL, V7, P1315, DOI 10.1046/j.1365-294x.1998.00463.x; Wilson D. E., 2005, MAMMAL SPECIES WORLD; WURSTER DH, 1968, CHROMOSOMA, V25, P152, DOI 10.1007/BF00327175	102	35	35	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2013	8	2							e56235	10.1371/journal.pone.0056235	http://dx.doi.org/10.1371/journal.pone.0056235			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IT	23437100	Green Published, Green Submitted, gold			2022-12-25	WOS:000315186000018
J	Dargent, F; Torres-Dowdall, J; Scott, ME; Ramnarine, I; Fussmann, GF				Dargent, Felipe; Torres-Dowdall, Julian; Scott, Marilyn E.; Ramnarine, Indar; Fussmann, Gregor F.			Can Mixed-Species Groups Reduce Individual Parasite Load? A Field Test with Two Closely Related Poeciliid Fishes (Poecilia reticulata and Poecilia picta)	PLOS ONE			English	Article							GYRODACTYLUS-BULLATARUDIS; EXPERIMENTAL INFECTIONS; JUVENILE STICKLEBACKS; TRINIDADIAN GUPPIES; HOST DIVERSITY; HERD-IMMUNITY; LIFE-HISTORY; POPULATIONS; DISEASE; SIZE	Predation and parasitism are two of the most important sources of mortality in nature. By forming groups, individuals can gain protection against predators but may increase their risk of being infected with contagious parasites. Animals might resolve this conflict by forming mixed-species groups thereby reducing the costs associated with parasites through a relative decrease in available hosts. We tested this hypothesis in a system with two closely related poeciliid fishes (Poecilia reticulata and Poecilia picta) and their host-specific monogenean ectoparasites (Gyrodactylus spp.) in Trinidad. Fish from three different rivers were sampled from single and mixed-species groups, measured and scanned for Gyrodactylus. The presence and abundance of Gyrodactylus were lower when fish of both species were part of mixed-species groups relative to single-species groups. This is consistent with the hypothesis that mixed-species groups provide a level of protection against contagious parasites. We discuss the importance of potentially confounding factors such as salinity and individual fish size.	[Dargent, Felipe; Fussmann, Gregor F.] McGill Univ, Dept Biol, Montreal, PQ H3A 1B1, Canada; [Torres-Dowdall, Julian] Colorado State Univ, Dept Biol, Ft Collins, CO 80523 USA; [Scott, Marilyn E.] McGill Univ, Inst Parasitol, Ste Anne De Bellevue, PQ, Canada; [Ramnarine, Indar] Univ W Indies, Dept Life Sci, St Augustine, Piarco Tunapuna, Trinidad Tobago	McGill University; Colorado State University; McGill University; University West Indies Mona Jamaica; University West Indies Saint Augustine	Dargent, F (corresponding author), McGill Univ, Dept Biol, 1205 Doctor Penfield Ave, Montreal, PQ H3A 1B1, Canada.	felipe.dargent@mail.mcgill.ca	Scott, Marilyn E/L-5347-2015; Dargent, Felipe/F-8749-2012	Dargent, Felipe/0000-0002-4510-0086; Fussmann, Gregor/0000-0001-9576-0122; Torres-Dowdall, Julian/0000-0003-2729-6246	Natural Sciences and Engineering Research Council of Canada (NSERC) Special Research Opportunity grant [SRO 356373-07]; Vanier CGS; Richard H Tomlinson Fellowship; McGill-STRI NEO	Natural Sciences and Engineering Research Council of Canada (NSERC) Special Research Opportunity grant(Natural Sciences and Engineering Research Council of Canada (NSERC)); Vanier CGS; Richard H Tomlinson Fellowship; McGill-STRI NEO	This study was supported by a Natural Sciences and Engineering Research Council of Canada (NSERC) Special Research Opportunity grant (SRO 356373-07) awarded to GF Fussmann (PI), ME Scott, AP Hendry and P Bentzen; and by a Vanier CGS, a Richard H Tomlinson Fellowship and a McGill-STRI NEO grant-in-aid awarded to F Dargent. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON RM, 1985, NATURE, V318, P323, DOI 10.1038/318323a0; Barber I, 1998, J FISH BIOL, V53, P1365, DOI 10.1111/j.1095-8649.1998.tb00256.x; Bates D, 2012, LINEAR MIXED EFFECTS; Cable J, 2007, INT J PARASITOL, V37, P1449, DOI 10.1016/j.ijpara.2007.04.013; Cable J, 2005, SYST PARASITOL, V60, P159, DOI 10.1007/s11230-004-6348-4; COTE IM, 1995, BEHAV ECOL, V6, P159, DOI 10.1093/beheco/6.2.159; DUGATKIN LA, 1994, ENVIRON BIOL FISH, V39, P215, DOI 10.1007/BF00004940; FREELAND WJ, 1983, AM NAT, V121, P223, DOI 10.1086/284052; Goncalves G, 2008, EXPERT REV VACCINES, V7, P1493, DOI 10.1586/14760584.7.10.1493; HAMILTON WD, 1971, J THEOR BIOL, V31, P295, DOI 10.1016/0022-5193(71)90189-5; HARRIS PD, 1992, J PARASITOL, V78, P912, DOI 10.2307/3283329; Hino T, 2000, J AVIAN BIOL, V31, P441, DOI 10.1034/j.1600-048X.2000.310402.x; HOUDE AE, 1992, BEHAV ECOL, V3, P346, DOI 10.1093/beheco/3.4.346; Huizinga M, 2009, J EVOLUTION BIOL, V22, P1860, DOI 10.1111/j.1420-9101.2009.01799.x; Johnson PTJ, 2012, ECOLOGY, V93, P56, DOI 10.1890/11-0636.1; KEARN GC, 1994, INT J PARASITOL, V24, P1227, DOI 10.1016/0020-7519(94)90193-7; KENNEDY CEJ, 1987, BEHAV ECOL SOCIOBIOL, V21, P291, DOI 10.1007/BF00299966; King TA, 2007, INT J PARASITOL, V37, P663, DOI 10.1016/j.ijpara.2006.11.015; King TA, 2009, PARASITOL INT, V58, P249, DOI 10.1016/j.parint.2009.04.005; Kolluru GR, 2009, BEHAV ECOL, V20, P131, DOI 10.1093/beheco/arn124; KRAUSE J, 1994, ETHOLOGY, V98, P128; Krause J, 2002, LIVING GROUPS; LANDEAU L, 1986, ANIM BEHAV, V34, P1372, DOI 10.1016/S0003-3472(86)80208-1; LoGiudice K, 2003, P NATL ACAD SCI USA, V100, P567, DOI 10.1073/pnas.0233733100; Magurran AE, 2001, BIOL J LINN SOC, V73, P1, DOI [10.1006/bijl.2000.0519, 10.1111/j.1095-8312.2001.tb01342.x]; MIKHEEV VN, 2009, J ICHTHYOL, V49, P1032, DOI DOI 10.1134/S0032945209110034; MOLLER AP, 1993, ADV STUD BEHAV, V22, P65, DOI 10.1016/S0065-3454(08)60405-2; Moore SM, 2012, ECOLOGY, V93, P1095, DOI 10.1890/11-0086.1; Poulin R, 1999, ETHOLOGY, V105, P959, DOI 10.1046/j.1439-0310.1999.00491.x; Poulin R, 1997, OECOLOGIA, V110, P278, DOI 10.1007/s004420050160; POULIN R, 1991, CONDOR, V93, P418, DOI 10.2307/1368958; POULIN R, 1989, BEHAV ECOL SOCIOBIOL, V24, P251, DOI 10.1007/BF00295205; PULLIAM HR, 1973, J THEOR BIOL, V38, P419, DOI 10.1016/0022-5193(73)90184-7; Reber A, 2008, ECOL LETT, V11, P682, DOI 10.1111/j.1461-0248.2008.01177.x; REZNICK DN, 1992, COPEIA, P782, DOI 10.2307/1446155; Roche B, 2012, PHILOS T R SOC B, V367, P2807, DOI 10.1098/rstb.2011.0364; Russell ST, 2006, BIOL J LINN SOC, V88, P397, DOI 10.1111/j.1095-8312.2006.00628.x; SASVARI L, 1992, ANIM BEHAV, V43, P289, DOI 10.1016/S0003-3472(05)80224-6; Schelkle B, 2011, AQUACULTURE, V311, P74, DOI 10.1016/j.aquaculture.2010.11.036; SCOTT ME, 1984, PARASITOLOGY, V89, P159, DOI 10.1017/S0031182000001207; Seeley TD, 2007, P ROY SOC B-BIOL SCI, V274, P67, DOI 10.1098/rspb.2006.3702; Stensland E, 2003, MAMMAL REV, V33, P205, DOI 10.1046/j.1365-2907.2003.00022.x; Stumbo AD, 2012, J ANIM ECOL; Tadiri CP, 2012, PARASITOLOGY FIRSTVI, V140, P1, DOI [10.1017/S0031182000055207, DOI 10.1017/S0031182000055207]; TERBORGH J, 1990, AM J PRIMATOL, V21, P87, DOI 10.1002/ajp.1350210203; Thieltges DW, 2008, PARASITOLOGY, V135, P407, DOI 10.1017/S0031182007000248; Tosh CR, 2007, P ROY SOC B-BIOL SCI, V274, P827, DOI 10.1098/rspb.2006.3760; van Oosterhout C, 2006, EVOLUTION, V60, P2562, DOI 10.1111/j.0014-3820.2006.tb01890.x; Ward AJW, 2002, BEHAV ECOL SOCIOBIOL, V52, P182, DOI 10.1007/s00265-002-0505-z; WOLF NG, 1985, BEHAV ECOL SOCIOBIOL, V17, P47, DOI 10.1007/BF00299428	50	7	7	2	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e56789	10.1371/journal.pone.0056789	http://dx.doi.org/10.1371/journal.pone.0056789			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437237	Green Published, gold, Green Submitted			2022-12-25	WOS:000315184200161
J	Jackson, CJ; Waller, RF				Jackson, Christopher J.; Waller, Ross F.			A Widespread and Unusual RNA Trans-Splicing Type in Dinoflagellate Mitochondria	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM; GENOME; TRANSCRIPTS; EXPRESSION; EVOLUTION; OXYRRHIS; INTRONS; GENES	Cytochrome oxidase subunit 3 (Cox3) is a mitochondrion-encoded core membrane protein of complex IV of the mitochondrial respiratory chain, and consists of seven trans-membrane helices. Here we show that in diverse later-branching dinoflagellates, cox3 is consistently split into two exons in the mitochondrial genome between helices six and seven. Gene exons are transcribed as two discrete oligoadenylated precursor RNAs, and these are subsequently trans-spliced to form a complete coding mRNA. This trans-splicing is highly unusual in that some of the oligoadenylated tail is incorporated at the splice site, such that a short string of adenosines links the two coding exons. This feature is consistently represented in diverse dinoflagellates, however the number of adenosines added varies according to the size of the coding gap between the two exons. Thus we observed between zero (Amphidinium carterae) and 10 (Symbiodinium sp.) adenosines added in different taxa, but the final coding sequence length is identical with the reading frame maintained. Northern analyses show that precursor cox3 transcripts are approximately equally abundant as mature cox3 mRNAs, suggesting a slow or regulated maturation process. These data indicate that the splicing mechanism in dinoflagellate mitochondria is tolerant of variations in the length of the precursor coding sequence, and implicates the use of a splicing template, or guide molecule, during splicing that controls mature mRNA length.	[Jackson, Christopher J.; Waller, Ross F.] Univ Melbourne, Sch Bot, Melbourne, Vic 3010, Australia	University of Melbourne	Waller, RF (corresponding author), Univ Melbourne, Sch Bot, Melbourne, Vic 3010, Australia.	r.waller@unimelb.edu.au	Waller, Ross F/D-5761-2016	Waller, Ross F/0000-0001-6961-9344	Australian Research Council Discovery [DP0663590]; University of Melbourne Science Faculty Scholarship	Australian Research Council Discovery(Australian Research Council); University of Melbourne Science Faculty Scholarship	This work was supported by an Australian Research Council Discovery grant (DP0663590), and C.J.J. was supported by the University of Melbourne Science Faculty Scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbrook AC, 2010, PHILOS T R SOC B, V365, P785, DOI 10.1098/rstb.2009.0250; Bonen L, 2001, TRENDS GENET, V17, P322, DOI 10.1016/S0168-9525(01)02324-1; Bonen L, 2008, MITOCHONDRION, V8, P26, DOI 10.1016/j.mito.2007.09.005; Burger G, 2009, TRENDS GENET, V25, P381, DOI 10.1016/j.tig.2009.07.003; Chaput H, 2002, PROTIST, V153, P111, DOI 10.1078/1434-4610-00090; Dorn R, 2001, P NATL ACAD SCI USA, V98, P9724, DOI 10.1073/pnas.151268698; Dorrell RG, 2012, P NATL ACAD SCI USA, V109, P18879, DOI 10.1073/pnas.1212270109; Gagliardi D, 2004, TRENDS GENET, V20, P260, DOI 10.1016/j.tig.2004.04.006; Galvis MLE, 1998, CURR GENET, V33, P320, DOI 10.1007/s002940050343; Gillespie DE, 1999, NUCLEIC ACIDS RES, V27, P2416, DOI 10.1093/nar/27.11.2416; Gornik SG, 2012, CURR BIOL IN PRESS; Grewe F, 2009, NUCLEIC ACIDS RES, V37, P5093, DOI 10.1093/nar/gkp532; Hastings KEM, 2005, TRENDS GENET, V21, P240, DOI 10.1016/j.tig.2005.02.005; Haugen P, 2005, TRENDS GENET, V21, P111, DOI 10.1016/j.tig.2004.12.007; Imanian B, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-172; Jackson CJ, 2012, GENOME BIOL EVOL, V4, P59, DOI 10.1093/gbe/evr122; Jackson CJ, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-41; Kamikawa R, 2011, CURR BIOL, V21, P311, DOI 10.1016/j.cub.2011.01.025; Keeling PJ, 2005, TRENDS ECOL EVOL, V20, P670, DOI 10.1016/j.tree.2005.09.005; Kiethega GN, 2011, MOL BIOL EVOL, V28, P2425, DOI 10.1093/molbev/msr075; Lasda EL, 2011, WIRES RNA, V2, P417, DOI 10.1002/wrna.71; Lin S., 2008, RNA DNA EDITING MOL, P280, DOI DOI 10.1002/9780470262269.CH13; Lin SJ, 2002, J MOL BIOL, V320, P727, DOI 10.1016/S0022-2836(02)00468-0; MANDL CW, 1991, BIOTECHNIQUES, V10, P484; Marande W, 2007, SCIENCE, V318, P415, DOI 10.1126/science.1148033; Moreira S, 2012, WIRES RNA, V3, P213, DOI 10.1002/wrna.1106; Nash EA, 2008, TRENDS GENET, V24, P328, DOI 10.1016/j.tig.2008.04.001; Patron NJ, 2006, J MOL BIOL, V357, P1373, DOI 10.1016/j.jmb.2006.01.084; Randau L, 2005, P NATL ACAD SCI USA, V102, P17934, DOI 10.1073/pnas.0509197102; Rehkopf DH, 2000, MOL BIOCHEM PARASIT, V105, P91, DOI 10.1016/S0166-6851(99)00170-X; Roy SW, 2012, MOL BIOL EVOL, V29, P43, DOI 10.1093/molbev/msr063; Shlomai J, 2004, CURR MOL MED, V4, P623, DOI 10.2174/1566524043360096; Shuman S, 2001, PROG NUCLEIC ACID RE, V66, P1; Slamovits CH, 2007, J MOL BIOL, V372, P356, DOI 10.1016/j.jmb.2007.06.085; Stuart KD, 2005, TRENDS BIOCHEM SCI, V30, P97, DOI 10.1016/j.tibs.2004.12.006; Tsukihara T, 1996, SCIENCE, V272, P1136, DOI 10.1126/science.272.5265.1136; Vlcek C, 2011, NUCLEIC ACIDS RES, V39, P979, DOI 10.1093/nar/gkq883; Waller RF, 2009, BIOESSAYS, V31, P237, DOI 10.1002/bies.200800164; Wang YL, 2006, NUCLEIC ACIDS RES, V34, P613, DOI 10.1093/nar/gkj438; Zhang H, 2008, J PHYCOL, V44, P703, DOI 10.1111/j.1529-8817.2008.00521.x; Zhang H, 2007, P NATL ACAD SCI USA, V104, P4618, DOI 10.1073/pnas.0700258104; Zhang HA, 2011, PROTIST, V162, P154, DOI 10.1016/j.protis.2010.03.003	42	19	19	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e56777	10.1371/journal.pone.0056777	http://dx.doi.org/10.1371/journal.pone.0056777			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437234	gold, Green Published			2022-12-25	WOS:000315184200158
J	Ntshoe, GM; McAnerney, JM; Archer, BN; Smit, SB; Harris, BN; Tempia, S; Mashele, M; Singh, B; Thomas, J; Cengimbo, A; Blumberg, LH; Puren, A; Moyes, J; van den Heever, J; Schoub, BD; Cohen, C				Ntshoe, Genevie M.; McAnerney, Johanna M.; Archer, Brett N.; Smit, Sheilagh B.; Harris, Bernice N.; Tempia, Stefano; Mashele, Mirriam; Singh, Beverley; Thomas, Juno; Cengimbo, Ayanda; Blumberg, Lucille H.; Puren, Adrian; Moyes, Jocelyn; van den Heever, Johann; Schoub, Barry D.; Cohen, Cheryl			Measles Outbreak in South Africa: Epidemiology of Laboratory-Confirmed Measles Cases and Assessment of Intervention, 2009-2011	PLOS ONE			English	Article							PLACENTAL-TRANSFER; ANTIBODIES; IMMUNITY; VIRUS; INFECTION; VACCINE; INFANTS	Background: Since 1995, measles vaccination at nine and 18 months has been routine in South Africa; however, coverage seldom reached >95%. We describe the epidemiology of laboratory-confirmed measles case-patients and assess the impact of the nationwide mass vaccination campaign during the 2009 to 2011 measles outbreak in South Africa. Methods: Serum specimens collected from patients with suspected-measles were tested for measles-specific IgM antibodies using an enzyme-linked immunosorbent assay and genotypes of a subset were determined. To estimate the impact of the nationwide mass vaccination campaign, we compared incidence in the seven months pre-(1 September 2009-11 April 2010) and seven months post-vaccination campaign (24 May 2010-31 December 2010) periods in seven provinces of South Africa. Results: A total of 18,431 laboratory-confirmed measles case-patients were reported from all nine provinces of South Africa (cumulative incidence 37 per 100,000 population). The highest cumulative incidence per 100,000 population was in children aged <1 year (603), distributed as follows: <6 months (302/100,000), 6 to 8 months (1083/100,000) and 9 to 11 months (724/100,000). Forty eight percent of case-patients were >= 5 years (cumulative incidence 54/100,000). Cumulative incidence decreased with increasing age to 2/100,000 in persons >= 40 years. A single strain of measles virus (genotype B3) circulated throughout the outbreak. Prior to the vaccination campaign, cumulative incidence in the targeted vs. non-targeted age group was 5.9-fold higher, decreasing to 1.7 fold following the campaign (P<0.001) and an estimated 1,380 laboratory-confirmed measles case-patients were prevented. Conclusion: We observed a reduction in measles incidence following the nationwide mass vaccination campaign even though it was conducted approximately one year after the outbreak started. A booster dose at school entry may be of value given the high incidence in persons >5 years.	[Ntshoe, Genevie M.; Smit, Sheilagh B.; Mashele, Mirriam; Puren, Adrian; Schoub, Barry D.] NHLS, NICD, Ctr Vaccines & Immunol, Johannesburg, South Africa; [McAnerney, Johanna M.; Moyes, Jocelyn; Cohen, Cheryl] Natl Hlth Lab Serv, Natl Inst Communicable Dis, Ctr Resp Dis & Meningitis, Johannesburg, South Africa; [Archer, Brett N.; Thomas, Juno; Cengimbo, Ayanda; Blumberg, Lucille H.] Natl Hlth Lab Serv, Natl Inst Communicable Dis, Div Publ Hlth Surveillance & Response, Johannesburg, South Africa; [Harris, Bernice N.] Univ Pretoria, Sch Hlth Syst & Publ Hlth, ZA-0002 Pretoria, South Africa; [Tempia, Stefano] NICD NHLS, US Ctr Dis Control & Prevent CDC, Johannesburg, South Africa; [Singh, Beverley] Natl Hlth Lab Serv, Natl Inst Communicable Dis, Ctr HIV & STI, Johannesburg, South Africa; [van den Heever, Johann] Dept Hlth, Expanded Programme Immunisat S Africa EPI SA, Pretoria, South Africa	National Health Laboratory Service; National Institute for Communicable Diseases (NICD); National Health Laboratory Service; National Institute for Communicable Diseases (NICD); National Health Laboratory Service; National Institute for Communicable Diseases (NICD); University of Pretoria; National Health Laboratory Service; National Institute for Communicable Diseases (NICD); National Health Laboratory Service; National Institute for Communicable Diseases (NICD)	Ntshoe, GM (corresponding author), NHLS, NICD, Ctr Vaccines & Immunol, Johannesburg, South Africa.	genevien@nicd.ac.za; cherylc@nicd.ac.za	Harris, Bernice N/AAN-6197-2021; Archer, Brett Nicholas/A-5610-2012; Puren, Adrian/AAC-2065-2020; Puren, Adrian/W-1679-2018; Moyes, Jocelyn/AAF-7882-2019	Harris, Bernice N/0000-0002-0924-3178; Archer, Brett Nicholas/0000-0002-4144-1094; Puren, Adrian/0000-0001-7531-4010; Puren, Adrian/0000-0001-7531-4010; Cohen, Cheryl/0000-0003-0376-2302; Thomas, Juno/0000-0002-8986-1135				[Anonymous], 2009, Wkly Epidemiol Rec, V84, P397; [Anonymous], 2011, Wkly Epidemiol Rec, V86, P129; Aylward RB, 1997, INT J EPIDEMIOL, V26, P662, DOI 10.1093/ije/26.3.662; Centers for Disease Control and Prevention (CDC), 1999, MMWR Morb Mortal Wkly Rep, V48, P585; deMoraesPinto MI, 1996, J INFECT DIS, V173, P1077, DOI 10.1093/infdis/173.5.1077; Department of Health, 1998, EPI DIS SURV FIELD G; Dubray C, 2006, VACCINE, V24, P3984, DOI 10.1016/j.vaccine.2006.01.049; EMBREE JE, 1992, J INFECT DIS, V165, P262, DOI 10.1093/infdis/165.2.262; European Center for Disease Prevention and Control, 2011, EP UPD MEASL EU EEA; EUVAC.NET, 2010, SURV COMM NETW VACC; Goodson JL, 2009, VACCINE, V27, P5870, DOI 10.1016/j.vaccine.2009.07.057; Heymann DL, 2004, CONTROL COMMUNICABLE, P347; HULL HF, 1983, LANCET, V1, P972; LEPAGE P, 1992, AM J DIS CHILD, V146, P550, DOI 10.1001/archpedi.1992.02160170030011; Leuridan E, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c1626; McAnerney J, 2008, COMMUNICABLE DIS SUR, V6, P2; McAnerney J, 2009, COMMUNICABLE DIS SUR, V7, P2; McMorrow ML, 2009, SAMJ S AFR MED J, V99, P314; National Department of Health South Africa, 2010, GUID MAN HIV CHILDR; PABST HF, 1992, PEDIATR INFECT DIS J, V11, P525, DOI 10.1097/00006454-199207000-00004; Scott S, 2005, J INFECT DIS, V191, P1854, DOI 10.1086/429963; Scott S, 2007, CLIN INFECT DIS, V45, P1417, DOI 10.1086/522989; Smit S, 2007, COMMUNICABLE DIS SUR, V5, P1; Statistics South Africa, 2010, STAT REL P0302 MID P; WHO, WHO UNICEF JOINT STA; World Health Organisation, 1990, WHOEPIGEN947; World Health Organisation Regional Office for Africa, MEASL PREEL; World Health Organization, 2009, MEASL; World Health Organization, 2006, WKLY EPIDEMIOL REC, V81, P469; World Health Organization, 1999, WHOCDSCSRISR991; World Health Organization, 2009, RESP COVID 19 HLTH S	31	33	35	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e55682	10.1371/journal.pone.0055682	http://dx.doi.org/10.1371/journal.pone.0055682			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437059	Green Published, Green Submitted, gold			2022-12-25	WOS:000315184200021
J	Ohta, S; Fukui, N; Sakai, KL				Ohta, Shinri; Fukui, Naoki; Sakai, Kuniyoshi L.			Syntactic Computation in the Human Brain: The Degree of Merger as a Key Factor	PLOS ONE			English	Article							LEFT PREFRONTAL CORTEX; SUPERIOR TEMPORAL CORTEX; SENTENCE COMPREHENSION; BROCAS AREA; LANGUAGE; JAPANESE; DORSAL; HONORIFICATION; SPECIALIZATION; ACQUISITION	Our goal of this study is to characterize the functions of language areas in most precise terms. Previous neuroimaging studies have reported that more complex sentences elicit larger activations in the left inferior frontal gyrus (L.F3op/F3t), although the most critical factor still remains to be identified. We hypothesize that pseudowords with grammatical particles and morphosyntactic information alone impose a construction of syntactic structures, just like normal sentences, and that "the Degree of Merger" (DoM) in recursively merged sentences parametrically modulates neural activations. Using jabberwocky sentences with distinct constructions, we fitted various parametric models of syntactic, other linguistic, and nonlinguistic factors to activations measured with functional magnetic resonance imaging. We demonstrated that the models of DoM and "DoM+ number of Search (searching syntactic features)" were the best to explain activations in the L. F3op/F3t and supramarginal gyrus (L. SMG), respectively. We further introduced letter strings, which had neither lexical associations nor grammatical particles, but retained both matching orders and symbol orders of sentences. By directly contrasting jabberwocky sentences with letter strings, localized activations in L. F3op/F3t and L. SMG were indeed independent of matching orders and symbol orders. Moreover, by using dynamic causal modeling, we found that the model with a inhibitory modulatory effect for the bottom-up connectivity from L. SMG to L. F3op/F3t was the best one. For this best model, the top-down connection from L. F3op/F3t to L. SMG was significantly positive. By using diffusion-tensor imaging, we confirmed that the left dorsal pathway of the superior longitudinal and arcuate fasciculi consistently connected these regions. Lastly, we established that nonlinguistic order-related and error-related factors significantly activated the right (R.) lateral premotor cortex and R. F3op/F3t, respectively. These results indicate that the identified network of L. F3op/F3t and L. SMG subserves the calculation of DoM in recursively merged sentences.	[Ohta, Shinri; Sakai, Kuniyoshi L.] Univ Tokyo, Grad Sch Arts & Sci, Dept Life Sci, Meguro Ku, Tokyo, Japan; [Ohta, Shinri] Japan Soc Promot Sci, Chiyoda Ku, Tokyo, Japan; [Fukui, Naoki] Sophia Univ, Dept Linguist, Chiyoda Ku, Tokyo 102, Japan; [Fukui, Naoki; Sakai, Kuniyoshi L.] Japan Sci & Technol Agcy, CREST, Chiyoda Ku, Tokyo, Japan; [Sakai, Kuniyoshi L.] Univ Tokyo, Grad Sch Arts & Sci, Dept Basic Sci, Meguro Ku, Tokyo, Japan	University of Tokyo; Japan Society for the Promotion of Science; Sophia University; Japan Science & Technology Agency (JST); University of Tokyo	Sakai, KL (corresponding author), Univ Tokyo, Grad Sch Arts & Sci, Dept Life Sci, Meguro Ku, Tokyo, Japan.	sakai@mind.c.u-tokyo.ac.jp	Ohta, Shinri/D-9919-2019	Ohta, Shinri/0000-0003-3240-0028	Core Research for Evolutional Science and Technology (CREST) grant from the Japan Science and Technology Agency (JST); Ministry of Education, Culture, Sports, Science, and Technology of Japan [20220005, 22222001]; Japan Society for the Promotion of Science (JSPS) [24N8931]; Grants-in-Aid for Scientific Research [12J08931] Funding Source: KAKEN	Core Research for Evolutional Science and Technology (CREST) grant from the Japan Science and Technology Agency (JST); Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This research was supported by a Core Research for Evolutional Science and Technology (CREST) grant from the Japan Science and Technology Agency (JST), by a Grant-in-Aid for Scientific Research (S) (Nos. 20220005 and 22222001) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan, and by a Grant-in-Aid for JSPS Fellows (No. 24N8931) from the Japan Society for the Promotion of Science (JSPS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe K, 2011, NAT NEUROSCI, V14, P1067, DOI 10.1038/nn.2869; Bahlmann J, 2008, NEUROIMAGE, V42, P525, DOI 10.1016/j.neuroimage.2008.04.249; Bahlmann J, 2007, HUM BRAIN MAPP, V28, P940, DOI 10.1002/hbm.20318; Beckers GJL, 2012, NEUROREPORT, V23, P139, DOI 10.1097/WNR.0b013e32834f1765; Botvinick MM, 2004, TRENDS COGN SCI, V8, P539, DOI 10.1016/j.tics.2004.10.003; Chikazoe J, 2007, J COGNITIVE NEUROSCI, V19, P69, DOI 10.1162/jocn.2007.19.1.69; Chomsky N., 1957, SYNTACTIC STRUCTURES; Chomsky N., 1986, KNOWLEDGE LANGUAGE I; Chomsky Noam., 1965, ASPECTS THEORY SYNTA; Chomsky Noam, 2004, STRUCTURES CARTOGRAP, P104; Corballis MC, 2007, COGNITIVE SCI, V31, P697, DOI 10.1080/15326900701399947; Dapretto M, 1999, NEURON, V24, P427, DOI 10.1016/S0896-6273(00)80855-7; den Ouden DB, 2012, NEUROIMAGE, V59, P815, DOI 10.1016/j.neuroimage.2011.07.057; Embick D, 2000, P NATL ACAD SCI USA, V97, P6150, DOI 10.1073/pnas.100098897; Friederici AD, 2003, CEREB CORTEX, V13, P170, DOI 10.1093/cercor/13.2.170; Friederici AD, 2009, NEUROREPORT, V20, P563, DOI 10.1097/WNR.0b013e3283297dee; Friston KJ, 2006, NEUROIMAGE, V30, P1097, DOI 10.1016/j.neuroimage.2006.02.007; Friston KJ, 2003, NEUROIMAGE, V19, P1273, DOI 10.1016/S1053-8119(03)00202-7; Fukui N, 2003, LINGUA, V113, P321, DOI 10.1016/S0024-3841(02)00080-3; Fukui Naoki., 2011, OXFORD HDB LINGUISTI, P73; Gentner TQ, 2006, NATURE, V440, P1204, DOI 10.1038/nature04675; Gibson E, 2000, IMAGE, LANGUAGE, BRAIN, P95; Griffiths JD, 2013, CEREB CORTEX, V23, P139, DOI 10.1093/cercor/bhr386; Gunji T., 1987, JAPANESE PHRASE STRU; Hashimoto R, 2002, NEURON, V35, P589, DOI 10.1016/S0896-6273(02)00788-2; Homae F, 2003, NEUROIMAGE, V20, P578, DOI 10.1016/S1053-8119(03)00272-6; Hopcroft J. E., 1979, INTRO AUTOMATA THEOR; Iijima K, 2009, NEUROIMAGE, V44, P1387, DOI 10.1016/j.neuroimage.2008.10.041; Indefrey P, 2001, NEUROIMAGE, V14, P546, DOI 10.1006/nimg.2001.0867; Ivana A, 2007, J EAST ASIAN LINGUIS, V16, P171, DOI 10.1007/s10831-007-9011-7; Kinno R, 2008, HUM BRAIN MAPP, V29, P1015, DOI 10.1002/hbm.20441; Kriegeskorte N, 2009, NAT NEUROSCI, V12, P535, DOI 10.1038/nn.2303; Lee H, 2007, J NEUROSCI, V27, P1184, DOI 10.1523/JNEUROSCI.4442-06.2007; Lewis R. L., 2002, SENTENCE PROCESSING, P85; Momo K, 2008, BRAIN LANG, V107, P81, DOI 10.1016/j.bandl.2007.12.003; Musso M, 2003, NAT NEUROSCI, V6, P774, DOI 10.1038/nn1077; O'Grady W., 2010, CONT LINGUISTICS INT, V6th ed.; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Pallier C, 2011, P NATL ACAD SCI USA, V108, P2522, DOI 10.1073/pnas.1018711108; Pattamadilok C, 2010, J NEUROSCI, V30, P8435, DOI 10.1523/JNEUROSCI.5791-09.2010; Petersson KM, 2004, COGNITIVE SCI, V28, P383, DOI 10.1016/j.cogsci.2003.12.003; Roder B, 2002, NEUROIMAGE, V15, P1003, DOI 10.1006/nimg.2001.1026; Saito M, 1998, LINGUIST INQ, V29, P439, DOI 10.1162/002438998553815; Sakai KL, 2005, SCIENCE, V310, P815, DOI 10.1126/science.1113530; Santi A, 2010, NEUROIMAGE, V51, P1285, DOI 10.1016/j.neuroimage.2010.03.034; Saur D, 2008, P NATL ACAD SCI USA, V105, P18035, DOI 10.1073/pnas.0805234105; Stromswold K, 1996, BRAIN LANG, V52, P452, DOI 10.1006/brln.1996.0024; Suzuki K, 2003, CEREB CORTEX, V13, P517, DOI 10.1093/cercor/13.5.517; Tatsuno Y, 2005, J NEUROSCI, V25, P1637, DOI 10.1523/JNEUROSCI.3978-04.2005; Tsujimura Natsuko., 2007, INTRO JAPANESE LINGU; Wilson SM, 2011, NEURON, V72, P397, DOI 10.1016/j.neuron.2011.09.014; Wong FCK, 2011, J NEUROSCI, V31, P8780, DOI 10.1523/JNEUROSCI.0999-11.2011; YNGVE VICTOR H., 1960, PROC AMER PHIL SOC, V104, P444	53	26	26	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e56230	10.1371/journal.pone.0056230	http://dx.doi.org/10.1371/journal.pone.0056230			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437097	gold, Green Published, Green Submitted			2022-12-25	WOS:000315184200048
J	Vila, M; Carrillo-Gavilan, A; Vayreda, J; Bugmann, H; Fridman, J; Grodzki, W; Haase, J; Kunstler, G; Schelhaas, M; Trasobares, A				Vila, Montserrat; Carrillo-Gavilan, Amparo; Vayreda, Jordi; Bugmann, Harald; Fridman, Jonas; Grodzki, Wojciech; Haase, Josephine; Kunstler, Georges; Schelhaas, MartJan; Trasobares, Antoni			Disentangling Biodiversity and Climatic Determinants of Wood Production	PLOS ONE			English	Article							SPECIES RICHNESS; ECOSYSTEM FUNCTION; FOREST DIVERSITY; METAANALYSIS; SENSITIVITY; PATTERNS; INCREASE; BIOMASS; GROWTH; SCALE	Background: Despite empirical support for an increase in ecosystem productivity with species diversity in synthetic systems, there is ample evidence that this relationship is dependent on environmental characteristics, especially in structurally more complex natural systems. Empirical support for this relationship in forests is urgently needed, as these ecosystems play an important role in carbon sequestration. Methodology/Principal Findings: We tested whether tree wood production is positively related to tree species richness while controlling for climatic factors, by analyzing 55265 forest inventory plots in 11 forest types across five European countries. On average, wood production was 24% higher in mixed than in monospecific forests. Taken alone, wood production was enhanced with increasing tree species richness in almost all forest types. In some forests, wood production was also greater with increasing numbers of tree types. Structural Equation Modeling indicated that the increase in wood production with tree species richness was largely mediated by a positive association between stand basal area and tree species richness. Mean annual temperature and mean annual precipitation affected wood production and species richness directly. However, the direction and magnitude of the influence of climatic variables on wood production and species richness was not consistent, and vary dependent on forest type. Conclusions: Our analysis is the first to find a local scale positive relationship between tree species richness and tree wood production occurring across a continent. Our results strongly support incorporating the role of biodiversity in management and policy plans for forest carbon sequestration.	[Vila, Montserrat; Carrillo-Gavilan, Amparo] Estn Biol Donana EBD CSIC, Seville, Spain; [Vayreda, Jordi] Ctr Recerca Ecol & Aplicac Forestals, Barcelona, Spain; [Bugmann, Harald; Trasobares, Antoni] ETH, Dept Environm Sci, Inst Terr Ecosyst, Zurich, Switzerland; [Fridman, Jonas] Swedish Univ Agr Sci, Dept Forest Resource Management, Swedish Natl Forest Inventory, S-90183 Umea, Sweden; [Grodzki, Wojciech] Dept Forest Management Mt Reg, Forest Res Inst, Krakow, Poland; [Haase, Josephine] Univ Freiburg, Fac Biol, D-79106 Freiburg, Germany; [Kunstler, Georges] UR Ecosyst Montagnards, Irstea, St Martin Dheres, France; [Schelhaas, MartJan] Univ Wageningen & Res Ctr, Alterra, Wageningen, Netherlands	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD); Centro de Investigacion Ecologica y Aplicaciones Forestales (CREAF); Swiss Federal Institutes of Technology Domain; ETH Zurich; Swedish University of Agricultural Sciences; Agricultural University Krakow; Forest Research Institute; University of Freiburg; INRAE; Wageningen University & Research	Vila, M (corresponding author), Estn Biol Donana EBD CSIC, Seville, Spain.	montse.vila@ebd.csic.es	Kunstler, Georges/F-9179-2012; Grodzki, Wojciech/R-8170-2018; Bugmann, Harald/A-1252-2008; Schelhaas, Mart-Jan/I-4731-2012; Vila, Montserrat/D-9339-2013; Trasobares, Antoni/J-8882-2017; Vayreda, Jordi/U-8172-2017	Kunstler, Georges/0000-0002-2544-1940; Grodzki, Wojciech/0000-0003-0623-752X; Vila, Montserrat/0000-0003-3171-8261; Trasobares, Antoni/0000-0002-8123-9405; Vayreda, Jordi/0000-0002-9538-7361; Schelhaas, Mart-Jan/0000-0003-4525-2677; Bugmann, Harald/0000-0003-4233-0094	EU project BACCARA [226299]; Spanish Ministerio de Ciencia e Innovacion project Consolider-Ingenio MONTES [CSD2008-00040]	EU project BACCARA; Spanish Ministerio de Ciencia e Innovacion project Consolider-Ingenio MONTES	The authors thank the National Forest Inventory Services of France, The Netherlands, Spain, Sweden and Switzerland for their long term effort in collecting forest data. The authors thank A. Sala and two anonymous referees for constructive comments on a previous version of this manuscript. Research has been partially funded by the EU project BACCARA (FP7/2007-2013 project No 226299), http://www.baccara-project.eu/) and the Spanish Ministerio de Ciencia e Innovacion project Consolider-Ingenio MONTES (CSD2008-00040), http://www.creaf.uab.es/montes/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	[Anonymous], 2006, SAS MIXED MODELS; Arbuckle JL, 2003, AMOS 18; BABAKUS E, 1987, J MARKETING RES, V24, P222, DOI 10.2307/3151512; Balvanera P, 2006, ECOL LETT, V9, P1146, DOI 10.1111/j.1461-0248.2006.00963.x; Baraloto C, 2010, ANN FOREST SCI, V67, DOI 10.1051/forest/2009110; Belote RT, 2011, FOREST ECOL MANAG, V261, P1315, DOI 10.1016/j.foreco.2011.01.010; Burger JA, 2009, FOREST ECOL MANAG, V258, P2335, DOI 10.1016/j.foreco.2009.03.015; Cadotte MW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005695; Cardinale BJ, 2007, P NATL ACAD SCI USA, V104, P18123, DOI 10.1073/pnas.0709069104; Caspersen JP, 2001, ECOL RES, V16, P895, DOI 10.1046/j.1440-1703.2001.00455.x; Chytry M, 2003, J VEG SCI, V14, P563, DOI 10.1111/j.1654-1103.2003.tb02183.x; Ciais P, 2008, NAT GEOSCI, V1, P425, DOI 10.1038/ngeo233; Costanza R, 2007, ECOL ECON, V61, P478, DOI 10.1016/j.ecolecon.2006.03.021; Diaz S., 2009, BIODIVERSITY ECOSYST, P149; Duffy JE, 2009, FRONT ECOL ENVIRON, V7, P437, DOI 10.1890/070195; Firn J, 2007, OECOLOGIA, V154, P521, DOI 10.1007/s00442-007-0850-8; Healy C, 2008, J ECOL, V96, P903, DOI 10.1111/j.1365-2745.2008.01419.x; Hooper DU, 2005, ECOL MONOGR, V75, P3, DOI 10.1890/04-0922; Hu LT, 1998, PSYCHOL METHODS, V3, P424, DOI 10.1037/1082-989X.3.4.424; Huston MA, 1997, OECOLOGIA, V110, P449, DOI 10.1007/s004420050180; Iriondo JM, 2003, BIOL CONSERV, V113, P367, DOI 10.1016/S0006-3207(03)00129-0; Legendre L., 1983, DEV ENV MODELLING; Liang JJ, 2007, FOREST ECOL MANAG, V243, P116, DOI 10.1016/j.foreco.2007.02.028; Liira J, 2010, PLANT BIOSYST, V144, P211, DOI 10.1080/11263500903560868; Loreau M, 2001, SCIENCE, V294, P804, DOI 10.1126/science.1064088; Luyssaert S, 2010, GLOBAL CHANGE BIOL, V16, P1429, DOI 10.1111/j.1365-2486.2009.02056.x; Milla R, 2009, ANN BOT-LONDON, V103, P1279, DOI 10.1093/aob/mcp068; Mittelbach GG, 2001, ECOLOGY, V82, P2381, DOI 10.1890/0012-9658(2001)082[2381:WITORB]2.0.CO;2; Morin X, 2011, ECOL LETT, V14, P1211, DOI 10.1111/j.1461-0248.2011.01691.x; Nadrowski K, 2010, CURR OPIN ENV SUST, V2, P75, DOI 10.1016/j.cosust.2010.02.003; Pan YD, 2011, SCIENCE, V333, P988, DOI 10.1126/science.1201609; Paquette A, 2011, GLOBAL ECOL BIOGEOGR, V20, P170, DOI 10.1111/j.1466-8238.2010.00592.x; Paquette A, 2009, ECOL SOC, V14; Pearl J., 2000, CAUSALITY MODELS REA, DOI DOI 10.1017/CBO9780511803161; Piotto D, 2008, FOREST ECOL MANAG, V255, P781, DOI 10.1016/j.foreco.2007.09.065; Potvin C, 2008, ECOL LETT, V11, P217, DOI 10.1111/j.1461-0248.2007.01148.x; Pretzsch H, 2005, ECOL STUD-ANAL SYNTH, V176, P41; Robert N, 2010, NATIONAL FOREST INVENTORIES: PATHWAYS FOR COMMON REPORTING, P207, DOI 10.1007/978-90-481-3233-1_12; Ryan MG, 1997, ADV ECOL RES, V27, P213, DOI 10.1016/S0065-2504(08)60009-4; Scherer-Lorenzen M, 2005, ECOL STUD-ANAL SYNTH, V176, P347; Scherer-Lorenzen M, 2007, PERSPECT PLANT ECOL, V9, P53, DOI 10.1016/j.ppees.2007.08.002; Schermelleh-Engel K, 2003, METHODS PSYCHOL RES, V8, P23, DOI DOI 10.1002/0470010940; Szwagrzyk J, 2007, J VEG SCI, V18, P555, DOI 10.1111/j.1654-1103.2007.tb02569.x; Tilman D, 1996, NATURE, V379, P718, DOI 10.1038/379718a0; Tomppo E, 2010, NATIONAL FOREST INVENTORIES: PATHWAYS FOR COMMON REPORTING, P1, DOI 10.1007/978-90-481-3233-1; Vallet P, 2011, J VEG SCI, V22, P932, DOI 10.1111/j.1654-1103.2011.01288.x; Vayreda J, 2012, GLOBAL CHANGE BIOL, V18, P1028, DOI 10.1111/j.1365-2486.2011.02606.x; Vehvilainen H, 2006, ECOGRAPHY, V29, P497, DOI 10.1111/j.0906-7590.2006.04457.x; Vila M, 2005, ECOL STU AN, V176, P65; Vila M, 2007, ECOL LETT, V10, P241, DOI 10.1111/j.1461-0248.2007.01016.x; Whittaker RJ, 2010, ECOLOGY, V91, P2522, DOI 10.1890/08-0968.1; Wu M.L, 2010, STRUCTURAL EQUATION; Zhang Y, 2012, J ECOL, V100, P742, DOI 10.1111/j.1365-2745.2011.01944.x	53	152	158	3	107	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e53530	10.1371/journal.pone.0053530	http://dx.doi.org/10.1371/journal.pone.0053530			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437038	Green Submitted, Green Published, gold			2022-12-25	WOS:000315184200005
J	Andorf, CM; Honavar, V; Sen, TZ				Andorf, Carson M.; Honavar, Vasant; Sen, Taner Z.			Predicting the Binding Patterns of Hub Proteins: A Study Using Yeast Protein Interaction Networks	PLOS ONE			English	Article							GDP-DISSOCIATION INHIBITOR; SACCHAROMYCES-CEREVISIAE; INTERACTION MAP; FAMILIES DATABASE; EVOLUTIONARY RATE; SCOP DATABASE; GENOME; MODULARITY; SEQUENCE; DESIGN	Background: Protein-protein interactions are critical to elucidating the role played by individual proteins in important biological pathways. Of particular interest are hub proteins that can interact with large numbers of partners and often play essential roles in cellular control. Depending on the number of binding sites, protein hubs can be classified at a structural level as singlish-interface hubs (SIH) with one or two binding sites, or multiple-interface hubs (MIH) with three or more binding sites. In terms of kinetics, hub proteins can be classified as date hubs (i.e., interact with different partners at different times or locations) or party hubs (i.e., simultaneously interact with multiple partners). Methodology: Our approach works in 3 phases: Phase I classifies if a protein is likely to bind with another protein. Phase II determines if a protein-binding (PB) protein is a hub. Phase III classifies PB proteins as singlish-interface versus multiple-interface hubs and date versus party hubs. At each stage, we use sequence-based predictors trained using several standard machine learning techniques. Conclusions: Our method is able to predict whether a protein is a protein-binding protein with an accuracy of 94% and a correlation coefficient of 0.87; identify hubs from non-hubs with 100% accuracy for 30% of the data; distinguish date hubs/party hubs with 69% accuracy and area under ROC curve of 0.68; and SIH/MIH with 89% accuracy and area under ROC curve of 0.84. Because our method is based on sequence information alone, it can be used even in settings where reliable protein-protein interaction data or structures of protein-protein complexes are unavailable to obtain useful insights into the functional and evolutionary characteristics of proteins and their interactions. Availability: We provide a web server for our three-phase approach: http://hybsvm.gdcb.iastate.edu.	[Andorf, Carson M.; Honavar, Vasant] Iowa State Univ, Dept Comp Sci, Ames, IA USA; [Honavar, Vasant; Sen, Taner Z.] Iowa State Univ, Bioinformat & Computat Biol Program, Ames, IA 50011 USA; [Sen, Taner Z.] ARS, USDA, Corn Insects & Crop Genet Res Unit, Ames, IA USA; [Sen, Taner Z.] Iowa State Univ, Dept Genet Dev & Cell Biol, Ames, IA USA	Iowa State University; Iowa State University; United States Department of Agriculture (USDA); Iowa State University	Sen, TZ (corresponding author), Iowa State Univ, Bioinformat & Computat Biol Program, Ames, IA 50011 USA.	taner@iastate.edu	Honavar, Vasant G/K-9835-2015	Honavar, Vasant G/0000-0001-5399-3489; Sen, Taner/0000-0002-5553-6190; Andorf, Carson/0000-0003-2380-6704	National Institute of Health [GM066387]; Integrative Graduate Education and Research Training award [0504304]; National Science Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R21GM066387, R33GM066387] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Integrative Graduate Education and Research Training award; National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded in part by the National Institute of Health grant GM066387 to VH. The work of CMA was supported in part by a graduate fellowship funded by an Integrative Graduate Education and Research Training award 0504304. The work of VH while working at the National Science Foundation was supported by the National Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afridi T.H., 2011, AMINO ACIDS; Agarwal S, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000817; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Andorf C, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-284; Andreeva A, 2004, NUCLEIC ACIDS RES, V32, pD226, DOI 10.1093/nar/gkh039; Andreeva A, 2008, NUCLEIC ACIDS RES, V36, pD419, DOI 10.1093/nar/gkm993; Aragues R, 2007, PLOS COMPUT BIOL, V3, P1761, DOI 10.1371/journal.pcbi.0030178; Bader GD, 2003, NUCLEIC ACIDS RES, V31, P248, DOI 10.1093/nar/gkg056; Baker M, 2012, NATURE, V484, P271, DOI 10.1038/484271a; Baldi P, 2000, BIOINFORMATICS, V16, P412, DOI 10.1093/bioinformatics/16.5.412; Bateman A, 2002, NUCLEIC ACIDS RES, V30, P276, DOI 10.1093/nar/30.1.276; Bellay J, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-2-r14; Berman HM, 2002, ACTA CRYSTALLOGR D, V58, P899, DOI 10.1107/S0907444902003451; Bertin N, 2007, PLOS BIOL, V5, P1206, DOI 10.1371/journal.pbio.0050153; Cukuroglu E, 2010, ANN BIOMED ENG, V38, P2068, DOI 10.1007/s10439-010-0048-9; Dandekar T, 1998, TRENDS BIOCHEM SCI, V23, P324, DOI 10.1016/S0968-0004(98)01274-2; Das J, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-92; De Las Rivas J, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000807; Dreze M, 2010, METHOD ENZYMOL, V470, P281, DOI 10.1016/S0076-6879(10)70012-4; Eisenberg D, 2000, NATURE, V405, P823, DOI 10.1038/35015694; Ekman D, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-6-r45; Finn RD, 2005, BIOINFORMATICS, V21, P410, DOI 10.1093/bioinformatics/bti011; Finn RD, 2010, NUCLEIC ACIDS RES, V38, pD211, DOI 10.1093/nar/gkp985; Fleishman SJ, 2011, SCIENCE, V332, P816, DOI 10.1126/science.1202617; Fong JH, 2010, MOL BIOSYST, V6, P1821, DOI 10.1039/c005144f; Frank E, 2004, BIOINFORMATICS, V20, P2479, DOI 10.1093/bioinformatics/bth261; Fromont-Racine M, 2000, YEAST, V17, P95, DOI 10.1002/1097-0061(20000630)17:2<95::AID-YEA16>3.0.CO;2-H; FromontRacine M, 1997, NAT GENET, V16, P277, DOI 10.1038/ng0797-277; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; Grigoryan G, 2009, NATURE, V458, P859, DOI 10.1038/nature07885; Groll M, 2008, NATURE, V452, P755, DOI 10.1038/nature06782; Gursoy A, 2008, BIOCHEM SOC T, V36, P1398, DOI 10.1042/BST0361398; Han JDJ, 2004, NATURE, V430, P88, DOI 10.1038/nature02555; Ho Y, 2002, NATURE, V415, P180, DOI 10.1038/415180a; Hsing M, 2009, BIOINFORMATION, V4, P164, DOI 10.6026/97320630004164; Huang H, 2007, PLOS COMPUT BIOL, V3, P2155, DOI 10.1371/journal.pcbi.0030214; Ignatev A, 2008, J BIOL CHEM, V283, P18377, DOI 10.1074/jbc.M709718200; Ito T, 2001, P NATL ACAD SCI USA, V98, P4569, DOI 10.1073/pnas.061034498; Ito T, 2000, P NATL ACAD SCI USA, V97, P1143, DOI 10.1073/pnas.97.3.1143; Jeong H, 2001, NATURE, V411, P41, DOI 10.1038/35075138; Jin GX, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001207; Kahali B, 2009, GENE, V429, P18, DOI 10.1016/j.gene.2008.09.032; Kar G, 2012, CURR PHARM DES; Kar G, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000601; Keskin O, 2008, CHEM REV, V108, P1225, DOI 10.1021/cr040409x; Kim PM, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.16; Kim PM, 2006, SCIENCE, V314, P1938, DOI 10.1126/science.1136174; Kuzu G, 2012, CURR OPIN STRUCT BIO; Latha AB, 2011, BIOINFORMATION, V7, P163; Liu CH, 2012, HUMAN PROTEIN PROTEI; Liu TQ, 2007, NUCLEIC ACIDS RES, V35, pD198, DOI 10.1093/nar/gkl999; Manna B, 2009, GENE, V434, P50, DOI 10.1016/j.gene.2008.12.013; Marcotte EM, 1999, NATURE, V402, P83, DOI 10.1038/47048; McCallum A., 1998, P AAAI 98 WORKSH LEA, P41; MCCULLOCH WS, 1990, B MATH BIOL, V52, P99, DOI 10.1016/S0092-8240(05)80006-0; Mewes HW, 2002, NUCLEIC ACIDS RES, V30, P31, DOI 10.1093/nar/30.1.31; Mirzarezaee M, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-172; Missiuro PV, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000350; Mitchell T.M, 2003, MACH LEARN; Nair MTaAS, 2009, INT J BIOINFORMATICS, V1, P70; Nash R, 2007, NUCLEIC ACIDS RES, V35, pD468, DOI 10.1093/nar/gkl931; Ofran Y, 2007, BIOINFORMATICS, V23, pE13, DOI 10.1093/bioinformatics/btl303; Pang KF, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-179; Patil A, 2010, INT J MOL SCI, V11, P1930, DOI 10.3390/ijms11041930; Platt J C, 1999, ADV KERNEL METHODS S; Quinlan J.R, 2014, C4 5 PROGRAMS MACHIN; Rak A, 2003, SCIENCE, V302, P646, DOI 10.1126/science.1087761; Rosenblatt F, 1962, PRINCIPLES NEURODYNA; Liu S, 2007, P NATL ACAD SCI USA, V104, P5330, DOI 10.1073/pnas.0606198104; Stark C, 2011, NUCLEIC ACIDS RES, V39, pD698, DOI 10.1093/nar/gkq1116; Taylor IW, 2009, NAT BIOTECHNOL, V27, P199, DOI 10.1038/nbt.1522; Tsai CJ, 2009, TRENDS BIOCHEM SCI, V34, P594, DOI 10.1016/j.tibs.2009.07.007; Uetz P, 2000, NATURE, V403, P623, DOI 10.1038/35001009; Vapnik V., 1998, STAT LEARNING THEORY; Venkatesan K, 2009, NAT METHODS, V6, P83, DOI 10.1038/NMETH.1280; von Mering C, 2002, NATURE, V417, P399, DOI 10.1038/nature750; Walhout AJM, 2001, METHODS, V24, P297, DOI 10.1006/meth.2001.1190; Xenarios I, 2002, NUCLEIC ACIDS RES, V30, P303, DOI 10.1093/nar/30.1.303; Xue LC, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-244; Yu HY, 2008, SCIENCE, V322, P104, DOI 10.1126/science.1158684; Zotenko E, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000140	82	9	9	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2013	8	2							e56833	10.1371/journal.pone.0056833	http://dx.doi.org/10.1371/journal.pone.0056833			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093HR	23431393	Green Published, gold, Green Submitted			2022-12-25	WOS:000315182800036
J	Zhao, MD; Zhang, RJ; Xu, XY; Liu, Y; Zhang, HX; Zhai, XY; Hu, XM				Zhao, Mingdong; Zhang, Ruijin; Xu, Xiaoyan; Liu, Yang; Zhang, Haixia; Zhai, Xiaoyu; Hu, Xuemei			IL-10 Reduces Levels of Apoptosis in Toxoplasma gondii-Infected Trophoblasts	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; HLA-G EXPRESSION; PLACENTAL TROPHOBLASTS; TNF-ALPHA; CELLS; PREGNANCY; INTERLEUKIN-10; MODULATION; GAMMA; MICE	Background: To analyze the effects of IL-10 on the HLA-G expression and the apoptosis of trophoblasts infected with Toxoplasma gondii. Methods: T. gondii-infected or uninfected human trophoblasts and immortalized human placental BeWo cells were cultured with or without human IL-10. Uninfected and infected cells without IL-10 cells served as controls. HLA-G expression was measured by real-time PCR and flow cytometry, respectively. Cells apoptosis were analyzed by flow cytometry. Apoptosis associated moleculars were measured by real-time PCR and Western bolt. Results: HLA-G expression was increased in the infected trophoblasts and BeWo cells compared to uninfected cells. Treatment of infected cells with IL-10 decreased HLA-G expression compared to infected cells while no change in treatment of uninfected cells compared with uninfected cells. Levels of apoptosis and apoptosis associated caspase-3 and caspase-8 decreased and c-FLIP levels increased in treated infected cells with IL-10 compared to infected cells and no difference in IL-10 treated uninfected cells compared to uninfected cells. Conclusions: IL-10 regulates HLA-G expression in T. gondii-infected trophoblasts. IL-10 treatment of infected trophoblasts reduced levels of apoptosis. This may contribute to the improvement in pregnancy outcomes when women infected with T. gondii treated with IL-10.	[Zhang, Ruijin; Xu, Xiaoyan; Liu, Yang; Zhang, Haixia; Zhai, Xiaoyu; Hu, Xuemei] Binzhou Med Univ, Dept Immunol, Yantai, Peoples R China; [Zhao, Mingdong] Binzhou Med Univ, Yantai Affiliated Hosp, Dept Radiol, Yantai, Peoples R China	Binzhou Medical University; Binzhou Medical University	Hu, XM (corresponding author), Binzhou Med Univ, Dept Immunol, Yantai, Peoples R China.	xue-mei-hu@163.com			National Natural Science Foundation of China [81171591, 81273243]; Science and Technology Development Planning Project of Shandong Province [2012GSF11809]; Natural Science Foundation of Shandong Province [ZR2010HM 012]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Development Planning Project of Shandong Province; Natural Science Foundation of Shandong Province(Natural Science Foundation of Shandong Province)	This study was supported in part by funds from the National Natural Science Foundation of China 81171591 and 81273243, Science and Technology Development Planning Project of Shandong Province 2012GSF11809, and Natural Science Foundation of Shandong Province ZR2010HM 012. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbasi M, 2003, J INFECT DIS, V188, P608, DOI 10.1086/377132; Almasry SM, 2012, J MOL HISTOL, V43, P253, DOI 10.1007/s10735-012-9410-6; Barbosa BF, 2008, CLIN EXP IMMUNOL, V151, P536, DOI 10.1111/j.1365-2249.2007.03583.x; Carruthers VB, 2002, ACTA TROP, V81, P111, DOI 10.1016/S0001-706X(01)00201-7; Chan G, 2002, AM J PATHOL, V161, P1371, DOI 10.1016/S0002-9440(10)64413-6; CHAOUAT G, 1995, J IMMUNOL, V154, P4261; Commodaro AG, 2009, MEM I OSWALDO CRUZ, V104, P345, DOI 10.1590/S0074-02762009000200030; Eslick J, 2004, INFLAMMATION, V28, P139, DOI 10.1023/B:IFLA.0000039560.00231.cd; Ferro EAV, 1999, PARASITOL RES, V85, P647, DOI 10.1007/s004360050609; Gazzinelli RT, 1996, J IMMUNOL, V157, P798; Golks A, 2005, J BIOL CHEM, V280, P14507, DOI 10.1074/jbc.M414425200; John T, 2007, CYTOKINE, V40, P226, DOI 10.1016/j.cyto.2007.10.002; Kanai T, 2001, AM J REPROD IMMUNOL, V45, P94, DOI 10.1111/j.8755-8920.2001.450205.x; Lafon M, 2005, J VIROL, V79, P15226, DOI 10.1128/JVI.79.24.15226-15237.2005; Moreau P, 1999, INT IMMUNOL, V11, P803, DOI 10.1093/intimm/11.5.803; Mouillot G, 2007, HUM IMMUNOL, V68, P277, DOI 10.1016/j.humimm.2006.10.016; Nash PB, 1998, J IMMUNOL, V160, P1824; Onno M, 2000, HUM IMMUNOL, V61, P1086, DOI 10.1016/S0198-8859(00)00191-9; Poulaki V, 2002, AM J PATHOL, V161, P643, DOI 10.1016/S0002-9440(10)64220-4; Rieger L, 2002, MOL HUM REPROD, V8, P255, DOI 10.1093/molehr/8.3.255; RouasFreiss N, 1997, P NATL ACAD SCI USA, V94, P11520, DOI 10.1073/pnas.94.21.11520; Salvesen GS, 1999, P NATL ACAD SCI USA, V96, P10964, DOI 10.1073/pnas.96.20.10964; Santiago B, 2004, J IMMUNOL, V172, P560, DOI 10.4049/jimmunol.172.1.560; Tenter AM, 2000, INT J PARASITOL, V30, P1217, DOI 10.1016/S0020-7519(00)00124-7; VINCE G, 1992, CLIN EXP IMMUNOL, V88, P174; Wang T, 2011, EXP PARASITOL, V127, P107, DOI 10.1016/j.exppara.2010.07.003; Yu JW, 2008, ONCOGENE, V27, P6216, DOI 10.1038/onc.2008.299; Zhang RJ, 2012, GYNECOL OBSTET INVES, V73, P223, DOI 10.1159/000333310; Zhou X, 2012, AM J OBSTET GYNECOL, V206, DOI 10.1016/j.ajog.2012.03.013	29	23	24	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e56455	10.1371/journal.pone.0056455	http://dx.doi.org/10.1371/journal.pone.0056455			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418570	Green Published, gold, Green Submitted			2022-12-25	WOS:000315970300163
J	Goveas, JS; Xie, CM; Chen, G; Li, WJ; Ward, BD; Franczak, MB; Jones, JL; Antuono, PG; Li, SJ				Goveas, Joseph S.; Xie, Chunming; Chen, Gang; Li, Wenjun; Ward, B. Douglas; Franczak, Malgorzata B.; Jones, Jennifer L.; Antuono, Piero G.; Li, Shi-Jiang			Functional Network Endophenotypes Unravel the Effects of Apolipoprotein E Epsilon 4 in Middle-Aged Adults	PLOS ONE			English	Article							MILD ALZHEIMERS-DISEASE; RESTING STATE FMRI; HUMAN BRAIN; COGNITIVE IMPAIRMENT; DEPRESSIVE SYMPTOMS; MEMORY DEFICITS; GENETIC RISK; OLDER-ADULTS; CONNECTIVITY; APOE	Apolipoprotein E-epsilon 4 (APOE-epsilon 4) accentuates memory decline, structural volume loss and cerebral amyloid deposition in cognitively healthy adults. We investigated whether APOE-epsilon 4 carriers will show disruptions in the intrinsic cognitive networks, including the default mode (DMN), executive control (ECN) and salience (SN) networks, relative to noncarriers in middle-aged healthy adults; and the extent to which episodic-memory performance is related to the altered functional connectivity (Fc) in these networks. Resting-state functional connectivity MRI (R-fMRI) was used to measure the differences in the DMN, ECN and SN Fc between 20 APOE-epsilon 4 carriers and 26 noncarriers. Multiple linear regression analyses were performed to determine the relationship between episodic-memory performance and Fc differences in the three resting-state networks across all subjects. There were no significant differences in the demographic and neuropsychological characteristics and the gray-matter volumes in the carriers and noncarriers. While mostly diminished DMN and ECN functional connectivities were seen, enhanced connections to the DMN structures were found in the SN in epsilon 4 carriers. Altered DMN and ECN were associated with episodic memory performance. Significant Fc differences in the brain networks implicated in cognition were seen in middle-aged individuals with a genetic risk for AD, in the absence of cognitive decline and gray-matter atrophy. Prospective studies are essential to elucidate the potential of R-fMRI technique as a biomarker for predicting conversion from normal to early AD in healthy APOE-epsilon 4 carriers.	[Goveas, Joseph S.; Li, Shi-Jiang] Med Coll Wisconsin, Dept Psychiat & Behav Med, Milwaukee, WI 53226 USA; [Xie, Chunming; Chen, Gang; Li, Wenjun; Ward, B. Douglas; Li, Shi-Jiang] Med Coll Wisconsin, Dept Biophys, Milwaukee, WI 53226 USA; [Franczak, Malgorzata B.; Jones, Jennifer L.; Antuono, Piero G.] Med Coll Wisconsin, Dept Neurol, Milwaukee, WI 53226 USA	Medical College of Wisconsin; Medical College of Wisconsin; Medical College of Wisconsin	Li, SJ (corresponding author), Med Coll Wisconsin, Dept Psychiat & Behav Med, Milwaukee, WI 53226 USA.	sjli@mcw.edu	Li, Shi-Jiang/M-2534-2017; Yue, Chunlin/B-3554-2014	Yue, Chunlin/0000-0002-2261-6725	Extendicare Foundation grant; National Institutes of Health grant [R01 AD20279]; Alzheimer's Association New Investigator [IRG-11-204070]; Advancing Healthier Wisconsin Endowment for Research; National Natural Science of Foundation of China [81171021, 91132727, 81171323]; Clinical and Translational Science Award program of the National Center for Research Resources [1UL1RR031973]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR031973] Funding Source: NIH RePORTER	Extendicare Foundation grant; National Institutes of Health grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alzheimer's Association New Investigator(Alzheimer's Association); Advancing Healthier Wisconsin Endowment for Research; National Natural Science of Foundation of China(National Natural Science Foundation of China (NSFC)); Clinical and Translational Science Award program of the National Center for Research Resources; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by Extendicare Foundation grant (to PGA), National Institutes of Health grant R01 AD20279 (to SJL), Alzheimer's Association New Investigator IRG-11-204070 (to JSG), Advancing Healthier Wisconsin Endowment for Research to MCW (to JSG), 1UL1RR031973 from the Clinical and Translational Science Award program of the National Center for Research Resources (to PGA, JSG, SJL), and the National Natural Science of Foundation of China 81171021, 91132727, 81171323 (to CX). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agosta F, 2012, NEUROBIOL AGING, V33, P1564, DOI 10.1016/j.neurobiolaging.2011.06.007; Andrews-Hanna JR, 2010, NEURON, V65, P550, DOI 10.1016/j.neuron.2010.02.005; Backman L, 2005, NEUROPSYCHOLOGY, V19, P520, DOI 10.1037/0894-4105.19.4.520; Beck A.T., 1996, PSYCHOL ASSESS, V10, DOI [10.1037/t00742-000, DOI 10.1037/T00742-000]; Birn RM, 2008, HUM BRAIN MAPP, V29, P740, DOI 10.1002/hbm.20577; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Biswal BB, 2010, P NATL ACAD SCI USA, V107, P4734, DOI 10.1073/pnas.0911855107; Bondi MW, 2005, NEUROLOGY, V64, P501, DOI 10.1212/01.WNL.0000150885.00929.7E; Bookheimer SY, 2000, NEW ENGL J MED, V343, P450, DOI 10.1056/NEJM200008173430701; Buckner RL, 2009, J NEUROSCI, V29, P1860, DOI 10.1523/JNEUROSCI.5062-08.2009; Caselli RJ, 2011, NEUROLOGY, V76, P1078, DOI 10.1212/WNL.0b013e318211c3ae; Caselli RJ, 2009, NEW ENGL J MED, V361, P255, DOI 10.1056/NEJMoa0809437; Chen G, 2011, RADIOLOGY, V259, P213, DOI 10.1148/radiol.10100734; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Craig AD, 2002, NAT REV NEUROSCI, V3, P655, DOI 10.1038/nrn894; Curtis CE, 2003, TRENDS COGN SCI, V7, P415, DOI 10.1016/S1364-6613(03)00197-9; Donix M, 2010, NEUROIMAGE, V53, P37, DOI 10.1016/j.neuroimage.2010.06.009; Filippini N, 2009, P NATL ACAD SCI USA, V106, P7209, DOI 10.1073/pnas.0811879106; Fleisher AS, 2009, NEUROIMAGE, V47, P1678, DOI 10.1016/j.neuroimage.2009.06.021; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; Fox MD, 2009, J NEUROPHYSIOL, V101, P3270, DOI 10.1152/jn.90777.2008; Glover GH, 2000, MAGNET RESON MED, V44, P162, DOI 10.1002/1522-2594(200007)44:1<162::AID-MRM23>3.0.CO;2-E; Gong JS, 2002, J BIOL CHEM, V277, P29919, DOI 10.1074/jbc.M203934200; Goveas J, 2011, BEHAV BRAIN RES, V219, P205, DOI 10.1016/j.bbr.2011.01.008; Goveas JS, 2011, J MAGN RESON IMAGING, V34, P764, DOI 10.1002/jmri.22662; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Hedden T, 2009, J NEUROSCI, V29, P12686, DOI 10.1523/JNEUROSCI.3189-09.2009; Jack CR, 2009, BRAIN, V132, P1355, DOI 10.1093/brain/awp062; Johnson SC, 2006, J NEUROSCI, V26, P6069, DOI 10.1523/JNEUROSCI.0959-06.2006; Kelly C, 2012, TRENDS COGN SCI, V16, P181, DOI 10.1016/j.tics.2012.02.001; Kerns JG, 2004, SCIENCE, V303, P1023, DOI 10.1126/science.1089910; Lezak M.D., 1995, NEUROPSYCHOLOGICAL A; Li WJ, 2012, NEUROIMAGE, V60, P1083, DOI 10.1016/j.neuroimage.2011.12.077; Machulda MM, 2011, ARCH NEUROL-CHICAGO, V68, P1131, DOI 10.1001/archneurol.2011.108; Mayeux R, 1998, NEW ENGL J MED, V338, P506, DOI 10.1056/NEJM199802193380804; Menon V, 2010, BRAIN STRUCT FUNCT, V214, P655, DOI 10.1007/s00429-010-0262-0; Mesulam MM, 1998, BRAIN, V121, P1013, DOI 10.1093/brain/121.6.1013; Morris JC, 2010, ANN NEUROL, V67, P122, DOI 10.1002/ana.21843; Muraskin J, 2012, NEUROIMAGE; NATHAN BP, 1994, SCIENCE, V264, P850, DOI 10.1126/science.8171342; Orfanidis SJ, 1996, INTRO SIGNAL PROCESS, V1st; Petrella JR, 2008, RADIOLOGY, V246, P20, DOI 10.1148/radiol.2461061994; Qi ZG, 2010, NEUROIMAGE, V50, P48, DOI 10.1016/j.neuroimage.2009.12.025; Rapp A, 2006, BIOCHIMIE, V88, P473, DOI 10.1016/j.biochi.2005.10.007; Reiman EM, 2005, P NATL ACAD SCI USA, V102, P8299, DOI 10.1073/pnas.0500579102; Reiman EM, 2009, P NATL ACAD SCI USA, V106, P6820, DOI 10.1073/pnas.0900345106; Resnick SM, 2010, NEUROLOGY, V74, P807, DOI 10.1212/WNL.0b013e3181d3e3e9; Rombouts SARB, 2003, NEUROIMAGE, V20, P1236, DOI 10.1016/S1053-8119(03)00386-0; ROSEN WG, 1980, ANN NEUROL, V7, P486, DOI 10.1002/ana.410070516; Saunders AM, 1996, LANCET, V348, P90, DOI 10.1016/S0140-6736(96)01251-2; Seeley WW, 2007, J NEUROSCI, V27, P2349, DOI 10.1523/JNEUROSCI.5587-06.2007; Seidenberg M, 2009, NEUROLOGY, V73, P612, DOI 10.1212/WNL.0b013e3181b389ad; Sheline YI, 2010, J NEUROSCI, V30, P17035, DOI 10.1523/JNEUROSCI.3987-10.2010; Sheline YI, 2010, BIOL PSYCHIAT, V67, P584, DOI 10.1016/j.biopsych.2009.08.024; Sojkova J, 2011, ARCH NEUROL-CHICAGO, V68, P232, DOI 10.1001/archneurol.2010.357; Sridharan D, 2008, P NATL ACAD SCI USA, V105, P12569, DOI 10.1073/pnas.0800005105; Storandt M, 2006, NEUROLOGY, V67, P467, DOI 10.1212/01.wnl.0000228231.26111.6e; Tiraboschi P, 2004, NEUROLOGY, V62, P1977, DOI 10.1212/01.WNL.0000128091.92139.0F; Trachtenberg AJ, 2012, NEUROIMAGE, V59, P565, DOI 10.1016/j.neuroimage.2011.07.059; Van Dijk KRA, 2012, NEUROIMAGE, V59, P431, DOI 10.1016/j.neuroimage.2011.07.044; Vemuri P, 2010, ANN NEUROL, V67, P308, DOI 10.1002/ana.21953; Villemagne VL, 2008, NEUROPSYCHOLOGIA, V46, P1688, DOI 10.1016/j.neuropsychologia.2008.02.008; Westlye ET, 2011, J NEUROSCI, V31, P7775, DOI 10.1523/JNEUROSCI.1230-11.2011; Xie CM, 2012, HUM BRAIN MAPP, V33, P1352, DOI 10.1002/hbm.21291; Xu GF, 2009, BRAIN, V132, P383, DOI 10.1093/brain/awn254; Yip AG, 2005, NEUROLOGY, V65, P259, DOI 10.1212/01.wnl.0000168863.49053.4d; Zar J. H., 1996, BIOSTATISTICAL ANAL; Zhong N, 2009, CURR ALZHEIMER RES, V6, P415, DOI 10.2174/156720509789207921; Zhou J, 2010, BRAIN, V133, P1352, DOI 10.1093/brain/awq075	71	35	36	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2013	8	2							e55902	10.1371/journal.pone.0055902	http://dx.doi.org/10.1371/journal.pone.0055902			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104BU	23424640	gold, Green Published			2022-12-25	WOS:000315965100028
J	Kuehne, LM; Padgham, BL; Olden, JD				Kuehne, Lauren M.; Padgham, Britta L.; Olden, Julian D.			The Soundscapes of Lakes across an Urbanization Gradient	PLOS ONE			English	Article							TRAFFIC NOISE; LANDSCAPE; BIODIVERSITY; ENVIRONMENT; ECOSYSTEMS; CHALLENGES; DIVERSITY; ANIMALS; IMPACT; TESTS	Background/Methodology: A significant implication of increasing urbanization is anthropogenic noise pollution. Although noise is strongly associated with disruption of animal communication systems and negative health effects for humans, the study of these consequences at ecologically relevant spatial and temporal scales (termed soundscape ecology) is in early stages of application. In this study, we examined the above- and below-water soundscape of recreational and residential lakes in the region surrounding a large metropolitan area. Using univariate and multivariate approaches we test the importance of large- and local-scale landscape factors in driving acoustic characteristics across an urbanization gradient, and visualize changes in the soundscape over space and time. Principal Findings: Anthropogenic noise (anthrophony) was strongly predicted by a landcover-based metric of urbanization (within a 10 km radius), with presence of a public park as a secondary influence; this urbanization signal was apparent even in below-water recordings. The percent of hourly measurements exceeding noise thresholds associated with outdoor disturbance was 67%, 17%, and 0%, respectively, for lakes characterized as High, Medium, and Low urbanization. Decreased biophony (proportion of natural sounds) was associated with presence of a public park followed by increased urbanization; time of day was also a significant predictor of biophony. Local-scale (shoreline) residential development was not related to changes in anthrophony or biophony. The patterns we identify are illustrated with a multivariate approach which allows use of entire sound samples and facilitates interpretation of changes in a soundscape. Conclusions/Significance: As highly valued residential and recreation areas, lakes represent everyday soundscapes important to both humans and wildlife. Our findings that many of these areas, particularly those with public parks, routinely experience sound types and levels associated with disturbance, suggests that urban planners need to account for the effect of increasing development on soundscapes to avoid compromising goals for ecological and human health.	[Kuehne, Lauren M.; Olden, Julian D.] Univ Washington, Sch Aquat & Fishery Sci, Seattle, WA 98195 USA; [Padgham, Britta L.] Univ Washington, Sch Marine & Environm Affairs, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Kuehne, LM (corresponding author), Univ Washington, Sch Aquat & Fishery Sci, Seattle, WA 98195 USA.	lkuehne@uw.edu	Olden, Julian D/A-8535-2010; Kuehne, Lauren Marie/AGZ-0367-2022; Vazquez-Dominguez, Guillermo GVD/L-7818-2014	Olden, Julian/0000-0003-2143-1187	National Science Foundation Graduate Research Fellowship Grant [DGE-0718124]; H. Mason Keeler Endowed Professorship from the School of Aquatic and Fishery Sciences	National Science Foundation Graduate Research Fellowship Grant; H. Mason Keeler Endowed Professorship from the School of Aquatic and Fishery Sciences	This work was supported in part by a National Science Foundation Graduate Research Fellowship Grant (# DGE-0718124), as well as the contributions of 49 individuals (none of whom are profit-making organizations) who funded the project via a crowdfunding campaign. JDO acknowledges support from the H. Mason Keeler Endowed Professorship from the School of Aquatic and Fishery Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti M, 2007, LANDSCAPE URBAN PLAN, V80, P345, DOI 10.1016/j.landurbplan.2006.08.001; Anderson MJ, 2006, BIOMETRICS, V62, P245, DOI 10.1111/j.1541-0420.2005.00440.x; Anderson MJ, 2001, CAN J FISH AQUAT SCI, V58, P626, DOI 10.1139/cjfas-58-3-626; [Anonymous], 2001, 60651 IEC; Barber JR, 2011, LANDSCAPE ECOL, V26, P1281, DOI 10.1007/s10980-011-9646-7; Barber JR, 2010, TRENDS ECOL EVOL, V25, P180, DOI 10.1016/j.tree.2009.08.002; Beatley T., 2011, BIOPHILIC CITIES INT; Carpenter SR, 2007, BIOSCIENCE, V57, P323, DOI 10.1641/B570407; CORNILLON PC, 1977, J ACOUST SOC AM, V61, P739, DOI 10.1121/1.381362; Depraetere M, 2012, ECOL INDIC, V13, P46, DOI 10.1016/j.ecolind.2011.05.006; Dudgeon D, 2006, BIOL REV, V81, P163, DOI 10.1017/S1464793105006950; Dumyahn SL, 2011, LANDSCAPE ECOL, V26, P1327, DOI 10.1007/s10980-011-9635-x; Ellis EC, 2011, PHILOS T R SOC A, V369, P1010, DOI 10.1098/rsta.2010.0331; Environmental Protection Agency, 1980, EPA NOIS CONTR PROGR; Francis CD, 2012, P ROY SOC B-BIOL SCI, V279, P2727, DOI 10.1098/rspb.2012.0230; Francis CD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027052; Frumkin P, 2001, AM J PREV MED, V20, P234, DOI 10.1016/S0749-3797(00)00317-2; Galloway W. J., 1974, POPULATION DISTRIBUT; Halfwerk W, 2011, J APPL ECOL, V48, P210, DOI 10.1111/j.1365-2664.2010.01914.x; Hansen AJ, 2002, BIOSCIENCE, V52, P151, DOI 10.1641/0006-3568(2002)052[0151:ECACOD]2.0.CO;2; Hempton Gordon, 2009, ONE SQUARE INCH SILE; Joo W, 2011, LANDSCAPE URBAN PLAN, V103, P259, DOI 10.1016/j.landurbplan.2011.08.001; Kight CR, 2011, ECOL LETT, V14, P1052, DOI 10.1111/j.1461-0248.2011.01664.x; Krause B, 2011, LANDSCAPE ECOL, V26, P1247, DOI 10.1007/s10980-011-9639-6; McKinney M. L., 2008, Urban Ecosystems, V11, P161, DOI 10.1007/s11252-007-0045-4; Melles S, 2003, CONSERV ECOL, V7; Miller NP, 2008, APPL ACOUST, V69, P77, DOI 10.1016/j.apacoust.2007.04.008; Mosisch Thorsten D., 1998, Lakes Reservoirs Research and Management, V3, P1, DOI 10.1111/j.1440-1770.1998.tb00028.x; National Marine Fisheries Service, 2008, REC PLAN SO RES KILL; National Park Service, 2000, 47 US DEP INT NAT PA; Oksanen J., 2015, VEGAN COMMUNITY ECOL, V22-1, P1; Ostrom E, 1999, SCIENCE, V284, P278, DOI 10.1126/science.284.5412.278; Pergams ORW, 2008, P NATL ACAD SCI USA, V105, P2295, DOI 10.1073/pnas.0709893105; Pijanowski BC, 2011, BIOSCIENCE, V61, P203, DOI 10.1525/bio.2011.61.3.6; Popper AN, 2003, MAR TECHNOL SOC J, V37, P35, DOI 10.4031/002533203787537050; Reed SE, 2012, ENVIRON MODELL SOFTW, V37, P1, DOI 10.1016/j.envsoft.2012.04.012; Schindler DW, 2009, LIMNOL OCEANOGR, V54, P2349, DOI 10.4319/lo.2009.54.6_part_2.2349; Slabbekoorn H, 2010, TRENDS ECOL EVOL, V25, P419, DOI 10.1016/j.tree.2010.04.005; SOUTHWORTH M, 1969, ENVIRON BEHAV, V1, P49; Sueur J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004065; Theobald DM, 2010, LANDSCAPE ECOL, V25, P999, DOI 10.1007/s10980-010-9484-z; US EPA, 1974, INF LEV ENV NOIS REQ; Villanueva-Rivera LJ, 2011, LANDSCAPE ECOL, V26, P1233, DOI 10.1007/s10980-011-9636-9; Vitousek PM, 1997, SCIENCE, V277, P494, DOI 10.1126/science.277.5325.494; Warren PS, 2006, ANIM BEHAV, V71, P491, DOI 10.1016/j.anbehav.2005.07.014; York D, 1994, RECREATIONAL BOATING	46	25	27	7	110	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2013	8	2							e55661	10.1371/journal.pone.0055661	http://dx.doi.org/10.1371/journal.pone.0055661			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104BU	23424636	Green Published, gold, Green Submitted			2022-12-25	WOS:000315965100024
J	Savinkova, L; Drachkova, I; Arshinova, T; Ponomarenko, P; Ponomarenko, M; Kolchanov, N				Savinkova, Ludmila; Drachkova, Irina; Arshinova, Tatyana; Ponomarenko, Petr; Ponomarenko, Mikhail; Kolchanov, Nikolay			An Experimental Verification of the Predicted Effects of Promoter TATA-Box Polymorphisms Associated with Human Diseases on Interactions between the TATA Boxes and TATA-Binding Protein	PLOS ONE			English	Article							TRIOSEPHOSPHATE ISOMERASE; BETA-THALASSEMIA; MUTATION; GENE; ELEMENTS; SEQUENCE; IDENTIFICATION; RECOGNITION; CONSENSUS; PATIENT	Human genome sequencing has resulted in a great body of data, including a stunningly large number of single nucleotide polymorphisms (SNPs) with unknown phenotypic manifestations. Identification and comprehensive analysis of regulatory SNPs in human gene promoters will help quantify the effects of these SNPs on human health. Based on our experimental and computer-aided study of SNPs in TATA boxes and the use of literature data, we have derived an equation for TBP/TATA equilibrium binding in three successive steps: TATA-binding protein (TBP) sliding along DNA due to their nonspecific affinity for each other <-> recognition of the TATA box <-> stabilization of the TBP/TATA complex. Using this equation, we have analyzed TATA boxes containing SNPs associated with human diseases and made in silico predictions of changes in TBP/TATA affinity. An electrophoretic mobility shift assay (EMSA)-based experimental study performed under the most standardized conditions demonstrates that the experimentally measured values are highly correlated with the predicted values: the coefficient of linear correlation, r, was 0.822 at a significance level of alpha<10(-7) for equilibrium K-D values, (-ln K-D), and 0.785 at a significance level of alpha<10(-3) for changes in equilibrium K-D (delta) due to SNPs in the TATA boxes (delta= ln[K-D,K- (TATAMut)] ( ln [K-D,K- TATA])). It has been demonstrated that the SNPs associated with increased risk of human diseases such as alpha-, beta- and delta-thalassemia, myocardial infarction and thrombophlebitis, changes in immune response, amyotrophic lateral sclerosis, lung cancer and hemophilia B Leyden cause 2-4-fold changes in TBP/TATA affinity in most cases. The results obtained strongly suggest that the TBP/TATA equilibrium binding equation derived can be used for analysis of TATA-box sequences and identification of SNPs with a potential of being functionally important.	[Savinkova, Ludmila; Drachkova, Irina; Arshinova, Tatyana; Ponomarenko, Petr; Ponomarenko, Mikhail; Kolchanov, Nikolay] Russian Acad Sci, Inst Cytol & Genet, Siberian Div, Novosibirsk 630090, Russia; [Kolchanov, Nikolay] Novosibirsk State Univ, Novosibirsk 630090, Russia	Russian Academy of Sciences; Institute of Cytology & Genetics ICG SB RAS; Novosibirsk State University	Savinkova, L (corresponding author), Russian Acad Sci, Inst Cytol & Genet, Siberian Div, Novosibirsk 630090, Russia.	savinkl@mail.ru	Ponomarenko, Mikhail P/Q-7909-2016; Drachkova, Irina/AAZ-5324-2020; Ponomarenko, Mikhail/AHD-3920-2022; Kolchanov, Nikolay/A-9916-2014	Ponomarenko, Mikhail P/0000-0003-1663-318X; Drachkova, Irina/0000-0002-2522-1657; Kolchanov, Nikolay/0000-0001-6800-8787	Russian Foundation for Basic Research [10-04-00462-a, 5278.2012.4]; Siberian Branch of the Russian Academy of Sciences [136]; Russian Academy of Sciences [B. 30, 30.29]	Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); Siberian Branch of the Russian Academy of Sciences(Russian Academy of Sciences); Russian Academy of Sciences(Russian Academy of Sciences)	The authors are grateful to Prof. Tatyana Merkulova for her valuable advice and Vladimir Koval for the MALDI-TOF/ MS analysis of oligodeoxynucleotides. This work was supported by grants 10-04-00462-a and Research schools - 5278.2012.4 from the Russian Foundation for Basic Research, grant 136 from the Siberian Branch of the Russian Academy of Sciences, "Biological Diversity" from the Russian Academy of Sciences, grant B. 30, #30.29, "Molecular and Cell Biology" RAS integration 6.8 "System biology: the computer-experimental approaches" and #28 "Life Origin and Biosphere becoming problems" programs (Russian Academy of Sciences). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afifi A, 2003, COMPUTER AIDED MULTI; ANTONARAKIS SE, 1984, P NATL ACAD SCI-BIOL, V81, P1154, DOI 10.1073/pnas.81.4.1154; ANTONIOU M, 1995, NUCLEIC ACIDS RES, V23, P3473, DOI 10.1093/nar/23.17.3473; Arnaud E, 2000, ARTERIOSCL THROM VAS, V20, P892, DOI 10.1161/01.ATV.20.3.892; Badens C, 1999, HEMOGLOBIN, V23, P339, DOI 10.3109/03630269909090749; Batley J, 2009, METHODS MOL BIOL, V537, P303, DOI 10.1007/978-1-59745-251-9_15; Baumann M, 2010, MOL BIOTECHNOL, V45, P241, DOI 10.1007/s12033-010-9265-6; Boldt AB, 2006, DIVERSITY MBL2 GENE; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BUCHER P, 1990, J MOL BIOL, V212, P563, DOI 10.1016/0022-2836(90)90223-9; Burgner D, 2003, GENES IMMUN, V4, P506, DOI 10.1038/sj.gene.6364022; CAI SP, 1989, AM J HUM GENET, V45, P112; COLEMAN RA, 1995, J BIOL CHEM, V270, P13850, DOI 10.1074/jbc.270.23.13850; De Gobbi M, 2006, SCIENCE, V312, P1215, DOI 10.1126/science.1126431; Drachkova I A, 2005, Mol Biol (Mosk), V39, P139; Eisen DP, 2003, CLIN INFECT DIS, V37, P1496, DOI 10.1086/379324; Faiger H, 1995, NUCLEIC ACIDS RES, V34, P104; FEI YJ, 1988, BIOCHEM BIOPH RES CO, V153, P741, DOI 10.1016/S0006-291X(88)81157-4; Frischknecht H, 2005, HEMOGLOBIN, V29, P151, DOI 10.1081/HEM-200058593; GODDE JS, 1995, NUCLEIC ACIDS RES, V23, P4557, DOI 10.1093/nar/23.22.4557; HAHN S, 1989, P NATL ACAD SCI USA, V86, P5718, DOI 10.1073/pnas.86.15.5718; Humphries A, 1999, HUM GENET, V104, P486, DOI 10.1007/s004390050992; Ioshikhes I, 1999, P NATL ACAD SCI USA, V96, P2891, DOI 10.1073/pnas.96.6.2891; Juo ZS, 1996, J MOL BIOL, V261, P239, DOI 10.1006/jmbi.1996.0456; Juven-Gershon T, 2010, DEV BIOL, V339, P225, DOI 10.1016/j.ydbio.2009.08.009; Kel A, 1999, J MOL BIOL, V288, P353, DOI 10.1006/jmbi.1999.2684; Muncie HL, 2009, AM FAM PHYSICIAN, V80, P339; Niemann S, 2007, MUSCLE NERVE, V36, P704, DOI 10.1002/mus.20855; ORKIN SH, 1983, NUCLEIC ACIDS RES, V11, P4727, DOI 10.1093/nar/11.14.4727; Orosz F, 2006, IUBMB LIFE, V58, P703, DOI 10.1080/15216540601115960; Pelkonen O, 2000, TOXICOLOGY, V144, P139, DOI 10.1016/S0300-483X(99)00200-0; PONCZ M, 1982, J BIOL CHEM, V257, P5994; Ponomarenko MP, 1999, BIOINFORMATICS, V15, P687, DOI 10.1093/bioinformatics/15.7.687; Ponomarenko PM, 2008, DOKL BIOCHEM BIOPHYS, V419, P88, DOI 10.1134/S1607672908020117; Powell RM, 2002, J BIOL CHEM, V277, P7776, DOI 10.1074/jbc.M110147200; Pugh B F, 1995, Methods Mol Biol, V37, P359; REIJNEN MJ, 1992, P NATL ACAD SCI USA, V89, P6300, DOI 10.1073/pnas.89.14.6300; RUF W, 1994, FASEB J, V8, P385, DOI 10.1096/fasebj.8.6.8168689; Savinkova LK, 2009, BIOCHEMISTRY-MOSCOW+, V74, P117, DOI 10.1134/S0006297909020011; Savinkova LK, 2007, ECOLOGICAL GENETIC, VV, P44, DOI [10.17816/ecogen5244-49, DOI 10.17816/ECOGEN5244-49]; Schechter AN, 2008, BLOOD, V112, P3927, DOI 10.1182/blood-2008-04-078188; Stewart JJ, 2006, J BIOL CHEM, V281, P22665, DOI 10.1074/jbc.M603237200; Stewart JJ, 2001, J BIOL CHEM, V276, P30078, DOI 10.1074/jbc.M105276200; Takahashi K, 2005, CLIN INFECT DIS, V41, pS440, DOI 10.1086/431987; TAKIHARA Y, 1986, BLOOD, V67, P547; Wang X, 2008, J CANCER RES CLIN, V134, P995, DOI 10.1007/s00432-008-0367-5; Wang Y, 2003, HEPATOLOGY, V37, P65, DOI 10.1053/jhep.2003.50017; Watanabe M, 1996, AM J HUM GENET, V58, P308; WOBBE CR, 1990, MOL CELL BIOL, V10, P3859, DOI 10.1128/MCB.10.8.3859; Wolner BS, 2001, J BIOL CHEM, V276, P6260, DOI 10.1074/jbc.M008273200; Zienolddiny S, 2004, INT J CANCER, V109, P353, DOI 10.1002/ijc.11695	51	37	44	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2013	8	2							e54626	10.1371/journal.pone.0054626	http://dx.doi.org/10.1371/journal.pone.0054626			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104BU	23424617	gold, Green Submitted, Green Published			2022-12-25	WOS:000315965100005
J	Yu, GH; Zhang, MW; Rao, DQ; Yang, JX				Yu, Guohua; Zhang, Mingwang; Rao, Dingqi; Yang, Junxing			Effect of Pleistocene Climatic Oscillations on the Phylogeography and Demography of Red Knobby Newt (Tylototriton shanjing) from Southwestern China	PLOS ONE			English	Article							TERMINALIA-FRANCHETII COMBRETACEAE; QINGHAI-TIBETAN PLATEAU; POPULATION-GROWTH; CHLOROPLAST PHYLOGEOGRAPHY; HISTORICAL DEMOGRAPHY; GENETIC CONSEQUENCES; EVOLUTIONARY HISTORY; DNA POLYMORPHISM; MTDNA SEQUENCES; ICE AGES	Factors that determine the genetic structure of species in southwestern China remain largely unknown. In this study, phylogeography and demography of Tylototriton shanjing was investigated from a mitochondrial perspective to address the role of the Quaternary ice ages in shaping phylogeographic history and genetic diversity of Yunnan. A total of 146 individuals from 19 populations across the entire range of the species were collected. We detected four maternal phylogenetic lineages corresponding to four population groups, and found that major glaciation events during the Pleistocene have triggered the intra-specific divergence. Coalescent simulations indicated that the populations retreated to different refugia located in southern Yunnan, northwestern Yunnan, the border region of western Yunnan with Myanmar, and middle-western Yunnan, respectively, during previous glacial periods in the Pleistocene, and these four refugia were not retained during the Last Glacial Maximum. Population expansions occurred during the last inter-glaciation, during which ice core and pollen data indicated that the temperature and precipitation gradually increased, and declines of population sizes started after the beginning of the Last Glacial Maximum when the climate became cooler and dryer. The paleodrainage system had no contribution to the current genetic structure and the rivers were not dispersal barriers for this salamander.	[Yu, Guohua; Zhang, Mingwang; Rao, Dingqi; Yang, Junxing] Chinese Acad Sci, Kunming Inst Zool, State Key Lab Genet Resources & Evolut, Kunming, Yunnan, Peoples R China; [Yu, Guohua] Univ Chinese Acad Sci, Beijing, Peoples R China; [Zhang, Mingwang] Sichuan Agr Univ, Coll Anim Sci & Technol, Yaan, Sichuan, Peoples R China	Chinese Academy of Sciences; Kunming Institute of Zoology; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Sichuan Agricultural University	Zhang, MW (corresponding author), Chinese Acad Sci, Kunming Inst Zool, State Key Lab Genet Resources & Evolut, Kunming, Yunnan, Peoples R China.	mwzhangkiz@hotmail.com; raodq@mail.kiz.ac.cn; yangjx@mail.kiz.ac.cn			State Key Laboratory of Genetic Resource and Evolution, Kunming Institute of Zoology; Chinese Academy of Sciences [GREKF11-01]; Shuang Zhi Ji Hua Foundation of Sichuan Agricultural University [01570709]	State Key Laboratory of Genetic Resource and Evolution, Kunming Institute of Zoology; Chinese Academy of Sciences(Chinese Academy of Sciences); Shuang Zhi Ji Hua Foundation of Sichuan Agricultural University	This study was supported by the open funds of the State Key Laboratory of Genetic Resource and Evolution, Kunming Institute of Zoology, the Chinese Academy of Sciences (GREKF11-01) and Shuang Zhi Ji Hua Foundation of Sichuan Agricultural University (01570709). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott RJ, 2003, MOL ECOL, V12, P299, DOI 10.1046/j.1365-294X.2003.01731.x; Axelrod D., 1996, FLORISTIC CHARACTERI, P43; Carranza S, 2008, J BIOGEOGR, V35, P724, DOI 10.1111/j.1365-2699.2007.01817.x; Carranza S, 2005, ZOOL J LINN SOC-LOND, V145, P555, DOI 10.1111/j.1096-3642.2005.00197.x; Carranza S, 2004, ZOOTAXA, P1; Clark MK, 2004, TECTONICS, V23, DOI 10.1029/2002TC001402; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; [崔之久 Cui Zhijiu], 2011, [第四纪研究, Quaternary Sciences], V31, P749; Depraz A, 2008, MOL ECOL, V17, P2449, DOI 10.1111/j.1365-294X.2008.03760.x; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Dupanloup I, 2002, MOL ECOL, V11, P2571, DOI 10.1046/j.1365-294X.2002.01650.x; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Fei L., 2010, COLORED ATLAS CHINES; FELSENSTEIN J, 1992, GENET RES, V59, P139, DOI 10.1017/S0016672300030354; Fu YX, 1997, GENETICS, V147, P915; Gao LM, 2007, MOL ECOL, V16, P4684, DOI 10.1111/j.1365-294X.2007.03537.x; Gavrilets S, 2003, EVOLUTION, V57, P2197; Gomez A, 2007, PHYLOGEOGRAPHY OF SOUTHERN EUROPEAN REFUGIA, P155, DOI 10.1007/1-4020-4904-8_5; Hamrick J. L., 1992, New Forests, V6, P95, DOI 10.1007/BF00120641; HARPENDING HC, 1994, HUM BIOL, V66, P591; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; Hewitt GM, 2004, PHILOS T R SOC B, V359, P183, DOI 10.1098/rstb.2003.1388; Hewitt GM, 1996, BIOL J LINN SOC, V58, P247, DOI 10.1111/j.1095-8312.1996.tb01434.x; Ho SYW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001615; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Hugall AF, 2007, SYST BIOL, V56, P543, DOI 10.1080/10635150701477825; Jijun L., 2001, QUAT SCI, V21, P381, DOI DOI 10.3321/J.ISSN:1001-7410.2001.05.001; Knowles LL, 2001, MOL ECOL, V10, P691, DOI 10.1046/j.1365-294x.2001.01206.x; KOCHER TD, 1989, P NATL ACAD SCI USA, V86, P6196, DOI 10.1073/pnas.86.16.6196; Li J.J., 1998, CHINESE SCI BULL, V43, P1569, DOI DOI 10.1360/CSB1998-43-15-1569; [李吉均 Li Jijun], 2004, [冰川冻土, Journal of Glaciology and Geocryology], V26, P235; Li SH, 2009, MOL ECOL, V18, P622, DOI 10.1111/j.1365-294X.2008.04028.x; Li ZJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034013; Liu Q, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031453; Lopez-Pujol J, 2011, J BIOGEOGR, V38, P1267, DOI 10.1111/j.1365-2699.2011.02504.x; Maddison WP, 2017, MESQUITE MODULAR SYS; Mao XG, 2010, MOL ECOL, V19, P2754, DOI 10.1111/j.1365-294X.2010.04704.x; Measey GJ, 2011, CONSERV GENET, V12, P61, DOI 10.1007/s10592-009-9989-7; Michaux JR, 2005, HEREDITY, V94, P52, DOI 10.1038/sj.hdy.6800561; Monaghan MT, 2001, HEREDITY, V86, P395, DOI 10.1046/j.1365-2540.2001.00843.x; MORITZ C, 1992, SYST BIOL, V41, P273, DOI 10.2307/2992567; NUSSBAUM RA, 1995, HERPETOLOGICA, V51, P257; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Qiu YX, 2009, NEW PHYTOL, V183, P480, DOI 10.1111/j.1469-8137.2009.02876.x; Qu Y, 2010, MOL ECOL, V19, P338, DOI 10.1111/j.1365-294X.2009.04445.x; Qu YH, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-174; Rambaut A, 2007, TRACER V 1 4; Ramos-Onsins SE, 2002, MOL BIOL EVOL, V19, P2092, DOI 10.1093/oxfordjournals.molbev.a004034; Ray N, 2003, MOL BIOL EVOL, V20, P76, DOI 10.1093/molbev/msg009; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Shi Y.F., 1998, UPLIFT ENV CHANGES Q; Shi Y.F., 1999, ACTA GEOGRAPH SIN, V54, P10, DOI DOI 10.1007/S11295-016-0968-0; [施雅风 Shi Yafeng], 2002, [冰川冻土, Journal of Glaciology and Geocryology], V24, P687; SLATKIN M, 1989, GENETICS, V123, P603; Sotiropoulos K, 2007, MOL PHYLOGENET EVOL, V45, P211, DOI 10.1016/j.ympev.2007.03.012; Sun YB, 2006, DATA CONTRIBUTION SE; Swofford D.L., 2002, PAUP PHYLOGENETIC AN, DOI 10.1111/j.0014-3820.2002.tb00191.x; TAJIMA F, 1989, GENETICS, V123, P585; Tang LY, 1998, J GLACIOL GEOCRYOL, V20, P133; Vieites DR, 2009, P NATL ACAD SCI USA, V106, P19715, DOI 10.1073/pnas.0902956106; Yang D-T, 2008, AMPHIBIA REPTILIA YU; Yuan QJ, 2008, MOL ECOL, V17, P1054, DOI 10.1111/j.1365-294X.2007.03628.x; Zhan XJ, 2011, MOL ECOL, V20, P3014, DOI 10.1111/j.1365-294X.2011.05144.x; Zhang DR, 2010, MOL ECOL, V19, P3406, DOI 10.1111/j.1365-294X.2010.04747.x; Zhang MW, 2010, MOL PHYLOGENET EVOL, V54, P47, DOI 10.1016/j.ympev.2009.10.019; Zhang Rong-Zu (Yong-Zu), 2002, Acta Zoologica Sinica, V48, P141; Zhang TC, 2011, MOL PHYLOGENET EVOL, V60, P1, DOI 10.1016/j.ympev.2011.04.009; Zhang TC, 2011, J PLANT RES, V124, P63, DOI 10.1007/s10265-010-0360-3; Zhang W, 2006, QUATERN INT, V154, P32, DOI 10.1016/j.quaint.2006.02.012; Zheng BX, 2002, QUATERN INT, V97-8, P93, DOI 10.1016/S1040-6182(02)00054-X; 唐领余, 2004, [中国科学. D辑, 地球科学, Science in China], V34, P436	73	24	26	8	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2013	8	2							e56066	10.1371/journal.pone.0056066	http://dx.doi.org/10.1371/journal.pone.0056066			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104BU	23424644	gold, Green Submitted, Green Published			2022-12-25	WOS:000315965100032
J	Zhang, R; Huang, H; Cao, PJ; Wang, ZZ; Chen, Y; Pan, Y				Zhang, Rui; Huang, Heng; Cao, Peijuan; Wang, Zhenzhen; Chen, Yan; Pan, Yi			Sma- and Mad-related Protein 7 (Smad7) Is Required for Embryonic Eye Development in the Mouse	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANTERIOR SEGMENT DEVELOPMENT; BONE MORPHOGENETIC PROTEINS; NEURAL CREST; TGF-BETA; RETINAL DEVELOPMENT; KNOCKOUT MICE; OPTIC VESICLE; GENE; EXPRESSION; OVEREXPRESSION	Smad7 is an intracellular inhibitory protein that antagonizes the signaling of TGF-beta family members. Deletion of Smad7 in the mouse leads to an abnormality in heart development. However, whether Smad7 has a functional role in the development of other organs has been elusive. Here we present evidence that Smad7 imparts a role to eye development in the mouse. Smad7 is expressed in both the lens and retina in the developing embryonic eye. Depletion of Smad7 caused various degrees of coloboma and microphthalmia with alterations in cell apoptosis and proliferation in eyes. Smad7 was implicated in lens differentiation but was not required for the induction of the lens placode. The development of the periocular mesenchyme was retarded with the down-regulation of Bmp7 and Pitx2 in mutant mice. Retinal spatial patterning was affected by Smad7 deletion and was accompanied by altered bone morphogenetic protein (BMP) signaling. At late gestation stages, TGF-beta signaling was up-regulated in the differentiating retina. Smad7 mutant mice displayed an expanded optic disc with increasing of sonic hedgehog (SHH) signaling. Furthermore, loss of Smad7 led to a temporal change in retinal neurogenesis. In conclusion, our study suggests that Smad7 is essential for eye development. In addition, our data indicate that alterations in the signaling of BMP, TGF-beta, and SHH likely underlie the defects in eye development caused by Smad7 deletion.	[Zhang, Rui; Huang, Heng; Cao, Peijuan; Wang, Zhenzhen; Chen, Yan; Pan, Yi] Chinese Acad Sci, Inst Nutr Sci, Shanghai Inst Biol Sci, Key Lab Nutr & Metab,Grad Sch, Shanghai 200031, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Chen, Y (corresponding author), Chinese Acad Sci, Inst Nutr Sci, Shanghai Inst Biol Sci, 294 Taiyuan Rd, Shanghai 200031, Peoples R China.	ychen3@sibs.ac.cn; ypan@sibs.ac.cn			Ministry of Science and Technology of China [2012CB524900, 2010CB529506]; National Natural Science Foundation of China [81021002, 81130077, 30971660]; Chinese Academy of Sciences [KSCX2-EW-R-08]; SA-SIBS Scholarship Program	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences); SA-SIBS Scholarship Program	This work was supported by Research Grants 2012CB524900 (to Y. C.) and 2010CB529506 (to Y. P. and Z. W.) from the Ministry of Science and Technology of China, 81021002 and 81130077 (to Y. C.) and 30971660 (to Y. P.) from the National Natural Science Foundation of China, and KSCX2-EW-R-08 (to Y. C.) from the Chinese Academy of Sciences and by a grant from the SA-SIBS Scholarship Program (to Y. P.).	Adler R, 2002, DEVELOPMENT, V129, P3161; Adler R, 2007, DEV BIOL, V305, P1, DOI 10.1016/j.ydbio.2007.01.045; Ashery-Padan R, 2001, CURR OPIN CELL BIOL, V13, P706, DOI 10.1016/S0955-0674(00)00274-X; Barbieri AM, 2002, DEVELOPMENT, V129, P805; Bassett EA, 2010, HUM MOL GENET, V19, P1791, DOI 10.1093/hmg/ddq060; Bottinger EP, 2002, J AM SOC NEPHROL, V13, P2600, DOI 10.1097/01.ASN.0000033611.79556.AE; Chapman DL, 1996, DEV DYNAM, V206, P379, DOI 10.1002/(SICI)1097-0177(199608)206:4<379::AID-AJA4>3.0.CO;2-F; Chen Q, 2009, J BIOL CHEM, V284, P292, DOI 10.1074/jbc.M807233200; Chow RL, 2001, ANNU REV CELL DEV BI, V17, P255, DOI 10.1146/annurev.cellbio.17.1.255; Cvekl A, 2004, BIOESSAYS, V26, P374, DOI 10.1002/bies.20009; Dong CM, 2002, P NATL ACAD SCI USA, V99, P3908, DOI 10.1073/pnas.062010399; Etchevers HC, 2001, DEVELOPMENT, V128, P1059; Evans AL, 2005, HUM MOL GENET, V14, P3347, DOI 10.1093/hmg/ddi365; Flugel-Koch C, 2002, DEV DYNAM, V225, P111, DOI 10.1002/dvdy.10144; Fuchshofer R, 2009, EXP EYE RES, V88, P1020, DOI 10.1016/j.exer.2009.01.002; Fuhrmann S, 2000, DEVELOPMENT, V127, P4599; Funaki T, 2003, CORNEA, V22, P153, DOI 10.1097/00003226-200303000-00015; Furuta Y, 1998, GENE DEV, V12, P3764, DOI 10.1101/gad.12.23.3764; Gage PJ, 2005, INVEST OPHTH VIS SCI, V46, P4200, DOI 10.1167/iovs.05-0691; Gage PJ, 1999, DEVELOPMENT, V126, P4643; Gregory-Evans CY, 2004, J MED GENET, V41, P881, DOI 10.1136/jmg.2004.025494; Grocott T, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1269; Hammerschmidt M, 2003, DEV DYNAM, V227, P128, DOI 10.1002/dvdy.10281; He W, 2002, EMBO J, V21, P2580, DOI 10.1093/emboj/21.11.2580; Heldin CH, 1997, NATURE, V390, P465, DOI 10.1038/37284; Ittner Lars M, 2005, J Biol, V4, P11, DOI 10.1186/jbiol29; Iwao K, 2009, J CLIN INVEST, V119, P1997, DOI 10.1172/JCI38519; Kim J, 2005, SCIENCE, V308, P1927, DOI 10.1126/science.1110175; Koshiba-Takeuchi K, 2000, SCIENCE, V287, P134, DOI 10.1126/science.287.5450.134; Li RG, 2006, J IMMUNOL, V176, P6777, DOI 10.4049/jimmunol.176.11.6777; Liu J, 2003, DEV BIOL, V256, P34, DOI 10.1016/S0012-1606(02)00115-X; Lupo G, 2005, DEVELOPMENT, V132, P1737, DOI 10.1242/dev.01726; Martinez-Morales JR, 2005, DEV CELL, V8, P565, DOI 10.1016/j.devcel.2005.01.022; McLaughlin T, 2003, CURR OPIN NEUROBIOL, V13, P57, DOI 10.1016/S0959-4388(03)00014-X; Monteleone G, 2008, MUCOSAL IMMUNOL, V1, pS50, DOI 10.1038/mi.2008.55; Morcillo J, 2006, DEVELOPMENT, V133, P3179, DOI 10.1242/dev.02493; Muller F, 2007, DEVELOPMENT, V134, P3483, DOI 10.1242/dev.02884; Mui SH, 2005, GENE DEV, V19, P1249, DOI 10.1101/gad.1276605; Mui SH, 2002, DEVELOPMENT, V129, P797; Murali D, 2005, DEVELOPMENT, V132, P913, DOI 10.1242/dev.01673; Pan Y, 2008, DEVELOPMENT, V135, P301, DOI 10.1242/dev.014829; Pan Y, 2006, DEVELOPMENT, V133, P4933, DOI 10.1242/dev.02679; Saika S, 2005, AM J PATHOL, V166, P1405, DOI 10.1016/S0002-9440(10)62358-9; Saika S, 2004, LAB INVEST, V84, P1259, DOI 10.1038/labinvest.3700151; Saika S, 2007, ARCH OPHTHALMOL-CHIC, V125, P647, DOI 10.1001/archopht.125.5.647; Sakuta H, 2006, J NEUROSCI, V26, P10868, DOI 10.1523/JNEUROSCI.3027-06.2006; Sanford LP, 1997, DEVELOPMENT, V124, P2659; SANYANUSIN P, 1995, NAT GENET, V9, P358, DOI 10.1038/ng0495-358; Sasagawa S, 2002, GENESIS, V33, P86, DOI 10.1002/gene.10095; Streit A, 2004, DEV BIOL, V276, P1, DOI 10.1016/j.ydbio.2004.08.037; Van Raay TJ, 2004, DEV NEUROSCI-BASEL, V26, P352, DOI 10.1159/000082277; Wawersik S, 1999, DEV BIOL, V207, P176, DOI 10.1006/dbio.1998.9153; Wigle JT, 1999, NAT GENET, V21, P318, DOI 10.1038/6844; Yang XH, 2004, SEMIN CELL DEV BIOL, V15, P91, DOI 10.1016/j.semcdb.2003.09.004; Yang ZY, 2003, DEV BIOL, V264, P240, DOI 10.1016/j.ydbio.2003.08.005; Zhang X, 2002, GENE DEV, V16, P2097, DOI 10.1101/gad.1007602; Zhang XM, 2001, DEV BIOL, V233, P271, DOI 10.1006/dbio.2000.0195	57	20	20	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 12	2013	288	15					10275	10285		10.1074/jbc.M112.416719	http://dx.doi.org/10.1074/jbc.M112.416719			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	125TU	23426374	hybrid, Green Published			2022-12-25	WOS:000317565000009
J	Camus, G; Herker, E; Modi, AA; Haas, JT; Ramage, HR; Farese, RV; Ott, M				Camus, Gregory; Herker, Eva; Modi, Ankit A.; Haas, Joel T.; Ramage, Holly R.; Farese, Robert V., Jr.; Ott, Melanie			Diacylglycerol Acyltransferase-1 Localizes Hepatitis C Virus NS5A Protein to Lipid Droplets and Enhances NS5A Interaction with the Viral Capsid Core	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM; INFECTIOUS VIRUS; HEPG2 CELLS; ASSOCIATION; 5A; REPLICATION; INHIBITOR; PROMOTES; POTENT; DGAT2	The triglyceride-synthesizing enzyme acyl CoA:diacylglycerol acyltransferase 1 (DGAT1) plays a critical role in hepatitis C virus (HCV) infection by recruiting the HCV capsid protein core onto the surface of cellular lipid droplets (LDs). Here we find a new interaction between the non-structural protein NS5A and DGAT1 and show that the trafficking of NS5A to LDs depends on DGAT1 activity. DGAT1 forms a complex with NS5A and core and facilitates the interaction between both viral proteins. A catalytically inactive mutant of DGAT1 (H426A) blocks the localization of NS5A, but not core, to LDs in a dominant-negative manner and impairs the release of infectious viral particles, underscoring the importance of DGAT1-mediated translocation of NS5A to LDs in viral particle production. We propose a model whereby DGAT1 serves as a cellular hub for HCV core and NS5A proteins, guiding both onto the surface of the same subset of LDs, those generated by DGAT1. These results highlight the critical role of DGAT1 as a host factor for HCV infection and as a potential drug target for antiviral therapy.	[Camus, Gregory; Herker, Eva; Modi, Ankit A.; Ramage, Holly R.; Ott, Melanie] Gladstone Inst Virol & Immunol, San Francisco, CA 94158 USA; [Herker, Eva] Leibniz Inst Expt Virol, Heinrich Pette Inst, D-20251 Hamburg, Germany; [Haas, Joel T.; Farese, Robert V., Jr.] Univ Calif San Francisco, Gladstone Inst Cardiovasc Dis, San Francisco, CA 94158 USA; [Farese, Robert V., Jr.; Ott, Melanie] Univ Calif San Francisco, Dept Med, San Francisco, CA 94158 USA; [Farese, Robert V., Jr.] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA	University of California System; University of California San Francisco; The J David Gladstone Institutes; Heinrich Pette Institute; University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Ott, M (corresponding author), Gladstone Inst Virol & Immunol, 1650 Owens St, San Francisco, CA 94158 USA.	mott@gladstone.ucsf.edu	Herker, Eva/AAQ-1944-2021; Haas, Joel/R-6379-2018; Herker, Eva/B-9699-2014	Haas, Joel/0000-0002-0028-5988; Herker, Eva/0000-0001-9644-2484; Ramage, Holly/0000-0002-0390-6786; Ott, Melanie/0000-0002-5697-1274	National Institutes of Health [R056 AI069090, P30 K026743]; American Liver Foundation; Human Frontiers Science Program; A. P. Giannini Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R03AI069090, P30AI027763] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK026743, R01DK056084, P30DK063720] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Liver Foundation; Human Frontiers Science Program(Human Frontier Science Program); A. P. Giannini Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R056 AI069090 (to M. O.) and P30 K026743 (to the University of California San Francisco Liver Center). This work was also supported by funds from the Gladstone Institutes and fellowships from the American Liver Foundation (to G. C.), the Human Frontiers Science Program (to E. H.), and the A. P. Giannini Foundation (to H. R. R.).	Amgen J. T. I., 2005, Anorectic Compounds, World Intellectual Property Organization, Patent No. [WO/2005/072740, 2005072740]; Appel N, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000035; Blight KJ, 2000, SCIENCE, V290, P1972, DOI 10.1126/science.290.5498.1972; Boson B, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002144; Boulant S, 2007, J GEN VIROL, V88, P2204, DOI 10.1099/vir.0.82898-0; Brass V, 2002, J BIOL CHEM, V277, P8130, DOI 10.1074/jbc.M111289200; Cheng D, 2001, BIOCHEM J, V359, P707, DOI 10.1042/0264-6021:3590707; Farese RV, 2009, CELL, V139, P855, DOI 10.1016/j.cell.2009.11.005; Feld JJ, 2005, NATURE, V436, P967, DOI 10.1038/nature04082; Gao M, 2010, NATURE, V465, P96, DOI 10.1038/nature08960; Goh PY, 2001, VIROLOGY, V290, P224, DOI 10.1006/viro.2001.1195; Herker E, 2012, J BIOL CHEM, V287, P2280, DOI 10.1074/jbc.R111.300202; Herker E, 2010, NAT MED, V16, P1295, DOI 10.1038/nm.2238; Jirasko V, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001233; Lemm JA, 2010, J VIROL, V84, P482, DOI 10.1128/JVI.01360-09; Li Mamie Z, 2012, Methods Mol Biol, V852, P51, DOI 10.1007/978-1-61779-564-0_5; Li QS, 2009, P NATL ACAD SCI USA, V106, P16410, DOI 10.1073/pnas.0907439106; Masaki T, 2008, J VIROL, V82, P7964, DOI 10.1128/JVI.00826-08; McFie PJ, 2011, J BIOL CHEM, V286, P28235, DOI 10.1074/jbc.M111.256008; McLauchlan J, 2002, EMBO J, V21, P3980, DOI 10.1093/emboj/cdf414; Miyanari Y, 2007, NAT CELL BIOL, V9, P1089, DOI 10.1038/ncb1631; Naldini L, 1996, SCIENCE, V272, P263, DOI 10.1126/science.272.5259.263; Nevo-Yassaf I, 2012, J VIROL, V86, P6491, DOI 10.1128/JVI.00496-12; Pharmaceuticals N., 2011, SAF TOL PHARM PK PHA; Pietschmann T, 2006, P NATL ACAD SCI USA, V103, P7408, DOI 10.1073/pnas.0504877103; Popescu CI, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001278; Shi ST, 2002, VIROLOGY, V292, P198, DOI 10.1006/viro.2001.1225; Steinmann E, 2007, PLOS PATHOG, V3, P962, DOI 10.1371/journal.ppat.0030103; Stone SJ, 2009, J BIOL CHEM, V284, P5352, DOI 10.1074/jbc.M805768200; Tellinghuisen TL, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000032; Wasley A, 2000, SEMIN LIVER DIS, V20, P1, DOI 10.1055/s-2000-9506; Wurie HR, 2012, FEBS J, V279, P3033, DOI 10.1111/j.1742-4658.2012.08684.x; Wurie HR, 2011, J BIOL CHEM, V286, P36238, DOI 10.1074/jbc.M111.251900; Yen CLE, 2008, J LIPID RES, V49, P2283, DOI 10.1194/jlr.R800018-JLR200; Zhao G, 2008, J MED CHEM, V51, P380, DOI 10.1021/jm7013887	35	81	82	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 5	2013	288	14					9915	9923		10.1074/jbc.M112.434910	http://dx.doi.org/10.1074/jbc.M112.434910			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	119RB	23420847	Green Published, hybrid			2022-12-25	WOS:000317114000031
J	Hojo, H; Ohba, S; Taniguchi, K; Shirai, M; Yano, F; Saito, T; Ikeda, T; Nakajima, K; Komiyama, Y; Nakagata, N; Suzuki, K; Mishina, Y; Yamada, M; Konno, T; Takato, T; Kawaguchi, H; Kambara, H; Chung, U				Hojo, Hironori; Ohba, Shinsuke; Taniguchi, Kiyomi; Shirai, Masataka; Yano, Fumiko; Saito, Taku; Ikeda, Toshiyuki; Nakajima, Keiji; Komiyama, Yuske; Nakagata, Naomi; Suzuki, Kentaro; Mishina, Yuji; Yamada, Masahisa; Konno, Tomohiro; Takato, Tsuyoshi; Kawaguchi, Hiroshi; Kambara, Hideki; Chung, Ung-il			Hedgehog-Gli Activators Direct Osteo-chondrogenic Function of Bone Morphogenetic Protein toward Osteogenesis in the Perichondrium	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHONDROCYTE DIFFERENTIATION; ENDOCHONDRAL SKELETON; LIMB CHONDROGENESIS; C3H10T1/2 CELLS; GROWTH-PLATE; FACTOR SOX9; TGF-BETA; IN-VIVO; OSTEOBLASTS; CARTILAGE	Specification of progenitors into the osteoblast lineage is an essential event for skeletogenesis. During endochondral ossification, cells in the perichondrium give rise to osteoblast precursors. Hedgehog (Hh) and bone morphogenetic protein (BMP) are suggested to regulate the commitment of these cells. However, properties of perichondrial cells and regulatory mechanisms of the specification process are still poorly understood. Here, we investigated the machineries by combining a novel organ culture system and single-cell expression analysis with mouse genetics and biochemical analyses. In a metatarsal organ culture reproducing bone collar formation, activation of BMP signaling enhanced the bone collar formation cooperatively with Hh input, whereas the signaling induced ectopic chondrocyte formation in the perichondrium without Hh input. Similar phenotypes were also observed in compound mutant mice, where signaling activities of Hh and BMP were genetically manipulated. Single-cell quantitative RT-PCR analyses showed heterogeneity of perichondrial cells in terms of natural characteristics and responsiveness to Hh input. In vitro analyses revealed that Hh signaling suppressed BMP-induced chondrogenic differentiation; Gli1 inhibited the expression of Sox5, Sox6, and Sox9 (SRY box-containing gene 9) as well as transactivation by Sox9. Indeed, ectopic expression of chondrocyte maker genes were observed in the perichondrium of metatarsals in Gli1(-/-) fetuses, and the phenotype was more severe in Gli1(-/-); Gli2(-/-) newborns. These data suggest that Hh-Gli activators alter the function of BMP to specify perichondrial cells into osteoblasts; the timing of Hh input and its target populations are critical for BMP function.	[Hojo, Hironori; Ohba, Shinsuke; Yano, Fumiko; Nakajima, Keiji; Komiyama, Yuske; Chung, Ung-il] Univ Tokyo, Ctr Dis Biol & Integrat Med, Tokyo 1130033, Japan; [Yano, Fumiko; Saito, Taku; Ikeda, Toshiyuki; Nakajima, Keiji; Komiyama, Yuske; Takato, Tsuyoshi; Kawaguchi, Hiroshi] Univ Tokyo, Dept Sensory & Motor Syst Med, Tokyo 1130033, Japan; [Konno, Tomohiro; Chung, Ung-il] Univ Tokyo, Dept Bioengn, Tokyo 1130033, Japan; [Taniguchi, Kiyomi; Shirai, Masataka; Kambara, Hideki] Hitachi Cent Res Lab, Tokyo 1858601, Japan; [Nakagata, Naomi; Suzuki, Kentaro] Kumamoto Univ, Ctr Anim Resources & Dev, Kumamoto 8600811, Japan; [Mishina, Yuji] Univ Michigan, Sch Dent, Dept Biol & Mat Sci, Ann Arbor, MI 48109 USA; [Yamada, Masahisa] RIKEN, Brain Sci Inst, Dev Neurobiol Lab, Wako, Saitama 3510198, Japan; [Yamada, Masahisa] Okinawa Inst Sci & Technol, Common Resources Grp, Okinawa 9040412, Japan	University of Tokyo; University of Tokyo; University of Tokyo; Hitachi Limited; Kumamoto University; University of Michigan System; University of Michigan; RIKEN; Okinawa Institute of Science & Technology Graduate University	Hojo, H (corresponding author), Univ Tokyo, Ctr Dis Biol & Integrat Med, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	hojo@bmw.t.u-tokyo.ac.jp; soba@bmw.t.u-tokyo.ac.jp	Ikeda, Toshiyuki/GVS-5588-2022; Konno, Tomohiro/E-5244-2011	Konno, Tomohiro/0000-0002-7814-3306; Hojo, Hironori/0000-0003-2245-6853; Ohba, Shinsuke/0000-0002-6874-8539; Nakagata, Naomi/0000-0002-5737-9993	Japan Society for the Promotion of Science; Center for NanoBio Integration; Center for Medical System Innovation; Funding Program for World Leading Innovative R&D on Science and Technology (FIRST program); Grants-in-Aid for Scientific Research [25670851] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Center for NanoBio Integration; Center for Medical System Innovation; Funding Program for World Leading Innovative R&D on Science and Technology (FIRST program)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by grants-in-aid for scientific research from the Japan Society for the Promotion of Science, as well as by the Center for NanoBio Integration, the Center for Medical System Innovation, and the Funding Program for World Leading Innovative R&D on Science and Technology (FIRST program).	Akiyama H, 2002, GENE DEV, V16, P2813, DOI 10.1101/gad.1017802; Akiyama H, 2005, P NATL ACAD SCI USA, V102, P14665, DOI 10.1073/pnas.0504750102; Bandyopadhyay A, 2006, PLOS GENET, V2, P2116, DOI 10.1371/journal.pgen.0020216; Bi WM, 1999, NAT GENET, V22, P85, DOI 10.1038/8792; Chen BZ, 2009, NAT CHEM BIOL, V5, P100, DOI 10.1038/nchembio.137; Chen GQ, 2012, INT J BIOL SCI, V8, P272, DOI 10.7150/ijbs.2929; Chimal-Monroy J, 2003, DEV BIOL, V257, P292, DOI 10.1016/S0012-1606(03)00066-6; Colnot C, 2004, DEV BIOL, V269, P55, DOI 10.1016/j.ydbio.2004.01.011; Date T, 2004, J ORTHOP SCI, V9, P503, DOI 10.1007/s00776-004-0815-2; Day TF, 2005, DEV CELL, V8, P739, DOI 10.1016/j.devcel.2005.03.016; Fernandez-Lloris R, 2003, MOL ENDOCRINOL, V17, P1332, DOI 10.1210/me.2002-0254; Hill TP, 2005, DEV CELL, V8, P727, DOI 10.1016/j.devcel.2005.02.013; Hojo H, 2012, J BIOL CHEM, V287, P17860, DOI 10.1074/jbc.M112.347716; Hojo H, 2010, J BONE MINER METAB, V28, P627, DOI 10.1007/s00774-010-0179-y; Ikeda T, 2004, ARTHRITIS RHEUM-US, V50, P3561, DOI 10.1002/art.20611; Joeng KS, 2009, DEVELOPMENT, V136, P4177, DOI 10.1242/dev.041624; Kamiya N, 2008, DEVELOPMENT, V135, P3801, DOI 10.1242/dev.025825; Mak KK, 2006, DEVELOPMENT, V133, P3695, DOI 10.1242/dev.02546; Kobayashi T, 2005, P NATL ACAD SCI USA, V102, P18023, DOI 10.1073/pnas.0503617102; Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5; Kronenberg HM, 2003, NATURE, V423, P332, DOI 10.1038/nature01657; Leung VYL, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002356; Long FX, 2012, NAT REV MOL CELL BIO, V13, P27, DOI 10.1038/nrm3254; Long FX, 2004, DEVELOPMENT, V131, P1309, DOI 10.1242/dev.01006; Long FX, 2001, DEVELOPMENT, V128, P5099; Lopez-Rios J, 2012, DEV CELL, V22, P837, DOI 10.1016/j.devcel.2012.01.006; Maes C, 2010, DEV CELL, V19, P329, DOI 10.1016/j.devcel.2010.07.010; Matsunobu T, 2009, DEV BIOL, V332, P325, DOI 10.1016/j.ydbio.2009.06.002; Mei W, 2005, BIOCHEM BIOPH RES CO, V328, P651, DOI 10.1016/j.bbrc.2004.11.067; Mo R, 1997, DEVELOPMENT, V124, P113; Murtaugh LC, 1999, GENE DEV, V13, P225, DOI 10.1101/gad.13.2.225; Nadeau JH, 2001, NAT REV GENET, V2, P165, DOI 10.1038/35056009; Nakashima K, 2002, CELL, V108, P17, DOI 10.1016/S0092-8674(01)00622-5; Park HL, 2000, DEVELOPMENT, V127, P1593; Pizette S, 2000, DEV BIOL, V219, P237, DOI 10.1006/dbio.2000.9610; Retting KN, 2009, DEVELOPMENT, V136, P1093, DOI 10.1242/dev.029926; Rodda SJ, 2006, DEVELOPMENT, V133, P3231, DOI 10.1242/dev.02480; Sekido R, 2008, NATURE, V453, P930, DOI 10.1038/nature06944; St-Jacques B, 1999, GENE DEV, V13, P2072, DOI 10.1101/gad.13.16.2072; Taniguchi K, 2009, NAT METHODS, V6, P503, DOI 10.1038/nmeth.1338; Yoon BS, 2005, P NATL ACAD SCI USA, V102, P5062, DOI 10.1073/pnas.0500031102; Yui PB, 2008, NAT CHEM BIOL, V4, P33, DOI 10.1038/nchembio.2007.54; Zehentner BK, 1999, J BONE MINER RES, V14, P1734, DOI 10.1359/jbmr.1999.14.10.1734; Zhao M, 2006, MOL CELL BIOL, V26, P6197, DOI 10.1128/MCB.02214-05	44	46	51	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 5	2013	288	14					9924	9932		10.1074/jbc.M112.409342	http://dx.doi.org/10.1074/jbc.M112.409342			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	119RB	23423383	Green Published, hybrid			2022-12-25	WOS:000317114000032
J	Mansky, KC; Jensen, ED; Davidova, J; Yamamoto, M; Gopalakrishnan, R				Mansky, Kim C.; Jensen, Eric D.; Davidova, Julia; Yamamoto, Masato; Gopalakrishnan, Rajaram			Protein Kinase D Promotes in Vitro Osteoclast Differentiation and Fusion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR EXPORT; CELL; REPRESSION	Although PKD is broadly expressed and involved in numerous cellular processes, its function in osteoclasts has not been previously reported. In this study, we found that PKD2 is the main PKD isoform expressed in osteoclastic cells. PKD phosphorylation, indicative of the activated state, increased after 2-3 days of treatment of bone marrow macrophages with M-CSF and RANKL, corresponding to the onset of preosteoclast fusion. RNAi against PKD2 and treatment with the PKD inhibitor CID755673 showed that PKD activity is dispensable for induction of bone marrow macrophages into tartrate-resistant acid phosphatase-positive preosteoclasts in culture but is required for the transition from mononucleated preosteoclasts to multinucleated osteoclasts. Loss of PKD activity reduced expression of DC-STAMP in RANKL-stimulated cultures. Overexpression of DC-STAMP was sufficient to rescue treatment with CID755673 and restore fusion into multinucleated osteoclasts. From these data, we conclude that PKD activity promotes differentiation of osteoclast progenitors through increased expression of DC-STAMP.	[Mansky, Kim C.] Univ Minnesota, Dept Dev & Surg Sci, Minneapolis, MN 55455 USA; [Jensen, Eric D.; Gopalakrishnan, Rajaram] Univ Minnesota, Dept Diagnost & Biol Sci, Minneapolis, MN 55455 USA; [Davidova, Julia; Yamamoto, Masato] Univ Minnesota, Dept Surg, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Jensen, ED (corresponding author), Univ Minnesota, Dept Diagnost & Biol Sci, Sch Dent, 515 Delaware St SE, Minneapolis, MN 55455 USA.	jens0709@umn.edu; gopal007@umn.edu		Mansky, Kim/0000-0002-2826-5030	National Institutes of Health [AR056642]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR061352, R01AR056642] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grant AR056642.	Bar-Shavit Z, 2007, J CELL BIOCHEM, V102, P1130, DOI 10.1002/jcb.21553; Bradley Elizabeth W., 2008, V455, P19, DOI 10.1007/978-1-59745-104-8_2; Davydova J, 2004, CANCER RES, V64, P4319, DOI 10.1158/0008-5472.CAN-04-0064; Dequiedt F, 2005, J EXP MED, V201, P793, DOI 10.1084/jem.20042034; Faccio R, 2003, J CELL BIOCHEM, V90, P871, DOI 10.1002/jcb.10694; Gartel AL, 2005, CANCER RES, V65, P3980, DOI 10.1158/0008-5472.CAN-04-3995; Helming L, 2009, TRENDS CELL BIOL, V19, P514, DOI 10.1016/j.tcb.2009.07.005; Jensen ED, 2009, J BIOL CHEM, V284, P2225, DOI 10.1074/jbc.M800586200; Koga T, 2004, NATURE, V428, P758, DOI 10.1038/nature02444; Pham L, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.216853; Mao DL, 2006, J CLIN INVEST, V116, P2869, DOI 10.1172/JCI28775; Matthews SA, 2006, MOL CELL BIOL, V26, P1569, DOI 10.1128/MCB.26.4.1569-1577.2006; Matthews SA, 1999, J BIOL CHEM, V274, P26543, DOI 10.1074/jbc.274.37.26543; Matthews SA, 2010, BIOCHEM J, V432, P153, DOI 10.1042/BJ20101188; Parra M, 2005, J BIOL CHEM, V280, P13762, DOI 10.1074/jbc.M413396200; Rozengurt E, 2005, J BIOL CHEM, V280, P13205, DOI 10.1074/jbc.R500002200; Rozengurt E, 2011, PHYSIOLOGY, V26, P23, DOI 10.1152/physiol.00037.2010; Tan MQ, 2009, ARTERIOSCL THROM VAS, V29, P1376, DOI 10.1161/ATVBAHA.109.191585; Vega RB, 2004, MOL CELL BIOL, V24, P8374, DOI 10.1128/MCB.24.19.8374-8385.2004; Wang QMJ, 2006, TRENDS PHARMACOL SCI, V27, P317, DOI 10.1016/j.tips.2006.04.003; Yagi M, 2005, J EXP MED, V202, P345, DOI 10.1084/jem.20050645	21	5	5	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 5	2013	288	14					9826	9834		10.1074/jbc.M112.444133	http://dx.doi.org/10.1074/jbc.M112.444133			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	119RB	23430742	Green Published, hybrid			2022-12-25	WOS:000317114000023
J	Hor, L; Dobson, RCJ; Downton, MT; Wagner, J; Hutton, CA; Perugini, MA				Hor, Lilian; Dobson, Renwick C. J.; Downton, Matthew T.; Wagner, John; Hutton, Craig A.; Perugini, Matthew A.			Dimerization of Bacterial Diaminopimelate Epimerase Is Essential for Catalysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIZE-DISTRIBUTION ANALYSIS; CRYSTAL-STRUCTURE; ANALYTICAL ULTRACENTRIFUGATION; PROTEIN INTERACTIONS; LYSINE BIOSYNTHESIS; ESCHERICHIA-COLI; SELF-ASSOCIATION; ACID EPIMERASE; ENZYME; MECHANISM	Diaminopimelate (DAP) epimerase is involved in the biosynthesis of meso-DAP and lysine, which are important precursors for the synthesis of peptidoglycan, housekeeping proteins, and virulence factors in bacteria. Accordingly, DAP epimerase is a promising antimicrobial target. Previous studies report that DAP epimerase exists as a monomeric enzyme. However, we show using analytical ultracentrifugation, X-ray crystallography, and enzyme kinetic analyses that DAP epimerase from Escherichia coli exists as a functional dimer in solution and the crystal state. Furthermore, the 2.0-angstrom X-ray crystal structure of the E. coli DAP epimerase dimer shows for the first time that the enzyme exists in an open, active conformation. The importance of dimerization was subsequently probed by using site-directed mutagenesis to generate a monomeric mutant (Y268A). Our studies show that Y268A is catalytically inactive, thus demonstrating that dimerization of DAP epimerase is essential for catalysis. Molecular dynamics simulations indicate that the DAP epimerase monomer is inherently more flexible than the dimer, suggesting that dimerization optimizes protein dynamics to support function. Our findings offer insight into the development of novel antimicrobial agents targeting the dimeric antibiotic target DAP epimerase.	[Hor, Lilian; Perugini, Matthew A.] La Trobe Univ, La Trobe Inst Mol Sci, Dept Biochem, Melbourne, Vic 3086, Australia; [Hor, Lilian; Dobson, Renwick C. J.; Perugini, Matthew A.] Univ Melbourne, Dept Biochem & Mol Biol, Parkville, Vic 3010, Australia; [Hor, Lilian; Hutton, Craig A.] Univ Melbourne, Sch Chem, Parkville, Vic 3010, Australia; [Hor, Lilian; Dobson, Renwick C. J.; Hutton, Craig A.; Perugini, Matthew A.] Bio21 Mol Sci & Biotechnol Inst, Parkville, Vic 3010, Australia; [Dobson, Renwick C. J.] Univ Canterbury, Biomol Interact Ctr, Christchurch 1, New Zealand; [Dobson, Renwick C. J.] Univ Canterbury, Sch Biol Sci, Christchurch 1, New Zealand; [Downton, Matthew T.; Wagner, John] Univ Melbourne, Victorian Life Sci Computat Initiat, IBM Res Collaboratory Life Sci Melbourne, Melbourne, Vic 3010, Australia	La Trobe University; University of Melbourne; University of Melbourne; University of Canterbury; University of Canterbury; University of Melbourne	Perugini, MA (corresponding author), La Trobe Univ, La Trobe Inst Mol Sci, Dept Biochem, Melbourne, Vic 3086, Australia.	M.Perugini@latrobe.edu.au	Dobson, Renwick/AAZ-7020-2021; Hutton, Craig/M-2442-2013	Dobson, Renwick/0000-0002-5506-4939; Hutton, Craig/0000-0002-2353-9258; Downton, Matthew/0000-0002-4693-1965	Victorian Life Sciences Computation Initiative Grant [VR0089]; University of Melbourne C.R. Roper Fellowship; Australian Research Council for Future Fellowship [FT0991245]	Victorian Life Sciences Computation Initiative Grant; University of Melbourne C.R. Roper Fellowship(University of Melbourne); Australian Research Council for Future Fellowship(Australian Research Council)	This work was supported in part by Victorian Life Sciences Computation Initiative Grant VR0089 to its Peak Computing Facility at the University of Melbourne, an initiative of the Victorian Government, Australia.; Supported by the University of Melbourne C.R. Roper Fellowship.; Supported by Australian Research Council for Future Fellowship FT0991245. To whom correspondence should be addressed: Dept. of Biochemistry, La Trobe Inst. for Molecular Science, La Trobe University, Melbourne, Victoria 3086, Australia. Tel.: 61-3-9479-6570; Fax: 61-3-9479-1266; E-mail: M.Perugini@latrobe.edu.au.	ANTIA M, 1957, BIOCHEM J, V65, P448, DOI 10.1042/bj0650448; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Blankenfeldt W, 2004, P NATL ACAD SCI USA, V101, P16431, DOI 10.1073/pnas.0407371101; Boughton BA, 2008, BIOORGAN MED CHEM, V16, P9975, DOI 10.1016/j.bmc.2008.10.026; Boughton BA, 2012, BIOORGAN MED CHEM, V20, P2419, DOI 10.1016/j.bmc.2012.01.045; Brookes E, 2010, MACROMOL BIOSCI, V10, P746, DOI 10.1002/mabi.200900474; Brookes E, 2010, EUR BIOPHYS J BIOPHY, V39, P423, DOI 10.1007/s00249-009-0418-0; Burgess BR, 2008, J BIOL CHEM, V283, P27598, DOI 10.1074/jbc.M804231200; Buschiazzo A, 2006, P NATL ACAD SCI USA, V103, P1705, DOI 10.1073/pnas.0509010103; Cardinale D, 2010, CURR MED CHEM, V17, P826, DOI 10.2174/092986710790712156; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cirilli M, 1998, BIOCHEMISTRY-US, V37, P16452, DOI 10.1021/bi982138o; Cox RJ, 2002, J CHEM SOC PERK T 1, P1029, DOI 10.1039/b201727j; Cox RJ, 2000, BIOORGAN MED CHEM, V8, P843, DOI 10.1016/S0968-0896(00)00044-4; Davis AJ, 2004, J BIOL CHEM, V279, P12462, DOI 10.1074/jbc.M312365200; Demeler B, 2004, ANAL BIOCHEM, V335, P279, DOI 10.1016/j.ab.2004.08.039; Demeler B., 2005, BIOINFORMATICS BASIC, P226; Demeler B, 2005, ANALYTICAL ULTRACENTRIFUGATION: TECHNIQUES AND METHODS, P210; Dogovski C., 2009, BIOTECHNOLOGY, P116; Dogovski C, 2012, BIOCHEMISTRY-US, P225, DOI DOI 10.85772/34121; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Foloppe N, 2001, J MOL BIOL, V310, P449, DOI 10.1006/jmbi.2001.4767; Garvey GS, 2007, PROTEIN SCI, V16, P1274, DOI 10.1110/ps.072801907; Gerrard JA, 2007, MINI-REV MED CHEM, V7, P151, DOI 10.2174/138955707779802561; Grassick A, 2004, PROTEINS, V55, P764, DOI 10.1002/prot.20025; Hor L, 2010, ACTA CRYSTALLOGR F, V66, P37, DOI 10.1107/S1744309109047708; Hutton CA, 2007, MOL BIOSYST, V3, P458, DOI 10.1039/b705624a; Hutton CA, 2003, MINI-REV MED CHEM, V3, P115, DOI 10.2174/1389557033405359; Koo CW, 1999, BIOCHEMISTRY-US, V38, P4416, DOI 10.1021/bi982911f; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; LESLIE AGW, 1991, CRYSTALLOGRAPHIC COM, P50; Liger D, 2005, PROTEINS, V60, P778, DOI 10.1002/prot.20548; Lloyd AJ, 2004, ACTA CRYSTALLOGR D, V60, P397, DOI 10.1107/S0907444903027999; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; Painter J, 2006, J APPL CRYSTALLOGR, V39, P109, DOI 10.1107/S0021889805038987; Parsons JF, 2004, BIOCHEMISTRY-US, V43, P12427, DOI 10.1021/bi049059z; Perugini MA, 2000, J BIOL CHEM, V275, P36758, DOI 10.1074/jbc.M005565200; Perugini MA, 2005, EUR BIOPHYS J BIOPHY, V34, P469, DOI 10.1007/s00249-005-0491-y; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Pillai B, 2009, J MOL BIOL, V385, P580, DOI 10.1016/j.jmb.2008.10.072; Pillai B, 2007, BIOCHEM BIOPH RES CO, V363, P547, DOI 10.1016/j.bbrc.2007.09.012; Pillai B, 2006, P NATL ACAD SCI USA, V103, P8668, DOI 10.1073/pnas.0602537103; Schuck P, 2002, BIOPHYS J, V82, P1096, DOI 10.1016/S0006-3495(02)75469-6; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Usha V, 2009, ACTA CRYSTALLOGR D, V65, P383, DOI 10.1107/S0907444909002522; Velarde M, 2009, J MOL BIOL, V391, P609, DOI 10.1016/j.jmb.2009.06.052; Vistica J, 2004, ANAL BIOCHEM, V326, P234, DOI 10.1016/j.ab.2003.12.014; Voss JE, 2010, J BIOL CHEM, V285, P5188, DOI 10.1074/jbc.M109.038166; Wells JA, 2007, NATURE, V450, P1001, DOI 10.1038/nature06526; Winn MD, 2003, METHOD ENZYMOL, V374, P300, DOI 10.1016/S0076-6879(03)74014-2; WISEMAN JS, 1984, J BIOL CHEM, V259, P8907	55	33	35	1	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 29	2013	288	13					9238	9248		10.1074/jbc.M113.450148	http://dx.doi.org/10.1074/jbc.M113.450148			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	116DG	23426375	hybrid, Green Published			2022-12-25	WOS:000316862200042
J	Garske, AK; Lawyer, CR; Peterson, BM; Illig, KR				Garske, Anna K.; Lawyer, Chloe R.; Peterson, Brittni M.; Illig, Kurt R.			Adolescent Changes in Dopamine D1 Receptor Expression in Orbitofrontal Cortex and Piriform Cortex Accompany an Associative Learning Deficit	PLOS ONE			English	Article							ORBITAL PREFRONTAL CORTEX; LATERAL OLFACTORY TRACT; BASOLATERAL AMYGDALA; NEURONAL-ACTIVITY; PRESYNAPTIC INHIBITION; POSTNATAL-DEVELOPMENT; TASK-PERFORMANCE; RAT FOREBRAIN; BEHAVIOR; MEMORY	The orbitofrontal cortex (OFC) and piriform cortex are involved in encoding the predictive value of olfactory stimuli in rats, and neural responses to olfactory stimuli in these areas change as associations are learned. This experience-dependent plasticity mirrors task-related changes previously observed in mesocortical dopamine neurons, which have been implicated in learning the predictive value of cues. Although forms of associative learning can be found at all ages, cortical dopamine projections do not mature until after postnatal day 35 in the rat. We hypothesized that these changes in dopamine circuitry during the juvenile and adolescent periods would result in age-dependent differences in learning the predictive value of environmental cues. Using an odor-guided associative learning task, we found that adolescent rats learn the association between an odor and a palatable reward significantly more slowly than either juvenile or adult rats. Further, adolescent rats displayed greater distractibility during the task than either juvenile or adult rats. Using real-time quantitative PCR and immunohistochemical methods, we observed that the behavioral deficit in adolescence coincides with a significant increase in D1 dopamine receptor expression compared to juvenile rats in both the OFC and piriform cortex. Further, we found that both the slower learning and increased distractibility exhibited in adolescence could be alleviated by experience with the association task as a juvenile, or by an acute administration of a low dose of either the dopamine D1 receptor agonist SKF-38393 or the D2 receptor antagonist eticlopride. These results suggest that dopaminergic modulation of cortical function may be important for learning the predictive value of environmental stimuli, and that developmental changes in cortical dopaminergic circuitry may underlie age-related differences in associative learning.	[Illig, Kurt R.] Univ St Thomas, Dept Biol, St Paul, MN 55105 USA; Univ St Thomas, Program Neurosci, St Paul, MN USA	University of St Thomas Minnesota; University of St Thomas Minnesota	Illig, KR (corresponding author), Univ St Thomas, Dept Biol, St Paul, MN 55105 USA.	krillig@stthomas.edu		Illig, Kurt/0000-0002-6373-9625				Anker JJ, 2010, PSYCHOPHARMACOLOGY, V208, P211, DOI 10.1007/s00213-009-1721-2; Bohn I, 2003, BEHAV BRAIN RES, V143, P49, DOI 10.1016/S0166-4328(03)00008-1; BOYSON SJ, 1986, J NEUROSCI, V6, P3177; Brenhouse HC, 2008, BEHAV NEUROSCI, V122, P460, DOI 10.1037/0735-7044.122.2.460; Brenhouse HC, 2008, J NEUROSCI, V28, P2375, DOI 10.1523/JNEUROSCI.5064-07.2008; Calu DJ, 2007, CEREB CORTEX, V17, P1342, DOI 10.1093/cercor/bhl045; Campbell KM, 1999, J NEUROSCI, V19, P5044; CHIODO LA, 1984, NEUROSCIENCE, V12, P1, DOI 10.1016/0306-4522(84)90133-7; Corbetta M, 2002, J COGNITIVE NEUROSCI, V14, P508, DOI 10.1162/089892902317362029; Dang LC, 2012, J NEUROSCI, V32, P9582, DOI 10.1523/JNEUROSCI.0909-12.2012; DIOP L, 1988, SYNAPSE, V2, P395, DOI 10.1002/syn.890020406; Dudchenko PA, 2000, J NEUROSCI, V20, P2964; Ekstrand JJ, 2001, J COMP NEUROL, V434, P308; Ennis M, 2001, J NEUROPHYSIOL, V86, P2986, DOI 10.1152/jn.2001.86.6.2986; Flores-Hernandez J, 2002, J NEUROPHYSIOL, V88, P3010, DOI 10.1152/jn.00361.2002; Furuyashiki T, 2008, J NEUROSCI, V28, P5127, DOI 10.1523/JNEUROSCI.0319-08.2008; Galef B.G. Jr, 1981, P211; GELLMAN RL, 1993, BRAIN RES, V600, P63, DOI 10.1016/0006-8993(93)90402-9; Hsia AY, 1999, J NEUROPHYSIOL, V82, P1082, DOI 10.1152/jn.1999.82.2.1082; Illig KR, 2005, J COMP NEUROL, V488, P224, DOI 10.1002/cne.20595; Kalivas PW, 2005, NEURON, V45, P647, DOI 10.1016/j.neuron.2005.02.005; KALSBEEK A, 1988, J COMP NEUROL, V269, P58, DOI 10.1002/cne.902690105; Kheramin S, 2004, PSYCHOPHARMACOLOGY, V175, P206, DOI 10.1007/s00213-004-1813-y; Komorowski RW, 2009, J NEUROSCI, V29, P9918, DOI 10.1523/JNEUROSCI.1378-09.2009; LEVEY AI, 1993, P NATL ACAD SCI USA, V90, P8861, DOI 10.1073/pnas.90.19.8861; Li W, 2006, NEURON, V52, P1097, DOI 10.1016/j.neuron.2006.10.026; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MEADORWOODRUFF JH, 1989, P NATL ACAD SCI USA, V86, P7625, DOI 10.1073/pnas.86.19.7625; Meyer EA, 2006, J COMP NEUROL, V498, P786, DOI 10.1002/cne.21077; Missale C, 1998, PHYSIOL REV, V78, P189, DOI 10.1152/physrev.1998.78.1.189; Moriceau S, 2005, DEV PSYCHOBIOL, V47, P230, DOI 10.1002/dev.20093; Moriceau S, 2004, J NEUROSCI, V24, P1182, DOI 10.1523/JNEUROSCI.4578-03.2004; Pirez N, 2008, J NEUROSCI, V28, P6360, DOI 10.1523/JNEUROSCI.0793-08.2008; Richards JB, 1999, PSYCHOPHARMACOLOGY, V146, P432, DOI 10.1007/PL00005488; Roesch MR, 2007, CEREB CORTEX, V17, P643, DOI 10.1093/cercor/bhk009; Schoenbaum G, 2003, BEHAV BRAIN RES, V146, P19, DOI 10.1016/j.bbr.2003.09.013; Schoenbaum G, 2003, LEARN MEMORY, V10, P129, DOI 10.1101/lm.55203; Schoenbaum G, 1998, NAT NEUROSCI, V1, P155, DOI 10.1038/407; Schoenbaum G, 1999, J NEUROSCI, V19, P1876; Schultz W, 1997, CURR OPIN NEUROBIOL, V7, P191, DOI 10.1016/S0959-4388(97)80007-4; Schultz W, 2000, ANNU REV NEUROSCI, V23, P473, DOI 10.1146/annurev.neuro.23.1.473; Schultz W, 1999, NEWS PHYSIOL SCI, V14, P249; SCHWOB JE, 1984, J COMP NEUROL, V223, P223, DOI 10.1002/cne.902230206; SCHWOB JE, 1984, J COMP NEUROL, V223, P203, DOI 10.1002/cne.902230205; SCHWOB JE, 1984, J COMP NEUROL, V223, P177, DOI 10.1002/cne.902230204; Spear LP, 2000, NEUROSCI BIOBEHAV R, V24, P417, DOI 10.1016/S0149-7634(00)00014-2; Stanwood GD, 1997, NEUROSCI LETT, V223, P13, DOI 10.1016/S0304-3940(97)13396-1; Sullivan RM, 2000, BEHAV NEUROSCI, V114, P957, DOI 10.1037/0735-7044.114.5.957; Tarazi FI, 1998, DEV BRAIN RES, V110, P227, DOI 10.1016/S0165-3806(98)00111-4; Tarazi FI, 2000, INT J DEV NEUROSCI, V18, P29, DOI 10.1016/S0736-5748(99)00108-2; Tremblay L, 2000, J NEUROPHYSIOL, V83, P1877, DOI 10.1152/jn.2000.83.4.1877; Tremblay L, 2000, J NEUROPHYSIOL, V83, P1864, DOI 10.1152/jn.2000.83.4.1864; Volkow ND, 2000, CEREB CORTEX, V10, P318, DOI 10.1093/cercor/10.3.318; Walz A, 2006, J NEUROBIOL, V66, P835, DOI 10.1002/neu.20266; Wang J, 2001, CEREB CORTEX, V11, P452, DOI 10.1093/cercor/11.5.452; Ward AS, 1997, EXP CLIN PSYCHOPHARM, V5, P130, DOI 10.1037/1064-1297.5.2.130; Wilson DA, 2003, J NEUROPHYSIOL, V90, P65, DOI 10.1152/jn.00133.2003; Wilson DA, 2003, TRENDS NEUROSCI, V26, P243, DOI 10.1016/S0166-2236(03)00076-6; Wilson DA, 1997, BEHAV NEURAL BIOL, V61, P1; Winstanley CA, 2006, CEREB CORTEX, V16, P106, DOI 10.1093/cercor/bhi088; Winstanley CA, 2007, ANN NY ACAD SCI, V1121, P639, DOI 10.1196/annals.1401.024; Winstanley CA, 2007, J NEUROSCI, V27, P10497, DOI 10.1523/JNEUROSCI.2566-07.2007; Wood ER, 1999, NATURE, V397, P613, DOI 10.1038/17605	63	21	21	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2013	8	2							e56191	10.1371/journal.pone.0056191	http://dx.doi.org/10.1371/journal.pone.0056191			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IT	23437091	Green Submitted, Green Published, gold			2022-12-25	WOS:000315186000015
J	Wang, MJ; Yin, BN; Matsueda, S; Deng, LJ; Li, Y; Zhao, W; Zou, J; Li, QT; Loo, C; Wang, RF; Wang, HY				Wang, Mingjun; Yin, Bingnan; Matsueda, Satoko; Deng, Lijuan; Li, Ying; Zhao, Wei; Zou, Jia; Li, Qingtian; Loo, Christopher; Wang, Rong-Fu; Wang, Helen Y.			Identification of Special AT-Rich Sequence Binding Protein 1 as a Novel Tumor Antigen Recognized by CD8(+) T Cells: Implication for Cancer Immunotherapy	PLOS ONE			English	Article							REED-STERNBERG CELLS; GENOME-WIDE; HODGKINS LYMPHOMA; IMMUNE SELECTION; PROSTATE-CANCER; GENE-EXPRESSION; GASTRIC-CANCER; UP-REGULATION; SATB1; MELANOMA	Background: A large number of human tumor-associated antigens that are recognized by CD8(+) T cells in a human leukocyte antigen class I (HLA-I)-restricted fashion have been identified. Special AT-rich sequence binding protein 1 (SATB1) is highly expressed in many types of human cancers as part of their neoplastic phenotype, and up-regulation of SATB1 expression is essential for tumor survival and metastasis, thus this protein may serve as a rational target for cancer vaccines. Methodology/Principal Findings: Twelve SATB1-derived peptides were predicted by an immuno-informatics approach based on the HLA-A*02 binding motif. These peptides were examined for their ability to induce peptide-specific T cell responses in peripheral blood mononuclear cells (PBMCs) obtained from HLA-A*02(+) healthy donors and/or HLA-A*02(+) cancer patients. The recognition of HLA-A*02(+) SATB1-expressing cancer cells was also tested. Among the twelve SATB1-derived peptides, SATB1(565-574) frequently induced peptide-specific T cell responses in PBMCs from both healthy donors and cancer patients. Importantly, SATB1(565-574)-specific T cells recognized and killed HLA-A*02(+) SATB1(+) cancer cells in an HLA-I-restricted manner. Conclusions/Significance: We have identified a novel HLA-A*02-restricted SATB1-derived peptide epitope recognized by CD8(+) T cells, which, in turn, recognizes and kills HLA-A*02(+) SATB1(+) tumor cells. The SATB1-derived epitope identified may be used as a diagnostic marker as well as an immune target for development of cancer vaccines.	[Wang, Mingjun; Yin, Bingnan; Deng, Lijuan; Zhao, Wei; Zou, Jia; Li, Qingtian; Loo, Christopher; Wang, Rong-Fu; Wang, Helen Y.] Methodist Hosp Res Inst, Ctr Inflammat & Epigenet, Houston, TX USA; [Wang, Mingjun; Matsueda, Satoko; Li, Ying; Wang, Rong-Fu; Wang, Helen Y.] Baylor Coll Med, Ctr Cell & Gene Therapy, Houston, TX 77030 USA	The Methodist Hospital System; The Methodist Hospital - Houston; The Methodist Hospital Research Institute; Baylor College of Medicine	Wang, HY (corresponding author), Methodist Hosp Res Inst, Ctr Inflammat & Epigenet, Houston, TX USA.	ywang4@tmhs.org		WANG, MINGJUN/0000-0002-5848-0444	National Cancer Institute; Methodist Hospital Research Institute; National Institutes of Health and Cancer Research Institute	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Methodist Hospital Research Institute; National Institutes of Health and Cancer Research Institute	This work was in part supported by grants from National Cancer Institute, National Institutes of Health and Cancer Research Institute, and The Methodist Hospital Research Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez JD, 2000, GENE DEV, V14, P521; Andersen MH, 2007, CLIN CANCER RES, V13, P5991, DOI 10.1158/1078-0432.CCR-07-0686; Beatty GL, 2008, EXPERT REV VACCINES, V7, P881, DOI 10.1586/14760584.7.7.881; Boon T, 1997, IMMUNOL TODAY, V18, P267, DOI 10.1016/S0167-5699(97)80020-5; Campoli M, 2002, VACCINE, V20, pA40, DOI 10.1016/S0264-410X(02)00386-9; Cheever MA, 2009, CLIN CANCER RES, V15, P5323, DOI 10.1158/1078-0432.CCR-09-0737; Chen HX, 2011, J DERMATOL SCI, V64, P39, DOI 10.1016/j.jdermsci.2011.06.007; Cheng C, 2010, APMIS, V118, P855, DOI 10.1111/j.1600-0463.2010.02673.x; Chu SH, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-149; Di Lorenzo G, 2011, NAT REV CLIN ONCOL, V8, P551, DOI 10.1038/nrclinonc.2011.72; Dudley ME, 2003, J IMMUNOTHER, V26, P332, DOI 10.1097/00002371-200307000-00005; DuPage M, 2012, NATURE, V482, P405, DOI 10.1038/nature10803; Fessing MY, 2011, J CELL BIOL, V194, P825, DOI 10.1083/jcb.201101148; FOGH J, 1977, J NATL CANCER I, V58, P209, DOI 10.1093/jnci/58.2.209; Fogh J, 1975, NEW HUMAN TUMOR CELL; Hammond AS, 2005, CLIN EXP IMMUNOL, V140, P109, DOI 10.1111/j.1365-2249.2005.02751.x; Han HJ, 2008, NATURE, V452, P187, DOI 10.1038/nature06781; Hodi FS, 2010, NEW ENGL J MED, V363, P711, DOI 10.1056/NEJMoa1003466; Kantoff PW, 2010, NEW ENGL J MED, V363, P411, DOI 10.1056/NEJMoa1001294; Kanzler H, 1996, BLOOD, V87, P3429, DOI 10.1182/blood.V87.8.3429.bloodjournal8783429; Kohwi-Shigematsu T, 2012, SEMINARS CANC BIOL; Lesterhuis WJ, 2011, NAT REV DRUG DISCOV, V10, P591, DOI 10.1038/nrd3500; Lu XM, 2010, ONCOL REP, V24, P981, DOI 10.3892/or_00000945; Matsueda S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045756; Matsushita H, 2012, NATURE, V482, P400, DOI 10.1038/nature10755; Mellman I, 2011, NATURE, V480, P480, DOI 10.1038/nature10673; Meng WJ, 2012, INT J COLORECTAL DIS, V27, P143, DOI 10.1007/s00384-011-1302-9; Mir R, 2012, CURRENT DRUG TARGETS; Mokhtar NM, 2012, CANCER INVEST, V30, P156, DOI 10.3109/07357907.2011.633290; Novellino L, 2005, CANCER IMMUNOL IMMUN, V54, P187, DOI 10.1007/s00262-004-0560-6; Pavan KP, 2006, MOL CELL, V22, P231, DOI 10.1016/j.molcel.2006.03.010; Riker A, 1999, SURGERY, V126, P112, DOI 10.1067/msy.1999.98739; Rosenberg SA, 2011, NAT REV CLIN ONCOL, V8, P577, DOI 10.1038/nrclinonc.2011.116; Savarese F, 2009, GENE DEV, V23, P2625, DOI 10.1101/gad.1815709; Schwartzentruber DJ, 2011, NEW ENGL J MED, V364, P2119, DOI 10.1056/NEJMoa1012863; Straten PT, 2010, ONCOTARGET, V1, P239; Toes REM, 2001, J EXP MED, V194, P1, DOI 10.1084/jem.194.1.1; Tu W, 2012, LIVER INT, V32, P1064, DOI 10.1111/j.1478-3231.2012.02815.x; VandenEynde BJ, 1997, INT J CLIN LAB RES, V27, P81, DOI 10.1007/BF02912440; Wang MJ, 2007, VACCINE, V25, P2823, DOI 10.1016/j.vaccine.2006.12.038; Weng JS, 2005, J CELL BIOCHEM, V96, P1034, DOI 10.1002/jcb.20600; Wolf J, 1996, BLOOD, V87, P3418, DOI 10.1182/blood.V87.8.3418.bloodjournal8783418; Xiang JD, 2012, ONCOL LETT, V3, P865, DOI 10.3892/ol.2012.571; Yamayoshi A, 2011, OLIGONUCLEOTIDES, V21, P115, DOI 10.1089/oli.2010.0277; Zeng G, 2001, P NATL ACAD SCI USA, V98, P3964, DOI 10.1073/pnas.061507398; Zhao XD, 2010, ORL-J OTO-RHIN-LARYN, V72, P1, DOI 10.1159/000264777; Zhou Lai-Yong, 2009, Nan Fang Yi Ke Da Xue Xue Bao, V29, P534	47	6	7	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2013	8	2							e56730	10.1371/journal.pone.0056730	http://dx.doi.org/10.1371/journal.pone.0056730			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IT	23437226	Green Submitted, Green Published, gold			2022-12-25	WOS:000315186000040
J	Kaushik, S; Mutt, E; Chellappan, A; Sankaran, S; Srinivasan, N; Sowdhamini, R				Kaushik, Swati; Mutt, Eshita; Chellappan, Ajithavalli; Sankaran, Sandhya; Srinivasan, Narayanaswamy; Sowdhamini, Ramanathan			Improved Detection of Remote Homologues Using Cascade PSI-BLAST: Influence of Neighbouring Protein Families on Sequence Coverage	PLOS ONE			English	Article							HIDDEN MARKOV-MODELS; TOMATO SUBTILASE 3; INTERMEDIATE SEQUENCE; FOLD RECOGNITION; PLANT PROTEASES; DATABASE; SEARCH; DOMAIN; PROTEOLYSIS; CLASSIFICATION	Background: Development of sensitive sequence search procedures for the detection of distant relationships between proteins at superfamily/fold level is still a big challenge. The intermediate sequence search approach is the most frequently employed manner of identifying remote homologues effectively. In this study, examination of serine proteases of prolyl oligopeptidase, rhomboid and subtilisin protein families were carried out using plant serine proteases as queries from two genomes including A. thaliana and O. sativa and 13 other families of unrelated folds to identify the distant homologues which could not be obtained using PSI-BLAST. Methodology/Principal Findings: We have proposed to start with multiple queries of classical serine protease members to identify remote homologues in families, using a rigorous approach like Cascade PSI-BLAST. We found that classical sequence based approaches, like PSI-BLAST, showed very low sequence coverage in identifying plant serine proteases. The algorithm was applied on enriched sequence database of homologous domains and we obtained overall average coverage of 88% at family, 77% at superfamily or fold level along with specificity of similar to 100% and Mathew's correlation coefficient of 0.91. Similar approach was also implemented on 13 other protein families representing every structural class in SCOP database. Further investigation with statistical tests, like jackknifing, helped us to better understand the influence of neighbouring protein families. Conclusions/Significance: Our study suggests that employment of multiple queries of a family for the Cascade PSI-BLAST searches is useful for predicting distant relationships effectively even at superfamily level. We have proposed a generalized strategy to cover all the distant members of a particular family using multiple query sequences. Our findings reveal that prior selection of sequences as query and the presence of neighbouring families can be important for covering the search space effectively in minimal computational time. This study also provides an understanding of the 'bridging' role of related families.	[Kaushik, Swati; Mutt, Eshita; Chellappan, Ajithavalli; Sowdhamini, Ramanathan] Tata Inst Fundamental Res, Natl Ctr Biol Sci, Bangalore, Karnataka, India; [Chellappan, Ajithavalli] Shanmugha Arts Sci Technol & Res Acad, Sch Chem & Biotechnol, Thanjavur, Tamil Nadu, India; [Sankaran, Sandhya; Srinivasan, Narayanaswamy] Indian Inst Sci, Mol Biophys Unit, Bangalore 560012, Karnataka, India	Tata Institute of Fundamental Research (TIFR); National Centre for Biological Sciences (NCBS); Shanmugha Arts, Science, Technology & Research Academy (SASTRA); Indian Institute of Science (IISC) - Bangalore	Srinivasan, N (corresponding author), Indian Inst Sci, Mol Biophys Unit, Bangalore 560012, Karnataka, India.	ns@mbu.iisc.ernet.in; mini@ncbs.res.in	Kaushik, Swati/AAR-6954-2020	Kaushik, Swati/0000-0002-3562-8522; Mutt, Eshita/0000-0003-3225-4761; Sandhya, Sankaran/0000-0003-0055-302X	Department of Biotechnology (DBT); DBT-BINC (Bioinformatics National Certification); NCBS-TIFR; DBT through Centre of Excellence Project [BT/01/COE/09/01]	Department of Biotechnology (DBT)(Department of Biotechnology (DBT) India); DBT-BINC (Bioinformatics National Certification); NCBS-TIFR; DBT through Centre of Excellence Project	SK thanks Department of Biotechnology (DBT) for financial support. EM thanks DBT-BINC (Bioinformatics National Certification) for financial support. RS thanks NCBS-TIFR for financial and infrastructural support. RS and NS also thank DBT for funding through Centre of Excellence Project (Grant number BT/01/COE/09/01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abola E. E., 1984, PROTEIN DATA BANK; Adam Z, 2002, TRENDS PLANT SCI, V7, P451, DOI 10.1016/S1360-1385(02)02326-9; Adam Z, 2001, PLANT PHYSIOL, V125, P1912, DOI 10.1104/pp.125.4.1912; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Apic Gordana, 2003, Journal of Structural and Functional Genomics, V4, P67, DOI 10.1023/A:1026113408773; Aroul-Selvam R, 2004, J MOL BIOL, V338, P633, DOI 10.1016/j.jmb.2004.03.039; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Baldi P, 2000, BIOINFORMATICS, V16, P412, DOI 10.1093/bioinformatics/16.5.412; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkp985, 10.1093/nar/gkr1065]; Ben-Hur A, 2003, BIOINFORMATICS, V19, pi26, DOI 10.1093/bioinformatics/btg1002; BODE W, 1987, EUR J BIOCHEM, V166, P673, DOI 10.1111/j.1432-1033.1987.tb13566.x; Cedzich A, 2009, J BIOL CHEM, V284, P14068, DOI 10.1074/jbc.M900370200; Cheng JL, 2006, BIOINFORMATICS, V22, P1456, DOI 10.1093/bioinformatics/btl102; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; Ekman D, 2005, J MOL BIOL, V348, P231, DOI 10.1016/j.jmb.2005.02.007; Fariselli P, 2007, BRIEF BIOINFORM, V8, P78, DOI 10.1093/bib/bbl032; Freeman M, 2004, NAT REV MOL CELL BIO, V5, P188, DOI 10.1038/nrm1334; Freeman M, 2003, CURR BIOL, V13, pR586, DOI 10.1016/S0960-9822(03)00519-0; Gerstein M, 1998, BIOINFORMATICS, V14, P707, DOI 10.1093/bioinformatics/14.8.707; Gowri VS, 2007, PROTEINS, V67, P789, DOI 10.1002/prot.21356; Gowri VS, 2003, NUCLEIC ACIDS RES, V31, P486, DOI 10.1093/nar/gkg063; Handstad T, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-23; Karplus K, 1998, BIOINFORMATICS, V14, P846, DOI 10.1093/bioinformatics/14.10.846; Lemberg MK, 2005, EMBO J, V24, P464, DOI 10.1038/sj.emboj.7600537; Li WZ, 2000, BIOINFORMATICS, V16, P1105, DOI 10.1093/bioinformatics/16.12.1105; Mahon P, 2000, PROTEIN SCI, V9, P1930, DOI 10.1110/ps.9.10.1930; Marchler-Bauer A, 2007, NUCLEIC ACIDS RES, V35, pD237, DOI 10.1093/nar/gkl951; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159; Ottmann C, 2009, P NATL ACAD SCI USA, V106, P17223, DOI 10.1073/pnas.0907587106; Ouyang S, 2007, NUCLEIC ACIDS RES, V35, pD883, DOI 10.1093/nar/gkl976; Palma JM, 2002, PLANT PHYSIOL BIOCH, V40, P521, DOI 10.1016/S0981-9428(02)01404-3; Park J, 1997, J MOL BIOL, V273, P349, DOI 10.1006/jmbi.1997.1288; Polgar L, 2002, CELL MOL LIFE SCI, V59, P349, DOI 10.1007/s00018-002-8427-5; Rautengarten C, 2005, PLOS COMPUT BIOL, V1, P297, DOI 10.1371/journal.pcbi.0010040; Rosenblum JS, 2003, CURR OPIN CHEM BIOL, V7, P496, DOI 10.1016/S1367-5931(03)00084-X; Salamov AA, 1999, PROTEIN ENG, V12, P95, DOI 10.1093/protein/12.2.95; Sandhya S, 2005, J BIOMOL STRUCT DYN, V23, P283, DOI 10.1080/07391102.2005.10507066; Schaller A, 2004, PLANTA, V220, P183, DOI 10.1007/s00425-004-1407-2; Teichmann SA, 2000, BIOINFORMATICS, V16, P117, DOI 10.1093/bioinformatics/16.2.117; Tripathi LP, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-200; Tusnady GE, 2001, BIOINFORMATICS, V17, P849, DOI 10.1093/bioinformatics/17.9.849; Wallqvist A, 2000, BIOINFORMATICS, V16, P988, DOI 10.1093/bioinformatics/16.11.988; Wang G, 2005, PROTEINS, V61, P46, DOI 10.1002/prot.20721; Wang YC, 2007, J MOL BIOL, V374, P1104, DOI 10.1016/j.jmb.2007.10.014; Wuchty S, 2001, MOL BIOL EVOL, V18, P1694, DOI 10.1093/oxfordjournals.molbev.a003957; YI TM, 1994, PROTEIN SCI, V3, P1315, DOI 10.1002/pro.5560030818	46	9	9	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e56449	10.1371/journal.pone.0056449	http://dx.doi.org/10.1371/journal.pone.0056449			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437136	Green Published, Green Accepted, gold, Green Submitted			2022-12-25	WOS:000315184200077
J	Letcher, PM; Lopez, S; Schmieder, R; Lee, PA; Behnke, C; Powell, MJ; McBride, RC				Letcher, Peter M.; Lopez, Salvador; Schmieder, Robert; Lee, Philip A.; Behnke, Craig; Powell, Martha J.; McBride, Robert C.			Characterization of Amoeboaphelidium protococcarum, an Algal Parasite New to the Cryptomycota Isolated from an Outdoor Algal Pond Used for the Production of Biofuel	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; CHYTRID ROZELLA-ALLOMYCIS; PSEUDAPHELIDIUM DREBESII; FINE-STRUCTURE; BIOMASS; MUSCLE	Mass culture of algae for the production of biofuels is a developing technology designed to offset the depletion of fossil fuel reserves. However, large scale culture of algae in open ponds can be challenging because of incidences of infestation with algal parasites. Without knowledge of the identity of the specific parasite and how to control these pests, algal-based biofuel production will be limited. We have characterized a eukaryotic parasite of Scenedesmus dimorphus growing in outdoor ponds used for biofuel production. We demonstrated that as the genomic DNA of parasite FD01 increases, the concentration of S. dimorphus cells decreases; consequently, this is a highly destructive pathogen. Techniques for culture of the parasite and host were developed, and the endoparasite was identified as the Aphelidea, Amoeboaphelidium protococcarum. Phylogenetic analysis of ribosomal sequences revealed that parasite FD01 placed within the recently described Cryptomycota, a poorly known phylum based on two species of Rozella and environmental samples. Transmission electron microscopy demonstrated that aplanospores of the parasite produced filose pseudopodia, which contained fine fibers the diameter of actin microfilaments. Multiple lipid globules clustered and were associated with microbodies, mitochondria and a membrane cisternae, an arrangement characteristic of the microbody-lipid globule complex of chytrid zoospores. After encystment and attachment to the host cells, the parasite injected its protoplast into the host between the host cell wall and plasma membrane. At maturity the unwalled parasite occupied the entire host cell. After cleavage of the protoplast into aplanospores, a vacuole and lipids remained in the host cell. Amoeboaphelidium protococcarum isolate FD01 is characteristic of the original description of this species and is different from strain X-5 recently characterized. Our results help put a face on the Cryptomycota, revealing that the phylum is more diverse than previously understood and include some of the Aphelidea as well as Rozella species and potentially Microsporidia.	[Letcher, Peter M.; Powell, Martha J.] Univ Alabama, Dept Biol Sci, Tuscaloosa, AL 35487 USA; [Lopez, Salvador; Lee, Philip A.; Behnke, Craig; McBride, Robert C.] Sapphire Energy Inc, Crop Protect Grp, San Diego, CA USA; [Schmieder, Robert] San Diego State Univ, Dept Comp Sci, San Diego, CA 92182 USA; [Schmieder, Robert] San Diego State Univ, Computat Sci Res Ctr, San Diego, CA 92182 USA	University of Alabama System; University of Alabama Tuscaloosa; California State University System; San Diego State University; California State University System; San Diego State University	Letcher, PM (corresponding author), Univ Alabama, Dept Biol Sci, Tuscaloosa, AL 35487 USA.	letch006@bama.ua.edu		Behnke, Craig/0000-0001-6949-7957	PL: NSF AFTOL [DEB-0732599]	PL: NSF AFTOL	PL: NSF AFTOL Grant DEB-0732599, www.nsf.gov. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adl SM, 2012, J EUKARYOT MICROBIOL, V59, P429, DOI 10.1111/j.1550-7408.2012.00644.x; Davis R, 2011, APPL ENERG, V88, P3524, DOI 10.1016/j.apenergy.2011.04.018; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fott B, 1957, U CAROL BIOL, V3, P229; Freeman KR, 2009, P NATL ACAD SCI USA, V106, P18315, DOI 10.1073/pnas.0907303106; Gao YH, 2012, CHEM CENT J, V6, DOI 10.1186/1752-153X-6-S1-S1; GROMOV B. V., 1966, MIKROBIOLOGIYA, V35, P1073; GROMOV B V, 1968, Acta Protozoologica, V6, P221; GROMOV BV, 1970, ARCH HYDROBIOL, V67, P452; Gromov BV, 2000, ZOOL ZH, V79, P517; Gromov BV, 1969, PHYCOLOGIA, V7, P19; Gromov BV, 1969, 3 INT C PROT, P96; Gromov BV, 1969, VESTN LENINGRAD U  B, V9, P140; Hall T, 1999, NUCL ACIDS S SER, V41, P95, DOI DOI 10.1021/BK-1999-0734.CH008; Hase R, 2000, J BIOSCI BIOENG, V89, P157, DOI 10.1016/S1389-1723(00)88730-7; HELD AA, 1973, CAN J BOT, V51, P1825, DOI 10.1139/b73-234; HELD AA, 1973, B TORREY BOT CLUB, V100, P203, DOI 10.2307/2484798; HELD AA, 1974, ARCH MICROBIOL, V95, P97, DOI 10.1007/BF02451752; Jones MDM, 2011, IMA FUNGUS, V2, P173, DOI 10.5598/imafungus.2011.02.02.08; Jones MDM, 2011, NATURE, V474, P200, DOI 10.1038/nature09984; Karpov SA, 2013, PROTIST, V164, P195, DOI 10.1016/j.protis.2012.08.001; Kirk PM, 2008, DICT FUNGI; Kozhenkova EV, 1999, INT J ALGAE, V1, P46; Lara E, 2010, PROTIST, V161, P116, DOI 10.1016/j.protis.2009.06.005; Mamkaeva K. A., 1969, NAUCHNYE DOKL VYSSHE, V8, P112; Pinevich A, 1997, CURR MICROBIOL, V34, P122, DOI 10.1007/s002849900155; POWELL MJ, 1984, MYCOLOGIA, V76, P1039, DOI 10.2307/3793019; REHNER SA, 1994, MYCOL RES, V98, P625, DOI 10.1016/S0953-7562(09)80409-7; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Scherffel A., 1925, Archiv fuer Protistenkunde Jena, V52, P1; SCHNEPF E, 1971, ARCH MIKROBIOL, V75, P230, DOI 10.1007/BF00408984; Schweikert M, 1996, ARCH PROTISTENKD, V147, P11; Schweikert M, 1997, PROTOPLASMA, V199, P113, DOI 10.1007/BF01294500; Sparrow F.K., 1960, AQUATIC PHYCOMYCETES; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Stephens E, 2010, TRENDS PLANT SCI, V15, P554, DOI 10.1016/j.tplants.2010.06.003; Ugwu CU, 2008, BIORESOURCE TECHNOL, V99, P4021, DOI 10.1016/j.biortech.2007.01.046; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; White T.J., 1990, PCR PROTOCOLS GUIDE, P315, DOI DOI 10.1016/B978-0-12-372180-8.50042-1; Zhu CJ, 1997, J APPL PHYCOL, V9, P189, DOI 10.1023/A:1007914806640; Zopf W, 1885, ENCYKLOPAEDIE NATURW	42	104	113	0	78	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e56232	10.1371/journal.pone.0056232	http://dx.doi.org/10.1371/journal.pone.0056232			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437098	gold, Green Submitted, Green Published			2022-12-25	WOS:000315184200049
J	Liu, K; Guo, TL; Hait, NC; Allegood, J; Parikh, HI; Xu, WF; Kellogg, GE; Grant, S; Spiegel, S; Zhang, SJ				Liu, Kai; Guo, Tai L.; Hait, Nitai C.; Allegood, Jeremy; Parikh, Hardik I.; Xu, Wenfang; Kellogg, Glen E.; Grant, Steven; Spiegel, Sarah; Zhang, Shijun			Biological Characterization of 3-(2-amino-ethyl)-5-[3-(4-butoxyl-phenyl)-propylidene]-thiazolidine-2,4-dione (K145) as a Selective Sphingosine Kinase-2 Inhibitor and Anticancer Agent	PLOS ONE			English	Article							BREAST-CANCER; FUNCTIONAL-CHARACTERIZATION; PROTEASOMAL-DEGRADATION; ANTITUMOR-ACTIVITY; MOLECULAR-CLONING; PROTEIN; SPHINGOSINE-1-PHOSPHATE; 1-PHOSPHATE; SURVIVAL; ANALOGS	In our effort to develop selective sphingosine kinase-2 (SphK2) inhibitors as pharmacological tools, a thiazolidine-2,4-dione analogue, 3-(2-amino-ethyl)-5-[3-(4-butoxyl-phenyl)-propylidene]-thiazolidine-2,4-dione (K145), was synthesized and biologically characterized. Biochemical assay results indicate that K145 is a selective SphK2 inhibitor. Molecular modeling studies also support this notion. In vitro studies using human leukemia U937 cells demonstrated that K145 accumulates in U937 cells, suppresses the S1P level, and inhibits SphK2. K145 also exhibited inhibitory effects on the growth of U937 cells as well as apoptotic effects in U937 cells, and that these effects may be through the inhibition of down-stream ERK and Akt signaling pathways. K145 also significantly inhibited the growth of U937 tumors in nude mice by both intraperitoneal and oral administration, thus demonstrating its in vivo efficacy as a potential lead anticancer agent. The antitumor activity of K145 was also confirmed in a syngeneic mouse model by implanting murine breast cancer JC cells in BALB/c mice. Collectively, these results strongly encourage further optimization of K145 as a novel lead compound for development of more potent and selective SphK2 inhibitors.	[Liu, Kai; Parikh, Hardik I.; Kellogg, Glen E.; Zhang, Shijun] Virginia Commonwealth Univ, Dept Med Chem, Richmond, VA 23298 USA; [Guo, Tai L.] Virginia Commonwealth Univ, Dept Pharmacol, Richmond, VA 23298 USA; [Guo, Tai L.] Virginia Commonwealth Univ, Dept Toxicol, Richmond, VA 23298 USA; [Hait, Nitai C.; Allegood, Jeremy; Spiegel, Sarah] Virginia Commonwealth Univ, Dept Biochem & Mol Biol, Richmond, VA 23298 USA; [Grant, Steven] Virginia Commonwealth Univ, Dept Internal Med, Richmond, VA 23298 USA; [Grant, Steven] Virginia Commonwealth Univ, Massey Canc Ctr, Richmond, VA 23298 USA; [Xu, Wenfang] Shandong Univ, Sch Pharmaceut Sci, Jinan, Shandong, Peoples R China	Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University; Shandong University	Zhang, SJ (corresponding author), Virginia Commonwealth Univ, Dept Med Chem, Richmond, VA 23298 USA.	szhang2@vcu.edu	Parikh, Hardik/AAG-4963-2021	Kellogg, Glen/0000-0002-6282-6794; Parikh, Hardik/0000-0002-5621-7343	National Institutes of Health [P30CA16059]; Multi-School AD William Fund from Virginia Commonwealth University; NIGMS [R37GM043880]; NATIONAL CANCER INSTITUTE [P30CA016059] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM043880] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Multi-School AD William Fund from Virginia Commonwealth University; NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Flow cytometry was supported in part by National Institutes of Health Grant P30CA16059 awarded to Massey Cancer Center, VCU. This work was supported in part by the Multi-School AD William Fund from Virginia Commonwealth University (SZ) and NIGMS Grant R37GM043880 (SS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 2005, FEBS J, V272, P5101, DOI 10.1111/j.1742-4658.2005.04945.x; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Alvarez SE, 2010, NATURE, V465, P1084, DOI 10.1038/nature09128; Baell JB, 2010, J MED CHEM, V53, P2719, DOI 10.1021/jm901137j; Beljanski V, 2011, CANCER BIOL THER, V11, P524, DOI 10.4161/cbt.11.5.14677; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cuvillier O, 1996, NATURE, V381, P800, DOI 10.1038/381800a0; Cuvillier O, 2001, BLOOD, V98, P2828, DOI 10.1182/blood.V98.9.2828; French KJ, 2006, J PHARMACOL EXP THER, V318, P596, DOI 10.1124/jpet.106.101345; French KJ, 2010, J PHARMACOL EXP THER, V333, P129, DOI 10.1124/jpet.109.163444; Gao P, 2011, MOL CANCER RES, V9, P1509, DOI 10.1158/1541-7786.MCR-11-0336; Gault CR, 2011, CRIT REV BIOCHEM MOL, V46, P342, DOI 10.3109/10409238.2011.597737; Grant S, 2008, J CLIN INVEST, V118, P3003, DOI 10.1172/JCI36898; Hait NC, 2005, J BIOL CHEM, V280, P29462, DOI 10.1074/jbc.M502922200; Hait NC, 2009, SCIENCE, V325, P1254, DOI 10.1126/science.1176709; Hamada Y, 1993, Patent, Patent No. [US5214202, 5214202]; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; Igarashi N, 2003, J BIOL CHEM, V278, P46832, DOI 10.1074/jbc.M306577200; Johnson KR, 2002, J BIOL CHEM, V277, P35257, DOI 10.1074/jbc.M203033200; Kellogg GE, 2000, EUR J MED CHEM, V35, P651, DOI 10.1016/S0223-5234(00)00167-7; Kennedy AJ, 2011, J MED CHEM, V54, P3524, DOI 10.1021/jm2001053; Kharel Y, 2012, BIOCHEM J, V447, P149, DOI 10.1042/BJ20120609; Kim JW, 2005, BIOORGAN MED CHEM, V13, P3475, DOI 10.1016/j.bmc.2005.02.053; Knight SD, 2010, ACS MED CHEM LETT, V1, P39, DOI 10.1021/ml900028r; Kohama T, 1998, J BIOL CHEM, V273, P23722, DOI 10.1074/jbc.273.37.23722; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lee BD, 2003, ONCOL RES, V14, P49, DOI 10.3727/000000003108748603; Li Q, 2009, MICRO NANO LETT, V4, P1, DOI 10.1049/mnl:20080036; Lim KG, 2011, J BIOL CHEM, V286, P18633, DOI 10.1074/jbc.M111.220756; Lim KG, 2011, CELL SIGNAL, V23, P1590, DOI 10.1016/j.cellsig.2011.05.010; Liu H, 2000, J BIOL CHEM, V275, P19513, DOI 10.1074/jbc.M002759200; Liu H, 2003, J BIOL CHEM, V278, P40330, DOI 10.1074/jbc.M304455200; Liu K, 2012, EUR J MED CHEM, V47, P125, DOI 10.1016/j.ejmech.2011.10.031; Maceyka M, 2012, TRENDS CELL BIOL, V22, P50, DOI 10.1016/j.tcb.2011.09.003; Marabotti A, 2008, J COMPUT CHEM, V29, P1955, DOI 10.1002/jcc.20954; Melo F, 2002, PROTEIN SCI, V11, P430, DOI 10.1002/pro.110430; Mendgen T, 2012, J MED CHEM, V55, P743, DOI 10.1021/jm201243p; Osawa Y, 2001, J IMMUNOL, V167, P173, DOI 10.4049/jimmunol.167.1.173; Paugh SW, 2008, BLOOD, V112, P1382, DOI 10.1182/blood-2008-02-138958; Paugh SW, 2003, FEBS LETT, V554, P189, DOI 10.1016/S0014-5793(03)01168-2; Pitson SM, 2011, TRENDS BIOCHEM SCI, V36, P97, DOI 10.1016/j.tibs.2010.08.001; Puneet P, 2010, SCIENCE, V328, P1290, DOI 10.1126/science.1188635; Pyne S, 2011, CANCER RES, V71, P6576, DOI 10.1158/0008-5472.CAN-11-2364; Raje MR, 2012, BIOORGAN MED CHEM, V20, P183, DOI 10.1016/j.bmc.2011.11.011; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Shaner RL, 2009, J LIPID RES, V50, P1692, DOI 10.1194/jlr.D800051-JLR200; Shu XD, 2002, MOL CELL BIOL, V22, P7758, DOI 10.1128/MCB.22.22.7758-7768.2002; Siow D, 2011, CRIT REV BIOCHEM MOL, V46, P365, DOI 10.3109/10409238.2011.580097; Spiegel S, 2003, NAT REV MOL CELL BIO, V4, P397, DOI 10.1038/nrm1103; Steelman LS, 2008, LEUKEMIA, V22, P686, DOI 10.1038/leu.2008.26; Strub GM, 2011, FASEB J, V25, P600, DOI 10.1096/fj.10-167502; Takabe K, 2008, PHARMACOL REV, V60, P181, DOI 10.1124/pr.107.07113; Tomasic T, 2009, CURR MED CHEM, V16, P1596, DOI 10.2174/092986709788186200; Tonelli F, 2010, CELL SIGNAL, V22, P1536, DOI 10.1016/j.cellsig.2010.05.022; Van Brocklyn JR, 2005, J NEUROPATH EXP NEUR, V64, P695, DOI 10.1097/01.jnen.0000175329.59092.2c; Verdonk ML, 2003, PROTEINS, V52, P609, DOI 10.1002/prot.10465; Yokota S, 2004, FEBS LETT, V578, P106, DOI 10.1016/j.febslet.2004.10.081	57	65	69	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e56471	10.1371/journal.pone.0056471	http://dx.doi.org/10.1371/journal.pone.0056471			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437140	Green Submitted, Green Published, gold			2022-12-25	WOS:000315184200080
J	Oliveira, AB; Moura, CFH; Gomes, E; Marco, CA; Urban, L; Miranda, MRA				Oliveira, Aurelice B.; Moura, Carlos F. H.; Gomes-Filho, Eneas; Marco, Claudia A.; Urban, Laurent; Miranda, Maria Raquel A.			The Impact of Organic Farming on Quality of Tomatoes Is Associated to Increased Oxidative Stress during Fruit Development	PLOS ONE			English	Article							PHENYLALANINE AMMONIA-LYASE; ANTIOXIDANT ACTIVITY; PHENOLIC CONTENT; TEMPERATURE; POLYPHENOLS; BENEFITS; PLANTS; GENES	This study was conducted with the objective of testing the hypothesis that tomato fruits from organic farming accumulate more nutritional compounds, such as phenolics and vitamin C as a consequence of the stressing conditions associated with farming system. Growth was reduced in fruits from organic farming while titratable acidity, the soluble solids content and the concentrations in vitamin C were respectively +29%, +57% and +55% higher at the stage of commercial maturity. At that time, the total phenolic content was +139% higher than in the fruits from conventional farming which seems consistent with the more than two times higher activity of phenylalanine ammonia lyase (PAL) we observed throughout fruit development in fruits from organic farming. Cell membrane lipid peroxidation (LPO) degree was 60% higher in organic tomatoes. SOD activity was also dramatically higher in the fruits from organic farming. Taken together, our observations suggest that tomato fruits from organic farming experienced stressing conditions that resulted in oxidative stress and the accumulation of higher concentrations of soluble solids as sugars and other compounds contributing to fruit nutritional quality such as vitamin C and phenolic compounds.	[Oliveira, Aurelice B.; Gomes-Filho, Eneas; Miranda, Maria Raquel A.] Univ Fed Ceara, Depto Bioquim & Biol Mol, Fortaleza, CE, Brazil; [Moura, Carlos F. H.] Embrapa Agroind Trop, Fortaleza, CE, Brazil; [Marco, Claudia A.] Univ Fed Ceara, Juazeiro Do N, CE, Brazil; [Urban, Laurent] Univ Avignon & Pays de Vaucluse, Avignon, France	Universidade Federal do Ceara; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); Universidade Federal do Ceara; Avignon Universite	Miranda, MRA (corresponding author), Univ Fed Ceara, Depto Bioquim & Biol Mol, Fortaleza, CE, Brazil.	rmiranda@ufc.br	Gomes-Filho, Enéas/AAG-2144-2020; Gomes-Filho, Enéas/F-4191-2010; de Miranda, Maria Raquel Alcântara/N-1942-2016	Gomes-Filho, Enéas/0000-0001-5945-6596; Gomes-Filho, Enéas/0000-0001-5945-6596; de Miranda, Maria Raquel Alcântara/0000-0003-0069-7242	BNB-Fundeci; CAPES-REUNI; CNPq/INCT Frutos Tropicais	BNB-Fundeci; CAPES-REUNI(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CNPq/INCT Frutos Tropicais	Funding was provided by BNB-Fundeci, CAPES-REUNI, and CNPq/INCT Frutos Tropicais. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], ANTIOXID REDOX SIGN, DOI DOI 10.1038/nrm3270; ASSOCIATION OF OFFICIAL ANALYTICAL CHEMISTRY, 2005, OFF METH AN ASS OFF; Basu A, 2007, EUR J CLIN NUTR, V61, P295, DOI 10.1038/sj.ejcn.1602510; BEERS RF, 1952, J BIOL CHEM, V195, P133; Beno-Moualem D, 2000, PHYTOPATHOLOGY, V90, P553, DOI 10.1094/PHYTO.2000.90.5.553; Bjelakovic G, 2007, JAMA-J AM MED ASSOC, V297, P842, DOI 10.1001/jama.297.8.842; Bouvier F, 1998, J BIOL CHEM, V273, P30651, DOI 10.1074/jbc.273.46.30651; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Caris-Veyrat C, 2004, J AGR FOOD CHEM, V52, P6503, DOI 10.1021/jf0346861; Chang A, 2008, J BIOL CHEM, V283, P33591, DOI 10.1074/jbc.M804428200; Chassy AW, 2006, J AGR FOOD CHEM, V54, P8244, DOI 10.1021/jf060950p; Chun OK, 2004, FOOD RES INT, V37, P337, DOI 10.1016/j.foodres.2004.02.001; Cunningham FX, 2002, PURE APPL CHEM, V74, P1409, DOI 10.1351/pac200274081409; El-Mergawi RA, 2010, J FOOD AGRIC ENVIRON, V8, P253; El-Shora HM, 2002, PLANT SCI, V162, P1, DOI 10.1016/S0168-9452(01)00471-X; Francis F. J., 1982, ANTHOCYANINS FOOD CO, P181, DOI [DOI 10.1016/B978-0-12-472550-8.50011-1, 10.1016/B978-0-12-472550-8.50011-1]; Fujita M, 2006, CURR OPIN PLANT BIOL, V9, P436, DOI 10.1016/j.pbi.2006.05.014; GIANNOPOLITIS CN, 1977, PLANT PHYSIOL, V59, P309, DOI 10.1104/pp.59.2.309; Grassmann J, 2002, PLANT PHYSIOL BIOCH, V40, P471, DOI 10.1016/S0981-9428(02)01395-5; Guo J, 2010, PLANT GROWTH REGUL, V62, P1, DOI 10.1007/s10725-010-9472-y; Hafiz IM, 2011, INT J MOL SCI, V12, P5238; HERMS DA, 1992, Q REV BIOL, V67, P283, DOI 10.1086/417659; Jin P, 2011, FOOD CHEM, V124, P262, DOI 10.1016/j.foodchem.2010.06.029; Kuntz M, 1998, PLANT J, V13, P351, DOI 10.1046/j.1365-313X.1998.00032.x; Kuskoski E. Marta, 2005, Food Sci. Technol (Campinas), V25, P726, DOI 10.1590/S0101-20612005000400016; Larrauri JA, 1997, J AGR FOOD CHEM, V45, P1390, DOI 10.1021/jf960282f; Lima VLAG, 2005, FOOD CHEM, V90, P565, DOI 10.1016/j.foodchem.2004.04.014; LORIO PL, 1986, FOREST ECOL MANAG, V14, P259, DOI 10.1016/0378-1127(86)90172-6; Luthria D, 2010, FOOD CHEM, V121, P406, DOI 10.1016/j.foodchem.2009.12.055; LUXMOORE RJ, 1991, TREE PHYSIOL, V9, P267, DOI 10.1093/treephys/9.1-2.267; Manach C, 2004, AM J CLIN NUTR, V79, P727, DOI 10.1093/ajcn/79.5.727; Mitchell AE, 2007, J AGR FOOD CHEM, V55, P6154, DOI 10.1021/jf070344+; Mori T, 2001, PLANT SCI, V160, P355, DOI 10.1016/S0168-9452(00)00399-X; NAKANO Y, 1981, PLANT CELL PHYSIOL, V22, P867; Obanda M, 1997, J SCI FOOD AGR, V74, P209, DOI [10.1002/(SICI)1097-0010(199706)74:2<209::AID-JSFA789>3.3.CO;2-W, 10.1002/(SICI)1097-0010(199706)74:2&lt;209::AID-JSFA789&gt;3.0.CO;2-4]; Olsson ME, 2006, J AGR FOOD CHEM, V54, P1248, DOI 10.1021/jf0524776; Poiroux-Gonord F, 2012, J SCI FOOD AGR, V92, P2076, DOI 10.1002/jsfa.5584; Poiroux-Gonord F, 2010, J AGR FOOD CHEM, V58, P12065, DOI 10.1021/jf1037745; Re R, 1999, FREE RADICAL BIO MED, V26, P1231, DOI 10.1016/S0891-5849(98)00315-3; Strohecker R., 1967, ANALISIS VITAMINAS M; Surh YJ, 2008, GENES NUTR, V2, P313, DOI 10.1007/s12263-007-0063-0; Urban L, 2008, C DINABIO MONTP; Vallverdu-Queralt A, 2012, FOOD CHEM, V130, P222, DOI 10.1016/j.foodchem.2011.07.017; Zhu SH, 2008, J SCI FOOD AGR, V88, P2324, DOI 10.1002/jsfa.3353; Zushi K, 2009, SCI HORTIC-AMSTERDAM, V122, P362, DOI 10.1016/j.scienta.2009.06.001	45	85	89	4	80	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e56354	10.1371/journal.pone.0056354	http://dx.doi.org/10.1371/journal.pone.0056354			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437115	Green Submitted, Green Published, gold			2022-12-25	WOS:000315184200060
J	Hayward, DC; Dosztanyi, Z; Clark-Walker, GD				Hayward, David C.; Dosztanyi, Zsuzsanna; Clark-Walker, George Desmond			The N-Terminal Intrinsically Disordered Domain of Mgm101p Is Localized to the Mitochondrial Nucleoid	PLOS ONE			English	Article							UNSTRUCTURED PROTEINS; SACCHAROMYCES-CEREVISIAE; DNA RECOMBINATION; MAINTENANCE; EVOLUTION; GENOME; MTDNA; PREDICTION; SERVER; SITES	The mitochondrial genome maintenance gene, MGM101, is essential for yeasts that depend on mitochondrial DNA replication. Previously, in Saccharomyces cerevisiae, it has been found that the carboxy-terminal two-thirds of Mgm101p has a functional core. Furthermore, there is a high level of amino acid sequence conservation in this region from widely diverse species. By contrast, the amino-terminal region, that is also essential for function, does not have recognizable conservation. Using a bioinformatic approach we find that the functional core from yeast and a corresponding region of Mgm101p from the coral Acropora millepora have an ordered structure, while the N-terminal domains of sequences from yeast and coral are predicted to be disordered. To examine whether ordered and disordered domains of Mgm101p have specific or general functions we made chimeric proteins from yeast and coral by swapping the two regions. We find, by an in vivo assay in S. cerevisiae, that the ordered domain of A. millepora can functionally replace the yeast core region but the disordered domain of the coral protein cannot substitute for its yeast counterpart. Mgm101p is found in the mitochondrial nucleoid along with enzymes and proteins involved in mtDNA replication. By attaching green fluorescent protein to the N-terminal disordered domain of yeast Mgm101p we find that GFP is still directed to the mitochondrial nucleoid where full-length Mgm101p-GFP is targeted.	[Hayward, David C.; Clark-Walker, George Desmond] Australian Natl Univ, Res Sch Biol, Canberra, ACT, Australia; [Dosztanyi, Zsuzsanna] Hungarian Acad Sci, Res Ctr Nat Sci, Inst Enzymol, Budapest, Hungary; [Clark-Walker, George Desmond] Australian Natl Univ, Res Sch Chem, Canberra, ACT, Australia	Australian National University; Hungarian Academy of Sciences; Hungarian Research Centre for Natural Sciences; Australian National University	Clark-Walker, GD (corresponding author), Australian Natl Univ, Res Sch Biol, Canberra, ACT, Australia.	des.clark-walker@anu.edu.au	Dosztanyi, Zsuzsanna/G-6422-2010; Dosztanyi, Zsuzsanna/M-9943-2019	Dosztanyi, Zsuzsanna/0000-0002-3624-5937; Hayward, David/0000-0003-2937-2425	Australian Research Council through the Centre for Molecular Genetics of Development; Centre of Excellence for Coral Reef Studies; Bolyai Janos fellowship;  [DP1095343]	Australian Research Council through the Centre for Molecular Genetics of Development(Australian Research Council); Centre of Excellence for Coral Reef Studies; Bolyai Janos fellowship(Hungarian Academy of Sciences); 	The authors thank the Australian Research Council for support through the Centre for Molecular Genetics of Development, the Centre of Excellence for Coral Reef Studies, and Discovery Grant DP1095343. Bolyai Janos fellowship for ZD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bogenhagen DF, 2008, J BIOL CHEM, V283, P3665, DOI 10.1074/jbc.M708444200; Bogenhagen DF, 2012, BBA-GENE REGUL MECH, V1819, P914, DOI 10.1016/j.bbagrm.2011.11.005; Brown CJ, 2011, CURR OPIN STRUC BIOL, V21, P441, DOI 10.1016/j.sbi.2011.02.005; Chen XJ, 2005, NAT REV GENET, V6, P815, DOI 10.1038/nrg1708; CHEN XJ, 1993, NUCLEIC ACIDS RES, V21, P3473, DOI 10.1093/nar/21.15.3473; ClarkWalker GD, 1996, MOL GEN GENET, V252, P746, DOI 10.1007/s004380050285; Claros MG, 1996, EUR J BIOCHEM, V241, P779, DOI 10.1111/j.1432-1033.1996.00779.x; Daughdrill GW, 2007, J MOL EVOL, V65, P277, DOI 10.1007/s00239-007-9011-2; DENTE L, 1983, NUCLEIC ACIDS RES, V11, P1645, DOI 10.1093/nar/11.6.1645; Dosztanyi Z, 2005, BIOINFORMATICS, V21, P3433, DOI 10.1093/bioinformatics/bti541; Dosztanyi Z, 2010, BRIEF BIOINFORM, V11, P225, DOI 10.1093/bib/bbp061; Dunker A K, 2000, Genome Inform Ser Workshop Genome Inform, V11, P161; Dunker AK, 2001, J MOL GRAPH MODEL, V19, P26, DOI 10.1016/S1093-3263(00)00138-8; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; Dyson HJ, 2002, CURR OPIN STRUC BIOL, V12, P54, DOI 10.1016/S0959-440X(02)00289-0; Elbaz Y, 2011, TRENDS BIOCHEM SCI, V36, P616, DOI 10.1016/j.tibs.2011.08.004; Galea CA, 2008, BIOCHEMISTRY-US, V47, P7598, DOI 10.1021/bi8006803; Garner, 1998, Genome Inform Ser Workshop Genome Inform, V9, P201; GIETZ RD, 1995, YEAST, V11, P355, DOI 10.1002/yea.320110408; Gilkerson RW, 2008, J CELL BIOL, V181, P1117, DOI 10.1083/jcb.200712101; Gray MW, 1999, SCIENCE, V283, P1476, DOI 10.1126/science.283.5407.1476; He B, 2009, CELL RES, V19, P929, DOI 10.1038/cr.2009.87; Hegyi H, 2007, BMC STRUCT BIOL, V7, DOI 10.1186/1472-6807-7-65; Hobbs AEA, 2001, J CELL BIOL, V152, P401, DOI 10.1083/jcb.152.2.401; Ito M, 2012, GENES CELLS; Itoh K, 2011, MITOCHONDRION, V11, P575, DOI 10.1016/j.mito.2011.03.002; Kaufman BA, 2000, P NATL ACAD SCI USA, V97, P7772, DOI 10.1073/pnas.140063197; Kucej M, 2007, TRENDS CELL BIOL, V17, P586, DOI 10.1016/j.tcb.2007.08.007; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Mbantenkhu M, 2011, J BIOL CHEM, V286, P42360, DOI 10.1074/jbc.M111.307512; Meeusen S, 1999, J CELL BIOL, V145, P291, DOI 10.1083/jcb.145.2.291; Meeusen S, 2003, J CELL BIOL, V163, P503, DOI 10.1083/jcb.200304040; Miyakawa I, 2009, MICROBIOL-SGM, V155, P1558, DOI 10.1099/mic.0.027474-0; Moya A, 2012, MOL ECOL, V21, P2440, DOI 10.1111/j.1365-294X.2012.05554.x; Nardozzi JD, 2012, J BIOL CHEM, V287, P37259, DOI 10.1074/jbc.M112.389965; Okamoto K, 1998, J CELL BIOL, V142, P613, DOI 10.1083/jcb.142.3.613; Peng K, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-208; Schlessinger A, 2011, CURR OPIN STRUC BIOL, V21, P412, DOI 10.1016/j.sbi.2011.03.014; Tillett D, 1999, NUCLEIC ACIDS RES, V27, DOI 10.1093/nar/27.19.e26; Tompa P, 2002, TRENDS BIOCHEM SCI, V27, P527, DOI 10.1016/S0968-0004(02)02169-2; Ward JJ, 2004, BIOINFORMATICS, V20, P2138, DOI 10.1093/bioinformatics/bth195; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Wright PE, 1999, J MOL BIOL, V293, P321, DOI 10.1006/jmbi.1999.3110; Zuo X, 2001, CHARACTERISATION SAC; Zuo XM, 2007, FEMS YEAST RES, V7, P131, DOI 10.1111/j.1567-1364.2006.00141.x; Zuo XM, 2002, GENETICS, V160, P1389	46	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e56465	10.1371/journal.pone.0056465	http://dx.doi.org/10.1371/journal.pone.0056465			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418572	Green Published, gold, Green Accepted, Green Submitted			2022-12-25	WOS:000315970300165
J	Kim, JH; Choi, KH; Jang, YJ; Bae, SS; Shin, BC; Choi, BT; Shin, HK				Kim, Ji Hyun; Choi, Kyung Ha; Jang, Young Jung; Bae, Sun Sik; Shin, Byung-Cheul; Choi, Byung Tae; Shin, Hwa Kyoung			Electroacupuncture Acutely Improves Cerebral Blood Flow and Attenuates Moderate Ischemic Injury via an Endothelial Mechanism in Mice	PLOS ONE			English	Article							NITRIC-OXIDE; STROKE PATIENTS; FUNCTIONAL RECOVERY; ARTERY OCCLUSION; BRAIN-INJURY; ACUPUNCTURE; STIMULATION; ARTERIOLES; EXPRESSION; RECEPTORS	Electroacupuncture (EA) is a novel therapy based on traditional acupuncture combined with modern eletrotherapy that is currently being investigated as a treatment for acute ischemic stroke. Here, we studied whether acute EA stimulation improves tissue and functional outcome following experimentally induced cerebral ischemia in mice. We hypothesized that endothelial nitric oxide synthase (eNOS)-mediated perfusion augmentation was related to the beneficial effects of EA by interventions in acute ischemic injury. EA stimulation at Baihui (GV20) and Dazhui (GV14) increased cerebral perfusion in the cerebral cortex, which was suppressed in eNOS KO, but there was no mean arterial blood pressure (MABP) response. The increased perfusion elicited by EA were completely abolished by a muscarinic acetylcholine receptor (mAChR) blocker (atropine), but not a beta-adrenergic receptor blocker (propranolol), an a-adrenergic receptor blocker (phentolamine), or a nicotinic acetylcholine receptor (nAChR) blocker (mecamylamine). In addition, EA increased acetylcholine (ACh) release and mAChR M3 expression in the cerebral cortex. Acute EA stimulation after occlusion significantly reduced infarct volume by 34.5% when compared to a control group of mice at 24 h after 60 min-middle cerebral artery occlusion (MCAO) (moderate ischemic injury), but not 90-min MCAO (severe ischemic injury). Furthermore, the impact of EA on moderate ischemic injury was totally abolished in eNOS KO. Consistent with a smaller infarct size, acute EA stimulation led to prominent improvement of neurological function and vestibule-motor function. Our results suggest that acute EA stimulation after moderate focal cerebral ischemia, but not severe ischemia improves tissue and functional recovery and ACh/eNOS-mediated perfusion augmentation might be related to these beneficial effects of EA by interventions in acute ischemic injury.	[Kim, Ji Hyun; Choi, Kyung Ha; Jang, Young Jung; Choi, Byung Tae; Shin, Hwa Kyoung] Pusan Natl Univ, Sch Korean Med, Div Meridian & Struct Med, Yangsan, Gyeongnam, South Korea; [Bae, Sun Sik] Pusan Natl Univ, Sch Med, Dept Pharmacol, Yangsan, Gyeongnam, South Korea; [Shin, Byung-Cheul] Pusan Natl Univ, Sch Korean Med, Div Clin Med, Yangsan, Gyeongnam, South Korea	Pusan National University; Pusan National University; Pusan National University Hospital; Pusan National University	Choi, BT (corresponding author), Pusan Natl Univ, Sch Korean Med, Div Meridian & Struct Med, Yangsan, Gyeongnam, South Korea.	choibt@pusan.ac.kr; julie@pusan.ac.kr			National Research Foundation of Korea (NRF); Ministry of Education, Science and Technology [2010-0007470]	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This research was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (2010-0007470). The funders had no role in study design, data collection and analysis.	Chen T, 2011, BRAIN RES BULL, V84, P163, DOI 10.1016/j.brainresbull.2010.11.015; Cummings M, 2001, Acupunct Med, V19, P64; DACEY RG, 1987, AM J PHYSIOL, V253, pH1253, DOI 10.1152/ajpheart.1987.253.5.H1253; DAUPHIN F, 1995, PHARMACOL THERAPEUT, V67, P385, DOI 10.1016/0163-7258(95)00022-4; DAUPHIN F, 1990, EUR J PHARMACOL, V178, P203, DOI 10.1016/0014-2999(90)90476-M; Dong H, 2009, NEUROL RES, V31, P853, DOI 10.1179/174313209X393960; Du YH, 2011, NEUROL RES, V33, P101, DOI 10.1179/016164110X12714125204317; Elhusseiny A, 2000, J CEREBR BLOOD F MET, V20, P298, DOI 10.1097/00004647-200002000-00011; Elhusseiny A, 1999, J CEREBR BLOOD F MET, V19, P794, DOI 10.1097/00004647-199907000-00010; ESTRADA C, 1983, BRAIN RES, V266, P261, DOI 10.1016/0006-8993(83)90657-1; FARACI FM, 1994, STROKE, V25, P692, DOI 10.1161/01.STR.25.3.692; Gao HM, 2002, ACUPUNCTURE ELECTRO, V27, P45, DOI 10.3727/036012902816026112; Gao HM, 2006, ACUPUNCTURE ELECTRO, V31, P259, DOI 10.3727/036012906815844247; Hamel E, 2004, PROG BRAIN RES, V145, P171, DOI 10.1016/S0079-6123(02)45012-7; Han XH, 2010, BRAIN INJURY, V24, P773, DOI 10.3109/02699051003610482; Hartig W, 2002, REV NEUROSCIENCE, V13, P95; Hopwood V, 2005, J ALTERN COMPLEM MED, V11, P175, DOI 10.1089/acm.2005.11.175; Huang Y, 2007, INT J NEUROSCI, V117, P1029, DOI 10.1080/00207450600936825; Huang ZH, 1996, J CEREBR BLOOD F MET, V16, P981, DOI 10.1097/00004647-199609000-00023; HUANG ZH, 1994, SCIENCE, V265, P1883, DOI 10.1126/science.7522345; KALARIA RN, 1994, J AUTONOM NERV SYST, V49, pS3; Kang KA, 2010, NEUROL RES, V32, pS84, DOI 10.1179/016164109X12537002794246; Kim DD, 2006, MICROCIRCULATION, V13, P577, DOI 10.1080/10739680600885210; Lee JD, 2003, NEURORADIOLOGY, V45, P780, DOI 10.1007/s00234-003-1080-3; Li XL, 2004, EXP NEUROL, V187, P94, DOI 10.1016/j.expneurol.2004.01.004; Limbourg FP, 2002, J CLIN INVEST, V110, P1729, DOI 10.1172/JCI200215481; Liu Ruihua, 2005, J Tradit Chin Med, V25, P190; Liu SY, 2009, AM J CHINESE MED, V37, P483, DOI 10.1142/S0192415X09006990; Liu Y, 2010, NEUROSCI LETT, V485, P74, DOI 10.1016/j.neulet.2010.08.068; NAESER MA, 1994, ACUPUNCTURE ELECTRO, V19, P227, DOI 10.3727/036012994816357231; Ren L, 2008, NEUROL RES, V30, P985, DOI 10.1179/174313208X325182; SAGHER O, 1993, J CEREBR BLOOD F MET, V13, P676, DOI 10.1038/jcbfm.1993.86; SATO A, 1995, ALZ DIS ASSOC DIS, V9, P28, DOI 10.1097/00002093-199505000-00007; Shiflett SC, 2007, TOP STROKE REHABIL, V14, P40, DOI 10.1310/tsr1404-40; SHIMIZU T, 1993, AM J PHYSIOL, V264, pH665, DOI 10.1152/ajpheart.1993.264.3.H665; Si QM, 1998, ACUPUNCTURE ELECTRO, V23, P117, DOI 10.3727/036012998816356562; Siu FKW, 2004, NEUROSCI LETT, V354, P158, DOI 10.1016/j.neulet.2003.10.009; Sun N, 2005, BRAIN RES, V1064, P98, DOI 10.1016/j.brainres.2005.09.060; Tao J, 2010, NEUROL RES, V32, P198, DOI 10.1179/174313209X414506; Tsuchiya M, 2007, ANESTH ANALG, V104, P301, DOI 10.1213/01.ane.0000230622.16367.fb; Uchida S, 2000, JPN J PHYSIOL, V50, P495, DOI 10.2170/jjphysiol.50.495; Wang QA, 2011, STROKE, V42, P389, DOI 10.1161/STROKEAHA.110.597336; Wang Q, 2009, STROKE, V40, P2157, DOI 10.1161/STROKEAHA.108.541490; Wang SJ, 2002, NEUROSCI LETT, V331, P115, DOI 10.1016/S0304-3940(02)00866-2; Yin CS, 2008, RES VET SCI, V84, P159, DOI 10.1016/j.rvsc.2007.04.004; Zhong SB, 2009, EVID-BASED COMPL ALT, V6, P51, DOI 10.1093/ecam/nem062; Zhou F, 2011, J APPL PHYSIOL, V111, P1877, DOI 10.1152/japplphysiol.00313.2011	47	52	56	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e56736	10.1371/journal.pone.0056736	http://dx.doi.org/10.1371/journal.pone.0056736			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418594	Green Published, Green Submitted, gold			2022-12-25	WOS:000315970300187
J	Xi, B; Cheng, H; Shen, Y; Chandak, GR; Zhao, XY; Hou, DQ; Wu, LJ; Wang, XY; Mi, J				Xi, Bo; Cheng, Hong; Shen, Yue; Chandak, Giriraj R.; Zhao, Xiaoyuan; Hou, Dongqing; Wu, Lijun; Wang, Xingyu; Mi, Jie			Study of 11 BMI-Associated Loci Identified in GWAS for Associations with Central Obesity in the Chinese Children	PLOS ONE			English	Article							BODY-MASS INDEX; GENOME-WIDE ASSOCIATION; WAIST CIRCUMFERENCE; ABDOMINAL OBESITY; COMMON VARIANTS; FTO GENE; RISK-FACTORS; FAT MASS; ADOLESCENTS; POLYMORPHISMS	Objective: Recent genome-wide association studies have identified many single nucleotide polymorphisms (SNPs) associated with body mass index (BMI)/generalized obesity. In this study, we aimed to examine the associations of identified SNPs with risk of central obesity in a child population from China. Methods: We genotyped 11 SNPs (FTO rs9939609, MC4R rs17782313, GNPDA2 rs10938397, BDNF rs6265, FAIM2 rs7138803, NPC1 rs1805081, SEC16B rs10913469, SH2B1 rs4788102, PCSK1rs6235, KCTD15 rs29941, BAT2 rs2844479) in the Chinese children (N = 3502, age range 6-18 years) from the Beijing Child and Adolescent Metabolic Syndrome (BCAMS). Based on the age- and sex- specific waist circumference (WC) standards generated in the BCAMS study, 1196 central obese cases and 2306 controls were identified. Results: Of 11 studied SNPs, four SNPs and genetic risk score (GRS) based on them were statistically significantly associated with central obesity by WC criteria (FTO rs9939609: OR = 1.29, 95%CI = 1.10-1.50, p = 0.001; MC4R rs17782313: OR = 1.27, 95%CI = 1.12-1.44, p = 1.32 x 10(-4); GNPDA2 rs10938397: OR = 1.22, 95%CI = 1.09-1.37, p = 4.09 x 10(-4); BDNF rs6265: OR = 1.20, 95%CI = 1.08-1.34, p = 8.86 x 10(-4); GRS: OR = 1.25, 95% CI 1.16-1.34, p = 2.58 x 10(-9)) after adjustment for sex, age, pubertal stage, physical activity and family history of obesity. Similar observations were made using weight-to-height ratio (WHtR) criterion. However, other SNPs were not associated with central obesity by WC as well as WHtR criterion. Conclusions: Our study replicates the statistically significant association of four SNPs (FTO rs9939609, MC4R rs17782313, GNPDA2 rs10938397, BDNF rs6265) with risk of central obesity in the Chinese children.	[Xi, Bo] Shandong Univ, Sch Publ Hlth, Dept Maternal & Child Hlth Care, Jinan 250100, Peoples R China; [Xi, Bo; Cheng, Hong; Shen, Yue; Zhao, Xiaoyuan; Hou, Dongqing; Wu, Lijun; Mi, Jie] Capital Inst Pediat, Dept Epidemiol, Beijing, Peoples R China; [Chandak, Giriraj R.] CSIR, Ctr Cellular & Mol Biol, Hyderabad, Andhra Pradesh, India; [Wang, Xingyu] Beijing Hypertens League Inst, Lab Human Genet, Beijing, Peoples R China	Shandong University; Capital Institute of Pediatrics (CIP); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Centre for Cellular & Molecular Biology (CCMB); Chinese Hypertension League	Mi, J (corresponding author), Capital Inst Pediat, Dept Epidemiol, Beijing, Peoples R China.	jiemi@vip.163.com		Chandak, Giriraj Ratan/0000-0002-3095-9453	National Natural Science Foundation of China [81172746]; Beijing Municipal Science & Technology Commission [D111100000611002]; National 'Twelfth Five-Year' Plan for Science & Technology Support Program [2012BAI03B03]; Beijing Health System Leading Talent Fund [2009-1-08]; Foundation for Outstanding Young Scientist in Shandong Province [BS2011YY026]; The Research Fund for the Doctoral Program of Higher Education of China [20120131120004]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Municipal Science & Technology Commission(Beijing Municipal Science & Technology Commission); National 'Twelfth Five-Year' Plan for Science & Technology Support Program; Beijing Health System Leading Talent Fund; Foundation for Outstanding Young Scientist in Shandong Province; The Research Fund for the Doctoral Program of Higher Education of China(Research Fund for the Doctoral Program of Higher Education of China (RFDP))	This study was supported by grants from the National Natural Science Foundation of China (81172746), the Beijing Municipal Science & Technology Commission (D111100000611002), the National 'Twelfth Five-Year' Plan for Science & Technology Support Program (2012BAI03B03), the Beijing Health System Leading Talent Fund (2009-1-08), and the Foundation for Outstanding Young Scientist in Shandong Province (BS2011YY026). The Research Fund for the Doctoral Program of Higher Education of China (20120131120004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benzinou M, 2008, NAT GENET, V40, P943, DOI 10.1038/ng.177; Bigaard J, 2005, INT J OBESITY, V29, P778, DOI 10.1038/sj.ijo.0802976; Bradfield JP, 2012, NAT GENET, V44, P526, DOI 10.1038/ng.2247; Cecil JE, 2008, NEW ENGL J MED, V359, P2558, DOI 10.1056/NEJMoa0803839; Chen F, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0031645, 10.1371/journal.pone.0039197]; Cheung CYY, 2011, EUR J ENDOCRINOL, V164, P381, DOI 10.1530/EJE-10-0902; FerroLuzzi A, 1995, WHO TECH REP SER, V854, P1; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Freedman DS, 2009, AM J CLIN NUTR, V90, P210, DOI 10.3945/ajcn.2009.27525; Heid CA, 1996, GENOME RES, V6, P986, DOI 10.1101/gr.6.10.986; Janssen I, 2004, AM J CLIN NUTR, V79, P379; Janssen I, 2011, OBES REV, V12, P397, DOI 10.1111/j.1467-789X.2010.00815.x; Li H, 2012, DIABETOLOGIA, V55, P981, DOI 10.1007/s00125-011-2370-7; Liang YJ, 2012, PEDIATR OBES, V7, P355, DOI 10.1111/j.2047-6310.2012.00066.x; Loos RJF, 2008, NAT GENET, V40, P768, DOI 10.1038/ng.140; McCarthy HD, 2006, INT J OBESITY, V30, P988, DOI 10.1038/sj.ijo.0803226; Meng LH., 2008, CHIN J EVID BASED PE, V3, P324; Meyre D, 2009, NAT GENET, V41, P157, DOI 10.1038/ng.301; Okada Y, 2012, NAT GENET, V44, P302, DOI 10.1038/ng.1086; Peng SH, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-71; Razquin C, 2011, MOL NUTR FOOD RES, V55, P136, DOI 10.1002/mnfr.201000445; SERDULA MK, 1993, PREV MED, V22, P167, DOI 10.1006/pmed.1993.1014; Shan XY, 2010, INT J PEDIATR OBES, V5, P383, DOI 10.3109/17477160903572001; Speliotes EK, 2010, NAT GENET, V42, P937, DOI 10.1038/ng.686; Tanaka M, 2012, J ATHEROSCLER THROMB, V19, P633, DOI 10.5551/jat.11940; Thorleifsson G, 2009, NAT GENET, V41, P18, DOI 10.1038/ng.274; Wen WQ, 2012, NAT GENET, V44, P307, DOI 10.1038/ng.1087; Willer CJ, 2009, NAT GENET, V41, P25, DOI 10.1038/ng.287; Wu LJ, 2010, DIABETES, V59, P3085, DOI 10.2337/db10-0273; Xi B, 2012, OBES REV, V13, P287, DOI 10.1111/j.1467-789X.2011.00944.x; Xi B, 2013, CLIN ENDOCRINOL, V79, P523, DOI 10.1111/cen.12091; Xi B, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-107; Xi B, 2009, BIOMED ENVIRON SCI, V22, P449, DOI 10.1016/S0895-3988(10)60001-3	33	38	41	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2013	8	2							e56472	10.1371/journal.pone.0056472	http://dx.doi.org/10.1371/journal.pone.0056472			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104BU	23424664	Green Published, gold, Green Submitted			2022-12-25	WOS:000315965100052
J	Finger, EC; Cheng, CF; Williams, TR; Rankin, EB; Bedogni, B; Tachiki, L; Spong, S; Giaccia, AJ; Powell, MB				Finger, E. C.; Cheng, C-F; Williams, T. R.; Rankin, E. B.; Bedogni, B.; Tachiki, L.; Spong, S.; Giaccia, A. J.; Powell, M. B.			CTGF is a therapeutic target for metastatic melanoma	ONCOGENE			English	Article						connective tissue growth factor (CTGF); melanoma; invasion; metastasis; therapeutic target; hypoxia	TISSUE GROWTH-FACTOR; PANCREATIC TUMOR-GROWTH; GENE-EXPRESSION; MALIGNANT-MELANOMA; HYPOXIC INDUCTION; CANCER; PROGRESSION; PROTEINS; ANGIOGENESIS; MECHANISMS	Metastatic melanoma remains a devastating disease with a 5-year survival rate of less than five percent. Despite recent advances in targeted therapies for melanoma, only a small percentage of melanoma patients experience durable remissions. Therefore, it is critical to identify new therapies for the treatment of advanced melanoma. Here, we define connective tissue growth factor (CTGF) as a therapeutic target for metastatic melanoma. Clinically, CTGF expression correlates with tumor progression and is strongly induced by hypoxia through HIF-1 and HIF-2-dependent mechanisms. Genetic inhibition of CTGF in human melanoma cells is sufficient to significantly reduce orthotopic tumor growth, as well as metastatic tumor growth in the lung of severe combined immunodeficient (SCID) mice. Mechanistically, inhibition of CTGF decreased invasion and migration associated with reduced matrix metalloproteinase-9 expression. Most importantly, the anti-CTGF antibody, FG-3019, had a profound inhibitory effect on the progression of established metastatic melanoma. These results offer the first preclinical validation of anti-CTGF therapy for the treatment of advanced melanoma and underscore the importance of tumor hypoxia in melanoma progression.	[Finger, E. C.; Cheng, C-F; Williams, T. R.; Rankin, E. B.; Tachiki, L.; Giaccia, A. J.; Powell, M. B.] Stanford Univ, Div Radiat & Canc Biol, Dept Radiat Oncol, Stanford, CA 94305 USA; [Bedogni, B.] Case Western Reserve Univ, Sch Med, Dept Biochem, Cleveland, OH 44106 USA; [Spong, S.] FibroGen Inc, San Francisco, CA USA	Stanford University; Case Western Reserve University; FibroGen	Powell, MB (corresponding author), Stanford Univ, Div Radiat & Canc Biol, Dept Radiat Oncol, 269 Campus Dr,CCSR-S-1250, Stanford, CA 94305 USA.	mbp@stanford.edu		Rankin, Erinn/0000-0002-2045-2296	NIH [CA67166, CA116685, CA120526, T32 CA121940, T32 CA09302]; NATIONAL CANCER INSTITUTE [R01CA120526, R01CA116685, T32CA121940, T32CA009302, P01CA067166] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank members of the Giaccia Laboratory for their insightful discussions. We kindly thank Dr Boris C Bastian for discussions and review of our tissue array analysis methodology and Dr Adam J Krieg for his insights on the microarray analysis. We appreciate Kathy Brown's guiding hand with the low passage melanoma cell lines. This investigation was supported by NIH grants CA67166 and CA116685 (AJG), CA120526 (MBP), T32 CA121940 (ECF) and T32 CA09302 (TRW).	Aguissa-Toure AH, 2012, CELL MOL LIFE SCI, V69, P1475, DOI 10.1007/s00018-011-0878-0; Bedogni B, 2008, J CLIN INVEST, V118, P3660, DOI 10.1172/JCI36157; Bedogni B, 2009, PIGM CELL MELANOMA R, V22, P166, DOI 10.1111/j.1755-148X.2009.00553.x; Bennewith KL, 2009, CANCER RES, V69, P775, DOI 10.1158/0008-5472.CAN-08-0987; Bindra RS, 2005, ANN NY ACAD SCI, V1059, P184, DOI 10.1196/annals.1339.049; BORK P, 1993, FEBS LETT, V327, P125, DOI 10.1016/0014-5793(93)80155-N; Braig S, 2011, BRIT J CANCER, V105, P231, DOI 10.1038/bjc.2011.226; Chan DA, 2007, CANCER METAST REV, V26, P333, DOI 10.1007/s10555-007-9063-1; Chan DA, 2009, CANCER CELL, V15, P527, DOI 10.1016/j.ccr.2009.04.010; Chen PP, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000534; Chu CY, 2008, J BIOMED SCI, V15, P675, DOI 10.1007/s11373-008-9264-9; Chujo S, 2009, J CELL PHYSIOL, V220, P189, DOI 10.1002/jcp.21750; Cicha I, 2009, BIOFACTORS, V35, P200, DOI 10.1002/biof.30; Dahl C, 2007, APMIS, V115, P1161, DOI 10.1111/j.1600-0463.2007.apm_855.xml.x; Dhar A., 2010, Experimental Oncology, V32, P2; Dornhofer N, 2006, CANCER RES, V66, P5816, DOI 10.1158/0008-5472.CAN-06-0081; Finger EC, 2010, CANCER METAST REV, V29, P285, DOI 10.1007/s10555-010-9224-5; Flaherty KT, 2012, NEW ENGL J MED, V367, P1694, DOI 10.1056/NEJMoa1210093; Hall-Glenn F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030562; Haluska FG, 2006, CLIN CANCER RES, V12, p2301S, DOI 10.1158/1078-0432.CCR-05-2518; Hanahan D, 1996, CELL, V86, P353, DOI 10.1016/S0092-8674(00)80108-7; Higgins DF, 2004, AM J PHYSIOL-RENAL, V287, pF1223, DOI 10.1152/ajprenal.00245.2004; Hubble J, 2009, NUCLEIC ACIDS RES, V37, pD898, DOI 10.1093/nar/gkn786; Koliopanos A, 2002, WORLD J SURG, V26, P420, DOI 10.1007/s00268-001-0242-x; Kondo S, 2002, CARCINOGENESIS, V23, P769, DOI 10.1093/carcin/23.5.769; Lartigau E, 1997, MELANOMA RES, V7, P400, DOI 10.1097/00008390-199710000-00006; Liu LY, 2008, WORLD J GASTROENTERO, V14, P2110, DOI 10.3748/wjg.14.2110; Mole DR, 2009, J BIOL CHEM, V284, P16767, DOI 10.1074/jbc.M901790200; Norman JT, 2000, KIDNEY INT, V58, P2351, DOI 10.1046/j.1523-1755.2000.00419.x; PATEL B, 1994, BIOCHEM MOL BIOL INT, V34, P639; Payne SL, 2007, J CELL BIOCHEM, V101, P1338, DOI 10.1002/jcb.21371; Perbal B, 2004, LANCET, V363, P62, DOI 10.1016/S0140-6736(03)15172-0; Rankin EB, 2008, CELL DEATH DIFFER, V15, P678, DOI 10.1038/cdd.2008.21; Riker AI, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-13; Sala-Torra O, 2007, BLOOD, V109, P3080, DOI 10.1182/blood-2006-06-031096; Samarin J, 2010, J BIOL CHEM, V285, P4328, DOI 10.1074/jbc.M109.049650; Shakunaga T, 2000, CANCER, V89, P1466, DOI 10.1002/1097-0142(20001001)89:7<1466::AID-CNCR8>3.0.CO;2-G; SHWEIKI D, 1992, NATURE, V359, P843, DOI 10.1038/359843a0; Turcotte S, 2008, CANCER CELL, V14, P90, DOI 10.1016/j.ccr.2008.06.004; Wilson TR, 2012, NATURE, V487, P505, DOI 10.1038/nature11249; Xie D, 2004, CLIN CANCER RES, V10, P2072, DOI 10.1158/1078-0432.CCR-0659-03; Zhang B, 2010, DIABETES, V59, P1809, DOI 10.2337/db09-1056; Zhang H, 2003, BLOOD, V101, P2253, DOI 10.1182/blood-2002-02-0629	43	52	58	2	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 27	2014	33	9					1093	1100		10.1038/onc.2013.47	http://dx.doi.org/10.1038/onc.2013.47			8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AB6XT	23435419	Green Accepted			2022-12-25	WOS:000331933800003
J	Walters, ZS; Villarejo-Balcells, B; Olmos, D; Buist, TWS; Missiaglia, E; Allen, R; Al-Lazikani, B; Garrett, MD; Blagg, J; Shipley, J				Walters, Z. S.; Villarejo-Balcells, B.; Olmos, D.; Buist, T. W. S.; Missiaglia, E.; Allen, R.; Al-Lazikani, B.; Garrett, M. D.; Blagg, J.; Shipley, J.			JARID2 is a direct target of the PAX3-FOXO1 fusion protein and inhibits myogenic differentiation of rhabdomyosarcoma cells	ONCOGENE			English	Article						rhabdomyosarcoma; PAX3-FOXO1; histone methylation; polycomb repressive complex 2; JARID2; myogenic differentiation	CHILDRENS ONCOLOGY GROUP; HIGH-RISK NEUROBLASTOMA; REPRESSIVE COMPLEX 2; MUSCLE STEM-CELLS; ALVEOLAR RHABDOMYOSARCOMA; GENE-EXPRESSION; HISTONE DEMETHYLASES; 13-CIS-RETINOIC ACID; TRANSCRIPTION FACTOR; CARDIAC DEVELOPMENT	Rhabdomyosarcomas (RMS) are the most frequent soft-tissue sarcoma in children and characteristically show features of developing skeletal muscle. The alveolar subtype is frequently associated with a PAX3-FOXO1 fusion protein that is known to contribute to the undifferentiated myogenic phenotype of RMS cells. Histone methylation of lysine residues controls developmental processes in both normal and malignant cell contexts. Here we show that JARID2, which encodes a protein known to recruit various complexes with histone-methylating activity to their target genes, is significantly overexpressed in RMS with PAX3-FOXO1 compared with the fusion gene-negative RMS (t-test; P<0.0001). Multivariate analyses showed that higher JARID2 levels are also associated with metastases at diagnosis, independent of fusion gene status and RMS subtype (n = 120; P = 0.039). JARID2 levels were altered by silencing or overexpressing PAX3-FOXO1 in RMS cell lines with and without the fusion gene, respectively. Consistent with this, we demonstrated that JARID2 is a direct transcriptional target of the PAX3-FOXO1 fusion protein. Silencing JARID2 resulted in reduced cell proliferation coupled with myogenic differentiation, including increased expression of Myogenin (MYOG) and Myosin Light Chain (MYL1) in RMS cell lines representative of both the alveolar and embryonal subtypes. Induced myogenic differentiation was associated with a decrease in JARID2 levels and this phenotype could be rescued by overexpressing JARID2. Furthermore, we that showed JARID2 binds to and alters the methylation status of histone H3 lysine 27 in the promoter regions of MYOG and MYL1 and that the interaction of JARID2 at these promoters is dependent on EED, a core component of the polycomb repressive complex 2 (PRC2). Therefore, JARID2 is a downstream effector of PAX3-FOXO1 that maintains an undifferentiated myogenic phenotype that is characteristic of RMS. JARID2 and other components of PRC2 may represent novel therapeutic targets for treating RMS patients.	[Walters, Z. S.; Villarejo-Balcells, B.; Olmos, D.; Buist, T. W. S.; Missiaglia, E.; Allen, R.; Shipley, J.] Inst Canc Res, Div Mol Pathol, Sarcoma Mol Pathol Team, London SM2 5NG, England; [Walters, Z. S.; Villarejo-Balcells, B.; Olmos, D.; Buist, T. W. S.; Missiaglia, E.; Allen, R.; Shipley, J.] Inst Canc Res, Div Canc Therapeut, Sarcoma Mol Pathol Team, London SM2 5NG, England; [Olmos, D.] Royal Marsden Hosp NHS Trust, Sarcoma Unit, London, England; [Buist, T. W. S.; Al-Lazikani, B.; Blagg, J.] Inst Canc Res, Div Canc Therapeut, Canc Res UK Canc Therapeut Unit, London SM2 5NG, England; [Missiaglia, E.] Univ Lausanne, Swiss Inst Bioinformat, Bioinformat Core Facil, Lausanne, Switzerland; [Garrett, M. D.] Inst Canc Res, Div Canc Therapeut, Canc Res UK Canc Therapeut Unit, Cell Cycle Control Team, London SM2 5NG, England	Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; Royal Marsden NHS Foundation Trust; Cancer Research UK; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; Swiss Institute of Bioinformatics; University of Lausanne; Cancer Research UK; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK	Shipley, J (corresponding author), Inst Canc Res, Div Mol Pathol, Sarcoma Mol Pathol Team, London SM2 5NG, England.	janet.shipley@icr.ac.uk	Al-Lazikani, Bissan/AFK-6457-2022; Al-Lazikani, Bissan/AAG-4723-2022; Olmos, David/L-5664-2015	Al-Lazikani, Bissan/0000-0003-3367-2519; missiaglia, edoardo/0000-0001-9221-0117; Shipley, Janet/0000-0001-6748-8678; Olmos Hidalgo, David/0000-0002-7003-4826; Walters, Zoe/0000-0002-1835-5868	Cancer Research UK [C5066/A10399]; Sarcoma UK; Chris Lucas Trust; Rob's ARTTT Charity; Medical Research Council; Spanish Society of Medical Oncology (SEOM) Translational Research Fellowship; NHS; Cancer Research UK [11566] Funding Source: researchfish; Sarcoma UK [SUK01.2009] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); Sarcoma UK; Chris Lucas Trust; Rob's ARTTT Charity; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Spanish Society of Medical Oncology (SEOM) Translational Research Fellowship; NHS; Cancer Research UK(Cancer Research UK); Sarcoma UK	We are very grateful for help and support with tumor collection and annotation from the Children's Cancer and Leukemia Group. We also thank David Landeira for help with the JARID2 antibody. This work was supported by grants from Cancer Research UK (C5066/A10399); Sarcoma UK; the Chris Lucas Trust; Rob's ARTTT Charity; the Medical Research Council for a studentship (TWSB); the Spanish Society of Medical Oncology (SEOM) Translational Research Fellowship (DO). We acknowledge NHS funding to the NIHR Biomedical Research Center.	AGUANNO S, 1990, CANCER RES, V50, P3377; Asp P, 2011, P NATL ACAD SCI USA, V108, pE149, DOI 10.1073/pnas.1102223108; Barlow JW, 2006, PEDIATR BLOOD CANCER, V47, P773, DOI 10.1002/pbc.20650; Bennicelli JL, 1996, P NATL ACAD SCI USA, V93, P5455, DOI 10.1073/pnas.93.11.5455; Calhabeu F, 2013, ONCOGENE, V32, P651, DOI 10.1038/onc.2012.73; Cao LA, 2010, CANCER RES, V70, P6497, DOI 10.1158/0008-5472.CAN-10-0582; Chang CJ, 2012, BRIT J CANCER, V106, P243, DOI 10.1038/bjc.2011.551; Charytonowicz E, 2009, CANCER LETT, V279, P126, DOI 10.1016/j.canlet.2008.09.039; Ciarapica R, 2009, CELL CYCLE, V8, P172, DOI 10.4161/cc.8.1.7292; Cloos PAC, 2008, GENE DEV, V22, P1115, DOI 10.1101/gad.1652908; Davicioni E, 2006, CANCER RES, V66, P6936, DOI 10.1158/0008-5472.CAN-05-4578; Davicioni E, 2009, AM J PATHOL, V174, P550, DOI 10.2353/ajpath.2009.080631; Epstein JA, 1998, MOL CELL BIOL, V18, P4118, DOI 10.1128/MCB.18.7.4118; FREDERICKS WJ, 1995, MOL CELL BIOL, V15, P1522; Grimwade D, 2010, CANCER TREAT RES, V145, P219, DOI 10.1007/978-0-387-69259-3_13; Juan AH, 2011, GENE DEV, V25, P789, DOI 10.1101/gad.2027911; Jung J, 2005, J BIOL CHEM, V280, P30916, DOI 10.1074/jbc.M414482200; Kikuchi K, 2008, BIOCHEM BIOPH RES CO, V365, P568, DOI 10.1016/j.bbrc.2007.11.017; Kim T, 2004, MOL CELL BIOL, V24, P10151, DOI 10.1128/MCB.24.23.10151-10160.2004; Kim TG, 2003, J BIOL CHEM, V278, P42247, DOI 10.1074/jbc.M307386200; Klose RJ, 2006, NAT REV GENET, V7, P715, DOI 10.1038/nrg1945; Landeira D, 2010, NAT CELL BIOL, V12, P618, DOI 10.1038/ncb2065; Lee MH, 2011, CANCER RES, V71, P3921, DOI 10.1158/0008-5472.CAN-10-3358; Li G, 2010, GENE DEV, V24, P368, DOI 10.1101/gad.1886410; Linardic CM, 2008, CANCER LETT, V270, P10, DOI 10.1016/j.canlet.2008.03.035; LOLLINI PL, 1991, INVAS METAST, V11, P116; Lu PJ, 1999, J BIOL CHEM, V274, P15633, DOI 10.1074/jbc.274.22.15633; Luo XL, 2011, J AM CHEM SOC, V133, P9451, DOI 10.1021/ja201597b; Matthay KK, 2009, J CLIN ONCOL, V27, P1007, DOI 10.1200/JCO.2007.13.8925; Merlino G, 1999, ONCOGENE, V18, P5340, DOI 10.1038/sj.onc.1203038; Missiaglia E, 2012, J CLIN ONCOL, V30, P1670, DOI 10.1200/JCO.2011.38.5591; Palacios D, 2010, MOL CELL BIOL, V30, P3805, DOI 10.1128/MCB.00050-10; Pasini D, 2010, NATURE, V464, P306, DOI 10.1038/nature08788; Peng JC, 2009, CELL, V139, P1290, DOI 10.1016/j.cell.2009.12.002; Richter GHS, 2009, P NATL ACAD SCI USA, V106, P5324, DOI 10.1073/pnas.0810759106; Schildhaus HU, 2011, HUM PATHOL, V42, P1667, DOI 10.1016/j.humpath.2010.12.025; Schulte JH, 2009, CANCER RES, V69, P2065, DOI 10.1158/0008-5472.CAN-08-1735; Shen XH, 2009, CELL, V139, P1303, DOI 10.1016/j.cell.2009.12.003; Shen XH, 2008, MOL CELL, V32, P491, DOI 10.1016/j.molcel.2008.10.016; Sorensen PHB, 2002, J CLIN ONCOL, V20, P2672, DOI 10.1200/JCO.2002.03.137; Stojic L, 2011, EPIGENET CHROMATIN, V4, DOI 10.1186/1756-8935-4-16; Takeuchi T, 1999, MECH DEVELOP, V86, P29, DOI 10.1016/S0925-4773(99)00100-8; Tonelli R, 2012, CLIN CANCER RES, V18, P796, DOI 10.1158/1078-0432.CCR-11-1981; Upadhyay AK, 2012, J MOL BIOL, V416, P319, DOI 10.1016/j.jmb.2011.12.036; Veal GJ, 2007, BRIT J CANCER, V96, P424, DOI 10.1038/sj.bjc.6603554; Verrier L, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001390; Williamson D, 2010, J CLIN ONCOL, V28, P2151, DOI 10.1200/JCO.2009.26.3814; Xia SJ, 2009, AM J PATHOL, V175, P2600, DOI 10.2353/ajpath.2009.090192; Xiang Y, 2007, P NATL ACAD SCI USA, V104, P19226, DOI 10.1073/pnas.0700735104; Zhang L, 2007, ONCOGENE, V26, P1595, DOI 10.1038/sj.onc.1209958	50	62	65	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 27	2014	33	9					1148	1157		10.1038/onc.2013.46	http://dx.doi.org/10.1038/onc.2013.46			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AB6XT	23435416	Green Accepted, Green Submitted			2022-12-25	WOS:000331933800008
J	Mora-Blanco, EL; Mishina, Y; Tillman, EJ; Cho, YJ; Thom, CS; Pomeroy, SL; Shao, W; Roberts, CWM				Mora-Blanco, E. L.; Mishina, Y.; Tillman, E. J.; Cho, Y-J; Thom, C. S.; Pomeroy, S. L.; Shao, W.; Roberts, C. W. M.			Activation of beta-catenin/TCF targets following loss of the tumor suppressor SNF5	ONCOGENE			English	Article						chromatin remodeling; tumor suppressor; Swi/Snf; beta-catenin; epigenetics	CHROMATIN REMODELING COMPLEXES; GENOMIC INSTABILITY; BINDING REGIONS; RHABDOID TUMORS; MULTIPLE ROLES; CANCER; DIFFERENTIATION; TUMORIGENESIS; MUTATIONS; CELLS	The SWI/SNF chromatin remodeling complex is a master regulator of developmental cell-fate decisions, although the key target pathways are poorly characterized. Here, we interrogated the contribution of the SWI/SNF subunit and tumor suppressor SNF5 to the regulation of developmental pathways using conditional mouse and cell culture models. We find that loss of SNF5 phenocopies beta-catenin hyperactivation and that SNF5 is essential for regulating Wnt/beta-catenin pathway target expression. These data provide insight into chromatin-based mechanisms that underlie developmental regulation and elucidate the emerging theme that mutation of this tumor suppressor complex can activate developmental pathways by uncoupling them from upstream control.	[Mora-Blanco, E. L.; Tillman, E. J.; Thom, C. S.; Roberts, C. W. M.] Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA; [Mora-Blanco, E. L.; Tillman, E. J.; Thom, C. S.; Roberts, C. W. M.] Harvard Univ, Sch Med, Dept Pediat, Div Hematol Oncol,Childrens Hosp Boston, Boston, MA 02115 USA; [Mishina, Y.; Shao, W.] Novartis Inst Biomed Res, Cambridge, MA USA; [Cho, Y-J; Pomeroy, S. L.] Childrens Hosp Boston, Dept Neurol, Boston, MA USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Boston Children's Hospital; Harvard Medical School; Novartis; Harvard University; Boston Children's Hospital	Roberts, CWM (corresponding author), Dana Farber Canc Inst, Dept Pediat Oncol, 450 Brookline Ave, Boston, MA 02115 USA.	Charles_Roberts@dfci.harvard.edu	Roberts, Charles/N-2541-2018	Roberts, Charles/0000-0003-1135-1896; Tillman, Erik/0000-0003-3599-0297	National Cancer Institute, National Institutes of Health [1F31CA130553, R01CA113794, U01-1156106]; Stand Up 2 Cancer Innovative Research Grant; The Garrett B Smith Foundation; Cure AT/RT; Miles for Mary; NATIONAL CANCER INSTITUTE [R01CA113794, F31CA130553, R01CA109467] Funding Source: NIH RePORTER	National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Stand Up 2 Cancer Innovative Research Grant; The Garrett B Smith Foundation; Cure AT/RT; Miles for Mary; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank ES McKenna for critical reading of the manuscript and A Lassar for helpful discussions. The in situ probe constructs were generously provided by C Tabin (Harvard Medical School). This work was supported in part by National Cancer Institute, National Institutes of Health Pre-Doctoral NRSA award 1F31CA130553 (ELMB), R01CA113794 (CWMR) and U01-1156106 (Stuart H Orkin). CWM R is a recipient of a Stand Up 2 Cancer Innovative Research Grant. Miles for Mary, The Garrett B Smith Foundation and Cure AT/RT Now provided additional support.	Barker N, 2001, EMBO J, V20, P4935, DOI 10.1093/emboj/20.17.4935; Biegel JA, 1999, CANCER RES, V59, P74; Bottomly D, 2010, NUCLEIC ACIDS RES, V38, P5735, DOI 10.1093/nar/gkq363; Chi TH, 2003, IMMUNITY, V19, P169, DOI 10.1016/S1074-7613(03)00199-7; Chien AJ, 2009, J INVEST DERMATOL, V129, P1614, DOI 10.1038/jid.2008.445; Cho YJ, 2011, J CLIN ONCOL, V29, P1424, DOI 10.1200/JCO.2010.28.5148; Collins RT, 2000, GENE DEV, V14, P3140, DOI 10.1101/gad.854300; Curtis CD, 2012, MOL CELL BIOL, V32, P1312, DOI 10.1128/MCB.06222-11; DasGupta R, 1999, DEVELOPMENT, V126, P4557; de la Serna IL, 2006, NAT REV GENET, V7, P461, DOI 10.1038/nrg1882; Ettenberg SA, 2010, P NATL ACAD SCI USA, V107, P15473, DOI 10.1073/pnas.1007428107; Gresh L, 2005, EMBO J, V24, P3313, DOI 10.1038/sj.emboj.7600802; Griffin CT, 2011, P NATL ACAD SCI USA, V108, P2282, DOI 10.1073/pnas.1013751108; Guidi CJ, 2001, MOL CELL BIOL, V21, P3598, DOI 10.1128/MCB.21.10.3598-3603.2001; Hill TP, 2006, DEVELOPMENT, V133, P1219, DOI 10.1242/dev.02298; Hill TP, 2005, DEV CELL, V8, P727, DOI 10.1016/j.devcel.2005.02.013; Ho L, 2010, NATURE, V463, P474, DOI 10.1038/nature08911; Hu MC, 2005, DEVELOPMENT, V132, P215, DOI 10.1242/dev.01573; Huang SMA, 2009, NATURE, V461, P614, DOI 10.1038/nature08356; Jagani Z, 2010, NAT MED, V16, P1429, DOI 10.1038/nm.2251; Klochendler-Yeivin A, 2000, EMBO REP, V1, P500, DOI 10.1093/embo-reports/kvd129; Lee RS, 2012, J CLIN INVEST, V122, P2983, DOI 10.1172/JCI64400; Logan M, 2002, GENESIS, V33, P77, DOI 10.1002/gene.10092; Mahmoudi T, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000539; McKenna ES, 2008, MOL CELL BIOL, V28, P6223, DOI 10.1128/MCB.00658-08; McKenna ES, 2009, CELL CYCLE, V8, P23, DOI 10.4161/cc.8.1.7290; Miller KA, 2007, DEV BIOL, V311, P665, DOI 10.1016/j.ydbio.2007.07.022; Ngo-Muller V, 2000, DEV BIOL, V219, P224, DOI 10.1006/dbio.2000.9612; Oruetxebarria I, 2004, J BIOL CHEM, V279, P3807, DOI 10.1074/jbc.M309333200; Park JI, 2009, NATURE, V460, P66, DOI 10.1038/nature08137; Roberts CWM, 2000, P NATL ACAD SCI USA, V97, P13796, DOI 10.1073/pnas.250492697; Roberts CWM, 2002, CANCER CELL, V2, P415, DOI 10.1016/S1535-6108(02)00185-X; Robinson G, 2012, NATURE, V488, P43, DOI 10.1038/nature11213; Schaefer CF, 2009, NUCLEIC ACIDS RES, V37, pD674, DOI 10.1093/nar/gkn653; Versteege I, 1998, NATURE, V394, P203, DOI 10.1038/28212; Willert Jennifer, 2002, BMC Dev Biol, V2, P8, DOI 10.1186/1471-213X-2-8; Wilson BG, 2011, NAT REV CANCER, V11, P481, DOI 10.1038/nrc3068; Wilson BG, 2010, CANCER CELL, V18, P316, DOI 10.1016/j.ccr.2010.09.006	38	54	55	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 13	2014	33	7					933	938		10.1038/onc.2013.37	http://dx.doi.org/10.1038/onc.2013.37			6	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AB2MN	23435428	Green Accepted			2022-12-25	WOS:000331626900015
J	Lai, SC; Nakayama, Y; Sequeira, JM; Wlodarczyk, BJ; Cabrera, RM; Finnell, RH; Bottiglieri, T; Quadros, EV				Lai, Shao-Chiang; Nakayama, Yasumi; Sequeira, Jeffrey M.; Wlodarczyk, Bogdan J.; Cabrera, Robert M.; Finnell, Richard H.; Bottiglieri, Teodoro; Quadros, Edward V.			The transcobalamin receptor knockout mouse: a model for vitamin B-12 deficiency in the central nervous system	FASEB JOURNAL			English	Article						cellular uptake; nullizygous; methylmalonic acid; homocysteine; CD320	CYSTATHIONINE BETA-SYNTHASE; LIQUID-CHROMATOGRAPHY; GENE; METABOLISM; PROTEIN; MEGALIN; BRAIN; MICE	The membrane receptor (TCblR/CD320) for transcobalamin (TC)-bound cobalamin (Cbl) facilitates the cellular uptake of Cbl. A genetically modified mouse model involving ablation of the CD320 gene was generated to study the effects on cobalamin homeostasis. The nonlethal nature of this knockout and the lack of systemic cobalamin deficiency point to other mechanisms for cellular Cbl uptake in the mouse. However, severe cobalamin depletion in the central nervous system (CNS) after birth (P<0.01) indicates that TCblR is the only receptor responsible for Cbl uptake in the CNS. Metabolic Cbl deficiency in the brain was evident from the increased methylmalonic acid (P<0.01-0.04), homocysteine (P<0.01), cystathionine (P<0.01), and the decreased S-adenosylmethionine/S-adenosyl homocysteine ratio (P<0.01). The CNS pathology of Cbl deficiency seen in humans may not manifest in this mouse model; however, it does provide a model with which to evaluate metabolic pathways and genes affected.-Lai, S.-C., Nakayama, Y., Sequeira, J. M., Wlodarczyk, B. J., Cabrera, R. M., Finnell, R. H., Bottiglieri, T., Quadros, E. V. The transcobalamin receptor knockout mouse: a model for vitamin B-12 deficiency in the central nervous system.	[Lai, Shao-Chiang; Quadros, Edward V.] Suny Downstate Med Ctr, Sch Grad Studies, Brooklyn, NY 11203 USA; [Nakayama, Yasumi; Sequeira, Jeffrey M.; Quadros, Edward V.] Suny Downstate Med Ctr, Dept Med, Brooklyn, NY 11203 USA; [Quadros, Edward V.] Suny Downstate Med Ctr, Dept Cell Biol, Brooklyn, NY 11203 USA; [Wlodarczyk, Bogdan J.; Cabrera, Robert M.; Finnell, Richard H.] Univ Texas Austin, Dell Pediat Res Inst, Austin, TX 78712 USA; [Bottiglieri, Teodoro] Baylor Res Inst, Inst Metab Dis, Dallas, TX USA	State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; University of Texas System; University of Texas Austin; Baylor Scott & White Health; Baylor University Medical Center	Quadros, EV (corresponding author), Suny Downstate Med Ctr, Box 20,450 Clarkson Ave, Brooklyn, NY 11203 USA.	edward.quadros@downstate.edu	Finnell, Richard/D-8174-2018	Finnell, Richard/0000-0002-5962-8754; Wlodarczyk, Bogdan J./0000-0001-5249-5832	U.S. National Institutes of Health [DK064732, HD067244]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD067244] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK064732, R01DK064732] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by U.S. National Institutes of Health grants DK064732 (E.V.Q.) and HD067244 (R.H.F.). The authors are most thankful to Dr. Erland Arning for his contributions to the analysis of metabolites.	ALLEN RH, 1993, FASEB J, V7, P1344, DOI 10.1096/fasebj.7.14.7901104; AWATA S, 1995, BIOCHEM MOL BIOL INT, V35, P1331; Cannata J. J., J BIOL CHEM, V240, P3249; CHANARIN I, 1985, BLOOD, V66, P479; COOPER BA, 1987, ANNU REV NUTR, V7, P291, DOI 10.1146/annurev.nu.07.070187.001451; Ducros V, 2006, CLIN CHEM LAB MED, V44, P987, DOI 10.1515/CCLM.2006.178; Enokido Y, 2005, FASEB J, V19, P1854, DOI 10.1096/fj.05-3724fje; Fasching C, 2010, METHODS MOL BIOL, V603, P371, DOI 10.1007/978-1-60761-459-3_36; Fernandez-Roig S, 2012, NUTR METAB, V9, DOI 10.1186/1743-7075-9-41; Hygum K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020638; Inoue-Choi M, 2012, INT J MOL EPIDEMIOL, V3, P160; JACOB E, 1975, J LAB CLIN MED, V86, P505; Leheste JR, 1999, AM J PATHOL, V155, P1361, DOI 10.1016/S0002-9440(10)65238-8; LINDEMANS J, 1982, BIOCHIM BIOPHYS ACTA, V720, P203, DOI 10.1016/0167-4889(82)90013-1; LINDENBAUM J, 1988, NEW ENGL J MED, V318, P1720, DOI 10.1056/NEJM198806303182604; Oh RC, 2003, AM FAM PHYSICIAN, V67, P979; Quadros E. V., 2000, Modern analytical methodologies in fat- and water-soluble vitamins., P313; Quadros EV, 2010, BRIT J HAEMATOL, V148, P195, DOI 10.1111/j.1365-2141.2009.07937.x; Quadros EV, 2009, BLOOD, V113, P186, DOI 10.1182/blood-2008-05-158949; Robert K, 2003, J HISTOCHEM CYTOCHEM, V51, P363, DOI 10.1177/002215540305100311; Rothenberg SP, 1997, METHOD ENZYMOL, V281, P261; Stanford WL, 2001, NAT REV GENET, V2, P756, DOI 10.1038/35093548; Verroust PJ, 2002, NEPHROL DIAL TRANSPL, V17, P1867, DOI 10.1093/ndt/17.11.1867; Willnow TE, 1996, P NATL ACAD SCI USA, V93, P8460, DOI 10.1073/pnas.93.16.8460; Yuan C, 2012, ANAL BIOANAL CHEM, V404, P133, DOI 10.1007/s00216-012-6099-z	25	26	28	0	13	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2013	27	6					2468	2475		10.1096/fj.12-219055	http://dx.doi.org/10.1096/fj.12-219055			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	154II	23430977	Green Published			2022-12-25	WOS:000319667600034
J	Liu, JX; Fan, SL; Lee, CJ; Greenleaf, AL; Zhou, P				Liu, Jiangxin; Fan, Shilong; Lee, Chul-Jin; Greenleaf, Arno L.; Zhou, Pei			Specific Interaction of the Transcription Elongation Regulator TCERG1 with RNA Polymerase II Requires Simultaneous Phosphorylation at Ser(2), Ser(5), and Ser(7) within the Carboxyl-terminal Domain Repeat	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FF DOMAINS; DIPOLAR COUPLINGS; CRYSTAL-STRUCTURE; CA150 BIND; CTD CODE; KINASE-I; PROTEINS; IDENTIFICATION; PHOSPHOCTD; INSIGHTS	The human transcription elongation regulator TCERG1 physically couples transcription elongation and splicing events by interacting with splicing factors through its N-terminal WW domains and the hyperphosphorylated C-terminal domain (CTD) of RNA polymerase II through its C-terminal FF domains. Here, we report biochemical and structural characterization of the C-terminal three FF domains (FF4-6) of TCERG1, revealing a rigid integral domain structure of the tandem FF repeat that interacts with the hyperphosphorylated CTD (PCTD). Although FF4 and FF5 adopt a classical FF domain fold containing three orthogonally packed alpha helices and a 310 helix, FF6 contains an additional insertion helix between alpha 1 and alpha 2. The formation of the integral tandem FF4-6 repeat is achieved by merging the last helix of the preceding FF domain and the first helix of the following FF domain and by direct interactions between neighboring FF domains. Using peptide column binding assays and NMR titrations, we show that binding of the FF4-6 tandem repeat to the PCTD requires simultaneous phosphorylation at Ser(2), Ser(5), and Ser(7) positions within two consecutive (YSPTSPS7)-S-1-P-2-T-3-S-4-P-5-S-6 heptad repeats. Such a sequence-specific PCTD recognition is achieved through CTD-docking sites on FF4 and FF5 of TCERG1 but not FF6. Our study presents the first example of a nuclear factor requiring all three phospho-Ser marks within the heptad repeat of the CTD for high affinity binding and provides a molecular interpretation for the biochemical connection between the Ser(7) phosphorylation enrichment in the CTD of the transcribing RNA polymerase II over introns and co-transcriptional splicing events.	[Liu, Jiangxin; Lee, Chul-Jin; Greenleaf, Arno L.; Zhou, Pei] Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA; [Fan, Shilong] Med Res Council MRC Ctr, Mol Biol Lab, Cambridge CB2 0QH, England	Duke University; MRC Laboratory Molecular Biology; UK Research & Innovation (UKRI); Medical Research Council UK (MRC)	Zhou, P (corresponding author), Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA.	peizhou@biochem.duke.edu	Zhou, Pei/O-6704-2019	Zhou, Pei/0000-0002-7823-3416	National Institutes of Health [GM079376, GM040505]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM040505, R01GM079376] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM079376 (to P. Z.) and GM040505 (to A. L. G.).	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Allen M, 2002, J MOL BIOL, V323, P411, DOI 10.1016/S0022-2836(02)00968-3; ALLISON LA, 1988, MOL CELL BIOL, V8, P321, DOI 10.1128/MCB.8.1.321; Bartkowiak B, 2011, GENET RES INT, V2011, DOI 10.4061/2011/623718; BASKARAN R, 1993, P NATL ACAD SCI USA, V90, P11167, DOI 10.1073/pnas.90.23.11167; Bedford MT, 1999, TRENDS BIOCHEM SCI, V24, P264, DOI 10.1016/S0968-0004(99)01417-6; Berjanskii MV, 2005, J AM CHEM SOC, V127, P14970, DOI 10.1021/ja054842f; Bonet R, 2008, PROTEINS, V73, P1001, DOI 10.1002/prot.22127; Buratowski S, 2003, NAT STRUCT BIOL, V10, P679, DOI 10.1038/nsb0903-679; Carty SM, 2000, P NATL ACAD SCI USA, V97, P9015, DOI 10.1073/pnas.160266597; Cavanagh J, 2007, PROTEIN NMR SPECTROSCOPY: PRINCIPLES AND PRACTICE, 2ND EDITION, P1; Chapman RD, 2007, SCIENCE, V318, P1780, DOI 10.1126/science.1145977; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cho EJ, 2001, GENE DEV, V15, P3319, DOI 10.1101/gad.935901; CORDEN JL, 1990, TRENDS BIOCHEM SCI, V15, P383, DOI 10.1016/0968-0004(90)90236-5; Cramer Patrick, 2001, Science (Washington D C), V292, P1863, DOI 10.1126/science.1059493; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dosset P, 2001, J BIOMOL NMR, V20, P223, DOI 10.1023/A:1011206132740; Egloff S, 2008, TRENDS GENET, V24, P280, DOI 10.1016/j.tig.2008.03.008; Egloff S, 2007, SCIENCE, V318, P1777, DOI 10.1126/science.1145989; Egloff S, 2012, TRENDS GENET, V28, P333, DOI 10.1016/j.tig.2012.03.007; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ester C, 2008, BMC BIOCHEM, V9, DOI 10.1186/1471-2091-9-29; Gasch A, 2006, J BIOL CHEM, V281, P356, DOI 10.1074/jbc.M508047200; Ghosh A, 2011, MOL CELL, V43, P299, DOI 10.1016/j.molcel.2011.06.001; Goddard T., 2008, SPARKY, V3; Goldstrohm AC, 2001, MOL CELL BIOL, V21, P7617, DOI 10.1128/MCB.21.22.7617-7628.2001; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Jones JC, 2004, J BIOL CHEM, V279, P24957, DOI 10.1074/jbc.M402218200; Jurica MS, 2002, RNA, V8, P426, DOI 10.1017/S1355838202021088; KAY LE, 1989, BIOCHEMISTRY-US, V28, P8972, DOI 10.1021/bi00449a003; KELLY WG, 1993, J BIOL CHEM, V268, P10416; Kim H, 2010, NAT STRUCT MOL BIOL, V17, P1279, DOI 10.1038/nsmb.1913; Kim M, 2009, J BIOL CHEM, V284, P26421, DOI 10.1074/jbc.M109.028993; Komarnitsky P, 2000, GENE DEV, V14, P2452, DOI 10.1101/gad.824700; Kubicek K, 2012, GENE DEV, V26, P1891, DOI 10.1101/gad.192781.112; Li M, 2005, P NATL ACAD SCI USA, V102, P17636, DOI 10.1073/pnas.0506350102; Lin KT, 2004, MOL CELL BIOL, V24, P9176, DOI 10.1128/MCB.24.20.9176-9185.2004; Lipsitz RS, 2004, ANNU REV BIOPH BIOM, V33, P387, DOI 10.1146/annurev.biophys.33.110502.140306; Lu M, 2009, J MOL BIOL, V393, P397, DOI 10.1016/j.jmb.2009.07.086; Lunde BM, 2010, NAT STRUCT MOL BIOL, V17, P1195, DOI 10.1038/nsmb.1893; Mayer A, 2010, NAT STRUCT MOL BIOL, V17, P1272, DOI 10.1038/nsmb.1903; McCracken S, 1997, NATURE, V385, P357, DOI 10.1038/385357a0; Meinhart A, 2005, GENE DEV, V19, P1401, DOI 10.1101/gad.1318105; Murphy JM, 2009, J MOL BIOL, V393, P409, DOI 10.1016/j.jmb.2009.08.049; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pearson JL, 2008, J BIOL CHEM, V283, P7949, DOI 10.1074/jbc.M709402200; Phatnani HP, 2006, GENE DEV, V20, P2922, DOI 10.1101/gad.1477006; Phatnani Hemali P, 2004, Methods Mol Biol, V257, P17, DOI 10.1385/1-59259-750-5:017; Phatnani HP, 2004, BIOCHEMISTRY-US, V43, P15702, DOI 10.1021/bi048364h; Sanchez-Alvarez M, 2006, MOL CELL BIOL, V26, P4998, DOI 10.1128/MCB.01991-05; Schroeder SC, 2000, GENE DEV, V14, P2435, DOI 10.1101/gad.836300; Schwer B, 2011, MOL CELL, V43, P311, DOI 10.1016/j.molcel.2011.05.024; Shaw PE, 2007, EMBO REP, V8, P40, DOI 10.1038/sj.embor.7400873; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Smith MJ, 2004, MOL CELL BIOL, V24, P9274, DOI 10.1128/MCB.24.21.9274-9285.2004; Sune C, 1997, MOL CELL BIOL, V17, P6029, DOI 10.1128/MCB.17.10.6029; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; Tietjen JR, 2010, NAT STRUCT MOL BIOL, V17, P1154, DOI 10.1038/nsmb.1900; Werner-Allen JW, 2011, J BIOL CHEM, V286, P5717, DOI 10.1074/jbc.M110.197129; Xiang KH, 2010, NATURE, V467, P729, DOI 10.1038/nature09391; Yang DW, 1999, J BIOMOL NMR, V14, P333, DOI 10.1023/A:1008314803561; Zeng JY, 2009, J BIOMOL NMR, V45, P265, DOI 10.1007/s10858-009-9366-3; Zhang DW, 2012, GENET RES INT, V2012, DOI 10.1155/2012/347214; ZHANG J, 1991, J BIOL CHEM, V266, P2290; Zhou ZL, 2002, NATURE, V419, P182, DOI 10.1038/nature01031	67	21	21	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 12	2013	288	15					10890	10901		10.1074/jbc.M113.460238	http://dx.doi.org/10.1074/jbc.M113.460238			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	125TU	23436654	Green Published, hybrid			2022-12-25	WOS:000317565000066
J	Ma, L; Yu, HG; Ni, ZM; Hu, SG; Ma, WB; Chu, C; Liu, Q; Zhang, YL				Ma, Li; Yu, Heguo; Ni, Zimei; Hu, Shuanggang; Ma, Wubin; Chu, Chen; Liu, Qiang; Zhang, Yonglian			Spink13, an Epididymis-specific Gene of the Kazal-type Serine Protease Inhibitor (SPINK) Family, Is Essential for the Acrosomal Integrity and Male Fertility	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANGIOTENSIN-CONVERTING ENZYME; IN-VITRO FERTILIZATION; AMINO-ACID-SEQUENCE; TRYPSIN-INHIBITOR; SPERM MATURATION; MOUSE SPERMATOZOA; ANCHORED PROTEIN; CHRONIC-PANCREATITIS; NETHERTON-SYNDROME; MOLECULAR-CLONING	Sperm maturation involves numerous surface modifications by a variety of secreted proteins from epididymal epithelia. The sperm surface architecture depends on correct localization of its components and highlights the importance of the sequence of the proteolytic processing of the sperm surface in the epididymal duct. The presence of several protease inhibitors from different families is consistent with the hypothesis that correctly timed epididymal protein processing is essential for proper sperm maturation. Here we show that the rat (Rattus norvegicus) epididymis-specific gene Spink13, an androgen-responsive serine protease inhibitor, could bind to the sperm acrosome region. Furthermore, knockdown of Spink13 in vivo dramatically enhanced the acrosomal exocytosis during the process of capacitation and thus led to a significant reduction in male fertility, indicating that Spink13 was essential for sperm maturation. We conclude that blockade of SPINK13 may provide a new putative target for post-testicular male contraceptives.	[Ma, Li; Ni, Zimei; Hu, Shuanggang; Ma, Wubin; Chu, Chen; Liu, Qiang; Zhang, Yonglian] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, Shanghai Key Lab Mol Androl,State Key Lab Mol Bio, Shanghai 200031, Peoples R China; [Yu, Heguo; Zhang, Yonglian] Shanghai Inst Planned Parenthood Res, Natl Populat & Family Planning Commiss Key Lab Co, Shanghai 200032, Peoples R China; [Ma, Li; Hu, Shuanggang; Ma, Wubin; Chu, Chen] Chinese Acad Sci, Grad Univ, Shanghai 200031, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Liu, Q (corresponding author), Inst Biochem & Cell Biol, 320 Yue Yang Rd, Shanghai 200031, Peoples R China.	qliu@sibcb.ac.cn; ylzhang@sibcb.ac.cn	Chu, Chen/J-6527-2019; Ma, Wubin/P-3045-2017	Chu, Chen/0000-0001-8084-0867; 	Chinese Academy of Sciences [KSCX2-EW-R-07]; National Natural Science Foundation [30930053, 31271600, 30770815]	Chinese Academy of Sciences(Chinese Academy of Sciences); National Natural Science Foundation(National Natural Science Foundation of China (NSFC))	This work was supported by Chinese Academy of Sciences Knowledge Innovation Program Grant KSCX2-EW-R-07, and National Natural Science Foundation Grants 30930053, 31271600, and 30770815.	AGERBERTH B, 1989, P NATL ACAD SCI USA, V86, P8590, DOI 10.1073/pnas.86.21.8590; Arnoys EJ, 2007, ACTA HISTOCHEM, V109, P89, DOI 10.1016/j.acthis.2006.10.002; Bendahmane M, 2002, ARCH BIOCHEM BIOPHYS, V404, P38, DOI 10.1016/S0003-9861(02)00278-3; Berger T, 2000, REPROD TOXICOL, V14, P45, DOI 10.1016/S0890-6238(99)00062-3; Birmingham A, 2007, NAT PROTOC, V2, P2068, DOI 10.1038/nprot.2007.278; Brattsand M, 2009, J INVEST DERMATOL, V129, P1656, DOI 10.1038/jid.2008.448; Cesari A, 2010, THERIOGENOLOGY, V74, P699, DOI 10.1016/j.theriogenology.2010.03.029; Chen H, 2006, BIOL REPROD, V74, P923, DOI 10.1095/biolreprod.105.048587; Cornwall GA, 2009, HUM REPROD UPDATE, V15, P213, DOI 10.1093/humupd/dmn055; COURTY Y, 1991, J REPROD FERTIL, V91, P293; Cui YP, 2010, INT J ONCOL, V37, P1521, DOI 10.3892/ijo_00000805; Dacheux JL, 2003, MICROSC RES TECHNIQ, V61, P7, DOI 10.1002/jemt.10312; Dematteis A, 2008, BIOL REPROD, V79, P493, DOI 10.1095/biolreprod.107.067538; FINK E, 1990, FEBS LETT, V270, P222, DOI 10.1016/0014-5793(90)81273-Q; Frenette G, 2001, MOL REPROD DEV, V59, P115, DOI 10.1002/mrd.1013; Gasiorowska A, 2011, DIGEST DIS SCI, V56, P894, DOI 10.1007/s10620-010-1349-4; Gyamera-Acheampong C, 2009, HUM REPROD UPDATE, V15, P237, DOI 10.1093/humupd/dmn060; Harlow E, 1988, ANTIBODIES LAB MANUA, P139; Hewett DR, 2005, HUM MOL GENET, V14, P335, DOI 10.1093/hmg/ddi030; Hobson JP, 2004, J BIOL CHEM, V279, P46981, DOI 10.1074/jbc.M403299200; Hoefnagel JJ, 2005, BLOOD, V105, P3671, DOI 10.1182/blood-2004-04-1594; Honda A, 2002, J BIOL CHEM, V277, P16976, DOI 10.1074/jbc.M112470200; Hu SG, 2010, MOL ENDOCRINOL, V24, P2392, DOI 10.1210/me.2010-0226; Ikawa M, 2010, J CLIN INVEST, V120, P984, DOI 10.1172/JCI41585; Inoue N, 2011, P NATL ACAD SCI USA, V108, P20008, DOI 10.1073/pnas.1116965108; Jalkanen J, 2006, BIOCHEM BIOPH RES CO, V349, P245, DOI 10.1016/j.bbrc.2006.08.023; Jin M, 2011, P NATL ACAD SCI USA, V108, P4892, DOI 10.1073/pnas.1018202108; Jones R, 1996, J CELL SCI, V109, P2561; Jones R, 1998, J REPROD FERTIL, P73; KATO I, 1987, BIOCHEMISTRY-US, V26, P193, DOI 10.1021/bi00375a027; KAZAL LA, 1948, J AM CHEM SOC, V70, P3034, DOI 10.1021/ja01189a060; Kondoh G, 2005, NAT MED, V11, P160, DOI 10.1038/nm1179; Lee B, 2011, J BIOL CHEM, V286, P29108, DOI 10.1074/jbc.M111.244905; Legare C, 1999, MOL REPROD DEV, V52, P225, DOI 10.1002/(SICI)1098-2795(199902)52:2&lt;225::AID-MRD14&gt;3.0.CO;2-M; LIU DY, 1993, BIOL REPROD, V48, P340, DOI 10.1095/biolreprod48.2.340; Liu Q, 2001, ENDOCRINOLOGY, V142, P4529, DOI 10.1210/en.142.10.4529; Lu SM, 2001, P NATL ACAD SCI USA, V98, P1410, DOI 10.1073/pnas.031581398; Magert HJ, 1999, J BIOL CHEM, V274, P21499, DOI 10.1074/jbc.274.31.21499; Martin-DeLeon PA, 2006, MOL CELL ENDOCRINOL, V250, P114, DOI 10.1016/j.mce.2005.12.033; Meyer-Hoffert U, 2010, J BIOL CHEM, V285, P32174, DOI 10.1074/jbc.M109.091850; MOORE HDM, 1992, FERTIL STERIL, V58, P776; MORITZ A, 1991, FEBS LETT, V278, P127, DOI 10.1016/0014-5793(91)80099-O; Nakamura Yasuo, 2003, Journal of Medical Investigation, V50, P78; Ohmuraya M, 2005, GASTROENTEROLOGY, V129, P696, DOI 10.1053/j.gastro.2005.05.057; ORGEBINCRIST MC, 1967, NATURE, V216, P816, DOI 10.1038/216816a0; Ou CM, 2012, INT J ANDROL, V35, P52, DOI 10.1111/j.1365-2605.2011.01159.x; Puente XS, 2004, GENOME RES, V14, P609, DOI 10.1101/gr.1946304; Rockett JC, 2004, MUTAT RES-FUND MOL M, V549, P225, DOI 10.1016/j.mrfmmm.2003.11.017; Sipila P, 2009, REPRODUCTION, V137, P379, DOI 10.1530/REP-08-0132; Stenman UH, 2011, ASIAN J ANDROL, V13, P628, DOI 10.1038/aja.2011.45; Syntin P, 1999, BIOL REPROD, V60, P1542, DOI 10.1095/biolreprod60.6.1542; Takano N, 2005, MOL REPROD DEV, V70, P1, DOI 10.1002/mrd.20184; Tulsiani DRP, 2003, MICROSC RES TECHNIQ, V61, P18, DOI 10.1002/jemt.10313; Tuysuz B, 2010, ACTA DERM-VENEREOL, V90, P95, DOI 10.2340/00015555-0769; van Hoef V., 2012, PEPTIDES IN PRESS; Wang J, 2008, HISTOCHEM CELL BIOL, V130, P387, DOI 10.1007/s00418-008-0425-8; Wapenaar MC, 2007, IMMUNOGENETICS, V59, P349, DOI 10.1007/s00251-007-0199-5; Witt H, 2000, NAT GENET, V25, P213, DOI 10.1038/76088; Xiao LQ, 2004, ACTA BIOCH BIOPH SIN, V36, P571, DOI 10.1093/abbs/36.8.571; Yamaguchi R, 2006, BIOL REPROD, V75, P760, DOI 10.1095/biolreprod.106.052977; Yeung CH, 2001, MOL HUM REPROD, V7, P617, DOI 10.1093/molehr/7.7.617; Zhao Y, 2011, CELL MOL LIFE SCI, V68, P697, DOI 10.1007/s00018-010-0478-4; Zhen W, 2009, BIOL REPROD, V80, P696, DOI 10.1095/biolreprod.108.071589; Zhou CX, 2004, NAT CELL BIOL, V6, P458, DOI 10.1038/ncb1127; Zhou YC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004106; Zhu CF, 2007, BIOL REPROD, V76, P63, DOI 10.1095/biolreprod.106.054635	66	33	37	1	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 5	2013	288	14					10154	10165		10.1074/jbc.M112.445866	http://dx.doi.org/10.1074/jbc.M112.445866			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	119RB	23430248	Green Published, hybrid			2022-12-25	WOS:000317114000056
J	Hu, YJ; Shao, ZY; Wang, Q; Jiang, YT; Ma, R; Tang, ZS; Liu, Z; Liang, JP; Huang, ZW				Hu, Yue-jian; Shao, Zi-yang; Wang, Qian; Jiang, Yun-tao; Ma, Rui; Tang, Zi-sheng; Liu, Zheng; Liang, Jing-ping; Huang, Zheng-wei			Exploring the Dynamic Core Microbiome of Plaque Microbiota during Head-and-Neck Radiotherapy Using Pyrosequencing	PLOS ONE			English	Article							ORAL MICROFLORA	Radiotherapy is the primary treatment modality used for patients with head-and-neck cancers, but inevitably causes microorganism-related oral complications. This study aims to explore the dynamic core microbiome of oral microbiota in supragingival plaque during the course of head-and-neck radiotherapy. Eight subjects aged 26 to 70 were recruited. Dental plaque samples were collected (over seven sampling time points for each patient) before and during radiotherapy. The V1-V3 hypervariable regions of bacterial 16S rRNA genes were amplified, and the high-throughput pyrosequencing was performed. A total of 140 genera belonging to 13 phyla were found. Four phyla (Actinobacteria, Bacteroidetes, Firmicutes, and Proteobacteria) and 11 genera (Streptococcus, Actinomyces, Veillonella, Capnocytophaga, Derxia, Neisseria, Rothia, Prevotella, Granulicatella, Luteococcus, and Gemella) were found in all subjects, supporting the concept of a core microbiome. Temporal variation of these major cores in relative abundance were observed, as well as a negative correlation between the number of OTUs and radiation dose. Moreover, an optimized conceptual framework was proposed for defining a dynamic core microbiome in extreme conditions such as radiotherapy. This study presents a theoretical foundation for exploring a core microbiome of communities from time series data, and may help predict community responses to perturbation as caused by exposure to ionizing radiation.	[Hu, Yue-jian; Wang, Qian; Jiang, Yun-tao; Ma, Rui; Tang, Zi-sheng; Liu, Zheng; Liang, Jing-ping; Huang, Zheng-wei] Shanghai Jiao Tong Univ, Dept Endodont, Sch Med, Shanghai Key Lab Stomatol,Peoples Hosp 9, Shanghai 200030, Peoples R China; [Shao, Zi-yang] Shanghai Jiao Tong Univ, Dept Oral & Maxillofacial Surg, Sch Med, Div Radiat Oncol,Peoples Hosp 9, Shanghai 200030, Peoples R China; [Hu, Yue-jian] Tongji Univ, Dept Endodont, Affiliated Stomatol Hosp, Sch Stomatol, Shanghai 200092, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Tongji University	Liang, JP (corresponding author), Shanghai Jiao Tong Univ, Dept Endodont, Sch Med, Shanghai Key Lab Stomatol,Peoples Hosp 9, Shanghai 200030, Peoples R China.	liangjp123@yahoo.com.cn; huangzhengwei@shsmu.edu.cn	Hu, Yue/HGE-1673-2022		National Natural Science Foundation (NSFC) [81070826/30872886]; Shanghai Rising-Star Program [12QH1401400]; Shanghai Jiaotong University [YG2011MS67]	National Natural Science Foundation (NSFC)(National Natural Science Foundation of China (NSFC)); Shanghai Rising-Star Program; Shanghai Jiaotong University	This work was supported by a grant from the National Natural Science Foundation (NSFC) No. 81070826/30872886 and partly sponsored by Shanghai Rising-Star Program No. 12QH1401400. Patient enrollment was funded by the Shanghai Jiaotong University grant (YG2011MS67). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AlAmri OD, 2012, ENVIRON POLLUT, V168, P107, DOI 10.1016/j.envpol.2012.04.015; Almstahl A, 1999, J DENT RES, V78, P1410, DOI 10.1177/00220345990780080601; Alvarado Yesid, 2002, Hematology, V7, P281, DOI 10.1080/1024533021000037216; Costello EK, 2009, SCIENCE, V326, P1694, DOI 10.1126/science.1177486; Farah CS, 2001, ORAL MICROBIOL IMMUN, V16, P358, DOI 10.1034/j.1399-302X.2001.160607.x; Hamady M, 2009, GENOME RES, V19, P1141, DOI 10.1101/gr.085464.108; Huse SM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034242; Junior GD, 2006, CURR OPIN ONCOL, V18, P266; Keijser BJF, 2008, J DENT RES, V87, P1016, DOI 10.1177/154405910808701104; Lazarevic V, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-523; Ling ZX, 2010, MICROB ECOL, V60, P677, DOI 10.1007/s00248-010-9712-8; MACFARLANE TW, 1974, J CLIN PATHOL, V27, P416, DOI 10.1136/jcp.27.5.416; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Nederfors T, 2000, Adv Dent Res, V14, P48; Schloss PD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027310; Schuurhuis JM, 2011, RADIOTHER ONCOL, V101, P403, DOI 10.1016/j.radonc.2011.09.018; Shade A, 2012, ENVIRON MICROBIOL, V14, P4, DOI 10.1111/j.1462-2920.2011.02585.x; Shao ZY, 2011, J RADIAT RES, V52, P834, DOI 10.1269/jrr.11085; Shih A, 2003, CANCER NURS, V26, P222, DOI 10.1097/00002820-200306000-00008; Siqueira Jose F Jr, 2012, J Oral Microbiol, V4, DOI 10.3402/jom.v4i0.10743; Tong HC, 2003, CARIES RES, V37, P261, DOI 10.1159/000070868; Turnbaugh PJ, 2007, NATURE, V449, P804, DOI 10.1038/nature06244; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Zaura E, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-259	24	38	42	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2013	8	2							e56343	10.1371/journal.pone.0056343	http://dx.doi.org/10.1371/journal.pone.0056343			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IT	23437114	Green Submitted, Green Published, gold			2022-12-25	WOS:000315186000023
J	Kumar, S; Mazumder, M; Dharavath, S; Gourinath, S				Kumar, Sudhir; Mazumder, Mohit; Dharavath, Sudhaker; Gourinath, S.			Single Residue Mutation in Active Site of Serine Acetyltransferase Isoform 3 from Entamoeba histolytica Assists in Partial Regaining of Feedback Inhibition by Cysteine	PLOS ONE			English	Article							ESCHERICHIA-COLI; L-CYSTINE; BIOSYNTHESIS; OVERPRODUCTION; SULFHYDRYLASE; MUTAGENESIS; COMPLEX; MUTANT; GENE	The cysteine biosynthetic pathway is essential for survival of the protist pathogen Entamoeba histolytica, and functions by producing cysteine for countering oxidative attack during infection in human hosts. Serine acetyltransferase ( SAT) and O-acetylserine sulfhydrylase (OASS) are involved in cysteine biosynthesis and are present in three isoforms each. While EhSAT1 and EhSAT2 are feedback inhibited by end product cysteine, EhSAT3 is nearly insensitive to such inhibition. The active site residues of EhSAT1 and of EhSAT3 are identical except for position 208, which is a histidine residue in EhSAT1 and a serine residue in EhSAT3. A combination of comparative modeling, multiple molecular dynamics simulations and free energy calculation studies showed a difference in binding energies of native EhSAT3 and of a S208H-EhSAT3 mutant for cysteine. Mutants have also been generated in vitro, replacing serine with histidine at position 208 in EhSAT3 and replacing histidine 208 with serine in EhSAT1. These mutants showed decreased affinity for substrate serine, as indicated by K-m, compared to the native enzymes. Inhibition kinetics in the presence of physiological concentrations of serine show that IC50 of EhSAT1 increases by about 18 folds from 9.59 mu M for native to 169.88 mu M for H208S-EhSAT1 mutant. Similar measurements with EhSAT3 confirm it to be insensitive to cysteine inhibition while its mutant (S208H-EhSAT3) shows a gain of cysteine inhibition by 36% and the IC50 of 3.5 mM. Histidine 208 appears to be one of the important residues that distinguish the serine substrate from the cysteine inhibitor.	[Kumar, Sudhir; Mazumder, Mohit; Dharavath, Sudhaker; Gourinath, S.] Jawaharlal Nehru Univ, Sch Life Sci, Delhi, India	Jawaharlal Nehru University, New Delhi	Gourinath, S (corresponding author), Jawaharlal Nehru Univ, Sch Life Sci, Delhi, India.	sgourinath@mail.jnu.ac.in	Kumar, Sudhir/AAE-3615-2020	Kumar, Sudhir/0000-0001-9673-5842; dharavath, Sudhaker/0000-0002-5973-0214; mazumder, mohit/0000-0002-2593-725X	University Grants Commission (UGC); DBT; Department of Biotechnology; Council of Scientific and Industrial research, Government of India; UGC resource networking; Department of Science and Technology; UGC; ICMR; DST-FIST	University Grants Commission (UGC)(University Grants Commission, India); DBT(Department of Biotechnology (DBT) India); Department of Biotechnology; Council of Scientific and Industrial research, Government of India(Council of Scientific & Industrial Research (CSIR) - India); UGC resource networking; Department of Science and Technology(Department of Science & Technology (India)); UGC(University Grants Commission, India); ICMR(Indian Council of Medical Research (ICMR)); DST-FIST(Department of Science & Technology (India))	SK and MM thank University Grants Commission (UGC) and DBT for fellowship respectively. The authors thank Programme support on Molecular Parasitology by Department of Biotechnology, and Council of Scientific and Industrial research, Government of India. The authors thank UGC resource networking and Department of Science and Technology-Fund for Improvement of S&T Infrastructure in Higher Educational Institutions funding for departmental central facility. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; S.K, M.M, S. D thanks UGC, DBT and ICMR for fellowship respectively. We thank UGC resource networking and DST-FIST funding for departmental central facility. We thank Dean, School of Biotechnology, JNU, New Delhi for granting access to Central Instrumentation Facility. We also thank Dr. Rajesh Pujari for his help in enzyme assays.	BAKKERGRUNWALD T, 1995, J EUKARYOT MICROBIOL, V42, P346, DOI 10.1111/j.1550-7408.1995.tb01592.x; Cheatham TE, 2011, AMBER 11; Chinthalapudi K, 2008, PROTEINS, V72, P1222, DOI 10.1002/prot.22013; CONNOLLY ML, 1983, J APPL CRYSTALLOGR, V16, P548, DOI 10.1107/S0021889883010985; Darden T, 1999, STRUCT FOLD DES, V7, pR55, DOI 10.1016/S0969-2126(99)80033-1; DENK D, 1987, J GEN MICROBIOL, V133, P515; Edelheit O, 2009, BMC BIOTECHNOL, V9, DOI 10.1186/1472-6750-9-61; Webb Benjamin, 2016, Curr Protoc Bioinformatics, V54, DOI [10.1002/0471140864.ps0209s50, 10.1002/cpps.20, 10.1002/0471250953.bi0506s15, 10.1002/cpbi.3]; Guan R, 2008, BIOCHEMISTRY-US, V47, P6322, DOI 10.1021/bi800075c; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Hussain S, 2009, MOL BIOCHEM PARASIT, V163, P39, DOI 10.1016/j.molbiopara.2008.09.006; Inoue K, 1999, EUR J BIOCHEM, V266, P220, DOI 10.1046/j.1432-1327.1999.00847.x; Kollman PA, 2000, ACCOUNTS CHEM RES, V33, P889, DOI 10.1021/ar000033j; Kumar S, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.197376; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Na GN, 2011, J BIOL CHEM, V286, P40423, DOI 10.1074/jbc.M111.247411; Nakamori S, 1998, APPL ENVIRON MICROB, V64, P1607; Noji M, 1998, J BIOL CHEM, V273, P32739, DOI 10.1074/jbc.273.49.32739; Nozaki T, 1999, J BIOL CHEM, V274, P32445, DOI 10.1074/jbc.274.45.32445; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Raj I, 2012, ACTA CRYSTALLOGRAP D, V68; SAITO K, 1995, J BIOL CHEM, V270, P16321, DOI 10.1074/jbc.270.27.16321; Schrodinger LLC, 2010, PYMOL MOL GRAPH SYST; SMITH IK, 1971, BIOCHIM BIOPHYS ACTA, V227, P288, DOI 10.1016/0005-2744(71)90061-1; Takagi H, 1999, FEBS LETT, V452, P323, DOI 10.1016/S0014-5793(99)00679-1; VAARA M, 1992, FEMS MICROBIOL LETT, V97, P249, DOI 10.1016/0378-1097(92)90344-N	26	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2013	8	2							e55932	10.1371/journal.pone.0055932	http://dx.doi.org/10.1371/journal.pone.0055932			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IT	23437075	Green Published, Green Submitted, gold			2022-12-25	WOS:000315186000013
J	Moncunill, G; Mayor, A; Jimenez, A; Nhabomba, A; Puyol, L; Manaca, MN; Barrios, D; Cistero, P; Guinovart, C; Aguilar, R; Bardaji, A; Pinazo, MJ; Angov, E; Dutta, S; Chitnis, CE; Munoz, J; Gascon, J; Dobano, C				Moncunill, Gemma; Mayor, Alfredo; Jimenez, Alfons; Nhabomba, Augusto; Puyol, Laura; Manaca, Maria N.; Barrios, Diana; Cistero, Pau; Guinovart, Caterina; Aguilar, Ruth; Bardaji, Azucena; Pinazo, Maria-Jesus; Angov, Evelina; Dutta, Sheetij; Chitnis, Chetan E.; Munoz, Jose; Gascon, Joaquim; Dobano, Carlota			Cytokine and Antibody Responses to Plasmodium falciparum in Naive Individuals during a First Malaria Episode: Effect of Age and Malaria Exposure	PLOS ONE			English	Article							ERYTHROCYTE-MEMBRANE PROTEIN-1; INFECTED ERYTHROCYTES; ACQUIRED-IMMUNITY; CLINICAL MALARIA; BLOOD-STAGE; PROTECTION; INTERFERON; ANTIGENS; ACQUISITION; TOLERANCE	Age- and exposure-dependent immune responses during a malaria episode may be key to understanding the role of these factors in the acquisition of immunity to malaria. Plasma/serum samples collected from naive Mozambican children (n = 48), European adults (naive travelers, n = 22; expatriates with few prior malaria exposures, n = 15) and Mozambican adults with long-life malaria exposure (n = 99) during and after a malaria episode were analyzed for IgG against merozoite proteins by Luminex and against infected erythrocytes by flow cytometry. Cytokines and chemokines were analyzed in plasmas/sera by suspension array technology. No differences were detected between children and adults with a primary infection, with the exception of higher IgG levels against 3D7 MSP-1(42) (P = 0.030) and a P. falciparum isolate (P = 0.002), as well as higher IL-12 (P = 0.020) in children compared to other groups. Compared to malaria-exposed adults, children, travelers and expatriates had higher concentrations of IFN-gamma (P <= 0.0090), IL-2 (P <= 0.0379) and IL-8 (P <= 0.0233). Children also had higher IL-12 (P = 0.0001), IL-4 (P = 0.003), IL-1 beta (P = 0.024) and TNF (P = 0.006) levels compared to malaria-exposed adults. Although IL-12 was elevated in children, overall the data do not support a role of age in immune responses to a first malaria episode. A T(H)1/pro-inflammatory response was the hallmark of non-immune subjects.	[Moncunill, Gemma; Mayor, Alfredo; Jimenez, Alfons; Puyol, Laura; Barrios, Diana; Cistero, Pau; Guinovart, Caterina; Aguilar, Ruth; Bardaji, Azucena; Pinazo, Maria-Jesus; Munoz, Jose; Gascon, Joaquim; Dobano, Carlota] Univ Barcelona, Barcelona Ctr Int Hlth Res, Hosp Clin, CRESIB, Barcelona, Spain; [Mayor, Alfredo; Nhabomba, Augusto; Manaca, Maria N.; Guinovart, Caterina; Aguilar, Ruth; Dobano, Carlota] Ctr Invest Saude Manhica, Maputo, Mozambique; [Angov, Evelina; Dutta, Sheetij] Walter Reed Army Inst Res, Silver Spring, MD USA; [Chitnis, Chetan E.] Int Ctr Genet Engn & Biotechnol, New Delhi, India	ISGlobal; CRESIB; University of Barcelona; Centro de Investigacao em Saude de Manhica; United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); Department of Biotechnology (DBT) India; International Center for Genetic Engineering & Biotechnology (ICGEB); International Center for Genetic Engineering & Biotechnology (ICGEB), New Delhi	Moncunill, G (corresponding author), Univ Barcelona, Barcelona Ctr Int Hlth Res, Hosp Clin, CRESIB, Barcelona, Spain.	gemma.moncunil@cresib.cat	Alonso, Azucena Bardají/V-5978-2018; Gutiérrez, José/GSJ-1846-2022; Gutiérrez, Jose Muñoz/X-5917-2018; Delgado, Maria Jesús Pinazo/X-6093-2018; JIMENEZ, ALFONS/L-2106-2019; Gascon, Joaquim/M-3598-2015; Mayor, Alfredo/H-7488-2017; Barrios-Rodríguez, Diana/D-3910-2018; Guinovart, Caterina/ABH-2981-2020; Cisteró, Pau/H-2468-2017; Aguilar, Ruth/D-2147-2018; Gutierrez, Jose Muñoz/AAH-6954-2020; Moncunill, Gemma/B-7989-2011; Bardají, Azucena/AAE-9145-2019; Dobaño, Carlota/N-4119-2014	Alonso, Azucena Bardají/0000-0002-5135-0540; Gutiérrez, Jose Muñoz/0000-0002-0945-1735; Delgado, Maria Jesús Pinazo/0000-0002-4237-1075; JIMENEZ, ALFONS/0000-0003-0301-3344; Gascon, Joaquim/0000-0002-5045-1585; Mayor, Alfredo/0000-0003-3890-2897; Barrios-Rodríguez, Diana/0000-0001-9929-5707; Cisteró, Pau/0000-0001-7225-4331; Aguilar, Ruth/0000-0003-3277-3107; Gutierrez, Jose Muñoz/0000-0002-0945-1735; Moncunill, Gemma/0000-0001-5105-9836; Dobaño, Carlota/0000-0002-6751-4060; Puyol, Laura/0000-0003-2840-7753; Fernandez, Ivette/0000-0001-5179-0477; Chitnis, Chetan/0000-0002-8773-9865	Ministerio de Ciencia e Innovacion [SAF2008-00743, SAF2005-25642-E, RYC-2008-02631]; Instituto de Salud Carlos III [PI050275, A107190024, PS0901113, CD10/00156, CP-4/00220, CM04/00028]; EU FP6 [LSHP-CT-2005-18902]; Fundacion Ramon Areces	Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); EU FP6(European Commission); Fundacion Ramon Areces	The study received financial support from the Ministerio de Ciencia e Innovacion (SAF2008-00743, SAF2005-25642-E, salary support RYC-2008-02631 to CD); the Instituto de Salud Carlos III (PI050275, A107190024, PS0901113, salary support CD10/00156 to GM, CP-4/00220 to AM, and CM04/00028 to CG), the EU FP6 (LSHP-CT-2005-18902), and the Fundacion Ramon Areces. The Centro de Investigacao em Saude de Manhica receives core support from the Spanish Agency for International Cooperation and Development (AECID). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGUIAR JC, 1992, AM J TROP MED HYG, V47, P621; Angov E, 2003, MOL BIOCHEM PARASIT, V128, P195, DOI 10.1016/S0166-6851(03)00077-X; Angov E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002189; Aponte JJ, 2007, PLOS MED, V4, P1259, DOI 10.1371/journal.pmed.0040242; Baird JK, 1998, J INFECT DIS, V178, P592, DOI 10.1086/517482; BAIRD JK, 1995, PARASITOL TODAY, V11, P105, DOI 10.1016/0169-4758(95)80167-7; BAIRD JK, 1991, AM J TROP MED HYG, V45, P65, DOI 10.4269/ajtmh.1991.45.65; Beeson JG, 2007, AM J TROP MED HYG, V77, P22, DOI 10.4269/ajtmh.2007.77.22; Bir N, 2006, INFECT IMMUN, V74, P5955, DOI 10.1128/IAI.00481-06; Bouchaud O, 2005, AM J TROP MED HYG, V72, P21, DOI 10.4269/ajtmh.2005.72.21; Boutlis CS, 2006, TRENDS PARASITOL, V22, P371, DOI 10.1016/j.pt.2006.06.002; Broad A, 2007, IMMUNOLOGY, V120, P103, DOI 10.1111/j.1365-2567.2006.02485.x; Campo JJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025779; Cham GKK, 2009, J IMMUNOL, V183, P3356, DOI 10.4049/jimmunol.0901331; Conway DJ, 2000, NAT MED, V6, P689, DOI 10.1038/76272; Cook PC, 2012, P NATL ACAD SCI USA, V109, P9977, DOI 10.1073/pnas.1121231109; Corbett NP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015041; Dobano C, 2012, CLIN VACCINE IMMUNOL, V19, P157, DOI 10.1128/CVI.05523-11; Dodoo D, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-142; Doolan DL, 2009, CLIN MICROBIOL REV, V22, P13, DOI 10.1128/CMR.00025-08; Elliott SR, 2007, AM J TROP MED HYG, V76, P860, DOI 10.4269/ajtmh.2007.76.860; Gigley JP, 2012, TRENDS PARASITOL, V28, P377, DOI 10.1016/j.pt.2012.07.001; Guinovart C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032362; Hansen DS, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000771; Hoffman SL, 1997, NAT MED, V3, P80, DOI 10.1038/nm0197-80; Horowitz A, 2010, J IMMUNOL, V184, P6043, DOI 10.4049/jimmunol.1000106; Keenihan SNH, 2003, AM J TROP MED HYG, V69, P36; Kocken CHM, 2002, INFECT IMMUN, V70, P4471, DOI 10.1128/IAI.70.8.4471-4476.2002; Langrish CL, 2004, IMMUNOL REV, V202, P96, DOI 10.1111/j.0105-2896.2004.00214.x; Mackintosh CL, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-155; Marsh K, 1999, PARASSITOLOGIA, VOL 41, NOS 1-3, SEPTEMBER 1999, P241; Mayor A, 2012, CLIN INFECT DIS, V54, P1561, DOI 10.1093/cid/cis236; Mayor A, 2011, INFECT IMMUN, V79, P1654, DOI 10.1128/IAI.01000-10; Mayor A, 2009, INFECT IMMUN, V77, P3857, DOI 10.1128/IAI.00049-09; McCall MBB, 2010, J LEUKOCYTE BIOL, V88, P1131, DOI 10.1189/jlb.0310137; Metenou S, 2007, J IMMUNOL, V178, P2770, DOI 10.4049/jimmunol.178.5.2770; Nielsen MA, 2004, INFECT IMMUN, V72, P3531, DOI 10.1128/IAI.72.6.3531-3535.2004; Oleinikov AV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031011; Pandey KC, 2002, MOL BIOCHEM PARASIT, V123, P23, DOI 10.1016/S0166-6851(02)00122-6; Perkins DJ, 2000, J INFECT DIS, V182, P988, DOI 10.1086/315762; Perry JA, 2005, J IMMUNOL, V174, P5921, DOI 10.4049/jimmunol.174.10.5921; Polley SD, 2004, VACCINE, V23, P718, DOI 10.1016/j.vaccine.2004.05.031; PrabhuDas M, 2011, NAT IMMUNOL, V12, P189, DOI 10.1038/ni0311-189; Reddy SB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032242; Reeder JC, 1997, ACTA TROP, V65, P163, DOI 10.1016/S0001-706X(97)00661-X; Richards JS, 2010, CLIN INFECT DIS, V51, pE50, DOI 10.1086/656413; Roussilhon C, 2007, PLOS MED, V4, P1791, DOI 10.1371/journal.pmed.0040320; Rovira-Vallbona E, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-181; Rovira-Vallbona E, 2011, J INFECT DIS, V204, P27, DOI 10.1093/infdis/jir217; Rutella S, 2006, BLOOD, V108, P1435, DOI 10.1182/blood-2006-03-006403; Salvado E, 2008, ENFERM INFEC MICR CL, V26, P282, DOI 10.1157/13120415; SEDEGAH M, 1994, P NATL ACAD SCI USA, V91, P10700, DOI 10.1073/pnas.91.22.10700; Stanisic DI, 2009, INFECT IMMUN, V77, P1165, DOI 10.1128/IAI.01129-08; Stevenson MM, 2006, PARASITE IMMUNOL, V28, P5, DOI 10.1111/j.1365-3024.2006.00772.x; Torre D, 2009, CLIN INFECT DIS, V48, P1481, DOI 10.1086/598508; Walther M, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000364; WHO, 2011, WORLD MALARIA REPORT 2011, P1	57	21	22	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2013	8	2							e55756	10.1371/journal.pone.0055756	http://dx.doi.org/10.1371/journal.pone.0055756			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IT	23437061	Green Published, gold, Green Submitted			2022-12-25	WOS:000315186000008
J	Chen, CC; Er, TK; Liu, YY; Hwang, JK; Barrio, MJ; Rodrigo, M; Garcia-Toro, E; Herreros-Villanueva, M				Chen, Chih-Chieh; Er, Tze-Kiong; Liu, Yen-Yi; Hwang, Jenn-Kang; Jesus Barrio, Maria; Rodrigo, Maximiliano; Garcia-Toro, Enrique; Herreros-Villanueva, Marta			Computational Analysis of KRAS Mutations: Implications for Different Effects on the KRAS p.G12D and p.G13D Mutations	PLOS ONE			English	Article							K-RAS MUTATIONS; COLORECTAL-CANCER; GROWTH; GENE; CETUXIMAB; ONCOGENE; CODON-13; EGFR; PROTOONCOGENE; ACTIVATION	Background: The issue of whether patients diagnosed with metastatic colorectal cancer who harbor KRAS codon 13 mutations could benefit from the addition of anti-epidermal growth factor receptor therapy remains under debate. The aim of the current study was to perform computational analysis to investigate the structural implications of the underlying mutations caused by c.38G>A (p.G13D) on protein conformation. Methods: Molecular dynamics (MD) simulations were performed to understand the plausible structural and dynamical implications caused by c.35G>A (p.G12D) and c.38G>A (p.G13D). The potential of mean force (PMF) simulations were carried out to determine the free energy profiles of the binding processes of GTP interacting with wild-type (WT) KRAS and its mutants (MT). Results: Using MD simulations, we observed that the root mean square deviation (RMSD) increased as a function of time for the MT c.35G>A (p.G12D) and MT c.38G>A (p.G13D) when compared with the WT. We also observed that the GTP-binding pocket in the c.35G>A (p.G12D) mutant is more open than that of the WT and the c.38G>A (p.G13D) proteins. Intriguingly, the analysis of atomic fluctuations and free energy profiles revealed that the mutation of c.35G>A (p.G12D) may induce additional fluctuations in the sensitive sites (P-loop, switch I and II regions). Such fluctuations may promote instability in these protein regions and hamper GTP binding. Conclusions: Taken together with the results obtained from MD and PMF simulations, the present findings implicate fluctuations at the sensitive sites (P-loop, switch I and II regions). Our findings revealed that KRAS mutations in codon 13 have similar behavior as KRAS WT. To gain a better insight into why patients with metastatic colorectal cancer (mCRC) and the KRAS c.38G>A (p.G13D) mutation appear to benefit from anti-EGFR therapy, the role of the KRAS c.38G>A (p.G13D) mutation in mCRC needs to be further investigated.	[Chen, Chih-Chieh; Liu, Yen-Yi; Hwang, Jenn-Kang] Natl Chiao Tung Univ, Inst Bioinformat & Syst Biol, Hsinchu, Taiwan; [Er, Tze-Kiong] Kaohsiung Med Univ Hosp, Dept Lab Med, Div Mol Diagnost, Kaohsiung, Taiwan; [Er, Tze-Kiong] Kaohsiung Med Univ, Grad Inst Med, Coll Med, Kaohsiung, Taiwan; [Er, Tze-Kiong] Kaohsiung Med Univ, Dept Med Lab Sci & Biotechnol, Kaohsiung, Taiwan; [Jesus Barrio, Maria] Hosp Gen Yague, Serv Oncol, Burgos, Spain; [Rodrigo, Maximiliano; Garcia-Toro, Enrique] Hosp Gen Yague, Serv Anat Patol, Burgos, Spain; [Herreros-Villanueva, Marta] Hosp Gen Yague, Unidad Invest, Burgos, Spain	National Yang Ming Chiao Tung University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University; Hospital General Yague; Hospital General Yague; Hospital General Yague	Herreros-Villanueva, M (corresponding author), Hosp Gen Yague, Unidad Invest, Burgos, Spain.	martahvh1978@hotmail.com	ER, TZE/AFN-4587-2022; , Herreros-Villanueva/M-5702-2016	ER, TZE/0000-0002-7068-1652; , Herreros-Villanueva/0000-0002-6905-0693; Liu, Yen-Yi/0000-0001-8386-4418	Kaohsiung Medical University Research Foundation [KMUH101-1M68]	Kaohsiung Medical University Research Foundation	This study was supported by a grant from the Kaohsiung Medical University Research Foundation (KMUH101-1M68). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Mulla F, 1999, J PATHOL, V187, P433, DOI 10.1002/(SICI)1096-9896(199903)187:4<433::AID-PATH273>3.0.CO;2-E; Allegra CJ, 2009, J CLIN ONCOL, V27, P2091, DOI 10.1200/JCO.2009.21.9170; Amado RG, 2008, J CLIN ONCOL, V26, P1626, DOI 10.1200/JCO.2007.14.7116; American Cancer Society, 2009, CANC FACTS FIG 2009; Andreyev HJN, 1998, J NATL CANCER I, V90, P675, DOI 10.1093/jnci/90.9.675; [Anonymous], 2009, STRATEGIC COMMENTS, V14, P1; Baselga J, 2008, J CLIN ONCOL, V26, P1582, DOI 10.1200/JCO.2007.15.3700; Bazan V, 2002, ANN ONCOL, V13, P1438, DOI 10.1093/annonc/mdf226; Benvenuti S, 2007, CANCER RES, V67, P2643, DOI 10.1158/0008-5472.CAN-06-4158; BOLLAG G, 1995, METHOD ENZYMOL, V255, P161; BOS JL, 1985, NATURE, V315, P726, DOI 10.1038/315726a0; Brink M, 2003, CARCINOGENESIS, V24, P703, DOI 10.1093/carcin/bgg009; Chang DZ, 2009, J HEMATOL ONCOL, V2, DOI 10.1186/1756-8722-2-18; Chen CC, 2006, NUCLEIC ACIDS RES, V34, pW152, DOI 10.1093/nar/gkl187; Chen CC, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-366; Chen J, 2012, CANC CHEMOTHER PHARM; Chen YL, 2009, J CHROMATOGR A, V1216, P5147, DOI 10.1016/j.chroma.2009.04.083; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; De Roock W, 2008, ANN ONCOL, V19, P508, DOI 10.1093/annonc/mdm496; De Roock W, 2010, JAMA-J AM MED ASSOC, V304, P1812, DOI 10.1001/jama.2010.1535; Di Fiore F, 2007, BRIT J CANCER, V96, P1166, DOI 10.1038/sj.bjc.6603685; Edkins S, 2006, CANCER BIOL THER, V5, P928, DOI 10.4161/cbt.5.8.3251; Er TK, 2010, CLIN LAB, V56, P175; Futatsugi N, 2001, BIOPHYS J, V81, P3483, DOI 10.1016/S0006-3495(01)75979-6; Gajate P, 2012, CLIN COLORECTAL CANC; GIDEON P, 1992, MOL CELL BIOL, V12, P2050, DOI 10.1128/MCB.12.5.2050; Guerrero S, 2000, CANCER RES, V60, P6750; Herreros-Villanueva M, 2011, MOL BIOL REP, V38, P1315, DOI 10.1007/s11033-010-0232-x; Hsu KC, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-S1-S33; Imamura Y, 2012, CLIN CANC RES OFFICI; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Karapetis CS, 2008, NEW ENGL J MED, V359, P1757, DOI 10.1056/NEJMoa0804385; Kirkwood JG, 1935, J CHEM PHYS, V3, P300, DOI 10.1063/1.1749657; KUMAR S, 1992, J COMPUT CHEM, V13, P1011, DOI 10.1002/jcc.540130812; Lievre A, 2006, CANCER RES, V66, P3992, DOI 10.1158/0008-5472.CAN-06-0191; Lievre A, 2008, J CLIN ONCOL, V26, P374, DOI 10.1200/JCO.2007.12.5906; Malumbres M, 2003, NAT REV CANCER, V3, P459, DOI 10.1038/nrc1097; Mao C, 2012, CANCER; MCGRATH JP, 1983, NATURE, V304, P501, DOI 10.1038/304501a0; Messner I, 2012, J CANC RES CLIN ONCO; Modest DP, 2011, ANTI-CANCER DRUG, V22, P913, DOI 10.1097/CAD.0b013e3283493160; Moroni M, 2005, LANCET ONCOL, V6, P279, DOI 10.1016/S1470-2045(05)70102-9; Neumann J, 2009, PATHOL RES PRACT, V205, P858, DOI 10.1016/j.prp.2009.07.010; Normanno N, 2009, NAT REV CLIN ONCOL, V6, P519, DOI 10.1038/nrclinonc.2009.111; Park JH, 2004, CLIN CHEM, V50, P1688, DOI 10.1373/clinchem.2004.034017; Parthasarathy S, 2000, PROTEIN ENG, V13, P9, DOI 10.1093/protein/13.1.9; Roux B., 1995, Computer Physics Communications, V91, P275, DOI 10.1016/0010-4655(95)00053-I; Samowitz WS, 2000, CANCER EPIDEM BIOMAR, V9, P1193; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; SEEBURG PH, 1984, NATURE, V312, P71, DOI 10.1038/312071a0; SLOAN SR, 1990, MOL CELL BIOL, V10, P405, DOI 10.1128/MCB.10.1.405; Tejpar S, 2012, J CLIN ONCOLOGY OFFI; TORRIE GM, 1977, J COMPUT PHYS, V23, P187, DOI 10.1016/0021-9991(77)90121-8; Tveit KM, 2012, J CLIN ONCOLOGY OFFI; US Food and Drug Administration, 2004, FDA APPR ERB COL CAN; US Food and Drug Administration, 2007, FDA APPR VECT PAN TR; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Ward RL, 1997, CANCER, V79, P1106, DOI 10.1002/(SICI)1097-0142(19970315)79:6<1106::AID-CNCR8>3.0.CO;2-D; Yamauchi M, 2012, GUT, V61, P794, DOI 10.1136/gutjnl-2012-302014; Yamauchi M, 2012, GUT, V61, P847, DOI 10.1136/gutjnl-2011-300865; Yang JM, 2004, PROTEINS, V55, P288, DOI 10.1002/prot.20035	61	50	51	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e55793	10.1371/journal.pone.0055793	http://dx.doi.org/10.1371/journal.pone.0055793			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437064	Green Submitted, Green Published, gold			2022-12-25	WOS:000315184200023
J	Colin, SP; Costello, JH; Katija, K; Seymour, J; Kiefer, K				Colin, Sean P.; Costello, John H.; Katija, Kakani; Seymour, Jamie; Kiefer, Kristen			Propulsion in Cubomedusae: Mechanisms and Utility	PLOS ONE			English	Article							JELLYFISH TRIPEDALIA-CYSTOPHORA; AUSTRALIAN BOX JELLYFISH; CHIRONEX-FLECKERI; SWIMMING PERFORMANCE; AURELIA-AURITA; FLOW PATTERNS; PREY SIZE; BEHAVIOR; MORPHOLOGY; PREDATION	Evolutionary constraints which limit the forces produced during bell contractions of medusae affect the overall medusan morphospace such that jet propulsion is limited to only small medusae. Cubomedusae, which often possess large prolate bells and are thought to swim via jet propulsion, appear to violate the theoretical constraints which determine the medusan morphospace. To examine propulsion by cubomedusae, we quantified size related changes in wake dynamics, bell shape, swimming and turning kinematics of two species of cubomedusae, Chironex fleckeri and Chiropsella bronzie. During growth, these cubomedusae transitioned from using jet propulsion at smaller sizes to a rowing-jetting hybrid mode of propulsion at larger sizes. Simple modifications in the flexibility and kinematics of their velarium appeared to be sufficient to alter their propulsive mode. Turning occurs during both bell contraction and expansion and is achieved by generating asymmetric vortex structures during both stages of the swimming cycle. Swimming characteristics were considered in conjunction with the unique foraging strategy used by cubomedusae.	[Colin, Sean P.; Kiefer, Kristen] Roger Williams Univ, Bristol, RI 02809 USA; [Colin, Sean P.; Costello, John H.] Marine Biol Labs, Whitman Ctr, Woods Hole, MA USA; [Costello, John H.] Providence Coll, Dept Biol, Providence, RI 02918 USA; [Katija, Kakani] Woods Hole Oceanog Inst, Woods Hole, MA 02543 USA; [Seymour, Jamie] James Cook Univ, Queensland Trop Hlth Alliance, Cairns, Australia	Marine Biological Laboratory - Woods Hole; Providence College; Woods Hole Oceanographic Institution; James Cook University	Colin, SP (corresponding author), Roger Williams Univ, Bristol, RI 02809 USA.	scolin@rwu.edu	Seymour, Jamie E/C-9748-2013; Katija, Kakani/R-4935-2019	Seymour, Jamie E/0000-0002-4805-3289; Colin, Sean/0000-0003-4463-5588	ONR MURI [N000140810654]; National Science Foundation [OCE 0623508]; Roger Williams University Foundation; Office of Integrative Activities [1004057] Funding Source: National Science Foundation	ONR MURI(MURIOffice of Naval Research); National Science Foundation(National Science Foundation (NSF)); Roger Williams University Foundation; Office of Integrative Activities(National Science Foundation (NSF)NSF - Office of the Director (OD))	This work was supported by an ONR MURI award (N000140810654) and National Science Foundation grant OCE 0623508 to JHC, SPC, JOD. And the work was supported by the Roger Williams University Foundation to Promote Scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAXTER EH, 1969, TOXICON, V7, P195, DOI 10.1016/0041-0101(69)90006-3; Blough T, 2011, BIOL BULL-US, V220, P6, DOI 10.1086/BBLv220n1p6; Buskey EJ, 2003, MAR BIOL, V142, P225, DOI 10.1007/s00227-002-0938-y; Carrette T, 2002, TOXICON, V40, P1547, DOI 10.1016/S0041-0101(02)00168-X; Chang-yu L, 2010, ECOLOGICAL STUDY BOX; Coates MM, 2006, J EXP BIOL, V209, P3758, DOI 10.1242/jeb.02431; Coates MM, 2003, INTEGR COMP BIOL, V43, P542, DOI 10.1093/icb/43.4.542; Colin SP, 2007, J EXP MAR BIOL ECOL, V351, P114, DOI 10.1016/j.jembe.2007.06.033; Colin SP, 2003, MAR ECOL PROG SER, V253, P305, DOI 10.3354/meps253305; Colin SP, 2002, J EXP BIOL, V205, P427; Conant F. S., 1898, CUBOMEDUSAE; Costello JH, 2002, LIMNOL OCEANOGR, V47, P934, DOI 10.4319/lo.2002.47.4.0934; COSTELLO JH, 1994, MAR BIOL, V121, P327, DOI 10.1007/BF00346741; Costello JH, 1995, MAR BIOL, V124, P399, DOI 10.1007/BF00363913; Costello JH, 2008, INVERTEBR BIOL, V127, P265, DOI 10.1111/j.1744-7410.2008.00126.x; Dabiri JO, 2010, J EXP BIOL, V213, P1217, DOI 10.1242/jeb.034660; Dabiri JO, 2005, J EXP BIOL, V208, P1257, DOI 10.1242/jeb.01519; Dabiri JO, 2007, J EXP BIOL, V210, P1868, DOI 10.1242/jeb.003772; Dabiri JO, 2006, J EXP BIOL, V209, P2025, DOI 10.1242/jeb.02242; Ford MD, 2000, SCI MAR, V64, P47; Garm A, 2007, J EXP BIOL, V210, P3616, DOI 10.1242/jeb.004044; Garm A, 2011, CURR BIOL, V21, P798, DOI 10.1016/j.cub.2011.03.054; GERRITSEN J, 1977, J FISH RES BOARD CAN, V34, P73, DOI 10.1139/f77-008; Gershwin LA, 2008, BIOL BULL-US, V215, P57, DOI 10.2307/25470683; GLADFELTER WB, 1972, HELGOLAND WISS MEER, V23, P38, DOI 10.1007/BF01616310; GLADFELTER WG, 1973, HELGOLAND WISS MEER, V25, P228, DOI 10.1007/BF01611199; Gordon M, 1998, ECOPHYSIOLOGY TROPIC; Gordon MR, 2009, HYDROBIOLOGIA, V616, P87, DOI 10.1007/s10750-008-9594-7; Graham WM, 2003, BIOL INVASIONS, V5, P53, DOI 10.1023/A:1024046707234; Hamner WM, 1995, MAR FRESHWATER RES, V46, P985, DOI 10.1071/MF9950985; Hoerner SF., 1958, FLUID DYNAMIC DRAG P; Katija K, 2011, MAR ECOL PROG SER, V435, P111, DOI 10.3354/meps09212; Kintner AH, 2005, TOXICON, V46, P699, DOI 10.1016/j.toxicon.2005.07.015; Kiorboe T, 2011, BIOL REV, V86, P311, DOI 10.1111/j.1469-185X.2010.00148.x; Majdalani J., 2006, VISCOUS FLUID FLOW, V3; Matanoski JC, 2001, MAR BIOL, V139, P191; Matsumoto GI, 1995, MAR FRESHW BEHAV PHY, V26, P139, DOI 10.1080/10236249509378935; Nilsson DE, 2005, NATURE, V435, P201, DOI 10.1038/nature03484; Nogueira M, 2008, BRAZ J OCEANOGR, V56, P157, DOI 10.1590/S1679-87592008000300001; OLESEN NJ, 1995, MAR ECOL PROG SER, V124, P63, DOI 10.3354/meps124063; Petie R, 2011, J EXP BIOL, V214, P2809, DOI 10.1242/jeb.057190; Purcell J.E., 1988, P463; Rakow KC, 2006, LIMNOL OCEANOGR, V51, P1097, DOI 10.4319/lo.2006.51.2.1097; Regula C, 2009, MAR ECOL PROG SER, V374, P135, DOI 10.3354/meps07756; Sahin M, 2009, J EXP BIOL, V212, P2656, DOI 10.1242/jeb.025536; Satterlie RA, 2005, BIOL BULL-US, V209, P154, DOI 10.2307/3593133; Seymour JE, 2004, MED J AUSTRALIA, V181, P707, DOI 10.5694/j.1326-5377.2004.tb06529.x; Shorten M, 2005, J ZOOL, V267, P371, DOI 10.1017/S0952836905007600; Stewart SE, 1996, MAR FRESHW BEHAV PHY, V27, P175, DOI 10.1080/10236249609378963; Suchman CL, 2000, J PLANKTON RES, V22, P2289, DOI 10.1093/plankt/22.12.2289; Suchman CL, 1998, MAR BIOL, V132, P237, DOI 10.1007/s002270050389; Weston J, 2009, MAR ECOL PROG SER, V374, P127, DOI 10.3354/meps07762	52	22	23	1	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e56393	10.1371/journal.pone.0056393	http://dx.doi.org/10.1371/journal.pone.0056393			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437122	gold, Green Published, Green Accepted			2022-12-25	WOS:000315184200066
J	Ferguson, PM; Feindel, KW; Slocombe, A; MacKay, M; Wignall, T; Delahunt, B; Tilley, RD; Hermans, IF				Ferguson, Peter M.; Feindel, Kirk W.; Slocombe, Angela; MacKay, Matthew; Wignall, Trudy; Delahunt, Brett; Tilley, Richard D.; Hermans, Ian F.			Strongly Magnetic Iron Nanoparticles Improve the Diagnosis of Small Tumours in the Reticuloendothelial System by Magnetic Resonance Imaging	PLOS ONE			English	Article							LYMPH-NODE METASTASES; OXIDE CORE/SHELL NANOPARTICLES; CONTRAST AGENT; PROSTATE-CANCER; BREAST-CANCER; MRI	Despite advances in non-invasive medical imaging, accurate nodal staging of malignancy continues to rely on surgery. Superparamagnetic iron oxide nanoparticles (IONP) with lymphotropic qualities have shown some promise as contrast agents for MRI of the lymph nodes, but recent large-scale studies failed to show consistent detection of tumours below 5 mm. Herein we compare imaging of splenic and lymph node tissue using iron/iron oxide core/shell nanoparticles (Fe NP) that have superior magnetic qualities to IONP, to determine whether improved negative contrast in T-2-weighted MRI can enhance the diagnosis of small tumours in the reticuloendothelial system. To provide an in vivo pre-clinical model of human lymph node micrometastases, breast cancer cells were injected into the spleens of mice, providing localised areas of tumour growth. MR images of groups of tumour-bearing and sham-treated animals were generated using a 1.5 T imaging system and analysed by two independent, blinded radiologists. Fe NP improved the sensitivity and specificity of MRI when compared to IONP, enabling accurate detection of tumours as small as 1-3 mm. The use of Fe NP as contrast agents have the potential to improve the diagnostic accuracy of MRI in cancer patients, leading to more rapid and effective treatment.	[Ferguson, Peter M.; Hermans, Ian F.] Victoria Univ Wellington, Malaghan Inst Med Res, Wellington, New Zealand; [Ferguson, Peter M.; Hermans, Ian F.] Victoria Univ Wellington, Sch Biol Sci, Wellington, New Zealand; [Ferguson, Peter M.; Delahunt, Brett] Univ Otago, Dept Pathol Mol Med, Wellington Sch Med & Hlth Sci, Wellington, New Zealand; [Feindel, Kirk W.] Natl Res Council Inst Biodiagnost Atlantic, Halifax, NS, Canada; [Slocombe, Angela; MacKay, Matthew; Wignall, Trudy] Wellington Hosp, Dept Radiol, Wellington, New Zealand; [Tilley, Richard D.] Victoria Univ Wellington, Sch Chem & Phys Sci, MacDiarmid Inst Adv Mat & Nanotechnol, Wellington, New Zealand	Malaghan Institute; Victoria University Wellington; Victoria University Wellington; University of Otago; National Research Council Canada; Victoria University Wellington	Ferguson, PM (corresponding author), Victoria Univ Wellington, Malaghan Inst Med Res, Wellington, New Zealand.	pferguson@malaghan.org.nz	Delahunt, Brett/AAG-2382-2019; Tilley, Richard/AAN-5610-2020; Hermans, Ian/I-3961-2013; Feindel, Kirk/H-9772-2014	Feindel, Kirk/0000-0002-4402-0180; Ferguson, Peter M./0000-0002-8335-0406; Hermans, Ian/0000-0002-7584-887X; Tilley, Richard/0000-0003-2097-063X	New Zealand Ministry of Science and Innovation [PROJ-13733-NMTS]; New Zealand Health Research Council; Wellington Medical Research Foundation; Natural Sciences and Engineering Research Council of Canada	New Zealand Ministry of Science and Innovation; New Zealand Health Research Council(Health Research Council of New Zealand); Wellington Medical Research Foundation; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This research was supported by the New Zealand Ministry of Science and Innovation (www.msi.govt.nz) through grant PROJ-13733-NMTS. P.F. was supported by the New Zealand Health Research Council (www.hrc.govt.nz) and the Wellington Medical Research Foundation (www.wmrf.co.nz/). K.W.F. was supported by the Natural Sciences and Engineering Research Council of Canada (www.nserc-crsng.gc.ca). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bellin MF, 2002, ABDOM IMAGING, V28, P155, DOI 10.1007/s00261-001-0182-9; Bittencourt LK, 2012, EUR RADIOL, V22, P468, DOI 10.1007/s00330-011-2269-1; Cheong S, 2012, CHEMPLUSCHEM, V77, P135, DOI 10.1002/cplu.201100074; Cheong S, 2011, ANGEW CHEM INT EDIT, V50, P4206, DOI 10.1002/anie.201100562; European Medicines Authority, 2008, EMEACHMP115272008 EM; Fauconnier N, 1997, J COLLOID INTERF SCI, V194, P427, DOI 10.1006/jcis.1997.5125; Harisinghani MG, 2006, AM J ROENTGENOL, V186, P144, DOI 10.2214/AJR.04.1287; Harisinghani MG, 2003, NEW ENGL J MED, V348, P2491, DOI 10.1056/NEJMoa022749; Heesakkers RAM, 2008, LANCET ONCOL, V9, P850, DOI 10.1016/S1470-2045(08)70203-1; Herman DAJ, 2011, CHEM COMMUN, V47, P9221, DOI 10.1039/c1cc13416g; Johnson PM, 2006, J CLIN ONCOL, V24, P3570, DOI 10.1200/JCO.2006.06.8866; Klumpp BD, 2012, ABDOM IMAGING, V37, P834, DOI 10.1007/s00261-011-9825-7; Kroon BK, 2005, J UROLOGY, V173, P816, DOI 10.1097/01.ju.0000154565.37397.4d; Motomura K, 2011, ANN SURG ONCOL, V18, P3422, DOI 10.1245/s10434-011-1710-7; Nakagawa T, 2007, CLIN CANCER RES, V13, P4105, DOI 10.1158/1078-0432.CCR-07-0419; Pisanic TR, 2007, BIOMATERIALS, V28, P2572, DOI 10.1016/j.biomaterials.2007.01.043; Saksena MA, 2006, EUR J RADIOL, V58, P367, DOI 10.1016/j.ejrad.2005.12.041; Tiefenauer LX, 1996, MAGN RESON IMAGING, V14, P391, DOI 10.1016/0730-725X(95)02106-4; Tudorica LA, 2012, MAGN RESON IMAGING, V30, P1257, DOI 10.1016/j.mri.2012.04.009; van den Brekel MWM, 1998, AM J NEURORADIOL, V19, P695; WEISSLEDER R, 1990, RADIOLOGY, V175, P494, DOI 10.1148/radiology.175.2.2326475; Willinek WA, 2008, EUR J RADIOL, V65, P2, DOI 10.1016/j.ejrad.2007.11.006; Wu LC, 2011, EUR J RADIOL, V80, P582, DOI 10.1016/j.ejrad.2009.11.027	23	9	9	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e56572	10.1371/journal.pone.0056572	http://dx.doi.org/10.1371/journal.pone.0056572			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437173	gold, Green Submitted, Green Published			2022-12-25	WOS:000315184200109
J	Hardy, GAD; Sieg, S; Rodriguez, B; Anthony, D; Asaad, R; Jiang, W; Mudd, J; Schacker, T; Funderburg, NT; Pilch-Cooper, HA; Debernardo, R; Rabin, RL; Lederman, MM; Harding, CV				Hardy, Gareth A. D.; Sieg, Scott; Rodriguez, Benigno; Anthony, Donald; Asaad, Robert; Jiang, Wei; Mudd, Joseph; Schacker, Timothy; Funderburg, Nicholas T.; Pilch-Cooper, Heather A.; Debernardo, Robert; Rabin, Ronald L.; Lederman, Michael M.; Harding, Clifford V.			Interferon-alpha Is the Primary Plasma Type-I IFN in HIV-1 Infection and Correlates with Immune Activation and Disease Markers	PLOS ONE			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; MYELOID DENDRITIC CELLS; ADAPTIVE IMMUNITY; T-CELLS; HIV-1-INFECTED PATIENTS; SIV INFECTION; EXPRESSION; INNATE; BLOOD; MATURATION	Type-I interferon (IFN-I) has been increasingly implicated in HIV-1 pathogenesis. Various studies have shown elevated IFN-I and an IFN-I-induced gene and protein expression signature in HIV-1 infection, yet the elevated IFN-I species has not been conclusively identified, its source remains obscure and its role in driving HIV-1 pathogenesis is controversial. We assessed IFN-I species in plasma by ELISAs and bioassay, and we investigated potential sources of IFN-I in blood and lymph node tissue by qRT-PCR. Furthermore, we measured the effect of therapeutic administration of IFN alpha in HCV-infected subjects to model the effect of IFN alpha on chronic immune activation. IFN-I bioactivity was significantly increased in plasma of untreated HIV-1-infected subjects relative to uninfected subjects (p = 0.012), and IFN alpha was the predominant IFN-I subtype correlating with IFN-I bioactivity (r = 0.658, p<0.001). IFN alpha was not detectable in plasma of subjects receiving anti-retroviral therapy. Elevated expression of IFN alpha mRNA was limited to lymph node tissue cells, suggesting that peripheral blood leukocytes are not a major source of IFN alpha in untreated chronic HIV-1 infection. Plasma IFN-I levels correlated inversely with CD4 T cell count (p = 0.003) and positively with levels of plasma HIV-1 RNA and CD38 expression on CD8 T cells (p = 0.009). In hepatitis C virus-infected subjects, treatment with IFN-I and ribavirin increased expression of CD38 on CD8 T cells (p = 0.003). These studies identify IFN alpha derived from lymph nodes, rather than blood leukocytes, as a possible source of the IFN-I signature that contributes to immune activation in HIV-1 infection.	[Hardy, Gareth A. D.; Mudd, Joseph; Lederman, Michael M.; Harding, Clifford V.] Case Western Reserve Univ, Dept Pathol, Cleveland, OH 44106 USA; [Hardy, Gareth A. D.; Sieg, Scott; Rodriguez, Benigno; Anthony, Donald; Asaad, Robert; Jiang, Wei; Mudd, Joseph; Funderburg, Nicholas T.; Pilch-Cooper, Heather A.; Debernardo, Robert; Lederman, Michael M.; Harding, Clifford V.] Univ Hosp Case Med Ctr, Cleveland, OH USA; [Sieg, Scott; Rodriguez, Benigno; Anthony, Donald; Asaad, Robert; Jiang, Wei; Mudd, Joseph; Funderburg, Nicholas T.; Pilch-Cooper, Heather A.; Lederman, Michael M.; Harding, Clifford V.] Case Western Reserve Univ, Dept Med, Div Infect Dis, Cleveland, OH 44106 USA; [Hardy, Gareth A. D.; Sieg, Scott; Rodriguez, Benigno; Anthony, Donald; Asaad, Robert; Jiang, Wei; Lederman, Michael M.; Harding, Clifford V.] Case Western Reserve Univ, Ctr AIDS Res, Cleveland, OH 44106 USA; [Anthony, Donald] Cleveland Vet Adm Med Ctr, Cleveland, OH USA; [Schacker, Timothy] Univ Minnesota, Dept Med, Minneapolis, MN 55455 USA; [Debernardo, Robert] Case Western Reserve Univ, Dept Obstet & Gynecol, Cleveland, OH 44106 USA; [Rabin, Ronald L.] US FDA, Ctr Biol Evaluat & Res, Lab Immunobiochem, Bethesda, MD 20014 USA	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University Hospital; Case Western Reserve University; Case Western Reserve University; University of Minnesota System; University of Minnesota Twin Cities; Case Western Reserve University; US Food & Drug Administration (FDA)	Harding, CV (corresponding author), Case Western Reserve Univ, Dept Pathol, Cleveland, OH 44106 USA.	cvh3@cwru.edu	Sieg, Scott/AAV-2429-2021; Funderburg, Nicholas/L-8022-2013; Rodriguez, Benigno/C-3365-2009	Rodriguez, Benigno/0000-0001-9736-7957; Rabin, Ronald/0000-0003-3496-0504; Funderburg, Nicholas/0000-0003-3113-1217	National Institutes of Health (NIH) [AI034343, AI069085]; Case Western Reserve University Center for AIDS Research (NIH) [AI036219]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI036219, R01AI069085, T32AI089474, R01AI034343] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Case Western Reserve University Center for AIDS Research (NIH); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health (NIH) grants AI034343 and AI069085 to CVH and by core facilities of the Case Western Reserve University Center for AIDS Research (NIH grant AI036219). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beignon AS, 2005, J CLIN INVEST, V115, P3265, DOI 10.1172/JCI26032; Benito JM, 2005, J INFECT DIS, V192, P2142, DOI 10.1086/498168; Bosinger SE, 2009, J CLIN INVEST, V119, P3556, DOI 10.1172/JCI40115; Brenchley JM, 2006, NAT MED, V12, P1365, DOI 10.1038/nm1511; Chehimi J, 2002, J IMMUNOL, V168, P4796, DOI 10.4049/jimmunol.168.9.4796; Colonna M, 2004, NAT IMMUNOL, V5, P1219, DOI 10.1038/ni1141; DESTEFANO E, 1982, J INFECT DIS, V146, P451, DOI 10.1093/infdis/146.4.451; Donaghy H, 2001, BLOOD, V98, P2574, DOI 10.1182/blood.V98.8.2574; Feldman S, 2001, CLIN IMMUNOL, V101, P201, DOI 10.1006/clim.2001.5111; Fonteneau JF, 2004, J VIROL, V78, P5223, DOI 10.1128/JVI.78.10.5223-5232.2004; Giorgi JV, 1999, J INFECT DIS, V179, P859, DOI 10.1086/314660; Hardy GAD, 2009, BLOOD, V113, P5497, DOI 10.1182/blood-2008-11-190231; Harris LD, 2010, J VIROL, V84, P7886, DOI 10.1128/JVI.02612-09; Hazenberg MD, 2000, NAT IMMUNOL, V1, P285, DOI 10.1038/79724; Herbeuval JP, 2006, P NATL ACAD SCI USA, V103, P7000, DOI 10.1073/pnas.0600363103; Honda K, 2003, P NATL ACAD SCI USA, V100, P10872, DOI 10.1073/pnas.1934678100; Izaguirre A, 2003, J LEUKOCYTE BIOL, V74, P1125, DOI 10.1189/jlb.0603255; Jacquelin B, 2009, J CLIN INVEST, V119, P3544, DOI 10.1172/JCI40093; Jones GJ, 2001, AIDS, V15, P1657, DOI 10.1097/00002030-200109070-00008; Kadowaki N, 2000, J EXP MED, V192, P219, DOI 10.1084/jem.192.2.219; Kadowaki N, 2002, HUM IMMUNOL, V63, P1126, DOI 10.1016/S0198-8859(02)00751-6; KONTSEK P, 1991, VIROLOGY, V181, P416, DOI 10.1016/0042-6822(91)90517-F; Lederman MM, 2011, J INFECT DIS, V204, P1217, DOI 10.1093/infdis/jir507; Liu ZY, 1997, J ACQ IMMUN DEF SYND, V16, P83, DOI 10.1097/00042560-199710010-00003; Manion M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030306; McCune JM, 2001, NATURE, V410, P974, DOI 10.1038/35073648; Mehandru S, 2006, PLOS MED, V3, P2335, DOI 10.1371/journal.pmed.0030484; MINAGAWA T, 1989, LIFE SCI, V45, pR3, DOI 10.1016/0024-3205(89)90147-1; Nascimbeni M, 2009, BLOOD, V113, P6112, DOI 10.1182/blood-2008-07-170803; Rodriguez B, 2006, AIDS, V20, P1379, DOI 10.1097/01.aids.0000233571.51899.ab; Santini SM, 2002, J INTERF CYTOK RES, V22, P1071, DOI 10.1089/10799900260442494; Sedaghat AR, 2008, J VIROL, V82, P1870, DOI 10.1128/JVI.02228-07; Siegal FP, 1999, SCIENCE, V284, P1835, DOI 10.1126/science.284.5421.1835; Stylianou E, 2000, CLIN EXP IMMUNOL, V119, P479, DOI 10.1046/j.1365-2249.2000.01144.x; Tilton JC, 2006, J VIROL, V80, P11486, DOI 10.1128/JVI.00324-06; VONSYDOW M, 1991, AIDS RES HUM RETROV, V7, P375, DOI 10.1089/aid.1991.7.375	36	111	113	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e56527	10.1371/journal.pone.0056527	http://dx.doi.org/10.1371/journal.pone.0056527			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437155	Green Submitted, Green Published, gold			2022-12-25	WOS:000315184200093
J	Iwata, T; Chiku, K; Amano, K; Kusumoto, M; Ohnishi-Kameyama, M; Ono, H; Akiba, M				Iwata, Taketoshi; Chiku, Kazuhiro; Amano, Ken-ichi; Kusumoto, Masahiro; Ohnishi-Kameyama, Mayumi; Ono, Hiroshi; Akiba, Masato			Effects of Lipooligosaccharide Inner Core Truncation on Bile Resistance and Chick Colonization by Campylobacter jejuni	PLOS ONE			English	Article							ANTIMICROBIAL RESISTANCE; NATURAL TRANSFORMATION; GANGLIOSIDE MIMICRY; ACID; LIPOPOLYSACCHARIDE; POLYSACCHARIDE; BACTERIA; REVEALS; CMEABC; GENE	Campylobacter jejuni is the most common bacterium that causes diarrhea worldwide, and chickens are considered the main reservoir of this pathogen. This study investigated the effects of serial truncation of lipooligosaccharide (LOS), a major component of the outer membrane of C. jejuni, on its bile resistance and intestinal colonization ability in chickens. Genes encoding manno-heptose synthetases or glycosyltransferases were inactivated to generate isogenic mutants. Serial truncation of the LOS core oligosaccharide caused a stepwise increase in susceptibilities of two C. jejuni strains, NCTC 11168 and 81-176, to bile acids. Inactivation of hldE, hldD, or waaC caused severe truncation of the core oligosaccharide, which greatly increased the susceptibility to bile acids. Both wild-type strains grew normally in chicken intestinal extracts, whereas the mutants with severe oligosaccharide truncation were not detected 12 h after inoculation. These mutants attained viable bacterial counts in the bile acid-free extracts 24 h after inoculation. The wild-type strain 11-164 was present in the cecal contents at >10(7) CFU/g on 5 days after challenge infection and after this time period, whereas its hldD mutant was present at <10(3) CFU/g throughout the experimental period. Trans- complementation of the hldD mutant with the wild-type hldD allele completely restored the in vivo colonization level to that of the wild-type strain. Mutants with a shorter LOS had higher hydrophobicities. Thus, the length of the LOS core oligosaccharide affected the surface hydrophobicity and bile resistance of C. jejuni as well as its ability to colonize chicken intestines.	[Iwata, Taketoshi; Kusumoto, Masahiro; Akiba, Masato] Natl Inst Anim Hlth, Bacterial & Parasit Dis Res Div, Tsukuba, Ibaraki 305, Japan; [Chiku, Kazuhiro; Ohnishi-Kameyama, Mayumi; Ono, Hiroshi] Natl Food Res Inst, Analyt Sci Div, Tsukuba, Ibaraki 305, Japan; [Amano, Ken-ichi] Akita Univ, Biosci Res Educ Ctr, Akita 010, Japan; [Akiba, Masato] Osaka Prefecture Univ, Grad Sch Life & Environm Sci, Izumisano, Osaka, Japan	National Agriculture & Food Research Organization - Japan; National Institute of Animal Health - Japan; National Agriculture & Food Research Organization - Japan; National Food Research Institute - Japan; Akita University; Osaka Metropolitan University	Akiba, M (corresponding author), Natl Inst Anim Hlth, Bacterial & Parasit Dis Res Div, Tsukuba, Ibaraki 305, Japan.	akiba@affrc.go.jp	Kusumoto, Masahiro/B-9616-2014; Chiku, Kazuhiro/O-3055-2018	Chiku, Kazuhiro/0000-0001-6857-8894	Ministry of Agriculture, Forestry, and Fisheries of Japan (Research project for ensuring food safety from farm to table) [DI-5101]	Ministry of Agriculture, Forestry, and Fisheries of Japan (Research project for ensuring food safety from farm to table)	This work was supported in part by a Grant-in-Aid from the Ministry of Agriculture, Forestry, and Fisheries of Japan (Research project for ensuring food safety from farm to table DI-5101). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Akiba M, 2006, J ANTIMICROB CHEMOTH, V57, P52, DOI 10.1093/jac/dki419; Bacon DJ, 2001, MOL MICROBIOL, V40, P769, DOI 10.1046/j.1365-2958.2001.02431.x; Baker J, 1999, AUST VET J, V77, P662, DOI 10.1111/j.1751-0813.1999.tb13159.x; Begley M, 2005, FEMS MICROBIOL REV, V29, P625, DOI 10.1016/j.femsre.2004.09.003; BLACK RE, 1988, J INFECT DIS, V157, P472, DOI 10.1093/infdis/157.3.472; Buswell CM, 1998, APPL ENVIRON MICROB, V64, P733; Buzby JC, 1997, J INFECT DIS, V176, pS192, DOI 10.1086/513785; Coker AO, 2002, EMERG INFECT DIS, V8, P237, DOI 10.3201/eid0803.010233; COLEMAN WG, 1983, J BIOL CHEM, V258, P1985; Edwards AD, 2009, VACCINE, V27, P3897, DOI 10.1016/j.vaccine.2009.04.006; Euzeby JP, 1997, INT J SYST BACTERIOL, V47, P590, DOI 10.1099/00207713-47-2-590; Fernandez-Cruz A, 2010, MEDICINE, V89, P319, DOI 10.1097/MD.0b013e3181f2638d; GREEN J, 1987, POULTRY SCI, V66, P535, DOI 10.3382/ps.0660535; Gudlavalleti SK, 2003, J BIOL CHEM, V278, P3957, DOI 10.1074/jbc.M210491200; Guerry P, 2002, INFECT IMMUN, V70, P787, DOI 10.1128/IAI.70.2.787-793.2002; Gunn JS, 2000, MICROBES INFECT, V2, P907, DOI 10.1016/S1286-4579(00)00392-0; Hansen CR, 2007, LETT APPL MICROBIOL, V45, P599, DOI 10.1111/j.1472-765X.2007.02232.x; HITCHCOCK PJ, 1983, J BACTERIOL, V154, P269, DOI 10.1128/JB.154.1.269-277.1983; Horrocks SM, 2009, ANAEROBE, V15, P18, DOI 10.1016/j.anaerobe.2008.09.001; Inzana TJ, 2002, INFECT IMMUN, V70, P4870, DOI 10.1128/IAI.70.9.4870-4879.2002; Javed MA, 2012, INFECT IMMUN, V80, P2361, DOI 10.1128/IAI.00151-12; Jeon B, 2009, J ANTIMICROB CHEMOTH, V63, P462, DOI 10.1093/jac/dkn529; Kanipes MI, 2006, J BACTERIOL, V188, P3273, DOI 10.1128/JB.188.9.3273-3279.2006; Karlyshev AV, 2005, MOL MICROBIOL, V55, P90, DOI 10.1111/j.1365-2958.2004.04374.x; Lin J, 2002, ANTIMICROB AGENTS CH, V46, P2124, DOI 10.1128/AAC.46.7.2124-2131.2002; Lin J, 2003, INFECT IMMUN, V71, P4250, DOI 10.1128/IAI.71.8.4250-4259.2003; Louis Petra, 2010, Science Progress, V93, P7, DOI 10.3184/003685009X12605525292307; Marsden GL, 2009, J BACTERIOL, V191, P2392, DOI 10.1128/JB.01397-08; MEINERSMANN RJ, 1991, AM J VET RES, V52, P1518; Merritt ME, 2009, J MED MICROBIOL, V58, P1533, DOI 10.1099/jmm.0.014092-0; Miller WG, 2000, APPL ENVIRON MICROB, V66, P5426, DOI 10.1128/AEM.66.12.5426-5436.2000; Naito M, 2010, J BACTERIOL, V192, P2182, DOI 10.1128/JB.01222-09; Nesper J, 2002, INFECT IMMUN, V70, P5990, DOI 10.1128/IAI.70.11.5990-5996.2002; Newell DG, 2003, APPL ENVIRON MICROB, V69, P4343, DOI 10.1128/AEM.69.8.4343-4351.2003; Nichols WA, 1997, INFECT IMMUN, V65, P1377, DOI 10.1128/IAI.65.4.1377-1386.1997; Oakland M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020084; Oldfield NJ, 2002, J BACTERIOL, V184, P2100, DOI 10.1128/JB.184.8.2100-2107.2002; Parkhill J, 2000, NATURE, V403, P665, DOI 10.1038/35001088; PENNER J L, 1988, Clinical Microbiology Reviews, V1, P157; PICKEN RN, 1977, J GEN MICROBIOL, V102, P319, DOI 10.1099/00221287-102-2-319; Pigrau C, 1997, CLIN INFECT DIS, V25, P1414, DOI 10.1086/516127; Preston A, 1996, CRIT REV MICROBIOL, V22, P139, DOI 10.3109/10408419609106458; Raetz CRH, 2007, ANNU REV BIOCHEM, V76, P295, DOI 10.1146/annurev.biochem.76.010307.145803; ROSENBERG M, 1980, FEMS MICROBIOL LETT, V9, P29, DOI 10.1016/0378-1097(80)90106-8; Sahm D.H., 1991, MANUAL CLIN MICROBIO; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; Smith DP, 2005, J FOOD PROTECT, V68, P1340, DOI 10.4315/0362-028X-68.7.1340; Szymanski CM, 2003, J BIOL CHEM, V278, P24509, DOI 10.1074/jbc.M301273200; Szymanski CM, 2003, TRENDS MICROBIOL, V11, P233, DOI 10.1016/S0966-842X(03)00079-9; Therisod H, 2001, ANAL CHEM, V73, P3804, DOI 10.1021/ac010313s; WANG Y, 1990, GENE, V94, P23, DOI 10.1016/0378-1119(90)90463-2; WANG Y, 1990, J BACTERIOL, V172, P949, DOI 10.1128/JB.172.2.949-955.1990; Wilson DJ, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000203; YORK WS, 1985, CARBOHYD RES, V138, P109, DOI 10.1016/0008-6215(85)85228-9; Yuki N, 2005, CURR OPIN NEUROL, V18, P557, DOI 10.1097/01.wco.0000174604.42272.2d	55	16	16	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e56900	10.1371/journal.pone.0056900	http://dx.doi.org/10.1371/journal.pone.0056900			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437265	Green Published, Green Submitted, gold			2022-12-25	WOS:000315184200180
J	Jang, S; Morris, S; Lukacs, NW				Jang, Sihyug; Morris, Susan; Lukacs, Nicholas W.			TSLP Promotes Induction of Th2 Differentiation but Is Not Necessary during Established Allergen-Induced Pulmonary Disease	PLOS ONE			English	Article							THYMIC STROMAL LYMPHOPOIETIN; T-CELL DIFFERENTIATION; IMMUNE-RESPONSES; DENDRITIC CELLS; AIRWAY HYPERREACTIVITY; HELMINTH INFECTION; INFLAMMATION; EXPRESSION; ASTHMA; MICE	Thymic stromal lymphopoietin (TSLP) has been implicated in the development of allergic inflammation by promoting Th2-type responses and has become a potential therapeutic target. Using in vitro T cell differentiation cultures we were able to validate that TSLP played a more critical role in the early development of Th2 immune responses with less significant enhancement of already developed Th2 responses. Adoptive transfer of naive DO11.10 ovalbumin-specific T cells followed by airway exposure to ovalbumin showed an early impairment of Th2 immune response in TSLP-/- mice compared to wild type mice during the development of a Th2 response. In contrast, transfer of already differentiated Th2 cells into TSLP-/- mice did not change lung pathology or Th2 cytokine production upon ovalbumin challenge compared to transfer into wild type mice. An allergen-induced Th2 airway model demonstrated that there was only a difference in gob5 expression (a mucus-associated gene) between wild type and TSLP-/- mice. Furthermore, when allergic animals with established disease were treated with a neutralizing anti-TSLP antibody there was no change in airway hyperreponsiveness (AHR) or Th2 cytokine production compared to the control antibody treated animals, whereas a change in gob5 gene expression was also observed similar to the TSLP-/- mouse studies. In contrast, when animals were treated with anti-TSLP during the initial stages of allergen sensitization there was a significant change in Th2 cytokines during the final allergen challenge. Collectively, these studies suggest that in mice TSLP has an important role during the early development of Th2 immune responses, whereas its role at later stages of allergic disease may not be as critical for maintaining the Th2-driven allergic disease.	[Jang, Sihyug; Morris, Susan; Lukacs, Nicholas W.] Univ Michigan, Dept Pathol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Lukacs, NW (corresponding author), Univ Michigan, Dept Pathol, Ann Arbor, MI 48109 USA.	nlukacs@umich.edu	Lukacs, Nicholas W/ABH-5583-2020		NIH [AI032302]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL059178] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI032302] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was funded by a NIH grant AI032302. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Shami A, 2005, J EXP MED, V202, P829, DOI 10.1084/jem.20050199; Al-Shami A, 2004, J EXP MED, V200, P159, DOI 10.1084/jem.20031975; Allakhverdi Z, 2009, J ALLERGY CLIN IMMUN, V123, P472, DOI 10.1016/j.jaci.2008.10.022; Berlin AA, 2006, LAB INVEST, V86, P557, DOI 10.1038/labinvest.3700419; Besin G, 2008, DIABETES, V57, P2107, DOI 10.2337/db08-0171; Blazquez AB, 2010, GASTROENTEROLOGY, V139, P1301, DOI 10.1053/j.gastro.2010.06.055; Campbell EM, 1999, J IMMUNOL, V163, P2160; Campbell EM, 1998, J IMMUNOL, V161, P7047; Demehri S, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000067; Dolgachev V, 2009, J IMMUNOL, V183, P5705, DOI 10.4049/jimmunol.0901666; Ebner S, 2007, J ALLERGY CLIN IMMUN, V119, P982, DOI 10.1016/j.jaci.2007.01.003; Han H, 2012, MUCOSAL IMMUNOL, V5, P342, DOI 10.1038/mi.2012.14; Han J, 2012, J ALLERGY CLIN IMMUN, V130, p[1175, e1179]; Humphreys NE, 2008, J IMMUNOL, V180, P2443, DOI 10.4049/jimmunol.180.4.2443; Ito T, 2005, J EXP MED, V202, P1213, DOI 10.1084/jem.20051135; Iwasaki M, 2002, J INVEST DERMATOL, V119, P609, DOI 10.1046/j.1523-1747.2002.01862.x; Jariwala S, 2011, CLIN EXP ALLERGY; Kato A, 2007, J IMMUNOL, V179, P1080, DOI 10.4049/jimmunol.179.2.1080; Kim S, 2010, J IMMUNOL, V184, P1143, DOI 10.4049/jimmunol.0902447; Kitajima M, 2011, EUR J IMMUNOL, V41, P1862, DOI 10.1002/eji.201041195; Lee HC, 2012, J ALLERGY CLIN IMMUN, V130, P1187, DOI 10.1016/j.jaci.2012.07.031; Leonard WJ, 2002, NAT IMMUNOL, V3, P605, DOI 10.1038/ni0702-605; Liu YJ, 2006, J EXP MED, V203, P269, DOI 10.1084/jem.20051745; Liu YJ, 2007, J ALLERGY CLIN IMMUN, V120, P238, DOI 10.1016/j.jaci.2007.06.004; Liu YJ, 2007, ANNU REV IMMUNOL, V25, P193, DOI 10.1146/annurev.immunol.25.022106.141718; Lu N, 2009, J EXP MED, V206, P2111, DOI 10.1084/jem.20090153; Martinez Fernando D, 2009, Proc Am Thorac Soc, V6, P272, DOI 10.1513/pats.200808-092RM; Massacand JC, 2009, P NATL ACAD SCI USA, V106, P13968, DOI 10.1073/pnas.0906367106; Mazzucchelli R, 2008, BLOOD, V112, P3283, DOI 10.1182/blood-2008-02-137414; Miyata M, 2008, EUR J IMMUNOL, V38, P1487, DOI 10.1002/eji.200737809; Miyata M, 2009, EUR J IMMUNOL, V39, P3078, DOI 10.1002/eji.200939302; Nguyen Khoa D, 2010, Allergy Asthma Clin Immunol, V6, P4, DOI 10.1186/1710-1492-6-4; Ober C, 2011, IMMUNOL REV, V242, P10, DOI 10.1111/j.1600-065X.2011.01029.x; Okayama Y, 2009, EUR RESPIR J, V34, P425, DOI 10.1183/09031936.00121008; Omori M, 2007, J IMMUNOL, V178, P1396, DOI 10.4049/jimmunol.178.3.1396; Oyoshi MK, 2010, J ALLERGY CLIN IMMUN, V126, P976, DOI 10.1016/j.jaci.2010.08.041; Pandey A, 2000, NAT IMMUNOL, V1, P59, DOI 10.1038/76923; Paul WE, 2010, NAT REV IMMUNOL, V10, P225, DOI 10.1038/nri2735; Qiao JO, 2011, IMMUNOL CELL BIOL, V89, P231, DOI 10.1038/icb.2010.85; Ramalingam TR, 2009, J IMMUNOL, V182, P6452, DOI 10.4049/jimmunol.0900181; ROBINSON DS, 1992, NEW ENGL J MED, V326, P298, DOI 10.1056/NEJM199201303260504; Saenz SA, 2008, IMMUNOL REV, V226, P172, DOI 10.1111/j.1600-065X.2008.00713.x; Seshasayee D, 2007, J CLIN INVEST, V117, P3868, DOI 10.1172/JCI33559; Siracusa MC, 2011, NATURE, V477, P229, DOI 10.1038/nature10329; Smith K, 2009, J ASTHMA, V46, P234, DOI 10.1080/02770900802627294; Sokol CL, 2008, NAT IMMUNOL, V9, P310, DOI 10.1038/ni1558; Soumelis V, 2002, NAT IMMUNOL, V3, P673, DOI 10.1038/ni805; Spadoni I, 2012, MUCOSAL IMMUNOL, V5, P184, DOI 10.1038/mi.2011.64; Tang H, 2010, NAT IMMUNOL, V11, P608, DOI 10.1038/ni.1883; Taylor BC, 2009, J EXP MED, V206, P655, DOI 10.1084/jem.20081499; Tekkanat KK, 2001, J IMMUNOL, V166, P3542, DOI 10.4049/jimmunol.166.5.3542; Wang YH, 2009, CLIN EXP ALLERGY, V39, P798, DOI 10.1111/j.1365-2222.2009.03241.x; Wang YH, 2007, J EXP MED, V204, P1837, DOI 10.1084/jem.20070406; Wang YH, 2006, IMMUNITY, V24, P827, DOI 10.1016/j.immuni.2006.03.019; Wills-Karp M, 1999, ANNU REV IMMUNOL, V17, P255, DOI 10.1146/annurev.immunol.17.1.255; Ying S, 2005, J IMMUNOL, V174, P8183, DOI 10.4049/jimmunol.174.12.8183; Yoo J, 2005, J EXP MED, V202, P541, DOI 10.1084/jem.20041503; Zhang F, 2011, CLIN EXP IMMUNOL, V164, P256, DOI 10.1111/j.1365-2249.2011.04328.x; Zhang Z, 2009, P NATL ACAD SCI USA, V106, P1536, DOI 10.1073/pnas.0812668106; Zhou BH, 2005, NAT IMMUNOL, V6, P1047, DOI 10.1038/ni1247; Ziegler SF, 2010, NAT IMMUNOL, V11, P289, DOI 10.1038/ni.1852	61	31	32	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e56433	10.1371/journal.pone.0056433	http://dx.doi.org/10.1371/journal.pone.0056433			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437132	Green Published, Green Submitted, gold			2022-12-25	WOS:000315184200073
J	Pedersen, R; Ingerslev, HC; Sturek, M; Alloosh, M; Cirera, S; Christoffersen, BO; Moesgaard, SG; Larsen, N; Boye, M				Pedersen, Rebecca; Ingerslev, Hans-Christian; Sturek, Michael; Alloosh, Mouhamad; Cirera, Susanna; Christoffersen, Berit O.; Moesgaard, Sophia G.; Larsen, Niels; Boye, Mette			Characterisation of Gut Microbiota in Ossabaw and Gottingen Minipigs as Models of Obesity and Metabolic Syndrome	PLOS ONE			English	Article							HIGH-FAT-DIET; CORONARY-ARTERY-DISEASE; INSULIN-RESISTANCE; DISTAL GUT; TIME; PCR; MICROFLORA; INCREASES; GLUCOSE	Background: Recent evidence suggests that the gut microbiota is an important contributing factor to obesity and obesity related metabolic disorders, known as the metabolic syndrome. The aim of this study was to characterise the intestinal microbiota in two pig models of obesity namely Gottingen minipigs and the Ossabaw minipigs. Methods and Findings: The cecal, ileal and colonic microbiota from lean and obese Osabaw and Gottingen minipigs were investigated by Illumina-based sequencing and by high throughput qPCR, targeting the 16S rRNA gene in different phylogenetic groups of bacteria. The weight gain through the study was significant in obese Gottingen and Ossabaw minipigs. The lean Gottingen minipigs' cecal microbiota contained significantly higher abundance of Firmicutes (P<0.006), Akkermensia (P<0.01) and Methanovibribacter (P<0.01) than obese Gottingen minipigs. The obese Gottingen cecum had higher abundances of the phyla Spirochaetes (P<0.03), Tenericutes (P<0.004), Verrucomicrobia (P<0.005) and the genus Bacteroides (P<0.001) compared to lean minipigs. The relative proportion of Clostridium cluster XIV was 7.6-fold higher in cecal microbiota of obese Gottingen minipigs as compared to lean. Obese Ossabaw minipigs had a higher abundance of Firmicutes in terminal ileum and lower abundance of Gottingen in colon than lean Ossabaw minipigs (P<0.01). Obese Ossabaws had significantly lower abundances of the genera Prevotella and Lactobacillus and higher abundance of Clostridium in their colon than the lean Ossabaws. Overall, the Gottingen and Ossabaw minipigs displayed different microbial communities in response to diet-induced obesity in the different sections of their intestine. Conclusion: Obesity-related changes in the composition of the gut microbiota were found in lean versus obese Gottingen and Ossabaw minipigs. In both pig models diet seems to be the defining factor that shapes the gut microbiota as observed by changes in different bacteria divisions between lean and obese minipigs.	[Pedersen, Rebecca; Ingerslev, Hans-Christian; Boye, Mette] Tech Univ Denmark, Natl Vet Inst, Dept Bacteriol Pathol & Parasitol, Frederiksberg C, Denmark; [Sturek, Michael; Alloosh, Mouhamad] Indiana Univ Sch Med, Dept Cellular & Integrat Physiol, Indianapolis, IN USA; [Cirera, Susanna] Tech Univ Denmark, Fac Hlth & Med Sci, Dept Vet Clin & Anim Sci, Frederiksberg C, Denmark; [Christoffersen, Berit O.; Moesgaard, Sophia G.] Novo Nordisk AS, Malov, Denmark; [Larsen, Niels] Danish Genome Inst, Aarhus C, Denmark	Technical University of Denmark; Indiana University System; Indiana University Bloomington; Technical University of Denmark; Novo Nordisk	Boye, M (corresponding author), Tech Univ Denmark, Natl Vet Inst, Dept Bacteriol Pathol & Parasitol, Frederiksberg C, Denmark.	mboy@vet.dtu.dk	Ingerslev, Hans-Christian/AAP-6079-2020; Cirera, Susanna/K-8540-2017; Sturek, Michael/CAH-2948-2022	Cirera, Susanna/0000-0001-8105-1579; Ingerslev, Hans-Christian/0000-0002-9761-7474	SHARE Foundation; Danielsen's Foundation; United States National Institutes of Health [HL062552]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL062552] Funding Source: NIH RePORTER	SHARE Foundation; Danielsen's Foundation; United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The lean Gottingen minipigs were funded by the SHARE Foundation and Danielsen's Foundation. Ossabaw minipig studies were funded by the United States National Institutes of Health grant HL062552. The characterization of Gottingen minipigs and Ossabaw minipigs has only been possible due to collaborations between research groups at Copenhagen University, Novo Nordisk A/S and Indiana University School of Medicine. The study sponsors have no involvement in the publication of this article. The funders of our study had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Armougom F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007125; Backhed F, 2004, P NATL ACAD SCI USA, V101, P15718, DOI 10.1073/pnas.0407076101; Backhed F, 2007, P NATL ACAD SCI USA, V104, P979, DOI 10.1073/pnas.0605374104; Bellinger DA, 2006, ILAR J, V47, P243, DOI 10.1093/ilar.47.3.243; Cani PD, 2008, PATHOL BIOL, V56, P305, DOI 10.1016/j.patbio.2007.09.008; Cani PD, 2007, DIABETOLOGIA, V50, P2374, DOI 10.1007/s00125-007-0791-0; Cani PD, 2008, DIABETES, V57, P1470, DOI 10.2337/db07-1403; Cani PD, 2007, DIABETES, V56, P1761, DOI 10.2337/db06-1491; Cani PD, 2011, PHARMACOL THERAPEUT, V130, P202, DOI 10.1016/j.pharmthera.2011.01.012; Cirera S, 2012, IMMUNITY UNPUB; Cleophas TJ., 2011, STAT ANAL CLIN DATA, pp. 41; Creely SJ, 2007, AM J PHYSIOL-ENDOC M, V292, pE740, DOI 10.1152/ajpendo.00302.2006; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Dyson MC, 2006, COMPARATIVE MED, V56, P35; Grundy SM, 2004, CIRCULATION, V109, P433, DOI 10.1161/01.CIR.0000111245.75752.C6; Guo X, 2008, LETT APPL MICROBIOL, V47, P367, DOI 10.1111/j.1472-765X.2008.02408.x; Guo XL, 2008, ANAEROBE, V14, P224, DOI 10.1016/j.anaerobe.2008.04.001; Hansen CHF, 2012, DIABETOLOGIA, V55, P2285, DOI 10.1007/s00125-012-2564-7; Hansen EE, 2011, P NATL ACAD SCI USA, V108, P4599, DOI 10.1073/pnas.1000071108; Hildebrandt MA, 2009, GASTROENTEROLOGY, V137, P1716, DOI 10.1053/j.gastro.2009.08.042; HILL MO, 1973, ECOLOGY, V54, P427, DOI 10.2307/1934352; Johansen T, 2001, COMPARATIVE MED, V51, P150; Jumpertz R, 2011, AM J CLIN NUTR, V94, P58, DOI 10.3945/ajcn.110.010132; Lam YY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034233; Larsen MO, 2005, AM J PHYSIOL-ENDOC M, V288, pE412, DOI 10.1152/ajpendo.00352.2004; Larsen MO, 2002, ANN NY ACAD SCI, V967, P414; Larsen N, 2012, BION META 16S UNPUB; Larsen N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009085; Lee L, 2009, HEPATOLOGY, V50, P56, DOI 10.1002/hep.22904; Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; Litten-Brown JC, 2010, ANIMAL, V4, P899, DOI 10.1017/S1751731110000200; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MANN HB, 1947, ANN MATH STAT, V18, P50, DOI 10.1214/aoms/1177730491; McKight P.E., 2010, CORSINI ENCY PSYCHOL, DOI 10.1002/9780470479216; Murphy EF, 2010, GUT, V59, P1635, DOI 10.1136/gut.2010.215665; Neeb ZP, 2010, COMPARATIVE MED, V60, P300; Schwiertz A, 2010, OBESITY, V18, P190, DOI 10.1038/oby.2009.167; Serino M, 2012, GUT, V61, P543, DOI 10.1136/gutjnl-2011-301012; Turnbaugh PJ, 2008, CELL HOST MICROBE, V3, P213, DOI 10.1016/j.chom.2008.02.015; World Health Organization, 2022, OB OV	41	84	89	0	80	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e56612	10.1371/journal.pone.0056612	http://dx.doi.org/10.1371/journal.pone.0056612			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437186	Green Published, gold, Green Submitted			2022-12-25	WOS:000315184200120
J	Rinnan, R; Michelsen, A; Baath, E				Rinnan, Riikka; Michelsen, Anders; Baath, Erland			Fungi Benefit from Two Decades of Increased Nutrient Availability in Tundra Heath Soil	PLOS ONE			English	Article							CLIMATE-CHANGE; ENVIRONMENTAL PERTURBATIONS; CARBON TURNOVER; FATTY-ACIDS; NITROGEN; RESPONSES; ECOSYSTEM; PLANTS; MINERALIZATION; COMMUNITY	If microbial degradation of carbon substrates in arctic soil is stimulated by climatic warming, this would be a significant positive feedback on global change. With data from a climate change experiment in Northern Sweden we show that warming and enhanced soil nutrient availability, which is a predicted long-term consequence of climatic warming and mimicked by fertilization, both increase soil microbial biomass. However, while fertilization increased the relative abundance of fungi, warming caused only a minimal shift in the microbial community composition based on the phospholipid fatty acid (PLFA) and neutral lipid fatty acid (NLFA) profiles. The function of the microbial community was also differently affected, as indicated by stable isotope probing of PLFA and NLFA. We demonstrate that two decades of fertilization have favored fungi relative to bacteria, and increased the turnover of complex organic compounds such as vanillin, while warming has had no such effects. Furthermore, the NLFA-to-PLFA ratio for C-13-incorporation from acetate increased in warmed plots but not in fertilized ones. Thus, fertilization cannot be used as a proxy for effects on warming in arctic tundra soils. Furthermore, the different functional responses suggest that the biomass increase found in both fertilized and warmed plots was mediated via different mechanisms.	[Rinnan, Riikka; Baath, Erland] Lund Univ, Dept Biol, Lund, Sweden; [Rinnan, Riikka; Michelsen, Anders] Univ Copenhagen, Dept Biol, Copenhagen, Denmark; [Rinnan, Riikka; Michelsen, Anders] Univ Copenhagen, Ctr Permafrost CENPERM, Copenhagen, Denmark	Lund University; University of Copenhagen; University of Copenhagen	Baath, E (corresponding author), Lund Univ, Dept Biol, Lund, Sweden.	erland.baath@biol.lu.se	Rinnan, Riikka/AAB-8552-2019; Rinnan, Riikka/C-9771-2010; Michelsen, Anders/L-5279-2014	Rinnan, Riikka/0000-0001-7222-700X; Rinnan, Riikka/0000-0001-7222-700X; Michelsen, Anders/0000-0002-9541-8658; Baath, Erland/0000-0002-2616-1342	Academy of Finland [108277]; European Commission [MEIF-CT-20065-024364]; Swedish Research Council [621-2009-4503]; Danish Council for Independent Research/Nature and Universe [10-084285]; Danish National Research Foundation	Academy of Finland(Academy of Finland); European Commission(European CommissionEuropean Commission Joint Research Centre); Swedish Research Council(Swedish Research CouncilEuropean Commission); Danish Council for Independent Research/Nature and Universe(Det Frie Forskningsrad (DFF)); Danish National Research Foundation(Danmarks Grundforskningsfond)	RR was supported by the Academy of Finland (decision no. 108277) and the European Commission (MEIF-CT-20065-024364). EB was supported by the Swedish Research Council (grant 621-2009-4503). AM was supported by the Danish Council for Independent Research/Nature and Universe (grant 10-084285). This work was part of LUCCI (Lund University Centre for Studies of Carbon Cycle and Climate Interactions) and the Center for Permafrost (CENPERM) funded by the Danish National Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham WR, 1998, APPL ENVIRON MICROB, V64, P4202; Andresen LC, 2008, PLANT SOIL, V313, P283, DOI 10.1007/s11104-008-9700-7; [Anonymous], 1997, INTRO SOIL MICROBIOL; Baath E, 2003, MICROBIAL ECOL, V45, P373, DOI 10.1007/s00248-003-2002-y; Bais HP, 2006, ANNU REV PLANT BIOL, V57, P233, DOI 10.1146/annurev.arplant.57.032905.105159; Berg Bjorn, 1997, Environmental Reviews, V5, P1, DOI 10.1139/er-5-1-1; BOSCHKER H. T. S., 2004, MOL MICROBIAL ECOLOG, P1673; Campioli M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034842; Carreiro MM, 2000, ECOLOGY, V81, P2359, DOI 10.1890/0012-9658(2000)081[2359:MESELD]2.0.CO;2; Cornelissen JHC, 2007, ECOL LETT, V10, P619, DOI 10.1111/j.1461-0248.2007.01051.x; DeForest JL, 2004, SOIL SCI SOC AM J, V68, P132, DOI 10.2136/sssaj2004.1320; Deslippe JR, 2011, GLOBAL CHANGE BIOL, V17, P1625, DOI 10.1111/j.1365-2486.2010.02318.x; Edwards IP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020421; FLAIG W, 1964, GEOCHIM COSMOCHIM AC, V28, P1523, DOI 10.1016/0016-7037(64)90003-1; Forsius M, 2010, AMBIO, V39, P136, DOI 10.1007/s13280-010-0022-7; Frostegard A, 1996, BIOL FERT SOILS, V22, P59, DOI 10.1007/BF00384433; FROSTEGARD A, 1991, J MICROBIOL METH, V14, P151, DOI 10.1016/0167-7012(91)90018-L; Frostegard A, 2011, SOIL BIOL BIOCHEM, V43, P1621, DOI 10.1016/j.soilbio.2010.11.021; Graglia E, 2001, ECOGRAPHY, V24, P5, DOI 10.1034/j.1600-0587.2001.240102.x; Hansen AH, 2006, OECOLOGIA, V147, P1, DOI 10.1007/s00442-005-0233-y; HAVSTROM M, 1993, OIKOS, V66, P389, DOI 10.2307/3544933; IPCC, 2007, CONTRIBUTION WORKING; Jastrow JD, 2007, CLIMATIC CHANGE, V80, P5, DOI 10.1007/s10584-006-9178-3; Jonasson S, 2006, SOIL BIOL BIOCHEM, V38, P526, DOI 10.1016/j.soilbio.2005.05.024; Jonasson S, 2001, GLOBAL BIOGEOCHEMICA, P139; Kuzyakov Y, 2010, SOIL BIOL BIOCHEM, V42, P1363, DOI 10.1016/j.soilbio.2010.04.003; Mack MC, 2004, NATURE, V431, P440, DOI 10.1038/nature02887; Michelsen A, 1996, OECOLOGIA, V105, P1, DOI 10.1007/BF00328785; Michelsen A, 2012, AMBIO, V41, P218, DOI 10.1007/s13280-012-0303-4; Neff JC, 2002, NATURE, V419, P915, DOI 10.1038/nature01136; Olsson PA, 2005, APPL ENVIRON MICROB, V71, P2592, DOI 10.1128/AEM.71.5.2592-2599.2005; Rinnan R, 2007, SOIL BIOL BIOCHEM, V39, P3014, DOI 10.1016/j.soilbio.2007.05.035; Rinnan R, 2007, GLOBAL CHANGE BIOL, V13, P28, DOI 10.1111/j.1365-2486.2006.01263.x; Rinnan R, 2009, APPL ENVIRON MICROB, V75, P3611, DOI 10.1128/AEM.02865-08; Ruess L, 1999, PLANT SOIL, V212, P63, DOI 10.1023/A:1004567816355; Rustad LE, 2001, OECOLOGIA, V126, P543, DOI 10.1007/s004420000544; Schmidt IK, 1999, APPL SOIL ECOL, V11, P147, DOI 10.1016/S0929-1393(98)00147-4; Sorensen LI, 2006, POLAR BIOL, V29, P189, DOI 10.1007/s00300-005-0038-9; Sorensen PL, 2012, PLANT ECOL, V213, P695, DOI 10.1007/s11258-012-0034-4; Sorensen PL, 2008, ECOSYSTEMS, V11, P1223, DOI 10.1007/s10021-008-9204-6; Strickland MS, 2010, SOIL BIOL BIOCHEM, V42, P1385, DOI 10.1016/j.soilbio.2010.05.007; Sturm M, 2001, NATURE, V411, P546, DOI 10.1038/35079180; van Wijk MT, 2004, GLOBAL CHANGE BIOL, V10, P105, DOI 10.1111/j.1365-2486.2003.00719.x; Waldrop MP, 2006, ECOSYSTEMS, V9, P921, DOI 10.1007/s10021-004-0149-0; Walker MD, 2006, P NATL ACAD SCI USA, V103, P1342, DOI 10.1073/pnas.0503198103; Wardle D.A, 2002, MG POP BIOL, V34, P1, DOI 10.1515/9781400847297; Wixon DL, 2013, SOIL BIOL BIOCHEM, V57, P769, DOI 10.1016/j.soilbio.2012.08.016	47	15	15	4	104	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e56532	10.1371/journal.pone.0056532	http://dx.doi.org/10.1371/journal.pone.0056532			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437159	Green Submitted, gold, Green Published			2022-12-25	WOS:000315184200097
J	Zhao, XD; Zhang, W; Liang, HJ; Ji, WY				Zhao, Xu-dong; Zhang, Wei; Liang, Hong-jun; Ji, Wen-yue			Overexpression of miR-155 Promotes Proliferation and Invasion of Human Laryngeal Squamous Cell Carcinoma via Targeting SOCS1 and STAT3	PLOS ONE			English	Article							BREAST-CANCER CELLS; EXPRESSION; ACTIVATION; CYTOKINE; TUMOR; GENE; INHIBITOR; GROWTH	MicroRNA155 plays an important role in many solid malignancies. Expression and function of miR-155 in laryngeal carcinoma have not been fully understood. This study aims to investigate the expression and function of miR-155 in laryngeal squamous cell carcinoma (LSCC), the relationship between miR-155 and its downstream target suppressor of cytokine signaling 1 (SOCS1)-STAT3 pathway, and the related clinicopathological factors. Sixty-three samples of laryngeal squamous cell carcinoma and twenty-one samples of control mucosa obtained from total laryngectomy cases were analyzed using Western blot analysis and real-time PCR. Hep-2 cells were cultured and transfected with miR-155 mimic and ASO. Cell proliferation, migration and invasion assays were used to determine the role of miR-155 in regulation of LSCC growth, migration, and invasion, respectively. The expression levels of miR-155 in LSCC were significantly higher than those in the control mucosa tissues. Downregulation of SOCS1 expression and elevated expression of STAT3 were also observed in LSCC. The relevance of the three factors were statistically significant. Moreover, knockdown of miR-155 elevated SOCS1expression level, suppressed STAT3 expression, and inhibited hep-2 cells growth, migration and invasion. Whereas overexpression of miR-155 inhibited SOCS1expression, elevated STAT3 expression, and promoted hep-2 cells growth, migration and invasion. Furthermore, the miR-155 levels in T-3 T-4 stages, and poor/moderate cell differentiation were significantly higher than those in T-2 stage and higher degree of cell differentiation. The STAT3 protein in poor/moderate cell differentiation was significantly higher than those in higher degree of cell differentiation. We firstly demonstrated the aberrant expression and function of miR-155 and its downstream targets in LSCC. The current findings suggest that miR-155 play promotingrole during the development of LSCC, and miR-155 may be a useful marker for the prognosis and assessment of therapeutic effects.	[Zhao, Xu-dong; Ji, Wen-yue] China Med Univ, Shengjing Hosp, Dept Otorhinolaryngol, Shenyang, Peoples R China; [Zhang, Wei] China Med Univ, Shengjing Hosp, Dept Endocrinol, Shenyang, Peoples R China; [Liang, Hong-jun] China Med Univ, Educ Adm Off, Shenyang, Peoples R China	China Medical University; China Medical University; China Medical University	Ji, WY (corresponding author), China Med Univ, Shengjing Hosp, Dept Otorhinolaryngol, Shenyang, Peoples R China.	jiwenyue@yahoo.cn			Liaoning Province Science Found Subject, "Laryngeal cancer surgical genetic diagnosis and treatment''	Liaoning Province Science Found Subject, "Laryngeal cancer surgical genetic diagnosis and treatment''	The funding of this work is Liaoning Province Science Found Subject, "Laryngeal cancer surgical genetic diagnosis and treatment.'' The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaronson DS, 2002, SCIENCE, V296, P1653, DOI 10.1126/science.1071545; Bakirtzi K, 2011, GASTROENTEROLOGY, V141, P1749, DOI 10.1053/j.gastro.2011.07.038; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Chu PY, 2010, SWISS MED WKLY, V140, DOI 10.4414/smw.2010.13065; Du ZM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019137; Dunlop EA, 2007, STEM CELLS, V25, P380, DOI 10.1634/stemcells.2006-0452; Eis PS, 2005, P NATL ACAD SCI USA, V102, P3627, DOI 10.1073/pnas.0500613102; Evans MK, 2007, ONCOGENE, V26, P1941, DOI 10.1038/sj.onc.1209993; Genden EM, 2007, ORAL ONCOL, V43, P431, DOI 10.1016/j.oraloncology.2006.08.007; Huang FJ, 2008, CANCER RES, V68, P9634, DOI 10.1158/0008-5472.CAN-08-1429; Jiang SA, 2010, CANCER RES, V70, P3119, DOI 10.1158/0008-5472.CAN-09-4250; Kim BH, 2011, EXP MOL MED, V43, P313, DOI [10.3858/emm.2011.43.5.035, 10.3858/emm.2011.43.2.035]; Kluge A, 2011, MOL ONCOL, V5, P256, DOI 10.1016/j.molonc.2011.03.004; Komazaki T, 2004, JPN J CLIN ONCOL, V34, P191, DOI 10.1093/jjco/hyh035; Lagos-Quintana M, 2002, CURR BIOL, V12, P735, DOI 10.1016/S0960-9822(02)00809-6; Ling Hui, 2011, Chin J Cancer, V30, P739, DOI 10.5732/cjc.011.10243; Liu B, 2008, LARYNGOSCOPE, V118, P1976, DOI 10.1097/MLG.0b013e31817fd3fa; Liu J, 2011, INT J CANC; Liu Y, 2011, CANCER PREV RES, V4, P1296, DOI 10.1158/1940-6207.CAPR-10-0317; O Flowers L, 2005, ONCOGENE, V24, P2114, DOI 10.1038/sj.onc.1208437; Park YJ, 2007, BIOCHEM BIOPH RES CO, V363, P361, DOI 10.1016/j.bbrc.2007.08.195; Saito M, 2011, CLIN CANCER RES, V17, P1875, DOI 10.1158/1078-0432.CCR-10-2961; Starr R, 1997, NATURE, V387, P917, DOI 10.1038/43206; Starska K, 2009, FOLIA HISTOCHEM CYTO, V47, P401, DOI 10.2478/v10042-009-0075-2; Wang FJ, 2010, GYNECOL ONCOL, V119, P586, DOI 10.1016/j.ygyno.2010.07.021; Xie Q, 2011, CANCER; Xiong H, 2011, MOL CARCINOGENESIS	28	43	43	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e56395	10.1371/journal.pone.0056395	http://dx.doi.org/10.1371/journal.pone.0056395			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437123	Green Submitted, gold, Green Published			2022-12-25	WOS:000315184200067
J	Arias, SCA; Valente, CP; Machado, FG; Fanelli, C; Origassa, CST; de Brito, T; Camara, NOS; Malheiros, DMAC; Zatz, R; Fujihara, CK				Alarcon Arias, Simone Costa; Valente, Carla Perez; Machado, Flavia Gomes; Fanelli, Camilla; Taemi Origassa, Clarice Silvia; de Brito, Thales; Saraiva Camara, Niels Olsen; Avancini Costa Malheiros, Denise Maria; Zatz, Roberto; Fujihara, Clarice Kazue			Regression of Albuminuria and Hypertension and Arrest of Severe Renal Injury by a Losartan-Hydrochlorothiazide Association in a Model of Very Advanced Nephropathy	PLOS ONE			English	Article							CONVERTING-ENZYME-INHIBITOR; RENIN-ANGIOTENSIN SYSTEM; LIMITS GLOMERULAR INJURY; LIPID-LOWERING TREATMENT; REMNANT KIDNEY MODEL; ATTACK TRIAL ALLHAT; MYCOPHENOLATE-MOFETIL; DIABETIC-NEPHROPATHY; NEPHRECTOMIZED RATS; METABOLIC SYNDROME	Treatments that effectively prevent chronic kidney disease (CKD) when initiated early often yield disappointing results when started at more advanced phases. We examined the long-term evolution of renal injury in the 5/6 nephrectomy model (Nx) and the effect of an association between an AT-1 receptor blocker, losartan (L), and hydrochlorothiazide (H), shown previously to be effective when started one month after Nx. Adult male Munich-Wistar rats underwent Nx, being divided into four groups: Nx+V, no treatment; Nx+L, receiving L monotherapy; Nx+LH, receiving the L+H association (LH), and Nx+AHHz, treated with the calcium channel blocker, amlodipine, the vascular relaxant, hydralazine, and H. This latter group served to assess the effect of lowering blood pressure (BP). Rats undergoing sham nephrectomy (S) were also studied. In a first protocol, treatments were initiated 60 days after Nx, when CKD is at a relatively early stage. In a second protocol, treatments were started 120 days after Nx, when glomerulosclerosis and interstitial fibrosis are already advanced. In both protocols, L treatment promoted only partial renoprotection, whereas LH brought BP, albuminuria, tubulointerstitial cell proliferation and plasma aldosterone below pretreatment levels, and completely detained progression of renal injury. Despite normalizing BP, the AHHz association failed to prevent renal damage, indicating that the renoprotective effect of LH was not due to a systemic hemodynamic action. These findings are inconsistent with the contention that thiazides are innocuous in advanced CKD. In Nx, LH promotes effective renoprotection even at advanced stages by mechanisms that may involve anti-inflammatory and intrarenal hemodynamic effects, but seem not to require BP normalization.	[Alarcon Arias, Simone Costa; Valente, Carla Perez; Machado, Flavia Gomes; Fanelli, Camilla; Avancini Costa Malheiros, Denise Maria; Zatz, Roberto; Fujihara, Clarice Kazue] Univ Sao Paulo, Fac Med, Dept Clin Med, Renal Div,Lab Renal Pathophysiol LIM 16, Sao Paulo, Brazil; [de Brito, Thales] Univ Sao Paulo, Fac Med, Dept Pathol, Sao Paulo, Brazil; [Taemi Origassa, Clarice Silvia; Saraiva Camara, Niels Olsen] Univ Sao Paulo, Fac Med, Immunol Lab, Div Nephrol, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo	Zatz, R (corresponding author), Univ Sao Paulo, Fac Med, Dept Clin Med, Renal Div,Lab Renal Pathophysiol LIM 16, Sao Paulo, Brazil.	r.zatz@uol.com.br	Origassa, Clarice/C-2676-2012; Fanelli, Camilla/D-6287-2012; Zatz, Roberto/D-5716-2012; Camara, Niels OS/G-8336-2011; MALHEIROS, DENISE MAC/L-7382-2017; camara, niels olsen saraiva/AAX-3269-2020; De Brito, Thales/L-2865-2017	Fanelli, Camilla/0000-0003-4425-7708; Camara, Niels OS/0000-0001-5436-1248; MALHEIROS, DENISE MAC/0000-0002-0409-816X; camara, niels olsen saraiva/0000-0001-5436-1248; De Brito, Thales/0000-0003-1106-7254	State of Sao Paulo Foundation for Research Support (FAPESP) [2008/55047-3]; Brazilian Council of Scientific and Technologic Development (CNPq) [304657/2007-7]	State of Sao Paulo Foundation for Research Support (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Brazilian Council of Scientific and Technologic Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This study was supported by grant 2008/55047-3 from the State of Sao Paulo Foundation for Research Support (FAPESP). RZ is the recipient of a Research Award (No. 304657/2007-7) from the Brazilian Council of Scientific and Technologic Development (CNPq). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldigier JC, 2005, J AM SOC NEPHROL, V16, P3306, DOI 10.1681/asn.2004090804; ANDERSON S, 1986, J CLIN INVEST, V77, P1993, DOI 10.1172/JCI112528; ANDERSON S, 1985, J CLIN INVEST, V76, P612, DOI 10.1172/JCI112013; Bidani AK, 2000, KIDNEY INT, V57, P1651, DOI 10.1046/j.1523-1755.2000.00009.x; Brown NJ, 2000, KIDNEY INT, V58, P1219, DOI 10.1046/j.1523-1755.2000.00277.x; Dussol B, 2005, NEPHROL DIAL TRANSPL, V20, P349, DOI 10.1093/ndt/gfh650; Dussol B, 2012, J CLIN HYPERTENS, V14, P32, DOI 10.1111/j.1751-7176.2011.00564.x; FLOEGE J, 1992, KIDNEY INT, V41, P297, DOI 10.1038/ki.1992.42; Fujihara CK, 2006, AM J PHYSIOL-RENAL, V290, pF632, DOI 10.1152/ajprenal.00259.2005; Fujihara CK, 2005, KIDNEY INT, V67, P1913, DOI 10.1111/j.1523-1755.2005.00290.x; Fujihara CK, 1998, KIDNEY INT, V54, P1510, DOI 10.1046/j.1523-1755.1998.00138.x; Fujihara CK, 2001, HYPERTENSION, V37, P170, DOI 10.1161/01.HYP.37.1.170; Fujihara CK, 2000, J AM SOC NEPHROL, V11, P283, DOI 10.1681/ASN.V112283; Fujihara CK, 2007, AM J PHYSIOL-RENAL, V292, pF1810, DOI 10.1152/ajprenal.00521.2006; Fujihara CK, 2010, AM J NEPHROL, V32, P95, DOI 10.1159/000315137; Furberg CD, 2002, JAMA-J AM MED ASSOC, V288, P2981; Goncalves ARR, 2004, AM J PHYSIOL-RENAL, V286, pF945, DOI 10.1152/ajprenal.00238.2003; Greene EL, 1996, J CLIN INVEST, V98, P1063, DOI 10.1172/JCI118867; HANING R, 1970, Endocrinology, V87, P1147; HARRIS RC, 1992, LAB INVEST, V66, P548; JEPSEN FL, 1979, VIRCHOWS ARCH A, V383, P265, DOI 10.1007/BF00430245; LAFAYETTE RA, 1992, J CLIN INVEST, V90, P766, DOI 10.1172/JCI115949; LEWIS EJ, 1993, NEW ENGL J MED, V329, P1456, DOI 10.1056/NEJM199311113292004; Maschio G, 1996, NEW ENGL J MED, V334, P939, DOI 10.1056/NEJM199604113341502; MEYER TW, 1987, KIDNEY INT, V31, P752, DOI 10.1038/ki.1987.62; Nagai Y, 2005, HYPERTENSION, V46, P1039, DOI 10.1161/01.HYP.0000174593.88899.68; Noda M, 1999, KIDNEY INT, V56, P898, DOI 10.1046/j.1523-1755.1999.00614.x; Piecha G, 2008, AM J PHYSIOL-RENAL, V295, pF137, DOI 10.1152/ajprenal.00065.2008; REUBI FC, 1961, CIRCULATION, V23, P200, DOI 10.1161/01.CIR.23.2.200; Reungjui S, 2007, J AM SOC NEPHROL, V18, P2724, DOI 10.1681/ASN.2007040416; Riser BL, 1996, AM J PATHOL, V148, P1915; Riser BL, 2001, AM J PATHOL, V158, P11, DOI 10.1016/S0002-9440(10)63938-7; Romero F, 1999, KIDNEY INT, V55, P945, DOI 10.1046/j.1523-1755.1999.055003945.x; Rozansky DJ, 2009, J CLIN INVEST, V119, P2601, DOI 10.1172/JCI38323; Soto K, 2004, KIDNEY INT, V65, P811, DOI 10.1111/j.1523-1755.2004.00455.x; STANTON BA, 1988, AM J PHYSIOL, V255, pF1269, DOI 10.1152/ajprenal.1988.255.6.F1269; Syrjanen J, 2000, NEPHROL DIAL TRANSPL, V15, P34, DOI 10.1093/ndt/15.1.34; Takase O, 2005, KIDNEY INT, V68, P464, DOI 10.1111/j.1523-1755.2005.00424.x; Tang S, 2003, J CLIN INVEST, V111, P515, DOI [10.1172/JCI16079, 10.1172/JCI200316079]; Teles F, 2009, KIDNEY INT, V75, P72, DOI 10.1038/ki.2008.528; Vaziri ND, 2006, AM J PHYSIOL-RENAL, V290, pF262, DOI 10.1152/ajprenal.00099.2005; WALLENSTEIN S, 1980, CIRC RES, V47, P1, DOI 10.1161/01.RES.47.1.1; Wright JT, 2008, ARCH INTERN MED, V168, P207, DOI 10.1001/archinternmed.2007.66; Wu LL, 1997, KIDNEY INT, V51, P1553, DOI 10.1038/ki.1997.214; Yamamoto M, 1997, J CLIN LAB ANAL, V11, P53, DOI 10.1002/(SICI)1098-2825(1997)11:1<53::AID-JCLA9>3.0.CO;2-L	45	31	31	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2013	8	2							e56215	10.1371/journal.pone.0056215	http://dx.doi.org/10.1371/journal.pone.0056215			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093HR	23431367	gold, Green Published, Green Submitted			2022-12-25	WOS:000315182800009
J	Delli Pizzi, S; Rossi, C; Di Matteo, V; Esposito, E; Guarnieri, S; Mariggio, MA; Franciotti, R; Caulo, M; Thomas, A; Onofrj, M; Tartaro, A; Bonanni, L				Delli Pizzi, Stefano; Rossi, Cosmo; Di Matteo, Vincenzo; Esposito, Ennio; Guarnieri, Simone; Mariggio, Maria Addolorata; Franciotti, Raffaella; Caulo, Massimo; Thomas, Astrid; Onofrj, Marco; Tartaro, Armando; Bonanni, Laura			Morphological and Metabolic Changes in the Nigro-Striatal Pathway of Synthetic Proteasome Inhibitor (PSI)-Treated Rats: A MRI and MRS Study	PLOS ONE			English	Article							MAGNETIC-RESONANCE-SPECTROSCOPY; PARKINSONS-DISEASE; SUBSTANTIA-NIGRA; IN-VIVO; MITOCHONDRIAL DYSFUNCTION; ALPHA-SYNUCLEIN; MODEL; DEGENERATION; BRAIN; QUANTIFICATION	Systemic administration of a Synthetic Proteasome Inihibitor (PSI) in rats has been described as able to provide a model of Parkinson's disease (PD), characterized by behavioral and biochemical modifications, including loss of dopaminergic neurons in the substantia nigra (SN), as assessed by post-mortem studies. With the present study we aimed to assess in-vivo by Magnetic Resonance (MR) possible morphological and metabolic changes in the nigro-striatal pathway of PSI-treated rats. 10 animals were subcutaneously injected with PSI 6.0 mg/kg dissolved in DMSO 100%. Injections were made thrice weekly over the course of two weeks. 5 more animals injected with DMSO 100% with the same protocol served as controls. The animals underwent MR sessions before and at four weeks after the end of treatment with either PSI or vehicle. MR Imaging was performed to measure SN volume and Proton MR Spectroscopy (H-1-MRS) was performed to measure metabolites changes at the striatum. Animals were also assessed for motor function at baseline and at 4 and 6 weeks after treatment. Dopamine and dopamine metabolite levels were measured in the striata at 6 weeks after treatment. PSI-treated animals showed volumetric reduction of the SN (p<0.02) at 4 weeks after treatment as compared to baseline. Immunofluorescence analysis confirmed MRI changes in SN showing a reduction of tyrosine hydroxylase expression as compared to neuron-specific enolase expression. A reduction of N-acetyl-aspartate/total creatine ratio (p = 0.05) and an increase of glutamate-glutamine-gamma amminobutirrate/total creatine were found at spectroscopy (p = 0.03). At 6 weeks after treatment, PSI-treated rats also showed motor dysfunction compared to baseline (p = 0.02), accompanied by dopamine level reduction in the striatum (p = 0.02). Treatment with PSI produced morphological and metabolic modifications of the nigro-striatal pathway, accompanied by motor dysfunction. MR demonstrated to be a powerful mean to assess in-vivo the nigro-striatal pathway morphology and metabolism in the PSI-based PD animal model.	[Delli Pizzi, Stefano; Franciotti, Raffaella; Caulo, Massimo; Tartaro, Armando] Univ G DAnnunzio, ITAB, Chieti, Italy; [Rossi, Cosmo] Gabriele dAnnunzio Univ Fdn, CeSI, Aging Res Ctr, Chieti, Italy; [Di Matteo, Vincenzo; Esposito, Ennio] Consorzio Mario Negri Sud, Ist Ric Farmacol Mario Negri, Neurophysiol Lab, Chieti, Italy; [Delli Pizzi, Stefano; Guarnieri, Simone; Mariggio, Maria Addolorata; Caulo, Massimo; Thomas, Astrid; Onofrj, Marco; Tartaro, Armando; Bonanni, Laura] Univ G dAnnunzio, Dept Neurosci & Imaging, Chieti, Italy; [Delli Pizzi, Stefano; Guarnieri, Simone; Mariggio, Maria Addolorata; Caulo, Massimo; Thomas, Astrid; Onofrj, Marco; Tartaro, Armando; Bonanni, Laura] Univ G dAnnunzio, CESI Aging Res Ctr, Chieti, Italy	G d'Annunzio University of Chieti-Pescara; G d'Annunzio University of Chieti-Pescara; Consorzio Mario Negri Sud; Istituto di Ricerche Farmacologiche Mario Negri IRCCS; G d'Annunzio University of Chieti-Pescara; G d'Annunzio University of Chieti-Pescara	Bonanni, L (corresponding author), Univ G dAnnunzio, Dept Neurosci & Imaging, Chieti, Italy.	l.bonanni@unich.it	Mariggiò, Maria Addolorata/T-9047-2017; Guarnieri, Simone/AAA-5921-2020; Franciotti, Raffaella/AAC-2664-2022; Bonanni, Laura/K-3868-2016; tartaro, armando at/K-2184-2016; onofrj, marco/K-7710-2016; Pizzi, Stefano Delli/J-3935-2016; THOMAS, Astrid Maria/K-7727-2016	Mariggiò, Maria Addolorata/0000-0001-5306-7143; Bonanni, Laura/0000-0001-7443-9233; tartaro, armando at/0000-0003-0095-2792; onofrj, marco/0000-0002-0480-2495; Pizzi, Stefano Delli/0000-0003-4075-0132; Guarnieri, Simone/0000-0002-2916-2965; THOMAS, Astrid Maria/0000-0003-3853-2996; Mariggio, Maria Addolorata/0000-0002-3508-8706	Italian Ministry of Health	Italian Ministry of Health(Ministry of Health, Italy)	This work has been supported by the Italian Ministry of Health, Grant Young Researchers 2007. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bove J, 2006, ANN NEUROL, V60, P260, DOI 10.1002/ana.20937; BRAFFMAN BH, 1989, AM J ROENTGENOL, V152, P159, DOI 10.2214/ajr.152.1.159; Brownell AL, 1998, NAT MED, V4, P1308, DOI 10.1038/3300; Bukhatwa S, 2010, BRAIN RES, V1354, P236, DOI 10.1016/j.brainres.2010.07.060; Cabanes E, 2001, J MAGN RESON, V150, P116, DOI 10.1006/jmre.2001.2318; Chassain C, 2008, J NEUROCHEM, V105, P874, DOI 10.1111/j.1471-4159.2007.05185.x; Chu YP, 2009, NEUROBIOL DIS, V35, P385, DOI 10.1016/j.nbd.2009.05.023; Clark JB, 1998, DEV NEUROSCI-BASEL, V20, P271, DOI 10.1159/000017321; Dauer W, 2003, NEURON, V39, P889, DOI 10.1016/S0896-6273(03)00568-3; Delli Pizzi S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044752; Gerlach M, 2006, J NEURAL TRANSM-SUPP, P133; Govindaraju V, 2000, NMR BIOMED, V13, P129, DOI 10.1002/1099-1492(200005)13:3<129::AID-NBM619>3.0.CO;2-V; Griffith HR, 2008, NMR BIOMED, V21, P381, DOI 10.1002/nbm.1203; Henchcliffe C, 2008, ANN NY ACAD SCI, V1147, P206, DOI 10.1196/annals.1427.037; Kickler N, 2009, NMR BIOMED, V22, P207, DOI 10.1002/nbm.1305; Kickler N, 2007, NMR BIOMED, V20, P757, DOI 10.1002/nbm.1141; Kordower JH, 2006, ANN NEUROL, V60, P264, DOI 10.1002/ana.20935; Landau AM, 2007, MOVEMENT DISORD, V22, P403, DOI 10.1002/mds.21306; Lang AE, 1998, NEW ENGL J MED, V339, P1044, DOI 10.1056/NEJM199810083391506; Manning-Bog AB, 2006, ANN NEUROL, V60, P256, DOI 10.1002/ana.20938; McNaught KSP, 2004, ANN NEUROL, V56, P149, DOI 10.1002/ana.20186; MILETICH RS, 1994, ANN NEUROL, V35, P689, DOI 10.1002/ana.410350609; Minati L, 2007, AM J NEURORADIOL, V28, P309; Modrego PJ, 2011, ACAD RADIOL, V18, P235, DOI 10.1016/j.acra.2010.09.022; MOKRY J, 1995, PHYSIOL RES, V44, P143; Naressi A, 2001, MAGN RESON MATER PHY, V12, P141, DOI 10.1016/S1352-8661(01)00111-9; Niu CS, 2009, STEREOT FUNCT NEUROS, V87, P69, DOI 10.1159/000202972; Olanow CW, 2006, MOVEMENT DISORD, V21, P1806, DOI 10.1002/mds.21013; Paxinos G., 1986, RAT BRAIN STEREOTAXI, V2nd; PUJOL J, 1992, ARCH NEUROL-CHICAGO, V49, P1119, DOI 10.1001/archneur.1992.00530350033015; Romero-Granados R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028927; Schapira AHV, 2006, ANN NEUROL, V60, P253, DOI 10.1002/ana.20934; Shin M, 2011, NEUROBIOL AGING, V32, P2100, DOI 10.1016/j.neurobiolaging.2009.11.015; Stefanova N, 2012, ACTA NEUROPATHOL, V124, P51, DOI 10.1007/s00401-012-0977-5; Torriani M, 2005, RADIOLOGY, V236, P609, DOI 10.1148/radiol.2362041661; van Vlieta SAM, 2008, BRAIN RES, V1189, P219, DOI 10.1016/j.brainres.2007.10.059; Vanhamme L, 1997, J MAGN RESON, V129, P35, DOI 10.1006/jmre.1997.1244; Vernon AC, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-1; Zeng BY, 2006, ANN NEUROL, V60, P248, DOI 10.1002/ana.20932	39	15	15	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2013	8	2							e56501	10.1371/journal.pone.0056501	http://dx.doi.org/10.1371/journal.pone.0056501			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093HR	23431380	Green Submitted, Green Published, gold			2022-12-25	WOS:000315182800022
J	Suyatin, DB; Wallman, L; Thelin, J; Prinz, CN; Jorntell, H; Samuelson, L; Montelius, L; Schouenborg, J				Suyatin, Dmitry B.; Wallman, Lars; Thelin, Jonas; Prinz, Christelle N.; Jorntell, Henrik; Samuelson, Lars; Montelius, Lars; Schouenborg, Jens			Nanowire-Based Electrode for Acute In Vivo Neural Recordings in the Brain	PLOS ONE			English	Article							SILICON NANOWIRES; ARRAYS; INTERFACES; PLATFORM; TISSUE; BIOMOLECULES; PERFORMANCE; POTENTIALS; SUBSTRATE; COMPUTER	We present an electrode, based on structurally controlled nanowires, as a first step towards developing a useful nanostructured device for neurophysiological measurements in vivo. The sensing part of the electrode is made of a metal film deposited on top of an array of epitaxially grown gallium phosphide nanowires. We achieved the first functional testing of the nanowire-based electrode by performing acute in vivo recordings in the rat cerebral cortex and withstanding multiple brain implantations. Due to the controllable geometry of the nanowires, this type of electrode can be used as a model system for further analysis of the functional properties of nanostructured neuronal interfaces in vivo.	[Suyatin, Dmitry B.; Prinz, Christelle N.; Samuelson, Lars; Montelius, Lars] Lund Univ, Div Solid State Phys, Lund, Sweden; [Suyatin, Dmitry B.; Prinz, Christelle N.; Samuelson, Lars; Montelius, Lars] Lund Univ, Nanometer Struct Consortium, Lund, Sweden; [Suyatin, Dmitry B.; Wallman, Lars; Thelin, Jonas; Prinz, Christelle N.; Jorntell, Henrik; Samuelson, Lars; Montelius, Lars; Schouenborg, Jens] Lund Univ, Fac Med, Neuronano Res Ctr, Lund, Sweden; [Wallman, Lars] Lund Univ, Dept Measurement Technol & Ind Elect Engn, Lund, Sweden	Lund University; Lund University; Lund University; Lund University	Schouenborg, J (corresponding author), Lund Univ, Fac Med, Neuronano Res Ctr, Lund, Sweden.	Jens.Schouenborg@med.lu.se	Samuelson, Lars/A-2171-2010; Suyatin, Dmitry B./A-4075-2010; Montelius, Lars/B-9071-2008	Samuelson, Lars/0000-0003-1971-9894; Suyatin, Dmitry B./0000-0002-6342-1449; Prinz, Christelle/0000-0002-1726-3275; Thelin, Jonas/0000-0002-6452-1476; Schouenborg, Jens/0000-0002-2815-6918; Montelius, Lars/0000-0001-9563-2307	Swedish Research Council (VR) [80658701, 621-2009-3266]; Knut and Alice Wallenberg Foundation [KAW 2004.0119]	Swedish Research Council (VR)(Swedish Research Council); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation)	This work was supported by the Swedish Research Council (VR) Linnaeus grant No. 80658701 and VR project No. 621-2009-3266 and The Knut and Alice Wallenberg Foundation project No. KAW 2004.0119. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almquist BD, 2010, P NATL ACAD SCI USA, V107, P5815, DOI 10.1073/pnas.0909250107; Ansaldo A, 2011, ACS NANO, V5, P2206, DOI 10.1021/nn103445d; Benabid AL, 2007, EXPERT REV MED DEVIC, V4, P895, DOI 10.1586/17434440.4.6.895; Berthing T, 2011, SMALL, V7, P640, DOI 10.1002/smll.201001642; Bruggemann D, 2011, NANOTECHNOLOGY, V22, DOI 10.1088/0957-4484/22/26/265104; CAMPBELL PK, 1991, IEEE T BIO-MED ENG, V38, P758, DOI 10.1109/10.83588; Cellot G, 2009, NAT NANOTECHNOL, V4, P126, DOI [10.1038/NNANO.2008.374, 10.1038/nnano.2008.374]; Chapin JK, 1999, NAT NEUROSCI, V2, P664, DOI 10.1038/10223; Cogan SF, 2008, ANNU REV BIOMED ENG, V10, P275, DOI 10.1146/annurev.bioeng.10.061807.160518; DRAKE KL, 1988, IEEE T BIO-MED ENG, V35, P719, DOI 10.1109/10.7273; Duan XJ, 2012, NAT NANOTECHNOL, V7, P174, DOI [10.1038/nnano.2011.223, 10.1038/NNANO.2011.223]; Dvir T, 2011, NAT NANOTECHNOL, V6, P13, DOI 10.1038/NNANO.2010.246; Fromherz P., 2003, NANOELECTRONICS INFO, P781; Hai A, 2010, NAT METHODS, V7, P200, DOI [10.1038/nmeth.1420, 10.1038/NMETH.1420]; Hallstrom W, 2007, NANO LETT, V7, P2960, DOI 10.1021/nl070728e; Hallstrom W, 2010, NANO LETT, V10, P782, DOI 10.1021/nl902675h; Hallstrom W, 2009, LANGMUIR, V25, P4343, DOI 10.1021/la900436e; Jog MS, 2002, J NEUROSCI METH, V117, P141, DOI 10.1016/S0165-0270(02)00092-4; Kawano T, 2010, BIOSENS BIOELECTRON, V25, P1809, DOI 10.1016/j.bios.2009.12.037; Keefer EW, 2008, NAT NANOTECHNOL, V3, P434, DOI 10.1038/nnano.2008.174; Kennedy PR, 2000, IEEE T REHABIL ENG, V8, P198, DOI 10.1109/86.847815; Kim W, 2007, J AM CHEM SOC, V129, P7228, DOI 10.1021/ja071456k; Kipke DR, 2008, J NEUROSCI, V28, P11830, DOI 10.1523/JNEUROSCI.3879-08.2008; Kipke DR, 2003, IEEE T NEUR SYS REH, V11, P151, DOI 10.1109/TNSRE.2003.814443; KOHLER P, 2009, FLEXIBLE MULTIELECTR, P536; Kotov NA, 2009, ADV MATER, V21, P3970, DOI 10.1002/adma.200801984; Lehew Gary, 2008, P1; Lewicki MS, 1998, NETWORK-COMP NEURAL, V9, pR53, DOI 10.1088/0954-898X/9/4/001; Lieber CM, 2011, MRS BULL, V36, P1052, DOI 10.1557/mrs.2011.269; Lind G, 2010, J NEURAL ENG, V7, DOI 10.1088/1741-2560/7/4/046005; Linsmeier CE, 2008, BIOMATERIALS, V29, P4598, DOI 10.1016/j.biomaterials.2008.08.028; Linsmeier CE, 2009, NANO LETT, V9, P4184, DOI 10.1021/nl902413x; Martin DC, 2010, POLYM REV, V50, P340, DOI 10.1080/15583724.2010.495440; Polikov VS, 2005, J NEUROSCI METH, V148, P1, DOI 10.1016/j.jneumeth.2005.08.015; Prinz C, 2008, NANOTECHNOLOGY, V19, DOI 10.1088/0957-4484/19/34/345101; ROBINSON DA, 1968, PR INST ELECTR ELECT, V56, P1065, DOI 10.1109/PROC.1968.6458; Robinson JT, 2012, NAT NANOTECHNOL, V7, P180, DOI [10.1038/nnano.2011.249, 10.1038/NNANO.2011.249]; Rousche PJ, 2001, IEEE T BIO-MED ENG, V48, P361, DOI 10.1109/10.914800; Rutten WLC, 2002, ANNU REV BIOMED ENG, V4, P407, DOI 10.1146/annurev.bioeng.4.020702.153427; SCHOUENBORG J, 1986, BRAIN RES, V397, P86, DOI 10.1016/0006-8993(86)91371-5; Schouenborg J, 2011, PROG BRAIN RES, V194, P61, DOI 10.1016/B978-0-444-53815-4.00017-0; Shalek AK, 2010, P NATL ACAD SCI USA, V107, P1870, DOI 10.1073/pnas.0909350107; Suyatin DB, 2009, J VAC SCI TECHNOL B, V27, P3092, DOI 10.1116/1.3264665; Takei K, 2010, BIOMED MICRODEVICES, V12, P41, DOI 10.1007/s10544-009-9356-y; Tian BZ, 2010, SCIENCE, V329, P830, DOI 10.1126/science.1192033; Timko BP, 2010, IEEE T NANOTECHNOL, V9, P269, DOI 10.1109/TNANO.2009.2031807; Vaadia E, 2009, FRONT NEUROSCI-SWITZ, V3, P151, DOI 10.3389/neuro.01.015.2009; Voge CM, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/1/011001; Wernersson LE, 2010, P IEEE, V98, P2047, DOI 10.1109/JPROC.2010.2065211; Witteveen JA, 2010, J VAC SCI TECHNOL B, V28, pC6K13, DOI 10.1116/1.3498764; Xie C, 2012, NAT NANOTECHNOL, V7, P185, DOI [10.1038/nnano.2012.8, 10.1038/NNANO.2012.8]; Xie C, 2010, NANO LETT, V10, P4020, DOI 10.1021/nl101950x; Yang PD, 2010, NANO LETT, V10, P1529, DOI 10.1021/nl100665r	53	63	64	0	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2013	8	2							e56673	10.1371/journal.pone.0056673	http://dx.doi.org/10.1371/journal.pone.0056673			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093HR	23431387	gold, Green Published, Green Submitted			2022-12-25	WOS:000315182800030
J	Sainz-Polo, MA; Ramirez-Escudero, M; Lafraya, A; Gonzalez, B; Marin-Navarro, J; Polaina, J; Sanz-Aparicio, J				Angela Sainz-Polo, M.; Ramirez-Escudero, Mercedes; Lafraya, Alvaro; Gonzalez, Beatriz; Marin-Navarro, Julia; Polaina, Julio; Sanz-Aparicio, Julia			Three-dimensional Structure of Saccharomyces Invertase ROLE OF A NON-CATALYTIC DOMAIN IN OLIGOMERIZATION AND SUBSTRATE SPECIFICITY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OCCIDENTALIS BETA-FRUCTOFURANOSIDASE; RAY-DIFFRACTION STRUCTURE; CRYSTAL-STRUCTURE; INTERNAL INVERTASE; YEAST INVERTASE; CEREVISIAE; BINDING; PROTEIN; ENZYME; INULINASE	Invertase is an enzyme that is widely distributed among plants and microorganisms and that catalyzes the hydrolysis of the disaccharide sucrose into glucose and fructose. Despite the important physiological role of Saccharomyces invertase (SInv) and the historical relevance of this enzyme as a model in early biochemical studies, its structure had not yet been solved. We report here the crystal structure of recombinant SInv at 3.3 angstrom resolution showing that the enzyme folds into the catalytic beta-propeller and beta-sandwich domains characteristic of GH32 enzymes. However, SInv displays an unusual quaternary structure. Monomers associate in two different kinds of dimers, which are in turn assembled into an octamer, best described as a tetramer of dimers. Dimerization plays a determinant role in substrate specificity because this assembly sets steric constraints that limit the access to the active site of oligosaccharides of more than four units. Comparative analysis of GH32 enzymes showed that formation of the SInv octamer occurs through a beta-sheet extension that seems unique to this enzyme. Interaction between dimers is determined by a short amino acid sequence at the beginning of the beta-sandwich domain. Our results highlight the role of the non-catalytic domain in fine-tuning substrate specificity and thus supplement our knowledge of the activity of this important family of enzymes. In turn, this gives a deeper insight into the structural features that rule modularity and protein-carbohydrate recognition.	[Angela Sainz-Polo, M.; Ramirez-Escudero, Mercedes; Gonzalez, Beatriz; Sanz-Aparicio, Julia] CSIC, Inst Quim Fis Rocasolano, Dept Cristalog & Biol Estructural, E-28006 Madrid, Spain; [Lafraya, Alvaro; Marin-Navarro, Julia; Polaina, Julio] CSIC, Inst Agroquim & Tecnol Alimentos, Valencia 46980, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Quimica Fisica Rocasolano (IQFR); Consejo Superior de Investigaciones Cientificas (CSIC); Instituto de Agroquimica y Tecnologia de los Alimentos (IATA)	Sanz-Aparicio, J (corresponding author), CSIC, Inst Quim Fis Rocasolano, Dept Cristalog & Biol Estructural, Serrano 119, E-28006 Madrid, Spain.	xjulia@iqfr.csic.es	ESCUDERO, MERCEDES RAMIREZ/Q-3965-2018; Escudero, Mercedes Ramirez/O-1690-2019; Sanz-Aparicio, Julia/F-6201-2013; , Marín-Navarro/F-7630-2016; Sainz-Polo, Maria-Angela/F-3947-2016; Polaina, Julio/H-4498-2012; Gonzalez, Beatriz/M-1219-2014	ESCUDERO, MERCEDES RAMIREZ/0000-0001-7253-9572; Escudero, Mercedes Ramirez/0000-0001-7253-9572; Sanz-Aparicio, Julia/0000-0002-6849-8621; , Marín-Navarro/0000-0001-7893-3423; Sainz-Polo, Maria-Angela/0000-0002-6269-4330; Gonzalez, Beatriz/0000-0002-0710-0202; Polaina, Julio/0000-0001-9912-0640; LAFRAYA, ALVARO/0000-0001-7488-8354	Spanish Ministry of Education and Science [BIO2010-20508-C04-02, BIO2010-20508-C04-03]; Junta para la Ampliacion de Estudios (JAE) predoctoral fellowship from the Consejo Superior de Investigaciones Cientificas	Spanish Ministry of Education and Science(Spanish Government); Junta para la Ampliacion de Estudios (JAE) predoctoral fellowship from the Consejo Superior de Investigaciones Cientificas	This work was supported in part by Grants BIO2010-20508-C04-02 and BIO2010-20508-C04-03 from the Spanish Ministry of Education and Science.; Supported by a Junta para la Ampliacion de Estudios (JAE) predoctoral fellowship from the Consejo Superior de Investigaciones Cientificas.	Alberto F, 2004, J BIOL CHEM, V279, P18903, DOI 10.1074/jbc.M313911200; Alvaro-Benito M, 2012, J BIOL CHEM, V287, P19674, DOI 10.1074/jbc.M112.355503; Alvaro-Benito M, 2010, APPL ENVIRON MICROB, V76, P7491, DOI 10.1128/AEM.01614-10; Alvaro-Benito M, 2010, J BIOL CHEM, V285, P13930, DOI 10.1074/jbc.M109.095430; Sainz-Polo MA, 2012, ACTA CRYSTALLOGR F, V68, P1538, DOI 10.1107/S1744309112044417; Barnett JA, 2003, MICROBIOL-SGM, V149, P557, DOI 10.1099/mic.0.26089-0; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; Bujacz A, 2011, FEBS J, V278, P1728, DOI 10.1111/j.1742-4658.2011.08098.x; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; CARLSON M, 1980, COLD SPRING HARB SYM, V45, P799, DOI 10.1101/SQB.1981.045.01.098; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Conde R, 2004, J BIOL CHEM, V279, P43789, DOI 10.1074/jbc.M406678200; Davies GJ, 1997, BIOCHEM J, V321, P557, DOI 10.1042/bj3210557; DELAFUENTE G, 1962, BIOCHIM BIOPHYS ACTA, V56, P49, DOI 10.1016/0006-3002(62)90526-7; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Dou YM, 2004, BIOINFORMATICS, V20, P2767, DOI 10.1093/bioinformatics/bth326; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; ESMON PC, 1987, J BIOL CHEM, V262, P4387; Flint HJ, 2012, NAT REV GASTRO HEPAT, V9, P577, DOI 10.1038/nrgastro.2012.156; GASCON S, 1968, J BIOL CHEM, V243, P1567; GASCON S, 1968, J BIOL CHEM, V243, P1573; GILL BLAND R. B., 1949, COMPT REND TRAV LAB CARLSBERG [COPENHAGEN] SER PHYSIOL, V24, P347; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; GROSSMANN MK, 1979, MOL GEN GENET, V175, P223, DOI 10.1007/BF00425540; Guharoy M, 2007, BIOINFORMATICS, V23, P1909, DOI 10.1093/bioinformatics/btm274; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lafraya A, 2011, APPL ENVIRON MICROB, V77, P6148, DOI 10.1128/AEM.05032-11; Lammens W, 2012, PLANT J, V70, P205, DOI 10.1111/j.1365-313X.2011.04858.x; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Michaelis L, 1913, BIOCHEM Z, V49, P333; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Nagem RAP, 2004, J MOL BIOL, V344, P471, DOI 10.1016/j.jmb.2004.09.024; Park J, 2012, J BIOL CHEM, V287, P31233, DOI 10.1074/jbc.M112.389270; PERLMAN D, 1981, CELL, V25, P525, DOI 10.1016/0092-8674(81)90071-4; Pouyez J, 2012, BIOCHIMIE, V94, P2423, DOI 10.1016/j.biochi.2012.06.020; REDDY AV, 1990, BIOCHEMISTRY-US, V29, P2482, DOI 10.1021/bi00462a007; Stein N, 2008, J APPL CRYSTALLOGR, V41, P641, DOI 10.1107/S0021889808006985; TAMMI M, 1987, J BIOL CHEM, V262, P4395; Verhaest M, 2005, PLANT J, V41, P400, DOI 10.1111/j.1365-313X.2004.02304.x; Verhaest M, 2006, ACTA CRYSTALLOGR D, V62, P1555, DOI 10.1107/S0907444906044489; Wasmer C, 2008, SCIENCE, V319, P1523, DOI 10.1126/science.1151839; WILLIAMS RS, 1985, J BIOL CHEM, V260, P3334; WINGE O, 1952, CR TRAV LAB CARLS P, V25, P141; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749	44	62	66	1	53	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 5	2013	288	14					9755	9766		10.1074/jbc.M112.446435	http://dx.doi.org/10.1074/jbc.M112.446435			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	119RB	23430743	Green Published, hybrid			2022-12-25	WOS:000317114000017
J	Rosenberg, MM; Ronen, D; Lahav, N; Nazirov, E; Ravid, S; Friedler, A				Rosenberg, Masha M.; Ronen, Daniel; Lahav, Noa; Nazirov, Elvira; Ravid, Shoshana; Friedler, Assaf			High Resolution Characterization of Myosin IIC Protein Tailpiece and Its Effect on Filament Assembly	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEAVY-CHAIN PHOSPHORYLATION; AMINO-ACID-SEQUENCE; NONMUSCLE MYOSIN; CELLULAR-LOCALIZATION; COILED-COIL; ROD; REGIONS; CHARGE; TAIL; DETERMINES	The motor protein nonmuscle myosin II (NMII) must undergo dynamic oligomerization into filaments to perform its cellular functions. A small nonhelical region at the tail of the long coiled-coil region (tailpiece) is a common feature of all dynamically assembling myosin II proteins. This tailpiece is a key regulatory domain affecting NMII filament assembly properties and is subject to phosphorylation in vivo. We previously demonstrated that the positively charged region of the tailpiece binds to assembly-incompetent NMII-C fragments, inducing filament assembly. In the current study, we investigated the molecular mechanisms by which the tailpiece regulates NMII-C self-assembly. Using alanine scan, we found that specific positive and aromatic residues within the positively charged region of the tailpiece are important for inducing NMII-C filament assembly and for filament elongation. Combining peptide arrays with deletion studies allowed us to identify the tailpiece binding sites in the coiled-coil rod. Elucidation of the mechanism by which the tailpiece induces filament assembly permitted us further investigation into the role of tailpiece phosphorylation. Sedimentation and CD spectroscopy identified that phosphorylation of Thr(1957) or Thr(1960) inhibited the ability of the tailpiece to bind the coiled-coil rod and to induce NMII-C filament formation. This study provides molecular insight into the role of specific residues within the NMII-C tailpiece that are responsible for shifting the oligomeric equilibrium of NMII-C toward filament assembly and determining its morphology.	[Rosenberg, Masha M.; Lahav, Noa; Friedler, Assaf] Hebrew Univ Jerusalem, Inst Chem, IL-91904 Jerusalem, Israel; [Ronen, Daniel; Nazirov, Elvira; Ravid, Shoshana] Hebrew Univ Jerusalem, Hadassah Med Sch, Inst Med Res Israel Canada, Dept Biochem & Mol Biol, IL-91120 Jerusalem, Israel	Hebrew University of Jerusalem; Hebrew University of Jerusalem	Ravid, S (corresponding author), Hebrew Univ Jerusalem, Hadassah Med Sch, Inst Med Res Israel Canada, Dept Biochem & Mol Biol, IL-91120 Jerusalem, Israel.	shoshr@ekmd.huji.ac.il; assaf.friedler@mail.huji.ac.il			European Research Council under the European Community [203413]	European Research Council under the European Community(European Research Council (ERC))	Supported by a starting grant from the European Research Council under the European Community Seventh Framework Programme (FP7/2007-2013)/ERC Grant 203413. To whom correspondence may be addressed. E-mail: assaf.friedler@mail.huji.ac.il.	ATKINSON SJ, 1992, J MOL BIOL, V226, P7, DOI 10.1016/0022-2836(92)90118-4; Ben-Ya'acov A, 2003, J BIOL CHEM, V278, P40032, DOI 10.1074/jbc.M306948200; Bresnick AR, 1999, CURR OPIN CELL BIOL, V11, P26, DOI 10.1016/S0955-0674(99)80004-0; Conti MA, 2008, J CELL SCI, V121, P11, DOI 10.1242/jcs.007112; Dulyaninova NG, 2007, MOL BIOL CELL, V18, P3144, DOI 10.1091/mbc.E06-11-1056; Dulyaninova NG, 2005, BIOCHEMISTRY-US, V44, P6867, DOI 10.1021/bi0500776; Even-Faitelson L, 2006, MOL BIOL CELL, V17, P2869, DOI 10.1091/mbc.e05-11-1001; Franke JD, 2005, BLOOD, V105, P161, DOI 10.1182/blood-2004-06-2067; Hayouka Z, 2007, P NATL ACAD SCI USA, V104, P8316, DOI 10.1073/pnas.0700781104; Ikebe M, 2001, J BIOL CHEM, V276, P30293, DOI 10.1074/jbc.M101969200; Katz C, 2011, CHEM SOC REV, V40, P2131, DOI 10.1039/c0cs00029a; Lauffenburger DA, 1996, CELL, V84, P359, DOI 10.1016/S0092-8674(00)81280-5; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; Matsumura F, 2005, TRENDS CELL BIOL, V15, P371, DOI 10.1016/j.tcb.2005.05.004; MCLACHLAN AD, 1984, ANNU REV BIOPHYS BIO, V13, P167; MCLACHLAN AD, 1982, NATURE, V299, P226, DOI 10.1038/299226a0; Murakami N, 2000, BIOCHEMISTRY-US, V39, P11441, DOI 10.1021/bi000347e; Nakasawa T, 2005, BIOCHEMISTRY-US, V44, P174, DOI 10.1021/bi048807h; Reingewertz TH, 2009, PROTEIN ENG DES SEL, V22, P281, DOI 10.1093/protein/gzp004; Ricketson D, 2010, P NATL ACAD SCI USA, V107, P20964, DOI 10.1073/pnas.1007025107; Ronen D, 2010, J BIOL CHEM, V285, P7079, DOI 10.1074/jbc.M109.049221; Ronen D, 2009, J BIOL CHEM, V284, P24948, DOI 10.1074/jbc.M109.023754; Rosenberg M, 2006, MOL BIOL CELL, V17, P1364, DOI 10.1091/mbc.e05-07-0597; Rosenberg M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001496; Sato MK, 2007, MOL BIOL CELL, V18, P1009, DOI 10.1091/mbc.E06-08-0706; Sellers J. R., 1999, MYOSINS; Sellers JR, 2000, BBA-MOL CELL RES, V1496, P3, DOI 10.1016/S0167-4889(00)00005-7; SINARD JH, 1990, J CELL BIOL, V111, P2417, DOI 10.1083/jcb.111.6.2417; Sohn RL, 1997, J MOL BIOL, V266, P317, DOI 10.1006/jmbi.1996.0790; Straussman R., 2005, THESIS HEBREW U JERU; Straussman R, 2007, J MOL BIOL, V366, P1232, DOI 10.1016/j.jmb.2006.11.083; Vicente-Manzanares M, 2009, NAT REV MOL CELL BIO, V10, P778, DOI 10.1038/nrm2786; WARRICK HM, 1987, ANNU REV CELL BIOL, V3, P379, DOI 10.1146/annurev.cb.03.110187.002115	33	6	6	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 5	2013	288	14					9779	9789		10.1074/jbc.M112.430173	http://dx.doi.org/10.1074/jbc.M112.430173			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	119RB	23426373	Green Published, hybrid			2022-12-25	WOS:000317114000019
J	Rubinow, KB; Wall, VZ; Nelson, J; Mar, D; Bomsztyk, K; Askari, B; Lai, MA; Smith, KD; Han, MS; Vivekanandan-Giri, A; Pennathur, S; Albert, CJ; Ford, DA; Davis, RJ; Bornfeldt, KE				Rubinow, Katya B.; Wall, Valerie Z.; Nelson, Joel; Mar, Daniel; Bomsztyk, Karol; Askari, Bardia; Lai, Marvin A.; Smith, Kelly D.; Han, Myoung Sook; Vivekanandan-Giri, Anuradha; Pennathur, Subramaniam; Albert, Carolyn J.; Ford, David A.; Davis, Roger J.; Bornfeldt, Karin E.			Acyl-CoA Synthetase 1 Is Induced by Gram-negative Bacteria and Lipopolysaccharide and Is Required for Phospholipid Turnover in Stimulated Macrophages	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; MESSENGER-RNA EXPRESSION; FATTY-ACIDS; SIGNAL-TRANSDUCTION; TRANSCRIPTION FACTORS; BIOLOGICAL SAMPLES; TERMINAL KINASE; MAP-KINASES; PPAR-ALPHA; IFN-GAMMA	The enzyme acyl-CoA synthetase 1 (ACSL1) is induced by peroxisome proliferator-activated receptor alpha (PPAR alpha) and PPAR gamma in insulin target tissues, such as skeletal muscle and adipose tissue, and plays an important role in beta-oxidation in these tissues. In macrophages, however, ACSL1 mediates inflammatory effects without significant effects on beta-oxidation. Thus, the function of ACSL1 varies in different tissues. We therefore investigated the signals and signal transduction pathways resulting in ACSL1 induction in macrophages as well as the consequences of ACSL1 deficiency for phospholipid turnover in LPS-activated macrophages. LPS, Gram-negative bacteria, IFN-gamma, and TNF alpha all induce ACSL1 expression in macrophages, whereas PPAR agonists do not. LPS-induced ACSL1 expression is dependent on Toll-like receptor 4 (TLR4) and its adaptor protein TRIF (Toll-like receptor adaptor molecule 1) but does not require the MyD88 (myeloid differentiation primary response gene 88) arm of TLR4 signaling; nor does it require STAT1 (signal transducer and activator of transcription 1) for maximal induction. Furthermore, ACSL1 deletion attenuates phospholipid turnover in LPS-stimulated macrophages. Thus, the regulation and biological function of ACSL1 in macrophages differ markedly from that in insulin target tissues. These results suggest that ACSL1 may have an important role in the innate immune response. Further, these findings illustrate an interesting paradigm in which the same enzyme, ACSL1, confers distinct biological effects in different cell types, and these disparate functions are paralleled by differences in the pathways that regulate its expression.	[Rubinow, Katya B.; Wall, Valerie Z.; Nelson, Joel; Mar, Daniel; Bomsztyk, Karol; Bornfeldt, Karin E.] Univ Washington, Diabet & Obes Ctr Excellence, Dept Med, Seattle, WA 98109 USA; [Askari, Bardia; Lai, Marvin A.; Smith, Kelly D.; Bornfeldt, Karin E.] Univ Washington, Diabet & Obes Ctr Excellence, Dept Pathol, Seattle, WA 98109 USA; [Han, Myoung Sook; Davis, Roger J.] Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01605 USA; [Vivekanandan-Giri, Anuradha; Pennathur, Subramaniam] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA; [Albert, Carolyn J.; Ford, David A.] St Louis Univ, Sch Med, Dept Biochem & Mol Biol, St Louis, MO 63104 USA; [Albert, Carolyn J.; Ford, David A.] St Louis Univ, Sch Med, Ctr Cardiovasc Res, St Louis, MO 63104 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Massachusetts System; University of Massachusetts Worcester; University of Michigan System; University of Michigan; Saint Louis University; Saint Louis University	Bornfeldt, KE (corresponding author), Univ Washington, Dept Med, Div Metab Endocrinol & Nutr, Diabet & Obes Ctr Excellence, 850 Republican St, Seattle, WA 98109 USA.	bornf@uw.edu	Bornfeldt, Karin/AAI-2241-2019; Ford, David/D-1819-2018	Bornfeldt, Karin/0000-0001-9208-6523; Ford, David/0000-0002-0029-1560; Davis, Roger/0000-0002-0130-1652; Han, Myoung Sook/0000-0002-7226-2590	National Institutes of Health [HL062887, HL092969, HL097365, 6K12HD053984, AI062859, HL074214, HL111906, DK082841, DK083310, R37 DK45978, T32DK007247, T32HL007312]; Juvenile Diabetes Research Foundation [42-2009-779]; Diabetes Research Center at the University of Washington (National Institutes of Health) [DK017047]; NIAID, National Institutes of Health [HHSN272200700038C]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD053984, U54HD042454] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL092969, R21HL111906, T32HL007028, T32HL007312, R01HL074214, R01HL062887, R01HL097365] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI062859] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK089503, R24DK082841, T32DK007247, P30DK017047, R01DK083310, R37DK045978] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); Diabetes Research Center at the University of Washington (National Institutes of Health); NIAID, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants HL062887, HL092969, HL097365 (to K. E. B.); 6K12HD053984 (to K. B. R.); AI062859 (to K. D. S.); HL074214 and HL111906 (to D. A. F.); DK082841 (to S. P.); and DK083310 and R37 DK45978 (to K. B.). This work was also supported by Juvenile Diabetes Research Foundation Grant 42-2009-779 (to K. B.). Part of the study was supported by the Diabetes Research Center at the University of Washington (National Institutes of Health Grant DK017047). This work was also supported by NIAID, National Institutes of Health, contract HHSN272200700038C, "Systems Approach to Immunity and Inflammation."; Supported by National Institutes of Health Training Grant T32DK007247.; Supported by National Institutes of Health Training Grant T32HL007312.	Beutler B, 2003, J LEUKOCYTE BIOL, V74, P479, DOI 10.1189/jlb.0203082; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bogoyevitch MA, 2004, BBA-PROTEINS PROTEOM, V1697, P89, DOI 10.1016/j.bbapap.2003.11.016; Coleman RA, 2002, J NUTR, V132, P2123, DOI 10.1093/jn/132.8.2123; Comalada M, 2012, EUR J IMMUNOL, V42, P1938, DOI 10.1002/eji.201242441; Cuenda A, 2007, BBA-MOL CELL RES, V1773, P1358, DOI 10.1016/j.bbamcr.2007.03.010; Das M, 2007, P NATL ACAD SCI USA, V104, P15759, DOI 10.1073/pnas.0707782104; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; de Jong H, 2007, BBA-MOL CELL BIOL L, V1771, P75, DOI 10.1016/j.bbalip.2006.11.007; Ellis JM, 2011, MOL CELL BIOL, V31, P1252, DOI 10.1128/MCB.01085-10; Ellis JM, 2010, CELL METAB, V12, P53, DOI 10.1016/j.cmet.2010.05.012; Flanagin S, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn001; Ford DA, 2008, J NEUROCHEM, V105, P1032, DOI 10.1111/j.1471-4159.2007.05203.x; Fujimoto Y, 2006, BIOL PHARM BULL, V29, P2174, DOI 10.1248/bpb.29.2174; Hale KK, 1999, J IMMUNOL, V162, P4246; Han J, 1997, NATURE, V386, P296, DOI 10.1038/386296a0; Han MS, 2013, SCIENCE, V339, P218, DOI 10.1126/science.1227568; Han XL, 2002, ANAL BIOCHEM, V302, P199, DOI 10.1006/abio.2001.5536; Han XL, 2005, MASS SPECTROM REV, V24, P367, DOI 10.1002/mas.20023; Hawn TR, 2006, J INFECT DIS, V193, P1693, DOI 10.1086/504525; Ho HH, 2008, J IMMUNOL, V181, P5089, DOI 10.4049/jimmunol.181.7.5089; HOISETH SK, 1981, NATURE, V291, P238, DOI 10.1038/291238a0; Hoshino K, 1999, J IMMUNOL, V162, P3749; Kang YJ, 2008, J IMMUNOL, V180, P5075, DOI 10.4049/jimmunol.180.7.5075; Kanter JE, 2012, P NATL ACAD SCI USA, V109, pE715, DOI 10.1073/pnas.1111600109; Lazear HM, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003118; Lefterova MI, 2010, MOL CELL BIOL, V30, P2078, DOI 10.1128/MCB.01651-09; Li LO, 2009, J BIOL CHEM, V284, P27816, DOI 10.1074/jbc.M109.022467; Lobo S, 2009, J BIOL CHEM, V284, P18347, DOI 10.1074/jbc.M109.017244; Ma W, 2004, J IMMUNOL, V172, P318, DOI 10.4049/jimmunol.172.1.318; Maloney NS, 2012, J VIROL, V86, P12655, DOI 10.1128/JVI.01564-12; Martin G, 1997, J BIOL CHEM, V272, P28210, DOI 10.1074/jbc.272.45.28210; Mashek DG, 2006, J LIPID RES, V47, P2004, DOI 10.1194/jlr.M600150-JLR200; Mullican SE, 2011, GENE DEV, V25, P2480, DOI 10.1101/gad.175950.111; Palsson-McDermott EM, 2004, IMMUNOLOGY, V113, P153, DOI 10.1111/j.1365-2567.2004.01976.x; Rakhshandehroo M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006796; Ruiz-Garcia A, 2011, J BIOL CHEM, V286, P19247, DOI 10.1074/jbc.M110.190298; Sanchez-Tillo E, 2007, J BIOL CHEM, V282, P12566, DOI 10.1074/jbc.M609662200; Sato S, 2003, J IMMUNOL, V171, P4304, DOI 10.4049/jimmunol.171.8.4304; Schieven GL, 2005, CURR TOP MED CHEM, V5, P921, DOI 10.2174/1568026054985902; SCHOONJANS K, 1995, J BIOL CHEM, V270, P19269, DOI 10.1074/jbc.270.33.19269; SCHOONJANS K, 1993, EUR J BIOCHEM, V216, P615, DOI 10.1111/j.1432-1033.1993.tb18181.x; Schwartz EA, 2010, ARTERIOSCL THROM VAS, V30, P802, DOI 10.1161/ATVBAHA.109.201681; Suram S, 2010, J BIOL CHEM, V285, P30676, DOI 10.1074/jbc.M110.143800; SUZUKI H, 1990, J BIOL CHEM, V265, P8681; Utsugi M, 2010, CYTOKINE, V51, P127, DOI 10.1016/j.cyto.2010.04.002; Wagner JD, 2010, J PHARMACOL EXP THER, V333, P844, DOI 10.1124/jpet.110.166736; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262; Zhu JZ, 2005, J BIOL CHEM, V280, P8617, DOI 10.1074/jbc.M413539200	49	45	47	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 5	2013	288	14					9957	9970		10.1074/jbc.M113.458372	http://dx.doi.org/10.1074/jbc.M113.458372			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	119RB	23426369	Green Published, hybrid			2022-12-25	WOS:000317114000035
J	Felli, N; Felicetti, F; Lustri, AM; Errico, MC; Bottero, L; Cannistraci, A; De Feo, A; Petrini, M; Pedini, F; Biffoni, M; Alvino, E; Negrini, M; Ferracin, M; Mattia, G; Care, A				Felli, Nadia; Felicetti, Federica; Lustri, Anna Maria; Errico, M. Cristina; Bottero, Lisabianca; Cannistraci, Alessio; De Feo, Alessandra; Petrini, Marina; Pedini, Francesca; Biffoni, Mauro; Alvino, Ester; Negrini, Massimo; Ferracin, Manuela; Mattia, Gianfranco; Care, Alessandra			miR-126&126*Restored Expressions Play a Tumor Suppressor Role by Directly Regulating ADAM9 and MMP7 in Melanoma	PLOS ONE			English	Article							MATRILYSIN MATRIX METALLOPROTEINASE-7; GROWTH-FACTOR; TERMINAL FRAGMENT; CANCER-THERAPY; MIR-126; CELLS; EGF; OSTEOPONTIN; GENE; METASTASIS	The abnormal expression of several microRNAs has a causal role in tumorigenesis with either antineoplastic or oncogenic functions. Here we demonstrated that miR-126 and miR-126* play a tumor suppressor role in human melanoma through the direct or indirect repression of several key oncogenic molecules. The expression levels of miR-126&126* were elevated in normal melanocytes and primary melanoma cell lines, whereas they markedly declined in metastatic cells. Indeed, the restored expression of miR-126&126* in two advanced melanoma cell lines was accompanied by a significant reduction of proliferation, invasion and chemotaxis in vitro as well as of growth and dissemination in vivo. In accordance, the reverse functional effects were obtained by knocking down miR-126&126* by transfecting antisense LNA oligonucleotides in melanoma cells. Looking for the effectors of these antineoplastic functions, we identified ADAM9 and MMP7, two metalloproteases playing a pivotal role in melanoma progression, as direct targets of miR-126&126*. In addition, as ADAM9 and MMP7 share a role in the proteolytic cleavage of the HB-EGF precursor, we looked for the effectiveness of this regulatory pathway in melanoma, confirming the decrease of HB-EGF activation as a consequence of miR-126&126*-dependent downmodulation of ADAM9 and MMP7. Finally, gene profile analyses showed that miR-126&126* reexpression was sufficient to inactivate other key signaling pathways involved in the oncogenic transformation, as PI3K/AKT and MAPK, and to restore melanogenesis, as indicated by KIT/MITF/TYR induction. In view of this miR-126&126* wide-ranging action, we believe that the replacement of these microRNAs might be considered a promising therapeutic approach.	[Felli, Nadia; Felicetti, Federica; Lustri, Anna Maria; Errico, M. Cristina; Bottero, Lisabianca; Cannistraci, Alessio; De Feo, Alessandra; Petrini, Marina; Pedini, Francesca; Biffoni, Mauro; Mattia, Gianfranco; Care, Alessandra] Ist Super Sanita, Dept Hematol Oncol & Mol Med, I-00161 Rome, Italy; [Negrini, Massimo; Ferracin, Manuela] Univ Ferrara, LTTA, Dept Expt & Diagnost Med, I-44100 Ferrara, Italy; [Alvino, Ester] CNR, Inst Translat Pharmacol, Rome, Italy	Istituto Superiore di Sanita (ISS); University of Ferrara; Consiglio Nazionale delle Ricerche (CNR); Istituto di Farmacologia Traslazionale (IFT-CNR)	Care, A (corresponding author), Ist Super Sanita, Dept Hematol Oncol & Mol Med, Viale Regina Elena 299, I-00161 Rome, Italy.	alessandra.care@iss.it	Negrini, Massimo/J-2377-2016; De Feo, Alessandra/C-7030-2019; Pedini, Francesca/N-5677-2017; Felicetti, Federica/N-7077-2017; Biffoni, Mauro/J-8318-2016; Ferracin, Manuela/K-2097-2016; Alvino, Ester/J-8148-2012; De Feo, Alessandra/ABI-1458-2020; Errico, Maria Cristina/K-3971-2016; CARE', Alessandra/H-5090-2016; Mattia, Gianfranco/K-5194-2016; Felli, Nadia/G-2088-2012	Negrini, Massimo/0000-0002-0007-1920; De Feo, Alessandra/0000-0002-9805-1361; Pedini, Francesca/0000-0002-3454-6162; Felicetti, Federica/0000-0003-4628-0696; Biffoni, Mauro/0000-0002-1304-9060; Ferracin, Manuela/0000-0002-1595-6887; Alvino, Ester/0000-0001-9467-7634; De Feo, Alessandra/0000-0002-9805-1361; Errico, Maria Cristina/0000-0003-3014-2643; CARE', Alessandra/0000-0003-4106-3342; Mattia, Gianfranco/0000-0001-7047-6360; Felli, Nadia/0000-0001-6763-3361; petrini, marina/0000-0003-4891-3389	Italian Ministry of Health; Italy-USA Program; Italian Association for Cancer Research (AIRC)	Italian Ministry of Health(Ministry of Health, Italy); Italy-USA Program; Italian Association for Cancer Research (AIRC)(Fondazione AIRC per la ricerca sul cancro)	This work was supported by grants from the Italian Ministry of Health, the Italy-USA Program and the Italian Association for Cancer Research (AIRC) to A.C. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnihotri R, 2001, J BIOL CHEM, V276, P28261, DOI 10.1074/jbc.M103608200; ALBINI A, 1987, CANCER RES, V47, P3239; Alvino E, 2002, J INVEST DERMATOL, V118, P79, DOI 10.1046/j.0022-202x.2001.01611.x; Bartolome RA, 2008, CANCER RES, V68, P8221, DOI 10.1158/0008-5472.CAN-08-0561; Bonci D, 2003, GENE THER, V10, P630, DOI 10.1038/sj.gt.3301936; Buback F, 2009, EXP DERMATOL, V18, P750, DOI 10.1111/j.1600-0625.2009.00926.x; Cara L B, 2007, MOL CARCINOGEN, V46, P671; Chappell WH, 2011, ONCOTARGET, V2, P135, DOI 10.18632/oncotarget.240; Duffy MJ, 2004, CLIN PROTEOMICS, V8, P9; Felicetti F, 2008, CANCER RES, V68, P2745, DOI 10.1158/0008-5472.CAN-07-2538; Felli N, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-85; Felli N, 2009, HAEMATOL-HEMATOL J, V94, P479, DOI 10.3324/haematol.2008.002345; Fry JL, 2010, CANCER RES, V70, P8187, DOI 10.1158/0008-5472.CAN-09-4231; Guo CG, 2008, GENE CHROMOSOME CANC, V47, P939, DOI 10.1002/gcc.20596; Hamada S, 2012, MOL CANCER RES, V10, P3, DOI 10.1158/1541-7786.MCR-11-0272; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Izumi Y, 1998, EMBO J, V17, P7260, DOI 10.1093/emboj/17.24.7260; Kasinski AL, 2011, NAT REV CANCER, V11, P849, DOI 10.1038/nrc3166; Kawasaki K, 2007, BRIT J DERMATOL, V156, P613, DOI 10.1111/j.1365-2133.2006.07678.x; Kivisaari AK, 2010, BRIT J DERMATOL, V163, P726, DOI 10.1111/j.1365-2133.2010.09924.x; Ko JM, 2011, J PATHOL, V223, P241, DOI 10.1002/path.2804; Li ZJ, 2008, P NATL ACAD SCI USA, V105, P15535, DOI 10.1073/pnas.0808266105; Lujambio A, 2012, NATURE, V482, P347, DOI 10.1038/nature10888; Miko E, 2011, FEBS LETT, V585, P1191, DOI 10.1016/j.febslet.2011.03.039; Mochizuki S, 2004, BIOCHEM BIOPH RES CO, V315, P79, DOI 10.1016/j.bbrc.2004.01.022; Mongaret C, 2011, INT J CANCER, V129, P791, DOI 10.1002/ijc.25746; Musiyenko A, 2008, J MOL MED, V86, P313, DOI 10.1007/s00109-007-0296-9; Nanba D, 2008, J CELL PHYSIOL, V214, P465, DOI 10.1002/jcp.21233; Niu J, 2002, INT J CANCER, V99, P529, DOI 10.1002/ijc.10397; Ohashi S, 2011, CANCER BIOL THER, V11, P184, DOI 10.4161/cbt.11.2.14140; Otsubo T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016617; Pines G, 2010, FEBS LETT, V584, P2699, DOI 10.1016/j.febslet.2010.04.019; Png KJ, 2012, NATURE, V481, P190, DOI 10.1038/nature10661; Roskoski R, 2005, BIOCHEM BIOPH RES CO, V337, P1, DOI 10.1016/j.bbrc.2005.08.055; Schmidt Maike, 2007, Novartis Found Symp, V283, P18; Sensi M, 2006, ONCOGENE, V25, P3357, DOI 10.1038/sj.onc.1209379; Shevde LA, 2010, CURR MOL MED, V10, P71, DOI 10.2174/156652410791065381; Shimizu T, 2012, CLIN CANCER RES, V18, P2316, DOI 10.1158/1078-0432.CCR-11-2381; Shimura T, 2008, CLIN CANCER RES, V14, P3956, DOI 10.1158/1078-0432.CCR-07-4794; Slack FJ, 2013, CLIN CHEM, V59, P325, DOI 10.1373/clinchem.2011.181016; Tavazoie SF, 2008, NATURE, V451, P147, DOI 10.1038/nature06487; Terzian T, 2011, J PATHOL, V224, P540, DOI 10.1002/path.2891; Toki F, 2005, J CELL PHYSIOL, V202, P839, DOI 10.1002/jcp.20175; Tomasetti M, 2012, CLIN BIOCHEM, V45, P575, DOI 10.1016/j.clinbiochem.2012.02.009; Wang SS, 2008, DEV CELL, V15, P261, DOI 10.1016/j.devcel.2008.07.002; Wang X, 2009, CIRCULATION, V119, P2480, DOI 10.1161/CIRCULATIONAHA.108.835488; Wielockx B, 2004, CYTOKINE GROWTH F R, V15, P111, DOI 10.1016/j.cytogfr.2003.12.001; Xiao LJ, 2012, INT J ONCOL, V40, P1714, DOI 10.3892/ijo.2011.1320; Yotsumoto F, 2008, BIOCHEM BIOPH RES CO, V365, P555, DOI 10.1016/j.bbrc.2007.11.015; Zhang J, 2008, BIOCHEM BIOPH RES CO, V377, P136, DOI 10.1016/j.bbrc.2008.09.089; Zhou YW, 2005, J INVEST DERMATOL, V124, P1044, DOI 10.1111/j.0022-202X.2005.23680.x; Zhu N, 2011, MOL CELL BIOCHEM, V351, P157, DOI 10.1007/s11010-011-0723-7; Zigrino P, 2005, INT J CANCER, V116, P853, DOI 10.1002/ijc.21087	53	76	78	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2013	8	2							e56824	10.1371/journal.pone.0056824	http://dx.doi.org/10.1371/journal.pone.0056824			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IT	23437250	Green Published, Green Submitted, gold			2022-12-25	WOS:000315186000050
J	Ronchi, G; Gambarotta, G; Di Scipio, F; Salamone, P; Sprio, AE; Cavallo, F; Perroteau, I; Berta, GN; Geuna, S				Ronchi, Giulia; Gambarotta, Giovanna; Di Scipio, Federica; Salamone, Paolina; Sprio, Andrea E.; Cavallo, Federica; Perroteau, Isabelle; Berta, Giovanni N.; Geuna, Stefano			ErbB2 Receptor Over-Expression Improves Post-Traumatic Peripheral Nerve Regeneration in Adult Mice	PLOS ONE			English	Article							SCHWANN-CELLS; NEUREGULIN-1; PROLIFERATION; SYSTEM; CARCINOGENESIS; TRASTUZUMAB; LAPATINIB; DISECTOR; RESCUE; BREAST	In a transgenic mice (BALB-neuT) over-expressing ErbB2 receptor, we investigated the adult mouse median nerve in physiological and pathological conditions. Results showed that, in physiological conditions, the grip function controlled by the median nerve in BALB-neuT mice was similar to wild-type (BALB/c). Stereological assessment of ErbB2-overexpressing intact nerves revealed no difference in number and size of myelinated fibers compared to wild-type mice. By contrast, after a nerve crush injury, the motor recovery was significantly faster in BALB-neuT compared to BALB/c mice. Moreover, stereological assessment revealed a significant higher number of regenerated myelinated fibers with a thinner axon and fiber diameter and myelin thickness in BALB-neuT mice. At day-2 post-injury, the level of the mRNAs coding for all the ErbB receptors and for the transmembrane (type III) Neuregulin 1 (NRG1) isoforms significantly decreased in both BALB/c and BALB-neuT mice, as shown by quantitative real time PCR. On the other hand, the level of the mRNAs coding for soluble NRG1 isoforms (type I/II, alpha and beta) increased at the same post-traumatic time point though, intriguingly, this response was significantly higher in BALB-neuT mice with respect to BALB/c mice. Altogether, these results suggest that constitutive ErbB2 receptor over-expression does not influence the physiological development of peripheral nerves, while it improves nerve regeneration following traumatic injury, possibly through the up-regulation of soluble NRG1 isoforms.	[Ronchi, Giulia; Gambarotta, Giovanna; Di Scipio, Federica; Salamone, Paolina; Sprio, Andrea E.; Cavallo, Federica; Perroteau, Isabelle; Berta, Giovanni N.; Geuna, Stefano] Univ Turin, Dept Clin & Biol Sci, Orbassano, TO, Italy; [Ronchi, Giulia; Geuna, Stefano] Univ Turin, Neurosci Inst Cavalieri Ottolenghi Fdn NICO, Orbassano, TO, Italy; [Cavallo, Federica] Univ Turin, Ctr Mol Biotechnol, Turin, Italy	University of Turin; University of Turin; University of Turin	Geuna, S (corresponding author), Univ Turin, Dept Clin & Biol Sci, Orbassano, TO, Italy.	stefano.geuna@unito.it	Gambarotta, Giovanna/I-8473-2012; Berta, Giovanni N./D-4418-2018; Ronchi, Giulia/J-4785-2018; Cavallo, Federica/C-5666-2011; Sprio, Andrea Elio/B-9370-2012	Gambarotta, Giovanna/0000-0002-8380-5925; Berta, Giovanni N./0000-0002-3263-9349; Ronchi, Giulia/0000-0002-4795-7024; Geuna, Stefano/0000-0002-6962-831X; Cavallo, Federica/0000-0003-4571-1060; Sprio, Andrea Elio/0000-0001-5891-871X; Perroteau, Isabelle/0000-0001-9797-2276	MIUR; Compagnia di San Paolo (MOVAG); Regione Piemonte (Progetto Ricerca Sanitaria Finalizzata); AIRC [IG 5377]	MIUR(Ministry of Education, Universities and Research (MIUR)); Compagnia di San Paolo (MOVAG)(Compagnia di San Paolo); Regione Piemonte (Progetto Ricerca Sanitaria Finalizzata)(Regione Piemonte); AIRC(Fondazione AIRC per la ricerca sul cancro)	This work was supported by grants from MIUR, Compagnia di San Paolo (MOVAG), Regione Piemonte (Progetto Ricerca Sanitaria Finalizzata) and AIRC (IG 5377). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambrosino E, 2006, CANCER RES, V66, P7734, DOI 10.1158/0008-5472.CAN-06-1432; Atanasoski S, 2006, J NEUROSCI, V26, P2124, DOI 10.1523/JNEUROSCI.4594-05.2006; Audisio C, 2008, NEUROREPORT, V19, P1605, DOI 10.1097/WNR.0b013e32831313ef; Audisio C, 2009, J NEUROSCI METH, V185, P89, DOI 10.1016/j.jneumeth.2009.09.021; Bangaru ML, 2011, J MOL NEUROSCI; Beer GM, 2001, J RECONSTR MICROSURG, V17, P531, DOI 10.1055/s-2001-17755; Berta GN, 2011, CANCER PREV RES, V4, P994, DOI 10.1158/1940-6207.CAPR-10-0301; Blackwell KL, 2010, J CLIN ONCOL, V28, P1124, DOI 10.1200/JCO.2008.21.4437; Boggio K, 1998, J EXP MED, V188, P589, DOI 10.1084/jem.188.3.589; Carroll SL, 1997, J NEUROSCI, V17, P1642; Citri A, 2006, NAT REV MOL CELL BIO, V7, P505, DOI 10.1038/nrm1962; Di Scipio F, 2008, MICROSC RES TECHNIQ, V71, P497, DOI 10.1002/jemt.20577; Falls DL, 2003, J NEUROCYTOL, V32, P619, DOI 10.1023/B:NEUR.0000020614.83883.be; Falls DL, 2003, EXP CELL RES, V284, P14, DOI 10.1016/S0014-4827(02)00102-7; FAWCETT JW, 1990, ANNU REV NEUROSCI, V13, P43, DOI 10.1146/annurev.neuro.13.1.43; Freeman M, 2000, NATURE, V408, P313, DOI 10.1038/35042500; Fricker FR, 2011, FUTUR NEUROL, V6, P809, DOI 10.2217/FNL.11.45; Fricker FR, 2011, J NEUROSCI, V31, P3225, DOI 10.1523/JNEUROSCI.2568-10.2011; Gambarotta G, 2004, J BIOL CHEM, V279, P48808, DOI 10.1074/jbc.M408374200; Garratt AN, 2000, J CELL BIOL, V148, P1035, DOI 10.1083/jcb.148.5.1035; Geuna S, 2000, J COMP NEUROL, V427, P333; Geuna S, 2000, ANN ANAT, V182, P23, DOI 10.1016/S0940-9602(00)80117-X; Geuna S, 2005, MICROSC RES TECHNIQ, V66, P270, DOI 10.1002/jemt.20167; Geuna S, 2009, INT REV NEUROBIOL, V87, P27, DOI 10.1016/S0074-7742(09)87003-7; Hudis CA, 2007, NEW ENGL J MED, V357, P39, DOI 10.1056/NEJMra043186; Khademi B, 2002, CANCER LETT, V184, P223, DOI 10.1016/S0304-3835(02)00242-2; Larsen JO, 1998, J NEUROSCI METH, V85, P107, DOI 10.1016/S0165-0270(98)00129-0; LEE KF, 1995, NATURE, V378, P394, DOI 10.1038/378394a0; Lemke G, 1996, MOL CELL NEUROSCI, V7, P247, DOI 10.1006/mcne.1996.0019; Magill C, 2008, NEUROL RES, V30, P1023, DOI 10.1179/174313208X362497; de Albornoz PM, 2011, BRIT MED BULL, V100, P73, DOI 10.1093/bmb/ldr005; Mei L, 2008, NAT REV NEUROSCI, V9, P437, DOI 10.1038/nrn2392; Meyer D, 1997, DEVELOPMENT, V124, P3575; Morris JK, 1999, NEURON, V23, P273, DOI 10.1016/S0896-6273(00)80779-5; MORRISSEY TK, 1995, P NATL ACAD SCI USA, V92, P1431, DOI 10.1073/pnas.92.5.1431; Moy B, 2007, ONCOLOGIST, V12, P756, DOI 10.1634/theoncologist.12-7-756; NADIM W, 1990, NEUROPATH APPL NEURO, V16, P411, DOI 10.1111/j.1365-2990.1990.tb01277.x; Newbern J, 2010, SEMIN CELL DEV BIOL, V21, P922, DOI 10.1016/j.semcdb.2010.08.008; Oh YS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023894; Ronchi G, 2010, J NEUROSCI METH, V188, P71, DOI 10.1016/j.jneumeth.2010.01.024; Ronchi G, 2009, J NEUROSCI METH, V179, P51, DOI 10.1016/j.jneumeth.2009.01.011; SALZER JL, 1980, J CELL BIOL, V84, P739, DOI 10.1083/jcb.84.3.739; Schmitz C, 1998, ANAT EMBRYOL, V198, P371, DOI 10.1007/s004290050191; Schulze A, 2001, GENE DEV, V15, P981, DOI 10.1101/gad.191101; SLAMON DJ, 1989, SCIENCE, V244, P707, DOI 10.1126/science.2470152; Syed Neeraja, 2010, Mol Cell Pharmacol, V2, P161; Syed N, 2010, J NEUROSCI, V30, P6122, DOI 10.1523/JNEUROSCI.1681-09.2010; Taveggia C, 2010, NAT REV NEUROL, V6, P276, DOI 10.1038/nrneurol.2010.37; Tos P, 2008, J NEUROSCI METH, V169, P119, DOI 10.1016/j.jneumeth.2007.11.030; Tos P, 2007, MICROSURG, V27, P48, DOI 10.1002/micr.20306; Tos P, 2009, INT REV NEUROBIOL, V87, P47, DOI 10.1016/S0074-7742(09)87004-9; Treekitkarnmongkol W, 2010, WORLD J GASTROENTERO, V16, P4047, DOI 10.3748/wjg.v16.i32.4047; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wadugu B, 2012, AM J PHYSIOL-HEART C, V302, pH2139, DOI 10.1152/ajpheart.00063.2012; Wasserman JD, 1998, CELL, V95, P355, DOI 10.1016/S0092-8674(00)81767-5; Woldeyesus MT, 1999, GENE DEV, V13, P2538, DOI 10.1101/gad.13.19.2538; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073	57	20	21	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2013	8	2							e56282	10.1371/journal.pone.0056282	http://dx.doi.org/10.1371/journal.pone.0056282			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IT	23437108	Green Published, Green Submitted, gold			2022-12-25	WOS:000315186000022
J	Li, Y; Xue, WJ; Liu, HB; Fan, P; Wang, XH; Ding, XM; Tian, XH; Feng, XS; Pan, XM; Zheng, J; Tian, PX; Ding, CG; Fan, XH				Li, Yang; Xue, Wujun; Liu, Hongbao; Fan, Ping; Wang, Xiaohong; Ding, Xiaoming; Tian, Xiaohui; Feng, Xinshun; Pan, Xiaoming; Zheng, Jin; Tian, Puxun; Ding, Chenguang; Fan, Xiaohu			Combined Strategy of Endothelial Cells Coating, Sertoli Cells Coculture and Infusion Improves Vascularization and Rejection Protection of Islet Graft	PLOS ONE			English	Article							GROWTH-FACTOR; HEME OXYGENASE-1; DIABETIC-RATS; TRANSPLANTATION; BETA; LANGERHANS; EXPRESSION; APOPTOSIS; SURVIVAL; ANGIOGENESIS	Improving islet graft revascularization and inhibiting rejection become crucial tasks for prolonging islet graft survival. Endothelial cells (ECs) are the basis of islet vascularization and Sertoli cells (SCs) have the talent to provide nutritional support and exert immunosuppressive effects. We construct a combined strategy of ECs coating in the presence of nutritious and immune factors supplied by SCs in a co-culture system to investigate the effect of vascularization and rejection inhibition for islet graft. In vivo, the combined strategy improved the survival and vascularization as well as inhibited lymphocytes and inflammatory cytokines. In vitro, we found the combinatorial strategy improved the function of islets and the effect of ECs-coating on islets. Combined strategy treated islets revealed higher levels of anti-apoptotic signal molecules (Bcl-2 and HSP-32), survival and function related molecules (PDX-1, Ki-67, ERK1/2 and Akt) and demonstrated increased vascular endothelial growth factor receptor 2 (KDR) and angiogenesis signal molecules (FAk and PLC-gamma). SCs effectively inhibited the activation of lymphocyte stimulated by islets and ECs. Predominantly immunosuppressive cytokines could be detected in culture supernatants of the SCs coculture group. These results suggest that ECs-coating and Sertoli cells co-culture or infusion synergistically enhance islet survival and function after transplantation.	[Li, Yang; Xue, Wujun; Wang, Xiaohong; Ding, Xiaoming; Tian, Xiaohui; Feng, Xinshun; Pan, Xiaoming; Zheng, Jin; Tian, Puxun; Ding, Chenguang] Xi An Jiao Tong Univ, Hosp Nephrol, Affiliated Hosp 1, Coll Med, Xian 710049, Peoples R China; [Liu, Hongbao] Fourth Mil Med Univ, Dept Nephrol, Xijing Hosp, Xian 710032, Peoples R China; [Fan, Ping] Xi An Jiao Tong Univ, Dept Rheumatism & Immunol, Affiliated Hosp 1, Coll Med, Xian 710049, Peoples R China; [Fan, Xiaohu] Univ Alberta, Edmonton, AB, Canada	Xi'an Jiaotong University; Air Force Military Medical University; Xi'an Jiaotong University; University of Alberta	Li, Y (corresponding author), Xi An Jiao Tong Univ, Hosp Nephrol, Affiliated Hosp 1, Coll Med, Xian 710049, Peoples R China.	leon4344@126.com; xwujun@126.com	Li, Yuan/GXV-1310-2022; li, yong/HDN-3885-2022; Li, Yang/GWM-7879-2022	Liu, Hongbao/0000-0002-1283-4956	National Nature Science Foundation of China [81270548]; nation "973" project [2009CB522400]; Science and technology project of Shaanxi [2012K16-09-02]; Youth Foundation of the First Affiliated Hospital, Medical College, Xi'an Jiaotong University [2011YK.20]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); nation "973" project; Science and technology project of Shaanxi; Youth Foundation of the First Affiliated Hospital, Medical College, Xi'an Jiaotong University	This work was supported by grants from National Nature Science Foundation of China (Nos. 81270548), the nation "973" project (2009CB522400), Science and technology project of Shaanxi (2012K16-09-02), Youth Foundation of the First Affiliated Hospital, Medical College, Xi'an Jiaotong University (2011YK.20). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlgren U, 1998, GENE DEV, V12, P1763, DOI 10.1101/gad.12.12.1763; Ahn YO, 2009, J IMMUNOL, V182, P6114, DOI 10.4049/jimmunol.0803725; Calzado MA, 2009, NAT CELL BIOL, V11, P85, DOI 10.1038/ncb1816; Chen C, 2011, AM J TRANSPLANT, V11, P215, DOI 10.1111/j.1600-6143.2010.03390.x; Dalle S, 2004, J BIOL CHEM, V279, P20345, DOI 10.1074/jbc.M312483200; Fan P, 2011, BIOCHEM BIOPH RES CO, V404, P829, DOI 10.1016/j.bbrc.2010.12.068; Fiorina P, 2003, TRANSPLANTATION, V75, P1296, DOI 10.1097/01.TP.0000061788.32639.D9; Griswold MD, 1998, SEMIN CELL DEV BIOL, V9, P411, DOI 10.1006/scdb.1998.0203; Hering BJ, 2005, TRANSPLANTATION, V79, P1296, DOI 10.1097/01.TP.0000157321.55375.86; Ichii H, 2007, AM J TRANSPLANT, V7, P1010, DOI 10.1111/j.1600-6143.2006.01687.x; Johansson M, 2006, ENDOCRINOLOGY, V147, P2315, DOI 10.1210/en.2005-0997; Johansson U, 2005, AM J TRANSPLANT, V5, P2632, DOI 10.1111/j.1600-6143.2005.01076.x; Johansson U, 2003, BIOCHEM BIOPH RES CO, V308, P474, DOI 10.1016/S0006-291X(03)01392-5; Kilani RT, 2003, PLACENTA, V24, P826, DOI 10.1016/S0143-4004(03)00129-2; KUTTY RK, 1994, J CELL PHYSIOL, V159, P371; Lee DY, 2006, AM J TRANSPLANT, V6, P1820, DOI 10.1111/j.1600-6143.2006.01414.x; Li Y, 2011, ARTIF ORGANS, V35, P634, DOI 10.1111/j.1525-1594.2010.01155.x; Li Y, 2010, TRANSPLANTATION, V89, P1430, DOI 10.1097/TP.0b013e3181da607e; Li Y, 2009, J ZHEJIANG UNIV-SC B, V10, P820, DOI 10.1631/jzus.B0920115; Li Zhao-Lun, 2008, Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi, V24, P1147; Linn T, 2003, FASEB J, V17, P881, DOI 10.1096/fj.02-0615fje; Matsumoto T, 2006, J ATHEROSCLER THROMB, V13, P130, DOI 10.5551/jat.13.130; McKinnon CM, 2001, DIABETOLOGIA, V44, P1203, DOI 10.1007/s001250100628; Meng ZX, 2006, DIABETOLOGIA, V49, P2959, DOI 10.1007/s00125-006-0447-5; MENGER MD, 1989, DIABETES, V38, P199, DOI 10.2337/diab.38.1.S199; Mottram PL, 1998, TRANSPLANTATION, V66, P1510, DOI 10.1097/00007890-199812150-00015; Muruve DA, 1997, HUM GENE THER, V8, P955, DOI 10.1089/hum.1997.8.8-955; Negi S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030415; Pan XM, 2011, TRANSPLANTATION, V92, P1208, DOI 10.1097/TP.0b013e3182356ca7; Plesner A, 2005, DIABETES, V54, P2533, DOI 10.2337/diabetes.54.9.2533; Robertson RP, 2004, NEW ENGL J MED, V350, P694, DOI 10.1056/NEJMra032425; Rodriguez AI, 2003, NEUROTOX RES, V5, P443, DOI 10.1007/BF03033174; Sakata N, 2010, TRANSPLANTATION, V89, P686, DOI 10.1097/TP.0b013e3181cb3e8d; Shapiro AMJ, 2005, TRANSPLANTATION, V79, P1304, DOI 10.1097/01.TP.0000157300.53976.2A; SKINNER MK, 1991, ENDOCR REV, V12, P45, DOI 10.1210/edrv-12-1-45; Song HJ, 2010, TRANSPL P, V42, P2662, DOI 10.1016/j.transproceed.2010.06.003; STAGNER JI, 1990, TRANSPLANT P, V22, P824; Tajik N, 2008, INT J IMMUNOGENET, V35, P9, DOI 10.1111/j.1744-313X.2007.00727.x; VAJKOCZY P, 1995, TRANSPLANTATION, V60, P123, DOI 10.1097/00007890-199507270-00002; [王于蓝 WANG Yulan], 2006, [上海交通大学学报. 医学版, Journal of Shanghai Jiaotong University. Medical Science], V26, P877; Zhang N, 2004, DIABETES, V53, P963, DOI 10.2337/diabetes.53.4.963; Zhu GQ, 2004, CLIN J CONSERV, V16, P371	42	10	12	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e56696	10.1371/journal.pone.0056696	http://dx.doi.org/10.1371/journal.pone.0056696			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437215	Green Published, gold, Green Submitted			2022-12-25	WOS:000315184200145
J	Meckenhauser, G; Hennig, RM; Nawrot, MP				Meckenhaeuser, Gundula; Hennig, R. Matthias; Nawrot, Martin P.			Critical Song Features for Auditory Pattern Recognition in Crickets	PLOS ONE			English	Article							CALLING-SONG; FEMALE CRICKETS; GRYLLUS; NEURONS; BEHAVIOR; GRASSHOPPER; SIGNALS; WALKING; ORTHOPTERA; PHONOTAXIS	Many different invertebrate and vertebrate species use acoustic communication for pair formation. In the cricket Gryllus bimaculatus, females recognize their species-specific calling song and localize singing males by positive phonotaxis. The song pattern of males has a clear structure consisting of brief and regular pulses that are grouped into repetitive chirps. Information is thus present on a short and a long time scale. Here, we ask which structural features of the song critically determine the phonotactic performance. To this end we employed artificial neural networks to analyze a large body of behavioral data that measured females' phonotactic behavior under systematic variation of artificially generated song patterns. In a first step we used four non-redundant descriptive temporal features to predict the female response. The model prediction showed a high correlation with the experimental results. We used this behavioral model to explore the integration of the two different time scales. Our result suggested that only an attractive pulse structure in combination with an attractive chirp structure reliably induced phonotactic behavior to signals. In a further step we investigated all feature sets, each one consisting of a different combination of eight proposed temporal features. We identified feature sets of size two, three, and four that achieve highest prediction power by using the pulse period from the short time scale plus additional information from the long time scale.	[Meckenhaeuser, Gundula; Nawrot, Martin P.] Free Univ Berlin, Inst Biol, Berlin, Germany; [Hennig, R. Matthias] Humboldt Univ, Dept Biol, Berlin, Germany	Free University of Berlin; Humboldt University of Berlin	Meckenhauser, G (corresponding author), Free Univ Berlin, Inst Biol, Berlin, Germany.	gundula.meckenhaeuser@fu-berlin.de	Nawrot, Martin Paul/AAO-5523-2020	Nawrot, Martin Paul/0000-0003-4133-6419	Deutsche Forschungsgemeinschaft (DFG) within the collaborative research center 'Theoretical Biology' [SFB 618]	Deutsche Forschungsgemeinschaft (DFG) within the collaborative research center 'Theoretical Biology'(German Research Foundation (DFG))	This work is supported by the Deutsche Forschungsgemeinschaft (DFG) within the collaborative research center 'Theoretical Biology' (SFB 618). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balakrishnan R, 2001, J COMP PHYSIOL A, V187, P255, DOI 10.1007/s003590100197; Beckers OM, 2011, ANIM BEHAV, V81, P519, DOI 10.1016/j.anbehav.2010.11.022; Benda J, 2008, J COMPUT NEUROSCI, V24, P113, DOI 10.1007/s10827-007-0044-8; Bishop C.M., 2006, PATTERN RECOGNITION; Desutter-Grandcolas L, 2003, ZOOL SCR, V32, P173, DOI 10.1046/j.1463-6409.2003.00107.x; DOHERTY JA, 1985, J COMP PHYSIOL A, V156, P787, DOI 10.1007/BF00610831; Duchamp-Viret P, 2003, EUR J NEUROSCI, V18, P2690, DOI 10.1111/j.1460-9568.2003.03001.x; Grobe B, 2012, J EXP BIOL, V215, P1681, DOI 10.1242/jeb.065466; Hedwig B, 2005, J EXP BIOL, V208, P915, DOI 10.1242/jeb.01452; Hedwig B, 2006, J COMP PHYSIOL A, V192, P677, DOI 10.1007/s00359-006-0115-8; Hennig RM, 2009, J COMP PHYSIOL A, V195, P971, DOI 10.1007/s00359-009-0473-0; Huber F., 1989, CRICKET BEHAV NEUROB; Kastenhuber E, 2011, CURR BIOL, V21, pR986, DOI 10.1016/j.cub.2011.10.048; Klappert K, 2003, ANIM BEHAV, V65, P225, DOI 10.1006/anbe.2002.2034; Kostarakos K, 2012, J NEUROSCI, V32, P9601, DOI 10.1523/JNEUROSCI.1170-12.2012; Mhatre N, 2007, J EXP BIOL, V210, P3661, DOI 10.1242/jeb.003764; Nissen S., 2003, REPORT, V3, P54; Pollack G, 2000, CURR OPIN NEUROBIOL, V10, P763, DOI 10.1016/S0959-4388(00)00161-6; RIEDMILLER M, 1993, 1993 IEEE INTERNATIONAL CONFERENCE ON NEURAL NETWORKS, VOLS 1-3, P586, DOI 10.1109/ICNN.1993.298623; SCHILDBERGER K, 1986, J COMP PHYSIOL A, V158, P291, DOI 10.1007/BF00603613; SCHILDBERGER K, 1984, J COMP PHYSIOL, V155, P171, DOI 10.1007/BF00612635; Schneider E, 2012, J COMP PHYSIOL A, V198, P181, DOI 10.1007/s00359-011-0698-6; Schul J, 1998, J COMP PHYSIOL A, V183, P401, DOI 10.1007/s003590050266; THORSON J, 1982, J COMP PHYSIOL, V146, P361, DOI 10.1007/BF00612706; von Helversen D., 1983, P95; von Helversen D, 1998, BIOL CYBERN, V79, P467, DOI 10.1007/s004220050496; von Helversen Otto, 1994, Progress in Zoology, V39, P253; von Philipsborn AC, 2011, NEURON, V69, P509, DOI 10.1016/j.neuron.2011.01.011; Webb B, 1995, ROBOT AUTON SYST, V16, P117, DOI 10.1016/0921-8890(95)00044-5; WEBER T, 1981, J COMP PHYSIOL, V141, P215, DOI 10.1007/BF01342668; Weiss M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045057; Wittmann JP, 2011, J COMPUT NEUROSCI, V31, P105, DOI 10.1007/s10827-010-0299-3; WOHLERS DW, 1982, J COMP PHYSIOL, V146, P161, DOI 10.1007/BF00610234; Woolley SC, 2004, PHYSIOL BEHAV, V83, P347, DOI 10.1016/j.physbeh.2004.08.021; Zorovic M, 2011, J NEUROPHYSIOL, V105, P2181, DOI 10.1152/jn.00416.2010	35	7	7	0	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e55349	10.1371/journal.pone.0055349	http://dx.doi.org/10.1371/journal.pone.0055349			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437054	Green Submitted, Green Published, gold			2022-12-25	WOS:000315184200016
J	Proctor, E; Waghray, M; Lee, CJ; Heidt, DG; Yalamanchili, M; Li, CW; Bednar, F; Simeone, DM				Proctor, Erica; Waghray, Meghna; Lee, Cheong Jun; Heidt, David G.; Yalamanchili, Malica; Li, Chenwei; Bednar, Filip; Simeone, Diane M.			Bmi1 Enhances Tumorigenicity and Cancer Stem Cell Function in Pancreatic Adenocarcinoma	PLOS ONE			English	Article							SELF-RENEWAL; MESENCHYMAL TRANSITION; EXPRESSION; OVEREXPRESSION; ONCOPROTEIN; MYC; IDENTIFICATION; TRANSFORMATION; PROLIFERATION; SENESCENCE	Background: Bmi1 is an integral component of the Polycomb Repressive Complex 1 (PRC1) and is involved in the pathogenesis of multiple cancers. It also plays a key role in the functioning of endogenous stem cells and cancer stem cells. Previous work implicated a role for cancer stem cells in the pathogenesis of pancreatic cancer. We hypothesized that Bmi1 plays an integral role in enhancing pancreatic tumorigenicity and the function of cancer stem cells in pancreatic ductal adenocarcinoma. Methods: We measured endogenous Bmi1 levels in primary human pancreatic ductal adenocarcinomas, pancreatic intraepithelial neoplasias (PanINs) and normal pancreas by immunohistochemistry and Western blotting. The function of Bmi1 in pancreatic cancer was assessed by alteration of Bmi1 expression in several cell model systems by measuring cell proliferation, cell apoptosis, in vitro invasion, chemotherapy resistance, and in vivo growth and metastasis in an orthotopic model of pancreatic cancer. We also assessed the cancer stem cell frequency, tumorsphere formation, and in vivo growth of human pancreatic cancer xenografts after Bmi1 silencing. Results: Bmi1 was overexpressed in human PanINs, pancreatic cancers, and in several pancreatic cancer cell lines. Overexpression of Bmi1 in MiaPaCa2 cells resulted in increased proliferation, in vitro invasion, larger in vivo tumors, more metastases, and gemcitabine resistance while opposite results were seen when Bmi1 was silenced in Panc-1 cells. Bmi1 was overexpressed in the cancer stem cell compartment of primary human pancreatic cancer xenografts. Pancreatic tumorspheres also demonstrated high levels of Bmi1. Silencing of Bmi1 inhibited secondary and tertiary tumorsphere formation, decreased primary pancreatic xenograft growth, and lowered the proportion of cancer stem cells in the xenograft tissue. Conclusions: Our results implicate Bmi1 in the invasiveness and growth of pancreatic cancer and demonstrate its key role in the regulation of pancreatic cancer stem cells.	[Proctor, Erica; Waghray, Meghna; Lee, Cheong Jun; Heidt, David G.; Yalamanchili, Malica; Li, Chenwei; Bednar, Filip; Simeone, Diane M.] Univ Michigan, Sch Med, Dept Surg, Ann Arbor, MI 48109 USA; [Simeone, Diane M.] Dept Mol & Integrat Physiol, Ann Arbor, MI USA; [Simeone, Diane M.] Univ Michigan, Sch Med, Ann Arbor, MI USA; [Simeone, Diane M.] Univ Michigan, Sch Med, Translat Oncol Program, Ann Arbor, MI USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Simeone, DM (corresponding author), Univ Michigan, Sch Med, Dept Surg, Ann Arbor, MI 48109 USA.	simeone@med.umich.edu	Lee, Cheong/AAD-1346-2019	Lee, Cheong/0000-0003-1439-5659	National Institutes of Health [R01 CA131045]; Rich Rogel Family Fund for Pancreatic Cancer Research; NATIONAL CANCER INSTITUTE [R01CA131045] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Rich Rogel Family Fund for Pancreatic Cancer Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funding was provided by National Institutes of Health R01 CA131045 and the Rich Rogel Family Fund for Pancreatic Cancer Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdouh M, 2009, J NEUROSCI, V29, P8884, DOI 10.1523/JNEUROSCI.0968-09.2009; Arumugam T, 2009, CANCER RES, V69, P5820, DOI 10.1158/0008-5472.CAN-08-2819; Bea S, 2001, CANCER RES, V61, P2409; Bracken AP, 2006, GENE DEV, V20, P1123, DOI 10.1101/gad.381706; Chen H, 2011, ORAL ONCOL, V47, P472, DOI 10.1016/j.oraloncology.2011.03.016; Cui HJ, 2007, AM J PATHOL, V170, P1370, DOI 10.2353/ajpath.2007.060754; Cui HJ, 2006, J BIOL CHEM, V281, P34696, DOI 10.1074/jbc.M604009200; Dhawan S, 2009, GENE DEV, V23, P906, DOI 10.1101/gad.1742609; Dimri GP, 2002, CANCER RES, V62, P4736; Dovey JS, 2008, P NATL ACAD SCI USA, V105, P11857, DOI 10.1073/pnas.0803574105; Fukuda A, 2012, GASTROENTEROLOGY, V143, P821, DOI 10.1053/j.gastro.2012.05.009; HAUPT Y, 1993, ONCOGENE, V8, P3161; Hezel AF, 2006, GENE DEV, V20, P1218, DOI 10.1101/gad.1415606; Jacobs JJL, 1999, NATURE, V397, P164, DOI 10.1038/16476; Jacobs JJL, 1999, GENE DEV, V13, P2678, DOI 10.1101/gad.13.20.2678; Jones S, 2008, SCIENCE, V321, P1801, DOI 10.1126/science.1164368; Kang MK, 2007, BRIT J CANCER, V96, P126, DOI 10.1038/sj.bjc.6603529; Kim JH, 2004, BREAST, V13, P383, DOI 10.1016/j.breast.2004.02.010; Kim JH, 2004, CANCER LETT, V203, P217, DOI 10.1016/j.canlet.2003.07.009; Konig J, 2005, INT J CANCER, V115, P359, DOI 10.1002/ijc.20831; Lessard J, 2003, NATURE, V423, P255, DOI 10.1038/nature01572; Leung C, 2004, NATURE, V428, P337, DOI 10.1038/nature02385; Li CW, 2007, CANCER RES, V67, P1030, DOI 10.1158/0008-5472.CAN-06-2030; Li YW, 2009, CANCER RES, V69, P6704, DOI 10.1158/0008-5472.CAN-09-1298; Lindstrom MS, 2001, ONCOGENE, V20, P2171, DOI 10.1038/sj.onc.1204303; Liu L, 2006, ONCOGENE, V25, P4370, DOI 10.1038/sj.onc.1209454; Liu SL, 2006, CANCER RES, V66, P6063, DOI 10.1158/0008-5472.CAN-06-0054; Lukacs RU, 2010, CELL STEM CELL, V7, P682, DOI 10.1016/j.stem.2010.11.013; Martinez-Romero C, 2009, J PATHOL, V219, P205, DOI 10.1002/path.2585; Molofsky AV, 2005, GENE DEV, V19, P1432, DOI 10.1101/gad.1299505; Nakauchi H, 2005, E SCHERING RES FDN W, V54, P85; Park IK, 2003, NATURE, V423, P302, DOI 10.1038/nature01587; Reinisch CM, 2007, J CUTAN PATHOL, V34, P174, DOI 10.1111/j.1600-0560.2006.00587.x; Sangiorgi E, 2009, P NATL ACAD SCI USA, V106, P7101, DOI 10.1073/pnas.0902508106; Song LB, 2006, CANCER RES, V66, P6225, DOI 10.1158/0008-5472.CAN-06-0094; Song WJ, 2010, CANCER SCI, V101, P1754, DOI 10.1111/j.1349-7006.2010.01577.x; Tateishi K, 2006, CLIN CANCER RES, V12, P6960, DOI 10.1158/1078-0432.CCR-06-0449; VANDERLUGT NMT, 1994, GENE DEV, V8, P757, DOI 10.1101/gad.8.7.757; VANLOHUIZEN M, 1991, CELL, V65, P737, DOI 10.1016/0092-8674(91)90382-9; Vonlanthen S, 2001, BRIT J CANCER, V84, P1372, DOI 10.1054/bjoc.2001.1791	40	82	83	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e55820	10.1371/journal.pone.0055820	http://dx.doi.org/10.1371/journal.pone.0055820			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437065	Green Published, Green Submitted, gold			2022-12-25	WOS:000315184200024
J	Williams, JJ; Mayurasakorn, K; Vannucci, SJ; Mastropietro, C; Bazan, NG; Ten, VS; Deckelbaum, RJ				Williams, Jill J.; Mayurasakorn, Korapat; Vannucci, Susan J.; Mastropietro, Christopher; Bazan, Nicolas G.; Ten, Vadim S.; Deckelbaum, Richard J.			N-3 Fatty Acid Rich Triglyceride Emulsions Are Neuroprotective after Cerebral Hypoxic-Ischemic Injury in Neonatal Mice	PLOS ONE			English	Article							DOCOSAHEXAENOIC ACID; EICOSAPENTAENOIC ACID; LIPID EMULSIONS; BLOOD CLEARANCE; PARTICLE-SIZE; BRAIN-INJURY; MODEL; STROKE; OMEGA-3-FATTY-ACIDS; NEUROINFLAMMATION	We questioned if acute administration of n-3 fatty acids (FA) carried in n-3 rich triglyceride (TG) emulsions provides neuroprotection in neonatal mice subjected to hypoxic-ischemic (H/I) brain injury. We examined specificity of FA, optimal doses, and therapeutic windows for neuroprotection after H/I. H/I insult was induced in C57BL/6J 10-day-old mice by right carotid artery ligation followed by exposure to 8% O-2 for 15 minutes at 37 degrees C. Intraperitoneal injection with n-3-rich TG emulsions, n-6 rich TG emulsions or saline for control was administered at different time points before and/or after H/I. In separate experiments, dose responses were determined with TG containing only docosahexaenoic acid (Tri-DHA) or eicosapentaenoic acid (Tri-EPA) with a range of 0.1-0.375 g n-3 TG/kg, administered immediately after H/I insult. Infarct volume and cerebral blood flow (CBF) were measured. Treatment with n-3 TG emulsions both before-and after-H/I significantly reduced total infarct volume by a mean of 43% when administered 90 min prior to H/I and by 47% when administered immediately after H/I. In post-H/I experiments Tri-DHA, but not Tri-EPA exhibited neuroprotective effects with both low and high doses (p<0.05). Moreover, delayed post-H/I treatment with Tri-DHA significantly decreased total infarct volume by a mean of 51% when administered at 0 hr, by 46% at 1 hr, and by 51% at 2 hr after H/I insult. No protective effect occurred with Tri-DHA injection at 4 hr after H/I. There were no n-3 TG related differences in CBF. A significant reduction in brain tissue death was maintained after Tri-DHA injection at 8 wk after the initial brain injury. Thus, n-3 TG, specifically containing DHA, is protective against H/I induced brain infarction when administered up to 2 hr after H/I injury. Acute administration of TG-rich DHA may prove effective for treatment of stroke in humans.	[Williams, Jill J.; Mayurasakorn, Korapat; Deckelbaum, Richard J.] Columbia Univ, Inst Human Nutr, Dept Pediat, Coll Phys & Surg, New York, NY 10032 USA; [Vannucci, Susan J.] Cornell Univ, Dept Pediat, Weill Cornell Med Coll, New York, NY 10021 USA; [Mastropietro, Christopher] Childrens Hosp Michigan, Dept Pediat, Detroit, MI USA; [Mastropietro, Christopher] Wayne State Univ, Detroit, MI 48202 USA; [Bazan, Nicolas G.] Louisiana State Univ, Hlth Sci Ctr, Neurosci Ctr Excellence, New Orleans, LA USA; [Ten, Vadim S.] Columbia Univ, Dept Pediat, Coll Phys & Surg, New York, NY 10027 USA	Columbia University; Cornell University; Children's Hospital of Michigan; Wayne State University; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Columbia University	Deckelbaum, RJ (corresponding author), Columbia Univ, Inst Human Nutr, Dept Pediat, Coll Phys & Surg, New York, NY 10032 USA.	rjd20@columbia.edu	Bazan, Nicolas/AAN-4121-2020; Mastropietro, Christopher/V-9078-2019	Bazan, Nicolas/0000-0002-9243-5444; Mastropietro, Christopher/0000-0002-7409-7664; Mayurasakorn, Korapat/0000-0003-3816-6463	National Institutes of Health [R01 HL040404, NS 056146, NS 046741]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL040404] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS046741, R01NS056146] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health Grants R01 HL040404, NS 056146 and NS 046741. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adolph M, 1999, ANN NUTR METAB, V43, P1, DOI 10.1159/000012761; Agustin L, 2000, INT PEDIAT, V15, P143; Bazan NG, 2012, MOL NEUROBIOL, V46, P221, DOI 10.1007/s12035-012-8322-5; Bazan NG, 2011, ANNU REV NUTR, V31, P321, DOI 10.1146/annurev.nutr.012809.104635; Belayev L, 2005, STROKE, V36, P118, DOI 10.1161/01.STR.0000149620.74770.2e; Belayev L, 2011, TRANSL STROKE RES, V2, P33, DOI 10.1007/s12975-010-0046-0; Belayev L, 2009, STROKE, V40, P3121, DOI 10.1161/STROKEAHA.109.555979; Berman DR, 2009, AM J OBSTET GYNECOL, V200, DOI 10.1016/j.ajog.2009.01.020; Blaxter K, 1989, ENERGY METABOLISM AN; Blondeau N, 2007, CIRC RES, V101, P176, DOI 10.1161/CIRCRESAHA.107.154443; Brott T, 1997, STROKE, V28, P2119, DOI 10.1161/01.STR.28.11.2119; Bruno A, 1999, NEUROLOGY, V52, P280, DOI 10.1212/WNL.52.2.280; Calder PC, 2010, NUTRIENTS, V2, P355, DOI 10.3390/nu2030355; Callaway JK, 2001, CLIN EXP PHARMACOL P, V28, P913, DOI 10.1046/j.1440-1681.2001.03547.x; Caspersen CS, 2008, DEV NEUROSCI-BASEL, V30, P319, DOI 10.1159/000121416; Deckelbaum RJ, 2006, AM J CLIN NUTR, V83, p1520S, DOI 10.1093/ajcn/83.6.1520S; Denis C, 1998, P NATL ACAD SCI USA, V95, P9524, DOI 10.1073/pnas.95.16.9524; Dirnagl U, 1999, TRENDS NEUROSCI, V22, P391, DOI 10.1016/S0166-2236(99)01401-0; GRANOT E, 1994, BIOCHEMISTRY-US, V33, P15190, DOI 10.1021/bi00254a030; Grimsgaard S, 1997, AM J CLIN NUTR, V66, P649, DOI 10.1093/ajcn/66.3.649; Huang J, 2000, STROKE, V31, P3054, DOI 10.1161/01.STR.31.12.3054; Khairallah RJ, 2010, BBA-BIOENERGETICS, V1797, P1555, DOI 10.1016/j.bbabio.2010.05.007; King VR, 2006, J NEUROSCI, V26, P4672, DOI 10.1523/JNEUROSCI.5539-05.2006; Lewandowski C, 2001, ANN EMERG MED, V37, P202, DOI 10.1067/mem.2001.111573; Lim SN, 2010, PROSTAG LEUKOTR ESS, V83, P193, DOI 10.1016/j.plefa.2010.08.003; LISZCZAK TM, 1984, ACTA NEUROPATHOL, V65, P150, DOI 10.1007/BF00690469; Lloyd-Jones D, 2010, CIRCULATION, V121, pE46, DOI 10.1161/CIRCULATIONAHA.109.192667; Marcheselli VL, 2003, J BIOL CHEM, V278, P43807, DOI 10.1074/jbc.M305841200; MARLER JR, 1995, NEW ENGL J MED, V333, P1581, DOI 10.1056/nejm199512143332401; Mayurasakorn K, 2011, FASEB J, V25; Mayurasakorn K, 2011, CURR OPIN CLIN NUTR, V14, P158, DOI 10.1097/MCO.0b013e328342cba5; Miller AT, 1986, ENERGY METABOLISM; Mukherjee PK, 2004, P NATL ACAD SCI USA, V101, P8491, DOI 10.1073/pnas.0402531101; Niatsetskaya ZV, 2012, J NEUROSCI, V32, P3235, DOI 10.1523/JNEUROSCI.6303-11.2012; Oliveira FLC, 1997, JPEN-PARENTER ENTER, V21, P224, DOI 10.1177/0148607197021004224; Pan HC, 2009, J NUTR BIOCHEM, V20, P715, DOI 10.1016/j.jnutbio.2008.06.014; Pavlakis SG, 2006, PEDIATR NEUROL, V34, P433, DOI 10.1016/j.pediatrneurol.2005.09.009; Perlman JM, 2007, J PERINATOL, V27, pS39, DOI 10.1038/sj.jp.7211716; Qi KM, 2006, J NUTR, V136, P2766, DOI 10.1093/jn/136.11.2766; Qi KM, 2003, JPEN-PARENTER ENTER, V27, P58, DOI 10.1177/014860710302700158; Qi KM, 2002, BIOCHEMISTRY-US, V41, P3119, DOI 10.1021/bi015770h; Raju TNK, 2007, PEDIATRICS, V120, P609, DOI 10.1542/peds.2007-0336; SCHWIEGELSHOHN B, 1995, J BIOL CHEM, V270, P1761, DOI 10.1074/jbc.270.4.1761; Seo T, 2005, CURR OPIN LIPIDOL, V16, P11, DOI 10.1097/00041433-200502000-00004; Singh A K, 1989, J Exp Pathol, V4, P9; Stanley WC, 2012, CURR OPIN CLIN NUTR, V15, P122, DOI 10.1097/MCO.0b013e32834fdaf7; Ten VS, 2012, NEUROL RES INT, V2012, DOI 10.1155/2012/542976; Ten VS, 2003, BEHAV BRAIN RES, V145, P209, DOI 10.1016/S0166-4328(03)00146-3; Terpstra AHM, 2001, J NUTR, V131, P2067, DOI 10.1093/jn/131.7.2067; Vannucci SJ, 2004, J EXP BIOL, V207, P3149, DOI 10.1242/jeb.01064; Ward RE, 2010, J NEUROTRAUM, V27, P1769, DOI 10.1089/neu.2010.1348; Williams JJ, 2009, FASEB J, V23; Williams JJ, 2011, FASEB J, V25	53	44	51	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e56233	10.1371/journal.pone.0056233	http://dx.doi.org/10.1371/journal.pone.0056233			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437099	Green Published, gold, Green Submitted			2022-12-25	WOS:000315184200050
J	Chinnakannan, SK; Nanda, SK; Baron, MD				Chinnakannan, Senthil K.; Nanda, Sambit K.; Baron, Michael D.			Morbillivirus V Proteins Exhibit Multiple Mechanisms to Block Type 1 and Type 2 Interferon Signalling Pathways	PLOS ONE			English	Article							NIPAH-VIRUS-V; DES-PETITS-RUMINANTS; ALPHA-INTERFERON; PREVENTING STAT1; INHIBIT STAT1; C-PROTEIN; RINDERPEST; PARAMYXOVIRUS; PHOSPHORYLATION; CELLS	Morbilliviruses form a closely related group of pathogenic viruses which encode three non-structural proteins V, W and C in their P gene. Previous studies with rinderpest virus (RPV) and measles virus (MeV) have demonstrated that these nonstructural proteins play a crucial role in blocking type I (IFN alpha/beta) and type II (IFN gamma) interferon action, and various mechanisms have been proposed for these effects. We have directly compared four important morbilliviruses, rinderpest (RPV), measles virus (MeV), peste des petits ruminants virus (PPRV) and canine distemper virus (CDV). These viruses and their V proteins could all block type I IFN action. However, the viruses and their V proteins had varying abilities to block type II IFN action. The ability to block type II IFN-induced gene transcription correlated with co-precipitation of STAT1 with the respective V protein, but there was no correlation between co-precipitation of either STAT1 or STAT2 and the abilities of the V proteins to block type I IFN-induced gene transcription or the creation of the antiviral state. Further study revealed that the V proteins of RPV, MeV, PPRV and CDV could all interfere with phosphorylation of the interferon-receptor-associated kinase Tyk2, and the V protein of highly virulent RPV could also block the phosphorylation of another such kinase, Jak1. Co-precipitation studies showed that morbillivirus V proteins all form a complex containing Tyk2 and Jak1. This study highlights the ability of morbillivirus V proteins to target multiple components of the IFN signalling pathways to control both type I and type II IFN action.	[Chinnakannan, Senthil K.; Nanda, Sambit K.; Baron, Michael D.] Pirbright Inst, Pirbright, Surrey, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Pirbright Institute	Baron, MD (corresponding author), Pirbright Inst, Pirbright, Surrey, England.	michael.baron@pirbright.ac.uk	Chinnakannan, Senthil/AAP-9369-2020	Chinnakannan, Senthil/0000-0002-4404-0229	Pirbright Institute; United Kingdom Biotechnology and Biological Sciences Research Council; United Kingdom Department for International Development; Biotechnology and Biological Sciences Research Council [BBS/E/I/00001433, BBS/E/I/00001719, BBS/E/I/00001368] Funding Source: researchfish; BBSRC [BBS/E/I/00001719, BBS/E/I/00001433, BBS/E/I/00001368] Funding Source: UKRI	Pirbright Institute(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); United Kingdom Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); United Kingdom Department for International Development; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	SKC and SKN received PhD studentships from the Institute for Animal Health (now known as The Pirbright Institute, www.pirbright.ac.uk). The laboratory of MDB receives funding from the United Kingdom Biotechnology and Biological Sciences Research Council (www.bbsrc.ac.uk) and the United Kingdom Department for International Development (www.dfid.gov.uk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Anderson J, 2011, VET REC, V169, P10, DOI 10.1136/vr.d4011; Andrejeva J, 2002, J VIROL, V76, P11379, DOI 10.1128/JVI.76.22.11379-11386.2002; Bailey D, 2005, VIRUS RES, V110, P119, DOI 10.1016/j.virusres.2005.01.013; Bailey D, 2007, VIRUS RES, V126, P250, DOI 10.1016/j.virusres.2007.01.015; Baron MD, 2011, VET REC, V169, P16, DOI 10.1136/vr.d3947; BELLINI WJ, 1985, J VIROL, V53, P908, DOI 10.1128/JVI.53.3.908-919.1985; Best SM, 2005, J VIROL, V79, P12828, DOI 10.1128/JVI.79.20.12828-12839.2005; Bonami F, 2007, J VIROL, V81, P12066, DOI 10.1128/JVI.00818-07; Bousse T, 2006, VIRUS RES, V121, P23, DOI 10.1016/j.virusres.2006.03.012; Boxer EL, 2009, VIROLOGY, V385, P134, DOI 10.1016/j.virol.2008.11.022; Caignard G, 2009, VIROLOGY, V383, P112, DOI 10.1016/j.virol.2008.10.014; Caignard G, 2007, VIROLOGY, V368, P351, DOI 10.1016/j.virol.2007.06.037; CATTANEO R, 1989, CELL, V56, P759, DOI 10.1016/0092-8674(89)90679-X; Chambers R, 2009, J GEN VIROL, V90, P1906, DOI 10.1099/vir.0.011700-0; Childs K, 2007, VIROLOGY, V359, P190, DOI 10.1016/j.virol.2006.09.023; Demaison C, 2002, HUM GENE THER, V13, P803, DOI 10.1089/10430340252898984; Devaux P, 2008, J VIROL, V82, P5359, DOI 10.1128/JVI.00169-08; Devaux P, 2007, VIROLOGY, V360, P72, DOI 10.1016/j.virol.2006.09.049; Devaux P, 2011, J VIROL, V85, P348, DOI 10.1128/JVI.00802-10; Didcock L, 1999, J VIROL, V73, P9928, DOI 10.1128/JVI.73.12.9928-9933.1999; Fauquet C.M., 1999, 8 INT COMM TAX VIR, P1730, DOI 10.1006/rwvi.1999.0277; Fontana JM, 2008, IMMUNOL REV, V225, P46, DOI 10.1111/j.1600-065X.2008.00669.x; Fontana JM, 2008, VIROLOGY, V374, P71, DOI 10.1016/j.virol.2007.12.031; Goodbourn S, 2009, J INTERF CYTOK RES, V29, P539, DOI 10.1089/jir.2009.0071; Gotoh B, 2002, REV MED VIROL, V12, P337, DOI 10.1002/rmv.357; Guo JT, 2005, J VIROL, V79, P1343, DOI 10.1128/JVI.79.3.1343-1350.2005; Hale BG, 2006, P NATL ACAD SCI USA, V103, P14194, DOI 10.1073/pnas.0606109103; Ho LJ, 2005, J IMMUNOL, V174, P8163, DOI 10.4049/jimmunol.174.12.8163; Holzer B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028594; Horvath CM, 2004, EUR J BIOCHEM, V271, P4621, DOI 10.1111/j.1432-1033.2004.04425.x; Horvath CM, 2004, CYTOKINE GROWTH F R, V15, P117, DOI 10.1016/j.cytogfr.2004.02.003; Huang ZH, 2003, J VIROL, V77, P8676, DOI 10.1128/JVI.77.16.8676-8685.2003; HUBER M, 1991, VIROLOGY, V185, P299, DOI 10.1016/0042-6822(91)90777-9; Kaushik R, 2004, J GEN VIROL, V85, P687, DOI 10.1099/vir.0.19702-0; Komatsu T, 2000, J VIROL, V74, P2477, DOI 10.1128/JVI.74.5.2477-2480.2000; Lin RJ, 2006, J VIROL, V80, P5908, DOI 10.1128/JVI.02714-05; Malur AG, 2005, J VIROL, V79, P7877, DOI 10.1128/JVI.79.12.7877-7882.2005; Nanda SK, 2006, J VIROL, V80, P7555, DOI 10.1128/JVI.02720-05; Nanda SK, 2009, VIROLOGY, V395, P223, DOI 10.1016/j.virol.2009.09.031; Ohno S, 2004, J GEN VIROL, V85, P2991, DOI 10.1099/vir.0.80308-0; Palosaari H, 2003, J VIROL, V77, P7635, DOI 10.1128/JVI.77.13.7635-7644.2003; Park MS, 2003, J VIROL, V77, P1501, DOI 10.1128/JVI.77.2.1501-1511.2003; Platanias LC, 2005, NAT REV IMMUNOL, V5, P375, DOI 10.1038/nri1604; Ramachandran A, 2009, J INTERF CYTOK RES, V29, P531, DOI 10.1089/jir.2009.0070; Randall RE, 2008, J GEN VIROL, V89, P1, DOI 10.1099/vir.0.83391-0; Rarnachandran A, 2008, J VIROL, V82, P8330, DOI 10.1128/JVI.00831-08; Rodriguez JJ, 2004, J VIROL, V78, P5358, DOI 10.1128/JVI.78.10.5358-5367.2004; Rodriguez JJ, 2003, J VIROL, V77, P11842, DOI 10.1128/JVI.77.21.11842-11845.2003; Rodriguez JJ, 2002, J VIROL, V76, P11476, DOI 10.1128/JVI.76.22.11476-11483.2002; Roeder PL, 2011, PREV VET MED, V102, P98, DOI 10.1016/j.prevetmed.2011.04.004; Rothlisberger A, 2010, J VIROL, V84, P6328, DOI 10.1128/JVI.01878-09; Shaw ML, 2004, J VIROL, V78, P5633, DOI 10.1128/JVI.78.11.5633-5641.2004; Sleeman K, 2005, VIROLOGY, V332, P225, DOI 10.1016/j.virol.2004.11.020; Stark GR, 1998, ANNU REV BIOCHEM, V67, P227, DOI 10.1146/annurev.biochem.67.1.227; Takeuchi K, 2003, FEBS LETT, V545, P177, DOI 10.1016/S0014-5793(03)00528-3; Takeuchi K, 2003, VIRUS RES, V94, P11, DOI 10.1016/S0168-1702(03)00117-5; Taylor W P, 1986, Rev Sci Tech, V5, P407, DOI 10.20506/rst.5.2.250; Valmas C, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000721; von Messling V, 2003, J VIROL, V77, P12579, DOI 10.1128/JVI.77.23.12579-12591.2003; von Messling V, 2006, J VIROL, V80, P6084, DOI 10.1128/JVI.00357-06; WOHLSEIN P, 1993, VET PATHOL, V30, P544, DOI 10.1177/030098589303000608; WOHLSEIN P, 1995, VET MICROBIOL, V44, P141, DOI 10.1016/0378-1135(95)00007-W; Yokota S, 2003, VIROLOGY, V306, P135, DOI 10.1016/S0042-6822(02)00026-0	65	45	49	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2013	8	2							e57063	10.1371/journal.pone.0057063	http://dx.doi.org/10.1371/journal.pone.0057063			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093HR	23431397	Green Published, gold, Green Submitted			2022-12-25	WOS:000315182800040
J	Xu, JC; Xu, W; Yao, HX; Sun, WX; Zhou, Q; Cai, L				Xu, Jiancheng; Xu, Wei; Yao, Hanxin; Sun, Weixia; Zhou, Qi; Cai, Lu			Associations of Serum and Urinary Magnesium with the Pre-Diabetes, Diabetes and Diabetic Complications in the Chinese Northeast Population	PLOS ONE			English	Article							DIETARY MAGNESIUM; PLASMA MAGNESIUM; RISK; HYPOMAGNESEMIA; PATHOGENESIS; PREVALENCE; DEFICIENCY; MELLITUS; CALCIUM; COPPER	The effect of magnesium (Mg) deficiency on the prevalence of diabetes and diabetic complications has received a great attention. The present study investigated the association of Mg level in the serum or urine of the patients, lived in the Northeast areas of China, with either pre-diabetes or diabetes with and without complications. From January 2010 to October 2011, patients with type 1 diabetes (T1D, n = 25), type 2 diabetes (T2D, n = 137), impaired fasting glucose (IFG, n = 12) or impaired glucose tolerance (IGT, n = 15), and age/gender matched control (n = 50) were enrolled in the First Hospital of Jilin University. In T2D group, there were 24, 34, and 50 patients with nephropathy, retinopathy or peripheral neuropathy. Serum Mg levels in the patients with IGT, IFG, T2D, and T1D were significantly lower than that of control. The urinary Mg levels were significantly increased only in T2D and T1D patients compared to control. There was no difference for these two changes among T2D with and without complications; In addition, there was a significantly positive correlation of serum Mg levels with serum Ca levels only in T2D patients, and also a significantly positive correlation of urinary Mg levels with urinary Ca levels in control, IGT patients, and T2D patients. Simvastatin treatment in T2D patients selectively reduced serum Ca levels and urinary Mg levels. These results suggest that the potential impact of Mg deficiency on metabolic syndrome, diabetes and diabetic complications needs to be received special attention.	[Xu, Jiancheng; Xu, Wei; Yao, Hanxin] Jilin Univ, Hosp 1, Dept Clin Lab, Changchun 130023, Peoples R China; [Zhou, Qi] Jilin Univ, Hosp 1, Dept Pediat, Changchun 130023, Peoples R China; [Sun, Weixia; Cai, Lu] Univ Louisville, Dept Pediat, Kosair Children Hosp Res Inst, Louisville, KY 40292 USA	Jilin University; Jilin University; University of Louisville	Zhou, Q (corresponding author), Jilin Univ, Hosp 1, Dept Pediat, Changchun 130023, Peoples R China.	qiqi0522@yeah.net; l0cai001@louisville.edu	Cai, Lu/AAG-9920-2019	Zhou, Qi/0000-0002-5084-8697; xu, jiancheng/0000-0001-8796-271X	National Science Foundation of China [81000330]; Jilin Science and Technology Development Program [20100124]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jilin Science and Technology Development Program	The data cited from the laboratories of authors were supported in part by grants from National Science Foundation of China (81000330, to Dr. JC Xu) and Jilin Science and Technology Development Program (20100124, to Dr. JC Xu). The authors are grateful to Zhenxing Chu and Jing Jiang who have assisted them to make statistical analysis. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal P, 2011, DIABETES METAB SYND, V5, P41, DOI 10.1016/j.dsx.2010.12.003; Canagaratna M C, 1984, Ceylon Med J, V29, P109; de Valk HW, 1999, DIABETES CARE, V22, P864, DOI 10.2337/diacare.22.5.864; Derakhshan R, 2011, MINERVA PEDIATR, V63, P27; Dong JY, 2011, DIABETES CARE, V34, P2116, DOI 10.2337/dc11-0518; ELIN RJ, 1987, CLIN CHEM, V33, P1965; ERASMUS RT, 1989, TROP GEOGR MED, V41, P234; Haenni A, 2001, METABOLISM, V50, P1147, DOI 10.1053/meta.2001.26755; HATWAL A, 1989, ACTA OPHTHALMOL, V67, P714; Kao WHL, 1999, ARCH INTERN MED, V159, P2151, DOI 10.1001/archinte.159.18.2151; Kousa A, 2012, ENVIRON RES, V112, P126, DOI 10.1016/j.envres.2011.11.001; Kupetsky-Rincon EA, 2012, ANN NUTR METAB, V61, P102, DOI 10.1159/000339380; Lee CT, 2006, KIDNEY INT, V69, P1786, DOI 10.1038/sj.ki.5000344; Leibowitz D, 2012, CLIN CARDIOL, V35, P764, DOI 10.1002/clc.22049; Li B, 2012, TOXICOL MECH METHODS; Li Y, 2009, MAGNESIUM RES, V22, P66, DOI 10.1684/mrh.2009.0163; Liu QJ, 2009, CURR MED CHEM, V16, P113, DOI 10.2174/092986709787002862; Mangou Apostolis, 2012, Endocrinol Nutr, V59, P109, DOI 10.1016/j.endonu.2011.10.003; MCNAIR P, 1978, DIABETES, V27, P1075, DOI 10.2337/diabetes.27.11.1075; Ohira T, 2009, AM J EPIDEMIOL, V169, P1437, DOI 10.1093/aje/kwp071; OLUKOGA AO, 1989, CENT AFR J MED, V35, P378; Pham PC, 2012, CLIN NEPHROL; Pham PCT, 2005, CLIN NEPHROL, V63, P429; Rodriguez-Moran M, 2001, ARCH MED RES, V32, P300, DOI 10.1016/S0188-4409(01)00298-3; Rodriguez-Moran M, 2011, MAGNESIUM RES, V24, P156, DOI 10.1684/mrh.2011.0299; Rosanoff A, 2004, J AM COLL NUTR, V23, p501S, DOI 10.1080/07315724.2004.10719389; Shaikh S, 2011, J PAK MED ASSOC, V61, P901; Sharma A, 2007, J INDIAN MED ASSOC, V105, P18; SHARMA A, 2007, J INDIAN MED ASSOC, V105, P20; Sharma Aradhana, 2007, J Indian Med Assoc, V105, P20; Shaw JE, 2010, DIABETES RES CLIN PR, V87, P4, DOI 10.1016/j.diabres.2009.10.007; Simmons D, 2010, DIABETES RES CLIN PR, V87, P261, DOI 10.1016/j.diabres.2009.11.003; Sun L, 2008, J CLIN ENDOCR METAB, V93, P4690, DOI 10.1210/jc.2008-1159; Sun L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038845; Viktorinova A, 2009, METABOLISM, V58, P1477, DOI 10.1016/j.metabol.2009.04.035; Wegner M, 2010, MAGNESIUM RES, V23, P97, DOI 10.1684/mrh.2010.0207; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047; Yang WY, 2010, NEW ENGL J MED, V362, P1090, DOI 10.1056/NEJMoa0908292; Zargar AH, 2002, SAUDI MED J, V23, P539; Zheng Y, 2008, HEMOGLOBIN, V32, P135, DOI 10.1080/03630260701727077	40	48	48	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e56750	10.1371/journal.pone.0056750	http://dx.doi.org/10.1371/journal.pone.0056750			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418599	Green Published, gold, Green Submitted			2022-12-25	WOS:000315970300192
J	Chan, MM; Wooden, JM; Tsang, M; Gilligan, DM; Hirenallur-S, DK; Finney, GL; Rynes, E; MacCoss, M; Ramirez, JA; Park, H; Iritani, BM				Chan, Maia M.; Wooden, Jason M.; Tsang, Mark; Gilligan, Diana M.; Hirenallur-S, Dinesh K.; Finney, Greg L.; Rynes, Eric; MacCoss, Michael; Ramirez, Julita A.; Park, Heon; Iritani, Brian M.			Hematopoietic Protein-1 Regulates the Actin Membrane Skeleton and Membrane Stability in Murine Erythrocytes	PLOS ONE			English	Article							RHO-GTPASES; INNATE IMMUNITY; CELL MEMBRANE; ALPHA-ADDUCIN; KINASE-C; IN-VIVO; ACTIVATION; CYTOSKELETON; SPECTRIN; MICE	Hematopoietic protein-1 (Hem-1) is a hematopoietic cell specific member of the WAVE (Wiskott-Aldrich syndrome verprolin-homologous protein) complex, which regulates filamentous actin (F-actin) polymerization in many cell types including immune cells. However, the roles of Hem-1 and the WAVE complex in erythrocyte biology are not known. In this study, we utilized mice lacking Hem-1 expression due to a non-coding point mutation in the Hem1 gene to show that absence of Hem-1 results in microcytic, hypochromic anemia characterized by abnormally shaped erythrocytes with aberrant F-actin foci and decreased lifespan. We find that Hem-1 and members of the associated WAVE complex are normally expressed in wildtype erythrocyte progenitors and mature erythrocytes. Using mass spectrometry and global proteomics, Coomassie staining, and immunoblotting, we find that the absence of Hem-1 results in decreased representation of essential erythrocyte membrane skeletal proteins including alpha- and beta-spectrin, dematin, p55, adducin, ankyrin, tropomodulin 1, band 3, and band 4.1. Hem1(-/-) erythrocytes exhibit increased protein kinase C-dependent phosphorylation of adducin at Ser724, which targets adducin family members for dissociation from spectrin and actin, and subsequent proteolysis. Increased adducin Ser724 phosphorylation in Hem1(-/-) erythrocytes correlates with decreased protein expression of the regulatory subunit of protein phosphatase 2A (PP2A), which is required for PP2A-dependent dephosphorylation of PKC targets. These results reveal a novel, critical role for Hem-1 in the homeostasis of structural proteins required for formation and stability of the actin membrane skeleton in erythrocytes.	[Chan, Maia M.; Tsang, Mark; Hirenallur-S, Dinesh K.; Ramirez, Julita A.; Park, Heon; Iritani, Brian M.] Univ Washington, Dept Comparat Med, Seattle, WA 98195 USA; [Wooden, Jason M.; Gilligan, Diana M.] Puget Sound Blood Ctr, Seattle, WA 98104 USA; [Finney, Greg L.; Rynes, Eric; MacCoss, Michael] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; Puget Sound Blood Center; University of Washington; University of Washington Seattle	Iritani, BM (corresponding author), Univ Washington, Dept Comparat Med, Seattle, WA 98195 USA.	biritani@uw.edu		Iritani, Brian/0000-0003-1903-7850	National Institutes of Health (NIH) [P41 GM103533, P30 AG013280]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103533] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG013280] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [K01OD010554] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Institutes of Health (NIH) grants P41 GM103533 and P30 AG013280. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An XL, 2007, BLOOD, V109, P1284, DOI 10.1182/blood-2006-07-036954; Baharians Z, 1998, J BIOL CHEM, V273, P19019, DOI 10.1074/jbc.273.30.19019; Barkalow KL, 2003, J CELL BIOL, V161, P557, DOI 10.1083/jcb.200211122; BAUMGARTNER S, 1995, J MOL BIOL, V251, P41, DOI 10.1006/jmbi.1995.0414; BEUTLER E, 1976, J LAB CLIN MED, V88, P328; Beutler E, 2007, BRIT J HAEMATOL, V136, P3, DOI 10.1111/j.1365-2141.2006.06351.x; Bokoch GM, 2005, TRENDS CELL BIOL, V15, P163, DOI 10.1016/j.tcb.2005.01.002; Bompard G, 2004, J CELL BIOL, V166, P957, DOI 10.1083/jcb.200403127; Boukharov AA, 1998, BIOCHEM J, V330, P1391, DOI 10.1042/bj3301391; Bruce LJ, 2003, BLOOD, V101, P4180, DOI 10.1182/blood-2002-09-2824; Burkhardt JK, 2008, ANNU REV IMMUNOL, V26, P233, DOI 10.1146/annurev.immunol.26.021607.090347; Campanella ME, 2008, BLOOD, V112, P3900, DOI 10.1182/blood-2008-03-146159; Chen HQ, 2007, J BIOL CHEM, V282, P4124, DOI 10.1074/jbc.M610231200; Chen K, 2009, P NATL ACAD SCI USA, V106, P17413, DOI 10.1073/pnas.0909296106; Finney GL, 2008, ANAL CHEM, V80, P961, DOI 10.1021/ac701649e; Fowler VM, 1996, CURR OPIN CELL BIOL, V8, P86, DOI 10.1016/S0955-0674(96)80052-4; Garcia S, 1999, IMMUNITY, V11, P163, DOI 10.1016/S1074-7613(00)80091-6; George A, 2010, BLOOD CELL MOL DIS, V45, P41, DOI 10.1016/j.bcmd.2010.02.006; Gilligan DM, 2002, BLOOD, V99, P2418, DOI 10.1182/blood.V99.7.2418; Harwood NE, 2011, COLD SPRING HARB PER, V3; Iolascon Achille, 2003, Rev Clin Exp Hematol, V7, P22; Iritani BM, 1997, EMBO J, V16, P7019, DOI 10.1093/emboj/16.23.7019; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; Kalfa TA, 2006, BLOOD, V108, P3637, DOI 10.1182/blood-2006-03-005942; Khan AA, 2008, J BIOL CHEM, V283, P14600, DOI 10.1074/jbc.M707818200; Konstantinidis DG, 2010, TRANSFUS CLIN BIOL, V17, P126, DOI 10.1016/j.tracli.2010.05.002; Kuhlman PA, 1997, BIOCHEMISTRY-US, V36, P13461, DOI 10.1021/bi970601b; Lach A, 2012, J BIOL CHEM, V287, P18974, DOI 10.1074/jbc.M111.332981; Matsuoka Y, 1998, J CELL BIOL, V142, P485, DOI 10.1083/jcb.142.2.485; Mohandas N, 2008, BLOOD, V112, P3939, DOI 10.1182/blood-2008-07-161166; Moyer JD, 2010, BLOOD, V116, P2590, DOI 10.1182/blood-2010-02-268458; Mulloy JC, 2010, BLOOD, V115, P936, DOI 10.1182/blood-2009-09-198127; Park H, 2010, FEBS LETT, V584, P4923, DOI 10.1016/j.febslet.2010.10.018; Park H, 2008, J EXP MED, V205, P2899, DOI 10.1084/jem.20080340; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pollitt AY, 2009, J CELL SCI, V122, P2575, DOI 10.1242/jcs.023879; Porro F, 2004, FEBS LETT, V576, P36, DOI 10.1016/j.febslet.2004.08.057; Ringrose JH, 2008, J PROTEOME RES, V7, P3060, DOI 10.1021/pr8001029; Ruediger R, 1997, VIROLOGY, V238, P432, DOI 10.1006/viro.1997.8873; Salomao M, 2008, P NATL ACAD SCI USA, V105, P8026, DOI 10.1073/pnas.0803225105; Sents W, 2012, FEBS J; Shi YG, 2009, CELL, V139, P468, DOI 10.1016/j.cell.2009.10.006; Shi ZT, 1999, J CLIN INVEST, V103, P331, DOI 10.1172/JCI3858; Slater SJ, 2001, BIOCHEMISTRY-US, V40, P4437, DOI 10.1021/bi001654n; Suzuki K, 2005, J CELL PHYSIOL, V203, P487, DOI 10.1002/jcp.20249; Takenawa T, 2007, NAT REV MOL CELL BIO, V8, P37, DOI 10.1038/nrm2069; TCHERNIA G, 1981, J CLIN INVEST, V68, P454, DOI 10.1172/JCI110275; van de Water B, 2000, J BIOL CHEM, V275, P25805, DOI 10.1074/jbc.M001680200; Weiner OD, 2006, PLOS BIOL, V4, P186, DOI 10.1371/journal.pbio.0040038; Wooden JM, 2011, BRIT J HAEMATOL, V154, P492, DOI 10.1111/j.1365-2141.2011.08612.x	50	15	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2013	8	2							e54902	10.1371/journal.pone.0054902	http://dx.doi.org/10.1371/journal.pone.0054902			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104BU	23424621	Green Submitted, Green Published, gold			2022-12-25	WOS:000315965100009
J	Zhu, YX; Ma, A; Zhang, HX; Li, CJ				Zhu, Yunxia; Ma, Ai; Zhang, Hongxiu; Li, Chaojun			PPAR gamma Activation Attenuates Glycated-Serum Induced Pancreatic Beta-Cell Dysfunction through Enhancing Pdx1 and Mafa Protein Stability	PLOS ONE			English	Article							STIMULATED INSULIN-SECRETION; RECEPTOR-GAMMA; PEROXISOME-PROLIFERATOR; OXIDATIVE STRESS; MITOCHONDRIAL BIOGENESIS; RESPONSE ELEMENT; APOPTOSIS; EXPRESSION; INHIBITION; THIAZOLIDINEDIONES	Pancreatic-duodenal homeobox-1 (Pdx1) and v-maf musculoaponeurotic fibrosarcoma oncogene homolog A (Mafa) play important roles in sustaining the pancreatic beta-cell differentiation phenotype. Peroxisome proliferator-activated receptor-gamma (PPAR gamma) is also a regulator of cell differentiation. Our previous study revealed that glycated serum (GS) causes beta-cell dedifferentiation by down-regulating beta-cell specific genes, such as insulin and Pdx1. Here, we show that GS enhanced the cellular accumulation of ubiquitin-conjugated proteins, including Pdx1 and Mafa, in pancreatic beta-cells. Pharmacologic inhibition of proteolytic activity restored the protein levels of Pdx1 and Mafa, whereas inhibition of de novo protein synthesis accelerated their degradation. These findings suggest that both Pdx1 and Mafa are regulated at the post-transcriptional level. We further show that activation of PPAR gamma could restore GS-induced reduction of Pdx1 and Mafa protein levels, leading to improved insulin secretion and synthesis. Moreover, ectopic expression of Bcl-xl, a mitochondrial regulator, also restored Pdx1 and Mafa protein levels, linking mitochondrial function to Pdx1 and Mafa stability. Taken together, our results identify a key role of PPAR gamma in regulating pancreatic beta-cell function by improving the stability of Pdx1 and Mafa proteins.	[Zhu, Yunxia; Ma, Ai; Li, Chaojun] Nanjing Normal Univ, Coll Life Sci, Jiangsu Key Lab Mol & Med Biotechnol, Nanjing, Jiangsu, Peoples R China; [Li, Chaojun] Nanjing Univ, Natl Resource Ctr Mutant Mice, Model Anim Res Ctr, MOE Key Lab Model Anim Dis Study, Nanjing 210008, Jiangsu, Peoples R China; [Li, Chaojun] Nanjing Univ, Natl Resource Ctr Mutant Mice, Sch Med, Nanjing 210008, Jiangsu, Peoples R China; [Zhang, Hongxiu] Nanjing Med Univ, Affiliated Hosp 1, Dept Obstet & Gynecol, Nanjing, Jiangsu, Peoples R China	Nanjing Normal University; Nanjing University; Nanjing University; Nanjing Medical University	Li, CJ (corresponding author), Nanjing Normal Univ, Coll Life Sci, Jiangsu Key Lab Mol & Med Biotechnol, Nanjing, Jiangsu, Peoples R China.	licj@nju.edu.cn	Zhu, Yunxia/G-6273-2014		National Basic Research Program of China (973 program) [2012CB524901]; National Natural Science Foundation of China [81200559]	National Basic Research Program of China (973 program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the National Basic Research Program of China (973 program, 2012CB524901) to Chaojun Li, and the National Natural Science Foundation of China (81200559) to Yunxia Zhu. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alavian KN, 2011, NAT CELL BIOL, V13, P1224, DOI 10.1038/ncb2330; Andersson AK, 2005, MOL CELL ENDOCRINOL, V240, P50, DOI 10.1016/j.mce.2005.06.001; Brown KK, 1999, DIABETES, V48, P1415, DOI 10.2337/diabetes.48.7.1415; Chandra V, 2008, NATURE, V456, P350, DOI 10.1038/nature07413; Chang-Chen KJ, 2008, REV ENDOCR METAB DIS, V9, P329, DOI 10.1007/s11154-008-9101-5; Dhar A, 2011, DIABETES, V60, P899, DOI 10.2337/db10-0627; Dubois M, 2000, DIABETOLOGIA, V43, P1165, DOI 10.1007/s001250051508; Dubois M, 2002, ANN ENDOCRINOL-PARIS, V63, P511; Evans-Molina C, 2009, MOL CELL BIOL, V29, P2053, DOI 10.1128/MCB.01179-08; Fong WH, 2010, MOL NEUROBIOL, V41, P180, DOI 10.1007/s12035-010-8103-y; Fuenzalida K, 2007, J BIOL CHEM, V282, P37006, DOI 10.1074/jbc.M700447200; Fukami K, 2008, CURR PHARM DESIGN, V14, P946, DOI 10.2174/138161208784139710; Grillo MA, 2008, AMINO ACIDS, V35, P29, DOI 10.1007/s00726-007-0606-0; Gupta D, 2008, J BIOL CHEM, V283, P32462, DOI 10.1074/jbc.M801813200; Han X, 2001, DIABETES, V50, P1047, DOI 10.2337/diabetes.50.5.1047; Higa M, 1999, P NATL ACAD SCI USA, V96, P11513, DOI 10.1073/pnas.96.20.11513; Humphrey RK, 2010, J BIOL CHEM, V285, P3406, DOI 10.1074/jbc.M109.006734; Kaneto H, 1999, DIABETES, V48, P2398, DOI 10.2337/diabetes.48.12.2398; Kaneto H, 2009, CURR MED CHEM, V16, P3144, DOI 10.2174/092986709788802980; Kaniuk NA, 2007, DIABETES, V56, P930, DOI 10.2337/db06-1160; Kanjanabuch T, 2007, KIDNEY INT, V71, P1232, DOI 10.1038/sj.ki.5002248; Kim H, 2004, DIABETES, V53, pS60, DOI 10.2337/diabetes.53.2007.S60; Kim H, 2000, DIABETES, V49, P1517, DOI 10.2337/diabetes.49.9.1517; Kim HI, 2002, DIABETES, V51, P676, DOI 10.2337/diabetes.51.3.676; Kim SK, 2002, NAT GENET, V30, P430, DOI 10.1038/ng860; Kitamura T, 2002, J CLIN INVEST, V110, P1839, DOI 10.1172/JCI200216857; Kono T, 2012, MOL ENDOCRINOL, V26, P257, DOI 10.1210/me.2011-1181; Lee JW, 2009, CELL SIGNAL, V21, P69, DOI 10.1016/j.cellsig.2008.09.015; Leibowitz G, 2001, DIABETES, V50, pS113, DOI 10.2337/diabetes.50.2007.S113; Li J, 2010, DIABETES OBES METAB, V12, P35, DOI 10.1111/j.1463-1326.2009.01093.x; Meng ZX, 2009, ENDOCRINOLOGY, V150, P5284, DOI 10.1210/en.2009-0671; Miglio G, 2009, NEUROCHEM INT, V55, P496, DOI 10.1016/j.neuint.2009.05.001; Moibi JA, 2007, DIABETES, V56, P88, DOI 10.2337/db06-0948; Okada K, 1999, J BIOL CHEM, V274, P23787, DOI 10.1074/jbc.274.34.23787; Puddu A, 2010, BIOCHEM BIOPH RES CO, V395, P122, DOI 10.1016/j.bbrc.2010.03.152; Ramasamy R, 2005, GLYCOBIOLOGY, V15, p16R, DOI 10.1093/glycob/cwi053; Ren YS, 2009, VASC PHARMACOL, V51, P169, DOI 10.1016/j.vph.2009.06.004; Rosen ED, 2003, MOL CELL BIOL, V23, P7222, DOI 10.1128/MCB.23.20.7222-7229.2003; Rosen ED, 2001, J BIOL CHEM, V276, P37731, DOI 10.1074/jbc.R100034200; Satoh T, 1997, J NEUROSCI RES, V50, P413, DOI 10.1002/(SICI)1097-4547(19971101)50:3<413::AID-JNR7>3.0.CO;2-L; Shimizu S, 1996, ONCOGENE, V13, P21; Shu TT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018782; Soro-Paavonen A, 2008, DIABETES, V57, P2461, DOI 10.2337/db07-1808; STADTMAN ER, 1992, SCIENCE, V257, P1220, DOI 10.1126/science.1355616; Strum JC, 2007, J ALZHEIMERS DIS, V11, P45; Tornero D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020423; Toth C, 2008, DIABETES, V57, P1002, DOI 10.2337/db07-0339; Vivas Y, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-86; Vlassara H, 2002, J INTERN MED, V251, P87, DOI 10.1046/j.1365-2796.2002.00932.x; Wang H, 2007, DIABETOLOGIA, V50, P348, DOI 10.1007/s00125-006-0490-2; Wu JS, 2009, J CELL PHYSIOL, V220, P58, DOI 10.1002/jcp.21730; Xu ZK, 2006, ACTA BIOCH BIOPH SIN, V38, P1, DOI 10.1111/j.1745-7270.2006.00128.x; Yki-Jarvinen H, 2004, NEW ENGL J MED, V351, P1106, DOI 10.1056/NEJMra041001; You YH, 2011, DIABETES METAB J, V35, P119, DOI 10.4093/dmj.2011.35.2.119; Zhang C, 2005, MOL CELL BIOL, V25, P4969, DOI 10.1128/MCB.25.12.4969-4976.2005; Zhang XF, 2009, ENDOCRINOLOGY, V150, P4065, DOI 10.1210/en.2009-0343; Zhao ZS, 2009, ENDOCRINOLOGY, V150, P2569, DOI 10.1210/en.2008-1342; Zhu YX, 2011, BIOCHEM BIOPH RES CO, V404, P159, DOI 10.1016/j.bbrc.2010.11.085	58	21	21	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2013	8	2							e56386	10.1371/journal.pone.0056386	http://dx.doi.org/10.1371/journal.pone.0056386			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104BU	23424659	Green Submitted, gold, Green Published			2022-12-25	WOS:000315965100047
J	Patki, M; Chari, V; Sivakumaran, S; Gonit, M; Trumbly, R; Ratnam, M				Patki, Mugdha; Chari, Venkatesh; Sivakumaran, Suneethi; Gonit, Mesfin; Trumbly, Robert; Ratnam, Manohar			The ETS Domain Transcription Factor ELK1 Directs a Critical Component of Growth Signaling by the Androgen Receptor in Prostate Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENE-EXPRESSION; DEPRIVATION THERAPY; BINDING; PROTEIN; FUSIONS; PHOSPHORYLATION; OVEREXPRESSION; DETERMINANTS; ACTIVATION; PATHWAYS	The androgen receptor (AR) is essential for diverse aspects of prostate development and function. Molecular mechanisms by which prostate cancer (PC) cells redirect AR signaling to genes that primarily support growth are unclear. A systematic search for critical AR-tethering proteins led to ELK1, an ETS transcription factor of the ternary complex factor subfamily. Although genetically redundant, ELK1 was obligatory for AR-dependent growth and clonogenic survival in both hormone-dependent PC and castration-recurrent PC cells but not for AR-negative cell growth. AR required ELK1 to up-regulate a major subset of its target genes that was strongly and primarily enriched for cell growth functions. AR functioned as a coactivator of ELK1 by association through its A/B domain, bypassing the classical mechanism of ELK1 activation by phosphorylation and without inducing ternary complex target genes. The ELK1-AR synergy per se was ligand-independent, although it required ligand for nuclear localization of AR as targeting the ARA/B domain to the nucleus recapitulated the action of hormone; accordingly, Casodex was a poor antagonist of the synergy. ELK3, the closest substitute for ELK1 in structure/function and genome recognition, did not interact with AR. ELK1 thus directs selective and sustained gene induction that is a substantial and critical component of growth signaling by AR in PC cells. The ELK1-AR interaction offers a functionally tumor-selective drug target.	[Patki, Mugdha; Chari, Venkatesh; Ratnam, Manohar] Barbara Ann Karmanos Canc Inst, Detroit, MI 48201 USA; [Patki, Mugdha; Chari, Venkatesh; Sivakumaran, Suneethi; Gonit, Mesfin; Trumbly, Robert] Univ Toledo, Med Ctr, Dept Biochem & Canc Biol, Toledo, OH 43614 USA; [Gonit, Mesfin] NCI, Lab Canc Prevent, NIH, Frederick, MD 21702 USA	Barbara Ann Karmanos Cancer Institute; University System of Ohio; University of Toledo; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Ratnam, M (corresponding author), Barbara Ann Karmanos Canc Inst, 4100 John R, Detroit, MI 48201 USA.	ratnamm@karmanos.org	Trumbly, Robert/AAF-6667-2020	Trumbly, Robert/0000-0001-5618-146X	Harold and Helen McMaster endowment	Harold and Helen McMaster endowment	This work was supported by the Harold and Helen McMaster endowment (to M. R.).	BEATO M, 1995, CELL, V83, P851, DOI 10.1016/0092-8674(95)90201-5; Besnard A, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00035; Best CJM, 2005, CLIN CANCER RES, V11, P6823, DOI 10.1158/1078-0432.CCR-05-0585; Boros J, 2009, GENOME RES, V19, P1963, DOI 10.1101/gr.093047.109; Cai CM, 2011, CANCER RES, V71, P6503, DOI 10.1158/0008-5472.CAN-11-0532; Cesari F, 2004, GENESIS, V38, P87, DOI 10.1002/gene.20003; Chen CD, 2004, NAT MED, V10, P33, DOI 10.1038/nm972; Chen SY, 2006, P NATL ACAD SCI USA, V103, P15969, DOI 10.1073/pnas.0604193103; Chng KR, 2012, EMBO J, V31, P2810, DOI 10.1038/emboj.2012.112; DEWINTER JAR, 1994, AM J PATHOL, V144, P735; Duan RQ, 2002, BIOCHEM BIOPH RES CO, V294, P384, DOI 10.1016/S0006-291X(02)00499-0; Duan RQ, 2001, J BIOL CHEM, V276, P11590, DOI 10.1074/jbc.M005492200; Gioeli D, 2011, MOL CANCER THER, V10, P1581, DOI 10.1158/1535-7163.MCT-10-1033; Glass CK, 2000, GENE DEV, V14, P121; Gonit M, 2011, MOL ENDOCRINOL, V25, P621, DOI 10.1210/me.2010-0409; Guo ZY, 2009, CANCER RES, V69, P2305, DOI 10.1158/0008-5472.CAN-08-3795; Hayward SW, 2000, RADIOL CLIN N AM, V38, P1, DOI 10.1016/S0033-8389(05)70146-9; Helgeson BE, 2008, CANCER RES, V68, P73, DOI 10.1158/0008-5472.CAN-07-5352; Hollenhorst PC, 2007, GENE DEV, V21, P1882, DOI 10.1101/gad.1561707; Holzbeierlein JM, 2004, CURR OPIN UROL, V14, P177, DOI 10.1097/00042307-200405000-00007; Hu R, 2009, CANCER RES, V69, P16, DOI 10.1158/0008-5472.CAN-08-2764; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Larsson R, 2011, CURR MED CHEM, V18, P4440, DOI 10.2174/092986711797287539; Li TH, 2007, NUCLEIC ACIDS RES, V35, P2767, DOI 10.1093/nar/gkm198; Linja MJ, 2001, CANCER RES, V61, P3550; Massie CE, 2007, EMBO REP, V8, P871, DOI 10.1038/sj.embor.7401046; Massie CE, 2011, EMBO J, V30, P2719, DOI 10.1038/emboj.2011.158; McKenna NJ, 2002, CELL, V108, P465, DOI 10.1016/S0092-8674(02)00641-4; Miyamoto H, 2004, PROSTATE, V61, P332, DOI 10.1002/pros.20115; Mukhopadhyay NK, 2006, EXP CELL RES, V312, P3782, DOI 10.1016/j.yexcr.2006.07.017; Norris JD, 2009, MOL CELL, V36, P405, DOI 10.1016/j.molcel.2009.10.020; Pratt WB, 1997, ENDOCR REV, V18, P306, DOI 10.1210/er.18.3.306; Safe S, 2004, PROG NUCLEIC ACID RE, V77, P1, DOI 10.1016/S0079-6603(04)77001-4; Safe S, 2008, J MOL ENDOCRINOL, V41, P263, DOI 10.1677/JME-08-0103; Shaffer PL, 2004, P NATL ACAD SCI USA, V101, P4758, DOI 10.1073/pnas.0401123101; Sharrocks AD, 2002, BIOCHEM SOC T, V30, P1; Shin S, 2009, CANCER RES, V69, P8102, DOI 10.1158/0008-5472.CAN-09-0941; Shore P, 1996, MOL CELL BIOL, V16, P3338; Singh D, 2002, CANCER CELL, V1, P203, DOI 10.1016/S1535-6108(02)00030-2; Tan PY, 2012, MOL CELL BIOL, V32, P399, DOI 10.1128/MCB.05958-11; Tomlins SA, 2006, CANCER RES, V66, P3396, DOI 10.1158/0008-5472.CAN-06-0168; Tomlins SA, 2005, SCIENCE, V310, P644, DOI 10.1126/science.1117679; Urbanucci A, 2012, ONCOGENE, V31, P2153, DOI 10.1038/onc.2011.401; Wang QB, 2009, CELL, V138, P245, DOI 10.1016/j.cell.2009.04.056; Wei GH, 2010, EMBO J, V29, P2147, DOI 10.1038/emboj.2010.106; WU HC, 1994, INT J CANCER, V57, P406, DOI 10.1002/ijc.2910570319; Yang SH, 2005, EMBO J, V24, P2161, DOI 10.1038/sj.emboj.7600690; Yang SH, 2003, MOL CELL, V12, P63, DOI 10.1016/S1097-2765(03)00265-X; Yordy JS, 2000, ONCOGENE, V19, P6503, DOI 10.1038/sj.onc.1204036; Yu JD, 2010, CANCER CELL, V17, P443, DOI 10.1016/j.ccr.2010.03.018; Zegarra-Moro OL, 2002, CANCER RES, V62, P1008; Zhang J, 2010, ONCOGENE, V29, P723, DOI 10.1038/onc.2009.373; Zhang J, 2008, PROSTATE, V68, P1206, DOI 10.1002/pros.20779	54	47	48	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 19	2013	288	16					11047	11065		10.1074/jbc.M112.438473	http://dx.doi.org/10.1074/jbc.M112.438473			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	130KW	23426362	hybrid, Green Published			2022-12-25	WOS:000317915500011
J	Nonaka, S; Nagaosa, K; Mori, T; Shiratsuchi, A; Nakanishi, Y				Nonaka, Saori; Nagaosa, Kaz; Mori, Toshinobu; Shiratsuchi, Akiko; Nakanishi, Yoshinobu			Integrin alpha PS3/beta nu-mediated Phagocytosis of Apoptotic Cells and Bacteria in Drosophila	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-NU; ENGULFMENT; CLEARANCE; MORPHOGENESIS; RECOGNITION; RECEPTOR; ELEGANS; PROTEIN; DRAPER; CED-1	Integrins exert a variety of cellular functions as heterodimers of two transmembrane subunits named alpha and beta. Integrin beta nu, a beta-subunit of Drosophila integrin, is involved in the phagocytosis of apoptotic cells and bacteria. Here, we searched for an alpha-subunit that forms a complex and cooperates with beta nu. Examinations of RNAi-treated animals suggested that alpha PS3, but not any of four other alpha-subunits, is required for the effective phagocytosis of apoptotic cells in Drosophila embryos. The mutation of alpha PS3-encoding scb, deficiency, insertion of P-element, or alteration of nucleotide sequences, brought about a reduction in the level of phagocytosis. The defect in phagocytosis by deficiency was reverted by the forced expression of scb. Furthermore, flies in which the expression of both alpha PS3 and beta nu was inhibited by RNAi showed a level of phagocytosis almost equal to that observed in flies with RNAi for either subunit alone. A loss of alpha PS3 also decreased the activity of larval hemocytes in the phagocytosis of Staphylococcus aureus. Finally, a co-immunoprecipitation analysis using a Drosophila cell line treated with a chemical cross-linker suggested a physical association between alpha PS3 and beta nu. These results collectively indicated that integrin alpha PS3/beta nu serves as a receptor in the phagocytosis of apoptotic cells and bacteria by Drosophila phagocytes.	[Nonaka, Saori; Nagaosa, Kaz; Shiratsuchi, Akiko; Nakanishi, Yoshinobu] Kanazawa Univ, Grad Sch Med Sci, Kanazawa, Ishikawa 9201192, Japan; [Nagaosa, Kaz; Mori, Toshinobu; Shiratsuchi, Akiko; Nakanishi, Yoshinobu] Kanazawa Univ, Sch Pharm, Kanazawa, Ishikawa 9201192, Japan	Kanazawa University; Kanazawa University	Nagaosa, K (corresponding author), Shizenken, Kakuma Machi, Kanazawa, Ishikawa 9201192, Japan.	knagaosa@p.kanazawa-u.ac.jp; nakanaka@p.kanazawa-u.ac.jp	Nagaosa, Kaz/G-3857-2014; Nakanishi, Yoshinobu/D-4602-2014; Shiratsuchi, Akiko/D-8391-2015; Nonaka, Saori/L-4092-2015	Nagaosa, Kaz/0000-0002-1695-2562; Nakanishi, Yoshinobu/0000-0002-8767-3587; Shiratsuchi, Akiko/0000-0002-7811-4409; Nonaka, Saori/0000-0003-2672-3082	Japan Society for the Promotion of Science [22370049, 23570160]; Astellas Foundation for Research on Metabolic Disorders; Danone Foundation; Grants-in-Aid for Scientific Research [22370049] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Astellas Foundation for Research on Metabolic Disorders; Danone Foundation(Danone Nutricia); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-aid for Scientific Research 22370049 (to Y. N.) and 23570160 (to A. S.) from the Japan Society for the Promotion of Science, a grant from Astellas Foundation for Research on Metabolic Disorders (to A. S.), and a grant from the Danone Foundation (to A. S.).	Aderem A, 1999, ANNU REV IMMUNOL, V17, P593, DOI 10.1146/annurev.immunol.17.1.593; Awasaki T, 2006, NEURON, V50, P855, DOI 10.1016/j.neuron.2006.04.027; Baum PD, 1997, NEURON, V19, P51, DOI 10.1016/S0896-6273(00)80347-5; BRAND AH, 1993, DEVELOPMENT, V118, P401; Brown NH, 2000, MATRIX BIOL, V19, P191, DOI 10.1016/S0945-053X(00)00064-0; Brown NH, 2000, DEV BIOL, V223, P1, DOI 10.1006/dbio.2000.9711; Bruckner K, 2004, DEV CELL, V7, P73, DOI 10.1016/j.devcel.2004.06.007; Callebaut I, 2003, BIOCHEM BIOPH RES CO, V300, P619, DOI 10.1016/S0006-291X(02)02904-2; Devenport D, 2004, DEVELOPMENT, V131, P5405, DOI 10.1242/dev.01427; Dupuy AG, 2008, J CELL SCI, V121, P1773, DOI 10.1242/jcs.018036; Franc NC, 1996, IMMUNITY, V4, P431, DOI 10.1016/S1074-7613(00)80410-0; Franc NC, 1999, SCIENCE, V284, P1991, DOI 10.1126/science.284.5422.1991; Giancotti FG, 1999, SCIENCE, V285, P1028, DOI 10.1126/science.285.5430.1028; Grotewiel MS, 1998, NATURE, V391, P455, DOI 10.1038/35079; Hanayama R, 2002, NATURE, V417, P182, DOI 10.1038/417182a; Hashimoto Y, 2009, J IMMUNOL, V183, P7451, DOI 10.4049/jimmunol.0901032; Hsieh HH, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002663; Hsu TY, 2010, CURR BIOL, V20, P477, DOI 10.1016/j.cub.2010.01.062; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; JURGENS G, 1984, ROUX ARCH DEV BIOL, V193, P283, DOI 10.1007/BF00848157; Kang YY, 2012, GENE DEV, V26, P1339, DOI 10.1101/gad.187815.112; Kinchen JM, 2007, J CELL SCI, V120, P2143, DOI 10.1242/jcs.03463; Kinchen JM, 2005, CURR TOP DEV BIOL, V65, P1; Kuraishi T, 2009, EMBO J, V28, P3868, DOI 10.1038/emboj.2009.343; Lauber K, 2004, MOL CELL, V14, P277, DOI 10.1016/S1097-2765(04)00237-0; Lettre G, 2006, NAT REV MOL CELL BIO, V7, P97, DOI 10.1038/nrm1836; Liao J, 2005, MED HYPOTHESES, V65, P23, DOI 10.1016/j.mehy.2005.01.028; Manaka J, 2004, J BIOL CHEM, V279, P48466, DOI 10.1074/jbc.M408597200; Mangahas PM, 2005, SEMIN CELL DEV BIOL, V16, P295, DOI 10.1016/j.semcdb.2004.12.005; Margadant C, 2011, CURR OPIN CELL BIOL, V23, P607, DOI 10.1016/j.ceb.2011.08.005; Nagaosa K, 2011, J BIOL CHEM, V286, P25770, DOI 10.1074/jbc.M110.204503; Nakanishi Y, 2011, DEV GROWTH DIFFER, V53, P149, DOI 10.1111/j.1440-169X.2010.01224.x; Okada R, 2012, J BIOL CHEM, V287, P3138, DOI 10.1074/jbc.M111.277921; Ravichandran KS, 2007, NAT REV IMMUNOL, V7, P964, DOI 10.1038/nri2214; Ravichandran KS, 2011, IMMUNITY, V35, P445, DOI 10.1016/j.immuni.2011.09.004; Reddien PW, 2004, ANNU REV CELL DEV BI, V20, P193, DOI 10.1146/annurev.cellbio.20.022003.114619; Savill J, 2000, NATURE, V407, P784, DOI 10.1038/35037722; Shiratsuchi A, 2012, J BIOL CHEM, V287, P21663, DOI 10.1074/jbc.M111.333807; Stark KA, 1997, DEVELOPMENT, V124, P4583; Stuart LM, 2005, IMMUNITY, V22, P539, DOI 10.1016/j.immuni.2005.05.002; Tsai PI, 2008, NEURAL DEV, V3, DOI 10.1186/1749-8104-3-26; Wada A, 2007, DEV BIOL, V301, P340, DOI 10.1016/j.ydbio.2006.09.020; Wang XC, 2010, NAT CELL BIOL, V12, P655, DOI 10.1038/ncb2068; Wu Y, 2006, TRENDS CELL BIOL, V16, P189, DOI 10.1016/j.tcb.2006.02.003; YEE GH, 1993, DEVELOPMENT, V118, P845; Zhou Z, 2001, CELL, V104, P43, DOI 10.1016/S0092-8674(01)00190-8	46	48	51	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 12	2013	288	15					10374	10380		10.1074/jbc.M113.451427	http://dx.doi.org/10.1074/jbc.M113.451427			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	125TU	23426364	Green Submitted, Green Published, hybrid			2022-12-25	WOS:000317565000018
J	Wang, DY; Fu, Q; Zhou, Y; Xu, B; Shi, Q; Igwe, B; Matt, L; Hell, JW; Wisely, EV; Oddo, S; Xiang, YK				Wang, Dayong; Fu, Qin; Zhou, Yuan; Xu, Bing; Shi, Qian; Igwe, Benedict; Matt, Lucas; Hell, Johannes W.; Wisely, Elena V.; Oddo, Salvatore; Xiang, Yang K.			beta(2) Adrenergic Receptor, Protein Kinase A (PKA) and c-Jun N-terminal Kinase (JNK) Signaling Pathways Mediate Tau Pathology in Alzheimer Disease Models	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYLOID-BETA; SYNAPSE-LOSS; PHOSPHORYLATION; MICROTUBULE; ACTIVATION; PEPTIDE; BINDING; NEURODEGENERATION; DEGENERATION; DYSFUNCTION	Alzheimer disease (AD) is characterized by neurodegeneration marked by loss of synapses and spines associated with hyperphosphorylation of tau protein. Accumulating amyloid beta peptide (A beta) in brain is linked to neurofibrillary tangles composed of hyperphosphorylated tau in AD. Here, we identify beta(2)-adrenergic receptor (beta(2)AR) that mediates A beta-induced tau pathology. In the prefrontal cortex (PFC) of 1-year-old transgenic mice with human familial mutant genes of presenilin 1 and amyloid precursor protein (PS1/APP), the phosphorylation of tau at Ser-214 Ser-262 and Thr-181, and the protein kinases including JNK, GSK3 alpha/beta, and Ca2+/calmodulin-dependent protein kinase II is increased significantly. Deletion of the beta(2)AR gene in PS1/APP mice greatly decreases the phosphorylation of these proteins. Further analysis reveals that in primary PFC neurons, A beta signals through a beta(2)AR-PKA-JNK pathway, which is responsible for most of the phosphorylation of tau at Ser-214 and Ser-262 and a significant portion of phosphorylation at Thr-181. A beta also induces a beta(2)AR-dependent arrestin-ERK1/2 activity that does not participate in phosphorylation of tau. However, inhibition of the activity of MEK, an upstream enzyme of ERK1/2, partially blocks A beta-induced tau phosphorylation at Thr-181. The density of dendritic spines and synapses is decreased in the deep layer of the PFC of 1-year-old PS1/APP mice, and the mice exhibit impairment of learning and memory in a novel object recognition paradigm. Deletion of the beta(2)AR gene ameliorates pathological effects in these senile PS1/APP mice. The study indicates that beta(2)AR may represent a potential therapeutic target for preventing the development of AD.	[Wang, Dayong; Fu, Qin; Zhou, Yuan; Shi, Qian; Igwe, Benedict; Xiang, Yang K.] Univ Illinois, Dept Mol & Integrat Physiol, Sch Mol & Cellular Biol, Urbana, IL 61801 USA; [Fu, Qin; Xu, Bing; Shi, Qian; Matt, Lucas; Hell, Johannes W.; Xiang, Yang K.] Univ Calif Davis, Dept Pharmacol, Davis, CA 95616 USA; [Fu, Qin] Huazhong Univ Sci & Technol, Dept Pharmacol, Tongji Med Coll, Wuhan 430030, Hubei, Peoples R China; [Wisely, Elena V.; Oddo, Salvatore] Univ Texas Hlth Sci Ctr San Antonio, Dept Physiol, San Antonio, TX 78229 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of California System; University of California Davis; Huazhong University of Science & Technology; University of Texas System; University of Texas Health San Antonio	Xiang, YK (corresponding author), Univ Calif Davis, Dept Pharmacol, Davis, CA 95616 USA.	ykxiang@ucdavis.edu	Hell, Johannes W./P-5085-2019; Fu, Qin/O-6960-2014	Igwe, Benedict/0000-0001-6008-6617; Matt, Lucas/0000-0003-3235-5140; Daoud, Elena/0000-0001-8840-5106; Shi, Qian/0000-0003-2634-9553; Wang, Dayong/0000-0002-2086-1663; Oddo, Salvatore/0000-0001-7304-7430; Fu, Qin/0000-0002-7954-7708	Alzheimer's Association; National Alliance for Research on Schizophrenia and Depression (NARSAD); Illinois Department of Public Health; NATIONAL INSTITUTE ON AGING [F30AG043248] Funding Source: NIH RePORTER	Alzheimer's Association(Alzheimer's Association); National Alliance for Research on Schizophrenia and Depression (NARSAD)(French National Research Agency (ANR)NARSAD); Illinois Department of Public Health; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by a new investigator research grant from the Alzheimer's Association (to Y. K. X.) and by The National Alliance for Research on Schizophrenia and Depression (NARSAD) Young Investigator Award and Alzheimer's Disease Research Fund from the Illinois Department of Public Health (to D. W.).	Bittner T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015477; Echeverria V, 2005, NEUROSCIENCE, V135, P1193, DOI 10.1016/j.neuroscience.2005.06.057; Giuffrida ML, 2009, J NEUROSCI, V29, P10582, DOI 10.1523/JNEUROSCI.1736-09.2009; Guo C, 2008, J BIOL CHEM, V283, P15903, DOI 10.1074/jbc.M710006200; Hall GF, 2000, J CELL SCI, V113, P1373; Hochbaum D, 2003, J BIOL CHEM, V278, P33738, DOI 10.1074/jbc.M305208200; Hoover BR, 2010, NEURON, V68, P1067, DOI 10.1016/j.neuron.2010.11.030; Jaworski T, 2011, AM J PATHOL, V179, P2001, DOI 10.1016/j.ajpath.2011.06.025; Jaworski Tomasz, 2010, Int J Alzheimers Dis, V2010, DOI 10.4061/2010/573138; Jaworski T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007280; JOHNSON GVW, 1992, J NEUROCHEM, V59, P2056; Johnson JD, 2008, BRAIN BEHAV IMMUN, V22, P1078, DOI 10.1016/j.bbi.2008.03.007; Litersky JM, 1996, BIOCHEM J, V316, P655, DOI 10.1042/bj3160655; Ma QL, 2009, J NEUROSCI, V29, P9078, DOI 10.1523/JNEUROSCI.1071-09.2009; Mattson MP, 2004, NATURE, V430, P631, DOI 10.1038/nature02621; Mitsuyama F, 2012, INT J ALZHEIMERS DIS, V2012; Mitsuyama Fuyuki, 2009, Italian Journal of Anatomy and Embryology, V114, P109; Morilak DA, 2005, PROG NEURO-PSYCHOPH, V29, P1214, DOI 10.1016/j.pnpbp.2005.08.007; Nagai T, 2002, FASEB J, V16, P50, DOI 10.1096/fj.02-0448fje; Ni YX, 2006, NAT MED, V12, P1390, DOI 10.1038/nm1485; Oakley H, 2006, J NEUROSCI, V26, P10129, DOI 10.1523/JNEUROSCI.1202-06.2006; Ploia C, 2011, J ALZHEIMERS DIS, V26, P315, DOI 10.3233/JAD-2011-110320; Prapong T, 2001, EXP NEUROL, V167, P59, DOI 10.1006/exnr.2000.7519; Ramos BP, 2007, PHARMACOL THERAPEUT, V113, P523, DOI 10.1016/j.pharmthera.2006.11.006; Rosenberg PB, 2008, AM J GERIAT PSYCHIAT, V16, P883, DOI 10.1097/JGP.0b013e318181276a; Sato S, 2002, J BIOL CHEM, V277, P42060, DOI 10.1074/jbc.M202241200; Thies E, 2007, J NEUROSCI, V27, P2896, DOI 10.1523/JNEUROSCI.4674-06.2007; Vogel J, 2009, NEUROPHARMACOLOGY, V57, P539, DOI 10.1016/j.neuropharm.2009.07.021; Wang DY, 2007, NEUROPSYCHOPHARMACOL, V32, P1261, DOI 10.1038/sj.npp.1301256; Wang DY, 2011, J BIOL CHEM, V286, P31852, DOI 10.1074/jbc.M111.244335; Wang DY, 2010, FASEB J, V24, P3511, DOI 10.1096/fj.10-156661; Yoshimura Y, 2003, NEUROSCI LETT, V353, P185, DOI 10.1016/j.neulet.2003.09.037; Yu JT, 2008, BRAIN RES, V1210, P216, DOI 10.1016/j.brainres.2008.03.019; Yu JT, 2011, BRAIN RES BULL, V84, P111, DOI 10.1016/j.brainresbull.2010.11.004; Zempel H, 2010, J NEUROSCI, V30, P11938, DOI 10.1523/JNEUROSCI.2357-10.2010	35	65	69	0	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 12	2013	288	15					10298	10307		10.1074/jbc.M112.415141	http://dx.doi.org/10.1074/jbc.M112.415141			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	125TU	23430246	Green Published, hybrid			2022-12-25	WOS:000317565000011
J	Barua, B; Fagnant, PM; Winkelmann, DA; Trybus, KM; Hitchcock-DeGregori, SE				Barua, Bipasha; Fagnant, Patricia M.; Winkelmann, Donald A.; Trybus, Kathleen M.; Hitchcock-DeGregori, Sarah E.			A Periodic Pattern of Evolutionarily Conserved Basic and Acidic Residues Constitutes the Binding Interface of Actin-Tropomyosin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CROSS-BRIDGE KINETICS; ALPHA-TROPOMYOSIN; COILED-COIL; F-ACTIN; ISOMETRIC TENSION; ATOMIC MODEL; FLEXIBILITY; MUTATIONS; SITES; GENE	Actin filament cytoskeletal and muscle functions are regulated by actin binding proteins using a variety of mechanisms. A universal actin filament regulator is the protein tropomyosin, which binds end-to-end along the length of the filament. The actin-tropomyosin filament structure is unknown, but there are atomic models in different regulatory states based on electron microscopy reconstructions, computational modeling of actin-tropomyosin, and docking of atomic resolution structures of tropomyosin to actin filament models. Here, we have tested models of the actin-tropomyosin interface in the "closed state" where tropomyosin binds to actin in the absence of myosin or troponin. Using mutagenesis coupled with functional analyses, we determined residues of actin and tropomyosin required for complex formation. The sites of mutations in tropomyosin were based on an evolutionary analysis and revealed a pattern of basic and acidic residues in the first halves of the periodic repeats (periods) in tropomyosin. In periods P1, P4, and P6, basic residues are most important for actin affinity, in contrast to periods P2, P3, P5, and P7, where both basic and acidic residues or predominantly acidic residues contribute to actin affinity. Hydrophobic interactions were found to be relatively less important for actin binding. We mutated actin residues in subdomains 1 and 3 (Asp(25)-Glu(334)-Lys(326)-Lys(328)) that are poised to make electrostatic interactions with the residues in the repeating motif on tropomyosin in the models. Tropomyosin failed to bind mutant actin filaments. Our mutagenesis studies provide the first experimental support for the atomic models of the actin-tropomyosin interface.	[Barua, Bipasha; Hitchcock-DeGregori, Sarah E.] Robert Wood Johnson Med Sch, Dept Neurosci & Cell Biol, Piscataway, NJ 08854 USA; [Barua, Bipasha; Winkelmann, Donald A.; Hitchcock-DeGregori, Sarah E.] Robert Wood Johnson Med Sch, Dept Pathol & Lab Med, Piscataway, NJ 08854 USA; [Fagnant, Patricia M.; Trybus, Kathleen M.] Univ Vermont, Dept Mol Physiol & Biophys, Burlington, VT 05405 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center; University of Vermont	Barua, B (corresponding author), Robert Wood Johnson Med Sch, Dept Neurosci & Cell Biol, 675 Hoes Ln, Piscataway, NJ 08854 USA.	baruabi@umdnj.edu			National Institutes of Health [GM093065, HL110869]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL110869] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM093065] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants GM093065 (to S. E. H.-D.) and HL110869 (to K. M. T.).	Barua B, 2012, P NATL ACAD SCI USA, V109, P18425, DOI 10.1073/pnas.1212754109; Barua B, 2011, P NATL ACAD SCI USA, V108, P10150, DOI 10.1073/pnas.1101221108; Behrmann E, 2012, CELL, V150, P327, DOI 10.1016/j.cell.2012.05.037; BOURDIEU L, 1995, PHYS REV E, V52, P6573, DOI 10.1103/PhysRevE.52.6573; Brown JH, 2005, P NATL ACAD SCI USA, V102, P18878, DOI 10.1073/pnas.0509269102; Brown JH, 2001, P NATL ACAD SCI USA, V98, P8496, DOI 10.1073/pnas.131219198; DRUMMOND DR, 1991, MOL GEN GENET, V226, P70, DOI 10.1007/BF00273589; Frieden C, 2000, BIOCHEM BIOPH RES CO, V271, P464, DOI 10.1006/bbrc.2000.2650; Fujii T, 2010, NATURE, V467, P724, DOI 10.1038/nature09372; Greenfield NJ, 1995, BIOCHEMISTRY-US, V34, P16797, DOI 10.1021/bi00051a030; Gunning P, 2008, PHYSIOL REV, V88, P1, DOI 10.1152/physrev.00001.2007; Hammell RL, 1996, J BIOL CHEM, V271, P4236; Haselgrove J. C., 1972, COLD SPRING HARB SYM, V37, P341; Hitchcock-DeGregori SE, 2008, ADV EXP MED BIOL, V644, P60; Hitchcock-DeGregori SE, 2002, BIOCHEMISTRY-US, V41, P15036, DOI 10.1021/bi026519k; HITCHCOCKDEGREGORI SE, 1982, J BIOL CHEM, V257, P2573; HUXLEY HE, 1973, COLD SPRING HARB SYM, V37, P361, DOI 10.1101/SQB.1973.037.01.046; Kawai M, 2009, J BIOPHYS, V2009; Kee AJ, 2008, ADV EXP MED BIOL, V644, P143; Laing NG, 2009, HUM MUTAT, V30, P1267, DOI 10.1002/humu.21059; Landis C, 1999, J BIOL CHEM, V274, P31279, DOI 10.1074/jbc.274.44.31279; Lehman W, 2008, ADV EXP MED BIOL, V644, P95; Li XC, 2011, BIOPHYS J, V100, P1005, DOI 10.1016/j.bpj.2010.12.3697; Lorenz M, 2010, P NATL ACAD SCI USA, V107, P12529, DOI 10.1073/pnas.1003604107; Lu XY, 2006, BIOPHYS J, V91, P4230, DOI 10.1529/biophysj.106.084608; Lu XY, 2003, J PHYSIOL-LONDON, V553, P457, DOI 10.1113/jphysiol.2003.053694; MCLACHLAN AD, 1976, J MOL BIOL, V103, P271, DOI 10.1016/0022-2836(76)90313-2; Miki M, 2011, J MOL BIOL, V414, P765, DOI 10.1016/j.jmb.2011.10.033; MONTEIRO PB, 1994, J BIOL CHEM, V269, P10461; Nitanai Y, 2007, ADV EXP MED BIOL, V592, P137; Noguchi TQP, 2010, J BIOL CHEM, V285, P4337, DOI 10.1074/jbc.M109.059881; OReilly D.R., 1992, BACULOVIRUS EXPRESSI; PARRY DAD, 1973, J MOL BIOL, V75, P33, DOI 10.1016/0022-2836(73)90527-5; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; PHILLIPS GN, 1986, J MOL BIOL, V192, P128, DOI 10.1016/0022-2836(86)90469-9; Pollard TD, 2009, SCIENCE, V326, P1208, DOI 10.1126/science.1175862; Singh A, 2006, STRUCTURE, V14, P43, DOI 10.1016/j.str.2005.09.016; Singh A, 2003, BIOCHEMISTRY-US, V42, P14114, DOI 10.1021/bi0348462; Singh A, 2007, BIOCHEMISTRY-US, V46, P14917, DOI 10.1021/bi701570b; Singh A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006336; Sumida JP, 2008, J BIOL CHEM, V283, P6728, DOI 10.1074/jbc.M707485200; Vibert P, 1997, J MOL BIOL, V266, P8, DOI 10.1006/jmbi.1996.0800; Wang CLA, 2010, INT REV CEL MOL BIO, V281, P91, DOI 10.1016/S1937-6448(10)81003-2; Wang Q, 2003, J CELL SCI, V116, P4227, DOI 10.1242/jcs.00709; WATERSTON RH, 1984, J MOL BIOL, V180, P473, DOI 10.1016/0022-2836(84)90023-8; WERTMAN KF, 1992, GENETICS, V132, P337; Whitby FG, 2000, PROTEINS, V38, P49; Wieczorek DF, 2008, ADV EXP MED BIOL, V644, P132; WINKELMANN DA, 1995, BIOPHYS J, V68, P2444, DOI 10.1016/S0006-3495(95)80426-1	49	42	42	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 5	2013	288	14					9602	9609		10.1074/jbc.M113.451161	http://dx.doi.org/10.1074/jbc.M113.451161			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	119RB	23420843	hybrid, Green Published			2022-12-25	WOS:000317114000004
J	Ranoa, DRE; Kelley, SL; Tapping, RI				Ranoa, Diana Rose E.; Kelley, Stacy L.; Tapping, Richard I.			Human Lipopolysaccharide-binding Protein (LBP) and CD14 Independently Deliver Triacylated Lipoproteins to Toll-like Receptor 1 (TLR1) and TLR2 and Enhance Formation of the Ternary Signaling Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BORRELIA-BURGDORFERI LIPOPROTEINS; ACTIVATES IMMUNE CELLS; GRAM-NEGATIVE BACTERIA; TREPONEMA-PALLIDUM; CRYSTAL-STRUCTURE; SOLUBLE CD14; STAPHYLOCOCCUS-AUREUS; CD14-DEFICIENT MICE; PATTERN-RECOGNITION; TLR4-MD-2 COMPLEX	Bacterial lipoproteins are the most potent microbial agonists for the Toll-like receptor 2 (TLR2) subfamily, and this pattern recognition event induces cellular activation, leading to host immune responses. Triacylated bacterial lipoproteins coordinately bind TLR1 and TLR2, resulting in a stable ternary complex that drives intracellular signaling. The sensitivity of TLR-expressing cells to lipoproteins is greatly enhanced by two lipid-binding serum proteins known as lipopolysaccharide-binding protein (LBP) and soluble CD14 (sCD14); however, the physical mechanism that underlies this increased sensitivity is not known. To address this, we measured the ability of LBP and sCD14 to drive ternary complex formation between soluble extracellular domains of TLR1 and TLR2 and a synthetic triacylated lipopeptide agonist. Importantly, addition of substoichiometric amounts of either LBP or sCD14 significantly enhanced formation of a TLR1.TLR2 lipopeptide ternary complex as measured by size exclusion chromatography. However, neither LBP nor sCD14 was physically associated with the final ternary complex. Similar results were obtained using outer surface proteinA(OspA), a naturally occurring triacylated lipoprotein agonist from Borrelia burgdorferi. Activation studies revealed that either LBP or sCD14 sensitized TLR-expressing cells to nanogram levels of either the synthetic lipopeptide or OspA lipoprotein agonist. Together, our results show that either LBP or sCD14 can drive ternary complex formation and TLR activation by acting as mobile carriers of triacylated lipopeptides or lipoproteins.	[Ranoa, Diana Rose E.; Tapping, Richard I.] Univ Illinois, Dept Microbiol, Urbana, IL 61801 USA; [Kelley, Stacy L.] Univ Illinois, Dept Biochem, Urbana, IL 61801 USA; [Tapping, Richard I.] Univ Illinois, Coll Med, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Tapping, RI (corresponding author), Univ Illinois, Dept Microbiol, Chem & Life Sci Lab CLSL B103, MC 110,601 S Goodwin Ave, Urbana, IL 61801 USA.	tapping@illinois.edu			National Institutes of Health from the NIAID [R01 AI052344]; University of Illinois Department of Microbiology; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI052344] Funding Source: NIH RePORTER	National Institutes of Health from the NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); University of Illinois Department of Microbiology; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 AI052344 (to R. I. T.) from the NIAID. This work was also supported by the University of Illinois Department of Microbiology.	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; AntalSzalmas P, 1997, J LEUKOCYTE BIOL, V61, P721, DOI 10.1002/jlb.61.6.721; BELISLE JT, 1994, J BACTERIOL, V176, P2151, DOI 10.1128/JB.176.8.2151-2157.1994; BRANDT ME, 1990, INFECT IMMUN, V58, P983, DOI 10.1128/IAI.58.4.983-991.1990; Branger J, 2005, CLIN IMMUNOL, V116, P174, DOI 10.1016/j.clim.2005.03.014; Branger J, 2004, INT IMMUNOL, V16, P1605, DOI 10.1093/intimm/dxh161; Correia JD, 2001, J BIOL CHEM, V276, P21129, DOI 10.1074/jbc.M009164200; Ehlers S, 2001, IMMUNOLOGY, V103, P113, DOI 10.1046/j.1365-2567.2001.01214.x; Elass E, 2007, FEBS LETT, V581, P1383, DOI 10.1016/j.febslet.2007.02.056; Erdile LF, 1997, VACCINE, V15, P988, DOI 10.1016/S0264-410X(96)00295-2; ERDILE LF, 1993, INFECT IMMUN, V61, P81, DOI 10.1128/IAI.61.1.81-90.1993; Fan XL, 1999, INFECT IMMUN, V67, P2964, DOI 10.1128/IAI.67.6.2964-2968.1999; Fierer J, 2002, J IMMUNOL, V168, P6396, DOI 10.4049/jimmunol.168.12.6396; FROON AHM, 1995, J INFECT DIS, V171, P1250, DOI 10.1093/infdis/171.5.1250; Funda DP, 2001, INFECT IMMUN, V69, P3772, DOI 10.1128/IAI.69.6.3772-3781.2001; Gioannini TL, 2005, J ENDOTOXIN RES, V11, P117, DOI 10.1179/096805105X35198; Guan Y, 2010, J IMMUNOL, V184, P5094, DOI 10.4049/jimmunol.0901888; HAZIOT A, 1988, J IMMUNOL, V141, P547; Haziot A, 1999, J IMMUNOL, V162, P4801; HAZIOT A, 1993, J IMMUNOL, V151, P1500; Haziot A, 1996, IMMUNITY, V4, P407, DOI 10.1016/S1074-7613(00)80254-X; Hirschfeld M, 2001, INFECT IMMUN, V69, P1477, DOI 10.1128/IAI.69.3.1477-1482.2001; Hirschfeld M, 1999, J IMMUNOL, V163, P2382; HOFFMANN P, 1988, IMMUNOBIOLOGY, V177, P158, DOI 10.1016/S0171-2985(88)80036-6; Iwasaki A, 2004, NAT IMMUNOL, V5, P987, DOI 10.1038/ni1112; Jack RS, 1997, NATURE, V389, P742, DOI 10.1038/39622; Jin MS, 2008, IMMUNITY, V29, P182, DOI 10.1016/j.immuni.2008.07.007; Jin MS, 2007, CELL, V130, P1071, DOI 10.1016/j.cell.2007.09.008; Kelley SL, 2013, J IMMUNOL, V190, P1304, DOI 10.4049/jimmunol.1202446; Kim HM, 2007, CELL, V130, P906, DOI 10.1016/j.cell.2007.08.002; Knapp S, 2003, INFECT IMMUN, V71, P6747, DOI 10.1128/IAI.71.12.6747-6753.2003; KRUGER C, 1991, CLIN EXP IMMUNOL, V85, P297; Lien E, 1999, J BIOL CHEM, V274, P33419, DOI 10.1074/jbc.274.47.33419; Manukyan M, 2005, EUR J IMMUNOL, V35, P911, DOI 10.1002/eji.200425336; MARTIN TR, 1992, J CLIN INVEST, V90, P2209, DOI 10.1172/JCI116106; Medzhitov R, 2009, IMMUNITY, V30, P766, DOI 10.1016/j.immuni.2009.06.004; Morrison TB, 1997, J IMMUNOL, V158, P4838; Muzio M, 2000, J LEUKOCYTE BIOL, V67, P450, DOI 10.1002/jlb.67.4.450; Nagai Y, 2002, NAT IMMUNOL, V3, P667, DOI 10.1038/ni809; Nakata T, 2006, CELL MICROBIOL, V8, P1899, DOI 10.1111/j.1462-5822.2006.00756.x; O'Neill LAJ, 2008, IMMUNITY, V29, P12, DOI 10.1016/j.immuni.2008.06.004; Omueti KO, 2007, J IMMUNOL, V178, P6387, DOI 10.4049/jimmunol.178.10.6387; Opitz B, 2001, J BIOL CHEM, V276, P22041, DOI 10.1074/jbc.M010481200; Ozinsky A, 2000, P NATL ACAD SCI USA, V97, P13766, DOI 10.1073/pnas.250476497; Park BS, 2009, NATURE, V458, P1191, DOI 10.1038/nature07830; Piazza M, 2010, BIOCHEM PHARMACOL, V80, P2050, DOI 10.1016/j.bcp.2010.06.019; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Schimke J, 1998, P NATL ACAD SCI USA, V95, P13875, DOI 10.1073/pnas.95.23.13875; Schroder NWJ, 2004, J IMMUNOL, V173, P2683, DOI 10.4049/jimmunol.173.4.2683; Schroder NWJ, 2003, J BIOL CHEM, V278, P15587, DOI 10.1074/jbc.M212829200; SCHUMANN RR, 1990, SCIENCE, V249, P1429, DOI 10.1126/science.2402637; Sellati TJ, 1999, J IMMUNOL, V163, P2049; Sellati TJ, 1998, J IMMUNOL, V160, P5455; SETOGUCHI M, 1989, BIOCHIM BIOPHYS ACTA, V1008, P213, DOI 10.1016/0167-4781(80)90012-3; Shimazu R, 1999, J EXP MED, V189, P1777, DOI 10.1084/jem.189.11.1777; Takeuchi O, 2000, J IMMUNOL, V164, P554, DOI 10.4049/jimmunol.164.2.554; Takeuchi O, 2001, INT IMMUNOL, V13, P933, DOI 10.1093/intimm/13.7.933; Takeuchi O, 1999, IMMUNITY, V11, P443, DOI 10.1016/S1074-7613(00)80119-3; Teghanemt A, 2008, J BIOL CHEM, V283, P21881, DOI 10.1074/jbc.M800672200; TOBIAS PS, 1986, J EXP MED, V164, P777, DOI 10.1084/jem.164.3.777; ULEVITCH RJ, 1995, ANNU REV IMMUNOL, V13, P437, DOI 10.1146/annurev.iy.13.040195.002253; Ulevitch RJ, 1999, CURR OPIN IMMUNOL, V11, P19, DOI 10.1016/S0952-7915(99)80004-1; Vasselon T, 2004, J IMMUNOL, V173, P7401, DOI 10.4049/jimmunol.173.12.7401; Vignal C, 2003, J IMMUNOL, V171, P2014, DOI 10.4049/jimmunol.171.4.2014; Weber JR, 2003, IMMUNITY, V19, P269, DOI 10.1016/S1074-7613(03)00205-X; WEIS JJ, 1994, INFECT IMMUN, V62, P4632, DOI 10.1128/IAI.62.10.4632-4636.1994; Wooten RM, 1998, J IMMUNOL, V160, P5485; WRIGHT SD, 1990, SCIENCE, V249, P1431, DOI 10.1126/science.1698311; Wurfel MM, 1997, J EXP MED, V186, P2051, DOI 10.1084/jem.186.12.2051; Zarember KA, 2002, J IMMUNOL, V168, P554, DOI 10.4049/jimmunol.168.2.554; Zweigner J, 2001, BLOOD, V98, P3800, DOI 10.1182/blood.V98.13.3800	71	76	80	0	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 5	2013	288	14					9729	9741		10.1074/jbc.M113.453266	http://dx.doi.org/10.1074/jbc.M113.453266			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	119RB	23430250	Green Published, hybrid			2022-12-25	WOS:000317114000015
J	Hill, MF; Patel, AV; Murphy, A; Smith, HM; Galindo, CL; Pentassuglia, L; Peng, XY; Lenneman, CG; Odiete, O; Friedman, DB; Kronenberg, MW; Zheng, SY; Zhao, ZM; Song, YN; Harrell, FE; Srinivas, M; Ganguly, A; Iaci, J; Parry, TJ; Caggiano, AO; Sawyer, DB				Hill, Michael F.; Patel, Amish V.; Murphy, Abigail; Smith, Holly M.; Galindo, Cristi L.; Pentassuglia, Laura; Peng, Xuyang; Lenneman, Carrie G.; Odiete, Oghenerukevwe; Friedman, David B.; Kronenberg, Marvin W.; Zheng, Siyuen; Zhao, Zhongming; Song, Yanna; Harrell, Frank E., Jr.; Srinivas, Maya; Ganguly, Anindita; Iaci, Jennifer; Parry, Tom J.; Caggiano, Anthony O.; Sawyer, Douglas B.			Intravenous Glial Growth Factor 2 (GGF2) Isoform of Neuregulin-1 beta Improves Left Ventricular Function, Gene and Protein Expression in Rats after Myocardial Infarction	PLOS ONE			English	Article							DIFFERENCE GEL-ELECTROPHORESIS; RECOMBINANT HUMAN NEUREGULIN-1; CHRONIC HEART-FAILURE; CARDIAC MYOCYTES; MITOCHONDRIAL DYSFUNCTION; ERBB2; CARDIOMYOPATHY; INHIBITION; STANDARD; SURVIVAL	Aims: Recombinant Neuregulin (NRG)-1 beta has multiple beneficial effects on cardiac myocytes in culture, and has potential as a clinical therapy for heart failure (HF). A number of factors may influence the effect of NRG-1 beta on cardiac function via ErbB receptor coupling and expression. We examined the effect of the NRG-1 beta isoform, glial growth factor 2 (GGF2), in rats with myocardial infarction (MI) and determined the impact of high-fat diet as well as chronicity of disease on GGF2 induced improvement in left ventricular systolic function. Potential mechanisms for GGF2 effects on the remote myocardium were explored using microarray and proteomic analysis. Methods and Results: Rats with MI were randomized to receive vehicle, 0.625 mg/kg, or 3.25 mg/kg GGF2 in the presence and absence of high-fat feeding beginning at day 7 post-MI and continuing for 4 weeks. Residual left ventricular (LV) function was improved in both of the GGF2 treatment groups compared with the vehicle treated MI group at 4 weeks of treatment as assessed by echocardiography. High-fat diet did not prevent the effects of high dose GGF2. In experiments where treatment was delayed until 8 weeks after MI, high but not low dose GGF2 treatment was associated with improved systolic function. mRNA and protein expression analysis of remote left ventricular tissue revealed a number of changes in myocardial gene and protein expression altered by MI that were normalized by GGF2 treatment, many of which are involved in energy production. Conclusions: This study demonstrates that in rats with MI induced systolic dysfunction, GGF2 treatment improves cardiac function. There are differences in sensitivity of the myocardium to GGF2 effects when administered early vs. late post-MI that may be important to consider in the development of GGF2 in humans.	[Hill, Michael F.; Patel, Amish V.; Murphy, Abigail; Smith, Holly M.; Galindo, Cristi L.; Pentassuglia, Laura; Peng, Xuyang; Lenneman, Carrie G.; Odiete, Oghenerukevwe; Kronenberg, Marvin W.; Sawyer, Douglas B.] Vanderbilt Univ, Med Ctr, Dept Med, Div Cardiovasc Med, Nashville, TN 37203 USA; [Friedman, David B.] Vanderbilt Univ, Dept Biochem, Med Ctr, Nashville, TN 37232 USA; [Zheng, Siyuen; Zhao, Zhongming] Vanderbilt Univ, Med Ctr, Nashville, TN USA; [Song, Yanna; Harrell, Frank E., Jr.] Vanderbilt Univ, Med Ctr, Dept Biostat, Nashville, TN USA; [Srinivas, Maya; Ganguly, Anindita; Iaci, Jennifer; Parry, Tom J.; Caggiano, Anthony O.] Acorda Therapeut Inc, Hawthorne, NY USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University	Sawyer, DB (corresponding author), Vanderbilt Univ, Med Ctr, Dept Med, Div Cardiovasc Med, Nashville, TN 37203 USA.	douglas.b.sawyer@Vanderbilt.Edu			National Institutes of Health [P20 HL101425, U01 HL100398]; Acorda Therapeutics, Inc.; NIH [DK59637]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL100398, R01HL068144, P20HL101425] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U24DK059637, U2CDK059637] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Acorda Therapeutics, Inc.; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the National Institutes of Health (P20 HL101425, U01 HL100398) and Acorda Therapeutics, Inc. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Several authors are employed by Acorda Therapeutics. These authors participated in study design and preparation of the manuscript.; Douglas Sawyer has received research support from Acorda Therapeutics, Inc. that helped to fund parts of this study. Several authors as noted on the title page are employees of Acorda Therapeutics, Inc., a company that is developing GGF2 for the treatment of cardiovascular and neurodegenerative disease. The authors note that these competing interests do not alter their adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.; We thank Lian Li and Zhizhang Wang for technical assistance with animal surgery and echocardiography. We thank Todd Peterson and the Vanderbilt University Insititute for Imaging Sciences for conducting Positron Emission Tomography imaging studies. Cardiac surgery and echocardiography were conducted in the Mouse Metabolic Phenotyping Center which is supported by NIH Grant DK59637.	Alban A, 2003, PROTEOMICS, V3, P36, DOI 10.1002/pmic.200390006; [Anonymous], NHLBI PROGR GEN APPL; Bersell K, 2009, CELL, V138, P257, DOI 10.1016/j.cell.2009.04.060; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Colak D, 2009, GENOMICS, V94, P20, DOI 10.1016/j.ygeno.2009.03.003; Friedman David B, 2007, Methods Mol Biol, V367, P219; Friedman DB, 2004, PROTEOMICS, V4, P793, DOI 10.1002/pmic.200300635; Ganguly A, 2008, CIRC RES, V103, pE51; Gao RL, 2010, J AM COLL CARDIOL, V55, P1907, DOI 10.1016/j.jacc.2009.12.044; Grazette LP, 2004, J AM COLL CARDIOL, V44, P2231, DOI 10.1016/j.jacc.2004.08.066; Guo YF, 2012, CHINESE MED J-PEKING, V125, P807, DOI 10.3760/cma.j.issn.0366-6999.2012.05.015; Hannenhalli S, 2006, CIRCULATION, V114, P1269, DOI 10.1161/CIRCULATIONAHA.106.632430; Jabbour A, 2011, EUR J HEART FAIL, V13, P83, DOI 10.1093/eurjhf/hfq152; Kuramochi Y, 2004, J BIOL CHEM, V279, P51141, DOI 10.1074/jbc.M408662200; Kuramochi Y, 2006, J MOL CELL CARDIOL, V41, P228, DOI 10.1016/j.yjmcc.2006.04.007; Liu XF, 2006, J AM COLL CARDIOL, V48, P1438, DOI 10.1016/j.jacc.2006.05.057; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MARCHIONNI MA, 1993, NATURE, V362, P312, DOI 10.1038/362312a0; Miller TA, 2009, BIOCHEM BIOPH RES CO, V379, P32, DOI 10.1016/j.bbrc.2008.11.150; Morgan EE, 2006, AM J PHYSIOL-HEART C, V290, pH1899, DOI 10.1152/ajpheart.01014.2005; Parkinson H, 2011, NUCLEIC ACIDS RES, V39, pD1002, DOI 10.1093/nar/gkq1040; Peng XY, 2005, J BIOL CHEM, V280, P13148, DOI 10.1074/jbc.M410838200; Pentassuglia L, 2009, EXP CELL RES, V315, P1302, DOI 10.1016/j.yexcr.2009.02.001; Rennison JH, 2007, AM J PHYSIOL-HEART C, V292, pH1498, DOI 10.1152/ajpheart.01021.2006; Rohrbach S, 1999, CIRCULATION, V100, P407, DOI 10.1161/01.CIR.100.4.407; Sawyer DB, 2002, CIRCULATION, V105, P1551, DOI 10.1161/01.CIR.0000013839.41224.1C; Sawyer DB, 2011, J MOL CELL CARDIOL, V51, P501, DOI 10.1016/j.yjmcc.2011.06.016; Trivedi CM, 2011, J MOL CELL CARDIOL, V50, P1056, DOI 10.1016/j.yjmcc.2011.02.015; Udelson JE, 2002, J CARD FAIL, V8, pS465, DOI 10.1054/jcaf.2002.129289; WESSEL D, 1984, ANAL BIOCHEM, V138, P141, DOI 10.1016/0003-2697(84)90782-6; Zhao YY, 1998, J BIOL CHEM, V273, P10261, DOI 10.1074/jbc.273.17.10261	31	29	33	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2013	8	2							e55741	10.1371/journal.pone.0055741	http://dx.doi.org/10.1371/journal.pone.0055741			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IT	23437060	Green Published, Green Submitted, gold			2022-12-25	WOS:000315186000007
J	Binagwaho, A; Pegurri, E; Drobac, PC; Mugwaneza, P; Stulac, SN; Wagner, CM; Karema, C; Tsague, L				Binagwaho, Agnes; Pegurri, Elisabetta; Drobac, Peter C.; Mugwaneza, Placidie; Stulac, Sara N.; Wagner, Claire M.; Karema, Corine; Tsague, Landry			Prevention of Mother-To-Child Transmission of HIV: Cost-Effectiveness of Antiretroviral Regimens and Feeding Options in Rwanda	PLOS ONE			English	Article							SINGLE-DOSE NEVIRAPINE; FORMULA-FED INFANTS; HIV-1-INFECTED WOMEN; TREATMENT PROGRAM; INFECTED WOMEN; FREE SURVIVAL; MORTALITY; ZIDOVUDINE; THERAPY; MORBIDITY	Background: Rwanda's National PMTCT program aims to achieve elimination of new HIV infections in children by 2015. In November 2010, Rwanda adopted the WHO 2010 ARV guidelines for PMTCT recommending Option B (HAART) for all HIV-positive pregnant women extended throughout breastfeeding and discontinued (short course-HAART) only for those not eligible for life treatment. The current study aims to assess the cost-effectiveness of this policy choice. Methods: Based on a cohort of HIV-infected pregnant women in Rwanda, we modelled the cost-effectiveness of six regimens: dual ARV prophylaxis with either 12 months breastfeeding or replacement feeding; short course HAART (Sc-HAART) prophylaxis with either 6 months breastfeeding, 12 months breastfeeding, or 18 months breastfeeding; and Sc-HAART prophylaxis with replacement feeding. Direct costs were modelled based on all inputs in each scenario and related unit costs. Effectiveness was evaluated by measuring HIV-free survival at 18 months. Savings correspond to the lifetime costs of HIV treatment and care avoided as a result of all vertical HIV infections averted. Results: All PMTCT scenarios considered are cost saving compared to "no intervention." Sc-HAART with 12 months breastfeeding or 6 months breastfeeding dominate all other scenarios. Sc-HAART with 12 months breastfeeding allows for more children to be alive and HIV-uninfected by 18 months than Sc-HAART with 6 months breastfeeding for an incremental cost per child alive and uninfected of 11,882 USD. This conclusion is sensitive to changes in the relative risk of mortality by 18 months for exposed HIV-uninfected children on replacement feeding from birth and those who were breastfed for only 6 months compared to those breastfeeding for 12 months or more. Conclusion: Our findings support the earlier decision by Rwanda to adopt WHO Option B and could inform alternatives for breastfeeding duration. Local contexts and existing care delivery models should be part of national policy decisions.	[Binagwaho, Agnes] Minist Hlth, Kigali, Rwanda; [Binagwaho, Agnes; Drobac, Peter C.; Stulac, Sara N.] Brigham & Womens Hosp, Div Global Hlth Equ, Boston, MA 02115 USA; [Pegurri, Elisabetta] UNAIDS Ethiopia, Addis Ababa, Ethiopia; [Drobac, Peter C.] Partners Hlth Inshuti Mu Buzima, Kigali, Rwanda; [Drobac, Peter C.; Mugwaneza, Placidie; Karema, Corine] Rwanda Biomed Ctr, Kigali, Rwanda; [Stulac, Sara N.] Partners Hlth, Boston, MA USA; [Wagner, Claire M.] Global Hlth Delivery Partnership, Boston, MA USA; [Tsague, Landry] UNICEF Zambia, Lusaka, Zambia	Harvard University; Brigham & Women's Hospital; Rwanda Biomedical Center; Partners Healthcare System	Binagwaho, A (corresponding author), Minist Hlth, Kigali, Rwanda.	abinagwaho@gmail.com						Arrive E, 2008, INT J EPIDEMIOL, V37, P474, DOI 10.1093/ije/dym216; Banerjee T, 2010, ANN TROP PAEDIATR, V30, P27, DOI 10.1179/146532810X12637745451915; Becquet R, 2007, PLOS MED, V4, P139, DOI 10.1371/journal.pmed.0040017; Carter RJ, 2010, JAIDS-J ACQ IMM DEF, V55, P404, DOI 10.1097/QAI.0b013e3181e73f4b; Center for Treatment and Research on AIDS Malaria Tuberculosis and Other Epidemics (TRAC-Plus) & Rwanda Ministry of Health, 2010, NAT STAND GUID CLIN; Center for Treatment and Research on AIDS Malaria Tuberculosis and Other Epidemics (TRAC-Plus) & Rwanda Ministry of Health, 2010, RWAND NAT GUID PREV; Center for Treatment and Research on AIDS Malaria Tuberculosis and Other Epidemics (TRAC-Plus) & Rwanda National AIDS Control Commission, 2010, HIV AIDS RWAND 2010; Chasela CS, 2010, NEW ENGL J MED, V362, P2271, DOI 10.1056/NEJMoa0911486; Clinton Health Access Initiative, 2010, ANT ARV PRIC LIST VE; Cooper ER, 2002, J ACQ IMMUN DEF SYND, V29, P484, DOI 10.1097/00126334-200204150-00009; Coutsoudis A, 2004, J INFECT DIS, V189, P2154, DOI 10.1086/420834; Dabis F, 2005, AIDS, V19, P309; De Cock KM, 2000, JAMA-J AM MED ASSOC, V283, P1175, DOI 10.1001/jama.283.9.1175; Franke MF, 2011, PEDIATR INFECT DIS J, V30, P614, DOI 10.1097/INF.0b013e31820a599e; Homsy J, 2010, JAIDS-J ACQ IMM DEF, V53, P28, DOI 10.1097/QAI.0b013e3181bdf65a; Iliff PJ, 2005, AIDS, V19, P699, DOI 10.1097/01.aids.0000166093.16446.c9; Ivers LC, 2011, AIDS RES THER, V8, DOI 10.1186/1742-6405-8-37; Kagaayi J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003877; Kuhn L, 2008, NEW ENGL J MED, V359, P130, DOI 10.1056/NEJMoa073788; Kuhn L, 2010, CLIN PERINATOL, V37, P843, DOI 10.1016/j.clp.2010.08.011; Lallemant M, 2004, NEW ENGL J MED, V351, P217, DOI 10.1056/NEJMoa033500; Lowrance DW, 2009, JAIDS-J ACQ IMM DEF, V52, P49, DOI 10.1097/QAI.0b013e3181b03316; Mahy M, 2010, SEX TRANSM INFECT, V86, pI48, DOI 10.1136/sti.2010.045989; Marseille E, 1999, LANCET, V354, P803, DOI 10.1016/S0140-6736(99)80009-9; Mbori-Ngacha D, 2001, JAMA-J AM MED ASSOC, V286, P2413, DOI 10.1001/jama.286.19.2413; National Bank of Rwanda, 2009, EXCH RAT RWF USD; National Institute of Statistics of Rwanda World Food Programme UNICEF World Vision, 2009, RWAND COMPR FOOD SEC; Nduati R, 2000, JAMA-J AM MED ASSOC, V283, P1167, DOI 10.1001/jama.283.9.1167; Omes C, 2004, 15 INT AIDS C BANGK; Orlando S, 2010, JAIDS-J ACQ IMM DEF, V55, P631, DOI 10.1097/QAI.0b013e3181f9f9f5; Peltier CA, 2009, AIDS, V23, P2415, DOI 10.1097/QAD.0b013e32832ec20d; Rich ML, 2012, JAIDS-J ACQ IMM DEF, V59, pE35, DOI 10.1097/QAI.0b013e31824476c4; Robberstad B, 2010, JAIDS-J ACQ IMM DEF, V55, P397, DOI 10.1097/QAI.0b013e3181eef4d3; Rollins N, 2006, HIV TRANSMISSION MOR; Rwanda Ministry of Health, 2010, FIN REC; Rwanda Ministry of Health, 2007, SURV INF VIH SIT SEN; Rwanda Ministry of Health, 2011, DEM HLTH SURV 2010 P; Rwanda Ministry of Health, 2001, NAT STRAT APPL NSA B; Rwanda National AIDS Control Commission, 2007, DAT EST AM FIN RES N; Rwanda National AIDS Control Commission, 2008, UN GEN ASS SPEC SESS; Rwanda National AIDS Control Commission, 2009, RWAND NAT STRAT PLAN; Rwanda National Institute of Statistics & ORC Macro, 2008, RWAND INT DEM HLTH S; Rwanda National Institute of Statistics & ORC Macro, 2006, RWAND DEM HLTH SURV; Scotland GS, 2003, AIDS, V17, P1045, DOI 10.1097/00002030-200305020-00014; Shaffer N, 1999, LANCET, V353, P773, DOI 10.1016/S0140-6736(98)10411-7; Shapiro RL, 2010, NEW ENGL J MED, V362, P2282, DOI 10.1056/NEJMoa0907736; Soderlund N, 1999, BRIT MED J, V318, P1650, DOI 10.1136/bmj.318.7199.1650; Stover J, 2008, SEX TRANSM INFECT, V84, pI24, DOI 10.1136/sti.2008.029868; Stringer EM, 2010, JAMA-J AM MED ASSOC, V304, P293, DOI 10.1001/jama.2010.990; Stringer JSA, 2000, J ACQ IMMUN DEF SYND, V24, P369, DOI 10.1097/00126334-200008010-00012; Sweat MD, 2004, AIDS, V18, P1661, DOI 10.1097/01.aids.0000131353.06784.8f; Teerawattananon Y, 2005, COST EFFECTIVENESS R, V3; Thior I, 2006, JAMA-J AM MED ASSOC, V296, P794, DOI 10.1001/jama.296.7.794; Tsague L, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-753; *UNAIDS, 2009, AIDS EP UPD; UNAIDS & WHO, 2009, UNAIDS REP GLOB AIDS; Universite de Bordeaux Institut de Sante Publique dEedDIIU UNICEF, 2010, PMCT PED HIV AIDS CA; van Griensven J, 2008, BMC PEDIATR, V8, DOI 10.1186/1471-2431-8-39; Victora CG, 2000, LANCET, V355, P451, DOI 10.1016/S0140-6736(00)82011-5; Violari A, 2008, NEW ENGL J MED, V359, P2233, DOI 10.1056/NEJMoa0800971; WHO, 2006, ANT DRUGS TREAT PREG; World Health Organization, 2012, PROGR UPD US ANT DRU; World Health Organization, 2010, PMTCT STRAT VIS 2010; World Health Organization, 2021, ANT DRUGS TREAT PREG; World Health Organization, 2010, GUID HIV INF FEED 20; World Health Organization (WHO), 2013, WORLD HLTH REPORT 20	66	18	18	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e54180	10.1371/journal.pone.0054180	http://dx.doi.org/10.1371/journal.pone.0054180			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437040	Green Published, gold, Green Submitted			2022-12-25	WOS:000315184200007
J	Chen, FH; Sarabipour, S; Hristova, K				Chen, Fenghao; Sarabipour, Sarvenaz; Hristova, Kalina			Multiple Consequences of a Single Amino Acid Pathogenic RTK Mutation: The A391E Mutation in FGFR3	PLOS ONE			English	Article							FIBROBLAST-GROWTH-FACTOR; RECEPTOR TYROSINE KINASE; MUENKE CRANIOSYNOSTOSIS; THANATOPHORIC DYSPLASIA; TRANSMEMBRANE MUTATION; ACANTHOSIS NIGRICANS; STRUCTURAL BASIS; CROUZON-SYNDROME; HEPARAN-SULFATE; POINT MUTATION	The A391E mutation in fibroblast growth factor receptor 3 (FGFR3) is the genetic cause for Crouzon syndrome with Acanthosis Nigricans. Here we investigate the effect of this mutation on FGFR3 activation in HEK 293 T cells over a wide range of fibroblast growth factor 1 concentrations using a physical-chemical approach that deconvolutes the effects of the mutation on dimerization, ligand binding, and efficiency of phosphorylation. It is believed that the mutation increases FGFR3 dimerization, and our results verify this. However, our results also demonstrate that the increase in dimerization is not the sole effect of the mutation, as the mutation also facilitates the phosphorylation of critical tyrosines in the activation loop of FGFR3. The activation of mutant FGFR3 is substantially increased due to a combination of these two effects. The low expression of the mutant, however, attenuates its signaling and may explain the mild phenotype in Crouzon syndrome with Acanthosis Nigricans. The results presented here provide new knowledge about the physical basis behind growth disorders and highlight the fact that a single RTK mutation may affect multiple steps in RTK activation.	[Chen, Fenghao; Sarabipour, Sarvenaz; Hristova, Kalina] Johns Hopkins Univ, Dept Mat Sci & Engn, Baltimore, MD 21218 USA	Johns Hopkins University	Hristova, K (corresponding author), Johns Hopkins Univ, Dept Mat Sci & Engn, Baltimore, MD 21218 USA.	kh@jhu.edu	Hristova, Kalina/A-3326-2010; Sarabipour, Sarvenaz/H-2992-2015	Sarabipour, Sarvenaz/0000-0001-5097-5509	United States National Institutes of Health (NIH) [GM068619]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068619] Funding Source: NIH RePORTER	United States National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding was provided by United States National Institutes of Health (NIH) GM068619. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adar R, 2002, J BONE MINER RES, V17, P860, DOI 10.1359/jbmr.2002.17.5.860; Angers S, 2000, P NATL ACAD SCI USA, V97, P3684, DOI 10.1073/pnas.060590697; Bell CA, 2000, MOL BIOL CELL, V11, P3589, DOI 10.1091/mbc.11.10.3589; Bellus GA, 2000, AM J HUM GENET, V67, P1411, DOI 10.1086/316892; Bonaventure J, 2007, FEBS J, V274, P3078, DOI 10.1111/j.1742-4658.2007.05835.x; Chen FH, 2011, BIOCHEMISTRY-US, V50, P8576, DOI 10.1021/bi200986f; Chen FH, 2011, BBA-BIOMEMBRANES, V1808, P2045, DOI 10.1016/j.bbamem.2011.04.007; Cho JY, 2004, P NATL ACAD SCI USA, V101, P609, DOI 10.1073/pnas.2237184100; Colvin JS, 1996, NAT GENET, V12, P390, DOI 10.1038/ng0496-390; Eswarakumar VP, 2005, CYTOKINE GROWTH F R, V16, P139, DOI 10.1016/j.cytogfr.2005.01.001; FANGER BO, 1989, FASEB J, V3, P71, DOI 10.1096/fasebj.3.1.2783412; Furdui CM, 2006, MOL CELL, V21, P711, DOI 10.1016/j.molcel.2006.01.022; Harada D, 2009, J BONE MINER METAB, V27, P9, DOI 10.1007/s00774-008-0009-7; Harmer NJ, 2006, BIOCHEM SOC T, V34, P442, DOI 10.1042/BST0340442; He LJ, 2012, BBA-BIOMEMBRANES, V1818, P995, DOI 10.1016/j.bbamem.2011.07.044; He LJ, 2011, J BIOL CHEM, V286, P13272, DOI 10.1074/jbc.M110.205583; He LJ, 2011, BBA-BIOMEMBRANES, V1808, P253, DOI 10.1016/j.bbamem.2010.08.007; He LJ, 2010, J BIOL CHEM, V285, P30103, DOI 10.1074/jbc.M109.094086; He LJ, 2008, J MOL BIOL, V384, P1130, DOI 10.1016/j.jmb.2008.10.036; Horton WA, 2007, LANCET, V370, P162, DOI 10.1016/S0140-6736(07)61090-3; Ibrahimi OA, 2004, HUM MOL GENET, V13, P2313, DOI 10.1093/hmg/ddh235; Ibrahimi OA, 2004, HUM MOL GENET, V13, P69, DOI 10.1093/hmg/ddh011; Khnykin D, 2006, GROWTH FACTORS, V24, P111, DOI 10.1080/08977190600621388; L'Horte CGM, 2005, EXP CELL RES, V304, P417; Lew ED, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000021; Li E, 2006, J MOL BIOL, V356, P600, DOI 10.1016/j.jmb.2005.11.077; Li E, 2006, BIOCHEMISTRY-US, V45, P6241, DOI 10.1021/bi060609y; Li E, 2010, CELL ADHES MIGR, V4, P249, DOI 10.4161/cam.4.2.10725; McIntosh I, 2000, CELL STRUCT FUNCT, V25, P85, DOI 10.1247/csf.25.85; MEYERS GA, 1995, NAT GENET, V11, P462, DOI 10.1038/ng1295-462; Mohammadi M, 2005, CYTOKINE GROWTH F R, V16, P107, DOI 10.1016/j.cytogfr.2005.01.008; Monsonego-Ornan E, 2000, MOL CELL BIOL, V20, P516, DOI 10.1128/MCB.20.2.516-522.2000; Naski MC, 1996, NAT GENET, V13, P233, DOI 10.1038/ng0696-233; Olsen SK, 2004, P NATL ACAD SCI USA, V101, P935, DOI 10.1073/pnas.0307287101; Ornitz DM, 2000, BIOESSAYS, V22, P108, DOI 10.1002/(SICI)1521-1878(200002)22:2<108::AID-BIES2>3.0.CO;2-M; ORNITZ DM, 1992, MOL CELL BIOL, V12, P240, DOI 10.1128/MCB.12.1.240; Passos-Bueno MR, 1999, HUM MUTAT, V14, P115; PERDUE JF, 1970, BIOCHIM BIOPHYS ACTA, V196, P125, DOI 10.1016/0005-2736(70)90001-5; Plotnikov AN, 1999, CELL, V98, P641, DOI 10.1016/S0092-8674(00)80051-3; Riese DJ, 2007, BIOESSAYS, V29, P558, DOI 10.1002/bies.20582; Robertson SC, 2000, TRENDS GENET, V16, P265, DOI 10.1016/S0168-9525(00)02021-7; Vajo Z, 2000, ENDOCR REV, V21, P23, DOI 10.1210/er.21.1.23; Webster MK, 1996, EMBO J, V15, P520, DOI 10.1002/j.1460-2075.1996.tb00384.x; WEINER DB, 1989, NATURE, V339, P230, DOI 10.1038/339230a0; Yun CH, 2007, CANCER CELL, V11, P217, DOI 10.1016/j.ccr.2006.12.017	45	11	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e56521	10.1371/journal.pone.0056521	http://dx.doi.org/10.1371/journal.pone.0056521			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437153	Green Published, Green Submitted, gold			2022-12-25	WOS:000315184200091
J	Dong, XB; Zhang, YJ; Zhang, ZD				Dong, Xiaobao; Zhang, Yong-Jun; Zhang, Ziding			Using Weakly Conserved Motifs Hidden in Secretion Signals to Identify Type-III Effectors from Bacterial Pathogen Genomes	PLOS ONE			English	Article							COMPUTATIONAL PREDICTION; VIRULENCE EFFECTORS; PROTEIN; SEQUENCE; IDENTIFICATION; COLLOCATION; DOMAINS; SITES; YOPE	Background: As one of the most important virulence factor types in gram-negative pathogenic bacteria, type-III effectors (TTEs) play a crucial role in pathogen-host interactions by directly influencing immune signaling pathways within host cells. Based on the hypothesis that type-III secretion signals may be comprised of some weakly conserved sequence motifs, here we used profile-based amino acid pair information to develop an accurate TTE predictor. Results: For a TTE or non-TTE, we first used a hidden Markov model-based sequence searching method (i.e., HHblits) to detect its weakly homologous sequences and extracted the profile-based k-spaced amino acid pair composition (HH-CKSAAP) from the N-terminal sequences. In the next step, the feature vector HH-CKSAAP was used to train a linear support vector machine model, which we designate as BEAN (Bacterial Effector ANalyzer). We compared our method with four existing TTE predictors through an independent test set, and our method revealed improved performance. Furthermore, we listed the most predictive amino acid pairs according to their weights in the established classification model. Evolutionary analysis shows that predictive amino acid pairs tend to be more conserved. Some predictive amino acid pairs also show significantly different position distributions between TTEs and non-TTEs. These analyses confirmed that some weakly conserved sequence motifs may play important roles in type-III secretion signals. Finally, we also used BEAN to scan one plant pathogen genome and showed that BEAN can be used for genome-wide TTE identification. The webserver and stand-alone version of BEAN are available at http://protein.cau.edu.cn:8080/bean/.	[Dong, Xiaobao; Zhang, Ziding] China Agr Univ, State Key Lab Agrobiotechnol, Coll Biol Sci, Beijing 100094, Peoples R China; [Zhang, Yong-Jun] Chinese Acad Agr Sci, State Key Lab Biol Plant Dis & Insect Pests, Inst Plant Protect, Beijing 100193, Peoples R China	China Agricultural University; Chinese Academy of Agricultural Sciences; Institute of Plant Protection, CAAS	Zhang, ZD (corresponding author), China Agr Univ, State Key Lab Agrobiotechnol, Coll Biol Sci, Beijing 100094, Peoples R China.	zidingzhang@cau.edu.cn	, zidingzhang/E-9320-2011	, zidingzhang/0000-0002-9296-571X; Dong, Xiaobao/0000-0003-1652-117X	National Natural Science Foundation of China [31271414, 31070259]; National Key Basic Research Program of China [2009CB918802, 2012CB114104]; Chinese Universities Scientific Fund [2012QJ146]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Basic Research Program of China(National Basic Research Program of China); Chinese Universities Scientific Fund	This work was supported by grants from the National Natural Science Foundation of China (31271414 and 31070259), the National Key Basic Research Program of China (2009CB918802 and 2012CB114104), and the Chinese Universities Scientific Fund (2012QJ146). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfano JR, 2009, MOL PLANT PATHOL, V10, P805, DOI 10.1111/j.1364-3703.2009.00588.x; Anderson DM, 1997, SCIENCE, V278, P1140, DOI 10.1126/science.278.5340.1140; Apweiler R, 2010, NUCLEIC ACIDS RES, V38, pD142, DOI 10.1093/nar/gkp846; Arnold R, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000376; Baltrus DA, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002132; Biegert A, 2008, BIOINFORMATICS, V24, P807, DOI 10.1093/bioinformatics/btn039; Buchko GW, 2010, MOL BIOSYST, V6, P2448, DOI 10.1039/c0mb00097c; Chen K, 2008, J COMPUT CHEM, V29, P1596, DOI 10.1002/jcc.20918; Chen K, 2007, BMC STRUCT BIOL, V7, DOI 10.1186/1472-6807-7-25; Chen K, 2007, BIOCHEM BIOPH RES CO, V355, P764, DOI 10.1016/j.bbrc.2007.02.040; Chen K, 2009, J COMPUT CHEM, V30, P163, DOI 10.1002/jcc.21053; Chen YZ, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-101; Chen Z, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022930; Chisholm ST, 2006, CELL, V124, P803, DOI 10.1016/j.cell.2006.02.008; Costa SCP, 2012, MBIO, V3, DOI 10.1128/mBio.00243-11; Davey NE, 2012, MOL BIOSYST, V8, P268, DOI 10.1039/c1mb05231d; Fuxreiter M, 2007, BIOINFORMATICS, V23, P950, DOI 10.1093/bioinformatics/btm035; Galan JE, 2006, NATURE, V444, P567, DOI 10.1038/nature05272; Galan JE, 2009, CELL HOST MICROBE, V5, P571, DOI 10.1016/j.chom.2009.04.008; Guttman DS, 2002, SCIENCE, V295, P1722, DOI 10.1126/science.295.5560.1722; KALDERON D, 1984, CELL, V39, P499, DOI 10.1016/0092-8674(84)90457-4; Lara-Tejero M, 2011, SCIENCE, V331, P1188, DOI 10.1126/science.1201476; Lindeberg M, 2012, TRENDS MICROBIOL, V20, P199, DOI 10.1016/j.tim.2012.01.003; Lower M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005917; McDermott JE, 2011, INFECT IMMUN, V79, P23, DOI 10.1128/IAI.00537-10; Muschiol S, 2011, INFECT IMMUN, V79, P571, DOI 10.1128/IAI.00825-10; PUGSLEY AP, 1993, MICROBIOL REV, V57, P50, DOI 10.1128/MMBR.57.1.50-108.1993; Pupko T, 2002, BIOINFORMATICS, V18, P1116, DOI 10.1093/bioinformatics/18.8.1116; Remmert M, 2012, NAT METHODS, V9, P173, DOI [10.1038/NMETH.1818, 10.1038/nmeth.1818]; Salanoubat M, 2002, NATURE, V415, P497, DOI 10.1038/415497a; Samudrala R, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000375; Sato Y, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-442; Schechter LM, 2006, MOL PLANT MICROBE IN, V19, P1180, DOI 10.1094/MPMI-19-1180; Schechter LM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036038; Schesser K, 1996, J BACTERIOL, V178, P7227, DOI 10.1128/jb.178.24.7227-7233.1996; Sory MP, 1995, P NATL ACAD SCI USA, V92, P11998, DOI 10.1073/pnas.92.26.11998; Tay DMM, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S7-S4; Tobe T, 2006, P NATL ACAD SCI USA, V103, P14941, DOI 10.1073/pnas.0604891103; Wang XB, 2009, PROTEIN ENG DES SEL, V22, P707, DOI 10.1093/protein/gzp055; Wang YJ, 2011, BIOINFORMATICS, V27, P777, DOI 10.1093/bioinformatics/btr021; WATTIAU P, 1993, MOL MICROBIOL, V8, P123, DOI 10.1111/j.1365-2958.1993.tb01209.x; Yang Y, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S1-S47	42	37	39	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e56632	10.1371/journal.pone.0056632	http://dx.doi.org/10.1371/journal.pone.0056632			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437191	Green Submitted, Green Published, gold			2022-12-25	WOS:000315184200123
J	Lee, D; Oka, T; Hunter, B; Robinson, A; Papp, S; Nakamura, K; Srisakuldee, W; Nickel, BE; Light, PE; Dyck, JRB; Lopaschuk, GD; Kardami, E; Opas, M; Michalak, M				Lee, Dukgyu; Oka, Tatsujiro; Hunter, Beth; Robinson, Alison; Papp, Sylvia; Nakamura, Kimitoshi; Srisakuldee, Wattamon; Nickel, Barbara E.; Light, Peter E.; Dyck, Jason R. B.; Lopaschuk, Gary D.; Kardami, Elissavet; Opas, Michal; Michalak, Marek			Calreticulin Induces Dilated Cardiomyopathy	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; SARCOPLASMIC-RETICULUM; CARDIAC MYOCYTES; TRANSGENIC MICE; GENE-EXPRESSION; CALCIUM-RELEASE; HUMAN HEART; CALSEQUESTRIN; MODULATION; HYPERTROPHY	Background: Calreticulin, a Ca2+-buffering chaperone of the endoplasmic reticulum, is highly expressed in the heart and is essential for cardiac development. After birth, the calreticulin gene is sharply down regulated in the heart, thus, adult hearts have negligible levels of calreticulin. In this study we tested the role of calreticulin in the adult heart. Methodology/Principal Findings: We generated an inducible transgenic mouse in which calreticulin is targeted to cardiac tissue using a Cre/loxP system and can be up-regulated in adult hearts. Echocardiography analysis of hearts transgenic mice expressing calreticulin revealed impaired left ventricular systolic and diastolic function and impaired valve function. There was altered expression of Ca2+ signaling molecules and the gap junction proteins, Connexin 43 and Sarcoplasmic reticulum associated Ca2+-handling proteins (including the cardiac ryanodine receptor, sarco/reticulum Ca2+-ATPase, and cardiac calsequestrin) were down-regulated in the transgenic hearts with increased of calreticulin. Conclusions/Significance: We show that in adult heart, up-regulated expression of calreticulin induces cardiomyopathy vivo leading to heart failure. This is due to an alternation in changes in a subset of Ca2+ handling genes, gap components and left ventricle remodeling.	[Lee, Dukgyu; Robinson, Alison; Michalak, Marek] Univ Alberta, Dept Biochem, Edmonton, AB, Canada; [Oka, Tatsujiro; Dyck, Jason R. B.; Lopaschuk, Gary D.] Univ Alberta, Dept Pediat, Edmonton, AB, Canada; [Hunter, Beth; Light, Peter E.; Lopaschuk, Gary D.] Univ Alberta, Dept Pharmacol, Edmonton, AB, Canada; [Papp, Sylvia; Opas, Michal] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada; [Nakamura, Kimitoshi] Kumamoto Univ, Sch Med, Dept Pediat, Kumamoto 860, Japan; [Srisakuldee, Wattamon; Nickel, Barbara E.; Kardami, Elissavet] Univ Manitoba, St Boniface Res Ctr, Dept Human Anat & Cell Sci & Physiol, Winnipeg, MB, Canada; [Srisakuldee, Wattamon; Nickel, Barbara E.; Kardami, Elissavet] Univ Manitoba, St Boniface Res Ctr, Inst Cardiovasc Sci, Winnipeg, MB, Canada	University of Alberta; University of Alberta; University of Alberta; University of Toronto; Kumamoto University; University of Manitoba; Children's Hospital Research Institute of Manitoba; University of Manitoba; Children's Hospital Research Institute of Manitoba	Michalak, M (corresponding author), Univ Alberta, Dept Biochem, Edmonton, AB, Canada.	marek.michalak@ualberta.ca		, Kimitoshi/0000-0003-4903-2428; Dyck, Jason/0000-0002-7045-2884; Kardami, Elissavet/0000-0002-3198-8432	Canadian Institutes of Health Research	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by the Canadian Institutes of Health Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad F, 2005, CIRCULATION, V112, P3140, DOI 10.1161/CIRCULATIONAHA.105.550806; Azfer A, 2006, AM J PHYSIOL-HEART C, V291, pH1411, DOI 10.1152/ajpheart.01378.2005; Bao M, 2011, CHANNELS, V5, P489, DOI 10.4161/chan.5.6.18523; Bruce AF, 2008, CARDIOVASC RES, V77, P757, DOI 10.1093/cvr/cvm083; BURNS K, 1994, NATURE, V367, P476, DOI 10.1038/367476a0; CHIEN KR, 1991, FASEB J, V5, P3037, DOI 10.1096/fasebj.5.15.1835945; Coe H, 2008, CELL STRESS CHAPERON, V13, P497, DOI 10.1007/s12192-008-0049-x; Danik SB, 2004, CIRC RES, V95, P1035, DOI 10.1161/01.RES.0000148664.33695.2a; DEDHAR S, 1994, NATURE, V367, P480, DOI 10.1038/367480a0; Dupont E, 2001, CIRCULATION, V103, P842, DOI 10.1161/01.CIR.103.6.842; Groenendyk J, 2010, CIRC RES, V107, P1185, DOI 10.1161/CIRCRESAHA.110.227033; Guo A, 2012, J BIOL CHEM, V287, P16670, DOI 10.1074/jbc.M112.340927; Guo L, 2001, J BIOL CHEM, V276, P2797, DOI 10.1074/jbc.C000822200; Gutstein WH, 2004, TRENDS CARDIOVAS MED, V14, P257, DOI 10.1016/S1050-1738(04)00112-4; Gyorke S, 2004, BIOL RES, V37, P603, DOI 10.4067/s0716-97602004000400014; Hasenfuss G, 1997, BASIC RES CARDIOL, V92, P87, DOI 10.1007/BF00794072; Heineke J, 2006, NAT REV MOL CELL BIO, V7, P589, DOI 10.1038/nrm1983; Hunter AW, 2005, MOL BIOL CELL, V16, P5686, DOI 10.1091/mbc.E05-08-0737; Li J, 2002, J CELL BIOL, V158; Lynch J, 2005, J CELL BIOL, V170, P37, DOI 10.1083/jcb.200412156; Lynch JM, 2012, CELL, V149, P1257, DOI 10.1016/j.cell.2012.03.050; Martindale JJ, 2006, CIRC RES, V98, P1186, DOI 10.1161/01.RES.0000220643.65941.8d; Mearini G, 2008, BBA-MOL BASIS DIS, V1782, P749, DOI 10.1016/j.bbadis.2008.06.009; Mery A, 2005, MOL BIOL CELL, V16, P2414, DOI 10.1091/mbc.E04-10-0883; Mesaeli N, 1999, J CELL BIOL, V144, P857, DOI 10.1083/jcb.144.5.857; MEYER M, 1995, CIRCULATION, V92, P778, DOI 10.1161/01.CIR.92.4.778; Michalak M, 2009, TRENDS CELL BIOL, V19, P253, DOI 10.1016/j.tcb.2009.03.006; Michalak M, 2009, BIOCHEM J, V417, P651, DOI 10.1042/BJ20081847; MILNER RE, 1991, J BIOL CHEM, V266, P7155; Minamino T, 2010, CIRC RES, V107, P1071, DOI 10.1161/CIRCRESAHA.110.227819; Miquerol L, 2003, Novartis Found Symp, V250, P80; Miquerol L., 2003, NOVART FDN SYMP, V250, P98; Miquerol L., 2003, NOVART FDN SYMP, V250, P276; Nakamura K, 2001, J CELL BIOL, V154, P961, DOI 10.1083/jcb.200102073; Nakamura K, 2001, J CLIN INVEST, V107, P1245, DOI 10.1172/JCI12412; Nickson P, 2007, CARDIOVASC RES, V73, P48, DOI 10.1016/j.cardiores.2006.10.001; Okada K, 2004, CIRCULATION, V110, P705, DOI 10.1161/01.CIR.0000137836.95625.D4; PATTON WF, 1995, J BIOL CHEM, V270, P21404, DOI 10.1074/jbc.270.36.21404; Rauch F, 2000, EXP CELL RES, V256, P105, DOI 10.1006/excr.2000.4818; Rodriguez-Sinovas A, 2007, PROG BIOPHYS MOL BIO, V94, P219, DOI 10.1016/j.pbiomolbio.2007.03.003; Sato Y, 1998, J BIOL CHEM, V273, P28470, DOI 10.1074/jbc.273.43.28470; Solan JL, 2009, BIOCHEM J, V419, P261, DOI 10.1042/BJ20082319; Srisakuldee W, 2009, CARDIOVASC RES, V83, P672, DOI 10.1093/cvr/cvp142; Terentyev D, 2003, P NATL ACAD SCI USA, V100, P11759, DOI 10.1073/pnas.1932318100; Terentyev D, 2008, BIOPHYS J, V95, P2037, DOI 10.1529/biophysj.107.128249; Terentyev D, 2007, J PHYSIOL-LONDON, V583, P71, DOI 10.1113/jphysiol.2007.136879; Tsutsui H, 1997, AM J PHYSIOL-HEART C, V272, pH168, DOI 10.1152/ajpheart.1997.272.1.H168; van Veen TAB, 2006, ADV CARDIOL, V42, P18, DOI 10.1159/000092560; Wanderling S, 2007, MOL BIOL CELL, V18, P3764, DOI 10.1091/mbc.E07-03-0275; Xu J, 2006, J BIOL CHEM, V281, P9152, DOI 10.1074/jbc.M510217200	50	23	24	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e56387	10.1371/journal.pone.0056387	http://dx.doi.org/10.1371/journal.pone.0056387			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437120	Green Submitted, Green Published, gold			2022-12-25	WOS:000315184200064
J	Shah, NK; Tyagi, P; Sharma, SK				Shah, Naman K.; Tyagi, Prajesh; Sharma, Surya K.			The Impact of Artemisinin Combination Therapy and Long-Lasting Insecticidal Nets on Forest Malaria Incidence in Tribal Villages of India, 2006-2011	PLOS ONE			English	Article							VECTORS ANOPHELES-CULICIFACIES; PLASMODIUM-FALCIPARUM; FIELD-EVALUATION; ORISSA; EPIDEMIOLOGY; TRANSMISSION; FLUVIATILIS; RESISTANCE; AREA; IMMUNITY	Introduction: New tools for malaria control, artemisinin combination therapy (ACT) and long-lasting insecticidal nets (LLINs) were recently introduced across India. We estimated the impact of universal coverage of ACT and ACT plus LLINs in a setting of hyperendemic, forest malaria transmission. Methods: We reviewed data collected through active and passive case detection in a vaccine trial cohort of 2,204 tribal people residing in Sundargarh district, Odisha between 2006 and 2011. We compared measures of transmission at the village and individual level in 2006-2009 versus 2010-2011 after ACT (in all villages) and LLINs (in three villages) were implemented. Results: During 2006-2009 malaria incidence per village ranged from 156-512 per 1000 persons per year and slide prevalence ranged from 28-53%. Routine indoor residual spray did not prevent seasonal peaks of malaria. Post-intervention impact in 2010-2011 was dramatic with ranges of 14-71 per 1000 persons per year and 6-16% respectively. When adjusted for village, ACT alone decreased the incidence of malaria by 83% (IRR 0.17, 95%CI: 0.10, 0.27) and areas using ACT and LLINs decreased the incidence of malaria by 86% (IRR 0.14, 95% CI: 0.05, 0.38). After intervention, the age of malaria cases, their parasite density, and proportion with fever at the time of screening increased. Conclusions: ACT, and LLINs along with ACT, effectively reduced malaria incidence in a closely monitored population living in a forest ecotype. It is unclear whether LLINs were impactful when prompt and quality antimalarial treatment was available. In spite of universal coverage, substantial malaria burden remained.	[Shah, Naman K.; Tyagi, Prajesh; Sharma, Surya K.] Natl Inst Malaria Res, New Delhi, India	Indian Council of Medical Research (ICMR); ICMR - National Institute of Malaria Research (NIMR)	Sharma, SK (corresponding author), Natl Inst Malaria Res, New Delhi, India.	suryaksharma@gmail.com						Barnes KI, 2005, PLOS MED, V2, P1123, DOI 10.1371/journal.pmed.0020330; Bhattarai A, 2007, PLOS MED, V4, P1784, DOI 10.1371/journal.pmed.0040309; Doolan DL, 2009, CLIN MICROBIOL REV, V22, P13, DOI 10.1128/CMR.00025-08; Greenwood BM, 1997, ANN TROP MED PARASIT, V91, P763, DOI 10.1080/00034989760518; JASWANT SINGH, 1953, Indian Journal of Malariology, V7, P267; Kondrashin A. V., 1992, Indian Journal of Malariology, V29, P129; Nanda N, 2000, J AM MOSQUITO CONTR, V16, P199; Nosten F, 2000, LANCET, V356, P297, DOI 10.1016/S0140-6736(00)02505-8; Okell LC, 2008, PLOS MED, V5, P1617, DOI 10.1371/journal.pmed.0050226; Otten M, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-14; Revised National Drug Policy, 2010, J INDIAN MED ASSOC, V108, P844; Shah NK, 2011, LANCET INFECT DIS, V11, P57, DOI 10.1016/S1473-3099(10)70214-0; Sharma SK, 2009, J MED ENTOMOL, V46, P342, DOI 10.1603/033.046.0220; Sharma SK, 2004, AM J TROP MED HYG, V71, P457, DOI 10.4269/ajtmh.2004.71.457; Sharma SK, 2004, ANN TROP MED PARASIT, V98, P459, DOI 10.1179/000349804225003569; Sharma SK, 2006, T ROY SOC TROP MED H, V100, P917, DOI 10.1016/j.trstmh.2006.01.007; Sharma SK, 2012, INDIAN J MED RES, V135, P382; Sharma SK, 2010, ACTA TROP, V116, P24, DOI 10.1016/j.actatropica.2010.05.002; Sharma VP, 1999, PARASSITOLOGIA, VOL 41, NOS 1-3, SEPTEMBER 1999, P349; Singh N, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-93; Sonal G S, 2010, J Indian Med Assoc, V108, P840; Valecha N, 2009, ACTA TROP, V111, P21, DOI 10.1016/j.actatropica.2009.01.013; White NJ, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-297	23	13	13	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e56740	10.1371/journal.pone.0056740	http://dx.doi.org/10.1371/journal.pone.0056740			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437229	Green Submitted, Green Published, gold			2022-12-25	WOS:000315184200155
J	Tesli, M; Skatun, KC; Ousdal, OT; Brown, AA; Thoresen, C; Agartz, I; Melle, I; Djurovic, S; Jensen, J; Andreassen, OA				Tesli, Martin; Skatun, Kristina C.; Ousdal, Olga Therese; Brown, Andrew Anand; Thoresen, Christian; Agartz, Ingrid; Melle, Ingrid; Djurovic, Srdjan; Jensen, Jimmy; Andreassen, Ole A.			CACNA1C Risk Variant and Amygdala Activity in Bipolar Disorder, Schizophrenia and Healthy Controls	PLOS ONE			English	Article							WHOLE-GENOME ASSOCIATION; RELEVANCE DETECTION; GENE POLYMORPHISM; FMRI; SYSTEM; SCALE; TASK; SET	Objectives: Several genetic studies have implicated the CACNA1C SNP rs1006737 in bipolar disorder (BD) and schizophrenia (SZ) pathology. This polymorphism was recently found associated with increased amygdala activity in healthy controls and patients with BD. We performed a functional Magnetic Resonance Imaging (fMRI) study in a sample of BD and SZ cases and healthy controls to test for altered amygdala activity in carriers of the rs1006737 risk allele (AA/AG), and to investigate if there were differences across the diagnostic groups. Methods: Rs1006737 was genotyped in 250 individuals (N = 66 BD, 61 SZ and 123 healthy controls), all of Northern European origin, who underwent an fMRI negative faces matching task. Statistical tests were performed with a model correcting for sex, age, diagnostic category and medication status in the total sample, and then in each diagnostic group. Results: In the total sample, carriers of the risk allele had increased activation in the left amygdala. Group-wise analyses showed that this effect was significant in the BD group, but not in the other diagnostic groups. However, there was no significant interaction effect for the risk allele between BD and the other groups. Conclusions: These results indicate that CACNA1C SNP rs1006737 affects amygdala activity during emotional processing across all diagnostic groups. The current findings add to the growing body of knowledge of the pleiotropic effect of this polymorphism, and further support that ion channel dysregulation is involved in the underlying mechanisms of BD and SZ.	[Tesli, Martin; Ousdal, Olga Therese; Agartz, Ingrid; Melle, Ingrid; Djurovic, Srdjan; Jensen, Jimmy; Andreassen, Ole A.] Univ Oslo, Inst Clin Med, Oslo, Norway; [Tesli, Martin; Skatun, Kristina C.; Ousdal, Olga Therese; Brown, Andrew Anand; Thoresen, Christian; Melle, Ingrid; Djurovic, Srdjan; Andreassen, Ole A.] Oslo Univ Hosp, Div Mental Hlth & Addict, Oslo, Norway; [Djurovic, Srdjan] Oslo Univ Hosp, Dept Med Genet, Oslo, Norway; [Melle, Ingrid] Karolinska Hosp & Inst, Dept Clin Neurosci, Psychiat Sect, HUBIN Project, Stockholm, Sweden; [Agartz, Ingrid] Diakonhjemmet Hosp, Dept Psychiat Res, Oslo, Norway; [Jensen, Jimmy] Charite, Dept Psychiat & Psychotherapy, D-13353 Berlin, Germany; [Brown, Andrew Anand] Wellcome Trust Sanger Inst, Hinxton, England	University of Oslo; University of Oslo; University of Oslo; Karolinska Institutet; Karolinska University Hospital; Diakonhjemmet Hospital; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Wellcome Trust Sanger Institute	Tesli, M (corresponding author), Univ Oslo, Inst Clin Med, Oslo, Norway.	m.s.tesli@medisin.uio.no	Jensen, Jimmy/H-7517-2014; Melle, Ingrid S/B-4858-2011; Andreassen, Ole A./AAY-7531-2020	Jensen, Jimmy/0000-0001-6841-1808; Melle, Ingrid S/0000-0002-9783-548X; Andreassen, Ole A./0000-0002-4461-3568; Djurovic, Srdjan/0000-0002-8140-8061; Agartz, Ingrid/0000-0002-9839-5391; Brown, Andrew/0000-0002-8087-3033	University of Oslo; Research Council of Norway [167153/V50, 163070/V50]; SouthEast Norway Health Authority [2004123, 2008-080]	University of Oslo; Research Council of Norway(Research Council of Norway); SouthEast Norway Health Authority	The study was supported by grants to the TOP study group from the University of Oslo (http://www.uio.no/english/), the Research Council of Norway (http://www.forskningsradet.no/servlet/Satellite?c=Page&cid=1177315753906&p=1177315753906&pagename=ForskningsradetEngels%2FHovedsidemal) (#167153/V50, #163070/V50) and the SouthEast Norway Health Authority (http://www.helse-sorost.no/omoss/english/Sider/page.aspx) (#2004123, #2008-080). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Athanasiu L, 2010, J PSYCHIATR RES, V44, P748, DOI 10.1016/j.jpsychires.2010.02.002; Bigos KL, 2010, ARCH GEN PSYCHIAT, V67, P939, DOI 10.1001/archgenpsychiatry.2010.96; Blond BN, 2012, BIPOLAR DISORD, V14, P340, DOI 10.1111/j.1399-5618.2012.01015.x; Catterall WA, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a003947; Chen CH, 2011, BIPOLAR DISORD, V13, P1, DOI 10.1111/j.1399-5618.2011.00893.x; Craddock N, 2010, BRIT J PSYCHIAT, V196, P92, DOI 10.1192/bjp.bp.109.073429; Djurovic S, 2010, J AFFECT DISORDERS, V126, P312, DOI 10.1016/j.jad.2010.04.007; Ferreira MAR, 2008, NAT GENET, V40, P1056, DOI 10.1038/ng.209; FRISTON KJ, 1995, NEUROIMAGE, V2, P45, DOI 10.1006/nimg.1995.1007; Green EK, 2010, MOL PSYCHIATR, V15, P1016, DOI 10.1038/mp.2009.49; Hallahan B, 2011, BIOL PSYCHIAT, V69, P326, DOI 10.1016/j.biopsych.2010.08.029; Hamshere ML, 2011, BRIT J PSYCHIAT, V198, P284, DOI 10.1192/bjp.bp.110.087866; Hariri AR, 2002, NEUROIMAGE, V17, P317, DOI 10.1006/nimg.2002.1179; Jogia J, 2011, MOL PSYCHIATR, V16, P1070, DOI 10.1038/mp.2011.49; KAY SR, 1987, SCHIZOPHRENIA BULL, V13, P261, DOI 10.1093/schbul/13.2.261; Maldjian JA, 2003, NEUROIMAGE, V19, P1233, DOI 10.1016/S1053-8119(03)00169-1; Nyegaard M, 2010, MOL PSYCHIATR, V15, P119, DOI 10.1038/mp.2009.69; Ousdal OT, 2008, NEUROSCIENCE, V156, P450, DOI 10.1016/j.neuroscience.2008.07.066; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Ripke S, 2011, NAT GENET, V43, P969, DOI 10.1038/ng.940; Rush AJ, 1996, PSYCHOL MED, V26, P477, DOI 10.1017/S0033291700035558; Sander D, 2003, REV NEUROSCIENCE, V14, P303, DOI 10.1515/REVNEURO.2003.14.4.303; Simonsen C, 2011, SCHIZOPHRENIA BULL, V37, P73, DOI 10.1093/schbul/sbp034; Sklar P, 2008, MOL PSYCHIATR, V13, P558, DOI 10.1038/sj.mp.4002151; Sklar P, 2011, NAT GENET, V43, P977, DOI 10.1038/ng.943; SPITZER RL, 1992, ARCH GEN PSYCHIAT, V49, P624; Splawski I, 2004, CELL, V119, P19, DOI 10.1016/j.cell.2004.09.011; Tottenham N, 2009, PSYCHIAT RES, V168, P242, DOI 10.1016/j.psychres.2008.05.006; Welander-Vatn AS, 2009, BIPOLAR DISORD, V11, P270, DOI 10.1111/j.1399-5618.2009.00680.x; Wessa M, 2010, MOL PSYCHIATR, V15, P1126, DOI 10.1038/mp.2009.103; Wray NR, 2012, MOL PSYCHIATR, V17, P36, DOI 10.1038/mp.2010.109; YOUNG RC, 1978, BRIT J PSYCHIAT, V133, P429, DOI 10.1192/bjp.133.5.429; Zhang QM, 2012, NEUROPSYCHOPHARMACOL, V37, P677, DOI 10.1038/npp.2011.242; Zuccotti A, 2011, TRENDS PHARMACOL SCI, V32, P366, DOI 10.1016/j.tips.2011.02.012	34	56	57	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e56970	10.1371/journal.pone.0056970	http://dx.doi.org/10.1371/journal.pone.0056970			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437284	Green Submitted, Green Published, gold			2022-12-25	WOS:000315184200193
J	Vilstrup, JT; Seguin-Orlando, A; Stiller, M; Ginolhac, A; Raghavan, M; Nielsen, SCA; Weinstock, J; Froese, D; Vasiliev, SK; Ovodov, ND; Clary, J; Helgen, KM; Fleischer, RC; Cooper, A; Shapiro, B; Orlando, L				Vilstrup, Julia T.; Seguin-Orlando, Andaine; Stiller, Mathias; Ginolhac, Aurelien; Raghavan, Maanasa; Nielsen, Sandra C. A.; Weinstock, Jacobo; Froese, Duane; Vasiliev, Sergei K.; Ovodov, Nikolai D.; Clary, Joel; Helgen, Kristofer M.; Fleischer, Robert C.; Cooper, Alan; Shapiro, Beth; Orlando, Ludovic			Mitochondrial Phylogenomics of Modern and Ancient Equids	PLOS ONE			English	Article							PHYLOGENETIC ANALYSIS; EVOLUTIONARY HISTORY; FOSSIL HORSES; GENUS EQUUS; PERISSODACTYLA; SEQUENCE; MAMMALIA; ACCURATE; GENOME; QUAGGA	The genus Equus is richly represented in the fossil record, yet our understanding of taxonomic relationships within this genus remains limited. To estimate the phylogenetic relationships among modern horses, zebras, asses and donkeys, we generated the first data set including complete mitochondrial sequences from all seven extant lineages within the genus Equus. Bayesian and Maximum Likelihood phylogenetic inference confirms that zebras are monophyletic within the genus, and the Plains and Grevy's zebras form a well-supported monophyletic group. Using ancient DNA techniques, we further characterize the complete mitochondrial genomes of three extinct equid lineages (the New World stilt-legged horses, NWSLH; the subgenus Sussemionus; and the Quagga, Equus quagga quagga). Comparisons with extant taxa confirm the NWSLH as being part of the caballines, and the Quagga and Plains zebras as being conspecific. However, the evolutionary relationships among the non-caballine lineages, including the now-extinct subgenus Sussemionus, remain unresolved, most likely due to extremely rapid radiation within this group. The closest living outgroups (rhinos and tapirs) were found to be too phylogenetically distant to calibrate reliable molecular clocks. Additional mitochondrial genome sequence data, including radiocarbon dated ancient equids, will be required before revisiting the exact timing of the lineage radiation leading up to modern equids, which for now were found to have possibly shared a common ancestor as far as up to 4 Million years ago (Mya).	[Vilstrup, Julia T.; Seguin-Orlando, Andaine; Ginolhac, Aurelien; Raghavan, Maanasa; Nielsen, Sandra C. A.; Orlando, Ludovic] Univ Copenhagen, Nat Hist Museum Denmark, Ctr GeoGenet, Copenhagen, Denmark; [Stiller, Mathias; Shapiro, Beth] Univ Calif Santa Cruz, Dept Ecol & Evolutionary Biol, Santa Cruz, CA 95064 USA; [Weinstock, Jacobo] Univ Southampton, Fac Humanities, Southampton, Hants, England; [Froese, Duane] Univ Alberta, Dept Earth & Atmospher Sci, Edmonton, AB T6G 2M7, Canada; [Vasiliev, Sergei K.] Russian Acad Sci, Inst Archaeol & Ethnog, Novosibirsk, Russia; [Ovodov, Nikolai D.] Russian Acad Sci, Inst Archaeol & Ethnog, Lab Archaeol & Paleogeog Cent Siberia, Novosibirsk, Russia; [Clary, Joel] Musee Confluences, Ctr Conservat & Etud Collect, Lyon, France; [Helgen, Kristofer M.] Smithsonian Inst, Div Mammals, Natl Museum Nat Hist, Washington, DC 20560 USA; [Fleischer, Robert C.] Smithsonian Inst, Natl Zool Pk, Ctr Conservat & Evolutionary Genet, Washington, DC 20008 USA; [Cooper, Alan] Univ Adelaide, Sch Earth & Environm Sci, Australian Ctr Ancient DNA, Adelaide, SA 5005, Australia	University of Copenhagen; University of California System; University of California Santa Cruz; University of Southampton; University of Alberta; Russian Academy of Sciences; Institute of Archaeology & Ethnography, Siberian Branch of Russian Academy of Sciences; Russian Academy of Sciences; Institute of Archaeology & Ethnography, Siberian Branch of Russian Academy of Sciences; Smithsonian Institution; Smithsonian National Museum of Natural History; Smithsonian Institution; Smithsonian National Zoological Park & Conservation Biology Institute; University of Adelaide	Orlando, L (corresponding author), Univ Copenhagen, Nat Hist Museum Denmark, Ctr GeoGenet, Copenhagen, Denmark.	lorlando@snm.ku.dk	Helgen, Kristofer M./AAB-8348-2019; Vilstrup Mouatt, Julia T./N-4553-2017; Cooper, Alan/E-8171-2012; Orlando, Ludovic/A-8932-2013	Helgen, Kristofer M./0000-0002-8776-4040; Vilstrup Mouatt, Julia T./0000-0001-6534-8452; Cooper, Alan/0000-0002-7738-7851; Orlando, Ludovic/0000-0003-3936-1850; Shapiro, Beth/0000-0002-2733-7776; Raghavan, Maanasa/0000-0003-1997-0739	Danish National Research foundation; Marie Curie Intra European Fellowship [FP7-IEF-299176]; Marie-Curie Career Integration Grant [FP7-CIG-293845]; Australian Research Council; US National Science Foundation ARC [0909456]; Searle Scholars Program; David and Lucille Packard Foundation	Danish National Research foundation(Danmarks Grundforskningsfond); Marie Curie Intra European Fellowship(European Commission); Marie-Curie Career Integration Grant; Australian Research Council(Australian Research Council); US National Science Foundation ARC; Searle Scholars Program; David and Lucille Packard Foundation(The David & Lucile Packard Foundation)	Julia Vilstrup is supported by a PhD grant from The Danish National Research foundation; Aurelien Ginolhac is supported by a Marie Curie Intra European Fellowship (FP7-IEF-299176); this research was also funded by one Marie-Curie Career Integration Grant (FP7-CIG-293845); Alan Cooper is supported by the Australian Research Council; Mathias Stiller and Beth Shapiro are supported by the US National Science Foundation ARC 0909456, the Searle Scholars Program, and by the David and Lucille Packard Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achilli A, 2012, P NATL ACAD SCI USA, V109, P2449, DOI 10.1073/pnas.1111637109; Anisimova M, 2006, SYST BIOL, V55, P539, DOI 10.1080/10635150600755453; Bell CJ, 2004, LATE CRETACEOUS CENO; BENNETT DK, 1980, SYST ZOOL, V29, P272, DOI 10.2307/2412662; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; EISENMANN V, 1979, CR ACAD SCI D NAT, V288, P497; Eisenmann V., 1980, CHEVAUX EQUUS SENSU; Eisenmann V, 1979, THESIS U P M CURIE P, VVI, P1; Eisenmann V, 2011, GEODIVERSITAS, V33, P519, DOI 10.5252/g2011n3a5; Eisenmann V, 2010, CR BIOL, V333, P235, DOI 10.1016/j.crvi.2009.12.013; Ekblom R, 2011, HEREDITY, V107, P1, DOI 10.1038/hdy.2010.152; Geigl EM, 2012, ANN ANAT, V194, P88, DOI 10.1016/j.aanat.2011.06.002; GEORGE M, 1986, MOL BIOL EVOL, V3, P535; Gilbert MTP, 2007, SCIENCE, V317, P1927, DOI 10.1126/science.1146971; Ginolhac A, 2011, BIOINFORMATICS, V27, P2153, DOI 10.1093/bioinformatics/btr347; Goto H, 2011, GENOME BIOL EVOL, V3, P1096, DOI 10.1093/gbe/evr067; Groves C., 2011, UNGULATE TAXONOMY; GROVES COLIN P., 1967, Z SAUGETIERK, V32, P321; Guindon S, 2005, NUCLEIC ACIDS RES, V33, pW557, DOI 10.1093/nar/gki352; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hailer F, 2012, SCIENCE, V336, P344, DOI 10.1126/science.1216424; HIGUCHI R, 1984, NATURE, V312, P282, DOI 10.1038/312282a0; Ho SYW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001615; Ho SYW, 2011, MOL ECOL, V20, P3087, DOI 10.1111/j.1365-294X.2011.05178.x; Ho SYW, 2006, TRENDS GENET, V22, P79, DOI 10.1016/j.tig.2005.11.006; Ho SYW, 2005, MOL BIOL EVOL, V22, P1561, DOI 10.1093/molbev/msi145; HOELZER GA, 1994, TRENDS ECOL EVOL, V9, P104, DOI 10.1016/0169-5347(94)90207-0; Jiang QY, 2011, MOL BIOL REP, V38, P593, DOI 10.1007/s11033-010-0145-8; KAMINSKI M, 1979, COMP BIOCHEM PHYS B, V63, P175, DOI 10.1016/0305-0491(79)90025-7; Kampmann ML, 2011, J VIROL METHODS, V178, P243, DOI 10.1016/j.jviromet.2011.09.001; Kircher M, 2012, METHODS MOL BIOL, V840, P197, DOI 10.1007/978-1-61779-516-9_23; Kruger K, 2005, J ANIM BREED GENET, V122, P78, DOI 10.1111/j.1439-0388.2005.00505.x; Leonard JA, 2005, BIOL LETTERS, V1, P291, DOI 10.1098/rsbl.2005.0323; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Lindgreen Stinus, 2012, BMC Res Notes, V5, P337, DOI 10.1186/1756-0500-5-337; Lippold S, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-328; Lorenzen ED, 2008, MOL ECOL, V17, P2812, DOI 10.1111/j.1365-294X.2008.03781.x; LOWENSTEIN JM, 1985, EXPERIENTIA, V41, P1192, DOI 10.1007/BF01951724; Luo Y, 2011, MITOCHONDR DNA, V22, P6, DOI 10.3109/19401736.2011.588221; MacFadden BJ, 2005, SCIENCE, V307, P1728, DOI 10.1126/science.1105458; MACFADDEN BJ, 1986, PALEOBIOLOGY, V12, P355, DOI 10.1017/S0094837300003109; Maddison WP, 1997, SYST BIOL, V46, P523, DOI 10.2307/2413694; Maricic T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014004; McCue ME, 2012, PLOS GENETICS, V8; Meyer Matthias, 2010, Cold Spring Harb Protoc, V2010, DOI 10.1101/pdb.prot5448; Musilova P, 2009, CHROMOSOME RES, V17, P783, DOI 10.1007/s10577-009-9069-3; Oakenfull E. Ann, 2000, Conservation Genetics, V1, P341, DOI 10.1023/A:1011559200897; Oakenfull EA, 1998, J MOL EVOL, V47, P772, DOI 10.1007/PL00006436; Oakenfull EA, 1998, ANIM GENET, V29, P456, DOI 10.1046/j.1365-2052.1998.296380.x; Orlando L, 2003, J MOL EVOL, V57, pS29, DOI 10.1007/s00239-003-0005-4; Orlando L, 2006, MOL ECOL, V15, P2083, DOI 10.1111/j.1365-294X.2006.02922.x; Orlando L, 2009, P NATL ACAD SCI USA, V106, P21754, DOI 10.1073/pnas.0903672106; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Price Samantha A., 2009, Zoosystematics and Evolution, V85, P277, DOI 10.1002/zoos.200900005; Prothero DR, 1989, EVOLUTION PERISSODAC; Rambaut A, 2009, TRACER V1 5 MCMC TRA; Reich D, 2010, NATURE, V468, P1053, DOI 10.1038/nature09710; Rohland N, 2010, MOL ECOL RESOUR, V10, P677, DOI 10.1111/j.1755-0998.2009.02824.x; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Schubert M, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-178; Shimodaira H, 2001, BIOINFORMATICS, V17, P1246, DOI 10.1093/bioinformatics/17.12.1246; Silvestro D, 2012, ORG DIVERS EVOL, V12, P335, DOI 10.1007/s13127-011-0056-0; Soubrier J, 2012, MOL BIOL EVOLUTION; Steiner CC, 2012, MOL PHYLOGENETICS EV; Steiner CC, 2011, ZOOL J LINN SOC-LOND, V163, P1289, DOI 10.1111/j.1096-3642.2011.00752.x; Stothard P, 2000, BIOTECHNIQUES, V28, P1102, DOI 10.2144/00286ir01; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Vilstrup JT, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-65; Wallner B, 2003, ANIM GENET, V34, P453, DOI 10.1046/j.0268-9146.2003.01044.x; Walsh HE, 1999, EVOLUTION, V53, P932, DOI 10.1111/j.1558-5646.1999.tb05386.x; Warmuth V, 2012, P NATL ACAD SCI USA, V109, P8202, DOI 10.1073/pnas.1111122109; Weinstock J, 2005, PLOS BIOL, V3, P1373, DOI 10.1371/journal.pbio.0030241; Xu Shuqing, 2007, Journal of Genetics and Genomics, V34, P720, DOI 10.1016/S1673-8527(07)60081-2; XU XF, 1994, GENE, V148, P357, DOI 10.1016/0378-1119(94)90713-7; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088	76	92	95	1	93	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e55950	10.1371/journal.pone.0055950	http://dx.doi.org/10.1371/journal.pone.0055950			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437078	Green Published, Green Accepted, gold			2022-12-25	WOS:000315184200033
J	Zhang, P; Liu, P; Dou, HW; Chen, L; Chen, LX; Lin, L; Tan, P; Vajta, G; Gao, JF; Du, YT; Ma, RLZ				Zhang, Peng; Liu, Peng; Dou, Hongwei; Chen, Lei; Chen, Longxin; Lin, Lin; Tan, Pingping; Vajta, Gabor; Gao, Jianfeng; Du, Yutao; Ma, Runlin Z.			Handmade Cloned Transgenic Sheep Rich in Omega-3 Fatty Acids	PLOS ONE			English	Article							CELL NUCLEAR TRANSFER; HIGH-EFFICIENCY; CLONING; DESATURASE; FAT-1; GENE; IDENTIFICATION; EXPRESSION; GENERATION; EMBRYOS	Technology of somatic cell nuclear transfer (SCNT) has been adapted worldwide to generate transgenic animals, although the traditional procedure relies largely on instrumental micromanipulation. In this study, we used the modified handmade cloning (HMC) established in cattle and pig to produce transgenic sheep with elevated levels of omega-3 (n-3) fatty acids. Codon-optimized nematode mfat-1 was inserted into a eukaryotic expression vector and was transferred into the genome of primary ovine fibroblast cells from a male Chinese merino sheep. Reverse transcriptase PCR, gas chromatography, and chromosome analyses were performed to select nuclear donor cells capable of converting omega-6 (n-6) into n-3 fatty acids. Blastocysts developed after 7 days of in vitro culture were surgically transplanted into the uterus of female ovine recipients of a local sheep breed in Xinjiang. For the HMC, approximately 8.9% (n = 925) of reconstructed embryos developed to the blastocyst stage. Four recipients became pregnant after 53 blastocysts were transplanted into 29 naturally cycling females, and a total of 3 live transgenic lambs were produced. Detailed analyses on one of the transgenic lambs revealed a single integration of the modified nematode mfat-1 gene at sheep chromosome 5. The transgenic sheep expressed functional n-3 fatty acid desaturase, accompanied by more than 2-folds reduction of n-6/n-3 ratio in the muscle (p<0.01) and other major organs/tissues (p<0.05). To our knowledge, this is the first report of transgenic sheep produced by the HMC. Compared to the traditional SCNT method, HMC showed an equivalent efficiency but proved cheaper and easier in operation.	[Zhang, Peng; Chen, Lei; Chen, Longxin; Tan, Pingping; Ma, Runlin Z.] Chinese Acad Sci, State Key Lab Mol & Dev Biol, Inst Genet & Dev Biol, Beijing, Peoples R China; [Liu, Peng; Dou, Hongwei; Lin, Lin; Vajta, Gabor; Du, Yutao] BGI ARK Biotechnol Co Ltd, Shenzhen, Peoples R China; [Vajta, Gabor] Cent Queensland Univ, IRIS, Rockhampton, Qld 4702, Australia; [Gao, Jianfeng] Shihezi Univ, Sch Life Sci, Shihezi, Peoples R China; [Du, Yutao] BGI Shenzhen, Shenzhen, Peoples R China; [Ma, Runlin Z.] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS; Central Queensland University; Shihezi University; Beijing Genomics Institute (BGI); Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Du, YT (corresponding author), BGI ARK Biotechnol Co Ltd, Shenzhen, Peoples R China.	duyt@genomics.cn; rlma@genetics.ac.cn	Chen, Longxin/HGD-3900-2022; Vajta, Gabor/I-3672-2016; Zhang, Peng/T-8441-2019; Zhang, Peng/T-8334-2019	Zhang, Peng/0000-0002-3394-6922; Lin, Lin/0000-0002-7546-4948	China Ministry of Agriculture [2009ZX08008-005B]; Chinese Academy of Sciences [KSZD-EW-005]	China Ministry of Agriculture(Ministry of Agriculture & Rural Affairs); Chinese Academy of Sciences(Chinese Academy of Sciences)	This study was funded by the research grants from the China Ministry of Agriculture (2009ZX08008-005B) and the Chinese Academy of Sciences (KSZD-EW-005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhojwani S, 2005, J REPROD DEVELOP, V51, P465, DOI 10.1262/jrd.17025; Chen L, 2012, J GENET GENOMICS, V39, P181, DOI 10.1016/j.jgg.2012.03.002; Du Y, 2007, THERIOGENOLOGY, V68, P1104, DOI 10.1016/j.theriogenology.2007.07.021; Duan B, 2012, THERIOGENOLOGY, V78, P793, DOI 10.1016/j.theriogenology.2012.03.027; Feltrin C., 2006, Reproduction Fertility and Development, V18, P126, DOI 10.1071/RDv18n2Ab35; Hiendleder S, 2005, REPROD FERT DEVELOP, V17, P69, DOI 10.1071/RD04115; Holm P, 1999, THERIOGENOLOGY, V52, P683, DOI 10.1016/S0093-691X(99)00162-4; Kang Jing X., 2005, BMC Biochemistry, V6, DOI 10.1186/1471-2091-6-5; Kang JX, 2005, J MEMBRANE BIOL, V206, P165, DOI 10.1007/s00232-005-0790-3; Kang JX, 2004, NATURE, V427, P504, DOI 10.1038/427504a; Kang ZB, 2001, P NATL ACAD SCI USA, V98, P4050, DOI 10.1073/pnas.061040198; Kragh PM, 2009, TRANSGENIC RES, V18, P545, DOI 10.1007/s11248-009-9245-4; Kragh PM, 2004, REPROD FERT DEVELOP, V16, P315, DOI 10.1071/RD04007; Lai LX, 2006, NAT BIOTECHNOL, V24, P435, DOI 10.1038/nbt1198; Lee JH, 2010, CELL REPROGRAM, V12, P347, DOI 10.1089/cell.2009.0096; Luo YL, 2011, TRANSGENIC RES, V20, P975, DOI 10.1007/s11248-010-9472-8; Mahjoub MR, 2010, J CELL BIOL, V191, P331, DOI 10.1083/jcb.201003009; Pan DK, 2010, SCI CHINA LIFE SCI, V53, P517, DOI 10.1007/s11427-010-0080-x; Riediger ND, 2009, J AM DIET ASSOC, V109, P668, DOI 10.1016/j.jada.2008.12.022; Schnieke AE, 1997, SCIENCE, V278, P2130, DOI 10.1126/science.278.5346.2130; Simopoulos AP, 2000, POULTRY SCI, V79, P961, DOI 10.1093/ps/79.7.961; Spychalla JP, 1997, P NATL ACAD SCI USA, V94, P1142, DOI 10.1073/pnas.94.4.1142; Vajta G, 2004, THERIOGENOLOGY, V62, P1465, DOI 10.1016/j.theriogenology.2004.02.010; Vajta G, 2001, Cloning, V3, P89, DOI 10.1089/15204550152475590; Vajta G, 2003, BIOL REPROD, V68, P571, DOI 10.1095/biolreprod.102.008771; Vajta G, 2000, MOL REPROD DEV, V55, P256, DOI 10.1002/(SICI)1098-2795(200003)55:3&lt;256::AID-MRD3&gt;3.0.CO;2-7; Wilmut I, 1997, NATURE, V385, P810, DOI 10.1038/385810a0; Wu XJ, 2012, TRANSGENIC RES, V21, P1359, DOI 10.1007/s11248-012-9612-4; Xie ZG, 2007, NEURON, V56, P79, DOI 10.1016/j.neuron.2007.08.026; Zhang P, 2012, CELL REPROGRAM, V14, P258, DOI 10.1089/cell.2011.0073; Zhang Peng, 2007, Journal of Northwest A & F University - Natural Science Edition, V35, P24; Zhu GM, 2008, TRANSGENIC RES, V17, P717, DOI 10.1007/s11248-008-9171-x	32	27	37	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e55941	10.1371/journal.pone.0055941	http://dx.doi.org/10.1371/journal.pone.0055941			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437077	gold, Green Published, Green Submitted			2022-12-25	WOS:000315184200032
J	Kutar, BMRNS; Rajpara, N; Upadhyay, H; Ramamurthy, T; Bhardwaj, AK				Kutar, Braj M. R. N. S.; Rajpara, Neha; Upadhyay, Hardik; Ramamurthy, Thandavarayan; Bhardwaj, Ashima K.			Clinical Isolates of Vibrio cholerae O1 El Tor Ogawa of 2009 from Kolkata, India: Preponderance of SXT Element and Presence of Haitian ctxB Variant	PLOS ONE			English	Article							RESISTANCE; BIOTYPE; ORIGIN; FLUVIALIS; VIRULENCE; PLASMIDS; STRAINS; NON-O1; GENE	Background: Increase in the number of multidrug resistant pathogens and the accompanied rise in case fatality rates has hampered the treatment of many infectious diseases including cholera. Unraveling the mechanisms responsible for multidrug resistance in the clinical isolates of Vibrio cholerae would help in understanding evolution of these pathogenic bacteria and their epidemic potential. This study was carried out to identify genetic factors responsible for multiple drug resistance in clinical isolates of Vibrio cholerae O1, serotype Ogawa, biotype El Tor isolated from the patients admitted to the Infectious Diseases Hospital, Kolkata, India, in 2009. Methodology/Principal Findings: One hundred and nineteen clinical isolates of V. cholerae were analysed for their antibiotic resistance phenotypes. Antibiogram analysis revealed that majority of the isolates showed resistance to cotrimoxazole, nalidixic acid, polymixin B and streptomycin. In PCR, SXT integrase was detected in 117 isolates and its sequence showed 99% identity notably to ICEVchInd5 from Sevagram, India, ICEVchBan5 from Bangladesh and VC1786ICE sequence from Haiti outbreak among others. Antibiotic resistance traits corresponding to SXT element were transferred from the parent Vibrio isolate to the recipient E. coli XL-1 Blue cells during conjugation. Double-mismatch-amplification mutation assay (DMAMA) revealed the presence of Haitian type ctxB allele of genotype 7 in 55 isolates and the classical ctxB allele of genotype 1 in 59 isolates. Analysis of topoisomerase sequences revealed the presence of mutation Ser83 -> Ile in gyrA and Ser85 -> Leu in parC. This clearly showed the circulation of SXT-containing V. cholerae as causative agent for cholera in Kolkata. Conclusions: There was predominance of SXT element in these clinical isolates from Kolkata region which also accounted for their antibiotic resistance phenotype typical of this element. DMAMA PCR showed them to be a mixture of isolates with different ctxB alleles like classical, El Tor and Haitian variants.	[Kutar, Braj M. R. N. S.; Rajpara, Neha; Upadhyay, Hardik; Bhardwaj, Ashima K.] Indian Inst Adv Res, Koba Inst Area, Sch Biol Sci & Biotechnol, Dept Human Hlth & Dis, Gandhinagar, Gujarat, India; [Ramamurthy, Thandavarayan] Natl Inst Cholera & Enter Dis, Kolkata, India	Indian Council of Medical Research (ICMR); ICMR - National Institute of Cholera & Enteric Diseases (NICED)	Bhardwaj, AK (corresponding author), Indian Inst Adv Res, Koba Inst Area, Sch Biol Sci & Biotechnol, Dept Human Hlth & Dis, Gandhinagar, Gujarat, India.	ashima.bhardwaj@gmail.com			Department of Biotechnology (DBT), Ministry of Science and Technology, Government of India [BT/PR/11634/INF/22/104/2008]; Puri Foundation for Education in India; Council of Scientific and Industrial Research, India [09/988(0003)/2010-EMR-I]; Indian Council of Medical Research, New Delhi, India [AMR/49/11-ECDI]	Department of Biotechnology (DBT), Ministry of Science and Technology, Government of India(Department of Biotechnology (DBT) IndiaMinistry of Science and Technology, Government of India); Puri Foundation for Education in India; Council of Scientific and Industrial Research, India(Council of Scientific & Industrial Research (CSIR) - India); Indian Council of Medical Research, New Delhi, India(Indian Council of Medical Research (ICMR))	This work was supported by the grant from the Department of Biotechnology (DBT), Ministry of Science and Technology, Government of India [Grant number BT/PR/11634/INF/22/104/2008]. The authors thankfully acknowledge the partial funding received from The Puri Foundation for Education in India. BMRNSK is a recipient of Junior Research Fellowship [Fellowship number 09/988(0003)/2010-EMR-I] from the Council of Scientific and Industrial Research, India. NR is a recipient of Senior Research Fellowship [Grant number AMR/49/11-ECDI] from Indian Council of Medical Research, New Delhi, India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhardwaj Ashima K, 2012, Recent Pat Antiinfect Drug Discov, V7, P73; Burrus V, 2004, RES MICROBIOL, V155, P376, DOI 10.1016/j.resmic.2004.01.012; Ceccarelli D, 2011, LANCET INFECT DIS, V11, P262, DOI 10.1016/S1473-3099(11)70078-0; Ceccarelli D, 2011, INT J MED MICROBIOL, V301, P318, DOI 10.1016/j.ijmm.2010.11.005; Chin CS, 2011, NEW ENGL J MED, V364, P33, DOI 10.1056/NEJMoa1012928; Chowdhury G, 2011, INT J ANTIMICROB AG, V38, P169, DOI 10.1016/j.ijantimicag.2011.04.013; CLSI, 2010, PERF STAND ANT SUS S; Faruque SM, 1998, MICROBIOL MOL BIOL R, V62, P1301, DOI 10.1128/MMBR.62.4.1301-1314.1998; Frerichs RR, 2012, CLIN MICROBIOL INFEC, V18, pE158, DOI 10.1111/j.1469-0691.2012.03841.x; Ghosh A, 2011, INDIAN J MED RES, V133, P225; Goel AK, 2010, INFECT GENET EVOL, V10, P815, DOI 10.1016/j.meegid.2009.06.022; Hasan NA, 2012, P NATL ACAD SCI USA, V109, pE2010, DOI 10.1073/pnas.1207359109; Hendriksen RS, 2011, MBIO, V2, DOI [10.1128/mBio.00157-11, 10.1128/mBio.00305-11]; KAPER JB, 1995, CLIN MICROBIOL REV, V8, P48, DOI 10.1128/CMR.8.1.48; Kumar P, 2010, FEMS MICROBIOL LETT, V303, P132, DOI 10.1111/j.1574-6968.2009.01868.x; Mekalanos JJ, 2012, P NATL ACAD SCI USA, V109, pE3206, DOI 10.1073/pnas.1212443109; Mohanty P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035752; Mutreja A, 2011, NATURE, V477, P462, DOI 10.1038/nature10392; Naha A, 2012, J CLIN MICROBIOL, V50, P1733, DOI 10.1128/JCM.00387-12; Nair GB, 2002, J CLIN MICROBIOL, V40, P3296, DOI 10.1128/JCM.40.9.3296-3299.2002; Pande K, 2012, INDIAN J MED RES, V135, P346; Pun SB, 2011, MBIO, V2, DOI 10.1128/mBio.00219-11; Rajpara N, 2009, INT J ANTIMICROB AG, V34, P220, DOI 10.1016/j.ijantimicag.2009.03.020; Reimer AR, 2011, EMERG INFECT DIS, V17, P2113, DOI 10.3201/eid1711.110794; Singh R, 2012, J MED MICROBIOL, V61, P369, DOI 10.1099/jmm.0.037226-0; Sjolund-Karlsson M, 2011, EMERG INFECT DIS, V17, P2151, DOI 10.3201/eid1711.110720; Son MS, 2011, J CLIN MICROBIOL, V49, P3739, DOI 10.1128/JCM.01286-11; Thungapathra M, 2002, ANTIMICROB AGENTS CH, V46, P2948, DOI 10.1128/AAC.46.9.2948-2955.2002; Waldor MK, 1996, J BACTERIOL, V178, P4157, DOI 10.1128/jb.178.14.4157-4165.1996; Wozniak RAF, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000786	30	20	22	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2013	8	2							e56477	10.1371/journal.pone.0056477	http://dx.doi.org/10.1371/journal.pone.0056477			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093HR	23431378	Green Published, Green Submitted, gold			2022-12-25	WOS:000315182800020
J	Lavoue, S; Miya, M; Musikasinthorn, P; Chen, WJ; Nishida, M				Lavoue, Sebastien; Miya, Masaki; Musikasinthorn, Prachya; Chen, Wei-Jen; Nishida, Mutsumi			Mitogenomic Evidence for an Indo-West Pacific Origin of the Clupeoidei (Teleostei: Clupeiformes)	PLOS ONE			English	Article							SEA-SURFACE TEMPERATURES; DISPERSAL-VICARIANCE ANALYSIS; PHYLOGENETIC-RELATIONSHIPS; EVOLUTIONARY HISTORY; MOLECULAR PHYLOGENY; DIVERSITY PATTERNS; GEOGRAPHIC RANGE; FOSSIL RECORD; CLUPEID FISH; GENUS	The clupeoid fishes are distributed worldwide, with marine, freshwater and euryhaline species living in either tropical or temperate environments. Regional endemism is important at the species and genus levels, and the highest species diversity is found in the tropical marine Indo-West Pacific region. The clupeoid distribution follows two general pattern of species richness, the longitudinal and latitudinal gradients. To test historical hypotheses explaining the formation of these two gradients, we have examined the early biogeography of the Clupeoidei in reconstructing the evolution of their habitat preferences along with their ancestral range distributions on a time-calibrated mitogenomic phylogeny. The phylogenetic results support the distinction of nine main lineages within the Clupeoidei, five of them new. We infer several independent transitions from a marine to freshwater environment and from a tropical to temperate environment that occurred after the initial diversification period of the Clupeoidei. These results combined with our ancestral range reconstruction hypothesis suggest that the probable region of origin and diversification of the Clupeoidei during the Cretaceous period was the tropical marine precursor to the present Indo-West Pacific region. Thus, our study favors the hypotheses of "Region of origin" and "Tropical conservatism" to explain the origins of the longitudinal and latitudinal gradients of clupeoid species richness, respectively. Additional geological and paleontological evidence further define the tropical marine paleo-region of origin as the eastern Tethys Sea region. The Cretaceous fossil record of the Clupeoidei is partially incongruent with the results here as it contains taxa found outside this region. We discuss three possible causes of conflict between our biogeographical hypothesis and the distributions of the Cretaceous clupeoid fossils: regional extinction, incomplete taxonomic sampling and incorrect timescale estimation.	[Lavoue, Sebastien; Chen, Wei-Jen] Natl Taiwan Univ, Inst Oceanog, Taipei 10764, Taiwan; [Lavoue, Sebastien; Nishida, Mutsumi] Univ Tokyo, Atmosphere & Ocean Res Inst, Chiba, Japan; [Miya, Masaki] Nat Hist Museum & Inst, Chiba, Japan; [Musikasinthorn, Prachya] Kasetsart Univ, Fac Fisheries, Bangkok, Thailand	National Taiwan University; University of Tokyo; Kasetsart University	Lavoue, S (corresponding author), Natl Taiwan Univ, Inst Oceanog, Taipei 10764, Taiwan.	microceb@hotmail.com	Lavoue, Sebastien/H-7118-2012; CHEN, Wei-Jen/A-2605-2008; Miya, Masaki/O-2664-2019	Lavoue, Sebastien/0000-0003-4798-6666; CHEN, Wei-Jen/0000-0003-4751-7632; Miya, Masaki/0000-0002-9791-9886	Japan Society for the Promotion of Science [16570082, 15380131, 19207007, 23370041]; University of Tokyo; National Science Council of Taiwan [NSC100-2811-M-002-069, NSC101-2811-M-002-069-071, NSC 99-2611-M-002-001-MY2]; Systematics Research Fund grant	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); University of Tokyo; National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); Systematics Research Fund grant	This study was funded by Research Grants Nos 16570082, 15380131, 19207007 and 23370041 from the Japan Society for the Promotion of Science. SL was supported by postdoctoral fellowships of The University of Tokyo and the National Science Council of Taiwan (NSC100-2811-M-002-069 and NSC101-2811-M-002-069-071). Fieldwork in Thailand in 2011 was supported by a Systematics Research Fund grant awarded to SL. PM acknowledges Nagao Natural Environment Foundation (NEF) that permitted his fieldwork. WJC' research is supported by a Research Grant (NSC 99-2611-M-002-001-MY2) from the National Science Council of Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfaro ME, 2009, P NATL ACAD SCI USA, V106, P13410, DOI 10.1073/pnas.0811087106; Amaral CRL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037247; Anderson JD, 2007, FISH B-NOAA, V105, P368; Arratia Gloria, 2000, Mitteilungen aus dem Museum fuer Naturkunde in Berlin Geowissenschaftliche Reihe, V3, P137; Arratia Gloria, 1997, Palaeo Ichthyologica, V7, P5; Azuma Y, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-215; Bellwood David R., 2002, P5, DOI 10.1016/B978-012615185-5/50003-7; Benton Michael J., 2009, P35; Blaber SJM, 1999, ESTUAR COAST SHELF S, V49, P689, DOI 10.1006/ecss.1999.0545; Bloom DD, 2012, J EVOLUTION BIOL, V25, P701, DOI 10.1111/j.1420-9101.2012.02464.x; Borsa P, 2004, CR BIOL, V327, P1113, DOI 10.1016/j.crvi.2004.09.003; Bowen BR, 2008, J FISH BIOL, V72, P1188, DOI 10.1111/j.1095-8649.2007.01785.x; Bowen BW, 1997, EVOLUTION, V51, P1601, DOI 10.1111/j.1558-5646.1997.tb01483.x; Briggs JC, 1999, EVOLUTION, V53, P326, DOI 10.1111/j.1558-5646.1999.tb03769.x; Briggs JC, 2007, DIVERS DISTRIB, V13, P544, DOI 10.1111/j.1472-4642.2007.00362.x; Briggs JC, 2012, J BIOGEOGR, V39, P12, DOI 10.1111/j.1365-2699.2011.02613.x; Britz Ralf, 1999, Ichthyological Exploration of Freshwaters, V10, P337; Carpenter KE, 2011, J MAR BIOL, V2011, pe1; CASTRO-AGUIRRE J L, 1990, Anales de la Escuela Nacional de Ciencias Biologicas Mexico, V33, P135; Castro-Aguirre Jose Luis, 2002, Bulletin Southern California Academy of Sciences, V101, P1; Crame J. Alistair, 2001, Diversity and Distributions, V7, P175, DOI 10.1111/j.1472-4642.2001.00106.x; Crisp MD, 2011, TRENDS ECOL EVOL, V26, P66, DOI 10.1016/j.tree.2010.11.005; Cunningham CW, 1998, TRENDS ECOL EVOL, V13, P361, DOI 10.1016/S0169-5347(98)01382-2; De Figueiredo FJ, 2009, J VERTEBR PALEONTOL, V29, P993, DOI 10.1671/039.029.0402; De Figueiredo FJ, 2009, ZOOTAXA, P21, DOI 10.11646/zootaxa.2164.1.2; Di Dario F, 2002, COPEIA, P496; Di Dario F, 2009, ZOOL J LINN SOC-LOND, V156, P363, DOI 10.1111/j.1096-3642.2008.00472.x; Dibattista JD, 2012, CYBIUM, V36, P447; Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075; Eschmeyer W. N., 2012, CATALOG FISHES ELECT; Eschmeyer William N., 2011, Zootaxa, V3148, P26; Fara E, 2010, SER TELEOST FISH BIO, P173, DOI 10.1201/b10194-7; Faria R, 2006, MOL PHYLOGENET EVOL, V40, P298, DOI 10.1016/j.ympev.2006.02.008; Filleul A, 2004, AM MUS NOVIT, P1, DOI 10.1206/0003-0082(2004)455<0001:ROSDOC>2.0.CO;2; Forey PL, 2003, J SYST PALAEONTOL, V1, P227, DOI 10.1017/S147720190300107X; Frey MA, 2008, MOL PHYLOGENET EVOL, V48, P1067, DOI 10.1016/j.ympev.2008.05.009; Garcia G, 2011, INT J FISH AQUA, V2, P41; Garcia G, 2008, MAR BIOL, V155, P325, DOI 10.1007/s00227-008-1030-z; Giersch S, 2011, SWISS J GEOSCI, V104, pS73, DOI 10.1007/s00015-011-0079-8; GOURENE G, 1988, Cybium, V12, P357; Gourene Germain, 1994, Journal of African Zoology, V108, P77; Grande L., 1982, American Museum Novitates, P1; GRANDE L, 1985, American Museum Novitates, P1; GRANDE L, 1985, B AM MUS NAT HIST, V181, P235; Grant WS, 2010, J BIOGEOGR, V37, P1352, DOI 10.1111/j.1365-2699.2010.02291.x; Grant WS, 2005, J FISH BIOL, V67, P1242, DOI 10.1111/j.1095-8649.2005.00820.x; Guiraud R, 2001, PALAEOTECTONIC ATLAS; HALLAM A, 1985, J GEOL SOC LONDON, V142, P433, DOI 10.1144/gsjgs.142.3.0433; HAQ BU, 1987, SCIENCE, V235, P1156, DOI 10.1126/science.235.4793.1156; Heath TA, 2008, J SYST EVOL, V46, P239, DOI 10.3724/SP.J.1002.2008.08016; Hillebrand H, 2004, MAR ECOL PROG SER, V273, P251, DOI 10.3354/meps273251; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Inoue JG, 2009, MOL PHYLOGENET EVOL, V51, P486, DOI 10.1016/j.ympev.2009.01.020; Ishiguro NB, 2005, J FISH BIOL, V67, P561, DOI 10.1111/j.0022-1112.2005.00746.x; Jerome M, 2003, J AGR FOOD CHEM, V51, P7326, DOI 10.1021/jf034652t; JERZMANSKA A, 1979, Acta Palaeontologica Polonica, V24, P65; JOKIEL P, 1992, J BIOGEOGR, V19, P449, DOI 10.2307/2845572; Jolly MT, 2012, MAR BIOL, V159, P675, DOI 10.1007/s00227-011-1845-x; Jurkovsek B, 2007, NEUES JAHRB GEOL P-A, V245, P83, DOI 10.1127/0077-7749/2007/0245-0083; Kimura S, 2009, ICHTHYOL RES, V56, P292, DOI 10.1007/s10228-009-0103-4; Lavoue S, 2005, MOL PHYLOGENET EVOL, V37, P165, DOI 10.1016/j.ympev.2005.03.024; Lavoue S, 2008, ICHTHYOL RES, V55, P328, DOI 10.1007/s10228-008-0044-3; Lavoue S, 2007, MOL PHYLOGENET EVOL, V43, P1096, DOI 10.1016/j.ympev.2006.09.018; Lavoue S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036287; Lavoue S, 2010, MOL PHYLOGENET EVOL, V56, P480, DOI 10.1016/j.ympev.2009.11.022; Li C, 2007, GENOME SCALE APPROAC; Li CH, 2007, MOL PHYLOGENET EVOL, V44, P386, DOI 10.1016/j.ympev.2006.10.030; Lieberman BS, 2003, ANNU REV ECOL EVOL S, V34, P51, DOI 10.1146/annurev.ecolsys.34.121101.153549; Lieberman BS, 2002, PALAEOGEOGR PALAEOCL, V178, P39, DOI 10.1016/S0031-0182(01)00367-4; Loeb MV, 2012, NEOTROP ICHTHYOL, V10, P13, DOI 10.1590/S1679-62252012000100002; Macpherson E, 2002, P ROY SOC B-BIOL SCI, V269, P1715, DOI 10.1098/rspb.2002.2091; Maddison, 2019, MESQUITE MODULAR SYS; Menezes NA, 2000, P BIOL SOC WASH, V113, P238; Milton DA, 2009, ECOLOGICAL CONNECTIVITY AMONG TROPICAL COASTAL ECOSYSTEMS, P325, DOI 10.1007/978-90-481-2406-0_9; Mittelbach GG, 2007, ECOL LETT, V10, P315, DOI 10.1111/j.1461-0248.2007.01020.x; Miyashita T, 2010, ICHTHYOL RES, V57, P121, DOI 10.1007/s10228-009-0132-z; Murray AM, 2005, J VERTEBR PALEONTOL, V25, P300, DOI 10.1671/0272-4634(2005)025[0300:ANCFCF]2.0.CO;2; Nakatani M, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-177; NELSON G, 1973, Bulletin of the American Museum of Natural History, V150, P131; NELSON G, 1984, COPEIA, P422, DOI 10.2307/1445200; NELSON G, 1995, JPN J ICHTHYOL, V41, P379; Nelson G. J., 1970, Am. Mus. Novit., VNo. 2410, P1; NELSON G J, 1970, Japanese Journal of Ichthyology, V17, P131; NELSON GJ, 1967, COPEIA, P389; Neraudeau D, 2000, PALAEOGEOGR PALAEOCL, V156, P71, DOI 10.1016/S0031-0182(99)00132-7; Norris RD, 1998, GEOLOGY, V26, P823, DOI 10.1130/0091-7613(1998)026<0823:LLSSTF>2.3.CO;2; Nylander JAA, 2008, SYSTEMATIC BIOL, V57, P257, DOI 10.1080/10635150802044003; Palkovacs EP, 2008, MOL ECOL, V17, P582, DOI 10.1111/j.1365-294X.2007.03593.x; Pearson PN, 2001, NATURE, V413, P481, DOI 10.1038/35097000; Peng Y., 1988, Journal of Fisheries of China, V12, P355; RANDALL JE, 1994, RAFFLES B ZOOL, V42, P893; Randall JE, 2012, PAC SCI, V66, P97, DOI 10.2984/66.1.6; Ree RH, 2005, EVOLUTION, V59, P2299; Ree RH, 2008, SYSTEMATIC BIOL, V57, P4, DOI 10.1080/10635150701883881; Ree RH, 2009, J BIOGEOGR, V36, P1211, DOI 10.1111/j.1365-2699.2008.02068.x; Renema W, 2008, SCIENCE, V321, P654, DOI 10.1126/science.1155674; Roberts T.R., 1972, Breviora, VNo. 382, P1; ROBERTS T R, 1981, Proceedings of the California Academy of Sciences, V42, P295; Roberts TR, 2008, RAFFLES B ZOOL, V56, P125; Rocha LA, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-157; Ronquist F, 1997, SYST BIOL, V46, P195, DOI 10.2307/2413643; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Ronquist F, 2011, ANNU REV ECOL EVOL S, V42, P441, DOI 10.1146/annurev-ecolsys-102209-144710; ROSEN BR, 1988, HELGOLANDER MEERESUN, V42, P269, DOI 10.1007/BF02366046; Saitoh K, 2011, ZOOL J LINN SOC-LOND, V161, P633, DOI 10.1111/j.1096-3642.2010.00651.x; Salisbury BA, 2001, SYST BIOL, V50, P557, DOI 10.1080/106351501750435103; Samonte IE, 2000, J HERED, V91, P247, DOI 10.1093/jhered/91.3.247; Santini F, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-194; Schouten S, 2003, GEOLOGY, V31, P1069, DOI 10.1130/G19876.1; Setiamarga DHE, 2009, BIOL LETTERS, V5, P812, DOI 10.1098/rsbl.2009.0419; Siebert Darrell J., 1997, Bulletin of the Natural History Museum Zoology Series, V63, P13; Silvestro D, 2012, ORG DIVERS EVOL, V12, P335, DOI 10.1007/s13127-011-0056-0; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Stephens RR, 1996, COPEIA, P475; Stiassny MLJ, 2002, COPEIA, P67, DOI 10.1643/0045-8511(2002)002[0067:ROSBCP]2.0.CO;2; Streelman JT, 2002, EVOLUTION, V56, P961; Takashima R., 2006, OCEANOGRAPHY, V19, P82, DOI DOI 10.5670/OCEANOG.2006.07; Tarduno JA, 1998, SCIENCE, V282, P2241, DOI 10.1126/science.282.5397.2241; TAVERNE L, 1977, Revue de Zoologie Africaine, V91, P330; Taverne L, 1997, BELG J ZOOL, V127, P75; Taverne L, 1997, OSTEOLOGIE POSITION, V1997, P203; Taverne Louis, 2011, Bollettino del Museo Civico di Storia Naturale di Verona Geologia Paleontologia Preistoria, V35, P3; Taverne Louis, 2007, Bollettino del Museo Civico di Storia Naturale di Verona Geologia Paleontologia Preistoria, V31, P37; Taverne Louis, 2007, Bollettino del Museo Civico di Storia Naturale di Verona Geologia Paleontologia Preistoria, V31, P21; Taverne Louis, 2004, Bollettino del Museo Civico di Storia Naturale di Verona Geologia Paleontologia Preistoria, V28, P17; Vermeij GJ, 2000, BIOL J LINN SOC, V70, P541; Wallace CC, 2006, P ROY SOC B-BIOL SCI, V273, P975, DOI 10.1098/rspb.2005.3307; Westneat MW, 2005, MOL PHYLOGENET EVOL, V36, P370, DOI 10.1016/j.ympev.2005.02.001; Whitehead P.J.P., 1988, FAO FISH SYNOP, V125, P305; WHITEHEAD PJ, 1968, J NAT HIST, V2, P477, DOI 10.1080/00222936800770971; WHITEHEAD PJP, 1985, CAN J FISH AQUAT SCI, V42, P3; WHITEHEAD PJP, 1985, FAO FISHERIES SYNOPS, V7, P1; Wiens JJ, 2004, TRENDS ECOL EVOL, V19, P639, DOI 10.1016/j.tree.2004.09.011; Wilson AB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001979; WILSON MVH, 1992, J PALEONTOL, V66, P839, DOI 10.1017/S0022336000020849; WONGRATANA T, 1987, P BIOL SOC WASH, V100, P104; Zachos J, 2001, SCIENCE, V292, P686, DOI 10.1126/science.1059412	137	58	59	1	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2013	8	2							e56485	10.1371/journal.pone.0056485	http://dx.doi.org/10.1371/journal.pone.0056485			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093HR	23431379	Green Submitted, gold, Green Published			2022-12-25	WOS:000315182800021
J	Pais, SV; Milho, C; Almeida, F; Mota, LJ				Pais, Sara V.; Milho, Catarina; Almeida, Filipe; Mota, Luis Jaime			Identification of Novel Type III Secretion Chaperone-Substrate Complexes of Chlamydia trachomatis	PLOS ONE			English	Article							OBLIGATE INTRACELLULAR PATHOGEN; YERSINIA-ENTEROCOLITICA; TRANSLOCATED PROTEIN; EFFECTOR PROTEIN; GENOME SEQUENCE; VIRULENCE; SYSTEM; FAMILY; EXPORT; CELLS	Chlamydia trachomatis is an obligate intracellular bacterial pathogen of humans that uses a type III secretion (T3S) system to manipulate host cells through the delivery of effector proteins into their cytosol and membranes. The function of T3S systems depends on small bacterial cytosolic chaperone-like proteins, which bind T3S substrates and ensure their appropriate secretion. To find novel T3S chaperone-substrate complexes of C. trachomatis we first searched its genome for genes encoding proteins with features of T3S chaperones. We then systematically tested for interactions between candidate chaperones and chlamydial T3S substrates by bacterial two-hybrid. This revealed interactions between Slc1 (a known T3S chaperone) or CT584 and several T3S substrates. Co-immunoprecipation after protein expression in Yersinia enterocolitica and protein overlay binding assays indicated that Slc1 interacted with the N-terminal region of the known T3S substrates Tarp (a previously described substrate of Slc1), CT694, and CT695, and that CT584 interacted with a central region of CT082, which we identified as a C. trachomatis T3S substrate using Y. enterocolitica as a heterologous system. Further T3S assays in Yersinia indicated that Slc1 or CT584 increased the amount of secreted Tarp, CT694, and CT695, or CT082, respectively. Expression of CT584 increased the intra-bacterial stability of CT082, while Slc1 did not affect the stability of its substrates. Overall, this indicated that in C. trachomatis Slc1 is a chaperone of multiple T3S substrates and that CT584 is a chaperone of the newly identified T3S substrate CT082.	[Pais, Sara V.; Milho, Catarina; Almeida, Filipe; Mota, Luis Jaime] Univ Nova Lisboa, Inst Tecnol Quim & Biol, Infect Biol Lab, Oeiras, Portugal; [Mota, Luis Jaime] Univ Nova Lisboa, Fac Ciencias & Tecnol, Dept Ciencias Vida, Caparica, Portugal	Universidade Nova de Lisboa; Universidade Nova de Lisboa	Mota, LJ (corresponding author), Univ Nova Lisboa, Inst Tecnol Quim & Biol, Infect Biol Lab, Oeiras, Portugal.	jmota@itqb.unl.pt	Almeida, Filipe/O-2871-2015; Mota, Luis/B-9497-2008; Milho, Catarina/AAD-7116-2021; Pais, Sara/O-3327-2015; da Silva Almeida, Filipe Manuel Baeta/AAP-5315-2021; Milho, Catarina/Q-4744-2018	Almeida, Filipe/0000-0001-5114-7721; Mota, Luis/0000-0002-5592-8397; Pais, Sara/0000-0003-2392-0451; da Silva Almeida, Filipe Manuel Baeta/0000-0001-5114-7721; Milho, Catarina/0000-0002-9074-8498; Milho, Catarina/0000-0002-4176-765X	Fundacao para a Ciencia e a Tecnologia (FCT) [PEst-OE/EQB/LA0004/2011, PTDC/SAU-MII/099623/2008, ERA-PTG/0005/2010]; European Commission [PERG03-GA-2008-230954]; European Society for Clinical Microbiology and Infectious Diseases (ESCMID); FCT [SFRH/BD/73545/2010]	Fundacao para a Ciencia e a Tecnologia (FCT)(Portuguese Foundation for Science and TechnologyEuropean Commission); European Commission(European CommissionEuropean Commission Joint Research Centre); European Society for Clinical Microbiology and Infectious Diseases (ESCMID); FCT(Portuguese Foundation for Science and TechnologyEuropean Commission)	This work was supported by Fundacao para a Ciencia e a Tecnologia (FCT) through grants PEst-OE/EQB/LA0004/2011, PTDC/SAU-MII/099623/2008, and ERA-PTG/0005/2010 (in the frame of ERA-NET PathoGenoMics), by the European Commission through a Marie Curie European Re-integration Grant (PERG03-GA-2008-230954), and by a European Society for Clinical Microbiology and Infectious Diseases (ESCMID) research grant. FA holds PhD fellowship SFRH/BD/73545/2010 from FCT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AbdelRahman YM, 2005, FEMS MICROBIOL REV, V29, P949, DOI 10.1016/j.femsre.2005.03.002; Almeida F, 2012, J BACTERIOL, V194, P6574, DOI 10.1128/JB.01428-12; Arnold R, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000376; BEbEar C, 2009, CLIN MICROBIOL INFEC, V15, P4, DOI 10.1111/j.1469-0691.2008.02647.x; Bennett JCQ, 2000, TRENDS MICROBIOL, V8, P202, DOI 10.1016/S0966-842X(00)01751-0; Betts HJ, 2008, J BACTERIOL, V190, P1680, DOI 10.1128/JB.01671-07; Betts HJ, 2009, CURR OPIN MICROBIOL, V12, P81, DOI 10.1016/j.mib.2008.11.009; Binet R, 2009, P NATL ACAD SCI USA, V106, P292, DOI 10.1073/pnas.0806768106; Birtalan SC, 2002, MOL CELL, V9, P971, DOI 10.1016/S1097-2765(02)00529-4; Boyd AP, 2000, J BACTERIOL, V182, P4811, DOI 10.1128/JB.182.17.4811-4821.2000; Brinkworth AJ, 2011, MOL MICROBIOL, V82, P131, DOI 10.1111/j.1365-2958.2011.07802.x; Bullock HD, 2012, J BIOL CHEM, V287, P28078, DOI 10.1074/jbc.M112.386904; Chellas-Gery B, 2007, CELL MICROBIOL, V9, P2417, DOI 10.1111/j.1462-5822.2007.00970.x; Clifton DR, 2004, P NATL ACAD SCI USA, V101, P10166, DOI 10.1073/pnas.0402829101; Cornelis GR, 2006, NAT REV MICROBIOL, V4, P811, DOI 10.1038/nrmicro1526; Costa SCP, 2012, MBIO, V3, DOI 10.1128/mBio.00243-11; Dehoux P, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-109; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; Feldman MF, 2003, FEMS MICROBIOL LETT, V219, P151, DOI 10.1016/S0378-1097(03)00042-9; Fields KA, 2005, J BACTERIOL, V187, P6466, DOI 10.1128/JB.187.18.6466-6478.2005; Fields KA, 2000, MOL MICROBIOL, V38, P1048, DOI 10.1046/j.1365-2958.2000.02212.x; Fling SP, 2001, P NATL ACAD SCI USA, V98, P1160, DOI 10.1073/pnas.98.3.1160; Ho TD, 2005, INFECT IMMUN, V73, P905, DOI 10.1128/IAI.73.2.905-911.2005; Hobolt-Pedersen AS, 2009, FEMS IMMUNOL MED MIC, V57, P46, DOI 10.1111/j.1574-695X.2009.00581.x; Hower S, 2009, MOL MICROBIOL, V72, P1423, DOI 10.1111/j.1365-2958.2009.06732.x; Iriarte M, 1998, MOL MICROBIOL, V29, P915, DOI 10.1046/j.1365-2958.1998.00992.x; Jewett TJ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000997; Journet L, 2003, SCIENCE, V302, P1757, DOI 10.1126/science.1091422; Kari L, 2011, P NATL ACAD SCI USA, V108, P7189, DOI 10.1073/pnas.1102229108; Karimova G, 1998, P NATL ACAD SCI USA, V95, P5752, DOI 10.1073/pnas.95.10.5752; KOVACH ME, 1995, GENE, V166, P175, DOI 10.1016/0378-1119(95)00584-1; Kurushima J, 2012, FEMS MICROBIOL LETT, V331, P144, DOI 10.1111/j.1574-6968.2012.02561.x; Lane BJ, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000014; Lara-Tejero M, 2011, SCIENCE, V331, P1188, DOI 10.1126/science.1201476; Lee SH, 2004, MOL MICROBIOL, V51, P483, DOI 10.1046/j.1365-2958.2003.03840.x; Lee VT, 2000, J BIOL CHEM, V275, P36869, DOI 10.1074/jbc.M002467200; Lee VT, 2001, J BACTERIOL, V183, P4970, DOI 10.1128/JB.183.17.4970-4978.2001; Letzelter M, 2006, EMBO J, V25, P3223, DOI 10.1038/sj.emboj.7601202; Li ZY, 2008, INFECT IMMUN, V76, P2746, DOI 10.1128/IAI.00010-08; Lilic M, 2006, MOL CELL, V21, P653, DOI 10.1016/j.molcel.2006.01.026; Lower M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005917; Markham AP, 2009, BIOCHEMISTRY-US, V48, P10353, DOI 10.1021/bi901200y; Mital J, 2010, CELL MICROBIOL, V12, P1235, DOI 10.1111/j.1462-5822.2010.01465.x; Munera D, 2010, J BACTERIOL, V192, P3534, DOI 10.1128/JB.00046-10; Muschiol S, 2011, INFECT IMMUN, V79, P571, DOI 10.1128/IAI.00825-10; Neyt C, 1999, MOL MICROBIOL, V31, P143, DOI 10.1046/j.1365-2958.1999.01154.x; Nguyen BD, 2012, P NATL ACAD SCI USA, V109, P1263, DOI 10.1073/pnas.1117884109; Olsson J, 2004, J BACTERIOL, V186, P4110, DOI 10.1128/JB.186.13.4110-4123.2004; Pallen MJ, 2003, FEMS MICROBIOL LETT, V223, P53, DOI 10.1016/S0378-1097(03)00344-6; Parsot C, 2003, CURR OPIN MICROBIOL, V6, P7, DOI 10.1016/S1369-5274(02)00002-4; Peters J, 2007, TRENDS MICROBIOL, V15, P241, DOI 10.1016/j.tim.2007.04.005; Pettersson J, 1996, SCIENCE, V273, P1231, DOI 10.1126/science.273.5279.1231; Rost B, 2004, NUCLEIC ACIDS RES, V32, pW321, DOI 10.1093/nar/gkh377; Saka HA, 2011, MOL MICROBIOL, V82, P1185, DOI 10.1111/j.1365-2958.2011.07877.x; Sambrook J, 2001, MOL CLONING LAB MANU; Samudrala R, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000375; Scidmore Marci A, 2005, Curr Protoc Microbiol, VChapter 11, DOI 10.1002/9780471729259.mc11a01s00; Silva-Herzog E, 2011, J BACTERIOL, V193, P3490, DOI 10.1128/JB.00203-11; Sorg I, 2007, EMBO J, V26, P3015, DOI 10.1038/sj.emboj.7601731; Spaeth KE, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000579; Stainier I, 2000, MOL MICROBIOL, V37, P1005, DOI 10.1046/j.1365-2958.2000.02026.x; Stainier I, 1997, MOL MICROBIOL, V26, P833, DOI 10.1046/j.1365-2958.1997.6281995.x; Stebbins CE, 2001, NATURE, V414, P77, DOI 10.1038/35102073; Stephens RS, 1998, SCIENCE, V282, P754, DOI 10.1126/science.282.5389.754; Stone CB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030220; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Subtil A, 2005, MOL MICROBIOL, V56, P1636, DOI 10.1111/j.1365-2958.2005.04647.x; Sukhan A, 2001, J BACTERIOL, V183, P1159, DOI 10.1128/JB.183.4.1159-1167.2001; Thomas NA, 2012, J BACTERIOL, V194, P3767, DOI 10.1128/JB.00406-12; Thomson NR, 2008, GENOME RES, V18, P161, DOI 10.1101/gr.7020108; Valdivia RH, 2008, CURR OPIN MICROBIOL, V11, P53, DOI 10.1016/j.mib.2008.01.003; Wang YB, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002258; Wright HR, 2008, LANCET, V371, P1945, DOI 10.1016/S0140-6736(08)60836-3; Yip CK, 2005, NAT STRUCT MOL BIOL, V12, P75, DOI 10.1038/nsmb879; Zurawski DV, 2004, MICROBIOL-SGM, V150, P2055, DOI 10.1099/mic.0.26997-0	75	30	32	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2013	8	2							e56292	10.1371/journal.pone.0056292	http://dx.doi.org/10.1371/journal.pone.0056292			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093HR	23431368	gold, Green Published, Green Submitted			2022-12-25	WOS:000315182800010
J	Paz, S; Malkinson, D; Green, MS; Tsioni, G; Papa, A; Danis, K; Sirbu, A; Ceianu, C; Katalin, K; Ferenczi, E; Zeller, H; Semenza, JC				Paz, Shlomit; Malkinson, Dan; Green, Manfred S.; Tsioni, Gil; Papa, Anna; Danis, Kostas; Sirbu, Anca; Ceianu, Cornelia; Katalin, Krisztalovics; Ferenczi, Emoke; Zeller, Herve; Semenza, Jan C.			Permissive Summer Temperatures of the 2010 European West Nile Fever Upsurge	PLOS ONE			English	Article							CULEX-PIPIENS DIPTERA; VECTOR COMPETENCE; ENVIRONMENTAL-TEMPERATURE; VIRUS TRANSMISSION; CLIMATE-CHANGE; CULICIDAE; OUTBREAK; INCUBATION; MOSQUITOS; EPIDEMIC	Background: In the summer of 2010, Europe experienced outbreaks of West Nile Fever (WNF) in humans, which was preceded by hot spells. The objective of this study was to identify potential drivers of these outbreaks, such as spring and summer temperatures, relative humidity (RH), and precipitation. Methods: Pearson and lag correlations, binary and multinomial logistic regressions were used to assess the relationship between the climatic parameters and these outbreaks. Results: For human morbidity, significant (<0.05) positive correlations were observed between a number of WNF cases and temperature, with a geographic latitude gradient: northern ("colder") countries displayed strong correlations with a lag of up to four weeks, in contrast to southern ("warmer") countries, where the response was immediate. The correlations with RH were weaker, while the association with precipitation was not consistent. Horse morbidity started three weeks later than in humans where integrated surveillance was conducted, and no significant associations with temperature or RH were found for lags of 0 to 4 weeks. Conclusions: Significant temperature deviations during summer months might be considered environmental precursors of WNF outbreaks in humans, particularly at more northern latitudes. These insights can guide vector abatement strategies by health practitioners in areas at risk for persistent transmission cycles.	[Paz, Shlomit; Malkinson, Dan; Tsioni, Gil] Univ Haifa, Dept Geog & Environm Studies, IL-31999 Haifa, Israel; [Green, Manfred S.] Univ Haifa, Sch Publ Hlth, IL-31999 Haifa, Israel; [Papa, Anna] Aristotle Univ Thessaloniki, Sch Med, Dept Microbiol, GR-54006 Thessaloniki, Greece; [Danis, Kostas] Hellen Ctr Dis Prevent & Control, Athens, Greece; [Sirbu, Anca] Natl Ctr Surveillance & Control Communicable Dis, Bucharest, Romania; [Ceianu, Cornelia] Cantacuzino Natl Inst Res & Dev Microbiol & Immun, Bucharest, Romania; [Katalin, Krisztalovics; Ferenczi, Emoke] Natl Ctr Epidemiol, Budapest, Hungary; [Zeller, Herve; Semenza, Jan C.] European Ctr Dis Prevent & Control ECDC, Stockholm, Sweden	University of Haifa; University of Haifa; Aristotle University of Thessaloniki; Cantacuzino Institute Bucharest; European Centre for Disease Prevention & Control	Semenza, JC (corresponding author), European Ctr Dis Prevent & Control ECDC, Stockholm, Sweden.	Jan.Semenza@ecdc.europa.eu	Danis, Kostas/ABD-7357-2020; Ceianu, Cornelia-Svetlana/A-7423-2018	Ceianu, Cornelia Svetlana/0000-0001-6222-0752; Green, Manfred S./0000-0002-9753-5612; Malkinson, Dan/0000-0001-6172-0253	European Centre for Disease Prevention and Control (ECDC); ECDC Specific Contract (Health impact assessment: Climate, weather and West Nile Virus in Europe) [OJ/01/14/2011-PROC/2011/008]; University of Haifa, Israel	European Centre for Disease Prevention and Control (ECDC); ECDC Specific Contract (Health impact assessment: Climate, weather and West Nile Virus in Europe); University of Haifa, Israel	Research under this project was funded by the European Centre for Disease Prevention and Control (ECDC) and performed under an ECDC Specific Contract (Health impact assessment: Climate, weather and West Nile Virus in Europe) Number OJ/01/14/2011-PROC/2011/008 - January 2011, with University of Haifa, Israel. ECDC staff specified the terms of reference for the project, collected the data and were involved in study design, data analysis and interpretation, and writing of the manuscript.	Amante C, 2009, NGDC24 NESDIS CIRES; Andrade CC, 2011, J GEN VIROL, V92, P2523, DOI 10.1099/vir.0.032318-0; [Anonymous], 2001, GLOBAL CHANGE HUM HL, DOI DOI 10.1023/A:1015089901425; CDC Division of vector-born infectious diseases, 2007, W NIL VIR VERT EC TR; Chase JM, 2003, ECOL LETT, V6, P1017, DOI 10.1046/j.1461-0248.2003.00533.x; CORNEL AJ, 1993, J MED ENTOMOL, V30, P449, DOI 10.1093/jmedent/30.2.449; Danis K, 2011, EMERG INFECT DIS, V17, P1868, DOI 10.3201/eid1710.110525; Dauphin G, 2004, COMP IMMUNOL MICROB, V27, P343, DOI 10.1016/j.cimid.2004.03.009; Dohm DJ, 2002, J MED ENTOMOL, V39, P221, DOI 10.1603/0022-2585-39.1.221; Dohm DJ, 2001, J MED ENTOMOL, V38, P462, DOI 10.1603/0022-2585-38.3.462; ECDC, 2011, ANN EP REP 2011 REP; Epstein PR, 2005, NEW ENGL J MED, V353, P1433, DOI 10.1056/NEJMp058079; Epstein PR, 2001, J URBAN HEALTH, V78, P367, DOI 10.1093/jurban/78.2.367; European Centre for Disease Prevention and Control, 2011, EXP CONS W NIL VIR I; Garcia-Bocanegra I, 2011, EMERG INFECT DIS, V17, P2397, DOI 10.3201/eid1712.110651; Gibbs SEJ, 2006, VECTOR-BORNE ZOONOT, V6, P73, DOI 10.1089/vbz.2006.6.73; Hamer GL, 2008, J MED ENTOMOL, V45, P125, DOI 10.1603/0022-2585(2008)45[125:CPDCAB]2.0.CO;2; Hubalek Z, 1999, EMERG INFECT DIS, V5, P643, DOI 10.3201/eid0505.990505; Kilpatrick AM, 2011, SCIENCE, V334, P323, DOI 10.1126/science.1201010; Kilpatrick AM, 2010, AM J TROP MED HYG, V83, P607, DOI 10.4269/ajtmh.2010.10-0005; Kilpatrick AM, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000092; Komar Nicholas, 2003, Adv Virus Res, V61, P185; Korukluoglu G, 2011, W NILE VIRUS INFECT; Leshem Y, BIRD MIGRATION VIA M; McLean RG, 2001, ANN NY ACAD SCI, V951, P54; Ministry of Health Israel, 2011, W NIL FEV REFR GUID; Moudy RM, 2007, AM J TROP MED HYG, V77, P365, DOI 10.4269/ajtmh.2007.77.365; National Oceanic and Atmospheric Administration USA, 2011, NNDC CLIM DAT ONL; NOAA, 2012, HEAT IND; Owen J, 2006, ECOHEALTH, V3, P79, DOI 10.1007/s10393-006-0025-9; Papa A, 2010, EUROSURVEILLANCE, V15; Patz J.A., 2003, CLIM CHANG HUM HLTH, V2, P103; Paz S, 2006, INT J ENVIRON HEAL R, V16, P1, DOI 10.1080/09603120500392400; Paz S, 2008, ECOHEALTH, V5, P40, DOI 10.1007/s10393-007-0150-0; Peterson AT, 2003, VECTOR-BORNE ZOONOT, V3, P27, DOI 10.1089/153036603765627433; Platonov AE, 2008, PARASITOL RES, V103, pS45, DOI 10.1007/s00436-008-1050-0; Reisen WK, 2008, EMERG INFECT DIS, V14, P1747, DOI 10.3201/eid1411.080719; Richards SL, 2007, VECTOR-BORNE ZOONOT, V7, P629, DOI 10.1089/vbz.2007.0101; Roehr B, 2012, BRIT MED J, V345, DOI 10.1136/bmj.e5633; Ruiz MO, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-19; Salkind N., 2007, ENCY MEASUREMENT STA; Savage HM, 1999, AM J TROP MED HYG, V61, P600, DOI 10.4269/ajtmh.1999.61.600; Semenza JC, 2009, LANCET INFECT DIS, V9, P365, DOI 10.1016/S1473-3099(09)70104-5; Sirbu A., 2011, EUROSURVEILLANCE, V16; Tibbetts J, 2007, ENVIRON HEALTH PERSP, V115, pA196, DOI 10.1289/ehp.115-a196; Tsai TF, 1998, LANCET, V352, P767, DOI 10.1016/S0140-6736(98)03538-7; Turell MJ, 2001, J MED ENTOMOL, V38, P130, DOI 10.1603/0022-2585-38.2.130; Uejio CK, 2012, VECTOR-BORNE ZOONOT, V12, P117, DOI 10.1089/vbz.2011.0655; Victorov D, 2010, W NILE FEVER OUTBREA; Weinberger M, 2001, EMERG INFECT DIS, V7, P686, DOI 10.3201/eid0704.010416; World Organisation for Animal Health (OIE), 2012, WORLD AN HLTH INF DA	51	76	79	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2013	8	2							e56398	10.1371/journal.pone.0056398	http://dx.doi.org/10.1371/journal.pone.0056398			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093HR	23431374	Green Published, Green Submitted, gold			2022-12-25	WOS:000315182800016
J	He, X; Li, D; Luo, ZW; Liang, H; Peng, H; Zhao, YY; Wang, ND; Liu, DH; Qin, C; Wei, Q; Yan, HM; Shao, YM				He, Xuan; Li, Dan; Luo, Zhenwu; Liang, Hua; Peng, Hong; Zhao, Yangyang; Wang, Nidan; Liu, Donghua; Qin, Chuan; Wei, Qiang; Yan, Huimin; Shao, Yiming			Compromised NK Cell-Mediated Antibody-Dependent Cellular Cytotoxicity in Chronic SIV/SHIV Infection	PLOS ONE			English	Article							NATURAL-KILLER-CELLS; DELTA T-CELLS; RHESUS MACAQUES; PROTECTIVE EFFICACY; IN-VITRO; ACTIVATION; METALLOPROTEASE; IDENTIFICATION; STIMULATION; INHIBITORS	Increasing evidence indicates that antibody-dependent cellular cytotoxicity (ADCC) contributes to the control of HIV/SIV infection. However, little is known about the ADCC function of natural killer (NK) cells in non-human primate model. Here we demonstrated that ADCC function of NK cells was significantly compromised in chronic SIV/SHIV infection, correlating closely with the expression of Fc gamma RIIIa receptor (CD16) on NK cells. CD32, another class of IgG Fc receptors, was identified on NK cells with higher expression in the infected macaques and the blockade of CD32 impacted the ability of NK cells to respond to antibody-coated target cells. The inhibition of matrix metalloproteases (MMPs), a group of enzymes normally involved in tissue/receptor remodeling, could restore NK cell-mediated ADCC with increased CD16 expression on macaque NK cells. These data offer a clearer understanding of NK cell-mediated ADCC in rhesus macaques, which will allow us to evaluate the ADCC repertoire arising from preclinical vaccination studies in non-human primates and inform us in the future design of effective HIV vaccination strategies.	[He, Xuan; Luo, Zhenwu; Yan, Huimin] Chinese Acad Sci, Wuhan Inst Virol, Beijing 100864, Peoples R China; [He, Xuan; Li, Dan; Luo, Zhenwu; Liang, Hua; Peng, Hong; Zhao, Yangyang; Wang, Nidan; Liu, Donghua; Shao, Yiming] Chinese Ctr Dis Control & Prevent, Natl Ctr AIDS STD Control & Prevent, State Key Lab Infect Dis Prevent & Control, Beijing, Peoples R China; [Qin, Chuan; Wei, Qiang] Chinese Acad Med Sci, Inst Lab Anim Sci, Beijing 100730, Peoples R China; [Qin, Chuan; Wei, Qiang] Peking Union Med Coll, Beijing 100021, Peoples R China	Chinese Academy of Sciences; Wuhan Institute of Virology, CAS; Chinese Center for Disease Control & Prevention; National Center for AIDS/STD Control & Prevention, Chinese Center for Disease Control & Prevention; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Laboratory Animal Science - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Yan, HM (corresponding author), Chinese Acad Sci, Wuhan Inst Virol, Beijing 100864, Peoples R China.	hmyan@wh.iov.cn; yshao08@gmail.com	zhao, yang/GXF-4424-2022; Luo, Zhenwu/H-9478-2018	Yan, Huimin/0000-0002-7243-8429	National Major projects for Infectious Diseases Control and Prevention [2012ZX10001008]; National Natural Science Foundation of China [81020108030, 31100126]; SKLID Development grant [2012SKLID103, 2011SKLID207]; Analysis of genetic and immunological background of Macaque Rhesus in China [2012ZX10004501-001-006]	National Major projects for Infectious Diseases Control and Prevention; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); SKLID Development grant; Analysis of genetic and immunological background of Macaque Rhesus in China	This work was supported by National Major projects for Infectious Diseases Control and Prevention (2012ZX10001008), National Natural Science Foundation of China (81020108030, 31100126), SKLID Development grant (2012SKLID103, 2011SKLID207), Analysis of genetic and immunological background of Macaque Rhesus in China (2012ZX10004501-001-006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHMAD A, 1994, J ACQ IMMUN DEF SYND, V7, P428; Alter G, 2004, J IMMUNOL METHODS, V294, P15, DOI 10.1016/j.jim.2004.08.008; Angelini DF, 2004, BLOOD, V104, P1801, DOI 10.1182/blood-2004-01-0331; Asmal M, 2011, J VIROL, V85, P5465, DOI 10.1128/JVI.00313-11; Berman NEJ, 1999, NEUROBIOL DIS, V6, P486, DOI 10.1006/nbdi.1999.0261; Boulet S, 2010, J IMMUNOL, V184, P2057, DOI 10.4049/jimmunol.0902621; Choi EI, 2008, J VIROL, V82, P6758, DOI 10.1128/JVI.02277-07; Couzi L, 2012, BLOOD, V119, P1418, DOI 10.1182/blood-2011-06-363655; Craston R, 1997, J IMMUNOL METHODS, V209, P37, DOI 10.1016/S0022-1759(97)00143-9; Dutertre CA, 2008, J LEUKOCYTE BIOL, V84, P1511, DOI 10.1189/jlb.0608343; Florese RH, 2006, J IMMUNOL, V177, P4028, DOI 10.4049/jimmunol.177.6.4028; Florese RH, 2009, J IMMUNOL, V182, P3718, DOI 10.4049/jimmunol.0803115; Forthal DN, 2001, AIDS RES HUM RETROV, V17, P553, DOI 10.1089/08892220151126661; Forthal DN, 1999, J INFECT DIS, V180, P1338, DOI 10.1086/314988; Gomez-Roman VR, 2006, J IMMUNOL METHODS, V308, P53, DOI 10.1016/j.jim.2005.09.018; Gomez-Roman VR, 2005, J IMMUNOL, V174, P2185, DOI 10.4049/jimmunol.174.4.2185; Grzywacz B, 2007, LEUKEMIA, V21, P356, DOI 10.1038/sj.leu.2404499; HARRISON D, 1991, J IMMUNOL, V147, P3459; Hu JL, 2007, NAT REV DRUG DISCOV, V6, P480, DOI 10.1038/nrd2308; Lichtfuss GF, 2011, J LEUKOCYTE BIOL, V89, P149, DOI 10.1189/jlb.0610371; Liu QQ, 2009, J VIROL, V83, P8705, DOI 10.1128/JVI.02666-08; Mastroianni CM, 2007, TRENDS MOL MED, V13, P449, DOI 10.1016/j.molmed.2007.09.001; Mavilio D, 2005, BLOOD, V106, P1718, DOI 10.1182/blood-2004-12-4762; Mehlhop E, 2002, J IMMUNOL METHODS, V260, P219, DOI 10.1016/S0022-1759(01)00544-0; Pereira LE, 2008, CELL IMMUNOL, V254, P10, DOI 10.1016/j.cellimm.2008.06.006; Permar SR, 2010, J VIROL, V84, P8209, DOI 10.1128/JVI.00656-10; Poonia B, 2012, CYTOTHERAPY, V14, P173, DOI 10.3109/14653249.2011.623693; Reeves RK, 2010, BLOOD, V115, P4439, DOI 10.1182/blood-2010-01-265595; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Richman DD, 2003, P NATL ACAD SCI USA, V100, P4144, DOI 10.1073/pnas.0630530100; Sankatsing SUC, 2004, AIDS, V18, P1925, DOI 10.1097/00002030-200409240-00008; SAWYER LA, 1990, AIDS RES HUM RETROV, V6, P341, DOI 10.1089/aid.1990.6.341; Sun Y, 2011, J VIROL, V85, P6906, DOI 10.1128/JVI.00326-11; Thobakgale CF, 2011, AIDS RES HUM RETROV, V27, P1005, DOI 10.1089/aid.2010.0227; Vargas-Inchaustegui DA, 2011, IMMUNOLOGY, V134, P326, DOI 10.1111/j.1365-2567.2011.03493.x; Wren L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038580; Xiao P, 2010, J VIROL, V84, P7161, DOI 10.1128/JVI.00410-10	37	8	8	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2013	8	2							e56309	10.1371/journal.pone.0056309	http://dx.doi.org/10.1371/journal.pone.0056309			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104BU	23424655	Green Published, gold, Green Submitted			2022-12-25	WOS:000315965100043
J	Korner, A; Deichmann, C; Rossetti, FF; Kohler, A; Konovalov, OV; Wedlich, D; Tanaka, M				Koerner, Alexander; Deichmann, Christina; Rossetti, Fernanda F.; Koehler, Almut; Konovalov, Oleg V.; Wedlich, Doris; Tanaka, Motomu			Cell Differentiation of Pluripotent Tissue Sheets Immobilized on Supported Membranes Displaying Cadherin-11	PLOS ONE			English	Article							X-RAY REFLECTIVITY; EPITHELIAL-MESENCHYMAL TRANSITIONS; QUARTZ-CRYSTAL MICROBALANCE; NEURAL CREST MIGRATION; LIPID-MEMBRANES; PHOSPHOLIPID-BILAYERS; MODEL MEMBRANE; ADHESION; XENOPUS; SURFACE	Investigating cohesive tissue sheets in controlled cultures still poses a challenge since the complex intercellular interactions are difficult to mimic in in vitro models. We used supported lipid membranes functionalized by the adhesive part of the extracellular domain of the cell adhesion molecule cadherin-11 for the immobilization of pluripotent tissue sheets, the animal cap isolated from Xenopus laevis blastula stage embryos. Cadherin-11 was bound via histidine tag to lipid membranes with chelator head groups. In the first step, quantitative functionalization of the membranes with cadherin-11 was confirmed by quartz crystal microbalance and high energy specular X-ray reflectivity. In the next step, animal cap tissue sheets induced to neural crest cell fate were cultured on the membranes functionalized with cadherin-11. The adhesion of cells within the cohesive tissue was significantly dependent on changes in lateral densities of cadherin-11. The formation of filopodia and lamellipodia in the cohesive tissue verified the viability and sustainability of the culture over several hours. The expression of the transcription factor slug in externally induced tissue demonstrated the applicability of lipid membranes displaying adhesive molecules for controlled differentiation of cohesive pluripotent tissue sheets.	[Koerner, Alexander; Rossetti, Fernanda F.; Tanaka, Motomu] Heidelberg Univ, Inst Phys Chem, Heidelberg, Germany; [Deichmann, Christina; Koehler, Almut; Wedlich, Doris] Karlsruhe Inst Technol KIT, Inst Zool, Karlsruhe, Germany; [Konovalov, Oleg V.] European Synchrotron Radiat Facil, F-38043 Grenoble, France; [Tanaka, Motomu] Karlsruhe Inst Technol KIT, Inst Toxicol & Genet, Cell Biophys Lab, Karlsruhe, Germany	Ruprecht Karls University Heidelberg; Helmholtz Association; Karlsruhe Institute of Technology; European Synchrotron Radiation Facility (ESRF); Helmholtz Association; Karlsruhe Institute of Technology	Rossetti, FF (corresponding author), Heidelberg Univ, Inst Phys Chem, Neuenheimer Feld 253, Heidelberg, Germany.	rossetti@uni-heidelberg.de; Doris.Wedlich@kit.edu	Koehler, Almut/AAW-8028-2020; Rossetti, Fernanda/AAG-2193-2020; Tanaka, Motomu/S-5949-2016; Konovalov, Oleg/C-6702-2019	Koehler, Almut/0000-0002-7575-0602; Tanaka, Motomu/0000-0003-3663-9554; Konovalov, Oleg/0000-0002-0390-5900	Heidelberg Academy of Sciences through the WIN Kolleg program, project BioForm; Helmholtz Association through the BioInterfaces program; DFG [RO 3643/1-1]	Heidelberg Academy of Sciences through the WIN Kolleg program, project BioForm; Helmholtz Association through the BioInterfaces program(Helmholtz Association); DFG(German Research Foundation (DFG))	This work was supported by the Heidelberg Academy of Sciences through the WIN Kolleg program, project BioForm (A. K., C. D., F. F. R., and A. K.), the Helmholtz Association through the BioInterfaces program (D. W. and M. T.) and the DFG (F. F. R, research fellowship RO 3643/1-1). M. T. is a member of German Cluster of Excellence "Cell Network". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABERCROMBIE M, 1958, EXP CELL RES, V15, P332, DOI 10.1016/0014-4827(58)90034-X; Albersdorfer A, 1997, BIOPHYS J, V73, P245, DOI 10.1016/S0006-3495(97)78065-2; ARIIZUMI T, 2009, CURR PROTOC STEM CEL, pCH1; Basch Martin L, 2004, Birth Defects Res C Embryo Today, V72, P109, DOI 10.1002/bdrc.20015; BAYER EA, 1979, BIOCHIM BIOPHYS ACTA, V550, P464, DOI 10.1016/0005-2736(79)90149-4; Becker SF, 2012, ARCH BIOCH BIOPHYSIC; BLANKENBURG R, 1989, BIOCHEMISTRY-US, V28, P8214, DOI 10.1021/bi00446a037; Borchers A, 2001, DEVELOPMENT, V128, P3049; Boulbitch A, 2001, BIOPHYS J, V81, P2743, DOI 10.1016/S0006-3495(01)75917-6; BRIAN AA, 1984, P NATL ACAD SCI-BIOL, V81, P6159, DOI 10.1073/pnas.81.19.6159; BRIEHER WM, 1994, J CELL BIOL, V126, P519, DOI 10.1083/jcb.126.2.519; Brochard-Wyart F, 2002, P NATL ACAD SCI USA, V99, P7854, DOI 10.1073/pnas.112221299; Bruinsma R, 2001, CR ACAD SCI IV-PHYS, V2, P803, DOI 10.1016/S1296-2147(01)01225-2; Bruinsma R, 2000, PHYS REV E, V61, P4253, DOI 10.1103/PhysRevE.61.4253; Dorn IT, 1998, BIOL CHEM, V379, P1151, DOI 10.1515/bchm.1998.379.8-9.1151; Fukui Y, 2003, DEV GROWTH DIFFER, V45, P499; Garcia AS, 2009, LANGMUIR, V25, P2994, DOI 10.1021/la802772y; Goennenwein S, 2003, BIOPHYS J, V85, P646, DOI 10.1016/S0006-3495(03)74508-1; Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221; Hadeball B, 1998, MECH DEVELOP, V72, P101, DOI 10.1016/S0925-4773(98)00022-7; Hammerschmidt M, 2008, DEVELOPMENT, V135, P3625, DOI 10.1242/dev.015701; HERZBERG F, 1991, MECH DEVELOP, V35, P33, DOI 10.1016/0925-4773(91)90039-9; Heuberger J, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a002915; Hook F, 1998, LANGMUIR, V14, P729, DOI 10.1021/la970815u; Kashef J, 2009, GENE DEV, V23, P1393, DOI 10.1101/gad.519409; Keller CA, 2000, PHYS REV LETT, V84, P5443, DOI 10.1103/PhysRevLett.84.5443; Keller CA, 1998, BIOPHYS J, V75, P1397, DOI 10.1016/S0006-3495(98)74057-3; KERN W, 1970, RCA REV, V31, P187; Kloboucek A, 1999, BIOPHYS J, V77, P2311, DOI 10.1016/S0006-3495(99)77070-0; Komura S, 2000, EUR PHYS J E, V3, P259, DOI 10.1007/s101890070018; Krieg M, 2008, NAT CELL BIOL, V10, P429, DOI 10.1038/ncb1705; Kulesa PM, 2006, P NATL ACAD SCI USA, V103, P3752, DOI 10.1073/pnas.0506977103; Kuriyama S, 2008, PHILOS T R SOC B, V363, P1349, DOI 10.1098/rstb.2007.2252; LaBonne C, 1998, DEVELOPMENT, V125, P2403; Larsson C, 2003, ANAL CHEM, V75, P5080, DOI 10.1021/ac034269n; Leckband D, 2006, ANNU REV BIOMED ENG, V8, P259, DOI 10.1146/annurev.bioeng.8.061505.095753; Limozin L, 2009, CHEMPHYSCHEM, V10, P2752, DOI 10.1002/cphc.200900601; Malkova S, 2005, BIOPHYS J, V89, P1861, DOI 10.1529/biophysj.105.061515; Marchi-Artzner V, 2001, CHEM-EUR J, V7, P1095, DOI 10.1002/1521-3765(20010302)7:5<1095::AID-CHEM1095>3.0.CO;2-B; MARRA J, 1985, BIOCHEMISTRY-US, V24, P4608, DOI 10.1021/bi00338a020; Marsh D, 2001, P NATL ACAD SCI USA, V98, P7777, DOI 10.1073/pnas.131023798; Marsh D., 1990, CRC HDB LIPID BILAYE; Martel L, 2002, J PHYS IV, V12, P365, DOI 10.1051/jp4:20020245; MAYOR R, 1995, DEVELOPMENT, V121, P767; Miller CE, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.238104; Morgan MJ, 2004, J BIOL CHEM, V279, P46826, DOI 10.1074/jbc.M406140200; MULLER HAJ, 1994, MECH DEVELOP, V47, P213, DOI 10.1016/0925-4773(94)90040-X; Nelson A, 2006, J APPL CRYSTALLOGR, V39, P273, DOI 10.1107/S0021889806005073; Nieuwkoop PD., 1956, DEVELOPMENT, DOI [DOI 10.1242/DEV.200356, 10.1242/dev.200356]; Ninomiya H, 2008, NAT CELL BIOL, V10, P61, DOI 10.1038/ncb1669; PARRATT LG, 1954, PHYS REV, V95, P359, DOI 10.1103/PhysRev.95.359; POKUTTA S, 1994, EUR J BIOCHEM, V223, P1019, DOI 10.1111/j.1432-1033.1994.tb19080.x; RADLER J, 1993, J PHYS II, V3, P727; Rossetti FF, 2005, LANGMUIR, V21, P6443, DOI 10.1021/la0509100; Sackmann E, 1996, SCIENCE, V271, P43, DOI 10.1126/science.271.5245.43; Sackmann E., 1995, HDB BIOL PHYS A&B, V1, P1; SAUERBREY G, 1959, Z PHYS, V155, P206, DOI 10.1007/BF01337937; SCHMITT L, 1994, J AM CHEM SOC, V116, P8485, DOI 10.1021/ja00098a008; Schubert T, 2008, J PHYS CHEM B, V112, P10041, DOI 10.1021/jp803937m; Seitz PC, 2009, CHEMPHYSCHEM, V10, P2876, DOI 10.1002/cphc.200900553; Shindo A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008897; Slanchev K, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000563; Steventon B, 2005, SEMIN CELL DEV BIOL, V16, P647, DOI 10.1016/j.semcdb.2005.06.001; Stroumpoulis D, 2007, LANGMUIR, V23, P3849, DOI 10.1021/la062375p; Takeichi M, 2011, DEV CELL, V21, P24, DOI 10.1016/j.devcel.2011.06.002; TAMM LK, 1985, BIOPHYS J, V47, P105, DOI 10.1016/S0006-3495(85)83882-0; Tanaka M, 2005, NATURE, V437, P656, DOI 10.1038/nature04164; Tanaka M, 2007, LANGMUIR, V23, P5638, DOI 10.1021/la0628219; Tao QH, 2007, DEVELOPMENT, V134, P2651, DOI 10.1242/dev.002824; Theveneau E, 2010, DEV CELL, V19, P39, DOI 10.1016/j.devcel.2010.06.012; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; Vallin J, 2001, J BIOL CHEM, V276, P30350, DOI 10.1074/jbc.M103167200; Weikl TR, 2002, EUROPHYS LETT, V59, P916, DOI 10.1209/epl/i2002-00130-3	74	19	19	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2013	8	2							e54749	10.1371/journal.pone.0054749	http://dx.doi.org/10.1371/journal.pone.0054749			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104BU	23424619	Green Published, Green Submitted, gold			2022-12-25	WOS:000315965100007
J	Shao, L; Guo, H; Yan, LM; Liu, H; Fang, Q				Shao, Ling; Guo, Hong; Yan, Li-Ming; Liu, Huan; Fang, Qin			Aquareovirus NS80 Recruits Viral Proteins to Its Inclusions, and Its C-Terminal Domain Is the Primary Driving Force for Viral Inclusion Formation	PLOS ONE			English	Article							GRASS CARP REOVIRUS; GREEN FLUORESCENT PROTEIN; FACTORY-LIKE INCLUSIONS; MU-NS; BLUETONGUE VIRUS; SIGMA-NS; MAMMALIAN REOVIRUSES; INFECTED-CELLS; REPLICATION; ASSOCIATION	Cytoplasmic inclusion bodies formed in reovirus-infected cells are the sites of viral replication and assembly. Previous studies have suggested that the NS80 protein of aquareovirus may be involved in the formation of viral inclusion bodies. However, it remains unknown whether other viral proteins are involved in the process, and what regions of NS80 may act coordinately in mediating inclusion formation. Here, we observed that globular cytoplasmic inclusions were formed in virus-infected cells and viral proteins NS80 and NS38 colocalized in the inclusions. During transfection, singly expressed NS80 could form cytoplasmic inclusions and recruit NS38 and GFP-tagged VP4 to these structures. Further treatment of cells with nocodazole, a microtubule inhibitor, did not disrupt the inclusion, suggesting that inclusion formation does not rely on microtubule network. Besides, we identified that the region 530-742 of NS80 was likely the minimal region required for inclusion formation, and the C-tail, coiled-coil region as well as the conserved linker region were essential for inclusion phenotype. Moreover, with series deletions from the N-terminus, a stepwise conversion occurred from large condensed cytoplasmic to small nuclear inclusions, then to a diffused intracellular distribution. Notablely, we found that the nuclear inclusions, formed by NS80 truncations (471 to 513-742), colocalized with cellular protein beta-catenin. These data indicated that NS80 could be a major mediator in recruiting NS38 and VP4 into inclusion structures, and the C-terminus of NS80 is responsible for inclusion formation.	[Shao, Ling; Guo, Hong; Yan, Li-Ming; Liu, Huan; Fang, Qin] Chinese Acad Sci, Wuhan Inst Virol, State Key Lab Virol, Wuhan, Peoples R China; [Shao, Ling; Yan, Li-Ming] Univ Chinese Acad Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Wuhan Institute of Virology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Fang, Q (corresponding author), Chinese Acad Sci, Wuhan Inst Virol, State Key Lab Virol, Wuhan, Peoples R China.	qfang@wh.iov.cn	fang, qin/GQA-8223-2022	shao, ling/0000-0001-9110-1963	National Natural Science Foundation of China [31072233, 31172434]; National Basic Research Program of China 973 Program [2009CB118701]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China 973 Program(National Basic Research Program of China)	This work was supported in part by grants from the National Natural Science Foundation of China (31072233, 31172434), and National Basic Research Program of China 973 Program, 2009CB118701). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold MM, 2008, VIROLOGY, V375, P412, DOI 10.1016/j.virol.2008.02.024; Attoui H, 2002, J GEN VIROL, V83, P1941, DOI 10.1099/0022-1317-83-8-1941; Becker MM, 2003, J VIROL, V77, P5948, DOI 10.1128/JVI.77.10.5948-5963.2003; Brandariz-Nunez A, 2010, J VIROL, V84, P4289, DOI 10.1128/JVI.02534-09; Broering TJ, 2005, J VIROL, V79, P6194, DOI 10.1128/JVI.79.10.6194-6206.2005; Broering TJ, 2004, J VIROL, V78, P1882, DOI 10.1128/JVI.78.4.1882-1892.2004; Broering TJ, 2002, J VIROL, V76, P8285, DOI 10.1128/JVI.76.16.8285-8297.2002; BROOKES SM, 1993, J GEN VIROL, V74, P525, DOI 10.1099/0022-1317-74-3-525; Busch LK, 2011, J GEN VIROL, V92, P2566, DOI 10.1099/vir.0.036459-0; Cai L, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-168; Cheng LP, 2008, J MOL BIOL, V382, P213, DOI 10.1016/j.jmb.2008.06.075; DALES S, 1963, P NATL ACAD SCI USA, V50, P268, DOI 10.1073/pnas.50.2.268; EATON BT, 1987, VIROLOGY, V157, P107, DOI 10.1016/0042-6822(87)90319-9; Eichwald C, 2004, J GEN VIROL, V85, P625, DOI 10.1099/vir.0.19611-0; Fan C, 2010, ARCH VIROL, V155, P1755, DOI 10.1007/s00705-010-0753-6; Fang Q, 2008, ARCH VIROL, V153, P675, DOI 10.1007/s00705-008-0048-3; Fang Q, 2005, SCI CHINA SER C, V48, P593, DOI 10.1360/062004-105; FANG Q, 1989, VIROL SIN, V3, P314; FUJIMURO M, 1994, FEBS LETT, V349, P173, DOI 10.1016/0014-5793(94)00647-4; Heath CM, 2001, J CELL BIOL, V153, P449, DOI 10.1083/jcb.153.3.449; HOPP TP, 1988, BIO-TECHNOL, V6, P1204, DOI 10.1038/nbt1088-1204; Ivanovic T, 2011, TRAFFIC, V12, P1179, DOI 10.1111/j.1600-0854.2011.01233.x; Jain RK, 2001, BIOCHEM J, V360, P645, DOI 10.1042/0264-6021:3600645; Kar AK, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-4; Ke L., 1990, Acta Hydrobiologica Sinica, V14, P153; Kobayashi T, 2006, J VIROL, V80, P9053, DOI 10.1128/JVI.00276-06; Kobayashi T, 2009, J VIROL, V83, P2892, DOI 10.1128/JVI.01495-08; LEE PWK, 1981, VIROLOGY, V108, P134, DOI 10.1016/0042-6822(81)90533-X; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; Lupiani Blanca, 1995, Annual Review of Fish Diseases, V5, P175, DOI 10.1016/0959-8030(95)00006-2; McCutcheon AM, 1999, VIROLOGY, V264, P16, DOI 10.1006/viro.1999.9990; McPhillips TH, 1998, J VIROL, V72, P3387, DOI 10.1128/JVI.72.4.3387-3389.1998; Miller CL, 2010, J VIROL, V84, P867, DOI 10.1128/JVI.01571-09; Miller CL, 2003, J VIROL, V77, P4566, DOI 10.1128/JVI.77.8.4566-4576.2003; Mohan KVK, 2003, J VIROL, V77, P12184, DOI 10.1128/JVI.77.22.12184-12192.2003; MORA M, 1987, VIROLOGY, V159, P265, DOI 10.1016/0042-6822(87)90464-8; Nason EL, 2000, J VIROL, V74, P6546, DOI 10.1128/JVI.74.14.6546-6555.2000; Novoa RR, 2005, BIOL CELL, V97, P147, DOI 10.1042/BC20040058; Patton JT, 2006, CURR TOP MICROBIOL, V309, P169; Shao Ling, 2010, Virologica Sinica, V25, P123, DOI 10.1007/s12250-010-3115-3; SHARPE AH, 1982, VIROLOGY, V120, P399, DOI 10.1016/0042-6822(82)90040-X; Silvestri LS, 2004, J VIROL, V78, P7763, DOI 10.1128/JVI.78.14.7763-7774.2004; Touris-Otero F, 2004, VIROLOGY, V319, P94, DOI 10.1016/j.virol.2003.10.034; VIRGIN HW, 1988, J VIROL, V62, P4594, DOI 10.1128/JVI.62.12.4594-4604.1988; WIENER JR, 1989, VIROLOGY, V169, P293, DOI 10.1016/0042-6822(89)90154-2; Wileman T, 2006, SCIENCE, V312, P875, DOI 10.1126/science.1126766; Wileman T, 2007, ANNU REV MICROBIOL, V61, P149, DOI 10.1146/annurev.micro.57.030502.090836; WINTON JR, 1987, J GEN VIROL, V68, P353, DOI 10.1099/0022-1317-68-2-353; Yang F, 1996, NAT BIOTECHNOL, V14, P1246, DOI 10.1038/nbt1096-1246; Zhang X, 2010, CELL, V141, P472, DOI 10.1016/j.cell.2010.03.041	50	19	20	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2013	8	2							e55334	10.1371/journal.pone.0055334	http://dx.doi.org/10.1371/journal.pone.0055334			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104BU	23424630	Green Submitted, gold, Green Published			2022-12-25	WOS:000315965100018
J	Tunc-Ozdemir, M; Rato, C; Brown, E; Rogers, S; Mooneyham, A; Frietsch, S; Myers, CT; Poulsen, LR; Malho, R; Harper, JF				Tunc-Ozdemir, Meral; Rato, Claudia; Brown, Elizabeth; Rogers, Stephanie; Mooneyham, Amanda; Frietsch, Sabine; Myers, Candace T.; Poulsen, Lisbeth Rosager; Malho, Rui; Harper, Jeffrey F.			Cyclic Nucleotide Gated Channels 7 and 8 Are Essential for Male Reproductive Fertility	PLOS ONE			English	Article							POLLEN-TUBE GROWTH; POLARIZED TIP GROWTH; ARABIDOPSIS-THALIANA; PLASMA-MEMBRANE; CATION CHANNEL; INSERTIONAL MUTAGENESIS; REVERSE GENETICS; ION CHANNELS; IN-VITRO; PROTEIN	The Arabidopsis thaliana genome contains 20 CNGCs, which are proposed to encode cyclic nucleotide gated, non-selective, Ca2+-permeable ion channels. CNGC7 and CNGC8 are the two most similar with 74% protein sequence identity, and both genes are preferentially expressed in pollen. Two independent loss-of-function T-DNA insertions were identified for both genes and used to generate plant lines in which only one of the two alleles was segregating (e.g., cngc7-1+/-/cngc8-2-/- and cngc7-3-/-/cngc8-1+/-). While normal pollen transmission was observed for single gene mutations, pollen harboring mutations in both cngc7 and 8 were found to be male sterile (transmission efficiency reduced by more than 3000-fold). Pollen grains harboring T-DNA disruptions of both cngc7 and 8 displayed a high frequency of bursting when germinated in vitro. The male sterile defect could be rescued through pollen expression of a CNGC7 or 8 transgene including a CNGC7 with an N-terminal GFP-tag. However, rescue efficiencies were reduced similar to 10- fold when the CNGC7 or 8 included an F to W substitution (F589W and F624W, respectively) at the junction between the putative cyclic nucleotide binding-site and the calmodulin binding-site, identifying this junction as important for proper functioning of a plant CNGC. Using confocal microscopy, GFP-CNGC7 was found to preferentially localize to the plasma membrane at the flanks of the growing tip. Together these results indicate that CNGC7 and 8 are at least partially redundant and provide an essential function at the initiation of pollen tube tip growth.	[Tunc-Ozdemir, Meral; Brown, Elizabeth; Rogers, Stephanie; Mooneyham, Amanda; Frietsch, Sabine; Myers, Candace T.; Poulsen, Lisbeth Rosager; Harper, Jeffrey F.] Univ Nevada, Dept Biochem, Reno, NV 89557 USA; [Rato, Claudia; Malho, Rui] Univ Lisbon, Fac Ciencias Lisboa, BioFIG, P-1699 Lisbon, Portugal; [Poulsen, Lisbeth Rosager] Univ Copenhagen, Dept Plant Biol & Biotechnol, Ctr Membrane Pumps Cells & Dis PUMPKIN, Danish Natl Res Fdn, Frederiksberg, Denmark	Nevada System of Higher Education (NSHE); University of Nevada Reno; Universidade de Lisboa; Danmarks Grundforskningsfond; University of Copenhagen	Harper, JF (corresponding author), Univ Nevada, Dept Biochem, Reno, NV 89557 USA.	jfharper@unr.edu	Poulsen, Lisbeth R/I-1843-2014; Malho, Rui/I-4503-2012; Poulsen, Lisbeth Rosager/AAP-1301-2020	Poulsen, Lisbeth R/0000-0002-9133-3358; Malho, Rui/0000-0001-5287-869X; Rato, Claudia/0000-0002-3971-046X	National Institutes of Health [1RO1 GM070813-01]; Department of Energy [DE-FG03-94ER20152]; COBRE NIH [GM103554]; Fundacao Ciencia e Tecnologia [PTDC/AGR-GPL/108156/2008]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM070813, P20GM103554] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Energy(United States Department of Energy (DOE)); COBRE NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fundacao Ciencia e Tecnologia(Portuguese Foundation for Science and Technology); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants to JFH from National Institutes of Health (1RO1 GM070813-01) for genetic analyses into the formation of calcium signals in pollen, and Department of Energy (DE-FG03-94ER20152) for subcellular localization studies on membrane proteins and regulation of plant cell growth. Funding for operation of the confocal microscope core came from COBRE NIH grant GM103554. This work was also supported by a grant to RM from Fundacao Ciencia e Tecnologia (PTDC/AGR-GPL/108156/2008; FEDER). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; Amien S, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000388; Boavida LC, 2007, PLANT J, V52, P570, DOI 10.1111/j.1365-313X.2007.03248.x; Boisson-Dernier A, 2009, DEVELOPMENT, V136, P3279, DOI 10.1242/dev.040071; Cardenas L, 2008, PLANT PHYSIOL, V146, P1611, DOI 10.1104/pp.107.113035; Chae K, 2011, ANN BOT-LONDON, V108, P627, DOI 10.1093/aob/mcr015; Chaiwongsar S, 2009, NEW PHYTOL, V183, P76, DOI 10.1111/j.1469-8137.2009.02833.x; Chang F, 2007, J INTEGR PLANT BIOL, V49, P1261, DOI 10.1111/j.1672-9072.2007.00524.x; CHEN TY, 1994, P NATL ACAD SCI USA, V91, P11757, DOI 10.1073/pnas.91.24.11757; CHEN TY, 1993, NATURE, V362, P764, DOI 10.1038/362764a0; Cheung AY, 2008, ANNU REV PLANT BIOL, V59, P547, DOI 10.1146/annurev.arplant.59.032607.092921; CHIANG CM, 1993, PEPTIDE RES, V6, P62; Christopher DA, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-48; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Einhauer A, 2001, J BIOCHEM BIOPH METH, V49, P455, DOI 10.1016/S0165-022X(01)00213-5; Frietsch S, 2007, P NATL ACAD SCI USA, V104, P14531, DOI 10.1073/pnas.0701781104; Gao F, 2012, PLANT J, V70, P1056, DOI 10.1111/j.1365-313X.2012.04969.x; Hellens RP, 2000, PLANT MOL BIOL, V42, P819, DOI 10.1023/A:1006496308160; Hepler PK, 2012, TRENDS PLANT SCI, V17, P32, DOI 10.1016/j.tplants.2011.10.007; Higashiyama T, 2000, PLANT PHYSIOL, V122, P11, DOI 10.1104/pp.122.1.11; Hill AE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036585; Honys D, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-11-r85; Hua BG, 2003, PLANT PHYSIOL, V132, P1353, DOI 10.1104/pp.103.020560; Iwano M, 2009, PLANT PHYSIOL, V150, P1322, DOI 10.1104/pp.109.139329; Jayaprakash P, 2001, J EXP BOT, V52, P851, DOI 10.1093/jexbot/52.357.851; Jiang LX, 2005, PLANT CELL, V17, P584, DOI 10.1105/tpc.104.027631; Jones MA, 2002, PLANT CELL, V14, P763, DOI 10.1105/tpc.010359; KAMMANN M, 1989, NUCLEIC ACIDS RES, V17, P5404, DOI 10.1093/nar/17.13.5404; Kaupp UB, 2002, PHYSIOL REV, V82, P769, DOI 10.1152/physrev.00008.2002; Kessler SA, 2011, CURR OPIN PLANT BIOL, V14, P622, DOI 10.1016/j.pbi.2011.07.012; Kohler C, 1999, PLANT J, V18, P97, DOI 10.1046/j.1365-313X.1999.00422.x; Konrad KR, 2011, CURR OPIN PLANT BIOL, V14, P721, DOI 10.1016/j.pbi.2011.09.005; KORSCHEN HG, 1995, NEURON, V15, P627, DOI 10.1016/0896-6273(95)90151-5; Li H, 2001, PLANT PHYSIOL, V126, P670, DOI 10.1104/pp.126.2.670; Li H, 1999, PLANT CELL, V11, P1731, DOI 10.1105/tpc.11.9.1731; Lin YK, 1997, PLANT CELL, V9, P1647, DOI 10.1105/tpc.9.9.1647; Ma LG, 2000, PLANT CELL PHYSIOL, V41, P372; Michard E, 2011, SCIENCE, V332, P434, DOI 10.1126/science.1201101; Moore I, 2009, PLANT CELL, V21, P1632, DOI 10.1105/tpc.109.068668; Moutinho A, 2001, P NATL ACAD SCI USA, V98, P10481, DOI 10.1073/pnas.171104598; Myers C, 2009, PLANT J, V59, P528, DOI 10.1111/j.1365-313X.2009.03894.x; Palanivelu R, 2003, CELL, V114, P47, DOI 10.1016/S0092-8674(03)00479-3; Potocky M, 2012, J PLANT PHYSIOL, V169, P1654, DOI 10.1016/j.jplph.2012.05.014; Qin Y, 2011, SEMIN CELL DEV BIOL, V22, P816, DOI 10.1016/j.semcdb.2011.06.004; Qin Y, 2009, PLOS GENET, V5, DOI [10.1371/journal.pgen.1000621, 10.1109/BMEI.2009.5304794]; Rato C, 2004, PLANT J, V38, P887, DOI 10.1111/j.1365-313X.2004.02091.x; Robertson WR, 2004, GENETICS, V168, P1677, DOI 10.1534/genetics.104.032326; Rosso MG, 2003, PLANT MOL BIOL, V53, P247, DOI 10.1023/B:PLAN.0000009297.37235.4a; Schiott M, 2004, P NATL ACAD SCI USA, V101, P9502, DOI 10.1073/pnas.0401542101; Sessions A, 2002, PLANT CELL, V14, P2985, DOI 10.1105/tpc.004630; Spalding EP, 2011, CURR OPIN PLANT BIOL, V14, P715, DOI 10.1016/j.pbi.2011.08.001; Takeuchi H, 2011, CURR OPIN PLANT BIOL, V14, P614, DOI 10.1016/j.pbi.2011.07.010; Wu JY, 2011, PLANT CELL REP, V30, P1193, DOI 10.1007/s00299-011-1027-9; Yan A, 2009, P NATL ACAD SCI USA, V106, P22002, DOI 10.1073/pnas.0910811106; Zhou LM, 2009, J INTEGR PLANT BIOL, V51, P751, DOI 10.1111/j.1744-7909.2009.00847.x	55	58	64	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2013	8	2							e55277	10.1371/journal.pone.0055277	http://dx.doi.org/10.1371/journal.pone.0055277			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104BU	23424627	Green Published, Green Submitted, gold			2022-12-25	WOS:000315965100015
J	Yu, QG; Chow, EMC; McCaw, SE; Hu, NJ; Byrd, D; Amet, T; Hu, SS; Ostrowski, MA; Gray-Owen, SD				Yu, Qigui; Chow, Edith M. C.; McCaw, Shannon E.; Hu, Ningjie; Byrd, Daniel; Amet, Tohti; Hu, Sishun; Ostrowski, Mario A.; Gray-Owen, Scott D.			Association of Neisseria gonorrhoeae Opa(CEA) with Dendritic Cells Suppresses Their Ability to Elicit an HIV-1-Specific T Cell Memory Response	PLOS ONE			English	Article							GONOCOCCAL OPACITY PROTEINS; HERPES-SIMPLEX-VIRUS; DC-SIGN CD209; CARCINOEMBRYONIC ANTIGEN FAMILY; HUMAN-IMMUNODEFICIENCY-VIRUS; SEROVAR-SPECIFIC IMMUNITY; EPITHELIAL-CELLS; OPA PROTEINS; ADHESION MOLECULE-1; CD40 LIGAND	Infection with Neisseria gonorrhoeae (N. gonorrhoeae) can trigger an intense local inflammatory response at the site of infection, yet there is little specific immune response or development of immune memory. Gonococcal surface epitopes are known to undergo antigenic variation; however, this is unlikely to explain the weak immune response to infection since individuals can be re-infected by the same serotype. Previous studies have demonstrated that the colony opacity-associated (Opa) proteins on the N. gonorrhoeae surface can bind human carcinoembryonic antigen-related cellular adhesion molecule 1 (CEACAM1) on CD4(+) T cells to suppress T cell activation and proliferation. Interesting in this regard, N. gonorrhoeae infection is associated with impaired HIV-1 (human immunodeficiency virus type 1)-specific cytotoxic T-lymphocyte (CTL) responses and with transient increases in plasma viremia in HIV-1-infected patients, suggesting that N. gonorrhoeae may also subvert immune responses to co-pathogens. Since dendritic cells (DCs) are professional antigen presenting cells (APCs) that play a key role in the induction of an adaptive immune response, we investigated the effects of N. gonorrhoeae Opa proteins on human DC activation and function. While morphological changes reminiscent of DC maturation were evident upon N. gonorrhoeae infection, we observed a marked downregulation of DC maturation marker CD83 when the gonococci expressing CEACAM1-specific Opa(CEA), but not other Opa variants. Consistent with a gonococcal-induced defect in maturation, Opa(CEA) binding to CEACAM1 reduced the DCs' capacity to stimulate an allogeneic T cell proliferative response. Moreover, Opa(CEA)-expressing N. gonorrhoeae showed the potential to impair DC-dependent development of specific adaptive immunity, since infection with Opa(CEA)-positive gonococci suppressed the ability of DCs to stimulate HIV-1-specific memory CTL responses. These results reveal a novel mechanism to explain why infection of N. gonorrhoeae fails to trigger an effective specific immune response or develop immune memory, and may affect the potent synergy between gonorrhea and HIV-1 infection.	[Yu, Qigui; Hu, Ningjie; Byrd, Daniel; Amet, Tohti; Hu, Sishun] Indiana Univ Sch Med, Dept Microbiol & Immunol, Indianapolis, IN 46204 USA; [Chow, Edith M. C.; McCaw, Shannon E.; Gray-Owen, Scott D.] Univ Toronto, Dept Mol Genet, Toronto, ON, Canada; Univ Toronto, Div Clin Sci, Toronto, ON, Canada	Indiana University System; Indiana University Bloomington; University of Toronto; University of Toronto	Yu, QG (corresponding author), Indiana Univ Sch Med, Dept Microbiol & Immunol, Indianapolis, IN 46204 USA.	andyu@iupui.edu; scott.gray.owen@utoronto.ca	Gray-Owen, Scott/AAG-7337-2022; Gray-Owen, Scott/AFL-7380-2022	Gray-Owen, Scott D./0000-0002-1477-3616	Grand Challenges Explorations (GCE) Phase II grant through the Bill & Melinda Gates Foundation [OPP1035237]; Showalter Research Trust Fund; United States National Institutes of Health (NIH) [T32 AI060519]; Research Facilities Improvement Program from the National Center for Research Resources, NIH [C06 RR015481-01]; Canadian Institutes for Health Research [MOP-15499, HET-85518]; Ontario HIV Treatment Network; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR015481] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI060519] Funding Source: NIH RePORTER	Grand Challenges Explorations (GCE) Phase II grant through the Bill & Melinda Gates Foundation; Showalter Research Trust Fund; United States National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research Facilities Improvement Program from the National Center for Research Resources, NIH; Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Ontario HIV Treatment Network; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by the Grand Challenges Explorations (GCE) Phase II grant through the Bill & Melinda Gates Foundation (OPP1035237 to QY), Showalter Research Trust Fund (QY), United States National Institutes of Health (NIH) T32 AI060519 (DB), the Research Facilities Improvement Program Grant Number C06 RR015481-01 from the National Center for Research Resources, NIH to Indiana University School of Medicine, the Canadian Institutes for Health Research grants MOP-15499 (SDG) and HET-85518 (SDG and MAO), and support from the Ontario HIV Treatment Network (SDG and MAO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACHTMAN M, 1988, J EXP MED, V168, P507, DOI 10.1084/jem.168.2.507; Alvarez CP, 2002, J VIROL, V76, P6841, DOI 10.1128/JVI.76.13.6841-6844.2002; [Anonymous], 2002, AIDS ALERT, V17, P63; Anzala AO, 2000, J INFECT DIS, V182, P459, DOI 10.1086/315733; Bamberger AM, 2006, CARCINOGENESIS, V27, P483, DOI 10.1093/carcin/bgi275; Beauchemin N, 1999, EXP CELL RES, V252, P243; BHAT KS, 1992, MOL MICROBIOL, V6, P1073, DOI 10.1111/j.1365-2958.1992.tb02172.x; Billker O, 2000, TRENDS MICROBIOL, V8, P258, DOI 10.1016/S0966-842X(00)01771-6; Bos MP, 1997, INFECT IMMUN, V65, P2353, DOI 10.1128/IAI.65.6.2353-2361.1997; Botling J, 1995, LEUKEMIA, V9, P2034; Boulton IC, 2002, NAT IMMUNOL, V3, P229, DOI 10.1038/ni769; Cambi A, 2003, EUR J IMMUNOL, V33, P532, DOI 10.1002/immu.200310029; Cella M, 1996, J EXP MED, V184, P747, DOI 10.1084/jem.184.2.747; Chen A, 2003, AIDS, V17, P625, DOI 10.1097/00002030-200303070-00019; CHEN T, 1995, J EXP MED, V182, P511, DOI 10.1084/jem.182.2.511; Chen T, 2001, J LEUKOCYTE BIOL, V70, P335; Chen T, 1997, J EXP MED, V185, P1557, DOI 10.1084/jem.185.9.1557; Chen T, 1996, P NATL ACAD SCI USA, V93, P14851, DOI 10.1073/pnas.93.25.14851; Ciesielski Carol A., 2003, Curr Infect Dis Rep, V5, P145, DOI 10.1007/s11908-003-0051-5; Cohen MS, 1997, LANCET, V349, P1868, DOI 10.1016/S0140-6736(97)02190-9; Colmenares M, 2002, J BIOL CHEM, V277, P36766, DOI 10.1074/jbc.M205270200; Dehio C, 1998, TRENDS MICROBIOL, V6, P489, DOI 10.1016/S0966-842X(98)01365-1; Donda A, 2000, EUR J IMMUNOL, V30, P2593, DOI 10.1002/1521-4141(200009)30:9<2593::AID-IMMU2593>3.0.CO;2-0; Engelmayer J, 1999, J IMMUNOL, V163, P6762; Feinberg H, 2001, SCIENCE, V294, P2163, DOI 10.1126/science.1066371; Ferreira VH, 2011, J INFECT DIS, V204, P299, DOI 10.1093/infdis/jir260; Fox KK, 1999, AM J EPIDEMIOL, V149, P353, DOI 10.1093/oxfordjournals.aje.a009820; Freissler E, 2000, CELL MICROBIOL, V2, P69, DOI 10.1046/j.1462-5822.2000.00036.x; Geijtenbeek TBH, 2003, APMIS, V111, P698, DOI 10.1034/j.1600-0463.2003.11107803.x; Geijtenbeek TBH, 2001, PLACENTA, V22, pS19, DOI 10.1053/plac.2001.0674; Geijtenbeek TBH, 2003, J EXP MED, V197, P7, DOI 10.1084/jem.20021229; Granucci F, 2003, CURR OPIN MICROBIOL, V6, P72, DOI 10.1016/S1369-5274(03)00007-9; Gray-Owen SD, 2006, NAT REV IMMUNOL, V6, P433, DOI 10.1038/nri1864; GrayOwen SD, 1997, EMBO J, V16, P3435, DOI 10.1093/emboj/16.12.3435; Greicius G, 2003, J LEUKOCYTE BIOL, V74, P126, DOI 10.1189/jlb.1202594; Hammarstrom S, 1999, SEMIN CANCER BIOL, V9, P67, DOI 10.1006/scbi.1998.0119; Hobbs MM, 1999, J INFECT DIS, V179, P371, DOI 10.1086/314608; JAMES JF, 1978, INFECT IMMUN, V19, P332, DOI 10.1128/IAI.19.1.332-340.1978; JERSE AE, 1994, J EXP MED, V179, P911, DOI 10.1084/jem.179.3.911; Kammerer R, 2001, J IMMUNOL, V166, P6537, DOI 10.4049/jimmunol.166.11.6537; Kammerer R, 1998, EUR J IMMUNOL, V28, P3664, DOI 10.1002/(SICI)1521-4141(199811)28:11<3664::AID-IMMU3664>3.0.CO;2-D; Kaufmann SHE, 2003, J EXP MED, V197, P1, DOI 10.1084/jem.20021964; Kaul R, 2001, J CLIN INVEST, V107, P341, DOI 10.1172/JCI10714; Knight SC, 1997, ANNU REV IMMUNOL, V15, P593, DOI 10.1146/annurev.immunol.15.1.593; Kruse M, 2000, J VIROL, V74, P7127, DOI 10.1128/JVI.74.15.7127-7136.2000; Kuespert K, 2006, CURR OPIN CELL BIOL, V18, P565, DOI 10.1016/j.ceb.2006.08.008; Kummer M, 2007, J VIROL, V81, P6326, DOI 10.1128/JVI.02327-06; KUPSCH EM, 1993, EMBO J, V12, P641, DOI 10.1002/j.1460-2075.1993.tb05697.x; Lechmann M, 2005, BIOCHEM BIOPH RES CO, V329, P132, DOI 10.1016/j.bbrc.2005.01.114; Lechmann M, 2001, J EXP MED, V194, P1813, DOI 10.1084/jem.194.12.1813; Lee HSW, 2008, J IMMUNOL, V180, P6827, DOI 10.4049/jimmunol.180.10.6827; Lee HSW, 2007, INFECT IMMUN, V75, P4449, DOI 10.1128/IAI.00222-07; Levine D, 2008, AM J PUBLIC HEALTH, V98, P393, DOI 10.2105/AJPH.2007.110767; Lozach PY, 2003, J BIOL CHEM, V278, P20358, DOI 10.1074/jbc.M301284200; Markel G, 2002, J CLIN INVEST, V110, P943, DOI 10.1172/JCI200215643; McCaw SE, 2004, INFECT IMMUN, V72, P2742, DOI 10.1128/IAI.72.5.2742-2752.2004; Merz AJ, 2000, NATURE, V407, P98, DOI 10.1038/35024105; Muenzner P, 2001, J BIOL CHEM, V276, P24331, DOI 10.1074/jbc.M006883200; MURPHY GL, 1989, CELL, V56, P539, DOI 10.1016/0092-8674(89)90577-1; NASSIF X, 1995, CLIN MICROBIOL REV, V8, P376, DOI 10.1128/CMR.8.3.376; Obrink B, 1997, CURR OPIN CELL BIOL, V9, P616, DOI 10.1016/S0955-0674(97)80114-7; Ostrowski MA, 2000, J IMMUNOL, V165, P6133, DOI 10.4049/jimmunol.165.11.6133; Pieper D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023290; PLUMMER FA, 1989, J CLIN INVEST, V83, P1472, DOI 10.1172/JCI114040; PLUMMER FA, 1987, REV INFECT DIS, V9, P846; PLUMMER FA, 1994, J CLIN INVEST, V93, P1748, DOI 10.1172/JCI117159; Pohlmann S, 2003, J VIROL, V77, P4070, DOI 10.1128/JVI.77.7.4070-4080.2003; Prechtel AT, 2007, J IMMUNOL, V178, P5454, DOI 10.4049/jimmunol.178.9.5454; Sadarangani M, 2011, FEMS MICROBIOL REV, V35, P498, DOI 10.1111/j.1574-6976.2010.00260.x; Salio M, 1999, EUR J IMMUNOL, V29, P3245, DOI 10.1002/(SICI)1521-4141(199910)29:10<3245::AID-IMMU3245>3.3.CO;2-O; Schmidt KA, 2000, SEX TRANSM DIS, V27, P278, DOI 10.1097/00007435-200005000-00008; Senechal B, 2004, BLOOD, V103, P4207, DOI 10.1182/blood-2003-12-4350; Slevogt H, 2008, NAT IMMUNOL, V9, P1270, DOI 10.1038/ni.1661; Stern N, 2005, J IMMUNOL, V174, P6692, DOI 10.4049/jimmunol.174.11.6692; SWANSON J, 1988, J EXP MED, V168, P2121, DOI 10.1084/jem.168.6.2121; Tailleux L, 2003, J EXP MED, V197, P121, DOI 10.1084/jem.20021468; Tassaneetrithep B, 2003, J EXP MED, V197, P823, DOI 10.1084/jem.20021840; VANPUTTEN JPM, 1995, EMBO J, V14, P2144, DOI 10.1002/j.1460-2075.1995.tb07208.x; Virji M, 1996, MOL MICROBIOL, V22, P929, DOI 10.1046/j.1365-2958.1996.01548.x; Virji M, 1996, MOL MICROBIOL, V22, P941, DOI 10.1046/j.1365-2958.1996.01551.x; Winter AJ, 1999, SEX TRANSM INFECT, V75, P261, DOI 10.1136/sti.75.4.261; Yu QG, 2006, J IMMUNOL, V176, P2486, DOI 10.4049/jimmunol.176.4.2486; Yu QG, 2003, J IMMUNOL, V170, P1797, DOI 10.4049/jimmunol.170.4.1797; Yu QG, 2004, J IMMUNOL, V172, P6047, DOI 10.4049/jimmunol.172.10.6047; Yu QG, 2006, J BIOL CHEM, V281, P39179, DOI 10.1074/jbc.M608864200; Zhang JZ, 2005, J IMMUNOL, V174, P7995, DOI 10.4049/jimmunol.174.12.7995; Zhang P, 2006, J LEUKOCYTE BIOL, V79, P731, DOI 10.1189/jlb.0405184	87	8	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2013	8	2							e56705	10.1371/journal.pone.0056705	http://dx.doi.org/10.1371/journal.pone.0056705			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104BU	23424672	Green Published, Green Submitted, gold			2022-12-25	WOS:000315965100060
J	Harte, MT; Gorski, JJ; Savage, KI; Purcell, JW; Barros, EW; Burn, PM; McFarlane, C; Mullan, PB; Kennedy, RD; Perkins, ND; Harkin, DP				Harte, M. T.; Gorski, J. J.; Savage, K. I.; Purcell, J. W.; Barros, E. W.; Burn, P. M.; McFarlane, C.; Mullan, P. B.; Kennedy, R. D.; Perkins, N. D.; Harkin, D. P.			NF-kappa B is a critical mediator of BRCA1-induced chemoresistance	ONCOGENE			English	Article						BRCA1; NF-kappa B; DNA damage; apoptosis	DOUBLE-STRAND BREAKS; DNA-REPAIR; BRCA1; CANCER; ACTIVATION; EXPRESSION; SUBUNIT; CHEMOTHERAPY; APOPTOSIS; COMPLEX	BRCA1 mediates resistance to apoptosis in response to DNA-damaging agents, causing BRCA1 wild-type tumours to be significantly more resistant to DNA damage than their mutant counterparts. In this study, we demonstrate that following treatment with the DNA-damaging agents, etoposide or camptothecin, BRCA1 is required for the activation of nuclear factor-kappa B (NF-kappa B), and that BRCA1 and NF-kappa B cooperate to regulate the expression of the NF-kappa B antiapoptotic targets BCL2 and XIAP. We show that BRCA1 and the NF-kappa B subunit p65/RelA associate constitutively, whereas the p50 NF-kappa B subunit associates with BRCA1 only upon DNA damage treatment. Consistent with this BRCA1 and p65 are present constitutively on the promoters of BCL2 and XIAP, whereas p50 is recruited to these promoters only in damage treated cells. Importantly, we demonstrate that the recruitment of p50 onto the promoters of BCL2 and XIAP is dependent upon BRCA1, but independent of its NF-kappa B partner subunit p65. The functional relevance of NF-kappa B activation by BRCA1 in response to etoposide and camptothecin is demonstrated by the significantly reduced survival of BRCA1 wild-type cells upon NF-kappa B inhibition. This study identifies a novel BRCA1-p50 complex, and demonstrates for the first time that NF-kappa B is required for BRCA1-mediated resistance to DNA damage. It reveals a functional interdependence between BRCA1 and NF-kappa B, further elucidating the role played by NF-kappa B in mediating cellular resistance of BRCA1 wild-type tumours to DNA-damaging agents.	[Harte, M. T.; Gorski, J. J.; Savage, K. I.; Barros, E. W.; Burn, P. M.; McFarlane, C.; Mullan, P. B.; Kennedy, R. D.; Harkin, D. P.] Queens Univ Belfast, Ctr Canc Res & Cell Biol, Belfast BT9 7BL, Antrim, North Ireland; [Purcell, J. W.] Abbott Biotherapeut, Global Pharmaceut Res & Dev, Biol Technol, Redwood City, CA USA; [Perkins, N. D.] Newcastle Univ, Sch Med, Inst Cell & Mol Biosci, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England	Queens University Belfast; Newcastle University - UK	Harte, MT (corresponding author), Queens Univ Belfast, Ctr Canc Res & Cell Biol, Lisburn Rd, Belfast BT9 7BL, Antrim, North Ireland.	m.harte@qub.ac.uk; d.harkin@qub.ac.uk	Kennedy, Richard/J-3489-2012	Kennedy, Richard/0000-0003-4737-6163; Savage, Kienan/0000-0002-4898-899X	Medical Research Council; Cancer Research UK; Cancer Focus Northern Ireland; Action Cancer; Medical Research Council [G0600267] Funding Source: researchfish; MRC [G0600267] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); Cancer Focus Northern Ireland; Action Cancer; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank Dr Stephen McMahon for help with statistical analysis of survival curves. This study was supported by Medical Research Council (M. T Harte and D. P Harkin); Cancer Research UK (KI Savage, JJ Gorski, P Burn, E Barros and DP Harkin); Cancer Focus Northern Ireland (KI Savage); Action Cancer (J.P Purcell).	Barre B, 2007, EMBO J, V26, P4841, DOI 10.1038/sj.emboj.7601899; Benezra M, 2003, J BIOL CHEM, V278, P26333, DOI 10.1074/jbc.M303076200; Bochar DA, 2000, CELL, V102, P257, DOI 10.1016/S0092-8674(00)00030-1; Chapppuis PO, 2002, J MED GENET, V39, P608, DOI 10.1136/jmg.39.8.608; DiDonato JA, 2012, IMMUNOL REV, V246, P379, DOI 10.1111/j.1600-065X.2012.01099.x; Farmer H, 2005, NATURE, V434, P917, DOI 10.1038/nature03445; Franken NAP, 2006, NAT PROTOC, V1, P2315, DOI 10.1038/nprot.2006.339; Freneaux P, 2000, BRIT J CANCER, V83, P1318, DOI 10.1054/bjoc.2000.1438; Gorski JJ, 2011, NUCLEIC ACIDS RES, V39, P9536, DOI 10.1093/nar/gkr679; Gorski JJ, 2010, BREAST CANCER RES TR, V122, P721, DOI 10.1007/s10549-009-0565-0; Habraken Y, 2003, ONCOGENE, V22, P6090, DOI 10.1038/sj.onc.1206893; Habraken Y, 2006, BIOCHEM PHARMACOL, V72, P1132, DOI 10.1016/j.bcp.2006.07.015; Harkin DP, 1999, CELL, V97, P575, DOI 10.1016/S0092-8674(00)80769-2; Harte MT, 2010, CANCER RES, V70, P2538, DOI 10.1158/0008-5472.CAN-09-2089; Hartman AR, 2002, NAT GENET, V32, P180, DOI 10.1038/ng953; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Hosey AM, 2007, J NATL CANCER I, V99, P1683, DOI 10.1093/jnci/djm207; Huen MSY, 2010, NAT REV MOL CELL BIO, V11, P138, DOI 10.1038/nrm2831; Kennedy RD, 2005, CANCER RES, V65, P10265, DOI 10.1158/0008-5472.CAN-05-1841; Kirova YM, 2005, EUR J CANCER, V41, P2304, DOI 10.1016/j.ejca.2005.02.037; McCool KW, 2012, IMMUNOL REV, V246, P311, DOI 10.1111/j.1600-065X.2012.01101.x; McEachern KA, 2003, J CELL BIOCHEM, V89, P120, DOI 10.1002/jcb.10487; Mullan PB, 2006, ONCOGENE, V25, P5854, DOI 10.1038/sj.onc.1209872; Mullan PB, 2006, BBA-REV CANCER, V1766, P205, DOI 10.1016/j.bbcan.2006.07.001; Mullan PB, 2005, ONCOGENE, V24, P5492, DOI 10.1038/sj.onc.1208698; Nakanishi C, 2005, NAT REV CANCER, V5, P297, DOI 10.1038/nrc1588; Perkins ND, 2007, NAT REV MOL CELL BIO, V8, P49, DOI 10.1038/nrm2083; Perkins ND, 2012, NAT REV CANCER, V12, P121, DOI 10.1038/nrc3204; Quinn JE, 2003, CANCER RES, V63, P6221; Quinn JE, 2007, CLIN CANCER RES, V13, P7413, DOI 10.1158/1078-0432.CCR-07-1083; Roy R, 2012, NAT REV CANCER, V12, P68, DOI 10.1038/nrc3181; Sabatel H, 2011, BIOCHEM PHARMACOL, V82, P1371, DOI 10.1016/j.bcp.2011.07.105; Schumm K, 2006, EMBO J, V25, P4820, DOI 10.1038/sj.emboj.7601343; Stilmann M, 2009, MOL CELL, V36, P365, DOI 10.1016/j.molcel.2009.09.032; Treszezamsky AD, 2007, CANCER RES, V67, P7078, DOI 10.1158/0008-5472.CAN-07-0601; Volcic M, 2012, NUCLEIC ACIDS RES, V40, P181, DOI 10.1093/nar/gkr687; Wang JX, 2009, EMBO REP, V10, P1272, DOI 10.1038/embor.2009.197	37	31	34	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 6	2014	33	6					713	723		10.1038/onc.2013.10	http://dx.doi.org/10.1038/onc.2013.10			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AA5IL	23435429	Green Accepted			2022-12-25	WOS:000331129200006
J	Wu, H; Downs, D; Ghosh, K; Ghosh, AK; Staib, P; Monod, M; Tang, J				Wu, Hao; Downs, Deborah; Ghosh, Koena; Ghosh, Arun K.; Staib, Peter; Monod, Michel; Tang, Jordan			Candida albicans secreted aspartic proteases 4-6 induce apoptosis of epithelial cells by a novel Trojan horse mechanism	FASEB JOURNAL			English	Article						virulence factors; integrins; infectious diseases; lysosome membrane	PROTEINASE GENE FAMILY; CRYSTAL-STRUCTURE; VIRULENCE; EXPRESSION; DEGRADATION; ACTIVATION; INHIBITORS; SAP6; EPIDEMIOLOGY; INFECTIONS	Systemic infection by the pathogenic yeast Candida albicans produces high mortality in immune- compromised people. Such infection starts with the penetration of the organism at the mucosal surfaces, facilitated by the secreted aspartic proteases (Saps) 4, 5, and 6. The functional mechanism of these virulence factors is unclear. We discovered that Saps 4-6 each contains amino acid motifs RGD/KGD to bind integrins on epithelial cell A549 and are internalized to endosomes and lysosomes. These processes are inhibited by RGD-containing peptides or by substituting RGD motifs of these Saps. The internalization of Saps 4-6 results in partial permeabilization of lysosomal membranes, measured by the redistribution of the lysosomal tropic dye acridine orange to the cytosol, and the triggering of apoptosis via caspase activation. Sap 2 and mutated Saps 4-6 contain no RGD motif, are ineffective in these processes, and a proteolytic inhibitor abolished Sap 4 activity in lysosome permeabilization. Same results were also seen for human tongue keratinocyte SCC-15 cells. Mucosal lesions from this fundamental new mechanism may permit C. albicans to enter the body and may be used to attack cells in immune defense during systemic infections. RGD-motif may also be incorporated in Sap inhibitors for Candidiasis drugs targeting to lysosomes.	[Wu, Hao; Downs, Deborah; Tang, Jordan] Oklahoma Med Res Fdn, Prot Studies Program, Oklahoma City, OK 73104 USA; [Ghosh, Koena; Ghosh, Arun K.] Purdue Univ, Dept Chem & Med Chem, W Lafayette, IN 47907 USA; [Staib, Peter] Hans Knoell Inst, Leibniz Inst Nat Prod Res & Infect Biol, Jena, Germany; [Monod, Michel] CHU Vaudois, Lab Mycol, CH-1011 Lausanne, Switzerland	Oklahoma Medical Research Foundation; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Hans Knoll Institute (HKI); University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV)	Tang, J (corresponding author), Oklahoma Med Res Fdn, Prot Studies Program, 825 NE 13th St, Oklahoma City, OK 73104 USA.	jordan-tang@omrf.org			NIAID NIH HHS [R01 AI094335] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI094335] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Albrecht A, 2006, J BIOL CHEM, V281, P688, DOI 10.1074/jbc.M509297200; ALJANABI J, 1972, J BIOL CHEM, V247, P4628; Aoki W, 2011, J BIOCHEM, V150, P431, DOI 10.1093/jb/mvr073; Arthur PG, 2008, FREE RADICAL BIO MED, V44, P24, DOI 10.1016/j.freeradbiomed.2007.09.003; BECKSAGUE CM, 1993, J INFECT DIS, V167, P1247, DOI 10.1093/infdis/167.5.1247; Borelli C, 2008, PROTEINS, V72, P1308, DOI 10.1002/prot.22021; Borelli C, 2007, PROTEINS, V68, P738, DOI 10.1002/prot.21425; Borg-von Zepelin M, 1998, MOL MICROBIOL, V28, P543, DOI 10.1046/j.1365-2958.1998.00815.x; Borg-von Zepelin M, 1999, J INVEST DERMATOL, V113, P747, DOI 10.1046/j.1523-1747.1999.00747.x; Caswell PT, 2009, NAT REV MOL CELL BIO, V10, P843, DOI 10.1038/nrm2799; Colina AR, 1996, INFECT IMMUN, V64, P4514, DOI 10.1128/IAI.64.11.4514-4519.1996; Correia A, 2010, INFECT IMMUN, V78, P4839, DOI 10.1128/IAI.00248-10; CUTFIELD SM, 1995, STRUCTURE, V3, P1261, DOI 10.1016/S0969-2126(01)00261-1; De Bernardis F, 1999, J INFECT DIS, V179, P201, DOI 10.1086/314546; Doulias PT, 2007, FREE RADICAL BIO MED, V42, P567, DOI 10.1016/j.freeradbiomed.2006.11.022; Eggimann P, 2003, LANCET INFECT DIS, V3, P685, DOI 10.1016/S1473-3099(03)00801-6; Ferri KF, 2001, NAT CELL BIOL, V3, pE255, DOI 10.1038/ncb1101-e255; Gasparoto TH, 2004, FEMS IMMUNOL MED MIC, V42, P219, DOI 10.1016/j.femsim.2004.05.006; Ghosh AK, 2000, J AM CHEM SOC, V122, P3522, DOI 10.1021/ja000300g; Guicciardi ME, 2004, ONCOGENE, V23, P2881, DOI 10.1038/sj.onc.1207512; Hauck CR, 2006, EUR J CELL BIOL, V85, P235, DOI 10.1016/j.ejcb.2005.08.002; Hernandez-Canaveral I, 2009, MEM I OSWALDO CRUZ, V104, P858, DOI 10.1590/S0074-02762009000600006; Hube B, 1997, INFECT IMMUN, V65, P3529, DOI 10.1128/IAI.65.9.3529-3538.1997; Johansson AC, 2010, APOPTOSIS, V15, P527, DOI 10.1007/s10495-009-0452-5; KAMINISHI H, 1995, INFECT IMMUN, V63, P984, DOI 10.1128/IAI.63.3.984-988.1995; Laforge M, 2007, J VIROL, V81, P11426, DOI 10.1128/JVI.00597-07; Lermann U, 2008, MICROBIOL-SGM, V154, P3281, DOI 10.1099/mic.0.2008/022525-0; Monod M, 2010, METH PRIN MED CHEM, V45, P573; Morschhauser J, 1997, FEMS MICROBIOL LETT, V153, P349, DOI 10.1016/S0378-1097(97)00273-5; Naglik JR, 2003, MICROBIOL MOL BIOL R, V67, P400, DOI 10.1128/MMBR.67.3.400-428.2003; Naglik JR, 1999, INFECT IMMUN, V67, P2482, DOI 10.1128/IAI.67.5.2482-2490.1999; Naglik JR, 2008, MICROBIOL-SGM, V154, P3266, DOI 10.1099/mic.0.2008/022293-0; Prince LR, 2008, J IMMUNOL, V180, P3502, DOI 10.4049/jimmunol.180.5.3502; RUCHEL R, 1981, BIOCHIM BIOPHYS ACTA, V659, P99, DOI 10.1016/0005-2744(81)90274-6; Ruoslahti E, 1996, ANNU REV CELL DEV BI, V12, P697, DOI 10.1146/annurev.cellbio.12.1.697; Sanglard D, 1997, INFECT IMMUN, V65, P3539, DOI 10.1128/IAI.65.9.3539-3546.1997; Shi F, 2008, J CELL SCI, V121, P2360, DOI 10.1242/jcs.014977; Staib F, 1965, Sabouraudia, V4, P187; Staib P, 2000, P NATL ACAD SCI USA, V97, P6102, DOI 10.1073/pnas.110031497; Staib P, 2008, ANTIMICROB AGENTS CH, V52, P146, DOI 10.1128/AAC.01072-07; Villar CC, 2007, INFECT IMMUN, V75, P2126, DOI 10.1128/IAI.00054-07; Villar CC, 2010, MOL ORAL MICROBIOL, V25, P215, DOI 10.1111/j.2041-1014.2010.00577.x; Wang L, 2008, CELL, V133, P693, DOI 10.1016/j.cell.2008.03.036	43	47	49	1	15	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	JUN	2013	27	6					2132	2144		10.1096/fj.12-214353	http://dx.doi.org/10.1096/fj.12-214353			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	154II	23430844	Green Published			2022-12-25	WOS:000319667600005
J	Infantes, S; Lorente, E; Barnea, E; Beer, I; Barriga, A; Lasala, F; Jimenez, M; Admon, A; Lopez, D				Infantes, Susana; Lorente, Elena; Barnea, Eilon; Beer, Ilan; Barriga, Alejandro; Lasala, Fatima; Jimenez, Mercedes; Admon, Arie; Lopez, Daniel			Natural HLA-B*2705 Protein Ligands with Glutamine as Anchor Motif IMPLICATIONS FOR HLA-B27 ASSOCIATION WITH SPONDYLOARTHROPATHY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CLASS-I MOLECULES; CONNECTIVE-TISSUE DISEASE; MASS-SPECTROMETRY DATA; T-CELL LYMPHOMA; ANKYLOSING-SPONDYLITIS; RHEUMATOID-ARTHRITIS; MUTANTS MIMICKING; PEPTIDE LIGANDS; HLA-B27; BINDING	The presentation of short viral peptide antigens by human leukocyte antigen (HLA) class I molecules on cell surfaces is a key step in the activation of cytotoxic T lymphocytes, which mediate the killing of pathogen-infected cells or initiate autoimmune tissue damage. HLA-B27 is a well known class I molecule that is used to study both facets of the cellular immune response. Using mass spectrometry analysis of complex HLA-bound peptide pools isolated from large amounts of HLA-B*2705(+) cells, we identified 200 naturally processed HLA-B*2705 ligands. Our analyses revealed that a change in the position (P) 2 anchor motif was detected in the 3% of HLA-B*2705 ligands identified. B*2705 class I molecules were able to bind these six GlnP2 peptides, which showed significant homology to pathogenic bacterial sequences, with a broad range of affinities. One of these ligands was able to bind with distinct conformations to HLA-B27 subtypes differentially associated with ankylosing spondylitis. These conformational differences could be sufficient to initiate autoimmune damage in patients with ankylosing spondylitis-associated subtypes. Therefore, these kinds of peptides (short, with GlnP2, and similar low affinity to all HLA-B27 subtypes tested but with unlike conformations in differentially ankylosing spondylitis-associated subtypes) must not be excluded from future researches involving potential arthritogenic peptides.	[Infantes, Susana; Lorente, Elena; Barriga, Alejandro; Lasala, Fatima; Jimenez, Mercedes; Lopez, Daniel] Inst Salud Carlos III, Ctr Nacl Microbiol, Majadahonda 28220, Madrid, Spain; [Barnea, Eilon; Admon, Arie] Technion Israel Inst Technol, IL-32000 Haifa, Israel; [Beer, Ilan] IBM Haifa Res Lab, IL-3498825 Haifa, Israel	Instituto de Salud Carlos III; Centro Nacional de Microbiologa (CNM); Technion Israel Institute of Technology	Lopez, D (corresponding author), Inst Salud Carlos III, Unidad Proc Antigen, Ctr Nacl Microbiol, Majadahonda 28220, Madrid, Spain.	dlopez@isciii.es	López, Daniel/I-2632-2014; Lorente, Elena/B-1219-2019	López, Daniel/0000-0003-0268-5878; Lorente, Elena/0000-0002-2246-6851; LASALA, FATIMA/0000-0001-8183-1866; Barriga, Alejandro/0000-0001-6357-1917; Admon, Arie/0000-0003-0504-3950	Programa Ramon y Cajal; Ministerio de Ciencia e Innovacion; Israel Science Foundation [ISF 916/05]	Programa Ramon y Cajal(Spanish Government); Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Israel Science Foundation(Israel Science Foundation)	This work was supported by grants from the Programa Ramon y Cajal and the Ministerio de Ciencia e Innovacion (to D. L.) and from the Israel Science Foundation (ISF 916/05) (to A. A.).	Alvarez I, 2001, J BIOL CHEM, V276, P32729, DOI 10.1074/jbc.M104663200; BARNSTABLE CJ, 1978, CELL, V14, P9, DOI 10.1016/0092-8674(78)90296-9; Beer I, 2004, PROTEOMICS, V4, P950, DOI 10.1002/pmic.200300652; Ben Dror L, 2010, ARTHRITIS RHEUM-US, V62, P420, DOI 10.1002/art.27257; BENJAMIN R, 1990, IMMUNOL TODAY, V11, P137, DOI 10.1016/0167-5699(90)90051-A; BJORKMAN PJ, 1987, NATURE, V329, P506, DOI 10.1038/329506a0; BJORKMAN PJ, 1987, NATURE, V329, P512, DOI 10.1038/329512a0; BREWERTON DA, 1973, LANCET, V1, P904; CALVO V, 1990, J IMMUNOL, V144, P4038; Chubinskaya S, 2001, J HISTOCHEM CYTOCHEM, V49, P1165, DOI 10.1177/002215540104900910; Colmegna I, 2004, CLIN MICROBIOL REV, V17, P348, DOI 10.1128/CMR.17.2.348-369.2004; de Castro JAL, 2004, TISSUE ANTIGENS, V63, P424, DOI 10.1111/j.0001-2815.2004.00220.x; ELLIS SA, 1982, HUM IMMUNOL, V5, P49, DOI 10.1016/0198-8859(82)90030-1; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Evans DM, 2011, NAT GENET, V43, P761, DOI 10.1038/ng.873; Fabian H, 2010, ARTHRITIS RHEUM-US, V62, P978, DOI 10.1002/art.27316; Fan QR, 1996, P NATL ACAD SCI USA, V93, P7178, DOI 10.1073/pnas.93.14.7178; Galocha B, 1996, TISSUE ANTIGENS, V48, P509, DOI 10.1111/j.1399-0039.1996.tb02664.x; Haroon N, 2012, ANN RHEUM DIS, V71, P589, DOI 10.1136/annrheumdis-2011-200347; HASSFELD W, 1995, ARTHRITIS RHEUM-US, V38, P777, DOI 10.1002/art.1780380610; Hoffman RW, 2008, CLIN IMMUNOL, V128, P8, DOI 10.1016/j.clim.2008.03.461; Hulsmeyer M, 2004, J EXP MED, V199, P271, DOI 10.1084/jem.20031690; Infantes S, 2010, MOL CELL PROTEOMICS, V9, P1533, DOI 10.1074/mcp.M900508-MCP200; Kaida D, 2007, NAT CHEM BIOL, V3, P576, DOI 10.1038/nchembio.2007.18; Levy Y, 1997, CLIN RHEUMATOL, V16, P606, DOI 10.1007/BF02247801; LJUNGGREN HG, 1985, J EXP MED, V162, P1745, DOI 10.1084/jem.162.6.1745; LOPEZ D, 1992, J IMMUNOL, V148, P996; MADDEN DR, 1992, CELL, V70, P1035, DOI 10.1016/0092-8674(92)90252-8; Marcilla M, 2008, TISSUE ANTIGENS, V71, P495, DOI 10.1111/j.1399-0039.2008.01051.x; McKie N, 1997, BIOCHEM BIOPH RES CO, V230, P335, DOI 10.1006/bbrc.1996.5957; PARKER KC, 1994, J IMMUNOL, V152, P163; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Rammensee HG, 1999, IMMUNOGENETICS, V50, P213, DOI 10.1007/s002510050595; Samino Y, 2006, J BIOL CHEM, V281, P6358, DOI 10.1074/jbc.M512263200; Samino Y, 2004, J BIOL CHEM, V279, P1151, DOI 10.1074/jbc.M305343200; Sandberg Y, 2004, J AM ACAD DERMATOL, V51, P111, DOI 10.1016/j.jaad.2004.01.043; SELEZNICK MJ, 1989, J RHEUMATOL, V16, P1379; Sesma L, 2005, J IMMUNOL, V174, P7833, DOI 10.4049/jimmunol.174.12.7833; Sesma L, 2002, J BIOL CHEM, V277, P16744, DOI 10.1074/jbc.M200371200; STORKUS WJ, 1987, J IMMUNOL, V138, P1657; Tran TM, 2006, ARTHRITIS RHEUM-US, V54, P1317, DOI 10.1002/art.21740; VILLADANGOS JA, 1994, J IMMUNOL, V152, P2317; Wang MJ, 2007, VACCINE, V25, P2823, DOI 10.1016/j.vaccine.2006.12.038; Yague J, 2001, J BIOL CHEM, V276, P43699, DOI 10.1074/jbc.M105981200; York IA, 1999, IMMUNOL REV, V172, P49, DOI 10.1111/j.1600-065X.1999.tb01355.x	46	17	18	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 12	2013	288	15					10882	10889		10.1074/jbc.M113.455352	http://dx.doi.org/10.1074/jbc.M113.455352			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	125TU	23430249	hybrid, Green Published			2022-12-25	WOS:000317565000065
J	Luang, S; Cho, JI; Mahong, B; Opassiri, R; Akiyama, T; Phasai, K; Komvongsa, J; Sasaki, N; Hua, YL; Matsuba, Y; Ozeki, Y; Jeon, JS; Cairns, JRK				Luang, Sukanya; Cho, Jung-Il; Mahong, Bancha; Opassiri, Rodjana; Akiyama, Takashi; Phasai, Kannika; Komvongsa, Juthamath; Sasaki, Nobuhiro; Hua, Yan-Ling; Matsuba, Yuki; Ozeki, Yoshihiro; Jeon, Jong-Seong; Cairns, James R. Ketudat			Rice Os9BGlu31 Is a Transglucosidase with the Capacity to Equilibrate Phenylpropanoid, Flavonoid, and Phytohormone Glycoconjugates	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENE FAMILY; PLANT GLYCOSYLTRANSFERASES; EXPRESSION ANALYSIS; HYDROLASE; GLUCOSE; GLUCOSYLTRANSFERASE; CLASSIFICATION; TOLERANCE; MECHANISM; CLONING	Glycosylation is an important mechanism of controlling the reactivities and bioactivities of plant secondary metabolites and phytohormones. Rice (Oryza sativa) Os9BGlu31 is a glycoside hydrolase family GH1 transglycosidase that acts to transfer glucose between phenolic acids, phytohormones, and flavonoids. The highest activity was observed with the donors feruloyl-glucose, 4-coumaroyl-glucose, and sinapoyl-glucose, which are known to serve as donors in acyl and glucosyl transfer reactions in the vacuole, where Os9BGlu31 is localized. The free acids of these compounds also served as the best acceptors, suggesting that Os9BGlu31 may equilibrate the levels of phenolic acids and carboxylated phytohormones and their glucoconjugates. The Os9BGlu31 gene is most highly expressed in senescing flag leaf and developing seed and is induced in rice seedlings in response to drought stress and treatment with phytohormones, including abscisic acid, ethephon, methyljasmonate, 2,4-dichlorophenoxyacetic acid, and kinetin. Although site-directed mutagenesis of Os9BGlu31 indicated a function for the putative catalytic acid/base (Glu(169)), catalytic nucleophile residues (Glu(387)), and His(386), the wild type enzyme displays an unusual lack of inhibition by mechanism-based inhibitors of GH1 beta-glucosidases that utilize a double displacement retaining mechanism.	[Luang, Sukanya; Opassiri, Rodjana; Phasai, Kannika; Komvongsa, Juthamath; Hua, Yan-Ling; Cairns, James R. Ketudat] Suranaree Univ Technol, Inst Sci, Sch Biochem, Nakhon Ratchasima 30000, Thailand; [Luang, Sukanya; Opassiri, Rodjana; Phasai, Kannika; Komvongsa, Juthamath; Hua, Yan-Ling; Cairns, James R. Ketudat] Suranaree Univ Technol, Inst Sci, Sch Chem, Nakhon Ratchasima 30000, Thailand; [Cho, Jung-Il; Mahong, Bancha; Jeon, Jong-Seong] Kyung Hee Univ, Grad Sch Biotechnol, Yongin 446701, South Korea; [Cho, Jung-Il; Mahong, Bancha; Jeon, Jong-Seong] Kyung Hee Univ, Crop Biotech Inst, Yongin 446701, South Korea; [Akiyama, Takashi] Natl Agr Res Ctr Hokkaido Reg, Toyohira Ku, Sapporo, Hokkaido 0628555, Japan; [Sasaki, Nobuhiro; Matsuba, Yuki; Ozeki, Yoshihiro] Tokyo Univ Agr & Technol, Fac Engn, Dept Biotechnol & Life Sci, Koganei, Tokyo 1848588, Japan; [Hua, Yan-Ling] Suranaree Univ Technol, Ctr Sci & Technol Equipment, Nakhon Ratchasima 30000, Thailand; [Cairns, James R. Ketudat] Chulabhorn Res Inst, Biochem Lab, Bangkok 10210, Thailand	Suranaree University of Technology; Suranaree University of Technology; Kyung Hee University; Kyung Hee University; National Agriculture & Food Research Organization - Japan; Tokyo University of Agriculture & Technology; Suranaree University of Technology; Chulabhorn Research Institute	Jeon, JS (corresponding author), Kyung Hee Univ, Grad Sch Biotechnol, Yongin 446701, South Korea.	jjeon@khu.ac.kr; cairns@sut.ac.th	Ozeki, Yoshihiro/C-2052-2013; OZEKI, Yoshihiro/AAM-2229-2020; Cairns, James R Ketudat/B-6407-2019; Jeon, Jong-Seong/AAJ-2161-2020; Rattanapitoon, Nathkapach/M-8175-2018	Ozeki, Yoshihiro/0000-0002-3002-368X; Jeon, Jong-Seong/0000-0001-6221-4993; Rattanapitoon, Nathkapach/0000-0002-2806-2129; Ketudat Cairns, James/0000-0003-3042-1626	Suranaree University of Technology; National Research Council; Higher Education Research Promotion and National Research University Project, Office of the Higher Education Commission of Thailand; Next-Generation BioGreen 21 Program from the Rural Development Administration [PJ008114022011]; World Class University Program [R33-2008-000-10168-0]	Suranaree University of Technology; National Research Council; Higher Education Research Promotion and National Research University Project, Office of the Higher Education Commission of Thailand; Next-Generation BioGreen 21 Program from the Rural Development Administration; World Class University Program	This work was supported by Suranaree University of Technology and the National Research Council, along with the Higher Education Research Promotion and National Research University Project, Office of the Higher Education Commission of Thailand; by Next-Generation BioGreen 21 Program Grant PJ008114022011 from the Rural Development Administration; and by World Class University Program Grant R33-2008-000-10168-0.	Bachem CWB, 1996, PLANT J, V9, P745, DOI 10.1046/j.1365-313X.1996.9050745.x; Bowles D, 2006, ANNU REV PLANT BIOL, V57, P567, DOI 10.1146/annurev.arplant.57.032905.105429; Cairns JRK, 2010, CELL MOL LIFE SCI, V67, P3389, DOI 10.1007/s00018-010-0399-2; Campbell JA, 1997, BIOCHEM J, V326, P929, DOI 10.1042/bj3260929u; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Cho JI, 2005, PLANT CELL REP, V24, P225, DOI 10.1007/s00299-004-0910-z; Cho JI, 2006, PLANTA, V224, P598, DOI 10.1007/s00425-006-0251-y; Cho JI, 2009, PLANT PHYSIOL, V149, P745, DOI 10.1104/pp.108.131227; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Eklof JM, 2010, PLANT PHYSIOL, V153, P456, DOI 10.1104/pp.110.156844; Gantt RW, 2011, NAT CHEM BIOL, V7, P685, DOI [10.1038/NCHEMBIO.638, 10.1038/nchembio.638]; HENRISSAT B, 1991, BIOCHEM J, V280, P309, DOI 10.1042/bj2800309; Henrissat B, 2000, PLANT PHYSIOL, V124, P1515, DOI 10.1104/pp.124.4.1515; HIRAGA K, 1974, AGR BIOL CHEM TOKYO, V38, P2521, DOI 10.1080/00021369.1974.10861512; HOSEL W, 1987, ARCH BIOCHEM BIOPHYS, V252, P152, DOI 10.1016/0003-9861(87)90019-1; Jain M, 2006, BIOCHEM BIOPH RES CO, V345, P646, DOI 10.1016/j.bbrc.2006.04.140; Jeon JS, 2000, PLANT J, V22, P561, DOI 10.1046/j.1365-313x.2000.00767.x; Karimi M, 2002, TRENDS PLANT SCI, V7, P193, DOI 10.1016/S1360-1385(02)02251-3; Koshland D. E., 1953, BIOL REV CAMB PHILOS, V28, P415; Kwon Y, 2012, PLANT BIOTECHNOL REP, V6, P213, DOI 10.1007/s11816-011-0214-z; Lairson LL, 2008, ANNU REV BIOCHEM, V77, P521, DOI 10.1146/annurev.biochem.76.061005.092322; Lairson LL, 2004, CHEM COMMUN, P2243, DOI 10.1039/b406490a; Lee SS, 2011, NAT CHEM BIOL, V7, P631, DOI [10.1038/NCHEMBIO.628, 10.1038/nchembio.628]; Lim EK, 2005, CHEM-EUR J, V11, P5486, DOI 10.1002/chem.200500115; Lim EK, 2004, EMBO J, V23, P2915, DOI 10.1038/sj.emboj.7600295; Matsuba Y, 2010, PLANT CELL, V22, P3374, DOI 10.1105/tpc.110.077487; Miyahara T., 2013, J PLANT PHYSL, DOI org/10.1016/j.jplph.2012.12.001; MOCK HP, 1993, PHYTOCHEMISTRY, V32, P575, DOI 10.1016/S0031-9422(00)95139-2; Moellering ER, 2010, SCIENCE, V330, P226, DOI 10.1126/science.1191803; Mugford ST, 2009, PLANT CELL, V21, P2473, DOI 10.1105/tpc.109.065870; Obel N, 2003, PLANTA, V216, P620, DOI 10.1007/s00425-002-0863-9; Opassiri R, 2003, PLANT SCI, V165, P627, DOI 10.1016/S0168-9452(03)00235-8; Opassiri R, 2006, BMC PLANT BIOL, V6, DOI 10.1186/1471-2229-6-33; Paetzel M, 2002, CHEM REV, V102, P4549, DOI 10.1021/cr010166y; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Piens K, 2008, J BIOL CHEM, V283, P21864, DOI 10.1074/jbc.M803057200; Raychaudhuri A, 2002, PLANT PHYSIOL, V130, P2061, DOI 10.1104/pp.011049; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Stehle F, 2009, PHYTOCHEMISTRY, V70, P1652, DOI 10.1016/j.phytochem.2009.07.023; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tanthanuch W, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-84; Wang PT, 2011, CHINESE SCI BULL, V56, P3538, DOI 10.1007/s11434-011-4802-7; WANG QP, 1995, J AM CHEM SOC, V117, P10137, DOI 10.1021/ja00145a035; WITHERS SG, 1990, J AM CHEM SOC, V112, P5887, DOI 10.1021/ja00171a043; Xu ZY, 2012, PLANT CELL, V24, P2184, DOI 10.1105/tpc.112.095935; Xu ZW, 2004, PLANT MOL BIOL, V55, P343, DOI 10.1007/s11103-004-0790-1; Zechel DL, 2000, ACCOUNTS CHEM RES, V33, P11, DOI 10.1021/ar970172+	47	39	42	0	41	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 5	2013	288	14					10111	10123		10.1074/jbc.M112.423533	http://dx.doi.org/10.1074/jbc.M112.423533			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	119RB	23430256	Green Published, hybrid			2022-12-25	WOS:000317114000052
J	Liaw, HH; Lin, CC; Juan, HF; Huang, HC				Liaw, Hao-Han; Lin, Chen-Ching; Juan, Hsueh-Fen; Huang, Hsuan-Cheng			Differential MicroRNA Regulation Correlates with Alternative Polyadenylation Pattern between Breast Cancer and Normal Cells	PLOS ONE			English	Article							3' UNTRANSLATED REGIONS; MESSENGER-RNAS; SITE; TRANSCRIPTION; TERMINATION; EXPRESSION; GENOMICS; CLEAVAGE	Alternative polyadenylation (APA) could result in mRNA isoforms with variable lengths of 39 UTRs. Gain of microRNA target sites in the 39 UTR of a long mRNA isoform may cause different regulation from the corresponding short isoform. It has been known that cancer cells globally exhibit a lower ratio of long and short isoforms (LSR); that is, they tend to express larger amounts of short isoforms. The objective of this study is to illustrate the relationship between microRNA differential regulation and LSR. We retrieved public APA annotations and isoform expression profiles of breast cancer and normal cells from a high-throughput sequencing method study specific for the mRNA 39 end. Combining microRNA expression profiles, we performed statistical analysis to reveal and estimate microRNA regulation on APA patterns in a global scale. First, we found that the amount of microRNA target sites in the alternative UTR (aUTR), the region only present in long isoforms, could affect the LSR of the target genes. Second, we observed that the genes whose aUTRs were targeted by up-regulated microRNAs in cancer cells had an overall lower LSR. Furthermore, the target sites of up-regulated microRNAs tended to appear in aUTRs. Finally, we demonstrated that the amount of target sites for up-regulated microRNAs in aUTRs correlated with the LSR change between cancer and normal cells. The results indicate that up-regulation of microRNAs might cause lower LSRs of target genes in cancer cells through degradation of their long isoforms. Our findings provide evidence of how microRNAs might play a crucial role in APA pattern shifts from normal to cancerous or proliferative states.	[Liaw, Hao-Han; Huang, Hsuan-Cheng] Natl Yang Ming Univ, Ctr Syst & Synthet Biol, Inst Biomed Informat, Taipei 112, Taiwan; [Lin, Chen-Ching; Juan, Hsueh-Fen] Natl Taiwan Univ, Dept Life Sci, Grad Inst Biomed Elect & Bioinformat, Taipei 10764, Taiwan	National Yang Ming Chiao Tung University; National Taiwan University	Juan, HF (corresponding author), Natl Taiwan Univ, Dept Life Sci, Grad Inst Biomed Elect & Bioinformat, Taipei 10764, Taiwan.	yukijuan@ntu.edu.tw; hsuancheng@ym.edu.tw	Huang, Hsuan-Cheng/C-7266-2011	Huang, Hsuan-Cheng/0000-0002-3386-0934; JUAN, HSUEH-FEN/0000-0003-4876-3309	National Science Council of Taiwan [99-2621-B-010-001-MY3, 99-2621-B-002-005-MY3]; National Taiwan University Cutting-Edge Steering Research Project [10R70602C3]; National Health Research Institutes [NHRI-EX101-9819PI]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); National Taiwan University Cutting-Edge Steering Research Project; National Health Research Institutes(National Health Research Institutes, Japan)	This work was supported by grants from the National Science Council of Taiwan (99-2621-B-010-001-MY3 and 99-2621-B-002-005-MY3), the National Taiwan University Cutting-Edge Steering Research Project (10R70602C3), and National Health Research Institutes (NHRI-EX101-9819PI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Boutet SC, 2012, CELL STEM CELL, V10, P327, DOI 10.1016/j.stem.2012.01.017; Chen CY, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-S1-S41; Croce CM, 2009, NAT REV GENET, V10, P704, DOI 10.1038/nrg2634; Derti A, 2012, GENOME RES, V22, P1173, DOI 10.1101/gr.132563.111; Farazi TA, 2011, CANCER RES, V71, P4443, DOI 10.1158/0008-5472.CAN-11-0608; Flynt AS, 2008, NAT REV GENET, V9, P831, DOI 10.1038/nrg2455; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Fu YG, 2011, GENOME RES, V21, P741, DOI 10.1101/gr.115295.110; Hwang HW, 2006, BRIT J CANCER, V94, P776, DOI 10.1038/sj.bjc.6603023; Jan CH, 2011, NATURE, V469, P97, DOI 10.1038/nature09616; Ji Z, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.69; Ji Z, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008419; Ji Z, 2009, P NATL ACAD SCI USA, V106, P7028, DOI 10.1073/pnas.0900028106; Kim VN, 2006, TRENDS GENET, V22, P165, DOI 10.1016/j.tig.2006.01.003; Legendre M, 2006, PLOS COMPUT BIOL, V2, P333, DOI 10.1371/journal.pcbi.0020043; LOGAN J, 1987, P NATL ACAD SCI USA, V84, P8306, DOI 10.1073/pnas.84.23.8306; Mangone M, 2010, SCIENCE, V329, P432, DOI 10.1126/science.1191244; Mayr C, 2009, CELL, V138, P673, DOI 10.1016/j.cell.2009.06.016; Mendell JT, 2005, CELL CYCLE, V4, P1179, DOI 10.4161/cc.4.9.2032; Ozsolak F, 2010, CELL, V143, P1018, DOI 10.1016/j.cell.2010.11.020; Sandberg R, 2008, SCIENCE, V320, P1643, DOI 10.1126/science.1155390; Shepard PJ, 2011, RNA, V17, P761, DOI 10.1261/rna.2581711; Shivdasani RA, 2006, BLOOD, V108, P3646, DOI 10.1182/blood-2006-01-030015; Singh P, 2009, CANCER RES, V69, P9422, DOI 10.1158/0008-5472.CAN-09-2236; Tian B, 2005, NUCLEIC ACIDS RES, V33, P201, DOI 10.1093/nar/gki158; Ulitsky I, 2012, GENOME RES; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; WHITELAW E, 1986, EMBO J, V5, P2915, DOI 10.1002/j.1460-2075.1986.tb04587.x; Zhang HB, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-12-r100	30	19	19	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2013	8	2							e56958	10.1371/journal.pone.0056958	http://dx.doi.org/10.1371/journal.pone.0056958			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IT	23437281	Green Published, Green Submitted, gold			2022-12-25	WOS:000315186000060
J	Okoh, VO; Felty, Q; Parkash, J; Poppiti, R; Roy, D				Okoh, Victor O.; Felty, Quentin; Parkash, Jai; Poppiti, Robert; Roy, Deodutta			Reactive Oxygen Species via Redox Signaling to PI3K/AKT Pathway Contribute to the Malignant Growth of 4-Hydroxy Estradiol-Transformed Mammary Epithelial Cells	PLOS ONE			English	Article							ESTROGEN-RECEPTOR-ALPHA; BREAST-CANCER CELLS; ANCHORAGE-INDEPENDENT GROWTH; SUPEROXIDE-DISMUTASE GENE; MALE SYRIAN-HAMSTERS; PROTEIN-KINASE; OXIDATIVE STRESS; CARCINOMA-CELLS; NEOPLASTIC TRANSFORMATION; AKT ACTIVATION	The purpose of this study was to investigate the effects of 17-beta-estradiol (E2)-induced reactive oxygen species (ROS) on the induction of mammary tumorigenesis. We found that ROS-induced by repeated exposures to 4-hydroxy-estradiol (4-OH-E2), a predominant catechol metabolite of E2, caused transformation of normal human mammary epithelial MCF-10A cells with malignant growth in nude mice. This was evident from inhibition of estrogen-induced breast tumor formation in the xenograft model by both overexpression of catalase as well as by co-treatment with Ebselen. To understand how 4-OH-E2 induces this malignant phenotype through ROS, we investigated the effects of 4-OH-E2 on redox-sensitive signal transduction pathways. During the malignant transformation process we observed that 4-OH-E2 treatment increased AKT phosphorylation through PI3K activation. The PI3K-mediated phosphorylation of AKT in 4-OH-E2-treated cells was inhibited by ROS modifiers as well as by silencing of AKT expression. RNA interference of AKT markedly inhibited 4-OH-E2-induced in vitro tumor formation. The expression of cell cycle genes, cdc2, PRC1 and PCNA and one of transcription factors that control the expression of these genes - nuclear respiratory factor-1 (NRF-1) was significantly up-regulated during the 4-OH-E2-mediated malignant transformation process. The increased expression of these genes was inhibited by ROS modifiers as well as by silencing of AKT expression. These results indicate that 4-OH-E2-induced cell transformation may be mediated, in part, through redox-sensitive AKT signal transduction pathways by up-regulating the expression of cell cycle genes cdc2, PRC1 and PCNA, and the transcription factor - NRF-1. In summary, our study has demonstrated that: (i) 4-OH-E2 is one of the main estrogen metabolites that induce mammary tumorigenesis and (ii) ROS-mediated signaling leading to the activation of PI3K/AKT pathway plays an important role in the generation of 4-OH-E2-induced malignant phenotype of breast epithelial cells. In conclusion, ROS are important signaling molecules in the development of estrogen-induced malignant breast lesions.	[Okoh, Victor O.; Felty, Quentin; Parkash, Jai; Roy, Deodutta] Florida Int Univ, Dept Environm & Occupat Hlth, Miami, FL 33199 USA; [Poppiti, Robert] Florida Int Univ, Dept Pathol, Miami, FL 33199 USA	State University System of Florida; Florida International University; State University System of Florida; Florida International University	Roy, D (corresponding author), Florida Int Univ, Dept Environm & Occupat Hlth, Miami, FL 33199 USA.	Droy@fiu.edu		Felty, Quentin/0000-0002-7151-0441	Department of Defense (CDMRP) [W81XWH-06-1-0468]; Veterans Affairs [I01BX001463] Funding Source: NIH RePORTER	Department of Defense (CDMRP)(United States Department of Defense); Veterans Affairs(US Department of Veterans Affairs)	This work was supported in part by the Department of Defense (CDMRP) grant W81XWH-06-1-0468 to DR. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad S, 1999, BIOCHEM PHARMACOL, V58, P425, DOI 10.1016/S0006-2952(99)00125-2; Ambrosone CB, 1999, CANCER RES, V59, P602; Arteaga E, 2003, MENOPAUSE, V10, P142, DOI 10.1097/00042192-200310020-00005; Ball P, 1983, ACTA ENDOCRINOL-COP, V93, P1; Banerjee S, 2003, BIOCHEM BIOPH RES CO, V300, P209, DOI 10.1016/S0006-291X(02)02830-9; BARNEA ER, 1983, STEROIDS, V41, P643, DOI 10.1016/0039-128X(83)90030-2; Barnett SF, 2005, CURR TOP MED CHEM, V5, P109, DOI 10.2174/1568026053507714; Bocchinfuso WP, 1999, CANCER RES, V59, P1869; Burdick AD, 2003, CANCER RES, V63, P7825; Cai QY, 2004, BREAST CANCER RES, V6, pR647, DOI 10.1186/bcr929; Castagnetta L, 2004, ANN NY ACAD SCI, V1028, P233, DOI 10.1196/annals.1321.028; Castagnetta LAM, 2002, CLIN CANCER RES, V8, P3146; Cejas P, 2004, CANCER CAUSE CONTROL, V15, P707, DOI 10.1023/B:CACO.0000036189.61607.52; Couse JF, 1999, ENDOCR REV, V20, P358, DOI 10.1210/er.20.3.358; Covey TM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013545; Cuendet M, 2004, MUTAT RES-FUND MOL M, V550, P109, DOI 10.1016/j.mrfmmm.2004.02.005; Das SK, 2000, J BIOL CHEM, V275, P28834, DOI 10.1074/jbc.M003827200; Debnath J, 2003, J CELL BIOL, V163, P315, DOI 10.1083/jcb.200304159; Devanesan P, 2001, CARCINOGENESIS, V22, P1573, DOI 10.1093/carcin/22.9.1573; Dolado I, 2008, CANCER CELL, V14, P427, DOI 10.1016/j.ccr.2008.11.006; Embrechts J, 2003, J AM SOC MASS SPECTR, V14, P482, DOI 10.1016/S1044-0305(03)00130-2; Felty Q, 2005, BIOCHEMISTRY-US, V44, P6900, DOI 10.1021/bi047629p; Felty Q, 2005, ONCOGENE, V24, P4883, DOI 10.1038/sj.onc.1208667; Fernandez SV, 2006, INT J CANCER, V118, P1862, DOI 10.1002/ijc.21590; GALEOTTI T, 1983, BIOCHEM PHARMACOL, V32, P3285, DOI 10.1016/0006-2952(83)90352-0; Gao N, 2004, TOXICOL APPL PHARM, V196, P124, DOI 10.1016/j.taap.2003.12.002; HENDERSON BE, 1988, CANCER RES, V48, P246; HOLLAND MB, 1995, CARCINOGENESIS, V16, P1955, DOI 10.1093/carcin/16.8.1955; Hutchinson J, 2001, MOL CELL BIOL, V21, P2203, DOI 10.1128/MCB.21.6.2203-2212.2001; Hutchinson JN, 2004, CANCER RES, V64, P3171, DOI 10.1158/0008-5472.CAN-03-3465; *IARC, 1979, IARC MON, V21, P139; IARC, 2007, IARC MON EV CARC RIS, V91; *IARC, 1999, IARC MON EV CARC RIS, V72, P399; Jin J, 2005, ONCOGENE, V24, P5459, DOI 10.1038/sj.onc.1208704; Kim MS, 2003, CANCER RES, V63, P5454; Lam EWN, 1997, CANCER RES, V57, P5550; Lareef MH, 2005, INT J ONCOL, V26, P423; Lee YR, 2005, BIOCHEM BIOPH RES CO, V336, P1221, DOI 10.1016/j.bbrc.2005.08.256; Leung YK, 2006, NEOPLASIA, V8, P242, DOI 10.1593/neo.05853; Li JJ, 2002, MOL CARCINOGEN, V33, P56, DOI 10.1002/mc.10022; LI JJ, 1987, FED PROC, V46, P1858; LI JJ, 1995, ONCOGENE, V10, P1989; Liehr JG, 1996, P NATL ACAD SCI USA, V93, P3294, DOI 10.1073/pnas.93.8.3294; LIEHR JG, 1989, CARCINOGENESIS, V10, P1983, DOI 10.1093/carcin/10.11.1983; Liu Suling, 2004, Breast J, V10, P514, DOI 10.1111/j.1075-122X.2004.21410.x; Maggiolini M, 2004, J MOL ENDOCRINOL, V32, P777, DOI 10.1677/jme.0.0320777; Markides CSA, 2005, J ENDOCRINOL, V185, P235, DOI 10.1677/joe.1.06014; Melov S, 1999, P NATL ACAD SCI USA, V96, P846, DOI 10.1073/pnas.96.3.846; Millward TA, 1999, TRENDS BIOCHEM SCI, V24, P186, DOI 10.1016/S0968-0004(99)01375-4; Mirza AM, 2000, CELL GROWTH DIFFER, V11, P279; Mitrunen K, 2001, CARCINOGENESIS, V22, P827, DOI 10.1093/carcin/22.5.827; Moon R. C., 1981, Banbury Report, V8, P353; National Toxicology Program, 2002, FED REGISTER, V67, P77283; NCI, 2003, US HORM MEN; Niwa K, 2003, ANTIOXID REDOX SIGN, V5, P713, DOI 10.1089/152308603770380016; OBERLEY LW, 1988, MOL CELL BIOCHEM, V84, P147, DOI 10.1007/BF00421049; OBERLEY LW, 1984, J THEOR BIOL, V106, P403, DOI 10.1016/0022-5193(84)90038-9; Okoh V, 2011, BBA-REV CANCER, V1815, P115, DOI 10.1016/j.bbcan.2010.10.005; Park SA, 2009, CANCER RES, V69, P2416, DOI 10.1158/0008-5472.CAN-08-2177; Parkash J, 2006, BIOCHEMISTRY-US, V45, P2872, DOI 10.1021/bi051855x; Piantadosi CA, 2006, J BIOL CHEM, V281, P324, DOI 10.1074/jbc.M508805200; ROEDERER M, 1990, P NATL ACAD SCI USA, V87, P4884, DOI 10.1073/pnas.87.12.4884; Rogan EG, 2003, CARCINOGENESIS, V24, P697, DOI 10.1093/carcin/bgg004; Roy D, 2004, CURR GENOMICS, V5, P245, DOI 10.2174/1389202043349471; ROY D, 1988, J BIOL CHEM, V263, P3646; ROY D, 1990, CARCINOGENESIS, V11, P567, DOI 10.1093/carcin/11.4.567; Roy D., 1997, J TOXICOL ENV HLTH, V49, P101; Roy D, 1998, FRONT BIOSCI-LANDMRK, V3, P913; Russo J, 2002, ENVIRON MOL MUTAGEN, V39, P254, DOI 10.1002/em.10052; Russo J, 2002, J STEROID BIOCHEM, V80, P149, DOI 10.1016/S0960-0760(01)00183-2; Russo J, 2003, J STEROID BIOCHEM, V87, P1, DOI 10.1016/S0960-0760(03)00390-X; Schulze A, 2001, GENE DEV, V15, P981, DOI 10.1101/gad.191101; Soini Y, 2001, J PATHOL, V195, P156, DOI 10.1002/path.946; Son YO, 2012, TOXICOL APPL PHARM, V264, P153, DOI 10.1016/j.taap.2012.07.028; Stauffer Frederic, 2005, Current Medicinal Chemistry - Anti-Cancer Agents, V5, P449, DOI 10.2174/1568011054866937; Steinmetz KA, 1996, J AM DIET ASSOC, V96, P1027, DOI 10.1016/S0002-8223(96)00273-8; Sun M, 2001, CANCER RES, V61, P5985; THOMAS RD, 1995, CARCINOGENESIS, V16, P891, DOI 10.1093/carcin/16.4.891; Torres-Arzayus MI, 2004, CANCER CELL, V6, P263, DOI 10.1016/j.ccr.2004.06.027; Wang XT, 2000, J BIOL CHEM, V275, P14624, DOI 10.1074/jbc.275.19.14624; WEISZ J, 1992, ENDOCRINOLOGY, V131, P655, DOI 10.1210/en.131.2.655; Wilson AM, 2001, CARCINOGENESIS, V22, P257, DOI 10.1093/carcin/22.2.257; Xie B, 1999, CARCINOGENESIS, V20, P1069, DOI 10.1093/carcin/20.6.1069; Yang YA, 2002, EXP CELL RES, V279, P80, DOI 10.1006/excr.2002.5600; Yusuf R, 2010, CANCER CELL INT, V10, DOI 10.1186/1475-2867-10-30; Zhang X, 2003, J BIOL CHEM, V278, P7580, DOI 10.1074/jbc.M212050200	86	77	83	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2013	8	2							e54206	10.1371/journal.pone.0054206	http://dx.doi.org/10.1371/journal.pone.0054206			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IT	23437041	gold, Green Submitted, Green Published			2022-12-25	WOS:000315186000002
J	Bekada, A; Fregel, R; Cabrera, VM; Larruga, JM; Pestano, J; Benhamamouch, S; Gonzalez, AM				Bekada, Asmahan; Fregel, Rosa; Cabrera, Vicente M.; Larruga, Jose M.; Pestano, Jose; Benhamamouch, Soraya; Gonzalez, Ana M.			Introducing the Algerian Mitochondrial DNA and Y-Chromosome Profiles into the North African Landscape	PLOS ONE			English	Article							HIGH-RESOLUTION ANALYSIS; MTDNA HAPLOGROUP-H; SUB-SAHARAN AFRICA; NEAR-EASTERN; GENETIC-STRUCTURE; MOLECULAR DISSECTION; POPULATION-STRUCTURE; PHYLOGENETIC TREE; WESTERN; SEQUENCE	North Africa is considered a distinct geographic and ethnic entity within Africa. Although modern humans originated in this Continent, studies of mitochondrial DNA (mtDNA) and Y-chromosome genealogical markers provide evidence that the North African gene pool has been shaped by the back-migration of several Eurasian lineages in Paleolithic and Neolithic times. More recent influences from sub-Saharan Africa and Mediterranean Europe are also evident. The presence of East-West and North-South haplogroup frequency gradients strongly reinforces the genetic complexity of this region. However, this genetic scenario is beset with a notable gap, which is the lack of consistent information for Algeria, the largest country in the Maghreb. To fill this gap, we analyzed a sample of 240 unrelated subjects from a northwest Algeria cosmopolitan population using mtDNA sequences and Y-chromosome biallelic polymorphisms, focusing on the fine dissection of haplogroups E and R, which are the most prevalent in North Africa and Europe respectively. The Eurasian component in Algeria reached 80% for mtDNA and 90% for Y-chromosome. However, within them, the North African genetic component for mtDNA (U6 and M1; 20%) is significantly smaller than the paternal (E-M81 and E-V65; 70%). The unexpected presence of the European-derived Y-chromosome lineages R-M412, R-S116, R-U152 and R-M529 in Algeria and the rest of the Maghreb could be the counterparts of the mtDNA H1, H3 and V subgroups, pointing to direct maritime contacts between the European and North African sides of the western Mediterranean. Female influx of sub-Saharan Africans into Algeria (20%) is also significantly greater than the male (10%). In spite of these sexual asymmetries, the Algerian uniparental profiles faithfully correlate between each other and with the geography.	[Bekada, Asmahan; Benhamamouch, Soraya] Univ Oran, Fac Sci, Dept Biotechnol, Oran, Algeria; [Fregel, Rosa; Cabrera, Vicente M.; Larruga, Jose M.; Gonzalez, Ana M.] Univ La Laguna, Fac Biol, Dept Genet, Tenerife, Spain; [Fregel, Rosa; Pestano, Jose] Univ Las Palmas Gran Canaria, Fac Med, Dept Genet, Las Palmas Gran Canaria, Spain; [Fregel, Rosa; Pestano, Jose] Inst Legal Med Las Palmas, Forens Genet Lab, Las Palmas Gran Canaria, Spain	Universite d'Oran; Universidad de la Laguna; Universidad de Las Palmas de Gran Canaria	Gonzalez, AM (corresponding author), Univ La Laguna, Fac Biol, Dept Genet, Tenerife, Spain.	amglez@ull.es	Pestano, Jose/A-9640-2017; Fregel, Rosa/H-4942-2015	Pestano, Jose/0000-0001-6454-4785; Fregel, Rosa/0000-0002-2951-6508	Spanish Ministerio de Ciencia e Innovacion [CGL2010-16195]; University of La Laguna; Algerian grant	Spanish Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); University of La Laguna; Algerian grant	This research was supported by Grant no. CGL2010-16195 from the Spanish Ministerio de Ciencia e Innovacion to AMG and JML, by grant "Ayuda para el mantenimiento de grupos de investigacion consolidados 2012" from the University of La Laguna to AMG, and by Algerian grant to BA "programme boursier de formation a l'etranger au titre de l'annee universitaire 2010-2011 pour la categorie PNE." The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achilli A, 2004, AM J HUM GENET, V75, P910, DOI 10.1086/425590; Achilli A, 2005, AM J HUM GENET, V76, P883, DOI 10.1086/430073; Alvarez-Iglesias V, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005112; ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779; Arredi B, 2004, AM J HUM GENET, V75, P338, DOI 10.1086/423147; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Bosch E, 2000, EUR J HUM GENET, V8, P360, DOI 10.1038/sj.ejhg.5200464; Bosch E, 2001, AM J HUM GENET, V68, P1019, DOI 10.1086/319521; Brakez Z, 2001, ANN HUM BIOL, V28, P295, DOI 10.1080/030144601300119106; Capelli C, 2006, ANN HUM GENET, V70, P207, DOI 10.1111/j.1529-8817.2005.00224.x; Capelli C, 2009, EUR J HUM GENET, V17, P848, DOI 10.1038/ejhg.2008.258; Casas MJ, 2006, AM J PHYS ANTHROPOL, V131, P539, DOI 10.1002/ajpa.20463; Cerezo M, 2012, GENOME RES, V22, P821, DOI 10.1101/gr.134452.111; Cerny V, 2007, ANN HUM GENET, V71, P433, DOI 10.1111/j.1469-1809.2006.00339.x; Cherni L, 2005, HUM BIOL, V77, P61, DOI 10.1353/hub.2005.0028; Cherni L, 2009, AM J PHYS ANTHROPOL, V139, P253, DOI 10.1002/ajpa.20979; Chiaroni J, 2010, EUR J HUM GENET, V18, P348, DOI 10.1038/ejhg.2009.166; Cinnioglu C, 2004, HUM GENET, V114, P127, DOI 10.1007/s00439-003-1031-4; CorteReal HBSM, 1996, ANN HUM GENET, V60, P331, DOI 10.1111/j.1469-1809.1996.tb01196.x; Coudray C, 2009, ANN HUM GENET, V73, P196, DOI 10.1111/j.1469-1809.2008.00493.x; Cruciani F, 2002, AM J HUM GENET, V70, P1197, DOI 10.1086/340257; Cruciani F, 2007, MOL BIOL EVOL, V24, P1300, DOI 10.1093/molbev/msm049; Cruciani F, 2006, HUM MUTAT, V27, DOI 10.1002/humu.9445; Cruciani F, 2011, AM J HUM GENET, V88, P814, DOI 10.1016/j.ajhg.2011.05.002; Cruciani F, 2010, EUR J HUM GENET, V18, P800, DOI 10.1038/ejhg.2009.231; Egyed B, 2007, FORENSIC SCI INT-GEN, V1, P158, DOI 10.1016/j.fsigen.2007.03.001; Ennafaa H, 2011, J HUM GENET, V56, P734, DOI 10.1038/jhg.2011.92; Ennafaa H, 2009, BMC GENET, V10, DOI 10.1186/1471-2156-10-8; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Fadhlaoui-Zid K, 2011, AM J PHYS ANTHROPOL, V146, P271, DOI 10.1002/ajpa.21581; Fadhlaoui-Zid K, 2011, AM J PHYS ANTHROPOL, V145, P107, DOI 10.1002/ajpa.21472; Falchi A, 2006, J HUM GENET, V51, P9, DOI 10.1007/s10038-005-0324-y; Fentress Elizabeth, 1996, BERBERS; Flores C, 2004, EUR J HUM GENET, V12, P855, DOI 10.1038/sj.ejhg.5201225; Flores C, 2005, J HUM GENET, V50, P435, DOI 10.1007/s10038-005-0274-4; Francalacci P, 2003, AM J PHYS ANTHROPOL, V121, P270, DOI 10.1002/ajpa.10265; Fregel R, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-181; Garcia O, 2011, HEREDITY, V106, P37, DOI 10.1038/hdy.2010.47; Gonzalez AM, 2006, ANN HUM GENET, V70, P631, DOI 10.1111/j.1469-1809.2006.00259.x; Gonzalez AM, 2003, AM J PHYS ANTHROPOL, V120, P391, DOI 10.1002/ajpa.10168; Gonzalez AM, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-223; Gresham D, 2001, AM J HUM GENET, V69, P1314, DOI 10.1086/324681; Grignani P, 2006, INT J LEGAL MED, V120, P151, DOI 10.1007/s00414-005-0059-5; Grugni V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041252; Harich N, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-138; Henn BM, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002397; Karafet TM, 2008, GENOME RES, V18, P830, DOI 10.1101/gr.7172008; Kefi R, 2005, ANTHROPOL-INT J HUM, V43, P1; King RJ, 2008, ANN HUM GENET, V72, P205, DOI 10.1111/j.1469-1809.2007.00414.x; Krings M, 1999, AM J HUM GENET, V64, P1166, DOI 10.1086/302314; Loogvali EL, 2004, MOL BIOL EVOL, V21, P2012, DOI 10.1093/molbev/msh209; Loueslati BY, 2006, AM J HUM BIOL, V18, P149, DOI 10.1002/ajhb.20473; Luis JR, 2004, AM J HUM GENET, V74, P532, DOI 10.1086/382286; Maca-Meyer N, 2003, BMC GENET, V4, DOI 10.1186/1471-2156-4-15; Maca-Meyer N, 2001, BMC GENET, V2, DOI 10.1186/1471-2156-2-13; Malyarchuk B, 2008, MOL BIOL EVOL, V25, P1651, DOI 10.1093/molbev/msn114; Malyarchuk B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010285; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Moorjani P, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001373; Murdock G.P., 1959, AFRICA ITS PEOPLES T; Myres NM, 2011, EUR J HUM GENET, V19, P95, DOI 10.1038/ejhg.2010.146; Nei N, 1987, MOL EVOLUTIONARY GEN; Newman JL., 1995, PEOPLING AFRICA GEOG; Olivieri A, 2006, SCIENCE, V314, P1767, DOI 10.1126/science.1135566; Ottoni C, 2011, AM J PHYS ANTHROPOL, V145, P118, DOI 10.1002/ajpa.21473; Ottoni C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013378; Pala M, 2009, AM J HUM GENET, V84, P814, DOI 10.1016/j.ajhg.2009.05.004; Pereira L, 2005, GENOME RES, V15, P19, DOI 10.1101/gr.3182305; Pereira L, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-390; Pereira L, 2010, EUR J HUM GENET, V18, P915, DOI 10.1038/ejhg.2010.21; Plaza S, 2003, ANN HUM GENET, V67, P312, DOI 10.1046/j.1469-1809.2003.00039.x; Quintana-Murci L, 1999, NAT GENET, V23, P437, DOI 10.1038/70550; Quintans B, 2004, FORENSIC SCI INT, V140, P251, DOI 10.1016/j.forsciint.2003.12.005; Rando JC, 1998, ANN HUM GENET, V62, P531, DOI 10.1046/j.1469-1809.1998.6260531.x; Reidla M, 2003, AM J HUM GENET, V73, P1178, DOI 10.1086/379380; Rhouda T, 2009, MITOCHONDRION, V9, P402, DOI 10.1016/j.mito.2009.07.003; Richards M, 2000, AM J HUM GENET, V67, P1251, DOI 10.1016/S0002-9297(07)62954-1; Richards M, 2003, AM J HUM GENET, V72, P1058, DOI 10.1086/374384; Robino C, 2008, INT J LEGAL MED, V122, P251, DOI 10.1007/s00414-007-0203-5; Roostalu U, 2007, MOL BIOL EVOL, V24, P436, DOI 10.1093/molbev/msl173; Santos C, 2005, MOL BIOL EVOL, V22, P1490, DOI 10.1093/molbev/msi141; Semino O, 2004, AM J HUM GENET, V74, P1023, DOI 10.1086/386295; Tambets K, 2004, AM J HUM GENET, V74, P661, DOI 10.1086/383203; Tofanelli S, 2009, EUR J HUM GENET, V17, P1520, DOI 10.1038/ejhg.2009.58; Torroni A, 2001, AM J HUM GENET, V69, P844, DOI 10.1086/323485; Trombetta B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016073; Underhill PA, 2007, ANNU REV GENET, V41, P539, DOI 10.1146/annurev.genet.41.110306.130407; van Oven M, 2009, HUM MUTAT, V30, pE386, DOI 10.1002/humu.20921; Watson E, 1997, AM J HUM GENET, V61, P691, DOI 10.1086/515503; Wendorf F, 1994, J RADIOCARBON ASS AM, P147	91	42	42	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2013	8	2							e56775	10.1371/journal.pone.0056775	http://dx.doi.org/10.1371/journal.pone.0056775			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	093HR	23431392	gold, Green Published, Green Submitted			2022-12-25	WOS:000315182800035
J	Coelho, JR; Carrico, JA; Knight, D; Martinez, JL; Morrissey, I; Oggioni, MR; Freitas, AT				Coelho, Joana Rosado; Carrico, Joao Andre; Knight, Daniel; Martinez, Jose-Luis; Morrissey, Ian; Oggioni, Marco Rinaldo; Freitas, Ana Teresa			The Use of Machine Learning Methodologies to Analyse Antibiotic and Biocide Susceptibility in Staphylococcus aureus	PLOS ONE			English	Article							PSEUDOMONAS-AERUGINOSA; BACTERIAL-RESISTANCE; ANTIMICROBIAL RESISTANCE; ESCHERICHIA-COLI; CLINICAL STRAINS; TRICLOSAN; EXPOSURE; EFFLUX; TYPHIMURIUM; BREAKPOINTS	Background: The rise of antibiotic resistance in pathogenic bacteria is a significant problem for the treatment of infectious diseases. Resistance is usually selected by the antibiotic itself; however, biocides might also co-select for resistance to antibiotics. Although resistance to biocides is poorly defined, different in vitro studies have shown that mutants presenting low susceptibility to biocides also have reduced susceptibility to antibiotics. However, studies with natural bacterial isolates are more limited and there are no clear conclusions as to whether the use of biocides results in the development of multidrug resistant bacteria. Methods: The main goal is to perform an unbiased blind-based evaluation of the relationship between antibiotic and biocide reduced susceptibility in natural isolates of Staphylococcus aureus. One of the largest data sets ever studied comprising 1632 human clinical isolates of S. aureus originated worldwide was analysed. The phenotypic characterization of 13 antibiotics and 4 biocides was performed for all the strains. Complex links between reduced susceptibility to biocides and antibiotics are difficult to elucidate using the standard statistical approaches in phenotypic data. Therefore, machine learning techniques were applied to explore the data. Results: In this pioneer study, we demonstrated that reduced susceptibility to two common biocides, chlorhexidine and benzalkonium chloride, which belong to different structural families, is associated to multidrug resistance. We have consistently found that a minimum inhibitory concentration greater than 2 mg/L for both biocides is related to antibiotic non-susceptibility in S. aureus. Conclusions: Two important results emerged from our work, one methodological and one other with relevance in the field of antibiotic resistance. We could not conclude on whether the use of antibiotics selects for biocide resistance or vice versa. However, the observation of association between multiple resistance and two biocides commonly used may be of concern for the treatment of infectious diseases in the future.	[Coelho, Joana Rosado; Carrico, Joao Andre; Freitas, Ana Teresa] Univ Tecn Lisboa, INESC ID IST, Lisbon, Portugal; [Carrico, Joao Andre] Univ Lisbon, Fac Med, Inst Mol Med, Inst Microbiol, P-1699 Lisbon, Portugal; [Knight, Daniel; Morrissey, Ian] Quotient Biores, Fordham, England; [Knight, Daniel] Univ Western Australia, Queen Elizabeth II Med Ctr, Nedlands, WA 6009, Australia; [Martinez, Jose-Luis] CSIC, Ctr Nacl Biotecnol, Dept Biotecnol Microbiana, Madrid, Spain; [Morrissey, Ian] IHMA Europe Sarl, Epalinges, Switzerland; [Oggioni, Marco Rinaldo] Univ Siena, Dipartimento Biotecnol, I-53100 Siena, Italy	INESC-ID; Universidade de Lisboa; Universidade de Lisboa; Quotient; University of Western Australia; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); IHMA Europe Sarl; University of Siena	Coelho, JR (corresponding author), Univ Tecn Lisboa, INESC ID IST, Lisbon, Portugal.	jrcoelho@kdbio.inesc-id.pt	Oggioni, Marco Rinaldo/K-3839-2016; Coelho, Joana Rosado/I-7008-2015; Carriço, Joao André/A-7367-2008; Freitas, Ana Teresa/C-3647-2008; Knight, Daniel R./F-2522-2014; Martinez, Jose L/A-4725-2013	Oggioni, Marco Rinaldo/0000-0003-4117-793X; Coelho, Joana Rosado/0000-0002-2827-7031; Carriço, Joao André/0000-0002-5274-2722; Freitas, Ana Teresa/0000-0002-2997-5990; Knight, Daniel R./0000-0002-9480-4733; Martinez, Jose L/0000-0001-8813-7607; Morrissey, Ian/0000-0001-8254-9651	FCT [PEst-OE/EEI/LA0021/2011]; FP7 Cooperation Work Programme: Food, Agriculture and Fisheries, and Biotechnologies (BIOHYPO project) [KBBE-227258]; European Union; Fundacao para a Ciencia e a Tecnologia [SFRH/BD/33719/2009]	FCT(Portuguese Foundation for Science and TechnologyEuropean Commission); FP7 Cooperation Work Programme: Food, Agriculture and Fisheries, and Biotechnologies (BIOHYPO project); European Union(European Commission); Fundacao para a Ciencia e a Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission)	This work was supported by FCT (INESC-ID multiannual funding) through the PIDDAC Program funds and under project PEst-OE/EEI/LA0021/2011 and the FP7 Cooperation Work Programme: Food, Agriculture and Fisheries, and Biotechnologies, KBBE-227258 (BIOHYPO project). Quotient Bioresearch received part-funding from the European Union in the scope of BIOHYPO project. The work of J. R. Coelho was supported by the PhD grant SFRH/BD/33719/2009 from Fundacao para a Ciencia e a Tecnologia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aase B, 2000, INT J FOOD MICROBIOL, V62, P57, DOI 10.1016/S0168-1605(00)00357-3; Abdi H., 2007, ENCY MEASUREMENT STA, V3, P103; Adriaans P., 1997, DATA MINING; Aiello AE, 2007, CLIN INFECT DIS, V45, pS137, DOI 10.1086/519255; Ambrose PG, 2006, PHARMACOTHERAPY, V26, P129, DOI 10.1592/phco.2006.26.1.129; Anunciacao O, 2010, ADV INTEL SOFT COMPU, V74, P43, DOI 10.1007/978-3-642-13214-8_6; Bailey AM, 2009, J ANTIMICROB CHEMOTH, V64, P973, DOI 10.1093/jac/dkp320; Beier RC, 2005, B ENVIRON CONTAM TOX, V75, P835, DOI 10.1007/s00128-005-0826-5; Beier RC, 2011, FOODBORNE PATHOG DIS, V8, P593, DOI 10.1089/fpd.2010.0702; Birosova L, 2009, J MED MICROBIOL, V58, P436, DOI 10.1099/jmm.0.003657-0; Chapman JS, 1998, INT BIODETER BIODEGR, V41, P241, DOI 10.1016/S0964-8305(98)00025-0; Chuanchuen R, 2002, J BACTERIOL, V184, P5036, DOI 10.1128/JB.184.18.5036-5044.2002; Chuanchuen R, 2001, ANTIMICROB AGENTS CH, V45, P428, DOI 10.1128/AAC.45.2.428-432.2001; Ciusa ML, 2012, INT J ANTIMICROB AG, V40, P210, DOI 10.1016/j.ijantimicag.2012.04.021; Clinical and Laboratory Standards Institute, 1999, METHODS DETERMINING; CLSI, 2018, PERFORMANCE STANDARD; CLSI, 2018, METHODS DILUTION ANT; Copitch JL, 2010, INT J ANTIMICROB AG, V36, P247, DOI 10.1016/j.ijantimicag.2010.04.012; EARSS, 2005, ANN REP EUR ANT RES; Espigares E, 2006, INT J HYG ENVIR HEAL, V209, P103, DOI 10.1016/j.ijheh.2005.08.006; Falagas ME, 2007, INT J ANTIMICROB AG, V29, P630, DOI 10.1016/j.ijantimicag.2006.12.012; Ferber D, 2000, SCIENCE, V288, P792, DOI 10.1126/science.288.5467.792; Francisco AP, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-87; Francisco AP, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-152; Harbarth S, 2005, EMERG INFECT DIS, V11, P794, DOI 10.3201/eid1106.050167; Hernandez A, 2011, PLOS PATHOG, V7, P12; Hesterberg T, 2003, BOOTSTRAP METHODS PE, V47, P1; Hochberg Y., 1987, MULTIPLE COMP PROCED; Hugard L, 1994, MED AFRIQUE NOIRE, V41, P31; Jansen WTM, 2006, DRUG RESIST UPDATE, V9, P123, DOI 10.1016/j.drup.2006.06.002; Kraskov A, 2008, EUROPHYSICS LETT, P70; Lambert RJW, 2004, J APPL MICROBIOL, V97, P699, DOI 10.1111/j.1365-2672.2004.02345.x; Levy SB, 2001, EMERG INFECT DIS, V7, P512, DOI 10.3201/eid0707.017705; Li MY, 2009, BIOINFORMATICS, V25, P497, DOI 10.1093/bioinformatics/btn641; Lucey B, 2000, EMERG INFECT DIS, V6, P50; LYON BR, 1987, MICROBIOL REV, V51, P88, DOI 10.1128/MMBR.51.1.88-134.1987; MacGowan AP, 2001, J ANTIMICROB CHEMOTH, V48, P17, DOI 10.1093/jac/48.suppl_1.17; Magiorakos AP, 2012, CLIN MICROBIOL INFEC, V18, P268, DOI 10.1111/j.1469-0691.2011.03570.x; Maillard JY, 2009, CHIM OGGI, V27, P26; Marchini J, 2005, NAT GENET, V37, P413, DOI 10.1038/ng1537; McMurry LM, 1998, FEMS MICROBIOL LETT, V166, P305, DOI 10.1016/S0378-1097(98)00347-4; Mitchell T.M, 2003, MACH LEARN; Molbak K, 1999, NEW ENGL J MED, V341, P1420, DOI 10.1056/NEJM199911043411902; Parikh SL, 2000, BIOCHEMISTRY-US, V39, P7645, DOI 10.1021/bi0008940; PAULSEN IT, 1993, ANTIMICROB AGENTS CH, V37, P761, DOI 10.1128/AAC.37.4.761; Rouillon S, 2006, PATHOL BIOL, V54, P325, DOI 10.1016/j.patbio.2006.01.011; Russell AD, 2004, J ANTIMICROB CHEMOTH, V53, P693, DOI 10.1093/jac/dkh171; Russell AD, 2002, J APPL MICROBIOL, V92, p1S, DOI 10.1046/j.1365-2672.92.5s1.14.x; Rutala WA, 2001, J HOSP INFECT, V48, pS64, DOI 10.1016/S0195-6701(01)90017-9; Sanchez P, 2005, ANTIMICROB AGENTS CH, V49, P781, DOI 10.1128/AAC.49.2.781-782.2005; SCCS, 2010, OP TRICL ANT RES EUR; Soumet C, 2005, LETT APPL MICROBIOL, V41, P291, DOI 10.1111/j.1472-765X.2005.01763.x; Tankovic J, 1997, MED MALADIES INFECT, V27, P207, DOI 10.1016/S0399-077X(97)80022-4; Tarca AL, 2007, PLOS COMPUT BIOL, V3, P953, DOI 10.1371/journal.pcbi.0030116; THABAUT A, 1983, MED MALADIES INFECT, V13, P128, DOI 10.1016/S0399-077X(83)80110-3; Turnidge J, 2006, CLIN MICROBIOL INFEC, V12, P418, DOI 10.1111/j.1469-0691.2006.01377.x; Weisstein EW, 2012, FISHERS EXACT TEST; WHO, 2007, WORLD HLTH REP A SAF	59	24	24	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2013	8	2							e55582	10.1371/journal.pone.0055582	http://dx.doi.org/10.1371/journal.pone.0055582			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093HR	23431361	gold, Green Published			2022-12-25	WOS:000315182800004
J	Todd, G; Noyes, C; Flavel, SC; Della Vedova, CB; Spyropoulos, P; Chatterton, B; Berg, D; White, JM				Todd, Gabrielle; Noyes, Carolyn; Flavel, Stanley C.; Della Vedova, Chris B.; Spyropoulos, Peter; Chatterton, Barry; Berg, Daniela; White, Jason M.			Illicit Stimulant Use Is Associated with Abnormal Substantia Nigra Morphology in Humans	PLOS ONE			English	Article							IDIOPATHIC PARKINSONS-DISEASE; TRANSCRANIAL SONOGRAPHY; MONOAMINE-OXIDASE; MDMA ECSTASY; METHAMPHETAMINE ABUSERS; CLINICAL-PHARMACOLOGY; DOPAMINE TRANSPORTERS; MOVEMENT-DISORDERS; RAT-BRAIN; AMPHETAMINE	Use of illicit stimulants such as methamphetamine, cocaine, and ecstasy is an increasing health problem. Chronic use can cause neurotoxicity in animals and humans but the long-term consequences are not well understood. The aim of the current study was to investigate the long-term effect of stimulant use on the morphology of the human substantia nigra. We hypothesised that history of illicit stimulant use is associated with an abnormally bright and enlarged substantia nigra (termed 'hyperechogenicity') when viewed with transcranial sonography. Substantia nigra morphology was assessed in abstinent stimulant users (n = 36; 31 +/- 9 yrs) and in two groups of control subjects: non-drug users (n = 29; 24 +/- 5 yrs) and cannabis users (n = 12; 2567 yrs). Substantia nigra morphology was viewed with transcranial sonography and the area of echogenicity at the anatomical site of the substantia nigra was measured at its greatest extent. The area of substantia nigra echogenicity was significantly larger in the stimulant group (0.273 +/- 0.078 cm(2)) than in the control (0.201 +/- 0.054 cm(2); P<0.001) and cannabis (0.202 +/- 0.045 cm(2); P<0.007) groups. 53% of stimulant users exhibited echogenicity that exceeded the 90th percentile for the control group. The results of the current study suggest that individuals with a history of illicit stimulant use exhibit abnormal substantia nigra morphology. Substantia nigra hyperechogenicity is a strong risk factor for developing Parkinson's disease later in life and further research is required to determine if the observed abnormality in stimulant users is associated with a functional deficit of the nigro-striatal system.	[Todd, Gabrielle; Noyes, Carolyn; Flavel, Stanley C.; Della Vedova, Chris B.; White, Jason M.] Univ S Australia, Sch Pharm & Med Sci, Adelaide, SA 5001, Australia; [Todd, Gabrielle; White, Jason M.] Univ S Australia, Sansom Inst, Adelaide, SA 5001, Australia; [Spyropoulos, Peter; Chatterton, Barry] Royal Adelaide Hosp, Dept Nucl Med PET & Bone Densitometry & Radiol, Adelaide, SA 5000, Australia; [Berg, Daniela] Hertie Inst Clin Brain Res, Dept Neurodegenerat, Tubingen, Germany; [Berg, Daniela] German Ctr Neurodegenerat Dis, Tubingen, Germany	University of South Australia; University of South Australia; Royal Adelaide Hospital; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE)	Todd, G (corresponding author), Univ S Australia, Sch Pharm & Med Sci, Adelaide, SA 5001, Australia.	gabrielle.todd@unisa.edu.au	Todd, Gabrielle/K-7122-2012; Berg, Daniela/A-8728-2019; Della Vedova, Chris B/F-4583-2013; White, Jason M/A-2795-2011	Todd, Gabrielle/0000-0002-2465-6026; Berg, Daniela/0000-0001-5796-5442; Della Vedova, Chris B/0000-0002-2361-3729; White, Jason M/0000-0001-6750-1078	Clive and Vera Ramaciotti Foundation [ID 2974/2010]; National Health and Medical Research Council of Australia [ID 627003]; University of South Australia	Clive and Vera Ramaciotti Foundation; National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); University of South Australia	This work was supported by the Clive and Vera Ramaciotti Foundation (establishment grant, ID 2974/2010), National Health and Medical Research Council of Australia (GT holds a Career Development Award; ID 627003), and University of South Australia (GT holds a Rsearch SA Fellowship; SF held an Australian Postgraduate Award; CDV, GT, and JW hold a Division of Health Sciences Research Grant). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIHW, 2011, 2010 NAT DRUG STRAT; *AUSTR I HLTH WELF, 2005, 2004 NAT DRUG STRAT; Beck A.T., 1996, PSYCHOL ASSESS, DOI DOI 10.1037/T00742-000; Behnke S, 2009, NEUROIMAGE, V47, P1237, DOI 10.1016/j.neuroimage.2009.05.072; BENOWITZ NL, 1993, PHARMACOL TOXICOL, V72, P3, DOI 10.1111/j.1600-0773.1993.tb01331.x; Benton AL, 1983, MULTILINGUAL APHASIA; Berg D, 2010, J NEURAL TRANSM, V117, P1287, DOI 10.1007/s00702-010-0504-6; Berg D, 2002, ARCH NEUROL-CHICAGO, V59, P999, DOI 10.1001/archneur.59.6.999; Berg D, 2001, J NEUROL, V248, P684, DOI 10.1007/s004150170114; Berg D, 2001, NEUROLOGY, V56, P13, DOI 10.1212/WNL.56.1.13; Berg D, 1999, ULTRASOUND MED BIOL, V25, P901, DOI 10.1016/S0301-5629(99)00046-0; Berg D, 1999, NEUROLOGY, V53, P1026, DOI 10.1212/WNL.53.5.1026; Berg D, 2008, LANCET NEUROL, V7, P1044, DOI 10.1016/S1474-4422(08)70239-4; Berg D, 2007, PARKINSONISM RELAT D, V13, pS429, DOI 10.1016/S1353-8020(08)70043-9; Berg D, 2011, ARCH NEUROL-CHICAGO, V68, P932, DOI 10.1001/archneurol.2011.141; Bouwmans AEP, 2010, INT REV NEUROBIOL, V90, P121, DOI 10.1016/S0074-7742(10)90009-3; Breen C, 2006, SUBST USE MISUSE, V41, P1095, DOI 10.1080/10826080500411528; Callaghan RC, 2010, MOVEMENT DISORD, V25, P2333, DOI 10.1002/mds.23263; COMMINS DL, 1987, J PHARMACOL EXP THER, V241, P338; de Wit H, 2009, ADDICT BIOL, V14, P22, DOI 10.1111/j.1369-1600.2008.00129.x; Doepp F, 2008, MOVEMENT DISORD, V23, P405, DOI 10.1002/mds.21861; FEARNLEY JM, 1991, BRAIN, V114, P2283, DOI 10.1093/brain/114.5.2283; Green AR, 2003, PHARMACOL REV, V55, P463, DOI 10.1124/pr.55.3.3; GRIGSBY J, 1995, PERCEPT MOTOR SKILL, V80, P732, DOI 10.2466/pms.1995.80.3.732; Hatzidimitriou G, 1999, J NEUROSCI, V19, P5096; Hochstrasser H, 2004, NEUROLOGY, V63, P1912, DOI 10.1212/01.WNL.0000144276.29988.C3; Huang YW, 2007, MOV DISORD; Jones SR, 1998, J NEUROSCI, V18, P1979; Kalant H, 2001, CAN MED ASSOC J, V165, P917; KEARCOLWELL JJ, 1978, J CLIN PSYCHOL, V34, P437, DOI 10.1002/1097-4679(197804)34:2<437::AID-JCLP2270340239>3.0.CO;2-K; Kim JY, 2007, MOVEMENT DISORD, V22, P1922, DOI 10.1002/mds.21628; Kish SJ, 2010, J PSYCHOPHARMACOL, V24, P281, DOI 10.1177/0269881108097724; Lew R, 1996, J PHARMACOL EXP THER, V276, P855; Lewis AJ, 2012, TOB CONTROL, V21, P39, DOI 10.1136/tc.2010.040287; Little KY, 2009, PSYCHIAT RES, V168, P173, DOI 10.1016/j.psychres.2008.10.034; MANTLE TJ, 1976, BIOCHEM PHARMACOL, V25, P2073, DOI 10.1016/0006-2952(76)90432-9; McCann UD, 1998, LANCET, V352, P1433, DOI 10.1016/S0140-6736(98)04329-3; Melega WP, 2007, NEUROREPORT, V18, P1741, DOI 10.1097/WNR.0b013e3282f0d4f4; Melega WP, 1996, SYNAPSE, V22, P63, DOI 10.1002/(SICI)1098-2396(199601)22:1<63::AID-SYN7>3.0.CO;2-G; Moore DJ, 2003, NEUROMOL MED, V4, P95, DOI 10.1385/NMM:4:1-2:95; Mrazik M, 2010, ARCH CLIN NEUROPSYCH, V25, P236, DOI 10.1093/arclin/acq006; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Quan Li, 2005, Legal Medicine, V7, P144, DOI 10.1016/j.legalmed.2004.11.002; Reneman L, 2002, NEUROPSYCHOPHARMACOL, V26, P387, DOI 10.1016/S0893-133X(01)00366-9; RICAURTE GA, 1992, J PHARMACOL EXP THER, V261, P616; RITZ MC, 1987, SCIENCE, V237, P1219, DOI 10.1126/science.2820058; Rossi S, 2009, CLIN NEUROPHYSIOL, V120, P2008, DOI 10.1016/j.clinph.2009.08.016; SCHMIDT CJ, 1987, BIOCHEM PHARMACOL, V36, P4095, DOI 10.1016/0006-2952(87)90566-1; Scorza MC, 1997, BIOCHEM PHARMACOL, V54, P1361, DOI 10.1016/S0006-2952(97)00405-X; Skoloudik D, 2007, ULTRASOUND MED BIOL, V33, P1347, DOI 10.1016/j.ultrasmedbio.2007.03.013; Skoloudik D, 2010, INT REV NEUROBIOL, V90, P7, DOI 10.1016/S0074-7742(10)90002-0; Spiegel J, 2006, BRAIN, V129, P1188, DOI 10.1093/brain/awl042; Subramanian T, 2010, ULTRASOUND MED BIOL, V36, P604, DOI 10.1016/j.ultrasmedbio.2009.12.001; Sulzer D, 2005, PROG NEUROBIOL, V75, P406, DOI 10.1016/j.pneurobio.2005.04.003; SULZER D, 1995, J NEUROSCI, V15, P4102; Thompson G.B., 1992, PSYCHOL ASSESSMENT, V4, P363; Tombaugh TN, 1999, ARCH CLIN NEUROPSYCH, V14, P167, DOI 10.1016/S0887-6177(97)00095-4; Tsai CF, 2007, J NEUROL, V254, P501, DOI 10.1007/s00415-006-0403-9; Volkow ND, 2001, J NEUROSCI, V21, P9414, DOI 10.1523/JNEUROSCI.21-23-09414.2001; Volkow ND, 2001, AM J PSYCHIAT, V158, P2015, DOI 10.1176/appi.ajp.158.12.2015; Wechsler D, 1987, WMS R WECHSLER MEMOR; Wechsler D., 1997, WAIS 3 WECHSLER ADUL, V3rd, DOI 10.1111/j.1749-6632.1989.tb21005.x; Yamamoto Bryan K., 2005, Critical Reviews in Neurobiology, V17, P87; Yamamoto BK, 2010, ANN NY ACAD SCI, V1187, P101, DOI 10.1111/j.1749-6632.2009.05141.x; Zecca L, 2005, MOVEMENT DISORD, V20, P1278, DOI 10.1002/mds.20550	65	36	36	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e56438	10.1371/journal.pone.0056438	http://dx.doi.org/10.1371/journal.pone.0056438			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418568	Green Accepted, gold, Green Submitted, Green Published			2022-12-25	WOS:000315970300161
J	Vargas, MR; Burton, NC; Gan, L; Johnson, DA; Schafer, M; Werner, S; Johnson, JA				Vargas, Marcelo R.; Burton, Neal C.; Gan, Li; Johnson, Delinda A.; Schaefer, Matthias; Werner, Sabine; Johnson, Jeffrey A.			Absence of Nrf2 or Its Selective Overexpression in Neurons and Muscle Does Not Affect Survival in ALS-Linked Mutant hSOD1 Mouse Models	PLOS ONE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; ANTIOXIDANT RESPONSE ELEMENT; MOTOR-NEURON; SUPEROXIDE-DISMUTASE; SPINAL-CORD; GLUTATHIONE BIOSYNTHESIS; MOLECULAR-MECHANISMS; OXIDATIVE STRESS; SKELETAL-MUSCLE; PRIMARY TARGET	The nuclear factor erythroid 2-related factor 2 (Nrf2) governs the expression of antioxidant and phase II detoxifying enzymes. Nrf2 activation can prevent or reduce cellular damage associated with several types of injury in many different tissues and organs. Dominant mutations in Cu/Zn-superoxide dismutase (SOD1) cause familial forms of amyotrophic lateral sclerosis (ALS), a fatal disorder characterized by the progressive loss of motor neurons and subsequent muscular atrophy. We have previously shown that Nrf2 activation in astrocytes delays neurodegeneration in ALS mouse models. To further investigate the role of Nrf2 in ALS we determined the effect of absence of Nrf2 or its restricted overexpression in neurons or type II skeletal muscle fibers on symptoms onset and survival in mutant hSOD1 expressing mice. We did not observe any detrimental effect associated with the lack of Nrf2 in two different mutant hSOD1 animal models of ALS. However, restricted Nrf2 overexpression in neurons or type II skeletal muscle fibers delayed disease onset but failed to extend survival in hSOD1(G93A) mice. These results highlight the concept that not only the pharmacological target but also the cell type targeted may be relevant when considering a Nrf2-mediated therapeutic approach for ALS.	[Vargas, Marcelo R.; Burton, Neal C.; Gan, Li; Johnson, Delinda A.; Johnson, Jeffrey A.] Univ Wisconsin, Div Pharmaceut Sci, Madison, WI 53706 USA; [Johnson, Jeffrey A.] Univ Wisconsin, Waisman Ctr, Madison, WI 53705 USA; [Johnson, Jeffrey A.] Univ Wisconsin, Mol & Environm Toxicol Ctr, Madison, WI USA; [Johnson, Jeffrey A.] Univ Wisconsin, Ctr Neurosci, Madison, WI USA; [Schaefer, Matthias; Werner, Sabine] Swiss Fed Inst Technol, Inst Mol Hlth Sci, Dept Biol, Hongg, Switzerland	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Johnson, JA (corresponding author), Univ Wisconsin, Div Pharmaceut Sci, Madison, WI 53706 USA.	jajohnson@pharmacy.wisc.edu	Schäfer, Matthias/K-1911-2012; Gan, Li/K-8775-2012	Schäfer, Matthias/0000-0001-6754-0448; Gan, Li/0000-0001-9522-0177; Werner, Sabine/0000-0001-7397-8710; Vargas, Marcelo/0000-0003-1039-4210	National Institute of Environmental Health Sciences (NIEHS) [ES08089, ES019186]; National Institute of General Medical Sciences [GM103542]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD003352] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES007015, R01ES008089, R00ES019186, R29ES008089] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103542] Funding Source: NIH RePORTER	National Institute of Environmental Health Sciences (NIEHS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by a grant from the National Institute of Environmental Health Sciences (NIEHS) ES08089 to J.A.J. Salary support for M. R. V. was provided by NIEHS grant ES019186 and National Institute of General Medical Sciences grant GM103542. The authors thank Dr. Albee Messing and the Waisman Intellectual and Developmental Disabilities Research Center (Waisman IDDRC, P30HD03352) for their technical support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beckman JS, 2001, TRENDS NEUROSCI, V24, pS15, DOI 10.1016/S0166-2236(00)01981-0; Boillee S, 2006, SCIENCE, V312, P1389, DOI 10.1126/science.1123511; Bruijn LI, 1997, NEURON, V18, P327, DOI 10.1016/S0896-6273(00)80272-X; Bruijn LI, 2004, ANNU REV NEUROSCI, V27, P723, DOI 10.1146/annurev.neuro.27.070203.144244; Calkins MJ, 2005, P NATL ACAD SCI USA, V102, P244, DOI 10.1073/pnas.0408487101; Chan KM, 1996, P NATL ACAD SCI USA, V93, P13943, DOI 10.1073/pnas.93.24.13943; Chen PC, 2009, P NATL ACAD SCI USA, V106, P2933, DOI 10.1073/pnas.0813361106; Cleveland DW, 2001, NAT REV NEUROSCI, V2, P806, DOI 10.1038/35097565; Dewachter I, 2002, J NEUROSCI, V22, P3445; Dobrowolny G, 2008, CELL METAB, V8, P425, DOI 10.1016/j.cmet.2008.09.002; Fischer LR, 2004, EXP NEUROL, V185, P232, DOI 10.1016/j.expneurol.2003.10.004; Frey D, 2000, J NEUROSCI, V20, P2534; GURNEY ME, 1994, SCIENCE, V264, P1772, DOI 10.1126/science.8209258; Howland DS, 2002, P NATL ACAD SCI USA, V99, P1604, DOI 10.1073/pnas.032539299; Hybertson BM, 2011, MOL ASPECTS MED, V32, P234, DOI 10.1016/j.mam.2011.10.006; Ilieva H, 2009, J CELL BIOL, V187, P761, DOI 10.1083/jcb.200908164; Innamorato NG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011838; Jakel RJ, 2007, BRAIN RES, V1144, P192, DOI 10.1016/j.brainres.2007.01.131; Johnson DA, 2002, J NEUROCHEM, V81, P1233, DOI 10.1046/j.1471-4159.2002.00913.x; Kobayashi M, 2005, ANTIOXID REDOX SIGN, V7, P385, DOI 10.1089/ars.2005.7.385; Kraft AD, 2004, J NEUROSCI, V24, P1101, DOI 10.1523/JNEUROSCI.3817-03.2004; Kraft AD, 2007, EXP NEUROL, V207, P107, DOI 10.1016/j.expneurol.2007.05.026; Lu SC, 2009, MOL ASPECTS MED, V30, P42, DOI 10.1016/j.mam.2008.05.005; Manfredi G, 2005, MITOCHONDRION, V5, P77, DOI 10.1016/j.mito.2005.01.002; Miller TM, 2006, P NATL ACAD SCI USA, V103, P19546, DOI 10.1073/pnas.0609411103; Mimoto T, 2012, BRAIN RES, V1446, P109, DOI 10.1016/j.brainres.2011.12.064; Musaro A, 2001, NAT GENET, V27, P195, DOI 10.1038/84839; Pehar M, 2007, J NEUROSCI, V27, P7777, DOI 10.1523/JNEUROSCI.0823-07.2007; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; Rowland LP, 2001, NEW ENGL J MED, V344, P1688, DOI 10.1056/NEJM200105313442207; Sarlette A, 2008, J NEUROPATH EXP NEUR, V67, P1055, DOI 10.1097/NEN.0b013e31818b4906; Schafer M, 2010, GENE DEV, V24, P1045, DOI 10.1101/gad.568810; Shih AY, 2003, J NEUROSCI, V23, P3394, DOI 10.1523/jneurosci.23-08-03394.2003; Taguchi K, 2011, GENES CELLS, V16, P123, DOI 10.1111/j.1365-2443.2010.01473.x; Turner BJ, 2008, PROG NEUROBIOL, V85, P94, DOI 10.1016/j.pneurobio.2008.01.001; Vargas MR, 2009, EXPERT REV MOL MED, V11, DOI 10.1017/S1462399409001094; Vargas MR, 2008, J NEUROSCI, V28, P13574, DOI 10.1523/JNEUROSCI.4099-08.2008; Vargas MR, 2006, J NEUROCHEM, V97, P687, DOI 10.1111/j.1471-4159.2006.03742.x; Vargas MR, 2005, J BIOL CHEM, V280, P25571, DOI 10.1074/jbc.M501920200; Wakabayashi N, 2010, ANTIOXID REDOX SIGN, V13, P1649, DOI 10.1089/ars.2010.3216; Yamanaka K, 2008, NAT NEUROSCI, V11, P251, DOI 10.1038/nn2047	41	34	36	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e56625	10.1371/journal.pone.0056625	http://dx.doi.org/10.1371/journal.pone.0056625			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418589	Green Published, gold, Green Submitted			2022-12-25	WOS:000315970300182
J	Ben-Ari, M; Inbar, M				Ben-Ari, Matan; Inbar, Moshe			When Herbivores Eat Predators: Predatory Insects Effectively Avoid Incidental Ingestion by Mammalian Herbivores	PLOS ONE			English	Article							IMPACT; PLANT; COCCINELLIDAE; ECOLOGY; ARTHROPODS; COLEOPTERA; DEFENSE; PREY; DEER; SIZE	The direct trophic links between mammalian herbivores and plant-dwelling insects have been practically ignored. Insects are ubiquitous on plants consumed by mammalian herbivores and are thus likely to face the danger of being incidentally ingested by a grazing mammal. A few studies have shown that some herbivorous hemipterans are able to avoid this peril by dropping to the ground upon detecting the heat and humidity on the mammal's breath. We hypothesized that if this risk affects the entire plant-dwelling insect community, other insects that share this habitat are expected to develop similar escape mechanisms. We assessed the ability of three species (adults and larvae) of coccinellid beetles, important aphid predators, to avoid incidental ingestion. Both larvae and adults were able to avoid incidental ingestion effectively by goats by dropping to the ground, demonstrating the importance of this behavior in grazed habitats. Remarkably, all adult beetles escaped by dropping off the plant and none used their functional wings to fly away. In controlled laboratory experiments, we found that human breath caused 60-80% of the beetles to drop. The most important component of mammalian herbivore breath in inducing adult beetles and larvae to drop was the combination of heat and humidity. The fact that the mechanism of dropping in response to mammalian breath developed in distinct insect orders and disparate life stages accentuates the importance of the direct influence of mammalian herbivores on plant-dwelling insects. This direct interaction should be given its due place when discussing trophic interactions.	[Ben-Ari, Matan; Inbar, Moshe] Univ Haifa, Dept Evolutionary & Environm Biol, IL-31999 Haifa, Israel	University of Haifa	Inbar, M (corresponding author), Univ Haifa, Dept Evolutionary & Environm Biol, IL-31999 Haifa, Israel.	minbar@research.haifa.ac.il		Inbar, Moshe/0000-0002-4707-9508	Israel Science Foundation [940/08]	Israel Science Foundation(Israel Science Foundation)	This work was partly supported by The Israel Science Foundation (Grant Number 940/08). No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON RM, 1980, J THEOR BIOL, V82, P283, DOI 10.1016/0022-5193(80)90104-6; Barrozo RB, 2004, J INSECT PHYSIOL, V50, P249, DOI 10.1016/j.jinsphys.2004.01.001; Begon M., 1996, ECOLOGY; Bravo SP, 1998, AM J PRIMATOL, V45, P411, DOI 10.1002/(SICI)1098-2345(1998)45:4<411::AID-AJP7>3.0.CO;2-Z; Dennis P, 2008, J APPL ECOL, V45, P279, DOI 10.1111/j.1365-2664.2007.01378.x; DIXON A. F. G., 1958, TRANS ROY ENTOMOL SOC LONDON, V110, P319; DIXON AFG, 1977, ANNU REV ECOL SYST, V8, P329, DOI 10.1146/annurev.es.08.110177.001553; GIBSON CWD, 1992, ECOGRAPHY, V15, P166, DOI 10.1111/j.1600-0587.1992.tb00020.x; Gish M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032706; Gish M, 2011, NATURWISSENSCHAFTEN, V98, P731, DOI 10.1007/s00114-011-0819-7; Gish M, 2010, CURR BIOL, V20, pR628, DOI 10.1016/j.cub.2010.06.065; Gomez Jose M., 2007, P104, DOI 10.1017/CBO9780511542701.006; GROSS P, 1993, ANNU REV ENTOMOL, V38, P251, DOI 10.1146/annurev.en.38.010193.001343; Hodek I, 2012, ECOLOGY BEHAV LADYBI, DOI DOI 10.1002/9781118223208; KING KL, 1983, AUST J ECOL, V8, P245, DOI 10.1111/j.1442-9993.1983.tb01322.x; Kleijn D, 2002, J ECOL, V90, P360, DOI 10.1046/j.1365-2745.2001.00676.x; Latham DR, 2009, ENVIRON ENTOMOL, V38, P1117, DOI 10.1603/022.038.0419; Laubertie E, 2006, J INSECT BEHAV, V19, P231, DOI 10.1007/s10905-006-9018-3; Lucas E, 1997, ENTOMOPHAGA, V42, P3, DOI 10.1007/BF02769874; Lucas E, 1998, ECOLOGY, V79, P1084, DOI 10.1890/0012-9658(1998)079[1084:IPAAPC]2.0.CO;2; Martinsen GD, 1998, ECOLOGY, V79, P192, DOI 10.1890/0012-9658(1998)079[0192:IIMBCP]2.0.CO;2; Mathisen KM, 2011, THESIS U AGR SCI UME; Miller LA, 2001, BIOSCIENCE, V51, P570, DOI 10.1641/0006-3568(2001)051[0570:HSIDAA]2.0.CO;2; MILLS LS, 1993, BIOSCIENCE, V43, P219, DOI 10.2307/1312122; Minoretti N, 2000, EUR J ENTOMOL, V97, P475, DOI 10.14411/eje.2000.073; Moretti M, 2009, ECOGRAPHY, V32, P299, DOI 10.1111/j.1600-0587.2008.05524.x; Morris MG, 2000, BIOL CONSERV, V95, P129, DOI 10.1016/S0006-3207(00)00028-8; Nunamaker RA, 2003, J MED ENTOMOL, V40, P957, DOI 10.1603/0022-2585-40.6.957; Obrycki JJ, 1998, ANNU REV ENTOMOL, V43, P295, DOI 10.1146/annurev.ento.43.1.295; Ohgushi T, 2005, ANNU REV ECOL EVOL S, V36, P81, DOI 10.1146/annurev.ecolsys.36.091704.175523; Ohno T, 2007, P R SOC B, V274, P555, DOI 10.1098/rspb.2006.3750; POLLARD E, 1994, BIOL CONSERV, V70, P189, DOI 10.1016/0006-3207(94)90287-9; Rambo JL, 1999, CONSERV BIOL, V13, P1047, DOI 10.1046/j.1523-1739.1999.98504.x; Ribak G, 2013, CURR BIOL IN PRESS; Roeder K.D., 1974, P CAN SOC ZOOL ANN M, P71; Sato S, 2005, ECOL ENTOMOL, V30, P220, DOI 10.1111/j.0307-6946.2005.00688.x; Scherber C, 2010, NATURE, V468, P553, DOI 10.1038/nature09492; SPANGLER HG, 1988, ANNU REV ENTOMOL, V33, P59, DOI 10.1146/annurev.en.33.010188.000423; STAMP NE, 1988, OECOLOGIA, V75, P619, DOI 10.1007/BF00776428; Stewart AJA, 2001, FORESTRY, V74, P259, DOI 10.1093/forestry/74.3.259; Tscharntke T, 1997, MULTITROPHIC INTERACTIONS IN TERRESTRIAL SYSTEMS, P277; van Noordwijk CGE, 2012, J INSECT CONSERV, V16, P909, DOI 10.1007/s10841-012-9478-z; van Wieren Spike E., 2008, V195, P263; Woodward G, 2005, TRENDS ECOL EVOL, V20, P402, DOI 10.1016/j.tree.2005.04.005; ZAMORA R, 1993, OIKOS, V66, P223, DOI 10.2307/3544808	45	14	16	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2013	8	2							e56748	10.1371/journal.pone.0056748	http://dx.doi.org/10.1371/journal.pone.0056748			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104BU	23424674	Green Published, gold, Green Submitted			2022-12-25	WOS:000315965100062
J	Carvalhais, LC; Dennis, PG; Badri, DV; Tyson, GW; Vivanco, JM; Schenk, PM				Carvalhais, Lilia C.; Dennis, Paul G.; Badri, Dayakar V.; Tyson, Gene W.; Vivanco, Jorge M.; Schenk, Peer M.			Activation of the Jasmonic Acid Plant Defence Pathway Alters the Composition of Rhizosphere Bacterial Communities	PLOS ONE			English	Article							ARABIDOPSIS-THALIANA; ANTIHERBIVORE DEFENSE; RESOURCE AVAILABILITY; GENE-EXPRESSION; RESISTANCE; SOIL; FLAVONOIDS; SPHAERICUS; RESPONSES; PROTEINS	Jasmonic acid (JA) signalling plays a central role in plant defences against necrotrophic pathogens and herbivorous insects, which afflict both roots and shoots. This pathway is also activated following the interaction with beneficial microbes that may lead to induced systemic resistance. Activation of the JA signalling pathway via application of methyl jasmonate (MeJA) alters the composition of carbon containing compounds released by roots, which are implicated as key determinants of rhizosphere microbial community structure. In this study, we investigated the influence of the JA defence signalling pathway activation in Arabidopsis thaliana on the structure of associated rhizosphere bacterial communities using 16S rRNA gene amplicon pyrosequencing. Application of MeJA did not directly influence bulk soil microbial communities but significant changes in rhizosphere community composition were observed upon activation of the jasmonate signalling pathway. Our results suggest that JA signalling may mediate plant-bacteria interactions in the soil upon necrotrophic pathogen and herbivorous insect attacks.	[Carvalhais, Lilia C.; Schenk, Peer M.] Univ Queensland, Sch Agr & Food Sci, Brisbane, Qld, Australia; [Dennis, Paul G.; Tyson, Gene W.] Univ Queensland, Sch Chem & Mol Biosci, Australian Ctr Ecogen, Brisbane, Qld, Australia; [Dennis, Paul G.; Tyson, Gene W.] Univ Queensland, Adv Water Management Ctr, Brisbane, Qld, Australia; [Badri, Dayakar V.; Vivanco, Jorge M.] Colorado State Univ, Dept Hort & Landscape Architecture, Ft Collins, CO 80523 USA; [Badri, Dayakar V.; Vivanco, Jorge M.] Colorado State Univ, Ctr Rhizosphere Biol, Ft Collins, CO 80523 USA	University of Queensland; University of Queensland; University of Queensland; Colorado State University; Colorado State University	Carvalhais, LC (corresponding author), Univ Queensland, Sch Agr & Food Sci, Brisbane, Qld, Australia.	l.carvalhais@uq.edu.au	Dennis, Paul G/H-2141-2017; Schenk, Peer/B-7879-2016; Tyson, Gene W/C-6558-2013	Dennis, Paul G/0000-0002-4895-3105; Schenk, Peer/0000-0003-4878-3799; Tyson, Gene W/0000-0001-8559-9427; Carvalhais, Lilia C./0000-0001-9882-526X	Australian Research Council [DP1094749]; National Science Foundation of the United States of America [MCB-0950857]; Div Of Molecular and Cellular Bioscience [0950857] Funding Source: National Science Foundation	Australian Research Council(Australian Research Council); National Science Foundation of the United States of America(National Science Foundation (NSF)); Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	Financial support for this work was provided by the Australian Research Council (DP1094749) and the National Science Foundation of the United States of America (MCB-0950857). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abou-Shanab RAI, 2007, CHEMOSPHERE, V68, P360, DOI 10.1016/j.chemosphere.2006.12.051; Achouak W, 1999, INT J SYST BACTERIOL, V49, P961, DOI 10.1099/00207713-49-3-961; Badri DV, 2008, NEW PHYTOL, V179, P209, DOI 10.1111/j.1469-8137.2008.02458.x; Berry C, 2012, J INVERTEBR PATHOL, V109, P1, DOI 10.1016/j.jip.2011.11.008; Bragg L, 2012, NAT METHODS, V9, P425, DOI 10.1038/nmeth.1990; Bravo A, 2011, INSECT BIOCHEM MOLEC, V41, P423, DOI 10.1016/j.ibmb.2011.02.006; BRYANT JP, 1989, NATURE, V340, P227, DOI 10.1038/340227a0; Buer CS, 2010, J INTEGR PLANT BIOL, V52, P98, DOI 10.1111/j.1744-7909.2010.00905.x; Bulgarelli D, 2012, NATURE, V488, P91, DOI 10.1038/nature11336; Campbell EJ, 2003, PLANT PHYSIOL, V133, P1272, DOI 10.1104/pp.103.024182; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Carvalhais LC, 2012, J MICROBIOL METH, V91, P246, DOI 10.1016/j.mimet.2012.08.011; COLEY PD, 1985, SCIENCE, V230, P895, DOI 10.1126/science.230.4728.895; Dennis PG, 2010, FEMS MICROBIOL ECOL, V72, P313, DOI 10.1111/j.1574-6941.2010.00860.x; Dennis PG, 2013, BIORESOURCE IN PRESS; Doornbos RF, 2011, MOL PLANT MICROBE IN, V24, P395, DOI 10.1094/MPMI-05-10-0115; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Faure D, 2009, PLANT SOIL, V321, P279, DOI 10.1007/s11104-008-9839-2; Hassan S, 2012, J EXP BOT, V63, P3429, DOI 10.1093/jxb/err430; Hein JW, 2008, MICROB ECOL, V55, P333, DOI 10.1007/s00248-007-9279-1; Hu XM, 2008, J BACTERIOL, V190, P2892, DOI 10.1128/JB.01652-07; Jin HJ, 2011, MICROBIOLOGY+, V80, P117, DOI 10.1134/S0026261711010097; Kazan K, 2008, PLANT PHYSIOL, V146, P1459, DOI 10.1104/pp.107.115717; Laluk K., 2010, Arabidopsis Book, V8, pe0136, DOI 10.1199/tab.0136; Legendre P, 2001, OECOLOGIA, V129, P271, DOI 10.1007/s004420100716; Lugtenberg B, 2009, ANNU REV MICROBIOL, V63, P541, DOI 10.1146/annurev.micro.62.081307.162918; Lundberg DS, 2012, NATURE, V488, P86, DOI 10.1038/nature11237; McConn M, 1997, P NATL ACAD SCI USA, V94, P5473, DOI 10.1073/pnas.94.10.5473; Naz I, 2010, PLANT SOIL, V334, P199, DOI 10.1007/s11104-010-0372-8; Puthoff DP, 2007, PLANT CELL REP, V26, P71, DOI 10.1007/s00299-006-0201-y; Rasmann S, 2008, PLANT PHYSIOL, V146, P875, DOI 10.1104/pp.107.112045; Raymond B, 2010, TRENDS MICROBIOL, V18, P189, DOI 10.1016/j.tim.2010.02.006; Schenk PM, 2000, P NATL ACAD SCI USA, V97, P11655, DOI 10.1073/pnas.97.21.11655; Sgroy V, 2009, APPL MICROBIOL BIOT, V85, P371, DOI 10.1007/s00253-009-2116-3; SIMPSON EH, 1949, NATURE, V163, P688, DOI 10.1038/163688a0; Stearns JC, 2012, MOL PLANT MICROBE IN, V25, P668, DOI 10.1094/MPMI-08-11-0213; Tjamos SE, 2005, MOL PLANT MICROBE IN, V18, P555, DOI 10.1094/MPMI-18-0555; Validov S, 2007, J APPL MICROBIOL, V102, P461, DOI 10.1111/j.1365-2672.2006.03083.x; van Frankenhuyzen K, 2009, J INVERTEBR PATHOL, V101, P1, DOI 10.1016/j.jip.2009.02.009; Van Wees SCM, 2008, CURR OPIN PLANT BIOL, V11, P443, DOI 10.1016/j.pbi.2008.05.005; Viruel E, 2011, ARCH MICROBIOL, V193, P489, DOI 10.1007/s00203-011-0692-y; Yadav S, 2011, J BASIC MICROB, V51, P98, DOI 10.1002/jobm.201000098; Yu XM, 2011, FEMS MICROBIOL LETT, V325, P30, DOI 10.1111/j.1574-6968.2011.02409.x; Zou CS, 2007, SOIL BIOL BIOCHEM, V39, P2371, DOI 10.1016/j.soilbio.2007.04.009	44	106	110	3	128	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2013	8	2							e56457	10.1371/journal.pone.0056457	http://dx.doi.org/10.1371/journal.pone.0056457			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104BU	23424661	Green Published, Green Submitted, gold			2022-12-25	WOS:000315965100049
J	Kish, LB; Nevels, RD				Kish, Laszlo B.; Nevels, Robert D.			Twisted Radio Waves and Twisted Thermodynamics	PLOS ONE			English	Article								We present and analyze a gedanken experiment and show that the assumption that an antenna operating at a single frequency can transmit more than two independent information channels to the far field violates the Second Law of Thermodynamics. Transmission of a large number of channels, each associated with an angular momenta 'twisted wave' mode, to the far field in free space is therefore not possible.	[Kish, Laszlo B.] Texas A&M Univ, Dept Elect & Comp Engn, Solid State Elect Photon & Nanoengn Div, College Stn, TX 77843 USA; [Nevels, Robert D.] Texas A&M Univ, Dept Elect & Comp Engn, Electromagnet & Microwaves Div, College Stn, TX USA	Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station	Kish, LB (corresponding author), Texas A&M Univ, Dept Elect & Comp Engn, Solid State Elect Photon & Nanoengn Div, College Stn, TX 77843 USA.	Laszlokish@tamu.edu						Boltzmann L., 1964, LECT GAS THEORY; Cartlidge E, 2011, NATURE NEWS, DOI [10.1038/news.2011.114, DOI 10.1038/NEWS.2011.114]; Edfors O, 2012, IEEE T ANTENN PROPAG, V60, P1126, DOI 10.1109/TAP.2011.2173142; Mair A, 2001, NATURE, V412, P313, DOI 10.1038/35085529; Nyquist H, 1928, PHYS REV, V32, P110, DOI 10.1103/PhysRev.32.110; Planck M., 1914, THEORY HEAT RAD; Tamagnone M, 2012, NEW J PHYS, V14, DOI 10.1088/1367-2630/14/11/118001; Tamburini F, 2012, NEW J PHYS, V14, DOI 10.1088/1367-2630/14/3/033001; Tamburini F, 2011, APPL PHYS LETT, V99, DOI 10.1063/1.3659466; Tamburini F, 2011, NAT PHYS, V7, P195, DOI [10.1038/nphys1907, 10.1038/NPHYS1907]; Thide B, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.087701; Wang J, 2012, NAT PHOTONICS, V6, P488, DOI [10.1038/nphoton.2012.138, 10.1038/NPHOTON.2012.138]	12	10	11	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2013	8	2							e56086	10.1371/journal.pone.0056086	http://dx.doi.org/10.1371/journal.pone.0056086			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104BU	23424647	Green Published, gold, Green Submitted			2022-12-25	WOS:000315965100035
J	Basu, D; Liang, Y; Liu, X; Himmeldirk, K; Faik, A; Kieliszewski, M; Held, M; Showalter, AM				Basu, Debarati; Liang, Yan; Liu, Xiao; Himmeldirk, Klaus; Faik, Ahmed; Kieliszewski, Marcia; Held, Michael; Showalter, Allan M.			Functional Identification of a Hydroxyproline-O-galactosyltransferase Specific for Arabinogalactan Protein Biosynthesis in Arabidopsis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM; GOLGI-APPARATUS; LECTIN DOMAINS; I-TASSER; GLYCOSYLATION; GALNAC; POLYSACCHARIDE; SOLUBILIZATION; CLASSIFICATION; COMPONENTS	Although plants contain substantial amounts of arabinogalactan proteins (AGPs), the enzymes responsible for AGP glycosylation are largely unknown. Bioinformatics indicated that AGP galactosyltransferases (GALTs) are members of the carbohydrate-active enzyme glycosyltransferase (GT) 31 family (CAZy GT31) involved in N- and O-glycosylation. Six Arabidopsis GT31 members were expressed in Pichia pastoris and tested for enzyme activity. The At4g21060 gene (named AtGALT2) was found to encode activity for adding galactose (Gal) to hydroxyproline (Hyp) in AGP protein backbones. AtGALT2 specifically catalyzed incorporation of [C-14] Gal from UDP-[C-14] Gal to Hyp of model substrate acceptors having AGP peptide sequences, consisting of non-contiguous Hyp residues, such as (Ala-Hyp) repetitive units exemplified by chemically synthesized (AO)(7) and anhydrous hydrogen fluoride-deglycosylated d(AO)(51). Microsomal preparations from Pichia cells expressing AtGALT2 incorporated [C-14] Gal to (AO)(7), and the resulting product co-eluted with (AO)(7) by reverse-phase HPLC. Acid hydrolysis of the [C-14]Gal-(AO)(7) product released C-14-radiolabel as Gal only. Base hydrolysis of the [C-14] Gal-(AO)(7) product released a C-14-radiolabeled fragment that co-eluted with a Hyp-Gal standard after high performance anion-exchange chromatography fractionation. AtGALT2 is specific for AGPs because substrates lacking AGP peptide sequences did not act as acceptors. Moreover, AtGALT2 uses only UDP-Gal as the substrate donor and requires Mg2+ or Mn2+ for high activity. Additional support that AtGALT2 encodes an AGP GALT was provided by two allelic AtGALT2 knock-out mutants, which demonstrated lower GALT activities and reductions in beta-Yariv-precipitated AGPs compared with wild type plants. Confocal microscopic analysis of fluorescently tagged AtGALT2 in tobacco epidermal cells indicated that AtGALT2 is probably localized in the endomembrane system consistent with its function.	[Basu, Debarati; Liang, Yan; Liu, Xiao; Faik, Ahmed; Showalter, Allan M.] Ohio Univ, Dept Environm & Plant Biol, Athens, OH 45701 USA; [Himmeldirk, Klaus; Kieliszewski, Marcia; Held, Michael] Ohio Univ, Dept Chem & Biochem, Mol & Cellular Biol Program, Athens, OH 45701 USA	University System of Ohio; Ohio University; University System of Ohio; Ohio University	Showalter, AM (corresponding author), Ohio Univ, Dept Environm & Plant Biol, Athens, OH 45701 USA.	showalte@ohio.edu	Liang, Yan/K-8199-2016; Faik, Ahmed/ABB-9120-2020	Liang, Yan/0000-0002-2144-1388; Held, Michael/0000-0003-2604-8048; Showalter, Allan/0000-0003-0775-4991	Ohio Plant Biotechnology Consortium [020340004090 GR0017687.01]; National Science Foundation [0918661]	Ohio Plant Biotechnology Consortium; National Science Foundation(National Science Foundation (NSF))	This work was supported by Ohio Plant Biotechnology Consortium Grant 020340004090 GR0017687.01 and National Science Foundation Grant 0918661.	BACIC A, 1987, CARBOHYD RES, V162, P85, DOI 10.1016/0008-6215(87)80203-3; Batoko H, 2000, PLANT CELL, V12, P2201, DOI 10.1105/tpc.12.11.2201; Bennett EP, 2012, GLYCOBIOLOGY, V22, P736, DOI 10.1093/glycob/cwr182; Boerjan W, 2003, ANNU REV PLANT BIOL, V54, P519, DOI 10.1146/annurev.arplant.54.031902.134938; Boevink P, 1998, PLANT J, V15, P441, DOI 10.1046/j.1365-313X.1998.00208.x; Boratyn GM, 2012, BIOL DIRECT, V7, DOI 10.1186/1745-6150-7-12; Castilho A, 2012, J BIOL CHEM, V287, P36518, DOI 10.1074/jbc.M112.402685; CLARKE A, 1979, P NATL ACAD SCI USA, V76, P3358, DOI 10.1073/pnas.76.7.3358; Cosgrove DJ, 2005, NAT REV MOL CELL BIO, V6, P850, DOI 10.1038/nrm1746; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Dodd RB, 2001, GLYCOBIOLOGY, V11, p71R, DOI 10.1093/glycob/11.5.71R; Egelund J, 2011, ANNU PLANT REV, V41, P213, DOI 10.1002/9781444391015.ch7; Ellis M, 2010, PLANT PHYSIOL, V153, P403, DOI 10.1104/pp.110.156000; Gao MG, 1999, PLANT J, V18, P43, DOI 10.1046/j.1365-313X.1999.00428.x; Geshi N, 2002, PHYSIOL PLANTARUM, V114, P540, DOI 10.1034/j.1399-3054.2002.1140406.x; Goto M, 2007, BIOSCI BIOTECH BIOCH, V71, P1415, DOI 10.1271/bbb.70080; Hanisch FA, 2001, BIOL CHEM, V382, P143, DOI 10.1515/BC.2001.022; Hassan H, 2000, J BIOL CHEM, V275, P38197, DOI 10.1074/jbc.M005783200; Henrissat B, 2000, PLANT PHYSIOL, V124, P1515, DOI 10.1104/pp.124.4.1515; HOFFMAN CS, 1987, GENE, V57, P267, DOI 10.1016/0378-1119(87)90131-4; Kato H, 2003, PLANTA, V217, P271, DOI 10.1007/s00425-003-0978-7; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kieliszewski MJ, 2001, CELL MOL LIFE SCI, V58, P1386, DOI 10.1007/PL00000783; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Liang Y, 2010, PLANT PHYSIOL, V154, P632, DOI 10.1104/pp.110.160051; Liu CG, 2007, PLANT PHYSIOL, V145, P863, DOI 10.1104/pp.107.102657; Molhoj M, 2004, PLANT PHYSIOL, V135, P1221, DOI 10.1104/pp.104.043745; Nothnagel EA, 1997, INT REV CYTOL, V174, P195, DOI 10.1016/S0074-7696(08)62118-X; Oka T, 2010, PLANT PHYSIOL, V152, P332, DOI 10.1104/pp.109.146266; Pedersen JW, 2011, J BIOL CHEM, V286, P32684, DOI 10.1074/jbc.M111.273722; Peugnet I, 2001, PLANTA, V213, P435, DOI 10.1007/s004250100539; Qu YM, 2008, PLANT MOL BIOL, V68, P43, DOI 10.1007/s11103-008-9351-3; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Saint-Jore CM, 2002, PLANT J, V29, P661, DOI 10.1046/j.0960-7412.2002.01252.x; Schultz CJ, 2000, PLANT CELL, V12, P1751, DOI 10.1105/tpc.12.9.1751; Schwacke R, 2003, PLANT PHYSIOL, V131, P16, DOI 10.1104/pp.011577; Seifert GJ, 2007, ANNU REV PLANT BIOL, V58, P137, DOI 10.1146/annurev.arplant.58.032806.103801; Showalter AM, 2010, PLANT PHYSIOL, V153, P485, DOI 10.1104/pp.110.156554; Shpak E, 2001, J BIOL CHEM, V276, P11272, DOI 10.1074/jbc.M011323200; Somerville C, 2004, SCIENCE, V306, P2206, DOI 10.1126/science.1102765; STRAHM A, 1981, PHYTOCHEMISTRY, V20, P1061, DOI 10.1016/0031-9422(81)83027-0; Strasser R, 2007, PLANT CELL, V19, P2278, DOI 10.1105/tpc.107.052985; Tan L, 2004, J BIOL CHEM, V279, P13156, DOI 10.1074/jbc.M311864200; Tan L, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00140; Tan L, 2010, J BIOL CHEM, V285, P24575, DOI 10.1074/jbc.M109.100149; Tryfona T, 2012, PLANT PHYSIOL, V160, P653, DOI 10.1104/pp.112.202309; Wandall HH, 2007, GLYCOBIOLOGY, V17, P374, DOI 10.1093/glycob/cwl082; Wu YY, 2010, J BIOL CHEM, V285, P13638, DOI 10.1074/jbc.M110.102715; Yang Z, 2012, J BIOL CHEM, V287, P11911, DOI 10.1074/jbc.M111.312918; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40	50	61	64	3	58	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 5	2013	288	14					10132	10143		10.1074/jbc.M112.432609	http://dx.doi.org/10.1074/jbc.M112.432609			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	119RB	23430255	Green Published, hybrid			2022-12-25	WOS:000317114000054
J	Biskup, T; Paulus, B; Okafuji, A; Hitomi, K; Getzoff, ED; Weber, S; Schleicher, E				Biskup, Till; Paulus, Bernd; Okafuji, Asako; Hitomi, Kenichi; Getzoff, Elizabeth D.; Weber, Stefan; Schleicher, Erik			Variable Electron Transfer Pathways in an Amphibian Cryptochrome TRYPTOPHAN VERSUS TYROSINE-BASED RADICAL PAIRS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BLUE-LIGHT PHOTORECEPTOR; COLI DNA PHOTOLYASE; TIME-RESOLVED EPR; PARAMAGNETIC-RESONANCE; FLAVIN COFACTOR; DROSOPHILA CRYPTOCHROME; DIMER REPAIR; ACTIVE-SITE; DUPLEX DNA; IN-VIVO	Electron transfer reactions play vital roles in many biological processes. Very often the transfer of charge(s) proceeds stepwise over large distances involving several amino acid residues. By using time-resolved electron paramagnetic resonance and optical spectroscopy, we have studied the mechanism of light-induced reduction of the FAD cofactor of cryptochrome/photolyase family proteins. In this study, we demonstrate that electron abstraction from a nearby amino acid by the excited FAD triggers further electron transfer steps even if the conserved chain of three tryptophans, known to be an effective electron transfer pathway in these proteins, is blocked. Furthermore, we were able to characterize this secondary electron transfer pathway and identify the amino acid partner of the resulting flavin-amino acid radical pair as a tyrosine located at the protein surface. This alternative electron transfer pathway could explain why interrupting the conserved tryptophan triad does not necessarily alter photoreactions of cryptochromes in vivo. Taken together, our results demonstrate that light-induced electron transfer is a robust property of cryptochromes and more intricate than commonly anticipated.	[Biskup, Till] Univ Oxford, Dept Chem, Phys & Theoret Chem Lab, Oxford OX1 3QZ, England; [Paulus, Bernd; Okafuji, Asako; Weber, Stefan; Schleicher, Erik] Univ Freiburg, Inst Phys Chem, D-79104 Freiburg, Germany; [Hitomi, Kenichi] Natl Inst Biomed Innovat, Sect Lab Equipment, Osaka 5670085, Japan; [Hitomi, Kenichi; Getzoff, Elizabeth D.] Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; [Hitomi, Kenichi; Getzoff, Elizabeth D.] Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA	University of Oxford; University of Freiburg; National Institute of Health Sciences - Japan; Scripps Research Institute; Scripps Research Institute	Schleicher, E (corresponding author), Univ Freiburg, Inst Phys Chem, Albertstr 21, D-79104 Freiburg, Germany.	erik.schleicher@physchem.uni-freiburg.de	Biskup, Till/D-5249-2012; Weber, Stefan/G-6164-2010; Biskup, Till/AAX-1107-2020; Schleicher, Erik/C-9951-2010	Biskup, Till/0000-0003-2913-0004; Biskup, Till/0000-0003-2913-0004; Schleicher, Erik/0000-0003-2953-050X	National Institutes of Health Grant [GM37684]; Deutsche Forschungsgemeinschaft [BI 1249/1-1, BI 1249/1-2]; Skaggs Institute for Chemical Biology; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM037684] Funding Source: NIH RePORTER	National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Skaggs Institute for Chemical Biology; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM37684 (to E. D. G.), Deutsche Forschungsgemeinschaft Grants BI 1249/1-1 and BI 1249/1-2 (to T. B.), and a grant from the Skaggs Institute for Chemical Biology (to K. H.).	AHMAD M, 1993, NATURE, V366, P162, DOI 10.1038/366162a0; Aubert C, 1999, P NATL ACAD SCI USA, V96, P5423, DOI 10.1073/pnas.96.10.5423; Banerjee R, 2007, J BIOL CHEM, V282, P14916, DOI 10.1074/jbc.M700616200; Bell-Pedersen D, 2005, NAT REV GENET, V6, P544, DOI 10.1038/nrg1633; BENT DV, 1975, J AM CHEM SOC, V97, P2599, DOI 10.1021/ja00843a002; Berndt A, 2007, J BIOL CHEM, V282, P13011, DOI 10.1074/jbc.M608872200; Biskup T, 2011, ANGEW CHEM INT EDIT, V50, P12647, DOI 10.1002/anie.201104321; Biskup T, 2009, ANGEW CHEM INT EDIT, V48, P404, DOI 10.1002/anie.200803102; Bittl R, 2005, BBA-BIOENERGETICS, V1707, P117, DOI 10.1016/j.bbabio.2004.03.012; Bleifuss G, 2001, BIOCHEMISTRY-US, V40, P15362, DOI 10.1021/bi010707d; Bouly JP, 2007, J BIOL CHEM, V282, P9383, DOI 10.1074/jbc.M609842200; Brazard J, 2010, J AM CHEM SOC, V132, P4935, DOI 10.1021/ja1002372; Brudler R, 2003, MOL CELL, V11, P59, DOI 10.1016/S1097-2765(03)00008-X; Brunelle SA, 2007, J PHYCOL, V43, P509, DOI 10.1111/j.1529-8817.2007.00339.x; BUCKLEY CD, 1987, CHEM PHYS LETT, V135, P307, DOI 10.1016/0009-2614(87)85162-X; Byrdin M, 2003, P NATL ACAD SCI USA, V100, P8676, DOI 10.1073/pnas.1531645100; Byrdin M, 2010, J PHYS CHEM A, V114, P3207, DOI 10.1021/jp9093589; Chaves I, 2011, ANNU REV PLANT BIOL, V62, P335, DOI 10.1146/annurev-arplant-042110-103759; CLOSS GL, 1987, J PHYS CHEM-US, V91, P3592, DOI 10.1021/j100297a026; Daiyasu H, 2004, GENES CELLS, V9, P479, DOI 10.1111/j.1356-9597.2004.00738.x; Essen LO, 2006, CURR OPIN STRUC BIOL, V16, P51, DOI 10.1016/j.sbi.2006.01.004; Froy O, 2002, CURR BIOL, V12, P147, DOI 10.1016/S0960-9822(01)00656-X; Gegear RJ, 2010, NATURE, V463, P804, DOI 10.1038/nature08719; Gindt YM, 1999, BIOCHEMISTRY-US, V38, P3857, DOI 10.1021/bi981191+; Giovani B, 2003, NAT STRUCT BIOL, V10, P489, DOI 10.1038/nsb933; Henbest KB, 2008, P NATL ACAD SCI USA, V105, P14395, DOI 10.1073/pnas.0803620105; Hitomi K, 2000, NUCLEIC ACIDS RES, V28, P2353, DOI 10.1093/nar/28.12.2353; Hitomi K, 2012, J BIOL CHEM, V287, P12060, DOI 10.1074/jbc.M111.244020; Hoang N, 2008, PLOS BIOL, V6, P1559, DOI 10.1371/journal.pbio.0060160; HORE PJ, 1987, CHEM PHYS LETT, V137, P495, DOI 10.1016/0009-2614(87)80617-6; JORNS MS, 1984, BIOCHEMISTRY-US, V23, P2673, DOI 10.1021/bi00307a021; Kao YT, 2008, J AM CHEM SOC, V130, P7695, DOI 10.1021/ja801152h; Kavakli IH, 2004, BIOCHEMISTRY-US, V43, P15103, DOI 10.1021/bi0478796; Kiontke S, 2011, EMBO J, V30, P4437, DOI 10.1038/emboj.2011.313; Klar T, 2007, J MOL BIOL, V366, P954, DOI 10.1016/j.jmb.2006.11.066; Kowalczyk RM, 2004, J AM CHEM SOC, V126, P11393, DOI 10.1021/ja049554i; Krapf S, 2010, PHYS CHEM CHEM PHYS, V12, P9516, DOI 10.1039/c000876a; Langenbacher T, 2009, J AM CHEM SOC, V131, P14274, DOI 10.1021/ja901628y; LI YF, 1991, BIOCHEMISTRY-US, V30, P6322, DOI 10.1021/bi00239a034; Liu ZY, 2011, P NATL ACAD SCI USA, V108, P14831, DOI 10.1073/pnas.1110927108; Losi A, 2011, PHOTOCHEM PHOTOBIOL, V87, P491, DOI 10.1111/j.1751-1097.2011.00913.x; Lukacs A, 2008, J AM CHEM SOC, V130, P14394, DOI 10.1021/ja805261m; MacFarlane AW, 2003, BIOCHEMISTRY-US, V42, P8558, DOI 10.1021/bi034015w; Maeda K, 2012, P NATL ACAD SCI USA, V109, P4774, DOI 10.1073/pnas.1118959109; MASSEY V, 1978, BIOCHEMISTRY-US, V17, P1, DOI 10.1021/bi00594a001; Moldt J, 2009, J BIOL CHEM, V284, P21670, DOI 10.1074/jbc.M109.018697; MOSER CC, 1992, NATURE, V355, P796, DOI 10.1038/355796a0; Mouritsen H, 2005, CURR OPIN NEUROBIOL, V15, P406, DOI 10.1016/j.conb.2005.06.003; Mouritsen H, 2012, CURR OPIN NEUROBIOL, V22, P343, DOI 10.1016/j.conb.2012.01.005; Muller M, 2009, CURR OPIN STRUC BIOL, V19, P277, DOI 10.1016/j.sbi.2009.05.003; Okafuji A, 2010, DNA REPAIR, V9, P495, DOI 10.1016/j.dnarep.2010.01.014; Ozturk N, 2008, J BIOL CHEM, V283, P3256, DOI 10.1074/jbc.M708612200; Ozturk N, 2011, P NATL ACAD SCI USA, V108, P516, DOI 10.1073/pnas.1017093108; Pokorny R, 2008, P NATL ACAD SCI USA, V105, P21023, DOI 10.1073/pnas.0805830106; Popovic DM, 2002, J AM CHEM SOC, V124, P3775, DOI 10.1021/ja016249d; Porcal G, 2003, PHYS CHEM CHEM PHYS, V5, P4123, DOI 10.1039/b306945a; Ritz T, 2000, BIOPHYS J, V78, P707, DOI 10.1016/S0006-3495(00)76629-X; Rodgers CT, 2009, P NATL ACAD SCI USA, V106, P353, DOI 10.1073/pnas.0711968106; Sancar A, 2004, ADV PROTEIN CHEM, V69, P73; Sancar A, 2004, J BIOL CHEM, V279, P34079, DOI 10.1074/jbc.R400016200; Sancar A, 2003, CHEM REV, V103, P2203, DOI 10.1021/cr0204348; Schleicher E, 2007, J BIOL CHEM, V282, P4738, DOI 10.1074/jbc.M604734200; Selby CP, 2006, P NATL ACAD SCI USA, V103, P17696, DOI 10.1073/pnas.0607993103; Snellenburg JJ, 2012, J STAT SOFTW, V49, P1, DOI 10.18637/jss.v049.i03; Song SH, 2007, J BIOL CHEM, V282, P17608, DOI 10.1074/jbc.M702874200; Stanewsky R, 2002, CELL TISSUE RES, V309, P11, DOI 10.1007/s00441-002-0569-0; Swartz TE, 2001, J BIOL CHEM, V276, P36493, DOI 10.1074/jbc.M103114200; Thiagarajan V, 2011, P NATL ACAD SCI USA, V108, P9402, DOI 10.1073/pnas.1101026108; Tommos C, 1999, BIOCHEMISTRY-US, V38, P9495, DOI 10.1021/bi990609g; van Stokkum IHM, 2004, BBA-BIOENERGETICS, V1657, P82, DOI 10.1016/j.bbabio.2004.04.011; WANG BY, 1989, BIOCHEMISTRY-US, V28, P1148, DOI 10.1021/bi00429a032; Wang HY, 2005, J PHYS CHEM B, V109, P1329, DOI 10.1021/jp044652b; Weber S, 2002, P NATL ACAD SCI USA, V99, P1319, DOI 10.1073/pnas.032469399; Weber S, 2011, PHOTOCHEM PHOTOBIOL, V87, P574, DOI 10.1111/j.1751-1097.2010.00885.x; Weber S, 2010, J PHYS CHEM B, V114, P14745, DOI 10.1021/jp103401u; Zeugner A, 2005, J BIOL CHEM, V280, P19437, DOI 10.1074/jbc.C500077200; Zikihara K, 2008, PHOTOCHEM PHOTOBIOL, V84, P1016, DOI 10.1111/j.1751-1097.2007.00364.x; Zoltowski BD, 2011, BIOCHEMISTRY-US, V50, P4, DOI 10.1021/bi101665s	79	48	50	0	74	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 29	2013	288	13					9249	9260		10.1074/jbc.M112.417725	http://dx.doi.org/10.1074/jbc.M112.417725			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	116DG	23430261	Green Published, hybrid			2022-12-25	WOS:000316862200043
J	Hopton, A; Thomas, K; MacPherson, H				Hopton, Ann; Thomas, Kate; MacPherson, Hugh			The Acceptability of Acupuncture for Low Back Pain: A Qualitative Study of Patient's Experiences Nested within a Randomised Controlled Trial	PLOS ONE			English	Article							FEAR-AVOIDANCE BELIEFS; EXPECTATIONS; OUTCOMES; PLACEBO; CARE	Introduction: The National Institute for Health and Clinical Excellence guidelines recommend acupuncture as a clinically effective treatment for chronic back pain. However, there is insufficient knowledge of what factors contribute to patients' positive and negative experiences of acupuncture, and how those factors interact in terms of the acceptability of treatment. This study used patient interviews following acupuncture treatment for back pain to identify, understand and describe the elements that contribute or detract from acceptability of treatment. Methods: The study used semi-structured interviews. Twelve patients were interviewed using an interview schedule as a sub-study nested within a randomised controlled trial of acupuncture for chronic back pain. The interviews were analysed using thematic analysis. Results and Discussion: Three over-arching themes emerged from the analysis. The first entitled facilitators of acceptability contained five subthemes; experience of pain relief, improvements in physical activity, relaxation, psychological benefit, reduced reliance on medication. The second over-arching theme identified barriers to acceptability, which included needle-related discomfort and temporary worsening of symptoms, pressure to continue treatment and financial cost. The third over-arching theme comprised mediators of acceptability, which included pre-treatment mediators such as expectation and previous experience, and treatment-related mediators of time, therapeutic alliance, lifestyle advice and the patient's active involvement in recovery. These themes inform our understanding of the acceptability of acupuncture to patients with low back pain. Conclusion: The acceptability of acupuncture treatment for low back pain is complex and multifaceted. The therapeutic relationship between the practitioner and patient emerged as a strong driver for acceptability, and as a useful vehicle to develop the patients' self-efficacy in pain management in the longer term. Unpleasant treatment related effects do not necessarily detract from patients' overall perception of acceptability.	[Hopton, Ann; MacPherson, Hugh] Univ York, Dept Hlth Sci, York YO10 5DD, N Yorkshire, England; [Thomas, Kate] Univ Sheffield, Hlth Serv Res Unit, Sheffield, S Yorkshire, England	University of York - UK; University of Sheffield	Hopton, A (corresponding author), Univ York, Dept Hlth Sci, York YO10 5DD, N Yorkshire, England.	ann.hopton@york.ac.uk		Hopton, Ann/0000-0002-2505-1176; MacPherson, Hugh/0000-0003-4255-4768	National Institute for Health Research (NIHR) Health Technology Assessment programme; NIHR Career Scientist Award [PAS/03/07/CSA/008]	National Institute for Health Research (NIHR) Health Technology Assessment programme(National Institute for Health Research (NIHR)); NIHR Career Scientist Award	This research was supported by the National Institute for Health Research (NIHR) Health Technology Assessment programme and in part by a NIHR Career Scientist Award, grant number PAS/03/07/CSA/008 awarded to HM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2009, NICE GUID 88, V1, P61; Braun V., 2006, MAY, V3, P77, DOI 10.1191/1478088706qp063oa; Breen A, 2007, EUR J PAIN, V11, P21, DOI 10.1016/j.ejpain.2005.12.006; Cedraschi C, 2005, BEST PRACT RES CL RH, V19, P577, DOI 10.1016/j.berh.2005.03.002; Corbett M, 2009, FAM PRACT, V26, P359, DOI 10.1093/fampra/cmp042; Craig P, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a1655; Evans M, 2011, J ALTERN COMPLEM MED, V17, P519, DOI 10.1089/acm.2010.0749; Foster NE, 2010, PAIN, V148, P398, DOI 10.1016/j.pain.2009.11.002; Hopton AK, 2010, ACUPUNCT MED, V28, P185, DOI 10.1136/aim.2010.002279; Linde K, 2007, PAIN, V128, P264, DOI 10.1016/j.pain.2006.12.006; MacPherson H, 2004, COMPLEMENT THER MED, V12, P136, DOI 10.1016/j.ctim.2004.07.043; MacPherson H, 2006, J ALTERN COMPLEM MED, V12, P873, DOI 10.1089/acm.2006.12.873; Newcomer KL, 2010, PM&R, V2, P514, DOI 10.1016/j.pmrj.2010.03.034; Nicholas MK, 2007, EUR J PAIN, V11, P153, DOI 10.1016/j.ejpain.2005.12.008; Rainville J, 2011, SPINE J, V11, P895, DOI 10.1016/j.spinee.2011.08.006; Ratcliffe J, 2006, BRIT MED J, V333, P626, DOI 10.1136/bmj.38932.806134.7C; So DW, 2002, AM J PUBLIC HEALTH, V92, P1662, DOI 10.2105/AJPH.92.10.1662; Thomas KJ, 2006, BMJ-BRIT MED J, V333, P623, DOI 10.1136/bmj.38878.907361.7C; Thomas K. J., 2005, HEALTH TECHNOL ASSES, V9, P1, DOI DOI 10.3310/hta9320; Toye Francine, 2012, Prim Health Care Res Dev, V13, P72, DOI 10.1017/S1463423611000387; Vickers AJ, 2012, ARCH INTERN MED, V172, P1444, DOI 10.1001/archinternmed.2012.3654; Wasan AD, 2010, J PAIN, V11, P555, DOI 10.1016/j.jpain.2009.09.013; Webb R, 2003, SPINE, V28, P1195, DOI 10.1097/00007632-200306010-00021; White P, 2012, PAIN, V153, P455, DOI 10.1016/j.pain.2011.11.007	24	21	21	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2013	8	2							e56806	10.1371/journal.pone.0056806	http://dx.doi.org/10.1371/journal.pone.0056806			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IT	23437246	Green Published, gold, Green Accepted			2022-12-25	WOS:000315186000047
J	Ma, YB; Kubicek, J; Labahn, J				Ma, Yanbin; Kubicek, Jan; Labahn, Joerg			Expression and Purification of Functional Human Mu Opioid Receptor from E.coli	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTORS; INFECTED INSECT CELLS; RAT NEUROTENSIN RECEPTOR; LARGE-SCALE PRODUCTION; ESCHERICHIA-COLI; MEMBRANE-PROTEINS; PICHIA-PASTORIS; OVEREXPRESSION; SOLUBILIZATION; SEQUENCE	N-terminally his-tagged human mu opioid receptor, a G protein-coupled receptor was produced in E. coli employing synthetic codon-usage optimized constructs. The receptor was expressed in inclusion bodies and membrane- inserted in different E. coli strains. By optimizing the expression conditions the expression level for the membrane-integrated receptor was raised to 0.3- 0.5 mg per liter of culture. Milligram quantities of receptor could be enriched by affinity chromatography from IPTG induced cultures grown at 18 degrees C. By size exclusion chromatography the protein fraction with the fraction of alpha- helical secondary structure expected for a 7-TM receptor was isolated, by CD-spectroscopy an alpha-helical content of ca. 45% was found for protein solubilised in the detergent Fos-12. Receptor in Fos-12 micelles was shown to bind endomorphin-1 with a K-D of 61 nM. A final yield of 0.17 mg functional protein per liter of culture was obtained.	[Ma, Yanbin; Kubicek, Jan; Labahn, Joerg] Forschungszentrum Julich, Inst Complex Syst ICS 6, D-52425 Julich, Germany; [Kubicek, Jan] QIAGEN GmbH, Hilden, Germany	Helmholtz Association; Research Center Julich; QIAGEN GmbH	Labahn, J (corresponding author), Forschungszentrum Julich, Inst Complex Syst ICS 6, D-52425 Julich, Germany.	j.labahn@fz-juelich.de	Labahn, Jörg/G-9593-2013	Labahn, Jörg/0000-0002-0648-8145				Akermoun M, 2005, PROTEIN EXPRES PURIF, V44, P65, DOI 10.1016/j.pep.2005.04.016; ANDRADE MA, 1993, PROTEIN ENG, V6, P383, DOI 10.1093/protein/6.4.383; Andre N, 2006, PROTEIN SCI, V15, P1115, DOI 10.1110/ps.062098206; Chaturvedi K, 2000, MOL BRAIN RES, V76, P64, DOI 10.1016/S0169-328X(99)00332-0; Cook BL, 2009, P NATL ACAD SCI USA, V106, P11925, DOI 10.1073/pnas.0811089106; Corin K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023036; Flower DR, 1999, BBA-REV BIOMEMBRANES, V1422, P207, DOI 10.1016/S0304-4157(99)00006-4; Fredriksson R, 2003, MOL PHARMACOL, V63, P1256, DOI 10.1124/mol.63.6.1256; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; GRISSHAMMER R, 1993, BIOCHEM J, V295, P571, DOI 10.1042/bj2950571; GRISSHAMMER R, 1995, Q REV BIOPHYS, V28, P315, DOI 10.1017/S0033583500003504; Grunewald S, 2004, RECEPTOR CHANNEL, V10, P37, DOI 10.1080/10606820490279466; Hassaine G, 2006, PROTEIN EXPRES PURIF, V45, P343, DOI 10.1016/j.pep.2005.06.007; Kaiser L, 2008, P NATL ACAD SCI USA, V105, P15726, DOI 10.1073/pnas.0804766105; Kieffer BL, 2002, PROG NEUROBIOL, V66, P285, DOI 10.1016/S0301-0082(02)00008-4; Kuszak AJ, 2009, J BIOL CHEM, V284, P26732, DOI 10.1074/jbc.M109.026922; Lundstrom Kenneth, 2006, Journal of Structural and Functional Genomics, V7, P77, DOI 10.1007/s10969-006-9011-2; Maggio R, 2005, FEBS J, V272, P2939, DOI 10.1111/j.1742-4658.2005.04729.x; Magnusdottir A, 2009, NAT METHODS, V6, P477, DOI 10.1038/nmeth0709-477; Manglik A, 2012, NATURE, V485, P321, DOI 10.1038/nature10954; Massotte D, 1999, J BIOTECHNOL, V69, P39, DOI 10.1016/S0168-1656(98)00209-0; Massotte D, 1997, J BIOL CHEM, V272, P19987, DOI 10.1074/jbc.272.32.19987; Miroux B, 1996, J MOL BIOL, V260, P289, DOI 10.1006/jmbi.1996.0399; Oates J, 2011, CURR OPIN STRUC BIOL, V21, P802, DOI 10.1016/j.sbi.2011.09.007; Ren H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004509; Sarramegna V, 2005, PROTEIN EXPRES PURIF, V43, P85, DOI 10.1016/j.pep.2005.05.007; Sarramegna V, 2003, CELL MOL LIFE SCI, V60, P1529, DOI 10.1007/s00018-003-3168-7; Sarramegna V, 2002, PROTEIN EXPRES PURIF, V24, P212, DOI 10.1006/prep.2001.1564; Schlyer S, 2006, DRUG DISCOV TODAY, V11, P481, DOI 10.1016/j.drudis.2006.04.008; Singh VK, 1997, NEUROIMMUNOMODULAT, V4, P285, DOI 10.1159/000097349; Stanasila L, 1999, EUR J BIOCHEM, V260, P430, DOI 10.1046/j.1432-1327.1999.00187.x; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Takeda S, 2002, FEBS LETT, V520, P97, DOI 10.1016/S0014-5793(02)02775-8; Tucker J, 1996, BIOCHEM J, V317, P891, DOI 10.1042/bj3170891; Tyndall JDA, 2005, MED CHEM, V1, P405, DOI 10.2174/1573406054368675; Wagner S, 2007, MOL CELL PROTEOMICS, V6, P1527, DOI 10.1074/mcp.M600431-MCP200; WALLIN E, 1995, PROTEIN ENG, V8, P693, DOI 10.1093/protein/8.7.693; Wang XQ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023076; Wang XQ, 2011, P NATL ACAD SCI USA, V108, P9049, DOI 10.1073/pnas.1018185108; Weiss HM, 2002, EUR J BIOCHEM, V269, P82, DOI 10.1046/j.0014-2956.2002.02618.x; Zadina JE, 1997, NATURE, V386, P499, DOI 10.1038/386499a0	41	8	8	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2013	8	2							e56500	10.1371/journal.pone.0056500	http://dx.doi.org/10.1371/journal.pone.0056500			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IT	23437147	Green Submitted, gold, Green Published			2022-12-25	WOS:000315186000030
J	Rai, A; Tzvetkov, N; Manstein, DJ				Rai, Amrita; Tzvetkov, Nikolay; Manstein, Dietmar J.			Functional Dissection of the Dictyostelium discoideum Dynamin B Mitochondrial Targeting Sequence	PLOS ONE			English	Article							PROTEIN IMPORT; PROCESSING PEPTIDASE; PRECURSOR PROTEINS; CRYSTAL-STRUCTURE; FUSION; CLEAVAGE; PREDICTION; REQUIRES; IDENTIFICATION; TRANSLOCATION	Most mitochondrial proteins are nuclear encoded and synthesized in the cytosol with an N-terminal mitochondrial targeting sequence or presequence for subsequent import into mitochondria. Here, we describe the proteolytic processing and inner membrane potential-dependent translocation of a dynamin family member by the Dictyostelium discoideum mitochondrial import system. Our results show that the unusual D. discoideum dynamin B presequence is removed through a processing mechanism that is common for mitochondrial matrix proteins. We identified a minimal segment of the dynamin B presequence containing seven lysine residues. This 47-residue region is, in combination with consensus matrix protease cleavage sites, necessary and sufficient for mitochondrial targeting. The correct positioning of these lysine residues plays a critical role for the proper processing and mitochondrial import of dynamin B in D. discoideum. Fluorescent proteins tagged with the dynamin B presequence or presequence regions supporting mitochondrial import in D. discoideum are imported with similar efficiency into the mitochondrial matrix of mammalian cells, indicating that the basic mechanisms underlying mitochondrial protein import are highly conserved from amoebozoa to mammalia.	[Rai, Amrita; Tzvetkov, Nikolay; Manstein, Dietmar J.] Hannover Med Sch, Inst Biophys Chem, Hannover, Germany	Hannover Medical School	Manstein, DJ (corresponding author), Hannover Med Sch, Inst Biophys Chem, Hannover, Germany.	manstein.dietmar@mh-hannover.de	Manstein, Dietmar J. J/M-1034-2013; Manstein, Dietmar J./AAG-2640-2019; Tzvetkov, Nikolay/N-2872-2014	Manstein, Dietmar J. J/0000-0003-0763-0147; Manstein, Dietmar J./0000-0003-0763-0147; Rai, Amrita/0000-0002-5471-5250	state of Lower-Saxony; German Research Council (DFG); NICHD	state of Lower-Saxony; German Research Council (DFG)(German Research Foundation (DFG)); NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	The work was supported by the state of Lower-Saxony and the German Research Council (DFG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Dr. Anurag Kumar Singh for help and stimulating discussions. The monoclonal anti-mitoporin antibody 70-100-1 developed by G. Gerisch and co-workers was obtained from the Developmental Studies Hybridoma Bank developed under the auspices of the NICHD and maintained by The University of Iowa, Department of Biology, Iowa City, IA 52242.	Ahmed AU, 2006, EUKARYOT CELL, V5, P1314, DOI 10.1128/EC.00386-05; Barth C, 2007, INT REV CYTOL, V263, P207, DOI 10.1016/S0074-7696(07)63005-8; BRANDA SS, 1995, J BIOL CHEM, V270, P27366, DOI 10.1074/jbc.270.45.27366; Chacinska A, 2009, CELL, V138, P628, DOI 10.1016/j.cell.2009.08.005; Chen H, 2006, BIOINFORMATICS, V22, P376, DOI 10.1093/bioinformatics/bti822; Cheng J, 2005, NUCLEIC ACIDS RES, V33, pW72, DOI 10.1093/nar/gki396; Claros MG, 1996, EUR J BIOCHEM, V241, P779, DOI 10.1111/j.1432-1033.1996.00779.x; DESHAIES RJ, 1988, NATURE, V332, P800, DOI 10.1038/332800a0; EGELHOFF TT, 1991, METHOD ENZYMOL, V196, P319; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; Faelber K, 2011, NATURE, V477, P556, DOI 10.1038/nature10369; Fan ACY, 2011, PROTEIN PEPTIDE LETT, V18, P122; Ford MGJ, 2011, NATURE, V477, P561, DOI 10.1038/nature10441; Gakh E, 2002, BBA-MOL CELL RES, V1592, P63, DOI 10.1016/S0167-4889(02)00265-3; GAVEL Y, 1990, PROTEIN ENG, V4, P33, DOI 10.1093/protein/4.1.33; GELI V, 1990, J BIOL CHEM, V265, P19216; Guda C, 2004, NUCLEIC ACIDS RES, V32, pW372, DOI 10.1093/nar/gkh374; HAUCKE V, 1995, J BIOL CHEM, V270, P5565, DOI 10.1074/jbc.270.10.5565; HAWLITSCHEK G, 1988, CELL, V53, P795, DOI 10.1016/0092-8674(88)90096-7; HENDRICK JP, 1989, P NATL ACAD SCI USA, V86, P4056, DOI 10.1073/pnas.86.11.4056; Herlan M, 2003, J BIOL CHEM, V278, P27781, DOI 10.1074/jbc.M211311200; Hermann GJ, 1998, J CELL BIOL, V143, P359, DOI 10.1083/jcb.143.2.359; Hoppins S, 2007, ANNU REV BIOCHEM, V76, P751, DOI 10.1146/annurev.biochem.76.071905.090048; Hoppins S, 2009, BBA-MOL CELL RES, V1793, P20, DOI 10.1016/j.bbamcr.2008.07.005; Horton P, 2007, NUCLEIC ACIDS RES, V35, pW585, DOI 10.1093/nar/gkm259; Ingerman E, 2005, J CELL BIOL, V170, P1021, DOI 10.1083/jcb.200506078; Insall R, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-6-222; ISAYA G, 1991, J CELL BIOL, V113, P65, DOI 10.1083/jcb.113.1.65; Ishihara N, 2004, J CELL SCI, V117, P6535, DOI 10.1242/jcs.01565; KARSLAKE C, 1990, BIOCHEMISTRY-US, V29, P9872, DOI 10.1021/bi00494a017; Knetsch MLW, 2002, J MUSCLE RES CELL M, V23, P605, DOI 10.1023/A:1024498805771; Meeusen S, 2006, CELL, V127, P383, DOI 10.1016/j.cell.2006.09.021; Neupert W, 2007, ANNU REV BIOCHEM, V76, P723, DOI 10.1146/annurev.biochem.76.052705.163409; Nolden M, 2005, CELL, V123, P277, DOI 10.1016/j.cell.2005.08.003; Praefcke GJK, 2004, NAT REV MOL CELL BIO, V5, P133, DOI 10.1038/nrm1313; Rai A, 2011, CELL MOL LIFE SCI, V68, P2751, DOI 10.1007/s00018-010-0590-5; Rapaport D, 1998, J BIOL CHEM, V273, P20150, DOI 10.1074/jbc.273.32.20150; ROISE D, 1988, EMBO J, V7, P649, DOI 10.1002/j.1460-2075.1988.tb02859.x; SAGAN L, 1967, J THEOR BIOL, V14, P225, DOI 10.1016/0022-5193(67)90079-3; Schmidt O, 2010, NAT REV MOL CELL BIO, V11, P655, DOI 10.1038/nrm2959; Sesaki H, 2003, BIOCHEM BIOPH RES CO, V308, P276, DOI 10.1016/S0006-291X(03)01348-2; SHEFFIELD WP, 1990, J BIOL CHEM, V265, P11069; Small I, 2004, PROTEOMICS, V4, P1581, DOI 10.1002/pmic.200300776; Smirnova E, 2001, MOL BIOL CELL, V12, P2245, DOI 10.1091/mbc.12.8.2245; Taylor AB, 2001, STRUCTURE, V9, P615, DOI 10.1016/S0969-2126(01)00621-9; TROLL H, 1992, J BIOL CHEM, V267, P21072; Tzvetkov N, 2006, BIOTECHNIQUES, V40, P145, DOI 10.2144/000112113; VONHEIJNE G, 1989, EUR J BIOCHEM, V180, P535; VONHEIJNE G, 1986, EMBO J, V5, P1335, DOI 10.1002/j.1460-2075.1986.tb04364.x	49	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2013	8	2							e56975	10.1371/journal.pone.0056975	http://dx.doi.org/10.1371/journal.pone.0056975			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IT	23437285	Green Published, gold, Green Submitted			2022-12-25	WOS:000315186000061
J	Shi, L; Shi, L; Wang, L; Duan, YH; Lei, W; Wang, Z; Li, J; Fan, XL; Li, XK; Li, SJ; Guo, Z				Shi, Lei; Shi, Lei; Wang, Ling; Duan, Yonghong; Lei, Wei; Wang, Zhen; Li, Jing; Fan, Xiangli; Li, Xiaokang; Li, Shujun; Guo, Zheng			The Improved Biological Performance of a Novel Low Elastic Modulus Implant	PLOS ONE			English	Article							IN-VIVO; BIOMECHANICAL CHARACTERIZATION; SHAPE-MEMORY; BONE LOSS; TITANIUM; TISSUE; MICROMOTION; MODEL; OSSEOINTEGRATION; DIFFERENTIATION	Background: The mismatch of the elastic modulus between implants and bone tissue can lead to stress shielding, bone resorption and poor osseointegration. Compared with normal bone tissue, this problem is much more serious in osteoporosis. The purpose of this study was designed to find out whether the novel Ti-24Nb-4Zr-7.9Sn (TNZS) implant with low elastic modulus and high strength was suitable for biomedical material, especially in osteoporosis. Methodology: In vitro study, the viability and Alkaline phosphatase (ALP) activity of osteoblasts on the TNZS and Ti-6V-4V (TAV) were observed. In vivo study, 30 adult female New Zealand rabbits were selected and divided randomly into two groups: sham-operation (SHAM, n = 6) and ovariectomised in combination with methylprednisolone treatment (OVX+MP, n = 24). Two implants were then placed in the tibia of each OVX + MP group rabbit, one in each side (left: TAV; right: TNZS). The OVX + MP group rabbits were sacrificed at 4 and 12 weeks after the implantation. The osteoporotic bone responses to the TNZS and TAV implants were evaluated by pull-out test, Micro-CT analyses and histological observation. Principal Findings: Compared with the TAV group, the TNZS group showed a significant increase (P<0.05) in cell viability and ALP activity, new bone formation and pull-out force. Conclusions: The novel TNZS implants show good biological performance both in vitro and in vivo, which suggests that the alloys are suitable for biomedical applications, especially in osteoporosis.	[Shi, Lei; Duan, Yonghong; Lei, Wei; Wang, Zhen; Li, Jing; Fan, Xiangli; Li, Xiaokang; Guo, Zheng] Fourth Mil Med Univ, Xijing Hosp, Inst Orthopaed, Xian 710032, Peoples R China; [Shi, Lei] Fourth Mil Med Univ, Inst Implantat, Stomatol Hosp, Xian 710032, Peoples R China; [Wang, Ling] Fourth Mil Med Univ, Inst Hlth Stat, Xian 710032, Peoples R China; [Li, Shujun] Chinese Acad Sci, Inst Met Res, Shenyang 110016, Peoples R China	Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University; Chinese Academy of Sciences; Institute of Metal Research, CAS	Guo, Z (corresponding author), Fourth Mil Med Univ, Xijing Hosp, Inst Orthopaed, Xian 710032, Peoples R China.	guozheng@fmmu.edu.cn		Lei, Wei/0000-0002-7346-6915	National Natural Science Foundation of China [30471754]; 863 Program of China [2007AA03Z431]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 863 Program of China(National High Technology Research and Development Program of China)	This work was supported financially in part by the National Natural Science Foundation of China (grant 30471754) and 863 Program of China (No. 2007AA03Z431). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aubin JE, 1998, BIOCHEM CELL BIOL, V76, P899, DOI 10.1139/bcb-76-6-899; Branemark R, 1998, J ORTHOPAED RES, V16, P61, DOI 10.1002/jor.1100160111; Branemark R, 1998, MED ENG PHYS, V20, P216, DOI 10.1016/S1350-4533(98)00023-X; Cao T, 2004, J PERIODONTAL RES, V39, P37, DOI 10.1111/j.1600-0765.2004.00703.x; Cao T, 2001, CLIN ORAL IMPLAN RES, V12, P604, DOI 10.1034/j.1600-0501.2001.120608.x; Cao XY, 2006, BIOMED MATER, V1, pL16, DOI 10.1088/1748-6041/1/4/L02; Carter DR, 1998, CLIN ORTHOP RELAT R, pS41; Castaneda S, 2008, J BONE MINER METAB, V26, P53, DOI 10.1007/s00774-007-0797-1; Chaudhari A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024186; COOK SD, 1983, J BIOMED MATER RES, V17, P519, DOI 10.1002/jbm.820170311; DHERT WJ, 2000, MECH TESTING BONE BO; Duyck J, 2006, ARCH ORAL BIOL, V51, P1, DOI 10.1016/j.archoralbio.2005.04.003; Eisenbarth E, 2004, BIOMATERIALS, V25, P5705, DOI 10.1016/j.biomaterials.2004.01.021; Ferrandini PL, 2007, J ALLOY COMPD, V433, P207, DOI 10.1016/j.jallcom.2006.06.094; Fu J, 2008, APPL SURF SCI, V255, P286, DOI 10.1016/j.apsusc.2008.06.064; Geetha M, 2009, PROG MATER SCI, V54, P397, DOI 10.1016/j.pmatsci.2008.06.004; Gibson L.J., 1997, CELLULAR SOLIDS; GRARDEL B, 1994, OSTEOPOROSIS INT, V4, P204, DOI 10.1007/BF01623240; Hanawa T, 2004, MAT SCI ENG C-BIO S, V24, P745, DOI 10.1016/j.msec.2004.08.018; Hao YL, 2007, ACTA BIOMATER, V3, P277, DOI 10.1016/j.actbio.2006.11.002; Hao YL, 2005, APPL PHYS LETT, V87, DOI 10.1063/1.2037192; He FM, 2009, INT J ORAL MAX SURG, V38, P677, DOI 10.1016/j.ijom.2009.03.716; HEAD WC, 1995, CLIN ORTHOP RELAT R, P85; Hedia HS, 2002, BIO-MED MATER ENG, V12, P111; Huiskes R, 1997, J MATER SCI-MATER M, V8, P785, DOI 10.1023/A:1018520914512; Inamura T, 2005, MAT SCI ENG C-BIO S, V25, P426, DOI 10.1016/j.msec.2005.01.025; Jasty M, 1997, J BONE JOINT SURG AM, V79A, P707, DOI 10.2106/00004623-199705000-00010; Jonsson AK, 2002, THIN SOLID FILMS, V402, P242, DOI 10.1016/S0040-6090(01)01715-1; Krishna BV, 2007, ACTA BIOMATER, V3, P997, DOI 10.1016/j.actbio.2007.03.008; Li BF, 2010, ACTA ORTHOP, V81, P396, DOI 10.3109/17453674.2010.483986; Lin DJ, 2007, BIOMATERIALS, V28, P2582, DOI 10.1016/j.biomaterials.2007.02.005; Miyazaki S, 2006, MAT SCI ENG A-STRUCT, V438, P18, DOI 10.1016/j.msea.2006.02.054; Mori H, 1997, J ORAL MAXIL SURG, V55, P351, DOI 10.1016/S0278-2391(97)90124-5; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Niinomi M, 2002, METALL MATER TRANS A, V33, P477, DOI 10.1007/s11661-002-0109-2; Niinomi M, 2003, SCI TECHNOL ADV MAT, V4, P445, DOI 10.1016/j.stam.2003.09.002; Park CH, 2007, J PERIODONTOL, V78, P273, DOI 10.1902/jop.2007.060252; Pearce AI, 2007, EUR CELLS MATER, V13, P1; Sanden B, 2001, EUR SPINE J, V10, P334, DOI 10.1007/s005860100291; Simon U, 2003, J BIOMECH, V36, P1079, DOI 10.1016/S0021-9290(03)00114-3; Southard TE, 2000, ORAL SURG ORAL MED O, V89, P244, DOI 10.1067/moe.2000.102223; Spoerke ED, 2008, J BIOMED MATER RES A, V84A, P402, DOI 10.1002/jbm.a.31317; Stoppie N, 2009, J BIOMED MATER RES A, V90A, P792, DOI 10.1002/jbm.a.32145; Sumitomo N, 2008, J MATER SCI-MATER M, V19, P1581, DOI 10.1007/s10856-008-3372-y; Szmukler-Moncler S, 1998, J BIOMED MATER RES, V43, P192, DOI 10.1002/(SICI)1097-4636(199822)43:2<192::AID-JBM14>3.0.CO;2-K; Takeuchi K, 2005, J BIOMED MATER RES A, V72A, P296, DOI 10.1002/jbm.a.30227; Thompson GJ, 1996, BIOMATERIALS, V17, P1949, DOI 10.1016/0142-9612(96)00009-9; Turner A. Simon, 2001, European Cells & Materials, V1, P66; Viceconti M, 2000, J BIOMECH, V33, P1611, DOI 10.1016/S0021-9290(00)00140-8; Wolff J, 1892, GESETZ TRANSFORMATIO	50	52	53	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2013	8	2							e55015	10.1371/journal.pone.0055015	http://dx.doi.org/10.1371/journal.pone.0055015			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IT	23437048	Green Published, gold, Green Submitted			2022-12-25	WOS:000315186000005
J	Vreven, T; Hwang, H; Weng, ZP				Vreven, Thom; Hwang, Howook; Weng, Zhiping			Exploring Angular Distance in Protein-Protein Docking Algorithms	PLOS ONE			English	Article							SHAPE COMPLEMENTARITY; GEOMETRIC FIT; PREDICTION; ELECTROSTATICS; RECOGNITION; PERFORMANCE; POTENTIALS; COMPLEXES; ZRANK; ZDOCK	We present a two-stage hybrid-resolution approach for rigid-body protein-protein docking. The first stage is carried out at low-resolution (15 degrees) angular sampling. In the second stage, we sample promising regions from the first stage at a higher resolution of 6 degrees. The hybrid-resolution approach produces the same results as a 6 degrees uniform sampling docking run, but uses only 17% of the computational time. We also show that the angular distance can be used successfully in clustering and pruning algorithms, as well as the characterization of energy funnels. Traditionally the root-mean-square-distance is used in these algorithms, but the evaluation is computationally expensive as it depends on both the rotational and translational parameters of the docking solutions. In contrast, the angular distances only depend on the rotational parameters, which are generally fixed for all docking runs. Hence the angular distances can be pre-computed, and do not add computational time to the post-processing of rigid-body docking results.	[Vreven, Thom; Hwang, Howook; Weng, Zhiping] Univ Massachusetts, Sch Med, Program Bioinformat & Integrat Biol, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester	Weng, ZP (corresponding author), Univ Massachusetts, Sch Med, Program Bioinformat & Integrat Biol, Worcester, MA 01605 USA.	Zhiping.Weng@umassmed.edu			National Institutes of Health [R01 GM084884]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084884] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by National Institutes of Health grant R01 GM084884 awarded to ZW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrusier N, 2008, PROTEINS, V73, P271, DOI 10.1002/prot.22170; Bajaj C, 2011, IEEE ACM T COMPUT BI, V8, P45, DOI 10.1109/TCBB.2009.57; Chen R, 2003, PROTEINS, V52, P80, DOI 10.1002/prot.10389; Chen R, 2002, PROTEINS, V47, P281, DOI 10.1002/prot.10092; Comeau SR, 2004, BIOINFORMATICS, V20, P45, DOI 10.1093/bioinformatics/btg371; Fleishman SJ, 2011, J MOL BIOL, V414, P289, DOI 10.1016/j.jmb.2011.09.031; Gabb HA, 1997, J MOL BIOL, V272, P106, DOI 10.1006/jmbi.1997.1203; Gray JJ, 2003, J MOL BIOL, V331, P281, DOI 10.1016/S0022-2836(03)00670-3; Hwang H, 2011, PROTEINS, V79, P2467, DOI 10.1002/prot.23070; Hwang H, 2010, PROTEINS, V78, P3104, DOI 10.1002/prot.22764; Hwang H, 2010, PROTEINS, V78, P3111, DOI 10.1002/prot.22830; KATCHALSKIKATZIR E, 1992, P NATL ACAD SCI USA, V89, P2195, DOI 10.1073/pnas.89.6.2195; London N, 2008, STRUCTURE, V16, P269, DOI 10.1016/j.str.2007.11.013; London N, 2008, BIOCHEM SOC T, V36, P1418, DOI 10.1042/BST0361418; Mandell JG, 2001, PROTEIN ENG, V14, P105, DOI 10.1093/protein/14.2.105; Mintseris J, 2007, PROTEINS, V69, P511, DOI 10.1002/prot.21502; Mitchell JC, 2008, SIAM J SCI COMPUT, V30, P525, DOI 10.1137/030601879; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159; NOREL R, 1995, J MOL BIOL, V252, P263, DOI 10.1006/jmbi.1995.0493; Pierce B, 2008, PROTEINS, V72, P270, DOI 10.1002/prot.21920; Pierce B, 2007, PROTEINS, V67, P1078, DOI 10.1002/prot.21373; Pierce BG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024657; Ravikant DVS, 2010, PROTEINS, V78, P400, DOI 10.1002/prot.22550; Ritchie DW, 2008, CURR PROTEIN PEPT SC, V9, P1, DOI 10.2174/138920308783565741; Shen Y, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000191; Smith GR, 2002, CURR OPIN STRUC BIOL, V12, P28, DOI 10.1016/S0959-440X(02)00285-3; Vakser IA, 1999, P NATL ACAD SCI USA, V96, P8477, DOI 10.1073/pnas.96.15.8477; Vreven T, 2012, PROTEIN SCI, V21, P396, DOI 10.1002/pro.2027; Vreven T, 2011, PROTEIN SCI, V20, P1576, DOI 10.1002/pro.687; Yershova A, INT J ROBOT RES, V29, P801; Zacharias M, 2010, CURR OPIN STRUC BIOL, V20, P180, DOI 10.1016/j.sbi.2010.02.001	31	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2013	8	2							e56645	10.1371/journal.pone.0056645	http://dx.doi.org/10.1371/journal.pone.0056645			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IT	23437194	Green Published, gold, Green Submitted			2022-12-25	WOS:000315186000037
J	Ebrahimpour, M; Putnins, TJ; Berryman, MJ; Allison, A; Ng, BWH; Abbott, D				Ebrahimpour, Maryam; Putnins, Talis J.; Berryman, Matthew J.; Allison, Andrew; Ng, Brian W. -H.; Abbott, Derek			Automated Authorship Attribution Using Advanced Signal Classification Techniques	PLOS ONE			English	Article								In this paper, we develop two automated authorship attribution schemes, one based on Multiple Discriminant Analysis (MDA) and the other based on a Support Vector Machine (SVM). The classification features we exploit are based on word frequencies in the text. We adopt an approach of preprocessing each text by stripping it of all characters except a-z and space. This is in order to increase the portability of the software to different types of texts. We test the methodology on a corpus of undisputed English texts, and use leave-one-out cross validation to demonstrate classification accuracies in excess of 90%. We further test our methods on the Federalist Papers, which have a partly disputed authorship and a fair degree of scholarly consensus. And finally, we apply our methodology to the question of the authorship of the Letter to the Hebrews by comparing it against a number of original Greek texts of known authorship. These tests identify where some of the limitations lie, motivating a number of open questions for future work. An open source implementation of our methodology is freely available for use at https://github.com/matthewberryman/author-detection.	[Ebrahimpour, Maryam; Putnins, Talis J.; Berryman, Matthew J.; Allison, Andrew; Ng, Brian W. -H.; Abbott, Derek] Univ Adelaide, Sch Elect & Elect Engn, Adelaide, SA, Australia; [Putnins, Talis J.] Stockholm Sch Econ Riga, Riga, Latvia; [Putnins, Talis J.] Univ Technol Sydney, Sydney, NSW 2007, Australia; [Berryman, Matthew J.] Univ Wollongong, SMART Infrastruct Facil, Wollongong, NSW, Australia	University of Adelaide; University of Technology Sydney; University of Wollongong	Abbott, D (corresponding author), Univ Adelaide, Sch Elect & Elect Engn, Adelaide, SA, Australia.	derek.abbott@adelaide.edu.au	Allison, Andrew/AAG-8356-2019; Abbott, Derek/E-8352-2011; Ng, Brian W.-H./D-3700-2018	Allison, Andrew/0000-0003-3865-511X; Abbott, Derek/0000-0002-0945-2674; Ng, Brian W.-H./0000-0002-8316-4996; Putnins, Talis/0000-0001-5731-499X				Adair D., 1944, WILLIAM MARY Q, V1, P235, DOI DOI 10.2307/1923729; Alviar JJ, 2008, NEW TESTAMENT STUD, V54, P139, DOI 10.1017/S0028688508000088; Ayat NE, 2005, PATTERN RECOGN, V38, P1733, DOI 10.1016/j.patcog.2005.03.011; Baayen H., 2002, 6 JADT, V1, P69; Berryman MJ, 2003, FLUCT NOISE LETT, V3, pL1, DOI 10.1142/S021947750300104X; Bosch RA, 1998, AM MATH MON, V105, P601, DOI 10.2307/2589242; CANNON RL, 1986, IEEE T PATTERN ANAL, V8, P248, DOI 10.1109/TPAMI.1986.4767778; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Diederich J, 2003, APPL INTELL, V19, P109, DOI 10.1023/A:1023824908771; Dunn J.C., 1973, J CYBERNETICS, V3, P32, DOI [10.1080/01969727308546046, DOI 10.1080/01969727308546046]; Estival D, 2008, J SCI VIETNAM NATL U, V1, P1; Eusebius, 1890, CHURCH HIST; Fung G., 2003, P 2003 C DIV COMP, P42; Gray D, 1998, 4 INT C OPT TECHN AP, P891; Gray D, 1998, WORKSH COMM GDR ISIS; Green S. B., 2005, USING SPSS WINDOWS M, V4th; Hirst G, 2012, ENGL STUD, V93, P357, DOI 10.1080/0013838X.2012.668789; Holmes D. I., 1995, LIT LINGUIST COMPUT, V10, P111, DOI DOI 10.1093/LLC/10.2.111; Hsu C. W., 2010, TECHNICAL REPORT; Iqbal F, 2008, DIGIT INVEST, V5, pS42, DOI 10.1016/j.diin.2008.05.001; Joachims T., 1998, EUROPEAN C MACHINE L, V1398, P137, DOI [DOI 10.1007/BFB0026683, 10.1007/BFb0026683]; Juola P, 2012, ENGL STUD, V93, P275, DOI 10.1080/0013838X.2012.668792; Koppel M, 2012, ENGL STUD, V93, P284, DOI 10.1080/0013838X.2012.668794; Krieg M, 2001, DEFENCE APPL SIGNAL, P126; Lewicki P, 2005, STAT METHODS APPL; Luyckx K., 2008, P 22 INT C COMP LING, P513; Mosteller F, 1964, INFERENCE DISPUTED A; Mustafa Tareef Kamil, 2010, Journal of Computer Sciences, V6, P235, DOI 10.3844/jcssp.2010.235.243; Ortuno M, 2002, EUROPHYS LETT, V57, P759, DOI 10.1209/epl/i2002-00528-3; PICARD RR, 1984, J AM STAT ASSOC, V79, P575, DOI 10.2307/2288403; Putnins TJ, 2005, P SPIE COMPLEX SYSTE, V6039, P1; Sabordo M, 2004, P SPIE SMART STRUCTU, P513; Savoy J, 2013, INFORM PROCESS MANAG, V49, P341, DOI 10.1016/j.ipm.2012.06.003; Sayoud H, 2012, LIT LINGUISTIC COMPU, V1, P1; Shawe-Taylor J., 2000, INTRO SUPPORT VECTOR; Stamatatos E, 2009, J AM SOC INF SCI TEC, V60, P538, DOI 10.1002/asi.21001; Theodoridis S, 2009, PATTERN RECOGNITION, 4RTH EDITION, P1; Tsimboukakis N, 2010, NEURAL COMPUT APPL, V19, P573, DOI 10.1007/s00521-009-0314-7; Tweedie FJ, 1996, COMPUT HUMANITIES, V30, P1, DOI 10.1007/BF00054024; Wallace DB, 2000, HEBREWS INTRO ARGUME; Xiaoling Chen, 2011, Machine Learning and Data Mining in Pattern Recognition. Proceedings 7th International Conference, MLDM 2011, P375, DOI 10.1007/978-3-642-23199-5_28; Zhao Y, 2005, LECT NOTES COMPUT SC, V3689, P174	42	17	17	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e54998	10.1371/journal.pone.0054998	http://dx.doi.org/10.1371/journal.pone.0054998			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437047	Green Published, gold, Green Submitted			2022-12-25	WOS:000315184200011
J	Garske, T; Ferguson, NM; Ghani, AC				Garske, Tini; Ferguson, Neil M.; Ghani, Azra C.			Estimating Air Temperature and Its Influence on Malaria Transmission across Africa	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM; ANOPHELES-GAMBIAE; CLIMATE-CHANGE; LAND-COVER; AQUATIC STAGES; MODEL; RISK; DYNAMICS; WEST; POPULATION	Malaria transmission is strongly influenced by climatic conditions which determine the abundance and seasonal dynamics of the Anopheles vector. In particular, water temperature influences larval development rates whereas air temperature determines adult longevity as well as the rate of parasite development within the adult mosquito. Although data on land surface temperature exist at a spatial resolution of approximately 1 km globally with four time steps per day, comparable data are not currently available for air temperature. In order to address this gap and demonstrate the importance of using the right type of temperature data, we fitted simple models of the relationship between land-surface and air temperature at lower resolution to obtain a high resolution estimate of air temperature across Africa. We then used these estimates to calculate some crucial malaria transmission parameters that strongly depend on air temperatures. Our results demonstrate substantial differences between air and surface temperatures that impact temperature-based maps of areas suitable for transmission. We present high resolution maps of the malaria transmission parameters driven by air temperature and their seasonal variation. The fitted air temperature datasets are made publicly available alongside this publication.	[Garske, Tini; Ferguson, Neil M.; Ghani, Azra C.] Univ London Imperial Coll Sci Technol & Med, Dept Infect Dis Epidemiol, MRC Ctr Outbreak Anal & Modelling, London, England	Imperial College London	Garske, T (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Infect Dis Epidemiol, MRC Ctr Outbreak Anal & Modelling, London, England.	t.garske@imperial.ac.uk	Ghani, Azra/B-8560-2009; Ferguson, Neil/B-8578-2008	Ferguson, Neil/0000-0002-1154-8093; Ghani, Azra/0000-0002-0007-4910	Medical Research Council; Bill and Melinda Gates Foundation; National Institute of General Medical Sciences (NIGMS) Models of Infectious Disease Agent Study (MIDAS) initiative; MRC [MR/K010174/1] Funding Source: UKRI; Medical Research Council [G0600719B, MR/K010174/1B, MR/K010174/1] Funding Source: researchfish; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM088491] Funding Source: NIH RePORTER	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); National Institute of General Medical Sciences (NIGMS) Models of Infectious Disease Agent Study (MIDAS) initiative(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank the Medical Research Council (http://www.mrc.ac.uk), the Bill and Melinda Gates Foundation (http://www.gatesfoundation.org) and the National Institute of General Medical Sciences (NIGMS) Models of Infectious Disease Agent Study (MIDAS) initiative (http://www.nigms.nih.gov/Research/FeaturedPrograms/MIDAS) for research funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afrane YA, 2005, J MED ENTOMOL, V42, P974, DOI 10.1603/0022-2585(2005)042[0974:EOMCCB]2.0.CO;2; [Anonymous], 1990, ALMANAC COMPUTERS; Bayoh MN, 2004, MED VET ENTOMOL, V18, P174, DOI 10.1111/j.0269-283X.2004.00495.x; Bayoh MN, 2003, B ENTOMOL RES, V93, P375, DOI 10.1079/BER2003259; Bounoua L, 2002, CLIMATIC CHANGE, V52, P29, DOI 10.1023/A:1013051420309; Cairns M, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1879; Craig MH, 1999, PARASITOL TODAY, V15, P105, DOI 10.1016/S0169-4758(99)01396-4; Dee DP, 2011, Q J ROY METEOR SOC, V137, P553, DOI 10.1002/qj.828; Depinay JMO, 2004, MALARIA J, V3, DOI 10.1186/1475-2875-3-29; DETINOVA T S, 1962, Monogr Ser World Health Organ, V47, P13; DETINOVA T. S., 1964, BULL WORLD HEALTH ORGAN, V30, P23; Ermert V, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-35; European Centre for Medium-Range Weather Forecasts, ECMWF DAT SERV; Gemperli A, 2006, TROP MED INT HEALTH, V11, P1032, DOI 10.1111/j.1365-3156.2006.01640.x; Gething PW, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-378; Gething PW, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-92; Githeko A.K., 2001, GLOB CHANGE HUM HLTH, V2, P54, DOI [10.1023/A:1011943131643, DOI 10.1023/A:1011943131643]; Gosoniu L, 2006, GEOSPATIAL HEALTH, V1, P127, DOI 10.4081/gh.2006.287; Gosoniu L, 2009, COMPUT STAT DATA AN, V53, P3358, DOI 10.1016/j.csda.2009.02.022; Guerra CA, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000774; Hay SI, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000209; Hay SI, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000048; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hoshen MB, 2004, MALARIA J, V3, DOI 10.1186/1475-2875-3-32; Ikemoto T, 2008, J MED ENTOMOL, V45, P963, DOI 10.1603/0022-2585(2008)45[963:TMDNMH]2.0.CO;2; Isaaks E.H., 1989, ISA; Joyce RJ, 2004, J HYDROMETEOROL, V5, P487, DOI 10.1175/1525-7541(2004)005<0487:CAMTPG>2.0.CO;2; Killeen GF, 2000, AM J TROP MED HYG, V62, P535, DOI 10.4269/ajtmh.2000.62.535; Kiszewski A, 2004, AM J TROP MED HYG, V70, P486, DOI 10.4269/ajtmh.2004.70.486; Kleinschmidt I, 2001, AM J EPIDEMIOL, V153, P1213, DOI 10.1093/aje/153.12.1213; Kleinschmidt I, 2001, TROP MED INT HEALTH, V6, P779, DOI 10.1046/j.1365-3156.2001.00790.x; Lindblade KA, 2000, TROP MED INT HEALTH, V5, P263, DOI 10.1046/j.1365-3156.2000.00551.x; LOEVINSOHN ME, 1994, LANCET, V343, P714, DOI 10.1016/S0140-6736(94)91586-5; Loveland TR, 1997, INT J REMOTE SENS, V18, P3291, DOI 10.1080/014311697217099; Macdonald G., 1957, EPIDEMIOLOGY CONTROL; Martens P, 1999, GLOBAL ENVIRON CHANG, V9, pS89, DOI 10.1016/S0959-3780(99)00020-5; Moiroux N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030558; Munga S, 2009, AM J TROP MED HYG, V81, P1079, DOI 10.4269/ajtmh.2009.09-0156; Paaijmans KP, 2008, HYDROL PROCESS, V22, P4789, DOI 10.1002/hyp.7099; Paaijmans KP, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-183; Paaijmans KP, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-196; Paaijmans KP, 2010, P NATL ACAD SCI USA, V107, P15135, DOI 10.1073/pnas.1006422107; Paaijmans KP, 2009, P NATL ACAD SCI USA, V106, P13844, DOI 10.1073/pnas.0903423106; Parham PE, 2010, ENVIRON HEALTH PERSP, V118, P620, DOI 10.1289/ehp.0901256; PARTON WJ, 1981, AGR METEOROL, V23, P205, DOI 10.1016/0002-1571(81)90105-9; Pascual M, 2008, P ROY SOC B-BIOL SCI, V275, P123, DOI 10.1098/rspb.2007.1068; Pascual M, 2006, P NATL ACAD SCI USA, V103, P5829, DOI 10.1073/pnas.0508929103; Press W. H., 1992, ART SCI COMPUTING; Rogers DJ, 2002, NATURE, V415, P710, DOI 10.1038/415710a; Scharlemann JPW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001408; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Shanks GD, 2002, EMERG INFECT DIS, V8, P1404, DOI 10.3201/eid0812.020077; Snijders AB, 1999, MULTILEVEL ANAL INTR; Snow RW, 1998, T ROY SOC TROP MED H, V92, P601, DOI 10.1016/S0035-9203(98)90781-7; Tanser FC, 2003, LANCET, V362, P1792, DOI 10.1016/S0140-6736(03)14898-2; Thomas MB, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001262; van Lieshout M, 2004, GLOBAL ENVIRON CHANG, V14, P87, DOI 10.1016/j.gloenvcha.2003.10.009; Vancutsem C, 2010, REMOTE SENS ENVIRON, V114, P449, DOI 10.1016/j.rse.2009.10.002; White MT, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-153; WHO, 2011, WORLD MALARIA REPORT 2011, P1; Yakob L, 2011, J R SOC INTERFACE, V8, P799, DOI 10.1098/rsif.2010.0537	61	41	41	0	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e56487	10.1371/journal.pone.0056487	http://dx.doi.org/10.1371/journal.pone.0056487			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437143	Green Submitted, Green Published, gold			2022-12-25	WOS:000315184200082
J	Ismail, Y; Lee, H; Riordan, SM; Grimm, MC; Zhang, L				Ismail, Yazan; Lee, Hoyul; Riordan, Stephen M.; Grimm, Michael C.; Zhang, Li			The Effects of Oral and Enteric Campylobacter concisus Strains on Expression of TLR4, MD-2, TLR2, TLR5 and COX-2 in HT-29 Cells	PLOS ONE			English	Article							TOLL-LIKE RECEPTOR-4; INFLAMMATORY-BOWEL-DISEASE; INTESTINAL EPITHELIAL-CELLS; CROHNS-DISEASE; IDENTIFICATION; HELICOBACTER; RESPONSIVENESS; STIMULATION; TOLERANCE; APOPTOSIS	Campylobacter concisus, a Gram-negative bacterium that colonizes the human oral cavity, has been shown to be associated with inflammatory bowel diseases (IBD). The effects of different C. concisus strains on intestinal epithelial expression of Toll like receptors (TLR) have not been investigated. This study examined the effects of C. concisus strains isolated from patients with IBD and controls on expression of TLR4, its co-receptor myeloid differentiation factor (MD)-2; TLR2, TLR5, cyclooxygenase-2 (COX-2) and interleukin (IL)-8 in HT-29 cells. Fourteen oral and enteric C. concisus strains isolated from patients with IBD and healthy controls were co-incubated with HT-29 cells. Expression of TLR4, MD-2, TLR2, TLR5 and COX-2 in HT-29 cells in response to C. concisus infection was examined by Western blot, flow cytometry analysis and immunofluorescent staining visualized by confocal microscope. Production of IL-8 was evaluated by enzyme-linked immunosorbent assay. Both oral and enteric C. concisus strains upregulated expression of TLR4 in HT-29 cells. The levels of glycosylated TLR4 (Gly-TLR4) and surface TLR4 induced by C. concisus strains isolated from patients with IBD were significantly higher than those induced by C. concisus strains isolated from the healthy controls. Four C. concisus strains isolated from patients with IBD induced more than two-fold increase of surface expression of MD-2. C. concisus did not affect expression of TLR2 and TLR5. All C. concisus strains induced production of IL-8 and COX-2 in HT-29 cells. This study shows that some C. concisus strains, most from patients with IBD, upregulate surface expression of TLR4 and MD-2 in HT-29 cells. These data suggest that a potential role of specific C. concisus strains in modulating the intestinal epithelial responses to bacterial LPS needs to be investigated.	[Ismail, Yazan; Lee, Hoyul; Zhang, Li] Univ New S Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW, Australia; [Riordan, Stephen M.] Prince Wales Hosp, Gastrointestinal & Liver Unit, Sydney, NSW, Australia; [Riordan, Stephen M.] Univ New S Wales, Fac Med, Sydney, NSW, Australia; [Grimm, Michael C.] Univ New S Wales, St George Clin Sch, Sydney, NSW, Australia	University of New South Wales Sydney; University of New South Wales Sydney; University of New South Wales Sydney	Zhang, L (corresponding author), Univ New S Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW, Australia.	L.Zhang@unsw.edu.au		Grimm, Michael/0000-0001-9426-3917; Zhang, Li/0000-0001-7506-8278; Ismail, Yazan/0000-0002-7020-3642	Broad Medical Research Program of the Broad Foundation [IBD0273-R]; faculty research grant from the University of New South Wales; Al-Balaq' Applied University, Jordan	Broad Medical Research Program of the Broad Foundation; faculty research grant from the University of New South Wales; Al-Balaq' Applied University, Jordan	This work was supported by the Broad Medical Research Program of the Broad Foundation (Grant no: IBD0273-R) and a faculty research grant from the University of New South Wales. Yazan Ismail is supported by a PhD scholarship from Al-Balaq' Applied University, Jordan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aabenhus R, 2005, J CLIN MICROBIOL, V43, P5091, DOI 10.1128/JCM.43.10.5091-5096.2005; Abreu MT, 2001, J IMMUNOL, V167, P1609, DOI 10.4049/jimmunol.167.3.1609; Andersen-Nissen E, 2005, P NATL ACAD SCI USA, V102, P9247, DOI 10.1073/pnas.0502040102; BASTYNS K, 1995, MOL CELL PROBE, V9, P247, DOI 10.1016/S0890-8508(95)90114-0; Bertelsen LS, 2003, INFECT IMMUN, V71, P2102, DOI 10.1128/IAI.71.4.2102-2109.2003; Cario E, 2000, INFECT IMMUN, V68, P7010, DOI 10.1128/IAI.68.12.7010-7017.2000; Chaban B, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-73; Correia JD, 2002, J BIOL CHEM, V277, P1845, DOI 10.1074/jbc.M109910200; D'Haens GR, 1998, GASTROENTEROLOGY, V114, P262, DOI 10.1016/S0016-5085(98)70476-7; Duchmann R, 1995, CLIN EXP IMMUNOL, V102, P448; Fukata M, 2006, GASTROENTEROLOGY, V131, P862, DOI 10.1053/j.gastro.2006.06.017; Furrie E, 2005, IMMUNOLOGY, V115, P565, DOI 10.1111/j.1365-2567.2005.02200.x; Fusunyan RD, 2001, PEDIATR RES, V49, P589, DOI 10.1203/00006450-200104000-00023; Gewirtz AT, 2001, J IMMUNOL, V167, P1882, DOI 10.4049/jimmunol.167.4.1882; GRIMM MC, 1995, CLIN EXP IMMUNOL, V100, P291, DOI 10.1111/j.1365-2249.1995.tb03667.x; Ismail Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038217; Jones NL, 1999, INFECT IMMUN, V67, P4237, DOI 10.1128/IAI.67.8.4237-4242.1999; Kalischuk LD, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-53; Kaser A, 2010, ANNU REV IMMUNOL, V28, P573, DOI 10.1146/annurev-immunol-030409-101225; Kim JM, 2006, EUR J IMMUNOL, V36, P2446, DOI 10.1002/eji.200535808; Lastovica AJ, 2009, J CLIN MICROBIOL, V47, P2360, DOI 10.1128/JCM.00568-09; Lynch OA, 2011, INT J FOOD MICROBIOL, V150, P171, DOI 10.1016/j.ijfoodmicro.2011.07.037; Macpherson A, 1996, GUT, V38, P365, DOI 10.1136/gut.38.3.365; Mahendran V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025417; Man SM, 2010, J INFECT DIS, V202, P1855, DOI 10.1086/657316; Man SM, 2010, INFLAMM BOWEL DIS, V16, P1008, DOI 10.1002/ibd.21157; Matsheka MI, 2001, J CLIN MICROBIOL, V39, P3684, DOI 10.1128/JCM.39.10.3684-3689.2001; Mukhopadhya I, 2011, PLOS ONE, V6; Nagai Y, 2002, NAT IMMUNOL, V3, P667, DOI 10.1038/ni809; Nielsen HL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023858; Ohnishi T, 2003, CLIN DIAGN LAB IMMUN, V10, P405, DOI 10.1128/CDLI.10.3.405-410.2003; Petersen RF, 2007, J APPL MICROBIOL, V103, P2601, DOI 10.1111/j.1365-2672.2007.03515.x; RUTGEERTS P, 1991, LANCET, V338, P771, DOI 10.1016/0140-6736(91)90663-A; Sartor RB, 2008, GASTROENTEROLOGY, V134, P577, DOI 10.1053/j.gastro.2007.11.059; Seksik P, 2010, INNATE IMMUN-LONDON, V16, P381, DOI 10.1177/1753425909357076; Shimazu R, 1999, J EXP MED, V189, P1777, DOI 10.1084/jem.189.11.1777; Singer II, 1998, GASTROENTEROLOGY, V115, P297, DOI 10.1016/S0016-5085(98)70196-9; Smith K, 2003, POETRY REV, V93, P5; Su B, 2003, INFECT IMMUN, V71, P3496, DOI 10.1128/IAI.71.6.3496-3502.2003; TANNER ACR, 1981, INT J SYST BACTERIOL, V31, P432, DOI 10.1099/00207713-31-4-432; TAUROG JD, 1994, J EXP MED, V180, P2359, DOI 10.1084/jem.180.6.2359; Thun MJ, 2002, JNCI-J NATL CANCER I, V94, P252, DOI 10.1093/jnci/94.4.252; Vamadevan AS, 2010, INNATE IMMUN-LONDON, V16, P93, DOI 10.1177/1753425909339231; VANDAMME P, 1989, J CLIN MICROBIOL, V27, P1775, DOI 10.1128/JCM.27.8.1775-1781.1989; Vandamme P, 2005, BERGEYS MANUAL SYSTE, V2, P1147; Veltkamp C, 2001, GASTROENTEROLOGY, V120, P900, DOI 10.1053/gast.2001.22547; Williams CS, 1999, ONCOGENE, V18, P7908, DOI 10.1038/sj.onc.1203286; Zeng H, 2003, J IMMUNOL, V171, P3668, DOI 10.4049/jimmunol.171.7.3668; Zhang L, 2010, J CLIN MICROBIOL, V48, P2965, DOI 10.1128/JCM.02391-09; Zhang L, 2009, J CLIN MICROBIOL, V47, P453, DOI 10.1128/JCM.01949-08	50	21	22	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e56888	10.1371/journal.pone.0056888	http://dx.doi.org/10.1371/journal.pone.0056888			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437263	Green Published, gold, Green Submitted			2022-12-25	WOS:000315184200178
J	MacGregor-Fors, I; Payton, ME				MacGregor-Fors, Ian; Payton, Mark E.			Contrasting Diversity Values: Statistical Inferences Based on Overlapping Confidence Intervals	PLOS ONE			English	Article							BIODIVERSITY	Ecologists often contrast diversity (species richness and abundances) using tests for comparing means or indices. However, many popular software applications do not support performing standard inferential statistics for estimates of species richness and/or density. In this study we simulated the behavior of asymmetric log-normal confidence intervals and determined an interval level that mimics statistical tests with P(alpha) = 0.05 when confidence intervals from two distributions do not overlap. Our results show that 84% confidence intervals robustly mimic 0.05 statistical tests for asymmetric confidence intervals, as has been demonstrated for symmetric ones in the past. Finally, we provide detailed user-guides for calculating 84% confidence intervals in two of the most robust and highly-used freeware related to diversity measurements for wildlife (i.e., EstimateS, Distance).	[MacGregor-Fors, Ian] Inst Ecol, AC, Red Ambiente & Sustentabilidad, Xalapa, Veracruz, Mexico; [Payton, Mark E.] Oklahoma State Univ, Dept Stat, Stillwater, OK 74078 USA	Instituto de Ecologia - Mexico; Oklahoma State University System; Oklahoma State University - Stillwater	MacGregor-Fors, I (corresponding author), Inst Ecol, AC, Red Ambiente & Sustentabilidad, Xalapa, Veracruz, Mexico.	ian.macgregor@inecol.edu.mx	MacGregor-Fors, Ian/P-1455-2014	MacGregor-Fors, Ian/0000-0003-3198-7322				Buckland ST, 2011, ECOSPHERE, V2, DOI 10.1890/ES11-00186.1; Colwell R.K., 2011, ESTIMATES STAT ESTIM; Colwell RK, 2012, J PLANT ECOL, V5, P3, DOI 10.1093/jpe/rtr044; Fernandez-Juricic E, 2001, BIODIVERS CONSERV, V10, P1303, DOI 10.1023/A:1016614625675; Gaines WL, 2007, RESTOR ECOL, V15, P670, DOI 10.1111/j.1526-100X.2007.00279.x; Gotelli Nicholas J., 2011, P39; Gotelli NJ, 2001, ECOL LETT, V4, P379, DOI 10.1046/j.1461-0248.2001.00230.x; Hubbell Stephen P., 2001, V32, pi; Limpert E, 2001, BIOSCIENCE, V51, P341, DOI 10.1641/0006-3568(2001)051[0341:LNDATS]2.0.CO;2; MAGURRAN A. E., 2004, MEASURING BIOLOGICAL; Magurran AE, 2011, BIOL DIVERSITY; Moreno C., 2001, THESIS SEA; Moreno CE, 2010, OECOLOGIA, V163, P279, DOI 10.1007/s00442-010-1591-7; Payton ME, 2003, J INSECT SCI, V3, DOI 10.1093/jis/3.1.34; SAS, 2008, PC SAS VERS 9 2; Sokal R. R., 2012, BIOMETRY; Thomas L, 2010, J APPL ECOL, V47, P5, DOI 10.1111/j.1365-2664.2009.01737.x	17	156	164	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e56794	10.1371/journal.pone.0056794	http://dx.doi.org/10.1371/journal.pone.0056794			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437239	gold, Green Published, Green Submitted			2022-12-25	WOS:000315184200163
J	Migita, K; Agematsu, K; Masumoto, J; Ida, H; Honda, S; Jiuchi, Y; Izumi, Y; Maeda, Y; Uehara, R; Nakamura, Y; Koga, T; Kawakami, A; Nakashima, M; Fujieda, Y; Nonaka, F; Eguchi, K; Furukawa, H; Nakamura, T; Nakamura, M; Yasunami, M				Migita, Kiyoshi; Agematsu, Kazunaga; Masumoto, Junya; Ida, Hiroaki; Honda, Seiyo; Jiuchi, Yuka; Izumi, Yasumori; Maeda, Yumi; Uehara, Ritei; Nakamura, Yoshikazu; Koga, Tomohiro; Kawakami, Atsushi; Nakashima, Munetoshi; Fujieda, Yuichiro; Nonaka, Fumiaki; Eguchi, Katsumi; Furukawa, Hiroshi; Nakamura, Tadashi; Nakamura, Minoru; Yasunami, Michio			The Contribution of SAA1 Polymorphisms to Familial Mediterranean Fever Susceptibility in the Japanese Population	PLOS ONE			English	Article							SERUM AMYLOID A1; GENE POLYMORPHISMS; RHEUMATOID-ARTHRITIS; FMF PATIENTS; SECONDARY; DISEASE; INTERLEUKIN-1-BETA; INFLAMMASOME; ALLELES; MEFV	Background/Aims: Familial Mediterranean Fever (FMF) has traditionally been considered to be an autosomal-recessive disease, however, it has been observed that substantial numbers of patients with FMF possess only 1 demonstrable MEFV mutation. The clinical profile of familial Mediterranean fever (FMF) may be influenced by MEFV allelic heterogeneity and other genetic and/or environmental factors. Methodology/Principal Findings: In view of the inflammatory nature of FMF, we investigated whether serum amyloid A (SAA) and interleukin-1 beta (IL-1b) gene polymorphisms may affect the susceptibility of Japanese patients with FMF. The genotypes of the -13C/T SNP in the 5'-flanking region of the SAA1 gene and the two SNPs within exon 3 of SAA1 (2995C/T and 3010C/T polymorphisms) were determined in 83 Japanese patients with FMF and 200 healthy controls. The same samples were genotyped for IL-1 beta-511 (C/T) and IL-1 receptor antagonist (IL-1Ra) variable number of tandem repeat (VNTR) polymorphisms. There were no significant differences between FMF patients and healthy subjects in the genotypic distribution of IL-1 beta -511 (C/T), IL-1Ra VNTR and SAA2 polymorphisms. The frequencies of SAA1.1 allele were significantly lower (21.7% versus 34.0%), and inversely the frequencies of SAA1.3 allele were higher (48.8% versus 37.5%) in FMF patients compared with healthy subjects. The frequency of -13T alleles, associated with the SAA1.3 allele in the Japanese population, was significantly higher (56.0% versus 41.0%, p = 0.001) in FMF patients compared with healthy subjects. Conclusions/Significance: Our data indicate that SAA1 gene polymorphisms, consisting of -13T/C SNP in the 5'-flanking region and SNPs within exon 3 (2995C/T and 3010C/T polymorphisms) of SAA1 gene, are associated with susceptibility to FMF in the Japanese population.	[Migita, Kiyoshi; Jiuchi, Yuka; Izumi, Yasumori; Maeda, Yumi; Nakamura, Minoru] Clin Res Ctr, Dept Gen Internal Med, Omura, Japan; [Migita, Kiyoshi; Jiuchi, Yuka; Izumi, Yasumori; Maeda, Yumi; Nakamura, Minoru] NHO Nagasaki Med Ctr, Omura, Japan; [Agematsu, Kazunaga] Shinshu Univ, Grad Sch Med, Dept Infect & Host Def, Asahi Ku, Matsumoto, Nagano, Japan; [Masumoto, Junya] Ehime Univ, Grad Sch Med, Dept Pathogenom, Toone City, Ehime, Japan; [Ida, Hiroaki; Honda, Seiyo] Kurume Univ, Sch Med, Dept Rheumatol, Kurume, Fukuoka 830, Japan; [Uehara, Ritei; Nakamura, Yoshikazu] Jichi Med Univ, Dept Publ Hlth, Mibu, Tochigi, Japan; [Koga, Tomohiro; Kawakami, Atsushi] Nagasaki Univ, Sch Med, Dept Internal Med 1, Nagasaki, Japan; [Nakashima, Munetoshi] Red Cross Nagasaki Atom Bomb Hosp, Dept Rheumatol, Mori, Nagasaki, Japan; [Fujieda, Yuichiro] Hokkaido Univ, Grad Sch Med, Dept Med 2, Sapporo, Hokkaido, Japan; [Nonaka, Fumiaki; Eguchi, Katsumi] Sasebo City Gen Hosp, Dept Rheumatol, Sasebo, Japan; [Furukawa, Hiroshi] NHO Sagamihara Hosp, Dept Rheumatol, Sagamihara, Kanagawa, Japan; [Nakamura, Tadashi] NTT W JAPAN Kyushu Hosp, Dept Rheumatol, Kumamoto, Japan; [Yasunami, Michio] Nagasaki Univ, Ctr Int Collaborat Res CICORN, Nagasaki 852, Japan; [Yasunami, Michio] Nagasaki Univ, Inst Trop Med, Nagasaki 852, Japan	Shinshu University; Ehime University; Kurume University; Jichi Medical University; Nagasaki University; Hokkaido University; Nagasaki University; Nagasaki University	Migita, K (corresponding author), Clin Res Ctr, Dept Gen Internal Med, Omura, Japan.	migita@nmc.hosp.go.jp	Furukawa, Hidemitsu/F-3478-2018; Koga, Tomohiro/V-9397-2019; Koga, Tomohiro/AAU-9697-2020; 藤枝, 雄一郎/AAG-1610-2020	Furukawa, Hidemitsu/0000-0002-0778-3330; 藤枝, 雄一郎/0000-0003-4705-341X; Koga, Tomohiro/0000-0003-2077-4428	Ministry of Health, Labour and Welfare of Japan	Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan)	This work was supported by a Grant-in-Aid for Research on intractable diseases from Ministry of Health, Labour and Welfare of Japan, "Study group of national-wide survey for Familial Mediterranean fever in Japan". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajiro Junya, 2006, Mod Rheumatol, V16, P294; Akar N, 2003, AMYLOID, V10, P12, DOI 10.3109/13506120308995251; Akar N, 2006, J NEPHROL, V19, P318; Aksentijevich I, 1997, CELL, V90, P797; Bakkaloglu A, 2004, J RHEUMATOL, V31, P1139; Balci-Peynircioglu B, 2008, CLIN EXP RHEUMATOL, V26, pS99; Ben-Chetrit E, 1998, LANCET, V351, P659, DOI 10.1016/S0140-6736(97)09408-7; Booth DR, 1998, AMYLOID, V5, P262, DOI 10.3109/13506129809007299; Booty MG, 2009, ARTHRITIS RHEUM-US, V60, P1851, DOI 10.1002/art.24569; Cazeneuve C, 2000, AM J HUM GENET, V67, P1136, DOI 10.1016/S0002-9297(07)62944-9; Chae JJ, 2009, BRIT J HAEMATOL, V146, P467, DOI 10.1111/j.1365-2141.2009.07733.x; Chae JJ, 2011, IMMUNITY, V34, P755, DOI 10.1016/j.immuni.2011.02.020; El-Shanti H, 2006, LANCET, V367, P1016, DOI 10.1016/S0140-6736(06)68430-4; Franchi L, 2009, NAT IMMUNOL, V10, P241, DOI 10.1038/ni.1703; Franchi L, 2009, IMMUNOL REV, V227, P106, DOI 10.1111/j.1600-065X.2008.00734.x; Gershoni-Baruch R, 2003, ARTHRITIS RHEUM, V48, P1149, DOI 10.1002/art.10944; Gershoni-Baruch R, 2003, J RHEUMATOL, V30, P308; Halle A, 2008, NAT IMMUNOL, V9, P857, DOI 10.1038/ni.1636; Jeru I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007676; Livneh A, 1997, ARTHRITIS RHEUM-US, V40, P1879, DOI 10.1002/art.1780401023; Marek-Yagel D, 2009, ARTHRITIS RHEUM-US, V60, P1862, DOI 10.1002/art.24570; MARHAUG G, 1994, BAILLIERE CLIN RHEUM, V8, P553, DOI 10.1016/S0950-3579(05)80115-3; Mavragani CP, 2007, AMYLOID, V14, P271, DOI 10.1080/13506120701614008; Migita K, 2007, J HEPATOL, V46, P381, DOI 10.1016/j.jhep.2006.09.015; Moriguchi M, 2005, AMYLOID, V12, P26, DOI 10.1080/13506120500032394; Moriguchi M, 2001, ARTHRITIS RHEUM, V44, P1266, DOI 10.1002/1529-0131(200106)44:6<1266::AID-ART218>3.0.CO;2-3; Nakamura T, 2006, RHEUMATOLOGY, V45, P43, DOI 10.1093/rheumatology/kei112; Nakamura T, 2011, CLIN EXP RHEUMATOL, V29, P850; Niemi K, 2011, J IMMUNOL, V186, P6119, DOI 10.4049/jimmunol.1002843; Ozen S, 2003, J RHEUMATOL, V30, P2014; Ozen S, 2006, J RHEUMATOL, V33, P2498; Ozen S, 2009, ARTHRITIS RHEUM, V60, P1575, DOI 10.1002/art.24565; Savic S, 2012, CURR OPIN RHEUMATOL, V24, P103, DOI 10.1097/BOR.0b013e32834dd2d5; Speletas M, 2009, HUM IMMUNOL, V70, P750, DOI 10.1016/j.humimm.2009.05.004; Tanaka M, 2007, CLIN EXP RHEUMATOL, V25, P792; Ting JPY, 2006, NAT REV IMMUNOL, V6, P183, DOI 10.1038/nri1788; van der Hilst JCH, 2008, RHEUMATOLOGY, V47, P1651, DOI 10.1093/rheumatology/ken371; YAKAR S, 1995, SEMIN ARTHRITIS RHEU, V24, P255, DOI 10.1016/S0049-0172(95)80035-2; Yamada T, 2003, AMYLOID, V10, P7, DOI 10.3109/13506120308995250; Yilmaz E, 2003, TURKISH J PEDIATR, V45, P198	40	21	22	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e55227	10.1371/journal.pone.0055227	http://dx.doi.org/10.1371/journal.pone.0055227			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437051	gold, Green Published, Green Submitted			2022-12-25	WOS:000315184200013
J	Shen, RX; Xie, F; Shen, H; Liu, Q; Zheng, T; Kou, XR; Wang, DX; Yang, JM				Shen, Rongxi; Xie, Feng; Shen, Hui; Liu, Qu; Zheng, Tao; Kou, Xingrui; Wang, Dexian; Yang, Jiamei			Negative Correlation of LIV-1 and E-Cadherin Expression in Hepatocellular Carcinoma Cells	PLOS ONE			English	Article							HUMAN-BREAST-CANCER; ZINC TRANSPORTER LIV-1; MESENCHYMAL TRANSITION; PROGRESSION; ESTROGEN; PROTEIN	LIV-1, a zinc transporter, is a mediator downstream of STAT3 both in zebrafish and mammalian cells, and is involved in epithelial-mesenchymal transition (EMT). Despite LIV-1 participates in cancer growth and metastasis, little is known about the association of LIV-1 with human liver cancer development. Therefore, the expression of LIV-1 mRNA was analyzed by reverse transcriptase polymerase chain reaction (RT-PCR) in 4 cultured cell lines (3 carcinoma and 1 normal liver cell lines), and the localization of LIV-1 protein was investigated by immunohistochemistry. Expression of LIV-1 protein was analyzed by Western blot both in 4 cultured cell lines and 120 liver tissues (100 carcinoma and 20 histologically normal tissues), and the relationship between its expression and clinicopathological finding was investigated in 100 hepatocellular carcinoma(HCC) tissues. Then stable siRNA expressing Hep-G2 cells were generated to assess the function of LIV-1 in liver cancer cells. We found that LIV-1 mRNA was more highly expressed in liver cancer cell lines compared to normal liver cell line. Western blot showed the expression of LIV-1 was higher in 61% liver carcinoma tissues than that in normal liver tissues. Down-regulated LIV-1 cells showed significant inhibition of proliferation in vitro and reduction of tumor growth in vivo. Furthermore, E-cadherin expression increased in LIV-1 siRNA expressing Hep-G2. These findings indicated that LIV-1 may induce the EMT in HCC cells.	[Shen, Rongxi; Xie, Feng; Liu, Qu; Zheng, Tao; Wang, Dexian; Yang, Jiamei] Second Mil Med Univ, Dept Special Treatment, Eastern Hepatobiliary Surg Hosp, Shanghai, Peoples R China; [Shen, Hui] Second Mil Med Univ, Dept Mil Hyg, Shanghai, Peoples R China; [Kou, Xingrui] Second Mil Med Univ, Eastern Hepatobiliary Surg Hosp, Tumor Immunol & Gene Therapy Ctr, Shanghai, Peoples R China	Naval Medical University; Naval Medical University; Naval Medical University	Yang, JM (corresponding author), Second Mil Med Univ, Dept Special Treatment, Eastern Hepatobiliary Surg Hosp, Shanghai, Peoples R China.	jiameiyang@gmail.com			China Postdoctoral Science Fund [20100470107]; China Postdoctoral Science Special Fund [201104750]; CSCO Fund [Y-B2011-006]; Ministry of Science and Technology of China [2008ZX10002-018]	China Postdoctoral Science Fund(China Postdoctoral Science Foundation); China Postdoctoral Science Special Fund; CSCO Fund; Ministry of Science and Technology of China(Ministry of Science and Technology, China)	This work was supported in part by grants from the China Postdoctoral Science Fund (20100470107), China Postdoctoral Science Special Fund (201104750), CSCO Fund (Y-B2011-006) and the Fund of the Ministry of Science and Technology of China (2008ZX10002-018). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bukholm IK, 1998, J PATHOL, V185, P262, DOI 10.1002/(SICI)1096-9896(199807)185:3<262::AID-PATH97>3.0.CO;2-Y; Cousins RJ, 1998, P NUTR SOC, V57, P307, DOI 10.1079/PNS19980045; Kamangar F, 2006, J CLIN ONCOL, V24, P2137, DOI 10.1200/JCO.2005.05.2308; Kasper G, 2005, INT J CANCER, V117, P961, DOI 10.1002/ijc.21235; Lue HW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027720; MANNING DL, 1994, EUR J CANCER, V30A, P675, DOI 10.1016/0959-8049(94)90543-6; MANNING DL, 1988, MOL CELL ENDOCRINOL, V59, P205, DOI 10.1016/0303-7207(88)90105-0; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Petersen OW, 2003, AM J PATHOL, V162, P391, DOI 10.1016/S0002-9440(10)63834-5; Shen H, 2009, MOL BIOL REP, V36, P653, DOI 10.1007/s11033-008-9225-4; Shiozaki H, 1996, CANCER, V77, P1605, DOI 10.1002/(SICI)1097-0142(19960415)77:8+<1605::AID-CNCR4>3.3.CO;2-R; Taylor KM, 2004, TRENDS ENDOCRIN MET, V15, P461, DOI 10.1016/j.tem.2004.10.003; Taylor KM, 2003, BIOCHEM J, V375, P51, DOI 10.1042/BJ20030478; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Unno J, 2009, INT J ONCOL, V35, P813, DOI 10.3892/ijo_00000394; VALLEE BL, 1993, PHYSIOL REV, V73, P79, DOI 10.2466/pr0.1993.73.1.79; Van Aken E, 2001, VIRCHOWS ARCH, V439, P725, DOI 10.1007/S004280100516; Yamashita S, 2004, NATURE, V429, P298, DOI 10.1038/nature02545; Zhao L, 2007, BIOCHEM BIOPH RES CO, V363, P82, DOI 10.1016/j.bbrc.2007.08.127; Zhao Le, 2007, Nan Fang Yi Ke Da Xue Xue Bao, V27, P1590	20	25	26	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e56542	10.1371/journal.pone.0056542	http://dx.doi.org/10.1371/journal.pone.0056542			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437163	gold, Green Submitted, Green Published			2022-12-25	WOS:000315184200101
J	Wang, SH; Chen, WJ; Chuang, LM; Hsiao, PC; Liu, PH; Hsiao, CK				Wang, Shi-Heng; Chen, Wei J.; Chuang, Lee-Ming; Hsiao, Po-Chang; Liu, Pi-Hua; Hsiao, Chuhsing K.			Inference of Cross-Level Interaction between Genes and Contextual Factors in a Matched Case-Control Metabolic Syndrome Study: A Bayesian Approach	PLOS ONE			English	Article							BODY-MASS INDEX; ENVIRONMENT INTERACTION; PHYSICAL-ACTIVITY; PPAR-GAMMA; MULTILEVEL ANALYSIS; POLYMORPHISM; ASSOCIATION; GENOTYPE; EXERCISE; EPIDEMIOLOGY	Genes, environment, and the interaction between them are each known to play an important role in the risk for developing complex diseases such as metabolic syndrome. For environmental factors, most studies focused on the measurements observed at the individual level, and therefore can only consider the gene-environment interaction at the same individual scale. Indeed the group-level (called contextual) environmental variables, such as community factors and the degree of local area development, may modify the genetic effect as well. To examine such cross-level interaction between genes and contextual factors, a flexible statistical model quantifying the variability of the genetic effects across different categories of the contextual variable is in need. With a Bayesian generalized linear mixed-effects model with an unconditional likelihood, we investigate whether the individual genetic effect is modified by the group-level residential environment factor in a matched case-control metabolic syndrome study. Such cross-level interaction is evaluated by examining the heterogeneity in allelic effects under various contextual categories, based on posterior samples from Markov chain Monte Carlo methods. The Bayesian analysis indicates that the effect of rs1801282 on metabolic syndrome development is modified by the contextual environmental factor. That is, even among individuals with the same genetic component of PPARG_Pro12Ala, living in a residential area with low availability of exercise facilities may result in higher risk. The modification of the group-level environment factors on the individual genetic attributes can be essential, and this Bayesian model is able to provide a quantitative assessment for such cross-level interaction. The Bayesian inference based on the full likelihood is flexible with any phenotype, and easy to implement computationally. This model has a wide applicability and may help unravel the complexity in development of complex diseases.	[Wang, Shi-Heng; Chen, Wei J.; Hsiao, Po-Chang; Hsiao, Chuhsing K.] Natl Taiwan Univ, Inst Epidemiol & Prevent Med, Coll Publ Hlth, Taipei 10764, Taiwan; [Chen, Wei J.; Hsiao, Po-Chang] Natl Taiwan Univ, Genet Epidemiol Core Lab, Ctr Genom Med, Taipei 10764, Taiwan; [Chen, Wei J.; Hsiao, Chuhsing K.] Natl Taiwan Univ, Dept Publ Hlth, Coll Publ Hlth, Taipei 10764, Taiwan; [Chuang, Lee-Ming] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan; [Chuang, Lee-Ming] Natl Taiwan Univ, Inst Clin Med, Coll Med, Taipei 10764, Taiwan; [Liu, Pi-Hua] Chang Gung Univ, Clin Informat & Med Stat Res Ctr, Guishan, Taiwan; [Hsiao, Chuhsing K.] Natl Taiwan Univ, Bioinformat & Biostat Core, Ctr Genom Med, Taipei 10764, Taiwan	National Taiwan University; National Taiwan University; National Taiwan University; National Taiwan University; National Taiwan University Hospital; National Taiwan University; Chang Gung University; National Taiwan University	Hsiao, CK (corresponding author), Natl Taiwan Univ, Inst Epidemiol & Prevent Med, Coll Publ Hlth, Taipei 10764, Taiwan.	ckhsiao@ntu.edu.tw	Chuang, Lee-Ming/AAF-3324-2019	Chen, Wei Jen/0000-0001-5899-5870; Hsiao, Po-Chang/0000-0002-5813-3389; Liu, Pi-Hua/0000-0002-7165-6248; CHUANG, LEE-MING/0000-0003-0978-2662; hsiao, chuhsing kate/0000-0003-4905-8484	NSC [100-2314-B-002-107-MY3, NSC 97-2314-B-002-040-MY3]; DOH [94-TD-G-111-036, 94HDI002]; National Taiwan University Center of Genomic Medicine; Research Center for Genes, Environment and Human Health in College of Public Health, National Taiwan University	NSC(Ministry of Science and Technology, Taiwan); DOH; National Taiwan University Center of Genomic Medicine; Research Center for Genes, Environment and Human Health in College of Public Health, National Taiwan University	This research was supported in part by NSC 100-2314-B-002-107-MY3, NSC 97-2314-B-002-040-MY3, DOH 94-TD-G-111-036, 94HDI002, and National Taiwan University Center of Genomic Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. WJC and CKH thank the support of Research Center for Genes, Environment and Human Health in College of Public Health, National Taiwan University.	Adamo KB, 2005, DIABETOLOGIA, V48, P1503, DOI 10.1007/s00125-005-1827-y; Altshuler D, 2000, NAT GENET, V26, P76, DOI 10.1038/79216; Aragaki CC, 1997, CANCER EPIDEM BIOMAR, V6, P307; Beamer BA, 1998, DIABETES, V47, P1806, DOI 10.2337/diabetes.47.11.1806; Bianchi G, 2008, QJM-INT J MED, V101, P713, DOI 10.1093/qjmed/hcn084; Blakely TA, 2000, J EPIDEMIOL COMMUN H, V54, P367, DOI 10.1136/jech.54.5.367; Cardona F, 2006, CLIN CHEM, V52, P1920, DOI 10.1373/clinchem.2006.069690; Chakravarthy MV, 2004, J APPL PHYSIOL, V96, P3, DOI 10.1152/japplphysiol.00757.2003; Deeb SS, 1998, NAT GENET, V20, P284, DOI 10.1038/3099; Dempfle A, 2008, EUR J HUM GENET, V16, P1164, DOI 10.1038/ejhg.2008.106; Eckel RH, 2005, LANCET, V365, P1415, DOI 10.1016/S0140-6736(05)66378-7; Franks PW, 2004, METABOLISM, V53, P11, DOI 10.1016/j.metabol.2003.08.005; Greenland S, 2001, INT J EPIDEMIOL, V30, P1343, DOI 10.1093/ije/30.6.1343; Greenland S, 2009, EPIDEMIOLOGY, V20, P14, DOI 10.1097/EDE.0b013e318193e7b5; Hara K, 2002, DIABETES, V51, P536, DOI 10.2337/diabetes.51.2.536; Heid IM, 2006, DIABETES, V55, P375, DOI 10.2337/diabetes.55.02.06.db05-0747; Hung RJ, 2004, CANCER EPIDEM BIOMAR, V13, P1013; Jiang Y, 2004, AM J HUM GENET, V75, P220, DOI 10.1086/422699; Kahara T, 2003, METABOLISM, V52, P209, DOI 10.1053/meta.2003.50038; Li SX, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000332; Lusis AJ, 2008, NAT REV GENET, V9, P819, DOI 10.1038/nrg2468; Merlo J, 2004, AM J EPIDEMIOL, V159, P1168, DOI 10.1093/aje/kwh160; Parnell AC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009672; Qi L, 2008, NUTR REV, V66, P684, DOI 10.1111/j.1753-4887.2008.00128.x; Rice K, 2008, J AM STAT ASSOC, V103, P385, DOI 10.1198/016214507000001463; Robert SA, 2004, SOC SCI MED, V59, P2421, DOI 10.1016/j.socscimed.2004.03.034; Ross NA, 2007, AM J PUBLIC HEALTH, V97, P500, DOI 10.2105/AJPH.2004.060954; Roux AVD, 2007, AM J PUBLIC HEALTH, V97, P493, DOI 10.2105/AJPH.2006.087734; Roux AVD, 2004, SOC SCI MED, V58, P1953, DOI 10.1016/S0277-9536(03)00414-3; Roux AVD, 2002, J EPIDEMIOL COMMUN H, V56, P588, DOI 10.1136/jech.56.8.588; Rutter M, 2008, J ABNORM CHILD PSYCH, V36, P969, DOI 10.1007/s10802-008-9256-2; Semmens BX, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006187; Semple RK, 2006, J CLIN INVEST, V116, P581, DOI 10.1172/JCI28003; Simmons RK, 2010, DIABETOLOGIA, V53, P600, DOI 10.1007/s00125-009-1620-4; Stephens JW, 2008, ATHEROSCLEROSIS, V200, P229, DOI 10.1016/j.atherosclerosis.2008.04.003; Thapar A, 2007, DEV PSYCHOPATHOL, V19, P989, DOI 10.1017/S0954579407000491; Wakefield J, 2010, GENET EPIDEMIOL, V34, P16, DOI 10.1002/gepi.20429; Wang SH, 2011, PREV MED, DOI [10.1016/j.ypmed.2011.1004.1017, DOI 10.1016/J.YPMED.2011.1004.1017]; Weiss EP, 2005, METABOLISM, V54, P97, DOI 10.1016/j.metabol.2004.08.006; Yu K, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002482; Zimmet P, 2001, NATURE, V414, P782, DOI 10.1038/414782a	41	2	2	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e56693	10.1371/journal.pone.0056693	http://dx.doi.org/10.1371/journal.pone.0056693			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437214	Green Published, Green Submitted, gold			2022-12-25	WOS:000315184200144
J	Sheng, Q; Cao, DG; Zhou, Y; Lei, QX; Han, HX; Li, FW; Lu, Y; Wang, CF				Sheng, Qian; Cao, Dingguo; Zhou, Yan; Lei, Qiuxia; Han, Haixia; Li, Fuwei; Lu, Yan; Wang, Cunfang			Detection of SNPs in the Cathepsin D Gene and Their Association with Yolk Traits in Chickens	PLOS ONE			English	Article							EGG-PRODUCTION; MOLECULAR-CLONING; QUALITY TRAITS; MESSENGER-RNA; EXPRESSION; IDENTIFICATION; PROTEIN; ENZYME	CTSD (Cathepsin D) is a key enzyme in yolk formation, and it primarily affects egg yolk weight and egg weight. However, recent research has mostly focused on the genomic structure of the CTSD gene and the enzyme's role in pathology, and less is known about the enzyme's functions in chickens. In this paper, the correlations between CTSD polymorphisms and egg quality traits were analyzed in local Shandong chicken breeds. CTSD polymorphisms were investigated by PCR-SSCP (polymerase chain reaction single strand conformation polymorphism) and sequencing analysis. Two variants were found to be associated with egg quality traits. One variant (2614T>C), located in exon 3, was novel. Another variant (5274G>T), located in intron 4, was previously referred to as rs16469410. Overall, our results indicated that CTSD would be a useful candidate gene in selection programs for improving yolk traits.	[Sheng, Qian; Wang, Cunfang] Shandong Polytech Univ, Shandong Prov Key Lab Microbiol Engn, Jinan, Shandong, Peoples R China; [Sheng, Qian; Cao, Dingguo; Zhou, Yan; Lei, Qiuxia; Han, Haixia; Li, Fuwei; Lu, Yan] Acad Agr Sci Shandong Prov, Inst Poultry Sci, Jinan, Shandong, Peoples R China; [Cao, Dingguo; Zhou, Yan; Lei, Qiuxia; Han, Haixia; Li, Fuwei; Lu, Yan] Poultry Breeding Engn Technol Ctr Shandong Prov, Jinan, Shandong, Peoples R China	Qilu University of Technology; Shandong Academy of Agricultural Sciences	Lu, Y (corresponding author), Acad Agr Sci Shandong Prov, Inst Poultry Sci, Jinan, Shandong, Peoples R China.	luyan1957@163.com; cunfangwang@163.com	WANG, CUNFANG/P-4640-2014	WANG, CUNFANG/0000-0001-7992-6524	Natural Science Foundation of Shandong Province [ZR2010CQ005]; Thoroughbred project of Shandong Province [2008LZ015]	Natural Science Foundation of Shandong Province(Natural Science Foundation of Shandong Province); Thoroughbred project of Shandong Province	This work was supported by the Natural Science Foundation of Shandong Province (ZR2010CQ005) and the Thoroughbred project of Shandong Province (2008LZ015). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhattacharya TK, 2011, ANIM BIOTECHNOL, V22, P71, DOI 10.1080/10495398.2011.555680; Boruszewska K, 2009, POULTRY SCI, V88, P932, DOI 10.3382/ps.2008-00445; Bourin M, 2012, POULTRY SCI, V91, P2288, DOI 10.3382/ps.2011-01910; Chai Y, 2012, ARCH GYNECOL OBSTET, V286, P465, DOI 10.1007/s00404-012-2318-2; Chen L, 2011, CARCINOGENESIS, V32, P986, DOI 10.1093/carcin/bgr065; De Stasio R, 1999, MOL REPROD DEV, V52, P126; Dekkers J C M, 2004, J Anim Sci, V82 E-Suppl, pE313; Down CF, 2012, BBA-GENE REGUL MECH, V1819, P855, DOI 10.1016/j.bbagrm.2012.03.008; Fan CF, 2012, TUMOR BIOL, V33, P1045, DOI 10.1007/s13277-012-0338-y; Fulton JE, 2012, ANIM GENET, V43, P102, DOI 10.1111/j.1365-2052.2012.02384.x; Gao M, 2010, J CELL BIOCHEM, V109, P1264, DOI 10.1002/jcb.22509; Hah YS, 2012, CANCER LETT, V323, P208, DOI 10.1016/j.canlet.2012.04.012; Liu WB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028600; Qian WF, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002603; RETZEK H, 1992, DNA CELL BIOL, V11, P661, DOI 10.1089/dna.1992.11.661; Ribeca C, 2012, ANIM GENET; Schreiweis MA, 2006, ANIM GENET, V37, P106, DOI 10.1111/j.1365-2052.2005.01394.x; Shubin AV, 2010, BIOMARKERS, V15, P608, DOI 10.3109/1354750X.2010.504310; Williford A, 2012, MOL BIOL EVOL, V29, P3755, DOI 10.1093/molbev/mss184; Yao JF, 2010, POULTRY SCI, V89, P883, DOI 10.3382/ps.2009-00613; Zelazowska M, 2009, CELL TISSUE RES, V335, P585, DOI 10.1007/s00441-007-0459-6; Zhang LC, 2005, POULTRY SCI, V84, P1209, DOI 10.1093/ps/84.8.1209	22	8	9	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2013	8	2							e56656	10.1371/journal.pone.0056656	http://dx.doi.org/10.1371/journal.pone.0056656			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093HR	23431385	Green Submitted, Green Published, gold			2022-12-25	WOS:000315182800028
J	Pignatelli, A; Borin, M; Iseppe, AF; Gambardella, C; Belluzzi, O				Pignatelli, Angela; Borin, Mirta; Iseppe, Alex Fogli; Gambardella, Cristina; Belluzzi, Ottorino			The h-Current in Periglomerular Dopaminergic Neurons of the Mouse Olfactory Bulb	PLOS ONE			English	Article							HYPERPOLARIZATION-ACTIVATED CURRENT; RABBIT SINOATRIAL NODE; RECEPTOR MESSENGER-RNA; CURRENT I-H; RAT-BRAIN; TYROSINE-HYDROXYLASE; PACEMAKER CHANNELS; PURKINJE-FIBERS; CATION CURRENT; CYCLIC-AMP	The properties of the hyperpolarization-activated cation current (I-h) were investigated in rat periglomerular dopaminergic neurons using patch-clamp recordings in thin slices. A reliable identification of single dopaminergic neurons was made possible by use of a transgenic line of mice expressing eGFP under the tyrosine hydroxylase promoter. At 37 degrees C and minimizing the disturbance of the intracellular milieu with perforated patches, this current shows a midpoint of activation around -82.7 mV, with a significant level of opening already at rest, thereby giving a substantial contribution to the resting potential, and ultimately playing a relevant function in the control of the cell excitability. The blockage of I-h has a profound influence on the spontaneous firing of these neurons, which result as strongly depressed. However the effect is not due to a direct role of the current in the pacemaker process, but to the I-h influence on the resting membrane potential. I-h kinetics is sensitive to the intracellular levels of cAMP, whose increase promotes a shift of the activation curve towards more positive potentials. The direct application of DA and 5-HT neurotransmitters, physiologically released onto bulbar dopaminergic neurons and known to act on metabotropic receptors coupled to the cAMP pathway, do not modify the I-h amplitude. On the contrary, noradrenaline almost halves the I-h amplitude. Our data indicate that the HCN channels do not participate directly to the pacemaker activity of periglomerular dopaminergic neurons, but influence their resting membrane potential by controlling the excitability profile of these cells, and possibly affecting the processing of sensory information taking place at the entry of the bulbar circuitry.	[Belluzzi, Ottorino] Univ Ferrara, Dipartimento Sci Vita & Biotecnol, I-44100 Ferrara, Italy; Ist Nazl Neurosci, Ferrara, Italy	University of Ferrara	Belluzzi, O (corresponding author), Univ Ferrara, Dipartimento Sci Vita & Biotecnol, I-44100 Ferrara, Italy.	mk5@unife.it	Pignatelli, Angela/L-4490-2013	Pignatelli, Angela/0000-0002-7160-1597; Fogli Iseppe, Alex/0000-0003-4616-293X; Belluzzi, Ottorino/0000-0002-7543-3818	Ministero della Universita e della Ricerca Scientifica (MIUR) - PRIN	Ministero della Universita e della Ricerca Scientifica (MIUR) - PRIN(Ministry of Education, Universities and Research (MIUR))	The research was supported by a grant from the Ministero della Universita e della Ricerca Scientifica (MIUR) - PRIN 2009. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARANEDA S, 1980, BRAIN RES, V196, P405, DOI 10.1016/0006-8993(80)90404-7; BAKER H, 1983, J NEUROSCI, V3, P69; BEAVO JA, 1970, MOL PHARMACOL, V6, P597; Biel M, 2009, PHYSIOL REV, V89, P847, DOI 10.1152/physrev.00029.2008; BOSMITH RE, 1993, BRIT J PHARMACOL, V110, P343, DOI 10.1111/j.1476-5381.1993.tb13815.x; Brent R. P., 1973, ALGORITHMS MINIMIZAT; Bucchi A, 2002, J GEN PHYSIOL, V120, P1, DOI 10.1085/jgp.20028593; Bucchi A, 2006, J PHYSIOL-LONDON, V572, P335, DOI 10.1113/jphysiol.2005.100776; Cadetti L, 2001, NEUROREPORT, V12, P3117, DOI 10.1097/00001756-200110080-00027; Cathala L, 1999, EUR J NEUROSCI, V11, P398, DOI 10.1046/j.1460-9568.1999.00452.x; Cuevas J, 1997, J NEUROPHYSIOL, V78, P1890, DOI 10.1152/jn.1997.78.4.1890; Davila NG, 2003, J NEUROPHYSIOL, V90, P395, DOI 10.1152/jn.01058.2002; Day HEW, 1997, J CHEM NEUROANAT, V13, P115, DOI 10.1016/S0891-0618(97)00042-2; DIFRANCESCO D, 1986, J PHYSIOL-LONDON, V377, P61, DOI 10.1113/jphysiol.1986.sp016177; DIFRANCESCO D, 1980, J PHYSIOL-LONDON, V308, P353, DOI 10.1113/jphysiol.1980.sp013475; DIFRANCESCO D, 1991, NATURE, V351, P145, DOI 10.1038/351145a0; DIFRANCESCO D, 1982, J PHYSIOL-LONDON, V329, P485, DOI 10.1113/jphysiol.1982.sp014315; Domyancic AV, 1997, J COMP NEUROL, V386, P358, DOI 10.1002/(SICI)1096-9861(19970929)386:3<358::AID-CNE3>3.0.CO;2-0; DOTY RL, 1989, PSYCHOPHARMACOLOGY, V98, P310, DOI 10.1007/BF00451680; Ennis M, 2001, J NEUROPHYSIOL, V86, P2986, DOI 10.1152/jn.2001.86.6.2986; Feigenspan A, 1998, J NEUROSCI, V18, P6776; Forsythe G.E., 1976, COMPUTER METHODS MAT; Fried HU, 2010, CELL TISSUE RES, V339, P463, DOI 10.1007/s00441-009-0904-9; GALL CM, 1987, J COMP NEUROL, V266, P307, DOI 10.1002/cne.902660302; Gambardella C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052329; GRACE AA, 1989, J NEUROSCI, V9, P3463; Gustincich S, 1997, NEURON, V18, P723, DOI 10.1016/S0896-6273(00)80313-X; GUTHRIE KM, 1991, SYNAPSE, V8, P61, DOI 10.1002/syn.890080109; Gutierrez-Mecinas M, 2005, EUR J NEUROSCI, V22, P1357, DOI 10.1111/j.1460-9568.2005.04328.x; HAINSWORTH AH, 1991, NEUROSCIENCE, V43, P81, DOI 10.1016/0306-4522(91)90419-O; HALASZ N, 1990, VERTEBRATE OLFACTORY; HART G, 1983, J PHYSIOL-LONDON, V337, P401, DOI 10.1113/jphysiol.1983.sp014631; Hayar A, 2004, J NEUROSCI, V24, P1190, DOI 10.1523/JNEUROSCI.4714-03.2004; Hibino H, 2010, PHYSIOL REV, V90, P291, DOI 10.1152/physrev.00021.2009; Holderith NB, 2003, EUR J NEUROSCI, V18, P344, DOI 10.1046/j.1460-9568.2003.02756.x; Inyushin MU, 2010, NEUROSCIENCE, V167, P287, DOI 10.1016/j.neuroscience.2010.01.052; KAMONDI A, 1991, J NEUROPHYSIOL, V66, P1902, DOI 10.1152/jn.1991.66.6.1902; KOSAKA T, 1985, BRAIN RES, V343, P166, DOI 10.1016/0006-8993(85)91172-2; KRATSKIN I, 2003, HDB OLFACTION GUSTAT, P139; Linster C, 2011, J NEUROPHYSIOL, V105, P1432, DOI 10.1152/jn.00960.2010; Maccaferri G, 1996, J PHYSIOL-LONDON, V497, P119, DOI 10.1113/jphysiol.1996.sp021754; Maher BJ, 2008, J NEUROPHYSIOL, V99, P1559, DOI 10.1152/jn.00636.2007; Matsushita N, 2002, J NEUROCHEM, V82, P295, DOI 10.1046/j.1471-4159.2002.00972.x; MCLEAN JH, 1988, J NEUROSCI, V8, P3658; MCLEAN JH, 1989, J COMP NEUROL, V285, P339, DOI 10.1002/cne.902850305; Mistrik P, 2005, J BIOL CHEM, V280, P27056, DOI 10.1074/jbc.M502696200; Monteggia LM, 2000, MOL BRAIN RES, V81, P129, DOI 10.1016/S0169-328X(00)00155-8; Moosmang S, 1999, BIOL CHEM, V380, P975, DOI 10.1515/BC.1999.121; Notomi T, 2004, J COMP NEUROL, V471, P241, DOI 10.1002/cne.11039; NOWYCKY MC, 1983, NEUROSCIENCE, V8, P717, DOI 10.1016/0306-4522(83)90005-2; PANULA P, 1989, NEUROSCIENCE, V28, P585, DOI 10.1016/0306-4522(89)90007-9; Panzanelli P, 2007, J COMP NEUROL, V502, P990, DOI 10.1002/cne.21356; PAPE HC, 1989, NATURE, V340, P715, DOI 10.1038/340715a0; PEDARZANI P, 1995, P NATL ACAD SCI USA, V92, P11716, DOI 10.1073/pnas.92.25.11716; Pena F, 2006, EXP BRAIN RES, V173, P282, DOI 10.1007/s00221-006-0473-z; Pignatelli A, 2005, J PHYSIOL-LONDON, V564, P501, DOI 10.1113/jphysiol.2005.084632; Pignatelli A, 2009, PFLUG ARCH EUR J PHY, V457, P899, DOI 10.1007/s00424-008-0535-0; Puopolo M, 2005, J NEUROPHYSIOL, V94, P3618, DOI 10.1152/jn.00225.2005; Saino-Saito S, 2004, J COMP NEUROL, V479, P389, DOI 10.1002/cne.20320; Santoro B, 2000, J NEUROSCI, V20, P5264, DOI 10.1523/JNEUROSCI.20-14-05264.2000; Sawamoto K, 2001, P NATL ACAD SCI USA, V98, P6423, DOI 10.1073/pnas.111152398; Sawamoto K, 2001, J NEUROSCI, V21, P3895, DOI 10.1523/JNEUROSCI.21-11-03895.2001; SEAMON KB, 1981, J CYCLIC NUCL PROT, V7, P201; Seifert R, 1999, P NATL ACAD SCI USA, V96, P9391, DOI 10.1073/pnas.96.16.9391; SHIPLEY MT, 1985, BRAIN RES, V329, P294, DOI 10.1016/0006-8993(85)90537-2; Shipley MT, 1996, J NEUROBIOL, V30, P123; Wahl-Schott C, 2009, CELL MOL LIFE SCI, V66, P470, DOI 10.1007/s00018-008-8525-0; Wainger BJ, 2001, NATURE, V411, P805, DOI 10.1038/35081088; WinzerSerhan UH, 1997, NEUROSCIENCE, V76, P241; Yagi J, 1998, J NEUROPHYSIOL, V80, P1094, DOI 10.1152/jn.1998.80.3.1094; Yanagida H, 2000, AM J PHYSIOL-CELL PH, V278, pC40, DOI 10.1152/ajpcell.2000.278.1.C40; YOUNG WS, 1980, P NATL ACAD SCI-BIOL, V77, P1696, DOI 10.1073/pnas.77.3.1696; ZABORSZKY L, 1986, J COMP NEUROL, V243, P488, DOI 10.1002/cne.902430405	73	10	10	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e56571	10.1371/journal.pone.0056571	http://dx.doi.org/10.1371/journal.pone.0056571			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418585	Green Published, Green Submitted, gold			2022-12-25	WOS:000315970300178
J	Lotter, H; Helk, E; Bernin, H; Jacobs, T; Prehn, C; Adamski, J; Gonzalez-Roldan, N; Holst, O; Tannich, E				Lotter, Hannelore; Helk, Elena; Bernin, Hannah; Jacobs, Thomas; Prehn, Cornelia; Adamski, Jerzy; Gonzalez-Roldan, Nestor; Holst, Otto; Tannich, Egbert			Testosterone Increases Susceptibility to Amebic Liver Abscess in Mice and Mediates Inhibition of IFN gamma Secretion in Natural Killer T Cells	PLOS ONE			English	Article							LEISHMANIA-DONOVANI INFECTION; ENTAMOEBA-HISTOLYTICA TROPHOZOITES; PLASMODIUM-CHABAUDI MALARIA; INVARIANT NKT CELLS; SEXUAL-DIMORPHISM; MURINE MACROPHAGES; DENDRITIC CELLS; CUTTING EDGE; NITRIC-OXIDE; BONE-MARROW	Amebic liver abscess (ALA), a parasitic disease due to infection with the protozoan Entamoeba histolytica, occurs age and gender dependent with strong preferences for adult males. Using a mouse model for ALA with a similar male bias for the disease, we have investigated the role of female and male sexual hormones and provide evidence for a strong contribution of testosterone. Removal of testosterone by orchiectomy significantly reduced sizes of abscesses in male mice, while substitution of testosterone increased development of ALA in female mice. Activation of natural killer T (NKT) cells, which are known to be important for the control of ALA, is influenced by testosterone. Specifically activated NKT cells isolated from female mice produce more IFN gamma compared to NKT cells derived from male mice. This high level production of IFN gamma in female derived NKT cells was inhibited by testosterone substitution, while the IFN gamma production in male derived NKT cells was increased by orchiectomy. Gender dependent differences were not a result of differences in the total number of NKT cells, but a result of a higher activation potential for the CD4(-) NKT cell subpopulation in female mice. Taken together, we conclude that the hormone status of the host, in particular the testosterone level, determines susceptibility to ALA at least in a mouse model of the disease.	[Lotter, Hannelore; Helk, Elena; Bernin, Hannah; Jacobs, Thomas; Tannich, Egbert] Bernhard Nocht Inst Trop Med, D-20359 Hamburg, Germany; [Prehn, Cornelia; Adamski, Jerzy] Helmholtz Ctr Munich, Inst Expt Genet, Genome Anal Ctr, Neuherberg, Germany; [Gonzalez-Roldan, Nestor] Leibniz Ctr Med & Biosci, Res Ctr Borstel, Div Immunobiol, Borstel, Germany; [Holst, Otto] Leibniz Ctr Med & Biosci, Res Ctr Borstel, Div Struct Biochem, Borstel, Germany	Bernhard Nocht Institut fur Tropenmedizin; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Forschungszentrum Borstel; Forschungszentrum Borstel	Lotter, H (corresponding author), Bernhard Nocht Inst Trop Med, Bernhard Nocht Str 74, D-20359 Hamburg, Germany.	lotter@bni-hamburg.de		Prehn, Cornelia/0000-0002-1274-4715; Adamski, Jerzy/0000-0001-9259-0199	Deutsche Forschungsgemeinschaft [TA110/8-1]; Collaborative Research Center, Germany [841]; German National Genome Research Network [NGFN2 : 01GR0430]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Collaborative Research Center, Germany; German National Genome Research Network	This work was supported by grants of the Deutsche Forschungsgemeinschaft (TA110/8-1) and the Collaborative Research Center 841, Germany. Part of this work was financed by the German National Genome Research Network (NGFN2 : 01GR0430). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acuna-Soto R, 2000, AM J GASTROENTEROL, V95, P1277, DOI 10.1111/j.1572-0241.2000.01525.x; BARNES PF, 1987, MEDICINE, V66, P472, DOI 10.1097/00005792-198711000-00005; Bebo BF, 1999, J IMMUNOL, V162, P35; BENDELAC A, 1995, SCIENCE, V268, P863, DOI 10.1126/science.7538697; Benten WPM, 1999, FASEB J, V13, P123, DOI 10.1096/fasebj.13.1.123; Benten WPM, 1997, J ENDOCRINOL, V153, P275, DOI 10.1677/joe.0.1530275; Benten WPM, 1998, FEBS LETT, V422, P349, DOI 10.1016/S0014-5793(98)00039-8; Blessmann J, 2003, J CLIN MICROBIOL, V41, P4745, DOI 10.1128/JCM.41.10.4745-4750.2003; Blessmann J, 2002, AM J TROP MED HYG, V66, P578, DOI 10.4269/ajtmh.2002.66.578; Bouman A, 2005, HUM REPROD UPDATE, V11, P411, DOI 10.1093/humupd/dmi008; CHANDLER VL, 1983, CELL, V33, P489, DOI 10.1016/0092-8674(83)90430-0; CUTOLO A, 1995, APPL OPTICS, V34, P7974, DOI 10.1364/AO.34.007974; DENIS M, 1989, INFECT IMMUN, V57, P1750, DOI 10.1128/IAI.57.6.1750-1756.1989; Doisne JM, 2011, J IMMUNOL, V186, P662, DOI 10.4049/jimmunol.1002725; Filipin MD, 2008, EXP PARASITOL, V120, P249, DOI 10.1016/j.exppara.2008.07.012; Friedl R, 2000, LIFE SCI, V68, P417, DOI 10.1016/S0024-3205(00)00953-X; Godfrey DI, 2010, NAT IMMUNOL, V11, P197, DOI 10.1038/ni.1841; Godfrey DI, 2004, NAT REV IMMUNOL, V4, P231, DOI 10.1038/nri1309; Gourdy P, 2005, BLOOD, V105, P2415, DOI 10.1182/blood-2004-07-2819; He YL, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000915; Kanda N, 1996, CLIN EXP IMMUNOL, V106, P410, DOI 10.1046/j.1365-2249.1996.d01-842.x; Kee SJ, 2012, HUM IMMUNOL, V73, P1011, DOI 10.1016/j.humimm.2012.07.335; Kenna T, 2003, J IMMUNOL, V171, P1775, DOI 10.4049/jimmunol.171.4.1775; Klein SL, 2004, PARASITE IMMUNOL, V26, P247, DOI 10.1111/j.0141-9838.2004.00710.x; Krucken J, 2005, INFECT IMMUN, V73, P436, DOI 10.1128/IAI.73.1.436-443.2005; Liu LM, 2006, PARASITOL RES, V99, P189, DOI 10.1007/s00436-006-0168-1; Liu LM, 2005, STEROIDS, V70, P604, DOI 10.1016/j.steroids.2005.02.020; Lotter H, 2006, INFECT IMMUN, V74, P118, DOI 10.1128/IAI.74.1.118-124.2006; Lotter H, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000434; Lutz MB, 1999, J IMMUNOL METHODS, V223, P77, DOI 10.1016/S0022-1759(98)00204-X; Mannik LA, 2011, IMMUNOLOGY, V132, P361, DOI 10.1111/j.1365-2567.2010.03369.x; Marriott I, 2006, IMMUNOL RES, V34, P177, DOI 10.1385/IR:34:3:177; MOCK BA, 1988, INFECT IMMUN, V56, P3316, DOI 10.1128/IAI.56.12.3316-3319.1988; Molling JW, 2005, INT J CANCER, V116, P87, DOI 10.1002/ijc.20998; Montoya CJ, 2007, IMMUNOLOGY, V122, P1, DOI 10.1111/j.1365-2567.2007.02647.x; Morales-Montor J, 2004, J PARASITOL, V90, P531, DOI 10.1645/GE-113R3; Mossmann H, 1997, LIFE SCI, V60, P839, DOI 10.1016/S0024-3205(97)00012-X; Nakazawa M, 1997, EXP PARASITOL, V85, P233, DOI 10.1006/expr.1997.4148; Neyrolles O, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000199; Porcelli SA, 1999, ANNU REV IMMUNOL, V17, P297, DOI 10.1146/annurev.immunol.17.1.297; Roberts CW, 2001, CLIN MICROBIOL REV, V14, P476, DOI 10.1128/CMR.14.3.476-488.2001; SALATA RA, 1987, AM J TROP MED HYG, V37, P72, DOI 10.4269/ajtmh.1987.37.72; Sandberg JK, 2003, EUR J IMMUNOL, V33, P588, DOI 10.1002/eji.200323707; Seydel KB, 2000, INFECT IMMUN, V68, P400, DOI 10.1128/IAI.68.1.400-402.2000; Shandera WX, 1998, SOUTH MED J, V91, P829, DOI 10.1097/00007611-199809000-00005; Snyder-Cappione JE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015412; Subleski JJ, 2009, J LEUKOCYTE BIOL, V86, P751, DOI 10.1189/jlb.0309118; Takahashi T, 2002, J IMMUNOL, V168, P3140, DOI 10.4049/jimmunol.168.7.3140; Travi B, 2002, MEM I OSWALDO CRUZ, V97, P887, DOI 10.1590/S0074-02762002000600025; Travison TG, 2007, J CLIN ENDOCR METAB, V92, P196, DOI 10.1210/jc.2006-1375; Tupin E, 2007, NAT REV MICROBIOL, V5, P405, DOI 10.1038/nrmicro1657; Volkmann A, 1996, EUR J IMMUNOL, V26, P2565, DOI 10.1002/eji.1830261105; Walderich B, 1997, AM J TROP MED HYG, V57, P70, DOI 10.4269/ajtmh.1997.57.70; Watanabe K, 1999, PARASITOL RES, V85, P522, DOI 10.1007/s004360050591; WESTPHAL O, 1983, PROG ALLERGY, V33, P9; Wingender G, 2010, J IMMUNOL, V185, P2721, DOI 10.4049/jimmunol.1001018; Wunderlich F, 2002, STEROIDS, V67, P535, DOI 10.1016/S0039-128X(01)00175-1; YAMAMOTO Y, 1991, INFECT IMMUN, V59, P4089, DOI 10.1128/IAI.59.11.4089-4096.1991; Zhang HP, 2001, PARASITOL RES, V87, P674, DOI 10.1007/s004360000354	59	50	52	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2013	8	2							e55694	10.1371/journal.pone.0055694	http://dx.doi.org/10.1371/journal.pone.0055694			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104BU	23424637	Green Published, Green Submitted, gold			2022-12-25	WOS:000315965100025
J	Braeutigam, C; Rago, L; Rolke, A; Waldmeier, L; Christofori, G; Winter, J				Braeutigam, C.; Rago, L.; Rolke, A.; Waldmeier, L.; Christofori, G.; Winter, J.			The RNA-binding protein Rbfox2: an essential regulator of EMT-driven alternative splicing and a mediator of cellular invasion	ONCOGENE			English	Article						Rbfox2; epithelial-mesenchymal transition; EMT; alternative splicing	EPITHELIAL-MESENCHYMAL TRANSITION; BREAST-CANCER; IN-VIVO; CARCINOMA; MIGRATION; FOX-1; METASTASIS; EXPRESSION; DYNAMIN; CELLS	The epithelial-mesenchymal transition (EMT), a prerequisite for cancer progression and metastasis formation, is regulated not only at the transcriptional but also at the post-transcriptional level, including at the level of alternative pre-mRNA splicing. Several recent studies have highlighted the involvement of splicing factors, including epithelial splicing regulatory proteins (Esrps) and RNA-binding Fox protein 2 (Rbfox2), in this process. Esrps regulate epithelial-specific splicing, and their expression is downregulated during EMT. By contrast, the role of Rbfox2 is controversial because Rbfox2 regulates epithelial as well as mesenchymal splicing events. Here, we have used several established cell culture models to investigate the functions of Rbfox2 during EMT. We demonstrate that induction of an EMT upregulates the expression of Rbfox2, which correlates with an increase in Rbfox2-regulated splicing events in the cortactin (Cttn), Pard3 and dynamin 2 (Dnm2) transcripts. At the same time, however, the epithelial-specific ability to splice the Enah, Slk and Tsc2 transcripts is either reduced or lost completely by Rbfox2, which might be due, in part, to downregulation of the expression of the Esrps cooperative factors. Depletion of Rbfox2 during EMT did not prevent the activation of transforming growth factor-beta signaling, the upregulation of mesenchymal markers or changes in cell morphology toward a mesenchymal phenotype. In addition, this depletion did not influence cell migration. However, depletion of Rbfox2 in cells that have completed an EMT significantly reduced their invasive potential. Taken together, our results suggest that during an EMT, Rbfox2-regulated splicing shifts from epithelial-to mesenchymal-specific events, leading to a higher degree of tissue invasiveness.	[Braeutigam, C.; Rago, L.; Rolke, A.; Winter, J.] Max Planck Inst Immunobiol & Epigenet, Dept Mol Embryol, D-79108 Freiburg, Germany; [Waldmeier, L.; Christofori, G.] Univ Basel, Dept Biomed, Basel, Switzerland; [Winter, J.] Johannes Gutenberg Univ Mainz, Univ Med Ctr Johannes Gutenberg, Inst Human Genet, D-55122 Mainz, Germany	Max Planck Society; University of Basel; Johannes Gutenberg University of Mainz	Winter, J (corresponding author), Max Planck Inst Immunobiol & Epigenet, Dept Mol Embryol, Stuebeweg 51, D-79108 Freiburg, Germany.	winter@immunbio.mpg.de			Max-Planck Society	Max-Planck Society(Max Planck Society)	This work was supported by the Max-Planck Society. We are grateful to Rolf Kemler for helpful discussions.	Baraniak AP, 2006, MOL CELL BIOL, V26, P1209, DOI 10.1128/MCB.26.4.1209-1222.2006; Barnes EA, 2010, AM J RESP CELL MOL, V43, P617, DOI 10.1165/rcmb.2008-0335OC; Bhowmick NA, 2001, MOL BIOL CELL, V12, P27, DOI 10.1091/mbc.12.1.27; Biamonti G, 2012, CELL MOL LIFE SCI, V69, P2515, DOI 10.1007/s00018-012-0931-7; Brown RL, 2011, J CLIN INVEST, V121, P1064, DOI 10.1172/JCI44540; Cheng CH, 2006, MOL CELL BIOL, V26, P362, DOI 10.1128/MCB.26.1.362-370.2006; Damianov A, 2010, RNA, V16, P405, DOI 10.1261/rna.1838210; Di Marcotullio L, 2011, ONCOGENE, V30, P65, DOI 10.1038/onc.2010.394; Dikshit B, 2013, ONCOGENE, V32, P3798, DOI 10.1038/onc.2012.393; Dow LE, 2008, ONCOGENE, V27, P5988, DOI 10.1038/onc.2008.219; Eppinga RD, 2012, ONCOGENE, V31, P1228, DOI 10.1038/onc.2011.329; Feng H, 2012, ONCOGENE, V31, P2691, DOI 10.1038/onc.2011.436; Ge XJ, 2005, GENOMICS, V86, P127, DOI 10.1016/j.ygeno.2005.04.008; Ghigna C, 2005, MOL CELL, V20, P881, DOI 10.1016/j.molcel.2005.10.026; Goswami S, 2009, CLIN EXP METASTAS, V26, P153, DOI 10.1007/s10585-008-9225-8; Guo M, 2012, CANCER RES, V72, P2017, DOI 10.1158/0008-5472.CAN-11-3985; Hidalgo-Carcedo C, 2011, NAT CELL BIOL, V13, P49, DOI 10.1038/ncb2133; Hirata E, 2012, J CELL SCI, V125, P858, DOI 10.1242/jcs.089995; Horiguchi K, 2012, ONCOGENE, V31, P3190, DOI 10.1038/onc.2011.493; HUH GS, 1994, GENE DEV, V8, P1561, DOI 10.1101/gad.8.13.1561; Jia YL, 2011, HEPATOLOGY, V54, P1808, DOI 10.1002/hep.24562; Jin Y, 2003, EMBO J, V22, P905, DOI 10.1093/emboj/cdg089; Kirkbride KC, 2011, CELL ADHES MIGR, V5, P187, DOI 10.4161/cam.5.2.14773; Kruchten AE, 2006, J CELL SCI, V119, P1683, DOI 10.1242/jcs.02963; Kuroyanagi H, 2009, CELL MOL LIFE SCI, V66, P3895, DOI 10.1007/s00018-009-0120-5; Lapuk A, 2010, MOL CANCER RES, V8, P961, DOI 10.1158/1541-7786.MCR-09-0528; Lehembre F, 2008, EMBO J, V27, P2603, DOI 10.1038/emboj.2008.178; LeMasters KE, 2012, BMC DEV BIOL, V12, DOI 10.1186/1471-213X-12-22; Liu H, 2006, P NATL ACAD SCI USA, V103, P4134, DOI 10.1073/pnas.0511342103; Massimi P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040279; Matsuda Yoko, 2012, Patholog Res Int, V2012, P574768, DOI 10.1155/2012/574768; MIETTINEN PJ, 1994, J CELL BIOL, V127, P2021, DOI 10.1083/jcb.127.6.2021; Modafferi EF, 1997, MOL CELL BIOL, V17, P6537, DOI 10.1128/MCB.17.11.6537; Moran-Jones K, 2009, CANCER RES, V69, P9219, DOI 10.1158/0008-5472.CAN-09-1852; Nakahata S, 2005, NUCLEIC ACIDS RES, V33, P2078, DOI 10.1093/nar/gki338; Nishikawa Y, 2011, ONCOL REP, V26, P587, DOI 10.3892/or.2011.1324; Oh S, 2012, BBA-REV CANCER, V1826, P1, DOI 10.1016/j.bbcan.2012.02.002; Philippar U, 2008, DEV CELL, V15, P813, DOI 10.1016/j.devcel.2008.09.003; Reed JR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045877; Roovers K, 2009, ONCOGENE, V28, P2839, DOI 10.1038/onc.2009.146; Shapiro IM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002218; Underwood JG, 2005, MOL CELL BIOL, V25, P10005, DOI 10.1128/MCB.25.22.10005-10016.2005; Valacca C, 2010, J CELL BIOL, V191, P87, DOI 10.1083/jcb.201001073; Venables JP, 2006, BIOESSAYS, V28, P378, DOI 10.1002/bies.20390; Venables JP, 2009, NAT STRUCT MOL BIOL, V16, P670, DOI 10.1038/nsmb.1608; Waldmeier L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048651; Warzecha CC, 2010, EMBO J, V29, P3286, DOI 10.1038/emboj.2010.195; Warzecha CC, 2009, MOL CELL, V33, P591, DOI 10.1016/j.molcel.2009.01.025; Wesche J, 2011, BIOCHEM J, V437, P199, DOI 10.1042/BJ20101603; Winter J, 2004, HUM GENET, V114, P541, DOI 10.1007/s00439-004-1114-x; Yang J, 2008, DEV CELL, V14, P818, DOI 10.1016/j.devcel.2008.05.009; Yeo GW, 2009, NAT STRUCT MOL BIOL, V16, P130, DOI 10.1038/nsmb.1545; Yilmaz M, 2009, CANCER METAST REV, V28, P15, DOI 10.1007/s10555-008-9169-0; Zhang CL, 2008, GENE DEV, V22, P2550, DOI 10.1101/gad.1703108	54	97	100	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 27	2014	33	9					1082	1092		10.1038/onc.2013.50	http://dx.doi.org/10.1038/onc.2013.50			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AB6XT	23435423				2022-12-25	WOS:000331933800002
J	Liu, Y; Qin, K; Meng, G; Zhang, JF; Zhou, JF; Zhao, GY; Luo, M; Zheng, XF				Liu, Yong; Qin, Kun; Meng, Geng; Zhang, Jinfang; Zhou, Jianfang; Zhao, Guangyu; Luo, Ming; Zheng, Xiaofeng			Structural and Functional Characterization of K339T Substitution Identified in the PB2 Subunit Cap-binding Pocket of Influenza A Virus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-TERMINAL DOMAIN; RNA-POLYMERASE; HOST-RANGE; MOLECULAR-BASIS; HIGH VIRULENCE; PA SUBUNIT; AMINO-ACID; REPLICATION; ENDONUCLEASE; SWINE	Influenza virus RNA-dependent RNA polymerase is a heterotrimer composed of PA, PB1, and PB2 subunits. RNA-dependent RNA polymerase is required for both transcription and replication of influenza viral RNA taking place in the nucleus of infected cells. A "cap-snatching" mechanism is used to generate a 5'-capped primer for transcription in which the cap-binding domain of PB2 (PB2(cap)) captures the 5' cap of the host pre-mRNA. Our statistical analysis of PB2 sequences showed that residue Lys(339) located in the cap-binding pocket of H5N1 PB2(cap) was gradually replaced by Thr(339) over the past decade. To understand the role of this amino acid polymorphism, we solved the crystal structures of PB2(cap) with or without a pre-mRNA cap analog, m(7)GTP, in the presence of Lys(339) or Thr(339). The structures showed that Lys(339) contributes to binding the gamma-phosphate group of m(7)GTP, and the replacement of Lys(339) by Thr eliminates this interaction. Isothermal titration calorimetry analysis showed that Thr(339) attenuated the PB2(cap) cap binding activity in vitro compared with Lys(339). Further functional studies confirmed that Thr(339)-PB2-containing ribonucleoprotein complex has a reduced influenza polymerase activity and RNA synthesis activity, and a reconstituted H5N1 virus containing the Thr(339) substitution exhibited a lower virulence to mice but more active replication in Madin-Darby canine kidney cells. The K339T substitution in the cap-binding pocket of PB2 modulates the polymerase activity and virulence by regulating the cap binding activity. It is informative to track variations in the cap-binding pocket of PB2 in surveillance of the evolution and spread of influenza virus.	[Liu, Yong; Meng, Geng; Zhang, Jinfang; Zheng, Xiaofeng] Peking Univ, Sch Life Sci, State Key Lab Prot & Plant Gene Res, Beijing 100871, Peoples R China; [Liu, Yong; Meng, Geng; Zhang, Jinfang; Zheng, Xiaofeng] Peking Univ, Sch Life Sci, Dept Biochem & Mol Biol, Beijing 100871, Peoples R China; [Qin, Kun; Zhou, Jianfang] Chinese Ctr Dis Control & Prevent, Chinese Natl Influenza Ctr, Natl Inst Viral Dis Control & Prevent, Beijing 102206, Peoples R China; [Luo, Ming] Univ Alabama Birmingham, Dept Microbiol, Birmingham, AL 35294 USA; [Zhao, Guangyu] Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Beijing 100071, Peoples R China	Peking University; Peking University; Chinese Center for Disease Control & Prevention; National Institute for Viral Disease Control & Prevention, Chinese Center for Disease Control & Prevention; University of Alabama System; University of Alabama Birmingham; Beijing Institute of Microbiology & Epidemiology	Zheng, XF (corresponding author), Peking Univ, Sch Life Sci, Beijing 100871, Peoples R China.	xiaofengz@pku.edu.cn	Meng, Geng/ACY-1510-2022		National High Technology and Development Program of China 973 Programs [2010CB911800]; National Natural Science Foundation of China [30930020]; International Centre for Genetic Engineering and Biotechnology [CRP/CHN09-01]; major research project for infectious disease [2013ZX10004611-003]	National High Technology and Development Program of China 973 Programs; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); International Centre for Genetic Engineering and Biotechnology; major research project for infectious disease	This work was supported by the National High Technology and Development Program of China 973 Programs (Grant 2010CB911800), National Natural Science Foundation of China (Grant 30930020), International Centre for Genetic Engineering and Biotechnology (Project CRP/CHN09-01), and a major research project for infectious disease (Project 2013ZX10004611-003).	Alizon S, 2009, J EVOLUTION BIOL, V22, P245, DOI 10.1111/j.1420-9101.2008.01658.x; Bogs J, 2011, J VIROL, V85, P10691, DOI 10.1128/JVI.00786-11; Bussey KA, 2010, J VIROL, V84, P4395, DOI 10.1128/JVI.02642-09; Chan AY, 2006, VIROLOGY, V351, P210, DOI 10.1016/j.virol.2006.03.005; Chen GW, 2006, EMERG INFECT DIS, V12, P1353, DOI 10.3201/eid1209.060276; Chen H, 2007, VIRUS RES, V128, P159, DOI 10.1016/j.virusres.2007.04.017; Coloma R, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000491; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Dias A, 2009, NATURE, V458, P914, DOI 10.1038/nature07745; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Foeglein A, 2011, J GEN VIROL, V92, P1650, DOI 10.1099/vir.0.031492-0; Gabriel G, 2005, P NATL ACAD SCI USA, V102, P18590, DOI 10.1073/pnas.0507415102; Gabriel G, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040011; Gabriel G, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1158; Garten RJ, 2009, SCIENCE, V325, P197, DOI 10.1126/science.1176225; Guilligay D, 2008, NAT STRUCT MOL BIOL, V15, P500, DOI 10.1038/nsmb.1421; Hara K, 2006, J VIROL, V80, P7789, DOI 10.1128/JVI.00600-06; Hatta M, 2001, SCIENCE, V293, P1840, DOI 10.1126/science.1062882; Herfst S, 2012, SCIENCE, V336, P1534, DOI 10.1126/science.1213362; Hoffmann E, 2000, P NATL ACAD SCI USA, V97, P6108, DOI 10.1073/pnas.100133697; Hudjetz B, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002488; Imai M, 2012, NATURE, V486, P420, DOI 10.1038/nature10831; Katz JM, 2000, J VIROL, V74, P10807, DOI 10.1128/JVI.74.22.10807-10810.2000; Lee MS, 2007, VET MICROBIOL, V124, P193, DOI 10.1016/j.vetmic.2007.04.021; Li ZJ, 2005, J VIROL, V79, P12058, DOI 10.1128/JVI.79.18.12058-12064.2005; Liu QF, 2012, J VIROL, V86, P1233, DOI 10.1128/JVI.05699-11; Massin P, 2005, J VIROL, V79, P13811, DOI 10.1128/JVI.79.21.13811-13816.2005; Mehle A, 2009, P NATL ACAD SCI USA, V106, P21312, DOI 10.1073/pnas.0911915106; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nakazono Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032634; Ng AKL, 2008, FASEB J, V22, P3638, DOI 10.1096/fj.08-112110; Ng AKL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036415; Noda T, 2006, NATURE, V439, P490, DOI 10.1038/nature04378; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; Ping JH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021740; PLOTCH SJ, 1981, CELL, V23, P847, DOI 10.1016/0092-8674(81)90449-9; Reperant LA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043115; Resa-Infante P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003904; Rolling T, 2009, J VIROL, V83, P6673, DOI 10.1128/JVI.00212-09; Schat KA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030960; Smith GJD, 2009, NATURE, V459, P1122, DOI 10.1038/nature08182; SUBBARAO EK, 1993, J VIROL, V67, P1761, DOI 10.1128/JVI.67.4.1761-1764.1993; Sugiyama K, 2009, EMBO J, V28, P1803, DOI 10.1038/emboj.2009.138; Tarendeau F, 2007, NAT STRUCT MOL BIOL, V14, P229, DOI 10.1038/nsmb1212; Vijaykrishna D, 2010, SCIENCE, V328, P1529, DOI 10.1126/science.1189132; Ye QZ, 2006, NATURE, V444, P1078, DOI 10.1038/nature05379; Yuan PW, 2009, NATURE, V458, P909, DOI 10.1038/nature07720; Zhang SJ, 2012, BBA-GENE REGUL MECH, V1819, P78, DOI 10.1016/j.bbagrm.2011.11.006; Zhu WF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033383; Zhu WF, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-29	50	34	36	2	49	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 19	2013	288	16					11013	11023		10.1074/jbc.M112.392878	http://dx.doi.org/10.1074/jbc.M112.392878			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	130KW	23436652	hybrid, Green Published			2022-12-25	WOS:000317915500008
J	Rodriguez-Guilbe, M; Oyola-Robles, D; Schreiter, ER; Baerga-Ortiz, A				Rodriguez-Guilbe, Maria; Oyola-Robles, Delise; Schreiter, Eric R.; Baerga-Ortiz, Abel			Structure, Activity, and Substrate Selectivity of the Orf6 Thioesterase from Photobacterium profundum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOG-FOLD THIOESTERASE; SP STRAIN SU; 4-HYDROXYBENZOYL-COA THIOESTERASE; ESCHERICHIA-COLI; FATTY-ACIDS; BIODIESEL PRODUCTION; CATALYTIC MECHANISM; HOTDOG-FOLD; BIOSYNTHESIS; PATHWAY	Thioesterase activity is typically required for the release of products from polyketide synthase enzymes, but no such enzyme has been characterized in deep-sea bacteria associated with the production of polyunsaturated fatty acids. In this work, we have expressed and purified the Orf6 thioesterase from Photobacterium profundum. Enzyme assays revealed that Orf6 has a higher specific activity toward long-chain fatty acyl-CoA substrates (palmitoyl-CoA and eicosapentaenoyl-CoA) than toward short-chain or aromatic acyl-CoA substrates. We determined a high resolution (1.05 angstrom) structure of Orf6 that reveals a hotdog hydrolase fold arranged as a dimer of dimers. The putative active site of this structure is occupied by additional electron density not accounted for by the protein sequence, consistent with the presence of an elongated compound. A second crystal structure (1.40 angstrom) was obtained from a crystal that was grown in the presence of Mg2+, which reveals the presence of a binding site for divalent cations at a crystal contact. The Mg2+-bound structure shows localized conformational changes (root mean square deviation of 1.63 angstrom), and its active site is unoccupied, suggesting a mechanism to open the active site for substrate entry or product release. These findings reveal a new thioesterase enzyme with a preference for long-chain CoA substrates in a deep-sea bacterium whose potential range of applications includes bioremediation and the production of biofuels.	[Rodriguez-Guilbe, Maria; Oyola-Robles, Delise; Baerga-Ortiz, Abel] Univ Puerto Rico, Sch Med, Dept Biochem, San Juan, PR 00936 USA; [Schreiter, Eric R.] Univ Puerto Rico, Dept Chem, San Juan, PR 00931 USA; [Schreiter, Eric R.] Howard Hughes Med Inst, Ashburn, VA 20147 USA	University of Puerto Rico; University of Puerto Rico Medical Sciences Campus; University of Puerto Rico; University of Puerto Rico Medical Sciences Campus; Howard Hughes Medical Institute	Schreiter, ER (corresponding author), Howard Hughes Med Inst, Janelia Farm Res Campus,19700 Helix Dr, Ashburn, VA 20147 USA.	schreitere@janelia.hhmi.org; abel.baerga@upr.edu		Schreiter, Eric/0000-0002-2864-7469	National Institutes of Health [R25GM061838]; National Science Foundation [CHE0953254]; United States Department of Energy Office [DE-AC02-06CH11357]; Office of Science, Office of Basic Energy Sciences, United States Department of Energy [DE-AC02-05CH11231]; National Center for Research Resources [2G12-RR003051]; National Institute on Minority Health and Health Disparities from the National Institutes of Health [8G12-MD007600]; NATIONAL CENTER FOR RESEARCH RESOURCES [G12RR003051] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM061838] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [G12MD007600] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); United States Department of Energy Office(United States Department of Energy (DOE)); Office of Science, Office of Basic Energy Sciences, United States Department of Energy(United States Department of Energy (DOE)); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute on Minority Health and Health Disparities from the National Institutes of Health; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This work was supported, in whole or in part, by National Institutes of Health Grant R25GM061838 (MBRS-RISE Program; to M. R.-G. and D. O.-R.). This work was also supported by National Science Foundation Grant CHE0953254 (to A. B.-O.).; We thank Dr. Eric Allen for providing the pfa genes from P. profundum and Mar~a Malave for initial cloning of the orf6 gene. Dr. Orestes Quesada and Ms. Carol Rodriguez helped with mass spectrometric analysis of the purified protein. We thank the staff of Advanced Photon Source beamline 23-ID and Advanced Light Source beamline 4.2.2 for support during x-ray data collection. M. R.-G. is especially grateful to Dr. Ruslan Sanishvili (Advanced Photon Source, Argonne National Laboratory) for invaluable help with crystallographic collection. Use of the Advanced Photon Source, an Office of Science User Facility operated for the United States Department of Energy Office of Science by the Argonne National Laboratory, was supported by the United States Department of Energy Office under Contract DE-AC02-06CH11357. The Advanced Light Source is supported by the Director, Office of Science, Office of Basic Energy Sciences, United States Department of Energy under Contract DE-AC02-05CH11231. Shared instrumentation was supported by National Center for Research Resources Grant 2G12-RR003051 and National Institute on Minority Health and Health Disparities Grant 8G12-MD007600 from the National Institutes of Health.	Allen EE, 2002, MICROBIOL-SGM, V148, P1903, DOI 10.1099/00221287-148-6-1903; Benning MM, 1998, J BIOL CHEM, V273, P33572, DOI 10.1074/jbc.273.50.33572; Bryson K, 2005, NUCLEIC ACIDS RES, V33, pW36, DOI 10.1093/nar/gki410; Cao J, 2009, BIOCHEMISTRY-US, V48, P1293, DOI 10.1021/bi801879z; Chen DQ, 2009, BIOCHEMISTRY-US, V48, P511, DOI 10.1021/bi802207t; Dillon SC, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-109; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Guo ZF, 2009, BIOCHEMISTRY-US, V48, P1712, DOI 10.1021/bi802165x; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P133, DOI 10.1107/S0907444909047374; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Khosla C, 2007, ANNU REV BIOCHEM, V76, P195, DOI 10.1146/annurev.biochem.76.053105.093515; Kotaka M, 2009, J BIOL CHEM, V284, P15739, DOI 10.1074/jbc.M809669200; Leesong M, 1996, STRUCTURE, V4, P253, DOI 10.1016/S0969-2126(96)00030-5; Liew CW, 2010, J MOL BIOL, V404, P291, DOI 10.1016/j.jmb.2010.09.041; Lu XF, 2008, METAB ENG, V10, P333, DOI 10.1016/j.ymben.2008.08.006; Marfori M, 2011, J BIOL CHEM, V286, P35643, DOI 10.1074/jbc.M111.225953; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; McGuffin LJ, 2003, BIOINFORMATICS, V19, P874, DOI 10.1093/bioinformatics/btg097; Metz JG, 2009, PLANT PHYSIOL BIOCH, V47, P472, DOI 10.1016/j.plaphy.2009.02.002; Metz JG, 2001, SCIENCE, V293, P290, DOI 10.1126/science.1059593; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nawabi P, 2011, APPL ENVIRON MICROB, V77, P8052, DOI 10.1128/AEM.05046-11; Okuyama H, 2007, APPL ENVIRON MICROB, V73, P665, DOI 10.1128/AEM.02270-06; Shulse CN, 2011, ENVIRON MICROBIOL, V13, P684, DOI 10.1111/j.1462-2920.2010.02373.x; Song F, 2006, J BIOL CHEM, V281, P11028, DOI 10.1074/jbc.M513896200; Song F, 2012, BIOCHEMISTRY-US, V51, P7000, DOI 10.1021/bi301059m; Staunton J, 2001, NAT PROD REP, V18, P380, DOI 10.1039/a909079g; Steen EJ, 2010, NATURE, V463, P559, DOI 10.1038/nature08721; Thoden JB, 2003, J BIOL CHEM, V278, P43709, DOI 10.1074/jbc.M308198200; Thoden JB, 2002, J BIOL CHEM, V277, P27468, DOI 10.1074/jbc.M203904200; Zheng YN, 2012, BIOTECHNOL BIOFUELS, V5, DOI 10.1186/1754-6834-5-76; Zhuang ZH, 2002, BIOCHEMISTRY-US, V41, P11152, DOI 10.1021/bi0262303	33	14	15	1	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 12	2013	288	15					10841	10848		10.1074/jbc.M112.446765	http://dx.doi.org/10.1074/jbc.M112.446765			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	125TU	23430744	Green Published, hybrid			2022-12-25	WOS:000317565000061
J	Morla, L; Brideau, G; Fila, M; Crambert, G; Cheval, L; Houillier, P; Ramakrishnan, S; Imbert-Teboul, M; Doucet, A				Morla, Luciana; Brideau, Gaelle; Fila, Marc; Crambert, Gilles; Cheval, Lydie; Houillier, Pascal; Ramakrishnan, Sureshkrishna; Imbert-Teboul, Martine; Doucet, Alain			Renal Proteinase-activated Receptor 2, a New Actor in the Control of Blood Pressure and Plasma Potassium Level	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CORTICAL COLLECTING DUCT; ANGIOTENSIN-II; SODIUM-TRANSPORT; RAT; CHANNELS; CHLORIDE; VASOPRESSIN; KIDNEY; ENAC; HYPERTENSION	Proteinase-activated receptor 2 (PAR2) is a G protein-coupled membrane receptor that is activated upon cleavage of its extracellular N-terminal domain by trypsin and related proteases. PAR2 is expressed in kidney collecting ducts, a main site of control of Na+ and K+ homeostasis, but its function remains unknown. We evaluated whether and how PAR2 might control electrolyte transport in collecting ducts, and thereby participate in the regulation of blood pressure and plasma K+ concentration. PAR2 is expressed at the basolateral border of principal and intercalated cells of the collecting duct where it inhibits K+ secretion and stimulates Na+ reabsorption, respectively. Invalidation of PAR2 gene impairs the ability of the kidney to control Na+ and K+ balance and promotes hypotension and hypokalemia in response to Na+ and K+ depletion, respectively. This study not only reveals a new role of proteases in the control of blood pressure and plasma potassium level, but it also identifies a second membrane receptor, after angiotensin 2 receptor, that differentially controls sodium reabsorption and potassium secretion in the late distal tubule. Conversely to angiotensin 2 receptor, PAR2 is involved in the regulation of sodium and potassium balance in the context of either stimulation or non-stimulation of the renin/angiotensin/aldosterone system. Therefore PAR2 appears not only as a new actor of the aldosterone paradox, but also as an aldosterone-independent modulator of blood pressure and plasma potassium.	[Morla, Luciana; Brideau, Gaelle; Fila, Marc; Crambert, Gilles; Cheval, Lydie; Houillier, Pascal; Ramakrishnan, Sureshkrishna; Imbert-Teboul, Martine; Doucet, Alain] Univ Paris 05, Univ Paris 06, Ctr Rech Cordeliers, INSERM,UMRS872, F-75270 Paris 06, France; [Morla, Luciana; Brideau, Gaelle; Fila, Marc; Crambert, Gilles; Cheval, Lydie; Houillier, Pascal; Ramakrishnan, Sureshkrishna; Imbert-Teboul, Martine; Doucet, Alain] CNRS, ERL7226, F-75270 Paris 06, France; [Houillier, Pascal] Univ Paris 05, Fac Med, F-75006 Paris, France; [Houillier, Pascal] Hop Europeen Georges Pompidou, Assistance Publ Hop Paris, Dept Physiol, F-75004 Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Cite	Doucet, A (corresponding author), Ctr Rech Cordeliers, ERL7226, 15 Rue Ecole Med, F-75270 Paris 06, France.	alain.doucet@crc.jussieu.fr	Crambert, Gilles/ABF-2753-2020; Houillier, Pascal/AAD-4903-2019	Houillier, Pascal/0000-0003-4953-6917; Morla, Luciana/0000-0002-1527-4392; Crambert, Gilles/0000-0001-7065-9124; CHEVAL, LYDIE/0000-0003-2957-6487	Amgen [2005/29-N]; Societe de Nephrologie; Agence Nationale de la Recherche [ANR-06-PHYSIO-035-01]; Fondation Leducq	Amgen(Amgen); Societe de Nephrologie; Agence Nationale de la Recherche(French National Research Agency (ANR)); Fondation Leducq(Leducq Foundation)	This work was supported in part by grants from Amgen (2005/29-N), the Societe de Nephrologie, the Agence Nationale de la Recherche (ANR-06-PHYSIO-035-01), and the Fondation Leducq.	Babilonia E, 2006, J AM SOC NEPHROL, V17, P2687, DOI 10.1681/ASN.2006050426; Bohm SK, 1996, J BIOL CHEM, V271, P22003; BOURDEAU JE, 1982, AM J PHYSIOL, V242, pF285, DOI 10.1152/ajprenal.1982.242.3.F285; Bucci M, 2005, VASC PHARMACOL, V43, P247, DOI 10.1016/j.vph.2005.07.009; Castaneda-Bueno M, 2012, P NATL ACAD SCI USA, V109, P7929, DOI 10.1073/pnas.1200947109; CHAMPIGNEULLE A, 1993, AM J PHYSIOL, V265, pF35, DOI 10.1152/ajprenal.1993.265.1.F35; COSTANZO LS, 1978, AM J PHYSIOL, V235, pF492, DOI 10.1152/ajprenal.1978.235.5.F492; Cuffe JE, 2002, J PHYSIOL-LONDON, V539, P209, DOI 10.1113/jphysiol.2001.013159; Dechenes G, 2000, J AM SOC NEPHROL, V11, P604, DOI 10.1681/ASN.V114604; Favata MF, 1998, J BIOL CHEM, V273, P18623, DOI 10.1074/jbc.273.29.18623; Ferrell WR, 2003, J CLIN INVEST, V111, P35, DOI 10.1172/JCI200316913; Frindt G, 2010, AM J PHYSIOL-RENAL, V299, pF890, DOI 10.1152/ajprenal.00323.2010; GUYTON AC, 1991, SCIENCE, V252, P1813, DOI 10.1126/science.2063193; Jin WL, 1998, BIOCHEMISTRY-US, V37, P13291, DOI 10.1021/bi981178p; Kahle KT, 2008, ANNU REV PHYSIOL, V70, P329, DOI 10.1146/annurev.physiol.70.113006.100651; Leviel F, 2010, J CLIN INVEST, V120, P1627, DOI 10.1172/JCI40145; Lifton RP, 2001, CELL, V104, P545, DOI 10.1016/S0092-8674(01)00241-0; Mamenko M, 2012, J BIOL CHEM, V287, P660, DOI 10.1074/jbc.M111.298919; Michlig S, 2004, J BIOL CHEM, V279, P51002, DOI 10.1074/jbc.M405674200; Miller RL, 2005, AM J PHYSIOL-CELL PH, V288, pC1134, DOI 10.1152/ajpcell.00084.2004; MORGAN T, 1982, Australian Family Physician, V11, P264; Morla L, 2008, J BIOL CHEM, V283, P28020, DOI 10.1074/jbc.M804399200; Ossovskaya VS, 2004, PHYSIOL REV, V84, P579, DOI 10.1152/physrev.00028.2003; Pech V, 2007, AM J PHYSIOL-RENAL, V292, pF914, DOI 10.1152/ajprenal.00361.2006; Peti-Peterdi J, 2002, J AM SOC NEPHROL, V13, P1131, DOI 10.1097/01.ASN.0000013292.78621.FD; Rothmeier AS, 2012, SEMIN IMMUNOPATHOL, V34, P133, DOI 10.1007/s00281-011-0289-1; Schmidlin O, 2005, HYPERTENSION, V45, P867, DOI 10.1161/01.HYP.0000164628.46415.66; Sekiguchi F., 2007, Inflammopharmacology, V15, P246, DOI 10.1007/s10787-007-1591-3; Shi HK, 2002, J BIOL CHEM, V277, P13539, DOI 10.1074/jbc.M111717200; TOMITA K, 1986, J CLIN INVEST, V77, P136, DOI 10.1172/JCI112268; TOMITA K, 1985, J CLIN INVEST, V76, P132, DOI 10.1172/JCI111935; Verlander JW, 2011, AM J PHYSIOL-RENAL, V301, pF1314, DOI 10.1152/ajprenal.00114.2011; Wei YA, 2007, J BIOL CHEM, V282, P6455, DOI 10.1074/jbc.M607477200; WHITESCARVER SA, 1984, SCIENCE, V223, P1430, DOI 10.1126/science.6322303; Youn JH, 2009, ANNU REV PHYSIOL, V71, P381, DOI 10.1146/annurev.physiol.010908.163241; Yue P, 2011, KIDNEY INT, V79, P423, DOI 10.1038/ki.2010.380	36	16	16	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 5	2013	288	14					10124	10131		10.1074/jbc.M112.446393	http://dx.doi.org/10.1074/jbc.M112.446393			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	119RB	23430254	hybrid, Green Published			2022-12-25	WOS:000317114000053
J	Andreu-Fernandez, V; Genoves, A; Messeguer, A; Orzaez, M; Sancho, M; Perez-Paya, E				Andreu-Fernandez, Vicente; Genoves, Ainhoa; Messeguer, Angel; Orzaez, Mar; Sancho, Monica; Perez-Paya, Enrique			BH3-Mimetics- and Cisplatin-Induced Cell Death Proceeds through Different Pathways Depending on the Availability of Death-Related Cellular Components	PLOS ONE			English	Article							APAF-1 LEVELS; CYTOCHROME-C; APOPTOSIS; MODULATION; RESISTANCE; INHIBITORS; AUTOPHAGY; PROTEINS; CED-4; MCL-1	Background: Owing to their important function in regulating cell death, pharmacological inhibition of Bcl-2 proteins by dubbed BH3-mimetics is a promising strategy for apoptosis induction or sensitization to chemotherapy. However, the role of Apaf-1, the main protein constituent of the apoptosome, in the process has yet not been analyzed. Furthermore as new chemotherapeutics develop, the possible chemotherapy-induced toxicity to rapidly dividing normal cells, especially sensitive differentiated cells, has to be considered. Such undesirable effects would probably be ameliorated by selectively and locally inhibiting apoptosis in defined sensitive cells. Methodology and Principal Findings: Mouse embryonic fibroblasts (MEFS) from Apaf-1 knock out mouse (MEFS KO Apaf-1) and Bax/Bak double KO (MEFS KO Bax/Bak), MEFS from wild-type mouse (MEFS wt) and human cervix adenocarcinoma (HeLa) cells were used to comparatively investigate the signaling cell death-induced pathways of BH3-mimetics, like ABT737 and GX15-070, with DNA damage-inducing agent cisplatin (cis-diammineplatinum(II) dichloride, CDDP). The study was performed in the absence or presence of apoptosis inhibitors namely, caspase inhibitors or apoptosome inhibitors. BH3-mimetic ABT737 required of Apaf-1 to exert its apoptosis-inducing effect. In contrast, BH3-mimetic GX15-070 and DNA damage-inducing CDDP induced cell death in the absence of both Bax/Bak and Apaf-1. GX15-070 induced autophagy-based cell death in all the cell lines analyzed. MEFS wt cells were protected from the cytotoxic effects of ABT737 and CDDP by chemical inhibition of the apoptosome through QM31, but not by using general caspase inhibitors. Conclusions: BH3-mimetic ABT737 not only requires Bax/Bak to exert its apoptosis-inducing effect, but also Apaf-1, while GX15-070 and CDDP induce different modalities of cell death in the absence of Bax/Bak or Apaf-1. Inclusion of specific Apaf-1 inhibitors in topical and well-localized administrations, but not in systemic ones, to avoid interferences with chemotherapeutics would be of interest to prevent chemotherapeutic-induced unwanted cell death which could improve cancer patient care.	[Andreu-Fernandez, Vicente; Genoves, Ainhoa; Orzaez, Mar; Sancho, Monica; Perez-Paya, Enrique] Ctr Invest Principe Felipe, Lab Peptide & Prot Chem, Valencia, Spain; [Messeguer, Angel] Inst Quim Avanzada Cataluna CSIC, Dept Chem & Biomol Nanotechnol, Barcelona, Spain; [Perez-Paya, Enrique] IBV CSIC, Inst Biomed Valencia, Valencia, Spain	Prince Felipe Research Center; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigacion y Desarrollo Pascual Vila (CID-CSIC); CSIC - Instituto de Quimica Avanzada de Cataluna (IQAC); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Biomedicina de Valencia (IBV)	Perez-Paya, E (corresponding author), Ctr Invest Principe Felipe, Lab Peptide & Prot Chem, Valencia, Spain.	eperez@cipf.es	Medina, Mónica Sancho/L-4660-2014; Orzaez, Mar/B-4992-2014	Medina, Mónica Sancho/0000-0003-3707-062X; Orzaez, Mar/0000-0003-3231-5835; Messeguer, Angel/0000-0002-8358-9425; Andreu Fernandez, Vicente/0000-0001-7183-8706	Spanish Ministry of Science and Innovation (MICINN) [BIO2007-60066, SAF2010-15512, SAF2011-30542-C02-01, CSD2008-00005C]; Generalitat Valenciana Prometeo [2010/005]; ERDF	Spanish Ministry of Science and Innovation (MICINN)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Generalitat Valenciana Prometeo(Center for Forestry Research & Experimentation (CIEF)); ERDF(European Commission)	This work was supported by grants from the Spanish Ministry of Science and Innovation (MICINN - BIO2007-60066, SAF2010-15512, SAF2011-30542-C02-01 and CSD2008-00005C) and Generalitat Valenciana Prometeo 2010/005 (partially funded with ERDF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cecconi F, 1998, CELL, V94, P727, DOI 10.1016/S0092-8674(00)81732-8; Hardwick JM, 2009, CELL, V138, P404, DOI 10.1016/j.cell.2009.07.003; Heidari N, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.53; Hellwig CT, 2012, MOL CANCER THER, V11, P3, DOI 10.1158/1535-7163.MCT-11-0434; Jeong SY, 2008, BMB REP, V41, P11, DOI 10.1146/annurev-genet-102108-134850; Johnson CE, 2007, P NATL ACAD SCI USA, V104, P20820, DOI 10.1073/pnas.0709101105; Kroemer G, 2005, NAT MED, V11, P725, DOI 10.1038/nm1263; Kuma A, 2007, AUTOPHAGY, V3, P323, DOI 10.4161/auto.4012; Linton SD, 2005, CURR TOP MED CHEM, V5, P1697, DOI 10.2174/156802605775009720; Maiuri MC, 2010, EMBO J, V29, P515, DOI 10.1038/emboj.2009.377; McCoy F, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.86; Mondragon L, 2008, J MED CHEM, V51, P521, DOI 10.1021/jm701195j; Mondragon L, 2009, APOPTOSIS, V14, P182, DOI 10.1007/s10495-008-0310-x; Moure A, 2011, CHEM-EUR J, V17, P7927, DOI 10.1002/chem.201100216; Nguyen M, 2007, P NATL ACAD SCI USA, V104, P19512, DOI 10.1073/pnas.0709443104; Oltersdorf T, 2005, NATURE, V435, P677, DOI 10.1038/nature03579; Perez-Paya E, 2011, MED RES REV, V31, P649, DOI 10.1002/med.20198; Potts MB, 2005, J CELL BIOL, V171, P925, DOI 10.1083/jcb.200504082; Rudin CM, 2012, CLIN CANCER RES, V18, P3163, DOI 10.1158/1078-0432.CCR-11-3090; Shamas-Din A, 2011, BBA-MOL CELL RES, V1813, P508, DOI 10.1016/j.bbamcr.2010.11.024; Slattery EL, 2010, J NEUROSCI, V30, P3473, DOI 10.1523/JNEUROSCI.4316-09.2010; Soengas MS, 2006, CELL DEATH DIFFER, V13, P352, DOI 10.1038/sj.cdd.4401755; Soengas MS, 2001, NATURE, V409, P207, DOI 10.1038/35051606; Trueb RM, 2009, SEMIN CUTAN MED SURG, V28, P11, DOI 10.1016/j.sder.2008.12.001; van Delft MF, 2006, CANCER CELL, V10, P389, DOI 10.1016/j.ccr.2006.08.027; Vogler M, 2012, CELL DEATH DIFFER, V19, P67, DOI 10.1038/cdd.2011.158; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; Zhai D, 2006, CELL DEATH DIFFER, V13, P1419, DOI 10.1038/sj.cdd.4401937; Zou H, 1997, CELL, V90, P405, DOI 10.1016/S0092-8674(00)80501-2	29	14	14	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2013	8	2							e56881	10.1371/journal.pone.0056881	http://dx.doi.org/10.1371/journal.pone.0056881			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IT	23437261	Green Published, gold, Green Submitted			2022-12-25	WOS:000315186000054
J	Murphy, MK; Huey, DJ; Reimer, AJ; Hu, JC; Athanasiou, KA				Murphy, Meghan K.; Huey, Daniel J.; Reimer, Andrew J.; Hu, Jerry C.; Athanasiou, Kyriacos A.			Enhancing Post-Expansion Chondrogenic Potential of Costochondral Cells in Self-Assembled Neocartilage	PLOS ONE			English	Article							HUMAN ARTICULAR CHONDROCYTES; IN-VITRO; SEEDING DENSITY; CARTILAGINOUS TISSUE; ENGINEERED CARTILAGE; CONDYLAR CARTILAGE; SOX9 EXPRESSION; COLLAGEN; GROWTH; HYDROXYPROLINE	The insufficient healing capacity of articular cartilage necessitates mechanically functional biologic tissue replacements. Using cells to form biomimetic cartilage implants is met with the challenges of cell scarcity and donor site morbidity, requiring expanded cells that possess the ability to generate robust neocartilage. To address this, this study assesses the effects of expansion medium supplementation (bFGF, TFP, FBS) and self-assembled construct seeding density (2, 3, 4 million cells/5 mm dia. construct) on the ability of costochondral cells to generate biochemically and biomechanically robust neocartilage. Results show TFP (1 ng/mL TGF-beta 1, 5 ng/mL bFGF, 10 ng/mL PDGF) supplementation of serum-free chondrogenic expansion medium enhances the post-expansion chondrogenic potential of costochondral cells, evidenced by increased glycosaminoglycan content, decreased type I/II collagen ratio, and enhanced compressive properties. Low density (2 million cells/construct) enhances matrix synthesis and tensile and compressive mechanical properties. Combined, TFP and Low density interact to further enhance construct properties. That is, with TFP, Low density increases type II collagen content by over 100%, tensile stiffness by over 300%, and compressive moduli by over 140%, compared with High density. In conclusion, the interaction of TFP and Low density seeding enhances construct material properties, allowing for a mechanically functional, biomimetic cartilage to be formed using clinically relevant costochondral cells.	[Murphy, Meghan K.; Huey, Daniel J.; Reimer, Andrew J.; Hu, Jerry C.; Athanasiou, Kyriacos A.] Univ Calif Davis, Dept Biomed Engn, Davis, CA 95616 USA	University of California System; University of California Davis	Athanasiou, KA (corresponding author), Univ Calif Davis, Dept Biomed Engn, Davis, CA 95616 USA.	athanasiou@ucdavis.edu	Hu, Jerry/E-7385-2013	Hu, Jerry/0000-0003-0651-1461	National Science Foundation Graduate Research Fellowship [DGE-1148897]; National Institutes of Health [R01DE015038, R01DE019666]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE019666, R01DE015038] Funding Source: NIH RePORTER	National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This material is based upon work supported by the National Science Foundation Graduate Research Fellowship under Grant No. DGE-1148897 (http://www.nsf.gov). Additionally, the authors acknowledge funding support from R01DE015038 and R01DE019666 from the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen KD, 2006, J BIOMECH, V39, P312, DOI 10.1016/j.jbiomech.2004.11.012; Anderson DEJ, 2008, ANN BIOMED ENG, V36, P1992, DOI 10.1007/s10439-008-9572-2; Barbero A, 2004, OSTEOARTHR CARTILAGE, V12, P476, DOI 10.1016/j.joca.2004.02.010; Barbero A, 2003, ARTHRITIS RHEUM-US, V48, P1315, DOI 10.1002/art.10950; BENYA PD, 1982, CELL, V30, P215, DOI 10.1016/0092-8674(82)90027-7; Bernstein P, 2009, J BIOMED MATER RES A, V91A, P910, DOI 10.1002/jbm.a.32308; Buckwalter JA, 2002, CLIN ORTHOP RELAT R, P21, DOI 10.1097/01.blo.0000026073.30435.dc; Darling EM, 2005, J ORTHOP RES, V23, P425, DOI 10.1016/j.orthres.2004.08.008; DESHMUKH K, 1973, BIOCHEM J, V133, P615, DOI 10.1042/bj1330615; DOLWICK MF, 1994, BRIT J ORAL MAX SURG, V32, P307, DOI 10.1016/0266-4356(94)90052-3; EDWARDS CA, 1980, CLIN CHIM ACTA, V104, P161, DOI 10.1016/0009-8981(80)90192-8; Farrar W B, 1979, J Ala Dent Assoc, V63, P19; Foty RA, 2005, DEV BIOL, V278, P255, DOI 10.1016/j.ydbio.2004.11.012; Francis K, 1997, P NATL ACAD SCI USA, V94, P12258, DOI 10.1073/pnas.94.23.12258; Giannoni P, 2005, OSTEOARTHR CARTILAGE, V13, P589, DOI 10.1016/j.joca.2005.02.015; Hagandora CK, 2012, TISSUE ENG A; HENRY CH, 1993, J ORAL MAXIL SURG, V51, P352, DOI 10.1016/S0278-2391(10)80343-X; Hsieh-Bonassera ND, 2009, TISSUE ENG PT A, V15, P3513, DOI [10.1089/ten.tea.2008.0628, 10.1089/ten.TEA.2008.0628]; Hu JC, 2006, TISSUE ENG, V12, P969, DOI 10.1089/ten.2006.12.969; Huang AH, 2008, OSTEOARTHR CARTILAGE, V16, P1074, DOI 10.1016/j.joca.2008.02.005; Huey DJ, 2013, CELLS TISSU IN PRESS; Huey DJ, 2012, CELL TRANSPLANTATION; Jadin KD, 2005, J HISTOCHEM CYTOCHEM, V53, P1109, DOI 10.1369/jhc.4A6511.2005; Jakob M, 2001, J CELL BIOCHEM, V81, P368, DOI 10.1002/1097-4644(20010501)81:2<368::AID-JCB1051>3.0.CO;2-J; Kobayashi S, 2008, J ORTHOP RES, V26, P493, DOI 10.1002/jor.20507; Kumar D, 2009, MOL CELL BIOL, V29, P4262, DOI 10.1128/MCB.01779-08; Lu XL, 2009, J DENT RES, V88, P244, DOI 10.1177/0022034508330432; MACINTOSH RB, 1977, J MAXILLOFAC SURG, V5, P257, DOI 10.1016/S0301-0503(77)80120-3; Martin I, 1999, EXP CELL RES, V253, P681, DOI 10.1006/excr.1999.4708; Martin I, 2001, J CELL BIOCHEM, V83, P121, DOI 10.1002/jcb.1203; Mauck RL, 2003, OSTEOARTHR CARTILAGE, V11, P879, DOI 10.1016/j.joca.2003.08.006; Mauck RL, 2002, ANN BIOMED ENG, V30, P1046, DOI 10.1114/1.1512676; NIMNI ME, 1983, SEMIN ARTHRITIS RHEU, V13, P1, DOI 10.1016/0049-0172(83)90024-0; OBEID G, 1988, J ORAL MAXIL SURG, V46, P177, DOI 10.1016/0278-2391(88)90079-1; PAL S, 1981, COLLAGEN REL RES, V1, P151; POSWILLO D, 1974, International Journal of Oral Surgery, V3, P400, DOI 10.1016/S0300-9785(74)80005-0; PUELACHER WC, 1994, INT J ORAL MAX SURG, V23, P49, DOI 10.1016/S0901-5027(05)80328-5; Reddy GK, 1996, CLIN BIOCHEM, V29, P225, DOI 10.1016/0009-9120(96)00003-6; Revell CM, 2008, ANN BIOMED ENG, V36, P1441, DOI 10.1007/s10439-008-9524-x; STEGEMAN.H, 1967, CLIN CHIM ACTA, V18, P267, DOI 10.1016/0009-8981(67)90167-2; Stewart MC, 2000, J BONE MINER RES, V15, P166, DOI 10.1359/jbmr.2000.15.1.166; Tallheden T, 2005, ARTHRITIS RES THER, V7, pR560, DOI 10.1186/ar1709; Talukdar S, 2011, BIOMATERIALS, V32, P8927, DOI 10.1016/j.biomaterials.2011.08.027; Tay AG, 2004, TISSUE ENG, V10, P762, DOI 10.1089/1076327041348572; Teramoto M, 2003, J BONE MINER METAB, V21, P276, DOI 10.1007/s00774-003-0421-y; VONDERMARK K, 1977, NATURE, V267, P531, DOI 10.1038/267531a0; Weinand C, 2006, ARCH ORTHOP TRAUM SU, V126, P599, DOI 10.1007/s00402-005-0100-7; Williams GM, 2005, ACTA BIOMATER, V1, P625, DOI 10.1016/j.actbio.2005.07.009; Williamson AK, 2003, TISSUE ENG, V9, P625, DOI 10.1089/107632703768247322; Wolford Larry M, 2006, Proc (Bayl Univ Med Cent), V19, P232; Woods A, 2005, J BIOL CHEM, V280, P11626, DOI 10.1074/jbc.M409158200; Yan D, 2009, BIOMATERIALS, V30, P814, DOI 10.1016/j.biomaterials.2008.10.042	52	18	19	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2013	8	2							e56983	10.1371/journal.pone.0056983	http://dx.doi.org/10.1371/journal.pone.0056983			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IT	23437288	Green Published, gold			2022-12-25	WOS:000315186000064
J	Lo, WC; Lee, ME; Narayan, M; Chou, CS; Park, HO				Lo, Wing-Cheong; Lee, Mid Eum; Narayan, Monisha; Chou, Ching-Shan; Park, Hay-Oak			Polarization of Diploid Daughter Cells Directed by Spatial Cues and GTP Hydrolysis of Cdc42 in Budding Yeast	PLOS ONE			English	Article							BUD-SITE-SELECTION; SACCHAROMYCES-CEREVISIAE; ACTIVATING PROTEIN; SYMMETRY-BREAKING; POLARITY; GENE; GROWTH; MORPHOGENESIS; ESTABLISHMENT; PATTERN	Cell polarization occurs along a single axis that is generally determined by a spatial cue. Cells of the budding yeast exhibit a characteristic pattern of budding, which depends on cell-type-specific cortical markers, reflecting a genetic programming for the site of cell polarization. The Cdc42 GTPase plays a key role in cell polarization in various cell types. Although previous studies in budding yeast suggested positive feedback loops whereby Cdc42 becomes polarized, these mechanisms do not include spatial cues, neglecting the normal patterns of budding. Here we combine live-cell imaging and mathematical modeling to understand how diploid daughter cells establish polarity preferentially at the pole distal to the previous division site. Live-cell imaging shows that daughter cells of diploids exhibit dynamic polarization of Cdc42-GTP, which localizes to the bud tip until the M phase, to the division site at cytokinesis, and then to the distal pole in the next G1 phase. The strong bias toward distal budding of daughter cells requires the distal-pole tag Bud8 and Rga1, a GTPase activating protein for Cdc42, which inhibits budding at the cytokinesis site. Unexpectedly, we also find that over 50% of daughter cells lacking Rga1 exhibit persistent Cdc42-GTP polarization at the bud tip and the distal pole, revealing an additional role of Rga1 in spatiotemporal regulation of Cdc42 and thus in the pattern of polarized growth. Mathematical modeling indeed reveals robust Cdc42-GTP clustering at the distal pole in diploid daughter cells despite random perturbation of the landmark cues. Moreover, modeling predicts different dynamics of Cdc42-GTP polarization when the landmark level and the initial level of Cdc42-GTP at the division site are perturbed by noise added in the model.	[Lo, Wing-Cheong; Chou, Ching-Shan] Ohio State Univ, Math Biosci Inst, Columbus, OH 43210 USA; [Lee, Mid Eum; Park, Hay-Oak] Ohio State Univ, Mol Cellular Dev Biol Program, Columbus, OH 43210 USA; [Narayan, Monisha; Chou, Ching-Shan] Ohio State Univ, Dept Math, Columbus, OH 43210 USA; [Park, Hay-Oak] Ohio State Univ, Dept Mol Genet, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Park, HO (corresponding author), Ohio State Univ, Mol Cellular Dev Biol Program, Columbus, OH 43210 USA.	park.294@osu.edu		LO, Wing Cheong/0000-0001-7771-5213; Park, Hay-Oak/0000-0001-5782-2257	Mathematical Biosciences Institute and National Science Foundation (NSF) grant [DMS 0931642]; NSF grant [DMS-1020625]; National Institutes of Health/National Institute of General Medical Sciences grant [GM076375]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM076375] Funding Source: NIH RePORTER	Mathematical Biosciences Institute and National Science Foundation (NSF) grant; NSF grant(National Science Foundation (NSF)); National Institutes of Health/National Institute of General Medical Sciences grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work has been supported by the Mathematical Biosciences Institute and National Science Foundation (NSF) grant DMS 0931642 (to WCL and CSC), NSF grant DMS-1020625 (to CSC), and National Institutes of Health/National Institute of General Medical Sciences grant GM076375 (to HOP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschuler SJ, 2008, NATURE, V454, P886, DOI 10.1038/nature07119; Arkowitz RA, 2011, SEMIN CELL DEV BIOL, V22, P806, DOI 10.1016/j.semcdb.2011.08.010; Ausubel F., 1999, CURRENT PROTOCOLS MO; BACON JSD, 1966, BIOCHEM J, V101, pC36, DOI 10.1042/bj1010036C; BENDER A, 1993, P NATL ACAD SCI USA, V90, P9926, DOI 10.1073/pnas.90.21.9926; BENDER A, 1989, P NATL ACAD SCI USA, V86, P9976, DOI 10.1073/pnas.86.24.9976; Bi EF, 1996, MOL CELL BIOL, V16, P5264; Caviston JP, 2003, MOL BIOL CELL, V14, P4051, DOI 10.1091/mbc.E03-04-0247; CHANT J, 1995, J CELL BIOL, V129, P751, DOI 10.1083/jcb.129.3.751; CHANT J, 1991, CELL, V65, P1213, DOI 10.1016/0092-8674(91)90016-R; CHANT J, 1991, CELL, V65, P1203, DOI 10.1016/0092-8674(91)90015-Q; Chen GC, 1996, MOL CELL BIOL, V16, P1376; Chen T, 2000, SCIENCE, V290, P1975, DOI 10.1126/science.290.5498.1975; Cullen PJ, 2002, MOL BIOL CELL, V13, P2990, DOI 10.1091/mbc.E02-03-0151; Etienne-Manneville S, 2004, J CELL SCI, V117, P1291, DOI 10.1242/jcs.01115; FREIFELDER D, 1960, J BACTERIOL, V80, P567, DOI 10.1128/JB.80.4.567-568.1960; Frydlova I, 2009, EUKARYOT CELL, V8, P586, DOI 10.1128/EC.00376-08; Fujita A, 2004, GENE, V327, P161, DOI 10.1016/j.gene.2003.11.021; Goryachev AB, 2008, FEBS LETT, V582, P1437, DOI 10.1016/j.febslet.2008.03.029; Guthrie C, 1991, GUIDE YEAST GENETICS; Harkins HA, 2001, MOL BIOL CELL, V12, P2497, DOI 10.1091/mbc.12.8.2497; HICKS JB, 1977, GENETICS, V85, P395; Howell AS, 2012, CELL, V149, P322, DOI 10.1016/j.cell.2012.03.012; Howell AS, 2012, GENETICS, V190, P51, DOI 10.1534/genetics.111.128314; Irazoqui JE, 2003, NAT CELL BIOL, V5, P1062, DOI 10.1038/ncb1068; Johnson JM, 2011, CURR OPIN GENET DEV, V21, P740, DOI 10.1016/j.gde.2011.09.007; Kang PJ, 2004, MOL BIOL CELL, V15, P5145, DOI 10.1091/mbc.E04-07-0600; Knaus M, 2007, EMBO J, V26, P4501, DOI 10.1038/sj.emboj.7601873; Kozminski KG, 2003, MOL BIOL CELL, V14, P4958, DOI 10.1091/mbc.E03-06-0426; Kozubowski L, 2008, CURR BIOL, V18, P1719, DOI 10.1016/j.cub.2008.09.060; Layton AT, 2011, CURR BIOL, V21, P184, DOI 10.1016/j.cub.2011.01.012; Marco E, 2007, CELL, V129, P411, DOI 10.1016/j.cell.2007.02.043; Marquitz AR, 2002, EMBO J, V21, P4012, DOI 10.1093/emboj/cdf416; Ni L, 2001, MOL BIOL CELL, V12, P2147, DOI 10.1091/mbc.12.7.2147; Ozbudak EM, 2005, DEV CELL, V9, P565, DOI 10.1016/j.devcel.2005.08.014; Park HO, 2007, MICROBIOL MOL BIOL R, V71, P48, DOI 10.1128/MMBR.00028-06; PARK HO, 1993, NATURE, V365, P269, DOI 10.1038/365269a0; POWERS S, 1991, CELL, V65, P1225, DOI 10.1016/0092-8674(91)90017-S; Richman TJ, 2002, EUKARYOT CELL, V1, P458, DOI 10.1128/EC.1.3.458-468.2002; Schenkman LR, 2002, J CELL BIOL, V156, P829, DOI 10.1083/jcb.200107041; Sheu YJ, 2000, MOL CELL BIOL, V20, P5235, DOI 10.1128/MCB.20.14.5235-5247.2000; Slaughter BD, 2009, DEV CELL, V17, P823, DOI 10.1016/j.devcel.2009.10.022; Smith GR, 2002, EUKARYOT CELL, V1, P469, DOI 10.1128/EC.1.3.469-480.2002; Sopko R, 2007, EMBO J, V26, P4487, DOI 10.1038/sj.emboj.7601847; STEVENSON BJ, 1995, GENE DEV, V9, P2949, DOI 10.1101/gad.9.23.2949; Taheri N, 2000, EMBO J, V19, P6686, DOI 10.1093/emboj/19.24.6686; Tong ZT, 2007, J CELL BIOL, V179, P1375, DOI 10.1083/jcb.200705160; Watanabe M, 2009, CURR GENET, V55, P365, DOI 10.1007/s00294-009-0251-0; Wedlich-Soldner R, 2003, SCIENCE, V299, P1231, DOI 10.1126/science.1080944; Wedlich-Soldner R, 2004, J CELL BIOL, V166, P889, DOI 10.1083/jcb.200405061; Yang S, 1997, J CELL BIOL, V136, P111, DOI 10.1083/jcb.136.1.111; Zahner JE, 1996, MOL CELL BIOL, V16, P1857; ZHENG Y, 1994, J BIOL CHEM, V269, P2369; ZHENG Y, 1993, J BIOL CHEM, V268, P24629	54	20	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e56665	10.1371/journal.pone.0056665	http://dx.doi.org/10.1371/journal.pone.0056665			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437206	gold, Green Published, Green Submitted			2022-12-25	WOS:000315184200136
J	Prior, T; Wild, M; Mullins, E; Bennett, P; Kumar, S				Prior, Tomas; Wild, Marianne; Mullins, Edward; Bennett, Phillip; Kumar, Sailesh			Sex Specific Differences in Fetal Middle Cerebral Artery and Umbilical Venous Doppler	PLOS ONE			English	Article							BLOOD-FLOW VELOCITY; PLACENTAL DYSFUNCTION; HUMAN-FETUS; WAVE-FORMS; GROWTH; RATIO; REDISTRIBUTION; AGE	Background: The incidence of several adverse pregnancy outcomes including fetal growth restriction are higher in pregnancies where the fetus is male, leading to suggestions that placental insufficiency is more common in these fetuses. Placental insufficiency associated with fetal growth restriction may be identified by multi-vessel Doppler assessment, but little evidence exists regarding sex specific differences in these Doppler indices or placental function. This study aims to investigate sex specific differences in fetal and placental perfusion and to correlate these changes with intra-partum outcome. Methods and Findings: This is a prospective cohort study. We measured Doppler indices of 388 term pregnancies immediately prior to the onset of active labour (<= 3 cm dilatation). Fetal sex was unknown at the time of the ultrasound assessment. Information from the ultrasound scan was not made available to clinical staff. Case notes and electronic records were reviewed following delivery. We report significantly lower Middle Cerebral artery pulsatility index (1.34 vs. 1.43, p = 0.004), Middle Cerebral artery peak velocity (53.47 cm/s vs. 58.10 cm/s, p = <0.001), and Umbilical venous flow/kg (56 ml/min/kg vs. 61 ml/min/kg, p = 0.02) in male fetuses. These differences however, were not associated with significant differences in intra-partum outcome. Conclusion: Sex specific differences in feto-placental perfusion indices exist. Whilst the physiological relevance of these is currently unknown, the identification of these differences adds to our knowledge of the physiology of male and female fetuses in utero. A number of disease processes have now been shown to have an association with changes in fetal haemodynamics in-utero, as well as having a sex bias, making further investigation of the sex specific differences present during fetal life important. Whilst the clinical application of these findings is currently limited, the results from this study do provide further insight into the gender specific circulatory differences present in the fetal period.	[Prior, Tomas; Wild, Marianne; Mullins, Edward; Bennett, Phillip; Kumar, Sailesh] Queen Charlottes & Chelsea Hosp, Ctr Fetal Care, London W6 0XG, England; [Prior, Tomas; Mullins, Edward; Bennett, Phillip; Kumar, Sailesh] Univ London Imperial Coll Sci Technol & Med, Inst Reprod & Dev Biol, London, England	Imperial College London; Imperial College London	Kumar, S (corresponding author), Queen Charlottes & Chelsea Hosp, Ctr Fetal Care, London W6 0XG, England.	Sailesh.Kumar@imperial.ac.uk	Kumar, Sailesh/M-3207-2014; Wild, Marianne Alexia/AFS-1683-2022	Kumar, Sailesh/0000-0003-0832-4811; Wild, Marianne Alexia/0000-0002-8440-2087; Bennett, Phillip/0000-0002-6253-4919; Mullins, Edward/0000-0003-1886-6358	Moonbeam Trust, a small charity funding research in Fetal Medicine	Moonbeam Trust, a small charity funding research in Fetal Medicine	This research was funded by the Moonbeam Trust, a small charity funding research in Fetal Medicine (http://www.moonbeamtrust.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbera A, 1999, AM J OBSTET GYNECOL, V181, P174, DOI 10.1016/S0002-9378(99)70456-4; Baron-Cohen S, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001081; Bekedam DJ, 2002, AM J OBSTET GYNECOL, V187, P1605, DOI 10.1067/mob.2002.127379; Benders MJNL, 2013, NEONATOLOGY, V103, P21, DOI 10.1159/000342336; BERKOWITZ GS, 1988, AM J OBSTET GYNECOL, V158, P1149, DOI 10.1016/0002-9378(88)90243-8; BYRNE J, 1987, AM J MED GENET, V26, P605, DOI 10.1002/ajmg.1320260315; Clifton VL, 2010, PLACENTA, V31, pS33, DOI 10.1016/j.placenta.2009.11.010; Edwards A, 2000, LANCET, V355, P203, DOI 10.1016/S0140-6736(99)05061-8; Eixarch E, 2008, ULTRASOUND OBST GYN, V32, P894, DOI 10.1002/uog.6249; GRAMELLINI D, 1992, OBSTET GYNECOL, V79, P416, DOI 10.1097/00006250-199203000-00018; JAKOBOVITS AA, 1991, EUR J OBSTET GYN R B, V40, P211, DOI 10.1016/0028-2243(91)90119-6; JAMES WH, 1995, HUM REPROD, V10, P1403, DOI 10.1093/HUMREP/10.6.1403; Lieberman E, 1997, AM J OBSTET GYNECOL, V176, P667, DOI 10.1016/S0002-9378(97)70567-2; Liu YN, 2012, MAGN RESON MED, V68, P912, DOI 10.1002/mrm.23286; Munne S, 1993, ZYGOTE, V1, P155, DOI 10.1017/S0967199400001416; Murji A, 2012, AM J MED GENET A, V158A, P779, DOI 10.1002/ajmg.a.35250; Murphy VE, 2003, AM J RESP CRIT CARE, V168, P1317, DOI 10.1164/rccm.200303-374OC; Piazze J, 2005, INT J GYNECOL OBSTET, V91, P233, DOI 10.1016/j.ijgo.2005.08.015; Rigano S, 2001, AM J OBSTET GYNECOL, V185, P834, DOI 10.1067/mob.2001.117356; Roza SJ, 2008, AM J EPIDEMIOL, V168, P1145, DOI 10.1093/aje/kwn233; Vatten LJ, 2004, EARLY HUM DEV, V76, P47, DOI 10.1016/j.earlhumdev.2003.10.006; VYAS S, 1990, BRIT J OBSTET GYNAEC, V97, P797, DOI 10.1111/j.1471-0528.1990.tb02573.x; Whitehouse AJO, 2012, J CHILD PSYCHOL PSYC, V53, P726, DOI 10.1111/j.1469-7610.2011.02523.x; WLADIMIROFF JW, 1987, OBSTET GYNECOL, V69, P705; WLADIMIROFF JW, 1986, BRIT J OBSTET GYNAEC, V93, P471, DOI 10.1111/j.1471-0528.1986.tb08656.x	25	23	23	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e56933	10.1371/journal.pone.0056933	http://dx.doi.org/10.1371/journal.pone.0056933			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437275	gold, Green Published, Green Submitted			2022-12-25	WOS:000315184200187
J	Landey, RB; Cenci, A; Georget, F; Bertrand, B; Camayo, G; Dechamp, E; Herrera, JC; Santoni, S; Lashermes, P; Simpson, J; Etienne, H				Landey, Roberto Bobadilla; Cenci, Alberto; Georget, Frederic; Bertrand, Benoit; Camayo, Gloria; Dechamp, Eveline; Carlos Herrera, Juan; Santoni, Sylvain; Lashermes, Philippe; Simpson, June; Etienne, Herve			High Genetic and Epigenetic Stability in Coffea arabica Plants Derived from Embryogenic Suspensions and Secondary Embryogenesis as Revealed by AFLP, MSAP and the Phenotypic Variation Rate	PLOS ONE			English	Article							CULTURE-INDUCED VARIATION; NUCLEAR-DNA CONTENT; TISSUE-CULTURE; SOMACLONAL VARIATION; SOMATIC EMBRYOGENESIS; CALLUS INDUCTION; CHROMOSOMAL VARIATIONS; TRANSPOSABLE ELEMENTS; METHYLATION PATTERNS; CELL-CULTURES	Embryogenic suspensions that involve extensive cell division are risky in respect to genome and epigenome instability. Elevated frequencies of somaclonal variation in embryogenic suspension-derived plants were reported in many species, including coffee. This problem could be overcome by using culture conditions that allow moderate cell proliferation. In view of true-to-type large-scale propagation of C. arabica hybrids, suspension protocols based on low 2,4-D concentrations and short proliferation periods were developed. As mechanisms leading to somaclonal variation are often complex, the phenotypic, genetic and epigenetic changes were jointly assessed so as to accurately evaluate the conformity of suspension-derived plants. The effects of embryogenic suspensions and secondary embryogenesis, used as proliferation systems, on the genetic conformity of somatic embryogenesis-derived plants (emblings) were assessed in two hybrids. When applied over a 6 month period, both systems ensured very low somaclonal variation rates, as observed through massive phenotypic observations in field plots (0.74% from 200 000 plant). Molecular AFLP and MSAP analyses performed on 145 three year-old emblings showed that polymorphism between mother plants and emblings was extremely low, i.e. ranges of 0-0.003% and 0.07-0.18% respectively, with no significant difference between the proliferation systems for the two hybrids. No embling was found to cumulate more than three methylation polymorphisms. No relation was established between the variant phenotype (27 variants studied) and a particular MSAP pattern. Chromosome counting showed that 7 of the 11 variant emblings analyzed were characterized by the loss of 1-3 chromosomes. This work showed that both embryogenic suspensions and secondary embryogenesis are reliable for true-to-type propagation of elite material. Molecular analyses revealed that genetic and epigenetic alterations are particularly limited during coffee somatic embryogenesis. The main change in most of the rare phenotypic variants was aneuploidy, indicating that mitotic aberrations play a major role in somaclonal variation in coffee.	[Landey, Roberto Bobadilla; Georget, Frederic; Bertrand, Benoit; Dechamp, Eveline; Etienne, Herve] Ctr Cooperat Int Rech Agron Dev, Unite Mixte Rech Resistance Plantes Bioagresseurs, Montpellier, France; [Cenci, Alberto; Lashermes, Philippe] Inst Rech Dev, Unite Mixte Rech Resistance Plantes Bioagresseurs, Montpellier, France; [Camayo, Gloria; Carlos Herrera, Juan] Ctr Nacl Invest Cafe, Manizales, Colombia; [Santoni, Sylvain] INRA, Unite Mixte Rech Ameliorat Genet & Adaptat Plante, Montpellier, France; [Simpson, June] Inst Politecn Nacl, Ctr Invest & Estudios Avanzados, Dept Plant Genet Engn, Guanajuato, Mexico	CIRAD; Institut de Recherche pour le Developpement (IRD); INRAE; CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional; Instituto Politecnico Nacional - Mexico	Etienne, H (corresponding author), Ctr Cooperat Int Rech Agron Dev, Unite Mixte Rech Resistance Plantes Bioagresseurs, Montpellier, France.	herve.etienne@cirad.fr	Simpson, June/I-1057-2012; Cenci, Alberto/H-2823-2019; Lashermes, Philippe/J-5295-2016	Simpson, June/0000-0002-1891-4914; Cenci, Alberto/0000-0002-4390-5948; Etienne, Herve/0000-0002-6208-9982; Bobadilla Landey, Roberto/0000-0002-6372-5354	Mexican Government through Consejo Nacional de Ciencia y Tecnologia (CONACyT) program [CVU:1623391]; PCP France-Mexico; CIRAD funds	Mexican Government through Consejo Nacional de Ciencia y Tecnologia (CONACyT) program; PCP France-Mexico; CIRAD funds	Financial support for this study was provided by the Mexican Government through a grant to Roberto Bobadilla Landey by the Consejo Nacional de Ciencia y Tecnologia (CONACyT) (CVU:1623391) program (http://www.conacyt.mx/), by another grant from the PCP France-Mexico (http://www.pcp-mexique.com/) and by the CIRAD funds for doctoral support (http://www.cirad.fr/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akula A, 2000, PLANT CELL REP, V19, P1140, DOI 10.1007/s002990000239; Al-Zahim MA, 1999, PLANT CELL REP, V18, P473, DOI 10.1007/s002990050606; Anthony F, 2001, EUPHYTICA, V118, P53, DOI 10.1023/A:1004013815166; Bairu MW, 2011, PLANT GROWTH REGUL, V63, P147, DOI 10.1007/s10725-010-9554-x; Baranek M, 2010, PLANT CELL TISS ORG, V101, P11, DOI 10.1007/s11240-009-9656-1; Bednarek PT, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-10; Bertrand B, 2011, EUPHYTICA, V181, P147, DOI 10.1007/s10681-011-0372-7; Birchler JA, 2007, PLANT CELL, V19, P395, DOI 10.1105/tpc.106.049338; Bukowska B, 2006, POL J ENVIRON STUD, V15, P365; Cenci A, 2012, PLANT MOL BIOL, V78, P135, DOI 10.1007/s11103-011-9852-3; de la Puente R, 2008, IN VITRO CELL DEV-PL, V44, P419, DOI 10.1007/s11627-008-9152-z; Dellaporta SL, 1983, PLANT MOL BIOL REP, V1, P19, DOI DOI 10.1007/BF02712670; Diaz-Martinez M, 2012, PLANT SCI, V185, P321, DOI 10.1016/j.plantsci.2012.01.004; Ducos JP, 2003, EUPHYTICA, V131, P215, DOI 10.1023/A:1023915613158; Duncan RR, 1997, ADV AGRON, V58, P201; Etienne H., 2005, V77, P167; Etienne H, 2003, TREE PHYSIOL, V23, P419, DOI 10.1093/treephys/23.6.419; Etienne H, 2001, TREE PHYSIOL, V21, P1031, DOI 10.1093/treephys/21.14.1031; Etienne Hervé, 2006, Braz. J. Plant Physiol., V18, P45, DOI 10.1590/S1677-04202006000100005; Etienne H, 2012, CAH AGRIC, V21, P115, DOI 10.1684/agr.2012.0553; Feschotte C, 2002, NAT REV GENET, V3, P329, DOI 10.1038/nrg793; Fiuk A, 2010, PLANT MOL BIOL REP, V28, P413, DOI 10.1007/s11105-009-0167-3; FUKUOKA H, 1994, PLANT MOL BIOL, V26, P899, DOI 10.1007/BF00028857; Gao XA, 2010, J PLANT GROWTH REGUL, V29, P257, DOI 10.1007/s00344-009-9133-4; Gillis K, 2007, PLANT CELL TISS ORG, V91, P115, DOI 10.1007/s11240-007-9236-1; GOZUKIRMIZI N, 1990, ACTA BOT NEERL, V39, P379; Guo WL, 2007, PLANT CELL REP, V26, P1297, DOI 10.1007/s00299-007-0320-0; Hao YJ, 2002, IN VITRO CELL DEV-PL, V38, P472, DOI [10.1079/IVP2002317, 10.1079/IVP200231]; HEINZE B, 1995, EUPHYTICA, V85, P341, DOI 10.1007/BF00023965; Henry IM, 2010, GENETICS, V186, P1231, DOI 10.1534/genetics.110.121079; Herrera JC, 2007, GENOME, V50, P619, DOI 10.1139/G07-034; Hornero J, 2001, INT J PLANT SCI, V162, P827, DOI 10.1086/320784; Hua YW, 2010, PLANT BREEDING, V129, P202, DOI 10.1111/j.1439-0523.2009.01663.x; JAHNE A, 1991, THEOR APPL GENET, V82, P74, DOI 10.1007/BF00231280; Jaligot E, 2004, GENOME, V47, P224, DOI 10.1139/G03-085; Jin SX, 2008, PLANT CELL REP, V27, P1303, DOI 10.1007/s00299-008-0557-2; KAEPPLER SM, 1993, IN VITRO CELL DEV-PL, V29P, P125, DOI 10.1007/BF02632283; Kaeppler SM, 2000, PLANT MOL BIOL, V43, P179, DOI 10.1023/A:1006423110134; Karp A., 1991, OXFORD SURVEYS PLANT, V7, P1; Karp A, 1994, PLANT CELL TISSUE CU, P139; KRUG CA, 1951, ADV GENET, V4, P127, DOI 10.1016/S0065-2660(08)60233-3; Lambe P, 1997, IN VITRO CELL DEV-PL, V33, P155, DOI 10.1007/s11627-997-0015-9; LARKIN PJ, 1987, IOWA STATE J RES, V61, P393; LARKIN PJ, 1981, THEOR APPL GENET, V60, P197, DOI 10.1007/BF02342540; Law JA, 2010, NAT REV GENET, V11, P204, DOI 10.1038/nrg2719; Leal F, 2006, PLANT CELL REP, V25, P978, DOI 10.1007/s00299-006-0162-1; Li XL, 2007, PLANT CELL TISS ORG, V90, P153, DOI 10.1007/s11240-007-9224-5; LOSCHIAVO F, 1989, THEOR APPL GENET, V77, P325, DOI 10.1007/BF00305823; Lu SY, 2006, PLANT CELL TISS ORG, V87, P77, DOI 10.1007/s11240-006-9138-7; Makarevitch I, 2010, PLANT PHYSIOL, V152, P927, DOI 10.1104/pp.109.150466; Mallon R, 2012, TREES-STRUCT FUNCT, V26, P731, DOI 10.1007/s00468-011-0639-6; Mckenzie N, 2002, THEOR APPL GENET, V105, P23, DOI 10.1007/s00122-002-0882-8; Menendez Yuffa A, 2000, ELECTRON J BIOTECHN, V3, P0; Miguel C, 2011, J EXP BOT, V62, P3713, DOI 10.1093/jxb/err155; Mujib A, 2007, PROPAG ORNAM PLANTS, V7, P169; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Neelakandan AK, 2012, PLANT CELL REP, V31, P597, DOI 10.1007/s00299-011-1202-z; Peraza-Echeverria S, 2001, PLANT SCI, V161, P359, DOI 10.1016/S0168-9452(01)00421-6; PESCHKE VM, 1992, ADV GENET, V30, P41, DOI 10.1016/S0065-2660(08)60318-1; PESCHKE VM, 1987, SCIENCE, V238, P804, DOI 10.1126/science.238.4828.804; Rani V, 2000, PLANT CELL REP, V19, P1013, DOI 10.1007/s002990000228; Rani V, 2000, IN VITRO CELL DEV-PL, V36, P319, DOI 10.1007/s11627-000-0059-6; ReynaLopez GE, 1997, MOL GEN GENET, V253, P703, DOI 10.1007/s004380050374; Ribas AF, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-92; Rival A, 1997, PLANT CELL REP, V16, P884, DOI 10.1007/s002990050339; Sahijram L, 2003, IN VITRO CELL DEV-PL, V39, P551, DOI 10.1079/IVP2003467; Sanchez-Teyer LF, 2003, MOL BIOTECHNOL, V23, P107, DOI 10.1385/MB:23:2:107; Saze H, 2008, SEMIN CELL DEV BIOL, V19, P527, DOI 10.1016/j.semcdb.2008.07.017; Schellenbaum P, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-78; Slotkin RK, 2007, NAT REV GENET, V8, P272, DOI 10.1038/nrg2072; Smulders MJM, 2011, PLANT GROWTH REGUL, V63, P137, DOI 10.1007/s10725-010-9531-4; Sondahl M. R., 1992, V8, P401; Teisson C, 1995, CURR PLANT SCI BIOT, V22, P105; Vanyushin BF, 2011, BBA-GENE REGUL MECH, V1809, P360, DOI 10.1016/j.bbagrm.2011.04.006; Von Aderkas P, 2000, TREE PHYSIOL, V20, P921; VOS P, 1995, NUCLEIC ACIDS RES, V23, P4407, DOI 10.1093/nar/23.21.4407; YASUDA T, 1985, PLANT CELL PHYSIOL, V26, P595, DOI 10.1093/oxfordjournals.pcp.a076946; Yu X, 2011, ANN APPL BIOL, V158, P237, DOI 10.1111/j.1744-7348.2011.00458.x; Zhang MS, 2010, J GENET GENOMICS, V37, P1, DOI 10.1016/S1673-8527(09)60020-5; Zoriniants SE, 2003, PLANT SCI, V164, P141, DOI 10.1016/S0168-9452(02)00322-9	80	47	49	2	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e56372	10.1371/journal.pone.0056372	http://dx.doi.org/10.1371/journal.pone.0056372			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418563	Green Published, Green Submitted, gold			2022-12-25	WOS:000315970300156
J	Ma, Z; Yang, HX; Liu, HH; Xu, MF; Runyan, RB; Eisenberg, CA; Markwald, RR; Borg, TK; Gao, BZ				Ma, Zhen; Yang, Huaxiao; Liu, Honghai; Xu, Meifeng; Runyan, Raymond B.; Eisenberg, Carol A.; Markwald, Roger R.; Borg, Thomas K.; Gao, Bruce Z.			Mesenchymal Stem Cell-Cardiomyocyte Interactions under Defined Contact Modes on Laser-Patterned Biochips	PLOS ONE			English	Article							MEMBRANE NANOTUBES; IN-VIVO; TUNNELING NANOTUBES; ANIMAL-CELLS; FUSION; MYOCYTES; TRANSDIFFERENTIATION; FIBROBLASTS; DIFFERENTIATION; COMMUNICATION	Understanding how stem cells interact with cardiomyocytes is crucial for cell-based therapies to restore the cardiomyocyte loss that occurs during myocardial infarction and other cardiac diseases. It has been thought that functional myocardial repair and regeneration could be regulated by stem cell-cardiomyocyte contact. However, because various contact modes (junction formation, cell fusion, partial cell fusion, and tunneling nanotube formation) occur randomly in a conventional coculture system, the particular regulation corresponding to a specific contact mode could not be analyzed. In this study, we used laser-patterned biochips to define cell-cell contact modes for systematic study of contact-mediated cellular interactions at the single-cell level. The results showed that the biochip design allows defined stem cell-cardiomyocyte contact-mode formation, which can be used to determine specific cellular interactions, including electrical coupling, mechanical coupling, and mitochondria transfer. The biochips will help us gain knowledge of contact-mediated interactions between stem cells and cardiomyocytes, which are fundamental for formulating a strategy to achieve stem cell-based cardiac tissue regeneration.	[Ma, Zhen; Yang, Huaxiao; Liu, Honghai; Gao, Bruce Z.] Clemson Univ, Dept Bioengn, Clemson, SC 29631 USA; [Xu, Meifeng] Univ Cincinnati, Med Ctr, Dept Pathol & Lab Med, Cincinnati, OH 45267 USA; [Runyan, Raymond B.] Univ Arizona, Dept Cellular & Mol Med, Tucson, AZ USA; [Eisenberg, Carol A.] New York Med Coll, Westchester Med Ctr, Stem Cell Lab, Valhalla, NY 10595 USA; [Markwald, Roger R.; Borg, Thomas K.] Med Univ S Carolina, Dept Regenerat Med & Cell Biol, Charleston, SC 29425 USA	Clemson University; University System of Ohio; University of Cincinnati; University of Arizona; New York Medical College; Westchester Medical Center; Medical University of South Carolina	Gao, BZ (corresponding author), Clemson Univ, Dept Bioengn, Clemson, SC 29631 USA.	zgao@clemson.edu	Yang, Huaxiao/AAV-2636-2021; Runyan, Raymond B/B-6977-2012; Yang, Huaxiao/ABA-8620-2020	Runyan, Raymond B/0000-0002-7410-916X; Ma, Zhen/0000-0001-5228-105X	National Institutes of Health (NIH) [P20RR021949, 5k25hl088262-04, 5R01 HL085847]; National Science Foundation (NSF) (MRI through SC GEAR program) [CBET-0923311]; Guangdong Provincial Department of Science and Technology, China [2011B050400011]; State Key Laboratory of Precision Measuring Technology and Instruments (Tianjin University); Siebel Institute Postdoctoral Fellowship [41523-31595-44-OYZHMA-IQKEH]; National Science Foundation (NSF) (SC EPSCoR RII through SC GEAR program) [EPS-0903795]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR021949] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K25HL088262, R01HL085847] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation (NSF) (MRI through SC GEAR program)(National Science Foundation (NSF)); Guangdong Provincial Department of Science and Technology, China; State Key Laboratory of Precision Measuring Technology and Instruments (Tianjin University); Siebel Institute Postdoctoral Fellowship; National Science Foundation (NSF) (SC EPSCoR RII through SC GEAR program)(National Science Foundation (NSF)NSF - Office of the Director (OD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was partially supported by National Institutes of Health (NIH) (SC COBRE P20RR021949, Career Award 5k25hl088262-04, and 5R01 HL085847); National Science Foundation (NSF) (MRI, CBET-0923311and SC EPSCoR RII EPS-0903795 through SC GEAR program); and Guangdong Provincial Department of Science and Technology, China (2011B050400011). BZG would also like to acknowledge the support from the grant established by the State Key Laboratory of Precision Measuring Technology and Instruments (Tianjin University). ZM would like to acknowledge his Siebel Institute Postdoctoral Fellowship (41523-31595-44-OYZHMA-IQKEH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abarbanell AM, 2009, ANN THORAC SURG, V88, P1036, DOI 10.1016/j.athoracsur.2009.02.093; Abel MP, 2011, BIOINTERPHASES, V6, P22, DOI 10.1116/1.3567416; Acquistapace A, 2011, STEM CELLS, V29, P812, DOI 10.1002/stem.632; Alvarez-Dolado M, 2003, NATURE, V425, P968, DOI 10.1038/nature02069; Alvarez-Dolado M, 2007, FRONT BIOSCI-LANDMRK, V12, P1, DOI 10.2741/2044; Alvarez-Dolado M, 2011, ADV EXP MED BIOL, V713, P161, DOI 10.1007/978-94-007-0763-4_10; Arnuthan G, 2002, ONCOGENE, V21, P7839, DOI 10.1038/sj.onc.1205983; Avitabile D, 2011, AM J PHYSIOL-HEART C, V300, pH1875, DOI 10.1152/ajpheart.00523.2010; Bereiter-Hahn J., 1990, International Review of Cytology, V122, P1, DOI 10.1016/S0074-7696(08)61205-X; Biswas G, 1999, EMBO J, V18, P522, DOI 10.1093/emboj/18.3.522; Cselenyak A, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-29; De Angelis A, 2010, CIRCULATION, V121, P276, DOI 10.1161/CIRCULATIONAHA.109.895771; Driesen RB, 2005, CARDIOVASC RES, V68, P37, DOI 10.1016/j.cardiores.2005.05.020; Garbade J, 2005, EUR J CARDIO-THORAC, V28, P685, DOI 10.1016/j.ejcts.2005.06.047; Gerdes HH, 2007, FEBS LETT, V581, P2194, DOI 10.1016/j.febslet.2007.03.071; He KM, 2011, CARDIOVASC RES, V92, P39, DOI 10.1093/cvr/cvr189; He KM, 2010, ACS NANO, V4, P3015, DOI 10.1021/nn1002198; He XQ, 2010, MOL CELL BIOCHEM, V339, P89, DOI 10.1007/s11010-009-0372-2; Hosoda T, 2009, P NATL ACAD SCI USA, V106, P17169, DOI 10.1073/pnas.0903089106; Ieda M, 2010, CELL, V142, P375, DOI 10.1016/j.cell.2010.07.002; Jopling C, 2010, NATURE, V464, P606, DOI 10.1038/nature08899; Kajstura J, 2005, CIRC RES, V96, P127, DOI 10.1161/01.RES.0000151843.79801.60; Kieken F, 2009, CIRC RES, V104, P1103, DOI 10.1161/CIRCRESAHA.108.190454; Lindstrom S, 2011, BBA-GEN SUBJECTS, V1810, P308, DOI 10.1016/j.bbagen.2010.04.009; Liu HH, 2011, J BIOMED OPT, V16, DOI 10.1117/1.3662457; Ma Z, 2012, CELL MOL BIOENG, V5, P327, DOI 10.1007/s12195-012-0240-0; Ma Z, 2012, BIOTECHNOL LETT, V34, P1385, DOI 10.1007/s10529-012-0906-7; Ma Z, 2012, LAB CHIP, V12, P566, DOI 10.1039/c2lc20699d; Ma Z, 2011, BIOFABRICATION, V3, DOI 10.1088/1758-5082/3/3/034107; Nygren JM, 2004, NAT MED, V10, P494, DOI 10.1038/nm1040; Oettgen P, 2006, CIRCULATION, V114, P353, DOI 10.1161/CIRCULATIONAHA.106.639385; Onfelt B, 2006, J IMMUNOL, V177, P8476, DOI 10.4049/jimmunol.177.12.8476; Orlic D, 2003, PEDIATR TRANSPLANT, V7, P86, DOI 10.1034/j.1399-3046.7.s3.13.x; Pedrotty DM, 2008, AM J PHYSIOL-HEART C, V295, pH390, DOI 10.1152/ajpheart.91531.2007; Pijnappels DA, 2008, CIRC RES, V103, P167, DOI 10.1161/CIRCRESAHA.108.176131; Pirlo RK, 2011, REV SCI INSTRUM, V82, DOI 10.1063/1.3529919; Plotnikov EY, 2008, J CELL MOL MED, V12, P1622, DOI 10.1111/j.1582-4934.2007.00205.x; Prochiantz A, 2003, NAT REV MOL CELL BIO, V4, P814, DOI 10.1038/nrm1227; Qian L, 2012, NATURE, V485, P593, DOI 10.1038/nature11044; Rogers TB, 2011, J MOL CELL CARDIOL, V50, P346, DOI 10.1016/j.yjmcc.2010.09.001; Rustom A, 2004, SCIENCE, V303, P1007, DOI 10.1126/science.1093133; Song YH, 2011, CELL CYCLE, V10, P2281, DOI 10.4161/cc.10.14.16513; Valarmathi MT, 2011, BIOMATERIALS, V32, P2834, DOI 10.1016/j.biomaterials.2011.01.012; Wang TZ, 2006, INT J CARDIOL, V109, P74, DOI 10.1016/j.ijcard.2005.05.072; Wang X, 2012, BBA-BIOMEMBRANES, V1818, P2082, DOI 10.1016/j.bbamem.2011.09.002; Wang X, 2010, P NATL ACAD SCI USA, V107, P17194, DOI 10.1073/pnas.1006785107; Xu MF, 2004, CIRCULATION, V110, P2658, DOI 10.1161/01.CIR.0000145609.20435.36; Zhang S, 2004, CIRCULATION, V110, P3803, DOI 10.1161/01.CIR.0000150796.18473.8E	48	28	30	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e56554	10.1371/journal.pone.0056554	http://dx.doi.org/10.1371/journal.pone.0056554			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418583	Green Published, gold, Green Submitted			2022-12-25	WOS:000315970300176
J	Uchida, F; Uzawa, K; Kasamatsu, A; Takatori, H; Sakamoto, Y; Ogawara, K; Shiiba, M; Bukawa, H; Tanzawa, H				Uchida, Fumihiko; Uzawa, Katsuhiro; Kasamatsu, Atsushi; Takatori, Hiroaki; Sakamoto, Yosuke; Ogawara, Katsunori; Shiiba, Masashi; Bukawa, Hiroki; Tanzawa, Hideki			Overexpression of CDCA2 in Human Squamous Cell Carcinoma: Correlation with Prevention of G1 Phase Arrest and Apoptosis	PLOS ONE			English	Article							DNA-DAMAGE; IONIZING-RADIATION; CANCER; EXPRESSION; CYCLE; ATM; P53; PROGRESSION; INHIBITION; ALCOHOL	Cell division cycle associated 2 (CDCA2) recruits protein phosphatase 1 to chromatin to antagonize activation of ataxia telangiectasia mutated (ATM)-dependent signal transduction. ATM kinase plays a critical role in the DNA damage response and its phosphorylation cascade to inhibit the p53-MDM2 interaction, which releases p53 to induce p21 and G1 cell-cycle arrest. However, the relevance of CDCA2 to human malignancy including oral squamous cell carcinoma (OSCC) is unknown. In the current study, we found that CDCA2 expression was up-regulated in OSCC cell lines. Functional studies with shRNA system showed that knockdown of CDCA2 significantly (P<0.05) inhibited cellular proliferation compared with the control cells by arresting cell-cycle progression at the G1 phase and up-regulating the cyclin-dependent kinase inhibitors (p21(Cip1), p27(Kip1), p15(INK4B), and p16(INK4A)). CDCA2 knockdown also promoted apoptosis after treatment with the DNA damage reagent, cisplatin. In clinical samples, the CDCA2 protein expression level in primary OSCCs was significantly (P<0.05) greater than in matched normal oral tissues (67/85, 79%). Furthermore, CDCA2-positive cases were correlated significantly (P<0.05) with high cancer progression. Our results showed for the first time that CDCA2 frequently is overexpressed in OSCCs and might be associated closely with OSCC progression by preventing cell-cycle arrest and apoptosis.	[Uchida, Fumihiko; Bukawa, Hiroki] Univ Tsukuba, Grad Sch Comprehens Human Sci, Dept Oral & Maxillofacial Surg, Tsukuba, Ibaraki, Japan; [Uzawa, Katsuhiro; Tanzawa, Hideki] Chiba Univ, Grad Sch Med, Dept Clin Mol Biol, Chuo Ku, Chiba, Japan; [Uzawa, Katsuhiro; Kasamatsu, Atsushi; Sakamoto, Yosuke; Ogawara, Katsunori; Shiiba, Masashi; Tanzawa, Hideki] Chiba Univ Hosp, Div Dent & Oral Maxillofacial Surg, Chuo Ku, Chiba, Japan; [Takatori, Hiroaki] Chiba Univ, Grad Sch Med, Dept Mol Genet, Chuo Ku, Chiba, Japan; [Bukawa, Hiroki] Univ Tsukuba, Fac Med, Dept Oral & Maxillofacial Surg, Tsukuba, Ibaraki, Japan	University of Tsukuba; Chiba University; Chiba University; University of Tsukuba	Uzawa, K (corresponding author), Chiba Univ, Grad Sch Med, Dept Clin Mol Biol, Chuo Ku, Chiba, Japan.	uzawak@faculty.chiba-u.jp		Uzawa, Katsuhiro/0000-0002-7036-0859	Ministry of Education, Culture, Sports, Science and Technology of Japan [23792317]; Grants-in-Aid for Scientific Research [24790989] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by a Grant-in-Aid Scientific Research (No. 23792317) from the Ministry of Education, Culture, Sports, Science and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bakkenist CJ, 2003, NATURE, V421, P499, DOI 10.1038/nature01368; Brew CT, 2006, INT J CANCER, V118, P857, DOI 10.1002/ijc.21445; Decker Patrice, 2002, Current Pharmaceutical Biotechnology, V3, P275, DOI 10.2174/1389201023378265; Endo Y, 2004, INT J CANCER, V110, P225, DOI 10.1002/ijc.20118; Halazonetis TD, 2008, SCIENCE, V319, P1352, DOI 10.1126/science.1140735; HARPER JW, 1995, MOL BIOL CELL, V6, P387, DOI 10.1091/mbc.6.4.387; He GG, 2005, ONCOGENE, V24, P2929, DOI 10.1038/sj.onc.1208474; Hoeijmakers JHJ, 2009, NEW ENGL J MED, V361, P1475, DOI 10.1056/NEJMra0804615; Hoeijmakers JHJ, 2001, NATURE, V411, P366, DOI 10.1038/35077232; Ishiwata J, 2012, INT J ONCOL, V40, P47, DOI 10.3892/ijo.2011.1178; Iyoda M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014082; Kasamatsu A, 2005, INT J MOL MED, V16, P269; KAWAMATA N, 1995, CANCER RES, V55, P2266; Khanna KK, 2001, NAT GENET, V27, P247, DOI 10.1038/85798; Krasnoselsky AL, 2005, ONCOGENE, V24, P1533, DOI 10.1038/sj.onc.1208341; Lombardi DP, 1999, CANCER RES, V59, P5724; Lukas J, 2004, DNA REPAIR, V3, P997, DOI 10.1016/j.dnarep.2004.03.006; Malumbres M, 2009, NAT REV CANCER, V9, P153, DOI 10.1038/nrc2602; Maude SL, 2005, CANCER RES, V65, P780; Norbury CJ, 2004, ONCOGENE, V23, P2797, DOI 10.1038/sj.onc.1207532; Ogoshi K, 2011, INT J ONCOL, V39, P329, DOI 10.3892/ijo.2011.1046; Peng AM, 2010, CURR BIOL, V20, P387, DOI 10.1016/j.cub.2010.01.020; Porter PL, 1997, NAT MED, V3, P222, DOI 10.1038/nm0297-222; Poschl G, 2004, ALCOHOL ALCOHOLISM, V39, P155, DOI 10.1093/alcalc/agh057; Qian JB, 2011, CURR BIOL, V21, P766, DOI 10.1016/j.cub.2011.03.047; Ryu B, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000594; Saito S, 2002, J BIOL CHEM, V277, P12491, DOI 10.1074/jbc.C200093200; Trinkle-Mulcahy L, 2006, J CELL BIOL, V172, P679, DOI 10.1083/jcb.200508154; Tvrdik D, 2002, J STRUCT BIOL, V140, P49, DOI 10.1016/S1047-8477(02)00535-X; Vagnarelli P, 2006, NAT CELL BIOL, V8, P1133, DOI 10.1038/ncb1475; Vagnarelli P, 2011, DEV CELL, V21, P328, DOI 10.1016/j.devcel.2011.06.020; Walker MG, 2001, CURR CANCER DRUG TAR, V1, P73, DOI 10.2174/1568009013334241; Ward JF, 2000, COLD SPRING HARB SYM, V65, P377, DOI 10.1101/sqb.2000.65.377; Werbrouck J, 2008, MUTAT RES-GEN TOX EN, V656, P74, DOI 10.1016/j.mrgentox.2008.07.013; Yamano Y, 2008, INT J ONCOL, V32, P1001; Yamano Y, 2011, HEAD NECK-J SCI SPEC, V33, P309, DOI 10.1002/hed.21445; Yamatoji M, 2010, INT J CANCER, V130, P2903	37	61	64	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e56381	10.1371/journal.pone.0056381	http://dx.doi.org/10.1371/journal.pone.0056381			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418564	gold, Green Published, Green Submitted			2022-12-25	WOS:000315970300157
J	Wang, JP; Li, ZX; Feng, M; Ren, KM; Shen, GX; Zhao, CY; Jin, XM; Jiang, KW				Wang, Jiangping; Li, Zhongxia; Feng, Mei; Ren, Keming; Shen, Guoxia; Zhao, Congying; Jin, Xiaoming; Jiang, Kewen			Opening of Astrocytic Mitochondrial ATP-Sensitive Potassium Channels Upregulates Electrical Coupling between Hippocampal Astrocytes in Rat Brain Slices	PLOS ONE			English	Article							GAP-JUNCTION PERMEABILITY; GLIAL-CELLS; K+-CHANNEL; DEPENDENT MECHANISM; CATION CHANNEL; NERVOUS-SYSTEM; NEURONS; OPENERS; MEMBRANE; OLIGODENDROCYTES	Astrocytes form extensive intercellular networks through gap junctions to support both biochemical and electrical coupling between adjacent cells. ATP-sensitive K+ (K-ATP) channels couple cell metabolic state to membrane excitability and are enriched in glial cells. Activation of astrocytic mitochondrial K-ATP (mitoK(ATP)) channel regulates certain astrocytic functions. However, less is known about its impact on electrical coupling between directly coupled astrocytes ex vivo. By using dual patch clamp recording, we found that activation of mitoK(ATP) channel increased the electrical coupling ratio in brain slices. The electrical coupling ratio started to increase 3 min after exposure to Diazoxide, a mitoK(ATP) channel activator, peaked at 5 min, and maintained its level with little adaptation until the end of the 10-min treatment. Blocking the mitoK(ATP) channel with 5-hydroxydecanoate, inhibited electrical coupling immediately, and by 10-min, the ratio dropped by 71% of the initial level. Activation of mitoK(ATP) channel also decreased the latency time of the transjunctional currents by 50%. The increase in the coupling ratio resulting from the activation of the mitoK(ATP) channel in a single astrocyte was further potentiated by the concurrent inhibiting of the channel on the recipient astrocyte. Furthermore, Meclofenamic acid, a gap-junction inhibitor which completely blocked the tracer coupling, hardly reversed the impact of mitoK(ATP) channel's activation on electrical coupling (by 7%). The level of mitochondrial Connexin43, a gap junctional subunit, significantly increased by 70% in astrocytes after 10-min Diazoxide treatment. Phospho-ERK signals were detected in Connexin43 immunoprecipitates in the Diazoxide-treated astrocytes, but not untreated control samples. Finally, inhibiting ERK could attenuate the effects of Diazoxide on electrical coupling by 61%. These findings demonstrate that activation of astrocytic mitoK(ATP) channel upregulates electrical coupling between hippocampal astrocytes ex vivo. In addition, this effect is mainly via up-regulation of the Connexin43-constituted gap junction coupling by an ERK-dependent mechanism in the mitochondria.	[Wang, Jiangping; Li, Zhongxia; Feng, Mei; Ren, Keming; Shen, Guoxia; Zhao, Congying; Jiang, Kewen] Zhejiang Univ, Sch Med, Childrens Hosp, Dept Neurol, Hangzhou 310003, Zhejiang, Peoples R China; [Wang, Jiangping] Zhejiang Univ, Sch Med, Childrens Hosp, Dept Rehabil, Hangzhou 310003, Zhejiang, Peoples R China; [Jin, Xiaoming] Indiana Univ Sch Med, Stark Neurosci Res Inst, Indianapolis, IN USA; [Jiang, Kewen] Zhejiang Univ, Sch Med, Childrens Hosp, Dept Lab, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University; Indiana University System; Indiana University Bloomington; Zhejiang University	Jiang, KW (corresponding author), Zhejiang Univ, Sch Med, Childrens Hosp, Dept Neurol, Hangzhou 310003, Zhejiang, Peoples R China.	kewenjiang@gmail.com	Jin, Xiaoming/AAH-3555-2020		National Natural Science Foundation of China [30471840, 30570644]; Natural Science Foundation of Zhejiang Province [Y205127, Y2080272, R2090266]; Qianjiang talents project of technology office in Zhejiang province [2010R10G2010055]; Fundamental Research Funds for the Central Universities; Key Laboratory of Medical Neurobiology of Ministry of Health at Zhejiang University	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Zhejiang Province(Natural Science Foundation of Zhejiang Province); Qianjiang talents project of technology office in Zhejiang province; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Key Laboratory of Medical Neurobiology of Ministry of Health at Zhejiang University	This publication was supported by the National Natural Science Foundation of China (30471840 and 30570644), Natural Science Foundation of Zhejiang Province (Y205127, Y2080272 and R2090266), Qianjiang talents project of technology office in Zhejiang province (2010R10G2010055), by the Fundamental Research Funds for the Central Universities, and by the Key Laboratory of Medical Neurobiology of Ministry of Health at Zhejiang University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar-Bryan L, 1999, ENDOCR REV, V20, P101, DOI 10.1210/er.20.2.101; Bahi-Buisson N, 2007, J CHILD NEUROL, V22, P1147, DOI 10.1177/0883073807306272; Bajgar R, 2001, J BIOL CHEM, V276, P33369, DOI 10.1074/jbc.M103320200; BRIGHTMA.MW, 1969, J CELL BIOL, V40, P648, DOI 10.1083/jcb.40.3.648; Brockhaus J, 2000, GLIA, V32, P205, DOI 10.1002/1098-1136(200012)32:3<205::AID-GLIA10>3.0.CO;2-6; Bushong EA, 2004, INT J DEV NEUROSCI, V22, P73, DOI 10.1016/j.ijdevneu.2003.12.008; Bushong EA, 2002, J NEUROSCI, V22, P183, DOI 10.1523/JNEUROSCI.22-01-00183.2002; Cahoy JD, 2008, J NEUROSCI, V28, P264, DOI 10.1523/JNEUROSCI.4178-07.2008; Cavalheiro RA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010666; Chen MK, 2003, J NEUROSCI, V23, P8568; D'Ascenzo M, 2007, P NATL ACAD SCI USA, V104, P1995, DOI 10.1073/pnas.0609408104; Downey JM, 2000, BASIC RES CARDIOL, V95, P272, DOI 10.1007/s003950070045; GANDOLFO G, 1989, EUR J PHARMACOL, V167, P181, DOI 10.1016/0014-2999(89)90762-0; Giaume C, 1997, GLIA, V21, P114; Gosejacob D, 2011, GLIA, V59, P511, DOI 10.1002/glia.21120; Hinterkeuser S, 2000, EUR J NEUROSCI, V12, P2087, DOI 10.1046/j.1460-9568.2000.00104.x; INOUE I, 1991, NATURE, V352, P244, DOI 10.1038/352244a0; Jiang K, 2011, NEUROSIGNALS, V19, P63, DOI 10.1159/000323575; Jiang KW, 2004, NEUROSCI RES, V50, P319, DOI 10.1016/j.neures.2004.08.001; Jiang KW, 2004, MOL BRAIN RES, V128, P83, DOI 10.1016/j.molbrainres.2004.06.005; Koulakoff A, 2008, GLIA, V56, P1299, DOI 10.1002/glia.20698; Liss B, 2005, NAT NEUROSCI, V8, P1742, DOI 10.1038/nn1570; MCLAINE PN, 1971, J PEDIATR-US, V79, P829, DOI 10.1016/S0022-3476(71)80402-X; Mebazaa A, 2003, INT J CLIN PRACT, V57, P410; Meme W, 2009, NEUROSCI RES, V63, P236, DOI 10.1016/j.neures.2008.12.008; Miki T, 2001, NAT NEUROSCI, V4, P507, DOI 10.1038/87455; Minami K, 2004, DIABETES, V53, pS176, DOI 10.2337/diabetes.53.suppl_3.S176; Nagy JI, 2004, BRAIN RES REV, V47, P191, DOI 10.1016/j.brainresrev.2004.05.005; Naitoh K, 2006, CARDIOVASC RES, V70, P374, DOI 10.1016/j.cardiores.2006.01.023; ORKAND RK, 1966, J NEUROPHYSIOL, V29, P788, DOI 10.1152/jn.1966.29.4.788; Proulx E, 2006, EUR J NEUROSCI, V23, P489, DOI 10.1111/j.1460-9568.2005.04558.x; RANSOM BR, 1990, GLIA, V3, P258, DOI 10.1002/glia.440030405; Rash JE, 2001, CELL COMMUN ADHES, V8, P315, DOI 10.3109/15419060109080745; Riess ML, 2008, J CARDIOVASC PHARM, V51, P483, DOI 10.1097/FJC.0b013e31816bf4a4; Rocheleau JV, 2006, PLOS BIOL, V4, P221, DOI 10.1371/journal.pbio.0040026; Rouach N, 2008, SCIENCE, V322, P1551, DOI 10.1126/science.1164022; Samavati L, 2002, AM J PHYSIOL-CELL PH, V283, pC273, DOI 10.1152/ajpcell.00514.2001; Santos DOC, 2009, PHYS BIOL, V6, DOI 10.1088/1478-3975/6/4/046019; SARGENT CA, 1993, J CARDIOVASC PHARM, V22, P564, DOI 10.1097/00005344-199310000-00009; Schools GP, 2006, J NEUROPHYSIOL, V96, P1383, DOI 10.1152/jn.00449.2006; Schwanstecher M, 1999, Methods Enzymol, V294, P445; Sershen H, 2012, BRIT J PHARMACOL, V167, P1000, DOI 10.1111/j.1476-5381.2012.02072.x; Strohschein S, 2011, GLIA, V59, P973, DOI 10.1002/glia.21169; Sun XL, 2008, NEUROPSYCHOPHARMACOL, V33, P1336, DOI 10.1038/sj.npp.1301501; Szewczyk A, 1997, BIOCHEM PHARMACOL, V54, P961, DOI 10.1016/S0006-2952(97)00136-6; Velasco A, 2000, J NEUROCHEM, V74, P1249; Volterra A, 2005, NAT REV NEUROSCI, V6, P626, DOI 10.1038/nrn1722; Wallraff A, 2006, J NEUROSCI, V26, P5438, DOI 10.1523/JNEUROSCI.0037-06.2006; WALZ W, 1994, J NEUROSCI RES, V38, P12, DOI 10.1002/jnr.490380104; Xu GJ, 2010, GLIA, V58, P481, DOI 10.1002/glia.20939; Xue J, 2008, AM J PHYSIOL-REG I, V294, pR451, DOI 10.1152/ajpregu.00528.2007; Yamada K, 2001, SCIENCE, V292, P1543, DOI 10.1126/science.1059829; Yang MK, 2009, J PHARMACOL SCI, V109, P222, DOI 10.1254/jphs.08132FP; Zahs KR, 1997, GLIA, V20, P10, DOI 10.1002/(SICI)1098-1136(199705)20:1<10::AID-GLIA2>3.3.CO;2-2; Zhang S, 2011, CELL MOL NEUROBIOL, V31, P111, DOI 10.1007/s10571-010-9560-6; Zhang S, 2009, J NEUROSCI RES, V87, P1230, DOI 10.1002/jnr.21931; Zhou F, 2008, J CELL MOL MED, V12, P1559, DOI 10.1111/j.1582-4934.2007.00144.x; Zhou M, 2002, MOL BRAIN RES, V101, P23, DOI 10.1016/S0169-328X(02)00137-7; Zhou M, 2009, J NEUROSCI, V29, P8551, DOI 10.1523/JNEUROSCI.5784-08.2009	59	10	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e56605	10.1371/journal.pone.0056605	http://dx.doi.org/10.1371/journal.pone.0056605			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418587	Green Published, gold, Green Submitted			2022-12-25	WOS:000315970300180
J	Kampylafka, EI; Alexopoulos, H; Kosmidis, ML; Panagiotakos, DB; Vlachoyiannopoulos, PG; Dalakas, MC; Moutsopoulos, HM; Tzioufas, AG				Kampylafka, Eleni I.; Alexopoulos, Haralampos; Kosmidis, Michalis L.; Panagiotakos, Demosthenes B.; Vlachoyiannopoulos, Panayiotis G.; Dalakas, Marinos C.; Moutsopoulos, Haralampos M.; Tzioufas, Athanasios G.			Incidence and Prevalence of Major Central Nervous System Involvement in Systemic Lupus Erythematosus: A 3-Year Prospective Study of 370 Patients	PLOS ONE			English	Article							NEUROPSYCHIATRIC SYNDROMES; ANTIPHOSPHOLIPID SYNDROME; NEUROMYELITIS-OPTICA; RISK-FACTORS; CRITERIA; DISEASE; CLASSIFICATION; EVENTS; COHORT; DAMAGE	Background: The incidence and prevalence of CNS involvement in SLE remains unclear owing to conflicting results in the published studies. The aim of the study was to evaluate the incidence and prevalence of major definite CNS events in SLE patients. Methods: 370 SLE patients with no previous history of CNS involvement were prospectively evaluated in a tertiary hospital referral center for 3 years. Major CNS manifestations were codified according to ACR definitions, including chorea, aseptic meningitis, psychosis, seizures, myelopathy, demyelinating syndrome, acute confusional state and strokes. Minor CNS events were excluded. ECLAM and SLEDAI-SELENA Modification scores were used to evaluate disease activity and SLICC/ACR Damage Index was used to assess accumulated damage. Results: 16/370 (4.3%) patients presented with a total of 23 major CNS events. These included seizures (35%), strokes (26%), myelopathy (22%), optic neuritis (8.7%), aseptic meningitis (4.3%) and acute psychosis (4.3%). Incidence was 7.8/100 person years. Among hospitalizations for SLE, 13% were due to CNS manifestations. Epileptic seizures were associated with high disease activity, while myelopathy correlated with lower disease activity and NMO-IgG antibodies (P <= 0.05). Stroke incidence correlated with APS coexistence (P = 0.06). Overall, CNS involvement correlated with high ECLAM and SLEDAI scores (P<0.001). Conclusions: Clinically severe CNS involvement is rare in SLE patients, accounting for 7.8/100 person years. CNS involvement correlates with high disease activity and coexistence of specific features that define the respective CNS syndromes.	[Kampylafka, Eleni I.; Alexopoulos, Haralampos; Kosmidis, Michalis L.; Vlachoyiannopoulos, Panayiotis G.; Dalakas, Marinos C.; Moutsopoulos, Haralampos M.; Tzioufas, Athanasios G.] Univ Athens, Sch Med, Dept Pathophysiol, Athens 11528, Greece; [Panagiotakos, Demosthenes B.] Harokopio Univ, Dept Nutr & Dietet, Athens, Greece	Athens Medical School; National & Kapodistrian University of Athens; Harokopio University Athens	Tzioufas, AG (corresponding author), Univ Athens, Sch Med, Dept Pathophysiol, Athens 11528, Greece.	agtzi@med.uoa.gr	Panagiotakos, Demosthenes/C-9776-2013; Panagiotakos, Demosthenes/M-9167-2019; TZIOUFAS, ATHANASIOS G/A-1690-2008; Panagiotakos, Demosthenes/K-8294-2019	Panagiotakos, Demosthenes/0000-0001-8583-153X; Panagiotakos, Demosthenes/0000-0001-8583-153X; Tzioufas, Athanasios/0000-0001-6666-8642; Alexopoulos, Harry/0000-0002-8672-7619	European Social Fund (ESF) fund through the Operational Program "Education and Lifelong Learning'' of the National Strategic Reference Framework (NSRF) Research Funding Program: Heracleitus II; Greek National fund through the Operational Program "Education and Lifelong Learning'' of the National Strategic Reference Framework (NSRF) Research Funding Program: Heracleitus II	European Social Fund (ESF) fund through the Operational Program "Education and Lifelong Learning'' of the National Strategic Reference Framework (NSRF) Research Funding Program: Heracleitus II; Greek National fund through the Operational Program "Education and Lifelong Learning'' of the National Strategic Reference Framework (NSRF) Research Funding Program: Heracleitus II	The present study has been co-financed by the European Social Fund (ESF) and Greek National funds through the Operational Program "Education and Lifelong Learning'' of the National Strategic Reference Framework (NSRF) Research Funding Program: Heracleitus II. http://www.elke.uoa.gr. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainiala H, 2001, NEUROLOGY, V57, P496, DOI 10.1212/WNL.57.3.496; Ainiala H, 2001, ARTHRIT RHEUM-ARTHR, V45, P419, DOI 10.1002/1529-0131(200110)45:5<419::AID-ART360>3.0.CO;2-X; Andrade RM, 2008, ANN RHEUM DIS, V67, P829, DOI 10.1136/ard.2007.077594; Bernatsky S, 2006, LUPUS, V15, P835, DOI 10.1177/0961203306073133; Bertsias GK, 2010, ANN RHEUM DIS, V69, P2074, DOI 10.1136/ard.2010.130476; Bertsias GK, 2010, NAT REV RHEUMATOL, V6, P358, DOI 10.1038/nrrheum.2010.62; Birnbaum J, 2009, ARTHRITIS RHEUM-US, V60, P3378, DOI 10.1002/art.24937; Bosnic Dubravka, 2008, Lijec Vjesn, V130, P136; Brey RL, 2002, NEUROLOGY, V58, P1214, DOI 10.1212/WNL.58.8.1214; Carlomagno S, 2000, J NEUROL, V247, P273, DOI 10.1007/s004150050583; Chambers SA, 2009, RHEUMATOLOGY, V48, P673, DOI 10.1093/rheumatology/kep062; COSTALLAT LTL, 1994, CLIN EXP RHEUMATOL, V12, P603; D'Cruz DP, 2007, LANCET, V369, P587, DOI 10.1016/S0140-6736(07)60279-7; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Fujieda Y, 2011, MOD RHEUMATOL, V21, P276, DOI 10.1007/s10165-010-0386-3; Gladman D, 1996, ARTHRITIS RHEUM, V39, P363, DOI 10.1002/art.1780390303; Govoni M, 2011, RHEUMATOLOGY OXFORD; Hanly JG, 2007, ARTHRITIS RHEUM-US, V56, P265, DOI 10.1002/art.22305; Hanly JG, 2010, ANN RHEUM DIS, V69, P529, DOI 10.1136/ard.2008.106351; Hanly JG, 2004, J RHEUMATOL, V31, P2156; Hochberg MC, 1997, ARTHRITIS RHEUM, V40, P1725, DOI 10.1002/art.1780400928; Joseph FG, 2007, NEUROLOGY, V69, P644, DOI 10.1212/01.wnl.0000267320.48939.d0; Karassa FB, 2000, QJM-MON J ASSOC PHYS, V93, P169, DOI 10.1093/qjmed/93.3.169; Kasitanon N, 2002, ASIAN PAC J ALLERGY, V20, P85; Kozora E, 2008, ARTHRIT RHEUM-ARTHR, V59, P1639, DOI 10.1002/art.24189; Lennon VA, 2004, LANCET, V364, P2106, DOI 10.1016/S0140-6736(04)17551-X; Lennon VA, 2005, J EXP MED, V202, P473, DOI 10.1084/jem.20050304; Liang MH, 1999, ARTHRITIS RHEUM-US, V42, P599; McCaffrey LM, 2011, HEART LUNG; Mikdashi J, 2004, RHEUMATOLOGY, V43, P1555, DOI 10.1093/rheumatology/keh384; Mitsikostas DD, 2004, BRAIN, V127, P1200, DOI 10.1093/brain/awh146; MIYACHI K, 1979, ARTHRITIS RHEUM, V22, P87, DOI 10.1002/art.1780220114; Miyakis S, 2006, J THROMB HAEMOST, V4, P295, DOI 10.1111/j.1538-7836.2006.01753.x; Mosca M, 2000, LUPUS, V9, P445, DOI 10.1191/096120300678828640; Padovan M, 2010, RHEUMATOL INT; Petri M, 2005, NEW ENGL J MED, V353, P2550, DOI 10.1056/NEJMoa051135; PETRI M, 1992, J RHEUMATOL, V19, P1559; Petri M, 2008, J RHEUMATOL, V35, P1776; Pittock SJ, 2008, ARCH NEUROL-CHICAGO, V65, P78, DOI 10.1001/archneurol.2007.17; Sfikakis PP, 1998, BRIT J RHEUMATOL, V37, P300; Tektonidou MG, 2006, ARCH INTERN MED, V166, P2278, DOI 10.1001/archinte.166.20.2278; Tzioufas AG, 2000, ANN RHEUM DIS, V59, P99, DOI 10.1136/ard.59.2.99; Unterman A, 2011, SEMIN ARTHRITIS RHEU, V41, P1, DOI 10.1016/j.semarthrit.2010.08.001; Valentinov Monov Simeon, 2007, Med Pregl, V60 Suppl 2, P70; Weening JJ, 2004, J AM SOC NEPHROL, V15, P241, DOI 10.1097/01.ASN.0000108969.21691.5D; Wingerchuk DM, 2006, NEUROLOGY, V66, P1485, DOI 10.1212/01.wnl.0000216139.44259.74; Wingerchuk DM, 2007, LANCET NEUROL, V6, P805, DOI 10.1016/S1474-4422(07)70216-8	47	51	54	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2013	8	2							e55843	10.1371/journal.pone.0055843	http://dx.doi.org/10.1371/journal.pone.0055843			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104BU	23424638	Green Published, gold, Green Submitted			2022-12-25	WOS:000315965100026
J	Papaix, J; David, O; Lannou, C; Monod, H				Papaix, Julien; David, Olivier; Lannou, Christian; Monod, Herve			Dynamics of Adaptation in Spatially Heterogeneous Metapopulations	PLOS ONE			English	Article							SENSITIVITY-ANALYSIS; EVOLUTION; AGGRESSIVENESS; SPECIALIZATION; COEVOLUTION; STRATEGIES; RESISTANCE; SPECIATION; DISPERSAL; SELECTION	The selection pressure experienced by organisms often varies across the species range. It is hence crucial to characterise the link between environmental spatial heterogeneity and the adaptive dynamics of species or populations. We address this issue by studying the phenotypic evolution of a spatial metapopulation using an adaptive dynamics approach. The singular strategy is found to be the mean of the optimal phenotypes in each habitat with larger weights for habitats present in large and well connected patches. The presence of spatial clusters of habitats in the metapopulation is found to facilitate specialisation and to increase both the level of adaptation and the evolutionary speed of the population when dispersal is limited. By showing that spatial structures are crucial in determining the specialisation level and the evolutionary speed of a population, our results give insight into the influence of spatial heterogeneity on the niche breadth of species.	[Papaix, Julien; Lannou, Christian] INRA, Plant Hlth & Environm Div, Biol & GEst Risques Agr Grp UR BIOGER CPP, Thiverval Grignon, France; [Papaix, Julien; David, Olivier; Monod, Herve] INRA, Appl Math & Informat Div, Math & Informat Appl Grp UR MIAJ, Jouy En Josas, France	AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay; INRAE; UDICE-French Research Universities; Universite Paris Saclay	Papaix, J (corresponding author), INRA, Plant Hlth & Environm Div, Biol & GEst Risques Agr Grp UR BIOGER CPP, Thiverval Grignon, France.	julien.papaix@jouy.inra.fr	Papaïx, Julien/S-3431-2016	David, Olivier/0000-0002-1389-7158	French National Institute for Agricultural Research	French National Institute for Agricultural Research	This study was supported by the French National Institute for Agricultural Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnagaud JY, 2011, GLOBAL ECOL BIOGEOGR, V20, P630, DOI 10.1111/j.1466-8238.2010.00629.x; Bolnick DI, 2011, TRENDS ECOL EVOL, V26, P183, DOI 10.1016/j.tree.2011.01.009; Bouvier A, 2009, ENVIRON MODELL SOFTW, V24, P843, DOI 10.1016/j.envsoft.2008.11.006; Burdon JJ, 2000, EVOL ECOL, V14, P261, DOI 10.1023/A:1011042721274; Caswell H., 2001, MATRIX POPULATION MO, V2nd ed.; Champagnat N, 2006, THEOR POPUL BIOL, V69, P297, DOI 10.1016/j.tpb.2005.10.004; Champagnat N, 2007, ANN APPL PROBAB, V17, P102, DOI 10.1214/105051606000000628; Chesson P, 2000, ANNU REV ECOL SYST, V31, P343, DOI 10.1146/annurev.ecolsys.31.1.343; Claessen D, 2007, EVOL ECOL RES, V9, P51; Clavel J, 2011, FRONT ECOL ENVIRON, V9, P222, DOI 10.1890/080216; DEAKIN MAB, 1966, AM NAT, V100, P690, DOI 10.1086/282462; Debarre F, 2010, J EVOLUTION BIOL, V23, P1090, DOI 10.1111/j.1420-9101.2010.01966.x; Debarre F, 2011, ECOL LETT, V14, P260, DOI 10.1111/j.1461-0248.2010.01580.x; Devictor V, 2008, OIKOS, V117, P507, DOI 10.1111/j.2008.0030-1299.16215.x; Devictor V, 2010, J APPL ECOL, V47, P15, DOI 10.1111/j.1365-2664.2009.01744.x; Dieckmann U, 1996, J MATH BIOL, V34, P579, DOI 10.1007/BF02409751; Doebeli M, 2003, NATURE, V421, P259, DOI 10.1038/nature01274; Durinx M, 2008, J MATH BIOL, V56, P673, DOI 10.1007/s00285-007-0134-2; Fahrig L, 2003, ANNU REV ECOL EVOL S, V34, P487, DOI 10.1146/annurev.ecolsys.34.011802.132419; Gandon S, 2000, P ROY SOC B-BIOL SCI, V267, P985, DOI 10.1098/rspb.2000.1100; Gautier M, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-550; Geritz SAH, 2005, J EVOLUTION BIOL, V18, P1174, DOI 10.1111/j.1420-9101.2004.00841.x; Geritz SAH, 1998, EVOL ECOL, V12, P35, DOI 10.1023/A:1006554906681; Hanski I, 2011, AM NAT, V177, P29, DOI 10.1086/657625; He HS, 2000, LANDSCAPE ECOL, V15, P591, DOI 10.1023/A:1008102521322; Jackson ST, 2009, P NATL ACAD SCI USA, V106, P19685, DOI 10.1073/pnas.0901644106; Johnson MTJ, 2007, J EVOLUTION BIOL, V20, P190, DOI 10.1111/j.1420-9101.2006.01201.x; JOHNSON R, 1981, PHYTOPATHOLOGY, V71, P567, DOI 10.1094/Phyto-71-567; KIRKPATRICK S, 1983, SCIENCE, V220, P671, DOI 10.1126/science.220.4598.671; Kocher TD, 2004, NAT REV GENET, V5, P288, DOI 10.1038/nrg1316; Lenormand T, 2002, TRENDS ECOL EVOL, V17, P183, DOI 10.1016/S0169-5347(02)02497-7; LEVENE H, 1953, AM NAT, V87, P331, DOI 10.1086/281792; Merila J, 2001, J EVOLUTION BIOL, V14, P892, DOI 10.1046/j.1420-9101.2001.00348.x; Meszena Geza, 1997, Journal of Biological Systems, V5, P265, DOI 10.1142/S0218339097000175; Mouquet N, 2003, AM NAT, V162, P544, DOI 10.1086/378857; Nagylaki T, 2008, LECT NOTES MATH, V1922, P117; Ovaskainen O, 2003, THEOR POPUL BIOL, V64, P481, DOI 10.1016/S0040-5809(03)00102-3; Pariaud B, 2009, PLANT PATHOL, V58, P409, DOI 10.1111/j.1365-3059.2009.02039.x; Pariaud B, 2009, PHYTOPATHOLOGY, V99, P869, DOI 10.1094/PHYTO-99-7-0869; Parnell S, 2009, PHYTOPATHOLOGY, V99, P1370, DOI 10.1094/PHYTO-99-12-1370; Parvinen K, 2004, THEOR POPUL BIOL, V66, P233, DOI 10.1016/j.tpb.2004.06.002; Plantegenest M, 2007, J R SOC INTERFACE, V4, P963, DOI 10.1098/rsif.2007.1114; Ravigne V, 2009, AM NAT, V174, pE141, DOI 10.1086/605369; Rhone B, 2008, MOL ECOL, V17, P930, DOI 10.1111/j.1365-294X.2007.03619.x; Robinson RA, 2002, J APPL ECOL, V39, P157, DOI 10.1046/j.1365-2664.2002.00695.x; Saltelli A, 2000, STAT SCI, V15, P377, DOI 10.1214/ss/1009213004; Skelsey P, 2010, PHYTOPATHOLOGY, V100, P1146, DOI 10.1094/PHYTO-06-09-0148; SMITH JM, 1973, NATURE, V246, P15, DOI 10.1038/246015a0; Sobol I.M., 1993, MATH MODEL COMPUT EX, V1, P407, DOI DOI 10.18287/0134-2452-2015-39-4-459-461; Soubeyrand S, 2009, AM NAT, V174, P308, DOI 10.1086/603624; Sudret B, 2008, RELIAB ENG SYST SAFE, V93, P964, DOI 10.1016/j.ress.2007.04.002; van den Berg F, 2011, EVOL ECOL, V25, P121, DOI 10.1007/s10682-010-9387-0; Waxman D, 2005, J EVOLUTION BIOL, V18, P1139, DOI 10.1111/j.1420-9101.2005.00948.x; With KA, 1997, OIKOS, V78, P151, DOI 10.2307/3545811; Xu XM, 2011, PLANT PATHOL, V60, P857, DOI 10.1111/j.1365-3059.2011.02441.x	56	23	23	0	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2013	8	2							e54697	10.1371/journal.pone.0054697	http://dx.doi.org/10.1371/journal.pone.0054697			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104BU	23424618	gold, Green Submitted, Green Published			2022-12-25	WOS:000315965100006
J	Sabin, LR; Zheng, Q; Thekkat, P; Yang, J; Hannon, GJ; Gregory, BD; Tudor, M; Cherry, S				Sabin, Leah R.; Zheng, Qi; Thekkat, Pramod; Yang, Jamie; Hannon, Gregory J.; Gregory, Brian D.; Tudor, Matthew; Cherry, Sara			Dicer-2 Processes Diverse Viral RNA Species	PLOS ONE			English	Article							VESICULAR STOMATITIS-VIRUS; ANTIVIRAL IMMUNITY; DROSOPHILA; INTERFERENCE; INFECTION; REPLICATION; SUPPRESSION; POLYMERASE; ALPHAVIRUS; INSECT	RNA silencing pathways play critical roles in gene regulation, virus infection, and transposon control. RNA interference (RNAi) is mediated by small interfering RNAs (siRNAs), which are liberated from double-stranded (ds)RNA precursors by Dicer and guide the RNA-induced silencing complex (RISC) to targets. Although principles governing small RNA sorting into RISC have been uncovered, the spectrum of RNA species that can be targeted by Dicer proteins, particularly the viral RNAs present during an infection, are poorly understood. Dicer-2 potently restricts viral infection in insects by generating virus-derived siRNAs from viral RNA. To better characterize the substrates of Dicer-2, we examined the virus-derived siRNAs produced during the Drosophila antiviral RNAi response to four different viruses using high-throughput sequencing. We found that each virus was uniquely targeted by the RNAi pathway; dicing substrates included dsRNA replication intermediates and intramolecular RNA stem loops. For instance, a putative intergenic RNA hairpin encoded by Rift Valley Fever virus generates abundant small RNAs in both Drosophila and mosquito cells, while repetitive sequences within the genomic termini of Vaccinia virus, which give rise to abundant small RNAs in Drosophila, were found to be transcribed in both insect and mammalian cells. Moreover, we provide evidence that the RNA species targeted by Dicer-2 can be modulated by the presence of a viral suppressor of RNAi. This study uncovered several novel, heavily targeted features within viral genomes, offering insight into viral replication, viral immune evasion strategies, and the mechanism of antiviral RNAi.	[Sabin, Leah R.; Cherry, Sara] Univ Penn, Dept Microbiol, Philadelphia, PA 19104 USA; [Sabin, Leah R.; Zheng, Qi; Yang, Jamie; Gregory, Brian D.; Cherry, Sara] Univ Penn, Penn Genome Frontiers Inst, Philadelphia, PA 19104 USA; [Zheng, Qi; Yang, Jamie; Gregory, Brian D.] Univ Penn, Dept Biol, Philadelphia, PA 19104 USA; [Tudor, Matthew] Univ Penn, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA; [Thekkat, Pramod; Hannon, Gregory J.] Cold Spring Harbor Lab, Howard Hughes Med Inst, Watson Sch Biol Sci, Cold Spring Harbor, NY 11724 USA	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; Cold Spring Harbor Laboratory; Howard Hughes Medical Institute	Gregory, BD (corresponding author), Univ Penn, Penn Genome Frontiers Inst, Philadelphia, PA 19104 USA.	bdgregor@sas.upenn.edu; mtudor@gmail.com; cherrys@mail.med.upenn.edu	Gregory, Brian D/G-2890-2010; Hannon, Gregory/AAB-3568-2019; Zheng, Qi/A-9208-2015	Zheng, Qi/0000-0002-2582-1222; cherry, sara/0000-0003-3956-6610; Tudor, Matthew/0000-0001-8766-195X; Sabin, Leah/0000-0003-1757-7415	Penn Genome Frontiers Institute; National Institutes of Health (NIH) [R01AI074951, U54AI057168]; NIH [T32GM007229, T32AI007324]; NATIONAL CANCER INSTITUTE [P30CA045508] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI074951, T32AI007324, U54AI057168] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM062534, T32GM007229] Funding Source: NIH RePORTER	Penn Genome Frontiers Institute; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from the Penn Genome Frontiers Institute to BG; from National Institutes of Health (NIH) (R01AI074951, U54AI057168) to SC; and from NIH (T32GM007229, T32AI007324) to LRS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER WA, 1992, J VIROL, V66, P2934, DOI 10.1128/JVI.66.5.2934-2942.1992; Aliyari R, 2008, CELL HOST MICROBE, V4, P387, DOI 10.1016/j.chom.2008.09.001; ARIF BM, 1995, J GEN VIROL, V76, P1, DOI 10.1099/0022-1317-76-1-1; Backes S, 2012, CELL HOST MICROBE, V12, P200, DOI 10.1016/j.chom.2012.05.019; Brackney DE, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000502; Campbell CL, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-47; CAPLEN H, 1985, J GEN VIROL, V66, P2271, DOI 10.1099/0022-1317-66-10-2271; Cherry S, 2004, NAT IMMUNOL, V5, P81, DOI 10.1038/ni1019; Cullen BR, 2006, NAT GENET, V38, pS25, DOI 10.1038/ng1793; Czech B, 2011, NAT REV GENET, V12, P19, DOI 10.1038/nrg2916; Czech B, 2009, MOL CELL, V36, P445, DOI 10.1016/j.molcel.2009.09.028; Ding SW, 2007, CELL, V130, P413, DOI 10.1016/j.cell.2007.07.039; EMERY VC, 1987, VIROLOGY, V156, P1, DOI 10.1016/0042-6822(87)90430-2; Filone CM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015483; Flynt A, 2009, P NATL ACAD SCI USA, V106, P5270, DOI 10.1073/pnas.0813412106; Galiana-Arnoux D, 2006, NAT IMMUNOL, V7, P590, DOI 10.1038/ni1335; Han YH, 2011, J VIROL, V85, P13153, DOI 10.1128/JVI.05518-11; Johnson KN, 1998, J GEN VIROL, V79, P191, DOI 10.1099/0022-1317-79-1-191; Keene KM, 2004, P NATL ACAD SCI USA, V101, P17240, DOI 10.1073/pnas.0406983101; Kim K, 2006, COLD SPRING HARB SYM, V71, P39, DOI 10.1101/sqb.2006.71.008; Kim VN, 2009, NAT REV MOL CELL BIO, V10, P126, DOI 10.1038/nrm2632; LAZZARINI RA, 1981, CELL, V26, P145, DOI 10.1016/0092-8674(81)90298-1; Lyles D., 2006, FIELDS VIROLOGY, P1363; Moser TS, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000954; Moss B, 2006, FIELDS VIROLOGY, P2905; Mueller S, 2010, P NATL ACAD SCI USA, V107, P19390, DOI 10.1073/pnas.1014378107; Myles KM, 2008, P NATL ACAD SCI USA, V105, P19938, DOI 10.1073/pnas.0803408105; Parameswaran P, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000764; *R DEV COR TEAM, R LANG ENV STAT COMP; Ramsburg E, 2005, J VIROL, V79, P15043, DOI 10.1128/JVI.79.24.15043-15053.2005; Sabin LR, 2009, CELL, V138, P340, DOI 10.1016/j.cell.2009.04.045; Sanchez-Vargas I, 2004, VIRUS RES, V102, P65, DOI 10.1016/j.virusres.2004.01.017; Sanchez-Vargas I, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000299; Schnettler E, 2012, J VIROL, V86, P13486, DOI 10.1128/JVI.01104-12; Scott JC, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000848; Shin SW, 2005, J BIOL CHEM, V280, P16499, DOI 10.1074/jbc.M500711200; Siu RWC, 2011, J VIROL, V85, P2907, DOI 10.1128/JVI.02052-10; van Rij RP, 2006, GENE DEV, V20, P2985, DOI 10.1101/gad.1482006; Venables W.N., 2002, MODERN APPL STAT S, V4th ed, DOI DOI 10.1007/978-0-387-21706-2; Vodovar N, 2011, J VIROL, V85, P11016, DOI 10.1128/JVI.05647-11	40	84	84	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2013	8	2							e55458	10.1371/journal.pone.0055458	http://dx.doi.org/10.1371/journal.pone.0055458			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104BU	23424633	Green Published, Green Submitted, gold, Green Accepted			2022-12-25	WOS:000315965100021
J	Binsky-Ehrenreich, I; Marom, A; Sobotta, MC; Shvidel, L; Berrebi, A; Hazan-Halevy, I; Kay, S; Aloshin, A; Sagi, I; Goldenberg, DM; Leng, L; Bucala, R; Herishanu, Y; Haran, M; Shachar, I				Binsky-Ehrenreich, I.; Marom, A.; Sobotta, M. C.; Shvidel, L.; Berrebi, A.; Hazan-Halevy, I.; Kay, S.; Aloshin, A.; Sagi, I.; Goldenberg, D. M.; Leng, L.; Bucala, R.; Herishanu, Y.; Haran, M.; Shachar, I.			CD84 is a survival receptor for CLL cells	ONCOGENE			English	Article						CD84; CD74; MIF; survival; apoptosis	CHRONIC LYMPHOCYTIC-LEUKEMIA; MIGRATION-INHIBITORY FACTOR; INVARIANT CHAIN; SLAM FAMILY; FACTOR MIF; TUMOR-GROWTH; B-CELLS; EXPRESSION; CANCER; SAP	Chronic lymphocytic leukemia (CLL) is characterized by the accumulation of CD5+ B lymphocytes in peripheral blood, lymphoid organs and bone marrow. The main feature of the disease is accumulation of the malignant cells due to decreased apoptosis. CD84 belongs to the signaling lymphocyte activating molecule family of immunoreceptors, and has an unknown function in CLL cells. Here, we show that the expression of CD84 is significantly elevated from the early stages of the disease, and is regulated by macrophage migration inhibitory factor and its receptor, CD74. Activation of cell surface CD84 initiates a signaling cascade that enhances CLL cell survival. Both downmodulation of CD84 expression and its immune-mediated blockade induce cell death in vitro and in vivo. In addition, analysis of samples derived from an on-going clinical trial, in which human subjects were treated with humanized anti-CD74 (milatuzumab), shows a decrease in CD84 messenger RNA and protein levels in milatuzumab-treated cells. This downregulation was correlated with reduction of Bcl-2 and Mcl-1 expression. Thus, our data show that overexpression of CD84 in CLL is an important survival mechanism that appears to be an early event in the pathogenesis of the disease. These findings suggest novel therapeutic strategies based on the blockade of this CD84-dependent survival pathway.	[Binsky-Ehrenreich, I.; Marom, A.; Sobotta, M. C.; Shachar, I.] Weizmann Inst Sci, Dept Immunol, IL-76100 Rehovot, Israel; [Shvidel, L.; Berrebi, A.; Haran, M.] Kaplan Med Ctr, Hematol Inst, Rehovot, Israel; [Hazan-Halevy, I.; Kay, S.; Herishanu, Y.] Tel Aviv Univ, Tel Aviv Sourasky Med Ctr, Dept Hematol, IL-69978 Tel Aviv, Israel; [Aloshin, A.; Sagi, I.] Weizmann Inst Sci, IL-76100 Rehovot, Israel; [Goldenberg, D. M.] Ctr Mol Med & Immunol, Garden State Canc Ctr, Morris Plains, NJ USA; [Leng, L.; Bucala, R.] Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06510 USA	Weizmann Institute of Science; Hebrew University of Jerusalem; Kaplan Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center; Weizmann Institute of Science; Yale University	Shachar, I (corresponding author), Weizmann Inst Sci, Dept Immunol, IL-76100 Rehovot, Israel.	idit.shachar@weizmann.ac.il		Leng, Lin/0000-0002-0605-358X	Israel Science Foundation; Israel Cancer Association; Gurwin Foundation; Israel Cancer Research Foundation (ICRF); NIH; Alliance for Lupus Research; USPHS from the National Cancer Institute, NIH [PO1-CA103985]; United Israel Appeal of Canada; NATIONAL CANCER INSTITUTE [P01CA103985] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR050498] Funding Source: NIH RePORTER	Israel Science Foundation(Israel Science Foundation); Israel Cancer Association; Gurwin Foundation; Israel Cancer Research Foundation (ICRF); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alliance for Lupus Research; USPHS from the National Cancer Institute, NIH; United Israel Appeal of Canada; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	The authors gratefully acknowledge members of the Shachar laboratory team for helpful discussions. This research was supported by the Israel Science Foundation, the Israel Cancer Association, The Gurwin Foundation, Israel Cancer Research Foundation (ICRF), the NIH and the Alliance for Lupus Research (RB, LL), and in part by USPHS grant PO1-CA103985 from the National Cancer Institute, NIH (DMG), and by the United Israel Appeal of Canada. I Shachar is the incumbent of the Dr Morton and Ann Kleiman Professorial Chair.	Bando H, 2002, JPN J CANCER RES, V93, P389, DOI 10.1111/j.1349-7006.2002.tb01269.x; BERNHAGEN J, 1994, BIOCHEMISTRY-US, V33, P14144, DOI 10.1021/bi00251a025; Bifulco C, 2008, CURR PHARM DESIGN, V14, P3790, DOI 10.2174/138161208786898608; Binsky I, 2007, P NATL ACAD SCI USA, V104, P13408, DOI 10.1073/pnas.0701553104; Binsky I, 2010, J IMMUNOL, V184, P4761, DOI 10.4049/jimmunol.0904149; Caligaris-Cappio F, 1999, J CLIN ONCOL, V17, P399, DOI 10.1200/JCO.1999.17.1.399; Calpe S, 2006, IMMUNOGENETICS, V58, P15, DOI 10.1007/s00251-005-0056-3; Cannons JL, 2010, IMMUNITY, V32, P253, DOI 10.1016/j.immuni.2010.01.010; Chesney J, 1999, MOL MED, V5, P181, DOI 10.1007/BF03402061; Cheson BD, 1996, BLOOD, V87, P4990, DOI 10.1182/blood.V87.12.4990.bloodjournal87124990; COCKS BG, 1995, NATURE, V376, P260, DOI 10.1038/376260a0; Cohen S, 2012, J IMMUNOL, V188, P259, DOI 10.4049/jimmunol.1101468; Datta MW, 2000, APPL IMMUNOHISTO M M, V8, P210, DOI 10.1097/00022744-200009000-00007; delaFuente MA, 1997, BLOOD, V90, P2398; Dios A, 2002, J MED CHEM, V45, P2410, DOI 10.1021/jm010534q; Durig J, 2007, CANCER RES, V67, P8653, DOI 10.1158/0008-5472.CAN-07-1198; Engel P, 2003, NAT REV IMMUNOL, V3, P813, DOI 10.1038/nri1202; Flaishon L, 2004, BLOOD, V104, P933, DOI 10.1182/blood-2003-11-4013; Goldman JP, 1998, BRIT J HAEMATOL, V103, P335, DOI 10.1046/j.1365-2141.1998.00980.x; Gordin M, 2010, J IMMUNOL, V185, P2020, DOI 10.4049/jimmunol.0902566; Gore Y, 2008, J BIOL CHEM, V283, P2784, DOI 10.1074/jbc.M703265200; Hallek M, 2008, BLOOD, V111, P5446, DOI 10.1182/blood-2007-06-093906; Haran M, 2004, LEUKEMIA, V18, P1948, DOI 10.1038/sj.leu.2403512; Hartmann TN, 2009, CANCER RES, V69, P3121, DOI 10.1158/0008-5472.CAN-08-4136; HO MK, 1984, METHOD ENZYMOL, V108, P313; Howie D, 2002, BLOOD, V99, P957, DOI 10.1182/blood.V99.3.957; Inabe K, 2002, BLOOD, V99, P584, DOI 10.1182/blood.V99.2.584; Ioachim HL, 1996, AM J SURG PATHOL, V20, P64, DOI 10.1097/00000478-199601000-00007; Ishigami S, 2001, CANCER LETT, V168, P87, DOI 10.1016/S0304-3835(01)00503-1; Kay S, 2006, CYTOM PART B-CLIN CY, V70B, P218, DOI 10.1002/cyto.b.20078; Latour S, 2004, SEMIN IMMUNOL, V16, P409, DOI 10.1016/j.smim.2004.08.020; Lazova R, 1997, CANCER-AM CANCER SOC, V79, P2115, DOI 10.1002/(SICI)1097-0142(19970601)79:11<2115::AID-CNCR8>3.0.CO;2-N; Leng L, 2003, J EXP MED, V197, P1467, DOI 10.1084/jem.20030286; Luger D, 2004, J CLIN IMMUNOL, V24, P579, DOI 10.1007/s10875-004-6245-2; Martin M, 2001, J IMMUNOL, V167, P3668, DOI 10.4049/jimmunol.167.7.3668; Matza D, 2003, TRENDS IMMUNOL, V24, P264, DOI 10.1016/S1471-4906(03)00073-5; Matza D, 2002, IMMUNITY, V17, P549, DOI 10.1016/S1074-7613(02)00455-7; Matza D, 2002, P NATL ACAD SCI USA, V99, P3018, DOI 10.1073/pnas.052703299; Matza D, 2001, J BIOL CHEM, V276, P27203, DOI 10.1074/jbc.M104684200; Meyer-Siegler KL, 2004, BMC CANCER, V4, DOI 10.1186/1471-2407-4-34; MeyerSiegler K, 1996, UROLOGY, V48, P448, DOI 10.1016/S0090-4295(96)00207-5; Mizue Y, 2000, INT J MOL MED, V5, P397; Morra M, 2001, EMBO J, V20, P5840, DOI 10.1093/emboj/20.21.5840; Nagy N, 2000, INT J CANCER, V88, P439, DOI 10.1002/1097-0215(20001101)88:3<439::AID-IJC17>3.0.CO;2-#; Nanda N, 2005, BLOOD, V106, P3028, DOI 10.1182/blood-2005-01-0333; NARNI F, 1986, BLOOD, V68, P372; Nichols KE, 2005, IMMUNOL REV, V203, P180, DOI 10.1111/j.0105-2896.2005.00230.x; Nishihira J, 2003, ANN NY ACAD SCI, V995, P171, DOI 10.1111/j.1749-6632.2003.tb03220.x; Oliver-Vila I, 2008, MOL IMMUNOL, V45, P2138, DOI 10.1016/j.molimm.2007.12.006; Palou E, 2000, TISSUE ANTIGENS, V55, P118, DOI 10.1034/j.1399-0039.2000.550203.x; Romero X, 2005, J IMMUNOL, V174, P7033, DOI 10.4049/jimmunol.174.11.7033; Shachar I, 1996, SCIENCE, V274, P106, DOI 10.1126/science.274.5284.106; Starlets D, 2006, BLOOD, V107, P4807, DOI 10.1182/blood-2005-11-4334; Stein R, 2004, BLOOD, V104, P3705, DOI 10.1182/blood-2004-03-0890; Stein R, 2007, CLIN CANCER RES, V13, p5556S, DOI 10.1158/1078-0432.CCR-07-1167; Stumptner-Cuvelette P, 2002, BBA-MOL CELL RES, V1542, P1, DOI 10.1016/S0167-4889(01)00166-5; Tangye SG, 2002, EUR J IMMUNOL, V32, P1640, DOI 10.1002/1521-4141(200206)32:6<1640::AID-IMMU1640>3.0.CO;2-S; Veenstra H, 1996, CELL IMMUNOL, V171, P68, DOI 10.1006/cimm.1996.0174; Veillette A, 2006, NAT REV IMMUNOL, V6, P56, DOI 10.1038/nri1761; Veillette A, 2003, CURR OPIN IMMUNOL, V15, P277, DOI 10.1016/S0952-7915(03)00041-4; Yan QR, 2007, P NATL ACAD SCI USA, V104, P10583, DOI 10.1073/pnas.0703893104; Young AN, 2001, AM J PATHOL, V158, P1639, DOI 10.1016/S0002-9440(10)64120-X	62	25	26	2	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 20	2014	33	8					1006	1016		10.1038/onc.2013.31	http://dx.doi.org/10.1038/onc.2013.31			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AB6XO	23435417	Green Accepted			2022-12-25	WOS:000331933200008
J	Nambu, S; Matsui, T; Goulding, CW; Takahashi, S; Ikeda-Saito, M				Nambu, Shusuke; Matsui, Toshitaka; Goulding, Celia W.; Takahashi, Satoshi; Ikeda-Saito, Masao			A New Way to Degrade Heme THE MYCOBACTERIUM TUBERCULOSIS ENZYME MhuD CATALYZES HEME DEGRADATION WITHOUT GENERATING CO	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RING-OPENING MECHANISM; STAPHYLOCOCCUS-AUREUS; CARBON-MONOXIDE; OXYGENASE COMPLEX; RESONANCE RAMAN; ISDG; IRON; SITE; VERDOHEME; SYSTEM	MhuD is an oxygen-dependent heme-degrading enzyme from Mycobacterium tuberculosis with high sequence similarity (similar to 45%) to Staphylococcus aureus IsdG and IsdI. Spectroscopic and mutagenesis studies indicate that the catalytically active 1: 1 heme-MhuD complex has an active site structure similar to those of IsdG and IsdI, including the nonplanarity (ruffling) of the heme group bound to the enzyme. Distinct from the canonical heme degradation, we have found that the MhuD catalysis does not generate CO. Product analyses by electrospray ionization-MS and NMR show that MhuD cleaves heme at the alpha-meso position but retains the meso-carbon atom at the cleavage site, which is removed by canonical heme oxygenases. The novel tetrapyrrole product of MhuD, termed "mycobilin," has an aldehyde group at the cleavage site and a carbonyl group at either the beta-meso or the delta-meso position. Consequently, MhuD catalysis does not involve verdoheme, the key intermediate of ring cleavage by canonical heme oxygenase enzymes. Ruffled heme is apparently responsible for the heme degradation mechanism unique to MhuD. In addition, MhuD heme degradation without CO liberation is biologically significant as one of the signals of M. tuberculosis transition to dormancy is mediated by the production of host CO.	[Nambu, Shusuke; Matsui, Toshitaka; Takahashi, Satoshi; Ikeda-Saito, Masao] Tohoku Univ, Inst Multidisciplinary Res Adv Mat, Aoba Ku, Sendai, Miyagi 9808577, Japan; [Goulding, Celia W.] Univ Calif Irvine, Dept Mol Biol & Biochem, Irvine, CA 92697 USA; [Goulding, Celia W.] Univ Calif Irvine, Dept Pharmaceut Sci, Irvine, CA 92697 USA	Tohoku University; University of California System; University of California Irvine; University of California System; University of California Irvine	Ikeda-Saito, M (corresponding author), Tohoku Univ, Inst Multidisciplinary Res Adv Mat, Aoba Ku, Katahira 2-1-1, Sendai, Miyagi 9808577, Japan.	mis2@tagen.tohoku.ac.jp	Takahashi, Satoshi/AAC-5532-2019; Ikeda-Saito, Masao/K-2703-2015; Matsui, Toshitaka/B-1570-2008; Ikeda-Saito, Masao/A-5992-2008	Takahashi, Satoshi/0000-0003-1506-9222; Matsui, Toshitaka/0000-0003-3865-8468; 	Japan Society for the Promotion of Science [21350087, 2412006, 24350081, 23657097, 23107702, 23550186]; Ministry of Education, Culture, Sports, Science and Technology, Japan; National Institutes of Health [AI081161]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI081161] Funding Source: NIH RePORTER	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by Grants-in-aid for Scientific Research 21350087, 2412006, and 24350081 (to M. I. S.), 23657097 and 23107702 (to S. T.), and 23550186 (to T. M.) from the Japan Society for the Promotion of Science; by the Strategic Alliance Project for the Creation of Nano-Materials, Nano-devices and Nano-systems from the Ministry of Education, Culture, Sports, Science and Technology, Japan; and by National Institutes of Health Grant AI081161 (to C.W.G.).	Antonini E., 1971, HEMOGLOBIN MYOGLOBIN, P40; Chim N, 2010, J MOL BIOL, V395, P595, DOI 10.1016/j.jmb.2009.11.025; De Montellano PRO, 1998, ACCOUNTS CHEM RES, V31, P543; Genco CA, 2001, MOL MICROBIOL, V39, P1, DOI 10.1046/j.1365-2958.2001.02231.x; Haley KP, 2011, J BACTERIOL, V193, P4749, DOI 10.1128/JB.00436-11; Hawkins BK, 1996, BBA-PROTEIN STRUCT M, V1295, P165, DOI 10.1016/0167-4838(96)00031-3; KERR EA, 1983, BIOCHEMISTRY-US, V22, P4373, DOI 10.1021/bi00288a005; Kitagawa T, 1988, BIOL APPL RAMAN SPEC, V3, P97; Kumar A, 2008, J BIOL CHEM, V283, P18032, DOI 10.1074/jbc.M802274200; Lai WZ, 2010, J AM CHEM SOC, V132, P12960, DOI 10.1021/ja104674q; Lee WC, 2008, J BIOL CHEM, V283, P30957, DOI 10.1074/jbc.M709486200; Maines MD, 1997, ANNU REV PHARMACOL, V37, P517, DOI 10.1146/annurev.pharmtox.37.1.517; Matera KM, 1997, BIOCHEMISTRY-US, V36, P4909, DOI 10.1021/bi962321m; Matsui T, 2005, J BIOL CHEM, V280, P36833, DOI 10.1074/jbc.M503529200; Matsui T, 2008, J AM CHEM SOC, V130, P4220, DOI 10.1021/ja710495z; Matsui T, 2010, ACCOUNTS CHEM RES, V43, P240, DOI 10.1021/ar9001685; Mazmanian SK, 2003, SCIENCE, V299, P906, DOI 10.1126/science.1081147; Migita CT, 2005, BIOCHEM BIOPH RES CO, V338, P584, DOI 10.1016/j.bbrc.2005.08.045; MORISHIMA I, 1995, INORG CHEM, V34, P1528, DOI 10.1021/ic00110a035; Poss KD, 1997, P NATL ACAD SCI USA, V94, P10925, DOI 10.1073/pnas.94.20.10925; Pruzinska A, 2003, P NATL ACAD SCI USA, V100, P15259, DOI 10.1073/pnas.2036571100; Puri S, 2006, J BACTERIOL, V188, P6476, DOI 10.1128/JB.00737-06; Reniere ML, 2010, MOL MICROBIOL, V75, P1529, DOI 10.1111/j.1365-2958.2010.07076.x; Roberts DM, 2004, J BIOL CHEM, V279, P23082, DOI 10.1074/jbc.M401230200; ROHLFS RJ, 1990, J BIOL CHEM, V265, P3168; Schmitt MP, 1997, J BACTERIOL, V179, P838, DOI 10.1128/jb.179.3.838-845.1997; Shelnutt JA, 1998, CHEM SOC REV, V27, P31; Shiloh MU, 2008, CELL HOST MICROBE, V3, P323, DOI 10.1016/j.chom.2008.03.007; Skaar EP, 2004, J BIOL CHEM, V279, P436, DOI 10.1074/jbc.M307952200; Skaar EP, 2006, J BACTERIOL, V188, P1071, DOI 10.1128/JB.188.3.1071-1080.2006; Suematsu M, 2000, HEPATOLOGY, V31, P3, DOI 10.1002/hep.510310102; TAKAHASHI S, 1994, J BIOL CHEM, V269, P1010; TAKAHASHI S, 1994, BIOCHEMISTRY-US, V33, P5531, DOI 10.1021/bi00184a023; Takayama SJ, 2011, P NATL ACAD SCI USA, V108, P13071, DOI 10.1073/pnas.1101459108; TENHUNEN R, 1969, J BIOL CHEM, V244, P6388; Ukpabi G, 2012, J BIOL CHEM, V287, P34179, DOI 10.1074/jbc.M112.393249; Voskuil MI, 2003, J EXP MED, V198, P705, DOI 10.1084/jem.20030205; Wandersman C, 2000, CURR OPIN MICROBIOL, V3, P215, DOI 10.1016/S1369-5274(00)00078-3; Wu RY, 2005, J BIOL CHEM, V280, P2840, DOI 10.1074/jbc.M409526200; YONETANI T, 1972, J BIOL CHEM, V247, P2447; YOSHIDA T, 1978, J BIOL CHEM, V253, P4230	41	81	83	0	31	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 5	2013	288	14					10101	10109		10.1074/jbc.M112.448399	http://dx.doi.org/10.1074/jbc.M112.448399			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	119RB	23420845	Green Published, hybrid			2022-12-25	WOS:000317114000051
J	Schael, S; Nuchel, J; Muller, S; Petermann, P; Kormann, J; Perez-Otano, I; Martinez, SM; Paulsson, M; Plomann, M				Schael, Sylvia; Nuechel, Julian; Mueller, Stefan; Petermann, Philipp; Kormann, Jan; Perez-Otano, Isabel; Marco Martinez, Sonia; Paulsson, Mats; Plomann, Markus			Casein Kinase 2 Phosphorylation of Protein Kinase C and Casein Kinase 2 Substrate in Neurons (PACSIN) 1 Protein Regulates Neuronal Spine Formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GTPASE-ACTIVATING PROTEIN; F-BAR DOMAIN; NEUROTROPHIC FACTOR; DENDRITIC SPINES; NMDA RECEPTORS; RHO GTPASES; SYNDAPIN-I; BRAIN; ENDOCYTOSIS; MEMBRANE	The PACSIN (protein kinase C and casein kinase 2 substrate in neurons) adapter proteins couple components of the clathrin-mediated endocytosis machinery with regulators of actin polymerization and thereby regulate the surface expression of specific receptors. The brain-specific PACSIN 1 is enriched at synapses and has been proposed to affect neuromorphogenesis and the formation and maturation of dendritic spines. In studies of how phosphorylation of PACSIN 1 contributes to neuronal function, we identified serine 358 as a specific site used by casein kinase 2 (CK2) in vitro and in vivo. Phosphorylated PACSIN 1 was found in neuronal cytosol and membrane fractions. This localization could be modulated by trophic factors such as brain-derived neurotrophic factor (BDNF). We further show that expression of a phospho-negative PACSIN 1 mutant, S358A, or inhibition of CK2 drastically reduces spine formation in neurons. We identified a novel protein complex containing the spine regulator Rac1, its GTPase-activating protein neuron-associated developmentally regulated protein (NADRIN), and PACSIN 1. CK2 phosphorylation of PACSIN 1 leads to a dissociation of the complex upon BDNF treatment and induces Rac1-dependent spine formation in dendrites of hippocampal neurons. These findings suggest that upon BDNF signaling PACSIN 1 is phosphorylated by CK2 which is essential for spine formation.	[Schael, Sylvia; Nuechel, Julian; Petermann, Philipp; Kormann, Jan; Paulsson, Mats; Plomann, Markus] Univ Cologne, Fac Med, Ctr Biochem, D-50931 Cologne, Germany; [Schael, Sylvia; Mueller, Stefan; Paulsson, Mats; Plomann, Markus] Univ Cologne, Fac Med, CMMC, D-50931 Cologne, Germany; [Paulsson, Mats] Univ Cologne, Fac Med, Cologne Excellence Cluster Cellular Stress Respon, D-50931 Cologne, Germany; [Perez-Otano, Isabel; Marco Martinez, Sonia] Univ Clin & Med Sch, Ctr Res Appl Med CIMA, Dept Neurosci, E-31008 Pamplona, Spain	University of Cologne; University of Cologne; University of Cologne	Plomann, M (corresponding author), Univ Cologne, Fac Med, Inst Biochem 2, Joseph Stelzmann Str 52, D-50931 Cologne, Germany.	markus.plomann@uni-koeln.de	Marco, Sonia/AAB-4691-2019; Marco, Sonia/AAA-6591-2019; Perez-Otano, Isabel/S-9613-2017	Marco, Sonia/0000-0001-5930-9553; Marco, Sonia/0000-0001-5930-9553; Perez-Otano, Isabel/0000-0002-7222-8202; Nuchel, Julian/0000-0002-8126-415X	Center for Molecular Medicine Cologne (CMMC); Koln Fortune program of the Medical Faculty of the University of Cologne; Fonds der Chemischen Industrie; Centro de Investigacion Medica Aplicada; Government of Navarra; Spanish Ministry of Innovation and Science [CSD2008-00005]	Center for Molecular Medicine Cologne (CMMC); Koln Fortune program of the Medical Faculty of the University of Cologne; Fonds der Chemischen Industrie(Fonds der Chemischen IndustrieEuropean Commission); Centro de Investigacion Medica Aplicada; Government of Navarra; Spanish Ministry of Innovation and Science(Spanish Government)	This work was supported by the Center for Molecular Medicine Cologne (CMMC) and the Koln Fortune program of the Medical Faculty of the University of Cologne (to M. Plomann).; Supported by a fellowship from the Fonds der Chemischen Industrie.; Supported by Centro de Investigacion Medica Aplicada and grants from the Government of Navarra and Spanish Ministry of Innovation and Science (Grant CSD2008-00005 to I. P.-O.).	Anggono V, 2006, NAT NEUROSCI, V9, P752, DOI 10.1038/nn1695; Blanquet PR, 2000, PROG NEUROBIOL, V60, P211, DOI 10.1016/S0301-0082(99)00026-X; Blanquet PR, 1998, NEUROSCIENCE, V86, P739, DOI 10.1016/S0306-4522(98)00087-6; Bourne JN, 2008, ANNU REV NEUROSCI, V31, P47, DOI 10.1146/annurev.neuro.31.060407.125646; de Kreu BJ, 2011, J CELL SCI, V124, P2375, DOI 10.1242/jcs.080630; Dharmalingam E, 2009, J NEUROSCI, V29, P13315, DOI 10.1523/JNEUROSCI.3973-09.2009; Ethell IM, 2005, PROG NEUROBIOL, V75, P161, DOI 10.1016/j.pneurobio.2005.02.003; Furuta B, 2002, J NEUROCHEM, V82, P1018, DOI 10.1046/j.1471-4159.2002.01021.x; Gao X, 2009, EXP NEUROL, V215, P178, DOI 10.1016/j.expneurol.2008.10.009; Giessel AJ, 2010, NEURON, V68, P936, DOI 10.1016/j.neuron.2010.09.004; Gorski JA, 2003, J NEUROSCI, V23, P6856; Guerra B, 1999, FEBS LETT, V462, P353, DOI 10.1016/S0014-5793(99)01553-7; Haditsch U, 2009, MOL CELL NEUROSCI, V41, P409, DOI 10.1016/j.mcn.2009.04.005; Halbach A, 2007, FEBS J, V274, P773, DOI 10.1111/j.1742-4658.2006.05622.x; Hilton JM, 2001, J BIOL CHEM, V276, P16341, DOI 10.1074/jbc.M011122200; Hinton R. H., 1997, SUBCELLULAR FRACTION, P31; Holt M, 2006, J BIOL CHEM, V281, P17076, DOI 10.1074/jbc.M513838200; Jones C, 2003, J BIOL CHEM, V278, P29024, DOI 10.1074/jbc.M304855200; Jourdi H, 2003, DEV BIOL, V263, P216, DOI 10.1016/j.ydbio.2003.07.008; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Meggio F, 2003, FASEB J, V17, P349, DOI 10.1096/fj.02-0473rev; Miyamoto Y, 2006, P NATL ACAD SCI USA, V103, P10444, DOI 10.1073/pnas.0603914103; Modregger J, 2000, J CELL SCI, V113, P4511; Moss SJ, 1996, INT REV NEUROBIOL, V39, P1, DOI 10.1016/S0074-7742(08)60662-5; Nakayama AY, 2000, HIPPOCAMPUS, V10, P582, DOI 10.1002/1098-1063(2000)10:5<582::AID-HIPO8>3.0.CO;2-K; Newpher TM, 2009, TRENDS CELL BIOL, V19, P218, DOI 10.1016/j.tcb.2009.02.004; Numakawa T, 2010, HISTOL HISTOPATHOL, V25, P237, DOI 10.14670/HH-25.237; Perez-Otano I, 2006, NAT NEUROSCI, V9, P611, DOI 10.1038/nn1680; Plomann M, 1998, EUR J BIOCHEM, V256, P201, DOI 10.1046/j.1432-1327.1998.2560201.x; Plomann M., 2009, POMBE CDC15 HOMOLOGY, P39; Qualmann B, 2000, J CELL BIOL, V148, P1047, DOI 10.1083/jcb.148.5.1047; Qualmann B, 1999, MOL BIOL CELL, V10, P501, DOI 10.1091/mbc.10.2.501; Rao YJ, 2010, P NATL ACAD SCI USA, V107, P8213, DOI 10.1073/pnas.1003478107; Rex CS, 2007, J NEUROSCI, V27, P3017, DOI 10.1523/JNEUROSCI.4037-06.2007; Richnau N, 2001, J BIOL CHEM, V276, P35060, DOI 10.1074/jbc.M103540200; Ridley AJ, 2006, TRENDS CELL BIOL, V16, P522, DOI 10.1016/j.tcb.2006.08.006; Roberts AC, 2009, NEURON, V63, P342, DOI 10.1016/j.neuron.2009.06.016; Roche Katherine W., 1994, Current Opinion in Neurobiology, V4, P383, DOI 10.1016/0959-4388(94)90100-7; Sanz-Clemente A, 2010, NEURON, V67, P984, DOI 10.1016/j.neuron.2010.08.011; Solyakov L, 2004, J BIOL CHEM, V279, P43403, DOI 10.1074/jbc.M403239200; Steffen A, 2004, EMBO J, V23, P749, DOI 10.1038/sj.emboj.7600084; Tashiro A, 2003, HISTOL HISTOPATHOL, V18, P617, DOI 10.14670/HH-18.617; Tashiro A, 2000, CEREB CORTEX, V10, P927, DOI 10.1093/cercor/10.10.927; Tolias KF, 2005, NEURON, V45, P525, DOI 10.1016/j.neuron.2005.01.024; Tolias KF, 2011, PROG NEUROBIOL, V94, P133, DOI 10.1016/j.pneurobio.2011.04.011	45	25	26	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 29	2013	288	13					9303	9312		10.1074/jbc.M113.461293	http://dx.doi.org/10.1074/jbc.M113.461293			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	116DG	23420842	Green Published, hybrid			2022-12-25	WOS:000316862200048
J	Deng, T; Huang, Y; Yu, SC; Gu, J; Huang, CR; Xiao, GX; Hao, YT				Deng, Te; Huang, Yong; Yu, Shicheng; Gu, Jing; Huang, Cunrui; Xiao, Gexin; Hao, Yuantao			Spatial-Temporal Clusters and Risk Factors of Hand, Foot, and Mouth Disease at the District Level in Guangdong Province, China	PLOS ONE			English	Article							ENTEROVIRUS 71; EPIDEMIOLOGY; OUTBREAK; HERPANGINA; MALARIA; CANCER; JAPAN; A6	Objective: Hand, foot, and mouth disease (HFMD) has posed a great threat to the health of children and become a public health priority in China. This study aims to investigate the epidemiological characteristics, spatial-temporal patterns, and risk factors of HFMD in Guangdong Province, China, and to provide scientific information for public health responses and interventions. Methods: HFMD surveillance data from May 2008 to December 2011were provided by the Chinese Center for Disease Control and Prevention. We firstly conducted a descriptive analysis to evaluate the epidemic characteristics of HFMD. Then, Kulldorff scan statistic based on a discrete Poisson model was used to detect spatial-temporal clusters. Finally, a spatial paneled model was applied to identify the risk factors. Results: A total of 641,318 HFMD cases were reported in Guangdong Province during the study period (total population incidence: 17.51 per 10,000). Male incidence was higher than female incidence for all age groups, and approximately 90% of the cases were children <= 5 years old. Spatial-temporal cluster analysis detected four most likely clusters and several secondary clusters (P<0.001) with the maximum cluster size 50% and 20% respectively during 2008-2011. Monthly average temperature, relative humidity, the proportion of population <= 5 years, male-to-female ratio, and total sunshine were demonstrated to be the risk factors for HFMD. Conclusion: Children <= 5 years old, especially boys, were more susceptible to HFMD and we should take care of their vulnerability. Provincial capital city Guangzhou and the Pearl River Delta regions had always been the spatial-temporal clusters and future public health planning and resource allocation should be focused on these areas. Furthermore, our findings showed a strong association between HFMD and meteorological factors, which may assist in predicting HFMD incidence.	[Deng, Te; Huang, Yong; Gu, Jing; Hao, Yuantao] Sun Yat Sen Univ, Dept Med Stat, Sch Publ Hlth, Guangzhou 510275, Guangdong, Peoples R China; [Deng, Te; Huang, Yong; Gu, Jing; Hao, Yuantao] Sun Yat Sen Univ, Epidemiol & Hlth Informat Res Ctr, Sch Publ Hlth, Guangzhou 510275, Guangdong, Peoples R China; [Yu, Shicheng; Xiao, Gexin] Chinese Ctr Dis Control & Prevent, Ctr Publ Hlth Surveillance & Informat Serv, Beijing, Peoples R China; [Huang, Cunrui] Griffith Univ, Sch Environm, Ctr Environm & Populat Hlth, Brisbane, Qld 4111, Australia	Sun Yat Sen University; Sun Yat Sen University; Chinese Center for Disease Control & Prevention; Griffith University	Hao, YT (corresponding author), Sun Yat Sen Univ, Dept Med Stat, Sch Publ Hlth, Guangzhou 510275, Guangdong, Peoples R China.	haoyt@mail.sysu.edu.cn	Huang, Cunrui/ABI-3312-2020	Huang, Yong/0000-0001-7973-4039				Ang LW, 2009, ANN ACAD MED SINGAP, V38, P106; [Anonymous], 2011, SATSCAN USER GUIDE V; Anselin L, 2006, GEOGR ANAL, V38, P5, DOI 10.1111/j.0016-7363.2005.00671.x; Anselin L., 2008, ECONOMETRICS PANEL D, P625, DOI 10.1007/978-3-540-75892-1_19; Blomqvist S, 2010, J CLIN VIROL, V48, P49, DOI 10.1016/j.jcv.2010.02.002; Chinese Center for Disease Control and Prevention(China CDC), 2008, NAT INC DEATH CAS NO; Chinese Center for Disease Control and Prevention(China CDC), 2011, NAT INC DEATH CAS NO; Chinese Center for Disease Control and Prevention(China CDC), 2010, NAT INC DEATH CAS NO; Chinese Center for Disease Control and Prevention(China CDC), 2009, NAT INC DEATH CAS NO; Chua Kaw Bing, 2011, Virologica Sinica, V26, P221, DOI 10.1007/s12250-011-3195-8; Elhorst J. P., 2010, HDB APPL SPATIAL ANA, P377, DOI DOI 10.1007/978-3-642-03647-7_19; Elhorst J P, 2010, MATLAB SOFTWARE SPAT; Elhorst JP, 2003, INT REGIONAL SCI REV, V26, P244, DOI 10.1177/0160017603253791; Fujimoto T, 2012, EMERG INFECT DIS, V18, P337, DOI 10.3201/eid1802.111147; Gaudart J, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-286; Ho MT, 1999, NEW ENGL J MED, V341, P929, DOI 10.1056/NEJM199909233411301; Hosoya M, 2006, PEDIATR INFECT DIS J, V25, P691, DOI 10.1097/01.inf.0000227959.89339.c3; Ji Z, 2012, MICROBES ENV; Kleinman KP, 2005, EPIDEMIOL INFECT, V133, P409, DOI 10.1017/S0950268804003528; Kulldorff M, 1997, AM J EPIDEMIOL, V146, P161; Kulldorff M, 2005, PLOS MED, V2, P216, DOI 10.1371/journal.pmed.0020059; Kulldorff M, 1998, AM J PUBLIC HEALTH, V88, P1377, DOI 10.2105/AJPH.88.9.1377; Kulldorff M, 1997, COMMUN STAT-THEOR M, V26, P1481, DOI 10.1080/03610929708831995; Liu MY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025287; Lv H, 2011, ZHEJIANG PREV MED, V23, P29; Ma E, 2010, JPN J INFECT DIS, V63, P422; Mao LX, 2010, J CLIN VIROL, V49, P100, DOI 10.1016/j.jcv.2010.07.009; Momoki TS, 2009, JPN J INFECT DIS, V62, P471; Openshaw, 1984, CONCEPTS TECHNIQUES, V38; Ruan F, 2011, PEDIATRICS, V127, pE898, DOI 10.1542/peds.2010-1497; Solomon T, 2010, LANCET INFECT DIS, V10, P778, DOI 10.1016/S1473-3099(10)70194-8; The Ministry of Health of the People's Republic of China, 2008, CAP J PUBLIC HLTH, P146; The Ministry of Health of The People's Republic of China, 2009, GAZETTE MINIST HLTH, P65; Urashima M, 2003, JPN J INFECT DIS, V56, P48; Weng KF, 2010, MICROBES INFECT, V12, P505, DOI 10.1016/j.micinf.2010.03.006; Xu W, 2011, ASIA PAC J PUBLIC HL; Zhang J, 2011, BIOMED ENVIRON SCI, V24, P214, DOI 10.3967/0895-3988.2011.03.002; Zhang WY, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-206; Zhang Y, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-94; Zhu FC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037206; Zhu Q, 2011, BIOMED ENVIRON SCI, V24, P349, DOI 10.3967/0895-3988.2011.04.005	41	99	111	0	76	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2013	8	2							e56943	10.1371/journal.pone.0056943	http://dx.doi.org/10.1371/journal.pone.0056943			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IT	23437278	Green Published, gold			2022-12-25	WOS:000315186000058
J	Stoppin-Mellet, V; Fache, V; Portran, D; Martiel, JL; Vantard, M				Stoppin-Mellet, Virginie; Fache, Vincent; Portran, Didier; Martiel, Jean-Louis; Vantard, Marylin			MAP65 Coordinate Microtubule Growth during Bundle Formation	PLOS ONE			English	Article							DYNAMIC INSTABILITY; CROSS-LINKING; PROTEIN; BINDING; ARRAYS; PRC1; INTERPHASE; GENERATION; REVEALS; ASE1P	Microtubules (MTs) are highly dynamical structures that play a crucial role in cell physiology. In cooperation with microtubule-associated proteins (MAPs), MTs form bundles endowing cells with specific mechanisms to control their shape or generate forces. Whether the dynamics of MTs is affected by the lateral connections that MAPs make between MTs during bundle formation is still under debate. Using in vitro reconstitution of MT bundling, we analyzed the dynamics of MT bundles generated by two plant MAP65 (MAP65-1/4), MAP65-1 being the plant ortholog of vertebrate PRC1 and yeast Ase1. MAP65-1/4 limit the amplitude of MT bundle depolymerization and increase the elongation phases. The subsequent sustained elongation of bundles is governed by the coordination of MT growth, so that MT ends come in close vicinity. We develop a model based on the assumption that both MAP65-1/4 block MT depolymerization. Model simulations reveal that rescue frequencies are higher between parallel than between anti-parallel MTs. In consequence the polarity of bundled MTs by MAP65 controls the amplitude of bundle's growth. Our results illustrate how MAP-induced MT-bundling, which is finely tuned by MT polarity, robustly coordinates MT elongation within bundles.	[Stoppin-Mellet, Virginie; Fache, Vincent; Portran, Didier; Martiel, Jean-Louis; Vantard, Marylin] Univ Grenoble 1, Physiol Cellulaire Vegetale Lab, Inst Rech Technol & Sci Vivant iRTSV,CNRS,INRA, Commissariat Energie Atom & Energies Alternat,CEA, Grenoble, France	INRAE; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS)	Stoppin-Mellet, V (corresponding author), Univ Grenoble 1, Physiol Cellulaire Vegetale Lab, Inst Rech Technol & Sci Vivant iRTSV,CNRS,INRA, Commissariat Energie Atom & Energies Alternat,CEA, Grenoble, France.	virginie.stoppin-mellet@cea.fr; marylin.vantard@cea.fr	Martiel, Jean-Louis/N-5250-2018; Martiel, Jean-Louis/M-7181-2014; stoppin-mellet, Virginie/I-9883-2017	Martiel, Jean-Louis/0000-0001-8638-7207; stoppin-mellet, Virginie/0000-0002-1958-1306; Portran, Didier/0000-0002-0356-398X	CNRS; CEA; French Research Ministry	CNRS(Centre National de la Recherche Scientifique (CNRS)); CEA(French Atomic Energy Commission); French Research Ministry(Ministry of Research, France)	This work was funded by grants from the CNRS, the CEA and from the French Research Ministry (D.P and V.F). We also thank the Agence Nationale de la Recherche (ANR-08-Syscom_013, J-L.M.) and the Institute of Complex Systems IXXI-Rhone-Alpes (J-L.M). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartolini F, 2006, J CELL SCI, V119, P4155, DOI 10.1242/jcs.03227; Barton DA, 2008, PLANT CELL, V20, P982, DOI 10.1105/tpc.108.058503; Bieling P, 2010, CELL, V142, P420, DOI 10.1016/j.cell.2010.06.033; Bratman SV, 2008, TRENDS CELL BIOL, V18, P580, DOI 10.1016/j.tcb.2008.09.004; Brun L, 2009, P NATL ACAD SCI USA, V106, P21173, DOI 10.1073/pnas.0910774106; Caillaud MC, 2008, PLANT CELL, V20, P423, DOI 10.1105/tpc.107.057422; Dhonukshe P, 2012, CELL, V149, P383, DOI 10.1016/j.cell.2012.02.051; Fache V, 2010, PLANT CELL, V22, P3804, DOI 10.1105/tpc.110.080606; Gaillard J, 2008, MOL BIOL CELL, V19, P4534, DOI 10.1091/mbc.E08-04-0341; HARDHAM AR, 1978, J CELL BIOL, V77, P14, DOI 10.1083/jcb.77.1.14; Hussey PJ, 2002, PLANT MOL BIOL, V50, P915, DOI 10.1023/A:1021236307508; HYMAN A, 1991, METHOD ENZYMOL, V196, P478; Janson ME, 2007, CELL, V128, P357, DOI 10.1016/j.cell.2006.12.030; Jiang W, 1998, MOL CELL, V2, P877, DOI 10.1016/S1097-2765(00)80302-0; Kiris E, 2010, METHOD CELL BIOL, V95, P481, DOI 10.1016/S0091-679X(10)95024-3; Laan L, 2008, P NATL ACAD SCI USA, V105, P8920, DOI 10.1073/pnas.0710311105; LEDBETTER MC, 1963, J CELL BIOL, V19, P239, DOI 10.1083/jcb.19.1.239; Loiodice I, 2005, MOL BIOL CELL, V16, P1756, DOI 10.1091/mbc.E04-10-0899; Lucas JR, 2011, PLANT CELL, V23, P1889, DOI 10.1105/tpc.111.084970; MITCHISON T, 1984, NATURE, V312, P237, DOI 10.1038/312237a0; Mollinari C, 2002, J CELL BIOL, V157, P1175, DOI 10.1083/jcb.200111052; Muller S, 2004, CURR BIOL, V14, P412, DOI 10.1016/j.cub.2004.02.032; SCHULZE E, 1986, J CELL BIOL, V102, P1020, DOI 10.1083/jcb.102.3.1020; Schuyler SC, 2003, J CELL BIOL, V160, P517, DOI 10.1083/jcb.200210021; Shaw SL, 2011, CYTOSKELETON, V68, P56, DOI 10.1002/cm.20495; Shaw SL, 2003, SCIENCE, V300, P1715, DOI 10.1126/science.1083529; Smertenko AP, 2004, PLANT CELL, V16, P2035, DOI 10.1105/tpc.104.023937; Subramanian R, 2010, CELL, V142, P433, DOI 10.1016/j.cell.2010.07.012; Tulin A, 2012, BIOPHYS J, V102, P802, DOI 10.1016/j.bpj.2012.01.008; Van Damme D, 2004, PLANT PHYSIOL, V136, P3956, DOI 10.1104/pp.104.051623; VANTARD M, 1994, EUR J BIOCHEM, V220, P847, DOI 10.1111/j.1432-1033.1994.tb18687.x; WALKER RA, 1988, J CELL BIOL, V107, P1437, DOI 10.1083/jcb.107.4.1437; Wicker-Planquart C, 2004, PLANT J, V39, P126, DOI 10.1111/j.1365-313X.2004.02115.x	33	21	21	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2013	8	2							e56808	10.1371/journal.pone.0056808	http://dx.doi.org/10.1371/journal.pone.0056808			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IT	23437247	Green Published, gold			2022-12-25	WOS:000315186000048
J	Weisberg, E; Liu, QS; Zhang, X; Nelson, E; Sattler, M; Liu, FY; Nicolais, M; Zhang, JM; Mitsiades, C; Smith, RW; Stone, R; Galinsky, I; Nonami, A; Griffin, JD; Gray, N				Weisberg, Ellen; Liu, Qingsong; Zhang, Xin; Nelson, Erik; Sattler, Martin; Liu, Feiyang; Nicolais, Maria; Zhang, Jianming; Mitsiades, Constantine; Smith, Robert W.; Stone, Richard; Galinsky, Ilene; Nonami, Atsushi; Griffin, James D.; Gray, Nathanael			Selective Akt Inhibitors Synergize with Tyrosine Kinase Inhibitors and Effectively Override Stroma-Associated Cytoprotection of Mutant FLT3-Positive AML Cells	PLOS ONE			English	Article							LYMPHOBLASTIC-LEUKEMIA CELLS; CONSTITUTIVE ACTIVATION; FLT3 INHIBITORS; APOPTOSIS; MUTATIONS; SURVIVAL; RESISTANCE; THERAPIES; PATHWAYS; CONTACT	Objectives: Tyrosine kinase inhibitor (TKI)-treated acute myeloid leukemia (AML) patients commonly show rapid and significant peripheral blood blast cell reduction, however a marginal decrease in bone marrow blasts. This suggests a protective environment and highlights the demand for a better understanding of stromal: leukemia cell communication. As a strategy to improve clinical efficacy, we searched for novel agents capable of potentiating the stroma-diminished effects of TKI treatment of mutant FLT3-expressing cells. Methods: We designed a combinatorial high throughput drug screen using well-characterized kinase inhibitor-focused libraries to identify novel kinase inhibitors capable of overriding stromal-mediated resistance to TKIs, such as PKC412 and AC220. Standard liquid culture proliferation assays, cell cycle and apoptosis analysis, and immunoblotting were carried out with cell lines or primary AML to validate putative candidates from the screen and characterize the mechanism(s) underlying observed synergy. Results and Conclusions: Our study led to the observation of synergy between selective Akt inhibitors and FLT3 inhibitors against mutant FLT3-positive AML in either the absence or presence of stroma. Our findings are consistent with evidence that Akt activation is characteristic of mutant FLT3-transformed cells, as well as observed residual Akt activity following FLT3 inhibitor treatment. In conclusion, our study highlights the potential importance of Akt as a signaling factor in leukemia survival, and supports the use of the co-culture chemical screen to identify agents able to potentiate TKI anti-leukemia activity in a cytoprotective microenvironment.	[Weisberg, Ellen; Nelson, Erik; Sattler, Martin; Nicolais, Maria; Mitsiades, Constantine; Smith, Robert W.; Stone, Richard; Galinsky, Ilene; Nonami, Atsushi; Griffin, James D.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Liu, Qingsong; Zhang, Xin; Zhang, Jianming; Gray, Nathanael] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Liu, Feiyang] Chinese Acad Sci, High Field Magnet Lab, Hefei, Anhui, Peoples R China	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard Medical School; Chinese Academy of Sciences; Hefei Institutes of Physical Science, CAS	Weisberg, E (corresponding author), Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Med Oncol, 44 Binney St, Boston, MA 02115 USA.	ellen_weisberg@dfci.harvard.edu; james_griffin@dfci.harvard.edu	刘, 青松/AEM-1932-2022; Liu, Qingsong/AFS-0714-2022	刘, 青松/0000-0002-7829-2547; Liu, Qingsong/0000-0002-7829-2547; Zhang, Jianming/0000-0001-6326-3906	National Institutes of Health (NIH) Library of Integrated Network-Based Cellular Signatures (LINCS) grant [HG006097]; Chinese Academy of Science High Magnetic Field Laboratory training grant; NIH grant [CA66996]; CAS; NATIONAL CANCER INSTITUTE [P01CA066996] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG006097] Funding Source: NIH RePORTER	National Institutes of Health (NIH) Library of Integrated Network-Based Cellular Signatures (LINCS) grant; Chinese Academy of Science High Magnetic Field Laboratory training grant; NIH grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CAS(Defence Research & Development Organisation (DRDO)Chinese Academy of Sciences); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	Grant Support: QL and NG are supported by National Institutes of Health (NIH) Library of Integrated Network-Based Cellular Signatures (LINCS) grant HG006097. FL is supported by a Chinese Academy of Science High Magnetic Field Laboratory training grant. JDG is supported by NIH grant CA66996. FL is supported by CAS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong SA, 2003, CANCER CELL, V3, P173, DOI 10.1016/S1535-6108(03)00003-5; BENDALL LJ, 1994, EXP HEMATOL, V22, P1252; CHOU TC, 1984, ADV ENZYME REGUL, V22, P27, DOI 10.1016/0065-2571(84)90007-4; Feldhahn N, 2012, ONCOIMMUNOLOGY, V1, P618, DOI 10.4161/onci.20249; Garrido SM, 2001, EXP HEMATOL, V29, P448, DOI 10.1016/S0301-472X(01)00612-9; Gaundar SS, 2009, CELL CYCLE, V8, P2975; Gu TL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019169; Kelly LM, 2002, BLOOD, V99, P310, DOI 10.1182/blood.V99.1.310; Kimbrel EA, 2009, MOL IMAGING, V8, P140, DOI 10.2310/7290.2009.00007; Kumagai MA, 1996, J CLIN INVEST, V97, P755, DOI 10.1172/JCI118474; Matsuo Y, 1997, LEUKEMIA, V11, P1469, DOI 10.1038/sj.leu.2400768; Mudry RE, 2000, BLOOD, V96, P1926, DOI 10.1182/blood.V96.5.1926.h8001926_1926_1932; Nefedova Y, 2003, LEUKEMIA, V17, P1175, DOI 10.1038/sj.leu.2402924; Panayiotidis P, 1996, BRIT J HAEMATOL, V92, P97, DOI 10.1046/j.1365-2141.1996.00305.x; Piloto O, 2007, BLOOD, V109, P1643, DOI 10.1182/blood-2006-05-023804; Quentmeier H, 2003, LEUKEMIA, V17, P120, DOI 10.1038/sj.leu.2402740; Ringshausen I, 2004, LEUKEMIA, V18, P1964, DOI 10.1038/sj.leu.2403544; Siendones E, 2007, HEMATOL ONCOL, V25, P30, DOI 10.1002/hon.805; Stirewalt DL, 2003, NAT REV CANCER, V3, P650, DOI 10.1038/nrc1169; Tabe Y, 2007, CANCER RES, V67, P684, DOI 10.1158/0008-5472.CAN-06-3166; Weisberg E, 2002, CANCER CELL, V1, P433, DOI 10.1016/S1535-6108(02)00069-7; Weisberg E, 2012, LEUKEMIA, V26, P2233, DOI 10.1038/leu.2012.96; Weisberg E, 2012, LEUKEMIA, V26, P985, DOI 10.1038/leu.2011.360; Weisberg E, 2010, LEUKEMIA, V24, P2100, DOI 10.1038/leu.2010.212; Weisberg E, 2008, MOL CANCER THER, V7, P1121, DOI 10.1158/1535-7163.MCT-07-2331; Weisberg E, 2008, BLOOD, V111, P3723, DOI 10.1182/blood-2007-09-114454; Weisberg E, 2009, DRUG RESIST UPDATE, V12, P81, DOI 10.1016/j.drup.2009.04.001; Zarrinkar PP, 2009, BLOOD, V114, P2984, DOI 10.1182/blood-2009-05-222034; Zeng ZH, 2006, CANCER RES, V66, P3737, DOI 10.1158/0008-5472.CAN-05-1278	29	36	38	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2013	8	2							e56473	10.1371/journal.pone.0056473	http://dx.doi.org/10.1371/journal.pone.0056473			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IT	23437141	Green Published, Green Submitted, gold			2022-12-25	WOS:000315186000029
J	Branch, TA				Branch, Trevor A.			Citation Patterns of a Controversial and High-Impact Paper: Worm et al. (2006) "Impacts of Biodiversity Loss on Ocean Ecosystem Services''	PLOS ONE			English	Article							FISHERIES; CONSERVATION	Citation patterns were examined for Worm et al. 2006 (Science 314:787-790), a high-impact paper that focused on relationships between marine biodiversity and ecosystem services. This paper sparked much controversy through its projection, highlighted in the press release, that all marine fisheries would be collapsed by 2048. Analysis of 664 citing papers revealed that only a small percentage (11%) referred to the 2048 projection, while 39% referred to fisheries collapse in general, and 40% to biodiversity and ecosystem services. The 2048 projection was mentioned more often in papers published soon after the original paper, in low-impact journals, and in journals outside of fields that would be expected to focus on biodiversity. Citing papers also mentioned the 2048 projection more often if they had few authors (28% of single-author papers vs. 2% of papers with 10 or more authors). These factors suggest that the more knowledgeable the authors of citing papers were about the controversy over the 2048 projection, the less likely they were to refer to it. A noteworthy finding was that if the original authors were also involved in the citing papers, they rarely (1 of 55 papers, 2%) mentioned the 2048 projection. Thus the original authors have emphasized the broader concerns about biodiversity loss, rather than the 2048 projection, as the key result of their study.	Univ Washington, Sch Aquat & Fishery Sci, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Branch, TA (corresponding author), Univ Washington, Sch Aquat & Fishery Sci, Seattle, WA 98195 USA.	tbranch@uw.edu						Banobi JA, 2011, ECOSPHERE, V2, DOI 10.1890/ES10-00142.1; Baron N, 2010, NATURE, V468, P1032, DOI 10.1038/4681032a; Bernton H, 2006, SEATTLE TIMES   1103; Branch TA, 2012, BOOKS PAPERS; Branch TA, 2008, MAR POLICY, V32, P38, DOI 10.1016/j.marpol.2007.04.001; Branch TA, 2011, CONSERV BIOL, V25, P777, DOI 10.1111/j.1523-1739.2011.01687.x; Branch TA, 2010, CAN J FISH AQUAT SCI, V67, P886, DOI 10.1139/F10-032; Briggs JC, 2007, SCIENCE, V316, P1282; Casey JM, 1998, SCIENCE, V281, P690, DOI 10.1126/science.281.5377.690; Conover DO, 2002, SCIENCE, V297, P94, DOI 10.1126/science.1074085; Crain CM, 2009, ANN NY ACAD SCI, V1162, P39, DOI 10.1111/j.1749-6632.2009.04496.x; Gutierrez NL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043765; Hilborn R, 2007, ECOSYSTEMS, V10, P1362, DOI 10.1007/s10021-007-9100-5; Hilborn R, 2007, AMBIO, V36, P296, DOI 10.1579/0044-7447(2007)36[296:MTSBLF]2.0.CO;2; Hilborn R, 2006, FISHERIES, V31, P554; Hilborn R, 2007, MAR POLICY, V31, P153, DOI 10.1016/j.marpol.2006.05.014; Hilborn R, 2012, CONSERV BIOL, V26, DOI 10.1111/j.1523-1739.2011.01800.x; Holker F, 2007, SCIENCE, V316, P1285, DOI 10.1126/science.1139114; Jaenike J, 2007, SCIENCE, V316, DOI 10.1126/science.1137730; Jensen OP, 2012, THEOR ECOL-NETH, V5, P3, DOI 10.1007/s12080-011-0146-9; Longhurst A, 2007, FISH RES, V86, P1, DOI 10.1016/j.fishres.2007.02.004; LUDWIG D, 1993, SCIENCE, V260, P17, DOI 10.1126/science.260.5104.17; Murawski S, 2007, SCIENCE, V316, P1281; Myers RA, 2003, NATURE, V423, P280, DOI 10.1038/nature01610; R Development Core Team, 2012, R LANG ENV STAT COMP; Roberts CM, 2001, SCIENCE, V294, P1920, DOI 10.1126/science.294.5548.1920; Stokstad E, 2009, SCIENCE, V324, P170, DOI 10.1126/science.324.5924.170; Wilberg MJ, 2007, SCIENCE, V316, DOI 10.1126/science.1137946; Worm B, 2006, SCIENCE, V314, P787, DOI 10.1126/science.1132294; Worm B, 2012, TRENDS ECOL EVOL, V27, P594, DOI 10.1016/j.tree.2012.07.005; Worm B, 2009, SCIENCE, V325, P578, DOI 10.1126/science.1173146	31	10	10	1	95	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e56723	10.1371/journal.pone.0056723	http://dx.doi.org/10.1371/journal.pone.0056723			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437224	Green Published, Green Submitted, gold			2022-12-25	WOS:000315184200153
J	Evans, K; Moore, R; Harris, S				Evans, Kate; Moore, Randall; Harris, Stephen			The Social and Ecological Integration of Captive-Raised Adolescent Male African Elephants (Loxodonta africana) into a Wild Population	PLOS ONE			English	Article							DOG LYCAON-PICTUS; NATIONAL-PARK; CONSERVATION; REINTRODUCTION; TRANSLOCATION; SURVIVAL; CHIMPANZEES; MOVEMENTS; PROGRAMS; RELEASE	Background: A rapid rise in the number of captive African elephants (Loxodonta africana) used in the tourism industry in southern Africa and orphaned elephants in human care has led to concerns about their long-term management, particularly males. One solution is to release them into the wild at adolescence, when young males naturally leave their herd. However, this raises significant welfare concerns: little is known about how well released elephants integrate into wild populations and whether they pose a greater threat to humans than wild elephants. We document the release of three captive-raised adolescent male African elephants in the Okavango Delta, Botswana. Methodology/Principal Findings: Despite having been part of a herd of working elephants for at least eight years, the three males progressively integrated into the complex fission-fusion society of wild bull elephants. In the three years following release, they showed no tendency to be closer to human habitation, and there were no significant differences between wild and captive-raised adolescent males in the total number of social interactions, size of ranges and habitat use. However, the captive-raised elephants sparred less and vocalised more, and spent more time alone and in smaller social groups. Thereafter the released elephants continued to expand their ranges and interact with both mixed-sex herds and males. One male was shot by farmers 94 months after release, along with ten wild elephants, on a ranch outside the protected area. Conclusions/Significance: We show that captive-raised adolescent male elephants can integrate into a wild population. Long-term studies are required to determine the longevity, breeding success, and eventual fate of released male elephants, but we identified no significant short-term welfare problems for the released elephants or recipient population. Release of captive-raised mammals with complex social systems is a husbandry option that should be explored further.	[Evans, Kate; Harris, Stephen] Univ Bristol, Sch Biol Sci, Bristol, Avon, England; [Evans, Kate] Elephants Africa, Maun, Botswana; [Moore, Randall] Elephant Back Safaris, Maun, Botswana	University of Bristol	Evans, K (corresponding author), Univ Bristol, Sch Biol Sci, Bristol, Avon, England.	Kate@ElephantsForAfrica.org	Evans, Kate/AAY-9703-2021		Elephant Back Safaris (Plc) Ltd; Whitley Wildlife Conservation Fund; Dulverton Trust	Elephant Back Safaris (Plc) Ltd; Whitley Wildlife Conservation Fund; Dulverton Trust	The work was funded by Elephant Back Safaris (Plc) Ltd, The Whitley Wildlife Conservation Fund and the Dulverton Trust. Elephant Back Safaris (Plc), through Randall Moore, contributed to the study design and final editing of the manuscript but played no role in data collection and analysis, decision to publish, or preparation of the manuscript. The Whitley Wildlife Conservation Fund and the Dulverton Trust funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aebischer N.J., 1992, P285; AEBISCHER NJ, 1993, ECOLOGY, V74, P1313, DOI 10.2307/1940062; BECK B, 1993, J ZOO WILDLIFE MED, V24, P394; Blanc Julian J., 2007, AFRICAN ELEPHANT STA; BLANCHARD BM, 1995, J WILDLIFE MANAGE, V59, P560, DOI 10.2307/3802463; Carter Scott, 2010, P263; CHENEY DL, 1986, ANIM BEHAV, V34, P1722, DOI 10.1016/S0003-3472(86)80259-7; Crawley M. J, 2002, STAT COMPUTING INTRO; Crawley MJ., 2007, R BOOK; Croze H., 1972, East African Wildlife Journal, V10, P91; Custance DM, 2002, INT J PRIMATOL, V23, P479, DOI 10.1023/A:1014961415219; Dietz J. M., 1994, P32; Dublin H.T., 2003, IUCNSSC AFESG GUIDEL; Evans KE, 2008, ANIM BEHAV, V76, P779, DOI 10.1016/j.anbehav.2008.03.019; Fischer J, 2000, BIOL CONSERV, V96, P1, DOI 10.1016/S0006-3207(00)00048-3; FRITTS SH, 1984, J WILDLIFE MANAGE, V48, P709, DOI 10.2307/3801418; Garai Marion E., 2001, Pachyderm, V31, P52; Garai Marion E., 2004, Pachyderm, V37, P28; GEORGIADIS N, 1994, J HERED, V85, P100, DOI 10.1093/oxfordjournals.jhered.a111405; Goossens B, 2005, BIOL CONSERV, V123, P461, DOI 10.1016/j.biocon.2005.01.008; Goossens B, 2002, ANIM CONSERV, V5, P225, DOI 10.1017/S1367943002002275; GRIFFITH B, 1989, SCIENCE, V245, P477, DOI 10.1126/science.245.4917.477; Griffiths CJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039395; Griffiths CJ, 2011, CURR BIOL, V21, P762, DOI 10.1016/j.cub.2011.03.042; Hanks J., 1972, East African Wildlife Journal, V10, P251; Hoegh-Guldberg O, 2008, SCIENCE, V321, P345, DOI 10.1126/science.1157897; Ishida Y, 2013, EVOL APPL, V6, P253, DOI 10.1111/j.1752-4571.2012.00286.x; Jellema A., 2002, VEGETATION MAP UNPUB; Kleiman D.G., 1991, Symposia of the Zoological Society of London, P125; Kruger SC, 1999, J ZOOL, V248, P543, DOI 10.1111/j.1469-7998.1999.tb01054.x; Lahiri-Choudhury D. K., 1993, Oryx, V27, P53; LEE PC, 1995, J ZOOL, V236, P29, DOI 10.1111/j.1469-7998.1995.tb01782.x; LEE PC, 1986, BEHAV ECOL SOCIOBIOL, V18, P353, DOI 10.1007/BF00299666; Lee Phyllis C., 1999, Symposia of the Zoological Society of London, V72, P102; Lee Phyllis C., 2011, P74; Lee Phyllis C., 2011, P260; Mendelsohn J, 2004, COMMUNAL LANDS E NAM; Mendelsohn J.M., 2010, OKAVANGO DELTA FLOOD; Moehrenschlager A, 2003, ANIM CONSERV, V6, P199, DOI 10.1017/S1367943003251; Moore RJ, 2000, ELEPHANTS AFRICA; Mosillo M, 1999, J WILDLIFE MANAGE, V63, P278, DOI 10.2307/3802510; Moss CJ, 1983, PRIMATE SOCIAL RELAT, P315; Pinter-Wollman N, 2009, BEHAVIOUR, V146, P1171, DOI 10.1163/156853909X413105; Poole J., 1982, THESIS U CAMBRIDGE C; Poole J. H., 1982, THESIS U CAMBRIDGE; Sarrazin F, 1996, TRENDS ECOL EVOL, V11, P474, DOI 10.1016/0169-5347(96)20092-8; Sikes RS, 2011, J MAMMAL, V92, P235, DOI 10.1644/10-MAMM-F-355.1; Slotow R., 2001, Koedoe, V44, P85; Slotow Rob, 2001, Pachyderm, V31, P14; Spalton JA, 1999, ORYX, V33, P168, DOI 10.1046/j.1365-3008.1999.00062.x; Stamps JA, 2007, APPL ANIM BEHAV SCI, V102, P392, DOI 10.1016/j.applanim.2006.05.038; Strier KB, 2000, PRIMATE MALES, P72; Stuart S.N., 1991, Symposia of the Zoological Society of London, P27; Sullivan BK, 2004, BIOL CONSERV, V117, P235, DOI 10.1016/j.biocon.2003.07.002; Tutin CEG, 2001, CONSERV BIOL, V15, P1247, DOI 10.1046/j.1523-1739.2001.00046.x; WESTERN D, 1983, J WILDLIFE MANAGE, V47, P1192, DOI 10.2307/3808191; Whitehouse AM, 2002, ORYX, V36, P243, DOI 10.1017/S0030605302000455; Wolf CM, 1996, CONSERV BIOL, V10, P1142, DOI 10.1046/j.1523-1739.1996.10041142.x; Woodroffe R, 1999, ORYX, V33, P143, DOI 10.1046/j.1365-3008.1999.00053.x; Yeager CP, 1997, CONSERV BIOL, V11, P802, DOI 10.1046/j.1523-1739.1997.95500.x; Zar J. H., 2009, BIOSTATISTICAL ANAL; [No title captured]; [No title captured]	63	22	23	3	129	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e55933	10.1371/journal.pone.0055933	http://dx.doi.org/10.1371/journal.pone.0055933			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437076	Green Published, Green Submitted, gold			2022-12-25	WOS:000315184200031
J	Gupta, R; Bhatty, M; Swiatlo, E; Nanduri, B				Gupta, Radha; Bhatty, Minny; Swiatlo, Edwin; Nanduri, Bindu			Role of an Iron-Dependent Transcriptional Regulator in the Pathogenesis and Host Response to Infection with Streptococcus pneumoniae	PLOS ONE			English	Article							NF-KAPPA-B; IN-VIVO; ANTIINFLAMMATORY CYTOKINE; PNEUMOCOCCAL PNEUMONIA; INFLAMMATORY MARKERS; ESCHERICHIA-COLI; IMMUNE-RESPONSES; ABC TRANSPORTER; STRESS-RESPONSE; PROTECTS MICE	Iron is a critical cofactor for many enzymes and is known to regulate gene expression in many bacterial pathogens. Streptococcus pneumoniae normally inhabits the upper respiratory mucosa but can also invade and replicate in lungs and blood. These anatomic sites vary considerably in both the quantity and form of available iron. The genome of serotype 4 pneumococcal strain TIGR4 encodes a putative iron-dependent transcriptional regulator (IDTR). A mutant deleted at idtr (Delta idtr) exhibited growth kinetics similar to parent strain TIGR4 in vitro and in mouse blood for up to 48 hours following infection. However, Delta idtr was significantly attenuated in a murine model of sepsis. IDTR down-regulates the expression of ten characterized and putative virulence genes in nasopharyngeal colonization and pneumonia. The host cytokine response was significantly suppressed in sepsis with Delta idtr. Since an exaggerated inflammatory response is associated with a poor prognosis in sepsis, the decreased inflammatory response could explain the increased survival with Delta idtr. Our results suggest that IDTR, which is dispensable for pneumococcal growth in vitro, is associated with regulation of pneumococcal virulence in specific host environments. Additionally, IDTR ultimately modulates the host cytokine response and systemic inflammation that contributes to morbidity and mortality of invasive pneumococcal disease.	[Gupta, Radha; Swiatlo, Edwin] Univ Mississippi, Med Ctr, Dept Microbiol, Jackson, MS 39216 USA; [Bhatty, Minny; Nanduri, Bindu] Mississippi State Univ, Coll Vet Med, Dept Basic Sci, Mississippi State, MS 39762 USA; [Swiatlo, Edwin] Univ Mississippi, Med Ctr, Dept Med, Jackson, MS 39216 USA	University of Mississippi; University of Mississippi Medical Center; Mississippi State University; University of Mississippi; University of Mississippi Medical Center	Swiatlo, E (corresponding author), Univ Mississippi, Med Ctr, Dept Microbiol, Jackson, MS 39216 USA.	eswiatlo@umc.edu	gupta, radha/GQQ-2292-2022		Mississippi INBRE grant from the National Institutes of Health	Mississippi INBRE grant from the National Institutes of Health	This work was funded by the Mississippi INBRE grant from the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparartion of the manuscript.	Adrian PV, 2000, ANTIMICROB AGENTS CH, V44, P355, DOI 10.1128/AAC.44.2.355-361.2000; ALONSODEVELASCO E, 1995, MICROBIOL REV, V59, P591, DOI 10.1128/MMBR.59.4.591-603.1995; Bernatoniene J, 2008, J INFECT DIS, V198, P1823, DOI 10.1086/593177; Biffl WL, 1996, J TRAUMA, V40, P575, DOI 10.1097/00005373-199604000-00009; BONE RC, 1992, CHEST, V101, P1644, DOI 10.1378/chest.101.6.1644; Brett PJ, 2008, MOL MICROBIOL, V70, P396, DOI 10.1111/j.1365-2958.2008.06418.x; Brown JS, 2002, INFECT IMMUN, V70, P4389, DOI 10.1128/IAI.70.8.4389-4398.2002; Brown JS, 2001, MOL MICROBIOL, V40, P572, DOI 10.1046/j.1365-2958.2001.02414.x; Brown JS, 2001, INFECT IMMUN, V69, P6702, DOI 10.1128/IAI.69.11.6702-6706.2001; de Jong HK, 2010, J INNATE IMMUN, V2, P422, DOI 10.1159/000316286; Draing C, 2006, J BIOL CHEM, V281, P33849, DOI 10.1074/jbc.M602676200; Escolar L, 1998, J MOL BIOL, V283, P537, DOI 10.1006/jmbi.1998.2119; Ferreira DM, 2009, CLIN VACCINE IMMUNOL, V16, P636, DOI 10.1128/CVI.00395-08; FISS EH, 1994, MOL MICROBIOL, V14, P557, DOI 10.1111/j.1365-2958.1994.tb02189.x; GOLDBERG MB, 1990, J BACTERIOL, V172, P6863, DOI 10.1128/jb.172.12.6863-6870.1990; GUNTERSEEBOTH K, 1995, GENE, V166, P117, DOI 10.1016/0378-1119(95)00628-7; Gupta R, 2009, MICROB PATHOGENESIS, V47, P101, DOI 10.1016/j.micpath.2009.05.003; Hill PJ, 1998, INFECT IMMUN, V66, P4123; Jones MR, 2005, J IMMUNOL, V175, P7530, DOI 10.4049/jimmunol.175.11.7530; Kellum JA, 2007, ARCH INTERN MED, V167, P1655, DOI 10.1001/archinte.167.15.1655; Khan AQ, 2002, INFECT IMMUN, V70, P749, DOI 10.1128/IAI.70.2.749-761.2002; Knapp S, 2004, J INFECT DIS, V189, P1506, DOI 10.1086/382962; Lau GW, 2001, MOL MICROBIOL, V40, P555, DOI 10.1046/j.1365-2958.2001.02335.x; Lau PCY, 2002, J MICROBIOL METH, V49, P193, DOI 10.1016/S0167-7012(01)00369-4; LITWIN CM, 1993, J BACTERIOL, V175, P706, DOI 10.1128/JB.175.3.706-715.1993; Ness TL, 2004, J IMMUNOL, V173, P6938, DOI 10.4049/jimmunol.173.11.6938; Ogunniyi AD, 2002, MICROBIOL-SGM, V148, P2045, DOI 10.1099/00221287-148-7-2045; Osuchowski MF, 2006, J IMMUNOL, V177, P1967, DOI 10.4049/jimmunol.177.3.1967; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Pozzi G, 1996, J BACTERIOL, V178, P6087, DOI 10.1128/jb.178.20.6087-6090.1996; PRINCE RW, 1993, J BACTERIOL, V175, P2589, DOI 10.1128/JB.175.9.2589-2598.1993; Quin LR, 2008, INFECT IMMUN, V76, P1122, DOI 10.1128/IAI.01066-07; Richardson AR, 2006, MOL MICROBIOL, V61, P927, DOI 10.1111/j.1365-2958.2006.05290.x; Rodriguez GM, 2002, INFECT IMMUN, V70, P3371, DOI 10.1128/IAI.70.7.3371-3381.2002; STAGGS TM, 1992, MOL MICROBIOL, V6, P2507; TAI SS, 1993, INFECT IMMUN, V61, P5401, DOI 10.1128/IAI.61.12.5401-5405.1993; Tamayo E, 2011, EUR CYTOKINE NETW, V22, P82, DOI 10.1684/ecn.2011.0281; Tettelin H, 2001, SCIENCE, V293, P498, DOI 10.1126/science.1061217; THOMAS CE, 1994, MOL MICROBIOL, V11, P725, DOI 10.1111/j.1365-2958.1994.tb00350.x; TILG H, 1994, BLOOD, V83, P113; VANDERIJN I, 1980, INFECT IMMUN, V27, P444, DOI 10.1128/IAI.27.2.444-448.1980; vanderPoll T, 1997, J INFECT DIS, V175, P118, DOI 10.1093/infdis/175.1.118; Wu HP, 2011, CRIT CARE, V15, DOI 10.1186/cc10464; Wu HY, 1997, MICROB PATHOGENESIS, V23, P127, DOI 10.1006/mpat.1997.0142; Zhu S, 2009, MOL MED, V15, P275, DOI 10.2119/molmed.2009.00062	45	6	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e55157	10.1371/journal.pone.0055157	http://dx.doi.org/10.1371/journal.pone.0055157			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437050	gold, Green Submitted, Green Published			2022-12-25	WOS:000315184200012
J	Katiyar, S; Kufareva, I; Behera, R; Thomas, SM; Ogata, Y; Pollastri, M; Abagyan, R; Mensa-Wilmot, K				Katiyar, Samiksha; Kufareva, Irina; Behera, Ranjan; Thomas, Sarah M.; Ogata, Yuko; Pollastri, Michael; Abagyan, Ruben; Mensa-Wilmot, Kojo			Lapatinib-Binding Protein Kinases in the African Trypanosome: Identification of Cellular Targets for Kinase-Directed Chemical Scaffolds	PLOS ONE			English	Article							CHROMOSOMAL PASSENGER COMPLEX; BLOOD-STREAM FORM; TYROSINE KINASE; GROWTH-FACTOR; ONCOGENE ADDICTION; DUAL INHIBITOR; DESIGN; EGFR; TRANSFERRIN; GW572016	Human African trypanosomiasis is caused by the eukaryotic microbe Trypanosoma brucei. To discover new drugs against the disease, one may use drugs in the clinic for other indications whose chemical scaffolds can be optimized via a medicinal chemistry campaign to achieve greater potency against the trypanosome. Towards this goal, we tested inhibitors of human EGFR and/or VEGFR as possible anti-trypanosome compounds. The 4-anilinoquinazolines canertinib and lapatinib, and the pyrrolopyrimidine AEE788 killed bloodstream T. brucei in vitro with GI(50) in the low micromolar range. Curiously, the genome of T. brucei does not encode EGFR or VEGFR, indicating that the drugs recognize alternate proteins. To discover these novel targets, a trypanosome lysate was adsorbed to an ATP-sepharose matrix and washed with a high salt solution followed by nicotinamide adenine dinucleotide (NAD+). Proteins that remained bound to the column were eluted with drugs, and identified by mass spectrometry/bioinformatics. Lapatinib bound to Tb927.4.5180 (termed T. brucei lapatinib-binding protein kinase-1 (TbLBPK1)) while AEE788 bound Tb927.5.800 (TbLBPK2). When the NAD+ wash was omitted from the protocol, AEE788, canertinib and lapatinib eluted TbLBPK1, TbLBPK2, and Tb927.3.1570 (TbLBPK3). In addition, both canertinib and lapatinib eluted Tb10.60.3140 (TbLBPK4), whereas only canertinib desorbed Tb10.61.1880 (TbCBPK1). Lapatinib binds to a unique conformation of protein kinases. To gain insight into the structural basis for lapatinib interaction with TbLBPKs, we constructed three-dimensional models of lapatinib center dot TbLBPK complexes, which confirmed that TbLBPKs can adopt lapatinib-compatible conformations. Further, lapatinib, AEE788, and canertinib were docked to TbLBPKs with favorable scores. Our studies (a) present novel targets of kinase-directed drugs in the trypanosome, and (b) offer the 4-anilinoquinazoline and pyrrolopyrimidines as scaffolds worthy of medicinal chemistry and structural biology campaigns to develop them into anti-trypanosome drugs.	[Katiyar, Samiksha; Behera, Ranjan; Thomas, Sarah M.; Mensa-Wilmot, Kojo] Univ Georgia, Dept Cellular Biol, Athens, GA 30602 USA; [Kufareva, Irina; Abagyan, Ruben] UCSD Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92093 USA; [Pollastri, Michael] Northeastern Univ, Dept Chem & Chem Biol, Boston, MA 02115 USA; [Ogata, Yuko] Fred Hutchinson Canc Res Ctr, Prote Facil, Seattle, WA 98104 USA	University System of Georgia; University of Georgia; Northeastern University; Fred Hutchinson Cancer Center	Abagyan, R (corresponding author), UCSD Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92093 USA.	rabagyan@ucsd.edu; mensawil@uga.edu	pollastri, Michael/AAR-5790-2020; Bansal, Reema/AAH-6896-2019	pollastri, Michael/0000-0001-9943-7197; Kufareva, Irina/0000-0001-9083-7039	National Institutes of Health [AI076647]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI076647] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health AI076647. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abagyan R, 1997, PROTEINS, P29; ABAGYAN R, 1994, J MOL BIOL, V235, P983, DOI 10.1006/jmbi.1994.1052; ABAGYAN R, 1994, J COMPUT CHEM, V15, P488, DOI 10.1002/jcc.540150503; Arnautova YA, 2011, PROTEINS, V79, P477, DOI 10.1002/prot.22896; Arora A, 2005, J PHARMACOL EXP THER, V315, P971, DOI 10.1124/jpet.105.084145; Atwell S, 2004, J BIOL CHEM, V279, P55827, DOI 10.1074/jbc.M409792200; Bantscheff M, 2007, NAT BIOTECHNOL, V25, P1035, DOI 10.1038/nbt1328; Barbarroja N, 2010, EXP HEMATOL; Barrett MP, 2007, BRIT J PHARMACOL, V152, P1155, DOI 10.1038/sj.bjp.0707354; Berriman M, 2005, SCIENCE, V309, P416, DOI 10.1126/science.1112642; Brehmer D, 2005, CANCER RES, V65, P379; Brun R, 2006, CURR OPIN INFECT DIS, V19, P415, DOI 10.1097/01.qco.0000244045.93016.b1; Burris HA, 2005, J CLIN ONCOL, V23, P5305, DOI 10.1200/JCO.2005.16.584; Calvo E, 2004, CLIN CANCER RES, V10, P7112, DOI 10.1158/1078-0432.CCR-04-1187; Chen R, 2006, CANCER RES, V66, P10959, DOI 10.1158/0008-5472.CAN-06-1216; Deutsch EW, 2010, PROTEOMICS, V10, P1150, DOI 10.1002/pmic.200900375; Duncan JS, 2012, METHODS MOL BIOL, V795, P119, DOI 10.1007/978-1-61779-337-0_8; El-Sayed NM, 2005, SCIENCE, V309, P409, DOI 10.1126/science.1112631; Gafken Philip R., 2009, V527, P159, DOI 10.1007/978-1-60327-834-8_12; Goldammer T, 2006, CYTOGENET GENOME RES, V112, p341C, DOI 10.1159/000089893; Hamadien M, 2000, PARASITOLOGY, V120, P281, DOI 10.1017/S0031182099005521; Haystead TAJ, 2006, CURR TOP MED CHEM, V6, P1117; Heymach JV, 2006, CLIN CANCER RES, V12, p4441S, DOI 10.1158/1078-0432.CCR-06-0286; Higdon R, 2007, OMICS, V11, P351, DOI 10.1089/omi.2007.0040; HIRUMI H, 1994, PARASITOL TODAY, V10, P80, DOI 10.1016/0169-4758(94)90402-2; Hubbard RD, 2008, BIOORG MED CHEM LETT, V18, P5738, DOI 10.1016/j.bmcl.2008.09.090; Johnson LN, 2009, Q REV BIOPHYS, V42, P1, DOI 10.1017/S0033583508004745; Kaouass M, 1997, MOL CELL BIOL, V17, P2994, DOI 10.1128/MCB.17.6.2994; Karaman MW, 2008, NAT BIOTECHNOL, V26, P127, DOI 10.1038/nbt1358; Kentrup H, 1996, J BIOL CHEM, V271, P3488; Kim JW, 2008, CANCER LETT, V272, P296, DOI 10.1016/j.canlet.2008.07.018; Kufareva I, 2011, STRUCTURE IN PRESS; Lackey KE, 2006, CURR TOP MED CHEM, V6, P435, DOI 10.2174/156802606776743156; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lemmon MA, 2010, CELL, V141, P1117, DOI 10.1016/j.cell.2010.06.011; LETWIN K, 1992, EMBO J, V11, P3521, DOI 10.1002/j.1460-2075.1992.tb05435.x; Li ZY, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002354; Li ZY, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003814; Lim WA, 2010, CELL, V142, P661, DOI 10.1016/j.cell.2010.08.023; Lochhead PA, 2003, BIOCHEM J, V374, P381, DOI 10.1042/BJ20030500; Lu C, 2007, CLIN CANCER RES, V13, P4209, DOI 10.1158/1078-0432.ccr-07-0197; MYERS T, 2007, CURR PROTOC BIOINFOR, pCH13; Nett IR, 2009, MOL CELL PROTEOMICS; Nett IRE, 2009, EUKARYOT CELL, V8, P617, DOI 10.1128/EC.00366-08; Ojo KK, 2008, ANTIMICROB AGENTS CH, V52, P3710, DOI 10.1128/AAC.00364-08; Olaussen KA, 2009, ONCOGENE, V28, P4249, DOI 10.1038/onc.2009.277; Panigrahi AK, 2009, PROTEOMICS, V9, P434, DOI 10.1002/pmic.200800477; Park YW, 2005, CLIN CANCER RES, V11, P1963, DOI 10.1158/1078-0432.CCR-04-1665; PARKER LL, 1992, P NATL ACAD SCI USA, V89, P2917, DOI 10.1073/pnas.89.7.2917; Parsons M, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-127; Rauch A, 2006, J PROTEOME RES, V5, P112, DOI 10.1021/pr0503533; Rixe O, 2009, CANCER CHEMOTH PHARM, V64, P1139, DOI 10.1007/s00280-009-0975-z; Roskoski R, 2004, BIOCHEM BIOPH RES CO, V324, P1155, DOI 10.1016/j.bbrc.2004.09.171; Rost B, 1999, PROTEIN ENG, V12, P85, DOI 10.1093/protein/12.2.85; Schapira M, 1999, J MOL RECOGNIT, V12, P177, DOI 10.1002/(SICI)1099-1352(199905/06)12:3<177::AID-JMR451>3.0.CO;2-Z; SCHELL D, 1991, PARASITOL RES, V77, P558, DOI 10.1007/BF00931012; Sessa G, 1996, PLANT CELL, V8, P2223, DOI 10.1105/tpc.8.12.2223; Sharma SV, 2006, CANCER CELL, V10, P425, DOI 10.1016/j.ccr.2006.09.014; Slichenmyer WJ, 2001, SEMIN ONCOL, V28, P80, DOI 10.1016/S0093-7754(01)90285-4; Smaill JB, 2001, J MED CHEM, V44, P429, DOI 10.1021/jm000372i; Subramanya S, 2009, BIOCHEM J, V417, P685, DOI 10.1042/BJ20080167; Subramanya S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008538; Traxler P, 2004, CANCER RES, V64, P4931, DOI 10.1158/0008-5472.CAN-03-3681; Trinks C, 2010, BIOCHEM BIOPH RES CO, V393, P6, DOI 10.1016/j.bbrc.2010.01.055; Urbaniak MD, 2009, MOL BIOCHEM PARASIT, V166, P183, DOI 10.1016/j.molbiopara.2009.03.001; Vema A, 2003, BIOORGAN MED CHEM, V11, P4643, DOI 10.1016/S0968-0896(03)00482-6; Walter SA, 2003, J BIOL CHEM, V278, P18221, DOI 10.1074/jbc.M212556200; Weinstein IB, 2006, NAT CLIN PRACT ONCOL, V3, P448, DOI 10.1038/ncponc0558; WHEELERALM E, 1992, J PROTOZOOL, V39, P413, DOI 10.1111/j.1550-7408.1992.tb01473.x; Wissner A, 2003, J MED CHEM, V46, P49, DOI 10.1021/jm020241c; Wood ER, 2004, CANCER RES, V64, P6652, DOI 10.1158/0008-5472.CAN-04-1168; Xia WL, 2002, ONCOGENE, V21, P6255, DOI 10.1038/sj.onc.1205794; Yun CH, 2007, CANCER CELL, V11, P217, DOI 10.1016/j.ccr.2006.12.017	73	30	30	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e56150	10.1371/journal.pone.0056150	http://dx.doi.org/10.1371/journal.pone.0056150			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437089	Green Published, gold			2022-12-25	WOS:000315184200043
J	Makonde, HM; Boga, HI; Osiemo, Z; Mwirichia, R; Stielow, JB; Goker, M; Klenk, HP				Makonde, Huxley M.; Boga, Hamadi I.; Osiemo, Zipporah; Mwirichia, Romano; Stielow, J. Benjamin; Goeker, Markus; Klenk, Hans-Peter			Diversity of Termitomyces Associated with Fungus-Farming Termites Assessed by Cultural and Culture-Independent Methods	PLOS ONE			English	Article							GROWING TERMITES; ODONTOTERMES-FORMOSANUS; HOST-SPECIFICITY; TRANSMISSION; SYMBIONTS; GUT; INFORMATION; ANTIFUNGAL; STABILIZES; CHARACTERS	Background: Fungus-cultivating termites make use of an obligate mutualism with fungi from the genus Termitomyces, which are acquired through either vertical transmission via reproductive alates or horizontally transmitted during the formation of new mounds. Termitomyces taxonomy, and thus estimating diversity and host specificity of these fungi, is challenging because fruiting bodies are rarely found. Molecular techniques can be applied but need not necessarily yield the same outcome than morphological identification. Methodology: Culture-dependent and culture-independent methods were used to comprehensively assess host specificity and gut fungal diversity. Termites were identified using mitochondrial cytochrome oxidase II (COII) genes. Twenty-three Termitomyces cultures were isolated from fungal combs. Internal transcribed spacer (ITS) clone libraries were constructed from termite guts. Presence of Termitomyces was confirmed using specific and universal primers. Termitomyces species boundaries were estimated by cross-comparison of macromorphological and sequence features, and ITS clustering parameters accordingly optimized. The overall trends in coverage of Termitomyces diversity and host associations were estimated using Genbank data. Results and Conclusion: Results indicate a monoculture of Termitomyces in the guts as well as the isolation sources (fungal combs). However, cases of more than one Termitomyces strains per mound were observed since mounds can contain different termite colonies. The newly found cultures, as well as the clustering analysis of GenBank data indicate that there are on average between one and two host genera per Termitomyces species. Saturation does not appear to have been reached, neither for the total number of known Termitomyces species nor for the number of Termitomyces species per host taxon, nor for the number of known hosts per Termitomyces species. Considering the rarity of Termitomyces fruiting bodies, it is suggested to base the future taxonomy of the group mainly on well-characterized and publicly accessible cultures.	[Makonde, Huxley M.; Goeker, Markus; Klenk, Hans-Peter] German Collect Microorganisms & Cell Cultures Gmb, Leibniz Inst DSMZ, Braunschweig, Germany; [Makonde, Huxley M.; Mwirichia, Romano] Jomo Kenyatta Univ Agr & Technol, Biotechnol Res Inst, Nairobi, Kenya; [Boga, Hamadi I.; Osiemo, Zipporah] Jomo Kenyatta Univ Agr & Technol, Nairobi, Kenya; [Stielow, J. Benjamin] CBS KNAW Fungal Biodivers Ctr, Utrecht, Netherlands	Leibniz Institut fur Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); Jomo Kenyatta University of Agriculture & Technology; Jomo Kenyatta University of Agriculture & Technology; Royal Netherlands Academy of Arts & Sciences; Westerdijk Fungal Biodiversity Institute (KNAW)	Goker, M (corresponding author), German Collect Microorganisms & Cell Cultures Gmb, Leibniz Inst DSMZ, Braunschweig, Germany.	markus.goeker@dsmz.de	Göker, Markus/AAX-6258-2021	Göker, Markus/0000-0002-5144-6200; Mwirichia, Romano/0000-0002-4198-5593; Boga, Hamadi/0000-0003-1930-5413	Deutscher Akademischer Austauschdienst (DAAD); Kenya National Council for Science and Technology (NCST) [NCST/5/003/PG/224]	Deutscher Akademischer Austauschdienst (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD)); Kenya National Council for Science and Technology (NCST)	This work was supported by the Deutscher Akademischer Austauschdienst (DAAD) within a Ph.D. scholarship (sandwich model) and a grant (NCST/5/003/PG/224) to HMM from the Kenya National Council for Science and Technology (NCST). The DSMZ supported this study via the employment of JBS, MG and HPK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aanen DK, 2002, P NATL ACAD SCI USA, V99, P14887, DOI 10.1073/pnas.222313099; Aanen DK, 2006, BIOL LETT-UK, V2, P209, DOI 10.1098/rsbl.2005.0424; Aanen DK, 2009, SCIENCE, V326, P1103, DOI 10.1126/science.1173462; Aanen DK, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-115; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Austin JW, 2004, ANN ENTOMOL SOC AM, V97, P548, DOI 10.1603/0013-8746(2004)097[0548:PAOTST]2.0.CO;2; Baker RH, 1997, SYST BIOL, V46, P654, DOI 10.2307/2413499; Baker RH, 1998, MOL PHYLOGENET EVOL, V9, P427, DOI 10.1006/mpev.1998.0519; BOTHA WJ, 1991, MYCOL RES, V95, P435, DOI 10.1016/S0953-7562(09)80843-5; Bulmer MS, 2004, MOL BIOL EVOL, V21, P2256, DOI 10.1093/molbev/msh236; FARRIS JS, 1979, SYST ZOOL, V28, P483, DOI 10.2307/2412562; FELSENSTEIN J, 1981, J MOL EVOL, V17, P368, DOI 10.1007/BF01734359; Fuller CA, 2007, J INSECT SCI, V7, DOI 10.1673/031.007.1401; Gams W, 2012, MYCOTAXON, V119, P495, DOI DOI 10.5248/119.495; Goker M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006319; Goker M, 2009, MYCOL RES, V113, P308, DOI 10.1016/j.mycres.2008.11.006; Guedegbe HJ, 2009, MYCOLOGIA, V101, P686, DOI 10.3852/08-182; Hawksworth DL, 2011, IMA FUNGUS, V2, P105, DOI 10.5598/imafungus.2011.02.01.14; Hess PN, 2007, BIOL J LINN SOC, V92, P669, DOI 10.1111/j.1095-8312.2007.00864.x; Ju YM, 2007, MYCOLOGIA, V99, P936, DOI 10.3852/mycologia.99.6.936; Katoh H, 2002, MOL ECOL, V11, P1565, DOI 10.1046/j.1365-294X.2002.01535.x; Kendrick B, 2011, GENERA HYPHOMYCETES; Kirk PM, 2008, DICT FUNGI; Kone NA, 2011, INSECT SOC, V58, P371, DOI 10.1007/s00040-011-0154-1; Korb J, 2003, BEHAV ECOL SOCIOBIOL, V53, P65, DOI 10.1007/s00265-002-0559-y; Lamberty M, 2001, J BIOL CHEM, V276, P4085, DOI 10.1074/jbc.M002998200; Lee C, 2002, BIOINFORMATICS, V18, P452, DOI 10.1093/bioinformatics/18.3.452; Legendre P., 1998, NUMERICAL ECOLOGY, V24; Licht HHF, 2006, MOL ECOL, V15, P3131, DOI 10.1111/j.1365-294X.2006.03008.x; Long YH, 2010, INSECT SCI, V17, P265, DOI 10.1111/j.1744-7917.2010.01327.x; Mathew GM, 2012, FEMS MICROBIOL ECOL, V79, P504, DOI 10.1111/j.1574-6941.2011.01232.x; MORIYA S, 2005, MICROBES ENVIRON, V20, P243, DOI DOI 10.1264/JSME2.20.243; NAKAMURA S, 1993, APPL ENVIRON MICROB, V59, P2311, DOI 10.1128/AEM.59.7.2311-2316.1993; Nobre T, 2010, P ROY SOC B-BIOL SCI, V277, P359, DOI 10.1098/rspb.2009.1373; Nobre T, 2011, MOL ECOL, V20, P2023, DOI 10.1111/j.1365-294X.2011.05064.x; Okane Izumi, 2007, Mycoscience, V48, P240, DOI 10.1007/s10267-007-0361-9; Osiemo ZB, 2010, INSECT SOC, V57, P351, DOI 10.1007/s00040-010-0092-3; Paccanaro A, 2006, NUCLEIC ACIDS RES, V34, P1571, DOI 10.1093/nar/gkj515; Pattengale ND, 2009, LECT NOTES COMPUT SC, V5541, P184, DOI 10.1007/978-3-642-02008-7_13; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Rouland-Lefevre C, 2002, MOL PHYLOGENET EVOL, V22, P423, DOI 10.1006/mpev.2001.1071; Ruijssenaars HJ, 2001, APPL MICROBIOL BIOT, V55, P143, DOI 10.1007/s002530000477; Sands W. L, 1969, BIOL TERMITES, P495; Schmitt-Wagner D, 2003, APPL ENVIRON MICROB, V69, P6018, DOI 10.1128/AEM.69.10.6018-6024.2003; Schoch CL, 2012, P NATL ACAD SCI USA, V109, P6241, DOI 10.1073/pnas.1117018109; Setaro SD, 2012, BIODIVERS CONSERV, V21, P2269, DOI 10.1007/s10531-011-0205-y; Shinzato N, 2005, ZOOL SCI, V22, P917, DOI 10.2108/zsj.22.917; SOKAL R. R., 1963, Principles of numerical taxonomy., P359; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Stielow B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015614; Swofford DL, 2001, PAUP PHYLOGENETIC AN; THOMAS R, 1985, T BRIT MYCOL SOC, V84, P519, DOI 10.1016/S0007-1536(85)80014-0; VANDERWESTHUIZEN GCA, 1990, MYCOL RES, V94, P923, DOI 10.1016/S0953-7562(09)81306-3; Visser AA, 2009, MOL ECOL, V18, P553, DOI 10.1111/j.1365-294X.2008.04036.x; Visser AA, 2012, MICROB ECOL, V63, P975, DOI 10.1007/s00248-011-9987-4; White T., 1990, PCR PROTOCOLS GUIDE, P315; Wiley EO, 2011, PHYLOGENETICS THEORY; Wood T.G., 1978, International Biological Programme, P245; Zantinge JL, 2003, ENZYME MICROB TECH, V32, P224, DOI 10.1016/S0141-0229(02)00249-1; Zhang YHP, 2006, BIOTECHNOL ADV, V24, P452, DOI 10.1016/j.biotechadv.2006.03.003	60	20	26	2	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e56464	10.1371/journal.pone.0056464	http://dx.doi.org/10.1371/journal.pone.0056464			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437139	Green Published, Green Submitted, gold			2022-12-25	WOS:000315184200079
J	Tochitani, S; Kondo, S				Tochitani, Shiro; Kondo, Shigeaki			Immunoreactivity for GABA, GAD65, GAD67 and Bestrophin-1 in the Meninges and the Choroid Plexus: Implications for Non-Neuronal Sources for GABA in the Developing Mouse Brain	PLOS ONE			English	Article							PROGENITOR CELLS; CEREBRAL-CORTEX; GLUTAMATE; RELEASE; ACID; NEUROGENESIS; INTERNEURONS; TRANSPORTER; EXPANSION; DELIVERY	Neural progenitors in the developing neocortex, neuroepithelial cells and radial glial cells, have a bipolar shape with a basal process contacting the basal membrane of the meninge and an apical plasma membrane facing the lateral ventricle, which the cerebrospinal fluid is filled with. Recent studies revealed that the meninges and the cerebrospinal fluid have certain roles to regulate brain development. gamma-aminobutyric acid (GABA) is a neurotransmitter which appears first during development and works as a diffusible factor to regulate the properties of neural progenitors. In this study, we examined whether GABA can be released from the meninges and the choroid plexus in the developing mouse brain. Immunohistochemical analyses showed that glutamic acid decarboxylase 65 and 67 (GAD65 and GAD67), both of which are GABA-synthesizing enzymes, are expressed in the meninges. The epithelial cells in the choroid plexus express GAD65. GABA immunoreactivity could be observed beneath the basal membrane of the meninge and in the epithelial cells of the choroid plexus. Expression analyses on Bestrophin-1, which is known as a GABA-permeable channel in differentiated glial cells, suggested that the cells in the meninges and the epithelial cells in the choroid plexus have the channels able to permeate non-synaptic GABA into the extracellular space. Further studies showed that GAD65/67-expressing meningeal cells appear in a manner with rostral to caudal and lateral to dorsal gradient to cover the entire neocortex by E14.5 during development, while the cells in the choroid plexus in the lateral ventricle start to express GAD65 on E11-E12, the time when the choroid plexus starts to develop in the developing brain. These results totally suggest that the meninges and the choroid plexus can work as non-neuronal sources for ambient GABA which can modulate the properties of neural progenitors during neocortical development.	[Tochitani, Shiro; Kondo, Shigeaki] Univ Tokushima, Grad Sch, Inst Hlth Biosci, Dept Anat & Dev Neurobiol, Tokushima 770, Japan; [Kondo, Shigeaki] Univ Tokushima, Fac Med, Student Lab, Tokushima 770, Japan	Tokushima University; Tokushima University	Tochitani, S (corresponding author), Univ Tokushima, Grad Sch, Inst Hlth Biosci, Dept Anat & Dev Neurobiol, Tokushima 770, Japan.	shiro@basic.med.tokushima-u.ac.jp		Tochitani, Shiro/0000-0001-5765-3668	Japan Society for the Promotion of Science [21791035, 23791227]; Ministry of Education, Science, Sports and Culture of Japan	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Science, Sports and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Grant-in-Aid for Young Scientists (B) #21791035 and #23791227 from the Japan Society for the Promotion of Science (to S. T.) and by a Grant-in-Aid for Scientific Research on Innovative Areas (Comprehensive Brain Science Network) from the Ministry of Education, Science, Sports and Culture of Japan (to S. T.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ben-Ari Y, 2012, FRONT CELL NEUROSCI, V6, DOI 10.3389/fncel.2012.00035; Brickley SG, 2012, NEURON, V73, P23, DOI 10.1016/j.neuron.2011.12.012; Cataltepe O, 1996, BRAIN RES, V709, P326, DOI 10.1016/0006-8993(95)01437-3; Conti F, 1999, J COMP NEUROL, V409, P482; Demarque M, 2002, NEURON, V36, P1051, DOI 10.1016/S0896-6273(02)01053-X; Evans JE, 1996, J COMP NEUROL, V376, P431, DOI 10.1002/(SICI)1096-9861(19961216)376:3<431::AID-CNE6>3.0.CO;2-3; Fietz SA, 2011, CURR OPIN NEUROBIOL, V21, P23, DOI 10.1016/j.conb.2010.10.002; Gao XB, 2000, J PHYSIOL-LONDON, V523, P629, DOI 10.1111/j.1469-7793.2000.t01-1-00629.x; Haydar TF, 2000, J NEUROSCI, V20, P5764, DOI 10.1523/JNEUROSCI.20-15-05764.2000; Huang X, 2010, P NATL ACAD SCI USA, V107, P8422, DOI 10.1073/pnas.0911838107; Inoue T, 2007, J NEUROSCI, V27, P5461, DOI 10.1523/JNEUROSCI.4046-06.2007; John JE, 2007, EPILEPSY RES, V75, P10, DOI 10.1016/j.eplepsyres.2007.03.014; Lee R, 2009, J PSYCHIATR RES, V43, P353, DOI 10.1016/j.jpsychires.2008.04.004; Lee S, 2010, SCIENCE, V330, P790, DOI 10.1126/science.1184334; Lehtinen MK, 2011, ANNU REV CELL DEV BI, V27, P653, DOI 10.1146/annurev-cellbio-092910-154026; Lehtinen MK, 2011, NEURON, V69, P893, DOI 10.1016/j.neuron.2011.01.023; LoTurco JJ, 1995, NEURON, V15, P1287, DOI 10.1016/0896-6273(95)90008-X; Owens DF, 1996, J NEUROSCI, V16, P6414; Represa A, 2005, TRENDS NEUROSCI, V28, P278, DOI 10.1016/j.tins.2005.03.010; Siegenthaler JA, 2011, CURR OPIN GENET DEV, V21, P249, DOI 10.1016/j.gde.2010.12.005; Siegenthaler JA, 2009, CELL, V139, P597, DOI 10.1016/j.cell.2009.10.004; Tanaka DH, 2006, DEVELOPMENT, V133, P2167, DOI 10.1242/dev.02382; Tochitani S, 2010, NEUROSCI LETT, V472, P128, DOI 10.1016/j.neulet.2010.01.071; Wang DD, 2009, J PHYSIOL-LONDON, V587, P1873, DOI 10.1113/jphysiol.2008.167635; Wonders CP, 2006, NAT REV NEUROSCI, V7, P687, DOI 10.1038/nrn1954; Yoon BE, 2012, NEUROCHEM RES, V37, P2474, DOI 10.1007/s11064-012-0808-z	26	13	15	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e56901	10.1371/journal.pone.0056901	http://dx.doi.org/10.1371/journal.pone.0056901			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437266	Green Submitted, gold, Green Published			2022-12-25	WOS:000315184200181
J	Cesano, A; Putta, S; Rosen, DB; Cohen, AC; Gayko, U; Mathi, K; Woronicz, J; Hawtin, RE; Cripe, L; Sun, ZX; Tallman, MS; Paietta, E				Cesano, Alessandra; Putta, Santosh; Rosen, David B.; Cohen, Aileen C.; Gayko, Urte; Mathi, Kavita; Woronicz, John; Hawtin, Rachael E.; Cripe, Larry; Sun, Zhuoxin; Tallman, Martin S.; Paietta, Elisabeth			Functional Pathway Analysis Using SCNP of FLT3 Receptor Pathway Deregulation in AML Provides Prognostic Information Independent from Mutational Status	PLOS ONE			English	Article							ACUTE MYELOID-LEUKEMIA; INTERNAL TANDEM DUPLICATION; ACUTE MYELOGENOUS LEUKEMIA; SIGNAL TRANSDUCER; NPM1 MUTATIONS; NORMAL CYTOGENETICS; POOR-PROGNOSIS; ADULT PATIENTS; OLDER-ADULTS; YOUNG-ADULT	FMS-like tyrosine kinase 3 receptor (FLT3) internal tandem duplication (ITD) mutations result in constitutive activation of this receptor and have been shown to increase the risk of relapse in patients with acute myeloid leukemia (AML); however, substantial heterogeneity in clinical outcomes still exists within both the ITD mutated and unmutated AML subgroups, suggesting alternative mechanisms of disease relapse not accounted by FLT3 mutational status. Single cell network profiling (SCNP) is a multiparametric flow cytometry based assay that simultaneously measures, in a quantitative fashion and at the single cell level, both extracellular surface marker levels and changes in intracellular signaling proteins in response to extracellular modulators. We previously reported an initial characterization of FLT3 ITD-mediated signaling using SCNP. Herein SCNP was applied sequentially to two separate cohorts of samples collected from elderly AML patients at diagnosis. In the first (training) study, AML samples carrying unmutated, wild-type FLT3 (FLT3 WT) displayed a wide range of induced signaling, with a fraction having signaling profiles comparable to FLT3 ITD AML samples. Conversely, the FLT3 ITD AML samples displayed more homogeneous induced signaling, with the exception of patients with low (, 40%) mutational load, which had profiles comparable to FLT3 WT AML samples. This observation was then confirmed in an independent (verification) cohort. Data from the second cohort were also used to assess the association between SCNP data and disease-free survival (DFS) in the context of FLT3 and nucleophosmin (NPM1) mutational status among patients who achieved complete remission (CR) to induction chemotherapy. The combination of SCNP read outs together with FLT3 and NPM1 molecular status improved the DFS prediction accuracy of the latter. Taken together, these results emphasize the value of comprehensive functional assessment of biologically relevant signaling pathways in AML as a basis for the development of highly predictive tests for guidance of post-remission therapy.	[Cesano, Alessandra; Putta, Santosh; Rosen, David B.; Cohen, Aileen C.; Gayko, Urte; Mathi, Kavita; Woronicz, John; Hawtin, Rachael E.] Nodality Inc, San Francisco, CA USA; [Cripe, Larry; Sun, Zhuoxin; Tallman, Martin S.; Paietta, Elisabeth] Eastern Cooperat Oncol Grp ECOG, Boston, MA USA; [Cripe, Larry] Indiana Univ, Simon Canc Ctr, Indianapolis, IN 46204 USA; [Sun, Zhuoxin] Dana Farber Canc Inst, Boston, MA 02115 USA; [Tallman, Martin S.] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA; [Paietta, Elisabeth] Montefiore Med Ctr, North Div, Bronx, NY 10467 USA	Indiana University System; Indiana University-Purdue University Indianapolis; Harvard University; Dana-Farber Cancer Institute; Memorial Sloan Kettering Cancer Center; Montefiore Medical Center; Yeshiva University; Albert Einstein College of Medicine	Cesano, A (corresponding author), Nodality Inc, San Francisco, CA USA.	Alessandra.Cesano@Nodality.com			Nodality, Inc.; NATIONAL CANCER INSTITUTE [U24CA114737] Funding Source: NIH RePORTER	Nodality, Inc.; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was funded by Nodality, Inc. The funder contributed to study design, data collection and analysis, decision to publish, and preparation of the manuscript.	Baker SJ, 2007, ONCOGENE, V26, P6724, DOI 10.1038/sj.onc.1210757; Becker H, 2010, J CLIN ONCOL, V28, P596, DOI 10.1200/JCO.2009.25.1496; Benekli M, 2002, BLOOD, V99, P252, DOI 10.1182/blood.V99.1.252; Benekli M, 2003, BLOOD, V101, P2940, DOI 10.1182/blood-2002-04-1204; Beran M, 2004, LEUKEMIA RES, V28, P547, DOI 10.1016/j.leukres.2003.09.016; Brown P, 2004, BLOOD, V104, P1841, DOI 10.1182/blood-2004-03-1034; Bunting KD, 2007, FRONT BIOSCI-LANDMRK, V12, P2807, DOI 10.2741/2274; Cesano A, 2010, ASH ANN M, V116, P2695; Cesano A, 2012, CYTOM PART B-CLIN CY, V82B, P158, DOI 10.1002/cyto.b.21007; Cheong JW, 2003, BRIT J HAEMATOL, V122, P454, DOI 10.1046/j.1365-2141.2003.04452.x; Choudhary C, 2005, INT J HEMATOL, V82, P93, DOI 10.1532/IJH97.05090; Cripe LD, 2006, ASH ANN M, V108, P423; DOSIL M, 1993, MOL CELL BIOL, V13, P6572, DOI 10.1128/MCB.13.10.6572; Estey EH, 2012, AM J HEMATOL, V87, P90, DOI 10.1002/ajh.22246; Falini B, 2005, NEW ENGL J MED, V352, P254, DOI 10.1056/NEJMoa041974; Fan JS, 2010, BLOOD, V116, P5298, DOI 10.1182/blood-2010-03-272591; Frohling S, 2002, BLOOD, V100, P4372, DOI 10.1182/blood-2002-05-1440; Gale RE, 2005, BLOOD, V106, P3658, DOI 10.1182/blood-2005-03-1323; Gale RE, 2008, BLOOD, V111, P2776, DOI 10.1182/blood-2007-08-109090; Gorello P, 2006, LEUKEMIA, V20, P1103, DOI 10.1038/sj.leu.2404149; Grimwade D, 2001, BLOOD, V98, P1312, DOI 10.1182/blood.V98.5.1312; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hayakawa F, 2000, ONCOGENE, V19, P624, DOI 10.1038/sj.onc.1203354; Iwai T, 1999, LEUKEMIA, V13, P38, DOI 10.1038/sj.leu.2401241; Jolliffe, 2002, PRINCIPAL COMPONENT; Kikushige Y, 2008, J IMMUNOL, V180, P7358, DOI 10.4049/jimmunol.180.11.7358; Kindler T, 2010, BLOOD, V116, P5089, DOI 10.1182/blood-2010-04-261867; Kiyoi H, 1999, BLOOD, V93, P3074; Kondo M, 1999, MED PEDIATR ONCOL, V33, P525; Kornblau SM, 2010, CLIN CANCER RES, V16, P3721, DOI 10.1158/1078-0432.CCR-10-0093; Kottaridis PD, 2001, BLOOD, V98, P1752, DOI 10.1182/blood.V98.6.1752; Krause DS, 2005, NEW ENGL J MED, V353, P172, DOI 10.1056/NEJMra044389; Lavagna-Sevenier C, 1998, LEUKEMIA, V12, P301, DOI 10.1038/sj.leu.2400921; Lyman SD, 1998, BLOOD, V91, P1101, DOI 10.1182/blood.V91.4.1101; Meshinchi S, 2001, BLOOD, V97, P89, DOI 10.1182/blood.V97.1.89; Mizuki M, 2000, BLOOD, V96, P3907, DOI 10.1182/blood.V96.12.3907; O'Donnell MR, 2012, NCCN CLIN PRACTICE G; Patel JP, 2012, NEW ENGL J MED, V366, P1079, DOI 10.1056/NEJMoa1112304; Purvis N, 1998, CYTOMETRY, V33, P156, DOI 10.1002/(SICI)1097-0320(19981001)33:2<156::AID-CYTO10>3.0.CO;2-T; Rosen DB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013543; Rosen DB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012405; ROTTAPEL R, 1994, ONCOGENE, V9, P1755; Rowe JM, 2004, BLOOD, V103, P479, DOI 10.1182/blood-2003-05-1686; Sallmyr A, 2008, BLOOD, V111, P3173, DOI 10.1182/blood-2007-05-092510; Schnittger S, 2011, LEUKEMIA, V25, P1297, DOI 10.1038/leu.2011.97; Scholl C, 2008, SEMIN ONCOL, V35, P336, DOI 10.1053/j.seminoncol.2008.04.004; Shults KE, 2006, CYTOM PART B-CLIN CY, V70B, P276, DOI 10.1002/cyto.b.20136; Stelzer GT, 2000, IMMUNOPHENOTYPING, P215; Thiede C, 2006, BLOOD, V107, P4011, DOI 10.1182/blood-2005-08-3167; Thiede C, 2002, BLOOD, V99, P4326, DOI 10.1182/blood.V99.12.4326; Wang L, 2008, CYTOM PART A, V73A, P279, DOI 10.1002/cyto.a.20507; Whitman SP, 2001, CANCER RES, V61, P7233; Yilmaz OH, 2006, NATURE, V441, P475, DOI 10.1038/nature04703; Zhang SL, 2000, J EXP MED, V192, P719, DOI 10.1084/jem.192.5.719; Zhang SL, 1999, J LEUKOCYTE BIOL, V65, P372, DOI 10.1002/jlb.65.3.372	55	5	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2013	8	2							e56714	10.1371/journal.pone.0056714	http://dx.doi.org/10.1371/journal.pone.0056714			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093HR	23431389	Green Submitted, gold, Green Published			2022-12-25	WOS:000315182800032
J	Xie, CF; Ma, L; Liu, J; Li, XX; Pei, HY; Xiang, ML; Chen, LJ				Xie, Caifeng; Ma, Liang; Liu, Juan; Li, Xiuxia; Pei, Heying; Xiang, Mingli; Chen, Lijuan			SKLB023 Blocks Joint Inflammation and Cartilage Destruction in Arthritis Models via Suppression of Nuclear Factor-Kappa B Activation in Macrophage	PLOS ONE			English	Article							RHEUMATOID-ARTHRITIS; TRANSCRIPTION FACTOR; SIGNAL-TRANSDUCTION; SYNOVIAL TISSUE; DISEASE; MECHANISMS; THERAPY; CELLS; THERAPEUTICS; DEGRADATION	Rheumatoid arthritis (RA) is the most common arthritis and is mainly characterized by symmetric polyarticular joint disorders. Our previous study demonstrated a novel small molecule compound (Z)-N-(3-Chlorophenyl)-2-(4-((2,4-dioxothiazolidin-5-ylidene) methyl) phenoxy) acet-amide (SKLB023) showed potently anti-arthritic effects in a rat arthritis model, however, the underlying mechanisms for this are largely unknown. Both NF-kappa B and macrophages were reported to play important roles in the pathologic processes of RA. The purposes of this study were to indicate whether NF-kappa B and macrophages contributed to anti-arthritic effects of SKLB023 in two experimental arthritis models. Our results showed that SKLB023 could significantly improve joint inflammation and cartilage destruction both in adjuvant induced arthritis (AIA) and collagen-induced arthritis (CIA) models. We further found that the binding activation of NF-kappa B to DNA in joint tissues and RAW264.7 macrophages were suppressed by SKLB023. SKLB023 also inhibited the NF-kappa B activity in peritoneal macrophages by luciferase assay. Furthermore, the number of macrophages in synovial tissues was decreased after the treatment of different doses of SKLB023. The levels of TNF-alpha, IL-1 beta, and IL-6 in plasma, and the levels of TNF-alpha, NO, and IL-1 beta in peritoneal macrophages were down-regulated by SKLB023. Finally, SKLB023 attenuated the expression of iNOS and COX-2 in vivo and suppressed the phosphorylations of components of the mitogen-activated protein kinases (MAPKs). These observations identify a novel function for SKLB023 as an inhibitor of NF-kappa B in macrophages of RA, highlighting that SKLB023 was a potential therapeutic strategy for RA.	[Xie, Caifeng; Ma, Liang; Liu, Juan; Li, Xiuxia; Pei, Heying; Xiang, Mingli; Chen, Lijuan] Sichuan Univ, W China Med Sch, State Key Lab Biotherapy, Chengdu 610064, Peoples R China	Sichuan University	Xiang, ML (corresponding author), Sichuan Univ, W China Med Sch, State Key Lab Biotherapy, Chengdu 610064, Peoples R China.	tmkxiang@gmail.com; lijuan17@hotmail.com		Ma, Liang/0000-0001-8327-7969	National Key Programs of China [2012ZX09103101-017]	National Key Programs of China	This work is supported by the National Key Programs of China during the 12th Five-Year Plan period (grant 2012ZX09103101-017). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amin Ashok R., 1999, Current Opinion in Rheumatology, V11, P202, DOI 10.1097/00002281-199905000-00009; Baldwin AS, 1996, ANNU REV IMMUNOL, V14, P649, DOI 10.1146/annurev.immunol.14.1.649; Barnes PJ, 1997, NEW ENGL J MED, V336, P1066, DOI 10.1056/NEJM199704103361506; Bendele A. M., 2001, Journal of Musculoskeletal & Neuronal Interactions, V1, P377; Bian ZM, 2003, EXP EYE RES, V76, P573, DOI 10.1016/S0014-4835(03)00029-0; Bingham CO, 2002, J RHEUMATOL, V29, P3; Bondeson J, 1999, P NATL ACAD SCI USA, V96, P5668, DOI 10.1073/pnas.96.10.5668; Bondeson J, 2011, EXPERT OPIN THER TAR, V15, P1355, DOI 10.1517/14728222.2011.636740; BRACKERTZ D, 1977, ARTHRITIS RHEUM, V20, P841, DOI 10.1002/art.1780200314; Brown KD, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2457; Choy EHS, 2001, NEW ENGL J MED, V344, P907, DOI 10.1056/NEJM200103223441207; Drosos AA, 2002, DRUGS, V62, P891, DOI 10.2165/00003495-200262060-00003; Dudler J, 2000, ANN RHEUM DIS, V59, P529, DOI 10.1136/ard.59.7.529; Emery P, 2006, BRIT MED J, V332, P152, DOI 10.1136/bmj.332.7534.152; Feldmann M, 2008, IMMUNOL REV, V223, P7, DOI 10.1111/j.1600-065X.2008.00626.x; Firestein GS, 2003, NATURE, V423, P356, DOI 10.1038/nature01661; Firestein GS, 1999, ARTHRITIS RHEUM-US, V42, P609, DOI 10.1002/1529-0131(199904)42:4<609::AID-ANR3>3.0.CO;2-I; Fritsche G, 2003, J IMMUNOL, V171, P1994, DOI 10.4049/jimmunol.171.4.1994; Gilmore TD, 2011, CURR TOP MICROBIOL, V349, P245, DOI 10.1007/82_2010_105; Guma M, 2011, J EXP MED, V208, P1889, DOI 10.1084/jem.20110242; Hammaker D, 2003, ANN RHEUM DIS, V62, P86; Hegen M, 2008, ANN RHEUM DIS, V67, P1505, DOI 10.1136/ard.2007.076430; Kinne RW, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2333; Kinne RW, 2000, ARTHRITIS RES, V2, P189, DOI 10.1186/ar86; Ma LA, 2011, J MED CHEM, V54, P2060, DOI 10.1021/jm1011534; Marok R, 1996, ARTHRITIS RHEUM, V39, P583, DOI 10.1002/art.1780390407; Miagkov AV, 1998, P NATL ACAD SCI USA, V95, P13859, DOI 10.1073/pnas.95.23.13859; Olsen NJ, 2004, NEW ENGL J MED, V350, P2167, DOI 10.1056/NEJMra032906; SCHREIBER E, 1989, NUCLEIC ACIDS RES, V17, P6419, DOI 10.1093/nar/17.15.6419; Simmonds RE, 2008, RHEUMATOLOGY, V47, P584, DOI 10.1093/rheumatology/kem298; Sinha P, 2007, J IMMUNOL, V179, P977, DOI 10.4049/jimmunol.179.2.977; Tak PP, 1997, ARTHRITIS RHEUM, V40, P217, DOI 10.1002/art.1780400206; Tak PP, 2001, J CLIN INVEST, V107, P7, DOI 10.1172/JCI11830; Tak PP, 2001, ARTHRITIS RHEUM, V44, P1897, DOI 10.1002/1529-0131(200108)44:8<1897::AID-ART328>3.0.CO;2-4; Thalhamer T, 2008, RHEUMATOLOGY, V47, P409, DOI 10.1093/rheumatology/kem297; Thurlings RM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007865; van Vollenhoven RF, 2009, NAT REV RHEUMATOL, V5, P531, DOI 10.1038/nrrheum.2009.182; Weissmann G, 2006, BULL HOSP JT DIS, V64, P12	38	17	18	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2013	8	2							e56349	10.1371/journal.pone.0056349	http://dx.doi.org/10.1371/journal.pone.0056349			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093HR	23431370	Green Published, Green Submitted, gold			2022-12-25	WOS:000315182800012
J	Xia, YS; Li, RH; Ning, ZX; Bai, GH; Siddique, KHM; Yan, GJ; Baum, M; Varshney, RK; Guo, PG				Xia, Yanshi; Li, Ronghua; Ning, Zhengxiang; Bai, Guihua; Siddique, Kadambot H. M.; Yan, Guijun; Baum, Michael; Varshney, Rajeev K.; Guo, Peiguo			Single Nucleotide Polymorphisms in HSP17.8 and Their Association with Agronomic Traits in Barley	PLOS ONE			English	Article							HEAT-SHOCK PROTEINS; MOLECULAR DIVERSITY; WILD BARLEY; POPULATION-STRUCTURE; QUANTITATIVE TRAITS; DROUGHT TOLERANCE; ABIOTIC STRESSES; GENES; DISCOVERY; VULGARE	Small heat shock protein 17.8 (HSP17.8) is produced abundantly in plant cells under heat and other stress conditions and may play an important role in plant tolerance to stress environments. However, HSP17.8 may be differentially expressed in different accessions of a crop species exposed to identical stress conditions. The ability of different genotypes to adapt to various stress conditions resides in their genetic diversity. Allelic variations are the most common forms of genetic variation in natural populations. In this study, single nucleotide polymorphisms (SNPs) of the HSP17.8 gene were investigated across 210 barley accessions collected from 30 countries using EcoTILLING technology. Eleven SNPs including 10 from the coding region of HSP17.8 were detected, which form nine distinguishable haplotypes in the barley collection. Among the 10 SNPs in the coding region, six are missense mutations and four are synonymous nucleotide changes. Five of the six missense changes are predicted to be deleterious to HSP17.8 function. The accessions from Middle East Asia showed the higher nucleotide diversity of HSP17.8 than those from other regions and wild barley (H. spontaneum) accessions exhibited greater diversity than the cultivated barley (H. vulgare) accessions. Four SNPs in HSP17.8 were found associated with at least one of the agronomic traits evaluated except for spike length, namely number of grains per spike, thousand kernel weight, plant height, flag leaf area and leaf color. The association between SNP and these agronomic traits may provide new insight for study of the gene's potential contribution to drought tolerance of barley.	[Xia, Yanshi; Li, Ronghua; Guo, Peiguo] Guangzhou Univ, Coll Life Sci, Int Crop Res Ctr Stress Resistance, Guangzhou, Guangdong, Peoples R China; [Xia, Yanshi; Ning, Zhengxiang] S China Univ Technol, Coll Light Ind & Food Sci, Guangzhou, Guangdong, Peoples R China; [Bai, Guihua] ARS, Hard Winter Wheat Genet Res Unit, USDA, Manhattan, KS USA; [Siddique, Kadambot H. M.; Yan, Guijun] Univ Western Australia, Inst Agr, Perth, WA 6009, Australia; [Baum, Michael] Int Ctr Agr Res Dry Areas, Aleppo, Syria; [Varshney, Rajeev K.] Int Crops Res Inst Semi Arid Trop, Patancheru 502324, Greater Hyderab, India	Guangzhou University; South China University of Technology; United States Department of Agriculture (USDA); University of Western Australia; CGIAR; International Center for Agricultural Research in the Dry Areas (ICARDA); CGIAR; International Crops Research Institute for the Semi-Arid-Tropics (ICRISAT)	Guo, PG (corresponding author), Guangzhou Univ, Coll Life Sci, Int Crop Res Ctr Stress Resistance, Guangzhou, Guangdong, Peoples R China.	guopg@yahoo.com	Varshney, Rajeev K/C-5295-2014; Li, Ronghua/AAP-8236-2021; Yan, Guijun/A-9809-2011; bai, guihua/L-6374-2019; Siddique, Kadambot H.M./B-3462-2011	Varshney, Rajeev K/0000-0002-4562-9131; Yan, Guijun/0000-0001-9628-1211; bai, guihua/0000-0002-1194-319X; Siddique, Kadambot H.M./0000-0001-6097-4235; Baum, Michael/0000-0002-8248-6088	National Natural Science Foundation of China [30871526]; Guangdong Province the Technology Plan in China [2008B050300003]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong Province the Technology Plan in China	This work was funded by the National Natural Science Foundation of China (30871526) (http://www.nsfc.gov.cn) and Guangdong Province the Technology Plan in China (2008B050300003) (http://www.gdstc.gov.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdellaoui Raoudha, 2007, Asian Journal of Plant Sciences, V6, P261; Andras C, 2011, EUPHYTICA, V181, P341, DOI 10.1007/s10681-011-0445-7; Breseghello F, 2006, GENETICS, V172, P1165, DOI 10.1534/genetics.105.044586; Bundock PC, 2004, THEOR APPL GENET, V109, P543, DOI 10.1007/s00122-004-1675-z; Ceccarelli S., 1995, Diversity, V11, P112; Chen GY, 2009, AGR SCI CHINA, V8, P1440, DOI 10.1016/S1671-2927(08)60357-0; Chung JD, 2010, BOT STUD, V51, P27; Comai L, 2004, PLANT J, V37, P778, DOI 10.1111/j.0960-7412.2003.01999.x; Duran C, 2009, PLANT BIOTECHNOL J, V7, P326, DOI 10.1111/j.1467-7652.2009.00407.x; Ellis RP, 2000, J EXP BOT, V51, P9, DOI 10.1093/jexbot/51.342.9; Gilchrist EJ, 2006, MOL ECOL, V15, P1367, DOI 10.1111/j.1365-294X.2006.02885.x; Grigorova B, 2011, ACTA PHYSIOL PLANT, V33, P2041, DOI 10.1007/s11738-011-0733-9; Guo P., 2007, J GUANGZHOU U NATURA, V6, P32; Guo P, 2007, AGR SCI CHINA, V5, P522; Guo PG, 2008, EUPHYTICA, V163, P203, DOI 10.1007/s10681-007-9629-6; Guo PG, 2009, J EXP BOT, V60, P3531, DOI 10.1093/jxb/erp194; Guo PG, 2010, Chinese Patent, Patent No. [ZL200910038725.9, 2009100387259]; Gupta R, 2011, RES J AGR SCI, V2, P87; Hu WH, 2009, PLANT SCI, V176, P583, DOI 10.1016/j.plantsci.2009.01.016; Inostroza L, 2009, MOL BREEDING, V23, P365, DOI 10.1007/s11032-008-9239-6; Kant P, 2008, PLANT CELL ENVIRON, V31, P697, DOI 10.1111/j.1365-3040.2008.01779.x; Kilian B, 2006, MOL GENET GENOMICS, V276, P230, DOI 10.1007/s00438-006-0136-6; Kim DH, 2011, PLANT PHYSIOL, V157, P132, DOI 10.1104/pp.111.178681; Lakew B, 2011, FIELD CROP RES, V120, P161, DOI 10.1016/j.fcr.2010.09.011; Li JZ, 2006, GENOME, V49, P454, DOI 10.1139/G05-128; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Liu XG, 2005, IUBMB LIFE, V57, P449, DOI 10.1080/15216540500138402; Malysheva-Otto LV, 2006, BMC GENET, V7, DOI 10.1186/1471-2156-7-6; Mohammed KAH, 2004, THESIS BONN U GERMAN; Myles S, 2009, PLANT CELL, V21, P2194, DOI 10.1105/tpc.109.068437; Nevo E., 1992, Barley: genetics, biochemistry, molecular biology and biotechnology., P19; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; Nieto C, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-34; PATERSON AH, 1988, NATURE, V335, P721, DOI 10.1038/335721a0; Peng JH, 2009, GENETICA, V135, P95, DOI 10.1007/s10709-008-9262-x; Peter-Schmid MKI, 2008, PLANT BREEDING, V127, P510, DOI 10.1111/j.1439-0523.2007.01478.x; Pritchard JK, 2000, GENETICS, V155, P945; Raghavan C, 2007, MOL BREEDING, V19, P87, DOI 10.1007/s11032-006-9046-x; Rostoks N, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-6-r54; Russell J, 2004, GENOME, V47, P389, DOI [10.1139/G03-125, 10.1139/g03-125]; Sato Y, 2008, PLANT CELL REP, V27, P329, DOI 10.1007/s00299-007-0470-0; Schmalenbach I, 2009, THEOR APPL GENET, V118, P483, DOI 10.1007/s00122-008-0915-z; Shou HX, 2004, P NATL ACAD SCI USA, V101, P3298, DOI 10.1073/pnas.0308095100; Song NH, 2011, NEW BIOTECHNOL, V28, P698, DOI 10.1016/j.nbt.2011.04.002; Stein N, 2007, THEOR APPL GENET, V114, P823, DOI 10.1007/s00122-006-0480-2; Sun DF, 2011, EUPHYTICA, V178, P31, DOI 10.1007/s10681-010-0260-6; Sun WN, 2002, BBA-GENE STRUCT EXPR, V1577, P1, DOI 10.1016/S0167-4781(02)00417-7; Szalma SJ, 2005, THEOR APPL GENET, V110, P1324, DOI 10.1007/s00122-005-1973-0; TAJIMA F, 1989, GENETICS, V123, P585; Tanksley SD, 1997, SCIENCE, V277, P1063, DOI 10.1126/science.277.5329.1063; Taylor NE, 2003, NUCLEIC ACIDS RES, V31, P3808, DOI 10.1093/nar/gkg574; Teulat B, 2001, THEOR APPL GENET, V103, P774, DOI 10.1007/s001220100619; Thornton KR, 2007, HEREDITY, V98, P340, DOI 10.1038/sj.hdy.6800967; Till BJ, 2006, NAT PROTOC, V1, P2465, DOI 10.1038/nprot.2006.329; Timperio AM, 2008, J PROTEOMICS, V71, P391, DOI 10.1016/j.jprot.2008.07.005; Varshney RK, 2012, FIELD CROP RES, V126, P171, DOI 10.1016/j.fcr.2011.10.008; Varshney RK, 2010, MOL BREEDING, V26, P229, DOI 10.1007/s11032-009-9373-9; Wang GX, 2007, PESTIC BIOCHEM PHYS, V88, P143, DOI 10.1016/j.pestbp.2006.10.006; Wang NA, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-137; Waters ER, 1996, J EXP BOT, V47, P325, DOI 10.1093/jxb/47.3.325; Wienholds E, 2003, GENOME RES, V13, P2700, DOI 10.1101/gr.1725103; Witkin SS, 2010, HEAT SHOCK PROTEINS, V4, P241, DOI 10.1007/978-90-481-2976-8_13; Wu DZ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022938; Xia Yanshi, 2012, PLoS One, V7, pe37573, DOI 10.1371/journal.pone.0037573; Yu JM, 2006, CURR OPIN BIOTECH, V17, P155, DOI 10.1016/j.copbio.2006.02.003; Yu SW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030765; Zeng XH, 2009, AGR SCI CHINA, V8, P8, DOI 10.1016/S1671-2927(09)60003-1; Zerr T, 2005, NUCLEIC ACIDS RES, V33, P2806, DOI 10.1093/nar/gki580; Zhu CS, 2008, PLANT GENOME-US, V1, P5, DOI 10.3835/plantgenome2008.02.0089	69	17	22	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e56816	10.1371/journal.pone.0056816	http://dx.doi.org/10.1371/journal.pone.0056816			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418603	gold, Green Published			2022-12-25	WOS:000315970300196
J	Zhou, J; Mo, YF; Li, H; Ran, XW; Yang, WY; Li, Q; Peng, YD; Li, YB; Gao, X; Luan, XJ; Wang, WQ; Jia, WP				Zhou, Jian; Mo, Yifei; Li, Hong; Ran, Xingwu; Yang, Wenying; Li, Qiang; Peng, Yongde; Li, Yanbing; Gao, Xin; Luan, Xiaojun; Wang, Weiqing; Jia, Weiping			Alanine Aminotransferase Is Associated with an Adverse Nocturnal Blood Glucose Profile in Individuals with Normal Glucose Regulation	PLOS ONE			English	Article							NONALCOHOLIC FATTY LIVER; INSULIN-RESISTANCE; METABOLIC SYNDROME; RISK; DISEASE; SENSITIVITY; PREDICTS; OBESITY; MEN; DETERMINANTS	Objective: Although the association between alanine aminotransferase (ALT) levels and risk of type 2 diabetes is well-studied, the effects of slightly increased ALT levels within the normal range on the temporal normal glucose profile remains poorly understood. Methods: A total of 322 Chinese subjects without impaired glucose tolerance or previous diagnoses of diabetes were recruited for study from 10 hospitals in urban areas across China. All subjects wore a continuous glucose monitoring (CGM) system for three consecutive days. The diurnal (06:00-20:00) and nocturnal (20:00-06:00) mean blood glucose (MBG) levels were calculated. Subjects were stratified by ALT quartile level and correlation analyses were performed. Results: The median ALT level was 17 IU/L, and subjects with ALT >= 17 IU/L had higher nocturnal MBG level than those with ALT < 17 IU/L (P<0.05). Nocturnal MBG was positively correlated with ALT levels (Pearson correlation analysis: r = 0.187, P = 0.001), and the correlation remained significant after correction for the homeostatic model assessment of insulin resistance index (HOMA-IR) (r = 0.105, P = 0.041). No correlations were found between diurnal MBG and ALT, and nocturnal or diurnal MBG and aspartate aminotransferase or gamma-glutamyltransferase (all, P>0.05). Multivariate stepwise regression analysis of elevated nocturnal MBG identified increased HOMA-IR, elevated ALT levels, and decreased homeostatic model assessment of beta-cell function as independent factors (all, P<0.05). Conclusions: Mildly elevated ALT levels, within the normal range, are associated with unfavorable nocturnal glucose profiles in Chinese subjects with normal glucose regulation.	[Zhou, Jian; Mo, Yifei; Jia, Weiping] Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Shanghai Clin Ctr Diabet, Dept Endocrinol & Metab,Shanghai Diabet Inst, Shanghai 200030, Peoples R China; [Li, Hong] Zhejiang Univ, Coll Med, Sir Run Run Shaw Hosp, Dept Endocrinol & Metab, Hangzhou 310003, Zhejiang, Peoples R China; [Ran, Xingwu] Sichuan Univ, West China Hosp, Dept Endocrinol & Metab, Chengdu 610064, Peoples R China; [Yang, Wenying] China Japan Friendship Hosp, Dept Endocrinol & Metab, Beijing, Peoples R China; [Li, Qiang] Harbin Med Univ, Affiliated Hosp 2, Dept Endocrinol & Metab, Harbin, Peoples R China; [Peng, Yongde] Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 1, Dept Endocrinol & Metab, Shanghai 200030, Peoples R China; [Li, Yanbing] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Endocrinol & Metab, Guangzhou 510275, Guangdong, Peoples R China; [Gao, Xin] Fudan Univ, Affiliated Zhongshan Hosp, Dept Endocrinol & Metab, Shanghai 200433, Peoples R China; [Luan, Xiaojun] First Peoples Hosp Foshan, Dept Endocrinol & Metab, Foshan, Peoples R China; [Wang, Weiqing] Shanghai Jiao Tong Univ, Ruijin Hosp, Shanghai Inst Endocrinol & Metab, Shanghai Clin Ctr Endocrine & Metab Dis,Sch Med, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Zhejiang University; Sichuan University; China-Japan Friendship Hospital; Harbin Medical University; Shanghai Jiao Tong University; Sun Yat Sen University; Fudan University; Shanghai Jiao Tong University	Jia, WP (corresponding author), Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Shanghai Clin Ctr Diabet, Dept Endocrinol & Metab,Shanghai Diabet Inst, Shanghai 200030, Peoples R China.	wpjia@sjtu.edu.cn	Jia, Weiping/B-7483-2012; li, yan/GTI-4638-2022		National Natural Science Foundation of China [81100590]; Shanghai Rising-Star Program [12QA1402500]; Shanghai United Developing Technology Project of Municipal Hospitals [SHDC12010115]; Shanghai Medical Program for Outstanding Young Talent [XYQ2011013]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Rising-Star Program; Shanghai United Developing Technology Project of Municipal Hospitals; Shanghai Medical Program for Outstanding Young Talent	This work was funded by the National Natural Science Foundation of China (81100590), http://www.nsfc.gov.cn; the Shanghai Rising-Star Program (12QA1402500), http://www.stcsm.gov.cn; the Shanghai United Developing Technology Project of Municipal Hospitals (SHDC12010115), http://www.shdc.org.cn; and Shanghai Medical Program for Outstanding Young Talent (XYQ2011013), http://wsj.sh.gov.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Diabetes Association, 2007, Diabetes Care, V30 Suppl 1, pS4; Angelico F, 2005, J CLIN ENDOCR METAB, V90, P1578, DOI 10.1210/jc.2004-1024; Angulo P, 2002, NEW ENGL J MED, V346, P1221, DOI 10.1038/nrdp.2015.80; Anonymous, 2007, Zhonghua Xinxueguanbing Zazhi, V35, P390; Bhatia LS, 2012, EUR HEART J, V33, P1190, DOI 10.1093/eurheartj/ehr453; Bian H, 2011, DIABETES TECHNOL THE, V13, P149, DOI 10.1089/dia.2010.0101; Bonnet F, 2011, DIABETES, V60, P1660, DOI 10.2337/db10-1806; Cai ZJ, 1999, WHO TECH REP SER, V887, P1; CEDERHOLM J, 1990, DIABETES RES CLIN PR, V10, P167, DOI 10.1016/0168-8227(90)90040-Z; Clark JM, 2003, AM J GASTROENTEROL, V98, P960, DOI [10.1016/S0002-9270(03)00265-X, 10.1111/j.1572-0241.2003.07486.x]; Daniel S, 1999, AM J GASTROENTEROL, V94, P3010, DOI 10.1111/j.1572-0241.1999.01451.x; Goessling W, 2008, GASTROENTEROLOGY, V135, P1935, DOI 10.1053/j.gastro.2008.09.018; Gronbaek Henning, 2008, Expert Rev Gastroenterol Hepatol, V2, P705, DOI 10.1586/17474124.2.5.705; Hanley AJG, 2004, DIABETES, V53, P2623, DOI 10.2337/diabetes.53.10.2623; Hsiao TJ, 2004, INT J OBESITY, V28, P167, DOI 10.1038/sj.ijo.0802519; Lee DH, 2004, J CLIN ENDOCR METAB, V89, P5410, DOI 10.1210/jc.2004-0505; Marchesini G, 2005, J ENDOCRINOL INVEST, V28, P333, DOI 10.1007/BF03347199; Marchesini G, 2003, HEPATOLOGY, V37, P917, DOI 10.1053/jhep.2003.50161; Marchesini G, 1999, AM J MED, V107, P450, DOI 10.1016/S0002-9343(99)00271-5; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Michael MD, 2000, MOL CELL, V6, P87, DOI 10.1016/S1097-2765(00)00010-1; Musso G, 2008, DIABETES CARE, V31, P562, DOI 10.2337/dc07-1526; Nannipieri M, 2005, DIABETES CARE, V28, P1757, DOI 10.2337/diacare.28.7.1757; Prati D, 2002, ANN INTERN MED, V137, P1, DOI 10.7326/0003-4819-137-1-200207020-00006; Ruhl CE, 2003, GASTROENTEROLOGY, V124, P71, DOI 10.1053/gast.2003.50004; Sattar N, 2004, DIABETES, V53, P2855, DOI 10.2337/diabetes.53.11.2855; Schindhelm RK, 2007, DIABETIC MED, V24, P430, DOI 10.1111/j.1464-5491.2007.02100.x; Schindhelm RK, 2007, ATHEROSCLEROSIS, V191, P391, DOI 10.1016/j.atherosclerosis.2006.04.006; Schindhelm RK, 2006, DIABETES-METAB RES, V22, P437, DOI 10.1002/dmrr.666; SELTZER HS, 1967, J CLIN INVEST, V46, P323, DOI 10.1172/JCI105534; Seppala-Lindroos A, 2002, J CLIN ENDOCR METAB, V87, P3023, DOI 10.1210/jc.87.7.3023; Shibata M, 2007, DIABETES CARE, V30, P2940, DOI 10.2337/dc07-0792; Suh SY, 2009, METABOLISM, V58, P1731, DOI 10.1016/j.metabol.2009.05.028; Targher G, 2007, DIABETES CARE, V30, P2119, DOI 10.2337/dc07-0349; Vozarova B, 2002, DIABETES, V51, P455, DOI 10.2337/diabetes.51.2.455; Vozarova B, 2002, DIABETES, V51, P1889, DOI 10.2337/diabetes.51.6.1889; Wang CC, 2009, J GASTROEN HEPATOL, V24, P1411, DOI 10.1111/j.1440-1746.2009.05872.x; Westerbacka J, 2007, DIABETES, V56, P2759, DOI 10.2337/db07-0156; Xia MF, 2011, CLIN EXP PHARMACOL P, V38, P373, DOI 10.1111/j.1440-1681.2011.05519.x; Zhou J, 2009, DIABETES CARE, V32, P1188, DOI 10.2337/dc09-0076	40	6	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2013	8	2							e56072	10.1371/journal.pone.0056072	http://dx.doi.org/10.1371/journal.pone.0056072			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104BU	23424646	Green Submitted, Green Published, gold			2022-12-25	WOS:000315965100034
J	Nakayama, H; Fukuda, S; Matsushita, N; Nishida-Fukuda, H; Inoue, H; Shirakata, Y; Hashimoto, K; Higashiyama, S				Nakayama, Hironao; Fukuda, Shinji; Matsushita, Natsuki; Nishida-Fukuda, Hisayo; Inoue, Hirofumi; Shirakata, Yuji; Hashimoto, Koji; Higashiyama, Shigeki			Human Antigen R-mediated mRNA Stabilization Is Required for Ultraviolet B-induced Autoinduction of Amphiregulin in Keratinocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPIDERMAL-GROWTH-FACTOR; FACTOR RECEPTOR; GENE-EXPRESSION; FACTOR FAMILY; HB-EGF; BINDING; PROTEIN; HUR; ACTIVATION; ELEMENT	All members of the EGF family are produced as transmembrane precursors that are proteolytically processed into soluble forms by disintegrin and metalloproteinases (ADAMs) for autocrine/paracrine pathways. In turn, the ligand-activated EGF receptor (EGFR) induces the expression of EGF family members, so-called "autoinduction." However, it is not well understood how this autoinduction occurs. In this study, we investigated the molecular mechanism of the autoinduction of amphiregulin (AREG), a member of the EGF family. We found that ultraviolet B (UVB) exposure increased the AREG mRNA level by stabilization of its mRNA in a human immortalized keratinocyte cell line, HaCaT. The 3' UTR of AREG mRNA was responsible for binding to an mRNA-binding protein, human antigen R (HuR), and the interaction between AREG mRNA and HuR was enhanced by UVB. Inducible knockdown of HuR expression significantly decreased AREG mRNA stability. Interestingly, treatment of HaCaT cells with an EGFR inhibitor, an EGFR neutralizing antibody, or an ADAM inhibitor destabilized AREG mRNA. In the case of ADAM inhibition, administration of soluble AREG restored the mRNA level, indicating that the stabilization occurs in a shedding-dependent manner of EGFR ligands. The HuR dependence of AREG mRNA and protein expression was also confirmed in human primary keratinocytes. Taken together, we propose a novel mechanism by which HuR regulates the stability of AREG mRNA in keratinocytes after UVB exposure and suggest that targeting of HuR functions might be crucial for understanding skin cancers caused by aberrant EGF family member-EGFR signaling.	[Nakayama, Hironao; Fukuda, Shinji; Nishida-Fukuda, Hisayo; Inoue, Hirofumi; Higashiyama, Shigeki] Ehime Univ, Grad Sch Med, Dept Biochem & Mol Genet, Toon, Ehime 7910295, Japan; [Nakayama, Hironao; Shirakata, Yuji; Hashimoto, Koji] Ehime Univ, Grad Sch Med, Dept Dermatol, Toon, Ehime 7910295, Japan; [Matsushita, Natsuki] Ehime Univ, Funct Genom Core Lab, Toon, Ehime 7910295, Japan; [Inoue, Hirofumi] Ehime Univ, Ehime Nikon BioImaging Core Lab, Toon, Ehime 7910295, Japan; [Inoue, Hirofumi; Higashiyama, Shigeki] Ehime Univ, Dept Cell Growth & Tumor Regulat, Proteomed Res Ctr ProMRes, Toon, Ehime 7910295, Japan; [Nakayama, Hironao; Higashiyama, Shigeki] Japan Soc Promot Sci, Strateg Young Researcher Overseas Visiting Progra, Chiyoda Ku, Tokyo 1020083, Japan	Ehime University; Ehime University; Ehime University; Ehime University; Ehime University; Japan Society for the Promotion of Science	Higashiyama, S (corresponding author), Ehime Univ, Grad Sch Med, Dept Biochem & Mol Genet, Toon, Ehime 7910295, Japan.	shigeki@m.ehime-u.ac.jp		Nishida-Fukuda, Hisayo/0000-0002-4661-779X	Ehime University; Ministry of Education, Culture, Sports, Science, and Technology of Japan [24390074, 22650228, 20390082]; Strategic Young Researcher Overseas Visiting Program for Accelerating Brain Circulation, Japan Society for the Promotion of Science (JSPS), Japan [S2207]	Ehime University; Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Strategic Young Researcher Overseas Visiting Program for Accelerating Brain Circulation, Japan Society for the Promotion of Science (JSPS), Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by a grant-in-aid for scientific research from Ehime University (to H. N.). This work was also supported by Grants-in-Aid for Scientific Research 24390074, 22650228, and 20390082 from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (to S. H.) and by Grant-in-Aid for Scientific Research S2207 from the Strategic Young Researcher Overseas Visiting Program for Accelerating Brain Circulation, Japan Society for the Promotion of Science (JSPS), Japan (to S. H.).	Abdelmohsen K, 2007, MOL CELL, V25, P543, DOI 10.1016/j.molcel.2007.01.011; Asakura M, 2002, NAT MED, V8, P35, DOI 10.1038/nm0102-35; BARNARD JA, 1994, J BIOL CHEM, V269, P22817; Brennan CM, 2001, CELL MOL LIFE SCI, V58, P266, DOI 10.1007/PL00000854; Chen CYA, 2002, MOL CELL BIOL, V22, P7268, DOI 10.1128/MCB.22.20.7268-7278.2002; Chen WX, 2001, ONCOGENE, V20, P3921, DOI 10.1038/sj.onc.1204530; Cok SJ, 2001, J BIOL CHEM, V276, P23179, DOI 10.1074/jbc.M008461200; COOK PW, 1991, MOL CELL BIOL, V11, P2547, DOI 10.1128/MCB.11.5.2547; COOK PW, 1992, CANCER RES, V52, P3224; Cook PW, 1997, J CLIN INVEST, V100, P2286, DOI 10.1172/JCI119766; Doller A, 2008, CELL SIGNAL, V20, P2165, DOI 10.1016/j.cellsig.2008.05.007; Durie D, 2011, ONCOGENE, V30, P1460, DOI 10.1038/onc.2010.527; Edwards DR, 2008, MOL ASPECTS MED, V29, P258, DOI 10.1016/j.mam.2008.08.001; Fernau NS, 2010, J BIOL CHEM, V285, P3896, DOI 10.1074/jbc.M109.081430; GILL GN, 1984, J BIOL CHEM, V259, P7755; GOISHI K, 1995, MOL BIOL CELL, V6, P967, DOI 10.1091/mbc.6.8.967; Gruber AR, 2011, NUCLEIC ACIDS RES, V39, pD66, DOI 10.1093/nar/gkq990; HASHIMOTO K, 1994, J BIOL CHEM, V269, P20060; Hashimoto K, 2000, J DERMATOL SCI, V24, pS46, DOI 10.1016/S0923-1811(00)00141-9; Higashiyama S, 2008, CANCER SCI, V99, P214, DOI 10.1111/j.1349-7006.2007.00676.x; Higashiyama S, 2011, J BIOCHEM, V150, P15, DOI 10.1093/jb/mvr068; Hinman MN, 2008, CELL MOL LIFE SCI, V65, P3168, DOI 10.1007/s00018-008-8252-6; Kawai T, 2006, MOL CELL BIOL, V26, P3295, DOI 10.1128/MCB.26.8.3295-3307.2006; Lee SB, 1999, CELL, V98, P663, DOI 10.1016/S0092-8674(00)80053-7; Matsushita N., 2013, BIOSCI BIOT IN PRESS; Miyoshi H, 1998, J VIROL, V72, P8150, DOI 10.1128/JVI.72.10.8150-8157.1998; Murphy G, 2008, NAT REV CANCER, V8, P929, DOI 10.1038/nrc2459; Nakayama H, 2012, MOL BIOL CELL, V23, P1964, DOI 10.1091/mbc.E11-08-0683; Narayanan DL, 2010, INT J DERMATOL, V49, P978, DOI 10.1111/j.1365-4632.2010.04474.x; O'Reilly SM, 2006, AM J PHYSIOL-CELL PH, V290, pC592, DOI 10.1152/ajpcell.00278.2005; Ornskov D, 2007, BIOCHEM BIOPH RES CO, V354, P885, DOI 10.1016/j.bbrc.2007.01.047; Pastore S, 2008, J INVEST DERMATOL, V128, P1365, DOI 10.1038/sj.jid.5701184; Peus D, 1998, J INVEST DERMATOL, V110, P966, DOI 10.1046/j.1523-1747.1998.00210.x; PLOWMAN GD, 1990, MOL CELL BIOL, V10, P1969, DOI 10.1128/MCB.10.5.1969; Qin L, 2005, J CELL BIOCHEM, V96, P632, DOI 10.1002/jcb.20550; Rodust PM, 2009, BRIT J DERMATOL, V161, P107, DOI 10.1111/j.1365-2133.2009.09458.x; Sahin U, 2004, J CELL BIOL, V164, P769, DOI 10.1083/jcb.200307137; Schafer B, 2004, J BIOL CHEM, V279, P47929, DOI 10.1074/jbc.M400129200; Seo MR, 2007, J BIOL CHEM, V282, P24720, DOI 10.1074/jbc.M702343200; Shirakata Y, 2000, J BIOL CHEM, V275, P5748, DOI 10.1074/jbc.275.8.5748; Singh B, 2009, INT J CANCER, V124, P531, DOI 10.1002/ijc.23974; Sorensen BS, 2004, MOL CELL BIOCHEM, V260, P129, DOI 10.1023/B:MCBI.0000026063.96267.98; Soyensen BS, 2006, EXP CELL RES, V312, P3651, DOI 10.1016/j.yexcr.2006.08.007; Tang QB, 2001, ONCOGENE, V20, P5164, DOI 10.1038/sj.onc.1204667; Tokumaru S, 2000, J CELL BIOL, V151, P209, DOI 10.1083/jcb.151.2.209; Tong X, 2007, MOL CELL BIOL, V27, P283, DOI 10.1128/MCB.01282-06; Uetani T, 2009, J BIOL CHEM, V284, P12399, DOI 10.1074/jbc.M900463200; Wang WG, 2000, MOL CELL BIOL, V20, P760, DOI 10.1128/MCB.20.3.760-769.2000; Weinheimer EM, 2007, AM J PHYSIOL-REG I, V292, pR2241, DOI 10.1152/ajpregu.00718.2006; Westmark CJ, 2005, ONCOGENE, V24, P502, DOI 10.1038/sj.onc.1208224; Xie GF, 2009, AM J PHYSIOL-GASTR L, V296, pG755, DOI 10.1152/ajpgi.90519.2008; Xu YR, 2006, J BIOL CHEM, V281, P27389, DOI 10.1074/jbc.M602355200; Yoshida M, 2012, CANCER SCI, V103, P708, DOI 10.1111/j.1349-7006.2012.02204.x	53	10	10	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 12	2013	288	15					10338	10348		10.1074/jbc.M112.417527	http://dx.doi.org/10.1074/jbc.M112.417527			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	125TU	23430747	hybrid, Green Published			2022-12-25	WOS:000317565000015
J	Mori, Y; Matsui, T; Fukuda, M				Mori, Yasunori; Matsui, Takahide; Fukuda, Mitsunori			Rabex-5 Protein Regulates Dendritic Localization of Small GTPase Rab17 and Neurite Morphogenesis in Hippocampal Neurons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE EXCHANGE FACTOR; AMYOTROPHIC-LATERAL-SCLEROSIS; DOMAIN-CONTAINING PROTEINS; CAENORHABDITIS-ELEGANS; RECYCLING ENDOSOMES; EPITHELIAL-CELLS; BINDING-ACTIVITY; DENN DOMAIN; COATED-PIT; FAMILY	Small GTPase Rab17 has recently been shown to regulate dendritic morphogenesis of mouse hippocampal neurons; however, the exact molecular mechanism of Rab17-mediated dendritogenesis remained to be determined, because no guanine nucleotide exchange factor (GEF) for Rab17 had been identified. In this study we screened for the Rab17-GEF by performing yeast two-hybrid assays with a GDP-locked Rab17 mutant as bait and found that Rabex-5 and ALS2, both of which were originally described as Rab5-GEFs, interact with Rab17. We also found that expression of Rabex-5, but not of ALS2, promotes translocation of Rab17 from the cell body to the dendrites of developing mouse hippocampal neurons. The shRNA-mediated knockdown of Rabex-5 or its known downstream target Rab5 in hippocampal neurons inhibited morphogenesis of both axons and dendrites, whereas knockdown of Rab17 affected dendrite morphogenesis alone. Based on these findings, we propose that Rabex-5 regulates neurite morphogenesis of hippocampal neurons by activating at least two downstream targets, Rab5, which is localized in both axons and dendrites, and Rab17, which is localized in dendrites alone.	[Mori, Yasunori; Matsui, Takahide; Fukuda, Mitsunori] Tohoku Univ, Lab Membrane Trafficking Mech, Dept Dev Biol & Neurosci, Grad Sch Life Sci,Aoba Ku, Sendai, Miyagi 9808578, Japan	Tohoku University	Fukuda, M (corresponding author), Tohoku Univ, Lab Membrane Trafficking Mech, Dept Dev Biol & Neurosci, Grad Sch Life Sci,Aoba Ku, Sendai, Miyagi 9808578, Japan.	nori@m.tohoku.ac.jp	Fukuda, MItsunori/I-1511-2015; Matsui, Takahide/S-4986-2018	Fukuda, MItsunori/0000-0002-8620-5853; Matsui, Takahide/0000-0002-3342-0170	Ministry of Education, Culture, Sports, and Technology (MEXT) of Japan; Daiichi-Sankyo Foundation of Life Science; Japan Society for the Promotion of Science (JSPS); Grants-in-Aid for Scientific Research [24700308] Funding Source: KAKEN	Ministry of Education, Culture, Sports, and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Daiichi-Sankyo Foundation of Life Science; Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by grants-in-aid for Scientific Research from the Ministry of Education, Culture, Sports, and Technology (MEXT) of Japan (to Y. M. and M. F.) and by a grant from the Daiichi-Sankyo Foundation of Life Science (to M. F.).; Supported by the Japan Society for the Promotion of Science (JSPS).	Allaire PD, 2010, MOL CELL, V37, P370, DOI 10.1016/j.molcel.2009.12.037; Barr F, 2010, CURR OPIN CELL BIOL, V22, P461, DOI 10.1016/j.ceb.2010.04.007; Burgo A, 2009, EMBO REP, V10, P1117, DOI 10.1038/embor.2009.186; Cai YY, 2008, CELL, V133, P1202, DOI 10.1016/j.cell.2008.04.049; Carney DS, 2006, TRENDS CELL BIOL, V16, P27, DOI 10.1016/j.tcb.2005.11.001; Delprato A, 2004, CELL, V118, P607, DOI 10.1016/j.cell.2004.08.009; Fukuda M, 2008, CELL MOL LIFE SCI, V65, P2801, DOI 10.1007/s00018-008-8351-4; Fukuda M, 1999, J BIOL CHEM, V274, P31421, DOI 10.1074/jbc.274.44.31421; Fukuda M, 1999, J BIOL CHEM, V274, P31428, DOI 10.1074/jbc.274.44.31428; FUKUDA M, 1995, J BIOL CHEM, V270, P26523, DOI 10.1074/jbc.270.44.26523; Fukuda M, 2011, CELL STRUCT FUNCT, V36, P155, DOI 10.1247/csf.11001; Fukuda M, 2011, BIOSCIENCE REP, V31, P159, DOI 10.1042/BSR20100112; Furutani Y, 2007, J NEUROSCI, V27, P8866, DOI 10.1523/JNEUROSCI.1047-07.2007; Gerondopoulos A, 2012, CURR BIOL, V22, P2135, DOI 10.1016/j.cub.2012.09.020; Gros-Louis F, 2003, ANN NEUROL, V53, P144, DOI 10.1002/ana.10422; Hadano S, 2001, NAT GENET, V29, P166, DOI 10.1038/ng1001-166; Hattula K, 2002, MOL BIOL CELL, V13, P3268, DOI 10.1091/mbc.E02-03-0143; Horiuchi H, 1997, CELL, V90, P1149, DOI 10.1016/S0092-8674(00)80380-3; Hunziker W, 1998, J BIOL CHEM, V273, P15734, DOI 10.1074/jbc.273.25.15734; Itoh T, 2006, GENES CELLS, V11, P1023, DOI 10.1111/j.1365-2443.2006.00997.x; James P, 1996, GENETICS, V144, P1425; Kobayashi H, 2012, J CELL SCI, V125, P2235, DOI 10.1242/jcs.098657; Kuroda TS, 2002, J BIOL CHEM, V277, P9212, DOI 10.1074/jbc.M112414200; Lai C, 2006, J NEUROSCI, V26, P11798, DOI 10.1523/JNEUROSCI.2084-06.2006; Mahoney TR, 2006, MOL BIOL CELL, V17, P2617, DOI 10.1091/mbc.E05-12-1170; Marat AL, 2011, J BIOL CHEM, V286, P13791, DOI 10.1074/jbc.R110.217067; Meijering E, 2004, CYTOM PART A, V58A, P167, DOI 10.1002/cyto.a.20022; Mori Y, 2012, J BIOL CHEM, V287, P8963, DOI 10.1074/jbc.M111.314385; Nordmann M, 2010, CURR BIOL, V20, P1654, DOI 10.1016/j.cub.2010.08.002; Ohbayashi N, 2012, MOL BIOL CELL, V23, P669, DOI 10.1091/mbc.E11-04-0324; Otomo A, 2003, HUM MOL GENET, V12, P1671, DOI 10.1093/hmg/ddg184; Sano H, 2011, J BIOL CHEM, V286, P16541, DOI 10.1074/jbc.C111.228908; Sato M, 2005, NAT CELL BIOL, V7, P559, DOI 10.1038/ncb1261; Sato M, 2008, EMBO J, V27, P1183, DOI 10.1038/emboj.2008.54; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Stenmark H, 2009, NAT REV MOL CELL BIO, V10, P513, DOI 10.1038/nrm2728; Tall GG, 2001, DEV CELL, V1, P73, DOI 10.1016/S1534-5807(01)00008-9; Tamura K, 2009, MOL BIOL CELL, V20, P2900, DOI 10.1091/mbc.E08-12-1161; Wada M, 1997, J BIOL CHEM, V272, P3875, DOI 10.1074/jbc.272.7.3875; WalchSolimena C, 1997, J CELL BIOL, V137, P1495, DOI 10.1083/jcb.137.7.1495; Wang L, 2011, MOL BIOL CELL, V22, P3853, DOI 10.1091/mbc.E11-03-0277; Yang Y, 2001, NAT GENET, V29, P160, DOI 10.1038/ng1001-160; Yoshimura S, 2010, J CELL BIOL, V191, P367, DOI 10.1083/jcb.201008051; Zacchi P, 1998, J CELL BIOL, V140, P1039, DOI 10.1083/jcb.140.5.1039; Zhang XJ, 2006, J CELL SCI, V119, P1053, DOI 10.1242/jcs.02810	45	30	31	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 5	2013	288	14					9835	9847		10.1074/jbc.M112.427591	http://dx.doi.org/10.1074/jbc.M112.427591			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	119RB	23430262	Green Published, hybrid			2022-12-25	WOS:000317114000024
J	Choi, HJ; Sanders, TA; Tormos, KV; Ameri, K; Tsai, JD; Park, AM; Gonzalez, J; Rajah, AM; Liu, XW; Quinonez, DM; Rinaudo, PF; Maltepe, E				Choi, Hwa J.; Sanders, Timothy A.; Tormos, Kathryn V.; Ameri, Kurosh; Tsai, Justin D.; Park, Angela M.; Gonzalez, Julissa; Rajah, Anthony M.; Liu, Xiaowei; Quinonez, Diana M.; Rinaudo, Paolo F.; Maltepe, Emin			ECM-Dependent HIF Induction Directs Trophoblast Stem Cell Fate via LIMK1-Mediated Cytoskeletal Rearrangement	PLOS ONE			English	Article							HYPOXIA-INDUCIBLE FACTOR-1-ALPHA; ACTIVATED PROTEIN-KINASE; PLACENTAL DEVELOPMENT; EXTRACELLULAR-MATRIX; VULVAR INDUCTION; MAP KINASE; C-MYC; OXYGEN; MOUSE; INTEGRIN	The Hypoxia-inducible Factor (HIF) family of transcriptional regulators coordinates the expression of dozens of genes in response to oxygen deprivation. Mammalian development occurs in a hypoxic environment and HIF-null mice therefore die in utero due to multiple embryonic and placental defects. Mouse embryonic stem cells do not differentiate into placental cells; therefore, trophoblast stem cells (TSCs) are used to study mouse placental development. Consistent with a requirement for HIF activity during placental development in utero, TSCs derived from HIF-null mice exhibit severe differentiation defects and fail to form trophoblast giant cells (TGCs) in vitro. Interestingly, differentiating TSCs induce HIF activity independent of oxygen tension via unclear mechanisms. Here, we show that altering the extracellular matrix (ECM) composition upon which TSCs are cultured changes their differentiation potential from TGCs to multinucleated syncytiotropholasts (SynTs) and blocks oxygen-independent HIF induction. We further find that modulation of Mitogen Activated Protein Kinase Kinase-1/2 (MAP2K1/2, MEK-1/2) signaling by ECM composition is responsible for this effect. In the absence of ECM-dependent cues, hypoxia-signaling pathways activate this MAPK cascade to drive HIF induction and redirect TSC fate along the TGC lineage. In addition, we show that integrity of the microtubule and actin cytoskeleton is critical for TGC fate determination. HIF-2 alpha ensures TSC cytoskeletal integrity and promotes invasive TGC formation by interacting with c-MYC to induce non-canonical expression of Lim domain kinase 1-an enzyme that regulates microtubule and actin stability, as well as cell invasion. Thus, we find that HIF can integrate positional and metabolic cues from within the TSC niche to regulate placental development by modulating the cellular cytoskeleton via non-canonical gene expression.	[Choi, Hwa J.; Sanders, Timothy A.; Tormos, Kathryn V.; Ameri, Kurosh; Tsai, Justin D.; Park, Angela M.; Rajah, Anthony M.; Maltepe, Emin] Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94143 USA; [Gonzalez, Julissa; Quinonez, Diana M.] San Francisco State Univ, Dept Biol, San Francisco, CA 94132 USA; [Liu, Xiaowei; Rinaudo, Paolo F.] Univ Calif San Francisco, Dept Obstet Gynecol & Reprod Sci, San Francisco, CA USA; [Tormos, Kathryn V.; Liu, Xiaowei; Rinaudo, Paolo F.; Maltepe, Emin] Univ Calif San Francisco, Ctr Reprod Sci, San Francisco, CA 94143 USA; [Maltepe, Emin] Univ Calif San Francisco, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, San Francisco, CA 94143 USA; [Maltepe, Emin] Univ Calif San Francisco, Dev & Stem Cell Biol Program, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; California State University System; San Francisco State University; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Maltepe, E (corresponding author), Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94143 USA.	emin.maltepe@ucsf.edu			California Institute for Regenerative Medicine [TB1-01194]; National Institutes of Health [HL087754, HD072455]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD072455, R01HD062803] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL087754] Funding Source: NIH RePORTER	California Institute for Regenerative Medicine(California Institute for Regenerative Medicine); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The research was made possible by a grant from the California Institute for Regenerative Medicine (Grant Number TB1-01194) and the National Institutes of Health (HL087754, HD072455). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adelman DM, 2000, GENE DEV, V14, P3191, DOI 10.1101/gad.853700; Armant DR, 2005, DEV BIOL, V280, P260, DOI 10.1016/j.ydbio.2005.02.009; Asanoma K, 2007, J BIOL CHEM, V282, P24065, DOI 10.1074/jbc.M701380200; Bissonauth V, 2006, DEVELOPMENT, V133, P3429, DOI 10.1242/dev.02526; Burton GJ, 2009, J ANAT, V215, P27, DOI 10.1111/j.1469-7580.2008.00978.x; Butcher DT, 2009, NAT REV CANCER, V9, P108, DOI 10.1038/nrc2544; Campbell I.D., 2011, COLD SPRING HARB PER, V3; Chandel NS, 1998, P NATL ACAD SCI USA, V95, P11715, DOI 10.1073/pnas.95.20.11715; Craig EA, 2008, DEV DYNAM, V237, P3102, DOI 10.1002/dvdy.21750; Dahl KDC, 2005, MOL CELL BIOL, V25, P10479, DOI 10.1128/MCB.25.23.10479-10491.2005; Dahl KDC, 2005, MOL BIOL CELL, V16, P1901; DAMSKY CH, 1992, J CLIN INVEST, V89, P210, DOI 10.1172/JCI115565; Dubois NC, 2008, DEVELOPMENT, V135, P2455, DOI 10.1242/dev.022707; Dunwoodie SL, 2009, DEV CELL, V17, P755, DOI 10.1016/j.devcel.2009.11.008; Emerling BM, 2005, MOL CELL BIOL, V25, P4853, DOI 10.1128/MCB.25.12.4853-4862.2005; Escuin D, 2005, CANCER RES, V65, P9021, DOI 10.1158/0008-5472.CAN-04-4095; Eshghi S, 2007, J CELL BIOL, V177, P871, DOI 10.1083/jcb.200702080; Fukuda R, 2002, J BIOL CHEM, V277, P38205, DOI 10.1074/jbc.M203781200; Galabova-Kovacs G, 2006, P NATL ACAD SCI USA, V103, P1325, DOI 10.1073/pnas.0507399103; Gauster M, 2010, CELL DEATH DIFFER, V17, P336, DOI 10.1038/cdd.2009.133; Giroux S, 1999, CURR BIOL, V9, P369, DOI 10.1016/S0960-9822(99)80164-X; Gordan JD, 2007, CANCER CELL, V11, P335, DOI 10.1016/j.ccr.2007.02.006; Guilak F, 2009, CELL STEM CELL, V5, P17, DOI 10.1016/j.stem.2009.06.016; Hamanaka RB, 2012, TRENDS BIOCHEM SCI, V35, P505; Hamanaka RB, 2009, CURR OPIN CELL BIOL, V21, P894, DOI 10.1016/j.ceb.2009.08.005; Harburger DS, 2009, J CELL SCI, V122, P159, DOI 10.1242/jcs.018093; Hatano N, 2003, GENES CELLS, V8, P847, DOI 10.1046/j.1365-2443.2003.00680.x; HSU JC, 1994, GENE DEV, V8, P2176, DOI 10.1101/gad.8.18.2176; Hughes CS, 2011, PROTEOMICS, V11, P3983, DOI 10.1002/pmic.201100030; Hynes RO, 2009, SCIENCE, V326, P1216, DOI 10.1126/science.1176009; Iyer NV, 1998, GENE DEV, V12, P149, DOI 10.1101/gad.12.2.149; Jiang BH, 1996, J BIOL CHEM, V271, P17771, DOI 10.1074/jbc.271.30.17771; Kaelin WG, 2008, MOL CELL, V30, P393, DOI 10.1016/j.molcel.2008.04.009; Karthikeyan VJ, 2012, J HUM HYPERTENS; Kim SH, 2011, J ENDOCRINOL, V209, P139, DOI 10.1530/JOE-10-0377; KORNFELD K, 1995, GENE DEV, V9, P756, DOI 10.1101/gad.9.6.756; Koshiji M, 2004, EMBO J, V23, P1949, DOI 10.1038/sj.emboj.7600196; Kozak KR, 1997, DEV BIOL, V191, P297, DOI 10.1006/dbio.1997.8758; Lee SH, 2012, J BIOL CHEM, V287, P14760, DOI 10.1074/jbc.M112.340232; Mabjeesh NJ, 2003, CANCER CELL, V3, P363, DOI 10.1016/S1535-6108(03)00077-1; Maltepe E, 1997, NATURE, V386, P403, DOI 10.1038/386403a0; Maltepe E, 2005, DEVELOPMENT, V132, P3393, DOI 10.1242/dev.01923; Maltepe E, 2010, J CLIN INVEST, V120, P1016, DOI 10.1172/JCI41211; Minamide LS, 2000, NAT CELL BIOL, V2, P628, DOI 10.1038/35023579; Nadeau V, 2009, DEVELOPMENT, V136, P1363, DOI 10.1242/dev.031872; Page EL, 2002, J BIOL CHEM, V277, P48403, DOI 10.1074/jbc.M209114200; Parast MM, 2001, DEV BIOL, V230, P43, DOI 10.1006/dbio.2000.0102; Pringle KG, 2009, HUM REPROD UPDATE; Ramos JW, 2008, INT J BIOCHEM CELL B, V40, P2707, DOI 10.1016/j.biocel.2008.04.009; Richard DE, 1999, J BIOL CHEM, V274, P32631, DOI 10.1074/jbc.274.46.32631; Rieu I, 2009, PLANT CELL, V21, P1031, DOI 10.1105/tpc.109.066001; Rosario GX, 2008, DEV BIOL, V314, P362, DOI 10.1016/j.ydbio.2007.12.007; Ross-Macdonald P, 2008, MOL CANCER THER, V7, P3490, DOI 10.1158/1535-7163.MCT-08-0826; Rossant J, 2001, NAT REV GENET, V2, P538, DOI 10.1038/35080570; Ryan HE, 1998, EMBO J, V17, P3005, DOI 10.1093/emboj/17.11.3005; Saba-El-Leil MK, 2003, EMBO REP, V4, P964, DOI 10.1038/sj.embor.embor939; Scales TME, 2011, CURR OPIN CELL BIOL, V23, P562, DOI 10.1016/j.ceb.2011.05.008; Scott RW, 2007, J MOL MED, V85, P555, DOI 10.1007/s00109-007-0165-6; Scott RW, 2010, J CELL BIOL, V191, P169, DOI 10.1083/jcb.201002041; Semenza GL, 2009, PHYSIOLOGY, V24, P97, DOI 10.1152/physiol.00045.2008; Shibukawa Y, 2012, MOL BIOL CELL; Simon MC, 2008, NAT REV MOL CELL BIO, V9, P285, DOI 10.1038/nrm2354; Skuli N, 2009, CANCER RES, V69, P3308, DOI 10.1158/0008-5472.CAN-08-2158; Sutherland A, 2003, DEV BIOL, V258, P241, DOI 10.1016/S0012-1606(03)00130-1; Swistowski A, 2010, STEM CELLS, V28, P1893, DOI 10.1002/stem.499; Swistowski A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006233; Tanaka S, 1998, SCIENCE, V282, P2072, DOI 10.1126/science.282.5396.2072; UMBHAUER M, 1995, NATURE, V376, P58, DOI 10.1038/376058a0; Votteler M, 2010, MACROMOL BIOSCI, V10, P1302, DOI 10.1002/mabi.201000102; WANG GL, 1995, P NATL ACAD SCI USA, V92, P5510, DOI 10.1073/pnas.92.12.5510; Wang J, 2002, CELLS TISSUES ORGANS, V172, P190, DOI 10.1159/000066970; Watson ED, 2005, PHYSIOLOGY, V20, P180, DOI 10.1152/physiol.00001.2005; WU Y, 1995, GENE DEV, V9, P742, DOI 10.1101/gad.9.6.742; Yoshie M, 2008, HUM REPROD, V23, P2766, DOI 10.1093/humrep/den317; Yusa K, 2009, NAT METHODS, V6, P363, DOI [10.1038/NMETH.1323, 10.1038/nmeth.1323]; Zhang LJ, 2011, DEVELOPMENT, V138, P455, DOI 10.1242/dev.046870; ZHENG Q, 1991, J CELL SCI, V100, P431	77	21	22	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2013	8	2							e56949	10.1371/journal.pone.0056949	http://dx.doi.org/10.1371/journal.pone.0056949			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IT	23437279	gold, Green Published, Green Submitted			2022-12-25	WOS:000315186000059
J	Eldor, R; Abel, R; Sever, D; Sadoun, G; Peled, A; Sionov, R; Melloul, D				Eldor, Roy; Abel, Roy; Sever, Dror; Sadoun, Gad; Peled, Amnon; Sionov, Ronit; Melloul, Danielle			Inhibition of Nuclear Factor-kappa B Activation in Pancreatic beta-Cells Has a Protective Effect on Allogeneic Pancreatic Islet Graft Survival	PLOS ONE			English	Article							XIAP OVEREXPRESSION; SIGNAL-TRANSDUCTION; INSULIN-SECRETION; GENE-TRANSFER; APOPTOSIS; TRANSPLANTATION; MASS; EXPRESSION; ALPHA; INTERLEUKIN-1-BETA	Pancreatic islet transplantation, a treatment for type 1 diabetes, has met significant challenges, as a substantial fraction of the islet mass fails to engraft, partly due to death by apoptosis in the peri- and post-transplantation periods. Previous evidence has suggested that NF-kappa B activation is involved in cytokine-mediated beta-cell apoptosis and regulates the expression of pro-inflammatory and chemokine genes. We therefore sought to explore the effects of beta-cell-specific inhibition of NF-kappa B activation as a means of cytoprotection in an allogeneic model of islet transplantation. To this end, we used islets isolated from the Tol-beta transgenic mouse, where NF-kappa B signalling can specifically and conditionally be inhibited in beta-cells by expressing an inducible and non-degradable form of I kappa beta alpha regulated by the tet-on system. Our results show that beta-cell-specific blockade of NF-kappa B led to a prolonged islet graft survival, with a relative higher preservation of the engrafted endocrine tissue and reduced inflammation. Importantly, a longer delay in allograft rejection was achieved when mice were systemically treated with the proteasome inhibitor, Bortezomib. Our findings emphasize the contribution of NF-kappa B activation in the allograft rejection process, and suggest an involvement of the CXCL10/IP-10 chemokine. Furthermore, we suggest a potential, readily available therapeutic agent that may temper this process.	[Eldor, Roy; Abel, Roy; Sever, Dror; Sadoun, Gad; Melloul, Danielle] Hadassah Univ Hosp, Dept Endocrinol, IL-91120 Jerusalem, Israel; [Peled, Amnon] Hadassah Univ Hosp, Goldyne Savad Inst Gene Therapy, IL-91120 Jerusalem, Israel; [Sionov, Ronit] Hebrew Univ Jerusalem, Hadassah Med Sch, IMRIC, Dept Biochem & Mol Biol, IL-91010 Jerusalem, Israel	Hebrew University of Jerusalem; Hebrew University of Jerusalem; Hebrew University of Jerusalem	Melloul, D (corresponding author), Hadassah Univ Hosp, Dept Endocrinol, IL-91120 Jerusalem, Israel.	daniellem@ekmd.huji.ac.il	Eldor, Roy/AAD-4397-2022		Juvenile Diabetes Research Foundation [1-2007-60]; European Union [036903]; Israel Ministry of Health	Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); European Union(European Commission); Israel Ministry of Health	This work was supported by grants from the Juvenile Diabetes Research Foundation (1-2007-60), and European Union (STREP Savebeta, contract nu 036903) in the Framework Programme 6 and the Israel Ministry of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker MS, 2003, SURGERY, V134, P126, DOI 10.1067/msy.2003.213; Baker MS, 2001, J SURG RES, V97, P117, DOI 10.1006/jsre.2001.6121; Barton FB, 2012, DIABETES CARE, V35, P1436, DOI 10.2337/dc12-0063; Bock T, 2003, DIABETES, V52, P1716, DOI 10.2337/diabetes.52.7.1716; Chang I, 2003, DIABETES, V52, P1169, DOI 10.2337/diabetes.52.5.1169; Contreras JL, 2001, TRANSPLANTATION, V71, P1015, DOI 10.1097/00007890-200104270-00001; Cottet S, 2002, DIABETES, V51, P1805, DOI 10.2337/diabetes.51.6.1805; De Paula D, 2007, J DRUG TARGET, V15, P358, DOI 10.1080/10611860701349695; Donath MY, 2010, TRENDS ENDOCRIN MET, V21, P261, DOI 10.1016/j.tem.2009.12.010; Eizirik DL, 2001, DIABETOLOGIA, V44, P2115, DOI 10.1007/s001250100021; Eldor R, 2006, P NATL ACAD SCI USA, V103, P5072, DOI 10.1073/pnas.0508166103; Eldor R, 2009, DIABETES RES CLIN PR, V86, pS7, DOI 10.1016/S0168-8227(09)70003-8; Emamaullee J, 2005, AM J TRANSPLANT, V5, P1297, DOI 10.1111/j.1600-6143.2005.00891.x; Emamaullee JA, 2005, DIABETES, V54, P2541, DOI 10.2337/diabetes.54.9.2541; Emamaullee JA, 2008, DIABETES, V57, P1556, DOI 10.2337/db07-1452; Emamaullee JA, 2007, DIABETES, V56, P1289, DOI 10.2337/db06-1653; Emamaullee JA, 2006, DIABETES, V55, P1907, DOI 10.2337/db05-1254; Gao Q, 2010, AM J TRANSPLANT, V10, P1588, DOI 10.1111/j.1600-6143.2010.03151.x; Giannoukakis N, 2000, J BIOL CHEM, V275, P36509, DOI 10.1074/jbc.M005943200; Goldberg A, 2007, FASEB J, V21, P2840, DOI 10.1096/fj.06-7910com; Grey ST, 2003, J IMMUNOL, V170, P6250, DOI 10.4049/jimmunol.170.12.6250; Hagerkvist R, 2007, FASEB J, V21, P618, DOI 10.1096/fj.06-6910com; Hammar EB, 2005, J BIOL CHEM, V280, P30630, DOI 10.1074/jbc.M502493200; Heimberg H, 2001, DIABETES, V50, P2219, DOI 10.2337/diabetes.50.10.2219; Jelsing J, 2012, J ENDOCRINOL, V214, P381, DOI 10.1530/JOE-11-0479; Karin M, 2002, NAT IMMUNOL, V3, P221, DOI 10.1038/ni0302-221; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; Kuo YR, 2010, AM J TRANSPLANT, V10, P213; Maedler K, 2006, DIABETES, V55, P2713, DOI 10.2337/db05-1430; Mandrup-Poulsen T, 2003, BIOCHEM PHARMACOL, V66, P1433, DOI 10.1016/S0006-2952(03)00494-5; Matsumoto S, 2006, EXPERT OPIN BIOL TH, V6, P23, DOI 10.1517/14712598.6.1.23; Melloul D, 2008, BIOCHEM SOC T, V36, P334, DOI 10.1042/BST0360334; Morimoto J, 2004, J IMMUNOL, V173, P7017, DOI 10.4049/jimmunol.173.11.7017; Nencioni A, 2006, CRIT REV IMMUNOL, V26, P487, DOI 10.1615/CritRevImmunol.v26.i6.20; Ortis F, 2008, DIABETOLOGIA, V51, P1213, DOI 10.1007/s00125-008-0999-7; Ortis F, 2006, MOL ENDOCRINOL, V20, P1867, DOI 10.1210/me.2005-0268; Ou D, 2005, HUM IMMUNOL, V66, P799, DOI 10.1016/j.humimm.2005.03.009; Perkins ND, 2007, NAT REV MOL CELL BIO, V8, P49, DOI 10.1038/nrm2083; Plesner A, 2005, DIABETES, V54, P2533, DOI 10.2337/diabetes.54.9.2533; Plesner A, 2010, ISLETS, V2, P18, DOI 10.4161/isl.2.1.9997; Poff JA, 2008, RADIOLOGY, V248, P485, DOI 10.1148/radiol.2482071674; Qin J, 2009, LIFE SCI, V84, P810, DOI 10.1016/j.lfs.2009.03.010; Rehman KK, 2003, J BIOL CHEM, V278, P9862, DOI 10.1074/jbc.M207700200; Rink JS, 2012, SURGERY, V151, P330, DOI 10.1016/j.surg.2011.07.011; Rivas-Carrillo JD, 2007, DIABETES, V56, P1259, DOI 10.2337/db06-1679; Robertson RP, 2010, ENDOCRIN METAB CLIN, V39, P655, DOI 10.1016/j.ecl.2010.05.010; Romagnani P, 2012, CLIN CHIM ACTA, V413, P1364, DOI 10.1016/j.cca.2012.02.009; Takahashi T, 2010, J SURG RES, V163, pE23, DOI 10.1016/j.jss.2010.04.044; Uno S, 2010, ENDOCR J, V57, P991, DOI 10.1507/endocrj.K10E-076; Yang H, 2002, TRANSPLANTATION, V74, P291, DOI 10.1097/00007890-200208150-00002; Zhao Yuxing, 2011, Inflammation & Allergy Drug Targets, V10, P208	51	19	21	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2013	8	2							e56924	10.1371/journal.pone.0056924	http://dx.doi.org/10.1371/journal.pone.0056924			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IT	23437272	Green Published, Green Submitted, gold			2022-12-25	WOS:000315186000056
J	Kuo, YM; Andrews, AJ				Kuo, Yin-Ming; Andrews, Andrew J.			Quantitating the Specificity and Selectivity of Gcn5-Mediated Acetylation of Histone H3	PLOS ONE			English	Article							POSTTRANSLATIONAL MODIFICATIONS; ACETYLTRANSFERASE; GCN5; IDENTIFICATION; METHYLATION; MECHANISM; PATTERNS; ASSAY; P300; H4	Lysine acetyltransferases (KATs) play a unique role in regulating gene transcription as well as maintaining the epigenetic state of the cell. KATs such as Gcn5 and p300/CBP can modify multiple residues on a single histone; however, order and specificity of acetylation can be altered by factors such as histone chaperones, subunit proteins or external stimulus. While the importance of acetylation is well documented, it has been difficult to quantitatively measure the specificity and selectivity of acetylation at different residues within a histone. In this paper, we demonstrate a label-free quantitative high throughput mass spectrometry-based assay capable of quantitatively monitoring all known acetylation sites of H3 simultaneously. Using this assay, we are able to analyze the steady-state enzyme kinetics of Gcn5, an evolutionarily conserved KAT. In doing so, we measured Gcn5-mediated acetylation at six residues (K14>K9 approximate to K23> K18> K27 approximate to K36) and the catalytic efficiency (k(cat)/K-m) for K9, K14, K18, and K23 as well as the nonenzymatic acetylation rate. We observed selectivity differences of up to -4 kcal/mol between K14 and K18, the highest and lowest measurable k(cat)/K-m. These data provide a first look at quantitating the specificity and selectivity of multiple lysines on a single substrate (H3) by Gcn5.	[Kuo, Yin-Ming; Andrews, Andrew J.] Fox Chase Canc Ctr, Dept Canc Biol, Philadelphia, PA 19111 USA	Fox Chase Cancer Center	Andrews, AJ (corresponding author), Fox Chase Canc Ctr, Dept Canc Biol, 7701 Burholme Ave, Philadelphia, PA 19111 USA.	Andrew.Andrews@fccc.edu	Kuo, Yin-Ming/F-8244-2011	Kuo, Yin-Ming/0000-0002-3036-1902	Pennsylvania Department of Health	Pennsylvania Department of Health	This project is funded, in part, under a grant with the Pennsylvania Department of Health. The Pennsylvania Department of Health specifically disclaims responsibility for any analysis, interpretations or conclusions. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Andrews AJ, 2010, MOL CELL, V37, P834, DOI 10.1016/j.molcel.2010.01.037; BENDER ML, 1965, ANNU REV BIOCHEM, V34, P49, DOI 10.1146/annurev.bi.34.070165.000405; Berger SL, 2002, CURR OPIN GENET DEV, V12, P142, DOI 10.1016/S0959-437X(02)00279-4; Berndsen CE, 2008, CURR OPIN STRUC BIOL, V18, P682, DOI 10.1016/j.sbi.2008.11.004; BOSSHARD HR, 1976, EXPERIENTIA, V32, P949, DOI 10.1007/BF01933911; BROT FE, 1969, J AM CHEM SOC, V91, P7187, DOI 10.1021/ja01053a050; Cai L, 2011, MOL CELL, V42, P426, DOI 10.1016/j.molcel.2011.05.004; COMMERFORD SL, 1982, P NATL ACAD SCI-BIOL, V79, P1163, DOI 10.1073/pnas.79.4.1163; Cornish-Bowden A, 2010, J PHYS CHEM B, V114, P16209, DOI 10.1021/jp106968p; Davey CA, 2002, J MOL BIOL, V319, P1097, DOI 10.1016/S0022-2836(02)00386-8; Deng LW, 2001, VIROLOGY, V289, P312, DOI 10.1006/viro.2001.1129; Fabris S, 2011, EPIGENETICS-US, V6, P188, DOI 10.4161/epi.6.2.13528; Fraga MF, 2005, NAT GENET, V37, P391, DOI 10.1038/ng1531; Garcia BA, 2005, J PROTEOME RES, V4, P2032, DOI 10.1021/pr050188r; Garcia BA, 2007, NAT PROTOC, V2, P933, DOI 10.1038/nprot.2007.106; Grant PA, 1999, J BIOL CHEM, V274, P5895, DOI 10.1074/jbc.274.9.5895; Hake SB, 2006, J BIOL CHEM, V281, P559, DOI 10.1074/jbc.M509266200; Hedstrom, 2020, ENZYME SPECIFICITY S; Hou LF, 2010, INT J CANCER, V127, P1866, DOI 10.1002/ijc.25190; HUDGIN RL, 1974, J BIOL CHEM, V249, P5536; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Jiang L, 2007, J BIOL CHEM, V282, P27923, DOI 10.1074/jbc.M704194200; Jin QH, 2011, EMBO J, V30, P249, DOI 10.1038/emboj.2010.318; Johnson L, 2004, NUCLEIC ACIDS RES, V32, P6511, DOI 10.1093/nar/gkh992; Kikuchi H, 2005, GENE, V347, P83, DOI 10.1016/j.gene.2004.12.007; Kim SC, 2006, J PROTEOME RES, V5, P3446, DOI 10.1021/pr0603396; Kim Y, 2000, ANAL BIOCHEM, V280, P308, DOI 10.1006/abio.2000.4546; Kuo MH, 2000, MOL CELL, V6, P1309, DOI 10.1016/S1097-2765(00)00129-5; Kuo MH, 1996, NATURE, V383, P269, DOI 10.1038/383269a0; Lau OD, 2000, J BIOL CHEM, V275, P21953, DOI 10.1074/jbc.M003219200; Lee KK, 2007, NAT REV MOL CELL BIO, V8, P284, DOI 10.1038/nrm2145; Li TT, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.011080; Liu B, 2009, J BIOL CHEM, V284, P32288, DOI 10.1074/jbc.M109.045856; Masumoto H, 2005, NATURE, V436, P294, DOI 10.1038/nature03714; McKittrick E, 2004, P NATL ACAD SCI USA, V101, P1525, DOI 10.1073/pnas.0308092100; Morris SA, 2007, J BIOL CHEM, V282, P7632, DOI 10.1074/jbc.M607909200; Neumann H, 2008, NAT CHEM BIOL, V4, P232, DOI 10.1038/nchembio.73; Oliver SS, 2011, CHEMBIOCHEM, V12, P299, DOI 10.1002/cbic.201000474; PAIK WK, 1970, BIOCHIM BIOPHYS ACTA, V213, P513, DOI 10.1016/0005-2787(70)90058-4; RADZICKA A, 1995, SCIENCE, V267, P90, DOI 10.1126/science.7809611; RUCHEL R, 1981, BIOCHIM BIOPHYS ACTA, V659, P99, DOI 10.1016/0005-2744(81)90274-6; Schiltz RL, 1999, J BIOL CHEM, V274, P1189, DOI 10.1074/jbc.274.3.1189; Schneider TD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022548; Schwer B, 2009, AGING CELL, V8, P604, DOI 10.1111/j.1474-9726.2009.00503.x; Seligson DB, 2009, AM J PATHOL, V174, P1619, DOI 10.2353/ajpath.2009.080874; Sterner DE, 2000, MICROBIOL MOL BIOL R, V64, P435, DOI 10.1128/MMBR.64.2.435-459.2000; Tanner KG, 1999, J BIOL CHEM, V274, P18157, DOI 10.1074/jbc.274.26.18157; Trievel RC, 2000, ANAL BIOCHEM, V287, P319, DOI 10.1006/abio.2000.4855; Truscott RJW, 2012, EXP EYE RES, V99, P48, DOI 10.1016/j.exer.2012.04.002; Wagner G.R., 2011, J AGING RES, V2011, DOI [DOI 10.4061/2011/234875, 10.4061/2011/234875]; Wellen KE, 2009, SCIENCE, V324, P1076, DOI 10.1126/science.1164097; Wolfenden R, 2006, CHEM REV, V106, P3379, DOI 10.1021/cr050311y; WU RS, 1986, CRIT REV BIOCHEM MOL, V20, P201, DOI 10.3109/10409238609083735; Zhang LW, 2003, CHROMOSOMA, V112, P77, DOI 10.1007/s00412-003-0244-6	54	68	68	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2013	8	2							e54896	10.1371/journal.pone.0054896	http://dx.doi.org/10.1371/journal.pone.0054896			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IT	23437046	Green Published, gold, Green Submitted			2022-12-25	WOS:000315186000004
J	Luo, Y; Xu, DQ; Dong, HY; Zhang, B; Liu, Y; Niu, W; Dong, MQ; Li, ZC				Luo, Ying; Xu, Dun-Quan; Dong, Hai-Ying; Zhang, Bo; Liu, Yi; Niu, Wen; Dong, Ming-Qing; Li, Zhi-Chao			Tanshinone IIA Inhibits Hypoxia-Induced Pulmonary Artery Smooth Muscle Cell Proliferation via Akt/Skp2/p27-Associated Pathway	PLOS ONE			English	Article							SALVIA-MILTIORRHIZA BUNGE; DEPENDENT KINASE INHIBITORS; P27(KIP1); APOPTOSIS; SKP2; HYPERTENSION; EXPRESSION; CANCER; P27; ACTIVATION	We previously showed that tanshinone IIA ameliorated the hypoxia-induced pulmonary hypertension (HPH) partially by attenuating pulmonary artery remodeling. The hypoxia-induced proliferation of pulmonary artery smooth muscle cells (PASMCs) is one of the major causes for pulmonary arterial remodeling, therefore the present study was performed to explore the effects and underlying mechanism of tanshinone IIA on the hypoxia-induced PASMCs proliferation. PASMCs were isolated from male Sprague-Dawley rats and cultured in normoxic (21%) or hypoxic (3%) condition. Cell proliferation was measured with 3-(4, 5-dimethylthiazal-2-yl)-2, 5-diphenyltetrazoliumbromide assay and cell counting. Cell cycle was measured with flow cytometry. The expression of of p27, Skp-2 and the phosphorylation of Akt were measured using western blot and/or RT-PCR respectively. The results showed that tanshinone IIA significantly inhibited the hypoxia-induced PASMCs proliferation in a concentration-dependent manner and arrested the cells in G1/G0-phase. Tanshinone IIA reversed the hypoxia-induced reduction of p27 protein, a cyclin-dependent kinase inhibitor, in PASMCs by slowing down its degradation. Knockdown of p27 with specific siRNA abolished the anti-proliferation of tanshinone IIA. Moreover, tanshinone IIA inhibited the hypoxia-induced increase of S-phase kinase-associated protein 2 (Skp2) and the phosphorylation of Akt, both of which are involved in the degradation of p27 protein. In vivo tanshinone IIA significantly upregulated the hypoxia-induced p27 protein reduction and downregulated the hypoxia-induced Skp2 increase in pulmonary arteries in HPH rats. Therefore, we propose that the inhibition of tanshinone IIA on hypoxia-induce PASMCs proliferation may be due to arresting the cells in G1/G0-phase by slowing down the hypoxia-induced degradation of p27 via Akt/Skp2-associated pathway. The novel information partially explained the anti-remodeling property of tanshinone IIA on pulmonary artery in HPH.	[Luo, Ying; Li, Zhi-Chao] Fourth Mil Med Univ, Xijing Hosp, Dept Pathol, Xian 710032, Peoples R China; [Luo, Ying; Xu, Dun-Quan; Dong, Hai-Ying; Zhang, Bo; Liu, Yi; Niu, Wen; Dong, Ming-Qing; Li, Zhi-Chao] Fourth Mil Med Univ, Dept Pathol & Pathophysiol, Xian 710032, Peoples R China	Air Force Military Medical University; Air Force Military Medical University	Dong, MQ (corresponding author), Fourth Mil Med Univ, Dept Pathol & Pathophysiol, Xian 710032, Peoples R China.	dongmqxh@fmmu.edu.cn; lizhic@fmmu.edu.cn			National Natural Science Foundation of China [81270328, 81201506, 81072642]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work is supported by National Natural Science Foundation of China (numbers 81270328, 81201506 and 81072642). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akyurek LM, 2010, BIOCHEM BIOPH RES CO, V396, P359, DOI 10.1016/j.bbrc.2010.04.097; Auld CA, 2006, BIOCHEM BIOPH RES CO, V346, P314, DOI 10.1016/j.bbrc.2006.05.117; Carrano AC, 2001, J CELL BIOL, V153, P1381, DOI 10.1083/jcb.153.7.1381; Chan P, 2011, AM J CHINESE MED, V39, P381, DOI 10.1142/S0192415X11008890; Chen J, 2012, ONCOL REP, V27, P523, DOI 10.3892/or.2011.1524; Chu IM, 2008, NAT REV CANCER, V8, P253, DOI 10.1038/nrc2347; Dai ZK, 2012, J NAT MED-TOKYO, V66, P192, DOI 10.1007/s11418-011-0576-0; Fouty BW, 2001, AM J RESP CELL MOL, V25, P652, DOI 10.1165/ajrcmb.25.5.4592; Fu JJ, 2007, EUR J PHARMACOL, V568, P213, DOI 10.1016/j.ejphar.2007.04.031; Gao S, 2012, ATHEROSCLEROSIS, V220, P3, DOI 10.1016/j.atherosclerosis.2011.06.041; Hengst L, 1996, SCIENCE, V271, P1861, DOI 10.1126/science.271.5257.1861; Hong HJ, 2010, ACTA PHARMACOL SIN, V31, P1569, DOI 10.1038/aps.2010.176; Hu L, 2009, CANCER RES, V69, P3374, DOI 10.1158/0008-5472.CAN-08-4290; Huang YF, 2009, J ETHNOPHARMACOL, V125, P436, DOI 10.1016/j.jep.2009.07.020; Jin UH, 2008, J CELL BIOCHEM, V104, P15, DOI 10.1002/jcb.21599; Kotoshiba Shuhei, 2005, Nihon Rinsho, V63, P2047; Li FL, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/927658; Li Xin, 2008, Zhongguo Zhong Yao Za Zhi, V33, P2146; Lin HK, 2009, NAT CELL BIOL, V11, P420, DOI 10.1038/ncb1849; Liu W, 2002, AM J PATHOL, V160, P511, DOI 10.1016/S0002-9440(10)64870-5; Miyamoto T, 2010, GYNECOL ENDOCRINOL, V26, P220, DOI [10.1080/09513590903215482, 10.3109/09513590903215482]; Pak O, 2007, EUR RESPIR J, V30, P364, DOI 10.1183/09031936.00128706; Shang QH, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/716459; Slingerland J, 2000, J CELL PHYSIOL, V183, P10, DOI 10.1002/(SICI)1097-4652(200004)183:1<10::AID-JCP2>3.0.CO;2-I; Stenmark KR, 2006, CIRC RES, V99, P675, DOI 10.1161/01.RES.0000243584.45145.3f; Sung HJ, 1999, EXP MOL MED, V31, P174, DOI 10.1038/emm.1999.28; Tanner FC, 2000, CIRCULATION, V101, P2022, DOI 10.1161/01.CIR.101.17.2022; TOYOSHIMA H, 1994, CELL, V78, P67, DOI 10.1016/0092-8674(94)90573-8; Tsvetkov LM, 1999, CURR BIOL, V9, P661, DOI 10.1016/S0960-9822(99)80290-5; Ungermannova D, 2005, J BIOL CHEM, V280, P30301, DOI 10.1074/jbc.M411103200; Vervoorts J, 2008, CELL MOL LIFE SCI, V65, P3255, DOI 10.1007/s00018-008-8296-7; Wang J, 2012, AM J RESP CELL MOL B; Wang J, 2010, EUR J PHARMACOL, V640, P129, DOI 10.1016/j.ejphar.2010.04.047; Won SH, 2012, PHYTOTHER RES, V26, P669, DOI 10.1002/ptr.3616; Won SH, 2010, BIOL PHARM BULL, V33, P1828, DOI 10.1248/bpb.33.1828; Wu YJ, 2009, J VASC SURG, V50, P1135, DOI 10.1016/j.jvs.2009.07.066; Yi Bin, 2008, Zhonghua Jiehe He Huxi Zazhi, V31, P586; Yu LY, 2006, BIOCHEM BIOPH RES CO, V345, P1565, DOI 10.1016/j.bbrc.2006.05.060; Yu LY, 2005, CIRC RES, V97, P937, DOI 10.1161/01.RES.0000188211.83193.1a; Zakynthinos E, 2011, CURR DRUG TARGETS, V12, P501, DOI 10.2174/138945011794751483; Zhang Y, 2012, ANTI-CANCER DRUG, V23, P212, DOI 10.1097/CAD.0b013e32834e5592; Zhou LL, 2008, LIFE SCI, V83, P394, DOI 10.1016/j.lfs.2008.07.011; Zhou LM, 2005, J CLIN PHARMACOL, V45, P1345, DOI 10.1177/0091270005282630	43	40	47	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2013	8	2							e56774	10.1371/journal.pone.0056774	http://dx.doi.org/10.1371/journal.pone.0056774			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IT	23437233	gold, Green Submitted, Green Published			2022-12-25	WOS:000315186000045
J	Moncada, X; Payacan, C; Arriaza, F; Lobos, S; Seelenfreund, D; Seelenfreund, A				Moncada, Ximena; Payacan, Claudia; Arriaza, Francisco; Lobos, Sergio; Seelenfreund, Daniela; Seelenfreund, Andrea			DNA Extraction and Amplification from Contemporary Polynesian Bark-Cloth	PLOS ONE			English	Article							WOOD	Background: Paper mulberry has been used for thousands of years in Asia and Oceania for making paper and bark-cloth, respectively. Museums around the world hold valuable collections of Polynesian bark-cloth. Genetic analysis of the plant fibers from which the textiles were made may answer a number of questions of interest related to provenance, authenticity or species used in the manufacture of these textiles. Recovery of nucleic acids from paper mulberry bark-cloth has not been reported before. Methodology: We describe a simple method for the extraction of PCR-amplifiable DNA from small samples of contemporary Polynesian bark- cloth (tapa) using two types of nuclear markers. We report the amplification of about 300 bp sequences of the ITS1 region and of a microsatellite marker. Conclusions: Sufficient DNA was retrieved from all bark-cloth samples to permit successful PCR amplification. This method shows a means of obtaining useful genetic information from modern bark-cloth samples and opens perspectives for the analyses of small fragments derived from ethnographic materials.	[Moncada, Ximena] CEAZA, La Serena, Chile; [Payacan, Claudia; Arriaza, Francisco; Lobos, Sergio; Seelenfreund, Daniela] Univ Chile, Dept Bioquim & Biol Mol, Fac Ciencias Quim & Farmaceut, Santiago, Chile; [Seelenfreund, Andrea] Univ Acad Humanismo Cristiano, Escuela Antropol, Area Ciencias Sociales, Santiago, Chile	Universidad de Chile; Universidad Academia de Humanismo Cristiano	Seelenfreund, D (corresponding author), Univ Chile, Dept Bioquim & Biol Mol, Fac Ciencias Quim & Farmaceut, Santiago, Chile.	dseelen@ciq.uchile.cl			FONDECYT grant from the Government of Chile (CONICYT) [1120175]	FONDECYT grant from the Government of Chile (CONICYT)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT)	FONDECYT grant 1120175 from the Government of Chile (CONICYT) (http://www.conicyt.cl/fondecyt/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asif MJ, 2005, PLANT MOL BIOL REP, V23, P185, DOI 10.1007/BF02772709; Barker Christine, 2002, Curtis's Botanical Magazine, V19, P8, DOI 10.1111/1467-8748.00324; Bell L. A., 1988, PAPYRUS TAPA AMATE R; Blattner FR, 1999, BIOTECHNIQUES, V27, P1180, DOI 10.2144/99276st04; Borges DB, 2012, GENET MOL RES, V11, P1586, DOI 10.4238/2012.May.22.8; Brown, 1996, OCEANIC CULTURE HIST, P117; Colchester Chloe, 2003, CLOTHING PACIFIC; Deguilloux MF, 2002, P ROY SOC B-BIOL SCI, V269, P1039, DOI 10.1098/rspb.2002.1982; Gilbert MTP, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000272; Green RC, 1979, EXPLORING VISUAL ART, P13; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [DOI 10.1021/BK-1999-0734.CH008, citeulike-article-id:691774, 10.12691/ajmr-6-4-3]; Hartnup K, 2011, MOL BIOL EVOL, V28, P2741, DOI 10.1093/molbev/msr107; HIGGINS DG, 1988, GENE, V73, P237, DOI 10.1016/0378-1119(88)90330-7; Howard M, 2006, STUDIES MAT CULTURES, V10; Kennedy R, 1934, J POLYNESIAN SOC, V43, P229; Kooijman S., 1988, POLYNESIAN BARKCLOTH; Lodhi M. A., 1994, Plant Molecular Biology Reporter, V12, P6, DOI 10.1007/BF02668658; Marota I, 2002, AM J PHYS ANTHROPOL, V117, P310, DOI 10.1002/ajpa.10045; Metraux A, 1971, BERNICE BISHOP MUSEU, V160; OHanlon M., 2005, ART CLOTHING PACIFIC, P61; Olsen ME, 2012, ANN ANAT, V194, P31, DOI 10.1016/j.aanat.2011.03.003; Prebble M, 2008, TERRA AUSTRALIS, V29, P227; Rachmayanti Y, 2009, FORENSIC SCI INT-GEN, V3, P185, DOI 10.1016/j.fsigen.2009.01.002; Schlumbaum A, 2008, VEG HIST ARCHAEOBOT, V17, P233, DOI 10.1007/s00334-007-0125-7; Seelenfreund D, 2011, NEW ZEAL J BOT, V49, P413, DOI 10.1080/0028825X.2011.579135; Seelenfreund D, 2010, NEW ZEAL J BOT, V48, P1; Speirs AK, 2009, TERRA AUSTRALIS, V30, P175; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Varma Astha, 2007, Biotechnology Journal, V2, P386, DOI 10.1002/biot.200600195; Vuissoz A, 2007, J ARCHAEOL SCI, V34, P823, DOI 10.1016/j.jas.2006.09.002; Zhao WG, 2005, PLANT SCI, V168, P519, DOI 10.1016/j.plantsci.2004.09.020	31	21	21	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2013	8	2							e56549	10.1371/journal.pone.0056549	http://dx.doi.org/10.1371/journal.pone.0056549			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IT	23437166	Green Published, gold, Green Submitted			2022-12-25	WOS:000315186000031
J	Park, CY; Kim, HS; Jang, J; Lee, H; Lee, JS; Yoo, JE; Lee, DR; Kim, DW				Park, Chul-Yong; Kim, Han-Soo; Jang, Jiho; Lee, Hyunji; Lee, Jae Souk; Yoo, Jeong-Eun; Lee, Dongjin R.; Kim, Dong-Wook			ABCD2 Is a Direct Target of beta-Catenin and TCF-4: Implications for X- Linked Adrenoleukodystrophy Therapy	PLOS ONE			English	Article							CHAIN FATTY-ACIDS; WNT/BETA-CATENIN; SKIN FIBROBLASTS; GENE-THERAPY; EXPRESSION; LOVASTATIN; PROTEIN; ACTIVATION; ALD; METABOLISM	X-linked adrenoleukodystrophy (X-ALD) is a peroxisomal disorder caused by mutations in the ABCD1 gene that encodes the peroxisomal ATP-binding cassette (ABC) transporter subfamily D member 1 protein (ABCD1), which is referred to as the adrenoleukodystrophy protein (ALDP). Induction of the ABCD2 gene, the closest homolog of ABCD1, has been mentioned as a possible therapeutic option for the defective ABCD1 protein in X-ALD. However, little is known about the transcriptional regulation of ABCD2 gene expression. Here, through in silico analysis, we found two putative TCF-4 binding elements between nucleotide positions -360 and -260 of the promoter region of the ABCD2 gene. The transcriptional activity of the ABCD2 promoter was strongly increased by ectopic expression of beta-catenin and TCF-4. In addition, mutation of either or both TCF-4 binding elements by site-directed mutagenesis decreased promoter activity. This was further validated by the finding that beta-catenin and the promoter of the ABCD2 gene were pulled down with a beta-catenin antibody in a chromatin immunoprecipitation assay. Moreover, real-time PCR analysis revealed that beta-catenin and TCF-4 increased mRNA levels of ABCD2 in both a hepatocellular carcinoma cell line and primary fibroblasts from an X-ALD patient. Interestingly, we found that the levels of very long chain fatty acids were decreased by ectopic expression of ABCD2-GFP as well as beta-catenin and TCF-4. Taken together, our results demonstrate for the first time the direct regulation of ABCD2 by beta-catenin and TCF-4.	[Park, Chul-Yong; Jang, Jiho; Lee, Hyunji; Lee, Jae Souk; Yoo, Jeong-Eun; Lee, Dongjin R.; Kim, Dong-Wook] Yonsei Univ, Coll Med, Dept Physiol, Seoul, South Korea; [Park, Chul-Yong; Jang, Jiho; Lee, Hyunji; Lee, Jae Souk; Yoo, Jeong-Eun; Lee, Dongjin R.; Kim, Dong-Wook] Yonsei Univ, Coll Med, Severance Biomed Res Inst, Seoul, South Korea; [Kim, Han-Soo] Yonsei Univ, Coll Med, Dept Lab Med, Seoul, South Korea; [Kim, Han-Soo] Yonsei Univ, Coll Med, Cell Therapy Ctr, Seoul, South Korea; [Lee, Jae Souk; Yoo, Jeong-Eun; Lee, Dongjin R.; Kim, Dong-Wook] Yonsei Univ, Coll Med, Brain Korea Project Med Sci 21, Seoul, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System	Kim, DW (corresponding author), Yonsei Univ, Coll Med, Dept Physiol, Seoul, South Korea.	dwkim2@yuhs.ac			National Research Foundation; Korean Ministry of Education, Science and Technology (the Bio & Medical Technology Development Program) [2012M3A9B4028631, 2012M3A9C7050126]; Korea Health technology R&D Project, Korean Ministry of Health Welfare [A120254, A100694]	National Research Foundation; Korean Ministry of Education, Science and Technology (the Bio & Medical Technology Development Program); Korea Health technology R&D Project, Korean Ministry of Health Welfare	This research was supported by grants from the National Research Foundation, Korean Ministry of Education, Science and Technology (the Bio & Medical Technology Development Program, 2012M3A9B4028631 and 2012M3A9C7050126), Korea Health technology R&D Project, Korean Ministry of Health & Welfare (A120254 and A100694). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arce L, 2006, ONCOGENE, V25, P7492, DOI 10.1038/sj.onc.1210056; AUBOURG P, 1993, NEW ENGL J MED, V329, P745, DOI 10.1056/NEJM199309093291101; Cadigan KM, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002881; Cartier N, 2009, SCIENCE, V326, P818, DOI 10.1126/science.1171242; Cha MY, 2004, HEPATOLOGY, V39, P1683, DOI 10.1002/hep.20245; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; de La Coste A, 1998, P NATL ACAD SCI USA, V95, P8847; Engelen M, 2010, NEW ENGL J MED, V362, P276, DOI 10.1056/NEJMc0907735; Flavigny E, 1999, FEBS LETT, V448, P261, DOI 10.1016/S0014-5793(99)00379-8; Fourcade S, 2001, EUR J BIOCHEM, V268, P3490, DOI 10.1046/j.1432-1327.2001.02249.x; Fuerer C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009370; Gondcaille C, 2005, J CELL BIOL, V169, P93, DOI 10.1083/jcb.200501036; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Holzinger A, 1997, BIOCHEM BIOPH RES CO, V239, P261, DOI 10.1006/bbrc.1997.7391; Jang J, 2011, ANN NEUROL, V70, P402, DOI 10.1002/ana.22486; Kemp S, 2001, HUM MUTAT, V18, P499, DOI 10.1002/humu.1227; Kemp S, 1998, NAT MED, V4, P1261, DOI 10.1038/3242; Kemp S, 2010, BRAIN PATHOL, V20, P831, DOI 10.1111/j.1750-3639.2010.00391.x; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Lee HY, 2004, SCIENCE, V303, P1020, DOI 10.1126/science.1091611; Malhotra S, 2009, CELL STEM CELL, V4, P27, DOI 10.1016/j.stem.2008.12.004; Moon RT, 2002, SCIENCE, V296, P1644, DOI 10.1126/science.1071549; Moon RT, 2004, NAT REV GENET, V5, P689, DOI 10.1038/nrg1427; Morita M, 2011, CURR DRUG TARGETS, V12, P694, DOI 10.2174/138945011795378577; Moser AB, 1999, ANN NEUROL, V45, P100, DOI 10.1002/1531-8249(199901)45:1<100::AID-ART16>3.0.CO;2-U; Moser HW, 2007, NAT CLIN PRACT NEURO, V3, P140, DOI 10.1038/ncpneuro0421; MOSER HW, 1980, ANN NEUROL, V7, P542, DOI 10.1002/ana.410070607; MOSSER J, 1993, NATURE, V361, P726, DOI 10.1038/361726a0; Netik A, 1999, HUM MOL GENET, V8, P907, DOI 10.1093/hmg/8.5.907; Nusse R, 2005, CELL RES, V15, P28, DOI 10.1038/sj.cr.7290260; Pai GS, 2000, MOL GENET METAB, V69, P312; Paik MJ, 2001, J CHROMATOGR B, V760, P149, DOI 10.1016/S0378-4347(01)00263-8; Park CY, 2009, J BIOL CHEM, V284, P9237, DOI 10.1074/jbc.M808773200; Pujol A, 2004, HUM MOL GENET, V13, P2997, DOI 10.1093/hmg/ddh323; Pujol A, 2000, GENOMICS, V70, P131, DOI 10.1006/geno.2000.6367; Pulukuri SMK, 2007, J BIOL CHEM, V282, P35594, DOI 10.1074/jbc.M705867200; Singh I, 1998, FEBS LETT, V426, P342, DOI 10.1016/S0014-5793(98)00370-6; Singh I, 1998, NEW ENGL J MED, V339, P702, DOI 10.1056/NEJM199809033391012; Singh I, 2010, BRAIN PATHOL, V20, P838, DOI 10.1111/j.1750-3639.2010.00392.x; Singh J, 2011, J LIPID RES, V52, P2056, DOI 10.1194/jlr.M017491; van Roermund CWT, 2008, FASEB J, V22, P4201, DOI 10.1096/fj.08-110866; Weinhofer I, 2005, J BIOL CHEM, V280, P41243, DOI 10.1074/jbc.M509450200; Weinhofer I, 2002, HUM MOL GENET, V11, P2701, DOI 10.1093/hmg/11.22.2701; Weinhofer I, 2008, EUR J CELL BIOL, V87, P933, DOI 10.1016/j.ejcb.2008.08.002	45	11	11	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2013	8	2							e56242	10.1371/journal.pone.0056242	http://dx.doi.org/10.1371/journal.pone.0056242			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IT	23437103	gold, Green Submitted, Green Published			2022-12-25	WOS:000315186000020
J	Adzemovic, MZ; Zeitelhofer, M; Eriksson, U; Olsson, T; Nilsson, I				Adzemovic, Milena Z.; Zeitelhofer, Manuel; Eriksson, Ulf; Olsson, Tomas; Nilsson, Ingrid			Imatinib Ameliorates Neuroinflammation in a Rat Model of Multiple Sclerosis by Enhancing Blood-Brain Barrier Integrity and by Modulating the Peripheral Immune Response	PLOS ONE			English	Article							EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; CENTRAL-NERVOUS-SYSTEM; MYELIN OLIGODENDROCYTE GLYCOPROTEIN; TISSUE-PLASMINOGEN ACTIVATOR; PDGF-CC; CELLS; MICE; CHEMOKINES; DISORDERS; INDUCTION	Central nervous system (CNS) disorders such as ischemic stroke, multiple sclerosis (MS) or Alzheimers disease are characterized by the loss of blood-brain barrier (BBB) integrity. Here we demonstrate that the small tyrosine kinase inhibitor imatinib enhances BBB integrity in experimental autoimmune encephalomyelitis, an animal model of multiple sclerosis (MS). Treatment was accompanied by decreased CNS inflammation and demyelination and especially reduced T-cell recruitment. This was supported by downregulation of the chemokine receptor (CCR) 2 in CNS and lymph nodes, and by modulation of the peripheral immune response towards an anti-inflammatory phenotype. Interestingly, imatinib ameliorated neuroinflammation, even when the treatment was initiated after the clinical manifestation of the disease. We have previously shown that imatinib reduces BBB disruption and stroke volume after experimentally induced ischemic stroke by targeting platelet-derived growth factor receptor -alpha (PDGFR-alpha) signaling. Here we demonstrate that PDGFR-alpha signaling is a central regulator of BBB integrity during neuroinflammation and therefore imatinib should be considered as a potentially effective treatment for MS.	[Adzemovic, Milena Z.; Zeitelhofer, Manuel; Olsson, Tomas] Karolinska Inst, Ctr Mol Med, Neuroimmunol Unit, Dept Clin Neurosci, Stockholm, Sweden; [Eriksson, Ulf; Nilsson, Ingrid] Karolinska Inst, Dept Med Biochem & Biophys, Div Vasc Biol, Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet	Olsson, T (corresponding author), Karolinska Inst, Ctr Mol Med, Neuroimmunol Unit, Dept Clin Neurosci, Stockholm, Sweden.	tomas.olsson@ki.se; ingrid.nilsson@ki.se		Zeitelhofer, Manuel/0000-0002-4324-2355; Olsson, Tomas/0000-0002-2938-1877	NHR Foundation; Wenner-Gren Fellowship; Soderberg's Foundation; AFA Foundation; Knut and Alice Wallenberg's Foundation; Swedish Research Council; LeDucq Foundation; Swedish Brain Foundation; Hallsten's Research Foundation; Swedish Agency for Innovation Systems (VINNOVA); Swedish Cancer Foundation; Swedish Stroke Foundation; Royal Swedish Agency; Magnus Bergwall's Foundation; Karolinska Institute	NHR Foundation; Wenner-Gren Fellowship; Soderberg's Foundation; AFA Foundation; Knut and Alice Wallenberg's Foundation(Knut & Alice Wallenberg Foundation); Swedish Research Council(Swedish Research CouncilEuropean Commission); LeDucq Foundation(Leducq Foundation); Swedish Brain Foundation; Hallsten's Research Foundation; Swedish Agency for Innovation Systems (VINNOVA)(Vinnova); Swedish Cancer Foundation; Swedish Stroke Foundation; Royal Swedish Agency; Magnus Bergwall's Foundation; Karolinska Institute(Karolinska Institutet)	This study was supported by the NHR Foundation (MZA, MZ), Wenner-Gren Fellowship (MZ), Soderberg's Foundation (TO), AFA Foundation (TO), Knut and Alice Wallenberg's Foundation (TO), Swedish Research Council (TO, UE, IN), LeDucq Foundation (UE), Swedish Brain Foundation and Hallsten's Research Foundation (UE), the Swedish Agency for Innovation Systems (VINNOVA) (UE), the Swedish Cancer Foundation (UE), Swedish Stroke Foundation (IN), Royal Swedish Agency (IN), Magnus Bergwall's Foundation (IN) and Karolinska Institute (IN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams MB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038760; Adzemovic MZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039794; AMOR S, 1994, J IMMUNOL, V153, P4349; Banisadr G, 2002, J NEUROCHEM, V81, P257, DOI 10.1046/j.1471-4159.2002.00809.x; Bondjers C, 2006, FASEB J, V20, P1703, DOI 10.1096/fj.05-4944fje; Bradl M, 2005, AM J PATHOL, V166, P1441, DOI 10.1016/S0002-9440(10)62361-9; Couturier N, 2008, J NEUROIMMUNOL, V195, P176, DOI 10.1016/j.jneuroim.2008.01.017; Crespo O, 2011, J CLIN IMMUNOL, V31, P1010, DOI 10.1007/s10875-011-9579-6; Dubreuil P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007258; Fife BT, 2000, J EXP MED, V192, P899, DOI 10.1084/jem.192.6.899; Fredriksson L, 2004, EMBO J, V23, P3793, DOI 10.1038/sj.emboj.7600397; Goverman J, 2009, NAT REV IMMUNOL, V9, P393, DOI 10.1038/nri2550; Greenwood J, 2011, NEUROPATH APPL NEURO, V37, P24, DOI 10.1111/j.1365-2990.2010.01140.x; Hirase T, 1997, J CELL SCI, V110, P1603; Hochmeister S, 2006, J NEUROPATH EXP NEUR, V65, P855, DOI 10.1097/01.jnen.0000235119.52311.16; Holman DW, 2011, BBA-MOL BASIS DIS, V1812, P220, DOI 10.1016/j.bbadis.2010.07.019; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Izikson L, 2000, J EXP MED, V192, P1075, DOI 10.1084/jem.192.7.1075; Ma QY, 2011, ANN NEUROL, V70, P920, DOI 10.1002/ana.22549; Mahad DJ, 2003, SEMIN IMMUNOL, V15, P23, DOI 10.1016/S1044-5323(02)00125-2; Mildner A, 2009, BRAIN, V132, P2487, DOI 10.1093/brain/awp144; Olson LE, 2011, DEV CELL, V20, P815, DOI 10.1016/j.devcel.2011.04.019; Park H, 2005, NAT IMMUNOL, V6, P1133, DOI 10.1038/ni1261; Persidsky Y, 2006, J NEUROIMMUNE PHARM, V1, P223, DOI 10.1007/s11481-006-9025-3; Ransohoff RM, 2012, NAT REV IMMUNOL, V12, P623, DOI 10.1038/nri3265; Ransohoff RM, 2012, J CLIN INVEST, V122, P1164, DOI 10.1172/JCI58644; Sallusto F, 1997, SCIENCE, V277, P2005, DOI 10.1126/science.277.5334.2005; Sato W, 2007, J IMMUNOL, V178, P7525, DOI 10.4049/jimmunol.178.12.7525; Sospedra M, 2005, ANNU REV IMMUNOL, V23, P683, DOI 10.1146/annurev.immunol.23.021704.115707; Storch MK, 1998, BRAIN PATHOL, V8, P681, DOI 10.1111/j.1750-3639.1998.tb00194.x; Su EJ, 2008, NAT MED, V14, P731, DOI 10.1038/nm1787; Thelen M, 2008, NAT IMMUNOL, V9, P953, DOI 10.1038/ni.f.207; Vermersch P, 2012, BMC NEUROL, V12, DOI 10.1186/1471-2377-12-36; Zhu B, 2007, J IMMUNOL, V179, P5228, DOI 10.4049/jimmunol.179.8.5228; Zlokovic BV, 2008, NEURON, V57, P178, DOI 10.1016/j.neuron.2008.01.003; Zlokovic BV, 2011, NAT REV NEUROSCI, V12, P723, DOI 10.1038/nrn3114	36	40	42	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e56586	10.1371/journal.pone.0056586	http://dx.doi.org/10.1371/journal.pone.0056586			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437178	Green Published, Green Submitted, gold			2022-12-25	WOS:000315184200114
J	Dorner, J; Struck, R; Zimmer, S; Peigney, C; Duerr, GD; Dewald, O; Kim, SC; Malan, D; Bettinger, T; Nickenig, G; Ghanem, A				Doerner, Jonas; Struck, Rafael; Zimmer, Sebastian; Peigney, Christine; Duerr, Georg Daniel; Dewald, Oliver; Kim, Se-Chan; Malan, Daniela; Bettinger, Thierry; Nickenig, Georg; Ghanem, Alexander			Ultrasound-Mediated Stimulation of Microbubbles after Acute Myocardial Infarction and Reperfusion Ameliorates Left-Ventricular Remodelling in Mice via Improvement of Borderzone Vascularization	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; MESENCHYMAL STEM-CELLS; 3-DIMENSIONAL ECHOCARDIOGRAPHY; CONTRAST ECHOCARDIOGRAPHY; IN-VITRO; ANGIOGENESIS; DELIVERY; INJURY; SURVIVAL; THERAPY	Aims: Post-infarction remodelling (PIR) determines left-ventricular (LV) function and prognosis after myocardial infarction. The aim of this study was to evaluate transthoracic ultrasound-mediated microbubble stimulation (UMS) as a novel gene- and cell-free therapeutic option after acute myocardial infarction and reperfusion (AMI/R) in mice. Methods and Results: For myocardial delivery of UMS, a novel therapeutic ultrasound-system (TIPS, Philips Medical) and commercially available microbubbles (BR1, Bracco Suisse SA) were utilized in a closed-chest mouse model. UMS was performed as myocardial post-conditioning (PC) on day four after 30 minutes of coronary occlusion and reperfusion. LV-morphology, as well as global and regional function were measured repeatedly with reconstructive 3-dimensional echocardiography applying an additional low-dose dobutamine protocol after two weeks. Scar size was quantified by means of histomorphometry. A total of 41 mice were investigated; 17 received PC with UMS. Mean ejection fraction (EF) prior UMS was similar in both groups 53%+/- 10 (w/o UMS) and 53%+/- 14 (UMS, p = 0.5), reflecting comparable myocardial mass at risk 17% +/- 8 (w/o UMS), 16%+/- 13 (UMS, p = 0.5). Two weeks after AMI/R, mice undergoing UMS demonstrated significantly better global LV-function (EF = 53% 67) as compared to the group without PC (EF = 39% +/- 11, p<0.01). The fraction of akinetic myocardial mass was significantly lower among mice undergoing UMS after AMI/R [27% +/- 10 (w/o UMS), 13% 68 (UMS), p<0.001)]. Our experiments showed a fast onset of transient, UMS-induced upregulation of vascular-endothelial and insulin-like growth factor (VEGF-a, IGF-1), as well as caveolin-3 (Cav-3). The mice undergoing PC with UMS after AMI/R showed a significantly lower scar size. In addition, the microvascular density was significantly higher in the borderzone of UMS-treated animals. Conclusion: UMS following AMI/R ameliorates PIR in mice via up-regulation of VEGF-a, IGF-1 and Cav-3, and consecutive improvement of myocardial borderzone vascularization.	[Doerner, Jonas; Struck, Rafael; Zimmer, Sebastian; Nickenig, Georg; Ghanem, Alexander] Univ Bonn, Dept Med Cardiol, Bonn, Germany; [Peigney, Christine; Duerr, Georg Daniel; Dewald, Oliver] Univ Clin Ctr Bonn, Dept Cardiac Surg, Bonn, Germany; [Kim, Se-Chan] Univ Bonn, Dept Anaesthesiol & Intens Care Med, Bonn, Germany; [Malan, Daniela] Univ Bonn, Inst Physiol 1, D-53115 Bonn, Germany; [Bettinger, Thierry] Bracco Suisse SA, Geneva Res Ctr, Plan Les Ouates, Switzerland	University of Bonn; University of Bonn; University of Bonn; University of Bonn; Bracco	Ghanem, A (corresponding author), Univ Bonn, Dept Med Cardiol, Bonn, Germany.	ghanem@uni-bonn.de	Duerr, Georg Daniel/ABE-4511-2020	Duerr, Georg Daniel/0000-0002-0310-6236; Kim, Se-Chan/0000-0003-3456-5440	BONFOR (Intramural research foundation of the University of Bonn); German Heart Foundation	BONFOR (Intramural research foundation of the University of Bonn); German Heart Foundation	J.D. and A.G. were supported by BONFOR (Intramural research foundation of the University of Bonn). A.G. was supported by the German Heart Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bekeredjian R, 2007, ULTRASOUND MED BIOL, V33, P1592, DOI 10.1016/j.ultrasmedbio.2007.05.003; Bonni A, 1999, SCIENCE, V286, P1358, DOI 10.1126/science.286.5443.1358; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Cittadini A, 2011, EUR J HEART FAIL, V13, P1264, DOI 10.1093/eurjhf/hfr143; Dawson D, 2004, CIRCULATION, V110, P1632, DOI 10.1161/01.CIR.0000142049.14227.AD; Dewald O, 2004, AM J PATHOL, V164, P665, DOI 10.1016/S0002-9440(10)63154-9; Epstein SE, 2001, CIRCULATION, V104, P115, DOI 10.1161/01.CIR.104.1.115; ERHARDT W, 1984, RES EXP MED, V184, P159, DOI 10.1007/BF01852390; Ferrara N, 2001, ACTA HAEMATOL-BASEL, V106, P148, DOI 10.1159/000046610; Fujii H, 2009, JACC-CARDIOVASC IMAG, V2, P869, DOI 10.1016/j.jcmg.2009.04.008; Fujio Y, 2000, CIRCULATION, V101, P660, DOI 10.1161/01.CIR.101.6.660; GAUDRON P, 1993, CIRCULATION, V87, P755, DOI 10.1161/01.CIR.87.3.755; Ghanem A, 2008, ULTRASOUND MED BIOL, V34, P559, DOI 10.1016/j.ultrasmedbio.2007.09.013; Ghanem A, 2006, ECHOCARDIOGR-J CARD, V23, P900, DOI 10.1111/j.1540-8175.2006.00323.x; Ghanem A, 2011, CELL TRANSPLANT, V20, P1621, DOI 10.3727/096368910X564049; Ghanem A, 2009, CELL TRANSPLANT, V18, P1289, DOI 10.3727/096368909X12483162197286; Ghanem A, 2009, J MOL CELL CARDIOL, V47, P411, DOI 10.1016/j.yjmcc.2009.06.008; Haider HK, 2008, CIRC RES, V103, P1300, DOI 10.1161/CIRCRESAHA.108.186742; Hoeben A, 2004, PHARMACOL REV, V56, P549, DOI 10.1124/pr.56.4.3; Kim SC, 2012, JOVE-J VIS EXP, DOI 10.3791/3896; Kuntz-Hehner S, 2001, RADIOLOGY, V220, P647, DOI 10.1148/radiol.2203001628; Miller DL, 2006, J AM COLL CARDIOL, V47, P1464, DOI 10.1016/j.jacc.2005.09.078; Padin-Iruegas ME, 2009, CIRCULATION, V120, P876, DOI 10.1161/CIRCULATIONAHA.109.852285; PFEFFER MA, 1990, CIRCULATION, V81, P1161, DOI 10.1161/01.CIR.81.4.1161; Roell W, 2007, NATURE, V450, P819, DOI 10.1038/nature06321; Rosano Jenna M, 2012, Cardiovasc Eng Technol, V3, P237; SCHNEIDER M, 1995, INVEST RADIOL, V30, P451, DOI 10.1097/00004424-199508000-00001; Seip R, 2010, IEEE T BIO-MED ENG, V57, P61, DOI 10.1109/TBME.2009.2028874; Sutton MGS, 2000, CIRCULATION, V101, P2981, DOI 10.1161/01.CIR.101.25.2981; Swanson SD, 2006, MAGN RESON IMAGING, V24, P603, DOI 10.1016/j.mri.2005.12.014; Taniyama Y, 2002, CIRCULATION, V105, P1233, DOI 10.1161/hc1002.105228; Tsutsumi YM, 2008, CIRCULATION, V118, P1979, DOI 10.1161/CIRCULATIONAHA.108.788331; Vancraeynest D, 2006, EUR HEART J, V27, P237, DOI 10.1093/eurheartj/ehi479; Woodman SE, 2002, J BIOL CHEM, V277, P38988, DOI 10.1074/jbc.M205511200; Yau TM, 2005, CIRCULATION, V112, pI123, DOI 10.1161/CIRCULATIONAHA.104.525147; Zarnitsyn VG, 2004, ULTRASOUND MED BIOL, V30, P527, DOI 10.1016/j.ultrasmedbio.2004.01.008; Zhang J, 2009, CIRCULATION, V119, P1776, DOI 10.1161/CIRCULATIONAHA.108.800565	37	8	8	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e56841	10.1371/journal.pone.0056841	http://dx.doi.org/10.1371/journal.pone.0056841			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437254	Green Published, Green Submitted, gold			2022-12-25	WOS:000315184200170
J	Howey-Jordan, LA; Brooks, EJ; Abercrombie, DL; Jordan, LKB; Brooks, A; Williams, S; Gospodarczyk, E; Chapman, DD				Howey-Jordan, Lucy A.; Brooks, Edward J.; Abercrombie, Debra L.; Jordan, Lance K. B.; Brooks, Annabelle; Williams, Sean; Gospodarczyk, Emily; Chapman, Demian D.			Complex Movements, Philopatry and Expanded Depth Range of a Severely Threatened Pelagic Shark, the Oceanic Whitetip (Carcharhinus longimanus) in the Western North Atlantic	PLOS ONE			English	Article							POSTRELEASE SURVIVAL; DIVING BEHAVIOR; WHALE SHARKS; HABITAT USE; TRACKING; PACIFIC; NICHE	Oceanic whitetip sharks (Carcharhinus longimanus) have recently been targeted for conservation in the western North Atlantic following severe declines in abundance. Pop-up satellite archival tags were applied to 11 mature oceanic whitetips (10 females, 1 male) near Cat Island in the central Bahamas 1-8 May 2011 to provide information about the horizontal and vertical movements of this species. Another large female was opportunistically tagged in the U.S. Exclusive Economic Zone (EEZ). Data from 1,563 total tracking days and 1,142,598 combined depth and temperature readings were obtained. Sharks tagged at Cat Island stayed within 500 km of the tagging site for similar to 30 days before dispersing across 16,422 km(2) of the western North Atlantic. Maximum individual displacement from the tagging site ranged from 290-1940 km after times at liberty from 30-245 days, with individuals moving to several different destinations (the northern Lesser Antilles, the northern Bahamas, and north of the Windward Passage). Many sharks returned to The Bahamas after similar to 150 days. Estimated residency times within The Bahamas EEZ, where longlining and commercial trade of sharks is illegal, were generally high (mean = 68.2% of time). Sharks spent 99.7% of their time shallower than 200 m and did not exhibit differences in day and night mean depths. There was a positive correlation between daily sea surface temperature and mean depth occupied, suggesting possible behavioral thermoregulation. All individuals made short duration (mean = 13.06 minutes) dives into the mesopelagic zone (down to 1082 m and 7.75 degrees C), which occurred significantly more often at night. Ascent rates during these dives were significantly slower than descent rates, suggesting that these dives are for foraging. The sharks tracked appear to be most vulnerable to pelagic fishing gear deployed from 0-125 m depths, which they may encounter from June to October after leaving the protected waters of The Bahamas EEZ.	[Howey-Jordan, Lucy A.; Jordan, Lance K. B.; Gospodarczyk, Emily] Microwave Telemetry Inc, Columbia, MD USA; [Brooks, Edward J.; Brooks, Annabelle; Williams, Sean] Cape Eleuthera Inst, Shark Res & Conservat Program, Eleuthera, Bahamas; [Abercrombie, Debra L.] Abercrombie & Fish, New York, NY USA; [Chapman, Demian D.] SUNY Stony Brook, Sch Marine & Atmospher Sci, Stony Brook, NY 11794 USA; [Chapman, Demian D.] SUNY Stony Brook, Inst Ocean Conservat Sci, Stony Brook, NY 11794 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Chapman, DD (corresponding author), SUNY Stony Brook, Sch Marine & Atmospher Sci, Stony Brook, NY 11794 USA.	demian.chapman@stonybrook.edu	Patterson, Ruth/A-7540-2018	Abercrombie, Debra/0000-0002-2572-1862	Microwave Telemetry, Inc.; The Pew Charitable Trusts; Roe Foundation; Cape Eleuthera Foundation	Microwave Telemetry, Inc.; The Pew Charitable Trusts; Roe Foundation; Cape Eleuthera Foundation	This study was, in part, funded by Microwave Telemetry, Inc. by providing the satellite tags used in this study. The family of the lead author of this study (Lucy Howey-Jordan) owns and operates Microwave Telemetry, Inc. In no way did the author's financial invovlment bias the results or the authors' interpretation. Other funding sources are The Pew Charitable Trusts, the Roe Foundation and the Cape Eleuthera Foundation. Additionally, the authors declare that the authors' affiliations with both Microwave Telemetry, Inc. and Abercrombie & Fish does not alter their adherence to all the PLOS ONE policies on sharing data and materials. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, ANIM BEHAV, V83, P301, DOI 10.1016/j.anbehav.2011.10.031; BACKUS RH, 1956, DEEP-SEA RES, V3, P178, DOI 10.1016/0146-6313(56)90002-8; Baird RW, 2003, 15 BIENN C BIO UNPUB; Baum J, 2006, CARCHARHINUS LONGIMA; Baum JK, 2004, ECOL LETT, V7, P135, DOI 10.1111/j.1461-0248.2003.00564.x; Bonfil R, 2010, AQUAT BIOL, V8, P115, DOI 10.3354/ab00217; Bonfil R, 2008, SHARKS OPEN OCEAN BI, P128; Boustany AM, 2002, NATURE, V415, P35, DOI 10.1038/415035b; Burgess GH, 2005, FISHERIES, V30, P19, DOI 10.1577/1548-8446(2005)30[19:ITCOSP]2.0.CO;2; Campana SE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016854; Campana SE, 2010, CAN J FISH AQUAT SCI, V67, P769, DOI 10.1139/F10-020; CAREY FG, 1990, MAR BIOL, V106, P329, DOI 10.1007/BF01344309; Carlson JK, 2011, SCRS2011099 NOAA SE; Cartamil DP, 2011, MAR BIOL, V158, P935, DOI 10.1007/s00227-010-1620-4; Castro J. I, 2011, SHARKS N AM; Chapman DD, 2007, MAR ECOL PROG SER, V344, P271, DOI 10.3354/meps06941; Clarke SC, 2006, CONSERV BIOL, V20, P201, DOI 10.1111/j.1523-1739.2005.00247.x; COMPAGNO L. J. V, 1984, FAO SPECIES CATALO 2; Cortes Enric, 2007, Gulf and Caribbean Research, V19, P37; Domeier ML, 2005, FISH B-NOAA, V103, P292; Galuardi B, 2010, ANALYZEPSAT; Galuardi B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037829; Graham RT, 2006, J ROY SOC INTERFACE, V3, P109, DOI 10.1098/rsif.2005.0082; Graves JE, 2009, FISH B-NOAA, V107, P373; HASTENRATH S, 1987, J PHYS OCEANOGR, V17, P1518, DOI 10.1175/1520-0485(1987)017<1518:ACOSTS>2.0.CO;2; James MC, 2006, CAN J ZOOL, V84, P754, DOI 10.1139/Z06-046; Johnson MP, 2008, J ANIM ECOL, V77, P1365; KOHLER N. E., 1998, MAR FISH REV, V60, P1, DOI DOI 10.7755/MFR.81.2.1; Lam CH, 2008, FISH RES, V91, P15, DOI 10.1016/j.fishres.2007.11.002; Mayr E., 1963, ANIMAL SPECIES EVOLU, P797; Musyl MK, 2011, MAR ECOL PROG SER, V433, P1, DOI 10.3354/meps09202; Musyl MK, 2011, FISH B-NOAA, V109, P341; Pinheiro J, 2001, MIXED EFFECTS MODELS; Prince ED, 2006, FISH OCEANOGR, V15, P451, DOI 10.1111/j.1365-2419.2005.00393.x; R Development Core Team, 2012, R LANG ENV STAT COMP; Rowat D, 2007, FISH RES, V84, P32, DOI 10.1016/j.fishres.2006.11.009; Sarkar D., 2019, NLME LINEAR NONLINEA; Sedberry GR, 2001, MAR BIOL, V139, P355; Sims DW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007351; Skomal GB, 2009, CURR BIOL, V19, P1019, DOI 10.1016/j.cub.2009.04.019; Speed CW, 2012, MAR ECOL PROG SER, V463, P231, DOI 10.3354/meps09864; Stafford-Deitsch J, 1989, SHARK PHOTOGRAPHERS; STEVENS JD, 1984, AUST J MAR FRESH RES, V35, P573, DOI 10.1071/MF9840573; Thums M, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2012.0477; Walsh W.A., 2011, NRWCPFCSC7201EBWP03; Weng KC, 2005, SCIENCE, V310, P104, DOI 10.1126/science.1114616	46	71	72	2	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e56588	10.1371/journal.pone.0056588	http://dx.doi.org/10.1371/journal.pone.0056588			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437180	gold, Green Published			2022-12-25	WOS:000315184200116
J	Nie, W; Liu, YG; Bian, JR; Li, B; Xiu, QY				Nie, Wei; Liu, Yongan; Bian, Jiarong; Li, Bin; Xiu, Qingyu			Effects of Polymorphisms-1112C/T and+2044A/G in Interleukin-13 Gene on Asthma Risk: A Meta-Analysis	PLOS ONE			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISMS; SERUM IGE LEVELS; ALLERGIC-ASTHMA; PROMOTER POLYMORPHISMS; IL-13 POLYMORPHISMS; PEDIATRIC ASTHMA; KOREAN CHILDREN; CANDIDATE GENES; ASSOCIATION; ATOPY	Background: Associations between interleukin-13 (IL-13) polymorphisms and asthma risk remained controversial and ambiguous. Therefore, we performed a meta-analysis to assess the associations between IL-13 polymorphisms and asthma susceptibility. Methods: Pubmed, EMBASE, Chinese National Knowledge Infrastructure (CNKI) and Wangfang databases were searched. Odds ratios (ORs) with 95% confidence intervals (CIs) were used to calculate the strength of association in the random-effects model. Results: Thirty-four studies were included in this meta-analysis. The results indicated that IL13 -1112C/T polymorphism was significantly associated with asthma risk (OR = 1.20, 95% CI 1.08-1.34, P = 0.0009) in a dominant genetic model. When stratifying for race, IL13 -1112C/T polymorphism exhibited increased asthma risk in Caucasians (OR = 1.30, 95% CI 1.09-1.55, P = 0.003), while no significant association was found in Asians and African Americans. In the subgroup analysis based on atopic status, significant association was observed in atopic patients (OR = 1.25, 95% CI 1.07-1.45, P = 0.004) but not in the non-atopic patients. In addition, a significant association between IL13+2044A/G polymorphism and asthma risk was observed (OR = 1.18, 95% CI 1.08-1.28, P = 0.0002). In the subgroup analysis by ethnicity, there were significant associations between IL13+2044A/G polymorphism and asthma risk in Asians (OR = 1.19, 95% CI 1.04-1.36, P = 0.01) and Caucasians (OR = 1.22, 95% CI 1.06-1.40, P = 0.005) but not in African Americans. In the subgroup analysis stratified by atopic status, a marginal significant association was found in atopic patients (OR = 1.12, 95% CI 1.00-1.26, P = 0.05). Conclusions: This meta-analysis suggested that the IL13 -1112C/T and +2044A/G polymorphisms were risk factors for asthma.	[Nie, Wei; Liu, Yongan; Bian, Jiarong; Xiu, Qingyu] Second Mil Med Univ, Shanghai Changzheng Hosp, Dept Resp Dis, Shanghai, Peoples R China; [Liu, Yongan] 411 Hosp PLA, Dept Intens Care Med, Shanghai, Peoples R China; [Li, Bin] Second Mil Med Univ, Shanghai Changzheng Hosp, Dept Radiol, Shanghai, Peoples R China	Naval Medical University; Naval Medical University	Xiu, QY (corresponding author), Second Mil Med Univ, Shanghai Changzheng Hosp, Dept Resp Dis, Shanghai, Peoples R China.	xiu_qingyu@126.com			National Natural Science Foundation of China [81170025]; National Ministry of Science and Technology [2011ZX09302-003-001]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Ministry of Science and Technology	This study was supported by grant 81170025 from National Natural Science Foundation of China and project of "Major New Drugs Innovation and Development" from the National Ministry of Science and Technology (2011ZX09302-003-001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arima K, 2002, J ALLERGY CLIN IMMUN, V109, P980, DOI 10.1067/mai.2002.124656; Battle NC, 2007, AM J RESP CRIT CARE, V175, P881, DOI 10.1164/rccm.200607-992OC; Baye TM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016522; Black S, 2009, ALLERGY, V64, P1172, DOI 10.1111/j.1398-9995.2009.01988.x; Blease K, 2001, J IMMUNOL, V166, P5219, DOI 10.4049/jimmunol.166.8.5219; Bottema RWB, 2010, INT ARCH ALLERGY IMM, V153, P259, DOI 10.1159/000314366; Cameron L, 2006, J IMMUNOL, V177, P8633, DOI 10.4049/jimmunol.177.12.8633; Chan IHS, 2008, ALLERGY, V63, P1031, DOI 10.1111/j.1398-9995.2008.01639.x; Corren J, 2011, NEW ENGL J MED, V365, P1088, DOI 10.1056/NEJMoa1106469; Cui L, 2012, CLIN BIOCHEM, V45, P285, DOI 10.1016/j.clinbiochem.2011.12.012; Daley D, 2009, HUM GENET, V125, P445, DOI 10.1007/s00439-009-0643-8; DeWan AT, 2010, J ALLERGY CLIN IMMUN, V126, P871, DOI 10.1016/j.jaci.2010.06.051; Dmitrieva-Zdorova E V, 2010, Genetika, V46, P111; Donfack J, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-145; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Feng D, 2009, HEILONGJIANG MED J, V33, P481; Grunig G, 1998, SCIENCE, V282, P2261, DOI 10.1126/science.282.5397.2261; Hakonarson H, 2001, AM J RESP CRIT CARE, V164, P2036, DOI 10.1164/ajrccm.164.11.2101086; Howard TD, 2001, AM J RESP CELL MOL, V25, P377, DOI 10.1165/ajrcmb.25.3.4483; HUANG SK, 1995, J IMMUNOL, V155, P2688; Jiang P, 2009, ALLERGY ASTHMA PROC, V30, P413, DOI 10.2500/aap.2009.30.3255; Kabesch M, 2006, J ALLERGY CLIN IMMUN, V117, P269, DOI 10.1016/j.jaci.2005.10.024; Kaishu Z, 2005, J CLIN PEDIAT, P312; Kang MJ, 2008, PHARMACOGENET GENOM, V18, P551, DOI 10.1097/FPC.0b013e3282fe94c5; Kauppi P, 2001, GENOMICS, V77, P35, DOI 10.1006/geno.2001.6613; Kim HB, 2008, CLIN EXP ALLERGY, V38, P774, DOI 10.1111/j.1365-2222.2008.02965.x; Kraan TCTMV, 1999, GENES IMMUN, V1, P61, DOI 10.1038/sj.gene.6363630; Lee YC, 2001, J ASTHMA, V38, P665, DOI 10.1081/JAS-100107544; Leung TF, 2001, CLIN EXP ALLERGY, V31, P1515, DOI 10.1046/j.1365-2222.2001.01212.x; Li H, 2009, J INVEST ALLERG CLIN, V19, P391; Li YF, 2008, RESP MED, V102, P984, DOI 10.1016/j.rmed.2008.02.008; Llanes E, 2009, INT ARCH ALLERGY IMM, V148, P228, DOI 10.1159/000161583; McKenzie GJ, 1998, IMMUNITY, V9, P423, DOI 10.1016/S1074-7613(00)80625-1; Moissidis I, 2005, GENET MED, V7, P406, DOI 10.1097/01.GIM.0000170994.24960.48; Munoz B, 2012, ENVIRON TOXICOL PHAR, V33, P226, DOI 10.1016/j.etap.2011.12.007; Murphy DM, 2010, CHEST, V137, P1417, DOI 10.1378/chest.09-1895; Nie W, 2012, CYTOKINE, V60, P849, DOI 10.1016/j.cyto.2012.08.023; Nie W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042062; Noguchi E, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002170; Palikhe NS, 2010, ALLERGY ASTHMA IMMUN, V2, P134, DOI 10.4168/aair.2010.2.2.134; Thakkinstian A, 2005, AM J EPIDEMIOL, V162, P201, DOI 10.1093/aje/kwi184; Thakkinstian A, 2005, STAT MED, V24, P1291, DOI 10.1002/sim.2010; Umetsu DT, 2002, NAT IMMUNOL, V3, P715, DOI 10.1038/ni0802-715; Undarmaa S, 2010, J HUM GENET, V55, P342, DOI 10.1038/jhg.2010.32; Venkayya R, 2002, AM J RESP CELL MOL, V26, P202, DOI 10.1165/ajrcmb.26.2.4600; Vercelli D, 2008, NAT REV IMMUNOL, V8, P169, DOI 10.1038/nri2257; von Mutius E, 2009, J ALLERGY CLIN IMMUN, V123, P3, DOI 10.1016/j.jaci.2008.10.046; Wang JY, 2009, J CLIN IMMUNOL, V29, P205, DOI 10.1007/s10875-008-9256-6; Wang Xiu-hai, 2009, Zhonghua Jiehe He Huxi Zazhi, V32, P161; Wills-Karp M, 1998, SCIENCE, V282, P2258, DOI 10.1126/science.282.5397.2258; Wong CK, 2001, CLIN EXP IMMUNOL, V125, P177, DOI 10.1046/j.1365-2249.2001.01602.x; Wu Bin, 2004, Zhonghua Jiehe He Huxi Zazhi, V27, P668; Wu XH, 2010, J ASTHMA, V47, P238, DOI 10.3109/02770900903509099; Xi Dong, 2004, J Huazhong Univ Sci Technolog Med Sci, V24, P219; Yang HJ, 2011, RESPIROLOGY, V16, P1127, DOI 10.1111/j.1440-1843.2011.02021.x; Yang L, 2010, ZHONG GUO XIAN DAI Y, V12, P46; Yang XX, 2011, ASIAN PAC J ALLERGY, V29, P273	57	30	33	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e56065	10.1371/journal.pone.0056065	http://dx.doi.org/10.1371/journal.pone.0056065			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437086	gold, Green Submitted, Green Published			2022-12-25	WOS:000315184200040
J	Silva, JM; Georgi, N; Costa, R; Sher, P; Reis, RL; Van Blitterswijk, CA; Karperien, M; Mano, JF				Silva, Joana M.; Georgi, Nicole; Costa, Rui; Sher, Praveen; Reis, Rui L.; Van Blitterswijk, Clemens A.; Karperien, Marcel; Mano, Joao F.			Nanostructured 3D Constructs Based on Chitosan and Chondroitin Sulphate Multilayers for Cartilage Tissue Engineering	PLOS ONE			English	Article							ARTICULAR-CARTILAGE; BIOMEDICAL APPLICATIONS; POLYELECTROLYTE MULTILAYERS; CELL-DIFFERENTIATION; HYALURONIC-ACID; STEM-CELLS; SCAFFOLDS; LAYER; FILMS; REGENERATION	Nanostructured three-dimensional constructs combining layer-by-layer technology (LbL) and template leaching were processed and evaluated as possible support structures for cartilage tissue engineering. Multilayered constructs were formed by depositing the polyelectrolytes chitosan (CHT) and chondroitin sulphate (CS) on either bidimensional glass surfaces or 3D packet of paraffin spheres. 2D CHT/CS multi-layered constructs proved to support the attachment and proliferation of bovine chondrocytes (BCH). The technology was transposed to 3D level and CHT/CS multi-layered hierarchical scaffolds were retrieved after paraffin leaching. The obtained nanostructured 3D constructs had a high porosity and water uptake capacity of about 300%. Dynamical mechanical analysis (DMA) showed the viscoelastic nature of the scaffolds. Cellular tests were performed with the culture of BCH and multipotent bone marrow derived stromal cells (hMSCs) up to 21 days in chondrogenic differentiation media. Together with scanning electronic microscopy analysis, viability tests and DNA quantification, our results clearly showed that cells attached, proliferated and were metabolically active over the entire scaffold. Cartilaginous extracellular matrix (ECM) formation was further assessed and results showed that GAG secretion occurred indicating the maintenance of the chondrogenic phenotype and the chondrogenic differentiation of hMSCs.	[Silva, Joana M.; Costa, Rui; Sher, Praveen; Reis, Rui L.; Mano, Joao F.] Univ Minho, Headquarters European Inst Excellence Tissue Engn, Res Grp Biomat Biodegradables & Biomimet 3Bs, Taipas, Guimaraes, Portugal; [Silva, Joana M.; Costa, Rui; Sher, Praveen; Reis, Rui L.; Mano, Joao F.] ICVS 3Bs PT Govt Associate Lab, Braga, Portugal; [Georgi, Nicole; Van Blitterswijk, Clemens A.; Karperien, Marcel] Univ Twente, MIRA Inst Biomed Technol & Tech Med, Dept Tissue Regenerat, NL-7500 AE Enschede, Netherlands; [Georgi, Nicole; Van Blitterswijk, Clemens A.; Karperien, Marcel] Univ Twente, MIRA Inst Biomed Technol & Tech Med, Dept Dev BioEngn, NL-7500 AE Enschede, Netherlands	Universidade do Minho; University of Twente; University of Twente	Mano, JF (corresponding author), Univ Minho, Headquarters European Inst Excellence Tissue Engn, Res Grp Biomat Biodegradables & Biomimet 3Bs, Taipas, Guimaraes, Portugal.	jmano@dep.uminho.pt	Silva, Joana/GYQ-9526-2022; Sher, Praveen/A-2721-2016; Silva, Joana M./AAQ-9354-2021; Mano, João F./A-4418-2009; Silva, Joana Marques/AAF-9867-2019; Reis, Rui L./A-8938-2008; Costa, Rui R/C-2526-2011; Karperien, Marcel/R-3270-2018	Sher, Praveen/0000-0003-2235-7855; Silva, Joana M./0000-0001-9487-4259; Mano, João F./0000-0002-2342-3765; Reis, Rui L./0000-0002-4295-6129; Costa, Rui R/0000-0001-8234-8729; Karperien, Marcel/0000-0003-0751-0604; UMinho, 3B's Research Group/0000-0002-5195-3456; van Blitterswijk, Clemens/0000-0003-2371-4615				Albrecht C, 2011, OSTEOARTHR CARTILAGE, V19, P1219, DOI 10.1016/j.joca.2011.07.004; Almodovar J, 2011, BIOMACROMOLECULES, V12, P2755, DOI 10.1021/bm200519y; Alves NM, 2009, MACROMOL BIOSCI, V9, P776, DOI 10.1002/mabi.200800336; Anselme K, 2000, BIOMATERIALS, V21, P667, DOI 10.1016/S0142-9612(99)00242-2; Boudou T, 2010, ADV MATER, V22, P441, DOI 10.1002/adma.200901327; Chatterjee S, 2005, J COLLOID INTERF SCI, V288, P30, DOI 10.1016/j.jcis.2005.02.055; Chen FH, 2006, NAT CLIN PRACT RHEUM, V2, P373, DOI 10.1038/ncprheum0216; Chen WC, 2011, J BIOSCI BIOENG, V111, P226, DOI 10.1016/j.jbiosc.2010.10.002; Chung C, 2008, ADV DRUG DELIVER REV, V60, P243, DOI 10.1016/j.addr.2007.08.027; Correia C, 2011, TISSUE ENG PART C-ME; Costa RR, 2011, SMALL, V7, P2640, DOI 10.1002/smll.201100875; Costa RR, 2009, ADV FUNCT MATER, V19, P3210, DOI 10.1002/adfm.200900568; Crouzier T, 2010, CURR OPIN COLLOID IN, V15, P417, DOI 10.1016/j.cocis.2010.05.007; Detzel CJ, 2011, TISSUE ENG PART B-RE, V17, P101, DOI [10.1089/ten.teb.2010.0548, 10.1089/ten.TEB.2010.0548]; Fajardo AR, 2010, CARBOHYD POLYM, V80, P934, DOI 10.1016/j.carbpol.2010.01.009; Fan HB, 2006, BIOMATERIALS, V27, P4573, DOI 10.1016/j.biomaterials.2006.04.013; Franke O, 2011, MAT SCI ENG C-MATER, V31, P789, DOI 10.1016/j.msec.2010.12.005; Fraser JRE, 1997, J INTERN MED, V242, P27, DOI 10.1046/j.1365-2796.1997.00170.x; Ghosh S, 2008, ACTA BIOMATER, V4, P950, DOI 10.1016/j.actbio.2008.02.001; Gong YH, 2007, ACTA BIOMATER, V3, P677, DOI 10.1016/j.actbio.2007.04.007; Heng BC, 2004, STEM CELLS, V22, P1152, DOI 10.1634/stemcells.2004-0062; Hutmacher DW, 2000, BIOMATERIALS, V21, P2529, DOI 10.1016/S0142-9612(00)00121-6; Jin R, 2010, ACTA BIOMATER, V6, P1968, DOI 10.1016/j.actbio.2009.12.024; KIRKPATRICK CJ, 1992, ADV BIOMAT, V10, P31; Kobo M, 2009, LIFE SCI, V85, P477, DOI [10.1016/j.lfs.209.08.005, 10.1016/j.lfs.2009.08.005]; Kohler K, 2005, J PHYS CHEM B, V109, P18250, DOI 10.1021/jp052208i; LeBaron RG, 2000, BIOMATERIALS, V21, P2575, DOI 10.1016/S0142-9612(00)00125-3; Lee SH, 2007, ADV DRUG DELIVER REV, V59, P339, DOI 10.1016/j.addr.2007.03.016; Liu YX, 2005, COLLOID SURFACE B, V46, P117, DOI 10.1016/j.colsurfb.2005.09.005; Mano JF, 2007, J TISSUE ENG REGEN M, V1, P261, DOI 10.1002/term.37; Mano JF, 2008, MACROMOL BIOSCI, V8, P69, DOI 10.1002/mabi.200700139; Mao JS, 2003, BIOMATERIALS, V24, P1621, DOI 10.1016/S0142-9612(02)00549-5; Martins AM, 2008, ACTA BIOMATER, V4, P1637, DOI 10.1016/j.actbio.2008.06.004; Martins GV, 2010, CARBOHYD POLYM, V80, P570, DOI 10.1016/j.carbpol.2009.10.030; Menzel EJ, 1998, CANCER LETT, V131, P3, DOI 10.1016/S0304-3835(98)00195-5; Miranda ES, 2011, TISSUE ENG PT A, V17, P2663, DOI 10.1089/ten.tea.2010.0635; Moutos FT, 2007, NAT MATER, V6, P162, DOI 10.1038/nmat1822; Neves SC, 2011, BIOMATERIALS, V32, P1068, DOI 10.1016/j.biomaterials.2010.09.073; Piai JF, 2009, ACTA BIOMATER, V5, P2601, DOI 10.1016/j.actbio.2009.03.035; Pieper JS, 1999, BIOMATERIALS, V20, P847, DOI 10.1016/S0142-9612(98)00240-3; Puppi D, 2010, PROG POLYM SCI, V35, P403, DOI 10.1016/j.progpolymsci.2010.01.006; Servaty R, 2001, INT J BIOL MACROMOL, V28, P121, DOI 10.1016/S0141-8130(00)00161-6; Sher P, 2010, SMALL, V6, P2644, DOI 10.1002/smll.201001066; Sobral JM, 2011, ACTA BIOMATER, V7, P1009, DOI 10.1016/j.actbio.2010.11.003; Suh JKF, 2000, BIOMATERIALS, V21, P2589; Sui W, 2008, COLLOID SURFACE B, V65, P69, DOI 10.1016/j.colsurfb.2008.02.022; Tang ZY, 2006, ADV MATER, V18, P3203, DOI 10.1002/adma.200600113; Temenoff JS, 2000, BIOMATERIALS, V21, P431, DOI 10.1016/S0142-9612(99)00213-6; Varghese JM, 2008, SENSOR ACTUAT B-CHEM, V135, P336, DOI 10.1016/j.snb.2008.09.001; Vinatier C, 2009, TRENDS BIOTECHNOL, V27, P307, DOI 10.1016/j.tibtech.2009.02.005; Voinova MV, 1999, PHYS SCRIPTA, V59, P391, DOI 10.1238/Physica.Regular.059a00391; VONDERMARK K, 1977, NATURE, V267, P531, DOI 10.1038/267531a0; Wu L, 2011, TISSUE ENG PT A, V17, P1425, DOI [10.1089/ten.TEA.2010.0517, 10.1089/ten.tea.2010.0517]; Yan LP, 2012, ACTA BIOMATER, V8, P289, DOI 10.1016/j.actbio.2011.09.037; Yan LP, 2010, J BIOMED MATER RES A, V95A, P465, DOI 10.1002/jbm.a.32869	55	108	108	0	93	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e55451	10.1371/journal.pone.0055451	http://dx.doi.org/10.1371/journal.pone.0055451			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437056	Green Published, Green Submitted, gold			2022-12-25	WOS:000315184200018
J	Zhang, EY; Yang, ZF; Wang, YF; Hu, YY; Song, XY; Xu, CW				Zhang, Enying; Yang, Zefeng; Wang, Yifan; Hu, Yunyun; Song, Xiyun; Xu, Chenwu			Nucleotide Polymorphisms and Haplotype Diversity of RTCS Gene in China Elite Maize Inbred Lines	PLOS ONE			English	Article							ZEA-MAYS L.; ROOT-SYSTEM ARCHITECTURE; LOB DOMAIN PROTEIN; DNA POLYMORPHISM; POPULATIONS; ENCODES; INITIATION; HETEROSIS; SELECTION; MARKERS	The maize RTCS gene, encoding a LOB domain transcription factor, plays important roles in the initiation of embryonic seminal and postembryonic shoot-borne root. In this study, the genomic sequences of this gene in 73 China elite inbred lines, including 63 lines from 5 temperate heteroric groups and 10 tropic germplasms, were obtained, and the nucleotide polymorphisms and haplotype diversity were detected. A total of 63 sequence variants, including 44 SNPs and 19 indels, were identified at this locus, and most of them were found to be located in the regions of UTR and intron. The coding region of this gene in all tested inbred lines carried 14 haplotypes, which encoding 7 deferring RTCS proteins. Analysis of the polymorphism sites revealed that at least 6 recombination events have occurred. Among all 6 groups tested, only the P heterotic group had a much lower nucleotide diversity than the whole set, and selection analysis also revealed that only this group was under strong negative selection. However, the set of Huangzaosi and its derived lines possessed a higher nucleotide diversity than the whole set, and no selection signal were identified.	[Zhang, Enying; Yang, Zefeng; Wang, Yifan; Hu, Yunyun; Xu, Chenwu] Yangzhou Univ, Coll Agr, Key Lab Crop Genet & Physiol Jiangsu Prov, Key Lab Plant Funct Genom,Minist Educ, Yangzhou, Peoples R China; [Zhang, Enying; Song, Xiyun] Qingdao Agr Univ, Coll Agron & Plant Protect, Qingdao, Peoples R China	Yangzhou University; Qingdao Agricultural University	Yang, ZF (corresponding author), Yangzhou Univ, Coll Agr, Key Lab Crop Genet & Physiol Jiangsu Prov, Key Lab Plant Funct Genom,Minist Educ, Yangzhou, Peoples R China.	zfyang@yzu.edu.cn; qtls@yzu.edu.cn		Yang, Zefeng/0000-0002-3465-8594	National Program on the Development of Basic Research [2011CB100100]; Priority Academic Program Development of Jiangsu Higher Education Institutions; National Natural Science Foundations [31200943, 31171187]; Natural Science Foundations of Jiangsu Province [BK2012261]	National Program on the Development of Basic Research(National Basic Research Program of China); Priority Academic Program Development of Jiangsu Higher Education Institutions; National Natural Science Foundations(National Natural Science Foundation of China (NSFC)); Natural Science Foundations of Jiangsu Province(Natural Science Foundation of Jiangsu Province)	This work was supported by grants from the National Program on the Development of Basic Research (2011CB100100), the Priority Academic Program Development of Jiangsu Higher Education Institutions, the National Natural Science Foundations (31200943 and 31171187) and the Natural Science Foundations of Jiangsu Province (BK2012261). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achon MA, 2012, ARCH VIROL; Aguiar CG, 2008, GENET MOL RES, V7, P1233, DOI 10.4238/vol7-4gmr495; Berilli APCG, 2011, GENET MOL RES, V10, P2589, DOI 10.4238/2011.October.25.6; Cai HG, 2012, THEOR APPL GENET, V125, P1313, DOI 10.1007/s00122-012-1915-6; Den Herder G, 2010, TRENDS PLANT SCI, V15, P600, DOI 10.1016/j.tplants.2010.08.009; FU YX, 1993, GENETICS, V133, P693; FULTON TM, 1995, PLANT MOL BIOL REP, V13, P207, DOI 10.1007/BF02670897; Garcia-Arenal F, 2003, INT MICROBIOL, V6, P225, DOI 10.1007/s10123-003-0142-z; Hammer GL, 2009, CROP SCI, V49, P299, DOI 10.2135/cropsci2008.03.0152; Hochholdinger F, 2004, ANN BOT-LONDON, V93, P359, DOI 10.1093/aob/mch056; Hochholdinger F, 2008, PLANT J, V54, P888, DOI 10.1111/j.1365-313X.2008.03459.x; Hochholdinger F, 2009, CURR OPIN PLANT BIOL, V12, P172, DOI 10.1016/j.pbi.2008.12.002; HUDSON RR, 1985, GENETICS, V111, P147; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lestari P, 2011, J HERED, V102, P735, DOI 10.1093/jhered/esr094; Li L, 2011, GENETICA, V139, P479, DOI 10.1007/s10709-011-9568-y; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Longin CFH, 2007, THEOR APPL GENET, V114, P393, DOI 10.1007/s00122-006-0422-z; Lu H, 2002, THEOR APPL GENET, V104, P119, DOI 10.1007/s001220200014; Majer C, 2012, PHILOS T R SOC B, V367, P1542, DOI 10.1098/rstb.2011.0238; Nuwaysir EF, 2002, GENOME RES, V12, P1749, DOI 10.1101/gr.362402; Reif JC, 2003, CROP SCI, V43, P1275, DOI 10.2135/cropsci2003.1275; Rozas J, 2009, METHODS MOL BIOL, V537, P337, DOI 10.1007/978-1-59745-251-9_17; Smith S, 2012, PHILOS T R SOC B, V367, P1441, DOI 10.1098/rstb.2011.0234; TAJIMA F, 1989, GENETICS, V123, P585; Taramino G, 2007, PLANT J, V50, P649, DOI 10.1111/j.1365-313X.2007.03075.x; Wen TJ, 2005, PLANT PHYSIOL, V138, P1637, DOI 10.1104/pp.105.062174; Yu Y, 2007, MAYDICA, V52, P181; Zhang JJ, 2012, BIOCHEM GENET, V50, P508, DOI 10.1007/s10528-012-9495-3	29	10	12	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e56495	10.1371/journal.pone.0056495	http://dx.doi.org/10.1371/journal.pone.0056495			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437145	Green Published, gold, Green Submitted			2022-12-25	WOS:000315184200084
J	Munoz, M; Camargo, M; Soto-De Leon, SC; Sanchez, R; Parra, D; Pineda, AC; Sussmann, O; Perez-Prados, A; Patarroyo, ME; Patarroyo, MA				Munoz, Marina; Camargo, Milena; Soto-De Leon, Sara C.; Sanchez, Ricardo; Parra, Diana; Pineda, Andrea C.; Sussmann, Otto; Perez-Prados, Antonio; Patarroyo, Manuel E.; Patarroyo, Manuel A.			Human Papillomavirus Detection from Human Immunodeficiency Virus-Infected Colombian Women's Paired Urine and Cervical Samples	PLOS ONE			English	Article							POSITIVE WOMEN; HPV INFECTION; DNA DETECTION; PRIMER SETS; PCR; CANCER; HIV; MY09/11; AMPLIFICATION; COINFECTION	Infection, coinfection and type-specific human papillomavirus (HPV) distribution was evaluated in human immunodeficiency virus (HIV)-positive women from paired cervical and urine samples. Paired cervical and urine samples (n = 204) were taken from HIV-positive women for identifying HPV-DNA presence by using polymerase chain reaction (PCR) with three generic primer sets (GP5+/6+, MY09/11 and pU1M/2R). HPV-positive samples were typed for six high-risk HPV (HR-HPV) (HPV-16, -18, -31, -33, -45 and -58) and two low-risk (LR-HPV) (HPV-6/11) types. Agreement between paired sample results and diagnostic performance was evaluated. HPV infection prevalence was 70.6% in cervical and 63.2% in urine samples. HPV-16 was the most prevalent HPV type in both types of sample (66.7% in cervical samples and 62.0% in urine) followed by HPV-31(47.2%) in cervical samples and HPV-58 (35.7%) in urine samples. There was 55.4% coinfection (infection by more than one type of HPV) in cervical samples and 40.2% in urine samples. Abnormal Papanicolau smears were observed in 25.3% of the women, presenting significant association with HPV-DNA being identified in urine samples. There was poor agreement of cervical and urine sample results in generic and type-specific detection of HPV. Urine samples provided the best diagnosis when taking cytological findings as reference. In conclusion including urine samples could be a good strategy for ensuring adherence to screening programs aimed at reducing the impact of cervical cancer, since this sample is easy to obtain and showed good diagnostic performance.	[Munoz, Marina; Camargo, Milena; Soto-De Leon, Sara C.; Sanchez, Ricardo; Patarroyo, Manuel E.; Patarroyo, Manuel A.] Fdn Inst Inmunol Colombia FIDIC, Bogota, Colombia; [Munoz, Marina; Camargo, Milena; Soto-De Leon, Sara C.; Pineda, Andrea C.; Patarroyo, Manuel A.] Univ Nacl Rosario, Sch Med & Hlth Sci, Bogota, Colombia; [Munoz, Marina; Sanchez, Ricardo; Patarroyo, Manuel E.] Univ Nacl Colombia, Bogota, Colombia; [Parra, Diana; Sussmann, Otto] Asistencia Cient Alta Complejidad SAS, Bogota, Colombia; [Perez-Prados, Antonio] Univ Publ Navarra, Pamplona, Spain	Universidad Nacional de Colombia; Universidad Publica de Navarra	Patarroyo, MA (corresponding author), Fdn Inst Inmunol Colombia FIDIC, Bogota, Colombia.	mapatarr.fidic@gmail.com	Leon, Sara Cecilia Soto-De/ABD-3186-2020; Pineda-Peña, Andrea-Clemencia/N-9809-2015; Patarroyo, Manuel A/I-8046-2016; De León, Sara Cecilia Soto/AAF-6301-2021; Murillo, Manuel Elkin M.E Patarroyo/S-1422-2017; Sanchez, Ricardo/K-8254-2015	Pineda-Peña, Andrea-Clemencia/0000-0003-1937-0506; Patarroyo, Manuel A/0000-0002-4751-2500; De León, Sara Cecilia Soto/0000-0003-4515-6749; Murillo, Manuel Elkin M.E Patarroyo/0000-0002-1119-6040; Camargo, Milena/0000-0003-0246-0716; Perez Prados, Antonio/0000-0002-6496-4242; Sanchez, Ricardo/0000-0002-7540-4734	Basque Cooperation Agency Development; Spanish Agency for International Development Cooperation (AECID)	Basque Cooperation Agency Development; Spanish Agency for International Development Cooperation (AECID)	This project was funded by the Basque Cooperation Agency Development and by the Spanish Agency for International Development Cooperation (AECID). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], GLOBAL HIV AIDS RESP; Brinkman JA, 2002, J CLIN MICROBIOL, V40, P3155, DOI 10.1128/JCM.40.9.3155-3161.2002; Camargo M, 2011, J VIROL METHODS, V178, P68, DOI 10.1016/j.jviromet.2011.08.014; Camargo M, 2011, ANN EPIDEMIOL, V21, P204, DOI 10.1016/j.annepidem.2010.11.003; Castellsague X, 2002, VIRUS RES, V89, P191, DOI 10.1016/S0168-1702(02)00188-0; Castle PE, 2007, SEX TRANSM DIS, V34, P849, DOI 10.1097/OLQ.0b013e318064c8c5; Cervantes Jorge, 2003, Rev. Inst. Med. trop. S. Paulo, V45, P131, DOI 10.1590/S0036-46652003000300003; Chirenje ZM, 2005, BEST PRACT RES CL OB, V19, P269, DOI 10.1016/j.bpobgyn.2004.10.002; Clarke B, 2002, J CLIN PATHOL-MOL PA, V55, P19, DOI 10.1136/mp.55.1.19; Cuschieri K, 2011, J MED VIROL, V83, P1983, DOI 10.1002/jmv.22183; D'Hauwers K, 2007, ASIAN J ANDROL, V9, P705, DOI 10.1111/j.1745-7262.2007.00287.x; de Sanjose S, 2002, VIRUS RES, V89, P201, DOI 10.1016/S0168-1702(02)00189-2; Del Mistro A, 2001, EUR J CANCER, V37, P1227, DOI 10.1016/S0959-8049(01)00107-1; Denny L, 2012, BEST PRACT RES CL OB, V26, P189, DOI 10.1016/j.bpobgyn.2011.08.001; Depuydt CE, 2007, J CELL MOL MED, V11, P881, DOI 10.1111/j.1582-4934.2007.00073.x; Feller L, 2007, SADJ, V62, P432; Ferenczy A, 2003, CAN MED ASSOC J, V169, P431; FUJINAGA Y, 1991, J GEN VIROL, V72, P1039, DOI 10.1099/0022-1317-72-5-1039; Gillison Maura L, 2003, J Natl Cancer Inst Monogr, P57; Heard I, 2009, CURR OPIN HIV AIDS, V4, P68, DOI 10.1097/COH.0b013e328319bcbe; HUSMAN AMDR, 1995, J GEN VIROL, V76, P1057; Iftner Thomas, 2003, J Natl Cancer Inst Monogr, P80; Jong EE, 2008, J CLIN VIROL, V41, P111, DOI 10.1016/j.jcv.2007.10.007; Karlsen F, 1996, J CLIN MICROBIOL, V34, P2095, DOI 10.1128/JCM.34.9.2095-2100.1996; Lee Yuan-Ming, 2001, Journal of Microbiology Immunology and Infection, V34, P87; Moscicki AB, 2005, J ADOLESCENT HEALTH, V37, pS3, DOI 10.1016/j.jadohealth.2005.09.011; Moscicki AB, 2006, VACCINE, V24, P42, DOI 10.1016/j.vaccine.2006.06.018; Munoz M, 2012, J VIROL METHODS, V185, P32, DOI 10.1016/j.jviromet.2012.05.023; OLMOS M, 2007, RECOMENDACIONES TAMI, P64; Posso HJ, 2005, ACCIONES PLAN OBLIGA, P190; Remmerbach TW, 2004, J CLIN VIROL, V30, P302, DOI 10.1016/j.jcv.2003.12.011; SAIKI RK, 1985, SCIENCE, V230, P1350, DOI 10.1126/science.2999980; Schiffman M, 2007, LANCET, V370, P890, DOI 10.1016/S0140-6736(13)60022-7; Schmitt M, 2008, J CLIN MICROBIOL, V46, P1050, DOI 10.1128/JCM.02227-07; Sehgal A, 2009, J OBSTET GYNAECOL, V29, P583, DOI 10.1080/01443610903061736; Sellors JW, 2000, CAN MED ASSOC J, V163, P513; Song ES, 2007, J KOREAN MED SCI, V22, P99, DOI 10.3346/jkms.2007.22.1.99; Sotlar K, 2004, J CLIN MICROBIOL, V42, P3176, DOI 10.1128/JCM.42.7.3176-3184.2004; Szostek S, 2006, ACTA BIOCHIM POL, V53, P603; Vorsters A, 2012, EUR J CLIN MICROBIOL, V31, P627, DOI 10.1007/s10096-011-1358-z; WHO/ICO, 2010, HUM PAP REL CANC COL	41	10	10	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e56509	10.1371/journal.pone.0056509	http://dx.doi.org/10.1371/journal.pone.0056509			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418581	Green Published, gold, Green Accepted			2022-12-25	WOS:000315970300174
J	Harris, IS; Blaser, H; Moreno, J; Treloar, AE; Gorrini, C; Sasaki, M; Mason, JM; Knobbe, CB; Rufini, A; Halle, M; Elia, AJ; Wakeham, A; Tremblay, ML; Melino, G; Done, S; Mak, TW				Harris, I. S.; Blaser, H.; Moreno, J.; Treloar, A. E.; Gorrini, C.; Sasaki, M.; Mason, J. M.; Knobbe, C. B.; Rufini, A.; Halle, M.; Elia, A. J.; Wakeham, A.; Tremblay, M. L.; Melino, G.; Done, S.; Mak, T. W.			PTPN12 promotes resistance to oxidative stress and supports tumorigenesis by regulating FOXO signaling	ONCOGENE			English	Article						oxidative stress; reactive oxygen species; antioxidant; protein tyrosine phosphatase; breast cancer	3-PHOSPHOINOSITIDE-DEPENDENT PROTEIN KINASE-1; BREAST-CANCER; TRANSCRIPTION FACTORS; REDOX REGULATION; APOPTOSIS; CELLS; PHOSPHORYLATION; METABOLISM; PEST; SGK	It is well known that protein tyrosine phosphatases (PTPs) that become oxidized due to exposure to reactive oxygen species (ROS) undergo a conformational change and are inactivated. However, whether PTPs can actively regulate ROS levels in order to prevent PTP inhibition has yet to be investigated. Here, we demonstrate that PTP non-receptor type 12 (PTPN12) protects cells against aberrant ROS accumulation and death induced by oxidative stress. Murine embryonic fibroblasts (MEFs) deficient in PTPN12 underwent increased ROS-induced apoptosis under conditions of antioxidant depletion. Cells lacking PTPN12 also showed defective activation of FOXO1/3a, transcription factors required for the upregulation of several antioxidant genes. PTPN12-mediated regulation of ROS appeared to be mediated by phosphoinositide-dependent kinase-1 (PDK1), which was hyperstimulated in the absence of PTPN12. As tight regulation of ROS to sustain survival is a key feature of cancer cells, we examined PTPN12 levels in tumors from a cohort of breast cancer patients. Patients whose tumors showed high levels of PTPN12 transcripts had a significantly poorer prognosis. Analysis of tissues from patients with various breast cancer subtypes revealed that more triple-negative breast cancers, the most aggressive breast cancer subtype, showed high PTPN12 expression than any other subtype. Furthermore, both human breast cancer cells and mouse mammary epithelial tumor cells engineered to lack PTPN12 exhibited reduced tumorigenic and metastatic potential in vivo that correlated with their elevated ROS levels. The involvement of PTPN12 in the antioxidant response of breast cancer cells suggests that PTPN12 may represent a novel therapeutic target for this disease.	[Harris, I. S.; Blaser, H.; Moreno, J.; Treloar, A. E.; Gorrini, C.; Sasaki, M.; Mason, J. M.; Knobbe, C. B.; Elia, A. J.; Wakeham, A.; Done, S.; Mak, T. W.] Univ Hlth Network, Princess Margaret Hosp, Campbell Family Inst Breast Canc Res, Toronto, ON M5G 2C1, Canada; [Harris, I. S.; Done, S.; Mak, T. W.] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada; [Moreno, J.; Done, S.] Univ Hlth Network, Lab Med Program, Toronto, ON M5G 2C1, Canada; [Moreno, J.; Done, S.] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada; [Knobbe, C. B.] Univ Dusseldorf, Dept Neuropathol, Dusseldorf, Germany; [Rufini, A.; Melino, G.] Univ Leicester, MRC Toxicol Unit, Lab Apoptosis Canc, Leicester, Leics, England; [Halle, M.; Tremblay, M. L.] McGill Univ, Rosalind & Morris Goodman Canc Ctr, Dept Biochem, Montreal, PQ, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; Heinrich Heine University Dusseldorf; University of Leicester; McGill University	Mak, TW (corresponding author), Univ Hlth Network, Princess Margaret Hosp, Campbell Family Inst Breast Canc Res, 620 Univ Ave,Suite 706, Toronto, ON M5G 2C1, Canada.	tmak@uhnres.utoronto.ca	Knobbe-Thomsen, Christiane/J-4963-2014; Knobbe-Thomsen, Christiane B/D-3116-2019	Knobbe-Thomsen, Christiane/0000-0003-1231-0076; Gorrini, Chiara/0000-0002-5239-6671; Done, Susan/0000-0002-1770-988X; Harris, Isaac/0000-0002-6855-2763	Natural Sciences and Engineering Council of Canada; Canadian Institutes of Health Research [179815]; Medical Research Council [MC_U132670600] Funding Source: researchfish; MRC [MC_U132670600] Funding Source: UKRI	Natural Sciences and Engineering Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank Dr Anne Brustle and Dr Dirk Brenner for helpful discussions, Dr Han You and Dr Walbert Bakker for reagents and Dr Mary Saunders for insightful scientific editing. This work was supported by a PGS-D grant from the Natural Sciences and Engineering Council of Canada (ISH) and grant no. 179815 from the Canadian Institutes of Health Research (TWM).	Allred DC, 1998, MODERN PATHOL, V11, P155; Arpaia E, 2012, ONCOGENE, V31, P884, DOI 10.1038/onc.2011.288; Bailey HH, 1997, J NATL CANCER I, V89, P1789, DOI 10.1093/jnci/89.23.1789; Bakker WJ, 2007, MOL CELL, V28, P941, DOI 10.1016/j.molcel.2007.10.035; Barr AJ, 2009, CELL, V136, P352, DOI 10.1016/j.cell.2008.11.038; Brunet A, 2001, MOL CELL BIOL, V21, P952, DOI 10.1128/MCB.21.3.952-965.2001; Cairns RA, 2011, NAT REV CANCER, V11, P85, DOI 10.1038/nrc2981; Casamayor A, 1999, BIOCHEM J, V342, P287, DOI 10.1042/0264-6021:3420287; Cheang MCU, 2008, CLIN CANCER RES, V14, P1368, DOI 10.1158/1078-0432.CCR-07-1658; Cheng ZY, 2009, NAT MED, V15, P1307, DOI 10.1038/nm.2049; Chin K, 2006, CANCER CELL, V10, P529, DOI 10.1016/j.ccr.2006.10.009; Cote JF, 1998, BIOCHEMISTRY-US, V37, P13128, DOI 10.1021/bi981259l; DeBerardinis RJ, 2010, ONCOGENE, V29, P313, DOI 10.1038/onc.2009.358; Essafi A, 2005, ONCOGENE, V24, P2317, DOI 10.1038/sj.onc.1208421; FORTELEONI G, 1988, TUMORI, V74, P665, DOI 10.1177/030089168807400608; Greer EL, 2005, ONCOGENE, V24, P7410, DOI 10.1038/sj.onc.1209086; Hoadley KA, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-258; Ishimoto T, 2011, CANCER CELL, V19, P387, DOI 10.1016/j.ccr.2011.01.038; Karisch R, 2011, CELL, V146, P826, DOI 10.1016/j.cell.2011.07.020; MEISTER A, 1983, SCIENCE, V220, P472, DOI 10.1126/science.6836290; Myatt SS, 2011, ANTIOXID REDOX SIGN, V14, P675, DOI 10.1089/ars.2010.3383; Nemoto S, 2002, SCIENCE, V295, P2450, DOI 10.1126/science.1069004; Nogueira V, 2008, CANCER CELL, V14, P458, DOI 10.1016/j.ccr.2008.11.003; Park J, 1999, EMBO J, V18, P3024, DOI 10.1093/emboj/18.11.3024; Rogoff D, 2010, REDOX REP, V15, P64, DOI 10.1179/174329210X12650506623249; Schafer ZT, 2009, NATURE, V461, P109, DOI 10.1038/nature08268; Storz P, 2011, ANTIOXID REDOX SIGN, V14, P593, DOI 10.1089/ars.2010.3405; Streit S, 2006, CANCER GENET CYTOGEN, V170, P48, DOI 10.1016/j.cancergencyto.2006.05.013; Sun TT, 2011, CELL, V144, P703, DOI 10.1016/j.cell.2011.02.003; Vaughn AE, 2008, NAT CELL BIOL, V10, P1477, DOI 10.1038/ncb1807; Wiseman H, 1996, BIOCHEM J, V313, P17, DOI 10.1042/bj3130017; Xu D, 2002, DEV CELL, V2, P251, DOI 10.1016/S1534-5807(02)00132-6; Yang KJ, 2008, J BIOL CHEM, V283, P1480, DOI 10.1074/jbc.M706361200; Yerushalmi R, 2012, BREAST CANCER RES TR, V132, P131, DOI 10.1007/s10549-011-1529-8	34	28	29	0	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 20	2014	33	8					1047	1054		10.1038/onc.2013.24	http://dx.doi.org/10.1038/onc.2013.24			8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AB6XO	23435421				2022-12-25	WOS:000331933200012
J	Stutzer, I; Selevsek, N; Esterhazy, D; Schmidt, A; Aebersold, R; Stoffel, M				Stuetzer, Ina; Selevsek, Nathalie; Esterhazy, Daria; Schmidt, Alexander; Aebersold, Ruedi; Stoffel, Markus			Systematic Proteomic Analysis Identifies beta-Site Amyloid Precursor Protein Cleaving Enzyme 2 and 1 (BACE2 and BACE1) Substrates in Pancreatic beta-Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ABSOLUTE QUANTIFICATION; STATISTICAL-MODEL; IGF-II; INSULIN; GLUCOSE; EXPRESSION; SECRETASE; MEMBRANE; EXOCYTOSIS; RECEPTORS	Expansion of functional islet beta-cell mass is a physiological process to compensate for increased insulin demand. Deficiency or pharmacological inhibition of the plasma membrane protease BACE2 enhances pancreatic beta-cell function and proliferation, and therefore BACE2 is a putative target for the therapeutic intervention under conditions of beta-cell loss and dysfunction. To gain a molecular understanding of BACE2 function, we performed a systematic and quantitative proteomic analysis to map the natural substrate repertoire of BACE2 and its homologue BACE1 in beta-cells. Loss-and gain-of-function studies of in vitro and in vivo models identified specific and functionally heterogeneous targets. Our analysis revealed non-redundant roles of BACE1/2 in ectodomain shedding with BACE1 regulating a broader and BACE2 a more distinct set of beta-cell-enriched substrates including two proteins of the seizure 6 protein family (SEZ6L and SEZ6L2). Lastly, our study provides insights into the global beta-cell sheddome and secretome, an important prerequisite to uncover novel mechanisms contributing to beta-cell homeostasis and a resource for therapeutic target and biomarker discoveries.	[Stuetzer, Ina; Selevsek, Nathalie; Esterhazy, Daria; Aebersold, Ruedi; Stoffel, Markus] ETH, Dept Biol, Inst Mol Hlth Sci, CH-8093 Zurich, Switzerland; [Stuetzer, Ina; Selevsek, Nathalie; Esterhazy, Daria; Aebersold, Ruedi; Stoffel, Markus] ETH, Inst Mol Syst Biol, CH-8093 Zurich, Switzerland; [Stuetzer, Ina; Esterhazy, Daria; Aebersold, Ruedi; Stoffel, Markus] ETH, Competence Ctr Syst Physiol & Metab Dis, CH-8093 Zurich, Switzerland; [Schmidt, Alexander] Univ Basel, Prote Core Facil, Biozentrum, CH-4056 Basel, Switzerland; [Aebersold, Ruedi] Univ Zurich, Fac Sci, CH-8057 Zurich, Switzerland; [Stoffel, Markus] Univ Zurich, Fac Med, CH-8057 Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Basel; University of Zurich; University of Geneva; University of Zurich	Stoffel, M (corresponding author), ETH, Inst Mol Hlth Sci, HPL H36,Schafmattstr 22, CH-8093 Zurich, Switzerland.	stoffel@biol.ethz.ch		Stoffel, Markus/0000-0003-1304-5817	Juvenile Diabetes Research Foundation; EU [CEED3]	Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); EU(European Commission)	This work was funded in part by a grant from the Juvenile Diabetes Research Foundation and EU Grant CEED3.	Akpinar P, 2005, CELL METAB, V2, P385, DOI 10.1016/j.cmet.2005.11.001; Arribas J, 2003, CURR TOP DEV BIOL, V54, P125, DOI 10.1016/S0070-2153(03)54007-8; Beraud-Dufour S, 2010, INT J BIOCHEM CELL B, V42, P1681, DOI 10.1016/j.biocel.2010.06.018; Blanton D, 2011, DIABETES, V60, P2566, DOI 10.2337/db11-0576; Bouwens L, 2005, PHYSIOL REV, V85, P1255, DOI 10.1152/physrev.00025.2004; Braun M, 2008, DIABETES, V57, P1618, DOI 10.2337/db07-0991; Brown J, 2009, VITAM HORM, V80, P699, DOI 10.1016/S0083-6729(08)00625-0; Buteau J, 2003, DIABETES, V52, P124, DOI 10.2337/diabetes.52.1.124; Butler GS, 2007, CURR PHARM DESIGN, V13, P263, DOI 10.2174/138161207779313524; Butler GS, 2009, NAT REV DRUG DISCOV, V8, P935, DOI 10.1038/nrd2945; Chang CY, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.014662; Danzer C, 2012, J PROTEOME RES, V11, P1598, DOI 10.1021/pr2007895; DOLAISKITABGI J, 1979, ENDOCRINOLOGY, V105, P256, DOI 10.1210/endo-105-1-256; Dowling P, 2011, PROTEOMICS, V11, P794, DOI 10.1002/pmic.201000530; Dowling P, 2008, ELECTROPHORESIS, V29, P4141, DOI 10.1002/elps.200800152; Eberhard D, 2009, CURR OPIN GENET DEV, V19, P469, DOI 10.1016/j.gde.2009.07.003; Esterhazy D, 2011, CELL METAB, V14, P365, DOI 10.1016/j.cmet.2011.06.018; Figueroa DJ, 2001, J ALZHEIMERS DIS, V3, P393, DOI 10.3233/JAD-2001-3405; Fukumoto H, 2002, ARCH NEUROL-CHICAGO, V59, P1381, DOI 10.1001/archneur.59.9.1381; Ghosh P, 2003, NAT REV MOL CELL BIO, V4, P202, DOI 10.1038/nrm1050; Gunnersen JM, 2007, NEURON, V56, P621, DOI 10.1016/j.neuron.2007.09.018; Hald J, 2012, DIABETOLOGIA, V55, P154, DOI 10.1007/s00125-011-2295-1; Hemming ML, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008477; Hill DJ, 1998, DIABETES CARE, V21, pB60; Holsinger RMD, 2002, ANN NEUROL, V51, P783, DOI 10.1002/ana.10208; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Hussain I, 2001, J BIOL CHEM, V276, P23322, DOI 10.1074/jbc.M101069200; In't Veld P, 2010, ADV EXP MED BIOL, V654, P1, DOI 10.1007/978-90-481-3271-3_1; KAHN SE, 1990, DIABETES, V39, P634, DOI 10.2337/diabetes.39.5.634; Kahn SE, 2006, NATURE, V444, P840, DOI 10.1038/nature05482; Kall L, 2004, J MOL BIOL, V338, P1027, DOI 10.1016/j.jmb.2004.03.016; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Kuhn PH, 2012, EMBO J, V31, P3157, DOI 10.1038/emboj.2012.173; Lichtenthaler SF, 2007, EMBO REP, V8, P537, DOI 10.1038/sj.embor.7400978; MacLean B, 2010, BIOINFORMATICS, V26, P966, DOI 10.1093/bioinformatics/btq054; Makridakis M, 2010, J PROTEOMICS, V73, P2291, DOI 10.1016/j.jprot.2010.07.001; MIYAZAKI JI, 1990, ENDOCRINOLOGY, V127, P126, DOI 10.1210/endo-127-1-126; Mueller LN, 2007, PROTEOMICS, V7, P3470, DOI 10.1002/pmic.200700057; Mziaut H, 2006, NAT CELL BIOL, V8, P435, DOI 10.1038/ncb1395; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; Overall CM, 2007, NAT REV MOL CELL BIO, V8, P245, DOI 10.1038/nrm2120; Picotti P, 2010, NAT METHODS, V7, P43, DOI [10.1038/NMETH.1408, 10.1038/nmeth.1408]; Prentki M, 2006, J CLIN INVEST, V116, P1802, DOI 10.1172/JCI29103; Rawson RB, 1997, MOL CELL, V1, P47, DOI 10.1016/S1097-2765(00)80006-4; Schiess R, 2009, MOL CELL PROTEOMICS, V8, P624, DOI 10.1074/mcp.M800172-MCP200; Schmidt A, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.37; Schroeter EH, 1998, NATURE, V393, P382, DOI 10.1038/30756; Selevsek N, 2011, PROTEOMICS, V11, P1135, DOI 10.1002/pmic.201000599; Silva JC, 2006, MOL CELL PROTEOMICS, V5, P144, DOI 10.1074/mcp.M500230-MCP200; Stutzer I, 2012, DIABETOLOGIA, V55, P1877, DOI 10.1007/s00125-012-2531-3; Thomas PD, 2003, NUCLEIC ACIDS RES, V31, P334, DOI 10.1093/nar/gkg115; Torii S, 2009, DIABETES, V58, P682, DOI 10.2337/db08-0970; Trajkovski M, 2004, J CELL BIOL, V167, P1063, DOI 10.1083/jcb.200408172; Whim MD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019478; Willnow TE, 2008, NAT REV NEUROSCI, V9, P899, DOI 10.1038/nrn2516; YATES JR, 1995, ANAL CHEM, V67, P1426, DOI 10.1021/ac00104a020; Zaina S, 1998, J BIOL CHEM, V273, P28610, DOI 10.1074/jbc.273.44.28610; Zhang QM, 1997, P NATL ACAD SCI USA, V94, P6232, DOI 10.1073/pnas.94.12.6232; Zhou LJ, 2012, J BIOL CHEM, V287, P25927, DOI 10.1074/jbc.M112.377465	59	63	68	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 12	2013	288	15					10536	10547		10.1074/jbc.M112.444703	http://dx.doi.org/10.1074/jbc.M112.444703			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	125TU	23430253	Green Published, hybrid			2022-12-25	WOS:000317565000033
J	Archer, E; Shook, RP; Thomas, DM; Church, TS; Katzmarzyk, PT; Hebert, JR; McIver, KL; Hand, GA; Lavie, CJ; Blair, SN				Archer, Edward; Shook, Robin P.; Thomas, Diana M.; Church, Timothy S.; Katzmarzyk, Peter T.; Hebert, James R.; McIver, Kerry L.; Hand, Gregory A.; Lavie, Carl J.; Blair, Steven N.			45-Year Trends in Women's Use of Time and Household Management Energy Expenditure	PLOS ONE			English	Article							NATIONAL NUTRITION SURVEY; PHYSICAL-ACTIVITY; BODY-WEIGHT; SEDENTARY BEHAVIOR; OBESITY; DISEASE; LIFE; INACTIVITY; WALKING; ADULTS	Context: Relationships between socio-environmental factors and obesity are poorly understood due to a dearth of longitudinal population-level research. The objective of this analysis was to examine 45-year trends in time-use, household management (HM) and energy expenditure in women. Design and Participants: Using national time-use data from women 19-64 years of age, we quantified time allocation and household management energy expenditure (HMEE) from 1965 to 2010. HM was defined as the sum of time spent in food preparation, post-meal cleaning activities (e.g., dish-washing), clothing maintenance (e.g., laundry), and general housework. HMEE was calculated using body weights from national surveys and metabolic equivalents. Results: The time allocated to HM by women (19-64 yrs) decreased from 25.7 hr/week in 1965 to 13.3 hr/week in 2010 (P<0.001), with non-employed women decreasing by 16.6 hr/week and employed women by 6.7 hr/week (P<0.001). HMEE for non-employed women decreased 42% from 25.1 Mj/week (6004 kilocalories per week) in 1965 to 14.6 Mj/week (3486 kcal/week) in 2010, a decrement of 10.5 Mj/week or 1.5 Mj/day (2518 kcal/week; 360 kcal/day) (P<0.001), whereas employed women demonstrated a 30% decrement of 3.9 Mj/week, 0.55 Mj/day (923 kcal/week, 132 kcal/day) (P<0.001). The time women spent in screen-based media use increased from 8.3 hr/week in 1965 to 16.5 hr/week in 2010 (P<0.001), with non-employed women increasing 9.6 hr/week and employed women 7.5 hr/week (P<0.001). Conclusions: From 1965 to 2010, there was a large and significant decrease in the time allocated to HM. By 2010, women allocated 25% more time to screen-based media use than HM (i.e., cooking, cleaning, and laundry combined). The reallocation of time from active pursuits (i.e., housework) to sedentary pastimes (e.g., watching TV) has important health consequences. These results suggest that the decrement in HMEE may have contributed to the increasing prevalence of obesity in women during the last five decades.	[Archer, Edward; Shook, Robin P.; McIver, Kerry L.; Hand, Gregory A.; Blair, Steven N.] Univ S Carolina, Dept Exercise Sci, Arnold Sch Publ Hlth, Columbia, SC 29208 USA; [Thomas, Diana M.] Montclair State Univ, Ctr Quantitat Obes Res, Montclair, NJ USA; [Church, Timothy S.; Katzmarzyk, Peter T.] Pennington Biomed Res Ctr, Baton Rouge, LA USA; [Hebert, James R.; Blair, Steven N.] Univ S Carolina, Dept Epidemiol & Biostat, Columbia, SC 29208 USA; [Hebert, James R.] Univ S Carolina, Canc Prevent & Control Program, Columbia, SC 29208 USA; [Lavie, Carl J.] Univ Queensland, Ochsner Heart & Vasc Inst, Sch Med, New Orleans, LA USA	University of South Carolina; University of South Carolina System; University of South Carolina Columbia; Montclair State University; Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center; University of South Carolina; University of South Carolina System; University of South Carolina Columbia; University of South Carolina; University of South Carolina System; University of South Carolina Columbia; Ochsner Health System; University of Queensland	Archer, E (corresponding author), Univ S Carolina, Dept Exercise Sci, Arnold Sch Publ Hlth, Columbia, SC 29208 USA.	archer.edwardc@gmail.com	Katzmarzyk, Peter T/N-1974-2017; Lavie, Carl J/A-6014-2011; Archer, Edward/J-9567-2017	Katzmarzyk, Peter T/0000-0002-9280-6022; Archer, Edward/0000-0002-9339-6918	Coca-Cola Company; Sanofi Aventis; Orexigen; Arena; Amylin; Body-Media	Coca-Cola Company; Sanofi Aventis(Sanofi-Aventis); Orexigen; Arena(Australian Renewable Energy Agency (ARENA)); Amylin; Body-Media	This study was funded via an unrestricted research grant from The Coca-Cola Company. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; GAH has received consultancy fees from The Coca-Cola Company. TSC receives honoraria for lectures from scientific, educational, and lay groups. TSC has a book entitled "Move Yourself: The Cooper Clinic Medical Director''s Guide to All the Healing Benefits of Exercise." TSC has received unrestricted research funding Cover Letter from The Coca-Cola Company. TSC has overseen study sites for large pharmaceutical trials funded by Sanofi Aventis, Orexigen, Arena and Amylin. TSC is a member of the Jenny Craig Medical Advisory Board and has served as a consultant to Technogym, Trestle Tree, Vivus, Lockton-Dunning and Neuliven Health. In addition, he serves as the Senior Medical Advisor for Catapult Health. DMT has received honoraria for service on the Scientific/Medical Advisory Boards for Jenny Craig. SNB receives book royalties (<$5,000/year) from Human Kinetics; honoraria for service on the Scientific/Medical Advisory Boards for Clarity, Technogym, Body Media, Santech, and Jenny Craig; and honoraria for lectures and consultations from scientific, educational, and lay groups which are donated to the University of South Carolina or not-for-profit organizations. SNB is a consultant on research projects with the University of Texas-Southwestern Medical School and the University of Miami. During the past 5-year period SNB has received research grants from The Coca-Cola Company and Body-Media. There are no patents, products in development or marketed products to declare. This does not alter the authors'' adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.	Adamo KB, 2012, INT J ENV RES PUB HE, V9, P1263, DOI 10.3390/ijerph9041263; Ainsworth BE, 2011, MED SCI SPORT EXER, V43, P1575, DOI 10.1249/MSS.0b013e31821ece12; [Anonymous], 1985, World Health Organ Tech Rep Ser, V724, P1; [Anonymous], 2009, NUTR REV, V67, P114, DOI 10.1111/j.1753-4887.2008.00136.x; Archer E, 2012, RES EXERC EPIDEMIOL, V14, P1; Archer E, 2011, PROG CARDIOVASC DIS, V53, P387, DOI 10.1016/j.pcad.2011.02.006; Beaglehole R, 2011, LANCET, V377, P1438, DOI 10.1016/S0140-6736(11)60393-0; Bianchi SM, 2000, SOC FORCES, V79, P191, DOI 10.2307/2675569; Bianchi SM., 2006, CHANGING RHYTHMS AM; Bianchi SM., 2005, ATUS EARL RES C, P5; Bianchi SM., 2005, WORK FAMILY HLTH WEL; Bianchi SM, 2011, ANN AM ACAD POLIT SS, V638, P21, DOI 10.1177/0002716211413731; BLACK AE, 1993, J AM DIET ASSOC, V93, P572, DOI 10.1016/0002-8223(93)91820-G; Blair SN, 2012, SCAND J MED SCI SPOR, V22, pE24, DOI 10.1111/j.1600-0838.2012.01462.x; Blair SN, 2009, BRIT J SPORT MED, V43, P1; Cecchini M, 2010, LANCET, V376, P1775, DOI 10.1016/S0140-6736(10)61514-0; Church TS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019657; Coltrane S, 2000, J MARRIAGE FAM, V62, P1208, DOI 10.1111/j.1741-3737.2000.01208.x; Costa DL, 1997, HLTH WELFARE DUIRNG; DIAZ EO, 1992, AM J CLIN NUTR, V56, P641, DOI 10.1093/ajcn/56.4.641; Drake Amanda J, 2011, Pediatr Endocrinol Rev, V9, P566; Droyvold WB, 2004, INT J OBESITY, V28, P410, DOI 10.1038/sj.ijo.0802569; Egerton M, 2005, 200528 I SOC EC RES; England Paula, 1986, HOUSEHOLDS EMPLOYMEN; Evenson KR, 2011, PREV MED, V53, P39, DOI 10.1016/j.ypmed.2011.04.014; Evenson KR, 2010, PREV MED, V50, P123, DOI 10.1016/j.ypmed.2009.12.015; FAO/WHO/UNU, 2001, HUM EN REQ REP JOINT; Fisher K, 2011, AM HERITAGE TIME USE; Fitzhugh EC, 2009, J PHYS ACT HEALTH, V6, P393, DOI 10.1123/jpah.6.4.393; Flegal KM, 2010, JAMA-J AM MED ASSOC, V303, P235, DOI 10.1001/jama.2009.2014; Funatogawa I, 2009, INT J EPIDEMIOL, V38, P83, DOI 10.1093/ije/dyn182; Godfrey KM, 2010, TRENDS ENDOCRIN MET, V21, P199, DOI 10.1016/j.tem.2009.12.008; Gunn SM, 2005, EUR J APPL PHYSIOL, V94, P476, DOI 10.1007/s00421-004-1302-3; Guthrie JF, 2002, J NUTR EDUC BEHAV, V34, P140, DOI 10.1016/S1499-4046(06)60083-3; Hall KD, 2012, AM J CLIN NUTR, V95, P989, DOI 10.3945/ajcn.112.036350; Hall KD, 2011, LANCET, V378, P826, DOI 10.1016/S0140-6736(11)60812-X; Hall KD, 2010, AM J PHYSIOL-ENDOC M, V298, pE449, DOI 10.1152/ajpendo.00559.2009; Hammermeister J, 2005, HEALTH COMMUN, V17, P253, DOI 10.1207/s15327027hc1703_3; Katanoda K, 2002, J NUTR SCI VITAMINOL, V48, P423, DOI 10.3177/jnsv.48.423; Keys A, 1950, BIOL HUMAN STARVATIO; Kozey SL, 2010, MED SCI SPORT EXER, V42, P1776, DOI 10.1249/MSS.0b013e3181d479f2; Krantz-Kent R, 2009, MON LABOR REV, V132, P46; Lanningham-Foster L, 2003, OBES RES, V11, P1178, DOI 10.1038/oby.2003.162; Lee IM, 2012, LANCET, V380, P219, DOI 10.1016/S0140-6736(12)61031-9; Matsumura Y, 2001, ASIA PAC J CLIN NUTR, V10, pS40, DOI 10.1046/j.1440-6047.2001.0100s1S40.x; McAllister EJ, 2009, CRIT REV FOOD SCI, V49, P868, DOI 10.1080/10408390903372599; McDonald NC, 2007, AM J PREV MED, V32, P509, DOI 10.1016/j.amepre.2007.02.022; NAS/IOM, 2005, REP PAN MACR DIET RE; Nayga RMJ, 2012, DEMAND FOOD AWAY HOM; [Nielsen Nielsen Media Research Research NM], 2006, AV DAIL VIEW 1950 20; Owen N, 2010, EXERC SPORT SCI REV, V38, P105, DOI 10.1097/JES.0b013e3181e373a2; PASQUET P, 1994, AM J CLIN NUTR, V60, P861, DOI 10.1093/ajcn/60.6.861; Rafferty AP, 2002, MED SCI SPORT EXER, V34, P1255, DOI 10.1097/00005768-200208000-00005; Ratzlaff CR, 2012, BRIT J SPORT MED, V46, P699, DOI 10.1136/bjsports-2011-090800; ROBERTS SB, 1990, AM J PHYSIOL, V259, pR461, DOI 10.1152/ajpregu.1990.259.3.R461; ROBINSON J, 1999, TIME LIFE; Robinson JP, 2009, SOC INDIC RES, V93, P47, DOI 10.1007/s11205-008-9370-0; ROSSITER JR, 1975, SOCIOMETRY, V38, P308, DOI 10.2307/2786167; SCHOELLER DA, 1995, METABOLISM, V44, P18, DOI 10.1016/0026-0495(95)90204-X; Silventoinen K, 2004, INT J OBESITY, V28, P710, DOI 10.1038/sj.ijo.0802614; Sims E A, 1973, Recent Prog Horm Res, V29, P457; Speakman JR, 2002, P NUTR SOC, V61, P473, DOI 10.1079/PNS2002194; Subar AF, 2003, AM J EPIDEMIOL, V158, P1, DOI 10.1093/aje/kwg092; Swinburn B, 2011, PUBLIC HEALTH NUTR, P1; Swinburn B, 2009, AM J CLIN NUTR, V90, P1453, DOI 10.3945/ajcn.2009.28595; Toosi M, 2002, CENTURY LABOR CHANGE; Tudor-Locke C, 2009, J PHYS ACT HEALTH, V6, P347, DOI 10.1123/jpah.6.3.347; Tudor-Locke C, 2007, INT J BEHAV NUTR PHY, V4, DOI 10.1186/1479-5868-4-45; USDA, 2004, NUTR CONT US FOOD SU; van der Ploeg HP, 2010, AM J EPIDEMIOL, V172, P1199, DOI 10.1093/aje/kwq265; Westerterp KR, 2008, INT J OBESITY, V32, P1256, DOI 10.1038/ijo.2008.74; Westerterp KR, 2004, CURR OPIN CLIN NUTR, V7, P607, DOI 10.1097/00075197-200411000-00004; Withers RT, 2006, EUR J APPL PHYSIOL, V97, P494, DOI 10.1007/s00421-006-0177-x; Yoshiike N, 2002, Obes Rev, V3, P183, DOI 10.1046/j.1467-789X.2002.00070.x; Zick CD, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-84	75	106	108	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e56620	10.1371/journal.pone.0056620	http://dx.doi.org/10.1371/journal.pone.0056620			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	093IE	23437187	Green Published, gold, Green Submitted			2022-12-25	WOS:000315184200121
J	Fan, F; Xue, WQ; Wu, BH; He, MG; Xie, HL; Ouyang, WF; Tu, SL; Chen, YM				Fan, Fan; Xue, Wen-Qiong; Wu, Bao-Hua; He, Ming-Guang; Xie, Hai-Li; Ouyang, Wei-Fu; Tu, Su-lan; Chen, Yu-Ming			Higher Fish Intake Is Associated with a Lower Risk of Hip Fractures in Chinese Men and Women: A Matched Case-Control Study	PLOS ONE			English	Article							N-3 FATTY-ACIDS; BONE-MINERAL DENSITY; POSTMENOPAUSAL WOMEN; VITAMIN-D; CALCIUM; OSTEOPOROSIS; CONSUMPTION; HEALTH; IMPACT; OMEGA-3-FATTY-ACIDS	Objectives: Fish is rich in nutrients that are favorable to bone health, but limited data are available regarding the relationship between fish intake and hip fractures. Our study examined the association between habitual fish intake and risk of hip fractures. Methods: A case-control study was performed between June 2009 and June 2012 in Guangdong Province, China. Five hundred and eighty-one hip fracture incident cases, aged 55 to 80 years (mean: 71 years), were enrolled from four hospitals. 1:1 matched controls by gender and age (+/- 3 years) were also recruited from communities and hospitals. Face-to-face interviews were used to obtain habitual dietary intake and information on various covariates. Results: Univariate conditional logistic regression analyses showed significantly dose-dependent inverse correlations between the risk of hip fractures and the intake of fresh-water fish, sea fish, mollusca, shellfish, and total fish in all of the subjects (p-trend: <0.001-0.016). After adjusting for covariates, the associations were slightly attenuated but remained significant for all (p-trend: <0.001-0.017) except for fresh-water fish (p = 0.553). The ORs (95% CI) of hip fractures for the highest (vs. lowest) quartile were 0.80 (0.48-1.31) for fresh-water fish, 0.31 (0.18-0.52) for sea fish, 0.55 (0.34-0.88) for mollusca and shellfish, and 0.47 (0.28-0.79) for total fish, respectively. Stratified and interaction analyses showed that the association was more significant in males than in females (p-interaction = 0.052). Conclusion: Higher intake of seafood is independently associated with lower risk of hip fractures in elderly Chinese. Increasing consumption of sea fish may benefit the prevention of hip fractures in this population.	[Fan, Fan; Xue, Wen-Qiong; Wu, Bao-Hua; Xie, Hai-Li; Ouyang, Wei-Fu; Tu, Su-lan; Chen, Yu-Ming] Sun Yat Sen Univ, Sch Publ Hlth, Guangdong Prov Key Lab Food Nutr & Hlth, Guangzhou 510275, Guangdong, Peoples R China; [Wu, Bao-Hua] Guangzhou Orthopaed Trauma Hosp, Guangzhou, Guangdong, Peoples R China; [He, Ming-Guang] Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, Guangzhou 510275, Guangdong, Peoples R China; [Ouyang, Wei-Fu] Guangdong Gen Hosp, Guangzhou, Guangdong, Peoples R China; [Tu, Su-lan] Orthopaed Hosp Baishi Dist, Jiangmen, Guangdong, Peoples R China; [Xue, Wen-Qiong] Sun Yat Sen Univ, Ctr Canc, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; Guangdong Academy of Medical Sciences & Guangdong General Hospital; Sun Yat Sen University	Chen, YM (corresponding author), Sun Yat Sen Univ, Sch Publ Hlth, Guangdong Prov Key Lab Food Nutr & Hlth, Guangzhou 510275, Guangdong, Peoples R China.	chenyum@mail.sysu.edu.cn	Chen, Yu/Y-3292-2019; He, Mingguang/AAY-5239-2020	He, Mingguang/0000-0002-6912-2810; chen, Yu-ming/0000-0003-1658-5528	National Natural Science Foundation of China [30872100, 81072299]; 5010 Program for Clinical Researches of Sun Yat-sen University [2007032]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 5010 Program for Clinical Researches of Sun Yat-sen University	The study was jointly supported by the National Natural Science Foundation of China (No. 30872100, 81072299) and the 5010 Program for Clinical Researches of Sun Yat-sen University (No. 2007032). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Caughey GE, 1996, AM J CLIN NUTR, V63, P116, DOI 10.1093/ajcn/63.1.116; Chen YM, 2010, OSTEOPOROSIS INT, V21, P939, DOI 10.1007/s00198-009-1029-4; CLAASSEN N, 1995, PROSTAG LEUKOTR ESS, V53, P13, DOI 10.1016/0952-3278(95)90078-0; CLAASSEN N, 1995, BONE, V16, pS385, DOI 10.1016/S8756-3282(95)80481-1; Cumming RG, 1997, J BONE MINER RES, V12, P1321, DOI 10.1359/jbmr.1997.12.9.1321; Dargent-Molina P, 2008, J BONE MINER RES, V23, P1915, DOI 10.1359/JBMR.080712; Farina EK, 2011, AM J CLIN NUTR, V93, P1142, DOI 10.3945/ajcn.110.005926; Ferrucci L, 2006, J CLIN ENDOCR METAB, V91, P439, DOI 10.1210/jc.2005-1303; Feskanich D, 2003, AM J CLIN NUTR, V77, P504, DOI 10.1093/ajcn/77.2.504; Fujiwara S, 1997, J BONE MINER RES, V12, P998, DOI 10.1359/jbmr.1997.12.7.998; Haag M, 2003, PROSTAG LEUKOTR ESS, V68, P423, DOI 10.1016/S0952-3278(03)00067-X; Jin S. G., 2008, 2002 NATL NUTR HL 10, P62; Kerstetter JE, 2011, CURR OPIN LIPIDOL, V22, P16, DOI 10.1097/MOL.0b013e3283419441; Kruger MC, 1997, PROG LIPID RES, V36, P131, DOI 10.1016/S0163-7827(97)00007-6; Leibson CL, 2002, J AM GERIATR SOC, V50, P1644, DOI 10.1046/j.1532-5415.2002.50455.x; Macdonald HM, 2004, AM J CLIN NUTR, V79, P155; MacDonald HM, 2005, PUBLIC HEALTH NUTR, V8, P409, DOI 10.1079/PHN2005705; Maggio M, 2009, CURR PHARM DESIGN, V15, P4157, DOI 10.2174/138161209789909728; Mithal A, 2009, ASIAN AUDIT EPIDEMIO; NEW SA, 2003, NUTR ASPECTS BONE HL; Pongchaiyakul Chatlert, 2008, Journal of the Medical Association of Thailand, V91, P581; Prentice A, 2004, PUBLIC HEALTH NUTR, V7, P227, DOI 10.1079/PHN2003590; REMER T, 1995, J AM DIET ASSOC, V95, P791, DOI 10.1016/S0002-8223(95)00219-7; Salari P, 2008, MED SCI MONITOR, V14, pRA37; Sellmeyer DE, 2001, AM J CLIN NUTR, V73, P118; Sun DX, 2003, J BONE MINER RES, V18, P1206, DOI 10.1359/jbmr.2003.18.7.1206; Suzuki T, 1997, BONE, V21, P461, DOI 10.1016/S8756-3282(97)00179-8; Tang BMP, 2007, LANCET, V370, P657, DOI 10.1016/S0140-6736(07)61342-7; Virtanen JK, 2010, J BONE MINER RES, V25, P1972, DOI 10.1002/jbmr.87; Yang Y., 2002, CHINA FOOD COMPOSITI, V2002nd ed.; Zalloua P, 2007, MATURITAS, V56, P1, DOI 10.1016/j.maturitas.2006.05.001; Zhang CX, 2009, ASIA PAC J CLIN NUTR, V18, P240	32	15	15	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e56849	10.1371/journal.pone.0056849	http://dx.doi.org/10.1371/journal.pone.0056849			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437256	Green Published, gold			2022-12-25	WOS:000315184200172
J	Hall, ML; Kingma, SA; Peters, A				Hall, Michelle L.; Kingma, Sjouke A.; Peters, Anne			Male Songbird Indicates Body Size with Low-Pitched Advertising Songs	PLOS ONE			English	Article							FEMALE MATE CHOICE; MULTIPLE BENEFITS; FAIRY-WRENS; FREQUENCY; BIRD; CALLS; EVOLUTION; CONTEXT; SIGNAL; COMMUNICATION	Body size is a key sexually selected trait in many animal species. If size imposes a physical limit on the production of loud low-frequency sounds, then low-pitched vocalisations could act as reliable signals of body size. However, the central prediction of this hypothesis - that the pitch of vocalisations decreases with size among competing individuals - has limited support in songbirds. One reason could be that only the lowest-frequency components of vocalisations are constrained, and this may go unnoticed when vocal ranges are large. Additionally, the constraint may only be apparent in contexts when individuals are indeed advertising their size. Here we explicitly consider signal diversity and performance limits to demonstrate that body size limits song frequency in an advertising context in a songbird. We show that in purple-crowned fairy-wrens, Malurus coronatus coronatus, larger males sing lower-pitched low-frequency advertising songs. The lower frequency bound of all advertising song types also has a significant negative relationship with body size. However, the average frequency of all their advertising songs is unrelated to body size. This comparison of different approaches to the analysis demonstrates how a negative relationship between body size and song frequency can be obscured by failing to consider signal design and the concept of performance limits. Since these considerations will be important in any complex communication system, our results imply that body size constraints on low-frequency vocalisations could be more widespread than is currently recognised.	[Hall, Michelle L.; Kingma, Sjouke A.; Peters, Anne] Max Planck Inst Ornithol, Radolfzell am Bodensee, Germany; [Hall, Michelle L.] Univ Melbourne, Dept Zool, Melbourne, Vic, Australia; [Kingma, Sjouke A.] Univ E Anglia, Sch Biol Sci, Norwich NR4 7TJ, Norfolk, England; [Peters, Anne] Monash Univ, Sch Biol Sci, Clayton, Vic, Australia	Max Planck Society; University of Melbourne; University of East Anglia; Monash University	Hall, ML (corresponding author), Max Planck Inst Ornithol, Radolfzell am Bodensee, Germany.	hall.m@unimelb.edu.au	Kingma, Sjouke Anne/B-3366-2011; Hall, Michelle L/A-1904-2010; Peters, Anne/A-1821-2010	Kingma, Sjouke Anne/0000-0002-6737-7975; Hall, Michelle L/0000-0002-1263-8314; Peters, Anne/0000-0001-8071-0560	Minerva Fellowship of the Max Planck Society; ARC Future Fellowship [FT110100505]	Minerva Fellowship of the Max Planck Society; ARC Future Fellowship(Australian Research Council)	This research was funded by a Minerva Fellowship of the Max Planck Society and an ARC Future Fellowship (FT110100505 to AP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bee MA, 2000, BEHAV ECOL, V11, P169, DOI 10.1093/beheco/11.2.169; Bradbury Jack W., 1998, pi; BYERS BE, 1995, CONDOR, V97, P390, DOI 10.2307/1369025; Byers BE, 2009, ANIM BEHAV, V77, P13, DOI 10.1016/j.anbehav.2008.10.003; Cardoso GC, 2008, ETHOLOGY, V114, P1084, DOI 10.1111/j.1439-0310.2008.01552.x; Cardoso GC, 2012, BEHAV ECOL, V23, P237, DOI 10.1093/beheco/arr200; Dalziell AH, 2008, ANIM BEHAV, V75, P489, DOI 10.1016/j.anbehav.2007.05.014; Donelson NC, 2005, BEHAVIOUR, V142, P761, DOI 10.1163/1568539054729088; Evans S, 2006, BIOL PSYCHOL, V72, P160, DOI 10.1016/j.biopsycho.2005.09.003; Fitch WT, 2000, ZOOL-ANAL COMPLEX SY, V103, P40; Fletcher NH, 2004, J ACOUST SOC AM, V115, P2334, DOI 10.1121/1.1694997; Galeotti P, 1997, ANIM BEHAV, V53, P687, DOI 10.1006/anbe.1996.0304; Geberzahn N, 2009, BEHAV ECOL SOCIOBIOL, V64, P193, DOI 10.1007/s00265-009-0836-0; Gillooly JF, 2010, P ROY SOC B-BIOL SCI, V277, P1325, DOI 10.1098/rspb.2009.2134; Greig EI, 2010, BEHAV ECOL, V21, P1360, DOI 10.1093/beheco/arq155; Hall ML, 2008, ANIM BEHAV, V76, P65, DOI 10.1016/j.anbehav.2008.01.010; Hall ML, 2009, BEHAV ECOL, V20, P222, DOI 10.1093/beheco/arn139; HANDFORD P, 1991, CONDOR, V93, P644, DOI 10.2307/1368196; HAUSER MD, 1993, AM NAT, V142, P528, DOI 10.1086/285553; Higgins P. J., 2001, HDB AUSTR NZ ANTARCT, V5; Hunt J, 2009, J EVOLUTION BIOL, V22, P13, DOI 10.1111/j.1420-9101.2008.01633.x; Illes AE, 2006, P ROY SOC B-BIOL SCI, V273, P1907, DOI 10.1098/rspb.2006.3535; Irwin DE, 2008, J EVOLUTION BIOL, V21, P435, DOI 10.1111/j.1420-9101.2007.01499.x; KEMPENAERS B, 1992, NATURE, V357, P494, DOI 10.1038/357494a0; Kingma SA, 2011, AM NAT, V177, P486, DOI 10.1086/658989; Kingma SA, 2010, J ANIM ECOL, V79, P757, DOI 10.1111/j.1365-2656.2010.01697.x; LANGMORE NE, 1992, ETHOLOGY, V90, P143; Martin JP, 2011, J FIELD ORNITHOL, V82, P259, DOI 10.1111/j.1557-9263.2011.00329.x; Moller AP, 1998, BEHAV ECOL SOCIOBIOL, V43, P345, DOI 10.1007/s002650050501; Patel R, 2010, ETHOLOGY, V116, P554, DOI 10.1111/j.1439-0310.2010.01769.x; Podos J, 1997, EVOLUTION, V51, P537, DOI 10.1111/j.1558-5646.1997.tb02441.x; Price JJ, 2006, ANIM BEHAV, V71, P799, DOI 10.1016/j.anbehav.2005.05.025; Reby D, 2003, ANIM BEHAV, V65, P519, DOI 10.1006/anbe.2003.2078; Riede T, 2006, P NATL ACAD SCI USA, V103, P5543, DOI 10.1073/pnas.0601262103; Riede T, 2010, J ANAT, V216, P23, DOI 10.1111/j.1469-7580.2009.01161.x; RYAN MJ, 1985, AM NAT, V126, P87, DOI 10.1086/284398; Searcy W.N.S, 2005, EVOLUTION ANIMAL COM; Smith JM, 1995, J THEOR BIOL, V177, P305; Spencer KA, 2011, BEHAV ECOL, V22, P1, DOI 10.1093/beheco/arq068; Taylor AM, 2010, ANIM BEHAV, V79, P205, DOI 10.1016/j.anbehav.2009.10.030; VALLET E, 1995, ANIM BEHAV, V49, P1603, DOI 10.1016/0003-3472(95)90082-9; Yin S, 2004, ANIM BEHAV, V68, P343, DOI 10.1016/j.anbehav.2003.07.016	42	62	65	1	76	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e56717	10.1371/journal.pone.0056717	http://dx.doi.org/10.1371/journal.pone.0056717			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437221	Green Published, gold			2022-12-25	WOS:000315184200151
J	Jeon, JS; Zervantonakis, IK; Chung, S; Kamm, RD; Charest, JL				Jeon, Jessie S.; Zervantonakis, Ioannis K.; Chung, Seok; Kamm, Roger D.; Charest, Joseph L.			In Vitro Model of Tumor Cell Extravasation	PLOS ONE			English	Article							BREAST-CANCER METASTASIS; MICROFLUIDIC PLATFORM; TRANSENDOTHELIAL MIGRATION; ENDOTHELIAL-CELLS; PERMEABILITY; GROWTH; ASSAY; PROLIFERATION; COCULTURE; ADHESION	Tumor cells that disseminate from the primary tumor and survive the vascular system can eventually extravasate across the endothelium to metastasize at a secondary site. In this study, we developed a microfluidic system to mimic tumor cell extravasation where cancer cells can transmigrate across an endothelial monolayer into a hydrogel that models the extracellular space. The experimental protocol is optimized to ensure the formation of an intact endothelium prior to the introduction of tumor cells and also to observe tumor cell extravasation by having a suitable tumor seeding density. Extravasation is observed for 38.8% of the tumor cells in contact with the endothelium within 1 day after their introduction. Permeability of the EC monolayer as measured by the diffusion of fluorescently-labeled dextran across the monolayer increased 3.8 fold 24 hours after introducing tumor cells, suggesting that the presence of tumor cells increases endothelial permeability. The percent of tumor cells extravasated remained nearly constant from1 to 3 days after tumor seeding, indicating extravasation in our system generally occurs within the first 24 hours of tumor cell contact with the endothelium.	[Jeon, Jessie S.; Zervantonakis, Ioannis K.; Kamm, Roger D.] MIT, Dept Mech Engn, Cambridge, MA 02139 USA; [Kamm, Roger D.] MIT, Dept Biol Engn, Cambridge, MA 02139 USA; [Chung, Seok] Korea Univ, Sch Mech Engn, Seoul, South Korea; [Charest, Joseph L.] Charles Stark Draper Lab, Cambridge, MA USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Korea University; The Charles Stark Draper Laboratory, Inc.	Kamm, RD (corresponding author), MIT, Dept Mech Engn, Cambridge, MA 02139 USA.	rdkamm@mit.edu; jcharest@draper.com	Jeon, Jessie Sungyun/J-2167-2015; Zervantonakis, Ioannis/N-9717-2019; Zervantonakis, Ioannis/C-2890-2011; Zervantonakis, Ioannis/ADS-2519-2022; Kamm, Roger D/I-7630-2012; Chung, Seok/B-1501-2015	Jeon, Jessie Sungyun/0000-0001-6690-5775; Zervantonakis, Ioannis/0000-0003-2386-9553; Zervantonakis, Ioannis/0000-0003-2386-9553; Zervantonakis, Ioannis/0000-0003-2386-9553; /0000-0002-7232-304X	National Cancer Institute [R21CA140096]; Repligen Fellowship in cancer research; Basic Science Research Program [2012-022481]; Human Resources Development Program [20124010203250]; Draper Laboratories Inc. (IRD Grant); Charles Stark Draper Laboratory; NATIONAL CANCER INSTITUTE [R33CA174550, R21CA140096] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Repligen Fellowship in cancer research; Basic Science Research Program; Human Resources Development Program; Draper Laboratories Inc. (IRD Grant); Charles Stark Draper Laboratory; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The research was supported by Award Number R21CA140096 from the National Cancer Institute, and Draper Laboratories Inc. (IR&D Grant). J. Jeon was supported by Repligen Fellowship in cancer research and S. Chung was supported by the Basic Science Research Program (grant No. 2012-022481) and the Human Resources Development Program (grant No. 20124010203250). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Joseph L. Charest is employed by Charles Stark Draper Laboratory, one of the funders of this study. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Al-Mehdi AB, 2000, NAT MED, V6, P100, DOI 10.1038/71429; ALBELDA SM, 1988, J APPL PHYSIOL, V64, P308, DOI 10.1152/jappl.1988.64.1.308; Bos PD, 2009, NATURE, V459, P1005, DOI 10.1038/nature08021; Chambers AF, 2002, NAT REV CANCER, V2, P563, DOI 10.1038/nrc865; Chung S, 2009, ADV MATER, V21, P4863, DOI 10.1002/adma.200901727; Chung S, 2009, LAB CHIP, V9, P269, DOI 10.1039/b807585a; CRISSMAN JD, 1988, CANCER RES, V48, P4065; DIMILLA PA, 1992, AICHE J, V38, P1092, DOI 10.1002/aic.690380712; Ewing J., 1928, NEOPLASTIC DIS TREAT, V3rd; Fidler IJ, 2003, NAT REV CANCER, V3, P453, DOI 10.1038/nrc1098; Gassmann P, 2009, INT J COLORECTAL DIS, V24, P851, DOI 10.1007/s00384-009-0694-2; Gupta GP, 2006, CELL, V127, P679, DOI 10.1016/j.cell.2006.11.001; Han S, 2012, LAB CHIP; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hayes DF, 2006, CLIN CANCER RES, V12, P4218, DOI 10.1158/1078-0432.CCR-05-2821; HENDRIX MJC, 1987, CANCER LETT, V38, P137, DOI 10.1016/0304-3835(87)90209-6; Joyce JA, 2009, NAT REV CANCER, V9, P239, DOI 10.1038/nrc2618; KOOP S, 1994, CANCER RES, V54, P4791; Kumar S, 2009, CANCER METAST REV, V28, P113, DOI 10.1007/s10555-008-9173-4; Li YH, 1999, CLIN EXP METASTAS, V17, P423, DOI 10.1023/A:1006614232388; Mareel M, 2003, PHYSIOL REV, V83, P337, DOI 10.1152/physrev.00024.2002; Michel CC, 1999, PHYSIOL REV, V79, P703, DOI 10.1152/physrev.1999.79.3.703; Mierke CT, 2011, J BIOL CHEM, V286, P40025, DOI 10.1074/jbc.M111.256172; Minn AJ, 2005, NATURE, V436, P518, DOI 10.1038/nature03799; Muthuswamy SK, 2001, NAT CELL BIOL, V3, P785, DOI 10.1038/ncb0901-785; Nagrath S, 2007, NATURE, V450, P1235, DOI 10.1038/nature06385; Naumov GN, 1999, J CELL SCI, V112, P1835; Polacheck WJ, 2011, P NATL ACAD SCI USA, V108, P11115, DOI 10.1073/pnas.1103581108; Psaila B, 2009, NAT REV CANCER, V9, P285, DOI 10.1038/nrc2621; Qian BZ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006562; Roussos ET, 2011, NAT REV CANCER, V11, P573, DOI 10.1038/nrc3078; Sahni A, 2009, INT J CANCER, V125, P577, DOI 10.1002/ijc.24340; Schluter K, 2006, AM J PATHOL, V169, P1064, DOI 10.2353/ajpath.2006.050566; Shin MK, 2011, LAB CHIP, V11, P3880, DOI 10.1039/c1lc20671k; Shin Y, 2012, NAT PROTOC, V7, P1247, DOI 10.1038/nprot.2012.051; Shin Y, 2011, LAB CHIP, V11, P2175, DOI 10.1039/c1lc20039a; Song JW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005756; Sporn MB, 1996, LANCET, V347, P1377, DOI 10.1016/S0140-6736(96)91015-6; Sudo R, 2009, FASEB J, V23, P2155, DOI 10.1096/fj.08-122820; Vargo-Gogola T, 2007, NAT REV CANCER, V7, P659, DOI 10.1038/nrc2193; Vickerman V, 2008, LAB CHIP, V8, P1468, DOI 10.1039/b802395f; Weis S, 2004, J CELL BIOL, V167, P223, DOI 10.1083/jcb.200408130; Weis SM, 2005, NATURE, V437, P497, DOI 10.1038/nature03987; Wirtz D, 2011, NAT REV CANCER, V11, P512, DOI 10.1038/nrc3080; Zervantonakis IK, 2012, P NATL ACAD SCI USA, V109, P13515, DOI 10.1073/pnas.1210182109; Zhang Q, 2012, LAB CHIP, V12, P2837, DOI 10.1039/c2lc00030j	46	143	151	0	110	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e56910	10.1371/journal.pone.0056910	http://dx.doi.org/10.1371/journal.pone.0056910			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437268	Green Published, gold, Green Submitted			2022-12-25	WOS:000315184200182
J	Meurer, SK; Alsamman, M; Sahin, H; Wasmuth, HE; Kisseleva, T; Brenner, DA; Trautwein, C; Weiskirchen, R; Scholten, D				Meurer, Steffen K.; Alsamman, Muhammad; Sahin, Hacer; Wasmuth, Hermann E.; Kisseleva, Tatiana; Brenner, David A.; Trautwein, Christian; Weiskirchen, Ralf; Scholten, David			Overexpression of Endoglin Modulates TGF-beta 1-Signalling Pathways in a Novel Immortalized Mouse Hepatic Stellate Cell Line	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; LIVER FIBROSIS; ENDOTHELIAL-CELLS; EXPRESSION; MECHANISMS; MYOFIBROBLASTS; ACTIVATION; MIGRATION; TRANSDIFFERENTIATION; FIBROGENESIS	Hepatic stellate cells (HSCs) play a major role in the pathogenesis of liver fibrosis. Working on primary HSCs requires difficult isolation procedures; therefore we have generated and here characterize a mouse hepatic stellate cell line expressing GFP under control of the collagen 1(I) promoter/enhancer. These cells are responsive to pro-fibrogenic stimuIi, such as PDGF or TGF-beta 1, and are able to activate intracellular signalling pathways including Smads and MAP kinases. Nevertheless, due to the basal level of activation, TGF-beta 1 did not significantly induce GFP expression contrasting the TGF-beta 1 regulated endogenous collagen I expression. We could demonstrate that the accessory TGF-beta-receptor endoglin, which is endogenously expressed at very low levels, has a differential effect on signalling of these cells when transiently overexpressed. In the presence of endoglin activation of Smad1/5/8 was drastically enhanced. Moreover, the phosphorylation of ERK1/2 was increased, and the expression of vimentin, alpha-smooth muscle actin and connective tissue growth factor was upregulated. Endoglin induced a slight increase in expression of the inhibitor of differentiation-2 while the amount of endogenous collagen type I was reduced. Therefore, this profibrogenic cell line with hepatic stellate cell origin is not only a promising novel experimental tool, which can be used in vivo for cell tracing experiments. Furthermore it allows investigating the impact of various regulatory proteins (e. g. endoglin) on profibrogenic signal transduction, differentiation and hepatic stellate cell biology.	[Meurer, Steffen K.; Weiskirchen, Ralf] RWTH Univ Hosp Aachen, Inst Clin Chem & Pathobiochem, Aachen, Germany; [Alsamman, Muhammad; Sahin, Hacer; Wasmuth, Hermann E.; Trautwein, Christian; Scholten, David] RWTH Univ Hosp Aachen, Dept Internal Med 3, Aachen, Germany; [Kisseleva, Tatiana; Brenner, David A.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA	RWTH Aachen University; RWTH Aachen University Hospital; RWTH Aachen University; RWTH Aachen University Hospital; University of California System; University of California San Diego	Scholten, D (corresponding author), RWTH Univ Hosp Aachen, Dept Internal Med 3, Aachen, Germany.	dscholten@ukaachen.de	Weiskirchen, Ralf/O-1734-2018	Weiskirchen, Ralf/0000-0003-3888-0931; Brenner, David/0000-0003-2573-525X	Deutsche Forschungsgemeinschaft [SFB/TRR 57 P13]; IZKF Aachen; START Program of the Medical Faculty of RWTH Aachen	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); IZKF Aachen; START Program of the Medical Faculty of RWTH Aachen	This work was supported by grants from the Deutsche Forschungsgemeinschaft (SFB/TRR 57 P13), the IZKF Aachen, and the START Program of the Medical Faculty of RWTH Aachen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asahina K, 2009, HEPATOLOGY, V49, P998, DOI 10.1002/hep.22721; Bataller R, 2005, J CLIN INVEST, V115, P209, DOI 10.1172/JCI200524282; Bernabeu C, 2007, J CELL BIOCHEM, V102, P1375, DOI 10.1002/jcb.21594; Blaner WS, 2009, BBA-MOL CELL BIOL L, V1791, P467, DOI 10.1016/j.bbalip.2008.11.001; Blobe GC, 2000, NEW ENGL J MED, V342, P1350, DOI 10.1056/NEJM200005043421807; BOROJEVIC R, 1985, IN VITRO CELL DEV B, V21, P382, DOI 10.1007/BF02623469; Brenner David A, 2009, Trans Am Clin Climatol Assoc, V120, P361; Cao Y, 2010, J BIOL CHEM, V285, P31840, DOI 10.1074/jbc.M110.151696; Cassiman D, 1999, AM J PATHOL, V155, P1831, DOI 10.1016/S0002-9440(10)65501-0; Clemente M, 2006, J VIRAL HEPATITIS, V13, P625, DOI 10.1111/j.1365-2893.2006.00733.x; Dennler S, 2002, J LEUKOCYTE BIOL, V71, P731; Diez-Marques L, 2002, BBA-MOL BASIS DIS, V1587, P36, DOI 10.1016/S0925-4439(02)00051-0; Dooley S, 2000, HEPATOLOGY, V31, P1094, DOI 10.1053/he.2000.6126; Dudas J, 2007, CELL TISSUE RES, V329, P503, DOI 10.1007/s00441-007-0437-z; Friedman SL, 2008, PHYSIOL REV, V88, P125, DOI 10.1152/physrev.00013.2007; GOUGOS A, 1990, J BIOL CHEM, V265, P8361; Guerrero-Esteo M, 1999, EUR J CELL BIOL, V78, P614, DOI 10.1016/S0171-9335(99)80046-6; Herrmann J, 2007, J CELL MOL MED, V11, P704, DOI 10.1111/j.1582-4934.2007.00060.x; Iwaisako K, 2012, J GASTROEN HEPATOL, V27, P65, DOI 10.1111/j.1440-1746.2011.07002.x; Jerkic M, 2006, CIRC RES, V99, P248, DOI 10.1161/01.RES.0000236755.98627.69; Kamada Y, 2012, GLYCOBIOLOGY; Kanzler S, 1999, AM J PHYSIOL-GASTR L, V276, pG1059, DOI 10.1152/ajpgi.1999.276.4.G1059; Kisseleva T, 2007, J GASTROEN HEPATOL, V22, pS73, DOI 10.1111/j.1440-1746.2006.04658.x; Lee JS, 2005, AM J PATHOL, V166, P1861, DOI 10.1016/S0002-9440(10)62495-9; Lee NY, 2007, J BIOL CHEM, V282, P21507, DOI 10.1074/jbc.M700176200; Magness ST, 2004, HEPATOLOGY, V40, P1151, DOI 10.1002/hep.20427; Meurer SK, 2005, BIOCHEM PHARMACOL, V70, P1026, DOI 10.1016/j.bcp.2005.07.001; Meurer SK, 2005, J BIOL CHEM, V280, P3078, DOI 10.1074/jbc.M405411200; Meurer SK, 2012, EUR J CELL BIOL, V91, P450, DOI 10.1016/j.ejcb.2011.09.004; Meurer SK, 2011, CELL SIGNAL, V23, P683, DOI 10.1016/j.cellsig.2010.12.002; Orlova VV, 2011, HISTOL HISTOPATHOL, V26, P1219, DOI 10.14670/HH-26.1219; Pannu J, 2007, J BIOL CHEM, V282, P10405, DOI 10.1074/jbc.M611742200; Rodriguez-Barbero A, 2006, CELL PHYSIOL BIOCHEM, V18, P135, DOI 10.1159/000095181; Santibanez JF, 2010, CARCINOGENESIS, V31, P2145, DOI 10.1093/carcin/bgq199; Sato M, 2003, J CLIN INVEST, V112, P1486, DOI 10.1172/JCI200319270; SCHAFER S, 1987, HEPATOLOGY, V7, P680, DOI 10.1002/hep.1840070411; Scherner O, 2007, J BIOL CHEM, V282, P13934, DOI 10.1074/jbc.M611062200; Schmidt-Weber CB, 2005, INT IMMUNOL, V17, P921, DOI 10.1093/intimm/dxh272; Schnabl B, 2002, LAB INVEST, V82, P323, DOI 10.1038/labinvest.3780426; Scholten D, 2011, AM J PATHOL, V179, P189, DOI 10.1016/j.ajpath.2011.03.049; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Tacke F, 2012, EXPERT REV GASTROENT, V6, P67, DOI [10.1586/EGH.11.92, 10.1586/egh.11.92]; Uchinami H, 2006, HEPATOLOGY, V44, P420, DOI 10.1002/hep.21268; Velasco S, 2008, J CELL SCI, V121, P913, DOI 10.1242/jcs.023283; Wasmuth HE, 2009, GASTROENTEROLOGY, V137, P309, DOI 10.1053/j.gastro.2009.03.053; Weiskirchen R, 2005, METH MOLEC MED, V117, P99; Wiercinska E, 2006, HEPATOLOGY, V43, P1032, DOI 10.1002/hep.21135; Wynn TA, 2008, J PATHOL, V214, P199, DOI 10.1002/path.2277; Xu L, 2005, GUT, V54, P142, DOI 10.1136/gut.2004.042127; Yagmur E, 2007, EUR J GASTROEN HEPAT, V19, P755, DOI 10.1097/MEG.0b013e3282202bea	50	33	35	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e56116	10.1371/journal.pone.0056116	http://dx.doi.org/10.1371/journal.pone.0056116			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437087	Green Published, gold			2022-12-25	WOS:000315184200041
J	Narusaka, M; Kubo, Y; Hatakeyama, K; Imamura, J; Ezura, H; Nanasato, Y; Tabei, Y; Takano, Y; Shirasu, K; Narusaka, Y				Narusaka, Mari; Kubo, Yasuyuki; Hatakeyama, Katsunori; Imamura, Jun; Ezura, Hiroshi; Nanasato, Yoshihiko; Tabei, Yutaka; Takano, Yoshitaka; Shirasu, Ken; Narusaka, Yoshihiro			Interfamily Transfer of Dual NB-LRR Genes Confers Resistance to Multiple Pathogens	PLOS ONE			English	Article							ARABIDOPSIS EDS1; EXPRESSION; DISEASE; PROTEIN; TOMATO; TRANSFORMATION; RECOGNITION; REQUIRES; AVRRPS4; CLONING	A major class of disease resistance (R) genes which encode nucleotide binding and leucine rich repeat (NB-LRR) proteins have been used in traditional breeding programs for crop protection. However, it has been difficult to functionally transfer NB-LRR-type R genes in taxonomically distinct families. Here we demonstrate that a pair of Arabidopsis (Brassicaceae) NB-LRR-type R genes, RPS4 and RRS1, properly function in two other Brassicaceae, Brassica rapa and Brassica napus, but also in two Solanaceae, Nicotiana benthamiana and tomato (Solanum lycopersicum). The solanaceous plants transformed with RPS4/RRS1 confer bacterial effector-specific immunity responses. Furthermore, RPS4 and RRS1, which confer resistance to a fungal pathogen Colletotrichum higginsianum in Brassicaceae, also protect against Colletotrichum orbiculare in cucumber (Cucurbitaceae). Importantly, RPS4/RRS1 transgenic plants show no autoimmune phenotypes, indicating that the NB-LRR proteins are tightly regulated. The successful transfer of two R genes at the family level implies that the downstream components of R genes are highly conserved. The functional interfamily transfer of R genes can be a powerful strategy for providing resistance to a broad range of pathogens.	[Narusaka, Mari; Narusaka, Yoshihiro] Res Inst Biol Sci Okayama, Okayama, Japan; [Kubo, Yasuyuki] Kyoto Prefectural Univ, Grad Sch Life & Environm Sci, Kyoto 606, Japan; [Hatakeyama, Katsunori] NARO Inst Vegetable & Tea Sci, Vegetable Breeding & Genome Res Div, Tsu, Mie, Japan; [Imamura, Jun] Tamagawa Univ, Grad Sch Agr, Tokyo, Japan; [Ezura, Hiroshi] Univ Tsukuba, Fac Life & Environm Sci, Ibaraki, Japan; [Nanasato, Yoshihiko; Tabei, Yutaka] Natl Inst Agrobiol Sci, Genetically Modified Organism Res Ctr, Ibaraki, Japan; [Takano, Yoshitaka] Kyoto Univ, Grad Sch Agr, Kyoto, Japan; [Shirasu, Ken] RIKEN Plant Sci Ctr, Yokohama, Kanagawa, Japan	Kyoto Prefectural University; University of Tsukuba; National Institute of Agrobiological Sciences - Japan; Kyoto University; RIKEN	Shirasu, K (corresponding author), RIKEN Plant Sci Ctr, Yokohama, Kanagawa, Japan.	ken.shirasu@psc.riken.jp; yo_narusaka@bio-ribs.com	Shirasu, Ken/ABF-5306-2020; Ezura, H/AAO-8184-2021; Shirasu, Ken/A-4455-2010	Shirasu, Ken/0000-0002-0349-3870; Shirasu, Ken/0000-0002-0349-3870	Programme for Promotion of Basic and Applied Researches for Innovations in Bio-oriented Industry; JSPS [21580060, 21780038, 24228008]	Programme for Promotion of Basic and Applied Researches for Innovations in Bio-oriented Industry; JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by the Programme for Promotion of Basic and Applied Researches for Innovations in Bio-oriented Industry to K.S., Y. Takano, Y. Narusaka and by JSPS Grant-in-Aid for Scientific Research (KAKENHI) (21580060 to Y. Narusaka, 21780038 to M.N. and 24228008 to K.S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAI S, 1968, MYCOPATH MYCOL APPL, V34, P337, DOI 10.1007/BF02051859; Ashikawa I, 2008, GENETICS, V180, P2267, DOI 10.1534/genetics.108.095034; Bhattacharjee S, 2011, SCIENCE, V334, P1405, DOI 10.1126/science.1211592; Birker D, 2009, PLANT J, V60, P602, DOI 10.1111/j.1365-313X.2009.03984.x; Chisholm ST, 2006, CELL, V124, P803, DOI 10.1016/j.cell.2006.02.008; Clemente T, 2006, METH MOL B, V343, P143; Deslandes L, 2003, P NATL ACAD SCI USA, V100, P8024, DOI 10.1073/pnas.1230660100; Eitas TK, 2008, P NATL ACAD SCI USA, V105, P6475, DOI 10.1073/pnas.0802157105; Eitas TK, 2010, CURR OPIN PLANT BIOL, V13, P472, DOI 10.1016/j.pbi.2010.04.007; Gojobori T, 2007, GENOME RES, V17, P175, DOI 10.1101/gr.5509507; Heidrich K, 2011, SCIENCE, V334, P1401, DOI 10.1126/science.1211641; HENDRICK CA, 1984, APPL ENVIRON MICROB, V48, P94, DOI 10.1128/AEM.48.1.94-101.1984; Hinsch M, 1996, MOL PLANT MICROBE IN, V9, P55, DOI 10.1094/MPMI-9-0055; HORSCH RB, 1985, SCIENCE, V227, P1229, DOI 10.1126/science.227.4691.1229; Huang HE, 2007, PHYTOPATHOLOGY, V97, P900, DOI 10.1094/PHYTO-97-8-0900; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Joshi RK, 2011, GENET MOL RES, V10, P2637, DOI 10.4238/2011.October.25.10; KELMAN A, 1954, PHYTOPATHOLOGY, V44, P693; KOHNOMURASE J, 1994, PLANT MOL BIOL, V26, P1115, DOI 10.1007/BF00040693; KUBO Y, 1982, PHYTOPATHOLOGY, V72, P498, DOI 10.1094/Phyto-72-498; Lacombe S, 2010, NAT BIOTECHNOL, V28, P365, DOI 10.1038/nbt.1613; Lee SK, 2009, GENETICS, V181, P1627, DOI 10.1534/genetics.108.099226; Loutre C, 2009, PLANT J, V60, P1043, DOI 10.1111/j.1365-313X.2009.04024.x; McDowell JM, 2011, SCIENCE, V334, P1354, DOI 10.1126/science.1216482; Meyers BC, 2003, PLANT CELL, V15, P809, DOI 10.1105/tpc.009308; Mukaihara T, 2004, MOL MICROBIOL, V54, P863, DOI 10.1111/j.1365-2958.2004.04328.x; Nanasato Y, 2013, PLANT BIOTECHNOL REP, V7, P267, DOI 10.1007/s11816-012-0260-1; Narusaka M, 2010, J GEN PLANT PATHOL, V76, P1, DOI 10.1007/s10327-009-0211-z; Narusaka M, 2009, PLANT J, V60, P218, DOI 10.1111/j.1365-313X.2009.03949.x; O'Connell RJ, 2012, NAT GENET, V44, P1060, DOI 10.1038/ng.2372; Peart JR, 2005, CURR BIOL, V15, P968, DOI 10.1016/j.cub.2005.04.053; Sinapidou E, 2004, PLANT J, V38, P898, DOI 10.1111/j.1365-313X.2004.02099.x; Sohn KH, 2012, P NATL ACAD SCI USA, V109, P16371, DOI 10.1073/pnas.1212332109; Sun HJ, 2006, PLANT CELL PHYSIOL, V47, P426, DOI 10.1093/pcp/pci251; Tabei Y, 1998, PLANT CELL REP, V17, P159, DOI 10.1007/s002990050371; Tai TH, 1999, P NATL ACAD SCI USA, V96, P14153, DOI 10.1073/pnas.96.24.14153; Takasaki T, 1997, BREEDING SCI, V47, P127; Takken FLW, 2000, PLANT J, V24, P275, DOI 10.1046/j.1365-313x.2000.00866.x; Tasset C, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001202; Wei CF, 2007, PLANT J, V51, P32, DOI 10.1111/j.1365-313X.2007.03126.x; Wulff BBH, 2011, CURR OPIN PLANT BIOL, V14, P468, DOI 10.1016/j.pbi.2011.04.002; Zhang Y, 2004, PLANT J, V40, P213, DOI 10.1111/j.1365-313X.2004.02201.x	42	60	61	0	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e55954	10.1371/journal.pone.0055954	http://dx.doi.org/10.1371/journal.pone.0055954			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437080	gold, Green Published, Green Submitted			2022-12-25	WOS:000315184200035
J	Rijavec, M; Korosec, P; Silar, M; Zidarn, M; Miljkovic, J; Kosnik, M				Rijavec, Matija; Korosec, Peter; Silar, Mira; Zidarn, Mihaela; Miljkovic, Jovan; Kosnik, Mitja			Hereditary Angioedema Nationwide Study in Slovenia Reveals Four Novel Mutations in SERPING1 Gene	PLOS ONE			English	Article							C1 INHIBITOR GENE; DEFICIENCY; FAMILIES; SPECTRUM; SEQUENCE; EDEMA	Hereditary angioedema (HAE) is a rare autosomal dominant disease characterized by swelling of the face, lips, tongue, larynx, genitalia, or extremities, with abdominal pain caused by intra-abdominal edema. HAE is caused by mutations affecting the C1 inhibitor gene, SERPING1, resulting in low levels of C1 inhibitor (Type I HAE) or normal levels of ineffective C1 inhibitor (Type II HAE). A nationwide survey identified nine unrelated families with HAE in Slovenia, among whom 17 individuals from eight families were recruited for genetic analyses. A diagnosis of HAE was established in the presence of clinical and laboratory criteria (low C1 inhibitor antigenic levels and/or function), followed up by a positive family history. Genetic studies were carried out using PCR and sequencing to detect SERPING1 mutations in promoter, noncoding exon 1, the 7 coding exons, and exon-intron boundaries. Multiplex ligation-dependent probe amplification was performed in order to search for large deletions/duplications in SERPING1 gene. A mutation responsible for HAE was identified in patients from seven families with the disease. In HAE type I families, one previously reported substitution (Gln67Stop, c.265C>T) and four novel mutations were identified. The new mutations included two missense substitutions, Ser128Phe (c.449C>T), and Glu429Lys (c.1351G>A), together with two frameshift mutations, indel (c.49delGinsTT) and deletion (c.593_594delCT). Both families with HAE type II harbored the two well-known substitutions affecting the arginyl residue at the reactive center in exon 8, Arg444Cys (c.1396C>T) and Arg444His (c.1397G>A), respectively. In one patient only the homozygous variant g.566T>C (c.-21T>C) was identified. Our study identified four novel mutations in the Slovenian HAE population, highlighting the heterogeneity of mutations in the SERPING1 gene causing C1 inhibitor deficiency and HAE. In a single patient with HAE a homozygous variant g.566T>C (c.-21T>C) might be responsible for the disease.	[Rijavec, Matija; Korosec, Peter; Silar, Mira; Zidarn, Mihaela; Kosnik, Mitja] Univ Clin Resp & Allerg Dis Golnik, Golnik, Slovenia; [Miljkovic, Jovan] Univ Clin Ctr Maribor, Dept Dermatovenerol, Maribor, Slovenia	University Clinic Golnik; University of Maribor	Rijavec, M (corresponding author), Univ Clin Resp & Allerg Dis Golnik, Golnik, Slovenia.	matija.rijavec@klinika-golnik.si	Košnik, Mitja/AAI-2295-2019	Košnik, Mitja/0000-0002-4701-7374; Zidarn, Mihaela/0000-0003-0515-5207; Rijavec, Matija/0000-0002-2596-4952; Korosec, Peter/0000-0002-0835-1599				Agostoni A, 2004, J ALLERGY CLIN IMMUN, V114, pS51, DOI 10.1016/j.jaci.2004.06.047; Bowen B, 2001, CLIN IMMUNOL, V98, P157, DOI 10.1006/clim.2000.4947; Bowen Tom, 2010, Allergy Asthma Clin Immunol, V6, P24, DOI 10.1186/1710-1492-6-24; Bygum A, 2011, ALLERGY, V66, P76, DOI 10.1111/j.1398-9995.2010.02456.x; Bygum A, 2009, BRIT J DERMATOL, V161, P1153, DOI 10.1111/j.1365-2133.2009.09366.x; CARTER PE, 1991, EUR J BIOCHEM, V197, P301, DOI 10.1111/j.1432-1033.1991.tb15911.x; Cicardi M, 2012, ALLERGY, V67, P147, DOI 10.1111/j.1398-9995.2011.02751.x; Cugno M, 2009, TRENDS MOL MED, V15, P69, DOI 10.1016/j.molmed.2008.12.001; Cumming SA, 2003, J MED GENET, V40, DOI 10.1136/jmg.40.10.e114; Duponchel Christiane, 2006, Hum Mutat, V27, P295, DOI 10.1002/humu.9414; Faiyaz-Ul-Haque M, 2010, INT ARCH ALLERGY IMM, V151, P149, DOI 10.1159/000236005; Freiberger T, 2002, HUM MUTAT, V19, DOI 10.1002/humu.9029; Frischmeyer PA, 2002, SCIENCE, V295, P2258, DOI 10.1126/science.1067338; Gosswein T, 2008, CYTOGENET GENOME RES, V121, P181, DOI 10.1159/000138883; Kalmar L, 2005, HUM MUTAT, V25, P1, DOI 10.1002/humu.20112; Kalmar L, 2003, HUM MUTAT, V22, DOI 10.1002/humu.9202; Kesim B, 2011, INT ARCH ALLERGY IMM, V156, P443, DOI 10.1159/000323915; Lopez-Lera A, 2011, MOL IMMUNOL, V49, P18, DOI 10.1016/j.molimm.2011.07.010; Pappalardo E, 2000, J ALLERGY CLIN IMMUN, V106, P1147, DOI 10.1067/mai.2000.110471; Pappalardo E, 2008, MOL IMMUNOL, V45, P3536, DOI 10.1016/j.molimm.2008.05.007; Roche O, 2005, ANN ALLERG ASTHMA IM, V94, P498, DOI 10.1016/S1081-1206(10)61121-0; Roche O, 2005, HUM MUTAT, V26, P135, DOI 10.1002/humu.20197; SKRIVER K, 1989, J BIOL CHEM, V264, P3066; Speletas M, 2009, HUM IMMUNOL, V70, P925, DOI 10.1016/j.humimm.2009.08.010; Varga L, 2011, J ANGIOEDEMA, P36; Verpy E, 1996, AM J HUM GENET, V59, P308; Zuraw BL, 2000, J ALLERGY CLIN IMMUN, V105, P541, DOI 10.1067/mai.2000.104780; Zuraw BL, 2008, NEW ENGL J MED, V359, P1027, DOI 10.1056/NEJMcp0803977	28	25	27	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e56712	10.1371/journal.pone.0056712	http://dx.doi.org/10.1371/journal.pone.0056712			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437219	Green Published, gold, Green Submitted			2022-12-25	WOS:000315184200149
J	Song, MA; Tiirikainen, M; Kwee, S; Okimoto, G; Yu, H; Wong, LL				Song, Min-Ae; Tiirikainen, Maarit; Kwee, Sandi; Okimoto, Gordon; Yu, Herbert; Wong, Linda L.			Elucidating the Landscape of Aberrant DNA Methylation in Hepatocellular Carcinoma	PLOS ONE			English	Article							CPG ISLAND SHORES; PROMOTER METHYLATION; GNAS CLUSTER; RISK-FACTORS; CANCER; TUMOR; GENE; HYPERMETHYLATION; HYPOMETHYLATION; PATHOGENESIS	Background: Hepatocellular carcinoma (HCC) is one of the most common cancers and frequently presents with an advanced disease at diagnosis. There is only limited knowledge of genome-scale methylation changes in HCC. Methods and Findings: We performed genome-wide methylation profiling in a total of 47 samples including 27 HCC and 20 adjacent normal liver tissues using the Illumina HumanMethylation450 BeadChip. We focused on differential methylation patterns in the promoter CpG islands as well as in various less studied genomic regions such as those surrounding the CpG islands, i.e. shores and shelves. Of the 485,577 loci studied, significant differential methylation (DM) was observed between HCC and adjacent normal tissues at 62,692 loci or 13% (p<1.03e-07). Of them, 61,058 loci (97%) were hypomethylated and most of these loci were located in the intergenic regions (43%) or gene bodies (33%). Our analysis also identified 10,775 differentially methylated (DM) loci (17% out of 62,692 loci) located in or surrounding the gene promoters, 4% of which reside in known Differentially Methylated Regions (DMRs) including reprogramming specific DMRs and cancer specific DMRs, while the rest (10,315) involving 4,106 genes could be potential new HCC DMR loci. Interestingly, the promoter-related DM loci occurred twice as frequently in the shores than in the actual CpG islands. We further characterized 982 DM loci in the promoter CpG islands to evaluate their potential biological function and found that the methylation changes could have effect on the signaling networks of Cellular development, Gene expression and Cell death (p = 1.0e-38), with BMP4, CDKN2A, GSTP1, and NFATC1 on the top of the gene list. Conclusion: Substantial changes of DNA methylation at a genome-wide level were observed in HCC. Understanding epigenetic changes in HCC will help to elucidate the pathogenesis and may eventually lead to identification of molecular markers for liver cancer diagnosis, treatment and prognosis.	[Song, Min-Ae; Tiirikainen, Maarit] Univ Hawaii, Ctr Canc, Honolulu, HI 96822 USA; [Song, Min-Ae; Tiirikainen, Maarit] Univ Hawaii Manoa, Dept Mol Biosci & Bioengn, Honolulu, HI 96822 USA; [Kwee, Sandi; Wong, Linda L.] Univ Hawaii, Ctr Canc, Canc Biol Program, Honolulu, HI 96822 USA; [Okimoto, Gordon; Yu, Herbert] Univ Hawaii, Ctr Canc, Canc Epidemiol Program, Honolulu, HI 96822 USA; [Kwee, Sandi] Queens Med Ctr, Hamamatsu Queens PET Imaging Ctr, Honolulu, HI USA	Cancer Research Center of Hawaii; University of Hawaii System; University of Hawaii System; University of Hawaii Manoa; Cancer Research Center of Hawaii; University of Hawaii System; Cancer Research Center of Hawaii; University of Hawaii System; The Queen's Medical Center	Wong, LL (corresponding author), Univ Hawaii, Ctr Canc, Canc Biol Program, Honolulu, HI 96822 USA.	hepatoma@aol.com	Song, Min-Ae/AAF-9672-2021; Tirikainen, M/B-6954-2012	Tirikainen, M/0000-0002-8124-3818; Kwee, Sandi/0000-0002-4624-8787	National Institutes of Health [3P30CA071789-12S6, P30CA071789-12S8]; NATIONAL CANCER INSTITUTE [P30CA071789] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [U54MD007584] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This study was funded partially by the following National Institutes of Health grants: 3P30CA071789-12S6 & P30CA071789-12S8. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ammerpohl O, 2012, INT J CANCER, V130, P1319, DOI 10.1002/ijc.26136; Clark SJ, 2002, ONCOGENE, V21, P5380, DOI 10.1038/sj.onc.1205598; Deaton AM, 2011, GENE DEV, V25, P1010, DOI 10.1101/gad.2037511; Doi A, 2009, NAT GENET, V41, P1350, DOI 10.1038/ng.471; Fattovich G, 2004, GASTROENTEROLOGY, V127, pS35, DOI 10.1053/j.gastro.2004.09.014; Feitelson MA, 2006, CANCER LETT, V239, P10, DOI 10.1016/j.canlet.2005.07.009; GALACTEROS F, 1991, BLOOD, V78, P1121; Gomaa AI, 2008, WORLD J GASTROENTERO, V14, P4300, DOI 10.3748/wjg.14.4300; Herath NI, 2006, J GASTROEN HEPATOL, V21, P15, DOI 10.1111/j.1440-1746.2005.04043.x; Hernandez-Vargas H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009749; Irizarry RA, 2009, NAT GENET, V41, P178, DOI 10.1038/ng.298; Issa JP, 2004, NAT REV CANCER, V4, P988, DOI 10.1038/nrc1507; Jones PA, 2002, NAT REV GENET, V3, P415, DOI 10.1038/nrg816; Jones PA, 2012, NAT REV GENET, V13, P484, DOI 10.1038/nrg3230; Kwee S, 2012, CTS-CLIN TRANSL SCI, V5, P65, DOI 10.1111/j.1752-8062.2011.00375.x; Lin CH, 2001, CANCER RES, V61, P4238; Maegdefrau U, 2009, J PATHOL, V218, P520, DOI 10.1002/path.2563; Matsuzaki K, 2005, CLIN CANCER RES, V11, P8564, DOI 10.1158/1078-0432.CCR-05-0859; Moribe T, 2009, INT J CANCER, V125, P388, DOI 10.1002/ijc.24394; Parkin DM, 2001, LANCET ONCOL, V2, P533, DOI 10.1016/S1470-2045(01)00486-7; Peters J, 2007, EPIGENETICS, V2, P207, DOI 10.4161/epi.2.4.5380; Peters J, 2008, ADV EXP MED BIOL, V626, P16; Rakyan VK, 2011, NAT REV GENET, V12, P529, DOI 10.1038/nrg3000; Sandoval J, 2011, EPIGENETICS-US, V6, P692, DOI 10.4161/epi.6.6.16196; Shen J, 2012, HEPATOLOGY, V55, P1799, DOI 10.1002/hep.25569; Tangkijvanich P, 2007, CLIN CHIM ACTA, V379, P127, DOI 10.1016/j.cca.2006.12.029; Tao R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019862; Tischoff I, 2008, WORLD J GASTROENTERO, V14, P1741, DOI 10.3748/wjg.14.1741; Wang JH, 2006, CLIN BIOCHEM, V39, P344, DOI 10.1016/j.clinbiochem.2006.01.008; Yang B, 2003, AM J PATHOL, V163, P1101, DOI 10.1016/S0002-9440(10)63469-4; Zhong S, 2002, CLIN CANCER RES, V8, P1087	31	121	130	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e55761	10.1371/journal.pone.0055761	http://dx.doi.org/10.1371/journal.pone.0055761			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437062	Green Published, gold, Green Submitted			2022-12-25	WOS:000315184200022
J	Walmsley, J; Rodriguez, JF; Mirams, GR; Burrage, K; Efimov, IR; Rodriguez, B				Walmsley, John; Rodriguez, Jose F.; Mirams, Gary R.; Burrage, Kevin; Efimov, Igor R.; Rodriguez, Blanca			mRNA Expression Levels in Failing Human Hearts Predict Cellular Electrophysiological Remodeling: A Population-Based Simulation Study	PLOS ONE			English	Article							HUMAN VENTRICULAR MYOCYTES; REPOLARIZATION; VARIABILITY; FAILURE; MODELS	Differences in mRNA expression levels have been observed in failing versus non-failing human hearts for several membrane channel proteins and accessory subunits. These differences may play a causal role in electrophysiological changes observed in human heart failure and atrial fibrillation, such as action potential (AP) prolongation, increased AP triangulation, decreased intracellular calcium transient (CaT) magnitude and decreased CaT triangulation. Our goal is to investigate whether the information contained in mRNA measurements can be used to predict cardiac electrophysiological remodeling in heart failure using computational modeling. Using mRNA data recently obtained from failing and non-failing human hearts, we construct failing and non-failing cell populations incorporating natural variability and up/down regulation of channel conductivities. Six biomarkers are calculated for each cell in each population, at cycle lengths between 1500 ms and 300 ms. Regression analysis is performed to determine which ion channels drive biomarker variability in failing versus non-failing cardiomyocytes. Our models suggest that reported mRNA expression changes are consistent with AP prolongation, increased AP triangulation, increased CaT duration, decreased CaT triangulation and amplitude, and increased delay between AP and CaT upstrokes in the failing population. Regression analysis reveals that changes in AP biomarkers are driven primarily by reduction in I-Kr, and changes in CaT biomarkers are driven predominantly by reduction in I-CaL and SERCA. In particular, the role of ICaL is pacing rate dependent. Additionally, alternans developed at fast pacing rates for both failing and non-failing cardiomyocytes, but the underlying mechanisms are different in control and heart failure.	[Walmsley, John; Mirams, Gary R.; Burrage, Kevin; Rodriguez, Blanca] Univ Oxford, Dept Comp Sci, Oxford, England; [Rodriguez, Jose F.] Univ Zaragoza, Aragon Inst Engn Res, Zaragoza, Spain; [Rodriguez, Jose F.] Biomed Res Networking Ctr Bioengn Biomat & Nanome, Zaragoza, Spain; [Burrage, Kevin] Queensland Univ Technol, Sch Math Sci, Brisbane, Qld 4001, Australia; [Efimov, Igor R.] Washington Univ, Dept Biomed Engn, St Louis, MO USA	University of Oxford; University of Zaragoza; CIBER - Centro de Investigacion Biomedica en Red; CIBERBBN; Queensland University of Technology (QUT); Washington University (WUSTL)	Rodriguez, B (corresponding author), Univ Oxford, Dept Comp Sci, Oxford, England.	blanca@cs.ox.ac.uk	Mirams, Gary/B-6653-2008; Efimov, Igor R/B-8040-2010; Efimov, Igor R./AAJ-3234-2021; Efimov, Igor/R-5544-2017; Matas, Jose F Rodriguez/H-4589-2011	Mirams, Gary/0000-0002-4569-4312; Efimov, Igor R/0000-0002-1483-5039; Efimov, Igor/0000-0002-1483-5039; Matas, Jose F Rodriguez/0000-0001-7612-266X; Walmsley, John/0000-0001-9171-7530; Burrage, Kevin/0000-0002-8111-1137; Rodriguez, Blanca/0000-0001-6361-3339	Engineering and Physical Sciences Research Council (EPSRC) through the Systems Biology Doctoral Training Centre at the University of Oxford; Salvador de Madariaga Research Program [PR2010-0552]; University of Zaragoza [171-242]; GlaxoSmithKline; National Institutes of Health (NIH) [NIH R01-HL0853689, NIH R01-HL114395]; Medical Research Council; GlaxoSmithKline Ltd.; MRC [G0700278] Funding Source: UKRI; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL114395] Funding Source: NIH RePORTER; Medical Research Council [G0700278] Funding Source: researchfish; National Centre for the Replacement [NC/K001337/1] Funding Source: researchfish	Engineering and Physical Sciences Research Council (EPSRC) through the Systems Biology Doctoral Training Centre at the University of Oxford(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Salvador de Madariaga Research Program; University of Zaragoza; GlaxoSmithKline(GlaxoSmithKline); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); GlaxoSmithKline Ltd.(GlaxoSmithKline); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Centre for the Replacement	JW is funded by the Engineering and Physical Sciences Research Council (EPSRC) (www.epsrc.ac.uk) through the Systems Biology Doctoral Training Centre at the University of Oxford (www.sysbiodtc.ox.ac.uk). JR is funded by the Salvador de Madariaga Research Program (PR2010-0552) and the University of Zaragoza (Project 171-242) (http://wzar.unizar.es/servicios/ingles/prese.htm). GM is funded by a GlaxoSmithKline Grants and Affiliates award (www.gsk.com). IE is funded by National Institutes of Health (NIH) grants NIH R01-HL0853689 and NIH R01-HL114395 (www.nih.gov). BR is funded by the Medical Research Council including a MRC Career Development Award, a MRC Centenary Award and Partnership with Industry Award (www.mrc.ac.uk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; One of the authors on this paper, Dr. GM, has received research support from GlaxoSmithKline Ltd. The authors declare this as a competing interest. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Ambrosi CM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054635; BEUCKELMANN DJ, 1992, CIRCULATION, V85, P1046, DOI 10.1161/01.CIR.85.3.1046; BEUCKELMANN DJ, 1993, CIRC RES, V73, P379, DOI 10.1161/01.RES.73.2.379; Bray MS, 2008, AM J PHYSIOL-HEART C, V294, pH1036, DOI 10.1152/ajpheart.01291.2007; Carusi A, 2012, AM J PHYSIOL-HEART C, V303, pH144, DOI 10.1152/ajpheart.01151.2011; Cooper J, 2011, PROG BIOPHYS MOL BIO, V107, P11, DOI 10.1016/j.pbiomolbio.2011.06.003; Cutler MJ, 2011, TRENDS PHARMACOL SCI, V32, P174, DOI 10.1016/j.tips.2010.12.001; DROUIN E, 1995, J AM COLL CARDIOL, V26, P185, DOI 10.1016/0735-1097(95)00167-X; Gaborit N, 2010, J MOL CELL CARDIOL, V49, P639, DOI 10.1016/j.yjmcc.2010.06.005; Glukhov A, 2010, CIRC RES, V106, P1; Glukhov AV, 2012, CIRCULATION, V125, P1835, DOI 10.1161/CIRCULATIONAHA.111.047274; GWATHMEY JK, 1987, CIRC RES, V61, P70, DOI 10.1161/01.RES.61.1.70; James AF, 2007, PROG BIOPHYS MOL BIO, V94, P265, DOI 10.1016/j.pbiomolbio.2005.05.010; Jeyaraj D, 2012, NATURE, V483, P96, DOI 10.1038/nature10852; Kubo H, 2001, CIRCULATION, V104, P1012, DOI 10.1161/hc3401.095073; Li GR, 2004, HEART RHYTHM, V1, P460, DOI 10.1016/j.hrthm.2004.06.003; Lloyd CM, 2008, BIOINFORMATICS, V24, P2122, DOI 10.1093/bioinformatics/btn390; Lou Q, 2011, CIRCULATION, V123, P1881, DOI 10.1161/CIRCULATIONAHA.110.989707; Nattel S, 2007, PHYSIOL REV, V87, P425, DOI 10.1152/physrev.00014.2006; Nattel S, 2010, J MOL CELL CARDIOL, V48, P96, DOI 10.1016/j.yjmcc.2009.07.016; O'Hara T, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002061; Piacentino V, 2003, CIRC RES, V92, P651, DOI 10.1161/01.RES.0000062469.83985.9B; Pitt-Francis J, 2009, COMPUT PHYS COMMUN, V180, P2452, DOI 10.1016/j.cpc.2009.07.019; Priebe L, 1998, CIRC RES, V82, P1206, DOI 10.1161/01.RES.82.11.1206; Pueyo E, 2011, BIOPHYS J, V101, P2892, DOI 10.1016/j.bpj.2011.09.060; Quinn TA, 2011, PROG BIOPHYS MOL BIO, V107, P4, DOI 10.1016/j.pbiomolbio.2011.07.001; Rodriguez JF, 2012, BIOPHYS J, V102, p543A, DOI 10.1016/j.bpj.2011.11.2965; Romero L, 2009, AM J PHYSIOL-HEART C, V297, pH1436, DOI 10.1152/ajpheart.00263.2009; Sarkar AX, 2012, J PHYSIOL-LONDON, V590, P2555, DOI 10.1113/jphysiol.2011.223313; Sarkar AX, 2011, HEART RHYTHM, V8, P1749, DOI 10.1016/j.hrthm.2011.05.023; Sarkar AX, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000914; Schroder F, 1998, CIRCULATION, V98, P969, DOI 10.1161/01.CIR.98.10.969; Sipido KR, 1998, CARDIOVASC RES, V37, P478, DOI 10.1016/S0008-6363(97)00280-0; Sobie EA, 2009, BIOPHYS J, V96, P1264, DOI 10.1016/j.bpj.2008.10.056; Soltysinska E, 2009, PFLUG ARCH EUR J PHY, V459, P11, DOI 10.1007/s00424-009-0718-3; Thomsen MB, 2009, CIRC RES, V104, P1382, DOI 10.1161/CIRCRESAHA.109.196972; Tomaselli GF, 2004, CIRC RES, V95, P754, DOI 10.1161/01.RES.0000145047.14691.db; Tomaselli GF, 1999, CARDIOVASC RES, V42, P270, DOI 10.1016/S0008-6363(99)00017-6; Trenor B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032659; VAHL CF, 1994, CIRC RES, V74, P952, DOI 10.1161/01.RES.74.5.952	40	54	54	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e56359	10.1371/journal.pone.0056359	http://dx.doi.org/10.1371/journal.pone.0056359			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437117	Green Published, Green Submitted, gold			2022-12-25	WOS:000315184200062
J	Zhang, J; Shen, YJ; Yuan, ZY; Yin, JH; Zang, W; Xu, YX; Lu, WY; Wang, YJ; Wang, Y; Cao, JP				Zhang, Jing; Shen, Yujuan; Yuan, Zhongying; Yin, Jianhai; Zang, Wei; Xu, Yuxin; Lu, Weiyuan; Wang, Yanjuan; Wang, Ying; Cao, Jianping			Primary Analysis of the Expressed Sequence Tags in a Pentastomid Nymph cDNA Library	PLOS ONE			English	Article							CYSTEINE PROTEASES; PARASITE	Background: Pentastomiasis is a rare zoonotic disease caused by pentastomids. Despite their worm-like appearance, they are commonly placed into a separate sub-class of the subphylum Crustacea, phylum Arthropoda. However, until now, the systematic classification of the pentastomids and the diagnosis of pentastomiasis are immature, and genetic information about pentastomid nylum is almost nonexistent. The objective of this study was to obtain information on pentastomid nymph genes and identify the gene homologues related to host-parasite interactions or stage-specific antigens. Methodology/Principal Findings: Total pentastomid nymph RNA was used to construct a cDNA library and 500 colonies were sequenced. Analysis shows one hundred and ninety-seven unigenes were identified. In which, 147 genes were annotated, and 75 unigenes (53.19%) were mapped to 82 KEGG pathways, including 29 metabolism pathways, 29 genetic information processing pathways, 4 environmental information processing pathways, 7 cell motility pathways and 5 organismal systems pathways. Additionally, two host-parasite interaction-related gene homologues, a putative Kunitz inhibitor and a putative cysteine protease. Conclusion/Significance: We first successfully constructed a cDNA library and gained a number of expressed sequence tags (EST) from pentastomid nymphs, which will lay the foundation for the further study on pentastomids and pentastomiasis.	[Zhang, Jing; Shen, Yujuan; Yuan, Zhongying; Yin, Jianhai; Zang, Wei; Xu, Yuxin; Lu, Weiyuan; Wang, Yanjuan; Wang, Ying; Cao, Jianping] World Hlth Org Collaborating Ctr Malaria Schistos, Natl Inst Parasit Dis, Chinese Ctr Dis Control & Prevent, Key Lab Parasite & Vector Biol,Minist Hlth, Shanghai, Peoples R China	Chinese Center for Disease Control & Prevention; National Institute of Parasitic Diseases, Chinese Center for Disease Control & Prevention; World Health Organization	Shen, YJ (corresponding author), World Hlth Org Collaborating Ctr Malaria Schistos, Natl Inst Parasit Dis, Chinese Ctr Dis Control & Prevent, Key Lab Parasite & Vector Biol,Minist Hlth, Shanghai, Peoples R China.	amyshyj12@163.com; caojp@yahoo.com	Cao, Jianping/AFL-5468-2022; Yin, Jianhai/GRS-2880-2022; Yin, Jianhai/AAF-5820-2020	Cao, Jianping/0000-0002-1974-0047; Yin, Jianhai/0000-0003-1333-8732; 	National S & T Major Program [2012ZX10004-201, 2009ZX10004-201]; Chinese Special Program for Scientific Research of Public Health [200802012]	National S & T Major Program; Chinese Special Program for Scientific Research of Public Health	JC was supported by grants from the National S & T Major Program No. 2012ZX10004-201 and 2009ZX10004-201. YS was supported by grants from the Chinese Special Program for Scientific Research of Public Health No. 200802012. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS MD, 1993, NAT GENET, V4, P373, DOI 10.1038/ng0893-373; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Cannon D. A., 1942, ANN TROP MED AND PARASITOL, V36, P160; Chen SH, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000647; Doumbo G, 1988, Med Trop (Mars), V48, P49; DRABICK JJ, 1987, REV INFECT DIS, V9, P1087; Draghici S, 2007, GENOME RES, V17, P1537, DOI 10.1101/gr.6202607; Dupuy D, 2007, NAT BIOTECHNOL, V25, P663, DOI 10.1038/nbt1305; Gonzalez S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007009; GUBLER U, 1983, GENE, V25, P263, DOI 10.1016/0378-1119(83)90230-5; Hami M, 2009, IRAN J PARASITOL, V4, P25; HERZOG U, 1985, ACTA TROP, V42, P261; JONES DAC, 1991, PARASITOLOGY, V103, P331, DOI 10.1017/S0031182000059849; Kanehisa M, 2004, NUCLEIC ACIDS RES, V32, pD277, DOI 10.1093/nar/gkh063; Ma KC, 2002, TROP MED INT HEALTH, V7, P166, DOI 10.1046/j.1365-3156.2002.00839.x; Machado MAC, 2006, J GASTROEN HEPATOL, V21, P1218, DOI 10.1111/j.1440-1746.2006.03203.x; Mapp E M, 1976, J Natl Med Assoc, V68, P198; McKerrow JH, 2006, ANNU REV PATHOL-MECH, V1, P497, DOI 10.1146/annurev.pathol.1.110304.100151; Na BK, 2006, CELL MICROBIOL, V8, P1034, DOI 10.1111/j.1462-5822.2006.00685.x; Rawlings ND, 2004, BIOCHEM J, V378, P705, DOI 10.1042/BJ20031825; Rawlings ND, 2008, NUCLEIC ACIDS RES, V36, pD320, DOI 10.1093/nar/gkm954; Sajid M, 2002, MOL BIOCHEM PARASIT, V120, P1, DOI 10.1016/S0166-6851(01)00438-8; SELF JT, 1972, T AM MICROSC SOC, V91, P2, DOI 10.2307/3224852	23	0	0	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e56511	10.1371/journal.pone.0056511	http://dx.doi.org/10.1371/journal.pone.0056511			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437150	Green Published, Green Submitted, gold			2022-12-25	WOS:000315184200088
J	Hu, N; Han, XF; Lane, EK; Gao, F; Zhang, YM; Ren, J				Hu, Nan; Han, Xuefeng; Lane, Erin K.; Gao, Feng; Zhang, Yingmei; Ren, Jun			Cardiac-Specific Overexpression of Metallothionein Rescues against Cigarette Smoking Exposure-Induced Myocardial Contractile and Mitochondrial Damage	PLOS ONE			English	Article							CYTOCHROME-C RELEASE; ENDOPLASMIC-RETICULUM STRESS; CHRONIC AKT ACTIVATION; NF-KAPPA-B; OXIDATIVE STRESS; CARDIOMYOCYTE DYSFUNCTION; CARDIOVASCULAR-DISEASE; PROTEIN-KINASE; APOPTOSIS; NICOTINE	Objectives: Second hand cigarette smoke is an independent risk factor for cardiovascular disease. Although a tie between smoking and cardiovascular disease is well established, the underlying mechanisms still remains elusive due to the lack of adequate animal models. This study was designed to use a mouse model of exposure to cigarette smoke, a surrogate of environmental tobacco smoke, to evaluate the impact of cardiac overexpression of heavy metal scavenger metallothionein on myocardial geometry, contractile and intracellular Ca2+ properties and apoptosis following side-stream smoke exposure. Methods: Adult male wild-type FVB and metallothionein transgenic mice were placed in a chamber exposed to cigarette smoke for 1 hour daily for 40 days. Echocardiographic, cardiomyocyte contractile and intracellular Ca2+ properties, fibrosis, apoptosis and mitochondrial damage were examined. Results: Our data revealed that smoke exposure enlarged ventricular end systolic and diastolic diameters, reduced myocardial and cardiomyocyte contractile function, disrupted intracellular Ca2+ homeostasis, facilitated fibrosis, apoptosis and mitochondrial damage (cytochrome C release and aconitase activity), the effects of which were attenuated or mitigated by metallothionein. In addition, side-stream smoke expose enhanced phosphorylation of Akt and GSK3 beta without affecting pan protein expression in the heart, the effect of which was abolished or ameliorated by metallothionein. Cigarette smoke extract interrupted cardiomyocyte contractile function and intracellular Ca2+ properties, the effect of which was mitigated by wortmannin and NAC. Conclusions: These data suggest that side-stream smoke exposure led to myocardial dysfunction, intracellular Ca2+ mishandling, apoptosis, fibrosis and mitochondrial damage, indicating the therapeutic potential of antioxidant against in second smoking-induced cardiac defects possibly via mitochondrial damage and apoptosis.	[Hu, Nan; Han, Xuefeng; Lane, Erin K.; Zhang, Yingmei; Ren, Jun] Univ Wyoming, Ctr Cardiovasc Res & Alternat Med, Coll Hlth Sci, Laramie, WY 82071 USA; [Han, Xuefeng; Gao, Feng] Fourth Mil Med Univ, Xijing Hosp, Dept Physiol, Xian 710032, Peoples R China; [Gao, Feng; Zhang, Yingmei; Ren, Jun] Fourth Mil Med Univ, Xijing Hosp, Dept Cardiol, Xian 710032, Peoples R China	University of Wyoming; Air Force Military Medical University; Air Force Military Medical University	Zhang, YM (corresponding author), Univ Wyoming, Ctr Cardiovasc Res & Alternat Med, Coll Hlth Sci, Laramie, WY 82071 USA.	zhangym197951@126.com; jren@uwyo.edu	Gao, Feng/X-4385-2019; Ren, Jun/ACG-5366-2022	Ren, Jun/0000-0002-0275-0783	NIH [5P20RR016474]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016474] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by NIH 5P20RR016474. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambrose JA, 2004, J AM COLL CARDIOL, V43, P1731, DOI 10.1016/j.jacc.2003.12.047; Arnoult D, 2002, J CELL BIOL, V159, P923, DOI 10.1083/jcb.200207071; Baarsma HA, 2011, AM J PHYSIOL-LUNG C, V300, pL910, DOI 10.1152/ajplung.00232.2010; Bye A, 2008, INHAL TOXICOL, V20, P635, DOI [10.1080/08958370701883821, 10.1080/08958370701883821 ]; Ceylan-Isik AF, 2010, J MOL CELL CARDIOL, V48, P367, DOI 10.1016/j.yjmcc.2009.11.003; Churg A, 2008, AM J PHYSIOL-LUNG C, V294, pL612, DOI 10.1152/ajplung.00390.2007; Dong F, 2005, CLIN SCI, V109, P277, DOI 10.1042/CS20040278; Doser TA, 2009, CIRCULATION, V119, P1941, DOI 10.1161/CIRCULATIONAHA.108.823799; Fang XJ, 2000, P NATL ACAD SCI USA, V97, P11960, DOI 10.1073/pnas.220413597; GIDDING SS, 1995, J AM COLL CARDIOL, V26, P211, DOI 10.1016/0735-1097(95)00118-J; Gu LZ, 2008, EUR J HEART FAIL, V10, P1057, DOI 10.1016/j.ejheart.2008.08.009; Gumustekin K, 2010, CELL BIOCHEM FUNCT, V28, P329, DOI 10.1002/cbf.1663; Guo R, 2009, J MOL CELL CARDIOL, V47, P228, DOI 10.1016/j.yjmcc.2009.03.018; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Howard LA, 2001, J PHARMACOL EXP THER, V299, P542; Hu N, 2011, TOXICOL LETT, V202, P8, DOI 10.1016/j.toxlet.2011.01.007; Jefferis BJ, 2010, HEART, V96, P854, DOI 10.1136/hrt.2009.191148; Kang YJ, 1999, P SOC EXP BIOL MED, V222, P263, DOI 10.1046/j.1525-1373.1999.d01-143.x; Khanna A, 2013, J NEUROIMMUNOL, V254, P69, DOI 10.1016/j.jneuroim.2012.09.006; Lemaitre V, 2011, TOXICOL SCI, V123, P542, DOI 10.1093/toxsci/kfr181; Li L, 2012, OBESITY SILVER SPRIN; Li Q, 2006, ALCOHOL ALCOHOLISM, V41, P585, DOI 10.1093/alcalc/agl080; Li SY, 2006, DIABETOLOGIA, V49, P1434, DOI 10.1007/s00125-006-0229-0; Liu XS, 1996, CELL, V86, P147, DOI 10.1016/S0092-8674(00)80085-9; Macha MA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014728; Matsui T, 2006, AM J PHYSIOL-ENDOC M, V290, pE789, DOI 10.1152/ajpendo.00564.2004; Miller LM, 2002, EXP LUNG RES, V28, P435, DOI 10.1080/01902140290096728; Minicucci Marcos F., 2009, Inflammation & Allergy Drug Targets, V8, P334; Nagoshi T, 2005, J CLIN INVEST, V115, P2128, DOI 10.1172/JCI23073; NEGRI E, 1993, BRIT MED J, V306, P1567, DOI 10.1136/bmj.306.6892.1567; Relling DP, 2006, J HYPERTENS, V24, P549, DOI 10.1097/01.hjh.0000203846.34314.94; Ren J, 2008, CRIT CARE MED, V36, P2106, DOI 10.1097/CCM.0b013e31817bf925; Ren J, 2008, AM J PHYSIOL-REG I, V294, pR793, DOI 10.1152/ajpregu.00713.2007; Repace J., 2007, EXPOSURE ANAL, P201; Sadeu JC, 2011, FERTIL STERIL, V95, P2410, DOI 10.1016/j.fertnstert.2011.03.072; Soldin OP, 2011, STEROIDS, V76, P653, DOI 10.1016/j.steroids.2011.02.042; Song JQ, 2009, APOPTOSIS, V14, P1299, DOI 10.1007/s10495-009-0398-7; Sorescu Dan, 2002, Congest Heart Fail, V8, P132, DOI 10.1111/j.1527-5299.2002.00717.x; Sun QH, 2009, CIRCULATION, V119, P538, DOI 10.1161/CIRCULATIONAHA.108.799015; Tafani M, 2002, J BIOL CHEM, V277, P10073, DOI 10.1074/jbc.M111350200; Talukder MAH, 2011, AM J PHYSIOL-HEART C, V300, pH388, DOI 10.1152/ajpheart.00868.2010; Togo S, 2010, EXP CELL RES, V316, P3501, DOI 10.1016/j.yexcr.2010.09.006; Tsurutani J, 2005, CARCINOGENESIS, V26, P1182, DOI 10.1093/carcin/bgi072; Turdi S, 2012, FREE RADICAL BIO MED, V53, P1327, DOI 10.1016/j.freeradbiomed.2012.07.084; Turgeon J, 2010, ATHEROSCLEROSIS, V208, P342, DOI 10.1016/j.atherosclerosis.2009.08.007; Ueno H, 2006, CARDIOVASC TOXICOL, V6, P39, DOI 10.1385/CT:6:1:39; Yang XP, 2006, FASEB J, V20, P1024, DOI 10.1096/fj.05-5288fje; Zhang YM, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-40; Zhou JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021173; Zhou X, 2010, CARDIOLOGY, V115, P243, DOI 10.1159/000301278	50	37	42	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2013	8	2							e57151	10.1371/journal.pone.0057151	http://dx.doi.org/10.1371/journal.pone.0057151			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093HR	23431404	gold, Green Published, Green Submitted			2022-12-25	WOS:000315182800047
J	Chen, YL; Zhang, H; Wang, HT; Yu, LC; Chen, Y				Chen, Yueling; Zhang, Hui; Wang, Hengtong; Yu, Lianchun; Chen, Yong			The Role of Coincidence-Detector Neurons in the Reliability and Precision of Subthreshold Signal Detection in Noise	PLOS ONE			English	Article							NEOCORTICAL PYRAMIDAL NEURONS; CORTICAL NEURAL-NETWORKS; SYNAPTIC INPUT; SOMATOSENSORY CORTEX; TEMPORAL INTEGRATION; SYNCHRONOUS SPIKING; SOUND LOCALIZATION; CURRENT TRANSIENTS; AUDITORY-SYSTEM; PSTH RESPONSE	Subthreshold signal detection is an important task for animal survival in complex environments, where noise increases both the external signal response and the spontaneous spiking of neurons. The mechanism by which neurons process the coding of signals is not well understood. Here, we propose that coincidence detection, one of the ways to describe the functionality of a single neural cell, can improve the reliability and the precision of signal detection through detection of presynaptic input synchrony. Using a simplified neuronal network model composed of dozens of integrate-and-fire neurons and a single coincidence-detector neuron, we show how the network reads out the subthreshold noisy signals reliably and precisely. We find suitable pairing parameters, the threshold and the detection time window of the coincidence-detector neuron, that optimize the precision and reliability of the neuron. Furthermore, it is observed that the refractory period induces an oscillation in the spontaneous firing, but the neuron can inhibit this activity and improve the reliability and precision further. In the case of intermediate intrinsic states of the input neuron, the network responds to the input more efficiently. These results present the critical link between spiking synchrony and noisy signal transfer, which is utilized in coincidence detection, resulting in enhancement of temporally sensitive coding scheme.	[Chen, Yueling; Zhang, Hui; Wang, Hengtong; Yu, Lianchun; Chen, Yong] Lanzhou Univ, Inst Theoret Phys, Lanzhou 730000, Peoples R China; [Chen, Yueling] Gansu Coll Tradit Chinese Med, Dept Phys, Lanzhou, Peoples R China; [Chen, Yong] Kings Coll London, Dept Math, London WC2R 2LS, England	Lanzhou University; Gansu University of Chinese Medicine; University of London; King's College London	Chen, Y (corresponding author), Lanzhou Univ, Inst Theoret Phys, Lanzhou 730000, Peoples R China.	ychen@lzu.edu.cn	Chen, Yong/B-9051-2008; Wang, Hengtong/O-6772-2015	Chen, Yong/0000-0003-2580-5895; Wang, Hengtong/0000-0001-6876-4769	National Natural Science Foundation of China [10975063, 11105062]; Fundamental Research Funds for the Central Universities [lzujbky-2012-17]; Program for New Century Excellent Talents in University [NCET-11-0206]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET))	This work was supported by the National Natural Science Foundation of China (Grants No. 10975063 and 11105062), the Fundamental Research Funds for the Central Universities (Grant No. lzujbky-2012-17), and the Program for New Century Excellent Talents in University (Grant No. NCET-11-0206). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABELES M, 1982, ISRAEL J MED SCI, V18, P83; Abeles M, 1991, CORTICONICS NEURAL C, DOI DOI 10.1017/CBO9780511574566; Agmon-Snir H, 1998, NATURE, V393, P268, DOI 10.1038/30505; Alonso JM, 1996, NATURE, V383, P815, DOI 10.1038/383815a0; Bender VA, 2006, J NEUROSCI, V26, P4166, DOI 10.1523/JNEUROSCI.0176-06.2006; BERNANDER O, 1991, P NATL ACAD SCI USA, V88, P11569, DOI 10.1073/pnas.88.24.11569; Berry MJ, 1998, J NEUROSCI, V18, P2200; Burkitt AN, 2006, BIOL CYBERN, V95, P97, DOI 10.1007/s00422-006-0082-8; Burkitt AN, 2006, BIOL CYBERN, V95, P1, DOI 10.1007/s00422-006-0068-6; Carr CE, 1999, NEURAL COMPUT, V11, P1, DOI 10.1162/089976699300016773; Chen Y, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.051909; de la Rocha J, 2007, NATURE, V448, P802, DOI 10.1038/nature06028; deCharms RC, 2000, ANNU REV NEUROSCI, V23, P613, DOI 10.1146/annurev.neuro.23.1.613; DeWeese MR, 2003, J NEUROSCI, V23, P7940; Diesmann M, 1999, NATURE, V402, P529, DOI 10.1038/990101; Diesmann M, 2001, NEUROCOMPUTING, V38, P565, DOI 10.1016/S0925-2312(01)00409-X; Engel AK, 2001, TRENDS COGN SCI, V5, P16, DOI 10.1016/S1364-6613(00)01568-0; Grande LA, 2004, J NEUROSCI, V24, P1839, DOI 10.1523/JNEUROSCI.3500-03.2004; Grothe B, 2003, NAT REV NEUROSCI, V4, P540, DOI 10.1038/nrn1136; Herrmann A, 2002, J COMPUT NEUROSCI, V12, P83, DOI 10.1023/A:1015739523224; Herrmann A, 2001, J COMPUT NEUROSCI, V11, P135, DOI 10.1023/A:1012841516004; Joris P, 2007, TRENDS NEUROSCI, V30, P70, DOI 10.1016/j.tins.2006.12.004; Joris PX, 1998, NEURON, V21, P1235, DOI 10.1016/S0896-6273(00)80643-1; Kandler K, 2004, CURR OPIN NEUROBIOL, V14, P96, DOI 10.1016/j.conb.2004.01.017; Kara P, 2000, NEURON, V27, P635, DOI 10.1016/S0896-6273(00)00072-6; Katz Y, 2007, PLOS COMPUT BIOL, V3, P2432, DOI 10.1371/journal.pcbi.0030234; Kempter R, 1998, NEURAL COMPUT, V10, P1987, DOI 10.1162/089976698300016945; Konig P, 1996, TRENDS NEUROSCI, V19, P130, DOI 10.1016/S0166-2236(96)80019-1; Kostal L, 2010, CHINESE J PHYSIOL, V53, P454, DOI 10.4077/CJP.2010.AMM031; Kreuz T, 2007, J NEUROSCI METH, V165, P151, DOI 10.1016/j.jneumeth.2007.05.031; Krips R, 2009, NEURAL COMPUT, V21, P2524, DOI 10.1162/neco.2009.07-07-563; MAINEN ZF, 1995, SCIENCE, V268, P1503, DOI 10.1126/science.7770778; Marsalek P, 2005, BIOL CYBERN, V92, P445, DOI 10.1007/s00422-005-0571-1; Marsalek P, 2000, BIOSYSTEMS, V58, P83, DOI 10.1016/S0303-2647(00)00110-6; McAlpine D, 2003, TRENDS NEUROSCI, V26, P347, DOI 10.1016/S0166-2236(03)00140-1; Mejias JF, 2008, J COMPUT NEUROSCI, V24, P222, DOI 10.1007/s10827-007-0052-8; MILLER MI, 1992, J ACOUST SOC AM, V92, P202, DOI 10.1121/1.404284; Oertel D, 2000, P NATL ACAD SCI USA, V97, P11773, DOI 10.1073/pnas.97.22.11773; Pantic L, 2003, NETWORK-COMP NEURAL, V14, P17, DOI 10.1088/0954-898X/14/1/302; Riehle A, 1997, SCIENCE, V278, P1950, DOI 10.1126/science.278.5345.1950; Rodriguez-Molina VM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000319; Roy SA, 2001, J NEUROSCI, V21, P2462, DOI 10.1523/JNEUROSCI.21-07-02462.2001; Rudolph M, 2003, J COMPUT NEUROSCI, V14, P239, DOI 10.1023/A:1023245625896; Salinas E, 2000, J NEUROSCI, V20, P6193, DOI 10.1523/JNEUROSCI.20-16-06193.2000; Shadlen Michael N., 1994, Current Opinion in Neurobiology, V4, P569, DOI 10.1016/0959-4388(94)90059-0; Shadlen MN, 1998, J NEUROSCI, V18, P3870; Sherrington C, 1923, INTEGRATIVE ACTION N; SOFTKY WR, 1993, J NEUROSCI, V13, P334; Stevens CF, 1998, NAT NEUROSCI, V1, P210, DOI 10.1038/659; Tollin DJ, 2002, J NEUROSCI, V22, P1454, DOI 10.1523/JNEUROSCI.22-04-01454.2002; Usrey WM, 1999, ANNU REV PHYSIOL, V61, P435, DOI 10.1146/annurev.physiol.61.1.435; Usrey WM, 2000, J NEUROSCI, V20, P5461, DOI 10.1523/JNEUROSCI.20-14-05461.2000; Wang HP, 2010, SCIENCE, V328, P106, DOI 10.1126/science.1183108	53	12	12	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e56822	10.1371/journal.pone.0056822	http://dx.doi.org/10.1371/journal.pone.0056822			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418604	Green Published, gold			2022-12-25	WOS:000315970300198
J	Goutte, A; Cherel, Y; Houssais, MN; Klein, V; Ozouf-Costaz, C; Raccurt, M; Robineau, C; Masse, G				Goutte, Aurelie; Cherel, Yves; Houssais, Marie-Noelle; Klein, Vincent; Ozouf-Costaz, Catherine; Raccurt, Mireille; Robineau, Camille; Masse, Guillaume			Diatom-Specific Highly Branched Isoprenoids as Biomarkers in Antarctic Consumers	PLOS ONE			English	Article							POLAR MARINE ECOSYSTEMS; SEA-ICE CONDITIONS; EUPHAUSIA-SUPERBA; ADELIE PENGUINS; FOOD-WEB; TERRE-ADELIE; SOUTHERN; VARIABILITY; SEABIRD; KRILL	The structure, functioning and dynamics of polar marine ecosystems are strongly influenced by the extent of sea ice. Ice algae and pelagic phytoplankton represent the primary sources of nutrition for higher trophic-level organisms in seasonally ice-covered areas, but their relative contributions to polar marine consumers remain largely unexplored. Here, we investigated the potential of diatom-specific lipid markers and highly branched isoprenoids (HBIs) for estimating the importance of these two carbon pools in an Antarctic pelagic ecosystem. Using GC-MS analysis, we studied HBI biomarkers in key marine species over three years in Adelie Land, Antarctica: euphausiids (ice krill Euphausia crystallorophias and Antarctic krill E. superba), fish (bald notothens Pagothenia borchgrevinki and Antarctic silverfish Pleuragramma antarcticum) and seabirds (Adelie penguins Pygoscelis adeliae, snow petrels Pagodroma nivea and cape petrels Daption capense). This study provides the first evidence of the incorporation of HBI lipids in Antarctic pelagic consumers. Specifically, a di-unsaturated HBI (diene) of sea ice origin was more abundant in ice-associated species than in pelagic species, whereas a tri-unsaturated HBI (triene) of phytoplanktonic origin was more abundant in pelagic species than in ice-associated species. Moreover, the relative abundances of diene and triene in seabird tissues and eggs were higher during a year of good sea ice conditions than in a year of poor ice conditions. In turn, the higher contribution of ice algal derived organic matter to the diet of seabirds was related to earlier breeding and higher breeding success. HBI biomarkers are a promising tool for estimating the contribution of organic matter derived from ice algae in pelagic consumers from Antarctica.	[Goutte, Aurelie; Houssais, Marie-Noelle; Klein, Vincent; Robineau, Camille; Masse, Guillaume] Univ Paris 06, UMR CNRS 7159, Lab Oceanog & Climat Experimentat & Approches Num, Paris, France; [Cherel, Yves] Ctr Etud Biol Chize, UPR 1934 CNRS, Beauvoir Sur Niort, France; [Ozouf-Costaz, Catherine] Museum Natl Hist Nat, UMR CNRS 7138, F-75231 Paris, France; [Raccurt, Mireille] Univ Lyon, UMR CNRS 5023, Villeurbanne, France; [Masse, Guillaume] CNRS, Takuvik, PQ, Canada; [Masse, Guillaume] Univ Laval, UMI 3376, Takuvik, PQ, Canada	Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite; Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Centre National de la Recherche Scientifique (CNRS); Laval University	Goutte, A (corresponding author), Univ Paris 06, UMR CNRS 7159, Lab Oceanog & Climat Experimentat & Approches Num, Paris, France.	agoutte@gmail.com	Goutte, Aurelie/F-7572-2017	Goutte, Aurelie/0000-0001-8322-5843; Chiaradia, Andre/0000-0002-6178-4211	European Research Council (ICEPROXY) [203441]; French Insitut Paul-Emile Victor (IPEV) [1010, 1124, 131, 1039, 109]	European Research Council (ICEPROXY); French Insitut Paul-Emile Victor (IPEV)	This work was funded by the European Research Council (ICEPROXY, project number 203441) and the French Insitut Paul-Emile Victor (IPEV projects No 1010, G. Masse; No1124, G. Lecointre; No 131, C. Duchamp; No 1039, J-Y. Toullec and No109, H. Weimerskirch). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainley DG, 1998, POLAR BIOL, V20, P311, DOI 10.1007/s003000050308; Arrigo KR, 2004, ANTARCT SCI, V16, P471, DOI 10.1017/S0954102004002263; Arrigo KR, 1997, SCIENCE, V276, P394, DOI 10.1126/science.276.5311.394; Atkinson A, 2004, NATURE, V432, P100, DOI 10.1038/nature02996; Barbara L, 2010, QUATERNARY SCI REV, V29, P2731, DOI 10.1016/j.quascirev.2010.06.027; Barbraud C, 2006, P NATL ACAD SCI USA, V103, P6248, DOI 10.1073/pnas.0510397103; Barbraud C, 2001, J AVIAN BIOL, V32, P297, DOI 10.1111/j.0908-8857.2001.320402.x; Beaman RJ, 2011, ANTARCT SCI, V23, P95, DOI 10.1017/S095410201000074X; Bec A, 2011, METHODS ECOL EVOL, V2, P651, DOI 10.1111/j.2041-210X.2011.00111.x; Belt ST, 2007, ORG GEOCHEM, V38, P16, DOI 10.1016/j.orggeochem.2006.09.013; Brown TA, 2012, POLAR BIOL, V35, P1281, DOI 10.1007/s00300-012-1164-9; Brown TA, 2012, J PLANKTON RES, V34, P647, DOI 10.1093/plankt/fbs045; Brown TA, 2012, POLAR BIOL, V35, P131, DOI 10.1007/s00300-011-1045-7; Budge SM, 2008, OECOLOGIA, V157, P117, DOI 10.1007/s00442-008-1053-7; CHASTEL O, 1993, OECOLOGIA, V94, P278, DOI 10.1007/BF00341328; Cherel Y, 2008, MAR BIOL, V154, P813, DOI 10.1007/s00227-008-0974-3; Clarke A, 2003, ENVIRON CONSERV, V30, P1, DOI 10.1017/S0376892903000018; Cottin M, 2012, MAR BIOL, V159, P1843, DOI 10.1007/s00227-012-1974-x; Croxall JP, 2002, SCIENCE, V297, P1510, DOI 10.1126/science.1071987; Damste JSS, 2004, SCIENCE, V304, P584, DOI 10.1126/science.1096806; EICKEN H, 1992, POLAR BIOL, V12, P3; Flores H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031775; GARRISON DL, 1991, AM ZOOL, V31, P17; Gosselin M, 1997, DEEP-SEA RES PT II, V44, P1623, DOI 10.1016/S0967-0645(97)00054-4; HOSHIAI T, 1989, P NIPR S POLAR BIOL, V2, P61; HUBOLD G, 1985, POLAR BIOL, V5, P43, DOI 10.1007/BF00446044; Johns L, 1999, ORG GEOCHEM, V30, P1471, DOI 10.1016/S0146-6380(99)00112-6; Kattner G, 1998, MAR ECOL PROG SER, V170, P203, DOI 10.3354/meps170203; La Mesa M, 2004, POLAR BIOL, V27, P321, DOI 10.1007/s00300-004-0599-z; La Mesa M, 2012, FISH FISH, V13, P241, DOI 10.1111/j.1467-2979.2011.00427.x; Lizotte MP, 2001, AM ZOOL, V41, P57, DOI 10.1668/0003-1569(2001)041[0057:TCOSIA]2.0.CO;2; Masse G, 2011, ANTARCT SCI, V23, P487, DOI 10.1017/S0954102011000381; Masse G, 2008, EARTH PLANET SC LETT, V269, P565, DOI 10.1016/j.epsl.2008.03.017; Micol T, 2001, POLAR BIOL, V24, P175, DOI 10.1007/s003000000193; Moline MA, 2004, GLOBAL CHANGE BIOL, V10, P1973, DOI 10.1111/j.1365-2486.2004.00825.x; Montes-Hugo MA, 2008, DEEP-SEA RES PT II, V55, P2106, DOI 10.1016/j.dsr2.2008.04.036; Muller J, 2009, NAT GEOSCI, V2, P772, DOI 10.1038/NGEO665; Nicol S, 2006, BIOSCIENCE, V56, P111, DOI 10.1641/0006-3568(2006)056[0111:KCASIE]2.0.CO;2; Ono A, 2011, POLAR SCI, V5, P146, DOI 10.1016/j.polar.2011.04.006; Quetin LB, 2001, AM ZOOL, V41, P74, DOI 10.1668/0003-1569(2001)041[0074:EVAIIO]2.0.CO;2; RIDOUX V, 1989, POLAR BIOL, V9, P137, DOI 10.1007/BF00297168; Schofield O, 2010, SCIENCE, V328, P1520, DOI 10.1126/science.1185779; SIEGEL V, 1995, MAR ECOL PROG SER, V123, P45, DOI 10.3354/meps123045; Smetacek V, 2005, NATURE, V437, P362, DOI 10.1038/nature04161; Spreen G, 2008, J GEOPHYS RES-OCEANS, V113, DOI 10.1029/2005JC003384; VEIT RR, 1991, AUK, V108, P790; Williams CT, 2010, J ORNITHOL, V151, P531, DOI 10.1007/s10336-010-0513-0	47	13	13	0	70	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e56504	10.1371/journal.pone.0056504	http://dx.doi.org/10.1371/journal.pone.0056504			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418580	Green Published, gold			2022-12-25	WOS:000315970300173
J	Kempuraj, D; Twait, EC; Williard, DE; Yuan, ZB; Meyerholz, DK; Samuel, I				Kempuraj, Duraisamy; Twait, Erik C.; Williard, Deborah E.; Yuan, Zuobiao; Meyerholz, David K.; Samuel, Isaac			The Novel Cytokine Interleukin-33 Activates Acinar Cell Proinflammatory Pathways and Induces Acute Pancreatic Inflammation in Mice	PLOS ONE			English	Article							SUBSTANCE-P; MAST-CELLS; SYSTEMIC INFLAMMATION; CHEMOKINE SYNTHESIS; ADHESION MOLECULES; HYDROGEN-SULFIDE; ORGAN FAILURE; IL-33; LIGATION; EXPRESSION	Background: Acute pancreatitis is potentially fatal but treatment options are limited as disease pathogenesis is poorly understood. IL-33, a novel IL-1 cytokine family member, plays a role in various inflammatory conditions but its role in acute pancreatitis is not well understood. Specifically, whether pancreatic acinar cells produce IL-33 when stressed or respond to IL-33 stimulation, and whether IL-33 exacerbates acute pancreatic inflammation is unknown. Methods/Results: In duct ligation-induced acute pancreatitis in mice and rats, we found that (a) IL-33 concentration was increased in the pancreas; (b) mast cells, which secrete and also respond to IL-33, showed degranulation in the pancreas and lung; (c) plasma histamine and pancreatic substance P concentrations were increased; and (d) pancreatic and pulmonary proinflammatory cytokine concentrations were increased. In isolated mouse pancreatic acinar cells, TNF-alpha stimulation increased IL-33 release while IL-33 stimulation increased proinflammatory cytokine release, both involving the ERK MAP kinase pathway; the flavonoid luteolin inhibited IL-33-stimulated IL-6 and CCL2/MCP-1 release. In mice without duct ligation, exogenous IL-33 administration induced pancreatic inflammation without mast cell degranulation or jejunal inflammation; pancreatic changes included multifocal edema and perivascular infiltration by neutrophils and some macrophages. ERK MAP kinase (but not p38 or JNK) and NF-kB subunit p65 were activated in the pancreas of mice receiving exogenous IL-33, and acinar cells isolated from the pancreas of these mice showed increased spontaneous cytokine release (IL-6, CXCL2/MIP-2 alpha). Also, IL-33 activated ERK in human pancreatic tissue. Significance: As exogenous IL-33 does not induce jejunal inflammation in the same mice in which it induces pancreatic inflammation, we have discovered a potential role for an IL-33/acinar cell axis in the recruitment of neutrophils and macrophages and the exacerbation of acute pancreatic inflammation. Conclusion: IL-33 is induced in acute pancreatitis, activates acinar cell proinflammatory pathways and exacerbates acute pancreatic inflammation.	[Kempuraj, Duraisamy; Twait, Erik C.; Williard, Deborah E.; Yuan, Zuobiao; Samuel, Isaac] Univ Iowa, Dept Surg, Roy J & Lucille A Carver Coll Med, Iowa City, IA 52242 USA; [Meyerholz, David K.] Univ Iowa, Dept Pathol, Roy J & Lucille A Carver Coll Med, Iowa City, IA 52242 USA	University of Iowa; University of Iowa	Samuel, I (corresponding author), Univ Iowa, Dept Surg, Roy J & Lucille A Carver Coll Med, Iowa City, IA 52242 USA.	Isaac-Samuel@uiowa.edu	duraisamy, kempuraj/R-3043-2019; Meyerholz, David/J-8131-2019; Duraisamy, Kempuraj/AAC-5638-2022	Meyerholz, David/0000-0003-1552-3253; Samuel, Isaac/0000-0003-2538-121X	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), National Institutes of Health, Bethesda, MD [R01 DK-071731]; American Recovery and Reinvestment Act [NIH R01 DK-071731]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK071731] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), National Institutes of Health, Bethesda, MD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); American Recovery and Reinvestment Act; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the following research awards to I. Samuel: (a) Grant R01 DK-071731, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), National Institutes of Health, Bethesda, MD., and b) American Recovery and Reinvestment Act of 2009 - Supplemental Award to NIH R01 DK-071731. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beltran CJ, 2010, INFLAMM BOWEL DIS, V16, P1097, DOI 10.1002/ibd.21175; Benoist C, 2002, NATURE, V420, P875, DOI 10.1038/nature01324; Bhatia M, 2000, J PATHOL, V190, P117; Bhatia M, 1998, P NATL ACAD SCI USA, V95, P4760, DOI 10.1073/pnas.95.8.4760; Bhatia M, 2010, ANTIOXID REDOX SIGN, V12, P1191, DOI 10.1089/ars.2009.2927; Bi Y, 2005, AM J PHYSIOL-GASTR L, V289, pG561, DOI 10.1152/ajpgi.00508.2004; CHURG A, 1971, AM J PATHOL, V63, P521; Demyanets S, 2011, ARTERIOSCL THROM VAS, V31, P2080, DOI 10.1161/ATVBAHA.111.231431; Deshmane SL, 2009, J INTERF CYTOK RES, V29, P313, DOI 10.1089/jir.2008.0027; Dib H, 2002, BRIT J SURG, V89, P172, DOI 10.1046/j.0007-1323.2001.01991.x; Enoksson M, 2011, J IMMUNOL, V186, P2523, DOI 10.4049/jimmunol.1003383; Hsu CL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011944; Hueber AJ, 2011, EUR J IMMUNOL, V41, P2229, DOI 10.1002/eji.201041360; Isenmann R, 2001, PANCREAS, V22, P274, DOI 10.1097/00006676-200104000-00008; Johnson CD, 2004, GUT, V53, P1340, DOI 10.1136/gut.2004.039883; Kandere-Grzybowska K, 2003, J IMMUNOL, V171, P4830, DOI 10.4049/jimmunol.171.9.4830; Kobayashi Y, 2008, FRONT BIOSCI-LANDMRK, V13, P2400, DOI 10.2741/2853; Kobori A, 2010, J GASTROENTEROL, V45, P999, DOI 10.1007/s00535-010-0245-1; Lee JP, 2010, ACTA PHARMACOL SIN, V31, P831, DOI 10.1038/aps.2010.62; Lefrancais E, 2012, P NATL ACAD SCI USA, V109, P1673, DOI 10.1073/pnas.1115884109; Liew FY, 2010, NAT REV IMMUNOL, V10, P103, DOI 10.1038/nri2692; Liu XJ, 2009, BIOCHEM BIOPH RES CO, V386, P181, DOI 10.1016/j.bbrc.2009.06.008; Lopez-Font I, 2010, WORLD J GASTROENTERO, V16, P3411, DOI 10.3748/wjg.v16.i27.3411; Lopez-Lazaro M, 2009, MINI-REV MED CHEM, V9, P31, DOI 10.2174/138955709787001712; Lunderius-Andersson C, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00082; Carvalho KMMB, 2010, BIOL PHARM BULL, V33, P1534, DOI 10.1248/bpb.33.1534; Masamune A, 2010, AM J PHYSIOL-GASTR L, V299, pG821, DOI 10.1152/ajpgi.00178.2010; McKay CJ, 1999, BRIT J SURG, V86, P1302, DOI 10.1046/j.1365-2168.1999.01246.x; Meyerholz DK, 2007, AM J SURG, V194, P652, DOI 10.1016/j.amjsurg.2007.07.014; Meyerhotz DK, 2008, AM J SURG, V196, P675, DOI 10.1016/j.amjsurg.2008.07.009; Miller AM, 2011, J INFLAMM-LOND, V8, DOI 10.1186/1476-9255-8-22; Milovanovic M, 2012, IMMUNOL RES, V52, P89, DOI 10.1007/s12026-012-8283-9; Moulin D, 2007, CYTOKINE, V40, P216, DOI 10.1016/j.cyto.2007.09.013; Nathan C, 2002, NATURE, V420, P846, DOI 10.1038/nature01320; Norman J, 1998, AM J SURG, V175, P76, DOI 10.1016/S0002-9610(97)00240-7; Norman JG, 1996, SURGERY, V120, P515, DOI 10.1016/S0039-6060(96)80072-9; Ouziel R, 2012, AM J PATHOL, V180, DOI [10.1016/j.aj-path.2012.03.009, DOI 10.1016/J.AJ-PATH.2012.03.009]; Palmer G, 2009, ARTHRITIS RHEUM-US, V60, P738, DOI 10.1002/art.24305; Pastorelli Luca, 2011, Therap Adv Gastroenterol, V4, P311, DOI 10.1177/1756283X11410770; Pastorelli L, 2010, P NATL ACAD SCI USA, V107, P8017, DOI 10.1073/pnas.0912678107; Ramnath RD, 2008, BRIT J PHARMACOL, V154, P1339, DOI 10.1038/bjp.2008.188; Ramnath RD, 2007, J CELL MOL MED, V11, P1326, DOI 10.1111/j.1582-4934.2007.00086.x; RANSON JHC, 1974, SURG GYNECOL OBSTET, V139, P69; Samuel I, 2010, PANCREATOLOGY, V10, P536, DOI 10.1159/000320776; Schmitz J, 2005, IMMUNITY, V23, P479, DOI 10.1016/j.immuni.2005.09.015; Seidelin JB, 2010, IMMUNOL LETT, V128, P80, DOI 10.1016/j.imlet.2009.11.001; Silver MR, 2010, INFLAMM RES, V59, P207, DOI 10.1007/s00011-009-0088-5; Tamizhselvi R, 2007, J CELL MOL MED, V11, P315, DOI 10.1111/j.1582-4934.2007.00024.x; Tenner S, 1997, GASTROENTEROLOGY, V113, P899, DOI 10.1016/S0016-5085(97)70185-9; Theoharides TC, 2010, P NATL ACAD SCI USA, V107, P4448, DOI 10.1073/pnas.1000803107; Verri WA, 2010, ANN RHEUM DIS, V69, P1697, DOI 10.1136/ard.2009.122655; Williard DE, 2010, AM J SURG, V200, P283, DOI 10.1016/j.amjsurg.2009.12.004; Xiang ZG, 2010, IMMUNOL LETT, V131, P159, DOI 10.1016/j.imlet.2010.04.005; Yadav A, 2010, CLIN CHIM ACTA, V411, P1570, DOI 10.1016/j.cca.2010.07.006; Yagami A, 2010, J IMMUNOL, V185, P5743, DOI 10.4049/jimmunol.0903818; Yonetci N, 2001, INT J PANCREATOL, V29, P163, DOI 10.1385/IJGC:29:3:163; Yuan Z, 2011, J GASTROINTEST SURG, V15, P1670, DOI 10.1007/s11605-011-1643-2; Zhao WH, 2010, CELL MOL IMMUNOL, V7, P260, DOI 10.1038/cmi.2010.3; Zhao X, 2005, LUNG, V183, P253, DOI 10.1007/s00408-004-2538-8	59	46	50	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e56866	10.1371/journal.pone.0056866	http://dx.doi.org/10.1371/journal.pone.0056866			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418608	Green Submitted, Green Published, gold			2022-12-25	WOS:000315970300202
J	Grau, M; Pauly, S; Ali, J; Walpurgis, K; Thevis, M; Bloch, W; Suhr, F				Grau, Marijke; Pauly, Sebastian; Ali, Jamal; Walpurgis, Katja; Thevis, Mario; Bloch, Wilhelm; Suhr, Frank			RBC-NOS-Dependent S-Nitrosylation of Cytoskeletal Proteins Improves RBC Deformability	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; RED-BLOOD-CELLS; PLASMA NITRITE; ENDOTHELIAL DYSFUNCTION; HYPOXIC VASODILATION; SIGNALING MOLECULE; HUMAN ERYTHROCYTES; HUMAN CIRCULATION; IN-VITRO; PATHWAY	Background: Red blood cells (RBC) possess a nitric oxide synthase (RBC-NOS) whose activation depends on the PI3-kinase/Akt kinase pathway. RBC-NOS-produced NO exhibits important biological functions like maintaining RBC deformability. Until now, the cellular target structure for NO, to exert its influence on RBC deformability, remains unknown. In the present study we analyzed the modification of RBC-NOS activity by pharmacological treatments, the resulting influence on RBC deformability and provide first evidence for possible target proteins of RBC-NOS-produced NO in the RBC cytoskeletal scaffold. Methods/Findings: Blood from fifteen male subjects was incubated with the NOS substrate L-arginine to directly stimulate enzyme activity. Direct inhibition of enzyme activity was induced by L-N5-(1-Iminoethyl)-ornithin (L-NIO). Indirect stimulation and inhibition of RBC-NOS were achieved by applying insulin and wortmannin, respectively, substances known to affect PI3-kinase/Akt kinase pathway. The NO donor sodium nitroprusside (SNP) and the NO scavenger 2-(4-carboxyphenyl)-4,4,5,5-tetramethylimidazoline-1-oxyl-3-oxide (cPTIO) were additionally applied as NO positive and negative controls, respectively. Immunohistochemical staining was used to determine phosphorylation and thus activation of RBC-NOS. As a marker for NO synthesis nitrite was measured in plasma and RBCs using chemiluminescence detection. S-nitrosylation of erythrocyte proteins was determined by biotin switch assay and modified proteins were identified using LC-MS. RBC deformability was determined by ektacytometry. The data reveal that activated RBC-NOS leads to increased NO production, S-nitrosylation of RBC proteins and RBC deformability, whereas RBC-NOS inhibition resulted in contrary effects. Conclusion/Significance: This study first-time provides strong evidence that RBC-NOS-produced NO modifies RBC deformability through direct S-nitrosylation of cytoskeleton proteins, most likely alpha- and beta-spectrins. Our data, therefore, gain novel insights into biological functions of RBC-NOS by connecting impaired RBC deformability abilities to specific posttranslational modifications of RBC proteins. By identifying likely NO-target proteins in RBC, our results will stimulate new therapeutic approaches for patients with microvascular disorders.	[Grau, Marijke; Pauly, Sebastian; Ali, Jamal; Bloch, Wilhelm; Suhr, Frank] German Sport Univ Cologne, Dept Mol & Cellular Sport Med, Cologne, Germany; [Walpurgis, Katja; Thevis, Mario] German Sport Univ Cologne, Inst Biochem, Ctr Prevent Doping Res, Cologne, Germany; [Bloch, Wilhelm; Suhr, Frank] German Sport Univ Cologne, German Res Ctr Elite Sport, Cologne, Germany	German Sport University Cologne; German Sport University Cologne; University of Cologne; German Sport University Cologne	Grau, M (corresponding author), German Sport Univ Cologne, Dept Mol & Cellular Sport Med, Cologne, Germany.	m.grau@dshs-koeln.de	Suhr, Frank/AAU-5080-2021	Suhr, Frank/0000-0002-9013-3944; Grau, Dr. Marijke/0000-0003-1980-9195	German Research Center of Elite Sport	German Research Center of Elite Sport	The study was supported by The German Research Center of Elite Sport (momentum). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal J, 1992, Indian J Pathol Microbiol, V35, P5; Banerjee R, 1998, CLIN HEMORHEOL MICRO, V19, P21; Baskurt OK, 2009, CLIN HEMORHEOL MICRO, V42, P75, DOI 10.3233/CH-2009-1202; Bateman RM, 2003, CRIT CARE, V7, P359, DOI 10.1186/cc2353; Bode-Boger SM, 1998, BRIT J CLIN PHARMACO, V46, P489, DOI 10.1046/j.1365-2125.1998.00803.x; Bohmer A, 2012, BLOOD, V119, P1322, DOI 10.1182/blood-2011-11-393124; Boger RH, 1998, CIRCULATION, V98, P1842, DOI 10.1161/01.CIR.98.18.1842; Bor-Kucukatay M, 2003, AM J PHYSIOL-HEART C, V284, pH1577, DOI 10.1152/ajpheart.00665.2002; Broillet MC, 1999, CELL MOL LIFE SCI, V55, P1036, DOI 10.1007/s000180050354; Bruckdorfer Richard, 2005, Molecular Aspects of Medicine, V26, P3, DOI 10.1016/j.mam.2004.09.002; Bryan NS, 2005, NAT CHEM BIOL, V1, P290, DOI 10.1038/nchembio734; Chakrabarti A, 2006, BIOSCIENCE REP, V26, P369, DOI 10.1007/s10540-006-9024-x; Chung KKK, 2004, SCIENCE, V304, P1328, DOI 10.1126/science.1093891; Cortese-Krott M.M., 2012, BLOOD; Cosby K, 2003, NAT MED, V9, P1498, DOI 10.1038/nm954; Crawford JH, 2006, BLOOD, V107, P566, DOI 10.1182/blood-2005-07-2668; FORSTERMANN U, 1994, HYPERTENSION, V23, P1121, DOI 10.1161/01.HYP.23.6.1121; Forsyth AM, 2012, MICROVASC RES, V83, P347, DOI 10.1016/j.mvr.2012.02.004; Foster MW, 2009, TRENDS MOL MED, V15, P391, DOI 10.1016/j.molmed.2009.06.007; Foster MW, 2003, TRENDS MOL MED, V9, P160, DOI 10.1016/S1471-4914(03)00028-5; Franco T, 2010, TRANSFUS CLIN BIOL, V17, P87, DOI 10.1016/j.tracli.2010.05.008; Gladwin MT, 2005, NAT CHEM BIOL, V1, P245, DOI 10.1038/nchembio1005-245; Gladwin MT, 2004, FREE RADICAL BIO MED, V36, P707, DOI 10.1016/j.freeradbiomed.2003.11.032; Grau M, 2007, J CHROMATOGR B, V851, P106, DOI 10.1016/j.jchromb.2007.02.002; Hardeman MR, 2001, CLIN HEMORHEOL MICRO, V25, P1; Heitzer T, 2001, CIRCULATION, V104, P2673, DOI 10.1161/hc4601.099485; Hendgen-Cotta U, 2008, METHOD ENZYMOL, V441, P295, DOI 10.1016/S0076-6879(08)01216-0; Hess DT, 2005, NAT REV MOL CELL BIO, V6, P150, DOI 10.1038/nrm1569; HISHIKAWA K, 1993, J HYPERTENS, V11, P639, DOI 10.1097/00004872-199306000-00008; IGNARRO LJ, 1989, SEMIN HEMATOL, V26, P63; Imbrogno S, 2001, J EXP BIOL, V204, P1719; Jaffrey SR, 2001, NAT CELL BIOL, V3, P193, DOI 10.1038/35055104; Jubelin BC, 1996, AM J HYPERTENS, V9, P1214, DOI 10.1016/S0895-7061(96)00257-9; Kang ES, 2000, J LAB CLIN MED, V135, P444, DOI 10.1067/mlc.2000.106805; Kelm M, 1999, CARDIOVASC RES, V41, P765, DOI 10.1016/S0008-6363(98)00259-4; Kleinbongard P, 2003, FREE RADICAL BIO MED, V35, P790, DOI 10.1016/S0891-5849(03)00406-4; Kleinbongard P, 2006, FREE RADICAL BIO MED, V40, P295, DOI 10.1016/j.freeradbiomed.2005.08.025; Kleinbongard P, 2006, BLOOD, V107, P2943, DOI 10.1182/blood-2005-10-3992; Lakshmi VM, 2007, LIFE SCI, V80, P644, DOI 10.1016/j.lfs.2006.10.010; Lane P, 2001, Sci STKE, V2001, pre1, DOI 10.1126/stke.2001.86.re1; Lauer T, 2001, P NATL ACAD SCI USA, V98, P12814, DOI 10.1073/pnas.221381098; Ludolph B, 2007, VASC HEALTH RISK MAN, V3, P1069; Lundberg JO, 2005, ARTERIOSCL THROM VAS, V25, P915, DOI 10.1161/01.ATV.0000161048.72004.c2; Martinez-Ruiz A, 2004, CARDIOVASC RES, V62, P43, DOI 10.1016/j.cardiores.2004.01.013; MCCALL TB, 1991, BRIT J PHARMACOL, V102, P234, DOI 10.1111/j.1476-5381.1991.tb12159.x; Michell BJ, 1999, CURR BIOL, V9, P845, DOI 10.1016/S0960-9822(99)80371-6; Mihov D, 2009, AM J PHYSIOL-CELL PH, V297, pC378, DOI 10.1152/ajpcell.00543.2008; Nagababu E, 2003, J BIOL CHEM, V278, P46349, DOI 10.1074/jbc.M307572200; Pelletier MM, 2006, FREE RADICAL BIO MED, V41, P541, DOI 10.1016/j.freeradbiomed.2006.05.001; Pries AR, 2003, CLIN HEMORHEOL MICRO, V29, P143; RADOMSKI MW, 1990, BRIT J PHARMACOL, V101, P325, DOI 10.1111/j.1476-5381.1990.tb12709.x; REES DD, 1990, BRIT J PHARMACOL, V101, P746, DOI 10.1111/j.1476-5381.1990.tb14151.x; Sessa WC, 2004, J CELL SCI, V117, P2427, DOI 10.1242/jcs.01165; Stamler JS, 2001, CELL, V106, P675, DOI 10.1016/S0092-8674(01)00495-0; Suhr F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045982; Suhr F, 2009, NITRIC OXIDE-BIOL CH, V20, P95, DOI 10.1016/j.niox.2008.10.004; Totzeck M, 2012, CIRCULATION, V126, P325, DOI 10.1161/CIRCULATIONAHA.111.087155; Tsikas D, 2000, FEBS LETT, V478, P1, DOI 10.1016/S0014-5793(00)01686-0; Tziakas DN, 2007, J AM COLL CARDIOL, V49, P2081, DOI 10.1016/j.jacc.2006.08.069; Ulker P, 2012, CLIN HEMORHEOL MICRO; Ulker P, 2011, NITRIC OXIDE-BIOL CH, V24, P184, DOI 10.1016/j.niox.2011.03.003; VALLANCE P, 1992, LANCET, V339, P572; Vallette G, 1998, BIOCHEM J, V331, P713, DOI 10.1042/bj3310713; Walpurgis K, 2012, PROTEOMICS, V12, P3263, DOI 10.1002/pmic.201200280; ZICHE M, 1994, J CLIN INVEST, V94, P2036, DOI 10.1172/JCI117557; ZICHE M, 1993, BIOCHEM BIOPH RES CO, V192, P1198, DOI 10.1006/bbrc.1993.1543	66	125	125	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2013	8	2							e56759	10.1371/journal.pone.0056759	http://dx.doi.org/10.1371/journal.pone.0056759			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104BU	23424675	Green Published, Green Submitted, gold			2022-12-25	WOS:000315965100063
J	Pick, M; Azzola, L; Osborne, E; Stanley, EG; Elefanty, AG				Pick, Marjorie; Azzola, Lisa; Osborne, Elissa; Stanley, Edouard G.; Elefanty, Andrew G.			Generation of Megakaryocytic Progenitors from Human Embryonic Stem Cells in a Feeder- and Serum-Free Medium	PLOS ONE			English	Article							HEMATOPOIETIC PROGENITORS; IN-VITRO; DIFFERENTIATION CULTURES; DEFINITIVE HEMATOPOIESIS; FUNCTIONAL PLATELETS; PERIPHERAL-BLOOD; MOUSE EMBRYO; CORD BLOOD; EXPRESSION; GROWTH	Background: The production of human platelets from embryonic stem cells in a defined culture system is a prerequisite for the generation of platelets for therapeutic use. As an important step towards this goal, we report the differentiation of human embryonic stem cells (hESCs) towards the megakaryocyte (Mk) lineage using a 'spin embryoid body' method in serum-free differentiation medium. Methodology and Principal Findings: Immunophenotypic analyses of differentiating hESC identified a subpopulation of cells expressing high levels of CD41a that expressed other markers associated with the Mk lineage, including CD110, CD42b and CD61. Differentiated cells were sorted on the basis of their expression of CD41a, CD34 and CD45 and assessed for Mk colony formation, expression of myeloid and Mk genes and ability to endoreplicate DNA. In a collagen-based colony assay, the CD41a(+) cells sorted from these differentiation cultures produced 100-800 Mk progenitors at day 13 and 25-160 Mk progenitors at day 20 of differentiation per 100,000 cells assayed. Differentiated Mk cells produced platelet-like particles which expressed CD42b and were activated by ADP, similar to platelets generated from precursors in cord blood. These studies were complemented by real time PCR analyses showing that subsets of cells enriched for CD41a(+) Mk precursors expressed high levels of Mk associated genes such as PF4 and MPL. Conversely, high levels of myeloid and erythroid related transcripts, such as GATA1, TAL1/SCL and PU.1, were detected in sorted fractions containing CD34(+) and CD45(+) cells. Conclusions: We describe a serum- and feeder-free culture system that enabled the generation of Mk progenitors from human embryonic stem cells. These cells formed colonies that included differentiated Mks that fragmented to form platelet-like particles. This protocol represents an important step towards the generation of human platelets for therapeutic use.	[Pick, Marjorie; Azzola, Lisa; Stanley, Edouard G.; Elefanty, Andrew G.] Monash Univ, Monash Immunol & Stem Cell Labs, Clayton, Vic, Australia; [Osborne, Elissa] Monash IVF, Monash Reprod Pathol & Genet, Clayton, Vic, Australia	Monash University	Pick, M (corresponding author), Hadassah Hebrew Univ, Med Ctr, Dept Hematol, Jerusalem, Israel.	Marjorie@cc.huji.ac.il	Stanley, Ed G/A-2985-2013; Elefanty, Andrew G/A-6066-2008	Stanley, Ed G/0000-0002-6389-3665; Elefanty, Andrew/0000-0001-6448-8314	Australian Stem Cell Centre; Juvenile Diabetes Research Foundation; National Health and Medical Research Council (NHMRC) of Australia; Israel Cancer Research Fund (NY, USA); Stem Cells Australia	Australian Stem Cell Centre; Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); National Health and Medical Research Council (NHMRC) of Australia(National Health and Medical Research Council (NHMRC) of Australia); Israel Cancer Research Fund (NY, USA); Stem Cells Australia	This work was supported by research grants from the Australian Stem Cell Centre, Stem Cells Australia, the Juvenile Diabetes Research Foundation, the National Health and Medical Research Council (NHMRC) of Australia and by a Research Fellowship from the Israel Cancer Research Fund (NY, USA) to MP. AGE and EGS are Senior Research Fellows of the NHMRC. The funders had no role in study design, data collection and analysis, decision to publlsh or preparation of the manuscript.	Basch RS, 1999, BRIT J HAEMATOL, V105, P1044, DOI 10.1046/j.1365-2141.1999.01446.x; Berthier R, 1997, EXP HEMATOL, V25, P481; Costa M, 2005, NAT METHODS, V2, P259, DOI 10.1038/NMETH748; Costa Magdaline, 2008, Curr Protoc Stem Cell Biol, VChapter 1, DOI 10.1002/9780470151808.sc01c01s5; DEBILI N, 1995, BLOOD, V86, P2516; Dumon S, 2006, EXP HEMATOL, V34, P654, DOI 10.1016/j.exphem.2006.01.014; Elefanty AG, 1999, BLOOD, V94, P3754, DOI 10.1182/blood.V94.11.3754.423k05_3754_3763; Eto K, 2002, P NATL ACAD SCI USA, V99, P12819, DOI 10.1073/pnas.202380099; Feng R, 1998, BONE MARROW TRANSPL, V21, P1217, DOI 10.1038/sj.bmt.1701273; Ferkowicz MJ, 2003, DEVELOPMENT, V130, P4393, DOI 10.1242/dev.00632; Fujimoto TT, 2003, BLOOD, V102, P4044, DOI 10.1182/blood-2003-06-1773; Gaur M, 2006, J THROMB HAEMOST, V4, P436, DOI 10.1111/j.1538-7836.2006.01744.x; Kennedy M, 2007, BLOOD, V109, P2679, DOI 10.1182/blood-2006-09-047704; Klimchenko O, 2009, BLOOD, V114, P1506, DOI 10.1182/blood-2008-09-178863; Lu SJ, 2011, CELL RES, V21, P530, DOI 10.1038/cr.2011.8; Mikkola HKA, 2003, BLOOD, V101, P508, DOI 10.1182/blood-2002-06-1699; Mitjavila-Garcia MT, 2002, DEVELOPMENT, V129, P2003; Nerlov C, 2000, BLOOD, V95, P2543, DOI 10.1182/blood.V95.8.2543.008k19_2543_2551; Ng ES, 2008, NAT PROTOC, V3, P768, DOI 10.1038/nprot.2008.42; Ng ES, 2005, BLOOD, V106, P1601, DOI 10.1182/blood-2005-03-0987; Pick M, 2007, STEM CELLS, V25, P2206, DOI 10.1634/stemcells.2006-0713; Richards M, 2002, NAT BIOTECHNOL, V20, P933, DOI 10.1038/nbt726; Ruf A, 1997, BRIT J HAEMATOL, V98, P51, DOI 10.1046/j.1365-2141.1997.1502965.x; RYO R, 1980, THROMB RES, V17, P645, DOI 10.1016/0049-3848(80)90367-9; Schipper LF, 2012, STEM CELLS, V30, P988, DOI 10.1002/stem.1071; Schipper LF, 2003, EXP HEMATOL, V31, P324, DOI 10.1016/S0301-472X(03)00004-3; Takayama N, 2008, BLOOD, V111, P5298, DOI 10.1182/blood-2007-10-117622; Takayama N, 2010, J EXP MED, V207, P2817, DOI 10.1084/jem.20100844; Uzan G, 1996, Stem Cells, V14 Suppl 1, P194; Vodyanik MA, 2005, BLOOD, V105, P617, DOI 10.1182/blood-2004-04-1649; Vodyanik MA, 2006, BLOOD, V108, P2095, DOI 10.1182/blood-2006-02-003327; Yu QC, 2012, BLOOD, V119, P6243, DOI 10.1182/blood-2011-12-396093; Zambidis ET, 2008, BLOOD, V112, P3601, DOI 10.1182/blood-2008-03-144766; Zambidis ET, 2005, BLOOD, V106, P860, DOI 10.1182/blood-2004-11-4522; Zhang P, 1999, P NATL ACAD SCI USA, V96, P8705, DOI 10.1073/pnas.96.15.8705	35	35	38	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2013	8	2							e55530	10.1371/journal.pone.0055530	http://dx.doi.org/10.1371/journal.pone.0055530			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104BU	23424635	Green Published, gold			2022-12-25	WOS:000315965100023
J	Ly, S; Altman, R; Petrlova, J; Lin, Y; Hilt, S; Huser, T; Laurence, TA; Voss, JC				Ly, Sonny; Altman, Robin; Petrlova, Jitka; Lin, Yu; Hilt, Silvia; Huser, Thomas; Laurence, Ted A.; Voss, John C.			Binding of Apolipoprotein E Inhibits the Oligomer Growth of Amyloid-beta Peptide in Solution as Determined by Fluorescence Cross-correlation Spectroscopy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FAMILIAL ALZHEIMER-DISEASE; TYPE-4 ALLELE; MOUSE MODEL; APOE; PATHOGENESIS; PATHWAYS; GENOTYPE; ASSOCIATION; EXCITATION; DEPOSITION	One of the primary neuropathological hallmarks of Alzheimer disease is the presence of extracellular amyloid plaques resulting from the aggregation of amyloid-beta (A beta) peptides. The intrinsic disorder of the A beta peptide drives self-association and progressive reordering of the conformation in solution, and this dynamic distribution of A beta complicates biophysical studies. This property poses a challenge for understanding the interaction of A beta with apolipoprotein E (apoE). ApoE plays a pivotal role in the aggregation and clearance of A beta peptides in the brain, and the epsilon 4 allele of APOE is the most significant known genetic modulator of Alzheimer risk. Understanding the interaction between apoE and A beta will provide insight into the mechanism by which different apoE isoforms determine Alzheimer disease risk. Here we applied alternating laser excitation fluorescence cross-correlation spectroscopy to observe the single molecule interaction of A beta with apoE in the hydrated state. The diffusion time of freely diffusing A beta in the absence of apoE shows significant self-aggregation, whereas in the presence of apoE, binding of the protein results in a more stable complex. These results show that apoE slows down the oligomerization of A beta in solution and provide direct insight into the process by which apoE influences the deposition and clearance of A beta peptides in the brain. Furthermore, by developing an approach to remove signals arising from very large A beta aggregates, we show that real-time single particle observations provide access to information regarding the fraction of apoE bound and the stoichiometry of apoE and A beta in the complex.	[Ly, Sonny; Laurence, Ted A.] Lawrence Livermore Natl Lab, Phys & Life Sci Directorate, Livermore, CA 94550 USA; [Altman, Robin; Petrlova, Jitka; Hilt, Silvia; Voss, John C.] Univ Calif Davis, Dept Biochem & Mol Med, Davis, CA 95616 USA; [Ly, Sonny; Lin, Yu; Huser, Thomas] Univ Calif Davis, NSF Ctr Biophoton Sci & Technol, Sacramento, CA 95817 USA	United States Department of Energy (DOE); Lawrence Livermore National Laboratory; University of California System; University of California Davis; National Science Foundation (NSF); University of California System; University of California Davis	Laurence, TA (corresponding author), Lawrence Livermore Natl Lab, L-470,7000 East Ave, Livermore, CA 94550 USA.	Laurence2@llnl.gov; jcvoss@ucdavis.edu	Huser, Thomas/K-7291-2019; Laurence, Ted A/E-4791-2011	Huser, Thomas/0000-0003-2348-7416; Laurence, Ted A/0000-0003-1474-779X; Voss, John/0000-0001-9279-209X; Lin, Yu/0000-0001-5109-0972	National Institutes of Health [R01 AG029246]; United States Department of Energy by Lawrence Livermore National Laboratory [DE-AC52-07NA27344]; NATIONAL INSTITUTE ON AGING [R01AG029246] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Department of Energy by Lawrence Livermore National Laboratory(United States Department of Energy (DOE)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 AG029246 (to J.C.V.).; This work was also supported by the United States Department of Energy by Lawrence Livermore National Laboratory under Contract DE-AC52-07NA27344.	Bacia K, 2006, NAT METHODS, V3, P83, DOI 10.1038/NMETH822; Basak JM, 2012, MOL NEURODEGENER, V7, DOI 10.1186/1750-1326-7-14; Bentley NM, 2002, BIOCHEM J, V366, P273, DOI 10.1042/BJ20020207; Bertram L, 2007, NAT GENET, V39, P17, DOI 10.1038/ng1934; Bien-Ly N, 2011, P NATL ACAD SCI USA, V108, P4236, DOI 10.1073/pnas.1018381108; Bu GJ, 2009, NAT REV NEUROSCI, V10, P333, DOI 10.1038/nrn2620; Castellano JM, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002156; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; den Hartigh LJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050513; EHRENBERG M, 1976, Q REV BIOPHYS, V9, P69, DOI 10.1017/S003358350000216X; Farrer LA, 1997, JAMA-J AM MED ASSOC, V278, P1349, DOI 10.1001/jama.278.16.1349; Gao TJ, 2011, PROTEIN SCI, V20, P437, DOI 10.1002/pro.577; Holtzman DM, 1999, J CLIN INVEST, V103, pR15, DOI 10.1172/JCI6179; Holtzman DM, 2001, J MOL NEUROSCI, V17, P147, DOI 10.1385/JMN:17:2:147; Hong HS, 2010, NEUROBIOL AGING, V31, P1690, DOI 10.1016/j.neurobiolaging.2008.09.019; Huang XD, 1997, J BIOL CHEM, V272, P26464, DOI 10.1074/jbc.272.42.26464; Kapanidis AN, 2004, P NATL ACAD SCI USA, V101, P8936, DOI 10.1073/pnas.0401690101; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Kettling U, 1998, P NATL ACAD SCI USA, V95, P1416, DOI 10.1073/pnas.95.4.1416; Kim J, 2011, J NEUROSCI, V31, P18007, DOI 10.1523/JNEUROSCI.3773-11.2011; Kim J, 2009, NEURON, V63, P287, DOI 10.1016/j.neuron.2009.06.026; Kim SA, 2004, P NATL ACAD SCI USA, V101, P105, DOI 10.1073/pnas.2436461100; Kohl T, 2002, P NATL ACAD SCI USA, V99, P12161, DOI 10.1073/pnas.192433499; KOPPEL DE, 1974, PHYS REV A, V10, P1938, DOI 10.1103/PhysRevA.10.1938; LADU MJ, 1994, J BIOL CHEM, V269, P23403; Laurence TA, 2008, J BIOL CHEM, V283, P22895, DOI 10.1074/jbc.M800174200; Ly S, 2011, BIOPHYS J, V101, P970, DOI 10.1016/j.bpj.2011.06.060; MAGDE D, 1972, PHYS REV LETT, V29, P705, DOI 10.1103/PhysRevLett.29.705; Mahley RW, 2007, CURR ALZHEIMER RES, V4, P537, DOI 10.2174/156720507783018334; Mahley RW, 2012, NEURON, V76, P871, DOI 10.1016/j.neuron.2012.11.020; Mahley RW, 1999, J LIPID RES, V40, P1; Manelli AM, 2004, J MOL NEUROSCI, V23, P235, DOI 10.1385/JMN:23:3:235; Miller AE, 2009, ANAL CHEM, V81, P5614, DOI 10.1021/ac9001645; Mitternacht S, 2011, J MOL BIOL, V410, P357, DOI 10.1016/j.jmb.2011.05.014; Muller BK, 2005, BIOPHYS J, V89, P3508, DOI 10.1529/biophysj.105.064766; NAMBA Y, 1991, BRAIN RES, V541, P163, DOI 10.1016/0006-8993(91)91092-F; PERICAKVANCE MA, 1991, AM J HUM GENET, V48, P1034; Petrlova J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035443; Petrlova J, 2011, PROTEINS, V79, P402, DOI 10.1002/prot.22891; Raber J, 2004, NEUROBIOL AGING, V25, P641, DOI 10.1016/j.neurobiolaging.2003.12.023; Schwille P, 1997, BIOPHYS J, V72, P1878, DOI 10.1016/S0006-3495(97)78833-7; Sharman MJ, 2010, J ALZHEIMERS DIS, V21, P403, DOI 10.3233/JAD-2010-100141; STRITTMATTER WJ, 1993, P NATL ACAD SCI USA, V90, P8098, DOI 10.1073/pnas.90.17.8098; STRITTMATTER WJ, 1993, P NATL ACAD SCI USA, V90, P1977, DOI 10.1073/pnas.90.5.1977; Tetali SD, 2006, J LIPID RES, V47, P1358, DOI 10.1194/jlr.M500559-JLR200; Tetali SD, 2010, J LIPID RES, V51, P1273, DOI 10.1194/jlr.M000406; Thews E, 2005, BIOPHYS J, V89, P2069, DOI 10.1529/biophysj.104.057919; Verghese PB, 2011, LANCET NEUROL, V10, P241, DOI 10.1016/S1474-4422(10)70325-2; Wildsmith KR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038013; WISNIEWSKI T, 1992, NEUROSCI LETT, V135, P235, DOI 10.1016/0304-3940(92)90444-C; Wu JW, 2010, J BIOL CHEM, V285, P6071, DOI 10.1074/jbc.M109.069542; Zlokovic BV, 2005, BRAIN PATHOL, V15, P78	52	32	32	0	39	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 26	2013	288	17					11628	11635		10.1074/jbc.M112.411900	http://dx.doi.org/10.1074/jbc.M112.411900			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	133RP	23430745	hybrid, Green Published			2022-12-25	WOS:000318157600002
J	Reyes-Palomares, A; Rodriguez-Lopez, R; Ranea, JAG; Jimenez, FS; Medina, MA				Reyes-Palomares, Armando; Rodriguez-Lopez, Rocio; Ranea, Juan A. G.; Sanchez Jimenez, Francisca; Angel Medina, Miguel			Global Analysis of the Human Pathophenotypic Similarity Gene Network Merges Disease Module Components	PLOS ONE			English	Article							PROTEIN-INTERACTION; PHENOTYPE; GENOME; BIOLOGY; TOPOLOGY; GENOTYPE; MEDICINE; ONTOLOGY; CLUSTERS	The molecular complexity of genetic diseases requires novel approaches to break it down into coherent biological modules. For this purpose, many disease network models have been created and analyzed. We highlight two of them, "the human diseases networks'' (HDN) and "the orphan disease networks" (ODN). However, in these models, each single node represents one disease or an ambiguous group of diseases. In these cases, the notion of diseases as unique entities reduces the usefulness of network-based methods. We hypothesize that using the clinical features (pathophenotypes) to define pathophenotypic connections between disease-causing genes improve our understanding of the molecular events originated by genetic disturbances. For this, we have built a pathophenotypic similarity gene network (PSGN) and compared it with the unipartite projections (based on gene-to-gene edges) similar to those used in previous network models (HDN and ODN). Unlike these disease network models, the PSGN uses semantic similarities. This pathophenotypic similarity has been calculated by comparing pathophenotypic annotations of genes (human abnormalities of HPO terms) in the "Human Phenotype Ontology". The resulting network contains 1075 genes (nodes) and 26197 significant pathophenotypic similarities (edges). A global analysis of this network reveals: unnoticed pairs of genes showing significant pathophenotypic similarity, a biological meaningful re-arrangement of the pathological relationships between genes, correlations of biochemical interactions with higher similarity scores and functional biases in metabolic and essential genes toward the pathophenotypic specificity and the pleiotropy, respectively. Additionally, pathophenotypic similarities and metabolic interactions of genes associated with maple syrup urine disease (MSUD) have been used to merge into a coherent pathological module. Our results indicate that pathophenotypes contribute to identify underlying co-dependencies among disease-causing genes that are useful to describe disease modularity.	[Reyes-Palomares, Armando; Rodriguez-Lopez, Rocio; Ranea, Juan A. G.; Sanchez Jimenez, Francisca; Angel Medina, Miguel] Univ Malaga, Dept Mol Biol & Biochem, Fac Sci, E-29071 Malaga, Spain; [Reyes-Palomares, Armando; Rodriguez-Lopez, Rocio; Ranea, Juan A. G.; Sanchez Jimenez, Francisca; Angel Medina, Miguel] CIBER Enfermedades Raras CIBERER, Malaga, Spain	Universidad de Malaga; CIBER - Centro de Investigacion Biomedica en Red; CIBERER	Medina, MA (corresponding author), Univ Malaga, Dept Mol Biol & Biochem, Fac Sci, E-29071 Malaga, Spain.	medina@uma.es	Medina, Miguel Ángel/K-1763-2014; Reyes-Palomares, Armando/A-1936-2009	Medina, Miguel Ángel/0000-0001-7275-6462; Reyes-Palomares, Armando/0000-0002-0289-6889; Garcia Ranea, Juan Antonio/0000-0003-0327-1837	Spanish Ministry of Economy and Competitiveness and FEDER [SAF2011/26518, SAF2009/09839, PI12/01096, PS09/02216]; Andalusian Government and FEDER [PIE P08-CTS-3759, CVI-6585, BIO-267]; INTERCONNECTA-AMER grant (Spanish Ministry of Economy and Competitiveness and FEDER);  [SAF2009-09839];  [SAF2012-33110]	Spanish Ministry of Economy and Competitiveness and FEDER(Spanish Government); Andalusian Government and FEDER; INTERCONNECTA-AMER grant (Spanish Ministry of Economy and Competitiveness and FEDER); ; 	The authors' experimental work is supported by grants SAF2011/26518, SAF2009/09839, PI12/01096 and PS09/02216 (Spanish Ministry of Economy and Competitiveness and FEDER), and PIE P08-CTS-3759, CVI-6585 and funds from group BIO-267 (Andalusian Government and FEDER). JR acknowledges grants SAF2009-09839 and SAF2012-33110 and FSJ acknowledges funds from an INTERCONNECTA-AMER grant (Spanish Ministry of Economy and Competitiveness and FEDER). The "CIBER de Enfermedades Raras" is an initiative from the ISCIII (Spain). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert R, 2005, J CELL SCI, V118, P4947, DOI 10.1242/jcs.02714; Albert R, 2002, REV MOD PHYS, V74, P47, DOI 10.1103/RevModPhys.74.47; Amberger J, 2009, NUCLEIC ACIDS RES, V37, pD793, DOI 10.1093/nar/gkn665; Auffray C, 2009, GENOME MED, V1, DOI 10.1186/gm2; Ayme Segolene, 2003, Soins, P46; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Barabasi AL, 2011, NAT REV GENET, V12, P56, DOI 10.1038/nrg2918; Baranzini SE, 2009, HUM MOL GENET, V18, P2078, DOI 10.1093/hmg/ddp120; Benfey PN, 2008, SCIENCE, V320, P495, DOI 10.1126/science.1153716; Bossi A, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.17; Brohee S, 2012, METHODS MOL BIOL, V804, P327, DOI 10.1007/978-1-61779-361-5_18; Brohee S, 2008, NAT PROTOC, V3, P1616, DOI 10.1038/nprot.2008.100; Bult CJ, 2008, NUCLEIC ACIDS RES, V36, pD724, DOI 10.1093/nar/gkm961; Cai JJ, 2010, GENOME BIOL EVOL, V2, P815, DOI 10.1093/gbe/evq064; Cerami E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008918; Chavali S, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-78; Espinosa O, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019693; Fawcett T, 2006, PATTERN RECOGN LETT, V27, P861, DOI 10.1016/j.patrec.2005.10.010; Feldman I, 2008, P NATL ACAD SCI USA, V105, P4323, DOI 10.1073/pnas.0701722105; Goh KI, 2007, P NATL ACAD SCI USA, V104, P8685, DOI 10.1073/pnas.0701361104; Guan YF, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000165; Hidalgo CA, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000353; Hill WG, 2012, GENETICS; Ideker T, 2008, GENOME RES, V18, P644, DOI 10.1101/gr.071852.107; Kohler S, 2009, AM J HUM GENET, V85, P457, DOI 10.1016/j.ajhg.2009.09.003; Lee DS, 2008, P NATL ACAD SCI USA, V105, P9880, DOI 10.1073/pnas.0802208105; Lee DS, 2010, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2010/12/P12015; Linghu B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-9-r91; Loscalzo J, 2011, WIRES SYST BIOL MED, V3, P619, DOI 10.1002/wsbm.144; Mistry M, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-327; Montanez R, 2010, BIOESSAYS, V32, P246, DOI 10.1002/bies.200900145; Nellis MM, 2001, AM J HUM GENET, V68, P232, DOI 10.1086/316950; Osborne JD, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-S1-S6; Oti M, 2009, AM J HUM GENET, V85, P801, DOI 10.1016/j.ajhg.2009.10.026; Park J, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.16; Resnik P, 1995, INT JOINT CONF ARTIF, P448; Robinson PN, 2010, CLIN GENET, V77, P525, DOI 10.1111/j.1399-0004.2010.01436.x; Robinson PN, 2008, AM J HUM GENET, V83, P610, DOI 10.1016/j.ajhg.2008.09.017; Robinson PN, 2012, HUM MUTAT, V33, P777, DOI 10.1002/humu.22080; Rolfsson O, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-155; Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675; van Driel MA, 2006, EUR J HUM GENET, V14, P535, DOI 10.1038/sj.ejhg.5201585; Veeramani B, 2009, J COMPUT BIOL, V16, P291, DOI 10.1089/cmb.2008.14TT; Vidal M, 2011, CELL, V144, P986, DOI 10.1016/j.cell.2011.02.016; Wagner GP, 2011, NAT REV GENET, V12, P204, DOI 10.1038/nrg2949; Wheelock CE, 2009, MOL BIOSYST, V5, P588, DOI 10.1039/b902356a; Xie MZ, 2012, BIOINFORMATICS, V28, P5, DOI 10.1093/bioinformatics/btr603; Xu T, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-472; Zhang ML, 2011, AM J HUM GENET, V88, P755, DOI 10.1016/j.ajhg.2011.05.006; Zhang SZ, 2012, GENE, V497, P58, DOI 10.1016/j.gene.2012.01.014; Zhu XW, 2007, GENE DEV, V21, P1010, DOI 10.1101/gad.1528707	51	13	13	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2013	8	2							e56653	10.1371/journal.pone.0056653	http://dx.doi.org/10.1371/journal.pone.0056653			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IT	23437198	Green Submitted, gold, Green Published			2022-12-25	WOS:000315186000038
J	Lotz, S; Goderie, S; Tokas, N; Hirsch, SE; Ahmad, F; Corneo, B; Le, S; Banerjee, A; Kane, RS; Stern, JH; Temple, S; Fasano, CA				Lotz, Steven; Goderie, Susan; Tokas, Nicolas; Hirsch, Sarah E.; Ahmad, Faizzan; Corneo, Barbara; Le, Sheila; Banerjee, Akhilesh; Kane, Ravi S.; Stern, Jeffrey H.; Temple, Sally; Fasano, Christopher A.			Sustained Levels of FGF2 Maintain Undifferentiated Stem Cell Cultures with Biweekly Feeding	PLOS ONE			English	Article							SELF-RENEWAL; PLGA MICROSPHERES; VASCULAR NICHE; HUMAN ES; DIFFERENTIATION; GROWTH; TROPHOBLAST; DERIVATION; LINES; FATE	An essential aspect of stem cell culture is the successful maintenance of the undifferentiated state. Many types of stem cells are FGF2 dependent, and pluripotent stem cells are maintained by replacing FGF2-containing media daily, while tissue-specific stem cells are typically fed every 3rd day. Frequent feeding, however, results in significant variation in growth factor levels due to FGF2 instability, which limits effective maintenance due to spontaneous differentiation. We report that stabilization of FGF2 levels using controlled release PLGA microspheres improves expression of stem cell markers, increases stem cell numbers and decreases spontaneous differentiation. The controlled release FGF2 additive reduces the frequency of media changes needed to maintain stem cell cultures, so that human embryonic stem cells and induced pluripotent stem cells can be maintained successfully with biweekly feedings.	[Lotz, Steven; Goderie, Susan; Tokas, Nicolas; Hirsch, Sarah E.; Ahmad, Faizzan; Corneo, Barbara; Le, Sheila; Stern, Jeffrey H.; Temple, Sally; Fasano, Christopher A.] Neural Stem Cell Inst, Rensselaer, NY USA; [Banerjee, Akhilesh; Kane, Ravi S.] Rensselaer Polytech Inst, Dept Chem & Biol Engn, Troy, NY USA; [Tokas, Nicolas; Hirsch, Sarah E.; Ahmad, Faizzan; Corneo, Barbara; Temple, Sally; Fasano, Christopher A.] SUNY Albany, Sch Publ Hlth, New York State Dept Hlth, Dept Biomed Sci, Albany, NY USA	Rensselaer Polytechnic Institute; State University of New York (SUNY) System; State University of New York (SUNY) Albany	Fasano, CA (corresponding author), Neural Stem Cell Inst, Rensselaer, NY USA.	chrisfasano@nstemcell.org		Corneo, Barbara/0000-0001-5189-6749	Regenerative Research Foundation, Rensselaer NY	Regenerative Research Foundation, Rensselaer NY	This work was supported by funding from the Regenerative Research Foundation, Rensselaer NY. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akopian V, 2010, IN VITRO CELL DEV-AN, V46, P247, DOI 10.1007/s11626-010-9297-z; Ashton RS, 2007, BIOMATERIALS, V28, P5518, DOI 10.1016/j.biomaterials.2007.08.038; Brons IGM, 2007, NATURE, V448, P191, DOI 10.1038/nature05950; Caldwell MA, 2004, EXP NEUROL, V188, P408, DOI 10.1016/j.expneurol.2004.05.007; Carvajal-Vergara X, 2010, NATURE, V465, P808, DOI 10.1038/nature09005; Chambers SM, 2009, NAT BIOTECHNOL, V27, P275, DOI 10.1038/nbt.1529; Chen G, 2012, STEM CELLS, V30, P623, DOI 10.1002/stem.1021; Dawson E, 2008, ADV DRUG DELIVER REV, V60, P215, DOI 10.1016/j.addr.2007.08.037; Eiselleova L, 2009, STEM CELLS, V27, P1847, DOI 10.1002/stem.128; Fasano CA, 2007, CELL STEM CELL, V1, P87, DOI 10.1016/j.stem.2007.04.001; Fasano CA, 2010, CELL STEM CELL, V6, P336, DOI 10.1016/j.stem.2010.03.001; Fasano CA, 2009, GENE DEV, V23, P561, DOI 10.1101/gad.1743709; Fisher OZ, 2010, ACCOUNTS CHEM RES, V43, P419, DOI 10.1021/ar900226q; Furue MK, 2008, P NATL ACAD SCI USA, V105, P13409, DOI 10.1073/pnas.0806136105; Gothard D, 2010, TISSUE ENG PART C-ME, V16, P583, DOI [10.1089/ten.tec.2009.0462, 10.1089/ten.TEC.2009.0462]; Greber B, 2011, EMBO J, V30, P4874, DOI 10.1038/emboj.2011.407; Johnstone ED, 2005, BIOL REPROD, V73, P1282, DOI 10.1095/biolreprod.105.044206; Johnstone ED, 2005, PLACENTA, V26, P548, DOI 10.1016/j.placenta.2004.08.012; Kennedy M, 2007, BLOOD, V109, P2679, DOI 10.1182/blood-2006-09-047704; Kokovay E, 2010, CELL STEM CELL, V7, P163, DOI 10.1016/j.stem.2010.05.019; Levenstein ME, 2006, STEM CELLS, V24, P568, DOI 10.1634/stemcells.2005-0247; Li J, 2007, DIFFERENTIATION, V75, P299, DOI 10.1111/j.1432-0436.2006.00143.x; Liang CZ, 2012, J MATER SCI-MATER M, V23, P1097, DOI 10.1007/s10856-012-4563-0; Lu JM, 2009, EXPERT REV MOL DIAGN, V9, P325, DOI 10.1586/ERM.09.15; Manuilova E S, 2001, Izv Akad Nauk Ser Biol, P704; Moioli EK, 2006, TISSUE ENG, V12, P537, DOI 10.1089/ten.2006.12.537; Nostro MC, 2011, DEVELOPMENT, V138, P861, DOI 10.1242/dev.055236; Qian XM, 1998, DEVELOPMENT, V125, P3143; Sathananthan A. H., 2005, Italian Journal of Anatomy and Embryology, V110, P151; Shen Q, 2008, CELL STEM CELL, V3, P289, DOI 10.1016/j.stem.2008.07.026; Shi L, 2002, J PHARM SCI-US, V91, P1019, DOI 10.1002/jps.10042; Tesar PJ, 2007, NATURE, V448, P196, DOI 10.1038/nature05972; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Thomson JA, 1998, APMIS, V106, P149, DOI 10.1111/j.1699-0463.1998.tb01330.x; Xu CH, 2001, NAT BIOTECHNOL, V19, P971, DOI 10.1038/nbt1001-971; Xu RH, 2002, NAT BIOTECHNOL, V20, P1261, DOI 10.1038/nbt761; Yu PZ, 2011, CELL STEM CELL, V8, P326, DOI 10.1016/j.stem.2011.01.001; Yuan SH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017540; Yue ZC, 2010, SCI CHINA LIFE SCI, V53, P78, DOI 10.1007/s11427-010-0010-y; Zhu GZ, 2000, NAT BIOTECHNOL, V18, P52, DOI 10.1038/71916	40	67	73	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e56289	10.1371/journal.pone.0056289	http://dx.doi.org/10.1371/journal.pone.0056289			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437109	Green Submitted, Green Published, gold			2022-12-25	WOS:000315184200055
J	Reza, S; Shaukat, A; Arain, TM; Riaz, QS; Mahmud, M				Reza, Sara; Shaukat, Asma; Arain, Tariq M.; Riaz, Qasim Sarwar; Mahmud, Maria			Expression of Osteopontin in Patients with Thyroid Dysfunction	PLOS ONE			English	Article							PLASMA OSTEOPONTIN; INTRACELLULAR OSTEOPONTIN; BONE SIALOPROTEIN; FOLLOW-UP; BREAST; CALCIFICATION; ASSOCIATION; MACROPHAGES; CELLS; INFLAMMATION	Thyroid dysfunctions are common endocrine problems. They are often misdiagnosed, misunderstood, and frequently overlooked. These disorders affect almost every aspect of health. Most of them remain undetected because the clinical assessment alone lacks both sensitivity and specificity. As it is not sufficient enough we require the biochemical tests to confirm the diagnosis. As a consequence there is still great interest in new biomarkers that complement existing diagnostic tools. Osteopontin, a glycoprotein that can be detected in plasma, was found to be upregulated in several patients with hyperthyroidism and downregulated in hypothyroid patients so it may represent a new biomarker. 100 patients with thyroid dysfunctions (50 hyperthyroid, 50 hypothyroid) and 100 normal subjects were included in the study. Osteopontin and other clinical parameters for diagnosis of thyroid disorders were measured. Osteopontin is positively correlated with T3 and T4 (r = 0.62 and r = 0.75 respectively) while it is negatively correlated with thyroid stimulating hormone (r = -0.52) showing a significant correlation (p-value <0.001). Our findings suggest that osteopontin might be useful as a novel prognostic biomarker in patients with impaired thyroid function.	[Reza, Sara; Shaukat, Asma] Quaid e Azam Med Coll, Dept Pathol, Bahawalpur, Pakistan; [Arain, Tariq M.] Bahawal Victoria Hosp, Dept Ophthalmol, Bahawalpur, Pakistan; [Riaz, Qasim Sarwar] St John Providence Hlth Syst, Dept Med, Warren, MI USA; [Mahmud, Maria] Carleton Univ, Dept Biol, Ottawa, ON K1S 5B6, Canada	St. John Hospital & Medical Center; Carleton University	Reza, S (corresponding author), Quaid e Azam Med Coll, Dept Pathol, Bahawalpur, Pakistan.	sara_qmc@hotmail.com						Agnholt J, 2007, SCAND J IMMUNOL, V65, P453, DOI 10.1111/j.1365-3083.2007.01908.x; Alam Khan V., J MED SCI, V2, P89, DOI [10.3923/jms.2002.89.94, DOI 10.3923/JMS.2002.89.94]; Andersen S, 2002, J CLIN ENDOCR METAB, V87, P1068, DOI 10.1210/jc.87.3.1068; Arora S, 2009, INDIAN J CLIN BIOCHE, V24, P370, DOI 10.1007/s12291-009-0067-1; Ashizawa N, 1996, J CLIN INVEST, V98, P2218, DOI 10.1172/JCI119031; Baral N., 2002, Southeast Asian Journal of Tropical Medicine and Public Health, V33, P638; Blake CA, 2011, EXP BIOL MED, V236, P445, DOI 10.1258/ebm.2010.010334; Boelaert K, 2005, J ENDOCRINOL, V187, P1, DOI 10.1677/joe.1.06131; Briese J, 2010, ANTICANCER RES, V30, P1681; Comabella M, 2005, J NEUROIMMUNOL, V158, P231, DOI 10.1016/j.jneuroim.2004.09.004; Fedarko NS, 2001, CLIN CANCER RES, V7, P4060; FITZPATRICK LA, 1994, J CLIN INVEST, V94, P1597, DOI 10.1172/JCI117501; Golledge J, 2004, STROKE, V35, P1636, DOI 10.1161/01.STR.0000129790.00318.a3; Gomez-Ambrosi J, 2007, J CLIN ENDOCR METAB, V92, P3719, DOI 10.1210/jc.2007-0349; Guarino V, 2005, J CLIN ENDOCR METAB, V90, P5270, DOI 10.1210/jc.2005-0271; Guo HT, 2001, J IMMUNOL, V166, P1079, DOI 10.4049/jimmunol.166.2.1079; Gursoy G., 2010, CLIN REV OPIN, V2, P35; Gursoy G, 2010, J MED MED SCI, V1, P55; He B, 2006, ONCOGENE, V25, P2192, DOI 10.1038/sj.onc.1209248; HEINEGARD D, 1989, CONNECT TISSUE RES, V21, P333; HIROTA S, 1993, AM J PATHOL, V143, P1003; Hullinger TG, 2001, EXP CELL RES, V262, P69, DOI 10.1006/excr.2000.5074; Junaid A, 2007, AM J PHYSIOL-CELL PH, V292, pC919, DOI 10.1152/ajpcell.00477.2006; Kurata M, 2006, CLIN SCI, V111, P319, DOI 10.1042/CS20060074; Kwon HM, 2000, J KOREAN MED SCI, V15, P485, DOI 10.3346/jkms.2000.15.5.485; LAFFON A, 1991, J CLIN INVEST, V88, P546, DOI 10.1172/JCI115338; Liou YM, 2005, J BIOMED SCI, V12, P869, DOI 10.1007/s11373-005-9023-0; Mansoor R., 2010, ANN PAK I MED SCI, V6, P101; Mirza M, 2008, INT J CANCER, V122, P889, DOI 10.1002/ijc.23204; MURRY CE, 1994, AM J PATHOL, V145, P1450; Nau GJ, 2000, CYTOKINE REFERENCE C, V1st, P689; Nau GJ, 2000, CYTOKINE REFERENCE C, V1st, P1859; NODA M, 1989, J CELL BIOL, V108, P713, DOI 10.1083/jcb.108.2.713; Phillips JA, 2001, THYROID HORMONE DISO; Riaz M, 2009, INT J ENDOCRINOL MET, V7, P12; Ricardo SD, 2000, AM J PHYSIOL-RENAL, V278, pF708, DOI 10.1152/ajprenal.2000.278.5.F708; Saha P. K., 2007, Indian Journal of Community Medicine, V32, P139; Scatena M, 2007, ARTERIOSCL THROM VAS, V27, P2302, DOI 10.1161/ATVBAHA.107.144824; Seiffge D, 1996, J RHEUMATOL, V23, P2086; Shamon M, 2009, HLTH DIS CONDITION; SHANAHAN CM, 1994, J CLIN INVEST, V93, P2393, DOI 10.1172/JCI117246; Sharp JA, 1999, LAB INVEST, V79, P869; Singhal H, 1997, CLIN CANCER RES, V3, P605; Sodhi CP, 2001, AM J PHYSIOL-RENAL, V280, pF667, DOI 10.1152/ajprenal.2001.280.4.F667; Standal T, 2004, EXP ONCOL, V26, P179; Suzuki K, 2002, J BONE MINER RES, V17, P1486, DOI 10.1359/jbmr.2002.17.8.1486; Uaesoontrachoon K, 2008, INT J BIOCHEM CELL B, V40, P2303, DOI 10.1016/j.biocel.2008.03.020; VANDERPUMP MPJ, 1995, CLIN ENDOCRINOL, V43, P55, DOI 10.1111/j.1365-2265.1995.tb01894.x; Wada T, 1999, CIRC RES, V84, P166, DOI 10.1161/01.RES.84.2.166; Wong CK, 2005, RHEUMATOLOGY, V44, P602, DOI 10.1093/rheumatology/keh558; Xu L, 2011, J CLIN ENDOCR METAB, V96, P1866; Yen PM, 2001, PHYSIOL REV, V81, P1097, DOI 10.1152/physrev.2001.81.3.1097; Zhu BQ, 2004, J CELL PHYSIOL, V198, P155, DOI 10.1002/jcp.10394; Zohar R, 2000, J CELL PHYSIOL, V184, P118, DOI 10.1002/(SICI)1097-4652(200007)184:1<118::AID-JCP13>3.3.CO;2-P	54	15	17	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e56533	10.1371/journal.pone.0056533	http://dx.doi.org/10.1371/journal.pone.0056533			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437160	gold, Green Published, Green Submitted			2022-12-25	WOS:000315184200098
J	Rivas, AL; Jankowski, MD; Piccinini, R; Leitner, G; Schwarz, D; Anderson, KL; Fair, JM; Hoogesteijn, AL; Wolter, W; Chaffer, M; Blum, S; Were, T; Konah, SN; Kempaiah, P; Ong'echa, JM; Diesterbeck, US; Pilla, R; Czerny, CP; Hittner, JB; Hyman, JM; Perkins, DJ				Rivas, Ariel L.; Jankowski, Mark D.; Piccinini, Renata; Leitner, Gabriel; Schwarz, Daniel; Anderson, Kevin L.; Fair, Jeanne M.; Hoogesteijn, Almira L.; Wolter, Wilfried; Chaffer, Marcelo; Blum, Shlomo; Were, Tom; Konah, Stephen N.; Kempaiah, Prakash; Ong'echa, John M.; Diesterbeck, Ulrike S.; Pilla, Rachel; Czerny, Claus-Peter; Hittner, James B.; Hyman, James M.; Perkins, Douglas J.			Feedback-Based, System-Level Properties of Vertebrate-Microbial Interactions	PLOS ONE			English	Article							COMPOSITIONAL DATA-ANALYSIS; DIFFERENTIAL CELL COUNTS; STAPHYLOCOCCUS-AUREUS; INFLAMMATORY REACTIONS; CLINICALLY HEALTHY; NEGATIVE-FEEDBACK; MALARIAL ANEMIA; BIOLOGY; MILK; EVOLUTION	Background: Improved characterization of infectious disease dynamics is required. To that end, three-dimensional (3D) data analysis of feedback-like processes may be considered. Methods: To detect infectious disease data patterns, a systems biology (SB) and evolutionary biology (EB) approach was evaluated, which utilizes leukocyte data structures designed to diminish data variability and enhance discrimination. Using data collected from one avian and two mammalian (human and bovine) species infected with viral, parasite, or bacterial agents (both sensitive and resistant to antimicrobials), four data structures were explored: (i) counts or percentages of a single leukocyte type, such as lymphocytes, neutrophils, or macrophages (the classic approach), and three levels of the SB/EB approach, which assessed (ii) 2D, (iii) 3D, and (iv) multi-dimensional (rotating 3D) host-microbial interactions. Results: In all studies, no classic data structure discriminated disease-positive (D+, or observations in which a microbe was isolated) from disease-negative (D-, or microbial-negative) groups: D+ and D-data distributions overlapped. In contrast, multi-dimensional analysis of indicators designed to possess desirable features, such as a single line of observations, displayed a continuous, circular data structure, whose abrupt inflections facilitated partitioning into subsets statistically significantly different from one another. In all studies, the 3D, SB/EB approach distinguished three (steady, positive, and negative) feedback phases, in which D-data characterized the steady state phase, and D+ data were found in the positive and negative phases. In humans, spatial patterns revealed false-negative observations and three malaria-positive data classes. In both humans and bovines, methicillin-resistant Staphylococcus aureus (MRSA) infections were discriminated from non-MRSA infections. Conclusions: More information can be extracted, from the same data, provided that data are structured, their 3D relationships are considered, and well-conserved (feedback-like) functions are estimated. Patterns emerging from such structures may distinguish well-conserved from recently developed host-microbial interactions. Applications include diagnosis, error detection, and modeling.	[Rivas, Ariel L.; Were, Tom; Konah, Stephen N.; Kempaiah, Prakash; Ong'echa, John M.; Perkins, Douglas J.] Univ New Mexico, Ctr Global Hlth, Albuquerque, NM 87131 USA; [Rivas, Ariel L.; Anderson, Kevin L.] N Carolina State Univ, Raleigh, NC 27695 USA; [Jankowski, Mark D.] Univ Wisconsin, Dept Zool, Madison, WI 53706 USA; [Piccinini, Renata; Pilla, Rachel] Univ Milan, Milan, Italy; [Leitner, Gabriel; Blum, Shlomo] Kimron Vet Inst, IL-50250 Bet Dagan, Israel; [Schwarz, Daniel; Diesterbeck, Ulrike S.; Czerny, Claus-Peter] Univ Gottingen, Fac Agr Sci, Dept Anim Sci, D-37073 Gottingen, Germany; [Fair, Jeanne M.] Los Alamos Natl Lab, Los Alamos, NM USA; [Hoogesteijn, Almira L.] CINVESTAV, Ctr Invest & Estudios Avanzados, Merida, Yucatan, Mexico; [Wolter, Wilfried] Regierungsprasidium Giessen, Wetzlar, Germany; [Chaffer, Marcelo] Univ Prince Edward Isl, Atlantic Vet Coll, Dept Hlth Management, Charlottetown, PE C1A 4P3, Canada; [Hittner, James B.] Coll Charleston, Dept Psychol, Charleston, SC 29401 USA; [Hyman, James M.] Tulane Univ, Dept Math, New Orleans, LA 70118 USA	University of New Mexico; University of North Carolina; North Carolina State University; University of Wisconsin System; University of Wisconsin Madison; University of Milan; Kimron Veterinary Institute; University of Gottingen; United States Department of Energy (DOE); Los Alamos National Laboratory; CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional; University of Prince Edward Island; College of Charleston; Tulane University	Rivas, AL (corresponding author), Univ New Mexico, Ctr Global Hlth, Albuquerque, NM 87131 USA.	alrivas@unm.edu	Hyman, James M/AAF-7389-2020; Piccinini, Renata/K-6321-2017; Were, Tom/AAJ-9664-2021	Hyman, James M/0000-0001-5247-5794; Piccinini, Renata/0000-0002-1003-3960; Were, Tom/0000-0002-0349-9906; Ong'echa, John/0000-0003-3928-6774; Pilla, Rachel/0000-0001-7758-2609; Kempaiah, Prakasha/0000-0002-2901-0339	Los Alamos National Laboratory, Los Alamos, New Mexico, USA; National Research Service Award; National Institutes of Environmental Health Sciences Training Grant [T32 ES07015]; FOGARTY INTERNATIONAL CENTER [D43TW005884] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI051305] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES007015] Funding Source: NIH RePORTER	Los Alamos National Laboratory, Los Alamos, New Mexico, USA(United States Department of Energy (DOE)Los Alamos National Laboratory); National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Environmental Health Sciences Training Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	Because this study is based on data already reported or generated by projects already funded, it did not have any funding support, except the support received from Los Alamos National Laboratory, meant to fund a preparatory meeting, which is indicated in Acknowledgments. The support of Los Alamos National Laboratory, Los Alamos, New Mexico, USA, is appreciated, as well as that of the National Research Service Award, which granted the Predoctoral Traineeship Award to M.J. (National Institutes of Environmental Health Sciences Training Grant T32 ES07015, Molecular and Environmental Toxicology Center, University of Wisconsin-Madison).	Abel J, 2011, J INNATE IMMUN, V3, P495, DOI 10.1159/000327714; Aitchison J, 2005, MATH GEOL, V37, P829, DOI 10.1007/s11004-005-7383-7; Aitchison J, 1986, STAT ANAL COMPOSITIO; Altman DG, 2006, BRIT MED J, V332, P1080, DOI 10.1136/bmj.332.7549.1080; Anderson KL, 2010, J DAIRY SCI, V93, P5673, DOI 10.3168/jds.2009-2885; Anderson KL, 2006, AM J VET RES, V67, P1185, DOI 10.2460/ajvr.67.7.1185; Angeli D, 2004, P NATL ACAD SCI USA, V101, P1822, DOI 10.1073/pnas.0308265100; Anwar S, 2009, CLIN EXP IMMUNOL, V157, P216, DOI 10.1111/j.1365-2249.2009.03950.x; Aubel D, 2010, CURR OPIN GENET DEV, V20, P634, DOI 10.1016/j.gde.2010.09.003; Auffray C, 2008, PROG BIOPHYS MOL BIO, V97, P79, DOI 10.1016/j.pbiomolbio.2007.09.002; Bannenberg GL, 2005, J IMMUNOL, V174, P4345, DOI 10.4049/jimmunol.174.7.4345; Baxter MJ, 2006, ARCHAEOMETRY, V48, P511, DOI 10.1111/j.1475-4754.2006.00270.x; Bocharov G, 2011, P NATL ACAD SCI USA, V108, P3318, DOI 10.1073/pnas.1019706108; Bogorad L, 2008, PHOTOSYNTH RES, V95, P11, DOI 10.1007/s11120-007-9236-3; Bootsma MCJ, 2011, J R SOC INTERFACE, V8, P578, DOI 10.1098/rsif.2010.0349; Boshra H, 2004, J IMMUNOL, V172, P4381, DOI 10.4049/jimmunol.172.7.4381; Boucher HW, 2008, CLIN INFECT DIS, V46, pS344, DOI 10.1086/533590; Cannon W.B., 1932, WISDOM BODY; Cedersund G, 2009, FEBS J, V276, P903, DOI 10.1111/j.1742-4658.2008.06845.x; Crofts AR, 2007, COMPLEXITY, V13, P14, DOI 10.1002/cplx.20180; D'Agata EMC, 2007, J THEOR BIOL, V249, P487, DOI 10.1016/j.jtbi.2007.08.011; Drack M, 2011, SEMIN CANCER BIOL, V21, P150, DOI 10.1016/j.semcancer.2011.05.001; Dustin ML, 2009, IMMUNITY, V30, P482, DOI 10.1016/j.immuni.2009.03.010; Edwards AM, 2011, TRENDS MICROBIOL, V19, P184, DOI 10.1016/j.tim.2010.12.005; FEINSTEIN AR, 1990, J CLIN EPIDEMIOL, V43, P109, DOI 10.1016/0895-4356(90)90064-V; Forrester J.W., 1961, IND DYNAMICS; Freeman M, 2000, NATURE, V408, P313, DOI 10.1038/35042500; Gisiger T, 2001, BIOL REV, V76, P161, DOI 10.1017/S1464793101005607; Goldberg DE, 2012, CELL, V148, P1271, DOI 10.1016/j.cell.2012.02.021; Goldbeter A, 2012, FEBS LETT, V586, P2955, DOI 10.1016/j.febslet.2012.07.041; Grimes DA, 2002, LANCET, V359, P881, DOI 10.1016/S0140-6736(02)07948-5; Groesser SN, 2012, SYST DYNAM REV, V28, P46, DOI 10.1002/sdr.476; Hebert A, 2000, FEMS MICROBIOL LETT, V193, P57, DOI 10.1016/S0378-1097(00)00455-9; Hernan MA, 2006, J EPIDEMIOL COMMUN H, V60, P578, DOI 10.1136/jech.2004.029496; Hu ZY, 2011, NONLINEAR ANAL-REAL, V12, P2356, DOI 10.1016/j.nonrwa.2011.02.009; Jankowski MD, 2010, TOXICOLOGY, V269, P81, DOI 10.1016/j.tox.2010.01.010; Johnson BR, 2010, BIOL PHILOS, V25, P843, DOI 10.1007/s10539-010-9230-6; Katz JN, 1999, AM POLIT SCI REV, V93, P15, DOI 10.2307/2585758; Kitano H, 2002, SCIENCE, V295, P1662, DOI 10.1126/science.1069492; Kitano H, 2002, NATURE, V420, P206, DOI 10.1038/nature01254; Kitano H, 2011, NAT CHEM BIOL, V7, P323, DOI 10.1038/nchembio.574; Kurakin A, 2009, THEOR BIOL MED MODEL, V6, DOI 10.1186/1742-4682-6-6; Laking G, 2006, HEALTH ECON, V15, P1109, DOI 10.1002/hec.1114; Leitner G, 2000, J VET MED B, V47, P581, DOI 10.1046/j.1439-0450.2000.00388.x; Lovejoy CO, 2005, GAIT POSTURE, V21, P95, DOI 10.1016/j.gaitpost.2004.01.001; Luni C, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-161; Macklem PT, 2008, J APPL PHYSIOL, V104, P1844, DOI 10.1152/japplphysiol.00942.2007; Maina RN, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-S3-S4; McBryde ES, 2009, INFECT CONT HOSP EP, V30, P1045, DOI 10.1086/606168; Mehr R, 2006, B MATH BIOL, V68, P1073, DOI 10.1007/s11538-006-9124-6; Melvin JA, 2011, BIOCHEMISTRY-US, V50, P7591, DOI 10.1021/bi200844h; Michod RE, 2006, J THEOR BIOL, V239, P257, DOI 10.1016/j.jtbi.2005.08.043; MILTON JG, 1989, J THEOR BIOL, V138, P129, DOI 10.1016/S0022-5193(89)80135-3; Mitrophanov AY, 2008, BIOESSAYS, V30, P542, DOI 10.1002/bies.20769; Nesse RM, 2008, EVOL APPL, V1, P28, DOI 10.1111/j.1752-4571.2007.00006.x; Noble D, 2011, PHARMACOPSYCHIATRY, V44, pS9, DOI 10.1055/s-0031-1271703; Noble D, 2010, PHILOS T R SOC A, V368, P1125, DOI 10.1098/rsta.2009.0245; Novelli EM, 2010, BRIT J HAEMATOL, V149, P711, DOI 10.1111/j.1365-2141.2010.08147.x; O'Meara WP, 2007, AM J TROP MED HYG, V77, P246, DOI 10.4269/ajtmh.2007.77.246; Ong'echa JM, 2006, AM J TROP MED HYG, V74, P376, DOI 10.4269/ajtmh.2006.74.376; Pelletier F, 2009, PHILOS T R SOC B, V364, P1483, DOI 10.1098/rstb.2009.0027; Romero-Gomez MP, 2012, DIAGN MICR INFEC DIS, V72, P282, DOI 10.1016/j.diagmicrobio.2011.11.012; Pilla R, 2012, J DAIRY SCI, V95, P4410, DOI 10.3168/jds.2012-5331; Pilla R, 2012, VET REC, V170, DOI 10.1136/vr.100510; Popper K., 1968, SYST ZOOL; Pritchard L, 2011, PLANT SCI, V180, P584, DOI 10.1016/j.plantsci.2010.12.008; Qu ZL, 2011, PROG BIOPHYS MOL BIO, V107, P21, DOI 10.1016/j.pbiomolbio.2011.06.004; Ray JCJ, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000676; Rerknimitr R, 2010, J GASTROEN HEPATOL, V25, P946, DOI 10.1111/j.1440-1746.2009.06153.x; Rivas AL, 2001, J VET DIAGN INVEST, V13, P399, DOI 10.1177/104063870101300506; Rivas AL, 2001, AM J VET RES, V62, P1840, DOI 10.2460/ajvr.2001.62.1840; Sawai H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010639; Schindler M, 2006, CELL BIOCHEM BIOPHYS, V45, P215, DOI 10.1385/CBB:45:2:215; Schmidt NJ, 1989, DIAGNOSTIC PROCEDURE; Schmitz J, 2005, J MOL EVOL, V61, P1, DOI 10.1007/s00239-004-0293-3; Schwarz D, 2011, J DAIRY SCI, V94, P5033, DOI 10.3168/jds.2011-4348; Schwarz D, 2011, J DAIRY RES, V78, P448, DOI 10.1017/S0022029911000574; Senge P. M., 1999, 5 DISCIPLINE ART PRA; Shiraishi T, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000851; Siawaya JFD, 2008, J INFECTION, V56, P340, DOI 10.1016/j.jinf.2008.02.007; Smilde AK, 2010, METABOLOMICS, V6, P3, DOI 10.1007/s11306-009-0191-1; Smith LC, 2001, IMMUNOL REV, V180, P16, DOI 10.1034/j.1600-065X.2001.1800102.x; Song Z, 2010, IEEE T PATTERN ANAL, V32, P1770, DOI 10.1109/TPAMI.2009.192; Stark J, 2007, IMMUNOL REV, V216, P213; Tarnok A, 2010, CURR MED CHEM, V17, P1719, DOI 10.2174/092986710791111251; Thieffry D, 2007, BRIEF BIOINFORM, V8, P220, DOI 10.1093/bib/bbm028; Thwaites GE, 2011, NAT REV MICROBIOL, V9, P215, DOI 10.1038/nrmicro2508; UMBARGER HE, 1956, SCIENCE, V123, P848, DOI 10.1126/science.123.3202.848; Villoslada P, 2009, ANN NEUROL, V65, P124, DOI 10.1002/ana.21634; Way JC, 2007, COMPLEXITY, V13, P22, DOI 10.1002/cplx.20198; Were T, 2011, J CLIN MICROBIOL, V49, P671, DOI 10.1128/JCM.01864-10; Wikler M. A., 2009, PERFORMANCE STANDARD; Zak DE, 2009, IMMUNOL REV, V227, P264, DOI 10.1111/j.1600-065X.2008.00721.x; Zeron ES, 2008, MATH MODEL NAT PHENO, V3, P67, DOI 10.1051/mmnp:2008055	94	12	13	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e53984	10.1371/journal.pone.0053984	http://dx.doi.org/10.1371/journal.pone.0053984			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437039	Green Published, Green Submitted, gold			2022-12-25	WOS:000315184200006
J	Stanczyk, NM; Brookfield, JFY; Field, LM; Logan, JG				Stanczyk, Nina M.; Brookfield, John F. Y.; Field, Linda M.; Logan, James G.			Aedes aegypti Mosquitoes Exhibit Decreased Repellency by DEET following Previous Exposure	PLOS ONE			English	Article							RHODNIUS-PROLIXUS STAL; BLOOD 1ST EVIDENCE; DROSOPHILA-MELANOGASTER; BLOODSUCKING INSECT; HOST PREFERENCE; PARASITIC WASP; DIPTERA; ODOR; ADAPTATION; VECTORS	DEET (N,N-Diethyl-m-toluamide) is one of the most widely used mosquito repellents. Although DEET has been shown to be extremely effective, recent studies have revealed that certain individual insects are unaffected by its presence. A genetic basis for this has been shown in Aedes aegypti mosquitoes and the fruit fly Drosophila melanogaster, but, for the triatomine bug, Rhodnius prolixus, a decrease in response to DEET occurred shortly after previous exposure, indicating that non-genetic factors may also be involved in DEET "insensitivity". In this study, we examined host-seeking behaviour and electrophysiological responses of A. aegypti after pre-exposure to DEET. We found that three hours after pre-exposure the mosquitoes showed behavioural insensitivity, and electroantennography revealed this correlated with the olfactory receptor neurons responding less to DEET. The change in behaviour as a result of pre-exposure to DEET has implications for the use of repellents and the ability of mosquitoes to overcome them.	[Stanczyk, Nina M.; Field, Linda M.] Rothamsted Res, Biol Chem & Crop Protect Dept, Harpenden, Herts, England; [Stanczyk, Nina M.; Brookfield, John F. Y.] Univ Nottingham, Sch Biol, Ctr Genet & Genom, Nottingham NG7 2RD, England; [Logan, James G.] London Sch Hyg & Trop Med, Dept Dis Control, London WC1, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Rothamsted Research; University of Nottingham; University of London; London School of Hygiene & Tropical Medicine	Logan, JG (corresponding author), London Sch Hyg & Trop Med, Dept Dis Control, London WC1, England.	james.logan@lshtm.ac.uk		Field, Linda/0000-0002-3328-2513	Lawes Trust Foundation; Biotechnology and Biological Sciences Research Council; Biotechnology and Biological Sciences Research Council [BBS/E/C/00005194, BBS/E/C/00005193] Funding Source: researchfish; BBSRC [BBS/E/C/00005193, BBS/E/C/00005194] Funding Source: UKRI	Lawes Trust Foundation; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The Lawes Trust Foundation is acknowledged for studentship (to NMS). Rothamsted receives grant-aided support from the Biotechnology and Biological Sciences Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramson CI, 2005, PSYCHOL REP, V97, P721, DOI 10.2466/pr0.97.3.721-731; Aldana E, 2008, PARASITOL RES, V103, P587, DOI 10.1007/s00436-008-1014-4; Alonso WJ, 2003, MEM I OSWALDO CRUZ, V98, P665, DOI 10.1590/S0074-02762003000500014; ARREDONDOJIMENEZ JI, 1992, J MED ENTOMOL, V29, P894, DOI 10.1093/jmedent/29.5.894; Barbarossa IT, 2007, CHEM SENSES, V32, P535, DOI 10.1093/chemse/bjm022; Barnard DR, 2002, J MED ENTOMOL, V39, P895, DOI 10.1603/0022-2585-39.6.895; BECKER HJ, 1970, MOL GEN GENET, V107, P194, DOI 10.1007/BF00333634; Bernhard N, 2000, LEARN MEMORY, V7, P199, DOI 10.1101/lm.7.4.199; Bhagavan S, 1997, PHYSIOL BEHAV, V61, P107, DOI 10.1016/S0031-9384(96)00357-5; Boeckh J, 1996, PESTIC SCI, V48, P359, DOI 10.1002/(SICI)1096-9063(199612)48:4&lt;359::AID-PS490&gt;3.0.CO;2-Z; CURTIS CF, 1987, MED VET ENTOMOL, V1, P109, DOI 10.1111/j.1365-2915.1987.tb00331.x; DAVIS EE, 1972, J ECON ENTOMOL, V65, P1058, DOI 10.1093/jee/65.4.1058; Devaud JM, 2001, J NEUROSCI, V21, P6274, DOI 10.1523/JNEUROSCI.21-16-06274.2001; Fradin MS, 2002, NEW ENGL J MED, V347, P13, DOI 10.1056/NEJMoa011699; Fradin MS, 1998, ANN INTERN MED, V128, P931, DOI 10.7326/0003-4819-128-11-199806010-00013; Frances SP, 2005, AUST J ENTOMOL, V44, P431, DOI 10.1111/j.1440-6055.2005.00498.x; Geier M, 1999, ENTOMOL EXP APPL, V92, P9, DOI 10.1023/A:1003797623701; Hamilton CE, 2011, MED VET ENTOMOL, V25, P428, DOI 10.1111/j.1365-2915.2011.00964.x; Hill N, 2007, BRIT MED J, V335, P1023, DOI 10.1136/bmj.39356.574641.55; Jhumur US, 2006, J MED ENTOMOL, V43, P1164, DOI 10.1603/0022-2585(2006)43[1164:NACROC]2.0.CO;2; Kaur JS, 2003, MED VET ENTOMOL, V17, P457, DOI 10.1111/j.1365-2915.2003.00455.x; Kelly DW, 2000, PARASITOLOGY, V120, P319, DOI 10.1017/S0031182099005442; Killeen GF, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-207; Kiszewski AE, 2010, J VECTOR DIS, V47, P217; KUENEN LPS, 1981, J INSECT PHYSIOL, V27, P721, DOI 10.1016/0022-1910(81)90010-X; Leinders-Zufall T, 1999, J NEUROSCI, V19, DOI 10.1523/JNEUROSCI.19-14-j0005.1999; LEWIS WJ, 1990, NATURE, V348, P635, DOI 10.1038/348635a0; Logan JG, 2008, J CHEM ECOL, V34, P308, DOI 10.1007/s10886-008-9436-0; McCall PJ, 2001, T ROY SOC TROP MED H, V95, P587, DOI 10.1016/S0035-9203(01)90087-2; McCall PJ, 2001, MED VET ENTOMOL, V15, P197, DOI 10.1046/j.0269-283x.2001.00304.x; Mwandawiro C, 2000, T ROY SOC TROP MED H, V94, P238, DOI 10.1016/S0035-9203(00)90303-1; Okech BA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004050; PAPAJ DR, 1989, ANNU REV ENTOMOL, V34, P315, DOI 10.1146/annurev.en.34.010189.001531; Park KC, 2001, PHYSIOL ENTOMOL, V26, P69, DOI 10.1046/j.1365-3032.2001.00219.x; Reeder NL, 2001, J ECON ENTOMOL, V94, P1584, DOI 10.1603/0022-0493-94.6.1584; RUTLEDGE LC, 1994, J AM MOSQUITO CONTR, V10, P93; Sanford MR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024218; Sfara V, 2011, J INSECT PHYSIOL, V57, P1431, DOI 10.1016/j.jinsphys.2011.07.009; Stanczyk NM, 2010, P NATL ACAD SCI USA, V107, P8575, DOI 10.1073/pnas.1001313107; Stortkuhl KF, 1999, J NEUROSCI, V19, P4839; Syed Z, 2008, P NATL ACAD SCI USA, V105, P13598, DOI 10.1073/pnas.0805312105; Tawatsin A, 2001, J VECTOR ECOL, V26, P76; Tomberlin JK, 2006, NATURWISSENSCHAFTEN, V93, P551, DOI 10.1007/s00114-006-0143-9; Vinauger C, 2012, ACTA TROP, V122, P24, DOI 10.1016/j.actatropica.2011.11.007; Vinauger C, 2011, J EXP BIOL, V214, P3039, DOI 10.1242/jeb.057075; Vinauger C, 2011, J EXP BIOL, V214, P3032, DOI 10.1242/jeb.056697; Waddell S, 2001, ANNU REV NEUROSCI, V24, P1283, DOI 10.1146/annurev.neuro.24.1.1283; Who, 2009, GUID EFF TEST MOSQ R, P1	48	59	59	0	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e54438	10.1371/journal.pone.0054438	http://dx.doi.org/10.1371/journal.pone.0054438			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437043	gold, Green Published, Green Submitted, Green Accepted			2022-12-25	WOS:000315184200008
J	Zhou, WJ; Zhang, YP; Schaefer, DA; Sha, LQ; Deng, Y; Deng, XB; Dai, KJ				Zhou, Wen-Jun; Zhang, Yi-Ping; Schaefer, Douglas A.; Sha, Li-Qing; Deng, Yun; Deng, Xiao-Bao; Dai, Kai-Jie			The Role of Stream Water Carbon Dynamics and Export in the Carbon Balance of a Tropical Seasonal Rainforest, Southwest China	PLOS ONE			English	Article							DISSOLVED ORGANIC-CARBON; INORGANIC CARBON; XISHUANGBANNA; NITROGEN; CATCHMENTS; FLUXES; RESPIRATION; PHOSPHORUS; DECOMPOSITION; TRANSPORT	A two-year study (2009 similar to 2010) was carried out to investigate the dynamics of different carbon (C) forms, and the role of stream export in the C balance of a 23.4-ha headwater catchment in a tropical seasonal rainforest at Xishuangbanna (XSBN), southwest China. The seasonal volumetric weighted mean (VWM) concentrations of total inorganic C (TIC) and dissolved inorganic C (DIC) were higher, and particulate inorganic C (PIC) and organic C (POC) were lower, in the dry season than the rainy season, while the VWM concentrations of total organic C (TOC) and dissolved organic C (DOC) were similar between seasons. With increased monthly stream discharge and stream water temperature (SWT), only TIC and DIC concentrations decreased significantly. The most important C form in stream export was DIC, accounting for 51.8% of the total C (TC) export; DOC, POC, and PIC accounted for 21.8%, 14.9%, and 11.5% of the TC export, respectively. Dynamics of C flux were closely related to stream discharge, with the greatest export during the rainy season. C export in the headwater stream was 47.1 kg C ha(-1) yr(-1), about 2.85% of the annual net ecosystem exchange. This finding indicates that stream export represented a minor contribution to the C balance in this tropical seasonal rainforest.	[Zhou, Wen-Jun; Zhang, Yi-Ping; Schaefer, Douglas A.; Sha, Li-Qing; Deng, Yun; Deng, Xiao-Bao; Dai, Kai-Jie] Chinese Acad Sci, Key Lab Trop Forest Ecol, Xishuangbanna Trop Bot Garden, Mengla, Yunnan, Peoples R China; [Zhou, Wen-Jun; Zhang, Yi-Ping; Schaefer, Douglas A.; Sha, Li-Qing; Deng, Yun; Deng, Xiao-Bao; Dai, Kai-Jie] Chinese Acad Sci, Xishuangbanna Trop Bot Garden, Kunming, Peoples R China; [Zhou, Wen-Jun; Zhang, Yi-Ping; Sha, Li-Qing; Deng, Yun; Deng, Xiao-Bao] Chinese Ecosyst Res Net, Xishuangbanna Stn Trop Rain Forest Ecosyst Studie, Mengla, Yunnan, Peoples R China; [Zhou, Wen-Jun] Univ Chinese Acad Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Xishuangbanna Tropical Botanical Garden, CAS; Chinese Academy of Sciences; Xishuangbanna Tropical Botanical Garden, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Zhang, YP (corresponding author), Chinese Acad Sci, Key Lab Trop Forest Ecol, Xishuangbanna Trop Bot Garden, Mengla, Yunnan, Peoples R China.	yipingzh@xtbg.ac.cn			National Science Foundation of China [40801035, 40571163]; CAS 135 program [XTBG-T03]; Strategic Priority Research Program-Climate Change: Carbon Budget and Related Issues of the Chinese Academy of Sciences [XDA05020302]; Development Program in Basic Science of China [2010CB833501]; Yunnan Natural Science Foundation of Yunnan Province, China [2008CD167]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); CAS 135 program; Strategic Priority Research Program-Climate Change: Carbon Budget and Related Issues of the Chinese Academy of Sciences(Chinese Academy of Sciences); Development Program in Basic Science of China; Yunnan Natural Science Foundation of Yunnan Province, China	This study was funded by the National Science Foundation of China (40801035, 40571163), the CAS 135 program (XTBG-T03) and Strategic Priority Research Program-Climate Change: Carbon Budget and Related Issues of the Chinese Academy of Sciences(XDA05020302), the Development Program in Basic Science of China (No. 2010CB833501), and the Yunnan Natural Science Foundation of Yunnan Province, China (2008CD167). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldrian E, 2008, J GEOPHYS RES-BIOGEO, V113, DOI 10.1029/2007JG000626; Baker A, 2008, AREA, V40, P117, DOI 10.1111/j.1475-4762.2007.00780.x; Benoy G, 2007, ENVIRON REV, V15, P175, DOI 10.1139/A07-006; Buffam I, 2001, BIOGEOCHEMISTRY, V53, P269, DOI 10.1023/A:1010643432253; Butman D, 2011, NAT GEOSCI, V4, P839, DOI [10.1038/ngeo1294, 10.1038/NGEO1294]; Butturini A, 2000, BIOGEOCHEMISTRY, V51, P303, DOI 10.1023/A:1006420229411; Cao Min, 1996, Tropical Ecology, V37, P183; Cole JJ, 2007, ECOSYSTEMS, V10, P171, DOI 10.1007/s10021-006-9013-8; Doctor DH, 2008, HYDROL PROCESS, V22, P2410, DOI 10.1002/hyp.6833; Elder JF, 2000, WETLANDS, V20, P113, DOI 10.1672/0277-5212(2000)020[0113:SAYODC]2.0.CO;2; [房秋兰 Fang Qiulan], 2005, [山地学报, Journal of Mountain Science], V23, P488; Finlay JC, 2003, BIOGEOCHEMISTRY, V62, P231, DOI 10.1023/A:1021183023963; Fujii K, 2011, GEODERMA, V163, P119, DOI 10.1016/j.geoderma.2011.04.012; Fujii K, 2009, GEODERMA, V152, P127, DOI 10.1016/j.geoderma.2009.05.028; Goller R, 2006, BIOGEOCHEMISTRY, V77, P57, DOI 10.1007/s10533-005-1061-1; Haaland S, 2010, BIOGEOCHEMISTRY, V97, P45, DOI 10.1007/s10533-009-9373-1; Johnson MS, 2006, HYDROL PROCESS, V20, P2599, DOI 10.1002/hyp.6218; Liu WJ, 2011, WATER ENVIRON J, V25, P138, DOI 10.1111/j.1747-6593.2009.00211.x; Lloret E, 2010, CHEM GEOL, V230, P65; Lu XT, 2010, FOREST ECOL MANAG, V260, P1798, DOI 10.1016/j.foreco.2010.08.024; McClain ME, 1997, GLOBAL BIOGEOCHEM CY, V11, P295, DOI 10.1029/97GB01056; MCDOWELL WH, 1994, LIMNOL OCEANOGR, V39, P111, DOI 10.4319/lo.1994.39.1.0111; MEYBECK M, 1982, AM J SCI, V282, P401, DOI 10.2475/ajs.282.4.401; Meyer JL, 1998, ECOSYSTEMS, V1, P240, DOI 10.1007/s100219900019; Moller A, 2005, J PLANT NUTR SOIL SC, V168, P649, DOI 10.1002/jpln.200521804; Neu V, 2011, BIOGEOCHEMISTRY, V105, P133, DOI 10.1007/s10533-011-9581-3; Palmer SM, 2001, BIOGEOCHEMISTRY, V52, P321, DOI 10.1023/A:1006447706565; [乔玉娜 QIAO Yuna], 2009, [生态环境学报, Ecology and Environmental Sciences], V18, P2300; Rantakari M, 2010, SCI TOTAL ENVIRON, V408, P1649, DOI 10.1016/j.scitotenv.2009.12.025; Raymond PA, 2010, BIOGEOCHEMISTRY, V100, P197, DOI 10.1007/s10533-010-9416-7; Ren Y., 1999, ACTA PHYSIOL SINICA, V23, P418; Richey JE, 2002, NATURE, V416, P617, DOI 10.1038/416617a; RICHEY JE, 1980, SCIENCE, V207, P1348, DOI 10.1126/science.207.4437.1348; Saunders TJ, 2006, HYDROL PROCESS, V20, P2549, DOI 10.1002/hyp.6215; Sha LQ, 2005, SCI CHINA SER D, V48, P189, DOI 10.1360/05zd0019; Shibata H, 2005, ECOL RES, V20, P325, DOI 10.1007/s11284-005-0048-7; Sousa ED, 2011, BIOGEOCHEMISTRY, V105, P159, DOI 10.1007/s10533-011-9613-z; Tan ZH, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL050006; Tan ZH, 2010, J GEOPHYS RES-ATMOS, V115, DOI 10.1029/2009JD012913; Tang JW, 2010, PLANT SOIL, V335, P271, DOI 10.1007/s11104-010-0414-2; [唐炎林 TANG Yanlin], 2007, [安徽农业科学, Journal of Anhui Agricultural Sciences], V35, P779; [王馨 WANG Xin], 2005, [热带气象学报, Journal of Tropical Meteorology], V21, P658; Wilson HF, 2008, ECOSYSTEMS, V11, P555, DOI 10.1007/s10021-008-9142-3; Yan Yu-Ping, 2008, Zhiwu Shengtai Xuebao, V32, P23; Zhang YP, 2010, ATMOS ENVIRON, V44, P3886, DOI 10.1016/j.atmosenv.2010.07.027; [张一平 Zhang Yiping], 2003, [生态学报, Acta Ecologica Sinica], V23, P2653; Zheng Z, 2006, BIOTROPICA, V38, P342, DOI 10.1111/j.1744-7429.2006.00151.x; Zhou GY, 2006, SCI CHINA SER D, V49, P311, DOI 10.1007/s11430-006-0311-y	48	8	13	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e56646	10.1371/journal.pone.0056646	http://dx.doi.org/10.1371/journal.pone.0056646			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437195	Green Submitted, Green Published, gold			2022-12-25	WOS:000315184200126
J	Gawecka, JE; Marh, J; Ortega, M; Yamauchi, Y; Ward, MA; Ward, WS				Gawecka, Joanna E.; Marh, Joel; Ortega, Michael; Yamauchi, Yasuhiro; Ward, Monika A.; Ward, W. Steven			Mouse Zygotes Respond to Severe Sperm DNA Damage by Delaying Paternal DNA Replication and Embryonic Development	PLOS ONE			English	Article							PROGRAMMED CELL-DEATH; PREIMPLANTATION DEVELOPMENT; CYCLOPHOSPHAMIDE EXPOSURE; MAMMALIAN-CELLS; NUCLEAR-MATRIX; BOVINE EMBRYO; RAT ZYGOTE; SPERMATOZOA; CHROMATIN; PHOSPHORYLATION	Mouse zygotes do not activate apoptosis in response to DNA damage. We previously reported a unique form of inducible sperm DNA damage termed sperm chromatin fragmentation (SCF). SCF mirrors some aspects of somatic cell apoptosis in that the DNA degradation is mediated by reversible double strand breaks caused by topoisomerase 2B (TOP2B) followed by irreversible DNA degradation by a nuclease(s). Here, we created zygotes using spermatozoa induced to undergo SCF (SCF zygotes) and tested how they responded to moderate and severe paternal DNA damage during the first cell cycle. We found that the TUNEL assay was not sensitive enough to identify the breaks caused by SCF in zygotes in either case. However, paternal pronuclei in both groups stained positively for gamma H2AX, a marker for DNA damage, at 5 hrs after fertilization, just before DNA synthesis, while the maternal pronuclei were negative. We also found that both pronuclei in SCF zygotes with moderate DNA damage replicated normally, but paternal pronuclei in the SCF zygotes with severe DNA damage delayed the initiation of DNA replication by up to 12 hrs even though the maternal pronuclei had no discernable delay. Chromosomal analysis of both groups confirmed that the paternal DNA was degraded after S-phase while the maternal pronuclei formed normal chromosomes. The DNA replication delay caused a marked retardation in progression to the 2-cell stage, and a large portion of the embryos arrested at the G2/M border, suggesting that this is an important checkpoint in zygotic development. Those embryos that progressed through the G2/M border died at later stages and none developed to the blastocyst stage. Our data demonstrate that the zygote responds to sperm DNA damage through a non-apoptotic mechanism that acts by slowing paternal DNA replication and ultimately leads to arrest in embryonic development.	[Gawecka, Joanna E.; Marh, Joel; Ortega, Michael; Yamauchi, Yasuhiro; Ward, Monika A.; Ward, W. Steven] Univ Hawaii Manoa, John A Burns Sch Med, Dept Anat Biochem & Physiol, Inst Biogenesis Res, Honolulu, HI 96822 USA	University of Hawaii System; University of Hawaii Manoa	Ward, WS (corresponding author), Univ Hawaii Manoa, John A Burns Sch Med, Dept Anat Biochem & Physiol, Inst Biogenesis Res, Honolulu, HI 96822 USA.	wward@hawaii.edu	Ortega, Michael/AAN-2379-2021		National Institutes of Health [1R01HD060722, 8P20GM103457, 1R01HD072380]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD072380, R01HD060722] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103457] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by National Institutes of Health grants 1R01HD060722, 8P20GM103457, and 1R01HD072380. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adiga SK, 2007, ONCOGENE, V26, P6141, DOI 10.1038/sj.onc.1210444; Adiga SK, 2007, REPRODUCTION, V133, P415, DOI 10.1530/REP-06-0048; Ajduk A, 2006, BIOL REPROD, P90; Aoki F, 1999, ZYGOTE, V7, P165, DOI 10.1017/S0967199499000532; Austin C.R., 1961, MAMMALIAN EGG; Baart EB, 2004, HUM REPROD, V19, P1140, DOI 10.1093/humrep/deh184; Barton TS, 2007, TOXICOL SCI, V100, P495, DOI 10.1093/toxsci/kfm242; Barton TS, 2005, P NATL ACAD SCI USA, V102, P7865, DOI 10.1073/pnas.0501200102; BEREZNEY R, 1975, SCIENCE, V189, P291, DOI 10.1126/science.1145202; Byrne AT, 1999, J REPROD FERTIL, V117, P97, DOI 10.1530/jrf.0.1170097; CHATOT CL, 1989, J REPROD FERTIL, V86, P679, DOI 10.1530/jrf.0.0860679; Dalal SN, 1999, MOL CELL BIOL, V19, P4465; Derijck A, 2008, HUM MOL GENET, V17, P1922, DOI 10.1093/hmg/ddn090; Derijck AAHA, 2006, DNA REPAIR, V5, P959, DOI 10.1016/j.dnarep.2006.05.043; Dijkwel PA, 1995, INT REV CYTOL, V162A, P455; Fear JM, 2011, BIOL REPROD, V84, P43, DOI 10.1095/biolreprod.110.086249; Gall L, 2008, REPRODUCTION, V135, P431, DOI 10.1530/REP-07-0284; Garber JC, 2011, GUIDE CARE USE LAB A; GAUTIER J, 1991, CELL, V67, P197, DOI 10.1016/0092-8674(91)90583-K; GAVRIELI Y, 1992, J CELL BIOL, V119, P493, DOI 10.1083/jcb.119.3.493; GENEROSO WM, 1979, P NATL ACAD SCI USA, V76, P435, DOI 10.1073/pnas.76.1.435; Gjorret JO, 2003, BIOL REPROD, V69, P1193, DOI 10.1095/biolreprod.102.013243; Gonzalez-Marin C, 2012, INT J MOL SCI, V13, P14026, DOI 10.3390/ijms131114026; Grenier L, 2010, BIOL REPROD, V83, P195, DOI 10.1095/biolreprod.109.083345; Hammoud SS, 2009, NATURE, V460, P473, DOI 10.1038/nature08162; HARDY K, 1989, DEVELOPMENT, V107, P597; Hardy K, 1997, MOL HUM REPROD, V3, P919, DOI 10.1093/molehr/3.10.919; Jurisicova A, 1996, MOL HUM REPROD, V2, P93, DOI 10.1093/molehr/2.2.93; Jurisicova A, 1998, MOL HUM REPROD, V4, P139, DOI 10.1093/molehr/4.2.139; KIMURA Y, 1995, BIOL REPROD, V52, P709, DOI 10.1095/biolreprod52.4.709; MATSUDA Y, 1989, INT J RADIAT BIOL, V55, P233, DOI 10.1080/09553008914550281; Matwee C, 2000, ZYGOTE, V8, P57, DOI 10.1017/S0967199400000836; McManus KJ, 2005, MOL BIOL CELL, V16, P5013, DOI 10.1091/mbc.E05-01-0065; MIKAMO K, 1983, MUTAT RES, V108, P265, DOI 10.1016/0027-5107(83)90125-2; Mu XF, 2011, BIOL REPROD, V85, P524, DOI 10.1095/biolreprod.110.089334; Nashun B, 2010, DEVELOPMENT, V137, P3785, DOI 10.1242/dev.051805; Nghiem P, 2001, P NATL ACAD SCI USA, V98, P9092, DOI 10.1073/pnas.161281798; PARDOLL DM, 1980, CELL, V19, P527, DOI 10.1016/0092-8674(80)90527-9; Redon CE, 2010, CLIN CANCER RES, V16, P4532, DOI 10.1158/1078-0432.CCR-10-0523; Reinhardt HC, 2012, TRENDS GENET, V28, P128, DOI 10.1016/j.tig.2011.12.002; Robinson L, 2012, HUM REPROD, V27, P2908, DOI 10.1093/humrep/des261; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; SCHLEGEL R, 1986, SCIENCE, V232, P1264, DOI 10.1126/science.2422760; Shaman JA, 2007, J CELL BIOCHEM, V102, P680, DOI 10.1002/jcb.21321; Shaman JA, 2006, BIOL REPROD, V75, P741, DOI 10.1095/biolreprod.106.055178; Shimura T, 2002, MOL CELL BIOL, V22, P2220, DOI 10.1128/MCB.22.7.2220-2228.2002; SIRLIN JL, 1959, EXP CELL RES, V18, P190, DOI 10.1016/0014-4827(59)90308-8; Sotolongo B, 2005, J ANDROL, V26, P272; Sotolongo B, 2003, BIOL REPROD, V69, P2029, DOI 10.1095/biolreprod.103.020594; Szczygiel M, 2003, MANIPULATING MOUSE E, P585; Szczygiel MA, 2003, BIOL REPROD, V68, P1903, DOI 10.1095/biolreprod.102.012377; Ward WS, 2010, MOL HUM REPROD, V16, P30, DOI 10.1093/molehr/gap080; Yamauchi Y, 2007, BIOL REPROD, V77, P803, DOI 10.1095/biolreprod.107.063040; Yamauchi Y, 2007, BIOL REPROD, V77, P636, DOI 10.1095/biolreprod.107.062406; Yamauchi Y, 2007, BIOL REPROD, V77, P407, DOI 10.1095/biolreprod.107.061473; Yamauchi Y, 2007, BIOL REPROD, V76, P1002, DOI 10.1095/biolreprod.106.059881; Yamauchi Y, 2007, BIOL REPROD, V76, P666, DOI 10.1095/biolreprod.106.057067; Yamauchi Y, 2009, J CELL BIOCHEM, V107, P214, DOI 10.1002/jcb.22117; Ziegler-Birling C, 2009, INT J DEV BIOL, V53, P1003, DOI 10.1387/ijdb.082707cz	59	89	90	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2013	8	2							e56385	10.1371/journal.pone.0056385	http://dx.doi.org/10.1371/journal.pone.0056385			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093HR	23431372	Green Submitted, gold, Green Published			2022-12-25	WOS:000315182800014
J	Klucken, J; Barth, J; Kugler, P; Schlachetzki, J; Henze, T; Marxreiter, F; Kohl, Z; Steidl, R; Hornegger, J; Eskofier, B; Winkler, J				Klucken, Jochen; Barth, Jens; Kugler, Patrick; Schlachetzki, Johannes; Henze, Thore; Marxreiter, Franz; Kohl, Zacharias; Steidl, Ralph; Hornegger, Joachim; Eskofier, Bjoern; Winkler, Juergen			Unbiased and Mobile Gait Analysis Detects Motor Impairment in Parkinson's Disease	PLOS ONE			English	Article							SOCIETY-SPONSORED REVISION; SCALE MDS-UPDRS; RATING-SCALE; INTERRATER RELIABILITY; DIAGNOSIS; WALKING	Motor impairments are the prerequisite for the diagnosis in Parkinson's disease (PD). The cardinal symptoms (bradykinesia, rigor, tremor, and postural instability) are used for disease staging and assessment of progression. They serve as primary outcome measures for clinical studies aiming at symptomatic and disease modifying interventions. One major caveat of clinical scores such as the Unified Parkinson Disease Rating Scale (UPDRS) or Hoehn&Yahr (H&Y) staging is its rater and time-of-assessment dependency. Thus, we aimed to objectively and automatically classify specific stages and motor signs in PD using a mobile, biosensor based Embedded Gait Analysis using Intelligent Technology (eGaIT). eGaIT consist of accelerometers and gyroscopes attached to shoes that record motion signals during standardized gait and leg function. From sensor signals 694 features were calculated and pattern recognition algorithms were applied to classify PD, H&Y stages, and motor signs correlating to the UPDRS-III motor score in a training cohort of 50 PD patients and 42 age matched controls. Classification results were confirmed in a second independent validation cohort (42 patients, 39 controls). eGaIT was able to successfully distinguish PD patients from controls with an overall classification rate of 81%. Classification accuracy increased with higher levels of motor impairment (91% for more severely affected patients) or more advanced stages of PD (91% for H&Y III patients compared to controls), supporting the PD-specific type of analysis by eGaIT. In addition, eGaIT was able to classify different H&Y stages, or different levels of motor impairment (UPDRS-III). In conclusion, eGaIT as an unbiased, mobile, and automated assessment tool is able to identify PD patients and characterize their motor impairment. It may serve as a complementary mean for the daily clinical workup and support therapeutic decisions throughout the course of the disease.	[Klucken, Jochen; Barth, Jens; Schlachetzki, Johannes; Henze, Thore; Marxreiter, Franz; Kohl, Zacharias; Winkler, Juergen] Univ Hosp Erlangen, Dept Mol Neurol, Erlangen, Germany; [Barth, Jens; Kugler, Patrick; Hornegger, Joachim; Eskofier, Bjoern] Univ Erlangen Nurnberg, Dept Comp Sci, Pattern Recognit Lab, Erlangen, Germany; [Barth, Jens; Steidl, Ralph] ASTRUM IT GmbH, Erlangen, Germany	University of Erlangen Nuremberg; University of Erlangen Nuremberg	Winkler, J (corresponding author), Univ Hosp Erlangen, Dept Mol Neurol, Erlangen, Germany.	jochen.klucken@uk-erlangen.de	Hornegger, Joachim/H-2465-2017; Eskofier, Bjoern/ABF-1284-2021; Marxreiter, Franz/ABB-6982-2020	Hornegger, Joachim/0000-0002-1834-8844; Eskofier, Bjoern/0000-0002-0417-0336; Marxreiter, Franz/0000-0002-5187-4344; Klucken, Jochen/0000-0001-6645-9437; Winkler, Jurgen/0000-0003-0630-9204; Schlachetzki, Johannes/0000-0002-7801-9743; Kugler, Patrick/0000-0002-1197-7621	Bavarian Research Foundation [AZ 974-11]; Bavarian Research Foundation ELAN ("Erlanger Leistungsbezogene Anschubfinanzierung und Nachwuchsforderung", University Hospital Erlangen, Germany) [AZ: 1008.17.1]; ASTRUM IT GmbH	Bavarian Research Foundation; Bavarian Research Foundation ELAN ("Erlanger Leistungsbezogene Anschubfinanzierung und Nachwuchsforderung", University Hospital Erlangen, Germany); ASTRUM IT GmbH	This work was funded by the Bavarian Research Foundation (AZ 974-11), ELAN ("Erlanger Leistungsbezogene Anschubfinanzierung und Nachwuchsforderung", University Hospital Erlangen, Germany - AZ: 1008.17.1), and by a project grant of ASTRUM IT GmbH. Shoes were provided by adidas (R) AG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bachlin M., 2009, P 4 INT C BOD AR NET, V7, P693; Barth J., 2011, C P IEEE ENG MED BIO; Barth J, 2012, C P IEEE ENG MED BIO, V2012; Bechtel N, 2010, NEUROLOGY, V75, P2150, DOI 10.1212/WNL.0b013e3182020123; Cabell L, 2013, J STRENGTH COND RES, V27, P1503, DOI 10.1519/JSC.0b013e318269f83d; Cancela J, 2010, IEEE ENG MED BIO, P1008, DOI 10.1109/IEMBS.2010.5627775; Cunningham L, 2011, IEEE T INF TECHNOL B, V15, P47, DOI 10.1109/TITB.2010.2091142; Dijkstra B, 2010, ARCH PHYS MED REHAB, V91, P1272, DOI 10.1016/j.apmr.2010.05.004; Duda R.O., 2000, PATTERN CLASSIFICATI; Ellis T, 2011, PARKINSONISM RELAT D, V17, P693, DOI 10.1016/j.parkreldis.2011.07.004; Eskofier B, 2009, PATTERN RECOGN LETT, V30, P1448, DOI 10.1016/j.patrec.2009.08.004; Eskofier BM, 2012, COMPUT METHOD BIOMEC, V15, P467, DOI 10.1080/10255842.2010.542153; Eskofier BM, 2011, COMPUT METHODS BIOME; Gelb DJ, 1999, ARCH NEUROL-CHICAGO, V56, P33, DOI 10.1001/archneur.56.1.33; Goetz CG, 2004, MOVEMENT DISORD, V19, P1453, DOI 10.1002/mds.20220; Goetz CG, 2004, MOVEMENT DISORD, V19, P1020, DOI 10.1002/mds.20213; Goetz CG, 2005, MOVEMENT DISORD, V20, P523, DOI 10.1002/mds.20464; Goetz CG, 2007, MOVEMENT DISORD, V22, P41, DOI 10.1002/mds.21198; Goetz CG, 2010, MOVEMENT DISORD, V25, P1190, DOI 10.1002/mds.23096; Goetz CG, 2009, MOVEMENT DISORD, V24, P551, DOI 10.1002/mds.22379; Hausdorff JM, 2007, HUM MOVEMENT SCI, V26, P555, DOI 10.1016/j.humov.2007.05.003; Jankovic J, 2008, J NEUROL NEUROSUR PS, V79, P368, DOI 10.1136/jnnp.2007.131045; Keijsers NLW, 2006, MOVEMENT DISORD, V21, P34, DOI 10.1002/mds.20633; Klucken J, 2011, NERVENARZT, V82, P1604, DOI 10.1007/s00115-011-3329-0; Lord S, 2008, GAIT POSTURE, V27, P357, DOI 10.1016/j.gaitpost.2007.04.001; Maetzler W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032240; Mariani B, 2010, J BIOMECH, V43, P2999, DOI 10.1016/j.jbiomech.2010.07.003; Moore ST, 2008, J NEUROSCI METH, V167, P340, DOI 10.1016/j.jneumeth.2007.08.023; Pansera M, 2009, IEEE ENG MED BIO, P1242, DOI 10.1109/IEMBS.2009.5333478; Patel S, 2010, IEEE ENG MED BIO, P4411, DOI 10.1109/IEMBS.2010.5627124; Patel S, 2009, IEEE T INF TECHNOL B, V13, P864, DOI 10.1109/TITB.2009.2033471; Poewe WH, 1998, ANN NEUROL, V44, pS1, DOI 10.1002/ana.410440703; Post B, 2007, MOVEMENT DISORD, V22, P1839, DOI 10.1002/mds.21537; Rajput AH, 2009, NEUROLOGY, V73, P206, DOI 10.1212/WNL.0b013e3181ae7af1; RICHARDS M, 1994, MOVEMENT DISORD, V9, P89, DOI 10.1002/mds.870090114; Rissanen SM, 2008, MED BIOL ENG COMPUT, V46, P849, DOI 10.1007/s11517-008-0369-0; Rochester L, 2008, MOVEMENT DISORD, V23, P2312, DOI 10.1002/mds.22219; Schimpl M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023299; Steffen T, 2008, PHYS THER, V88, P733, DOI 10.2522/ptj.20070214; Theodoridis S, 2009, PATTERN RECOGNITION, 4RTH EDITION, P1; Tolosa E, 2006, LANCET NEUROL, V5, P75, DOI 10.1016/S1474-4422(05)70285-4; Tomlinson CL, 2010, MOVEMENT DISORD, V25, P2649, DOI 10.1002/mds.23429; Witten I. H., 2005, DATA MINING PRACTICA; Zung WWK, 1994, INT SKALEN PSYCHIAT, P101	44	141	145	1	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2013	8	2							e56956	10.1371/journal.pone.0056956	http://dx.doi.org/10.1371/journal.pone.0056956			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093HR	23431395	Green Published, Green Submitted, gold			2022-12-25	WOS:000315182800038
J	Le Borgne, M; Filbert, EL; Shaw, AS				Le Borgne, Marie; Filbert, Erin L.; Shaw, Andrey S.			Kinase Suppressor of Ras 1 Is Not Required for the Generation of Regulatory and Memory T Cells	PLOS ONE			English	Article							TUBEROUS SCLEROSIS; IN-VIVO; MAMMALIAN TARGET; S6 KINASE; MTOR; ACTIVATION; PHOSPHORYLATION; RAPAMYCIN; DIFFERENTIATION; KSR2	The mammalian target of rapamycin (mTOR) kinase is a critical regulator of the differentiation of helper and regulatory CD4+ T cells, as well as memory CD8+ T cells. In this study, we investigated the role of the ERK signaling pathway in regulating mTOR activation in T cells. We showed that activation of ERK following TCR engagement is required for sustained mTOR complex 1 (mTORC1) activation. Absence of kinase suppressor of Ras 1 (KSR1), a scaffold protein of the ERK signaling pathway, or inhibition of ERK resulted in decreased mTORC1 activity following T cell activation. However, KSR1-deficient mice displayed normal regulatory CD4+ T cell development, as well as normal memory CD8+ T cell responses to LCMV and Listeria monocytogenes infection. These data indicate that despite its role in mTORC1 activation, KSR1 is not required in vivo for mTOR-dependent T cell differentiation.	[Le Borgne, Marie; Filbert, Erin L.; Shaw, Andrey S.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63130 USA; [Le Borgne, Marie; Shaw, Andrey S.] Washington Univ, Sch Med, Howard Hughes Med Inst, St Louis, MO 63110 USA	Washington University (WUSTL); Howard Hughes Medical Institute; Washington University (WUSTL)	Le Borgne, M (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63130 USA.	mleborgne@wustl.edu	Le Borgne, Marie/P-2313-2015	Le Borgne, Marie/0000-0002-3439-4867; Shaw, Andrey/0000-0001-5685-0272	Howard Hughes Medical Institute NIH [AI057966]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI057966] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK020579] Funding Source: NIH RePORTER	Howard Hughes Medical Institute NIH(Howard Hughes Medical InstituteUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Howard Hughes Medical Institute (http://www.hhmi.org/) NIH AI057966. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araki K, 2009, NATURE, V460, P108, DOI 10.1038/nature08155; Battaglia M, 2005, BLOOD, V105, P4743, DOI 10.1182/blood-2004-10-3932; Burnett PE, 1998, P NATL ACAD SCI USA, V95, P1432, DOI 10.1073/pnas.95.4.1432; Chi H, 2012, NAT REV IMMUNOL, V12, P325, DOI 10.1038/nri3198; Costanzo-Garvey DL, 2009, CELL METAB, V10, P366, DOI 10.1016/j.cmet.2009.09.010; Delgoffe GM, 2011, NAT IMMUNOL, V12, P295, DOI 10.1038/ni.2005; Delgoffe GM, 2009, IMMUNITY, V30, P832, DOI 10.1016/j.immuni.2009.04.014; Dougherty MK, 2009, MOL CELL, V34, P652, DOI 10.1016/j.molcel.2009.06.001; Fernandez MR, 2012, MOL CELL BIOL, V32, P3718, DOI 10.1128/MCB.06754-11; Giurisato E, 2009, MOL CELL BIOL, V29, P1554, DOI 10.1128/MCB.01421-08; Kang J, 2008, J LEUKOCYTE BIOL, V83, P1230, DOI 10.1189/jlb.1207851; Lee K, 2010, IMMUNITY, V32, P743, DOI 10.1016/j.immuni.2010.06.002; Lehman JA, 2003, J BIOL CHEM, V278, P28130, DOI 10.1074/jbc.M300376200; Lin J, 2009, MOL CELL BIOL, V29, P2082, DOI 10.1128/MCB.01634-08; Liu GW, 2010, NAT IMMUNOL, V11, P1047, DOI 10.1038/ni.1939; Ma L, 2005, CELL, V121, P179, DOI 10.1016/j.cell.2005.02.031; Michalek RD, 2011, J IMMUNOL, V186, P3299, DOI 10.4049/jimmunol.1003613; Mitaksov V, 2007, CHEM BIOL, V14, P909, DOI 10.1016/j.chembiol.2007.07.010; Nguyen A, 2002, MOL CELL BIOL, V22, P3035, DOI 10.1128/MCB.22.9.3035-3045.2002; Pearce EL, 2009, NATURE, V460, P103, DOI 10.1038/nature08097; Pope C, 2001, J IMMUNOL, V166, P3402, DOI 10.4049/jimmunol.166.5.3402; Rao RR, 2010, IMMUNITY, V32, P67, DOI 10.1016/j.immuni.2009.10.010; Roux PP, 2004, P NATL ACAD SCI USA, V101, P13489, DOI 10.1073/pnas.0405659101; Salmond RJ, 2009, J IMMUNOL, V183, P7388, DOI 10.4049/jimmunol.0902294; Saxena M, 2000, SEMIN IMMUNOL, V12, P387, DOI 10.1006/smim.2000.0219; Schluns KS, 2000, NAT IMMUNOL, V1, P426, DOI 10.1038/80868; Shaw AS, 2009, NAT REV IMMUNOL, V9, P47, DOI 10.1038/nri2473; Sinclair LV, 2008, NAT IMMUNOL, V9, P513, DOI 10.1038/ni.1603; Tee AR, 2003, J BIOL CHEM, V278, P37288, DOI 10.1074/jbc.M303257200; Turner MS, 2009, J IMMUNOL, V183, P4895, DOI 10.4049/jimmunol.0901459; Wherry EJ, 2003, NAT IMMUNOL, V4, P225, DOI 10.1038/ni889; Zheng Y, 2007, J IMMUNOL, V178, P2163, DOI 10.4049/jimmunol.178.4.2163; Zheng Y, 2009, J IMMUNOL, V183, P6095, DOI 10.4049/jimmunol.0803510; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025	34	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2013	8	2							e57137	10.1371/journal.pone.0057137	http://dx.doi.org/10.1371/journal.pone.0057137			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093HR	23431403	Green Published, gold, Green Submitted			2022-12-25	WOS:000315182800046
J	Zhang, YX; Liu, Y; Dong, J; Wang, YX; Wang, J; Zhuang, GQ; Han, SJ; Guo, QQ; Luo, YX; Zhang, J; Peng, XX; Zhang, L; Yan, YX; Yang, XH; Wang, H; Han, X; Liu, GX; Kang, YH; Liu, YQ; Weng, SF; Zhang, H; Zhang, XQ; Jia, KB; Wang, L; Zhao, L; Xiao, ZX; Zhang, SH; Wu, HH; Lai, QX; Qi, N; Wang, W; Gaisano, H; Liu, F; He, Y				Zhang, Yu-Xiang; Liu, Yan; Dong, Jing; Wang, You-Xin; Wang, Jing; Zhuang, Guo-Qing; Han, Shu-Jing; Guo, Qing-Qing; Luo, Yan-Xia; Zhang, Jie; Peng, Xiao-Xia; Zhang, Ling; Yan, Yu-Xiang; Yang, Xing-Hua; Wang, Hong; Han, Xu; Liu, Guang-Xu; Kang, You-Hou; Liu, You-Qin; Weng, Sheng-Feng; Zhang, Hong; Zhang, Xiao-Qiang; Jia, Ke-Bao; Wang, Li; Zhao, Lei; Xiao, Zhong-Xin; Zhang, Shu-Hua; Wu, Hui-Hui; Lai, Qing-Xuan; Qi, Na; Wang, Wei; Gaisano, Herbert; Liu, Fen; He, Yan			An Exploratory Study of the Association between KCNB1 rs1051295 and Type 2 Diabetes and Its Related Traits in Chinese Han Population	PLOS ONE			English	Article							PANCREATIC BETA-CELLS; POTASSIUM CHANNEL; INSULIN-SECRETION; K+ CHANNELS; VARIANTS; KCNQ1; SUSCEPTIBILITY; EXCITABILITY; GLUCOSE	Since the KCNB1 encoding Kv2.1 channel accounts for the majority of Kv currents modulating insulin secretion by pancreatic islet beta-cells, we postulated that KCNB1 is a plausible candidate gene for genetic variation contributing to the variable compensatory secretory function of beta-cells in type-2 diabetes (T2D). We conducted two studies, a case-control study and a cross-section study, to investigate the association of common single-nucleotide polymorphisms (SNPs) in KCNB1 with T2D and its linking traits. In the case-control study, we first examined the association of 20 tag SNPs of KCNB1 with T2D in a population with 226 T2D patients and non-diabetic subjects (screening study). We then identified the association in an enlarged population of 412 T2D patients and non-diabetic subjects (replication study). In the cross-sectional study, we investigated the linkage between the candidate SNP rs1051295 and T2D by comparing beta-cell function and insulin sensitivity among rs1051295 genotypes in a general population of 1051 subjects at fasting and after glucose loading (oral glucose tolerance tests, OGTT) in 84 fasting glucose impaired subjects, and several T2D-related traits. We found that among the 19 available tag SNPs, only the KCNB1 rs1051295 was associated with T2D (P = 0.027), with the rs1051295 TT genotype associated with an increased risk of T2D compared with genotypes CC (P = 0.009). At fasting, rs1051295 genotype TT was associated with a 9.8% reduction in insulin sensitivity compared to CC (P = 0.008); along with increased plasma triglycerides (TG) levels (TT/CC: P = 0.046) and increased waist/hip (W/H) ratio (TT/CC: P = 0.013; TT/TC: P = 0.002). OGTT confirmed that genotype TT exhibited reduced insulin sensitivity by 16.3% (P = 0.030) compared with genotype TC+CC in a fasting glucose impaired population. The KCNB1 rs1051295 genotype TT in the Chinese Han population is associated with decreased insulin sensitivity and increased plasma TG and W/H ratio, which together contribute to an increased risk for T2D.	[Zhang, Yu-Xiang; Liu, Yan; Wang, You-Xin; Han, Shu-Jing; Guo, Qing-Qing; Luo, Yan-Xia; Zhang, Jie; Peng, Xiao-Xia; Zhang, Ling; Yan, Yu-Xiang; Yang, Xing-Hua; Wang, Hong; Han, Xu; Liu, Guang-Xu; Liu, Fen; He, Yan] Capital Med Univ, Sch Publ Hlth & Family Med, Dept Epidemiol & Hlth Stat, Beijing, Peoples R China; [Zhang, Yu-Xiang; Wang, You-Xin; Han, Shu-Jing; Guo, Qing-Qing; Luo, Yan-Xia; Zhang, Jie; Peng, Xiao-Xia; Zhang, Ling; Yan, Yu-Xiang; Yang, Xing-Hua; Han, Xu; Liu, Guang-Xu; Liu, Fen; He, Yan] Beijing Municipal Key Lab Clin Epidemiol, Beijing, Peoples R China; [Liu, Yan] Peking Univ, Peoples Hosp, Infect Control Off, Beijing 100871, Peoples R China; [Dong, Jing; Liu, You-Qin] Capital Med Univ, Beijing Xuanwu Hosp, Hlth Med Ctr, Beijing, Peoples R China; [Wang, Jing; Jia, Ke-Bao; Wang, Li; Zhao, Lei] Capital Med Univ, Beijing Xuanwu Hosp, Dept Endocrinol, Beijing, Peoples R China; [Zhuang, Guo-Qing; Lai, Qing-Xuan; Wang, Wei] Chinese Acad Sci, Grad Univ, Coll Life Sci, Beijing, Peoples R China; [Kang, You-Hou; Gaisano, Herbert] Univ Toronto, Dept Med, Toronto, ON, Canada; [Kang, You-Hou; Gaisano, Herbert] Univ Toronto, Dept Physiol, Toronto, ON, Canada; [Weng, Sheng-Feng; Zhang, Hong; Zhang, Xiao-Qiang] Beijing Geriatr Hosp, Dept Clin Lab, Beijing, Peoples R China; [Xiao, Zhong-Xin; Zhang, Shu-Hua; Wu, Hui-Hui] Capital Med Univ, Expt Teaching Ctr, Beijing, Peoples R China; [Qi, Na] Capital Med Univ, Ctr Clin Lab, Beijing, Peoples R China	Capital Medical University; Peking University; Capital Medical University; Capital Medical University; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; University of Toronto; University of Toronto; Capital Medical University; Capital Medical University	Gaisano, H (corresponding author), Univ Toronto, Dept Med, Toronto, ON, Canada.	herbert.gaisano@utoronto.ca; liufen05@ccmu.edu.cn; yanhe118@sina.com	wang, YA XING/K-9671-2016; Liu, Fen/R-7749-2019	wang, YA XING/0000-0003-2749-7793; Wang, Youxin/0000-0002-6574-6706	National Natural Science Foundation of China [30971178, 30670778, 30901239]; Canadian Institute for Health Research [MOP 69083]; Beijing Municipal Education Commission [KM201010025009]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Canadian Institute for Health Research(Canadian Institutes of Health Research (CIHR)); Beijing Municipal Education Commission(Beijing Municipal Commission of Education)	This work was supported by National Natural Science Foundation of China (30971178, 30670778) (http://www.nsfc.gov.cn/nsfc/cen/xxgk/slzz.html) to YH and (30901239) to FL, and Canadian Institute for Health Research (MOP 69083) (http://www.cihr-irsc.gc.ca/e/193.html) to HG. YH is also supported by Beijing Municipal Education Commission (KM201010025009) (http://www.usrn.edu.cn/pages/info_list.jsp?classcode = 704&boardid = 704&pageno = 1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S; Ashcroft FM, 2004, REV ENDOCR METAB DIS, V5, P135, DOI 10.1023/B:REMD.0000021435.87776.a7; Feinshreiber L, 2010, J CELL SCI, V123, P1940, DOI 10.1242/jcs.063719; Feinshreiber L, 2009, ANN NY ACAD SCI, V1152, P87, DOI 10.1111/j.1749-6632.2008.03997.x; Gloyn AL, 2003, DIABETES, V52, P568, DOI 10.2337/diabetes.52.2.568; Gutman GA, 2005, PHARMACOL REV, V57, P473, DOI 10.1124/pr.57.4.10; Herrington J, 2005, J PHYSIOL-LONDON, V567, P159, DOI 10.1113/jphysiol.2005.089375; Holmkvist J, 2007, DIABETOLOGIA, V50, P2467, DOI 10.1007/s00125-007-0846-2; Hu C, 2009, DIABETOLOGIA, V52, P1322, DOI 10.1007/s00125-009-1335-6; Jacobson DA, 2007, CELL METAB, V6, P229, DOI 10.1016/j.cmet.2007.07.010; Kahn BB, 1998, CELL, V92, P593, DOI 10.1016/S0092-8674(00)81125-3; Leung YM, 2007, ENDOCR REV, V28, P653, DOI 10.1210/er.2007-0010; MacDonald PE, 2003, DIABETOLOGIA, V46, P1046, DOI 10.1007/s00125-003-1159-8; Neyroud N, 1997, NAT GENET, V15, P186, DOI 10.1038/ng0297-186; O'Rahilly S, 2009, NATURE, V462, P307, DOI 10.1038/nature08532; Pongs O., 2008, V44, P145, DOI 10.1007/400_2007_032; Qi QB, 2009, HUM MOL GENET, V18, P3508, DOI 10.1093/hmg/ddp294; Ramirez-Ponce MP, 2003, J MEMBRANE BIOL, V196, P129, DOI 10.1007/s00232-003-0631-1; Ramirez-Ponce MP, 2002, J ENDOCRINOL, V174, DOI 10.1677/joe.0.1740299; Retnakaran R, 2009, DIABETIC MED, V26, P1198, DOI 10.1111/j.1464-5491.2009.02841.x; Rosengren AH, 2012, DIABETES, V61, P1726, DOI 10.2337/db11-1516; Schwetz TA, 2011, J BIOL CHEM, V286, P4123, DOI 10.1074/jbc.M110.171322; Unoki H, 2008, NAT GENET, V40, P1098, DOI 10.1038/ng.208; van Vliet-Ostaptchouk JV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032148; Wang Q, 1996, NAT GENET, V12, P17, DOI 10.1038/ng0196-17; Xiao Xiangjun, 2009, BMC Proc, V3 Suppl 7, pS134; Yasuda K, 2008, NAT GENET, V40, P1092, DOI 10.1038/ng.207; Zhuang GQ, 2009, BIOCHEM BIOPH RES CO, V379, P812, DOI 10.1016/j.bbrc.2008.12.059	28	23	23	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2013	8	2							e56365	10.1371/journal.pone.0056365	http://dx.doi.org/10.1371/journal.pone.0056365			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093HR	23431371	gold, Green Submitted, Green Published			2022-12-25	WOS:000315182800013
J	Wu, M; Wang, ZW; Meng, CS; Wang, KL; Hu, YN; Wang, LZ; Wang, QM				Wu, Meng; Wang, Ziwen; Meng, Chuisong; Wang, Kailiang; Hu, Yanna; Wang, Lizhong; Wang, Qingmin			Discovery and SARs of Trans-3-Aryl Acrylic Acids and Their Analogs as Novel Anti- Tobacco Mosaic Virus (TMV) Agents	PLOS ONE			English	Article							ANTIOXIDANT ACTIVITY; ANTIVIRAL ACTIVITIES; DERIVATIVES; IDENTIFICATION; INHIBITION; FERULATE; EXTRACTS; GROWTH; DESIGN; RICE	A series of trans-3-aryl acrylic acids 1-27 and their derivatives 28-34 were prepared and evaluated for their antiviral activity against tobacco mosaic virus (TMV) for the first time. The bioassay results showed that most of these compounds exhibited good antiviral activity against TMV, of which compounds 1, 5, 6, 20, 27 and 34 exhibited significantly higher activity against TMV than commercial Ribavirin both in vitro and in vivo. Furthermore, these compounds have more simple structure than commercial Ribavirin, and can be synthesized more efficiently. These new findings demonstrate that trans-3-aryl acrylic acids and their derivatives represent a new template for antiviral studies and could be considered for novel therapy against plant virus infection.	[Wu, Meng; Wang, Ziwen; Meng, Chuisong; Wang, Kailiang; Hu, Yanna; Wang, Lizhong; Wang, Qingmin] Nankai Univ, Res Inst Elementoorgan Chem, State Key Lab Elementoorgan Chem, Tianjin 300071, Peoples R China	Nankai University	Wang, QM (corresponding author), Nankai Univ, Res Inst Elementoorgan Chem, State Key Lab Elementoorgan Chem, Tianjin 300071, Peoples R China.	wangqm@nankai.edu.cn			National Key Project for Basic Research [2010CB126106]; National Natural Science Foundation of China [21132003, 21121002]; China Postdoctoral Science Foundation [20090460057, 2011M500519, 2012T50207]; National Key Technology Research and Development Program [2012BAK25B03]	National Key Project for Basic Research(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); National Key Technology Research and Development Program(National Key Technology R&D Program)	The authors gratefully acknowledge the National Key Project for Basic Research (2010CB126106) and the National Natural Science Foundation of China (21132003, 21121002) and China Postdoctoral Science Foundation (20090460057, 2011M500519, 2012T50207) for financial support. The authors thank China Agricultural University to supply some of chemical reagents and the National Key Technology Research and Development Program (2012BAK25B03-3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An TY, 2001, PHYTOCHEMISTRY, V58, P1267, DOI 10.1016/S0031-9422(01)00382-X; Bos L., 1982, Crop Protection, V1, P263, DOI 10.1016/0261-2194(82)90002-3; Cardenas M, 2006, BIOORGAN MED CHEM, V14, P2966, DOI 10.1016/j.bmc.2005.12.021; CHAN RIM, 1986, CANCER LETT, V31, P27, DOI 10.1016/0304-3835(86)90163-1; Chaves N, 2001, J CHEM ECOL, V27, P611, DOI 10.1023/A:1010336921853; Chen HM, 1996, J AGR FOOD CHEM, V44, P2619, DOI 10.1021/jf950833m; Creager Angela N. H., 1999, Plant Cell, V11, P301; Guardiola F, 1996, FOOD CHEM TOXICOL, V34, P193, DOI 10.1016/0278-6915(95)00094-1; Han CK, 2000, BIOORG MED CHEM LETT, V10, P39, DOI 10.1016/S0960-894X(99)00577-6; Hu DY, 2008, J AGR FOOD CHEM, V56, P998, DOI 10.1021/jf072394k; Hudson EA, 2000, CANCER EPIDEM BIOMAR, V9, P1163; Lam A, 2008, J AGR FOOD CHEM, V56, P11407, DOI 10.1021/jf8021942; Laranjinha J, 1996, BIOCHEM PHARMACOL, V51, P395, DOI 10.1016/0006-2952(95)02171-X; Li DD, 2011, BIOORGAN MED CHEM, V19, P5012, DOI 10.1016/j.bmc.2011.06.044; Long N, 2008, J AGR FOOD CHEM, V56, P5242, DOI 10.1021/jf800405m; Luo Y, 2011, BIOORGAN MED CHEM, V19, P4730, DOI 10.1016/j.bmc.2011.06.088; Nystrom L, 2005, J AGR FOOD CHEM, V53, P2503, DOI 10.1021/jf048051t; Park IK, 2000, J AGR FOOD CHEM, V48, P2528, DOI 10.1021/jf9904160; Qian XH, 2010, J AGR FOOD CHEM, V58, P2613, DOI 10.1021/jf904098w; Ren YP, 2010, PHARM RES-DORDR, V27, P2509, DOI 10.1007/s11095-010-0251-2; Ritzenthaler C, 2005, CURR OPIN BIOTECH, V16, P118, DOI 10.1016/j.copbio.2005.02.009; Seiber JN, 2011, J AGR FOOD CHEM, V59, P1, DOI 10.1021/jf1046078; TANAKA A, 1971, YUKAGAKU, V20, P792; van der Watt E, 2001, J ETHNOPHARMACOL, V76, P87, DOI 10.1016/S0378-8741(01)00197-0; Walker TS, 2003, J AGR FOOD CHEM, V51, P2548, DOI 10.1021/jf021166h; Wang KL, 2010, J AGR FOOD CHEM, V58, P2703, DOI 10.1021/jf902543r; Wei L. Z., 2010, Antiviral composition containing fucoidan and ribavirin for preventing and treating plant viral diseases, Patent No. [CN 101869111 A, 101869111]; Wu M, 2011, ORG BIOMOL CHEM, V9, P141, DOI 10.1039/c0ob00287a; Yamashita S, 2009, EUR J ORG CHEM, V2009, P1173, DOI 10.1002/ejoc.200801047; Yasukawa K, 1998, BIOL PHARM BULL, V21, P1072, DOI 10.1248/bpb.21.1072; [钟江春 Zhong Jiangchun], 2005, [化学试剂, Chemical Reagents], V27, P241; Zou HB, 2006, BIOORGAN MED CHEM, V14, P2060, DOI 10.1016/j.bmc.2005.10.056; Zou HB, 2010, BIOORGAN MED CHEM, V18, P6351, DOI 10.1016/j.bmc.2010.07.016; 胡益勇, 2006, [中成药, Chinese Traditional Patent Medicine], V28, P253	34	11	13	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e56475	10.1371/journal.pone.0056475	http://dx.doi.org/10.1371/journal.pone.0056475			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418574	Green Published, gold, Green Submitted			2022-12-25	WOS:000315970300167
J	Siemens, N; Kreikemeyer, B				Siemens, Nikolai; Kreikemeyer, Bernd			Heterologous Expression of Ralp3 in Streptococcus pyogenes M2 and M6 Strains Affects the Virulence Characteristics	PLOS ONE			English	Article							GROUP-A STREPTOCOCCUS; SEROTYPE M49; PATHOGENICITY REGION; PROTEIN F1; BINDING; FIBRONECTIN; STREPTOKINASE; INVASION; CELLS; TRANSCRIPTION	Background: Ralp3 is a transcriptional regulator present in a serotype specific fashion on the chromosome of the human pathogen Streptococcus pyogenes (group A streptococci, GAS). In serotypes harbouring the ralp3 gene either positive or negative effects on important metabolic and virulence genes involved in colonization and immune evasion in the human host were observed. A previous study revealed that deletion of ralp3 in a GAS M49 serotype significantly attenuated many virulence traits and caused metabolic disadvantages. This leads to two questions: (i) which kind of consequences could Ralp3 expression have in GAS serotypes naturally lacking this gene, and (ii) is Ralp3 actively lost during evolution in these serotypes. Methodology/Principal Findings: We investigated the role of Ralp3 in GAS M2 and M6 pathogenesis. Both serotypes lack ralp3 on their chromosome. The heterologous expression of ralp3 in both serotypes resulted in reduced attachment to and internalization into the majority of tested epithelial cells. Both ralp3 expression strains showed a decreased ability to survive in human blood and exclusively M2:: ralp3 showed decreased survival in human serum. Both mutants secreted more active SpeB in the supernatant, resulting in a higher activity compared to wild type strains. The respective M2 and M6 wild type strains outcompeted the ralp3 expression strains in direct metabolic competition assays. The phenotypic changes observed in the M2: ralp3 and M6: ralp3 were verified on the transcriptional level. Consistent with the virulence data, tested genes showed transcript level changes in the same direction. Conclusions/Significance: Together these data suggest that Ralp3 can take over transcriptional control of virulence genes in serotypes lacking the ralp3 gene. Those serotypes most likely lost Ralp3 during evolution since obviously expression of this gene is disadvantageous for metabolism and pathogenesis.	[Siemens, Nikolai; Kreikemeyer, Bernd] Univ Rostock, Rostock Univ Hosp, Inst Med Microbiol Virol & Hyg, D-18055 Rostock, Germany	University of Rostock	Kreikemeyer, B (corresponding author), Univ Rostock, Rostock Univ Hosp, Inst Med Microbiol Virol & Hyg, D-18055 Rostock, Germany.	bernd.kreikemeyer@med.uni-rostock.de		Kreikemeyer, Bernd/0000-0001-9527-5098; Siemens, Nikolai/0000-0003-0657-3822	Federal Ministry of Education and Research (BMBF): BMBF ERANet "Pathogenomics" II; Rostock University Medical Faculty FORUN program; BMBF ERANet "SysMO" II	Federal Ministry of Education and Research (BMBF): BMBF ERANet "Pathogenomics" II; Rostock University Medical Faculty FORUN program; BMBF ERANet "SysMO" II	The work of NS and BK was supported by the following grants awarded from the Federal Ministry of Education and Research (BMBF): BMBF ERANet "Pathogenomics" II and BMBF ERANet "SysMO" II. The authors further acknowledge funds from the Rostock University Medical Faculty FORUN program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beckert S, 2001, INFECT IMMUN, V69, P534, DOI 10.1128/IAI.69.1.534-537.2001; Boyle MDP, 1997, THROMB HAEMOSTASIS, V77, P1; Carapetis JR, 2005, LANCET INFECT DIS, V5, P685, DOI 10.1016/S1473-3099(05)70267-X; Carroll RK, 2011, MOL MICROBIOL, V81, P588, DOI 10.1111/j.1365-2958.2011.07709.x; Courtney HS, 2002, ANN MED, V34, P77, DOI 10.1080/07853890252953464; Cunningham MW, 2000, CLIN MICROBIOL REV, V13, P470, DOI 10.1128/CMR.13.3.470-511.2000; Ferretti JJ, 2001, P NATL ACAD SCI USA, V98, P4658, DOI 10.1073/pnas.071559398; Fiedler T, 2010, INT J MED MICROBIOL, V300, P248, DOI 10.1016/j.ijmm.2009.07.004; Granok AB, 2000, J BACTERIOL, V182, P1529, DOI 10.1128/JB.182.6.1529-1540.2000; HANSKI E, 1992, P NATL ACAD SCI USA, V89, P6172, DOI 10.1073/pnas.89.13.6172; Hytonen J, 2001, MOL MICROBIOL, V39, P512, DOI 10.1046/j.1365-2958.2001.02269.x; Jadoun J, 1998, J INFECT DIS, V178, P147, DOI 10.1086/515589; Kreikemeyer B, 2004, J BIOL CHEM, V279, P15850, DOI 10.1074/jbc.M313613200; Kreikemeyer B, 2003, TRENDS MICROBIOL, V11, P224, DOI 10.1016/S0966-842X(03)00098-2; Kreikemeyer B, 1999, FEMS MICROBIOL LETT, V178, P305, DOI 10.1016/S0378-1097(99)00373-0; Kreikemeyer B, 2001, MOL MICROBIOL, V39, P392, DOI 10.1046/j.1365-2958.2001.02226.x; Kreikemeyer B, 2007, INFECT IMMUN, V75, P5698, DOI 10.1128/IAI.00175-07; Kwinn LA, 2007, J BACTERIOL, V189, P1322, DOI 10.1128/JB.01256-06; Loughman JA, 2007, MOL MICROBIOL, V64, P269, DOI 10.1111/j.1365-2958.2007.05663.x; Lyon WR, 1998, EMBO J, V17, P6263, DOI 10.1093/emboj/17.21.6263; Nakata M, 2009, INFECT IMMUN, V77, P32, DOI 10.1128/IAI.00772-08; Ozeri V, 1998, MOL MICROBIOL, V30, P625, DOI 10.1046/j.1365-2958.1998.01097.x; Pancholi V, 2003, MICROB PATHOGENESIS, V35, P293, DOI 10.1016/j.micpath.2003.08.004; Rezcallah MS, 2004, MICROBIOL-SGM, V150, P365, DOI 10.1099/mic.0.26826-0; Ribardo DA, 2006, MOL MICROBIOL, V62, P491, DOI 10.1111/j.1365-2958.2006.05381.x; Ringdahl U, 1998, J BIOL CHEM, V273, P6424, DOI 10.1074/jbc.273.11.6424; ROSEY EL, 1991, J BACTERIOL, V173, P5992, DOI 10.1128/jb.173.19.5992-5998.1991; Sanderson-Smith ML, 2008, FASEB J, V22, P2715, DOI 10.1096/fj.07-105643; Siemens N, 2012, J BACTERIOL, V194, P3618, DOI 10.1128/JB.00227-12; Siemens N, 2011, J BIOL CHEM, V286, P21612, DOI 10.1074/jbc.M110.202671; Sun HM, 2012, P NATL ACAD SCI USA, V109, P3469, DOI 10.1073/pnas.1201031109	31	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2013	8	2							e55109	10.1371/journal.pone.0055109	http://dx.doi.org/10.1371/journal.pone.0055109			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104BU	23424622	Green Published, Green Submitted, gold			2022-12-25	WOS:000315965100010
J	Vianello, S; Yu, H; Voisin, V; Haddad, H; He, X; Foutz, AS; Sebrie, C; Gillet, B; Roulot, M; Fougerousse, F; Perronnet, C; Vaillend, C; Matecki, S; Escolar, D; Bossi, L; Israel, M; de la Porte, S				Vianello, Sara; Yu, Hua; Voisin, Vincent; Haddad, Hafedh; He, Xun; Foutz, Arthur S.; Sebrie, Catherine; Gillet, Brigitte; Roulot, Morgane; Fougerousse, Francoise; Perronnet, Caroline; Vaillend, Cyrille; Matecki, Stefan; Escolar, Diana; Bossi, Laura; Israel, Maurice; de la Porte, Sabine			Arginine butyrate: a therapeutic candidate for Duchenne muscular dystrophy	FASEB JOURNAL			English	Article						DMD; mdx; pharmacology; treatment; NO; histone deacetylase	DEFICIENT SKELETAL-MUSCLE; GLOBIN GENE-EXPRESSION; NITRIC-OXIDE; MDX MICE; BETA-HEMOGLOBINOPATHIES; SATELLITE CELLS; UTROPHIN TRANSGENE; REGENERATION; DYSTROPHINOPATHIES; LOCALIZATION	As a strategy to treat Duchenne muscular dystrophy, we used arginine butyrate, which combines two pharmacological activities: nitric oxide pathway activation, and histone deacetylase inhibition. Continuous intraperitoneal administration to dystrophin-deficient mdx mice resulted in a near 2-fold increase in utrophin (protein homologous to dystrophin) in skeletal muscle, heart, and brain, accompanied by an improvement of the dystrophic phenotype in both adult and newborn mice (45 and 70% decrease in creatine kinase level, respectively; 14% increase in tidal volume, 30% decrease in necrotic area in limb and 23% increase in isometric force). Intermittent administration, as performed in clinical trials, was then used to reduce the frequency of injections and to improve safety. This also enhanced utrophin level around 2-fold (EC50 = 284 mg/ml) and alleviated the dystrophic phenotype (inverted grid and grip test performance near to wild-type values, creatine kinase level decreased by 50%). Skin biopsies were used to monitor treatment efficacy, instead of invasive muscle biopsies, and this could be done a few days after the start of treatment. A 2-fold increase in utrophin expression was also shown in cultured human myotubes. In vivo and in vitro experiments demonstrated that the drug combination acts synergistically. Together, these data constitute a proof of principle of the beneficial effects of arginine butyrate on muscular dystrophy.-Vianello, S., Yu, H., Voisin, V., Haddad, H., He, X., Foutz, A. S., Sebrie, C., Gillet, B., Roulot, M., Fougerousse, F., Perronnet, C., Vaillend, C., Matecki, S., Escolar, D., Bossi, L., Israel, M., de la Porte, S. Arginine butyrate: a therapeutic candidate for Duchenne muscular dystrophy.	[Vianello, Sara; Yu, Hua; Voisin, Vincent; Haddad, Hafedh; He, Xun; Roulot, Morgane; Israel, Maurice; de la Porte, Sabine] Inst Neurobiol Alfred Fessard, FRC2118, CNRS, UPR Neurobiol & Dev 3294, Gif Sur Yvette, France; [Foutz, Arthur S.] Inst Neurobiol Alfred Fessard, FRC2118, CNRS, UPR Neurobiol Genet & Integrat 2216, Gif Sur Yvette, France; [Sebrie, Catherine; Gillet, Brigitte] Inst Chim Subst Nat Resonance Magnet Nucl RMN Bio, CNRS, Gif Sur Yvette, France; [Fougerousse, Francoise] Genethon, Evry, France; [Perronnet, Caroline; Vaillend, Cyrille] Univ Paris 11, Ctr Neurosci Paris Sud, Orsay, France; [Perronnet, Caroline; Vaillend, Cyrille] CNRS, UMR 8195, F-91405 Orsay, France; [Matecki, Stefan] Univ Montpellier, INSERM, ERI, Ctr Hosp Univ CHU A Villeneuve, F-34059 Montpellier, France; [Escolar, Diana] Johns Hopkins Sch Med, Baltimore, MD USA; [Bossi, Laura] BioParc, Domain Therapeut, Illkirch Graffenstaden, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); Universite Jean Monnet; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; CHU de Montpellier; Johns Hopkins University; Johns Hopkins Medicine	de la Porte, S (corresponding author), CNRS, Inst Neurobiol Alfred Fessard Neurobiol & Dev, UPR 3294, Ave Terrasse,Bat 32-33, F-91198 Gif Sur Yvette, France.	sabine.delaporte@inaf.cnrs-gif.fr	de la PORTE, Sabine/AAE-4208-2022; Vaillend, Cyrille/K-4626-2012; de la Porte, Sabine/N-5275-2018	de la PORTE, Sabine/0000-0002-7725-8646; Vaillend, Cyrille/0000-0002-8783-8185; 	European Community [QLRI-CT-2002-02769]; Association Francaise contre les Myopathies [2004.001/10689, 2007.1563/12507, 2008.0797/13466]; Muscular Dystrophy Association [MDA3561, MDA4078]	European Community(European Commission); Association Francaise contre les Myopathies(Association Francaise contre les Myopathies); Muscular Dystrophy Association(Muscular Dystrophy Association)	The authors thank Francesca Consolaro for technical assistance for the experiments on the chromatin acetylation state. The authors thank the French Banque de Tissus pour la Recherche (BTR; Institut de Myologie) for providing surgical residues of human paravertebral striated muscles. BTR is a partner of the EuroBioBank network funded by the European Community under the Fifth Framework Program (QLRI-CT-2002-02769). The authors thank M. Bonora (Paris) for help with the respiration protocols and the Imagif qPCR platform. This work was supported by the Association Francaise contre les Myopathies (2004.001/10689, 2007.1563/12507, 2008.0797/13466); and the Muscular Dystrophy Association (MDA3561, MDA4078). The authors declare no conflicts of interest.	Anderson JE, 2000, MOL BIOL CELL, V11, P1859, DOI 10.1091/mbc.11.5.1859; Anderson JE, 2003, NEUROMUSCULAR DISORD, V13, P388, DOI 10.1016/S0960-8966(03)00029-4; Anderson JL, 2002, BRAIN, V125, P4, DOI 10.1093/brain/awf012; Archer JD, 2006, FASEB J, V20, P738, DOI 10.1096/fj.05-4821fje; Baby SM, 2010, BRAIN PATHOL, V20, P323, DOI 10.1111/j.1750-3639.2009.00275.x; Barton ER, 2005, MUSCLE NERVE, V32, P751, DOI 10.1002/mus.20425; Benabdellah F, 2009, NEUROBIOL DIS, V36, P252, DOI 10.1016/j.nbd.2009.07.013; Bia BL, 1999, J MOL CELL CARDIOL, V31, P1857, DOI 10.1006/jmcc.1999.1018; Brunelli S, 2007, P NATL ACAD SCI USA, V104, P264, DOI 10.1073/pnas.0608277104; Chaubourt E, 1999, NEUROBIOL DIS, V6, P499, DOI 10.1006/nbdi.1999.0256; Chaubourt E, 2002, J PHYSIOLOGY-PARIS, V96, P43, DOI 10.1016/S0928-4257(01)00079-1; Chazalette D, 2005, FEBS LETT, V579, P1079, DOI 10.1016/j.febslet.2004.12.081; Colussi C, 2009, FASEB J, V23, P2131, DOI 10.1096/fj.08-115618; EDOM F, 1994, DEV BIOL, V164, P219, DOI 10.1006/dbio.1994.1193; Fairclough RJ, 2011, EXP PHYSIOL, V96, P1101, DOI 10.1113/expphysiol.2010.053025; Faller D V, 1995, Curr Opin Hematol, V2, P109; Finsterer J, 2003, CARDIOLOGY, V99, P1, DOI 10.1159/000068446; Fisher R, 2001, NEUROMUSCULAR DISORD, V11, P713, DOI 10.1016/S0960-8966(01)00220-6; Guerron AD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011220; Guilhermet R. G., 1996, Productions Animales (Paris), V9, P265; Gurpur PB, 2009, AM J PATHOL, V174, P999, DOI 10.2353/ajpath.2009.080537; Hnia K, 2008, AM J PATHOL, V172, P1509, DOI 10.2353/ajpath.2008.071009; Hoey A. J., 2006, P AUSTR PHYSL SOC, V37, P57; Ishikawa K, 1997, JPN HEART J, V38, P163; Jeng MR, 2002, AM J HEMATOL, V69, P103, DOI 10.1002/ajh.10047; KARPATI G, 1993, J NEUROPATH EXP NEUR, V52, P119, DOI 10.1097/00005072-199303000-00004; LOVE DR, 1989, NATURE, V339, P55, DOI 10.1038/339055a0; Marbini A, 1996, J NEUROL SCI, V143, P156, DOI 10.1016/S0022-510X(96)00210-9; Marques MJ, 2005, NEUROSCI LETT, V382, P342, DOI 10.1016/j.neulet.2005.03.023; MATSUMURA K, 1994, MUSCLE NERVE, V17, P2, DOI 10.1002/mus.880170103; Minetti GC, 2006, NAT MED, V12, P1147, DOI 10.1038/nm1479; Nico B, 2004, NEUROSCIENCE, V125, P921, DOI 10.1016/j.neuroscience.2004.02.008; OZAWA E, 1995, HUM MOL GENET, V4, P1711, DOI 10.1093/hmg/4.suppl_1.1711; PERRINE SP, 1989, BLOOD, V74, P454; PERRINE SP, 1993, EXPERIENTIA, V49, P133, DOI 10.1007/BF01989417; PERRINE SP, 1994, AM J PEDIAT HEMATOL, V16, P67; PERRINE SP, 1993, NEW ENGL J MED, V328, P81, DOI 10.1056/NEJM199301143280202; Perrine SP, 2008, PEDIATR ANN, V37, P339, DOI 10.3928/00904481-20080501-10; Perronnet C, 2012, HUM MOL GENET, V21, P2263, DOI 10.1093/hmg/dds047; Rafael JA, 1998, NAT GENET, V19, P79, DOI 10.1038/ng0598-79; Salimena M, 2004, HISTOCHEM CELL BIOL, V122, P435, DOI 10.1007/s00418-004-0707-8; Sander M, 2000, P NATL ACAD SCI USA, V97, P13818, DOI 10.1073/pnas.250379497; Segalat L, 2005, EXP CELL RES, V302, P170, DOI 10.1016/j.yexcr.2004.09.007; SHER GD, 1995, NEW ENGL J MED, V332, P1606, DOI 10.1056/NEJM199506153322404; Straub V, 1997, J CELL BIOL, V139, P375, DOI 10.1083/jcb.139.2.375; Tanveer N, 2009, CLIN NEUROL NEUROSUR, V111, P496, DOI 10.1016/j.clineuro.2009.01.011; Thomas GD, 1998, P NATL ACAD SCI USA, V95, P15090, DOI 10.1073/pnas.95.25.15090; Tinsley J, 1998, NAT MED, V4, P1441, DOI 10.1038/4033; Tinsley JM, 1996, NATURE, V384, P349, DOI 10.1038/384349a0; Voisin V, 2004, INT REV CYTOL, V240, P1, DOI 10.1016/S0074-7696(04)40001-1; Voisin V, 2005, NEUROBIOL DIS, V20, P123, DOI 10.1016/j.nbd.2005.02.010	51	19	19	0	18	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2013	27	6					2256	2269		10.1096/fj.12-215723	http://dx.doi.org/10.1096/fj.12-215723			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	154II	23430975	Green Submitted, Bronze			2022-12-25	WOS:000319667600016
J	Konishi, H; Matsumoto, S; Namikawa, K; Kiyama, H				Konishi, Hiroyuki; Matsumoto, Sakiko; Namikawa, Kazuhiko; Kiyama, Hiroshi			N-terminal Cleaved Pancreatitis-associated Protein-III (PAP-III) Serves as a Scaffold for Neurites and Promotes Neurite Outgrowth	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LECTIN REGIII-GAMMA; BACTERICIDAL LECTIN; WALLERIAN DEGENERATION; NEUROTROPHIC FACTOR; NERVE REGENERATION; MOTOR-NEURONS; SCHWANN-CELLS; RAT; EXPRESSION; FAMILY	Pancreatitis-associated protein (PAP)-III, also known as regenerating gene/regenerating islet-derived (Reg)-III gamma, is a small secretory protein whose expression is substantially induced in injured nerves. Here, we found that PAP-III protein underwent proteolytic N-terminal processing by trypsin-like protease(s) in injured sciatic nerves after axotomy. In vitro studies demonstrated that the N terminus-truncated PAP-III (Delta N-PAP-III) polymerized into a filament with a relatively uniform diameter of 10-20 nm, and the filaments formed higher order structures in a Na+ concentration-dependent manner. When the Delta N-PAP-III fibers were added to the culture media, the Delta N-PAP-III fibers were tightly attached to neurites and somata of primary cortical neurons in vitro. In contrast, little association with glial cells was observed. When dense matrices of Delta N-PAP-III fibers were sheeted on a culture dish, neurites preferentially adhered to the fibers, and neurite extension was enhanced. This neurite outgrowth activity was significantly suppressed by preincubation with antibodies against PAP-III. These results imply that the released PAP-III might be cleaved and forms Delta N-PAP-III fibers at the nerve injury sites. Consequently, these resulting fibers would provide regenerating axons with a platform for extension.	[Konishi, Hiroyuki; Matsumoto, Sakiko; Kiyama, Hiroshi] Nagoya Univ, Grad Sch Med, Dept Funct Anat & Neurosci, Nagoya, Aichi 4668550, Japan; [Konishi, Hiroyuki; Matsumoto, Sakiko; Namikawa, Kazuhiko; Kiyama, Hiroshi] Osaka City Univ, Grad Sch Med, Dept Anat & Neurobiol, Osaka 5458585, Japan; [Konishi, Hiroyuki; Kiyama, Hiroshi] Nagoya Univ, Grad Sch Med, CREST, Japan Sci & Technol Agcy, Nagoya, Aichi 4668550, Japan; [Namikawa, Kazuhiko] Tech Univ Carolo Wilhelmina Braunschweig, Div Cell Biol & Cell Physiol, Inst Zool, D-83106 Braunschweig, Germany	Nagoya University; Osaka Metropolitan University; Japan Science & Technology Agency (JST); Nagoya University; Braunschweig University of Technology	Kiyama, H (corresponding author), Dept Funct Anat & Neurosci, Showa Ku, 65 Tsurumai Cho, Nagoya, Aichi 4668550, Japan.	kiyama@med.nagoya-u.ac.jp	KONISHI, Hiroyuki/M-8871-2014; Kiyama, Hiroshi/M-8867-2014	Kiyama, Hiroshi/0000-0001-5963-046X; Konishi, Hiroyuki/0000-0002-4321-8339	Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan; Core Research for Evolutional Science and Technology (CREST) of the Japan Science and Technology Agency	Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Core Research for Evolutional Science and Technology (CREST) of the Japan Science and Technology Agency(Core Research for Evolutional Science and Technology (CREST))	This work was supported in part by Grants-in-aid for scientific research from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan, and Core Research for Evolutional Science and Technology (CREST) of the Japan Science and Technology Agency.	Algul H, 2007, J CLIN INVEST, V117, P1490, DOI 10.1172/JCI29882; Ampo KI, 2009, J NEUROTRAUM, V26, P1683, DOI 10.1089/neu.2008-0847; Averill S, 2002, J NEUROSCI, V22, P7493; BEUCHE W, 1984, J NEUROCYTOL, V13, P767, DOI 10.1007/BF01148493; Bodeker H, 1999, Mol Cell Biol Res Commun, V2, P150, DOI 10.1006/mcbr.1999.0166; BRADSHAW AD, 1995, DEVELOPMENT, V121, P3593; Brandl K, 2008, NATURE, V455, P804, DOI 10.1038/nature07250; Brandl K, 2007, J EXP MED, V204, P1891, DOI 10.1084/jem.20070563; Cash HL, 2006, SCIENCE, V313, P1126, DOI 10.1126/science.1127119; Fang MR, 2010, ANAT REC, V293, P464, DOI 10.1002/ar.21087; FRIGERIO JM, 1993, BIOCHIM BIOPHYS ACTA, V1216, P329, DOI 10.1016/0167-4781(93)90167-C; FRIGERIO JM, 1993, BIOCHEMISTRY-US, V32, P9236, DOI 10.1021/bi00086a032; Gironella M, 2005, GUT, V54, P1244, DOI 10.1136/gut.2004.056309; Gironella M, 2007, GUT, V56, P1091, DOI 10.1136/gut.2006.116087; Graf R, 2001, J BIOL CHEM, V276, P21028, DOI 10.1074/jbc.M010717200; Hassanain E, 2011, PANCREAS, V40, P1151, DOI 10.1097/MPA.0b013e3182218006; Ho MR, 2006, J BIOL CHEM, V281, P33566, DOI 10.1074/jbc.M604513200; Hunt SP, 2007, HEPATOLOGY, V45, P1585, DOI 10.1002/hep.21705; Kawahara S, 2011, NEUROSCIENCE, V175, P273, DOI 10.1016/j.neuroscience.2010.11.020; KEIM V, 1991, GASTROENTEROLOGY, V100, P775, DOI 10.1016/0016-5085(91)80025-5; KISHIRO Y, 1995, CELL STRUCT FUNCT, V20, P151, DOI 10.1247/csf.20.151; Konishi H, 2006, GLIA, V53, P723, DOI 10.1002/glia.20327; Lehotzky RE, 2010, P NATL ACAD SCI USA, V107, P7722, DOI 10.1073/pnas.0909449107; Livesey FJ, 1997, NATURE, V390, P614, DOI 10.1038/37615; Maeda M, 2005, EXP NEUROL, V193, P350, DOI 10.1016/j.expneurol.2005.01.018; Marz-Weiss P, 2011, CELL MOL NEUROBIOL, V31, P1141, DOI 10.1007/s10571-011-9715-0; MATSUOKA I, 1991, J NEUROSCI, V11, P3165; Medveczky P, 2009, BIOCHEM J, V420, P335, DOI 10.1042/BJ20090005; Mukherjee S, 2009, J BIOL CHEM, V284, P4881, DOI 10.1074/jbc.M808077200; MULLER U, 1995, MOL BIOL CELL, V6, P433; NAKAJIMA K, 1992, J NEUROCHEM, V58, P1401, DOI 10.1111/j.1471-4159.1992.tb11356.x; NAKANISHI K, 1994, BRAIN RES, V659, P169, DOI 10.1016/0006-8993(94)90876-1; Namikawa K, 2005, BIOCHEM BIOPH RES CO, V332, P126, DOI 10.1016/j.bbrc.2005.04.105; Namikawa K, 2006, J NEUROSCI, V26, P7460, DOI 10.1523/JNEUROSCI.0023-06.2006; Nishimune H, 2000, NAT CELL BIOL, V2, P906, DOI 10.1038/35046558; Schiesser M, 2001, PANCREAS, V22, P186, DOI 10.1097/00006676-200103000-00012; STOLL G, 1989, J NEUROCYTOL, V18, P671, DOI 10.1007/BF01187086; Tebar LA, 2008, P NATL ACAD SCI USA, V105, P11400, DOI 10.1073/pnas.0711978105; TSUYUKI E, 1956, J BIOL CHEM, V222, P479; Ushijima R, 2005, BIOCHEM BIOPH RES CO, V330, P880, DOI 10.1016/j.bbrc.2005.03.063; Vaishnava S, 2011, SCIENCE, V334, P255, DOI 10.1126/science.1209791; Van Ba IAT, 2012, J BIOL CHEM, V287, P4726, DOI 10.1074/jbc.M111.260349	42	7	7	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 12	2013	288	15					10205	10213		10.1074/jbc.M112.395301	http://dx.doi.org/10.1074/jbc.M112.395301			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	125TU	23426365	hybrid, Green Published			2022-12-25	WOS:000317565000003
J	Zhang, N; Lin, JK; Chen, J; Liu, XF; Liu, JL; Luo, HS; Li, YQ; Cui, S				Zhang, Nan; Lin, Jun-kai; Chen, Juan; Liu, Xiong-fei; Liu, Jia-li; Luo, Hao-shu; Li, Yue-qin; Cui, Sheng			MicroRNA 375 Mediates the Signaling Pathway of Corticotropin-releasing Factor (CRF) Regulating Pro-opiomelanocortin (POMC) Expression by Targeting Mitogen-activated Protein Kinase 8	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PITUITARY-ADRENAL AXIS; T-CELL LYMPHOMAS; GENE-EXPRESSION; NUCLEAR RECEPTORS; BETA-ENDORPHIN; TUMOR-CELLS; ALPHA-MSH; TRANSCRIPTION; TPL-2; INVOLVEMENT	Pro-opiomelanocortin (POMC) is a common precursor of melanocortin-related peptides in the pituitary and primarily regulated by corticotropin-releasing factor (CRF). Our results show that miR-375 is highly expressed in the mouse pituitary gland and located specifically in the intermediate lobe of pituitary. The functional studies show that the forced inhibition of endogenous miR-375 in AtT-20 mouse pituitary tumor cells and in the intermediate lobe of the pituitary gland significantly increases POMC expression, whereas miR-375 overexpression down-regulates POMC expression and ACTH secretion stimulated by CRF. This function of miR-375 is accomplished by its binding to the 3'-UTR of mitogen-activated protein kinase kinase kinase-8. Our results here have demonstrated that miR-375 acts as a negative regulating molecule mediating the signaling pathway of CRF and affecting POMC expression by targeting mitogen-activated protein kinase kinase kinase-8, which subsequently down-regulates ERK1/2 phosphorylation and nerve growth factor-induced clone B (NGFI-B) transcription activity. Taken together, our results show that miR-375 is a novel negative regulator of POMC expression and related hormone secretion.	[Zhang, Nan; Lin, Jun-kai; Chen, Juan; Liu, Xiong-fei; Liu, Jia-li; Luo, Hao-shu; Li, Yue-qin; Cui, Sheng] China Agr Univ, State Key Lab Agrobiotechnol, Coll Biol Sci, Beijing 100193, Peoples R China	China Agricultural University	Cui, S (corresponding author), China Agr Univ, 2 Yuanmingyuan Xilu, Beijing 100193, Peoples R China.	cuisheng@cau.edu.cn			National Basic Research Program of China [2009CB941702, 2012CB944703]; Natural Science Foundation of China [31172287, 31172289]	National Basic Research Program of China(National Basic Research Program of China); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Basic Research Program of China (2009CB941702 and 2012CB944703) and the Natural Science Foundation of China (31172287 and 31172289).	AFFOLTER HU, 1985, J BIOL CHEM, V260, P5477; Arzt E, 2006, TRENDS PHARMACOL SCI, V27, P531, DOI 10.1016/j.tips.2006.08.007; Bak M, 2008, RNA, V14, P432, DOI 10.1261/rna.783108; Becquet D, 2001, MOL CELL ENDOCRINOL, V175, P93, DOI 10.1016/S0303-7207(01)00393-8; BERTAGNA X, 1994, ENDOCRIN METAB CLIN, V23, P467, DOI 10.1016/S0889-8529(18)30079-3; Ceci JD, 1997, GENE DEV, V11, P688, DOI 10.1101/gad.11.6.688; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Dermitzaki E, 2012, J CELL PHYSIOL, V227, P1861, DOI 10.1002/jcp.22914; Drouin J, 1998, J STEROID BIOCHEM, V65, P59, DOI 10.1016/S0960-0760(97)00180-5; El Ouaamari A, 2008, DIABETES, V57, P2708, DOI 10.2337/db07-1614; Gavrin LK, 2005, BIOORG MED CHEM LETT, V15, P5288, DOI 10.1016/j.bmcl.2005.08.029; Getting SJ, 1999, J IMMUNOL, V162, P7446; Hatziapostolou M, 2008, CANCER RES, V68, P1851, DOI 10.1158/0008-5472.CAN-07-5793; HEIJNEN C J, 1987, Brain Behavior and Immunity, V1, P284, DOI 10.1016/0889-1591(87)90031-6; Hjalt TA, 2000, DEV DYNAM, V218, P195, DOI 10.1002/(SICI)1097-0177(200005)218:1<195::AID-DVDY17>3.0.CO;2-C; KNIGHT RM, 1987, PEPTIDES, V8, P927, DOI 10.1016/0196-9781(87)90082-9; Kovalovsky D, 2002, MOL ENDOCRINOL, V16, P1638, DOI 10.1210/me.16.7.1638; Kruger J, 2006, NUCLEIC ACIDS RES, V34, pW451, DOI 10.1093/nar/gkl243; Lamolet B, 2001, CELL, V104, P849, DOI 10.1016/S0092-8674(01)00282-3; LITVIN Y, 1984, J BIOL CHEM, V259, P296; Liu JX, 2001, P NATL ACAD SCI USA, V98, P8674, DOI 10.1073/pnas.141234898; LUINI A, 1985, P NATL ACAD SCI USA, V82, P8034, DOI 10.1073/pnas.82.23.8034; LUNDBLAD JR, 1988, ENDOCR REV, V9, P135, DOI 10.1210/edrv-9-1-135; Maira M, 1999, MOL CELL BIOL, V19, P7549; MAKRIS A, 1993, J VIROL, V67, P4283, DOI 10.1128/JVI.67.7.4283-4289.1993; Mao ZG, 2010, DIAGN PATHOL, V5, DOI 10.1186/1746-1596-5-79; Murphy EP, 1997, MOL ENDOCRINOL, V11, P39, DOI 10.1210/me.11.1.39; Nemoto T, 2012, AM J PHYSIOL-ENDOC M, V302, pE781, DOI 10.1152/ajpendo.00616.2011; Obernosterer G, 2007, NAT PROTOC, V2, P1508, DOI 10.1038/nprot.2007.153; PATRIOTIS C, 1994, P NATL ACAD SCI USA, V91, P9755, DOI 10.1073/pnas.91.21.9755; PATRIOTIS C, 1993, P NATL ACAD SCI USA, V90, P2251, DOI 10.1073/pnas.90.6.2251; Phillips A, 1997, MOL CELL BIOL, V17, P5952, DOI 10.1128/MCB.17.10.5952; Phillips A, 1997, MOL CELL BIOL, V17, P5946, DOI 10.1128/MCB.17.10.5946; Poy MN, 2009, P NATL ACAD SCI USA, V106, P5813, DOI 10.1073/pnas.0810550106; Poy MN, 2004, NATURE, V432, P226, DOI 10.1038/nature03076; Rajewsky N, 2004, DEV BIOL, V267, P529, DOI 10.1016/j.ydbio.2003.12.003; RAYMOND V, 1981, MOL CELL ENDOCRINOL, V22, P295, DOI 10.1016/0303-7207(81)90038-1; Rehmsmeier M, 2004, RNA, V10, P1507, DOI 10.1261/rna.5248604; Reyes R, 2008, ANAT HISTOL EMBRYOL, V37, P263, DOI 10.1111/j.1439-0264.2007.00839.x; RIVIER C, 1983, NATURE, V305, P325, DOI 10.1038/305325a0; Schneeberger M., 2012, MOL METAB IN PRESS; Sei C, 2002, PEPTIDES, V23, P1409, DOI 10.1016/S0196-9781(02)00079-7; Simonini PDR, 2010, CANCER RES, V70, P9175, DOI 10.1158/0008-5472.CAN-10-1318; Stevens A, 2010, RESULTS PROBL CELL D, V50, P63, DOI 10.1007/400_2009_30; Tsigos C, 2002, J PSYCHOSOM RES, V53, P865, DOI 10.1016/S0022-3999(02)00429-4; Zhang ZC, 2010, J BIOL CHEM, V285, P34718, DOI 10.1074/jbc.M110.126441	46	54	54	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 12	2013	288	15					10361	10373		10.1074/jbc.M112.425504	http://dx.doi.org/10.1074/jbc.M112.425504			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	125TU	23430746	Green Published, hybrid			2022-12-25	WOS:000317565000017
J	Yanagawa, M; Yamashita, T; Shichida, Y				Yanagawa, Masataka; Yamashita, Takahiro; Shichida, Yoshinori			Glutamate Acts as a Partial Inverse Agonist to Metabotropic Glutamate Receptor with a Single Amino Acid Mutation in the Transmembrane Domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTORS; BINDING-SITE; FLUORESCENT PROTEIN; ACTIVATION SWITCH; RHODOPSIN; FAMILY; REARRANGEMENT; MODULATOR; VARIANT; TOOL	Metabotropic glutamate receptor (mGluR), a prototypical family 3 G protein-coupled receptor (GPCR), has served as a model for studying GPCR dimerization, and growing evidence has revealed that a glutamate-induced dimeric rearrangement promotes activation of the receptor. However, structural information of the seven-transmembrane domain is severely limited, in contrast to the well studied family 1 GPCRs including rhodopsins and adrenergic receptors. Homology modeling of mGluR8 transmembrane domain with rhodopsin as a template suggested the presence of a conserved water-mediated hydrogen-bonding network between helices VI and VII, which presumably constrains the receptor in an inactive conformation. We therefore conducted a mutational analysis to assess structural similarities between mGluR and family 1 GPCRs. Mutational experiments confirmed that the disruption of the hydrogen-bonding network by T789Y(6.43) mutation induced high constitutive activity. Unexpectedly, this high constitutive activity was suppressed by glutamate, the natural agonist ligand, indicating that glutamate acts as a partial inverse agonist to this mutant. Fluorescence energy transfer analysis of T789Y(6.43) suggested that the glutamate-induced reduction of the activity originated not from the dimeric rearrangement but from conformational changes within each protomer. Double mutational analysis showed that the specific interaction between Tyr-789(6.43) and Gly-831(7.45) in T789Y(6.43) mutant was important for this phenotype. Therefore, the present study is consistent with the notion that the metabotropic glutamate receptor shares a common activation mechanism with family 1 GPCRs, where rearrangement between helices VI and VII causes the active state formation.	[Yanagawa, Masataka; Yamashita, Takahiro; Shichida, Yoshinori] Kyoto Univ, Grad Sch Sci, Dept Biophys, Kyoto 6068502, Japan	Kyoto University	Shichida, Y (corresponding author), Kyoto Univ, Grad Sch Sci, Dept Biophys, Kyoto 6068502, Japan.	shichida@rh.biophys.kyoto-u.ac.jp	Yanagawa, Masataka/C-3789-2017	Yanagawa, Masataka/0000-0001-7832-0918	Ministry of Education, Culture, Sports, Science, and Technology (MEXT), Japan; Global Center of Excellence Program "Formation of a Strategic Base for Biodiversity and Evolutionary Research: from Genome to Ecosystem" [A06]; Japan Society for the Promotion of Science (JSPS) [08J01259];  [20227002];  [21026019]	Ministry of Education, Culture, Sports, Science, and Technology (MEXT), Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Global Center of Excellence Program "Formation of a Strategic Base for Biodiversity and Evolutionary Research: from Genome to Ecosystem"; Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); ; 	This work was supported by the Ministry of Education, Culture, Sports, Science, and Technology (MEXT), Japan, Grants-in-aid for Scientific Research 20227002 and 21026019, and the Global Center of Excellence Program "Formation of a Strategic Base for Biodiversity and Evolutionary Research: from Genome to Ecosystem" (Program A06), and Japan Society for the Promotion of Science (JSPS) Research Fellowship for Young Scientists 08J01259.	Angel TE, 2009, P NATL ACAD SCI USA, V106, P8555, DOI 10.1073/pnas.0903545106; Ballesteros J. A., 1995, RECEPTOR MOL BIOL, V25, P366, DOI [10.1016/S1043-9471(05)80049-7, DOI 10.1016/S1043-9471(05)80049-7]; Binet V, 2007, J BIOL CHEM, V282, P12154, DOI 10.1074/jbc.M611071200; Bruno A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042023; Choe HW, 2011, NATURE, V471, P651, DOI 10.1038/nature09789; Deupi X, 2012, P NATL ACAD SCI USA, V109, P119, DOI 10.1073/pnas.1114089108; Deupi X, 2010, PHYSIOLOGY, V25, P293, DOI 10.1152/physiol.00002.2010; Webb Benjamin, 2016, Curr Protoc Bioinformatics, V54, DOI [10.1002/0471140864.ps0209s50, 10.1002/cpps.20, 10.1002/0471250953.bi0506s15, 10.1002/cpbi.3]; Govaerts C, 2001, J BIOL CHEM, V276, P22991, DOI 10.1074/jbc.M102244200; Grell L, 2006, BIOCHEM MOL BIOL EDU, V34, P402, DOI 10.1002/bmb.2006.494034062672; Hlavackova V, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002720; Huang SL, 2011, P NATL ACAD SCI USA, V108, P15480, DOI 10.1073/pnas.1107775108; Khelashvili G, 2010, BIOINFORMATICS, V26, P1804, DOI 10.1093/bioinformatics/btq264; Kobilka BK, 2007, TRENDS PHARMACOL SCI, V28, P397, DOI 10.1016/j.tips.2007.06.003; Kunishima N, 2000, NATURE, V407, P971, DOI 10.1038/35039564; Malherbe P, 2003, MOL PHARMACOL, V64, P823, DOI 10.1124/mol.64.4.823; Malherbe P, 2003, J BIOL CHEM, V278, P8340, DOI 10.1074/jbc.M211759200; Miedlich SU, 2004, J BIOL CHEM, V279, P7254, DOI 10.1074/jbc.M307191200; Muto T, 2007, P NATL ACAD SCI USA, V104, P3759, DOI 10.1073/pnas.0611577104; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Okada T, 2004, J MOL BIOL, V342, P571, DOI 10.1016/j.jmb.2004.07.044; Okada T, 2002, P NATL ACAD SCI USA, V99, P5982, DOI 10.1073/pnas.082666399; Petrel C, 2003, J BIOL CHEM, V278, P49487, DOI 10.1074/jbc.M308010200; Pin JP, 2003, PHARMACOL THERAPEUT, V98, P325, DOI 10.1016/S0163-7258(03)00038-X; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Rizzo MA, 2004, NAT BIOTECHNOL, V22, P445, DOI 10.1038/nbt945; Smit MJ, 2007, ANNU REV PHARMACOL, V47, P53, DOI 10.1146/annurev.pharmtox.47.120505.105126; Tateyama M, 2004, NAT STRUCT MOL BIOL, V11, P637, DOI 10.1038/nsmb770; Urizar E, 2005, J BIOL CHEM, V280, P17135, DOI 10.1074/jbc.M414678200; Urwyler S, 2011, PHARMACOL REV, V63, P59, DOI 10.1124/pr.109.002501; Vroling B, 2011, NUCLEIC ACIDS RES, V39, pD309, DOI 10.1093/nar/gkq1009; Yamashita T, 2008, J NEUROCHEM, V106, P850, DOI 10.1111/j.1471-4159.2008.05443.x; Yanagawa M, 2011, J BIOL CHEM, V286, P22971, DOI 10.1074/jbc.M110.206870; Yanagawa M, 2009, MOL PHARMACOL, V76, P201, DOI 10.1124/mol.109.056549	35	11	12	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 5	2013	288	14					9593	9601		10.1074/jbc.M112.437780	http://dx.doi.org/10.1074/jbc.M112.437780			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	119RB	23420844	Green Published, hybrid			2022-12-25	WOS:000317114000003
J	El-Adawy, H; Hotzel, H; Tomaso, H; Neubauer, H; Taboada, EN; Ehricht, R; Hafez, HM				El-Adawy, Hosny; Hotzel, Helmut; Tomaso, Herbert; Neubauer, Heinrich; Taboada, Eduardo N.; Ehricht, Ralf; Hafez, Hafez M.			Detection of Genetic Diversity in Campylobacter jejuni Isolated from a Commercial Turkey Flock Using flaA Typing, MLST Analysis and Microarray Assay	PLOS ONE			English	Article							FRAGMENT-LENGTH-POLYMORPHISM; COLI; SEQUENCE; RECOMBINATION; INSTABILITY; DYNAMICS; ABILITY	Campylobacter is genetically highly diverse and undergoes frequent intraspecific recombination. Turkeys have been identified as an important reservoir for Campylobacter jejuni which is of public health significance. The assessment of the genetic diversity among Campylobacter population is critical for our understanding of the epidemiology of this bacterium. The genetic profiles were different according to the molecular typing methods used. The performance of established flaA genotyping, multilocus sequencing typing (MLST) and DNA microarray assay based on the ArrayTube (TM) technology was evaluated using 14 Campylobacter jejuni isolated from a commercial turkey flock. The flaA typing was performed using PCR-RFLP with restriction enzymes Sau3AI, AluI, a 'composite' flaA analysis of AluI and Sau3AI and DdeI. The 14 isolates were differentiated into 3, 5, 7 and 9 genotypes, respectively. Entire flaA gene and short variable region (SVR) sequences were analysed. Sequencing of the entire flaA provided 11 different genotypes. flaA-SVR sequence analysis detected 8 flaA alleles and 4 flaA peptides. One new flaA allele type (528) was identified. MLST analysis represented 10 different sequence types (STs) and 5 clonal complexes (CCs). The microarray assay recognised 14 different genotypes. The discriminatory indices were 0.560, 0.802, 0.857, and 0.912 for flaA-RFLP depending on the used enzymes, 0.890 for flaA-SVR, 0.967 for entire flaA sequencing, 0.945 for MLST and 1.00 for the DNA microarray assay. The flaA gene was genetically stable over 20 passages on blood agar. In conclusion, the different typing tools demonstrated a high level of genetic heterogeneity of Campylobacter jejuni in a turkey flock, indicating that a single flock can be infected by multiple genotypes within one rearing cycle. DNA microarray-based assays had the highest discriminatory power when compared with other genotyping tools.	[El-Adawy, Hosny; Hotzel, Helmut; Tomaso, Herbert; Neubauer, Heinrich] Friedrich Loeffler Inst, Inst Bacterial Infect & Zoonoses, Jena, Germany; [El-Adawy, Hosny; Hafez, Hafez M.] Free Univ Berlin, Inst Poultry Dis, Berlin, Germany; [El-Adawy, Hosny] Kafrelsheikh Univ, Fac Vet Med, Dept Poultry Dis, Kafr Al Sheikh, Egypt; [Taboada, Eduardo N.] Publ Hlth Agcy Canada, Lab Foodborne Zoonoses, Lethbridge, AB, Canada; [Ehricht, Ralf] Alere Technol GmbH, Jena, Germany	Friedrich Loeffler Institute; Free University of Berlin; Egyptian Knowledge Bank (EKB); Kafrelsheikh University; Public Health Agency of Canada; Alere	El-Adawy, H (corresponding author), Friedrich Loeffler Inst, Inst Bacterial Infect & Zoonoses, Jena, Germany.	hosnyeladawy@yahoo.com	Tomaso, Herbert/C-6327-2017; Taboada, Eduardo N/Y-4854-2018	Taboada, Eduardo N/0000-0001-8373-3653; El-Adawy, Hosny/0000-0002-8585-4237	Friedrich Loeffler Institute (Federal Research Institute for Animal Health), Institute of Bacterial Infections and Zoonoses, Jena, Germany; Egyptian ministry of higher education; Egyptian Cultural and Educational office of the Arab Republic of Egypt in Germany	Friedrich Loeffler Institute (Federal Research Institute for Animal Health), Institute of Bacterial Infections and Zoonoses, Jena, Germany; Egyptian ministry of higher education(Science and Technology Development Fund (STDF)); Egyptian Cultural and Educational office of the Arab Republic of Egypt in Germany(Egyptian Cultural & Educational Bureau)	This research was supported by grants from Friedrich Loeffler Institute (Federal Research Institute for Animal Health), Institute of Bacterial Infections and Zoonoses, Jena, Germany to HE and in part by a grant from the Egyptian ministry of higher education. HE is a scholarship recipient from the Egyptian Cultural and Educational office of the Arab Republic of Egypt in Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alter T, 2011, VET MICROBIOL, V147, P90, DOI 10.1016/j.vetmic.2010.06.005; [Anonymous], 2006, 1027212006 ISO; Ayling RD, 1996, RES VET SCI, V60, P168, DOI 10.1016/S0034-5288(96)90013-2; Behringer M, 2011, J MICROBIOL METH, V84, P194, DOI 10.1016/j.mimet.2010.11.016; Buchanan CJ, 2011, P 16 INT WORKSH CAMP, P164; Chuma T, 1997, J VET MED SCI, V59, P1011, DOI 10.1292/jvms.59.1011; Clark CG, 2012, J CLIN MICROBIOL, V50, P798, DOI 10.1128/JCM.05733-11; Colles FM, 2003, APPL ENVIRON MICROB, V69, P7409, DOI 10.1128/AEM.69.12.7409-7413.2003; Dingle KE, 2001, J CLIN MICROBIOL, V39, P14, DOI 10.1128/JCM.39.1.14-23.2001; Drummond A, 2010, GENEIOUS V5 1; Eberle KN, 2012, POULTRY SCI, V91, P255, DOI 10.3382/ps.2011-01414; Ehricht R, 2006, MOL CELL PROBE, V20, P60, DOI 10.1016/j.mcp.2005.09.003; El-Adawy H, 2012, POULTRY SCI, V91, P454, DOI 10.3382/ps.2010-01810; European Food Safety Authority (EFSA), 2011, EFSA J, V10, P2597; Foley SL, 2009, INFECT GENET EVOL, V9, P430, DOI 10.1016/j.meegid.2009.03.004; Fouts DE, 2005, PLOS BIOL, V3, P72, DOI 10.1371/journal.pbio.0030015; Gu WM, 2009, APPL ENVIRON MICROB, V75, P474, DOI 10.1128/AEM.02012-08; Hafez HM, 2001, ARCH GEFLUGELKD, V65, P130; Hanninen ML, 1999, APPL ENVIRON MICROB, V65, P2272; Harrington CS, 2003, J APPL MICROBIOL, V95, P1321, DOI 10.1046/j.1365-2672.2003.02101.x; Harrington CS, 1997, J CLIN MICROBIOL, V35, P2386, DOI 10.1128/JCM.35.9.2386-2392.1997; HUNTER PR, 1988, J CLIN MICROBIOL, V26, P2465, DOI 10.1128/JCM.26.11.2465-2466.1988; Levesque S, 2008, J CLIN MICROBIOL, V46, P3404, DOI 10.1128/JCM.00042-08; Manning G, 2001, APPL ENVIRON MICROB, V67, P1185, DOI 10.1128/AEM.67.3.1185-1189.2001; Meinersmann RJ, 1997, J CLIN MICROBIOL, V35, P2810, DOI 10.1128/JCM.35.11.2810-2814.1997; Miller MB, 2009, CLIN MICROBIOL REV, V22, P611, DOI 10.1128/CMR.00019-09; NACHAMKIN I, 1993, J CLIN MICROBIOL, V31, P1531, DOI 10.1128/JCM.31.6.1531-1536.1993; Parkhill J, 2000, NATURE, V403, P665, DOI 10.1038/35001088; Pearson BM, 2003, FEBS LETT, V554, P224, DOI 10.1016/S0014-5793(03)01164-5; Petersen L, 2000, LETT APPL MICROBIOL, V31, P14, DOI 10.1046/j.1472-765X.2000.00757.x; Petersen L, 2001, J APPL MICROBIOL, V91, P217, DOI 10.1046/j.1365-2672.2001.01383.x; Ridley AM, 2008, J APPL MICROBIOL, V105, P95, DOI 10.1111/j.1365-2672.2008.03759.x; Ring M, 2005, AVIAN DIS, V49, P390, DOI 10.1637/7319-010305R1.1; Suerbaum S, 2001, J BACTERIOL, V183, P2553, DOI 10.1128/JB.183.8.2553-2559.2001; Taboada Eduardo N., 2007, V396, P223; Taboada EN, 2004, J CLIN MICROBIOL, V42, P4566, DOI 10.1128/JCM.42.10.4566-4576.2004; Thomas LM, 1997, APPL ENVIRON MICROB, V63, P1874, DOI 10.1128/AEM.63.5.1874-1877.1997; Volokhov D, 2003, J CLIN MICROBIOL, V41, P4071, DOI 10.1128/JCM.41.9.4071-4080.2003; Wassenaar TM, 2000, APPL ENVIRON MICROB, V66, P1, DOI 10.1128/AEM.66.1.1-9.2000; Wassenaar TM, 1998, APPL ENVIRON MICROB, V64, P1816	40	24	25	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e51582	10.1371/journal.pone.0051582	http://dx.doi.org/10.1371/journal.pone.0051582			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437035	Green Submitted, Green Published, gold			2022-12-25	WOS:000315184200002
J	Podlas, K; Helfenstein, F; Richner, H				Podlas, Katarzyna; Helfenstein, Fabrice; Richner, Heinz			Brood Reduction via Intra-clutch Variation in Testosterone - An Experimental Test in the Great Tit	PLOS ONE			English	Article							MATERNAL YOLK TESTOSTERONE; IMMUNE FUNCTION; HATCHING ASYNCHRONY; SIBLING COMPETITION; HORMONE DEPOSITION; PRENATAL EXPOSURE; SEX-RATIOS; GROWTH; ANDROGENS; FEMALE	In birds, yolk androgen concentrations in eggs can increase or decrease over the laying sequence and common hypotheses hold that this serves to favour the competitive ability of either first- or last-hatched chicks depending on the prevailing conditions, and thus promote brood reduction or maintenance of original brood size respectively. Intra-clutch variation of testosterone can shift relative competitive ability of siblings and hence competitive dynamics. In a natural population of great tits, we experimentally investigated the effects and function of maternal testosterone on offspring phenotype in relation to the laying position of the egg in a context of hatching asynchrony. To this end, we created three types of clutches where either the first three or the last three eggs of a clutch were injected with testosterone (T) dissolved in sesame oil, and the remaining eggs with sesame oil only, or where all eggs of a clutch were injected with sesame oil. Increased levels of yolk T in the last-laid eggs resulted in the last-hatched chicks being significantly lighter and smaller than their siblings, while increased levels of T in the first-laid eggs had no direct effect on the first- hatched chicks, but an indirect negative effect on their siblings. Our results suggest that females can potentially adjust offspring phenotype by modulating, over the laying sequence, the amounts of T deposited in the eggs. These results are in contradiction, however, with current hypotheses and previous findings, which suggest that under good conditions higher levels of maternally derived T in the last-laid eggs should mitigate the negative effects of hatching asynchrony.	[Podlas, Katarzyna; Helfenstein, Fabrice; Richner, Heinz] Univ Bern, Inst Ecol & Evolut, Bern, Switzerland; [Helfenstein, Fabrice] Univ Neuchatel, Inst Biol, CH-2000 Neuchatel, Switzerland	University of Bern; University of Neuchatel	Podlas, K (corresponding author), Univ Bern, Inst Ecol & Evolut, Bern, Switzerland.	podlas.kasia@gmail.com	Richner, Heinz/B-1659-2008; Helfenstein, Fabrice/I-5634-2013	Richner, Heinz/0000-0001-7390-0526; Helfenstein, Fabrice/0000-0001-8412-0461	Swiss National Science Foundation grant [31003A_122566]	Swiss National Science Foundation grant(Swiss National Science Foundation (SNSF))	The study was financially supported by a Swiss National Science Foundation grant, 31003A_122566 to HR (http://www.snf.ch/E/Pages/default.aspx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBERT DJ, 1989, PHYSIOL BEHAV, V46, P185, DOI 10.1016/0031-9384(89)90253-9; ALEXANDER J, 1988, PARASITOL TODAY, V4, P189, DOI 10.1016/0169-4758(88)90077-4; Alonso-Alvarez C, 2007, P ROY SOC B-BIOL SCI, V274, P819, DOI 10.1098/rspb.2006.3764; Amundsen T, 1998, ECOLOGY, V79, P295, DOI 10.1890/0012-9658(1998)079[0295:HAIGTA]2.0.CO;2; Andersson S, 2004, J EVOLUTION BIOL, V17, P501, DOI 10.1111/j.1420-9101.2004.00706.x; BATE LA, 1985, CAN J ANIM SCI, V65, P627, DOI 10.4141/cjas85-074; Beissinger SR, 1997, TRENDS ECOL EVOL, V12, P112, DOI 10.1016/S0169-5347(97)84921-X; Bernardo J, 1996, AM ZOOL, V36, P83; Berthouly A, 2007, FUNCT ECOL, V21, P335, DOI 10.1111/j.1365-2435.2006.01236.x; BIERE A, 1991, J EVOLUTION BIOL, V4, P447, DOI 10.1046/j.1420-9101.1991.4030447.x; Boncoraglio G, 2011, AM NAT, V178, P64, DOI 10.1086/660278; Bruggeman V, 2002, COMP BIOCHEM PHYS A, V131, P839, DOI 10.1016/S1095-6433(02)00022-3; Carere C, 2007, TRENDS ENDOCRIN MET, V18, P73, DOI 10.1016/j.tem.2007.01.003; CLARK MM, 1995, PHYSIOL BEHAV, V57, P297, DOI 10.1016/0031-9384(94)00239-2; Clark MM, 2002, ANIM BEHAV, V63, P1129, DOI 10.1006/anbe.2002.3019; Dijkstra C, 1998, BEHAV ECOL, V9, P287, DOI 10.1093/beheco/9.3.287; Dloniak SM, 2006, NATURE, V440, P1190, DOI 10.1038/nature04540; DVORAK M, 1981, VET MED-CZECH, V26, P65; Eising CM, 2001, P ROY SOC B-BIOL SCI, V268, P839, DOI 10.1098/rspb.2001.1594; Eising CM, 2003, ANIM BEHAV, V66, P1027, DOI 10.1006/anbe.2003.2287; Eising CM, 2006, BIOL LETTERS, V2, P20, DOI 10.1098/rsbl.2005.0391; FENNELL MJ, 1992, POULTRY SCI, V71, P357, DOI 10.3382/ps.0710357; Fisher MO, 2006, PLOS BIOL, V4, P1462, DOI 10.1371/journal.pbio.0040251; FORD JJ, 1982, BIOL REPROD, V27, P425, DOI 10.1095/biolreprod27.2.425; Gaillard RC, 1998, DOMEST ANIM ENDOCRIN, V15, P345, DOI 10.1016/S0739-7240(98)00028-9; Galvan I, 2010, J EXP BIOL, V213, P3127, DOI 10.1242/jeb.045096; Gil D, 1999, SCIENCE, V286, P126, DOI 10.1126/science.286.5437.126; Gil D, 2008, ADV STUD BEHAV, V38, P337, DOI 10.1016/S0065-3454(08)00007-7; GRANT VJ, 1994, BRIT J MED PSYCHOL, V67, P343, DOI 10.1111/j.2044-8341.1994.tb01802.x; Groothuis TGG, 2005, BIOL LETTERS, V1, P78, DOI 10.1098/rsbl.2004.0233; Groothuis TGG, 2008, BIOL LETTERS, V4, P465, DOI 10.1098/rsbl.2008.0258; Groothuis TGG, 2008, PHILOS T R SOC B, V363, P1647, DOI 10.1098/rstb.2007.0007; GROSSMAN CJ, 1985, SCIENCE, V227, P257, DOI 10.1126/science.3871252; Hadfield J.D, 2012, MCMCGLMM COURSE NOTE; Hales CN, 1996, BIOCHEM SOC T, V24, P341, DOI 10.1042/bst0240341; Hudson R, 2008, BEHAV ECOL SOCIOBIOL, V62, P299, DOI 10.1007/s00265-007-0417-z; Janzen FJ, 1998, GEN COMP ENDOCR, V111, P306, DOI 10.1006/gcen.1998.7115; Kaiser S, 2005, NEUROSCI BIOBEHAV R, V29, P283, DOI 10.1016/j.neubiorev.2004.09.015; Lipar JL, 1999, AUK, V116, P231, DOI 10.2307/4089471; Lipar JL, 2000, P ROY SOC B-BIOL SCI, V267, P2005, DOI 10.1098/rspb.2000.1242; Lovern MB, 2001, GEN COMP ENDOCR, V124, P226, DOI 10.1006/gcen.2001.7704; Manikkam M, 2004, ENDOCRINOLOGY, V145, P790, DOI 10.1210/en.2003-0478; Martin JT, 2000, EUR J PHARMACOL, V405, P251, DOI 10.1016/S0014-2999(00)00557-4; McCormick MI, 1999, OECOLOGIA, V118, P412, DOI 10.1007/s004420050743; Mock D. W., 1997, EVOLUTION SIBLING RI; MONTALVO AM, 1994, EVOLUTION, V48, P828, DOI 10.1111/j.1558-5646.1994.tb01365.x; Morales J, 2006, BIOL LETTERS, V2, P334, DOI 10.1098/rsbl.2006.0471; Mostl E, 2001, WIEN TIERARZTL MONAT, V88, P62; Mousseau T.A., 1998, MATERNAL EFFECTS ADA; Muller W, 2005, P ROY SOC B-BIOL SCI, V272, P1971, DOI 10.1098/rspb.2005.3178; Muller W, 2010, BEHAV ECOL, V21, P493, DOI 10.1093/beheco/arq010; Navara KJ, 2006, BEHAV ECOL SOCIOBIOL, V60, P392, DOI 10.1007/s00265-006-0177-1; Nelson R. J., 2000, INTRO BEHAV ENDOCRIN; Nelson RJ, 2006, BIOL AGRESSION; Neuenschwander S, 2003, BEHAV ECOL, V14, P457, DOI 10.1093/beheco/arg025; Okuliarova M, 2011, COMP BIOCHEM PHYS A, V160, P81, DOI 10.1016/j.cbpa.2011.05.012; Oyegbile TO, 2005, HORM BEHAV, V48, P259, DOI 10.1016/j.yhbeh.2005.04.007; PALME R, 1994, ADVANCES IN STEROID ANALYSIS '93, P111; PARICHY DM, 1992, OECOLOGIA, V91, P579, DOI 10.1007/BF00650334; Pettifor RA, 2001, J ANIM ECOL, V70, P62, DOI 10.1046/j.1365-2656.2001.00465.x; Pinheiro J, 2001, MIXED EFFECTS MODELS; Pitala N, 2009, J AVIAN BIOL, V40, P225, DOI 10.1111/j.1600-048X.2009.04452.x; R Development Core Team, 2007, R LANG ENV STAT COMP; Randall P, 2002, PLAST RECONSTR SURG, V109, P1713, DOI 10.1097/00006534-200204150-00038; Remes V, 2011, BEHAV ECOL SOCIOBIOL, V65, P1257, DOI 10.1007/s00265-011-1139-9; Ros AFH, 1999, IBIS, V141, P451, DOI 10.1111/j.1474-919X.1999.tb04414.x; Rosser CB, 2003, BIOL REPROD, V68, P293; Royle NJ, 2001, BEHAV ECOL, V12, P381, DOI 10.1093/beheco/12.4.381; Ruuskanen S, 2010, HORM BEHAV, V57, P119, DOI 10.1016/j.yhbeh.2009.09.017; SAAL FSV, 1989, J ANIM SCI, V67, P1824; Saino N, 2002, J EVOLUTION BIOL, V15, P735, DOI 10.1046/j.1420-9101.2002.00448.x; Schwabl H, 1997, NATURE, V386, P231, DOI 10.1038/386231a0; Schwabl H, 1996, J EXP ZOOL, V276, P157, DOI 10.1002/(SICI)1097-010X(19961001)276:2<157::AID-JEZ9>3.3.CO;2-Y; SCHWABL H, 1993, P NATL ACAD SCI USA, V90, P11446, DOI 10.1073/pnas.90.24.11446; Schwabl H, 1996, COMP BIOCHEM PHYS A, V114, P271, DOI 10.1016/0300-9629(96)00009-6; Schwabl H, 1997, CONTROL OFFFSPRING F, P1677; SCHWAEGERLE KE, 1990, J ECOL, V78, P15, DOI 10.2307/2261033; SLOB AK, 1980, J ENDOCRINOL, V87, P81, DOI 10.1677/joe.0.0870081; Smith AS, 2008, AM J PRIMATOL, V70, P46; Sockman KW, 2000, P ROY SOC B-BIOL SCI, V267, P1451, DOI 10.1098/rspb.2000.1163; Staub NL, 1997, GEN COMP ENDOCR, V108, P1, DOI 10.1006/gcen.1997.6962; Strasser R, 2004, BEHAV ECOL SOCIOBIOL, V56, P491, DOI 10.1007/s00265-004-0810-9; Tobler M, 2007, BIOLOGY LETT, V3, P408, DOI 10.1098/rsbl.2007.0127; Tschirren B, 2005, J ANIM ECOL, V74, P675, DOI 10.1111/j.1365-2656.2005.00963.x; Tschirren B, 2004, P ROY SOC B-BIOL SCI, V271, P1371, DOI 10.1098/rspb.2004.2730; Urban RJ, 2011, HORM RES PAEDIAT, V76, P81, DOI 10.1159/000329184; van de Pol MV, 2009, ANIM BEHAV, V77, P753, DOI 10.1016/j.anbehav.2008.11.006; Verboven N, 2003, P ROY SOC B-BIOL SCI, V270, P2223, DOI 10.1098/rspb.2003.2496; Wolf CJ, 2002, TOXICOL SCI, V65, P71, DOI 10.1093/toxsci/65.1.71; Zuur Alain F., 2009, P1	90	8	9	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e56672	10.1371/journal.pone.0056672	http://dx.doi.org/10.1371/journal.pone.0056672			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437207	Green Published, gold			2022-12-25	WOS:000315184200137
J	Reiner, T; Parrondo, R; de las Pozas, A; Palenzuela, D; Perez-Stable, C				Reiner, Teresita; Parrondo, Ricardo; de las Pozas, Alicia; Palenzuela, Deanna; Perez-Stable, Carlos			Betulinic Acid Selectively Increases Protein Degradation and Enhances Prostate Cancer-Specific Apoptosis: Possible Role for Inhibition of Deubiquitinase Activity	PLOS ONE			English	Article							SMALL-MOLECULE INHIBITOR; NF-KAPPA-B; CELL-LINES; TRANSGENIC MOUSE; CYCLIN D1; IN-VITRO; PROTEASOME; THERAPY; TUMOR; ENZYMES	Inhibition of the ubiquitin-proteasome system (UPS) of protein degradation is a valid anti-cancer strategy and has led to the approval of bortezomib for the treatment of multiple myeloma. However, the alternative approach of enhancing the degradation of oncoproteins that are frequently overexpressed in cancers is less developed. Betulinic acid (BA) is a plant-derived small molecule that can increase apoptosis specifically in cancer but not in normal cells, making it an attractive anti-cancer agent. Our results in prostate cancer suggested that BA inhibited multiple deubiquitinases (DUBs), which resulted in the accumulation of poly-ubiquitinated proteins, decreased levels of oncoproteins, and increased apoptotic cell death. In normal fibroblasts, however, BA did not inhibit DUB activity nor increased total poly-ubiquitinated proteins, which was associated with a lack of effect on cell death. In the TRAMP transgenic mouse model of prostate cancer, treatment with BA (10 mg/kg) inhibited primary tumors, increased apoptosis, decreased angiogenesis and proliferation, and lowered androgen receptor and cyclin D1 protein. BA treatment also inhibited DUB activity and increased ubiquitinated proteins in TRAMP prostate cancer but had no effect on apoptosis or ubiquitination in normal mouse tissues. Overall, our data suggests that BA-mediated inhibition of DUBs and induction of apoptotic cell death specifically in prostate cancer but not in normal cells and tissues may provide an effective non-toxic and clinically selective agent for chemotherapy.	[Reiner, Teresita; Parrondo, Ricardo; de las Pozas, Alicia; Palenzuela, Deanna; Perez-Stable, Carlos] Bruce W Carter Vet Affairs Med Ctr, Geriatr Res Educ & Clin Ctr, Miami, FL USA; [Reiner, Teresita; Parrondo, Ricardo; de las Pozas, Alicia; Palenzuela, Deanna; Perez-Stable, Carlos] Bruce W Carter Vet Affairs Med Ctr, Res Serv, Miami, FL USA; [Perez-Stable, Carlos] Univ Miami, Miller Sch Med, Dept Med, Div Gerontol & Geriatr Med, Miami, FL 33136 USA; [Perez-Stable, Carlos] Univ Miami, Miller Sch Med, Sylvester Comprehens Canc Ctr, Miami, FL 33136 USA	Geriatric Research Education & Clinical Center; University of Miami; University of Miami	Perez-Stable, C (corresponding author), Bruce W Carter Vet Affairs Med Ctr, Geriatr Res Educ & Clin Ctr, Miami, FL USA.	cperez@med.miami.edu			Veterans Affairs Merit Review [6996.06 MR]	Veterans Affairs Merit Review(US Department of Veterans Affairs)	Veterans Affairs Merit Review 6996.06 MR http://www.research.va.gov/programs/blrd/merit_review.cfm. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Borodovsky A, 2001, EMBO J, V20, P5187, DOI 10.1093/emboj/20.18.5187; Chen CD, 2004, NAT MED, V10, P33, DOI 10.1038/nm972; Chintharlapalli S, 2007, CANCER RES, V67, P2816, DOI 10.1158/0008-5472.CAN-06-3735; Colland F, 2010, BIOCHEM SOC T, V38, P137, DOI 10.1042/BST0380137; Colland F, 2009, MOL CANCER THER, V8, P2286, DOI 10.1158/1535-7163.MCT-09-0097; Comstock CES, 2011, J BIOL CHEM, V286, P8117, DOI 10.1074/jbc.M110.170720; D'Arcy P, 2011, NAT MED, V17, P1636, DOI 10.1038/nm.2536; Ding ZH, 2011, NATURE, V470, P269, DOI 10.1038/nature09677; Draker R, 2011, NUCLEIC ACIDS RES, V39, P3529, DOI 10.1093/nar/gkq1352; Drobnjak M, 2000, CLIN CANCER RES, V6, P1891; Dupont S, 2009, CELL, V136, P123, DOI 10.1016/j.cell.2008.10.051; Faus H, 2005, MOL CELL ENDOCRINOL, V245, P138, DOI 10.1016/j.mce.2005.11.011; Fulda S, 2009, DRUG DISCOV TODAY, V14, P885, DOI 10.1016/j.drudis.2009.05.015; Gao Y, 2011, CANCER RES, V71, P5182, DOI 10.1158/0008-5472.CAN-10-2016; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; Gomez LA, 2006, MOL CANCER THER, V5, P1216, DOI 10.1158/1535-7163.MCT-05-0467; Gottlieb RA, 2002, METHODS, V26, P341, DOI 10.1016/S1046-2023(02)00040-3; GREENBERG NM, 1995, P NATL ACAD SCI USA, V92, P3439, DOI 10.1073/pnas.92.8.3439; Huang L, 2007, FEBS LETT, V581, P4955, DOI 10.1016/j.febslet.2007.09.031; Hussain S, 2009, CELL CYCLE, V8, P1688, DOI 10.4161/cc.8.11.8739; Kaplan-Lefko PJ, 2003, PROSTATE, V55, P219, DOI 10.1002/pros.10215; Kapuria V, 2010, CANCER RES, V70, P9265, DOI 10.1158/0008-5472.CAN-10-1530; Kasperczyk H, 2005, ONCOGENE, V24, P6945, DOI 10.1038/sj.onc.1208842; Katsiki M, 2007, REJUV RES, V10, P157, DOI 10.1089/rej.2006.0513; Kessler JH, 2007, CANCER LETT, V251, P132, DOI 10.1016/j.canlet.2006.11.003; Kon N, 2010, ONCOGENE, V29, P1270, DOI 10.1038/onc.2009.427; Krishan A, 1990, Methods Cell Biol, V33, P121; LaCasse EC, 2008, ONCOGENE, V27, P6252, DOI 10.1038/onc.2008.302; Lee BH, 2010, NATURE, V467, P179, DOI 10.1038/nature09299; Liu JL, 2011, CELL, V147, P223, DOI 10.1016/j.cell.2011.08.037; Love KR, 2007, NAT CHEM BIOL, V3, P697, DOI 10.1038/nchembio.2007.43; Luo J, 2009, CELL, V136, P823, DOI 10.1016/j.cell.2009.02.024; Morris MJ, 2007, J UROLOGY, V178, P2378, DOI 10.1016/j.juro.2007.08.015; Newman RM, 2004, J BIOL CHEM, V279, P41504, DOI 10.1074/jbc.M407349200; Orlowski RZ, 2008, CLIN CANCER RES, V14, P1649, DOI 10.1158/1078-0432.CCR-07-2218; Parrondo R, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-182; Perez-Stable C, 2006, CANCER LETT, V231, P49, DOI 10.1016/j.canlet.2005.01.018; PISHA E, 1995, NAT MED, V1, P1046, DOI 10.1038/nm1095-1046; Reiner T, 2009, CANCER LETT, V276, P21, DOI 10.1016/j.canlet.2008.10.026; Reyes-Turcu FE, 2009, ANNU REV BIOCHEM, V78, P363, DOI 10.1146/annurev.biochem.78.082307.091526; Sacco JJ, 2010, IUBMB LIFE, V62, P140, DOI 10.1002/iub.300; Schwickart M, 2010, NATURE, V463, P103, DOI 10.1038/nature08646; Shin YG, 1999, J CHROMATOGR B, V732, P331, DOI 10.1016/S0378-4347(99)00291-1; Soldatenkov VA, 1997, CANCER RES, V57, P3881; Song MS, 2008, NATURE, V455, P813, DOI 10.1038/nature07290; Susin SA, 1999, NATURE, V397, P441, DOI 10.1038/17135; van Bokhoven A, 2003, PROSTATE, V57, P205, DOI 10.1002/pros.10290; Zuco V, 2002, CANCER LETT, V175, P17, DOI 10.1016/S0304-3835(01)00718-2	48	56	60	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2013	8	2							e56234	10.1371/journal.pone.0056234	http://dx.doi.org/10.1371/journal.pone.0056234			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104BU	23424652	gold, Green Published, Green Submitted			2022-12-25	WOS:000315965100040
J	Kuebler, U; Wirtz, PH; Sakai, M; Stemmer, A; Ehlert, U				Kuebler, Ulrike; Wirtz, Petra H.; Sakai, Miho; Stemmer, Andreas; Ehlert, Ulrike			Acute Stress Reduces Wound-Induced Activation of Microbicidal Potential of Ex Vivo Isolated Human Monocyte-Derived Macrophages	PLOS ONE			English	Article							PSYCHOLOGICAL STRESS; NORADRENALINE; NEUTROPHILS; RESPONSES; INHIBITION; EXPRESSION; SYSTEM; ALPHA; CELLS	Background: Psychological stress delays wound healing but the precise underlying mechanisms are unclear. Macrophages play an important role in wound healing, in particular by killing microbes. We hypothesized that (a) acute psychological stress reduces wound-induced activation of microbicidal potential of human monocyte-derived macrophages (HMDM), and (b) that these reductions are modulated by stress hormone release. Methods: Fourty-one healthy men (mean age 35 +/- 13 years) were randomly assigned to either a stress or stress-control group. While the stress group underwent a standardized short-term psychological stress task after catheter-induced wound infliction, stress-controls did not. Catheter insertion was controlled. Assessing the microbicidal potential, we investigated PMA-activated superoxide anion production by HMDM immediately before and 1, 10 and 60 min after stress/rest. Moreover, plasma norepinephrine and epinephrine and salivary cortisol were repeatedly measured. In subsequent in vitro studies, whole blood was incubated with norepinephrine in the presence or absence of phentolamine (norepinephrine blocker) before assessing HMDM microbicidal potential. Results: Compared with stress-controls, HMDM of the stressed subjects displayed decreased superoxide anion-responses after stress (p's<.05). Higher plasma norepinephrine levels statistically mediated lower amounts of superoxide anion-responses (indirect effect 95% CI: 4.14-44.72). Norepinephrine-treated HMDM showed reduced superoxide anion-production (p<.001). This effect was blocked by prior incubation with phentolamine. Conclusions: Our results suggest that acute psychological stress reduces wound-induced activation of microbicidal potential of HMDM and that this reduction is mediated by norepinephrine. This might have implications for stress-induced impairment in wound healing.	[Kuebler, Ulrike; Wirtz, Petra H.; Ehlert, Ulrike] Univ Zurich, Dept Clin Psychol & Psychotherapy, Zurich, Switzerland; [Wirtz, Petra H.] Univ Bern, Bern, Switzerland; [Sakai, Miho; Stemmer, Andreas] Swiss Fed Inst Technol, Nanotechnol Grp, Zurich, Switzerland	University of Zurich; University of Bern; Swiss Federal Institutes of Technology Domain; ETH Zurich	Wirtz, PH (corresponding author), Univ Zurich, Dept Clin Psychol & Psychotherapy, Zurich, Switzerland.	petra.wirtz@psy.unibe.ch	Wirtz, Petra/G-6317-2011		Chocosuisse Foundation [2009]; Swiss National Science Foundation [PP00P1_128565/1]	Chocosuisse Foundation; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This study was supported by the Chocosuisse Foundation Grant 2009 (to PHW) and by the Swiss National Science Foundation Grant PP00P1_128565/1 (to PHW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altemus M, 2001, J INVEST DERMATOL, V117, P309, DOI 10.1046/j.1523-1747.2001.01373.x; Atanackovic D, 2003, J NEUROIMMUNOL, V142, P159, DOI 10.1016/S0165-5728(03)00267-4; BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173; Blotta MH, 1997, J IMMUNOL, V158, P5589; Colton CA, 1996, NEUROCHEM INT, V29, P43, DOI 10.1016/0197-0186(95)00139-5; Dale DC, 2008, BLOOD, V112, P935, DOI 10.1182/blood-2007-12-077917; Delavary BM, 2011, IMMUNOBIOLOGY, V216, P753, DOI 10.1016/j.imbio.2011.01.001; Dhabhar FS, 2012, PSYCHONEUROENDOCRINO, V37, P1345, DOI 10.1016/j.psyneuen.2012.05.008; Dickerson SS, 2004, PSYCHOL BULL, V130, P355, DOI 10.1037/0033-2909.130.3.355; Duffield JS, 2003, CLIN SCI, V104, P27, DOI 10.1042/CS20020240; Dunston CR, 2010, CLIN EXP IMMUNOL, V161, P407, DOI 10.1111/j.1365-2249.2010.04213.x; Ehrenreich H, 1997, ALCOHOL CLIN EXP RES, V21, P1285, DOI 10.1097/00000374-199710000-00019; El-Benna J, 2005, ARCH IMMUNOL THER EX, V53, P199; Ellard DR, 2001, INT J PSYCHOPHYSIOL, V41, P93, DOI 10.1016/S0167-8760(00)00180-X; Engelhardt E, 1998, AM J PATHOL, V153, P1849, DOI 10.1016/S0002-9440(10)65699-4; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; Gouin JP, 2011, IMMUNOL ALLERGY CLIN, V31, P81, DOI 10.1016/j.iac.2010.09.010; Reyes-Garcia MG, 2009, J NEUROIMMUNOL, V216, P20, DOI 10.1016/j.jneuroim.2009.06.024; Hashimoto S, 1999, BLOOD, V94, P837, DOI 10.1182/blood.V94.3.837.413k02_837_844; Hunter M, 2009, FRONT BIOSCI-LANDMRK, V14, P4079, DOI 10.2741/3514; KIRSCHBAUM C, 1993, NEUROPSYCHOBIOLOGY, V28, P76, DOI 10.1159/000119004; Martinez FO, 2008, FRONT BIOSCI-LANDMRK, V13, P453, DOI 10.2741/2692; Palermo-Neto J, 2003, BRAIN BEHAV IMMUN, V17, P43, DOI 10.1016/S0889-1591(02)00057-0; Pelegrin P, 2009, EMBO J, V28, P2114, DOI 10.1038/emboj.2009.163; Persoons JHA, 1997, AM J RESP CELL MOL, V17, P203, DOI 10.1165/ajrcmb.17.2.2466; Porcheray F, 2005, CLIN EXP IMMUNOL, V142, P481, DOI 10.1111/j.1365-2249.2005.02934.x; Preacher KJ, 2008, BEHAV RES METHODS, V40, P879, DOI 10.3758/BRM.40.3.879; Pruessner JC, 2003, PSYCHONEUROENDOCRINO, V28, P916, DOI 10.1016/S0306-4530(02)00108-7; Robles TF, 2007, PSYCHOSOM MED, V69, P807, DOI 10.1097/PSY.0b013e318157b12e; Robles TF, 2009, HEALTH PSYCHOL, V28, P373, DOI 10.1037/a0014662; Sakai M, 2009, BIOSENS BIOELECTRON, V25, P68, DOI 10.1016/j.bios.2009.06.005; Schroder K, 2004, J LEUKOCYTE BIOL, V75, P163, DOI 10.1189/jlb.0603252; Siddiqi M, 2001, CYTOMETRY, V46, P243, DOI 10.1002/cyto.1134; SMEDES F, 1982, J CHROMATOGR, V231, P25, DOI 10.1016/S0378-4347(00)80506-X; Stanojevic S, 2007, STRESS, V10, P65, DOI 10.1080/10253890601181289; Stout RD, 2004, J LEUKOCYTE BIOL, V76, P509, DOI 10.1189/jlb.0504272; Stroncek J. D., 2008, OVERVIEW WOUND HEALI; Tan AS, 2000, J IMMUNOL METHODS, V238, P59, DOI 10.1016/S0022-1759(00)00156-3; Taylor PR, 2005, ANNU REV IMMUNOL, V23, P901, DOI 10.1146/annurev.immunol.23.021704.115816; van der Voort CR, 2000, J NEUROIMMUNOL, V108, P82, DOI 10.1016/S0165-5728(00)00253-8; VANDERPOLL T, 1994, INFECT IMMUN, V62, P2046, DOI 10.1128/IAI.62.5.2046-2050.1994; Verhoeckx KCM, 2005, J VET PHARMACOL THER, V28, P531, DOI 10.1111/j.1365-2885.2005.00691.x; Walburn J, 2009, J PSYCHOSOM RES, V67, P253, DOI 10.1016/j.jpsychores.2009.04.002; Wirtz PH, 2008, PSYCHONEUROENDOCRINO, V33, P1102, DOI 10.1016/j.psyneuen.2008.05.002; Wirtz PH, 2004, AM J HYPERTENS, V17, P489, DOI 10.1016/j.amjhyper.2004.01.010; Wlaschek M, 2005, WOUND REPAIR REGEN, V13, P452, DOI 10.1111/j.1067-1927.2005.00065.x; Woods JA, 2000, INT J SPORTS MED, V21, pS24	48	10	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2013	8	2							e55875	10.1371/journal.pone.0055875	http://dx.doi.org/10.1371/journal.pone.0055875			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	086CJ	23431364	Green Published, Green Accepted, gold			2022-12-25	WOS:000314660300042
J	Allen, S; Richardson, JM; Mehlert, A; Ferguson, MAJ				Allen, Simon; Richardson, Julia M.; Mehlert, Angela; Ferguson, Michael A. J.			Structure of a Complex Phosphoglycan Epitope from gp72 of Trypanosoma cruzi	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LEISHMANIA-MAJOR; SURFACE GLYCOPROTEIN; DICTYOSTELIUM-DISCOIDEUM; INSECT; LIPOPHOSPHOGLYCAN; ATTACHMENT; PARASITE; DELETION; MUCINS; GENE	The parasitic protozoan organism Trypanosoma cruzi is the causative agent of Chagas disease. The insect vector-dwelling epimastigote form of the organism expresses a low abundance glycoprotein associated with the flagellum adhesion zone, called gp72. The gp72 glycoprotein was first identified with an anti-carbohydrate IgG3 monoclonal antibody called WIC29.26 and has been shown to have an unusual sugar composition. Here, we describe a new way to isolate the WIC29.26 carbohydrate epitope of gp72. Using H-1 NMR and mass spectrometry before and after derivatization, we provide an almost complete primary chemical structure for the epitope, which is that of a complex phosphosaccharide: Galf beta 1-4Rhap alpha 1-2Fucp alpha 1-4(Galp beta 1-3)(Galp alpha 1-2)Xylp beta 1-4Xylp beta 1-3(Xylp beta 1-2Galp alpha 1-4(Galp beta 1-3)(Rhap alpha 1-2)Fucp alpha 1-4)GlcNAcp, with phosphate attached to one or other of the two Galp terminal residues and in which all residues are of the D-absolute configuration, except for fucose and rhamnose which are L. Combined with previous data (Haynes, P. A., Ferguson, M. A., and Cross, G. A. (1996) Glycobiology 6, 869-878), we postulate that this complex structure and its variants lacking one or more residues are linked to Thr and Ser residues in gp72 via a phosphodiester linkage (GlcNAcp alpha 1-P-Thr/Ser) and that these units may form phosphosaccharide repeats through GlcNAcp alpha 1-P-Galp linkages. The gp72 glycoprotein is associated with the flagellum adhesion zone on the parasite surface, and its ligation has been implicated in inhibiting parasite differentiation from the epimastigote to the metacyclic trypomastigote stage. The detailed structure of the unique phosphosaccharide component of gp72 reported here provides a template for future biosynthetic and functional studies.	[Allen, Simon; Mehlert, Angela; Ferguson, Michael A. J.] Univ Dundee, Div Biol Chem & Drug Discovery, Coll Life Sci, Dundee DD1 5EH, Scotland; [Richardson, Julia M.] Univ Edinburgh, Sch Biol Sci, Edinburgh EH9 3JR, Midlothian, Scotland	University of Dundee; University of Edinburgh	Ferguson, MAJ (corresponding author), Univ Dundee, Div Biol Chem & Drug Discovery, Coll Life Sci, Dundee DD1 5EH, Scotland.	m.a.j.ferguson@dundee.ac.uk	Richardson, Julia/D-1808-2013	Richardson, Julia/0000-0002-1547-3009; Ferguson, Michael/0000-0003-1321-8714	Wellcome Trust [085622, 083481, 100476]; Biotechnology and Biological Sciences Research Council	Wellcome Trust(Wellcome TrustEuropean Commission); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by a Wellcome Trust Programme Grant 085622 (to M. A. J. F.) and by a doctoral studentship from the Biotechnology and Biological Sciences Research Council (to S. A.). The mass spectrometry facility at the College of Life Sciences of the University of Dundee is supported by Wellcome Trust Strategic Awards 083481 and 100476.	Acosta-Serrano A, 2001, MOL BIOCHEM PARASIT, V114, P143, DOI 10.1016/S0166-6851(01)00245-6; Basombrio MA, 2002, J PARASITOL, V88, P489, DOI 10.1645/0022-3395(2002)088[0489:TDOTGG]2.0.CO;2; Buscaglia CA, 2006, NAT REV MICROBIOL, V4, P229, DOI 10.1038/nrmicro1351; COOPER R, 1993, J CELL BIOL, V122, P149, DOI 10.1083/jcb.122.1.149; COOPER R, 1991, MOL BIOCHEM PARASIT, V49, P45, DOI 10.1016/0166-6851(91)90129-T; DEJESUS AR, 1993, J CELL SCI, V106, P1023; Dobson DE, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001185; FERGUSON MAJ, 1985, BIOCHIM BIOPHYS ACTA, V842, P39, DOI 10.1016/0304-4165(85)90290-9; FERGUSON MAJ, 1983, BIOCHEM J, V213, P313, DOI 10.1042/bj2130313; FERGUSON MAJ, 1994, GLYCOBIOLOGY PRACTIC, P349; GERWIG GJ, 1979, CARBOHYD RES, V77, P1, DOI 10.1016/S0008-6215(00)83788-X; Giorgi ME, 2011, CARBOHYD RES, V346, P1389, DOI 10.1016/j.carres.2011.04.006; GORIN PAJ, 1979, J PROTOZOOL, V26, P473, DOI 10.1111/j.1550-7408.1979.tb04656.x; GUSTAFSON GL, 1980, J BIOL CHEM, V255, P7208; Haynes PA, 1996, J CELL SCI, V109, P2979; Haynes PA, 1998, GLYCOBIOLOGY, V8, P1, DOI 10.1093/glycob/8.1.1; Haynes PA, 1996, GLYCOBIOLOGY, V6, P869, DOI 10.1093/glycob/6.8.869; Ilg T, 2000, PARASITOL TODAY, V16, P489, DOI 10.1016/S0169-4758(00)01791-9; Kamhawi S, 2000, PARASITOLOGY, V121, P25, DOI 10.1017/S0031182099006125; Kamhawi S, 2004, CELL, V119, P329, DOI 10.1016/j.cell.2004.10.009; LaCount DJ, 2002, J BIOL CHEM, V277, P17580, DOI 10.1074/jbc.M200873200; MacRae JI, 2005, J BIOL CHEM, V280, P12201, DOI 10.1074/jbc.M412939200; MCCONVILLE MJ, 1992, EMBO J, V11, P3593, DOI 10.1002/j.1460-2075.1992.tb05443.x; MCCONVILLE MJ, 1990, J BIOL CHEM, V265, P19611; Mendonca-Previato L, 2005, CURR OPIN STRUC BIOL, V15, P499, DOI 10.1016/j.sbi.2005.08.011; Mreyen M, 2000, J BIOL CHEM, V275, P12164, DOI 10.1074/jbc.275.16.12164; Rocha GM, 2006, J STRUCT BIOL, V154, P89, DOI 10.1016/j.jsb.2005.11.008; SCHNEIDER P, 1994, J BIOL CHEM, V269, P18332; SHER A, 1982, NATURE, V300, P639, DOI 10.1038/300639a0; SNARY D, 1981, MOL BIOCHEM PARASIT, V3, P343, DOI 10.1016/0166-6851(81)90035-9; Soares RP, 2012, AM J TROP MED HYG, V87, P87, DOI 10.4269/ajtmh.2012.12-0015; Thomson LM, 2002, J BIOL CHEM, V277, P48899, DOI 10.1074/jbc.M208942200; Turnock DC, 2007, EUKARYOT CELL, V6, P1450, DOI 10.1128/EC.00175-07	33	19	19	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 19	2013	288	16					11093	11105		10.1074/jbc.M113.452763	http://dx.doi.org/10.1074/jbc.M113.452763			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	130KW	23436655	hybrid, Green Published			2022-12-25	WOS:000317915500015
J	De Bock, M; Fillet, M; Hannon, M; Seidel, L; Merville, MP; Gothot, A; Beguin, Y; Baron, F				De Bock, Muriel; Fillet, Marianne; Hannon, Muriel; Seidel, Laurence; Merville, Marie-Paule; Gothot, Andre; Beguin, Yves; Baron, Frederic			Kinetics of IL-7 and IL-15 Levels after Allogeneic Peripheral Blood Stem Cell Transplantation following Nonmyeloablative Conditioning	PLOS ONE			English	Article							VERSUS-HOST-DISEASE; BONE-MARROW-TRANSPLANTATION; IMMUNE RECONSTITUTION; T-CELLS; HOMEOSTATIC PROLIFERATION; THYMIC OUTPUT; PLASMA-LEVELS; IN-VIVO; GRAFT; NAIVE	Background: We analysed kinetics of IL-7 and IL-15 levels in 70 patients given peripheral blood stem cells after nonmyeloablative conditioning. Methods: EDTA-anticoagulated plasma and serum samples were obtained before conditioning and about once per week after transplantation until day 100. Samples were aliquoted and stored at -80 degrees C within 3 hours after collection until measurement of cytokines. IL-7 and IL-15 levels were measured by ELISAs. Results: Median IL-7 plasma levels remained below 6 pg/L throughout the first 100 days, although IL-7 plasma levels were significantly higher on days 7 (5.1 pg/mL, P = 0.002), 14 (5.2 pg/mL, P<0.001), and 28 (5.1 pg/mL, P = 0.03) (but not thereafter) than before transplantation (median value of 3.8 pg/mL). Median IL-15 serum levels were significantly higher on days 7 (12.5 pg/mL, P<0.001), 14 (10.5 pg/mL, P<0.001), and 28 (6.2 pg/mL, P<0.001) than before transplantation (median value of 2.4 pg/mL). Importantly, IL-7 and IL-15 levels on days 7 or 14 after transplantation did not predict grade II-IV acute GVHD. Conclusions: These data suggest that IL-7 and IL-15 levels remain relatively low after nonmyeloablative transplantation, and that IL-7 and IL-15 levels early after nonmyeloablative transplantation do not predict for acute GVHD.	[De Bock, Muriel; Fillet, Marianne; Hannon, Muriel; Merville, Marie-Paule; Gothot, Andre; Beguin, Yves; Baron, Frederic] Univ Liege, Grp Interdisciplinaire Genoprote Appl GIGA I3, Liege, Belgium; [Seidel, Laurence] Univ Liege, Dept Stat, Liege, Belgium; [Beguin, Yves; Baron, Frederic] Univ Liege, Div Hematol, Dept Med, Liege, Belgium; [Beguin, Yves; Baron, Frederic] Ctr Hosp Univ CHU Liege, Liege, Belgium	University of Liege; University of Liege; University of Liege; University of Liege	Baron, F (corresponding author), Univ Liege, Grp Interdisciplinaire Genoprote Appl GIGA I3, Liege, Belgium.	f.baron@ulg.ac.be		Fillet, Marianne/0000-0002-1453-6282	FNRS; Belgian Foundation against Cancer (FBC); anti-cancer; Leon Fredericq foundations from the ULg; CHU of Liege; Terry Fox foundation	FNRS(Fonds de la Recherche Scientifique - FNRS); Belgian Foundation against Cancer (FBC); anti-cancer; Leon Fredericq foundations from the ULg; CHU of Liege; Terry Fox foundation	The study was in part supported by funds from the FNRS (http://www2.frs-fnrs.be/), the Belgian Foundation against Cancer (FBC) (http://www.cancer.be/), the anti-cancer (http://www.cac.ulg.ac.be/) and the Leon Fredericq foundations (http://www.fondsleonfredericq.be/) from the ULg, the CHU of Liege, and by the Terry Fox foundation (http://www.terryfox.org/). MdB and MH are Televie Research Fellows, and MPM and FB are Senior Research Associates at the National Fund for Scientific Research (FNRS) Belgium. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Ghosh A, 1999, BONE MARROW TRANSPL, V24, P535, DOI 10.1038/sj.bmt.1701921; Almawi WY, 2001, CELL TRANSPLANT, V10, P615, DOI 10.3727/000000001783986387; Alpdogan O, 2005, BLOOD, V105, P865, DOI 10.1182/blood-2003-09-3344; Alpdogan O, 2001, BLOOD, V98, P2256, DOI 10.1182/blood.V98.7.2256; Alves NL, 2003, BLOOD, V102, P2541, DOI 10.1182/blood-2003-01-0183; Bahceci E, 2003, BRIT J HAEMATOL, V122, P934, DOI 10.1046/j.1365-2141.2003.04522.x; Baron F, 2006, LEUKEMIA, V20, P1690, DOI 10.1038/sj.leu.2404335; Baron F, 2005, J CLIN ONCOL, V23, P1993, DOI 10.1200/JCO.2005.08.136; Baron F, 2004, BLOOD, V104, P2254, DOI 10.1182/blood-2004-04-1506; Baron F, 2012, LEUKEMIA, V26, P2462, DOI 10.1038/leu.2012.135; Baron F, 2003, TRANSPLANTATION, V76, P1705, DOI 10.1097/01.TP.0000093987.11389.F7; Baron F, 2006, BIOL BLOOD MARROW TR, V12, P1176, DOI 10.1016/j.bbmt.2006.07.004; Baron F, 2010, BIOL BLOOD MARROW TR, V16, P838, DOI 10.1016/j.bbmt.2010.01.011; Baron F, 2009, BIOL BLOOD MARROW TR, V15, P580, DOI 10.1016/j.bbmt.2009.01.018; Beq S, 2006, J IMMUNOL, V176, P914, DOI 10.4049/jimmunol.176.2.914; Berard M, 2003, J IMMUNOL, V170, P5018, DOI 10.4049/jimmunol.170.10.5018; Bolotin E, 1999, BONE MARROW TRANSPL, V23, P783, DOI 10.1038/sj.bmt.1701655; Bosch M, 2012, CURR OPIN HEMATOL, V19, P324, DOI 10.1097/MOH.0b013e328353bc7d; Castermans E, 2008, HAEMATOLOGICA, V93, P240, DOI 10.3324/haematol.11708; Castermans E, 2011, HAEMATOL-HEMATOL J, V96, P298, DOI 10.3324/haematol.2010.029702; Chu YW, 2004, BLOOD, V104, P1110, DOI 10.1182/blood-2003-10-3635; Clave E, 2009, BLOOD, V113, P6477, DOI 10.1182/blood-2008-09-176594; Crooks GM, 2006, BIOL BLOOD MARROW TR, V12, P42, DOI 10.1016/j.bbmt.2005.10.015; De Bock M, 2012, BIOL BLOOD MARROW TR, V18, pS275, DOI 10.1016/j.bbmt.2011.12.194; Dean RM, 2008, J CLIN ONCOL, V26, P5735, DOI 10.1200/JCO.2008.17.1314; Douek DC, 2000, LANCET, V355, P1875, DOI 10.1016/S0140-6736(00)02293-5; Fallen PR, 2003, BONE MARROW TRANSPL, V32, P1001, DOI 10.1038/sj.bmt.1704235; Federmann B, 2011, LEUKEMIA, V25, P121, DOI 10.1038/leu.2010.235; Fehniger TA, 2001, BLOOD, V97, P14, DOI 10.1182/blood.V97.1.14; Fry TJ, 2003, BLOOD, V101, P2294, DOI 10.1182/blood-2002-07-2297; Goldrath AW, 2002, J EXP MED, V195, P1515, DOI 10.1084/jem.20020033; Gress RE, 2010, BIOL BLOOD MARROW TR, V16, pS133, DOI 10.1016/j.bbmt.2009.10.003; Hagel LM, 2010, ASH ANN M, V116, P1271; Hazenberg MD, 2002, BLOOD, V99, P3449, DOI 10.1182/blood.V99.9.3449; Hochberg EP, 2001, BLOOD, V98, P1116, DOI 10.1182/blood.V98.4.1116; Huntington ND, 2011, P NATL ACAD SCI USA, V108, P6217, DOI 10.1073/pnas.1019167108; Krenger W, 2011, BLOOD, V117, P6768, DOI 10.1182/blood-2011-02-334623; Lange T, 2011, LEUKEMIA, V25, P498, DOI 10.1038/leu.2010.283; Lewin SR, 2002, BLOOD, V100, P2235, DOI 10.1182/blood.V100.6.2235.h81802002235_2235_2242; Lodolce JP, 1998, IMMUNITY, V9, P669, DOI 10.1016/S1074-7613(00)80664-0; Mackall CL, 2001, BLOOD, V97, P1491, DOI 10.1182/blood.V97.5.1491; Mackall CL, 2011, NAT REV IMMUNOL, V11, P330, DOI 10.1038/nri2970; MARANINCHI D, 1987, LANCET, V2, P175; Miller JS, 2010, BIOL BLOOD MARROW TR, V16, P565, DOI 10.1016/j.bbmt.2010.02.005; Mohty M, 2007, HAEMATOLOGICA, V92, P1004, DOI 10.3324/haematol.10971; Peggs KS, 2006, CYTOTHERAPY, V8, P427, DOI 10.1080/14653240600851938; Perales MA, 2012, BLOOD, V120, P4882, DOI 10.1182/blood-2012-06-437236; Puel A, 1998, NAT GENET, V20, P394, DOI 10.1038/3877; Ram R, 2012, BIOL BLOOD MARROW TR, V18, P414, DOI 10.1016/j.bbmt.2011.08.016; Sandmaier BM, 2007, BIOL BLOOD MARROW TR, V13, P87, DOI 10.1016/j.bbmt.2006.10.015; Soiffer RJ, 2011, BLOOD, V117, P6963, DOI 10.1182/blood-2011-01-332007; Sportes C, 2008, J EXP MED, V205, P1701, DOI 10.1084/jem.20071681; Storek J, 2003, BIOL BLOOD MARROW TR, V9, P781, DOI 10.1016/j.bbmt.2003.09.003; Storek J, 2003, BLOOD, V101, P4209, DOI 10.1182/blood-2002-08-2671; Tan JT, 2002, J EXP MED, V195, P1523, DOI 10.1084/jem.20020066; Thiant S, 2011, BONE MARROW TRANSPL, V46, P1374, DOI 10.1038/bmt.2010.300; Thiant S, 2010, BONE MARROW TRANSPL, V45, P1546, DOI 10.1038/bmt.2010.13; Toubert A, 2012, TISSUE ANTIGENS, V79, P83, DOI 10.1111/j.1399-0039.2011.01820.x; WEIDEN PL, 1979, NEW ENGL J MED, V300, P1068, DOI 10.1056/NEJM197905103001902; Weinberg K, 2001, BLOOD, V97, P1458, DOI 10.1182/blood.V97.5.1458	60	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2013	8	2							e55876	10.1371/journal.pone.0055876	http://dx.doi.org/10.1371/journal.pone.0055876			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IT	23437070	Green Published, gold			2022-12-25	WOS:000315186000010
J	Rempel, H; Sun, B; Calosing, C; Abadjian, L; Monto, A; Pulliam, L				Rempel, Hans; Sun, Bing; Calosing, Cyrus; Abadjian, Linda; Monto, Alexander; Pulliam, Lynn			Monocyte Activation in HIV/HCV Coinfection Correlates with Cognitive Impairment	PLOS ONE			English	Article							HEPATITIS-C VIRUS; HUMAN-IMMUNODEFICIENCY-VIRUS; ACTIVE ANTIRETROVIRAL THERAPY; MAGNETIC-RESONANCE-SPECTROSCOPY; HIV-INFECTION; MICROBIAL TRANSLOCATION; NEUROPSYCHOLOGICAL IMPAIRMENT; IMMUNE ACTIVATION; VIRAL-HEPATITIS; GENE-EXPRESSION	Coinfection with human immunodeficiency virus (HIV) and hepatitis C virus (HCV) challenges the immune system with two viruses that elicit distinct immune responses. Chronic immune activation is a hallmark of HIV infection and an accurate indicator of disease progression. Suppressing HIV viremia by antiretroviral therapy (ART) effectively prolongs life and significantly improves immune function. HIV/HCV coinfected individuals have peripheral immune activation despite effective ART control of HIV viral load. Here we examined freshly isolated CD14 monocytes for gene expression using high-density cDNA microarrays and analyzed T cell subsets, CD4 and CD8, by flow cytometry to characterize immune activation in monoinfected HCV and HIV, and HIV-suppressed coinfected subjects. To determine the impact of coinfection on cognition, subjects were evaluated in 7 domains for neuropsychological performance, which were summarized as a global deficit score (GDS). Monocyte gene expression analysis in HIV-suppressed coinfected subjects identified 43 genes that were elevated greater than 2.5 fold. Correlative analysis of subjects' GDS and gene expression found eight genes with significance after adjusting for multiple comparisons. Correlative expression of six genes was confirmed by qPCR, five of which were categorized as type 1 IFN response genes. Global deficit scores were not related to plasma lipopolysaccharide levels. In the T cell compartment, coinfection significantly increased expression of activation markers CD38 and HLADR on both CD4 and CD8 T cells but did not correlate with GDS. These findings indicate that coinfection is associated with a type 1 IFN monocyte activation profile which was further found to correlate with cognitive impairment, even in subjects with controlled HIV infection. HIV-suppressed coinfected subjects with controlled HIV viral load experiencing immune activation could benefit significantly from successful anti-HCV therapy and may be considered as preferential candidates.	[Rempel, Hans; Sun, Bing; Calosing, Cyrus; Pulliam, Lynn] Vet Affairs Med Ctr, Dept Lab Med, San Francisco, CA 94121 USA; [Abadjian, Linda] Vet Affairs Med Ctr, Dept Mental Hlth, San Francisco, CA 94121 USA; [Monto, Alexander] Vet Affairs Med Ctr, Dept Med, San Francisco, CA 94121 USA; [Monto, Alexander; Pulliam, Lynn] Univ Calif San Francisco, San Francisco, CA 94143 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); US Department of Veterans Affairs; Veterans Health Administration (VHA); US Department of Veterans Affairs; Veterans Health Administration (VHA); University of California System; University of California San Francisco	Pulliam, L (corresponding author), Vet Affairs Med Ctr, Dept Lab Med, San Francisco, CA 94121 USA.	lynn.pulliam@ucsf.edu			National Institutes of Health [RO1 MH085538]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK026743] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH085538] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by a grant to Lynn Pulliam from the National Institutes of Health [RO1 MH085538]. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alter MJ, 2006, J HEPATOL, V44, pS6, DOI 10.1016/j.jhep.2005.11.004; Ancuta P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002516; Anderson KB, 2004, CLIN INFECT DIS, V39, P1507, DOI 10.1086/425360; Aronow HA, 2008, AIDS READ, V18, P43; Balagopal A, 2008, GASTROENTEROLOGY, V135, P226, DOI 10.1053/j.gastro.2008.03.022; Battegay M, 2006, LANCET INFECT DIS, V6, P280, DOI 10.1016/S1473-3099(06)70463-7; BENJAMINI Y, 1995, J R STAT SOC B, V57, P125; Bower M, 2006, CURR OPIN INFECT DIS, V19, P14, DOI 10.1097/01.qco.0000200295.30285.13; Brenchley JM, 2006, NAT MED, V12, P1365, DOI 10.1038/nm1511; Brenchley JM, 2006, NAT IMMUNOL, V7, P235, DOI 10.1038/ni1316; Brown JN, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003664; Carey CL, 2004, J CLIN EXP NEUROPSYC, V26, P307, DOI 10.1080/13803390490510031; Clifford DB, 2009, NEUROLOGY, V73, P309, DOI 10.1212/WNL.0b013e3181af7a10; Crystal H, 2012, JAIDS-J ACQ IMM DEF, V59, P149, DOI 10.1097/QAI.0b013e318240566b; El Yakoubi W, 2012, STEM CELLS; Garvey LJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038980; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Giorgi JV, 1999, J INFECT DIS, V179, P859, DOI 10.1086/314660; Gonzalez VD, 2009, J VIROL, V83, P11407, DOI 10.1128/JVI.01211-09; Hazenberg MD, 2003, AIDS, V17, P1881, DOI 10.1097/00002030-200309050-00006; Heaton R K, 1995, J Int Neuropsychol Soc, V1, P231; Heaton RK, 2004, J INT NEUROPSYCH SOC, V10, P317, DOI 10.1017/S1355617704102130; Heaton RK, 2011, J NEUROVIROL, V17, P3, DOI 10.1007/s13365-010-0006-1; Hinkin CH, 2008, J ADDICT DIS, V27, P11, DOI 10.1300/J069v27n02_02; IHAKA R, 1996, J COMPUTATIONAL GRAP, V5, P299, DOI DOI 10.2307/1390807; Kageyama R, 2007, DEVELOPMENT, V134, P1243, DOI 10.1242/dev.000786; Kottilil S, 2009, HEPATOLOGY, V50, P34, DOI 10.1002/hep.23055; Kovacs A, 2008, J INFECT DIS, V197, P1402, DOI 10.1086/587696; Koziel MJ, 2007, NEW ENGL J MED, V356, P1445, DOI 10.1056/NEJMra065142; Lempicki RA, 2006, J INFECT DIS, V193, P1172, DOI 10.1086/501365; Mandl JN, 2008, NAT MED, V14, P1077, DOI 10.1038/nm.1871; McAndrews MP, 2005, HEPATOLOGY, V41, P801, DOI 10.1002/hep.20635; Moir S, 2011, ANNU REV PATHOL-MECH, V6, P223, DOI 10.1146/annurev-pathol-011110-130254; Nelson DR, 2012, ANN HEPATOL, V11, P15, DOI 10.1016/S1665-2681(19)31482-6; Operskalski Eva A, 2011, Curr HIV/AIDS Rep, V8, P12, DOI 10.1007/s11904-010-0071-3; Perry W, 2005, AIDS, V19, pS79, DOI 10.1097/01.aids.0000192074.18691.31; Pulliam L, 2004, J NEUROIMMUNOL, V157, P93, DOI 10.1016/j.jneuroim.2004.08.039; Pulliam L, 2011, AIDS, V25, P1721, DOI 10.1097/QAD.0b013e328349f022; Rempel H, 2010, AIDS, V24, P1415, DOI 10.1097/QAD.0b013e32833ac623; Rempel H, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001967; Santer DM, 2012, J IMMUNOL, V188, P902, DOI 10.4049/jimmunol.1102797; Schouten J, 2011, AIDS, V25, P561, DOI 10.1097/QAD.0b013e3283437f9a; Schroeder A, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-3; Silvestri G, 2007, J CLIN INVEST, V117, P3148, DOI 10.1172/JCI33034; Steel A, 2008, HIV MED, V9, P118, DOI 10.1111/j.1468-1293.2007.00528.x; Stylianou E, 2000, CLIN EXP IMMUNOL, V119, P479, DOI 10.1046/j.1365-2249.2000.01144.x; Sun B, 2012, J ACQUIR IMMUNE DEFI; Sun B, 2010, J NEUROVIROL, V16, P115, DOI 10.3109/13550280903559789; Tilton JC, 2006, J VIROL, V80, P11486, DOI 10.1128/JVI.00324-06; Vivithanaporn P, 2012, J NEUROL SCI, V312, P45, DOI 10.1016/j.jns.2011.08.025; Weissenborn K, 2004, J HEPATOL, V41, P845, DOI 10.1016/j.jhep.2004.07.022	51	23	23	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2013	8	2							e55776	10.1371/journal.pone.0055776	http://dx.doi.org/10.1371/journal.pone.0055776			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IT	23437063	Green Submitted, Green Published, gold			2022-12-25	WOS:000315186000009
J	Chen, HY; Luo, ZL; Dong, LW; Tan, YX; Yang, JM; Feng, GS; Wu, MC; Li, Z; Wang, HY				Chen, Haiyang; Luo, Zaili; Dong, Liwei; Tan, Yexiong; Yang, Jiamei; Feng, Gensheng; Wu, Mengchao; Li, Zhong; Wang, Hongyang			CD133/Prominin-1-Mediated Autophagy and Glucose Uptake Beneficial for Hepatoma Cell Survival	PLOS ONE			English	Article							CANCER STEM-CELLS; EXTRACELLULAR MEMBRANE-PARTICLES; HEPATOCELLULAR-CARCINOMA CELLS; TUMOR-INITIATING CELLS; SELF-RENEWAL; STEM/PROGENITOR CELLS; THERAPEUTIC TARGET; NEURAL PROGENITORS; MARKER PROMININ-1; CD133 EXPRESSION	CD133/Prominin-1 is a pentaspan transmembrane protein that has been frequently used as a biomarker for cancer stem cells, although its biological function is unclear. The aim of our study was to explore the intrinsic functions of CD133 membrane protein in hepatoma cells during autophagy, apoptosis, tumorigenesis and cell survival through expression or downregulation of CD133. In this study, CD133 was found to be dynamically released from plasma membrane into cytoplasm in both of complete medium(CM) and low glucose medium (LGM), and LGM promoted this translocation. Expression of CD133 enhanced autophagic activity in LGM, while silencing CD133 attenuated this activity in HCC LM3 and Huh-7 cells, suggesting that CD133 is associated with autophagy. Immunofluorescence and time-lapsed confocal techniques confirmed that CD133 was associated with autophagy marker, microtubule-associated protein light chain3 (LC3) and lysosome marker during the glucose starvation. We further found that Huh-7 cells with stable expression of shCD133 (Huh-7sh133) impaired the ability of cell proliferation and formation of xenograft tumors in the NOD/SCID mice. Although loss of CD133 did not affect the rates of glucose uptake in Huh-7con and Huh-7sh133 cells under the CM, Huh-7sh133 cells obviously died fast than Huh-7con cells in the LGM and decreased the rate of glucose uptake and ATP production. Furthermore, targeting CD133 by CD133mAb resulted in cell death in HepG2 cells, especially in the LGM, via inhibition of autophagic activity and increase of apoptosis. The results demonstrated that CD133 is involved in cell survival through regulation of autophagy and glucose uptake, which may be necessary for cancer stem cells to survive in tumor microenvironment.	[Chen, Haiyang; Luo, Zaili; Dong, Liwei; Tan, Yexiong; Li, Zhong; Wang, Hongyang] Second Mil Med Univ, Eastern Hepatobiliary Surg Hosp, Int Cooperat Lab Signal Transduct, Shanghai, Peoples R China; [Yang, Jiamei; Wu, Mengchao] Second Mil Med Univ, Eastern Hepatobiliary Surg Hosp, Dept Surg, Shanghai, Peoples R China; [Feng, Gensheng] Univ Calif San Diego, Dept Pathol, La Jolla, CA 92093 USA; [Feng, Gensheng] Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA; [Li, Zhong] Zhengzhou Univ, Affiliated Hosp 3, Zhengzhou, Peoples R China; [Li, Zhong] Zhengzhou Univ, Coll Med, Zhengzhou, Peoples R China; [Wang, Hongyang] Jiao Tong Univ, Sch Med, Shanghai Canc Inst, State Key Lab Oncogenes & Related Genes, Shanghai 200030, Peoples R China	Naval Medical University; Naval Medical University; University of California System; University of California San Diego; University of California System; University of California San Diego; Zhengzhou University; Zhengzhou University; Shanghai Jiao Tong University	Li, Z (corresponding author), Second Mil Med Univ, Eastern Hepatobiliary Surg Hosp, Int Cooperat Lab Signal Transduct, Shanghai, Peoples R China.	zhli@smmu.edu.cn; hywangk@vip.sina.com		Dong, Li-Wei/0000-0003-2116-1674	National Natural Science Foundation of China [81041070, 81272427, 30921006]; Eastern Hepatobiliary Surgery Hospital/Institute; Ministry of Science and Technology Key Program [2012ZX10002-009, 2012ZX10002-011]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Eastern Hepatobiliary Surgery Hospital/Institute; Ministry of Science and Technology Key Program	This work was supported by grants from the National Natural Science Foundation of China to Z. Li (81041070, 81272427), and HYW(30921006); the start-up fund of Eastern Hepatobiliary Surgery Hospital/Institute to Z. Li and the Ministry of Science and Technology Key Program to MCW, HYW(2012ZX10002-009, -011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Hajj M, 2007, CURR OPIN ONCOL, V19, P61; Amaravadi RK, 2011, CLIN CANCER RES, V17, P654, DOI 10.1158/1078-0432.CCR-10-2634; Angelastro JM, 2010, MOL CANCER RES, V8, P1105, DOI 10.1158/1541-7786.MCR-09-0383; Bakondi B, 2011, STEM CELLS DEV, V20, P1021, DOI 10.1089/scd.2010.0198; Bauer N, 2011, EMBO MOL MED, V3, P398, DOI 10.1002/emmm.201100147; Bertolini G, 2009, P NATL ACAD SCI USA, V106, P16281, DOI 10.1073/pnas.0905653106; Bourseau-Guilmain E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025515; Broder CC, 1997, J LEUKOCYTE BIOL, V62, P20, DOI 10.1002/jlb.62.1.20; Corbeil D, 2001, TRAFFIC, V2, P82, DOI 10.1034/j.1600-0854.2001.020202.x; Corbeil D, 2000, J BIOL CHEM, V275, P5512, DOI 10.1074/jbc.275.8.5512; Corbeil D, 2010, FEBS LETT, V584, P1659, DOI 10.1016/j.febslet.2010.01.050; Corbo C, 2012, PROTEOMICS, V12, P2045, DOI 10.1002/pmic.201100370; Damek-Poprawa M, 2011, J DENT RES, V90, P638, DOI 10.1177/0022034510393511; Ding W, 2009, HEPATOLOGY, V49, P1277, DOI 10.1002/hep.22743; Dubreuil V, 2007, J CELL BIOL, V176, P483, DOI 10.1083/jcb.200608137; Eskelinen EL, 2011, CURR OPIN PHARMACOL, V11, P294, DOI 10.1016/j.coph.2011.03.009; Fargeas CA, 2011, WORLD J GASTROENTERO, V17, P4149, DOI 10.3748/wjg.v17.i36.4149; Frank NY, 2005, CANCER RES, V65, P4320, DOI 10.1158/0008-5472.CAN-04-3327; Fu XY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043204; Griguer CE, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003655; Huttner HB, 2008, STEM CELLS, V26, P698, DOI 10.1634/stemcells.2007-0639; Lardon J, 2008, PANCREAS, V36, pE1, DOI 10.1097/mpa.0b013e318149f2dc; Li Y, 2003, J CANCER RES CLIN, V129, P43, DOI 10.1007/s00432-002-0396-4; Li Z, 2005, NAT CELL BIOL, V7, P399, DOI 10.1038/ncb1236; Lomonaco SL, 2009, INT J CANCER, V125, P717, DOI 10.1002/ijc.24402; Ma S, 2008, ONCOGENE, V27, P1749, DOI 10.1038/sj.onc.1210811; Ma S, 2007, GASTROENTEROLOGY, V132, P2542, DOI 10.1053/j.gastro.2007.04.025; Ma S, 2010, CELL STEM CELL, V7, P694, DOI 10.1016/j.stem.2010.11.010; Mak AB, 2012, CANCER RES, V72, P1929, DOI 10.1158/0008-5472.CAN-11-3589; Marzesco AM, 2005, J CELL SCI, V118, P2849, DOI 10.1242/jcs.02439; Maw MA, 2000, HUM MOL GENET, V9, P27, DOI 10.1093/hmg/9.1.27; Mizrak D, 2008, J PATHOL, V214, P3, DOI 10.1002/path.2283; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Oliver L, 2012, STEM CELLS DEV; Piao LS, 2012, CANCER LETT, V315, P129, DOI 10.1016/j.canlet.2011.10.012; Rappa G, 2008, STEM CELLS, V26, P3008, DOI 10.1634/stemcells.2008-0601; Rausch V, 2012, J PATHOL, V227, P325, DOI 10.1002/path.3994; Salemi S, 2012, CELL RES, V22, P432, DOI 10.1038/cr.2011.200; Shmelkov SV, 2008, J CLIN INVEST, V118, P2111, DOI 10.1172/JCI34401; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Smith LM, 2008, BRIT J CANCER, V99, P100, DOI 10.1038/sj.bjc.6604437; Song W, 2008, INT J CLIN PRACT, V62, P1212, DOI 10.1111/j.1742-1241.2008.01777.x; Spee B, 2010, GUT, V59, P247, DOI 10.1136/gut.2009.188367; Suetsugi A, 2006, BIOCHEM BIOPH RES CO, V351, P820, DOI 10.1016/j.bbrc.2006.10.128; Tabu K, 2008, CELL RES, V18, P1037, DOI 10.1038/cr.2008.270; Tang KH, 2012, HEPATOLOGY, V55, P807, DOI 10.1002/hep.24739; Vessoni AT, 2012, STEM CELLS DEV, V21, P513, DOI 10.1089/scd.2011.0526; Wang RC, 2010, FEBS LETT, V584, P1417, DOI 10.1016/j.febslet.2010.01.009; Yang ZJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028405; Yang ZL, 2012, ONCOL LETT, V4, P75, DOI 10.3892/ol.2012.694; Yin SY, 2007, INT J CANCER, V120, P1444, DOI 10.1002/ijc.22476; Zacchigna S, 2009, J NEUROSCI, V29, P2297, DOI 10.1523/JNEUROSCI.2034-08.2009; Zhang CS, 2011, ANN SURG ONCOL, V18, P2373, DOI 10.1245/s10434-011-1599-1; Zhang J, 2012, INT J ONCOL, V40, P747, DOI 10.3892/ijo.2011.1242; Zhang LX, 2012, CANCER RES, V72, P4276, DOI 10.1158/0008-5472.CAN-12-1013; Zhang Q, 2012, STEM CELLS DEV, V21, P1321, DOI 10.1089/scd.2011.0684; Zobalova R, 2008, BIOCHEM BIOPH RES CO, V373, P567, DOI 10.1016/j.bbrc.2008.06.073	57	39	39	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e56878	10.1371/journal.pone.0056878	http://dx.doi.org/10.1371/journal.pone.0056878			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437259	Green Published, Green Submitted, gold			2022-12-25	WOS:000315184200175
J	Hannula-Jouppi, K; Massinen, S; Siljander, T; Makela, S; Kivinen, K; Leinonen, R; Jiao, H; Aitos, P; Karppelin, M; Vuopio, J; Syrjanen, J; Kere, J				Hannula-Jouppi, Katariina; Massinen, Satu; Siljander, Tuula; Makela, Siru; Kivinen, Katja; Leinonen, Rasko; Jiao, Hong; Aitos, Paivi; Karppelin, Matti; Vuopio, Jaana; Syrjanen, Jaana; Kere, Juha			Genetic Susceptibility to Non-Necrotizing Erysipelas/Cellulitis	PLOS ONE			English	Article							PROINFLAMMATORY RESPONSES; INFECTIOUS-DISEASES; PROSTAGLANDIN E-2; POLYMORPHISM; CELLULITIS; RECEPTOR; ASSOCIATION; EXPRESSION; BACTERIAL; LEPROSY	Background: Bacterial non-necrotizing erysipelas and cellulitis are often recurring, diffusely spreading infections of the skin and subcutaneous tissues caused most commonly by streptococci. Host genetic factors influence infection susceptibility but no extensive studies on the genetic determinants of human erysipelas exist. Methods: We performed genome-wide linkage with the 10,000 variant Human Mapping Array (HMA10K) array on 52 Finnish families with multiple erysipelas cases followed by microsatellite fine mapping of suggestive linkage peaks. A scan with the HMA250K array was subsequently performed with a subset of cases and controls. Results: Significant linkage was found at 9q34 (nonparametric multipoint linkage score (NPLall) 3.84, p = 0.026), which is syntenic to a quantitative trait locus for susceptibility to group A streptococci infections on chromosome 2 in mouse. Sequencing of candidate genes in the 9q34 region did not conclusively associate any to erysipelas/cellulitis susceptibility. Suggestive linkage (NPLall>3.0) was found at three loci: 3q22-24, 21q22, and 22q13. A subsequent denser genome scan with the HMA250K array supported the 3q22 locus, in which several SNPs in the promoter of AGTR1 (Angiotensin II receptor type I) suggestively associated with erysipelas/cellulitis susceptibility. Conclusions: Specific host genetic factors may cause erysipelas/cellulitis susceptibility in humans.	[Hannula-Jouppi, Katariina; Massinen, Satu; Makela, Siru; Aitos, Paivi; Kere, Juha] Univ Helsinki, Dept Med Genet, Helsinki, Finland; [Hannula-Jouppi, Katariina; Massinen, Satu; Makela, Siru; Aitos, Paivi; Kere, Juha] Univ Helsinki, Folkhalsan Inst Genet, Helsinki, Finland; [Siljander, Tuula; Vuopio, Jaana] Natl Inst Hlth & Welf, Dept Infect Dis Surveillance & Control, Helsinki, Finland; [Kivinen, Katja; Leinonen, Rasko; Jiao, Hong; Kere, Juha] Karolinska Inst, Ctr Biosci, Dept Biosci & Nutr, Huddinge, Sweden; [Karppelin, Matti; Syrjanen, Jaana] Tampere Univ Hosp, Dept Internal Med, Tampere, Finland; [Syrjanen, Jaana] Univ Tampere, Sch Med, FIN-33101 Tampere, Finland; [Kere, Juha] Karolinska Inst, Sci Life Lab, Huddinge, Sweden	University of Helsinki; University of Helsinki; Finland National Institute for Health & Welfare; Karolinska Institutet; Tampere University; Tampere University Hospital; Tampere University; Karolinska Institutet	Hannula-Jouppi, K (corresponding author), Univ Helsinki, Dept Med Genet, Helsinki, Finland.	katariina.hannula@helsinki.fi	Hannula-Jouppi, Katariina SE/F-4476-2011; Kere, Juha/A-9179-2008; Kere, Juha/AAX-9117-2021	Kere, Juha/0000-0003-1974-0271; Kere, Juha/0000-0003-1974-0271; Karppelin, Matti/0000-0002-7503-6900; Syrjanen, Jaana/0000-0002-7335-573X; Kivinen, Katja/0000-0002-1135-7625; Leinonen, Rasko/0000-0002-2639-7187; Hannula-Jouppi, Katariina/0000-0003-3864-2853	Academy of Finland/Microbes and Man Research Program; Helsinki Biomedical Graduate School; Sigrid Juselius Foundation; Swedish Research Council	Academy of Finland/Microbes and Man Research Program; Helsinki Biomedical Graduate School; Sigrid Juselius Foundation(Sigrid Juselius Foundation); Swedish Research Council(Swedish Research CouncilEuropean Commission)	This work was supported by the Academy of Finland/Microbes and Man Research Program, Helsinki Biomedical Graduate School, Sigrid Juselius Foundation, and the Swedish Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdeltawab NF, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000042; Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Aziz RK, 2007, GENES IMMUN, V8, P404, DOI 10.1038/sj.gene.6364402; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bellamy R, 2000, P NATL ACAD SCI USA, V97, P8005, DOI 10.1073/pnas.140201897; Bisno AL, 1996, NEW ENGL J MED, V334, P240, DOI 10.1056/NEJM199601253340407; Bjorndottir S, 2005, CLIN INFECT DIS, V41, P1416, DOI 10.1086/497127; Blackwell JM, 2009, CLIN MICROBIOL REV, V22, P370, DOI 10.1128/CMR.00048-08; Bucheton B, 2003, AM J HUM GENET, V73, P1052, DOI 10.1086/379084; Burgner D, 2006, LANCET INFECT DIS, V6, P653, DOI 10.1016/S1473-3099(06)70601-6; Burton EA, 2006, APPL ENVIRON MICROB, V72, P5043, DOI 10.1128/AEM.00558-06; Casanova JL, 2007, EMBO J, V26, P915, DOI 10.1038/sj.emboj.7601558; Chatellier S, 2000, INFECT IMMUN, V68, P3523, DOI 10.1128/IAI.68.6.3523-3534.2000; Cue D, 1998, INFECT IMMUN, V66, P4593, DOI 10.1128/IAI.66.10.4593-4601.1998; Doerschug KC, 2010, CRIT CARE, V14, DOI 10.1186/cc8887; Goldmann O, 2005, J IMMUNOL, V175, P3862, DOI 10.4049/jimmunol.175.6.3862; Goldmann O, 2010, J IMMUNOL, V185, P2372, DOI 10.4049/jimmunol.1000838; Gu JJ, 2009, IMMUNOL REV, V228, P170, DOI 10.1111/j.1600-065X.2008.00751.x; Harris SG, 2002, TRENDS IMMUNOL, V23, P144, DOI 10.1016/S1471-4906(01)02154-8; Jobin MC, 2006, MICROB PATHOGENESIS, V40, P29, DOI 10.1016/j.micpath.2005.10.003; Karppelin M, 2010, CLIN MICROBIOL INFEC, V16, P729, DOI 10.1111/j.1469-0691.2009.02906.x; Kong A, 2002, NAT GENET, V31, P241, DOI 10.1038/ng917; Kotb M, 2002, NAT MED, V8, P1398, DOI 10.1038/nm800; MacKenzie A, 2011, PHARMACOL THERAPEUT, V131, P187, DOI 10.1016/j.pharmthera.2010.11.001; Maloney CG, 2000, J LEUKOCYTE BIOL, V67, P615, DOI 10.1002/jlb.67.5.615; Martin MM, 2006, J BIOL CHEM, V281, P18277, DOI 10.1074/jbc.M601496200; McNamara DR, 2007, ARCH INTERN MED, V167, P709, DOI 10.1001/archinte.167.7.709; Medina Eva, 2005, Briefings in Functional Genomics & Proteomics, V4, P248, DOI 10.1093/bfgp/4.3.248; Mira MT, 2003, NAT GENET, V33, P412, DOI 10.1038/ng1096; Mortensen EM, 2007, PHARMACOTHERAPY, V27, P1619, DOI 10.1592/phco.27.12.1619; Nakada T, 2011, CRIT CARE MED, V39, P1641, DOI 10.1097/CCM.0b013e318218665a; Nooh MM, 2011, J IMMUNOL, V186, P3156, DOI 10.4049/jimmunol.1002057; Palatini P, 2009, AM J HYPERTENS, V22, P208, DOI 10.1038/ajh.2008.319; Pavlotsky Felix, 2004, J Dtsch Dermatol Ges, V2, P89, DOI 10.1046/j.1439-0353.2004.03028.x; Rodriguez A, 2007, SCIENCE, V316, P608, DOI 10.1126/science.1139253; Ruiz N, 1998, MOL MICROBIOL, V27, P337, DOI 10.1046/j.1365-2958.1998.00681.x; Saha S, 2005, AM J PHYSIOL-REG I, V288, pR1100, DOI 10.1152/ajpregu.00872.2004; Sato H, 1998, LUPUS, V7, P530, DOI 10.1191/096120398678920622; Schlosser A, 2009, J IMMUNOL, V183, P3800, DOI 10.4049/jimmunol.0901526; Siddiqui MR, 2001, NAT GENET, V27, P439, DOI 10.1038/86958; Siljander T, 2008, CLIN INFECT DIS, V46, P855, DOI 10.1086/527388; Stelnicki EJ, 1998, J INVEST DERMATOL, V111, P57, DOI 10.1046/j.1523-1747.1998.00238.x; Suchankova P, 2009, REGUL PEPTIDES, V152, P28, DOI 10.1016/j.regpep.2008.11.001; Thai TH, 2007, SCIENCE, V316, P604, DOI 10.1126/science.1141229; Thomsen T, 2011, MOL IMMUNOL, V48, P369, DOI 10.1016/j.molimm.2010.09.019; Toivonen HTT, 2000, IEEE INTERNATIONAL SYMPOSIUM ON BIO-INFORMATICS AND BIOMEDICAL ENGINEERING, PROCEEDINGS, P99, DOI 10.1109/BIBE.2000.889596; Vannberg FO, 2011, IMMUNOL REV, V240, P105, DOI 10.1111/j.1600-065X.2010.00996.x; Vasku V, 2000, ARCH DERMATOL RES, V292, P531, DOI 10.1007/s004030000176; Wang B, 1997, INFECT IMMUN, V65, P2119, DOI 10.1128/IAI.65.6.2119-2126.1997	49	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e56225	10.1371/journal.pone.0056225	http://dx.doi.org/10.1371/journal.pone.0056225			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437094	Green Submitted, gold, Green Published			2022-12-25	WOS:000315184200046
J	Haugaard, LK; Ajslev, TA; Zimmermann, E; Angquist, L; Sorensen, TIA				Haugaard, Line K.; Ajslev, Teresa A.; Zimmermann, Esther; Angquist, Lars; Sorensen, Thorkild I. A.			Being an Only or Last-Born Child Increases Later Risk of Obesity	PLOS ONE			English	Article							BODY-MASS INDEX; BIRTH-ORDER; OVERWEIGHT; ASSOCIATION; WEIGHT; HEIGHT; COHORT; SIZE	Background: Studies have suggested that number of siblings and birth order is associated with obesity. However, studies combining these exposures are needed. This study aimed at investigating obesity in children and young adults in regard to different combinations of family size and birth order. Methods: Two cohorts selected from the general population were investigated: The Copenhagen School Health Records Register (CSHRR) and a Draft Board (DB) sample with measured heights and weights in childhood (age 13 years) and young adulthood (age 19 years), respectively. Information on birth order, number of siblings, and relevant covariates were available on 29 327 children, as well as on 323 obese young men and 575 randomly selected controls of young men representing approximately 58 000. The relation between number of siblings and birth order, respectively, and having a Body Mass Index (BMI) z-score above or equal to the 95th percentile in childhood or having a BMI of at least 31.00 kg/m(2) in young adulthood was analysed using logistic regression analyses adjusted for relevant confounders. Results: Only children had significantly higher odds of obesity both in childhood and in young adulthood compared with children with siblings, odds ratio (OR) = 1.44 (95% Confidence Interval (CI): 1.26-1.66) and OR = 1.76 (95% CI: 1.18-2.61), respectively. No association between first-born status and obesity was found. The OR of last-born children being obese was also significantly increased in childhood, e. g. OR = 1.93 (95% CI: 1.0923.43) of obesity if last-born in a family of four children. This was not found in young adulthood. Additionally, higher spacing to previous sibling (average 1872 vs. 1303 days; p = 0.026 in four children families) was observed in obese last-born compared to non-obese last-born children. Conclusion: Being an only or last-born child is associated with obesity. These associations may provide leads to targeted prevention of obesity in children.	[Haugaard, Line K.; Ajslev, Teresa A.; Zimmermann, Esther; Angquist, Lars; Sorensen, Thorkild I. A.] Frederiksberg Univ Hosp, Inst Prevent Med, Frederiksberg, Denmark; [Haugaard, Line K.; Ajslev, Teresa A.; Zimmermann, Esther; Angquist, Lars; Sorensen, Thorkild I. A.] Bispebjerg Hosp, Inst Prevent Med, Frederiksberg, Denmark; [Sorensen, Thorkild I. A.] Univ Copenhagen, Fac Hlth & Med Sci, Novo Nordisk Fdn Ctr Basic Metab Res, Copenhagen, Denmark	University of Copenhagen; Bispebjerg Hospital; Novo Nordisk Foundation; University of Copenhagen	Ajslev, TA (corresponding author), Frederiksberg Univ Hosp, Inst Prevent Med, Frederiksberg, Denmark.	teresa.ajslev@regionh.dk		Zimmermann, Esther/0000-0001-5854-0542; Gjaerde, Line Klingen/0000-0001-6894-1024; Angquist, Lars/0000-0002-9516-4424	University Graduate Center - Food, Fitness and Pharma program through the Danish Strategic Research Council	University Graduate Center - Food, Fitness and Pharma program through the Danish Strategic Research Council	This study has been funded by the University Graduate Center - Food, Fitness and Pharma program through the Danish Strategic Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker JL, 2007, NEW ENGL J MED, V357, P2329, DOI 10.1056/NEJMoa072515; BELMONT L, 1973, SCIENCE, V182, P1096, DOI 10.1126/science.182.4117.1096; Bruch H, 1940, PSYCHOSOM MED, V2, P141, DOI 10.1097/00006842-194004000-00005; Chen AY, 2010, PREV CHRONIC DIS, V7; CHRISTENSEN U, 1981, HUM BIOL, V53, P403; Dahly DL, 2010, INT J OBESITY, V34, P751, DOI 10.1038/ijo.2009.275; Gorber SC, 2007, OBES REV, V8, P307, DOI 10.1111/j.1467-789X.2007.00347.x; Herman KM, 2009, INT J PEDIATR OBES, V4, P281, DOI 10.3109/17477160802596171; Hunsberger M, 2012, NUTR DIABETES, V2, DOI 10.1038; Jappe E, 2005, FORAELDREMYNDIGHED S; Knudsen LB, 1998, DAN MED BULL, V45, P221; Knudsen LB, 1993, BEFOLKNING VALG STAT, V44; Kopelman P, 2007, OBES REV, V8, pVI; Lesthaeghe R, 2010, POPUL DEV REV, V36, P211, DOI 10.1111/j.1728-4457.2010.00328.x; LISSAU I, 1994, LANCET, V343, P324, DOI 10.1016/S0140-6736(94)91163-0; Ochiai H, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-766; Olsen LW, 2006, EPIDEMIOLOGY, V17, P292, DOI 10.1097/01.ede.0000208349.16893.e0; Ramlau-Hansen CH, 2007, HUM REPROD, V22, P1634, DOI 10.1093/humrep/dem035; RAVELLI GP, 1979, AM J EPIDEMIOL, V109, P66, DOI 10.1093/oxfordjournals.aje.a112660; Rugholm S, 2005, OBES RES, V13, P2187, DOI 10.1038/oby.2005.271; Shah PS, 2010, ACTA OBSTET GYN SCAN, V89, P862, DOI 10.3109/00016349.2010.486827; Shaw C, 1999, Popul Trends, P7; Siervo M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013907; SONNEHOLM S, 1977, J CHRON DIS, V30, P351, DOI 10.1016/0021-9681(77)90029-7; SONNEHOLM S, 1983, BRIT MED J, V287, P795, DOI 10.1136/bmj.287.6395.795; SORENSEN TIA, 1988, AM J EPIDEMIOL, V127, P104, DOI 10.1093/oxfordjournals.aje.a114770; SORENSEN TIA, 1977, J CHRON DIS, V30, P359, DOI 10.1016/0021-9681(77)90030-3; Stenhammar C, 2010, ACTA PAEDIATR, V99, P1205, DOI 10.1111/j.1651-2227.2010.01776.x; Trombini E, 2003, PERCEPT MOTOR SKILL, V97, P613, DOI 10.2466/PMS.97.5.613-620; Wang HB, 2007, PREV MED, V44, P45, DOI 10.1016/j.ypmed.2006.07.015; Wells JCK, 2011, AM J EPIDEMIOL, V174, P1028, DOI 10.1093/aje/kwr232; Whitaker RC, 2007, CHILD ABUSE NEGLECT, V31, P1187, DOI 10.1016/j.chiabu.2007.04.008	32	40	42	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e56357	10.1371/journal.pone.0056357	http://dx.doi.org/10.1371/journal.pone.0056357			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437116	Green Published, gold, Green Submitted			2022-12-25	WOS:000315184200061
J	McBride, S; Huelse, M; Lee, M				McBride, Sebastian; Huelse, Martin; Lee, Mark			Identifying the Computational Requirements of an Integrated Top-Down-Bottom-Up Model for Overt Visual Attention within an Active Vision System	PLOS ONE			English	Article							PARIETAL CORTEX; SUPERIOR COLLICULUS; PRIORITY MAP; INHIBITION; SALIENCE; IDENTIFICATION; PERCEPTION; SEARCH; MEMORY; RETURN	Computational visual attention systems have been constructed in order for robots and other devices to detect and locate regions of interest in their visual world. Such systems often attempt to take account of what is known of the human visual system and employ concepts, such as 'active vision', to gain various perceived advantages. However, despite the potential for gaining insights from such experiments, the computational requirements for visual attention processing are often not clearly presented from a biological perspective. This was the primary objective of this study, attained through two specific phases of investigation: 1) conceptual modeling of a top-down-bottom-up framework through critical analysis of the psychophysical and neurophysiological literature, 2) implementation and validation of the model into robotic hardware (as a representative of an active vision system). Seven computational requirements were identified: 1) transformation of retinotopic to egocentric mappings, 2) spatial memory for the purposes of medium-term inhibition of return, 3) synchronization of 'where' and 'what' information from the two visual streams, 4) convergence of top-down and bottom-up information to a centralized point of information processing, 5) a threshold function to elicit saccade action, 6) a function to represent task relevance as a ratio of excitation and inhibition, and 7) derivation of excitation and inhibition values from object-associated feature classes. The model provides further insight into the nature of data representation and transfer between brain regions associated with the vertebrate 'active' visual attention system. In particular, the model lends strong support to the functional role of the lateral intraparietal region of the brain as a primary area of information consolidation that directs putative action through the use of a 'priority map'.	[McBride, Sebastian] Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge, England; [Huelse, Martin; Lee, Mark] Abersytwyth Univ, Dept Comp Sci, Aberystwyth, Dyfed, Wales	University of Cambridge; Aberystwyth University	McBride, S (corresponding author), Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge, England.	sdm47@cam.ac.uk			EC; UK EPSRC [EP/C516303/1]; Engineering and Physical Sciences Research Council [EP/C516303/1] Funding Source: researchfish	EC(European CommissionEuropean Commission Joint Research Centre); UK EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was supported by the EC-FP7 projects IMCLeVeR and ROSSI and through UK EPSRC grant EP/C516303/1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baddeley RJ, 2006, VISION RES, V46, P2824, DOI 10.1016/j.visres.2006.02.024; Bendiksby MS, 2006, NEUROPSYCHOLOGIA, V44, P2411, DOI 10.1016/j.neuropsychologia.2006.04.011; Buschman TJ, 2007, SCIENCE, V315, P1860, DOI 10.1126/science.1138071; CASAGRANDE VA, 1972, SCIENCE, V177, P444, DOI 10.1126/science.177.4047.444; Chao F, 2010, ROBOT AUTON SYST, V58, P239, DOI 10.1016/j.robot.2009.08.002; Dorris MC, 2004, NEURON, V44, P365, DOI 10.1016/j.neuron.2004.09.009; Falkner AL, 2010, J NEUROSCI, V30, P12787, DOI 10.1523/JNEUROSCI.2327-10.2010; Fecteau JH, 2006, TRENDS COGN SCI, V10, P382, DOI 10.1016/j.tics.2006.06.011; Foulsham T, 2007, PERCEPTION, V36, P1123, DOI 10.1068/p5659; Foulsham T, 2011, COGN COMPUT, V3, P48, DOI 10.1007/s12559-010-9069-9; Fuchs I, 2011, COGN COMPUT, V3, P25, DOI 10.1007/s12559-010-9062-3; Gold JI, 2007, ANNU REV NEUROSCI, V30, P535, DOI 10.1146/annurev.neuro.29.051605.113038; GOODALE MA, 1992, TRENDS NEUROSCI, V15, P20, DOI 10.1016/0166-2236(92)90344-8; Gottlieb J, 2007, NEURON, V53, P9, DOI 10.1016/j.neuron.2006.12.009; Gottlieb J, 2009, VISION RES, V49, P1216, DOI 10.1016/j.visres.2008.03.023; Grabenhorst F, 2010, J NEUROPHYSIOL, V104, P1649, DOI 10.1152/jn.00352.2010; Hooge ITC, 2005, VISION RES, V45, P1901, DOI 10.1016/j.visres.2005.01.030; Hulse M, 2011, 2011 IEEE INTERNATIONAL CONFERENCE ON DEVELOPMENT AND LEARNING (ICDL); Hulse M, 2010, IEEE T AUTON MENT DE, V2, P355, DOI 10.1109/TAMD.2010.2081667; Itti L, 2000, VISION RES, V40, P1489, DOI 10.1016/S0042-6989(99)00163-7; Jacob M, 2011, COGN COMPUT, V3, P105, DOI 10.1007/s12559-010-9084-x; Klein RM, 2000, TRENDS COGN SCI, V4, P138, DOI 10.1016/S1364-6613(00)01452-2; Lamme VAF, 2000, TRENDS NEUROSCI, V23, P571, DOI 10.1016/S0166-2236(00)01657-X; Li L, 2010, BRAIN RES, V1344, P173, DOI 10.1016/j.brainres.2010.05.016; Ludwig CJH, 2009, COGNITIVE PSYCHOL, V59, P180, DOI 10.1016/j.cogpsych.2009.04.002; Macaluso E, 2003, EXP BRAIN RES, V149, P62, DOI 10.1007/s00221-002-1335-y; McHaffie JG, 2005, TRENDS NEUROSCI, V28, P401, DOI 10.1016/j.tins.2005.06.006; Mevorach C, 2010, J NEUROSCI, V30, P6072, DOI 10.1523/JNEUROSCI.0241-10.2010; Milner AD, 2008, NEUROPSYCHOLOGIA, V46, P774, DOI 10.1016/j.neuropsychologia.2007.10.005; Mital PK, 2011, COGN COMPUT, V3, P5, DOI 10.1007/s12559-010-9074-z; Monosov IE, 2010, P NATL ACAD SCI USA, V107, P13105, DOI 10.1073/pnas.1002870107; Nassi JJ, 2009, NAT REV NEUROSCI, V10, P360, DOI 10.1038/nrn2619; Pare M, 2001, J NEUROPHYSIOL, V85, P2545, DOI 10.1152/jn.2001.85.6.2545; Parkhurst D, 2002, VISION RES, V42, P107, DOI 10.1016/S0042-6989(01)00250-4; Parkhurst DJ, 2003, SPATIAL VISION, V16, P125, DOI 10.1163/15685680360511645; Platt ML, 2004, METH NE FRO NEUROSCI, P1; Rebhan S, 2011, COGN COMPUT, V3, P124, DOI 10.1007/s12559-010-9077-9; Rothkopf CA, 2007, J VISION, V7, DOI 10.1167/7.14.16; Schmolesky MT, 1998, J NEUROPHYSIOL, V79, P3272, DOI 10.1152/jn.1998.79.6.3272; Smith TJ, 2009, VIS COGN, V17, P1083, DOI 10.1080/13506280802678557; Stein Barry E., 1991, P85; Stein BE, 2009, HEARING RES, V258, P4, DOI 10.1016/j.heares.2009.03.012; Stein BE, 2002, NEUROSCIENTIST, V8, P306, DOI 10.1177/107385840200800406; Stottinger E, 2010, EXP BRAIN RES, V202, P79, DOI 10.1007/s00221-009-2114-9; Striemer C, 2009, NEUROPSYCHOLOGIA, V47, P1491, DOI 10.1016/j.neuropsychologia.2008.12.021; Tatler B, 2008, INT J PSYCHOL, V43, P37; Theeuwes J, 2006, PSYCHON B REV, V13, P608, DOI 10.3758/BF03193970; Theeuwes J, 2010, ACTA PSYCHOL, V135, P77, DOI 10.1016/j.actpsy.2010.02.006; WESTWOOD DA, 2009, OXFORD HDB HUMAN ACT, P88; Wu CT, 2007, BRAIN RES, V1134, P187, DOI 10.1016/j.brainres.2006.11.088; Zylberberg A, 2009, FRONT COMPUT NEUROSC, V3, DOI 10.3389/neuro.10.004.2009	51	1	1	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e54585	10.1371/journal.pone.0054585	http://dx.doi.org/10.1371/journal.pone.0054585			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437044	Green Published, gold, Green Submitted			2022-12-25	WOS:000315184200009
J	Napoli, N; Strollo, R; Pitocco, D; Bizzarri, C; Maddaloni, E; Maggi, D; Manfrini, S; Schwartz, A; Pozzilli, P				Napoli, Nicola; Strollo, Rocky; Pitocco, Dario; Bizzarri, Carla; Maddaloni, Ernesto; Maggi, Daria; Manfrini, Silvia; Schwartz, Ann; Pozzilli, Paolo		IMDIAB Grp	Effect of Calcitriol on Bone Turnover and Osteocalcin in Recent-Onset Type 1 Diabetes	PLOS ONE			English	Article							VITAMIN-D SUPPLEMENTATION; BETA-CELL FUNCTION; INSULIN REQUIREMENT; BIOCHEMICAL MARKERS; SERUM OSTEOCALCIN; HEALTHY-CHILDREN; PLASMA-GLUCOSE; HIP-FRACTURES; MINERAL MASS; FAT MASS	Background: Vitamin D supplementation in childhood improves the achievement of peak bone mass. We investigated the effect of supplementation with calcitriol on bone turnover in recent-onset type 1 diabetes (T1D). Moreover, the association between osteocalcin and parameters of beta-cell function and metabolic control was examined. Methodology/Principal Findings: We conducted a post-hoc analysis of a double-blind, placebo-controlled study of calcitriol supplementation to preserve beta-cell function. 27 recent-onset T1D subjects, mean age 22 years, were randomized to 0.25 mu g calcitriol per day or placebo (1:1) and followed up for one year. Changes in bone formation (osteoclacin) and resorption (beta-CrossLaps) markers, and differences between placebo and calcitriol-treated group were evaluated. At baseline, osteocalcin levels were significantly lower in female than in male patients (P<0.01) while no other metabolic parameters as HbA1c and C-peptide differed between gender. No significant correlations were found in relation to HbA1c, insulin requirement and C-peptide. At 1 year follow-up, no significant differences were observed between calcitriol and placebo groups for osteocalcin and beta-CrossLaps. In the placebo group osteocalcin levels were unrelated with parameters of metabolic control, such as C-peptide, insulin requirement or HbA1c. Changes of C-peptide, insulin requirement and HbA1c were not related to osteocalcin levels. Conclusions: Supplementation with 0.25 mu g calcitriol per day to patients with new-onset T1D does not affect circulating markers of bone turnover. OC levels were unrelated to beta-cell function and other metabolic parameters suggesting that OC is ineffective to control pancreatic function in presence of aggressive autoimmune destruction.	[Napoli, Nicola; Strollo, Rocky; Maddaloni, Ernesto; Maggi, Daria; Manfrini, Silvia; Pozzilli, Paolo] Univ Campus Biomed, Dept Endocrinol & Diabet, Rome, Italy; [Napoli, Nicola] Washington Univ, Div Bone & Mineral Dis, St Louis, MO USA; [Strollo, Rocky] Univ London, Barts & London Sch Med, William Harvey Res Inst, Bone & Joint Res Unit, London, England; [Pitocco, Dario] Catholic Univ, Rome, Italy; [Bizzarri, Carla] Bambino Gesu Pediat Hosp, Rome, Italy; [Schwartz, Ann] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Pozzilli, Paolo] Univ London, Barts & London Sch Med, Ctr Diabet, London, England	University Campus Bio-Medico - Rome Italy; Washington University (WUSTL); University of London; Queen Mary University London; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; IRCCS Bambino Gesu; University of California System; University of California San Francisco; University of London; Queen Mary University London	Pozzilli, P (corresponding author), Univ Campus Biomed, Dept Endocrinol & Diabet, Rome, Italy.	p.pozzilli@unicampus.it	Maddaloni, Ernesto/N-1891-2014; Strollo, Rocky/K-5015-2016; Buzzetti, Raffaella/K-3090-2016; Pitocco, Dario/K-4210-2018; palermo, andrea/D-7406-2015; Bizzarri, Carla/AAI-2429-2019; Napoli, Nicola/K-8242-2016	Maddaloni, Ernesto/0000-0003-3844-9463; Strollo, Rocky/0000-0001-8967-7613; Buzzetti, Raffaella/0000-0003-1490-6041; palermo, andrea/0000-0002-1143-4926; Bizzarri, Carla/0000-0002-5616-9185; Pozzilli, Paolo/0000-0001-5090-636X; Napoli, Nicola/0000-0002-3091-8205; Pitocco, Dario/0000-0002-6220-686X; cavallo, maria gisella/0000-0001-6630-8049	Ministero Universita e Ricerca Scientifica (Progetti di Interesse Nazionale PRIN)	Ministero Universita e Ricerca Scientifica (Progetti di Interesse Nazionale PRIN)(Ministry of Education, Universities and Research (MIUR))	This study was supported by a grant from Ministero Universita e Ricerca Scientifica (Progetti di Interesse Nazionale PRIN) to Paolo Pozzilli, P.I. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBRIGHT F, 1948, J CLIN ENDOCRINOL, V8, P637, DOI 10.1210/jcem-8-8-637; Bizzarri C, 2010, DIABETES CARE, V33, P1962, DOI [10.2337/dc10-0814, 10.2337/dc10-1168]; Bock G, 2011, DIABETES-METAB RES, V27, P942, DOI 10.1002/dmrr.1276; Brandao FR, 2007, DIABETES RES CLIN PR, V78, P334, DOI 10.1016/j.diabres.2007.04.009; Cauley JA, 2008, ANN INTERN MED, V149, P242, DOI 10.7326/0003-4819-149-4-200808190-00005; CUMMINGS SR, 1993, LANCET, V341, P72, DOI 10.1016/0140-6736(93)92555-8; Dahlquist G, 1999, DIABETOLOGIA, V42, P51, DOI 10.1007/s001250051112; Ducy P, 2011, DIABETOLOGIA, V54, P1291, DOI 10.1007/s00125-011-2155-z; El-Hajj Fuleihan G, 2006, J CLIN ENDOCR METAB, V91, P405, DOI 10.1210/jc.2005-1436; Fares JE, 2003, BONE, V33, P242, DOI 10.1016/S8756-3282(03)00160-1; Ferron M, 2008, P NATL ACAD SCI USA, V105, P5266, DOI 10.1073/pnas.0711119105; Hofbauer LC, 2007, J BONE MINER RES, V22, P1317, DOI 10.1359/JBMR.070510; Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra070553; Hypponen E, 2001, LANCET, V358, P1500, DOI 10.1016/S0140-6736(01)06580-1; Iki M, 2012, OSTEOPOROSIS INT, V23, P761, DOI 10.1007/s00198-011-1600-7; Kanazawa I, 2011, OSTEOPOROSIS INT, V22, P187, DOI 10.1007/s00198-010-1184-7; Kanazawa I, 2009, J CLIN ENDOCR METAB, V94, P45, DOI 10.1210/jc.2008-1455; Kindblom JM, 2009, J BONE MINER RES, V24, P785, DOI [10.1359/jbmr.081234, 10.1359/JBMR.081234]; Lee NK, 2007, CELL, V130, P456, DOI 10.1016/j.cell.2007.05.047; Leger J, 2006, J CLIN ENDOCR METAB, V91, P3947, DOI 10.1210/jc.2006-0711; Lehtonen-Veromaa MKM, 2002, AM J CLIN NUTR, V76, P1446, DOI 10.1093/ajcn/76.6.1446; Mathieu C, 2005, DIABETOLOGIA, V48, P1247, DOI 10.1007/s00125-005-1802-7; MATHIEU C, 1994, DIABETOLOGIA, V37, P552, DOI 10.1007/BF00403372; McCabe LR, 2007, J CELL BIOCHEM, V102, P1343, DOI 10.1002/jcb.21573; Motyl KJ, 2010, ARCH BIOCHEM BIOPHYS, V503, P2, DOI 10.1016/j.abb.2010.07.030; Oz SG, 2006, J NATL MED ASSOC, V98, P1598; Pater A, 2010, J PEDIATR ENDOCR MET, V23, P81; Peppone LJ, 2010, OSTEOPOROSIS INT, V21, P1133, DOI 10.1007/s00198-009-1136-2; Pozzilli P, 2005, HORM METAB RES, V37, P680, DOI 10.1055/s-2005-870578; Rizzoli R, 2010, BONE, V46, P294, DOI 10.1016/j.bone.2009.10.005; Schou AJ, 2003, ACTA PAEDIATR, V92, P797, DOI 10.1080/08035250310002984; Szulc P, 2000, OSTEOPOROSIS INT, V11, P281, DOI 10.1007/s001980070116; Thrailkill KM, 2012, OSTEOPOROSIS INT, V23, P1799, DOI 10.1007/s00198-011-1807-7; Thrailkill KM, 2005, DIABETES, V54, P2875, DOI 10.2337/diabetes.54.10.2875; Thrailkill KM, 2005, AM J PHYSIOL-ENDOC M, V289, pE735, DOI 10.1152/ajpendo.00159.2005; Vestergaard P, 2007, OSTEOPOROSIS INT, V18, P427, DOI 10.1007/s00198-006-0253-4; Viljakainen HT, 2006, J BONE MINER RES, V21, P836, DOI 10.1359/JBMR.060302; Walter M, 2010, DIABETES CARE, V33, P1443, DOI 10.2337/dc09-2297; Winzenberg T, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.c7254; Zamora SA, 1999, J CLIN ENDOCR METAB, V84, P4541, DOI 10.1210/jc.84.12.4541; Zhou M, 2009, EUR J ENDOCRINOL, V161, P723, DOI 10.1530/EJE-09-0585	41	15	15	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e56488	10.1371/journal.pone.0056488	http://dx.doi.org/10.1371/journal.pone.0056488			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437144	gold, Green Published, Green Submitted			2022-12-25	WOS:000315184200083
J	Zhang, JY; Li, P; Wang, YP; Liu, JX; Zhang, ZJ; Cheng, WD; Wang, YY				Zhang, Junying; Li, Peng; Wang, Yanping; Liu, Jianxun; Zhang, Zhanjun; Cheng, Weidong; Wang, Yongyan			Ameliorative Effects of a Combination of Baicalin, Jasminoidin and Cholic Acid on Ibotenic Acid-Induced Dementia Model in Rats	PLOS ONE			English	Article							EPIDERMAL-GROWTH-FACTOR; THYROTROPIN-RELEASING-HORMONE; NEURAL STEM-CELLS; IMPAIRED RECOGNITION MEMORY; TRANSGENIC MOUSE MODEL; RETINOIC ACID; ALZHEIMERS-DISEASE; IN-VITRO; CARBONYL REDUCTASE; AMYLOID DEPOSITION	Aims: To investigate the therapeutic effects and acting mechanism of a combination of Chinese herb active components, i.e., a combination of baicalin, jasminoidin and cholic acid (CBJC) on Alzheimer's disease (AD). Methods: Male rats were intracerebroventricularly injected with ibotenic acid (IBO), and CBJC was orally administered. Therapeutic effect was evaluated with the Morris water maze test, FDG-PET examination, and histological examination, and the acting mechanism was studied with DNA microarrays and western blotting. Results: CBJC treatment significantly attenuated IBO-induced abnormalities in cognition, brain functional images, and brain histological morphology. Additionally, the expression levels of 19 genes in the forebrain were significantly influenced by CBJC; approximately 60% of these genes were related to neuroprotection and neurogenesis, whereas others were related to anti-oxidation, protein degradation, cholesterol metabolism, stress response, angiogenesis, and apoptosis. Expression of these genes was increased, except for the gene related to apoptosis. Changes in expression for 5 of these genes were confirmed by western blotting. Conclusion: CBJC can ameliorate the IBO-induced dementia in rats and may be significant in the treatment of AD. The therapeutic mechanism may be related to CBJC's modulation of a number of processes, mainly through promotion of neuroprotection and neurogenesis, with additional promotion of anti-oxidation, protein degradation, etc.	[Zhang, Junying; Cheng, Weidong] Lanzhou Univ, Sch Basic Med Sci, Lanzhou 730000, Peoples R China; [Zhang, Junying; Zhang, Zhanjun] Beijing Normal Univ, State Key Lab Cognit Neurosci & Learning, Beijing 100875, Peoples R China; [Li, Peng; Liu, Jianxun] China Acad Chinese Med Sci, Lab Res Ctr, Xiyuan Hosp, Beijing, Peoples R China; [Wang, Yanping; Wang, Yongyan] China Acad Chinese Med Sci, Inst Basic Clin Med, Beijing, Peoples R China	Lanzhou University; Beijing Normal University; China Academy of Chinese Medical Sciences; Xiyuan Hospital, CACMS; China Academy of Chinese Medical Sciences; Institute of Basic Research In Clinical Medicine, CACMS	Zhang, ZJ (corresponding author), Beijing Normal Univ, State Key Lab Cognit Neurosci & Learning, Beijing 100875, Peoples R China.	zhang_rzs@bnu.edu; weidong_c@yahoo.cn			Fundamental Research Funds for the Central Universities [248-105102]; Program for New Century Excellent Talents in University [NCET-10]; Project of Institute of Basic Clinical Medicine, China Academy of Chinese Medical Sciences [Z0175]	Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); Project of Institute of Basic Clinical Medicine, China Academy of Chinese Medical Sciences	This study was supported by the Fundamental Research Funds for the Central Universities (248-105102), Program for New Century Excellent Talents in University (NCET-10) and Project of Institute of Basic Clinical Medicine, China Academy of Chinese Medical Sciences (Z0175). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABE K, 1992, NEUROSCI RES, V14, P117, DOI 10.1016/0168-0102(92)90087-S; Akama K, 2011, BBA-PROTEINS PROTEOM, V1814, P265, DOI 10.1016/j.bbapap.2010.10.009; Arai Y, 2005, J NEUROSCI, V25, P9752, DOI 10.1523/JNEUROSCI.2512-05.2005; Beattie J, 2006, BIOCHEM J, V395, P1, DOI 10.1042/BJ20060086; Bennett GW, 1997, EXP GERONTOL, V32, P451, DOI 10.1016/S0531-5565(96)00159-3; Benoit BO, 2001, J NEUROBIOL, V46, P265, DOI 10.1002/1097-4695(200103)46:4<265::AID-NEU1007>3.0.CO;2-B; Bergink S, 2006, NEUROBIOL DIS, V23, P708, DOI 10.1016/j.nbd.2006.06.005; Bi WM, 2007, HUM MOL GENET, V16, P1802, DOI 10.1093/hmg/ddm128; Boneva NB, 2011, HIPPOCAMPUS, V21, P162, DOI 10.1002/hipo.20732; Botella JA, 2004, CURR BIOL, V14, P782, DOI 10.1016/j.cub.2004.04.036; Calza L, 2003, P NATL ACAD SCI USA, V100, P7325, DOI 10.1073/pnas.1132092100; Chen-Plotkin AS, 2011, ANN NEUROL, V69, P655, DOI 10.1002/ana.22271; Christie VB, 2010, J NEUROSCI METH, V193, P239, DOI 10.1016/j.jneumeth.2010.08.022; Clark RE, 2000, J NEUROSCI, V20, P8853; Corcoran JPT, 2004, EUR J NEUROSCI, V20, P896, DOI 10.1111/j.1460-9568.2004.03563.x; Cui J, 2003, ZHONG GUO ZU ZHI HUA, V12, P81; Cunha-Reis D, 2006, ANN NY ACAD SCI, V1070, P210, DOI 10.1196/annals.1317.016; Ding Y, 2008, J NEUROSCI, V28, P11622, DOI 10.1523/JNEUROSCI.3153-08.2008; Encinas M, 2000, J NEUROCHEM, V75, P991, DOI 10.1046/j.1471-4159.2000.0750991.x; Etchamendy N, 2001, J NEUROSCI, V21, P6423, DOI 10.1523/JNEUROSCI.21-16-06423.2001; Farias EF, 2005, J NATL CANCER I, V97, P21, DOI 10.1093/jnci/dji004; Flore M, 2002, PHYSIOL BEHAV, V77, P437; Fujita Jun, 1999, Journal of Molecular Microbiology and Biotechnology, V1, P243; Guo XF, 2000, GUANG ZHOU ZHONG YI, V17, P9; Hauck SM, 2008, MOL CELL PROTEOMICS, V7, P1349, DOI 10.1074/mcp.M700456-MCP200; Heo H, 2009, J ETHNOPHARMACOL, V122, P20, DOI 10.1016/j.jep.2008.11.026; Hicks D, 1998, GEN PHARMACOL, V30, P265, DOI 10.1016/S0306-3623(97)00356-X; Hoffrogge R, 2006, PROTEOMICS, V6, P1833, DOI 10.1002/pmic.200500556; Hu JG, 2001, J BIOL CHEM, V276, P47863, DOI 10.1074/jbc.M104068200; Ishikawa E, 2009, J NEUROL SCI, V285, P78, DOI 10.1016/j.jns.2009.05.026; Ji C, 2009, J ALZHEIMERS DIS, V16, P331, DOI 10.3233/JAD-2009-0979; Johansson K, 2010, FREE RADICAL BIO MED, V49, P1638, DOI 10.1016/j.freeradbiomed.2010.08.013; Kehoe PG, 1999, NAT GENET, V21, P71, DOI 10.1038/5009; Kim DH, 2006, MECH AGEING DEV, V127, P719, DOI 10.1016/j.mad.2006.05.002; Kim YB, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-42; Klafki HW, 2006, BRAIN, V129, P2840, DOI 10.1093/brain/awl280; Koriyama Y, 2010, J NEUROCHEM, V115, P79, DOI 10.1111/j.1471-4159.2010.06903.x; Kovacs T, 2001, NEUROREPORT, V12, P285, DOI 10.1097/00001756-200102120-00021; Kuhn HG, 1997, J NEUROSCI, V17, P5820; Laskowski A, 2005, BRAIN RES, V1037, P78, DOI 10.1016/j.brainres.2004.12.035; Lee JW, 2009, COOPERATION INTEGRIN; Lee KH, 2000, J FOOD DRUG ANAL, V8, P219; Li M, 2011, CHEMBIOCHEM, V12, P449, DOI 10.1002/cbic.201000570; Luo GA, 2006, SCI TECHNOL MOD TRAD, V8, P6; Luo LG, 2002, J ALZHEIMERS DIS, V4, P97, DOI 10.3233/JAD-2002-4204; Marchal-Victorion S, 2003, MOL CELL NEUROSCI, V24, P198, DOI 10.1016/S1044-7431(03)00161-1; Maser E, 2006, BIOCHEM BIOPH RES CO, V340, P1019, DOI 10.1016/j.bbrc.2005.12.113; Matt N, 2005, DEV DYNAM, V233, P167, DOI 10.1002/dvdy.20313; MELLOW AM, 1989, PSYCHOPHARMACOLOGY, V98, P403, DOI 10.1007/BF00451695; MIYAMOTO M, 1994, EUR J PHARMACOL, V271, P357; MORRISON RS, 1988, J NEUROSCI RES, V21, P71, DOI 10.1002/jnr.490210111; Nordberg A, 2001, ALZHEIMER'S DISEASE, P153, DOI 10.1002/0470846453.ch15; Ono K, 2004, EXP NEUROL, V189, P380, DOI 10.1016/j.expneurol.2004.05.035; Paspalas CD, 2009, CEREB CORTEX, V19, P1666, DOI 10.1093/cercor/bhn203; Pattnaik BR, 2009, AM J PHYSIOL-CELL PH, V297, pC1001, DOI 10.1152/ajpcell.00250.2009; Rangon CM, 2005, J PHARMACOL EXP THER, V314, P745, DOI 10.1124/jpet.105.086405; Rashid MA, 2010, FREE RADICAL BIO MED, V49, P1522, DOI 10.1016/j.freeradbiomed.2010.08.015; Reilly JF, 2003, P NATL ACAD SCI USA, V100, P4837, DOI 10.1073/pnas.0330745100; Sakurai T, 2006, BBA-MOL CELL RES, V1763, P290, DOI 10.1016/j.bbamcr.2006.02.007; Salama RHM, 2006, CANCER LETT, V233, P16, DOI 10.1016/j.canlet.2005.02.047; Sarang SS, 2002, PHYSIOL GENOMICS, V11, P45, DOI 10.1152/physiolgenomics.00064.2002; Sultana R, 2007, NEUROCHEM RES, V32, P655, DOI 10.1007/s11064-006-9123-x; Tak E, 2011, J HEPATOL, V54, P328, DOI 10.1016/j.jhep.2010.06.045; Takahashi J, 1999, J NEUROBIOL, V38, P65, DOI 10.1002/(SICI)1097-4695(199901)38:1<65::AID-NEU5>3.3.CO;2-H; Tanaka M, 2009, BIOL PHARM BULL, V32, P1220, DOI 10.1248/bpb.32.1220; Wang TW, 2005, DEVELOPMENT, V132, P2721, DOI 10.1242/dev.01867; Wellmann S, 2004, J CELL SCI, V117, P1785, DOI 10.1242/jcs.01026; Xiao Lin, 2005, Shengli Xuebao, V57, P705; Yamada M, 2003, THYROID, V13, P1111, DOI 10.1089/10507250360731505; Yamazaki M, 2009, BIOL PHARM BULL, V32, P1043, DOI 10.1248/bpb.32.1043; Yu J, 2009, CLIN EXP PHARMACOL P, V36, P539, DOI 10.1111/j.1440-1681.2008.05105.x; Zaben M, 2009, STEM CELLS, V27, P2539, DOI 10.1002/stem.184; Zannis VI, 2008, ANN MED, V40, P14, DOI 10.1080/07853890701687219; Zhang Zhan-jun, 2006, Chinese Pharmacological Bulletin, V22, P964; Zhang ZJ, 2006, THESIS BEIJING U TRA, P31; Zhao BQ, 2011, INT J PHARMACEUT, V405, P1, DOI 10.1016/j.ijpharm.2010.11.018; Zhong XG, 2004, BEI JING ZHONG YI YA, V27, P21; Zola SM, 2000, J NEUROSCI, V20, P451, DOI 10.1523/JNEUROSCI.20-01-00451.2000; Zou K, 2007, J NEUROSCI, V27, P8628, DOI 10.1523/JNEUROSCI.1549-07.2007	79	19	25	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e56658	10.1371/journal.pone.0056658	http://dx.doi.org/10.1371/journal.pone.0056658			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437202	Green Published, gold			2022-12-25	WOS:000315184200132
J	Wang, YL; Feng, SH; Zhu, J; Zhu, GP; Li, DS; Wang, Y; Zhu, YX; Sun, GH; Ji, QH				Wang, Yu-Long; Feng, Shou-Hao; Zhu, Ji; Zhu, Guo-Pei; Li, Duan-Shu; Wang, Yu; Zhu, Yong-Xue; Sun, Guo-Hua; Ji, Qing-Hai			Impact of Lymph Node Ratio on the Survival of Patients with Hypopharyngeal Squamous Cell Carcinoma: A Population-Based Analysis	PLOS ONE			English	Article							POSITIVE BREAST-CANCER; LARYNGEAL-CANCER; GASTRIC-CANCER; STAGING SYSTEM; UNITED-STATES; NECK CANCERS; HEAD; PATTERNS; ADEQUACY	Objective: To analyze the impact of the lymph node ratio (LNR, ratio of metastatic to examined nodes) on the prognosis of hypopharyngeal cancer patients. Methods: SEER (Surveillance, Epidemiology and End Results)-registered hypopharyngeal cancer patients with lymph node metastasis were evaluated using multivariate Cox regression analysis to identify the prognostic role of the LNR. The categorical LNR was compared with the continuous LNR and pN classifications to predict cause-specific survival (CSS) and overall survival (OS) rates of hypopharyngeal cancer patients. Results: Multivariate analysis of 916 pN+ hypopharyngeal cancer cases identified race, primary site, radiation sequence, T classification, N classification, M classification, the number of regional lymph nodes examined, the continuous LNR (Hazard ratio 2.415, 95% CI 1.707-3.416, P<0.001) and age as prognostic variables that were associated with CSS in hypopharyngeal cancer. The categorical LNR showed a higher C-index and lower Akaike information criterion (AIC) value than the continuous LNR. When patients (n = 1152) were classified into four risk groups according to LNR, R0 (LNR = 0), R1 (LNR <= 0.05), R2 (LNR 0.05-0.30) and R3 (LNR >0.30), the Cox regression model for CSS and OS using the R classification had a higher C-index value and lower AIC value than the model using the pN classification. Significant improvements in both CSS and OS were found for R2 and R3 patients with postoperative radiotherapy. Conclusions: LNR is a significant prognostic factor for the survival of hypopharyngeal cancer patients. Using the cutoff points 0.05/0.30, the R classification was more accurate than the pN classification in predicting survival and can be used to select high risk patients for postoperative treatment.	[Wang, Yu-Long; Feng, Shou-Hao; Li, Duan-Shu; Wang, Yu; Zhu, Yong-Xue; Sun, Guo-Hua; Ji, Qing-Hai] Fudan Univ, Canc Hosp, Dept Head & Neck Surg, Shanghai 200433, Peoples R China; [Wang, Yu-Long; Feng, Shou-Hao; Zhu, Ji; Zhu, Guo-Pei; Li, Duan-Shu; Wang, Yu; Zhu, Yong-Xue; Sun, Guo-Hua; Ji, Qing-Hai] Fudan Univ, Shanghai Med Coll, Dept Oncol, Shanghai 200433, Peoples R China; [Zhu, Ji; Zhu, Guo-Pei] Fudan Univ, Canc Hosp, Dept Radiat Oncol, Shanghai 200433, Peoples R China; [Zhu, Ji] Fudan Univ, Canc Hosp, Dept Clin Stat, Shanghai 200433, Peoples R China	Fudan University; Fudan University; Fudan University; Fudan University	Ji, QH (corresponding author), Fudan Univ, Canc Hosp, Dept Head & Neck Surg, Shanghai 200433, Peoples R China.	jiqinghai@shca.org.cn	zhu, ji/HDM-1538-2022; Wang, Yu-Long/AEF-9362-2022	Wang, Yu-Long/0000-0002-3830-7257; Zhu, Ji/0000-0001-7134-9419	National Science Foundation of China [81001204]	National Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Science Foundation of China (81001204 to Y-L Wang). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernier J, 2005, HEAD NECK-J SCI SPEC, V27, P843, DOI 10.1002/hed.20279; Bernier J, 2005, ONCOLOGIST, V10, P215, DOI 10.1634/theoncologist.10-3-215; Bisdas S, 2009, INT J RADIAT ONCOL, V73, P1313, DOI 10.1016/j.ijrobp.2008.06.1956; Bradburn MJ, 2003, BRIT J CANCER, V89, P605, DOI 10.1038/sj.bjc.6601120; Camp RL, 2004, CLIN CANCER RES, V10, P7252, DOI 10.1158/1078-0432.CCR-04-0713; Ceelen W, 2010, ANN SURG ONCOL, V17, P2847, DOI 10.1245/s10434-010-1158-1; Chen AY, 2011, ARCH OTOLARYNGOL, V137, P1017, DOI 10.1001/archoto.2011.171; Deng JY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043925; Gao P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035021; Glynn RW, 2012, LARYNGOSCOPE, V122, P1967, DOI 10.1002/lary.23401; Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4; Hoffman HT, 2006, LARYNGOSCOPE, V116, P1, DOI 10.1097/01.mlg.0000236095.97947.26; Howlader NNA, SEER CANC STAT REV 1; KOTWALL C, 1987, AM J SURG, V154, P439, DOI 10.1016/0002-9610(89)90020-2; Ligier K, 2011, ORAL ONCOL, V47, P302, DOI 10.1016/j.oraloncology.2011.02.013; Mendenhall WM, 2003, HEAD NECK-J SCI SPEC, V25, P535, DOI 10.1002/hed.10253; Pfister DG, 2011, J NATL COMPR CANC NE, V9, P596, DOI 10.6004/jnccn.2011.0053; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Song YX, 2012, PLOS ONE, V6; Spillane AJ, 2011, ANN SURG, V253, P109, DOI 10.1097/SLA.0b013e3181f9b8b6; Suarez C, 2012, HEAD NECK; Takes RP, 2012, HEAD NECK-J SCI SPEC, V34, P270, DOI 10.1002/hed.21613; Vinh-Hung V, 2010, ONCOLOGIST, V15, P1050, DOI 10.1634/theoncologist.2010-0044; Vinh-Hung V, 2009, J CLIN ONCOL, V27, P1062, DOI 10.1200/JCO.2008.18.6965; Wang JP, 2012, ANN SURG, V255, P478, DOI 10.1097/SLA.0b013e31824857e2; Wang W, 2011, ANN ONCOL, V22, P2049, DOI 10.1093/annonc/mdq716	26	36	36	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2013	8	2							e56613	10.1371/journal.pone.0056613	http://dx.doi.org/10.1371/journal.pone.0056613			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093HR	23431384	gold, Green Published, Green Submitted			2022-12-25	WOS:000315182800027
J	Reimold, FR; Braun, N; Zsengeller, ZK; Stillman, IE; Karumanchi, SA; Toka, HR; Latus, J; Fritz, P; Biegger, D; Segerer, S; Alscher, MD; Bhasin, MK; Alper, SL				Reimold, Fabian R.; Braun, Niko; Zsengeller, Zsuzsanna K.; Stillman, Isaac E.; Karumanchi, S. Ananth; Toka, Hakan R.; Latus, Joerg; Fritz, Peter; Biegger, Dagmar; Segerer, Stephan; Alscher, M. Dominik; Bhasin, Manoj K.; Alper, Seth L.			Transcriptional Patterns in Peritoneal Tissue of Encapsulating Peritoneal Sclerosis, a Complication of Chronic Peritoneal Dialysis	PLOS ONE			English	Article							FLUID-FLOW STRESS; MESENCHYMAL TRANSITION; GENE-EXPRESSION; FIBRONECTIN; CELLS; PATHOGENESIS; MORTALITY; MEMBRANE; EPIDEMIOLOGY; INFLAMMATION	Encapsulating peritoneal sclerosis (EPS) is a devastating complication of peritoneal dialysis (PD), characterized by marked inflammation and severe fibrosis of the peritoneum, and associated with high morbidity and mortality. EPS can occur years after termination of PD and, in severe cases, leads to intestinal obstruction and ileus requiring surgical intervention. Despite ongoing research, the pathogenesis of EPS remains unclear. We performed a global transcriptome analysis of peritoneal tissue specimens from EPS patients, PD patients without EPS, and uremic patients without history of PD or EPS (Uremic). Unsupervised and supervised bioinformatics analysis revealed distinct transcriptional patterns that discriminated these three clinical groups. The analysis identified a signature of 219 genes expressed differentially in EPS as compared to PD and Uremic groups. Canonical pathway analysis of differentially expressed genes showed enrichment in several pathways, including antigen presentation, dendritic cell maturation, B cell development, chemokine signaling and humoral and cellular immunity (P value<0.05). Further interactive network analysis depicted effects of EPS-associated genes on networks linked to inflammation, immunological response, and cell proliferation. Gene expression changes were confirmed by qRT-PCR for a subset of the differentially expressed genes. EPS patient tissues exhibited elevated expression of genes encoding sulfatase1, thrombospondin 1, fibronectin 1 and alpha smooth muscle actin, among many others, while in EPS and PD tissues mRNAs encoding leptin and retinol-binding protein 4 were markedly down-regulated, compared to Uremic group patients. Immunolocalization of Collagen 1 alpha 1 revealed that Col1a1 protein was predominantly expressed in the submesothelial compact zone of EPS patient peritoneal samples, whereas PD patient peritoneal samples exhibited homogenous Col1a1 staining throughout the tissue samples. The results are compatible with the hypothesis that encapsulating peritoneal sclerosis is a distinct pathological process from the simple peritoneal fibrosis that accompanies all PD treatment.	[Reimold, Fabian R.; Stillman, Isaac E.; Karumanchi, S. Ananth; Toka, Hakan R.; Alper, Seth L.] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Div Renal, Boston, MA 02215 USA; [Reimold, Fabian R.; Karumanchi, S. Ananth; Bhasin, Manoj K.; Alper, Seth L.] Harvard Univ, Sch Med, Dept Med, Boston, MA USA; [Reimold, Fabian R.; Braun, Niko; Latus, Joerg; Alscher, M. Dominik] Robert Bosch Krankenhaus, Dept Gen Internal Med & Nephrol, Stuttgart, Germany; [Braun, Niko; Latus, Joerg; Alscher, M. Dominik] Inst Digital Med, Stuttgart, Germany; [Zsengeller, Zsuzsanna K.; Stillman, Isaac E.] Beth Israel Deaconess Med Ctr, Dept Pathol, Boston, MA 02215 USA; [Zsengeller, Zsuzsanna K.; Stillman, Isaac E.; Karumanchi, S. Ananth; Toka, Hakan R.; Bhasin, Manoj K.; Alper, Seth L.] Harvard Univ, Sch Med, Boston, MA USA; [Karumanchi, S. Ananth; Alper, Seth L.] Beth Israel Deaconess Med Ctr, Vasc Biol Res Ctr, Boston, MA 02215 USA; [Toka, Hakan R.] Brigham & Womens Hosp, Div Nephrol, Boston, MA 02115 USA; [Toka, Hakan R.] Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; [Fritz, Peter; Biegger, Dagmar] Robert Bosch Krankenhaus, Dept Diagnost Med, Div Pathol, Stuttgart, Germany; [Biegger, Dagmar] Dr Margarete Fischer Bosch Inst Clin Pharmacol, Stuttgart, Germany; [Segerer, Stephan] Univ Zurich Hosp, Div Nephrol, CH-8091 Zurich, Switzerland; [Bhasin, Manoj K.] Beth Israel Deaconess Med Ctr, Div Interdisciplinary Med & Biotechnol, Boston, MA 02215 USA; [Bhasin, Manoj K.] Beth Israel Deaconess Med Ctr, Dept Med, Boston, MA 02215 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Harvard Medical School; Bosch; Robert Bosch Krankenhaus; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Bosch; Robert Bosch Krankenhaus; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; University of Zurich; University Zurich Hospital; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Beth Israel Deaconess Medical Center	Alper, SL (corresponding author), Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Div Renal, Boston, MA 02215 USA.	salper@bidmc.harvard.edu	Stillman, Isaac E/ABC-7278-2020; Karumanchi, Subbian Ananth/AAI-1694-2021; Toka, Hakan/AAQ-2162-2021	Latus, Joerg/0000-0003-0584-4870; Segerer, Stephan/0000-0002-1936-9719; Alscher, Mark Dominik/0000-0002-9658-1211; Zsengeller, Zsuzsanna/0000-0002-4540-5728; Bhasin, Manoj/0000-0001-5172-420X	Baxter International, Inc.; Howard Hughes Medical Institute; NIH [DK34854]; Swiss National Science Foundation [32003B-129710]; Robert Bosch Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK034854] Funding Source: NIH RePORTER	Baxter International, Inc.; Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Robert Bosch Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by Baxter International, Inc. (NB, SS and MDA), the Howard Hughes Medical Institute (SAK) and NIH DK34854 (Harvard Digestive Diseases Center to SLA). FRR was supported by a Fellowship of the Robert Bosch Foundation. SS is supported by the Swiss National Science Foundation (32003B-129710). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alscher DM, 2007, AM J KIDNEY DIS, V49, P452, DOI 10.1053/j.ajkd.2006.11.040; Aoki S, 2011, BIOCHEM BIOPH RES CO, V416, P391, DOI 10.1016/j.bbrc.2011.11.051; Aoki S, 2011, PERITON DIALYSIS INT, V31, P466, DOI 10.3747/pdi.2010.00157; Augustine T, 2009, NEPHRON CLIN PRACT, V111, pC149, DOI 10.1159/000191214; Ayuzawa N, 2012, PERITON DIALYSIS INT, V32, P159, DOI 10.3747/pdi.2010.00234; Baroni G, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/912595; Bhasin M, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-342; Bige N, 2012, KIDNEY INT, V81, P1226, DOI 10.1038/ki.2012.21; Braun N, 2012, PLOS ONE IN PRESS; Braun N, 2010, NEPHROLOGE, V5, P531; Braun N, 2011, NEPHROL THER, V7, P162, DOI 10.1016/j.nephro.2010.12.011; Braun N, 2011, PERITON DIALYSIS INT, V31, P291, DOI 10.3747/pdi.2010.00118; Braun N, 2011, NEPHROL DIAL TRANSPL, V26, P1033, DOI 10.1093/ndt/gfq488; Brown MC, 2009, CLIN J AM SOC NEPHRO, V4, P1222, DOI 10.2215/CJN.01260209; Coral K, 2012, CURR EYE RES; Doerner AM, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-100; El-Haibi CP, 2012, P NATL ACAD SCI US; Fieren MWJA, 2007, PERITON DIALYSIS INT, V27, P619; Fieren MWJA, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/976241; Garcia-Lopez E, 2012, NAT REV NEPHROL, V8, P224, DOI 10.1038/nrneph.2012.13; Garibotto G, 2012, NUTR METAB CARDIOVAS; Graham TE, 2006, NEW ENGL J MED, V354, P2552, DOI 10.1056/NEJMoa054862; GRINNELL F, 1984, J CELL BIOCHEM, V26, P107, DOI 10.1002/jcb.240260206; Guo H, 2007, J AM SOC NEPHROL, V18, P2689, DOI 10.1681/ASN.2007010121; Han ML, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039520; Herranz N, 2012, MOL CELL, V46, P369, DOI 10.1016/j.molcel.2012.03.002; Honda Kazuho, 2003, Adv Perit Dial, V19, P169; Imai Toshimi, 2011, Adv Perit Dial, V27, P11; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jenkins SJ, 2011, SCIENCE, V332, P1284, DOI 10.1126/science.1204351; Johnson DW, 2010, KIDNEY INT, V77, P904, DOI 10.1038/ki.2010.16; Kauffmann Audrey, 2009, Bioinformatics, V25, P415, DOI 10.1093/bioinformatics/btn647; Kawanishi H, 2005, PERITON DIALYSIS INT, V25, pS14; Kawanishi H, 2004, AM J KIDNEY DIS, V44, P729, DOI 10.1053/j.ajkd.2004.06.020; Kawanishi H, 2001, Adv Perit Dial, V17, P200; Kawanishi Hideki, 2011, Adv Perit Dial, V27, P53; Kawanishi Hideki, 2008, Adv Perit Dial, V24, P51; Koak Y, 2008, EUR J GASTROEN HEPAT, V20, P148, DOI 10.1097/MEG.0b013e3282cf4d98; Korte MR, 2011, AM J TRANSPLANT, V11, P599, DOI 10.1111/j.1600-6143.2010.03434.x; Korte MR, 2011, NEPHROL DIAL TRANSPL, V26, P691, DOI 10.1093/ndt/gfq362; Lai KN, 2012, PERITON DIALYSIS INT, V32, P280, DOI 10.3747/pdi.2010.00176; Lameire N, 2010, NAT REV NEPHROL, V6, P75, DOI 10.1038/nrneph.2009.210; Latus J, 2012, NEPHROL DIAL TRANSPL; Le SJ, 2010, DIFFERENTIATION, V79, P232, DOI 10.1016/j.diff.2010.03.001; Leask A, 2004, FASEB J, V18, P816, DOI 10.1096/fj.03-1273rev; Li C, 2001, P NATL ACAD SCI USA, V98, P31, DOI 10.1073/pnas.011404098; Lorkova L, 2012, ONCOL REP, V27, P318, DOI 10.3892/or.2011.1513; Lugassy J, 2012, J BIOL CHEM, V287, P3541, DOI 10.1074/jbc.M111.261016; Margetts PJ, 2005, J AM SOC NEPHROL, V16, P425, DOI 10.1681/ASN.2004060436; Margetts PJ, 2012, NEPHROL DIAL TRANSPL; Matsubara K, 2004, NEPHROLOGY, V9, P256, DOI 10.1111/j.1440-1797.2004.00271.x; Mehrotra R, 2011, AM J KIDNEY DIS, V58, P418, DOI 10.1053/j.ajkd.2011.03.018; Minutolo V, 2008, G CHIR, V29, P173; Mizuno M, 2012, AM J PHYSIOL-RENAL, V302, pF1245, DOI 10.1152/ajprenal.00652.2011; Mizuno T, 2011, NEPHROL DIAL TRANSPL, V26, P1821, DOI 10.1093/ndt/gfq683; Muro AF, 2008, AM J RESP CRIT CARE, V177, P638, DOI 10.1164/rccm.200708-1291OC; Nakamoto H, 2005, PERITON DIALYSIS INT, V25, pS30; Nakamoto H, 2008, PERITON DIALYSIS INT, V28, pS83; Nakamura S, 2004, SEMIN NEPHROL, V24, P502, DOI 10.1016/j.semnephrol.2004.06.027; Park SH, 2008, PERITON DIALYSIS INT, V28, pS21; da Luz MMP, 2011, SURG TODAY, V41, P1644, DOI 10.1007/s00595-010-4493-8; Sagara A, 2011, J AM SOC NEPHROL, p36A; Schwenger V, 2006, J AM SOC NEPHROL, V17, P199, DOI 10.1681/ASN.2005020155; Sweetwyne MT, 2012, MATRIX BIOL, V31, P178, DOI 10.1016/j.matbio.2012.01.006; Tamayo P, 1999, P NATL ACAD SCI USA, V96, P2907, DOI 10.1073/pnas.96.6.2907; Teta D, 2005, NEPHROL DIAL TRANSPL, V20, P1329, DOI 10.1093/ndt/gfh812; Toyohara T, 2011, INTERNAL MED, V50, P2519, DOI 10.2169/internalmedicine.50.5810; Ulmer C, 2012, SURGERY; Valenick LV, 2005, EXP CELL RES, V309, P48, DOI 10.1016/j.yexcr.2005.05.024; Van Vliet AI, 2001, J PATHOL, V193, P256; Vlijm A, 2009, PERITON DIALYSIS INT, V29, P517; Wang Chengxiong, 2007, Sheng Wu Yi Xue Gong Cheng Xue Za Zhi, V24, P736; Wang HR, 2012, KIDNEY BLOOD PRESS R, V35, P211, DOI 10.1159/000332402; Wang WJ, 2012, KIDNEY INT, V81, P1002, DOI 10.1038/ki.2011.457; Weigle DS, 1997, J CLIN ENDOCR METAB, V82, P561, DOI 10.1210/jc.82.2.561; Wojcik Katarina, 2007, Med Pregl, V60 Suppl 2, P114; Wong CF, 2005, PERITON DIALYSIS INT, V25, P285; Yamamoto Hiroyasu, 2002, Adv Perit Dial, V18, P135; Yanez-Mo M, 2003, NEW ENGL J MED, V348, P403, DOI 10.1056/NEJMoa020809; Yerlikaya FH, 2011, RENAL FAILURE, V33, P819, DOI 10.3109/0886022X.2011.601831; Yeung KY, 2001, BIOINFORMATICS, V17, P763, DOI 10.1093/bioinformatics/17.9.763; Yokoi H, 2012, KIDNEY INT, V81, P160, DOI 10.1038/ki.2011.305	82	15	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e56389	10.1371/journal.pone.0056389	http://dx.doi.org/10.1371/journal.pone.0056389			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418565	Green Published, Green Accepted, gold			2022-12-25	WOS:000315970300158
J	Ridgers, ND; Timperio, A; Crawford, D; Salmon, J				Ridgers, Nicola D.; Timperio, Anna; Crawford, David; Salmon, Jo			What Factors Are Associated with Adolescents' School Break Time Physical Activity and Sedentary Time?	PLOS ONE			English	Article							CHILDREN; RECESS; LUNCHTIME	Purpose: Adolescents' physical activity levels during school break time are low and understanding correlates of physical activity and sedentary time in this context is important. This study investigated cross-sectional and longitudinal associations between a range of individual, behavioural, social and policy/organisational correlates and objectively measured school break time physical activity and sedentary time. Methods: In 2006, 146 adolescents (50% males; mean age = 14.1 +/- 0.6 years) completed a questionnaire and wore an accelerometer for >= 3 school days. Time spent engaged in sedentary, light (LPA) and moderate-to-vigorous physical activity (MVPA) during school break times (recess and lunchtime) were calculated using existing cut-points. Measures were repeated in 2008 among 111 adolescents. Multilevel models examined cross-sectional and longitudinal associations. Results: Bringing in equipment was cross-sectionally associated with 3.2% more MVPA during break times. Females engaged in 5.1% more sedentary time than males, whilst older adolescents engaged in less MVPA than younger adolescents. Few longitudinal associations were observed. Adolescents who brought sports equipment to school engaged in 7.2% less LPA during break times two years later compared to those who did not bring equipment to school. Conclusion: These data suggest that providing equipment and reducing restrictions on bringing in sports equipment to school may promote physical activity during school recess. Strategies targeting females' and older adolescents', in particular, are warranted.	[Ridgers, Nicola D.; Timperio, Anna; Crawford, David; Salmon, Jo] Deakin Univ, Ctr Phys Act & Nutr Res C PAN, Melbourne, Vic, Australia	Deakin University	Ridgers, ND (corresponding author), Deakin Univ, Ctr Phys Act & Nutr Res C PAN, Melbourne, Vic, Australia.	nicky.ridgers@deakin.edu.au	Salmon, Jo/C-1226-2009; Timperio, Anna F/A-3086-2013; Ridgers, Nicola/AGN-1339-2022; Crawford, David A/K-6301-2015; Salmon, Jo/X-2630-2019; Ridgers, Nicola/B-2092-2013	Salmon, Jo/0000-0002-4734-6354; Timperio, Anna F/0000-0002-8773-5012; Crawford, David A/0000-0002-2467-7556; Salmon, Jo/0000-0002-4734-6354; Ridgers, Nicola/0000-0001-5713-3515	Australian Research Council [DP0664206]; Australian Research Council Discovery Early Career Researcher Award [DE120101173]; Victorian Health Promotion Foundation Public Health Fellowship; National Health and Medical Research Council Principal Research Fellowship [APP1026216]	Australian Research Council(Australian Research Council); Australian Research Council Discovery Early Career Researcher Award(Australian Research Council); Victorian Health Promotion Foundation Public Health Fellowship; National Health and Medical Research Council Principal Research Fellowship(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by funding from the Australian Research Council (HEAPS T2 and T3; ID DP0664206). NDR is supported by an Australian Research Council Discovery Early Career Researcher Award (DE120101173), AT is supported by a Victorian Health Promotion Foundation Public Health Fellowship, and JS is supported by a National Health and Medical Research Council Principal Research Fellowship (APP1026216). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen LB, 2006, LANCET, V368, P299, DOI 10.1016/S0140-6736(06)69075-2; Cardon G, 2008, INT J BEHAV NUTR PHY, V5, DOI 10.1186/1479-5868-5-11; Cole TJ, 2000, BMJ-BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240; Crawford D, 2010, INT J OBESITY, V34, P1177, DOI 10.1038/ijo.2010.57; Department of Health, 2004, LEAST 5 WEEK EV IMP; Department of Health and Ageing, 2005, AUSTR PHYS ACT REC C; Department of Health Western Australia & Edith Cowan University, 2015, REFRSH ED FOOD NUTR; Freedson P, 2005, MED SCI SPORT EXER, V37, pS523, DOI 10.1249/01.mss.0000185658.28284.ba; Haug E, 2008, INT J BEHAV NUTR PHY, V5, DOI 10.1186/1479-5868-5-47; Haug E, 2010, HEALTH EDUC RES, V25, P248, DOI 10.1093/her/cyn050; Haug E, 2010, HEALTH PROMOT INT, V25, P63, DOI 10.1093/heapro/dap040; Hohepa M, 2006, J ADOLESCENT HEALTH, V39, P328, DOI 10.1016/j.jadohealth.2005.12.024; Hohepa M, 2007, INT J BEHAV NUTR PHY, V4, DOI 10.1186/1479-5868-4-54; Hohepa M, 2009, J SCI MED SPORT, V12, P284, DOI 10.1016/j.jsams.2007.11.005; Kimm SYS, 2000, MED SCI SPORT EXER, V32, P1445, DOI 10.1097/00005768-200008000-00013; Kirby J, 2011, J PHYS ACT HEALTH, V8, P785, DOI 10.1123/jpah.8.6.785; Kriemler S, 2011, BRIT J SPORT MED, V45, P923, DOI 10.1136/bjsports-2011-090186; Leggett C, 2012, INT J PUBLIC HEALTH, V57, P315, DOI 10.1007/s00038-011-0306-0; Martinez-Gomez D, 2010, PEDIATR EXERC SCI, V22, P218, DOI 10.1123/pes.22.2.218; Mo Frank, 2005, Int J Adolesc Med Health, V17, P49; Mulhall P, 2011, J PHYS ACT HEALTH, V8, P244, DOI 10.1123/jpah.8.2.244; Ommundsen Y, 2006, INT J BEHAV NUTR PHY, V3, DOI 10.1186/1479-5868-3-32; Plewis I, 2003, BRIT J EDUC STUD, V51, P408, DOI 10.1046/j.1467-8527.2003.00246.x; Ridgers ND, 2010, INT J BEHAV NUTR PHY, V7, DOI 10.1186/1479-5868-7-74; Ridgers ND, 2012, AM J PREV MED, V43, P320, DOI 10.1016/j.amepre.2012.05.019; Ridgers ND, 2012, BRIT J SPORT MED, V46, P741, DOI 10.1136/bjsm.2011.084921; Ridgers ND, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-15; Ridgers ND, 2011, HEALTH EDUC RES, V26, P586, DOI 10.1093/her/cyr014; Rothon C, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-32; Sallis JF, 2000, MED SCI SPORT EXER, V32, P963, DOI 10.1097/00005768-200009000-00012; Sallis JF, 2002, HLTH BEHAV HLTH ED T, V3, P462; Stanley RM, 2012, J SCI MED SPORT, V15, P44, DOI 10.1016/j.jsams.2011.08.002; Tabachnick B.G., 2013, USING MULTIVARIATE S, V6th ed; Timperio A, 2012, J SCI MED SPORT, V15, P122, DOI 10.1016/j.jsams.2011.07.010; Trost SG, 2011, MED SCI SPORT EXER, V43, P1360, DOI 10.1249/MSS.0b013e318206476e; U.S. Department of Health and Human Services, 2008, PHYS ACT GUID AM, P15; Van der Horst K, 2007, MED SCI SPORT EXER, V39, P1241, DOI 10.1249/mss.0b013e318059bf35; Wilson DK, 2005, J PEDIATR PSYCHOL, V30, P293, DOI 10.1093/jpepsy/jsi039	38	30	31	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e56838	10.1371/journal.pone.0056838	http://dx.doi.org/10.1371/journal.pone.0056838			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	104DM	23418606	Green Published, Green Submitted, gold			2022-12-25	WOS:000315970300200
J	Hjelholt, A; Carlsen, T; Deleuran, B; Jurik, AG; Schiottz-Christensen, B; Christiansen, G; Birkelund, S				Hjelholt, Astrid; Carlsen, Thomas; Deleuran, Bent; Jurik, Anne Grethe; Schiottz-Christensen, Berit; Christiansen, Gunna; Birkelund, Svend			Increased Levels of IgG Antibodies against Human HSP60 in Patients with Spondyloarthritis	PLOS ONE			English	Article							HEAT-SHOCK PROTEINS; ANKYLOSING-SPONDYLITIS PATIENTS; HEAT-SHOCK-PROTEIN-60 HSP60; RHEUMATOID-ARTHRITIS; REACTIVE ARTHRITIS; 60 KDA; HLA-B27; CELLS; SERA; SUBCLASSES	Spondyloarthritis (SpA) comprises a heterogeneous group of inflammatory diseases, with strong association to human leukocyte antigen (HLA)-B27. A triggering bacterial infection has been considered as the cause of SpA, and bacterial heat shock protein (HSP) seems to be a strong T cell antigen. Since bacterial and human HSP60, also named HSPD1, are highly homologous, cross-reactivity has been suggested in disease initiation. In this study, levels of antibodies against bacterial and human HSP60 were analysed in SpA patients and healthy controls, and the association between such antibodies and disease severity in relation to HLA-B27 was evaluated. Serum samples from 82 patients and 50 controls were analysed by enzyme-linked immunosorbent assay (ELISA) for immunoglobulin (Ig)G1, IgG2, IgG3 and IgG4 antibodies against human HSP60 and HSP60 from Chlamydia trachomatis, Salmonella enteritidis and Campylobacter jejuni. Disease severity was assessed by the clinical scorings Bath Ankylosing Spondylitis Disease Activity Index (BASDAI), Bath Ankylosing Spondylitis Functional Index (BASFI) and Bath Ankylosing Spondylitis Metrology Index (BASMI). Levels of IgG1 and IgG3 antibodies against human HSP60, but not antibodies against bacterial HSP60, were elevated in the SpA group compared with the control group. Association between IgG3 antibodies against human HSP60 and BASMI was shown in HLA-B27(+) patients. Only weak correlation between antibodies against bacterial and human HSP60 was seen, and there was no indication of cross-reaction. These results suggest that antibodies against human HSP60 is associated with SpA, however, the theory that antibodies against human HSP60 is a specific part of the aetiology, through cross-reaction to bacterial HSP60, cannot be supported by results from this study. We suggest that the association between elevated levels of antibodies against human HSP60 and disease may reflect a general activation of the immune system and an increased expression of human HSP60 in the synovium of patients with SpA.	[Hjelholt, Astrid; Deleuran, Bent; Christiansen, Gunna] Aarhus Univ, Dept Biomed Med Microbiol & Immunol, Aarhus, Denmark; [Carlsen, Thomas; Birkelund, Svend] Aarhus Univ, Dept Hlth Sci & Technol, Aarhus, Denmark; [Deleuran, Bent] Aarhus Univ Hosp, Dept Rheumatol, DK-8000 Aarhus, Denmark; [Jurik, Anne Grethe] Aarhus Univ Hosp, Dept Radiol, DK-8000 Aarhus, Denmark; [Schiottz-Christensen, Berit] Aarhus Clin Rheumat Dis, Aarhus, Denmark; [Christiansen, Gunna; Birkelund, Svend] Loke Diagnost, Risskov, Denmark	Aarhus University; Aarhus University; Aarhus University; Aarhus University	Hjelholt, A (corresponding author), Aarhus Univ, Dept Biomed Med Microbiol & Immunol, Aarhus, Denmark.	astrid.hjelholt@studmed.au.dk		Hjelholt, Astrid Johannesson/0000-0002-3114-4176; Schiottz-Christensen, Berit/0000-0003-3866-856X; Jurik, Anne Grethe/0000-0003-2571-0466; Deleuran, Bent/0000-0002-7079-1587; Birkelund, Svend/0000-0001-6171-5606; Christiansen, Gunna/0000-0003-0540-1367	EuroPathoGenomics -'EPG' [LSHB-CT-2005-512061]; Lundbeck Foundation [R19-A2023]; Danish Rheumatism Association [R80-A1287]; Institute of Clinical Medicine Aarhus University; Jens Aage Sorensens and wife Edit Sorensens Foundation	EuroPathoGenomics -'EPG'; Lundbeck Foundation(Lundbeckfonden); Danish Rheumatism Association; Institute of Clinical Medicine Aarhus University; Jens Aage Sorensens and wife Edit Sorensens Foundation	The study was supported by the EuroPathoGenomics -'EPG' (contract no. LSHB-CT-2005-512061), The Lundbeck Foundation (contract no. R19-A2023), Danish Rheumatism Association (contract no. R80-A1287), The Institute of Clinical Medicine Aarhus University and Jens Aage Sorensens and wife Edit Sorensens Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADLERSBERG JB, 1975, P NATL ACAD SCI USA, V72, P723, DOI 10.1073/pnas.72.2.723; Avery DT, 2008, J IMMUNOL, V181, P1767, DOI 10.4049/jimmunol.181.3.1767; Barr A, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3178; Bax CJ, 2004, SEX TRANSM INFECT, V80, P415, DOI 10.1136/sti.2004.009167; BENJAMIN R, 1990, IMMUNOL TODAY, V11, P137, DOI 10.1016/0167-5699(90)90051-A; Bowness P, 2002, RHEUMATOLOGY, V41, P857, DOI 10.1093/rheumatology/41.8.857; Braun J, 2007, LANCET, V369, P1379, DOI 10.1016/S0140-6736(07)60635-7; CAMBRIDGE G, 1994, ANN RHEUM DIS, V53, P24, DOI 10.1136/ard.53.1.24; Cancino-Diaz JC, 2004, BRIT J OPHTHALMOL, V88, P247, DOI 10.1136/bjo.2003.023390; De Maio A, 2011, CELL STRESS CHAPERON, V16, P235, DOI 10.1007/s12192-010-0236-4; Dominguez-Lopez ML, 2009, CLIN EXP RHEUMATOL, V27, P626; Dominguez-Lopez ML, 2002, SCAND J RHEUMATOL, V31, P260, DOI 10.1080/030097402760375133; DOUGADOS M, 1991, ARTHRITIS RHEUM, V34, P1218, DOI 10.1002/art.1780341003; Drasbek M, 2004, BMC MICROBIOL, V4, DOI 10.1186/1471-2180-4-7; FitzGerald O, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2580; Garraud O, 2012, BMC IMMUNOL, V13, DOI 10.1186/1471-2172-13-63; Gaston JSH, 1998, BIOTHERAPY, V10, P197, DOI 10.1007/BF02678297; Handley HH, 1996, CLIN EXP IMMUNOL, V103, P429; Hjelholt A, 2011, HUM REPROD, V26, P2069, DOI 10.1093/humrep/der167; Huang MN, 2010, SEMIN ARTHRITIS RHEU, V40, P164, DOI 10.1016/j.semarthrit.2009.10.002; Huhtinen M, 2001, INVEST OPHTH VIS SCI, V42, P1816; Kampinga HH, 2009, CELL STRESS CHAPERON, V14, P105, DOI 10.1007/s12192-008-0068-7; Liu YD, 2011, INT J NEUROSCI, V121, P570, DOI 10.3109/00207454.2011.596293; Locht H, 2002, J RHEUMATOL, V29, P767; Manolova I, 2002, RHEUMATOL INT, V21, P227, DOI 10.1007/s00296-002-0174-2; McMichael A, 2002, ARTHRITIS RES THER, V4, pS153, DOI 10.1186/ar571; Merendino AM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009247; MORELL A, 1972, J IMMUNOL, V108, P195; MORELL A, 1970, J CLIN INVEST, V49, P673, DOI 10.1172/JCI106279; NEEDLEMAN SB, 1970, J MOL BIOL, V48, P443, DOI 10.1016/0022-2836(70)90057-4; Pfister G, 2005, J CELL SCI, V118, P1587, DOI 10.1242/jcs.02292; Pockley AG, 1999, CELL STRESS CHAPERON, V4, P29, DOI 10.1054/csac.1998.0121; Rashid T, 2011, DISCOV MED, V12, P187; Raska Milan, 2005, Biomedical Papers (Olomouc), V149, P243; Schett G, 2001, ARTHRITIS RES, V3, P80, DOI 10.1186/ar144; SCHMITT J, 1993, MOL BIOL REP, V18, P223, DOI 10.1007/BF01674434; Schroeder HW, 2010, J ALLERGY CLIN IMMUN, V125, pS41, DOI 10.1016/j.jaci.2009.09.046; SHARIF M, 1992, ARTHRITIS RHEUM, V35, P1427, DOI 10.1002/art.1780351205; Sieper J, 2000, ARTHRITIS RHEUM, V43, P720, DOI 10.1002/1529-0131(200004)43:4<720::AID-ANR2>3.0.CO;2-8; Spiegelberg H L, 1974, Adv Immunol, V19, P259, DOI 10.1016/S0065-2776(08)60254-0; STEVENS TL, 1988, NATURE, V334, P255, DOI 10.1038/334255a0; TAUROG JD, 1994, J EXP MED, V180, P2359, DOI 10.1084/jem.180.6.2359; Thiel A, 2000, ARTHRITIS RHEUM-US, V43, P2834, DOI 10.1002/1529-0131(200012)43:12<2834::AID-ANR25>3.0.CO;2-7; Townes JM, 2010, CLIN INFECT DIS, V50, P247, DOI 10.1086/649540; Wegener HC, 2003, EMERG INFECT DIS, V9, P774; Zeidler H, 2004, CURR OPIN RHEUMATOL, V16, P380, DOI 10.1097/01.bor.0000126150.04251.f9; Zugel U, 1999, CLIN MICROBIOL REV, V12, P19, DOI 10.1128/CMR.12.1.19	47	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2013	8	2							e56210	10.1371/journal.pone.0056210	http://dx.doi.org/10.1371/journal.pone.0056210			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104BU	23424650	Green Published, Green Submitted, gold			2022-12-25	WOS:000315965100038
J	Yamakawa, K; Matsumoto, N; Imamura, Y; Muroya, T; Yamada, T; Nakagawa, J; Shimazaki, J; Ogura, H; Kuwagata, Y; Shimazu, T				Yamakawa, Kazuma; Matsumoto, Naoya; Imamura, Yukio; Muroya, Takashi; Yamada, Tomoki; Nakagawa, Junichiro; Shimazaki, Junya; Ogura, Hiroshi; Kuwagata, Yasuyuki; Shimazu, Takeshi			Electrical Vagus Nerve Stimulation Attenuates Systemic Inflammation and Improves Survival in a Rat Heatstroke Model	PLOS ONE			English	Article							CHOLINERGIC ANTIINFLAMMATORY PATHWAY; TUMOR-NECROSIS-FACTOR; KAPPA-B ACTIVATION; HEAT-STRESS; RELEASE; INJURY; SHOCK; RESUSCITATION; ACETYLCHOLINE; ENDOTOXEMIA	This study was performed to gain insights into novel therapeutic approaches for the treatment of heatstroke. The central nervous system regulates peripheral immune responses via the vagus nerve, the primary neural component of the cholinergic anti-inflammatory pathway. Electrical vagus nerve stimulation (VNS) reportedly suppresses pro-inflammatory cytokine release in several models of inflammatory disease. Here, we evaluated whether electrical VNS attenuates severe heatstroke, which induces a systemic inflammatory response. Anesthetized rats were subjected to heat stress (41.5 degrees C for 30 minutes) with/without electrical VNS. In the VNS-treated group, the cervical vagus nerve was stimulated with constant voltage (10 V, 2 ms, 5 Hz) for 20 minutes immediately after completion of heat stress. Sham-operated animals underwent the same procedure without stimulation under a normothermic condition. Seven-day mortality improved significantly in the VNS-treated group versus control group. Electrical VNS significantly suppressed induction of pro-inflammatory cytokines such as tumor necrosis factor-alpha and interleukin-6 in the serum 6 hours after heat stress. Simultaneously, the increase of soluble thrombomodulin and E-selectin following heat stress was also suppressed by VNS treatment, suggesting its protective effect on endothelium. Immunohistochemical analysis using tissue preparations obtained 6 hours after heat stress revealed that VNS treatment attenuated infiltration of inflammatory (CD11b-positive) cells in lung and spleen. Interestingly, most cells with increased CD11b positivity in response to heat stress did not express alpha 7 nicotinic acetylcholine receptor in the spleen. These data indicate that electrical VNS modulated cholinergic anti-inflammatory pathway abnormalities induced by heat stress, and this protective effect was associated with improved mortality. These findings may provide a novel therapeutic strategy to combat severe heatstroke in the critical care setting.	[Yamakawa, Kazuma; Matsumoto, Naoya; Muroya, Takashi; Yamada, Tomoki; Nakagawa, Junichiro; Shimazaki, Junya; Ogura, Hiroshi; Kuwagata, Yasuyuki; Shimazu, Takeshi] Osaka Univ, Grad Sch Med, Dept Traumatol & Acute Crit Med, Osaka, Japan; [Imamura, Yukio] Kyoto Univ, Grad Sch Med, Unit Liveable Cities, Kyoto, Japan	Osaka University; Kyoto University	Yamakawa, K (corresponding author), Osaka Univ, Grad Sch Med, Dept Traumatol & Acute Crit Med, Osaka, Japan.	k.yamakawa0911@gmail.com	Yamakawa, Kazuma/AAD-3436-2022	Yamakawa, Kazuma/0000-0003-2999-4021	Ministry of Education, Culture, Sports, Science, and Technology in Japan [24791938]; Grants-in-Aid for Scientific Research [24592734, 24791938] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology in Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by a Grant-in-aid for scientific research from the Ministry of Education, Culture, Sports, Science, and Technology in Japan (No. 24791938). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altavilla D, 2006, SHOCK, V25, P500, DOI 10.1097/01.shk.0000209539.91553.82; Bansal V, 2010, J TRAUMA, V68, P1059, DOI 10.1097/TA.0b013e3181d87373; Bernik TR, 2002, J VASC SURG, V36, P1231, DOI 10.1067/mva.2002.129643; Bernik TR, 2002, J EXP MED, V195, P781, DOI 10.1084/jem.20011714; Borovikova LV, 2000, NATURE, V405, P458, DOI 10.1038/35013070; BOUCHAMA A, 1991, J APPL PHYSIOL, V70, P2640, DOI 10.1152/jappl.1991.70.6.2640; Bouchama A, 2002, NEW ENGL J MED, V346, P1978, DOI 10.1056/NEJMra011089; BOUCHAMA A, 1995, INTENS CARE MED, V21, P623, DOI 10.1007/BF01711537; Bouchama A, 2008, ARTERIOSCL THROM VAS, V28, P1318, DOI 10.1161/ATVBAHA.107.161737; Cai BL, 2009, J CELL MOL MED, V13, P3774, DOI 10.1111/j.1582-4934.2008.00550.x; Chang CK, 2006, CURR MED CHEM, V13, P3145, DOI 10.2174/092986706778742945; Chen CC, 2009, AM J MED SCI, V338, P382, DOI 10.1097/MAJ.0b013e3181b272ae; Guarini S, 2003, CIRCULATION, V107, P1189, DOI 10.1161/01.CIR.0000050627.90734.ED; Hagiwara S, 2011, J SURG RES, V171, P762, DOI 10.1016/j.jss.2010.05.008; Hagiwara S, 2010, INFLAMM RES, V59, P511, DOI 10.1007/s00011-009-0155-y; Hagiwara S, 2010, SHOCK, V33, P282, DOI 10.1097/SHK.0b013e3181b0ef7b; Hsiao SH, 2007, RESUSCITATION, V73, P437, DOI 10.1016/j.resuscitation.2006.11.003; Huang H, 2009, VET IMMUNOL IMMUNOP, V132, P116, DOI 10.1016/j.vetimm.2009.05.003; Huston JM, 2006, J EXP MED, V203, P1623, DOI 10.1084/jem.20052362; Kondo Masahide, 2011, Environ Health Prev Med, V16, P279, DOI 10.1007/s12199-011-0228-8; Leon LR, 2010, J APPL PHYSIOL, V109, P1980, DOI 10.1152/japplphysiol.00301.2010; Niederbichler AD, 2009, BURNS, V35, P783, DOI 10.1016/j.burns.2008.08.023; Nybo L, 2007, PROG BRAIN RES, V162, P29, DOI 10.1016/S0079-6123(06)62003-7; Pohanka M, 2011, CURR MED CHEM, V18, P539, DOI 10.2174/092986711794480140; Roberts GT, 2008, ARTERIOSCL THROM VAS, V28, P1130, DOI 10.1161/ATVBAHA.107.158709; Saeed RW, 2005, J EXP MED, V201, P1113, DOI 10.1084/jem.20040463; Sharma HS, 2005, INDIAN J MED RES, V121, P621; Shen KH, 2008, SHOCK, V30, P668, DOI 10.1097/SHK.0b013e31817538cb; Song XM, 2010, BURNS, V36, P75, DOI 10.1016/j.burns.2009.02.002; Swirski FK, 2009, SCIENCE, V325, P612, DOI 10.1126/science.1175202; Tracey KJ, 2002, NATURE, V420, P853, DOI 10.1038/nature01321; van Westerloo DJ, 2005, J INFECT DIS, V191, P2138, DOI 10.1086/430323; Wang H, 2004, NAT MED, V10, P1216, DOI 10.1038/nm1124; Wang H, 2003, NATURE, V421, P384, DOI 10.1038/nature01339; Wessler I, 2008, BRIT J PHARMACOL, V154, P1558, DOI 10.1038/bjp.2008.185	35	26	36	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2013	8	2							e56728	10.1371/journal.pone.0056728	http://dx.doi.org/10.1371/journal.pone.0056728			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104BU	23424673	Green Submitted, Green Published, gold			2022-12-25	WOS:000315965100061
J	Yang, Z; Xu, BH; Lu, JL; Tian, XG; Li, MA; Sun, K; Huang, F; Liu, Y; Xu, M; Bi, YF; Wang, WQ				Yang, Zhi; Xu, Baihui; Lu, Jieli; Tian, Xiaoguang; Li, Mian; Sun, Kan; Huang, Fei; Liu, Yu; Xu, Min; Bi, Yufang; Wang, Weiqing			Autonomic Test by EZSCAN in the Screening for Prediabetes and Diabetes	PLOS ONE			English	Article							NEUROPATHY; PREVALENCE; ACCURACY; SKIN	Background: Autonomic neuropathy is common in diabetics and may occur in prediabetes. A new and noninvasive autonomic test-EZSCAN evaluates sudomotor function precisely. No generally accepted EZSCAN thresholds to screen for prediabetes and diabetes have been defined. Methodology and Principal Findings: Cross-sectional study of 5, 824 Chinese adults aged 40 and older was conducted in Shanghai, China. We used EZSCAN to evaluate autonomic function in different glucose status and screen for prediabetes and diabetes. The prevalence of prediabetes and diabetes were 21.9% and 17.5% respectively. Compared with the lowest quintile, the highest quintile of EZSCAN value had odds ratios for having dysglycemia (prediabetes or diabetes) of 2.08 (95% CI 1.67-2.58) in total population, 2.89 (95% CI 2.06-4.05) in men and 1.70 (95% CI 1.28-2.25) in women after adjustment for confounding factors. EZSCAN value improved the areas under ROC curve for detection of dysglycemia or diabetes beyond the contribution of conventional risk factors by 0.8% and 12.9%. The cut-off point of EZSCAN value higher than 30% provided reasonable sensitivities (70.3-83.7%) to detect dysglycemia not only in total population regardless of sex but also in individuals with high risk of developing diabetes. Conclusions and Significance: EZSCAN value higher than 30% indicate an increased risk of prevalent prediabetes and diabetes, suggesting that subjects with EZSCAN >= 30% should be further evaluated by oral glucose tolerance test. The improvement of EZSCAN for diabetes detection was still of limited clinical relevance. Thus the clinical application value of EZSCAN is needed to be explored in future studies.	[Yang, Zhi; Xu, Baihui; Lu, Jieli; Tian, Xiaoguang; Li, Mian; Sun, Kan; Huang, Fei; Liu, Yu; Xu, Min; Bi, Yufang; Wang, Weiqing] E Inst Shanghai Univ, Shanghai Jiao Tong Univ, Sch Med, Rui Jin Hosp,Minist Hlth,Key Lab Endocrine & Meta, Shanghai, Peoples R China; [Yang, Zhi; Xu, Baihui; Lu, Jieli; Tian, Xiaoguang; Li, Mian; Sun, Kan; Huang, Fei; Liu, Yu; Xu, Min; Bi, Yufang; Wang, Weiqing] Shanghai Jiao Tong Univ, Rui Jin Hosp, Dept Endocrinol & Metab,Shanghai Inst Endocrine &, Shanghai Clin Ctr Endocrine & Metab Dis,Sch Med, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University	Wang, WQ (corresponding author), E Inst Shanghai Univ, Shanghai Jiao Tong Univ, Sch Med, Rui Jin Hosp,Minist Hlth,Key Lab Endocrine & Meta, Shanghai, Peoples R China.	wqingw@hotmail.com			Key Laboratory for Endocrine and Metabolic Diseases of Ministry of Health [1994DP131044]; National Natural Science Foundation of China [81222008, 81100564, 30911120493, 81170739, 81130016]; Shanghai Natural Science Foundation [10ZR1426400]; Shanghai Committee of Science and Technology [10X1403000]	Key Laboratory for Endocrine and Metabolic Diseases of Ministry of Health; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Natural Science Foundation(Natural Science Foundation of Shanghai); Shanghai Committee of Science and Technology(Shanghai Science & Technology Committee)	This study was supported by the grants from the Key Laboratory for Endocrine and Metabolic Diseases of Ministry of Health (1994DP131044), the National Natural Science Foundation of China (numbers 81222008, 81100564, 30911120493, 81170739 and 81130016), the Shanghai Natural Science Foundation (number 10ZR1426400) and Shanghai Committee of Science and Technology (10X1403000). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, DIABETES CARE, V35, pS11, DOI [10.2337/dc35-S011, 10.2337/dc12-s004, 10.2337/dc12-s011]; Bossuyt PM, 2003, CROAT MED J, V44, P639; Brunswick P, 2007, P ANN INT IEEE EMBS, P4544, DOI 10.1109/IEMBS.2007.4353350; Calvet J. H., 2011, BR J DIABETES VASC D, V11, P204, DOI DOI 10.1177/1474651411402629; Chizmadzhev YA, 1998, BIOPHYS J, V74, P843, DOI 10.1016/S0006-3495(98)74008-1; Dyck PJ, 2006, DIABETES CARE, V29, P2282, DOI 10.2337/dc06-0525; Edwards JL, 2008, PHARMACOL THERAPEUT, V120, P1, DOI 10.1016/j.pharmthera.2008.05.005; England JD, 2009, NEUROLOGY, V72, P177, DOI 10.1212/01.wnl.0000336345.70511.0f; Gallop RJ, 2003, UNDERSTAND STAT, V2, P219, DOI DOI 10.1207/S15328031US0204_01; Illigens BMW, 2009, CLIN AUTON RES, V19, P79, DOI 10.1007/s10286-008-0506-8; Isak B, 2008, DIABETES-METAB RES, V24, P563, DOI 10.1002/dmrr.859; Licht CMM, 2010, J CLIN ENDOCR METAB, V95, P2458, DOI 10.1210/jc.2009-2801; Mayaudon H, 2010, DIABETES METAB, V36, P450, DOI 10.1016/j.diabet.2010.05.004; Ozaki R, 2011, DIABETES TECHNOL THE, V13, P937, DOI 10.1089/dia.2011.0023; Pacher P, 2002, DIABETES, V51, P514, DOI 10.2337/diabetes.51.2.514; Pencina MJ, 2004, STAT MED, V23, P2109, DOI 10.1002/sim.1802; Pop-Busui R, 2010, DIABETES CARE, V33, P434, DOI 10.2337/dc09-1294; Rajabally YA, 2011, ACTA NEUROL SCAND, V124, P1, DOI 10.1111/j.1600-0404.2010.01425.x; Ramachandran A, 2010, DIABETES RES CLIN PR, V88, P302, DOI 10.1016/j.diabres.2010.01.023; Sheng CS, 2011, DIABETOL METAB SYNDR, V3, DOI 10.1186/1758-5996-3-36; Sumner CJ, 2003, NEUROLOGY, V60, P108, DOI 10.1212/WNL.60.1.108; Sun K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043449; Tesfaye S, 2010, DIABETES CARE, V33, P2285, DOI 10.2337/dc10-1303; Vinik AI, 2011, DIABETIC MED, V28, P643, DOI 10.1111/j.1464-5491.2010.03184.x; Vinik AI, 2003, DIABETES CARE, V26, P1553, DOI 10.2337/diacare.26.5.1553; Watkins LL, 2000, DIABETES CARE, V23, P826, DOI 10.2337/diacare.23.6.826; Whiting DR, 2011, DIABETES RES CLIN PR, V94, P311, DOI 10.1016/j.diabres.2011.10.029; Yang WY, 2010, NEW ENGL J MED, V362, P1090, DOI 10.1056/NEJMoa0908292; Zhou BF, 2002, BIOMED ENVIRON SCI, V15, P83	29	13	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2013	8	2							e56480	10.1371/journal.pone.0056480	http://dx.doi.org/10.1371/journal.pone.0056480			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104BU	23424665	Green Published, Green Submitted, gold			2022-12-25	WOS:000315965100053
J	Dolga, AM; Netter, MF; Perocchi, F; Doti, N; Meissner, L; Tobaben, S; Grohm, J; Zischka, H; Plesnila, N; Decher, N; Culmsee, C				Dolga, Amalia M.; Netter, Michael F.; Perocchi, Fabiana; Doti, Nunzianna; Meissner, Lilja; Tobaben, Svenja; Grohm, Julia; Zischka, Hans; Plesnila, Nikolaus; Decher, Niels; Culmsee, Carsten			Mitochondrial Small Conductance SK2 Channels Prevent Glutamate-induced Oxytosis and Mitochondrial Dysfunction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CA2+-ACTIVATED K+ CHANNELS; POTASSIUM CHANNELS; ATP CHANNEL; PROVIDES NEUROPROTECTION; THERAPEUTIC TARGETS; MOUSE MODEL; CELL-DEATH; MODULATION; FORM; AIF	Small conductance calcium-activated potassium (SK2/K(Ca)2.2) channels are known to be located in the neuronal plasma membrane where they provide feedback control of NMDA receptor activity. Here, we provide evidence that SK2 channels are also located in the inner mitochondrial membrane of neuronal mitochondria. Patch clamp recordings in isolated mitoplasts suggest insertion into the inner mitochondrial membrane with the C and N termini facing the intermembrane space. Activation of SK channels increased mitochondrial K+ currents, whereas channel inhibition attenuated these currents. In a model of glutamate toxicity, activation of SK2 channels attenuated the loss of the mitochondrial transmembrane potential, blocked mitochondrial fission, prevented the release of proapoptotic mitochondrial proteins, and reduced cell death. Neuroprotection was blocked by specific SK2 inhibitory peptides and siRNA targeting SK2 channels. Activation of mitochondrial SK2 channels may therefore represent promising targets for neuroprotective strategies in conditions of mitochondrial dysfunction.	[Dolga, Amalia M.; Doti, Nunzianna; Tobaben, Svenja; Grohm, Julia; Culmsee, Carsten] Univ Marburg, Inst Pharmakol & Klin Pharm, Fachbereich Pharm, D-35032 Marburg, Germany; [Netter, Michael F.; Decher, Niels] Univ Marburg, Inst Physiol & Pathophysiol, Fachbereich Med, D-35037 Marburg, Germany; [Perocchi, Fabiana] Harvard Univ, Sch Med, Dept Syst Biol & Med, Boston, MA 02114 USA; [Perocchi, Fabiana] Massachusetts Gen Hosp, Boston, MA 02114 USA; [Perocchi, Fabiana] Univ Munich, Gene Ctr, D-81377 Munich, Germany; [Doti, Nunzianna; Plesnila, Nikolaus] Royal Coll Surgeons Ireland, Dept Neurodegenerat, Dublin 2, Ireland; [Doti, Nunzianna] CNR, Inst Biostruct & Bioimaging, I-1680131 Naples, Italy; [Meissner, Lilja; Plesnila, Nikolaus] Univ Munich, Sch Med, Inst Stroke & Dementia Res, D-81377 Munich, Germany; [Zischka, Hans] German Res Ctr Environm Hlth GmbH, Helmholtz Zentrum Munchen, Inst Toxicol, D-85764 Neuherberg, Germany	Philipps University Marburg; Philipps University Marburg; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; University of Munich; Royal College of Surgeons - Ireland; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biostrutture e Bioimmagini (IBB-CNR); University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health	Dolga, AM (corresponding author), Univ Marburg, Inst Pharmakol & Klin Pharm, Fachbereich Pharm, Karl von Frisch Str 1, D-35032 Marburg, Germany.	dolga@staff.uni-marburg.de; culmsee@staff.uni-marburg.de	Culmsee, Carsten/ABC-3120-2021; Zischka, Hans/M-1490-2017; Decher, Niels/AAF-5002-2020; Plesnila, Nikolaus/T-7522-2019; Dolga, Amalia/C-9664-2018; Doti, Nunzianna/ABC-9948-2020	Culmsee, Carsten/0000-0002-5121-5015; Zischka, Hans/0000-0002-4047-1566; Dolga, Amalia/0000-0001-5400-5614; perocchi, fabiana/0000-0002-1102-6500	Alzheimer Forschung Initiative e.V	Alzheimer Forschung Initiative e.V	This work was supported in part by a grant from Alzheimer Forschung Initiative e.V.	Adelman JP, 2012, ANNU REV PHYSIOL, V74, P245, DOI 10.1146/annurev-physiol-020911-153336; Albrecht P, 2010, CNS NEUROL DISORD-DR, V9, P373, DOI 10.2174/187152710791292567; Allen D, 2011, J CEREBR BLOOD F MET, V31, P2302, DOI 10.1038/jcbfm.2011.90; Alvina K, 2010, J NEUROSCI, V30, P7249, DOI 10.1523/JNEUROSCI.6341-09.2010; Baughman JM, 2011, NATURE, V476, P341, DOI 10.1038/nature10234; Bednarczyk P, 2009, ACTA BIOCHIM POL, V56, P385; Bishop MW, 2010, J NEUROPHYSIOL, V104, P3009, DOI 10.1152/jn.00466.2010; Blank T, 2003, NAT NEUROSCI, V6, P911, DOI 10.1038/nn1101; Cheng Y, 2010, FEBS LETT, V584, P2005, DOI 10.1016/j.febslet.2009.12.038; Culmsee C, 2005, J NEUROSCI, V25, P10262, DOI 10.1523/JNEUROSCI.2818-05.2005; Diemert S, 2012, J NEUROSCI METH, V203, P69, DOI 10.1016/j.jneumeth.2011.09.012; Dolga AM, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.30; Dolga AM, 2008, J NEUROCHEM, V107, P1158, DOI 10.1111/j.1471-4159.2008.05701.x; Dolga AM, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00196; Dolga AM, 2012, GLIA, V60, P2050, DOI 10.1002/glia.22419; Eliseev RA, 2003, BBA-BIOENERGETICS, V1604, P1, DOI 10.1016/S0005-2728(03)00005-7; Emanuelsson O, 2000, J MOL BIOL, V300, P1005, DOI 10.1006/jmbi.2000.3903; Faber ESL, 2005, NAT NEUROSCI, V8, P635, DOI 10.1038/nn1450; GARCIA ML, 1991, J BIOENERG BIOMEMBR, V23, P615, DOI 10.1007/BF00785814; Grohm J, 2012, CELL DEATH DIFFER, V19, P1446, DOI 10.1038/cdd.2012.18; Hirschberg B, 1998, J GEN PHYSIOL, V111, P565, DOI 10.1085/jgp.111.4.565; HOCHMAN J, 1985, BIOCHEMISTRY-US, V24, P2509, DOI 10.1021/bi00331a017; Hougaard C, 2007, BRIT J PHARMACOL, V151, P655, DOI 10.1038/sj.bjp.0707281; Ishii TM, 1997, J BIOL CHEM, V272, P23195, DOI 10.1074/jbc.272.37.23195; Jaburek M, 1998, J BIOL CHEM, V273, P13578; Jentsch TJ, 2000, NAT REV NEUROSCI, V1, P21, DOI 10.1038/35036198; Kasumu AW, 2012, CHEM BIOL, V19, P1340, DOI 10.1016/j.chembiol.2012.07.013; Kirichok Y, 2004, NATURE, V427, P360, DOI 10.1038/nature02246; Landshamer S, 2008, CELL DEATH DIFFER, V15, P1553, DOI 10.1038/cdd.2008.78; Liu D, 2010, J ALZHEIMERS DIS, V22, P443, DOI 10.3233/JAD-2010-101017; Maher P, 1996, J NEUROSCI, V16, P6394; Malinska D, 2010, FEBS LETT, V584, P2043, DOI 10.1016/j.febslet.2010.01.013; Marchi Saverio, 2012, J Signal Transduct, V2012, P329635, DOI 10.1155/2012/329635; Mootha VK, 2003, P NATL ACAD SCI USA, V100, P605, DOI 10.1073/pnas.242716699; Ngo-Anh TJ, 2005, NAT NEUROSCI, V8, P642, DOI 10.1038/nn1449; Oxler EM, 2012, APOPTOSIS, V17, P1027, DOI 10.1007/s10495-012-0748-8; Peixoto PM, 2010, FEBS LETT, V584, P2142, DOI 10.1016/j.febslet.2010.02.046; Poulopoulou C, 2010, NEUROBIOL DIS, V37, P339, DOI 10.1016/j.nbd.2009.10.012; Sailer CA, 2004, MOL CELL NEUROSCI, V26, P458, DOI 10.1016/j.mcn.2004.03.002; Soh H, 2001, BIOPHYS J, V80, P2207, DOI 10.1016/S0006-3495(01)76193-0; SORGATO MC, 1987, NATURE, V330, P498, DOI 10.1038/330498a0; Stocker M, 2004, NAT REV NEUROSCI, V5, P758, DOI 10.1038/nrn1516; Strobaek D, 2006, MOL PHARMACOL, V70, P1771, DOI 10.1124/mol.106.027110; Szabo I, 2005, J BIOL CHEM, V280, P12790, DOI 10.1074/jbc.M413548200; Szabo I, 2010, FEBS LETT, V584, P2049, DOI 10.1016/j.febslet.2010.01.038; Szewczyk A, 2010, FEBS LETT, V584, P2063, DOI 10.1016/j.febslet.2010.02.048; Tobaben S, 2011, CELL DEATH DIFFER, V18, P282, DOI 10.1038/cdd.2010.92; Tuteja D, 2010, CIRC RES, V107, P851, DOI 10.1161/CIRCRESAHA.109.215269; Walter JT, 2006, NAT NEUROSCI, V9, P389, DOI 10.1038/nn1648; Wang Y, 2008, MED HYPOTHESES, V71, P546, DOI 10.1016/j.mehy.2008.05.021; YarovYarovoy V, 1997, BBA-BIOENERGETICS, V1321, P128, DOI 10.1016/S0005-2728(97)00051-0	51	67	68	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 12	2013	288	15					10792	10804		10.1074/jbc.M113.453522	http://dx.doi.org/10.1074/jbc.M113.453522			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	125TU	23430260	Green Published, hybrid			2022-12-25	WOS:000317565000057
J	Ekberg, K; Wielandt, AG; Buch-Pedersen, MJ; Palmgren, MG				Ekberg, Kira; Wielandt, Alex G.; Buch-Pedersen, Morten J.; Palmgren, Michael G.			A Conserved Asparagine in a P-type Proton Pump Is Required for Efficient Gating of Protons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEMBRANE H+-ATPASE; PLANT PLASMA-MEMBRANE; CYTOCHROME-C-OXIDASE; ESCHERICHIA-COLI; CRYSTAL-STRUCTURE; D-PATHWAY; PARACOCCUS-DENITRIFICANS; MOLECULAR-MECHANISMS; H+/ATP STOICHIOMETRY; ENERGY TRANSDUCTION	The minimal proton pumping machinery of the Arabidopsis thaliana P-type plasma membrane H+-ATPase isoform 2 (AHA2) consists of an aspartate residue serving as key proton donor/acceptor (Asp-684) and an arginine residue controlling the pK(a) of the aspartate. However, other important aspects of the proton transport mechanism such as gating, and the ability to occlude protons, are still unclear. An asparagine residue (Asn-106) in transmembrane segment 2 of AHA2 is conserved in all P-type plasma membrane H+-ATPases. In the crystal structure of the plant plasma membrane H+-ATPase, this residue is located in the putative ligand entrance pathway, in close proximity to the central proton donor/acceptor Asp-684. Substitution of Asn-106 resulted in mutant enzymes with significantly reduced ability to transport protons against a membrane potential. Sensitivity toward orthovanadate was increased when Asn-106 was substituted with an aspartate residue, but decreased in mutants with alanine, lysine, glutamine, or threonine replacement of Asn-106. The apparent proton affinity was decreased for all mutants, most likely due to a perturbation of the local environment of Asp-684. Altogether, our results demonstrate that Asn-106 is important for closure of the proton entrance pathway prior to proton translocation across the membrane.	[Ekberg, Kira; Wielandt, Alex G.; Buch-Pedersen, Morten J.; Palmgren, Michael G.] Univ Copenhagen, Dept Plant & Environm Sci, Ctr Membrane Pumps Cells & Dis PUMPKIN, Danish Natl Res Fdn, DK-1871 Frederiksberg, Denmark	Danmarks Grundforskningsfond; University of Copenhagen	Palmgren, MG (corresponding author), Univ Copenhagen, Dept Plant & Environm Sci, Thorvaldsensvej 40, DK-1871 Frederiksberg C, Denmark.	palmgren@life.ku.dk	Palmgren, Michael/A-9808-2013	Palmgren, Michael/0000-0002-9982-6114	Danish National Research Foundation through the PUMPKIN Center of Excellence	Danish National Research Foundation through the PUMPKIN Center of Excellence	This work was supported by the Danish National Research Foundation through the PUMPKIN Center of Excellence.	Accardi A, 2004, NATURE, V427, P803, DOI 10.1038/nature02314; Axelsen KB, 1999, BIOCHEMISTRY-US, V38, P7227, DOI 10.1021/bi982482l; Berman MC, 2001, BBA-BIOMEMBRANES, V1513, P95, DOI 10.1016/S0005-2736(01)00356-X; BLATT MR, 1987, J MEMBRANE BIOL, V98, P169, DOI 10.1007/BF01872129; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brandsburg-Zabary S, 2000, BBA-BIOENERGETICS, V1458, P120, DOI 10.1016/S0005-2728(00)00063-3; BRISKIN DP, 1991, PLANT PHYSIOL, V95, P242, DOI 10.1104/pp.95.1.242; BROWN GC, 1992, FASEB J, V6, P2961, DOI 10.1096/fasebj.6.11.1644259; Buch-Pedersen MJ, 2009, PFLUG ARCH EUR J PHY, V457, P573, DOI 10.1007/s00424-008-0503-8; Buch-Pedersen MJ, 2003, J BIOL CHEM, V278, P17845, DOI 10.1074/jbc.M212729200; Buch-Pedersen MJ, 2000, J BIOL CHEM, V275, P39167, DOI 10.1074/jbc.M007537200; Buch-Pedersen MJ, 2006, J BIOL CHEM, V281, P38285, DOI 10.1074/jbc.M604781200; CAIN BD, 1989, J BIOL CHEM, V264, P3292; CID A, 1987, CURR GENET, V12, P105, DOI 10.1007/BF00434664; Decoursey TE, 2003, PHYSIOL REV, V83, P475, DOI 10.1152/physrev.00028.2002; Dong H, 2010, J BIOL CHEM, V285, P39811, DOI 10.1074/jbc.M110.175844; Durr KL, 2008, J MOL BIOL, V384, P865, DOI 10.1016/j.jmb.2008.09.074; Dutzler R, 2003, SCIENCE, V300, P108, DOI 10.1126/science.1082708; Einholm AP, 2007, J BIOENERG BIOMEMBR, V39, P357, DOI 10.1007/s10863-007-9106-x; Ekberg K, 2010, P NATL ACAD SCI USA, V107, P21400, DOI 10.1073/pnas.1010416107; Ekberg K, 2010, J BIOL CHEM, V285, P7344, DOI 10.1074/jbc.M109.096123; Henry RM, 2009, J MOL BIOL, V387, P1165, DOI 10.1016/j.jmb.2009.02.042; HILL JE, 1986, YEAST, V2, P163, DOI 10.1002/yea.320020304; Hirsch RE, 1998, SCIENCE, V280, P918, DOI 10.1126/science.280.5365.918; Jiang WP, 1998, P NATL ACAD SCI USA, V95, P6607, DOI 10.1073/pnas.95.12.6607; Kaila VRI, 2008, BBA-BIOENERGETICS, V1777, P890, DOI 10.1016/j.bbabio.2008.03.016; Lanfermeijer FC, 1998, PROTEIN EXPRES PURIF, V12, P29, DOI 10.1006/prep.1997.0788; Lepp H, 2008, BBA-BIOENERGETICS, V1777, P897, DOI 10.1016/j.bbabio.2008.04.013; Moller JV, 2010, Q REV BIOPHYS, V43, P501, DOI 10.1017/S003358351000017X; Moller JV, 1996, BBA-REV BIOMEMBRANES, V1286, P1, DOI 10.1016/0304-4157(95)00017-8; Morth JP, 2007, NATURE, V450, P1043, DOI 10.1038/nature06419; NAGLE JF, 1978, P NATL ACAD SCI USA, V75, P298, DOI 10.1073/pnas.75.1.298; ONSAGER L, 1969, SCIENCE, V166, P1359, DOI 10.1126/science.166.3911.1359; Palmgren MG, 2001, ANNU REV PLANT PHYS, V52, P817, DOI 10.1146/annurev.arplant.52.1.817; Pawate AS, 2002, BIOCHEMISTRY-US, V41, P13417, DOI 10.1021/bi026582+; Pedersen BP, 2007, NATURE, V450, P1111, DOI 10.1038/nature06417; PERLIN DS, 1986, ARCH BIOCHEM BIOPHYS, V248, P53, DOI 10.1016/0003-9861(86)90400-5; Pfitzner U, 2000, BIOCHEMISTRY-US, V39, P6756, DOI 10.1021/bi992235x; REGENBERG B, 1995, PLANT CELL, V7, P1655, DOI 10.1105/tpc.7.10.1655; SKULACHEV VP, 1994, ANTON LEEUW INT J G, V65, P271, DOI 10.1007/BF00872213; Sorensen TLM, 2004, SCIENCE, V304, P1672, DOI 10.1126/science.1099366; Toyoshima C, 2000, NATURE, V405, P647, DOI 10.1038/35015017; VENEMA K, 1995, J BIOL CHEM, V270, P19659, DOI 10.1074/jbc.270.33.19659; VILLALBA JM, 1992, J BIOL CHEM, V267, P12341; Vorburger T, 2008, FEBS J, V275, P2137, DOI 10.1111/j.1742-4658.2008.06368.x; WILSON TH, 1980, J SUPRAMOL STR CELL, V13, P421, DOI 10.1002/jss.400130403	47	12	12	2	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 5	2013	288	14					9610	9618		10.1074/jbc.M112.417345	http://dx.doi.org/10.1074/jbc.M112.417345			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	119RB	23420846	Green Published, hybrid			2022-12-25	WOS:000317114000005
J	Harmon, JM; Bacikova, D; Gable, K; Gupta, SD; Han, GS; Sengupta, N; Somashekarappa, N; Dunn, TM				Harmon, Jeffrey M.; Bacikova, Dagmar; Gable, Kenneth; Gupta, Sita D.; Han, Gongshe; Sengupta, Nivedita; Somashekarappa, Niranjanakumari; Dunn, Teresa M.			Topological and Functional Characterization of the ssSPTs, Small Activating Subunits of Serine Palmitoyltransferase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEUROPATHY TYPE-I; SPHINGOLIPID BIOSYNTHESIS; CRYSTAL-STRUCTURE; PROTEINS MEDIATE; ENZYME; MUTATIONS; YEAST; CLONING; GENES; HOMEOSTASIS	The topological and functional organization of the two isoforms of the small subunits of human serine palmitoyltransferase (hssSPTs) that activate the catalytic hLCB1/hLCB2 heterodimer was investigated. A variety of experimental approaches placed the N termini of the ssSPTs in the cytosol, their C termini in the lumen, and showed that they contain a single transmembrane domain. Deletion analysis revealed that the ability to activate the heterodimer is contained in a conserved 33-amino acid core domain that has the same membrane topology as the full-length protein. In combination with analysis of isoform chimera and site-directed mutagenesis, a single amino acid residue in this core (Met(25) in ssSPTa and Val(25) in ssSPTb) was identified which confers specificity for palmitoylor stearoyl-CoA, respectively, in both yeast and mammalian cells. This same residue also determines which isoform is a better activator of a mutant heterodimer, hLCB1(S331)F/hLCB2a, which has increased basal SPT activity and decreased amino acid substrate selectivity. This suggests that the role of the ssSPTs is to increase SPT activity without compromising substrate specificity. In addition, the observation that the C-terminal domains of ssSPTa and ssSPTb, which are highly conserved within each subfamily but are the most divergent regions between isoform subfamilies, are not required for activation of the heterodimer or for acyl-CoA selectivity suggests that the ssSPTs have additional roles that remain to be discovered.	[Harmon, Jeffrey M.; Bacikova, Dagmar; Somashekarappa, Niranjanakumari] Uniformed Serv Univ Hlth Sci, Dept Pharmacol, Bethesda, MD 20814 USA; [Gable, Kenneth; Gupta, Sita D.; Han, Gongshe; Sengupta, Nivedita; Dunn, Teresa M.] Uniformed Serv Univ Hlth Sci, Dept Biochem & Mol Biol, Bethesda, MD 20814 USA	Uniformed Services University of the Health Sciences - USA; Uniformed Services University of the Health Sciences - USA	Dunn, TM (corresponding author), Uniformed Serv Univ Hlth Sci, Dept Biochem & Mol Biol, 4301 Jones Bridge Rd, Bethesda, MD 20814 USA.	tdunn@usuhs.edu		Harmon, Jeffrey/0000-0001-7833-931X	National Institutes of Health [R01NS072446]; Uniformed Services University [R071KD, CO75PI]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS072446] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Uniformed Services University; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01NS072446. This work was also supported by Uniformed Services University Grants R071KD and CO75PI.	Alexeev D, 1998, J MOL BIOL, V284, P401, DOI 10.1006/jmbi.1998.2086; Astner I, 2005, EMBO J, V24, P3166, DOI 10.1038/sj.emboj.7600792; Breslow DK, 2010, NATURE, V463, P1048, DOI 10.1038/nature08787; Gable K, 2002, J BIOL CHEM, V277, P10194, DOI 10.1074/jbc.M107873200; Gable K, 2000, J BIOL CHEM, V275, P7597, DOI 10.1074/jbc.275.11.7597; Gable K, 2010, J BIOL CHEM, V285, P22844, DOI 10.1074/jbc.M110.122259; Han G, 2009, P NATL ACAD SCI USA, V106, P8186, DOI 10.1073/pnas.0811269106; Han GS, 2006, J BIOL CHEM, V281, P39935, DOI 10.1074/jbc.M609365200; Han GS, 2004, J BIOL CHEM, V279, P53707, DOI 10.1074/jbc.M410014200; Han SM, 2010, P NATL ACAD SCI USA, V107, P5851, DOI 10.1073/pnas.0911617107; Hanada K, 2000, METHOD ENZYMOL, V312, P304; Hanada K, 2003, BBA-MOL CELL BIOL L, V1632, P16, DOI 10.1016/S1388-1981(03)00059-3; Hornemann T, 2006, J BIOL CHEM, V281, P37275, DOI 10.1074/jbc.M608066200; Ikushiro H, 2003, BBA-PROTEINS PROTEOM, V1647, P116, DOI 10.1016/S1570-9639(03)00074-8; Ikushiro H, 2001, J BIOL CHEM, V276, P18249, DOI 10.1074/jbc.M101550200; Lowther J, 2012, BIOCHEM SOC T, V40, P547, DOI 10.1042/BST20110769; Momin AA, 2009, LIPIDS, V44, P725, DOI 10.1007/s11745-009-3316-4; Monaghan E, 2002, YEAST, V19, P659, DOI 10.1002/yea.864; Penno A, 2010, J BIOL CHEM, V285, P11178, DOI 10.1074/jbc.M109.092973; Raman MCC, 2010, BIOPOLYMERS, V93, P811, DOI 10.1002/bip.21482; Raman MCC, 2009, J BIOL CHEM, V284, P17328, DOI 10.1074/jbc.M109.008680; Rotthier A, 2011, HUM MUTAT, V32, pE2211, DOI 10.1002/humu.21481; Rotthier A, 2010, AM J HUM GENET, V87, P513, DOI 10.1016/j.ajhg.2010.09.010; Rotthier A, 2009, BRAIN, V132, P2699, DOI 10.1093/brain/awp198; Schmidt A, 2001, BIOCHEMISTRY-US, V40, P5151, DOI 10.1021/bi002204y; Siow DL, 2012, J BIOL CHEM, V287, P40198, DOI 10.1074/jbc.C112.404012; Tsegaye Y, 2007, J BIOL CHEM, V282, P28195, DOI 10.1074/jbc.M705074200; Wilson WH, 2005, SCIENCE, V309, P1090, DOI 10.1126/science.1113109; Yard BA, 2007, J MOL BIOL, V370, P870, DOI 10.1016/j.jmb.2007.04.086; ZHAO C, 1994, J BIOL CHEM, V269, P21480	30	41	43	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 5	2013	288	14					10144	10153		10.1074/jbc.M113.451526	http://dx.doi.org/10.1074/jbc.M113.451526			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	119RB	23426370	Green Published, hybrid			2022-12-25	WOS:000317114000055
J	Furtado, JM; Ashander, LM; Mohs, K; Chipps, TJ; Appukuttan, B; Smith, JR				Furtado, Joao M.; Ashander, Liam M.; Mohs, Kathleen; Chipps, Timothy J.; Appukuttan, Binoy; Smith, Justine R.			Toxoplasma gondii Migration within and Infection of Human Retina	PLOS ONE			English	Article							OCULAR TOXOPLASMOSIS; TRANSEPITHELIAL MIGRATION; VASCULAR ENDOTHELIUM; GLOBAL REASSESSMENT; MEMORIAL-LECTURE; GROWTH-FACTOR; IN-VITRO; CELLS; EXPRESSION; RETINOCHOROIDITIS	Toxoplasmic retinochoroiditis is a common blinding retinal infection caused by the parasite, Toxoplasma gondii. Basic processes relating to establishment of infection in the human eye by T. gondii tachyzoites have not been investigated. To evaluate the ability of tachyzoites to navigate the human retina, we developed an ex vivo assay, in which a suspension containing 1.5x10(7) parasites replaced vitreous in a posterior eyecup. After 8 hours, the retina was formalin-fixed and paraffin-embedded, and sections were immunostained to identify tachyzoites. To determine the preference of tachyzoites for human retinal neuronal versus glial populations, we infected dissociated retinal cultures, subsequently characterized by neuron-specific enolase or glial fibrillary acidic protein expression, and retinal cell lines, with YFP-expressing tachyzoites. In migration assays, retinas contained 110-250 live tachyzoites; 64.5-95.2% (mean = 79.6%) were localized to the nerve fiber layer, but some were detected in the outer retina. Epifluorescence imaging of dissociated retinal cultures 24 hours after infection indicated preferential infection of glia. This observation was confirmed in growth assays, with significantly higher (p <= 0.005) numbers of tachyzoites measured in glial verus neuronal cell lines. Our translational studies indicate that, after entering retina, tachyzoites may navigate multiple tissue layers. Tachyzoites preferentially infect glial cells, which exist throughout the retina. These properties may contribute to the success of T. gondii as a human pathogen.	[Furtado, Joao M.; Ashander, Liam M.; Mohs, Kathleen; Chipps, Timothy J.; Appukuttan, Binoy; Smith, Justine R.] Oregon Hlth & Sci Univ, Casey Eye Inst, Portland, OR 97201 USA; [Smith, Justine R.] Oregon Hlth & Sci Univ, Dept Cell & Dev Biol, Portland, OR 97201 USA	Oregon Health & Science University; Oregon Health & Science University	Smith, JR (corresponding author), Oregon Hlth & Sci Univ, Casey Eye Inst, Portland, OR 97201 USA.	justine.smith@flinders.edu.au	Smith, Justine/Y-9044-2019; Furtado, Joao M./AAB-5356-2022; Furtado, Joao/D-4436-2012	Smith, Justine/0000-0002-4756-5493; Furtado, Joao M./0000-0003-2490-5747; 	National Institutes of Health [R21 EY019550]; Research to Prevent Blindness; NATIONAL EYE INSTITUTE [P30EY010572, R21EY019550] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research to Prevent Blindness(Research to Prevent Blindness (RPB)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	Funding for this study was provided by the National Institutes of Health (R21 EY019550) and Research to Prevent Blindness (unrestricted grant to Casey Eye Institute). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbosa BF, 2008, CLIN EXP IMMUNOL, V151, P536, DOI 10.1111/j.1365-2249.2007.03583.x; Barragan A, 2005, CELL MICROBIOL, V7, P561, DOI 10.1111/j.1462-5822.2005.00486.x; Barragan A, 2002, J EXP MED, V195, P1625, DOI 10.1084/jem.20020258; Black MW, 2000, MICROBIOL MOL BIOL R, V64, P607, DOI 10.1128/MMBR.64.3.607-623.2000; Blader IJ, 2001, J BIOL CHEM, V276, P24223, DOI 10.1074/jbc.M100951200; BULOW R, 1991, J IMMUNOL, V147, P3496; Carruthers VB, 2002, ACTA TROP, V81, P111, DOI 10.1016/S0001-706X(01)00201-7; Channon JY, 2000, INFECT IMMUN, V68, P4822, DOI 10.1128/IAI.68.8.4822-4826.2000; Coppens I, 2006, CELL MICROBIOL, V8, P1, DOI 10.1111/j.1462-5822.2005.00647.x; Furtado JM, 2012, IMMUNOL CELL BIOL, V90, P912, DOI 10.1038/icb.2012.21; Furtado JM, 2012, INVEST OPHTH VIS SCI, V53, P6856, DOI 10.1167/iovs.12-10384; Gaudin C, 1996, INVEST OPHTH VIS SCI, V37, P2258; Gubbels MJ, 2003, ANTIMICROB AGENTS CH, V47, P309, DOI 10.1128/AAC.47.1.309-316.2003; Halonen SK, 1996, J NEUROPATH EXP NEUR, V55, P1150, DOI 10.1097/00005072-199611000-00006; Holland GN, 2004, AM J OPHTHALMOL, V137, P1, DOI 10.1016/j.ajo.2003.10.032; Holland GN, 2003, AM J OPHTHALMOL, V136, P973, DOI 10.1016/j.ajo.2003.09.040; Khan A, 2009, EUKARYOT CELL, V8, P1828, DOI 10.1128/EC.00150-09; Knight BC, 2006, J NEUROIMMUNOL, V179, P126, DOI 10.1016/j.jneuroim.2006.06.002; KUWABARA T, 1960, ARCH OPHTHALMOL-CHIC, V64, P904, DOI 10.1001/archopht.1960.01840010906012; Limb GA, 2002, INVEST OPHTH VIS SCI, V43, P864; Lum F, 2005, AM J OPHTHALMOL, V140, P724; MCFALL RC, 1977, CANCER RES, V37, P1003; Montoya JG, 1997, CURRENT CONCEPTS IMM, P163; Nagineni CN, 2002, CLIN EXP IMMUNOL, V128, P372, DOI 10.1046/j.1365-2249.2002.01815.x; NICHOLSON DH, 1976, ARCH OPHTHALMOL-CHIC, V94, P248, DOI 10.1001/archopht.1976.03910030120009; Plattner F, 2008, ANNU REV MICROBIOL, V62, P471, DOI 10.1146/annurev.micro.62.081307.162802; Romano C, 2007, PROG RETIN EYE RES, V26, P379, DOI 10.1016/j.preteyeres.2007.03.001; Sibley LD, 2004, SCIENCE, V304, P248, DOI 10.1126/science.1094717; Smith JR, 2004, INVEST OPHTH VIS SCI, V45, P1157, DOI 10.1167/iovs.03-1105; Smith JR, 2007, BRIT J OPHTHALMOL, V91, P226, DOI 10.1136/bjo.2006.101121; Stanford MR, 2009, MEM I OSWALDO CRUZ, V104, P312, DOI 10.1590/S0074-02762009000200027; YEO JH, 1983, OPHTHALMOLOGY, V90, P885, DOI 10.1016/S0161-6420(83)80012-8	32	22	23	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2013	8	2							e54358	10.1371/journal.pone.0054358	http://dx.doi.org/10.1371/journal.pone.0054358			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IT	23437042	Green Submitted, Green Published, gold			2022-12-25	WOS:000315186000003
J	Raveney, BJE; Oki, S; Yamamura, T				Raveney, Ben J. E.; Oki, Shinji; Yamamura, Takashi			Nuclear Receptor NR4A2 Orchestrates Th17 Cell-Mediated Autoimmune Inflammation via IL-21 Signalling	PLOS ONE			English	Article							T-CELLS; DIFFERENTIATION; EXPRESSION; T(H)17; IL-17; INTERLEUKIN-21; GENERATION; INDUCTION; APOPTOSIS; PATHWAY	IL-17-producing CD4(+) T helper 17 (Th17) cells are pathogenic in a range of human autoimmune diseases and corresponding animal models. We now demonstrate that such T cells infiltrating the target organ during the induction of experimental autoimmune encephalomyelitis (EAE) and experimental autoimmune uveoretinitis (EAU) specifically express NR4A2. Further, we reveal a critical involvement of NR4A2 in Th17 cell functions and Th17 cell-driven autoimmune diseases. When NR4A2 expression was blocked with siRNA, full Th17 differentiation was prevented in vitro: although cells expressed the master Th17 regulator, ROR gamma t, they expressed reduced levels of IL-23R and were unable to produce IL-17 and IL-21. Notably, Th17 differentiation in the absence of NR4A2 was restored by exogenous IL-21, indicating that NR4A2 controls full maturation of Th17 cells via autocrine IL-21 signalling. Preventing NR4A2 expression in vivo by systemic treatment with NR4A2-specific siRNA also reduced Th17 effector responses and furthermore protected mice from EAE induction. In addition, the lack of disease was associated with a reduction in autocrine IL-21 production and IL-23R expression. Similar modulation of NR4A2 expression was also effective as an intervention, reversing established autoimmune responses and ameliorating clinical disease symptoms. Thus, NR4A2 appears to control Th17 differentiation and so plays an essential role in the development of Th17-mediated autoimmune disease. As NR4A2 is also upregulated during human autoimmune disease, targeting NR4A2 may provide a new therapeutic approach in treating autoimmune disease.	[Raveney, Ben J. E.; Oki, Shinji; Yamamura, Takashi] Natl Ctr Neurol & Psychiat, Natl Inst Neurosci, Dept Immunol, Tokyo, Japan	National Center for Neurology & Psychiatry - Japan	Yamamura, T (corresponding author), Natl Ctr Neurol & Psychiat, Natl Inst Neurosci, Dept Immunol, Tokyo, Japan.	yamamura@ncnp.go.jp		Raveney, Ben/0000-0003-2641-5733	Ministry of Health, Labour, and Welfare of Japan, the Council for Science and Technology Policy (CSTP); Ministry of Education, Science, Culture, Sports, and Technology of Japan; JSPS [18109009]; JSPS KAKENHI Grant [21590087]; JSPS Postdoctoral Fellowship [P08517]; Grants-in-Aid for Scientific Research [24590108] Funding Source: KAKEN	Ministry of Health, Labour, and Welfare of Japan, the Council for Science and Technology Policy (CSTP); Ministry of Education, Science, Culture, Sports, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); JSPS KAKENHI Grant(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); JSPS Postdoctoral Fellowship(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the grants from the Ministry of Health, Labour, and Welfare of Japan, the Council for Science and Technology Policy (CSTP) and the Ministry of Education, Science, Culture, Sports, and Technology of Japan. TY is a recipient of a JSPS Grant-in-Aid for Scientific Research (KAKENHI) No. 18109009, SO is a recipient of a JSPS KAKENHI Grant No. 21590087, and BJER was a recipient of a JSPS Postdoctoral Fellowship for Foreign Researchers No. P08517. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aherne CM, 2009, MOL IMMUNOL, V46, P3345, DOI 10.1016/j.molimm.2009.07.019; Bauquet AT, 2009, NAT IMMUNOL, V10, P167, DOI 10.1038/ni.1690; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Bettelli E, 2007, CURR OPIN IMMUNOL, V19, P652, DOI 10.1016/j.coi.2007.07.020; Copland DA, 2008, INVEST OPHTH VIS SCI, V49, P5458, DOI 10.1167/iovs.08-2348; Coquet JM, 2008, J IMMUNOL, V180, P7097, DOI 10.4049/jimmunol.180.11.7097; Cua DJ, 2003, NATURE, V421, P744, DOI 10.1038/nature01355; Damsker JM, 2010, ANN NY ACAD SCI, V1183, P211, DOI 10.1111/j.1749-6632.2009.05133.x; Das J, 2009, J EXP MED, V206, P2407, DOI 10.1084/jem.20082286; Doi Y, 2008, P NATL ACAD SCI USA, V105, P8381, DOI 10.1073/pnas.0803454105; ELIAS D, 1994, DIABETES, V43, P992, DOI 10.2337/diabetes.43.8.992; Fraser JM, 2006, IMMUNOLOGY, V119, P126, DOI 10.1111/j.1365-2567.2006.02414.x; Ghoreschi K, 2010, NATURE, V467, P967, DOI 10.1038/nature09447; Goverman J, 2009, NAT REV IMMUNOL, V9, P393, DOI 10.1038/nri2550; Hirota K, 2011, NAT IMMUNOL, V12, P255, DOI 10.1038/ni.1993; Hofstetter HH, 2005, CELL IMMUNOL, V237, P123, DOI 10.1016/j.cellimm.2005.11.002; Hueber W, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001107; Ivanov II, 2007, SEMIN IMMUNOL, V19, P409, DOI 10.1016/j.smim.2007.10.011; Jager A, 2009, J IMMUNOL, V183, P7169, DOI 10.4049/jimmunol.0901906; Klemann C, 2009, AM J PATHOL, V174, P2234, DOI 10.2353/ajpath.2009.081084; Komiyama Y, 2006, J IMMUNOL, V177, P566, DOI 10.4049/jimmunol.177.1.566; Korn T, 2007, SEMIN IMMUNOL, V19, P362, DOI 10.1016/j.smim.2007.10.007; Korn T, 2007, NATURE, V448, P484, DOI 10.1038/nature05970; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Langrish CL, 2005, J EXP MED, V201, P233, DOI 10.1084/jem.20041257; LAW SW, 1992, MOL ENDOCRINOL, V6, P2129, DOI 10.1210/me.6.12.2129; Le WD, 2003, NAT GENET, V33, P85, DOI 10.1038/ng1066; Leonard WJ, 2005, NAT REV IMMUNOL, V5, P688, DOI 10.1038/nri1688; Luger D, 2008, J EXP MED, V205, P799, DOI 10.1084/jem.20071258; Man SM, 2007, BRAIN PATHOL, V17, P243, DOI 10.1111/j.1750-3639.2007.00067.x; Matusevicius D, 1999, MULT SCLER J, V5, P101, DOI 10.1177/135245859900500206; McGeachy MJ, 2007, SEMIN IMMUNOL, V19, P372, DOI 10.1016/j.smim.2007.10.012; Mensah-Brown EPK, 2006, EUR J IMMUNOL, V36, P216, DOI 10.1002/eji.200535325; Monteleone G, 2005, GASTROENTEROLOGY, V128, P687, DOI 10.1053/j.gastro.2004.12.042; Nurieva R, 2007, NATURE, V448, P480, DOI 10.1038/nature05969; O'Kane M, 2008, J INVEST DERMATOL, V128, P300, DOI 10.1038/sj.jid.5701023; Pearen MA, 2010, MOL ENDOCRINOL, V24, P1891, DOI 10.1210/me.2010-0015; Perlmann T, 2004, CELL TISSUE RES, V318, P45, DOI 10.1007/s00441-004-0974-7; Raveney BJE, 2008, ARCH OPHTHALMOL-CHIC, V126, P1390, DOI 10.1001/archopht.126.10.1390; Raveney BJE, 2009, J IMMUNOL, V183, P2321, DOI 10.4049/jimmunol.0901340; Saijo K, 2009, CELL, V137, P47, DOI 10.1016/j.cell.2009.01.038; Satoh J, 2005, NEUROBIOL DIS, V18, P537, DOI 10.1016/j.nbd.2004.10.007; Sekiya T, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1272; Shao H, 2006, EXP EYE RES, V82, P323, DOI 10.1016/j.exer.2005.07.008; Sonderegger I, 2008, EUR J IMMUNOL, V38, P1833, DOI 10.1002/eji.200838511; Sospedra M, 2005, ANNU REV IMMUNOL, V23, P683, DOI 10.1146/annurev.immunol.23.021704.115707; Steinman L, 2008, J EXP MED, V205, P1517, DOI 10.1084/jem.20072066; Takeshita F, 2005, P NATL ACAD SCI USA, V102, P12177, DOI 10.1073/pnas.0501753102; Veldhoen M, 2008, NATURE, V453, P106, DOI 10.1038/nature06881; Vollmer TL, 2005, J IMMUNOL, V174, P2696, DOI 10.4049/jimmunol.174.5.2696; Zhou L, 2008, NATURE, V453, P236, DOI 10.1038/nature06878; Zhou LA, 2007, NAT IMMUNOL, V8, P967, DOI 10.1038/ni1488	52	56	57	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2013	8	2							e56595	10.1371/journal.pone.0056595	http://dx.doi.org/10.1371/journal.pone.0056595			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IT	23437182	gold, Green Published, Green Submitted			2022-12-25	WOS:000315186000033
J	Bennett, TL; Kraft, SM; Reaves, BJ; Mima, J; O'Brien, KM; Starai, VJ				Bennett, Terry L.; Kraft, Shannon M.; Reaves, Barbara J.; Mima, Joji; O'Brien, Kevin M.; Starai, Vincent J.			LegC3, an Effector Protein from Legionella pneumophila, Inhibits Homotypic Yeast Vacuole Fusion In Vivo and In Vitro	PLOS ONE			English	Article							PHAGOSOME-LYSOSOME FUSION; TRANS-SNARE COMPLEX; MEMBRANE-FUSION; SACCHAROMYCES-CEREVISIAE; VESICLE TRAFFICKING; SYNAPTIC EXOCYTOSIS; MUTATIONAL ANALYSIS; PLASMA-MEMBRANE; ALPHA-SNAP; DOCKING	During infection, the intracellular pathogenic bacterium Legionella pneumophila causes an extensive remodeling of host membrane trafficking pathways, both in the construction of a replication-competent vacuole comprised of ER-derived vesicles and plasma membrane components, and in the inhibition of normal phagosome: endosome/lysosome fusion pathways. Here, we identify the LegC3 secreted effector protein from L. pneumophila as able to inhibit a SNARE- and Rab GTPase-dependent membrane fusion pathway in vitro, the homotypic fusion of yeast vacuoles (lysosomes). This vacuole fusion inhibition appeared to be specific, as similar secreted coiled-coiled domain containing proteins from L. pneumophila, LegC7/YlfA and LegC2/YlfB, did not inhibit vacuole fusion. The LegC3-mediated fusion inhibition was reversible by a yeast cytosolic extract, as well as by a purified soluble SNARE, Vam7p. LegC3 blocked the formation of trans-SNARE complexes during vacuole fusion, although we did not detect a direct interaction of LegC3 with the vacuolar SNARE protein complexes required for fusion. Additionally, LegC3 was incapable of inhibiting a defined synthetic model of vacuolar SNARE- driven membrane fusion, further suggesting that LegC3 does not directly inhibit the activity of vacuolar SNAREs, HOPS complex, or Sec17p/18p during membrane fusion. LegC3 is likely utilized by Legionella to modulate eukaryotic membrane fusion events during pathogenesis.	[Bennett, Terry L.; O'Brien, Kevin M.; Starai, Vincent J.] Univ Georgia, Dept Microbiol, Athens, GA 30602 USA; [Kraft, Shannon M.; Reaves, Barbara J.; Starai, Vincent J.] Infect Dis Univ Georgia, Athens, GA USA; [Mima, Joji] Osaka Univ, Inst Prot Res, Osaka, Japan	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; Osaka University	Starai, VJ (corresponding author), Univ Georgia, Dept Microbiol, Athens, GA 30602 USA.	vjstarai@uga.edu		Lenz, Shannon/0000-0001-5705-1819	University of Georgia; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI100913] Funding Source: NIH RePORTER	University of Georgia; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	V.J.S. was supported by University of Georgia startup funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AbuKwaik Y, 1996, APPL ENVIRON MICROB, V62, P2022, DOI 10.1128/AEM.62.6.2022-2028.1996; Albert S, 1999, EMBO J, V18, P5216, DOI 10.1093/emboj/18.19.5216; Arasaki K, 2010, TRAFFIC, V11, P587, DOI 10.1111/j.1600-0854.2010.01050.x; BANTA LM, 1990, MOL CELL BIOL, V10, P4638, DOI 10.1128/MCB.10.9.4638; Banuelos MG, 2010, CURR GENET, V56, P121, DOI 10.1007/s00294-009-0285-3; BAUMERT M, 1989, EMBO J, V8, P379, DOI 10.1002/j.1460-2075.1989.tb03388.x; BLOCK MR, 1988, P NATL ACAD SCI USA, V85, P7852, DOI 10.1073/pnas.85.21.7852; BUCHMEIER NA, 1991, INFECT IMMUN, V59, P2232, DOI 10.1128/IAI.59.7.2232-2238.1991; Burstein D, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000508; Campodonico EM, 2005, MOL MICROBIOL, V56, P918, DOI 10.1111/j.1365-2958.2005.04595.x; Cao XC, 1998, EMBO J, V17, P2156, DOI 10.1093/emboj/17.8.2156; Cheever ML, 2006, PROTEIN SCI, V15, P1873, DOI 10.1110/ps.062194906; Christoforidis S, 1999, NAT CELL BIOL, V1, P249, DOI 10.1038/12075; Christoforidis S, 1999, NATURE, V397, P621, DOI 10.1038/17618; CLARY DO, 1990, CELL, V61, P709, DOI 10.1016/0092-8674(90)90482-T; Clemens DL, 2000, INFECT IMMUN, V68, P2671, DOI 10.1128/IAI.68.5.2671-2684.2000; Collins KM, 2007, P NATL ACAD SCI USA, V104, P8755, DOI 10.1073/pnas.0702290104; Collins KM, 2005, EMBO J, V24, P1775, DOI 10.1038/sj.emboj.7600658; de Felipe KS, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000117; Delevoye C, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000022; Fasshauer D, 1998, P NATL ACAD SCI USA, V95, P15781, DOI 10.1073/pnas.95.26.15781; Fernandez-Moreira E, 2006, INFECT IMMUN, V74, P3285, DOI 10.1128/IAI.01382-05; Fratti RA, 2007, J BIOL CHEM, V282, P14861, DOI 10.1074/jbc.M700971200; Gerrard SR, 2000, TRAFFIC, V1, P45, DOI 10.1034/j.1600-0854.2000.010108.x; Goody Roger S, 2011, Commun Integr Biol, V4, P72, DOI 10.4161/cib.4.1.13857; GOUD B, 1988, CELL, V53, P753, DOI 10.1016/0092-8674(88)90093-1; HAAS A, 1994, J CELL BIOL, V126, P87, DOI 10.1083/jcb.126.1.87; Haas A, 1996, EMBO J, V15, P3296, DOI 10.1002/j.1460-2075.1996.tb00694.x; Haas Albert, 1995, Methods in Cell Science, V17, P283, DOI 10.1007/BF00986234; Hackstadt T, 1999, CELL MICROBIOL, V1, P119, DOI 10.1046/j.1462-5822.1999.00012.x; HATA Y, 1993, NATURE, V366, P347, DOI 10.1038/366347a0; Heidtman M, 2009, CELL MICROBIOL, V11, P230, DOI 10.1111/j.1462-5822.2008.01249.x; HORWITZ MA, 1983, J EXP MED, V158, P1319, DOI 10.1084/jem.158.4.1319; HORWITZ MA, 1983, J EXP MED, V158, P2108, DOI 10.1084/jem.158.6.2108; Hubber A, 2010, ANNU REV CELL DEV BI, V26, P261, DOI 10.1146/annurev-cellbio-100109-104034; Ingmundson A, 2007, NATURE, V450, P365, DOI 10.1038/nature06336; Ivanov SS, 2010, J BIOL CHEM, V285, P34686, DOI 10.1074/jbc.M110.170746; Jones EW, 2002, METHOD ENZYMOL, V351, P127; Jun Y, 2006, EMBO J, V25, P5260, DOI 10.1038/sj.emboj.7601413; KAISER CA, 1987, SCIENCE, V235, P312, DOI 10.1126/science.3541205; Katz L, 2000, MOL BIOL CELL, V11, P3849, DOI 10.1091/mbc.11.11.3849; Lang T, 2001, EMBO J, V20, P2202, DOI 10.1093/emboj/20.9.2202; Li JC, 2002, BIOTECHNOL PROGR, V18, P831, DOI 10.1021/bp020066t; Lin RC, 1997, NEURON, V19, P1087, DOI 10.1016/S0896-6273(00)80399-2; Luo ZQ, 2004, P NATL ACAD SCI USA, V101, P841, DOI 10.1073/pnas.0304916101; MALHOTRA V, 1988, CELL, V54, P221, DOI 10.1016/0092-8674(88)90554-5; Mayer A, 1996, CELL, V85, P83, DOI 10.1016/S0092-8674(00)81084-3; Merz AJ, 2004, P NATL ACAD SCI USA, V101, P11548, DOI 10.1073/pnas.0404583101; Merz AJ, 2004, J CELL BIOL, V164, P195, DOI 10.1083/jcb.200310105; Miaczynska M, 2002, EXP CELL RES, V272, P8, DOI 10.1006/excr.2001.5401; Mima J, 2008, EMBO J, V27, P2031, DOI 10.1038/emboj.2008.139; Mima J, 2009, J BIOL CHEM, V284, P27114, DOI 10.1074/jbc.M109.010223; Mima J, 2009, P NATL ACAD SCI USA, V106, P16191, DOI 10.1073/pnas.0908694106; NASH TW, 1984, J CLIN INVEST, V74, P771, DOI 10.1172/JCI111493; Nichols BJ, 1997, NATURE, V387, P199, DOI 10.1038/387199a0; Ninio S, 2005, MOL MICROBIOL, V55, P912, DOI 10.1111/j.1365-2958.2004.04435.x; Paumet F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007375; PEVSNER J, 1994, NEURON, V13, P353, DOI 10.1016/0896-6273(94)90352-2; Price A, 2000, J CELL BIOL, V148, P1231, DOI 10.1083/jcb.148.6.1231; Reese C, 2005, NATURE, V436, P410, DOI 10.1038/nature03722; ROTHMAN JE, 1994, ADV SEC MESS PHOSPH, V29, P81; Roy CR, 1998, MOL MICROBIOL, V28, P663, DOI 10.1046/j.1365-2958.1998.00841.x; Schwartz ML, 2009, J CELL BIOL, V185, P535, DOI 10.1083/jcb.200811082; Scidmore MA, 2003, INFECT IMMUN, V71, P973, DOI 10.1128/IAI.71.2.973-984.2003; Scott BL, 2004, J CELL BIOL, V167, P75, DOI 10.1083/jcb.200405018; Seeley ES, 2002, MOL BIOL CELL, V13, P782, DOI 10.1091/mbc.01-10-0512; Shen JS, 2007, CELL, V128, P183, DOI 10.1016/j.cell.2006.12.016; Siggers KA, 2008, CELL HOST MICROBE, V4, P8, DOI 10.1016/j.chom.2008.06.004; Slusarewicz P, 1997, P NATL ACAD SCI USA, V94, P5582, DOI 10.1073/pnas.94.11.5582; Starai VJ, 2008, MOL BIOL CELL, V19, P2500, DOI 10.1091/mbc.E08-01-0077; Starai VJ, 2007, P NATL ACAD SCI USA, V104, P13551, DOI 10.1073/pnas.0704741104; Stroupe C, 2006, EMBO J, V25, P1579, DOI 10.1038/sj.emboj.7601051; Stroupe C, 2009, P NATL ACAD SCI USA, V106, P17626, DOI 10.1073/pnas.0903801106; STRUCK DK, 1981, BIOCHEMISTRY-US, V20, P4093, DOI 10.1021/bi00517a023; Sutton RB, 1998, NATURE, V395, P347, DOI 10.1038/26412; Thorngren N, 2004, EMBO J, V23, P2765, DOI 10.1038/sj.emboj.7600286; Toonen RFG, 2003, TRENDS CELL BIOL, V13, P177, DOI 10.1016/S0962-8924(03)00031-X; TRIMBLE WS, 1988, P NATL ACAD SCI USA, V85, P4538, DOI 10.1073/pnas.85.12.4538; Ungermann C, 1998, NATURE, V396, P543, DOI 10.1038/25069; VIDA TA, 1995, J CELL BIOL, V128, P779, DOI 10.1083/jcb.128.5.779; Vogel JP, 1998, SCIENCE, V279, P873, DOI 10.1126/science.279.5352.873; von der Haar T, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001078; WADA Y, 1990, MOL CELL BIOL, V10, P2214, DOI 10.1128/MCB.10.5.2214; WALWORTH NC, 1989, EMBO J, V8, P1685, DOI 10.1002/j.1460-2075.1989.tb03560.x; Wang L, 2003, J CELL BIOL, V160, P365, DOI 10.1083/jcb.200209095; Wang L, 2002, CELL, V108, P357, DOI 10.1016/S0092-8674(02)00632-3; Webb GC, 1997, GENETICS, V147, P467; Weber Stefan S., 2006, PLoS Pathogens, V2, DOI 10.1371/journal.ppat.0020046; Weber T, 1998, CELL, V92, P759, DOI 10.1016/S0092-8674(00)81404-X; WEIDMAN PJ, 1989, J CELL BIOL, V108, P1589, DOI 10.1083/jcb.108.5.1589; Wickner W, 2010, ANNU REV CELL DEV BI, V26, P115, DOI 10.1146/annurev-cellbio-100109-104131; Xu ZY, 1996, J CELL BIOL, V132, P787, DOI 10.1083/jcb.132.5.787	92	26	26	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e56798	10.1371/journal.pone.0056798	http://dx.doi.org/10.1371/journal.pone.0056798			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437241	gold, Green Published, Green Submitted			2022-12-25	WOS:000315184200165
J	Cagnazzi, D; Parra, GJ; Westley, S; Harrison, PL				Cagnazzi, Daniele; Parra, Guido J.; Westley, Shane; Harrison, Peter L.			At the Heart of the Industrial Boom: Australian Snubfin Dolphins in the Capricorn Coast, Queensland, Need Urgent Conservation Action	PLOS ONE			English	Article							PACIFIC HUMPBACK DOLPHINS; ORCAELLA-BREVIROSTRIS; SITE FIDELITY; HOME-RANGE; POPULATION; SURVIVAL; EXTINCTION; MANAGEMENT; ABUNDANCE; HABITAT	The recent industrial boom along the Australian coastline has increased concerns about the long term conservation of snubfin dolphins along the Queensland coast. National assessment of the conservation status and management of the Australian snubfin dolphin is currently hindered by the lack of adequate biological and ecological information throughout most of its range. In response to the issue of determining the conservation status of species with broad ranges, the IUCN has provided a framework for assessing the threatened status of regional populations. In this study we assessed the conservation status of a small geographically isolated population of snubfin dolphins living in the Fitzroy River region, Queensland, Australia, against the IUCN criteria for regional populations. A review of all available sightings data and stranding information indicates that this is the southernmost resident population of snubfin dolphins in Australian waters. The Fitzroy River snubfin dolphin population is composed of less than 100 individuals, with a representative range and core area of less than 400 and 300 km(2) respectively. The area most often used by snubfin dolphins within the representative range and core area was estimated to be about 292 and 191 km(2), respectively. A decrease in representative range, core area and preferred habitat between 14 and 25% is projected to occur if a planned industrial port development were to occur. These results are robust to uncertainty and considering the low level of formal protection and future threats, a classification of this subpopulation under the IUCN Red List as "Endangered'' is appropriate.	[Cagnazzi, Daniele; Harrison, Peter L.] So Cross Univ, Marine Ecol Res Ctr, Sch Environm Sci & Engn, Lismore, NSW 2480, Australia; [Parra, Guido J.] Flinders Univ S Australia, Sch Biol Sci, Cetacean Ecol Behav & Evolut Lab, Adelaide, SA 5001, Australia; [Parra, Guido J.] S Australian Res & Dev Inst SARDI, W Beach, Australia; [Westley, Shane] Fitzroy Basin Assoc Inc Level 1, Rockhampton, Qld, Australia	Southern Cross University; Flinders University South Australia	Cagnazzi, D (corresponding author), So Cross Univ, Marine Ecol Res Ctr, Sch Environm Sci & Engn, Lismore, NSW 2480, Australia.	daniele.cagnazzi@scu.edu.au	Cagnazzi, Daniele/AAT-6290-2020; Harrison, Peter L/B-4763-2011	Cagnazzi, Daniele/0000-0002-7901-4565; Harrison, Peter L/0000-0002-4048-2409; Parra, Guido J./0000-0002-1284-4898	Fitzroy River Basin Association trough the Natural Heritage Trust and Care of Your Country programs of the Australian Federal government	Fitzroy River Basin Association trough the Natural Heritage Trust and Care of Your Country programs of the Australian Federal government	Funding was provided by the Fitzroy River Basin Association trough the Natural Heritage Trust and Care of Your Country programs of the Australian Federal government (Website: www.fba.org.au/). The funders had no role in study design, data collection and analysis, and decision to publish, but only on the project development and manuscript preparation. No limitations have been imposed by the funding agencies.	Allen Simon J., 2012, Pacific Conservation Biology, V18, P56; Anderson DR, 1998, J APPL STAT, V25, P263, DOI 10.1080/02664769823250; Baker JD, 2007, P ROY SOC B-BIOL SCI, V274, P407, DOI 10.1098/rspb.2006.3737; Beasley I, 2005, MAR MAMMAL SCI, V21, P365, DOI 10.1111/j.1748-7692.2005.tb01239.x; Bejder L, 2012, CONSERV BIOL, V18; Beyer H. L., 2011, GEOSPATIAL MODELING; BRAY JR, 1957, ECOL MONOGR, V27, P326, DOI 10.2307/1942268; Burnham K. P., 1998, MODEL SELECTION INFE; Cagnazzi D., 2011, CONSERVATION STATUS; Cagnazzi DD, 2011, MAR MAMMAL SCI, V27, P255, DOI 10.1111/j.1748-7692.2009.00296.x; Chilvers BL, 2005, BIOL CONSERV, V122, P559, DOI 10.1016/j.biocon.2004.08.013; Chilvers BL, 2003, MAR MAMMAL SCI, V19, P85, DOI 10.1111/j.1748-7692.2003.tb01094.x; Choquet R., 2005, U CARE 2 2 USERS MAN; Corkrey R, 2008, J AM STAT ASSOC, V103, P948, DOI 10.1198/016214507000001256; Day JC, 2002, OCEAN COAST MANAGE, V45, P139, DOI 10.1016/S0964-5691(02)00052-2; DEHP, 2012, STRAND HOT SPOTS; Department of Sustainability Environment Water Population and Communities, 2013, ORC HEINS SPEC PROF; Douvere F, 2012, REACTIVE MONITORING; Eberhard R, 2012, FITZROY RIVER ESTUAR; Environmental Systems Research Institute (ESRI), 2011, ARCGIS DESKT V 10; Estes JA, 2011, SCIENCE, V333, P301, DOI 10.1126/science.1205106; Fahrig L, 2001, BIOL CONSERV, V100, P65, DOI 10.1016/S0006-3207(00)00208-1; Frere CH, 2011, CONSERV GENET, V12, P1633, DOI 10.1007/s10592-011-0242-9; Gardenfors U, 2001, CONSERV BIOL, V15, P1206, DOI 10.1046/j.1523-1739.2001.00112.x; Gaston KJ, 2009, J APPL ECOL, V46, P1, DOI 10.1111/j.1365-2664.2008.01596.x; GBRMPA, 2009, GREAT BARR REEF OUTL GREAT BARR REEF OUTL; GBRMPA, 2007, OP POL WHAL DOLPH CO; Gladstone PC, 2012, W BASIN PORT DEV ENV; Hampe A, 2005, ECOL LETT, V8, P461, DOI 10.1111/j.1461-0248.2005.00739.x; Heithaus MR, 2008, TRENDS ECOL EVOL, V23, P202, DOI 10.1016/j.tree.2008.01.003; Hood G.M., 2010, POPTOOLS VERSION 3 2; IUCN, 2003, GUID APPL IUCN RED L; Jaramillo-Legorreta A, 2007, CONSERV BIOL, V21, P1653, DOI 10.1111/j.1523-1739.2007.00825.x; Jefferson TA, 2009, MAR POLICY, V33, P305, DOI 10.1016/j.marpol.2008.07.011; Karczmarski L, 1996, ECOLOGICAL STUDIES H; Kreb D, 2005, ORYX, V39, P178, DOI 10.1017/S0030605305000426; Lawler I. R., 2007, CLIMATE CHANGE GREAT, P497; Lotze HK, 2006, SCIENCE, V312, P1806, DOI 10.1126/science.1128035; Manly B., 1993, RESOURCE SELECTION A; Manly BFJ, 1997, RANDOMIZATION BOOTST; Michell G, 2010, FITROY TERMINAL INNO; Parra GJ, 2006, BIOL CONSERV, V129, P167, DOI 10.1016/j.biocon.2005.10.031; Parra GJ, 2002, RAFFLES B ZOOL, P141; Parra GJ, 2006, J ANIM ECOL, V75, P862, DOI 10.1111/j.1365-2656.2006.01104.x; Parra GJ, 2006, ECOGRAPHY, V29, P396; Paterson R.A., 1998, Memoirs of the Queensland Museum, V42, P554; Pledger S., 2007, RESOURCE SELECTION T; POLLOCK KH, 1990, WILDLIFE MONOGR, P1; Pradel R, 1997, BIOMETRICS, V53, P60, DOI 10.2307/2533097; Pradel R., 1993, P29; Rayment W, 2009, MAR MAMMAL SCI, V25, P537, DOI 10.1111/j.1748-7692.2008.00271.x; Reeves RR, 2008, SOUSA CHINENSIS E TA; Ross G.J., 2006, REV CONSERVATION STA; Schwarz CJ, 1996, BIOMETRICS, V52, P860, DOI 10.2307/2533048; Seabloom EW, 2002, P NATL ACAD SCI USA, V99, P11229, DOI 10.1073/pnas.162064899; Seaman DE, 1996, ECOLOGY, V77, P2075, DOI 10.2307/2265701; SEBER GAF, 1992, INT STAT REV, V60, P129, DOI 10.2307/1403646; Slooten E, 2010, AQUAT CONSERV, V20, P334, DOI 10.1002/aqc.1084; Smith BD, 2004, IUCN 2012 IUCN RED L; Spielman D, 2004, P NATL ACAD SCI USA, V101, P15261, DOI 10.1073/pnas.0403809101; Taylor BL, 2000, CONSERV BIOL, V14, P1243, DOI 10.1046/j.1523-1739.2000.99409.x; Taylor BL, 2007, ADM REP; Turvey ST, 2010, P ROY SOC B-BIOL SCI, V277, P3139, DOI 10.1098/rspb.2010.0584; Wade PR, 1998, MAR MAMMAL SCI, V14, P1, DOI 10.1111/j.1748-7692.1998.tb00688.x; Wang JY, 2007, MAMMALIA, V71, P157, DOI 10.1515/MAMM.2007.032; White G.C., 2002, P 2 INT WILDL MAN C, P368; White GC, 1999, BIRD STUDY, V46, P120, DOI 10.1080/00063659909477239; Wilson B, 1999, ECOL APPL, V9, P288, DOI 10.1890/1051-0761(1999)009[0288:ESAATI]2.0.CO;2; Xstrata, 2012, BAL ISL COAL EXP TER	69	38	39	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e56729	10.1371/journal.pone.0056729	http://dx.doi.org/10.1371/journal.pone.0056729			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437225	Green Published, Green Submitted, gold			2022-12-25	WOS:000315184200154
J	Giachello, CNG; Premoselli, F; Montarolo, PG; Ghirardi, M				Giachello, Carlo Natale Giuseppe; Premoselli, Federica; Montarolo, Pier Giorgio; Ghirardi, Mirella			Pentylenetetrazol-Induced Epileptiform Activity Affects Basal Synaptic Transmission and Short-Term Plasticity in Monosynaptic Connections	PLOS ONE			English	Article							SYNAPSIN-I PHOSPHORYLATION; READILY RELEASABLE POOL; ACTIVATED PROTEIN-KINASE; PAIRED-PULSE FACILITATION; INDUCED BURSTING ACTIVITY; RAB3 EFFECTOR PROTEIN; VESICLE POOLS; POSTTETANIC POTENTIATION; BUCCAL GANGLIA; HELIX-POMATIA	Epileptic activity is generally induced in experimental models by local application of epileptogenic drugs, including pentylenetetrazol (PTZ), widely used on both vertebrate and invertebrate neurons. Despite the high prevalence of this neurological disorder and the extensive research on it, the cellular and molecular mechanisms underlying epileptogenesis still remain unclear. In this work, we examined PTZ-induced neuronal changes in Helix monosynaptic circuits formed in vitro, as a simpler experimental model to investigate the effects of epileptiform activity on both basal release and post-tetanic potentiation (PTP), a form of short-term plasticity. We observed a significant enhancement of basal synaptic strength, with kinetics resembling those of previously described use-dependent forms of plasticity, determined by changes in estimated quantal parameters, such as the readily releasable pool and the release probability. Moreover, these neurons exhibited a strong reduction in PTP expression and in its decay time constant, suggesting an impairment in the dynamic reorganization of synaptic vesicle pools following prolonged stimulation of synaptic transmission. In order to explain this imbalance, we determined whether epileptic activity is related to the phosphorylation level of synapsin, which is known to modulate synaptic plasticity. Using western blot and immunocytochemical staining we found a PTZ-dependent increase in synapsin phosphorylation at both PKA/CaMKI/IV and MAPK/Erk sites, both of which are important for modulating synaptic plasticity. Taken together, our findings suggest that prolonged epileptiform activity leads to an increase in the synapsin phosphorylation status, thereby contributing to an alteration of synaptic strength in both basal condition and tetanus-induced potentiation.	[Giachello, Carlo Natale Giuseppe; Premoselli, Federica; Montarolo, Pier Giorgio; Ghirardi, Mirella] Univ Turin, Dept Neurosci, Physiol Sect, Turin, Italy; [Montarolo, Pier Giorgio; Ghirardi, Mirella] Ist Nazl Neurosci, Turin, Italy	University of Turin	Giachello, CNG (corresponding author), Univ Turin, Dept Neurosci, Physiol Sect, Turin, Italy.	carlo.giachello@unito.it	ghirardi, mirella/AEQ-0420-2022		Italian Ministry of the University and Research (PRIN); Compagnia di San Paolo	Italian Ministry of the University and Research (PRIN)(Ministry of Education, Universities and Research (MIUR)); Compagnia di San Paolo(Compagnia di San Paolo)	This work was supported by Grants from Italian Ministry of the University and Research (PRIN 2009 grants to PGM) and Compagnia di San Paolo (to PGM and MG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTRUP U, 1988, BRAIN RES, V456, P401, DOI 10.1016/0006-8993(88)90248-X; ALTRUP U, 1991, COMP BIOCHEM PHYS C, V99, P579, DOI 10.1016/0742-8413(91)90290-A; Altrup U, 2003, BRAIN RES, V975, P73, DOI 10.1016/S0006-8993(03)02588-5; Altrup U, 1994, Neurosci Behav Physiol, V24, P23, DOI 10.1007/BF02355649; Altrup U, 2004, CURR DRUG TARGETS, V5, P473, DOI 10.2174/1389450043345344; ALTRUP U, 1987, BRAIN RES, V414, P271, DOI 10.1016/0006-8993(87)90007-2; APPLEGATE MD, 1988, J NEUROSCI, V8, P1096; BAHLER M, 1987, NATURE, V326, P704, DOI 10.1038/326704a0; BENFENATI F, 1989, J CELL BIOL, V108, P1863, DOI 10.1083/jcb.108.5.1863; BENFENATI F, 1992, NEURON, V8, P377, DOI 10.1016/0896-6273(92)90303-U; Berkeley JL, 2002, J NEUROCHEM, V82, P192, DOI 10.1046/j.1471-4159.2002.00977.x; BLOOM FE, 1979, P NATL ACAD SCI USA, V76, P5982, DOI 10.1073/pnas.76.11.5982; Bloom O, 2003, J CELL BIOL, V161, P737, DOI 10.1083/jcb.200212140; BOULTON CL, 1993, EUR J PHARMACOL, V236, P131, DOI 10.1016/0014-2999(93)90235-A; Bracey JM, 2009, BRAIN RES, V1283, P167, DOI 10.1016/j.brainres.2009.05.066; Casadio A, 2004, J NEUROSCI RES, V75, P32, DOI 10.1002/jnr.10841; CASTELLUCCI V, 1970, SCIENCE, V167, P1745, DOI 10.1126/science.167.3926.1745; CECCARELLI B, 1980, PHYSIOL REV, V60, P396, DOI 10.1152/physrev.1980.60.2.396; Cesca F, 2010, PROG NEUROBIOL, V91, P313, DOI 10.1016/j.pneurobio.2010.04.006; CHALAZONITIS N, 1968, CR SOC BIOL, V162, P1552; Chi P, 2003, NEURON, V38, P69, DOI 10.1016/S0896-6273(03)00151-X; Chi P, 2001, NAT NEUROSCI, V4, P1187, DOI 10.1038/nn756; Christoffersen GRJ, 1997, PROG NEUROBIOL, V53, P45, DOI 10.1016/S0301-0082(97)00031-2; Cousin MA, 2003, J BIOL CHEM, V278, P29065, DOI 10.1074/jbc.M302386200; Debanne D, 1996, J PHYSIOL-LONDON, V491, P163, DOI 10.1113/jphysiol.1996.sp021204; DECAMILLI P, 1979, P NATL ACAD SCI USA, V76, P5977; DECAMILLI P, 1983, J CELL BIOL, V96, P1337, DOI 10.1083/jcb.96.5.1337; DECAMILLI P, 1983, J CELL BIOL, V96, P1355, DOI 10.1083/jcb.96.5.1355; Delgado R, 2000, NEURON, V28, P941, DOI 10.1016/S0896-6273(00)00165-3; Dobrunz LE, 1997, NEURON, V18, P995, DOI 10.1016/S0896-6273(00)80338-4; Doussau F, 1998, J NEUROSCI, V18, P3147; Etholm L, 2012, EPILEPSY RES, V99, P252, DOI 10.1016/j.eplepsyres.2011.12.004; Etholm L, 2009, EPILEPSY BEHAV, V14, P582, DOI 10.1016/j.yebeh.2009.02.021; Fassio A, 2011, HUM MOL GENET, V20, P2297, DOI 10.1093/hmg/ddr122; Felmy F, 2006, J NEUROPHYSIOL, V96, P2840, DOI 10.1152/jn.00783.2006; Fioravante D, 2007, J NEUROPHYSIOL, V98, P3568, DOI 10.1152/jn.00604.2007; FISCHER J, 1980, EPILEPSIA, V21, P571, DOI 10.1111/j.1528-1157.1980.tb04311.x; Fiumara F, 2004, J CELL SCI, V117, P5145, DOI 10.1242/jcs.01388; Fiumara F, 2007, J CELL SCI, V120, P3228, DOI 10.1242/jcs.012005; Fornasiero EF, 2012, J NEUROSCI, V32, P12214, DOI 10.1523/JNEUROSCI.1554-12.2012; FRIED G, 1982, P NATL ACAD SCI-BIOL, V79, P2717, DOI 10.1073/pnas.79.8.2717; Gaffield MA, 2006, NEURON, V51, P317, DOI 10.1016/j.neuron.2006.06.031; Garcia CC, 2004, J MED GENET, V41, P183, DOI 10.1136/jmg.2003.013680; Ghirardi M, 1996, INVERTEBR NEUROSCI, V2, P41, DOI 10.1007/BF02336659; Giachello CNG, 2012, NEURAL PLAST, V2012, DOI 10.1155/2012/670821; Giachello CNG, 2010, J CELL SCI, V123, P881, DOI 10.1242/jcs.056846; Giovedi S, 2004, J BIOL CHEM, V279, P43769, DOI 10.1074/jbc.M404168200; Giovedi S, 2004, J BIOL CHEM, V279, P43760, DOI 10.1074/jbc.M403293200; Gitler D, 2004, J NEUROSCI, V24, P11368, DOI 10.1523/JNEUROSCI.3795-04.2004; Gitler D, 2004, J NEUROSCI, V24, P3711, DOI 10.1523/JNEUROSCI.5225-03.2004; GREENGARD P, 1993, SCIENCE, V259, P780, DOI 10.1126/science.8430330; Habets RLP, 2005, J PHYSIOL-LONDON, V564, P173, DOI 10.1113/jphysiol.2004.079160; Habets RLP, 2007, J PHYSIOL-LONDON, V581, P467, DOI 10.1113/jphysiol.2006.127365; Hagler DJ, 2001, J NEUROPHYSIOL, V85, P2324, DOI 10.1152/jn.2001.85.6.2324; Higashima M, 2002, BRAIN RES, V949, P157, DOI 10.1016/S0006-8993(02)02976-1; HIROKAWA N, 1989, J CELL BIOL, V108, P111, DOI 10.1083/jcb.108.1.111; HOVORKA J, 1989, NEUROSCI LETT, V107, P179, DOI 10.1016/0304-3940(89)90813-6; Humeau Y, 2001, J NEUROSCI, V21, P4195, DOI 10.1523/JNEUROSCI.21-12-04195.2001; Humeau Y, 2007, J PHYSIOL-LONDON, V583, P983, DOI 10.1113/jphysiol.2007.139899; HUTTNER WB, 1983, J CELL BIOL, V96, P1374, DOI 10.1083/jcb.96.5.1374; Jovanovic JN, 2000, NAT NEUROSCI, V3, P323, DOI 10.1038/73888; Jovanovic JN, 1996, P NATL ACAD SCI USA, V93, P3679, DOI 10.1073/pnas.93.8.3679; Jovanovic JN, 2001, J NEUROSCI, V21, P7944, DOI 10.1523/JNEUROSCI.21-20-07944.2001; Kidokoro Y, 2004, BRAIN RES REV, V47, P18, DOI 10.1016/j.brainresrev.2004.05.004; Kim JH, 2003, NEURON, V40, P151, DOI 10.1016/S0896-6273(03)00595-6; Kim SM, 2009, P NATL ACAD SCI USA, V106, P4000, DOI 10.1073/pnas.0806064106; Kopanitsa MV, 1997, NEUROPHYSIOLOGY+, V29, P357, DOI 10.1007/BF02463356; Korogod N, 2005, J NEUROSCI, V25, P5127, DOI 10.1523/JNEUROSCI.1295-05.2005; Kuromi H, 2003, J NEUROCYTOL, V32, P551, DOI 10.1023/B:NEUR.0000020610.13554.3c; Kuromi H, 2000, NEURON, V27, P133, DOI 10.1016/S0896-6273(00)00015-5; Kushner SA, 2005, J NEUROSCI, V25, P9721, DOI 10.1523/JNEUROSCI.2836-05.2005; LANGMEIER M, 1980, EPILEPSIA, V21, P255, DOI 10.1111/j.1528-1157.1980.tb04071.x; LANGMEIER M, 1983, EPILEPSIA, V24, P616, DOI 10.1111/j.1528-1157.1983.tb03427.x; LI L, 1995, P NATL ACAD SCI USA, V92, P9235, DOI 10.1073/pnas.92.20.9235; Lu WY, 2001, NEURON, V29, P243, DOI 10.1016/S0896-6273(01)00194-5; Luk CC, 2011, EUR J NEUROSCI, V34, P569, DOI 10.1111/j.1460-9568.2011.07784.x; MADEJA M, 1989, COMP BIOCHEM PHYS C, V94, P585, DOI 10.1016/0742-8413(89)90117-5; MANABE T, 1993, J NEUROPHYSIOL, V70, P1451, DOI 10.1152/jn.1993.70.4.1451; Massey PV, 2004, J NEUROSCI, V24, P7821, DOI 10.1523/JNEUROSCI.1697-04.2004; Massobrio P, 2009, NEUROSCI LETT, V467, P121, DOI 10.1016/j.neulet.2009.10.019; Matsubara M, 1996, J BIOL CHEM, V271, P21108, DOI 10.1074/jbc.271.35.21108; MATSUMOTO H, 1964, SCIENCE, V144, P193, DOI 10.1126/science.144.3615.193; Menegon A, 2006, J NEUROSCI, V26, P11670, DOI 10.1523/JNEUROSCI.3321-06.2006; Merlo D, 2004, J NEUROCHEM, V89, P654, DOI 10.1111/j.1471-4159.2004.02382.x; Millar AG, 2002, J NEUROSCI, V22, P9661; Nateri AS, 2007, EMBO J, V26, P4891, DOI 10.1038/sj.emboj.7601911; ONOZUKA M, 1987, BIOCHEM PHARMACOL, V36, P1407, DOI 10.1016/0006-2952(87)90106-7; ONOZUKA M, 1986, BRAIN RES, V362, P33, DOI 10.1016/0006-8993(86)91395-8; ONOZUKA M, 1989, GEN PHARMACOL-VASC S, V20, P627, DOI 10.1016/0306-3623(89)90098-0; ONOZUKA M, 1986, EXP NEUROL, V94, P802, DOI 10.1016/0014-4886(86)90260-8; Orenbuch A, 2012, J NEUROSCI, V32, P3969, DOI 10.1523/JNEUROSCI.5058-11.2012; Otsu Y, 2004, J NEUROSCI, V24, P420, DOI 10.1523/JNEUROSCI.4452-03.2004; PIERIBONE VA, 1995, NATURE, V375, P493, DOI 10.1038/375493a0; Pivovarov A S, 2002, Neurosci Behav Physiol, V32, P223, DOI 10.1023/A:1015045920384; PRINCE DA, 1969, ELECTROEN CLIN NEURO, V26, P476, DOI 10.1016/0013-4694(69)90124-2; PURPURA DP, 1966, J NEUROPHYSIOL, V29, P954, DOI 10.1152/jn.1966.29.5.954; Reijmers LGJE, 2000, NEUROSCIENCE, V101, P1023, DOI 10.1016/S0306-4522(00)00394-8; Richards DA, 2000, NEURON, V27, P551, DOI 10.1016/S0896-6273(00)00065-9; Rizzoli SO, 2005, NAT REV NEUROSCI, V6, P57, DOI 10.1038/nrn1583; Rizzoli SO, 2004, SCIENCE, V303, P2037, DOI 10.1126/science.1094682; ROSAHL TW, 1995, NATURE, V375, P488, DOI 10.1038/375488a0; Rosenmund C, 1996, NEURON, V16, P1197, DOI 10.1016/S0896-6273(00)80146-4; Sakaba T, 2001, P NATL ACAD SCI USA, V98, P331, DOI 10.1073/pnas.021541098; Schneggenburger R, 2002, TRENDS NEUROSCI, V25, P206, DOI 10.1016/S0166-2236(02)02139-2; Schneggenburger R, 1999, NEURON, V23, P399, DOI 10.1016/S0896-6273(00)80789-8; SCHULZE H, 1975, NEUROSCI LETT, V1, P277, DOI 10.1016/0304-3940(75)90043-9; SCHULZEBONHAGE A, 1993, COMP BIOCHEM PHYS A, V106, P537, DOI 10.1016/0300-9629(93)90250-8; Schweizer FE, 2006, CURR OPIN NEUROBIOL, V16, P298, DOI 10.1016/j.conb.2006.05.006; Sennepin AD, 2009, ANAL BIOCHEM, V393, P129, DOI 10.1016/j.ab.2009.06.004; Shoji Y, 1998, J NEUROPHYSIOL, V80, P638, DOI 10.1152/jn.1998.80.2.638; SPECKMAN.EJ, 1973, EPILEPSIA, V14, P397, DOI 10.1111/j.1528-1157.1973.tb03979.x; SPILLANE DM, 1995, NEUROPHARMACOLOGY, V34, P1573, DOI 10.1016/0028-3908(95)00107-H; STEFFENS H, 1980, ZOOMORPHOLOGIE, V95, P195, DOI 10.1007/BF00998122; SUGAYA E, 1978, SCIENCE, V200, P797, DOI 10.1126/science.644325; SUGAYA E, 1987, BRAIN RES, V416, P183, DOI 10.1016/0006-8993(87)91515-0; Tao-Cheng JH, 2006, NEUROSCIENCE, V141, P1217, DOI 10.1016/j.neuroscience.2006.04.061; TEHRANI MHJ, 1995, EPILEPSY RES, V22, P13, DOI 10.1016/0920-1211(95)00033-7; Upadhaya R, 2011, ANAL BIOCHEM, V419, P342, DOI 10.1016/j.ab.2011.08.014; Ure A, 2006, NEUROSCI LETT, V392, P10, DOI 10.1016/j.neulet.2005.08.045; Valente P, 2012, J NEUROSCI, V32, P5868, DOI 10.1523/JNEUROSCI.5275-11.2012; VALTORTA F, 1988, NEUROSCIENCE, V24, P593, DOI 10.1016/0306-4522(88)90353-3; Vasileva M, 2012, EUR J NEUROSCI, V36, P3005, DOI 10.1111/j.1460-9568.2012.08225.x; Volianskis A, 2003, J PHYSIOL-LONDON, V550, P459, DOI 10.1113/jphysiol.2003.044214; Xi ZQ, 2007, EUR J NEUROL, V14, P865, DOI 10.1111/j.1468-1331.2007.01777.x; Yechikhov S, 2001, EPILEPSY RES, V46, P15, DOI 10.1016/S0920-1211(01)00255-8; Zhao Y, 2004, J NEUROPHYSIOL, V91, P1500, DOI 10.1152/jn.01019.2003; ZUCKER RS, 1993, J PHYSIOL-PARIS, V87, P25, DOI 10.1016/0928-4257(93)90021-K; Zucker RS, 2002, ANNU REV PHYSIOL, V64, P355, DOI 10.1146/annurev.physiol.64.092501.114547	128	7	7	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e56968	10.1371/journal.pone.0056968	http://dx.doi.org/10.1371/journal.pone.0056968			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437283	Green Published, Green Submitted, gold			2022-12-25	WOS:000315184200192
J	Ilina, EN; Shitikov, EA; Ikryannikova, LN; Alekseev, DG; Kamashev, DE; Malakhova, MV; Parfenova, TV; Afanas'ev, MV; Ischenko, DS; Bazaleev, NA; Smirnova, TG; Larionova, EE; Chernousova, LN; Beletsky, AV; Mardanov, AV; Ravin, NV; Skryabin, KG; Govorun, VM				Ilina, Elena N.; Shitikov, Egor A.; Ikryannikova, Larisa N.; Alekseev, Dmitry G.; Kamashev, Dmitri E.; Malakhova, Maja V.; Parfenova, Tatjana V.; Afanas'ev, Maxim V.; Ischenko, Dmitry S.; Bazaleev, Nikolai A.; Smirnova, Tatjana G.; Larionova, Elena E.; Chernousova, Larisa N.; Beletsky, Alexey V.; Mardanov, Andrei V.; Ravin, Nikolai V.; Skryabin, Konstantin G.; Govorun, Vadim M.			Comparative Genomic Analysis of Mycobacterium tuberculosis Drug Resistant Strains from Russia	PLOS ONE			English	Article							RIFAMPIN RESISTANCE; ETHAMBUTOL RESISTANCE; ISONIAZID RESISTANCE; POPULATION-GENETICS; EFFLUX PUMP; MUTATIONS; POLYMORPHISM; MECHANISMS; DIVERSITY; EVOLUTION	Tuberculosis caused by multidrug-resistant (MDR) and extensively drug-resistant (XDR) Mycobacterium tuberculosis (MTB) strains is a growing problem in many countries. The availability of the complete nucleotide sequences of several MTB genomes allows to use the comparative genomics as a tool to study the relationships of strains and differences in their evolutionary history including acquisition of drug-resistance. In our work, we sequenced three genomes of Russian MTB strains of different phenotypes - drug susceptible, MDR and XDR. Of them, MDR and XDR strains were collected in Tomsk (Siberia, Russia) during the local TB outbreak in 1998-1999 and belonged to rare KQ and KY families in accordance with IS6110 typing, which are considered endemic for Russia. Based on phylogenetic analysis, our isolates belonged to different genetic families, Beijing, Ural and LAM, which made the direct comparison of their genomes impossible. For this reason we performed their comparison in the broader context of all M. tuberculosis genomes available in GenBank. The list of unique individual non-synonymous SNPs for each sequenced isolate was formed by comparison with all SNPs detected within the same phylogenetic group. For further functional analysis, all proteins with unique SNPs were ascribed to 20 different functional classes based on Clusters of Orthologous Groups (COG). We have confirmed drug resistant status of our isolates that harbored almost all known drug-resistance associated mutations. Unique SNPs of an XDR isolate CTRI-4(XDR), belonging to a Beijing family were compared in more detail with SNPs of additional 14 Russian XDR strains of the same family. Only type specific mutations in genes of repair, replication and recombination system (COG category L) were found common within this group. Probably the other unique SNPs discovered in CTRI-4(XDR) may have an important role in adaptation of this microorganism to its surrounding and in escape from antituberculosis drugs treatment.	[Ilina, Elena N.; Shitikov, Egor A.; Ikryannikova, Larisa N.; Alekseev, Dmitry G.; Kamashev, Dmitri E.; Malakhova, Maja V.; Parfenova, Tatjana V.; Afanas'ev, Maxim V.; Ischenko, Dmitry S.; Bazaleev, Nikolai A.; Govorun, Vadim M.] Res Inst Phys Chem Med, Moscow, Russia; [Smirnova, Tatjana G.; Larionova, Elena E.; Chernousova, Larisa N.] Cent TB Res Inst RAMS, Moscow, Russia; [Beletsky, Alexey V.; Mardanov, Andrei V.; Ravin, Nikolai V.; Skryabin, Konstantin G.] Ctr Bioengn RAS, Moscow, Russia; [Alekseev, Dmitry G.; Ischenko, Dmitry S.] Moscow Inst Phys & Technol, Dolgoprudnyi, Russia	Lopukhin Federal Research & Clinical Center of Physical-Chemical Medicine of Federal Medical Biological Agency; Research Center of Biotechnology RAS; Russian Academy of Sciences; Moscow Institute of Physics & Technology	Shitikov, EA (corresponding author), Res Inst Phys Chem Med, Moscow, Russia.	egorshtkv@gmail.com	Ilina, Elena N/N-8190-2015; Beletsky, Alexey/AAA-5366-2019; Shitikov, Egor/AAJ-4171-2021; Mardanov, Andrey/S-2294-2016; Ravin, Nikolai V/C-5907-2014; Alexeev, Dmitry/A-6167-2013; Ilina, Elena/ABI-1172-2020; Govorun, Vadim M/A-9043-2018; Shitikov, Egor/Q-2520-2017; Ikryannikova, Larisa/AAT-7326-2021; Kamashev, Dmitri/K-6560-2017	Ilina, Elena N/0000-0003-0130-5079; Beletsky, Alexey/0000-0002-7611-2354; Shitikov, Egor/0000-0002-4865-6004; Mardanov, Andrey/0000-0002-8245-8757; Alexeev, Dmitry/0000-0003-0783-1176; Ilina, Elena/0000-0003-0130-5079; Shitikov, Egor/0000-0002-4865-6004; Kamashev, Dmitri/0000-0003-4158-5300; Ravin, Nikolai/0000-0002-1456-1832; Larionova, Elena/0000-0002-6032-175X	Ministry of Education and Science of the Russian Federation [16.522.11.2003]	Ministry of Education and Science of the Russian Federation(Ministry of Education and Science, Russian Federation)	This work was partly supported by 16.522.11.2003 grant of the Ministry of Education and Science of the Russian Federation. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharya A, 2010, OXID MED CELL LONGEV, V3, P23, DOI 10.4161/oxim.3.1.10095; Achtman M, 2008, ANNU REV MICROBIOL, V62, P53, DOI 10.1146/annurev.micro.62.081307.162832; da Silva PEA, 2011, FEMS IMMUNOL MED MIC, V63, P1, DOI 10.1111/j.1574-695X.2011.00831.x; Da Silva PEA, 2011, J ANTIMICROB CHEMOTH, V66, P1417, DOI 10.1093/jac/dkr173; Andreevskaia S N, 2006, Probl Tuberk Bolezn Legk, P29; Brimacombe M, 2007, ANTIMICROB AGENTS CH, V51, P4157, DOI 10.1128/AAC.00619-07; Brossier F, 2011, ANTIMICROB AGENTS CH, V55, P355, DOI 10.1128/AAC.01030-10; Brudey K, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-23; Brzostek A, 2004, INT J TUBERC LUNG D, V8, P1032; Casali N, 2012, GENOME RES, V22, P735, DOI 10.1101/gr.128678.111; *CDCP, 2006, MMWR-MORBID MORTAL W, V55, P1176; Chakravorty S, 2008, J CLIN MICROBIOL, V46, P2555, DOI 10.1128/JCM.00666-08; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Comas I, 2012, NAT GENET, V44, P106, DOI 10.1038/ng.1038; Comas I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007815; Comas I, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000600; Danilchanka O, 2008, ANTIMICROB AGENTS CH, V52, P2503, DOI 10.1128/AAC.00298-08; Darling ACE, 2004, GENOME RES, V14, P1394, DOI 10.1101/gr.2289704; Das S, 2009, J BIOSCIENCES, V34, P397, DOI 10.1007/s12038-009-0046-y; De Rossi Edda, 2002, Molecular Medicine (Baltimore), V8, P714; Dos Vultos T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001538; Eddy SR, 2004, NAT BIOTECHNOL, V22, P1035, DOI 10.1038/nbt0804-1035; Farnia P, 2010, INT J CLIN EXP MED, V3, P308; Filliol I, 2006, J BACTERIOL, V188, P759, DOI 10.1128/JB.188.2.759-772.2006; Fukuda M, 1999, J ANTIMICROB CHEMOTH, V43, P281, DOI 10.1093/jac/43.2.281; Gagneux S, 2006, P NATL ACAD SCI USA, V103, P2869, DOI 10.1073/pnas.0511240103; Gandhi NR, 2006, LANCET, V368, P1575, DOI 10.1016/S0140-6736(06)69573-1; Georghiou SB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033275; Gupta R, 2010, NAT MED, V16, P466, DOI 10.1038/nm.2120; Gutacker MM, 2002, GENETICS, V162, P1533; Hazbon MH, 2006, ANTIMICROB AGENTS CH, V50, P2640, DOI 10.1128/AAC.00112-06; HENIKOFF S, 1992, P NATL ACAD SCI USA, V89, P10915, DOI 10.1073/pnas.89.22.10915; Hershberg R, 2008, PLOS BIOL, V6, P2658, DOI 10.1371/journal.pbio.0060311; Ioerger TR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007778; Jureen P, 2008, ANTIMICROB AGENTS CH, V52, P1852, DOI 10.1128/AAC.00110-08; Kamerbeek J, 1997, J CLIN MICROBIOL, V35, P907, DOI 10.1128/JCM.35.4.907-914.1997; Keshavjee S, 2008, LANCET, V372, P1403, DOI 10.1016/S0140-6736(08)61204-0; Kim S, 2011, PROTEINS, V79, P2983, DOI 10.1002/prot.23119; Kohanski MA, 2007, CELL, V130, P797, DOI 10.1016/j.cell.2007.06.049; Kremer K, 2004, J CLIN MICROBIOL, V42, P4040, DOI 10.1128/JCM.42.9.4040-4049.2004; Kurepina N, 2005, J CLIN MICROBIOL, V43, P2148, DOI 10.1128/JCM.43.5.2148-2154.2005; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; Mathys V, 2009, ANTIMICROB AGENTS CH, V53, P2100, DOI 10.1128/AAC.01197-08; McCammon MT, 2005, ANTIMICROB AGENTS CH, V49, P2200, DOI 10.1128/AAC.49.6.2200-2209.2005; Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626; Mlambo CK, 2008, INT J TUBERC LUNG D, V12, P99; Mokrousov I, 2002, RES MICROBIOL, V153, P629, DOI 10.1016/S0923-2508(02)01374-8; Mokrousov I, 2012, INFECT GENET EVOL, V12, P619, DOI 10.1016/j.meegid.2011.09.026; Moodley P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017513; Motiwala AS, 2010, J INFECT DIS, V201, P881, DOI 10.1086/650999; Nisa S, 2010, J ANTIMICROB CHEMOTH, V65, P2347, DOI 10.1093/jac/dkq311; Pasca MR, 2004, ANTIMICROB AGENTS CH, V48, P3175, DOI 10.1128/AAC.48.8.3175-3178.2004; Plinke C, 2006, ANTIMICROB AGENTS CH, V50, P1900, DOI 10.1128/AAC.50.5.1900-1902.2006; Punga VV, 2009, INT J TUBERC LUNG D, V13, P1309; Pym AS, 2002, INFECT IMMUN, V70, P4955, DOI 10.1128/IAI.70.9.4955-4960.2002; Rad ME, 2003, EMERG INFECT DIS, V9, P838, DOI 10.3201/eid0907.020803; Ramaswamy S., 1998, Tubercle and Lung Disease, V79, P3, DOI 10.1054/tuld.1998.0002; Rengarajan J, 2004, MOL MICROBIOL, V53, P275, DOI 10.1111/j.1365-2958.2004.04120.x; Sandgren A, 2009, PLOS MED, V6, P132, DOI 10.1371/journal.pmed.1000002; Sassetti CM, 2003, MOL MICROBIOL, V48, P77, DOI 10.1046/j.1365-2958.2003.03425.x; Schurch AC, 2011, INFECT GENET EVOL, V3, P3; Schurek KN, 2008, ANTIMICROB AGENTS CH, V52, P4213, DOI 10.1128/AAC.00507-08; Shah N. S., 2007, Morbidity and Mortality Weekly Report, V56, P250; Shi WL, 2011, SCIENCE, V333, P1630, DOI 10.1126/science.1208813; Shin SS, 2010, AM J RESP CRIT CARE, V182, P426, DOI 10.1164/rccm.200911-1768OC; Smith PA, 2007, NAT CHEM BIOL, V3, P549, DOI 10.1038/nchembio.2007.27; Sreevatsan S, 1997, ANTIMICROB AGENTS CH, V41, P1677, DOI 10.1128/AAC.41.8.1677; Sreevatsan S, 1997, P NATL ACAD SCI USA, V94, P9869, DOI 10.1073/pnas.94.18.9869; Supply P, 2006, J CLIN MICROBIOL, V44, P4498, DOI 10.1128/JCM.01392-06; Suzuki Y, 1998, J CLIN MICROBIOL, V36, P1220, DOI 10.1128/JCM.36.5.1220-1225.1998; Tatusov RL, 1997, SCIENCE, V278, P631, DOI 10.1126/science.278.5338.631; Tatusov RL, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-41; The Federal Service for Surveillance of Consumer Rights Protection and Human Well-Being of the Russian Federation, 2009, STAT REP SAN EP SIT; Toungoussova OS, 2005, EUR J CLIN MICROBIOL, V24, P202, DOI 10.1007/s10096-005-1284-z; VANEMBDEN JDA, 1993, J CLIN MICROBIOL, V31, P406, DOI 10.1128/JCM.31.2.406-409.1993; Velayati AA, 2009, CHEMOTHERAPY, V55, P303, DOI 10.1159/000226425; Via LE, 2010, J CLIN MICROBIOL, V48, P402, DOI 10.1128/JCM.01476-09; Vilcheze C, 2005, ANTIMICROB AGENTS CH, V49, P708, DOI 10.1128/AAC.49.2.708-720.2005; Wade MM, 2004, FRONT BIOSCI-LANDMRK, V9, P975, DOI 10.2741/1289; Wang QZ, 2007, J PROTEOME RES, V6, P4564, DOI 10.1021/pr070242z; Wong SY, 2011, ANTIMICROB AGENTS CH, V55, P2515, DOI 10.1128/AAC.01814-10; World Health Organization, 2010, WHOHTMTB20107; Zhang Y, 2009, INT J TUBERC LUNG D, V13, P1320; ZHANG Y, 1992, NATURE, V358, P591, DOI 10.1038/358591a0; Zhang YY, 2011, J BACTERIOL, V193, P5591, DOI 10.1128/JB.05452-11	85	39	41	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e56577	10.1371/journal.pone.0056577	http://dx.doi.org/10.1371/journal.pone.0056577			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437175	Green Submitted, Green Published, gold			2022-12-25	WOS:000315184200111
J	Lee, EJ; De Winter, JM; Buck, D; Jasper, JR; Malik, FI; Labeit, S; Ottenheijm, CA; Granzier, H				Lee, Eun-Jeong; De Winter, Josine M.; Buck, Danielle; Jasper, Jeffrey R.; Malik, Fady I.; Labeit, Siegfried; Ottenheijm, Coen A.; Granzier, Henk			Fast Skeletal Muscle Troponin Activation Increases Force of Mouse Fast Skeletal Muscle and Ameliorates Weakness Due to Nebulin-Deficiency	PLOS ONE			English	Article							THIN FILAMENT LENGTH; NEMALINE MYOPATHY; DEPENDENT ACTIVATION; ACTIN; SARCOMERE; GENE; FIBERS; TITIN; MUTATIONS; DISEASE	The effect of the fast skeletal muscle troponin activator, CK-2066260, on calcium-induced force development was studied in skinned fast skeletal muscle fibers from wildtype (WT) and nebulin deficient (NEB KO) mice. Nebulin is a sarcomeric protein that when absent (NEB KO mouse) or present at low levels (nemaline myopathy (NM) patients with NEB mutations) causes muscle weakness. We studied the effect of fast skeletal troponin activation on WT muscle and tested whether it might be a therapeutic mechanism to increase muscle strength in nebulin deficient muscle. We measured tension-pCa relations with and without added CK-2066260. Maximal active tension in NEB KO tibialis cranialis fibers in the absence of CK-2066260 was similar to 60% less than in WT fibers, consistent with earlier work. CK-2066260 shifted the tension-calcium relationship leftwards, with the largest relative increase (up to 8-fold) at low to intermediate calcium levels. This was a general effect that was present in both WT and NEB KO fiber bundles. At pCa levels above similar to 6.0 (i.e., calcium concentrations <1 mu M), CK-2066260 increased tension of NEB KO fibers to beyond that of WT fibers. Crossbridge cycling kinetics were studied by measuring k(tr) (rate constant of force redevelopment following a rapid shortening/restretch). CK-2066260 greatly increased k(tr) at submaximal activation levels in both WT and NEB KO fiber bundles. We also studied the sarcomere length (SL) dependence of the CK-2066260 effect (SL 2.1 mu m and 2.6 mu m) and found that in the NEB KO fibers, CK-2066260 had a larger effect on calcium sensitivity at the long SL. We conclude that fast skeletal muscle troponin activation increases force at submaximal activation in both wildtype and NEB KO fiber bundles and, importantly, that this troponin activation is a potential therapeutic mechanism for increasing force in NM and other skeletal muscle diseases with loss of muscle strength.	[Lee, Eun-Jeong; Buck, Danielle; Ottenheijm, Coen A.; Granzier, Henk] Univ Arizona, Dept Physiol, Tucson, AZ 85721 USA; [De Winter, Josine M.; Ottenheijm, Coen A.] Vrije Univ Amsterdam, Med Ctr Amsterdam, Dept Physiol, Inst Cardiovasc Res, Amsterdam, Netherlands; [Jasper, Jeffrey R.; Malik, Fady I.] Cytokinetics Inc, Res & Early Dev, San Francisco, CA USA; [Labeit, Siegfried] Heidelberg Univ, Univ Med Mannheim, Dept Integrat Pathophysiol, Mannheim, Germany	University of Arizona; Vrije Universiteit Amsterdam; Ruprecht Karls University Heidelberg	Granzier, H (corresponding author), Univ Arizona, Dept Physiol, Tucson, AZ 85721 USA.	Granzier@email.arizona.edu			A Foundation for Building Strength in Nemaline Myopathy; NIH [AR05387]; SarcoSI; NEMMYOP; VIDI [016.126.319]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR053897] Funding Source: NIH RePORTER	A Foundation for Building Strength in Nemaline Myopathy; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); SarcoSI; NEMMYOP; VIDI(Netherlands Organization for Scientific Research (NWO)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	Generous support by 'A Foundation for Building Strength in Nemaline Myopathy' is acknowledged. Additional support from NIH AR05387 (HG), SarcoSI and NEMMYOP(SL and CACO) and a VIDI grant (016.126.319) to CACO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal PB, 2007, AM J HUM GENET, V80, P162, DOI 10.1086/510402; Bang ML, 2006, J CELL BIOL, V173, P905, DOI 10.1083/jcb.200603119; Bang ML, 2009, FASEB J, V23, P4117, DOI 10.1096/fj.09-137729; BRENNER B, 1988, P NATL ACAD SCI USA, V85, P3265, DOI 10.1073/pnas.85.9.3265; Castillo A, 2009, BIOPHYS J, V96, P1856, DOI 10.1016/j.bpj.2008.10.053; Chandra M, 2009, J BIOL CHEM, V284, P30889, DOI 10.1074/jbc.M109.049718; Donner K, 2002, NEUROMUSCULAR DISORD, V12, P151, DOI 10.1016/S0960-8966(01)00252-8; FABIATO A, 1979, J PHYSIOL-PARIS, V75, P463; GRANZIER HLM, 1991, AM J PHYSIOL, V260, pC1060, DOI 10.1152/ajpcell.1991.260.5.C1060; Huxley HE, 2004, EUR J BIOCHEM, V271, P1403, DOI 10.1111/j.1432-1033.2004.04044.x; JASMIN BJ, 1987, J APPL PHYSIOL, V63, P713, DOI 10.1152/jappl.1987.63.2.713; JIN JP, 1991, J BIOL CHEM, V266, P21215; JIN JP, 1991, FEBS LETT, V281, P93, DOI 10.1016/0014-5793(91)80366-B; Johnston JJ, 2000, AM J HUM GENET, V67, P814, DOI 10.1086/303089; Kazmierski ST, 2003, J MOL BIOL, V328, P835, DOI 10.1016/S0022-2836(03)00348-6; KENTISH JC, 1986, CIRC RES, V58, P755, DOI 10.1161/01.RES.58.6.755; Konhilas JP, 2002, PFLUG ARCH EUR J PHY, V445, P305, DOI 10.1007/s00424-002-0902-1; Konhilas JP, 2002, J PHYSIOL-LONDON, V544, P225, DOI 10.1113/jphysiol.2002.024505; KRUGER M, 1991, J CELL BIOL, V115, P97, DOI 10.1083/jcb.115.1.97; LABEIT S, 1995, J MOL BIOL, V248, P308, DOI 10.1016/S0022-2836(95)80052-2; Lahmers S, 2004, CIRC RES, V94, P505, DOI 10.1161/01.RES.0000115522.52554.86; LAING N, 1995, NAT GENET, V10, P249, DOI 10.1038/ng0695-249a; Laing NG, 2005, BIOESSAYS, V27, P809, DOI 10.1002/bies.20269; Lawlor MW, 2011, SKELET MUSCLE, V1, DOI 10.1186/2044-5040-1-23; METZGER JM, 1989, J GEN PHYSIOL, V93, P855, DOI 10.1085/jgp.93.5.855; METZGER JM, 1990, SCIENCE, V247, P1088, DOI 10.1126/science.2309121; Moreno-Gonzalez A, 2007, J PHYSIOL-LONDON, V579, P313, DOI 10.1113/jphysiol.2006.124164; Muhle-Goll C, 2001, J MOL BIOL, V313, P431, DOI 10.1006/jmbi.2001.5017; North KN, 1997, J MED GENET, V34, P705, DOI 10.1136/jmg.34.9.705; Nowak KJ, 1999, NAT GENET, V23, P208, DOI 10.1038/13837; Ottenheijm CAC, 2006, AM J RESP CRIT CARE, V173, P527, DOI 10.1164/rccm.200507-1056OC; Ottenheijm CAC, 2010, J STRUCT BIOL, V170, P334, DOI 10.1016/j.jsb.2009.11.013; Ottenheijm CAC, 2009, HUM MOL GENET, V18, P2359, DOI 10.1093/hmg/ddp168; Pappas CT, 2010, J CELL BIOL, V189, P859, DOI 10.1083/jcb.201001043; Pelin K, 1999, P NATL ACAD SCI USA, V96, P2305, DOI 10.1073/pnas.96.5.2305; Regnier M, 1996, BIOPHYS J, V71, P2786, DOI 10.1016/S0006-3495(96)79471-7; Russell AJ, 2012, NAT MED, V18, P452, DOI 10.1038/nm.2618; Sanoudou D, 2001, TRENDS MOL MED, V7, P362, DOI 10.1016/S1471-4914(01)02089-5; Takano K, 2010, SCIENCE, V330, P1536, DOI 10.1126/science.1197767; WANG SM, 1988, J CELL BIOL, V107, P1075, DOI 10.1083/jcb.107.3.1075; WANG SM, 1985, J MUSCLE RES CELL M, V6, P293, DOI 10.1007/BF00713171; Warren CM, 2003, ELECTROPHORESIS, V24, P1695, DOI 10.1002/elps.200305392; Witt CC, 2006, EMBO J, V25, P3843, DOI 10.1038/sj.emboj.7601242; WRIGHT J, 1993, J MUSCLE RES CELL M, V14, P476, DOI 10.1007/BF00297210	44	20	20	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e55861	10.1371/journal.pone.0055861	http://dx.doi.org/10.1371/journal.pone.0055861			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437068	gold, Green Published, Green Submitted			2022-12-25	WOS:000315184200027
J	Nagy-Szakal, D; Hollister, EB; Luna, RA; Szigeti, R; Tatevian, N; Smith, CW; Versalovic, J; Kellermayer, R				Nagy-Szakal, Dorottya; Hollister, Emily B.; Luna, Ruth Ann; Szigeti, Reka; Tatevian, Nina; Smith, C. Wayne; Versalovic, James; Kellermayer, Richard			Cellulose Supplementation Early in Life Ameliorates Colitis in Adult Mice	PLOS ONE			English	Article							INFLAMMATORY BOWEL DISEASES; DEXTRAN SULFATE SODIUM; HUMAN LARGE-INTESTINE; DIETARY FIBER; ULCERATIVE-COLITIS; COLONIC-MUCOSA; GUT MICROBIOTA; FERMENTATION; DIVERSITY; SEQUENCES	Decreased consumption of dietary fibers, such as cellulose, has been proposed to promote the emergence of inflammatory bowel diseases (IBD: Crohn disease [CD] and ulcerative colitis [UC]) where intestinal microbes are recognized to play an etiologic role. However, it is not known if transient fiber consumption during critical developmental periods may prevent consecutive intestinal inflammation. The incidence of IBD peaks in young adulthood indicating that pediatric environmental exposures may be important in the etiology of this disease group. We studied the effects of transient dietary cellulose supplementation on dextran sulfate sodium (DSS) colitis susceptibility during the pediatric period in mice. Cellulose supplementation stimulated substantial shifts in the colonic mucosal microbiome. Several bacterial taxa decreased in relative abundance (e.g., Coriobacteriaceae [p = 0.001]), and other taxa increased in abundance (e.g., Peptostreptococcaceae [p = 0.008] and Clostridiaceae [p = 0.048]). Some of these shifts persisted for 10 days following the cessation of cellulose supplementation. The changes in the gut microbiome were associated with transient trophic and anticolitic effects 10 days following the cessation of a cellulose-enriched diet, but these changes diminished by 40 days following reversal to a low cellulose diet. These findings emphasize the transient protective effect of dietary cellulose in the mammalian large bowel and highlight the potential role of dietary fibers in amelioration of intestinal inflammation.	[Nagy-Szakal, Dorottya; Kellermayer, Richard] Baylor Coll Med, Dept Pediat, Sect Pediat Gastroenterol, Houston, TX 77030 USA; [Nagy-Szakal, Dorottya; Smith, C. Wayne; Kellermayer, Richard] ARS, USDA, Childrens Nutr Res Ctr, Houston, TX USA; [Hollister, Emily B.; Luna, Ruth Ann; Szigeti, Reka; Versalovic, James] Baylor Coll Med, Dept Pathol, Houston, TX 77030 USA; [Hollister, Emily B.; Luna, Ruth Ann; Smith, C. Wayne; Versalovic, James; Kellermayer, Richard] Texas Childrens Hosp, Houston, TX 77030 USA; [Tatevian, Nina] Univ Texas Hlth Sci Ctr, Dept Pathol & Lab Med, Houston, TX USA	Baylor College of Medicine; United States Department of Agriculture (USDA); Baylor College of Medicine; Baylor College of Medicine; University of Texas System; University of Texas Health Science Center Houston	Kellermayer, R (corresponding author), Baylor Coll Med, Dept Pediat, Sect Pediat Gastroenterol, Houston, TX 77030 USA.	kellerma@bcm.edu			Broad Medical Research Program, the Broad Foundation [IBD-0252]; Child Health Research Career Development Agency of the Baylor College of Medicine; Crohn's and Colitis Foundation of America-Children's Digestive Health and Nutrition Foundation/North American Society of Pediatric Gastroenterology Hepatology and Nutrition, (CCFA) [2426]; United States Department of Agriculture [6250-51000-046]	Broad Medical Research Program, the Broad Foundation; Child Health Research Career Development Agency of the Baylor College of Medicine; Crohn's and Colitis Foundation of America-Children's Digestive Health and Nutrition Foundation/North American Society of Pediatric Gastroenterology Hepatology and Nutrition, (CCFA); United States Department of Agriculture(United States Department of Agriculture (USDA))	This work was supported in part by the Broad Medical Research Program, the Broad Foundation (IBD-0252); the Child Health Research Career Development Agency of the Baylor College of Medicine; the Crohn's and Colitis Foundation of America-Children's Digestive Health and Nutrition Foundation/North American Society of Pediatric Gastroenterology Hepatology and Nutrition, (CCFA Ref #2426); the United States Department of Agriculture 6250-51000-046. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BURKITT DP, 1973, P NUTR SOC, V32, P145, DOI 10.1079/PNS19730032; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; CUMMINGS JH, 1983, LANCET, V1, P1206; CUMMINGS JH, 1984, GUT, V25, P805, DOI 10.1136/gut.25.8.805; De Filippo C, 2010, P NATL ACAD SCI USA, V107, P14691, DOI 10.1073/pnas.1005963107; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Fox J, 2007, MOUSE BIOMEDICAL RES, DOI DOI 10.1016/B978-012369454-6/50094-7; Frank DN, 2007, P NATL ACAD SCI USA, V104, P13780, DOI 10.1073/pnas.0706625104; GOODLAD RA, 1983, BRIT J NUTR, V50, P91, DOI 10.1079/BJN19830075; GOODLAD RA, 1987, GUT, V28, P221, DOI 10.1136/gut.28.Suppl.221; Haas BJ, 2011, GENOME RES, V21, P494, DOI 10.1101/gr.112730.110; Hashimoto T, 2012, NATURE, V487, P477, DOI 10.1038/nature11228; Hou JK, 2011, AM J GASTROENTEROL, V106, P563, DOI 10.1038/ajg.2011.44; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Kellermayer R, 2011, FASEB J, V25, P1449, DOI 10.1096/fj.10-172205; Kellermayer R, 2010, AM J MED GENET A, V152A, P3022, DOI 10.1002/ajmg.a.33726; Kellermayer R, 2010, HUM MOL GENET, V19, P2168, DOI 10.1093/hmg/ddq095; Kitajima S, 2000, EXP ANIM TOKYO, V49, P9, DOI 10.1538/expanim.49.9; Komiyama Y, 2011, SCAND J GASTROENTERO, V46, P40, DOI 10.3109/00365521.2010.513062; Lepage P, 2011, GASTROENTEROLOGY, V141, P227, DOI 10.1053/j.gastro.2011.04.011; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Maathuis A, 2009, J AM COLL NUTR, V28, P657, DOI 10.1080/07315724.2009.10719798; Maslowski KM, 2009, NATURE, V461, P1282, DOI 10.1038/nature08530; McCullough JS, 1998, GUT, V42, P799, DOI 10.1136/gut.42.6.799; Nagy-Szakal D, 2012, GUT MICROBES, V3; Nagy-Szakal D, 2012, J PEDIAT GA IN PRESS; Nagy-Szakal D, 2011, GUT MICROBES, V2, P178, DOI 10.4161/gmic.2.3.16107; Naito Y, 2006, J NUTR BIOCHEM, V17, P402, DOI 10.1016/j.jnutbio.2005.08.010; Packey CD, 2008, J INTERN MED, V263, P597, DOI 10.1111/j.1365-2796.2008.01962.x; PELL JD, 1995, GASTROENTEROLOGY, V108, P1745, DOI 10.1016/0016-5085(95)90136-1; PERRET V, 1977, GUT, V18, P382, DOI 10.1136/gut.18.5.382; Riehle K, BCM BIOINFO IN PRESS; Rodriguez-Cabezas ME, 2003, CLIN NUTR, V22, P463, DOI 10.1016/S0261-5614(03)00045-1; Sartor RB, 2011, MUCOSAL IMMUNOL, V4, P127, DOI 10.1038/mi.2010.87; Scarpa M, 2011, SURGERY, V150, P56, DOI 10.1016/j.surg.2011.02.009; Schaible TD, 2011, HUM MOL GENET, V20, P1687, DOI 10.1093/hmg/ddr044; Schwartz L, 2008, AM J PHYSIOL-GASTR L, V295, pG934, DOI 10.1152/ajpgi.90296.2008; Swidsinski A, 2002, GASTROENTEROLOGY, V122, P44, DOI 10.1053/gast.2002.30294; Tannock GW, 2012, INFLAMM BOWEL DIS, V18, P925, DOI 10.1002/ibd.21936; Tao R, 2007, NAT MED, V13, P1299, DOI 10.1038/nm1652; Walker AW, 2011, ISME J, V5, P220, DOI 10.1038/ISMEJ.2010.118; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; WOLIN MJ, 1981, SCIENCE, V213, P1463, DOI 10.1126/science.7280665	43	39	40	8	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e56685	10.1371/journal.pone.0056685	http://dx.doi.org/10.1371/journal.pone.0056685			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437211	Green Submitted, gold, Green Published			2022-12-25	WOS:000315184200141
J	Abraham, MC; Metheetrairut, C; Irish, VF				Abraham, Mary C.; Metheetrairut, Chanatip; Irish, Vivian F.			Natural Variation Identifies Multiple Loci Controlling Petal Shape and Size in Arabidopsis thaliana	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; BHLH TRANSCRIPTION FACTOR; RECOMBINANT INBRED LINES; ZINC-FINGER PROTEIN; PLANT ORGAN SIZE; CELL-PROLIFERATION; FLOWER DEVELOPMENT; FLORAL DEVELOPMENT; DEVELOPING LEAVES; LEAF DEVELOPMENT	Natural variation in organ morphologies can have adaptive significance and contribute to speciation. However, the underlying allelic differences responsible for variation in organ size and shape remain poorly understood. We have utilized natural phenotypic variation in three Arabidopsis thaliana ecotypes to examine the genetic basis for quantitative variation in petal length, width, area, and shape. We identified 23 loci responsible for such variation, many of which appear to correspond to genes not previously implicated in controlling organ morphology. These analyses also demonstrated that allelic differences at distinct loci can independently affect petal length, width, area or shape, suggesting that these traits behave as independent modules. We also showed that ERECTA (ER), encoding a leucine-rich repeat (LRR) receptor-like serine-threonine kinase, is a major effect locus determining petal shape. Allelic variation at the ER locus was associated with differences in petal cell proliferation and concomitant effects on petal shape. ER has been previously shown to be required for regulating cell division and expansion in other contexts; the ER receptor-like kinase functioning to also control organ-specific proliferation patterns suggests that allelic variation in common signaling components may nonetheless have been a key factor in morphological diversification.	[Abraham, Mary C.; Metheetrairut, Chanatip; Irish, Vivian F.] Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA; [Irish, Vivian F.] Yale Univ, Dept Ecol & Evolutionary Biol, New Haven, CT USA	Yale University; Yale University	Irish, VF (corresponding author), Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA.	Vivian.irish@yale.edu		Metheetrairut, Chanatip/0000-0002-4394-5085	NSF [IOS-0817744]; Yale University	NSF(National Science Foundation (NSF)); Yale University	Funding support from NSF (http://www.nsf.gov/) grant # IOS-0817744 (to V.F.I.) and from a Yale University (http://www.yale.edu/) Brown Fellowship (to M.C.A.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Anastasiou E, 2007, DEV CELL, V13, P843, DOI 10.1016/j.devcel.2007.10.001; Balasubramanian S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004318; Borevitz JO, 2002, GENETICS, V160, P683; Breuninger H, 2010, CURR TOP DEV BIOL, V91, P185, DOI 10.1016/S0070-2153(10)91007-7; Brewer MT, 2006, PLANT PHYSIOL, V141, P15, DOI 10.1104/pp.106.077867; Brioudes F, 2009, PLANT J, V60, P1070, DOI 10.1111/j.1365-313X.2009.04023.x; Brock MT, 2007, EVOLUTION, V61, P2913, DOI 10.1111/j.1558-5646.2007.00240.x; Cao J, 2011, NAT GENET, V43, P956, DOI 10.1038/ng.911; Carles CC, 2005, DEVELOPMENT, V132, P897, DOI 10.1242/dev.01642; CHURCHILL GA, 1994, GENETICS, V138, P963; Coen E, 2004, P NATL ACAD SCI USA, V101, P4728, DOI 10.1073/pnas.0306308101; Conlon I, 1999, CELL, V96, P235, DOI 10.1016/S0092-8674(00)80563-2; Cumming G, 2007, J CELL BIOL, V177, P7, DOI 10.1083/jcb.200611141; Dinneny JR, 2004, DEVELOPMENT, V131, P1101, DOI 10.1242/dev.00949; Disch S, 2006, CURR BIOL, V16, P272, DOI 10.1016/j.cub.2005.12.026; Donnelly PM, 1999, DEV BIOL, V215, P407, DOI 10.1006/dbio.1999.9443; Eriksson S, 2010, CURR BIOL, V20, P527, DOI 10.1016/j.cub.2010.01.039; Fletcher JC, 2001, DEVELOPMENT, V128, P1323; Fowlkes CC, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002346; Frary A, 2004, THEOR APPL GENET, V109, P523, DOI 10.1007/s00122-004-1669-x; Fu J, 2009, NAT GENET, V41, P166, DOI 10.1038/ng.308; Green AA, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000537; Hamant O, 2008, SCIENCE, V322, P1650, DOI 10.1126/science.1165594; Hamant O, 2010, CURR OPIN GENET DEV, V20, P454, DOI 10.1016/j.gde.2010.04.009; HILL JP, 1989, CAN J BOT, V67, P2922, DOI 10.1139/b89-375; Ingram GC, 2006, CURR OPIN PLANT BIOL, V9, P12, DOI 10.1016/j.pbi.2005.11.007; Ingram GC, 2005, CURR BIOL, V15, pR663, DOI 10.1016/j.cub.2005.08.026; Irish VF, 2008, TRENDS PLANT SCI, V13, P430, DOI 10.1016/j.tplants.2008.05.006; JANSEN RC, 1993, GENETICS, V135, P205; Jenik PD, 2000, DEVELOPMENT, V127, P1267; Juenger T, 2000, GENETICS, V156, P1379; Juenger T, 2005, EVOL DEV, V7, P259, DOI 10.1111/j.1525-142X.2005.05028.x; Kawade K, 2010, DEVELOPMENT, V137, P4221, DOI 10.1242/dev.057117; Kazama T, 2010, PLANT CELL PHYSIOL, V51, P1046, DOI 10.1093/pcp/pcq051; Keurentjes JJB, 2007, P NATL ACAD SCI USA, V104, P1708, DOI 10.1073/pnas.0610429104; Koornneef M, 2004, ANNU REV PLANT BIOL, V55, P141, DOI 10.1146/annurev.arplant.55.031903.141605; Koumproglou R, 2002, PLANT J, V31, P355, DOI 10.1046/j.1365-313X.2002.01353.x; Krizek BA, 1999, DEV GENET, V25, P224, DOI 10.1002/(SICI)1520-6408(1999)25:3&lt;224::AID-DVG5&gt;3.0.CO;2-Y; Lecuit T, 2007, NATURE, V450, P189, DOI 10.1038/nature06304; Li YH, 2008, GENE DEV, V22, P1331, DOI 10.1101/gad.463608; LISTER C, 1993, PLANT J, V4, P745, DOI 10.1046/j.1365-313X.1993.04040745.x; Massonnet C, 2010, PLANT PHYSIOL, V152, P2142, DOI 10.1104/pp.109.148338; Millenaar FF, 2005, PLANT PHYSIOL, V137, P998, DOI 10.1104/pp.104.053967; Mizukami Y, 2000, P NATL ACAD SCI USA, V97, P942, DOI 10.1073/pnas.97.2.942; Nag A, 2009, P NATL ACAD SCI USA, V106, P22534, DOI 10.1073/pnas.0908718106; Nath U, 2003, SCIENCE, V299, P1404, DOI 10.1126/science.1079354; Ohno CK, 2004, DEVELOPMENT, V131, P1111, DOI 10.1242/dev.00991; Palatnik JF, 2003, NATURE, V425, P257, DOI 10.1038/nature01958; Pyke KA, 1998, PLANT PHYSIOL, V116, P797, DOI 10.1104/pp.116.2.797; Reddy GV, 2004, DEVELOPMENT, V131, P4225, DOI 10.1242/dev.01261; REDEI GP, 1962, GENETICS, V47, P443; Shpak ED, 2004, DEVELOPMENT, V131, P1491, DOI 10.1242/dev.01028; Sicard A, 2011, PLANT CELL, V23, P3156, DOI 10.1105/tpc.111.088237; Singer T, 2006, PLOS GENET, V2, P1352, DOI 10.1371/journal.pgen.0020144; Sloan J, 2009, PLANT PHYSIOL, V151, P1844, DOI 10.1104/pp.109.144683; SMYTH DR, 1990, PLANT CELL, V2, P755, DOI 10.1105/tpc.2.8.755; Strange A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019949; Szecsi J, 2006, EMBO J, V25, P3912, DOI 10.1038/sj.emboj.7601270; Takeda S, 2004, DEVELOPMENT, V131, P425, DOI 10.1242/dev.00938; Terpstra IR, 2010, PLANT PHYSIOL, V154, P1067, DOI 10.1104/pp.110.159996; Tisne S, 2008, PLANT PHYSIOL, V148, P1117, DOI 10.1104/pp.108.124271; Torii KU, 1996, PLANT CELL, V8, P735, DOI 10.1105/tpc.8.4.735; Tsukaya H, 2002, PLANT CELL PHYSIOL, V43, P372, DOI 10.1093/pcp/pcf051; Van Ooijen JW, 1999, HEREDITY, V83, P613, DOI 10.1038/sj.hdy.6886230; van Zanten M, 2010, PLANT J, V61, P83, DOI 10.1111/j.1365-313X.2009.04035.x; van Zanten M, 2009, TRENDS PLANT SCI, V14, P214, DOI 10.1016/j.tplants.2009.01.010; Varaud E, 2011, PLANT CELL, V23, P973, DOI 10.1105/tpc.110.081653; Wang JW, 2008, PLANT CELL, V20, P1231, DOI 10.1105/tpc.108.058180; Whitney HM, 2009, CURR BIOL, V19, P948, DOI 10.1016/j.cub.2009.04.051; Wricke G., 1986, QUANTITATIVE GENETIC; ZENG ZB, 1994, GENETICS, V136, P1457	72	19	22	1	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e56743	10.1371/journal.pone.0056743	http://dx.doi.org/10.1371/journal.pone.0056743			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418598	gold, Green Submitted, Green Published			2022-12-25	WOS:000315970300191
J	Saino, N; Romano, M; Rubolini, D; Caprioli, M; Ambrosini, R; Boncoraglio, G; Canova, L				Saino, Nicola; Romano, Maria; Rubolini, Diego; Caprioli, Manuela; Ambrosini, Roberto; Boncoraglio, Giuseppe; Canova, Luca			Population and Colony-Level Determinants of Tertiary Sex Ratio in the Declining Barn Swallow	PLOS ONE			English	Article							NATURAL-POPULATIONS; ORTOLAN BUNTINGS; HIRUNDO-RUSTICA; FARMLAND BIRDS; SELECTION; DISPERSAL; EVOLUTION; ABILITY; TRENDS; COSTS	Sex ratio of adults (tertiary sex ratio, TSR) is a major feature of animal populations with consequences for their behaviour, genetic structure and viability. Spatial and temporal variation in TSR occurs within species but the mechanisms behind it are poorly understood. In this long-term study of a declining population of a socially monogamous, colonial, migratory bird, the barn swallow (Hirundo rustica), we first analyzed population-level variation in TSR (= proportion of males) of yearlings at sexual maturation in relation to ecological conditions as gauged by annual survival rate of adults. TSR was male-biased both among yearlings and older individuals, but male bias of yearlings was more pronounced after years with larger decline in adult survival. Thus, male offspring were less susceptible to the adverse ecological conditions that cause increased mortality. Dispersal and settling site decisions can have major consequences on fitness via the effects of local TSR on mating and sperm competition. Breeding barn swallows are highly philopatric while natal dispersal is high and, together with mortality, is the main determinant of colony TSR. We thus also investigated the mechanisms of breeding colony choice by yearlings and found that TSR of new-settlers in a given colony and year was negatively predicted by TSR of returning, early arriving older individuals in that year, but not by overall TSR at the colony in the previous year. This suggests that in our male-biased population new-settler males respond to local TSR upon arrival to choose the sites with larger breeding opportunities. Hence, variation in ecological conditions as reflected by adult survival can shift the TSR of individuals recruiting into a local population, with potentially various demographic consequences. However, breeding site choice based on TSR tends to homogenize TSR at a population level likely by facilitating settling of dispersing males in colonies with less male-biased TSR.	[Saino, Nicola; Romano, Maria; Rubolini, Diego; Caprioli, Manuela; Boncoraglio, Giuseppe] Univ Milan, Dipartimento Biosci, Milan, Italy; [Ambrosini, Roberto] Univ Milano Bicocca, Dipartimento Biotecnol & Biosci, Milan, Italy; [Canova, Luca] Univ Pavia, Dipartimento Biol & Biotecnol, I-27100 Pavia, Italy	University of Milan; University of Milano-Bicocca; University of Pavia	Saino, N (corresponding author), Univ Milan, Dipartimento Biosci, Milan, Italy.	nicola.saino@unimi.it	Ambrosini, Roberto/F-3188-2012; Canova, Luca/P-6066-2017; Rubolini, Diego/F-2851-2011	Ambrosini, Roberto/0000-0002-7148-1468; Canova, Luca/0000-0002-5011-7413; Rubolini, Diego/0000-0003-2703-5783; Saino, Nicola/0000-0002-0230-3967				Alatalo RV, 1995, LEKS; Ambrosini R, 2002, J APPL ECOL, V39, P524, DOI 10.1046/j.1365-2664.2002.00721.x; Ambrosini R, 2012, BIRD CONSERV INT, V22, P411, DOI 10.1017/S0959270912000056; Ambrosini R, 2011, BIRD STUDY, V58, P495, DOI 10.1080/00063657.2011.609883; Bani L, 2009, ETHOL ECOL EVOL, V21, P27, DOI 10.1080/08927014.2009.9522509; Bennett P. M., 2002, OX ECOL EV; Bensch S, 1999, J EVOLUTION BIOL, V12, P1104; BirdLife International, 2004, BIRDL CONSERV SER, V12; Boncoraglio G, 2008, BEHAV ECOL SOCIOBIOL, V62, P729, DOI 10.1007/s00265-007-0498-8; Both C, 2010, P ROY SOC B-BIOL SCI, V277, P1259, DOI 10.1098/rspb.2009.1525; BULL J J, 1988, P96; Clarke AL, 1997, OIKOS, V79, P429, DOI 10.2307/3546885; Clobert J, 2009, ECOL LETT, V12, P197, DOI 10.1111/j.1461-0248.2008.01267.x; Dale S, 2001, OIKOS, V92, P344, DOI 10.1034/j.1600-0706.2001.920217.x; Dale S, 2011, J AVIAN BIOL, V42, P114, DOI 10.1111/j.1600-048X.2010.05147.x; Darwin G., 1871, P423; Donald PF, 2007, IBIS, V149, P671, DOI 10.1111/j.1474-919X.2007.00724.x; EMLEN ST, 1977, SCIENCE, V197, P215, DOI 10.1126/science.327542; Fisher R.A., 1930, GENETICAL THEORY NAT; Fuller RJ, 1995, CONSERV BIOL, V9, P1425, DOI 10.1046/j.1523-1739.1995.09061425.x; Hanski I., 1999, METAPOPULATION ECOLO; Hewison AJM, 1999, BEHAV ECOL SOCIOBIOL, V45, P339, DOI 10.1007/s002650050569; Ims Rolf A., 1997, P247, DOI 10.1016/B978-012323445-2/50015-8; Kokko H, 2006, PHILOS T R SOC B, V361, P319, DOI 10.1098/rstb.2005.1784; Kruuk LEB, 1999, NATURE, V399, P459, DOI 10.1038/20917; Liker A, 2005, EVOLUTION, V59, P890, DOI 10.1554/04-560; Moller AP, 1995, J EVOLUTION BIOL, V8, P671, DOI 10.1046/j.1420-9101.1995.8060671.x; Moller AP., 1994, SEXUAL SELECTION BAR; Nichols J., 2001, DISPERSAL; Nicolaus M, 2012, J ANIM ECOL, V81, P827, DOI 10.1111/j.1365-2656.2012.01959.x; Perrin N, 2000, AM NAT, V155, P116, DOI 10.1086/303296; Post E, 1999, AM NAT, V154, P194, DOI 10.1086/303224; PROMISLOW DEL, 1992, P ROY SOC B-BIOL SCI, V247, P203, DOI 10.1098/rspb.1992.0030; Saino N, 1999, J ANIM ECOL, V68, P999, DOI 10.1046/j.1365-2656.1999.00350.x; Saino N, 2006, BEHAV ECOL, V17, P172, DOI 10.1093/beheco/arj023; Saino N, 2004, ECOL LETT, V7, P21, DOI 10.1046/j.1461-0248.2003.00553.x; Saino N, 2013, J ORN IN PRESS; Saino N, 2008, EVOL ECOL, V22, P659, DOI 10.1007/s10682-007-9189-1; Saino N, 2012, J ANIM ECOL, V81, P1004, DOI 10.1111/j.1365-2656.2012.01989.x; Saino N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019593; Skalski J.R., 2005, WILDLIFE DEMOGRAPHY; Steifetten O, 2006, BIOL CONSERV, V132, P88, DOI 10.1016/j.biocon.2006.03.016; Tiainen J., 2000, LINNUT VUOSIKIRJA, V1999, P98; TRIVERS RL, 1973, SCIENCE, V179, P90, DOI 10.1126/science.179.4068.90; Tschirren B, 2003, J ANIM ECOL, V72, P839, DOI 10.1046/j.1365-2656.2003.00755.x; Tucker GM, 1994, BIRDS EUROPE THEIR C, V3; Turner A., 2006, BARN SWALLOW; West SA, 2002, SCIENCE, V295, P1685, DOI 10.1126/science.1069043; Wilkinson NI, 2002, BIRD STUDY, V49, P177, DOI 10.1080/00063650209461263; Woolfenden BE, 2001, AUK, V118, P156, DOI 10.1642/0004-8038(2001)118[0156:DOBHCA]2.0.CO;2; Wretenberg J, 2007, J APPL ECOL, V44, P933, DOI 10.1111/j.1365-2664.2007.01349.x	51	8	8	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e56493	10.1371/journal.pone.0056493	http://dx.doi.org/10.1371/journal.pone.0056493			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418577	Green Published, Green Submitted, gold			2022-12-25	WOS:000315970300170
J	Villela, AD; Ducati, RG; Rosado, LA; Bloch, CJ; Prates, MV; Goncalves, DC; Ramos, CHI; Basso, LA; Santos, DS				Villela, Anne Drumond; Ducati, Rodrigo Gay; Rosado, Leonardo Astolfi; Bloch, Carlos Junior; Prates, Maura Vianna; Goncalves, Danieli Cristina; Inacio Ramos, Carlos Henrique; Basso, Luiz Augusto; Santos, Diogenes Santiago			Biochemical Characterization of Uracil Phosphoribosyltransferase from Mycobacterium tuberculosis	PLOS ONE			English	Article							PURINE NUCLEOSIDE PHOSPHORYLASE; DRUG-RESISTANT TUBERCULOSIS; SULFOLOBUS-SOLFATARICUS; ESCHERICHIA-COLI; BACILLUS-CALDOLYTICUS; KINETIC MECHANISM; SALVAGE PATHWAY; GENE-EXPRESSION; BINDING; PURIFICATION	Uracil phosphoribosyltransferase (UPRT) catalyzes the conversion of uracil and 5-phosphoribosyl-alpha-1-pyrophosphate (PRPP) to uridine 5'-monophosphate (UMP) and pyrophosphate (PPi). UPRT plays an important role in the pyrimidine salvage pathway since UMP is a common precursor of all pyrimidine nucleotides. Here we describe cloning, expression and purification to homogeneity of upp-encoded UPRT from Mycobacterium tuberculosis (MtUPRT). Mass spectrometry and N-terminal amino acid sequencing unambiguously identified the homogeneous protein as MtUPRT. Analytical ultracentrifugation showed that native MtUPRT follows a monomer-tetramer association model. MtUPRT is specific for uracil. GTP is not a modulator of MtUPRT ativity. MtUPRT was not significantly activated or inhibited by ATP, UTP, and CTP. Initial velocity and isothermal titration calorimetry studies suggest that catalysis follows a sequential ordered mechanism, in which PRPP binding is followed by uracil, and PPi product is released first followed by UMP. The pH-rate profiles indicated that groups with pK values of 5.7 and 8.1 are important for catalysis, and a group with a pK value of 9.5 is involved in PRPP binding. The results here described provide a solid foundation on which to base upp gene knockout aiming at the development of strategies to prevent tuberculosis.	[Villela, Anne Drumond; Ducati, Rodrigo Gay; Rosado, Leonardo Astolfi; Basso, Luiz Augusto; Santos, Diogenes Santiago] Pontificia Univ Catolica Rio Grande do Sul PUCRS, INCT TB, CPBMF, Porto Alegre, RS, Brazil; [Villela, Anne Drumond; Rosado, Leonardo Astolfi; Basso, Luiz Augusto; Santos, Diogenes Santiago] Pontificia Univ Catolica Rio Grande do Sul PUCRS, Programa Posgrad Biol Celular & Mol, Porto Alegre, RS, Brazil; [Rosado, Leonardo Astolfi] Pontificia Univ Catolica Rio Grande do Sul PUCRS, Programa Posgrad Med & Ciencias Saude, Porto Alegre, RS, Brazil; [Bloch, Carlos Junior; Prates, Maura Vianna] Empresa Brasileira Pesquisa Agr Recursos Genet &, Lab Espectrometria Massa, Estacao Parque Biol, Brasilia, DF, Brazil; [Goncalves, Danieli Cristina] Univ Estadual Campinas, UNICAMP, Inst Biol, Campinas, SP, Brazil; [Goncalves, Danieli Cristina; Inacio Ramos, Carlos Henrique] Univ Estadual Campinas, UNICAMP, Inst Quim, Campinas, SP, Brazil	Pontificia Universidade Catolica Do Rio Grande Do Sul; Pontificia Universidade Catolica Do Rio Grande Do Sul; Pontificia Universidade Catolica Do Rio Grande Do Sul; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); Universidade de Sao Paulo; Universidade Estadual de Campinas; Universidade Estadual de Campinas	Basso, LA (corresponding author), Pontificia Univ Catolica Rio Grande do Sul PUCRS, INCT TB, CPBMF, Porto Alegre, RS, Brazil.	luiz.basso@pucrs.br; diogenes@pucrs.br	Bloch, Carlos/S-8375-2019; Goncalves, Danieli C/H-2089-2019; Ramos, CH/C-1571-2012; Prates, Maura/S-8399-2019; Basso, Luiz Augusto/T-9308-2019; Ducati, Rodrigo/M-5286-2013	Goncalves, Danieli C/0000-0003-0429-204X; Ramos, CH/0000-0002-7246-9081; Prates, Maura/0000-0002-0206-5890; Basso, Luiz Augusto/0000-0003-0903-2407; Astolfi Rosado, Leonardo/0000-0002-4349-0244; Ducati, Rodrigo/0000-0002-8783-8847; Bloch Jr, Carlos/0000-0003-2799-6883	Decit/SCTIE/MS-MCT-CNPq-FNDCT-CAPES; FAPERGS-CNPq-PRONEX (Fundacao de Amparoa Pesquisa do estado do Rio Grand do Sul); "Embrapa Recursos Geneticos e Biotecnologia", Brazil; FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo); National Research Council of Brazil (CNPq) [520182/99-5, 304051/1975-06, 304034/2008-8]; CNPq (The National Council for Scientific and Technological Development)	Decit/SCTIE/MS-MCT-CNPq-FNDCT-CAPES; FAPERGS-CNPq-PRONEX (Fundacao de Amparoa Pesquisa do estado do Rio Grand do Sul); "Embrapa Recursos Geneticos e Biotecnologia", Brazil(Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA)); FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); National Research Council of Brazil (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CNPq (The National Council for Scientific and Technological Development)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by funds of Decit/SCTIE/MS-MCT-CNPq-FNDCT-CAPES to National Institute of Science and Technology on Tuberculosis (INCT-TB) to DSS and LAB. LAB and DSS also acknowledge financial support awarded by FAPERGS-CNPq-PRONEX-2009 (Fundacao de Amparoa Pesquisa do estado do Rio Grand do Sul). CB acknowledges financial support from "Embrapa Recursos Geneticos e Biotecnologia", Brazil. CHIR acknowledges financial support from FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo). LAB (CNPq, 520182/99-5), DSS (CNPq, 304051/1975-06), CBJ (304034/2008-8), and CHIR are Research Career Awardees of the National Research Council of Brazil (CNPq). RGD was a post-doctoral fellow of CNPq (The National Council for Scientific and Technological Development). ADV and LAR acknowledge scholarships awarded by CNPq (The National Council for Scientific and Technological Development). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arent S, 2005, BIOCHEMISTRY-US, V44, P883, DOI 10.1021/bi048041l; Borges JC, 2011, CURR MED CHEM, V18, P1276; Martinelli LKB, 2011, MOL BIOSYST, V7, P1289, DOI 10.1039/c0mb00245c; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brand GD, 2006, PEPTIDES, V27, P2137, DOI 10.1016/j.peptides.2006.04.020; Brown A, 2009, INT J MOL SCI, V10, P3457, DOI 10.3390/ijms10083457; Christoffersen S, 2009, J MOL BIOL, V393, P464, DOI 10.1016/j.jmb.2009.08.019; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Cook P. F., 2007, ENZYME KINETICS MECH; Copeland R. A., 2005, EVALUATION ENZYME IN; DAI YP, 1995, INT J PARASITOL, V25, P207, DOI 10.1016/0020-7519(94)00090-B; De Brabandere H, 2008, ANAL CHEM, V80, P6689, DOI 10.1021/ac8006335; de Mendonca JD, 2011, MOL BIOSYST, V7, P119, DOI 10.1039/c0mb00085j; Ducati RG, 2007, CURR DRUG TARGETS, V8, P423, DOI 10.2174/138945007780059004; Ducati RG, 2011, CURR MED CHEM, V18, P1258; Ducati R.G., 2010, INT REV BIOPHYS CHEM, V1, P34; Ducati RG, 2010, BIOORGAN MED CHEM, V18, P4769, DOI 10.1016/j.bmc.2010.05.009; Ducati RG, 2009, ARCH BIOCHEM BIOPHYS, V486, P155, DOI 10.1016/j.abb.2009.04.011; Ducati RG, 2006, MEM I OSWALDO CRUZ, V101, P697, DOI 10.1590/S0074-02762006000700001; Grossman TH, 1998, GENE, V209, P95, DOI 10.1016/S0378-1119(98)00020-1; HENRI V, 1913, BIOCHEM Z, V49, P333; Ichikawa Wataru, 2006, Gastric Cancer, V9, P145, DOI 10.1007/s10120-006-0373-8; Jain A, 2008, FEMS IMMUNOL MED MIC, V53, P145, DOI 10.1111/j.1574-695X.2008.00400.x; Jensen HK, 1997, PROTEIN EXPRES PURIF, V10, P356, DOI 10.1006/prep.1997.0755; Jensen KF, 2005, FEBS J, V272, P1440, DOI 10.1111/j.1742-4658.2005.04576.x; Jensen KF, 1996, EUR J BIOCHEM, V240, P637, DOI 10.1111/j.1432-1033.1996.0637h.x; Kadziola A, 2002, ACTA CRYSTALLOGR D, V58, P936, DOI 10.1107/S0907444902005024; Kamath AT, 2005, VACCINE, V23, P3753, DOI 10.1016/j.vaccine.2005.03.001; Kantardjieff KA, 2005, ACTA CRYSTALLOGR D, V61, P355, DOI 10.1107/S090744490403389X; KELLEY KC, 1995, GENE, V156, P33, DOI 10.1016/0378-1119(95)00008-T; Kim S, 2009, FEBS J, V276, P4715, DOI 10.1111/j.1742-4658.2009.07168.x; LADBURY JE, 2004, BIOCALORIMETRY, V2; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Li JX, 2007, J HUM GENET, V52, P415, DOI 10.1007/s10038-007-0129-2; Linde L, 1996, BBA-PROTEIN STRUCT M, V1296, P16, DOI 10.1016/0167-4838(96)00045-3; Lundegaard C, 1999, BIOCHEMISTRY-US, V38, P3327, DOI 10.1021/bi982279q; Moffatt Barbara A, 2002, Arabidopsis Book, V1, pe0018, DOI 10.1199/tab.0018; NATALINI P, 1979, J BIOL CHEM, V254, P1558; Nunes JES, 2011, ARCH BIOCHEM BIOPHYS, V512, P143, DOI 10.1016/j.abb.2011.05.020; Pieters J, 2008, CELL HOST MICROBE, V3, P399, DOI 10.1016/j.chom.2008.05.006; RASMUSSEN UB, 1986, BIOCHIM BIOPHYS ACTA, V881, P268, DOI 10.1016/0304-4165(86)90013-9; Renck D, 2010, ARCH BIOCHEM BIOPHYS, V497, P35, DOI 10.1016/j.abb.2010.03.004; Rostirolla DC, 2011, ARCH BIOCHEM BIOPHYS, V505, P202, DOI 10.1016/j.abb.2010.10.019; Sambandamurthy VK, 2005, MICROBES INFECT, V7, P955, DOI 10.1016/j.micinf.2005.04.001; Sanchez-Quitian ZA, 2010, J STRUCT BIOL, V169, P413, DOI 10.1016/j.jsb.2009.12.019; Sassetti CM, 2003, P NATL ACAD SCI USA, V100, P12989, DOI 10.1073/pnas.2134250100; Schumacher MA, 2002, P NATL ACAD SCI USA, V99, P78, DOI 10.1073/pnas.012399599; Schumacher MA, 1998, EMBO J, V17, P3219, DOI 10.1093/emboj/17.12.3219; Segel H.L., 1975, ENZYME KINETICS BEHA; Stewart GR, 2003, NAT REV MICROBIOL, V1, P97, DOI 10.1038/nrmicro749; Suzuki NN, 2004, STRUCTURE, V12, P751, DOI 10.1016/j.str.2004.02.038; Velayati AA, 2009, EUR RESPIR J, V34, P1202, DOI 10.1183/09031936.00081909; Villela AD, 2011, CURR MED CHEM, V18, P1286; WHO, 2011, WHO GLOBAL TUBERCULO; Yablonski MJ, 1996, J BIOL CHEM, V271, P10704, DOI 10.1074/jbc.271.18.10704	55	17	17	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2013	8	2							e56445	10.1371/journal.pone.0056445	http://dx.doi.org/10.1371/journal.pone.0056445			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104BU	23424660	Green Published, gold, Green Submitted			2022-12-25	WOS:000315965100048
J	Santini, S; Stagni, V; Giambruno, R; Fianco, G; Di Benedetto, A; Mottolese, M; Pellegrini, M; Barila, D				Santini, S.; Stagni, V.; Giambruno, R.; Fianco, G.; Di Benedetto, A.; Mottolese, M.; Pellegrini, M.; Barila, D.			ATM kinase activity modulates ITCH E3-ubiquitin ligase activity	ONCOGENE			English	Article						Ataxia Telangiectasia; ATM kinase; ITCH E3-ubiquitin ligase; c-FLIP-L; c-Jun; protein ubiquitination and degradation	E3 UBIQUITIN LIGASES; INDUCED CELL-DEATH; C-FLIPL; ACTIVATION; PROTEIN; DEGRADATION; APOPTOSIS; CASPASE-8; PHOSPHORYLATION; PROLIFERATION	Ataxia Telangiectasia Mutated (ATM) kinase, a central regulator of the DNA damage response, regulates the activity of several E3-ubiquitin ligases, and the ubiquitination-proteasome system is a consistent target of ATM. ITCH is an E3-ubiquitin ligase that modulates the ubiquitination of several targets, therefore participating to the regulation of several cellular responses, such as the DNA damage response, tumor necrosis factor alpha (TNF alpha), Notch and Hedgehog signaling, and the differentiation of 'naive' lymphocytes into T helper type 2 cells. Here we uncover ATM as a novel positive modulator of ITCH E3-ubiquitin ligase activity. A single residue on ITCH protein, S161, which is part of an ATM SQ consensus motif, is required for ATM-dependent activation of ITCH. ATM activity enhances ITCH enzymatic activity, which in turn drives the ubiquitination and degradation of c-FLIP-L and c-Jun, previously identified as ITCH substrates. Importantly, ATM-deficient mice show resistance to hepatocyte cell death, similarly to Itch-deficient animals, providing in vivo genetic evidence for this circuit. Our data identify ITCH as a novel component of the ATM-dependent signaling pathway and suggest that the impairment of the correct functionality of ITCH caused by Atm deficiency may contribute to the complex clinical features linked to Ataxia Telangiectasia.	[Santini, S.; Stagni, V.; Fianco, G.; Barila, D.] Univ Roma Tor Vergata, Dept Biol, I-00143 Rome, Italy; [Santini, S.; Stagni, V.; Fianco, G.; Barila, D.] Ist Ricovero Cura Carattere, Lab Cell Signaling, Rome, Italy; [Giambruno, R.] Austrian Acad Sci, CeMM Res Ctr Mol Med, A-1010 Vienna, Austria; [Di Benedetto, A.; Mottolese, M.] Regina Elena Inst Canc Res, Dept Pathol, Rome, Italy; [Pellegrini, M.] Univ Roma La Sapienza, Dept Expt Med, I-00185 Rome, Italy	University of Rome Tor Vergata; Austrian Academy of Sciences; CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences; IRCCS Istituti Fisioterapici Ospitalieri (IFO); IRCCS Regina Elena; Sapienza University Rome	Barila, D (corresponding author), Univ Roma Tor Vergata, Dept Biol, Fdn Santa Lucia Via Fosso Fiorano 64, I-00143 Rome, Italy.	daniela.barila@uniroma2.it	Pellegrini, manuela/AAC-1423-2022; Barilà, Daniela/K-8506-2016; Giambruno, Roberto/W-4868-2017; Giambruno, Roberto/AAI-6717-2021	Barilà, Daniela/0000-0002-6192-1562; Giambruno, Roberto/0000-0002-4566-261X; Giambruno, Roberto/0000-0002-4566-261X; Di Benedetto, Anna/0000-0002-9853-8671; stagni, venturina/0000-0002-3971-0398; pellegrini, manuela/0000-0001-6387-5187	Italian Telethon Foundation 'Comitato Telethon Fondazione Onlus' [GGP07252]; AIRC [IG10590, MFAG8904, IG8706]; Fondazione Santa Lucia	Italian Telethon Foundation 'Comitato Telethon Fondazione Onlus'(Fondazione Telethon); AIRC(Fondazione AIRC per la ricerca sul cancro); Fondazione Santa Lucia	We acknowledge Y Shiloh, Y Lerenthal, M Kastan, J Melino, M Rossi, S Polo, D Bohmann and J Tschopp for kindly providing reagents; G Cesareni for critical reading of the manuscript; A Totaro for technical support for point mutagenesis; and D Giaccari for helping with the in vivo experiments performed in compliance with the 'Tor Vergata' University Institutional Animal Care. This work has been supported by research grants from Italian Telethon Foundation 'Comitato Telethon Fondazione Onlus' (GGP07252) and by AIRC (IG10590) to DB, AIRC (MFAG8904) to MP and AIRC (IG8706) to MM. SS has been supported by Fondazione Santa Lucia.	Altaba AR, 2002, NAT REV CANCER, V2, P361, DOI 10.1038/nrc796; Bar-Shira A, 2002, ONCOGENE, V21, P849, DOI 10.1038/sj.onc.1205127; Barila D, 2003, MOL CELL BIOL, V23, P2790, DOI 10.1128/MCB.23.8.2790-2799.2003; Bernassola F, 2008, CANCER CELL, V14, P10, DOI 10.1016/j.ccr.2008.06.001; Bhatti S, 2011, CELL MOL LIFE SCI, V68, P2977, DOI 10.1007/s00018-011-0683-9; Biton S, 2006, J BIOL CHEM, V281, P17482, DOI 10.1074/jbc.M601895200; Chang LF, 2006, CELL, V124, P601, DOI 10.1016/j.cell.2006.01.021; Cheng Q, 2010, CELL CYCLE, V9, P472, DOI 10.4161/cc.9.3.10556; Daugherity EK, 2012, CELL CYCLE, V11, P1918, DOI 10.4161/cc.20259; Di Marcotullio L, 2011, ONCOGENE, V30, P65, DOI 10.1038/onc.2010.394; Di Marcotullio L, 2006, NAT CELL BIOL, V8, P1415, DOI 10.1038/ncb1510; Gallagher E, 2006, P NATL ACAD SCI USA, V103, P1717, DOI 10.1073/pnas.0510664103; Ganten TM, 2004, CELL DEATH DIFFER, V11, pS86, DOI 10.1038/sj.cdd.4401437; Gao BX, 2006, J BIOL CHEM, V281, P29711, DOI 10.1074/jbc.M604596200; Gao M, 2004, SCIENCE, V306, P271, DOI 10.1126/science.1099414; Gilot D, 2005, CARCINOGENESIS, V26, P2086, DOI 10.1093/carcin/bgi187; Hansen TM, 2007, BIOCHEM BIOPH RES CO, V361, P33, DOI 10.1016/j.bbrc.2007.06.104; Kee Y, 2007, BIOCHEM BIOPH RES CO, V354, P329, DOI 10.1016/j.bbrc.2007.01.025; Lens SMA, 2002, MOL CELL BIOL, V22, P5419, DOI 10.1128/MCB.22.15.5419-5433.2002; Liu YC, 2007, SEMIN IMMUNOL, V19, P197, DOI 10.1016/j.smim.2007.02.003; Matei IR, 2006, IMMUNOL REV, V209, P142, DOI 10.1111/j.0105-2896.2006.00361.x; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; Melino G, 2008, CELL DEATH DIFFER, V15, P1103, DOI 10.1038/cdd.2008.60; Mongiardi MP, 2011, CELL CYCLE, V10, P4311, DOI 10.4161/cc.10.24.18663; Mouchantaf R, 2006, J BIOL CHEM, V281, P38738, DOI 10.1074/jbc.M605959200; Moyal L, 2011, MOL CELL, V41, P529, DOI 10.1016/j.molcel.2011.02.015; Mu JJ, 2007, J BIOL CHEM, V282, P17330, DOI 10.1074/jbc.C700079200; Mund T, 2009, EMBO REP, V10, P501, DOI 10.1038/embor.2009.30; Rossi M, 2005, EMBO J, V24, P836, DOI 10.1038/sj.emboj.7600444; Schattenberg JM, 2011, J HEPATOL, V55, P1272, DOI 10.1016/j.jhep.2011.03.008; Shiloh Y, 2003, NAT REV CANCER, V3, P155, DOI 10.1038/nrc1011; Stagni V, 2008, BLOOD, V111, P829, DOI 10.1182/blood-2007-04-085399; Stagni V, 2010, CARCINOGENESIS, V31, P1956, DOI 10.1093/carcin/bgq193; Stokes MP, 2007, P NATL ACAD SCI USA, V104, P19855, DOI 10.1073/pnas.0707579104; Weizman N, 2003, J BIOL CHEM, V278, P6741, DOI 10.1074/jbc.M211168200; Winter M, 2008, NAT CELL BIOL, V10, P812, DOI 10.1038/ncb1743; Yang C, 2006, MOL CELL, V21, P135, DOI 10.1016/j.molcel.2005.11.014; Yu JW, 2008, ONCOGENE, V27, P6216, DOI 10.1038/onc.2008.299	38	28	29	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 27	2014	33	9					1113	1123		10.1038/onc.2013.52	http://dx.doi.org/10.1038/onc.2013.52			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AB6XT	23435430	Green Accepted			2022-12-25	WOS:000331933800005
J	Bertacchini, J; Beretti, F; Cenni, V; Guida, M; Gibellini, F; Mediani, L; Marin, O; Maraldi, NM; de Pol, A; Lattanzi, G; Cocco, L; Marmiroli, S				Bertacchini, Jessika; Beretti, Francesca; Cenni, Vittoria; Guida, Marianna; Gibellini, Federica; Mediani, Laura; Marin, Oriano; Maraldi, Nadir M.; de Pol, Anto; Lattanzi, Giovanna; Cocco, Lucio; Marmiroli, Sandra			The protein kinase Akt/PKB regulates both prelamin A degradation and Lmna gene expression	FASEB JOURNAL			English	Article						14.3.3; lamina phosphorylation; nuclear signaling; nucleus; cell cycle	LAMIN-A; NUCLEAR-ENVELOPE; PHOSPHORYLATION; AKT; ACTIVATION; LOCALIZATION; SUBSTRATE; APOPTOSIS; AUTOPHAGY; EXTENDS	The serine/threonine kinase Akt/PKB is a major signaling hub integrating metabolic, survival, growth, and cell cycle regulatory signals. The definition of the phospho-motif cipher driving phosphorylation by Akt led to the identification of hundreds of putative substrates, and it is therefore pivotal to identify those whose phosphorylation by Akt is of consequence to biological processes. The Lmna gene products lamin A/C and the lamin A precursor prelamin A are type V intermediate filament proteins forming a filamentous meshwork, the lamina, underneath the inner nuclear membrane, for nuclear envelope structures organization and interphase chromatin anchoring. In our previous work, we reported that A-type lamins are phosphorylated by Akt at S301 and S404 in physiological conditions and are therefore bona fide substrates of Akt. We report here that Akt phosphorylation at S404 targets the precursor prelamin A for degradation. We further demonstrate that Akt also regulates Lmna transcription. Our study unveils a previously unknown function of Akt in the control of prelamin A stability and expression. Moreover, given the large number of diseases related to prelamin A, our findings represent a further important step bridging basic A-type lamin physiology to therapeutic approaches for lamin A-linked disorders.	[Bertacchini, Jessika; Beretti, Francesca; Guida, Marianna; Gibellini, Federica; Mediani, Laura; de Pol, Anto; Marmiroli, Sandra] Univ Modena & Reggio Emilia, Cellular Signaling Lab, Dept Surg Med Dent & Morphol, I-41124 Modena, Italy; [Bertacchini, Jessika; Guida, Marianna; Maraldi, Nadir M.; Cocco, Lucio] Univ Bologna, Dept Biomed Sci, Cellular Signaling Lab, Bologna, Italy; [Cenni, Vittoria; Maraldi, Nadir M.; Lattanzi, Giovanna; Marmiroli, Sandra] Natl Res Council Italy CNR, Inst Mol Genet, IOR, Bologna, Italy; [Marin, Oriano] Univ Padua, Dept Biomed Sci, Padua, Italy	Universita di Modena e Reggio Emilia; University of Bologna; Consiglio Nazionale delle Ricerche (CNR); Istituto di Genetica Molecolare (IGM-CNR); University of Padua	Marmiroli, S (corresponding author), Univ Modena & Reggio Emilia, Cellular Signaling Lab, Dept Surg Med Dent & Morphol, Via Pozzo 71, I-41124 Modena, Italy.	sandra.marmiroli@unimore.it	BERTACCHINI, JESSIKA/F-4382-2017; Lattanzi, Giovanna/AAY-3186-2020; LATTANZI, GIOVANNA/P-8214-2015; Cenni, Vittoria/C-7361-2019; Cocco, Lucio/AAI-2206-2020; Marmiroli, Sandra/J-5242-2016	BERTACCHINI, JESSIKA/0000-0001-9218-9215; Lattanzi, Giovanna/0000-0002-7103-8722; LATTANZI, GIOVANNA/0000-0002-7103-8722; Cenni, Vittoria/0000-0001-8062-1840; Cocco, Lucio/0000-0002-9206-8277; Marmiroli, Sandra/0000-0001-5545-9319; DE POL, Anto/0000-0003-4279-5422; Mediani, Laura/0000-0002-5870-1155	Fondazione Angela Serra for Cancer Research (Modena, Italy); Italian Ministero dell'Istruzione; dell'Universita e della Ricerca (MIUR)-Programma di Ricerca di Rilevante Interesse Nazionale (PRIN); MIUR-Fondo per gli Investimenti della Ricerca di Base; MIUR-FIRB; Fondazione Carisbo, and Associazione Italiana Progeria Sammy Basso (AIProSaB) Italy	Fondazione Angela Serra for Cancer Research (Modena, Italy); Italian Ministero dell'Istruzione(Ministry of Education, Universities and Research (MIUR)); dell'Universita e della Ricerca (MIUR)-Programma di Ricerca di Rilevante Interesse Nazionale (PRIN)(Ministry of Education, Universities and Research (MIUR)); MIUR-Fondo per gli Investimenti della Ricerca di Base; MIUR-FIRB(Ministry of Education, Universities and Research (MIUR)Fund for Investment in Basic Research (FIRB)); Fondazione Carisbo, and Associazione Italiana Progeria Sammy Basso (AIProSaB) Italy	The authors are grateful to Maria Ruzzene for helpful discussion, to Loren Fong (University of California, Los Angeles, CA, USA) for antibodies against prelamin A, and to Giacomo Spinsanti for skillful technical assistance with realtime PCR. S.M. and J.B. acknowledge the "International Short Term Mobility Program" from Italian Consiglio Nazionale delle Ricerche (CNR) and Fondazione CaRiMo, respectively. M.G. was supported in part by Fondazione Angela Serra for Cancer Research (Modena, Italy). This work was supported by grants from Italian Ministero dell'Istruzione, dell'Universita e della Ricerca (MIUR)-Programma di Ricerca di Rilevante Interesse Nazionale (PRIN), MIUR-Fondo per gli Investimenti della Ricerca di Base (FIRB; Human Proteome Net), MIUR-FIRB (Accordi di Programma 2010), Fondazione Carisbo, and Associazione Italiana Progeria Sammy Basso (AIProSaB) Italy.	Alessi DR, 1997, CURR BIOL, V7, P261, DOI 10.1016/S0960-9822(06)00122-9; Barth S, 2010, J PATHOL, V221, P117, DOI 10.1002/path.2694; Bergo MO, 2002, P NATL ACAD SCI USA, V99, P13049, DOI 10.1073/pnas.192460799; Brunet A, 2002, J CELL BIOL, V156, P817, DOI 10.1083/jcb.200112059; Butin-Israeli V, 2012, TRENDS GENET, V28, P464, DOI 10.1016/j.tig.2012.06.001; Cao K, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002346; Cenni V, 2003, CELL MOL LIFE SCI, V60, P2710, DOI 10.1007/s00018-003-3349-4; Cenni V, 2011, EUR J HISTOCHEM, V55, P200, DOI 10.4081/ejh.2011.e36; Cenni V, 2008, J PROTEOME RES, V7, P4727, DOI 10.1021/pr800262g; Cenni V, 2011, MOL BIOL CELL, V22, P2946, DOI 10.1091/mbc.E10-11-0928; Christofk HR, 2011, J PROTEOME RES, V10, P4158, DOI 10.1021/pr200578n; Coffinier C, 2010, J BIOL CHEM, V285, P20818, DOI 10.1074/jbc.M110.128835; Corrigan DP, 2005, BIOCHEM J, V387, P129, DOI 10.1042/BJ20041359; Davies BSJ, 2011, NUCLEUS-PHILA, V2, P4, DOI [10.4161/nucl.2.1.13723, 10.1093/hmg/ddq158]; Davies BSJ, 2009, ANNU REV GENOM HUM G, V10, P153, DOI 10.1146/annurev-genom-082908-150150; Dechat T, 2008, GENE DEV, V22, P832, DOI 10.1101/gad.1652708; Eriksson JE, 2009, J CLIN INVEST, V119, P1763, DOI 10.1172/JCI38339; Eriksson M, 2003, NATURE, V423, P293, DOI 10.1038/nature01629; Feng JH, 2004, J BIOL CHEM, V279, P41189, DOI 10.1074/jbc.M406731200; Fong LG, 2006, J CLIN INVEST, V116, P743, DOI 10.1172/JCI27125; Gao TY, 2005, MOL CELL, V18, P13, DOI 10.1016/j.molcel.2005.03.008; Goldman RD, 2004, P NATL ACAD SCI USA, V101, P8963, DOI 10.1073/pnas.0402943101; Gonzalez E, 2009, P NATL ACAD SCI USA, V106, P7004, DOI 10.1073/pnas.0901933106; Graziotto JJ, 2012, AUTOPHAGY, V8, P147, DOI 10.4161/auto.8.1.18331; Jung HJ, 2012, P NATL ACAD SCI USA, V109, pE423, DOI 10.1073/pnas.1111780109; Kandel ES, 2002, MOL CELL BIOL, V22, P7831, DOI 10.1128/MCB.22.22.7831-7841.2002; Lin HK, 2009, NAT CELL BIOL, V11, P420, DOI 10.1038/ncb1849; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Maraldi NM, 2011, J CELL BIOCHEM, V112, P979, DOI 10.1002/jcb.22992; Maraldi T, 2009, MOL HUM REPROD, V15, P499, DOI 10.1093/molehr/gap048; Maraldi T, 2011, INT J ONCOL, V38, P427, DOI 10.3892/ijo.2010.850; Margalit A, 2007, TRENDS CELL BIOL, V17, P202, DOI 10.1016/j.tcb.2007.02.004; Marmiroli S, 2009, J CELL PHYSIOL, V220, P553, DOI 10.1002/jcp.21807; Mattioli E, 2011, CELL DEATH DIFFER, V18, P1305, DOI 10.1038/cdd.2010.183; Meek SEM, 2004, J BIOL CHEM, V279, P32046, DOI 10.1074/jbc.M403044200; Mirandola P, 2006, INT J ONCOL, V28, P127; Moritz A, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000998; Muchir A, 2010, DEV CELL, V19, P355, DOI 10.1016/j.devcel.2010.08.019; Muralikrishna B, 2001, EUR J BIOCHEM, V268, P3736, DOI 10.1046/j.1432-1327.2001.02281.x; Naetar N, 2008, NAT CELL BIOL, V10, P1341, DOI 10.1038/ncb1793; Okumura K, 2004, BIOCHEM BIOPH RES CO, V320, P487, DOI 10.1016/j.bbrc.2004.05.191; Persad S, 2001, J BIOL CHEM, V276, P27462, DOI 10.1074/jbc.M102940200; Prokocimer M, 2009, J CELL MOL MED, V13, P1059, DOI [10.1111/j.1582-4934.2009.00676.x, 10.1111/j.1582-4934.2008.00676.x]; Rusinol AE, 2006, J CELL SCI, V119, P3265, DOI 10.1242/jcs.03156; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Scaffidi P, 2005, NAT MED, V11, P440, DOI 10.1038/nm1204; Shtivelman E, 2002, CURR BIOL, V12, P919, DOI 10.1016/S0960-9822(02)00843-6; Stewart CL, 2007, SCIENCE, V318, P1408, DOI 10.1126/science.1142034; Toker A, 2000, J BIOL CHEM, V275, P8271, DOI 10.1074/jbc.275.12.8271; Varela I, 2008, NAT MED, V14, P767, DOI 10.1038/nm1786; Wan X, 2007, ONCOGENE, V26, P1932, DOI 10.1038/sj.onc.1209990; WEBER K, 1989, FEBS LETT, V257, P411, DOI 10.1016/0014-5793(89)81584-4; Worman HJ, 2012, J PATHOL, V226, P316, DOI 10.1002/path.2999	53	58	61	1	13	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2013	27	6					2145	2155		10.1096/fj.12-218214	http://dx.doi.org/10.1096/fj.12-218214			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	154II	23430973				2022-12-25	WOS:000319667600006
J	Takusagawa, F				Takusagawa, Fusao			Microsomal Prostaglandin E Synthase Type 2 (mPGES2) Is a Glutathione-dependent Heme Protein, and Dithiothreitol Dissociates the Bound Heme to Produce Active Prostaglandin E-2 Synthase in Vitro	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							THROMBOXANE SYNTHASE; IDENTIFICATION; CYCLOOXYGENASES; DEGRADATION; ENZYME	An x-ray study indicated that microsomal prostaglandin E synthase type 2 (mPGES2) is a heme-bound protein and catalyzes prostaglandin (PG) H-2 degradation, but not PGE(2) formation (Yamada, T., and Takusagawa, F. (2007) Biochemistry 46, 8414-8424). In response to the x-ray study, Watanabe et al. claimed that mPGES2 is a heme-free protein and that both the heme-free and heme-bound proteins have PGE(2) synthesis activity in the presence of dithiothreitol (Watanabe, K., Ito, S., and Yamamoto, S. (2008) Biochem. Biophys. Res. Commun. 367, 782-786). To resolve the contradictory results, the heme-binding scheme of mPGES2 was further characterized in vivo and in vitro by absorption and fluorescence spectroscopies. A substantial amount of heme-bound mPGES2 was detected in cell extracts. The heme content in mPGES2 was increased along with an increase in Fe3+ in the culture medium. Heme-free mPGES2 was converted to the heme-bound form by mixing it with pig liver extract, indicating that mPGES2 is capable of forming a complex with heme in mammalian cells. Heme binds to mPGES2 only in the presence of glutathione. The newly determined heme dissociation constant (2.9 nM) supports strongly that mPGES2 is a heme-bound protein in vivo. The bound heme was not dissociated by oxidation by H2O2 or reduction by glutathione or 2-mercaptoethanol. However, reduction by dithiothreitol (an artificial reducing compound) induced the bound heme to dissociate from mPGES2 and released heme-free mPGES2, which exhibited PGE(2) synthesis activity in vitro. Imidazole bound to mPGES2 by stacking on the bound heme and inhibited heme oxidation by H2O2 and reduction by dithiothreitol.	Univ Kansas, Dept Mol Biosci, Lawrence, KS 66045 USA	University of Kansas	Takusagawa, F (corresponding author), Univ Kansas, Dept Mol Biosci, 3004 Haworth Hall,1200 Sunnyside Ave, Lawrence, KS 66045 USA.	xraymain@ku.edu						CAPDEVILA JH, 1995, BIOCHEMISTRY-US, V34, P3325, DOI 10.1021/bi00010a023; Chaudhry U, 2010, EXP NEUROL, V223, P359, DOI 10.1016/j.expneurol.2009.07.027; CHLOPICKI S, 2004, EICOSANOIDS, P267; DICZFALUSY U, 1977, FEBS LETT, V84, P271, DOI 10.1016/0014-5793(77)80704-7; Gonzalez-Michaca L, 2004, AM J PHYSIOL-RENAL, V286, pF370, DOI 10.1152/ajprenal.00300.2003; Gryglewski RJ, 2008, PHARMACOL REP, V60, P3; Jakobsson PJ, 1999, P NATL ACAD SCI USA, V96, P7220, DOI 10.1073/pnas.96.13.7220; Jania LA, 2009, PROSTAG OTH LIPID M, V88, P73, DOI 10.1016/j.prostaglandins.2008.10.003; KEETING PE, 1987, EXP EYE RES, V44, P261, DOI 10.1016/S0014-4835(87)80010-6; Murakami M, 2003, J BIOL CHEM, V278, P37937, DOI 10.1074/jbc.M305108200; Nicholls D. G., 2002, BIOENERGETICS, P96; OHASHI K, 1992, J BIOL CHEM, V267, P789; Rife CL, 2003, PROTEINS, V53, P777, DOI 10.1002/prot.10452; Seo T, 2009, VIRCHOWS ARCH, V454, P667, DOI 10.1007/s00428-009-0777-z; STOCKER R, 1990, FREE RADICAL RES COM, V9, P101, DOI 10.3109/10715769009148577; Taketani S, 2005, TOHOKU J EXP MED, V205, P297, DOI 10.1620/tjem.205.297; Tanikawa N, 2002, BIOCHEM BIOPH RES CO, V291, P884, DOI 10.1006/bbrc.2002.6531; Tanioka T, 2000, J BIOL CHEM, V275, P32775, DOI 10.1074/jbc.M003504200; Tracz MJ, 2007, J AM SOC NEPHROL, V18, P414, DOI 10.1681/ASN.2006080894; Tsiftsoglou AS, 2006, PHARMACOL THERAPEUT, V111, P327, DOI 10.1016/j.pharmthera.2005.10.017; Ueno N, 2005, BIOCHEM BIOPH RES CO, V338, P70, DOI 10.1016/j.bbrc.2005.08.152; Watanabe K, 1999, BBA-MOL CELL BIOL L, V1439, P406, DOI 10.1016/S1388-1981(99)00084-0; Watanabe K, 1997, BIOCHEM BIOPH RES CO, V235, P148, DOI 10.1006/bbrc.1997.6708; Watanabe K, 2003, BIOCHEM BIOPH RES CO, V306, P577, DOI 10.1016/S0006-291X(03)01025-8; Watanabe K, 2008, BIOCHEM BIOPH RES CO, V367, P782, DOI 10.1016/j.bbrc.2008.01.029; Wu T, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-22; Yamada T, 2005, J MOL BIOL, V348, P1163, DOI 10.1016/j.jmb.2005.03.035; Yamada T, 2007, BIOCHEMISTRY-US, V46, P8414, DOI 10.1021/bi700605m; Yu R, 2011, J PHARMACOL EXP THER, V339, P716, DOI 10.1124/jpet.111.185405	29	21	21	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 5	2013	288	14					10166	10175		10.1074/jbc.M112.418475	http://dx.doi.org/10.1074/jbc.M112.418475			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	119RB	23426368	Green Published, hybrid			2022-12-25	WOS:000317114000057
J	Klemencic, M; Novinec, M; Maier, S; Hartmann, U; Lenarcic, B				Klemencic, Marina; Novinec, Marko; Maier, Silke; Hartmann, Ursula; Lenarcic, Brigita			The Heparin-Binding Activity of Secreted Modular Calcium-Binding Protein 1 (SMOC-1) Modulates Its Cell Adhesion Properties	PLOS ONE			English	Article							GROWTH-FACTOR; SULFATE; IDENTIFICATION; SITE; PROTEOGLYCANS; INTEGRINS; MIGRATION; RECEPTOR	Secreted modular calcium-binding proteins 1 and 2 (SMOC-1 and SMOC-1) are extracellular calcium-binding proteins belonging to the BM-40 family of proteins. In this work we have identified a highly basic region in the extracellular calcium-binding (EC) domain of the SMOC-1 similar to other known glycosaminoglycan-binding motifs. Size-exclusion chromatography shows that full length SMOC-1 as well as its C-terminal EC domain alone bind heparin and heparan sulfate, but not the related chondroitin sulfate or dermatan sulfate glycosaminoglycans. Intrinsic tryptophan fluorescence measurements were used to quantify the binding of heparin to full length SMOC-1 and the EC domain alone. The calculated equilibrium dissociation constants were in the lower micromolar range. The binding site consists of two antiparallel alpha helices and mutagenesis experiments have shown that heparin-binding residues in both helices must be replaced in order to abolish heparin binding. Furthermore, we show that the SMOC-1 EC domain, like the SMOC-2 EC domain, supports the adhesion of epithelial HaCaT cells. Heparin-binding impaired mutants failed to support S1EC-mediated cell adhesion and together with the observation that S1EC in complex with soluble heparin attenuated cell adhesion we conclude that a functional and accessible S1EC heparin-binding site mediates adhesion of epithelial cells to SMOC-1.	[Klemencic, Marina; Novinec, Marko; Lenarcic, Brigita] Univ Ljubljana, Dept Chem & Biochem, Fac Chem & Chem Technol, Ljubljana, Slovenia; [Maier, Silke; Hartmann, Ursula] Univ Cologne, Ctr Biochem, Fac Med, D-50931 Cologne, Germany; [Hartmann, Ursula] Cologne Excellence Cluster Cellular Stress Respon, Cologne, Germany; [Lenarcic, Brigita] Jozef Stefan Inst, Dept Biochem Mol & Struct Biol, Ljubljana, Slovenia	University of Ljubljana; University of Cologne; University of Cologne; Slovenian Academy of Sciences & Arts (SASA); Jozef Stefan Institute	Lenarcic, B (corresponding author), Univ Ljubljana, Dept Chem & Biochem, Fac Chem & Chem Technol, Ljubljana, Slovenia.	brigita.lenarcic@fkkt.uni-lj.si	Novinec, Marko/J-9789-2019	Novinec, Marko/0000-0003-1824-1649; Lenarcic, Brigita/0000-0002-2508-3776	Slovenian Research Agency; Slovene Human Resources, Development and Scholarship Fund	Slovenian Research Agency(Slovenian Research Agency - Slovenia); Slovene Human Resources, Development and Scholarship Fund	This work was supported by the Slovenian Research Agency and by the Slovene Human Resources, Development and Scholarship Fund with a travel grant to MK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abban CY, 2010, VIROLOGY, V403, P1, DOI 10.1016/j.virol.2010.04.007; Abouzeid H, 2011, AM J HUM GENET, V88, P92, DOI 10.1016/j.ajhg.2010.12.002; BAEUERLE PA, 1986, BIOCHEM BIOPH RES CO, V141, P870, DOI 10.1016/S0006-291X(86)80253-4; Bernfield M, 1999, ANNU REV BIOCHEM, V68, P729, DOI 10.1146/annurev.biochem.68.1.729; BOUKAMP P, 1988, J CELL BIOL, V106, P761, DOI 10.1083/jcb.106.3.761; Brekken Rolf A., 2001, Matrix Biology, V19, P816; Choi YA, 2010, J PROTEOME RES, V9, P2946, DOI 10.1021/pr901110q; Copeland R.A., 2000, ENZYMES PRACTICAL IN, Vsecond, P94; Dreieicher E, 2009, J AM SOC NEPHROL, V20, P1963, DOI 10.1681/ASN.2008060653; Dreyfuss JL, 2009, AN ACAD BRAS CIENC, V81, P409, DOI 10.1590/S0001-37652009000300007; Esko JD, 2001, J CLIN INVEST, V108, P169, DOI 10.1172/JCI200113530; Girard JP, 1996, J BIOL CHEM, V271, P4511; Hambrock HO, 2003, J BIOL CHEM, V278, P11351, DOI 10.1074/jbc.M212291200; Hileman RE, 1998, BIOESSAYS, V20, P156, DOI 10.1002/(SICI)1521-1878(199802)20:2<156::AID-BIES8>3.3.CO;2-#; Iozzo RV, 2005, NAT REV MOL CELL BIO, V6, P646, DOI 10.1038/nrm1702; Ishitsuka R, 1998, J BIOL CHEM, V273, P9935, DOI 10.1074/jbc.273.16.9935; Katsumoto TR, 2011, INT J RHEUMATOL, V2011, DOI 10.1155/2011/208219; Kohfeldt E, 1997, FEBS LETT, V414, P557, DOI 10.1016/S0014-5793(97)01070-3; Koivisto L, 1999, CELL ADHES COMMUN, V7, P245, DOI 10.3109/15419069909010806; Kreuger J, 2006, J CELL BIOL, V174, P323, DOI 10.1083/jcb.200604035; Lecona E, 2003, BIOCHEM J, V373, P437, DOI 10.1042/BJ20021721; Liu PJ, 2008, MOL BIOL CELL, V19, P248, DOI 10.1091/mbc.E07-05-0510; Lortat-Jacob H, 2012, J BIOL CHEM, V287, P18005, DOI 10.1074/jbc.M111.337089; Maier S, 2008, EXP CELL RES, V314, P2477, DOI 10.1016/j.yexcr.2008.05.020; MAURER P, 1995, J MOL BIOL, V253, P347, DOI 10.1006/jmbi.1995.0557; MURPHYULLRICH JE, 1995, J CELL BIOCHEM, V57, P341, DOI 10.1002/jcb.240570218; Mythreye K, 2009, CELL SIGNAL, V21, P1548, DOI 10.1016/j.cellsig.2009.05.001; Novinec M, 2008, PROTEIN EXPRES PURIF, V62, P75, DOI 10.1016/j.pep.2008.07.009; Okada I, 2011, AM J HUM GENET, V88, P30, DOI 10.1016/j.ajhg.2010.11.012; Pei JM, 2007, NUCLEIC ACIDS RES, V35, pW649, DOI 10.1093/nar/gkm227; Rainger J, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002114; Rocnik EF, 2006, J BIOL CHEM, V281, P22855, DOI 10.1074/jbc.M513463200; Tiedemann K, 2001, J BIOL CHEM, V276, P36035, DOI 10.1074/jbc.M104985200; Torrent M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042692; Vannahme C, 2003, BIOCHEM J, V373, P805, DOI 10.1042/BJ20030532; Vannahme C, 2002, J BIOL CHEM, V277, P37977, DOI 10.1074/jbc.M203830200; VOGEL BE, 1990, J BIOL CHEM, V265, P5934; Wang Z, 2012, J BIOL CHEM, V287, P13063, DOI 10.1074/jbc.M111.294819; Woods A, 2001, J CLIN INVEST, V107, P935, DOI 10.1172/JCI12802; ZHU HY, 1995, J BIOL CHEM, V270, P21869, DOI 10.1074/jbc.270.37.21869	40	15	15	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2013	8	2							e56839	10.1371/journal.pone.0056839	http://dx.doi.org/10.1371/journal.pone.0056839			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IT	23437253	Green Published, Green Submitted, gold			2022-12-25	WOS:000315186000053
J	Lin, YR; Chen, YL; Wang, KB; Wu, YF; Wang, YK; Huang, SC; Liu, TA; Nayak, M; Yip, BS; Wu, TK				Lin, Yan-Ren; Chen, Yao-Li; Wang, Keh-Bin; Wu, Yi-Fang; Wang, Yu-Kuo; Huang, Sheng-Cih; Liu, Tzu-An; Nayak, Manoswini; Yip, Bak-Sau; Wu, Tung-Kung			The Thermostable Direct Hemolysin from Grimontia hollisae Causes Acute Hepatotoxicity In Vitro and In Vivo	PLOS ONE			English	Article							VIBRIO-HOLLISAE; SEVERE GASTROENTERITIS; ENDOTOXIN REMOVAL; PARAHAEMOLYTICUS; IDENTIFICATION; ENTEROTOXICITY; CYTOTOXICITY; BACTEREMIA; DIARRHEA; ZONATION	Background: G. hollisae thermostable direct hemolysin (Gh-TDH) is produced by most strains of G. hollisae. This toxin has been reported to be absorbed in the intestines in humans. Secondary liver injury might be caused by venous return of the toxin through the portal system. We aimed to firstly analyze the in vitro and in vivo hepatotoxicity of Gh-TDH. Methods: Liver cells (primary human non-cancer cell and FL83B mouse cells) were treated and mice (BALB/c) were fed with this toxin to investigate its hepatotoxicity. Morphological examination and cytotoxicity assays using liver cells were also performed. Fluorescein isothiocyanate-conjugated toxin was used to analyze the localization of this protein in liver cells. Mice were subjected to liver function measurements and liver biopsies following toxin treatment and wild-type bacterial infection. PET (positron emission tomography)/CT (computed tomography) images were taken to assess liver metabolism during acute injury and recovery. Results: The effect of hepatotoxicity was dose and time dependent. Cellular localization showed that the toxin was initially located around the cellular margins and subsequently entered the nucleus. Liver function measurements and liver biopsies of the mice following treatment with toxin or infection with wild-type Grimontia hollisae showed elevated levels of transaminases and damage to the periportal area, respectively. The PET/CT images revealed that the reconstruction of the liver continued for at least one week after exposure to a single dose of the toxin or bacterial infection. Conclusions: The hepatotoxicity of Gh-TDH was firstly demonstrated. The damage was located in the periportal area of the liver, and the liver became functionally insufficient.	[Lin, Yan-Ren; Wu, Yi-Fang; Wang, Yu-Kuo; Huang, Sheng-Cih; Nayak, Manoswini; Wu, Tung-Kung] Natl Chiao Tung Univ, Dept Biol Sci & Technol, Hsinchu, Taiwan; [Lin, Yan-Ren] Changhua Christian Hosp, Dept Emergency Med, Changhua, Taiwan; [Chen, Yao-Li] Changhua Christian Hosp, Transplant Med & Surg Res Ctr, Changhua, Taiwan; [Wang, Keh-Bin] Kuang Tien Gen Hosp, Dept Nucl Med, Taichung, Taiwan; [Liu, Tzu-An] Natl Hlth Res Inst, Inst Cellular & Syst Med, Zhunan, Miaoli County, Taiwan; [Yip, Bak-Sau] Natl Taiwan Univ Hosp, Dept Neurol, Hsin Chu Branch, Hsinchu, Taiwan; [Lin, Yan-Ren; Chen, Yao-Li] Chung Shan Med Univ, Sch Med, Taichung, Taiwan	National Yang Ming Chiao Tung University; Changhua Christian Hospital; Changhua Christian Hospital; National Health Research Institutes - Taiwan; National Taiwan University; National Taiwan University Hospital; Chung Shan Medical University	Wang, YK (corresponding author), Natl Chiao Tung Univ, Dept Biol Sci & Technol, Hsinchu, Taiwan.	yu.kuo@yahoo.com.tw; neuron.nctu@gmail.com; tkwmll@mail.nctu.edu.tw	Lin, Yan-Ren/AAU-4136-2020	Lin, Yan-Ren/0000-0002-9015-2678; Yip, Bak-Sau/0000-0001-7942-8293	National Chiao Tung University; Ministry of Education, Aiming for Top University Plan (MOE ATU Program); National Science Council [NSC-99-2113-M-009 -004 -MY2]	National Chiao Tung University; Ministry of Education, Aiming for Top University Plan (MOE ATU Program); National Science Council(Ministry of Science and Technology, Taiwan)	The authors thank National Chiao Tung University and the Ministry of Education, Aiming for Top University Plan (MOE ATU Program), and the National Science Council (NSC-99-2113-M-009 -004 -MY2) for financially supporting this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABBOTT SL, 1994, CLIN INFECT DIS, V18, P310, DOI 10.1093/clinids/18.3.310; Anspach FB, 2001, J BIOCHEM BIOPH METH, V49, P665, DOI 10.1016/S0165-022X(01)00228-7; Cai SH, 2007, J APPL MICROBIOL, V103, P289, DOI 10.1111/j.1365-2672.2006.03250.x; CARNAHAN AM, 1994, J CLIN MICROBIOL, V32, P1805, DOI 10.1128/JCM.32.7.1805-1806.1994; Fukui T, 2005, BIOCHEMISTRY-US, V44, P9825, DOI 10.1021/bi050311s; GrasRouzet S, 1996, EUR J CLIN MICROBIOL, V15, P864, DOI 10.1007/BF01691217; HICKMAN FW, 1982, J CLIN MICROBIOL, V15, P395, DOI 10.1128/JCM.15.3.395-401.1982; JUNGERMANN K, 1988, SEMIN LIVER DIS, V8, P329, DOI 10.1055/s-2008-1040554; Jungermann K, 1996, ANNU REV NUTR, V16, P179, DOI 10.1146/annurev.nu.16.070196.001143; JUNGERMANN K, 1986, ENZYME, V35, P161, DOI 10.1159/000469338; Lesmana M, 2002, DIAGN MICR INFEC DIS, V43, P91, DOI 10.1016/S0732-8893(02)00373-5; Morris JG, 2003, CLIN INFECT DIS, V37, P272, DOI 10.1086/375600; MORRIS JG, 1982, LANCET, V1, P1294; Naim R, 2001, FEMS MICROBIOL LETT, V195, P237, DOI 10.1016/S0378-1097(01)00015-5; Nishibuchi M, 1996, MICROBIOL IMMUNOL, V40, P59, DOI 10.1111/j.1348-0421.1996.tb03304.x; NISHIBUCHI M, 1988, APPL ENVIRON MICROB, V54, P2144, DOI 10.1128/AEM.54.8.2144-2146.1988; Park KS, 2004, MICROBIOL IMMUNOL, V48, P313, DOI 10.1111/j.1348-0421.2004.tb03512.x; Petsch D, 2000, J BIOTECHNOL, V76, P97, DOI 10.1016/S0168-1656(99)00185-6; Raimondi F, 2000, INFECT IMMUN, V68, P3180, DOI 10.1128/IAI.68.6.3180-3185.2000; RANK EL, 1988, J CLIN MICROBIOL, V26, P375, DOI 10.1128/JCM.26.2.375-376.1988; Shinoda S, 2004, MICROBIOL IMMUNOL, V48, P547, DOI 10.1111/j.1348-0421.2004.tb03551.x; Shinoda S, 1999, J NAT TOXINS, V8, P259; Tatsumi M, 2003, CANCER RES, V63, P6252; Wang YK, 2011, INT J BIOL SCI, V7, P333, DOI 10.7150/ijbs.7.333; Wang YK, 2011, ACTA CRYSTALLOGR F, V67, P224, DOI 10.1107/S1744309110050219; Wu TK, 2007, J BACTERIOL, V189, P8215, DOI 10.1128/JB.01039-07; Yeung P S Marie, 2004, Foodborne Pathog Dis, V1, P74, DOI 10.1089/153531404323143594; YOH M, 1986, CAN J MICROBIOL, V32, P632, DOI 10.1139/m86-118; YOH M, 1989, J BACTERIOL, V171, P6859, DOI 10.1128/jb.171.12.6859-6861.1989	29	4	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2013	8	2							e56226	10.1371/journal.pone.0056226	http://dx.doi.org/10.1371/journal.pone.0056226			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IT	23437095	Green Published, gold, Green Submitted			2022-12-25	WOS:000315186000017
J	Xu, Y; Luo, QQ; Zhou, MG				Xu, Ying; Luo, Qing-quan; Zhou, Ming-guo			Identification and Characterization of Integron-Mediated Antibiotic Resistance in the Phytopathogen Xanthomonas oryzae pv. oryzae	PLOS ONE			English	Article							STREPTOMYCIN-RESISTANCE; GENE CASSETTES; SPREAD; PREVALENCE; MICHIGAN; SEQUENCE; ELEMENTS; HUMANS	Four streptomycin-resistant isolates of Xanthomonas oryzae pv. oryzae (YNA7-1, YNA10-2, YNA11-2, and YNA12-2) were examined via PCR amplification for the presence of class 1, class 2, and class 3 integrons and aadA1 and aadA2 genes, which confer resistance to streptomycin and spectinomycin. The class 1 integrase gene intI1 and the aminoglycoside adenylyltransferase gene aadA1 were identified in all four resistant isolates but not in 25 sensitive isolates. PCR amplifications showed that 7790-bp, 7162-bp, 7790-bp, and 7240-bp resistance integrons with transposition gene modules (tni module) in 3' conserved segments existed in YNA7-1, YNA10-2, YNA11-2, and YNA12-2, respectively. Subsequent analysis of sequences indicated that the integrons of YNA7-1 and YNA11-2 carried three gene cassettes in the order vertical bar aacA3 vertical bar arr3 vertical bar aadA1 vertical bar. The integron of YNA10-2 carried only vertical bar arr3 vertical bar aadA1 vertical bar gene cassettes. The integron of YNA12-2 lacked a 550-bp sequence including part of intI1 but it still carried vertical bar aacA3 vertical bar arr3 vertical bar aadA1 vertical bar gene cassettes. The analysis of inactive mutants and complementation tests confirmed that the aacA3 gene conferred resistance to tobramycin, kanamycin, gentamicin and netilmicin; the arr3 gene conferred resistance to rifampicin; and the aadA1 gene conferred resistance to streptomycin and spectinomycin. The resistance phenotypes of the four isolates corresponded with their resistance gene cassettes, except that YNA7-1 and YNA12-2 did not show rifampicin resistance. Sequence comparison revealed that no gene cassette array in GenBank was in the same order as in the integrons of the four resistant isolates in this study and the aadA1, which was identical in the four resistant isolates, showed 99% identity with aadA1 sequences in GenBank. The result of a stability test showed that the resistance phenotype, the aadA1 gene, and the intI1 gene were completely stable in YNA7-1 and YNA12-2 but unstable in YNA10-2 and YNA11-2. To our knowledge, this is the first report of resistance integron in a phytopathogenic bacteria.	[Xu, Ying; Zhou, Ming-guo] Nanjing Agr Univ, Coll Plant Protect, Nanjing, Jiangsu, Peoples R China; [Xu, Ying; Luo, Qing-quan] Shanghai Landscape Gardening Res Inst, Shanghai, Peoples R China	Nanjing Agricultural University	Zhou, MG (corresponding author), Nanjing Agr Univ, Coll Plant Protect, Nanjing, Jiangsu, Peoples R China.	xuying2002@gmail.com		Luo, Qingquan/0000-0003-4371-273X	National Natural Science Foundation of China [31100100]; Agro-scientific Research in the Public Interest [201303023]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Agro-scientific Research in the Public Interest	This study was sponsored by the National Natural Science Foundation of China (No. 31100100) and Agro-scientific Research in the Public Interest (No. 201303023). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2006, M2A9 CLSI; Binh CTT, 2009, RES MICROBIOL, V160, P427, DOI 10.1016/j.resmic.2009.06.005; Cambray G, 2011, MOBILE DNA-UK, V2, DOI 10.1186/1759-8753-2-6; Chen GongYou, 2004, Scientia Agricultura Sinica, V37, P1301; CHIOU CS, 1995, PHYTOPATHOLOGY, V85, P324, DOI 10.1094/Phyto-85-324; CHIOU CS, 1991, PHYTOPATHOLOGY, V81, P710, DOI 10.1094/Phyto-81-710; Clinical and Laboratory Standards Institute (CLSI), 2011, M100S12 CLSI; Cox KD, 2007, PHYTOPATHOLOGY, V97, P448, DOI 10.1094/PHYTO-97-4-0448; DEFEYTER R, 1990, GENE, V88, P65, DOI 10.1016/0378-1119(90)90060-5; Dubois W, 2002, ANTIMICROB AGENTS CH, V46, P638, DOI 10.1128/AAC.46.3.638-645.2002; Fluit AC, 1999, EUR J CLIN MICROBIOL, V18, P761, DOI 10.1007/s100960050398; Gillings MR, 2005, P NATL ACAD SCI USA, V102, P4419, DOI 10.1073/pnas.0406620102; HALL RM, 1995, MOL MICROBIOL, V15, P593, DOI 10.1111/j.1365-2958.1995.tb02368.x; Jeung JU, 2006, PHYTOPATHOLOGY, V96, P867, DOI 10.1094/PHYTO-96-0867; Lee K, 2005, ANTIMICROB AGENTS CH, V49, P4485, DOI 10.1128/AAC.49.11.4485-4491.2005; Mazel D, 2000, ANTIMICROB AGENTS CH, V44, P1568, DOI 10.1128/AAC.44.6.1568-1574.2000; Mazel D, 2006, NAT REV MICROBIOL, V4, P608, DOI 10.1038/nrmicro1462; MCMANUS PS, 1994, PHYTOPATHOLOGY, V84, P627, DOI 10.1094/Phyto-84-627; Miko A, 2005, J ANTIMICROB CHEMOTH, V56, P1025, DOI 10.1093/jac/dki365; Mongkolsuk S, 1998, FEMS MICROBIOL LETT, V169, P269, DOI 10.1111/j.1574-6968.1998.tb13328.x; Partridge SR, 2009, FEMS MICROBIOL REV, V33, P757, DOI 10.1111/j.1574-6976.2009.00175.x; Post V, 2007, ANTIMICROB AGENTS CH, V51, P3467, DOI 10.1128/AAC.00220-07; Rayamajhi N, 2008, J VET MED SCI, V70, P1133, DOI 10.1292/jvms.70.1133; Rowe-Magnus DA, 2002, INT J MED MICROBIOL, V292, P115, DOI 10.1078/1438-4221-00197; Salzberg SL, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-204; Schnabel EL, 1999, APPL ENVIRON MICROB, V65, P4898; SHAW KJ, 1993, MICROBIOL REV, V57, P138, DOI 10.1128/MMBR.57.1.138-163.1993; SHAW KJ, 1989, ANTIMICROB AGENTS CH, V33, P2052, DOI 10.1128/AAC.33.12.2052; [沈光斌 Shen Guangbin], 2002, [植物保护, Plant Protection], V28, P9; Stalder T, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00119; Stokes HW, 2011, FEMS MICROBIOL REV, V35, P790, DOI 10.1111/j.1574-6976.2011.00273.x; STOKES HW, 1989, MOL MICROBIOL, V3, P1669, DOI 10.1111/j.1365-2958.1989.tb00153.x; Strange RN, 2005, ANNU REV PHYTOPATHOL, V43, P83, DOI 10.1146/annurev.phyto.43.113004.133839; Sun QH, 2003, FEMS MICROBIOL LETT, V226, P145, DOI 10.1016/S0378-1097(03)00583-4; Sunde M, 2005, J ANTIMICROB CHEMOTH, V56, P87, DOI 10.1093/jac/dki150; Sundin GW, 2000, J ANTIMICROB CHEMOTH, V46, P848, DOI 10.1093/jac/46.5.848; SUNDIN GW, 1993, APPL ENVIRON MICROB, V59, P1018, DOI 10.1128/AEM.59.4.1018-1024.1993; Sundin GW, 2002, CURR MICROBIOL, V45, P63, DOI 10.1007/s00284-001-0100-y; Vinue L, 2008, J ANTIMICROB CHEMOTH, V62, P934, DOI 10.1093/jac/dkn331; Wang WenXiang, 1998, Acta Phytophylacica Sinica, V25, P171; Weldhagen GF, 2004, INT J ANTIMICROB AG, V23, P556, DOI 10.1016/j.ijantimicag.2004.03.007; Xu Y, 2010, J PHYTOPATHOL, V158, P601, DOI 10.1111/j.1439-0434.2009.01657.x; Xue N, 1973, B AGR SCI TECHNOL, P21; Xue YH, 2002, JIANGXI PLANT PROTEC, V25, P68; Zhao SH, 2001, APPL ENVIRON MICROB, V67, P1558, DOI 10.1128/AEM.67.4.1558-1564.2001; Zhu M. J., 1992, Plant Protection, V18, P26	46	16	18	3	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2013	8	2							e55962	10.1371/journal.pone.0055962	http://dx.doi.org/10.1371/journal.pone.0055962			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IT	23437082	gold, Green Published, Green Submitted			2022-12-25	WOS:000315186000014
J	Budatha, M; Silva, S; Montoya, TI; Suzuki, A; Shah-Simpson, S; Wieslander, CK; Yanagisawa, M; Word, RA; Yanagisawa, H				Budatha, Madhusudhan; Silva, Simone; Montoya, Teodoro Ignacio; Suzuki, Ayako; Shah-Simpson, Sheena; Wieslander, Cecilia Karin; Yanagisawa, Masashi; Word, Ruth Ann; Yanagisawa, Hiromi			Dysregulation of Protease and Protease Inhibitors in a Mouse Model of Human Pelvic Organ Prolapse	PLOS ONE			English	Article							ELASTIC FIBER HOMEOSTASIS; UTEROSACRAL LIGAMENTS; EXTRACELLULAR-MATRIX; CELL APOPTOSIS; KNOCKOUT MICE; VAGINAL WALL; RAT UTERUS; IN-VIVO; FIBULIN-5; WOMEN	Mice deficient for the fibulin-5 gene (Fbln5(-/-)) develop pelvic organ prolapse (POP) due to compromised elastic fibers and upregulation of matrix metalloprotease (MMP)-9. Here, we used casein zymography, inhibitor profiling, affinity pull-down, and mass spectrometry to discover additional protease upregulated in the vaginal wall of Fbln5(-/-) mice, herein named V1 (25 kDa). V1 was a serine protease with trypsin-like activity similar to protease, serine (PRSS) 3, a major extrapancreatic trypsinogen, was optimum at pH 8.0, and predominantly detected in estrogenized vaginal epithelium of Fbln5(-/-) mice. PRSS3 was (a) localized in epithelial secretions, (b) detected in media of vaginal organ culture from both Fbln5(-/-) and wild type mice, and (c) cleaved fibulin-5 in vitro. Expression of two serine protease inhibitors [Serpina1a (alpha 1-antitrypsin) and Elafin] was dysregulated in Fbln5(-/-) epithelium. Finally, we confirmed that PRSS3 was expressed in human vaginal epithelium and that SERPINA1 and Elafin were downregulated in vaginal tissues from women with POP. These data collectively suggest that the balance between proteases and their inhibitors contributes to support of the pelvic organs in humans and mice.	[Budatha, Madhusudhan; Shah-Simpson, Sheena; Yanagisawa, Hiromi] Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA; [Silva, Simone; Montoya, Teodoro Ignacio; Wieslander, Cecilia Karin; Word, Ruth Ann] Univ Texas SW Med Ctr Dallas, Dept Obstet & Gynecol, Dallas, TX 75390 USA; [Suzuki, Ayako; Yanagisawa, Masashi] Univ Texas SW Med Ctr Dallas, Dept Mol Genet, Dallas, TX 75390 USA; [Suzuki, Ayako; Yanagisawa, Masashi] Univ Texas SW Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas	Word, RA (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Obstet & Gynecol, Dallas, TX 75390 USA.	ruth.word@utsouthwestern.edu; hiromi.yanagisawa@utsouthwestern.edu	Budatha, Madhusudhan/A-1523-2015; Yanagisawa, Hiromi/Y-2843-2019	Yanagisawa, Hiromi/0000-0002-7576-9186; Suzuki, Ayako/0000-0001-9581-6341; Tomko, Sheena/0000-0002-2355-2794	NIH [R01AG028048, R01HD06482401]; Human Tissue and Biological Fluid Repository [P01HD11149]; Welch Foundation [I1646]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD011149, R01HD064824] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL106305] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG028048] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Human Tissue and Biological Fluid Repository; Welch Foundation(The Welch Foundation); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported in part by Grants from the NIH (R01AG028048, R01HD06482401), the Human Tissue and Biological Fluid Repository supported by P01HD11149, and The Welch Foundation (I1646). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Awla D, 2012, J LEUKOCYTE BIOL, V91, P711, DOI 10.1189/jlb.0811443; Budatha M, 2011, J CLIN INVEST, V121, P2048, DOI 10.1172/JCI45636; Bump RC, 1998, OBSTET GYN CLIN N AM, V25, P723, DOI 10.1016/S0889-8545(05)70039-5; Drewes PG, 2007, AM J PATHOL, V170, P578, DOI 10.2353/ajpath.2007.060662; Gustilo-Ashby Arlan Marcus, 2010, Female Pelvic Med Reconstr Surg, V16, P21, DOI 10.1097/SPV.0b013e3181d00035; HAVRAN RT, 1977, J HISTOCHEM CYTOCHEM, V25, P1178, DOI 10.1177/25.10.72100; Hirai M, 2007, J CELL BIOL, V176, P1061, DOI 10.1083/jcb.200611026; King AE, 2003, J CLIN ENDOCR METAB, V88, P4426, DOI 10.1210/jc.2003-030239; KOIVUNEN E, 1991, CANCER RES, V51, P2107; Liu XQ, 2004, NAT GENET, V36, P178, DOI 10.1038/ng1297; Liu YS, 1999, P NATL ACAD SCI USA, V96, P14694, DOI 10.1073/pnas.96.26.14694; Man WC, 2009, INT UROGYNECOL J, V20, P1423, DOI 10.1007/s00192-009-0905-y; Moon YJ, 2011, J UROLOGY, V185, P1786, DOI 10.1016/j.juro.2010.12.040; Nakanishi J, 2010, J INVEST DERMATOL, V130, P944, DOI 10.1038/jid.2009.364; Nyaruhucha CNM, 1997, J BIOL CHEM, V272, P10573; Petrache I, 2006, AM J PATHOL, V169, P1155, DOI 10.2353/ajpath.2006.060058; Petrache L, 2006, AM J RESP CRIT CARE, V173, P1222, DOI 10.1164/rccm.200512-1842OC; Rahn DD, 2008, AM J PHYSIOL-REG I, V295, pR1351, DOI 10.1152/ajpregu.90447.2008; Rahn DD, 2009, AM J PATHOL, V174, P206, DOI 10.2353/ajpath.2009.080212; Sahin-Toth M, 2005, PROTEIN PEPTIDE LETT, V12, P457, DOI 10.2174/0929866054395356; SHARROW L, 1989, P SOC EXP BIOL MED, V192, P121; Shaw JLV, 2008, BIOL CHEM, V389, P1513, DOI 10.1515/BC.2008.171; Soderberg MW, 2009, MOL HUM REPROD, V15, P251, DOI 10.1093/molehr/gap011; STARCHER B, 1985, CONNECT TISSUE RES, V13, P207, DOI 10.3109/03008208509152400; Suzuki A, 1996, REPROD TOXICOL, V10, P129, DOI 10.1016/0890-6238(95)02055-1; Takacs P, 2008, INT UROGYNECOL J, V19, P1559, DOI 10.1007/s00192-008-0690-z; Takacs P, 2010, ARCH GYNECOL OBSTET, V282, P389, DOI 10.1007/s00404-009-1262-2; Takacs P, 2009, INT UROGYNECOL J, V20, P207, DOI 10.1007/s00192-008-0757-x; Taraseviciene-Stewart L, 2008, J CLIN INVEST, V118, P394, DOI 10.1172/JCI31811; Toth J, 2007, NEUROCHEM RES, V32, P1423, DOI 10.1007/s11064-007-9327-8; Vierkotten S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022959; Wieslander CK, 2008, BIOL REPROD, V78, P521, DOI 10.1095/biolreprod.107.063024; Wieslander CK, 2009, BIOL REPROD, V80, P407, DOI 10.1095/biolreprod.108.072900; Yanagisawa H, 2002, NATURE, V415, P168, DOI 10.1038/415168a; Zhao BH, 2012, J OBSTET GYNAECOL RE, V38, P925, DOI 10.1111/j.1447-0756.2011.01814.x	35	19	21	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e56376	10.1371/journal.pone.0056376	http://dx.doi.org/10.1371/journal.pone.0056376			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437119	Green Submitted, Green Published, gold			2022-12-25	WOS:000315184200063
J	Liu, Q; Emadi, S; Shen, JX; Sierks, MR; Wu, J				Liu, Qiang; Emadi, Sharareh; Shen, Jian-Xin; Sierks, Michael R.; Wu, Jie			Human alpha 4 beta 2 Nicotinic Acetylcholine Receptor as a Novel Target of Oligomeric alpha-Synuclein	PLOS ONE			English	Article							D-ASPARTATE RECEPTORS; PARKINSONS-DISEASE; LEWY BODIES; RAT-BRAIN; GABAERGIC INTERNEURONS; SYNAPTIC-TRANSMISSION; DOPAMINERGIC-NEURONS; CHOLINERGIC RECEPTOR; HIPPOCAMPAL-NEURONS; CIGARETTE-SMOKING	Cigarette smoking is associated with a decreased incidence of Parkinson disease (PD) through unknown mechanisms. Interestingly, a decrease in the numbers of alpha 4 beta 2 nicotinic acetylcholine receptors (alpha 4 beta 2-nAChRs) in PD patients suggests an alpha 4 beta 2-nAChR-mediated cholinergic deficit in PD. Although oligomeric forms of alpha-synuclein have been recognized to be toxic and involved in the pathogenesis of PD, their direct effects on nAChR-mediated cholinergic signaling remains undefined. Here, we report for the first time that oligomeric alpha-synuclein selectively inhibits human alpha 4 beta 2-nAChR-mediated currents in a dose-dependent, non-competitive and use-independent manner. We show that pre-loading cells with guanyl-59-yl thiophosphate fails to prevent this inhibition, suggesting that the alpha-synuclein-induced inhibition of alpha 4 beta 2-nAChR function is not mediated by nAChR internalization. By using a pharmacological approach and cultures expressing transfected human nAChRs, we have shown a clear effect of oligomeric alpha-synuclein on alpha 4 beta 2-nAChRs, but not on alpha 4 beta 4- or alpha 7-nAChRs, suggesting nAChR subunit selectivity of oligomeric alpha-synuclein-induced inhibition. In addition, by combining the size exclusion chromatography and atomic force microscopy (AFM) analyses, we find that only large (>4 nm) oligomeric alpha-synuclein aggregates (but not monomeric, small oligomeric or fibrillar alpha-synuclein aggregates) exhibit the inhibitory effect on human alpha 4 beta 2-nAChRs. Collectively, we have provided direct evidence that alpha 4 beta 2-nAChR is a sensitive target to mediate oligomeric alpha-synuclein-induced modulation of cholinergic signaling, and our data imply that therapeutic strategies targeted toward alpha 4 beta 2-nAChRs may have potential for developing new treatments for PD.	[Liu, Qiang; Wu, Jie] St Josephs Hosp, Barrow Neurol Inst, Div Neurol, Phoenix, AZ USA; [Emadi, Sharareh; Sierks, Michael R.] Arizona State Univ, Dept Chem Engn, Tempe, AZ USA; [Shen, Jian-Xin; Wu, Jie] Shantou Univ, Coll Med, Dept Physiol, Shantou, Peoples R China; [Wu, Jie] Univ Arizona, Coll Med, Dept Basic Med Sci, Phoenix, AZ USA	Barrow Neurological Institute; St. Joseph's Hospital and Medical Center; Arizona State University; Arizona State University-Tempe; Shantou University; University of Arizona	Wu, J (corresponding author), St Josephs Hosp, Barrow Neurol Inst, Div Neurol, Phoenix, AZ USA.	Jie.Wu@chw.edu	Liu, Qiang/HHZ-3181-2022		Michael J. Fox Foundation; Arizona Biomedical Research Commission	Michael J. Fox Foundation; Arizona Biomedical Research Commission	This work was supported by grants from the Michael J. Fox Foundation and the Arizona Biomedical Research Commission. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkondon M, 2001, J NEUROPHYSIOL, V86, P3043, DOI 10.1152/jn.2001.86.6.3043; Allison DW, 2011, SYNAPSE, V65, P804, DOI 10.1002/syn.20907; Aracava Y, 2005, J PHARMACOL EXP THER, V312, P1195, DOI 10.1124/jpet.104.077172; Baba M, 1998, AM J PATHOL, V152, P879; BENCHERIF M, 1993, J NEUROCHEM, V61, P852, DOI 10.1111/j.1471-4159.1993.tb03596.x; Brown RE, 2008, EUR J NEUROSCI, V27, P352, DOI 10.1111/j.1460-9568.2008.06024.x; Buhler AV, 2002, J NEUROPHYSIOL, V87, P548, DOI 10.1152/jn.00316.2001; Chen DN, 1997, J BIOL CHEM, V272, P24024, DOI 10.1074/jbc.272.38.24024; Chen H, 2010, NEUROLOGY, V74, P878, DOI 10.1212/WNL.0b013e3181d55f38; Conway KA, 2000, ANN NY ACAD SCI, V920, P42; Ding TT, 2002, BIOCHEMISTRY-US, V41, P10209, DOI 10.1021/bi020139h; Eaton JB, 2003, MOL PHARMACOL, V64, P1283, DOI 10.1124/mol.64.6.1283; Emadi S, 2009, J BIOL CHEM, V284, P11048, DOI 10.1074/jbc.M806559200; Everitt BJ, 1997, ANNU REV PSYCHOL, V48, P649, DOI 10.1146/annurev.psych.48.1.649; Fayuk D, 2004, MOL PHARMACOL, V66, P658, DOI 10.1124/mol.104.000042; FLORES CM, 1992, MOL PHARMACOL, V41, P31; FRANDSEN A, 1989, J NEUROCHEM, V53, P297, DOI 10.1111/j.1471-4159.1989.tb07327.x; Gotti C, 2006, NEUROBIOL DIS, V23, P481, DOI 10.1016/j.nbd.2006.04.005; Guan ZZ, 2002, BRAIN RES, V956, P358, DOI 10.1016/S0006-8993(02)03571-0; Hall S., 2012, ARCH NEUROL-CHICAGO, P1; He P, 2012, FASEB J, V26, P334, DOI 10.1096/fj.11-192716; Jeyarasasingam G, 2002, NEUROSCIENCE, V109, P275, DOI 10.1016/S0306-4522(01)00488-2; Ji D, 2001, NEURON, V31, P131, DOI 10.1016/S0896-6273(01)00332-4; Ji DY, 2000, J NEUROPHYSIOL, V83, P2682, DOI 10.1152/jn.2000.83.5.2682; Kawamata J, 2012, CURR DRUG TARGETS, V13, P623, DOI 10.2174/138945012800399026; Kiyohara Chikako, 2011, Fukuoka Acta Medica, V102, P254; Lester DB, 2010, CNS NEUROSCI THER, V16, P137, DOI 10.1111/j.1755-5949.2010.00142.x; Lindstrom J, 1996, Ion Channels, V4, P377; Liu QA, 2006, ACTA PHARMACOL SIN, V27, P1277, DOI 10.1111/j.1745-7254.2006.00430.x; Liu Q, 2009, J NEUROSCI, V29, P918, DOI 10.1523/JNEUROSCI.3952-08.2009; Louis ED, 2008, NEUROLOGY, V70, P1682, DOI 10.1212/01.wnl.0000311271.42596.32; LUKAS RJ, 1993, MOL CELL NEUROSCI, V4, P1, DOI 10.1006/mcne.1993.1001; Lukas RJ, 1999, PHARMACOL REV, V51, P397; Luscher C, 1999, NEURON, V24, P649, DOI 10.1016/S0896-6273(00)81119-8; Martin-Ruiz CM, 2000, NEUROPHARMACOLOGY, V39, P2830, DOI 10.1016/S0028-3908(00)00110-6; McClure-Begley TD, 2009, MOL PHARMACOL, V75, P918, DOI 10.1124/mol.108.052274; Murray TA, 2012, MOL PHARMACOL, V81, P175, DOI 10.1124/mol.111.074088; PATEL MN, 1993, NEUROTOXICOLOGY, V14, P35; Peng JH, 1999, BRAIN RES, V825, P172, DOI 10.1016/S0006-8993(99)01066-5; PERRY EK, 1986, CAN J NEUROL SCI, V13, P521; PUCHACZ E, 1994, FEBS LETT, V354, P155, DOI 10.1016/0014-5793(94)01108-7; Quik M, 2011, PHARMACOL REV, V63, P938, DOI 10.1124/pr.110.003269; Samochocki M, 2003, J PHARMACOL EXP THER, V305, P1024, DOI 10.1124/jpet.102.045773; Sharma G, 2001, P NATL ACAD SCI USA, V98, P4148, DOI 10.1073/pnas.071540198; Son JH, 2008, J COMP NEUROL, V511, P286, DOI 10.1002/cne.21828; Spillantini MG, 1998, NEUROSCI LETT, V251, P205, DOI 10.1016/s0304-3940(98)00504-7; Takeuchi H, 2009, J NEUROSCI RES, V87, P576, DOI 10.1002/jnr.21869; Tamamaki N, 2003, J COMP NEUROL, V467, P60, DOI 10.1002/cne.10905; Texido L, 2005, BRIT J PHARMACOL, V145, P672, DOI 10.1038/sj.bjp.0706221; Vekrellis K, 2011, LANCET NEUROL, V10, P1041, DOI 10.1016/S1474-4422(11)70213-7; Velez-Fort M, 2009, GLIA, V57, P1104, DOI 10.1002/glia.20834; Volles MJ, 2007, J MOL BIOL, V366, P1510, DOI 10.1016/j.jmb.2006.12.044; Volles MJ, 2003, BIOCHEMISTRY-US, V42, P7871, DOI 10.1021/bi030086j; Volles MJ, 2001, BIOCHEMISTRY-US, V40, P7812, DOI 10.1021/bi0102398; WHITING P, 1987, P NATL ACAD SCI USA, V84, P595, DOI 10.1073/pnas.84.2.595; Wirdefeldt K, 2011, EUR J EPIDEMIOL, V26, pS1, DOI 10.1007/s10654-011-9581-6; Wood SJ, 1999, J BIOL CHEM, V274, P19509, DOI 10.1074/jbc.274.28.19509; Wu J, 2006, J PHYSIOL-LONDON, V576, P103, DOI 10.1113/jphysiol.2006.114645	58	10	11	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e55886	10.1371/journal.pone.0055886	http://dx.doi.org/10.1371/journal.pone.0055886			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437071	Green Submitted, Green Published, gold			2022-12-25	WOS:000315184200029
J	Men, H; Bryda, EC				Men, Hongsheng; Bryda, Elizabeth C.			Derivation of a Germline Competent Transgenic Fischer 344 Embryonic Stem Cell Line	PLOS ONE			English	Article							GENE KNOCKOUT RATS; HOMOLOGOUS RECOMBINATION; TRANSMISSION; BLASTOCYSTS; GENERATION; EXPRESSION; CULTURE	Embryonic stem (ES) cell-based gene manipulation is an effective method for the generation of mutant animal models in mice and rats. Availability of germline-competent ES cell lines from inbred rat strains would allow for creation of new genetically modified models in the desired genetic background. Fischer344 (F344) males carrying an enhanced green fluorescence protein (EGFP) transgene were used as the founder animals for the derivation of ES cell lines. After establishment of ES cell lines, rigorous quality control testing that included assessment of pluripotency factor expression, karyotype analysis, and pathogen/sterility testing was conducted in selected ES cell lines. One male ES cell line, F344-Tg.EC4011, was further evaluated for germline competence by injection into Dark Agouti (DA) X Sprague Dawley (SD) blastocysts. Resulting chimeric animals were bred with wild-type SD mates and germline transmissibility of the ES cell line was confirmed by identification of pups carrying the ES cell line-derived EGFP transgene. This is the first report of a germline competent F344 ES cell line. The availability of a new germline competent ES cell line with a stable fluorescence reporter from an inbred transgenic rat strain provides an important new resource for genetic manipulations to create new rat models.	[Men, Hongsheng; Bryda, Elizabeth C.] Univ Missouri, Dept Vet Pathobiol, Rat Resource & Res Ctr, Columbia, MO 65212 USA	University of Missouri System; University of Missouri Columbia	Bryda, EC (corresponding author), Univ Missouri, Dept Vet Pathobiol, Rat Resource & Res Ctr, Columbia, MO 65212 USA.	brydae@missouri.edu			National Institutes of Health [8P40 OD011062-12]; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD011062] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The project was supported by grant funding to the Rat Resource and Research Center (RRRC) from the National Institutes of Health (8P40 OD011062-12) (URL http://dpcpsi.nih.gov/orip/cm/index.aspx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott A, 2004, NATURE, V428, P464, DOI 10.1038/428464a; Bryda EC, 2006, BIOTECHNIQUES, V41, P715, DOI 10.2144/000112289; Buehr M, 2008, CELL, V135, P1287, DOI 10.1016/j.cell.2008.12.007; Capecchi MR, 2005, NAT REV GENET, V6, P507, DOI 10.1038/nrg1619; Carstea Ana Claudia, 2009, World J Stem Cells, V1, P22, DOI 10.4252/wjsc.v1.i1.22; GILL TJ, 1989, SCIENCE, V245, P269, DOI 10.1126/science.2665079; Hong J, 2012, STEM CELLS DEV, V21, P1571, DOI 10.1089/scd.2011.0370; Kakinoki Ryosuke, 2002, J Orthop Sci, V7, P252, DOI 10.1007/s007760200042; Kawamata M, 2010, P NATL ACAD SCI USA, V107, P14223, DOI 10.1073/pnas.1009582107; Li P, 2008, CELL, V135, P1299, DOI 10.1016/j.cell.2008.12.006; Linder CC, 2001, LAB ANIMAL, V30, P34; Lois C, 2002, SCIENCE, V295, P868, DOI 10.1126/science.1067081; Men HS, 2012, STEM CELLS DEV, V21, P2606, DOI 10.1089/scd.2012.0040; Nichols Jennifer, 2006, V329, P91; Oh SH, 1998, BIOL REPROD, V59, P884, DOI 10.1095/biolreprod59.4.884; Schoonjans L, 2003, STEM CELLS, V21, P90, DOI 10.1634/stemcells.21-1-90; SCHWARTZBERG PL, 1989, SCIENCE, V246, P799, DOI 10.1126/science.2554496; Tong C, 2011, NAT PROTOC, V6, P827, DOI 10.1038/nprot.2011.338; Tong C, 2010, NATURE, V467, P211, DOI 10.1038/nature09368; Xu J, 2002, HUM MOL GENET, V11, P1409, DOI 10.1093/hmg/11.12.1409; Zhao XY, 2010, J GENET GENOMICS, V37, P467, DOI 10.1016/S1673-8527(09)60066-7	21	15	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e56518	10.1371/journal.pone.0056518	http://dx.doi.org/10.1371/journal.pone.0056518			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437152	Green Published, Green Submitted, gold			2022-12-25	WOS:000315184200090
J	Sansom, FM; Tang, L; Ralton, JE; Saunders, EC; Naderer, T; McConville, MJ				Sansom, Fiona M.; Tang, Leonie; Ralton, Julie E.; Saunders, Eleanor C.; Naderer, Thomas; McConville, Malcolm J.			Leishmania major Methionine Sulfoxide Reductase A Is Required for Resistance to Oxidative Stress and Efficient Replication in Macrophages	PLOS ONE			English	Article							TRYPANOTHIONE REDUCTASE; ESCHERICHIA-COLI; MYCOBACTERIUM-SMEGMATIS; ANTIOXIDANT DEFENSE; PROTEIN-REGULATION; A MSRA; GENE; EXPRESSION; VIRULENCE; ENZYME	Leishmania are protozoan parasites that proliferate within the phagolysome of mammalian macrophages. While a number of anti-oxidant systems in these parasites have been shown to protect against endogenous as well as host-generated reactive oxygen species, the potential role of enzymes involved in the repair of oxidatively damaged proteins remains uncharacterized. The Leishmania spp genomes encode a single putative methionine sulfoxide reductase (MsrA) that could have a role in reducing oxidized free and proteinogenic methionine residues. A GFP-fusion of L. major MsrA was shown to have a cytoplasmic localization by immunofluorescence microscopy and subcellular fractionation. An L. major msrA null mutant, generated by targeted replacement of both chromosomal allelles, was viable in rich medium but was unable to reduce exogenous methionine sulfoxide when cultivated in the presence of this amino acid, indicating that msrA encodes a functional MsrA. The Delta msrA mutant exhibited increased sensitivity to H2O2 compared to wild type parasites and was unable to proliferate normally in macrophages. Wild type sensitivity to H2O2 and infectivity in macrophages was restored by complementation of the mutant with a plasmid encoding MsrA. Unexpectedly, the Delta msrA mutant was able to induce normal lesions in susceptible BALB/c indicating that this protein is not essential for pathogenesis in vivo. Our results suggest that Leishmania MsrA contributes to the anti-oxidative defences of these parasites, but that complementary oxidative defence mechansims are up-regulated in lesion amastigotes.	[Sansom, Fiona M.; Tang, Leonie; Ralton, Julie E.; Saunders, Eleanor C.; Naderer, Thomas; McConville, Malcolm J.] Univ Melbourne, Inst Mol Sci & Biotechnol Bio21, Dept Biochem & Mol Biol, Parkville, Vic 3052, Australia; [Sansom, Fiona M.] Univ Melbourne, Fac Vet Sci, Parkville, Vic 3052, Australia	University of Melbourne; University of Melbourne	McConville, MJ (corresponding author), Univ Melbourne, Inst Mol Sci & Biotechnol Bio21, Dept Biochem & Mol Biol, Parkville, Vic 3052, Australia.	malcolmm@unimelb.edu.au	Sansom, Fiona M/W-8445-2019	Sansom, Fiona/0000-0002-9433-2545; Naderer, Thomas/0000-0003-2691-0283; Saunders, Eleanor/0000-0002-3247-8522	National Health and Medical Research Council [APP1006023]	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by the National Health and Medical Research Council (http://www.nhmrc.gov.au/), under project grant APP1006023. FMS is a NH&MRC Peter Doherty Australian Biomedical Fellow. MJM is a NH&MRC Principal Research Fellow. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alamuri P, 2004, MOL MICROBIOL, V53, P1397, DOI 10.1111/j.1365-2958.2004.04190.x; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Arias DG, 2011, FREE RADICAL BIO MED, V50, P37, DOI 10.1016/j.freeradbiomed.2010.10.695; Ariyanayagam MR, 2001, MOL BIOCHEM PARASIT, V115, P189, DOI 10.1016/S0166-6851(01)00285-7; Besteiro S, 2007, INT J PARASITOL, V37, P1063, DOI 10.1016/j.ijpara.2007.03.008; Boughton BA, 2011, ANAL CHEM, V83, P7523, DOI 10.1021/ac201610x; CHAN J, 1989, P NATL ACAD SCI USA, V86, P2453, DOI 10.1073/pnas.86.7.2453; Croft SL, 2011, CLIN MICROBIOL INFEC, V17, P1478, DOI 10.1111/j.1469-0691.2011.03630.x; CRUZ A, 1991, P NATL ACAD SCI USA, V88, P7170, DOI 10.1073/pnas.88.16.7170; Das K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036247; den Boer M, 2011, CLIN MICROBIOL INFEC, V17, P1471, DOI 10.1111/j.1469-0691.2011.03635.x; Denkel LA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026974; Dhandayuthapani S, 2001, J BACTERIOL, V183, P5645, DOI 10.1128/JB.183.19.5645-5650.2001; Dhandayuthapani S, 2009, TUBERCULOSIS, V89, pS26, DOI 10.1016/S1472-9792(09)70008-3; Dolai S, 2008, FREE RADICAL BIO MED, V45, P1520, DOI 10.1016/j.freeradbiomed.2008.08.029; Dolai S, 2009, EUKARYOT CELL, V8, P1721, DOI 10.1128/EC.00198-09; Douglas T, 2004, J BACTERIOL, V186, P3590, DOI 10.1128/JB.186.11.3590-3598.2004; Dumas C, 1997, EMBO J, V16, P2590, DOI 10.1093/emboj/16.10.2590; El Hassouni M, 1999, P NATL ACAD SCI USA, V96, P887, DOI 10.1073/pnas.96.3.887; Etienne F, 2003, BIOCHEM BIOPH RES CO, V300, P378, DOI 10.1016/S0006-291X(02)02870-X; FREEDMAN DJ, 1993, MOL BIOCHEM PARASIT, V62, P37, DOI 10.1016/0166-6851(93)90175-W; Goujon M, 2010, NUCLEIC ACIDS RES, V38, pW695, DOI 10.1093/nar/gkq313; Grimaud R, 2001, J BIOL CHEM, V276, P48915, DOI 10.1074/jbc.M105509200; Ha DS, 1996, MOL BIOCHEM PARASIT, V77, P57, DOI 10.1016/0166-6851(96)02580-7; Hansel A, 2002, FASEB J, V16, P911, DOI 10.1096/fj.01-0737fje; Ivens AC, 2005, SCIENCE, V309, P436, DOI 10.1126/science.1112680; Kaya A, 2010, BIOCHEMISTRY-US, V49, P8618, DOI 10.1021/bi100908v; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lei Y, 2011, MOL MICROBIOL, V80, P726, DOI 10.1111/j.1365-2958.2011.07603.x; Leifso K, 2007, MOL BIOCHEM PARASIT, V152, P35, DOI 10.1016/j.molbiopara.2006.11.009; Lin ZD, 2007, P NATL ACAD SCI USA, V104, P9597, DOI 10.1073/pnas.0703774104; McConville MJ, 2011, ANNU REV MICROBIOL, V65, P543, DOI 10.1146/annurev-micro-090110-102913; Merlen T, 1999, AM J TROP MED HYG, V60, P41, DOI 10.4269/ajtmh.1999.60.41; Morales MA, 2010, P NATL ACAD SCI USA, V107, P8381, DOI 10.1073/pnas.0914768107; Moreira W, 2009, FREE RADICAL BIO MED, V46, P367, DOI 10.1016/j.freeradbiomed.2008.10.034; Moskovitz J, 2005, CURR PHARM DESIGN, V11, P1451, DOI 10.2174/1381612053507846; Moskovitz J, 2005, BBA-PROTEINS PROTEOM, V1703, P213, DOI 10.1016/j.bbapap.2004.09.003; Moskovitz J, 1996, P NATL ACAD SCI USA, V93, P2095, DOI 10.1073/pnas.93.5.2095; Moskovitz J, 2000, J BIOL CHEM, V275, P14167, DOI 10.1074/jbc.275.19.14167; MOSKOVITZ J, 1995, J BACTERIOL, V177, P502, DOI 10.1128/jb.177.3.502-507.1995; Mukherjee A, 2009, MOL MICROBIOL, V74, P914, DOI 10.1111/j.1365-2958.2009.06907.x; Mullin KA, 2001, MOL BIOL CELL, V12, P2364, DOI 10.1091/mbc.12.8.2364; Murray HW, 2005, LANCET, V366, P1561, DOI 10.1016/S0140-6736(05)67629-5; Naderer T, 2006, P NATL ACAD SCI USA, V103, P5502, DOI 10.1073/pnas.0509196103; Naderer T, 2008, MOL MICROBIOL, V69, P858, DOI 10.1111/j.1365-2958.2008.06314.x; Naderer T, 2011, MOL MICROBIOL, V80, P471, DOI 10.1111/j.1365-2958.2011.07584.x; Nare B, 2009, CURR GENET, V55, P287, DOI 10.1007/s00294-009-0244-z; Oza SL, 2005, MOL BIOCHEM PARASIT, V139, P107, DOI 10.1016/j.molbiopara.2004.10.004; Pal S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011271; Peters NC, 2008, SCIENCE, V321, P970, DOI 10.1126/science.1159194; Plewes KA, 2003, INFECT IMMUN, V71, P5910, DOI 10.1128/IAI.71.10.5910-5920.2003; Rochette Annie, 2008, BMC Genomics, V9, P255, DOI 10.1186/1471-2164-9-255; Sacks D, 2002, NAT REV IMMUNOL, V2, P845, DOI 10.1038/nri933; Saunders EC, 2011, J BIOL CHEM, V286, P27706, DOI 10.1074/jbc.M110.213553; Spath GF, 2003, P NATL ACAD SCI USA, V100, P9536, DOI 10.1073/pnas.1530604100; TITUS RG, 1985, PARASITE IMMUNOL, V7, P545, DOI 10.1111/j.1365-3024.1985.tb00098.x; Tovar J, 1998, MOL MICROBIOL, V29, P653, DOI 10.1046/j.1365-2958.1998.00968.x; Tovar J, 1998, P NATL ACAD SCI USA, V95, P5311, DOI 10.1073/pnas.95.9.5311; Van Assche T, 2011, FREE RADICAL BIO MED, V51, P337, DOI 10.1016/j.freeradbiomed.2011.05.011; Vickers TJ, 2006, J BIOL CHEM, V281, P38150, DOI 10.1074/jbc.M608387200; Vickers TJ, 2004, J BIOL CHEM, V279, P49003, DOI 10.1074/jbc.M407958200; Vougier S, 2003, BIOCHEM J, V373, P531, DOI 10.1042/BJ20030443; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Weissbach H, 2005, BBA-PROTEINS PROTEOM, V1703, P203, DOI 10.1016/j.bbapap.2004.10.004; Williams RAM, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002695; Wizemann TM, 1996, P NATL ACAD SCI USA, V93, P7985, DOI 10.1073/pnas.93.15.7985; Zhao C, 2010, INFECT IMMUN, V78, P3889, DOI 10.1128/IAI.00165-10	67	18	18	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e56064	10.1371/journal.pone.0056064	http://dx.doi.org/10.1371/journal.pone.0056064			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437085	Green Published, Green Submitted, gold			2022-12-25	WOS:000315184200039
J	Wascher, CAF; Bugnyar, T				Wascher, Claudia A. F.; Bugnyar, Thomas			Behavioral Responses to Inequity in Reward Distribution and Working Effort in Crows and Ravens	PLOS ONE			English	Article							CAPUCHIN MONKEYS; CARRION CROWS; TOKEN-EXCHANGE; AVERSION; PERCEPTIONS; PERFORMANCE; EVOLUTION; COGNITION; FAIRNESS; CORVIDS	Sensitivity to inequity is considered to be a crucial cognitive tool in the evolution of human cooperation. The ability has recently been shown also in primates and dogs, raising the question of an evolutionary basis of inequity aversion. We present first evidence that two bird species are sensitive to other individuals' efforts and payoffs. In a token exchange task we tested both behavioral responses to inequity in the quality of reward (preferred versus non-preferred food) and to the absence of reward in the presence of a rewarded partner, in 5 pairs of corvids (6 crows, 4 ravens). Birds decreased their exchange performance when the experimental partner received the reward as a gift, which indicates that they are sensitive to other individuals' working effort. They also decreased their exchange performance in the inequity compared with the equity condition. Notably, corvids refused to take the reward after a successful exchange more often in the inequity compared with the other conditions. Our findings indicate that awareness to other individuals' efforts and payoffs may evolve independently of phylogeny in systems with a given degree of social complexity.	[Wascher, Claudia A. F.; Bugnyar, Thomas] Univ Vienna, Core Facil, Konrad Lorenz Forsch Stelle, Gruenau, Austria; [Wascher, Claudia A. F.] Univ Vienna, Dept Behav Biol, Vienna, Austria; [Wascher, Claudia A. F.; Bugnyar, Thomas] Univ Vienna, Dept Cognit Biol, Vienna, Austria	University of Vienna; University of Vienna; University of Vienna	Wascher, CAF (corresponding author), Univ Vienna, Core Facil, Konrad Lorenz Forsch Stelle, Gruenau, Austria.	claudia.wascher@klf.ac.at	Wascher, Claudia/I-4060-2019	Wascher, Claudia/0000-0003-4360-363X	L'Oreal Women in Science scholarship; European Science Foundation EUROCORES program "The evolution of cooperation and trading: Cooperation in Corvids" [I105-G11]; Austrian Science Foundation (FWF) [Y366-B17]; Austrian Science Fund (FWF) [Y 366] Funding Source: researchfish	L'Oreal Women in Science scholarship; European Science Foundation EUROCORES program "The evolution of cooperation and trading: Cooperation in Corvids"; Austrian Science Foundation (FWF)(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	The project was funded by a L'Oreal Women in Science scholarship to CAFW, and the European Science Foundation EUROCORES program "The evolution of cooperation and trading: Cooperation in Corvids" (I105-G11; http://www.esf.org)) and Austrian Science Foundation (FWF Start Y366-B17; http://www.fwf.ac.at) to TB. Permanent support was provided by the "Verein der Forderer" and the Herzog von Cumberland Stiftung. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baglione V, 2003, SCIENCE, V300, P1947, DOI 10.1126/science.1082429; Baglione V, 2002, ANIM BEHAV, V64, P887, DOI 10.1006/anbe.2002.2007; Bettencourt LA, 1997, J RETAILING, V73, P39, DOI 10.1016/S0022-4359(97)90014-2; Brauer J, 2009, AM J PRIMATOL, V71, P175, DOI 10.1002/ajp.20639; Brosnan S.F., 2006, SOC JUSTICE RES, V19, P153, DOI [10.1007/s11211-006-0002-z, DOI 10.1007/S11211-006-0002-Z]; Brosnan SF, 2010, PHILOS T R SOC B, V365, P2699, DOI 10.1098/rstb.2010.0154; Brosnan SF, 2010, ANIM BEHAV, V79, P1229, DOI 10.1016/j.anbehav.2010.02.019; Brosnan SF, 2009, ANIM COGN, V12, P587, DOI 10.1007/s10071-009-0218-z; Brosnan SF, 2005, P ROY SOC B-BIOL SCI, V272, P253, DOI 10.1098/rspb.2004.2947; Brosnan SF, 2003, NATURE, V425, P297, DOI 10.1038/nature01963; Bugnyar T, 2007, CURR BIOL, V17, P1804, DOI 10.1016/j.cub.2007.09.048; Bugnyar T, 2007, ANIM BEHAV, V74, P757, DOI 10.1016/j.anbehav.2006.08.019; Burnham KP, 2004, SOCIOL METHOD RES, V33, P261, DOI 10.1177/0049124104268644; Clayton N, 2005, CURR BIOL, V15, pR80, DOI 10.1016/j.cub.2005.01.020; Dufour V, 2012, BIOL LETTERS, V8, P201, DOI 10.1098/rsbl.2011.0726; Emery NJ, 2004, SCIENCE, V306, P1903, DOI 10.1126/science.1098410; Fehr E, 2004, TRENDS COGN SCI, V8, P185, DOI 10.1016/j.tics.2004.02.007; Fletcher GE, 2008, AM J PRIMATOL, V70, P901, DOI 10.1002/ajp.20576; Fontenot MB, 2007, ANIM BEHAV, V74, P487, DOI 10.1016/j.anbehav.2007.01.015; Fraser ON, 2012, ANIM BEHAV, V83, P171, DOI 10.1016/j.anbehav.2011.10.023; Fraser ON, 2010, ANIM BEHAV, V79, P927, DOI 10.1016/j.anbehav.2010.01.008; GUTH W, 1990, J ECON PSYCHOL, V11, P417, DOI 10.1016/0167-4870(90)90021-Z; Hare B, 2002, SCIENCE, V298, P1634, DOI 10.1126/science.1072702; HEINRICH B, 1991, BEHAV ECOL SOCIOBIOL, V28, P13; Heinrich B, 2007, SCI AM, V296, P64, DOI 10.1038/scientificamerican0407-64; Hodge SJ, 2009, BEHAV ECOL, V20, P930, DOI 10.1093/beheco/arp071; Janssen O, 2001, ACAD MANAGE J, V44, P1039, DOI 10.2307/3069447; Marzluff JM, 1996, ANIM BEHAV, V51, P89, DOI 10.1006/anbe.1996.0008; Mcgowan A, 2007, IBIS, V149, P170; PRITCHARD RD, 1972, J APPL PSYCHOL, V56, P75, DOI 10.1037/h0032135; Raihani NJ, 2012, ANIM BEHAV, V84, P665, DOI 10.1016/j.anbehav.2012.06.023; Range F, 2009, P NATL ACAD SCI USA, V106, P340, DOI 10.1073/pnas.0810957105; Roma PG, 2006, J COMP PSYCHOL, V120, P67, DOI 10.1037/0735-7036.120.1.67; Roth A.E., 1995, HDB EXPT EC, P253; Scheid C, 2010, ANIM COGN, V13, P545, DOI 10.1007/s10071-009-0305-1; Seed AM, 2008, P ROY SOC B-BIOL SCI, V275, P1421, DOI 10.1098/rspb.2008.0111; Silk JB, 2011, P NATL ACAD SCI USA, V108, P10910, DOI 10.1073/pnas.1100305108; Stevens JR, 2004, TRENDS COGN SCI, V8, P60, DOI 10.1016/j.tics.2003.12.003; Takimoto A, 2010, ANIM COGN, V13, P249, DOI 10.1007/s10071-009-0262-8; Talbot CF, 2011, BIOL LETTERS, V7, P680, DOI 10.1098/rsbl.2011.0211; van Wolkenten M, 2007, P NATL ACAD SCI USA, V104, P18854, DOI 10.1073/pnas.0707182104; Wascher CAF, 2012, ANIM COGN, V15, P1015, DOI 10.1007/s10071-012-0508-8; Wascher CAF, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00118; Wynne CDL, 2004, NATURE, V428, P140, DOI [10.1038/428140a, 10.1038/428140b]	44	58	60	4	76	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e56885	10.1371/journal.pone.0056885	http://dx.doi.org/10.1371/journal.pone.0056885			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437262	Green Submitted, Green Published, gold			2022-12-25	WOS:000315184200177
J	Welcker, J; Chastel, O; Gabrielsen, GW; Guillaumin, J; Kitaysky, AS; Speakman, JR; Tremblay, Y; Bech, C				Welcker, Jorg; Chastel, Olivier; Gabrielsen, Geir W.; Guillaumin, Jerome; Kitaysky, Alexander S.; Speakman, John R.; Tremblay, Yann; Bech, Claus			Thyroid Hormones Correlate with Basal Metabolic Rate but Not Field Metabolic Rate in a Wild Bird Species	PLOS ONE			English	Article							DOUBLY-LABELED WATER; KITTIWAKES RISSA-TRIDACTYLA; DAILY ENERGY-EXPENDITURE; BODY-COMPOSITION; PHYSICAL-ACTIVITY; INDIVIDUAL VARIATION; THYROXINE; VOLES; THERMOGENESIS; REPEATABILITY	Thyroid hormones (TH) are known to stimulate in vitro oxygen consumption of tissues in mammals and birds. Hence, in many laboratory studies a positive relationship between TH concentrations and basal metabolic rate (BMR) has been demonstrated whereas evidence from species in the wild is scarce. Even though basal and field metabolic rates (FMR) are often thought to be intrinsically linked it is still unknown whether a relationship between TH and FMR exists. Here we determine the relationship between the primary thyroid hormone triiodothyronine (T3) with both BMR and FMR in a wild bird species, the black-legged kittiwake (Rissa tridactyla). As predicted we found a strong and positive relationship between plasma concentrations of T3 and both BMR and mass-independent BMR with coefficients of determination ranging from 0.36 to 0.60. In contrast there was no association of T3 levels with either whole-body or mass-independent FMR (R-2 = 0.06 and 0.02, respectively). In accordance with in vitro studies our data suggests that TH play an important role in modulating BMR and may serve as a proxy for basal metabolism in wild birds. However, the lack of a relationship between TH and FMR indicates that levels of physical activity in kittiwakes are largely independent of TH concentrations and support recent studies that cast doubt on a direct linkage between BMR and FMR.	[Welcker, Jorg; Gabrielsen, Geir W.] Norwegian Polar Res Inst, Tromso, Norway; [Welcker, Jorg; Kitaysky, Alexander S.] Univ Alaska Fairbanks, Inst Arctic Biol, Fairbanks, AK USA; [Chastel, Olivier; Guillaumin, Jerome; Tremblay, Yann] CNRS, Ctr Etud Biol Chize, Chize, France; [Speakman, John R.] Univ Aberdeen, Inst Biol & Environm Sci, Aberdeen, Scotland; [Speakman, John R.] Chinese Acad Sci, Inst Genet & Dev Biol, Beijing, Peoples R China; [Tremblay, Yann] Ctr Rech Halieut Mediterraneenne & Trop, Sete, France; [Bech, Claus] Norwegian Univ Sci & Technol, Dept Biol, N-7034 Trondheim, Norway	Norwegian Polar Institute; University of Alaska System; University of Alaska Fairbanks; Centre National de la Recherche Scientifique (CNRS); University of Aberdeen; Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS; Norwegian University of Science & Technology (NTNU)	Welcker, J (corresponding author), Norwegian Polar Res Inst, Tromso, Norway.	jorg.welcker@npolar.no	Bech, Claus/C-1086-2011; Bech, Claus/N-1077-2019; Speakman, John R./A-9494-2008	Bech, Claus/0000-0002-0860-0663; Bech, Claus/0000-0002-0860-0663; Speakman, John R./0000-0002-2457-1823	French Polar Institute (IPEV Program) [330]; Research Council of Norway [197192/V40]; Norwegian Polar Institute	French Polar Institute (IPEV Program); Research Council of Norway(Research Council of Norway); Norwegian Polar Institute	The study was financially supported by the French Polar Institute (IPEV Program 330 to O. Chastel), the Research Council of Norway (project 197192/V40 to JW) and the Norwegian Polar Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARKER SB, 1951, PHYSIOL REV, V31, P205, DOI 10.1152/physrev.1951.31.3.205; BARKER SB, 1952, AM J PHYSIOL, V170, P81, DOI 10.1152/ajplegacy.1952.170.1.81; Barrett RT, 2007, MAR ECOL PROG SER, V349, P269, DOI 10.3354/meps07116; Bech C, 2002, COMP BIOCHEM PHYS A, V133, P765, DOI 10.1016/S1095-6433(02)00153-8; Bech C, 1999, P ROY SOC B-BIOL SCI, V266, P2161, DOI 10.1098/rspb.1999.0903; Berteaux D, 1996, FUNCT ECOL, V10, P751, DOI 10.2307/2390510; BOBEK S, 1977, GEN COMP ENDOCR, V31, P169, DOI 10.1016/0016-6480(77)90014-4; Burger MF, 2002, PHYSIOL BIOCHEM ZOOL, V75, P187, DOI 10.1086/338955; Butler PJ, 2004, FUNCT ECOL, V18, P168, DOI 10.1111/j.0269-8463.2004.00821.x; Careau V, 2012, J EXPT BIOL IN PRESS; Chastel O, 2003, J AVIAN BIOL, V34, P298, DOI 10.1034/j.1600-048X.2003.02528.x; Corbel H, 2008, GEN COMP ENDOCR, V155, P804, DOI 10.1016/j.ygcen.2007.11.006; DAAN S, 1989, J BIOL RHYTHM, V4, P267; DAAN S, 1990, AM J PHYSIOL, V259, pR333, DOI 10.1152/ajpregu.1990.259.2.R333; DAWSON WR, 1992, ORNIS SCAND, V23, P381, DOI 10.2307/3676664; DuBois E, 1936, BASAL METABOLISM HLT; Duriez O, 2004, ARDEA, V92, P31; EALES JG, 1988, AM ZOOL, V28, P351; Ellis HI, 2002, BIOL MARINE BIRDS; EMLEN W, 1972, SCIENCE, V175, P79, DOI 10.1126/science.175.4017.79; FREAKE HC, 1995, ANNU REV NUTR, V15, P263, DOI 10.1146/annurev.nu.15.070195.001403; Fridolfsson AK, 1999, J AVIAN BIOL, V30, P116, DOI 10.2307/3677252; Fyhn M, 2001, PHYSIOL BIOCHEM ZOOL, V74, P343, DOI 10.1086/320419; GABRIELSEN GW, 1988, J COMP PHYSIOL B, V157, P703, DOI 10.1007/BF00691000; GRATTOTREVOR CL, 1991, J FIELD ORNITHOL, V62, P19; Hammond KA, 1997, NATURE, V386, P457, DOI 10.1038/386457a0; HARPER ME, 1993, J BIOL CHEM, V268, P14850; Hulbert AJ, 2004, PHYSIOL BIOCHEM ZOOL, V77, P869, DOI 10.1086/422768; Hulbert AJ, 2000, BIOL REV, V75, P519, DOI 10.1017/S146479310000556X; Johnstone AM, 2005, AM J CLIN NUTR, V82, P941, DOI 10.1093/ajcn/82.5.941; JOOS B, 1990, PHYSIOL ZOOL, V63, P873, DOI 10.1086/physzool.63.5.30152618; Kim B, 2008, THYROID, V18, P141, DOI 10.1089/thy.2007.0266; KLANDORF H, 1978, GEN COMP ENDOCR, V36, P238, DOI 10.1016/0016-6480(78)90029-1; Levine JA, 2003, J APPL PHYSIOL, V94, P165, DOI 10.1152/japplphysiol.00499.2002; Li YG, 2010, COMP BIOCHEM PHYS A, V157, P204, DOI 10.1016/j.cbpa.2010.06.183; McNabb F.M. Anne, 2000, P461; Meerlo P, 1997, PHYSIOL ZOOL, V70, P362, DOI 10.1086/639616; MENDEL CM, 1989, ENDOCR REV, V10, P232, DOI 10.1210/edrv-10-3-232; Moe B, 2002, J AVIAN BIOL, V33, P225, DOI 10.1034/j.1600-048X.2002.330304.x; Nagy K. A., 1983, DOUBLY LABELLED WATE; NIIMI AJ, 1978, J FISH RES BOARD CAN, V35, P1265, DOI 10.1139/f78-197; Nilsson JA, 2002, P ROY SOC B-BIOL SCI, V269, P1735, DOI 10.1098/rspb.2002.2071; R Development Core Team, 2012, R LANG ENV STAT COMP; Rolfe DFS, 1997, PHYSIOL REV, V77, P731, DOI 10.1152/physrev.1997.77.3.731; Ronning B, 2008, J COMP PHYSIOL B, V178, P779, DOI 10.1007/s00360-008-0268-6; Silvestri E, 2005, ACTA PHYSIOL SCAND, V184, P265, DOI 10.1111/j.1365-201X.2005.01463.x; Speakman J.R., 1997, DOUBLY LABELLED WATE; Speakman JR, 2004, PHYSIOL BIOCHEM ZOOL, V77, P900, DOI 10.1086/427059; Speakman JR, 2005, PHYSIOL BIOCHEM ZOOL, V78, P650, DOI 10.1086/430234; Speakman JR, 2000, ADV ECOL RES, V30, P177; Speakman JR, 2003, P NATL ACAD SCI USA, V100, P14057, DOI 10.1073/pnas.2235671100; SPEAKMAN JR, 1987, J THEOR BIOL, V127, P79, DOI 10.1016/S0022-5193(87)80162-5; SPEAKMAN JR, 1990, ANAL CHEM, V62, P703, DOI 10.1021/ac00206a011; SPEAKMAN JR, 1993, FUNCT ECOL, V7, P746; SPEAKMAN JR, 1994, FUNCT ECOL, V8, P336, DOI 10.2307/2389826; Starling RD, 1998, J APPL PHYSIOL, V85, P1063, DOI 10.1152/jappl.1998.85.3.1063; STENLOF K, 1993, SCAND J CLIN LAB INV, V53, P793, DOI 10.3109/00365519309086491; Tieleman BI, 2008, BEHAV ECOL, V19, P949, DOI 10.1093/beheco/arn051; Toubro S, 1996, J CLIN ENDOCR METAB, V81, P2670, DOI 10.1210/jc.81.7.2670; Van Trigt R, 2002, J APPL PHYSIOL, V93, P2147, DOI 10.1152/japplphysiol.01134.2001; Vezina F, 2009, PHYSIOL BIOCHEM ZOOL, V82, P129, DOI 10.1086/596512; Visser GH, 1999, PHYSIOL BIOCHEM ZOOL, V72, P740, DOI 10.1086/316713; WEINER J, 1992, TRENDS ECOL EVOL, V7, P384, DOI 10.1016/0169-5347(92)90009-Z; Welcker J, 2010, J ANIM ECOL, V79, P205, DOI 10.1111/j.1365-2656.2009.01626.x; Welcker J, 2009, FUNCT ECOL, V23, P1081, DOI 10.1111/j.1365-2435.2009.01585.x; Westerterp KR, 2008, INT J OBESITY, V32, P1256, DOI 10.1038/ijo.2008.74; White CR, 2004, PHYSIOL BIOCHEM ZOOL, V77, P929, DOI 10.1086/425186; WITHERS PC, 1977, J APPL PHYSIOL, V42, P120, DOI 10.1152/jappl.1977.42.1.120	68	42	43	1	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e56229	10.1371/journal.pone.0056229	http://dx.doi.org/10.1371/journal.pone.0056229			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437096	Green Published, Green Accepted, gold			2022-12-25	WOS:000315184200047
J	Mutyal, NN; Radosevich, A; Tiwari, AK; Stypula, Y; Wali, R; Kunte, D; Roy, HK; Backman, V				Mutyal, Nikhil N.; Radosevich, Andrew; Tiwari, Ashish K.; Stypula, Yolanda; Wali, Ramesh; Kunte, Dhananjay; Roy, Hemant K.; Backman, Vadim			Biological Mechanisms Underlying Structural Changes Induced by Colorectal Field Carcinogenesis Measured with Low-Coherence Enhanced Backscattering (LEBS) Spectroscopy	PLOS ONE			English	Article							ADENOMATOUS POLYPOSIS-COLI; PROTEIN-KINASE-C; LIGHT-SCATTERING; CELL-PROLIFERATION; COLONIC NEOPLASIA; GENE-EXPRESSION; CANCER CELLS; STEM-CELL; RISK; MUCOSA	We previously reported the utility of Low-Coherence Enhanced Backscattering (LEBS) Spectroscopy in detecting optical changes in uninvolved rectal mucosa, changes that are indicative of the presence of advanced colorectal adenomas elsewhere in the colon (field carcinogenesis). We hypothesized that the alterations in optical signatures are due to structural changes in colonocytes. To elucidate those colonocyte changes, we used LEBS and an early time point in an animal model of colorectal field carcinogenesis - rats treated with azoxymethane (AOM). Changes in LEBS markers in intact mucosa from AOM-treated rats could be at least partially attributed to changes in colonocytes. To investigate the molecular mechanisms underlying the colonocyte abnormalities in premalignant colon, we took a candidate approach. We compared expression profiles of genes implicated directly or indirectly in cytoskeletal dysregulation in colorectal tissues from saline-treated versus AOM-treated rats. Our data suggest that a number of genes known to affect colon tumorigenesis are up-regulated in colonocytes, and genes previously reported to be tumor suppressors in metastatic cancer are down-regulated in colonocytes, despite the colonocytes being histologically normal. To further understand the role of the cytoskeleton in generating changes in optical markers of cells, we used pharmacological disruption (using colchicine) of the cytoskeleton. We found that differences in optical markers (between AOM- and control-treated rats) were negated by the disruption, suggesting cytoskeletal involvement in the optical changes. These studies provide significant insights into the micro-architectural alterations in early colon carcinogenesis, and may enable optimization of both bio-photonic and molecular risk stratification techniques to personalize colorectal cancer screening.	[Mutyal, Nikhil N.; Radosevich, Andrew; Stypula, Yolanda; Backman, Vadim] Northwestern Univ, Dept Biomed Engn, Evanston, IL 60208 USA; [Tiwari, Ashish K.; Wali, Ramesh; Kunte, Dhananjay; Roy, Hemant K.] NorthShore Univ Healthsyst, Dept Internal Med, Evanston, IL USA	Northwestern University; NorthShore University Health System	Roy, HK (corresponding author), NorthShore Univ Healthsyst, Dept Internal Med, Evanston, IL USA.	h-roy@northwestern.edu	Backman, Vadim/B-6689-2009; Roy, Hemant/AAC-9096-2020		NIH [R01CA128641, R01 EB003682, R01CA156186 U01CA111257]; NSF [CBET-0937987]; NATIONAL CANCER INSTITUTE [R01CA128641, U01CA111257, R01CA156186] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB003682] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was supported by NIH grants R01CA128641, R01 EB003682, R01CA156186 U01CA111257, and NSF grant CBET-0937987. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANTI M, 1993, GUT, V34, P525, DOI 10.1136/gut.34.4.525; Arifler D, 2007, BIOPHYS J, V92, P3260, DOI 10.1529/biophysj.106.089839; BARER R, 1954, Q J MICROSC SCI, V95, P399; Barnes CJ, 1999, INT J CANCER, V80, P68; Bernstein C, 1999, CANCER RES, V59, P2353; BISSONNETTE M, 1995, J CLIN INVEST, V95, P2215, DOI 10.1172/JCI117911; Brittan M, 2004, GUT, V53, P899, DOI 10.1136/gut.2003.025478; Calabrese P, 2004, AM J PATHOL, V164, P1337, DOI 10.1016/S0002-9440(10)63220-8; Caro-Gonzalez HY, 2012, J CELL SCI, V125, P1247, DOI 10.1242/jcs.095166; Chen LC, 2004, CANCER RES, V64, P3694, DOI 10.1158/0008-5472.CAN-03-3264; Dakubo GD, 2007, CANCER CELL INT, V7, DOI 10.1186/1475-2867-7-2; Damania D, 2012, CANCER RES, V72, P2720, DOI 10.1158/0008-5472.CAN-11-3807; Damania D, 2010, BIOPHYS J, V99, P989, DOI 10.1016/j.bpj.2010.05.023; Kim YL, 2003, IEEE J SEL TOP QUANT, V9, P243, DOI 10.1109/JSTQE.2003.814183; KOPELOVICH L, 1977, P NATL ACAD SCI USA, V74, P3019, DOI 10.1073/pnas.74.7.3019; Marshall TW, 2011, MOL BIOL CELL, V22, P3962, DOI 10.1091/mbc.E11-05-0469; MCGARRITY TJ, 1994, DIGEST DIS SCI, V39, P458, DOI 10.1007/BF02088328; Polley ACJ, 2006, CANCER RES, V66, P6553, DOI 10.1158/0008-5472.CAN-06-0534; Preston SL, 2003, CANCER RES, V63, P3819; RAO JY, 1991, CANCER RES, V51, P2762; RICHTER A, 1993, CANCER LETT, V74, P65, DOI 10.1016/0304-3835(93)90045-B; Rogers JD, 2009, OPT LETT, V34, P1891, DOI 10.1364/OL.34.001891; Rosenberg DW, 2009, CARCINOGENESIS, V30, P183, DOI 10.1093/carcin/bgn267; Roy HK, 2009, CANCER RES, V69, P4476, DOI 10.1158/0008-5472.CAN-08-4780; Roy HK, 2006, CLIN CANCER RES, V12, P961, DOI 10.1158/1078-0432.CCR-05-1605; Roy P, 2004, CELL MOTIL CYTOSKEL, V57, P84, DOI 10.1002/cm.10160; Stypula Y, 2012, GASTROENTEROLOGY S1, V138, pS; Takahashi M, 2004, CANCER SCI, V95, P475, DOI 10.1111/j.1349-7006.2004.tb03235.x; Takayama T, 1998, NEW ENGL J MED, V339, P1277, DOI 10.1056/NEJM199810293391803; Turzhitsky V, 2011, J BIOMED OPT, V16, DOI 10.1117/1.3589349; Vandecandelaere A, 1997, BIOCHEM J, V323, P189, DOI 10.1042/bj3230189; Vlecken DH, 2009, ZEBRAFISH, V6, P433, DOI 10.1089/zeb.2009.0602	32	10	10	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2013	8	2							e57206	10.1371/journal.pone.0057206	http://dx.doi.org/10.1371/journal.pone.0057206			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093HR	23431406	gold, Green Published, Green Submitted			2022-12-25	WOS:000315182800049
J	Vaupel, JW; Missov, TI; Metcalf, CJE				Vaupel, James W.; Missov, Trifon I.; Metcalf, C. Jessica E.			Optimal Semelparity	PLOS ONE			English	Article							SEED SIZE; NATURAL-SELECTION; MONOCARPIC PLANTS; GENERAL-MODEL; REPRODUCTION; DYNAMICS; HISTORY; GROWTH; AGE	Semelparous organisms have a simple life cycle characterized by immediate death after reproduction. We assume that semelparous life histories can be separated into a juvenile non-reproductive period followed by an adult period during which reproduction is possible. We derive formulae for the optimal age and size at reproduction and for the optimal size of the offspring (e.g., seeds). Our main contribution is to determine the conditions under which the optimal size of the offspring does not depend on the optimal size at reproduction and vice versa.	[Vaupel, James W.; Missov, Trifon I.] Max Planck Inst Demog Res, Lab Survival & Longev, Rostock, Germany; [Vaupel, James W.] Univ So Denmark, Max Planck Odense Ctr Biodemog Aging, Odense, Denmark; [Vaupel, James W.] Duke Univ, Populat Res Inst, Durham, NC USA; [Missov, Trifon I.] Univ Rostock, Inst Sociol & Demog, Fac Econ & Social Sci, D-18055 Rostock, Germany; [Metcalf, C. Jessica E.] Univ Oxford, Dept Zool, Oxford OX1 3PS, England	Max Planck Society; University of Southern Denmark; Duke University; University of Rostock; University of Oxford	Missov, TI (corresponding author), Max Planck Inst Demog Res, Lab Survival & Longev, Rostock, Germany.	missov@demogr.mpg.de	Missov, Trifon I./AAE-6540-2020	Missov, Trifon I./0000-0002-7312-4261; Vaupel, James/0000-0003-0783-3905	Max Planck Institute for Demographic Rsearch; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P2CHD047879] Funding Source: NIH RePORTER	Max Planck Institute for Demographic Rsearch; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	The study was funded by the Max Planck Institute for Demographic Rsearch (http://www.demogr.mpg.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams PA, 1996, EVOLUTION, V50, P1052, DOI 10.1111/j.1558-5646.1996.tb02346.x; ARTHUR WB, 1984, POPUL INDEX, V50, P214, DOI 10.2307/2736755; BRAITHWAITE RW, 1979, AM NAT, V113, P151, DOI 10.1086/283372; Burd M, 2006, ECOLOGY, V87, P2755, DOI 10.1890/0012-9658(2006)87[2755:APFRIM]2.0.CO;2; Charnov Eric L., 1993, P1; COLE LC, 1954, Q REV BIOL, V29, P103, DOI 10.1086/400074; Falster DS, 2008, AM NAT, V172, P299, DOI 10.1086/589889; FRITZ RS, 1982, AM NAT, V120, P264, DOI 10.1086/283987; Geritz SAH, 1999, THEOR POPUL BIOL, V55, P324, DOI 10.1006/tpbi.1998.1409; HAMILTON WD, 1966, J THEOR BIOL, V12, P12, DOI 10.1016/0022-5193(66)90184-6; Kiawi M, 2006, OIKOS, V113, P168; KLINKHAMER PGL, 1992, FUNCT ECOL, V6, P308, DOI 10.2307/2389522; Lewontin R. C., 1965, P77; Metcalf JC, 2003, TRENDS ECOL EVOL, V18, P471, DOI 10.1016/S0169-5347(03)00162-9; Moles AT, 2005, SCIENCE, V307, P576, DOI 10.1126/science.1104863; Rees M., 2000, ECOLOGICAL CONSEQUEN, P237; Rees M, 2007, J ECOL, V95, P926, DOI 10.1111/j.1365-2745.2007.01277.x; Rees M, 2006, AM NAT, V168, pE53, DOI 10.1086/505762; Rees M, 2010, AM NAT, V176, pE152, DOI 10.1086/657037; Roff Derek, 2002, pi; SMITH CC, 1974, AM NAT, V108, P499, DOI 10.1086/282929; TAYLOR HM, 1974, THEOR POPUL BIOL, V5, P104, DOI 10.1016/0040-5809(74)90053-7; TULJAPURKAR S, 1990, P NATL ACAD SCI USA, V87, P1139, DOI 10.1073/pnas.87.3.1139; Venable DL, 2009, J ECOL, V97, P27, DOI 10.1111/j.1365-2745.2008.01461.x; West GB, 2001, NATURE, V413, P628, DOI 10.1038/35098076; WILBUR HM, 1973, SCIENCE, V182, P1305, DOI 10.1126/science.182.4119.1305	27	5	5	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2013	8	2							e57133	10.1371/journal.pone.0057133	http://dx.doi.org/10.1371/journal.pone.0057133			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093HR	23431401	gold, Green Published, Green Submitted			2022-12-25	WOS:000315182800044
J	Wang, H; Wang, HS; Zhou, BH; Li, CL; Zhang, F; Wang, XF; Zhang, G; Bu, XZ; Cai, SH; Du, J				Wang, Hao; Wang, Hong-Sheng; Zhou, Bin-Hua; Li, Cui-Lin; Zhang, Fan; Wang, Xian-Feng; Zhang, Ge; Bu, Xian-Zhang; Cai, Shao-Hui; Du, Jun			Epithelial-Mesenchymal Transition (EMT) Induced by TNF-alpha Requires AKT/GSK-3 beta-Mediated Stabilization of Snail in Colorectal Cancer	PLOS ONE			English	Article							NF-KAPPA-B; TRANSCRIPTION FACTOR SNAIL; TUMOR-NECROSIS-FACTOR; E-CADHERIN; GENE-EXPRESSION; CELL-MIGRATION; BETA-CATENIN; INFLAMMATION; CARCINOMA; PHOSPHORYLATION	Chronic inflammation-promoted metastasis has been considered as a major challenge in cancer therapy. Pro-inflammatory cytokine TNF alpha can induce cancer invasion and metastasis associated with epithelial-mesenchymal transition (EMT). However, the underlying mechanisms are not entirely clear. In this study, we showed that TNF alpha induces EMT in human HCT116 cells and thereby promotes colorectal cancer (CRC) invasion and metastasis. TNF alpha-induced EMT was characterized by acquiring mesenchymal spindle-like morphology and increasing the expression of N-cadherin and fibronectin with a concomitant decrease of E-cadherin and Zona occludin-1(ZO-1). TNF alpha treatment also increased the expression of transcription factor Snail, but not Slug, ZEB1 and Twist. Overexpression of Snail induced a switch from E-cadherin to N-cadherin expression in HCT116 cells, which is a characteristic of EMT. Conversely, knockdown of Snail significantly attenuated TNF alpha-induced EMT in HCT116 cells, suggesting that Snail plays a crucial role in TNF alpha-induced EMT. Interestingly, exposure to TNF alpha rapidly increased Snail protein expression and Snail nuclear localization but not mRNA level upregulation. Finally, we demonstrated that TNF alpha elevated Snail stability by activating AKT pathway and subsequently repressing GSK-3 beta activity and decreasing the association of Snail with GSK-3 beta. Knockdown of GSK-3 beta further verified our finding. Taken together, these results revealed that AKT/GSK-3 beta-mediated stabilization of Snail is required for TNF alpha-induced EMT in CRC cells. Our study provides a better understanding of inflammation-induced CRC metastasis.	[Wang, Hao; Wang, Hong-Sheng; Zhou, Bin-Hua; Li, Cui-Lin; Zhang, Fan; Wang, Xian-Feng; Zhang, Ge; Bu, Xian-Zhang; Du, Jun] Sun Yat Sen Univ, Sch Pharmaceut Sci, Dept Microbial & Biochem Pharm, Guangzhou 510275, Guangdong, Peoples R China; [Cai, Shao-Hui] Jinan Univ, Coll Pharm, Dept Pharmacol, Guangzhou, Guangdong, Peoples R China	Sun Yat Sen University; Jinan University	Cai, SH (corresponding author), Jinan Univ, Coll Pharm, Dept Pharmacol, Guangzhou, Guangdong, Peoples R China.	csh5689@sina.com; dujun@mail.sysu.edu.cn	Wang, Hongsheng/N-1940-2019; Bu, Xianzhang/E-9180-2012	Wang, Hongsheng/0000-0002-0054-4820; 	National Basic Research Program of China (973 Program) [2011CB935800]; National Natural Science Foundation of China [30873032, 81071712]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was funded by the National Basic Research Program of China (973 Program, No. 2011CB935800), and the National Natural Science Foundation of China (No. 30873032 and No. 81071712). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bachelder RE, 2005, J CELL BIOL, V168, P29, DOI 10.1083/jcb.200409067; Balkwill F, 2009, NAT REV CANCER, V9, P361, DOI 10.1038/nrc2628; Barrallo-Gimeno A, 2005, DEVELOPMENT, V132, P3151, DOI 10.1242/dev.01907; Batlle E, 2000, NAT CELL BIOL, V2, P84, DOI 10.1038/35000034; Blanco MJ, 2002, ONCOGENE, V21, P3241, DOI 10.1038/sj.onc.1205416; Burke F, 1996, CYTOKINE, V8, P578, DOI 10.1006/cyto.1996.0077; Cano A, 2000, NAT CELL BIOL, V2, P76, DOI 10.1038/35000025; Chen RQ, 2012, CANCER RES, V72, P1579, DOI 10.1158/0008-5472.CAN-11-2055; Cheng CW, 2001, ONCOGENE, V20, P3814, DOI 10.1038/sj.onc.1204505; Choo MK, 2005, CANCER LETT, V230, P47, DOI 10.1016/j.canlet.2004.12.027; Christofori G, 2006, NATURE, V441, P444, DOI 10.1038/nature04872; Condeelis J, 2006, CELL, V124, P263, DOI 10.1016/j.cell.2006.01.007; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Csiszar A, 2004, PATHOL ONCOL RES, V10, P109, DOI 10.1007/BF02893465; De Craene B, 2005, CELL SIGNAL, V17, P535, DOI 10.1016/j.cellsig.2004.10.011; Dominguez D, 2003, MOL CELL BIOL, V23, P5078, DOI 10.1128/MCB.23.14.5078-5089.2003; Dong CF, 2012, J CLIN INVEST, V122, P1469, DOI 10.1172/JCI57349; Fan XJ, 2013, HUM PATHOL, V44, P173, DOI 10.1016/j.humpath.2012.03.029; Grille SJ, 2003, CANCER RES, V63, P2172; Grimm M, 2011, CELL ONCOL, V34, P315, DOI 10.1007/s13402-011-0027-7; Julien S, 2007, ONCOGENE, V26, P7445, DOI 10.1038/sj.onc.1210546; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Karin M, 2005, NAT REV IMMUNOL, V5, P749, DOI 10.1038/nri1703; Larue L, 2005, ONCOGENE, V24, P7443, DOI 10.1038/sj.onc.1209091; Li CW, 2012, CANCER RES, V72, P1290, DOI 10.1158/0008-5472.CAN-11-3123; Liu CM, 2002, CELL, V108, P837, DOI 10.1016/S0092-8674(02)00685-2; Logullo AF, 2010, ONCOL REP, V23, P313, DOI 10.3892/or_00000638; Mak P, 2010, CANCER CELL, V17, P319, DOI 10.1016/j.ccr.2010.02.030; Moody SE, 2005, CANCER CELL, V8, P197, DOI 10.1016/j.ccr.2005.07.009; Nieto MA, 2002, NAT REV MOL CELL BIO, V3, P155, DOI 10.1038/nrm757; Olmeda D, 2007, ONCOGENE, V26, P1862, DOI 10.1038/sj.onc.1209997; Peinado H, 2007, NAT REV CANCER, V7, P415, DOI 10.1038/nrc2131; Pon YL, 2008, CANCER RES, V68, P6524, DOI 10.1158/0008-5472.CAN-07-6302; Saegusa M, 2009, AM J PATHOL, V174, P2107, DOI 10.2353/ajpath.2009.081018; Schmalhofer O, 2009, CANCER METAST REV, V28, P151, DOI 10.1007/s10555-008-9179-y; Shacter E, 2002, ONCOLOGY-NY, V16, P217; Sheehan KM, 2008, ONCOGENE, V27, P323, DOI 10.1038/sj.onc.1210647; Storci G, 2010, J CELL PHYSIOL, V225, P682, DOI 10.1002/jcp.22264; Szlosarek P, 2006, EUR J CANCER, V42, P745, DOI 10.1016/j.ejca.2006.01.012; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; van Kempen LCLT, 2003, EUR J CELL BIOL, V82, P539, DOI 10.1078/0171-9335-00346; Vandromme M, 1996, TRENDS BIOCHEM SCI, V21, P59, DOI 10.1016/S0968-0004(96)80182-4; Voulgari A, 2009, BBA-REV CANCER, V1796, P75, DOI 10.1016/j.bbcan.2009.03.002; Wu YD, 2010, CELL ADHES MIGR, V4, P199, DOI 10.4161/cam.4.2.10943; Wu Y, 2009, CELL CYCLE, V8, P3267, DOI 10.4161/cc.8.20.9699; Wu Y, 2009, CANCER CELL, V15, P416, DOI 10.1016/j.ccr.2009.03.016; Xiong H, 2012, J BIOL CHEM, V287, P5819, DOI 10.1074/jbc.M111.295964; Xue CS, 2003, CANCER RES, V63, P3386; Zhou BHP, 2004, NAT CELL BIOL, V6, P931, DOI 10.1038/ncb1173	50	144	148	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2013	8	2							e56664	10.1371/journal.pone.0056664	http://dx.doi.org/10.1371/journal.pone.0056664			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093HR	23431386	gold, Green Submitted, Green Published			2022-12-25	WOS:000315182800029
J	Li, ZW; Li, CL; Du, LL; Zhou, Y; Wu, W				Li, Zongwen; Li, Chunliu; Du, Lianlian; Zhou, Yan; Wu, Wei			Human Chorionic Gonadotropin beta Induces Migration and Invasion via Activating ERK1/2 and MMP-2 in Human Prostate Cancer DU145 Cells	PLOS ONE			English	Article							NF-KAPPA-B; GROWTH; HCG; EXTRACELLULAR-SIGNAL-REGULATED-KINASE-1/2; STEROIDOGENESIS; BINDING	We previously demonstrated that human chorionic gonadotropin beta (hCG beta) induced migration and invasion in human prostate cancer cells. However, the involved molecular mechanisms are unclear. Here, we established a stable prostate cancer cell line overexpressing hCG beta and tested hCG beta-triggered signaling pathways causing cell migration and invasion. ELISA showed that the hCG beta amount secreted into medium increased with culture time after the hCG beta-transfected cells were incubated for 3, 6, 9, 12 and 24 h. More, hCG beta standards promoted MAPK (ERK1/2) phosphorylation and increased MMP-2 expression and activity in both dose-and time-dependent manners in hCG beta non-transfected cells. In addition, hCG beta promoted ERK1/2 phosphorylation and increased MMP-2 expression and activity significantly in hCG beta transfected DU145 cells. Whereas ERK1/2 blocker PD98059 (25 mu M) significantly downregulated phosphorylated ERK1/2 and MMP-2. Particularly, hCG beta promoted cell migration and invasion, yet the PD98059 diminished the hCG beta-induced cell motility under those conditions. These results indicated that hCG beta induced cell motility via promoting ERK1/2 phosphorylation and MMP-2 upregulation in human prostate cancer DU145 cells.	[Li, Zongwen; Li, Chunliu; Du, Lianlian; Wu, Wei] Capital Med Univ, Sch Publ Hlth & Family Med, Dept Epidemiol & Hlth Stat, Beijing, Peoples R China; [Zhou, Yan; Wu, Wei] Capital Med Univ, Sch Basic Med Sci, Dept Biochem, Beijing, Peoples R China	Capital Medical University; Capital Medical University	Wu, W (corresponding author), Capital Med Univ, Sch Publ Hlth & Family Med, Dept Epidemiol & Hlth Stat, Beijing, Peoples R China.	weiwu207@ccmu.edu.cn			Science and Development Plan of Beijing Education Committee [KM200910025008]; National Natural Science Foundation of China [81272843]	Science and Development Plan of Beijing Education Committee; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was funded by Science and Development Plan of Beijing Education Committee (grant number: KM200910025008) and National Natural Science Foundation of China (grant number: 81272843). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aalinkeel R, 2011, IMMUNOL INVEST, V40, P447, DOI 10.3109/08820139.2011.557795; Armstrong AJ, 2008, UROL ONCOL-SEMIN ORI, V26, P430, DOI 10.1016/j.urolonc.2007.11.006; Babykutty S, 2012, CLIN EXP METASTAS, V29, P471, DOI 10.1007/s10585-012-9464-6; Bao BY, 2006, CARCINOGENESIS, V27, P32, DOI 10.1093/carcin/bgi170; Barqawi AB, 2012, ADV UROLOGY; Chen YY, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/378415; Chiu HW, 2012, PLOS ONE; Cole LA, 2012, AM J CANCER RES, V2, P22; Cole LA, 2009, EXPERT REV MOL DIAGN, V9, P51, DOI 10.1586/14737159.9.1.51; Couvelard A, 2004, VIRCHOWS ARCH, V445, P279, DOI 10.1007/s00428-004-1078-1; Darwish OM, 2012, MANAGEMENT BIOCH REC; Dashevsky O, 2009, INT J CANCER, V124, P1773, DOI 10.1002/ijc.24016; de Medeiros SF, 2009, HUM REPROD UPDATE, V15, P69, DOI 10.1093/humupd/dmn036; Fluhr H, 2008, FERTIL STERIL, V90, P1384, DOI [10.1016/j.fertnstert.2007.07.1357, 10.1016/j.fertnstert.2007.08.023]; Fong Y, 2010, J FOOD SCI, V75, pH30, DOI 10.1111/j.1750-3841.2009.01438.x; Iles RK, 2010, MOL CELL ENDOCRINOL, V329, P62, DOI 10.1016/j.mce.2010.07.014; Ilic D, 2012, MATURITAS, V72, P269, DOI 10.1016/j.maturitas.2012.04.014; Jiang C, 2010, CANCER IMMUNOL IMMUN, V59, P1771, DOI 10.1007/s00262-010-0902-5; Khare P, 2012, INDIAN J BIOCHEM BIO, V49, P92; Kim Y, 2009, BMB REP, V42, P758, DOI 10.5483/BMBRep.2009.42.11.758; Leahy M, 2012, EUROPEAN J ONCOLOGY; Liu D, 2012, J UROLOGY, V187, P1241, DOI 10.1016/j.juro.2011.12.015; Manna PR, 2007, J ENDOCRINOL, V193, P53, DOI 10.1677/JOE-06-0201; Martinelle N, 2004, ENDOCRINOLOGY, V145, P4629, DOI 10.1210/en.2004-0496; Massart C, 2005, CLIN CHEM LAB MED, V43, P886, DOI 10.1515/CCLM.2005.150; Nishimura R, 2000, METH MOLEC MED, V39, P135; Prast J, 2008, ENDOCRINOLOGY, V149, P979, DOI 10.1210/en.2007-1282; Reis ST, 2011, INT J BIOL MARKER, V26, P255, DOI 10.5301/JBM.2011.8831; Song MO, 2012, TOXICOLOGY, V292, P23, DOI 10.1016/j.tox.2011.11.013; Stio M, 2011, ANTICANCER RES, V31, P4091; Tan CT, 2008, CARCINOGENESIS, V29, P1519, DOI 10.1093/carcin/bgn108; Tokar E, 2005, CLIN EXP METASTAS, V22, P275, DOI 10.1007/s10585-005-8393-z; Tsai EM, 2008, FERTIL STERIL, V89, P1522, DOI 10.1016/j.fertnstert.2007.05.053; Wilkins-Port CE, 2012, BIOCHEM RES INT, V2012, DOI 10.1155/2012/454368; Wu W, 2006, CANCER-AM CANCER SOC, V106, P68, DOI 10.1002/cncr.21549; Yu HS, 2013, PROSTATE, V73, P89, DOI 10.1002/pros.22544	36	23	23	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2013	8	2							e54592	10.1371/journal.pone.0054592	http://dx.doi.org/10.1371/journal.pone.0054592			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104BU	23424616	Green Published, gold, Green Submitted			2022-12-25	WOS:000315965100004
J	Kurihara, T; Jones, CN; Yu, YM; Fischman, AJ; Watada, S; Tompkins, RG; Fagan, SP; Irimia, D				Kurihara, Tomohiro; Jones, Caroline N.; Yu, Yong-Ming; Fischman, Alan J.; Watada, Susumu; Tompkins, Ronald G.; Fagan, Shawn P.; Irimia, Daniel			Resolvin D2 restores neutrophil directionality and improves survival after burns	FASEB JOURNAL			English	Article						chemotaxis; microfluidics; inflammation; innate immunity; lipid mediators	THERMAL-INJURY; D1; SEPSIS; INFECTION; MEDIATORS; TRAUMA; INFLAMMATION; MICE; RESOLUTION; MORTALITY	Following severe burns and trauma injuries, the changes of neutrophil migratory phenotype are a double-edged sword. Activated neutrophils migrate into injured tissues and help contain microbial infections, but they can also enter normal tissues and damage vital organs. Depleting the neutrophils from circulation protects vital organs against neutrophil-induced damage but leaves the body exposed to infectious complications. Here we show that restoring normal neutrophil migratory phenotype in rats with burn injuries correlates with improved survival in a classical double-injury model of sequential burn and septic insults. We uncovered that the directionality of neutrophils from burned rats can be restored both in vitro by 1 nM resolvin D2 (RvD2) and in vivo by RvD2 for 7 d, 25 ng/kg body mass (8-10 ng/rat). Restoring neutrophil directionality dramatically increases survival after a second septic insult at d 9 postburn. Survival of RvD2-treated animals increases from 0 to 100% after lipopolysaccharide injection and is extended by 1 wk after cecal ligation. Survival does not significantly increase when the restoration of neutrophil directionality is incomplete, following shorter regimens of RvD2. We conclude that restoring neutrophil directionality using RvD2 could have prophylactic value and delay lethal complications after burn injuries.-Kurihara T., Jones, C. N., Yu, Y.-M., Fischman, A. J., Watada, S., Tompkins, R. G., Fagan, S. P., Irimia, D. Resolvin D2 restores neutrophil directionality and improves survival after burns.	[Kurihara, Tomohiro; Jones, Caroline N.; Yu, Yong-Ming; Fischman, Alan J.; Watada, Susumu; Tompkins, Ronald G.; Fagan, Shawn P.; Irimia, Daniel] Shriners Hosp Children, Boston, MA USA; [Kurihara, Tomohiro; Jones, Caroline N.; Yu, Yong-Ming; Watada, Susumu; Tompkins, Ronald G.; Fagan, Shawn P.; Irimia, Daniel] Harvard Univ, Sch Med, Dept Surg, Massachusetts Gen Hosp, Boston, MA 02115 USA; [Jones, Caroline N.; Irimia, Daniel] Harvard Univ, Massachusetts Gen Hosp, Sch Med, BioMEMS Resource Ctr, Boston, MA USA; [Fischman, Alan J.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Nucl Med, Boston, MA USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital	Irimia, D (corresponding author), MGH CNY, 114 16th St,1404, Boston, MA 02129 USA.	dirimia@hms.harvard.edu	Irimia, Daniel/A-4095-2008; Irimia, Daniel/S-5404-2019	Irimia, Daniel/0000-0001-7347-2082; Irimia, Daniel/0000-0001-7347-2082	Shriners Burns Hospital; U.S. National Institutes of Health [GM-092804, GM-007035, DE-019938]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB002503] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE019938] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007035, R01GM092804] Funding Source: NIH RePORTER	Shriners Burns Hospital; U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by funds from Shriners Burns Hospital and U.S. National Institutes of Health grants GM-092804, GM-007035, and DE-019938.	Ambravaneswaran V, 2010, INTEGR BIOL-UK, V2, P639, DOI 10.1039/c0ib00011f; BABCOCK GF, 1990, CLIN IMMUNOL IMMUNOP, V54, P117, DOI 10.1016/0090-1229(90)90011-E; Bento AF, 2011, J IMMUNOL, V187, P1957, DOI 10.4049/jimmunol.1101305; Bohr S, 2013, WOUND REPAIR REGEN, V21, P35, DOI 10.1111/j.1524-475X.2012.00853.x; Branski LK, 2009, SURG INFECT, V10, P389, DOI 10.1089/sur.2009.024; Butler KL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011921; Calvano SE, 2005, NATURE, V437, P1032, DOI 10.1038/nature03985; Carter EA, 1996, J TRAUMA, V40, P930, DOI 10.1097/00005373-199606000-00011; Centers for Disease Control and Prevention, 2012, WEB BAS INJ STAT QUE; Chiang N, 2012, NATURE, V484, P524, DOI 10.1038/nature11042; Chipp E, 2010, ANN PLAS SURG, V65, P228, DOI 10.1097/SAP.0b013e3181c9c35c; Claria J, 2012, J IMMUNOL, V189, P2597, DOI 10.4049/jimmunol.1201272; Fazal N, 2000, CRIT CARE MED, V28, P1550, DOI 10.1097/00003246-200005000-00048; Greenhalgh DG, 2007, J BURN CARE RES, V28, P776, DOI 10.1097/BCR.0b013e3181599bc9; Hu ZH, 2004, AM J PHYSIOL-CELL PH, V286, pC170, DOI 10.1152/ajpcell.00187.2003; Huber-Lang MS, 2001, FASEB J, V15, P568; Irimia D, 2010, ANNU REV BIOMED ENG, V12, P259, DOI 10.1146/annurev-bioeng-070909-105241; Jones CN, 2012, P NATL ACAD SCI USA, V109, P20560, DOI 10.1073/pnas.1210269109; Kasuga K, 2008, J IMMUNOL, V181, P8677, DOI 10.4049/jimmunol.181.12.8677; Kotz KT, 2010, NAT MED, V16, P1042, DOI 10.1038/nm.2205; Krishnamoorthy S, 2012, AM J PATHOL, V180, P2018, DOI 10.1016/j.ajpath.2012.01.028; Levy BD, 2001, NAT IMMUNOL, V2, P612, DOI 10.1038/89759; Liu T, 2006, MOL CELL PROTEOMICS, V5, P1899, DOI 10.1074/mcp.M600068-MCP200; MacKenzie EJ, 2006, NEW ENGL J MED, V354, P366, DOI 10.1056/NEJMsa052049; Mann EA, 2012, SHOCK, V37, P4, DOI 10.1097/SHK.0b013e318237d6bf; Noel G, 2011, SHOCK, V36, P149, DOI 10.1097/SHK.0b013e3182205cbc; Norling LV, 2012, ARTERIOSCL THROM VAS, V32, P1970, DOI 10.1161/ATVBAHA.112.249508; Park CK, 2011, J NEUROSCI, V31, P18433, DOI 10.1523/JNEUROSCI.4192-11.2011; Pillay J, 2010, BLOOD, V116, P625, DOI 10.1182/blood-2010-01-259028; Reutershan J, 2006, J CLIN INVEST, V116, P695, DOI 10.1172/JCI27009; Serhan CN, 2002, J EXP MED, V196, P1025, DOI 10.1084/jem.20020760; Serhan CN, 2000, J EXP MED, V192, P1197, DOI 10.1084/jem.192.8.1197; Sheridan R. L., 1997, Journal of Burn Care and Rehabilitation, V18, P455; SOLOMKIN JS, 1990, J TRAUMA, V30, pS80; Spite M, 2009, NATURE, V461, P1287, DOI 10.1038/nature08541; Sun YP, 2007, J BIOL CHEM, V282, P9323, DOI 10.1074/jbc.M609212200; TCHERVENKOV JI, 1988, ARCH SURG-CHICAGO, V123, P1477; Tsai WC, 2000, INFECT IMMUN, V68, P4289, DOI 10.1128/IAI.68.7.4289-4296.2000; Tsuda Y, 2004, IMMUNITY, V21, P215, DOI 10.1016/j.immuni.2004.07.006; WEISS SJ, 1989, NEW ENGL J MED, V320, P365; Williams FN, 2009, CRIT CARE, V13, DOI 10.1186/cc8170; Wolf K, 2009, SEMIN CELL DEV BIOL, V20, P931, DOI 10.1016/j.semcdb.2009.08.005; Xiao WZ, 2011, J EXP MED, V208, P2581, DOI 10.1084/jem.20111354; Zhang MJ, 2012, ANNU REV NUTR, V32, P203, DOI 10.1146/annurev-nutr-071811-150726	44	61	68	0	17	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2013	27	6					2270	2281		10.1096/fj.12-219519	http://dx.doi.org/10.1096/fj.12-219519			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	154II	23430978	Green Published			2022-12-25	WOS:000319667600017
J	Gilkes, DM; Bajpai, S; Chaturvedi, P; Wirtz, D; Semenza, GL				Gilkes, Daniele M.; Bajpai, Saumendra; Chaturvedi, Pallavi; Wirtz, Denis; Semenza, Gregg L.			Hypoxia-inducible Factor 1 (HIF-1) Promotes Extracellular Matrix Remodeling under Hypoxic Conditions by Inducing P4HA1, P4HA2, and PLOD2 Expression in Fibroblasts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SYNDROME TYPE-VI; BREAST-CANCER; LYSYL HYDROXYLASE; PROLYL 4-HYDROXYLASES; MAMMARY-TUMORS; FACTOR-I; COLLAGEN; METASTASIS; FIBROSIS; GROWTH	Extracellular matrix (ECM) composition, organization, and compliance provide both architectural and chemical cues that modulate tissue structure and function. ECM produced by stromal fibroblasts plays a key role in breast cancer invasion and metastasis, which are also stimulated by intratumoral hypoxia. Here, we demonstrate that hypoxia-inducible factor 1 (HIF-1) is a critical regulator of ECM remodeling by fibroblasts under hypoxic conditions. HIF-1 activates expression of genes encoding collagen prolyl (P4HA1 and P4HA2) and lysyl (PLOD2) hydroxylases. P4HA1 and P4HA2 are required for collagen deposition, whereas PLOD2 is required for ECM stiffening and collagen fiber alignment. Together P4HA1, P4HA2, and PLOD2 mediate remodeling of ECM composition, alignment, and mechanical properties in response to hypoxia. HIF-1-dependent ECM remodeling by hypoxic fibroblasts induces changes in breast cancer cell morphology, adhesion, and motility that promote invasion and metastasis.	[Gilkes, Daniele M.; Chaturvedi, Pallavi; Semenza, Gregg L.] Johns Hopkins Univ, Sch Med, Vasc Program, Inst Cell Engn, Baltimore, MD 21205 USA; [Gilkes, Daniele M.; Chaturvedi, Pallavi; Semenza, Gregg L.] Johns Hopkins Univ, Sch Med, Inst Med Genet, Baltimore, MD 21205 USA; [Semenza, Gregg L.] Johns Hopkins Univ, Sch Med, Dept Pediat, Baltimore, MD 21205 USA; [Semenza, Gregg L.] Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD 21205 USA; [Semenza, Gregg L.] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; [Semenza, Gregg L.] Johns Hopkins Univ, Sch Med, Dept Radiat Oncol, Baltimore, MD 21205 USA; [Semenza, Gregg L.] Johns Hopkins Univ, Sch Med, Dept Biol Chem, Baltimore, MD 21205 USA; [Gilkes, Daniele M.; Bajpai, Saumendra; Wirtz, Denis; Semenza, Gregg L.] Johns Hopkins Univ, Ctr Oncol, Baltimore, MD 21218 USA; [Bajpai, Saumendra; Wirtz, Denis] Johns Hopkins Univ, Dept Chem & Biomol Engn, Baltimore, MD 21218 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University	Semenza, GL (corresponding author), Johns Hopkins Univ, Sch Med, Dept Pediat, 733 North Broadway,Suite 671, Baltimore, MD 21205 USA.	gsemenza@jhmi.edu	Bajpai, Saumendra/B-8120-2014; Gilkes, Daniele M/AAI-8133-2020	Gilkes, Daniele M/0000-0003-3984-9338; Bajpai, Saumendra/0000-0002-9397-2102	National Institutes of Health through the NCI [U54-CA143868]; American Cancer Society [122437-RP-12-090-01-COUN]; Susan G. Komen Breast Cancer Foundation; NATIONAL CANCER INSTITUTE [U54CA143868] Funding Source: NIH RePORTER	National Institutes of Health through the NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); American Cancer Society(American Cancer Society); Susan G. Komen Breast Cancer Foundation(Susan G. Komen Breast Cancer Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by National Institutes of Health Grant U54-CA143868 through the NCI. This work was also supported by American Cancer Society Grant 122437-RP-12-090-01-COUN.; Recipient of a Susan G. Komen Breast Cancer Foundation postdoctoral fellowship award.	Annunen P, 1997, J BIOL CHEM, V272, P17342, DOI 10.1074/jbc.272.28.17342; Aro E, 2012, J BIOL CHEM, V287, P37134, DOI 10.1074/jbc.M112.352872; Bos R, 2003, CANCER, V97, P1573, DOI 10.1002/cncr.11246; Brinckmann J, 1996, J INVEST DERMATOL, V107, P589, DOI 10.1111/1523-1747.ep12582991; Chaturvedi P, 2013, J CLIN INVEST, V123, P189, DOI 10.1172/JCI64993; Conklin MW, 2011, AM J PATHOL, V178, P1221, DOI 10.1016/j.ajpath.2010.11.076; Dales JP, 2005, INT J CANCER, V116, P734, DOI 10.1002/ijc.20984; De Wever O, 2008, INT J CANCER, V123, P2229, DOI 10.1002/ijc.23925; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Erler JT, 2009, CANCER CELL, V15, P35, DOI 10.1016/j.ccr.2008.11.012; Erler JT, 2006, NATURE, V440, P1222, DOI 10.1038/nature04695; Frantz C, 2010, J CELL SCI, V123, P4195, DOI 10.1242/jcs.023820; Generali D, 2006, CLIN CANCER RES, V12, P4562, DOI 10.1158/1078-0432.CCR-05-2690; Gilkes DM, 2013, MOL CANCER RES, V11, P456, DOI 10.1158/1541-7786.MCR-12-0629; Gillies RJ, 2007, CANCER METAST REV, V26, P311, DOI 10.1007/s10555-007-9065-z; Goetz JG, 2011, CELL, V146, P148, DOI 10.1016/j.cell.2011.05.040; Halberg N, 2009, MOL CELL BIOL, V29, P4467, DOI 10.1128/MCB.00192-09; Higgins DF, 2007, J CLIN INVEST, V117, P3810, DOI 10.1172/JCI30487; Hofbauer KH, 2003, EUR J BIOCHEM, V270, P4515, DOI 10.1046/j.1432-1033.2003.03846.x; Horino Y, 2002, LIFE SCI, V71, P3031, DOI 10.1016/S0024-3205(02)02142-2; Hynes RO, 2009, SCIENCE, V326, P1216, DOI 10.1126/science.1176009; Ingman WV, 2006, DEV DYNAM, V235, P3222, DOI 10.1002/dvdy.20972; Jarvelainen H, 2009, PHARMACOL REV, V61, P198, DOI 10.1124/pr.109.001289; Kukkola L, 2003, J BIOL CHEM, V278, P47685, DOI 10.1074/jbc.M306806200; Leek RD, 2002, J MAMMARY GLAND BIOL, V7, P177, DOI 10.1023/A:1020304003704; Levental KR, 2009, CELL, V139, P891, DOI 10.1016/j.cell.2009.10.027; Luo WB, 2012, P NATL ACAD SCI USA, V109, pE3367, DOI 10.1073/pnas.1217394109; Moon JO, 2009, AM J PHYSIOL-GASTR L, V296, pG582, DOI 10.1152/ajpgi.90368.2008; Myllyharju J, 2003, MATRIX BIOL, V22, P15, DOI 10.1016/S0945-053X(03)00006-4; Myllyharju J, 2004, TRENDS GENET, V20, P33, DOI 10.1016/j.tig.2003.11.004; Myllyharju J, 2010, CELL TISSUE RES, V339, P19, DOI 10.1007/s00441-009-0841-7; Paszek MJ, 2005, CANCER CELL, V8, P241, DOI 10.1016/j.ccr.2005.08.010; Provenzano P.P., 2010, CURR PROTOC CELL BIO; Provenzano PP, 2008, BIOPHYS J, V95, P5374, DOI 10.1529/biophysj.108.133116; Provenzano PP, 2006, BMC MED, V4, DOI 10.1186/1741-7015-4-38; Provenzano PP, 2009, CLIN EXP METASTAS, V26, P357, DOI 10.1007/s10585-008-9204-0; Reddy GK, 1996, CLIN BIOCHEM, V29, P225, DOI 10.1016/0009-9120(96)00003-6; Schindl M, 2002, CLIN CANCER RES, V8, P1831; Schito L, 2012, P NATL ACAD SCI USA, V109, pE2707, DOI 10.1073/pnas.1214019109; Semenza GL, 2010, ONCOGENE, V29, P625, DOI 10.1038/onc.2009.441; Semenza GL, 2009, PHYSIOLOGY, V24, P97, DOI 10.1152/physiol.00045.2008; STEINMANN B, 1995, SCIENCE, V267, P258, DOI 10.1126/science.7809634; STEINMANN B, 1995, AM J HUM GENET, V57, P1505; Takahashi Y, 2000, J BIOL CHEM, V275, P14139, DOI 10.1074/jbc.275.19.14139; Valtavaara M, 1998, J BIOL CHEM, V273, P12881, DOI 10.1074/jbc.273.21.12881; van der Slot AJ, 2003, J BIOL CHEM, V278, P40967, DOI 10.1074/jbc.M307380200; WANG GL, 1995, P NATL ACAD SCI USA, V92, P5510, DOI 10.1073/pnas.92.12.5510; Wang WG, 2002, CANCER RES, V62, P6278; Wong CCL, 2012, J MOL MED, V90, P803, DOI 10.1007/s00109-011-0855-y; Wong CCL, 2011, P NATL ACAD SCI USA, V108, P16369, DOI 10.1073/pnas.1113483108; Wyckoff JB, 2007, CANCER RES, V67, P2649, DOI 10.1158/0008-5472.CAN-06-1823; Yamamoto Y, 2008, BREAST CANCER RES TR, V110, P465, DOI 10.1007/s10549-007-9742-1; Yeowell HN, 1997, ARCH BIOCHEM BIOPHYS, V347, P126, DOI 10.1006/abbi.1997.0319; Zhang H, 2012, ONCOGENE, V31, P1757, DOI 10.1038/onc.2011.365	54	311	325	5	54	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 12	2013	288	15					10819	10829		10.1074/jbc.M112.442939	http://dx.doi.org/10.1074/jbc.M112.442939			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	125TU	23423382	hybrid, Green Published			2022-12-25	WOS:000317565000059
J	Tamai, T; Yamaguchi, O; Hikoso, S; Takeda, T; Taneike, M; Oka, T; Oyabu, J; Murakawa, T; Nakayama, H; Uno, Y; Horie, K; Nishida, K; Sonenberg, N; Shah, AM; Takeda, J; Komuro, I; Otsu, K				Tamai, Takahito; Yamaguchi, Osamu; Hikoso, Shungo; Takeda, Toshihiro; Taneike, Manabu; Oka, Takafumi; Oyabu, Jota; Murakawa, Tomokazu; Nakayama, Hiroyuki; Uno, Yoshihiro; Horie, Kyoji; Nishida, Kazuhiko; Sonenberg, Nahum; Shah, Ajay M.; Takeda, Junji; Komuro, Issei; Otsu, Kinya			Rheb (Ras Homologue Enriched in Brain)-dependent Mammalian Target of Rapamycin Complex 1 (mTORC1) Activation Becomes Indispensable for Cardiac Hypertrophic Growth after Early Postnatal Period	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSLATION INITIATION; DEPENDENT TRANSLATION; PRESSURE-OVERLOAD; GENE-EXPRESSION; PROTEIN-KINASE; CELL-GROWTH; AUTOPHAGY; MICE; SURVIVAL; DISEASE	Cardiomyocytes proliferate during fetal life but lose their ability to proliferate soon after birth and further increases in cardiac mass are achieved through an increase in cell size or hypertrophy. Mammalian target of rapamycin complex 1 (mTORC1) is critical for cell growth and proliferation. Rheb (Ras homologue enriched in brain) is one of the most important upstream regulators of mTORC1. Here, we attempted to clarify the role of Rheb in the heart using cardiac-specific Rheb-deficient mice (Rheb(-/-)). Rheb(-/-) mice died from postnatal day 8 to 10. The heart-to-body weight ratio, an index of cardiomyocyte hypertrophy, in Rheb(-/-) was lower than that in the control (Rheb(+/+)) at postnatal day 8. The cell surface area of cardiomyocytes isolated from the mouse hearts increased from postnatal days 5 to 8 in Rheb(+/+) mice but not in Rheb(-/-) mice. Ultrastructural analysis indicated that sarcomere maturation was impaired in Rheb(-/-) hearts during the neonatal period. Rheb(-/-) hearts exhibited no difference in the phosphorylation level of S6 or 4E-BP1, downstream of mTORC1 at postnatal day 3 but showed attenuation at postnatal day 5 or 8 compared with the control. Polysome analysis revealed that the mRNA translation activity decreased in Rheb(-/-) hearts at postnatal day 8. Furthermore, ablation of eukaryotic initiation factor 4E-binding protein 1 in Rheb(-/-) mice improved mRNA translation, cardiac hypertrophic growth, sarcomere maturation, and survival. Thus, Rheb-dependent mTORC1 activation becomes essential for cardiomyocyte hypertrophic growth after early postnatal period.	[Tamai, Takahito; Yamaguchi, Osamu; Hikoso, Shungo; Takeda, Toshihiro; Taneike, Manabu; Oka, Takafumi; Oyabu, Jota; Murakawa, Tomokazu; Nishida, Kazuhiko; Komuro, Issei; Otsu, Kinya] Osaka Univ, Grad Sch Med, Dept Cardiovasc Med, Suita, Osaka 5650871, Japan; [Taneike, Manabu; Nishida, Kazuhiko; Shah, Ajay M.; Otsu, Kinya] Kings Coll London, British Heart Fdn Ctr, Cardiovasc Div, London SE5 9NU, England; [Nakayama, Hiroyuki] Osaka Univ, Grad Sch Pharmaceut Sci, Dept Clin Pharmacol & Pharmacogen, Suita, Osaka 5650871, Japan; [Uno, Yoshihiro] Osaka Univ, Lab Reprod Engn, Inst Expt Anim Sci, Suita, Osaka 5650871, Japan; [Horie, Kyoji; Takeda, Junji] Osaka Univ, Grad Sch Med, Dept Social & Environm Med, Suita, Osaka 5650871, Japan; [Sonenberg, Nahum] McGill Univ, Dept Biochem, Montreal, PQ H3G 1Y6, Canada; [Sonenberg, Nahum] McGill Univ, McGill Canc Ctr, Montreal, PQ H3G 1Y6, Canada	Osaka University; University of London; King's College London; Osaka University; Osaka University; Osaka University; McGill University; McGill University	Otsu, K (corresponding author), Kings Coll London, Cardiovasc Div, 125 Coldharbour Ln, London SE5 9NU, England.	kinya.otsu@kcl.ac.uk	Hikoso, Shungo/R-4281-2018	Shah, Ajay/0000-0002-6547-0631; Horie, Kyoji/0000-0001-9036-8180; Hikoso, Shungo/0000-0003-2284-1970; Yamaguchi, Osamu/0000-0002-7461-369X	Ministry of Education, Culture, Sports, and Science, Japan [CH/11/3/29051]; British Heart Foundation [RG/11/12/29052]	Ministry of Education, Culture, Sports, and Science, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); British Heart Foundation(British Heart Foundation)	This work was supported by Grant-in-aid for Scientific Research CH/11/3/29051 from the Ministry of Education, Culture, Sports, and Science, Japan to Osaka University and Grant RG/11/12/29052 from the British Heart Foundation to King's College London.	Ahuja P, 2007, PHYSIOL REV, V87, P521, DOI 10.1152/physrev.00032.2006; Dowling RJO, 2007, CANCER RES, V67, P10804, DOI 10.1158/0008-5472.CAN-07-2310; Dowling RJO, 2010, SCIENCE, V328, P1172, DOI 10.1126/science.1187532; Gingras AC, 2001, GENE DEV, V15, P807, DOI 10.1101/gad.887201; Goorden SMI, 2011, MOL CELL BIOL, V31, P1672, DOI 10.1128/MCB.00985-10; Gromov PS, 1995, FEBS LETT, V377, P221, DOI 10.1016/0014-5793(95)01349-0; Gwinn DM, 2008, MOL CELL, V30, P214, DOI 10.1016/j.molcel.2008.03.003; Hara T, 2006, NATURE, V441, P885, DOI 10.1038/nature04724; Hikoso S, 2004, CIRCULATION, V110, P2631, DOI 10.1161/01.CIR.0000146798.70980.9A; Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2; Inoki K, 2003, GENE DEV, V17, P1829, DOI 10.1101/gad.1110003; Kim J, 2011, NAT CELL BIOL, V13, P132, DOI 10.1038/ncb2152; Koritzinsky M, 2006, EMBO J, V25, P1114, DOI 10.1038/sj.emboj.7600998; Laplante M, 2009, J CELL SCI, V122, P3589, DOI 10.1242/jcs.051011; Li FQ, 1996, J MOL CELL CARDIOL, V28, P1737, DOI 10.1006/jmcc.1996.0163; Liu PT, 2003, GENOME RES, V13, P476, DOI 10.1101/gr.749203; LYONS GE, 1990, J CELL BIOL, V111, P2427, DOI 10.1083/jcb.111.6.2427; Magnuson B, 2012, BIOCHEM J, V441, P1, DOI 10.1042/BJ20110892; McMullen JR, 2004, MOL CELL BIOL, V24, P6231, DOI 10.1128/MCB.24.14.6231-6240.2004; Nakai A, 2007, NAT MED, V13, P619, DOI 10.1038/nm1574; Nishida K, 2004, MOL CELL BIOL, V24, P10611, DOI 10.1128/MCB.24.24.10611-10620.2004; Nobukuni T, 2005, P NATL ACAD SCI USA, V102, P14238, DOI 10.1073/pnas.0506925102; Ravikumar B, 2004, NAT GENET, V36, P585, DOI 10.1038/ng1362; Richter JD, 2005, NATURE, V433, P477, DOI 10.1038/nature03205; Sancak Y, 2007, MOL CELL, V25, P903, DOI 10.1016/j.molcel.2007.03.003; Sciarretta S, 2012, CIRCULATION, V125, P1134, DOI 10.1161/CIRCULATIONAHA.111.078212; Shiojima I, 2006, GENE DEV, V20, P3347, DOI 10.1101/gad.1492806; Tsukiyama-Kohara K, 2001, NAT MED, V7, P1128, DOI 10.1038/nm1001-1128; Vander Haar E, 2007, NAT CELL BIOL, V9, P316, DOI 10.1038/ncb1547; Wang YN, 2008, J MOL CELL CARDIOL, V45, P812, DOI 10.1016/j.yjmcc.2008.07.016; YAMAGATA K, 1994, J BIOL CHEM, V269, P16333; Yuan J, 2005, MOL BIOL REP, V32, P205, DOI 10.1007/s11033-005-0984-x; Zhang DH, 2010, J CLIN INVEST, V120, P2805, DOI 10.1172/JCI43008; Zou J, 2011, DEV CELL, V20, P97, DOI 10.1016/j.devcel.2010.11.020	34	36	36	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 5	2013	288	14					10176	10187		10.1074/jbc.M112.423640	http://dx.doi.org/10.1074/jbc.M112.423640			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	119RB	23426372	Green Published, hybrid			2022-12-25	WOS:000317114000058
J	Yang, YF; Ye, YM; Lin, XC; Wu, KL; Yu, MB				Yang, Yangfan; Ye, Yiming; Lin, Xianchai; Wu, Kaili; Yu, Minbin			Inhibition of Pirfenidone on TGF-beta2 Induced Proliferation, Migration and Epithlial-Mesenchymal Transition of Human Lens Epithelial Cells Line SRA01/04	PLOS ONE			English	Article							POSTERIOR CAPSULE OPACIFICATION; IDIOPATHIC PULMONARY-FIBROSIS; GROWTH-FACTOR-BETA; INTRAOCULAR-LENS; COLLAGEN PRODUCTION; CATARACT-SURGERY; IN-VITRO; BAG; TRANSDIFFERENTIATION; IMPLANTATION	Background: Posterior capsular opacification (PCO) is a common complication of cataract surgery. Transforming growth factor-beta 2 (TGF-beta 2) plays important roles in the development of PCO. The existing pharmacological treatments are not satisfactory and can have toxic side effects. Methodologies/Principal Findings: We evaluated the effect of pirfenidone on proliferation, migration and epithlial-mesenchymal transition of human lens epithelial cell line SRA01/04 (HLECs) in vitro. After treatment with 0, 0.25, and 0.5 mg/ml pirfenidone, cell proliferation was measured by MTT assay. Cell viability was determined by trypan blue exclusion assay and measurement of lactate dehydrogenase (LDH) activity released from the damaged cells. And cell migration was measured by scratch assay in the absence or presence of transforming growth factor-beta 2 (TGF-beta 2). The expressions of TGF-beta 2 and SMADs were evaluated with real-time RT-PCR, western blot, and immunofluorescence analyses. The mesenchymal phenotypic marker fibronectin (FN) was demonstrated by Immunocytofluorescence analyses. The cells had high viability, which did not vary across different concentrations of pirfenidone (0 [control] 0.3, 0.5 or 1.0 mg/ml) after 24 hours. Pirfenidone (0 similar to 0.5 mg/ml) had no significant cytotoxicity effect on SRA01/04 by LDH assay. Pirfenidone significantly inhibited the proliferation and TGF-beta 2-induced cell migration and the effects were dose-dependent, and inhibited TGF-beta 2-induced fibroblastic phenotypes and TGF-beta 2-induced expression of FN in SRA01/04 cells. The cells showed dose-dependent decreases in mRNA and protein levels of TGF-beta 2 and SMADs. Pirfenidone also depressed the TGF-beta 2-induced expression of SMADs and blocked the nuclear translocation of SMADs in cells. Conclusion: Pirfenidone inhibits TGF-beta 2-induced proliferation, migration and epithlial-mesenchymal transition of human lens epithelial cells line SRA01/04 at nontoxic concentrations. This effect may be achieved by down regulation of TGF-beta/SAMD signaling in SRA01/04 cells.	[Yang, Yangfan; Ye, Yiming; Lin, Xianchai; Wu, Kaili; Yu, Minbin] Sun Yat Sen Univ, State Key Lab Ophthalmol, Zhongshan Ophthalm Ctr, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University	Yu, MB (corresponding author), Sun Yat Sen Univ, State Key Lab Ophthalmol, Zhongshan Ophthalm Ctr, Guangzhou 510275, Guangdong, Peoples R China.	yuminbin@mail.sysu.edu.cn		Yang, Yangfan/0000-0002-0007-6481	Guangdong Science and Technology Fund [2009B030801193]; Medical Scientific Research Foundation of Guangdong Province [B2012128]; Fundamental Research Funds of State Key Laboratory of Ophthalmology, People's Republic of China	Guangdong Science and Technology Fund; Medical Scientific Research Foundation of Guangdong Province; Fundamental Research Funds of State Key Laboratory of Ophthalmology, People's Republic of China	This study was funded by Guangdong Science and Technology Fund (Grant No. 2009B030801193), Medical Scientific Research Foundation of Guangdong Province (Grant No. B2012128) and Fundamental Research Funds of State Key Laboratory of Ophthalmology, People's Republic of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Buehl W, 2008, J CATARACT REFR SURG, V34, P1976, DOI 10.1016/j.jcrs.2008.07.029; Choi K, 2012, MOL VIS, V18, P1010; Dawes LJ, 2007, EXP EYE RES, V84, P1009, DOI 10.1016/j.exer.2006.12.017; Dawes LJ, 2009, INVEST OPHTH VIS SCI, V50, P5318, DOI 10.1167/iovs.08-3223; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Di Sario A, 2002, J HEPATOL, V37, P584, DOI 10.1016/S0168-8278(02)00245-3; Findl O, 2010, COCHRANE DB SYST REV, V41, P507; Hazra S, 2012, INT J OPHTHALMOL-CHI, V5, P59, DOI 10.3980/j.issn.2222-3959.2012.01.12; Hewitson TD, 2001, J NEPHROL, V14, P453; Hilberg O, 2012, CLIN RESPIR J, V6, P131, DOI 10.1111/j.1752-699X.2012.00302.x; Ibaraki N, 1998, EXP EYE RES, V67, P577, DOI 10.1006/exer.1998.0551; Kim H, 2010, INVEST OPHTH VIS SCI, V51, P3061, DOI 10.1167/iovs.09-4257; Kim SY, 2007, CLIN EXP OPHTHALMOL, V35, P755, DOI 10.1111/j.1442-9071.2007.01588.x; Lee BS, 1998, J CLIN ENDOCR METAB, V83, P219, DOI 10.1210/jc.83.1.219; Lee EH, 1999, INVEST OPHTH VIS SCI, V40, P2025; Lin XC, 2009, INVEST OPHTH VIS SCI, V50, P3763, DOI 10.1167/iovs.08-2815; Lukaszewska-Smyk Agnieszka, 2011, Klin Oczna, V113, P175; Massague J, 2000, NAT REV MOL CELL BIO, V1, P169, DOI 10.1038/35043051; Menapace R, 2008, GRAEF ARCH CLIN EXP, V246, P787, DOI 10.1007/s00417-008-0779-6; Ozes ON, 2006, CHEST, V130, p230S, DOI 10.1378/chest.130.4_MeetingAbstracts.230S-a; Pandey SK, 2002, J CATARACT REFR SURG, V28, P139, DOI 10.1016/S0886-3350(01)01069-0; Sun GY, 2011, MOL VIS, V17, P2191; Symonds JG, 2006, EXP EYE RES, V83, P771, DOI 10.1016/j.exer.2006.03.017; Tassignon MJ, 2011, J CATARACT REFR SURG, V37, P2120, DOI 10.1016/j.jcrs.2011.06.025; Wang GQ, 2010, INT J OPHTHALMOL-CHI, V3, P141, DOI 10.3980/j.issn.2222-3959.2010.02.11; Wang M, 2007, J CATARACT REFR SURG, V33, P2122, DOI 10.1016/j.jcrs.2007.07.041; Wormstone IM, 2006, EXP EYE RES, V83, P1238, DOI 10.1016/j.exer.2006.06.013; Wormstone IM, 2009, EXP EYE RES, V88, P257, DOI 10.1016/j.exer.2008.10.016; Wormstone IM, 2002, INVEST OPHTH VIS SCI, V43, P2301; Yazici AT, 2012, MIDDLE EAST AFR J OP, V19, P115, DOI 10.4103/0974-9233.92126; Zhong H, 2011, INVEST OPHTH VIS SCI, V52, P3136, DOI 10.1167/iovs.10-6240	31	12	17	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2013	8	2							e56837	10.1371/journal.pone.0056837	http://dx.doi.org/10.1371/journal.pone.0056837			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IT	23437252	Green Published, gold, Green Submitted			2022-12-25	WOS:000315186000052
J	Muratore, CR; Hodgson, NW; Trivedi, MS; Abdolmaleky, HM; Persico, AM; Lintas, C; De la Monte, S; Deth, RC				Muratore, Christina R.; Hodgson, Nathaniel W.; Trivedi, Malav S.; Abdolmaleky, Hamid M.; Persico, Antonio M.; Lintas, Carla; De la Monte, Suzanne; Deth, Richard C.			Age-Dependent Decrease and Alternative Splicing of Methionine Synthase mRNA in Human Cerebral Cortex and an Accelerated Decrease in Autism	PLOS ONE			English	Article							ONSET ALZHEIMERS-DISEASE; MTHFR GENE POLYMORPHISM; HUMAN PREFRONTAL CORTEX; NECROSIS-FACTOR-ALPHA; N-ACETYL-CYSTEINE; OXIDATIVE STRESS; HUMAN PLASMA; CEREBROSPINAL-FLUID; GLUTATHIONE CONCENTRATIONS; PHOSPHOLIPID METHYLATION	The folate and vitamin B12-dependent enzyme methionine synthase (MS) is highly sensitive to cellular oxidative status, and lower MS activity increases production of the antioxidant glutathione, while simultaneously decreasing more than 200 methylation reactions, broadly affecting metabolic activity. MS mRNA levels in postmortem human cortex from subjects across the lifespan were measured and a dramatic progressive biphasic decrease of more than 400-fold from 28 weeks of gestation to 84 years was observed. Further analysis revealed alternative splicing of MS mRNA, including deletion of folate-binding domain exons and age-dependent deletion of exons from the cap domain, which protects vitamin B12 (cobalamin) from oxidation. Although three species of MS were evident at the protein level, corresponding to full-length and alternatively spliced mRNA transcripts, decreasing mRNA levels across the lifespan were not associated with significant changes in MS protein or methionine levels. MS mRNA levels were significantly lower in autistic subjects, especially at younger ages, and this decrease was replicated in cultured human neuronal cells by treatment with TNF-alpha, whose CSF levels are elevated in autism. These novel findings suggest that rather than serving as a housekeeping enzyme, MS has a broad and dynamic role in coordinating metabolism in the brain during development and aging. Factors adversely affecting MS activity, such as oxidative stress, can be a source of risk for neurological disorders across the lifespan via their impact on methylation reactions, including epigenetic regulation of gene expression.	[Muratore, Christina R.; Hodgson, Nathaniel W.; Trivedi, Malav S.; Deth, Richard C.] Northeastern Univ, Dept Pharmaceut Sci, Sch Pharm, Boston, MA 02115 USA; [Abdolmaleky, Hamid M.] Boston Univ, Sch Med, Genet Program, Boston, MA 02118 USA; [Persico, Antonio M.; Lintas, Carla] Univ Campus Biomed, Lab Mol Psychiat & Neurogenet, Rome, Italy; [De la Monte, Suzanne] Brown Univ, Rhode Isl Hosp, Dept Pathol & Med, Providence, RI 02903 USA; [De la Monte, Suzanne] Brown Univ, Warren Alpert Sch Med, Providence, RI 02912 USA	Northeastern University; Boston University; University Campus Bio-Medico - Rome Italy; Brown University; Lifespan Health Rhode Island; Rhode Island Hospital; Brown University	Deth, RC (corresponding author), Northeastern Univ, Dept Pharmaceut Sci, Sch Pharm, Boston, MA 02115 USA.	r.deth@neu.edu	LINTAS, CARLA/AAB-6248-2022; Persico, Antonio/AAB-9504-2022; de la monte, suzanne/L-7670-2019; Deth, Richard/AFV-2608-2022	de la monte, suzanne/0000-0001-5886-2306; Persico, Antonio/0000-0001-8910-4479; Lintas, Carla/0000-0003-1209-8554; Mostafavi Abdolmaleky, Hamid/0000-0002-8872-5174; Hodgson, Nathaniel/0000-0001-8299-3963	Autism Research Institute; SafeMinds; National Autism Association; Autism Speaks; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R28AA012725] Funding Source: NIH RePORTER	Autism Research Institute; SafeMinds; National Autism Association; Autism Speaks; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported by research grants to RCD from the Autism Research Institute (http://www.autism.com/), SafeMinds(http://www.safeminds.org/) the National Autism Association (http://www.nationalautismassociation.org/) and to CRM from Autism Speaks (http://www.autismspeaks.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdallah MW, 2011, WORLD J BIOL PS 1219; Al-Gadani Y, 2009, CLIN BIOCHEM, V42, P1032, DOI 10.1016/j.clinbiochem.2009.03.011; Mico JA, 2011, BMC PSYCHIATRY, V11, DOI 10.1186/1471-244X-11-26; Bandarian V, 2002, NAT STRUCT BIOL, V9, P53; Bandarian V, 2003, P NATL ACAD SCI USA, V100, P8156, DOI 10.1073/pnas.1133218100; Ben Othmen L, 2008, PROG NEURO-PSYCHOPH, V32, P155, DOI 10.1016/j.pnpbp.2007.08.003; BENZI G, 1995, FREE RADICAL BIO MED, V19, P77, DOI 10.1016/0891-5849(94)00244-E; Berk M, 2008, BIOL PSYCHIAT, V64, P361, DOI 10.1016/j.biopsych.2008.03.004; Bertram L, 2007, NAT GENET, V39, P17, DOI 10.1038/ng1934; Beyer K, 2005, ANN NY ACAD SCI, V1057, P260, DOI 10.1196/annals.1322.021; Bollati V, 2011, BRAIN BEHAV IMMUN, V25, P1078, DOI 10.1016/j.bbi.2011.01.017; CASTAGNA A, 1995, NEUROLOGY, V45, P1678, DOI 10.1212/WNL.45.9.1678; Chauhan Abha, 2006, Pathophysiology, V13, P171, DOI 10.1016/j.pathophys.2006.05.007; Chauhan A, 2012, NEUROCHEM RES, V37, P1681, DOI 10.1007/s11064-012-0775-4; Chez MG, 2007, PEDIATR NEUROL, V36, P361, DOI 10.1016/j.pediatrneurol.2007.01.012; Clarke R, 1998, ARCH NEUROL-CHICAGO, V55, P1449, DOI 10.1001/archneur.55.11.1449; Colantuoni C, 2011, NATURE, V478, P519, DOI 10.1038/nature10524; Cowling VH, 2010, BIOCHEM J, V425, P295, DOI 10.1042/BJ20091352; Dietrich-Muszalska A, 2009, NEUROPSYCHOBIOLOGY, V59, P1, DOI 10.1159/000202822; Dixon MM, 1996, STRUCTURE, V4, P1263, DOI 10.1016/S0969-2126(96)00135-9; Do KQ, 2009, CURR OPIN NEUROBIOL, V19, P220, DOI 10.1016/j.conb.2009.05.001; Evans JC, 2004, P NATL ACAD SCI USA, V101, P3729, DOI 10.1073/pnas.0308082100; FINKELSTEIN JD, 1990, J NUTR BIOCHEM, V1, P228, DOI 10.1016/0955-2863(90)90070-2; Gawryluk JW, 2011, INT J NEUROPSYCHOPH, V14, P123, DOI 10.1017/S1461145710000805; Gawryluk JW, 2010, INT J NEUROPSYCHOPH, V16, P1; Geier DA, 2009, J NEUROL SCI, V280, P101, DOI 10.1016/j.jns.2008.08.021; Giustarini D, 2006, J GERONTOL A-BIOL, V61, P1030, DOI 10.1093/gerona/61.10.1030; Gottfries CG, 1998, J NEURAL TRANSM, V105, P773, DOI 10.1007/s007020050094; Gregory SG, 2009, BMC MED, V7, DOI 10.1186/1741-7015-7-62; Hack V, 1998, BLOOD, V92, P59, DOI 10.1182/blood.V92.1.59.413a05_59_67; Hald A, 2005, EXP NEUROL, V193, P279, DOI 10.1016/j.expneurol.2005.01.013; HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298; James SJ, 2006, AM J MED GENET B, V141B, P947, DOI 10.1002/ajmg.b.30366; James SJ, 2004, AM J CLIN NUTR, V80, P1611, DOI 10.1093/ajcn/80.6.1611; Jarrett JT, 1998, BIOCHEMISTRY-US, V37, P5372, DOI 10.1021/bi9730893; Jensen KP, 2005, J PHYS CHEM B, V109, P10505, DOI 10.1021/jp050802m; Jones DP, 2002, FREE RADICAL BIO MED, V33, P1290, DOI 10.1016/S0891-5849(02)01040-7; Kabil H, 2011, P NATL ACAD SCI USA, V108, P16831, DOI 10.1073/pnas.1102008108; Karijolich J, 2010, METHODS MOL BIOL, V629, P1, DOI 10.1007/978-1-60761-657-3_1; Kimball SR, 2010, J BIOL CHEM, V285, P29027, DOI 10.1074/jbc.R110.137208; LaSalle JM, 2009, EPIGENOMICS-UK, V1, P119, DOI [10.2217/epi.09.13, 10.2217/EPI.09.13]; LaSalle JM, 1998, P NATL ACAD SCI USA, V95, P1675, DOI 10.1073/pnas.95.4.1675; Lavoie S, 2008, NEUROPSYCHOPHARMACOL, V33, P2187, DOI 10.1038/sj.npp.1301624; Li XH, 2009, J NEUROIMMUNOL, V207, P111, DOI 10.1016/j.jneuroim.2008.12.002; Li XY, 2010, J NEUROSCI, V30, P4552, DOI 10.1523/JNEUROSCI.5865-09.2010; Licatalosi DD, 2006, NEURON, V52, P93, DOI 10.1016/j.neuron.2006.09.017; Maruyama Y, 2009, NUCLEIC ACIDS RES, V37, pD762, DOI 10.1093/nar/gkn872; Matsuzawa D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001944; McCaddon A, 2006, J ALZHEIMERS DIS, V9, P361; MCCONKIEROSELL A, 1993, AM J HUM GENET, V53, P800; Mehler MF, 2007, PHYSIOL REV, V87, P799, DOI 10.1152/physrev.00036.2006; Ming X, 2005, PROSTAG LEUKOTR ESS, V73, P379, DOI 10.1016/j.plefa.2005.06.002; Moreira Paula I, 2005, Curr Alzheimer Res, V2, P403; Motorin Y, 2011, WIRES RNA, V2, P611, DOI 10.1002/wrna.79; Nagarajan Raman P, 2006, Epigenetics, V1, pe1; Nguyen A, 2010, FASEB J, V24, P3036, DOI 10.1096/fj.10-154484; Nishiyama M, 2000, J Epidemiol, V10, P163; Numata S, 2012, AM J HUM GENET, V90, P260, DOI 10.1016/j.ajhg.2011.12.020; Obeid R, 2007, CLIN CHEM, V53, P1129, DOI 10.1373/clinchem.2006.085241; Oulhaj A, 2010, INT J GERIATR PSYCH, V25, P82, DOI 10.1002/gps.2303; Page MM, 2010, MECH AGEING DEV, V131, P242, DOI 10.1016/j.mad.2010.02.005; Pasca SP, 2009, J CELL MOL MED, V13, P4229, DOI 10.1111/j.1582-4934.2008.00463.x; Pastural E, 2009, PROSTAG LEUKOTR ESS, V81, P253, DOI 10.1016/j.plefa.2009.06.003; Petrossian TC, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.000976; Raffa M, 2011, BMC PSYCHIATRY, V11, DOI 10.1186/1471-244X-11-124; Ramocki MB, 2009, ANN NEUROL, V66, P771, DOI 10.1002/ana.21715; Raymond J, 2006, SCIENCE, V311, P1764, DOI 10.1126/science.1118439; RICHIE JP, 1994, FASEB J, V8, P1302, DOI 10.1096/fasebj.8.15.8001743; Rose S, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.61; Samiec PS, 1998, FREE RADICAL BIO MED, V24, P699, DOI 10.1016/S0891-5849(97)00286-4; Sati S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031621; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Seripa D, 2003, NEUROBIOL AGING, V24, P933, DOI 10.1016/S0197-4580(03)00040-X; Sharma A, 1999, MOL PSYCHIATR, V4, P235, DOI 10.1038/sj.mp.4000522; Shungu DC, 2012, NMR BIOMED, V25, P1073, DOI 10.1002/nbm.2772; Singh T, 2011, AGEING RES REV, V10, P319, DOI 10.1016/j.arr.2010.11.002; Smith AD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012244; Strausberg RL, 2002, P NATL ACAD SCI USA, V99, P16899, DOI 10.1073/pnas.242603899; TALLAN HH, 1958, J BIOL CHEM, V230, P707; Thatcher KN, 2005, HUM MOL GENET, V14, P785, DOI 10.1093/hmg/ddi073; Uthus EO, 2006, MECH AGEING DEV, V127, P444, DOI 10.1016/j.mad.2006.01.001; Vargas DL, 2005, ANN NEUROL, V57, P67, DOI 10.1002/ana.20315; Vitvitsky V, 2006, J BIOL CHEM, V281, P35785, DOI 10.1074/jbc.M602799200; Waly M, 2004, MOL PSYCHIATR, V9, P358, DOI 10.1038/sj.mp.4001476; Wan MM, 1999, AM J HUM GENET, V65, P1520, DOI 10.1086/302690; Wang BB, 2005, J MOL NEUROSCI, V27, P23, DOI 10.1385/JMN:27:1:023; Wang SC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002698; Wood SJ, 2009, NEUROBIOL DIS, V33, P354, DOI 10.1016/j.nbd.2008.11.018; YANG CS, 1995, J CHROMATOGR B, V674, P23; Yorbik O, 2002, PROSTAG LEUKOTR ESS, V67, P341, DOI 10.1054/plef.2002.0439; Zhang X, 2012, ACTA BIOCH BIOPH SIN, V44, P14, DOI 10.1093/abbs/gmr100; Zhao R, 2001, J NEUROCHEM, V78, P788, DOI 10.1046/j.1471-4159.2001.00471.x; Zhao XY, 2007, EPIGENETICS-US, V2, P126, DOI 10.4161/epi.2.2.4236; Zou CG, 2005, ANTIOXID REDOX SIGN, V7, P547, DOI 10.1089/ars.2005.7.547; Zou CG, 2003, J BIOL CHEM, V278, P16802, DOI 10.1074/jbc.M212376200	95	47	47	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e56927	10.1371/journal.pone.0056927	http://dx.doi.org/10.1371/journal.pone.0056927			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437274	Green Published, gold, Green Submitted			2022-12-25	WOS:000315184200186
J	Wang, XD; Liu, AP; Wu, YY; Wang, P				Wang, Xiao-Dong; Liu, A-Ping; Wu, Yin-Yuan; Wang, Peng			Rapid Extraction of Lexical Tone Phonology in Chinese Characters: A Visual Mismatch Negativity Study	PLOS ONE			English	Article							CATEGORICAL PERCEPTION; ELECTROPHYSIOLOGICAL EVIDENCE; AUTOMATIC ACTIVATION; LINGUISTIC PITCH; WORD RECOGNITION; MEMORY TRACES; SPEECH; BRAIN; ORTHOGRAPHY; ORIENTATION	Background: In alphabetic languages, emerging evidence from behavioral and neuroimaging studies shows the rapid and automatic activation of phonological information in visual word recognition. In the mapping from orthography to phonology, unlike most alphabetic languages in which there is a natural correspondence between the visual and phonological forms, in logographic Chinese, the mapping between visual and phonological forms is rather arbitrary and depends on learning and experience. The issue of whether the phonological information is rapidly and automatically extracted in Chinese characters by the brain has not yet been thoroughly addressed. Methodology/Principal Findings: We continuously presented Chinese characters differing in orthography and meaning to adult native Mandarin Chinese speakers to construct a constant varying visual stream. In the stream, most stimuli were homophones of Chinese characters: The phonological features embedded in these visual characters were the same, including consonants, vowels and the lexical tone. Occasionally, the rule of phonology was randomly violated by characters whose phonological features differed in the lexical tone. Conclusions/Significance: We showed that the violation of the lexical tone phonology evoked an early, robust visual response, as revealed by whole-head electrical recordings of the visual mismatch negativity (vMMN), indicating the rapid extraction of phonological information embedded in Chinese characters. Source analysis revealed that the vMMN was involved in neural activations of the visual cortex, suggesting that the visual sensory memory is sensitive to phonological information embedded in visual words at an early processing stage.	[Wang, Xiao-Dong] Nanyang Technol Univ, Div Psychol, Sch Humanities & Social Sci, Singapore 639798, Singapore; [Liu, A-Ping] Anhui Univ, Dept Econ, Hefei 230039, Peoples R China; [Wu, Yin-Yuan] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA; [Wu, Yin-Yuan] Harvard Univ, Sch Med, Childrens Hosp Boston, Boston, MA USA; [Liu, A-Ping; Wang, Peng] Chinese Acad Sci, Inst Tech Biol & Agr Engn, CAS Key Lab Ion Beam Bioengn, Hefei, Peoples R China	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Anhui University; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard Medical School; Chinese Academy of Sciences	Wang, XD (corresponding author), Nanyang Technol Univ, Div Psychol, Sch Humanities & Social Sci, Singapore 639798, Singapore.	XD-Wang@ntu.edu.sg						Alario FX, 2007, J EXP CHILD PSYCHOL, V97, P205, DOI 10.1016/j.jecp.2007.02.001; [Anonymous], 1976, ACOUSTICAL STUDIES M; Astikainen P., 2009, BEHAV BRAIN FUNCT, V20, P5; Astikainen P, 2008, EUR J NEUROSCI, V28, P2319, DOI 10.1111/j.1460-9568.2008.06510.x; BAO ZM, 1995, J EAST ASIAN LINGUIS, V4, P175, DOI 10.1007/BF01731508; BENTAL E, 1968, EXP NEUROL, V20, P341, DOI 10.1016/0014-4886(68)90077-0; Bentin S, 1999, J COGNITIVE NEUROSCI, V11, P235, DOI 10.1162/089892999563373; Bles M, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-20; Booth JR, 2008, BRAIN RES, V1189, P78, DOI 10.1016/j.brainres.2007.10.080; Booth JR, 1999, DEV PSYCHOL, V35, P3, DOI 10.1037/0012-1649.35.1.3; Brem S, 2005, NEUROREPORT, V16, P45, DOI 10.1097/00001756-200501190-00011; Calvert GA, 2000, CURR BIOL, V10, P649, DOI 10.1016/S0960-9822(00)00513-3; Calvert GA, 1999, NEUROREPORT, V10, P2619, DOI 10.1097/00001756-199908200-00033; Chandrasekaran B, 2009, EAR HEARING, V30, P552, DOI 10.1097/AUD.0b013e3181a7e1c2; Chang Y, 2011, BIOL PSYCHIAT, V69, P742, DOI 10.1016/j.biopsych.2010.12.024; CHEN HC, 1982, MEM COGNITION, V10, P216, DOI 10.3758/BF03197632; Czigler I, 2002, PSYCHOPHYSIOLOGY, V39, P869, DOI 10.1111/1469-8986.3960869; Czigler I, 2007, J PSYCHOPHYSIOL, V21, P224, DOI 10.1027/0269-8803.21.34.224; DEHAENE S, 1995, NEUROREPORT, V6, P2153, DOI 10.1097/00001756-199511000-00014; Ehri LC, 2005, BL HBK DEV PSYCHOL, P135, DOI 10.1002/9780470757642.ch8; FERRAND L, 1992, Q J EXP PSYCHOL-A, V45, P353, DOI 10.1080/02724989208250619; FOX E, 1994, BRIT J PSYCHOL, V85, P41, DOI 10.1111/j.2044-8295.1994.tb02507.x; Gandour J, 2002, J COGNITIVE NEUROSCI, V14, P1076, DOI 10.1162/089892902320474526; Ganis G, 2012, NEUROIMAGE, V62, P1563, DOI 10.1016/j.neuroimage.2012.05.043; HAMALAINEN MS, 1994, MED BIOL ENG COMPUT, V32, P35, DOI 10.1007/BF02512476; Hickok G, 2000, NEUROSCI LETT, V287, P156, DOI 10.1016/S0304-3940(00)01143-5; Hickok G, 2007, NAT REV NEUROSCI, V8, P393, DOI 10.1038/nrn2113; Ilmoniemi R J, 1993, Brain Topogr, V5, P331, DOI 10.1007/BF01128686; KATZ RB, 1992, Q J EXP PSYCHOL-A, V45, P575, DOI 10.1080/14640749208401334; Kenemans JL, 2003, NEUROREPORT, V14, P1239, DOI 10.1097/00001756-200307010-00010; Kimura M, 2011, NEUROREPORT, V22, P669, DOI 10.1097/WNR.0b013e32834973ba; Klein D, 2001, NEUROIMAGE, V13, P646, DOI 10.1006/nimg.2000.0738; LESCH MF, 1993, J EXP PSYCHOL LEARN, V19, P285, DOI 10.1037/0278-7393.19.2.285; Lin SE, 2011, NEUROSCIENCE, V190, P200, DOI 10.1016/j.neuroscience.2011.05.071; Luo H, 2006, P NATL ACAD SCI USA, V103, P19558, DOI 10.1073/pnas.0607065104; Macaluso E, 2004, NEUROIMAGE, V21, P725, DOI 10.1016/j.neuroimage.2003.09.049; Maekawa T, 2005, CLIN NEUROPHYSIOL, V116, P2392, DOI 10.1016/j.clinph.2005.07.006; Maekawa T, 2009, NEUROSCI RES, V65, P107, DOI 10.1016/j.neures.2009.06.005; MARSOLEK CJ, 1992, J EXP PSYCHOL LEARN, V18, P492, DOI 10.1037/0278-7393.18.3.492; Marsolek CJ, 1996, MEM COGNITION, V24, P539, DOI 10.3758/BF03201082; McCandliss BD, 2003, MENT RETARD DEV D R, V9, P196, DOI 10.1002/mrdd.10080; Mo L, 2011, P NATL ACAD SCI USA, V108, P14026, DOI 10.1073/pnas.1111860108; Naatanen R, 2007, CLIN NEUROPHYSIOL, V118, P2544, DOI 10.1016/j.clinph.2007.04.026; Naatanen R, 1997, NATURE, V385, P432, DOI 10.1038/385432a0; Naatanen R, 2003, INT J PSYCHOPHYSIOL, V48, P179, DOI 10.1016/S0167-8760(03)00053-9; Naatanen R, 2011, BRAIN, V134, P3432, DOI 10.1093/brain/awr064; Naatanen R, 2011, PSYCHOPHYSIOLOGY, V48, P4, DOI 10.1111/j.1469-8986.2010.01114.x; Newman RL, 2004, COGNITIVE BRAIN RES, V21, P94, DOI 10.1016/j.cogbrainres.2004.05.006; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Peng DS, 2004, COGNITIVE BRAIN RES, V20, P156, DOI 10.1016/j.cogbrainres.2004.02.006; Pike Kenneth, 1948, TONE LANGUAGES TECHN; Proverbio AM, 2004, J COGNITIVE NEUROSCI, V16, P301, DOI 10.1162/089892904322984580; Pulvermuller F, 2001, NEUROIMAGE, V14, P607, DOI 10.1006/nimg.2001.0864; Qiu XH, 2011, NEUROSCI LETT, V491, P53, DOI 10.1016/j.neulet.2011.01.006; Ren GQ, 2009, NEUROSCIENCE, V162, P87, DOI 10.1016/j.neuroscience.2009.04.021; Rossion B, 2003, NEUROIMAGE, V20, P1609, DOI 10.1016/j.neuroimage.2003.07.010; RUGG MD, 1984, NEUROPSYCHOLOGIA, V22, P435, DOI 10.1016/0028-3932(84)90038-1; Schulte-Korne G, 1999, NEUROREPORT, V10, P3697, DOI 10.1097/00001756-199911260-00043; Sharma J, 2000, NATURE, V404, P841, DOI 10.1038/35009043; Shtyrov Y, 2002, NEUROREPORT, V13, P521, DOI 10.1097/00001756-200203250-00033; Stefanics G, 2011, NEUROIMAGE; Stefanics G, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00046; Stoeckel C, 2009, CORTEX, V45, P1091, DOI 10.1016/j.cortex.2008.12.004; Tales A, 1999, NEUROREPORT, V10, P3363, DOI 10.1097/00001756-199911080-00020; Tales A, 2006, NEUROREPORT, V17, P887, DOI 10.1097/01.wnr.0000223383.42295.fa; Thierry G, 2009, P NATL ACAD SCI USA, V106, P4567, DOI 10.1073/pnas.0811155106; van Atteveldt N, 2004, NEURON, V43, P271, DOI 10.1016/j.neuron.2004.06.025; Vellutino FR, 2004, J CHILD PSYCHOL PSYC, V45, P2, DOI 10.1046/j.0021-9630.2003.00305.x; von Melchner L, 2000, NATURE, V404, P871, DOI 10.1038/35009102; Wang XD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030027; Whatmough C, 1999, BRAIN LANG, V66, P275, DOI 10.1006/brln.1998.1996; Wilson LB, 2011, NEUROIMAGE, V55, P724, DOI 10.1016/j.neuroimage.2010.12.019; Wong Patrick C. M., 2009, Seminars in Speech and Language, V30, P162, DOI 10.1055/s-0029-1225953; Wong PCM, 2004, J NEUROSCI, V24, P9153, DOI 10.1523/JNEUROSCI.2225-04.2004; Xi J, 2010, NEUROSCIENCE, V170, P223, DOI 10.1016/j.neuroscience.2010.06.077; Zhao L, 2006, NEUROSCI LETT, V410, P126, DOI 10.1016/j.neulet.2006.09.081; Ziegler JC, 2000, Q J EXP PSYCHOL-A, V53, P671, DOI 10.1080/027249800410508	77	15	15	3	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e56778	10.1371/journal.pone.0056778	http://dx.doi.org/10.1371/journal.pone.0056778			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	093IE	23437235	Green Published, gold			2022-12-25	WOS:000315184200159
J	Kamshilin, AA; Teplov, V; Nippolainen, E; Miridonov, S; Giniatullin, R				Kamshilin, Alexei A.; Teplov, Victor; Nippolainen, Ervin; Miridonov, Serguei; Giniatullin, Rashid			Variability of Microcirculation Detected by Blood Pulsation Imaging	PLOS ONE			English	Article							LASER; PHOTOPLETHYSMOGRAPHY; LIGHT; FLOW; SKIN; WAVELENGTH; CAMERA; RANGE	The non-invasive assessment of blood flow is invaluable for the diagnostic and monitoring treatment of numerous vascular and neurological diseases. We developed a non-invasive and non-contact method of blood pulsation imaging capable of visualizing and monitoring of the two-dimensional distribution of two key parameters of peripheral blood flow: the blood pulsation amplitude and blood pulsation phase. The method is based on the photoplethysmographic imaging in the reflection mode. In contrast with previous imaging systems we use new algorithm for data processing which allows two dimensional mapping of blood pulsations in large object's areas after every cardiac cycle. In our study we carried out the occlusion test of the arm and found (i) the extensive variability of 2D-distribution of blood pulsation amplitude from one cardiac cycle to another, and (ii) existence of the adjacent spots to which the blood is asynchronously supplied. These observations show that the method can be used for studying of the multicomponent regulation of peripheral blood circulation. The proposed technique is technologically simple and cost-effective, which makes it applicable for monitoring the peripheral microcirculation in clinical settings for example, in diagnostics or testing the efficiency of new medicines.	[Kamshilin, Alexei A.; Teplov, Victor; Nippolainen, Ervin] Univ Eastern Finland, Dept Appl Phys, Kuopio, Finland; [Miridonov, Serguei] Ctr Invest Cient & Educ Super Ensenada, Opt Dept, Ensenada, Baja California, Mexico; [Giniatullin, Rashid] Univ Eastern Finland, AI Virtanen Inst, Dept Neurobiol, Kuopio, Finland	University of Eastern Finland; CICESE - Centro de Investigacion Cientifica y de Educacion Superior de Ensenada; University of Eastern Finland	Kamshilin, AA (corresponding author), Univ Eastern Finland, Dept Appl Phys, Kuopio, Finland.	alexei.kamshilin@uef.fi	Giniatullin, Rashid/Y-9687-2018; Kamshilin, Alexei A./Q-9775-2016; Miridonov, Serguei/A-6109-2009; Nippolainen, Ervin/J-9123-2014	Kamshilin, Alexei A./0000-0003-2506-9736; Miridonov, Serguei/0000-0002-4069-9229; Giniatullin, Rashid/0000-0002-1580-6280; Nippolainen, Ervin/0000-0002-1317-2683	Academy of Finland [128582]	Academy of Finland(Academy of Finland)	Partial financial support provided by the Academy of Finland, http://www.aka.fi/en-GB/A/ (project no. 128582), is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Allen J, 2007, PHYSIOL MEAS, V28, pR1, DOI 10.1088/0967-3334/28/3/R01; ANDERSON RR, 1981, J INVEST DERMATOL, V77, P13, DOI 10.1111/1523-1747.ep12479191; Bernjak A, 2012, J PHYSIOL-LONDON, V590, P363, DOI 10.1113/jphysiol.2011.214528; Berntson GG, 1997, PSYCHOPHYSIOLOGY, V34, P623, DOI 10.1111/j.1469-8986.1997.tb02140.x; Burton AC, 1939, AM J PHYSIOL, V127, P437, DOI 10.1152/ajplegacy.1939.127.3.437; CUI W, 1990, IEEE T BIO-MED ENG, V37, P632, DOI 10.1109/10.55667; DETRAFFORD J, 1984, MED BIOL ENG COMPUT, V22, P479, DOI 10.1007/BF02447713; Dunn AK, 2003, OPT LETT, V28, P28, DOI 10.1364/OL.28.000028; Figueiras E, 2012, REV SCI INSTRUM, V83, DOI 10.1063/1.3694571; FUJII H, 1985, OPT LETT, V10, P104, DOI 10.1364/OL.10.000104; Guyton A.C., 1981, TXB MED PHYSL; Hertzman A B, 1937, AM J PHYSIOL, V119, P334; Humeau A, 2007, MED BIOL ENG COMPUT, V45, P421, DOI 10.1007/s11517-007-0170-5; ISHIMARU A, 1989, APPL OPTICS, V28, P2210, DOI 10.1364/AO.28.002210; KAMAL AAR, 1989, COMPUT METH PROG BIO, V28, P257, DOI 10.1016/0169-2607(89)90159-4; Kamshilin AA, 2011, BIOMED OPT EXPRESS, V2, P996, DOI 10.1364/BOE.2.000996; Khanokh B, 2004, MED BIOL ENG COMPUT, V42, P80, DOI 10.1007/BF02351014; Leutenegger M, 2011, BIOMED OPT EXPRESS, V2, P1470, DOI 10.1364/BOE.2.001470; O'Doherty J, 2009, J BIOMED OPT, V14, DOI 10.1117/1.3149863; Serov A, 2005, OPT EXPRESS, V13, P6416, DOI 10.1364/OPEX.13.006416; Serov A, 2005, OPT EXPRESS, V13, P3681, DOI 10.1364/OPEX.13.003681; Stefanovska A, 1999, IEEE T BIO-MED ENG, V46, P1230, DOI 10.1109/10.790500; Ulyanov SS, 2000, APPL OPTICS, V39, P6385, DOI 10.1364/AO.39.006385; Wieringa FP, 2005, ANN BIOMED ENG, V33, P1034, DOI 10.1007/s10439-005-5763-2; Xu RX, 2010, J VIS EXP, V46, P2095	26	37	44	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2013	8	2							e57117	10.1371/journal.pone.0057117	http://dx.doi.org/10.1371/journal.pone.0057117			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093HR	23431399	gold, Green Published, Green Submitted			2022-12-25	WOS:000315182800042
J	Penner, J; Adum, GB; McElroy, MT; Doherty-Bone, T; Hirschfeld, M; Sandberger, L; Weldon, C; Cunningham, AA; Ohst, T; Wombwell, E; Portik, DM; Reid, D; Hillers, A; Ofori-Boateng, C; Oduro, W; Plotner, J; Ohler, A; Leache, AD; Rodel, MO				Penner, Johannes; Adum, Gilbert B.; McElroy, Matthew T.; Doherty-Bone, Thomas; Hirschfeld, Mareike; Sandberger, Laura; Weldon, Che; Cunningham, Andrew A.; Ohst, Torsten; Wombwell, Emma; Portik, Daniel M.; Reid, Duncan; Hillers, Annika; Ofori-Boateng, Caleb; Oduro, William; Ploetner, Joerg; Ohler, Annemarie; Leache, Adam D.; Roedel, Mark-Oliver			West Africa - A Safe Haven for Frogs? A Sub-Continental Assessment of the Chytrid Fungus (Batrachochytrium dendrobatidis)	PLOS ONE			English	Article							EMERGING INFECTIOUS-DISEASE; NORTH-AMERICAN BULLFROG; AMPHIBIAN CHYTRIDIOMYCOSIS; POPULATION DECLINES; SPECIES DISTRIBUTIONS; HIGH PREVALENCE; RECENT HISTORY; PATHOGEN; TRADE; CONSERVATION	A putative driver of global amphibian decline is the panzootic chytrid fungus Batrachochytrium dendrobatidis (Bd). While Bd has been documented across continental Africa, its distribution in West Africa remains ambiguous. We tested 793 West African amphibians (one caecilian and 61 anuran species) for the presence of Bd. The samples originated from seven West African countries - Benin, Burkina Faso, Cote d'Ivoire, Ghana, Guinea, Liberia, Sierra Leone - and were collected from a variety of habitats, ranging from lowland rainforests to montane forests, montane grasslands to humid and dry lowland savannahs. The species investigated comprised various life-history strategies, but we focused particularly on aquatic and riparian species. We used diagnostic PCR to screen 656 specimen swabs and histology to analyse 137 specimen toe tips. All samples tested negative for Bd, including a widespread habitat generalist Hoplobatrachus occipitalis which is intensively traded on the West African food market and thus could be a potential dispersal agent for Bd. Continental fine-grained (30 arc seconds) environmental niche models suggest that Bd should have a broad distribution across West Africa that includes most of the regions and habitats that we surveyed. The surprising apparent absence of Bd in West Africa indicates that the Dahomey Gap may have acted as a natural barrier. Herein we highlight the importance of this Bd-free region of the African continent especially for the long-term conservation of several threatened species depending on fast flowing forest streams (Conraua alleni ("Vulnerable'') and Petropedetes natator ("Near Threatened'')) as well as the "Critically Endangered'' viviparous toad endemic to the montane grasslands of Mount Nimba (Nimbaphrynoides occidentalis).	[Penner, Johannes; Hirschfeld, Mareike; Sandberger, Laura; Ohst, Torsten; Ploetner, Joerg; Roedel, Mark-Oliver] Leibniz Inst Res Evolut & Biodivers, Museum Nat Kunde, Berlin, Germany; [Adum, Gilbert B.; Ofori-Boateng, Caleb; Oduro, William] KNUST, CANR, Fac Renewable Nat Resources, Dept Wildlife & Range Management, Kumasi, Ghana; [McElroy, Matthew T.; Reid, Duncan; Leache, Adam D.] Univ Washington, Dept Biol, Seattle, WA 98195 USA; [McElroy, Matthew T.; Reid, Duncan; Leache, Adam D.] Univ Washington, Burke Museum, Seattle, WA 98195 USA; [Doherty-Bone, Thomas] Nat Hist Museum, Dept Life Sci, London SW7 5BD, England; [Doherty-Bone, Thomas; Cunningham, Andrew A.; Wombwell, Emma] Zool Soc London, Inst Zool, London NW1 4RY, England; [Weldon, Che] North West Univ, Unit Environm Res, Potchefstroom, South Africa; [Ohst, Torsten] Charite, Inst Microbiol & Hyg, D-13353 Berlin, Germany; [Portik, Daniel M.] Univ Calif Berkeley, Museum Vertebrate Zool, Berkeley, CA 94720 USA; [Portik, Daniel M.] Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA; [Hillers, Annika] Royal Soc Protect Birds, Kenema, Sierra Leone; [Ofori-Boateng, Caleb] Forestry Res Inst Ghana, Kumasi, Ghana; [Ohler, Annemarie] Museum Natl Hist Nat, Dept Systemat & Evolut Origine Struct & Evolut Bi, F-75231 Paris, France	Leibniz Institut fur Evolutions und Biodiversitatsforschung; Kwame Nkrumah University Science & Technology; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Natural History Museum London; Zoological Society of London; North West University - South Africa; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of California System; University of California Berkeley; University of California System; University of California Berkeley; Royal Society for Protection of Birds; Museum National d'Histoire Naturelle (MNHN)	Penner, J (corresponding author), Leibniz Inst Res Evolut & Biodivers, Museum Nat Kunde, Berlin, Germany.	johannes.penner@mfn-berlin.de	Doherty-Bone, Thomas/L-7109-2016; Cunningham, Andrew A/E-7536-2010; Ohler, Annemarie/AAB-7721-2019	Doherty-Bone, Thomas/0000-0002-8074-5955; Ohler, Annemarie/0000-0001-6531-464X; Penner, Johannes/0000-0001-8166-5992; Sandberger-Loua, Laura/0000-0001-6731-6411; Weldon, Che/0000-0001-6716-0787; Petersen, Mareike/0000-0001-8666-1931	German Ministry for Education and Research (BMBF) through the BIOTA-West project [01LC0617J]; Defra's Darwin Initiative/ZSL's Wildlife Wood Project; Rufford Small Grants Foundation; German Science Foundation [DFG PL 213/6-1]; DFG [VE 183/4-1, RO 3064/1-2]; Rapid Assessment Program and Critical Ecosystem Partnership Fund of Conservation International; World Wide Fund for Nature and BirdLife International	German Ministry for Education and Research (BMBF) through the BIOTA-West project(Federal Ministry of Education & Research (BMBF)); Defra's Darwin Initiative/ZSL's Wildlife Wood Project; Rufford Small Grants Foundation; German Science Foundation(German Research Foundation (DFG)); DFG(German Research Foundation (DFG)); Rapid Assessment Program and Critical Ecosystem Partnership Fund of Conservation International; World Wide Fund for Nature and BirdLife International	Fieldwork in Benin, Burkina Faso and Cote d'Ivoire was funded by the German Ministry for Education and Research (BMBF) through the BIOTA-West project (01LC0617J). In Ghana, fieldwork for GBA, COB and WO was supported by Defra's Darwin Initiative/ZSL's Wildlife Wood Project and the Rufford Small Grants Foundation respectively. Analyses of samples in Berlin were conducted within a project financed by the German Science Foundation (DFG PL 213/6-1). The authors further thank the DFG (VE 183/4-1, RO 3064/1-2), the Rapid Assessment Program and Critical Ecosystem Partnership Fund of Conservation International, the World Wide Fund for Nature and BirdLife International for additional funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams MJ, 2010, ECOL APPL, V20, P289, DOI 10.1890/08-2319.1; Annis SL, 2004, J WILDLIFE DIS, V40, P420, DOI 10.7589/0090-3558-40.3.420; [Anonymous], 2010, MAPPING SPECIES DIST; ARNAUD M, 1991, ISPRS J PHOTOGRAMM, V46, P205, DOI 10.1016/0924-2716(91)90054-Y; Bai CM, 2012, DIVERS DISTRIB, V18, P307, DOI 10.1111/j.1472-4642.2011.00878.x; Balaz V, 2012, HERPETOL J, V22, P191; Bancroft BA, 2011, BIODIVERS CONSERV, V20, P1911, DOI 10.1007/s10531-011-0066-4; Becker CG, 2011, P NATL ACAD SCI USA, V108, P9893, DOI 10.1073/pnas.1014497108; Bell RC, 2011, ECOHEALTH, V8, P116, DOI 10.1007/s10393-010-0364-4; Berger L, 1998, P NATL ACAD SCI USA, V95, P9031, DOI 10.1073/pnas.95.15.9031; Berger L., 1999, DECLINES DISAPPEARAN, V1999, P23; Berger L., 1999, ZOOS PRINT J, V15, P184, DOI DOI 10.11609/JOTT.ZPJ.15.1.184-90; Berger L, 2001, DEV MANAGEMENT STRAT, P83; Bosch J, 2001, BIOL CONSERV, V97, P331, DOI 10.1016/S0006-3207(00)00132-4; Bosch J, 2007, P ROY SOC B-BIOL SCI, V274, P253, DOI 10.1098/rspb.2006.3713; Boyle DG, 2004, DIS AQUAT ORGAN, V60, P141, DOI 10.3354/dao060141; Bradley GA, 2002, J WILDLIFE DIS, V38, P206, DOI 10.7589/0090-3558-38.1.206; Briggs CJ, 2010, P NATL ACAD SCI USA, V107, P9695, DOI 10.1073/pnas.0912886107; Burgess N.D., 2004, TERRESTRIAL ECOREGIO; Burgin Shelley, 2005, Acta Zoologica Sinica, V51, P344; Burrowes Patricia A., 2011, Herpetological Review, V42, P359; Carey C, 2006, ECOHEALTH, V3, P5, DOI 10.1007/s10393-005-0006-4; Catenazzi A, 2010, DIS AQUAT ORGAN, V92, P187, DOI 10.3354/dao02250; Channing Alan, 2006, Journal of East African Natural History, V95, P117, DOI 10.2982/0012-8317(2006)95[117:TBARHO]2.0.CO;2; Chatelain C., 2004, Biodiversity of West African forests: an ecological atlas of woody plant species, P15, DOI 10.1079/9780851997346.0015; Chatelain C, 1996, BIODIVERS CONSERV, V5, P37, DOI 10.1007/BF00056291; Conradie Werner, 2011, Herpetological Review, V42, P369; Conradie W, 2011, AFR ZOOL, V46, P95, DOI 10.3377/004.046.0122; Crawford AJ, 2010, P NATL ACAD SCI USA, V107, P13777, DOI 10.1073/pnas.0914115107; Daszak P, 1999, EMERG INFECT DIS, V5, P735, DOI 10.3201/eid0506.990601; Daszak P, 2003, DIVERS DISTRIB, V9, P141, DOI 10.1046/j.1472-4642.2003.00016.x; Daversa David, 2011, Herpetological Review, V42, P67; Doherty-Bone TM, 2013, DIS AQUAT ORGAN, V102, P187, DOI 10.3354/dao02557; Drew A, 2006, DIS AQUAT ORGAN, V68, P245, DOI 10.3354/dao068245; El Mouden E. H., 2011, Herpetological Review, V42, P71; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Elith J, 2011, DIVERS DISTRIB, V17, P43, DOI 10.1111/j.1472-4642.2010.00725.x; Farr TG, 2007, REV GEOPHYS, V45, DOI 10.1029/2005RG000183; Farrer RA, 2011, P NATL ACAD SCI USA, V108, P18732, DOI 10.1073/pnas.1111915108; Fisher Matthew C., 2007, Fungal Biology Reviews, V21, P2, DOI 10.1016/j.fbr.2007.02.002; Fisher MC, 2009, ANNU REV MICROBIOL, V63, P291, DOI 10.1146/annurev.micro.091208.073435; Garland S, 2011, DIS AQUAT ORGAN, V94, P101, DOI 10.3354/dao02327; Garmyn A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035038; Garner TWJ, 2006, BIOL LETTERS, V2, P455, DOI 10.1098/rsbl.2006.0494; Goka K, 2009, MOL ECOL, V18, P4757, DOI 10.1111/j.1365-294X.2009.04384.x; Goldberg TL, 2007, J WILDLIFE DIS, V43, P521, DOI 10.7589/0090-3558-43.3.521; Gower DJ, 2012, HERPETOL J, V22, P225; Grafe TU, 2011, J HERPETOL, V45, P28, DOI 10.1670/10-016.1; Greenbaum Eli, 2008, Herpetological Review, V39, P70; Hansen M, 2003, VEGETATION CONTINUOU; Heard M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023150; Heikkinen RK, 2012, ECOGRAPHY, V35, P276, DOI 10.1111/j.1600-0587.2011.06999.x; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hillers A., 2008, Endangered Species Research, V5, P13, DOI 10.3354/esr00099; Hopkins Samantha, 2003, Herpetological Review, V34, P334; Hyatt AD, 2007, DIS AQUAT ORGAN, V73, P175, DOI 10.3354/dao073175; Imasuen AA, 2009, FROGLOG, V90, P6; Imasuen Abigail A., 2011, Herpetological Review, V42, P379; IUCN, 2019, IUCN RED LIST THREAT; Johnson ML, 2005, DIS AQUAT ORGAN, V65, P181, DOI 10.3354/dao065181; Johnson ML, 2003, DIS AQUAT ORGAN, V57, P255, DOI 10.3354/dao057255; Kielgast J, 2010, ANIM CONSERV, V13, P36, DOI 10.1111/j.1469-1795.2009.00297.x; Kilburn VL, 2011, DIS AQUAT ORGAN, V97, P127, DOI 10.3354/dao02409; Kilpatrick AM, 2010, TRENDS ECOL EVOL, V25, P109, DOI 10.1016/j.tree.2009.07.011; Kinney VC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016708; Kriger KM, 2007, J ZOOL, V271, P352, DOI 10.1111/j.1469-7998.2006.00220.x; Kriger KM, 2007, DIVERS DISTRIB, V13, P781, DOI 10.1111/j.1472-4642.2007.00394.x; Kriger KM, 2009, ECOHEALTH, V6, P6, DOI 10.1007/s10393-009-0228-y; Lamirande EW, 2002, P 6 INT S PATH REPT, P3; Lips KR, 2008, PLOS BIOL, V6, P441, DOI 10.1371/journal.pbio.0060072; Lips KR, 1999, CONSERV BIOL, V13, P117, DOI 10.1046/j.1523-1739.1999.97185.x; Lips KR, 2006, P NATL ACAD SCI USA, V103, P3165, DOI 10.1073/pnas.0506889103; Lips KR, 2004, BIOL CONSERV, V119, P555, DOI 10.1016/j.biocon.2004.01.017; Lotters S, 2009, ECOHEALTH, V6, P358, DOI 10.1007/s10393-010-0281-6; Longcore JR, 2007, J WILDLIFE MANAGE, V71, P435, DOI 10.2193/2006-345; Mayaux P, 2004, J BIOGEOGR, V31, P861, DOI 10.1111/j.1365-2699.2004.01073.x; Mazzoni R, 2003, EMERG INFECT DIS, V9, P995; McDonald K, 1999, DECLINES DISAPPEARAN, P14; Mohneke M., 2010, Traffic Bulletin, V22, P117; Mohneke Meike, 2009, Salamandra, V45, P193; Murray K, 2011, HYGIENE PROTOCOLS CO; Murray KA, 2012, HUM ECOL RISK ASSESS, V18, P200, DOI 10.1080/10807039.2012.632310; Murray KA, 2011, J APPL ECOL, V48, P163, DOI 10.1111/j.1365-2664.2010.01890.x; Murray KA, 2009, CONSERV BIOL, V23, P1242, DOI 10.1111/j.1523-1739.2009.01211.x; Muths E, 2003, BIOL CONSERV, V110, P357, DOI 10.1016/S0006-3207(02)00239-2; Parker JM, 2002, COMPARATIVE MED, V52, P265; Peterson AT, 2011, MONOGRAPHS POPULATIO, P328, DOI [DOI 10.5860/CHOICE.49-6266, 10.1515/9781400840670, DOI 10.1515/9781400840670]; Phillips S.J., 2004, P 21 INT C MACH LEAR, P655, DOI [DOI 10.1145/1015330.1015412, 10.1145/1015330.1015412]; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; Phillott AD, 2010, DIS AQUAT ORGAN, V92, P175, DOI 10.3354/dao02162; Piotrowski JS, 2004, MYCOLOGIA, V96, P9, DOI 10.2307/3761981; Puschendorf R, 2009, DIVERS DISTRIB, V15, P401, DOI 10.1111/j.1472-4642.2008.00548.x; Rachowicz LJ, 2006, ECOLOGY, V87, P1671, DOI 10.1890/0012-9658(2006)87[1671:EIDAAP]2.0.CO;2; Reeder Natalie M.M., 2011, Herpetology Notes, V4, P83; Ribas L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008408; Rodel M-O, 2000, HERPETOFAUNA W AFRIC, VI; Rodder D, 2008, ANIM CONSERV, V11, P513, DOI 10.1111/j.1469-1795.2008.00210.x; Roedder Dennis, 2009, Diversity, V1, P52; Rodder D, 2010, DIS AQUAT ORGAN, V92, P201, DOI 10.3354/dao02197; Ron SR, 2005, BIOTROPICA, V37, P209, DOI 10.1111/j.1744-7429.2005.00028.x; Sandberger L, 2010, ZOOTAXA, P56; Schloegel LM, 2010, ANIM CONSERV, V13, P53, DOI 10.1111/j.1469-1795.2009.00307.x; Schloegel LM, 2012, MOL ECOL, V21, P5162, DOI 10.1111/j.1365-294X.2012.05710.x; Schloegel LM, 2009, BIOL CONSERV, V142, P1420, DOI 10.1016/j.biocon.2009.02.007; SCHMIDT B. R., 2009, METHODEN FELDHERPETO, P229; Skerratt LF, 2011, J HERPETOL, V45, P444, DOI 10.1670/10-193.1; Skerratt LF, 2010, DIS AQUAT ORGAN, V92, P117, DOI 10.3354/dao02272; Skerratt LF, 2007, ECOHEALTH, V4, P125, DOI 10.1007/s10393-007-0093-5; Soto-Azat C, 2009, DIS AQUAT ORGAN, V84, P163, DOI 10.3354/dao02029; Soto-Azat C, 2010, DIVERS DISTRIB, V16, P126, DOI 10.1111/j.1472-4642.2009.00618.x; Speare R, 2004, AUST VET J, V82, P300, DOI 10.1111/j.1751-0813.2004.tb12710.x; St-Amour V, 2008, EMERG INFECT DIS, V14, P1175, DOI 10.3201/eid1407.070602; Stockwell MP, 2010, ANIM CONSERV, V13, P62, DOI 10.1111/j.1469-1795.2010.00407.x; Stuart S. N., 2008, THREATENED AMPHIBIAN; Tinoco BA, 2009, BIRD CONSERV INT, V19, P63, DOI 10.1017/S0959270908007703; Tittensor DP, 2009, J BIOGEOGR, V36, P1111, DOI 10.1111/j.1365-2699.2008.02062.x; Van Sluys M, 2008, DIS AQUAT ORGAN, V81, P93, DOI 10.3354/dao01953; Vences Miguel, 2005, Front Zool, V2, P5, DOI 10.1186/1742-9994-2-5; Vredenburg VT, 2012, HERPETOLOGY NOTES, V5, P507, DOI DOI 10.1186/1756-0500-5-507; Wake DB, 2012, SCIENCE, V335, P1052, DOI 10.1126/science.1218364; Waldman B., 2001, Surveillance (Wellington), V28, P9; Webb R, 2007, DIS AQUAT ORGAN, V74, P13, DOI 10.3354/dao074013; Weldon C, 2004, EMERG INFECT DIS, V10, P2100, DOI 10.3201/eid1012.030804; Weldon C., 2004, FROGLOG, V62, P2; Weldon C, 2011, FUNGAL DIS EMERGING, P355; Weldon C, 2007, AFR J HERPETOL, V56, P77, DOI 10.1080/21564574.2007.9635553; Weldon Che, 2008, Museo Regionale di Scienze Naturali Monografie (Turin), V45, P95; White T.J., 1990, PCR PROTOCOLS GUIDE, P315, DOI DOI 10.1016/B978-0-12-372180-8.50042-1; Whitfield SM, 2012, BIOTROPICA, V44, P779, DOI 10.1111/j.1744-7429.2012.00872.x; Wollenberg KC, 2010, ECOHEALTH, V7, P248, DOI 10.1007/s10393-010-0313-2; Woodhams DC, 2007, ANIM CONSERV, V10, P409, DOI 10.1111/j.1469-1795.2007.00130.x; Woodhams DC, 2008, ECOLOGY, V89, P1627, DOI 10.1890/06-1842.1; Young BE, 2001, CONSERV BIOL, V15, P1213, DOI 10.1046/j.1523-1739.2001.00218.x	134	26	30	1	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e56236	10.1371/journal.pone.0056236	http://dx.doi.org/10.1371/journal.pone.0056236			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23426141	Green Published, Green Submitted, gold			2022-12-25	WOS:000315970300133
J	Tanida, M; Yamamoto, N; Shibamoto, T; Rahmouni, K				Tanida, Mamoru; Yamamoto, Naoki; Shibamoto, Toshishige; Rahmouni, Kamal			Involvement of Hypothalamic AMP-Activated Protein Kinase in Leptin-Induced Sympathetic Nerve Activation	PLOS ONE			English	Article							BLOOD-PRESSURE; FOOD-INTAKE; MELANOCORTIN SYSTEM; ARTERIAL-PRESSURE; HYPERTENSIVE-RATS; ADIPOSE-TISSUE; RESISTANCE; NEURONS	In mammals, leptin released from the white adipose tissue acts on the central nervous system to control feeding behavior, cardiovascular function, and energy metabolism. Central leptin activates sympathetic nerves that innervate the kidney, adipose tissue, and some abdominal organs in rats. AMP-activated protein kinase (AMPK) is essential in the intracellular signaling pathway involving the activation of leptin receptors (ObRb). We investigated the potential of AMPK alpha 2 in the sympathetic effects of leptin using in vivo siRNA injection to knockdown AMPK alpha 2 in rats, to produce reduced hypothalamic AMPK alpha 2 expression. Leptin effects on body weight, food intake, and blood FFA levels were eliminated in AMPK alpha 2 siRNA-treated rats. Leptin-evoked enhancements of the sympathetic nerve outflows to the kidney, brown and white adipose tissues were attenuated in AMPK alpha 2 siRNA-treated rats. To check whether AMPK alpha 2 was specific to sympathetic changes induced by leptin, we examined the effects of injecting MT-II, a melanocortin-3 and -4 receptor agonist, on the sympathetic nerve outflows to the kidney and adipose tissue. MT-II-induced sympatho-excitation in the kidney was unchanged in AMPK alpha 2 siRNA-treated rats. However, responses of neural activities involving adipose tissue to MT-II were attenuated in AMPK alpha 2 siRNA-treated rats. These results suggest that hypothalamic AMPK alpha 2 is involved not only in appetite and body weight regulation but also in the regulation of sympathetic nerve discharges to the kidney and adipose tissue. Thus, AMPK might function not only as an energy sensor, but as a key molecule in the cardiovascular, thermogenic, and lipolytic effects of leptin through the sympathetic nervous system.	[Tanida, Mamoru; Shibamoto, Toshishige] Kanazawa Med Univ, Dept Physiol 2, Uchinada, Ishikawa 92002, Japan; [Tanida, Mamoru] Ritsumeikan Univ, Coll Life Sci, Dept Biomed Sci, Kusatsu, Shiga, Japan; [Yamamoto, Naoki] Ritsumeikan Univ, Coll Pharmacol, Kusatsu, Shiga, Japan; [Rahmouni, Kamal] Univ Iowa Carver, Coll Med, Dept Pharmacol, Iowa City, IA USA; [Rahmouni, Kamal] Univ Iowa Carver, Coll Med, Dept Internal Med, Iowa City, IA USA	Kanazawa Medical University; Ritsumeikan University; Ritsumeikan University; University of Iowa; University of Iowa	Tanida, M (corresponding author), Kanazawa Med Univ, Dept Physiol 2, Uchinada, Ishikawa 92002, Japan.	mtanida@kanazawa-med.ac.jp	Rahmouni, Kamal/Y-1788-2019	Rahmouni, Kamal/0000-0001-5136-6748	Ministry of Education, Culture, Sports, Science, and Technology of Japan [23689008]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL084207] Funding Source: NIH RePORTER	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This research was supported by grants from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (Grant-in-Aid for Young Scientists to MT, 23689008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amato S, 2011, SCIENCE, V332, P247, DOI 10.1126/science.1201678; Breit A, 2011, MOL CELL ENDOCRINOL, V331, P232, DOI 10.1016/j.mce.2010.07.007; Brito MN, 2007, ENDOCRINOLOGY, V148, P5339, DOI 10.1210/en.2007-0621; Casto RM, 1998, NEUROSCI LETT, V246, P29, DOI 10.1016/S0304-3940(98)00223-7; Chikahisa S, 2009, NEUROPHARMACOLOGY, V57, P369, DOI 10.1016/j.neuropharm.2009.07.015; Claret M, 2007, J CLIN INVEST, V117, P2325, DOI 10.1172/JCI31516; Dhillon SS, 2011, ENDOCRINOLOGY, V152, P4138, DOI 10.1210/en.2011-0178; Ford RJ, 2012, J HYPERTENS, V30, P725, DOI 10.1097/HJH.0b013e32835050ca; Gao S, 2007, P NATL ACAD SCI USA, V104, P17358, DOI 10.1073/pnas.0708385104; Harlan SM, 2011, CIRC RES, V108, P808, DOI 10.1161/CIRCRESAHA.111.240226; Harlan SM, 2011, HYPERTENSION, V57, P627, DOI 10.1161/HYPERTENSIONAHA.110.166538; Haynes WG, 1999, HYPERTENSION, V33, P542, DOI 10.1161/01.HYP.33.1.542; Kumagai H, 2012, HYPERTENS RES, V35, P132, DOI 10.1038/hr.2011.208; Kuo JJ, 2003, HYPERTENSION, V41, P768, DOI 10.1161/01.HYP.0000048194.97428.1A; Lopez M, 2010, NAT MED, V16, P1001, DOI 10.1038/nm.2207; Minokoshi Y, 2004, NATURE, V428, P569, DOI 10.1038/nature02440; Minokoshi Y, 2008, NUTRITION, V24, P786, DOI 10.1016/j.nut.2008.06.002; Niijima A, 1999, NEUROSCI LETT, V262, P125, DOI 10.1016/S0304-3940(99)00054-3; Rahmouni K, 2003, HYPERTENSION, V41, P763, DOI 10.1161/01.HYP.0000048342.54392.40; Rahmouni K, 2005, DIABETES, V54, P2012, DOI 10.2337/diabetes.54.7.2012; Rahmouni K, 2007, HYPERTENSION, V49, P647, DOI 10.1161/01.HYP.0000254827.59792.b2; Rahmouni K, 2009, DIABETES, V58, P536, DOI 10.2337/db08-0822; Shen J, 2007, NEUROSCI LETT, V416, P193, DOI 10.1016/j.neulet.2007.02.003; Tanida M, 2006, LIFE SCI, V78, P1149, DOI 10.1016/j.lfs.2005.05.058; Tanida M, 2011, NEUROSCI LETT, V503, P167, DOI 10.1016/j.neulet.2011.08.013; Tanida M, 2011, NEUROSCI LETT, V491, P211, DOI 10.1016/j.neulet.2011.01.040; Toda C, 2009, DIABETES, V58, P2757, DOI 10.2337/db09-0638; Wang Q, 2009, STROKE, V40, P2157, DOI 10.1161/STROKEAHA.108.541490; Wang SX, 2011, HYPERTENSION, V57, P1010, DOI 10.1161/HYPERTENSIONAHA.110.168906; Yang CS, 2010, DIABETES, V59, P2435, DOI 10.2337/db10-0221; Yasuda T, 2004, EXP BIOL MED, V229, P235, DOI 10.1177/153537020422900303; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0	32	69	70	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e56660	10.1371/journal.pone.0056660	http://dx.doi.org/10.1371/journal.pone.0056660			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418591	Green Published, Green Submitted, gold			2022-12-25	WOS:000315970300184
J	Yu, L; Yuan, X; Wang, D; Barakat, B; Williams, ED; Hannigan, GE				Yu, L.; Yuan, X.; Wang, D.; Barakat, B.; Williams, E. D.; Hannigan, G. E.			Selective regulation of p38 beta protein and signaling by integrin-linked kinase mediates bladder cancer cell migration	ONCOGENE			English	Article						integrin-linked kinase; p38(MAPK) protein kinases; p38 beta isoform; bladder cancer; cell migration; heat shock protein 27	P38-ALPHA MAP KINASE; IN-SITU; PROXIMITY LIGATION; ENDOTHELIAL-CELLS; P38; GROWTH; CARCINOMA; EXPRESSION; ADHESION; ILK	Integrin-linked kinase (ILK) and p38(MAPK) are protein kinases that transduce extracellular signals regulating cell migration and actin cytoskeletal organization. ILK-dependent regulation of p38(MAPK) is critical for mammalian kidney development and in smooth muscle cell migration, however, specific p38 isoforms has not been previously examined in ILK-regulated responses. Signaling by ILK and p38(MAPK) is often dysregulated in bladder cancer, and here we report a strong positive correlation between protein levels of ILK and p38 beta, which is the predominant isoform found in bladder cancer cells, as well as in patient-matched normal bladder and tumor samples. Knockdown by RNA interference of either p38 beta or ILK disrupts serum-induced, Rac1-dependent migration and actin cytoskeletal organization in bladder cancer cells. Surprisingly, ILK knockdown causes the selective reduction in p38 beta cellular protein level, without inhibiting p38 beta messenger RNA (mRNA) expression. The loss of p38 beta protein in ILK-depleted cells is partially rescued by the 26S proteasomal inhibitor MG132. Using co-precipitation and bimolecular fluorescent complementation assays, we find that ILK selectively forms cytoplasmic complexes with p38 beta. In situ proximity ligation assays further demonstrate that serum-stimulated assembly of endogenous ILK-p38 beta complexes is sensitive to QLT-0267, a small molecule ILK kinase inhibitor. Finally, inhibition of ILK reduces the amplitude and period of serum-induced activation of heat shock protein 27 (Hsp27), a target of p38 beta implicated in actin cytoskeletal reorganization. Our work identifies Hsp27 as a novel target of ILK-p38 beta signaling complexes, playing a key role in bladder cancer cell migration.	[Yu, L.; Yuan, X.; Wang, D.; Barakat, B.; Williams, E. D.; Hannigan, G. E.] Monash Univ, Monash Inst Med Res, Ctr Canc Res, Clayton, Vic, Australia; [Yuan, X.] Univ Sch Med, Xinhua Hosp, Dept Clin Lab, Shanghai, Peoples R China	Monash University	Williams, ED (corresponding author), Monash Univ, Monash Inst Med Res, Ctr Canc Res, Clayton, Vic, Australia.	elizabeth.williams@monash.edu; greg.hannigan@monash.edu	Yu, Liang/D-6771-2014; Wang, Die/H-8860-2017; Williams, Elizabeth D/B-1538-2008	Wang, Die/0000-0001-7628-7309; Williams, Elizabeth D/0000-0002-3364-6655	National Health and Medical Research Council of Australia; Victorian Government's Operational Infrastructure Support Program	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Victorian Government's Operational Infrastructure Support Program	We thank Drs Aaron Irving, Dakang Xu and Howard Yim (Centre for Cancer Research, MIMR) for consultation and helpful discussions. Dr S Dedhar (University of British Columbia) kindly provided QLT-0267. This work was supported by grants to GH and EDW from the National Health and Medical Research Council of Australia, with additional support through the Victorian Government's Operational Infrastructure Support Program.	Cabodi S, 2010, NAT REV CANCER, V10, P858, DOI 10.1038/nrc2967; Chaffer CL, 2005, CLIN EXP METASTAS, V22, P115, DOI 10.1007/s10585-005-5141-3; Cornford PA, 2000, CANCER RES, V60, P7099; Coso S, 2011, EXP CELL RES, V317, P2397, DOI 10.1016/j.yexcr.2011.07.023; Coulthard LR, 2009, TRENDS MOL MED, V15, P369, DOI 10.1016/j.molmed.2009.06.005; Cuenda A, 2007, BBA-MOL CELL RES, V1773, P1358, DOI 10.1016/j.bbamcr.2007.03.010; Barrantes IDB, 2011, P NATL ACAD SCI USA, V108, P12764, DOI 10.1073/pnas.1015013108; DJAKIEW D, 1993, CANCER RES, V53, P1416; Dolado I, 2007, CANCER CELL, V11, P191, DOI 10.1016/j.ccr.2006.12.013; Esfandiarei Mitra, 2010, BMC Cell Biol, V11, P16, DOI 10.1186/1471-2121-11-16; Estrada Y, 2009, PIGM CELL MELANOMA R, V22, P66, DOI 10.1111/j.1755-148X.2008.00520.x; Filipenko NR, 2005, ONCOGENE, V24, P5837, DOI 10.1038/sj.onc.1208737; Fukuda T, 2003, J BIOL CHEM, V278, P51324, DOI 10.1074/jbc.M309122200; Gao J, 2011, INT J BIOCHEM CELL B, V43, P1294, DOI 10.1016/j.biocel.2011.05.003; Gao Y, 2004, P NATL ACAD SCI USA, V101, P7618, DOI 10.1073/pnas.0307512101; Hannigan G, 2005, NAT REV CANCER, V5, P51, DOI 10.1038/nrc1524; Hannigan GE, 1996, NATURE, V379, P91, DOI 10.1038/379091a0; Herbsleb M, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-37; Hui LJ, 2007, NAT GENET, V39, P741, DOI 10.1038/ng2033; Irving AT, 2012, IMMUNITY, V36, P795, DOI 10.1016/j.immuni.2012.02.020; Cerezo-Guisado MI, 2011, CARCINOGENESIS, V32, P1093, DOI 10.1093/carcin/bgr079; Jarvius M, 2007, MOL CELL PROTEOMICS, V6, P1500, DOI 10.1074/mcp.M700166-MCP200; Jones TJ, 2012, J CELL PHYSIOL, V227, P70, DOI 10.1002/jcp.22704; Junttila MR, 2007, ONCOGENE, V26, P5267, DOI 10.1038/sj.onc.1210332; Kumar B, 2010, CANCER RES, V70, P832, DOI 10.1158/0008-5472.CAN-09-2918; Leung-Hagesteijn C, 2005, MOL CELL BIOL, V25, P3648, DOI 10.1128/MCB.25.9.3648-3657.2005; Li QX, 2008, J BIOL CHEM, V283, P11014, DOI 10.1074/jbc.M709682200; Lu HZ, 2006, CIRCULATION, V114, P2271, DOI 10.1161/CIRCULATIONAHA.106.642330; Mackinnon AC, 2002, CURR BIOL, V12, P787, DOI 10.1016/S0960-9822(02)00810-2; Matsui Y, 2012, INT J CANCER, V130, P521, DOI 10.1002/ijc.26008; Maydan M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012356; Mongroo PS, 2004, ONCOGENE, V23, P8959, DOI 10.1038/sj.onc.1208112; Montanez E, 2009, EMBO J, V28, P3132, DOI 10.1038/emboj.2009.295; Nakrieko KA, 2008, MOL BIOL CELL, V19, P1462, DOI 10.1091/mbc.E07-06-0526; New L, 2003, MOL BIOL CELL, V14, P2603, DOI 10.1091/mbc.E02-08-0538; New L, 1998, EMBO J, V17, P3372, DOI 10.1093/emboj/17.12.3372; Otto KB, 2011, UROL ONCOL, V30, P415; Qian Y, 2005, ONCOGENE, V24, P3154, DOI 10.1038/sj.onc.1208525; Remy G, 2010, CELL SIGNAL, V22, P660, DOI 10.1016/j.cellsig.2009.11.020; Roussos ET, 2011, NAT REV CANCER, V11, P573, DOI 10.1038/nrc3078; Sakai T, 2003, GENE DEV, V17, P926, DOI 10.1101/gad.255603; Schindler EM, 2009, CANCER RES, V69, P4648, DOI 10.1158/0008-5472.CAN-08-4455; Shyu YJ, 2008, NAT PROTOC, V3, P588, DOI 10.1038/nprot.2008.16; Silva G, 2006, J IMMUNOL, V177, P1894, DOI 10.4049/jimmunol.177.3.1894; Smeeton J, 2010, DEVELOPMENT, V137, P3233, DOI 10.1242/dev.052845; Soderberg O, 2006, NAT METHODS, V3, P995, DOI 10.1038/nmeth947; Song HY, 2006, J CANCER RES CLIN, V132, P92, DOI 10.1007/s00432-005-0044-x; Tan C, 2002, J BIOL CHEM, V277, P3109, DOI 10.1074/jbc.M108673200; Ventura JJ, 2007, NAT GENET, V39, P750, DOI 10.1038/ng2037; Wagner EF, 2009, NAT REV CANCER, V9, P537, DOI 10.1038/nrc2694; Wang AX, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-167; Yong HY, 2009, EXPERT OPIN INV DRUG, V18, P1893, DOI 10.1517/13543780903321490; Zervas CG, 2001, J CELL BIOL, V152, P1007, DOI 10.1083/jcb.152.5.1007; Zhu ZK, 2010, MOL PHARMACEUT, V7, P1283, DOI 10.1021/mp100073s	54	25	26	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 6	2014	33	6					690	701		10.1038/onc.2013.20	http://dx.doi.org/10.1038/onc.2013.20			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AA5IL	23435415				2022-12-25	WOS:000331129200004
J	Haviv, H; Habeck, M; Kanai, R; Toyoshima, C; Karlish, SJD				Haviv, Haim; Habeck, Michael; Kanai, Ryuta; Toyoshima, Chikashi; Karlish, Steven J. D.			Neutral Phospholipids Stimulate Na,K-ATPase Activity A SPECIFIC LIPID-PROTEIN INTERACTION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SARCOPLASMIC-RETICULUM CA2+-ATPASE; SODIUM-POTASSIUM PUMP; MOLECULAR ACTIVITY; CRYSTAL-STRUCTURE; PICHIA-PASTORIS; DIETARY SUPPLEMENTATION; BIOLOGICAL-MEMBRANES; FXYD PROTEINS; STEADY-STATE; NA+,K+-ATPASE	Membrane proteins interact with phospholipids either via an annular layer surrounding the transmembrane segments or by specific lipid-protein interactions. Although specifically bound phospholipids are observed in many crystal structures of membrane proteins, their roles are not well understood. Na,K-ATPase is highly dependent on acid phospholipids, especially phosphatidylserine, and previous work on purified detergent-soluble recombinant Na, K-ATPase showed that phosphatidylserine stabilizes and specifically interacts with the protein. Most recently the phosphatidylserine binding site has been located between transmembrane segments of alpha TM8-10 and the FXYD protein. This paper describes stimulation of Na, K-ATPase activity of the purified human alpha 1 beta 1 or alpha 1 beta 1FXYD1 complexes by neutral phospholipids, phosphatidylcholine, or phosphatidylethanolamine. In the presence of phosphatidylserine, soy phosphatidylcholine increases the Na, K-ATPase turnover rate from 5483 +/- 144 to 7552 +/- 105 (p < 0.0001). Analysis of alpha 1 beta 1FXYD1 complexes prepared with native or synthetic phospholipids shows that the stimulatory effect is structurally selective for neutral phospholipids with polyunsaturated fatty acyl chains, especially dilinoleoyl phosphatidylcholine or phosphatidylethanolamine. By contrast to phosphatidylserine, phosphatidylcholine or phosphatidylethanolamine destabilizes the Na, K-ATPase. Structural selectivity for stimulation of Na, K-ATPase activity and destabilization by neutral phospholipids distinguish these effects from the stabilizing effects of phosphatidylserine and imply that the phospholipids bind at distinct sites. A re-examination of electron densities of shark Na, K-ATPase is consistent with two bound phospholipids located between transmembrane segments alpha TM8-10 and TMFXYD(site A) and between TM2, -4, -6, -and 9 (site B). Comparison of the phospholipid binding pockets in E2 and E1 conformations suggests a possible mechanism of stimulation of Na, K-ATPase activity by the neutral phospholipid.	[Haviv, Haim; Habeck, Michael; Karlish, Steven J. D.] Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel; [Kanai, Ryuta; Toyoshima, Chikashi] Univ Tokyo, Inst Mol & Cellular Biosci, Bungkyo Ku, Tokyo 1130032, Japan	Weizmann Institute of Science; University of Tokyo	Karlish, SJD (corresponding author), Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel.	Steven.Karlish@weizmann.ac.il	Toyoshima, Chikashi/R-4153-2019	Habeck, Michael/0000-0002-4586-0499; Toyoshima, Chikashi/0000-0001-9640-0778	Helen and Milton A. Kimmelman Center for Biomolecular Structure and Assembly, Weizmann Institute	Helen and Milton A. Kimmelman Center for Biomolecular Structure and Assembly, Weizmann Institute	Supported by the Helen and Milton A. Kimmelman Center for Biomolecular Structure and Assembly, Weizmann Institute.	Adamian L, 2011, BBA-BIOMEMBRANES, V1808, P1092, DOI 10.1016/j.bbamem.2010.12.008; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cohen E, 2005, J BIOL CHEM, V280, P16610, DOI 10.1074/jbc.M414290200; Cornelius F, 2003, BIOCHEMISTRY-US, V42, P8541, DOI 10.1021/bi034532e; CORNELIUS F, 1995, BBA-BIOMEMBRANES, V1235, P205, DOI 10.1016/0005-2736(95)80006-2; Cornelius F, 2001, BIOCHEMISTRY-US, V40, P8842, DOI 10.1021/bi010541g; Cornelius F, 2008, BIOCHEMISTRY-US, V47, P1652, DOI 10.1021/bi702128x; DEPONT JJHHM, 1978, BIOCHIM BIOPHYS ACTA, V508, P464, DOI 10.1016/0005-2736(78)90092-5; Else PL, 2003, ANN NY ACAD SCI, V986, P525, DOI 10.1111/j.1749-6632.2003.tb07240.x; Garty H, 2006, ANNU REV PHYSIOL, V68, P431, DOI 10.1146/annurev.physiol.68.040104.131852; Geering K, 2006, AM J PHYSIOL-RENAL, V290, pF241, DOI 10.1152/ajprenal.00126.2005; Geering K, 2008, CURR OPIN NEPHROL HY, V17, P526, DOI 10.1097/MNH.0b013e3283036cbf; Gerbi A, 1997, DIABETOLOGIA, V40, P496, DOI 10.1007/s001250050707; GERBI A, 1993, BIOCHIM BIOPHYS ACTA, V1165, P291, DOI 10.1016/0005-2760(93)90139-Z; Gerbi A, 1998, J NEUROCHEM, V71, P732; Haviv H, 2007, BIOCHEMISTRY-US, V46, P12855, DOI 10.1021/bi701248y; Hayashi Y, 1988, Prog Clin Biol Res, V268A, P205; Hunte C, 2008, CURR OPIN STRUC BIOL, V18, P406, DOI 10.1016/j.sbi.2008.03.008; Jorgensen PL, 2003, ANNU REV PHYSIOL, V65, P817, DOI 10.1146/annurev.physiol.65.092101.142558; JORGENSEN PL, 1988, METHOD ENZYMOL, V156, P29; Kaplan JH, 2002, ANNU REV BIOCHEM, V71, P511, DOI 10.1146/annurev.biochem.71.102201.141218; Kapri-Pardes E, 2011, J BIOL CHEM, V286, P42888, DOI 10.1074/jbc.M111.293852; Katz A, 2010, J BIOL CHEM, V285, P19582, DOI 10.1074/jbc.M110.119248; Lee AG, 2004, BBA-BIOMEMBRANES, V1666, P62, DOI 10.1016/j.bbamem.2004.05.012; Lee AG, 2003, BBA-BIOMEMBRANES, V1612, P1, DOI 10.1016/S0005-2736(03)00056-7; Lee AG, 2011, TRENDS BIOCHEM SCI, V36, P493, DOI 10.1016/j.tibs.2011.06.007; Lifshitz Y, 2007, BIOCHEMISTRY-US, V46, P14937, DOI 10.1021/bi701812c; Marsh D, 2008, BBA-BIOMEMBRANES, V1778, P1545, DOI 10.1016/j.bbamem.2008.01.015; Mishra NK, 2011, J BIOL CHEM, V286, P9699, DOI 10.1074/jbc.M110.184234; Moller JV, 2005, CURR OPIN STRUC BIOL, V15, P387, DOI 10.1016/j.sbi.2005.06.005; Morth JP, 2007, NATURE, V450, P1043, DOI 10.1038/nature06419; Obara K, 2005, P NATL ACAD SCI USA, V102, P14489, DOI 10.1073/pnas.0506222102; Ogawa H, 2009, P NATL ACAD SCI USA, V106, P13742, DOI 10.1073/pnas.0907054106; Olesen C, 2007, NATURE, V450, P1036, DOI 10.1038/nature06418; Palmgren MG, 2011, ANNU REV BIOPHYS, V40, P243, DOI 10.1146/annurev.biophys.093008.131331; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Shinoda T, 2009, NATURE, V459, P446, DOI 10.1038/nature07939; Strugatsky D, 2003, J BIOL CHEM, V278, P46064, DOI 10.1074/jbc.M308303200; Toyoshima C, 2004, NATURE, V432, P361, DOI 10.1038/nature02981; Toyoshima C, 2008, ARCH BIOCHEM BIOPHYS, V476, P3, DOI 10.1016/j.abb.2008.04.017; Toyoshima C, 2011, STRUCTURE, V19, P1732, DOI 10.1016/j.str.2011.10.016; Toyoshima C, 2011, P NATL ACAD SCI USA, V108, P1833, DOI 10.1073/pnas.1017659108; Toyoshima C, 2009, BBA-MOL CELL RES, V1793, P941, DOI 10.1016/j.bbamcr.2008.10.008; Turner N, 2003, NATURWISSENSCHAFTEN, V90, P521, DOI 10.1007/s00114-003-0470-z; Turner N, 2006, PHYSIOL BIOCHEM ZOOL, V79, P522, DOI 10.1086/502815; WHEELER KP, 1970, J PHYSIOL-LONDON, V207, P303, DOI 10.1113/jphysiol.1970.sp009063; Winther AML, 2010, J BIOL CHEM, V285, P28883, DOI 10.1074/jbc.M110.136242; Yatime L, 2011, J STRUCT BIOL, V174, P296, DOI 10.1016/j.jsb.2010.12.004; YEAGLE PL, 1988, BIOCHEMISTRY-US, V27, P6449, DOI 10.1021/bi00417a037	49	35	39	0	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 5	2013	288	14					10073	10081		10.1074/jbc.M112.446997	http://dx.doi.org/10.1074/jbc.M112.446997			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	119RB	23430748	Green Published, hybrid			2022-12-25	WOS:000317114000045
J	Chattopadhyay, S; Basak, T; Nayak, MK; Bhardwaj, G; Mukherjee, A; Bhowmick, R; Sengupta, S; Chakrabarti, O; Chatterjee, NS; Chawla-Sarkar, M				Chattopadhyay, Shiladitya; Basak, Trayambak; Nayak, Mukti Kant; Bhardwaj, Gourav; Mukherjee, Anupam; Bhowmick, Rahul; Sengupta, Shantanu; Chakrabarti, Oishee; Chatterjee, Nabendu S.; Chawla-Sarkar, Mamta			Identification of Cellular Calcium Binding Protein Calmodulin as a Regulator of Rotavirus A Infection during Comparative Proteomic Study	PLOS ONE			English	Article							INTESTINAL EPITHELIAL-CELLS; MAJOR CAPSID PROTEIN; VP6 PROTEIN; IN-VITRO; EXPRESSION; INCREASE; ASSAY; NEUTRALIZATION; MECHANISMS; INHIBITION	Rotavirus (RV) being the major diarrhoegenic virus causes around 527000 children death (< 5years age) worldwide. In cellular environment, viruses constantly adapt and modulate to survive and replicate while the host cell also responds to combat the situation and this results in the differential regulation of cellular proteins. To identify the virus induced differential expression of proteins, 2D-DIGE (Two-dimensional Difference Gel Electrophoresis) based proteomics was used. For this, HT-29 cells were infected with RV strain SA11 for 0 hours, 3 hours and 9 hours post infection (hpi), differentially expressed spots were excised from the gel and identified using MALDI-TOF/TOF mass spectrometry. 2D-DIGE based proteomics study identified 32 differentially modulated proteins, of which 22 were unique. Some of these were validated in HT-29 cell line and in BALB/c mice model. One of the modulated cellular proteins, calmodulin (CaM) was found to directly interact with RV protein VP6 in the presence of Ca2+. Ca2+-CaM/VP6 interaction positively regulates RV propagation since both CaM inhibitor (W-7) and Ca2+ chelator (BAPTA-AM) resulted in decreased viral titers. This study not only identifies differentially modulated cellular proteins upon infection with rotavirus in 2D-DIGE but also confirmed positive engagement of cellular Ca2+/CaM during viral pathogenesis.	[Chattopadhyay, Shiladitya; Mukherjee, Anupam; Bhowmick, Rahul; Chawla-Sarkar, Mamta] Natl Inst Cholera & Enter Dis, Div Virol, Kolkata, W Bengal, India; [Basak, Trayambak; Bhardwaj, Gourav] CSIR Inst Genom & Integrat Biol, Delhi, India; [Nayak, Mukti Kant; Sengupta, Shantanu] Univ Calcutta, Dept Zool, Kolkata, W Bengal, India; [Chakrabarti, Oishee] Saha Inst Nucl Phys, Struct Genom Sect, Kolkata, W Bengal, India; [Chatterjee, Nabendu S.] Natl Inst Cholera & Enter Dis, Div Biochem, Kolkata, W Bengal, India	Indian Council of Medical Research (ICMR); ICMR - National Institute of Cholera & Enteric Diseases (NICED); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Genomics & Integrative Biology (IGIB); University of Calcutta; Saha Institute of Nuclear Physics; Indian Council of Medical Research (ICMR); ICMR - National Institute of Cholera & Enteric Diseases (NICED)	Chawla-Sarkar, M (corresponding author), Natl Inst Cholera & Enter Dis, Div Virol, Kolkata, W Bengal, India.	chawlam70@gmail.com	Basak, Trayambak/AAB-8534-2020; Bhowmick, Rahul/AAD-4433-2022; Mukherjee, Anupam/ABB-9438-2020; Bhardwaj, Gourav/L-1746-2019	Bhowmick, Rahul/0000-0002-5412-1209; Mukherjee, Anupam/0000-0002-0612-2258; Bhardwaj, Gourav/0000-0002-9543-8237; Basak, Trayambak/0000-0001-7683-3189	Indian Council of Medical Research (ICMR); Okayama University, Japan; Dr. D.S. Kothari Postdoctoral Research Fellowship (UGC)	Indian Council of Medical Research (ICMR)(Indian Council of Medical Research (ICMR)); Okayama University, Japan; Dr. D.S. Kothari Postdoctoral Research Fellowship (UGC)	Financial assistance and support from Indian Council of Medical Research (ICMR) and Okayama University, Japan are acknowledged. The authors are thankful to CSIR-IGIB for their generous support. MKN is financially supported by Dr. D.S. Kothari Postdoctoral Research Fellowship (UGC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adebiyi A, 2011, J BIOL CHEM, V286, P4341, DOI 10.1074/jbc.M110.179747; Albrecht D, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-32; Anonymous, 2008, Morbidity and Mortality Weekly Report, V57, P1255; Bagchi P, 2012, VIRUS RES, V169, P144, DOI 10.1016/j.virusres.2012.07.021; Bagchi P, 2010, J VIROL, V84, P6834, DOI 10.1128/JVI.00225-10; Banos DM, 1997, J VIROL, V71, P419; Barro M, 2007, J VIROL, V81, P4473, DOI 10.1128/JVI.02498-06; Bhowmick R, 2012, J BIOL CHEM, V287, P35004, DOI 10.1074/jbc.M112.369595; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brunet JP, 2000, J VIROL, V74, P10801, DOI 10.1128/JVI.74.22.10801-10806.2000; Brunet JP, 2000, J VIROL, V74, P2323, DOI 10.1128/JVI.74.5.2323-2332.2000; BUTTKE TM, 1993, J IMMUNOL METHODS, V157, P233, DOI 10.1016/0022-1759(93)90092-L; Campagna M, 2012, J VIROL IN PRESS; CARPIO M, 1981, CAN J COMP MED, V45, P38; Chaplin PJ, 1996, J INTERF CYTOK RES, V16, P25, DOI 10.1089/jir.1996.16.25; Chawla-Sarkar M, 2004, CELL DEATH DIFFER, V11, P915, DOI 10.1038/sj.cdd.4401416; Chin D, 2000, TRENDS CELL BIOL, V10, P322, DOI 10.1016/S0962-8924(00)01800-6; Choi J, 2006, CELL CYCLE, V5, P2183, DOI 10.4161/cc.5.19.3265; Crawford SE, 2012, P NATL ACAD IN PRESS; Cuadras MA, 2002, J VIROL, V76, P4467, DOI 10.1128/JVI.76.9.4467-4482.2002; Dhillon NK, 2003, LETT APPL MICROBIOL, V36, P382, DOI 10.1046/j.1472-765X.2003.01324.x; Dutta D, 2011, J BIOL CHEM, V286, P20065, DOI 10.1074/jbc.M111.231878; Dutta D, 2009, VIROLOGY, V391, P325, DOI 10.1016/j.virol.2009.06.044; Estes MK, 2007, FIELDS VIROLOGY, P1917; FORMAL SB, 1961, BRIT J EXP PATHOL, V42, P504; FRANCO MA, 1994, J GEN VIROL, V75, P589, DOI 10.1099/0022-1317-75-3-589; Garaicoechea L, 2008, J VIROL, V82, P9753, DOI 10.1128/JVI.00436-08; GINN DI, 1992, J GEN VIROL, V73, P3017, DOI 10.1099/0022-1317-73-11-3017; Graff JW, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000280; Holloway G, 2006, J VIROL, V80, P10624, DOI 10.1128/JVI.00390-06; Holloway G, 2009, J VIROL, V83, P4942, DOI 10.1128/JVI.01450-08; Hoshino Y, 2000, J HEALTH POPUL NUTR, V18, P5; IKURA M, 1992, SCIENCE, V256, P632, DOI 10.1126/science.1585175; Jain V, 2001, J CLIN MICROBIOL, V39, P3524, DOI 10.1128/JCM.39.10.3524-3529.2001; Joyal JL, 1997, J BIOL CHEM, V272, P28183, DOI 10.1074/jbc.272.45.28183; Jurado LA, 1999, PHYSIOL REV, V79, P661, DOI 10.1152/physrev.1999.79.3.661; Kahl CR, 2003, ENDOCR REV, V24, P719, DOI 10.1210/er.2003-0008; KALICA AR, 1981, VIROLOGY, V112, P385, DOI 10.1016/0042-6822(81)90285-3; KAPIKIAN AZ, 1981, INFECT IMMUN, V33, P415, DOI 10.1128/IAI.33.2.415-425.1981; McNeal MM, 2007, VIRAL IMMUNOL, V20, P571, DOI 10.1089/vim.2007.0055; MEADOR WE, 1992, SCIENCE, V257, P1251, DOI 10.1126/science.1519061; Murthy AK, 2004, CELL IMMUNOL, V230, P56, DOI 10.1016/j.cellimm.2004.09.002; NISHIKAWA M, 1980, NATURE, V287, P863, DOI 10.1038/287863a0; Pammit MA, 2004, ANTIMICROB AGENTS CH, V48, P4513, DOI 10.1128/AAC.48.12.4513-4519.2004; Parez N, 2004, J VIROL, V78, P12489, DOI 10.1128/JVI.78.22.12489-12496.2004; Perez JF, 1998, VIROLOGY, V252, P17, DOI 10.1006/viro.1998.9433; Ponnudurai RP, 2012, J PROTEOMICS, V75, P1004, DOI 10.1016/j.jprot.2011.10.016; RASMUSSEN CD, 1992, CELL MOTIL CYTOSKEL, V21, P45, DOI 10.1002/cm.970210106; Rhoads AR, 1997, FASEB J, V11, P331, DOI 10.1096/fasebj.11.5.9141499; Rollo EE, 1999, J IMMUNOL, V163, P4442; Rossen JWA, 2004, J VIROL, V78, P9721, DOI 10.1128/JVI.78.18.9721-9730.2004; Saha A, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001275; SAKAGUCHI T, 1988, J CLIN MICROBIOL, V26, P600, DOI 10.1128/JCM.26.3.600-601.1988; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Sen A, 2009, J VIROL, V83, P10322, DOI 10.1128/JVI.01186-09; SMITH EM, 1979, J GEN VIROL, V43, P513, DOI 10.1099/0022-1317-43-3-513; Tsunemitsu H, 2005, J GEN VIROL, V86, P2569, DOI 10.1099/vir.0.80938-0; Wang JF, 2011, BLOOD, V117, P1260, DOI 10.1182/blood-2010-06-289215; Xu AM, 1998, J VIROL, V72, P9865, DOI 10.1128/JVI.72.12.9865-9872.1998; Xu AM, 1999, BIOCHEM J, V342, P683, DOI 10.1042/0264-6021:3420683; Yadav AK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024442; Yamniuk AP, 2004, MOL BIOTECHNOL, V27, P33, DOI 10.1385/MB:27:1:33; Yap Kyoko L., 2000, Journal of Structural and Functional Genomics, V1, P8, DOI 10.1023/A:1011320027914; Zambrano JL, 2011, VIROL J, V20, P348; Zhang MJ, 1998, BIOCHEM CELL BIOL, V76, P313, DOI 10.1139/bcb-76-2-3-313	66	26	26	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e56655	10.1371/journal.pone.0056655	http://dx.doi.org/10.1371/journal.pone.0056655			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437200	Green Submitted, Green Published, gold			2022-12-25	WOS:000315184200130
J	Chen, P; Yu, CB; Ruan, B; Yang, SG; Ren, JJ; Xu, WJ; Luo, ZB; Li, LJ				Chen, Ping; Yu, Chengbo; Ruan, Bing; Yang, Shigui; Ren, Jingjing; Xu, Weijian; Luo, Zhuanbo; Li, Lanjuan			Prevalence of Hepatitis B in Insular Regions of Southeast China: A Community-Based Study	PLOS ONE			English	Article							C VIRUS-INFECTIONS; HEPATOCELLULAR-CARCINOMA; DISEASE BURDEN; HBSAG-CARRIERS; POPULATION; RISK; JAPAN; HBEAG	Objective: Hepatitis B virus (HBV) infection remains a significant public health problem. The purpose of this study was to investigate the seroepidemiology of HBV in people living in the insular regions, and to provide the most recent baseline data for planning and monitoring of health. Methods: A cross-sectional, community-based survey was conducted without age restriction, on two isolated islands, Zhoushan and Yuhuan, China. The study sample was selected by random multistage cluster sampling. Serological samples and demographic information were collected from 15878 participants. Results: The prevalences of anti-HBV core antibody (anti-HBc), hepatitis B virus surface antigen (HBsAg), and anti-HBV surface antibody (anti-HBs) were 33.1, 10.4, and 56.1%, respectively. We found statistically significant differences of HBV markers in men versus women (P < 0.01). The prevalence of HBV infection increased with age. There were significant differences in the rates of HBsAg and anti-HBc positivity between the two islands (P, 0.01). Alanine aminotransferase (ALT) levels were elevated (>38 IU/L) in 15.6% and 7.2% of the HBsAg-positive and negative groups, respectively. Elevated ALT levels were significantly higher in males (12.0%) compared with females (5.8%) (P, 0.01). The alpha-fetoprotein (AFP) positivity rate was 0.6% in HBsAg-positive participants over the age of 30. Conclusion: Due to the geographic location, we found that the HBV prevalence and potential for the development of hepatocellular carcinoma remained high in insular regions of southeast China, and are far above the national figures. Although a vaccination program has been in effect over the last 20 years, several additional measures should be adopted by the government to limit the spread of hepatitis B. These include the management of high risk persons and the floating population living on the islands, expansion of the immune population, and increased health education for fisherman.	[Chen, Ping; Yu, Chengbo; Ruan, Bing; Yang, Shigui; Ren, Jingjing; Luo, Zhuanbo; Li, Lanjuan] Zhejiang Univ, Sch Med, Affiliated Hosp 1, State Key Lab Diag & Treatment Infect Dis,Key Lab, Hangzhou 310003, Zhejiang, Peoples R China; [Xu, Weijian] Zhejiang Univ, Sch Med, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University	Li, LJ (corresponding author), Zhejiang Univ, Sch Med, Affiliated Hosp 1, State Key Lab Diag & Treatment Infect Dis,Key Lab, Hangzhou 310003, Zhejiang, Peoples R China.	ljli@zju.edu.cn			National Scientific and Technological Major Project of China [2009ZX10004-901, 2011ZX10004-901]	National Scientific and Technological Major Project of China	This study was funded by the National Scientific and Technological Major Project of China (Grant No. 2009ZX10004-901,2011ZX10004-901). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andre F, 2000, VACCINE, V18, pS20, DOI 10.1016/S0264-410X(99)00456-9; Bwogi J, 2009, AFR HEALTH SCI, V9, P98; Chen K, 2009, ZHEJINAGPREV MED, V5, P1; Chen YS, 2007, CHIN J EXP CLIN INFE, V1, P5; CHU CM, 1993, CLIN INFECT DIS, V16, P709, DOI 10.1093/clind/16.5.709; Cui FQ, 2007, CHIN J VACCINES IMMU, V13, P1; Fu YX, 2002, ZHEJINAGPREV MED, V3, P49; Ganem D, 2004, NEW ENGL J MED, V350, P1118, DOI 10.1056/NEJMra031087; Gogos CA, 2003, EUR J EPIDEMIOL, V18, P551, DOI 10.1023/A:1024698715741; Goldstein ST, 2005, INT J EPIDEMIOL, V34, P1329, DOI 10.1093/ije/dyi206; HAYASHI J, 1988, MICROBIOL IMMUNOL, V32, P843, DOI 10.1111/j.1348-0421.1988.tb01445.x; Ishiguro S, 2009, EUR J CANCER PREV, V18, P26, DOI 10.1097/CEJ.0b013e3282fa9edd; Li Q, 2008, ZHEJIANG J PREVENTIV, V12, P18; Liang XF, 2009, VACCINE, V27, P6550, DOI 10.1016/j.vaccine.2009.08.048; Liu J, 2007, LANCET, V369, P1582, DOI 10.1016/S0140-6736(07)60723-5; Luo ZB, 2011, EUR J GASTROEN HEPAT, V23, P695, DOI 10.1097/MEG.0b013e328347322b; Nguyen VTT, 2009, J VIRAL HEPATITIS, V16, P453, DOI 10.1111/j.1365-2893.2009.01117.x; Nguyen VTT, 2007, J GASTROEN HEPATOL, V22, P2093, DOI 10.1111/j.1440-1746.2007.05010.x; Pereira LMMB, 2009, AM J TROP MED HYG, V81, P240; Shi J, 2005, BRIT J CANCER, V92, P607, DOI 10.1038/sj.bjc.6602333; Statistics ZPBo, 2011, MAIN DAT B 6 NAT CEN; Tang A, 2007, STRAIT J PREVENTIVE, V6, P43; Torpy Janet M, 2011, JAMA, V305, P1500, DOI 10.1001/jama.305.14.1500; Wang CS, 2002, AM J TROP MED HYG, V66, P389, DOI 10.4269/ajtmh.2002.66.389; [王鸣 WANG Ming], 2009, [中华流行病学杂志, Chinese Journal of Epidemiology], V30, P1317; Wu Jiang, 2007, Zhonghua Liu Xing Bing Xue Za Zhi, V28, P555; Xia GL, 1996, INT HEPATOL COMMUN, V5, P62, DOI 10.1016/S0928-4346(96)82012-3; Yang SG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047808; Yao J, 2004, B CHINESE FDN HEPATI; Yao J, 2006, CHIN J VACCINE IMMUN, V6, P132; Yu AJ, 1997, SCI TRAVEL MED, V1, P14	31	29	31	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e56444	10.1371/journal.pone.0056444	http://dx.doi.org/10.1371/journal.pone.0056444			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437134	Green Submitted, Green Published, gold			2022-12-25	WOS:000315184200075
J	Datta, S; Mukhopadhyay, S				Datta, Sutapa; Mukhopadhyay, Subhasis			A Composite Method Based on Formal Grammar and DNA Structural Features in Detecting Human Polymerase II Promoter Region	PLOS ONE			English	Article							CONTEXT-FREE GRAMMARS; CORE PROMOTER; REGULATORY ELEMENTS; GENE MARKERS; CPG ISLANDS; PREDICTION; RNA; IDENTIFICATION; LANGUAGE; SEQUENCES	An important step in understanding gene regulation is to identify the promoter regions where the transcription factor binding takes place. Predicting a promoter region de novo has been a theoretical goal for many researchers for a long time. There exists a number of in silico methods to predict the promoter region de novo but most of these methods are still suffering from various shortcomings, a major one being the selection of appropriate features of promoter region distinguishing them from non-promoters. In this communication, we have proposed a new composite method that predicts promoter sequences based on the interrelationship between structural profiles of DNA and primary sequence elements of the promoter regions. We have shown that a Context Free Grammar (CFG) can formalize the relationships between different primary sequence features and by utilizing the CFG, we demonstrate that an efficient parser can be constructed for extracting these relationships from DNA sequences to distinguish the true promoter sequences from non-promoter sequences. Along with CFG, we have extracted the structural features of the promoter region to improve upon the efficiency of our prediction system. Extensive experiments performed on different datasets reveals that our method is effective in predicting promoter sequences on a genome-wide scale and performs satisfactorily as compared to other promoter prediction techniques.	[Datta, Sutapa] Univ Calcutta, Dept Biophys Mol Biol & Bioinformat, Kolkata, W Bengal, India; Univ Calcutta, Distributed Informat Ctr Bioinformat, Kolkata, W Bengal, India	University of Calcutta; University of Calcutta	Datta, S (corresponding author), Univ Calcutta, Dept Biophys Mol Biol & Bioinformat, Kolkata, W Bengal, India.	sutapadatta2005@gmail.com			Department of Biotechnology, Government of India [BT/BI/04/001/93, BT/BI/10/019/99]	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India)	Financial support was received from the Department of Biotechnology, Government of India, grant no. BT/BI/04/001/93 and BT/BI/10/019/99 (http://dbtindia.nic.in). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abeel T, 2008, BIOINFORMATICS, V24, pI24, DOI 10.1093/bioinformatics/btn172; Abeel T, 2008, GENOME RES, V18, P310, DOI 10.1101/gr.6991408; Bajic VB, 2004, NAT BIOTECHNOL, V22, P1467, DOI 10.1038/nbt1032; Bajic VB, 2003, NUCLEIC ACIDS RES, V31, P3560, DOI 10.1093/nar/gkg570; Bajic VB, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-s1-s3; Bajic VB, 2006, PLOS GENET, V2, P614, DOI 10.1371/journal.pgen.0020054; Baldi P, 1998, Proc Int Conf Intell Syst Mol Biol, V6, P35; Bianchi D, 1996, P 1 ONL WORKSH SOFT, P113; BIRD AP, 1987, EMBO J, V6, P999, DOI 10.1002/j.1460-2075.1987.tb04851.x; Burden S, 2005, BIOINFORMATICS, V21, P601, DOI 10.1093/bioinformatics/bti047; Cai Y, 2007, BIOINFORMATICS, V23, P2760, DOI 10.1093/bioinformatics/btm446; Carninci P, 2006, NAT GENET, V38, P626, DOI 10.1038/ng1789; Choi CH, 2004, NUCLEIC ACIDS RES, V32, P1584, DOI 10.1093/nar/gkh335; COLLADOVIDES J, 1992, P NATL ACAD SCI USA, V89, P9405, DOI 10.1073/pnas.89.20.9405; Cross SH, 1999, NUCLEIC ACIDS RES, V27, P2099, DOI 10.1093/nar/27.10.2099; Damasevicius R, 2010, NEUROCOMPUTING, V73, P633, DOI 10.1016/j.neucom.2009.09.018; Davuluri RV, 2001, NAT GENET, V29, P412, DOI 10.1038/ng780; Down TA, 2002, GENOME RES, V12, P458, DOI 10.1101/gr.216102; Dyrka W, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-323; Florquin K, 2005, NUCLEIC ACIDS RES, V33, P4255, DOI 10.1093/nar/gki737; Fujita PA, 2011, NUCLEIC ACIDS RES, V39, pD876, DOI 10.1093/nar/gkq963; Gan YL, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-4; Gan YL, 2009, BIOINFORMATICS, V25, P2006, DOI 10.1093/bioinformatics/btp359; GARDINERGARDEN M, 1987, J MOL BIOL, V196, P261, DOI 10.1016/0022-2836(87)90689-9; Goni JR, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-12-r263; Hannenhalli S, 2001, Bioinformatics, V17 Suppl 1, pS90; Ioshikhes IP, 2000, NAT GENET, V26, P61, DOI 10.1038/79189; Karolchik D, 2004, NUCLEIC ACIDS RES, V32, pD493, DOI 10.1093/nar/gkh103; Knudsen B, 2003, NUCLEIC ACIDS RES, V31, P3423, DOI 10.1093/nar/gkg614; Knudsen B, 1999, BIOINFORMATICS, V15, P446, DOI 10.1093/bioinformatics/15.6.446; LARSEN F, 1992, GENOMICS, V13, P1095, DOI 10.1016/0888-7543(92)90024-M; Leung SW, 2001, BIOINFORMATICS, V17, P226, DOI 10.1093/bioinformatics/17.3.226; Liao GC, 2000, P NATL ACAD SCI USA, V97, P3347, DOI 10.1073/pnas.050017397; Liu RX, 2002, GENOME RES, V12, P462, DOI 10.1101/gr.198002; Loose C, 2006, NATURE, V443, P867, DOI 10.1038/nature05233; Maston GA, 2006, ANNU REV GENOM HUM G, V7, P29, DOI 10.1146/annurev.genom.7.080505.115623; Ohler U, 2002, GENOME BIOL, V3, DOI [10.1186/gb-2002-3-12-research0087, DOI 10.1186/GB-2002-3-12-RESEARCH0087]; Ohler U, 2006, NUCLEIC ACIDS RES, V34, P5943, DOI 10.1093/nar/gkl608; Park Hyun-Seok, 2011, Genomics & Informatics, V9, P5; Pedersen AG, 1999, COMPUT CHEM, V23, P191, DOI 10.1016/S0097-8485(99)00015-7; Rivas E, 2000, BIOINFORMATICS, V16, P334, DOI 10.1093/bioinformatics/16.4.334; Rombauts S, 2003, PLANT PHYSIOL, V132, P1162, DOI 10.1104/pp.102.017715; Sakakibara Y, 2005, IEEE T PATTERN ANAL, V27, P1051, DOI 10.1109/TPAMI.2005.140; SAKAKIBARA Y, 1994, NUCLEIC ACIDS RES, V22, P5112, DOI 10.1093/nar/22.23.5112; Scherf M, 2000, J MOL BIOL, V297, P599, DOI 10.1006/jmbi.2000.3589; Searls DB, 1997, COMPUT APPL BIOSCI, V13, P333; Searls DB, 2002, NATURE, V420, P211, DOI 10.1038/nature01255; Smale ST, 2003, ANNU REV BIOCHEM, V72, P449, DOI 10.1146/annurev.biochem.72.121801.161520; Solovyev VV, 2003, NUCLEIC ACIDS RES, V31, P3540, DOI 10.1093/nar/gkg525; Sonnenburg S, 2006, BIOINFORMATICS, V22, pE472, DOI 10.1093/bioinformatics/btl250; Tsafnat G, 2011, BIOINFORMATICS, V27, P791, DOI 10.1093/bioinformatics/btr036; Zeng J, 2009, BRIEF BIOINFORM, V10, P498, DOI 10.1093/bib/bbp027	53	9	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e54843	10.1371/journal.pone.0054843	http://dx.doi.org/10.1371/journal.pone.0054843			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437045	gold, Green Published, Green Submitted			2022-12-25	WOS:000315184200010
J	Lei, XH; Bochner, BR				Lei, Xiang-He; Bochner, Barry R.			Using Phenotype MicroArrays to Determine Culture Conditions That Induce or Repress Toxin Production by Clostridium difficile and Other Microorganisms	PLOS ONE			English	Article							INTESTINAL EPITHELIAL-CELLS; BIOTIN-LIMITED CONDITIONS; PSEUDOMEMBRANOUS COLITIS; COLORIMETRIC ASSAY; ESCHERICHIA-COLI; GENE-EXPRESSION; RHO-PROTEINS; SIGMA-FACTOR; RIBOTYPE 027; INFECTION	Toxin production is a central issue in the pathogenesis of Clostridium difficile and many other pathogenic microorganisms. Toxin synthesis is influenced by a variety of known and unknown factors of genetics, physiology, and environment. To facilitate the study of toxin production by C. difficile, we have developed a new, reliable, quantitative, and robust cell-based cytotoxicity assay. Then we combined this new assay with Phenotype MicroArrays (PM) technology which provides high throughput testing of culture conditions. This allowed us to quantitatively measure toxin production by C. difficile type strain ATCC 9689 under 768 culture conditions. The culture conditions include different carbon, nitrogen, phosphorus, and sulfur sources. Among these, 89 conditions produced strong toxin induction and 31 produced strong toxin repression. Strong toxin inducers included adenine, guanosine, arginine dipeptides, gamma-D-Glu-Gly, methylamine, and others. Some leucine dipeptides and the triple-leucine tripeptide were among the strongest toxin repressors. While some results are consistent with previous observations, others are new observations that provide insights into toxin regulation and pathogenesis of C. difficile. Additionally, we have demonstrated that this combined assay technology can be applied broadly to a wide range of toxin producing microorganisms. This study is the first demonstration of simultaneous assessment of a large number of culture conditions influencing bacterial toxin production. The new functional cytotoxin quantitation method developed provides a valuable tool for studying toxigenic microorganisms and may also find applications in clinical and epidemiological research.	[Lei, Xiang-He; Bochner, Barry R.] Biolog Inc, Hayward, CA 94545 USA		Lei, XH (corresponding author), Biolog Inc, Hayward, CA 94545 USA.	xlei@biolog.com			National Institute of Health (NIH) STTR Grant [GM073965]; Biolog Inc.; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R41GM073965, R42GM073965] Funding Source: NIH RePORTER	National Institute of Health (NIH) STTR Grant; Biolog Inc.; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Principal funding for the research at Biolog was provided by National Institute of Health (NIH) STTR Grant GM073965. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was partly funded by Biolog Inc. Xiang-He Lei is employed by Biolog Inc. Barry Bochner is the CEO and CSO of Biolog Inc., has ownership of stock and made the decision to publish the manuscript. Patents 6,271,022, 6,387,651, 6,436,631, 6,472,201, 6,686,173, 6,696,239 and 6,727,076 have been issued to Biolog, Inc., and the Phenotype MicroArrays described in this manuscript are produced and marketed by Biolog, Inc. There are no further patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors. The authors include the names of the patents ( Journal requirement 3) as follows: 6,271,022: Device for Incubating and Monitoring Multiwell Assays; 6,387,651: Comparative Phenotype Analysis of Two or More Microorganisms Using a Plurality of Substrates within a Microwell Device; 6,436,631: Comparative Phenotype Analysis for Assessment of Biological Active Compounds such as Antimicrobials; 6,472,201: Comparative Phenotype Analysis; 6,686,173: Comparative Phenotype Analysis of Two or More Microorganisms Using a Plurality of Substrates within a Multiwell Testing Device; 6,696,239: Comparative Phenotype Analysis for Assessment of Biological Active Compounds such as Antimicrobials; 6,727,076: Comparative Phenotype Analysis.	Ananthakrishnan AN, 2011, NAT REV GASTRO HEPAT, V8, P17, DOI 10.1038/nrgastro.2010.190; Antunes A, 2011, MOL MICROBIOL, V79, P882, DOI 10.1111/j.1365-2958.2010.07495.x; ARONSSON B, 1981, MED MICROBIOL IMMUN, V170, P27, DOI 10.1007/BF02123794; BARTLETT JG, 1978, GASTROENTEROLOGY, V75, P778; Bochner BR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018147; Bochner BR, 2009, FEMS MICROBIOL REV, V33, P191, DOI 10.1111/j.1574-6976.2008.00149.x; Bochner BR, 2003, NAT REV GENET, V4, P309, DOI 10.1038/nrg1046; Bochner BR, 2001, GENOME RES, V11, P1246, DOI 10.1101/gr.186501; BONGAERTS GPA, 1994, MICROB PATHOGENESIS, V17, P1, DOI 10.1006/mpat.1994.1047; Bouvet PJM, 2008, J CLIN MICROBIOL, V46, P3703, DOI 10.1128/JCM.00866-08; CHANG TW, 1978, INFECT IMMUN, V20, P526, DOI 10.1128/IAI.20.2.526-529.1978; CHUNG WB, 1993, CAN J VET RES, V57, P159; Cloud J, 2009, CLIN GASTROENTEROL H, V7, P868, DOI 10.1016/j.cgh.2009.05.018; Curry SR, 2007, J CLIN MICROBIOL, V45, P215, DOI 10.1128/JCM.01599-06; CZUPRYNSKI CJ, 1983, INFECT IMMUN, V39, P1368, DOI 10.1128/IAI.39.3.1368-1376.1983; Dineen SS, 2007, MOL MICROBIOL, V66, P206, DOI 10.1111/j.1365-2958.2007.05906.x; Dineen SS, 2010, J BACTERIOL, V192, P5350, DOI 10.1128/JB.00341-10; Dupuy B, 2008, J MED MICROBIOL, V57, P685, DOI 10.1099/jmm.0.47775-0; Dupuy B, 1998, MOL MICROBIOL, V27, P107, DOI 10.1046/j.1365-2958.1998.00663.x; Egerer M, 2007, J BIOL CHEM, V282, P25314, DOI 10.1074/jbc.M703062200; Egerer M, 2009, J BIOL CHEM, V284, P3389, DOI 10.1074/jbc.M806002200; FLORIN I, 1981, INFECT IMMUN, V33, P67, DOI 10.1128/IAI.33.1.67-74.1981; Gardiner DM, 2009, MICROBIOL-SGM, V155, P3149, DOI 10.1099/mic.0.029546-0; Gardiner DM, 2009, FUNGAL GENET BIOL, V46, P604, DOI 10.1016/j.fgb.2009.04.004; GEORGE WL, 1978, LANCET, V1, P802; Gerhard R, 2008, J MED MICROBIOL, V57, P765, DOI 10.1099/jmm.0.47769-0; Goldblith S. A., 1961, ANAL HUMAN FECAL COM; Goldenberg SD, 2011, J INFECTION, V62, P355, DOI 10.1016/j.jinf.2011.03.001; HAMMOND GA, 1995, MICROB PATHOGENESIS, V19, P203, DOI 10.1016/S0882-4010(95)90263-5; HASLAM SC, 1986, J MED MICROBIOL, V21, P293, DOI 10.1099/00222615-21-4-293; He M, 2010, P NATL ACAD SCI USA, V107, P7527, DOI 10.1073/pnas.0914322107; Hussack G, 2010, TOXINS, V2, P998, DOI 10.3390/toxins2050998; JUST I, 1994, J BIOL CHEM, V269, P10706; JUST I, 1995, J BIOL CHEM, V270, P13932, DOI 10.1074/jbc.270.23.13932; JUST I, 1995, NATURE, V375, P500, DOI 10.1038/375500a0; Karasawa T, 1997, MICROBIOL IMMUNOL, V41, P581, DOI 10.1111/j.1348-0421.1997.tb01895.x; KARASAWA T, 1995, MICROBIOL-UK, V141, P371, DOI 10.1099/13500872-141-2-371; Karlsson S, 1999, MICROBIOL-UK, V145, P1683, DOI 10.1099/13500872-145-7-1683; Karlsson S, 2003, INFECT IMMUN, V71, P1784, DOI 10.1128/IAI.71.4.1784-1793.2003; Karlsson S, 2008, MICROBIOL-SGM, V154, P3430, DOI 10.1099/mic.0.2008/019778-0; KNOOP FC, 1979, INFECT IMMUN, V23, P31, DOI 10.1128/IAI.23.1.31-33.1979; Kuehne SA, 2010, NATURE, V467, P711, DOI 10.1038/nature09397; KUSHNARYOV VM, 1992, CANCER RES, V52, P5096; Kyne L, 2000, NEW ENGL J MED, V342, P390, DOI 10.1056/NEJM200002103420604; Lanis JM, 2012, MOL MICROBIOL, V84, P66, DOI 10.1111/j.1365-2958.2012.08009.x; Lanis JM, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001061; Leav BA, 2010, VACCINE, V28, P965, DOI 10.1016/j.vaccine.2009.10.144; Lim PL, 2011, SINGAP MED J, V52, P361; Loo VG, 2005, NEW ENGL J MED, V353, P2442, DOI 10.1056/NEJMoa051639; Lowy I, 2010, NEW ENGL J MED, V362, P197, DOI 10.1056/NEJMoa0907635; LYERLY DM, 1985, INFECT IMMUN, V47, P349, DOI 10.1128/IAI.47.2.349-352.1985; MacCannell DR, 2006, J CLIN MICROBIOL, V44, P2147, DOI 10.1128/JCM.02563-05; Maegavva T, 2002, J MED MICROBIOL, V51, P34, DOI 10.1099/0022-1317-51-1-34; Mahida YR, 1996, GUT, V38, P337, DOI 10.1136/gut.38.3.337; Matamouros S, 2007, MOL MICROBIOL, V64, P1274, DOI 10.1111/j.1365-2958.2007.05739.x; McDonald LC, 2005, NEW ENGL J MED, V353, P2433, DOI 10.1056/NEJMoa051590; Merrigan M, 2010, J BACTERIOL, V192, P4904, DOI 10.1128/JB.00445-10; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Mullan N, 2011, INFECT IMMUN, V79, P1623, DOI 10.1128/IAI.00686-10; Murray R, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-103; OSGOOD DP, 1993, APPL ENVIRON MICROB, V59, P3985, DOI 10.1128/AEM.59.12.3985-3988.1993; Planche T, 2011, J CLIN PATHOL, V64, P1, DOI 10.1136/jcp.2010.080135; Puri AW, 2010, CHEM BIOL, V17, P1201, DOI 10.1016/j.chembiol.2010.09.011; RIEGLER M, 1995, J CLIN INVEST, V95, P2004, DOI 10.1172/JCI117885; ROTHMAN SW, 1986, J CLIN PATHOL, V39, P672, DOI 10.1136/jcp.39.6.672; ROTHMAN SW, 1984, INFECT IMMUN, V46, P324, DOI 10.1128/IAI.46.2.324-331.1984; Rupnik M, 1998, J CLIN MICROBIOL, V36, P2240, DOI 10.1128/JCM.36.8.2240-2247.1998; Rupnik M, 2010, METHODS MOL BIOL, V646, P67, DOI 10.1007/978-1-60327-365-7_5; Rupnik M, 2009, NAT REV MICROBIOL, V7, P526, DOI 10.1038/nrmicro2164; Ryder AB, 2010, J CLIN MICROBIOL, V48, P4129, DOI 10.1128/JCM.01104-10; Satchell KJF, 2007, INFECT IMMUN, V75, P5079, DOI 10.1128/IAI.00525-07; Saujet L, 2011, J BACTERIOL, V193, P3186, DOI 10.1128/JB.00272-11; Savidge TC, 2011, NAT MED, V17, P1136, DOI 10.1038/nm.2405; Sebaihia M, 2006, NAT GENET, V38, P779, DOI 10.1038/ng1830; Singh MP, 2009, J MICROBIOL METH, V77, P102, DOI 10.1016/j.mimet.2009.01.014; Sirard S, 2011, J CLIN MICROBIOL, V49, P4040, DOI 10.1128/JCM.05053-11; Songer JG, 2006, ANAEROBE, V12, P1, DOI 10.1016/j.anaerobe.2005.09.001; Stabler RA, 2006, J BACTERIOL, V188, P7297, DOI 10.1128/JB.00664-06; Stabler RA, 2010, GUT MICROBES, V1, P269, DOI 10.4161/gmic.1.4.11870; Stabler RA, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-9-r102; Tae CH, 2009, J KOREAN MED SCI, V24, P520, DOI 10.3346/jkms.2009.24.3.520; Underwood S, 2009, J BACTERIOL, V191, P7296, DOI 10.1128/JB.00882-09; Verdoorn BP, 2010, DIAGN MICR INFEC DIS, V66, P24, DOI 10.1016/j.diagmicrobio.2009.08.015; Warny M, 2005, LANCET, V366, P1079, DOI 10.1016/S0140-6736(05)67420-X; Wilkins TD, 2003, J CLIN MICROBIOL, V41, P531, DOI 10.1128/JCM.41.2.531-534.2003; WILSON KH, 1986, J INFECT DIS, V153, P547, DOI 10.1093/infdis/153.3.547; WILSON KH, 1986, INFECT IMMUN, V54, P354, DOI 10.1128/IAI.54.2.354-358.1986; WILSON KH, 1988, INFECT IMMUN, V56, P2610, DOI 10.1128/IAI.56.10.2610-2614.1988; Wilson V, 2010, CLIN INFECT DIS, V50, pE77, DOI 10.1086/653012; Wolff D, 2009, EUR J CLIN MICROBIOL, V28, P959, DOI 10.1007/s10096-009-0731-7; Yamakawa K, 1996, J MED MICROBIOL, V44, P111, DOI 10.1099/00222615-44-2-111; Yamakawa K, 1998, J MED MICROBIOL, V47, P767, DOI 10.1099/00222615-47-9-767; Yang GL, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-192	93	13	13	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e56545	10.1371/journal.pone.0056545	http://dx.doi.org/10.1371/journal.pone.0056545			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437164	Green Published, gold, Green Submitted			2022-12-25	WOS:000315184200102
J	Mondal, P; Datta, S; Maiti, GP; Baral, A; Jha, GN; Panda, CK; Chowdhury, S; Ghosh, S; Roy, B; Roychoudhury, S				Mondal, Pinaki; Datta, Sayantan; Maiti, Guru Prasad; Baral, Aradhita; Jha, Ganga Nath; Panda, Chinmay Kumar; Chowdhury, Shantanu; Ghosh, Saurabh; Roy, Bidyut; Roychoudhury, Susanta			Comprehensive SNP Scan of DNA Repair and DNA Damage Response Genes Reveal Multiple Susceptibility Loci Conferring Risk to Tobacco Associated Leukoplakia and Oral Cancer	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMAS; PROTEIN-KINASE; COMMON VARIANTS; INDIAN POPULATION; NECK-CANCER; POLYMORPHISMS; HEAD; EXPRESSION; MODULATE; ATM	Polymorphic variants of DNA repair and damage response genes play major role in carcinogenesis. These variants are suspected as predisposition factors to Oral Squamous Cell Carcinoma (OSCC). For identification of susceptible variants affecting OSCC development in Indian population, the "maximally informative'' method of SNP selection from HapMap data to non-HapMap populations was applied. Three hundred twenty-five SNPs from 11 key genes involved in double strand break repair, mismatch repair and DNA damage response pathways were genotyped on a total of 373 OSCC, 253 leukoplakia and 535 unrelated control individuals. The significantly associated SNPs were validated in an additional cohort of 144 OSCC patients and 160 controls. The rs12515548 of MSH3 showed significant association with OSCC both in the discovery and validation phases (discovery P-value: 1.43E-05, replication P-value: 4.84E-03). Two SNPs (rs12360870 of MRE11A, P-value: 2.37E-07 and rs7003908 of PRKDC, P-value: 7.99E-05) were found to be significantly associated only with leukoplakia. Stratification of subjects based on amount of tobacco consumption identified SNPs that were associated with either high or low tobacco exposed group. The study reveals a synergism between associated SNPs and lifestyle factors in predisposition to OSCC and leukoplakia.	[Mondal, Pinaki; Roychoudhury, Susanta] Indian Inst Chem Biol, CSIR, Canc Biol & Inflammatory Disorder Div, Kolkata, W Bengal, India; [Datta, Sayantan; Ghosh, Saurabh; Roy, Bidyut] Indian Stat Inst, Human Genet Unit, Kolkata, W Bengal, India; [Maiti, Guru Prasad; Panda, Chinmay Kumar] Chittaranjan Natl Canc Inst, Kolkata, W Bengal, India; [Baral, Aradhita; Chowdhury, Shantanu] Inst Genom & Integrat Biol, CSIR, Prote & Struct Biol Unit, New Delhi, India; [Jha, Ganga Nath] Vinoba Bhave Univ, Dept Anthropol, Hazaribagh, Bihar, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Biology (IICB); Indian Statistical Institute; Indian Statistical Institute Kolkata; Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Genomics & Integrative Biology (IGIB); Vinoba Bhave University	Roychoudhury, S (corresponding author), Indian Inst Chem Biol, CSIR, Canc Biol & Inflammatory Disorder Div, Kolkata, W Bengal, India.	susantarc@gmail.com	Roychoudhury, Susanta/AAD-7946-2021; Mondal, Pinaki/AAB-8998-2022; Maiti, Prasad/M-7729-2014	Maiti, Prasad/0000-0003-1936-363X	Department of Biotechnology [BT/PR/5524/Med/14/649/2004, BT/01/COE/05/04]	Department of Biotechnology	This study was supported in part by Department of Biotechnology Grants BT/PR/5524/Med/14/649/2004 and BT/01/COE/05/04. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharya S, 1996, P NATL ACAD SCI USA, V93, P13629, DOI 10.1073/pnas.93.24.13629; Anantharaman D, 2011, ORAL ONCOL, V47, P866, DOI 10.1016/j.oraloncology.2011.06.015; Anderson Carl W., 1992, Critical Reviews in Eukaryotic Gene Expression, V2, P283; Andrew AS, 2006, CARCINOGENESIS, V27, P1030, DOI 10.1093/carcin/bgi284; Ariumi Y, 1999, ONCOGENE, V18, P4616, DOI 10.1038/sj.onc.1202823; BANNISTER AJ, 1993, NUCLEIC ACIDS RES, V21, P1289, DOI 10.1093/nar/21.5.1289; Bartkova J, 2005, NATURE, V434, P864, DOI 10.1038/nature03482; Basu A, 2003, GENOME RES, V13, P2277, DOI 10.1101/gr.1413403; Bau DT, 2010, LARYNGOSCOPE, V120, P2417, DOI 10.1002/lary.21009; Belitsky GA, 2008, BIOCHEMISTRY-MOSCOW+, V73, P543, DOI 10.1134/S0006297908050076; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berndt SI, 2007, INT J CANCER, V120, P1548, DOI 10.1002/ijc.22510; Brahmachari SK, 2008, J GENET, V87, P3; Bujalkova M, 2008, CLIN CHEM, V54, P1844, DOI 10.1373/clinchem.2008.108902; Castrilli G, 2002, J ORAL PATHOL MED, V31, P234, DOI 10.1034/j.1600-0714.2002.310407.x; Chapman JR, 2012, MOL CELL, V47, P497, DOI 10.1016/j.molcel.2012.07.029; Conde J, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-344; Demsar J, 2004, ORANGE EXPT MACHINE; Dhillon VS, 2011, MUTAGENESIS, V26, P33, DOI 10.1093/mutage/geq076; Dikshit R, 2012, LANCET, V379, P1807, DOI 10.1016/S0140-6736(12)60358-4; Dong XQ, 2011, ONCOLOGIST, V16, P61, DOI 10.1634/theoncologist.2010-0127; Efimova EV, 2008, CANCER RES, V70, P6277; Enomoto A, 2001, TOXICOL SCI, V59, P169, DOI 10.1093/toxsci/59.1.169; Falck J, 2005, NATURE, V434, P605, DOI 10.1038/nature03442; Farnebo L, 2009, INT J MOL MED, V24, P549, DOI 10.3892/ijmm_00000264; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Furness S, 2010, COCHRANE DB SYST REV, P1; Gangwar R, 2009, MUTAT RES-GEN TOX EN, V680, P56, DOI 10.1016/j.mrgentox.2009.09.008; Hine CM, 2008, P NATL ACAD SCI USA, V105, P20810, DOI 10.1073/pnas.0807990106; Hoffmann M, 2009, ONCOL REP, V21, P809, DOI 10.3892/or_00000288; IIJIMA S, 1992, EUR J BIOCHEM, V206, P595, DOI 10.1111/j.1432-1033.1992.tb16964.x; Jakulin A, 2003, LECT NOTES ARTIFICIA, V2838; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Khanna KK, 2001, NAT GENET, V27, P247, DOI 10.1038/85798; Koessler T, 2008, GUT, V57, P1097, DOI 10.1136/gut.2007.137265; Kolodner RD, 2000, NATURE, V407, P687, DOI 10.1038/35037701; Kumar A, 2012, MUTAT RES-FUND MOL M, V729, P24, DOI 10.1016/j.mrfmmm.2011.09.001; Lee PH, 2008, NUCLEIC ACIDS RES, V36, pD820, DOI 10.1093/nar/gkm904; Leemans CR, 2011, NAT REV CANCER, V11, P9, DOI 10.1038/nrc2982; Lieber MR, 2008, J BIOL CHEM, V283, P1, DOI 10.1074/jbc.R700039200; Majumder M, 2007, INT J CANCER, V120, P2148, DOI 10.1002/ijc.22547; Mandal RK, 2010, DNA CELL BIOL, V29, P669, DOI 10.1089/dna.2010.1047; Mangoni M, 2010, INT J RAD ONCOL BIOL; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; McKay JD, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001333; McKean-Cowdin R, 2009, CANCER EPIDEM BIOMAR, V18, P1118, DOI 10.1158/1055-9965.EPI-08-1078; MICHALSKI RS, 1983, ARTIF INTELL, V20, P111, DOI 10.1016/0004-3702(83)90016-4; Misra C, 2009, MOL CARCINOGEN, V48, P790, DOI 10.1002/mc.20523; Mitra AK, 2011, INDIAN J MED RES, V133, P605; Mitra AK, 2009, J EXP CLIN CANC RES, V28, DOI 10.1186/1756-9966-28-104; Mitra S, 2005, INT J CANCER, V117, P786, DOI 10.1002/ijc.21263; Moore JH, 2006, J THEOR BIOL, V241, P252, DOI 10.1016/j.jtbi.2005.11.036; Mukherjee S, 2012, J ORAL PATHOL MED, V41, P292, DOI 10.1111/j.1600-0714.2011.01097.x; Mukherjee Sanjit, 2011, Indian J Dent Res, V22, P735, DOI 10.4103/0970-9290.93475; Narang A, 2011, AM J HUM GENET, V89, P111, DOI 10.1016/j.ajhg.2011.06.004; Picelli S, 2010, EUR J CANCER, V46, P1041, DOI 10.1016/j.ejca.2010.01.013; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; R Core Team, 2021, R LANG ENV STAT COMP; [Registrar General of India Centre for Global Health Research Ministry of Home Affairs], 2009, CAUS DEATH IND 2001; Reich D, 2009, NATURE, V461, P489, DOI 10.1038/nature08365; Sarkar-Roy N, 2011, INT J DATA MIN BIOIN, V5, P706, DOI 10.1504/IJDMB.2011.045418; Sengupta S, 2007, CANCER-AM CANCER SOC, V109, P703, DOI 10.1002/cncr.22430; Song HL, 2006, CARCINOGENESIS, V27, P2235, DOI 10.1093/carcin/bgl089; Vogelsang M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036962; Wang J, 2010, PLOS GENET, V6; WHO Tobacco Free Initiative, 2011, WHO CRIT IMP ANT HUM, P38; Wrangle JM, 2007, CURR OPIN ONCOL, V19, P180, DOI 10.1097/CCO.0b013e3280f01026; Zhou F, 2011, J HUAZHONG U SCI-MED, V31, P154, DOI 10.1007/s11596-011-0242-5	69	24	24	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e56952	10.1371/journal.pone.0056952	http://dx.doi.org/10.1371/journal.pone.0056952			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437280	Green Published, gold, Green Submitted			2022-12-25	WOS:000315184200190
J	Murthy, S; Wu, M; Bai, VU; Hou, ZZ; Menon, M; Barrack, ER; Kim, SH; Reddy, GPV				Murthy, Shalini; Wu, Min; Bai, V. Uma; Hou, Zizheng; Menon, Mani; Barrack, Evelyn R.; Kim, Sahn-Ho; Reddy, G. Prem-Veer			Role of Androgen Receptor in Progression of LNCaP Prostate Cancer Cells from G(1) to S Phase	PLOS ONE			English	Article							DNA-REPLICATION; CYCLE PROGRESSION; GROWTH-INHIBITION; HUMAN-CHROMOSOMES; TRANSCRIPTION; RNA; COMPLEX; PROLIFERATION; CASTRATION; CDC6	Background: The androgen receptor (AR) plays a critical role in the proliferation of prostate cancer cells. However, its mechanism of action in proliferation remains unknown. An understanding of the mechanism of AR action in proliferation may lead to the development of effective strategies for the treatment of prostate cancer. Methodology/Principal Findings: In this study we report that pulse treatment of synchronized LNCaP cells with Casodex, an AR-antagonist, for 4 hours in mid-G(1) phase was sufficient to prevent cells from entering S phase. Since the assembly of pre-replication complex (pre-RC) in G(1) is required for the progression of cells from G(1) to S phase, the effect of Casodex during mid-G(1) suggested that the role of AR in proliferation might be to regulate the assembly of pre-RC. To test this possibility, we investigated the interaction between AR and Cdc6, an essential component of pre-RC in LNCaP cells. AR co-localized and co-immunoprecipitated with Cdc6, and Casodex treatment disrupted this interaction. AR-immunoprecipitate (AR-IP) also contained cyclin E and cyclin A, which play a critical role in pre-RC assembly and cell cycle entry into S phase, and DNA polymerase-alpha, PCNA, and ribonucleotide reductase, which are essential for the initiation of DNA synthesis. In addition, in cells in S phase, AR co-sedimented with components of the DNA replication machinery of cells that entered S phase. Conclusions/Significance: Together, these observations suggest a novel role of AR as a component of the pre-RC to exert control over progression of LNCaP cells from G(1) to S phase through a mechanism that is independent of its role as a transcription factor.	[Murthy, Shalini; Wu, Min; Bai, V. Uma; Hou, Zizheng; Menon, Mani; Barrack, Evelyn R.; Kim, Sahn-Ho; Reddy, G. Prem-Veer] Henry Ford Hosp, Vattikuti Urol Inst, Detroit, MI 48202 USA	Henry Ford Health System; Henry Ford Hospital	Reddy, GPV (corresponding author), Henry Ford Hosp, Vattikuti Urol Inst, Detroit, MI 48202 USA.	preddy1@hfhs.org		Murthy, Shalini/0000-0001-5517-9894	Department of Defense [W81XWH-05-1-0071]	Department of Defense(United States Department of Defense)	This work was supported in part by grant W81XWH-05-1-0071 from the Department of Defense to GPR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold JT, 2007, PROSTATE, V67, P1152, DOI 10.1002/pros.20585; Bai VU, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034875; Bai VU, 2005, J CELL PHYSIOL, V204, P381, DOI 10.1002/jcp.20422; Bosco G, 2001, NAT CELL BIOL, V3, P289, DOI 10.1038/35060086; Carter MF, 1972, FETSCHRIFT UROLOGICA, P27; Chen CD, 2004, NAT MED, V10, P33, DOI 10.1038/nm972; Cifuentes E, 2004, P NATL ACAD SCI USA, V101, P464, DOI 10.1073/pnas.0307161101; Cifuentes E, 2003, J CELL PHYSIOL, V195, P337, DOI 10.1002/jcp.10317; Compagno D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001006; D'Antonio JM, 2009, ENDOCR-RELAT CANCER, V16, P325, DOI 10.1677/ERC-08-0205; Dai HQ, 2009, J CELL BIOCHEM, V106, P798, DOI 10.1002/jcb.22015; DEGREGORI J, 1995, MOL CELL BIOL, V15, P4215; Eder IE, 2000, CANCER GENE THER, V7, P997, DOI 10.1038/sj.cgt.7700202; Frouin I, 2003, EMBO REP, V4, P666, DOI 10.1038/sj.embor.embor886; Gilbert DM, 2002, CURR OPIN CELL BIOL, V14, P377, DOI 10.1016/S0955-0674(02)00326-5; Haag P, 2005, J STEROID BIOCHEM, V96, P251, DOI 10.1016/j.jsbmb.2005.04.029; Hateboer G, 1998, MOL CELL BIOL, V18, P6679, DOI 10.1128/MCB.18.11.6679; HOLMQUIST G, 1982, CELL, V31, P121, DOI 10.1016/0092-8674(82)90411-1; Huggins C, 2002, J UROLOGY, V167, P948, DOI 10.1016/S0022-5347(02)80307-X; JAUMOT M, 1994, BIOCHEM BIOPH RES CO, V203, P1527, DOI 10.1006/bbrc.1994.2359; Jin F, 2009, NUCLEIC ACIDS RES, V37, P4826, DOI 10.1093/nar/gkp510; Karnani N, 2010, MOL BIOL CELL, V21, P393, DOI 10.1091/mbc.E09-08-0707; Koochekpour S, 2007, PROSTATE, V67, P178, DOI 10.1002/pros.20513; Lee ECY, 2003, CELL DEATH DIFFER, V10, P761, DOI 10.1038/sj.cdd.4401228; Liao XB, 2005, MOL CANCER THER, V4, P505, DOI 10.1158/1535-7163.MCT-04-0313; Mendoza-Maldonado R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013720; Murthy S, 2006, J CELL PHYSIOL, V209, P711, DOI 10.1002/jcp.20842; NOGUCHI H, 1983, CELL, V32, P443, DOI 10.1016/0092-8674(83)90464-6; Pienta KJ, 2006, CLIN CANCER RES, V12, P1665, DOI 10.1158/1078-0432.CCR-06-0067; Quero L, 2010, PROSTATE, V70, P401, DOI 10.1002/pros.21074; Reddy G P, 1993, Crit Rev Eukaryot Gene Expr, V3, P255; Reddy G.P., 2004, CELL CYCLE GROWTH CO, P149; REDDY GPV, 1980, P NATL ACAD SCI-BIOL, V77, P3312; Ricciardelli C, 2005, PROSTATE, V63, P19, DOI 10.1002/pros.20154; RIEGMAN PHJ, 1991, MOL ENDOCRINOL, V5, P1921, DOI 10.1210/mend-5-12-1921; Sathya G, 2003, CANCER RES, V63, P8029; Schwaiger M, 2006, CURR OPIN GENET DEV, V16, P177, DOI 10.1016/j.gde.2006.02.007; Sequeira-Mendes J, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000446; Shah RB, 2004, CANCER RES, V64, P9209, DOI 10.1158/0008-5472.CAN-04-2442; Shi YK, 2008, AM J PATHOL, V173, P1758, DOI 10.2353/ajpath.2008.080363; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Sivanandam A, 2010, CURR PROTEIN PEPT SC, V11, P451, DOI 10.2174/138920310791824075; Snoek R, 2009, CLIN CANCER RES, V15, P39, DOI 10.1158/1078-0432.CCR-08-1726; Snyder M, 2009, J BIOL CHEM, V284, P13466, DOI 10.1074/jbc.M809471200; SUBRAMANYAM C, 1990, J CELL PHYSIOL, V144, P423, DOI 10.1002/jcp.1041440309; Yuan X, 2006, AM J PATHOL, V169, P682, DOI 10.2353/ajpath.2006.051047; YUNIS JJ, 1977, CHROMOSOMA, V61, P335, DOI 10.1007/BF00288617; Zegarra-Moro OL, 2002, CANCER RES, V62, P1008; Zhan P, 2002, J STEROID BIOCHEM, V83, P101, DOI 10.1016/S0960-0760(02)00275-3	49	21	23	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e56692	10.1371/journal.pone.0056692	http://dx.doi.org/10.1371/journal.pone.0056692			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437213	Green Published, gold, Green Submitted			2022-12-25	WOS:000315184200143
J	Schuettengruber, B; Cavalli, G				Schuettengruber, Bernd; Cavalli, Giacomo			Polycomb Domain Formation Depends on Short and Long Distance Regulatory Cues	PLOS ONE			English	Article							DROSOPHILA GAGA FACTOR; EMBRYONIC STEM-CELLS; RNA-POLYMERASE-II; GROUP PROTEINS; RESPONSE ELEMENTS; DEVELOPMENTAL REGULATORS; DYNAMIC REGULATION; BITHORAX COMPLEX; PCG PROTEINS; HISTONE H3	Background: Polycomb group (PcG) proteins dynamically define cellular identities through the epigenetic repression of key developmental genes. In Drosophila, cis-regulatory regions termed PcG response elements (PREs) act as nucleation sites for PcG proteins to create large repressive PcG domains that are marked by trimethylation of lysine 27 on histone H3 (H3K27me3). In addition to an action in cis, PREs can interact over long distances, thereby enhancing PcG dependent silencing. How PcG domains are established, which factors limit their propagation in cis, and how long range interactions of PREs in trans affect the chromatin structure is largely unknown. Principal Findings: We demonstrate that the insertion of a PRE-containing transgene in the Drosophila genome generates an artificial PcG domain and we analyze its organization by quantitative ChIP and ChIP-on-chip experiments. Intriguingly, a boundary element and known insulator proteins do not necessarily interfere with spreading of H3K27me3. Instead, domain borders correlate with the presence of promoter regions bound by RNA Polymerase II and active chromatin marks. In contrast, genes that are silent during early fly development get included within the PcG domain and this incorporation interferes with gene activation at later developmental stages. Moreover, trans-interaction of the transgenic PRE with its homologous endogenous PRE results in increased PcG binding, correlating with reinforced silencing of genes within the domain borders. Conclusions: Our results suggest that higher-order organization of PcG-bound chromatin can stabilize gene silencing within PcG domains. Further we propose that multi-protein complexes associated with active promoters are able to define the limits of PcG domains. Future work aimed to pinpoint the factors providing this barrier function will be required to understand the precise molecular mechanism by which active promoter regions can act as boundaries to stop spreading of H3K27me3.	[Schuettengruber, Bernd; Cavalli, Giacomo] CNRS, Inst Genet Humaine, Montpellier, France	Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier	Schuettengruber, B (corresponding author), CNRS, Inst Genet Humaine, Montpellier, France.	bernd.schuttengruber@igh.cnrs.fr; Giacomo.Cavalli@igh.cnrs.fr	cavalli, giacomo/Z-2754-2019; Cavalli, Giacomo/A-7958-2008	cavalli, giacomo/0000-0003-3709-3469; Cavalli, Giacomo/0000-0003-3709-3469; Schuettengruber, Bernd/0000-0001-7338-4648	Centre National de la Recherche Scientifique; Human Frontiers in Science Program Organization; European Union FP 6 (Network of Excellence "The Epigenome''); European Union FP 7 (Network of Excellence EpigeneSys), the Association pour la Recherche sur le Cancer; Agence Nationale pour la Recherche (ANR - iPolycomb); European Research Council (Advanced Investigator grant FlyingPolycomb); Fondation de la Recherche Medicale; Institut National de la Sante et de la Recherche Medicale	Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Human Frontiers in Science Program Organization(Human Frontier Science Program); European Union FP 6 (Network of Excellence "The Epigenome''); European Union FP 7 (Network of Excellence EpigeneSys), the Association pour la Recherche sur le Cancer; Agence Nationale pour la Recherche (ANR - iPolycomb)(French National Research Agency (ANR)); European Research Council (Advanced Investigator grant FlyingPolycomb); Fondation de la Recherche Medicale(Fondation pour la Recherche Medicale); Institut National de la Sante et de la Recherche Medicale(Institut National de la Sante et de la Recherche Medicale (Inserm))	Research in the lab of GC was funded by the Centre National de la Recherche Scientifique, the Human Frontiers in Science Program Organization, the European Union FP 6 (Network of Excellence "The Epigenome'') and FP 7 (Network of Excellence EpigeneSys), the Association pour la Recherche sur le Cancer, the Agence Nationale pour la Recherche (ANR - iPolycomb) and the European Research Council (Advanced Investigator grant FlyingPolycomb). BS was supported by a fellowship of the Fondation de la Recherche Medicale and by the Institut National de la Sante et de la Recherche Medicale. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bantignies F, 2003, GENE DEV, V17, P2406, DOI 10.1101/gad.269503; Bantignies F, 2011, CELL, V144, P214, DOI 10.1016/j.cell.2010.12.026; Bartkuhn M, 2009, EMBO J, V28, P877, DOI 10.1038/emboj.2009.34; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Bracken AP, 2006, GENE DEV, V20, P1123, DOI 10.1101/gad.381706; Breiling A, 2001, NATURE, V412, P651, DOI 10.1038/35088090; Buchenau P, 1998, J CELL BIOL, V141, P469, DOI 10.1083/jcb.141.2.469; Cao R, 2004, CURR OPIN GENET DEV, V14, P155, DOI 10.1016/j.gde.2004.02.001; CLEVELAND WS, 1979, J AM STAT ASSOC, V74, P829, DOI 10.2307/2286407; Comet I, 2006, DEV CELL, V11, P117, DOI 10.1016/j.devcel.2006.05.009; Comet I, 2011, P NATL ACAD SCI USA, V108, P2294, DOI 10.1073/pnas.1002059108; Cuddapah S, 2009, GENOME RES, V19, P24, DOI 10.1101/gr.082800.108; FARKAS G, 1994, NATURE, V371, P806, DOI 10.1038/371806a0; Ficz G, 2005, DEVELOPMENT, V132, P3963, DOI 10.1242/dev.01950; Francis NJ, 2004, SCIENCE, V306, P1574, DOI 10.1126/science.1100576; Grimaud C, 2006, CELL, V124, P957, DOI 10.1016/j.cell.2006.01.036; Kahn TG, 2006, J BIOL CHEM, V281, P29064, DOI 10.1074/jbc.M605430200; Kwong C, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000178; Lanzuolo C, 2007, NAT CELL BIOL, V9, P1167, DOI 10.1038/ncb1637; Lee MG, 2007, SCIENCE, V318, P447, DOI 10.1126/science.1149042; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Margueron R, 2009, NATURE, V461, P762, DOI 10.1038/nature08398; Mihaly J, 1997, DEVELOPMENT, V124, P1809; Muller J, 2006, CURR OPIN GENET DEV, V16, P476, DOI 10.1016/j.gde.2006.08.005; Nakayama T, 2007, GENE DEV, V21, P552, DOI 10.1101/gad.1503407; Negre N, 2006, METHOD ENZYMOL, V410, P316, DOI 10.1016/S0076-6879(06)10015-4; Negre N, 2006, PLOS BIOL, V4, P917, DOI 10.1371/journal.pbio.0040170; Negre N, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000814; Oktaba K, 2008, DEV CELL, V15, P877, DOI 10.1016/j.devcel.2008.10.005; Richly H, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.84; Saurin AJ, 1998, J CELL BIOL, V142, P887, DOI 10.1083/jcb.142.4.887; Schmitges FW, 2011, MOL CELL, V42, P330, DOI 10.1016/j.molcel.2011.03.025; Schuettengruber B, 2007, CELL, V128, P735, DOI 10.1016/j.cell.2007.02.009; Schuettengruber B, 2009, DEVELOPMENT, V136, P3531, DOI 10.1242/dev.033902; Schuettengruber B, 2009, PLOS BIOL, V7, P146, DOI 10.1371/journal.pbio.1000013; Schwartz YB, 2008, CURR OPIN CELL BIOL, V20, P266, DOI 10.1016/j.ceb.2008.03.002; Schwartz YB, 2006, NAT GENET, V38, P700, DOI 10.1038/ng1817; Schwartz YB, 2012, GENOME RES, V22, P2188, DOI 10.1101/gr.138156.112; Sexton T, 2012, CELL, V148, P458, DOI 10.1016/j.cell.2012.01.010; Simon JA, 2009, NAT REV MOL CELL BIO, V10, P697, DOI 10.1038/nrm2763; Smith ER, 2008, MOL CELL BIOL, V28, P1041, DOI 10.1128/MCB.01504-07; Squazzo SL, 2006, GENOME RES, V16, P890, DOI 10.1101/gr.5306606; Stock JK, 2007, NAT CELL BIOL, V9, P1428, DOI 10.1038/ncb1663; Tolhuis B, 2006, NAT GENET, V38, P694, DOI 10.1038/ng1792; Van Bortle K, 2012, GENOME RES, V22, P2176, DOI 10.1101/gr.136788.111; Voigt P, 2012, CELL, V151, P181, DOI 10.1016/j.cell.2012.09.002; ZINK D, 1995, EMBO J, V14, P5660, DOI 10.1002/j.1460-2075.1995.tb00253.x	47	24	24	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e56531	10.1371/journal.pone.0056531	http://dx.doi.org/10.1371/journal.pone.0056531			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437158	Green Submitted, gold, Green Published			2022-12-25	WOS:000315184200096
J	Takahara, T; Minamoto, T; Doi, H				Takahara, Teruhiko; Minamoto, Toshifumi; Doi, Hideyuki			Using Environmental DNA to Estimate the Distribution of an Invasive Fish Species in Ponds	PLOS ONE			English	Article							LEPOMIS-MACROCHIRUS; BLUEGILL SUNFISH; TROPHIC POLYMORPHISM; RICHNESS	Knowledge of the presence of an invasive species is critical to monitoring the sustainability of communities and ecosystems. Environmental DNA (eDNA), DNA fragments that are likely to be bound to organic matters in the water or in shed cells, has been used to monitor the presence of aquatic animals. Using an eDNA-based method, we estimated the presence of the invasive bluegill sunfish, Lepomis macrochirus, in 70 ponds located in seven locales on the Japanese mainland and on surrounding islands. We quantified the concentration of DNA copies in a 1 L water sample using quantitative real-time polymerase chain reaction (qPCR) with a primer/probe set. In addition, we visually observed the bluegill presence in the ponds from the shoreline. We detected bluegill eDNA in all the ponds where bluegills were observed visually and some where bluegills were not observed. Bluegills were also less prevalent on the islands than the mainland, likely owing to limited dispersal and introduction by humans. Our eDNA method simply and rapidly detects the presence of this invasive fish species with less disturbance to the environment during field surveys than traditional methods.	[Takahara, Teruhiko; Doi, Hideyuki] Hiroshima Univ, Inst Sustainable Sci & Dev, Higashihiroshima, Japan; [Minamoto, Toshifumi] Res Inst Human & Nat, Kyoto, Japan; [Minamoto, Toshifumi] Kobe Univ, Grad Sch Human Dev & Environm, Kobe, Hyogo 657, Japan	Hiroshima University; Research Institute for Humanity & Nature (RIHN); Kobe University	Takahara, T (corresponding author), Hiroshima Univ, Inst Sustainable Sci & Dev, Higashihiroshima, Japan.	takahara@hiroshima-u.ac.jp	Minamoto, Toshifumi/C-6453-2009; Doi, Hideyuki/D-2012-2010	Minamoto, Toshifumi/0000-0002-5379-1622; Doi, Hideyuki/0000-0002-2701-3982	JSPS KAKENHI [24770022, 24657020]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JSPS KAKENHI Grant Number: 24770022 and 24657020 to HD and TM, respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AZUMA M, 1992, HYDROBIOLOGIA, V243, P269, DOI 10.1007/BF00007042; Bayley PB, 2001, T AM FISH SOC, V130, P620, DOI 10.1577/1548-8659(2001)130<0620:AATEPO>2.0.CO;2; Blanchet S, 2012, FISHERIES MANAG ECOL, V19, P120, DOI 10.1111/j.1365-2400.2011.00832.x; Dejean T, 2012, J APPL ECOL, V49, P953, DOI 10.1111/j.1365-2664.2012.02171.x; Elton C. S., 1958, ECOLOGY INVASIONS AN; Ficetola GF, 2008, BIOL LETTERS, V4, P423, DOI 10.1098/rsbl.2008.0118; Foote AD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041781; Goldberg CS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022746; IMAI S, 1987, ATLAS FISH KAGOSHIMA; Jerde CL, 2011, CONSERV LETT, V4, P150, DOI 10.1111/j.1755-263X.2010.00158.x; Kawamura K, 2006, MOL ECOL, V15, P613, DOI 10.1111/j.1365-294X.2006.02823.x; Kawamura K, 2010, MOL ECOL, V19, P5371, DOI 10.1111/j.1365-294X.2010.04886.x; Kier G, 2009, P NATL ACAD SCI USA, V106, P9322, DOI 10.1073/pnas.0810306106; KIRYU T, 1992, REV EXOTIC LARGEMOUT, P89; Lockwood J, 2006, INVASION ECOLOGY; Lodge DM, 2012, MOL ECOL, V21, P2555, DOI 10.1111/j.1365-294X.2012.05600.x; MACARTHUR RH, 1968, THEORY ISLAND BIOGEO; Manel S, 2001, J APPL ECOL, V38, P921, DOI 10.1046/j.1365-2664.2001.00647.x; Maruyama T, 1987, INTRO PROCESS FOREIG; Matsuzaki SS, 2009, OECOLOGIA, V158, P673, DOI 10.1007/s00442-008-1180-1; Minamoto T, 2012, LIMNOLOGY, V13, P193, DOI 10.1007/s10201-011-0362-4; Mito Toshikazu, 2004, Global Environmental Research, V8, P171; Mooney H.A., 1986, Ecological Studies, P250; R Development Core Team, 2012, R LANG ENV STAT COMP; Takahara T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035868; TERASHIMA A., 1977, TANSUIGYO, V3, P38; Thomsen PF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041732; Thomsen PF, 2012, MOL ECOL, V21, P2565, DOI 10.1111/j.1365-294X.2011.05418.x; Uchii K, 2007, LIMNOLOGY, V8, P59, DOI 10.1007/s10201-006-0196-7; Valentini A, 2009, TRENDS ECOL EVOL, V24, P110, DOI 10.1016/j.tree.2008.09.011; Wetzel R.G., 2001, LIMNOLOGY LAKE RIVER, DOI DOI 10.1046/J.1529-8817.2001.37602.X; YOKOGAWA K, 1992, REV EXOTIC LARGEMOUT, P75; Yonekura R, 2002, ECOL RES, V17, P49, DOI 10.1046/j.1440-1703.2002.00462.x; ZARET TM, 1973, SCIENCE, V182, P449, DOI 10.1126/science.182.4111.449	34	246	268	7	270	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e56584	10.1371/journal.pone.0056584	http://dx.doi.org/10.1371/journal.pone.0056584			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437177	Green Published, gold, Green Submitted			2022-12-25	WOS:000315184200113
J	Taliaferro, JM; Marwha, D; Aspden, JL; Mavrici, D; Cheng, NE; Kohlstaedt, LA; Rio, DC				Taliaferro, J. Matthew; Marwha, Dhruv; Aspden, Julie L.; Mavrici, Daniela; Cheng, Nathalie E.; Kohlstaedt, Lori A.; Rio, Donald C.			The Drosophila Splicing Factor PSI Is Phosphorylated by Casein Kinase II and Tousled-Like Kinase	PLOS ONE			English	Article							BINDING PROTEIN-PSI; DNA-DAMAGE; NUCLEAR ACTIN; IN-VIVO; RNA; ELEMENT; PURIFICATION; MELANOGASTER; DOMAIN; SITE	Alternative splicing of pre-mRNA is a highly regulated process that allows cells to change their genetic informational output. These changes are mediated by protein factors that directly bind specific pre-mRNA sequences. Although much is known about how these splicing factors regulate pre-mRNA splicing events, comparatively little is known about the regulation of the splicing factors themselves. Here, we show that the Drosophila splicing factor P element Somatic Inhibitor (PSI) is phosphorylated at at least two different sites by at minimum two different kinases, casein kinase II (CK II) and tousled-like kinase (tlk). These phosphorylation events may be important for regulating protein-protein interactions involving PSI. Additionally, we show that PSI interacts with several proteins in Drosophila S2 tissue culture cells, the majority of which are splicing factors.	[Taliaferro, J. Matthew; Marwha, Dhruv; Aspden, Julie L.; Mavrici, Daniela; Cheng, Nathalie E.; Kohlstaedt, Lori A.; Rio, Donald C.] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Rio, Donald C.] Univ Calif Berkeley, Ctr Integrat Genom, Berkeley, CA 94720 USA; [Kohlstaedt, Lori A.; Rio, Donald C.] Univ Calif Berkeley, Calif Inst Quantitat Biosci QB3, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Rio, DC (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.	don_rio@berkeley.edu		Taliaferro, Matthew/0000-0001-7580-1433; Aspden, Julie/0000-0002-8537-6204	United States National Institutes of Health (NIH) [GM61987, GM097352-01A1, GM094890-01, S10RR025622]; University of California CRCC graduate fellowship; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR025622] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061987, R01GM097352, R01GM094890, R01GM104385] Funding Source: NIH RePORTER	United States National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of California CRCC graduate fellowship; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by United States National Institutes of Health (NIH) grants GM61987, GM097352-01A1, GM094890-01 and S10RR025622. JMT was supported by a University of California CRCC graduate fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams MD, 1997, GENE DEV, V11, P129, DOI 10.1101/gad.11.1.129; Anko ML, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-3-r17; Amarasinghe AK, 2001, RNA, V7, P1239, DOI 10.1017/S1355838201010603; Ben-Dov C, 2008, J BIOL CHEM, V283, P1229, DOI 10.1074/jbc.R700033200; Blanchette M, 2005, GENE DEV, V19, P1306, DOI 10.1101/gad.1314205; Boudrez A, 2002, J BIOL CHEM, V277, P31834, DOI 10.1074/jbc.M204427200; BOURBON HM, 1995, J BIOL CHEM, V270, P11130, DOI 10.1074/jbc.270.19.11130; Carrera P, 2003, GENE DEV, V17, P2578, DOI 10.1101/gad.276703; Chaouki AS, 2006, PLOS GENET, V2, P1974, DOI 10.1371/journal.pgen.0020178; ECHALIER G, 1969, CR ACAD SCI D NAT, V268, P1771; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; GLOVER CVC, 1983, J BIOL CHEM, V258, P3258; Graveley BR, 2011, NATURE, V471, P473, DOI 10.1038/nature09715; Groth A, 2003, EMBO J, V22, P1676, DOI 10.1093/emboj/cdg151; Hammond LE, 1997, MOL CELL BIOL, V17, P7260, DOI 10.1128/MCB.17.12.7260; Ignjatovic T, 2005, J MOL BIOL, V351, P52, DOI 10.1016/j.jmb.2005.04.077; Jaffe L, 1997, GENE DEV, V11, P1327, DOI 10.1101/gad.11.10.1327; KEMP BE, 1990, TRENDS BIOCHEM SCI, V15, P342, DOI 10.1016/0968-0004(90)90073-K; Krause DR, 2003, ONCOGENE, V22, P5927, DOI 10.1038/sj.onc.1206691; Labourier E, 2002, GENE DEV, V16, P72, DOI 10.1101/gad.948602; Labourier E, 2001, MOL CELL, V8, P363, DOI 10.1016/S1097-2765(01)00311-2; Lareau LF, 2007, NATURE, V446, P926, DOI 10.1038/nature05676; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; MENKO AS, 1980, BIOCHIM BIOPHYS ACTA, V629, P359, DOI 10.1016/0304-4165(80)90108-7; Olave IA, 2002, ANNU REV BIOCHEM, V71, P755, DOI 10.1146/annurev.biochem.71.110601.135507; Packman LC, 1997, FEBS LETT, V400, P45, DOI 10.1016/S0014-5793(96)01324-5; Pan Q, 2008, NAT GENET, V40, P1413, DOI 10.1038/ng.259; Pilyugin M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008328; PINOLROMA S, 1990, METHOD ENZYMOL, V181, P317; PINOLROMA S, 1990, METHOD ENZYMOL, V181, P326; ROTH MB, 1990, J CELL BIOL, V111, P2217, DOI 10.1083/jcb.111.6.2217; SIEBEL CW, 1994, GENE DEV, V8, P1713, DOI 10.1101/gad.8.14.1713; SIEBEL CW, 1992, GENE DEV, V6, P1386, DOI 10.1101/gad.6.8.1386; SIEBEL CW, 1995, GENE DEV, V9, P269, DOI 10.1101/gad.9.3.269; Szakmary A, 1996, P NATL ACAD SCI USA, V93, P1607, DOI 10.1073/pnas.93.4.1607; Tabb DL, 2002, J PROTEOME RES, V1, P21, DOI 10.1021/pr015504q; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Wang JW, 1997, J BIOL CHEM, V272, P22227, DOI 10.1074/jbc.272.35.22227; Wang X, 1999, EMBO J, V18, P4549, DOI 10.1093/emboj/18.16.4549; Washburn MP, 2001, NAT BIOTECHNOL, V19, P242, DOI 10.1038/85686; Willert K, 1997, EMBO J, V16, P3089, DOI 10.1093/emboj/16.11.3089; Xiao SH, 1998, EMBO J, V17, P6359, DOI 10.1093/emboj/17.21.6359; Xiao SH, 1997, GENE DEV, V11, P334, DOI 10.1101/gad.11.3.334; Zhai B, 2008, J PROTEOME RES, V7, P1675, DOI 10.1021/pr700696a; Zheng B, 2009, FEBS J, V276, P2669, DOI 10.1111/j.1742-4658.2009.06986.x	45	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e56401	10.1371/journal.pone.0056401	http://dx.doi.org/10.1371/journal.pone.0056401			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437125	gold, Green Published, Green Submitted			2022-12-25	WOS:000315184200069
J	Xing, YM; Zhang, LC; Liang, HQ; Lv, J; Song, C; Guo, SX; Wang, CL; Lee, TS; Lee, MW				Xing, Yong-Mei; Zhang, Li-Chun; Liang, Han-Qiao; Lv, Jing; Song, Chao; Guo, Shun-Xing; Wang, Chun-Lan; Lee, Tae-Soo; Lee, Min-Woong			Sclerotial Formation of Polyporus umbellatus by Low Temperature Treatment under Artificial Conditions	PLOS ONE			English	Article							OXALIC-ACID; DIFFERENTIATION; GROWTH; ROLFSII; EXTRACT	Background: Polyporus umbellatus sclerotia have been used as a diuretic agent in China for over two thousand years. A shortage of the natural P. umbellatus has prompted researchers to induce sclerotial formation in the laboratory. Methodology/Principal Finding: P. umbellatus cultivation in a sawdust-based substrate was investigated to evaluate the effect of low temperature conditions on sclerotial formation. A phenol-sulfuric acid method was employed to determine the polysaccharide content of wild P. umbellatus sclerotia and mycelia and sclerotia grown in low-temperature treatments. In addition, reactive oxygen species (ROS) content, expressed as the fluorescence intensity of mycelia during sclerotial differentiation was determined. Analysis of ROS generation and sclerotial formation in mycelia after treatment with the antioxidants such as diphenyleneiodonium chloride (DPI), apocynin (Apo), or vitamin C were studied. Furthermore, macroscopic and microscopic characteristics of sclerotial differentiation were observed. Sclerotia were not induced by continuous cultivation at 25 degrees C. The polysaccharide content of the artificial sclerotia is 78% of that of wild sclerotia. In the low-temperature treatment group, the fluorescent intensity of ROS was higher than that of the room temperature (25 degrees C) group which did not induce sclerotial formation all through the cultivation. The antioxidants DPI and Apo reduced ROS levels and did not induce sclerotial formation. Although the concentration-dependent effects of vitamin C (5-15 mg mL(-1)) also reduced ROS generation and inhibited sclerotial formation, using a low concentration of vitamin C (1 mg mL(-1)) successfully induced sclerotial differentiation and increased ROS production. Conclusions/Significance: Exposure to low temperatures induced P. umbellatus sclerotial morphogenesis during cultivation. Low temperature treatment enhanced ROS in mycelia, which may be important in triggering sclerotial differentiation in P. umbellatus. Moreover, the application of antioxidants impaired ROS generation and inhibited sclerotial formation. Our findings may help to provide new insights into the biological mechanisms underlying sclerotial morphogenesis in P. umbellatus.	[Xing, Yong-Mei; Zhang, Li-Chun; Liang, Han-Qiao; Lv, Jing; Song, Chao; Guo, Shun-Xing; Wang, Chun-Lan] Chinese Acad Med Sci, Inst Med Plant Dev, Beijing 100730, Peoples R China; [Xing, Yong-Mei; Zhang, Li-Chun; Liang, Han-Qiao; Lv, Jing; Song, Chao; Guo, Shun-Xing; Wang, Chun-Lan] Peking Union Med Coll, Beijing 100021, Peoples R China; [Lee, Tae-Soo] Univ Incheon, Dept Life Sci, Inchon, South Korea; [Lee, Min-Woong] Dongguk Univ, Dept Life Sci, Seoul, South Korea	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Medicinal Plant Development - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Incheon National University; Dongguk University	Guo, SX (corresponding author), Chinese Acad Med Sci, Inst Med Plant Dev, Beijing 100730, Peoples R China.	sxguo2006@yahoo.com.cn; clwang@implad.ac.cn	Cubała, Wiesław J./N-6113-2018	Cubała, Wiesław J./0000-0001-6343-8454	National Natural Sciences Foundation of China [30830117, 31201666]; International Science and Technology Cooperation Projects of China [2011DFA31260]; National Research Foundation [NRF 2011-0016999]	National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC)); International Science and Technology Cooperation Projects of China; National Research Foundation	The research was financially supported by the National Natural Sciences Foundation of China (No. 30830117, 31201666), the International Science and Technology Cooperation Projects of China (No. 2011DFA31260) and the National Research Foundation (NRF 2011-0016999). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre J, 2005, TRENDS MICROBIOL, V13, P111, DOI 10.1016/j.tim.2005.01.007; [Anonymous], [No title captured]; Belozerskaya TA, 2006, MICROBIOLOGY+, V75, P427, DOI 10.1134/S0026261706040102; Brys K, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-91; Chang W, 2005, BMC GENOMICS, V6, P1, DOI 10.1186/1471-2164-6-115; Cheng XH, 2006, J INTEGR PLANT BIOL, V48, P1312, DOI 10.1111/j.1744-7909.2006.00349.x; CHET I, 1975, ANNU REV PHYTOPATHOL, V13, P169, DOI 10.1146/annurev.py.13.090175.001125; DUBOIS M, 1956, ANAL CHEM, V28, P350, DOI 10.1021/ac60111a017; Erental A., 2008, Fungal Biology Reviews, V22, P6, DOI 10.1016/j.fbr.2007.10.001; Georgiou CD, 2003, MYCOLOGIA, V95, P308, DOI 10.2307/3762041; Georgiou CD, 2001, FUNGAL GENET BIOL, V34, P11, DOI 10.1006/fgbi.2001.1285; Georgiou CD, 2000, MYCOL RES, V104, P1191, DOI 10.1017/S0953756200002707; Georgiou CD, 1997, MYCOL RES, V101, P460, DOI 10.1017/S0953756296002882; Georgiou CD, 2000, MYCOLOGIA, V92, P825, DOI 10.2307/3761577; Georgiou CD, 2006, INTEGR COMP BIOL, V46, P609; Gessler NN, 2007, BIOCHEMISTRY-MOSCOW+, V72, P1091, DOI 10.1134/S0006297907100070; Goitre L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011786; GUO S., 1992, MYCOSYSTEMA, V11, P49; Guo SX, 1996, CHIN J CHIN METER ME, V21, P515; Guo WJ, 2011, CRYPTOGAMIE MYCOL, V32, P171, DOI 10.7872/crym.v32.iss2.2011.171; HADAR Y, 1983, CAN J MICROBIOL, V29, P21, DOI 10.1139/m83-004; Halliwell B, 1996, ANNU REV NUTR, V16, P33, DOI 10.1146/annurev.nu.16.070196.000341; HANSBERG W, 1990, J THEOR BIOL, V142, P201, DOI 10.1016/S0022-5193(05)80222-X; Kang Peng, 2012, African Journal of Pharmacy and Pharmacology, V6, P2686; Kim HJ, 2011, APPL ENVIRON MICROB, V77, P7721, DOI 10.1128/AEM.05472-11; Knutson CA, 1997, CEREAL CHEM, V74, P471, DOI 10.1094/CCHEM.1997.74.4.471; Kyung-DalChoi, 2003, Mycobiology, V31, P105; Li XQ, 2011, J ETHNOPHARMACOL, V135, P1, DOI 10.1016/j.jep.2010.06.028; Li XQ, 2010, CELL IMMUNOL, V265, P50, DOI 10.1016/j.cellimm.2010.07.002; Lin Y F, 1988, Zhongguo Yao Li Xue Bao, V9, P345; Liu YY, 2009, LETT APPL MICROBIOL, V49, P283, DOI 10.1111/j.1472-765X.2009.02656.x; Liu YY, 2010, MYCOPATHOLOGIA, V169, P139, DOI 10.1007/s11046-009-9238-0; OHSAWA T, 1992, CHEM PHARM BULL, V40, P143, DOI 10.1248/cpb.40.143; Patsoukis N, 2008, CAN J MICROBIOL, V54, P28, DOI [10.1139/W07-108, 10.1139/w07-108]; PUNJA ZK, 1985, CAN J PLANT PATHOL, V7, P109, DOI 10.1080/07060668509501485; RAWN CD, 1991, J GEN MICROBIOL, V137, P1063, DOI 10.1099/00221287-137-5-1063; Singh UP, 2002, CAN J MICROBIOL, V48, P443, DOI [10.1139/w02-040, 10.1139/W02-040]; Wang GF, 2006, HERALD MED, V25, P346; [邢晓科 Xing Xiaoke], 2004, [微生物学通报, Microbiology], V31, P34; Xing XK, 2005, MYCOPATHOLOGIA, V159, P583, DOI 10.1007/s11046-005-0255-3; Xing YM, 2011, CURR MICROBIOL, V62, P1218, DOI 10.1007/s00284-010-9848-2; Xing YM, 2011, MYCOL PROG, V10, P121, DOI 10.1007/s11557-010-0725-y; Yan S C, 1988, Zhong Xi Yi Jie He Za Zhi, V8, P141; YOU JS, 1994, AM J CHINESE MED, V22, P19, DOI 10.1142/S0192415X94000048; Yun L.L., 2010, J LIAONING FORESTRY, V3, P35; Zhao YY, 2010, PLANTA MED, V76, P1755, DOI 10.1055/s-0030-1249926; Zhao YY, 2010, BIOMED CHROMATOGR, V24, P222, DOI 10.1002/bmc.1277	47	18	28	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e56190	10.1371/journal.pone.0056190	http://dx.doi.org/10.1371/journal.pone.0056190			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437090	Green Submitted, Green Published, gold			2022-12-25	WOS:000315184200044
J	Poole, DN; Tracy, JK; Levitz, L; Rochas, M; Sangare, K; Yekta, S; Tounkara, K; Aboubacar, B; Koita, O; Lurie, M; De Groot, AS				Poole, Danielle N.; Tracy, J. Kathleen; Levitz, Lauren; Rochas, Mali; Sangare, Kotou; Yekta, Shahla; Tounkara, Karamoko; Aboubacar, Ben; Koita, Ousmane; Lurie, Mark; De Groot, Anne S.			A Cross-Sectional Study to Assess HPV Knowledge and HPV Vaccine Acceptability in Mali	PLOS ONE			English	Article							SUB-SAHARAN AFRICA; HUMAN-PAPILLOMAVIRUS INFECTION; CERVICAL-CANCER; RISK-FACTORS; HEALTH; WOMEN; PREVALENCE; DETERMINANTS; PREVENTION; AWARENESS	Despite a high prevalence of oncogenic human papilloma virus (HPV) infection and cervical cancer mortality, HPV vaccination is not currently available in Mali. Knowledge of HPV and cervical cancer in Mali, and thereby vaccine readiness, may be limited. Research staff visited homes in a radial pattern from a central location to recruit adolescent females and males aged 12-17 years and men and women aged >= 18 years (N = 51) in a peri-urban village of Bamako, Mali. Participants took part in structured interviews assessing knowledge, attitudes, and practices related to HPV, cervical cancer, and HPV vaccination. We found low levels of HPV and cervical cancer knowledge. While only 2.0% of respondents knew that HPV is a sexually transmitted infection (STI), 100% said they would be willing to receive HPV vaccination and would like the HPV vaccine to be available in Mali. Moreover, 74.5% said they would vaccinate their child(ren) against HPV. Men were found to have significantly greater autonomy in the decision to vaccinate themselves than women and adolescents (p = 0.005), a potential barrier to be addressed by immunization campaigns. HPV vaccination would be highly acceptable if the vaccine became widely available in Bamako, Mali. This study demonstrates the need for a significant investment in health education if truly informed consent is to be obtained for HPV vaccination. Potential HPV vaccination campaigns should provide more information about HPV and the vaccine. Barriers to vaccination, including the significantly lower ability of the majority of the target population to autonomously decide to get vaccinated, must also be addressed in future HPV vaccine campaigns.	[Poole, Danielle N.; Lurie, Mark] Brown Univ, Publ Hlth Program, Providence, RI 02912 USA; [Tracy, J. Kathleen] Univ Maryland, Sch Med, Dept Epidemiol, Baltimore, MD 21201 USA; [Tracy, J. Kathleen] Univ Maryland, Sch Med, Dept Publ Hlth, Baltimore, MD 21201 USA; [Levitz, Lauren; Rochas, Mali; Tounkara, Karamoko; Aboubacar, Ben; De Groot, Anne S.] GAIA Vaccine Fdn, Providence, RI USA; [Levitz, Lauren; Rochas, Mali; Tounkara, Karamoko; Aboubacar, Ben; De Groot, Anne S.] GAIA Vaccine Fdn, Bamako, Mali; [Sangare, Kotou; Koita, Ousmane] Univ Bamako, Bamako, Mali; [Yekta, Shahla; De Groot, Anne S.] Univ Rhode Isl, Providence, RI 02908 USA	Brown University; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University of Bamako; University of Rhode Island	Poole, DN (corresponding author), Brown Univ, Publ Hlth Program, Providence, RI 02912 USA.	danielle.n.poole@gmail.com	De Groot, Annie/B-6221-2013; Lurie, Mark N/I-3133-2014	De Groot, Annie/0000-0001-5911-1459; Levitz, Lauren/0000-0002-5103-0221; Sangare, Kotou/0000-0002-6750-820X	Merck Company Foundation, United States through Merck Sharp Dohme Corp.; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R24HD041020] Funding Source: NIH RePORTER	Merck Company Foundation, United States through Merck Sharp Dohme Corp.; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	The authors received funding from the Merck Company Foundation, a United States-based, private, charitable foundation funded entirely through Merck Sharp & Dohme Corp. No additional external funding was received for this study. The funders had no role in study design, data collection, and analysis, decision to publish, or preparation of the manuscript.	Arrossi S, 2012, VACCINE, V30, P2467, DOI 10.1016/j.vaccine.2012.01.032; Bayo S, 2002, INT J EPIDEMIOL, V31, P202, DOI 10.1093/ije/31.1.202; Becker-Dreps S, 2010, VACCINE, V28, P4864, DOI 10.1016/j.vaccine.2010.05.034; Bekele A, 2010, TROP MED INT HEALTH, V15, P890, DOI 10.1111/j.1365-3156.2010.02552.x; Biddlecom A, 2006, LANCET, V367, P1299, DOI 10.1016/S0140-6736(06)68555-3; BOSCH FX, 1995, JNCI-J NATL CANCER I, V87, P796, DOI 10.1093/jnci/87.11.796; Buys P, 2009, WORLD DEV, V37, P1494, DOI 10.1016/j.worlddev.2009.01.011; Castle PE, 2005, JNCI-J NATL CANCER I, V97, P1066, DOI 10.1093/jnci/dji186; Centre WIICoHaCCHI, 2012, HUM PAP REL CANC MAL; Coleman MA, 2011, VACCINE, V29, P3945, DOI 10.1016/j.vaccine.2011.03.093; Collumbien M, 2000, Cult Health Sex, V2, P135, DOI 10.1080/136910500300769; Dudgeon MR, 2004, SOC SCI MED, V59, P1379, DOI 10.1016/j.socscimed.2003.11.035; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Giuliano AR, 2011, NEW ENGL J MED, V364, P401, DOI 10.1056/NEJMoa0909537; Haupt RM, 2011, J ADOLESCENT HEALTH, V49, P467, DOI 10.1016/j.jadohealth.2011.07.003; Hawkes S, 1998, HEALTH POLICY PLANN, V13, P121, DOI 10.1093/heapol/13.2.121; IPPF, 2000, REPR RIGHTS 2000; Kruger-Kjaer S, 1998, INT J CANCER, V76, P613, DOI 10.1002/(SICI)1097-0215(19980529)76:5&lt;613::AID-IJC1&gt;3.0.CO;2-T; LaMontagne DS, 2011, B WORLD HEALTH ORGAN, V89, P821, DOI [10.2471/BLT.11.089862, 10.2471/BLT.11.08986]; Leplege A, 2006, QUAL LIFE RES, V15, P1373, DOI 10.1007/s11136-006-0023-y; Leyva M, 2006, CALIF J HLTH PROMOT, V4, P13, DOI DOI 10.32398/CJHP.V4I2.1930; Louie KS, 2009, BRIT J CANCER, V100, P1191, DOI 10.1038/sj.bjc.6604974; Louie KS, 2009, TROP MED INT HEALTH, V14, P1287, DOI 10.1111/j.1365-3156.2009.02372.x; Markovic M, 2005, SOC SCI MED, V61, P2528, DOI 10.1016/j.socscimed.2005.05.001; Marlow LAV, 2007, BRIT J CANCER, V97, P691, DOI 10.1038/sj.bjc.6603927; Marshall H, 2007, AUST NZ J PUBL HEAL, V31, P235, DOI 10.1111/j.1467-842X.2007.00054.x; Munoz N, 2003, NEW ENGL J MED, V348, P518, DOI 10.1056/NEJMoa021641; Munoz N, 2009, LANCET, V373, P1949, DOI 10.1016/S0140-6736(09)60691-7; Oh JK, 2010, VACCINE, V28, P1854, DOI 10.1016/j.vaccine.2009.11.079; Paovonen J, 2009, LANCET, V374, P301, DOI 10.1016/S0140-6736(09)61248-4; Parkin DM, 2006, INT J CANCER, V118, P3030, DOI 10.1002/ijc.21731; Perkins RB, 2010, WOMEN HEALTH ISS, V20, P35, DOI 10.1016/j.whi.2009.09.001; Remes P, 2012, VACCINE, V30, P5363, DOI 10.1016/j.vaccine.2012.06.025; Reyes-Ortiz CA, 2007, J AM GERIATR SOC, V55, pS159; Sauvain-Dugerdil C, 2008, STUD FAMILY PLANN, V39, P263, DOI 10.1111/j.1728-4465.2008.00174.x; StataCorp LP, 2007, STAT STAT SOFTW REL, P10; Tracy JK, 2011, TROP MED INT HEALTH, V16, P1432, DOI 10.1111/j.1365-3156.2011.02843.x; Tracy L, 2011, CLIN INFECT DIS, V52, P641, DOI 10.1093/cid/ciq190; (UNAIDS) JUNPoHA, 2010, GLOB REP UNAIDS REP; USAID, 2007, USAID COUNTR HLTH ST; Waller J, 2004, PREV MED, V38, P745, DOI 10.1016/j.ypmed.2004.01.003; Winkler JL, 2008, VACCINE, V26, pL73, DOI 10.1016/j.vaccine.2008.05.027; Wong LP, 2011, INT J BEHAV MED, V18, P105, DOI 10.1007/s12529-010-9104-y; WRIGHT TC, 1994, OBSTET GYNECOL, V84, P591	44	32	32	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2013	8	2							e56402	10.1371/journal.pone.0056402	http://dx.doi.org/10.1371/journal.pone.0056402			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	093HR	23431375	gold, Green Published			2022-12-25	WOS:000315182800017
J	Bohm, S; Buchberger, A				Boehm, Stefanie; Buchberger, Alexander			The Budding Yeast Cdc48(Shp1) Complex Promotes Cell Cycle Progression by Positive Regulation of Protein Phosphatase 1 (Glc7)	PLOS ONE			English	Article							SPINDLE-ASSEMBLY CHECKPOINT; AAA-ATPASE CDC48/P97; AURORA B ACTIVITY; SACCHAROMYCES-CEREVISIAE; CHROMOSOME SEGREGATION; MITOTIC SPINDLE; UBX DOMAIN; ENDOPLASMIC-RETICULUM; NUCLEAR-LOCALIZATION; KINETOCHORE FUNCTION	The conserved, ubiquitin-selective AAA ATPase Cdc48 regulates numerous cellular processes including protein quality control, DNA repair and the cell cycle. Cdc48 function is tightly controlled by a multitude of cofactors mediating substrate specificity and processing. The UBX domain protein Shp1 is a bona fide substrate-recruiting cofactor of Cdc48 in the budding yeast S. cerevisiae. Even though Shp1 has been proposed to be a positive regulator of Glc7, the catalytic subunit of protein phosphatase 1 in S. cerevisiae, its cellular functions in complex with Cdc48 remain largely unknown. Here we show that deletion of the SHP1 gene results in severe growth defects and a cell cycle delay at the metaphase to anaphase transition caused by reduced Glc7 activity. Using an engineered Cdc48 binding-deficient variant of Shp1, we establish the Cdc48(Shp1) complex as a critical regulator of mitotic Glc7 activity. We demonstrate that shp1 mutants possess a perturbed balance of Glc7 phosphatase and Ipl1 (Aurora B) kinase activities and show that hyper-phosphorylation of the kinetochore protein Dam1, a key mitotic substrate of Glc7 and Ipl1, is a critical defect in shp1. We also show for the first time a physical interaction between Glc7 and Shp1 in vivo. Whereas loss of Shp1 does not significantly affect Glc7 protein levels or localization, it causes reduced binding of the activator protein Glc8 to Glc7. Our data suggest that the Cdc48(Shp1) complex controls Glc7 activity by regulating its interaction with Glc8 and possibly further regulatory subunits.	[Boehm, Stefanie; Buchberger, Alexander] Univ Wurzburg, Dept Biochem, Bioctr, D-97070 Wurzburg, Germany	University of Wurzburg	Buchberger, A (corresponding author), Univ Wurzburg, Dept Biochem, Bioctr, D-97070 Wurzburg, Germany.	alexander.buchberger@biozentrum.uni-wuerzburg.de	Buchberger, Alexander/AAF-4728-2019; Buchberger, Alexander/J-4070-2019	Buchberger, Alexander/0000-0002-2836-0820; Buchberger, Alexander/0000-0002-2836-0820	German Research Foundation (DFG) [BU951/3-1, BU951/3-2, BU951/4-1]	German Research Foundation (DFG)(German Research Foundation (DFG))	This work was supported by grants BU951/3-1, BU951/3-2 and BU951/4-1 by the German Research Foundation (DFG) (http://www.dfg.de/en/index.jsp) to A.B. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyoshi B, 2009, GENE DEV, V23, P2887, DOI 10.1101/gad.1865909; Alberts SM, 2009, J BIOL CHEM, V284, P16082, DOI 10.1074/jbc.M809282200; Alexandru G, 2008, CELL, V134, P804, DOI 10.1016/j.cell.2008.06.048; Archambault V, 2004, MOL CELL, V14, P699, DOI 10.1016/j.molcel.2004.05.025; AXTON JM, 1990, CELL, V63, P33, DOI 10.1016/0092-8674(90)90286-N; Baker SH, 1997, GENETICS, V145, P615; Beltrao P, 2012, CELL, V150, P413, DOI 10.1016/j.cell.2012.05.036; Berchtold D, 2009, MOL BIOL CELL, V20, P1565, DOI 10.1091/mbc.E08-10-1001; Bharucha JP, 2008, MOL BIOL CELL, V19, P1032, DOI 10.1091/mbc.E07-05-0499; Biggins S, 1999, GENE DEV, V13, P532, DOI 10.1101/gad.13.5.532; BLACK S, 1995, YEAST, V11, P747, DOI 10.1002/yea.320110806; Bloecher A, 2000, J CELL BIOL, V149, P125, DOI 10.1083/jcb.149.1.125; Bloecher A, 1999, GENE DEV, V13, P517, DOI 10.1101/gad.13.5.517; Bloom J, 2007, NAT REV MOL CELL BIO, V8, P149, DOI 10.1038/nrm2105; Bohm S, 2011, MOL CELL BIOL, V31, P1528, DOI 10.1128/MCB.00962-10; Braun S, 2002, EMBO J, V21, P615, DOI 10.1093/emboj/21.4.615; Bruderer RM, 2004, J BIOL CHEM, V279, P49609, DOI 10.1074/jbc.M408695200; Buchberger A, 2002, TRENDS CELL BIOL, V12, P216, DOI 10.1016/S0962-8924(02)02269-9; Buchberger A, 2001, J MOL BIOL, V307, P17, DOI 10.1006/jmbi.2000.4462; Buchberger A, SUBCELL BIO IN PRESS; Buchberger A, 2010, SUBCELL BIOCHEM, V54, P17, DOI 10.1007/978-1-4419-6676-6_2; CANNON JF, 1994, GENETICS, V136, P485; Cannon JF, 2010, ADV APPL MICROBIOL, V73, P27, DOI 10.1016/S0065-2164(10)73002-1; Cao K, 2003, CELL, V115, P355, DOI 10.1016/S0092-8674(03)00815-8; Castermans D, 2012, CELL RES, V22, P1058, DOI 10.1038/cr.2012.20; CHAN CSM, 1993, GENETICS, V135, P677; Cheeseman IM, 2001, J CELL BIOL, V152, P197, DOI 10.1083/jcb.152.1.197; Cheeseman LM, 2002, CELL, V111, P163, DOI 10.1016/S0092-8674(02)00973-X; Cheng YL, 2010, J CELL SCI, V123, P2024, DOI 10.1242/jcs.066043; Cohen PTW, 2002, J CELL SCI, V115, P241; Cosma MP, 1999, CELL, V97, P299, DOI 10.1016/S0092-8674(00)80740-0; Cui DY, 2004, J BIOL CHEM, V279, P9713, DOI 10.1074/jbc.M310793200; Daniel JA, 2006, GENETICS, V172, P53, DOI 10.1534/genetics.105.046441; Dargemont C, 2012, BBA-MOL CELL RES, V1823, P138, DOI 10.1016/j.bbamcr.2011.07.011; Decottignies A, 2004, YEAST, V21, P127, DOI 10.1002/yea.1071; Dreveny I, 2004, EMBO J, V23, P1030, DOI 10.1038/sj.emboj.7600139; Egloff MP, 1997, EMBO J, V16, P1876, DOI 10.1093/emboj/16.8.1876; FERNANDEZ A, 1992, J CELL BIOL, V116, P1421, DOI 10.1083/jcb.116.6.1421; FINLEY D, 1987, CELL, V48, P1035, DOI 10.1016/0092-8674(87)90711-2; FRANCISCO L, 1994, MOL CELL BIOL, V14, P4731, DOI 10.1128/MCB.14.7.4731; FRANCISCO L, 1994, CELL MOL BIOL RES, V40, P207; Fu XR, 2003, J CELL BIOL, V163, P21, DOI 10.1083/jcb.200307025; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; GIETZ RD, 1988, GENE, V74, P527, DOI 10.1016/0378-1119(88)90185-0; Hanzelmann P, 2011, STRUCTURE, V19, P833, DOI 10.1016/j.str.2011.03.018; Hardwick KG, 1999, GENETICS, V152, P509; Hartmann-Petersen R, 2004, CURR BIOL, V14, P824, DOI 10.1016/j.cub.2004.04.029; HISAMOTO N, 1994, MOL CELL BIOL, V14, P3158, DOI 10.1128/MCB.14.5.3158; Hitt R, 2004, FEMS YEAST RES, V4, P721, DOI 10.1016/j.femsyr.2004.02.003; HOYT MA, 1991, CELL, V66, P507, DOI 10.1016/0092-8674(81)90014-3; Hsieh MT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018988; Hsu JY, 2000, CELL, V102, P279, DOI 10.1016/S0092-8674(00)00034-9; Hwang LH, 1998, SCIENCE, V279, P1041, DOI 10.1126/science.279.5353.1041; Ishii K, 1996, EMBO J, V15, P6629, DOI 10.1002/j.1460-2075.1996.tb01053.x; Janke C, 2004, YEAST, V21, P947, DOI 10.1002/yea.1142; Jarosch E, 2002, NAT CELL BIOL, V4, P134, DOI 10.1038/ncb746; Jentsch S, 2007, TRENDS BIOCHEM SCI, V32, P6, DOI 10.1016/j.tibs.2006.11.005; Kaneko Y, 2010, FEBS LETT, V584, P3873, DOI 10.1016/j.febslet.2010.07.061; Kang JS, 2001, J CELL BIOL, V155, P763, DOI 10.1083/jcb.200105029; Keating P, 2009, J CELL SCI, V122, P4375, DOI 10.1242/jcs.055566; Knop M, 1999, YEAST, V15, P963, DOI 10.1002/(SICI)1097-0061(199907)15:10B<963::AID-YEA399>3.0.CO;2-W; Kozubowski L, 2003, MOL BIOL CELL, V14, P26, DOI 10.1091/mbc.E02-06-0373; Krick R, 2010, J CELL BIOL, V190, P965, DOI 10.1083/jcb.201002075; Lampert F, 2010, J CELL BIOL, V189, P641, DOI 10.1083/jcb.200912021; Larson JR, 2008, MOL BIOL CELL, V19, P3040, DOI 10.1091/mbc.E08-02-0130; LI R, 1991, CELL, V66, P519, DOI 10.1016/0092-8674(81)90015-5; Li YM, 2002, GENE DEV, V16, P183, DOI 10.1101/gad.959402; Liu D, 2010, J CELL BIOL, V188, P809, DOI 10.1083/jcb.201001006; LIU HP, 1992, GENETICS, V132, P665; MACKELVIE SH, 1995, MOL CELL BIOL, V15, P3777; Meadows JC, 2011, DEV CELL, V20, P739, DOI 10.1016/j.devcel.2011.05.008; Meyer H, 2012, NAT CELL BIOL, V14, P117, DOI 10.1038/ncb2407; Meyer Hemmo H, 2005, Biochim Biophys Acta, V1744, P481; Meyer HH, 2000, EMBO J, V19, P2181, DOI 10.1093/emboj/19.10.2181; Meyer HH, 2002, EMBO J, V21, P5645, DOI 10.1093/emboj/cdf579; MOIR D, 1982, GENETICS, V100, P547; Musacchio A, 2007, NAT REV MOL CELL BIO, V8, P379, DOI 10.1038/nrm2163; Nasmyth K, 2000, SCIENCE, V288, P1379, DOI 10.1126/science.288.5470.1379; Neuber O, 2005, NAT CELL BIOL, V7, P993, DOI 10.1038/ncb1298; Niedenthal RK, 1996, YEAST, V12, P773, DOI 10.1002/(SICI)1097-0061(19960630)12:8<773::AID-YEA972>3.3.CO;2-C; OHKURA H, 1989, CELL, V57, P997, DOI 10.1016/0092-8674(89)90338-3; Pedelini L, 2007, J BIOL CHEM, V282, P3282, DOI 10.1074/jbc.M607171200; Peggie MW, 2002, J CELL SCI, V115, P195; Peters C, 1999, SCIENCE, V285, P1084, DOI 10.1126/science.285.5430.1084; Pinsky BA, 2005, TRENDS CELL BIOL, V15, P486, DOI 10.1016/j.tcb.2005.07.005; Pinsky BA, 2006, NAT CELL BIOL, V8, P78, DOI 10.1038/ncb1341; Pinsky BA, 2006, MOL CELL BIOL, V26, P2648, DOI 10.1128/MCB.26.7.2648-2660.2006; Pinsky BA, 2009, CURR BIOL, V19, P1182, DOI 10.1016/j.cub.2009.06.043; Posch M, 2010, J CELL BIOL, V191, P61, DOI 10.1083/jcb.200912046; Rosenberg JS, 2011, CURR BIOL, V21, P942, DOI 10.1016/j.cub.2011.04.011; Sambade M, 2005, GENETICS, V170, P1539, DOI 10.1534/genetics.105.042812; Sassoon I, 1999, GENE DEV, V13, P545, DOI 10.1101/gad.13.5.545; Sato BK, 2006, YEAST, V23, P1053, DOI 10.1002/yea.1407; Schuberth C, 2008, CELL MOL LIFE SCI, V65, P2360, DOI 10.1007/s00018-008-8072-8; Schuberth C, 2005, NAT CELL BIOL, V7, P999, DOI 10.1038/ncb1299; Schuberth C, 2004, EMBO REP, V5, P818, DOI 10.1038/sj.embor.7400203; Schuberth C, 2006, THESIS LUDWIG MAXIMI; Shang C, 2003, MOL BIOL CELL, V14, P3342, DOI 10.1091/mbc.E02-11-0765; SHERMAN F, 1991, METHOD ENZYMOL, V194, P3; Skibbens RV, 1998, ANNU REV GENET, V32, P307, DOI 10.1146/annurev.genet.32.1.307; Starita LM, 2012, PROTEOMICS, V12, P236, DOI 10.1002/pmic.201100166; Stark MJR, 1996, YEAST, V12, P1647, DOI 10.1002/(SICI)1097-0061(199612)12:16<1647::AID-YEA71>3.0.CO;2-Q; Stolz A, 2011, TRENDS BIOCHEM SCI, V36, P515, DOI 10.1016/j.tibs.2011.06.001; Straight AF, 1998, J CELL BIOL, V143, P687, DOI 10.1083/jcb.143.3.687; Tagwerker C, 2006, MOL CELL PROTEOMICS, V5, P737, DOI 10.1074/mcp.M500368-MCP200; Tan YSH, 2003, J BIOL CHEM, V278, P147, DOI 10.1074/jbc.M208058200; Tatchell K, 2011, P NATL ACAD SCI USA, V108, P3994, DOI 10.1073/pnas.1014406108; Tien JF, 2010, J CELL BIOL, V189, P713, DOI 10.1083/jcb.200910142; TUNG HYL, 1995, MOL CELL BIOL, V15, P6064; Uchiyama K, 2005, J BIOCHEM, V137, P115, DOI 10.1093/jb/mvi028; Uhlmann F, 1999, NATURE, V400, P37, DOI 10.1038/21831; Vanoosthuyse V, 2009, CURR BIOL, V19, P1176, DOI 10.1016/j.cub.2009.05.060; Verma R, 2011, MOL CELL, V41, P82, DOI 10.1016/j.molcel.2010.12.017; Wang CW, 2012, J CELL SCI, V125, P2930, DOI 10.1242/jcs.100230; WANG YC, 1995, MOL CELL BIOL, V15, P6838; Wilcox AJ, 2009, NAT CELL BIOL, V11, P1481, DOI 10.1038/ncb1997; Wilson WA, 2005, BIOCHEM BIOPH RES CO, V329, P161, DOI 10.1016/j.bbrc.2005.01.106; WINEY M, 1995, J CELL BIOL, V129, P1601, DOI 10.1083/jcb.129.6.1601; Wu XL, 2001, BIOCHEMISTRY-US, V40, P7410, DOI 10.1021/bi002796k; Wurzenberger C, 2012, J CELL BIOL, V198, P173, DOI 10.1083/jcb.201112112; Ye YH, 2001, NATURE, V414, P652, DOI 10.1038/414652a; Yuan XM, 2001, J MOL BIOL, V311, P255, DOI 10.1006/jmbi.2001.4864; ZHANG SR, 1995, MOL CELL BIOL, V15, P2037	123	13	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e56486	10.1371/journal.pone.0056486	http://dx.doi.org/10.1371/journal.pone.0056486			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418575	Green Published, Green Submitted, gold			2022-12-25	WOS:000315970300168
J	Fernandez-Silva, I; Whitney, J; Wainwright, B; Andrews, KR; Ylitalo-Ward, H; Bowen, BW; Toonen, RJ; Goetze, E; Karl, SA				Fernandez-Silva, Iria; Whitney, Jonathan; Wainwright, Benjamin; Andrews, Kimberly R.; Ylitalo-Ward, Heather; Bowen, Brian W.; Toonen, Robert J.; Goetze, Erica; Karl, Stephen A.			Microsatellites for Next-Generation Ecologists: A Post-Sequencing Bioinformatics Pipeline	PLOS ONE			English	Article							TRANSPOSABLE ELEMENTS; REPETITIVE ELEMENTS; DNA; IDENTIFICATION; POPULATIONS; MARKERS	Microsatellites are the markers of choice for a variety of population genetic studies. The recent advent of next-generation pyrosequencing has drastically accelerated microsatellite locus discovery by providing a greater amount of DNA sequencing reads at lower costs compared to other techniques. However, laboratory testing of PCR primers targeting potential microsatellite markers remains time consuming and costly. Here we show how to reduce this workload by screening microsatellite loci via bioinformatic analyses prior to primer design. Our method emphasizes the importance of sequence quality, and we avoid loci associated with repetitive elements by screening with repetitive sequence databases available for a growing number of taxa. Testing with the Yellowstripe Goatfish Mulloidichthys flavolineatus and the marine planktonic copepod Pleuromamma xiphias we show higher success rate of primers selected by our pipeline in comparison to previous in silico microsatellite detection methodologies. Following the same pipeline, we discover and select microsatellite loci in nine additional species including fishes, sea stars, copepods and octopuses.	[Fernandez-Silva, Iria; Whitney, Jonathan; Wainwright, Benjamin; Andrews, Kimberly R.; Ylitalo-Ward, Heather; Bowen, Brian W.; Toonen, Robert J.; Karl, Stephen A.] Univ Hawaii, Hawaii Inst Marine Biol, Kaneohe, HI USA; [Andrews, Kimberly R.; Goetze, Erica] Univ Hawaii, Sch Ocean & Earth Sci & Technol, Dept Oceanog, Honolulu, HI 96822 USA	University of Hawaii System; University of Hawaii System	Fernandez-Silva, I (corresponding author), Univ Hawaii, Hawaii Inst Marine Biol, Kaneohe, HI USA.	iriafernandezsilva@gmail.com	Fernandez-Silva, Iria/AAA-8996-2020; Toonen, Rob/V-6230-2019	Toonen, Rob/0000-0001-6339-4340	National Oceanic and Atmospheric Administration (NOAA) National Centers for Coastal Ocean Science Coral Reef Ecosystem Studies grant [NA07NOS4780187, NA07NOS478190, NA07NOS4780189]; NOAA Coral Reef Conservation Program; Hawaii Undersea Research Laboratory [NA05OAR4301108, HC07-11, HC08-06]; NOAA Pacific Island Fisheries Science Center grant [NA10NMF4520121]; NOAA National Marine Sanctuaries Program MOA grant [2005-008/66882]; University of Hawai'i College of Arts Sciences; American Society for Ichthyologists Herpetologists; National Science Foundation (NSF) [OCE-1029478]; Fulbright - Spanish Ministry of Science and Technology fellowship; University of Hawaii NSF EPSCoR program (Investing in Multidisciplinary University Activities) [EPS-0903833]; Society for Integrative & Comparative Biology	National Oceanic and Atmospheric Administration (NOAA) National Centers for Coastal Ocean Science Coral Reef Ecosystem Studies grant; NOAA Coral Reef Conservation Program(National Oceanic Atmospheric Admin (NOAA) - USA); Hawaii Undersea Research Laboratory; NOAA Pacific Island Fisheries Science Center grant; NOAA National Marine Sanctuaries Program MOA grant; University of Hawai'i College of Arts Sciences; American Society for Ichthyologists Herpetologists; National Science Foundation (NSF)(National Science Foundation (NSF)); Fulbright - Spanish Ministry of Science and Technology fellowship; University of Hawaii NSF EPSCoR program (Investing in Multidisciplinary University Activities); Society for Integrative & Comparative Biology	This research was supported by the National Oceanic and Atmospheric Administration (NOAA) National Centers for Coastal Ocean Science Coral Reef Ecosystem Studies grant NA07NOS4780187 to the Bishop Museum, NA07NOS478190 to the University of Hawaii, NA07NOS4780189 to the State of Hawaii; the NOAA Coral Reef Conservation Program research grants program administered by Hawaii Undersea Research Laboratory under award NA05OAR4301108, project numbers HC07-11 and HC08-06; NOAA Pacific Island Fisheries Science Center grant NA10NMF4520121 to B.W.B.; NOAA National Marine Sanctuaries Program (http://sanctuaries.noaa.gov/) MOA grant 2005-008/66882 to R.J.T.; the University of Hawai'i College of Arts & Sciences, Society for Integrative & Comparative Biology Grant-in-Aid of Research, and the American Society for Ichthyologists & Herpetologists to JLW; the National Science Foundation (NSF) under award OCE-1029478 to E.G. and K.R.A; and a Fulbright - Spanish Ministry of Science and Technology fellowship to I.F.S. This work was further supported by the University of Hawaii NSF EPSCoR program (Investing in Multidisciplinary University Activities, EPS-0903833, J. Gaines, PI) in support of the core functional genomics facility at the Hawaii Institute of Marine Biology, SOEST, UH-Manoa. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allentoft ME, 2009, BIOTECHNIQUES, V46, P195, DOI 10.2144/000113086; Baums IB, 2005, MAR ECOL PROG SER, V288, P115, DOI 10.3354/meps288115; Boutin-Ganache I, 2001, BIOTECHNIQUES, V31, P24, DOI 10.2144/01311bm02; Carreras-Carbonell J, 2006, MOL ECOL, V15, P3527, DOI 10.1111/j.1365-294X.2006.03003.x; Castoe TA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030953; Concepcion GT, 2010, CONSERV GENET RESOUR, V2, P11, DOI 10.1007/s12686-009-9118-4; de Koning APJ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002384; Ellegren H, 2004, NAT REV GENET, V5, P435, DOI 10.1038/nrg1348; ESTOUP A, 1996, MICROSATELLITE MARKE; Fernandez-Silva I, 2008, THEOR APPL GENET, V118, P139, DOI 10.1007/s00122-008-0883-3; Ferreira Daniela Cristina, 2011, Mob Genet Elements, V1, P112; Feschotte C, 2002, NAT REV GENET, V3, P329, DOI 10.1038/nrg793; Gaffney PM, 2003, J MOL EVOL, V56, P308, DOI 10.1007/s00239-002-2402-5; Gaither MR, 2010, CONSERV GENET RESOUR, V2, P169, DOI 10.1007/s12686-009-9119-3; Gardner MG, 2011, MOL ECOL RESOUR, V11, P1093, DOI 10.1111/j.1755-0998.2011.03037.x; Gilles A, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-245; GLENN T, 1996, MICROSATELLITE MANUA; Glenn TC, 2005, METHOD ENZYMOL, V395, P202, DOI 10.1016/S0076-6879(05)95013-1; Gu WJ, 2008, ANAL BIOCHEM, V380, P77, DOI 10.1016/j.ab.2008.05.015; Guichoux E, 2011, MOL ECOL RESOUR, V11, P591, DOI 10.1111/j.1755-0998.2011.03014.x; Harismendy O, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r32; Jarne P, 1996, TRENDS ECOL EVOL, V11, P424, DOI 10.1016/0169-5347(96)10049-5; Kohany O, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-474; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Li YC, 2002, MOL ECOL, V11, P2453, DOI 10.1046/j.1365-294X.2002.01643.x; Malausa T, 2011, MOL ECOL RESOUR, V11, P638, DOI 10.1111/j.1755-0998.2011.02992.x; McInerney CE, 2011, HEREDITY, V106, P78, DOI 10.1038/hdy.2010.36; Meglecz E, 2010, BIOINFORMATICS, V26, P403, DOI 10.1093/bioinformatics/btp670; Neff BD, 2001, EVOLUTION, V55, P1717, DOI 10.1111/j.0014-3820.2001.tb00822.x; Niu BF, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-187; Ramsay L, 1999, PLANT J, V17, P415, DOI 10.1046/j.1365-313X.1999.00392.x; Rozen S, 2000, Methods Mol Biol, V132, P365; Selkoe KA, 2006, ECOL LETT, V9, P615, DOI 10.1111/j.1461-0248.2006.00889.x; Sinama M, 2011, EUR J ENTOMOL, V108, P261, DOI 10.14411/eje.2011.035; Smith S, 2009, B ENTOMOL RES, V101, P551; TOONEN RJ, 1997, MICROSATELLITE UNPUB; Zhang DX, 2003, MOL ECOL, V12, P563, DOI 10.1046/j.1365-294X.2003.01773.x; Zhang DX, 2004, TRENDS ECOL EVOL, V19, P507, DOI 10.1016/j.tree.2004.07.020	38	39	44	0	75	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2013	8	2							e55990	10.1371/journal.pone.0055990	http://dx.doi.org/10.1371/journal.pone.0055990			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104BU	23424642	Green Published, gold			2022-12-25	WOS:000315965100030
J	Hu, D; Fukuhara, A; Miyata, Y; Yokoyama, C; Otsuki, M; Kihara, S; Shimomura, I				Hu, Di; Fukuhara, Atsunori; Miyata, Yugo; Yokoyama, Chieko; Otsuki, Michio; Kihara, Shinji; Shimomura, Iichiro			Adiponectin Regulates Vascular Endothelial Growth Factor-C Expression in Macrophages via Syk-ERK Pathway	PLOS ONE			English	Article							METABOLIC SYNDROME; TYROSINE KINASE; CELL APOPTOSIS; HYPERTENSION; ACTIVATION; OBESITY; FAMILY; HYPOADIPONECTINEMIA; LYMPHANGIOGENESIS; MECHANISM	Adiponectin is exclusively expressed in adipose tissues and exhibits protective effects against cardiovascular and metabolic diseases. It enhances AMP-activated kinase (AMPK) and peroxisome proliferator-activated receptor alpha (PPAR alpha) signaling in the liver and skeletal muscles, however, its signaling pathways in macrophages remain to be elucidated. Here, we show that adiponectin upregulated the expression of vascular endothelial growth factor (VEGF)-C, and induced phosphorylation of extracellular signal-regulated kinase (ERK) in macrophages. Inhibition of Syk abrogated adiponectin-induced VEGF-C expression and ERK phosphorylation. Furthermore, inhibition of ERK blocked the induction of VEGF-C gene. Inhibition of Syk, but not that of ERK, abrogated adiponectin-induced expression of cyclooxygenase (COX)-2, tissue inhibitor of metalloproteinase (TIMP)-1, and interleukin (IL)-6. These results indicate that adiponectin regulates VEGF-C expression via Syk-ERK pathway in macrophages.	[Hu, Di; Fukuhara, Atsunori; Miyata, Yugo; Yokoyama, Chieko; Otsuki, Michio; Shimomura, Iichiro] Osaka Univ, Grad Sch Med, Dept Metab Med, Suita, Osaka, Japan; [Kihara, Shinji] Osaka Univ, Grad Sch Med, Dept Biomed Informat, Div Hlth Sci, Suita, Osaka, Japan	Osaka University; Osaka University	Fukuhara, A (corresponding author), Osaka Univ, Grad Sch Med, Dept Metab Med, 2-2 Yamadaoka, Suita, Osaka, Japan.	fukuhara@endmet.med.osaka-u.ac.jp	Fukuhara, Atsunori/A-9601-2018	Fukuhara, Atsunori/0000-0002-6289-3778; Miyata, Yugo/0000-0002-3245-4600	Ministry of Health, Labor and Welfare, Japan; Ministry of Education, Culture, Sports, Science and Technology; Takeda Science Foundation; Grants-in-Aid for Scientific Research [22590978] Funding Source: KAKEN	Ministry of Health, Labor and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan); Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Takeda Science Foundation(Takeda Science Foundation (TSF)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a Grant-in-Aid for JSPS fellowship. This work was supported by a grant from the Ministry of Health, Labor and Welfare, Japan, a grant from the Ministry of Education, Culture, Sports, Science and Technology, and a grant from Takeda Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Awazawa M, 2011, CELL METAB, V13, P401, DOI 10.1016/j.cmet.2011.02.010; Berg AH, 2002, TRENDS ENDOCRIN MET, V13, P84, DOI 10.1016/S1043-2760(01)00524-0; Bohmer R, 2010, DEV CELL, V18, P437, DOI 10.1016/j.devcel.2010.01.009; Brakenhielm E, 2004, P NATL ACAD SCI USA, V101, P2476, DOI 10.1073/pnas.0308671100; Chow WS, 2007, HYPERTENSION, V49, P1455, DOI 10.1161/HYPERTENSIONAHA.107.086835; HOTAMISLIGIL GS, 1994, DIABETES, V43, P1271, DOI 10.2337/diabetes.43.11.1271; Iwashima Y, 2004, HYPERTENSION, V43, P1318, DOI 10.1161/01.HYP.0000129281.03801.4b; Kadowaki T, 2006, J CLIN INVEST, V116, P1784, DOI 10.1172/JCI29126; Kumada M, 2004, CIRCULATION, V109, P2046, DOI 10.1161/01.CIR.0000127953.98131.ED; KUROSAKI T, 1994, J EXP MED, V179, P1725, DOI 10.1084/jem.179.5.1725; Kusunoki N, 2010, ARTHRITIS RHEUM-US, V62, P1641, DOI 10.1002/art.27450; Machnik A, 2009, NAT MED, V15, P545, DOI 10.1038/nm.1960; Maeda K, 1996, BIOCHEM BIOPH RES CO, V221, P286, DOI 10.1006/bbrc.1996.0587; Matsuzawa Y, 1999, ANN NY ACAD SCI, V892, P146, DOI 10.1111/j.1749-6632.1999.tb07793.x; Mocsai A, 2010, NAT REV IMMUNOL, V10, P387, DOI 10.1038/nri2765; Ohashi K, 2006, HYPERTENSION, V47, P1108, DOI 10.1161/01.HYP.0000222368.43759.a1; Okamoto Y, 2008, CIRC RES, V102, P218, DOI 10.1161/CIRCRESAHA.107.164988; Ouchi N, 2001, CIRCULATION, V103, P1057, DOI 10.1161/01.CIR.103.8.1057; Riba R, 2008, J THROMB HAEMOST, V6, P1012, DOI 10.1111/j.1538-7836.2008.02982.x; Shibata S, 2012, J IMMUNOL, V189, P3231, DOI 10.4049/jimmunol.1101739; Shimomura I, 1996, NAT MED, V2, P800, DOI 10.1038/nm0796-800; Skobe M, 2001, NAT MED, V7, P192, DOI 10.1038/84643; Slack EC, 2007, EUR J IMMUNOL, V37, P1600, DOI 10.1002/eji.200636830; Takemura Y, 2007, J CLIN INVEST, V117, P375, DOI 10.1172/JCI29709; Tsubakio-Yamamoto K, 2008, BIOCHEM BIOPH RES CO, V375, P390, DOI 10.1016/j.bbrc.2008.08.009; Wijesekara N, 2010, J BIOL CHEM, V285, P33623, DOI 10.1074/jbc.M109.085084; Yamaguchi N, 2005, FEBS LETT, V579, P6821, DOI 10.1016/j.febslet.2005.11.019; Yokota T, 2000, BLOOD, V96, P1723, DOI 10.1182/blood.V96.5.1723	28	13	15	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2013	8	2							e56071	10.1371/journal.pone.0056071	http://dx.doi.org/10.1371/journal.pone.0056071			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104BU	23424645	Green Published, Green Submitted, gold			2022-12-25	WOS:000315965100033
J	Lee, TT; Zhang, XD; Chuang, CC; Chen, JJ; Chen, YA; Chen, SC; Chen, TY; Tang, CY				Lee, Ting-Ting; Zhang, Xiao-Dong; Chuang, Chao-Chin; Chen, Jing-Jer; Chen, Yi-An; Chen, Shu-Ching; Chen, Tsung-Yu; Tang, Chih-Yung			Myotonia Congenita Mutation Enhances the Degradation of Human CLC-1 Chloride Channels	PLOS ONE			English	Article							TRANSMEMBRANE CONDUCTANCE REGULATOR; CYSTIC-FIBROSIS; QUALITY-CONTROL; SKELETAL-MUSCLE; INTRACELLULAR-TRANSPORT; PROTEASOME INHIBITORS; TORPEDO ELECTROPLAX; RAPID DEGRADATION; CLCN1 MUTATIONS; HUMAN-DISEASES	Myotonia congenita is a hereditary muscle disorder caused by mutations in the human voltage-gated chloride (Cl-) channel CLC-1. Myotonia congenita can be inherited in an autosomal recessive (Becker type) or dominant (Thomsen type) fashion. One hypothesis for myotonia congenita is that the inheritance pattern of the disease is determined by the functional consequence of the mutation on the gating of CLC-1 channels. Several disease-related mutations, however, have been shown to yield functional CLC-1 channels with no detectable gating defects. In this study, we have functionally and biochemically characterized a myotonia mutant: A531V. Despite a gating property similar to that of wild-type (WT) channels, the mutant CLC-1 channel displayed a diminished whole-cell current density and a reduction in the total protein expression level. Our biochemical analyses further demonstrated that the reduced expression of A531V can be largely attributed to an enhanced proteasomal degradation as well as a defect in protein trafficking to surface membranes. Moreover, the A531V mutant protein also appeared to be associated with excessive endosomal-lysosomal degradation. Neither the reduced protein expression nor the diminished current density was rescued by incubating A531V-expressing cells at 27 degrees C. These results demonstrate that the molecular pathophysiology of A531V does not involve anomalous channel gating, but rather a disruption of the balance between the synthesis and degradation of the CLC-1 channel protein.	[Lee, Ting-Ting; Chuang, Chao-Chin; Chen, Jing-Jer; Chen, Yi-An; Tang, Chih-Yung] Natl Taiwan Univ, Coll Med, Dept Physiol, Taipei 10764, Taiwan; [Zhang, Xiao-Dong; Chen, Tsung-Yu] Univ Calif Davis, Ctr Neurosci, Davis, CA 95616 USA; [Chen, Shu-Ching] Natl Taiwan Univ Hosp, Dept Med Res, Taipei, Taiwan; [Tang, Chih-Yung] Natl Taiwan Univ, Coll Med, Grad Inst Brain & Mind Sci, Taipei 10764, Taiwan	National Taiwan University; University of California System; University of California Davis; National Taiwan University; National Taiwan University Hospital; National Taiwan University	Tang, CY (corresponding author), Natl Taiwan Univ, Coll Med, Dept Physiol, Taipei 10764, Taiwan.	tang@ntu.edu.tw		TANG, CHIH-YUNG/0000-0003-1065-2865; Chen, Shu-Ching/0000-0001-9112-1526	National Science Council, Taiwan [NSC 96-2320-B-002-069-MY3]; National Institutes of Health, USA [R01GM065447]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065447] Funding Source: NIH RePORTER	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); National Institutes of Health, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by research grants from National Science Council, Taiwan (NSC 96-2320-B-002-069-MY3) to CYT, and from National Institutes of Health, USA (R01GM065447) to TYC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson CL, 2006, CIRCULATION, V113, P365, DOI 10.1161/CIRCULATIONAHA.105.570200; Aridor M, 1999, NAT MED, V5, P745, DOI 10.1038/10466; Aridor M, 2002, TRAFFIC, V3, P781, DOI 10.1034/j.1600-0854.2002.31103.x; Aridor M, 2000, TRAFFIC, V1, P836, DOI 10.1034/j.1600-0854.2000.011104.x; Bagola K, 2011, BBA-BIOMEMBRANES, V1808, P925, DOI 10.1016/j.bbamem.2010.06.025; Balch WE, 2008, SCIENCE, V319, P916, DOI 10.1126/science.1141448; BRETAG AH, 1987, PHYSIOL REV, V67, P618, DOI 10.1152/physrev.1987.67.2.618; BRYANT SH, 1971, J PHYSIOL-LONDON, V219, P367, DOI 10.1113/jphysiol.1971.sp009667; Cai ZW, 2011, ACTA PHARMACOL SIN, V32, P693, DOI 10.1038/aps.2011.71; Chen TY, 2005, ANNU REV PHYSIOL, V67, P809, DOI 10.1146/annurev.physiol.67.032003.153012; Cheng J, 2004, J BIOL CHEM, V279, P1892, DOI 10.1074/jbc.M308640200; Ciechanover A, 2005, NAT REV MOL CELL BIO, V6, P79, DOI 10.1038/nrm1552; Colding-Jorgensen E, 2005, MUSCLE NERVE, V32, P19, DOI 10.1002/mus.20295; DALEMANS W, 1991, NATURE, V354, P526, DOI 10.1038/354526a0; DENNING GM, 1992, NATURE, V358, P761, DOI 10.1038/358761a0; Douglas PM, 2010, J CELL BIOL, V190, P719, DOI 10.1083/jcb.201005144; DUBRIDGE RB, 1987, MOL CELL BIOL, V7, P379, DOI 10.1128/MCB.7.1.379; Duffield M, 2003, J GEN PHYSIOL, V121, P149, DOI 10.1085/jgp.20028741; DULHUNTY AF, 1979, J MEMBRANE BIOL, V45, P293, DOI 10.1007/BF01869290; Dutzler R, 2002, NATURE, V415, P287, DOI 10.1038/415287a; Dutzler R, 2003, SCIENCE, V300, P108, DOI 10.1126/science.1082708; Ellgaard L, 1999, SCIENCE, V286, P1882, DOI 10.1126/science.286.5446.1882; Feng LA, 2010, SCIENCE, V330, P635, DOI 10.1126/science.1195230; French PJ, 1996, J CLIN INVEST, V98, P1304, DOI 10.1172/JCI118917; Hebert DN, 2007, PHYSIOL REV, V87, P1377, DOI 10.1152/physrev.00050.2006; Ibba M, 1999, SCIENCE, V286, P1893, DOI 10.1126/science.286.5446.1893; Jurkat-Rott K, 2002, J NEUROL, V249, P1493, DOI 10.1007/s00415-002-0871-5; Kisselev AF, 2001, CHEM BIOL, V8, P739, DOI 10.1016/S1074-5521(01)00056-4; Koh YH, 2005, J BIOL CHEM, V280, P32499, DOI 10.1074/jbc.M506199200; Kubisch C, 1998, HUM MOL GENET, V7, P1753, DOI 10.1093/hmg/7.11.1753; Lee DH, 1998, TRENDS CELL BIOL, V8, P397, DOI 10.1016/S0962-8924(98)01346-4; Ling H, 1996, J AM SOC NEPHROL, V7, P73; Lossin C, 2008, ADV GENET, V63, P25, DOI 10.1016/S0065-2660(08)01002-X; Ma D, 2002, CURR OPIN NEUROBIOL, V12, P287, DOI 10.1016/S0959-4388(02)00319-7; Macias MJ, 2007, BIOCHEM J, V403, P79, DOI 10.1042/BJ20061230; Mihic A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018273; Miki H, 2010, J BIOL CHEM, V285, P19967, DOI 10.1074/jbc.M109.092684; MILLER C, 1984, P NATL ACAD SCI-BIOL, V81, P2772, DOI 10.1073/pnas.81.9.2772; MILLER C, 1982, PHILOS T ROY SOC B, V299, P401, DOI 10.1098/rstb.1982.0140; Nufer O, 2002, J CELL SCI, V115, P619; Okiyoneda T, 2010, SCIENCE, V329, P805, DOI 10.1126/science.1191542; Papponen H, 1999, NEUROLOGY, V53, P297, DOI 10.1212/WNL.53.2.297; Papponen H, 2008, MUSCLE NERVE, V37, P317, DOI 10.1002/mus.20922; PTACEK LJ, 1993, NEW ENGL J MED, V328, P482; Pusch M, 2002, HUM MUTAT, V19, P423, DOI 10.1002/humu.10063; Saviane C, 1999, J GEN PHYSIOL, V113, P457, DOI 10.1085/jgp.113.3.457; Schubert U, 2000, NATURE, V404, P770, DOI 10.1038/35008096; Sharma M, 2004, J CELL BIOL, V164, P923, DOI 10.1083/jcb.200312018; Skovronsky DM, 2000, BIOCHEMISTRY-US, V39, P810, DOI 10.1021/bi991728z; STEINMEYER K, 1991, NATURE, V354, P301, DOI 10.1038/354301a0; Sun C, 2001, EUR J HUM GENET, V9, P903, DOI 10.1038/sj.ejhg.5200736; Tseng PY, 2007, J GEN PHYSIOL, V130, P217, DOI 10.1085/jgp.200709817; Vandenberghe W, 2004, CURR OPIN CELL BIOL, V16, P134, DOI 10.1016/j.ceb.2004.01.003; Vembar SS, 2008, NAT REV MOL CELL BIO, V9, P944, DOI 10.1038/nrm2546; Wan J, 2005, NEUROLOGY, V64, P2090, DOI 10.1212/01.WNL.0000167409.59089.C0; Wang XD, 2004, J CELL BIOL, V167, P65, DOI 10.1083/jcb.200401035; WARD CL, 1994, J BIOL CHEM, V269, P25710; Weinberger S, 2012, J PHYSIOL-LONDON, V590, P3449, DOI 10.1113/jphysiol.2012.232785; Wong W, 2002, J BIOL CHEM, V277, P20423, DOI 10.1074/jbc.M109412200; Wu FF, 2002, BRAIN, V125, P2392, DOI 10.1093/brain/awf246	60	18	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2013	8	2							e55930	10.1371/journal.pone.0055930	http://dx.doi.org/10.1371/journal.pone.0055930			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104BU	23424641	gold, Green Submitted, Green Published			2022-12-25	WOS:000315965100029
J	Mamidala, P; Wijeratne, AJ; Wijeratne, S; Poland, T; Qazi, SS; Doucet, D; Cusson, M; Beliveau, C; Mittapalli, O				Mamidala, Praveen; Wijeratne, Asela J.; Wijeratne, Saranga; Poland, Therese; Qazi, Sohail S.; Doucet, Daniel; Cusson, Michel; Beliveau, Catherine; Mittapalli, Omprakash			Identification of Odor-Processing Genes in the Emerald Ash Borer, Agrilus planipennis	PLOS ONE			English	Article							SEX-PHEROMONE COMPONENT; DROSOPHILA-MELANOGASTER; OLFACTORY RECEPTORS; BINDING-PROTEINS; APIS-MELLIFERA; CHEMOSENSORY PROTEINS; ANOPHELES-GAMBIAE; DEGRADING ENZYME; BOMBYX-MORI; P450 ENZYME	Background: Insects rely on olfaction to locate food, mates, and suitable oviposition sites for successful completion of their life cycle. Agrilus planipennis Fairmaire (emerald ash borer) is a serious invasive insect pest that has killed tens of millions of North American ash (Fraxinus spp) trees and threatens the very existence of the genus Fraxinus. Adult A. planipennis are attracted to host volatiles and conspecifics; however, to date no molecular knowledge exists on olfaction in A. planipennis. Hence, we undertook an antennae-specific transcriptomic study to identify the repertoire of odor processing genes involved in A. planipennis olfaction. Methodology and Principal Findings: We acquired 139,085 Roche/454 GS FLX transcriptomic reads that were assembled into 30,615 high quality expressed sequence tags (ESTs), including 3,249 isotigs and 27,366 non-isotigs (contigs and singletons). Intriguingly, the majority of the A. planipennis antennal transcripts (59.72%) did not show similarity with sequences deposited in the non-redundant database of GenBank, potentially representing novel genes. Functional annotation and KEGG analysis revealed pathways associated with signaling and detoxification. Several odor processing genes (9 odorant binding proteins, 2 odorant receptors, 1 sensory neuron membrane protein and 134 odorant/xenobiotic degradation enzymes, including cytochrome P450s, glutathione-S-transferases; esterases, etc.) putatively involved in olfaction processes were identified. Quantitative PCR of candidate genes in male and female A. planipennis in different developmental stages revealed developmental- and sex-biased expression patterns. Conclusions and Significance: The antennal ESTs derived from A. planipennis constitute a rich molecular resource for the identification of genes potentially involved in the olfaction process of A. planipennis. These findings should help in understanding the processing of antennally-active compounds (e.g. 7-epi-sesquithujene) previously identified in this serious invasive pest.	[Mamidala, Praveen; Mittapalli, Omprakash] Ohio State Univ, Ohio Agr & Res Dev Ctr, Dept Entomol, Wooster, OH USA; [Wijeratne, Asela J.; Wijeratne, Saranga] Ohio State Univ, Ohio Agr & Res Dev Ctr, Dept Mol & Cellular Imaging Ctr, Wooster, OH USA; [Poland, Therese] Michigan State Univ, USDA, US Forest Serv, No Res Stn, E Lansing, MI 48824 USA; [Qazi, Sohail S.; Doucet, Daniel] Nat Resources Canada, Sault Ste Marie, ON, Canada; [Cusson, Michel; Beliveau, Catherine] Nat Resources Canada, Quebec City, PQ, Canada	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Michigan State University; United States Department of Agriculture (USDA); United States Forest Service; Natural Resources Canada; Natural Resources Canada	Mittapalli, O (corresponding author), Ohio State Univ, Ohio Agr & Res Dev Ctr, Dept Entomol, Wooster, OH USA.	mittapalli.1@osu.edu	Wijeratne, Saranga/I-5341-2016; Poland, Therese/AAZ-9272-2021; Qazi, Sohail/AAH-5106-2019; Cusson, Michel/AAG-9036-2019	Wijeratne, Saranga/0000-0002-9782-4406; Poland, Therese/0000-0001-7684-1306; Qazi, Sohail/0000-0003-1317-6657; Mamidala, Praveen/0000-0001-8587-0635	USDA APHIS/USDA Forest Service Accelerated Emerald Ash Borer Research Program [GRT00011769/60016270]; State and Federal funds appropriated to the Ohio Agricultural Research and Development Center; The Ohio State University; Genomic Research and Development Initiative grant from Natural Resources Canada	USDA APHIS/USDA Forest Service Accelerated Emerald Ash Borer Research Program; State and Federal funds appropriated to the Ohio Agricultural Research and Development Center; The Ohio State University(Ohio State University); Genomic Research and Development Initiative grant from Natural Resources Canada(Natural Resources Canada)	This research was supported by a grant from the USDA APHIS (GRT00011769/60016270)/USDA Forest Service Accelerated Emerald Ash Borer Research Program, by State and Federal funds appropriated to the Ohio Agricultural Research and Development Center, The Ohio State University and by a Genomic Research and Development Initiative grant from Natural Resources Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abuin L, 2011, NEURON, V69, P44, DOI 10.1016/j.neuron.2010.11.042; Angelini DR, 2009, DEV BIOL, V327, P240, DOI 10.1016/j.ydbio.2008.10.047; Anulewicz Andrea C., 2007, Arboriculture & Urban Forestry, V33, P338; Bai XD, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0016336, 10.1371/journal.pone.0016368]; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Bengtsson JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031620; Benton R, 2006, PLOS BIOL, V4, P240, DOI 10.1371/journal.pbio.0040020; Benton R, 2007, NATURE, V450, P289, DOI 10.1038/nature06328; Benton R, 2009, CELL, V136, P149, DOI 10.1016/j.cell.2008.12.001; Blatch GL, 1999, BIOESSAYS, V21, P932, DOI 10.1002/(SICI)1521-1878(199911)21:11<932::AID-BIES5>3.0.CO;2-N; Briand L, 2002, EUR J BIOCHEM, V269, P4586, DOI 10.1046/j.1432-1033.2002.03156.x; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Cappaert David, 2005, American Entomologist, V51, P152; Chinkers M, 2001, TRENDS ENDOCRIN MET, V12, P28, DOI 10.1016/S1043-2760(00)00335-0; Chung HR, 2007, MOL BIOL EVOL, V24, P1934, DOI 10.1093/molbev/msm121; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Crook DJ, 2008, ANN ENTOMOL SOC AM, V101, P1103, DOI 10.1603/0013-8746-101.6.1103; Crook DJ, 2008, ENVIRON ENTOMOL, V37, P356, DOI 10.1603/0046-225X(2008)37[356:DOAHSL]2.0.CO;2; Croset V, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001064; Dani FR, 2010, J PROTEOME RES, V9, P1822, DOI 10.1021/pr900969k; Das AK, 1998, EMBO J, V17, P1192, DOI 10.1093/emboj/17.5.1192; de Groot P, 2008, J CHEM ECOL, V34, P1170, DOI 10.1007/s10886-008-9514-3; Durand N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015026; Engsontia P, 2008, INSECT BIOCHEM MOLEC, V38, P387, DOI 10.1016/j.ibmb.2007.10.005; Gao Q, 1999, GENOMICS, V60, P31, DOI 10.1006/geno.1999.5894; Grosse-Wilde E, 2011, P NATL ACAD SCI USA, V108, P7449, DOI 10.1073/pnas.1017963108; Gu SH, 2011, INSECT BIOCHEM MOLEC, V41, P254, DOI 10.1016/j.ibmb.2011.01.002; Hallem EA, 2004, TRENDS GENET, V20, P453, DOI 10.1016/j.tig.2004.06.015; Harada E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029710; Hattori D, 2009, NATURE, V461, P644, DOI 10.1038/nature08431; Hatzfeld M, 1999, INT REV CYTOL, V186, P179; He P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028921; Hu ZL, 2008, ONLINE J BIOINFORMAT, V9, P108, DOI DOI 10.1186/1471-2105-13-134; Huber DPW, 2007, INSECT MOL BIOL, V16, P335, DOI 10.1111/j.1365-2583.2007.00731.x; Ishida Y, 2002, INSECT BIOCHEM MOLEC, V32, P1775, DOI 10.1016/S0965-1748(02)00136-4; Ishida Y, 2008, P NATL ACAD SCI USA, V105, P9076, DOI 10.1073/pnas.0802610105; Jacquin-Joly E, 2004, J CHEM ECOL, V30, P2359, DOI 10.1007/s10886-004-7941-3; Jacquin-Joly E, 2012, INT J BIOL SCI, V8, P1036, DOI 10.7150/ijbs.4469; Jin X, 2008, P NATL ACAD SCI USA, V105, P10996, DOI 10.1073/pnas.0803309105; Jones WD, 2005, CURR BIOL, V15, pR119, DOI 10.1016/j.cub.2005.02.007; Karatolos N, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-56; Kirkness EF, 2010, P NATL ACAD SCI USA, V107, P12168, DOI 10.1073/pnas.1003379107; Krieger J, 2002, EUR J NEUROSCI, V16, P619, DOI 10.1046/j.1460-9568.2002.02109.x; Landolt Peter J., 1997, American Entomologist, V43, P12; Larsson MC, 2004, NEURON, V43, P703, DOI 10.1016/j.neuron.2004.08.019; Leal WS, 1999, FEBS LETT, V464, P85, DOI 10.1016/S0014-5793(99)01683-X; Leal WS, 2005, SEMIOCHEMICALS PEST, P45; Lelito JP, 2007, J INSECT BEHAV, V20, P537, DOI 10.1007/s10905-007-9097-9; Lelito JP, 2009, J CHEM ECOL, V35, P104, DOI 10.1007/s10886-008-9583-3; Liu R, 2012, INSECT MOL BIOL, V21, P41, DOI 10.1111/j.1365-2583.2011.01114.x; Liu Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048260; Maibeche-Coisne M, 2004, P NATL ACAD SCI USA, V101, P11459, DOI 10.1073/pnas.0403537101; Mamidala P, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-6; Matz Mikhail V, 2003, Methods Mol Biol, V221, P41; Mittapalli O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013708; Nei M, 2008, NAT REV GENET, V9, P951, DOI 10.1038/nrg2480; Nichols Z, 2008, INSECT BIOCHEM MOLEC, V38, P398, DOI 10.1016/j.ibmb.2007.11.003; Niu BF, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-187; Niwa R, 2004, J BIOL CHEM, V279, P35942, DOI 10.1074/jbc.M404514200; Oakeshott JG, 2010, INSECT MOL BIOL, V19, P147, DOI 10.1111/j.1365-2583.2009.00961.x; Pelosi P, 2006, CELL MOL LIFE SCI, V63, P1658, DOI 10.1007/s00018-005-5607-0; Petryk A, 2003, P NATL ACAD SCI USA, V100, P13773, DOI 10.1073/pnas.2336088100; Pitts RJ, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-271; Poland TM, 2006, J FOREST, V104, P118; Pureswaran DS, 2009, J INSECT BEHAV, V22, P205, DOI 10.1007/s10905-008-9166-8; Rajarapu SP, 2012, INSECT SCI, V19, P41, DOI 10.1111/j.1744-7917.2011.01447.x; Richards S, 2008, NATURE, V452, P949, DOI 10.1038/nature06784; Richards S, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000313; Robertson HM, 1999, INSECT MOL BIOL, V8, P501, DOI 10.1046/j.1365-2583.1999.00146.x; Robertson HM, 2006, GENOME RES, V16, P1395, DOI 10.1101/gr.5057506; Rodriguez-Saona C, 2006, CHEMOECOLOGY, V16, P75, DOI 10.1007/s00049-005-0329-1; Rodriguez-Saona Cesar R., 2007, Great Lakes Entomologist, V40, P1; Rogers ME, 1999, J EXP BIOL, V202, P1625; Rogers ME, 1997, J BIOL CHEM, V272, P14792, DOI 10.1074/jbc.272.23.14792; Ryall KL, 2012, ENVIRON ENTOMOL, V41, P648, DOI 10.1603/EN11312; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Sato K, 2009, RESULTS PROBL CELL D, V47, P121, DOI 10.1007/400_2008_10; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Seaver EC, 1996, DEVELOPMENT, V122, P567; Sedgwick SG, 1999, TRENDS BIOCHEM SCI, V24, P311, DOI 10.1016/S0968-0004(99)01426-7; Shen Jian-Mei, 2011, Acta Entomologica Sinica, V54, P265; Silk PJ, 2009, NATURWISSENSCHAFTEN, V96, P601, DOI 10.1007/s00114-009-0513-1; Small GJ, 2000, INSECT MOL BIOL, V9, P647, DOI 10.1046/j.1365-2583.2000.00229.x; Smith A, 2006, EFFECTS COMMUNITY ST, V122; Smith TF, 1999, TRENDS BIOCHEM SCI, V24, P181, DOI 10.1016/S0968-0004(99)01384-5; Smyth RR, 2003, J INSECT BEHAV, V16, P347, DOI 10.1023/A:1024824025210; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tegoni M, 2004, TRENDS BIOCHEM SCI, V29, P257, DOI 10.1016/j.tibs.2004.03.003; Touhara K, 2009, ANNU REV PHYSIOL, V71, P307, DOI 10.1146/annurev.physiol.010908.163209; Vieira FG, 2011, GENOME BIOL EVOL, V3, P476, DOI 10.1093/gbe/evr033; Vogel H, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-29; VOGT RG, 1981, NATURE, V293, P161, DOI 10.1038/293161a0; VOGT RG, 1985, P NATL ACAD SCI USA, V82, P8827, DOI 10.1073/pnas.82.24.8827; Vogt RG, 2002, J EXP BIOL, V205, P719; Vogt RG, 2009, INSECT BIOCHEM MOLEC, V39, P448, DOI 10.1016/j.ibmb.2009.03.007; Vosshall LB, 2001, CHEM SENSES, V26, P207, DOI 10.1093/chemse/26.2.207; Vosshall Leslie B., 2003, P567, DOI 10.1016/B978-012107151-6/50021-9; Vosshall LB, 2011, CHEM SENSES, V36, P497, DOI 10.1093/chemse/bjr022; Wang Q, 1999, J BIOL CHEM, V274, P10309, DOI 10.1074/jbc.274.15.10309; Warren JT, 2004, INSECT BIOCHEM MOLEC, V34, P991, DOI 10.1016/j.ibmb.2004.06.009; Watson FL, 2005, SCIENCE, V309, P1874, DOI 10.1126/science.1116887; Weiss LA, 2011, NEURON, V69, P258, DOI 10.1016/j.neuron.2011.01.001; Wojtasek H, 1999, FEBS LETT, V458, P333, DOI 10.1016/S0014-5793(99)01178-3; Xu YL, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-632; Yin J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033589; Zdobnov EM, 2001, BIOINFORMATICS, V17, P847, DOI 10.1093/bioinformatics/17.9.847; Zhi-Liang H, 2007, PLANT AN GEN 15 C SA; Zhou JJ, 2010, INSECT MOL BIOL, V19, P113, DOI 10.1111/j.1365-2583.2009.00919.x; Zhou JJ, 2009, J MOL BIOL, V389, P529, DOI 10.1016/j.jmb.2009.04.015; Zhu JY, 2012, COMP FUNCT GENOM, DOI 10.1155/2012/491748	110	41	47	1	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2013	8	2							e56555	10.1371/journal.pone.0056555	http://dx.doi.org/10.1371/journal.pone.0056555			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104BU	23424668	gold, Green Published			2022-12-25	WOS:000315965100056
J	Conibear, AC; Rosengren, KJ; Daly, NL; Henriques, ST; Craik, DJ				Conibear, Anne C.; Rosengren, K. Johan; Daly, Norelle L.; Henriques, Sonia Troeira; Craik, David J.			The Cyclic Cystine Ladder in theta-Defensins Is Important for Structure and Stability, but Not Antibacterial Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYCLOTIDE KALATA B1; ANTIMICROBIAL PEPTIDE RTD-1; CIRCULAR PROTEINS; BETA; ALPHA; MUTAGENESIS; RETROCYCLIN; LIGATION; BINDING; VIRUS	theta-Defensins are ribosomally synthesized cyclic peptides found in the leukocytes of some primate species and have promising applications as antimicrobial agents and scaffolds for peptide drugs. The cyclic cystine ladder motif, comprising a cyclic peptide backbone and three parallel disulfide bonds, is characteristic of theta-defensins. In this study, we explore the role of the cyclic peptide backbone and cystine ladder in the structure, stability, and activity of theta-defensins. theta-Defensin analogues with different numbers and combinations of disulfide bonds were synthesized and characterized in terms of their NMR solution structures, serum and thermal stabilities, and their antibacterial and membrane-binding activities. Whereas the structures and stabilities of the peptides were primarily dependent on the number and position of the disulfide bonds, their antibacterial and membrane-binding properties were dependent on the cyclic backbone. The results provide insights into the mechanism of action of theta-defensins and illustrate the potential of theta-defensin analogues as scaffolds for peptide drug design.	[Conibear, Anne C.; Rosengren, K. Johan; Daly, Norelle L.; Henriques, Sonia Troeira; Craik, David J.] Univ Queensland, Inst Mol Biosci, Div Chem & Struct Biol, Brisbane, Qld 4072, Australia; [Rosengren, K. Johan] Univ Queensland, Sch Biomed Sci, Brisbane, Qld 4072, Australia	University of Queensland; University of Queensland	Craik, DJ (corresponding author), Univ Queensland, Inst Mol Biosci, Div Chem & Struct Biol, Brisbane, Qld 4072, Australia.	d.craik@imb.uq.edu.au	Conibear, Anne/AFO-0979-2022; Craik, David/B-1695-2010; Rosengren, K. Johan/P-4450-2016; Henriques, Sonia Troeira/J-3500-2016; Conibear, Anne/AAL-3855-2020; Daly, Norelle L/D-4302-2013; Conibear, Anne/C-5246-2014	Conibear, Anne/0000-0002-5482-6225; Craik, David/0000-0003-0007-6796; Rosengren, K. Johan/0000-0002-5007-8434; Henriques, Sonia Troeira/0000-0001-9564-9651; Conibear, Anne/0000-0002-5482-6225; Daly, Norelle L/0000-0002-4697-6602; Conibear, Anne/0000-0002-5482-6225	Australian Research Council [DP0984390, DE120103152]; University of Queensland; National Health and Medical Research Council [APP631420, APP1026501]; Queensland Government	Australian Research Council(Australian Research Council); University of Queensland(University of Queensland); National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Queensland Government	This work was supported by Australian Research Council Grant DP0984390.; Supported by a University of Queensland International scholarship.; Supported by National Health and Medical Research Council Career Development Award Grant APP631420.; Supported by a Queensland Government smart state fellowship. Present address: Queensland Tropical Health Alliance, School of Pharmacy and Molecular Sciences and Centre for Biodiscovery and Molecular Development of Therapeutics, James Cook University, Cairns, QLD 4878, Australia.; Supported by a Discovery Early Career Research Award DE120103152 from the Australian Research Council.; Recipient of National Health and Medical Research Council Professorial Fellow Grant APP1026501. To whom correspondence should be addressed. Tel.: 61( 0)7-3346-2019; E-mail: d.craik@imb.uq.edu.au.	Abuja PM, 2004, FEBS LETT, V566, P301, DOI 10.1016/j.febslet.2004.03.112; Azimi I, 2011, ANTIOXID REDOX SIGN, V14, P113, DOI 10.1089/ars.2010.3620; Brogden KA, 2005, NAT REV MICROBIOL, V3, P238, DOI 10.1038/nrmicro1098; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chakraborty K, 2005, BIOCHEMISTRY-US, V44, P14638, DOI 10.1021/bi050921s; Chan DI, 2006, BBA-BIOMEMBRANES, V1758, P1184, DOI 10.1016/j.bbamem.2006.04.006; Colgrave ML, 2004, BIOCHEMISTRY-US, V43, P5965, DOI 10.1021/bi049711q; Conibear AC, 2012, BIOCHEMISTRY-US, V51, P9718, DOI 10.1021/bi301363a; Conibear AC, 2012, BIOPOLYMERS, V98, P518, DOI 10.1002/bip.22121; Craik DJ, 2006, CURR OPIN DRUG DISC, V9, P251; Craik DJ, 2006, SCIENCE, V311, P1563, DOI 10.1126/science.1125248; Daly NL, 2000, J BIOL CHEM, V275, P19068, DOI 10.1074/jbc.M000450200; Daly NL, 2007, BIOCHEMISTRY-US, V46, P9920, DOI 10.1021/bi700720e; DAWSON PE, 1994, SCIENCE, V266, P776, DOI 10.1126/science.7973629; Doss M, 2009, J IMMUNOL, V182, P7878, DOI 10.4049/jimmunol.0804049; Gallo SA, 2006, J BIOL CHEM, V281, P18787, DOI 10.1074/jbc.M602422200; Garcia AE, 2008, INFECT IMMUN, V76, P5883, DOI 10.1128/IAI.01100-08; Gibbs AC, 1998, NAT STRUCT BIOL, V5, P284, DOI 10.1038/nsb0498-284; Goransson U, 2012, J BIOL CHEM, V287, P27001, DOI 10.1074/jbc.R111.300129; Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284; Henriques ST, 2012, J BIOL CHEM, V287, P33629, DOI 10.1074/jbc.M112.372011; Henriques ST, 2011, J BIOL CHEM, V286, P24231, DOI 10.1074/jbc.M111.253393; Henriques ST, 2010, BIOPOLYMERS, V94, P314, DOI 10.1002/bip.21367; Henriques ST, 2010, DRUG DISCOV TODAY, V15, P57, DOI 10.1016/j.drudis.2009.10.007; Hoover DM, 2003, ANTIMICROB AGENTS CH, V47, P2804, DOI 10.1128/AAC.47.9.2804-2809.2003; Huang YH, 2010, J BIOL CHEM, V285, P10797, DOI 10.1074/jbc.M109.089854; Korsinczky MLJ, 2005, BIOCHEMISTRY-US, V44, P1145, DOI 10.1021/bi048297r; Lehrer RI, 2004, NAT REV MICROBIOL, V2, P727, DOI 10.1038/nrmicro976; Lehrer RI, 2012, J BIOL CHEM, V287, P27014, DOI 10.1074/jbc.R112.346098; Maemoto A, 2004, J BIOL CHEM, V279, P44188, DOI 10.1074/jbc.M406154200; Montalban-Lopez M, 2012, J BIOL CHEM, V287, P27007, DOI 10.1074/jbc.R112.354688; Munk C, 2003, AIDS RES HUM RETROV, V19, P875, DOI 10.1089/088922203322493049; Nederveen AJ, 2005, PROTEINS, V59, P662, DOI 10.1002/prot.20408; Schaal JB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051337; Schmidt NW, 2011, J AM CHEM SOC, V133, P6720, DOI 10.1021/ja200079a; Schroeder BO, 2011, NATURE, V469, P419, DOI 10.1038/nature09674; Selsted ME, 2004, CURR PROTEIN PEPT SC, V5, P365, DOI 10.2174/1389203043379459; Selsted ME, 2005, NAT IMMUNOL, V6, P551, DOI 10.1038/ni1206; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Tang M, 2006, BIOPHYS J, V90, P3616, DOI 10.1529/biophysj.105.062075; Tang YQ, 1999, SCIENCE, V286, P498, DOI 10.1126/science.286.5439.498; Torcato IM, 2013, BBA-BIOMEMBRANES, V1828, P944, DOI 10.1016/j.bbamem.2012.12.002; Trabi M, 2001, BIOCHEMISTRY-US, V40, P4211, DOI 10.1021/bi002028t; Vermeer LS, 2012, J BIOL CHEM, V287, P34120, DOI 10.1074/jbc.M112.359067; Vlieghe P, 2010, DRUG DISCOV TODAY, V15, P40, DOI 10.1016/j.drudis.2009.10.009; Wang CK, 2009, J BIOL CHEM, V284, P10672, DOI 10.1074/jbc.M900021200; Wang W, 2003, J IMMUNOL, V170, P4708, DOI 10.4049/jimmunol.170.9.4708; Weiss TM, 2002, BIOCHEMISTRY-US, V41, P10070, DOI 10.1021/bi025853d; Wiegand I, 2008, NAT PROTOC, V3, P163, DOI 10.1038/nprot.2007.521; WISHART DS, 1995, J BIOMOL NMR, V5, P67, DOI 10.1007/BF00227471; WLODAWER A, 1989, SCIENCE, V245, P616, DOI 10.1126/science.2548279; Wu CL, 2012, NAT CHEM, V4, P1045, DOI [10.1038/NCHEM.1487, 10.1038/nchem.1487]; Wu ZB, 2003, P NATL ACAD SCI USA, V100, P8880, DOI 10.1073/pnas.1533186100; Yasin B, 2004, J VIROL, V78, P5147, DOI 10.1128/JVI.78.10.5147-5156.2004	54	57	60	0	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 12	2013	288	15					10830	10840		10.1074/jbc.M113.451047	http://dx.doi.org/10.1074/jbc.M113.451047			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	125TU	23430740	Green Published, hybrid			2022-12-25	WOS:000317565000060
J	Lorenz, MA; El Azzouny, MA; Kennedy, RT; Burant, CF				Lorenz, Matthew A.; El Azzouny, Mahmoud A.; Kennedy, Robert T.; Burant, Charles F.			Metabolome Response to Glucose in the beta-Cell Line INS-1 832/13	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STIMULATED INSULIN-SECRETION; ACYL-COA ESTERS; MOUSE PANCREATIC-ISLETS; SENSITIVE K+ CHANNEL; MALONYL-COA; MECHANISMS; EXOCYTOSIS; PYRUVATE; NUCLEOTIDES; CARBOXYLASE	Glucose-stimulated insulin secretion (GSIS) from pancreatic beta-cells is triggered by metabolism of the sugar to increase ATP/ADP ratio that blocks the K-ATP channel leading to membrane depolarization and insulin exocytosis. Other metabolic pathways believed to augment insulin secretion have yet to be fully elucidated. To study metabolic changes during GSIS, liquid chromatography with mass spectrometry was used to determine levels of 87 metabolites temporally following a change in glucose from 3 to 10 mM glucose and in response to increasing concentrations of glucose in the INS-1 832/13 beta-cell line. U-[C-13]Glucose was used to probe flux in specific metabolic pathways. Results include a rapid increase in ATP/ADP, anaplerotic tricarboxylic acid cycle flux, and increases in the malonyl CoA pathway, support prevailing theories of GSIS. Novel findings include that aspartate used for anaplerosis does not derive from the glucose fuel added to stimulate insulin secretion, glucose flux into glycerol-3-phosphate, and esterification of long chain CoAs resulting in rapid consumption of long chain CoAs and de novo generation of phosphatidic acid and diacylglycerol. Further, novel metabolites with potential roles in GSIS such as 5-aminoimidazole-4-carboxamide ribotide (ZMP), GDP-mannose, and farnesyl pyrophosphate were found to be rapidly altered following glucose exposure.	[Lorenz, Matthew A.; El Azzouny, Mahmoud A.; Kennedy, Robert T.] Univ Michigan, Dept Chem, Ann Arbor, MI 48105 USA; [Kennedy, Robert T.] Univ Michigan, Dept Pharmacol, Ann Arbor, MI 48105 USA; [Burant, Charles F.] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48105 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Burant, CF (corresponding author), Univ Michigan, Dept Internal Med, 6309 Brehm Tower,1000 Wall St, Ann Arbor, MI 48105 USA.	burantc@umich.edu	Kennedy, Robert/G-9095-2016; ElAzzouny, Mahmoud/G-5748-2013; Burant, Charles/GPC-5690-2022	Kennedy, Robert/0000-0003-2447-7471; Burant, Charles/0000-0001-9189-5003	National Institutes of Health [DK046960, DK079084]; MI Nutrition Obesity Research Center [P30 DK089503]; Michigan Diabetes Research and Training Center [P60 DK20572]; Michigan Regional Comprehensive Metabolomics Resource Core [U24 DK097153]; Robert C. and Veronica Atkins Foundation; A. Alfred Taubman Institute; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK046960, R37DK046960, R01DK079084, P30DK089503, U24DK097153, P60DK020572] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MI Nutrition Obesity Research Center; Michigan Diabetes Research and Training Center; Michigan Regional Comprehensive Metabolomics Resource Core; Robert C. and Veronica Atkins Foundation; A. Alfred Taubman Institute; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in part or in whole, by National Institutes of Health Grants DK046960 (to R. T. K.), DK079084 (to C. F. B. and R. T. K.), MI Nutrition Obesity Research Center (P30 DK089503), the Michigan Diabetes Research and Training Center (P60 DK20572), the Michigan Regional Comprehensive Metabolomics Resource Core (U24 DK097153), and the Robert C. and Veronica Atkins Foundation, and the A. Alfred Taubman Institute (to C. F. B.).	Akkan A G, 1994, Diabetes Res, V25, P13; Becker DJ, 2003, GLYCOBIOLOGY, V13, p41R, DOI 10.1093/glycob/cwg054; Bender K, 2006, BIOCHEM SOC T, V34, P811, DOI 10.1042/BST0340811; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Branstrom R, 2004, DIABETOLOGIA, V47, P277, DOI 10.1007/s00125-003-1299-x; CORKEY BE, 1989, J BIOL CHEM, V264, P21608; Corkey BE, 2000, J NUTR, V130, p299S, DOI 10.1093/jn/130.2.299S; da Silva Xavier Gabriela, 2003, Biochem J, V371, P761, DOI 10.1042/BJ20021812; Detimary P, 1996, J BIOL CHEM, V271, P20559, DOI 10.1074/jbc.271.34.20559; Faergeman NJ, 1997, BIOCHEM J, V323, P1; Fridlyand LE, 2005, AM J PHYSIOL-ENDOC M, V289, pE839, DOI 10.1152/ajpendo.00595.2004; Guay C, 2007, J BIOL CHEM, V282, P35657, DOI 10.1074/jbc.M707294200; HALL ML, 1960, BIOCHEM BIOPH RES CO, V3, P239, DOI 10.1016/0006-291X(60)90231-X; Hardie DG, 2008, INT J OBESITY, V32, pS7, DOI 10.1038/ijo.2008.116; Hasan NM, 2010, ARCH BIOCHEM BIOPHYS, V499, P62, DOI 10.1016/j.abb.2010.05.007; HASHIMOTO T, 1971, EUR J BIOCHEM, V24, P128, DOI 10.1111/j.1432-1033.1971.tb19663.x; Henquin JC, 2009, DIABETES OBES METAB, V11, P168, DOI 10.1111/j.1463-1326.2009.01109.x; Henquin JC, 2000, DIABETES, V49, P1751, DOI 10.2337/diabetes.49.11.1751; Hohmeier HE, 2000, DIABETES, V49, P424, DOI 10.2337/diabetes.49.3.424; Hoy M, 2002, FEBS LETT, V531, P199, DOI 10.1016/S0014-5793(02)03500-7; Jacobs RL, 2007, J BIOL CHEM, V282, P4516, DOI 10.1074/jbc.M605702200; Jensen MV, 2008, AM J PHYSIOL-ENDOC M, V295, pE1287, DOI 10.1152/ajpendo.90604.2008; Jitrapakdee S, 2010, DIABETOLOGIA, V53, P1019, DOI 10.1007/s00125-010-1685-0; Kibbey RG, 2007, CELL METAB, V5, P253, DOI 10.1016/j.cmet.2007.02.008; Kowluru A, 2010, DIABETES, V59, P967, DOI 10.2337/db09-1334; Krippeit-Drews P, 2003, PFLUG ARCH EUR J PHY, V445, P556, DOI 10.1007/s00424-002-0975-x; Kwan EP, 2007, DIABETES OBES METAB, V9, P99, DOI 10.1111/j.1463-1326.2007.00788.x; LIANG Y, 1991, DIABETES, V40, P327, DOI 10.2337/diabetes.40.3.327; Lorenz MA, 2011, ANAL CHEM, V83, P3406, DOI 10.1021/ac103313x; Lu DH, 2002, P NATL ACAD SCI USA, V99, P2708, DOI 10.1073/pnas.052005699; Lu W, 2008, J CHROMATOGR B, V871, P236, DOI 10.1016/j.jchromb.2008.04.031; Luciani DS, 2006, J PHYSIOL-LONDON, V572, P379, DOI 10.1113/jphysiol.2005.101766; MacDonald MJ, 2005, AM J PHYSIOL-ENDOC M, V288, pE1, DOI 10.1152/ajpendo.00218.2004; MACDONALD MJ, 1995, J BIOL CHEM, V270, P20051; Maechler P, 2001, NATURE, V414, P807, DOI 10.1038/414807a; McKenna MC, 2006, BIOCHEM PHARMACOL, V71, P399, DOI 10.1016/j.bcp.2005.10.011; McTaggart SJ, 2006, CELL MOL LIFE SCI, V63, P255, DOI 10.1007/s00018-005-5298-6; Muoio DM, 2008, NAT REV MOL CELL BIO, V9, P193, DOI 10.1038/nrm2327; Nilsson T, 1996, BIOCHEM J, V314, P91, DOI 10.1042/bj3140091; Nolan CJ, 2006, DIABETES, V55, pS16, DOI 10.2337/db06-S003; Odegaard ML, 2010, J BIOL CHEM, V285, P16530, DOI 10.1074/jbc.M109.092593; Poitout V, 2008, AM J PHYSIOL-ENDOC M, V294, pE214, DOI 10.1152/ajpendo.00638.2007; PRENTKI M, 1992, J BIOL CHEM, V267, P5802; Prentki M, 2012, MOL CELL ENDOCRINOL, V353, P88, DOI 10.1016/j.mce.2011.11.004; Roduit R, 2004, DIABETES, V53, P1007, DOI 10.2337/diabetes.53.4.1007; Sato Y, 2010, ANAL CHEM, V82, P9858, DOI 10.1021/ac102211r; Schuit F, 1997, J BIOL CHEM, V272, P18572, DOI 10.1074/jbc.272.30.18572; Simpson NE, 2006, DIABETOLOGIA, V49, P1338, DOI 10.1007/s00125-006-0216-5; Spegel P, 2011, BIOCHEM J, V435, P277, DOI 10.1042/BJ20100655; Straub SG, 2004, AM J PHYSIOL-CELL PH, V287, pC565, DOI 10.1152/ajpcell.00079.2004; Straub SG, 2002, DIABETES-METAB RES, V18, P451, DOI 10.1002/dmrr.329; Sullivan FX, 1998, J BIOL CHEM, V273, P8193, DOI 10.1074/jbc.273.14.8193; Tarasov A, 2004, DIABETES, V53, pS113, DOI 10.2337/diabetes.53.suppl_3.S113; WILCOCK AR, 1972, BIOCHEM MED METAB B, V6, P116, DOI 10.1016/0006-2944(72)90029-4; Wollheim CB, 2002, DIABETES, V51, pS37, DOI 10.2337/diabetes.51.2007.S37; Zhang QM, 1997, P NATL ACAD SCI USA, V94, P6232, DOI 10.1073/pnas.94.12.6232; ZHANG S, 1995, J ENDOCRINOL, V147, P33, DOI 10.1677/joe.0.1470033	57	60	60	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 12	2013	288	15					10923	10935		10.1074/jbc.M112.414961	http://dx.doi.org/10.1074/jbc.M112.414961			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	125TU	23426361	hybrid, Green Published			2022-12-25	WOS:000317565000069
J	Yan, JP; Kaur, S; DeLucia, M; Hao, CL; Mehrens, J; Wang, CP; Golczak, M; Palczewski, K; Gronenborn, AM; Ahn, J; Skowronski, J				Yan, Junpeng; Kaur, Sarabpreet; DeLucia, Maria; Hao, Caili; Mehrens, Jennifer; Wang, Chuanping; Golczak, Marcin; Palczewski, Krzysztof; Gronenborn, Angela M.; Ahn, Jinwoo; Skowronski, Jacek			Tetramerization of SAMHD1 Is Required for Biological Activity and Inhibition of HIV Infection	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESTRICTION FACTOR SAMHD1; AICARDI-GOUTIERES SYNDROME; IMMUNODEFICIENCY-VIRUS TYPE-1; E3 UBIQUITIN LIGASE; VPX; REPLICATION; PROTEIN; GENE; DEGRADATION; MACROPHAGES	SAMHD1 is a dGTP-activated dNTPase that has been implicated as a modulator of the innate immune response. In monocytes and their differentiated derivatives, as well as in quiescent cells, SAMHD1strongly inhibits HIV-1 infection and, to a lesser extent, HIV-2 and simian immunodeficiency virus (SIV) because of their virion-associated virulence factor Vpx, which directs SAMHD1 for proteasomal degradation. Here, we used a combination of biochemical and virologic approaches to gain insights into the functional organization of human SAMHD1. We found that the catalytically active recombinant dNTPase is a dGTP-induced tetramer. Chemical cross-linking studies revealed SAMHD1 tetramers in human monocytic cells, in which it strongly restricts HIV-1 infection. The propensity of SAMHD1 to maintain the tetrameric state in vitro is regulated by its C terminus, located outside of the catalytic domain. Accordingly, we show that the C terminus is required for the full ability of SAMHD1 to deplete dNTP pools and to inhibit HIV-1 infection in U937 monocytes. Interestingly, the human SAMHD1 C terminus contains a docking site for HIV-2/SIVmac Vpx and is known to have evolved under positive selection. This evidence indicates that Vpx targets a functionally important element in SAMHD1. Together, our findings imply that SAMHD1 tetramers are the biologically active form of this dNTPase and provide new insights into the functional organization of SAMHD1.	[Yan, Junpeng; Kaur, Sarabpreet; Hao, Caili; Wang, Chuanping; Skowronski, Jacek] Case Western Reserve Sch Med, Dept Mol Biol & Microbiol, Cleveland, OH 44106 USA; [Golczak, Marcin; Palczewski, Krzysztof] Case Western Reserve Sch Med, Dept Pharmacol, Cleveland, OH 44106 USA; [DeLucia, Maria; Mehrens, Jennifer; Gronenborn, Angela M.; Ahn, Jinwoo] Univ Pittsburgh, Sch Med, Dept Biol Struct, Pittsburgh, PA 15260 USA; [DeLucia, Maria; Mehrens, Jennifer; Gronenborn, Angela M.; Ahn, Jinwoo; Skowronski, Jacek] Univ Pittsburgh, Sch Med, Pittsburgh Ctr HIV Prot Interact, Pittsburgh, PA 15260 USA	Case Western Reserve University; Case Western Reserve University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Ahn, J (corresponding author), Univ Pittsburgh, Sch Med, Dept Biol Struct, Pittsburgh, PA 15260 USA.	jahn@structbio.pitt.edu; jacek.skowronski@case.edu		Gronenborn, Angela M/0000-0001-9072-3525	National Institutes of Health [AI077459, AI100673, P50GM082251]; CWRU/UH Center for AIDS Research Grant [P30AI036219]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI100673, P30AI036219, R01AI077459] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM082251] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CWRU/UH Center for AIDS Research Grant; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants AI077459 and AI100673 (to J. S.), P50GM082251 (to A. M. G., J. A., and J. S.), and CWRU/UH Center for AIDS Research Grant P30AI036219.	Ahn J, 2012, J BIOL CHEM, V287, P12550, DOI 10.1074/jbc.M112.340711; Baldauf HM, 2012, NAT MED, V18, P1682, DOI 10.1038/nm.2964; Bergamaschi A, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-31; Berger A, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002425; Brandariz-Nunez A, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-49; CONNOR RI, 1995, VIROLOGY, V206, P935, DOI 10.1006/viro.1995.1016; Crow YJ, 2009, HUM MOL GENET, V18, pR130, DOI 10.1093/hmg/ddp293; Descours B, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-87; Fromentin E, 2010, ANAL CHEM, V82, P1982, DOI 10.1021/ac902737j; Goldstone DC, 2011, NATURE, V480, P379, DOI 10.1038/nature10623; Goujon C, 2006, GENE THER, V13, P991, DOI 10.1038/sj.gt.3302753; Goujon C, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-2; Hirsch VM, 1998, NAT MED, V4, P1401, DOI 10.1038/3992; Hofmann H, 2012, J VIROL, V86, P12552, DOI 10.1128/JVI.01657-12; Hrecka K, 2007, P NATL ACAD SCI USA, V104, P11778, DOI 10.1073/pnas.0702102104; Hrecka K, 2011, NATURE, V474, P658, DOI 10.1038/nature10195; Janardhan A, 2004, PLOS BIOL, V2, P65, DOI 10.1371/journal.pbio.0020006; Jepps H, 2008, EARLY HUM DEV, V84, P783, DOI 10.1016/j.earlhumdev.2008.09.001; Kaushik R, 2009, CELL HOST MICROBE, V6, P68, DOI 10.1016/j.chom.2009.05.022; KAWAMURA M, 1994, MICROBIOL IMMUNOL, V38, P871, DOI 10.1111/j.1348-0421.1994.tb02140.x; Kim B, 2012, J BIOL CHEM, V287, P21570, DOI 10.1074/jbc.C112.374843; Laguette N, 2012, CELL HOST MICROBE, V11, P205, DOI 10.1016/j.chom.2012.01.007; Laguette N, 2011, NATURE, V474, P654, DOI 10.1038/nature10117; Lahouassa H, 2012, NAT IMMUNOL, V13, P223, DOI 10.1038/ni.2236; Lim ES, 2012, CELL HOST MICROBE, V11, P194, DOI 10.1016/j.chom.2012.01.004; Luban J, 2012, CELL HOST MICROBE, V12, P408, DOI 10.1016/j.chom.2012.10.002; Manel N, 2010, NATURE, V467, P214, DOI 10.1038/nature09337; Negre D, 2000, GENE THER, V7, P1613, DOI 10.1038/sj.gt.3301292; Powell RD, 2011, J BIOL CHEM, V286, P43596, DOI 10.1074/jbc.C111.317628; Rice GI, 2009, NAT GENET, V41, P829, DOI 10.1038/ng.373; Sunseri N, 2011, J VIROL, V85, P6263, DOI 10.1128/JVI.00346-11; Suzuki K, 2007, INT J HEMATOL, V85, P384, DOI 10.1532/IJH97.06213; TANAKA M, 1990, CELL, V60, P375, DOI 10.1016/0092-8674(90)90589-7; Vorontsov II, 2011, J BIOL CHEM, V286, P33158, DOI 10.1074/jbc.M111.250456; Wei W, 2012, CELL MICROBIOL, V14, P1745, DOI 10.1111/j.1462-5822.2012.01835.x; Xin BZ, 2011, P NATL ACAD SCI USA, V108, P5372, DOI 10.1073/pnas.1014265108; Yang YG, 2007, CELL, V131, P873, DOI 10.1016/j.cell.2007.10.017; YU XF, 1991, J VIROL, V65, P5088, DOI 10.1128/JVI.65.9.5088-5091.1991	38	110	116	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 12	2013	288	15					10406	10417		10.1074/jbc.M112.443796	http://dx.doi.org/10.1074/jbc.M112.443796			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	125TU	23426366	Green Published, hybrid			2022-12-25	WOS:000317565000021
J	Reddy, K; Zamiri, B; Stanley, SYR; Macgregor, RB; Pearson, CE				Reddy, Kaalak; Zamiri, Bita; Stanley, Sabrina Y. R.; Macgregor, Robert B., Jr.; Pearson, Christopher E.			The Disease-associated r(GGGGCC)(n) Repeat from the C9orf72 Gene Forms Tract Length-dependent Uni- and Multimolecular RNA G-quadruplex Structures	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEXANUCLEOTIDE REPEAT; MESSENGER-RNA; TRANSLATION; INSTABILITY; BINDING; 5'-UTR; EXPANSIONS; STABILITY; PROTEIN; REGION	Certain DNA and RNA sequences can form G-quadruplexes, which can affect promoter activity, genetic instability, RNA splicing, translation, and neurite mRNA localization. Amyotrophic lateral sclerosis and frontotemporal dementia were recently shown to be caused by expansion of a (GGGGCC)(n). (GGCCCC)(n) repeat in the C9orf72 gene. Mutant r(GGGGCC)(n)-containing transcripts aggregate in nuclear foci possibly sequestering repeat-binding proteins, suggesting a toxic RNA pathogenesis. We demonstrate that the r(GGGGCC)(n) RNA but not the C-rich r(GGCCCC)(n) RNA forms extremely stable uni- and multimolecular parallel G-quadruplex structures (up to 95 degrees C). Multimolecular G-quadruplex formation is influenced by repeat number and RNA concentration. MBNL1, a splicing factor that is sequestered in myotonic dystrophy patients by binding to expanded r(CUG)n repeat hairpins, does not bind the C9orf72 repeats, but the splicing factor ASF/SF2 can bind the r(GGGGCC)(n) repeat. Because multimolecular G-quadruplexes are enhanced by repeat length, RNA-RNA interactions facilitated by G-quadruplex formation at expanded repeats might influence transcript aggregation and foci formation in amyotrophic lateral sclerosis-frontotemporal dementia cells. Tract length-dependent G-quadruplex formation by the C9orf72RNA should be considered when assessing the role of this repeat in C9orf72 gene activity, protein binding, transcript foci formation, and translation of the C9orf72 product, including the non-canonical repeat-associated non-ATG translation (RAN translation) into pathologic dipeptide repeats, as well as any oligonucleotide repeat-based therapy.	[Reddy, Kaalak; Pearson, Christopher E.] Hosp Sick Children, Program Genet & Genome Biol, Toronto, ON M5G 1L7, Canada; [Reddy, Kaalak; Stanley, Sabrina Y. R.; Pearson, Christopher E.] Univ Toronto, Program Mol Genet, Toronto, ON M5G 1L7, Canada; [Zamiri, Bita; Macgregor, Robert B., Jr.] Univ Toronto, Leslie Dan Fac Pharm, Grad Dept Pharmaceut Sci, Toronto, ON M5S 3M2, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto	Pearson, CE (corresponding author), Hosp Sick Children, Program Genet & Genome Biol, 101 Coll St,East Tower,15-312 TMDT, Toronto, ON M5G 1L7, Canada.	cepearson.sickkids@gmail.com		Pearson, Christopher/0000-0001-9545-4205	Amyotrophic Lateral Sclerosis Association of America; Canadian Institutes of Health Research (CIHR); Natural Science and Engineering Research Council of Canada; Ontario Graduate Scholarship (OGS)	Amyotrophic Lateral Sclerosis Association of America; Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Natural Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Ontario Graduate Scholarship (OGS)(Ontario Graduate Scholarship)	This work was supported by grants from the Amyotrophic Lateral Sclerosis Association of America (to C. E. P.), the Canadian Institutes of Health Research (CIHR) to (C. E. P.), and the Natural Science and Engineering Research Council of Canada (to R. B. M.).; supported by an Ontario Graduate Scholarship (OGS).	Abu-Ghazalah RM, 2009, BIOPHYS CHEM, V141, P180, DOI 10.1016/j.bpc.2009.01.013; Arora A, 2009, FEBS J, V276, P3628, DOI 10.1111/j.1742-4658.2009.07082.x; Ash PEA, 2013, NEURON, V77, P639, DOI 10.1016/j.neuron.2013.02.004; Batra R, 2010, HUM MOL GENET, V19, pR77, DOI 10.1093/hmg/ddq132; Biffi G, 2013, NAT CHEM, V5, P182, DOI [10.1038/NCHEM.1548, 10.1038/nchem.1548]; Bugaut A, 2012, NUCLEIC ACIDS RES, V40, P4727, DOI 10.1093/nar/gks068; Cartegni L, 2003, NUCLEIC ACIDS RES, V31, P3568, DOI 10.1093/nar/gkg616; DeJesus-Hernandez M, 2011, NEURON, V72, P245, DOI 10.1016/j.neuron.2011.09.011; Didiot MC, 2008, NUCLEIC ACIDS RES, V36, P4902, DOI 10.1093/nar/gkn472; Faudale M, 2012, CHEM COMMUN, V48, P874, DOI 10.1039/c1cc15850c; Fisette JF, 2012, J NEUROCHEM, V121, P763, DOI 10.1111/j.1471-4159.2012.07680.x; Fratta P, 2012, SCI REP-UK, V2, DOI 10.1038/srep01016; Gomez-Tortosa E, 2013, NEUROLOGY, V80, P366, DOI 10.1212/WNL.0b013e31827f08ea; Graff-Radford NR, 2007, SEMIN NEUROL, V27, P48, DOI 10.1055/s-2006-956755; Kino Y, 2004, HUM MOL GENET, V13, P495, DOI 10.1093/hmg/ddh056; Kumari S, 2007, NAT CHEM BIOL, V3, P218, DOI 10.1038/nchembio864; Lipps HJ, 2009, TRENDS CELL BIOL, V19, P414, DOI 10.1016/j.tcb.2009.05.002; Lopes J, 2011, EMBO J, V30, P4033, DOI 10.1038/emboj.2011.316; Marcel V, 2011, CARCINOGENESIS, V32, P271, DOI 10.1093/carcin/bgq253; Melko M, 2010, BIOCHIMIE, V92, P919, DOI 10.1016/j.biochi.2010.05.018; Merkina EE, 2005, BIOPHYS J, V89, P365, DOI 10.1529/biophysj.105.061259; Miller JW, 2000, EMBO J, V19, P4439, DOI 10.1093/emboj/19.17.4439; Mori K, 2013, SCIENCE, V339, P1335, DOI 10.1126/science.1232927; Neidle S, 2010, FEBS J, V277, P1118, DOI 10.1111/j.1742-4658.2009.07463.x; Neidle S, 2009, CURR OPIN STRUC BIOL, V19, P239, DOI 10.1016/j.sbi.2009.04.001; Pearson CE, 1996, BIOCHEMISTRY-US, V35, P5041, DOI 10.1021/bi9601013; Pearson CE, 2005, NAT REV GENET, V6, P729, DOI 10.1038/nrg1689; Pearson CE, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002018; Pedroso IA, 2007, BIOPOLYMERS, V87, P74, DOI 10.1002/bip.20790; Piazza A, 2010, NUCLEIC ACIDS RES, V38, P4337, DOI 10.1093/nar/gkq136; Reddy K, 2011, NUCLEIC ACIDS RES, V39, P1749, DOI 10.1093/nar/gkq935; Renton AE, 2011, NEURON, V72, P257, DOI 10.1016/j.neuron.2011.09.010; Rowland LP, 2001, NEW ENGL J MED, V344, P1688, DOI 10.1056/NEJM200105313442207; Sellier C, 2010, EMBO J, V29, P1248, DOI 10.1038/emboj.2010.21; Shin J, 2009, NEUROSCI LETT, V466, P99, DOI 10.1016/j.neulet.2009.07.079; Siddiqui-Jain A, 2002, P NATL ACAD SCI USA, V99, P11593, DOI 10.1073/pnas.182256799; Sobczak K, 2010, J BIOL CHEM, V285, P12755, DOI 10.1074/jbc.M109.078790; TACKE R, 1995, EMBO J, V14, P3540, DOI 10.1002/j.1460-2075.1995.tb07360.x; Viglasky V, 2010, BIOCHEMISTRY-US, V49, P2110, DOI 10.1021/bi902099u; Wheeler TM, 2009, SCIENCE, V325, P336, DOI 10.1126/science.1173110; Willemsen R, 2011, CLIN GENET, V80, P214, DOI 10.1111/j.1399-0004.2011.01723.x; Wojciechowska M, 2011, RNA BIOL, V8, P565, DOI 10.4161/rna.8.4.15397; Wu YL, 2010, FEBS J, V277, P3470, DOI 10.1111/j.1742-4658.2010.07760.x; Yuan Y, 2007, NUCLEIC ACIDS RES, V35, P5474, DOI 10.1093/nar/gkm601; Zhai QQ, 2012, BIOORG MED CHEM LETT, V22, P1142, DOI 10.1016/j.bmcl.2011.11.099; Zu T, 2011, P NATL ACAD SCI USA, V108, P260, DOI 10.1073/pnas.1013343108	46	227	230	2	60	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 5	2013	288	14					9860	9866		10.1074/jbc.C113.452532	http://dx.doi.org/10.1074/jbc.C113.452532			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	119RB	23423380	hybrid, Green Published			2022-12-25	WOS:000317114000026
J	Cao, HR; Yin, XL; Cao, YJ; Jin, YC; Wang, S; Kong, YH; Chen, YX; Gao, JG; Heller, S; Xu, ZG				Cao, Huiren; Yin, Xiaolei; Cao, Yujie; Jin, Yecheng; Wang, Shan; Kong, Yanhui; Chen, Yuexing; Gao, Jiangang; Heller, Stefan; Xu, Zhigang			FCHSD1 and FCHSD2 Are Expressed in Hair Cell Stereocilia and Cuticular Plate and Regulate Actin Polymerization In Vitro	PLOS ONE			English	Article							AMES WALTZER MICE; INNER-EAR; SYNAPTIC GROWTH; NERVOUS WRECK; MYOSIN VIIA; MOLECULAR TREADMILL; PLASMA-MEMBRANE; PCH PROTEINS; LOCALIZATION; TIPS	Mammalian FCHSD1 and FCHSD2 are homologous proteins containing an amino-terminal F-BAR domain and two SH3 domains near their carboxyl-termini. We report here that FCHSD1 and FCHSD2 are expressed in mouse cochlear sensory hair cells. FCHSD1 mainly localizes to the cuticular plate, whereas FCHSD2 mainly localizes along the stereocilia in a punctuate pattern. Nervous Wreck (Nwk), the Drosophila ortholog of FCHSD1 and FCHSD2, has been shown to bind Wsp and play an important role in F-actin assembly. We show that, like its Drosophila counterpart, FCHSD2 interacts with WASP and N-WASP, the mammalian orthologs of Drosophila Wsp, and stimulates F-actin assembly in vitro. In contrast, FCHSD1 doesn't bind WASP or N-WASP, and can't stimulate F-actin assembly when tested in vitro. We found, however, that FCHSD1 binds via its F-BAR domain to the SH3 domain of Sorting Nexin 9 (SNX9), a well characterized BAR protein that has been shown to promote WASP-Arp2/3-dependent F-actin polymerization. FCHSD1 greatly enhances SNX9's WASP-Arp2/3-dependent F-actin polymerization activity. In hair cells, SNX9 was detected in the cuticular plate, where it colocalizes with FCHSD1. Our results suggest that FCHSD1 and FCHSD2 could modulate F-actin assembly or maintenance in hair cell stereocilia and cuticular plate.	[Cao, Huiren; Yin, Xiaolei; Cao, Yujie; Jin, Yecheng; Wang, Shan; Kong, Yanhui; Chen, Yuexing; Gao, Jiangang; Xu, Zhigang] Shandong Univ, Sch Life Sci, Inst Dev Biol, Shandong Prov Key Lab Anim Cells & Dev Biol, Jinan, Shandong, Peoples R China; [Heller, Stefan] Stanford Univ, Sch Med, Dept Otolaryngol Head & Neck Surg, Stanford, CA USA; [Heller, Stefan] Stanford Univ, Sch Med, Dept Cellular & Mol Physiol, Stanford, CA USA	Shandong University; Stanford University; Stanford University	Xu, ZG (corresponding author), Shandong Univ, Sch Life Sci, Inst Dev Biol, Shandong Prov Key Lab Anim Cells & Dev Biol, Jinan, Shandong, Peoples R China.	xuzg@sdu.edu.cn			National Basic Research Program of China (973) [2011CB504505]; National Natural Science Foundation of China [31070969]; Excellent Young Scientists Foundation of Shandong Province [BS2010SW017]; National Institutes of Health [DC004563, DC010363]	National Basic Research Program of China (973)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Excellent Young Scientists Foundation of Shandong Province; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by grants from National Basic Research Program of China (973) (2011CB504505) to ZX, National Natural Science Foundation of China (31070969) to ZX, Excellent Young Scientists Foundation of Shandong Province (BS2010SW017) to ZX, and National Institutes of Health grants DC004563 and DC010363 to SH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed ZM, 2003, HUM MOL GENET, V12, P3215, DOI 10.1093/hmg/ddg358; ASSAD JA, 1991, NEURON, V7, P985, DOI 10.1016/0896-6273(91)90343-X; Avraham KB, 1997, HUM MOL GENET, V6, P1225, DOI 10.1093/hmg/6.8.1225; Belyantseva IA, 2003, P NATL ACAD SCI USA, V100, P13958, DOI 10.1073/pnas.2334417100; Beurg M, 2009, NAT NEUROSCI, V12, P553, DOI 10.1038/nn.2295; Chitu V, 2007, TRENDS CELL BIOL, V17, P145, DOI 10.1016/j.tcb.2007.01.003; Co C, 2007, CELL, V128, P901, DOI 10.1016/j.cell.2006.12.049; Coyle IP, 2004, NEURON, V41, P521, DOI 10.1016/S0896-6273(04)00016-9; Delprat B, 2005, HUM MOL GENET, V14, P401, DOI 10.1093/hmg/ddi036; FLOCK A, 1977, J CELL BIOL, V75, P339, DOI 10.1083/jcb.75.2.339; FLOCK A, 1981, J NEUROCYTOL, V10, P133, DOI 10.1007/BF01181749; Goodyear RJ, 2005, J COMP NEUROL, V485, P75, DOI 10.1002/cne.20513; HASSON T, 1995, P NATL ACAD SCI USA, V92, P9815, DOI 10.1073/pnas.92.21.9815; Hasson T, 1997, J CELL BIOL, V137, P1287, DOI 10.1083/jcb.137.6.1287; Heller S, 1998, P NATL ACAD SCI USA, V95, P11400, DOI 10.1073/pnas.95.19.11400; Howard L, 1999, J BIOL CHEM, V274, P31693, DOI 10.1074/jbc.274.44.31693; Itoh T, 2005, DEV CELL, V9, P791, DOI 10.1016/j.devcel.2005.11.005; Itoh T, 2006, BBA-MOL CELL BIOL L, V1761, P897, DOI 10.1016/j.bbalip.2006.06.015; Katoh M, 2004, INT J MOL MED, V13, P749; Kikkawa YS, 2008, ANAT REC, V291, P224, DOI 10.1002/ar.20632; Kruth KA, 2012, J BIOL CHEM, V287, P27217, DOI 10.1074/jbc.M112.377283; Legendre K, 2008, J CELL SCI, V121, P3347, DOI 10.1242/jcs.028134; Li Y, 2010, AM J HUM GENET, V86, P479, DOI 10.1016/j.ajhg.2010.02.003; Lundmark R, 2009, J CELL SCI, V122, P5, DOI 10.1242/jcs.037135; Manor U, 2008, SEMIN CELL DEV BIOL, V19, P502, DOI 10.1016/j.semcdb.2008.07.006; Mburu P, 2006, P NATL ACAD SCI USA, V103, P10973, DOI 10.1073/pnas.0600923103; Merritt RC, 2012, CURR BIOL, V22, P320, DOI 10.1016/j.cub.2011.12.053; Mullins RD, 1997, J CELL BIOL, V136, P331, DOI 10.1083/jcb.136.2.331; O'Connor-Giles KM, 2008, NEURON, V58, P507, DOI 10.1016/j.neuron.2008.03.007; Ohno H, 2003, ONCOGENE, V22, P8422, DOI 10.1038/sj.onc.1206996; Pawlowski KS, 2006, JARO-J ASSOC RES OTO, V7, P83, DOI 10.1007/s10162-005-0024-5; Peng AW, 2009, J NEUROSCI, V29, P15083, DOI 10.1523/JNEUROSCI.2782-09.2009; POLLARD TD, 1984, J CELL BIOL, V99, P769, DOI 10.1083/jcb.99.3.769; Rehman AU, 2010, AM J HUM GENET, V86, P378, DOI 10.1016/j.ajhg.2010.01.030; Rodal AA, 2008, J NEUROSCI, V28, P8316, DOI 10.1523/JNEUROSCI.2304-08.2008; Rodal AA, 2011, J CELL BIOL, V193, P201, DOI 10.1083/jcb.201009052; Rzadzinska AK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007097; Rzadzinska AK, 2004, J CELL BIOL, V164, P887, DOI 10.1083/jcb.200310055; Salles FT, 2009, NAT CELL BIOL, V11, P443, DOI 10.1038/ncb1851; SCARFONE E, 1988, NEUROSCI LETT, V93, P13, DOI 10.1016/0304-3940(88)90004-3; Schneider ME, 2006, J NEUROSCI, V26, P10243, DOI 10.1523/JNEUROSCI.2812-06.2006; Schneider ME, 2002, NATURE, V418, P837, DOI 10.1038/418837a; Self T, 1999, DEV BIOL, V214, P331, DOI 10.1006/dbio.1999.9424; Self T, 1998, DEVELOPMENT, V125, P557; Senften M, 2006, J NEUROSCI, V26, P2060, DOI 10.1523/JNEUROSCI.4251-05.2006; SLEPECKY N, 1985, HEARING RES, V20, P245, DOI 10.1016/0378-5955(85)90029-2; SOBIN A, 1983, ACTA OTO-LARYNGOL, V96, P407, DOI 10.3109/00016488309132726; SPUDICH JA, 1971, J BIOL CHEM, V246, P4866; Tsujita K, 2006, J CELL BIOL, V172, P269, DOI 10.1083/jcb.200508091; Xu ZG, 2008, J NEUROSCI, V28, P11269, DOI 10.1523/JNEUROSCI.3833-08.2008; Yan D, 2011, INT J EXP PATHOL, V92, P66, DOI 10.1111/j.1365-2613.2010.00751.x; Yarar D, 2007, DEV CELL, V13, P43, DOI 10.1016/j.devcel.2007.04.014; Zhang DS, 2012, NATURE, V481, P520, DOI 10.1038/nature10745	53	28	28	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e56516	10.1371/journal.pone.0056516	http://dx.doi.org/10.1371/journal.pone.0056516			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437151	gold, Green Submitted, Green Published			2022-12-25	WOS:000315184200089
J	Chung, PY; Chung, LY; Navaratnam, P				Chung, Pooi Yin; Chung, Lip Yong; Navaratnam, Parasakthi			Transcriptional Profiles of the Response of Methicillin-Resistant Staphylococcus aureus to Pentacyclic Triterpenoids	PLOS ONE			English	Article							ANTIMICROBIAL ACTIVITY; VIRULENCE DETERMINANTS; ANTIBIOTICS; EXPRESSION; MECA; INHIBITION; TARGETS	Staphylococcus aureus is an important human pathogen in both hospital and the community that has demonstrated resistance to all currently available antibiotics over the last two decades. Multidrug-resistant isolates of methicillin-resistant S. aureus (MRSA) exhibiting decreased susceptibilities to glycopeptides has also emerged, representing a crucial challenge for antimicrobial therapy and infection control. The availability of complete whole-genome nucleotide sequence data of various strains of S. aureus presents an opportunity to explore novel compounds and their targets to address the challenges presented by antimicrobial drug resistance in this organism. Study compounds alpha-amyrin [3 beta-hydroxy-urs-12-en-3-ol (AM)], betulinic acid [3 beta-hydroxy-20(29)-lupaene-28-oic acid (BA)] and betulinaldehyde [3 beta-hydroxy-20(29)-lupen-28-al (BE)] belong to pentacyclic triterpenoids and were reported to exhibit antimicrobial activities against bacteria and fungi, including S. aureus. The MIC values of these compounds against a reference strain of methicillin-resistant S. aureus (MRSA) (ATCC 43300) ranged from 64 mu g/ml to 512 mu g/ml. However, the response mechanisms of S. aureus to these compounds are still poorly understood. The transcription profile of reference strain of MRSA treated with sub-inhibitory concentrations of the three compounds was determined using Affymetrix GeneChips. The findings showed that these compounds regulate multiple desirable targets in cell division, two-component system, ABC transporters, fatty acid biosynthesis, peptidoglycan biosynthesis, aminoacyl-tRNA synthetase, ribosome and beta-lactam resistance pathways which could be further explored in the development of therapeutic agents for the treatment of S. aureus infections.	[Chung, Pooi Yin; Navaratnam, Parasakthi] Monash Univ, Sch Med & Hlth Sci, Selangor, Malaysia; [Chung, Lip Yong] Univ Malaya, Fac Med, Dept Pharm, Kuala Lumpur, Malaysia	Monash University; Monash University Sunway; Universiti Malaya	Chung, PY (corresponding author), Int Med Univ, Kuala Lumpur 57000, Malaysia.	pychu6@student.monash.edu	CHUNG, LIP YONG/B-7764-2010	CHUNG, LIP YONG/0000-0002-3596-768X	Ministry of Science, Technology and Innovation, Malaysia [02-02-10-SF0056]; Monash University [5140029-000-00]	Ministry of Science, Technology and Innovation, Malaysia(Ministry of Energy, Science, Technology, Environment and Climate Change (MESTECC), Malaysia); Monash University(Monash University)	This project was partly funded by the Ministry of Science, Technology and Innovation, Malaysia (eScience 02-02-10-SF0056) (March 2010 to February 2012) and Monash University (Seed Grant 5140029-000-00) (April 2009 to March 2010) under Parasakthi Navaratnam. Both the funding bodies provided financial support for the conduct of the research and are not involved in the study design; in the collection, analysis and interpretation of data; in the writing of the report; and in the decision to submit the paper for publication. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrett CT, 2003, CURR OPIN BIOTECH, V14, P621, DOI 10.1016/j.copbio.2003.10.003; Bio-Rad Laboratories, 2006, REAL TIM PCR APPL GU; Brotz-Oesterhelt H, 2010, FUTURE MICROBIOL, V5, P1553, DOI 10.2217/FMB.10.119; Bronner S, 2004, FEMS MICROBIOL REV, V28, P183, DOI 10.1016/j.femsre.2003.09.003; CASSELS R, 1995, J BACTERIOL, V177, P5161, DOI 10.1128/jb.177.17.5161-5165.1995; Champney W. Scott, 2006, Infectious Disorders - Drug Targets, V6, P377; Chandramu C, 2003, PHYTOTHER RES, V17, P129, DOI 10.1002/ptr.1088; Cheung AL, 2004, FEMS IMMUNOL MED MIC, V40, P1, DOI 10.1016/S0928-8244(03)00309-2; Chung PY, 2011, ANN CLIN MICROB ANTI, V10, DOI 10.1186/1476-0711-10-25; Chung PY, 2004, PHARM BIOL, V42, P292, DOI 10.1080/13880200490511837; El Zoeiby A, 2003, MOL MICROBIOL, V47, P1, DOI 10.1046/j.1365-2958.2003.03289.x; Feng HH, 2009, J BIOMED BIOTECHNOL, DOI 10.1155/2009/617509; Gibbons S, 2004, NAT PROD REP, V21, P263, DOI 10.1039/b212695h; Giraudo AT, 1999, FEMS MICROBIOL LETT, V177, P15, DOI 10.1016/S0378-1097(99)00282-7; Hutter B, 2004, ANTIMICROB AGENTS CH, V48, P2838, DOI 10.1128/AAC.48.8.2838-2844.2004; Infectious Diseases Society of America (IDSA), 2004, BAD BUGS NO DRUGS AN; KuwaharaArai K, 1996, ANTIMICROB AGENTS CH, V40, P2680, DOI 10.1128/AAC.40.12.2680; Lange RP, 2007, CURR PHARM DESIGN, V13, P3140, DOI 10.2174/138161207782110408; Levy SB, 2004, NAT MED, V10, pS122, DOI 10.1038/nm1145; Livermore DM, 2003, CLIN INFECT DIS, V36, pS11, DOI 10.1086/344654; Lock RL, 2008, NAT REV DRUG DISCOV, V7, P324, DOI 10.1038/nrd2510; Macheboeuf P, 2006, FEMS MICROBIOL REV, V30, P673, DOI 10.1111/j.1574-6976.2006.00024.x; Maguire BA, 2009, MICROBIOL MOL BIOL R, V73, P22, DOI 10.1128/MMBR.00030-08; Mallavadhani UV, 2004, BIOL PHARM BULL, V27, P1576, DOI 10.1248/bpb.27.1576; McAleese F, 2006, J BACTERIOL, V188, P1120, DOI 10.1128/JB.188.3.1120-1133.2006; Monaghan RL, 2006, BIOCHEM PHARMACOL, V71, P901, DOI 10.1016/j.bcp.2005.11.023; Novick RP, 2003, MOL MICROBIOL, V48, P1429, DOI 10.1046/j.1365-2958.2003.03526.x; Ohlsen K, 2007, FUTURE MICROBIOL, V2, P655, DOI 10.2217/17460913.2.6.655; Park HS, 2007, J ANTIMICROB CHEMOTH, V60, P568, DOI 10.1093/jac/dkm236; Qiu JF, 2006, FEMS MICROBIOL LETT, V263, P26, DOI 10.1111/j.1574-6968.2006.00394.x; RYFFEL C, 1992, ANTIMICROB AGENTS CH, V36, P25, DOI 10.1128/AAC.36.1.25; Schuhly W, 1999, PLANTA MED, V65, P740, DOI 10.1055/s-1999-14054; Silver LL, 2007, NAT REV DRUG DISCOV, V6, P41, DOI 10.1038/nrd2202; Singh B, 2003, PHYTOTHER RES, V17, P814, DOI 10.1002/ptr.1202; Speziali CD, 2006, J BACTERIOL, V188, P2048, DOI 10.1128/JB.188.6.2048-2055.2006; Tao JS, 2000, EXPERT OPIN INV DRUG, V9, P1767, DOI 10.1517/13543784.9.8.1767; Tsiodras S, 2001, LANCET, V358, P207, DOI 10.1016/S0140-6736(01)05410-1; Utaida S, 2003, MICROBIOL-SGM, V149, P2719, DOI 10.1099/mic.0.26426-0; Vollmer W, 2008, CHEM BIOL, V15, P93, DOI 10.1016/j.chembiol.2008.02.001; Wang DC, 2008, FEMS MICROBIOL LETT, V279, P217, DOI 10.1111/j.1574-6968.2007.01031.x; Weller TMA, 1999, J ANTIMICROB CHEMOTH, V43, P15, DOI 10.1093/jac/43.1.15; Xue T, 2011, INFECT IMMUN, V79, P2154, DOI 10.1128/IAI.01180-10; Yu L, 2008, J BIOTECHNOL, V135, P304, DOI 10.1016/j.jbiotec.2008.04.010; Zhang HZ, 2001, SCIENCE, V291, P1962, DOI 10.1126/science.1055144; Zhang YM, 2008, NAT REV MICROBIOL, V6, P222, DOI 10.1038/nrmicro1839	45	17	18	4	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e56687	10.1371/journal.pone.0056687	http://dx.doi.org/10.1371/journal.pone.0056687			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437212	gold, Green Published, Green Submitted			2022-12-25	WOS:000315184200142
J	Pang, ZL; Shao, JP; Chen, L; Lu, XH; Hu, J; Qin, ZH; Liu, XL				Pang, Zhili; Shao, Jingpeng; Chen, Lei; Lu, Xiaohong; Hu, Jian; Qin, Zhaohai; Liu, Xili			Resistance to the Novel Fungicide Pyrimorph in Phytophthora capsici: Risk Assessment and Detection of Point Mutations in CesA3 That Confer Resistance	PLOS ONE			English	Article							BASE-LINE SENSITIVITY; PLANT PATHOGEN; HOST-RANGE; BLIGHT; VIRULENCE; MEFENOXAM; POPULATION; DIVERSITY; METALAXYL; GENES	Pyrimorph is a novel fungicide with high activity against the plant pathogen Phytophthora capsici. We investigated the risk that P. capsici can develop resistance to pyrimorph. The baseline sensitivities of 226 P. capsici isolates, tested by mycelial growth inhibition, showed a unimodal distribution with a mean EC50 value of 1.4261 (+/-0.4002) mu g/ml. Twelve pyrimorph-resistant mutants were obtained by repeated exposure to pyrimorph in vitro with a frequency of approximately 1 x 10(-4). The resistance factors of the mutants ranged from 10.67 to 56.02. Pyrimorph resistance of the mutants was stable after 10 transfers on pyrimorph-free medium. Fitness in sporulation, cystospore germination, and pathogenicity in the pyrimorph-resistant mutants was similar to or less than that in the parental wild-type isolates. On detached pepper leaves and pepper plants treated with the recommended maximum dose of pyrimorph, however, virulence was greater for mutants with a high level of pyrimorph resistance than for the wild type. The results suggest that the risk of P. capsici developing resistance to pyrimorph is low to moderate. Among mutants with a high level of pyrimorph resistance, EC50 values for pyrimorph and CAA fungicides flumorph, dimethomorph, and mandipropamid were positively correlated. This indicated that point mutations in cellulose synthase 3 (CesA3) may confer resistance to pyrimorph. Comparison of CesA3 in isolates with a high level of pyrimorph resistance and parental isolates showed that an amino acid change from glutamine to lysine at position 1077 resulted in stable, high resistance in the mutants. Based on the point mutations, an allele-specific PCR method was developed to detect pyrimorph resistance in P. capsici populations.	[Pang, Zhili; Shao, Jingpeng; Chen, Lei; Lu, Xiaohong; Hu, Jian; Liu, Xili] China Agr Univ, Coll Agr & Biotechnol, Dept Plant Pathol, Beijing 100094, Peoples R China; [Qin, Zhaohai] China Agr Univ, Coll Sci, Dept Appl Chem, Beijing 100094, Peoples R China	China Agricultural University; China Agricultural University	Liu, XL (corresponding author), China Agr Univ, Coll Agr & Biotechnol, Dept Plant Pathol, Beijing 100094, Peoples R China.	seedling@cau.edu.cn	Chen, Lei/A-2487-2015	Chen, Lei/0000-0001-5331-9574; Pang, Zhili/0000-0001-8047-1272	China National Science Foundation [31272061]; special Fund for Agro-scientific Research in the Public Interest [201003004, 201303023]	China National Science Foundation(National Natural Science Foundation of China (NSFC)); special Fund for Agro-scientific Research in the Public Interest	This work was funded by the China National Science Foundation (NO. 31272061) and special Fund for Agro-scientific Research in the Public Interest (No. 201003004, 201303023). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoki Y, 2011, PEST MANAG SCI, V67, P1557, DOI 10.1002/ps.2214; Bi Y, 2011, PHYTOPATHOLOGY, V101, P1104, DOI 10.1094/PHYTO-01-11-0010; Blum M, 2011, PEST MANAG SCI, V67, P1211, DOI 10.1002/ps.2238; Blum M, 2010, FUNGAL GENET BIOL, V47, P499, DOI 10.1016/j.fgb.2010.02.009; Blum M, 2010, MOL PLANT PATHOL, V11, P227, DOI 10.1111/j.1364-3703.2009.00604.x; BRASIER CM, 1979, T BRIT MYCOL SOC, V72, P111, DOI 10.1016/S0007-1536(79)80015-7; Cafe AC, 1995, PLANT PATHOL, V44, P1025, DOI 10.1111/j.1365-3059.1995.tb02661.x; Chen L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042069; Chen Xiao-xia, 2007, Nongyaoxue Xuebao, V9, P229; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Davidson CR, 2002, PLANT DIS, V86, P1049, DOI [10.1094/PDIS.2002.86.9.1049A, 10.1094/PDIS.2002.86.7.813B]; Drenkard E, 2000, PLANT PHYSIOL, V124, P1483, DOI 10.1104/pp.124.4.1483; Dunn AR, 2010, PLANT DIS, V94, P1461, DOI 10.1094/PDIS-03-10-0221; Enzenbacher TB, 2012, PLANT DIS, V96, P1404, DOI 10.1094/PDIS-09-11-0771-RE; Gevens AJ, 2007, PHYTOPATHOLOGY, V97, P421, DOI 10.1094/PHYTO-97-4-0421; Granke LL, 2012, EUR J PLANT PATHOL, V132, P281, DOI 10.1007/s10658-011-9873-4; HARTMAN GL, 1993, PLANT DIS, V77, P588, DOI 10.1094/PD-77-0588; Hausbeck MK, 2004, PLANT DIS, V88, P1292, DOI 10.1094/PDIS.2004.88.12.1292; Hayashi K, 2004, THEOR APPL GENET, V108, P1212, DOI 10.1007/s00122-003-1553-0; Huang Xiong-ying, 2007, Nongyaoxue Xuebao, V9, P376; HWANG BK, 1995, PLANT DIS, V79, P221, DOI 10.1094/PD-79-0221; KIM FS, 1992, PLANT DIS, V76, P486, DOI 10.1094/PD-76-0486; Kreutzer WA, 1940, PHYTOPATHOLOGY, V30, P972; Lamour KH, 2000, PHYTOPATHOLOGY, V90, P396, DOI 10.1094/PHYTO.2000.90.4.396; Lamour KH, 2012, MOL PLANT PATHOL, V13, P329, DOI 10.1111/j.1364-3703.2011.00754.x; Leonian LH, 1922, PHYTOPATHOLOGY, V12, P401; Liu YongGang, 2008, Acta Phytophylacica Sinica, V35, P448; Lu XH, 2010, PHYTOPATHOLOGY, V100, P1162, DOI 10.1094/PHYTO-12-09-0351; Luo HeRong, 1999, Journal of Hunan Agricultural University, V25, P52; McINTOSH D. L., 1964, CAN J BOT, V42, P1411, DOI 10.1139/b64-137; Parra G, 2001, PLANT DIS, V85, P1069, DOI 10.1094/PDIS.2001.85.10.1069; [戚仁德 Qi Rende], 2012, [植物病理学报, Acta Phytopathologica Sinica], V42, P45; Qin Z., 2005, China Patent CN, Patent No. 566095; Quesada-Ocampo LM, 2011, PHYTOPATHOLOGY, V101, P1061, DOI 10.1094/PHYTO-11-10-0325; RAMSEY G. B., 1960, PLANT DIS REPORTER, V44, P692; Ristaino JB, 1998, APPL ENVIRON MICROB, V64, P948; Silvar C, 2006, PLANT DIS, V90, P1135, DOI 10.1094/PD-90-1135; Sun HY, 2010, J PHYTOPATHOL, V158, P244, DOI 10.1111/j.1439-0434.2009.01606.x; Sun WX, 2008, CAN J PLANT PATHOL, V30, P414, DOI 10.1080/07060660809507539; Tian D, 2004, PLANT DIS, V88, P485, DOI 10.1094/PDIS.2004.88.5.485; Wang HC, 2009, PLANT PATHOL, V58, P571, DOI 10.1111/j.1365-3059.2008.01990.x; Yan XJ, 2010, J AGR FOOD CHEM, V58, P2720, DOI 10.1021/jf902410x; Yin YN, 2010, PESTIC BIOCHEM PHYS, V97, P36, DOI 10.1016/j.pestbp.2009.12.002; Zhao CQ, 2011, PEST MANAG SCI, V67, P1178, DOI 10.1002/ps.2198; Zhu LX, 2007, ANTIMICROB AGENTS CH, V51, P3707, DOI 10.1128/AAC.01461-06; Zhu SS, 2008, PEST MANAG SCI, V64, P255, DOI 10.1002/ps.1515	46	52	59	10	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2013	8	2							e56513	10.1371/journal.pone.0056513	http://dx.doi.org/10.1371/journal.pone.0056513			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093HR	23431382	gold, Green Published, Green Submitted			2022-12-25	WOS:000315182800024
J	Mallat, J; Barrailler, S; Lemyze, M; Pepy, F; Gasan, G; Tronchon, L; Thevenin, D				Mallat, Jihad; Barrailler, Stephanie; Lemyze, Malcolm; Pepy, Florent; Gasan, Gaelle; Tronchon, Laurent; Thevenin, Didier			Use of Sodium-Chloride Difference and Corrected Anion Gap as Surrogates of Stewart Variables in Critically Ill Patients	PLOS ONE			English	Article							CARBON DIOXIDE TENSION; ACID-BASE EQUILIBRIA; INTENSIVE-CARE-UNIT; METABOLIC-ACIDOSIS; SERUM-PROTEINS; DIAGNOSIS; EXCESS; BLOOD; BICARBONATE; CHEMISTRY	Introduction: To investigate whether the difference between sodium and chloride ([Na+] - [Cl-]) and anion gap corrected for albumin and lactate (AG(corr)) could be used as apparent strong ion difference (SIDapp) and strong ion gap (SIG) surrogates (respectively) in critically ill patients. Methods: A total of 341 patients were prospectively observed; 161 were allocated to the modeling group, and 180 to the validation group. Simple regression analysis was used to construct a mathematical model between SIDapp and [Na+] -[Cl-] and between SIG and AGcorr in the modeling group. Area under the receiver operating characteristic (ROC) curve was also measured. The mathematical models were tested in the validation group. Results: in the modeling group, SIDapp and SIG were well predicted by [Na+] -[Cl-] and AG(corr) (R-2 = 0.973 and 0.96, respectively). Accuracy values of [Na+] - [Cl-] for the identification of SIDapp acidosis (<42.7 mEq/L) and alkalosis (>47.5 mEq/L) were 0.992 (95% confidence interval [CI], 0.963-1) and 0.998 (95% CI, 0.972-1), respectively. The accuracy of AGcorr in revealing SIG acidosis (>8 mEq/L) was 0.974 (95% CI: 0.936-0.993). These results were validated by showing excellent correlations and good agreements between predicted and measured SIDapp and between predicted and measured SIG in the validation group (R-2 = 0.977; bias = 0 +/- 1.5 mEq/L and R-2 = 0.96; bias = 20.2 +/- 1.8 mEq/L, respectively). Conclusions: SIDapp and SIG can be substituted by [Na+] - [Cl-] and by AG(corr) respectively in the diagnosis and management of acid-base disorders in critically ill patients.	[Mallat, Jihad; Barrailler, Stephanie; Lemyze, Malcolm; Pepy, Florent; Gasan, Gaelle; Tronchon, Laurent; Thevenin, Didier] Ctr Hosp Dr Schaffner, Dept Intens Care Unit, Lens, France		Mallat, J (corresponding author), Ctr Hosp Dr Schaffner, Dept Intens Care Unit, Lens, France.	mallatjihad@gmail.com		Mallat, Jihad/0000-0001-6372-7360				Adrogue HJ, 2010, J AM SOC NEPHROL, V21, P920, DOI 10.1681/ASN.2009121211; ANDERSEN OS, 1960, SCAND J CLIN LAB INV, V12, P172, DOI 10.3109/00365516009062419; ASTRUP P, 1956, SCAND J CLIN LAB INV, V8, P33, DOI 10.3109/00365515609049241; Bewick V, 2004, CRIT CARE, V8, P508, DOI 10.1186/cc3000; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Boniatti MM, 2009, INTENS CARE MED, V35, P1377, DOI 10.1007/s00134-009-1496-2; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; Fencl V, 2000, AM J RESP CRIT CARE, V162, P2246, DOI 10.1164/ajrccm.162.6.9904099; FENCL V, 1993, RESP PHYSIOL, V91, P1, DOI 10.1016/0034-5687(93)90085-O; FIELD A., 2009, DESCOBRINDO ESTATIST, V2; Figge J, 1998, CRIT CARE MED, V26, P1807, DOI 10.1097/00003246-199811000-00019; FIGGE J, 1991, J LAB CLIN MED, V117, P453; FIGGE J, 1992, J LAB CLIN MED, V120, P713; Gauthier PM, 2002, CRIT CARE CLIN, V18, P289, DOI 10.1016/S0749-0704(01)00012-4; GILFIX BM, 1993, J CRIT CARE, V8, P187, DOI 10.1016/0883-9441(93)90001-2; Gunnerson Kyle J, 2003, Curr Opin Crit Care, V9, P468, DOI 10.1097/00075198-200312000-00002; Henderson LJ, 1908, AM J PHYSIOL, V21, P427, DOI 10.1152/ajplegacy.1908.21.4.427; KELLEHER SP, 1986, ARCH INTERN MED, V146, P1839, DOI 10.1001/archinte.146.9.1839; Maciel Alexandre Toledo, 2009, BMJ Case Rep, V2009, DOI 10.1136/bcr.09.2008.1011; Mallat J, 2012, AM J EMERG MED, V30, P391, DOI 10.1016/j.ajem.2010.11.039; Mansoor S, 2007, CLIN BIOCHEM, V40, P226, DOI 10.1016/j.clinbiochem.2006.10.011; MCAULIFFE JJ, 1986, AM J MED, V81, P86, DOI 10.1016/0002-9343(86)90187-7; Moviat M, 2003, CRIT CARE, V7, pR41, DOI 10.1186/cc2184; Murray Deirdre M, 2004, Pediatr Crit Care Med, V5, P240, DOI 10.1097/01.PCC.0000112367.50051.3B; Nagaoka D, 2010, J CRIT CARE, V25, P525, DOI 10.1016/j.jcrc.2010.02.003; Nguyen BV, 2009, ANESTH ANALG, V109, P1517, DOI 10.1213/ANE.0b013e3181b62664; OH MS, 1977, NEW ENGL J MED, V297, P814, DOI 10.1056/NEJM197710132971507; Parikh C, 2001, RENAL FAILURE, V23, P91, DOI 10.1081/JDI-100001288; Park M, 2008, BRAZ J MED BIOL RES, V41, P241; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; SIGGAARDANDERSEN O, 1977, SCAND J CLIN LAB INV, V37, P15, DOI 10.3109/00365517709098927; Sirker AA, 2002, ANAESTHESIA, V57, P348, DOI 10.1046/j.0003-2409.2001.02447.x; STEWART PA, 1983, CAN J PHYSIOL PHARM, V61, P1444, DOI 10.1139/y83-207; Story D A, 2004, Crit Care Resusc, V6, P188; Story DA, 2004, BRIT J ANAESTH, V92, P54, DOI 10.1093/bja/aeh018; Tabachnick B. G., 2007, USING MULTIVARIATE S, P117; Van Slyke DD, 1923, J BIOL CHEM, V56, P765; Yunos NM, 2010, CRIT CARE, V14, DOI 10.1186/cc9052	38	20	20	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e56635	10.1371/journal.pone.0056635	http://dx.doi.org/10.1371/journal.pone.0056635			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418590	gold, Green Published, Green Submitted			2022-12-25	WOS:000315970300183
J	Pizon, M; Zimon, DS; Pachmann, U; Pachmann, K				Pizon, Monika; Zimon, Dorothea Sonja; Pachmann, Ulrich; Pachmann, Katharina			Insulin-Like Growth Factor Receptor I (IGF-IR) and Vascular Endothelial Growth Factor Receptor 2 (VEGFR-2) Are Expressed on the Circulating Epithelial Tumor Cells of Breast Cancer Patients	PLOS ONE			English	Article							TRASTUZUMAB; THERAPY	Background: Circulating epithelial tumor cell (CETC) analysis is a promising diagnostic field for estimating the risk for metastatic relapse and progression in patients with malignant disease. CETCs characterization can be used as a liquid biopsy for prognostic and predictive purposes in breast and other cancers. IGF-IR and VEGFR-2 play an important role in tumor growth and the progression of cancer disease. The purpose of the current study was therefore to investigate their expression on CETCs. Methods: CETCs were determined from the blood of 50 patients suffering from breast cancer. The number of vital CETCs and the expression of IGF-IR and VEGFR-2 were investigated using the maintrac (R) method. Results: IGF-IR and VEGFR-2 expression on the surface of CETCs were detected in 84% of patients. A statistically high correlation was found between IGF-IR and VEGFR-2 (r = 0.745 and p<0.001) on the CETCs. The co-expression of both receptors was confirmed in some experiments and ranged between 70% and 100%. Statistically significant correlations were observed between the number of CETCs and IGF-IR (r = 0.315 and p<0.05) and VEGFR-2 (r = 0.310 and p<0.05) expression. The presence of CETCs and the level of IGF-IR and VEGFR-2 expression were not associated with tumor stage, hormone receptor status or nodal/distant metastasis. Summary: In this study, a parallel and co-expression of IGF-IR and VEGFR-2 was examined on the surface of CETCs in breast cancer patients for the first time. Characterization of CETCs may be a promising approach for the rational design of targeted anticancer therapies.	[Pizon, Monika; Zimon, Dorothea Sonja; Pachmann, Ulrich] Transfus Ctr Bayreuth, Bayreuth, Germany; [Pachmann, Katharina] Univ Jena, Oncol Res Lab, Clin Internal Med 2, Jena, Germany	Friedrich Schiller University of Jena	Pizon, M (corresponding author), Transfus Ctr Bayreuth, Bayreuth, Germany.	tzb.info@t-online.de	PIZON, Monika/AAT-3582-2021					Ashworth T. R, 1869, AUST MED J, V14, P146, DOI DOI 10.1038/SJ.BJC.6604218; Belfiore A, 2008, J MAMMARY GLAND BIOL, V13, P381, DOI 10.1007/s10911-008-9099-z; Browne BC, 2011, ANN ONCOL, V22, P68, DOI 10.1093/annonc/mdq349; Cristofanilli M, 2005, J CLIN ONCOL, V23, P1420, DOI 10.1200/JCO.2005.08.140; Davison Z, 2011, NEOPLASIA, V13, P504, DOI 10.1593/neo.101590; de Bono JS, 2007, CLIN CANCER RES, V13, P3611, DOI 10.1158/1078-0432.CCR-07-0268; Gajkowska A, 2006, FOLIA HISTOCHEM CYTO, V44, P53; Giatromanolaki A, 2007, EUR J CLIN INVEST, V37, P878, DOI 10.1111/j.1365-2362.2007.01866.x; Guo SC, 2010, BBA-REV CANCER, V1806, P108, DOI 10.1016/j.bbcan.2010.04.004; Hayes DF, 2006, CLIN CANCER RES, V12, P4218, DOI 10.1158/1078-0432.CCR-05-2821; Hicks DJ, 2006, BIOTECH HISTOCHEM, V81, P23, DOI 10.1080/10520290600725375; Ignatiadis M, 2008, CURR OPIN OBSTET GYN, V20, P55, DOI 10.1097/GCO.0b013e3282f22b2e; Kallergi G, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2452; Kowanetz M, 2006, CLIN CANCER RES, V12, P5018, DOI 10.1158/1078-0432.CCR-06-1520; Lianidou ES, 2011, CLIN CHEM LAB MED, V49, P1579, DOI 10.1515/CCLM.2011.628; Munagala R, 2011, INDIAN J PHARMACOL, V43, P236, DOI 10.4103/0253-7613.81497; Nakopoulou L, 2002, HUM PATHOL, V33, P863, DOI 10.1053/hupa.2002.126879; Pachmann K, 2005, CLIN CHEM LAB MED, V43, P617, DOI 10.1515/CCLM.2005.107; Pachmann K, 2008, J CLIN ONCOL, V26, P1208, DOI 10.1200/JCO.2007.13.6523; Pachmann K, 2011, J CANCER RES CLIN, V137, P1317, DOI 10.1007/s00432-011-1000-6; Pachmann U, 2011, CANCER, V2; RAILO MJ, 1994, EUR J CANCER, V30A, P307, DOI 10.1016/0959-8049(94)90247-X; Ring A, 2004, LANCET ONCOL, V5, P79, DOI 10.1016/S1470-2045(04)01381-6; Ross JS, 2009, AM J CLIN PATHOL, V132, P237, DOI 10.1309/AJCPJI7DEOLKCS6F; Shimizu C, 2004, HUM PATHOL, V35, P1537, DOI 10.1016/j.humpath.2004.09.005; Strati A, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-422; Wong ALA, 2012, INT J BREAST CANCER, V2012, DOI 10.1155/2012/415170	27	16	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e56836	10.1371/journal.pone.0056836	http://dx.doi.org/10.1371/journal.pone.0056836			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418605	gold, Green Published			2022-12-25	WOS:000315970300199
J	Azar, WJ; Zivkovic, S; Werther, GA; Russo, VC				Azar, W. J.; Zivkovic, S.; Werther, G. A.; Russo, V. C.			IGFBP-2 nuclear translocation is mediated by a functional NLS sequence and is essential for its pro-tumorigenic actions in cancer cells	ONCOGENE			English	Article						IGFBP-2; cancer cells; VEGF; angiogenesis and CAM assay; NLS; Importin alpha/beta	GROWTH-FACTOR-BINDING; ACID-LABILE SUBUNIT; LOCALIZATION SIGNAL; BREAST-CANCER; IN-VIVO; IMPORTIN-ALPHA; NUCLEOCYTOPLASMIC TRANSPORT; PROMOTER ACTIVITY; STRUCTURAL BASIS; PROTEIN IMPORT	IGFBP-2 is highly expressed in both the serum and tumor tissues of most cancers, and is considered one of the most significant genes in the signature of major cancers. IGFBP-2 mainly modulates IGF actions in the pericellular space; however, there is considerable evidence to suggest that IGFBP-2 may also act independently of the IGFs. These IGF-independent actions of IGFBP-2 are exerted either via interactions at the cell surface or intracellularly, via interaction with cytoplasmic or nuclear-binding partners. The precise mechanism underlying the intracellular/intranuclear localization of IGFBP-2 remains unclear. In this study, we investigated IGFBP-2 nuclear localization in several common cancer cells with the aim of dissecting the mechanism of its nuclear trafficking. IGFBP-2 is detected in the nuclei of common cancer cells, including breast, prostate and several neuroblastoma cell lines, using cell fractionation and confocal microscopy. Via nuclear import assays, we show that nuclear entry of IGFBP-2 is mediated by the classical nuclear import mechanisms, primarily through importin-alpha, as demonstrated by the use of blocking, competition and co-immunoprecipitation assays. Bioinformatics analysis of the IGFBP-2 protein sequence with PSORT II identified a classical nuclear localization signal (cNLS) sequence at 179PKKLRPP185, within the IGFBP-2 linker domain, mutagenesis of which abolishes IGFBP-2 nuclear import. Accordingly, the NLS(mut)IGFBP-2 fails to activate the VEGF promoter, which would otherwise occur in the presence of wild-type IGFBP-2. As a consequence, no activation of angiogenic processes were observed in NLS(mut)IGFBP-2 expressing SHEP cells when implanted onto our in vivo quail chorio-allantoic membrane model. Taken together, these data show for the first time that IGFBP-2 possesses a functional NLS sequence and that IGFBP-2 actively translocates into the nucleus by a classical nuclear import mechanism, involving formation of IGFBP-2 complexes with importin-alpha. Nuclear IGFBP-2 is required for the activation of VEGF expression and consequent angiogenesis.	[Azar, W. J.; Zivkovic, S.; Werther, G. A.; Russo, V. C.] Royal Childrens Hosp, Murdoch Childrens Res Inst, Parkville, Vic 3052, Australia; [Azar, W. J.; Werther, G. A.; Russo, V. C.] Univ Melbourne, Dept Paediat, Parkville, Vic 3052, Australia	Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; University of Melbourne	Russo, VC (corresponding author), Royal Childrens Hosp, Murdoch Childrens Res Inst, Flemington Rd, Parkville, Vic 3052, Australia.	vince.russo@mcri.edu.au			National Health and Medical Research Council (NHMRC) of Australia [1008062]; Melbourne University (MRS)	National Health and Medical Research Council (NHMRC) of Australia(National Health and Medical Research Council (NHMRC) of Australia); Melbourne University (MRS)	We wish to thank Professor Dev Mukhopadhyay (Mayo Clinic, Rochester, MN, USA) for kindly supplying the VEGF constructs used in these studies, Dr Mark Denham (Neuroscience, University of Melbourne) for his assistance in developing the GFP-SHEP cells clones, Dr Donald Newgreen (MCRI) for his assistance in developing CAM assays and Dr Sheena Azar for constant assistance during manuscript preparation. This work was supported by the National Health and Medical Research Council (NHMRC) of Australia Project Grants 1008062 (to GAW and VCR). WJA is the recipient of a Melbourne University (MRS) PhD scholarship.	ADAM EJH, 1994, J CELL BIOL, V125, P547, DOI 10.1083/jcb.125.3.547; Azar WJ, 2011, ENDOCRINOLOGY, V152, P3332, DOI 10.1210/en.2011-1121; Ben-Shmuel A, 2012, ONCOGENE, V6, P340; Besnard V, 2001, BBA-MOL CELL RES, V1538, P47, DOI 10.1016/S0167-4889(00)00136-1; BOOTH BA, 1995, GROWTH REGULAT, V5, P1; BREEUWER M, 1990, CELL, V60, P999, DOI 10.1016/0092-8674(90)90348-I; Busund LT, 2005, J CLIN PATHOL, V58, P361, DOI 10.1136/jcp.2004.020834; Butt AJ, 2003, J BIOL CHEM, V278, P29676, DOI 10.1074/jbc.M301965200; Catimel B, 2001, J BIOL CHEM, V276, P34189, DOI 10.1074/jbc.M103531200; CHELSKY D, 1989, MOL CELL BIOL, V9, P2487, DOI 10.1128/MCB.9.6.2487; CHI NC, 1995, J CELL BIOL, V130, P265, DOI 10.1083/jcb.130.2.265; CHIDA K, 1992, P NATL ACAD SCI USA, V89, P4290, DOI 10.1073/pnas.89.10.4290; Chook YM, 2001, CURR OPIN STRUC BIOL, V11, P703, DOI 10.1016/S0959-440X(01)00264-0; Cingolani G, 2002, MOL CELL, V10, P1345, DOI 10.1016/S1097-2765(02)00727-X; COHEN P, 1993, J CLIN ENDOCR METAB, V76, P1031, DOI 10.1210/jc.76.4.1031; DANG CV, 1988, MOL CELL BIOL, V8, P4048, DOI 10.1128/MCB.8.10.4048; DINGWALL C, 1991, TRENDS BIOCHEM SCI, V16, P478, DOI 10.1016/0968-0004(91)90184-W; DUBOIS V, 1993, BIOCHEM BIOPH RES CO, V192, P295, DOI 10.1006/bbrc.1993.1413; Elmlinger MW, 2001, ENDOCRINOLOGY, V142, P1652, DOI 10.1210/en.142.4.1652; Firth SM, 2002, ENDOCR REV, V23, P824, DOI 10.1210/er.2001-0033; Firth SM, 1998, J BIOL CHEM, V273, P2631, DOI 10.1074/jbc.273.5.2631; Firth SM, 2001, ENDOCRINOLOGY, V142, P2147, DOI 10.1210/en.142.5.2147; Flyvbjerg A, 1997, J CLIN ENDOCR METAB, V82, P2308, DOI 10.1210/jc.82.7.2308; Forwood JK, 2001, MOL BIOL CELL, V12, p500A; Forwood JK, 2001, J BIOL CHEM, V276, P46575, DOI 10.1074/jbc.M101668200; Forwood JK, 2001, BIOCHEMISTRY-US, V40, P5208, DOI 10.1021/bi002732+; Fukushima T, 2007, J BIOL CHEM, V282, P18634, DOI 10.1074/jbc.M609567200; Fuller GN, 1999, CANCER RES, V59, P4228; Gorlich D, 1996, SCIENCE, V271, P1513, DOI 10.1126/science.271.5255.1513; GORLICH D, 1994, CELL, V79, P767, DOI 10.1016/0092-8674(94)90067-1; Higgins S, 2009, ENDOCRINOLOGY, V150, P4044, DOI 10.1210/en.2008-1797; Hodel AE, 2006, J BIOL CHEM, V281, P23545, DOI 10.1074/jbc.M601718200; Hodel MR, 2001, J BIOL CHEM, V276, P1317, DOI 10.1074/jbc.M008522200; Hoeflich A, 2004, BIOCHEM BIOPH RES CO, V324, P705, DOI 10.1016/j.bbrc.2004.09.111; IMAMURA T, 1990, SCIENCE, V249, P1567, DOI 10.1126/science.1699274; IMAMURA T, 1992, J BIOL CHEM, V267, P5676; Iosef C, 2008, ENDOCRINOLOGY, V149, P1214, DOI 10.1210/en.2007-0959; Ivanova IA, 2007, CELL CYCLE, V6, P2186, DOI 10.4161/cc.6.17.4650; JONES JI, 1995, ENDOCR REV, V16, P3, DOI 10.1210/er.16.1.3; KALDERON D, 1984, CELL, V39, P499, DOI 10.1016/0092-8674(84)90457-4; KALDERON D, 1984, NATURE, V311, P33, DOI 10.1038/311033a0; Kehlenbach RH, 1998, J CELL BIOL, V141, P863, DOI 10.1083/jcb.141.4.863; Koike M, 1999, ONCOGENE, V18, P7495, DOI 10.1038/sj.onc.1203247; Lange A, 2007, J BIOL CHEM, V282, P5101, DOI 10.1074/jbc.R600026200; Lee SJ, 2005, NATURE, V435, P693, DOI 10.1038/nature03578; Lufei CC, 2009, FEBS LETT, V583, P271, DOI 10.1016/j.febslet.2008.12.011; Marfori M, 2012, TRAFFIC, V13, P532, DOI 10.1111/j.1600-0854.2012.01329.x; Mattaj IW, 1998, ANNU REV BIOCHEM, V67, P265, DOI 10.1146/annurev.biochem.67.1.265; Miyako K, 2009, MOL ENDOCRINOL, V23, P169, DOI 10.1210/me.2008-0168; Mohan S, 2002, J ENDOCRINOL, V175, P19, DOI 10.1677/joe.0.1750019; Moore MG, 2003, INT J CANCER, V105, P14, DOI 10.1002/ijc.11015; Mukhopadhyay D, 1997, MOL CELL BIOL, V17, P5629, DOI 10.1128/MCB.17.9.5629; Nakai K, 1999, TRENDS BIOCHEM SCI, V24, P34, DOI 10.1016/S0968-0004(98)01336-X; Nam TJ, 1997, ENDOCRINOLOGY, V138, P2972, DOI 10.1210/en.138.7.2972; Oh Y, 1998, INT CONGR SER, V1151, P125; Pereira JJ, 2004, CANCER RES, V64, P977, DOI 10.1158/0008-5472.CAN-03-3056; Perks CM, 1999, J MOL ENDOCRINOL, V22, P141, DOI 10.1677/jme.0.0220141; RICHARDSON WD, 1986, CELL, V44, P77, DOI 10.1016/0092-8674(86)90486-1; Rivera J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006433; ROBBINS J, 1991, CELL, V64, P615, DOI 10.1016/0092-8674(91)90245-T; Russo V. C., 1995, Progress in Growth Factor Research, V6, P329, DOI 10.1016/0955-2235(95)00018-6; Russo VC, 2005, ENDOCR REV, V26, P916, DOI 10.1210/er.2004-0024; Russo VC, 1997, ENDOCRINOLOGY, V138, P4858, DOI 10.1210/en.138.11.4858; Russo VC, 2005, ENDOCRINOLOGY, V146, P4445, DOI 10.1210/en.2005-0467; Russo VC, 2004, 12 INT C END MED INT; Schedlich LJ, 2004, BIOCHEM BIOPH RES CO, V314, P83, DOI 10.1016/j.bbrc.2003.12.049; Schedlich LJ, 1998, J BIOL CHEM, V273, P18347, DOI 10.1074/jbc.273.29.18347; Schedlich LJ, 2000, J BIOL CHEM, V275, P23462, DOI 10.1074/jbc.M002208200; Schedlich LJ, 2007, MOL ENDOCRINOL, V21, P2378, DOI 10.1210/me.2006-0558; Schutt BS, 2004, J MOL ENDOCRINOL, V32, P859, DOI 10.1677/jme.0.0320859; Shen XC, 2012, MOL CELL BIOL, V32, P4116, DOI 10.1128/MCB.01011-12; So AI, 2008, CLIN CANCER RES, V14, P6944, DOI 10.1158/1078-0432.CCR-08-0408; Song SW, 2003, P NATL ACAD SCI USA, V100, P13970, DOI 10.1073/pnas.2332186100; TAGAWA T, 1995, J CELL BIOL, V130, P255, DOI 10.1083/jcb.130.2.255; Terrien X, 2005, BIOCHEM J, V392, P457, DOI 10.1042/BJ20050517; Twigg SM, 1998, J BIOL CHEM, V273, P6074, DOI 10.1074/jbc.273.11.6074; Wang H, 2003, CANCER RES, V63, P4315; Weinzimer SA, 2001, J CLIN ENDOCR METAB, V86, P1806, DOI 10.1210/jc.86.4.1806; Zhou GL, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-74	79	57	62	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 30	2014	33	5					578	588		10.1038/onc.2012.630	http://dx.doi.org/10.1038/onc.2012.630			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AA5GW	23435424				2022-12-25	WOS:000331125100006
J	Werzner, A; Pavlidis, P; Ometto, L; Stephan, W; Laurent, S				Werzner, Annegret; Pavlidis, Pavlos; Ometto, Lino; Stephan, Wolfgang; Laurent, Stefan			Selective Sweep in the Flotillin-2 Region of European Drosophila melanogaster	PLOS ONE			English	Article							POSITIVE SELECTION; LINKAGE DISEQUILIBRIUM; GENE-EXPRESSION; SEGREGATING SITES; HITCHHIKING; POLYMORPHISM; POPULATIONS; DEMOGRAPHY; SIGNATURE; PROTEINS	Localizing genes that are subject to recent positive selection is a major goal of evolutionary biology. In the model organism Drosophila melanogaster many attempts have been made in recent years to identify such genes by conducting so-called genome scans of selection. These analyses consisted in typing a large number of genetic markers along the genomes of a sample of individuals and then identifying those loci that harbor patterns of genetic variation, which are compatible with the ones generated by a selective sweep. In this study we conduct an in-depth analysis of a genomic region located on the X chromosome of D. melanogaster that was identified as a potential target of recent positive selection by a previous genome scan of selection. To this end we re-sequenced 20 kilobases around the Flotillin-2 gene (Flo-2) and conducted a detailed analysis of the allele frequencies and linkage disequilibria observed in this new dataset. The results of this analysis reveal eight genetic novelties that are specific to temperate populations of D. melanogaster and that may have arisen during the expansion of the species outside its ancestral sub-Saharan habitat since about 16,000 years ago.	[Werzner, Annegret; Pavlidis, Pavlos; Ometto, Lino; Stephan, Wolfgang; Laurent, Stefan] Univ Munich, Sect Evolutionary Biol, Dept Biol 2, Planegg Martinsried, Germany	University of Munich	Laurent, S (corresponding author), Univ Munich, Sect Evolutionary Biol, Dept Biol 2, Planegg Martinsried, Germany.	laurent@bio.lmu.de	Ometto, Lino/C-3609-2008; Stephan, Wolfgang/GOV-6503-2022	Ometto, Lino/0000-0002-2679-625X; 	DFG Research Unit "Natural selection in structured populations" [STE 325/12]; Volkswagen-Foundation [I/824234]	DFG Research Unit "Natural selection in structured populations"; Volkswagen-Foundation(Volkswagen)	This work has been supported by funds from the DFG Research Unit "Natural selection in structured populations" (grant STE 325/12) to WS and grant I/824234 from the Volkswagen-Foundation to PP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beaumont MA, 2002, GENETICS, V162, P2025; Beisswanger S, 2006, GENETICS, V172, P265, DOI 10.1534/genetics.105.049346; Beisswanger S, 2008, P NATL ACAD SCI USA, V105, P5447, DOI 10.1073/pnas.0710892105; BRAVERMAN JM, 1995, GENETICS, V140, P783, DOI 10.1093/genetics/140.2.783; CALLIS J, 1987, GENE DEV, V1, P1183, DOI 10.1101/gad.1.10.1183; CHOI T, 1991, MOL CELL BIOL, V11, P3070, DOI 10.1128/MCB.11.6.3070; DAVID JR, 1988, TRENDS GENET, V4, P106, DOI 10.1016/0168-9525(88)90098-4; Duchen P, 2013, GENETICS; Fay JC, 2000, GENETICS, V155, P1405; Fiston-Lavier AS, 2010, GENE, V463, P18, DOI 10.1016/j.gene.2010.04.015; Glinka S, 2003, GENETICS, V165, P1269; Gronke S, 2005, CELL METAB, V1, P323, DOI 10.1016/j.cmet.2005.04.003; Hoehne M, 2005, MOL CELL NEUROSCI, V30, P326, DOI 10.1016/j.mcn.2005.07.007; Hutter S, 2007, GENETICS, V177, P469, DOI 10.1534/genetics.107.074922; Hutter S, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-1-r12; Iida K, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-75; Jensen JD, 2005, GENETICS, V170, P1401, DOI 10.1534/genetics.104.038224; Jensen JD, 2007, GENETICS, V176, P2371, DOI 10.1534/genetics.106.069450; Juarez MT, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002424; KAPLAN NL, 1989, GENETICS, V123, P887; Katanaev VL, 2008, EMBO J, V27, P509, DOI 10.1038/sj.emboj.7601981; Kim Y, 2004, GENETICS, V167, P1513, DOI 10.1534/genetics.103.025387; Kim Y, 2002, GENETICS, V160, P765; Laurent SJY, 2011, MOL BIOL EVOL, V28, P2041, DOI 10.1093/molbev/msr031; Li HP, 2006, PLOS GENET, V2, P1580, DOI 10.1371/journal.pgen.0020166; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; MEREDITH J, 1993, DEV BIOL, V159, P500, DOI 10.1006/dbio.1993.1259; Muller L, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-81; Neron B, 2009, BIOINFORMATICS, V25, P3005, DOI 10.1093/bioinformatics/btp493; Neumann-Giesen C, 2004, BIOCHEM J, V378, P509, DOI 10.1042/BJ20031100; Nielsen R, 2005, GENOME RES, V15, P1566, DOI 10.1101/gr.4252305; Ometto L, 2005, MOL BIOL EVOL, V22, P2119, DOI 10.1093/molbev/msi207; Pavlidis P, 2010, GENETICS, V185, P907, DOI 10.1534/genetics.110.116459; Przeworski M, 2002, GENETICS, V160, P1179; Ramos-Onsins SE, 2007, GENET RES, V89, P231, DOI 10.1017/S0016672307008877; Rubin GM, 2000, SCIENCE, V287, P2222, DOI 10.1126/science.287.5461.2222; Smith JM, 2007, GENET RES, V89, P391, DOI [10.1017/S0016672308009579, 10.1017/S0016672300014634]; Stephan W, 2007, HEREDITY, V98, P65, DOI 10.1038/sj.hdy.6800901; Stephan W, 2006, GENETICS, V172, P2647, DOI 10.1534/genetics.105.050179; STEPHAN W, 1992, THEOR POPUL BIOL, V41, P237, DOI 10.1016/0040-5809(92)90045-U; Stuermer CAO, 2005, BIOCHEM SOC SYMP, V72, P109, DOI 10.1042/bss0720109; Stuermer CAO, 2001, MOL BIOL CELL, V12, P3031, DOI 10.1091/mbc.12.10.3031; Svetec N, 2011, MOL ECOL, V20, P530, DOI 10.1111/j.1365-294X.2010.04951.x; TAJIMA F, 1989, GENETICS, V123, P585; TAJIMA F, 1983, GENETICS, V105, P437; Takeuchi H, 2005, BIOCHEM J, V389, P637, DOI 10.1042/BJ20050498; Tweedie S, 2009, NUCLEIC ACIDS RES, V37, pD555, DOI 10.1093/nar/gkn788; WATTERSON GA, 1975, THEOR POPUL BIOL, V7, P256, DOI 10.1016/0040-5809(75)90020-9; Xu XJ, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002478	49	3	3	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2013	8	2							e56629	10.1371/journal.pone.0056629	http://dx.doi.org/10.1371/journal.pone.0056629			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IT	23437190	Green Submitted, Green Published, gold			2022-12-25	WOS:000315186000036
J	Fujimoto, Z; Suzuki, R; Shiotsuki, T; Tsuchiya, W; Tase, A; Momma, M; Yamazaki, T				Fujimoto, Zui; Suzuki, Rintaro; Shiotsuki, Takahiro; Tsuchiya, Wataru; Tase, Akira; Momma, Mitsuru; Yamazaki, Toshimasa			Crystal Structure of Silkworm Bombyx mori JHBP in Complex With 2-Methyl-2,4-Pentanediol: Plasticity of JH-Binding Pocket and Ligand-Induced Conformational Change of the Second Cavity in JHBP	PLOS ONE			English	Article							JUVENILE-HORMONE-BINDING; PROTEIN; HEMOLYMPH; AFFINITY; MODEL; SPECTROSCOPY; ISOMERS	Juvenile hormones (JHs) control a diversity of crucial life events in insects. In Lepidoptera which major agricultural pests belong to, JH signaling is critically controlled by a species-specific high-affinity, low molecular weight JH-binding protein (JHBP) in hemolymph, which transports JH from the site of its synthesis to target tissues. Hence, JHBP is expected to be an excellent target for the development of novel specific insect growth regulators (IGRs) and insecticides. A better understanding of the structural biology of JHBP should pave the way for the structure-based drug design of such compounds. Here, we report the crystal structure of the silkworm Bombyx mori JHBP in complex with two molecules of 2-methyl-2,4-pentanediol (MPD), one molecule (MPD1) bound in the JH-binding pocket while the other (MPD2) in a second cavity. Detailed comparison with the apo-JHBP and JHBP-JH II complex structures previously reported by us led to a number of intriguing findings. First, the JH-binding pocket changes its size in a ligand-dependent manner due to flexibility of the gate alpha 1 helix. Second, MPD1 mimics interactions of the epoxide moiety of JH previously observed in the JHBP-JH complex, and MPD can compete with JH in binding to the JH-binding pocket. We also confirmed that methoprene, which has an MPD-like structure, inhibits the complex formation between JHBP and JH while the unepoxydated JH III (methyl farnesoate) does not. These findings may open the door to the development of novel IGRs targeted against JHBP. Third, binding of MPD to the second cavity of JHBP induces significant conformational changes accompanied with a cavity expansion. This finding, together with MPD2-JHBP interaction mechanism identified in the JHBP-MPD complex, should provide important guidance in the search for the natural ligand of the second cavity.	[Fujimoto, Zui; Suzuki, Rintaro; Tsuchiya, Wataru; Tase, Akira; Momma, Mitsuru; Yamazaki, Toshimasa] Natl Inst Agrobiol Sci, Biomol Res Unit, Tsukuba, Ibaraki, Japan; [Shiotsuki, Takahiro] Natl Inst Agrobiol Sci, Insect Growth Regulat Res Unit, Tsukuba, Ibaraki, Japan	National Institute of Agrobiological Sciences - Japan; National Institute of Agrobiological Sciences - Japan	Yamazaki, T (corresponding author), Natl Inst Agrobiol Sci, Biomol Res Unit, Tsukuba, Ibaraki, Japan.	tyamazak@nias.affrc.go.jp	Suzuki, Rintaro/J-8016-2012	Fujimoto, Zui/0000-0002-3551-6854; tu wu, she/0000-0001-6693-7320	Program for Promotion of Basic Research Activities for Innovative Bioscience of Japan (PROBRAIN); NIAS Strategic Research Fund	Program for Promotion of Basic Research Activities for Innovative Bioscience of Japan (PROBRAIN); NIAS Strategic Research Fund	The authors acknowledge the financial support from the Program for Promotion of Basic Research Activities for Innovative Bioscience of Japan (PROBRAIN) and the NIAS Strategic Research Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beamer LJ, 1997, SCIENCE, V276, P1861, DOI 10.1126/science.276.5320.1861; Dobryszycki P, 2004, BIOPHYS J, V86, P1138, DOI 10.1016/S0006-3495(04)74188-0; Dundas J, 2006, NUCLEIC ACIDS RES, V34, pW116, DOI 10.1093/nar/gkl282; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gilbert LI, 2000, INSECT BIOCHEM MOLEC, V30, P617, DOI 10.1016/S0965-1748(00)00034-5; GOODMAN W, 1978, P NATL ACAD SCI USA, V75, P185, DOI 10.1073/pnas.75.1.185; Goodman W.G., 1985, P491; GRENIER S, 1993, ANN APPL BIOL, V122, P369, DOI 10.1111/j.1744-7348.1993.tb04042.x; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Hamiaux C, 2009, J BIOL CHEM, V284, P3496, DOI 10.1074/jbc.M807467200; Henrick CA, 2007, J AM MOSQUITO CONTR, V23, P225, DOI 10.2987/8756-971X(2007)23[225:M]2.0.CO;2; HIDAYAT P, 1994, INSECT BIOCHEM MOLEC, V24, P709, DOI 10.1016/0965-1748(94)90058-2; Kawabata T, 2010, PROTEINS, V78, P1195, DOI 10.1002/prot.22639; Kolodziejczyk R, 2008, J MOL BIOL, V377, P870, DOI 10.1016/j.jmb.2008.01.026; KRAMER KJ, 1974, P NATL ACAD SCI USA, V71, P493, DOI 10.1073/pnas.71.2.493; Krzyzanowska D, 1998, J PEPT RES, V51, P96; KURATA K, 1994, COMP BIOCHEM PHYS B, V109, P105, DOI 10.1016/0305-0491(94)90147-3; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; Metcalf R. L., 1993, DESTRUCTIVE USEFUL I; MIYAMOTO J, 1993, ACS SYM SER, V524, P144; Mogensen JE, 2002, J BIOL CHEM, V277, P23684, DOI 10.1074/jbc.M202065200; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; OZYHAR A, 1987, EUR J BIOCHEM, V162, P675, DOI 10.1111/j.1432-1033.1987.tb10690.x; PRESTWICH GD, 1985, P NATL ACAD SCI USA, V82, P5290, DOI 10.1073/pnas.82.16.5290; Qiu XY, 2007, NAT STRUCT MOL BIOL, V14, P106, DOI 10.1038/nsmb1197; ROLLER H, 1967, ANGEW CHEM INT EDIT, V6, P179, DOI 10.1002/anie.196701792; SCHOOLEY DA, 1978, BIOCHEM BIOPH RES CO, V81, P743, DOI 10.1016/0006-291X(78)91414-6; SEVALA VL, 1993, INVERTEBR REPROD DEV, V23, P189, DOI 10.1080/07924259.1993.9672314; Shimanuki H., 1992, HIVE HONEY BE, VRev. ed.; Stobiecka A, 2008, FRONT BIOSCI-LANDMRK, V13, P2866, DOI 10.2741/2891; Suzuki R, 2011, SCI REP-UK, V1, DOI 10.1038/srep00133; Suzuki R, 2009, BIOMOL NMR ASSIGN, V3, P73, DOI 10.1007/s12104-009-9144-x; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Terwilliger TC, 2003, ACTA CRYSTALLOGR D, V59, P38, DOI 10.1107/S0907444902018036; TOUHARA K, 1993, BIOCHEMISTRY-US, V32, P2068, DOI 10.1021/bi00059a026; TROWELL SC, 1992, COMP BIOCHEM PHYS B, V103, P795, DOI 10.1016/0305-0491(92)90196-X; Truman JW, 1999, NATURE, V401, P447, DOI 10.1038/46737; Vermunt AMW, 2001, INSECT MOL BIOL, V10, P147, DOI 10.1046/j.1365-2583.2001.00249.x; WIECZOREK E, 1991, EUR J BIOCHEM, V201, P347, DOI 10.1111/j.1432-1033.1991.tb16292.x; Wyatt GR, 1996, ADV INSECT PHYSIOL, V26, P1, DOI 10.1016/S0065-2806(08)60030-2	42	10	12	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e56261	10.1371/journal.pone.0056261	http://dx.doi.org/10.1371/journal.pone.0056261			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437107	Green Published, gold, Green Submitted			2022-12-25	WOS:000315184200054
J	He, J; Jing, Y; Li, W; Qian, X; Xu, Q; Li, FS; Liu, LZ; Jiang, BH; Jiang, Y				He, Jun; Jing, Yi; Li, Wei; Qian, Xu; Xu, Qing; Li, Feng-Shan; Liu, Ling-Zhi; Jiang, Bing-Hua; Jiang, Yue			Roles and Mechanism of miR-199a and miR-125b in Tumor Angiogenesis	PLOS ONE			English	Article							HUMAN OVARIAN-CANCER; RIBOSOMAL S6 KINASE; GROWTH-FACTOR; MICRORNA EXPRESSION; DOWN-REGULATION; ACTIVATION; CELLS; ERBB2; STATISTICS; INCREASES	MicroRNAs (miRNAs) have been shown to be involved in different aspects of cancer biology including tumor angiogenesis. In this study, we identified that two miRNAs, miR-199a and miR-125b were downregulated in ovarian cancer tissues and cell lines. Overexpression of miR-199a and miR-125b inhibited tumor-induced angiogenesis associated with the decrease of HIF-1 alpha and VEGF expression in ovarian cancer cells. Moreover, the levels of miR-199a and miR-125b were negatively correlated with VEGF mRNA levels in ovarian tissues. We further showed that direct targets of miR-199a and miR-125b HER2 and HER3 were functionally relevant. Forced expression of HER2 and HER3 rescued miR-199a- and miR-125b-inhibiting angiogenesis responses and Akt/p70S6K1/HIF-1 alpha pathway. This study provides a rationale for new therapeutic approach to suppress tumor angiogenesis using miR-199a, miR-125b, or their mimics for ovarian cancer treatment in the future.	[He, Jun; Li, Wei; Qian, Xu; Xu, Qing; Jiang, Bing-Hua] Nanjing Med Univ, State Key Lab Reprod Med, Dept Pathol, Ctr Canc, Nanjing, Jiangsu, Peoples R China; [He, Jun; Jing, Yi; Liu, Ling-Zhi; Jiang, Bing-Hua] Thomas Jefferson Univ, Dept Pathol Anat & Cell Biol, Philadelphia, PA 19107 USA; [Li, Feng-Shan] Nanjing Maternal & Child Care Serv Ctr, Dept Pathol, Nanjing, Jiangsu, Peoples R China; [Jiang, Yue] Fujian Normal Univ, Fac Software, Fuzhou, Fujian, Peoples R China; [Jiang, Yue] Fujian Normal Univ, Coll Life Sci, Fuzhou, Fujian, Peoples R China	Nanjing Medical University; Jefferson University; Fujian Normal University; Fujian Normal University	Jiang, BH (corresponding author), Nanjing Med Univ, State Key Lab Reprod Med, Dept Pathol, Ctr Canc, Nanjing, Jiangsu, Peoples R China.	binghjiang@yahoo.com; yuejiang123@hotmail.com		Liu, Ling-Zhi/0000-0001-9234-457X; Jiang, Bing-Hua/0000-0003-4526-2031; He, Jun/0000-0002-5162-6041; Hartl, Carla/0000-0001-9769-7462	National Natural Science Foundation of China [81071642, 30871296]; National Cancer Institute, NIH [R01CA109460]; NATIONAL CANCER INSTITUTE [R01CA109460] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Cancer Institute, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by National Natural Science Foundation of China (81071642 and 30871296), and by National Cancer Institute, NIH (R01CA109460). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe Y, 2009, J BIOL CHEM, V284, P14939, DOI 10.1074/jbc.M900097200; Dufner A, 1999, EXP CELL RES, V253, P100, DOI 10.1006/excr.1999.4683; Edwards BK, 2005, JNCI-J NATL CANCER I, V97, P1407, DOI 10.1093/jnci/dji289; Engelman JA, 2006, CLIN CANCER RES, V12, p4372S, DOI 10.1158/1078-0432.CCR-06-0795; FOLKMAN J, 1971, NEW ENGL J MED, V285, P1182; Forsythe JA, 1996, MOL CELL BIOL, V16, P4604; He J, 2012, EMBO REP, V13, P1116, DOI 10.1038/embor.2012.162; Iorio MV, 2007, CANCER RES, V67, P8699, DOI 10.1158/0008-5472.CAN-07-1936; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Jemal A, 2007, CA-CANCER J CLIN, V57, P43, DOI 10.3322/canjclin.57.1.43; Klos KS, 2006, CANCER RES, V66, P2028, DOI 10.1158/0008-5472.CAN-04-4559; Kuehbacher A, 2007, CIRC RES, V101, P59, DOI 10.1161/CIRCRESAHA.107.153916; Laughner E, 2001, MOL CELL BIOL, V21, P3995, DOI 10.1128/MCB.21.12.3995-4004.2001; Liu LZ, 2008, CANCER RES, V68, P8183, DOI 10.1158/0008-5472.CAN-08-0819; MAINESBANDIERA SL, 1992, AM J OBSTET GYNECOL, V167, P729, DOI 10.1016/S0002-9378(11)91579-8; Nam EJ, 2008, CLIN CANCER RES, V14, P2690, DOI 10.1158/1078-0432.CCR-07-1731; Plummer PN, 2013, CANCER RES, V73, P341, DOI 10.1158/0008-5472.CAN-12-0271; Pore N, 2004, MOL BIOL CELL, V15, P4841, DOI 10.1091/mbc.E04-05-0374; Rane S, 2009, CIRC RES, V104, P879, DOI 10.1161/CIRCRESAHA.108.193102; Sasahira T, 2012, BRIT J CANCER, V107, P700, DOI 10.1038/bjc.2012.330; Scaltriti M, 2006, CLIN CANCER RES, V12, P5268, DOI 10.1158/1078-0432.CCR-05-1554; Scott GK, 2007, J BIOL CHEM, V282, P1479, DOI 10.1074/jbc.M609383200; Staszel T, 2011, POL ARCH MED WEWN, V121, P361, DOI 10.20452/pamw.1093; Testa JR, 2005, ONCOGENE, V24, P7391, DOI 10.1038/sj.onc.1209100; Weis SM, 2011, NAT MED, V17, P1359, DOI 10.1038/nm.2537; Yang H, 2008, CANCER RES, V68, P425, DOI 10.1158/0008-5472.CAN-07-2488	26	92	94	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e56647	10.1371/journal.pone.0056647	http://dx.doi.org/10.1371/journal.pone.0056647			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437196	Green Published, Green Submitted, gold			2022-12-25	WOS:000315184200127
J	Looi, CY; Arya, A; Cheah, FK; Muharram, B; Leong, KH; Mohamad, K; Wong, WF; Rai, N; Mustafa, MR				Looi, Chung Yeng; Arya, Aditya; Cheah, Foo Kit; Muharram, Bushra; Leong, Kok Hoong; Mohamad, Khalit; Wong, Won Fen; Rai, Nitika; Mustafa, Mohd Rais			Induction of Apoptosis in Human Breast Cancer Cells via Caspase Pathway by Vernodalin Isolated from Centratherum anthelminticum (L.) Seeds	PLOS ONE			English	Article							CHROMATOGRAPHY MASS-SPECTROMETRY; DEPENDENT KINASE INHIBITOR; L KUNTZE SEED; SESQUITERPENE LACTONES; LIQUID-CHROMATOGRAPHY; TRADITIONAL MEDICINE; VERNONIA-AMYGDALINA; VERNOLIC ACID; MCF-7 CELLS; T-CELLS	Background: Centratherum anthelminticum (L.) seeds (CA) is a well known medicinal herb in Indian sub-continent. We recently reported anti-oxidant property of chloroform fraction of Centratherum anthelminticum (L.) seeds (CACF) by inhibiting tumor necrosis factor-alpha (TNF-alpha)-induced growth of human breast cancer cells. However, the active compounds in CACF have not been investigated previously. Methodology/Principal Findings: In this study, we showed that CACF inhibited growth of MCF-7 human breast cancer cells. CACF induced apoptosis in MCF-7 cells as marked by cell size shrinkage, deformed cytoskeletal structure and DNA fragmentation. To identify the cytotoxic compound, CACF was subjected to bioassay-guided fractionation which yielded 6 fractions. CACF fraction A and B (CACF-A, -B) demonstrated highest activity among all the fractions. Further HPLC isolation, NMR and LC-MS analysis of CACF-A led to identification of vernodalin as the cytotoxic agent in CACF-A, and -B. 12,13-dihydroxyoleic acid, another major compound in CACF-C fraction was isolated for the first time from Centratherum anthelminticum (L.) seeds but showed no cytotoxic effect against MCF-7 cells. Vernodalin inhibited cell growth of human breast cancer cells MCF-7 and MDA-MB-231 by induction of cell cycle arrest and apoptosis. Increased of reactive oxygen species (ROS) production, coupled with downregulation of anti-apoptotic molecules (Bcl-2, Bcl-xL) led to reduction of mitochondrial membrane potential (MMP) and release of cytochrome c in both human breast cancer cells treated with vernodalin. Release of cytochrome c from mitochondria to cytosol triggered activation of caspase cascade, PARP cleavage, DNA damage and eventually cell death. Conclusions/Significance: To the best of our knowledge, this is the first comprehensive study on cytotoxic and apoptotic mechanism of vernodalin isolated from the Centratherum anthelminticum (L.) seeds in human breast cancer cells. Overall, our data suggest a potential therapeutic value of vernodalin to be further developed as new anti-cancer drug.	[Looi, Chung Yeng; Arya, Aditya; Cheah, Foo Kit; Muharram, Bushra; Mustafa, Mohd Rais] Univ Malaya, Fac Med, Dept Pharmacol, Kuala Lumpur 50603, Malaysia; [Arya, Aditya; Leong, Kok Hoong; Mohamad, Khalit] Univ Malaya, Fac Med, Dept Pharm, Kuala Lumpur, Malaysia; [Wong, Won Fen] Univ Malaya, Fac Med, Dept Med Microbiol, Kuala Lumpur, Malaysia; [Rai, Nitika] Amritum Biobot Herbs Res Lab Pvt Ltd, Jogli, India	Universiti Malaya; Universiti Malaya; Universiti Malaya	Looi, CY (corresponding author), Univ Malaya, Fac Med, Dept Pharmacol, Kuala Lumpur 50603, Malaysia.	looicy@um.edu.my	Looi, Chung Yeng/A-2623-2013; Mustafa, Mohamed R/B-1647-2009; Mohd, Mustafa b Ali/B-9184-2010; Leong, Kok Hoong/D-9505-2012; Leong, Kok Hoong/J-1956-2015; Wong, Won Fen/D-3087-2012	Looi, Chung Yeng/0000-0002-4830-3495; Mustafa, Mohamed R/0000-0002-7864-5189; Mohd, Mustafa b Ali/0000-0002-4220-5384; Leong, Kok Hoong/0000-0002-7317-6117; Leong, Kok Hoong/0000-0002-7317-6117; Wong, Won Fen/0000-0003-1082-1956; Arya, Aditya/0000-0002-8747-3462	University Malaya [RP001-2012B]; University Malaya High Impact research grant from Ministry of Higher Education (MOHE), Malaysia [H-20001-E00002]	University Malaya(Universiti Malaya); University Malaya High Impact research grant from Ministry of Higher Education (MOHE), Malaysia	This study was supported by University Malaya research grant (RP001-2012B) and University Malaya High Impact research grant (H-20001-E00002) from Ministry of Higher Education (MOHE), Malaysia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allwood JW, 2010, PHYTOCHEM ANALYSIS, V21, P33, DOI 10.1002/pca.1187; Ani V, 2011, BMC COMPLEM ALTERN M, V11, DOI 10.1186/1472-6882-11-40; Arya A, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/627256; Ashok P, 2010, INDIAN J PHARM SCI, V72, P697, DOI 10.4103/0250-474X.84577; Azaizeh H, 2006, EVID-BASED COMPL ALT, V3, P229, DOI 10.1093/ecam/nel034; Ballot C, 2009, MOL CANCER THER, V8, P3307, DOI 10.1158/1535-7163.MCT-09-0639; BHAKUNI DS, 1969, INDIAN J EXP BIOL, V7, P250; Cheng JT, 2000, J CLIN PHARMACOL, V40, P445, DOI 10.1177/00912700022009198; Chinnaiyan Arul M., 1999, Neoplasia (New York), V1, P5; Chukwujekwu JC, 2009, S AFR J BOT, V75, P176, DOI 10.1016/j.sajb.2008.10.001; Crawford AD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014694; DEKOK TMCM, 1994, CARCINOGENESIS, V15, P1399, DOI 10.1093/carcin/15.7.1399; Drexler HG, 1998, LEUKEMIA, V12, P845, DOI 10.1038/sj.leu.2401043; Engel RH, 2006, FRONT BIOSCI-LANDMRK, V11, P300, DOI 10.2741/1798; Fiers W, 1999, ONCOGENE, V18, P7719, DOI 10.1038/sj.onc.1203249; Forouzanfar MH, 2011, LANCET, V378, P1461, DOI 10.1016/S0140-6736(11)61351-2; Gogvadze V, 2008, TRENDS CELL BIOL, V18, P165, DOI 10.1016/j.tcb.2008.01.006; Gourlay CW, 2005, NAT REV MOL CELL BIO, V6, P583, DOI 10.1038/nrm1682; Hedenfalk IA, 2002, ADV CANCER RES, V84, P1, DOI 10.1016/S0065-230X(02)84001-5; HENION JD, 1980, BIOMED MASS SPECTROM, V7, P115, DOI 10.1002/bms.1200070306; Hosamani KM, 2000, IND CROP PROD, V12, P93, DOI 10.1016/S0926-6690(00)00041-8; Hosamani KM, 2003, IND CROP PROD, V18, P111, DOI 10.1016/S0926-6690(03)00031-1; Hu YM, 1998, P NATL ACAD SCI USA, V95, P4386, DOI 10.1073/pnas.95.8.4386; Indran IR, 2011, BBA-BIOENERGETICS, V1807, P735, DOI 10.1016/j.bbabio.2011.03.010; Kasim LS, 2011, PAK J PHARM SCI, V24, P475; KOSHIMIZU K, 1994, PHYSIOL BEHAV, V56, P1209, DOI 10.1016/0031-9384(94)90368-9; Kottke TJ, 2002, J BIOL CHEM, V277, P804, DOI 10.1074/jbc.M108419200; Kuiper GGJM, 1998, ENDOCRINOLOGY, V139, P4252, DOI 10.1210/en.139.10.4252; Kumar S, 1999, CLIN EXP PHARMACOL P, V26, P295, DOI 10.1046/j.1440-1681.1999.03031.x; KUPCHAN SM, 1969, J ORG CHEM, V34, P3908, DOI 10.1021/jo01264a035; Lambertini E, 2004, INT J ONCOL, V24, P419; Lev E, 2006, J ETHNOBIOL ETHNOMED, V2, DOI 10.1186/1746-4269-2-4; Liu Wen-Zhe, 2004, Zhiwu Shengli yu Fenzi Shengwuxue Xuebao, V30, P405; Liu YQ, 2010, TETRAHEDRON LETT, V51, P6584, DOI 10.1016/j.tetlet.2010.10.031; Looi CY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023640; Lowe SW, 2000, CARCINOGENESIS, V21, P485, DOI 10.1093/carcin/21.3.485; Mc Gee MM, 2002, FEBS LETT, V515, P66, DOI 10.1016/S0014-5793(02)02440-7; MORRIS LJ, 1969, LIPIDS, V4, P50, DOI 10.1007/BF02531794; Niessen WMA, 1998, J CHROMATOGR A, V794, P407, DOI 10.1016/S0021-9673(97)01112-6; Oh SY, 2007, MOL CANCER THER, V6, P2178, DOI 10.1158/1535-7163.MCT-07-0111; Ohtake F, 2003, NATURE, V423, P545, DOI 10.1038/nature01606; Pan MH, 2010, J AGR FOOD CHEM, V58, P226, DOI 10.1021/jf903067g; Paris F, 2002, MOL CELL ENDOCRINOL, V193, P43, DOI 10.1016/S0303-7207(02)00094-1; Pedersen MM, 2009, PHYTOCHEMISTRY, V70, P601, DOI 10.1016/j.phytochem.2009.02.005; Purnima A, 2009, INDIAN J PHARM SCI, V71, P461, DOI 10.4103/0250-474X.57302; Rabe T, 2002, J ETHNOPHARMACOL, V80, P91, DOI 10.1016/S0378-8741(02)00010-7; Sarkar FH, 2007, ACTA PHARMACOL SIN, V28, P1305, DOI 10.1111/j.1745-7254.2007.00689.x; Scartezzini P, 2000, J ETHNOPHARMACOL, V71, P23, DOI 10.1016/S0378-8741(00)00213-0; Sharma S, 1991, J Hyg Epidemiol Microbiol Immunol, V35, P157; Shimizu S, 1996, ONCOGENE, V13, P21; Shimizu S, 1998, P NATL ACAD SCI USA, V95, P1455, DOI 10.1073/pnas.95.4.1455; Simon HU, 2000, APOPTOSIS, V5, P415, DOI 10.1023/A:1009616228304; Sims AH, 2007, NAT CLIN PRACT ONCOL, V4, P516, DOI 10.1038/ncponc0908; SINGHAL K C, 1992, Indian Journal of Experimental Biology, V30, P546; Tan AR, 2002, SEMIN ONCOL, V29, P77, DOI 10.1053/sonc.2002.34059; THOMPSON CB, 1995, SCIENCE, V267, P1456, DOI 10.1126/science.7878464; VOLKOV SK, 1994, J CHROMATOGR B, V660, P405, DOI 10.1016/0378-4347(94)00290-8; Wang Q, 2011, CURR MED CHEM, V18, P2025, DOI 10.2174/092986711795590110; WANI MC, 1971, J AM CHEM SOC, V93, P2325, DOI 10.1021/ja00738a045; Weir NM, 2007, CANCER BIOL THER, V6, P178, DOI 10.4161/cbt.6.2.3577; Wohlbold L, 2006, CELL CYCLE, V5, P546, DOI 10.4161/cc.5.5.2541; Wong WF, 2012, J IMMUNOL, V188, P5408, DOI 10.4049/jimmunol.1102991; Wong YH, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/164689; Woo HJ, 2011, J ETHNOPHARMACOL, V135, P626, DOI 10.1016/j.jep.2011.03.067; Yang J, 1997, SCIENCE, V275, P1129, DOI 10.1126/science.275.5303.1129; Yesilada E, 2004, J ETHNOPHARMACOL, V95, P213, DOI 10.1016/j.jep.2004.07.021; Yu R, 2006, J INT MED RES, V34, P231, DOI 10.1177/147323000603400301	67	100	101	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e56643	10.1371/journal.pone.0056643	http://dx.doi.org/10.1371/journal.pone.0056643			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437193	gold, Green Published, Green Accepted			2022-12-25	WOS:000315184200125
J	Lucchi, NW; Narayanan, J; Karell, MA; Xayavong, M; Kariuki, S; DaSilva, AJ; Hill, V; Udhayakumar, V				Lucchi, Naomi W.; Narayanan, Jothikumar; Karell, Mara A.; Xayavong, Maniphet; Kariuki, Simon; DaSilva, Alexandre J.; Hill, Vincent; Udhayakumar, Venkatachalam			Molecular Diagnosis of Malaria by Photo-Induced Electron Transfer Fluorogenic Primers: PET-PCR	PLOS ONE			English	Article							18S RIBOSOMAL-RNA; PLASMODIUM-FALCIPARUM; TESTS; EPIDEMIOLOGY; ELIMINATION; GAMETOCYTES; MICROSCOPY; TANZANIA; VIVAX; ASSAY	There is a critical need for developing new malaria diagnostic tools that are sensitive, cost effective and capable of performing large scale diagnosis. The real-time PCR methods are particularly robust for large scale screening and they can be used in malaria control and elimination programs. We have designed novel self-quenching photo-induced electron transfer (PET) fluorogenic primers for the detection of P. falciparum and the Plasmodium genus by real-time PCR. A total of 119 samples consisting of different malaria species and mixed infections were used to test the utility of the novel PET-PCR primers in the diagnosis of clinical samples. The sensitivity and specificity were calculated using a nested PCR as the gold standard and the novel primer sets demonstrated 100% sensitivity and specificity. The limits of detection for P. falciparum was shown to be 3.2 parasites/mu l using both Plasmodium genus and P. falciparum-specific primers and 5.8 parasites/mu l for P. ovale, 3.5 parasites/mu l for P. malariae and 5 parasites/mu l for P. vivax using the genus specific primer set. Moreover, the reaction can be duplexed to detect both Plasmodium spp. and P. falciparum in a single reaction. The PET-PCR assay does not require internal probes or intercalating dyes which makes it convenient to use and less expensive than other real-time PCR diagnostic formats. Further validation of this technique in the field will help to assess its utility for large scale screening in malaria control and elimination programs.	[Lucchi, Naomi W.; Xayavong, Maniphet; DaSilva, Alexandre J.; Udhayakumar, Venkatachalam] Ctr Dis Control & Prevent, Div Parasit Dis & Malaria, Ctr Global Hlth, Atlanta, GA 30333 USA; [Narayanan, Jothikumar; Hill, Vincent] Ctr Dis Control & Prevent, Waterborne Dis Prevent Branch, Natl Ctr Emerging & Zoonot Infect Dis, Atlanta, GA USA; [Karell, Mara A.; Udhayakumar, Venkatachalam] Atlanta Res & Educ Fdn, VA Med Ctr, Decatur, GA USA; [Kariuki, Simon] Ctr Dis Control & Prevent, Malaria Branch, Kenya Med Res Inst, Kisumu, Kenya	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; US Department of Veterans Affairs; Veterans Health Administration (VHA); Atlanta VA Health Care System; Kenya Medical Research Institute	Lucchi, NW (corresponding author), Ctr Dis Control & Prevent, Div Parasit Dis & Malaria, Ctr Global Hlth, Atlanta, GA 30333 USA.	NLucchi@cdc.gov	Hill, Vincent/G-1789-2012; Kariuki, Simon/AFT-6596-2022	Hill, Vincent/0000-0001-7069-7737; Lucchi, Naomi/0000-0001-8789-8041; Karell, Mara/0000-0003-3875-4679	Atlanta Research and Education Foundation, Atlanta, Georgia; Malaria Branch, CDC	Atlanta Research and Education Foundation, Atlanta, Georgia; Malaria Branch, CDC	This study was supported by the Atlanta Research and Education Foundation, Atlanta, Georgia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank the Malaria Branch, CDC, for supporting this project and Dr. John W. Barnwell for proving some of the samples used in this study. The use of trade names and names of commercial sources is for identification only and does not imply endorsement by the Centers for Disease Control and Prevention or the U.S. Department of Health and Human Services. The findings and conclusions in this presentation are those of the authors and do not necessarily represent those of the Centers for Disease Control and Prevention.	Alonso PL, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000406; [Anonymous], 2011, PLOS MED, V8; Bousema T, 2011, CLIN MICROBIOL REV, V24, P377, DOI 10.1128/CMR.00051-10; Demas A, 2011, J CLIN MICROBIOL, V49, P2411, DOI 10.1128/JCM.02603-10; Drakeley C, 2006, TRENDS PARASITOL, V22, P424, DOI 10.1016/j.pt.2006.07.001; Erdman Laura K, 2008, Travel Med Infect Dis, V6, P82, DOI 10.1016/j.tmaid.2007.10.001; Gamboa D, PLOS ONE, V5, pe8091; Koita OA, 2012, AM J TROP MED HYG, V86, P194, DOI 10.4269/ajtmh.2012.10-0665; McMorrow ML, 2011, CLIN MICROBIOL INFEC, V17, P1624, DOI 10.1111/j.1469-0691.2011.03639.x; McMorrow ML, 2008, AM J TROP MED HYG, V79, P385, DOI 10.4269/ajtmh.2008.79.385; Najera JA, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000412; Nazarenko Irina, 2006, V335, P95; Ngasala B, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-199; Okell LC, 2009, J INFECT DIS, V200, P1509, DOI 10.1086/644781; Ouedraogo AL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008410; Perandin F, 2004, J CLIN MICROBIOL, V42, P1214, DOI 10.1128/JCM.42.3.1214-1219.2004; Rougemont M, 2004, J CLIN MICROBIOL, V42, P5636, DOI 10.1128/JCM.42.12.5636-5643.2004; Singh B, 2004, LANCET, V363, P1017, DOI 10.1016/S0140-6736(04)15836-4; Singh B, 1999, AM J TROP MED HYG, V60, P687, DOI 10.4269/ajtmh.1999.60.687; Taylor SM, 2010, J CLIN MICROBIOL, V48, P512, DOI 10.1128/JCM.01800-09; WHO, 2010, WORLD MALARIA REPORT 2010, P1; Wongsrichanalai C, 2007, AM J TROP MED HYG, V77, P119, DOI 10.4269/ajtmh.2007.77.119	22	82	82	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e56677	10.1371/journal.pone.0056677	http://dx.doi.org/10.1371/journal.pone.0056677			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437209	gold, Green Published, Green Submitted			2022-12-25	WOS:000315184200139
J	Powers, KE; Heatherton, TF				Powers, Katherine E.; Heatherton, Todd F.			Implicitly Priming the Social Brain: Failure to Find Neural Effects	PLOS ONE			English	Article							EXCLUSION; BELONG; NEED; SELF; ACTIVATION; REJECTION; BEHAVIOR; TRAIT; AUTOMATICITY; PURSUIT	Humans have a fundamental need for social relationships. Rejection from social groups is especially detrimental, rendering the ability to detect threats to social relationships and respond in adaptive ways critical. Indeed, previous research has shown that experiencing social rejection alters the processing of subsequent social cues in a variety of socially affiliative and avoidant ways. Because social perception and cognition occurs spontaneously and automatically, detecting threats to social relationships may occur without conscious awareness or control. Here, we investigated the automaticity of social threat detection by examining how implicit primes affect neural responses to social stimuli. However, despite using a well-established implicit priming paradigm and large sample size, we failed to find any evidence that implicit primes induced changes at the neural level. That implicit primes influence behavior has been demonstrated repeatedly and across a variety of domains, and our goal is not to question these effects. Rather, we offer the present study as cautionary evidence that such a paradigm may not be amenable to scanning in an fMRI environment.	[Powers, Katherine E.; Heatherton, Todd F.] Dartmouth Coll, Dept Psychol & Brain Sci, Ctr Cognit Neurosci, Hanover, NH 03755 USA	Dartmouth College	Powers, KE (corresponding author), Dartmouth Coll, Dept Psychol & Brain Sci, Ctr Cognit Neurosci, Hanover, NH 03755 USA.	katherine.e.powers@dartmouth.edu			National Institute of Mental Health [R01MH059282]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH059282] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This research was supported by a grant from the National Institute of Mental Health (R01MH059282) to TFH. (www.nimh.nih.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarts H, 2002, BRIT J SOC PSYCHOL, V41, P123, DOI 10.1348/014466602165090; Adolphs R, 2009, ANNU REV PSYCHOL, V60, P693, DOI 10.1146/annurev.psych.60.110707.163514; Bargh JA, 1996, J PERS SOC PSYCHOL, V71, P230, DOI 10.1037/0022-3514.71.2.230; Bargh JA, 2001, J PERS SOC PSYCHOL, V81, P1014, DOI 10.1037//0022-3514.81.6.1014; Bargh JA, 2000, PSYCHOL BULL, V126, P925, DOI 10.1037//0033-2909.126.6.925; BAUMEISTER RF, 1995, PSYCHOL BULL, V117, P497, DOI 10.1037/0033-2909.117.3.497; Baumeister RF, 2007, SOC PERSONAL PSYCHOL, V1, P506, DOI 10.1111/j.1751-9004.2007.00020.x; Bowlby J, 1969, ATTACHMENT LOSS SEPA; DeWall CN, 2006, J PERS SOC PSYCHOL, V91, P1, DOI 10.1037/0022-3514.91.1.1; DeWall CN, 2011, J PERS, V79, P979, DOI 10.1111/j.1467-6494.2010.00695.x; DeWall CN, 2010, SOC PSYCHOL PERS SCI, V1, P168, DOI 10.1177/1948550610361387; Eisenberger NI, 2003, SCIENCE, V302, P290, DOI 10.1126/science.1089134; Eisenberger NI, 2005, SOCIAL OUTCAST OSTRA, P109; Fitzsimons GM, 2003, J PERS SOC PSYCHOL, V84, P148, DOI 10.1037/0022-3514.84.1.148; Frith U, 2001, CURR DIR PSYCHOL SCI, V10, P151, DOI 10.1111/1467-8721.00137; Gallagher HL, 2003, TRENDS COGN SCI, V7, P77, DOI 10.1016/S1364-6613(02)00025-6; Gardner WL, 2000, PERS SOC PSYCHOL B, V26, P486, DOI 10.1177/0146167200266007; Heatherton TF, 2011, ANNU REV PSYCHOL, V62, P363, DOI 10.1146/annurev.psych.121208.131616; Levesque C, 2003, PERS SOC PSYCHOL B, V29, P1570, DOI 10.1177/0146167203256877; Maner JK, 2007, J PERS SOC PSYCHOL, V92, P42, DOI 10.1037/0022-3514.92.1.42; Mather M, 2005, TRENDS COGN SCI, V9, P496, DOI 10.1016/j.tics.2005.08.005; Mitchell JP, 2002, P NATL ACAD SCI USA, V99, P15238, DOI 10.1073/pnas.232395699; MITCHELL JP, 2009, COGNITIVE NEUROSCIEN, P951; Pickett CL, 2004, PERS SOC PSYCHOL B, V30, P1095, DOI 10.1177/0146167203262085; Powers KE, 2012, FRONT INTEGR NEUROSC, V6, DOI 10.3389/fnint.2012.00046; Powers KE, SOC COGN AF IN PRESS; Shariff AF, 2007, PSYCHOL SCI, V18, P803, DOI 10.1111/j.1467-9280.2007.01983.x; Somerville LH, 2006, NAT NEUROSCI, V9, P1007, DOI 10.1038/nn1728; Sommer KL, 2002, PERS SOC PSYCHOL B, V28, P926, DOI 10.1177/01467202028007006; SRULL TK, 1979, J PERS SOC PSYCHOL, V37, P1660, DOI 10.1037/0022-3514.37.10.1660; Twenge JM, 2007, J PERS SOC PSYCHOL, V92, P56, DOI 10.1037/0022-3514.92.1.56; Twenge JM, 2003, J PERS SOC PSYCHOL, V85, P409, DOI 10.1037/0022-3514.85.3.409; Twenge JM, 2001, J PERS SOC PSYCHOL, V81, P1058, DOI 10.1037//0022-3514.81.6.1058; Vohs KD, 2001, J PERS SOC PSYCHOL, V81, P1103, DOI 10.1037/0022-3514.81.6.1103; Wagner DD, 2011, CEREB CORTEX, V21, P2788, DOI 10.1093/cercor/bhr074; Williams LE, 2008, SCIENCE, V322, P606, DOI 10.1126/science.1162548	36	7	7	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e56596	10.1371/journal.pone.0056596	http://dx.doi.org/10.1371/journal.pone.0056596			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	093IE	23437183	Green Published, gold			2022-12-25	WOS:000315184200118
J	Chang, SX; Wang, YK; Lu, JJ; Gai, JY; Li, JJ; Chu, P; Guan, RZ; Zhao, TJ				Chang, Shengxin; Wang, Yankun; Lu, Jiangjie; Gai, Junyi; Li, Jijie; Chu, Pu; Guan, Rongzhan; Zhao, Tuanjie			The Mitochondrial Genome of Soybean Reveals Complex Genome Structures and Gene Evolution at Intercellular and Phylogenetic Levels	PLOS ONE			English	Article							COMPLETE NUCLEOTIDE-SEQUENCE; CHLOROPLAST GENOME; NUCLEAR GENOME; MALE-STERILITY; DNA; RNA; L.; CLASSIFICATION; RECOMBINATION; ORGANIZATION	Determining mitochondrial genomes is important for elucidating vital activities of seed plants. Mitochondrial genomes are specific to each plant species because of their variable size, complex structures and patterns of gene losses and gains during evolution. This complexity has made research on the soybean mitochondrial genome difficult compared with its nuclear and chloroplast genomes. The present study helps to solve a 30-year mystery regarding the most complex mitochondrial genome structure, showing that pairwise rearrangements among the many large repeats may produce an enriched molecular pool of 760 circles in seed plants. The soybean mitochondrial genome harbors 58 genes of known function in addition to 52 predicted open reading frames of unknown function. The genome contains sequences of multiple identifiable origins, including 6.8 kb and 7.1 kb DNA fragments that have been transferred from the nuclear and chloroplast genomes, respectively, and some horizontal DNA transfers. The soybean mitochondrial genome has lost 16 genes, including nine protein-coding genes and seven tRNA genes; however, it has acquired five chloroplast-derived genes during evolution. Four tRNA genes, common among the three genomes, are derived from the chloroplast. Sizeable DNA transfers to the nucleus, with pericentromeric regions as hotspots, are observed, including DNA transfers of 125.0 kb and 151.6 kb identified unambiguously from the soybean mitochondrial and chloroplast genomes, respectively. The soybean nuclear genome has acquired five genes from its mitochondrial genome. These results provide biological insights into the mitochondrial genome of seed plants, and are especially helpful for deciphering vital activities in soybean.	[Chang, Shengxin; Lu, Jiangjie; Gai, Junyi; Guan, Rongzhan; Zhao, Tuanjie] Natl Ctr Soybean Improvement, Nanjing, Jiangsu, Peoples R China; [Chang, Shengxin; Lu, Jiangjie; Gai, Junyi; Guan, Rongzhan; Zhao, Tuanjie] Minist Agr, Key Lab Biol & Genet Improvement Soybean, Nanjing, Jiangsu, Peoples R China; [Chang, Shengxin; Wang, Yankun; Gai, Junyi; Li, Jijie; Chu, Pu; Guan, Rongzhan; Zhao, Tuanjie] Nanjing Agr Univ, Natl Key Lab Crop Genet & Germplasm Enhancement, Nanjing, Jiangsu, Peoples R China	Ministry of Agriculture & Rural Affairs; Nanjing Agricultural University	Guan, RZ (corresponding author), Natl Ctr Soybean Improvement, Nanjing, Jiangsu, Peoples R China.	guanrzh@njau.edu.cn; tjzhao@njau.edu.cn	lujiang, grant/E-4785-2010	Guan, Rongzhan/0000-0001-9177-6610	National Key Basic Research Program of China [2011CB1093, 2010CB1259, 2011CB109300]; National Hightech R&D Program of China [2012AA101106]; National Key Technology RD Program [2010BAD01B02, 2011BAD13B09]; National Natural Science Foundation of China [31071442, 30970289]	National Key Basic Research Program of China(National Basic Research Program of China); National Hightech R&D Program of China(National High Technology Research and Development Program of China); National Key Technology RD Program(National Key Technology R&D Program); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Key Basic Research Program of China (2011CB1093, 2010CB1259, 2011CB109300), the National Hightech R&D Program of China (2012AA101106), the National Key Technology R&D Program (2010BAD01B02, 2011BAD13B09) and the National Natural Science Foundation of China (31071442, 30970289). The authors wish to thank Shanghai Majorbio Bio-pharm Biotechnology Company (China) for their help with sequencing of the mtDNA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams KL, 2000, NATURE, V408, P354, DOI 10.1038/35042567; Adams KL, 2003, MOL PHYLOGENET EVOL, V29, P380, DOI 10.1016/S1055-7903(03)00194-5; Adams KL, 2002, P NATL ACAD SCI USA, V99, P9905, DOI 10.1073/pnas.042694899; Adams KL, 2001, GENETICS, V158, P1289; Alverson AJ, 2011, PLANT CELL, V23, P2499, DOI 10.1105/tpc.111.087189; Alverson AJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016404; Alverson AJ, 2010, MOL BIOL EVOL, V27, P1436, DOI 10.1093/molbev/msq029; ANDRE C, 1992, TRENDS GENET, V8, P128, DOI 10.1016/0168-9525(92)90370-J; Arrieta-Montiel M, 2001, GENETICS, V158, P851; BAILEYSERRES J, 1987, CURR GENET, V12, P49, DOI 10.1007/BF00420727; Berg OG, 2000, MOL BIOL EVOL, V17, P951, DOI 10.1093/oxfordjournals.molbev.a026376; Blanchard JL, 1996, MOL BIOL EVOL, V13, P893, DOI 10.1093/oxfordjournals.molbev.a025650; Boore JL, 1999, NUCLEIC ACIDS RES, V27, P1767, DOI 10.1093/nar/27.8.1767; Chang SX, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-497; Chaw SM, 2008, MOL BIOL EVOL, V25, P603, DOI 10.1093/molbev/msn009; Chen J, 2011, PLOS ONE, V10; Clifton SW, 2004, PLANT PHYSIOL, V136, P3486, DOI 10.1104/pp.104.044602; Du JC, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-113; EHARA T, 1990, EXP CELL RES, V190, P104, DOI 10.1016/0014-4827(90)90150-9; Feng X, 2009, THEOR APPL GENET, V118, P1361, DOI 10.1007/s00122-009-0986-5; Goremykin VV, 2009, MOL BIOL EVOL, V26, P99, DOI 10.1093/molbev/msn226; GRABAU EA, 1992, CROP SCI, V32, P271, DOI 10.2135/cropsci1992.0011183X003200010055x; Gray MW, 1999, SCIENCE, V283, P1476, DOI 10.1126/science.283.5407.1476; Handa H, 2003, NUCLEIC ACIDS RES, V31, P5907, DOI 10.1093/nar/gkg795; Hazkani-Covo E, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000834; Henze K, 2001, TRENDS GENET, V17, P383, DOI 10.1016/S0168-9525(01)02312-5; Hong YG, 1998, VIROLOGY, V246, P158, DOI 10.1006/viro.1998.9178; Huang CY, 2003, NATURE, V422, P72, DOI 10.1038/nature01435; Janska H, 1998, PLANT CELL, V10, P1163, DOI 10.1105/tpc.10.7.1163; JOYCE PBM, 1989, NUCLEIC ACIDS RES, V17, P5461, DOI 10.1093/nar/17.14.5461; Keeling PJ, 2008, NAT REV GENET, V9, P605, DOI 10.1038/nrg2386; Kubo T, 2000, NUCLEIC ACIDS RES, V28, P2571, DOI 10.1093/nar/28.13.2571; Kubo T, 2008, MITOCHONDRION, V8, P5, DOI 10.1016/j.mito.2007.10.006; Kwok EY, 2004, J MICROSC-OXFORD, V214, P124, DOI 10.1111/j.0022-2720.2004.01317.x; Lang BF, 1999, ANNU REV GENET, V33, P351, DOI 10.1146/annurev.genet.33.1.351; Liu HT, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-163; Lohse M, 2007, CURR GENET, V52, P267, DOI 10.1007/s00294-007-0161-y; LONSDALE DM, 1984, NUCLEIC ACIDS RES, V12, P9249, DOI 10.1093/nar/12.24.9249; Manchekar M, 2006, J MOL BIOL, V356, P288, DOI 10.1016/j.jmb.2005.11.070; Matsuo M, 2005, PLANT CELL, V17, P665, DOI 10.1105/tpc.104.027706; Milne I, 2009, BIOINFORMATICS, V25, P126, DOI 10.1093/bioinformatics/btp666; MOEYKENS CA, 1995, PLANT MOL BIOL, V29, P245, DOI 10.1007/BF00043649; MOTA M, 1963, CYTOLOGIA, V28, P409, DOI 10.1508/cytologia.28.409; Mower JP, 2012, GENOME BIOL EVOL, V4, P670, DOI 10.1093/gbe/evs042; Newton K.J., 2004, PLANT MITOCHONDRIA; Notsu Y, 2002, MOL GENET GENOMICS, V268, P434, DOI 10.1007/s00438-002-0767-1; Ogihara Y, 2005, NUCLEIC ACIDS RES, V33, P6235, DOI 10.1093/nar/gki925; PALMER JD, 1984, NATURE, V307, P437, DOI 10.1038/307437a0; PALMER JD, 1987, CURR GENET, V11, P565, DOI 10.1007/BF00384620; Richly E, 2004, MOL BIOL EVOL, V21, P1972, DOI 10.1093/molbev/msh210; Rousseau-Gueutin M, 2011, PLANT PHYSIOL, V157, P2181, DOI 10.1104/pp.111.185074; Saski C, 2005, PLANT MOL BIOL, V59, P309, DOI 10.1007/s11103-005-8882-0; Schmutz J, 2010, NATURE, V463, P178, DOI 10.1038/nature08670; Sloan DB, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001241; Smith DR, 2011, GENOME BIOL EVOL, V3, P743, DOI [10.1093/gbe/evr068, 10.1093/gbe/evr001]; Stegemann S, 2006, PLANT CELL, V18, P2869, DOI 10.1105/tpc.106.046466; SYNENKI RM, 1978, PLANT PHYSIOL, V61, P460, DOI 10.1104/pp.61.3.460; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tavare S., 1986, LECT MATH LIFE SCI, V17, P57, DOI DOI 10.1016/J.MARPOLBUL.2009.11.011; Thorsness PE, 1996, INT REV CYTOL, V165, P207, DOI 10.1016/S0074-7696(08)62223-8; Unseld M, 1997, NAT GENET, V15, P57, DOI 10.1038/ng0197-57; Wang D, 2007, MOL BIOL EVOL, V24, P2040, DOI 10.1093/molbev/msm133; Wicker T, 2007, NAT REV GENET, V8, P973, DOI 10.1038/nrg2165; YU HS, 1994, PLANT CELL, V6, P1477, DOI 10.1105/tpc.6.10.1477; Zhang TW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030531	65	53	62	4	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2013	8	2							e56502	10.1371/journal.pone.0056502	http://dx.doi.org/10.1371/journal.pone.0056502			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093HR	23431381	Green Submitted, Green Published, gold			2022-12-25	WOS:000315182800023
J	Drong, AW; Nicholson, G; Hedman, AK; Meduri, E; Grundberg, E; Small, KS; Shin, SY; Bell, JT; Karpe, F; Soranzo, N; Spector, TD; McCarthy, MI; Deloukas, P; Rantalainen, M; Lindgren, CM				Drong, Alexander W.; Nicholson, George; Hedman, Asa K.; Meduri, Eshwar; Grundberg, Elin; Small, Kerrin S.; Shin, So-Youn; Bell, Jordana T.; Karpe, Fredrik; Soranzo, Nicole; Spector, Tim D.; McCarthy, Mark I.; Deloukas, Panos; Rantalainen, Mattias; Lindgren, Cecilia M.		MolPAGE Consortia	The Presence of Methylation Quantitative Trait Loci Indicates a Direct Genetic Influence on the Level of DNA Methylation in Adipose Tissue	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; METAANALYSIS; TOOL	Genetic variants that associate with DNA methylation at CpG sites (methylation quantitative trait loci, meQTLs) offer a potential biological mechanism of action for disease associated SNPs. We investigated whether meQTLs exist in abdominal subcutaneous adipose tissue (SAT) and if CpG methylation associates with metabolic syndrome (MetSyn) phenotypes. We profiled 27,718 genomic regions in abdominal SAT samples of 38 unrelated individuals using differential methylation hybridization (DMH) together with genotypes at 5,227,243 SNPs and expression of 17,209 mRNA transcripts. Validation and replication of significant meQTLs was pursued in an independent cohort of 181 female twins. We find that, at 5% false discovery rate, methylation levels of 149 DMH regions associate with at least one SNP in a +/-500 kilobase cis-region in our primary study. We sought to validate 19 of these in the replication study and find that five of these significantly associate with the corresponding meQTL SNPs from the primary study. We find that none of the 149 meQTL top SNPs is a significant expression quantitative trait locus in our expression data, but we observed association between expression levels of two mRNA transcripts and cis-methylation status. Our results indicate that DNA CpG methylation in abdominal SAT is partly under genetic control. This study provides a starting point for future investigations of DNA methylation in adipose tissue.	[Drong, Alexander W.; Hedman, Asa K.; Bell, Jordana T.; McCarthy, Mark I.; Lindgren, Cecilia M.] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England; [Nicholson, George; Rantalainen, Mattias] Univ Oxford, Dept Stat, Oxford OX1 3TG, England; [Meduri, Eshwar; Grundberg, Elin; Shin, So-Youn; Soranzo, Nicole; Deloukas, Panos] Wellcome Trust Sanger Inst, Hinxton, England; [Grundberg, Elin; Small, Kerrin S.; Bell, Jordana T.; Spector, Tim D.] Kings Coll London, Dept Twin Res, London WC2R 2LS, England; [Karpe, Fredrik; McCarthy, Mark I.] Univ Oxford, Oxford Ctr Diabet Endocrinol & Metab, Oxford, England	University of Oxford; Wellcome Centre for Human Genetics; University of Oxford; Wellcome Trust Sanger Institute; University of London; King's College London; University of Oxford	Lindgren, CM (corresponding author), Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England.	celi@well.ox.ac.uk	Rantalainen, Mattias/J-3125-2012; Bell, Jordana/AAH-7312-2019; Drong, Alexander/AAG-1115-2020; Deloukas, Panos/B-2922-2013; McCarthy, Mark/M-3763-2015	Deloukas, Panos/0000-0001-9251-070X; Meduri, Eshwar/0000-0002-3821-312X; Soranzo, Nicole/0000-0003-1095-3852; Hedman, Asa/0000-0001-5413-204X; McCarthy, Mark/0000-0002-4393-0510; Lindgren, Cecilia/0000-0002-4903-9374; Bell, Jordana/0000-0002-3858-5986; Small, Kerrin/0000-0003-4566-0005; Karpe, Fredrik/0000-0002-2751-1770; Nicholson, George/0000-0001-9588-6075	Wellcome Trust [090532/Z/09/Z, 091746/Z/10/Z, 098051]; European Community's Sixth Framework Programme, MolPAGE Consortium [LSHG-CT-2004-512066]; Epigenomics AG; MolPAGE; Sir Henry Wellcome Trust postdoctoral fellowship; Medical Research Council [G0802460]; MRC [G0802460] Funding Source: UKRI	Wellcome Trust(Wellcome Trust); European Community's Sixth Framework Programme, MolPAGE Consortium; Epigenomics AG; MolPAGE; Sir Henry Wellcome Trust postdoctoral fellowship; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the Wellcome Trust (090532/Z/09/Z) and the European Community's Sixth Framework Programme, MolPAGE Consortium (LSHG-CT-2004-512066), which included both academic and commercial partners. The latter, included Epigenomics AG, whose involvement in MolPAGE was funded on a 50/50 basis. Epigenomics took no patents on the work and has no active products in the field of diabetes and obesity. None of the authors own stocks or shares of Epigenomics AG, are employed or members of the board of Epigenomics AG, or have received research grants, travel grants, or any gifts of any kind from Epigenomics AG. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials. AWD is a Wellcome Trust Student (093933Z/10/Z). JTB was funded by a Sir Henry Wellcome Trust postdoctoral fellowship. NS is supported by the Wellcome Trust (Core Grant Number 091746/Z/10/Z). PD is supported by the Wellcome Trust core grant 098051 which also covered costs for methylation profiling with the 27K methylation array, carried out by the Genotyping Facility at the Wellcome Trust Sanger Institute. MR is a MRC biomedical informatics fellow (Medical Research Council, fellowship G0802460). CML is a Wellcome Trust Research Career Development Fellow (086596/Z/08/Z).	AGGERBECK M, 1993, BIOCHEMISTRY-US, V32, P9065, DOI 10.1021/bi00086a011; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Andrew T, 2001, Twin Res, V4, P464, DOI 10.1375/1369052012803; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bell CG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014040; Bell JT, 2012, PLOS GENET, V8, P189, DOI 10.1371/journal.pgen.1002629; Bell JT, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-1-r10; Berger SL, 2009, GENE DEV, V23, P781, DOI 10.1101/gad.1787609; Boyce BF, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2165; Chang YH, 2011, METABOLISM, V60, P1064, DOI 10.1016/j.metabol.2010.11.002; Dai MH, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni179; Eckhardt F, 2006, NAT GENET, V38, P1378, DOI 10.1038/ng1909; Fassbender A, 2010, METHODS MOL BIOL, V576, P155, DOI 10.1007/978-1-59745-545-9_9; Feinberg AP, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001262; Gibbs JR, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000952; Grundberg E, 2012, NAT GENET, V44, P1084, DOI 10.1038/ng.2394; Heid IM, 2010, NAT GENET, V42, P949, DOI 10.1038/ng.685; Howie B, 2012, NAT GENET, V44, P955, DOI 10.1038/ng.2354; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; *IDF, 2009, IDF WORLDW DEF MET S; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Kerkel K, 2008, NAT GENET, V40, P904, DOI 10.1038/ng.174; Kuehnen P, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002543; Lewin J, 2007, INT J BIOCHEM CELL B, V39, P1539, DOI 10.1016/j.biocel.2007.03.006; Morison IM, 2001, NUCLEIC ACIDS RES, V29, P275, DOI 10.1093/nar/29.1.275; Nabipour I, 2010, METABOLISM, V59, P742, DOI 10.1016/j.metabol.2009.09.019; Nica AC, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002003; PANTEGHINI M, 1990, CLIN BIOCHEM, V23, P311, DOI 10.1016/0009-9120(90)80062-N; Pinnick KE, 2011, P NUTR SOC, V70, P57, DOI 10.1017/S0029665110004015; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Reinhard H, 2010, DIABETES CARE, V33, P2561, DOI 10.2337/dc10-0858; Richards EJ, 2006, NAT REV GENET, V7, P395, DOI 10.1038/nrg1834; Rossin EJ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001273; Schalkwyk LC, 2010, AM J HUM GENET, V86, P196, DOI 10.1016/j.ajhg.2010.01.014; Schumacher A, 2006, NUCLEIC ACIDS RES, V34, P528, DOI 10.1093/nar/gkj461; Segre AV, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001058; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Spector TD, 2006, TWIN RES HUM GENET, V9, P899, DOI 10.1375/twin.9.6.899; Speliotes EK, 2010, NAT GENET, V42, P937, DOI 10.1038/ng.686; Tan GD, 2006, DIABETOLOGIA, V49, P158, DOI 10.1007/s00125-005-0044-z; Toperoff G, 2012, HUM MOL GENET, V21, P371, DOI 10.1093/hmg/ddr472; Zeggini E, 2008, NAT GENET, V40, P638, DOI 10.1038/ng.120	43	63	64	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2013	8	2							e55923	10.1371/journal.pone.0055923	http://dx.doi.org/10.1371/journal.pone.0055923			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093HR	23431366	Green Published, Green Submitted, gold			2022-12-25	WOS:000315182800008
J	Wei, HB; Zhou, B; Zhang, F; Tu, YY; Hu, YN; Zhang, BG; Zhai, QW				Wei, Haibin; Zhou, Ben; Zhang, Fang; Tu, Yanyang; Hu, Yanan; Zhang, Baoguo; Zhai, Qiwei			Profiling and Identification of Small rDNA-Derived RNAs and Their Potential Biological Functions	PLOS ONE			English	Article							RIBOSOMAL DNA REPEAT; COMPLETE SEQUENCE; GENE; MICRORNAS; BIOGENESIS; ORGANIZATION; EXPRESSION; GERMLINE; PATHWAY; TRANSCRIPTOME	Small non-coding RNAs constitute a large family of regulatory molecules with diverse functions. Notably, some small non-coding RNAs matched to rDNA have been identified as qiRNAs and small guide RNAs involved in various biological processes. However, a large number of small rDNA-derived RNAs (srRNAs) are usually neglected and yet to be investigated. We systematically investigated srRNAs using small RNA datasets generated by high-throughput sequencing, and found srRNAs are mainly mapped to rRNA coding regions in sense direction. The datasets from immunoprecipitation and high-throughput sequencing demonstrate that srRNAs are co-immunoprecipitated with Argonaute (AGO) proteins. Furthermore, the srRNA expression profile in mouse liver is affected by diabetes. Overexpression or inhibition of srRNAs in cultured cells shows that srRNAs are involved in various signaling pathways. This study presents a global view of srRNAs in total small RNA and AGO protein complex from different species, and demonstrates that srRNAs are correlated with diabetes, and involved in some biological processes. These findings provide new insights into srRNAs and their functions in various physiological and pathological processes.	[Wei, Haibin; Zhou, Ben; Zhang, Fang; Tu, Yanyang; Hu, Yanan; Zhang, Baoguo; Zhai, Qiwei] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Nutr Sci, Key Lab Nutr & Metab, Shanghai, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Zhai, QW (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Nutr Sci, Key Lab Nutr & Metab, Shanghai, Peoples R China.	qwzhai@sibs.ac.cn	Zhou, Ben/AAB-5808-2020; Zhou, Ben/G-1850-2017; Zhou, Ben/R-9844-2019	Zhou, Ben/0000-0001-7177-2882; Zhou, Ben/0000-0001-7177-2882; Zhai, Qiwei/0000-0002-9617-7403; Zhang, Fang/0000-0002-7000-554X; zhang, bao guo/0000-0002-0800-0342	National Natural Science Foundation of China [30825009, 30970619, 31030022, 81021002, 31200591]; National Basic Research Program of China (973 Program) [2009CB918403]; Program of Shanghai Subject Chief Scientist [11XD1405800]; Knowledge Innovation Program of the Chinese Academy of Sciences [KSCX2-EW-R-09]; Postdoctoral Fellowship Program of Shanghai Institutes for Biological Sciences [2011KIP511]; SA-SIBS Scholarship Program	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China (973 Program)(National Basic Research Program of China); Program of Shanghai Subject Chief Scientist; Knowledge Innovation Program of the Chinese Academy of Sciences(Chinese Academy of SciencesKnowledge Innovation Program of the Chinese Academy of Sciences); Postdoctoral Fellowship Program of Shanghai Institutes for Biological Sciences; SA-SIBS Scholarship Program	This research was supported by grants from National Natural Science Foundation of China (30825009, 30970619, 31030022, 81021002 and 31200591), National Basic Research Program of China (973 Program, 2009CB918403), Program of Shanghai Subject Chief Scientist (11XD1405800), Knowledge Innovation Program of the Chinese Academy of Sciences (KSCX2-EW-R-09), Postdoctoral Fellowship Program of Shanghai Institutes for Biological Sciences (2011KIP511) and SA-SIBS Scholarship Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agius L, 2007, BEST PRACT RES CL EN, V21, P587, DOI 10.1016/j.beem.2007.09.001; Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Barrett T, 2011, NUCLEIC ACIDS RES, V39, pD1005, DOI 10.1093/nar/gkq1184; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Basturea GN, 2011, RNA, V17, P338, DOI 10.1261/rna.2448911; Ben-Shem A, 2010, SCIENCE, V330, P1203, DOI 10.1126/science.1194294; Benhamed M, 2012, NAT CELL BIOL, V14, P266, DOI 10.1038/ncb2443; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BOWMAN LH, 1983, MOL CELL BIOL, V3, P1501, DOI 10.1128/MCB.3.8.1501; Boyle AP, 2008, BIOINFORMATICS, V24, P2537, DOI 10.1093/bioinformatics/btn480; Bushati N, 2007, ANNU REV CELL DEV BI, V23, P175, DOI 10.1146/annurev.cellbio.23.090506.123406; Cheloufi S, 2010, NATURE, V465, P584, DOI 10.1038/nature09092; Chen X, 2008, CELL RES, V18, P997, DOI 10.1038/cr.2008.282; Choudhuri S, 2009, BIOCHEM BIOPH RES CO, V388, P177, DOI 10.1016/j.bbrc.2009.08.039; CHU S, 1994, P NATL ACAD SCI USA, V91, P659, DOI 10.1073/pnas.91.2.659; Czech B, 2008, NATURE, V453, P798, DOI 10.1038/nature07007; Deng W, 2006, GENOME RES, V16, P20, DOI 10.1101/gr.4139206; Elbarbary RA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005908; Ender C, 2008, MOL CELL, V32, P519, DOI 10.1016/j.molcel.2008.10.017; Gavrilova O, 2003, J BIOL CHEM, V278, P34268, DOI 10.1074/jbc.M300043200; Ghildiyal M, 2009, NAT REV GENET, V10, P94, DOI 10.1038/nrg2504; Girard A, 2006, NATURE, V442, P199, DOI 10.1038/nature04917; GONZALEZ IL, 1995, GENOMICS, V27, P320, DOI 10.1006/geno.1995.1049; Grozdanov P, 2003, GENOMICS, V82, P637, DOI 10.1016/S0888-7543(03)00199-X; Hamilton AJ, 1999, SCIENCE, V286, P950, DOI 10.1126/science.286.5441.950; Hou J, 2011, CANCER CELL, V19, P232, DOI 10.1016/j.ccr.2011.01.001; Huang J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008206; Hutvagner G, 2008, NAT REV MOL CELL BIO, V9, P22, DOI 10.1038/nrm2321; Jin QH, 2010, CELL RES, V20, P470, DOI 10.1038/cr.2010.24; Juliano C, 2011, ANNU REV GENET, V45, P447, DOI 10.1146/annurev-genet-110410-132541; Kampers T, 1996, FEBS LETT, V399, P344, DOI 10.1016/S0014-5793(96)01386-5; KAPLAN R, 1975, J BIOL CHEM, V250, P1854; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lee HC, 2009, NATURE, V459, P274, DOI 10.1038/nature08041; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Liu QH, 2010, ANNU REV BIOCHEM, V79, P295, DOI 10.1146/annurev.biochem.052208.151733; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Martin M., 2011, EMBNET J, V17, P10, DOI 10.14806/ej.17.1.200; Nemeth A, 2008, EPIGENETICS-US, V3, P243, DOI 10.4161/epi.3.5.6913; Pasquinelli AE, 2002, ANNU REV CELL DEV BI, V18, P495, DOI 10.1146/annurev.cellbio.18.012502.105832; Rederstorff M, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq057; SAKAI K, 1995, GENOMICS, V26, P521, DOI 10.1016/0888-7543(95)80170-Q; Schaeffer HJ, 1999, MOL CELL BIOL, V19, P2435; Schmid AI, 2011, DIABETES CARE, V34, P448, DOI 10.2337/dc10-1076; Sim S, 2011, WIRES RNA, V2, P686, DOI 10.1002/wrna.85; SRIVASTAVA AK, 1993, MAMM GENOME, V4, P445, DOI 10.1007/BF00296819; Stadler PF, 2009, MOL BIOL EVOL, V26, P1975, DOI 10.1093/molbev/msp112; Swaminathan K, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r12; Tontonoz P, 2008, ANNU REV BIOCHEM, V77, P289, DOI 10.1146/annurev.biochem.77.061307.091829; Tseng H, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001843; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Volpe TA, 2002, SCIENCE, V297, P1833, DOI 10.1126/science.1074973; Watanabe T, 2006, GENE DEV, V20, P1732, DOI 10.1101/gad.1425706; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Wei W, 2012, CELL, V149, P101, DOI 10.1016/j.cell.2012.03.002; Wei YY, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-1-r6; Winter J, 2009, NAT CELL BIOL, V11, P228, DOI 10.1038/ncb0309-228; Zentner GE, 2011, NUCLEIC ACIDS RES, V39, P4949, DOI 10.1093/nar/gkq1326; Zhang XM, 2011, MOL CELL, V42, P356, DOI 10.1016/j.molcel.2011.04.010; Zhao WH, 2008, NATURE, V451, P587, DOI 10.1038/nature06515; ZHU YJ, 1995, P NATL ACAD SCI USA, V92, P7921, DOI 10.1073/pnas.92.17.7921; Zundel MA, 2009, RNA, V15, P977, DOI 10.1261/rna.1381309	62	37	39	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e56842	10.1371/journal.pone.0056842	http://dx.doi.org/10.1371/journal.pone.0056842			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418607	Green Published, Green Submitted, gold			2022-12-25	WOS:000315970300201
J	Luo, WR; Li, SY; Peng, BL; Ye, YF; Deng, XB; Yao, KT				Luo, Weiren; Li, Siyi; Peng, Bailu; Ye, Yanfen; Deng, Xubin; Yao, Kaitai			Embryonic Stem Cells Markers SOX2, OCT4 and Nanog Expression and Their Correlations with Epithelial-Mesenchymal Transition in Nasopharyngeal Carcinoma	PLOS ONE			English	Article							CYCLE ARREST; CANCER; PLURIPOTENCY; COEXPRESSION; NICHE	Expression of embryonic stem cells (ESCs) markers (SOX2, OCT4, Nanog and Nestin) is crucial for progression of various human malignancies. The purpose of this study was to investigate the expression and prognostic impact of these molecules in nasopharyngeal carcinoma (NPC) patients by immunohistochemistry and immunofluorescence. In the present study, we found that the expression levels of SOX2, OCT4 and Nanog were highly expressed in NPC compared with the non-tumorous tissues. Furthermore, these proteins correlated significantly with several clinicalpathological factors and epithelial-mesenchymal transition (EMT)-associated indicators (E-cadherin/N-cadherin and Snail). In multivariate analyses, high expression of OCT4 (P = 0.013) and Nanog (P = 0.040), but not that of SOX2, was associated with worse survival and had strongly independent prognostic effects. Of note, OCT4 and Nanog were more frequently located at the invasive front of tumors, and correlated significantly with various aggressive behaviors including T classification, N classification, M classification and clinical stage. Furthermore, patients with co-expression of OCT4 and Nanog in the invasive front had significantly worse survival (P = 0.005). Interestingly, at the invasive front, these molecules correlated significantly with Nestin expression in endothelial cells (P < 0.001). These findings provide evidence that ESCs biomarkers OCT4 and Nanog serves as independent prognostic factors for NPC. Additionally, cancer cells in the invasive front of NPC acquiring ESCs-like features should be maintained by vascular niches.	[Luo, Weiren; Li, Siyi] Guangdong Med Coll, Secondary Clin Coll, Dept Pathol, Dongguan, Peoples R China; [Luo, Weiren; Peng, Bailu; Ye, Yanfen; Deng, Xubin; Yao, Kaitai] Southern Med Univ, Canc Res Inst, Guangzhou, Guangdong, Peoples R China	Guangdong Medical University; Southern Medical University - China	Yao, KT (corresponding author), Southern Med Univ, Canc Res Inst, Guangzhou, Guangdong, Peoples R China.	yao.kaitai@yahoo.cn	Luo, Weiren/AAI-8364-2020	Luo, Weiren/0000-0002-2762-6332	National Natural Science Foundation of China [81202125]; National Natural Science Foundation of China - Guangdong Joint Fund [u0732006]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of China - Guangdong Joint Fund	This work was supported by National Natural Science Foundation of China (81202125) and National Natural Science Foundation of China - Guangdong Joint Fund (u0732006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avilion AA, 2003, GENE DEV, V17, P126, DOI 10.1101/gad.224503; Cabarcas SM, 2011, INT J CANCER, V129, P2315, DOI 10.1002/ijc.26312; Calabrese C, 2007, CANCER CELL, V11, P69, DOI 10.1016/j.ccr.2006.11.020; Chiou SH, 2008, CLIN CANCER RES, V14, P4085, DOI 10.1158/1078-0432.CCR-07-4404; Chiou SH, 2010, CANCER RES, V70, P10433, DOI 10.1158/0008-5472.CAN-10-2638; Clevers H, 2011, NAT MED, V17, P313, DOI 10.1038/nm.2304; Dick JE, 2008, BLOOD, V112, P4793, DOI 10.1182/blood-2008-08-077941; Ferletta M, 2011, INT J CANCER, V129, P45, DOI 10.1002/ijc.25647; Gilbertson RJ, 2007, NAT REV CANCER, V7, P733, DOI 10.1038/nrc2246; Guo Y, 2011, HISTOPATHOLOGY, V59, P763, DOI 10.1111/j.1365-2559.2011.03993.x; Han JH, 2012, CANCER LETT, V321, P80, DOI 10.1016/j.canlet.2012.02.021; Han X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041335; He H, 2012, J CLIN NEUROSCI, V19, P121, DOI 10.1016/j.jocn.2011.07.026; Hu JJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045965; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Jeter CR, 2011, ONCOGENE, V30, P3833, DOI 10.1038/onc.2011.114; Kong QL, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000940; Kumar SM, 2012, ONCOGENE, V31, P4898, DOI 10.1038/onc.2011.656; Lee C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050501; Leis O, 2012, ONCOGENE, V31, P1354, DOI 10.1038/onc.2011.338; Li CG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049693; Li JN, 2013, INT J CANCER, V133, P525, DOI 10.1002/ijc.27896; Li X, 2009, CURR MOL MED, V9, P751, DOI 10.2174/156652409788970698; Lim J, 2012, DEVELOPMENT, V139, P3471, DOI 10.1242/dev.071209; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; Luo WR, 2012, ANN SURG ONCOL, V19, P2971, DOI 10.1245/s10434-012-2347-x; Luo WR, 2012, HISTOPATHOLOGY, V61, P237, DOI 10.1111/j.1365-2559.2012.04212.x; Luo WR, 2012, HISTOPATHOLOGY, V61, P113, DOI 10.1111/j.1365-2559.2012.04205.x; Luo WR, 2012, INT J CANCER, V131, P1863, DOI 10.1002/ijc.27467; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Matsuoka J, 2012, J SURG RES, V174, P130, DOI 10.1016/j.jss.2010.11.903; Mei YP, 2007, CELL CYCLE, V6, P1379, DOI 10.4161/cc.6.11.4274; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Moore KA, 2006, SCIENCE, V311, P1880, DOI 10.1126/science.1110542; Nakajima S, 2004, CLIN CANCER RES, V10, P4125, DOI 10.1158/1078-0432.CCR-0578-03; Pesce M, 2001, STEM CELLS, V19, P271, DOI 10.1634/stemcells.19-4-271; Polyak K, 2009, NAT REV CANCER, V9, P265, DOI 10.1038/nrc2620; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Saigusa S, 2009, ANN SURG ONCOL, V16, P3488, DOI 10.1245/s10434-009-0617-z; Sarkar D, 2012, INT J CANCER, V130, P328, DOI 10.1002/ijc.26029; Scheel C, 2011, INT J CANCER, V129, P2310, DOI 10.1002/ijc.26311; Sholl LM, 2010, AM J SURG PATHOL, V34, P1193, DOI 10.1097/PAS.0b013e3181e5e024; Sneddon JB, 2007, CELL STEM CELL, V1, P607, DOI 10.1016/j.stem.2007.11.009; Suzuki S, 2010, J HISTOCHEM CYTOCHEM, V58, P721, DOI 10.1369/jhc.2010.955609; Wang Pei, 2010, Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi, V24, P261; Wei WI, 2005, LANCET, V365, P2041, DOI 10.1016/S0140-6736(05)66698-6; Werling AM, 2011, HISTOPATHOLOGY, V58, P286, DOI 10.1111/j.1365-2559.2011.03748.x; Wiese C, 2004, CELL MOL LIFE SCI, V61, P2510, DOI 10.1007/s00018-004-4144-6; Yin X, 2012, ANN SURG ONCOL, V19, P2877, DOI 10.1245/s10434-012-2314-6; Zhang Y, 2010, J OTOLARYNGOL-HEAD N, V39, P157, DOI 10.2310/7070.2009.090150	50	133	141	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2013	8	2							e56324	10.1371/journal.pone.0056324	http://dx.doi.org/10.1371/journal.pone.0056324			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104BU	23424657	Green Published, Green Submitted, gold			2022-12-25	WOS:000315965100045
J	Jin, L; Sturgis, EM; Cao, XL; Song, XC; Salahuddin, T; Wei, QY; Li, GJ				Jin, Lei; Sturgis, Erich M.; Cao, Xiaolin; Song, Xicheng; Salahuddin, Taufiq; Wei, Qingyi; Li, Guojun			Interleukin-10 promoter variants predict HPV-positive tumors and survival of squamous cell carcinoma of the oropharynx	FASEB JOURNAL			English	Article						IL-10 variants; HPV; oropharyngeal cancer; smoking; biomarkers; survival	HUMAN-PAPILLOMAVIRUS; IL-10 POLYMORPHISMS; CYTOKINE SYNTHESIS; TONSILLAR CANCER; GENE PROMOTER; NECK-CANCER; RISK-FACTOR; HEAD; ASSOCIATION; INFECTION	Interleukin-10 (IL-10) plays an important role in a host's defense against human papillomavirus (HPV) infection. IL-10 promoter variants may affect its expression level or functional efficiency and, subsequently, susceptibility to and survival of HPV16-associated squamous cell carcinoma of oropharynx (SCCOP). We determined tumor HPV16 DNA and genotyped three IL-10 promoter polymorphisms in 309 incident patients with SCCOP. Compared with the patients with corresponding common homozygous genotypes, patients carrying variant genotypes of IL-10 rs1800871 and rs1800872 were similar to 2.5 times more likely to have HPV16(+) tumors among patients with SCCOP. Among HPV16(+) patients with SCCOP only, compared to those with the corresponding variant genotypes, the patients with IL-10 rs1800871 and rs1800872 CC genotypes had significantly better survival and similar to 70-80% reduced risk of death/recurrence after multivariable adjustment. Additionally, functional relevance of these variants was characterized to explore the genotype-phenotype correlation. Our findings indicate that IL-10 genetic variants may be associated with tumor HPV16(+) SCCOP and predict survival of HPV16(+) patients with SCCOP. Larger studies are needed to validate our findings.	[Jin, Lei; Sturgis, Erich M.; Cao, Xiaolin; Song, Xicheng; Salahuddin, Taufiq; Li, Guojun] Univ Texas MD Anderson Canc Ctr, Dept Head & Neck Surg, Houston, TX 77030 USA; [Wei, Qingyi; Li, Guojun] Univ Texas MD Anderson Canc Ctr, Dept Epidemiol, Houston, TX 77030 USA; [Jin, Lei; Sturgis, Erich M.] Southern Med Univ, Sch Med, Jinling Hosp, Dept Stomatol, Nanjing, Jiangsu, Peoples R China; [Song, Xicheng] Qingdao Univ, Yuhuangding Hosp, Dept Otorhinolaryngol & Head & Neck Surg, Yantai, Peoples R China	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Southern Medical University - China; Qingdao University	Li, GJ (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Head & Neck Surg, Unit 1445, 1515 Holcombe Blvd, Houston, TX 77030 USA.	gli@mdanderson.org			U.S. National Institute of Environmental Health Sciences [R01 ES-11740]; U.S. National Institutes of Health [CA 135679, CA133099]; NATIONAL CANCER INSTITUTE [R03CA135679, K07CA133099] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES011740] Funding Source: NIH RePORTER	U.S. National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	The authors gratefully thank Ms. Dawn Chalaire for article editing, and Dr. Chong Zhao and Ms. Yingdong Li for laboratory support. This study was supported by U.S. National Institute of Environmental Health Sciences grant R01 ES-11740 (to Q. W.) and U.S. National Institutes of Health grants CA 135679 and CA133099 (to G. L.) The authors declare no conflicts of interest.	Bolpetti A, 2010, BMC IMMUNOL, V11, DOI 10.1186/1471-2172-11-27; Dahlstrom KR, 2003, CLIN CANCER RES, V9, P2620; Farzaneh F, 2006, BJOG-INT J OBSTET GY, V113, P961, DOI 10.1111/j.1471-0528.2006.00956.x; Fortis C, 1996, CANCER LETT, V104, P1, DOI 10.1016/0304-3835(96)04213-9; Gerger A, 2010, BREAST CANCER RES TR, V119, P701, DOI 10.1007/s10549-009-0417-y; Gillison ML, 2000, JNCI-J NATL CANCER I, V92, P709, DOI 10.1093/jnci/92.9.709; Guan XX, 2010, CLIN CANCER RES, V16, P1416, DOI 10.1158/1078-0432.CCR-09-2877; Hammarstedt L, 2006, INT J CANCER, V119, P2620, DOI 10.1002/ijc.22177; Huang SY, 1999, J INTERF CYTOK RES, V19, P697, DOI 10.1089/107999099313532; Ivansson EL, 2007, INT J CANCER, V121, P2451, DOI 10.1002/ijc.22989; Jeong SW, 2010, J KOREAN MED SCI, V25, P1024, DOI 10.3346/jkms.2010.25.7.1024; Ji XM, 2009, CANCER-AM CANCER SOC, V115, P1660, DOI 10.1002/cncr.24184; Kundu N, 1996, JNCI-J NATL CANCER I, V88, P536, DOI 10.1093/jnci/88.8.536; Lech-Maranda E, 2004, BLOOD, V103, P3529, DOI 10.1182/blood-2003-06-1850; MALEFYT RD, 1991, J EXP MED, V174, P1209; Marur S, 2010, LANCET ONCOL, V11, P781, DOI 10.1016/S1470-2045(10)70017-6; Mellin H, 2000, INT J CANCER, V89, P300, DOI 10.1002/1097-0215(20000520)89:3<300::AID-IJC14>3.0.CO;2-G; Michaud DS, 2006, CANCER RES, V66, P4525, DOI 10.1158/0008-5472.CAN-05-3987; Miller CS, 2001, ORAL SURG ORAL MED O, V91, P622, DOI 10.1067/moe.2001.115392; Miller DL, 2012, BIOCHEM J, V443, P339, DOI 10.1042/BJ20112017; MOORE KW, 1990, SCIENCE, V248, P1230, DOI 10.1126/science.2161559; Park JS, 2001, INT J CANCER, V91, P822, DOI 10.1002/1097-0215(200002)9999:9999<::AID-IJC1130>3.0.CO;2-0; Ritchie JM, 2003, INT J CANCER, V104, P336, DOI 10.1002/ijc.10960; ROUSSET F, 1992, P NATL ACAD SCI USA, V89, P1890, DOI 10.1073/pnas.89.5.1890; Seifart C, 2005, DIS MARKERS, V21, P157, DOI 10.1155/2005/707131; Shrestha S, 2007, CANCER EPIDEM BIOMAR, V16, P1626, DOI 10.1158/1055-9965.EPI-06-0881; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Sturgis EM, 2002, CURR OPIN ONCOL, V14, P310, DOI 10.1097/00001622-200205000-00010; Sturgis EM, 2007, CANCER-AM CANCER SOC, V110, P1429, DOI 10.1002/cncr.22963; TAN JQ, 1993, J IMMUNOL, V151, P4545; Turner DM, 1997, EUR J IMMUNOGENET, V24, P1, DOI 10.1111/j.1365-2370.1997.tb00001.x; VELDE AAT, 1992, J IMMUNOL, V149, P4048; Vineis P, 2004, JNCI-J NATL CANCER I, V96, P99, DOI 10.1093/jnci/djh014; Vuoristo MS, 2007, CANCER GENET CYTOGEN, V176, P54, DOI 10.1016/j.cancergencyto.2007.03.002; Westendorp RGJ, 1997, LANCET, V349, P170, DOI 10.1016/S0140-6736(96)06413-6; Yao JG, 2008, CLIN CHIM ACTA, V388, P84, DOI 10.1016/j.cca.2007.10.012; Zoodsma M, 2005, INT J GYNECOL CANCER, V15, P282, DOI 10.1111/j.1525-1438.2005.00433.x	37	12	13	1	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2013	27	6					2496	2503		10.1096/fj.12-226803	http://dx.doi.org/10.1096/fj.12-226803			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	154II	23430974	Green Published			2022-12-25	WOS:000319667600037
J	Bion, RAH; Miyazawa, K; Kikuchi, H; Mazuka, R				Bion, Ricardo A. H.; Miyazawa, Kouki; Kikuchi, Hideaki; Mazuka, Reiko			Learning Phonemic Vowel Length from Naturalistic Recordings of Japanese Infant-Directed Speech	PLOS ONE			English	Article							ENGLISH	In Japanese, vowel duration can distinguish the meaning of words. In order for infants to learn this phonemic contrast using simple distributional analyses, there should be reliable differences in the duration of short and long vowels, and the frequency distribution of vowels must make these differences salient enough in the input. In this study, we evaluate these requirements of phonemic learning by analyzing the duration of vowels from over 11 hours of Japanese infant-directed speech. We found that long vowels are substantially longer than short vowels in the input directed to infants, for each of the five oral vowels. However, we also found that learning phonemic length from the overall distribution of vowel duration is not going to be easy for a simple distributional learner, because of the large base-rate effect (i.e., 94% of vowels are short), and because of the many factors that influence vowel duration (e.g., intonational phrase boundaries, word boundaries, and vowel height). Therefore, a successful learner would need to take into account additional factors such as prosodic and lexical cues in order to discover that duration can contrast the meaning of words in Japanese. These findings highlight the importance of taking into account the naturalistic distributions of lexicons and acoustic cues when modeling early phonemic learning.	[Bion, Ricardo A. H.] Stanford Univ, Dept Psychol, Stanford, CA 94305 USA; [Miyazawa, Kouki] RIKEN, Brain Sci Inst, Lab Language Dev, Wako, Saitama, Japan; [Miyazawa, Kouki; Kikuchi, Hideaki; Mazuka, Reiko] Fac Human Sci, Tokorozawa, Saitama, Japan; [Mazuka, Reiko] Duke Univ, Dept Psychol & Neurosci, Durham, NC USA	Stanford University; RIKEN; Duke University	Bion, RAH (corresponding author), Stanford Univ, Dept Psychol, Stanford, CA 94305 USA.	ricardoh@stanford.edu	Mazuka, Reiko/N-7400-2015	Mazuka, Reiko/0000-0001-7862-7768	Kakenhi, the Japanese Ministry of Education, Culture, Sports, Science and Techonology [21610028]; RIKEN Brain Science Institute summer school program	Kakenhi, the Japanese Ministry of Education, Culture, Sports, Science and Techonology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); RIKEN Brain Science Institute summer school program	The research reported in this paper was in part supported by Grants-In-Aid for Scientific Research to the last author (RM) (Kakenhi, the Japanese Ministry of Education, Culture, Sports, Science and Techonology No. 21610028), and RIKEN Brain Science Institute summer school program, during which first author conducted most of the analyses. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baayen RH, 2008, J MEM LANG, V59, P390, DOI 10.1016/j.jml.2007.12.005; Boersma P, 2001, GLOT INT, V5, P341; Cohen J., 1988, STAT POWER ANAL BEHA, V2nd; Cooper W.E., 1980, SYNTAX SPEECH; Feldman N. H., 2009, P 31 ANN M COGN SCI, P2208; Feldman N, 2011, PROC ANN BUCLD, P197; FRY DB, 1955, J ACOUST SOC AM, V27, P765, DOI 10.1121/1.1908022; Klatt D., 1975, J PHONETICS, V3, P129, DOI DOI 10.1016/S0095-4470(19)31360-9; Kunnari S., 2001, PSYCHOL LANGUAGE COM, V5, P13; Maekawa K., 2003, ISCA IEEE WORKSH SPO, P7; Maye J, 2002, COGNITION, V82, pB101, DOI 10.1016/S0010-0277(01)00157-3; Maye J, 2000, PROC ANN BUCLD, P522; Mazuka R., 2006, IEICE TECHNICAL REPO, V106, P11; Mugitani R, 2009, DEV PSYCHOL, V45, P236, DOI 10.1037/a0014043; PETERSON GE, 1960, J ACOUST SOC AM, V32, P693, DOI 10.1121/1.1908183; Sato Y, 2010, DEV PSYCHOL, V46, P106, DOI 10.1037/a0016718; Swingley D, 2007, COGNITIVE PSYCHOL, V54, P99, DOI 10.1016/j.cogpsych.2006.05.001; Swingley D, 2009, PHILOS T R SOC B, V364, P3617, DOI 10.1098/rstb.2009.0107; Vallabha GK, 2007, P NATL ACAD SCI USA, V104, P13273, DOI 10.1073/pnas.0705369104; Werker JF, 2007, COGNITION, V103, P147, DOI 10.1016/j.cognition.2006.03.006	20	19	19	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e51594	10.1371/journal.pone.0051594	http://dx.doi.org/10.1371/journal.pone.0051594			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	093IE	23437036	Green Published, gold, Green Submitted			2022-12-25	WOS:000315184200003
J	Blasco, R; Rosell, J; Dominguez-Rodrigo, M; Lozano, S; Pasto, I; Riba, D; Vaquero, M; Peris, JF; Arsuaga, JL; de Castro, JMB; Carbonell, E				Blasco, Ruth; Rosell, Jordi; Dominguez-Rodrigo, Manuel; Lozano, Sergi; Pasto, Ignasi; Riba, David; Vaquero, Manuel; Fernandez Peris, Josep; Luis Arsuaga, Juan; Maria Bermudez de Castro, Jose; Carbonell, Eudald			Learning by Heart: Cultural Patterns in the Faunal Processing Sequence during the Middle Pleistocene	PLOS ONE			English	Article							CARNIVORE TOOTH-MARKS; GRAN DOLINA SITE; BOLOMOR CAVE VALENCIA; FLK 22 ZINJANTHROPUS; SIERRA-DE-ATAPUERCA; HUMAN CONSUMPTION; PERCUSSION MARKS; OLDUVAI GORGE; CUT MARKS; HAMMERSTONE PERCUSSION	Social learning, as an information acquisition process, enables intergenerational transmission and the stabilisation of cultural forms, generating and sustaining behavioural traditions within human groups. Archaeologically, such social processes might become observable by identifying repetitions in the record that result from the execution of standardised actions. From a zooarchaeological perspective, the processing and consumption of carcasses may be used to identify these types of phenomena at the sites. To investigate this idea, several faunal assemblages from Bolomor Cave (Valencia, Spain, MIS 9-5e) and Gran Dolina TD10-1 (Burgos, Spain, MIS 9) were analysed. The data show that some butchery activities exhibit variability as a result of multiple conditioning factors and, therefore, the identification of cultural patterns through the resulting cut-marks presents additional difficulties. However, other activities, such as marrow removal by means of intentional breakage, seem to reflect standardised actions unrelated to the physical characteristics of the bones. The statistical tests we applied show no correlation between the less dense areas of the bones and the location of impacts. Comparison of our experimental series with the archaeological samples indicates a counter-intuitive selection of the preferred locus of impact, especially marked in the case of Bolomor IV. This fact supports the view that bone breakage was executed counter-intuitively and repetitively on specific sections because it may have been part of an acquired behavioural repertoire. These reiterations differ between levels and sites, suggesting the possible existence of cultural identities or behavioural predispositions dependant on groups. On this basis, the study of patterns could significantly contribute to the identification of occupational strategies and organisation of the hominids in a territory. In this study, we use faunal data in identifying the mechanics of intergenerational information transmission within Middle Pleistocene human communities and provide new ideas for the investigation of occupational dynamics from a zooarchaeological approach.	[Blasco, Ruth; Rosell, Jordi; Lozano, Sergi; Pasto, Ignasi; Riba, David; Vaquero, Manuel; Carbonell, Eudald] Inst Catala Paleoecol Humana & Evolucio Social, IPHES, Tarragona, Spain; [Blasco, Ruth; Rosell, Jordi; Lozano, Sergi; Pasto, Ignasi; Riba, David; Vaquero, Manuel; Carbonell, Eudald] Univ Rovira & Virgili, Area Prehist, Tarragona, Spain; [Blasco, Ruth] Gibraltar Museum, Gibraltar, Spain; [Dominguez-Rodrigo, Manuel] Univ Complutense, Dept Prehist, E-28040 Madrid, Spain; [Dominguez-Rodrigo, Manuel] Museo Origenes, IDEA Inst Evolucio Africa, Madrid, Spain; [Fernandez Peris, Josep] Diputac Valencia, Museo Prehist, SIP Serv Invest Prehist, Valencia, Spain; [Luis Arsuaga, Juan] Univ Complutense, Dept Paleontol, Fac Ciencias Geol, E-28040 Madrid, Spain; [Luis Arsuaga, Juan] Ctr Invest UCM ISCIII Evoluc & Comportamiento Hum, Madrid, Spain; [Maria Bermudez de Castro, Jose] CENIEH Ctr Nacl Invest Sobre Evoluc Humana, Burgos, Spain; [Carbonell, Eudald] Inst Vertebrate Paleontol & Paleoanthropol IVPP, Beijing, Peoples R China	ICREA; Universitat Rovira i Virgili; Catalan Institute of Human Paleo-Ecology & Social Evolution (IPHES); Universitat Rovira i Virgili; Complutense University of Madrid; Complutense University of Madrid; Complutense University of Madrid; UCM-ISCIII Center for Human Evolution & Behavior; Centro Nacional de Investigacion de La Evolucion Humana (CENIEH); Chinese Academy of Sciences; Institute of Vertebrate Paleontology & Paleoanthropology, CAS	Blasco, R (corresponding author), Inst Catala Paleoecol Humana & Evolucio Social, IPHES, Tarragona, Spain.	rblascolopez@gmail.com	Rosell, Jordi/G-8705-2015; Carbonell, Eudald/G-3003-2015; Lozano, Sergi/B-5974-2015; Blasco, Ruth/AAG-8200-2019; Vaquero, Manuel/W-1405-2019	Rosell, Jordi/0000-0002-6758-6291; Lozano, Sergi/0000-0003-1895-9327; Blasco, Ruth/0000-0001-9804-739X; Vaquero, Manuel/0000-0001-6572-8543; Pasto, Ignasi/0000-0003-1780-4577; Arsuaga, Juan Luis/0000-0001-5361-2295; Bermudez de Castro, Jose Maria/0000-0003-1314-3273	Junta de Castilla y Leon and Atapuerca Foundation; Spanish Ministry of Science and Innovation [CGL2012-38434-C03-01, CGL2012-38434-C03-02, CGL2012-38434-C03-03, CGL2012-38358, HAR2010-18952-C02-01]; Generalitat de Catalunya [2009 SGR 188]; COFUND Marie Curie Actions, EU-FP7; Atapuerca Foundation	Junta de Castilla y Leon and Atapuerca Foundation(Junta de Castilla y Leon); Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Generalitat de Catalunya(Generalitat de Catalunya); COFUND Marie Curie Actions, EU-FP7; Atapuerca Foundation	The Bolomor excavation is part of the program of archaeological excavations conducted by the SIP (Prehistoric Investigation Service) of the Prehistory Museum of Valencia under the authority of the Provincial Council of Valencia, Spain. The field excavation work in the Atapuerca sites is supported by Junta de Castilla y Leon and Atapuerca Foundation. This research was supported with funding from the Spanish Ministry of Science and Innovation, project nos. CGL2012-38434-C03-01, CGL2012-38434-C03-02, CGL2012-38434-C03-03, CGL2012-38358 and HAR2010-18952-C02-01, and from Generalitat de Catalunya, 2009 SGR 188. R. Blasco and S. Lozano are Beatriu de Pinos post-doctoral research fellowships (Generalitat de Catalunya and COFUND Marie Curie Actions, EU-FP7) and D. Riba is a pre-doctoral research fellowship from Atapuerca Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allue E, 2010, ARCHAEOL ANTHROP SCI, V2, P11, DOI 10.1007/s12520-010-0023-2; Aura J. E., 2009, MONOGRAFIAS ARQUEOLO, V44, P343; Aura Tortosa JE, 2002, J ARCHAEOL METHOD TH, V9, P215; Banks WE, 2008, J ARCHAEOL SCI, V35, P481, DOI 10.1016/j.jas.2007.05.011; Barba R, 2005, J TAPHONOMY, V3, P29; Berger GW, 2008, J HUM EVOL, V55, P300, DOI 10.1016/j.jhevol.2008.02.012; Bicho N, 2006, J ANTHROPOL ARCHAEOL, V25, P485, DOI 10.1016/j.jaa.2006.03.009; Binford L., 1987, PLEISTOCENE OLD WORL, P17; Binford L.R., 1981, BONES ANCIENT MEN MO; Binford L.R., 2001, CONSTRUCTING FRAMES; Binford L. R., 1978, NUNAMIUT ETHNOARCHAE; Binford LR., 1984, FAUNAL REMAINS KLASI; Blackmore S, 2000, SCI AM, V283, P64, DOI 10.1038/scientificamerican1000-64; Blasco R, 2011, AMPLITUD DIETA CARNI; Blasco R, 2008, J ARCHAEOL SCI, V35, P2839, DOI 10.1016/j.jas.2008.05.013; Blasco R, 2012, CR PALEVOL, V11, P265, DOI 10.1016/j.crpv.2012.01.003; Blasco R, 2012, QUATERN INT, V252, P16, DOI 10.1016/j.quaint.2011.03.019; Blasco R, 2010, J ARCHAEOL SCI, V37, P2051, DOI 10.1016/j.jas.2010.03.010; Blasco R, 2009, J ARCHAEOL SCI, V36, P2213, DOI 10.1016/j.jas.2009.06.006; BLUMENSCHINE RJ, 1988, NATURE, V333, P763, DOI 10.1038/333763a0; Blumenschine RJ, 1996, J ARCHAEOL SCI, V23, P493, DOI 10.1006/jasc.1996.0047; BLUMENSCHINE RJ, 1988, J ARCHAEOL SCI, V15, P483, DOI 10.1016/0305-4403(88)90078-7; Blumenschine RJ, 2007, J HUM EVOL, V53, P420, DOI 10.1016/j.jhevol.2007.01.011; Bodu P, 1990, PALEOLITHIQUE MOYEN, V3, P309; BROMAGE TG, 1984, AM J PHYS ANTHROPOL, V65, P359, DOI 10.1002/ajpa.1330650404; Buikstra J.E., 1989, BONE MODIFICATION, P247; Bunn H.T., 1983, BAR International Series, V163, P143; BUNN HT, 1988, J ANTHROPOL ARCHAEOL, V7, P412, DOI 10.1016/0278-4165(88)90004-9; Bunn HT, 2001, MEAT EATING HUMAN EV, P350; Butzer KW, 1982, ARCHAEOLOGY HUMAN EC; Byrne RW, 1998, BEHAV BRAIN SCI, V21, P667, DOI 10.1017/S0140525X98001745; Capaldo S.D., 1995, THESIS RUTGERS U NEW; Capaldo SD, 1997, J HUM EVOL, V33, P555, DOI 10.1006/jhev.1997.0150; CAPALDO SD, 1994, AM ANTIQUITY, V59, P724, DOI 10.2307/282345; Capaldo SD, 1998, J HUM EVOL, V35, P323; Carbonell E, 2004, ZONA ARQUEOLOGICA, V4, P102; Cochard D., 2004, THESIS U BORDEAUX 1, P1; Cochard D, 2012, QUATERN INT, V264, P32, DOI 10.1016/j.quaint.2012.02.014; Csibra G., 2006, ROOTS HUMAN SOCIALIT, P229; Csibra G, 2006, ATTENTION PERFORM, P249; Csibra G, 2011, PHILOS T R SOC B, V366, P1149, DOI 10.1098/rstb.2010.0319; Cuartero F., 2008, SAGUNTUM, V39, P27; David N, 2001, ETHNOARCHAEOLOGY ACT; Dennett Daniel C., 1995, DARWINS DANGEROUS ID; Dominguez-Rodrigo A, 2007, J HUM EVOL, V53, P427, DOI 10.1016/j.jhevol.2007.05.010; Dominguez-Rodrigo M, 1997, J HUM EVOL, V33, P669, DOI 10.1006/jhev.1997.0161; Dominguez-Rodrigo M, 2006, J HUM EVOL, V50, P170, DOI 10.1016/j.jhevol.2005.09.005; Dominguez-Rodrigo M, 2003, EVOL ANTHROPOL, V12, P275, DOI 10.1002/evan.10119; Dominguez-Rodrigo M, 2003, J ARCHAEOL SCI, V30, P381, DOI 10.1006/jasc.2002.0842; Dominguez-Rodrigo M, 2002, J WORLD PREHIST, V16, P1, DOI 10.1023/A:1014507129795; Dominguez-Rodrigo M, 2008, WORLD ARCHAEOL, V40, P67, DOI 10.1080/00438240701843629; Dominguez-Rodrigo M, 2009, J ARCHAEOL SCI, V36, P884, DOI 10.1016/j.jas.2008.11.007; Emerson AM., 1993, BONES BEHAV ETHNOARC, P138; Enloe J. G., 1993, BONES BEHAV ETHNOARC, P82; Falgueres C, 1999, J HUM EVOL, V37, P343, DOI 10.1006/jhev.1999.0326; Fernandez Peris J, 2007, IND LITICAS PLEISTOC, V108; Peris JF, 2012, QUATERN INT, V247, P267, DOI 10.1016/j.quaint.2010.10.014; FernandezPenis J., 2008, TREBALLS ARQUEOL, V14, P141; Ferreira Bicho N, 2000, ANTIQUITY, V74, P500; Fisher J.W., 1995, J ARCHAEOL METHOD TH, V2, P7, DOI [10.1007/bf02228434, DOI 10.1007/BF02228434]; Flannery K.V., 1986, GUIL A NAQUITZ ARCHA, P285; Frison G.C., 1978, PREHISTORIC HUNTERS; Frison GC, 1970, PLAINS ANTHR MEMOIR, V7; Fumanal M. P., 1995, CUATERNARIO PAIS VAL, P115; Galan AB, 2009, J ARCHAEOL SCI, V36, P776, DOI 10.1016/j.jas.2008.11.003; Gamble Clive, 2005, P154; Chacon MG, 2007, BAR INT SER, V1725, P187; Gifford-Gonzalez Diane, 1989, BONE MODIFICATION, P61; GIFFORDGONZALEZ D, 1991, J ANTHROPOL ARCHAEOL, V10, P215, DOI 10.1016/0278-4165(91)90014-O; Goren-Inbar N, 2011, PHILOS T R SOC B, V366, P1038, DOI 10.1098/rstb.2010.0365; Gowlett JAJ., 1996, MODELLING EARLY HUMA, P191; Guillon F, 1986, BRULES SECS FRAICHES, P191; Hahn J, 1987, WURTTEMBERG, V14, P1; Hanson M, 2007, J ARCHAEOL SCI, V34, P1902, DOI 10.1016/j.jas.2007.01.009; Haws JA, 2003, THESIS U WISCONSIN M; Hockett B, 2002, J ARCHAEOL METHOD TH, V9, P269, DOI 10.1023/A:1019503030246; Hockett BS, 2006, ANIMAIS PREHISTORIA, P137; Isaac GL., 1967, KROEBER ANTHR SOC PA, V37, P31; Jacobi R., 2004, P PREHIST SOC, V70, P1, DOI [10.1017/S0079497X00001110, DOI 10.1017/S0079497X00001110]; Johansen L., 2004, OLDEHOLTWOLDE HAMBUR; Jones K.T., 1983, CARNIVORES HUMAN SCA, P171; Lam YM, 1999, AM ANTIQUITY, V64, P343, DOI 10.2307/2694283; Landt MJ, 2007, J ARCHAEOL SCI, V34, P1629, DOI 10.1016/j.jas.2006.12.001; Laroulandie V, 2005, BIOSPHERE TO LITHOSPHERE: NEW STUDIES IN VERTEBRATE TAPHONOMY, P25; Lloveras Lluis, 2009, Journal of Taphonomy, V7, P179; Lopez-Ortega E, 2011, J ARCHAEOL SCI, V38, P3112, DOI 10.1016/j.jas.2011.07.011; Louchart A., 2002, QUATERNAIRE, V3-4, P297; Lupo KD, 2002, J ARCHAEOL SCI, V29, P85, DOI 10.1006/jasc.2001.0690; Lyman RL, 2005, J ARCHAEOL SCI, V32, P1722, DOI 10.1016/j.jas.2005.06.003; Lyman RL, 2008, CAMB MAN ARCHAEOL, P1, DOI 10.1017/CBO9780511813863; Lyman RL, 2003, J ARCHAEOL SCI, V30, P595, DOI 10.1016/S0305-4403(02)00236-4; Lyman RL., 1995, ANCIENT PEOPLES LAND, P233; Lyman RL., 1994, VERTEBRATE TAPHONOMY, DOI [DOI 10.1017/CBO9781139878302, 10.1017/CBO9781139878302]; Mallol C, 2008, GEOARCHAEOLOGY, V23, P13, DOI 10.1002/gea.20206; MAREAN CW, 1992, J ARCHAEOL SCI, V19, P101, DOI 10.1016/0305-4403(92)90009-R; Martinez I, 2008, J HUM EVOL, V54, P118, DOI 10.1016/j.jhevol.2007.07.006; Martinez I, 2009, MUNIBE, V60, P1; Martinez I, 2009, ANTHROPOLOGIE, V113, P255, DOI 10.1016/j.anthro.2009.01.003; Mayne Correia P., 1997, FORENSIC TAPHONOMY P, P275, DOI DOI 10.1201/9781439821923.CH18; Meltzoff Andrew N., 1996, P347, DOI 10.1016/B978-012273965-1/50017-0; Menendez L., 2009, THESIS U ROVIRA VIRG; Mithen S., 1994, CAMB ARCHAEOL J, V4, P3, DOI DOI 10.1017/S0959774300000949; MURDOCK GP, 1973, ETHNOLOGY, V12, P203, DOI 10.2307/3773347; Nadel D, 2004, P NATL ACAD SCI USA, V101, P6821, DOI 10.1073/pnas.0308557101; NICHOLSON RA, 1993, J ARCHAEOL SCI, V20, P411, DOI 10.1006/jasc.1993.1025; Nilssen P.J., 2000, THESIS U CAPE TOWN; Noe-Nygaard N., 1989, HUMAN EVOLUTION, V4, P461; OConnell JF, 1997, CURR ANTHROPOL, V38, P86, DOI 10.1086/204585; Oliver JS, 1993, OCCASIONAL PAPER, P200; Olle A, 2013, QUATERN INT, V295, P138, DOI 10.1016/j.quaint.2011.11.009; Outram A, 1998, J ARCHAEOL SCI, V25, P839, DOI 10.1006/jasc.1997.0229; Outram AK, 2001, J ARCHAEOL SCI, V28, P401, DOI 10.1006/jasc.2000.0619; Padilla M., 2008, ARQUEOWEB, V9, P1; Pares JM, 1999, J HUM EVOL, V37, P325, DOI 10.1006/jhev.1999.0331; Peretto C., 1996, REPERTI PALEONTOLOGI, P187; Perez Ripoll M, 2004, 24 RENC INT ARCH HIS, P191; Perez-Gonzalez A, 2001, ANTHROPOLOGIE, V105, P27; Pickering TR, 2006, J ARCHAEOL SCI, V33, P459, DOI 10.1016/j.jas.2005.09.001; Pickering TR, 2004, J HUM EVOL, V46, P595, DOI 10.1016/j.jhevol.2004.03.002; POTTS R, 1981, NATURE, V291, P577, DOI 10.1038/291577a0; RIPOLL MP, 2005, MUNIBE, V57, P239; Rodriguez J, 2011, QUATERNARY SCI REV, V30, P1396, DOI 10.1016/j.quascirev.2010.02.021; Rodriguez X.P., 2004, BAR INT SERIES, V1323; Roebroeks W, 2001, J HUM EVOL, V41, P437, DOI 10.1006/jhev.2001.0499; Rosell J, 2011, J HUM EVOL, V61, P125, DOI 10.1016/j.jhevol.2011.02.001; Rosell J, 2012, QUATERN INT, V252, P56, DOI 10.1016/j.quaint.2011.02.019; Rosell Jordi, 2009, Journal of Taphonomy, V7, P305; Sampson CG, 1998, J ARCHAEOL SCI, V25, P985, DOI 10.1006/jasc.1997.0282; Sanchis Serra A, 2010, THESIS U VALENCIA; Schmider B, 1992, MARSANGY UNCAMPEMENT, V55; SELVAGGIO MM, 1994, J HUM EVOL, V27, P215, DOI 10.1006/jhev.1994.1043; SHIPMAN P, 1984, J ARCHAEOL SCI, V11, P307, DOI 10.1016/0305-4403(84)90013-X; SHIPMAN P, 1984, PALEOBIOLOGY, V10, P358, DOI 10.1017/S0094837300008320; SHIPMAN P, 1983, J ANTHROPOL ARCHAEOL, V2, P57, DOI 10.1016/0278-4165(83)90008-9; Speth J., 2012, FARMING, V2012, P1; Speth JD, 2002, J ARCHAEOL SCI, V29, P471, DOI 10.1006/jasc.2001.0740; Stahl PW, 2007, J ANTHROPOL ARCHAEOL, V26, P329, DOI 10.1016/j.jaa.2007.02.004; Stapert D, 2006, PALEO AKTUEEL, V17, P18; Stapert D, 2007, PAL ARCHS J ARCHAEOL, V1, P1; Steadman DW, 2002, J ARCHAEOL SCI, V29, P571, DOI 10.1006/jasc.2001.0739; STEVENSON MG, 1985, AM ANTIQUITY, V50, P63, DOI 10.2307/280634; STINER MC, 1995, J ARCHAEOL SCI, V22, P223, DOI 10.1006/jasc.1995.0024; Stout D, 2002, CURR ANTHROPOL, V43, P693, DOI 10.1086/342638; Tennie C, 2009, PHILOS T R SOC B, V364, P2405, DOI 10.1098/rstb.2009.0052; Tomasello M, 2005, BEHAV BRAIN SCI, V28, P675, DOI 10.1017/S0140525X05000129; TOMASELLO M, 1993, BEHAV BRAIN SCI, V16, P495, DOI 10.1017/S0140525X0003123X; Tomasello M., 2009, CULTURAL ORIGINS HUM; Vaquero M, 2001, J FIELD ARCHAEOL, V28, P93, DOI 10.1179/jfa.2001.28.1-2.93; Vaquero M, 2001, J ARCHAEOL SCI, V28, P1209, DOI 10.1006/jasc.2001.0656; Vaquero M., 2004, SETTLEMENT DYNAMICS, V2, P367; VILLA P, 1991, J HUM EVOL, V21, P27, DOI 10.1016/0047-2484(91)90034-S; Werner D, 1990, AMAZON JOURNEY ANTHR; White M, 2003, CURR ANTHROPOL, V44, P598, DOI 10.1086/377653; White T.D., 1992, PREHISTORIC CANNIBAL; Whiten A, 2000, COGNITIVE SCI, V24, P477; Yellen J.E., 1977, STUDIES ARCHEOLOGY; Yellen J. E., 1977, EXPT ARCHAEOLOGY, V271, P1; YELLEN JE, 1991, J ANTHROPOL ARCHAEOL, V10, P1, DOI 10.1016/0278-4165(91)90019-T; Zubrow E, 2010, I EUROPEAN MEDITERRA	159	48	49	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e55863	10.1371/journal.pone.0055863	http://dx.doi.org/10.1371/journal.pone.0055863			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	093IE	23437069	Green Submitted, Green Accepted, gold, Green Published			2022-12-25	WOS:000315184200028
J	Luque-Casado, A; Zabala, M; Morales, E; Mateo-March, M; Sanabria, D				Luque-Casado, Antonio; Zabala, Mikel; Morales, Esther; Mateo-March, Manuel; Sanabria, Daniel			Cognitive Performance and Heart Rate Variability: The Influence of Fitness Level	PLOS ONE			English	Article							AEROBIC EXERCISE; BRAIN; ATTENTION; ADULTS	In the present study, we investigated the relation between cognitive performance and heart rate variability as a function of fitness level. We measured the effect of three cognitive tasks (the psychomotor vigilance task, a temporal orienting task, and a duration discrimination task) on the heart rate variability of two groups of participants: a high-fit group and a low-fit group. Two major novel findings emerged from this study. First, the lowest values of heart rate variability were found during performance of the duration discrimination task, compared to the other two tasks. Second, the results showed a decrement in heart rate variability as a function of the time on task, although only in the low-fit group. Moreover, the high-fit group showed overall faster reaction times than the low-fit group in the psychomotor vigilance task, while there were not significant differences in performance between the two groups of participants in the other two cognitive tasks. In sum, our results highlighted the influence of cognitive processing on heart rate variability. Importantly, both behavioral and physiological results suggested that the main benefit obtained as a result of fitness level appeared to be associated with processes involving sustained attention.	[Luque-Casado, Antonio; Sanabria, Daniel] Univ Granada, Dept Psicol Expt, Granada, Spain; [Luque-Casado, Antonio; Zabala, Mikel; Morales, Esther] Univ Granada, Dept Educ Fis & Deport, Granada, Spain; [Mateo-March, Manuel] Univ Miguel Hernandez, Elche, Spain	University of Granada; University of Granada; Universidad Miguel Hernandez de Elche	Luque-Casado, A (corresponding author), Univ Granada, Dept Psicol Expt, Granada, Spain.	antonioluque@ugr.es	Sanabria, Daniel/C-3409-2012; Zabala, Mikel/AAE-8977-2021; Mateo-March, Manuel/AAF-8979-2021; Luque-Casado, Antonio/AAA-2072-2019; March, Manuel Mateo/A-8938-2012	Sanabria, Daniel/0000-0002-4164-7607; Mateo-March, Manuel/0000-0003-4418-8263; Luque-Casado, Antonio/0000-0002-9293-637X; March, Manuel Mateo/0000-0003-4418-8263	Spanish Ministerio de Educacion y Cultura [FPU-AP2010-3630]; Junta de Andalucia [SEJ2007-63645]; CONSOLIDER INGENIO (Direccion General de Investigacion) [CSD2008-00048]	Spanish Ministerio de Educacion y Cultura(German Research Foundation (DFG)); Junta de Andalucia(Junta de Andalucia); CONSOLIDER INGENIO (Direccion General de Investigacion)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	This research was supported by the Spanish Ministerio de Educacion y Cultura with a predoctoral grant (FPU-AP2010-3630) to the first author, Spanish grants SEJ2007-63645 from the Junta de Andalucia to Daniel Sanabria, Mikel Zabala and Esther Morales, and the CSD2008-00048 CONSOLIDER INGENIO (Direccion General de Investigacion) to Daniel Sanabria (http://www.juntadeandalucia.es/organismos/economiainnovacioncienciayempleo.html, http://www.educacion.gob.es/portada.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acevedo E.O., 2006, PSYCHOBIOLOGY PHYS A; Acharya UR, 2006, MED BIOL ENG COMPUT, V44, P1031, DOI 10.1007/s11517-006-0119-0; Albinet CT, 2010, EUR J APPL PHYSIOL, V109, P617, DOI 10.1007/s00421-010-1393-y; *AM COLL SPORTS ME, 2005, ACSMS GUID EX TEST P; Aubert AE, 2003, SPORTS MED, V33, P889, DOI 10.2165/00007256-200333120-00003; Basner M, 2011, SLEEP, V34, P581, DOI 10.1093/sleep/34.5.581; Botvinick MM, 2001, PSYCHOL REV, V108, P624, DOI 10.1037//0033-295X.108.3.624; Camm AJ, 1996, EUR HEART J, V17, P354; Chaddock L, 2010, DEV NEUROSCI-BASEL, V32, P249, DOI 10.1159/000316648; Chang YK, 2012, BRAIN RES, V1453, P87, DOI 10.1016/j.brainres.2012.02.068; Chang YK, 2009, PSYCHOL SPORT EXERC, V10, P19, DOI 10.1016/j.psychsport.2008.05.004; Cinaz Burcu, 2010, IADIS Multi Conference on Computer Science and Information Systems (MCCSIS 2010). Proceedings of the IADIS International Conferences. Computer Graphics, Visualization, Computer Vision and Image Processing 2010. Visual Communication 2010: Creative Industries Photography and Culture. Web Virtual Reality and Three-Dimensional Worlds 2010. Part of the IADIS Multi Conference on Computer Science and Information Systems 2010, P189; Colcombe S, 2003, PSYCHOL SCI, V14, P125, DOI 10.1111/1467-9280.t01-1-01430; Correa A, 2006, EXP BRAIN RES, V169, P58, DOI 10.1007/s00221-005-0131-x; Correa A, 2006, BRAIN RES, V1070, P202, DOI 10.1016/j.brainres.2005.11.094; Correa A, 2004, PERCEPT PSYCHOPHYS, V66, P264, DOI 10.3758/BF03194878; Cotman CW, 2007, TRENDS NEUROSCI, V30, P464, DOI 10.1016/j.tins.2007.06.011; Duncan J, 2000, TRENDS NEUROSCI, V23, P475, DOI 10.1016/S0166-2236(00)01633-7; Erickson KI, 2011, PNAS; FINNEY D, 1964, PROBIT ANAL STAT TRE; Hansen AL, 2004, EUR J APPL PHYSIOL, V93, P263, DOI 10.1007/s00421-004-1208-0; Hillman CH, 2008, NAT REV NEUROSCI, V9, P58, DOI 10.1038/nrn2298; Hjortskov N, 2004, EUR J APPL PHYSIOL, V92, P84, DOI 10.1007/s00421-004-1055-z; Huertas F, 2011, J SPORT EXERCISE PSY, V33, P649, DOI 10.1123/jsep.33.5.649; Ivry RB, 2004, CURR OPIN NEUROBIOL, V14, P225, DOI 10.1016/j.conb.2004.03.013; LEVY MN, 1994, VAGAL CONTROL HEART; Loh S, 2004, BEHAV RES METH INS C, V36, P339, DOI 10.3758/BF03195580; Luft CD, 2009, BIOL PSYCHOL, V82, P196, DOI 10.1016/j.biopsycho.2009.07.007; Macar Francoise, 2006, Cogn Process, V7, P89, DOI 10.1007/s10339-005-0025-7; MALIK M, 1989, MED BIOL ENG COMPUT, V27, P603, DOI 10.1007/BF02441642; Mateo M, 2012, EUR J APPL PHYSIOL, V112, P113, DOI 10.1007/s00421-011-1962-8; McMorris T., 2009, EXERCISE COGNITIVE F, DOI [10.1002/9780470740668.ch2, DOI 10.1002/9780470740668.CH2]; Mukherjee S, 2011, CLIN NEUROPHYSIOL, V122, P2059, DOI 10.1016/j.clinph.2011.02.032; Norman D. A., 1986, CONSCIOUSNESS SELF R, V4, P1; Posner MI, 2005, PLOS BIOL, V3, P204, DOI 10.1371/journal.pbio.0030051; Pumprla J, 2002, INT J CARDIOL, V84, P1, DOI 10.1016/S0167-5273(02)00057-8; Renaud M, 2010, FRONT AGING NEUROSCI, V2, DOI 10.3389/fnagi.2010.00148; Sanabria D, 2011, PSYCHOL SPORT EXERC, V12, P570, DOI 10.1016/j.psychsport.2011.04.002; Smith PJ, 2010, PSYCHOSOM MED, V72, P239, DOI 10.1097/PSY.0b013e3181d14633; Taelman J, 2011, EUR J APPL PHYSIOL, V111, P1497, DOI 10.1007/s00421-010-1776-0; Tarvainen MP, 2009, IFMBE PROC, V22, P1022; Tarvainen MP, 2002, IEEE T BIO-MED ENG, V49, P172, DOI 10.1109/10.979357; Thayer JF, 2009, ANN BEHAV MED, V37, P141, DOI 10.1007/s12160-009-9101-z; Thayer JF, 2009, NEUROSCI BIOBEHAV R, V33, P81, DOI 10.1016/j.neubiorev.2008.08.004; Thomas AG, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00086; Trivino M, 2010, BRAIN, V133, P1173, DOI 10.1093/brain/awp346; WILKINSON RT, 1982, HUM FACTORS, V24, P487, DOI 10.1177/001872088202400409	47	86	88	3	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e56935	10.1371/journal.pone.0056935	http://dx.doi.org/10.1371/journal.pone.0056935			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	093IE	23437276	Green Published, Green Submitted, gold			2022-12-25	WOS:000315184200188
J	Reiffel, AJ; Kafka, C; Hernandez, KA; Popa, S; Perez, JL; Zhou, S; Pramanik, S; Brown, BN; Ryu, WS; Bonassar, LJ; Spector, JA				Reiffel, Alyssa J.; Kafka, Concepcion; Hernandez, Karina A.; Popa, Samantha; Perez, Justin L.; Zhou, Sherry; Pramanik, Satadru; Brown, Bryan N.; Ryu, Won Seuk; Bonassar, Lawrence J.; Spector, Jason A.			High-Fidelity Tissue Engineering of Patient-Specific Auricles for Reconstruction of Pediatric Microtia and Other Auricular Deformities	PLOS ONE			English	Article							HUMAN EAR; CULTURED CHONDROCYTES; IN-VITRO; CARTILAGE; RABBIT; MODEL; SHAPE; BEHAVIOR; CONSTRUCT; IMPLANTS	Introduction: Autologous techniques for the reconstruction of pediatric microtia often result in suboptimal aesthetic outcomes and morbidity at the costal cartilage donor site. We therefore sought to combine digital photogrammetry with CAD/CAM techniques to develop collagen type I hydrogel scaffolds and their respective molds that would precisely mimic the normal anatomy of the patient-specific external ear as well as recapitulate the complex biomechanical properties of native auricular elastic cartilage while avoiding the morbidity of traditional autologous reconstructions. Methods: Three-dimensional structures of normal pediatric ears were digitized and converted to virtual solids for mold design. Image-based synthetic reconstructions of these ears were fabricated from collagen type I hydrogels. Half were seeded with bovine auricular chondrocytes. Cellular and acellular constructs were implanted subcutaneously in the dorsa of nude rats and harvested after 1 and 3 months. Results: Gross inspection revealed that acellular implants had significantly decreased in size by 1 month. Cellular constructs retained their contour/projection from the animals' dorsa, even after 3 months. Post-harvest weight of cellular constructs was significantly greater than that of acellular constructs after 1 and 3 months. Safranin O-staining revealed that cellular constructs demonstrated evidence of a self-assembled perichondrial layer and copious neocartilage deposition. Verhoeff staining of 1 month cellular constructs revealed de novo elastic cartilage deposition, which was even more extensive and robust after 3 months. The equilibrium modulus and hydraulic permeability of cellular constructs were not significantly different from native bovine auricular cartilage after 3 months. Conclusions: We have developed high-fidelity, biocompatible, patient-specific tissue-engineered constructs for auricular reconstruction which largely mimic the native auricle both biomechanically and histologically, even after an extended period of implantation. This strategy holds immense potential for durable patient-specific tissue-engineered anatomically proper auricular reconstructions in the future.	[Reiffel, Alyssa J.; Hernandez, Karina A.; Perez, Justin L.; Spector, Jason A.] Weill Cornell Med Coll, Div Plast Surg, Lab Bioregenerat Med & Surg, New York, NY 10021 USA; [Kafka, Concepcion; Popa, Samantha; Zhou, Sherry; Pramanik, Satadru; Brown, Bryan N.; Ryu, Won Seuk; Bonassar, Lawrence J.] Cornell Univ, Dept Biomed Engn, Ithaca, NY USA; [Brown, Bryan N.] Univ Pittsburgh, Dept Bioengn, Pittsburgh, PA USA	Cornell University; Cornell University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Reiffel, AJ (corresponding author), Weill Cornell Med Coll, Div Plast Surg, Lab Bioregenerat Med & Surg, New York, NY 10021 USA.	Jas2037@med.cornell.edu	Bonassar, Lawrence J/C-2103-2016	Bonassar, Lawrence J/0000-0003-1094-6433	Ruth L. Kirschstein National Research Service Award (NRSA) Institutional Research Training Grant [T32 HL083824-05]; Morgan Seed Grant Award for Collaborative Multidisciplinary Research in Tissue Engineering; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL083824] Funding Source: NIH RePORTER	Ruth L. Kirschstein National Research Service Award (NRSA) Institutional Research Training Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Morgan Seed Grant Award for Collaborative Multidisciplinary Research in Tissue Engineering; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported in part by the Ruth L. Kirschstein National Research Service Award (NRSA) Institutional Research Training Grant T32 HL083824-05 (Dr. Reiffel) and a Morgan Seed Grant Award for Collaborative Multidisciplinary Research in Tissue Engineering (Drs. Spector and Bonassar). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], [No title captured]; Bichara DA, 2012, TISSUE ENG PART B-RE, V18, P51, DOI [10.1089/ten.TEB.2011.0326, 10.1089/ten.teb.2011.0326]; Bowles RD, 2010, TISSUE ENG PT A, V16, P1339, DOI [10.1089/ten.tea.2009.0442, 10.1089/ten.TEA.2009.0442]; Britt JC, 1998, ARCH OTOLARYNGOL, V124, P671, DOI 10.1001/archotol.124.6.671; Cai H, 2005, BIO-MED MATER ENG, V15, P375; Cao YL, 1997, PLAST RECONSTR SURG, V100, P297, DOI 10.1097/00006534-199708000-00001; Chang SCN, 2003, PLAST RECONSTR SURG, V112, P793, DOI 10.1097/01.PRS.0000069711.31021.94; Chang SCN, 2001, J BIOMED MATER RES, V55, P503, DOI 10.1002/1097-4636(20010615)55:4<503::AID-JBM1043>3.0.CO;2-S; Chung C, 2008, TISSUE ENG PT A, V14, P1121, DOI [10.1089/ten.tea.2007.0291, 10.1089/tea.2007.0291]; Cross VL, 2010, BIOMATERIALS, V31, P8596, DOI 10.1016/j.biomaterials.2010.07.072; Dahl JP, 2011, OTOLARYNG HEAD NECK, V145, P915, DOI 10.1177/0194599811419092; ELSDALE T, 1972, J CELL BIOL, V54, P626, DOI 10.1083/jcb.54.3.626; Funayama A, 2008, J ORTHOP SCI, V13, P225, DOI 10.1007/s00776-008-1220-z; Gleghorn JP, 2007, EUR CELLS MATER, V14, P20, DOI 10.22203/eCM.v014a02; Haisch A, 2002, EUR ARCH OTO-RHINO-L, V259, P316, DOI 10.1007/s00405-002-0446-1; Henderson JH, 2007, TISSUE ENG, V13, P843, DOI 10.1089/ten.2006.0256; Ibusuki Shinichi, 2009, J Knee Surg, V22, P72; Isogai N, 2004, TISSUE ENG, V10, P673, DOI 10.1089/1076327041348527; Kusuhara H, 2009, WOUND REPAIR REGEN, V17, P136, DOI 10.1111/j.1524-475X.2008.00451.x; Lee SJ, 2011, BIOMACROMOLECULES, V12, P306, DOI 10.1021/bm100856g; Liu Y, 2010, BIOMATERIALS, V31, P2176, DOI 10.1016/j.biomaterials.2009.11.080; Luquetti DV, 2012, AM J MED GENET A, V158A, P124, DOI 10.1002/ajmg.a.34352; Park SS, 2004, BIOMATERIALS, V25, P2363, DOI 10.1016/j.biomaterials.2003.09.019; Rodriguez A, 1999, PLAST RECONSTR SURG, V103, P1111, DOI 10.1097/00006534-199904040-00001; Romo T, 2009, ANN PLAS SURG, V62, P384, DOI 10.1097/SAP.0b013e31819fae51; Rotter N, 2002, ARCH BIOCHEM BIOPHYS, V403, P132, DOI 10.1016/S0003-9861(02)00263-1; Roy R, 2004, J BIOMED MATER RES A, V68A, P597, DOI 10.1002/jbm.a.10068; Ruszymah BHI, 2011, INT J PEDIATR OTORHI, V75, P805, DOI 10.1016/j.ijporl.2011.03.012; Sanz E, 2007, PLAST RECONSTR SURG, V119, P1707, DOI 10.1097/01.prs.0000258849.76630.d2; Shieh SJ, 2004, BIOMATERIALS, V25, P1545, DOI 10.1016/S0142-9612(03)00501-5; VACANTI CA, 1991, PLAST RECONSTR SURG, V88, P753, DOI 10.1097/00006534-199111000-00001; Viren T, 2010, ULTRASOUND MED BIOL, V36, P833, DOI 10.1016/j.ultrasmedbio.2010.02.015; Zhou LB, 2011, TISSUE ENG PT A, V17, P1573, DOI 10.1089/ten.tea.2010.0627	33	120	137	1	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e56506	10.1371/journal.pone.0056506	http://dx.doi.org/10.1371/journal.pone.0056506			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437148	Green Published, gold, Green Submitted, Green Accepted			2022-12-25	WOS:000315184200086
J	Santoleri, F; Sorice, P; Lasala, R; Rizzo, RC; Costantini, A				Santoleri, Fiorenzo; Sorice, Paola; Lasala, Ruggero; Rizzo, Rosa Carmela; Costantini, Alberto			Patient Adherence and Persistence with Imatinib, Nilotinib, Dasatinib in Clinical Practice	PLOS ONE			English	Article							MEDICATION COMPLIANCE; THERAPY	Introduction: The aim of this study is to evaluate adherence and persistence of patients treated with Imatinib, Nilotinib or Dasatinib, also giving economic evaluations on therapy costs for Received Daily Dose (RDD). Materials and Methods: In this retrospective study, we took into account 3 years from 1st Jan. 2009 to 31st March. 2012. Treatment adherence was quantified utilizing ratio between RDD and PDD (Prescribed Daily Dose). Persistence is reckoned taking into account the actual therapy days, comparing posology with supplied dose, drawing the graph using Kaplan-Meir method. Results: Adherence results in values between 0.8 and 1.0 for Nilotinib (Adh =0.93), Imatinib (Adh =0.83) and Dasatinib (0.85). Imatinib has better persistence, 90% of patients in treatment exceed one year of treatment versus 83.3% for Nilotinib and 80% for Dasatinib. The cost per single day of treatment (cost per RDD) was (sic) 39.41 for Imatinib, (sic) 113.60 for Nilotinib and (sic) 94.84 for Dasatinib. Conclusion: Patients with CML have a loose of adherence both in first line with Imatinib and in second line of therapy with Dasatinib and Nilotinib. Loss of adherence remains a big problem and could be minimized by a patient-oriented project invlolving physicians, nurses, pharmacists and caregiver.	[Santoleri, Fiorenzo; Sorice, Paola; Lasala, Ruggero; Rizzo, Rosa Carmela; Costantini, Alberto] Gen Hosp Pescara, Pescara, Italy		Santoleri, F (corresponding author), Gen Hosp Pescara, Pescara, Italy.	fiorenzosantoleri@hotmail.com		Santoleri, Fiorenzo/0000-0002-9105-0745; Lasala, Ruggero/0000-0003-2411-8743				[Anonymous], MED COMPL PERS SPEC; Bartel SB, 2007, AM J HEALTH-SYST PH, V64, pS8, DOI 10.2146/ajhp070036; Caetano PA, 2006, CLIN THER, V28, P1411, DOI 10.1016/j.clinthera.2006.09.021; Cassidy J, 2006, BRIT J CANCER, V94, P1122, DOI 10.1038/sj.bjc.6603059; Cramer JA, 2008, INT J CLIN PRACT, V62, P76, DOI 10.1111/j.1742-1241.2007.01630.x; Cramer JA, 2008, VALUE HEALTH, V11, P44, DOI 10.1111/j.1524-4733.2007.00213.x; Foulon V, 2011, ACTA CLIN BELG, V66, P85, DOI 10.2143/ACB.66.2.2062525; Gebbia V, 2011, EXPERT OPINDRUG 1213; Goodin S, 2011, J ONCOL PRACT, V7, P7, DOI 10.1200/JOP.2010.000068; Guerin A, 2012, CURR MED RES OPIN, V28, P1155, DOI 10.1185/03007995.2012.705264; Halpern R, 2011, PATIENT PREFER ADHER, V5, P73, DOI 10.2147/PPA.S15702; Ho PM, 2009, CIRCULATION, V119, P3028, DOI 10.1161/CIRCULATIONAHA.108.768986; Mahtani KR, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005025.pub3; Mancini R, 2012, J SUPPORTONCOL  0120; Marin D, 2010, J CLIN ONCOL, V28, P2381, DOI 10.1200/JCO.2009.26.3087; Peterson AM, 2007, VALUE HEALTH, V10, P3, DOI 10.1111/j.1524-4733.2006.00139.x; Schwappach DLB, 2010, EUR J CANCER CARE, V19, P285, DOI 10.1111/j.1365-2354.2009.01127.x; World Health Organisation Collaborating Center for Drug Statistics Methodology, 2011, GUID ATC CLASS DDD A; Zedler BK, 2011, CLIN THER, V33, P581, DOI 10.1016/j.clinthera.2011.04.020; Zedler BK, 2011, CLIN THER, V33, P62, DOI 10.1016/j.clinthera.2011.02.003	20	33	35	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e56813	10.1371/journal.pone.0056813	http://dx.doi.org/10.1371/journal.pone.0056813			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437249	Green Published, Green Submitted, gold			2022-12-25	WOS:000315184200169
J	Zhang, FY; Lu, X; Lv, ZY; Zhang, L; Zhu, MM; Jiang, WM; Wang, GF; Sun, XF; Tang, KX				Zhang, Fangyuan; Lu, Xu; Lv, Zongyou; Zhang, Ling; Zhu, Mengmeng; Jiang, Weiming; Wang, Guofeng; Sun, Xiaofen; Tang, Kexuan			Overexpression of the Artemisia Orthologue of ABA Receptor, AaPYL9, Enhances ABA Sensitivity and Improves Artemisinin Content in Artemisia annua L.	PLOS ONE			English	Article							ANTHOCYANIN BIOSYNTHETIC GENES; ABSCISIC-ACID; SIGNAL-TRANSDUCTION; NEGATIVE REGULATOR; POSITIVE REGULATOR; ANTIMALARIAL-DRUG; PLANT HORMONES; LEAF GROWTH; ARABIDOPSIS; EXPRESSION	The phytohormone abscisic acid (ABA) plays an important role in plant development and environmental stress response. In this study, we cloned an ABA receptor orthologue, AaPYL9, from Artemisia annua L. AaPYL9 is expressed highly in leaf and flower. AaPYL9 protein can be localized in both nucleus and cytoplasm. Yeast two-hybrid assay shows AaPYL9 can specifically interact with AtABI1 but not with AtABI2, AtHAB1 or AtHAB2. ABA can enhance the interaction between AaPYL9 and AtABI1 while AaPYL9-89 Pro -> Ser and AaPYL9-116 His -> Ala point mutations abolishes the interaction. BiFC assay shows that AaPYL9 interacts with AtABI1 in nucleus in planta. Transgenic Arabidopsis plants over-expressing AaPYL9 are more sensitive to ABA in the seed germination and primary root growth than wild type. Consistent with this, ABA report genes have higher expression in AaPYL9 overexpressing plants compared to wild type after ABA treatment. Moreover, overexpression of AaPYL9 in A. annua increases not only drought tolerance, but also artemisinin content after ABA treatment, with significant enhancement of the expression of key genes in artemisinin biosynthesis. This study provides a way to develop A. annua with high-yielding artemisinin and high drought resistance.	[Zhang, Fangyuan; Lu, Xu; Lv, Zongyou; Zhang, Ling; Zhu, Mengmeng; Jiang, Weiming; Wang, Guofeng; Sun, Xiaofen; Tang, Kexuan] Shanghai Jiao Tong Univ, Sch Agr & Biol, Plant Biotechnol Res Ctr, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University	Tang, KX (corresponding author), Shanghai Jiao Tong Univ, Sch Agr & Biol, Plant Biotechnol Res Ctr, Shanghai 200030, Peoples R China.	kxtang1@yahoo.com	Tang, Kexuan/E-3555-2013	Tang, Kexuan/0000-0002-8748-9624; Jiang, Weimin/0000-0002-2546-5256	China National High-Tech 863 Program [2011AA100605]; Shanghai Leading Academic Discipline Project [B209]	China National High-Tech 863 Program(National High Technology Research and Development Program of China); Shanghai Leading Academic Discipline Project(Shanghai Leading Academic Discipline Project)	This work was funded by China National High-Tech 863 Program (2011AA100605) and Shanghai Leading Academic Discipline Project (B209). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chai YM, 2011, J EXP BOT, V62, P5079, DOI 10.1093/jxb/err207; Covello PS, 2007, PHYTOCHEMISTRY, V68, P1864, DOI 10.1016/j.phytochem.2007.02.016; Cutler S, 2005, PLANT PHYSIOL, V138, P558, DOI 10.1104/pp.104.900152; Cutler SR, 2010, ANNU REV PLANT BIOL, V61, P651, DOI 10.1146/annurev-arplant-042809-112122; De Smet I, 2006, TRENDS PLANT SCI, V11, P434, DOI 10.1016/j.tplants.2006.07.003; Efferth T, 2006, CURR DRUG TARGETS, V7, P407, DOI 10.2174/138945006776359412; El-Sayed M, 2004, PLANT GROWTH REGUL, V44, P53, DOI 10.1007/s10725-004-2604-5; Ferreira JFS, 1996, PHYTOCHEMISTRY, V41, P97, DOI 10.1016/0031-9422(95)00542-0; Finkelstein RR, 2002, PLANT CELL, V14, pS15, DOI 10.1105/tpc.010441; Finkelstein R, 2008, ANNU REV PLANT BIOL, V59, P387, DOI 10.1146/annurev.arplant.59.032607.092740; Fujii H, 2009, NATURE, V462, P660, DOI 10.1038/nature08599; Fujita Y, 2009, PLANT CELL PHYSIOL, V50, P2123, DOI 10.1093/pcp/pcp147; Furihata T, 2006, P NATL ACAD SCI USA, V103, P1988, DOI 10.1073/pnas.0505667103; Gonzalez-Guzman M, 2012, PLANT CELL, V24, P2483, DOI 10.1105/tpc.112.098574; Graham IA, 2010, SCIENCE, V327, P328, DOI 10.1126/science.1182612; Hoth S, 2002, J CELL SCI, V115, P4891, DOI 10.1242/jcs.00175; Jeannette E, 1999, PLANT J, V18, P13, DOI 10.1046/j.1365-313X.1999.00423.x; Jeong ST, 2004, PLANT SCI, V167, P247, DOI 10.1016/j.plantsci.2004.03.021; Jia HF, 2011, PLANT PHYSIOL, V157, P188, DOI 10.1104/pp.111.177311; Jing FY, 2009, BIOLOGIA, V64, P319, DOI 10.2478/s11756-009-0040-8; Kim H, 2012, J EXP BOT, V63, P1013, DOI 10.1093/jxb/err338; Kim JS, 2006, J PLANT BIOL, V49, P16, DOI 10.1007/BF03030784; Klingler JP, 2010, J EXP BOT, V61, P3199, DOI 10.1093/jxb/erq151; Kuhn JM, 2006, PLANT PHYSIOL, V140, P127, DOI 10.1104/pp.105.070318; Lackman P, 2011, P NATL ACAD SCI USA, V108, P5891, DOI 10.1073/pnas.1103010108; Leonhardt N, 2004, PLANT CELL, V16, P596, DOI 10.1105/tpc.019000; Li G, 2012, PLANT BIOLOGY, V14, P244, DOI 10.1111/j.1438-8677.2011.00504.x; Lopez-Molina L, 2003, GENE DEV, V17, P410, DOI 10.1101/gad.1055803; Loreti E, 2008, NEW PHYTOL, V179, P1004, DOI 10.1111/j.1469-8137.2008.02511.x; Luo LJ, 2010, J EXP BOT, V61, P3509, DOI 10.1093/jxb/erq185; Ma Y, 2009, SCIENCE, V324, P1064, DOI 10.1126/science.1172408; Melcher K, 2010, NAT STRUCT MOL BIOL, V17, P1102, DOI 10.1038/nsmb.1887; Melcher K, 2009, NATURE, V462, P602, DOI 10.1038/nature08613; Miyazono K, 2009, NATURE, V462, P609, DOI 10.1038/nature08583; Moes D, 2008, PLANT J, V54, P806, DOI 10.1111/j.1365-313X.2008.03454.x; Mori K, 2005, VITIS, V44, P161; Nemhauser JL, 2006, CELL, V126, P467, DOI 10.1016/j.cell.2006.05.050; Nishimura N, 2007, PLANT J, V50, P935, DOI 10.1111/j.1365-313X.2007.03107.x; Nishimura N, 2010, PLANT J, V61, P290, DOI 10.1111/j.1365-313X.2009.04054.x; Nishimura N, 2009, SCIENCE, V326, P1373, DOI 10.1126/science.1181829; Pandey S, 2006, PLANT PHYSIOL, V141, P243, DOI 10.1104/pp.106.079038; Park SY, 2009, SCIENCE, V324, P1068, DOI 10.1126/science.1173041; Peterson FC, 2010, NAT STRUCT MOL BIOL, V17, P1109, DOI 10.1038/nsmb.1898; Raghavendra AS, 2010, TRENDS PLANT SCI, V15, P395, DOI 10.1016/j.tplants.2010.04.006; Reymond M, 2003, PLANT PHYSIOL, V131, P664, DOI 10.1104/pp.013839; Robert N, 2006, FEBS LETT, V580, P4691, DOI 10.1016/j.febslet.2006.07.047; Romero MR, 2006, PLANTA MED, V72, P1169, DOI 10.1055/s-2006-947198; Saavedra X, 2010, PLANT PHYSIOL, V152, P133, DOI 10.1104/pp.109.146381; Santiago J, 2009, NATURE, V462, P665, DOI 10.1038/nature08591; Santiago J, 2009, PLANT J, V60, P575, DOI 10.1111/j.1365-313X.2009.03981.x; Seki Motoaki, 2002, Funct Integr Genomics, V2, P282, DOI 10.1007/s10142-002-0070-6; Umezawa T, 2010, PLANT CELL PHYSIOL, V51, P1821, DOI 10.1093/pcp/pcq156; Utzinger J, 2007, CURR OPIN INVEST DR, V8, P105; van Loon LC, 2006, ANNU REV PHYTOPATHOL, V44, P135, DOI 10.1146/annurev.phyto.44.070505.143425; VANDENBERGHE DR, 1995, J NAT PRODUCTS, V58, P798, DOI 10.1021/np50119a027; Wang RS, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-216; Weiner JJ, 2010, CURR OPIN PLANT BIOL, V13, P495, DOI 10.1016/j.pbi.2010.09.007; Welcker C, 2007, J EXP BOT, V58, P339, DOI 10.1093/jxb/erl227; YAMAGUCHISHINOZAKI K, 1994, PLANT CELL, V6, P251, DOI 10.1105/tpc.6.2.251; Yin P, 2009, NAT STRUCT MOL BIOL, V16, P1230, DOI 10.1038/nsmb.1730; Zhang L, 2009, BIOTECHNOL APPL BIOC, V52, P199, DOI 10.1042/BA20080068; Zhang XR, 2006, NAT PROTOC, V1, P641, DOI 10.1038/nprot.2006.97; Zhang XR, 2005, GENE DEV, V19, P1532, DOI 10.1101/gad.1318705; Zhu JK, 2002, ANNU REV PLANT BIOL, V53, P247, DOI 10.1146/annurev.arplant.53.091401.143329	64	35	43	1	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e56697	10.1371/journal.pone.0056697	http://dx.doi.org/10.1371/journal.pone.0056697			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437216	Green Published, gold, Green Submitted			2022-12-25	WOS:000315184200146
J	Muganyizi, PS; Kidanto, H				Muganyizi, Projestine S.; Kidanto, Hussein			Sickle Cell Disease in Pregnancy: Trend and Pregnancy Outcomes at a Tertiary Hospital in Tanzania	PLOS ONE			English	Article							MORTALITY; CHILDREN; COHORT; EXPERIENCE; MANAGEMENT; SURVIVAL; NIGERIA; MALARIA; ANEMIA	SCD in pregnancy is associated with increased adverse fetal and maternal outcomes. In Tanzania where the frequency of sickle cell trait is 13% there has been scanty data on SCD in pregnancy. With progressive improvement in childhood survival the burden of SCD in pregnancy will increase. We analyzed all deliveries at Muhimbili National Hospital (MNH) from 1999 to 2011. Fetal and maternal outcomes of SCD deliveries were compared with non-SCD. Data were analyzed using IBM SPSS statistics version 19. Chi square and Fisher Exact tests were used to compare proportions and the independent t-test for continuous data. To predict risks of adverse effects, odds ratios were determined using multivariate logistic regression. A p-value<0.05 was considered significant. In total, 157,473 deliveries occurred at MNH during the study period, of which 149 were SCD (incidence of 95 SCD per 100,000 deliveries). The incidence of SCD had increased from 76 per 100,000 deliveries in the 1999-2002 period to over 100 per 100, 000 deliveries in recent years. The mean maternal age at delivery was lower in SCD (24.0 +/- 5.5 years) than in non-SCD deliveries (26.2 +/- 6.0 years), p<0.001. Compared with non-SCD (2.9 +/- 0.7 Kg), SCD deliveries had less mean birth-weight (2.6 +/- 0.6 Kg), p<0.001. SCD were more likely than non-SCD to deliver low APGAR score at 5 minutes (34.5% Vs 15.0%, OR = 3.0, 95%CI: 2.1-4.2), stillbirths (25.7% Vs 7.5%, OR = 4.0, 95%CI: 2.8-5.8). There was excessive risk of maternal deaths in SCD compared to non-SCD (11.4% Vs 0.4%, OR = 29, 95%CI: 17.3-48.1). The leading cause of deaths in SCD was infections in wholly 82% in contrast to only 32% in non-SCD. In conclusion SCD in pregnancy is an emerging problem at MNH with increased adverse fetal outcomes and excessive maternal mortality mainly due to infections.	[Muganyizi, Projestine S.; Kidanto, Hussein] MUHAS, Sch Med, Dept Obstet & Gynecol, Dar Es Salaam, Tanzania	Muhimbili University of Health & Allied Sciences	Muganyizi, PS (corresponding author), MUHAS, Sch Med, Dept Obstet & Gynecol, Dar Es Salaam, Tanzania.	promuga@yahoo.com						Afolabi BB, 2009, J OBSTET GYNAECOL, V29, P104, DOI 10.1080/01443610802667112; Al Jama FE, 2009, ARCH GYNECOL OBSTET, V280, P793, DOI 10.1007/s00404-009-1002-7; ANGASTINIOTIS M, 1995, B WORLD HEALTH ORGAN, V73, P375; Asnani MR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026281; Barfield WD, 2010, AM J PREV MED, V38, pS542, DOI 10.1016/j.amepre.2009.12.020; DARE FO, 1992, INT J GYNECOL OBSTET, V37, P163, DOI 10.1016/0020-7292(92)90376-T; Diallo D, 2002, CURR OPIN HEMATOL, V9, P111, DOI 10.1097/00062752-200203000-00005; ELSHAFEI AM, 1988, AUST NZ J OBSTET GYN, V28, P41; Makani J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014699; Makani J, 2010, BLOOD, V115, P215, DOI 10.1182/blood-2009-07-233528; McAuley CF, 2010, BLOOD, V116, P1663, DOI 10.1182/blood-2010-01-265249; [NHS S.C.a], 2009, NHD HDB LAB; Ogedengbe O K, 1993, West Afr J Med, V12, P96; Patra PK, 2011, J COMMUN GENET, V2, P147, DOI 10.1007/s12687-011-0050-4; Quinn CT, 2004, BLOOD, V103, P4023, DOI 10.1182/blood-2003-11-3758; Rahimy MC, 2000, BLOOD, V96, P1685, DOI 10.1182/blood.V96.5.1685.h8001685_1685_1689; Rajab KE, 2004, SAUDI MED J, V25, P265; Serjeant G R, 2005, East Afr Med J, V82, P367; Serjeant G R, 2003, East Afr Med J, V80, P384; Serjeant GR, 2005, BJOG-INT J OBSTET GY, V112, P1308, DOI 10.1111/j.1471-0528.2005.00678.x; Serjeant GR, 2004, OBSTET GYNECOL, V103, P1278, DOI 10.1097/01.AOG.0000127433.23611.54; Serjeant GR, 2001, ARCH DIS CHILD, V85, P375, DOI 10.1136/adc.85.5.375; Smith JA, 1996, OBSTET GYNECOL, V87, P199, DOI 10.1016/0029-7844(95)00367-3; Stuart MJ, 2004, LANCET, V364, P1343, DOI 10.1016/S0140-6736(04)17192-4; Sun PM, 2001, AM J OBSTET GYNECOL, V184, P1127, DOI 10.1067/mob.2001.115477; Telfer P, 2007, HAEMATOLOGICA, V92, P905, DOI 10.3324/haematol.10937; United Republic of Tanzania. National Bureau of Statistics (NBS), 2011, TANZ DEM HLTH SURV 2; Wierenga KJJ, 2001, LANCET, V357, P680, DOI 10.1016/S0140-6736(00)04132-5	28	28	29	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e56541	10.1371/journal.pone.0056541	http://dx.doi.org/10.1371/journal.pone.0056541			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418582	Green Published, Green Submitted, gold			2022-12-25	WOS:000315970300175
J	Schaible, B; McClean, S; Selfridge, A; Broquet, A; Asehnoune, K; Taylor, CT; Schaffer, K				Schaible, Bettina; McClean, Siobhan; Selfridge, Andrew; Broquet, Alexis; Asehnoune, Karim; Taylor, Cormac T.; Schaffer, Kirsten			Hypoxia Modulates Infection of Epithelial Cells by Pseudomonas aeruginosa	PLOS ONE			English	Article							NF-KAPPA-B; TRANSMEMBRANE CONDUCTANCE REGULATOR; INDUCIBLE FACTOR-I; CFTR EXPRESSION; GENE-EXPRESSION; UP-REGULATION; INTERNALIZATION; KINASE; SURVIVAL; HIF-1-ALPHA	Pseudomonas aeruginosa (P. aeruginosa) is an opportunistic pathogen commonly associated with lung and wound infections. Hypoxia is a frequent feature of the microenvironment of infected tissues which induces the expression of genes associated with innate immunity and inflammation in host cells primarily through the activation of the hypoxia-inducible factor (HIF) and Nuclear factor kappaB (NF-kappa B) pathways which are regulated by oxygen-dependent prolyl-hydroxylases. Hypoxia also affects virulence and antibiotic resistance in bacterial pathogens. However, less is known about the impact of hypoxia on host-pathogen interactions such as bacterial adhesion and infection. In the current study, we demonstrate that hypoxia decreases the internalization of P. aeruginosa into cultured epithelial cells resulting in decreased host cell death. This response can also be elicited by the hydroxylase inhibitor Dimethyloxallyl Glycine (DMOG). Reducing HIF-2 alpha expression or Rho kinase activity diminished the effects of hypoxia on P. aeruginosa infection. Furthermore, in an in vivo pneumonia infection model, application of DMOG 48 h before infection with P. aeruginosa significantly reduced mortality. Thus, hypoxia reduces P. aeruginosa internalization into epithelial cells and pharmacologic manipulation of the host pathways involved may represent new therapeutic targets in the treatment of P. aeruginosa infection.	[Schaible, Bettina; Selfridge, Andrew; Taylor, Cormac T.] Univ Coll Dublin, UCD Sch Med & Med Sci, Dublin 2, Ireland; [Schaible, Bettina; Selfridge, Andrew; Taylor, Cormac T.] Univ Coll Dublin, Conway Inst, Dublin 2, Ireland; [Schaible, Bettina] Queenss Univ, Sch Pharm, Belfast, Antrim, North Ireland; [McClean, Siobhan] Inst Technol Tallaght, Dublin, Ireland; [Broquet, Alexis; Asehnoune, Karim] Univ Nantes, Fac Med, Lab UPRES EA Therapeut Clin & Expt Infect 3826, Nantes, France; [Asehnoune, Karim] CHU Nantes, Hotel Dieu HME, Serv Anesthesie Reanimat Chirurg, F-44035 Nantes 01, France; [Schaffer, Kirsten] St Vincents Univ Hosp, Dept Microbiol, Dublin 4, Ireland	University College Dublin; University College Dublin; Technological University Dublin; Nantes Universite; Nantes Universite; CHU de Nantes; University College Dublin; Saint Vincent's University Hospital	Schaffer, K (corresponding author), St Vincents Univ Hosp, Dept Microbiol, Dublin 4, Ireland.	kirsten.e.schaffer@ucd.ie		McClean, Siobhan/0000-0001-6389-2542; Broquet, Alexis/0000-0002-6635-9601; Taylor, Cormac/0000-0002-0946-1247	Irish Research Council for Science, Engineering Technology; Science Foundation Ireland	Irish Research Council for Science, Engineering Technology(Irish Research Council for Science, Engineering and Technology); Science Foundation Ireland(Science Foundation IrelandEuropean Commission)	This work was supported by grants from the Irish Research Council for Science, Engineering & Technology, and Science Foundation Ireland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bajmoczi M, 2009, AM J PHYSIOL-CELL PH, V297, pC263, DOI 10.1152/ajpcell.00527.2008; Bruning U, 2011, MOL CELL BIOL, V31, P4087, DOI 10.1128/MCB.01276-10; Colgan SP, 2010, NAT REV GASTRO HEPAT, V7, P281, DOI 10.1038/nrgastro.2010.39; COZENS AL, 1994, AM J RESP CELL MOL, V10, P38, DOI 10.1165/ajrcmb.10.1.7507342; Cramer T, 2003, CELL, V112, P645, DOI 10.1016/S0092-8674(03)00154-5; Cummins EP, 2006, P NATL ACAD SCI USA, V103, P18154, DOI 10.1073/pnas.0602235103; Eltzschig HK, 2011, NEW ENGL J MED, V364, P656, DOI 10.1056/NEJMra0910283; Eltzschig HK, 2009, ANESTHESIOLOGY, V111, P904, DOI 10.1097/ALN.0b013e3181b060f2; Engel J, 2009, CURR OPIN MICROBIOL, V12, P61, DOI 10.1016/j.mib.2008.12.007; Evans DJ, 2002, MICROB PATHOGENESIS, V33, P135, DOI 10.1006/mpat.2002.0521; Fitzpatrick SF, 2011, J IMMUNOL, V186, P1091, DOI 10.4049/jimmunol.1002256; Furuta GT, 2001, J EXP MED, V193, P1027, DOI 10.1084/jem.193.9.1027; Garrity-Ryan L, 2000, INFECT IMMUN, V68, P7100, DOI 10.1128/IAI.68.12.7100-7113.2000; Greijer AE, 2005, J PATHOL, V206, P291, DOI 10.1002/path.1778; Guimbellot JS, 2008, AM J RESP CELL MOL, V39, P514, DOI 10.1165/rcmb.2007-0452OC; Ha U, 2001, INFECT IMMUN, V69, P4398, DOI 10.1128/IAI.69.7.4398-4406.2001; Hayden MS, 2012, GENE DEV, V26, P203, DOI 10.1101/gad.183434.111; Hidron AI, 2008, INFECT CONT HOSP EP, V29, P996, DOI 10.1086/591861; Hirakata Y, 2000, J INFECT DIS, V181, P765, DOI 10.1086/315276; Hirota SA, 2010, GASTROENTEROLOGY, V139, P259, DOI 10.1053/j.gastro.2010.03.045; Jacqueline C, 2012, J ANTIMICROB CHEMOTH; Jantsch J, 2008, J IMMUNOL, V180, P4697, DOI 10.4049/jimmunol.180.7.4697; Kaelin WG, 2008, MOL CELL, V30, P393, DOI 10.1016/j.molcel.2008.04.009; Karhausen J, 2004, J CLIN INVEST, V114, P1098, DOI 10.1172/JCI200421086; Keely S, 2010, MOL BIOL CELL, V21, P538, DOI 10.1091/mbc.E09-07-0573; Kempf VAJ, 2005, CIRCULATION, V111, P1054, DOI 10.1161/01.CIR.0000155608.07691.B7; Koh MY, 2012, TRENDS BIOCHEM SCI, V37, P364, DOI 10.1016/j.tibs.2012.06.004; Magret M, 2011, CRIT CARE, V15, DOI 10.1186/cc10036; MAHENTHIRALINGAM E, 1994, INFECT IMMUN, V62, P596, DOI 10.1128/IAI.62.2.596-605.1994; Marteyn B, 2010, NATURE, V465, P355, DOI 10.1038/nature08970; Maynard MA, 2007, CELL CYCLE, V6, P2810, DOI 10.4161/cc.6.22.4947; Naldini A, 2012, J CELL PHYSIOL, V227, P587, DOI 10.1002/jcp.22761; Nizet V, 2009, NAT REV IMMUNOL, V9, P609, DOI 10.1038/nri2607; Pielage JF, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000031; Pier GB, 1997, P NATL ACAD SCI USA, V94, P12088, DOI 10.1073/pnas.94.22.12088; Sadikot RT, 2006, J IMMUNOL, V176, P4923, DOI 10.4049/jimmunol.176.8.4923; Schaible B, 2012, ANTIMICROB AGENTS CH, V56, P2114, DOI 10.1128/AAC.05574-11; Schaible B, 2010, RESP PHYSIOL NEUROBI, V174, P235, DOI 10.1016/j.resp.2010.08.006; Schmiedl A, 2010, CELL TISSUE RES, V342, P67, DOI 10.1007/s00441-010-1036-y; Semenza G.L., 2007, SCI STKE, V2007, pcm8; Spilker T, 2004, J CLIN MICROBIOL, V42, P2074, DOI 10.1128/JCM.42.5.2074-2079.2004; Taylor CT, 2008, J PHYSIOL-LONDON, V586, P4055, DOI 10.1113/jphysiol.2008.157669; Taylor CT, 2008, BIOCHEM J, V409, P19, DOI 10.1042/BJ20071249; Taylor CT, 2009, ANN NY ACAD SCI, V1177, P178, DOI 10.1111/j.1749-6632.2009.05024.x; Taylor CT, 1999, J BIOL CHEM, V274, P19447, DOI 10.1074/jbc.274.27.19447; Tian YM, 2011, J BIOL CHEM, V286, P13041, DOI 10.1074/jbc.M110.211110; Turcotte S, 2003, J CELL SCI, V116, P2247, DOI 10.1242/jcs.00427; Uehata M, 1997, NATURE, V389, P990, DOI 10.1038/40187; Vogel S, 2010, J BIOL CHEM, V285, P33756, DOI 10.1074/jbc.M110.132985; Walmsley SR, 2005, J EXP MED, V201, P105, DOI 10.1084/jem.20040624; Worlitzsch D, 2002, J CLIN INVEST, V109, P317, DOI 10.1172/JCI0213870; Zaidi T, 2004, INVEST OPHTH VIS SCI, V45, P4066, DOI 10.1167/iovs.04-0627; Zheng W, 2009, FASEB J, V23, P204, DOI 10.1096/fj.08-110221	53	46	49	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e56491	10.1371/journal.pone.0056491	http://dx.doi.org/10.1371/journal.pone.0056491			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418576	Green Submitted, gold, Green Published			2022-12-25	WOS:000315970300169
J	Lamichhane, JR; Fabi, A; Ridolfi, R; Varvaro, L				Lamichhane, Jay Ram; Fabi, Alfredo; Ridolfi, Roberto; Varvaro, Leonardo			Epidemiological Study of Hazelnut Bacterial Blight in Central Italy by Using Laboratory Analysis and Geostatistics	PLOS ONE			English	Article							ARBORICOLA PV. CORYLINA; GEOGRAPHIC INFORMATION-SYSTEMS; CLIMATE-CHANGE; SPATIAL-ANALYSIS; PLANT-PATHOGENS; PHYSICAL-PROPERTIES; ELEVATED CO2; SOIL-PH; DISEASE; SPREAD	Incidence of Xanthomonas arboricola pv. corylina, the causal agent of hazelnut bacterial blight, was analyzed spatially in relation to the pedoclimatic factors. Hazelnut grown in twelve municipalities situated in the province of Viterbo, central Italy was studied. A consistent number of bacterial isolates were obtained from the infected tissues of hazelnut collected in three years (2010-2012). The isolates, characterized by phenotypic tests, did not show any difference among them. Spatial patterns of pedoclimatic data, analyzed by geostatistics showed a strong positive correlation of disease incidence with higher values of rainfall, thermal shock and soil nitrogen; a weak positive correlation with soil aluminium content and a strong negative correlation with the values of Mg/K ratio. No correlation of the disease incidence was found with soil pH. Disease incidence ranged from very low (<1%) to very high (almost 75%) across the orchards. Young plants (4-year old) were the most affected by the disease confirming a weak negative correlation of the disease incidence with plant age. Plant cultivars did not show any difference in susceptibility to the pathogen. Possible role of climate change on the epidemiology of the disease is discussed. Improved management practices are recommended for effective control of the disease.	[Lamichhane, Jay Ram; Fabi, Alfredo; Ridolfi, Roberto; Varvaro, Leonardo] Univ Tuscia, Dept Sci & Technol Agr Forestry Nat & Energy DAFN, Viterbo, Italy; [Lamichhane, Jay Ram; Fabi, Alfredo; Varvaro, Leonardo] Hazelnut Res Ctr, Viterbo, Italy	Tuscia University	Varvaro, L (corresponding author), Univ Tuscia, Dept Sci & Technol Agr Forestry Nat & Energy DAFN, Viterbo, Italy.	varvaro@unitus.it	Fabi, Alfredo/AAB-4073-2020	Lamichhane, Jay Ram/0000-0001-9780-0941				Agrios G. N., 2005, PLANT PATHOL; Aloj B, 1987, INF AGRARIO, V26, P55; Anderson PK, 2004, TRENDS ECOL EVOL, V19, P535, DOI 10.1016/j.tree.2004.07.021; Ayers SH, 1919, USDA B; Balestra GM, 1997, PSEUDOMONAS SYRINGAE, P88; BARBIERI M, 1988, CONTRIB MINERAL PETR, V99, P485, DOI 10.1007/BF00371939; BARNETT HL, 1959, ANNU REV MICROBIOL, V13, P191, DOI 10.1146/annurev.mi.13.100159.001203; Barss HP, 1913, OREGON AGR EXPT STAT, V14, P213; Berry PM, 2002, GLOBAL ECOL BIOGEOGR, V11, P453, DOI 10.1111/j.1466-8238.2002.00304.x; Bianco M, 2002, P 2 NAT C HAZ GIFF V, P52; Boccacci P, 2009, ACTA HORTIC, V845, P127; Bradbury JF, 1987, CMI DESCRIPTIONS PAT; Brent K. J., 1998, FUNGICIDE RESISTANCE; Broders KD, 2009, PHYTOPATHOLOGY, V99, P957, DOI 10.1094/PHYTO-99-8-0957; BUTTERWORTH J, 1991, J APPL BACTERIOL, V71, P484, DOI 10.1111/j.1365-2672.1991.tb03822.x; CAMBARDELLA CA, 1994, SOIL SCI SOC AM J, V58, P1501, DOI 10.2136/sssaj1994.03615995005800050033x; CAMPBELL CL, 1985, ANNU REV PHYTOPATHOL, V23, P129; Cannon RJC, 1998, GLOBAL CHANGE BIOL, V4, P785, DOI 10.1046/j.1365-2486.1998.00190.x; Chakraborty S, 2011, PLANT PATHOL, V60, P2, DOI 10.1111/j.1365-3059.2010.02411.x; Chakraborty S, 2003, NEW PHYTOL, V159, P733, DOI 10.1046/j.1469-8137.2003.00842.x; CHELLEMI DO, 1988, PHYTOPATHOLOGY, V78, P221, DOI 10.1094/Phyto-78-221; Clark I, 1979, PRATICAL GEOSTATISTI; Cliff AD, 1977, SPATIAL AUTOCORRELAT; Coakley SM, 1999, ANNU REV PHYTOPATHOL, V37, P399, DOI 10.1146/annurev.phyto.37.1.399; COOKSEY DA, 1990, ANNU REV PHYTOPATHOL, V28, P201, DOI 10.1146/annurev.py.28.090190.001221; CRESSIE N, 1988, MATH GEOL, V20, P405, DOI 10.1007/BF00892986; CRESSIE N, 1985, J INT ASS MATH GEOL, V17, P563, DOI 10.1007/BF01032109; Cristofori V, 2011, FRUTTICOL, V5, P44; DELHAIZE E, 1995, PLANT PHYSIOL, V107, P315, DOI 10.1104/pp.107.2.315; Deutsch C.V., 1992, GSLIB GEOSTATISTICAL; Dordas C, 2008, AGRON SUSTAIN DEV, V28, P33, DOI 10.1051/agro:2007051; Duffy BK, 1997, PHYTOPATHOLOGY, V87, P1118, DOI 10.1094/PHYTO.1997.87.11.1118; Eastman J. R, 1999, GUIDE GIS IMAGE PROC; Eastman JR, 2001, GUIDE GIS IMAGE PROC, VI; Fabi A, 2005, ACTA HORTIC, P427, DOI 10.17660/ActaHortic.2005.686.59; Fabi A, 2009, ACTA HORTIC, V845, P507, DOI 10.17660/ActaHortic.2009.845.78; Fabi A, 2006, P 12 C MED PHYT UN J, P217; FAO, 2010, FAO STAT; FERRIN DM, 1986, PHYTOPATHOLOGY, V76, P1153, DOI 10.1094/Phyto-76-1153; Fiori M, 2006, PETRIA, V16, P71; Fitt BDL, 2011, PLANT PATHOL, V60, P44, DOI 10.1111/j.1365-3059.2010.02413.x; FOY CD, 1978, ANNU REV PLANT PHYS, V29, P511, DOI 10.1146/annurev.pp.29.060178.002455; Franke J, 2009, PHYTOPATHOLOGY, V99, P974, DOI 10.1094/PHYTO-99-8-0974; Fuhrer J, 2003, AGR ECOSYST ENVIRON, V97, P1, DOI 10.1016/S0167-8809(03)00125-7; Gardan L, 1986, EPPO EPO B, V16, P13; Gardan L, 1983, P INT C HAZ AV IT, P443; Genet JL, 2006, PEST MANAG SCI, V62, P188, DOI 10.1002/ps.1146; Gent DH, 2012, PLANT PATHOL, V61, P37, DOI 10.1111/j.1365-3059.2011.02491.x; Gisi U, 2007, PLANT PATHOL, V56, P199, DOI 10.1111/j.1365-3059.2006.01512.x; Goodchild MF, 1993, ENV MODELING GIS, P8; Goovaerts P., 1997, GEOSTATISTICS NATURA, DOI DOI 10.2307/1270969; GOTTWALD TR, 1995, PLANT DIS, V79, P266, DOI 10.1094/PD-79-0266; GRAY SM, 1986, PHYTOPATHOLOGY, V76, P243, DOI 10.1094/Phyto-76-243; Guo X.D., 2000, J APPL ECOL, V11, P557; HAAS JH, 1976, PHYTOPATHOLOGY, V66, P1219, DOI 10.1094/Phyto-66-1219; Hannan J.M., 2011, THESIS IOWA STATE U; Henne DC, 2012, PLANT DIS, V96, P948, DOI 10.1094/PDIS-09-11-0805-RE; HIRANO SS, 1990, ANNU REV PHYTOPATHOL, V28, P155, DOI 10.1146/annurev.py.28.090190.001103; Isaaks E.H., 1989, APPL GEOSTATISTICS; Jaime-Garcia R, 2001, PHYTOPATHOLOGY, V91, P1156, DOI 10.1094/PHYTO.2001.91.12.1156; JAKOBSEN ST, 1993, ACTA AGR SCAND B-S P, V43, P1, DOI 10.1080/09064719309410223; Johansson O. A. H., 1977, Proceedings, International Seminar on Soil Environment and Fertility Management in Intensive Agriculture (SEFMIA), Japan 1977., P487; Kazempour MN, 2006, J PLANT PATHOL, V88, P341; KINRAIDE TB, 1992, PLANT PHYSIOL, V99, P1461, DOI 10.1104/pp.99.4.1461; KLEMENT Z, 1967, ANNU REV PHYTOPATHOL, V5, P17, DOI 10.1146/annurev.py.05.090167.000313; KLEMENT Z., 1961, Phytopathologische Zeitschrift, V41, P217, DOI 10.1111/j.1439-0434.1961.tb04050.x; Lamichhane JR, 2012, PLANT DIS, V96, P1577, DOI 10.1094/PDIS-04-12-0375-PDN; Lamichhane JR, 2012, J PHYTOPATHOL, V160, P752, DOI 10.1111/jph.12004; Lamichhane JR, 2012, ACTA HORT IN PRESS; LARKIN RP, 1995, PHYTOPATHOLOGY, V85, P191, DOI 10.1094/Phyto-85-191; LEBEN C, 1968, PHYTOPATHOLOGY, V58, P1143; LEE YA, 1992, PHYTOPATHOLOGY, V82, P971, DOI 10.1094/Phyto-82-971; Lelliot R.A., 1987, METHODS PLANT PATHOL, V2; Luck J, 2011, PLANT PATHOL, V60, P113, DOI 10.1111/j.1365-3059.2010.02414.x; MADDEN LV, 1982, PHYTOPATHOLOGY, V72, P195, DOI 10.1094/Phyto-72-195; Marschner H., 1995, MINERAL NUTR HIGHER, Vsecond, DOI DOI 10.1016/B978-0-12-473542-2.X5000-7; Martin HL, 2004, PLANT DIS, V88, P921, DOI 10.1094/PDIS.2004.88.9.921; Martins L, 2007, EUR J PLANT PATHOL, V119, P159, DOI 10.1007/s10658-007-9155-3; Martins LM, 2005, ACTA HORTIC, P621, DOI 10.17660/ActaHortic.2005.693.83; Martins LM, 1999, ACTA HORTIC, P447, DOI 10.17660/ActaHortic.1999.494.67; Martins Luis M., 2001, Forest Snow and Landscape Research, V76, P357; Mazzone P., 2006, PETRIA, V16, P19; Me G, 2006, PETRIA, V16, P7; MELAKEBERHAN H, 1995, PLANT DIS, V79, P886, DOI 10.1094/PD-79-0886; Melloy P, 2010, GLOBAL CHANGE BIOL, V16, P3363, DOI 10.1111/j.1365-2486.2010.02178.x; MILES WG, 1977, PHYTOPATHOLOGY, V67, P895, DOI 10.1094/Phyto-67-895; Miller PW, 1949, OREGON AGR EXPT STAT, V6; MOORE LW, 1974, PHYTOPATHOLOGY, V64, P1537, DOI 10.1094/Phyto-64-1537; Nelson Merritt R., 1997, AAAS Annual Meeting and Science Innovation Exposition, V163, pA22; Nelson MR, 1999, PLANT DIS, V83, P308, DOI 10.1094/PDIS.1999.83.4.308; NELSON MR, 1994, PHYTOPATHOLOGY, V84, P898, DOI 10.1094/Phyto-84-898; NICOT PC, 1984, PHYTOPATHOLOGY, V74, P1399, DOI 10.1094/Phyto-74-1399; NOE JP, 1985, J NEMATOL, V17, P86; Noviello C., 1968, LIEBIGS ANN CHEM, V4, P3; OEPP/EPPO, 1990, EPPO TECHN DOC; OEPP/EPPO, 2004, OEPP EPPO B, V34, P155; OEPP/EPPO, 1986, OEPP EPPO B, V16, P13; Oliver M. A., 1990, International Journal of Geographical Information Systems, V4, P313, DOI 10.1080/02693799008941549; OMAR MA, 1966, SOIL SCI, V101, P437, DOI 10.1097/00010694-196606000-00003; Orum TV, 1997, PLANT DIS, V81, P911, DOI 10.1094/PDIS.1997.81.8.911; Pangga IB, 2011, PLANT PATHOL, V60, P70, DOI 10.1111/j.1365-3059.2010.02408.x; PATHAK A N, 1971, Zeitschrift fuer Pflanzenernaehrung und Bodenkunde, V130, P118, DOI 10.1002/jpln.19711300204; Pedica A, 1997, ACTA HORTIC, P123, DOI 10.17660/ActaHortic.1997.445.17; PETRI L., 1932, BOLL R STAZ PATOL VEG [FLORENCE], V12, P1; PETRI L., 1933, BOLL R STAZ PATOL VEG, V13, P1; Pettiet J. V., 1988, Proceedings, Beltwide Cotton Production Research Conferences, 3-8 Jan. 1988, New Orleans, Louisiana, USA., P517; Pietrarelli L, 2006, J PLANT PATHOL, V88, P245; Pimentel D, 2001, AGR ECOSYST ENVIRON, V84, P1, DOI 10.1016/S0167-8809(00)00178-X; Poschenrieder G, 2006, BAYERISCHE LANDESANS, P32; PRINCE AL, 1947, SOIL SCI, V63, P69, DOI 10.1097/00010694-194701000-00008; PROCTOR CH, 1984, COMMUN STAT-THEOR M, V13, P617, DOI 10.1080/03610928408828706; Pulawska J, 2010, J PLANT PATHOL, V92, P803; RAMIREZ BN, 1975, PHYTOPATHOLOGY, V65, P780, DOI 10.1094/Phyto-65-780; Ristaino JB, 2000, ANNU REV PHYTOPATHOL, V38, P541, DOI 10.1146/annurev.phyto.38.1.541; Roberts SJ, 1997, EUR J PLANT PATHOL, V103, P711, DOI 10.1023/A:1008609206778; Roberts SJ, 1985, THESIS U LEEDS; Schaad N. W., 2001, LAB GUIDE IDENTIFICA, V3rd, P1; Scortichini M, 2002, PLANT PATHOL, V51, P374, DOI 10.1046/j.1365-3059.2002.00691.x; Scortichini M, 1991, INF FITOPATOL, V41, P251; Scortichini M, 2001, INFORM AGRARIO, V21, P85; SEEM RC, 1984, ANNU REV PHYTOPATHOL, V22, P133, DOI 10.1146/annurev.py.22.090184.001025; Shear GM, 1944, PHYTOPATHOLOGY, V34, P603; Siscaro G, 2006, PETRIA, V16, P59; Snoeijers SS, 2000, EUR J PLANT PATHOL, V106, P493, DOI 10.1023/A:1008720704105; Star J, 1990, GEOGRAPHIC INFORM SY; STEIN A, 1994, PHYTOPATHOLOGY, V84, P1227, DOI 10.1094/Phyto-84-1227; Stein M.L., 1999, INTERPOLATION SPATIA; SUNDIN GW, 1993, APPL ENVIRON MICROB, V59, P1018, DOI 10.1128/AEM.59.4.1018-1024.1993; TEWARI S. N., 1971, Proceedings, International Symposium on Soil Fertility Evaluation, New Delhi, Indian Society of Soil Science, V1, P317; Tombesi A., 2002, 2 CONV NAZ NOCC, V296, P11; Tombesi A., 1991, AA VV FRUTTICOLTURA, P614; TRANGMAR BB, 1985, ADV AGRON, V38, P45; van Maanen A, 2003, EUR J PLANT PATHOL, V109, P669, DOI 10.1023/A:1026018005613; Vanneste J. L., 2005, New Zealand Plant Protection, V58, P101; Varvaro L, 1993, INF FITOPATOL, V2, P54; VAUTERIN L, 1995, INT J SYST BACTERIOL, V45, P472, DOI 10.1099/00207713-45-3-472; Vigouroux A., 1993, ACTA HORTIC, V384, P607; Virdis S, 2008, THESIS U SASSARI SAR; Voisin A., 1963, GRASS TETANY; WEAVER DJ, 1975, PHYTOPATHOLOGY, V65, P984, DOI 10.1094/Phyto-65-984; White PJ, 2010, ANN BOT-LONDON, V105, P1073, DOI 10.1093/aob/mcq085; WILKINSON SR, 1990, MET IONS BIOL SYST, V26, P33; Wu BM, 2001, PHYTOPATHOLOGY, V91, P134, DOI 10.1094/PHYTO.2001.91.2.134; Yamamoto JK., 1999, NATURAL RESOURCES RE, V8, P153, DOI DOI 10.1023/A:1021894703729; Yang X B, 2001, GLOB CHANGE HUM HLTH, V2, P90, DOI [10.1023/A:1015086831467, DOI 10.1023/A:1015086831467]	145	25	26	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2013	8	2							e56298	10.1371/journal.pone.0056298	http://dx.doi.org/10.1371/journal.pone.0056298			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104BU	23424654	Green Published, gold, Green Submitted			2022-12-25	WOS:000315965100042
J	Liu, AH; Gao, F; Kanno, Y; Jordan, MC; Kamiya, Y; Seo, M; Ayele, BT				Liu, Aihua; Gao, Feng; Kanno, Yuri; Jordan, Mark C.; Kamiya, Yuji; Seo, Mitsunori; Ayele, Belay T.			Regulation of Wheat Seed Dormancy by After-Ripening Is Mediated by Specific Transcriptional Switches That Induce Changes in Seed Hormone Metabolism and Signaling	PLOS ONE			English	Article							ARABIDOPSIS-THALIANA SEEDS; ACTIVATED PROTEIN-KINASES; ABSCISIC-ACID; GENE-EXPRESSION; DIFFERENTIAL EXPRESSION; GIBBERELLIN METABOLISM; CONJUGATE HYDROLASES; FLORAL DEVELOPMENT; JASMONIC ACID; CROSS-TALK	Treatments that promote dormancy release are often correlated with changes in seed hormone content and/or sensitivity. To understand the molecular mechanisms underlying the role of after-ripening (seed dry storage) in triggering hormone related changes and dormancy decay in wheat (Triticum aestivum), temporal expression patterns of genes related to abscisic acid (ABA), gibberellin (GA), jasmonate and indole acetic acid (IAA) metabolism and signaling, and levels of the respective hormones were examined in dormant and after-ripened seeds in both dry and imbibed states. After-ripening mediated developmental switch from dormancy to germination appears to be associated with declines in seed sensitivity to ABA and IAA, which are mediated by transcriptional repressions of PROTEIN PHOSPHATASE 2C, SNF1-RELATED PROTEIN KINASE2, ABA INSENSITIVE5 and LIPID PHOSPHATE PHOSPHTASE2, and AUXIN RESPONSE FACTOR and RELATED TO UBIQUITIN1 genes. Transcriptomic analysis of wheat seed responsiveness to ABA suggests that ABA inhibits the germination of wheat seeds partly by repressing the transcription of genes related to chromatin assembly and cell wall modification, and activating that of GA catabolic genes. After-ripening induced seed dormancy decay in wheat is also associated with the modulation of seed IAA and jasmonate contents. Transcriptional control of members of the ALLENE OXIDE SYNTHASE, 3-KETOACYL COENZYME A THIOLASE, LIPOXYGENASE and 12-OXOPHYTODIENOATE REDUCTASE gene families appears to regulate seed jasmonate levels. Changes in the expression of GA biosynthesis genes, GA 20-OXIDASE and GA 3-OXIDASE, in response to after-ripening implicate this hormone in enhancing dormancy release and germination. These findings have important implications in the dissection of molecular mechanisms underlying regulation of seed dormancy in cereals.	[Liu, Aihua; Gao, Feng; Ayele, Belay T.] Univ Manitoba, Dept Plant Sci, Winnipeg, MB R3T 2N2, Canada; [Jordan, Mark C.] Agr & Agri Food Canada, Cereal Res Ctr, Winnipeg, MB, Canada; [Kanno, Yuri; Kamiya, Yuji; Seo, Mitsunori] RIKEN Plant Sci Ctr, Yokohama, Kanagawa, Japan	University of Manitoba; Agriculture & Agri Food Canada; RIKEN	Ayele, BT (corresponding author), Univ Manitoba, Dept Plant Sci, Winnipeg, MB R3T 2N2, Canada.	b_ayele@umanitoba.ca	Seo, Mitsunori/N-9603-2015; Kamiya, Yuji/F-9420-2010; kanno, yuri/C-9211-2017; Ponnusamy, Murugavel/X-5699-2018	Kamiya, Yuji/0000-0003-4415-520X; Ponnusamy, Murugavel/0000-0001-5558-8719; Seo, Mitsunori/0000-0001-8325-7984	Natural Sciences and Engineering Research Council of Canada; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK085065] Funding Source: NIH RePORTER	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by a grant from the Natural Sciences and Engineering Research Council of Canada to BTA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An YQ, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-105; Appleford NEJ, 2006, PLANTA, V223, P568, DOI 10.1007/s00425-005-0104-0; Ayele BT, 2012, J PLANT GROWTH REGUL, V31, P235, DOI 10.1007/s00344-011-9234-8; Barrero JM, 2012, NEW PHYTOL, V193, P376, DOI 10.1111/j.1469-8137.2011.03938.x; Barrero JM, 2009, PLANT PHYSIOL, V150, P1006, DOI 10.1104/pp.109.137901; Bassel GW, 2011, P NATL ACAD SCI USA, V108, P9709, DOI 10.1073/pnas.1100958108; BERESTETZKY V, 1991, BIOCHEM PHYSIOL PFL, V187, P13, DOI 10.1016/S0015-3796(11)80178-2; Berger S, 1996, PLANT PHYSIOL, V111, P525, DOI 10.1104/pp.111.2.525; Bewley JD, 1997, PLANT CELL, V9, P1055, DOI 10.1105/tpc.9.7.1055; BIALEK K, 1989, PLANT PHYSIOL, V91, P775, DOI 10.1104/pp.91.2.775; BIALEK K, 1992, PLANT PHYSIOL, V100, P509, DOI 10.1104/pp.100.1.509; BIALEK K, 1992, PLANT PHYSIOL, V100, P2002, DOI 10.1104/pp.100.4.2002; Blazejczyk M, 2007, FLEXARRAY VERSION 1; Brady SM, 2003, PLANT J, V34, P67, DOI 10.1046/j.1365-313X.2003.01707.x; Cadman CSC, 2006, PLANT J, V46, P805, DOI 10.1111/j.1365-313X.2006.02738.x; Cao DN, 2006, PLANT PHYSIOL, V142, P509, DOI 10.1104/pp.106.082289; Carrera E, 2008, PLANT J, V53, P214, DOI 10.1111/j.1365-313X.2007.03331.x; Chen KG, 2010, ACTA PHYSIOL PLANT, V32, P789, DOI 10.1007/s11738-010-0464-3; Chibani K, 2006, PLANT PHYSIOL, V142, P1493, DOI 10.1104/pp.106.087452; Chono M, 2006, J EXP BOT, V57, P2421, DOI 10.1093/jxb/erj215; del Pozo JC, 1999, P NATL ACAD SCI USA, V96, P15342, DOI 10.1073/pnas.96.26.15342; Dharmasiri N, 2005, DEV CELL, V9, P109, DOI 10.1016/j.devcel.2005.05.014; Dill A, 2004, PLANT CELL, V16, P1392, DOI 10.1105/tpc.020958; Du Z, 2010, NUCLEIC ACIDS RES, V38, pW64, DOI 10.1093/nar/gkq310; Ellis C, 2002, PLANTA, V215, P549, DOI 10.1007/s00425-002-0787-4; Finch-Savage WE, 2007, PLANT J, V51, P60, DOI 10.1111/j.1365-313X.2007.03118.x; Finch-Savage WE, 2006, NEW PHYTOL, V171, P501, DOI 10.1111/j.1469-8137.2006.01787.x; Finkelstein RR, 2002, CURR OPIN PLANT BIOL, V5, P26, DOI 10.1016/S1369-5266(01)00225-4; Finkelstein R, 2008, ANNU REV PLANT BIOL, V59, P387, DOI 10.1146/annurev.arplant.59.032607.092740; Fujii H, 2009, P NATL ACAD SCI USA, V106, P8380, DOI 10.1073/pnas.0903144106; Gao F, 2012, PLANT BIOTECHNOL J, V10, P465, DOI 10.1111/j.1467-7652.2012.00682.x; Gomez-Cadenas A, 1999, P NATL ACAD SCI USA, V96, P1767, DOI 10.1073/pnas.96.4.1767; Gubler F, 2005, CURR OPIN PLANT BIOL, V8, P183, DOI 10.1016/j.pbi.2005.01.011; Gubler F, 2008, PLANT PHYSIOL, V147, P886, DOI 10.1104/pp.107.115469; Heitz T, 2012, J BIOL CHEM, V287, P6296, DOI 10.1074/jbc.M111.316364; Henderson JT, 2004, PLANT PHYSIOL, V134, P995, DOI 10.1104/pp.103.030148; HILHORST HWM, 1995, SEED SCI RES, V5, P61, DOI 10.1017/S0960258500002634; Holdsworth MJ, 2008, NEW PHYTOL, V179, P33, DOI 10.1111/j.1469-8137.2008.02437.x; Jacobsen JV, 2002, PHYSIOL PLANTARUM, V115, P428, DOI 10.1034/j.1399-3054.2002.1150313.x; JACOBSEN SE, 1993, PLANT CELL, V5, P887, DOI 10.1105/tpc.5.8.887; Jones HD, 1997, PLANT J, V12, P911, DOI 10.1046/j.1365-313X.1997.12040911.x; Kaneko M, 2004, PLANT CELL, V16, P33, DOI 10.1105/tpc.017327; Kanno Y, 2010, PLANT CELL PHYSIOL, V51, P1988, DOI 10.1093/pcp/pcq158; Katagiri T, 2005, PLANT J, V43, P107, DOI 10.1111/j.1365-313X.2005.02431.x; Kazan K, 2008, PLANT PHYSIOL, V146, P1459, DOI 10.1104/pp.107.115717; Kermode AR, 2005, J PLANT GROWTH REGUL, V24, P319, DOI 10.1007/s00344-005-0110-2; Kline KG, 2010, PLANT PHYSIOL, V154, P479, DOI 10.1104/pp.110.160846; KOORNNEEF M, 1980, THEOR APPL GENET, V58, P257, DOI 10.1007/BF00265176; Kucera B, 2005, SEED SCI RES, V15, P281, DOI 10.1079/SSR2005218; Lackman P, 2011, P NATL ACAD SCI USA, V108, P5891, DOI 10.1073/pnas.1103010108; LeClere S, 2002, J BIOL CHEM, V277, P20446, DOI 10.1074/jbc.M111955200; Lefebvre V, 2006, PLANT J, V45, P309, DOI 10.1111/j.1365-313X.2005.02622.x; LEYSER HMO, 1993, NATURE, V364, P161, DOI 10.1038/364161a0; Li CJ, 2012, PLANT CELL ENVIRON, V35, P952, DOI 10.1111/j.1365-3040.2011.02464.x; Lim PO, 2010, J EXP BOT, V61, P1419, DOI 10.1093/jxb/erq010; Linkies A, 2012, PLANT CELL REP, V31, P253, DOI 10.1007/s00299-011-1180-1; Liu PP, 2007, PLANT J, V52, P133, DOI 10.1111/j.1365-313X.2007.03218.x; Liu YX, 2007, PLANT CELL, V19, P433, DOI 10.1105/tpc.106.049221; LIU YQ, 1994, PLANTA, V194, P368, DOI 10.1007/BF00197537; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ljung K, 2002, PLANT MOL BIOL, V50, P309, DOI 10.1023/A:1016024017872; Ma Y, 2009, SCIENCE, V324, P1064, DOI 10.1126/science.1172408; MCCARTY DR, 1991, CELL, V66, P895, DOI 10.1016/0092-8674(91)90436-3; MCCARTY DR, 1989, PLANT CELL, V1, P523, DOI 10.1105/tpc.1.5.523; McGinnis KM, 2003, PLANT CELL, V15, P1120, DOI 10.1105/tpc.010827; McKibbin RS, 2002, P NATL ACAD SCI USA, V99, P10203, DOI 10.1073/pnas.152318599; MORRIS CF, 1989, PLANT PHYSIOL, V90, P643, DOI 10.1104/pp.90.2.643; Nag R, 2005, PLANT MOL BIOL, V59, P821, DOI 10.1007/s11103-005-1387-z; Nakamura S, 2001, J EXP BOT, V52, P875, DOI 10.1093/jexbot/52.357.875; Nakashima K, 2009, PLANT PHYSIOL, V149, P88, DOI 10.1104/pp.108.129791; Nambara E, 2010, SEED SCI RES, V20, P55, DOI 10.1017/S0960258510000012; Ogawa M, 2003, PLANT CELL, V15, P1591, DOI 10.1105/tpc.011650; Okamoto M, 2006, PLANT PHYSIOL, V141, P97, DOI 10.1104/pp.106.079475; Olszewski N, 2002, PLANT CELL, V14, pS61, DOI 10.1105/tpc.010476; Park SY, 2009, SCIENCE, V324, P1068, DOI 10.1126/science.1173041; Penfield S, 2006, CURR BIOL, V16, P2366, DOI 10.1016/j.cub.2006.10.057; Peng JR, 1999, NATURE, V400, P256, DOI 10.1038/22307; Preston J, 2009, PLANT CELL PHYSIOL, V50, P1786, DOI 10.1093/pcp/pcp121; Rampey RA, 2004, PLANT PHYSIOL, V135, P978, DOI 10.1104/pp.104.039677; Rikiishi K, 2010, J CEREAL SCI, V51, P292, DOI 10.1016/j.jcs.2010.01.003; ROUSSELIN P, 1992, THEOR APPL GENET, V85, P213, DOI 10.1007/BF00222862; Saavedra L, 2009, PLANT CELL PHYSIOL, V50, P595, DOI 10.1093/pcp/pcp018; Saeed AI, 2006, METHOD ENZYMOL, V411, P134, DOI 10.1016/S0076-6879(06)11009-5; Schruff MC, 2006, DEVELOPMENT, V133, P251, DOI 10.1242/dev.02194; Schwechheimer C, 2001, SCIENCE, V292, P1379, DOI 10.1126/science.1059776; Seo M, 2006, PLANT J, V48, P354, DOI 10.1111/j.1365-313X.2006.02881.x; Simpson G. M., 1990, SEED DORMANCY GRASSE; Steber CM, 1998, GENETICS, V149, P509; Sun TP, 2004, ANNU REV PLANT BIOL, V55, P197, DOI 10.1146/annurev.arplant.55.031903.141753; Tanaka M, 2008, PLANT PHYSIOL, V146, P149, DOI 10.1104/pp.107.111674; Tiwari SB, 2003, PLANT CELL, V15, P533, DOI 10.1105/tpc.008417; Townley-Smith TF, 2008, CAN J PLANT SCI, V88, P347, DOI 10.4141/CJPS07004; Tyler L, 2004, PLANT PHYSIOL, V135, P1008, DOI 10.1104/pp.104.039578; Ueguchi-Tanaka M, 2005, NATURE, V437, P693, DOI 10.1038/nature04028; Ullah H, 2002, PLANT PHYSIOL, V129, P897, DOI 10.1104/pp.005017; Umezawa T, 2009, P NATL ACAD SCI USA, V106, P17588, DOI 10.1073/pnas.0907095106; Rodriguez MV, 2009, ANN BOT-LONDON, V104, P975, DOI 10.1093/aob/mcp184; WALKERSIMMONS M, 1987, PLANT PHYSIOL, V84, P61, DOI 10.1104/pp.84.1.61; Yamaguchi S, 2008, ANNU REV PLANT BIOL, V59, P225, DOI 10.1146/annurev.arplant.59.032607.092804; Yao Z, 2012, J PLANT PHYSIOL, V169, P1477, DOI 10.1016/j.jplph.2012.06.001; Yildiz K, 2007, ASIAN J CHEM, V19, P1098; Yoshida T, 2006, PLANT PHYSIOL, V140, P115, DOI 10.1104/pp.105.070128; Yoshida T, 2010, PLANT J, V61, P672, DOI 10.1111/j.1365-313X.2009.04092.x; Zhang XR, 2005, GENE DEV, V19, P1532, DOI 10.1101/gad.1318705	104	328	350	30	104	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e56570	10.1371/journal.pone.0056570	http://dx.doi.org/10.1371/journal.pone.0056570			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23468976	Green Published, gold, Green Submitted			2022-12-25	WOS:000315184200108
J	Liu, EK; Yan, CR; Mei, XR; Zhang, YQ; Fan, TL				Liu, Enke; Yan, Changrong; Mei, Xurong; Zhang, Yanqing; Fan, Tinglu			Long-Term Effect of Manure and Fertilizer on Soil Organic Carbon Pools in Dryland Farming in Northwest China	PLOS ONE			English	Article							DIFFERENT CROPPING SYSTEMS; SEQUESTRATION RATES; DEPTH DISTRIBUTION; LOESS PLATEAU; MATTER; TILLAGE; MANAGEMENT; FRACTIONS; DYNAMICS; QUALITY	An understanding of the dynamics of soil organic carbon (SOC) as affected by farming practices is imperative for maintaining soil productivity and mitigating global warming. The objectives of this study were to investigate the effects of long-term fertilization on SOC and SOC fractions for the whole soil profile (0-100 cm) in northwest China. The study was initiated in 1979 in Gansu, China and included six treatments: unfertilized control (CK), nitrogen fertilizer (N), nitrogen and phosphorus (P) fertilizers (NP), straw plus N and P fertilizers (NP+S), farmyard manure (FYM), and farmyard manure plus N and P fertilizers (NP+FYM). Results showed that SOC concentration in the 0-20 cm soil layer increased with time except in the CK and N treatments. Long-term fertilization significantly influenced SOC concentrations and storage to 60 cm depth. Below 60 cm, SOC concentrations and storages were statistically not significant between all treatments. The concentration of SOC at different depths in 0-60 cm soil profile was higher under NP+FYM follow by under NP+S, compared to under CK. The SOC storage in 0-60 cm in NP+FYM, NP+S, FYM and NP treatments were increased by 41.3%, 32.9%, 28.1% and 17.9%, respectively, as compared to the CK treatment. Organic manure plus inorganic fertilizer application also increased labile soil organic carbon pools in 0-60 cm depth. The average concentration of particulate organic carbon (POC), dissolved organic carbon (DOC) and microbial biomass carbon (MBC) in organic manure plus inorganic fertilizer treatments (NP+S and NP+FYM) in 0-60 cm depth were increased by 64.9-91.9%, 42.5-56.9%, and 74.7-99.4%, respectively, over the CK treatment. The POC, MBC and DOC concentrations increased linearly with increasing SOC content. These results indicate that long-term additions of organic manure have the most beneficial effects in building carbon pools among the investigated types of fertilization.	[Liu, Enke; Yan, Changrong; Mei, Xurong; Zhang, Yanqing] Chinese Acad Agr Sci, Inst Environm & Sustainable Dev Agr, Beijing 100193, Peoples R China; [Liu, Enke; Yan, Changrong; Mei, Xurong; Zhang, Yanqing] Minist Agr Peoples Republ China MOA, Key Lab Dryland Farming g Agr, Beijing, Peoples R China; [Fan, Tinglu] Gansu Acad Agr Sci, Dryland Agr Inst, Lanzhou, Gansu, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Environment & Sustainable Development in Agriculture, CAAS; Ministry of Agriculture & Rural Affairs	Yan, CR (corresponding author), Chinese Acad Agr Sci, Inst Environm & Sustainable Dev Agr, Beijing 100193, Peoples R China.	yancr@ieda.org.cn; zhangyq@ieda.org.cn	Seo, Mitsunori/N-9603-2015; Kamiya, Yuji/F-9420-2010; kanno, yuri/C-9211-2017; Ponnusamy, Murugavel/X-5699-2018	Kamiya, Yuji/0000-0003-4415-520X; Ponnusamy, Murugavel/0000-0001-5558-8719; Seo, Mitsunori/0000-0001-8325-7984	National Basic Research Program of China (973 Program) [2012CB955904]; Chinese National Scientific Foundation [31000253, 31170490]; National Key Technologies RD Program [2012BAD09B01]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK085065] Funding Source: NIH RePORTER	National Basic Research Program of China (973 Program)(National Basic Research Program of China); Chinese National Scientific Foundation; National Key Technologies RD Program(National Key Technology R&D Program); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by the National Basic Research Program of China (973 Program) (No.2012CB955904), the Chinese National Scientific Foundation (No. 31000253, 31170490), the 12th five-year plan of the National Key Technologies R&D Program (No. 2012BAD09B01). The authors declare that no additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Black C.A, 1965, AM SOC AGRON MADISON, P482; Blair N, 2006, SOIL TILL RES, V91, P39, DOI 10.1016/j.still.2005.11.001; Bronson KF, 1998, ADV SOIL S, P35; CAMBARDELLA CA, 1992, SOIL SCI SOC AM J, V56, P777, DOI 10.2136/sssaj1992.03615995005600030017x; Chakraborty A, 2011, BIOL FERT SOILS, V47, P227, DOI 10.1007/s00374-010-0509-1; Chan KY, 1997, SOIL SCI SOC AM J, V61, P1376, DOI 10.2136/sssaj1997.03615995006100050013x; Chapman H.D., 1965, METHODS SOIL ANAL 2, P891; Doran JW, 1996, ADV AGRON, V56, P1, DOI 10.1016/S0065-2113(08)60178-9; Dou F, 2008, SOIL SCI SOC AM J, V72, P1445, DOI 10.2136/sssaj2007.0230; Dou F, 2007, SOIL TILL RES, V94, P530, DOI 10.1016/j.still.2006.10.001; FAO-UNESCO, 1988, SOIL MAP WORLD; Gami SK, 2009, SOIL TILL RES, V106, P95, DOI 10.1016/j.still.2009.10.003; Gong W, 2009, GEODERMA, V149, P318, DOI 10.1016/j.geoderma.2008.12.010; GOYAL S, 1992, SOIL BIOL BIOCHEM, V24, P1081, DOI 10.1016/0038-0717(92)90056-4; GREGORICH EG, 1994, CAN J SOIL SCI, V74, P367, DOI 10.4141/cjss94-051; Halvorson AD, 2002, SOIL SCI SOC AM J, V66, P906, DOI 10.2136/sssaj2002.0906; Haynes RJ, 2005, ADV AGRON, V85, P221, DOI 10.1016/S0065-2113(04)85005-3; Janzen HH, 1997, DEV SOIL SCI, V25, P277; Jiang PK, 2006, FOREST ECOL MANAG, V236, P30, DOI 10.1016/j.foreco.2006.06.010; Kalbitz K, 2000, SOIL SCI, V165, P277, DOI 10.1097/00010694-200004000-00001; Kanchikerimath M, 2001, AGR ECOSYST ENVIRON, V86, P155, DOI 10.1016/S0167-8809(00)00280-2; Liang BC, 1998, BIOL FERT SOILS, V26, P88, DOI 10.1007/s003740050348; Liang Q, 2012, NUTR CYCL AGROECOSYS, V92, P21, DOI 10.1007/s10705-011-9469-6; Lorenz K, 2005, ADV AGRON, V88, P35, DOI 10.1016/S0065-2113(05)88002-2; Lou YL, 2011, CATENA, V87, P386, DOI 10.1016/j.catena.2011.07.006; LYNCH JM, 1980, SOIL BIOL BIOCHEM, V12, P547, DOI 10.1016/0038-0717(80)90033-4; Majumder B, 2008, SOIL SCI SOC AM J, V72, P775, DOI 10.2136/sssaj2006.0378; Marschner P, 2003, SOIL BIOL BIOCHEM, V35, P453, DOI 10.1016/S0038-0717(02)00297-3; Melero S, 2009, SOIL TILL RES, V104, P292, DOI 10.1016/j.still.2009.04.001; Nayak AK, 2012, FIELD CROP RES, V127, P129, DOI 10.1016/j.fcr.2011.11.011; OCIO JA, 1991, SOIL BIOL BIOCHEM, V23, P655, DOI 10.1016/0038-0717(91)90079-Y; Ouedraogo E, 2007, SOIL TILL RES, V94, P64, DOI 10.1016/j.still.2006.07.001; Powlson DS, 2012, AGR ECOSYST ENVIRON, V146, P23, DOI 10.1016/j.agee.2011.10.004; Puget P, 2001, SOIL SCI SOC AM J, V65, P771, DOI 10.2136/sssaj2001.653771x; Purakayastha TJ, 2008, GEODERMA, V144, P370, DOI 10.1016/j.geoderma.2007.12.006; Rudrappa L, 2006, SOIL TILL RES, V88, P180, DOI 10.1016/j.still.2005.05.008; Sa JCD, 2009, SOIL TILL RES, V103, P46, DOI 10.1016/j.still.2008.09.003; Saviozzi A, 2001, PLANT SOIL, V233, P251, DOI 10.1023/A:1010526209076; Six J, 2002, PLANT SOIL, V241, P155, DOI 10.1023/A:1016125726789; Su YZ, 2006, NUTR CYCL AGROECOSYS, V75, P285, DOI 10.1007/s10705-006-9034-x; VANCE ED, 1987, SOIL BIOL BIOCHEM, V19, P703, DOI 10.1016/0038-0717(87)90052-6; Verma S, 2007, BIOL FERT SOILS, V44, P235, DOI 10.1007/s00374-007-0207-9; West TO, 2002, SOIL SCI SOC AM J, V66, P1930, DOI 10.2136/sssaj2002.1930; Wu TY, 2005, J PLANT NUTR SOIL SC, V168, P100, DOI 10.1002/jpln.200321295; Xing N., 2001, STUDY DRYLAND AGR N; Xu MG, 2011, BIOL FERT SOILS, V47, P745, DOI 10.1007/s00374-011-0579-8; Zhang WJ, 2009, NUTR CYCL AGROECOSYS, V84, P59, DOI 10.1007/s10705-008-9226-7; Zhang X, 1998, HYDROL PROCESS, V12, P171, DOI 10.1002/(SICI)1099-1085(199801)12:1&lt;171::AID-HYP570&gt;3.0.CO;2-L	48	328	350	30	104	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e56536	10.1371/journal.pone.0056536	http://dx.doi.org/10.1371/journal.pone.0056536			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23468976	Green Submitted, Green Published, gold			2022-12-25	WOS:000315184200099
J	Liu, N; He, S; Ma, L; Ponnusamy, M; Tang, JH; Tolbert, E; Bayliss, G; Zhao, TC; Yan, HD; Zhuang, SG				Liu, Na; He, Song; Ma, Li; Ponnusamy, Murugavel; Tang, Jinhua; Tolbert, Evelyn; Bayliss, George; Zhao, Ting C.; Yan, Haidong; Zhuang, Shougang			Blocking the Class I Histone Deacetylase Ameliorates Renal Fibrosis and Inhibits Renal Fibroblast Activation via Modulating TGF-Beta and EGFR Signaling	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; CHRONIC KIDNEY-DISEASE; OBSTRUCTIVE NEPHROPATHY; INTERSTITIAL FIBROSIS; MOLECULAR-MECHANISMS; CARDIAC-HYPERTROPHY; FACTOR RECEPTOR; ANGIOTENSIN-II; SOLID TUMORS; INJURY	Background: Histone deacetylase (HDAC) inhibitors are promising anti-fibrosis drugs; however, nonselective inhibition of class I and class II HDACs does not allow a detailed elucidation of the individual HDAC functions in renal fibrosis. In this study, we investigated the effect of MS-275, a selective class I HDAC inhibitor, on the development of renal fibrosis in a murine model of unilateral ureteral obstruction (UUO) and activation of cultured renal interstitial fibroblasts. Methods/Findings: The UUO model was established by ligation of the left ureter and the contralateral kidney was used as a control. At seven days after UUO injury, kidney developed fibrosis as indicated by deposition of collagen fibrils and increased expression of collagen I, fibronectin and alpha-smooth muscle actin (alpha-SMA). Administration of MS-275 inhibited all these fibrotic responses and suppressed UUO-induced production of transforming growth factor-beta1 (TGF- beta), increased expression of TGF-beta receptor I, and phosphorylation of Smad-3. MS-275 was also effective in suppressing phosphorylation and expression of epidermal growth factor receptor (EGFR) and its downstream signaling molecule, signal transducer and activator of transcription-3. Moreover, class I HDAC inhibition reduced the number of renal tubular cells arrested in the G2/M phase of the cell cycle, a cellular event associated with TGF-beta1overproduction. In cultured renal interstitial fibroblasts, MS-275 treatment inhibited TGF-beta induced phosphorylation of Smad-3, differentiation of renal fibroblasts to myofibroblasts and proliferation of myofibroblasts. Conclusions and Significance: These results demonstrate that class I HDACs are critically involved in renal fibrogenesis and renal fibroblast activation through modulating TGF-beta and EGFR signaling and suggest that blockade of class I HDAC may be a useful treatment for renal fibrosis.	[Liu, Na; Tang, Jinhua; Yan, Haidong; Zhuang, Shougang] Tongji Univ, Sch Med, Shanghai E Hosp, Dept Nephrol, Shanghai 200092, Peoples R China; [Liu, Na; He, Song; Ma, Li; Ponnusamy, Murugavel; Tang, Jinhua; Tolbert, Evelyn; Bayliss, George; Zhuang, Shougang] Brown Univ, Rhode Isl Hosp, Dept Med, Providence, RI 02903 USA; [Liu, Na; He, Song; Ma, Li; Ponnusamy, Murugavel; Tang, Jinhua; Tolbert, Evelyn; Bayliss, George; Zhuang, Shougang] Brown Univ, Alpert Med Sch, Providence, RI 02912 USA; [He, Song] Shekou Peoples Hosp, Dept Lab Med, Shenzhen, Guangdong, Peoples R China; [Zhao, Ting C.] Boston Univ, Sch Med, Roger William Med Ctr, Dept Surg, Providence, RI USA	Tongji University; Brown University; Lifespan Health Rhode Island; Rhode Island Hospital; Brown University; Boston University; Roger Williams Medical Center	Yan, HD (corresponding author), Tongji Univ, Sch Med, Shanghai E Hosp, Dept Nephrol, Shanghai 200092, Peoples R China.	yhdcmu@sina.com; szhuang@lifespan.org	Seo, Mitsunori/N-9603-2015; Kamiya, Yuji/F-9420-2010; kanno, yuri/C-9211-2017; Ponnusamy, Murugavel/X-5699-2018	Kamiya, Yuji/0000-0003-4415-520X; Ponnusamy, Murugavel/0000-0001-5558-8719; Seo, Mitsunori/0000-0001-8325-7984	National Institutes of Health [DK-085065]; national nature science foundation of China [81270778, 81170638, 81200492]; Pudong New District Foundation of China [PWZxk2010-02]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK085065] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); national nature science foundation of China(National Natural Science Foundation of China (NSFC)); Pudong New District Foundation of China; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grants from the National Institutes of Health (DK-085065 to SZ), the national nature science foundation of China (81270778 to SZ, 81170638 to HY, 81200492 to NL), and Pudong New District Foundation of China (PWZxk2010-02). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Backs J, 2006, CIRC RES, V98, P15, DOI 10.1161/01.RES.0000197782.21444.8f; Bogaard HJ, 2011, AM J RESP CRIT CARE, V183, P1402, DOI 10.1164/rccm.201007-1106OC; Bonner JC, 2004, CYTOKINE GROWTH F R, V15, P255, DOI 10.1016/j.cytogfr.2004.03.006; Boor P, 2010, NAT REV NEPHROL, V6, P643, DOI 10.1038/nrneph.2010.120; Bottinger EP, 2007, SEMIN NEPHROL, V27, P309, DOI 10.1016/j.semnephrol.2007.02.009; Bruzzese F, 2011, J CELL PHYSIOL, V226, P2378, DOI 10.1002/jcp.22574; Cavasin MA, 2012, CIRC RES, V110, P739, DOI 10.1161/CIRCRESAHA.111.258426; Chen JC, 2012, J AM SOC NEPHROL, V23, P215, DOI 10.1681/ASN.2011070645; Choi Y, 2008, EXP MOL MED, V40, P574, DOI 10.3858/emm.2008.40.5.574; Dalgard CL, 2008, CLIN CANCER RES, V14, P3113, DOI 10.1158/1078-0432.CCR-07-4836; Deribe YL, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000576; Dikic I, 2003, BIOCHEM SOC T, V31, P1178; Fraczek J, 2009, J CELL MOL MED, V13, P2990, DOI 10.1111/j.1582-4934.2009.00831.x; Gao YS, 2010, J BIOL CHEM, V285, P11219, DOI 10.1074/jbc.M109.042754; Gilbert RE, 2011, KIDNEY INT, V79, P1312, DOI 10.1038/ki.2011.39; Glasgow E, 2008, ENDOCR-RELAT CANCER, V15, P59, DOI 10.1677/ERC-07-0168; Hemmatazad H, 2009, ARTHRITIS RHEUM-US, V60, P1519, DOI 10.1002/art.24494; Kee HJ, 2006, CIRCULATION, V113, P51, DOI 10.1161/CIRCULATIONAHA.105.559724; Kim HJ, 2011, AM J TRANSL RES, V3, P166; Knipstein J, 2011, EXPERT OPIN INV DRUG, V20, P1455, DOI 10.1517/13543784.2011.613822; Kook H, 2003, J CLIN INVEST, V112, P863, DOI 10.1172/JCI200319137; Lan HY, 2011, INT J BIOL SCI, V7, P1056, DOI 10.7150/ijbs.7.1056; Lan HY, 2011, CONTRIB NEPHROL, V170, P75, DOI 10.1159/000324949; Lautrette A, 2005, NAT MED, V11, P867, DOI 10.1038/nm1275; Liu N, 2012, J AM SOC NEPHROL, V23, P854, DOI 10.1681/ASN.2011050493; Liu N, 2011, J AM SOC NEPHROL, V22, P1064, DOI 10.1681/ASN.2010090956; Liu YH, 2006, KIDNEY INT, V69, P213, DOI 10.1038/sj.ki.5000054; Liu YH, 2011, NAT REV NEPHROL, V7, P684, DOI 10.1038/nrneph.2011.149; Lopez-Hernandez FJ, 2012, CELL TISSUE RES, V347, P141, DOI 10.1007/s00441-011-1275-6; Ma L, 2010, P NATL ACAD SCI USA, V107, P19314, DOI 10.1073/pnas.1010253107; Mannaerts I, 2010, HEPATOLOGY, V51, P603, DOI 10.1002/hep.23334; Marumo T, 2010, AM J PHYSIOL-RENAL, V298, pF133, DOI 10.1152/ajprenal.00400.2009; Miyajima A, 2000, KIDNEY INT, V58, P2301, DOI 10.1046/j.1523-1755.2000.00414.x; MORI S, 1995, J BIOL CHEM, V270, P29447, DOI 10.1074/jbc.270.49.29447; Noronha IL, 2002, NEPHROL DIAL TRANSPL, V17, P363, DOI 10.1093/ndt/17.3.363; Pang MY, 2010, J PHARMACOL EXP THER, V335, P266, DOI 10.1124/jpet.110.168385; Pang MY, 2010, KIDNEY INT, V78, P257, DOI 10.1038/ki.2010.154; Pang MY, 2009, AM J PHYSIOL-RENAL, V297, pF996, DOI 10.1152/ajprenal.00282.2009; Prince HM, 2009, CLIN CANCER RES, V15, P3958, DOI 10.1158/1078-0432.CCR-08-2785; Qi W, 2008, INT J BIOCHEM CELL B, V40, P9, DOI 10.1016/j.biocel.2007.01.006; Ryan QC, 2005, J CLIN ONCOL, V23, P3912, DOI 10.1200/JCO.2005.02.188; Singh BN, 2010, EXPERT REV ANTICANC, V10, P935, DOI [10.1586/era.10.62, 10.1586/ERA.10.62]; Tan JH, 2010, J HEMATOL ONCOL, V3, DOI 10.1186/1756-8722-3-5; Tang XL, 2007, CELL, V131, P93, DOI 10.1016/j.cell.2007.07.034; Terzi F, 2000, J CLIN INVEST, V106, P225, DOI 10.1172/JCI8315; Thiagalingam S, 2003, ANN NY ACAD SCI, V983, P84, DOI 10.1111/j.1749-6632.2003.tb05964.x; Trivedi CM, 2007, NAT MED, V13, P324, DOI 10.1038/nm1552; Van Beneden K, 2011, J AM SOC NEPHROL, V22, P1863, DOI 10.1681/ASN.2010111196; Walkinshaw DR, 2008, J CELL BIOCHEM, V104, P1541, DOI 10.1002/jcb.21746; Wynn TA, 2008, J PATHOL, V214, P199, DOI 10.1002/path.2277; Yang L, 2010, NAT MED, V16, P535, DOI 10.1038/nm.2144; Yuan ZL, 2005, SCIENCE, V307, P269, DOI 10.1126/science.1105166	52	328	350	30	104	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2013	8	1							e54001	10.1371/journal.pone.0054001	http://dx.doi.org/10.1371/journal.pone.0054001			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072OV	23468976	Green Submitted, Green Published, gold			2022-12-25	WOS:000313682700073
J	Sampaio-Silva, F; Magalhaes, T; Carvalho, F; Dinis-Oliveira, RJ; Silvestre, R				Sampaio-Silva, Fernanda; Magalhaes, Teresa; Carvalho, Felix; Dinis-Oliveira, Ricardo Jorge; Silvestre, Ricardo			Profiling of RNA Degradation for Estimation of Post Morterm Interval	PLOS ONE			English	Article							REAL-TIME PCR; MESSENGER-RNA; GENE-EXPRESSION; POSTMORTEM INTERVAL; HOUSEKEEPING GENES; QUALITY-CONTROL; HUMAN BRAIN; RT-PCR; QUANTIFICATION; IDENTIFICATION	An estimation of the post mortem interval (PMI) is frequently touted as the Holy Grail of forensic pathology. During the first hours after death, PMI estimation is dependent on the rate of physical observable modifications including algor, rigor and livor mortis. However, these assessment methods are still largely unreliable and inaccurate. Alternatively, RNA has been put forward as a valuable tool in forensic pathology, namely to identify body fluids, estimate the age of biological stains and to study the mechanism of death. Nevertheless, the attempts to find correlation between RNA degradation and PMI have been unsuccessful. The aim of this study was to characterize the RNA degradation in different post mortem tissues in order to develop a mathematical model that can be used as coadjuvant method for a more accurate PMI determination. For this purpose, we performed an eleven-hour kinetic analysis of total extracted RNA from murine's visceral and muscle tissues. The degradation profile of total RNA and the expression levels of several reference genes were analyzed by quantitative real-time PCR. A quantitative analysis of normalized transcript levels on the former tissues allowed the identification of four quadriceps muscle genes (Actb, Gapdh, Ppia and Srp72) that were found to significantly correlate with PMI. These results allowed us to develop a mathematical model with predictive value for estimation of the PMI (confidence interval of +/-51 minutes at 95%) that can become an important complementary tool for traditional methods.	[Sampaio-Silva, Fernanda; Silvestre, Ricardo] Univ Porto, Inst Mol & Cell Biol IBMC, P-4100 Oporto, Portugal; [Sampaio-Silva, Fernanda; Dinis-Oliveira, Ricardo Jorge; Silvestre, Ricardo] Adv Inst Hlth Sci North, Dept Sci, CESPU, CRL, Gandra, Portugal; [Magalhaes, Teresa; Dinis-Oliveira, Ricardo Jorge] Univ Porto, Fac Med, Dept Legal Med & Forens Sci, P-4100 Oporto, Portugal; [Magalhaes, Teresa; Dinis-Oliveira, Ricardo Jorge] Ctr Forens Sci CENCIFOR, Coimbra, Portugal; [Carvalho, Felix; Dinis-Oliveira, Ricardo Jorge] Univ Porto, Fac Pharm, Dept Biol Sci, REQUIMTE,Lab Toxicol, P-4100 Oporto, Portugal; [Dinis-Oliveira, Ricardo Jorge] Polytech Hlth Inst North, Dept Diagnost & Therapeut Technol, CESPU, CRL, Vila Nova De Famalicao, Portugal; [Magalhaes, Teresa] Natl Inst Legal Med & Forens Sci, North Branch, Oporto, Portugal; [Magalhaes, Teresa] Univ Porto, Biomed Sci Inst Abel Salazar, P-4100 Oporto, Portugal	Universidade do Porto; Universidade do Porto; Universidade de Coimbra; Universidade do Porto; Instituto Nacional de Medicina Legal e Ciencias Forenses, IP; Universidade do Porto	Silvestre, R (corresponding author), Univ Porto, Inst Mol & Cell Biol IBMC, Rua Campo Alegre 823, P-4100 Oporto, Portugal.	rleal@ibmc.up.pt	Magalhães, Teresa/J-7897-2013; Silvestre, Ricardo/C-7243-2011; Carvalho, Félix/D-4914-2013; Dinis-Oliveira, Ricardo Jorge/D-9186-2013	Silvestre, Ricardo/0000-0002-9270-2717; Carvalho, Félix/0000-0003-3858-3494; Dinis-Oliveira, Ricardo Jorge/0000-0001-7430-6297; Magalhaes, Teresa/0000-0002-8098-8076; Sampaio Silva, Fernanda/0000-0002-7936-5154	FCT [SFRH/BPD/36865/2007]; Programa Ciencia; Programa Operacional Potencial Humano POPH, QREN- Tipologia 4.2, Promocao do Emprego Cientifico; Fundo Social Europeu; Ministry of Science, Technology and Higher Education (MCTES)	FCT(Portuguese Foundation for Science and TechnologyEuropean Commission); Programa Ciencia(Spanish Government); Programa Operacional Potencial Humano POPH, QREN- Tipologia 4.2, Promocao do Emprego Cientifico; Fundo Social Europeu; Ministry of Science, Technology and Higher Education (MCTES)	Ricardo Jorge Dinis-Oliveira acknowledges FCT for his Post-Doc grant (SFRH/BPD/36865/2007). Ricardo Silvestre was supported by Programa Ciencia, financed by Programa Operacional Potencial Humano POPH, QREN- Tipologia 4.2, Promocao do Emprego Cientifico, co-funded by Fundo Social Europeu and National funding from Ministry of Science, Technology and Higher Education (MCTES). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson S, 2005, FORENSIC SCI INT, V148, P37, DOI 10.1016/j.forsciint.2004.04.071; Bahar B, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-108; Bauer M, 2007, FORENSIC SCI INT-GEN, V1, P69, DOI 10.1016/j.fsigen.2006.11.002; Bauer M, 2003, FORENSIC SCI INT, V138, P94, DOI 10.1016/j.forsciint.2003.09.008; Bauer Martin, 2003, Leg Med (Tokyo), V5, P220, DOI 10.1016/j.legalmed.2003.08.001; Becker C, 2010, METHODS, V50, P237, DOI 10.1016/j.ymeth.2010.01.010; Bustin SA, 2000, J MOL ENDOCRINOL, V25, P169, DOI 10.1677/jme.0.0250169; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Catts VS, 2005, MOL BRAIN RES, V138, P164, DOI 10.1016/j.molbrainres.2005.04.017; Courts C, 2010, FORENSIC SCI INT, V203, P106, DOI 10.1016/j.forsciint.2010.07.002; de Jonge HJM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000898; de Kok JB, 2005, LAB INVEST, V85, P154, DOI 10.1038/labinvest.3700208; Dheda K, 2004, BIOTECHNIQUES, V37, P112, DOI 10.2144/04371RR03; Dinis-Oliveira RJ, 2010, TOXICOL MECH METHOD, V20, P363, DOI 10.3109/15376516.2010.497976; Draper N.R., 1998, WILEY SERIES PROBABI, V326; Fleige Simone, 2006, Molecular Aspects of Medicine, V27, P126, DOI 10.1016/j.mam.2005.12.003; Fleige S, 2006, BIOTECHNOL LETT, V28, P1601, DOI 10.1007/s10529-006-9127-2; Haas C, 2009, FORENSIC SCI INT-GEN, V3, P80, DOI 10.1016/j.fsigen.2008.11.003; Heinrich M, 2007, INT J LEGAL MED, V121, P136, DOI 10.1007/s00414-006-0131-9; Heinrich M, 2007, FORENSIC SCI INT-GEN, V1, P163, DOI 10.1016/j.fsigen.2007.01.002; Henssge C, 2007, FORENSIC SCI INT, V165, P182, DOI 10.1016/j.forsciint.2006.05.017; Hruz T, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-156; Huggett J, 2005, GENES IMMUN, V6, P279, DOI 10.1038/sj.gene.6364190; HUMPHREYS-BEHER M G, 1986, Biotechnology and Applied Biochemistry, V8, P392; Juusola J, 2005, FORENSIC SCI INT, V152, P1, DOI 10.1016/j.forsciint.2005.02.020; Juusola J, 2007, J FORENSIC SCI, V52, P1252, DOI 10.1111/j.1556-4029.2007.00550.x; Koppelkamm A, 2011, INT J LEGAL MED, V125, P573, DOI 10.1007/s00414-011-0578-1; Koppelkamm A, 2010, INT J LEGAL MED, V124, P371, DOI 10.1007/s00414-010-0433-9; Kouadjo KE, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-127; Liu LJ, 2007, J HUAZHONG U SCI-MED, V27, P362, DOI 10.1007/s11596-007-0404-7; MADEA B, 1994, FORENSIC SCI INT, V69, P221, DOI 10.1016/0379-0738(94)90386-7; Madea B, 2005, FORENSIC SCI INT, V151, P139, DOI 10.1016/j.forsciint.2005.01.013; Nygard AB, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-67; Partemi S, 2010, FORENSIC SCI INT, V203, P99, DOI 10.1016/j.forsciint.2010.07.005; Prahlow J, 2010, FORENSIC PATHOLOGY FOR POLICE, DEATH INVESTIGATORS, ATTORNEYS, AND FORENSIC SCIENTISTS, P1, DOI 10.1007/978-1-59745-404-9; Preece P, 2003, MOL BRAIN RES, V118, P60, DOI 10.1016/S0169-328X(03)00337-1; Sieger J, 2000, ENCY FORENSIC SCI; Silver N, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-33; Stan AD, 2006, BRAIN RES, V1123, P1, DOI 10.1016/j.brainres.2006.09.025; Thellin O, 1999, J BIOTECHNOL, V75, P291, DOI 10.1016/S0168-1656(99)00163-7; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vennemann M, 2010, FORENSIC SCI INT, V203, P71, DOI 10.1016/j.forsciint.2010.07.006; Vennemann M, 2010, FORENSIC SCI INT, V203, P76, DOI 10.1016/j.forsciint.2010.07.007; Weis S, 2007, J NEUROSCI METH, V165, P198, DOI 10.1016/j.jneumeth.2007.06.001; Zhang XZ, 2005, BMC MOL BIOL, V6, DOI 10.1186/1471-2199-6-4; Zhao Dong, 2006, Legal Medicine, V8, P132, DOI 10.1016/j.legalmed.2005.09.001	46	89	93	1	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e56507	10.1371/journal.pone.0056507	http://dx.doi.org/10.1371/journal.pone.0056507			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437149	Green Published, gold			2022-12-25	WOS:000315184200087
J	Yeh, CB; Hsieh, MJ; Lin, CW; Chiou, HL; Lin, PY; Chen, TY; Yang, SF				Yeh, Chao-Bin; Hsieh, Ming-Ju; Lin, Chiao-Wen; Chiou, Hui-Ling; Lin, Pen-Yuan; Chen, Tzy-Yen; Yang, Shun-Fa			The Antimetastatic Effects of Resveratrol on Hepatocellular Carcinoma through the Downregulation of a Metastasis-Associated Protease by SP-1 Modulation	PLOS ONE			English	Article							PLASMINOGEN-ACTIVATOR; ORAL-CANCER; SIGNALING PATHWAY; KAPPA-B; EXPRESSION; INVASION; CELLS; INHIBITION; ANGIOGENESIS; APOPTOSIS	Background: The mortality and morbidity rates from cancer metastasis have not declined in Taiwan, especially because of hepatocellular carcinoma (HCC). Resveratrol has been shown to have benefits such as cardioprotection, providing antioxidative, anti-inflammatory, anti-cancer properties in previous studies. Therefore, HCC cells were subjected to treatment with resveratrol and then analyzed to determine the effects of resveratrol on the migration and invasion. Methodology and Principal Findings: Modified Boyden chamber assays revealed that resveratrol treatment significantly inhibited cell migration and invasion capacities of Huh7 cell lines that have low cytotoxicity in vitro, even at a high concentration of 100 mu M. The results of casein zymography and western blotting revealed that the activities and protein levels of the urokinase-type plasminogen activator (u-PA) were inhibited by resveratrol. Western blot analysis also showed that resveratrol inhibits phosphorylation of JNK1/2. Tests of the mRNA level, real-time PCR, and promoter assays evaluated the inhibitory effects of resveratrol on u-PA expression in HCC cells. The chromatin immunoprecipitation (ChIP) assay showed that reactive in transcription protein of nuclear factor SP-1 was inhibited by resveratrol. Conclusions: Resveratrol inhibits u-PA expression and the metastasis of HCC cells and is a powerful chemopreventive agent. The inhibitory effects were associated with the downregulation of the transcription factors of SP-1 signaling pathways.	[Yeh, Chao-Bin; Chen, Tzy-Yen] Chung Shan Med Univ, Sch Med, Taichung, Taiwan; [Yeh, Chao-Bin] Chung Shan Med Univ, Dept Emergency Med, Taichung, Taiwan; [Yeh, Chao-Bin] Chung Shan Med Univ Hosp, Dept Emergency Med, Taichung, Taiwan; [Hsieh, Ming-Ju; Chiou, Hui-Ling] Chung Shan Med Univ, Sch Med Lab & Biotechnol, Taichung, Taiwan; [Lin, Chiao-Wen] Chung Shan Med Univ, Inst Oral Sci, Taichung, Taiwan; [Lin, Pen-Yuan] Taipei Med Univ, Sch Pharm, Taipei, Taiwan; [Chen, Tzy-Yen] Chung Shan Med Univ Hosp, Dept Internal Med, Taichung, Taiwan; [Yang, Shun-Fa] Chung Shan Med Univ, Inst Med, Taichung, Taiwan; [Yang, Shun-Fa] Chung Shan Med Univ Hosp, Dept Med Res, Taichung, Taiwan	Chung Shan Medical University; Chung Shan Medical University; Chung Shan Medical University; Chung Shan Medical University Hospital; Chung Shan Medical University; Chung Shan Medical University; Taipei Medical University; Chung Shan Medical University; Chung Shan Medical University Hospital; Chung Shan Medical University; Chung Shan Medical University; Chung Shan Medical University Hospital	Chen, TY (corresponding author), Chung Shan Med Univ, Sch Med, Taichung, Taiwan.	cshy042@csh.org.tw; ysf@csmu.edu.tw	Yang, Shun-Fa/AAN-1519-2020; Hsieh, Ming-Ju/GQB-3025-2022	Yang, Shun-Fa/0000-0002-0365-7927; Yeh, Chao-Bin/0000-0002-3978-5576; Ryu, Soojin/0000-0002-7059-0160; Hsieh, Ming-Ju/0000-0001-9726-3234	Chung Shan Medical University Hospital, Taiwan [CSH-2012-C-006]	Chung Shan Medical University Hospital, Taiwan	This study was supported by a research grant from Chung Shan Medical University Hospital, Taiwan (CSH-2012-C-006). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Athar M, 2009, ARCH BIOCHEM BIOPHYS, V486, P95, DOI 10.1016/j.abb.2009.01.018; Bae S, 2011, MOL CELLS, V32, P243, DOI 10.1007/s10059-011-1037-z; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chan CF, 2004, CLIN CANCER RES, V10, P4140, DOI 10.1158/1078-0432.CCR-03-0574; Chen TY, 2011, ANN SURG ONCOL, V18, P2348, DOI 10.1245/s10434-011-1574-x; Chien MH, 2012, FOOD CHEM TOXICOL, V50, P558, DOI 10.1016/j.fct.2011.12.016; Fabre KM, 2011, CANCER BIOL THER, V12, P915, DOI 10.4161/cbt.12.10.17714; Freeman MR, 2011, CANCER BIOL THER, V12, P966, DOI 10.4161/cbt.12.11.18136; Gupta SC, 2010, CANCER METAST REV, V29, P405, DOI 10.1007/s10555-010-9235-2; Hsu WH, 2012, J CELL PHYSIOL, V227, P697, DOI 10.1002/jcp.22777; Johnson WD, 2011, FOOD CHEM TOXICOL, V49, P3319, DOI 10.1016/j.fct.2011.08.023; Kundu JK, 2008, CANCER LETT, V269, P243, DOI 10.1016/j.canlet.2008.03.057; Kunimasa K, 2011, MOL NUTR FOOD RES, V55, P1730, DOI 10.1002/mnfr.201100098; Lee MF, 2011, J AGR FOOD CHEM, V59, P11853, DOI 10.1021/jf202426k; Liu M, 2011, COMMUN INTEGR BIOL, P4382; Mohapatra P, 2011, ONCOL RES, V19, P311, DOI 10.3727/096504011X13079697132844; Nam EH, 2012, CARCINOGENESIS, V33, P563, DOI 10.1093/carcin/bgs005; Piotrowska H., 2011, MUTAT RES, V750, P60; Previdi S, 2010, GYNECOL ONCOL, V118, P182, DOI 10.1016/j.ygyno.2010.03.020; Reddy KB, 2003, CANCER METAST REV, V22, P395, DOI 10.1023/A:1023781114568; Roy S, 2011, OXID MED CELL LONGEV, V2011, DOI 10.1155/2011/703676; Ryu J, 2011, ANTICANCER RES, V31, P4223; Scarlatti F, 2003, FASEB J, V17, P2339, DOI 10.1096/fj.03-0292fje; Szekeres T, 2011, ANN NY ACAD SCI, V1215, P89, DOI 10.1111/j.1749-6632.2010.05864.x; Szekeres T, 2010, PHARM RES-DORDR, V27, P1042, DOI 10.1007/s11095-010-0090-1; Thummarati P, 2012, WORLD J GASTROENTERO, V18, P244, DOI 10.3748/wjg.v18.i3.244; VONDERAHE D, 1988, NUCLEIC ACIDS RES, V16, P7527, DOI 10.1093/nar/16.15.7527; Weng CJ, 2012, CANCER TREAT REV, V38, P76, DOI 10.1016/j.ctrv.2011.03.001; Weng CJ, 2010, ANN SURG ONCOL, V17, P3394, DOI 10.1245/s10434-010-1124-y; Weng CJ, 2009, J AGR FOOD CHEM, V57, P5235, DOI 10.1021/jf900531m; Woo JH, 2004, ONCOGENE, V23, P1845, DOI 10.1038/sj.onc.1207307; Yang SF, 2008, J DENT RES, V87, P401, DOI 10.1177/154405910808700413; Yang SF, 2007, J ETHNOPHARMACOL, V110, P483, DOI 10.1016/j.jep.2006.10.010; Yang SF, 2010, J BIOL CHEM, V285, P29808, DOI 10.1074/jbc.M110.108183; Yang SF, 2010, FOOD CHEM TOXICOL, V48, P1052, DOI 10.1016/j.fct.2010.01.019; Yeh CB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031055	36	51	53	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e56661	10.1371/journal.pone.0056661	http://dx.doi.org/10.1371/journal.pone.0056661			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	24223943	Green Published, gold			2022-12-25	WOS:000315184200133
J	Li, ZY; Xu, ZS; Chen, Y; He, GY; Yang, GX; Chen, M; Li, LC; Ma, YZ				Li, Zhi-Yong; Xu, Zhao-Shi; Chen, Yang; He, Guang-Yuan; Yang, Guang-Xiao; Chen, Ming; Li, Lian-Cheng; Ma, You-Zhi			A Novel Role for Arabidopsis CBL1 in Affecting Plant Responses to Glucose and Gibberellin during Germination and Seedling Development	PLOS ONE			English	Article							SUCROSE-SPECIFIC INDUCTION; SUGAR SIGNAL-TRANSDUCTION; GENE-EXPRESSION; ABSCISIC-ACID; CALCIUM SENSORS; PROTEIN-KINASE; BETA-AMYLASE; BINDING; CA2+; ABA	Glucose and phytohormones such as abscisic acid (ABA), ethylene, and gibberellin (GA) coordinately regulate germination and seedling development. However, there is still inadequate evidence to link their molecular roles in affecting plant responses. Calcium acts as a second messenger in a diverse range of signal transduction pathways. As calcium sensors unique to plants, calcineurin B-like (CBL) proteins are well known to modulate abiotic stress responses. In this study, it was found that CBL1 was induced by glucose in Arabidopsis. Loss-of-function mutant cbl1 exhibited hypersensitivity to glucose and paclobutrazol, a GA biosynthetic inhibitor. Several sugar-responsive and GA biosynthetic gene expressions were altered in the cbl1 mutant. CBL1 protein physically interacted with AKIN beta 1, the regulatory beta subunit of the SnRK1 complex which has a central role in sugar signaling. Our results indicate a novel role for CBL1 in modulating responses to glucose and GA signals.	[Li, Zhi-Yong; Xu, Zhao-Shi; Chen, Yang; Chen, Ming; Li, Lian-Cheng; Ma, You-Zhi] Chinese Acad Agr Sci, Key Lab Biol & Genet Improvement Triticeae Crops, Natl Key Facil Crop Gene Resources & Genet Improv, Inst Crop Sci,Minist Agr, Beijing 100193, Peoples R China; [Li, Zhi-Yong; He, Guang-Yuan; Yang, Guang-Xiao] Huazhong Univ Sci & Technol, Coll Life Sci & Technol, Chinese Natl Ctr Plant Gene Res Wuhan HUST Part, Genet Engn Int Cooperat Base,Chinese Minist Sci &, Wuhan 430074, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Crop Sciences, CAAS; Ministry of Agriculture & Rural Affairs; Huazhong University of Science & Technology	Xu, ZS (corresponding author), Chinese Acad Agr Sci, Key Lab Biol & Genet Improvement Triticeae Crops, Natl Key Facil Crop Gene Resources & Genet Improv, Inst Crop Sci,Minist Agr, Beijing 100193, Peoples R China.	xuzhaoshi@yahoo.com.cn; tuissa_2009@yahoo.com.cn; mayouzhi@yahoo.com.cn	LI, ZHIYONG/AAE-3158-2019; Li, Zhiyong/U-9472-2018	LI, ZHIYONG/0000-0002-2151-5535; Li, Zhiyong/0000-0002-2151-5535	National Transgenic Key Project of MOA [2011ZX08002-002]; International S & T Cooperation Key Projects of MoST [2009DFB30340]	National Transgenic Key Project of MOA; International S & T Cooperation Key Projects of MoST	This research was financially supported by National Transgenic Key Project of MOA (2011ZX08002-002) and International S & T Cooperation Key Projects of MoST (Grant No. 2009DFB30340). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht V, 2003, PLANT J, V36, P457, DOI 10.1046/j.1365-313X.2003.01892.x; Arenas-Huertero F, 2000, GENE DEV, V14, P2085; Avila J, 2012, PLANT PHYSIOL, V159, P1277, DOI 10.1104/pp.112.198432; Baena-Gonzalez E, 2007, NATURE, V448, P938, DOI 10.1038/nature06069; Barker L, 2000, PLANT CELL, V12, P1153, DOI 10.1105/tpc.12.7.1153; Batistic O, 2008, PLANT CELL, V20, P1346, DOI 10.1105/tpc.108.058123; Batistic O, 2012, BBA-GEN SUBJECTS, V1820, P1283, DOI 10.1016/j.bbagen.2011.10.012; Batistic O, 2009, BBA-MOL CELL RES, V1793, P985, DOI 10.1016/j.bbamcr.2008.10.006; BENTSINK L, 2002, ARABIDOPSIS BOOK, P1, DOI DOI 10.1199/TAB.0050; Chan MT, 1998, P NATL ACAD SCI USA, V95, P6543, DOI 10.1073/pnas.95.11.6543; Chen PW, 2006, PLANT CELL, V18, P2326, DOI 10.1105/tpc.105.038844; Cheong YH, 2003, PLANT CELL, V15, P1833, DOI 10.1105/tpc.012393; Cheong YH, 2007, PLANT J, V52, P223, DOI 10.1111/j.1365-313X.2007.03236.x; Crevillen P, 2005, J BIOL CHEM, V280, P8143, DOI 10.1074/jbc.M411713200; D'Angelo C, 2006, PLANT J, V48, P857, DOI 10.1111/j.1365-313X.2006.02921.x; Daviere JM, 2008, CURR OPIN GENET DEV, V18, P295, DOI 10.1016/j.gde.2008.05.004; Dekkers BJW, 2004, PLANTA, V218, P579, DOI 10.1007/s00425-003-1154-9; Finkelstein RR, 2002, CURR OPIN PLANT BIOL, V5, P26, DOI 10.1016/S1369-5266(01)00225-4; Finkelstein RR, 2000, PLANT CELL, V12, P599, DOI 10.1105/tpc.12.4.599; Furuichi T, 2001, PLANT CELL PHYSIOL, V42, P1149, DOI 10.1093/pcp/pce150; Gibson SI, 2005, CURR OPIN PLANT BIOL, V8, P93, DOI 10.1016/j.pbi.2004.11.003; Gibson SI, 2004, J EXP BOT, V55, P253, DOI 10.1093/jxb/erh048; Gibson SI, 2001, BIOCHEM BIOPH RES CO, V280, P196, DOI 10.1006/bbrc.2000.4062; GRIERSON C, 1994, PLANT J, V5, P815, DOI 10.1046/j.1365-313X.1994.5060815.x; Gu ZM, 2008, GENE, V415, P1, DOI 10.1016/j.gene.2008.02.011; Harmon AC, 2000, TRENDS PLANT SCI, V5, P154, DOI 10.1016/S1360-1385(00)01577-6; Harper JF, 2001, TRENDS PLANT SCI, V6, P395, DOI 10.1016/S1360-1385(01)02023-4; Hauvermale AL, 2012, PLANT PHYSIOL, V160, P83, DOI 10.1104/pp.112.200956; Huang CL, 2011, PLANT SCI, V181, P57, DOI 10.1016/j.plantsci.2011.03.011; Huijser C, 2000, PLANT J, V23, P577, DOI 10.1046/j.1365-313x.2000.00822.x; ISHIGURO S, 1994, MOL GEN GENET, V244, P563, DOI 10.1007/BF00282746; JANG JC, 1994, PLANT CELL, V6, P1665, DOI 10.1105/tpc.6.11.1665; Jossier M, 2009, PLANT J, V59, P316, DOI 10.1111/j.1365-313X.2009.03871.x; Koch K, 2004, CURR OPIN PLANT BIOL, V7, P235, DOI 10.1016/j.pbi.2004.03.014; Koch KE, 1996, ANNU REV PLANT PHYS, V47, P509, DOI 10.1146/annurev.arplant.47.1.509; Kolukisaoglu U, 2004, PLANT PHYSIOL, V134, P43, DOI 10.1104/pp.103.033068; Lan WZ, 2011, MOL PLANT, V4, P527, DOI 10.1093/mp/ssr031; Lee SC, 2002, GENE DEV, V16, P646, DOI 10.1101/gad.969002; Leon P, 2003, TRENDS PLANT SCI, V8, P110, DOI 10.1016/S1360-1385(03)00011-6; Li XF, 2009, J INTEGR PLANT BIOL, V51, P513, DOI 10.1111/j.1744-7909.2009.00811.x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu CA, 2002, PLANT CELL, V14, P1963, DOI 10.1105/tpc.001735; Luan S, 2002, PLANT CELL, V14, pS389, DOI 10.1105/tpc.001115; Luan S, 2009, TRENDS PLANT SCI, V14, P37, DOI 10.1016/j.tplants.2008.10.005; Maeo K, 2001, PLANT MOL BIOL, V46, P627, DOI 10.1023/A:1010684908364; Martin T, 1997, PLANT J, V11, P53, DOI 10.1046/j.1365-313X.1997.11010053.x; Mitchum MG, 2006, PLANT J, V45, P804, DOI 10.1111/j.1365-313X.2005.02642.x; Mitsui T, 1999, PLANT CELL PHYSIOL, V40, P884, DOI 10.1093/oxfordjournals.pcp.a029618; Moore B, 2003, SCIENCE, V300, P332, DOI 10.1126/science.1080585; MORELL MK, 1987, PLANT PHYSIOL, V85, P182, DOI 10.1104/pp.85.1.182; Nagira Y, 2006, J PLANT RES, V119, P137, DOI 10.1007/s10265-005-0256-9; Olszewski N, 2002, PLANT CELL, V14, pS61, DOI 10.1105/tpc.010476; Pandey GK, 2004, PLANT CELL, V16, P1912, DOI 10.1105/tpc.021311; Pego JV, 2000, TRENDS PLANT SCI, V5, P531, DOI 10.1016/S1360-1385(00)01783-0; Pierre M, 2007, PLANT CELL, V19, P2804, DOI 10.1105/tpc.107.051870; Polge C, 2008, PLANT PHYSIOL, V148, P1570, DOI 10.1104/pp.108.123026; Polge C, 2007, TRENDS PLANT SCI, V12, P20, DOI 10.1016/j.tplants.2006.11.005; Preuss ML, 2006, J CELL BIOL, V172, P991, DOI 10.1083/jcb.200508116; Price J, 2004, PLANT CELL, V16, P2128, DOI 10.1105/tpc.104.022616; Price J, 2003, PLANT PHYSIOL, V132, P1424, DOI 10.1104/pp.103.020347; Qiu QS, 2002, P NATL ACAD SCI USA, V99, P8436, DOI 10.1073/pnas.122224699; Rolland F, 2006, ANNU REV PLANT BIOL, V57, P675, DOI 10.1146/annurev.arplant.57.032905.105441; Rushton PJ, 1995, PLANT MOL BIOL, V29, P691, DOI 10.1007/BF00041160; SADKA A, 1994, PLANT CELL, V6, P737, DOI 10.1105/tpc.6.5.737; Sanders D, 1999, PLANT CELL, V11, P691, DOI 10.1105/tpc.11.4.691; Sheen J, 1999, CURR OPIN PLANT BIOL, V2, P410, DOI 10.1016/S1369-5266(99)00014-X; Shi JR, 1999, PLANT CELL, V11, P2393, DOI 10.1105/tpc.11.12.2393; Sivak M.N., 1998, ADV FOOD NUTR RES, V41, P1; Smeekens S, 2000, ANNU REV PLANT PHYS, V51, P49, DOI 10.1146/annurev.arplant.51.1.49; Solfanelli C, 2006, PLANT PHYSIOL, V140, P637, DOI 10.1104/pp.105.072579; Sun CX, 2003, PLANT CELL, V15, P2076, DOI 10.1105/tpc.014597; Taniguchi H, 1999, BIOPHYS CHEM, V82, P129, DOI 10.1016/S0301-4622(99)00112-X; Teng S, 2005, PLANT PHYSIOL, V139, P1840, DOI 10.1104/pp.105.066688; Urwin NAR, 1997, PLANT MOL BIOL, V35, P929, DOI 10.1023/A:1005950915499; Walter M, 2004, PLANT J, V40, P428, DOI 10.1111/j.1365-313X.2004.02219.x; Wang MY, 2007, PLANT MOL BIOL, V65, P733, DOI 10.1007/s11103-007-9238-8; Weinl S, 2009, NEW PHYTOL, V184, P517, DOI 10.1111/j.1469-8137.2009.02938.x; Xiao WY, 2000, PLANT MOL BIOL, V44, P451, DOI 10.1023/A:1026501430422; Xu J, 2006, CELL, V125, P1347, DOI 10.1016/j.cell.2006.06.011; Yang TB, 2003, TRENDS PLANT SCI, V8, P505, DOI 10.1016/j.tplants.2003.09.004; Yoo SD, 2007, NAT PROTOC, V2, P1565, DOI 10.1038/nprot.2007.199; Yuan K, 2006, J EXP BOT, V57, P3359, DOI 10.1093/jxb/erl096; Zhou L, 1998, P NATL ACAD SCI USA, V95, P10294, DOI 10.1073/pnas.95.17.10294	83	51	60	2	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e56412	10.1371/journal.pone.0056412	http://dx.doi.org/10.1371/journal.pone.0056412			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	24086647	Green Published, Green Submitted, gold			2022-12-25	WOS:000315184200070
J	Zhang, C; Kong, LX; Liu, Q; Lei, X; Zhu, T; Yin, J; Lin, BR; Deng, ZX; You, DL				Zhang, Chen; Kong, Lingxin; Liu, Qian; Lei, Xuan; Zhu, Tao; Yin, Jun; Lin, Birun; Deng, Zixin; You, Delin			In Vitro Characterization of Echinomycin Biosynthesis: Formation and Hydroxylation of L-Tryptophanyl-S-Enzyme and Oxidation of (2S,3S) beta- Hydroxytryptophan	PLOS ONE			English	Article							MBTH-LIKE PROTEINS; ESCHERICHIA-COLI; CROSS-TALK; ANTIBIOTICS; GENE; 2,3-DIOXYGENASE; THIOCORALINE; ACID; ADENYLATION; SEQUENCE	Quinoxaline-2-carboxylic acid (QXC) and 3-hydroxyquinaldic acid (HQA) feature in quinomycin family and confer anticancer activity. In light of the significant potency against cancer, the biosynthetic gene clusters have been reported from many different Streptomyces strains, and the biosynthetic pathway were proposed mainly based on the in vivo feeding experiment with isotope labeled putative intermediates. Herein we report another gene cluster from Streptomyces griseovariabilis subsp. bandungensis subsp. nov responsible for the biosynthesis of echinomycin (a member of quinomycin family, also named quinomycin A) and presented in vitro evidence to corroborate the previous hypothesis on QXC biosynthesis, showing that only with the assistance of a MbtH-like protein Qui5, did the didomain NRPS protein (Qui18) perform the loading of a L-tryptophan onto its own PCP domain. Particularly, it was found that Qui5 and Qui18 subunits form a functional tetramer through size exclusion chromatography. The subsequent hydroxylation on beta-carbon of the loaded L-tryptophan proved in vitro to be completed by cytochrome P450-dependent hydroxylase Qui15. Importantly, only the Qui18 loaded L-tryptophan can be hydroxylated by Qui15 and the enzyme was inactive on free L-tryptophan. Additionally, the chemically synthesized (2S,3S) b-hydroxytryptophan was detected to be converted by the tryptophan 2,3-dioxygenase Qui17 through LC-MS, which enriched our previous knowledge that tryptophan 2,3-dioxygenase nearly exclusively acted on L-tryptophan and 6-fluoro-tryptophan.	[Zhang, Chen; Kong, Lingxin; Liu, Qian; Lei, Xuan; Zhu, Tao; Yin, Jun; Deng, Zixin; You, Delin] Shanghai Jiao Tong Univ, State Key Lab Microbial Metab, Shanghai 200030, Peoples R China; [Zhang, Chen; Kong, Lingxin; Liu, Qian; Lei, Xuan; Zhu, Tao; Yin, Jun; Deng, Zixin; You, Delin] Shanghai Jiao Tong Univ, Sch Life Sci & Biotechnol, Shanghai 200030, Peoples R China; [Lin, Birun] Guangdong Acad Agr Sci, Inst Plant Protect, Guangzhou, Guangdong, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Guangdong Academy of Agricultural Sciences	You, DL (corresponding author), Shanghai Jiao Tong Univ, State Key Lab Microbial Metab, Shanghai 200030, Peoples R China.	dlyou@sjtu.edu.cn	Moreno, Carlos S/B-3863-2009; Teodoro, George/L-3216-2013	Moreno, Carlos S/0000-0002-5582-0028; Wang, Fusheng/0000-0002-9369-9361	National Science Foundation of China (973 Program); Ministry of Science and Technology (863 Program); Shanghai Municipal Council of Science and Technology	National Science Foundation of China (973 Program)(National Basic Research Program of ChinaNational Natural Science Foundation of China (NSFC)); Ministry of Science and Technology (863 Program); Shanghai Municipal Council of Science and Technology(Shanghai Leading Academic Discipline Project)	This work was supported by grants from the National Science Foundation of China, the Ministry of Science and Technology (973 and 863 Programs), Shanghai Pujiang Program from the Shanghai Municipal Council of Science and Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADDESS KJ, 1994, BIOCHEMISTRY-US, V33, P12386, DOI 10.1021/bi00207a005; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Boll B, 2011, J BIOL CHEM, V286, P36281, DOI 10.1074/jbc.M111.288092; Chen H, 2002, CHEM BIOL, V9, P103, DOI 10.1016/S1074-5521(02)00090-X; Chen HW, 2001, CHEM BIOL, V8, P301, DOI 10.1016/S1074-5521(01)00009-6; Erba E, 1999, BRIT J CANCER, V80, P971, DOI 10.1038/sj.bjc.6690451; Felnagle EA, 2010, BIOCHEMISTRY-US, V49, P8815, DOI 10.1021/bi1012854; Forouhar F, 2007, P NATL ACAD SCI USA, V104, P473, DOI 10.1073/pnas.0610007104; Furuya K, 1998, FEMS MICROBIOL LETT, V168, P243, DOI 10.1111/j.1574-6968.1998.tb13280.x; Gust B, 2003, P NATL ACAD SCI USA, V100, P1541, DOI 10.1073/pnas.0337542100; HUANG CH, 1982, BIOCHEMISTRY-US, V21, P3704, DOI 10.1021/bi00258a028; Kieser T., 2000, PRACTICAL STREPTOMYC, V4362; Koketsu K, 2006, ORG LETT, V8, P4719, DOI 10.1021/ol061738+; Lautru S, 2007, MICROBIOL-SGM, V153, P1405, DOI 10.1099/mic.0.2006/003145-0; Mady ASA, 2011, MOL BIOSYST, V7, P1999, DOI 10.1039/c1mb05044c; Menendez N, 2007, MICROBIOL-SGM, V153, P3061, DOI 10.1099/mic.0.2007/007922-0; NAKANO MM, 1992, MOL GEN GENET, V232, P313, DOI 10.1007/BF00280011; Praseuth AP, 2008, BIOTECHNOL PROGR, V24, P1226, DOI 10.1002/btpr.34; SAMBROOK J, 2000, MOL CLONING LAB MANU; Schmoock G, 2005, J BIOL CHEM, V280, P4339, DOI 10.1074/jbc.M411026200; Sheoran A, 2008, MOL BIOSYST, V4, P622, DOI 10.1039/b801391h; Thackray SJ, 2008, BIOCHEM SOC T, V36, P1120, DOI 10.1042/BST0361120; Watanabe K, 2006, NAT CHEM BIOL, V2, P423, DOI 10.1038/nchembio803; Watanabe K, 2009, J AM CHEM SOC, V131, P9347, DOI 10.1021/ja902261a; Watanabe K, 2009, CURR OPIN CHEM BIOL, V13, P189, DOI 10.1016/j.cbpa.2009.02.012; Zhang WK, 2012, CHEM BIOL, V19, P422, DOI 10.1016/j.chembiol.2012.01.016; Zhang WJ, 2010, BIOCHEMISTRY-US, V49, P9946, DOI 10.1021/bi101539b	27	91	93	1	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2013	8	2							e56772	10.1371/journal.pone.0056772	http://dx.doi.org/10.1371/journal.pone.0056772			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IT	24236209	Green Submitted, Green Published, gold			2022-12-25	WOS:000315186000044
J	Kong, J; Cooper, LAD; Wang, FS; Gao, JJ; Teodoro, G; Scarpace, L; Mikkelsen, T; Schniederjan, MJ; Moreno, CS; Saltz, JH; Brat, DJ				Kong, Jun; Cooper, Lee A. D.; Wang, Fusheng; Gao, Jingjing; Teodoro, George; Scarpace, Lisa; Mikkelsen, Tom; Schniederjan, Matthew J.; Moreno, Carlos S.; Saltz, Joel H.; Brat, Daniel J.			Machine-Based Morphologic Analysis of Glioblastoma Using Whole-Slide Pathology Images Uncovers Clinically Relevant Molecular Correlates	PLOS ONE			English	Article							MICROSCOPY IMAGES; NUCLEAR-STRUCTURE; CLASSIFICATION; OLIGODENDROGLIOMA; SURVIVAL; RECONSTRUCTION; SEGMENTATION; FRAMEWORK; COMPONENT; UPDATE	Pathologic review of tumor morphology in histologic sections is the traditional method for cancer classification and grading, yet human review has limitations that can result in low reproducibility and inter-observer agreement. Computerized image analysis can partially overcome these shortcomings due to its capacity to quantitatively and reproducibly measure histologic structures on a large-scale. In this paper, we present an end-to-end image analysis and data integration pipeline for large-scale morphologic analysis of pathology images and demonstrate the ability to correlate phenotypic groups with molecular data and clinical outcomes. We demonstrate our method in the context of glioblastoma (GBM), with specific focus on the degree of the oligodendroglioma component. Over 200 million nuclei in digitized pathology slides from 117 GBMs in the Cancer Genome Atlas were quantitatively analyzed, followed by multiplatform correlation of nuclear features with molecular and clinical data. For each nucleus, a Nuclear Score (NS) was calculated based on the degree of oligodendroglioma appearance, using a regression model trained from the optimal feature set. Using the frequencies of neoplastic nuclei in low and high NS intervals, we were able to cluster patients into three well-separated disease groups that contained low, medium, or high Oligodendroglioma Component (OC). We showed that machine-based classification of GBMs with high oligodendroglioma component uncovered a set of tumors with strong associations with PDGFRA amplification, proneural transcriptional class, and expression of the oligodendrocyte signature genes MBP, HOXD1, PLP1, MOBP and PDGFRA. Quantitative morphologic features within the GBMs that correlated most strongly with oligodendrocyte gene expression were high nuclear circularity and low eccentricity. These findings highlight the potential of high throughput morphologic analysis to complement and inform human-based pathologic review.	[Kong, Jun; Cooper, Lee A. D.; Wang, Fusheng; Gao, Jingjing; Teodoro, George; Moreno, Carlos S.; Saltz, Joel H.; Brat, Daniel J.] Emory Univ, Ctr Comprehens Informat, Atlanta, GA 30322 USA; [Kong, Jun; Cooper, Lee A. D.; Wang, Fusheng; Teodoro, George; Moreno, Carlos S.; Saltz, Joel H.; Brat, Daniel J.] Emory Univ, Dept Biomed Informat, Atlanta, GA 30322 USA; [Teodoro, George] Georgia Inst Technol, Coll Comp, Atlanta, GA 30332 USA; [Scarpace, Lisa; Mikkelsen, Tom] Henry Ford Hosp, Dept Neurol, Detroit, MI 48202 USA; [Schniederjan, Matthew J.; Moreno, Carlos S.; Brat, Daniel J.] Emory Univ, Dept Pathol & Lab Med, Atlanta, GA 30322 USA; [Moreno, Carlos S.; Brat, Daniel J.] Emory Univ, Winship Canc Inst, Atlanta, GA 30322 USA	Emory University; Emory University; University System of Georgia; Georgia Institute of Technology; Henry Ford Health System; Henry Ford Hospital; Emory University; Emory University	Kong, J (corresponding author), Emory Univ, Ctr Comprehens Informat, Atlanta, GA 30322 USA.	jun.kong@emory.edu	Moreno, Carlos S/B-3863-2009; Teodoro, George/L-3216-2013	Moreno, Carlos S/0000-0002-5582-0028; Wang, Fusheng/0000-0002-9369-9361	PHS from the Clinical and Translational Science Award Program, National Institutes of Health [UL 1RR025008]; National Cancer Institute, National Institutes of Health [HHSN261200800001E]; Georgia Cancer Coalition; Winship Cancer Institute Cancer Center Support Grant [P30 CA138292]	PHS from the Clinical and Translational Science Award Program, National Institutes of Health; National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Georgia Cancer Coalition; Winship Cancer Institute Cancer Center Support Grant	This work was supported in part by PHS Grant UL 1RR025008 from the Clinical and Translational Science Award Program, National Institutes of Health, Contract No. HHSN261200800001E from the National Cancer Institute, National Institutes of Health, the Georgia Cancer Coalition, and the Winship Cancer Institute Cancer Center Support Grant P30 CA138292. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appin CL, 2013, BRAIN PATHOL, V23, P454, DOI 10.1111/bpa.12018; Backlund LM, 2003, CLIN CANCER RES, V9, P4151; Bender R, 2005, STAT MED, V24, P1713, DOI 10.1002/sim.2059; Brat DJ, 2008, J NEURO-ONCOL, V89, P287, DOI 10.1007/s11060-008-9618-1; Chen XW, 2006, IEEE T BIO-MED ENG, V53, P762, DOI 10.1109/TBME.2006.870201; Cooper LAD, 2012, J AM MED INFORM ASSN, V19, P317, DOI 10.1136/amiajnl-2011-000700; Cooper LAD, 2011, I S BIOMED IMAGING, P1624, DOI 10.1109/ISBI.2011.5872714; Cooper LAD, 2010, IEEE T BIO-MED ENG, V57, P2617, DOI 10.1109/TBME.2010.2060338; DAVID H, 2005, LINEAR RANK TESTS SU; Deb P, 2005, NEUROL INDIA, V53, P329; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; FOX J, 2002, ROBUST REGRESSION; Freedman D. A., 2005, STAT MODELS THEORY P; Gupta M, 2005, AM J CLIN PATHOL, V124, P755, DOI 10.1309/6JNX4PA60TQ5U5VG; Hegi ME, 2012, ACTA NEUROPATHOL, V123, P841, DOI 10.1007/s00401-011-0938-4; Hu MX, 2007, LECT NOTES COMPUT SC, V4791, P68; Jain AK, 2000, IEEE T PATTERN ANAL, V22, P4, DOI 10.1109/34.824819; Kong J, 2011, I S BIOMED IMAGING, P2128, DOI 10.1109/ISBI.2011.5872833; Kong J, 2011, IEEE ENG MED BIO, P6605, DOI 10.1109/IEMBS.2011.6091629; Kong J, 2011, IEEE ENG MED BIO, P87, DOI 10.1109/IEMBS.2011.6089903; Kong J, 2011, IEEE T BIO-MED ENG, V58, P3469, DOI 10.1109/TBME.2011.2169256; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; MANTEL NATHAN, 1966, CANCERCHEMOTHERAP REP, V50, P163; *NCI, 2001, HE CANC GEN ATL; Newcombe RG, 1998, STAT MED, V17, P873, DOI 10.1002/(SICI)1097-0258(19980430)17:8<873::AID-SIM779>3.0.CO;2-I; Ohgaki H, 2005, J NEUROPATH EXP NEUR, V64, P479, DOI 10.1093/jnen/64.6.479; PASTORINO S, 2012, P 103 ANN M AM ASS C, V72; PUDIL P, 1994, PATTERN RECOGN LETT, V15, P1119, DOI 10.1016/0167-8655(94)90127-9; Pytel P, 2009, ARCH PATHOL LAB MED, V133, P1062, DOI 10.1043/1543-2165-133.7.1062; Rivals I, 2007, BIOINFORMATICS, V23, P401, DOI 10.1093/bioinformatics/btl633; Roerdink J. B. T. M., 2000, Fundamenta Informaticae, V41, P187; Rohde GK, 2008, CYTOM PART A, V73A, P341, DOI 10.1002/cyto.a.20506; SEBER GAF, 1984, MULTIVARIATE OBSERVA; Smith JS, 2000, J NEUROPATH EXP NEUR, V59, P495, DOI 10.1093/jnen/59.6.495; Tsai A, 2003, IEEE T MED IMAGING, V22, P137, DOI 10.1109/TMI.2002.808355; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Wang W, 2011, IEEE T MED IMAGING, V30, P621, DOI 10.1109/TMI.2010.2089693; Wang W, 2010, CYTOM PART A, V77A, P485, DOI 10.1002/cyto.a.20853	40	91	93	1	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e81049	10.1371/journal.pone.0081049	http://dx.doi.org/10.1371/journal.pone.0081049			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24236209	Green Submitted, Green Published, gold			2022-12-25	WOS:000327254700212
J	Liu, HP; Liu, ZH; Chen, JX; Chen, L; He, X; Zheng, RJ; Yang, H; Song, P; Weng, D; Hu, HL; Fan, L; Xiao, HP; Kaufmann, SHE; Ernst, J; Ge, BX				Liu, Haipeng; Liu, Zhonghua; Chen, Jianxia; Chen, Ling; He, Xin; Zheng, Ruijuan; Yang, Hong; Song, Peng; Weng, Dong; Hu, Haili; Fan, Lin; Xiao, Heping; Kaufmann, Stefan H. E.; Ernst, Joel; Ge, Baoxue			Induction of CCL8/MCP-2 by Mycobacteria through the Activation of TLR2/PI3K/Akt Signaling Pathway	PLOS ONE			English	Article							TUBERCULOUS PLEURAL EFFUSIONS; HELPER T-CELLS; INTERFERON-GAMMA; DIAGNOSTIC UTILITY; UP-REGULATION; HOST DISEASE; PLASMA CCL8; EXPRESSION; MCP-2; RECRUITMENT	Pleural tuberculosis (TB), together with lymphatic TB, constitutes more than half of all extrapulmonary cases. Pleural effusions (PEs) in TB are representative of lymphocytic PEs which are dominated by T cells. However, the mechanism underlying T lymphocytes homing and accumulation in PEs is still incompletely understood. Here we performed a comparative analysis of cytokine abundance in PEs from TB patients and non-TB patients by protein array analysis and observed that MCP-2/CCL8 is highly expressed in the TB-PEs as compared to peripheral blood. Meanwhile, we observed that CCR5, the primary receptor used by MCP-2/CCL8, is mostly expressed on pleural CD4(+) T lymphocytes. Furthermore, we found that infection with either Mycobacterium bovis Bacillus Calmette-Guerin (BCG) or Mycobacterium tuberculosis H37Rv induced production of MCP-2/CCL8 at both transcriptional and protein level in Raw264.7 and THP-1 macrophage cells, mouse peritoneal macrophages as well as human PBMC monocyte-derived macrophages (MDMs). The induction of MCP-2/CCL8 by mycobacteria is dependent on the activation of TLR2/PI3K/Akt and p38 signaling pathway. We conclude that accumulation of MCP-2/CCL8 in TB-PEs may function as a biomarker for TB diagnosis.	[Liu, Haipeng; Liu, Zhonghua; Chen, Jianxia; Zheng, Ruijuan; Ge, Baoxue] Tongji Univ, Sch Med, Shanghai Pulm Hosp, Shanghai TB Key Lab, Shanghai 200092, Peoples R China; [Liu, Haipeng; Yang, Hong; Song, Peng; Weng, Dong; Ge, Baoxue] Tongji Univ, Sch Med, Dept Microbiol & Immunol, Shanghai 200092, Peoples R China; [Liu, Haipeng; Chen, Jianxia; Chen, Ling; He, Xin; Yang, Hong; Song, Peng; Weng, Dong; Ge, Baoxue] Tongji Univ, Sch Med, Shanghai Pulm Hosp, Clin Translat Res Ctr, Shanghai 200092, Peoples R China; [Hu, Haili; Fan, Lin; Xiao, Heping] Tongji Univ, Sch Med, Shanghai Pulm Hosp, TB Dept, Shanghai 200092, Peoples R China; [Kaufmann, Stefan H. E.] Max Planck Inst Infect Biol, Dept Immunol, Berlin, Germany; [Ernst, Joel] NYU, Sch Med, Div Infect Dis, New York, NY USA	Tongji University; Tongji University; Tongji University; Tongji University; Max Planck Society; New York University	Ge, BX (corresponding author), Tongji Univ, Sch Med, Shanghai Pulm Hosp, Shanghai TB Key Lab, Shanghai 200092, Peoples R China.	baoxue_ge@tongji.edu.cn	; Kaufmann, Stefan HE/I-5454-2014	Liu, Haipeng/0000-0002-3338-6291; Kaufmann, Stefan HE/0000-0001-9866-8268	National Natural Science Foundation of China [81200003]; National Basic Research Program of China (973 Program) [2012CB518700]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China (973 Program)(National Basic Research Program of China)	This work was supported in part by a grant from the National Natural Science Foundation of China (81200003); in part by a grant from the National Basic Research Program of China (973 Program 2012CB518700). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ameglio F, 2005, INT J TUBERC LUNG D, V9, P98; ANTONY VB, 1985, J CLIN INVEST, V76, P1514, DOI 10.1172/JCI112131; ANTONY VB, 1983, ACTA CYTOL, V27, P355; Bandow K, 2012, FEBS LETT, V586, P1540, DOI 10.1016/j.febslet.2012.04.018; BARNES PF, 1989, J IMMUNOL, V142, P1114; Baumann MH, 2007, CHEST, V131, P1125, DOI 10.1378/chest.06-2352; Behar SM, 2011, MUCOSAL IMMUNOL, V4, P279, DOI 10.1038/mi.2011.3; BOSSINK AWJ, 1995, BLOOD, V86, P3841, DOI 10.1182/blood.V86.10.3841.bloodjournal86103841; Cooper AM, 2009, ANNU REV IMMUNOL, V27, P393, DOI 10.1146/annurev.immunol.021908.132703; Dheda K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004689; Dietrich J, 2009, APMIS, V117, P440, DOI 10.1111/j.1600-0463.2009.02458.x; Flynn JL, 2011, MUCOSAL IMMUNOL, V4, P271, DOI 10.1038/mi.2011.14; Gong XQ, 1997, J BIOL CHEM, V272, P11682, DOI 10.1074/jbc.272.18.11682; Gopi A, 2007, CHEST, V131, P880, DOI 10.1378/chest.06-2063; Hamm H, 1997, EUR RESPIR J, V10, P1150, DOI 10.1183/09031936.97.10051150; Harding CV, 2010, NAT REV MICROBIOL, V8, P296, DOI 10.1038/nrmicro2321; Huynh KK, 2011, CURR OPIN IMMUNOL, V23, P464, DOI 10.1016/j.coi.2011.06.002; Jiang J, 2007, CHEST, V131, P1133, DOI 10.1378/chest.06-2273; Kohmo S, 2012, TUBERCULOSIS, V92, P248, DOI 10.1016/j.tube.2012.01.001; Kong L, 2008, CELL RES, V18, P745, DOI 10.1038/cr.2008.65; Liang QL, 2008, RESP MED, V102, P744, DOI 10.1016/j.rmed.2007.12.007; Light RW, 2002, NEW ENGL J MED, V346, P1971, DOI 10.1056/NEJMcp010731; Maddocks S, 2009, TUBERCULOSIS, V89, P285, DOI 10.1016/j.tube.2009.05.003; Mege JL, 2011, CURR OPIN INFECT DIS, V24, P230, DOI 10.1097/QCO.0b013e328344b73e; Mitra DK, 2005, EUR J IMMUNOL, V35, P2367, DOI 10.1002/eji.200525977; Moser B, 2001, NAT IMMUNOL, V2, P123, DOI 10.1038/84219; Ota A, 2009, EXP HEMATOL, V37, P525, DOI 10.1016/j.exphem.2008.12.006; Pierer M, 2004, J IMMUNOL, V172, P1256, DOI 10.4049/jimmunol.172.2.1256; Pokkali S, 2008, CYTOKINE, V41, P307, DOI 10.1016/j.cyto.2007.12.009; Porcel JM, 2009, LUNG, V187, P263, DOI 10.1007/s00408-009-9165-3; Ragno S, 2001, IMMUNOLOGY, V104, P99, DOI 10.1046/j.1365-2567.2001.01274.x; Ruffing N, 1998, CELL IMMUNOL, V189, P160, DOI 10.1006/cimm.1998.1379; Ruhwald M, 2008, EUR RESPIR J, V32, P1607, DOI 10.1183/09031936.00055508; Scriba TJ, 2008, J IMMUNOL, V180, P1962, DOI 10.4049/jimmunol.180.3.1962; Sun XG, 2006, INFECT IMMUN, V74, P5943, DOI 10.1128/IAI.00082-06; Supriya P, 2008, DIAGN MICR INFEC DIS, V62, P186, DOI 10.1016/j.diagmicrobio.2008.05.011; Trajman A, 2008, EUR RESPIR J, V31, P1098, DOI 10.1183/09031936.00147507; VANDAMME J, 1994, J IMMUNOL, V152, P5495; Villena V, 2002, ARCH BRONCONEUMOL, V38, P21, DOI 10.1016/S0300-2896(02)75142-9; Wang Ting-ting, 2011, Zhonghua Xue Ye Xue Za Zhi, V32, P592; WANGOO A, 1993, CLIN EXP IMMUNOL, V94, P43; Wu C, 2010, RESPIROLOGY, V15, P522, DOI 10.1111/j.1440-1843.2010.01719.x; Yamamoto M, 2011, EXP HEMATOL, V39, P1101, DOI 10.1016/j.exphem.2011.07.006; Yang WB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040450; Ye ZJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031710; Ye ZJ, 2012, AM J RESP CRIT CARE, V185, P660, DOI 10.1164/rccm.201107-1198OC	46	58	61	1	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e56815	10.1371/journal.pone.0056815	http://dx.doi.org/10.1371/journal.pone.0056815			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418602	Green Published, gold			2022-12-25	WOS:000315970300195
J	Hung, CJ; Wu, CC; Chen, WY; Chang, CY; Kuan, YH; Pan, HC; Liao, SL; Chen, CJ				Hung, Chih-Jen; Wu, Chih-Cheng; Chen, Wen-Ying; Chang, Cheng-Yi; Kuan, Yu-Hsiang; Pan, Hung-Chuan; Liao, Su-Lan; Chen, Chun-Jung			Depression-Like Effect of Prenatal Buprenorphine Exposure in Rats	PLOS ONE			English	Article							ELEMENT-BINDING PROTEIN; OXIDATIVE STRESS; METHADONE TREATMENT; PREFRONTAL CORTEX; POSTMORTEM BRAIN; OPIOID RECEPTOR; GENE-EXPRESSION; SUICIDE VICTIMS; MECHANISMS; INCREASES	Studies indicate that perinatal opioid exposure produces a variety of short-and long-term neurobehavioral consequences. However, the precise modes of action are incompletely understood. Buprenorphine, a mixed agonist/antagonist at the opioid receptors, is currently being used in clinical trials for managing pregnant opioid addicts. This study provides evidence of depression-like consequence following prenatal exposure to supra-therapeutic dose of buprenorphine and sheds light on potential mechanisms of action in a rat model involving administration of intraperitoneal injection to pregnant Sprague-Dawley rats starting from gestation day 7 and lasting for 14 days. Results showed that pups at postnatal day 21 but not the dams had worse parameters of depression-like neurobehaviors using a forced swimming test and tail suspension test, independent of gender. Neurobehavioral changes were accompanied by elevation of oxidative stress, reduction of plasma levels of brain-derived neurotrophic factor (BDNF) and serotonin, and attenuation of tropomyosin-related kinase receptor type B (TrkB) phosphorylation, extracellular signal-regulated kinase (ERK) phosphorylation, protein kinase A activity, cAMP response element-binding protein (CREB) phosphorylation, and CREB DNA-binding activity. Since BDNF/serotonin and CREB signaling could orchestrate a positive feedback loop, our findings suggest that the induction of oxidative stress, reduction of BDNF and serotonin expression, and attenuation of CREB signaling induced by prenatal exposure to supra-therapeutic dose of buprenorphine provide evidence of potential mechanism for the development of depression-like neurobehavior.	[Hung, Chih-Jen; Wu, Chih-Cheng] Taichung Vet Gen Hosp, Dept Anesthesiol, Taichung, Taiwan; [Hung, Chih-Jen; Chen, Chun-Jung] HungKuang Univ, Grad Sch Nursing, Taichung, Taiwan; [Wu, Chih-Cheng] Providence Univ, Dept Financial & Computat Math, Taichung, Taiwan; [Chen, Wen-Ying] Natl Chung Hsing Univ, Dept Vet Med, Taichung 40227, Taiwan; [Chang, Cheng-Yi] Fong Yuan Hosp, Dept Surg, Taichung, Taiwan; [Kuan, Yu-Hsiang] Chung Shan Med Univ, Dept Pharmacol, Taichung, Taiwan; [Pan, Hung-Chuan] Taichung Vet Gen Hosp, Dept Neurosurg, Taichung, Taiwan; [Pan, Hung-Chuan] Natl Yang Ming Univ, Fac Med, Sch Med, Taipei 112, Taiwan; [Liao, Su-Lan; Chen, Chun-Jung] Taichung Vet Gen Hosp, Dept Educ & Res, Taichung, Taiwan; [Chen, Chun-Jung] Natl Chung Hsing Univ, Inst Biomed Sci, Taichung 40227, Taiwan; [Chen, Chun-Jung] Tunghai Univ, Ctr Gen Educ, Taichung 40704, Taiwan	Taichung Veterans General Hospital; Hungkuang University; Providence University - Taiwan; National Chung Hsing University; Chung Shan Medical University; Taichung Veterans General Hospital; National Yang Ming Chiao Tung University; Taichung Veterans General Hospital; National Chung Hsing University; Tunghai University	Chen, CJ (corresponding author), HungKuang Univ, Grad Sch Nursing, Taichung, Taiwan.	cjchen@vghtc.gov.tw	Kuan, Yu-Hsiang/R-1181-2019	Kuan, Yu-Hsiang/0000-0002-8991-6394	Taichung Veterans General Hospital [TCVGH-1007306C]; Yen Tjing Ling Medical Foundation, Taiwan, Republic of China [CI-98-10]	Taichung Veterans General Hospital; Yen Tjing Ling Medical Foundation, Taiwan, Republic of China	This study was supported by grants from Taichung Veterans General Hospital [TCVGH-1007306C] and the Yen Tjing Ling Medical Foundation [CI-98-10], Taiwan, Republic of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alto WA, 2011, AM J OBSTET GYNECOL, V205, P302, DOI 10.1016/j.ajog.2011.04.001; Belmaker RH, 2008, NEW ENGL J MED, V358, P55, DOI [10.1056/NEJMra073096, 10.1038/nrdp.2016.65]; Bhatia HS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028451; Blandthorn J, 2011, WOMEN BIRTH, V24, P32, DOI 10.1016/j.wombi.2010.07.001; Chung CP, 2013, PSYCHIAT RES, V206, P213, DOI 10.1016/j.psychres.2012.10.018; Coyle MG, 2012, ADDICTION, V107, P63, DOI 10.1111/j.1360-0443.2012.04040.x; Dwivedi Y, 2002, AM J PSYCHIAT, V159, P66, DOI 10.1176/appi.ajp.159.1.66; Dwivedi Y, 2001, J NEUROCHEM, V77, P916, DOI 10.1046/j.1471-4159.2001.00300.x; Dwivedi Yogesh, 2008, Neuropsychiatr Dis Treat, V4, P161; Englberger W, 2006, EUR J PHARMACOL, V534, P95, DOI 10.1016/j.ejphar.2006.01.022; Farid WO, 2008, CURR NEUROPHARMACOL, V6, P125, DOI 10.2174/157015908784533842; Guzman DC, 2006, NEUROCHEM RES, V31, P549, DOI 10.1007/s11064-006-9053-7; Hariri AR, 2006, TRENDS COGN SCI, V10, P182, DOI 10.1016/j.tics.2006.02.011; Jansson LM, 2011, NEUROTOXICOL TERATOL, V33, P240, DOI 10.1016/j.ntt.2010.09.003; JARVIS MAE, 1994, J PSYCHOACTIVE DRUGS, V26, P155, DOI 10.1080/02791072.1994.10472263; Kakko J, 2008, DRUG ALCOHOL DEPEN, V96, P69, DOI 10.1016/j.drugalcdep.2008.01.025; Karege F, 2005, MOL BRAIN RES, V136, P29, DOI 10.1016/j.molbrainres.2004.12.020; Krishnan V, 2008, NATURE, V455, P894, DOI 10.1038/nature07455; Lesch KP, 2001, J AFFECT DISORDERS, V62, P57, DOI 10.1016/S0165-0327(00)00351-7; Li J, 2013, EUR J PHARMACOL, V707, P112, DOI 10.1016/j.ejphar.2013.03.010; Liebenberg N, 2011, NEUROSCI LETT, V498, P158, DOI 10.1016/j.neulet.2011.05.004; Lund IO, 2013, SUBST ABUS-RES TREAT, V7, P61, DOI 10.4137/SART.S10955; Malanga CJ, 1999, CLIN PERINATOL, V26, P17, DOI 10.1016/S0095-5108(18)30070-8; Marquez P, 2007, NEUROPHARMACOLOGY, V52, P1336, DOI 10.1016/j.neuropharm.2007.01.005; Ng F, 2008, INT J NEUROPSYCHOPH, V11, P851, DOI 10.1017/S1461145707008401; Ozcan ME, 2004, INT CLIN PSYCHOPHARM, V19, P89, DOI 10.1097/01.yic.0000110796.97676.89; Pandey GN, 2007, INT J NEUROPSYCHOPH, V10, P621, DOI 10.1017/S1461145706007231; Patapoutian A, 2001, CURR OPIN NEUROBIOL, V11, P272, DOI 10.1016/S0959-4388(00)00208-7; Pettit AS, 2012, NEUROSCIENCE, V200, P211, DOI 10.1016/j.neuroscience.2011.10.039; Qi XL, 2008, NEUROBIOL DIS, V31, P278, DOI 10.1016/j.nbd.2008.05.003; Reus GZ, 2011, BEHAV BRAIN RES, V221, P166, DOI 10.1016/j.bbr.2011.02.024; Robinson SE, 2002, NEUROTOXICOL TERATOL, V24, P137, DOI 10.1016/S0892-0362(01)00185-4; ROUNSAVILLE BJ, 1982, ARCH GEN PSYCHIAT, V39, P151; Sanchez ES, 2008, GLIA, V56, P1017, DOI 10.1002/glia.20675; Shirayama Y, 2002, J NEUROSCI, V22, P3251, DOI 10.1523/JNEUROSCI.22-08-03251.2002; Tardito D, 2006, PHARMACOL REV, V58, P115, DOI 10.1124/pr.58.1.7; Velez ML, 2009, PEDIATR RES, V66, P704, DOI 10.1203/PDR.0b013e3181bc035d; Walsh SL, 2003, DRUG ALCOHOL DEPEN, V70, pS13, DOI 10.1016/S0376-8716(03)00056-5; Wu VW, 2001, EUR J PHARMACOL, V414, P211, DOI 10.1016/S0014-2999(01)00807-X; Xuan AG, 2012, LIFE SCI, V90, P463, DOI 10.1016/j.lfs.2012.01.001; Zhang LL, 2011, NEUROSCIENCE, V196, P203, DOI 10.1016/j.neuroscience.2011.08.069	41	55	55	0	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2013	8	12							e82262	10.1371/journal.pone.0082262	http://dx.doi.org/10.1371/journal.pone.0082262			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276HL	24367510	Green Submitted, Green Published, gold			2022-12-25	WOS:000328740300026
J	Srinivasan, K; Raman, R; Jayaraman, A; Viswanathan, K; Sasisekharan, R				Srinivasan, Karunya; Raman, Rahul; Jayaraman, Akila; Viswanathan, Karthik; Sasisekharan, Ram			Quantitative Description of Glycan-Receptor Binding of Influenza A Virus H7 Hemagglutinin	PLOS ONE			English	Article							RESPIRATORY DROPLET TRANSMISSION	In the context of recently emerged novel influenza strains through reassortment, avian influenza subtypes such as H5N1, H7N7, H7N2, H7N3 and H9N2 pose a constant threat in terms of their adaptation to the human host. Among these subtypes, it was recently demonstrated that mutations in H5 and H9 hemagglutinin (HA) in the context of lab-generated reassorted viruses conferred aerosol transmissibility in ferrets (a property shared by human adapted viruses). We previously demonstrated that the quantitative binding affinity of HA to alpha 2 -> 6 sialylated glycans (human receptors) is one of the important factors governing human adaptation of HA. Although the H7 subtype has infected humans causing varied clinical outcomes from mild conjunctivitis to severe respiratory illnesses, it is not clear where the HA of these subtypes stand in regard to human adaptation since its binding affinity to glycan receptors has not yet been quantified. In this study, we have quantitatively characterized the glycan receptor-binding specificity of HAs from representative strains of Eurasian (H7N7) and North American (H7N2) lineages that have caused human infection. Furthermore, we have demonstrated for the first time that two specific mutations; Gln226 -> Leu and Gly228 -> Ser in glycan receptor-binding site of H7 HA substantially increase its binding affinity to human receptor. Our findings contribute to a framework for monitoring the evolution of H7 HA to be able to adapt to human host.	[Srinivasan, Karunya; Raman, Rahul; Jayaraman, Akila; Viswanathan, Karthik; Sasisekharan, Ram] MIT, Dept Biol Engn, Singapore MIT Alliance Res & Technol, Koch Inst Integrat Canc Res,Harvard MIT Div Hlth, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Singapore-MIT Alliance for Research & Technology Centre (SMART)	Sasisekharan, R (corresponding author), MIT, Dept Biol Engn, Singapore MIT Alliance Res & Technol, Koch Inst Integrat Canc Res,Harvard MIT Div Hlth, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	rams@mit.edu			National Institutes of Health [GM R37 GM057073-13]; Singapore - MIT Alliance for Research and Technology (SMART); NATIONAL CANCER INSTITUTE [P30CA014051] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM057073] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Singapore - MIT Alliance for Research and Technology (SMART); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health GM R37 GM057073-13 and in part by the Singapore - MIT Alliance for Research and Technology (SMART). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belser JA, 2008, P NATL ACAD SCI USA, V105, P7558, DOI 10.1073/pnas.0801259105; Belser JA, 2009, J VIROL, V83, P7075, DOI 10.1128/JVI.00535-09; Chen LM, 2012, VIROLOGY, V422, P105, DOI 10.1016/j.virol.2011.10.006; de Wit E, 2008, VACCINE, V26, pD54, DOI 10.1016/j.vaccine.2008.07.072; Fouchier RAM, 2004, P NATL ACAD SCI USA, V101, P1356, DOI 10.1073/pnas.0308352100; Gambaryan AS, 2012, J VIROL, V86, P4370, DOI 10.1128/JVI.06959-11; Ge SQ, 2011, CRIT REV MICROBIOL, V37, P157, DOI 10.3109/1040841X.2010.536523; Herfst S, 2012, SCIENCE, V336, P1534, DOI 10.1126/science.1213362; Imai M, 2012, NATURE, V486, P420, DOI 10.1038/nature10831; Jayaraman A, 2012, PLOS ONE IN PRESS; Jayaraman A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017616; Jonges M, 2011, J VIROL, V85, P10598, DOI 10.1128/JVI.05369-11; Kimble JB, 2011, P NATL ACAD SCI USA, V108, P12084, DOI 10.1073/pnas.1108058108; Maines TR, 2011, VIROLOGY, V413, P139, DOI 10.1016/j.virol.2011.02.015; Matrosovich MN, 2004, P NATL ACAD SCI USA, V101, P4620, DOI 10.1073/pnas.0308001101; Medina RA, 2011, NAT REV MICROBIOL, V9, P590, DOI 10.1038/nrmicro2613; Neumann G, 2009, NATURE, V459, P931, DOI 10.1038/nature08157; Pappas C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011158; Pearce MB, 2012, P NATL ACAD SCI USA, V109, P3944, DOI 10.1073/pnas.1119945109; Peiris JSM, 2009, REV SCI TECH OIE, V28, P161, DOI 10.20506/rst.28.1.1871; Shriver Z, 2009, CHEM BIOL, V16, P803, DOI 10.1016/j.chembiol.2009.08.002; Sorrell EM, 2009, P NATL ACAD SCI USA, V106, P7565, DOI 10.1073/pnas.0900877106; Srinivasan A, 2008, P NATL ACAD SCI USA, V105, P2800, DOI 10.1073/pnas.0711963105; Viswanathan K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013768; Yang H, 2012, J VIROL, V86, P8645, DOI 10.1128/JVI.00281-12; Yang H, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001081; Yang H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008905	27	67	81	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e49597	10.1371/journal.pone.0049597	http://dx.doi.org/10.1371/journal.pone.0049597			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23626667	Green Published, gold, Green Submitted			2022-12-25	WOS:000315184200001
J	Hung, CM; Lin, RC; Chu, JH; Yeh, CF; Yao, CJ; Li, SH				Hung, Chih-Ming; Lin, Rong-Chien; Chu, Jui-Hua; Yeh, Chia-Fen; Yao, Chiou-Ju; Li, Shou-Hsien			The De Novo Assembly of Mitochondrial Genomes of the Extinct Passenger Pigeon (Ectopistes migratorius) with Next Generation Sequencing	PLOS ONE			English	Article							ANCIENT DNA; NUCLEAR GENOME; AMPLIFICATION; MTDNA	The information from ancient DNA (aDNA) provides an unparalleled opportunity to infer phylogenetic relationships and population history of extinct species and to investigate genetic evolution directly. However, the degraded and fragmented nature of aDNA has posed technical challenges for studies based on conventional PCR amplification. In this study, we present an approach based on next generation sequencing to efficiently sequence the complete mitochondrial genome (mitogenome) of two extinct passenger pigeons (Ectopistes migratorius) using de novo assembly of massive short (90 bp), paired-end or single-end reads. Although varying levels of human contamination and low levels of postmortem nucleotide lesion were observed, they did not impact sequencing accuracy. Our results demonstrated that the de novo assembly of shotgun sequence reads could be a potent approach to sequence mitogenomes, and offered an efficient way to infer evolutionary history of extinct species.	[Hung, Chih-Ming] Univ Minnesota, Bell Museum, St Paul, MN 55108 USA; [Hung, Chih-Ming] Univ Minnesota, Dept Ecol Evolut & Behav, St Paul, MN 55108 USA; [Hung, Chih-Ming; Lin, Rong-Chien; Chu, Jui-Hua; Yeh, Chia-Fen; Li, Shou-Hsien] Natl Taiwan Normal Univ, Dept Life Sci, Taipei, Taiwan; [Yao, Chiou-Ju] Natl Museum Nat Sci, Dept Biol, Taichung, Taiwan	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; National Taiwan Normal University	Li, SH (corresponding author), Natl Taiwan Normal Univ, Dept Life Sci, Taipei, Taiwan.	t43028@ntnu.edu.tw	Kuan, Yu-Hsiang/R-1181-2019	Kuan, Yu-Hsiang/0000-0002-8991-6394	National Science Council of Taiwan	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan)	This project is funded by the National Science Council of Taiwan to SHL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Axelsson E, 2008, MOL BIOL EVOL, V25, P2181, DOI 10.1093/molbev/msn163; Binladen J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000197; Briggs AW, 2009, SCIENCE, V325, P318, DOI 10.1126/science.1174462; Brotherton P, 2007, NUCLEIC ACIDS RES, V35, P5717, DOI 10.1093/nar/gkm588; Cassista S, 2009, UNDERGRADUATE J ANTH, V1, P141; Catling Paul M., 2001, Biodiversity, V2, P2; COLLURA RV, 1995, NATURE, V378, P485, DOI 10.1038/378485a0; Dalen L, 2007, P NATL ACAD SCI USA, V104, P6726, DOI 10.1073/pnas.0701341104; de Moraes-Barros N, 2007, GENET MOL BIOL, V30, P1181, DOI 10.1590/S1415-47572007000600024; Edwards CJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009255; Ermini L, 2008, CURR BIOL, V18, P1687, DOI 10.1016/j.cub.2008.09.028; Gilbert MTP, 2008, P NATL ACAD SCI USA, V105, P8327, DOI 10.1073/pnas.0802315105; Gilbert MTP, 2007, SCIENCE, V317, P1927, DOI 10.1126/science.1146971; Gilbert MTP, 2003, AM J HUM GENET, V72, P48, DOI 10.1086/345379; Gregory T.R., 2005, ANIMAL GENOME SIZE D; Ho SYW, 2010, MITOCHONDRION, V10, P1, DOI 10.1016/j.mito.2009.09.005; Kan XZ, 2010, GENET MOL RES, V9, P1234, DOI 10.4238/vol9-2gmr853; Knapp M, 2010, GENES-BASEL, V1, P227, DOI 10.3390/genes1020227; Krause J, 2006, NATURE, V439, P724, DOI 10.1038/nature04432; Lambert DM, 2002, SCIENCE, V295, P2270, DOI 10.1126/science.1068105; Leonard JA, 2008, MOL ECOL, V17, P4186, DOI 10.1111/j.1365-294X.2008.03891.x; Lindqvist C, 2010, P NATL ACAD SCI USA, V107, P5053, DOI 10.1073/pnas.0914266107; LOPEZ JV, 1994, J MOL EVOL, V39, P174; Luo CW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030087; Millar CD, 2008, TRENDS ECOL EVOL, V23, P386, DOI 10.1016/j.tree.2008.04.002; Miller W, 2008, NATURE, V456, P387, DOI 10.1038/nature07446; Miller W, 2009, GENOME RES, V19, P213, DOI 10.1101/gr.082628.108; Morin PA, 2010, GENOME RES, V20, P908, DOI 10.1101/gr.102954.109; Nee S, 1997, SCIENCE, V278, P692, DOI 10.1126/science.278.5338.692; Oskam CL, 2010, P ROY SOC B-BIOL SCI, V277, P1991, DOI 10.1098/rspb.2009.2019; Paabo S, 2004, ANNU REV GENET, V38, P645, DOI 10.1146/annurev.genet.37.110801.143214; Pacheco MA, 2011, MOL BIOL EVOL, V28, P1927, DOI 10.1093/molbev/msr014; Poinar HN, 2006, SCIENCE, V311, P392, DOI 10.1126/science.1123360; Poulakakis N, 2008, P NATL ACAD SCI USA, V105, P15464, DOI 10.1073/pnas.0805340105; Quail MA, 2008, NAT METHODS, V5, P1005, DOI 10.1038/nmeth.1270; Rawlence NJ, 2009, P ROY SOC B-BIOL SCI, V276, P3395, DOI 10.1098/rspb.2009.0755; Rohland N, 2004, BIOTECHNIQUES, V36, P814, DOI 10.2144/04365ST05; Rowe KC, 2011, MOL ECOL RESOUR, V11, P1082, DOI 10.1111/j.1755-0998.2011.03052.x; Schorger A, 1955, PASSENGER PIGEON; Shapiro B, 2004, SCIENCE, V306, P1561, DOI 10.1126/science.1101074; Shapiro B, 2002, SCIENCE, V295, P1683, DOI 10.1126/science.295.5560.1683; Stiller M, 2009, GENOME RES, V19, P1843, DOI 10.1101/gr.095760.109	42	55	55	0	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e56301	10.1371/journal.pone.0056301	http://dx.doi.org/10.1371/journal.pone.0056301			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	24367510	Green Submitted, Green Published, gold			2022-12-25	WOS:000315184200057
J	Liu, Y; Luo, HS; Liang, CB; Xia, H; Xu, WJ; Chen, JH; Chen, MK				Liu, Ying; Luo, Hesheng; Liang, Chengbo; Xia, Hong; Xu, Wenjuan; Chen, Jihong; Chen, Mingkai			Actions of Hydrogen Sulfide and ATP-Sensitive Potassium Channels on Colonic Hypermotility in a Rat Model of Chronic Stress	PLOS ONE			English	Article							SMOOTH-MUSCLE-CELLS; IRRITABLE-BOWEL-SYNDROME; ENTERIC NERVOUS-SYSTEM; K+ CHANNELS; GASTROINTESTINAL-TRACT; VISCERAL HYPERSENSITIVITY; CALCIUM-CHANNELS; IN-VITRO; MOTILITY; COLITIS	Objective: To investigate the potential role of hydrogen sulphide (H2S) and ATP-sensitive potassium (K-ATP) channels in chronic stress-induced colonic hypermotility. Methods: Male Wistar rats were submitted daily to 1 h of water avoidance stress (WAS) or sham WAS (SWAS) for 10 consecutive days. Organ bath recordings, H2S production, immunohistochemistry and western blotting were performed on rat colonic samples to investigate the role of endogenous H2S in repeated WAS-induced hypermotility. Organ bath recordings and western blotting were used to detect the role of K-ATP channels in repeated WAS. Results: Repeated WAS increased the number of fecal pellets per hour and the area under the curve of the spontaneous contractions of colonic strips, and decreased the endogenous production of H2S and the expression of H2S-producing enzymes in the colon devoid of mucosa and submucosa. Inhibitors of H2S-producing enzymes increased the contractile activity of colonic strips in the SWAS rats. NaHS concentration-dependently inhibited the spontaneous contractions of the strips and the NaHS IC50 for the WAS rats was significantly lower than that for the SWAS rats. The inhibitory effect of NaHS was significantly reduced by glybenclamide. Repeated WAS treatment resulted in up-regulation of Kir6.1 and SUR2B of K-ATP channels in the colon devoid of mucosa and submucosa. Conclusion: The colonic hypermotility induced by repeated WAS may be associated with the decreased production of endogenous H2S. The increased expression of the subunits of K-ATP channels in colonic smooth muscle cells may be a defensive response to repeated WAS. H2S donor may have potential clinical utility in treating chronic stress-induced colonic hypermotility.	[Liu, Ying; Luo, Hesheng; Liang, Chengbo; Xia, Hong; Xu, Wenjuan; Chen, Jihong; Chen, Mingkai] Wuhan Univ, Renmin Hosp, Dept Gastroenterol, Wuhan 430072, Peoples R China; [Liu, Ying] Guilin Med Coll, Affiliated Hosp, Dept Gastroenterol, Guilin, Peoples R China	Wuhan University; Guilin Medical University	Luo, HS (corresponding author), Wuhan Univ, Renmin Hosp, Dept Gastroenterol, Wuhan 430072, Peoples R China.	xhkhsluo@126.com		Chen, Mingkai/0000-0001-6771-0523; Chen, Mingkai/0000-0003-2652-6863	National Natural Science Foundation of China [81070297]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (No. 81070297). The URL of the funder's website is http://www.nsfc.gov.cn/Portal0/default152.htm. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ataka K, 2012, AM J PHYSIOL-GASTR L, V303, pG519, DOI 10.1152/ajpgi.00390.2011; Bradesi S, 2005, AM J PHYSIOL-GASTR L, V289, pG42, DOI 10.1152/ajpgi.00500.2004; Bulbul M, 2012, AM J PHYSIOL-GASTR L, V302, pG702, DOI 10.1152/ajpgi.00447.2011; Choudhury BK, 2009, AM J PHYSIOL-GASTR L, V296, pG1238, DOI 10.1152/ajpgi.90712.2008; Dhaese I, 2010, EUR J PHARMACOL, V628, P179, DOI 10.1016/j.ejphar.2009.11.024; Dhaese I, 2009, EUR J PHARMACOL, V606, P180, DOI 10.1016/j.ejphar.2009.01.011; Distrutti E, 2006, J PHARMACOL EXP THER, V316, P325, DOI 10.1124/jpet.105.091595; Fiorucci S, 2007, BRIT J PHARMACOL, V150, P996, DOI 10.1038/sj.bjp.0707193; Fiorucci S, 2006, GASTROENTEROLOGY, V131, P259, DOI 10.1053/j.gastro.2006.02.033; Flagg TP, 2010, PHYSIOL REV, V90, P799, DOI 10.1152/physrev.00027.2009; Gallego D, 2008, NEUROGASTROENT MOTIL, V20, P1306, DOI 10.1111/j.1365-2982.2008.01201.x; Gil V, 2011, BRIT J PHARMACOL, V164, P485, DOI 10.1111/j.1476-5381.2011.01431.x; Hansen MB, 2003, PHARMACOL TOXICOL, V92, P249, DOI 10.1034/j.1600-0773.2003.920601.x; Hennig B, 2009, BRIT J PHARMACOL, V158, P1263, DOI 10.1111/j.1476-5381.2009.00385.x; Hosoki R, 1997, BIOCHEM BIOPH RES CO, V237, P527, DOI 10.1006/bbrc.1997.6878; Jimenez M, 2010, NEUROGASTROENT MOTIL, V22, P1149, DOI 10.1111/j.1365-2982.2010.01600.x; Jin XC, 2004, AM J PHYSIOL-GASTR L, V287, pG274, DOI 10.1152/ajpgi.00472.2003; Jun JY, 2001, AM J PHYSIOL-CELL PH, V281, pC857, DOI 10.1152/ajpcell.2001.281.3.C857; Kasparek MS, 2012, J SURG RES, V175, P234, DOI 10.1016/j.jss.2011.03.069; Koh SD, 1998, BIOPHYS J, V75, P1793, DOI 10.1016/S0006-3495(98)77621-0; Konturek PC, 2011, J PHYSIOL PHARMACOL, V62, P591; Leffler CW, 2006, J APPL PHYSIOL, V100, P1065, DOI 10.1152/japplphysiol.00793.2005; Li QJ, 2011, AM J PHYSIOL-GASTR L, V300, pG154, DOI 10.1152/ajpgi.00393.2010; Liang CB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031774; Linden DR, 2008, J NEUROCHEM, V106, P1577, DOI 10.1111/j.1471-4159.2008.05502.x; Linden DR, 2010, ANTIOXID REDOX SIGN, V12, P1135, DOI 10.1089/ars.2009.2885; Martin GR, 2010, DIGEST LIVER DIS, V42, P103, DOI 10.1016/j.dld.2009.05.016; Paravicini TM, 2003, CLIN EXP PHARMACOL P, V30, P855, DOI 10.1046/j.1440-1681.2003.03920.x; Pluja L, 1998, CAN J PHYSIOL PHARM, V76, P1166, DOI 10.1139/cjpp-76-12-1166; Szabo C, 2007, NAT REV DRUG DISCOV, V6, P917, DOI 10.1038/nrd2425; Teague B, 2002, BRIT J PHARMACOL, V137, P139, DOI 10.1038/sj.bjp.0704858; Teramoto N, 2006, J PHYSIOL-LONDON, V572, P617, DOI 10.1113/jphysiol.2006.105973; Tian XY, 2006, BRAIN RES, V1088, P101, DOI 10.1016/j.brainres.2006.03.014; Wallace JL, 2007, FASEB J, V21, P4070, DOI 10.1096/fj.07-8669com; Wallace JL, 2009, GASTROENTEROLOGY, V137, P569, DOI 10.1053/j.gastro.2009.04.012; Xu GY, 2009, MOL PAIN, V5, DOI 10.1186/1744-8069-5-44; Zhang M, 2010, NEUROGASTROENT MOTIL, V22, pe162, DOI 10.1111/j.1365-2982.2009.01467.x; Zhao P, 2009, EUR J PHARMACOL, V616, P223, DOI 10.1016/j.ejphar.2009.05.014	38	130	141	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2013	8	2							e55853	10.1371/journal.pone.0055853	http://dx.doi.org/10.1371/journal.pone.0055853			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092WJ	23437170	Green Submitted, Green Published, gold			2022-12-25	WOS:000315153400167
J	Zhang, DY; Ali, Z; Wang, CB; Xu, L; Yi, JX; Xu, ZL; Liu, XQ; He, XL; Huang, YH; Khan, IA; Trethowan, RM; Ma, HX				Zhang, Da Yong; Ali, Zulfiqar; Wang, Chang Biao; Xu, Ling; Yi, Jin Xin; Xu, Zhao Long; Liu, Xiao Qing; He, Xiao Lan; Huang, Yi Hong; Khan, Iqrar Ahmad; Trethowan, Richard M.; Ma, Hong Xiang			Genome-Wide Sequence Characterization and Expression Analysis of Major Intrinsic Proteins in Soybean (Glycine max L.)	PLOS ONE			English	Article							INTEGRAL MEMBRANE-PROTEIN; PLANT AQUAPORINS; PLASMA-MEMBRANE; WATER TRANSPORT; GENE FAMILY; ARABIDOPSIS; IDENTIFICATION; CHANNELS; NODULIN; SELECTIVITY	Water is essential for all living organisms. Aquaporin proteins are the major facilitator of water transport activity through cell membranes of plants including soybean. These proteins are diverse in plants and belong to a large major intrinsic (MIP) protein family. In higher plants, MIPs are classified into five subfamilies including plasma membrane intrinsic proteins (PIP), tonoplast intrinsic proteins (TIP), NOD26-like intrinsic proteins (NIP), small basic intrinsic proteins (SIP), and the recently discovered X intrinsic proteins (XIP). This paper reports genome wide assembly of soybean MIPs, their functional prediction and expression analysis. Using a bioinformatic homology search, 66 GmMIPs were identified in the soybean genome. Phylogenetic analysis of amino acid sequences of GmMIPs divided the large and highly similar multi-gene family into 5 subfamilies: GmPIPs, GmTIPs, GmNIPs, GmSIPs and GmXIPs. GmPIPs consisted of 22 genes and GmTIPs 23, which showed high sequence similarity within subfamilies. GmNIPs contained 13 and GmSIPs 6 members which were diverse. In addition, we also identified a two member GmXIP, a distinct 5th subfamily. GmMIPs were further classified into twelve subgroups based on substrate selectivity filter analysis. Expression analyses were performed for a selected set of GmMIPs using semi-quantitative reverse transcription (semi-RT-qPCR) and qPCR. Our results suggested that many GmMIPs have high sequence similarity but diverse roles as evidenced by analysis of sequences and their expression. It can be speculated that GmMIPs contains true aquaporins, glyceroporins, aquaglyceroporins and mixed transport facilitators.	[Zhang, Da Yong; Ali, Zulfiqar; Xu, Ling; Yi, Jin Xin; Xu, Zhao Long; Liu, Xiao Qing; He, Xiao Lan; Huang, Yi Hong; Ma, Hong Xiang] Jiangsu Acad Agr Sci, Inst Biotechnol, Nanjing, Jiangsu, Peoples R China; [Ali, Zulfiqar] Univ Agr Faisalabad, Dept Plant Breeding & Genet, Faisalabad, Pakistan; [Wang, Chang Biao] Shanxi Agr Sci, Cotton Res Inst, Yuncheng, Peoples R China; [Xu, Zhao Long] Nanjing Agr Univ, Nanjing, Jiangsu, Peoples R China; [Khan, Iqrar Ahmad] Univ Agr Faisalabad, Coll Agr & Appl Biol, Faisalabad, Pakistan; [Trethowan, Richard M.] Univ Sydney, Plant Breeding Inst, Sydney, NSW 2006, Australia	Jiangsu Academy of Agricultural Sciences; University of Agriculture Faisalabad; Chinese Academy of Agricultural Sciences; Institute of Cotton Research, CAAS; Nanjing Agricultural University; University of Agriculture Faisalabad; University of Sydney	Ali, Z (corresponding author), Jiangsu Acad Agr Sci, Inst Biotechnol, Nanjing, Jiangsu, Peoples R China.	zulfiqarpbg@hotmail.com; hxma@jaas.ac.cn	Ali, Zulfiqar/AAF-2663-2019; Wang, Changbiao/S-8473-2019; Ali, Zulfiqar/AAF-4171-2021; Trethowan, Richard/ADZ-7680-2022	Ali, Zulfiqar/0000-0003-1228-3338; Zhang, Dan-Dan/0000-0002-1498-6718; Trethowan, Richard/0000-0003-0105-875X	Jiangsu sister province of China; Punjab sister province of China; National Science Foundation of China [31101166, 30971798]; Jiangsu Natural Science Foundation, China [BK2010474]; Special Fund for Independent Innovation of Agricultural Science and Technology in Jiangsu [CX(12)5132, CX(12)1005-2]; Jiangsu Key Laboratory for Bioresources of Saline Soils [JKLBS2012002]; Project in the National Science & Technology Pillar Program [2011BAD35B06-4-3]	Jiangsu sister province of China; Punjab sister province of China; National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jiangsu Natural Science Foundation, China(Natural Science Foundation of Jiangsu Province); Special Fund for Independent Innovation of Agricultural Science and Technology in Jiangsu; Jiangsu Key Laboratory for Bioresources of Saline Soils; Project in the National Science & Technology Pillar Program	ZA is thankful for financial assistance from Jiangsu and Punjab sister provinces of China and Pakistan for his visit at Jiangsu Academy of Agricultural Sciences, Nanjing, People's Republic of China. This study was sponsored by National Science Foundation of China (31101166, 30971798); the Jiangsu Natural Science Foundation, China (BK2010474); the Special Fund for Independent Innovation of Agricultural Science and Technology in Jiangsu (CX(12)5132, CX(12) 1005-2); Jiangsu Key Laboratory for Bioresources of Saline Soils (JKLBS2012002) and the Project in the National Science & Technology Pillar Program during the Twelfth Five-year Plan Period (2011BAD35B06-4-3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aharon R, 2003, PLANT CELL, V15, P439, DOI 10.1105/tpc.009225; Alexandersson E, 2005, PLANT MOL BIOL, V59, P469, DOI 10.1007/s11103-005-0352-1; Barkla BJ, 1999, TRENDS PLANT SCI, V4, P86, DOI 10.1016/S1360-1385(99)01388-6; Boursiac Y, 2005, PLANT PHYSIOL, V139, P790, DOI 10.1104/pp.105.065029; Chaumont F, 2005, BIOL CELL, V97, P749, DOI 10.1042/BC20040133; Chaumont F, 1998, PLANT PHYSIOL, V117, P1143, DOI 10.1104/pp.117.4.1143; Chaumont F, 2001, PLANT PHYSIOL, V125, P1206, DOI 10.1104/pp.125.3.1206; DANIELS MJ, 1994, PLANT PHYSIOL, V106, P1325, DOI 10.1104/pp.106.4.1325; Danielson JAH, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-45; DENKER BM, 1988, J BIOL CHEM, V263, P15634; FORTIN MG, 1987, NUCLEIC ACIDS RES, V15, P813, DOI 10.1093/nar/15.2.813; Froger A, 1998, PROTEIN SCI, V7, P1458, DOI 10.1002/pro.5560070623; Guenther JF, 2000, PLANTA, V210, P741, DOI 10.1007/s004250050675; Guenther JF, 2003, PLANT CELL, V15, P981, DOI 10.1105/tpc.009787; Gupta AB, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-134; Gustafson CE, 2000, AM J PHYSIOL-RENAL, V278, pF317, DOI 10.1152/ajprenal.2000.278.2.F317; Heymann JB, 1999, NEWS PHYSIOL SCI, V14, P187; Hove RM, 2011, PLANT MOL BIOL, V75, P413, DOI 10.1007/s11103-011-9737-5; Javot H, 2002, ANN BOT-LONDON, V90, P301, DOI 10.1093/aob/mcf199; Jiang LW, 1998, J CELL BIOL, V143, P1183, DOI 10.1083/jcb.143.5.1183; Johanson U, 2001, PLANT PHYSIOL, V126, P1358, DOI 10.1104/pp.126.4.1358; Johansson I, 2000, BBA-BIOMEMBRANES, V1465, P324, DOI 10.1016/S0005-2736(00)00147-4; Johansson I, 1998, PLANT CELL, V10, P451, DOI 10.1105/tpc.10.3.451; Kaldenhoff R, 2006, BBA-BIOMEMBRANES, V1758, P1134, DOI 10.1016/j.bbamem.2006.03.012; Li GW, 2008, J PLANT PHYSIOL, V165, P1879, DOI 10.1016/j.jplph.2008.05.002; Liu LH, 2003, PLANT PHYSIOL, V133, P1220, DOI 10.1104/pp.103.027409; Marone Maria, 2001, Biological Procedures Online, V3, P19, DOI 10.1251/bpo20; Maurel C, 2002, INT REV CYTOL, V215, P105; Maurel C, 2001, PLANT PHYSIOL, V125, P135, DOI 10.1104/pp.125.1.135; Maurel C, 2008, ANNU REV PLANT BIOL, V59, P595, DOI 10.1146/annurev.arplant.59.032607.092734; Maurel C, 2007, FEBS LETT, V581, P2227, DOI 10.1016/j.febslet.2007.03.021; Mitani-Ueno N, 2011, J EXP BOT, V62, P4391, DOI 10.1093/jxb/err158; Park W, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-142; Quigley F, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2001-3-1-research0001; Rivers RL, 1997, J BIOL CHEM, V272, P16256, DOI 10.1074/jbc.272.26.16256; Sade N, 2009, NEW PHYTOL, V181, P651, DOI 10.1111/j.1469-8137.2008.02689.x; Sakurai J, 2005, PLANT CELL PHYSIOL, V46, P1568, DOI 10.1093/pcp/pci172; Tuteja JH, 2004, PLANT CELL, V16, P819, DOI 10.1105/tpc.021352; Tyerman SD, 2002, PLANT CELL ENVIRON, V25, P173, DOI 10.1046/j.0016-8025.2001.00791.x; Uehlein N, 2003, NATURE, V425, P734, DOI 10.1038/nature02027; Wallace IS, 2006, BBA-BIOMEMBRANES, V1758, P1165, DOI 10.1016/j.bbamem.2006.03.024; Wallace IS, 2004, PLANT PHYSIOL, V135, P1059, DOI 10.1104/pp.103.033415; Weig A, 1997, PLANT PHYSIOL, V114, P1347, DOI 10.1104/pp.114.4.1347; Winer J, 1999, ANAL BIOCHEM, V270, P41, DOI 10.1006/abio.1999.4085	44	116	128	2	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e56312	10.1371/journal.pone.0056312	http://dx.doi.org/10.1371/journal.pone.0056312			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437113	Green Published, gold, Green Submitted			2022-12-25	WOS:000315184200059
J	Dobson-Stone, C; Hallupp, M; Loy, CT; Thompson, EM; Haan, E; Sue, CM; Panegyres, PK; Razquin, C; Seijo-Martinez, M; Rene, R; Gascon, J; Campdelacreu, J; Schmoll, B; Volk, AE; Brooks, WS; Schofield, PR; Pastor, P; Kwok, JBJ				Dobson-Stone, Carol; Hallupp, Marianne; Loy, Clement T.; Thompson, Elizabeth M.; Haan, Eric; Sue, Carolyn M.; Panegyres, Peter K.; Razquin, Cristina; Seijo-Martinez, Manuel; Rene, Ramon; Gascon, Jordi; Campdelacreu, Jaume; Schmoll, Birgit; Volk, Alexander E.; Brooks, William S.; Schofield, Peter R.; Pastor, Pau; Kwok, John B. J.			C9ORF72 Repeat Expansion in Australian and Spanish Frontotemporal Dementia Patients	PLOS ONE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; MOTOR-NEURON DISEASE; HEXANUCLEOTIDE REPEAT; LOBAR DEGENERATION; HETEROGENEITY; MUTATIONS; FTD; ALS	A hexanucleotide repeat expansion in C9ORF72 has been established as a common cause of frontotemporal dementia (FTD). However, the minimum repeat number necessary for disease pathogenesis is not known. The aims of our study were to determine the frequency of the C9ORF72 repeat expansion in two FTD patient collections (one Australian and one Spanish, combined n = 190), to examine C9ORF72 expansion allele length in a subset of FTD patients, and to examine C9ORF72 allele length in 'non-expansion' patients (those with <30 repeats). The C9ORF72 repeat expansion was detected in 5-17% of patients (21-41% of familial FTD patients). For one family, the expansion was present in the proband but absent in the mother, who was diagnosed with dementia at age 68. No association was found between C9ORF72 non-expanded allele length and age of onset and in the Spanish sample mean allele length was shorter in cases than in controls. Southern blotting analysis revealed that one of the nine 'expansion-positive' patients examined, who had neuropathologically confirmed frontotemporal lobar degeneration with TDP-43 pathology, harboured an 'intermediate' allele with a mean size of only similar to 65 repeats. Our study indicates that the C9ORF72 repeat expansion accounts for a significant proportion of Australian and Spanish FTD cases. However, C9ORF72 allele length does not influence the age at onset of 'non-expansion' FTD patients in the series examined. Expansion of the C9ORF72 allele to as little as similar to 65 repeats may be sufficient to cause disease.	[Dobson-Stone, Carol; Hallupp, Marianne; Loy, Clement T.; Brooks, William S.; Schofield, Peter R.; Kwok, John B. J.] Neurosci Res Australia, Sydney, NSW, Australia; [Dobson-Stone, Carol; Loy, Clement T.; Brooks, William S.; Schofield, Peter R.; Kwok, John B. J.] Univ New S Wales, Sch Med Sci, Sydney, NSW, Australia; [Loy, Clement T.] Westmead Hosp, Huntington Dis Serv, Sydney, NSW, Australia; [Loy, Clement T.] Univ Sydney, Sydney Sch Publ Hlth, Sydney, NSW 2006, Australia; [Thompson, Elizabeth M.; Haan, Eric] Womens & Childrens Hosp, S Australia Clin Genet Serv, Adelaide, SA, Australia; [Thompson, Elizabeth M.; Haan, Eric] Univ Adelaide, Dept Paediat, Adelaide, SA, Australia; [Sue, Carolyn M.] Royal N Shore Hosp, Kolling Inst Med Res, Dept Neurogenet, Sydney, NSW, Australia; [Sue, Carolyn M.] Univ Sydney, Sydney, NSW 2006, Australia; [Panegyres, Peter K.] Neurodegenerat Disorders Res Pty Ltd, Subiaco, WA, Australia; [Razquin, Cristina; Pastor, Pau] Univ Navarra, Ctr Appl Med Res, Div Neurosci, Neurogenet Lab, E-31080 Pamplona, Spain; [Seijo-Martinez, Manuel] Hosp Salnes, Dept Neurol, Pontevedra, Spain; [Rene, Ramon; Gascon, Jordi; Campdelacreu, Jaume] Bellvitge Hosp, Dept Neurol, Barcelona, Spain; [Schmoll, Birgit; Volk, Alexander E.] Univ Hosp Ulm, Inst Human Genet, Ulm, Germany; [Pastor, Pau] Univ Navarra, Sch Med, Univ Navarra Clin, Dept Neurol, E-31080 Pamplona, Spain; [Pastor, Pau] Inst Salud Carlos III, Ctr Invest Biomed Red Enfermedades Neurodegenerat, CIBERNED, Madrid, Spain	Neuroscience Research Australia; University of New South Wales Sydney; University of Sydney; University of Sydney; Womens & Childrens Hospital Australia; University of Adelaide; Royal North Shore Hospital; University of Sydney; Kolling Institute of Medical Research; University of Sydney; University of Navarra; Complexo Hospitalario Universitario de Pontevedra; Hospital Salnes; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Bellvitge University Hospital; University of Barcelona; Ulm University; University of Navarra; CIBERNED; Instituto de Salud Carlos III	Kwok, JBJ (corresponding author), Neurosci Res Australia, Sydney, NSW, Australia.	j.kwok@neura.edu.au	Razquin, Cristina/H-2366-2017; Pastor, Pau/C-9834-2009; Schofield, Peter/C-9669-2011	Razquin, Cristina/0000-0003-3480-2645; Pastor, Pau/0000-0002-7493-8777; Schofield, Peter/0000-0003-2967-9662; Brooks, William Seymour/0000-0001-8603-4233; Dobson-Stone, Carol/0000-0002-2211-0257; Kwok, John/0000-0001-9574-6195	National Health and Medical Research Council of Australia (NHMRC) [630428, 510217, 630434]; UTE project FIMA; European Social Fund [PTQ-10-03810]; NHMRC; Australian Research Council; National Institute of Health; Wicking Foundation; Beyond Blue Foundation; Janssen-Cilag	National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); UTE project FIMA; European Social Fund(European Social Fund (ESF)); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wicking Foundation; Beyond Blue Foundation; Janssen-Cilag(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc)	This work was funded by the National Health and Medical Research Council of Australia (http://www.nhmrc.gov.au/) (NHMRC Project Grants #630428 to Dr. Dobson-Stone, #510217 to Dr. Kwok and Prof. Schofield, and Senior Principal Research Fellowship #630434 to Prof. Halliday) and by the UTE project FIMA to P.P. C.R. holds a 'Torres Quevedo' fellowship from the Spanish Ministry of Science and Technology, co-financed by the European Social Fund (PTQ-10-03810). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Dr. Dobson-Stone and Dr. Kwok receive grant funding from the National Health and Medical Research Council of Australia (NHMRC). Dr. Panegyres provides services for Neurodegenerative Disorders Research Pty Ltd, a not-for-profit organization. Prof. Schofield receives grant funding from the NHMRC, Australian Research Council, National Institute of Health, Wicking Foundation and Beyond Blue Foundation. He has received speaker fees from Janssen-Cilag. He has held stock options (unexercised and now lapsed) in Brain Resource Ltd. He is Executive Director & CEO (paid employment) of Neuroscience Research Australia (a not-for-profit company) and Director (unpaid) of not-for-profit companies Neuroscience Research Australia Foundation, The Health-Science Alliance, and Neuroscience Australia (NSA). This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Al-Saif A, 2011, ANN NEUROL, V70, P913, DOI 10.1002/ana.22534; Boeve BF, 2012, BRAIN, V135, P765, DOI 10.1093/brain/aws004; Byrne S, 2012, LANCET NEUROL, V11, P232, DOI 10.1016/S1474-4422(12)70014-5; Chio A, 2012, J NEUROL NEUROSUR PS, V83, P730, DOI 10.1136/jnnp-2012-302219; Dejesus-Hernandez M, 2012, PARKINSONISM RELAT D; DeJesus-Hernandez M, 2011, NEURON, V72, P245, DOI 10.1016/j.neuron.2011.09.011; Dobson-Stone C, 2012, NEUROLOGY, V79, P995, DOI 10.1212/WNL.0b013e3182684634; Garcia-Redondo A, 2012, HUM MUTAT; Hsiung GYR, 2012, BRAIN, V135, P709, DOI 10.1093/brain/awr354; Josephs KA, 2011, ACTA NEUROPATHOL, V122, P137, DOI 10.1007/s00401-011-0839-6; Lattante S, 2012, NEUROLOGY, V79, P66, DOI 10.1212/WNL.0b013e31825dceca; Luty AA, 2010, ANN NEUROL, V68, P639, DOI 10.1002/ana.22274; Luty AA, 2008, BMC NEUROL, V8, DOI 10.1186/1471-2377-8-32; Majounie E, 2012, NEUROBIOL AGING, V33; Majounie E, 2012, LANCET NEUROL, V11, P323, DOI 10.1016/S1474-4422(12)70043-1; Mok K, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.08.005; Murray ME, 2011, ACTA NEUROPATHOL, V122, P673, DOI 10.1007/s00401-011-0907-y; Ratti A, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2012.06.008; Renton AE, 2011, NEURON, V72, P257, DOI 10.1016/j.neuron.2011.09.010; Rohrer JD, 2009, NEUROLOGY, V73, P1451, DOI 10.1212/WNL.0b013e3181bf997a; Rollinson S, 2009, NEUROBIOL AGING, V30, P656, DOI 10.1016/j.neurobiolaging.2009.01.009; Rutherford NJ, 2012, NEUROBIOL AGING, V33; Schoser B, 2010, CURR GENOMICS, V11, P77, DOI 10.2174/138920210790886844; Seelaar H, 2011, J NEUROL NEUROSUR PS, V82, P476, DOI 10.1136/jnnp.2010.212225; Simon-Sanchez J, 2012, BRAIN, V135, P723, DOI 10.1093/brain/awr353; Sleegers K, 2010, ANNU REV NEUROSCI, V33, P71, DOI 10.1146/annurev-neuro-060909-153144; Smith BN, 2012, EUR J HUM GENET; Snowden JS, 2012, BRAIN, V135, P693, DOI 10.1093/brain/awr355; van Blitterswijk M, 2012, HUM MOL GENET, V21, P3776, DOI 10.1093/hmg/dds199	29	66	66	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e56899	10.1371/journal.pone.0056899	http://dx.doi.org/10.1371/journal.pone.0056899			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23653281	Green Published, Green Submitted, gold			2022-12-25	WOS:000315184200179
J	Liu, HJ; Xu, YF; Lin, XJ; Shi, J; Chen, SY				Liu, Hongjie; Xu, Yongfang; Lin, Xinjin; Shi, Jian; Chen, Shiyi			Associations between Perceived HIV Stigma and Quality of Life at the Dyadic Lvel: The Actor-Partner Interdependence Model	PLOS ONE			English	Article							YOUNG ADOLESCENTS; CAREGIVERS; SCHIZOPHRENIA; INDIVIDUALISM; COLLECTIVISM; PERSPECTIVES; SEROSTATUS; INFECTION; HIV/AIDS; DISEASE	Background: Few studies have investigated the relationship between HIV-related stigma and quality life at the dyadic level. The objective of this study was to examine the actor and partner effects of stigma that was perceived by people living with HIV/AIDS (PLWHAs) and caregivers on quality of life at the dyadic level. Method: A survey was conducted among 148 dyads consisting of one PLWHA and one caregiver (296 participants) in Nanning, China. The interdependent relationship between a pair of dyadic members that influences the associations between stigma and quality of life was analyzed, using an innovative dyadic analysis technique: the Actor-Partner Interdependence Model (APIM). Results: We found in this dyadic analysis that (1) PLWHAs compared to their caregivers exhibited a higher level of perceived HIV stigma and lower level of quality of life measured in four domains; (2) both PLWHAs' and caregivers' perceived HIV stigma influenced their own quality of life; (3) The quality of life was not substantially influenced by their partners' perceived stigma; and (4) Both actor and partner effects of stigma on quality of life were similar among PLWHAs and their caregivers. Conclusion: As HIV stigma and quality of life are complex phenomena rooted in cultures, intervention programs should be carefully planned based on social or cognitive theories and should be culturally adopted.	[Liu, Hongjie] Univ Maryland, Sch Publ Hlth, Dept Epidemiol & Biostat, College Pk, MD 20742 USA; [Xu, Yongfang; Lin, Xinjin; Shi, Jian; Chen, Shiyi] Nanning Ctr Dis Control & Prevent, Nanning, Guangxi, Peoples R China	University System of Maryland; University of Maryland College Park	Liu, HJ (corresponding author), Univ Maryland, Sch Publ Hlth, Dept Epidemiol & Biostat, College Pk, MD 20742 USA.	hliu1210@umd.edu	; Kaufmann, Stefan HE/I-5454-2014	Liu, Haipeng/0000-0002-3338-6291; Kaufmann, Stefan HE/0000-0001-9866-8268	National Institutes of Health-National Institute of Child Health and Human Development [R01 HD068305-01]; Virginia Commonwealth University School of Medicine	National Institutes of Health-National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Virginia Commonwealth University School of Medicine	This work was partially supported by a research grant (R01 HD068305-01) from the National Institutes of Health-National Institute of Child Health and Human Development and a research grant from the Virginia Commonwealth University School of Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abasiubong F, 2011, AIDS CARE, V23, P494, DOI 10.1080/09540121.2010.516340; Andrinopoulos K, 2011, AIDS EDUC PREV, V23, P367, DOI 10.1521/aeap.2011.23.4.367; Aranda-Naranjo B, 2004, J ASSOC NURSE AIDS C, V15, p20S, DOI 10.1177/1055329004269183; Boyer L, 2012, BMC FAM PRACT, V13, DOI 10.1186/1471-2296-13-42; Brown L, 2003, AIDS EDUC PREV, V15, P49, DOI 10.1521/aeap.15.1.49.23844; Caqueo-Urizar A, 2009, HEALTH QUAL LIFE OUT, V7, DOI 10.1186/1477-7525-7-84; Chinese Ministry of Health, 2012, CHIN AIDS RESP PROGR; Cook WL, 2005, INT J BEHAV DEV, V29, P101, DOI 10.1080/01650250444000405; Feaster DJ, 2002, PSYCHOL HEALTH, V17, P339, DOI 10.1080/08870440290029584; Flaskerud J H, 1998, Health Care Women Int, V19, P23, DOI 10.1080/073993398246557; Goffman E., 1963, BEHAV PUBLIC PLACES; Goffman E., 1968, STIGMA NOTES MANAGEM; Group W, 1996, WHOQOL BREF INTR ADM; Ha TH, 2012, AIDS CARE, V24, P39, DOI 10.1080/09540121.2011.592820; Harper A, 1998, PSYCHOL MED, V28, P551, DOI 10.1017/S0033291798006667; Holzemer WL, 2009, J ASSOC NURSE AIDS C, V20, P161, DOI 10.1016/j.jana.2009.02.002; HUI CH, 1986, J CROSS CULT PSYCHOL, V17, P225, DOI 10.1177/0022002186017002006; Kelley H.H., 1978, INTERPERSONAL RELATI; Kenny D. A., 2006, DYADIC DATA ANAL; KUYKEN W, 1995, SOC SCI MED, V41, P1403, DOI 10.1016/0277-9536(95)00112-k; Laursen B, 2005, INT J BEHAV DEV, V29, P97, DOI 10.1080/01650250444000450; Lee SJ, 2007, AM J PUBLIC HEALTH, V97, P1820, DOI 10.2105/AJPH.2005.084871; Li Li, 2008, Fam Syst Health, V26, P431; Li XH, 2011, AIDS PATIENT CARE ST, V25, P665, DOI 10.1089/apc.2011.0174; Lin T. Y., 1981, NORMAL ABNORMAL BEHA, P387, DOI DOI 10.1007/978-94-017-4986-2_20; Liu H, 2009, SEX TRANSM INFECT, V85, P65, DOI 10.1136/sti.2008.032714; Liu HJ, 2006, AIDS PATIENT CARE ST, V20, P133, DOI 10.1089/apc.2006.20.133; Liu HJ, 2002, SEX TRANSM DIS, V29, P335, DOI 10.1097/00007435-200206000-00005; Liu HJ, 2012, AIDS PATIENT CARE ST, V26, P565, DOI 10.1089/apc.2012.0227; Liu Hongjie, 2011, Stigma Res Action, V1, P27; Liu HJ, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-563; Mitchell MM, 2009, AIDS PATIENT CARE ST, V23, P611, DOI 10.1089/apc.2008.0279; Muth?n L.K., 2010, MPLUS USERS GUIDE V; Nelms TP, 2002, J FAMILY NURSING, V8, P282; Poindexter CC, 1999, SOC WORK, V44, P46, DOI 10.1093/sw/44.1.46; Rusbult CE, 2003, ANNU REV PSYCHOL, V54, P351, DOI 10.1146/annurev.psych.54.101601.145059; Scambler G, 1998, LANCET, V352, P1054, DOI 10.1016/S0140-6736(98)08068-4; Shan D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021839; Skevington SM, 2004, QUAL LIFE RES, V13, P299, DOI 10.1023/B:QURE.0000018486.91360.00; Thibaut J., 1959, SOCIAL PSYCHOL GROUP; TRIANDIS HC, 1988, J PERS SOC PSYCHOL, V54, P323, DOI 10.1037/0022-3514.54.2.323; WHOQOL Group, 2004, WHO QUAL LIF WHOQOL; Wight RG, 2006, SOC SCI MED, V62, P444, DOI 10.1016/j.socscimed.2005.06.004; Yang LH, 2008, SOC SCI MED, V67, P398, DOI 10.1016/j.socscimed.2008.03.011; Zendjidjian X, 2012, J AFFECT DISORDERS, V136, P660, DOI 10.1016/j.jad.2011.10.011	45	58	61	1	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2013	8	2							e55680	10.1371/journal.pone.0055680	http://dx.doi.org/10.1371/journal.pone.0055680			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	085EU	23418602	gold, Green Submitted, Green Published			2022-12-25	WOS:000314597900050
J	Morgan, MAJ; Muller, PSS; Mould, A; Newland, SA; Nichols, J; Robertson, EJ; Cooke, A; Bikoff, EK				Morgan, Marc A. J.; Muller, Pari S. S.; Mould, Arne; Newland, Stephen A.; Nichols, Jennifer; Robertson, Elizabeth J.; Cooke, Anne; Bikoff, Elizabeth K.			The Nonconventional MHC Class II Molecule DM Governs Diabetes Susceptibility in NOD Mice	PLOS ONE			English	Article							INVARIANT CHAIN; ANTIGEN PRESENTATION; PEPTIDE BINDING; CELL MATURATION; MUTANT MICE; H2-M; COMPLEXES; MOUSE; REQUIREMENTS; REPERTOIRE	The spontaneous destruction of insulin producing pancreatic beta cells in non-obese diabetic (NOD) mice provides a valuable model of type 1 diabetes. As in humans, disease susceptibility is controlled by the classical MHC class II genes that guide CD4(+) T cell responses to self and foreign antigens. It has long been suspected that the dedicated class II chaperone designated HLA-DM in humans or H-2M in mice also makes an important contribution, but due to tight linkage within the MHC, a possible role played by DM peptide editing has not been previously tested by conventional genetic approaches. Here we exploited newly established germ-line competent NOD ES cells to engineer a loss of function allele. DM deficient NOD mice display defective class II peptide occupancy and surface expression, and are completely protected against type 1 diabetes. Interestingly the mutation results in increased proportional representation of CD4(+)Foxp3(+) regulatory T cells and the absence of pathogenic CD4(+) T effectors. Overall, this striking phenotype establishes that DM-mediated peptide selection plays an essential role in the development of autoimmune diabetes in NOD mice.	[Morgan, Marc A. J.; Muller, Pari S. S.; Mould, Arne; Robertson, Elizabeth J.; Bikoff, Elizabeth K.] Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England; [Newland, Stephen A.; Cooke, Anne] Univ Cambridge, Dept Pathol, Cambridge CB2 1QP, England; [Nichols, Jennifer] Univ Cambridge, MRC, Cambridge Stem Cell Inst, Wellcome Trust, Cambridge, England	University of Oxford; University of Cambridge; University of Cambridge; Wellcome Trust Sanger Institute	Bikoff, EK (corresponding author), Univ Oxford, Sir William Dunn Sch Pathol, S Parks Rd, Oxford OX1 3RE, England.	elizabeth.bikoff@path.ox.ac.uk	Cooke, Anne/S-4763-2019; Mallat, Ziad/D-4041-2012; Hardy, Christopher/A-8794-2008; Chariton, Anthony/F-2373-2011; Court, Leon/J-7138-2013	Cooke, Anne/0000-0003-3327-6081; Mallat, Ziad/0000-0003-0443-7878; Hardy, Christopher/0000-0002-7419-566X; Chariton, Anthony/0000-0002-5809-3372; , Bin/0000-0001-9190-968X; Nichols, Jennifer/0000-0002-8650-1388; Court, Leon/0000-0003-3673-9504; Mould, Arne/0000-0002-2004-4348	Wellcome Trust; MRC [G0801841] Funding Source: UKRI; Medical Research Council [G0801841] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by grants from the Wellcome Trust. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders AK, 2011, NAT IMMUNOL, V12, P54, DOI 10.1038/ni.1967; Bikoff EK, 2001, J IMMUNOL, V166, P5087, DOI 10.4049/jimmunol.166.8.5087; Brode S, 2006, J IMMUNOL, V177, P6603, DOI 10.4049/jimmunol.177.10.6603; Busch R, 2005, IMMUNOL REV, V207, P242, DOI 10.1111/j.0105-2896.2005.00306.x; Corper AL, 2000, SCIENCE, V288, P505, DOI 10.1126/science.288.5465.505; Denzin LK, 2005, IMMUNOL REV, V207, P279, DOI 10.1111/j.0105-2896.2005.00302.x; Derbinski J, 2010, CURR OPIN IMMUNOL, V22, P592, DOI 10.1016/j.coi.2010.08.003; Fallang LE, 2008, J IMMUNOL, V181, P5451, DOI 10.4049/jimmunol.181.8.5451; FungLeung WP, 1996, SCIENCE, V271, P1278, DOI 10.1126/science.271.5253.1278; Gunther S, 2010, P NATL ACAD SCI USA, V107, P22219, DOI 10.1073/pnas.1014708107; Guerder S, 2012, CURR OPIN IMMUNOL, V24, P99, DOI 10.1016/j.coi.2012.01.008; Hanna J, 2009, CELL STEM CELL, V5, P124, DOI 10.1016/j.stem.2009.06.007; HATTORI M, 1986, SCIENCE, V231, P733, DOI 10.1126/science.3003909; Hausmann DHF, 1999, J EXP MED, V189, P1723, DOI 10.1084/jem.189.11.1723; HERMEL E, 1995, IMMUNOGENETICS, V42, P136, DOI 10.1007/BF00178588; Hinterberger M, 2010, NAT IMMUNOL, V11, P512, DOI 10.1038/ni.1874; Hou TY, 2011, J IMMUNOL, V187, P2442, DOI 10.4049/jimmunol.1100255; JARDETZKY TS, 1990, EMBO J, V9, P1797, DOI 10.1002/j.1460-2075.1990.tb08304.x; Karlsson L, 2005, CURR OPIN IMMUNOL, V17, P65, DOI 10.1016/j.coi.2004.11.003; Kenty G, 1998, J IMMUNOL, V160, P606; Klein L, 2009, NAT REV IMMUNOL, V9, P833, DOI 10.1038/nri2669; Koonce CH, 2004, J IMMUNOL, V173, P3271, DOI 10.4049/jimmunol.173.5.3271; Koonce CH, 2003, J IMMUNOL, V170, P3751, DOI 10.4049/jimmunol.170.7.3751; Kovats S, 1998, J EXP MED, V187, P245, DOI 10.1084/jem.187.2.245; Latek RR, 2000, IMMUNITY, V12, P699, DOI 10.1016/S1074-7613(00)80220-4; Lee KH, 2001, NAT IMMUNOL, V2, P501, DOI 10.1038/88694; Lennon GP, 2009, IMMUNITY, V31, P643, DOI 10.1016/j.immuni.2009.07.008; Lieberman SM, 2003, TISSUE ANTIGENS, V62, P359, DOI 10.1034/j.1399-0039.2003.00152.x; Martin WD, 1996, CELL, V84, P543, DOI 10.1016/S0092-8674(00)81030-2; Mellanby RJ, 2008, AUTOIMMUNITY, V41, P383, DOI 10.1080/08916930801991021; Mellanby RJ, 2006, J IMMUNOL, V177, P7588, DOI 10.4049/jimmunol.177.11.7588; Miyazaki T, 1996, CELL, V84, P531, DOI 10.1016/S0092-8674(00)81029-6; Mohan JF, 2011, J EXP MED, V208, P2375, DOI 10.1084/jem.20111502; Nichols J, 2009, NAT MED, V15, P814, DOI 10.1038/nm.1996; Peleraux A, 1996, IMMUNOGENETICS, V43, P204, DOI 10.1007/BF00587301; Rich JD, 2003, J IMMUNOL, V171, P853, DOI 10.4049/jimmunol.171.2.853; Schulze MSED, 2012, CURR OPIN IMMUNOL, V24, P105, DOI 10.1016/j.coi.2011.11.004; Serreze DV, 2001, CURR DIRECT AUTOIMMU, V4, P31; Stadinski B, 2010, IMMUNITY, V32, P446, DOI 10.1016/j.immuni.2010.04.008; Stadinski BD, 2010, NAT IMMUNOL, V11, P225, DOI 10.1038/ni.1844; Suri A, 2005, J CLIN INVEST, V115, P2268, DOI 10.1172/JCI25350; TODD JA, 1987, NATURE, V329, P599, DOI 10.1038/329599a0; Todd JA, 2001, IMMUNITY, V15, P387, DOI 10.1016/S1074-7613(01)00202-3; Tourne S, 1997, P NATL ACAD SCI USA, V94, P9255, DOI 10.1073/pnas.94.17.9255; Yi W, 2010, J CLIN INVEST, V120, P1324, DOI 10.1172/JCI40220	45	84	89	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e56738	10.1371/journal.pone.0056738	http://dx.doi.org/10.1371/journal.pone.0056738			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23991013	gold, Green Published, Green Submitted			2022-12-25	WOS:000315970300189
J	Wu, DM; Kraut, JA; Abraham, WM				Wu, Dongmei; Kraut, Jeffrey A.; Abraham, William M.			Sabiporide Improves Cardiovascular Function, Decreases the Inflammatory Response and Reduces Mortality in Acute Metabolic Acidosis in Pigs	PLOS ONE			English	Article							EXTRACELLULAR ACIDOSIS; EXCHANGE INHIBITION; SODIUM-BICARBONATE; LACTIC-ACIDOSIS; MECHANISMS; CONTRACTILITY; MYOCARDIUM; ACTIVATION; MANAGEMENT; DIAGNOSIS	Introduction: Acute metabolic acidosis impairs cardiovascular function and increases the mortality of critically ill patients. However, the precise mechanism(s) underlying these effects remain unclear. We hypothesized that targeting pH-regulatory protein, Na+/H+ exchanger (NHE1) could be a novel approach for the treatment of acute metabolic acidosis. The aim of the present study was to examine the impact of a novel NHE1 inhibitor, sabiporide, on cardiovascular function, blood oxygen transportation, and inflammatory response in an experimental model of metabolic acidosis produced by hemorrhage-induced hypovolemia followed by an infusion of lactic acid. Methods and Results: Anesthetized pigs were subjected to hypovolemia for 30 minutes. The animals then received a bolus infusion of sabiporide (3 mg/kg) or vehicle, followed by an infusion of lactic acid for 2 hours. The animals were continuously monitored for additional 3 hours. Hypovolemia followed by a lactic acid infusion resulted in a severe metabolic acidosis with blood pH falling to 6.8. In association with production of the acidemia, there was an excessive increase in pulmonary artery pressure (PAP) and pulmonary vascular resistance (PVR). Treatment with sabiporide significantly attenuated the increase in PAP by 38% and PVR by 67%, as well as significantly improved cardiac output by 51%. Sabiporide treatment also improved mixed venous blood oxygen saturation (55% in sabiporide group vs. 28% in control group), and improved systemic blood oxygen delivery by 36%. In addition, sabiporide treatment reduced plasma levels of TNF-alpha (by 33%), IL-6 (by 63%), troponin-I (by 54%), ALT (by 34%), AST (by 35%), and urea (by 40%). Conclusion: These findings support the possible beneficial effects of sabiporide in the treatment of acute metabolic acidosis and could have implications for the treatment of metabolic acidosis in man.	[Wu, Dongmei] Mt Sinai Med Ctr, Dept Res, Div Neonatol, Miami Beach, FL 33140 USA; [Abraham, William M.] Mt Sinai Med Ctr, Div Pulm & Crit Care Med, Miami Beach, FL 33140 USA; [Wu, Dongmei] Chonbuk Natl Univ, Dept BIN Fus Technol, Jeonju, South Korea; [Kraut, Jeffrey A.] Vet Adm Greater Angeles Healthcare Syst, Div Nephrol Med & Res Serv, Los Angeles, CA USA; [Kraut, Jeffrey A.] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA	Mount Sinai Medical Center; Mount Sinai Medical Center; Jeonbuk National University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Wu, DM (corresponding author), Mt Sinai Med Ctr, Dept Res, Div Neonatol, Miami Beach, FL 33140 USA.	dongmeiwu@bellsouth.net	Wu, Dongmei/I-3213-2016; Chen, Zhong-Hua/B-8927-2008; Dai, Fei/F-6512-2010; Wu, Dezhi/AAO-9316-2020; Wu, Dongrui/E-1956-2011; Schaefer, Dirk/I-9806-2018	Chen, Zhong-Hua/0000-0002-7531-320X; Wu, Dongrui/0000-0002-7153-9703; Schaefer, Dirk/0000-0002-5695-9312; Wu, Dezhi/0000-0002-7900-0542; Parsons, Thomas/0000-0003-0331-5019; Wu, Feibo/0000-0001-8797-3398	USAMRMC [W81XWH-06-1-0719]; Ministry of Education, Science and Technology [R31-20029, 2012007331]; National Research Foundation of Korea (NRF); honbuk National University, Korea	USAMRMC(United States Department of DefenseUnited States ArmyU.S. Army Medical Research & Materiel Command (USAMRMC)); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); National Research Foundation of Korea (NRF)(National Research Foundation of Korea); honbuk National University, Korea	This work was supported by a USAMRMC grant W81XWH-06-1-0719 (to DW); and in part by the World Class University Program (R31-20029) funded by the Ministry of Education, Science and Technology; by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (2012007331); and by New Faculty funding from Chonbuk National University, Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adrogue HJ, 1998, NEW ENGL J MED, V338, P107, DOI 10.1056/NEJM199801083380207; ANDERSON SE, 1990, AM J PHYSIOL, V259, pC940, DOI 10.1152/ajpcell.1990.259.6.C940; BRIMIOULLE S, 1990, AM J PHYSIOL, V258, pH347, DOI 10.1152/ajpheart.1990.258.2.H347; CINGOLANI HE, 1975, SURGERY, V77, P427; COOPER DJ, 1993, AM REV RESPIR DIS, V148, P317, DOI 10.1164/ajrccm/148.2.317; Doods H, 2013, J BIOMEDICI IN PRESS; Forsythe SM, 2000, CHEST, V117, P260, DOI 10.1378/chest.117.1.260; Gunnerson KJ, 2006, CRIT CARE, V10, DOI 10.1186/cc3987; HUSEBY JS, 1981, CHEST, V79, P552, DOI 10.1378/chest.79.5.552; Karmazyn M, 1999, J THROMB THROMBOLYS, V8, P33, DOI 10.1023/A:1008990530176; Kellum JA, 2004, CRIT CARE, V8, P331, DOI 10.1186/cc2900; Kellum JA, 2004, AM J PHYSIOL-REG I, V286, pR686, DOI 10.1152/ajpregu.00564.2003; Kellum JA, 2004, CHEST, V125, P243, DOI 10.1378/chest.125.1.243; Kraut JA, 2005, AM J KIDNEY DIS, V45, P978, DOI 10.1053/j.ajkd.2005.03.003; Kraut JA, 2010, NAT REV NEPHROL, V6, P274, DOI 10.1038/nrneph.2010.33; Lin X, 2012, RESUSCITATION; MARSIGLIA JC, 1973, CARDIOVASC RES, V7, P336, DOI 10.1093/cvr/7.3.336; Martinez D, 2006, J IMMUNOL, V176, P1163, DOI 10.4049/jimmunol.176.2.1163; MATHIEU D, 1991, CRIT CARE MED, V19, P1352, DOI 10.1097/00003246-199111000-00008; Nemeth ZH, 2002, AM J PHYSIOL-CELL PH, V283, pC396, DOI 10.1152/ajpcell.00491.2001; SAHN DJ, 1978, CIRCULATION, V58, P1072, DOI 10.1161/01.CIR.58.6.1072; Schiller N B, 1989, J Am Soc Echocardiogr, V2, P358; Serrano CV, 1996, AM J PHYSIOL-CELL PH, V271, pC962, DOI 10.1152/ajpcell.1996.271.3.C962; Siesjo BK, 1996, ACT NEUR S, V66, P8; Sikes PJ, 2005, CRIT CARE MED, V33, P605, DOI 10.1097/01.ccm.0000155910.89252.FE; Vaughan-Jones Richard D, 2006, J Cardiovasc Electrophysiol, V17 Suppl 1, pS134, DOI 10.1111/j.1540-8167.2006.00394.x; Webster KA, 1999, J CLIN INVEST, V104, P239; WIKLUND L, 1985, CRIT CARE MED, V13, P109, DOI 10.1097/00003246-198502000-00012; Wu DM, 2000, BASIC RES CARDIOL, V95, P449, DOI 10.1007/s003950070020; Wu DM, 2008, SHOCK, V29, P519, DOI 10.1097/SHK.0b013e318150757a; Wu DM, 2012, RESUSCITATION, V83, P774, DOI 10.1016/j.resuscitation.2011.11.025; Wu DM, 2009, CRIT CARE MED, V37, P1994, DOI 10.1097/CCM.0b013e3181a0052e	32	207	219	3	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2013	8	1							e53932	10.1371/journal.pone.0053932	http://dx.doi.org/10.1371/journal.pone.0053932			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YV	23437188	Green Submitted, Green Published, gold			2022-12-25	WOS:000313552400061
J	Wu, DZ; Cai, SG; Chen, MX; Ye, LZ; Chen, ZH; Zhang, HT; Dai, F; Wu, FB; Zhang, GP				Wu, Dezhi; Cai, Shengguan; Chen, Mingxian; Ye, Lingzhen; Chen, Zhonghua; Zhang, Haitao; Dai, Fei; Wu, Feibo; Zhang, Guoping			Tissue Metabolic Responses to Salt Stress in Wild and Cultivated Barley	PLOS ONE			English	Article							PROLINE ACCUMULATION; GAS-CHROMATOGRAPHY; SODIUM-TRANSPORT; ABIOTIC STRESS; DROUGHT STRESS; TOLERANCE; PLANTS; ARABIDOPSIS; HOMEOSTASIS; MANNITOL	A thorough understanding of the mechanisms underlying barley salt tolerance and exploitation of elite genetic resource are essential for utilizing wild barley germplasm in developing barley varieties with salt tolerance. In order to reveal the physiological and molecular difference in salt tolerance between Tibetan wild barley (Hordeum spontaneum) and cultivated barley (Hordeum vulgare), profiles of 82 key metabolites were studies in wild and cultivated barley in response to salinity. According to shoot dry biomass under salt stress, XZ16 is a fast growing and salt tolerant wild barley. The results of metabolite profiling analysis suggested osmotic adjustment was a basic mechanism, and polyols played important roles in developing salt tolerance only in roots, and high level of sugars and energy in roots and active photosynthesis in leaves were important for barley to develop salt tolerance. The metabolites involved in tolerance enhancement differed between roots and shoots, and also between genotypes. Tibetan wild barley, XZ16 had higher chlorophyll content and higher contents of compatible solutes than CM72, while the cultivated barley, CM72 probably enhanced its salt tolerance mainly through increasing glycolysis and energy consumption, when the plants were exposed to high salinity. The current research extends our understanding of the mechanisms involved in barley salt tolerance and provides possible utilization of Tibetan wild barley in developing barley cultivars with salt tolerance.	[Wu, Dezhi; Cai, Shengguan; Chen, Mingxian; Ye, Lingzhen; Zhang, Haitao; Dai, Fei; Wu, Feibo; Zhang, Guoping] Zhejiang Univ, Dept Agron, Key Lab Crop Germplasm Resource Zhejiang Prov, Hangzhou 310003, Zhejiang, Peoples R China; [Chen, Zhonghua] Univ Western Sydney, Sch Sci & Hlth, Penrith, NSW 1797, Australia	Zhejiang University; Western Sydney University	Zhang, GP (corresponding author), Zhejiang Univ, Dept Agron, Key Lab Crop Germplasm Resource Zhejiang Prov, Hangzhou 310003, Zhejiang, Peoples R China.	zhanggp@zju.edu.cn	Wu, Dongmei/I-3213-2016; Chen, Zhong-Hua/B-8927-2008; Dai, Fei/F-6512-2010; Wu, Dezhi/AAO-9316-2020; Wu, Dongrui/E-1956-2011; Schaefer, Dirk/I-9806-2018	Chen, Zhong-Hua/0000-0002-7531-320X; Wu, Dongrui/0000-0002-7153-9703; Schaefer, Dirk/0000-0002-5695-9312; Wu, Dezhi/0000-0002-7900-0542; Parsons, Thomas/0000-0003-0331-5019; Wu, Feibo/0000-0001-8797-3398	Natural Science Foundation of China [31129005, 31171544]; Natural Science Foundation of Zhejiang Province, China [Z3110054]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Zhejiang Province, China(Natural Science Foundation of Zhejiang Province)	This research was supported by Natural Science Foundation of China (31129005 and 31171544), Natural Science Foundation of Zhejiang Province, China (Z3110054). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abebe T, 2003, PLANT PHYSIOL, V131, P1748, DOI 10.1104/pp.102.003616; Alvarez S, 2008, PLANT CELL ENVIRON, V31, P325, DOI 10.1111/j.1365-3040.2007.01770.x; Armengaud P, 2009, PLANT PHYSIOL, V150, P772, DOI 10.1104/pp.108.133629; Blumwald E, 2000, CURR OPIN CELL BIOL, V12, P431, DOI 10.1016/S0955-0674(00)00112-5; BOHNERT HJ, 1995, PLANT CELL, V7, P1099, DOI 10.1105/tpc.7.7.1099; Chen THH, 2002, CURR OPIN PLANT BIOL, V5, P250, DOI 10.1016/S1369-5266(02)00255-8; Chen Z, 2005, PLANT CELL ENVIRON, V28, P1230, DOI 10.1111/j.1365-3040.2005.01364.x; Chen Z, 2007, J EXP BOT, V58, P4245, DOI 10.1093/jxb/erm284; Chen ZH, 2007, PLANT PHYSIOL, V145, P1714, DOI 10.1104/pp.107.110262; Cuin TA, 2007, PLANTA, V225, P753, DOI 10.1007/s00425-006-0386-x; Dai F, 2012, P NATL ACAD SCI USA, V109, P16969, DOI 10.1073/pnas.1215265109; Dai HX, 2011, J PLANT NUTR SOIL SC, V174, P952, DOI 10.1002/jpln.201100148; DELAUNEY AJ, 1993, PLANT J, V4, P215, DOI 10.1046/j.1365-313X.1993.04020215.x; Du J, 2008, PLANT J, V56, P653, DOI 10.1111/j.1365-313X.2008.03602.x; Fiehn O, 2002, PLANT MOL BIOL, V48, P155, DOI 10.1023/A:1013713905833; Gong QQ, 2005, PLANT J, V44, P826, DOI 10.1111/j.1365-313X.2005.02587.x; Hare PD, 1998, PLANT CELL ENVIRON, V21, P535, DOI 10.1046/j.1365-3040.1998.00309.x; Hong ZL, 2000, PLANT PHYSIOL, V122, P1129, DOI 10.1104/pp.122.4.1129; Kaplan F, 2004, PLANT PHYSIOL, V136, P4159, DOI 10.1104/pp.104.052142; Kim HK, 2010, PHYTOCHEM ANALYSIS, V21, P4, DOI 10.1002/pca.1188; Kim JK, 2007, J EXP BOT, V58, P415, DOI 10.1093/jxb/erl216; Kronzucker HJ, 2011, NEW PHYTOL, V189, P54, DOI 10.1111/j.1469-8137.2010.03540.x; Lisec J, 2006, NAT PROTOC, V1, P387, DOI 10.1038/nprot.2006.59; Liu JP, 1997, PLANT PHYSIOL, V114, P591, DOI 10.1104/pp.114.2.591; Luedemann A, 2008, BIOINFORMATICS, V24, P732, DOI 10.1093/bioinformatics/btn023; Miller G, 2010, PLANT CELL ENVIRON, V33, P453, DOI 10.1111/j.1365-3040.2009.02041.x; Munns R, 2005, NEW PHYTOL, V167, P645, DOI 10.1111/j.1469-8137.2005.01487.x; Munns R, 2008, ANNU REV PLANT BIOL, V59, P651, DOI 10.1146/annurev.arplant.59.032607.092911; Nevo E, 2010, PLANT CELL ENVIRON, V33, P670, DOI 10.1111/j.1365-3040.2009.02107.x; Nicholson JK, 1999, XENOBIOTICA, V29, P1181, DOI 10.1080/004982599238047; Oliver MJ, 2011, PLANT CELL, V23, P1231, DOI 10.1105/tpc.110.082800; PHARR DM, 1995, HORTSCIENCE, V30, P1182, DOI 10.21273/HORTSCI.30.6.1182; Qiu L, 2011, THEOR APPL GENET, V122, P695, DOI 10.1007/s00122-010-1479-2; Renberg L, 2010, PLANT PHYSIOL, V154, P187, DOI 10.1104/pp.110.157651; Rizhsky L, 2004, PLANT PHYSIOL, V134, P1683, DOI 10.1104/pp.103.033431; Roessner U, 2006, PLANT PHYSIOL, V142, P1087, DOI 10.1104/pp.106.084053; Sakamoto A, 1998, PLANT MOL BIOL, V38, P1011, DOI 10.1023/A:1006095015717; Sanchez DH, 2008, PHYSIOL PLANTARUM, V132, P209, DOI 10.1111/j.1399-3054.2007.00993.x; Shabala S, 2005, J EXP BOT, V56, P1369, DOI 10.1093/jxb/eri138; Shulaev V, 2008, PHYSIOL PLANTARUM, V132, P199, DOI 10.1111/j.1399-3054.2007.01025.x; Stoop JMH, 1996, TRENDS PLANT SCI, V1, P139, DOI 10.1016/S1360-1385(96)80048-3; Ueda A, 2004, J EXP BOT, V55, P2213, DOI 10.1093/jxb/erh242; Urano K, 2010, CURR OPIN PLANT BIOL, V13, P132, DOI 10.1016/j.pbi.2009.12.006; Wang X, 2008, PLANTA, V227, P611, DOI 10.1007/s00425-007-0643-7; Widodo, 2009, J EXP BOT, V60, P4089, DOI 10.1093/jxb/erp243; Wu DZ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022938; Xia JG, 2011, NAT PROTOC, V6, P743, DOI 10.1038/nprot.2011.319; XU T, 1982, Acta Genetica Sinica, V9, P440; Yamaguchi T, 2005, TRENDS PLANT SCI, V10, P615, DOI 10.1016/j.tplants.2005.10.002; Zhang H, 2012, J PROTEOME RES, V11, P49, DOI 10.1021/pr200861w; Zhao J, 2010, EUPHYTICA, V172, P395, DOI 10.1007/s10681-009-0064-8; Zhu JK, 2003, CURR OPIN PLANT BIOL, V6, P441, DOI 10.1016/S1369-5266(03)00085-2; Zhu JK, 2002, ANNU REV PLANT BIOL, V53, P247, DOI 10.1146/annurev.arplant.53.091401.143329; Zhu JK, 2001, TRENDS PLANT SCI, V6, P66, DOI 10.1016/S1360-1385(00)01838-0	54	207	219	3	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e55431	10.1371/journal.pone.0055431	http://dx.doi.org/10.1371/journal.pone.0055431			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085JH	23437188	Green Published, Green Submitted, gold			2022-12-25	WOS:000314610600104
J	Hu, YF; Jiang, HS; Wang, Q; Xie, ZS; Pan, SY				Hu, Yafang; Jiang, Haishan; Wang, Qun; Xie, Zuoshan; Pan, Suyue			Identification of a Novel Nonsense Mutation p.Tyr1957Ter of CACNA1A in a Chinese Family with Episodic Ataxia 2	PLOS ONE			English	Article							CALCIUM-CHANNEL; CLINICAL SPECTRUM; TYPE-2; GENE; SCA6	Type 2 episodic ataxia (EA2) is the most common subtype among a group of rare hereditary syndromes characterized by recurrent attacks of ataxia. More than 60 mutations and several gene rearrangements due to large deletions in CACNA1A gene have been reported so far for the cause of EA2. Because CACNA1A gene is a large gene containing 47 exons and there is no hot spot mutation, direct sequencing will be a challenge in clinical genetic testing. In this study, we used next generation sequencing technology to identify a novel nonsense mutation of CACNA1A (p.Tyr1957Ter, NP_001120693.1) resulting in truncated protein without 305 amino acids in the c-terminus. Sanger sequencing confirmed the heterozygous mutation of CACNA1A in a Chinese family with 11 affected individuals. Affected individuals experienced recurrent attacks with or without nystagmus, dysarthria, seizure, myokymia, dystonia, weakness, blurred vision, visual field defects, diplopia, migraine, dizziness, nausea and vomiting, sweating and abdominal pain. This is the first report of EA2 in a Chinese family that carries a novel mutation in CACNA1A gene and had abdominal pain as a novel phenotype associated with EA2.	[Hu, Yafang; Jiang, Haishan; Wang, Qun; Xie, Zuoshan; Pan, Suyue] So Med Univ, Nanfang Hosp, Dept Neurol, Guangzhou, Guangdong, Peoples R China	Southern Medical University - China	Pan, SY (corresponding author), So Med Univ, Nanfang Hosp, Dept Neurol, Guangzhou, Guangdong, Peoples R China.	pansuyue82@yahoo.com.cn	Rillig, Matthias C./AAE-6980-2019; HAO, Zhipeng/C-9197-2009; HAO, Zhipeng/AAC-4170-2021; Chen, Baodong/A-7707-2009; Rillig, Matthias C./B-3675-2009; Hu, Yu-Feng/V-1401-2019	Rillig, Matthias C./0000-0003-3541-7853; HAO, Zhipeng/0000-0002-1211-596X; HAO, Zhipeng/0000-0002-1211-596X; Chen, Baodong/0000-0002-1790-7800; Rillig, Matthias C./0000-0003-3541-7853; CHANG, HSIAO-HUANG/0000-0002-0393-4496; Pan, Suyue/0000-0003-2744-1984; Hu, Yu-Feng/0000-0001-5715-2070	Nanfang Hospital, Southern Medical University, China	Nanfang Hospital, Southern Medical University, China	This work was supported by the chief program funding of Nanfang Hospital, Southern Medical University, China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BROWNE DL, 1994, NAT GENET, V8, P136, DOI 10.1038/ng1094-136; Denier C, 1999, NEUROLOGY, V52, P1816, DOI 10.1212/WNL.52.9.1816; Escayg A, 2000, AM J HUM GENET, V66, P1531, DOI 10.1086/302909; Eunson LH, 2005, NEUROLOGY, V65, P308, DOI 10.1212/01.wnl.0000169020.82223.dd; Evans RM, 2006, TRENDS NEUROSCI, V29, P617, DOI 10.1016/j.tins.2006.08.006; Few AP, 2011, J BIOL CHEM, V286, P41917, DOI 10.1074/jbc.M111.292417; Jen J, 2004, NEUROLOGY, V62, P17, DOI 10.1212/01.WNL.0000101675.61074.50; Jen JC, 2007, BRAIN, V130, P2484, DOI 10.1093/brain/awm126; Jen JC, 2005, NEUROLOGY, V65, P529, DOI 10.1212/01.WNL.0000172638.58172.5a; Labrum RW, 2009, J MED GENET, V46, P786, DOI 10.1136/jmg.2009.067967; Mantuano E, 2010, J NEUROL SCI, V291, P30, DOI 10.1016/j.jns.2010.01.010; Matsuyama Z, 2003, J NEUROL SCI, V210, P91, DOI 10.1016/S0022-510X(03)00008-X; Mezghrani A, 2008, J NEUROSCI, V28, P4501, DOI 10.1523/JNEUROSCI.2844-07.2008; MORI Y, 1991, NATURE, V350, P398, DOI 10.1038/350398a0; Ophoff RA, 1996, CELL, V87, P543, DOI 10.1016/S0092-8674(00)81373-2; Page KM, 2010, J BIOL CHEM, V285, P835, DOI 10.1074/jbc.M109.065045; Riant F, 2008, ARCH NEUROL-CHICAGO, V65, P817, DOI 10.1001/archneur.65.6.817; Riant F, 2010, NEUROGENETICS, V11, P101, DOI 10.1007/s10048-009-0208-y; STEA A, 1994, P NATL ACAD SCI USA, V91, P10576, DOI 10.1073/pnas.91.22.10576; Tang BS, 2000, ARCH NEUROL-CHICAGO, V57, P540, DOI 10.1001/archneur.57.4.540; USOWICZ MM, 1992, NEURON, V9, P1185, DOI 10.1016/0896-6273(92)90076-P; Walter JT, 2006, NAT NEUROSCI, V9, P389, DOI 10.1038/nn1648; Wan Jijun, 2011, Front Neurol, V2, P51, DOI 10.3389/fneur.2011.00051; Wang Junling, 2011, Zhong Nan Da Xue Xue Bao Yi Xue Ban, V36, P482, DOI 10.3969/j.issn.1672-7347.2011.06.003; Zhuchenko O, 1997, NAT GENET, V15, P62, DOI 10.1038/ng0197-62	25	89	94	5	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2013	8	2							e56362	10.1371/journal.pone.0056362	http://dx.doi.org/10.1371/journal.pone.0056362			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092YP	23441182	Green Submitted, gold, Green Published			2022-12-25	WOS:000315159200039
J	Hu, YJ; Rillig, MC; Xiang, D; Hao, ZP; Chen, BD				Hu, Yajun; Rillig, Matthias C.; Xiang, Dan; Hao, Zhipeng; Chen, Baodong			Changes of AM Fungal Abundance along Environmental Gradients in the Arid and Semi-Arid Grasslands of Northern China	PLOS ONE			English	Article							ARBUSCULAR MYCORRHIZAL FUNGI; SOIL ORGANIC-CARBON; PARTICLE-SIZE; NITROGEN; GROWTH; TEMPERATURE; PLANT; PHOSPHORUS; DISTRIBUTIONS; COMMUNITIES	Arbuscular mycorrhizal (AM) fungi are ubiquitous symbionts of higher plants in terrestrial ecosystems, while the occurrence of the AM symbiosis is influenced by a complex set of abiotic and biotic factors. To reveal the regional distribution pattern of AM fungi as driven by multiple environmental factors, and to understand the ecological importance of AM fungi in natural ecosystems, we conducted a field investigation on AM fungal abundance along environmental gradients in the arid and semi-arid grasslands of northern China. In addition to plant parameters recorded in situ, soil samples were collected, and soil chemo-physical and biological parameters were measured in the lab. Statistical analyses were performed to reveal the relative contribution of climatic, edaphic and vegetation factors to AM fungal abundance, especially for extraradical hyphal length density (HLD) in the soil. The results indicated that HLD were positively correlated with mean annual temperature (MAT), soil clay content and soil pH, but negatively correlated with both soil organic carbon (SOC) and soil available N. The multiple regressions and structural equation model showed that MAT was the key positive contributor and soil fertility was the key negative contributor to HLD. Furthermore, both the intraradical AM colonization (IMC) and relative abundance of AM fungi, which was quantified by real-time PCR assay, tended to decrease along the increasing SOC content. With regard to the obvious negative correlation between MAT and SOC in the research area, the positive correlation between MAT and HLD implied that AM fungi could potentially mitigate soil carbon losses especially in infertile soils under global warming. However, direct evidence from long-term experiments is still expected to support the AM fungal contribution to soil carbon pools.	[Hu, Yajun; Xiang, Dan; Hao, Zhipeng; Chen, Baodong] Chinese Acad Sci, Ecoenvironm Sci Res Ctr, State Key Lab Urban & Reg Ecol, Beijing, Peoples R China; [Rillig, Matthias C.] Free Univ Berlin, Inst Biol, Dahlem Ctr Plant Sci, Berlin, Germany; [Rillig, Matthias C.] Berlin Brandenburg Inst Adv Biodivers Res BBIB, Berlin, Germany	Chinese Academy of Sciences; Research Center for Eco-Environmental Sciences (RCEES); Free University of Berlin	Chen, BD (corresponding author), Chinese Acad Sci, Ecoenvironm Sci Res Ctr, State Key Lab Urban & Reg Ecol, POB 934, Beijing, Peoples R China.	bdchen@rcees.ac.cn	Rillig, Matthias C./AAE-6980-2019; HAO, Zhipeng/C-9197-2009; HAO, Zhipeng/AAC-4170-2021; Chen, Baodong/A-7707-2009; Rillig, Matthias C./B-3675-2009; Hu, Yu-Feng/V-1401-2019	Rillig, Matthias C./0000-0003-3541-7853; HAO, Zhipeng/0000-0002-1211-596X; HAO, Zhipeng/0000-0002-1211-596X; Chen, Baodong/0000-0002-1790-7800; Rillig, Matthias C./0000-0003-3541-7853; CHANG, HSIAO-HUANG/0000-0002-0393-4496; Pan, Suyue/0000-0003-2744-1984; Hu, Yu-Feng/0000-0001-5715-2070	Knowledge Innovation Program of the Chinese Academy of Sciences [KZCX2-YW-JC403, KZCX2-YW-BR-17]; Joint Project of Ministry of Environmental Protection, P.R. China; Chinese Academy of Sciences [STSN-21-04]; State Key Laboratory of Urban and Regional Ecology, P.R. China [SKLURE2008-1-03]; Alexander-von-Humboldt Foundation fellowship	Knowledge Innovation Program of the Chinese Academy of Sciences(Chinese Academy of SciencesKnowledge Innovation Program of the Chinese Academy of Sciences); Joint Project of Ministry of Environmental Protection, P.R. China; Chinese Academy of Sciences(Chinese Academy of Sciences); State Key Laboratory of Urban and Regional Ecology, P.R. China; Alexander-von-Humboldt Foundation fellowship(Alexander von Humboldt Foundation)	The study was financially supported by the Knowledge Innovation Program of the Chinese Academy of Sciences (KZCX2-YW-JC403 and KZCX2-YW-BR-17), Joint Project of Ministry of Environmental Protection, P.R. China and the Chinese Academy of Sciences (STSN-21-04) and State Key Laboratory of Urban and Regional Ecology, P.R. China (Project SKLURE2008-1-03). BC was supported by an Alexander-von-Humboldt Foundation fellowship during the writing of this paper. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auge RM, 2001, MYCORRHIZA, V11, P3, DOI 10.1007/s005720100097; Bai YF, 2008, ECOLOGY, V89, P2140, DOI 10.1890/07-0992.1; Bohrer G, 2001, J VEG SCI, V12, P279, DOI 10.2307/3236612; Cai Xiaobu, 2005, Yingyong Shengtai Xuebao, V16, P859; Cheng L, 2012, SCIENCE, V337, P1084, DOI 10.1126/science.1224304; CORNFIELD AH, 1960, NATURE, V187, P260, DOI 10.1038/187260a0; Ekschmitt K, 2008, J PLANT NUTR SOIL SC, V171, P27, DOI 10.1002/jpln.200700051; Fierer N, 2005, APPL ENVIRON MICROB, V71, P4117, DOI 10.1128/AEM.71.7.4117-4120.2005; Gaur A, 2000, MYCORRHIZA, V10, P43, DOI 10.1007/s005720050286; Gavito ME, 2005, NEW PHYTOL, V168, P179, DOI 10.1111/j.1469-8137.2005.01481.x; Gryndler M, 2006, MYCORRHIZA, V16, P159, DOI 10.1007/s00572-005-0027-4; Hawkes CV, 2008, GLOBAL CHANGE BIOL, V14, P1181, DOI 10.1111/j.1365-2486.2007.01535.x; HAYMAN DS, 1982, PHYTOPATHOLOGY, V72, P1119; Heinemeyer A, 2004, J EXP BOT, V55, P525, DOI 10.1093/jxb/erh049; Hooper D, 2008, ELECT J BUSINESS RES, V6, P53, DOI DOI 10.21427/D7CF7R; JAKOBSEN I, 1992, NEW PHYTOL, V120, P371, DOI 10.1111/j.1469-8137.1992.tb01077.x; Jennings D.H., 1995, PHYSL FUNGAL NUTR; Johnson NC, 2003, ECOLOGY, V84, P1895, DOI 10.1890/0012-9658(2003)084[1895:NEAMAA]2.0.CO;2; Kaschuk G, 2009, SOIL BIOL BIOCHEM, V41, P1233, DOI 10.1016/j.soilbio.2009.03.005; KOSKE RE, 1987, MYCOLOGIA, V79, P55, DOI 10.2307/3807744; Lekberg Y, 2007, J ECOL, V95, P95, DOI 10.1111/j.1365-2745.2006.01193.x; Lekberg Y, 2011, ECOLOGY, V92, P1292, DOI 10.1890/10-1516.1; Liu A, 2000, PLANT SOIL, V221, P157, DOI 10.1023/A:1004777821422; Lumini E, 2010, ENVIRON MICROBIOL, V12, P2165, DOI 10.1111/j.1462-2920.2009.02099.x; Melillo JM, 2002, SCIENCE, V298, P2173, DOI 10.1126/science.1074153; Nelson D. W., 1996, Methods of soil analysis. Part 3 - chemical methods., P961; Nilsson LO, 2005, NEW PHYTOL, V165, P613, DOI 10.1111/j.1469-8137.2004.01233.x; OLSEN STERLING R., 1954, U S DEPT AGRIC CIRC, V939, P1; PHILLIPS JM, 1970, T BRIT MYCOL SOC, V55, P158, DOI 10.1016/S0007-1536(70)80110-3; READ DJ, 1991, FRONTIERS IN MYCOLOGY, P101; Rillig MC, 2004, CAN J SOIL SCI, V84, P355, DOI 10.4141/S04-003; Rillig MC, 2004, ECOL LETT, V7, P740, DOI 10.1111/j.1461-0248.2004.00620.x; Rillig MC, 2002, OIKOS, V97, P52, DOI 10.1034/j.1600-0706.2002.970105.x; Roda JJ, 2008, ARID LAND RES MANAG, V22, P310, DOI 10.1080/15324980802388199; Rousk J, 2010, ISME J, V4, P1340, DOI 10.1038/ismej.2010.58; Sato Kouichi, 2005, Grassland Science, V51, P179, DOI 10.1111/j.1744-697X.2005.00023.x; Smith SE, 2008, MYCORRHIZAL SYMBIOSIS, 3RD EDITION, P1; Smith SE, 2003, PLANT PHYSIOL, V133, P16, DOI 10.1104/pp.103.024380; SOEDARJO M, 1995, MYCORRHIZA, V5, P337, DOI 10.1007/BF00207406; Staddon PL, 2003, SCIENCE, V300, P1138, DOI 10.1126/science.1084269; TENNANT D, 1975, J ECOL, V63, P995, DOI 10.2307/2258617; Ter Braak C. J. F., 2012, CANOCO REFERENCE MAN; Tian H, 2009, LAND DEGRAD DEV, V20, P41, DOI 10.1002/ldr.876; Treseder KK, 2006, ECOSYSTEMS, V9, P305, DOI 10.1007/s10021-005-0110-x; Treseder KK, 2004, NEW PHYTOL, V164, P347, DOI 10.1111/j.1469-8137.2004.01159.x; Treseder KK, 2002, NEW PHYTOL, V155, P507, DOI 10.1046/j.1469-8137.2002.00470.x; Trouvelot A., 1986, PHYSL GENETICAL ASPE, V39, P217, DOI DOI 10.1177/004057368303900411; TYLER SW, 1992, SOIL SCI SOC AM J, V56, P362, DOI 10.2136/sssaj1992.03615995005600020005x; Verbruggen E, 2013, NEW PHYTOL, V197, P366, DOI 10.1111/nph.12079; Wan YF, 2011, AGR ECOSYST ENVIRON, V141, P23, DOI 10.1016/j.agee.2011.02.004; Wilson GWT, 2009, ECOL LETT, V12, P452, DOI 10.1111/j.1461-0248.2009.01303.x; Wright SF, 1996, SOIL SCI, V161, P575, DOI 10.1097/00010694-199609000-00003; Yang HS, 2011, CATENA, V87, P70, DOI 10.1016/j.catena.2011.05.009; [周涛 Zhou Tao], 2003, [地理学报, Acta Geographica Sinica], V58, P727; Zhu YG, 2003, TRENDS PLANT SCI, V8, P407, DOI 10.1016/S1360-1385(03)00184-5	55	89	94	5	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2013	8	2							e57593	10.1371/journal.pone.0057593	http://dx.doi.org/10.1371/journal.pone.0057593			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115ZB	23441182	Green Published, Green Submitted, gold			2022-12-25	WOS:000316849500118
J	Lin, CW; Chen, PN; Chen, MK; Yang, WE; Tang, CH; Yang, SF; Hsieh, YS				Lin, Chiao-Wen; Chen, Pei-Ni; Chen, Mu-Kuan; Yang, Wei-En; Tang, Chih-Hsin; Yang, Shun-Fa; Hsieh, Yih-Shou			Kaempferol Reduces Matrix Metalloproteinase-2 Expression by Down-Regulating ERK1/2 and the Activator Protein-1 Signaling Pathways in Oral Cancer Cells	PLOS ONE			English	Article							NF-KAPPA-B; PROGNOSTIC-SIGNIFICANCE; COLORECTAL-CANCER; TISSUE INHIBITOR; INVASION; FLAVONOIDS; CARCINOMA; MIGRATION; INACTIVATION; INFLAMMATION	Background: Kaempferol has been proposed as a potential drug for cancer chemoprevention and treatment because it is a natural polyphenol contained in plant-based foods. Recent studies have demonstrated that kaempferol protects against cardiovascular disease and cancer. Based on this finding, we investigated the mechanisms by which kaempferol produces the anti-metastatic effect in human tongue squamous cell carcinoma SCC4 cells. Methodology/Principal Findings: In this study, we provided molecular evidence associated with the anti-metastatic effect of kaempferol by demonstrating a substantial suppression of SCC4 cell migration and invasion. This effect was associated with reduced expressions of MMP-2 and TIMP-2 mRNA and protein levels. Analysis of the transcriptional regulation indicated that kaempferol inhibited MMP-2 transcription by suppressing c-Jun activity. Kaempferol also produced an inhibitory effect on the phosphorylation of ERK1/2. Conclusions: These findings provide new insights into the molecular mechanisms involved in the anti-metastatic effect of kaempferol, and are valuable in the prevention of oral cancer metastasis.	[Lin, Chiao-Wen] Chung Shan Med Univ, Inst Oral Sci, Taichung, Taiwan; [Lin, Chiao-Wen] Chung Shan Med Univ Hosp, Dept Dent, Taichung, Taiwan; [Chen, Pei-Ni; Hsieh, Yih-Shou] Chung Shan Med Univ, Inst Biochem & Biotechnol, Taichung, Taiwan; [Chen, Pei-Ni; Hsieh, Yih-Shou] Chung Shan Med Univ Hosp, Dept Clin Lab, Taichung, Taiwan; [Chen, Mu-Kuan] Changhua Christian Hosp, Dept Otorhinolaryngol Head & Neck Surg, Changhua, Taiwan; [Yang, Wei-En; Yang, Shun-Fa] Chung Shan Med Univ, Inst Med, Taichung, Taiwan; [Tang, Chih-Hsin] China Med Univ, Grad Inst Basic Med Sci, Taichung, Taiwan; [Tang, Chih-Hsin] Asia Univ, Coll Hlth Sci, Dept Biotechnol, Taichung, Taiwan; [Yang, Shun-Fa] Chung Shan Med Univ Hosp, Dept Med Res, Taichung, Taiwan	Chung Shan Medical University; Chung Shan Medical University; Chung Shan Medical University Hospital; Chung Shan Medical University; Chung Shan Medical University; Chung Shan Medical University Hospital; Changhua Christian Hospital; Chung Shan Medical University; China Medical University Taiwan; Asia University Taiwan; Chung Shan Medical University; Chung Shan Medical University Hospital	Yang, SF (corresponding author), Chung Shan Med Univ, Inst Med, Taichung, Taiwan.	ysf@csmu.edu.tw; csmcysh@csmu.edu.tw	Zou, Quan/A-7801-2015; Tang, Chih Hsin/O-5212-2015; Yang, Shun-Fa/AAN-1519-2020	Tang, Chih Hsin/0000-0002-7113-8352; Yang, Shun-Fa/0000-0002-0365-7927; Tsai, Kelvin/0000-0002-1612-2868	National Science Council, Taiwan [NSC-100-2632-B-040-001-MY3]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	This study was financially supported by grants from National Science Council, Taiwan (NSC-100-2632-B-040-001-MY3). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker EA, 2006, BRIT J ORAL MAX SURG, V44, P482, DOI 10.1016/j.bjoms.2005.10.005; Bestwick CS, 2005, BBA-MOL BASIS DIS, V1740, P340, DOI 10.1016/j.bbadis.2004.10.005; Bosetti C, 2005, CANCER EPIDEM BIOMAR, V14, P805, DOI 10.1158/1055-9965.EPI-04-0838; Bosetti C, 2006, NUTR CANCER, V56, P123, DOI 10.1207/s15327914nc5602_1; Bourboulia D, 2013, ONCOTARGET, V4, P166; Calderon-Montano JM, 2011, MINI-REV MED CHEM, V11, P298, DOI 10.2174/138955711795305335; Chen HJ, 2013, ONCOL REP, V30, P925, DOI 10.3892/or.2013.2490; Chen PN, 2006, J DENT RES, V85, P220, DOI 10.1177/154405910608500303; Chen PN, 2005, CHEM-BIOL INTERACT, V156, P141, DOI 10.1016/j.cbi.2005.08.005; Chen YJ, 2008, CANCER SCI, V99, P1507, DOI 10.1111/j.1349-7006.2008.00863.x; Chien MH, 2012, FOOD CHEM TOXICOL, V50, P558, DOI 10.1016/j.fct.2011.12.016; Cortes JR, 2007, J IMMUNOL, V179, P3881, DOI 10.4049/jimmunol.179.6.3881; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; de Vicente JC, 2005, ORAL ONCOL, V41, P568, DOI 10.1016/j.oraloncology.2004.12.008; Deryugina EI, 2006, CANCER METAST REV, V25, P9, DOI 10.1007/s10555-006-7886-9; Douglas DA, 1997, J PROTEIN CHEM, V16, P237, DOI 10.1023/A:1026348808069; Forastiere AA, 2003, NEW ENGL J MED, V349, P2091, DOI 10.1056/NEJMoa031317; Fuhrman B, 2001, CURR OPIN LIPIDOL, V12, P41, DOI 10.1097/00041433-200102000-00008; Gohji K, 1996, CANCER RES, V56, P3196; Hong IK, 2005, EXP MOL MED, V37, P230, DOI 10.1038/emm.2005.31; Hong S, 2005, J BIOL CHEM, V280, P25202, DOI 10.1074/jbc.M413985200; Hsieh YS, 2007, CARCINOGENESIS, V28, P977, DOI 10.1093/carcin/bgl221; Huang WW, 2013, INT J ONCOL, V42, P2069, DOI 10.3892/ijo.2013.1909; Huang YB, 2013, INT J UROL; Iype E M, 2001, J Postgrad Med, V47, P171; Jeong JC, 2009, NEUROCHEM RES, V34, P991, DOI 10.1007/s11064-008-9868-5; Kang JW, 2010, PHYTOTHER RES, V24, pS77, DOI 10.1002/ptr.2913; Kawabata K, 2005, BIOSCI BIOTECH BIOCH, V69, P307, DOI 10.1271/bbb.69.307; Labbe D, 2009, J NUTR, V139, P646, DOI 10.3945/jn.108.102616; Leifler KS, 2013, J IMMUNOL, V190, P4420, DOI 10.4049/jimmunol.1202610; LIOTTA LA, 1980, NATURE, V284, P67, DOI 10.1038/284067a0; Luo HT, 2009, NUTR CANCER, V61, P554, DOI 10.1080/01635580802666281; Ma CY, 2011, J AGR FOOD CHEM, V59, P9032, DOI 10.1021/jf202027n; Marfe G, 2009, J CELL BIOCHEM, V106, P643, DOI 10.1002/jcb.22044; Massano J, 2006, ORAL SURG ORAL MED O, V102, P67, DOI 10.1016/j.tripleo.2005.07.038; Mink PJ, 2007, AM J CLIN NUTR, V85, P895, DOI 10.1093/ajcn/85.3.895; Nijveldt RJ, 2001, AM J CLIN NUTR, V74, P418; Peng CY, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/732578; Rossi M, 2006, CANCER EPIDEM BIOMAR, V15, P1555, DOI 10.1158/1055-9965.EPI-06-0017; Shan B, 2013, ASIAN PAC J TROP MED, V6, P826, DOI 10.1016/S1995-7645(13)60146-7; Sun CY, 2006, ACTA PHARMACOL SIN, V27, P1447, DOI 10.1111/j.1745-7254.2006.00343.x; Valente P, 1998, INT J CANCER, V75, P246, DOI 10.1002/(SICI)1097-0215(19980119)75:2<246::AID-IJC13>3.0.CO;2-B; Wang XX, 2013, TUMOUR BIOL; Weng CJ, 2008, CARCINOGENESIS, V29, P147, DOI 10.1093/carcin/bgm261; Westermarck J, 1999, FASEB J, V13, P781, DOI 10.1096/fasebj.13.8.781; Xiao HB, 2009, EUR J PHARMACOL, V616, P213, DOI 10.1016/j.ejphar.2009.06.022; Yang JS, 2013, FOOD CHEM TOXICOL, V59, P801, DOI 10.1016/j.fct.2013.06.028; Yang SF, 2010, FOOD CHEM TOXICOL, V48, P1052, DOI 10.1016/j.fct.2010.01.019; Yu YL, 2010, J AGR FOOD CHEM, V58, P1630, DOI 10.1021/jf903043r; Zhao MJ, 2013, INT J MED SCI, V10, P995, DOI 10.7150/ijms.5963	50	410	418	5	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2013	8	11							e80883	10.1371/journal.pone.0080883	http://dx.doi.org/10.1371/journal.pone.0080883			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256LY	24278338	Green Published, Green Submitted, gold			2022-12-25	WOS:000327313100123
J	Lin, C; Zou, Y; Qin, J; Liu, XR; Jiang, Y; Ke, CH; Zou, Q				Lin, Chen; Zou, Ying; Qin, Ji; Liu, Xiangrong; Jiang, Yi; Ke, Caihuan; Zou, Quan			Hierarchical Classification of Protein Folds Using a Novel Ensemble Classifier	PLOS ONE			English	Article							REPRESENTATIVE SET; SCOP; RECOGNITION; SELECTION; DATABASE; IMPACT	The analysis of biological information from protein sequences is important for the study of cellular functions and interactions, and protein fold recognition plays a key role in the prediction of protein structures. Unfortunately, the prediction of protein fold patterns is challenging due to the existence of compound protein structures. Here, we processed the latest release of the Structural Classification of Proteins (SCOP, version 1.75) database and exploited novel techniques to impressively increase the accuracy of protein fold classification. The techniques proposed in this paper include ensemble classifying and a hierarchical framework, in the first layer of which similar or redundant sequences were deleted in two manners; a set of base classifiers, fused by various selection strategies, divides the input into seven classes; in the second layer of which, an analogous ensemble method is adopted to predict all protein folds. To our knowledge, it is the first time all protein folds can be intelligently detected hierarchically. Compared with prior studies, our experimental results demonstrated the efficiency and effectiveness of our proposed method, which achieved a success rate of 74.21%, which is much higher than results obtained with previous methods (ranging from 45.6% to 70.5%). When applied to the second layer of classification, the prediction accuracy was in the range between 23.13% and 46.05%. This value, which may not be remarkably high, is scientifically admirable and encouraging as compared to the relatively low counts of proteins from most fold recognition programs. The web server Hierarchical Protein Fold Prediction (HPFP) is available at http://datamining.xmu.edu.cn/software/hpfp.	[Lin, Chen; Zou, Ying; Liu, Xiangrong; Jiang, Yi; Zou, Quan] Xiamen Univ, Sch Informat Sci & Technol, Xiamen, Peoples R China; [Qin, Ji; Ke, Caihuan] Xiamen Univ, Coll Oceanog & Environm Sci, Xiamen, Peoples R China; [Lin, Chen; Liu, Xiangrong] Xiamen Univ, Shenzhen Res Inst, Shenzhen, Peoples R China	Xiamen University; Xiamen University; Xiamen University	Lin, C (corresponding author), Xiamen Univ, Sch Informat Sci & Technol, Xiamen, Peoples R China.	chenlin@xmu.edu.cn; zouquan@xmu.edu.cn	Zou, Quan/A-7801-2015; Tang, Chih Hsin/O-5212-2015; Yang, Shun-Fa/AAN-1519-2020	Tang, Chih Hsin/0000-0002-7113-8352; Yang, Shun-Fa/0000-0002-0365-7927; Tsai, Kelvin/0000-0002-1612-2868	Natural Science Foundation of China [61001013, 61102136]; Natural Science Foundation of Fujian Province of China [2011J05158, 2010J01350]; National Basic Research Program of China [2010CB1264000]; Base Research Project of Shenzhen Bureau of Science, Technology and Information [JC201006030858A, JCYJ20120618155655087]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Fujian Province of China(Natural Science Foundation of Fujian Province); National Basic Research Program of China(National Basic Research Program of China); Base Research Project of Shenzhen Bureau of Science, Technology and Information	The work was supported by the Natural Science Foundation of China (No. 61001013, No. 61102136), Natural Science Foundation of Fujian Province of China (No. 2011J05158, No. 2010J01350), The National Basic Research Program of China (No. 2010CB1264000) and the Base Research Project of Shenzhen Bureau of Science, Technology and Information(JC201006030858A, JCYJ20120618155655087). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreeva A, 2008, NUCLEIC ACIDS RES, V36, pD419, DOI 10.1093/nar/gkm993; BOBERG J, 1992, PROTEINS, V14, P265, DOI 10.1002/prot.340140212; Boisvert S, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-110; Bologna G, 2003, ARTIF INTELL MED, V28, P141, DOI 10.1016/S0933-3657(03)00055-1; Breiman L, 2001, MACH LEARN, V45, P5, DOI 10.1023/A:1010933404324; Cai CZ, 2003, NUCLEIC ACIDS RES, V31, P3692, DOI 10.1093/nar/gkg600; Cai YD, 2003, ANAL BIOCHEM, V268, P407; Cai YD, 2010, MOL CELLS, V30, P99, DOI 10.1007/s10059-010-0093-0; Chen K, 2007, BIOINFORMATICS, V23, P2843, DOI 10.1093/bioinformatics/btm475; Chen W, 2012, GENET MOL RES, V11, P174, DOI 10.4238/2012.January.27.4; Cheng XY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038979; Chou KC, 2004, CURR MED CHEM, V11, P2105, DOI 10.2174/0929867043364667; CHOU KC, 1995, CRIT REV BIOCHEM MOL, V30, P275, DOI 10.3109/10409239509083488; CHOU KC, 1991, PROTEINS, V9, P280, DOI 10.1002/prot.340090406; Ding CHQ, 2001, BIOINFORMATICS, V17, P349, DOI 10.1093/bioinformatics/17.4.349; Dubchak I, 1999, PROTEINS, V35, P401, DOI 10.1002/(SICI)1097-0134(19990601)35:4<401::AID-PROT3>3.0.CO;2-K; Feng JH, 2012, VLDB J, V21, P437, DOI 10.1007/s00778-011-0252-8; FINKELSTEIN AV, 1987, PROG BIOPHYS MOL BIO, V50, P171, DOI 10.1016/0079-6107(87)90013-7; Hartigan J. A., 1979, Applied Statistics, V28, P100, DOI 10.2307/2346830; HOBOHM U, 1994, PROTEIN SCI, V3, P522; HOBOHM U, 1992, PROTEIN SCI, V1, P409; Holm L, 1999, NUCLEIC ACIDS RES, V27, P244, DOI 10.1093/nar/27.1.244; Honda M, 2005, J AUTOIMMUN, V25, P133, DOI 10.1016/j.jaut.2005.03.009; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159; Nanni L, 2006, NEUROCOMPUTING, V69, P2434, DOI 10.1016/j.neucom.2006.01.026; Shen HB, 2006, BIOINFORMATICS, V22, P1717, DOI 10.1093/bioinformatics/btl170; Shen HB, 2009, J THEOR BIOL, V256, P441, DOI 10.1016/j.jtbi.2008.10.007; Vendruscolo M, 2005, P NATL ACAD SCI USA, V102, P5641, DOI 10.1073/pnas.0500274102; Zhang W, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002325; Zhou ZH, 2002, ARTIF INTELL, V137, P239, DOI 10.1016/S0004-3702(02)00190-X; Zou Q, 2013, J COMPUT THEOR NANOS, V10, P1038, DOI 10.1166/jctn.2013.2804	31	410	418	5	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e56499	10.1371/journal.pone.0056499	http://dx.doi.org/10.1371/journal.pone.0056499			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	24278338	Green Submitted, Green Published, gold			2022-12-25	WOS:000315184200085
